PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Ganmor, E; Katz, Y; Lampl, I				Ganmor, Elad; Katz, Yonatan; Lampl, Ilan			Intensity-Dependent Adaptation of Cortical and Thalamic Neurons Is Controlled by Brainstem Circuits of the Sensory Pathway	NEURON			English	Article							RAT BARREL CORTEX; PERIODIC WHISKER DEFLECTIONS; UNDERLYING CONTRAST ADAPTATION; NEOCORTICAL PYRAMIDAL NEURONS; INFORMATION-PROCESSING STATES; PRINCIPAL TRIGEMINAL NUCLEUS; SOMATOSENSORY CORTEX; VISUAL-CORTEX; IN-VIVO; RETICULAR NUCLEUS	Current views of sensory adaptation in the rat somatosensory system suggest that it results mainly from short-term synaptic depression. Experimental and theoretical studies predict that increasing the intensity of sensory stimulation, followed by an increase in firing probability at early sensory stages, is expected to attenuate the response at later stages disproportionately more than weaker stimuli, due to greater depletion of synaptic resources and the relatively slow recovery process. This may lead to coding ambiguity of stimulus intensity during adaptation. In contrast, we found that increasing the intensity of repetitive whisker stimulation entails less adaptation in cortical neurons. In a series of recordings, from the trigeminal ganglion to the thalamus, we pinpointed the source of the unexpected pattern of adaptation to the brainstem trigeminal complex. We suggest that low-level sensory processing counterbalances later effects of short-term synaptic depression by increasing the throughput of high-intensity sensory inputs	[Ganmor, Elad; Katz, Yonatan; Lampl, Ilan] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Lampl, I (corresponding author), Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel.	ilan.lampl@weizmann.ac.il		Lampl, Ilan/0000-0002-9380-0730; Katz, Yonatan/0000-0002-1256-9515; Katz, Yonatan/0000-0003-1674-0508	Israel Science Foundation [326/07]; Minerva Foundation; Federal German Ministry for Education and Research; Israeli Ministry of Science and Technology; Henry S. and Anne Reich Research Fund for Mental Health; Asher and Jeanette Alhadeff Research Award; Sir Charles Clore fellowship	Israel Science Foundation(Israel Science Foundation); Minerva Foundation; Federal German Ministry for Education and Research(Federal Ministry of Education & Research (BMBF)); Israeli Ministry of Science and Technology(Ministry of Science, Technology and Space (MOST), Israel); Henry S. and Anne Reich Research Fund for Mental Health; Asher and Jeanette Alhadeff Research Award; Sir Charles Clore fellowship	We would like to thank Marina Taran and Valerie Mazig for their help with the histological reconstructions and Prof. M. Tsodyks and Muna Jubran for their helpful comments on this work. This work was supported by Grant No 326/07 from the Israel Science Foundation and by the Minerva Foundation funded by the Federal German Ministry for Education and Research and the Israeli Ministry of Science and Technology. Support was provided also by the Henry S. and Anne Reich Research Fund for Mental Health, the Asher and Jeanette Alhadeff Research Award, and Sir Charles Clore fellowship.	Adorjan P, 1999, REV NEUROSCIENCE, V10, P181; Andermann ML, 2006, NAT NEUROSCI, V9, P543, DOI 10.1038/nn1671; Arabzadeh E, 2005, PLOS BIOL, V3, P155, DOI 10.1371/journal.pbio.0030017; Arabzadeh E, 2003, J NEUROSCI, V23, P9146; Arabzadeh E, 2006, J NEUROSCI, V26, P9216, DOI 10.1523/JNEUROSCI.1491-06.2006; Beierlein M, 2002, J NEUROPHYSIOL, V88, P1924, DOI 10.1152/jn.2002.88.4.1924; Bellavance MA, 2010, J NEUROSCI, V30, P1057, DOI 10.1523/JNEUROSCI.4805-09.2010; Berg RW, 2003, J NEUROPHYSIOL, V89, P104, DOI 10.1152/jn.00600.2002; Blakemore C., 2010, VISION CODING EFFICI, P363, DOI 10.1017/cbo9780511626197.034; Brecht M, 2002, J PHYSIOL-LONDON, V543, P49, DOI 10.1113/jphysiol.2002.018465; Brenner N, 2000, NEURON, V26, P695, DOI 10.1016/S0896-6273(00)81205-2; Bruno RM, 2006, SCIENCE, V312, P1622, DOI 10.1126/science.1124593; Carandini M, 1997, SCIENCE, V276, P949, DOI 10.1126/science.276.5314.949; Carvalho TP, 2009, NEURON, V61, P774, DOI 10.1016/j.neuron.2009.01.013; Castro-Alamancos MA, 2004, NEURON, V41, P455, DOI 10.1016/S0896-6273(03)00853-5; Castro-Alamancos MA, 2002, J NEUROPHYSIOL, V87, P946, DOI 10.1152/jn.00426.2001; Castro-Alamancos MA, 2002, J PHYSIOL-LONDON, V539, P567, DOI 10.1113/jphysiol.2001.013283; Chance FS, 1998, J NEUROSCI, V18, P4785; Chelaru MI, 2008, CEREB CORTEX, V18, P771, DOI 10.1093/cercor/bhm119; Chung S, 2002, NEURON, V34, P437, DOI 10.1016/S0896-6273(02)00659-1; Cotillon-Williams N, 2008, J NEUROPHYSIOL, V99, P1137, DOI 10.1152/jn.01159.2007; Deschenes M, 2003, J NEUROSCI, V23, P6778; Diaz-Quesada M, 2008, J NEUROSCI, V28, P696, DOI 10.1523/JNEUROSCI.4931-07.2008; Dragoi V, 2002, NAT NEUROSCI, V5, P883, DOI 10.1038/nn900; Ego-Stengel V, 2005, J NEUROPHYSIOL, V93, P1450, DOI 10.1152/jn.00912.2004; Fairhall AL, 2001, NATURE, V412, P787, DOI 10.1038/35090500; Fraser G, 2006, SOMATOSENS MOT RES, V23, P111, DOI 10.1080/08990220600906589; Fuhrmann G, 2004, J PHYSIOL-LONDON, V557, P415, DOI 10.1113/jphysiol.2003.058107; Furuta T, 2008, J NEUROSCI, V28, P1789, DOI 10.1523/JNEUROSCI.4627-07.2008; Gabernet L, 2005, NEURON, V48, P315, DOI 10.1016/j.neuron.2005.09.022; Gil Z, 1997, NEURON, V19, P679, DOI 10.1016/S0896-6273(00)80380-3; Gil Z, 1999, NEURON, V23, P385, DOI 10.1016/S0896-6273(00)80788-6; GOTTSCHALDT KM, 1981, SCIENCE, V214, P183, DOI 10.1126/science.7280690; Hartings JA, 2003, J NEUROPHYSIOL, V90, P3087, DOI 10.1152/jn.00469.2003; Heiss JE, 2008, J NEUROSCI, V28, P13320, DOI 10.1523/JNEUROSCI.2646-08.2008; Higley MJ, 2006, J NEUROSCI, V26, P448, DOI 10.1523/JNEUROSCI.3506-05.2006; JACQUIN MF, 1990, SOMATOSENS MOT RES, V7, P399, DOI 10.3109/08990229009144716; Jones LM, 2004, J NEUROPHYSIOL, V92, P665, DOI 10.1152/jn.00031.2004; Katz Y, 2006, J NEUROSCI, V26, P13363, DOI 10.1523/JNEUROSCI.4056-06.2006; Kerr JND, 2007, J NEUROSCI, V27, P13316, DOI 10.1523/JNEUROSCI.2210-07.2007; Khatri V, 2004, J NEUROPHYSIOL, V92, P3244, DOI 10.1152/jn.00257.2004; Kohn A, 2007, J NEUROPHYSIOL, V97, P3155, DOI 10.1152/jn.00086.2007; Landisman CE, 2007, CEREB CORTEX, V17, P2853, DOI 10.1093/cercor/bhm025; Lo FS, 1999, J NEUROPHYSIOL, V82, P2765, DOI 10.1152/jn.1999.82.5.2765; Lundstrom BN, 2008, NAT NEUROSCI, V11, P1335, DOI 10.1038/nn.2212; Maravall M, 2007, PLOS BIOL, V5, P323, DOI 10.1371/journal.pbio.0050019; Moore CI, 1998, J NEUROPHYSIOL, V80, P2882, DOI 10.1152/jn.1998.80.6.2882; Muller JR, 1999, SCIENCE, V285, P1405, DOI 10.1126/science.285.5432.1405; Paxinos G., 1986, RAT BRAIN STEREOTAXI, V2nd; Petersen CCH, 2003, PFLUG ARCH EUR J PHY, V447, P126, DOI 10.1007/s00424-003-1167-z; Pierret T, 2000, J NEUROSCI, V20, P7455; Pinault D, 2004, BRAIN RES REV, V46, P1, DOI 10.1016/j.brainresrev.2004.04.008; Pinto DJ, 2000, J NEUROPHYSIOL, V83, P1158, DOI 10.1152/jn.2000.83.3.1158; Ray S, 2008, J NEUROSCI, V28, P7334, DOI 10.1523/JNEUROSCI.1588-08.2008; Sanchez-Vives MV, 2000, J NEUROSCI, V20, P4267; Sanchez-Vives MV, 2000, J NEUROSCI, V20, P4286; Sarid L, 2007, P NATL ACAD SCI USA, V104, P16353, DOI 10.1073/pnas.0707853104; Sharpee TO, 2006, NATURE, V439, P936, DOI 10.1038/nature04519; SHOSAKU A, 1989, PROG NEUROBIOL, V32, P77, DOI 10.1016/0301-0082(89)90011-7; Shoykhet M, 2000, SOMATOSENS MOT RES, V17, P171; Temereanca S, 2008, J NEUROSCI, V28, P11153, DOI 10.1523/JNEUROSCI.1586-08.2008; Tsodyks M, 1998, NEURAL COMPUT, V10, P821, DOI 10.1162/089976698300017502; Tsodyks MV, 1997, P NATL ACAD SCI USA, V94, P719, DOI 10.1073/pnas.94.2.719; Ulanovsky N, 2003, NAT NEUROSCI, V6, P391, DOI 10.1038/nn1032; Urbain N, 2007, J NEUROSCI, V27, P12407, DOI 10.1523/JNEUROSCI.2914-07.2007; Veinante P, 1999, J NEUROSCI, V19, P5085; WAINWRIGHT MJ, 2002, NATURAL IMAGE STAT D; Wark B, 2007, CURR OPIN NEUROBIOL, V17, P423, DOI 10.1016/j.conb.2007.07.001; Wehr M, 2005, NEURON, V47, P437, DOI 10.1016/j.neuron.2005.06.009; Wilent WB, 2004, J NEUROSCI, V24, P3985, DOI 10.1523/JNEUROSCI.5782-03.2004; Yu CX, 2006, PLOS BIOL, V4, P819, DOI 10.1371/journal.pbio.0040124; Yu XJ, 2009, J NEUROPHYSIOL, V101, P980, DOI 10.1152/jn.91130.2008; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	73	36	37	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 29	2010	66	2					273	286		10.1016/j.neuron.2010.03.032	http://dx.doi.org/10.1016/j.neuron.2010.03.032			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	591NQ	20435003	Bronze			2022-12-24	WOS:000277308200012
J	Martinez-Cerdeno, V; Noctor, SC; Espinosa, A; Ariza, J; Parker, P; Orasji, S; Daadi, MM; Bankiewicz, K; Alvarez-Buylla, A; Kriegstein, AR				Martinez-Cerdeno, Veronica; Noctor, Stephen C.; Espinosa, Ana; Ariza, Jeanelle; Parker, Philip; Orasji, Samantha; Daadi, Marcel M.; Bankiewicz, Krystof; Alvarez-Buylla, Arturo; Kriegstein, Arnold R.			Embryonic MGE Precursor Cells Grafted into Adult Rat Striatum Integrate and Ameliorate Motor Symptoms in 6-OHDA-Lesioned Rats	CELL STEM CELL			English	Article							MEDIAL GANGLIONIC EMINENCE; PARKINSONS-DISEASE; PROJECTION NEURONS; GABAERGIC INTERNEURONS; GENE-THERAPY; DLX GENES; GAD GENE; MODEL; NEOSTRIATUM; FOREBRAIN	We investigated a strategy to ameliorate the motor symptoms of rats that received 6-hydroxydopamine (6-OHDA) lesions, a rodent model of Parkinson's disease, through transplantation of embryonic medial ganglionic eminence (MGE) cells into the striatum. During brain development, embryonic MGE cells migrate into the striatum and neocortex where they mature into GABAergic interneurons and play a key role in establishing the balance between excitation and inhibition. Unlike most other embryonic neurons, MGE cells retain the capacity for migration and integration when transplanted into the postnatal and adult brain. We performed MGE cell transplantation into the basal ganglia of control and 6-OHDA-lesioned rats. Transplanted MGE cells survived, differentiated into GABA(+) neurons, integrated into host circuitry, and modifed motor behavior in both lesioned and control rats. Our data suggest that MGE cell transplantation into the striatum is a promising approach to investigate the potential benefits of remodeling basal ganglia circuitry in neurodegenerative diseases.	[Martinez-Cerdeno, Veronica; Noctor, Stephen C.; Ariza, Jeanelle; Parker, Philip; Kriegstein, Arnold R.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Espinosa, Ana] Univ Miguel Hernandez, E-03550 Alacant, Spain; [Espinosa, Ana] CSIC, Inst Neurociencias Alicante, E-03550 Alacant, Spain; [Orasji, Samantha] Leiden Univ, Med Ctr, NL-2300 Leiden, Netherlands; [Daadi, Marcel M.; Bankiewicz, Krystof; Alvarez-Buylla, Arturo] Univ Calif San Francisco, Dept Neurosurg, San Francisco, CA 94143 USA; [Martinez-Cerdeno, Veronica; Noctor, Stephen C.; Ariza, Jeanelle; Parker, Philip; Alvarez-Buylla, Arturo; Kriegstein, Arnold R.] Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; Universidad Miguel Hernandez de Elche; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Miguel Hernandez de Elche; CSIC-UMH - Instituto de Neurociencias de Alicante (IN); Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Martinez-Cerdeno, V (corresponding author), Univ Calif Davis, Shriners Hosp No Calif, Inst Pediat Regenerat Med, 2425 Stockton BLVD, Sacramento, CA 95817 USA.	vmartinezcerdeno@ucdavis.edu; kriegsteina@stemcell.ucsf.edu	Espinosa Martínez, Ana Belén/AAD-4487-2021	Espinosa Martínez, Ana Belén/0000-0002-3738-3514; Parker, Philip R. L./0000-0002-6224-9747; Alvarez-Buylla, Arturo/0000-0003-4426-8925	Rudd Foundation; Bernard Osher Foundation; FPI fellowship [BFU2004-04660]; Neurona Therapeutics; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD032116] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS028478] Funding Source: NIH RePORTER	Rudd Foundation; Bernard Osher Foundation; FPI fellowship(Spanish Government); Neurona Therapeutics; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank William Walantus and Eduardo Esquenazi for technical assistance, Dr. Joseph Lo Turco and Dr. John Rubenstein for helpful comments on the manuscript, Dr. John Rubenstein, Dr. Scott Baraban, and the UCSF MGE group for helpful advice on this project, and Francoise Chanut for editing an early version of the manuscript. The authors would like to acknowledge support from the Rudd Foundation, the Bernard Osher Foundation, and the FPI fellowship (associated to project BFU2004-04660) to A.E. A.R.K. and A.A.-B. are cofounders of and have a financial interest in Neurona Therapeutics.	Alvarez-Dolado M, 2006, J NEUROSCI, V26, P7380, DOI 10.1523/JNEUROSCI.1540-06.2006; Anderson S, 1999, CEREB CORTEX, V9, P646, DOI 10.1093/cercor/9.6.646; Anderson SA, 1997, SCIENCE, V278, P474, DOI 10.1126/science.278.5337.474; Anderson SA, 1997, NEURON, V19, P27, DOI 10.1016/S0896-6273(00)80345-1; Benabid AL, 2000, ARCH MED RES, V31, P282, DOI 10.1016/S0188-4409(00)00077-1; BERGER K, 1991, BRAIN RES BULL, V26, P301, DOI 10.1016/0361-9230(91)90242-C; Butt SJB, 2005, NEURON, V48, P591, DOI 10.1016/j.neuron.2005.09.034; Campbell K, 1995, NEURON, V15, P1259, DOI 10.1016/0896-6273(95)90006-3; CREESE I, 1977, SCIENCE, V197, P596, DOI 10.1126/science.877576; Daadi MM, 2009, CELL TRANSPLANT, V18, P815, DOI 10.3727/096368909X470829; DAHL CB, 1989, PHARMACOL TOXICOL, V64, P302, DOI 10.1111/j.1600-0773.1989.tb00652.x; DEACON TW, 1994, BRAIN RES, V668, P211, DOI 10.1016/0006-8993(94)90526-6; DeFelipe J, 1999, J COMP NEUROL, V412, P515, DOI 10.1002/(SICI)1096-9861(19990927)412:3<515::AID-CNE10>3.0.CO;2-1; DeLong MR, 2007, ARCH NEUROL-CHICAGO, V64, P20, DOI 10.1001/archneur.64.1.20; Du YZ, 2002, J NEUROSCI RES, V68, P647, DOI 10.1002/jnr.10245; During M J, 2001, Hum Gene Ther, V12, P1589; Goto S, 1997, EXP NEUROL, V147, P503, DOI 10.1006/exnr.1997.6628; GrasbonFrodl EM, 1997, NEUROBIOL DIS, V3, P299, DOI 10.1006/nbdi.1996.0124; HUDSON JL, 1993, BRAIN RES, V626, P167, DOI 10.1016/0006-8993(93)90576-9; Kaplitt MG, 2007, LANCET, V369, P2097, DOI 10.1016/S0140-6736(07)60982-9; Kawaguchi Y, 1997, NEUROSCI RES, V27, P1, DOI 10.1016/S0168-0102(96)01134-0; KAWAGUCHI Y, 1995, TRENDS NEUROSCI, V18, P527, DOI 10.1016/0166-2236(95)98374-8; KAWAGUCHI Y, 1993, J NEUROSCI, V13, P4908; Koos T, 1999, NAT NEUROSCI, V2, P467, DOI 10.1038/8138; Koos T, 2004, J NEUROSCI, V24, P7916, DOI 10.1523/JNEUROSCI.2163-04.2004; KUBOTA Y, 1994, BRAIN RES, V649, P159, DOI 10.1016/0006-8993(94)91060-X; Larsson E, 2001, BRAIN RES, V913, P117, DOI 10.1016/S0006-8993(01)02762-7; Lavdas AA, 1999, J NEUROSCI, V19, P7881; Lee B, 2005, GENE THER, V12, P1215, DOI 10.1038/sj.gt.3302520; Litvan I, 2007, J NEUROPATH EXP NEUR, V66, P251, DOI 10.1097/nen.0b013e3180415e42; LJUNGBERG T, 1976, EUR J PHARMACOL, V36, P181, DOI 10.1016/0014-2999(76)90270-3; Luk KC, 2001, NEUROSCIENCE, V104, P93, DOI 10.1016/S0306-4522(01)00038-0; Luo J, 2002, SCIENCE, V298, P425, DOI 10.1126/science.1074549; Mallet N, 2006, J NEUROSCI, V26, P3875, DOI 10.1523/JNEUROSCI.4439-05.2006; Marin O, 2000, J NEUROSCI, V20, P6063; Modo M, 2003, NEUROREPORT, V14, P39, DOI 10.1097/00001756-200301200-00007; Noctor SC, 2008, J COMP NEUROL, V508, P28, DOI 10.1002/cne.21669; Olsson M, 1998, NEUROSCIENCE, V84, P867, DOI 10.1016/S0306-4522(97)00532-0; Olsson M, 1997, NEUROSCIENCE, V79, P57, DOI 10.1016/S0306-4522(96)00606-9; OLSSON M, 1995, NEUROSCIENCE, V69, P1169, DOI 10.1016/0306-4522(95)00325-D; Paxinos G., 2004, J CHEM INF MODEL, V5th; Piccini P, 2002, LANCET NEUROL, V1, P472, DOI 10.1016/S1474-4422(02)00235-1; Plenz D, 1998, J NEUROSCI, V18, P266; Pow DV, 2005, CELL TISSUE RES, V320, P379, DOI 10.1007/s00441-004-0928-0; Rymar VV, 2004, J COMP NEUROL, V469, P325, DOI 10.1002/cne.11008; Salin P, 2009, NEUROBIOL DIS, V34, P545, DOI 10.1016/j.nbd.2009.03.006; Tepper JM, 2004, CURR OPIN NEUROBIOL, V14, P685, DOI 10.1016/j.conb.2004.10.003; Terpstra BT, 2007, J NEUROSCI METH, V166, P13, DOI 10.1016/j.jneumeth.2007.06.022; UNGERSTEDT U, 1971, ACTA PHYSIOL SCAND, P49; UNGERSTEDT U, 1970, Brain Research, V24, P485, DOI 10.1016/0006-8993(70)90187-3; West MJ, 1996, J COMP NEUROL, V370, P11; Wichterle H, 1999, NAT NEUROSCI, V2, P461, DOI 10.1038/8131; Wilkins A, 2003, J NEUROSCI, V23, P4967, DOI 10.1523/jneurosci.23-12-04967.2003; Winkler C, 1999, EXP NEUROL, V155, P165, DOI 10.1006/exnr.1998.6916; Zhao YG, 2003, P NATL ACAD SCI USA, V100, P9005, DOI 10.1073/pnas.1537759100	55	82	84	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	MAR 5	2010	6	3					238	250		10.1016/j.stem.2010.01.004	http://dx.doi.org/10.1016/j.stem.2010.01.004			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	577WL	20207227	Green Accepted, Green Submitted, Bronze			2022-12-24	WOS:000276254600011
J	Hayashi-Takagi, A; Takaki, M; Graziane, N; Seshadri, S; Murdoch, H; Dunlop, AJ; Makino, Y; Seshadri, AJ; Ishizuka, K; Srivastava, DP; Xie, Z; Baraban, JM; Houslay, MD; Tomoda, T; Brandon, NJ; Kamiya, A; Yan, Z; Penzes, P; Sawa, A				Hayashi-Takagi, Akiko; Takaki, Manabu; Graziane, Nick; Seshadri, Saurav; Murdoch, Hannah; Dunlop, Allan J.; Makino, Yuichi; Seshadri, Anupamaa J.; Ishizuka, Koko; Srivastava, Deepak P.; Xie, Zhong; Baraban, Jay M.; Houslay, Miles D.; Tomoda, Toshifumi; Brandon, Nicholas J.; Kamiya, Atsushi; Yan, Zhen; Penzes, Peter; Sawa, Akira			Disrupted-in-Schizophrenia 1 (DISC1) regulates spines of the glutamate synapse via Rac1	NATURE NEUROSCIENCE			English	Article							CORTICAL PYRAMIDAL NEURONS; NMDA RECEPTOR ACTIVATION; DENDRITIC SPINES; EXCITATORY SYNAPSES; PLASTICITY; SUSCEPTIBILITY; ARCHITECTURE; DENSITY; COMPLEX; PROTEIN	Synaptic spines are dynamic structures that regulate neuronal responsiveness and plasticity. We examined the role of the schizophrenia risk factor DISC1 in the maintenance of spine morphology and function. We found that DISC1 anchored Kalirin-7 (Kal-7), regulating access of Kal-7 to Rac1 and controlling the duration and intensity of Rac1 activation in response to NMDA receptor activation in both cortical cultures and rat brain in vivo. These results explain why Rac1 and its activator (Kal-7) serve as important mediators of spine enlargement and why constitutive Rac1 activation decreases spine size. This mechanism likely underlies disturbances in glutamatergic neurotransmission that have been frequently reported in schizophrenia that can lead to alteration of dendritic spines with consequential major pathological changes in brain function. Furthermore, the concept of a signalosome involving disease-associated factors, such as DISC1 and glutamate, may well contribute to the multifactorial and polygenetic characteristics of schizophrenia.	[Hayashi-Takagi, Akiko; Takaki, Manabu; Seshadri, Saurav; Seshadri, Anupamaa J.; Ishizuka, Koko; Kamiya, Atsushi; Sawa, Akira] Johns Hopkins Univ, Sch Med, Dept Psychiat, Baltimore, MD 21205 USA; [Graziane, Nick; Yan, Zhen] SUNY Buffalo, Dept Physiol & Biophys, Buffalo, NY 14260 USA; [Murdoch, Hannah; Dunlop, Allan J.; Houslay, Miles D.] Univ Glasgow, Fac Biomed & Life Sci, Glasgow, Lanark, Scotland; [Makino, Yuichi; Baraban, Jay M.; Sawa, Akira] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; [Srivastava, Deepak P.; Xie, Zhong; Penzes, Peter] Northwestern Univ, Feinberg Sch Med, Dept Physiol, Chicago, IL 60611 USA; [Tomoda, Toshifumi] City Hope Natl Med Ctr, Beckman Res Inst, Duarte, CA USA; [Brandon, Nicholas J.] Pfizer, Princeton, NJ USA	Johns Hopkins University; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University of Glasgow; Johns Hopkins University; Northwestern University; Feinberg School of Medicine; City of Hope; Beckman Research Institute of City of Hope; Pfizer	Sawa, A (corresponding author), Johns Hopkins Univ, Sch Med, Dept Psychiat, Baltimore, MD 21205 USA.	asawa1@jhmi.edu	Xie, Zhong/B-6829-2011; Houslay, Miles/AAM-5281-2020; kamiya, atsushi/L-8550-2016; Houslay, Miles D/A-6825-2011; Takaki, Manabu/AFK-8037-2022; Penzes, Peter/L-3987-2016	Xie, Zhong/0000-0002-8348-4455; kamiya, atsushi/0000-0002-4274-5567; Takaki, Manabu/0000-0002-7371-2821; Penzes, Peter/0000-0001-5449-1640; Srivastava, Deepak Prakash/0000-0001-6512-9065; Seshadri, Anupamaa/0000-0001-8432-7518; Graziane, Nicholas/0000-0002-7055-7029; Brandon, Nicholas/0000-0002-3917-0096; Houslay, Miles/0000-0002-3826-8091; Baraban, Jay/0000-0002-8165-2638	US National Institutes of Health [MH-084018, MH-069853, MH-088753, MH-071316, MH-084233, NS-048911]; Stanley; Cure Huntington's Disease Initiative; HighQ; S R Foundation; RUSK; National Alliance for Research on Schizophrenia and Depression; National Alliance for Autism Research; Medical Research Council [G0600765]; European Union [LSHB-CT-2006-037189]; NATIONAL INSTITUTE OF MENTAL HEALTH [P20MH084018, RC1MH088753, R01MH084233, R01MH071316, R01MH069853] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048911] Funding Source: NIH RePORTER; MRC [G0600765] Funding Source: UKRI	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stanley; Cure Huntington's Disease Initiative; HighQ; S R Foundation; RUSK; National Alliance for Research on Schizophrenia and Depression(NARSAD); National Alliance for Autism Research; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union(European Commission); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank Y. Lema and P. Talalay for help with manuscript preparation, A. Gruber, P. O'Donnell, P. F. Worley, R. L. Huganir, J.D. Rothstein, N. Shahani, H. Ujike, S. Kuroda, H. Bito and M. Nuriya for scientific discussions and J. Gogos, R. A. Cerione, H. Cline and A. Jeromin for providing us with reagents. This work was supported by grants from the US National Institutes of Health (MH-084018, MH-069853 and MH-088753 to A. S., MH-071316 to P. P., and MH-084233 and NS-048911 to Z.Y.), as well as by grants from Stanley (A. S.), Cure Huntington's Disease Initiative (A. S.), HighQ (A. S.), S & R Foundation (A. S.), RUSK (A. S.), National Alliance for Research on Schizophrenia and Depression (A. S., A.H.-T., A. K. and P. P.), National Alliance for Autism Research (P. P.), Uehara (A.H.-T. and M. T.), Medical Research Council (G0600765 to M. D. H.) and the European Union (LSHB-CT-2006-037189 to M. D. H.).	Blanpied TA, 2008, P NATL ACAD SCI USA, V105, P12587, DOI 10.1073/pnas.0711669105; Bolger GB, 2006, BIOCHEM J, V398, P23, DOI 10.1042/BJ20060423; Cahill ME, 2009, P NATL ACAD SCI USA, V106, P13058, DOI 10.1073/pnas.0904636106; CAI X, J BIOL CHEM, V277, P36553; Callicott JH, 2005, P NATL ACAD SCI USA, V102, P8627, DOI 10.1073/pnas.0500515102; Camargo LM, 2007, MOL PSYCHIATR, V12, P74, DOI 10.1038/sj.mp.4001880; Cannon TD, 2005, ARCH GEN PSYCHIAT, V62, P1205, DOI 10.1001/archpsyc.62.11.1205; Carlisle HJ, 2005, TRENDS NEUROSCI, V28, P182, DOI 10.1016/j.tins.2005.01.008; Chubb JE, 2008, MOL PSYCHIATR, V13, P36, DOI 10.1038/sj.mp.4002106; Djinovic-Carugo K, 2002, FEBS LETT, V513, P119, DOI 10.1016/S0014-5793(01)03304-X; Fischer M, 1998, NEURON, V20, P847, DOI 10.1016/S0896-6273(00)80467-5; Garey LJ, 1998, J NEUROL NEUROSUR PS, V65, P446, DOI 10.1136/jnnp.65.4.446; Glantz LA, 2000, ARCH GEN PSYCHIAT, V57, P65, DOI 10.1001/archpsyc.57.1.65; Goff DC, 2001, AM J PSYCHIAT, V158, P1367, DOI 10.1176/appi.ajp.158.9.1367; Harrison PJ, 2006, MOL PSYCHIATR, V11, P981, DOI 10.1038/sj.mp.4001886; Hashimoto R, 2007, DRUG TODAY, V43, P645, DOI 10.1358/dot.2007.43.9.1088821; Hill JJ, 2006, MOL PSYCHIATR, V11, P557, DOI 10.1038/sj.mp.4001792; Holtmaat AJGD, 2005, NEURON, V45, P279, DOI 10.1016/j.neuron.2005.01.003; Hsueh YP, 1997, NEURON, V18, P803, DOI 10.1016/S0896-6273(00)80319-0; Ishizuka K, 2007, MOL PSYCHIATR, V12, P897, DOI 10.1038/sj.mp.4002024; Ishizuka K, 2006, BIOL PSYCHIAT, V59, P1189, DOI 10.1016/j.biopsych.2006.03.065; Jaaro-Peled H, 2009, TRENDS NEUROSCI, V32, P485, DOI 10.1016/j.tins.2009.05.007; Kamiya A, 2005, NAT CELL BIOL, V7, P1167, DOI 10.1038/ncb1328; Kirkpatrick B, 2006, J COMP NEUROL, V497, P436, DOI 10.1002/cne.21007; Koike H, 2006, P NATL ACAD SCI USA, V103, P3693, DOI 10.1073/pnas.0511189103; Kvajo M, 2008, P NATL ACAD SCI USA, V105, P7076, DOI 10.1073/pnas.0802615105; Luo LQ, 1996, NATURE, V379, P837, DOI 10.1038/379837a0; Ma XM, 2008, J NEUROSCI, V28, P711, DOI 10.1523/JNEUROSCI.5283-07.2008; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; McCullumsmith RE, 2004, INT REV NEUROBIOL, V59, P19; McGlashan TH, 2000, ARCH GEN PSYCHIAT, V57, P637, DOI 10.1001/archpsyc.57.7.637; McGlashan TH, 1996, SCHIZOPHRENIA BULL, V22, P201, DOI 10.1093/schbul/22.2.201; Millar JK, 2005, SCIENCE, V310, P1187, DOI 10.1126/science.1112915; Mirnics K, 2001, TRENDS NEUROSCI, V24, P479, DOI 10.1016/S0166-2236(00)01862-2; Moghaddam B, 2003, NEURON, V40, P881, DOI 10.1016/S0896-6273(03)00757-8; Murdoch H, 2007, J NEUROSCI, V27, P9513, DOI 10.1523/JNEUROSCI.1493-07.2007; Pilowsky LS, 2006, MOL PSYCHIATR, V11, P118, DOI 10.1038/sj.mp.4001751; Rabiner CA, 2005, NEUROSCIENTIST, V11, P148, DOI 10.1177/1073858404271250; Saneyoshi T, 2008, NEURON, V57, P94, DOI 10.1016/j.neuron.2007.11.016; Schurov IL, 2004, MOL PSYCHIATR, V9, P1100, DOI 10.1038/sj.mp.4001574; Sheng M, 2007, ANNU REV BIOCHEM, V76, P823, DOI 10.1146/annurev.biochem.76.060805.160029; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; STCLAIR D, 1990, LANCET, V336, P13, DOI 10.1016/0140-6736(90)91520-K; Steen RG, 2005, NEUROPSYCHOPHARMACOL, V30, P1949, DOI 10.1038/sj.npp.1300850; Steward O, 2001, NEURON, V30, P227, DOI 10.1016/S0896-6273(01)00275-6; Tashiro A, 2000, CEREB CORTEX, V10, P927, DOI 10.1093/cercor/10.10.927; Taya S, 2007, J NEUROSCI, V27, P15, DOI 10.1523/JNEUROSCI.3826-06.2006; Tolias KF, 2005, NEURON, V45, P525, DOI 10.1016/j.neuron.2005.01.024; Xie Z, 2007, NEURON, V56, P640, DOI 10.1016/j.neuron.2007.10.005	50	310	315	0	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2010	13	3					327	U12		10.1038/nn.2487	http://dx.doi.org/10.1038/nn.2487			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	559WW	20139976	Green Accepted, Green Published			2022-12-24	WOS:000274860100014
J	Noh, J; Seal, RP; Garver, JA; Edwards, RH; Kandler, K				Noh, Jihyun; Seal, Rebecca P.; Garver, Jessica A.; Edwards, Robert H.; Kandler, Karl			Glutamate co-release at GABA/glycinergic synapses is crucial for the refinement of an inhibitory map	NATURE NEUROSCIENCE			English	Article							LONG-TERM DEPRESSION; AUDITORY BRAIN-STEM; RAT MEDIAL NUCLEUS; VESICULAR GLUTAMATE; COCHLEAR NUCLEUS; TRANSPORTER TYPE-3; SUPERIOR OLIVE; DEAFNESS; VGLUT3; OTOFERLIN	Many nonglutamatergic synaptic terminals in the mammalian brain contain the vesicular glutamate transporter 3 (VGLUT3), indicating that they co-release the excitatory neurotransmitter glutamate. However, the functional role of glutamate co-transmission at these synapses is poorly understood. In the auditory system, VGLUT3 expression and glutamate co-transmission are prominent in a developing GABA/glycinergic sound-localization pathway. We found that mice with a genetic deletion of Vglut3 (also known as Slc17a8) had disrupted glutamate co-transmission and severe impairment in the refinement of this inhibitory pathway. Specifically, loss of glutamate co-transmission disrupted synaptic silencing and the strengthening of GABA/glycinergic connections that normally occur with maturation. Functional mapping studies further revealed that these deficits markedly degraded the precision of tonotopy in this inhibitory auditory pathway. These results indicate that glutamate co-transmission is crucial for the synaptic reorganization and topographic specification of a developing inhibitory circuit.	[Noh, Jihyun; Garver, Jessica A.; Kandler, Karl] Univ Pittsburgh, Sch Med, Inst Eye & Ear, Dept Otolaryngol, Pittsburgh, PA 15260 USA; [Noh, Jihyun; Garver, Jessica A.; Kandler, Karl] Univ Pittsburgh, Sch Med, Inst Eye & Ear, Dept Neurobiol, Pittsburgh, PA USA; [Seal, Rebecca P.; Edwards, Robert H.] Univ Calif San Francisco, Sch Med, Dept Neurol, San Francisco, CA 94143 USA; [Seal, Rebecca P.; Edwards, Robert H.] Univ Calif San Francisco, Sch Med, Dept Physiol, San Francisco, CA 94143 USA; [Kandler, Karl] Univ Pittsburgh, Ctr Neural Basis Cognit, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Kandler, K (corresponding author), Univ Pittsburgh, Sch Med, Inst Eye & Ear, Dept Otolaryngol, Pittsburgh, PA 15260 USA.	kkarl@pitt.edu		Kandler, Karl/0000-0002-6053-6400; Seal, Rebecca/0000-0003-4955-703X	National Institute on Deafness Other Communication Disorders [DC-04199]; NATIONAL INSTITUTE OF MENTAL HEALTH [F32MH068085] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004199] Funding Source: NIH RePORTER	National Institute on Deafness Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank D. Gillespie for initial recordings from Vglut3<SUP>-/-</SUP> mice and K. Cihil for help with genotyping. Otoferlin knockout mice (pachanga)<SUP>37</SUP> were generously supplied by U. Mueller (Scripps Institute). We are grateful to E. Aizenman, J. Castro, A. Clause and T. Tzounopoulos for comments on the manuscript. K. K. was supported by the National Institute on Deafness and Other Communication Disorders (DC-04199), R.P.S. by the National Alliance for Research on Schizophrenia and Depression and R. H. E. by the National Institute on Drug Abuse and the National Institute of Mental Health.	Aamodt SM, 2000, J NEUROPHYSIOL, V83, P1580, DOI 10.1152/jn.2000.83.3.1580; Akerman CJ, 2006, J NEUROSCI, V26, P5117, DOI 10.1523/JNEUROSCI.0319-06.2006; Allen TGJ, 2006, J NEUROSCI, V26, P1588, DOI 10.1523/JNEUROSCI.3979-05.2006; Behrends JC, 1998, J NEUROPHYSIOL, V79, P2999, DOI 10.1152/jn.1998.79.6.2999; Beurg M, 2008, J NEUROSCI, V28, P1798, DOI 10.1523/JNEUROSCI.4653-07.2008; Blaesse P, 2005, CELL TISSUE RES, V320, P33, DOI 10.1007/s00441-004-1054-8; Boulland JL, 2004, J COMP NEUROL, V480, P264, DOI 10.1002/cne.20354; FORSYTHE ID, 1993, P ROY SOC B-BIOL SCI, V251, P143, DOI 10.1098/rspb.1993.0021; Fremeau RT, 2002, P NATL ACAD SCI USA, V99, P14488, DOI 10.1073/pnas.222546799; Gabellec MM, 2007, EUR J NEUROSCI, V25, P1373, DOI 10.1111/j.1460-9568.2007.05400.x; Gaiarsa JL, 2002, TRENDS NEUROSCI, V25, P564, DOI 10.1016/S0166-2236(02)02269-5; Gillespie DC, 2005, NAT NEUROSCI, V8, P332, DOI 10.1038/nn1397; GODA Y, 1994, P NATL ACAD SCI USA, V91, P12942, DOI 10.1073/pnas.91.26.12942; Gras C, 2005, NEUROPHARMACOLOGY, V49, P901, DOI 10.1016/j.neuropharm.2005.07.023; Gras C, 2008, NAT NEUROSCI, V11, P292, DOI 10.1038/nn2052; Herzog E, 2004, NEUROSCIENCE, V123, P983, DOI 10.1016/j.neuroscience.2003.10.039; Jones TA, 2007, J NEUROPHYSIOL, V98, P1898, DOI 10.1152/jn.00472.2007; Kandler K, 1998, NAT NEUROSCI, V1, P119, DOI 10.1038/368; KANDLER K, 1995, J NEUROSCI, V15, P6890; KANDLER K, 1993, J COMP NEUROL, V328, P161, DOI 10.1002/cne.903280202; KIL J, 1995, J COMP NEUROL, V353, P317, DOI 10.1002/cne.903530302; Kim G, 2003, NAT NEUROSCI, V6, P282, DOI 10.1038/nn1015; Kotak VC, 1998, J NEUROSCI, V18, P4646; Leake PA, 2006, J COMP NEUROL, V497, P13, DOI 10.1002/cne.20968; Leao RN, 2006, J PHYSIOL-LONDON, V571, P563, DOI 10.1113/jphysiol.2005.098780; Leao RN, 2004, J PHYSIOL-LONDON, V559, P25, DOI 10.1113/jphysiol.2004.067421; LIPPE WR, 1994, J NEUROSCI, V14, P1486, DOI 10.1523/JNEUROSCI.14-03-01486.1994; Longo-Guess C, 2007, HEARING RES, V234, P21, DOI 10.1016/j.heares.2007.09.005; McLean HA, 1996, J PHYSIOL-LONDON, V496, P471, DOI 10.1113/jphysiol.1996.sp021699; Mentis GZ, 2005, P NATL ACAD SCI USA, V102, P7344, DOI 10.1073/pnas.0502788102; Morishita W, 1996, J NEUROPHYSIOL, V76, P59, DOI 10.1152/jn.1996.76.1.59; Nabekura J, 2004, NAT NEUROSCI, V7, P17, DOI 10.1038/nn1170; Nishimaru H, 2005, P NATL ACAD SCI USA, V102, P5245, DOI 10.1073/pnas.0501331102; Ramakrishnan NA, 2009, J BIOL CHEM, V284, P1364, DOI 10.1074/jbc.M803605200; Roux I, 2006, CELL, V127, P277, DOI 10.1016/j.cell.2006.08.040; Ruel J, 2008, AM J HUM GENET, V83, P278, DOI 10.1016/j.ajhg.2008.07.008; SANES DH, 1988, J NEUROSCI, V8, P682; SANES DH, 1990, J NEUROSCI, V10, P3494; Schwander M, 2007, J NEUROSCI, V27, P2163, DOI 10.1523/JNEUROSCI.4975-06.2007; Seal RP, 2008, NEURON, V57, P263, DOI 10.1016/j.neuron.2007.11.032; Seal RP, 2006, CURR OPIN PHARMACOL, V6, P114, DOI 10.1016/j.coph.2005.12.001; SOMMER I, 1993, EXP BRAIN RES, V95, P223; Somogyi J, 2004, EUR J NEUROSCI, V19, P552, DOI 10.1111/j.0953-816X.2003.03091.x; STEVENS CF, 1994, NATURE, V371, P704, DOI 10.1038/371704a0; Tollin DJ, 2003, NEUROSCIENTIST, V9, P127, DOI 10.1177/1073858403252228; Tritsch NX, 2007, NATURE, V450, P50, DOI 10.1038/nature06233; Turrigiano GG, 2008, CELL, V135, P422, DOI 10.1016/j.cell.2008.10.008; Walmsley B, 2006, J PHYSIOL-LONDON, V572, P313, DOI 10.1113/jphysiol.2006.104851; WU SH, 1991, J NEUROPHYSIOL, V65, P230, DOI 10.1152/jn.1991.65.2.230	49	130	131	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2010	13	2					232	U120		10.1038/nn.2478	http://dx.doi.org/10.1038/nn.2478			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	548SE	20081852	Green Accepted			2022-12-24	WOS:000273985800019
J	Voon, V; Pessiglione, M; Brezing, C; Gallea, C; Fernandez, HH; Dolan, RJ; Hallett, M				Voon, Valerie; Pessiglione, Mathias; Brezing, Christina; Gallea, Cecile; Fernandez, Hubert H.; Dolan, Raymond J.; Hallett, Mark			Mechanisms Underlying Dopamine-Mediated Reward Bias in Compulsive Behaviors	NEURON			English	Article							TEMPORAL DIFFERENCE MODELS; IMPULSE CONTROL DISORDERS; PARKINSONS-DISEASE; PATHOLOGICAL GAMBLERS; DRUG-USE; STIMULATION; PREDICTION; MEDICATION; ADDICTION; HUMANS	Pathological behaviors such as problem gambling or shopping are characterized by compulsive choice despite alternative options and negative costs. Reinforcement learning algorithms allow a computation of prediction error, a comparison of actual and expected outcomes, which updates our predictions and influences our subsequent choices. Using a reinforcement learning model, we show data consistent with the idea that dopamine agonists in susceptible individuals with Parkinson's disease increase the rate of learning from gain outcomes. Dopamine agonists also increase striatal prediction error activity, thus signifying a "better than expected" outcome. Thus, our findings are consistent with a model whereby a distorted estimation of the gain cue underpins a choice bias toward gains.	[Voon, Valerie; Brezing, Christina; Gallea, Cecile; Hallett, Mark] NIH, Bethesda, MD 20892 USA; [Pessiglione, Mathias] Hop La Pitie Salpetriere, INSERM, F-75013 Paris, France; [Fernandez, Hubert H.] Univ Florida, Gainesville, FL 32610 USA; [Dolan, Raymond J.] UCL, Wellcome Trust Ctr Neuroimaging, London WC1N 3BG, England	National Institutes of Health (NIH) - USA; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; State University System of Florida; University of Florida; University of London; University College London	Voon, V (corresponding author), NIH, Bldg 10, Bethesda, MD 20892 USA.	voonval@gmail.com	Voon, Valerie/O-7038-2017; Pessiglione, Mathias/E-2141-2017	Voon, Valerie/0000-0001-6790-1776; Pessiglione, Mathias/0000-0002-6992-3677; Afifa, Sayyidah/0000-0002-1151-9583; Dolan, Ray/0000-0001-9356-761X; GALLEA, Cecile/0000-0001-8070-8794	National Institute of Neurological Disorders and Stroke, National Institutes of Health; NINDS/NIH; Wellcome Trust; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003031] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported and conducted by the National Institute of Neurological Disorders and Stroke, National Institutes of Health. We would like to thank Dr. Grisel Lopez and the Parkinson Disease clinic at the National Institute of Neurological Disorders (NINDS), National Institutes of Health (NIH) for assistance in recruitment and assessment of patients. We would like to thank the patients for their involvement with this study. This study was funded and conducted at intramural NINDS/NIH. R.J.D. is supported by a Wellcome Trust Programme Grant.	Bayer HM, 2005, NEURON, V47, P129, DOI 10.1016/j.neuron.2005.05.020; Berthet A, 2009, J NEUROSCI, V29, P4829, DOI 10.1523/JNEUROSCI.5884-08.2009; Dagher A, 2009, NEURON, V61, P502, DOI 10.1016/j.neuron.2009.01.031; Daw ND, 2002, NEURAL NETWORKS, V15, P603, DOI 10.1016/S0893-6080(02)00052-7; Dolan RJ, 2007, PHILOS T R SOC B, V362, P787, DOI 10.1098/rstb.2007.2088; Duvernoy H.M., 1999, HUMAN BRAIN SURFACE; Evans AH, 2006, ANN NEUROL, V59, P852, DOI 10.1002/ana.20822; Frank MJ, 2007, SCIENCE, V318, P1309, DOI 10.1126/science.1146157; Frank MJ, 2007, P NATL ACAD SCI USA, V104, P16311, DOI 10.1073/pnas.0706111104; Frank MJ, 2004, SCIENCE, V306, P1940, DOI 10.1126/science.1102941; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Goudriaan AE, 2005, COGNITIVE BRAIN RES, V23, P137, DOI 10.1016/j.cogbrainres.2005.01.017; Hobson DE, 2002, JAMA-J AM MED ASSOC, V287, P455, DOI 10.1001/jama.287.4.455; Lomanowska A, 2004, PHARMACOL BIOCHEM BE, V77, P617, DOI 10.1016/j.pbb.2003.12.018; MCELROY SL, 1994, J CLIN PSYCHIAT, V55, P242; O'Doherty JP, 2003, NEURON, V38, P329, DOI 10.1016/S0896-6273(03)00169-7; Pessiglione M, 2006, NATURE, V442, P1042, DOI 10.1038/nature05051; Petry NM, 2001, J ABNORM PSYCHOL, V110, P482, DOI 10.1037/0021-843X.110.3.482; Redish AD, 2004, SCIENCE, V306, P1944, DOI 10.1126/science.1102384; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Seymour B, 2004, NATURE, V429, P664, DOI 10.1038/nature02581; Seymour B, 2005, NAT NEUROSCI, V8, P1234, DOI 10.1038/nn1527; Steeves TDL, 2009, BRAIN, V132, P1376, DOI 10.1093/brain/awp054; Sutton R.S., 2015, REINFORCEMENT LEARNI, V2nd ed.; van Eimeren T, 2009, NEUROPSYCHOPHARMACOL, V34, P2758, DOI [10.1038/sj.npp.npp2009124, 10.1038/npp.2009.124]; Voon V, 2007, CURR OPIN NEUROL, V20, P484, DOI 10.1097/WCO.0b013e32826fbc8f; Voon V, 2009, LANCET NEUROL, V8, P1140, DOI 10.1016/S1474-4422(09)70287-X; Weintraub D, 2006, ARCH NEUROL-CHICAGO, V63, P969, DOI 10.1001/archneur.63.7.969; Zernig G, 2007, PHARMACOLOGY, V80, P65, DOI 10.1159/000103923	29	216	218	0	33	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	JAN 14	2010	65	1					135	142		10.1016/j.neuron.2009.12.027	http://dx.doi.org/10.1016/j.neuron.2009.12.027			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	546DZ	20152119	Bronze, Green Accepted, Green Submitted			2022-12-24	WOS:000273791200014
J	Liu, BH; Li, PY; Sun, YJJ; Li, YT; Zhang, LI; Tao, HW				Liu, Bao-hua; Li, Pingyang; Sun, Yujiao J.; Li, Ya-tang; Zhang, Li I.; Tao, Huizhong Whit			Intervening inhibition underlies simple-cell receptive field structure in visual cortex	NATURE NEUROSCIENCE			English	Article							CAT STRIATE CORTEX; PRIMARY AUDITORY-CORTEX; CORTICAL SIMPLE CELLS; ORIENTATION SELECTIVITY; COMPLEX CELLS; DIRECTION SELECTIVITY; BALANCED INHIBITION; SINGLE CELLS; NEURONS; MOUSE	Synaptic inputs underlying spike receptive fields are important for understanding mechanisms of neuronal processing. Using whole-cell voltage-clamp recordings from neurons in mouse primary visual cortex, we examined the spatial patterns of their excitatory and inhibitory synaptic inputs evoked by On and Off stimuli. Neurons with either segregated or overlapped On/Off spike subfields had substantial overlaps between all the four synaptic subfields. The segregated receptive-field structures were generated by the integration of excitation and inhibition with a stereotypic 'overlap-but-mismatched' pattern: the peaks of excitatory On/Off subfields were separated and flanked colocalized peaks of inhibitory On/Off subfields. The small mismatch of excitation/inhibition led to an asymmetric inhibitory shaping of On/Off spatial tunings, resulting in a great enhancement of their distinctiveness. Thus, slightly separated On/Off excitation, together with intervening inhibition, can create simple-cell receptive-field structure and the dichotomy of receptive-field structures may arise from a fine-tuning of the spatial arrangement of synaptic inputs.	[Liu, Bao-hua; Li, Pingyang; Sun, Yujiao J.; Li, Ya-tang; Zhang, Li I.; Tao, Huizhong Whit] Univ So Calif, Keck Sch Med, Zilkha Neurogenet Inst, Los Angeles, CA 90033 USA; [Zhang, Li I.] Univ So Calif, Keck Sch Med, Dept Physiol & Biophys, Los Angeles, CA 90033 USA; [Tao, Huizhong Whit] Univ So Calif, Keck Sch Med, Dept Cell & Neurobiol, Los Angeles, CA 90033 USA	University of Southern California; University of Southern California; University of Southern California	Tao, HW (corresponding author), Univ So Calif, Keck Sch Med, Zilkha Neurogenet Inst, Los Angeles, CA 90033 USA.	liizhang@usc.edu; htao@usc.edu	Li, Ya-tang/AAF-2573-2020; Li, Ping/GYV-4914-2022; Sun, Yujiao/E-5668-2015; Tao, Huizhong W/HDM-9767-2022; Li, Ya-tang/A-9583-2011	Li, Ya-tang/0000-0003-2763-1534; Sun, Yujiao Jennifer/0000-0003-2437-2936	US National Institutes of Health [EY018718, EY019049]; Karl Kirchgessner Foundation; Searle Scholar Program; Klingenstein Foundation; David and Lucile Packard Foundation; NATIONAL EYE INSTITUTE [R21EY018718, R01EY019049] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC008983] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Karl Kirchgessner Foundation; Searle Scholar Program; Klingenstein Foundation(Klingenstein Philanthropies); David and Lucile Packard Foundation(The David & Lucile Packard Foundation); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank A. Sampath and D. Li for their helpful suggestions. This work was supported by grants to H. W. T. from the US National Institutes of Health (EY018718 and EY019049) and The Karl Kirchgessner Foundation. L.I.Z. is supported by the Searle Scholar Program, the Klingenstein Foundation, and the David and Lucile Packard Foundation.	Abbott LF, 2002, NAT NEUROSCI, V5, P391, DOI 10.1038/nn0502-391; Azzalini A, 1999, J ROY STAT SOC B, V61, P579, DOI 10.1111/1467-9868.00194; Borg-Graham LJ, 1998, NATURE, V393, P369, DOI 10.1038/30735; Carandini M, 2000, J NEUROSCI, V20, P470, DOI 10.1523/JNEUROSCI.20-01-00470.2000; Dantzker JL, 2000, NAT NEUROSCI, V3, P701, DOI 10.1038/76656; de la Cera EG, 2006, VISION RES, V46, P2546, DOI 10.1016/j.visres.2006.01.011; DEAN AF, 1983, J PHYSIOL-LONDON, V344, P305, DOI 10.1113/jphysiol.1983.sp014941; Debanne D, 1998, J PHYSIOL-LONDON, V508, P523, DOI 10.1111/j.1469-7793.1998.00523.x; DRAGER UC, 1975, J COMP NEUROL, V160, P269, DOI 10.1002/cne.901600302; Ferster D, 2000, ANNU REV NEUROSCI, V23, P441, DOI 10.1146/annurev.neuro.23.1.441; FERSTER D, 1988, J NEUROSCI, V8, P1172; GREEN DG, 1980, VISION RES, V20, P827, DOI 10.1016/0042-6989(80)90063-2; HEGGELUND P, 1986, J PHYSIOL-LONDON, V373, P277, DOI 10.1113/jphysiol.1986.sp016047; Higley MJ, 2006, J NEUROSCI, V26, P448, DOI 10.1523/JNEUROSCI.3506-05.2006; Hines M, 1993, NEURAL SYSTEMS ANAL, P127; Hirsch JA, 2006, TRENDS NEUROSCI, V29, P30, DOI 10.1016/j.tins.2005.11.001; Hirsch JA, 1998, J NEUROSCI, V18, P9517; Hirsch JA, 2003, NAT NEUROSCI, V6, P1300, DOI 10.1038/nn1152; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Jagadeesh B, 1997, J NEUROPHYSIOL, V78, P2772, DOI 10.1152/jn.1997.78.5.2772; JONES JP, 1987, J NEUROPHYSIOL, V58, P1187, DOI 10.1152/jn.1987.58.6.1187; Liu BH, 2007, NAT NEUROSCI, V10, P1594, DOI 10.1038/nn2012; Liu BH, 2009, J NEUROSCI, V29, P10520, DOI 10.1523/JNEUROSCI.1915-09.2009; Liu Y, 2007, J NEUROSCI, V27, P5301, DOI 10.1523/JNEUROSCI.0376-07.2007; MANGINI NJ, 1980, J COMP NEUROL, V193, P203, DOI 10.1002/cne.901930114; Margrie TW, 2002, PFLUG ARCH EUR J PHY, V444, P491, DOI 10.1007/s00424-002-0831-z; Martinez LM, 2005, NAT NEUROSCI, V8, P372, DOI 10.1038/nn1404; Mata ML, 2005, J NEUROPHYSIOL, V93, P919, DOI 10.1152/jn.00668.2004; Mechler F, 2002, VISION RES, V42, P1017, DOI 10.1016/S0042-6989(02)00025-1; METIN C, 1988, EXP BRAIN RES, V69, P594; Miller KD, 2003, CEREB CORTEX, V13, P73, DOI 10.1093/cercor/13.1.73; Moore CI, 1998, J NEUROPHYSIOL, V80, P2882, DOI 10.1152/jn.1998.80.6.2882; NELSON S, 1994, SCIENCE, V265, P774, DOI 10.1126/science.8047882; Niell CM, 2008, J NEUROSCI, V28, P7520, DOI 10.1523/JNEUROSCI.0623-08.2008; PALMER LA, 1981, J NEUROPHYSIOL, V46, P260, DOI 10.1152/jn.1981.46.2.260; Petreanu L, 2009, NATURE, V457, P1142, DOI 10.1038/nature07709; Priebe NJ, 2004, NAT NEUROSCI, V7, P1113, DOI 10.1038/nn1310; REMTULLA S, 1985, VISION RES, V25, P21, DOI 10.1016/0042-6989(85)90076-8; SCHILLER PH, 1976, J NEUROPHYSIOL, V39, P1288, DOI 10.1152/jn.1976.39.6.1288; SILLITO AM, 1975, J PHYSIOL-LONDON, V250, P305, DOI 10.1113/jphysiol.1975.sp011056; SOMERS DC, 1995, J NEUROSCI, V15, P5448; Tan AYY, 2004, J NEUROPHYSIOL, V92, P630, DOI 10.1152/jn.01020.2003; Tao HW, 2005, NEURON, V45, P829, DOI 10.1016/j.neuron.2005.01.046; Troyer TW, 1998, J NEUROSCI, V18, P5908; WAGOR E, 1980, J COMP NEUROL, V193, P187, DOI 10.1002/cne.901930113; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116; Wu GK, 2008, NEURON, V58, P132, DOI 10.1016/j.neuron.2008.01.035; Yoshimura Y, 2005, NAT NEUROSCI, V8, P1552, DOI 10.1038/nn1565; Zhang LI, 2003, NATURE, V424, P201, DOI 10.1038/nature01796	49	98	99	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2010	13	1					89	U256		10.1038/nn.2443	http://dx.doi.org/10.1038/nn.2443			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	536PM	19946318	Green Accepted			2022-12-24	WOS:000273056300018
J	Parra, LM; Zou, YM				Parra, Liseth M.; Zou, Yimin			Sonic hedgehog induces response of commissural axons to Semaphorin repulsion during midline crossing	NATURE NEUROSCIENCE			English	Article							GUIDANCE; ATTRACTION; GROWTH; NETRIN-1; SLIT; PROTEINS; RECEPTOR; FAMILY	Pathfinding axons change responses to guidance cues at intermediate targets. During midline crossing, spinal cord commissural axons acquire responsiveness to class 3 Semaphorins and Slits, which regulate their floor plate exit and restrict their post-crossing trajectory into a longitudinal pathway. We found that Sonic Hedgehog (Shh) could activate the repulsive response of pre-crossing axons to Semaphorins. Blocking Shh function with a monoclonal antibody to Shh, 5E1, in 'open-book' explants or by expressing a dominant-negative form of Patched-1, Ptch1(Delta loop2), or a Smoothened (Smo) shRNA construct in commissural neurons resulted in severe guidance defects, including stalling and knotting inside the floor plate, recrossing, randomized anterior-posterior projection and overshooting after crossing, reminiscent of Neuropilin-2 mutant embryos. Enhancing protein kinase A activity in pre-crossing axons diminished Shh-induced Semaphorin repulsion and caused profound midline stalling and overshooting/wandering of post-crossing axons. Therefore, a morphogen, Shh, can act as a switch of axon guidance responses.	[Parra, Liseth M.; Zou, Yimin] Univ Calif San Diego, Div Biol Sci, Neurobiol Sect, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Zou, YM (corresponding author), Univ Calif San Diego, Div Biol Sci, Neurobiol Sect, La Jolla, CA 92093 USA.	yzou@ucsd.edu			US National Institutes of Health [RO1 NS046357]; University of California, San Diego [T32GM7240-31]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007240] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047484, R01NS046357] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California, San Diego(University of California System); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank V. Castellani for Sema3b cDNA (Universite Claude Bernard), T. M. Jessell for 5E1, S. Brenner-Morton for antibody to HNF-3 beta (4C7, Developmental Studies Hybridoma Bank), J. Lu for her technical assistance, B. Shafer for encouragement during the course of this study and for critically reading the manuscript, and members of the Zou laboratory for helpful discussions. We also thank the former Neurobiology, Pharmacology and Physiology Department at the University of Chicago, where this study began. This work was supported by a US National Institutes of Health grant to Y.Z. (RO1 NS046357). L. M. P. was supported by the Cellular and Molecular Genetics training grant T32GM7240-31 at the University of California, San Diego.	Bourikas D, 2005, NAT NEUROSCI, V8, P297, DOI 10.1038/nn1396; Charron F, 2003, CELL, V113, P11, DOI 10.1016/S0092-8674(03)00199-5; Chen Z, 2008, NEURON, V58, P325, DOI 10.1016/j.neuron.2008.02.016; Dickson BJ, 2006, ANNU REV CELL DEV BI, V22, P651, DOI 10.1146/annurev.cellbio.21.090704.151234; Guan W, 2008, DEV BIOL, V314, P317, DOI 10.1016/j.ydbio.2007.11.030; Hopker VH, 1999, NATURE, V401, P69, DOI 10.1038/43441; KENNEDY TE, 1994, CELL, V78, P435; Long H, 2004, NEURON, V42, P213, DOI 10.1016/S0896-6273(04)00179-5; Lyuksyutova AI, 2003, SCIENCE, V302, P1984, DOI 10.1126/science.1089610; Marigo V, 1996, NATURE, V384, P176, DOI 10.1038/384176a0; Marigo V, 1996, DEVELOPMENT, V122, P1225; Nishiyama M, 2003, NATURE, V423, P990, DOI 10.1038/nature01751; Ogden SK, 2008, NATURE, V456, P967, DOI 10.1038/nature07459; Pasterkamp RJ, 2009, CURR OPIN NEUROBIOL, V19, P263, DOI 10.1016/j.conb.2009.06.001; Sabatier C, 2004, CELL, V117, P157, DOI 10.1016/S0092-8674(04)00303-4; Serafini T, 1996, CELL, V87, P1001, DOI 10.1016/S0092-8674(00)81795-X; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; Song HJ, 1998, SCIENCE, V281, P1515, DOI 10.1126/science.281.5382.1515; Taipale J, 2002, NATURE, V418, P892, DOI 10.1038/nature00989; Terman JR, 2004, SCIENCE, V303, P1204, DOI 10.1126/science.1092121; Trousse F, 2001, DEVELOPMENT, V128, P3927; Wolf AM, 2008, J NEUROSCI, V28, P3456, DOI 10.1523/JNEUROSCI.0029-08.2008; Zoo YM, 2000, CELL, V102, P363, DOI 10.1016/S0092-8674(00)00041-6	23	95	98	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2010	13	1					29	U181		10.1038/nn.2457	http://dx.doi.org/10.1038/nn.2457			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	536PM	19946319				2022-12-24	WOS:000273056300010
J	Chou, SJ; Perez-Garcia, CG; Kroll, TT; O'Leary, DDM				Chou, Shen-Ju; Perez-Garcia, Carlos G.; Kroll, Todd T.; O'Leary, Dennis D. M.			Lhx2 specifies regional fate in Emx1 lineage of telencephalic progenitors generating cerebral cortex	NATURE NEUROSCIENCE			English	Article							GABAERGIC NEURONS; OLFACTORY-BULB; GENES; SPECIFICATION; NEOCORTEX; MICE; FAMILY; AREAS; IDENTIFICATION; NEUROGENESIS	Cerebral cortex is comprised of regions, including six-layer neocortex and three-layer olfactory cortex, generated by telencephalic progenitors of an Emx1 lineage. The mechanism specifying region-specific subpopulations in this lineage is unknown. We found that the LIM homeodomain transcription factor Lhx2 in mice, expressed in graded levels by progenitors, determines their regional identity and fate decisions to generate neocortex or olfactory cortex. Deletion of Lhx2 with Emx1-cre at embryonic day 10.5 (E10.5) altered the fates of progenitors, causing them to generate three-layer cortex, phenocopying olfactory cortex rather than lateral neocortex. Progenitors did not generate ectopic olfactory cortex following Lhx2 deletion at E11.5. Thus, Lhx2 regulates a regional-fate decision by telencephalic progenitors during a critical period that ends as they differentiate from neuroepithelial cells to neuronogenic radial glia. These findings establish a genetic mechanism for determining regional-fate in the Emx1 lineage of telencephalic progenitors that generate cerebral cortex.	[Chou, Shen-Ju; Perez-Garcia, Carlos G.; Kroll, Todd T.; O'Leary, Dennis D. M.] Salk Inst Biol Studies, Mol Neurobiol Lab, La Jolla, CA USA	Salk Institute	O'Leary, DDM (corresponding author), Salk Inst Biol Studies, Mol Neurobiol Lab, La Jolla, CA USA.	doleary@salk.edu		Perez-Garcia, Carlos G./0000-0003-1571-4850; Kroll, Todd/0000-0002-9605-8359	US National Institutes of Health; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH086147] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS031558] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank B. Higgins and H. Gutierrez for technical assistance, Y. Nakagawa for help with screening for Lhx2 genomic DNA, K. Jones for Emx1-cre mice, K.-A. Nave for Nex-cre mice, and P. M. Soriano for ROSA26-LacZ reporter mice. This work was supported by grants from the US National Institutes of Health to D. D. M. O.	Abbie AA, 1942, J COMP NEUROL, V76, P509, DOI 10.1002/cne.900760310; Aboitiz F, 2002, BRAIN RES REV, V39, P141, DOI 10.1016/S0165-0173(02)00180-7; Anderson S, 1999, CEREB CORTEX, V9, P646, DOI 10.1093/cercor/9.6.646; Ariens-Kappers C.U., 1936, COMP ANATOMY NERVOUS; Arlotta P, 2005, NEURON, V45, P207, DOI 10.1016/j.neuron.2004.12.036; Armentano M, 2007, NAT NEUROSCI, V10, P1277, DOI 10.1038/nn1958; Assimacopoulos S, 2003, J NEUROSCI, V23, P6399; Bayer S.A., 1991, NEOCORTICAL DEV; Bishop KM, 2002, J NEUROSCI, V22, P7627; Britanova O, 2008, NEURON, V57, P378, DOI 10.1016/j.neuron.2007.12.028; Bulchand S, 2001, MECH DEVELOP, V100, P165, DOI 10.1016/S0925-4773(00)00515-3; Carney RSE, 2006, J NEUROSCI, V26, P11562, DOI 10.1523/JNEUROSCI.3092-06.2006; Casarosa S, 1999, DEVELOPMENT, V126, P525; Caviness V S Jr, 1982, Brain Res, V256, P293; Chen H, 1997, NEURON, V19, P547, DOI 10.1016/S0896-6273(00)80371-2; Colombo E, 2004, DEV DYNAM, V231, P631, DOI 10.1002/dvdy.20164; Goebbels S, 2006, GENESIS, V44, P611, DOI 10.1002/dvg.20256; Gorski JA, 2002, J NEUROSCI, V22, P6309; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Graus-Porta D, 2001, NEURON, V31, P367, DOI 10.1016/S0896-6273(01)00374-9; Grove EA, 1998, DEVELOPMENT, V125, P2315; Hamasaki T, 2004, NEURON, V43, P359, DOI 10.1016/j.neuron.2004.07.016; Hirata T, 2002, DEV BRAIN RES, V136, P17, DOI 10.1016/S0165-3806(02)00304-8; Hoglund PJ, 2005, BIOCHEM BIOPH RES CO, V336, P175, DOI 10.1016/j.bbrc.2005.08.048; Kriajevska M, 2002, J BIOL CHEM, V277, P5229, DOI 10.1074/jbc.M110976200; Mangale VS, 2008, SCIENCE, V319, P304, DOI 10.1126/science.1151695; Matsuoka H, 2005, J BIOL CHEM, V280, P29355, DOI 10.1074/jbc.M500010200; Monuki ES, 2001, NEURON, V32, P591, DOI 10.1016/S0896-6273(01)00504-9; O'Leary DDM, 2007, NEURON, V56, P252, DOI 10.1016/j.neuron.2007.10.010; Porter FD, 1997, DEVELOPMENT, V124, P2935; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Sahara S, 2009, NEURON, V63, P48, DOI 10.1016/j.neuron.2009.06.006; SANIDES F, 1969, ANN NY ACAD SCI, V167, P404, DOI 10.1111/j.1749-6632.1969.tb20459.x; Schuurmans C, 2004, EMBO J, V23, P2892, DOI 10.1038/sj.emboj.7600278; SHIPLEY MT, 1984, BRAIN RES BULL, V12, P669, DOI 10.1016/0361-9230(84)90148-5; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; ULINKSKI PS, 1983, DORSAL VENTRICULAR R; Vyas A, 2003, J COMP NEUROL, V466, P545, DOI 10.1002/cne.10900; Yun KS, 2003, J COMP NEUROL, V461, P151, DOI 10.1002/cne.10685	39	96	99	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2009	12	11					1381	1389		10.1038/nn.2427	http://dx.doi.org/10.1038/nn.2427			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	511UE	19820705	Green Accepted			2022-12-24	WOS:000271194100010
J	Gaudry, Q; Kristan, WB				Gaudry, Quentin; Kristan, William B., Jr.			Behavioral choice by presynaptic inhibition of tactile sensory terminals	NATURE NEUROSCIENCE			English	Article							LEECH HIRUDO-MEDICINALIS; CENTRAL-NERVOUS-SYSTEM; LOCAL BENDING REFLEX; FEEDING-BEHAVIOR; NEURONAL CONTROL; DECISION-MAKING; CONSUMMATORY PHASE; TERM POTENTIATION; INDUCED ANALGESIA; CHLORIDE CHANNEL	When presented with multiple stimuli, animals generally choose to respond only to one input. The neuronal mechanisms determining such behavioral choices are poorly understood. We found that the medicinal leech had greatly diminished responses to moderate mechanosensory input as it fed. Feeding dominated other responses by suppressing transmitter release from mechanosensory neurons onto all of their neuronal targets. The effects of feeding on synaptic transmission could be mimicked by serotonin. Furthermore, the serotonin antagonist mianserin blocked feeding-induced decreases in synaptic transmission. These results indicate that feeding predominates behaviors by using serotonin at an early stage of sensory processing, namely on presynaptic terminals of mechanosensory neurons.	[Gaudry, Quentin; Kristan, William B., Jr.] Univ Calif San Diego, Div Biol Sci, Grad Program Neurosci, La Jolla, CA 92093 USA; [Kristan, William B., Jr.] Univ Calif San Diego, Div Biol Sci, Neurobiol Sect, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Kristan, WB (corresponding author), Univ Calif San Diego, Div Biol Sci, Grad Program Neurosci, La Jolla, CA 92093 USA.	wkristan@ucsd.edu			US National Institutes of Health [MH43396, NS35336]; National Science Foundation [IOB-0523959]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH043396] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035336] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors are extremely grateful to M. Scanziani for experimental suggestions and critical review of the manuscript. We would also like to thank K. Mesce for valuable editorial assistance and K. Todd for help with confocal microscopy and tissue processing. This work was supported by the US National Institutes of Health (MH43396 and NS35336 to W. B. K.) and the National Science Foundation (IOB-0523959 to K. Mesce and W. B. K.).	Ali DW, 1998, J PHYSIOL-LONDON, V509, P211, DOI 10.1111/j.1469-7793.1998.211bo.x; Baca SM, 2008, NEURON, V57, P276, DOI 10.1016/j.neuron.2007.11.028; Briggman KL, 2006, J NEUROSCI, V26, P10925, DOI 10.1523/JNEUROSCI.3265-06.2006; BRODFUEHRER PD, 1986, J COMP PHYSIOL A, V159, P489, DOI 10.1007/BF00604169; BRODFUEHRER PD, 1995, J NEUROBIOL, V27, P403, DOI 10.1002/neu.480270312; BUCHER HU, 1995, PEDIATR RES, V38, P332, DOI 10.1203/00006450-199509000-00010; Catarsi S, 1997, J NEUROSCI, V17, P5792; Clarac F, 1996, EXP BRAIN RES, V112, P163; DAVIS WJ, 1974, J COMP PHYSIOL, V90, P207, DOI 10.1007/BF00701474; DICKINSON MH, 1984, J COMP PHYSIOL, V154, P449, DOI 10.1007/BF00610160; Esch T, 2002, J NEUROSCI, V22, P11045; Fields H, 2004, NAT REV NEUROSCI, V5, P565, DOI 10.1038/nrn1431; Fields HL, 2007, REGION ANESTH PAIN M, V32, P242, DOI 10.1016/j.rapm.2007.01.001; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; GROOME JR, 1995, J EXP BIOL, V198, P1233; Jankowska E, 2008, BRAIN RES REV, V57, P46, DOI 10.1016/j.brainresrev.2007.06.022; Jing J, 2000, J NEUROPHYSIOL, V83, P1346, DOI 10.1152/jn.2000.83.3.1346; KAVALIERS M, 1991, BRAIN RES, V568, P173, DOI 10.1016/0006-8993(91)91394-G; Kitson SL, 2007, CURR PHARM DESIGN, V13, P2621, DOI 10.2174/138161207781663000; Kristan WB, 2005, PROG NEUROBIOL, V76, P279, DOI 10.1016/j.pneurobio.2005.09.004; KRISTAN WB, 2007, BEHAV CHOICE; Kupfermann I, 2001, CURR OPIN NEUROBIOL, V11, P673, DOI 10.1016/S0959-4388(01)00267-7; LENT CM, 1991, J COMP PHYSIOL A, V168, P191, DOI 10.1007/BF00218411; LENT CM, 1985, BRAIN RES BULL, V14, P643, DOI 10.1016/0361-9230(85)90114-5; LENT CM, 1984, J COMP PHYSIOL, V154, P457, DOI 10.1007/BF00610161; LOCKERY SR, 1990, J NEUROSCI, V10, P1816; LOCKERY SR, 1991, J COMP PHYSIOL A, V168, P165, DOI 10.1007/BF00218409; Machens CK, 2005, SCIENCE, V307, P1121, DOI 10.1126/science.1104171; MCNAUGHTON BL, 1982, J PHYSIOL-LONDON, V324, P249, DOI 10.1113/jphysiol.1982.sp014110; Misell LM, 1998, BEHAV BRAIN RES, V90, P13, DOI 10.1016/S0166-4328(97)00072-7; Miyase CI, 2005, NEUROSCI LETT, V379, P169, DOI 10.1016/j.neulet.2004.12.058; Murakami M, 2005, NEURON, V46, P285, DOI 10.1016/j.neuron.2005.02.025; Norekian TP, 2001, AM ZOOL, V41, P993, DOI 10.1668/0003-1569(2001)041[0993:SNSNOA]2.0.CO;2; Olsen SR, 2008, NATURE, V452, P956, DOI 10.1038/nature06864; ORT CA, 1974, J COMP PHYSIOL, V94, P121, DOI 10.1007/BF00617838; Poulet JFA, 2002, NATURE, V418, P872, DOI 10.1038/nature00919; Puhl JG, 2008, J NEUROSCI, V28, P4192, DOI 10.1523/JNEUROSCI.0136-08.2008; Ranganathan R, 2000, NATURE, V408, P470, DOI 10.1038/35044083; Rudomin P, 1999, EXP BRAIN RES, V129, P1, DOI 10.1007/s002210050933; SCHULZ PE, 1995, J PHYSIOLOGY-PARIS, V89, P3, DOI 10.1016/0928-4257(96)80546-8; Shaw BK, 1997, J NEUROSCI, V17, P786; Shaw BK, 1999, J NEUROPHYSIOL, V82, P1114, DOI 10.1152/jn.1999.82.3.1114; Sherrington CS, 1906, INTEGRATIVE ACTION N, DOI 10.1037/13798-000; Shiba K, 2007, J NEUROSCI, V27, P5156, DOI 10.1523/JNEUROSCI.0001-07.2007; Wang XJ, 2008, NEURON, V60, P215, DOI 10.1016/j.neuron.2008.09.034; WEEKS JC, 1978, J EXP BIOL, V77, P71; Wilson RJA, 1996, J EXP BIOL, V199, P1405; Wilson RJA, 2000, BEHAV NEUROSCI, V114, P635; Zhang X, 2000, J NEUROBIOL, V43, P304, DOI 10.1002/(SICI)1097-4695(20000605)43:3<304::AID-NEU8>3.0.CO;2-M	49	72	72	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2009	12	11					1450	1457		10.1038/nn.2400	http://dx.doi.org/10.1038/nn.2400			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	511UE	19801989				2022-12-24	WOS:000271194100019
J	Benucci, A; Ringach, DL; Carandini, M				Benucci, Andrea; Ringach, Dario L.; Carandini, Matteo			Coding of stimulus sequences by population responses in visual cortex	NATURE NEUROSCIENCE			English	Article							CAT STRIATE CORTEX; ORIENTATION SELECTIVITY; IN-VIVO; VISIBLE PERSISTENCE; ICONIC MEMORY; DYNAMICS; NEURONS; MECHANISMS; NEUROPHYSIOLOGY; SUPPRESSION	Neuronal populations in sensory cortex represent time-changing sensory input through a spatiotemporal code. What are the rules that govern this code? We measured membrane potentials and spikes from neuronal populations in cat visual cortex (V1) using voltage-sensitive dyes and electrode arrays. We first characterized the population response to a single orientation. As response amplitude grew, the population tuning width remained constant for membrane potential responses and became progressively sharper for spike responses. We then asked how these single-orientation responses combine to code for successive orientations. We found that they combined through simple linear summation. Linearity, however, was violated after stimulus offset, when responses exhibited an unexplained persistence. As a result of linearity, the interactions between responses to successive stimuli were minimal. Our results indicate that higher cortical areas may reconstruct the stimulus sequence from V1 population responses through a simple instantaneous decoder. Therefore, spatial and temporal codes in area V1 operate largely independently.	[Benucci, Andrea; Carandini, Matteo] UCL, Inst Ophthalmol, London, England; [Benucci, Andrea; Carandini, Matteo] Smith Kettlewell Eye Res Inst, San Francisco, CA USA; [Ringach, Dario L.] Univ Calif Los Angeles, Jules Stein Eye Inst, Dept Neurobiol, Los Angeles, CA 90024 USA; [Ringach, Dario L.] Univ Calif Los Angeles, Jules Stein Eye Inst, Dept Psychol, Los Angeles, CA 90024 USA	University of London; University College London; The Smith-Kettlewell Eye Research Institute; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Benucci, A (corresponding author), UCL, Inst Ophthalmol, London, England.	a.benucci@ucl.ac.uk	Benucci, Andrea/N-6361-2015; Carandini, Matteo/ABD-8296-2021	Benucci, Andrea/0000-0002-7698-6289; Carandini, Matteo/0000-0003-4880-7682	McKnight Endowment Fund for Neuroscience; US National Institutes of Health [EY017396, EY018322]; NATIONAL EYE INSTITUTE [R01EY017396, R01EY018322] Funding Source: NIH RePORTER	McKnight Endowment Fund for Neuroscience; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank I. Nauhaus, R. A. Frazor, L. Busse and S. Katzner for help with data acquisition. We thank W. T. Newsome, W. S. Geisler and G. Felsen for helpful discussions. This work was supported by a Scholar Award from the McKnight Endowment Fund for Neuroscience ( M. C.) and by US National Institutes of Health grants EY017396 ( M. C.) and EY018322 ( D. L. R.). M. C. holds the GlaxoSmithKline/ Fight for Sight Chair in Visual Neuroscience.	Averbeck BB, 2006, NAT REV NEUROSCI, V7, P358, DOI 10.1038/nrn1888; Azouz R, 2000, P NATL ACAD SCI USA, V97, P8110, DOI 10.1073/pnas.130200797; Benucci A, 2007, NEURON, V55, P103, DOI 10.1016/j.neuron.2007.06.017; BENYISHAI R, 1995, P NATL ACAD SCI USA, V92, P3844, DOI 10.1073/pnas.92.9.3844; Broome BM, 2006, NEURON, V51, P467, DOI 10.1016/j.neuron.2006.07.018; Buonomano DV, 2009, NAT REV NEUROSCI, V10, P113, DOI 10.1038/nrn2558; Carandini M, 2005, J NEUROSCI, V25, P10577, DOI 10.1523/JNEUROSCI.3726-05.2005; Carandini M, 1997, VISION RES, V37, P3061, DOI 10.1016/S0042-6989(97)00100-4; Carandini M, 2000, J NEUROSCI, V20, P470, DOI 10.1523/JNEUROSCI.20-01-00470.2000; CELEBRINI S, 1993, VISUAL NEUROSCI, V10, P811, DOI 10.1017/S0952523800006052; Chen G, 2005, J PHYSIOL-LONDON, V564, P233, DOI 10.1113/jphysiol.2004.080051; Chichilnisky EJ, 2001, NETWORK-COMP NEURAL, V12, P199, DOI 10.1088/0954-898X/12/2/306; Civillico EF, 2006, J NEUROPHYSIOL, V96, P336, DOI 10.1152/jn.00128.2006; COLTHEART M, 1980, PERCEPT PSYCHOPHYS, V27, P183, DOI 10.3758/BF03204258; DEAN AF, 1986, EXP BRAIN RES, V62, P143; Dragoi V, 2002, NAT NEUROSCI, V5, P883, DOI 10.1038/nn900; DUYSEN J, 1985, VISION RES, V25, P171, DOI 10.1016/0042-6989(85)90110-5; Felsen G, 2002, NEURON, V36, P945, DOI 10.1016/S0896-6273(02)01011-5; Ferster D, 2000, ANNU REV NEUROSCI, V23, P441, DOI 10.1146/annurev.neuro.23.1.441; GEISLER WS, 1995, VISION RES, V35, P2723, DOI 10.1016/0042-6989(95)00029-Y; Gillespie DC, 2001, NAT NEUROSCI, V4, P1014, DOI 10.1038/nn731; Goldberg JA, 2004, NEURON, V42, P489, DOI 10.1016/S0896-6273(04)00197-7; Grinvald A, 2004, NAT REV NEUROSCI, V5, P874, DOI 10.1038/nrn1536; HUBERMAN Michael, 2002, CAT PRIMARY VISUAL C, P146; Kenet T, 2003, NATURE, V425, P954, DOI 10.1038/nature02078; Keysers C, 2005, COGN NEUROPSYCHOL, V22, P316, DOI 10.1080/02643290442000103; KOVACS G, 1995, P NATL ACAD SCI USA, V92, P5587, DOI 10.1073/pnas.92.12.5587; Mazer JA, 2002, P NATL ACAD SCI USA, V99, P1645, DOI 10.1073/pnas.022638499; McCormick DA, 2003, CEREB CORTEX, V13, P1219, DOI 10.1093/cercor/bhg104; Muller JR, 1999, SCIENCE, V285, P1405, DOI 10.1126/science.285.5432.1405; NELSON SB, 1991, J NEUROSCI, V11, P344; Normann RA, 1999, VISION RES, V39, P2577, DOI 10.1016/S0042-6989(99)00040-1; Oram MW, 1998, TRENDS NEUROSCI, V21, P259, DOI 10.1016/S0166-2236(97)01216-2; Petersen CCH, 2003, J NEUROSCI, V23, P1298, DOI 10.1523/JNEUROSCI.23-04-01298.2003; Pouget A, 2003, ANNU REV NEUROSCI, V26, P381, DOI 10.1146/annurev.neuro.26.041002.131112; Ringach DL, 2007, J NEUROSCI, V27, P7673, DOI 10.1523/JNEUROSCI.1048-07.2007; Ringach DL, 1997, NATURE, V387, P281, DOI 10.1038/387281a0; Ringach DL, 2003, J NEUROPHYSIOL, V90, P342, DOI 10.1152/jn.01018.2002; ROLLS ET, 1994, P ROY SOC B-BIOL SCI, V257, P9, DOI 10.1098/rspb.1994.0087; Salinas E, 1994, J Comput Neurosci, V1, P89, DOI 10.1007/BF00962720; Schummers J, 2007, FRONT NEUROSCI-SWITZ, V1, P145, DOI 10.3389/neuro.01.1.1.011.2007; SEUNG HS, 1993, P NATL ACAD SCI USA, V90, P10749, DOI 10.1073/pnas.90.22.10749; Shapley R, 2003, NEURON, V38, P689, DOI 10.1016/S0896-6273(03)00332-5; Sharon D, 2002, SCIENCE, V295, P512, DOI 10.1126/science.1065916; SHEVELEV IA, 1993, NEUROSCIENCE, V56, P865, DOI 10.1016/0306-4522(93)90133-Z; TOLHURST DJ, 1980, EXP BRAIN RES, V38, P431; Touryan J, 2002, J NEUROSCI, V22, P10811; VOLGUSHEV M, 1995, VISUAL NEUROSCI, V12, P621, DOI 10.1017/S0952523800008919; Xing DJ, 2005, J NEUROPHYSIOL, V94, P799, DOI 10.1152/jn.01139.2004; Yu BM, 2007, J NEUROPHYSIOL, V97, P3763, DOI 10.1152/jn.00482.2006	50	53	56	1	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2009	12	10					1317	U145		10.1038/nn.2398	http://dx.doi.org/10.1038/nn.2398			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	498US	19749748	Green Accepted			2022-12-24	WOS:000270170200021
J	Fourcaudot, E; Gambino, F; Casassus, G; Poulain, B; Humeau, Y; Luthi, A				Fourcaudot, Elodie; Gambino, Frederic; Casassus, Guillaume; Poulain, Bernard; Humeau, Yann; Luethi, Andreas			L-type voltage-dependent Ca2+ channels mediate expression of presynaptic LTP in amygdala	NATURE NEUROSCIENCE			English	Article							GATED CALCIUM-CHANNELS; LONG-TERM POTENTIATION; SYNAPTIC PLASTICITY; LATERAL AMYGDALA; BRAIN	The molecular mechanisms underlying the expression of postsynaptic long-term potentiation (LTP) at glutamatergic synapses are well understood. However, little is known about those that mediate the expression of presynaptic LTP. We found that presynaptic LTP at cortical inputs to the mouse lateral amygdala was blocked and reversed by L-type voltage-dependent Ca2+ channel (L-VDCC) blockers. Thus, a persistent increase in L-VDCC-mediated glutamate release underlies the expression of presynaptic LTP in the amygdala.	[Fourcaudot, Elodie; Casassus, Guillaume; Humeau, Yann; Luethi, Andreas] Friedrich Miescher Inst Biomed Res, Basel, Switzerland; [Fourcaudot, Elodie; Gambino, Frederic; Poulain, Bernard; Humeau, Yann] CNRS, UPR3212, Strasbourg, France	Friedrich Miescher Institute for Biomedical Research; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Luthi, A (corresponding author), Friedrich Miescher Inst Biomed Res, Basel, Switzerland.	andreas.luthi@fmi.ch		gambino, frederic/0000-0002-2981-5030	Agence Nationale pour la Recherche; European Neuroscience Institutes Network; Eucor Learning and Teaching Mobility Program; Swiss National Science Foundation; Austrian Science Fund; Novartis Research Foundation	Agence Nationale pour la Recherche(French National Research Agency (ANR)); European Neuroscience Institutes Network(European Commission); Eucor Learning and Teaching Mobility Program; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Austrian Science Fund(Austrian Science Fund (FWF)); Novartis Research Foundation	We thank J. Letzkus and all members of the Luthi laboratory for helpful discussions and comments on the manuscript. This study was supported by the Agence Nationale pour la Recherche, the European Neuroscience Institutes Network, the Eucor Learning and Teaching Mobility Program, the Swiss National Science Foundation, the Austrian Science Fund and the Novartis Research Foundation.	Bauer EP, 2002, J NEUROSCI, V22, P5239, DOI 10.1523/JNEUROSCI.22-12-05239.2002; CASTILLO PE, 1994, NEURON, V12, P261, DOI 10.1016/0896-6273(94)90269-0; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Catterall WA, 2008, NEURON, V59, P882, DOI 10.1016/j.neuron.2008.09.005; Coppola T, 2001, J BIOL CHEM, V276, P32756, DOI 10.1074/jbc.M100929200; FISHER RE, 1990, J NEUROPHYSIOL, V64, P91, DOI 10.1152/jn.1990.64.1.91; Fourcaudot E, 2008, P NATL ACAD SCI USA, V105, P15130, DOI 10.1073/pnas.0806938105; Humeau Y, 2003, NATURE, V426, P841, DOI 10.1038/nature02194; Kiyonaka S, 2007, NAT NEUROSCI, V10, P691, DOI 10.1038/nn1904; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Mato S, 2008, NEUROPHARMACOLOGY, V54, P87, DOI 10.1016/j.neuropharm.2007.04.014; Nicoll RA, 2005, NAT REV NEUROSCI, V6, P863, DOI 10.1038/nrn1786; Pelkey KA, 2006, NEURON, V52, P497, DOI 10.1016/j.neuron.2006.08.032; Shinnick-Gallagher P, 2003, ANN NY ACAD SCI, V985, P135	15	56	56	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2009	12	9					1093	1095		10.1038/nn.2378	http://dx.doi.org/10.1038/nn.2378			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	487ZD	19648911				2022-12-24	WOS:000269317300009
J	Wu, XS; McNeil, BD; Xu, JH; Fan, JM; Xue, L; Melicoff, E; Adachi, R; Bai, L; Wu, LG				Wu, Xin-Sheng; McNeil, Benjamin D.; Xu, Jianhua; Fan, Junmei; Xue, Lei; Melicoff, Ernestina; Adachi, Roberto; Bai, Li; Wu, Ling-Gang			Ca2+ and calmodulin initiate all forms of endocytosis during depolarization at a nerve terminal	NATURE NEUROSCIENCE			English	Article							ADRENAL CHROMAFFIN CELLS; RETINAL BIPOLAR CELLS; CLATHRIN-MEDIATED ENDOCYTOSIS; FROG NEUROMUSCULAR-JUNCTION; SYNAPTIC VESICLE EXOCYTOSIS; READILY RELEASABLE POOL; FAST CNS SYNAPSE; HIPPOCAMPAL SYNAPSES; RAPID ENDOCYTOSIS; PHYSIOLOGICAL TEMPERATURES	Although endocytosis maintains synaptic transmission, how endocytosis is initiated is unclear. We found that calcium influx initiated all forms of endocytosis at a single nerve terminal in rodents, including clathrin-dependent slow endocytosis, bulk endocytosis, rapid endocytosis and endocytosis overshoot (excess endocytosis), with each being evoked with a correspondingly higher calcium threshold. As calcium influx increased, endocytosis gradually switched from very slow endocytosis to slow endocytosis to bulk endocytosis to rapid endocytosis and to endocytosis overshoot. The calcium-induced endocytosis rate increase was a result of the speeding up of membrane invagination and fission. Pharmacological experiments suggested that the calcium sensor mediating these forms of endocytosis is calmodulin. In addition to its role in recycling vesicles, calcium/calmodulin-initiated endocytosis facilitated vesicle mobilization to the readily releasable pool, probably by clearing fused vesicle membrane at release sites. Our findings provide a unifying mechanism for the initiation of various forms of endocytosis that are critical in maintaining exocytosis.	[Wu, Xin-Sheng; McNeil, Benjamin D.; Xu, Jianhua; Fan, Junmei; Xue, Lei; Bai, Li; Wu, Ling-Gang] Natl Inst Neurol Disorders & Stroke, Bethesda, MD 20824 USA; [Melicoff, Ernestina; Adachi, Roberto] Univ Texas MD Anderson Canc Ctr, Dept Pulm Med, Houston, TX 77030 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); University of Texas System; UTMD Anderson Cancer Center	Wu, LG (corresponding author), Natl Inst Neurol Disorders & Stroke, Bethesda, MD 20824 USA.	wul@ninds.nih.gov	fan, junmei/D-6147-2011	Xu, Jianhua/0000-0003-0084-8856; Adachi, Roberto/0000-0002-0146-0768; Melicoff, Ernestina/0000-0001-5696-7112; McNeil, Benjamin/0000-0001-7545-3598	National Institute of Neurological Disorders; US National Institutes of Health; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003009, ZIANS003105] Funding Source: NIH RePORTER	National Institute of Neurological Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institute of Neurological Disorders and Stroke Intramural Research Program of the US National Institutes of Health.	Artalejo CR, 1996, NEURON, V16, P195, DOI 10.1016/S0896-6273(00)80036-7; ARTALEJO CR, 1995, P NATL ACAD SCI USA, V92, P8328, DOI 10.1073/pnas.92.18.8328; AUGUSTINE GJ, 1992, J PHYSIOL-LONDON, V450, P247, DOI 10.1113/jphysiol.1992.sp019126; Balaji J, 2008, J NEUROSCI, V28, P6742, DOI 10.1523/JNEUROSCI.1082-08.2008; Balaji J, 2007, P NATL ACAD SCI USA, V104, P20576, DOI 10.1073/pnas.0707574105; Beutner D, 2001, NEURON, V29, P681, DOI 10.1016/S0896-6273(01)00243-4; Borst JGG, 1996, NATURE, V383, P431, DOI 10.1038/383431a0; CECCARELLI B, 1980, J CELL BIOL, V87, P297, DOI 10.1083/jcb.87.1.297; Clayton EL, 2007, J PHYSIOL-LONDON, V585, P687, DOI 10.1113/jphysiol.2007.137539; Cousin MA, 1998, NEUROSCI LETT, V253, P1, DOI 10.1016/S0304-3940(98)00610-7; Gad H, 1998, NEURON, V21, P607, DOI 10.1016/S0896-6273(00)80570-X; Gandhi SP, 2003, NATURE, V423, P607, DOI 10.1038/nature01677; Granseth B, 2006, NEURON, V51, P773, DOI 10.1016/j.neuron.2006.08.029; HENKEL AW, 1995, NEUROPHARMACOLOGY, V34, P1397, DOI 10.1016/0028-3908(95)00126-Q; Holt M, 2003, J NEUROSCI, V23, P1329, DOI 10.1523/JNEUROSCI.23-04-01329.2003; Jockusch WJ, 2005, NEURON, V46, P869, DOI 10.1016/j.neuron.2005.05.004; Kopp-Scheinpflug C, 2008, NEUROSCIENCE, V154, P160, DOI 10.1016/j.neuroscience.2008.01.088; Kushmerick C, 2006, J NEUROSCI, V26, P1366, DOI 10.1523/JNEUROSCI.3889-05.2006; MALGAROLI A, 1995, SCIENCE, V268, P1624, DOI 10.1126/science.7777862; Marks B, 1998, CURR BIOL, V8, P740, DOI 10.1016/S0960-9822(98)70297-0; Murthy VN, 1999, NAT NEUROSCI, V2, P503, DOI 10.1038/9149; Neher E, 2008, NEURON, V59, P861, DOI 10.1016/j.neuron.2008.08.019; Neves G, 2001, P NATL ACAD SCI USA, V98, P15282, DOI 10.1073/pnas.261311698; Nicholson-Tomishima K, 2004, P NATL ACAD SCI USA, V101, P16648, DOI 10.1073/pnas.0406968101; Nucifora PGP, 1998, J PHYSIOL-LONDON, V508, P483, DOI 10.1111/j.1469-7793.1998.483bq.x; Poskanzer KE, 2006, NEURON, V50, P49, DOI 10.1016/j.neuron.2006.02.021; Pyle JL, 2000, NEURON, V28, P221, DOI 10.1016/S0896-6273(00)00098-2; RAMASWAMI M, 1994, NEURON, V13, P363, DOI 10.1016/0896-6273(94)90353-0; Renden R, 2007, J NEUROPHYSIOL, V98, P3349, DOI 10.1152/jn.00898.2007; Richards DA, 2000, NEURON, V27, P551, DOI 10.1016/S0896-6273(00)00065-9; Rizzoli SO, 2004, SCIENCE, V303, P2037, DOI 10.1126/science.1094682; Ryan TA, 1997, NATURE, V388, P478, DOI 10.1038/41335; Sankaranarayanan S, 2001, NAT NEUROSCI, V4, P129, DOI 10.1038/83949; Sankaranarayanan S, 2000, NAT CELL BIOL, V2, P197, DOI 10.1038/35008615; Satzler K, 2002, J NEUROSCI, V22, P10567; Smith C, 1997, J CELL BIOL, V139, P885, DOI 10.1083/jcb.139.4.885; Sun J, 2007, NATURE, V450, P676, DOI 10.1038/nature06308; Tadross MR, 2008, CELL, V133, P1228, DOI 10.1016/j.cell.2008.05.025; THOMAS P, 1994, J CELL BIOL, V124, P667, DOI 10.1083/jcb.124.5.667; von Gersdorff H, 2002, NAT REV NEUROSCI, V3, P53, DOI 10.1038/nrn705; VONGERSDORFF H, 1994, NATURE, V370, P652, DOI 10.1038/370652a0; Wu LG, 1996, NEURON, V17, P769, DOI 10.1016/S0896-6273(00)80208-1; Wu LG, 2007, J NEUROSCI, V27, P11793, DOI 10.1523/JNEUROSCI.3471-07.2007; Wu W, 2005, J NEUROSCI, V25, P11676, DOI 10.1523/JNEUROSCI.2972-05.2005; Wu W, 2007, P NATL ACAD SCI USA, V104, P10234, DOI 10.1073/pnas.0611512104; Wu XS, 2007, J NEUROSCI, V27, P3046, DOI 10.1523/JNEUROSCI.4415-06.2007; Xu JH, 2005, NEURON, V46, P633, DOI 10.1016/j.neuron.2005.03.024; Xu JH, 2008, NAT NEUROSCI, V11, P45, DOI 10.1038/nn2021; Xu J, 2007, NEURON, V54, P567, DOI 10.1016/j.neuron.2007.05.004; Yamashita T, 2005, SCIENCE, V307, P124, DOI 10.1126/science.1103631	50	172	175	4	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2009	12	8					1003	U70		10.1038/nn.2355	http://dx.doi.org/10.1038/nn.2355			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	475WS	19633667	Green Accepted			2022-12-24	WOS:000268396300014
J	Lathia, JD; Gallagher, J; Heddleston, JM; Wang, JL; Eyler, CE; MacSwords, J; Wu, QL; Vasanji, A; McLendon, RE; Hjelmeland, AB; Rich, JN				Lathia, Justin D.; Gallagher, Joseph; Heddleston, John M.; Wang, Jialiang; Eyler, Christine E.; MacSwords, Jennifer; Wu, Qiulian; Vasanji, Amit; McLendon, Roger E.; Hjelmeland, Anita B.; Rich, Jeremy N.			Integrin Alpha 6 Regulates Glioblastoma Stem Cells	CELL STEM CELL			English	Article							CANCER-CELLS; BRAIN; TUMORS; GROWTH; IDENTIFICATION; EXPRESSION; PATHWAY; MARKER; NICHE; ANGIOGENESIS	Cancer stem cells (CSCs) are a subpopulation of tumor cells suggested to be critical for tumor maintenance, metastasis, and therapeutic resistance. Prospective identification and targeting of CSCs are therefore priorities for the development of novel therapeutic paradigms. Although CSC enrichment has been achieved with cell surface proteins including CD133 (Prominin-1), the roles of current CSC markers in tumor maintenance remain unclear. We examined the glioblastoma stem cell (GSC) perivascular microenvironment in patient specimens to identify enrichment markers with a functional significance and identified integrin alpha 6 as a candidate. Integrin alpha 6 is coexpressed with conventional GSC markers and enriches for GSCs. Targeting integrin alpha 6 in GSCs inhibits self-renewal, proliferation, and tumor formation capacity. Our results provide evidence that GSCs express high levels of integrin alpha 6, which can serve not only as an enrichment marker but also as a promising antiglioblastoma therapy.	[Lathia, Justin D.; Gallagher, Joseph; Heddleston, John M.; Eyler, Christine E.; MacSwords, Jennifer; Wu, Qiulian; Hjelmeland, Anita B.; Rich, Jeremy N.] Cleveland Clin, Dept Stem Cell Biol & Regenerat Med, Cleveland, OH 44195 USA; [Wang, Jialiang] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27705 USA; [Eyler, Christine E.] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27705 USA; [McLendon, Roger E.] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27705 USA	Cleveland Clinic Foundation; Duke University; Duke University; Duke University	Rich, JN (corresponding author), Cleveland Clin, Dept Stem Cell Biol & Regenerat Med, Cleveland, OH 44195 USA.	richj@ccf.org	Rich, Jeremy N./A-9501-2012; Rich, Jeremy/AAM-1445-2021; Lathia, Justin/AHB-8296-2022; Eyler, Christine E/A-2921-2010		Childhood Brain Tumor Foundation; Pediatric Brain Tumor Foundation of the United States; Accelerate Brain Cancer Cure; Alexander and Margaret Stewart Trust; Brain Tumor Society; Goldhirsh Foundation; Duke Comprehensive Cancer Center Stem Cell Initiative; NIH [NSO47409, NS054276, CA112958, CA116659]; Damon Runyon Cancer Research Foundation; Sidney Kimmel Foundation; National Brain Tumor Society; National Institutes of Neurological Disorders and Stroke (NINDS) [F30 NS063496]; American Brain Tumor Association; National Service Research Award [NCI F32 CA142159]; Duke University; Cleveland Clinic Foundation Tissue Procurement Service; NATIONAL CANCER INSTITUTE [F32CA142159, R01CA116659, R01CA129958] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F30NS063496, R01NS054276, K02NS047409] Funding Source: NIH RePORTER	Childhood Brain Tumor Foundation; Pediatric Brain Tumor Foundation of the United States; Accelerate Brain Cancer Cure; Alexander and Margaret Stewart Trust; Brain Tumor Society; Goldhirsh Foundation; Duke Comprehensive Cancer Center Stem Cell Initiative; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Damon Runyon Cancer Research Foundation; Sidney Kimmel Foundation; National Brain Tumor Society; National Institutes of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); American Brain Tumor Association; National Service Research Award; Duke University; Cleveland Clinic Foundation Tissue Procurement Service; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Dr. Mike Cook, Dr. Beth Harvat, Cathy Shemo, Moneen Morgan, and Sage O'Bryant for flow cytometry assistance, Linda Vargo for histology assistance, and the members of the Rich laboratory for technical assistance and critical review of the manuscript. We are also grateful to Dr. Michael Forrester for advice on the DNA fragmentation assay and to Drs. Mahendra S. Rao, Richard Ransohoff, Thomas Egelhoff, Yogen Saunthararajah, and Jeongwu Lee for valuable insight and comments on the manuscript. Work in the J.N.R. laboratory is supported by the Childhood Brain Tumor Foundation, the Pediatric Brain Tumor Foundation of the United States, Accelerate Brain Cancer Cure, Alexander and Margaret Stewart Trust, Brain Tumor Society, Goldhirsh Foundation, Duke Comprehensive Cancer Center Stem Cell Initiative Grant, and NIH grants NSO47409, NS054276, CA112958, and CA116659. J.N.R. is a Damon Runyon-Lilly Clinical Investigator supported by the Damon Runyon Cancer Research Foundation and a Sidney Kimmel Foundation for Cancer Research Scholar. A.B.H. is supported by the National Brain Tumor Society. C.E.E. is supported by a National Research Service Award from the National Institutes of Neurological Disorders and Stroke (NINDS F30 NS063496). J.D.L. is supported by an American Brain Tumor Association Basic Research Fellowship (sponsored by the Joelle Syverson Fund) and a National Service Research Award (NCI F32 CA142159). The Duke University Brain Tumor Tissue Bank is supported by the Duke University Brain Cancer SPORE, and we thank D. Satterfield, L. Ehinger, J. Funkhouser, and J. Faison for technical assistance. Studies were also supported by the Cleveland Clinic Foundation Tissue Procurement Service, and we thank S. Staugatis, R. Weil, and M. McGraw for their assistance.	Al-Mayhani TMF, 2009, J NEUROSCI METH, V176, P192, DOI 10.1016/j.jneumeth.2008.07.022; ALOISI F, 1992, J NEUROSCI RES, V32, P494, DOI 10.1002/jnr.490320405; Bao SD, 2008, CANCER RES, V68, P6043, DOI 10.1158/0008-5472.CAN-08-1079; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Bao SD, 2006, CANCER RES, V66, P7843, DOI 10.1158/0008-5472.CAN-06-1010; Bar EE, 2007, STEM CELLS, V25, P2524, DOI 10.1634/stemcells.2007-0166; Beier D, 2007, CANCER RES, V67, P4010, DOI 10.1158/0008-5472.CAN-06-4180; Bidlingmaier S, 2008, J MOL MED, V86, P1025, DOI 10.1007/s00109-008-0357-8; Calabrese C, 2007, CANCER CELL, V11, P69, DOI 10.1016/j.ccr.2006.11.020; Campos LS, 2004, DEVELOPMENT, V131, P3433, DOI 10.1242/dev.01199; Eyler CE, 2008, STEM CELLS, V26, P3027, DOI 10.1634/stemcells.2007-1073; Fan X, 2006, CANCER RES, V66, P7445, DOI 10.1158/0008-5472.CAN-06-0858; Fortunel NO, 2003, SCIENCE, V302, P393; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Georges-Labouesse E, 1998, CURR BIOL, V8, P983, DOI 10.1016/S0960-9822(98)70402-6; Gilbertson RJ, 2007, NAT REV CANCER, V7, P733, DOI 10.1038/nrc2246; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; GINGRAS MC, 1995, J NEUROIMMUNOL, V57, P143, DOI 10.1016/0165-5728(94)00178-Q; Graus-Porta D, 2001, NEURON, V31, P367, DOI 10.1016/S0896-6273(01)00374-9; Hall PE, 2006, STEM CELLS, V24, P2078, DOI 10.1634/stemcells.2005-0595; Hall PE, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-71; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hemmati HD, 2003, P NATL ACAD SCI USA, V100, P15178, DOI 10.1073/pnas.2036535100; Hoey T, 2009, CELL STEM CELL, V5, P168, DOI 10.1016/j.stem.2009.05.019; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Ignatova TN, 2002, GLIA, V39, P193, DOI 10.1002/glia.10094; Jaksch M, 2008, CANCER RES, V68, P7882, DOI 10.1158/0008-5472.CAN-08-0723; Joo KM, 2008, LAB INVEST, V88, P808, DOI 10.1038/labinvest.2008.57; Kerever A, 2007, STEM CELLS, V25, P2146, DOI 10.1634/stemcells.2007-0082; Lathia JD, 2007, DEV DYNAM, V236, P3267, DOI 10.1002/dvdy.21319; Lathia JD, 2007, J COMP NEUROL, V505, P630, DOI 10.1002/cne.21520; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Lee TH, 2006, J BIOL CHEM, V281, P40450, DOI 10.1074/jbc.M607525200; Li Z, 2009, CANCER CELL, V15, P501, DOI 10.1016/j.ccr.2009.03.018; Liu GT, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-67; Loulier K, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000176; Ogden AT, 2008, NEUROSURGERY, V62, P505, DOI 10.1227/01.neu.0000316019.28421.95; Patrawala L, 2007, CANCER RES, V67, P6796, DOI 10.1158/0008-5472.CAN-07-0490; PAULUS W, 1993, AM J PATHOL, V143, P154; Piccirillo SGM, 2006, NATURE, V444, P761, DOI 10.1038/nature05349; Piccirillo SGM, 2009, ONCOGENE, V28, P1807, DOI 10.1038/onc.2009.27; Pollard SM, 2009, CELL STEM CELL, V4, P568, DOI 10.1016/j.stem.2009.03.014; Read TA, 2009, CANCER CELL, V15, P135, DOI 10.1016/j.ccr.2008.12.016; Reardon DA, 2008, J CLIN ONCOL, V26, P5610, DOI 10.1200/JCO.2008.16.7510; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Schmid RS, 2003, CEREB CORTEX, V13, P219, DOI 10.1093/cercor/13.3.219; Shen Q, 2008, CELL STEM CELL, V3, P289, DOI 10.1016/j.stem.2008.07.026; Shu Q, 2008, STEM CELLS, V26, P1414, DOI 10.1634/stemcells.2007-1009; Singh SK, 2003, CANCER RES, V63, P5821; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Son MJ, 2009, CELL STEM CELL, V4, P440, DOI 10.1016/j.stem.2009.03.003; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Taylor MD, 2005, CANCER CELL, V8, P323, DOI 10.1016/j.ccr.2005.09.001; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720; VAILLANT F, 2003, CANCER RES, V68, P7711; Vitolo D, 1996, HISTOPATHOLOGY, V28, P521, DOI 10.1046/j.1365-2559.1996.d01-471.x; Wang JL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003769; Wang J, 2008, INT J CANCER, V122, P761, DOI 10.1002/ijc.23130; Yuan XP, 2004, ONCOGENE, V23, P9392, DOI 10.1038/sj.onc.1208311; Zheng HW, 2008, NATURE, V455, P1129, DOI 10.1038/nature07443	60	463	471	0	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAY 7	2010	6	5					421	432		10.1016/j.stem.2010.02.018	http://dx.doi.org/10.1016/j.stem.2010.02.018			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	598NO	20452317	Green Accepted, Bronze			2022-12-24	WOS:000277844800010
J	Bergquist, S; Dickman, DK; Davis, GW				Bergquist, Sharon; Dickman, Dion K.; Davis, Graeme W.			A Hierarchy of Cell Intrinsic and Target-Derived Homeostatic Signaling	NEURON			English	Article							PRESYNAPTIC TRANSMITTER RELEASE; POTASSIUM CHANNELS; K+ CURRENT; SYNAPTIC-TRANSMISSION; EXCITATORY SYNAPSES; IDENTIFIED NEURONS; RETROGRADE SIGNAL; PYRAMIDAL NEURONS; NETWORK FUNCTION; GENETIC-ANALYSIS	Homeostatic control of neural function can be mediated by the regulation of ion channel expression, neurotransmitter receptor abundance, or modulation of presynaptic release. These processes can be implemented through cell autonomous or intercellular signaling. It remains unknown whether different forms of homeostatic regulation can be coordinated to achieve constant neural function. One way to approach this question is to confront a simple neural system with conflicting perturbations and determine whether the outcome reflects a coordinated, homeostatic response. Here, we demonstrate that two A-type potassium channel genes, shal and shaker, are reciprocally, transcriptionally coupled to maintain A-type channel expression. We then demonstrate that this homeostatic control of A-type channel expression prevents target-dependent, homeostatic modulation of synaptic transmission. Thus, we uncover a homeostatic mechanism that reciprocally regulates A-type potassium channels, and we define a hierarchical relationship between cell-intrinsic control of ion channel expression and target-derived homeostatic control of synaptic transmission.	[Bergquist, Sharon; Dickman, Dion K.; Davis, Graeme W.] Univ Calif San Francisco, Dept Biochem & Biophys, Program Neurosci, San Francisco, CA 94158 USA	University of California System; University of California San Francisco	Davis, GW (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, Program Neurosci, San Francisco, CA 94158 USA.	graeme.davis@ucsf.edu			NIH [NS39313]; ARCS; A.P. Giannini Foundation; Jane Coffin Childs Memorial Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039313] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ARCS; A.P. Giannini Foundation; Jane Coffin Childs Memorial Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to thank M. Mueller and C.A. Frank for reading prior versions of the text and helpful comments and E. Pym and C. Massaro for technical assistance. These studies were supported by NIH Grant number NS39313 to G.W.D. S.B.B. was supported by an ARCS fellowship. D.K.D. was supported by the A.P. Giannini Foundation and Jane Coffin Childs Memorial Fund.	Albin SD, 2004, J NEUROSCI, V24, P6871, DOI 10.1523/JNEUROSCI.1538-04.2004; ATKINSON NS, 1991, SCIENCE, V253, P551, DOI 10.1126/science.1857984; BAKER K, 1990, NEURON, V4, P129, DOI 10.1016/0896-6273(90)90449-P; Baro DJ, 1996, J NEUROSCI, V16, P1689; Baro DJ, 2000, J NEUROSCI, V20, P6619, DOI 10.1523/JNEUROSCI.20-17-06619.2000; Bernard C, 2004, SCIENCE, V305, P532, DOI 10.1126/science.1097065; Bernard C, 2003, J NEUROPHYSIOL, V90, P1807, DOI 10.1152/jn.00286.2003; Bernard C, 2001, NEUROSCIENCE, V103, P17, DOI 10.1016/S0306-4522(00)00524-8; Birnbaum SG, 2004, PHYSIOL REV, V84, P803, DOI 10.1152/physrev.00039.2003; Borodinsky LN, 2004, NATURE, V429, P523, DOI 10.1038/nature02518; BURGESS DL, 1995, NAT GENET, V10, P461, DOI 10.1038/ng0895-461; Castro PA, 2001, J NEUROSCI, V21, P6626, DOI 10.1523/JNEUROSCI.21-17-06626.2001; Chen XX, 2006, J NEUROSCI, V26, P12143, DOI 10.1523/JNEUROSCI.2667-06.2006; Cossart R, 2001, NAT NEUROSCI, V4, P52, DOI 10.1038/82900; Davis GW, 2006, ANNU REV NEUROSCI, V29, P307, DOI 10.1146/annurev.neuro.28.061604.135751; Davis GW, 1998, NEURON, V20, P305, DOI 10.1016/S0896-6273(00)80458-4; Desai NS, 1999, LEARN MEMORY, V6, P284; Dickman DK, 2009, SCIENCE, V326, P1127, DOI 10.1126/science.1179685; El-Hassar L, 2007, J PHYSIOL-LONDON, V578, P193, DOI 10.1113/jphysiol.2006.119297; Frank CA, 2006, NEURON, V52, P663, DOI 10.1016/j.neuron.2006.09.029; Frank CA, 2009, NEURON, V61, P556, DOI 10.1016/j.neuron.2008.12.028; Frohlich F, 2008, J NEUROSCI, V28, P1709, DOI 10.1523/JNEUROSCI.4263-07.2008; GANETZKY B, 1982, J NEUROPHYSIOL, V47, P501, DOI 10.1152/jn.1982.47.3.501; Gasque G, 2005, J NEUROSCI, V25, P2348, DOI 10.1523/JNEUROSCI.4384-04.2005; GHO M, 1992, J EXP BIOL, V170, P93; Glykys J, 2006, J NEUROPHYSIOL, V95, P2796, DOI 10.1152/jn.01122.2005; Goldberg EM, 2005, J NEUROSCI, V25, P5230, DOI 10.1523/JNEUROSCI.0722-05.2005; Goold CP, 2007, NEURON, V56, P109, DOI 10.1016/j.neuron.2007.08.006; Hernandez-Pineda R, 1999, J NEUROPHYSIOL, V82, P1512, DOI 10.1152/jn.1999.82.3.1512; Hodge JJL, 2005, J NEUROBIOL, V63, P235, DOI 10.1002/neu.20126; Itri JN, 2005, NAT NEUROSCI, V8, P650, DOI 10.1038/nn1448; JAN YN, 1977, PROC R SOC SER B-BIO, V198, P87, DOI 10.1098/rspb.1977.0087; Kaneko M, 2008, NEURON, V58, P673, DOI 10.1016/j.neuron.2008.04.023; KAPLAN WD, 1969, GENETICS, V61, P399; Koh K, 2008, SCIENCE, V321, P372, DOI 10.1126/science.1155942; MacLean JN, 2003, NEURON, V37, P109, DOI 10.1016/S0896-6273(02)01104-2; Marder E, 2002, BIOESSAYS, V24, P1145, DOI 10.1002/bies.10185; Marder E, 1996, P NATL ACAD SCI USA, V93, P13481, DOI 10.1073/pnas.93.24.13481; Marder E, 2006, NAT REV NEUROSCI, V7, P563, DOI 10.1038/nrn1949; Marder E, 2007, ANNU REV PHYSIOL, V69, P291, DOI 10.1146/annurev.physiol.69.031905.161516; MartinezPadron M, 1997, J NEUROSCI, V17, P3412; Mody I, 2005, J PHYSIOL-LONDON, V562, P37, DOI 10.1113/jphysiol.2004.077362; Muraro NI, 2008, J NEUROSCI, V28, P2099, DOI 10.1523/JNEUROSCI.5092-07.2008; Nerbonne JM, 2008, J PHYSIOL-LONDON, V586, P1565, DOI 10.1113/jphysiol.2007.146597; Paradis S, 2001, NEURON, V30, P737, DOI 10.1016/S0896-6273(01)00326-9; Petersen SA, 1997, NEURON, V19, P1237, DOI 10.1016/S0896-6273(00)80415-8; Pielage J, 2008, NEURON, V58, P195, DOI 10.1016/j.neuron.2008.02.017; Prinz AA, 2004, NAT NEUROSCI, V7, P1345, DOI 10.1038/nn1352; Rudy B, 2001, TRENDS NEUROSCI, V24, P517, DOI 10.1016/S0166-2236(00)01892-0; Rutherford LC, 1998, NEURON, V21, P521, DOI 10.1016/S0896-6273(00)80563-2; Schulz DJ, 2007, P NATL ACAD SCI USA, V104, P13187, DOI 10.1073/pnas.0705827104; Schulz DJ, 2006, NAT NEUROSCI, V9, P356, DOI 10.1038/nn1639; SHENG M, 1993, NATURE, V365, P72, DOI 10.1038/365072a0; SOLC CK, 1988, J NEUROSCI, V8, P2556; Stellwagen D, 2006, NATURE, V440, P1054, DOI 10.1038/nature04671; Swensen AM, 2005, J NEUROSCI, V25, P3509, DOI 10.1523/JNEUROSCI.3929-04.2005; TSUNODA S, 1995, J NEUROSCI, V15, P1741, DOI 10.1523/JNEUROSCI.15-03-01741.1995; TURRIGIANO G, 1995, J NEUROSCI, V15, P3640; Turrigiano GG, 2008, CELL, V135, P422, DOI 10.1016/j.cell.2008.10.008; Van Wart A, 2006, J NEUROSCI, V26, P7172, DOI 10.1523/JNEUROSCI.1101-06.2006; WEI A, 1990, SCIENCE, V248, P599, DOI 10.1126/science.2333511; White BH, 2001, NEURON, V31, P699, DOI 10.1016/S0896-6273(01)00415-9; WU CF, 1983, SCIENCE, V220, P1076, DOI 10.1126/science.6302847	63	72	72	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 29	2010	66	2					220	234		10.1016/j.neuron.2010.03.023	http://dx.doi.org/10.1016/j.neuron.2010.03.023			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	591NQ	20434999	Green Accepted, Bronze			2022-12-24	WOS:000277308200008
J	Zhou, Y; Liu, BH; Wu, GYK; Kim, YJ; Xiao, ZJ; Tao, HZW; Zhang, LI				Zhou, Yi; Liu, Bao-hua; Wu, Guangying K.; Kim, Young-Joo; Xiao, Zhongju; Tao, Huizhong W.; Zhang, Li I.			Preceding Inhibition Silences Layer 6 Neurons in Auditory Cortex	NEURON			English	Article							VISUAL-CORTEX; IN-VIVO; CORTICOFUGAL MODULATION; RESPONSE PROPERTIES; CORTICAL-NEURONS; CORTICOTHALAMIC PROJECTIONS; ORIENTATION SELECTIVITY; FEEDFORWARD INHIBITION; SOMATOSENSORY CORTEX; BALANCED INHIBITION	A canonical feedforward circuit is proposed to underlie sensory cortical responses with balanced excitation and inhibition in layer 4 (L4). However, in another input layer, L6, sensory responses and the underlying synaptic circuits remain largely unclear. Here, cell-attached recordings in rat primary auditory cortex revealed that for the majority of L6 excitatory neurons, tonal stimuli did not drive spike responses, but suppressed spontaneous firings. Whole-cell recordings further revealed that the silencing resulted from tone-evoked strong inhibition arriving earlier than excitation. This pattern of inputs can be attributed to a parallel feedforward circuit with both excitatory and inhibitory inputs disynaptically relayed. In contrast, in the other neurons directly driven by thalamic input, stimuli evoked excitation preceding relatively weak inhibition, resulting in robust spike responses. Thus, the dichotomy of L6 response properties arises from two distinct patterns of excitatory-inhibitory interplay. The parallel circuit module generating preceding inhibition may provide a gating mechanism for conditional corticothalamic feedback.	[Xiao, Zhongju] So Med Univ, Sch Basic Med Sci, Dept Physiol, Guangzhou 510515, Guangdong, Peoples R China; [Zhou, Yi; Liu, Bao-hua; Wu, Guangying K.; Kim, Young-Joo; Tao, Huizhong W.; Zhang, Li I.] Univ So Calif, Keck Sch Med, Zilkha Neurogenet Inst, Los Angeles, CA 90089 USA; [Tao, Huizhong W.] Univ So Calif, Keck Sch Med, Dept Cell & Neurobiol, Los Angeles, CA 90089 USA; [Zhang, Li I.] Univ So Calif, Keck Sch Med, Dept Physiol & Biophys, Los Angeles, CA 90089 USA	Southern Medical University - China; University of Southern California; University of Southern California; University of Southern California	Xiao, ZJ (corresponding author), So Med Univ, Sch Basic Med Sci, Dept Physiol, Guangzhou 510515, Guangdong, Peoples R China.	xiaozj@fimmu.com; liizhang@usc.edu	Wu, Guangying/E-8117-2010; Zhou, Yi/B-3854-2012; Tao, Huizhong W/HDM-9767-2022	Zhou, Yi/0000-0002-2623-8960; Wu, Guangying/0000-0002-7243-5412	US National Institutes of Health/National Institute on Deafness and Other Communication Disorders [R01 DC008983, R21 DC008588]; Searle Scholar Program; Klingenstein Foundation; David and Lucile Packard Foundation; National Natural Science Foundation of China [30730039, 30970982, 30670665]; NATIONAL EYE INSTITUTE [R01EY019049] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R21DC008588, R01DC008983] Funding Source: NIH RePORTER	US National Institutes of Health/National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Searle Scholar Program; Klingenstein Foundation(Klingenstein Philanthropies); David and Lucile Packard Foundation(The David & Lucile Packard Foundation); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by grants to L.I.Z.. from the US National Institutes of Health/National Institute on Deafness and Other Communication Disorders (R01 DC008983, R21 DC008588). the Searle Scholar Program, the Klingenstein Foundation, and the David and Lucile Packard Foundation (Packard Fellowships for Science and Engineering). Z. Xiao is supported by National Natural Science Foundation of China (Grant Numbers 30730039, 30970982, and 30670665).	Anderson JS, 2000, J NEUROPHYSIOL, V84, P909, DOI 10.1152/jn.2000.84.2.909; Atencio CA, 2008, J NEUROSCI, V28, P3897, DOI 10.1523/JNEUROSCI.5366-07.2008; Borg-Graham LJ, 1998, NATURE, V393, P369, DOI 10.1038/30735; Crick F, 1998, NATURE, V391, P245, DOI 10.1038/34584; CRICK F, 1984, P NATL ACAD SCI-BIOL, V81, P4586, DOI 10.1073/pnas.81.14.4586; de la Rocha J, 2008, J NEUROSCI, V28, P9151, DOI 10.1523/JNEUROSCI.1789-08.2008; DOUGLAS RJ, 1991, J PHYSIOL-LONDON, V440, P735, DOI 10.1113/jphysiol.1991.sp018733; Gabernet L, 2005, NEURON, V48, P315, DOI 10.1016/j.neuron.2005.09.022; GAMES KD, 1988, HEARING RES, V34, P1, DOI 10.1016/0378-5955(88)90047-0; GILBERT CD, 1975, J COMP NEUROL, V163, P81, DOI 10.1002/cne.901630106; Goard M, 2009, NAT NEUROSCI, V12, P1444, DOI 10.1038/nn.2402; Higley MJ, 2006, J NEUROSCI, V26, P448, DOI 10.1523/JNEUROSCI.3506-05.2006; Hines M, 1993, NEURAL SYSTEMS ANAL, P127; JAHR CE, 1990, J NEUROSCI, V10, P1830; JAHR CE, 1990, J NEUROSCI, V10, P3178; Kaur S, 2005, NEUROSCIENCE, V134, P1033, DOI 10.1016/j.neuroscience.2005.04.052; Kumar P, 2008, J NEUROPHYSIOL, V100, P1909, DOI 10.1152/jn.90684.2008; Lakatos P, 2007, NEURON, V53, P279, DOI 10.1016/j.neuron.2006.12.011; Liu BH, 2007, NAT NEUROSCI, V10, P1594, DOI 10.1038/nn2012; Llano DA, 2008, J COMP NEUROL, V507, P1209, DOI 10.1002/cne.21602; Llano DA, 2009, CEREB CORTEX, V19, P2810, DOI 10.1093/cercor/bhp050; Margrie TW, 2002, PFLUG ARCH EUR J PHY, V444, P491, DOI 10.1007/s00424-002-0831-z; Marino J, 2005, NAT NEUROSCI, V8, P194, DOI 10.1038/nn1391; Mitchell JF, 2009, NEURON, V63, P879, DOI 10.1016/j.neuron.2009.09.013; Moore CI, 1999, TRENDS NEUROSCI, V22, P513, DOI 10.1016/S0166-2236(99)01452-6; MOUNTCASTLE VB, 1969, J NEUROPHYSIOL, V32, P452, DOI 10.1152/jn.1969.32.3.452; NELSON S, 1994, SCIENCE, V265, P774, DOI 10.1126/science.8047882; OJIMA H, 1994, CEREB CORTEX, V4, P646, DOI 10.1093/cercor/4.6.646; Ojima H, 2002, CEREB CORTEX, V12, P1079, DOI 10.1093/cercor/12.10.1079; Okun M, 2008, NAT NEUROSCI, V11, P535, DOI 10.1038/nn.2105; Pinault D, 1996, J NEUROSCI METH, V65, P113, DOI 10.1016/0165-0270(95)00144-1; Pouille F, 2001, SCIENCE, V293, P1159, DOI 10.1126/science.1060342; Prieto JJ, 1999, J COMP NEUROL, V404, P332, DOI 10.1002/(SICI)1096-9861(19990215)404:3<332::AID-CNE5>3.0.CO;2-R; Recanzone GH, 2000, HEARING RES, V150, P104, DOI 10.1016/S0378-5955(00)00194-5; Rouiller EM, 2000, BRAIN RES BULL, V53, P727, DOI 10.1016/S0361-9230(00)00364-6; Salinas E, 2000, J NEUROSCI, V20, P6193, DOI 10.1523/JNEUROSCI.20-16-06193.2000; Schreiner CE, 2000, ANNU REV NEUROSCI, V23, P501, DOI 10.1146/annurev.neuro.23.1.501; SHAMMA SA, 1985, HEARING RES, V19, P1, DOI 10.1016/0378-5955(85)90094-2; SHERMAN SM, 1986, EXP BRAIN RES, V63, P1; SILLITO AM, 1994, NATURE, V369, P479, DOI 10.1038/369479a0; Sirota MG, 2005, J NEUROSCI, V25, P5915, DOI 10.1523/JNEUROSCI.0489-05.2005; SOMERS DC, 1995, J NEUROSCI, V15, P5448; Suga N, 2003, NAT REV NEUROSCI, V4, P783, DOI 10.1038/nrn1222; Sutter ML, 2003, J NEUROPHYSIOL, V90, P2629, DOI 10.1152/jn.00722.2002; SWADLOW HA, 1989, J NEUROPHYSIOL, V62, P288, DOI 10.1152/jn.1989.62.1.288; Takayanagi M, 2006, NEUROSCIENCE, V142, P769, DOI 10.1016/j.neuroscience.2006.06.048; Tan AYY, 2004, J NEUROPHYSIOL, V92, P630, DOI 10.1152/jn.01020.2003; TSUMOTO T, 1980, J COMP NEUROL, V193, P223, DOI 10.1002/cne.901930115; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; VILLA AEP, 1991, EXP BRAIN RES, V86, P506, DOI 10.1007/BF00230524; VOLKOV IO, 1991, NEUROSCIENCE, V43, P307, DOI 10.1016/0306-4522(91)90295-Y; Wallace MN, 2008, EXP BRAIN RES, V184, P179, DOI 10.1007/s00221-007-1092-z; Wang JA, 2002, BRAIN RES, V944, P219, DOI 10.1016/S0006-8993(02)02926-8; Wang XQ, 2005, NATURE, V435, P341, DOI 10.1038/nature03565; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116; Winer JA, 2005, HEARING RES, V207, P1, DOI 10.1016/j.heares.2005.06.007; Winer JA, 2005, TRENDS NEUROSCI, V28, P255, DOI 10.1016/j.tins.2005.03.009; Winer JA, 2001, J COMP NEUROL, V430, P27; Wu GK, 2008, NEURON, V58, P132, DOI 10.1016/j.neuron.2008.01.035; Wu GY, 2006, NEURON, V52, P705, DOI 10.1016/j.neuron.2006.10.009; Yan J, 2002, EUR J NEUROSCI, V16, P119, DOI 10.1046/j.1460-9568.2002.02046.x; Zarrinpar A, 2006, J NEUROPHYSIOL, V95, P1751, DOI 10.1152/jn.00974.2005; Zhang LI, 2001, NAT NEUROSCI, V4, P1123, DOI 10.1038/nn745; Zhang LI, 2003, NATURE, V424, P201, DOI 10.1038/nature01796; Zhang YF, 2000, J NEUROPHYSIOL, V84, P325, DOI 10.1152/jn.2000.84.1.325; Zhang YF, 1997, J NEUROPHYSIOL, V78, P3489, DOI 10.1152/jn.1997.78.6.3489; Zhang YF, 2008, CEREB CORTEX, V18, P1521, DOI 10.1093/cercor/bhm188; Zhang ZW, 1997, J NEUROSCI, V17, P6365	68	80	84	0	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 11	2010	65	5					706	717		10.1016/j.neuron.2010.02.021	http://dx.doi.org/10.1016/j.neuron.2010.02.021			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	571NF	20223205	Green Accepted, Bronze			2022-12-24	WOS:000275758000013
J	Oguro, H; Yuan, J; Ichikawa, H; Ikawa, T; Yamazaki, S; Kawamoto, H; Nakauchi, H; Iwama, A				Oguro, Hideyuki; Yuan, Jin; Ichikawa, Hitoshi; Ikawa, Tonnokatsu; Yamazaki, Satoshi; Kawamoto, Hiroshi; Nakauchi, Hiromitsu; Iwama, Atsushi			Poised Lineage Specification in Multipotential Hematopoietic Stem and Progenitor Cells by the Polycomb Protein Bmi1	CELL STEM CELL			English	Article							DEVELOPMENTAL REGULATORS; SELF-RENEWAL; EXPRESSION; PROLIFERATION; LYMPHOPOIESIS; MAINTENANCE; INK4A; GENES; FATE; EBF	Polycomb group (PcG) proteins are essential regulators of stem cells. PcG and trithorax group proteins mark developmental regulator gene promoters with bivalent domains consisting of overlapping repressive and activating histone modifications to keep them poised for activation in embryonic stem cells. Bmi1, a component of PcG complexes, maintains the self-renewal capacity of adult stem cells, but its role in multipotency remains obscure. Here we show that Bmi1 is critical for multipotency of hematopoietic stem cells (HSCs) and multipotent progenitors (MPPs). B cell lineage developmental regulator genes, Ebf1 and Pax5, appeared to be transcriptionally repressed by bivalent domains before lineage commitment. Loss of Bmi1 resulted in a resolution of bivalent domains at the Ebf1 and Pax5 loci, leading to their premature expression in HSC/MPPs accompanied by accelerated lymphoid specification and a marked reduction in HSC/MPPs. Thus, Bmi1 is required to reinforce bivalent domains at key developmental regulator gene loci to maintain lineage specification poised for activation in adult stem cells.	[Oguro, Hideyuki; Yuan, Jin; Iwama, Atsushi] Chiba Univ, Grad Sch Med, Dept Cellular & Mol Med, Chiba 2608670, Japan; [Oguro, Hideyuki; Yuan, Jin; Iwama, Atsushi] CREST, JST, Chiyoda Ku, Tokyo 1020075, Japan; [Yamazaki, Satoshi; Nakauchi, Hiromitsu] ERATO, JST, Chiyoda Ku, Tokyo 1020075, Japan; [Ichikawa, Hitoshi] Natl Canc Ctr, Res Inst, Div Genet, Tokyo 1040045, Japan; [Ikawa, Tonnokatsu; Kawamoto, Hiroshi] RIKEN Res Ctr Allergy & Immunol, Lab Lymphocyte Dev, Yokohama, Kanagawa 2300045, Japan; [Yamazaki, Satoshi; Nakauchi, Hiromitsu] Univ Tokyo, Inst Med Sci, Ctr Med Expt, Lab Stem Cell Therapy, Tokyo 1088679, Japan	Chiba University; Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST); National Cancer Center - Japan; RIKEN; University of Tokyo	Iwama, A (corresponding author), Chiba Univ, Grad Sch Med, Dept Cellular & Mol Med, Chiba 2608670, Japan.	aiwama@faculty.chiba-u.jp	Oguro, Hideyuki/Q-5478-2019	Oguro, Hideyuki/0000-0002-9070-4575	Japanese Society for the Promotion of Science; Global COE Program; MEXT, Japan; Japan Science and Technology Corporation (JST); Takeda Science Foundation;  [20052009]	Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Global COE Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Corporation (JST)(Japan Science & Technology Agency (JST)); Takeda Science Foundation(Takeda Science Foundation (TSF)); 	We thank Maarten van Lohuizen and Ronald A. DePinho for providing Bmi1<SUP>+/-</SUP> mice and Ink4a<SUP>+/-</SUP> mice, respectively, Naohito Nozaki for the Bmi1 antibody, and Yuji Yamazaki for flow cytometric sorting. H.O. is supported by a postdoctoral fellowship from the Japanese Society for the Promotion of Science. This work was supported in part by Grants-in-Aid for Scientific Research (#20052009) and for the Global COE Program (Global Center for Education and Research in Immune System Regulation and Treatment), MEXT, Japan, a Grant-in-Aid for the Core Research for Evolutional Science and Technology (CREST) from the Japan Science and Technology Corporation (JST), and a grant from the Takeda Science Foundation.	Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Chiba T, 2008, CANCER RES, V68, P7742, DOI 10.1158/0008-5472.CAN-07-5882; Dias S, 2008, CURR OPIN GENET DEV, V18, P441, DOI 10.1016/j.gde.2008.07.015; Iwama A, 2004, IMMUNITY, V21, P843, DOI 10.1016/j.immuni.2004.11.004; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Ku M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000242; Laslo P, 2008, SEMIN IMMUNOL, V20, P228, DOI 10.1016/j.smim.2008.08.003; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Liu HF, 2007, GENE DEV, V21, P1179, DOI 10.1101/gad.1529307; Masuda K, 2005, EMBO J, V24, P4052, DOI 10.1038/sj.emboj.7600878; Mendenhall EM, 2008, CURR OPIN GENET DEV, V18, P109, DOI 10.1016/j.gde.2008.01.010; Miyazaki M, 2008, IMMUNITY, V28, P231, DOI 10.1016/j.immuni.2007.12.013; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Oguro H, 2006, J EXP MED, V203, P2247, DOI 10.1084/jem.20052477; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Pietersen AM, 2008, CURR OPIN CELL BIOL, V20, P201, DOI 10.1016/j.ceb.2008.01.004; Pongubala JMR, 2008, NAT IMMUNOL, V9, P203, DOI 10.1038/ni1555; Raaphorst FM, 2001, TRENDS IMMUNOL, V22, P682, DOI 10.1016/S1471-4906(01)02082-8; Roessler S, 2007, MOL CELL BIOL, V27, P579, DOI 10.1128/MCB.01192-06; Souabni A, 2002, IMMUNITY, V17, P781, DOI 10.1016/S1074-7613(02)00472-7; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; Spivakov M, 2007, NAT REV GENET, V8, P263, DOI 10.1038/nrg2046; Su IH, 2003, NAT IMMUNOL, V4, P124, DOI 10.1038/ni876; VANDERLUGT NMT, 1994, GENE DEV, V8, P757, DOI 10.1101/gad.8.7.757; Voncken JW, 1999, J CELL SCI, V112, P4627; Zhang Z, 2003, EMBO J, V22, P4759, DOI 10.1093/emboj/cdg464	28	147	152	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAR 5	2010	6	3					279	286		10.1016/j.stem.2010.01.005	http://dx.doi.org/10.1016/j.stem.2010.01.005			8	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	577WL	20207230	Bronze			2022-12-24	WOS:000276254600014
J	Xu, HP; Chen, H; Ding, Q; Xie, ZH; Chen, L; Diao, L; Wang, P; Gan, L; Crair, MC; Tian, N				Xu, Hong-ping; Chen, Hui; Ding, Qian; Xie, Zheng-Hua; Chen, Ling; Diao, Ling; Wang, Ping; Gan, Lin; Crair, Michael C.; Tian, Ning			The Immune Protein CD3 zeta Is Required for Normal Development of Neural Circuits in the Retina	NEURON			English	Article							EYE-SPECIFIC SEGREGATION; NICOTINIC ACETYLCHOLINE-RECEPTOR; RETINOTOPIC MAP REFINEMENT; LATERAL GENICULATE-NUCLEUS; OCULAR DOMINANCE COLUMNS; MHC CLASS-I; VISUAL-CORTEX; MICE LACKING; SYNAPTIC-TRANSMISSION; SUPERIOR COLLICULUS	Emerging evidence suggests that immune proteins regulate activity-dependent synapse formation in the central nervous system (CNS). Mice with mutations in class I major histocompatibility complex (MHCI) genes have incomplete eye-specific segregation of retinal ganglion cell (RGC) axon projections to the CNS. This effect has been attributed to causes that are nonretinal in origin. We show that a key component of MHCI receptor, CD3 zeta is expressed in RGCs. CD3 zeta-deficient mice have reduced RGC dendritic motility, an increase in RGC dendritic density, and a selective defect of glutamate-receptor-mediated synaptic activity in the retina. Disrupted RGC synaptic activity and dendritic motility is associated with a failure of eye-specific segregation of RGC axon projections to the CNS. These results provide direct evidence of an unrecognized requirement for immune proteins in the developmental regulation of RGC synaptic wiring and indicate a possible retinal origin for the disruption of eye-specific segregation found in immune-deficient mice.	[Chen, Hui; Chen, Ling; Wang, Ping; Tian, Ning] Univ Utah, Sch Med, Dept Ophthalmol & Visual Sci, Salt Lake City, UT 84132 USA; [Xu, Hong-ping; Crair, Michael C.] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06520 USA; [Ding, Qian; Xie, Zheng-Hua; Gan, Lin] Univ Rochester, Dept Ophthalmol, Rochester, NY 14642 USA; [Diao, Ling] Yale Univ, Dept Biol, New Haven, CT 06520 USA	Utah System of Higher Education; University of Utah; Yale University; University of Rochester; Yale University	Tian, N (corresponding author), Univ Utah, Sch Med, Dept Ophthalmol & Visual Sci, Salt Lake City, UT 84132 USA.		Chen, Hui/J-5907-2013	Chen, Hui/0000-0002-1560-8540	NIH [R01 EY012345, P30 EY000785, R01 EY015788, P30EY000785, R01EY013426]; NATIONAL EYE INSTITUTE [R01EY013426, R01EY012345, P30EY000785, R01EY015788] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by NIH grants R01 EY012345 and P30 EY000785, Research to Prevent Blindness (RPB), and Funds from the Connecticut Lion, Eye Research Foundation (N T), James Hudson Brown-Alexander B Coxe Fellowship from Yale University (H -P X). NIH grants R01 EY015788 and P30EY000785 (M CC), and NIH grant R01EY013426 (L G) We wish to thank Dr Nigel Daw for critical reading of the manuscript We also thank Dr Zhinan Yin for critical discussion, Dr Susumu Tomita, and Ms Yueyi Zhang for technical support	Akerman CJ, 2002, NEURON, V36, P869, DOI 10.1016/S0896-6273(02)01010-3; Baniyash M, 2004, NAT REV IMMUNOL, V4, P675, DOI 10.1038/nri1434; Bansal A, 2000, J NEUROSCI, V20, P7672; Baudouin SJ, 2008, MOL BIOL CELL, V19, P2444, DOI 10.1091/mbc.E07-09-0947; BODNARENKO SR, 1993, NATURE, V364, P144, DOI 10.1038/364144a0; Boulanger LM, 2004, NAT REV NEUROSCI, V5, P521, DOI 10.1038/nrn1428; Boulanger LM, 2001, CURR OPIN NEUROBIOL, V11, P568, DOI 10.1016/S0959-4388(00)00251-8; Cang JH, 2005, NEURON, V48, P797, DOI 10.1016/j.neuron.2005.09.015; Chandrasekaran AR, 2005, J NEUROSCI, V25, P6929, DOI 10.1523/JNEUROSCI.1470-05.2005; Chapman B, 2000, SCIENCE, V287, P2479, DOI 10.1126/science.287.5462.2479; Corriveau RA, 1998, NEURON, V21, P505, DOI 10.1016/S0896-6273(00)80562-0; Demas J, 2003, J NEUROSCI, V23, P2851; Demas J, 2006, NEURON, V50, P247, DOI 10.1016/j.neuron.2006.03.033; Diao L, 2004, J NEUROBIOL, V61, P236, DOI 10.1002/neu.20041; Feller MB, 1996, SCIENCE, V272, P1182, DOI 10.1126/science.272.5265.1182; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Fourgeaud L, 2007, CELL, V131, P1034, DOI 10.1016/j.cell.2007.11.031; Goddard CA, 2007, P NATL ACAD SCI USA, V104, P6828, DOI 10.1073/pnas.0702023104; Grubb MS, 2004, J NEUROSCI, V24, P8459, DOI 10.1523/JNEUROSCI.1527-04.2004; Hooks BM, 2006, NEURON, V52, P281, DOI 10.1016/j.neuron.2006.07.007; Huberman AD, 2003, SCIENCE, V300, P994, DOI 10.1126/science.1080694; Huberman AD, 2006, NEURON, V52, P247, DOI 10.1016/j.neuron.2006.07.028; Huh GS, 2000, SCIENCE, V290, P2155, DOI 10.1126/science.290.5499.2155; Ishii T, 2003, CURR BIOL, V13, P394, DOI 10.1016/S0960-9822(03)00092-7; Ishii T, 2008, J NEUROSCI, V28, P2332, DOI 10.1523/JNEUROSCI.4807-07.2008; Li JYH, 2001, DEVELOPMENT, V128, P4979; Linda H, 1999, J NEUROIMMUNOL, V101, P76, DOI 10.1016/S0165-5728(99)00135-6; LOVE PE, 1993, SCIENCE, V261, P918, DOI 10.1126/science.7688481; Majewska A, 2003, P NATL ACAD SCI USA, V100, P16024, DOI 10.1073/pnas.2636949100; McLaughlin T, 2003, NEURON, V40, P1147, DOI 10.1016/S0896-6273(03)00790-6; Mrsic-Flogel TD, 2005, J NEUROSCI, V25, P6921, DOI 10.1523/JNEUROSCI.1555-05.2005; Muir-Robinson G, 2002, J NEUROSCI, V22, P5259; Oray S, 2004, NEURON, V44, P1021, DOI 10.1016/j.neuron.2004.12.001; PARNAVELAS JG, 1973, EXP NEUROL, V40, P742, DOI 10.1016/0014-4886(73)90108-8; Penn AA, 1998, SCIENCE, V279, P2108, DOI 10.1126/science.279.5359.2108; RICCIO RV, 1985, DEV BRAIN RES, V19, P173, DOI 10.1016/0165-3806(85)90189-0; Rossi FM, 2001, P NATL ACAD SCI USA, V98, P6453, DOI 10.1073/pnas.101120998; SHATZ CJ, 1988, SCIENCE, V242, P87, DOI 10.1126/science.3175636; SHOLL DA, 1953, J ANAT, V87, P387; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; STOCKTON RA, 1989, J GEN PHYSIOL, V93, P101, DOI 10.1085/jgp.93.1.101; STRYKER MP, 1986, J NEUROSCI, V6, P2117; Sun WZ, 2002, J COMP NEUROL, V451, P115, DOI 10.1002/cne.10323; Syken J, 2003, P NATL ACAD SCI USA, V100, P13048, DOI 10.1073/pnas.1735415100; Syken J, 2006, SCIENCE, V313, P1795, DOI 10.1126/science.1128232; Tian N, 2003, NEURON, V39, P85, DOI 10.1016/S0896-6273(03)00389-1; Torborg CL, 2005, NAT NEUROSCI, V8, P72, DOI 10.1038/nn1376; Torborg CL, 2004, J NEUROSCI METH, V135, P17, DOI 10.1016/j.jneumeth.2003.11.019; Vistamehr S, 2004, VISUAL NEUROSCI, V21, P23, DOI 10.1017/S0952523804041033; Wachtmeister L, 1998, PROG RETIN EYE RES, V17, P485, DOI 10.1016/S1350-9462(98)00006-8; Wallace W, 2004, J NEUROSCI, V24, P6928, DOI 10.1523/JNEUROSCI.1110-04.2004; WONG ROL, 1993, NEURON, V11, P923, DOI 10.1016/0896-6273(93)90122-8; Wong ROL, 2002, NAT REV NEUROSCI, V3, P803, DOI 10.1038/nrn941; Wong WT, 2000, J NEUROSCI, V20, P5024; Xu HP, 2008, J COMP NEUROL, V509, P53, DOI 10.1002/cne.21727; Xu HP, 2007, J COMP NEUROL, V503, P244, DOI 10.1002/cne.21379; Zhou Z J, 2001, Prog Brain Res, V131, P599; Ziv Y, 2006, NAT NEUROSCI, V9, P268, DOI 10.1038/nn1629	58	54	54	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 25	2010	65	4					503	515		10.1016/j.neuron.2010.01.035	http://dx.doi.org/10.1016/j.neuron.2010.01.035			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	566HD	20188655	Green Accepted, Bronze			2022-12-24	WOS:000275359800009
J	Tanimura, A; Yamazaki, M; Hashimotodani, Y; Uchigashima, M; Kawata, S; Abe, M; Kita, Y; Hashimoto, K; Shimizu, T; Watanabe, M; Sakimura, K; Kano, M				Tanimura, Asami; Yamazaki, Maya; Hashimotodani, Yuki; Uchigashima, Motokazu; Kawata, Shinya; Abe, Manabu; Kita, Yoshihiro; Hashimoto, Kouichi; Shimizu, Takao; Watanabe, Masahiko; Sakimura, Kenji; Kano, Masanobu			The Endocannabinoid 2-Arachidonoylglycerol Produced by Diacylglycerol Lipase alpha Mediates Retrograde Suppression of Synaptic Transmission	NEURON			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; CANNABINOID CB1 RECEPTOR; ENDOGENOUS CANNABINOIDS; PRESYNAPTIC INHIBITION; HIPPOCAMPAL SYNAPSES; GABA RELEASE; BRAIN; SYSTEM; DEPOLARIZATION; ACTIVATION	Endocannabinoids are released from postsynaptic neurons and cause retrograde suppression of synaptic transmission. Anandamide and 2-arachidonoylglycerol (2-AG) are regarded as two major endocannabinoids. To determine to what extent 2-AG contributes to retrograde signaling, we generated and analyzed mutant mice lacking either of the two 2-AG synthesizing enzymes diacylglycerol lipase alpha (DGL alpha) and beta (DGL beta). We found that endocannabinoid-mediated retrograde synaptic suppression was totally absent in the cerebellum, hippocampus, and striatum of DGL alpha knockout mice, whereas the retrograde suppression was intact in DGL beta knockout brains. The basal 2-AG content was markedly reduced and stimulus-induced elevation of 2-AG was absent in DGL alpha knockout brains, whereas the 2-AG content was normal in DGL beta knockout brains. Morphology of the brain and expression of molecules required for 2-AG production other than DGLs were normal in the two knockout mice. We conclude that 2-AG produced by DGL alpha, but not by DGL beta, mediates retrograde suppression at central synapses.	[Tanimura, Asami; Hashimotodani, Yuki; Kawata, Shinya; Hashimoto, Kouichi; Kano, Masanobu] Univ Tokyo, Grad Sch Med, Dept Neurophysiol, Tokyo 1130033, Japan; [Kita, Yoshihiro; Shimizu, Takao] Univ Tokyo, Grad Sch Med, Dept Biochem & Mol Biol, Tokyo 1130033, Japan; [Yamazaki, Maya; Abe, Manabu; Sakimura, Kenji] Niigata Univ, Dept Cellular Neurobiol, Brain Res Inst, Niigata 9518585, Japan; [Uchigashima, Motokazu; Watanabe, Masahiko] Hokkaido Univ, Sch Med, Dept Anat, Sapporo, Hokkaido 0608638, Japan; [Hashimoto, Kouichi] Japan Sci & Technol Agcy, CREST, PRESTO, Kawaguchi, Saitama 3320012, Japan	University of Tokyo; University of Tokyo; Niigata University; Hokkaido University; Japan Science & Technology Agency (JST)	Kano, M (corresponding author), Univ Tokyo, Grad Sch Med, Dept Neurophysiol, Tokyo 1130033, Japan.	mkano-tky@m.u-tokyo.ac.jp	Watanabe, Masahiko/S-3614-2019; Shimizu, Takao/AAV-7052-2021; Hashimotodani, Yuki/W-4690-2018; Abe, Manabu/A-9221-2008; Yamazaki, Maya/C-6952-2012; WATANABE, Masahiko/A-4055-2012; Uchigashima, Motokazu/C-5715-2012	Watanabe, Masahiko/0000-0001-5037-7138; Hashimotodani, Yuki/0000-0001-6723-2736; WATANABE, Masahiko/0000-0001-5037-7138; Kano, Masanobu/0000-0002-0725-3292; Hashimoto, Kouichi/0000-0002-3884-8213	Strategic Research Program for Brain Sciences; MEXT, Japan;  [17023021];  [21220006];  [18-08582];  [20-04030];  [17023001]	Strategic Research Program for Brain Sciences(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); ; ; ; ; 	We thank T. Yoshida for helping with some experiments and R. Natsume for helping with the generation of knockout mice. This work has been supported by Grants-in-Aid for Scientific Research 17023021 (M.K.), 21220006 (M.K.), 18-08582 (Y.H.), 20-04030 (M.U.), and 17023001 (M.W.); the Strategic Research Program for Brain Sciences (Development of Biomarker Candidates for Social Behavior); and the Global COE Program (integrative Life Science Based on the Study of Biosignaling Mechanisms) from MEXT, Japan.	Batchelor AM, 1997, NATURE, V385, P74, DOI 10.1038/385074a0; Bisogno T, 2003, J CELL BIOL, V163, P463, DOI 10.1083/jcb.200305129; Bisogno T, 2005, PHARMACOL BIOCHEM BE, V81, P224, DOI 10.1016/j.pbb.2005.01.027; Brown SP, 2003, NAT NEUROSCI, V6, P1048, DOI 10.1038/nn1126; Chevaleyre V, 2003, NEURON, V38, P461, DOI 10.1016/S0896-6273(03)00235-6; Chevaleyre V, 2006, ANNU REV NEUROSCI, V29, P37, DOI 10.1146/annurev.neuro.29.051605.112834; DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919; Galante M, 2004, J NEUROSCI, V24, P4865, DOI 10.1523/JNEUROSCI.0403-04.2004; Haj-Dahmane S, 2005, J NEUROSCI, V25, P896, DOI 10.1523/JNEUROSCI.3258-04.2005; Harkany T, 2007, TRENDS PHARMACOL SCI, V28, P83, DOI 10.1016/j.tips.2006.12.004; Hashimotodani Y, 2005, NEURON, V45, P257, DOI 10.1016/j.neuron.2005.01.004; Hashimotodani Y, 2008, NEUROPHARMACOLOGY, V54, P58, DOI 10.1016/j.neuropharm.2007.06.002; Hashimotodani Y, 2007, CURR OPIN NEUROBIOL, V17, P360, DOI 10.1016/j.conb.2007.03.012; Hashimotodani Y, 2007, NEUROSCIENTIST, V13, P127, DOI 10.1177/1073858406296716; Hashimotodani Y, 2007, J NEUROSCI, V27, P1211, DOI 10.1523/JNEUROSCI.4159-06.2007; Heifets BD, 2009, ANNU REV PHYSIOL, V71, P283, DOI 10.1146/annurev.physiol.010908.163149; Iversen L, 2003, BRAIN, V126, P1252, DOI 10.1093/brain/awg143; Jung KM, 2005, MOL PHARMACOL, V68, P1196, DOI 10.1124/mol.105.013961; Kano M, 2009, PHYSIOL REV, V89, P309, DOI 10.1152/physrev.00019.2008; Katona I, 1999, J NEUROSCI, V19, P4544; Katona I, 2008, NAT MED, V14, P923, DOI 10.1038/nm.f.1869; Katona I, 2006, J NEUROSCI, V26, P5628, DOI 10.1523/JNEUROSCI.0309-06.2006; Kawamura Y, 2006, J NEUROSCI, V26, P2991, DOI 10.1523/JNEUROSCI.4872-05.2006; Kim J, 2002, J NEUROSCI, V22, P10182; Kreitzer AC, 2001, NEURON, V29, P717, DOI 10.1016/S0896-6273(01)00246-X; Lafourcade M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000709; Maejima T, 2001, NEURON, V31, P463, DOI 10.1016/S0896-6273(01)00375-0; Maejima T, 2005, J NEUROSCI, V25, P6826, DOI 10.1523/JNEUROSCI.0945-05.2005; MECHOULAM R, 1995, BIOCHEM PHARMACOL, V50, P83, DOI 10.1016/0006-2952(95)00109-D; Melis M, 2004, J NEUROSCI, V24, P53, DOI 10.1523/JNEUROSCI.4503-03.2004; Mishina M, 2007, NEUROSCI RES, V58, P105, DOI 10.1016/j.neures.2007.01.004; Narushima M, 2006, NEUROSCI RES, V54, P159, DOI 10.1016/j.neures.2005.12.004; Narushima M, 2007, J NEUROSCI, V27, P496, DOI 10.1523/JNEUROSCI.4644-06.2007; Ohno-Shosaku T, 2002, J NEUROSCI, V22, P3864, DOI 10.1523/JNEUROSCI.22-10-03864.2002; Ohno-Shosaku T, 2002, EUR J NEUROSCI, V15, P953, DOI 10.1046/j.1460-9568.2002.01929.x; Ohno-Shosaku T, 2001, NEURON, V29, P729, DOI 10.1016/S0896-6273(01)00247-1; Palomaki VAB, 2007, J NEUROCHEM, V101, P972, DOI 10.1111/j.1471-4159.2006.04403.x; Safo PK, 2005, NEURON, V48, P647, DOI 10.1016/j.neuron.2005.09.020; Suarez J, 2008, J COMP NEUROL, V509, P400, DOI 10.1002/cne.21774; SUGIURA T, 1995, BIOCHEM BIOPH RES CO, V215, P89, DOI 10.1006/bbrc.1995.2437; Sugiura T, 2006, PROG LIPID RES, V45, P405, DOI 10.1016/j.plipres.2006.03.003; Szabo B, 2006, J PHYSIOL-LONDON, V577, P263, DOI 10.1113/jphysiol.2006.119362; Uchigashima M, 2007, J NEUROSCI, V27, P3663, DOI 10.1523/JNEUROSCI.0448-07.2007; Vandevoorde S, 2007, CHEM BIODIVERS, V4, P1858, DOI 10.1002/cbdv.200790156; Varma N, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-24-j0003.2001; Wilson RI, 2001, NATURE, V410, P588, DOI 10.1038/35069076; Yoshida T, 2006, J NEUROSCI, V26, P4740, DOI 10.1523/JNEUROSCI.0054-06.2006; Zhao YJ, 2009, J NEUROPHYSIOL, V101, P2434, DOI 10.1152/jn.00047.2009	48	338	346	0	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 11	2010	65	3					320	327		10.1016/j.neuron.2010.01.021	http://dx.doi.org/10.1016/j.neuron.2010.01.021			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	564BF	20159446	Bronze			2022-12-24	WOS:000275185200006
J	Haruno, M; Frith, CD				Haruno, Masahiko; Frith, Christopher D.			Activity in the amygdala elicited by unfair divisions predicts social value orientation	NATURE NEUROSCIENCE			English	Article							NEURAL BASIS	'Social value orientation' characterizes individual differences in anchoring attitudes toward the division of resources. Here, by contrasting people with prosocial and individualistic orientations using functional magnetic resonance imaging, we demonstrate that degree of inequity aversion in prosocials is predictable from amygdala activity and unaffected by cognitive load. This result suggests that automatic emotional processing in the amygdala lies at the core of prosocial value orientation.	[Haruno, Masahiko] Adv Telecommun Res Inst, Computat Neurosci Labs, Kyoto, Japan; [Haruno, Masahiko] Tamagawa Univ, Brain Sci Inst, Tokyo, Japan; [Frith, Christopher D.] UCL, Wellcome Trust Ctr Neuroimaging, London, England; [Frith, Christopher D.] Univ Aarhus, Ctr Functionally Integrat Neurosci, Aarhus, Denmark	Advanced Telecommunications Research Institute International; University of London; University College London; Aarhus University	Haruno, M (corresponding author), Adv Telecommun Res Inst, Computat Neurosci Labs, Kyoto, Japan.	mharuno@lab.tamagawa.ac.jp	Frith, Chris D/A-2171-2009	Frith, Chris D/0000-0002-8665-0690	Strategic Research Program for Brain Sciences (SRPBS); Ministry of Education, Culture, Sports, Science and Technology Japan; Royal Society of UK; Danish National Research Foundation; Humanities Research Council Consciousness [AHE511112/1]; AHRC [AH/E511112/1] Funding Source: UKRI; Arts and Humanities Research Council [AH/E511112/1] Funding Source: researchfish	Strategic Research Program for Brain Sciences (SRPBS); Ministry of Education, Culture, Sports, Science and Technology Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Royal Society of UK(Royal Society of London); Danish National Research Foundation(Danmarks Grundforskningsfond); Humanities Research Council Consciousness; AHRC(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC)); Arts and Humanities Research Council(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC))	We thank S. Tada and Y. Furukawa for technical assistance. This research was supported by the Strategic Research Program for Brain Sciences (SRPBS) and Tamagawa University Global Center of Excellence grant from the Ministry of Education, Culture, Sports, Science and Technology Japan. M.H. was supported by the Royal Society of UK, and C.D.F. was supported by the Danish National Research Foundation and the Arts and Humanities Research Council Consciousness in a Natural and Cultural Context scheme (AHE511112/1).	Adolphs R, 2002, J COGNITIVE NEUROSCI, V14, P1264, DOI 10.1162/089892902760807258; Bogaert S, 2008, BRIT J SOC PSYCHOL, V47, P453, DOI 10.1348/014466607X244970; de Quervain DJF, 2004, SCIENCE, V305, P1254, DOI 10.1126/science.1100735; Friston K. J., 1995, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Haidt J, 2001, PSYCHOL REV, V108, P814, DOI 10.1037//0033-295X.108.4.814; Haruno M, 2006, J NEUROPHYSIOL, V95, P948, DOI 10.1152/jn.00382.2005; Hsu M, 2008, SCIENCE, V320, P1092, DOI 10.1126/science.1153651; Knoch D, 2007, ANN NY ACAD SCI, V1104, P123, DOI 10.1196/annals.1390.004; O'Doherty J, 2004, SCIENCE, V304, P452, DOI 10.1126/science.1094285; Rushworth MFS, 2008, NAT NEUROSCI, V11, P389, DOI 10.1038/nn2066; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; Tabibnia G, 2008, PSYCHOL SCI, V19, P339, DOI 10.1111/j.1467-9280.2008.02091.x; Valdesolo P, 2008, J EXP SOC PSYCHOL, V44, P1334, DOI 10.1016/j.jesp.2008.03.010; Van Lange PAM, 1999, J PERS SOC PSYCHOL, V77, P337, DOI 10.1037/0022-3514.77.2.337; WHALEN PJ, 2009, HUMAN AMYGDALA, P43	15	114	120	4	70	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2010	13	2					160	161		10.1038/nn.2468	http://dx.doi.org/10.1038/nn.2468			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	548SE	20023652	Green Accepted, Green Published			2022-12-24	WOS:000273985800010
J	Rossi, EA; Roorda, A				Rossi, Ethan A.; Roorda, Austin			The relationship between visual resolution and cone spacing in the human fovea	NATURE NEUROSCIENCE			English	Article							HUMAN RETINA; ADAPTIVE OPTICS; GANGLION-CELLS; TOPOGRAPHY; VISION; ACUITY; LIMITS	Visual resolution decreases rapidly outside of the foveal center. The anatomical and physiological basis for this reduction is unclear. We used simultaneous adaptive optics imaging and psychophysical testing to measure cone spacing and resolution across the fovea, and found that resolution was limited by cone spacing only at the foveal center. Immediately outside of the center, resolution was worse than cone spacing predicted and better matched the sampling limit of midget retinal ganglion cells.	[Rossi, Ethan A.; Roorda, Austin] Univ Calif Berkeley, Vis Sci Grad Grp, Berkeley, CA 94720 USA; [Roorda, Austin] Univ Calif Berkeley, Sch Optometry, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Rossi, EA (corresponding author), Univ Calif Berkeley, Vis Sci Grad Grp, Berkeley, CA 94720 USA.	earossi@berkeley.edu	Rossi, Ethan/A-7933-2013; Rossi, Ethan/AAC-6204-2019	Rossi, Ethan/0000-0003-3210-0551; Rossi, Ethan/0000-0003-3210-0551	National Science Foundation Science and Technology Center [AST-9876783]; University of California, Santa Cruz; National Institutes of Health [EY014375]; NATIONAL EYE INSTITUTE [R01EY014375] Funding Source: NIH RePORTER	National Science Foundation Science and Technology Center(National Science Foundation (NSF)); University of California, Santa Cruz(University of California System); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank K. Grieve for her assistance with data collection and P. Tiruveedhula for his help on software development. This work was supported by the National Science Foundation Science and Technology Center for Adaptive Optics under cooperative agreement AST-9876783 managed by the University of California, Santa Cruz and by National Institutes of Health grant EY014375.	Anderson RS, 1999, J OPT SOC AM A, V16, P2334, DOI 10.1364/JOSAA.16.002334; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; CURCIO CA, 1990, J COMP NEUROL, V292, P497, DOI 10.1002/cne.902920402; CURCIO CA, 1990, J COMP NEUROL, V300, P5, DOI 10.1002/cne.903000103; DACEY DM, 1993, J NEUROSCI, V13, P5334, DOI 10.1523/JNEUROSCI.13-12-05334.1993; Drasdo N, 2007, VISION RES, V47, P2901, DOI 10.1016/j.visres.2007.01.007; ENOCH JM, 1973, DOC OPHTHALMOL, V34, P143, DOI 10.1007/BF00151803; GREEN DG, 1970, J PHYSIOL-LONDON, V207, P351, DOI 10.1113/jphysiol.1970.sp009065; Liang JZ, 1997, J OPT SOC AM A, V14, P2884, DOI 10.1364/JOSAA.14.002884; Marcos S, 1997, J OPT SOC AM A, V14, P731, DOI 10.1364/JOSAA.14.000731; Polyak S. L., 1941, RETINA-J RET VIT DIS; Roorda A, 2002, OPT EXPRESS, V10, P405, DOI 10.1364/OE.10.000405; Rossi EA, 2007, J VISION, V7, DOI 10.1167/7.8.14; THIBOS LN, 1987, J OPT SOC AM A, V4, P1524, DOI 10.1364/JOSAA.4.001524; WILLIAMS DR, 1987, J OPT SOC AM A, V4, P1514, DOI 10.1364/JOSAA.4.001514	15	151	152	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2010	13	2					156	157		10.1038/nn.2465	http://dx.doi.org/10.1038/nn.2465			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	548SE	20023654	Green Accepted			2022-12-24	WOS:000273985800009
J	Baumgartner, T; Fischbacher, U; Feierabend, A; Lutz, K; Fehr, E				Baumgartner, Thomas; Fischbacher, Urs; Feierabend, Anja; Lutz, Kai; Fehr, Ernst			The Neural Circuitry of a Broken Promise	NEURON			English	Article							ANTERIOR CINGULATE CORTEX; PREFRONTAL CORTEX; COGNITIVE CONTROL; DETECTING DECEPTION; SOCIAL COOPERATION; VIRTUAL-REALITY; REWARD; BRAIN; AMYGDALA; RESPONSES	Promises are one of the oldest human-specific psychological mechanisms fostering cooperation and trust. Here, we study the neural underpinnings of promise keeping and promise breaking. Subjects first make a promise decision (promise stage), then they anticipate whether the promise affects the interaction partner's decision (anticipation stage) and are subsequently free to keep or break the promise (decision stage). Findings revealed that the breaking of the promise is associated with increased activation in the DLPFC, ACC, and amygdala, suggesting that the dishonest act involves an emotional conflict due to the suppression of the honest response. Moreover, the breach of the promise can be predicted by a perfidious brain activity pattern (anterior insula, ACC, inferior frontal gyrus) during the promise and anticipation stage, indicating that brain measurements may reveal malevolent intentions before dishonest or deceitful acts are actually committed.	[Baumgartner, Thomas; Feierabend, Anja; Fehr, Ernst] Univ Zurich, Inst Empir Res Econ, Lab Social & Neural Syst Res, CH-8006 Zurich, Switzerland; [Fischbacher, Urs] Univ Konstanz, Dept Econ, D-7750 Constance, Germany; [Fischbacher, Urs] Thurgau Inst Econ, Kreuzlingen, Switzerland; [Lutz, Kai] Univ Zurich, Inst Psychol, Dept Neuropsychol, CH-8006 Zurich, Switzerland	University of Zurich; University of Konstanz; University of Zurich	Baumgartner, T (corresponding author), Univ Zurich, Inst Empir Res Econ, Lab Social & Neural Syst Res, CH-8006 Zurich, Switzerland.	t.baumgartner@iew.uzh.ch; efehr@iew.uzh.ch	Fischbacher, Urs/H-2693-2014; Lutz, Kai/C-1433-2011	Fischbacher, Urs/0000-0002-5115-8815; Baumgartner, Thomas/0000-0001-5966-7377	Swiss National Science Foundation; University of Zurich	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); University of Zurich	This work is part of Project 9 of the National Competence Center for Research (NCCR) in Affective Sciences. The NCCR is financed by the Swiss National Science Foundation. E.F. also gratefully acknowledges support from the research priority program at the University of Zurich on the "Foundations of Human Social Behavior."	Abe N, 2006, CEREB CORTEX, V16, P192, DOI 10.1093/cercor/bhi097; Abe N, 2007, J COGNITIVE NEUROSCI, V19, P287, DOI 10.1162/jocn.2007.19.2.287; Adolphs R, 2005, NATURE, V433, P68, DOI 10.1038/nature03086; Amaral DG, 2003, ANN NY ACAD SCI, V1000, P337, DOI 10.1196/annals.1280.015; Aron AR, 2007, J NEUROSCI, V27, P11860, DOI 10.1523/JNEUROSCI.3644-07.2007; Aron AR, 2007, NEUROSCIENTIST, V13, P214, DOI 10.1177/1073858407299288; Baumgartner T, 2006, CYBERPSYCHOL BEHAV, V9, P30, DOI 10.1089/cpb.2006.9.30; Baumgartner T, 2008, NEURON, V58, P639, DOI 10.1016/j.neuron.2008.04.009; Baumgartner T, 2008, FRONT HUM NEUROSCI, V2, DOI 10.3389/neuro.09.008.2008; Beeli G, 2008, BEHAV BRAIN FUNCT, V4, DOI 10.1186/1744-9081-4-33; Behrens TEJ, 2008, NATURE, V456, P245, DOI 10.1038/nature07538; Botvinick M, 1999, NATURE, V402, P179, DOI 10.1038/46035; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Buckholtz JW, 2008, NEURON, V60, P930, DOI 10.1016/j.neuron.2008.10.016; Camerer C, 2005, J ECON LIT, V43, P9, DOI 10.1257/0022051053737843; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; Casey BJ, 2002, J NEUROSCI, V22, P8647; Charness G, 2006, ECONOMETRICA, V74, P1579, DOI 10.1111/j.1468-0262.2006.00719.x; Christie R, 1970, STUDIES MACHIAVELLIS; Costa P.T., 1992, NEO FFI PERSONALITY; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; de Quervain DJF, 2004, SCIENCE, V305, P1254, DOI 10.1126/science.1100735; Decety J, 2004, NEUROIMAGE, V23, P744, DOI 10.1016/j.neuroimage.2004.05.025; Delgado MR, 2008, SCIENCE, V321, P1849, DOI 10.1126/science.1158860; Delgado MR, 2005, NAT NEUROSCI, V8, P1611, DOI 10.1038/nn1575; Delgado MR, 2004, CEREB CORTEX, V14, P1022, DOI 10.1093/cercor/bhh062; Eisenberger NI, 2003, SCIENCE, V302, P290, DOI 10.1126/science.1089134; ELLICKSON RC, 2001, SOCIAL NORMS, P35; Elster J., 1989, CEMENT SOC STUDY SOC; Etkin A, 2006, NEURON, V51, P871, DOI 10.1016/j.neuron.2006.07.029; Fehr E, 2002, HUM NATURE-INT BIOS, V13, P1, DOI 10.1007/s12110-002-1012-7; Fehr E, 2003, NATURE, V425, P785, DOI 10.1038/nature02043; Fehr E, 2007, TRENDS COGN SCI, V11, P419, DOI 10.1016/j.tics.2007.09.002; Fliessbach K, 2007, SCIENCE, V318, P1305, DOI 10.1126/science.1145876; Glimcher PW, 2004, SCIENCE, V306, P447, DOI 10.1126/science.1102566; Gneezy U, 2005, AM ECON REV, V95, P384, DOI 10.1257/0002828053828662; Grezes J, 2006, NEUROIMAGE, V30, P601, DOI 10.1016/j.neuroimage.2005.09.038; Grezes J, 2004, J NEUROSCI, V24, P5500, DOI 10.1523/JNEUROSCI.0219-04.2004; Herwig U, 2010, PSYCHOL MED, V40, P789, DOI 10.1017/S0033291709991073; Herwig U, 2007, NEUROIMAGE, V37, P652, DOI 10.1016/j.neuroimage.2007.05.023; Herwig U, 2007, NEUROIMAGE, V34, P848, DOI 10.1016/j.neuroimage.2006.09.035; Horne C., 2001, SOCIAL NORMS, P3; Jancke L, 2008, NEUROREPORT, V19, P1127, DOI 10.1097/WNR.0b013e3283056521; King-Casas B, 2005, SCIENCE, V308, P78, DOI 10.1126/science.1108062; Knoch D, 2008, CEREB CORTEX, V18, P1987, DOI 10.1093/cercor/bhm237; Knoch D, 2006, SCIENCE, V314, P829, DOI 10.1126/science.1129156; Knutson B, 2007, NEURON, V53, P147, DOI 10.1016/j.neuron.2006.11.010; Kozel FA, 2005, BIOL PSYCHIAT, V58, P605, DOI 10.1016/j.biopsych.2005.07.040; Langleben DD, 2005, HUM BRAIN MAPP, V26, P262, DOI 10.1002/hbm.20191; Lee TMC, 2005, NEUROIMAGE, V28, P305, DOI 10.1016/j.neuroimage.2005.06.051; Lieberman MD, 2007, ANNU REV PSYCHOL, V58, P259, DOI 10.1146/annurev.psych.58.110405.085654; Liu X, 2007, J NEUROSCI, V27, P4587, DOI 10.1523/JNEUROSCI.5227-06.2007; Meyer-Lindenberg A, 2006, P NATL ACAD SCI USA, V103, P6269, DOI 10.1073/pnas.0511311103; Nunez JM, 2005, NEUROIMAGE, V25, P267, DOI 10.1016/j.neuroimage.2004.10.041; Phan KL, 2002, NEUROIMAGE, V16, P331, DOI 10.1006/nimg.2002.1087; Phan KL, 2005, ACAD RADIOL, V12, P164, DOI 10.1016/j.acra.2004.11.023; Phillips ML, 2003, BIOL PSYCHIAT, V54, P504, DOI 10.1016/S0006-3223(03)00168-9; Pruessmann KP, 1999, MAGNET RESON MED, V42, P952, DOI 10.1002/(SICI)1522-2594(199911)42:5<952::AID-MRM16>3.0.CO;2-S; Rilling JK, 2007, BIOL PSYCHIAT, V61, P1260, DOI 10.1016/j.biopsych.2006.07.021; Rilling JK, 2002, NEURON, V35, P395, DOI 10.1016/S0896-6273(02)00755-9; Rilling JK, 2004, NEUROREPORT, V15, P2539, DOI 10.1097/00001756-200411150-00022; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; Satpute AB, 2006, BRAIN RES, V1079, P86, DOI 10.1016/j.brainres.2006.01.005; Singer T, 2006, NATURE, V439, P466, DOI 10.1038/nature04271; Sip KE, 2008, TRENDS COGN SCI, V12, P48, DOI 10.1016/j.tics.2007.11.008; Spence SA, 2004, PHILOS T R SOC B, V359, P1755, DOI 10.1098/rstb.2004.1555; Spence SA, 2001, NEUROREPORT, V12, P2849, DOI 10.1097/00001756-200109170-00019; Spence SA, 2008, NEUROIMAGE, V40, P1411, DOI 10.1016/j.neuroimage.2008.01.035; Spitzer M, 2007, NEURON, V56, P185, DOI 10.1016/j.neuron.2007.09.011; Tabibnia G, 2008, PSYCHOL SCI, V19, P339, DOI 10.1111/j.1467-9280.2008.02091.x; Vanberg C, 2008, ECONOMETRICA, V76, P1467, DOI 10.3982/ECTA7673; Voss T., 2001, SOCIAL NORMS, P105; Zink CF, 2008, NEURON, V58, P273, DOI 10.1016/j.neuron.2008.01.025	73	125	136	3	52	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	DEC 10	2009	64	5					756	770		10.1016/j.neuron.2009.11.017	http://dx.doi.org/10.1016/j.neuron.2009.11.017			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	537OW	20005830	Bronze, Green Accepted, Green Submitted			2022-12-24	WOS:000273123700019
J	Makino, H; Malinow, R				Makino, Hiroshi; Malinow, Roberto			AMPA Receptor Incorporation into Synapses during LTP: The Role of Lateral Movement and Exocytosis	NEURON			English	Article							LONG-TERM POTENTIATION; SYNAPTIC PLASTICITY; DENDRITIC SPINES; RECYCLING ENDOSOMES; POSTSYNAPTIC MEMBRANE; EXCITATORY SYNAPSES; PYRAMIDAL NEURONS; TRAFFICKING; GLUR1; DELIVERY	The regulated trafficking of AMPA receptors (AMPARs) to synapses is thought to underlie the enhanced transmission in long-term potentiation (LTP), a cellular model of memory. However, there is controversy regarding the nonsynaptic site, either on the surface or intracellularly, from which AMPARs move into synapses during LTP. Using recombinant surface-fluorescent receptors in organotypic rat hippocampal slices, we show that the majority of AMPARs incorporated into synapses during LTP is from lateral diffusion of spine surface receptors containing GluR1, an AMPAR subunit. Following synaptic potentiation, AMPARs in intracellular pools containing GluR1 are driven to the surface primarily on dendrites. These exocytosed receptors likely serve to replenish the local extrasynaptic pool available for subsequent bouts of plasticity. These results clarify the role of intracellular and surface AMPARs during synaptic plasticity.	[Makino, Hiroshi; Malinow, Roberto] Univ Calif San Diego, Dept Neurosci, San Diego, CA 92093 USA; [Makino, Hiroshi; Malinow, Roberto] Univ Calif San Diego, Div Neurobiol, San Diego, CA 92093 USA; [Makino, Hiroshi; Malinow, Roberto] Cold Spring Harbor Lab, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Cold Spring Harbor Laboratory	Malinow, R (corresponding author), Univ Calif San Diego, Dept Neurosci, San Diego, CA 92093 USA.	rmalinow@ucsd.edu	Makino, Hiroshi/Q-3779-2016	Makino, Hiroshi/0000-0003-1591-8001	Elizabeth Sloan Livingston Fellowship; National Institute of Health; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH049159, R01MH049159] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG032132] Funding Source: NIH RePORTER	Elizabeth Sloan Livingston Fellowship; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Nancy Dawkins and Irina Hunton for technical support, Dr. Mauricio Montal for the BoNT/A-LC construct, Dr. Jeff Isaacson and past and current members of the Malinow laboratory for helpful discussions and critical review of the manuscript. This work was supported by an Elizabeth Sloan Livingston Fellowship (H.M.) and National Institute of Health (R.M.).	Adesnik H, 2005, NEURON, V48, P977, DOI 10.1016/j.neuron.2005.11.030; ANDERSEN P, 1977, NATURE, V266, P736, DOI 10.1038/266736a0; Andrasfalvy BK, 2004, J PHYSIOL-LONDON, V559, P543, DOI 10.1113/jphysiol.2004.065219; Ashby MC, 2004, J NEUROSCI, V24, P5172, DOI 10.1523/JNEUROSCI.1042-04.2004; Ashby MC, 2006, J NEUROSCI, V26, P7046, DOI 10.1523/JNEUROSCI.1235-06.2006; Borgdorff AJ, 2002, NATURE, V417, P649, DOI 10.1038/nature00780; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; Collingridge GL, 2004, NAT REV NEUROSCI, V5, P952, DOI 10.1038/nrn1556; Dean C, 2009, NAT NEUROSCI, V12, P767, DOI 10.1038/nn.2315; Ehlers MD, 2007, NEURON, V54, P447, DOI 10.1016/j.neuron.2007.04.010; Fernandez-Alfonso T, 2008, BRAIN CELL BIOL, V36, P87, DOI 10.1007/s11068-008-9030-y; Gerges NZ, 2006, EMBO J, V25, P1623, DOI 10.1038/sj.emboj.7601065; Harvey CD, 2007, NATURE, V450, P1195, DOI 10.1038/nature06416; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Heine M, 2008, SCIENCE, V320, P201, DOI 10.1126/science.1152089; Kopec CD, 2006, J NEUROSCI, V26, P2000, DOI 10.1523/JNEUROSCI.3918-05.2006; Kopec CD, 2007, J NEUROSCI, V27, P13706, DOI 10.1523/JNEUROSCI.3503-07.2007; Lledo PM, 1998, SCIENCE, V279, P399, DOI 10.1126/science.279.5349.399; Lu W, 2009, NEURON, V62, P254, DOI 10.1016/j.neuron.2009.02.027; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Newpher TM, 2008, NEURON, V58, P472, DOI 10.1016/j.neuron.2008.04.030; Oh MC, 2006, J BIOL CHEM, V281, P752, DOI 10.1074/jbc.M509677200; Park M, 2004, SCIENCE, V305, P1972, DOI 10.1126/science.1102026; Park M, 2006, NEURON, V52, P817, DOI 10.1016/j.neuron.2006.09.040; Passafaro M, 2001, NAT NEUROSCI, V4, P917, DOI 10.1038/nn0901-917; PETRALIA RS, 1992, J COMP NEUROL, V318, P329, DOI 10.1002/cne.903180309; Serulle Y, 2007, NEURON, V56, P670, DOI 10.1016/j.neuron.2007.09.016; Sharma K, 2006, MOL CELL NEUROSCI, V31, P702, DOI 10.1016/j.mcn.2006.01.010; Sheng M, 2002, SCIENCE, V298, P776, DOI 10.1126/science.1075333; Shepherd JD, 2007, ANNU REV CELL DEV BI, V23, P613, DOI 10.1146/annurev.cellbio.23.090506.123516; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Triller A, 2005, TRENDS NEUROSCI, V28, P133, DOI 10.1016/j.tins.2005.01.001; Wang ZP, 2008, CELL, V135, P535, DOI 10.1016/j.cell.2008.09.057; Yang YL, 2008, J NEUROSCI, V28, P5740, DOI 10.1523/JNEUROSCI.3998-07.2008; Yang YL, 2008, P NATL ACAD SCI USA, V105, P11388, DOI 10.1073/pnas.0802978105; Yudowski GA, 2007, J NEUROSCI, V27, P11112, DOI 10.1523/JNEUROSCI.2465-07.2007; Zamanillo D, 1999, SCIENCE, V284, P1805, DOI 10.1126/science.284.5421.1805	40	334	342	0	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 12	2009	64	3					381	390		10.1016/j.neuron.2009.08.035	http://dx.doi.org/10.1016/j.neuron.2009.08.035			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	521MF	19914186	Green Accepted, Bronze			2022-12-24	WOS:000271924800012
J	Bjorkqvist, M; Wild, EJ; Tabrizi, SJ				Bjorkqvist, Maria; Wild, Edward J.; Tabrizi, Sarah J.			Harnessing Immune Alterations in Neurodegenerative Diseases	NEURON			English	Editorial Material							HUNTINGTONS-DISEASE; ACTIVATION; PLASMA; TARGET; ONSET	Immune dysfunction, a well-established feature of neuroinflammatory disease, is increasingly recognized in neurodegenerative conditions. Its role is emerging as an early and active participant in neuropathology. Inflammation could be modified, with disease-slowing effects, by targeted interventions; it is also readily detectible and could serve as a source of valuable biomarkers.	[Bjorkqvist, Maria] Lund Univ, Wallenberg Neurosci Ctr, Dept Expt Med Sci, Neuronal Survival Unit, S-22184 Lund, Sweden; [Wild, Edward J.; Tabrizi, Sarah J.] UCL, Inst Neurol, Dept Neurodegenerat Dis, London WC1N 3BG, England	Lund University; University of London; University College London	Bjorkqvist, M (corresponding author), Lund Univ, Wallenberg Neurosci Ctr, Dept Expt Med Sci, Neuronal Survival Unit, S-22184 Lund, Sweden.	maria.bjorkqvist@med.lu.se; sarah.tabrizi@prion.ucl.ac.uk	Wild, Edward/G-1436-2016	Wild, Edward/0000-0002-6921-7887; Bjorkqvist, Maria/0000-0001-8550-0431; Tabrizi, Sarah/0000-0003-2716-2045	MRC [G0700877] Funding Source: UKRI; Medical Research Council [G0700877] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Bjorkqvist M, 2008, J EXP MED, V205, P1869, DOI 10.1084/jem.20080178; Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; Dalrymple A, 2007, J PROTEOME RES, V6, P2833, DOI 10.1021/pr0700753; Fiala M, 2010, EXP GERONTOL, V45, P57, DOI 10.1016/j.exger.2009.08.003; Giorgini F, 2005, NAT GENET, V37, P526, DOI 10.1038/ng1542; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Hirsch EC, 2009, LANCET NEUROL, V8, P382, DOI 10.1016/S1474-4422(09)70062-6; Lobsiger CS, 2007, NAT NEUROSCI, V10, P1355, DOI 10.1038/nn1988; Lucin KM, 2009, NEURON, V64, P110, DOI 10.1016/j.neuron.2009.08.039; Ransohoff RM, 2009, ANNU REV IMMUNOL, V27, P119, DOI 10.1146/annurev.immunol.021908.132528; Ray S, 2007, NAT MED, V13, P1359, DOI 10.1038/nm1653; Schwab C, 2008, J ALZHEIMERS DIS, V13, P359; Tai YF, 2007, BRAIN, V130, P1759, DOI 10.1093/brain/awm044; Turner MR, 2009, LANCET NEUROL, V8, P94, DOI 10.1016/S1474-4422(08)70293-X	14	32	32	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	OCT 15	2009	64	1					21	24		10.1016/j.neuron.2009.09.034	http://dx.doi.org/10.1016/j.neuron.2009.09.034			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	515FY	19840543	Bronze			2022-12-24	WOS:000271454400005
J	Deng, WB				Deng, Wenbin			PARylation: Strengthening the Connection between Cancer and Pluripotency	CELL STEM CELL			English	Editorial Material							STEM-CELLS; CHROMATIN; ACTIVATION; MICE	Pluripotency and tumorgenicity appear fundamentally linked. Recent investigations into the role of PARylation in chromatin remodeling (Ahel et al., 2009; Gottschalk et al., 2009), combined with the demonstration that p53 serves as a barrier to pluripotency (Banito et al., 2009), further strengthen this connection.	Univ Calif Davis, Dept Cell Biol & Human Anat, Inst Pediat Regenerat Med, Sch Med, Sacramento, CA 95817 USA	University of California System; University of California Davis	Deng, WB (corresponding author), Univ Calif Davis, Dept Cell Biol & Human Anat, Inst Pediat Regenerat Med, Sch Med, 2425 Stockton Blvd, Sacramento, CA 95817 USA.	wbdeng@ucdavis.edu						Ahel D, 2009, SCIENCE, V325, P1240, DOI 10.1126/science.1177321; Banito A, 2009, GENE DEV, V23, P2134, DOI 10.1101/gad.1811609; Boland MJ, 2009, NATURE, V461, P91, DOI 10.1038/nature08310; Gao FR, 2009, J BIOL CHEM, V284, P22263, DOI 10.1074/jbc.M109.033118; Gaspar-Maia A, 2009, NATURE, V460, P863, DOI 10.1038/nature08212; Gottschalk AJ, 2009, P NATL ACAD SCI USA, V106, P13770, DOI 10.1073/pnas.0906920106; Kang L, 2009, CELL STEM CELL, V5, P135, DOI 10.1016/j.stem.2009.07.001; Krizhanovsky V, 2009, NATURE, V460, P1085, DOI 10.1038/4601085a; Timinszky G, 2009, NAT STRUCT MOL BIOL, V16, P923, DOI 10.1038/nsmb.1664; Zhao XY, 2009, NATURE, V461, P86, DOI 10.1038/nature08267; Zhao Y, 2008, CELL STEM CELL, V3, P475, DOI 10.1016/j.stem.2008.10.002	11	10	10	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	OCT 2	2009	5	4					349	350		10.1016/j.stem.2009.09.002	http://dx.doi.org/10.1016/j.stem.2009.09.002			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	514NP	19796612	Bronze			2022-12-24	WOS:000271401900004
J	Sipp, D				Sipp, Douglas			Gold Standards in the Diamond Age: The Commodification of Pluripotency	CELL STEM CELL			English	Editorial Material							EMBRYONIC STEM-CELLS; IPS CELLS; LINES; EXPRESSION; CLINICS	Human embryonic stem cells have been characterized as a rare and precious resource because of the scarcity of the materials used in their creation and the many restrictions that have been placed on their derivation and use. With the advent of induced pluripotent stem cells, however, pluripotency stands to become a plentiful and unencumbered commodity.	RIKEN, Ctr Dev Biol, Chuo Ku, Kobe, Hyogo 6500047, Japan	RIKEN	Sipp, D (corresponding author), RIKEN, Ctr Dev Biol, Chuo Ku, 2-2-3 Minatojima Minamimachi, Kobe, Hyogo 6500047, Japan.	sipp@cdb.riken.jp	Sipp, Doug/C-9218-2017	Sipp, Doug/0000-0002-5979-0938				Aalto-Setala K, 2009, PLOS BIOL, V7, P204, DOI 10.1371/journal.pbio.1000042; Andrews PW, 2002, PHILOS T R SOC B, V357, P405, DOI 10.1098/rstb.2002.1058; Chin MH, 2009, CELL STEM CELL, V5, P111, DOI 10.1016/j.stem.2009.06.008; Daley GQ, 2009, CELL STEM CELL, V4, P200, DOI 10.1016/j.stem.2009.02.009; Ellis J, 2009, CELL STEM CELL, V4, P198, DOI 10.1016/j.stem.2009.02.010; Kang L, 2009, CELL STEM CELL, V5, P135, DOI 10.1016/j.stem.2009.07.001; Kiatpongsan S, 2009, SCIENCE, V323, P1564, DOI 10.1126/science.1168451; Lau D, 2008, CELL STEM CELL, V3, P591, DOI 10.1016/j.stem.2008.11.001; Maherali N, 2008, CELL STEM CELL, V3, P595, DOI 10.1016/j.stem.2008.11.008; Mathews DJH, 2009, CELL STEM CELL, V5, P11, DOI 10.1016/j.stem.2009.06.005; Miura K, 2009, NAT BIOTECHNOL, V27, P743, DOI 10.1038/nbt.1554; Nakatsuji N, 2008, NAT BIOTECHNOL, V26, P739, DOI 10.1038/nbt0708-739; Scott CT, 2009, NAT BIOTECHNOL, V27, P696, DOI 10.1038/nbt0809-696; WEINTRAUB H, 1989, P NATL ACAD SCI USA, V86, P5434, DOI 10.1073/pnas.86.14.5434; Yamanaka S, 2009, CELL, V137, P13, DOI 10.1016/j.cell.2009.03.034; Zhao XY, 2009, NATURE, V461, P86, DOI 10.1038/nature08267; Zhou Q, 2008, CELL STEM CELL, V3, P382, DOI 10.1016/j.stem.2008.09.015	17	9	9	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	OCT 2	2009	5	4					360	363		10.1016/j.stem.2009.09.005	http://dx.doi.org/10.1016/j.stem.2009.09.005			4	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	514NP	19796616	Bronze			2022-12-24	WOS:000271401900008
J	Bultje, RS; Castaneda-Castellanos, DR; Jan, LY; Jan, YN; Kriegstein, AR; Shi, SH				Bultje, Ronald S.; Castaneda-Castellanos, David R.; Jan, Lily Yen; Jan, Yuh-Nung; Kriegstein, Arnold R.; Shi, Song-Hai			Mammalian Par3 Regulates Progenitor Cell Asymmetric Division via Notch Signaling in the Developing Neocortex	NEURON			English	Article							RADIAL GLIAL-CELLS; CENTRAL-NERVOUS-SYSTEM; NEURAL STEM-CELLS; CORTICAL NEUROGENESIS; CEREBRAL-CORTEX; NEUROEPITHELIAL CELLS; MOUSE NUMB; INTERMEDIATE PROGENITORS; NEURONS ARISE; POLARITY	Asymmetric cell division of radial glial progenitors produces neurons while allowing self-renewal; however, little is known about the mechanism that generates asymmetry in daughter cell fate specification. Here, we found that mammalian partition defective protein 3 (mPar3), a key cell polarity determinant, exhibits dynamic distribution in radial glial progenitors. While it is enriched at the lateral membrane domain in the ventricular endfeet during interphase, mPar3 becomes dispersed and shows asymmetric localization as cell cycle progresses. Either removal or ectopic expression of mPar3 prevents radial glial progenitors from dividing asymmetrically yet generates different outcomes in daughter cell fate specification. Furthermore, the expression level of mPar3 affects Notch signaling, and manipulations of Notch signaling or Numb expression suppress mPar3 regulation of radial glial cell division and daughter cell fate specification. These results reveal a critical molecular pathway underlying asymmetric cell division of radial glial progenitors in the mammalian neocortex.	[Bultje, Ronald S.; Shi, Song-Hai] Mem Sloan Kettering Canc Ctr, Dev Biol Program, New York, NY 10065 USA; [Bultje, Ronald S.] Cornell Univ, Weill Med Coll, Dept Pharmacol, New York, NY 10065 USA; [Castaneda-Castellanos, David R.] Columbia Univ, Dept Physiol & Cellular Biophys, New York, NY 10032 USA; [Castaneda-Castellanos, David R.; Kriegstein, Arnold R.] Univ Calif San Francisco, Sch Med, Dept Neurol, San Francisco, CA 94143 USA; [Jan, Lily Yen; Jan, Yuh-Nung] Univ Calif San Francisco, Howard Hughes Med Inst, Dept Physiol, San Francisco, CA 94143 USA; [Jan, Lily Yen; Jan, Yuh-Nung] Univ Calif San Francisco, Howard Hughes Med Inst, Dept Biochem, San Francisco, CA 94143 USA; [Jan, Lily Yen; Jan, Yuh-Nung] Univ Calif San Francisco, Howard Hughes Med Inst, Dept Biophys, San Francisco, CA 94143 USA	Memorial Sloan Kettering Cancer Center; Cornell University; Columbia University; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Shi, SH (corresponding author), Mem Sloan Kettering Canc Ctr, Dev Biol Program, 1275 York Ave, New York, NY 10065 USA.	shis@mskcc.org		Jan, Lily/0000-0003-3938-8498; Jan, Yuh Nung/0000-0003-1367-6299	March of Dimes Birth Defects Foundation; Whitehall Foundation; DANA Foundation; Autism Speaks Foundation; Esther A. & Joseph Klingenstein Foundation; NARSAD; NIH; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH083624] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA024681] Funding Source: NIH RePORTER	March of Dimes Birth Defects Foundation(March of Dimes); Whitehall Foundation; DANA Foundation; Autism Speaks Foundation; Esther A. & Joseph Klingenstein Foundation; NARSAD(NARSAD); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work is supported by grants from March of Dimes Birth Defects Foundation, Whitehall Foundation, DANA Foundation, Autism Speaks Foundation, The Esther A. & Joseph Klingenstein Foundation, NARSAD (to S.-H.S.), and NIH (to S.-H.S. and A.R.K.). L.Y.J and Y.-N.J. are investigators of Howard Hughes Medical Institute.	AakuSaraste E, 1996, DEV BIOL, V180, P664, DOI 10.1006/dbio.1996.0336; Adams RJ, 1996, J NEUROSCI, V16, P7610; Anthony TE, 2004, NEURON, V41, P881, DOI 10.1016/S0896-6273(04)00140-0; Astrom K E, 1991, Adv Anat Embryol Cell Biol, V123, P1; Buchman JJ, 2007, NAT REV NEUROSCI, V8, P89, DOI 10.1038/nrn2058; Cappello S, 2006, NAT NEUROSCI, V9, P1099, DOI 10.1038/nn1744; CHENN A, 1995, CELL, V82, P631, DOI 10.1016/0092-8674(95)90035-7; Chenn A, 1998, MOL CELL NEUROSCI, V11, P183, DOI 10.1006/mcne.1998.0680; Costa MR, 2008, DEVELOPMENT, V135, P11, DOI 10.1242/dev.009951; Doe CQ, 1998, J NEUROBIOL, V36, P111, DOI 10.1002/(SICI)1097-4695(199808)36:2<111::AID-NEU2>3.0.CO;2-4; Fishell G, 2003, CURR OPIN NEUROBIOL, V13, P34, DOI 10.1016/S0959-4388(03)00013-8; Gaiano N, 2002, ANNU REV NEUROSCI, V25, P471, DOI 10.1146/annurev.neuro.25.030702.130823; Gaiano N, 2000, NEURON, V26, P395, DOI 10.1016/S0896-6273(00)81172-1; Haubensak W, 2004, P NATL ACAD SCI USA, V101, P3196, DOI 10.1073/pnas.0308600100; Haydar TF, 2003, P NATL ACAD SCI USA, V100, P2890, DOI 10.1073/pnas.0437969100; Izumi Y, 1998, J CELL BIOL, V143, P95, DOI 10.1083/jcb.143.1.95; Jan YN, 2001, NAT REV NEUROSCI, V2, P772, DOI 10.1038/35097516; Joberty G, 2000, NAT CELL BIOL, V2, P531, DOI 10.1038/35019573; Johansson AS, 2000, J CELL SCI, V113, P3267; Johnson K, 2003, NAT CELL BIOL, V5, P12, DOI 10.1038/ncb0103-12; Kamei Y, 1998, GLIA, V23, P191, DOI 10.1002/(SICI)1098-1136(199807)23:3<191::AID-GLIA2>3.0.CO;2-8; Kemphues K, 2000, CELL, V101, P345, DOI 10.1016/S0092-8674(00)80844-2; KEMPHUES KJ, 1988, CELL, V52, P311, DOI 10.1016/S0092-8674(88)80024-2; Klezovitch O, 2004, GENE DEV, V18, P559, DOI 10.1101/gad.1178004; KNOBLICH JA, 1995, NATURE, V377, P624, DOI 10.1038/377624a0; Knoblich JA, 2008, CELL, V132, P583, DOI 10.1016/j.cell.2008.02.007; Kosodo Y, 2004, EMBO J, V23, P2314, DOI 10.1038/sj.emboj.7600223; Kuo CT, 2006, CELL, V127, P1253, DOI 10.1016/j.cell.2006.10.041; Lechler T, 2005, NATURE, V437, P275, DOI 10.1038/nature03922; Li HS, 2003, NEURON, V40, P1105, DOI 10.1016/S0896-6273(03)00755-4; Lin D, 2000, NAT CELL BIOL, V2, P540, DOI 10.1038/35019582; Malatesta P, 2000, DEVELOPMENT, V127, P5253; Manabe N, 2002, DEV DYNAM, V225, P61, DOI 10.1002/dvdy.10139; Miyata T, 2004, DEVELOPMENT, V131, P3133, DOI 10.1242/dev.01173; Miyata T, 2001, NEURON, V31, P727, DOI 10.1016/S0896-6273(01)00420-2; Mizutani K, 2007, NATURE, V449, P351, DOI 10.1038/nature06090; Nishimura T, 2007, DEV CELL, V13, P15, DOI 10.1016/j.devcel.2007.05.003; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Noctor SC, 2002, J NEUROSCI, V22, P3161, DOI 10.1523/JNEUROSCI.22-08-03161.2002; Noctor SC, 2008, J COMP NEUROL, V508, P28, DOI 10.1002/cne.21669; Petersen PH, 2004, NAT NEUROSCI, V7, P803, DOI 10.1038/nn1289; Petersen PH, 2002, NATURE, V419, P929, DOI 10.1038/nature01124; Rasin MR, 2007, NAT NEUROSCI, V10, P819, DOI 10.1038/nn1924; RHYU MS, 1994, CELL, V76, P477, DOI 10.1016/0092-8674(94)90112-0; Roegiers F, 2004, CURR OPIN CELL BIOL, V16, P195, DOI 10.1016/j.ceb.2004.02.010; Ross SE, 2003, NEURON, V39, P13, DOI 10.1016/S0896-6273(03)00365-9; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Sanada K, 2005, CELL, V122, P119, DOI 10.1016/j.cell.2005.05.009; Sauer FC, 1935, J COMP NEUROL, V62, P377, DOI 10.1002/cne.900620207; Shen Q, 2002, DEVELOPMENT, V129, P4843; Shi SH, 2003, CELL, V112, P63, DOI 10.1016/S0092-8674(02)01249-7; SHOUKIMAS GM, 1978, J COMP NEUROL, V179, P795, DOI 10.1002/cne.901790407; Tabata H, 2001, NEUROSCIENCE, V103, P865, DOI 10.1016/S0306-4522(01)00016-1; Takahashi T, 1996, J NEUROSCI, V16, P6183; Tamamaki N, 2001, NEUROSCI RES, V41, P51, DOI 10.1016/S0168-0102(01)00259-0; Tawk M, 2007, NATURE, V446, P797, DOI 10.1038/nature05722; Vasioukhin V, 2006, DEV NEUROSCI-BASEL, V28, P13, DOI 10.1159/000090749; Weng AP, 2003, MOL CELL BIOL, V23, P655, DOI 10.1128/MCB.23.2.655-664.2003; Wodarz A, 2003, MECH DEVELOP, V120, P1297, DOI 10.1016/j.mod.2003.06.003; Yoon K, 2005, NAT NEUROSCI, V8, P709, DOI 10.1038/nn1475; Yoon KJ, 2008, NEURON, V58, P519, DOI 10.1016/j.neuron.2008.03.018; Zhong WM, 1996, NEURON, V17, P43, DOI 10.1016/S0896-6273(00)80279-2; Zhong WM, 2000, P NATL ACAD SCI USA, V97, P6844, DOI 10.1073/pnas.97.12.6844; Zilian O, 2001, CURR BIOL, V11, P494, DOI 10.1016/S0960-9822(01)00149-X	65	255	265	1	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 30	2009	63	2					189	202		10.1016/j.neuron.2009.07.004	http://dx.doi.org/10.1016/j.neuron.2009.07.004			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	479IS	19640478	Green Accepted, Bronze			2022-12-24	WOS:000268653500008
J	Deng, PY; Xiao, ZY; Yang, CX; Rojanathammanee, L; Grisanti, L; Watt, J; Geiger, JD; Liu, RG; Porter, JE; Lei, SB				Deng, Pan-Yue; Xiao, Zhaoyang; Yang, Chuanxiu; Rojanathammanee, Lalida; Grisanti, Laurel; Watt, John; Geiger, Jonathan D.; Liu, Rugao; Porter, James E.; Lei, Saobo			GABA(B) Receptor Activation Inhibits Neuronal Excitability and Spatial Learning in the Entorhinal Cortex by Activating TREK-2 K+ Channels	NEURON			English	Article							BACKGROUND POTASSIUM CHANNELS; MEDIAL TEMPORAL-LOBE; CEREBELLAR GRANULE NEURONS; PROTEIN-COUPLED RECEPTORS; ARACHIDONIC-ACID; PARAHIPPOCAMPAL REGION; FUNCTIONAL EXPRESSION; INTRINSIC CONNECTIONS; LEAK CHANNELS; RAT	The entorhinal cortex (EC) is regarded as the gateway to the hippocampus and thus is essential for learning and memory. Whereas the EC expresses a high density of GABA(B) receptors, the functions of these receptors in this region remain unexplored. Here, we examined the effects of GABA(B) receptor activation on neuronal excitability in the EC and spatial learning. Application of baclofen, a specific GABA(B) receptor agonist, inhibited significantly neuronal excitability in the EC. GABA(B) receptor-mediated inhibition in the EC was mediated via activating TREK-2, a type of two-pore domain K+ channels, and required the functions of inhibitory G proteins and protein kinase A pathway. Depression of neuronal excitability in the EC underlies GABA(B) receptor.-mediated inhibition of spatial learning as assessed by Morris water maze. Our study indicates that GABA(B) receptors exert a tight control over spatial learning by modulating neuronal excitability in the EC.	[Deng, Pan-Yue; Xiao, Zhaoyang; Yang, Chuanxiu; Rojanathammanee, Lalida; Grisanti, Laurel; Geiger, Jonathan D.; Porter, James E.; Lei, Saobo] Univ N Dakota, Sch Med & Hlth Sci, Dept Pharmacol Physiol & Therapeut, Grand Forks, ND 58203 USA; [Watt, John; Liu, Rugao] Univ N Dakota, Sch Med & Hlth Sci, Dept Anat & Cell Biol, Grand Forks, ND 58203 USA	University of North Dakota Grand Forks; University of North Dakota Grand Forks	Lei, SB (corresponding author), Univ N Dakota, Sch Med & Hlth Sci, Dept Pharmacol Physiol & Therapeut, Grand Forks, ND 58203 USA.	slei@medicine.nodak.edu			National Institute of Mental Health [1R01MH08288]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH082881] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by National Institute of Mental Health Grant 1R01MH08288. We sincerely appreciate the valuable advices for the water maze experiments from Dr. Fred J. Helmstetter in the University of Wisconsin-Milwaukee.	Aller MI, 2005, J NEUROSCI, V25, P11455, DOI 10.1523/JNEUROSCI.3153-05.2005; Arnsten AFT, 2005, TRENDS MOL MED, V11, P121, DOI 10.1016/j.molmed.2005.01.006; Avoli M, 2002, PROG NEUROBIOL, V68, P167, DOI 10.1016/S0301-0082(02)00077-1; Bang H, 2000, J BIOL CHEM, V275, P17412, DOI 10.1074/jbc.M000445200; Bayliss Douglas A, 2003, Mol Interv, V3, P205, DOI 10.1124/mi.3.4.205; Beene DL, 2007, CURR OPIN CELL BIOL, V19, P192, DOI 10.1016/j.ceb.2007.02.011; Burwell RD, 2000, ANN NY ACAD SCI, V911, P25; Chemin J, 2003, EMBO J, V22, P5403, DOI 10.1093/emboj/cdg528; Chen XD, 2006, P NATL ACAD SCI USA, V103, P3422, DOI 10.1073/pnas.0507710103; Couve A, 2000, MOL CELL NEUROSCI, V16, P296, DOI 10.1006/mcne.2000.0908; Deng PY, 2008, MOL CELL NEUROSCI, V39, P273, DOI 10.1016/j.mcn.2008.07.005; Deng PY, 2007, MOL PHARMACOL, V72, P208, DOI 10.1124/mol.107.034389; Deng PY, 2006, J PHYSIOL-LONDON, V577, P497, DOI 10.1113/jphysiol.2006.118141; Dickson CT, 2000, J NEUROPHYSIOL, V83, P2562, DOI 10.1152/jn.2000.83.5.2562; Dolorfo CL, 1998, J COMP NEUROL, V398, P49, DOI 10.1002/(SICI)1096-9861(19980817)398:1<49::AID-CNE4>3.0.CO;2-9; Dolorfo CL, 1998, J COMP NEUROL, V398, P25; Fakler B, 1996, EMBO J, V15, P4093, DOI 10.1002/j.1460-2075.1996.tb00784.x; FALKAI P, 1988, BIOL PSYCHIAT, V24, P515, DOI 10.1016/0006-3223(88)90162-X; Fink M, 1996, EMBO J, V15, P6854, DOI 10.1002/j.1460-2075.1996.tb01077.x; Fogle KJ, 2007, J NEUROSCI, V27, P2802, DOI 10.1523/JNEUROSCI.4376-06.2007; Goldstein SAN, 2001, NAT REV NEUROSCI, V2, P175, DOI 10.1038/35058574; Haist F, 2001, NAT NEUROSCI, V4, P1139, DOI 10.1038/nn739; Han J, 2002, J PHYSIOL-LONDON, V542, P431, DOI 10.1113/jphysiol.2002.017590; Helm KA, 2005, NEUROPHARMACOLOGY, V48, P956, DOI 10.1016/j.neuropharm.2005.01.019; Heurteaux C, 2004, EMBO J, V23, P2684, DOI 10.1038/sj.emboj.7600234; Honore E, 2007, NAT REV NEUROSCI, V8, P251, DOI 10.1038/nrn2117; Huang DY, 2008, MED HYPOTHESES, V70, P618, DOI 10.1016/j.mehy.2007.06.016; Hundsrucker C., 2008, V186, P483, DOI 10.1007/978-3-540-72843-6_20; HYMAN BT, 1984, SCIENCE, V225, P1168, DOI 10.1126/science.6474172; Kang D, 2004, J BIOL CHEM, V279, P28063, DOI 10.1074/jbc.M402940200; Kang D, 2007, EXP DERMATOL, V16, P1016, DOI 10.1111/j.1600-0625.2007.00626.x; Kang D, 2007, J PHYSIOL-LONDON, V583, P57, DOI 10.1113/jphysiol.2007.136150; Kang DW, 2006, AM J PHYSIOL-CELL PH, V291, pC649, DOI 10.1152/ajpcell.00047.2006; Kim D, 2005, CURR PHARM DESIGN, V11, P2717, DOI 10.2174/1381612054546824; Kim Y, 2000, J BIOL CHEM, V275, P9340, DOI 10.1074/jbc.275.13.9340; KOHLER C, 1986, J COMP NEUROL, V246, P149, DOI 10.1002/cne.902460202; Kotzbauer PT, 2001, J MOL NEUROSCI, V17, P225, DOI 10.1385/JMN:17:2:225; Lesage F, 2000, J BIOL CHEM, V275, P28398, DOI 10.1074/jbc.M002822200; Lesage F, 2003, NEUROPHARMACOLOGY, V44, P1, DOI 10.1016/S0028-3908(02)00339-8; Lesage F, 1996, EMBO J, V15, P1004, DOI 10.1002/j.1460-2075.1996.tb00437.x; Maingret F, 1999, J BIOL CHEM, V274, P26691, DOI 10.1074/jbc.274.38.26691; Mathie A, 2007, CURR OPIN INVEST DR, V8, P555; Mathie A, 2007, J PHYSIOL-LONDON, V578, P377, DOI 10.1113/jphysiol.2006.121582; McNamara RK, 1996, PHARMACOL BIOCHEM BE, V53, P303, DOI 10.1016/0091-3057(95)02025-X; MEVES H, 1994, PROG NEUROBIOL, V43, P175, DOI 10.1016/0301-0082(94)90012-4; MISGELD U, 1995, PROG NEUROBIOL, V46, P423, DOI 10.1016/0301-0082(95)00012-K; Mizukami K, 2002, PROG NEURO-PSYCHOPH, V26, P393, DOI 10.1016/S0278-5846(01)00247-0; Murbartian J, 2005, J BIOL CHEM, V280, P30175, DOI 10.1074/jbc.M503862200; Oike H, 2006, BBA-MOL CELL BIOL L, V1761, P1078, DOI 10.1016/j.bbalip.2006.07.005; Pan Ya-ping, 2003, Yaoxue Xuebao, V38, P721; Prasad KMR, 2004, AM J PSYCHIAT, V161, P1612, DOI 10.1176/appi.ajp.161.9.1612; RUDY JW, 2008, NEUROBIOLOGY LEARNIN, P142; Sandoz G, 2008, J NEUROSCI, V28, P8545, DOI 10.1523/JNEUROSCI.1962-08.2008; Sandoz G, 2006, EMBO J, V25, P5864, DOI 10.1038/sj.emboj.7601437; Sano Y, 2003, J BIOL CHEM, V278, P27406, DOI 10.1074/jbc.M206810200; Simkin D, 2008, J PHYSIOL-LONDON, V586, P5651, DOI 10.1113/jphysiol.2008.161927; SPENCER SS, 1994, EPILEPSIA, V35, P721, DOI 10.1111/j.1528-1157.1994.tb02502.x; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; Steffenach HA, 2005, NEURON, V45, P301, DOI 10.1016/j.neuron.2004.12.044; STEWARD O, 1976, J COMP NEUROL, V169, P347, DOI 10.1002/cne.901690306; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Talley EM, 2000, NEURON, V25, P399, DOI 10.1016/S0896-6273(00)80903-4; van Haeften T, 2003, HIPPOCAMPUS, V13, P943, DOI 10.1002/hipo.10144; Veale EL, 2007, MOL PHARMACOL, V71, P1666, DOI 10.1124/mol.106.033241; von Bohlen und Halbach O, 2005, CELL TISSUE RES, V322, P201, DOI 10.1007/s00441-005-0004-4; WITTER MP, 1989, PROG NEUROBIOL, V33, P161, DOI 10.1016/0301-0082(89)90009-9; Witter MP, 2000, ANN NY ACAD SCI, V911, P1; Witter MP, 2000, HIPPOCAMPUS, V10, P398; Xu W, 2004, NEUROSCIENCE, V126, P313, DOI 10.1016/j.neuroscience.2004.03.055	69	90	94	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 30	2009	63	2					230	243		10.1016/j.neuron.2009.06.022	http://dx.doi.org/10.1016/j.neuron.2009.06.022			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	479IS	19640481	Green Accepted, Bronze			2022-12-24	WOS:000268653500011
J	Asadollahi, A; Mysore, SP; Knudsen, EI				Asadollahi, Ali; Mysore, Shreesh P.; Knudsen, Eric I.			Stimulus-driven competition in a cholinergic midbrain nucleus	NATURE NEUROSCIENCE			English	Article							OWL OPTIC TECTUM; ISTHMI PARS PARVOCELLULARIS; LATERAL INTRAPARIETAL AREA; FRONTAL EYE FIELD; TOP-DOWN CONTROL; SUPERIOR COLLICULUS; BARN OWL; VISUAL-ATTENTION; TARGET SELECTION; INHIBITION	The mechanisms by which the brain selects a particular stimulus as the next target for gaze are poorly understood. A cholinergic nucleus in the owl's midbrain exhibits functional properties that suggest its role in bottom-up stimulus selection. Neurons in the nucleus isthmi pars parvocellularis (Ipc) responded to wide ranges of visual and auditory features, but they were not tuned to particular values of those features. Instead, they encoded the relative strengths of stimuli across the entirety of space. Many neurons exhibited switch-like properties, abruptly increasing their responses to a stimulus in their receptive field when it became the strongest stimulus. This information propagates directly to the optic tectum, a structure involved in gaze control and stimulus selection, as periodic (25-50 Hz) bursts of cholinergic activity. The functional properties of Ipc neurons resembled those of a salience map, a core component in computational models for spatial attention and gaze control.	[Asadollahi, Ali; Mysore, Shreesh P.; Knudsen, Eric I.] Stanford Sch Med, Dept Neurobiol, Stanford, CA USA	Stanford University	Asadollahi, A (corresponding author), Stanford Sch Med, Dept Neurobiol, Stanford, CA USA.	asad@stanford.edu	Asadollahi, Ali/AAV-4971-2021	Asadollahi, Ali/0000-0002-7915-6846; Mysore, Shreesh/0000-0002-7781-8252	US National Institutes of Health [R01 EY019179]; NATIONAL EYE INSTITUTE [R01EY019179] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank P. Knudsen for technical support, C. Goddard and S. Devarajan for helpful discussions and T. Moore, B. Noudoost and N. Steinmets for reviewing the manuscript. This work was supported by grants from the US National Institutes of Health (R01 EY019179) to E.I.K.	Bisley JW, 2003, SCIENCE, V299, P81, DOI 10.1126/science.1077395; Buschman TJ, 2007, SCIENCE, V315, P1860, DOI 10.1126/science.1138071; CARANDINI M, 1994, SCIENCE, V264, P1333, DOI 10.1126/science.8191289; Endo T, 2005, J NEUROPHYSIOL, V94, P3893, DOI 10.1152/jn.00211.2005; Fecteau JH, 2006, TRENDS COGN SCI, V10, P382, DOI 10.1016/j.tics.2006.06.011; Goldberg ME, 2002, ANN NY ACAD SCI, V956, P205, DOI 10.1111/j.1749-6632.2002.tb02820.x; GOLDBERG ME, 1972, J NEUROPHYSIOL, V35, P560, DOI 10.1152/jn.1972.35.4.560; Itti L, 2001, NAT REV NEUROSCI, V2, P194, DOI 10.1038/35058500; Itti L, 2000, VISION RES, V40, P1489, DOI 10.1016/S0042-6989(99)00163-7; KARTEN HJ, 1969, ANN NY ACAD SCI, V167, P164, DOI 10.1111/j.1749-6632.1969.tb20442.x; KNUDSEN EI, 1995, J NEUROSCI, V15, P5139; KNUDSEN EI, 1982, J NEUROSCI, V2, P1177; Knudsen EI, 1996, EXP BRAIN RES, V108, P23; Lakatos P, 2008, SCIENCE, V320, P110, DOI 10.1126/science.1154735; Maczko KA, 2006, J NEUROSCI, V26, P12799, DOI 10.1523/JNEUROSCI.3946-06.2006; Marin G, 2005, J NEUROSCI, V25, P7081, DOI 10.1523/JNEUROSCI.1379-05.2005; Marin G, 2007, J NEUROSCI, V27, P8112, DOI 10.1523/JNEUROSCI.1420-07.2007; Marino J, 2005, NAT NEUROSCI, V8, P194, DOI 10.1038/nn1391; McPeek RM, 2002, J NEUROPHYSIOL, V88, P2019, DOI 10.1152/jn.2002.88.4.2019; Muller JR, 2005, P NATL ACAD SCI USA, V102, P524, DOI 10.1073/pnas.0408311101; Mysore SP, 2010, J NEUROSCI, V30, P1727, DOI 10.1523/JNEUROSCI.3740-09.2010; Parkhurst D, 2002, VISION RES, V42, P107, DOI 10.1016/S0042-6989(01)00250-4; Reynolds JH, 2004, ANNU REV NEUROSCI, V27, P611, DOI 10.1146/annurev.neuro.26.041002.131039; RIZZOLATTI G, 1974, J NEUROPHYSIOL, V37, P1262, DOI 10.1152/jn.1974.37.6.1262; Sarter M, 2005, BRAIN RES REV, V48, P98, DOI 10.1016/j.brainresrev.2004.08.006; SCHILLER PH, 1987, J NEUROPHYSIOL, V57, P1033, DOI 10.1152/jn.1987.57.4.1033; SERENO MI, 1987, J COMP NEUROL, V261, P319, DOI 10.1002/cne.902610302; Shipp S, 2004, TRENDS COGN SCI, V8, P223, DOI 10.1016/j.tics.2004.03.004; Sommer MA, 2000, J NEUROPHYSIOL, V83, P1979, DOI 10.1152/jn.2000.83.4.1979; SORENSON EM, 1989, J COMP NEUROL, V281, P641, DOI 10.1002/cne.902810412; Sparks DL, 2002, NAT REV NEUROSCI, V3, P952, DOI 10.1038/nrn986; Stein BE., 1993, MERGING SENSES; Wang SR, 2003, BRAIN RES REV, V41, P13, DOI 10.1016/S0165-0173(02)00217-5; Wang Y, 2006, J COMP NEUROL, V494, P7, DOI 10.1002/cne.20821; Winkowski DE, 2007, J NEUROSCI, V27, P13279, DOI 10.1523/JNEUROSCI.3937-07.2007; Winkowski DE, 2008, NEURON, V60, P698, DOI 10.1016/j.neuron.2008.09.013; Witten IB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010396; YAN K, 1986, NEUROSCI LETT, V64, P340, DOI 10.1016/0304-3940(86)90352-6; Yu CJ, 2003, NEUROSCIENCE, V118, P135, DOI 10.1016/S0306-4522(02)00768-6	39	51	51	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2010	13	7					889	U138		10.1038/nn.2573	http://dx.doi.org/10.1038/nn.2573			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	615YF	20526331	Green Accepted			2022-12-24	WOS:000279173900023
J	Buecker, C; Chen, HH; Polo, JM; Daheron, L; Bu, L; Barakat, TS; Okwieka, P; Porter, A; Gribnau, J; Hochedlinger, K; Geijsen, N				Buecker, Christa; Chen, Hsu-Hsin; Polo, Jose Maria; Daheron, Laurence; Bu, Lei; Barakat, Tahsin Stefan; Okwieka, Patricia; Porter, Andrew; Gribnau, Joost; Hochedlinger, Konrad; Geijsen, Niels			A Murine ESC-like State Facilitates Transgenesis and Homologous Recombination in Human Pluripotent Stem Cells	CELL STEM CELL			English	Article							HUMAN BLASTOCYSTS; MOUSE EMBRYOS; GROUND-STATE; SELF-RENEWAL; METHYLATION; CHROMATIN; EPIBLAST; LINES; DIFFERENTIATION; GENERATION	Murine pluripotent stem cells can exist in two functionally distinct states, LIF-dependent embryonic stem cells (ESCs) and bFGF-dependent epiblast stem cells (EpiSCs). However, human pluripotent cells so far seemed to assume only an epiblast-like state. Here we demonstrate that human iPSC reprogramming in the presence of LIF yields human stem cells that display morphological, molecular, and functional properties of murine ESCs. We termed these hLR5 iPSCs because they require the expression of five ectopic reprogramming factors, Oct4, Sox2, Klf4, cMyc, and Nanog, to maintain this more naive state. The cells are "metastable" and upon ectopic factor withdrawal they revert to standard human iPSCs. Finally, we demonstrate that the hLR5 state facilitates gene targeting, and as such provides a powerful tool for the generation of recombinant human pluripotent stem cell lines.	[Buecker, Christa; Chen, Hsu-Hsin; Polo, Jose Maria; Daheron, Laurence; Okwieka, Patricia; Hochedlinger, Konrad; Geijsen, Niels] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Regenerat Med, Boston, MA 02114 USA; [Polo, Jose Maria; Hochedlinger, Konrad] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Canc, Boston, MA 02114 USA; [Bu, Lei] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Cardiovasc Res Ctr, Boston, MA 02114 USA; [Buecker, Christa; Chen, Hsu-Hsin; Polo, Jose Maria; Daheron, Laurence; Bu, Lei; Hochedlinger, Konrad; Geijsen, Niels] Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Hochedlinger, Konrad] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Barakat, Tahsin Stefan; Gribnau, Joost] Univ Med Ctr, Erasmus MC, Dept Reprod & Dev, NL-3000 CA Rotterdam, Netherlands; [Porter, Andrew] Univ London Imperial Coll Sci Technol & Med, Gene Therapy Grp, Dept Haematol, London W12 0NN, England; [Geijsen, Niels] Hubrecht Inst Dev Biol & Stem Cell Res, NL-3584 CT Utrecht, Netherlands	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard University; Erasmus University Rotterdam; Erasmus MC; Imperial College London; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW)	Geijsen, N (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Regenerat Med, Boston, MA 02114 USA.	ngeijsen@mgh.harvard.edu	Bu, Lei/F-4461-2011; Barakat, Stefan/X-8234-2019	Barakat, Stefan/0000-0003-1231-1562; Polo, Jose M/0000-0002-2531-778X; Buecker, Christa/0000-0003-3055-2642; BU, LEI/0000-0003-4476-2157	NIH; Dutch Science Organization (NWO); Gottlieb Daimler- and Karl Benz-Foundation; National Science Council (Taiwan, ROC); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD048769] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dutch Science Organization (NWO)(Netherlands Organization for Scientific Research (NWO)); Gottlieb Daimler- and Karl Benz-Foundation; National Science Council (Taiwan, ROC)(Ministry of Science and Technology, Taiwan); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The authors thank Tim Ahfeldt, Nimet Maherali, and Chad Cowan for providing human iPSCs, Laura Prickett-Rice and Kat Folz-Donahue at the HSCI/MGH Flow Cytometry Core facility cell sorting; and Jason West and Meredith Bryden for technical support. This work was supported by grants from the NIH and a grant from the Dutch Science Organization (NWO). C.B. was supported by the Gottlieb Daimler- and Karl Benz-Foundation. H.-H.C. was supported by the National Science Council (Taiwan, ROC).	Bao SQ, 2009, NATURE, V461, P1292, DOI 10.1038/nature08534; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Bu L, 2009, NATURE, V460, P113, DOI 10.1038/nature08191; Buehr M, 2008, CELL, V135, P1287, DOI 10.1016/j.cell.2008.12.007; Chou YF, 2008, CELL, V135, P449, DOI 10.1016/j.cell.2008.08.035; Cowan CA, 2004, NEW ENGL J MED, V350, P1353, DOI 10.1056/NEJMsr040330; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Francis NJ, 2004, SCIENCE, V306, P1574, DOI 10.1126/science.1100576; Guo G, 2009, DEVELOPMENT, V136, P1063, DOI 10.1242/dev.030957; Hanna J, 2009, CELL STEM CELL, V4, P513, DOI 10.1016/j.stem.2009.04.015; Li WL, 2009, CELL STEM CELL, V4, P16, DOI 10.1016/j.stem.2008.11.014; Liao J, 2009, CELL STEM CELL, V4, P11, DOI 10.1016/j.stem.2008.11.013; Maherali N, 2008, CELL STEM CELL, V3, P340, DOI 10.1016/j.stem.2008.08.003; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Pray-Grant MG, 2005, NATURE, V433, P434, DOI 10.1038/nature03242; Ptaszek LM, 2007, CELL STEM CELL, V1, P600, DOI 10.1016/j.stem.2007.11.004; Ringrose L, 2004, MOL CELL, V16, P641, DOI 10.1016/j.molcel.2004.10.015; Santos-Rosa H, 2003, MOL CELL, V12, P1325, DOI 10.1016/S1097-2765(03)00438-6; Silva SS, 2008, P NATL ACAD SCI USA, V105, P4820, DOI 10.1073/pnas.0712136105; Sims RJ, 2005, J BIOL CHEM, V280, P41789, DOI 10.1074/jbc.C500395200; SMITH AG, 1988, NATURE, V336, P688, DOI 10.1038/336688a0; Sommer CA, 2009, STEM CELLS, V27, P543, DOI 10.1634/stemcells.2008-1075; Song H, 2010, CELL STEM CELL, V6, P80, DOI 10.1016/j.stem.2009.11.016; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Thomson JA, 1998, CURR TOP DEV BIOL, V38, P133; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Wysocka J, 2005, CELL, V121, P859, DOI 10.1016/j.cell.2005.03.036; Xu RH, 2005, NAT METHODS, V2, P185, DOI 10.1038/NMETH744; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X	36	165	174	0	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	JUN 4	2010	6	6					535	546		10.1016/j.stem.2010.05.003	http://dx.doi.org/10.1016/j.stem.2010.05.003			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	611SB	20569691	Bronze, Green Accepted			2022-12-24	WOS:000278840700014
J	Zeng, YA; Nusse, R				Zeng, Yi Arial; Nusse, Roel			Wnt Proteins Are Self-Renewal Factors for Mammary Stem Cells and Promote Their Long-Term Expansion in Culture	CELL STEM CELL			English	Article							GENE-EXPRESSION; GLAND; CANCER; TUMORS; IDENTIFICATION; TRANSCRIPTION; REGULATOR; RECEPTOR; FAMILY; GATA-3	Adult stem cells have the ability to self-renew and to generate specialized cells. Self-renewal is dependent on extrinsic niche factors but few of those signals have been identified. In addition, stem cells tend to differentiate in the absence of the proper signals and are therefore difficult to maintain in cell culture. The mammary gland provides an excellent system to study self-renewal signals, because the organ develops postnatally, arises from stem cells, and is readily generated from transplanted cells. We show here that adult mammary glands contain a Wnt-responsive cell population that is enriched for stem cells. In addition, stem cells mutant for the negative-feedback regulator Axin2 and therefore sensitized to Wnt signals have a competitive advantage in mammary gland reconstitution assays. In cell culture experiments, exposure to purified Wnt protein clonally expands mammary stem cells for many generations and maintains their ability to generate functional glands in transplantation assays. We conclude that Wnt proteins serve as rate-limiting self-renewal signals acting directly on mammary stem cells.	[Zeng, Yi Arial; Nusse, Roel] Stanford Univ, Howard Hughes Med Inst, Dept Dev Biol, Sch Med,Beckman Ctr, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University	Nusse, R (corresponding author), Stanford Univ, Howard Hughes Med Inst, Dept Dev Biol, Sch Med,Beckman Ctr, B271,279 Campus Dr, Stanford, CA 94305 USA.	rnusse@stanford.edu			Howard Hughes Medical Institute; California Institute of Regenerative Medicine; Morton Family Foundation	Howard Hughes Medical Institute(Howard Hughes Medical Institute); California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); Morton Family Foundation	We thank various colleagues, in particular Renee van Amerongen, Angela Bowman, Margaret Fuller, Esther Verheyen, Jill Helms, and Mike Clarke for comments and discussions. Matt van de Rijn kindly provided advice on histology. Priya Rajaraman and Steve Artandi helped in cleared fat pad assays. We thank Christophe Fuerer for providing the 7XTcf-FFluc//SV40 construct and Walter Birchmeier for the Axin2<SUP>lacz</SUP> mouse strain. This work was supported by the Howard Hughes Medical Institute, a fellowship from the California Institute of Regenerative Medicine, and the Morton Family Foundation.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Asselin-Labat ML, 2007, NAT CELL BIOL, V9, P201, DOI 10.1038/ncb1530; Badders NM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006594; Baker R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008854; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Boras-Granic K, 2006, DEV BIOL, V295, P219, DOI 10.1016/j.ydbio.2006.03.030; Bouras T, 2008, CELL STEM CELL, V3, P429, DOI 10.1016/j.stem.2008.08.001; Brisken C, 2000, GENE DEV, V14, P650; BUHLER TA, 1993, DEV BIOL, V155, P87, DOI 10.1006/dbio.1993.1009; Chu EY, 2004, DEVELOPMENT, V131, P4819, DOI 10.1242/dev.01347; Clarke MF, 2006, CELL, V124, P1111, DOI 10.1016/j.cell.2006.03.011; DEOME KB, 1959, CANCER RES, V19, P515; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Fuerer C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009370; GAVIN BJ, 1992, MOL CELL BIOL, V12, P2418, DOI 10.1128/MCB.12.5.2418; HUGUET EL, 1994, CANCER RES, V54, P2615; Jaks V, 2008, NAT GENET, V40, P1291, DOI 10.1038/ng.239; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Kalani MYS, 2008, P NATL ACAD SCI USA, V105, P16970, DOI 10.1073/pnas.0808616105; Kaplan RN, 2007, TRENDS MOL MED, V13, P72, DOI 10.1016/j.molmed.2006.12.003; Kordon EC, 1998, DEVELOPMENT, V125, P1921; Kouros-Mehr H, 2006, CELL, V127, P1041, DOI 10.1016/j.cell.2006.09.048; Lane TF, 1997, ONCOGENE, V15, P2133, DOI 10.1038/sj.onc.1201593; Leung JY, 2002, J BIOL CHEM, V277, P21657, DOI 10.1074/jbc.M200139200; Lindvall C, 2006, J BIOL CHEM, V281, P35081, DOI 10.1074/jbc.M607571200; Lindvall C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005813; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; NUSSE R, 1982, CELL, V31, P99, DOI 10.1016/0092-8674(82)90409-3; OLSON DJ, 1994, CELL GROWTH DIFFER, V5, P197; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Richert MM, 2000, J MAMMARY GLAND BIOL, V5, P227, DOI 10.1023/A:1026499523505; ROELINK H, 1990, P NATL ACAD SCI USA, V87, P4519, DOI 10.1073/pnas.87.12.4519; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Stingl J, 2007, NAT REV CANCER, V7, P791, DOI 10.1038/nrc2212; Teissedre B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004537; Vaillant F, 2008, CANCER RES, V68, P7711, DOI 10.1158/0008-5472.CAN-08-1949; Visvader JE, 2006, CANCER RES, V66, P9798, DOI 10.1158/0008-5472.CAN-06-2254; WEBERHALL SJ, 1994, DIFFERENTIATION, V57, P205, DOI 10.1046/j.1432-0436.1994.5730205.x; Welm B, 2003, CELL PROLIFERAT, V36, P17, DOI 10.1046/j.1365-2184.36.s.1.3.x; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Woodward WA, 2005, J CELL SCI, V118, P3585, DOI 10.1242/jcs.02532; YOUNG LJT, 1971, EXP GERONTOL, V6, P49, DOI 10.1016/0531-5565(71)90048-9	44	306	316	0	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUN 4	2010	6	6					568	577		10.1016/j.stem.2010.03.020	http://dx.doi.org/10.1016/j.stem.2010.03.020			10	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	611SB	20569694	Green Accepted, Bronze			2022-12-24	WOS:000278840700017
J	Liu, J; Ward, A; Gao, JW; Dong, YM; Nishio, N; Inada, H; Kang, LJ; Yu, Y; Ma, D; Xu, T; Mori, I; Xie, ZX; Xu, XZS				Liu, Jie; Ward, Alex; Gao, Jingwei; Dong, Yongming; Nishio, Nana; Inada, Hitoshi; Kang, Lijun; Yu, Yong; Ma, Di; Xu, Tao; Mori, Ikue; Xie, Zhixiong; Xu, X. Z. Shawn			C-elegans phototransduction requires a G protein-dependent cGMP pathway and a taste receptor homolog	NATURE NEUROSCIENCE			English	Article							NUCLEOTIDE-GATED CHANNEL; OLFACTORY RECEPTORS; SUGAR PERCEPTION; PHOTORECEPTORS; EXPRESSION; SUBUNIT; FAMILY; ALPHA; SENSITIVITY; NEURONS	The eyeless animal C. elegans is able to sense light and engages in phototaxis behavior that is mediated by photoreceptor cells. However, the molecular and cellular mechanisms underlying phototransduction in C. elegans remain largely unclear. By recording the photoreceptor neuron ASJ in wild-type and various mutant worms, we found that phototransduction in ASJ is a G protein-mediated process and requires membrane-associated guanylate cyclases, but not typical phosphodiesterases. In addition, we found that C. elegans phototransduction requires LITE-1, a candidate photoreceptor protein known to be a member of the invertebrate taste receptor family. Our genetic, pharmacological and electrophysiological data suggest a model in which LITE-1 transduces light signals in ASJ via G protein signaling, which leads to upregulation of the second messenger cGMP, followed by opening of cGMP-sensitive CNG channels and stimulation of photoreceptor cells. Our results identify a phototransduction cascade in C. elegans and implicate the function of a 'taste receptor' in phototransduction.	[Liu, Jie; Ward, Alex; Gao, Jingwei; Dong, Yongming; Kang, Lijun; Yu, Yong; Ma, Di; Xu, X. Z. Shawn] Univ Michigan, Inst Life Sci, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Liu, Jie; Ward, Alex; Gao, Jingwei; Dong, Yongming; Kang, Lijun; Yu, Yong; Ma, Di; Xu, X. Z. Shawn] Univ Michigan, Neurosci Program, Ann Arbor, MI 48109 USA; [Gao, Jingwei; Xie, Zhixiong] Wuhan Univ, Coll Life Sci, Wuhan 430072, Hubei, Peoples R China; [Nishio, Nana; Inada, Hitoshi; Mori, Ikue] Nagoya Univ, Grp Mol Neurobiol, Nagoya, Aichi 4648601, Japan; [Nishio, Nana; Inada, Hitoshi; Mori, Ikue] Nagoya Univ, Grad Sch Sci, CREST JST, Nagoya, Aichi 4648601, Japan; [Inada, Hitoshi] Harvard Univ, Dept Mol & Cell Biol, Cambridge, MA 02138 USA; [Yu, Yong; Xu, Tao] Chinese Acad Sci, Inst Biophys, Beijing 100080, Peoples R China	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Wuhan University; Nagoya University; Japan Science & Technology Agency (JST); Nagoya University; Harvard University; Chinese Academy of Sciences; Institute of Biophysics, CAS	Xu, XZS (corresponding author), Univ Michigan, Inst Life Sci, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA.	shawnxu@umich.edu	Dong, Yongming/H-9502-2013; Inada, Hitoshi/GQH-1084-2022; Inada, Hitoshi/T-2773-2019; liu, jie/B-4901-2011	Dong, Yongming/0000-0002-6510-0913; Inada, Hitoshi/0000-0002-6121-3830; Inada, Hitoshi/0000-0002-6121-3830; liu, jie/0000-0002-1215-5814; KANG, Lijun/0000-0001-9939-5134	National Eye Institute [T32EY13934]; Chinese 111 project [CB06081]; National Institute of General Medical Sciences; Pew scholar award; NATIONAL EYE INSTITUTE [T32EY013934] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078276, R01GM083241] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Chinese 111 project(Ministry of Education, China - 111 Project); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Pew scholar award; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank P. Hu, A. Kumar and B. Ye for comments, M. Koelle for PTX plasmid and B. Decaluwe and S. Gu for technical assistance. Some strains were obtained from the Caenorhabditis Genetics Center, the Oklahoma Knockout Consortium and S. Mitani. A.W. was supported by a predoctoral training grant from the National Eye Institute (T32EY13934 to The University of Michigan). J.G. and Z.X. received support from the Chinese 111 project (CB06081). This work was supported by grants from the National Institute of General Medical Sciences and a Pew scholar award to X.Z.S.X.	Bargmann CI., 2006, WORMBOOK, P1, DOI [10.1895/wormbook.1.123.1, DOI 10.1895/WORMBOOK.1.123.1]; Benton R, 2006, PLOS BIOL, V4, P240, DOI 10.1371/journal.pbio.0040020; Berson DM, 2007, PFLUG ARCH EUR J PHY, V454, P849, DOI 10.1007/s00424-007-0242-2; Birnby DA, 2000, GENETICS, V155, P85; Bounoutas A, 2007, PFLUG ARCH EUR J PHY, V454, P691, DOI 10.1007/s00424-006-0187-x; BOWES C, 1990, NATURE, V347, P677, DOI 10.1038/347677a0; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Clyne PJ, 2000, SCIENCE, V287, P1830, DOI 10.1126/science.287.5459.1830; Coburn CM, 1996, NEURON, V17, P695, DOI 10.1016/S0896-6273(00)80201-9; Darby C, 2001, INFECT IMMUN, V69, P6271, DOI 10.1128/IAI.69.10.6271-6275.2001; Ebbs ML, 2007, PFLUG ARCH EUR J PHY, V454, P735, DOI 10.1007/s00424-007-0246-y; Edwards SL, 2008, PLOS BIOL, V6, P1715, DOI 10.1371/journal.pbio.0060198; Feng ZY, 2006, CELL, V127, P621, DOI 10.1016/j.cell.2006.09.035; Fu YB, 2007, PFLUG ARCH EUR J PHY, V454, P805, DOI 10.1007/s00424-006-0194-y; Gardiner A, 2009, BIOL LETTERS, V5, P244, DOI 10.1098/rsbl.2008.0723; Gomez MD, 2000, J NEUROSCI, V20, P5254, DOI 10.1523/JNEUROSCI.20-14-05254.2000; Goodman MB, 1998, NEURON, V20, P763, DOI 10.1016/S0896-6273(00)81014-4; Gotow T, 2008, BRAIN RES, V1225, P3, DOI 10.1016/j.brainres.2008.04.059; Goubaeva F, 2003, J BIOL CHEM, V278, P19634, DOI 10.1074/jbc.M300052200; Gray JM, 2004, NATURE, V430, P317, DOI 10.1038/nature02714; Hallem EA, 2006, ANNU REV ENTOMOL, V51, P113, DOI 10.1146/annurev.ento.51.051705.113646; Inada H, 2006, GENETICS, V172, P2239, DOI 10.1534/genetics.105.050013; Ishimoto H, 2005, EMBO J, V24, P3259, DOI 10.1038/sj.emboj.7600796; Jansen G, 1999, NAT GENET, V21, P414, DOI 10.1038/7753; Komatsu H, 1996, NEURON, V17, P707, DOI 10.1016/S0896-6273(00)80202-0; L'Etoile ND, 2000, NEURON, V25, P575, DOI 10.1016/S0896-6273(00)81061-2; LEYTE A, 1992, EMBO J, V11, P4795, DOI 10.1002/j.1460-2075.1992.tb05585.x; Li W, 2006, NATURE, V440, P684, DOI 10.1038/nature04538; Miranda-Vizuete A, 2006, FEBS LETT, V580, P484, DOI 10.1016/j.febslet.2005.12.046; Murakami M, 2001, MECH DEVELOP, V109, P27, DOI 10.1016/S0925-4773(01)00507-X; Nagel G, 2005, CURR BIOL, V15, P2279, DOI 10.1016/j.cub.2005.11.032; O'Halloran DM, 2006, J MOL EVOL, V63, P87, DOI 10.1007/s00239-005-0215-z; Omori K, 2007, CIRC RES, V100, P309, DOI 10.1161/01.RES.0000256354.95791.f1; PALCZEWSKI K, 1994, NEURON, V13, P395, DOI 10.1016/0896-6273(94)90355-7; Ramot D, 2008, NAT NEUROSCI, V11, P908, DOI 10.1038/nn.2157; Roayaie K, 1998, NEURON, V20, P55, DOI 10.1016/S0896-6273(00)80434-1; Rogers C, 2006, CURR BIOL, V16, P649, DOI 10.1016/j.cub.2006.03.023; Sato K, 2008, NATURE, V452, P1002, DOI 10.1038/nature06850; Scott K, 2005, NEURON, V48, P455, DOI 10.1016/j.neuron.2005.10.015; Scott K, 2001, CELL, V104, P661, DOI 10.1016/S0092-8674(02)02052-4; STERN JH, 1986, P NATL ACAD SCI USA, V83, P1163, DOI 10.1073/pnas.83.4.1163; Tanis JE, 2008, GENETICS, V178, P157, DOI 10.1534/genetics.107.079780; Terakita A, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-213; Thorne N, 2008, J COMP NEUROL, V506, P548, DOI 10.1002/cne.21547; Tremblay J, 2002, MOL CELL BIOCHEM, V230, P31, DOI 10.1023/A:1014260204524; TROEMEL ER, 1995, CELL, V83, P207, DOI 10.1016/0092-8674(95)90162-0; Ueno K, 2006, J NEUROSCI, V26, P6143, DOI 10.1523/JNEUROSCI.0857-06.2006; Ueno K, 2008, EUR J NEUROSCI, V28, P1956, DOI 10.1111/j.1460-9568.2008.06507.x; Ward A, 2008, NAT NEUROSCI, V11, P916, DOI 10.1038/nn.2155; Xiong WH, 1998, NAT NEUROSCI, V1, P359, DOI 10.1038/nn0998_359	50	128	148	2	52	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2010	13	6					715	U88		10.1038/nn.2540	http://dx.doi.org/10.1038/nn.2540			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	600QY	20436480	Green Accepted			2022-12-24	WOS:000278003300016
J	Tang, CHA; Hinteregger, E; Shang, YH; Rosbash, M				Tang, Chih-Hang Anthony; Hinteregger, Erica; Shang, Yuhua; Rosbash, Michael			Light-Mediated TIM Degradation within Drosophila Pacemaker Neurons (s-LNvs) Is Neither Necessary nor Sufficient for Delay Zone Phase Shifts	NEURON			English	Article							CIRCADIAN CLOCK; TEMPERATURE ENTRAINMENT; LATERAL NEURONS; COMPOUND EYES; CRYPTOCHROME; TIMELESS; RHYTHMS; SUBSET; PHOTORECEPTOR; ABLATION	Circadian systems are entrained and phase shifted by light. In Drosophila, the model of light-mediated phase shifting begins with photon capture by CRYPTOCHROME (CRY) followed by rapid TIMELESS (TIM) degradation. In this study, we focused on phase delays and assayed TIM degradation within individual brain clock neurons in response to light pulses in the early night. Surprisingly, there was no detectable change in TIM staining intensity within the eight pacemaker s-LNvs. This indicates that TIM degradation within s-LNvs is not necessary for phase delays, and similar assays in other genotypes indicate that it is also not sufficient. In contrast, more dorsal circadian neurons appear light-sensitive in the early night. Because CRY is still necessary within the s-LNvs for phase shifting, the results challenge the canonical cell-autonomous molecular model and raise the question of how the pacemaker neuron transcription-translation clock is reset by light in the early night.	[Tang, Chih-Hang Anthony; Hinteregger, Erica; Shang, Yuhua; Rosbash, Michael] Brandeis Univ, Howard Hughes Med Inst, Natl Ctr Behav Genom, Waltham, MA 02454 USA; [Tang, Chih-Hang Anthony; Hinteregger, Erica; Shang, Yuhua; Rosbash, Michael] Brandeis Univ, Dept Biol, Waltham, MA 02454 USA	Brandeis University; Howard Hughes Medical Institute; Brandeis University	Rosbash, M (corresponding author), Brandeis Univ, Howard Hughes Med Inst, Natl Ctr Behav Genom, Waltham, MA 02454 USA.	rosbash@brandeis.edu		Tang, Chih-hang/0000-0002-5097-5709	NIH [P01 NS44232, P30 NS45713]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS045713, P01NS044232] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Patrick Emery, Charlotte Helfrich-Forster, Francois Rouyer, Amita Sehgal, and Corinna Wulbeck for comments on the manuscript and members of the Rosbash lab for helpful discussions. We also thank Amita Sehgal for providing jetlag mutant strains, Paul Taghert for R6-GAL4 strain, Francois Rouyer for UAS-cryRNAi strain, and Shawn Jennings for generating the anti-TIM antiserum. We especially thank Charlotte Helfrich-Forster for her generous support of the anti-cry antibody. We are grateful to Kristyna Palm Danish for administrative assistance. The work was supported in part by NIH grants P01 NS44232 and P30 NS45713 (to M.R.).	Benito J, 2008, J BIOL RHYTHM, V23, P296, DOI 10.1177/0748730408318588; Blanchardon E, 2001, EUR J NEUROSCI, V13, P871, DOI 10.1046/j.0953-816x.2000.01450.x; Busza A, 2004, SCIENCE, V304, P1503, DOI 10.1126/science.1096973; Ceriani MF, 1999, SCIENCE, V285, P553, DOI 10.1126/science.285.5427.553; EDERY I, 1994, SCIENCE, V263, P237, DOI 10.1126/science.8284676; Emery P, 2000, NEURON, V26, P493, DOI 10.1016/S0896-6273(00)81181-2; Emery P, 1998, CELL, V95, P669, DOI 10.1016/S0092-8674(00)81637-2; Helfrich-Forster C, 2007, J COMP NEUROL, V500, P47, DOI 10.1002/cne.21146; Helfrich-Forster C, 1998, J COMP PHYSIOL A, V182, P435, DOI 10.1007/s003590050192; Helfrich-Forster C, 2001, NEURON, V30, P249, DOI 10.1016/S0896-6273(01)00277-X; Kaushik R, 2007, PLOS BIOL, V5, P1257, DOI 10.1371/journal.pbio.0050146; Koh K, 2006, SCIENCE, V312, P1809, DOI 10.1126/science.1124951; Lee CG, 1996, SCIENCE, V271, P1740, DOI 10.1126/science.271.5256.1740; Lin FJ, 2001, MOL CELL BIOL, V21, P7287, DOI 10.1128/MCB.21.21.7287-7294.2001; Lin Y, 2004, J NEUROSCI, V24, P7951, DOI 10.1523/JNEUROSCI.2370-04.2004; Marrus SB, 1996, EMBO J, V15, P6877, DOI 10.1002/j.1460-2075.1996.tb01080.x; Miyasako Y, 2007, J BIOL RHYTHM, V22, P115, DOI 10.1177/0748730407299344; Murad A, 2007, NEURON, V53, P689, DOI 10.1016/j.neuron.2007.01.034; Myers MP, 1996, SCIENCE, V271, P1736, DOI 10.1126/science.271.5256.1736; Naidoo N, 1999, SCIENCE, V285, P1737, DOI 10.1126/science.285.5434.1737; Nitabach MN, 2008, CURR BIOL, V18, pR84, DOI 10.1016/j.cub.2007.11.061; Nitabach MN, 2002, CELL, V109, P485, DOI 10.1016/S0092-8674(02)00737-7; Park JH, 2000, P NATL ACAD SCI USA, V97, P3608, DOI 10.1073/pnas.070036197; Peng Y, 2003, PLOS BIOL, V1, P32, DOI 10.1371/journal.pbio.0000013; Peschel N, 2009, CURR BIOL, V19, P241, DOI 10.1016/j.cub.2008.12.042; Picot M, 2007, PLOS BIOL, V5, P2513, DOI 10.1371/journal.pbio.0050315; Picot M, 2009, J NEUROSCI, V29, P8312, DOI 10.1523/JNEUROSCI.0279-08.2009; Renn SCP, 1999, CELL, V99, P791, DOI 10.1016/S0092-8674(00)81676-1; Rieger D, 2003, J BIOL RHYTHM, V18, P377, DOI 10.1177/0748730403256997; Sehadova H, 2009, NEURON, V64, P251, DOI 10.1016/j.neuron.2009.08.026; SEHGAL A, 1994, SCIENCE, V263, P1603, DOI 10.1126/science.8128246; Shang YH, 2008, P NATL ACAD SCI USA, V105, P19587, DOI 10.1073/pnas.0809577105; Sidote D, 1998, MOL CELL BIOL, V18, P2004, DOI 10.1128/MCB.18.4.2004; Stanewsky R, 1998, CELL, V95, P681, DOI 10.1016/S0092-8674(00)81638-4; Stoleru D, 2005, NATURE, V438, P238, DOI 10.1038/nature04192; Stoleru D, 2004, NATURE, V431, P862, DOI 10.1038/nature02926; Stoleru D, 2007, CELL, V129, P207, DOI 10.1016/j.cell.2007.02.038; Suri VP, 1998, NEURON, V21, P225, DOI 10.1016/S0896-6273(00)80529-2; Veleri S, 2007, J BIOL RHYTHM, V22, P29, DOI 10.1177/0748730406295754; Yang ZH, 1998, NEURON, V21, P215, DOI 10.1016/S0896-6273(00)80528-0; Yoshii T, 2008, J COMP NEUROL, V508, P952, DOI 10.1002/cne.21702; Yoshii T, 2009, J BIOL RHYTHM, V24, P452, DOI 10.1177/0748730409348551; Yuan Q, 2005, NEURON, V47, P115, DOI 10.1016/j.neuron.2005.05.027; Zeng HK, 1996, NATURE, V380, P129, DOI 10.1038/380129a0	44	45	47	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 13	2010	66	3					378	385		10.1016/j.neuron.2010.04.015	http://dx.doi.org/10.1016/j.neuron.2010.04.015			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	598HE	20471351	Bronze, Green Accepted			2022-12-24	WOS:000277825200007
J	Snider, J; Pillai, A; Stevens, CF				Snider, Joseph; Pillai, Andrea; Stevens, Charles F.			A Universal Property of Axonal and Dendritic Arbors	NEURON			English	Article							CONNECTIVITY; SPECIFICATION; NEURONS	Axonal and dendritic arbors can be characterized statistically by their spatial density function, a function that specifies the probability of finding a branch of a particular arbor at each point in a neural circuit. Based on an analysis of over a thousand arbors from many neuron types in various species, we have discovered an unexpected simplicity in arbor structure: all of the arbors we have examined, both axonal and dendritic, can be described by a Gaussian density function truncated at about two standard deviations. Because all arbors are characterized by density functions with this single functional form, only four parameters are required to specify an arbor's size and shape: the total length of its branches and the standard deviations of the Gaussian in three orthogonal directions. This simplicity in arbor structure can have implications for the developmental wiring of neural circuits.	[Snider, Joseph; Pillai, Andrea; Stevens, Charles F.] Salk Inst Biol Studies, La Jolla, CA 92037 USA	Salk Institute	Stevens, CF (corresponding author), Salk Inst Biol Studies, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	stevens@salk.edu		Snider, Joseph/0000-0002-0176-5107	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		BARRENBLATT GI, 1996, SCALING SELF SIMILAR, V14; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; Binzegger T, 2004, J NEUROSCI, V24, P8441, DOI 10.1523/JNEUROSCI.1400-04.2004; Binzegger T, 2005, CEREB CORTEX, V15, P152, DOI 10.1093/cercor/bhh118; Charron F, 2007, ADV EXP MED BIOL, V621, P116, DOI 10.1007/978-0-387-76715-4_9; Chklovskii DB, 2004, NEURON, V43, P609, DOI 10.1016/j.neuron.2004.08.012; Clandinin TR, 2009, CURR OPIN NEUROBIOL, V19, P174, DOI 10.1016/j.conb.2009.04.011; Cline HT, 2001, CURR OPIN NEUROBIOL, V11, P118, DOI 10.1016/S0959-4388(00)00182-3; De Gennes P.-G., 1979, SCALING CONCEPTS POL; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; Gao FB, 2007, CURR OPIN NEUROBIOL, V17, P525, DOI 10.1016/j.conb.2007.08.004; Hellwig B, 2000, BIOL CYBERN, V82, P111, DOI 10.1007/PL00007964; Hsieh J, 2004, CURR OPIN GENET DEV, V14, P461, DOI 10.1016/j.gde.2004.07.006; Jaynes E.T., 2003, PROBABILITY THEORY L; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Jimbo H. C., 2004, ACTA MATH U COMENIAN, V73, P107; Kalisman N, 2003, BIOL CYBERN, V88, P210, DOI 10.1007/s00422-002-0377-3; KRONE G, 1986, PROC R SOC SER B-BIO, V226, P421, DOI 10.1098/rspb.1986.0002; Lee S, 2007, P NATL ACAD SCI USA, V104, P12931, DOI 10.1073/pnas.0705469104; LILEY DTJ, 1994, NETWORK-COMP NEURAL, V5, P175, DOI 10.1088/0954-898X/5/2/004; Louvi A, 2006, NAT REV NEUROSCI, V7, P93, DOI 10.1038/nrn1847; Lubke J, 2003, CEREB CORTEX, V13, P1051, DOI 10.1093/cercor/13.10.1051; Luo LQ, 2007, NEURON, V56, P284, DOI 10.1016/j.neuron.2007.10.014; Niell CM, 2005, NEURON, V45, P941, DOI 10.1016/j.neuron.2005.01.047; PETERS A, 1993, CEREB CORTEX, V3, P69, DOI 10.1093/cercor/3.1.69; Price DJ, 2006, EUR J NEUROSCI, V23, P910, DOI 10.1111/j.1460-9568.2006.04620.x; Shepherd GMG, 2005, NAT NEUROSCI, V8, P782, DOI 10.1038/nn1447; SHOLL DA, 1953, NATURE, V171, P387, DOI 10.1038/171387a0; Stepanyants A, 2002, NEURON, V34, P275, DOI 10.1016/S0896-6273(02)00652-9; Stevens C.F., 1982, Lectures on Mathematics in the Life Sciences, V15, P1; Stevens Charles F, 2009, J Biol, V8, P14, DOI 10.1186/jbiol119; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; UTTLEY AM, 1955, PROC R SOC SER B-BIO, V144, P229, DOI 10.1098/rspb.1955.0054; Uylings HBM, 2002, NETWORK-COMP NEURAL, V13, P397, DOI 10.1088/0954-898X/13/3/309; WASSLE H, 1991, PHYSIOL REV, V71, P447, DOI 10.1152/physrev.1991.71.2.447; Wen Q, 2009, P NATL ACAD SCI USA, V106, P12536, DOI 10.1073/pnas.0901530106	36	31	31	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 15	2010	66	1					45	56		10.1016/j.neuron.2010.02.013	http://dx.doi.org/10.1016/j.neuron.2010.02.013			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	587TP	20399728	Bronze			2022-12-24	WOS:000277016200008
J	Peters, JH; McDougall, SJ; Fawley, JA; Smith, SM; Andresen, MC				Peters, James H.; McDougall, Stuart J.; Fawley, Jessica A.; Smith, Stephen M.; Andresen, Michael C.			Primary Afferent Activation of Thermosensitive TRPV1 Triggers Asynchronous Glutamate Release at Central Neurons	NEURON			English	Article							NUCLEUS-TRACTUS-SOLITARIUS; RAT AORTIC BARORECEPTORS; TRANSMITTER RELEASE; NEUROTRANSMITTER RELEASE; SYNAPTIC-TRANSMISSION; VISCERAL AFFERENTS; IN-VITRO; HIPPOCAMPAL SYNAPSES; VESICLE FUSION; BRAIN-STEM	TRPV1 receptors feature prominently in nociception of spinal primary afferents but are also expressed in unmyelinated cranial visceral primary afferents linked to homeostatic regulation. Cranial visceral afferents enter the brain at the solitary tract nucleus (NTS) to control the heart, lungs, and other vital organs. Here we identify a role for central TRPV1 in the activity-dependent facilitation of glutamatergic transmission from solitary tract (ST) afferents. Fast, synchronous ST-NTS transmission from capsaicin-sensitive (TRPV1+) and -insensitive (TRPV1-) afferents was similar. However, afferent activation triggered long-lasting asynchronous glutamate release only from TRPV1+ synapses. Asynchronous release was proportional to synchronous EPSC amplitude, activity, and calcium entry. TRPV1 antagonists and low temperature blocked asynchronous release, but not evoked EPSCs. At physiological afferent frequencies, asynchronous release strongly potentiated the duration of postsynaptic spiking. This activity-dependent TPRV1-mediated facilitation is a form of synaptic plasticity that brings a unique central integrative feature to the CNS and autonomic regulation.	[Peters, James H.; McDougall, Stuart J.; Fawley, Jessica A.; Andresen, Michael C.] Oregon Hlth & Sci Univ, Dept Physiol & Pharmacol, Portland, OR 97239 USA; [Smith, Stephen M.] Oregon Hlth & Sci Univ, Div Pulm & Crit Care Med, Portland, OR 97239 USA	Oregon Health & Science University; Oregon Health & Science University	Andresen, MC (corresponding author), Oregon Hlth & Sci Univ, Dept Physiol & Pharmacol, Portland, OR 97239 USA.	andresen.ohsu@gmail.com	McDougall, Stuart/J-8310-2012	Andresen, Michael/0000-0003-0524-1172; Fawley, Jessica/0000-0002-8723-6096; Smith, Stephen/0000-0002-0331-7615; McDougall, Stuart/0000-0002-8778-675X	National Institutes of Health, U.S.A; National Health and Medical Research Council of Australia; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083115, F32HL088894, R01HL041119, R01HL105703] Funding Source: NIH RePORTER	National Institutes of Health, U.S.A(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank Craig Jahr for comments on an early version of the manuscript. J.H.P., J.A.F., S.M.S., and M.C.A. are funded by the National Institutes of Health, U.S.A. S.J.M. is funded by the National Health and Medical Research Council of Australia. The authors declare no competing financial interests.	Andresen MC, 2004, BRAZ J MED BIOL RES, V37, P549, DOI 10.1590/S0100-879X2004000400012; Andresen MC, 2008, AM J PHYSIOL-HEART C, V295, pH2032, DOI 10.1152/ajpheart.00568.2008; Atluri PP, 1998, J NEUROSCI, V18, P8214; Bailey TW, 2006, J NEUROSCI, V26, P6131, DOI 10.1523/JNEUROSCI.5176-05.2006; Best AR, 2009, NEURON, V62, P555, DOI 10.1016/j.neuron.2009.04.018; Chapman ER, 2008, ANNU REV BIOCHEM, V77, P615, DOI 10.1146/annurev.biochem.77.062005.101135; Chen CF, 1999, J NEUROSCI, V19, P6257; COLERIDGE JCG, 1984, REV PHYSIOL BIOCH P, V99, P1, DOI 10.1007/BFb0027715; Cummings DD, 1996, J NEUROSCI, V16, P5312; Doyle MW, 2002, J NEUROSCI, V22, P8222; Doyle MW, 2001, J NEUROPHYSIOL, V85, P2213, DOI 10.1152/jn.2001.85.5.2213; Fan W, 1999, AM J PHYSIOL-REG I, V277, pR748, DOI 10.1152/ajpregu.1999.277.3.R748; Fan W, 1998, AM J PHYSIOL-HEART C, V275, pH632, DOI 10.1152/ajpheart.1998.275.2.H632; FORTIN G, 1993, BRAIN RES, V630, P125, DOI 10.1016/0006-8993(93)90650-C; Gibson HE, 2008, NEURON, V57, P746, DOI 10.1016/j.neuron.2007.12.027; GODA Y, 1994, P NATL ACAD SCI USA, V91, P12942, DOI 10.1073/pnas.91.26.12942; Gunthorpe MJ, 2004, NEUROPHARMACOLOGY, V46, P133, DOI 10.1016/S0028-3908(03)00305-8; Hefft S, 2005, NAT NEUROSCI, V8, P1319, DOI 10.1038/nn1542; Hui EF, 2005, P NATL ACAD SCI USA, V102, P5210, DOI 10.1073/pnas.0500941102; Jin YH, 2004, J NEUROSCI, V24, P4709, DOI 10.1523/JNEUROSCI.0753-04.2004; Julius D, 2001, NATURE, V413, P203, DOI 10.1038/35093019; Kauer JA, 2009, TRENDS NEUROSCI, V32, P215, DOI 10.1016/j.tins.2008.12.006; Kerr AM, 2008, P NATL ACAD SCI USA, V105, P15581, DOI 10.1073/pnas.0800621105; Kline DD, 2009, J NEUROPHYSIOL, V101, P2270, DOI 10.1152/jn.91304.2008; Kline DD, 2005, J NEUROSCI, V25, P3389, DOI 10.1523/JNEUROSCI.4556-04.2005; Lawson SN, 2002, EXP PHYSIOL, V87, P239, DOI 10.1113/eph8702350; Li BY, 2007, NEUROSCI LETT, V421, P62, DOI 10.1016/j.neulet.2007.05.036; Loewy AD., 1990, CENTRAL REGULATION A, P88; Lou XL, 2005, NATURE, V435, P497, DOI 10.1038/nature03568; Lu T, 2000, NEURON, V26, P683, DOI 10.1016/S0896-6273(00)81204-0; Lumpkin EA, 2007, NATURE, V445, P858, DOI 10.1038/nature05662; Matthews G, 1996, ANNU REV NEUROSCI, V19, P219; McDougall SJ, 2009, J NEUROSCI, V29, P12886, DOI 10.1523/JNEUROSCI.3491-09.2009; Meinrenken CJ, 2002, J NEUROSCI, V22, P1648, DOI 10.1523/JNEUROSCI.22-05-01648.2002; MENDELOWITZ D, 1995, J NEUROPHYSIOL, V73, P872, DOI 10.1152/jn.1995.73.2.872; Neher E, 2008, NEURON, V59, P861, DOI 10.1016/j.neuron.2008.08.019; Otsu Y, 2004, J NEUROSCI, V24, P420, DOI 10.1523/JNEUROSCI.4452-03.2004; Patapoutian A, 2009, NAT REV DRUG DISCOV, V8, P55, DOI 10.1038/nrd2757; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Peters JH, 2008, J NEUROSCI, V28, P11731, DOI 10.1523/JNEUROSCI.3419-08.2008; Saper CB, 2002, ANNU REV NEUROSCI, V25, P433, DOI 10.1146/annurev.neuro.25.032502.111311; Sara Y, 2005, NEURON, V45, P563, DOI 10.1016/j.neuron.2004.12.056; Sharma G, 2003, NEURON, V38, P929, DOI 10.1016/S0896-6273(03)00322-2; Silver RA, 1998, J PHYSIOL-LONDON, V510, P881, DOI 10.1111/j.1469-7793.1998.881bj.x; Smith BN, 1998, J PHYSIOL-LONDON, V512, P149, DOI 10.1111/j.1469-7793.1998.149bf.x; Smith SM, 2008, TRENDS NEUROSCI, V31, P559, DOI 10.1016/j.tins.2008.08.005; Sudhof TC, 2002, J BIOL CHEM, V277, P7629, DOI 10.1074/jbc.R100052200; Sun J, 2007, NATURE, V450, P676, DOI 10.1038/nature06308; Swanson DM, 2005, J MED CHEM, V48, P1857, DOI 10.1021/jm0495071; Wolfel M, 2007, J NEUROSCI, V27, P3198, DOI 10.1523/JNEUROSCI.4471-06.2007; Yao J, 2009, BIOPHYS J, V96, P3611, DOI 10.1016/j.bpj.2009.02.016	51	137	138	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 11	2010	65	5					657	669		10.1016/j.neuron.2010.02.017	http://dx.doi.org/10.1016/j.neuron.2010.02.017			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	571NF	20223201	Green Accepted, Bronze			2022-12-24	WOS:000275758000009
J	Harlow, EG; Till, SM; Russell, TA; Wijetunge, LS; Kind, P; Contractor, A				Harlow, Emily G.; Till, Sally M.; Russell, Theron A.; Wijetunge, Lasani S.; Kind, Peter; Contractor, Anis			Critical Period Plasticity Is Disrupted in the Barrel Cortex of Fmr1 Knockout Mice	NEURON			English	Article							X MENTAL-RETARDATION; MOUSE SOMATOSENSORY CORTEX; LONG-TERM POTENTIATION; ACTIVITY-DEPENDENT REGULATION; THALAMOCORTICAL SYNAPSES; SILENT SYNAPSES; SYNAPTIC PLASTICITY; LAYER-IV; CEREBRAL-CORTEX; MESSENGER-RNA	Alterations in sensory processing constitute prominent symptoms of fragile X syndrome; however, little is known about how disrupted synaptic and circuit development in sensory cortex contributes to these deficits. To investigate how the loss of fragile X mental retardation protein (FMRP) impacts the development of cortical synapses, we examined excitatory thalamocortical synapses in somatosensory cortex during the perinatal critical period in Fmr1 knockout mice. FMRP ablation resulted in dysregulation of glutamatergic signaling maturation. The fraction of silent synapses persisting to later developmental times was increased; there was a temporal delay in the window for synaptic plasticity, while other forms of developmental plasticity were not altered in Fmr1 knockout mice. Our results indicate that FMRP is required for the normal developmental progression of synaptic maturation, and loss of this important RNA binding protein impacts the timing of the critical period for layer IV synaptic plasticity.	[Harlow, Emily G.; Russell, Theron A.; Contractor, Anis] Northwestern Univ, Feinberg Sch Med, Dept Physiol, Chicago, IL 60611 USA; [Till, Sally M.; Wijetunge, Lasani S.; Kind, Peter] Univ Edinburgh, Ctr Integrat Physiol, Edinburgh EH8 9XD, Midlothian, Scotland	Northwestern University; Feinberg School of Medicine; University of Edinburgh	Contractor, A (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Physiol, 303 E Chicago Ave, Chicago, IL 60611 USA.	a-contractor@northwestern.edu		Kind, Peter/0000-0002-4256-9639; Contractor, Anis/0000-0002-5131-2536	FRAXA Research Foundation; Autism Speaks; Brain Research Foundation; MRC (UK); NIH/NIMH [T32MH067564]; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH067564] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS058894] Funding Source: NIH RePORTER; Medical Research Council [G0700967, G0601584] Funding Source: researchfish; MRC [G0601584, G0700967] Funding Source: UKRI	FRAXA Research Foundation; Autism Speaks; Brain Research Foundation; MRC (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIH/NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank Geoffrey Swanson and Gordon Shepherd for comments on the manuscript. WE would like to thank Thomas Gillingwater for help with electron microscopy. The FMRP antibody (rAM1) was kindly made available by Claudia Bagni. This work was supported by grants from the FRAXA Research Foundation, Autism Speaks, and the Brain Research Foundation to A.C., and from FRAXA and the MRC (UK) to P.K. E.G.H. was funded by the Training Program in Neurobiology of Information Storage NIH/NIMH T32MH067564.	Abdel-Majid RM, 1998, NAT GENET, V19, P289, DOI 10.1038/980; AGMON A, 1991, NEUROSCIENCE, V41, P365, DOI 10.1016/0306-4522(91)90333-J; Antar LN, 2006, MOL CELL NEUROSCI, V32, P37, DOI 10.1016/j.mcn.2006.02.001; BAKKER CE, 1994, CELL, V78, P23; Bannister NJ, 2005, J NEUROSCI, V25, P5259, DOI 10.1523/JNEUROSCI.0827-05.2005; Baranek Grace T, 2008, Phys Occup Ther Pediatr, V28, P79; Barnett MW, 2006, J NEUROSCI, V26, P1355, DOI 10.1523/JNEUROSCI.3164-05.2006; Barth AL, 2001, NAT NEUROSCI, V4, P235, DOI 10.1038/85070; Bear MF, 2005, GENES BRAIN BEHAV, V4, P393, DOI 10.1111/j.1601-183X.2005.00135.x; Bear MF, 2004, TRENDS NEUROSCI, V27, P370, DOI 10.1016/j.tins.2004.04.009; Bureau I, 2008, J NEUROSCI, V28, P5178, DOI 10.1523/JNEUROSCI.1076-08.2008; Castren M, 2002, NEUROBIOL DIS, V11, P221, DOI 10.1006/nbdi.2002.0544; Chen L, 2001, NEUROSCIENCE, V103, P1043, DOI 10.1016/S0306-4522(01)00036-7; CRAIR MC, 1995, NATURE, V375, P325, DOI 10.1038/375325a0; Datwani A, 2002, J NEUROSCI, V22, P9171; Daw MI, 2006, J NEUROSCI, V26, P4178, DOI 10.1523/JNEUROSCI.0150-06.2006; Daw MI, 2007, MOL CELL NEUROSCI, V34, P493, DOI 10.1016/j.mcn.2007.01.001; Desai NS, 2006, J NEUROPHYSIOL, V96, P1734, DOI 10.1152/jn.00221.2006; Dolen G, 2007, NEURON, V56, P955, DOI 10.1016/j.neuron.2007.12.001; Feldman DE, 2005, SCIENCE, V310, P810, DOI 10.1126/science.1115807; Feldman DE, 1998, NEURON, V21, P347, DOI 10.1016/S0896-6273(00)80544-9; Fox K, 1996, P NATL ACAD SCI USA, V93, P5584, DOI 10.1073/pnas.93.11.5584; Frankland PW, 2004, MOL PSYCHIATR, V9, P417, DOI 10.1038/sj.mp.4001432; Galvez R, 2005, AM J MED GENET A, V135A, P155, DOI 10.1002/ajmg.a.30709; Galvez R, 2003, BRAIN RES, V971, P83, DOI 10.1016/S0006-8993(03)02363-1; Garber KB, 2008, EUR J HUM GENET, V16, P666, DOI 10.1038/ejhg.2008.61; Godfraind JM, 1996, AM J MED GENET, V64, P246; Hannan AJ, 2001, NAT NEUROSCI, V4, P282, DOI 10.1038/85132; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Hensch TK, 2004, ANNU REV NEUROSCI, V27, P549, DOI 10.1146/annurev.neuro.27.070203.144327; Isaac JTR, 1997, NEURON, V18, P269, DOI 10.1016/S0896-6273(00)80267-6; Itami C, 2000, BRAIN RES, V857, P141, DOI 10.1016/S0006-8993(99)02352-5; Iwasato T, 2000, NATURE, V406, P726, DOI 10.1038/35021059; Iwasato T, 2008, J NEUROSCI, V28, P5931, DOI 10.1523/JNEUROSCI.0815-08.2008; Kau ASM, 2002, MICROSC RES TECHNIQ, V57, P174, DOI 10.1002/jemt.10069; Kidd FL, 1999, NATURE, V400, P569, DOI 10.1038/23040; LAND PW, 1985, J COMP NEUROL, V238, P225, DOI 10.1002/cne.902380209; Larson J, 2005, J NEUROSCI, V25, P9460, DOI 10.1523/JNEUROSCI.2638-05.2005; Lauterborn JC, 2007, J NEUROSCI, V27, P10685, DOI 10.1523/JNEUROSCI.2624-07.2007; Li JX, 2002, MOL CELL NEUROSCI, V19, P138, DOI 10.1006/mcne.2001.1085; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; Lu HC, 2003, NAT NEUROSCI, V6, P939, DOI 10.1038/nn1106; Lu HC, 2001, NEURON, V32, P619, DOI 10.1016/S0896-6273(01)00501-3; Lu R, 2004, P NATL ACAD SCI USA, V101, P15201, DOI 10.1073/pnas.0404995101; Lush ME, 2005, INT J DEV NEUROSCI, V23, P523, DOI 10.1016/j.ijdevneu.2005.04.003; Marie H, 2005, NEURON, V45, P741, DOI 10.1016/j.neuron.2005.01.039; Meredith RM, 2007, NEURON, V54, P627, DOI 10.1016/j.neuron.2007.04.028; Nimchinsky EA, 2001, J NEUROSCI, V21, P5139, DOI 10.1523/JNEUROSCI.21-14-05139.2001; Nosyreva ED, 2006, J NEUROPHYSIOL, V95, P3291, DOI 10.1152/jn.01316.2005; Penagarikano O, 2007, ANNU REV GENOM HUM G, V8, P109, DOI 10.1146/annurev.genom.8.080706.092249; Petersen CCH, 2007, NEURON, V56, P339, DOI 10.1016/j.neuron.2007.09.017; Restivo L, 2005, P NATL ACAD SCI USA, V102, P11557, DOI 10.1073/pnas.0504984102; SCHLAGGAR BL, 1993, NATURE, V364, P623, DOI 10.1038/364623a0; Schutt J, 2009, J BIOL CHEM, V284, P25479, DOI 10.1074/jbc.M109.042663; She WC, 2009, EUR J NEUROSCI, V29, P1379, DOI 10.1111/j.1460-9568.2009.06696.x; Takasaki C, 2008, J NEUROSCI, V28, P4995, DOI 10.1523/JNEUROSCI.0861-08.2008; Todd PK, 2003, MOL BRAIN RES, V110, P267, DOI 10.1016/S0169-328X(02)00657-5; Todd PK, 2000, MOL BRAIN RES, V80, P17, DOI 10.1016/S0169-328X(00)00098-X; VANDERLO.H, 1973, SCIENCE, V179, P395, DOI 10.1126/science.179.4071.395; Villasana LE, 2006, J NEUROSCI METH, V158, P30, DOI 10.1016/j.jneumeth.2006.05.008; Watson RF, 2006, J NEUROSCI, V26, P5393, DOI 10.1523/JNEUROSCI.0750-06.2006; WELKER C, 1974, J COMP NEUROL, V158, P437, DOI 10.1002/cne.901580405; Wijetunge LS, 2008, J NEUROSCI, V28, P13028, DOI 10.1523/JNEUROSCI.2600-08.2008; Wilson BM, 2007, P NATL ACAD SCI USA, V104, P2454, DOI 10.1073/pnas.0610875104; WONGRILEY M, 1979, BRAIN RES, V171, P11, DOI 10.1016/0006-8993(79)90728-5; WOOLSEY TA, 1970, BRAIN RES, V17, P205, DOI 10.1016/0006-8993(70)90079-X; Yanagisawa T, 2004, EUR J NEUROSCI, V20, P3006, DOI 10.1111/j.1460-9568.2004.03756.x; Yun SW, 2006, BRAIN RES, V1110, P159, DOI 10.1016/j.brainres.2006.06.086; Zalfa F, 2007, NAT NEUROSCI, V10, P578, DOI 10.1038/nn1893; Zhao MG, 2005, J NEUROSCI, V25, P7385, DOI 10.1523/JNEUROSCI.1520-05.2005	70	176	177	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 11	2010	65	3					385	398		10.1016/j.neuron.2010.01.024	http://dx.doi.org/10.1016/j.neuron.2010.01.024			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	564BF	20159451	Bronze, Green Accepted			2022-12-24	WOS:000275185200011
J	Haider, B; Krause, MR; Duque, A; Yu, YG; Touryan, J; Mazer, JA; McCormick, DA				Haider, Bilal; Krause, Matthew R.; Duque, Alvaro; Yu, Yuguo; Touryan, Jonathan; Mazer, James A.; McCormick, David A.			Synaptic and Network Mechanisms of Sparse and Reliable Visual Cortical Activity during Nonclassical Receptive Field Stimulation	NEURON			English	Article							CAT STRIATE CORTEX; MACAQUE V1 NEURONS; SURROUND SUPPRESSION; FEEDFORWARD INHIBITION; RESPONSE VARIABILITY; ALERT MONKEYS; IN-VIVO; SOMATOSENSORY CORTEX; CONTRAST INVARIANCE; BALANCED INHIBITION	During natural vision, the entire visual field is stimulated by images rich in spatiotemporal structure. Although many visual system studies restrict stimuli to the classical receptive field (CRIF), it is known that costimulation of the CRF and the surrounding nonclassical receptive field (nCRF) increases neuronal response sparseness. The cellular and network mechanisms underlying increased response sparseness remain largely unexplored. Here we show that combined CRF + nCRF stimulation increases the sparseness, reliability, and precision of spiking and membrane potential responses in classical regular spiking (RSC) pyramidal neurons of cat primary visual cortex. Conversely, fast-spiking interneurons exhibit increased activity and decreased selectivity during CRF + nCRF stimulation. The increased sparseness and reliability of RSC neuron spiking is associated with increased inhibitory barrages and narrower visually evoked synaptic potentials. Our experimental observations were replicated with a simple computational model, suggesting that network interactions among neuronal subtypes ultimately sharpen recurrent excitation, producing specific and reliable visual responses.	[Haider, Bilal; Krause, Matthew R.; Duque, Alvaro; Yu, Yuguo; Touryan, Jonathan; Mazer, James A.; McCormick, David A.] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06510 USA; [McCormick, David A.] Yale Univ, Sch Med, Kavli Inst Neurosci, New Haven, CT 06510 USA	Yale University; Yale University	McCormick, DA (corresponding author), Yale Univ, Sch Med, Dept Neurobiol, 333 Cedar St, New Haven, CT 06510 USA.	david.mccormick@yale.edu	Touryan, Jonathan/AAA-7108-2019; Kobelt, Liza/F-5926-2011; Krause, Matthew/AAA-1346-2021; Mazer, James/R-9886-2019	Touryan, Jonathan/0000-0001-7343-7869; Krause, Matthew/0000-0002-1837-687X; Haider, Bilal/0000-0002-6382-1426; Yu, Yuguo/0000-0003-0603-2890	NATIONAL EYE INSTITUTE [R01EY012388] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS026143] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY012388, R01 EY012388-10, R01 EY012388-11, R01 EY012388-09] Funding Source: Medline; NINDS NIH HHS [R37 NS026143] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Anderson JS, 2001, J NEUROSCI, V21, P2104, DOI 10.1523/JNEUROSCI.21-06-02104.2001; Anderson JS, 2000, SCIENCE, V290, P1968, DOI 10.1126/science.290.5498.1968; Angelucci A, 2006, PROG BRAIN RES, V154, P93, DOI 10.1016/S0079-6123(06)54005-1; Azouz R, 2003, NEURON, V37, P513, DOI 10.1016/S0896-6273(02)01186-8; Azouz R, 1997, CEREB CORTEX, V7, P534, DOI 10.1093/cercor/7.6.534; Bair W, 2003, J NEUROSCI, V23, P7690; Barlow H B, 1972, Perception, V1, P371, DOI 10.1068/p010371; Bruno RM, 2006, SCIENCE, V312, P1622, DOI 10.1126/science.1124593; Bruno RM, 2002, J NEUROSCI, V22, P10966; Carandini M, 2005, J NEUROSCI, V25, P10577, DOI 10.1523/JNEUROSCI.3726-05.2005; Carandini M, 2007, NEURON, V54, P11, DOI 10.1016/j.neuron.2007.03.019; Cavanaugh JR, 2002, J NEUROPHYSIOL, V88, P2547, DOI 10.1152/jn.00693.2001; Cavanaugh JR, 2002, J NEUROPHYSIOL, V88, P2530, DOI 10.1152/jn.00692.2001; Chen G, 2005, J PHYSIOL-LONDON, V564, P233, DOI 10.1113/jphysiol.2004.080051; Chen Y, 2008, NAT NEUROSCI, V11, P974, DOI 10.1038/nn.2147; Contreras D, 2003, J NEUROSCI, V23, P6936; David SV, 2005, NETWORK-COMP NEURAL, V16, P239, DOI 10.1080/09548980500464030; de la Rocha J, 2007, NATURE, V448, P802, DOI 10.1038/nature06028; DEANGELIS GC, 1993, J NEUROPHYSIOL, V69, P1091, DOI 10.1152/jn.1993.69.4.1091; DEANGELIS GC, 1994, J NEUROPHYSIOL, V71, P347, DOI 10.1152/jn.1994.71.1.347; Desbordes G, 2008, PLOS BIOL, V6, P2672, DOI 10.1371/journal.pbio.0060324; DeWeese MR, 2006, J NEUROSCI, V26, P12206, DOI 10.1523/JNEUROSCI.2813-06.2006; Durand S, 2007, VISUAL NEUROSCI, V24, P679, DOI 10.1017/S0952523807070563; El Boustani S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000519; Felsen G, 2005, PLOS BIOL, V3, P1819, DOI 10.1371/journal.pbio.0030342; Fitzpatrick D, 2000, CURR OPIN NEUROBIOL, V10, P438, DOI 10.1016/S0959-4388(00)00113-6; Gabernet L, 2005, NEURON, V48, P315, DOI 10.1016/j.neuron.2005.09.022; Gilbert CD, 1996, P NATL ACAD SCI USA, V93, P615, DOI 10.1073/pnas.93.2.615; Greenberg DS, 2008, NAT NEUROSCI, V11, P749, DOI 10.1038/nn.2140; Gur M, 1997, J NEUROSCI, V17, P2914; Hahnloser RHR, 2002, NATURE, V419, P65, DOI 10.1038/nature00974; Haider B, 2006, J NEUROSCI, V26, P4535, DOI 10.1523/JNEUROSCI.5297-05.2006; Haider B, 2009, NEURON, V62, P171, DOI 10.1016/j.neuron.2009.04.008; Hasenstaub A, 2005, NEURON, V47, P423, DOI 10.1016/j.neuron.2005.06.016; HEGGELUND P, 1978, EXP BRAIN RES, V32, P197; Higley MJ, 2006, J NEUROSCI, V26, P448, DOI 10.1523/JNEUROSCI.3506-05.2006; Houweling AR, 2008, NATURE, V451, P65, DOI 10.1038/nature06447; Hromadka T, 2008, PLOS BIOL, V6, P124, DOI 10.1371/journal.pbio.0060016; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Ito M, 1999, NEURON, V22, P593, DOI 10.1016/S0896-6273(00)80713-8; Jacob V, 2008, NEURON, V60, P1112, DOI 10.1016/j.neuron.2008.10.017; Jonas P, 2004, TRENDS NEUROSCI, V27, P30, DOI 10.1016/j.tins.2003.10.010; Jones HE, 2001, J NEUROPHYSIOL, V86, P2011, DOI 10.1152/jn.2001.86.4.2011; JONES JP, 1987, J NEUROPHYSIOL, V58, P1187, DOI 10.1152/jn.1987.58.6.1187; KAPADIA MK, 1995, NEURON, V15, P843, DOI 10.1016/0896-6273(95)90175-2; Kapfer C, 2007, NAT NEUROSCI, V10, P743, DOI 10.1038/nn1909; Kara P, 2000, NEURON, V27, P635, DOI 10.1016/S0896-6273(00)00072-6; KISVARDAY ZF, 1993, EUR J NEUROSCI, V5, P1558, DOI 10.1111/j.1460-9568.1993.tb00226.x; Lehky SR, 2005, VISION RES, V45, P57, DOI 10.1016/j.visres.2004.07.021; Litvak V, 2003, J NEUROSCI, V23, P3006; Liu BH, 2009, J NEUROSCI, V29, P10520, DOI 10.1523/JNEUROSCI.1915-09.2009; Maimon G, 2009, NEURON, V62, P426, DOI 10.1016/j.neuron.2009.03.021; MARTIN KAC, 1984, J PHYSIOL-LONDON, V353, P463, DOI 10.1113/jphysiol.1984.sp015347; Mazer JA, 2003, NEURON, V40, P1241, DOI 10.1016/S0896-6273(03)00764-5; Mazer JA, 2002, P NATL ACAD SCI USA, V99, P1645, DOI 10.1073/pnas.022638499; MCGUIRE BA, 1991, J COMP NEUROL, V305, P370, DOI 10.1002/cne.903050303; Miller KD, 2002, J NEUROPHYSIOL, V87, P653, DOI 10.1152/jn.00425.2001; Mitchell JF, 2007, NEURON, V55, P131, DOI 10.1016/j.neuron.2007.06.018; Monier C, 2003, NEURON, V37, P663, DOI 10.1016/S0896-6273(03)00064-3; MOVSHON JA, 1978, J PHYSIOL-LONDON, V283, P53, DOI 10.1113/jphysiol.1978.sp012488; Niven JE, 2008, J EXP BIOL, V211, P1792, DOI 10.1242/jeb.017574; Nowak LG, 2003, J NEUROPHYSIOL, V89, P1541, DOI 10.1152/jn.00580.2002; Nowak LG, 1997, CEREB CORTEX, V7, P487, DOI 10.1093/cercor/7.6.487; Okamoto M, 2009, EUR J NEUROSCI, V29, P1035, DOI 10.1111/j.1460-9568.2009.06645.x; Okun M, 2008, NAT NEUROSCI, V11, P535, DOI 10.1038/nn.2105; Olshausen BA, 2004, CURR OPIN NEUROBIOL, V14, P481, DOI 10.1016/j.conb.2004.07.007; Olshausen BA, 1996, NETWORK-COMP NEURAL, V7, P333, DOI 10.1088/0954-898X/7/2/014; Ozeki H, 2009, NEURON, V62, P578, DOI 10.1016/j.neuron.2009.03.028; Pospischil M, 2007, J NEUROPHYSIOL, V97, P2544, DOI 10.1152/jn.01000.2006; Pouille F, 2001, SCIENCE, V293, P1159, DOI 10.1126/science.1060342; Rodriguez-Molina VM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000319; ROLLS ET, 1995, J NEUROPHYSIOL, V73, P713, DOI 10.1152/jn.1995.73.2.713; Shadlen MN, 1998, J NEUROSCI, V18, P3870; Silberberg G, 2007, NEURON, V53, P735, DOI 10.1016/j.neuron.2007.02.012; Simoncelli EP, 2003, CURR OPIN NEUROBIOL, V13, P144, DOI 10.1016/S0959-4388(03)00047-3; Stein RB, 2005, NAT REV NEUROSCI, V6, P389, DOI 10.1038/nrn1668; Swadlow HA, 2003, CEREB CORTEX, V13, P25, DOI 10.1093/cercor/13.1.25; Theunissen FE, 2001, NETWORK-COMP NEURAL, V12, P289, DOI 10.1088/0954-898X/12/3/304; Tiesinga P, 2008, NAT REV NEUROSCI, V9, P97, DOI 10.1038/nrn2315; Tolhurst DJ, 2009, J NEUROSCI, V29, P2355, DOI 10.1523/JNEUROSCI.3869-08.2009; Vinje WE, 2002, J NEUROSCI, V22, P2904, DOI 10.1523/JNEUROSCI.22-07-02904.2002; Vinje WE, 2000, SCIENCE, V287, P1273, DOI 10.1126/science.287.5456.1273; Wang ST, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.018103; Wang XJ, 2003, J NEUROPHYSIOL, V89, P3279, DOI 10.1152/jn.00242.2003; Waters J, 2006, J NEUROSCI, V26, P8267, DOI 10.1523/JNEUROSCI.2152-06.2006; Webb BS, 2005, J NEUROSCI, V25, P11666, DOI 10.1523/JNEUROSCI.3414-05.2005; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116; Willmore B, 2001, NETWORK-COMP NEURAL, V12, P255, DOI 10.1088/0954-898X/12/3/302; Wu GK, 2008, NEURON, V58, P132, DOI 10.1016/j.neuron.2008.01.035; Yao HS, 2007, NAT NEUROSCI, V10, P772, DOI 10.1038/nn1895; Yen SC, 2007, J NEUROPHYSIOL, V97, P1326, DOI 10.1152/jn.00747.2006; Yoshimura Y, 2005, NAT NEUROSCI, V8, P1552, DOI 10.1038/nn1565	92	181	183	0	22	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 14	2010	65	1					107	121		10.1016/j.neuron.2009.12.005	http://dx.doi.org/10.1016/j.neuron.2009.12.005			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	546DZ	20152117	Bronze, Green Accepted			2022-12-24	WOS:000273791200012
J	Kalashnikova, E; Lorca, RA; Kaur, I; Barisone, GA; Li, BN; Ishimaru, T; Trimmer, JS; Mohapatra, DP; Diaz, E				Kalashnikova, Evgenia; Lorca, Ramon A.; Kaur, Inderpreet; Barisone, Gustavo A.; Li, Bonnie; Ishimaru, Tatsuto; Trimmer, James S.; Mohapatra, Durga P.; Diaz, Elva			SynDIG1: An Activity-Regulated, AMPA-Receptor-Interacting Transmembrane Protein that Regulates Excitatory Synapse Development	NEURON			English	Article							DENDRITIC SPINES; HOMEOSTATIC PLASTICITY; GLUTAMATE RECEPTORS; HIPPOCAMPAL-NEURONS; AUXILIARY SUBUNITS; SILENT SYNAPSES; TRAFFICKING; EXPRESSION; SYNAPTOGENESIS; MECHANISMS	During development of the central nervous system, precise synaptic connections between presynaptic and postsynaptic neurons are formed. While significant progress has been made in our understanding of AMPA receptor trafficking during synaptic plasticity, less is known about the molecules that recruit AMPA receptors to nascent synapses during synaptogenesis. Here we identify a type 11 transmembrane protein (SynDIG1) that regulates AMPA receptor content at developing synapses in dissociated rat hippocampal neurons. SynDIG1 colocalizes with AMPA receptors at synapses and at extrasynaptic sites and associates with AMPA receptors in heterologous cells and brain. Altered levels of SynDIG1 in cultured neurons result in striking changes in excitatory synapse number and function. SynDIG1-mediated synapse development is dependent on association with AMPA receptors via its extracellular C terminus. Intriguingly, SynDIG1 content in dendritic spines is regulated by neuronal activity. Altogether, we define SynDIG1 as an activity-regulated transmembrane protein that regulates excitatory synapse development.	[Kalashnikova, Evgenia; Kaur, Inderpreet; Barisone, Gustavo A.; Li, Bonnie; Ishimaru, Tatsuto; Trimmer, James S.; Mohapatra, Durga P.; Diaz, Elva] Univ Calif Davis, Sch Med, Dept Pharmacol, Davis, CA 95616 USA; [Lorca, Ramon A.; Mohapatra, Durga P.] Univ Iowa, Carver Coll Med, Dept Pharmacol, Iowa City, IA 52242 USA	University of California System; University of California Davis; University of Iowa	Diaz, E (corresponding author), Univ Calif Davis, Sch Med, Dept Pharmacol, Davis, CA 95616 USA.	ediaz@ucdavis.edu	Mohapatra, Durga/M-2133-2017	Mohapatra, Durga/0000-0001-5016-1281; Lorca, Ramon/0000-0001-9159-1739	Alfred P. Sloan Research Foundation; Whitehall Foundation; National Science Foundation [0542281, 0842724]; NIH-NINDS [NS42225]; University of Iowa Office of the Vice President of Research; National Center for Research Resources, NIH [C06 RR-12088-01]; Direct For Biological Sciences [0842724] Funding Source: National Science Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR012088] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042225] Funding Source: NIH RePORTER	Alfred P. Sloan Research Foundation(Alfred P. Sloan Foundation); Whitehall Foundation; National Science Foundation(National Science Foundation (NSF)); NIH-NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); University of Iowa Office of the Vice President of Research; National Center for Research Resources, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants to E.D. from the Alfred P. Sloan Research Foundation, the Whitehall Foundation, and the National Science Foundation (0542281; 0842724); to J.S.T from the NIH-NINDS (NS42225); and to D.P.M. from start-up funds from the University of Iowa Office of the Vice President of Research. Confocal image acquisition was conducted in a facility supported by Research Facilities Improvement Program Grant Number C06 RR-12088-01 from the National Center for Research Resources, NIH.	Alvarez VA, 2006, J NEUROSCI, V26, P7820, DOI 10.1523/JNEUROSCI.1957-06.2006; ARAKI K, 1993, BIOCHEM BIOPH RES CO, V197, P1267, DOI 10.1006/bbrc.1993.2614; Barry MF, 2002, CURR OPIN NEUROBIOL, V12, P279, DOI 10.1016/S0959-4388(02)00329-X; Bats C, 2007, NEURON, V53, P719, DOI 10.1016/j.neuron.2007.01.030; BekeleArcuri Z, 1996, NEUROPHARMACOLOGY, V35, P851, DOI 10.1016/0028-3908(96)00128-1; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; Chen P, 2006, ANTI-CANCER DRUG, V17, P53, DOI 10.1097/01.cad.0000185182.80227.48; Collingridge GL, 2009, NEUROPHARMACOLOGY, V56, P2, DOI 10.1016/j.neuropharm.2008.06.063; Dalva MB, 2007, NAT REV NEUROSCI, V8, P206, DOI 10.1038/nrn2075; de Chaldee M, 2006, GENOMICS, V87, P200, DOI 10.1016/j.ygeno.2005.10.009; Diaz E, 2002, NEURON, V36, P417, DOI 10.1016/S0896-6273(02)01016-4; DUMESNILBOUSEZ N, 1992, J NEUROCYTOL, V21, P506, DOI 10.1007/BF01186954; Ehrlich I, 2004, J NEUROSCI, V24, P916, DOI 10.1523/JNEUROSCI.4733-03.2004; Elias GM, 2006, NEURON, V52, P307, DOI 10.1016/j.neuron.2006.09.012; Goslin K., 1998, CULTURING NERVE CELL, P339; Jordan BA, 2004, MOL CELL PROTEOMICS, V3, P857, DOI 10.1074/mcp.M400045-MCP200; Kayser MS, 2006, J NEUROSCI, V26, P12152, DOI 10.1523/JNEUROSCI.3072-06.2006; Ko JW, 2006, NEURON, V50, P233, DOI 10.1016/j.neuron.2006.04.005; Liao DH, 1999, NAT NEUROSCI, V2, P37, DOI 10.1038/4540; Lissin DV, 1998, P NATL ACAD SCI USA, V95, P7097, DOI 10.1073/pnas.95.12.7097; Makino H, 2009, NEURON, V64, P381, DOI 10.1016/j.neuron.2009.08.035; Malenka RC, 2003, ANN NY ACAD SCI, V1003, P1, DOI 10.1196/annals.1300.001; McAllister AM, 2007, ANNU REV NEUROSCI, V30, P425, DOI 10.1146/annurev.neuro.29.051605.112830; Mi RF, 2002, J NEUROSCI, V22, P7606; Nicoll RA, 2006, SCIENCE, V311, P1253, DOI 10.1126/science.1123339; O'Brien R, 2002, J NEUROSCI, V22, P4487, DOI 10.1523/JNEUROSCI.22-11-04487.2002; O'Brien RJ, 1998, NEURON, V21, P1067, DOI 10.1016/S0896-6273(00)80624-8; Petralia RS, 1999, NAT NEUROSCI, V2, P31, DOI 10.1038/4532; Petrini EM, 2009, NEURON, V63, P92, DOI 10.1016/j.neuron.2009.05.025; Scheiffele P, 2003, ANNU REV NEUROSCI, V26, P485, DOI 10.1146/annurev.neuro.26.043002.094940; Schwenk J, 2009, SCIENCE, V323, P1313, DOI 10.1126/science.1167852; Sharma K, 2006, MOL CELL NEUROSCI, V31, P702, DOI 10.1016/j.mcn.2006.01.010; Sheng M, 2003, NEUROSCI RES, V46, P127, DOI 10.1016/S0168-0102(03)00040-3; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; ULMER JB, 1991, EUR J CELL BIOL, V54, P38; Waites CL, 2005, ANNU REV NEUROSCI, V28, P251, DOI 10.1146/annurev.neuro.27.070203.144336; Wierenga CJ, 2005, J NEUROSCI, V25, P2895, DOI 10.1523/JNEUROSCI.5217-04.2005; Wyszynski M, 2002, NEURON, V34, P39, DOI 10.1016/S0896-6273(02)00640-2; Zuo J, 1997, NATURE, V388, P769, DOI 10.1038/42009	40	102	111	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 14	2010	65	1					80	93		10.1016/j.neuron.2009.12.021	http://dx.doi.org/10.1016/j.neuron.2009.12.021			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	546DZ	20152115	Green Accepted, Bronze			2022-12-24	WOS:000273791200010
J	Restani, L; Cerri, C; Pietrasanta, M; Gianfranceschi, L; Maffei, L; Caleo, M				Restani, Laura; Cerri, Chiara; Pietrasanta, Marta; Gianfranceschi, Laura; Maffei, Lamberto; Caleo, Matteo			Functional Masking of Deprived Eye Responses by Callosal Input during Ocular Dominance Plasticity	NEURON			English	Article							MOUSE VISUAL-CORTEX; NERVE GROWTH-FACTOR; EXPERIENCE-DEPENDENT PLASTICITY; CORPUS-CALLOSUM; CRITICAL PERIOD; STRIATE CORTEX; MONOCULAR DEPRIVATION; BINOCULAR RESPONSES; PARKINSONS-DISEASE; RECEPTIVE-FIELDS	Monocular deprivation (MD) is a well-known paradigm of experience-dependent plasticity in which cortical neurons exhibit a shift of ocular dominance (OD) toward the open eye. The mechanisms underlying this form of plasticity are incompletely understood. Here we demonstrate the involvement of callosal connections in the synaptic modifications occurring during MD. Rats at the peak of the critical period were deprived for 7 days, resulting in the expected OD shift toward the open eye. Acute microinjection of the activity blocker muscimol into the visual cortex contralateral to the recording site restored binocularity of cortical cells. Continuous silencing of callosal input throughout the period of MD also resulted in substantial attenuation of the OD shift. Blockade of interhemispheric communication selectively enhanced deprived eye responses with no effect on open eye-driven activity. We conclude that callosal inputs play a key role in functional weakening of less active connections during OD plasticity.	[Restani, Laura; Maffei, Lamberto; Caleo, Matteo] CNR, Ist Neurosci, I-56100 Pisa, Italy; [Restani, Laura; Cerri, Chiara; Pietrasanta, Marta; Gianfranceschi, Laura; Maffei, Lamberto] Scuola Normale Super Pisa, I-56100 Pisa, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Neuroscienze (IN-CNR); Scuola Normale Superiore di Pisa	Caleo, M (corresponding author), CNR, Ist Neurosci, Via G Moruzzi 1, I-56100 Pisa, Italy.	caleo@in.cnr.it	Restani, Laura/AAY-5659-2020; Restani, Laura/ABH-1733-2020; pietrasanta, marta/K-6825-2012	CALEO, MATTEO/0000-0002-4333-6378; RESTANI, LAURA/0000-0002-8295-8452; cerri, chiara/0000-0001-9930-7931; pietrasanta, marta/0000-0002-9176-0202	Italian Ministry for University and Research; Scuola Normale Superiore, Pisa	Italian Ministry for University and Research(Ministry of Education, Universities and Research (MIUR)); Scuola Normale Superiore, Pisa	We thank G.C. Cappagli and C. Orsini for excellent technical assistance. This work was funded by Italian Ministry for University and Research. L.R. was supported by a Young Investigator grant from Scuola Normale Superiore, Pisa.	AggounZouaoui D, 1996, EUR J NEUROSCI, V8, P1132, DOI 10.1111/j.1460-9568.1996.tb01281.x; Antonini A, 1999, J NEUROSCI, V19, P4388; Bloom JS, 2005, NEUROPSYCHOL REV, V15, P59, DOI 10.1007/s11065-005-6252-y; Caleo M, 1999, NEUROSCIENCE, V91, P1017, DOI 10.1016/S0306-4522(98)00682-4; Caleo M, 2007, J NEUROSCI, V27, P4530, DOI 10.1523/JNEUROSCI.0772-07.2007; Cincotta M, 2006, MOVEMENT DISORD, V21, P1019, DOI 10.1002/mds.20850; CUSICK CG, 1982, J COMP NEUROL, V212, P385, DOI 10.1002/cne.902120406; CUSICK CG, 1981, BRAIN RES, V214, P239, DOI 10.1016/0006-8993(81)91192-6; CYNADER M, 1981, NATURE, V290, P139, DOI 10.1038/290139a0; DIAO YC, 1983, EXP BRAIN RES, V49, P410; DRAGER UC, 1975, J COMP NEUROL, V160, P269, DOI 10.1002/cne.901600302; DUFFY FH, 1976, NATURE, V260, P256, DOI 10.1038/260256a0; ELBERGER AJ, 1985, EXP BRAIN RES, V57, P213; Fecteau S, 2006, BEHAV NEUROL, V17, P159, DOI 10.1155/2006/632141; Fierro B, 2006, BEHAV NEUROL, V17, P169, DOI 10.1155/2006/465323; Frenkel MY, 2004, NEURON, V44, P917, DOI 10.1016/j.neuron.2004.12.003; Gazzaniga MS, 2005, NAT REV NEUROSCI, V6, P653, DOI 10.1038/nrn1723; Gordon JA, 1996, J NEUROSCI, V16, P3274; HATA Y, 1994, SCIENCE, V265, P1732, DOI 10.1126/science.8085163; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Hensch TK, 1998, SCIENCE, V282, P1504, DOI 10.1126/science.282.5393.1504; Houzel JC, 1999, J PHYSIOL-PARIS, V93, P271, DOI 10.1016/S0928-4257(00)80056-X; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; INNOCENTI GM, 1979, NATURE, V280, P231, DOI 10.1038/280231a0; INNOCENTI GM, 1980, ARCH ITAL BIOL, V118, P124; Innocenti GM, 2005, NAT REV NEUROSCI, V6, P955, DOI 10.1038/nrn1790; INNOCENTI GM, 1985, J NEUROSCI, V5, P255; JACOBSON S, 1974, BRAIN RES, V74, P149, DOI 10.1016/0006-8993(74)90118-8; JACOBSON S, 1970, EXP NEUROL, V28, P193, DOI 10.1016/0014-4886(70)90229-3; LEWIS JW, 1995, J COMP NEUROL, V361, P119, DOI 10.1002/cne.903610110; Li JY, 2007, MOVEMENT DISORD, V22, P813, DOI 10.1002/mds.21386; Liu CH, 2008, NEURON, V58, P340, DOI 10.1016/j.neuron.2008.02.020; Lodovichi C, 2000, J NEUROSCI, V20, P2155; Maffei A, 2006, NATURE, V443, P81, DOI 10.1038/nature05079; MAFFEI L, 1992, J NEUROSCI, V12, P4651; Mandolesi G, 2005, CURR BIOL, V15, P2119, DOI 10.1016/j.cub.2005.10.045; Maya-Vetencourt JF, 2008, SCIENCE, V320, P385, DOI 10.1126/science.1150516; MINCIACCHI D, 1984, BEHAV BRAIN RES, V13, P183, DOI 10.1016/0166-4328(84)90148-7; Mizuno H, 2007, J NEUROSCI, V27, P6760, DOI 10.1523/JNEUROSCI.1215-07.2007; MOWER GD, 1989, DEV BRAIN RES, V45, P211, DOI 10.1016/0165-3806(89)90040-0; Mrsic-Flogel TD, 2007, NEURON, V54, P961, DOI 10.1016/j.neuron.2007.05.028; Nair DG, 2007, NEUROIMAGE, V34, P253, DOI 10.1016/j.neuroimage.2006.09.010; OLAVARRIA J, 1983, BRAIN RES, V279, P233, DOI 10.1016/0006-8993(83)90182-8; Paul LK, 2007, NAT REV NEUROSCI, V8, P287, DOI 10.1038/nrn2107; PAYNE BR, 1994, BEHAV BRAIN RES, V64, P55, DOI 10.1016/0166-4328(94)90118-X; PAYNE BR, 1980, SCIENCE, V207, P1097, DOI 10.1126/science.7355278; Pham TA, 1999, NEURON, V22, P63, DOI 10.1016/S0896-6273(00)80679-0; Pizzorusso T, 2002, SCIENCE, V298, P1248, DOI 10.1126/science.1072699; Pizzorusso T, 1997, NEUROSCIENCE, V80, P307; Porciatti V, 1999, VISION RES, V39, P3071, DOI 10.1016/S0042-6989(99)00022-X; REITER HO, 1988, P NATL ACAD SCI USA, V85, P3623, DOI 10.1073/pnas.85.10.3623; SILLITO AM, 1981, NATURE, V291, P318, DOI 10.1038/291318a0; Taha S, 2002, NEURON, V34, P425, DOI 10.1016/S0896-6273(02)00673-6; TOYAMA K, 1974, EXP BRAIN RES, V21, P45; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P1003, DOI 10.1152/jn.1963.26.6.1003	55	55	57	1	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	DEC 10	2009	64	5					707	718		10.1016/j.neuron.2009.10.019	http://dx.doi.org/10.1016/j.neuron.2009.10.019			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	537OW	20005826	Bronze			2022-12-24	WOS:000273123700015
J	Chung, S; Leung, A; Han, BS; Chang, MY; Moon, JI; Kim, CH; Hong, S; Pruszak, J; Isacson, O; Kim, KS				Chung, Sangmi; Leung, Amanda; Han, Baek-Soo; Chang, Mi-Yoon; Moon, Jung-Il; Kim, Chun-Hyung; Hong, Sunghoi; Pruszak, Jan; Isacson, Ole; Kim, Kwang-Soo			Wnt1-Imx1a Forms a Novel Autoregulatory Loop and Controls Midbrain Dopaminergic Differentiation Synergistically with the SHH-FoxA2 Pathway	CELL STEM CELL			English	Article							EMBRYONIC STEM-CELLS; FLOOR PLATE; PARKINSONS-DISEASE; NEURON DEVELOPMENT; ISTHMIC ORGANIZER; SONIC HEDGEHOG; BETA-CATENIN; FGF8; HINDBRAIN; GROWTH	Selective degeneration of midbrain dopaminergic (mDA) neurons is associated with Parkinson's disease (PD), and thus an in-depth understanding of molecular pathways underlying mDA development will be crucial for optimal bioassays and cell replacement therapy for PD. In this study, we identified a novel Wnt1-Lmx1a autoregulatory loop during mDA differentiation of ESCs and confirmed its in vivo presence during embryonic development. We found that the Wnt1-Lmx1a autoregulatory loop directly regulates Otx2 through the beta-catenin complex and Nurr1 and Pitx3 through Lmx1a. We also found that Lmx1a and Lmx1b cooperatively regulate mDA differentiation with overlapping and cross-regulatory functions. Furthermore, coactivation of both Wnt1 and SHH pathways by exogenous expression of Lmx1a, Otx2, and FoxA2 synergistically enhanced the differentiation of ESCs to mDA neurons. Together with previous works, this study shows that two regulatory loops (Wnt1-Lmx1a and SHH-FoxA2) critically link extrinsic signals to cell-intrinsic factors and cooperatively regulate mDA neuron development.	[Chung, Sangmi; Leung, Amanda; Han, Baek-Soo; Chang, Mi-Yoon; Moon, Jung-Il; Kim, Chun-Hyung; Hong, Sunghoi; Kim, Kwang-Soo] Harvard Univ, McLean Hosp, Sch Med, Dept Psychiat,Mol Neurobiol Lab, Belmont, MA 02478 USA; [Chung, Sangmi; Leung, Amanda; Han, Baek-Soo; Chang, Mi-Yoon; Moon, Jung-Il; Kim, Chun-Hyung; Hong, Sunghoi; Kim, Kwang-Soo] Harvard Univ, McLean Hosp, Sch Med, Program Neurosci, Belmont, MA 02478 USA; [Chung, Sangmi; Leung, Amanda; Han, Baek-Soo; Chang, Mi-Yoon; Moon, Jung-Il; Kim, Chun-Hyung; Hong, Sunghoi; Pruszak, Jan; Isacson, Ole; Kim, Kwang-Soo] Harvard Univ, McLean Hosp, Sch Med, Harvard Stem Cell Inst, Belmont, MA 02478 USA; [Pruszak, Jan; Isacson, Ole] Harvard Univ, McLean Hosp, Sch Med, Neurogenerat Labs, Belmont, MA 02478 USA	Harvard University; McLean Hospital; Harvard University; McLean Hospital; Harvard University; McLean Hospital; Harvard University; McLean Hospital	Kim, KS (corresponding author), Harvard Univ, McLean Hosp, Sch Med, Dept Psychiat,Mol Neurobiol Lab, Belmont, MA 02478 USA.	kskim@mclean.harvard.edu	Pruszak, Jan/G-6972-2015	Pruszak, Jan/0000-0003-4297-4009; Isacson, Ole/0000-0001-8091-8302	NIH [P50 NS39793, MH48866]; Korean Brain Research Center; Dongyang Corporation Co. in Korea; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH048866, R29MH048866] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS039793] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Korean Brain Research Center; Dongyang Corporation Co. in Korea; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH grants P50 NS39793 and MH48866 and international grants from the Korean Brain Research Center and Dongyang Corporation Co. in Korea. The authors also thank Dr. Siew-Lan Ang at MRC, UK, for sharing her unpublished work as a personal communication. We appreciate Dr. German at UCSF, Dr. Birchmeier at Max Delbruck Center for Molecular Medicine, Dr. Morgan at NIGH, and Dr. Duester at Burnham Institute for kindly providing us with valuable antibodies.	Andersson E, 2006, CELL, V124, P393, DOI [10.1016/j.cell.2005.10.037, 10.1016/J.CELL.2005.10.037]; Andersson E, 2006, DEVELOPMENT, V133, P507, DOI 10.1242/dev.02224; Ang SL, 2006, DEVELOPMENT, V133, P3499, DOI 10.1242/dev.02501; Arenas E, 2008, CELL STEM CELL, V2, P110, DOI 10.1016/j.stem.2008.01.012; BJORKLUND A, 1984, HDB CHEM NEUROANATOM; Castelo-Branco G, 2004, J CELL SCI, V117, P5731, DOI 10.1242/jcs.01505; Chi CL, 2003, DEVELOPMENT, V130, P2633, DOI 10.1242/dev.00487; Chung S, 2002, EUR J NEUROSCI, V16, P1829, DOI 10.1046/j.1460-9568.2002.02255.x; Ferri ALM, 2007, DEVELOPMENT, V134, P2761, DOI 10.1242/dev.000141; Guo C, 2007, DEVELOPMENT, V134, P317, DOI 10.1242/dev.02745; Hobert O, 2000, TRENDS GENET, V16, P75, DOI 10.1016/S0168-9525(99)01883-1; Jeong Y, 2003, DEVELOPMENT, V130, P3891, DOI 10.1242/dev.00590; Joksimovic M, 2009, NAT NEUROSCI, V12, P125, DOI 10.1038/nn.2243; Kawasaki H, 2000, NEURON, V28, P31, DOI 10.1016/S0896-6273(00)00083-0; Kele J, 2006, DEVELOPMENT, V133, P495, DOI 10.1242/dev.02223; Kim JH, 2002, NATURE, V418, P50, DOI 10.1038/nature00900; Kittappa R, 2007, PLOS BIOL, V5, P2875, DOI 10.1371/journal.pbio.0050325; Lang AE, 1998, NEW ENGL J MED, V339, P1044, DOI 10.1056/NEJM199810083391506; Lee SMK, 1997, DEVELOPMENT, V124, P959; Liu AM, 2001, DEVELOPMENT, V128, P181; Matsunaga E, 2002, DEVELOPMENT, V129, P5269; MCMAHON AP, 1992, CELL, V69, P581, DOI 10.1016/0092-8674(92)90222-X; MCMAHON AP, 1990, CELL, V62, P1073, DOI 10.1016/0092-8674(90)90385-R; Megason SG, 2002, DEVELOPMENT, V129, P2087; Millonig JH, 2000, NATURE, V403, P764, DOI 10.1038/35001573; Ono Y, 2007, DEVELOPMENT, V134, P3213, DOI 10.1242/dev.02879; Pabst O, 2000, DEV GENES EVOL, V210, P47, DOI 10.1007/PL00008188; Prakash N, 2006, DEVELOPMENT, V133, P89, DOI 10.1242/dev.02181; Pruszak J, 2007, STEM CELLS, V25, P2257, DOI 10.1634/stemcells.2006-0744; Saarimaki-Vire J, 2007, J NEUROSCI, V27, P8581, DOI 10.1523/JNEUROSCI.0192-07.2007; Sasaki H, 1997, DEVELOPMENT, V124, P1313; Smidt MP, 2007, NAT REV NEUROSCI, V8, P21, DOI 10.1038/nrn2039; Smidt MP, 2000, NAT NEUROSCI, V3, P337, DOI 10.1038/73902; Tang MZ, 2009, DEVELOPMENT, V136, P2027, DOI 10.1242/dev.034330; Vernay B, 2005, J NEUROSCI, V25, P4856, DOI 10.1523/JNEUROSCI.5158-04.2005; Vokes SA, 2007, DEVELOPMENT, V134, P1977, DOI 10.1242/dev.001966; Ye WL, 1998, CELL, V93, P755, DOI 10.1016/S0092-8674(00)81437-3; Yochum GS, 2007, P NATL ACAD SCI USA, V104, P3324, DOI 10.1073/pnas.0611576104	38	142	147	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	DEC 4	2009	5	6					646	658		10.1016/j.stem.2009.09.015	http://dx.doi.org/10.1016/j.stem.2009.09.015			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	543YH	19951692	Bronze, Green Accepted			2022-12-24	WOS:000273616700012
J	Lakatos, P; O'Connell, MN; Barczak, A; Mills, A; Javitt, DC; Schroeder, CE				Lakatos, Peter; O'Connell, Monica N.; Barczak, Annamaria; Mills, Aimee; Javitt, Daniel C.; Schroeder, Charles E.			The Leading Sense: Supramodal Control of Neurophysiological Context by Attention	NEURON			English	Article							THALAMIC RETICULAR NUCLEUS; SUPERIOR TEMPORAL SULCUS; NEURONS IN-VIVO; AUDITORY-CORTEX; MULTISENSORY CONVERGENCE; AUDIOVISUAL INTEGRATION; THETA-OSCILLATIONS; PREFRONTAL CORTEX; DORSAL THALAMUS; NEURAL DYNAMICS	Attending to a stimulus enhances its neuronal representation, even at the level of primary sensory cortex. Cross-modal modulation can similarly enhance a neuronal representation, and this process can also operate at the primary cortical level. Phase reset of ongoing neuronal oscillatory activity has been shown to be an important element of the underlying modulation of local cortical excitability in both cases. We investigated the influence of attention on oscillatory phase reset in primary auditory and visual cortices of macaques performing an intermodal selective attention task. In addition to responses "driven" by preferred modality stimuli, we noted that both preferred and nonpreferred modality stimuli could "modulate" local cortical excitability by phase reset of ongoing oscillatory activity, and that this effect was linked to their being attended. These findings outline a supramodal mechanism by which attention can control neurophysiological context, thus determining the representation of specific sensory content in primary sensory cortex.	[Lakatos, Peter; O'Connell, Monica N.; Barczak, Annamaria; Mills, Aimee; Javitt, Daniel C.; Schroeder, Charles E.] Nathan S Kline Inst Psychiat Res, Cognit Neurosci & Schizophrenia Program, Orangeburg, NY 10962 USA; [Barczak, Annamaria] NYU, Sch Med, Dept Physiol & Neurosci, New York, NY 10016 USA; [Lakatos, Peter; Javitt, Daniel C.] NYU, Sch Med, Dept Psychiat, New York, NY 10016 USA; [Schroeder, Charles E.] Columbia Univ Coll Phys & Surg, Dept Psychiat, New York, NY 10032 USA	Nathan Kline Institute for Psychiatric Research; New York University; New York University; Columbia University	Lakatos, P (corresponding author), Nathan S Kline Inst Psychiat Res, Cognit Neurosci & Schizophrenia Program, Orangeburg, NY 10962 USA.	plakatos@nki.rfmh.org	Javitt, Daniel/U-6015-2019	Lakatos, Peter/0000-0003-0221-4021; Barczak, Annamaria/0000-0002-0829-1768	NIMH [MH061989, MH060358]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH061989, R01MH060358] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R21DC010415] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank Dr. Ashesh D. Mehta and Dr. Istvan Ulbert for their invaluable assistance in collecting the data. Support for this work was provided by NIMH grants MH061989 and MH060358.	Allman BL, 2007, J NEUROPHYSIOL, V98, P545, DOI 10.1152/jn.00173.2007; Alsius A, 2005, CURR BIOL, V15, P839, DOI 10.1016/j.cub.2005.03.046; Alsius A, 2007, EXP BRAIN RES, V183, P399, DOI 10.1007/s00221-007-1110-1; Azouz R, 1999, J NEUROSCI, V19, P2209; Basar E., 1980, EEG BRAIN DYNAMICS R; BERTELSON P, 1981, PERCEPT PSYCHOPHYS, V29, P578, DOI 10.3758/BF03207374; Bishop GH, 1933, AM J PHYSIOL, V103, P213, DOI 10.1152/ajplegacy.1932.103.1.213; Bollimunta A, 2008, J NEUROSCI, V28, P9976, DOI 10.1523/JNEUROSCI.2699-08.2008; Bolognini N, 2007, PERCEPTION, V36, P1477, DOI 10.1068/p5846; Brosch M, 2005, J NEUROSCI, V25, P6797, DOI 10.1523/JNEUROSCI.1571-05.2005; Busse L, 2005, P NATL ACAD SCI USA, V102, P18751, DOI 10.1073/pnas.0507704102; BUZSAKI G, 1995, CURR OPIN NEUROBIOL, V5, P504, DOI 10.1016/0959-4388(95)80012-3; Buzsaki G., 2003, CURRENT PRACTICE CLI, P1; Caclin A, 2002, PERCEPT PSYCHOPHYS, V64, P616, DOI 10.3758/BF03194730; Canolty RT, 2006, SCIENCE, V313, P1626, DOI 10.1126/science.1128115; Chandrasekaran C, 2009, J NEUROPHYSIOL, V101, P773, DOI 10.1152/jn.90843.2008; COLAVITA FB, 1974, PERCEPT PSYCHOPHYS, V16, P409, DOI 10.3758/BF03203962; Crabtree JW, 1998, NAT NEUROSCI, V1, P389, DOI 10.1038/1603; Crabtree JW, 2002, J NEUROSCI, V22, P8754; Diederich A, 2008, BRAIN RES, V1242, P219, DOI 10.1016/j.brainres.2008.05.081; Fiser J, 2004, NATURE, V431, P573, DOI 10.1038/nature02907; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; Fujisaki W, 2004, NAT NEUROSCI, V7, P773, DOI 10.1038/nn1268; Ghazanfar AA, 2008, J NEUROSCI, V28, P4457, DOI 10.1523/JNEUROSCI.0541-08.2008; Ghazanfar AA, 2006, TRENDS COGN SCI, V10, P278, DOI 10.1016/j.tics.2006.04.008; Guillery RW, 1998, TRENDS NEUROSCI, V21, P28, DOI 10.1016/S0166-2236(97)01157-0; Hackett TA, 2007, PERCEPTION, V36, P1419, DOI 10.1068/p5841; Jones E G, 1998, Adv Neurol, V77, P49; Jones EG, 1998, NEUROSCIENCE, V85, P331, DOI 10.1016/S0306-4522(97)00581-2; Kamondi A, 1998, HIPPOCAMPUS, V8, P244, DOI 10.1002/(SICI)1098-1063(1998)8:3<244::AID-HIPO7>3.0.CO;2-J; Kayser C, 2008, CEREB CORTEX, V18, P1560, DOI 10.1093/cercor/bhm187; Kayser C, 2009, NEURON, V61, P597, DOI 10.1016/j.neuron.2009.01.008; Klimesch W, 2007, NEUROSCI BIOBEHAV R, V31, P1003, DOI 10.1016/j.neubiorev.2007.03.005; Lakatos P, 2005, J NEUROPHYSIOL, V94, P1904, DOI 10.1152/jn.00263.2005; Lakatos P, 2008, SCIENCE, V320, P110, DOI 10.1126/science.1154735; Lakatos P, 2007, NEURON, V53, P279, DOI 10.1016/j.neuron.2006.12.011; Large EW, 1999, PSYCHOL REV, V106, P119, DOI 10.1037/0033-295X.106.1.119; Makeig S, 2004, TRENDS COGN SCI, V8, P204, DOI 10.1016/j.tics.2004.03.008; Maris E, 2007, J NEUROSCI METH, V163, P161, DOI 10.1016/j.jneumeth.2007.02.011; MCGURK H, 1976, NATURE, V264, P746, DOI 10.1038/264746a0; Meredith MA, 2009, NEUROREPORT, V20, P126, DOI 10.1097/WNR.0b013e32831d7bb6; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; MITZDORF U, 1985, PHYSIOL REV, V65, P37, DOI 10.1152/physrev.1985.65.1.37; NICKERSON RS, 1973, PSYCHOL REV, V80, P489, DOI 10.1037/h0035437; Nobrel AC, 2007, CURR OPIN NEUROBIOL, V17, P465, DOI 10.1016/j.conb.2007.07.006; Occelli V, 2009, EXP BRAIN RES, V193, P409, DOI 10.1007/s00221-008-1637-9; Sanabria D, 2005, EXP BRAIN RES, V166, P548, DOI 10.1007/s00221-005-2395-6; Sauseng P, 2007, NEUROSCIENCE, V146, P1435, DOI 10.1016/j.neuroscience.2007.03.014; SAYERS BMA, 1974, NATURE, V247, P481, DOI 10.1038/247481a0; Schroeder CE, 2003, INT J PSYCHOPHYSIOL, V50, P5, DOI 10.1016/S0167-8760(03)00120-X; Schroeder CE, 1998, CEREB CORTEX, V8, P575, DOI 10.1093/cercor/8.7.575; Schroeder CE, 2008, TRENDS COGN SCI, V12, P106, DOI 10.1016/j.tics.2008.01.002; Schroeder CE, 2009, TRENDS NEUROSCI, V32, P9, DOI 10.1016/j.tins.2008.09.012; Senkowski D, 2008, NEUROIMAGE, V43, P379, DOI 10.1016/j.neuroimage.2008.06.046; Senkowski D, 2008, TRENDS NEUROSCI, V31, P401, DOI 10.1016/j.tins.2008.05.002; Shah AS, 2004, CEREB CORTEX, V14, P476, DOI 10.1093/cercor/bhh009; Shams L, 2000, NATURE, V408, P788, DOI 10.1038/35048669; Smiley JF, 2007, J COMP NEUROL, V502, P894, DOI 10.1002/cne.21325; Soto-Faraco S, 2004, COGN AFFECT BEHAV NE, V4, P208, DOI 10.3758/CABN.4.2.208; Stein BE, 2008, NAT REV NEUROSCI, V9, P255, DOI 10.1038/nrn2331; STERIADE M, 1993, J NEUROSCI, V13, P3252, DOI 10.1523/jneurosci.13-08-03252.1993; Stone JV, 2001, P ROY SOC B-BIOL SCI, V268, P31, DOI 10.1098/rspb.2000.1326; SUMBY WH, 1954, J ACOUST SOC AM, V26, P212, DOI 10.1121/1.1907309; Talsma D, 2007, CEREB CORTEX, V17, P679, DOI 10.1093/cercor/bhk016; van der Burg E, 2008, VIS COGN, V16, P1140; Van der Burg E, 2008, J EXP PSYCHOL HUMAN, V34, P1053, DOI 10.1037/0096-1523.34.5.1053; VanRullen R, 2007, P NATL ACAD SCI USA, V104, P19204, DOI 10.1073/pnas.0707316104; Vroomen J, 2004, COGNITIVE BRAIN RES, V22, P32, DOI 10.1016/j.cogbrainres.2004.07.003; Werner-Reiss U, 2008, J NEUROSCI, V28, P3747, DOI 10.1523/JNEUROSCI.5044-07.2008; Zikopoulos B, 2007, REV NEUROSCIENCE, V18, P417; Zikopoulos B, 2006, J NEUROSCI, V26, P7348, DOI 10.1523/JNEUROSCI.5511-05.2006	71	272	275	1	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 12	2009	64	3					419	430		10.1016/j.neuron.2009.10.014	http://dx.doi.org/10.1016/j.neuron.2009.10.014			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	521MF	19914189	Green Accepted, Bronze			2022-12-24	WOS:000271924800015
J	Goard, M; Dan, Y				Goard, Michael; Dan, Yang			Basal forebrain activation enhances cortical coding of natural scenes	NATURE NEUROSCIENCE			English	Article							NUCLEUS BASALIS; VISUAL-CORTEX; CHOLINERGIC MODULATION; SYNAPTIC-TRANSMISSION; ACETYLCHOLINE-RELEASE; PREFRONTAL CORTEX; CEREBRAL-CORTEX; BARREL CORTEX; NEURONS; NEUROMODULATION	The nucleus basalis of the basal forebrain is an essential component of the neuromodulatory system controlling the behavioral state of an animal and it is thought to be important in regulating arousal and attention. However, the effect of nucleus basalis activation on sensory processing remains poorly understood. Using polytrode recording in rat visual cortex, we found that nucleus basalis stimulation caused prominent decorrelation between neurons and marked improvement in the reliability of neuronal responses to natural scenes. The decorrelation depended on local activation of cortical muscarinic acetylcholine receptors, whereas the increased reliability involved distributed neural circuits, as evidenced by nucleus basalis-induced changes in thalamic responses. Further analysis showed that the decorrelation and increased reliability improved cortical representation of natural stimuli in a complementary manner. Thus, the basal forebrain neuromodulatory circuit, which is known to be activated during aroused and attentive states, acts through both local and distributed mechanisms to improve sensory coding.	[Goard, Michael; Dan, Yang] Univ Calif Berkeley, Helen Wills Neurosci Inst, Dept Mol & Cell Biol, Howard Hughes Med Inst,Div Neurobiol, Berkeley, CA 94720 USA	Howard Hughes Medical Institute; University of California System; University of California Berkeley	Dan, Y (corresponding author), Univ Calif Berkeley, Helen Wills Neurosci Inst, Dept Mol & Cell Biol, Howard Hughes Med Inst,Div Neurobiol, Berkeley, CA 94720 USA.	ydan@berkeley.edu		Dan, Yang/0000-0002-3818-877X; Goard, Michael/0000-0002-5366-8501	US National Institute of Neurological Disorders and Stroke [F31NS059258]; NATIONAL EYE INSTITUTE [R01EY018861] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS059258] Funding Source: NIH RePORTER	US National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank T. Blanche, D. Feldman, R. Froemke, D. Jones, D. Kleinfeld, C. Niell and A. Vahidnia for technical help and useful discussions. This work was supported by grants from the US National Institutes of Health to Y. D. and a Ruth L. Kirschstein National Research Service Award to M. G. (award number F31NS059258 from the US National Institute of Neurological Disorders and Stroke).	Bakin JS, 1996, P NATL ACAD SCI USA, V93, P11219, DOI 10.1073/pnas.93.20.11219; Barlow H, 2001, NETWORK-COMP NEURAL, V12, P241, DOI 10.1088/0954-898X/12/3/301; Bazhenov M, 2002, J NEUROSCI, V22, P8691; Berridge CW, 2003, BRAIN RES REV, V42, P33, DOI 10.1016/S0165-0173(03)00143-7; Bezdudnaya T, 2006, NEURON, V49, P421, DOI 10.1016/j.neuron.2006.01.010; Blanche TJ, 2005, J NEUROPHYSIOL, V93, P2987, DOI 10.1152/jn.01023.2004; BUZSAKI G, 1988, J NEUROSCI, V8, P4007; Castro-Alamancos MA, 2004, PROG NEUROBIOL, V74, P213, DOI 10.1016/j.pneurobio.2004.09.002; Disney AA, 2007, NEURON, V56, P701, DOI 10.1016/j.neuron.2007.09.034; Everitt BJ, 1997, ANNU REV PSYCHOL, V48, P649, DOI 10.1146/annurev.psych.48.1.649; Fiser J, 2004, NATURE, V431, P573, DOI 10.1038/nature02907; Froemke RC, 2007, NATURE, V450, P425, DOI 10.1038/nature06289; Gil Z, 1997, NEURON, V19, P679, DOI 10.1016/S0896-6273(00)80380-3; HASSELMO ME, 1995, BEHAV BRAIN RES, V67, P1, DOI 10.1016/0166-4328(94)00113-T; Hazan L, 2006, J NEUROSCI METH, V155, P207, DOI 10.1016/j.jneumeth.2006.01.017; Herrero JL, 2008, NATURE, V454, P1110, DOI 10.1038/nature07141; Hsieh CY, 2000, BRAIN RES, V880, P51, DOI 10.1016/S0006-8993(00)02766-9; Jones BE, 2008, ANN NY ACAD SCI, V1129, P26, DOI 10.1196/annals.1417.026; Jones BE, 2004, PROG BRAIN RES, V145, P157, DOI 10.1016/S0079-6123(03)45011-5; Kilgard MP, 1998, SCIENCE, V279, P1714, DOI 10.1126/science.279.5357.1714; Kimura F, 1999, EUR J NEUROSCI, V11, P3597, DOI 10.1046/j.1460-9568.1999.00779.x; Kruglikov I, 2008, NEURON, V58, P911, DOI 10.1016/j.neuron.2008.04.024; Laplante F, 2005, NEUROSCIENCE, V132, P501, DOI 10.1016/j.neuroscience.2004.11.059; Lee MG, 2005, J NEUROSCI, V25, P4365, DOI 10.1523/JNEUROSCI.0178-05.2005; LEHMANN J, 1980, NEUROSCIENCE, V5, P1161, DOI 10.1016/0306-4522(80)90195-5; Lin SC, 2006, J NEUROPHYSIOL, V96, P3209, DOI 10.1152/jn.00524.2006; MCCORMICK DA, 1992, PROG NEUROBIOL, V39, P337, DOI 10.1016/0301-0082(92)90012-4; METHERATE R, 1992, J NEUROSCI, V12, P4701; METHERATE R, 1993, SYNAPSE, V14, P132, DOI 10.1002/syn.890140206; MULLER CM, 1989, BRAIN RES, V487, P335, DOI 10.1016/0006-8993(89)90837-8; Oldford E, 2003, NEUROSCIENCE, V117, P769, DOI 10.1016/S0306-4522(02)00663-2; PARENT A, 1988, J COMP NEUROL, V277, P281, DOI 10.1002/cne.902770209; Parikh V, 2007, NEURON, V56, P141, DOI 10.1016/j.neuron.2007.08.025; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Petersen CCH, 2003, P NATL ACAD SCI USA, V100, P13638, DOI 10.1073/pnas.2235811100; Poulet JFA, 2008, NATURE, V454, P881, DOI 10.1038/nature07150; Robbins TW, 1997, BIOL PSYCHOL, V45, P57, DOI 10.1016/S0301-0511(96)05222-2; Roberts MJ, 2005, J NEUROPHYSIOL, V93, P2062, DOI 10.1152/jn.00911.2004; Sarter M, 2005, BRAIN RES REV, V48, P98, DOI 10.1016/j.brainresrev.2004.08.006; SATO H, 1987, J NEUROPHYSIOL, V58, P765, DOI 10.1152/jn.1987.58.4.765; Sherman SM, 1996, VISUAL NEUROSCI, V13, P205, DOI 10.1017/S0952523800007446; SILLITO AM, 1983, BRAIN RES, V289, P143, DOI 10.1016/0006-8993(83)90015-X; STERIADE M, 1987, J NEUROPHYSIOL, V57, P260, DOI 10.1152/jn.1987.57.1.260; Tsodyks M, 1999, SCIENCE, V286, P1943, DOI 10.1126/science.286.5446.1943; Worgotter F, 1998, NATURE, V396, P165, DOI 10.1038/24157; Xiang ZX, 1998, SCIENCE, V281, P985, DOI 10.1126/science.281.5379.985; Yu AJ, 2005, NEURON, V46, P681, DOI 10.1016/j.neuron.2005.04.026; Zhang F, 2007, NAT REV NEUROSCI, V8, P577, DOI 10.1038/nrn2192; Zilles K, 1989, EXS, V57, P212; Zinke W, 2006, EUR J NEUROSCI, V24, P314, DOI 10.1111/j.1460-9568.2006.04882.x	50	378	384	0	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2009	12	11					1444	1449		10.1038/nn.2402	http://dx.doi.org/10.1038/nn.2402			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	511UE	19801988	Green Submitted, Green Accepted			2022-12-24	WOS:000271194100018
J	Zhang, XC; Lei, K; Yuan, XB; Wu, XH; Zhuang, Y; Xu, T; Xu, R; Han, M				Zhang, Xiaochang; Lei, Kai; Yuan, Xiaobing; Wu, Xiaohui; Zhuang, Yuan; Xu, Tian; Xu, Rener; Han, Min			SUN1/2 and Syne/Nesprin-1/2 Complexes Connect Centrosome to the Nucleus during Neurogenesis and Neuronal Migration in Mice	NEURON			English	Article							MEMBRANE PROTEIN; LIS1; ENVELOPE; DYNEIN; LAMIN; ANCHORAGE; NESPRIN-2; ROLES; LOCALIZATION; MECHANISMS	Nuclear movement is critical during neurogenesis and neuronal migration, which are fundamental for mammalian brain development. Although dynein, Lis1, and other cytoplasmic proteins are known for their roles in connecting microtubules to the nucleus during interkinetic nuclear migration (INM) and nucleokinesis, the factors connecting dynein/Lis1 to the nuclear envelope (NE) remain to be determined. We report here that the SUN-domain proteins SUM and SUN2 and the KASH-domain proteins Syne-1/Nesprin-1 and Syne-2/Nesprin-2 play critical roles in neurogenesis and neuronal migration in mice. We show that SUM and SUN2 redundantly form complexes with Syne-2 to mediate the centrosome-nucleus coupling during both INM and radial neuronal migration in the cerebral cortex. Syne-2 is connected to the centrosome through interactions with both dynein/dynactin and kinesin complexes. Syne-2 mutants also display severe defects in learning and memory. These results fill. an important gap in our understanding of the mechanism of nuclear movement during brain development.	[Zhang, Xiaochang; Lei, Kai; Wu, Xiaohui; Zhuang, Yuan; Xu, Tian; Xu, Rener; Han, Min] Fudan Univ, Sch Life Sci, Inst Dev Biol & Mol Med, Shanghai 200433, Peoples R China; [Yuan, Xiaobing] Chinese Acad Sci, Inst Neurosci, Shanghai 200031, Peoples R China; [Yuan, Xiaobing] Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Neurobiol, Shanghai 200031, Peoples R China; [Zhuang, Yuan] Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA; [Xu, Tian] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA; [Xu, Tian] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06520 USA; [Han, Min] Univ Colorado, Howard Hughes Med Inst, Boulder, CO 80309 USA; [Han, Min] Univ Colorado, Dept MCDB, Boulder, CO 80309 USA	Fudan University; Chinese Academy of Sciences; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Duke University; Howard Hughes Medical Institute; Yale University; Yale University; Howard Hughes Medical Institute; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Xu, R (corresponding author), Fudan Univ, Sch Life Sci, Inst Dev Biol & Mol Med, Shanghai 200433, Peoples R China.	rener_xu@fudan.edu.cn; mhan@colorado.edu	zhang, xiaochang/G-4857-2014	zhang, xiaochang/0000-0001-5768-7470; Yuan, Xiaobing/0000-0002-1632-8460; zhuang, yuan/0000-0002-2964-3654	National Talent Training Fund in Basic Research of China [J0630643]; Ministry of Science and Technology; National Natural Science Foundation of China; Ministry of Education of China; Shanghai Municipal Government	National Talent Training Fund in Basic Research of China; Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China(Ministry of Education, China); Shanghai Municipal Government	We thank Angelika A. Noegel (University of Cologne), Yuanyi Feng (Northwestern University), Deanna Smith (University of South Carolina), Jinbo Deng (Henan University), and Li-Huei Tsai (MM for gifts of antibodies; Xu Ding, Diana Ronai, Aileen Sewell, Max Cohen, Brian Kudlow, and Jing Cui for valuable comments and discussions; Chuantao Zhao, Di Xia, Xiaoping Huang, Boying Tan, Yanling Yang, and Xiaoqian Jin and others in X. Yuan's laboratory and at IDM for assistance; and Beibei Ying, Wufan Tao, Kejing Deng, Ling Sun, and Yuri Zheng for advice. Kai Lei held the funding of National Talent Training Fund in Basic Research of China (no. J0630643). This work was supported by grants from the Ministry of Science and Technology (973 program), National Natural Science Foundation of China, Ministry of Education of China (211 program), and Shanghai Municipal Government.	Chae T, 1997, NEURON, V18, P29, DOI 10.1016/S0896-6273(01)80044-1; Chen G, 2008, NAT NEUROSCI, V11, P36, DOI 10.1038/nn2018; Chi YH, 2009, DEVELOPMENT, V136, P965, DOI 10.1242/dev.029868; Crisp M, 2006, J CELL BIOL, V172, P41, DOI 10.1083/jcb.200509124; DARCANGELO G, 1995, NATURE, V374, P719, DOI 10.1038/374719a0; Deacon RMJ, 2006, NAT PROTOC, V1, P13, DOI 10.1038/nprot.2006.3; Dehay C, 2007, NAT REV NEUROSCI, V8, P438, DOI 10.1038/nrn2097; Del Bene F, 2008, CELL, V134, P1055, DOI 10.1016/j.cell.2008.07.017; Ding X, 2007, DEV CELL, V12, P863, DOI 10.1016/j.devcel.2007.03.018; Feng YY, 2004, NEURON, V44, P279, DOI 10.1016/j.neuron.2004.09.023; Feng YY, 2001, NAT REV NEUROSCI, V2, P408, DOI 10.1038/35077559; Feng YY, 2000, NEURON, V28, P665, DOI 10.1016/S0896-6273(00)00145-8; Fridkin A, 2004, P NATL ACAD SCI USA, V101, P6987, DOI 10.1073/pnas.0307880101; Grady RM, 2005, P NATL ACAD SCI USA, V102, P4359, DOI 10.1073/pnas.0500711102; Gros-Louis F, 2007, NAT GENET, V39, P80, DOI 10.1038/ng1927; Haque F, 2006, MOL CELL BIOL, V26, P3738, DOI 10.1128/MCB.26.10.3738-3751.2006; Hatten ME, 1999, ANNU REV NEUROSCI, V22, P511, DOI 10.1146/annurev.neuro.22.1.511; Higginbotham HR, 2007, TRENDS NEUROSCI, V30, P276, DOI 10.1016/j.tins.2007.04.001; Hodzic DM, 2004, J BIOL CHEM, V279, P25805, DOI 10.1074/jbc.M313157200; Holleran EA, 2001, J BIOL CHEM, V276, P36598, DOI 10.1074/jbc.M104838200; Holleran EA, 1996, J CELL BIOL, V135, P1815, DOI 10.1083/jcb.135.6.1815; Howell BW, 1997, NATURE, V389, P733, DOI 10.1038/39607; Keays DA, 2007, CELL, V128, P45, DOI 10.1016/j.cell.2006.12.017; Kracklauer MP, 2007, FLY, V1, P75, DOI 10.4161/fly.4254; Lei K, 2009, P NATL ACAD SCI USA, V106, P10207, DOI 10.1073/pnas.0812037106; Luke Y, 2008, J CELL SCI, V121, P1887, DOI 10.1242/jcs.019075; Malone CJ, 1999, DEVELOPMENT, V126, P3171; Malone CJ, 2003, CELL, V115, P825, DOI 10.1016/S0092-8674(03)00985-1; McGee MD, 2006, MOL BIOL CELL, V17, P1790, DOI 10.1091/mbc.E05-09-0894; Mejat A, 2009, J CELL BIOL, V184, P31, DOI 10.1083/jcb.200811035; Molyneaux BJ, 2007, NAT REV NEUROSCI, V8, P427, DOI 10.1038/nrn2151; Morris NR, 2003, CURR OPIN CELL BIOL, V15, P54, DOI 10.1016/S0955-0674(02)00004-2; Mosley-Bishop KL, 1999, CURR BIOL, V9, P1211, DOI 10.1016/S0960-9822(99)80501-6; Osmani N, 2006, CURR BIOL, V16, P2395, DOI 10.1016/j.cub.2006.10.026; Padmakumar VC, 2005, J CELL SCI, V118, P3419, DOI 10.1242/jcs.02471; Puckelwartz MJ, 2009, HUM MOL GENET, V18, P607, DOI 10.1093/hmg/ddn386; Reinsch S, 1998, J CELL SCI, V111, P2283; Roux KJ, 2009, P NATL ACAD SCI USA, V106, P2194, DOI 10.1073/pnas.0808602106; Saito T, 2006, NAT PROTOC, V1, P1552, DOI 10.1038/nprot.2006.276; Sambrook J, 2001, MOL CLONING LAB MANU; Sasaki S, 2000, NEURON, V28, P681, DOI 10.1016/S0896-6273(00)00146-X; Schroer TA, 2004, ANNU REV CELL DEV BI, V20, P759, DOI 10.1146/annurev.cellbio.20.012103.094623; Sheldon M, 1997, NATURE, V389, P730, DOI 10.1038/39601; Shi SH, 2003, CELL, V112, P63, DOI 10.1016/S0092-8674(02)01249-7; Shu TZ, 2004, NEURON, V44, P263, DOI 10.1016/j.neuron.2004.09.030; Solecki DJ, 2004, NAT NEUROSCI, V7, P1195, DOI 10.1038/nn1332; Starr DA, 2005, BIOESSAYS, V27, P1136, DOI 10.1002/bies.20312; Starr DA, 2002, SCIENCE, V298, P406, DOI 10.1126/science.1075119; Starr DA, 2001, DEVELOPMENT, V128, P5039; Tanaka T, 2004, J CELL BIOL, V165, P709, DOI 10.1083/jcb.200309025; Tsai JW, 2007, NAT NEUROSCI, V10, P970, DOI 10.1038/nn1934; Tsai JW, 2005, J CELL BIOL, V170, P935, DOI 10.1083/jcb.200505166; Tsai LH, 2005, NEURON, V46, P383, DOI 10.1016/j.neuron.2005.04.013; Tsujikawa M, 2007, P NATL ACAD SCI USA, V104, P14819, DOI 10.1073/pnas.0700178104; Vergnes L, 2004, P NATL ACAD SCI USA, V101, P10428, DOI 10.1073/pnas.0401424101; Wilhelmsen K, 2005, J CELL BIOL, V171, P799, DOI 10.1083/jcb.200506083; Wilhelmsen K, 2006, J CELL SCI, V119, P5021, DOI 10.1242/jcs.03295; Wynshaw-Boris A, 2007, CLIN GENET, V72, P296, DOI 10.1111/j.1399-0004.2007.00888.x; Xie ZG, 2003, CELL, V114, P469, DOI 10.1016/S0092-8674(03)00605-6; Xie ZG, 2007, NEURON, V56, P79, DOI 10.1016/j.neuron.2007.08.026; Ying MY, 2006, J BIOL CHEM, V281, P12580, DOI 10.1074/jbc.M511677200; Yingling J, 2008, CELL, V132, P474, DOI 10.1016/j.cell.2008.01.026; Zhang QP, 2005, J CELL SCI, V118, P673, DOI 10.1242/jcs.01642; Zhang XC, 2007, DEVELOPMENT, V134, P901, DOI 10.1242/dev.02783; Zhen YY, 2002, J CELL SCI, V115, P3207	65	332	341	0	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 29	2009	64	2					173	187		10.1016/j.neuron.2009.08.018	http://dx.doi.org/10.1016/j.neuron.2009.08.018			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	521AA	19874786	Green Accepted, Bronze			2022-12-24	WOS:000271889900008
J	Harel, L; Costa, B; Tcherpakov, M; Zapatka, M; Oberthuer, A; Hansford, LM; Vojvodic, M; Levy, Z; Chen, ZY; Lee, FS; Avigad, S; Yaniv, I; Shi, LM; Eils, R; Fischer, M; Brors, B; Kaplan, DR; Fainzilber, M				Harel, Liraz; Costa, Barbara; Tcherpakov, Marianna; Zapatka, Marc; Oberthuer, Andre; Hansford, Loen M.; Vojvodic, Milijana; Levy, Zehava; Chen, Zhe-Yu; Lee, Francis S.; Avigad, Smadar; Yaniv, Isaac; Shi, Leming; Eils, Roland; Fischer, Matthias; Brors, Benedikt; Kaplan, David R.; Fainzilber, Mike			CCM2 Mediates Death Signaling by the TrkA Receptor Tyrosine Kinase	NEURON			English	Article							CEREBRAL CAVERNOUS MALFORMATIONS; P75 NEUROTROPHIN RECEPTOR; 2-HIT MECHANISM; CELL-DEATH; APOPTOSIS; MEDULLOBLASTOMA; ACTIVATION; NEUROBLASTOMA; EXPRESSION; PATHWAY	The TrkA receptor tyrosine kinase is crucial for differentiation and survival of nerve-growth-factor-dependent neurons. Paradoxically, TrkA also induces cell death in pediatric tumor cells of neural origin, via an unknown mechanism. Here, we show that CCM2, a gene product associated with cerebral cavernous malformations, interacts with the juxtamembrane region of TrkA via its phosphotyrosine binding (PTB) domain and mediates TrkA-induced death in diverse cell types. Both the PTB and Karet domains of CCM2 are required for TrkA-dependent cell death, such that the PTB domain determines the specificity of the interaction, and the Karet domain links to death pathways. Downregulation of CCM2 in medulloblastoma or neuroblastoma cells attenuates TrkA-dependent death. Combined high expression levels of CCM2 and TrkA are correlated with long-term survival in a large cohort of human neuroblastoma patients. Thus, CCM2 is a key mediator of TrkA-dependent cell death in pediatric neuroblastic tumors.	[Harel, Liraz; Costa, Barbara; Tcherpakov, Marianna; Levy, Zehava; Fainzilber, Mike] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel; [Zapatka, Marc; Eils, Roland; Brors, Benedikt] German Canc Res Ctr, Dept Theoret Bioinformat B080, D-69120 Heidelberg, Germany; [Oberthuer, Andre; Fischer, Matthias] Univ Cologne, Childrens Hosp, Dept Pediat Oncol & Hematol, D-50924 Cologne, Germany; [Oberthuer, Andre; Fischer, Matthias] Univ Cologne, Childrens Hosp, CMMC, D-50924 Cologne, Germany; [Hansford, Loen M.; Vojvodic, Milijana; Kaplan, David R.] Hosp Sick Children, Cell Biol Program, Toronto, ON M5G 1L7, Canada; [Chen, Zhe-Yu] Shandong Univ, Sch Med, Dept Neurobiol, Jinan 250012, Shandong, Peoples R China; [Lee, Francis S.] Cornell Univ, Weill Med Coll, Dept Psychiat, New York, NY 10021 USA; [Lee, Francis S.] Cornell Univ, Weill Med Coll, Dept Pharmacol, New York, NY 10021 USA; [Avigad, Smadar; Yaniv, Isaac] Schneider Childrens Med Ctr Israel, Felsenstein Med Res Ctr, IL-49202 Petah Tiqwa, Israel; [Shi, Leming] US FDA, Natl Ctr Toxicol Res, Jefferson, AR 72079 USA; [Eils, Roland] Univ Heidelberg, Dept Bioinformat & Funct Genom, IPMB, D-69120 Heidelberg, Germany	Weizmann Institute of Science; Helmholtz Association; German Cancer Research Center (DKFZ); University of Cologne; University of Cologne; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Shandong University; Cornell University; Cornell University; Tel Aviv University; US Food & Drug Administration (FDA); Ruprecht Karls University Heidelberg	Fainzilber, M (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	mike.fainzilber@weizmann.ac.il	Shi, Leming/B-3150-2010; Brors, Benedikt/E-5620-2013; Eils, Roland/B-6121-2009; Zapatka, Marc/G-9896-2013	Shi, Leming/0000-0002-7143-2033; Brors, Benedikt/0000-0001-5940-3101; Eils, Roland/0000-0002-0034-4036; Zapatka, Marc/0000-0001-8287-5967; Fainzilber, Mike/0000-0001-8173-8557; Costa, Barbara/0000-0001-5958-5099	Israel Science Foundation; M.D. Moross Institute for Cancer Research; National Cancer Institute of Canada; European Commission [CT-2006-037260]; German Federal Ministry of Research and Education [01 GS0895, 01 GS0896]; Deutsche Krebshilfe [50-2719]; Auerbachstiftung; Competence Network Pediatric Oncology and Hematology (KPOH); U.S. Food and Drug Administration (FDA) Office of Critical Path Programs	Israel Science Foundation(Israel Science Foundation); M.D. Moross Institute for Cancer Research; National Cancer Institute of Canada(Canadian Cancer Society (CCS)); European Commission(European CommissionEuropean Commission Joint Research Centre); German Federal Ministry of Research and Education; Deutsche Krebshilfe(Deutsche Krebshilfe); Auerbachstiftung; Competence Network Pediatric Oncology and Hematology (KPOH); U.S. Food and Drug Administration (FDA) Office of Critical Path Programs	We thank Moses Chao, Carlos Ibanez, Virginia Lee, and Louis Reichardt for generous gifts of cell lines or reagents. Supported by the Israel Science Foundation, the M.D. Moross Institute for Cancer Research, the National Cancer Institute of Canada, the European Commission (FP6 RTN Endocyte and FP6 LSHC CT-2006-037260), the German Federal Ministry of Research and Education (National Genome Research Network Plus, grants 01 GS0895 and 01 GS0896), the Deutsche Krebshilfe (grant 50-2719), the Auerbachstiftung, and the Competence Network Pediatric Oncology and Hematology (KPOH). M. Fainzilber is the incumbent of the Chaya Professorial Chair in Molecular Neuroscience at the Weizmann Institute of Science. L. Shi acknowledges support from the U.S. Food and Drug Administration (FDA) Office of Critical Path Programs, however the views presented in this article do not necessarily reflect those of the U.S. FDA.	Akers AL, 2009, HUM MOL GENET, V18, P919, DOI 10.1093/hmg/ddn430; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; Bronfman FC, 2003, J NEUROSCI, V23, P3209; Bronfman FC, 2004, EMBO REP, V5, P867, DOI 10.1038/sj.embor.7400219; CHAO MV, 2003, SCI STKE, pPE38; Chen L, 2009, STROKE, V40, P1474, DOI 10.1161/STROKEAHA.108.527135; Chen ZY, 2005, MOL BIOL CELL, V16, P5761, DOI 10.1091/mbc.E05-07-0651; Chou TT, 2000, J BIOL CHEM, V275, P565, DOI 10.1074/jbc.275.1.565; Eberhart CG, 2001, J NEUROPATH EXP NEUR, V60, P462, DOI 10.1093/jnen/60.5.462; Goudreault M, 2009, MOL CELL PROTEOMICS, V8, P157, DOI 10.1074/mcp.M800266-MCP200; Gulino A, 2008, CURR OPIN ONCOL, V20, P668, DOI 10.1097/CCO.0b013e32831369f4; Hansen K, 2007, J NEUROCHEM, V103, P259, DOI 10.1111/j.1471-4159.2007.04753.x; Hothorn T, 2003, COMPUT STAT DATA AN, V43, P121, DOI 10.1016/S0167-9473(02)00225-6; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Jung EJ, 2008, MOL CELLS, V26, P12; Kim JYH, 1999, CANCER RES, V59, P711; Kleaveland B, 2009, NAT MED, V15, P169, DOI 10.1038/nm.1918; Lavoie JF, 2005, J BIOL CHEM, V280, P29199, DOI 10.1074/jbc.M502364200; Muragaki Y, 1997, J NEUROSCI, V17, P530; Nakagawara A, 2004, PROG BRAIN RES, V146, P233, DOI 10.1016/S0079-6123(03)46015-9; Ohta T, 2006, NEUROPATHOLOGY, V26, P170, DOI 10.1111/j.1440-1789.2006.00678.x; Pagenstecher A, 2009, HUM MOL GENET, V18, P911, DOI 10.1093/hmg/ddn420; PENG X, 1995, NEURON, V15, P395, DOI 10.1016/0896-6273(95)90043-8; Plummer NW, 2006, MAMM GENOME, V17, P119, DOI 10.1007/s00335-005-0098-8; Taylor JMG, 2008, CLIN CANCER RES, V14, P5977, DOI 10.1158/1078-0432.CCR-07-4534; Tcherpakov M, 2002, J BIOL CHEM, V277, P49101, DOI 10.1074/jbc.C200533200; Ullrich NJ, 2003, NEUROL CLIN, V21, P897, DOI 10.1016/S0733-8619(03)00014-8; Whitehead KJ, 2009, NAT MED, V15, P177, DOI 10.1038/nm.1911; Yano H, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-03-j0003.2001; Zawistowski JS, 2005, HUM MOL GENET, V14, P2521, DOI 10.1093/hmg/ddi256	30	45	45	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 10	2009	63	5					585	591		10.1016/j.neuron.2009.08.020	http://dx.doi.org/10.1016/j.neuron.2009.08.020			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	494XH	19755102	Bronze			2022-12-24	WOS:000269852300006
J	van Beers, RJ				van Beers, Robert J.			Motor Learning Is Optimally Tuned to the Properties of Motor Noise	NEURON			English	Article							MOVEMENT VARIABILITY; REACHING MOVEMENTS; ADAPTATION; ACCURACY; DYNAMICS; TASK; TRANSFORMATIONS; UNCERTAINTY; CALIBRATION; SYSTEMS	In motor learning, our brain uses movement errors to adjust planning of future movements. This process has traditionally been studied by examining how motor planning is adjusted in response to visuomotor or dynamic perturbations. Here, I show that the learning strategy can be better identified from the statistics of movements made in the absence of perturbations. The strategy identified this way differs from the learning mechanism assumed in mainstream models for motor learning. Crucial for this strategy is that motor noise arises partly centrally, in movement planning, and partly peripherally, in movement execution. Corrections are made by modification of central planning signals from the previous movement, which include the effects of planning but not execution noise. The size of the corrections is such that the movement variability is minimized. This physiologically plausible strategy is optimally tuned to the properties of motor noise, and likely underlies learning in many motor tasks.	[van Beers, Robert J.] Univ Utrecht, Dept Phys Man, Helmholtz Inst, NL-3584 CH Utrecht, Netherlands; [van Beers, Robert J.] Vrije Univ Amsterdam, Res Inst MOVE, Fac Human Movement Sci, NL-1081 BT Amsterdam, Netherlands	Utrecht University; Vrije Universiteit Amsterdam	van Beers, RJ (corresponding author), Univ Utrecht, Dept Phys Man, Helmholtz Inst, Padualaan 8, NL-3584 CH Utrecht, Netherlands.	r.vanbeers@fbw.vu.nl	van Beers, Robert J/R-7248-2018	van Beers, Robert J/0000-0003-3847-8918				Baddeley RJ, 2003, J NEUROSCI, V23, P3066; Berniker M, 2008, NAT NEUROSCI, V11, P1454, DOI 10.1038/nn.2229; Burge J, 2008, J VISION, V8, DOI 10.1167/8.4.20; Cheng S, 2006, NEURAL COMPUT, V18, P760, DOI 10.1162/089976606775774651; Cheng S, 2007, J NEUROPHYSIOL, V97, P3057, DOI 10.1152/jn.00897.2006; Churchland MM, 2006, NEURON, V52, P1085, DOI 10.1016/j.neuron.2006.10.034; Churchland MM, 2006, J NEUROSCI, V26, P3697, DOI 10.1523/JNEUROSCI.3762-05.2006; Crapse TB, 2008, NAT REV NEUROSCI, V9, P587, DOI 10.1038/nrn2457; d'Avella A, 2006, J NEUROSCI, V26, P7791, DOI 10.1523/JNEUROSCI.0830-06.2006; Diedrichsen J, 2005, J NEUROSCI, V25, P9919, DOI 10.1523/JNEUROSCI.1874-05.2005; Donchin O, 2003, J NEUROSCI, V23, P9032; Faisal AA, 2008, NAT REV NEUROSCI, V9, P292, DOI 10.1038/nrn2258; GORDON J, 1994, EXP BRAIN RES, V99, P97, DOI 10.1007/BF00241415; HANSEN RM, 1977, VISION RES, V17, P919, DOI 10.1016/0042-6989(77)90067-0; Ingram HA, 2000, EXP BRAIN RES, V132, P114, DOI 10.1007/s002219900322; Jones KE, 2002, J NEUROPHYSIOL, V88, P1533, DOI 10.1152/jn.2002.88.3.1533; Kagerer FA, 1997, EXP BRAIN RES, V115, P557, DOI 10.1007/PL00005727; KENDALL MG, 1954, BIOMETRIKA, V41, P403, DOI 10.1093/biomet/41.3-4.403; Klassen J, 2005, EXP BRAIN RES, V164, P250, DOI 10.1007/s00221-005-2247-4; Kording KP, 2007, NAT NEUROSCI, V10, P779, DOI 10.1038/nn1901; Korenberg AT, 2002, CAH PSYCHOL COGN, V21, P537; Krakauer JW, 2000, J NEUROSCI, V20, P8916, DOI 10.1523/jneurosci.20-23-08916.2000; Magescas F, 2006, J COGNITIVE NEUROSCI, V18, P75, DOI 10.1162/089892906775250058; MARRIOTT FHC, 1954, BIOMETRIKA, V41, P390; MARSHALL RJ, 1980, BIOMETRIKA, V67, P567; Miall RC, 1996, NEURAL NETWORKS, V9, P1265, DOI 10.1016/S0893-6080(96)00035-4; Mulliken GH, 2008, P NATL ACAD SCI USA, V105, P8170, DOI 10.1073/pnas.0802602105; Rokni U, 2007, NEURON, V54, P653, DOI 10.1016/j.neuron.2007.04.030; Scheidt RA, 2001, J NEUROPHYSIOL, V86, P971, DOI 10.1152/jn.2001.86.2.971; Scheidt RA, 2007, J NEUROPHYSIOL, V97, P2824, DOI 10.1152/jn.00870.2006; SHADMEHR R, 1994, J NEUROSCI, V14, P3208; Shadmehr R., 2005, COMPUTATIONAL NEUROB; Smeets JBJ, 2006, P NATL ACAD SCI USA, V103, P18781, DOI 10.1073/pnas.0607687103; Smith MA, 2006, PLOS BIOL, V4, P1035, DOI 10.1371/journal.pbio.0040179; SPERRY RW, 1950, J COMP PHYSIOL PSYCH, V43, P482, DOI 10.1037/h0055479; Thoroughman KA, 2000, NATURE, V407, P742, DOI 10.1038/35037588; Troyer TW, 2000, J NEUROPHYSIOL, V84, P1204, DOI 10.1152/jn.2000.84.3.1204; van Beers RJ, 2004, J NEUROPHYSIOL, V91, P1050, DOI 10.1152/jn.00652.2003; van Beers RJ, 1998, EXP BRAIN RES, V122, P367, DOI 10.1007/s002210050525; von Helmholtz H., 1867, HDB PHYSL OPTIK, VVol. 9, DOI 10.1007/BF01708548; VONHOLST E, 1950, NATURWISSENSCHAFTEN, V37, P464, DOI 10.1007/BF00622503; Wei KL, 2009, J NEUROPHYSIOL, V101, P655, DOI 10.1152/jn.90545.2008; Welch R. B., 1978, PERCEPTUAL MODIFICAT; WING AM, 1973, PERCEPT PSYCHOPHYS, V14, P5, DOI 10.3758/BF03198607; Woodworth RS, 1899, PSYCHOL REV-MONOGR S, V3, P1	45	178	178	0	18	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	AUG 13	2009	63	3					406	417		10.1016/j.neuron.2009.06.025	http://dx.doi.org/10.1016/j.neuron.2009.06.025			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	487OY	19679079	Green Submitted, Bronze			2022-12-24	WOS:000269285500014
J	Hasegawa, K; Pomeroy, JE; Pera, MF				Hasegawa, Kouichi; Pomeroy, Jordan E.; Pera, Martin F.			Current Technology for the Derivation of Pluripotent Stem Cell Lines from Human Embryos	CELL STEM CELL			English	Review							DEFINED CULTURE-CONDITIONS; FIBROBLAST-GROWTH-FACTOR; IN-VITRO FERTILIZATION; SELF-RENEWAL; HUMAN BLASTOCYSTS; CRYOPRESERVATION METHOD; ROCK INHIBITOR; SERUM-FREE; UNDIFFERENTIATED GROWTH; MAINTAIN PLURIPOTENCY	Technology for the derivation, propagation, and characterization of pluripotent stem cell lines from the human embryo has undergone considerable refinement and improvement since the first published description of human embryonic stem cells in 1998. In particular, there has been extensive effort to optimize protocols and develop defined culture systems with a view toward future clinical applications of embryonic stem cell-derived products. Here, we review the current status of methodology for human embryonic stem cell derivation and culture, and we highlight the challenges that remain for workers in the field.	[Hasegawa, Kouichi; Pomeroy, Jordan E.; Pera, Martin F.] Univ So Calif, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Keck Sch Med, Los Angeles, CA 90033 USA	University of Southern California	Pera, MF (corresponding author), Univ So Calif, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Keck Sch Med, Los Angeles, CA 90033 USA.	pera@usc.edu	Hasegawa, Kouichi/Y-9349-2019; PERA, MARTIN/A-9812-2012	Hasegawa, Kouichi/0000-0001-5947-5471; PERA, MARTIN/0000-0001-6239-0428; Pomeroy, Jordan/0000-0003-2640-7960				Adewumi O, 2007, NAT BIOTECHNOL, V25, P803, DOI 10.1038/nbt1318; Ahrlund-Richter L, 2009, CELL STEM CELL, V4, P20, DOI 10.1016/j.stem.2008.11.012; AKOPIAN V, 2010, CELL DEV BIOL ANIM, V46, P247; Amit M, 2000, DEV BIOL, V227, P271, DOI 10.1006/dbio.2000.9912; Amit M, 2004, BIOL REPROD, V70, P837, DOI 10.1095/biolreprod.103.021147; Armstrong L, 2006, HUM MOL GENET, V15, P1894, DOI 10.1093/hmg/ddl112; Bajpai R, 2008, MOL REPROD DEV, V75, P818, DOI 10.1002/mrd.20809; Bendall SC, 2007, NATURE, V448, P1015, DOI 10.1038/nature06027; Biggers JD, 2008, FERTIL STERIL, V90, P473, DOI 10.1016/j.fertnstert.2008.08.010; Blum B, 2008, ADV CANCER RES, V100, P133, DOI 10.1016/S0065-230X(08)00005-5; BONGSO A, 1994, HUM REPROD, V9, P2110, DOI 10.1093/oxfordjournals.humrep.a138401; Bongso A, 2005, STEM CELL REV, V1, P87, DOI 10.1385/SCR:1:2:087; Botros L, 2008, MOL HUM REPROD, V14, P679, DOI 10.1093/molehr/gan066; Braam SR, 2008, STEM CELLS, V26, P2257, DOI 10.1634/stemcells.2008-0291; Catalina P, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-76; Chen AE, 2009, CELL STEM CELL, V4, P103, DOI 10.1016/j.stem.2008.12.001; Chin MH, 2009, CELL STEM CELL, V5, P111, DOI 10.1016/j.stem.2009.06.008; Choudhary M, 2007, STEM CELLS, V25, P3045, DOI 10.1634/stemcells.2007-0296; Chung Y, 2006, NATURE, V439, P216, DOI 10.1038/nature04277; Chung Y, 2008, CELL STEM CELL, V2, P113, DOI 10.1016/j.stem.2007.12.013; Cooke MJ, 2006, STEM CELLS DEV, V15, P254, DOI 10.1089/scd.2006.15.254; COOPER S, 1988, DEVELOPMENT, V104, P565; Cowan CA, 2004, NEW ENGL J MED, V350, P1353, DOI 10.1056/NEJMsr040330; Crook JM, 2007, CELL STEM CELL, V1, P490, DOI 10.1016/j.stem.2007.10.004; Daheron L, 2004, STEM CELLS, V22, P770, DOI 10.1634/stemcells.22-5-770; Damoiseaux R, 2009, STEM CELLS, V27, P533, DOI 10.1634/stemcells.2008-0596; Desbordes SC, 2008, CELL STEM CELL, V2, P602, DOI 10.1016/j.stem.2008.05.010; Doi A, 2009, NAT GENET, V41, P1350, DOI 10.1038/ng.471; Dravid G, 2005, STEM CELLS, V23, P1489, DOI 10.1634/stemcells.2005-0034; Eiselleova L, 2009, STEM CELLS, V27, P1847, DOI 10.1002/stem.128; Ellerstrom C, 2006, STEM CELLS, V24, P2170, DOI 10.1634/stemcells.2006-0130; Ellerstrom C, 2010, METHODS MOL BIOL, V584, P121, DOI 10.1007/978-1-60761-369-5_7; Ellis J, 2009, CELL STEM CELL, V4, P198, DOI 10.1016/j.stem.2009.02.010; Escobedo-Lucea C, 2010, METHODS MOL BIOL, V584, P55, DOI 10.1007/978-1-60761-369-5_3; Evseenko D, 2009, STEM CELLS DEV, V18, P919, DOI 10.1089/scd.2008.0293; Ezashi T, 2005, P NATL ACAD SCI USA, V102, P4783, DOI 10.1073/pnas.0501283102; Fletcher JM, 2006, CLONING STEM CELLS, V8, P319, DOI 10.1089/clo.2006.8.319; Fong WJ, 2005, BIOPROC BIOSYST ENG, V27, P381, DOI 10.1007/s00449-005-0421-5; Forsyth NR, 2006, CLONING STEM CELLS, V8, P16, DOI 10.1089/clo.2006.8.16; Fujioka T, 2004, INT J DEV BIOL, V48, P1149, DOI 10.1387/ijdb.041852tf; Gauthaman K, 2009, BRIT J PHARMACOL, V157, P962, DOI 10.1111/j.1476-5381.2009.00241.x; Geens M, 2009, HUM REPROD, V24, P2709, DOI 10.1093/humrep/dep262; Gerecht S, 2007, P NATL ACAD SCI USA, V104, P11298, DOI 10.1073/pnas.0703723104; Gertow K, 2007, CURR PROTOC STEM CEL; Gonzalez R, 2010, P NATL ACAD SCI USA, V107, P3552, DOI 10.1073/pnas.0914019107; Hasegawa K, 2006, STEM CELLS, V24, P2649, DOI 10.1634/stemcells.2005-0657; Heng BC, 2007, BIOSCIENCE REP, V27, P257, DOI 10.1007/s10540-007-9051-2; Hu BY, 2010, P NATL ACAD SCI USA, V107, P4335, DOI 10.1073/pnas.0910012107; Humphrey RK, 2004, STEM CELLS, V22, P522, DOI 10.1634/stemcells.22-4-522; Hunt Charles J, 2007, Methods Mol Biol, V368, P261; Hyun I, 2007, CELL STEM CELL, V1, P367, DOI 10.1016/j.stem.2007.09.006; Ilic D., 2007, CURR PROTOC STEM CEL; Ilic D, 2009, STEM CELLS DEV, V18, P1343, DOI 10.1089/scd.2008.0416; Kattal N, 2008, FERTIL STERIL, V90, P1069, DOI 10.1016/j.fertnstert.2007.07.1349; Katz-Jaffe MG, 2009, MOL HUM REPROD, V15, P271, DOI 10.1093/molehr/gap012; Kim DS, 2010, STEM CELL REV REP, V6, P270, DOI 10.1007/s12015-010-9138-1; Kim HS, 2005, STEM CELLS, V23, P1228, DOI 10.1634/stemcells.2004-0296; Klimanskaya I, 2006, NATURE, V444, P481, DOI 10.1038/nature05142; Krawetz R, 2010, TISSUE ENG PART C-ME, V16, P573, DOI [10.1089/ten.tec.2009.0228, 10.1089/ten.TEC.2009.0228]; Kulkeaw K, 2010, STEM CELL REV REP, V6, P381, DOI 10.1007/s12015-010-9150-5; Laurent LC, 2010, NAT METHODS, V7, P6, DOI 10.1038/nmeth0110-06; Lee H, 2009, REGEN MED, V4, P759, DOI [10.2217/rme.09.46, 10.2217/RME.09.46]; Lee JY, 2010, FERTIL STERIL, V93, P976, DOI 10.1016/j.fertnstert.2008.10.017; Lerou PH, 2008, NAT PROTOC, V3, P923, DOI 10.1038/nprot.2008.60; Levenstein ME, 2008, STEM CELLS, V26, P3099, DOI 10.1634/stemcells.2007-1056; Li J, 2007, DIFFERENTIATION, V75, P299, DOI 10.1111/j.1432-0436.2006.00143.x; Li XY, 2009, HUM REPROD, V24, P580, DOI 10.1093/humrep/den404; Li Y, 2005, BIOTECHNOL BIOENG, V91, P688, DOI 10.1002/bit.20536; Lin TX, 2009, NAT METHODS, V6, P805, DOI [10.1038/nmeth.1393, 10.1038/NMETH.1393]; Liu YX, 2006, BIOCHEM BIOPH RES CO, V346, P131, DOI 10.1016/j.bbrc.2006.05.086; Loser P, 2010, STEM CELLS, V28, P240, DOI 10.1002/stem.286; Lu J, 2006, P NATL ACAD SCI USA, V103, P5688, DOI 10.1073/pnas.0601383103; Ludwig TE, 2006, NAT BIOTECHNOL, V24, P185, DOI 10.1038/nbt1177; Ludwig Tenneille, 2007, Curr Protoc Stem Cell Biol, VChapter 1, DOI 10.1002/9780470151808.sc01c02s2; Maherali N, 2008, CELL STEM CELL, V3, P595, DOI 10.1016/j.stem.2008.11.008; Manton KJ, 2010, STEM CELLS DEV, V19, P1297, DOI 10.1089/scd.2009.0504; Martin-Ibanez R, 2008, HUM REPROD, V23, P2744, DOI 10.1093/humrep/den316; McCormick JB, 2009, CELL STEM CELL, V4, P107, DOI 10.1016/j.stem.2009.01.002; Meng GL, 2010, STEM CELLS DEV, V19, P547, DOI 10.1089/scd.2009.0303; Meng Y, 2010, FASEB J, V24, P1056, DOI 10.1096/fj.08-126821; Mercader A, 2006, METHOD ENZYMOL, V420, P3, DOI 10.1016/S0076-6879(06)20001-6; Mitalipova M, 2003, STEM CELLS, V21, P521, DOI 10.1634/stemcells.21-5-521; Mitalipova MM, 2005, NAT BIOTECHNOL, V23, P19, DOI 10.1038/nbt0105-19; Miyazaki T, 2008, BIOCHEM BIOPH RES CO, V375, P27, DOI 10.1016/j.bbrc.2008.07.111; Morris GJ, 2006, REPROD BIOMED ONLINE, V13, P421, DOI 10.1016/S1472-6483(10)61448-4; Mosher JT, 2010, NEW ENGL J MED, V362, P183, DOI 10.1056/NEJMc0910371; Muller FJ, 2010, CELL STEM CELL, V6, P412, DOI 10.1016/j.stem.2010.04.009; Narva E, 2010, NAT BIOTECHNOL, V28, P371, DOI 10.1038/nbt.1615; Ng ES, 2005, BLOOD, V106, P1601, DOI 10.1182/blood-2005-03-0987; Nie Y, 2009, BIOTECHNOL PROGR, V25, P20, DOI 10.1002/btpr.110; Oh SKW, 2009, STEM CELL RES, V2, P219, DOI 10.1016/j.scr.2009.02.005; Peiffer I, 2010, METHODS MOL BIOL, V584, P97, DOI 10.1007/978-1-60761-369-5_5; Pera MF, 2004, J CELL SCI, V117, P1269, DOI 10.1242/jcs.00970; Phillips BW, 2008, J BIOTECHNOL, V138, P24, DOI 10.1016/j.jbiotec.2008.07.1997; Prokhorova TA, 2009, STEM CELLS DEV, V18, P47, DOI 10.1089/scd.2007.0266; Przyborski SA, 2005, STEM CELLS, V23, P1242, DOI 10.1634/stemcells.2005-0014; Rajala K, 2007, HUM REPROD, V22, P1231, DOI 10.1093/humrep/del523; Reubinoff BE, 2001, HUM REPROD, V16, P2187, DOI 10.1093/humrep/16.10.2187; Reubinoff BE, 2000, NAT BIOTECHNOL, V18, P399, DOI 10.1038/74447; Richards M, 2004, STEM CELLS, V22, P779, DOI 10.1634/stemcells.22-5-779; Rowland TJ, 2010, STEM CELLS DEV, V19, P1231, DOI 10.1089/scd.2009.0328; Sathananthan AH, 2010, METHODS MOL BIOL, V584, P1, DOI 10.1007/978-1-60761-369-5_1; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Scott CT, 2009, NAT BIOTECHNOL, V27, P696, DOI 10.1038/nbt0809-696; Smith KP, 2009, J CELL PHYSIOL, V220, P21, DOI 10.1002/jcp.21681; Soh BS, 2007, STEM CELLS, V25, P3029, DOI 10.1634/stemcells.2007-0372; SOLTER D, 1975, P NATL ACAD SCI USA, V72, P5099, DOI 10.1073/pnas.72.12.5099; Steiner D, 2010, NAT BIOTECHNOL, V28, P361, DOI 10.1038/nbt.1616; Stojkovic P, 2005, STEM CELLS, V23, P306, DOI 10.1634/stemcells.2004-0137; Strom S, 2007, HUM REPROD, V22, P3051, DOI 10.1093/humrep/dem335; Suemori H, 2006, BIOCHEM BIOPH RES CO, V345, P926, DOI 10.1016/j.bbrc.2006.04.135; Swistowski A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006233; Terstegge S, 2007, BIOTECHNOL BIOENG, V96, P195, DOI 10.1002/bit.21061; Terstegge S, 2009, J BIOTECHNOL, V143, P224, DOI 10.1016/j.jbiotec.2009.07.002; Thomas RJ, 2009, BIOTECHNOL BIOENG, V102, P1636, DOI 10.1002/bit.22187; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Turetsky T, 2008, HUM REPROD, V23, P46, DOI 10.1093/humrep/dem351; Unger C, 2008, HUM MOL GENET, V17, pR48, DOI 10.1093/hmg/ddn079; Vallier L, 2005, J CELL SCI, V118, P4495, DOI 10.1242/jcs.02553; Vallier L, 2009, DEVELOPMENT, V136, P1339, DOI 10.1242/dev.033951; Wagner KE, 2010, METHODS MOL BIOL, V584, P109, DOI 10.1007/978-1-60761-369-5_6; Ware CB, 2009, CELL STEM CELL, V4, P359, DOI 10.1016/j.stem.2009.03.001; Ware Carol B., 2007, V407, P43, DOI 10.1007/978-1-59745-536-7_4; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Werbowetski-Ogilvie TE, 2009, NAT BIOTECHNOL, V27, P91, DOI 10.1038/nbt.1516; Wong RCB, 2007, STEM CELLS DEV, V16, P989, DOI 10.1089/scd.2007.0057; Xiao L, 2006, STEM CELLS, V24, P1476, DOI 10.1634/stemcells.2005-0299; Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971; Xu RH, 2002, NAT BIOTECHNOL, V20, P1261, DOI 10.1038/nbt761; Xu RH, 2005, NAT METHODS, V2, P185, DOI 10.1038/NMETH744; Xu Y, 2010, P NATL ACAD SCI USA, V107, P8129, DOI 10.1073/pnas.1002024107; Yao S, 2006, P NATL ACAD SCI USA, V103, P6907, DOI 10.1073/pnas.0602280103; Yu PB, 2008, NAT MED, V14, P1363, DOI 10.1038/nm.1888	133	25	25	2	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUN 4	2010	6	6					521	531		10.1016/j.stem.2010.05.010	http://dx.doi.org/10.1016/j.stem.2010.05.010			11	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	611SB	20569689	Bronze			2022-12-24	WOS:000278840700012
J	Sul, JH; Kim, H; Huh, N; Lee, D; Jung, MW				Sul, Jung Hoon; Kim, Hoseok; Huh, Namjung; Lee, Daeyeol; Jung, Min Whan			Distinct Roles of Rodent Orbitofrontal and Medial Prefrontal Cortex in Decision Making	NEURON			English	Article							MIXED-STRATEGY GAME; FRONTAL-CORTEX; MIDBRAIN DOPAMINE; CINGULATE CORTEX; CELL-ACTIVITY; NEURAL BASIS; HUMAN BRAIN; RAT; REWARD; BEHAVIOR	We investigated how different subregions of rodent prefrontal cortex contribute to value-based decision making, by comparing neural signals related to animal's choice, its outcome, and action value in orbitofrontal cortex (OFC) and medial prefrontal cortex (mPFC) of rats performing a dynamic two-armed bandit task. Neural signals for upcoming action selection arose in the mPFC, including the anterior cingulate cortex, only immediately before the behavioral manifestation of animal's choice, suggesting that rodent prefrontal cortex is not involved in advanced action planning. Both OFC and mPFC conveyed signals related to the animal's past choices and their outcomes over multiple trials, but neural signals for chosen value and reward prediction error were more prevalent in the OFC. Our results suggest that rodent OFC and mPFC serve distinct roles in value-based decision making and that the OFC plays a prominent role in updating the values of outcomes expected from chosen actions.	[Sul, Jung Hoon; Kim, Hoseok; Huh, Namjung; Jung, Min Whan] Ajou Univ, Sch Med, Inst Med Sci, Neurosci Lab, Suwon 443721, South Korea; [Lee, Daeyeol] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06510 USA	Ajou University; Yale University	Jung, MW (corresponding author), Ajou Univ, Sch Med, Inst Med Sci, Neurosci Lab, Suwon 443721, South Korea.	min@ajou.ac.kr	Jung, Min Whan/GXF-5216-2022; Lee, Daeyeol/A-6794-2008	Lee, Daeyeol/0000-0003-3474-019X; Kim, Hoseok/0000-0002-2633-7416	Brain Research Center; National Institute of Health; NATIONAL INSTITUTE ON DRUG ABUSE [RL1DA024855] Funding Source: NIH RePORTER	Brain Research Center; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank Inah Lee for his helpful comments on the manuscript. This work was supported by a grant from Brain Research Center of the 21st Century Frontier Research Program (M.W.J.) and the National Institute of Health (D.L.).	Amiez C, 2005, EUR J NEUROSCI, V21, P3447, DOI 10.1111/j.1460-9568.2005.04170.x; Baeg EH, 2001, CEREB CORTEX, V11, P441, DOI 10.1093/cercor/11.5.441; Baeg EH, 2003, NEURON, V40, P177, DOI 10.1016/S0896-6273(03)00597-X; Baeg EH, 2007, J NEUROSCI, V27, P909, DOI 10.1523/JNEUROSCI.4759-06.2007; Bayer HM, 2005, NEURON, V47, P129, DOI 10.1016/j.neuron.2005.05.020; BEAR MF, 1995, NEURON, V15, P1, DOI 10.1016/0896-6273(95)90056-X; Belova MA, 2007, NEURON, V55, P970, DOI 10.1016/j.neuron.2007.08.004; BERENDSE HW, 1992, J COMP NEUROL, V316, P314, DOI 10.1002/cne.903160305; Birrell JM, 2000, J NEUROSCI, V20, P4320; Buckley MJ, 2009, SCIENCE, V325, P52, DOI 10.1126/science.1172377; Coe B, 2002, J NEUROSCI, V22, P5081, DOI 10.1523/JNEUROSCI.22-12-05081.2002; Corrado G, 2007, J NEUROSCI, V27, P8178, DOI 10.1523/JNEUROSCI.1590-07.2007; Curtis CE, 2010, TRENDS COGN SCI, V14, P216, DOI 10.1016/j.tics.2010.03.006; Daw ND, 2006, NATURE, V441, P876, DOI 10.1038/nature04766; Feierstein CE, 2006, NEURON, V51, P495, DOI 10.1016/j.neuron.2006.06.032; Felsen G, 2008, NEURON, V60, P137, DOI 10.1016/j.neuron.2008.09.019; Furuyashiki T, 2008, J NEUROSCI, V28, P5127, DOI 10.1523/JNEUROSCI.0319-08.2008; Hong S, 2008, NEURON, V60, P720, DOI 10.1016/j.neuron.2008.09.035; Huh N, 2009, LEARN MEMORY, V16, P315, DOI 10.1101/lm.1295509; Ito M, 2009, J NEUROSCI, V29, P9861, DOI 10.1523/JNEUROSCI.6157-08.2009; Jung MW, 2008, REV NEUROSCIENCE, V19, P29; Kennerley SW, 2009, EUR J NEUROSCI, V29, P2061, DOI 10.1111/j.1460-9568.2009.06743.x; Kennerley SW, 2009, J COGNITIVE NEUROSCI, V21, P1162, DOI 10.1162/jocn.2009.21100; Kesner RP, 2004, NEUROBIOL LEARN MEM, V82, P199, DOI 10.1016/j.nlm.2004.05.007; Kim H, 2009, J NEUROSCI, V29, P14701, DOI 10.1523/JNEUROSCI.2728-09.2009; Kim YB, 2007, J NEUROPHYSIOL, V98, P3548, DOI 10.1152/jn.00310.2007; Lau B, 2005, J EXP ANAL BEHAV, V84, P555, DOI 10.1901/jeab.2005.110-04; Lee D, 2008, NAT NEUROSCI, V11, P404, DOI 10.1038/nn2065; Lee DY, 2007, ANN NY ACAD SCI, V1104, P108, DOI 10.1196/annals.1390.007; Lee D, 2007, J NEUROSCI, V27, P8170, DOI 10.1523/JNEUROSCI.1561-07.2007; Lee DY, 2006, CURR OPIN NEUROBIOL, V16, P191, DOI 10.1016/j.conb.2006.02.001; Mainen ZF, 2009, CURR OPIN NEUROBIOL, V19, P84, DOI 10.1016/j.conb.2009.03.010; Matsumoto M, 2007, NAT NEUROSCI, V10, P647, DOI 10.1038/nn1890; Matsumoto M, 2009, NATURE, V459, P837, DOI 10.1038/nature08028; Morris G, 2004, NEURON, V43, P133, DOI 10.1016/j.neuron.2004.06.012; NEAFSEY EJ, 1986, BRAIN RES REV, V11, P77, DOI 10.1016/0165-0173(86)90011-1; O'Doherty JP, 2007, ANN NY ACAD SCI, V1121, P254, DOI 10.1196/annals.1401.036; O'Doherty JP, 2003, NEURON, V38, P329, DOI 10.1016/S0896-6273(03)00169-7; O'Doherty JP, 2004, CURR OPIN NEUROBIOL, V14, P769, DOI 10.1016/j.conb.2004.10.016; Ostlund SB, 2007, J NEUROSCI, V27, P4819, DOI 10.1523/JNEUROSCI.5443-06.2007; Ragozzino ME, 2007, ANN NY ACAD SCI, V1121, P355, DOI 10.1196/annals.1401.013; REEP RL, 1990, J COMP NEUROL, V294, P262, DOI 10.1002/cne.902940210; Rescorla R., 1972, CLASSICAL CONDITION, DOI DOI 10.1101/GR.110528.110; Rolls ET, 2008, PROG NEUROBIOL, V86, P216, DOI 10.1016/j.pneurobio.2008.09.001; Rolls ET, 2000, CEREB CORTEX, V10, P284, DOI 10.1093/cercor/10.3.284; ROSENKILDE CE, 1981, BRAIN RES, V209, P375, DOI 10.1016/0006-8993(81)90160-8; Rushworth MFS, 2007, TRENDS COGN SCI, V11, P168, DOI 10.1016/j.tics.2007.01.004; Rushworth MFS, 2008, NAT NEUROSCI, V11, P389, DOI 10.1038/nn2066; Rushworth MFS, 2007, CURR OPIN NEUROBIOL, V17, P220, DOI 10.1016/j.conb.2007.03.001; Rushworth MFS, 2009, CURR OPIN NEUROBIOL, V19, P75, DOI 10.1016/j.conb.2009.02.005; SANDERSON KJ, 1984, BRAIN RES, V292, P251, DOI 10.1016/0006-8993(84)90761-3; Schilman EA, 2008, NEUROSCI LETT, V432, P40, DOI 10.1016/j.neulet.2007.12.024; Schoenbaum G, 2006, TRENDS NEUROSCI, V29, P116, DOI 10.1016/j.tins.2005.12.006; Schoenbaum G, 2009, NAT REV NEUROSCI, V10, P885, DOI 10.1038/nrn2753; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Schultz W, 2006, ANNU REV PSYCHOL, V57, P87, DOI 10.1146/annurev.psych.56.091103.070229; Seo H, 2008, PHILOS T R SOC B, V363, P3845, DOI 10.1098/rstb.2008.0158; Seo H, 2007, J NEUROSCI, V27, P8366, DOI 10.1523/JNEUROSCI.2369-07.2007; Seo H, 2009, J NEUROSCI, V29, P7278, DOI 10.1523/JNEUROSCI.1479-09.2009; Sutton R.S., 2015, REINFORCEMENT LEARNI, V2nd ed.; Takahashi YK, 2009, NEURON, V62, P269, DOI 10.1016/j.neuron.2009.03.005; THORPE SJ, 1983, EXP BRAIN RES, V49, P93; Vertes RP, 2006, NEUROSCIENCE, V142, P1, DOI 10.1016/j.neuroscience.2006.06.027; Vertes RP, 2004, SYNAPSE, V51, P32, DOI 10.1002/syn.10279; Wallis JD, 2007, ANNU REV NEUROSCI, V30, P31, DOI 10.1146/annurev.neuro.30.051606.094334	65	232	234	0	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 13	2010	66	3					449	460		10.1016/j.neuron.2010.03.033	http://dx.doi.org/10.1016/j.neuron.2010.03.033			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	598HE	20471357	Green Accepted, Green Published, Bronze			2022-12-24	WOS:000277825200013
J	Tang, FC; Barbacioru, C; Bao, SQ; Lee, C; Nordman, E; Wang, XH; Lao, KQ; Surani, MA				Tang, Fuchou; Barbacioru, Catalin; Bao, Siqin; Lee, Caroline; Nordman, Ellen; Wang, Xiaohui; Lao, Kaiqin; Surani, M. Azim			Tracing the Derivation of Embryonic Stem Cells from the Inner Cell Mass by Single-Cell RNA-Seq Analysis	CELL STEM CELL			English	Article							SELF-RENEWAL; PLURIPOTENCY; DIFFERENTIATION; NANOG; EXPRESSION; GENES; DICER; ESTABLISHMENT; DOWNSTREAM; COMPONENT	During the transition from the inner cell mass (ICM) cells of blastocysts to pluripotent embryonic stem cells (ESCs) in vitro, a normal developmental program is replaced in cells that acquire a capacity for infinite self-renewal and pluripotency. We explored the underlying mechanism of this switch by using RNA-Seq transcriptome analysis at the resolution of single cells. We detected significant molecular transitions and major changes in transcript variants, which include genes for general metabolism. Furthermore, the expression of repressive epigenetic regulators increased with a concomitant decrease in gene activators that might be necessary to sustain the inherent plasticity of ESCs. Furthermore, we detected changes in microRNAs (miRNAs), with one set that targets early differentiation genes while another set targets pluripotency genes to maintain the unique ESC epigenotype. Such genetic and epigenetic events may contribute to a switch from a normal developmental program in adult cells during the formation of diseased tissues, including cancers.	[Barbacioru, Catalin; Nordman, Ellen; Wang, Xiaohui; Lao, Kaiqin] Appl Biosyst Inc, Genet Syst, Foster City, CA 94404 USA; [Tang, Fuchou; Bao, Siqin; Lee, Caroline; Surani, M. Azim] Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst Canc & Dev, Cambridge CB2 1QN, England	Thermo Fisher Scientific; Applied Biosystems; University of Cambridge	Lao, KQ (corresponding author), Appl Biosyst Inc, Genet Syst, 850 Lincoln Ctr Dr, Foster City, CA 94404 USA.	kai.lao@lifetech.com; a.surani@gurdon.cam.ac.uk		Surani, Azim/0000-0002-8640-4318	Wellcome Trust; Medical Research Council [G0800784B, G0800784] Funding Source: researchfish; MRC [G0800784] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We would like to thank J. Bodeau, E. Dimalanta, S. Dadi, E. Langit, P. Brzoska, J. Au-Young, and J. Sherlock for performing sequencing runs, design, and preparation of real-time PCR assays. We would also like to thank K. Hayashi, S. Jeffery, and W. Mifsud for insightful discussions. The work was supported by a grant from the Wellcome Trust to M.A.S.	Aksoy I, 2007, STEM CELLS, V25, P2996, DOI 10.1634/stemcells.2007-0066; Bao SQ, 2009, NATURE, V461, P1292, DOI 10.1038/nature08534; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Card DAG, 2008, MOL CELL BIOL, V28, P6426, DOI 10.1128/MCB.00359-08; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chen M, 2009, NAT REV MOL CELL BIO, V10, P741, DOI 10.1038/nrm2777; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Chou YF, 2008, CELL, V135, P449, DOI 10.1016/j.cell.2008.08.035; Cloonan N, 2008, NAT METHODS, V5, P613, DOI 10.1038/nmeth.1223; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Fujikura J, 2002, GENE DEV, V16, P784, DOI 10.1101/gad.968802; Gangaraju VK, 2009, NAT REV MOL CELL BIO, V10, P116, DOI 10.1038/nrm2621; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Johnson BV, 2006, CURR OPIN GENET DEV, V16, P447, DOI 10.1016/j.gde.2006.08.012; Kaji K, 2006, NAT CELL BIOL, V8, P285, DOI 10.1038/ncb1372; Kaji K, 2007, DEVELOPMENT, V134, P1123, DOI 10.1242/dev.02802; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; Koutsourakis M, 1999, DEVELOPMENT, V126, P723; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Kunath T, 2007, DEVELOPMENT, V134, P2895, DOI 10.1242/dev.02880; Kunin V, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-401; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Loh YH, 2008, CELL CYCLE, V7, P885, DOI 10.4161/cc.7.7.5636; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Morrisey EE, 1998, GENE DEV, V12, P3579, DOI 10.1101/gad.12.22.3579; Murchison EP, 2005, P NATL ACAD SCI USA, V102, P12135, DOI 10.1073/pnas.0505479102; Nichols J, 2009, DEVELOPMENT, V136, P3215, DOI 10.1242/dev.038893; Niwa H, 2007, DEVELOPMENT, V134, P635, DOI 10.1242/dev.02787; O'Carroll D, 2001, MOL CELL BIOL, V21, P4330, DOI 10.1128/MCB.21.13.4330-4336.2001; Ogawa K, 2007, J CELL SCI, V120, P55, DOI 10.1242/jcs.03296; Ralston A, 2008, DEV BIOL, V313, P614, DOI 10.1016/j.ydbio.2007.10.054; Seguin CA, 2008, CELL STEM CELL, V3, P182, DOI 10.1016/j.stem.2008.06.018; Sharov AA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-269; Shen XH, 2008, MOL CELL, V32, P491, DOI 10.1016/j.molcel.2008.10.016; Smith A, 2006, NATURE, V441, P1060, DOI 10.1038/nature04954; Stavridis MP, 2007, DEVELOPMENT, V134, P2889, DOI 10.1242/dev.02858; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Takahashi K, 2003, NATURE, V423, P541, DOI 10.1038/nature01646; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tang FC, 2006, NAT PROTOC, V1, P1154, DOI 10.1038/nprot.2006.161; Tang FC, 2010, NAT PROTOC, V5, P516, DOI 10.1038/nprot.2009.236; Tang FC, 2009, NAT METHODS, V6, P377, DOI [10.1038/NMETH.1315, 10.1038/nmeth.1315]; Tsuneyoshi N, 2008, BIOCHEM BIOPH RES CO, V367, P899, DOI 10.1016/j.bbrc.2007.12.189; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Wang YM, 2007, NAT GENET, V39, P380, DOI 10.1038/ng1969; Yeom YI, 1996, DEVELOPMENT, V122, P881; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; Zamore PD, 2005, SCIENCE, V309, P1519, DOI 10.1126/science.1111444; Zwaka TP, 2005, DEVELOPMENT, V132, P227, DOI 10.1242/dev.01586	53	376	391	2	69	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAY 7	2010	6	5					468	478		10.1016/j.stem.2010.03.015	http://dx.doi.org/10.1016/j.stem.2010.03.015			11	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	598NO	20452321	Green Published, hybrid			2022-12-24	WOS:000277844800014
J	Chalk, M; Herrero, JL; Gieselmann, MA; Delicato, LS; Gotthardt, S; Thiele, A				Chalk, Matthew; Herrero, Jose L.; Gieselmann, Mark A.; Delicato, Louise S.; Gotthardt, Sascha; Thiele, Alexander			Attention Reduces Stimulus-Driven Gamma Frequency Oscillations and Spike Field Coherence in V1	NEURON			English	Article							MUSCARINIC ACETYLCHOLINE-RECEPTORS; MACAQUE V1; NEURONAL SYNCHRONIZATION; SPATIAL INTEGRATION; NORMALIZATION MODEL; VISUAL-CORTEX; TOP-DOWN; MODULATION; RESPONSES; SELECTIVITY	Rhythmic activity of neuronal ensembles has been proposed to play an important role in cognitive functions such as attention, perception, and memory. Here we investigate whether rhythmic activity in VI of the macaque monkey (macaca mulatta) is affected by top-down visual attention. We measured the local field potential (LFP) and V1 spiking activity while monkeys performed an attention-demanding detection task. We show that gamma oscillations were strongly modulated by the stimulus and by attention. Stimuli that engaged inhibitory mechanisms induced the largest gamma LFP oscillations and the largest spike field coherence. Directing attention toward a visual stimulus at the receptive field of the recorded neurons decreased LFP gamma power and gamma spike field coherence. This decrease could reflect an attention-mediated reduction of surround inhibition. Changes in synchrony in Vi would thus be a byproduct of reduced inhibitory drive, rather than a mechanism that directly aids perceptual processing.	[Herrero, Jose L.; Gieselmann, Mark A.; Delicato, Louise S.; Gotthardt, Sascha; Thiele, Alexander] Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Chalk, Matthew] Univ Edinburgh, Sch Informat, Edinburgh EH8 9AB, Midlothian, Scotland	Newcastle University - UK; University of Edinburgh	Thiele, A (corresponding author), Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	alex.thiele@ncl.ac.uk	Delicato, Louise/AAT-1921-2020	Delicato, Louise/0000-0001-8271-2324; Thiele, Alexander/0000-0003-4894-0213; Chalk, Matthew/0000-0001-7782-4436	BBSRC; Wellcome Trust; BBSRC [BB/F021399/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F021399/1] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We would like to thank the staff of the Comparative Biology Centre (Newcastle University) for excellent technical support. The work was supported by the BBSRC and the Wellcome Trust.	Berens P, 2008, FRONT NEUROSCI-SWITZ, V2, P199, DOI 10.3389/neuro.01.037.2008; Bichot NP, 2005, SCIENCE, V308, P529, DOI 10.1126/science.1109676; Borgers C, 2005, NEURAL COMPUT, V17, P557, DOI 10.1162/0899766053019908; Borgers C, 2008, P NATL ACAD SCI USA, V105, P18023, DOI 10.1073/pnas.0809511105; Buehlmann A, 2008, J NEUROSCI, V28, P7679, DOI 10.1523/JNEUROSCI.5640-07.2008; Buia C, 2006, J COMPUT NEUROSCI, V20, P247, DOI 10.1007/s10827-006-6358-0; Buschman TJ, 2007, SCIENCE, V315, P1860, DOI 10.1126/science.1138071; Carrasco M, 2004, NAT NEUROSCI, V7, P308, DOI 10.1038/nn1194; Chun MM, 2002, CURR OPIN NEUROBIOL, V12, P184, DOI 10.1016/S0959-4388(02)00309-4; Deco G, 2009, EUR J NEUROSCI, V30, P347, DOI 10.1111/j.1460-9568.2009.06833.x; Disney AA, 2008, J COMP NEUROL, V507, P1748, DOI 10.1002/cne.21616; Disney AA, 2006, J COMP NEUROL, V499, P49, DOI 10.1002/cne.21096; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; Ghose GM, 2009, J NEUROPHYSIOL, V101, P2089, DOI 10.1152/jn.90654.2008; Gieselmann MA, 2008, EUR J NEUROSCI, V28, P447, DOI 10.1111/j.1460-9568.2008.06358.x; Gregoriou GG, 2009, SCIENCE, V324, P1207, DOI 10.1126/science.1171402; HEEGER DJ, 1992, VISUAL NEUROSCI, V9, P181, DOI 10.1017/S0952523800009640; Henrie JA, 2005, J NEUROPHYSIOL, V94, P479, DOI 10.1152/jn.00919.2004; Herrero JL, 2008, NATURE, V454, P1110, DOI 10.1038/nature07141; Hupe JM, 1998, NATURE, V394, P784, DOI 10.1038/29537; Lee J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004651; Martinez-Trujillo JC, 2004, CURR BIOL, V14, P744, DOI 10.1016/j.cub.2004.04.028; McAdams CJ, 2000, J NEUROPHYSIOL, V83, P1751, DOI 10.1152/jn.2000.83.3.1751; Munk MHJ, 1996, SCIENCE, V272, P271, DOI 10.1126/science.272.5259.271; Nauhaus I, 2009, NAT NEUROSCI, V12, P70, DOI 10.1038/nn.2232; Ozeki H, 2009, NEURON, V62, P578, DOI 10.1016/j.neuron.2009.03.028; PERCIVAL DB, 1993, SPECTRAL ANAL PHYS A, V98; Pestilli F, 2005, VISION RES, V45, P1867, DOI 10.1016/j.visres.2005.01.019; Rensink RA, 2000, VISION RES, V40, P1469, DOI 10.1016/S0042-6989(00)00003-1; Reynolds JH, 2009, NEURON, V61, P168, DOI 10.1016/j.neuron.2009.01.002; Roberts M, 2007, NAT NEUROSCI, V10, P1483, DOI 10.1038/nn1967; Rodriguez R, 2004, J NEUROSCI, V24, P10369, DOI 10.1523/JNEUROSCI.1839-04.2004; Roelfsema PR, 1998, NATURE, V395, P376, DOI 10.1038/26475; Sarter M, 2005, BRAIN RES REV, V48, P98, DOI 10.1016/j.brainresrev.2004.08.006; Sceniak MP, 2001, J NEUROPHYSIOL, V85, P1873, DOI 10.1152/jn.2001.85.5.1873; SPITZER H, 1988, SCIENCE, V240, P338, DOI 10.1126/science.3353728; Steinmetz PN, 2000, NATURE, V404, P187, DOI 10.1038/35004588; Sundberg KA, 2009, NEURON, V61, P952, DOI 10.1016/j.neuron.2009.02.023; Thiele A, 2006, J NEUROSCI METH, V158, P207, DOI 10.1016/j.jneumeth.2006.05.032; Thiele A, 2004, P NATL ACAD SCI USA, V101, P9810, DOI 10.1073/pnas.0307754101; Tiesinga PHE, 2004, NEURAL COMPUT, V16, P251, DOI 10.1162/089976604322742029; Traub RD, 1996, NATURE, V383, P621, DOI 10.1038/383621a0; Treue S, 1996, NATURE, V382, P539, DOI 10.1038/382539a0; Whittington MA, 2003, TRENDS NEUROSCI, V26, P676, DOI 10.1016/j.tins.2003.09.016; Womelsdorf T, 2007, CURR OPIN NEUROBIOL, V17, P154, DOI 10.1016/j.conb.2007.02.002; Xiang ZX, 2002, J NEUROPHYSIOL, V88, P740, DOI 10.1152/jn.2002.88.2.740; Xiang ZX, 1998, SCIENCE, V281, P985, DOI 10.1126/science.281.5379.985; Yu AJ, 2005, NEURON, V46, P681, DOI 10.1016/j.neuron.2005.04.026	50	190	192	2	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 15	2010	66	1					114	125		10.1016/j.neuron.2010.03.013	http://dx.doi.org/10.1016/j.neuron.2010.03.013			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	587TP	20399733	hybrid, Green Published, Green Accepted, Green Submitted			2022-12-24	WOS:000277016200013
J	Zhao, XH; He, XL; Han, XL; Yu, Y; Ye, F; Chen, Y; Hoang, T; Xu, XM; Mi, QS; Xin, M; Wang, F; Appel, B; Lu, QR				Zhao, Xianghui; He, Xuelian; Han, Xiaolei; Yu, Yang; Ye, Feng; Chen, Ying; Hoang, ThaoNguyen; Xu, Xiaomei; Mi, Qing-Sheng; Xin, Mei; Wang, Fan; Appel, Bruce; Lu, Q. Richard			MicroRNA-Mediated Control of Oligodendrocyte Differentiation	NEURON			English	Article							MULTIPLE-SCLEROSIS; GENE; CNS; NEUROGENESIS; CELLS; DICER; IDENTIFICATION; SPECIFICATION; REQUIREMENT; EXPRESSION	MicroRNAs (miRNAs) regulate various biological processes, but evidence for miRNAs that control the differentiation program of specific neural cell types has been elusive. To determine the role of miRNAs in the formation of myelinating oligodendrocytes, we selectively deleted a miRNA-processing enzyme, Dicer1, in oligodendrocyte lineage cells. Mice lacking Dicer1 display severe myelinating deficits despite an expansion of the oligodendrocyte progenitor pool. To search for miRNAs responsible for the induction of oligodendrocyte maturation, we identified miR-219 and miR-338 as oligodendrocyte-specific miRNAs in spinal cord. Overexpression of these miRNAs is sufficient to promote oligodendrocyte differentiation. Additionally, blockage of these miRNA activities in oligodendrocyte precursor culture and knockdown of miR-219 in zebrafish inhibit oligodendrocyte maturation. miR-219 and miR-338 function in part by directly repressing negative regulators of oligodendrocyte differentiation, including transcription factors Sox6 and Hes5. These findings illustrate that miRNAs are important regulators of oligodendrocyte differentiation, providing new targets for myelin repair.	[Zhao, Xianghui; Ye, Feng; Chen, Ying; Hoang, ThaoNguyen; Xu, Xiaomei; Lu, Q. Richard] Univ Texas SW Med Ctr Dallas, Dept Dev Biol, Dallas, TX 75390 USA; [Zhao, Xianghui; Ye, Feng; Chen, Ying; Hoang, ThaoNguyen; Xu, Xiaomei; Lu, Q. Richard] Univ Texas SW Med Ctr Dallas, Kent Waldrep Fdn Ctr Basic Neurosci Res Nerve Gro, Dallas, TX 75390 USA; [He, Xuelian; Han, Xiaolei; Yu, Yang] Sichuan Univ, W China Womens & Childrens Hosp, W China Dev & Stem Cell Inst, Chengdu 610041, Peoples R China; [He, Xuelian; Wang, Fan] Sichuan Univ, Dept Anat, Coll Preclin & Forens Med, Chengdu 610041, Peoples R China; [Mi, Qing-Sheng] Henry Ford Hlth Syst, Dept Dermatol, Henry Ford Immunol Program, Detroit, MI 48202 USA; [Mi, Qing-Sheng] Henry Ford Hlth Syst, Dept Internal Med, Henry Ford Immunol Program, Detroit, MI 48202 USA; [Xin, Mei; Lu, Q. Richard] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Appel, Bruce] Univ Colorado, Dept Pediat, Denver, CO 80045 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Sichuan University; Sichuan University; Henry Ford Health System; Henry Ford Hospital; Henry Ford Health System; Henry Ford Hospital; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Colorado System; University of Colorado Denver	Lu, QR (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Dev Biol, Dallas, TX 75390 USA.	qrichard.lu@utsouthwestern.edu	han, xiao/HDN-9782-2022; Messier, Claude/A-2322-2008; Appel, Bruce/X-6418-2019	Messier, Claude/0000-0002-4791-1763; Appel, Bruce/0000-0003-4500-0672; Zhao, Xianghui/0000-0003-1165-0140	US National Multiple Sclerosis Society [RG3978, PP0144]; US National Institutes of Health [NS050389]; Harry Weaver Neuroscience Scholar; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050389, R01NS046668] Funding Source: NIH RePORTER	US National Multiple Sclerosis Society(National Multiple Sclerosis Society); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harry Weaver Neuroscience Scholar(National Multiple Sclerosis Society); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors would like to thank Huashun Li, Qinjie Weng, Zhangyan Ma, Linan Chen, Wei Liu, Christina Kearns, and Sarah Casper for technical support. We thank Drs. Jonah Chan and Jianrong Li for a critical reading of the manuscript, Jason Dugas and Ben Barres for communicating unpublished results, Michael Wegner for Sox6 antibody, Fiona Doetsch for miRNA in situ protocol, James Amatruda for PCR primers, and Ellen Lu for graph drawing. This study was funded by grants from the US National Multiple Sclerosis Society (RG3978 and PP0144) and the US National Institutes of Health (NS050389 to Q.R.L.). Q.R.L. is a Harry Weaver Neuroscience Scholar.	Barik S, 2008, NUCLEIC ACIDS RES, V36, P5232, DOI 10.1093/nar/gkn513; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Berger J, 2001, CURR OPIN NEUROL, V14, P305, DOI 10.1097/00019052-200106000-00007; Chen Y, 2007, NAT PROTOC, V2, P1044, DOI 10.1038/nprot.2007.149; Cheng HYM, 2007, NEURON, V54, P813, DOI 10.1016/j.neuron.2007.05.017; Cheng LC, 2009, NAT NEUROSCI, V12, P399, DOI 10.1038/nn.2294; Copray S, 2009, GLIA, V57, P1579, DOI 10.1002/glia.20881; Dugas JC, 2010, NEURON, V65, P597, DOI 10.1016/j.neuron.2010.01.027; Emery B, 2009, CELL, V138, P172, DOI 10.1016/j.cell.2009.04.031; Flynt AS, 2008, NAT REV GENET, V9, P831, DOI 10.1038/nrg2455; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Harfe BD, 2005, P NATL ACAD SCI USA, V102, P10898, DOI 10.1073/pnas.0504834102; Hobert O, 2004, TRENDS BIOCHEM SCI, V29, P462, DOI 10.1016/j.tibs.2004.07.001; Hsieh J, 2004, J CELL BIOL, V164, P111, DOI 10.1083/jcb.200308101; John GR, 2002, NAT MED, V8, P1115, DOI 10.1038/nm781; Kawase-Koga Y, 2009, DEV DYNAM, V238, P2800, DOI 10.1002/dvdy.22109; Kim J, 2004, P NATL ACAD SCI USA, V101, P360, DOI 10.1073/pnas.2333854100; Kondo T, 2000, DEVELOPMENT, V127, P2989; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lau P, 2008, J NEUROSCI, V28, P11720, DOI 10.1523/JNEUROSCI.1932-08.2008; LEE JE, 1995, SCIENCE, V268, P836, DOI 10.1126/science.7754368; Leucht C, 2008, NAT NEUROSCI, V11, P641, DOI 10.1038/nn.2115; Liu AX, 2006, EMBO J, V25, P4833, DOI 10.1038/sj.emboj.7601352; Lu QR, 2002, CELL, V109, P75, DOI 10.1016/S0092-8674(02)00678-5; Megason SG, 2002, DEVELOPMENT, V129, P2087; Miller RH, 2002, PROG NEUROBIOL, V67, P451, DOI 10.1016/S0301-0082(02)00058-8; Okado H, 2009, DEV BIOL, V331, P140, DOI 10.1016/j.ydbio.2009.04.030; Pfaff SL, 1996, CELL, V84, P309, DOI 10.1016/S0092-8674(00)80985-X; Raghunath M, 2000, MOL BRAIN RES, V77, P151, DOI 10.1016/S0169-328X(00)00048-6; Rowitch DH, 2004, NAT REV NEUROSCI, V5, P409, DOI 10.1038/nrn1389; Schratt G, 2009, CURR OPIN NEUROBIOL, V19, P213, DOI 10.1016/j.conb.2009.05.015; Shen SM, 2008, J MOL NEUROSCI, V35, P13, DOI 10.1007/s12031-007-9014-x; Shin D, 2009, ANN NEUROL, V66, P843, DOI 10.1002/ana.21927; Shin Jimann, 2003, Methods in Cell Science, V25, P7, DOI 10.1023/B:MICS.0000006847.09037.3a; Stefani G, 2008, NAT REV MOL CELL BIO, V9, P219, DOI 10.1038/nrm2347; Stolt CC, 2006, DEV CELL, V11, P697, DOI 10.1016/j.devcel.2006.08.011; Thomson JM, 2006, GENE DEV, V20, P2202, DOI 10.1101/gad.1444406; Trapp BD, 1998, NEW ENGL J MED, V338, P278, DOI 10.1056/NEJM199801293380502; Tsai LM, 2010, CLIN EXP PHARMACOL P, V37, P102, DOI 10.1111/j.1440-1681.2009.05269.x; Vernay B, 2005, J NEUROSCI, V25, P4856, DOI 10.1523/JNEUROSCI.5158-04.2005; Visvanathan J, 2007, GENE DEV, V21, P744, DOI 10.1101/gad.1519107; Wang SL, 1998, NEURON, V21, P63, DOI 10.1016/S0896-6273(00)80515-2; Wegner M, 2008, J MOL NEUROSCI, V35, P3, DOI 10.1007/s12031-007-9008-8; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; Ye F, 2009, NAT NEUROSCI, V12, P829, DOI 10.1038/nn.2333	46	367	392	3	58	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 11	2010	65	5					612	626		10.1016/j.neuron.2010.02.018	http://dx.doi.org/10.1016/j.neuron.2010.02.018			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	571NF	20223198	Green Accepted, Bronze			2022-12-24	WOS:000275758000006
J	Li, PL; Zon, LI				Li, Pulin; Zon, Leonard I.			Resolving the controversy about N-cadherin and hematopoietic stem cells	CELL STEM CELL			English	Editorial Material							NICHE; ADHESION; EXPRESSION; DEPEND		[Li, Pulin; Zon, Leonard I.] Howard Hughes Med Inst, Stem Cell Program, Hematol Oncol, Childrens Hosp,Harvard Med Sch, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Howard Hughes Medical Institute	Zon, LI (corresponding author), Howard Hughes Med Inst, Stem Cell Program, Hematol Oncol, Childrens Hosp,Harvard Med Sch, Boston, MA 02115 USA.			Li, Pulin/0000-0002-8525-4936	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Foudi A, 2009, NAT BIOTECHNOL, V27, P84, DOI 10.1038/nbt.1517; FUJIMORI T, 1993, MOL BIOL CELL, V4, P37, DOI 10.1091/mbc.4.1.37; Haug JS, 2008, CELL STEM CELL, V2, P367, DOI 10.1016/j.stem.2008.01.017; Hosokawa K, 2007, BIOCHEM BIOPH RES CO, V363, P578, DOI 10.1016/j.bbrc.2007.09.014; Hosokawa K, 2010, CELL STEM CELL, V6, P194, DOI 10.1016/j.stem.2009.04.013; Kiel MJ, 2007, CELL STEM CELL, V1, P204, DOI 10.1016/j.stem.2007.06.001; Kiel MJ, 2009, CELL STEM CELL, V4, P170, DOI 10.1016/j.stem.2008.10.005; Kostetskii I, 2005, CIRC RES, V96, P346, DOI 10.1161/01.RES.0000156274.72390.2c; Matsunami H, 1995, DEV BIOL, V172, P466, DOI 10.1006/dbio.1995.8029; Radice GL, 1997, DEV BIOL, V181, P64, DOI 10.1006/dbio.1996.8443; Voog J, 2010, CELL STEM CELL, V6, P103, DOI 10.1016/j.stem.2010.01.011; Wilson A, 2004, GENE DEV, V18, P2747, DOI 10.1101/gad.313104; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	15	39	39	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAR 5	2010	6	3					199	202		10.1016/j.stem.2010.02.007	http://dx.doi.org/10.1016/j.stem.2010.02.007			4	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	577WL	20207222	Bronze			2022-12-24	WOS:000276254600015
J	Bremer, J; Baumann, F; Tiberi, C; Wessig, C; Fischer, H; Schwarz, P; Steele, AD; Toyka, KV; Nave, KA; Weis, J; Aguzzi, A				Bremer, Juliane; Baumann, Frank; Tiberi, Cinzia; Wessig, Carsten; Fischer, Heike; Schwarz, Petra; Steele, Andrew D.; Toyka, Klaus V.; Nave, Klaus-Armin; Weis, Joachim; Aguzzi, Adriano			Axonal prion protein is required for peripheral myelin maintenance	NATURE NEUROSCIENCE			English	Article							MICE DEFICIENT; AMINO-TERMINUS; PRP; KNOCKOUT; CLEAVAGE; LACKING; DOPPEL; MOUSE; MUTATION; REVEALS	The integrity of peripheral nerves relies on communication between axons and Schwann cells. The axonal signals that ensure myelin maintenance are distinct from those that direct myelination and are largely unknown. Here we show that ablation of the prion protein PrPC triggers a chronic demyelinating polyneuropathy (CDP) in four independently targeted mouse strains. Ablation of the neighboring Prnd locus, or inbreeding to four distinct mouse strains, did not modulate the CDP. CDP was triggered by depletion of PrPC specifically in neurons, but not in Schwann cells, and was suppressed by PrPC expression restricted to neurons but not to Schwann cells. CDP was prevented by PrPC variants that undergo proteolytic amino-proximal cleavage, but not by variants that are nonpermissive for cleavage, including secreted PrPC lacking its glycolipid membrane anchor. These results indicate that neuronal expression and regulated proteolysis of PrPC are essential for myelin maintenance.	[Bremer, Juliane; Baumann, Frank; Tiberi, Cinzia; Fischer, Heike; Schwarz, Petra; Aguzzi, Adriano] Univ Zurich Hosp, Inst Neuropathol, CH-8091 Zurich, Switzerland; [Wessig, Carsten; Toyka, Klaus V.] Univ Wurzburg, Dept Neurol, D-8700 Wurzburg, Germany; [Steele, Andrew D.] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Nave, Klaus-Armin] Max Planck Inst Expt Med, Dept Neurogenet, D-37075 Gottingen, Germany; [Weis, Joachim] Rheinisch Westfal TH Univ Aachen, Inst Neuropathol, Fac Med, Aachen, Germany	University of Zurich; University Zurich Hospital; University of Wurzburg; California Institute of Technology; Max Planck Society; RWTH Aachen University	Aguzzi, A (corresponding author), Univ Zurich Hosp, Inst Neuropathol, CH-8091 Zurich, Switzerland.	adriano.aguzzi@usz.ch	Nave, Klaus-Armin/C-8883-2011; Bremer, Juliane/AAH-9487-2020; Baumann, Frank/F-7737-2016; Aguzzi, Adriano/A-3351-2008; Weis, Joachim/G-1984-2014; Bremer, Juliane/E-2298-2012	Weis, Joachim/0000-0003-3280-6773; Aguzzi, Adriano/0000-0002-0344-6708	European Union; Novartis Foundation; Swiss National Foundation; University of Zurich; Departmental Research Fund	European Union(European Commission); Novartis Foundation(Novartis); Swiss National Foundation(Swiss National Science Foundation (SNSF)); University of Zurich; Departmental Research Fund	We thank M. Delic, R. Moos, D. Goriounov, C. Tostado, H. Mader, K. Nairz, M. Bieri, N. Wey and D. Meijer for methodological advice and technical help. G. Mallucci provided tgNFH-Cre and tgPrnp<SUP>loxP</SUP> mice, D. Meijer provided tgDhh-Cre mice, J.C. Manson provided Prnp<SUP>Edbg/Edbg</SUP> mice, J. Collinge provided Prnp<SUP>o/o</SUP> FVB mice, S. Lindquist and W. Jackson provided Prnp<SUP>GFP/GFP</SUP> mice and P. Saftig and A. Rittger provided nerves from BACE1<SUP>-/-</SUP> mice. We thank W. B. Macklin for the PLP plasmid; T. Rulicke for pronuclear injections and H. Welzl, I. Drescher and S. Wirth for help with behavioral tests. J. A. Girault and M. T. Dours-Zimmermann donated anti-paranodine/Caspr and anti-versican antibodies, respectively. We thank B. Seifert for statistical consulting. A. A. received an ERC Advanced Investigator Grant and grants from the European Union ( PRIORITY and LUPAS), the Novartis Foundation and the Swiss National Foundation. J. B. received a Career Development award from the University of Zurich. C. W. and K. V. T. were supported by the Departmental Research Fund.	Aguzzi A, 2008, ANNU REV NEUROSCI, V31, P439, DOI 10.1146/annurev.neuro.31.060407.125620; Baumann F, 2007, EMBO J, V26, P538, DOI 10.1038/sj.emboj.7601510; Behrens A, 2002, EMBO J, V21, P3652, DOI 10.1093/emboj/cdf386; Bermingham JR, 2006, NAT NEUROSCI, V9, P76, DOI 10.1038/nn1598; Brandner S, 1996, NATURE, V379, P339, DOI 10.1038/379339a0; Britsch S, 2007, ADV ANAT EMBRYOL CEL, V190, P1; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; Chen SZ, 2003, MOL CELL NEUROSCI, V22, P227, DOI 10.1016/S1044-7431(02)00014-3; Chesebro B, 2005, SCIENCE, V308, P1435, DOI 10.1126/science.1110837; COLLINGE J, 1994, NATURE, V370, P295, DOI 10.1038/370295a0; Fischer M, 1996, EMBO J, V15, P1255, DOI 10.1002/j.1460-2075.1996.tb00467.x; Genoud N, 2004, P NATL ACAD SCI USA, V101, P4198, DOI 10.1073/pnas.0400131101; Heikenwalder M, 2008, IMMUNITY, V29, P998, DOI 10.1016/j.immuni.2008.10.014; Hu XY, 2006, NAT NEUROSCI, V9, P1520, DOI 10.1038/nn1797; Isaacs JD, 2006, CLIN EXP IMMUNOL, V146, P1, DOI 10.1111/j.1365-2249.2006.03194.x; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Lindeboom F, 2003, NUCLEIC ACIDS RES, V31, P5405, DOI 10.1093/nar/gkg723; Liu T, 2002, J BIOL CHEM, V277, P47671, DOI 10.1074/jbc.M207458200; Lledo PM, 1996, P NATL ACAD SCI USA, V93, P2403, DOI 10.1073/pnas.93.6.2403; Mallucci GR, 2002, EMBO J, V21, P202, DOI 10.1093/emboj/21.3.202; Mange A, 2004, BIOL CELL, V96, P125, DOI 10.1016/j.biolcel.2003.11.007; MANSON JC, 1994, MOL NEUROBIOL, V8, P121, DOI 10.1007/BF02780662; McMahon HEM, 2001, J BIOL CHEM, V276, P2286, DOI 10.1074/jbc.M007243200; Meotti FC, 2007, BRAIN RES, V1151, P84, DOI 10.1016/j.brainres.2007.03.024; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Moore RC, 1999, J MOL BIOL, V292, P797, DOI 10.1006/jmbi.1999.3108; Mouillet-Richard S, 2000, SCIENCE, V289, P1925, DOI 10.1126/science.289.5486.1925; Nave KA, 2008, ANNU REV NEUROSCI, V31, P535, DOI 10.1146/annurev.neuro.30.051606.094309; Nazor KE, 2007, BBA-MOL BASIS DIS, V1772, P645, DOI 10.1016/j.bbadis.2007.04.004; Nico PBC, 2005, BEHAV BRAIN RES, V162, P173, DOI 10.1016/j.bbr.2005.02.003; Nishida N, 1999, LAB INVEST, V79, P689; Ogata T, 2004, J NEUROSCI, V24, P6724, DOI 10.1523/JNEUROSCI.5520-03.2004; Parkin ET, 2007, P NATL ACAD SCI USA, V104, P11062, DOI 10.1073/pnas.0609621104; Polymenidou M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003872; Prinz M, 2004, J NEUROSCI, V24, P5974, DOI 10.1523/JNEUROSCI.0122-04.2004; Radovanovic I, 2005, J NEUROSCI, V25, P4879, DOI 10.1523/JNEUROSCI.0328-05.2005; Rutishauser D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004446; Santuccione A, 2005, J CELL BIOL, V169, P341, DOI 10.1083/jcb.200409127; Schneider B, 2003, P NATL ACAD SCI USA, V100, P13326, DOI 10.1073/pnas.2235648100; Shmerling D, 1998, CELL, V93, P203, DOI 10.1016/S0092-8674(00)81572-X; Steele AD, 2007, PRION, V1, P83, DOI 10.4161/pri.1.2.4346; Sunyach C, 2007, J BIOL CHEM, V282, P1956, DOI 10.1074/jbc.M609663200; Toni M, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/69469; Walmsley AR, 2009, MOL CELL NEUROSCI, V40, P242, DOI 10.1016/j.mcn.2008.10.012; Watt NT, 2005, BIOCHEM SOC T, V33, P1123, DOI 10.1042/BST20051123; Willem M, 2006, SCIENCE, V314, P664, DOI 10.1126/science.1132341; Zielasek J, 1996, MUSCLE NERVE, V19, P946, DOI 10.1002/(SICI)1097-4598(199608)19:8<946::AID-MUS2>3.0.CO;2-8	47	296	297	0	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2010	13	3					310	U9		10.1038/nn.2483	http://dx.doi.org/10.1038/nn.2483			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	559WW	20098419				2022-12-24	WOS:000274860100012
J	Nishimura, EK; Suzuki, M; Igras, V; Du, JY; Lonning, S; Miyachi, Y; Roes, J; Beermann, F; Fisher, DE				Nishimura, Emi K.; Suzuki, Misa; Igras, Vivien; Du, Jinyan; Lonning, Scott; Miyachi, Yoshiki; Roes, Juergen; Beermann, Friedrich; Fisher, David E.			Key Roles for Transforming Growth Factor beta in Melanocyte Stem Cell Maintenance	CELL STEM CELL			English	Article							TGF-BETA; IN-VIVO; DOPACHROME TAUTOMERASE; MASTER REGULATOR; SELF-RENEWAL; HAIR CYCLE; NICHE; SKIN; DIFFERENTIATION; ACTIVATION	Melanocyte stem cells in the bulge area of hair follicles are responsible for hair pigmentation, and defects in them cause hair graying. Here we describe the process of melanocyte stem cell entry into the quiescent state and show that niche-derived transforming growth factor beta (TGF-beta) signaling plays important roles in this process. In vitro, TGF-beta not only induces reversible cell cycle arrest, but also promotes melanocyte immaturity by clownregulating MITF, the master transcriptional regulator of melanocyte differentiation, and its downstream melanogenic genes. In vivo, TGF-beta signaling is activated in melanocyte stem cells when they reenter the quiescent noncycling state during the hair cycle and this process requires Bcl2 for cell survival. Furthermore, targeted TGF-beta type II receptor (TGFbRII) deficiency in the melanocyte lineage causes incomplete maintenance of melanocyte stem cell immaturity and results in mild hair graying. These data demonstrate that the TGF-beta signaling pathway is one of the key niche factors that regulate melanocyte stem cell immaturity and quiescence.	[Nishimura, Emi K.] Tokyo Med & Dent Univ, Med Res Inst, Dept Stem Cell Biol, Chiyoda Ku, Tokyo 1010062, Japan; [Nishimura, Emi K.; Suzuki, Misa] Kanazawa Univ, Div Stem Cell Med, Canc Res Inst, Kanazawa, Ishikawa 9200934, Japan; [Igras, Vivien; Fisher, David E.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Dermatol, Boston, MA 02114 USA; [Igras, Vivien; Fisher, David E.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Melanoma Program Med Oncol, Boston, MA 02114 USA; [Du, Jinyan] Broad Inst Biomed Res, Boston, MA 02115 USA; [Du, Jinyan] Dana Farber Canc Inst, Boston, MA 02115 USA; [Lonning, Scott] Genzyme Corp, Cambridge, MA 01701 USA; [Miyachi, Yoshiki] Kyoto Univ, Grad Sch Med, Dept Dermatol, Sakyo Ku, Kyoto 6068507, Japan; [Roes, Juergen] UCL, Windeyer Inst Med Sci, Dept Med, London W1P 6DB, England; [Beermann, Friedrich] Ecole Polytech Fed Lausanne, Sch Life Sci, Swiss Inst Expt Canc Res ISREC, CH-1015 Lausanne, Switzerland	Tokyo Medical & Dental University (TMDU); Kanazawa University; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute; Sanofi-Aventis; Genzyme Corporation; Kyoto University; University of London; University College London; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute Experimental Cancer Research	Nishimura, EK (corresponding author), Tokyo Med & Dent Univ, Med Res Inst, Dept Stem Cell Biol, Chiyoda Ku, 2-3-10 Kandasurugadai, Tokyo 1010062, Japan.	nishscm@tmd.ac.jp		Roes, Jurgen/0000-0003-3235-2345	Uehara Memorial Foundation; Kato Memorial Bioscience Foundation; NIH; Melanoma Research Alliance; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR043369] Funding Source: NIH RePORTER	Uehara Memorial Foundation(Uehara Memorial Foundation); Kato Memorial Bioscience Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Melanoma Research Alliance; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank Dr. Tetsuo Watabe, Dr. Kohei Miyazono, Dr. Elaine Fuchs, Dr. Vincent Hearing, and Dr. Elizabeth Hearing for antibodies, Dr. Ian Jackson for the Dct-LacZ transgenic mice, and Dr. Hans Widlund for discussion. The research was funded by grants from the Uehara Memorial Foundation, the Kato Memorial Bioscience Foundation (to E.K.N.), and grants from the NIH and the Melanoma Research Alliance (to D.E.F., who is also a Distinguished Clinical Scholar of the Doris Duke Medical Foundation).	Batard P, 2000, J CELL SCI, V113, P383; Boyer R.F, 1993, MODERN EXPT BIOCH; Bruckheimer EM, 2002, PROSTATE, V53, P133, DOI 10.1002/pros.10143; Busca R, 2000, PIGM CELL RES, V13, P60, DOI 10.1034/j.1600-0749.2000.130203.x; Cazac BB, 2000, IMMUNITY, V13, P443, DOI 10.1016/S1074-7613(00)00044-3; Chin L, 2006, GENE DEV, V20, P2149, DOI 10.1101/gad.1437206; Chu W, 2000, ONCOGENE, V19, P395, DOI 10.1038/sj.onc.1203315; COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; Cotsarelis G, 2006, J INVEST DERMATOL, V126, P1459, DOI 10.1038/sj.jid.5700376; Curtin JA, 2006, J CLIN ONCOL, V24, P4340, DOI 10.1200/JCO.2006.06.2984; DASCH JR, 1989, J IMMUNOL, V142, P1536; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Delmas V, 2003, GENESIS, V36, P73, DOI 10.1002/gene.10197; Falk S, 2008, CELL STEM CELL, V2, P472, DOI 10.1016/j.stem.2008.03.006; Foitzik K, 2000, FASEB J, V14, P752, DOI 10.1096/fasebj.14.5.752; Guasch G, 2007, CANCER CELL, V12, P313, DOI 10.1016/j.ccr.2007.08.020; Guyonneau L, 2004, MOL CELL BIOL, V24, P3396, DOI 10.1128/MCB.24.8.3396-3403.2004; Huang YL, 1998, J BIOMED SCI, V5, P185; Inomata K, 2009, CELL, V137, P1088, DOI 10.1016/j.cell.2009.03.037; Karlsson G, 2007, J EXP MED, V204, P467, DOI 10.1084/jem.20060465; Kim DS, 2004, INT J BIOCHEM CELL B, V36, P1482, DOI 10.1016/j.biocel.2003.10.023; Lang D, 2005, NATURE, V433, P884, DOI 10.1038/nature03292; Larsson J, 2003, BLOOD, V102, P3129, DOI 10.1182/blood-2003-04-1300; Levy C, 2006, TRENDS MOL MED, V12, P406, DOI 10.1016/j.molmed.2006.07.008; Li LH, 2005, ANNU REV CELL DEV BI, V21, P605, DOI 10.1146/annurev.cellbio.21.012704.131525; Ling H, 2003, J AM SOC NEPHROL, V14, P377, DOI 10.1097/01.ASN.0000042168.43665.9B; MacKenzie MAF, 1997, DEV BIOL, V192, P99, DOI 10.1006/dbio.1997.8738; Massague J, 2006, FEBS LETT, V580, P2811, DOI 10.1016/j.febslet.2006.04.033; McGill GG, 2002, CELL, V109, P707, DOI 10.1016/S0092-8674(02)00762-6; Michard Q, 2008, FREE RADICAL BIO MED, V44, P1023, DOI 10.1016/j.freeradbiomed.2007.11.021; Nishimura EK, 1999, DEV BIOL, V215, P155, DOI 10.1006/dbio.1999.9478; Nishimura EK, 2005, SCIENCE, V307, P720, DOI 10.1126/science.1099593; Nishimura EK, 2002, NATURE, V416, P854, DOI 10.1038/416854a; Nishioka E, 1999, MELANOMA RES, V9, P433, DOI 10.1097/00008390-199910000-00002; Nystul TG, 2006, CURR OPIN GENET DEV, V16, P463, DOI 10.1016/j.gde.2006.08.003; Pak BJ, 2004, ONCOGENE, V23, P30, DOI 10.1038/sj.onc.1207007; Paus R, 1999, J INVEST DERMATOL, V113, P523, DOI 10.1046/j.1523-1747.1999.00740.x; Qiao W, 2006, ONCOGENE, V25, P207, DOI 10.1038/sj.onc.1209029; Salm SN, 2005, J CELL BIOL, V170, P81, DOI 10.1083/jcb.200412015; Scadden DT, 2006, NATURE, V441, P1075, DOI 10.1038/nature04957; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; Soma T, 2003, J INVEST DERMATOL, V121, P969, DOI 10.1046/j.1523-1747.2003.12516.x; Steingrimsson E, 2004, ANNU REV GENET, V38, P365, DOI 10.1146/annurev.genet.38.072902.092717; Suda T, 2005, TRENDS IMMUNOL, V26, P426, DOI 10.1016/j.it.2005.06.006; Suzuki I, 1997, J INVEST DERMATOL, V108, P838, DOI 10.1111/1523-1747.ep12292572; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Vance KW, 2004, PIGM CELL RES, V17, P318, DOI 10.1111/j.1600-0749.2004.00164.x; VANTVEER LJ, 1989, MOL CELL BIOL, V9, P3114, DOI 10.1128/MCB.9.7.3114; Watabe T, 2009, CELL RES, V19, P103, DOI 10.1038/cr.2008.323; Watt FM, 2000, SCIENCE, V287, P1427, DOI 10.1126/science.287.5457.1427; Yamazaki S, 2007, ANN NY ACAD SCI, V1106, P54, DOI 10.1196/annals.1392.017; YANG L, 2005, CANCER RES, V1, P8671; Yang LL, 2009, MOL BIOL CELL, V20, P882, DOI 10.1091/mbc.E08-07-0731	53	159	175	1	22	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	FEB 5	2010	6	2					130	140		10.1016/j.stem.2009.12.010	http://dx.doi.org/10.1016/j.stem.2009.12.010			11	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	555OC	20144786	Bronze, Green Accepted			2022-12-24	WOS:000274520800008
J	Bucurenciu, I; Bischofberger, J; Jonas, P				Bucurenciu, Iancu; Bischofberger, Josef; Jonas, Peter			A small number of open Ca2+ channels trigger transmitter release at a central GABAergic synapse	NATURE NEUROSCIENCE			English	Article							CALCIUM-CHANNEL; N-TYPE; VESICLE; CALYX	To determine the number of open Ca2+ channels necessary for transmitter release at the inhibitory basket cell-granule cell synapse in rat hippocampus, we combined presynaptic Ca2+ imaging, recording of postsynaptic currents and modeling. We found that that the opening of three or fewer Ca2+ channels triggered transmitter release. Furthermore, a small number of Ca2+ channels were able to evoke release with high temporal precision, despite stochastic Ca2+ channel opening.	[Bucurenciu, Iancu; Bischofberger, Josef; Jonas, Peter] Univ Freiburg, Inst Physiol 1, Freiburg, Germany; [Bischofberger, Josef] Univ Basel, Inst Physiol, Basel, Switzerland; [Jonas, Peter] Freiburg Inst Adv Studies, Freiburg, Germany	University of Freiburg; University of Basel	Jonas, P (corresponding author), Univ Freiburg, Inst Physiol 1, Freiburg, Germany.	peter.jonas@physiologie.uni-freiburg.de		Jonas, Peter/0000-0001-5001-4804; Bischofberger, Josef/0000-0002-4006-1663	Deutsche Forschungsgemeinschaft [780/A5, TR 3/B10]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank J. Behrends and E. Eggermann for critically reading the manuscript and S. Becherer, I. Koeva, M. Northemann, U. Thirimanna and K. Winterhalter for technical assistance. This work was supported by the Deutsche Forschungsgemeinschaft (Sonderforschungsbereich 780/A5, TR 3/B10, and Leibniz program).	AUGUSTINE GJ, 1991, ANN NY ACAD SCI, V635, P365, DOI 10.1111/j.1749-6632.1991.tb36505.x; Bertram R, 1999, BIOPHYS J, V76, P735, DOI 10.1016/S0006-3495(99)77240-1; Borst JGG, 1996, NATURE, V383, P431, DOI 10.1038/383431a0; Brandt A, 2005, J NEUROSCI, V25, P11577, DOI 10.1523/JNEUROSCI.3411-05.2005; Bucurenciu I, 2008, NEURON, V57, P536, DOI 10.1016/j.neuron.2007.12.026; Fedchyshyn MJ, 2005, J NEUROSCI, V25, P4131, DOI 10.1523/JNEUROSCI.0350-05.2005; Li LY, 2007, J NEUROSCI, V27, P13420, DOI 10.1523/JNEUROSCI.1709-07.2007; MINTZ IM, 1995, NEURON, V15, P675, DOI 10.1016/0896-6273(95)90155-8; Neher E, 1998, CELL CALCIUM, V24, P345, DOI 10.1016/S0143-4160(98)90058-6; Shahrezaei V, 2006, J NEUROSCI, V26, P13240, DOI 10.1523/JNEUROSCI.1418-06.2006; Stanley EF, 1997, TRENDS NEUROSCI, V20, P404, DOI 10.1016/S0166-2236(97)01091-6; STANLEY EF, 1993, NEURON, V11, P1007, DOI 10.1016/0896-6273(93)90214-C; WHEELER DB, 1994, SCIENCE, V264, P107, DOI 10.1126/science.7832825; Wu LG, 1999, J NEUROSCI, V19, P726; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	15	83	84	0	10	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2010	13	1					19	21		10.1038/nn.2461	http://dx.doi.org/10.1038/nn.2461			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	536PM	20010820				2022-12-24	WOS:000273056300007
J	de Wit, J; Sylwestrak, E; O'Sullivan, ML; Otto, S; Tiglio, K; Savas, JN; Yates, JR; Comoletti, D; Taylor, P; Ghosh, A				de Wit, Joris; Sylwestrak, Emily; O'Sullivan, Matthew L.; Otto, Stefanie; Tiglio, Katie; Savas, Jeffrey N.; Yates, John R., III; Comoletti, Davide; Taylor, Palmer; Ghosh, Anirvan			LRRTM2 Interacts with Neurexin1 and Regulates Excitatory Synapse Formation	NEURON			English	Article							ADHESION MOLECULES; AMPA RECEPTORS; PROTEINS; PSD-95; FAMILY; DISEASE; GENE; IDENTIFICATION	We identify the leucine-rich repeat transmembrane protein LRRTM2 as a key regulator of excitatory synapse development and function. LRRTM2 localizes to excitatory synapses in transfected hippocampal neurons, and shRNA-mediated knockdown of LRRTM2 leads to a decrease in excitatory synapses without affecting inhibitory synapses. LRRTM2 interacts with PSD-95 and regulates surface expression of AMPA receptors, and lentivirus-mediated knockdown of LRRTM2 in vivo decreases the strength of evoked excitatory synaptic currents. Structure-function studies indicate that LRRTM2 induces presynaptic differentiation via the extracellular LRR domain. We identify Neurexin1 as a receptor for LRRTM2 based on affinity chromatography. LRRTM2 binds to both Neurexin 1 alpha and Neurexin 1 beta, and shRNA-mediated knockdown of Neurexin1 abrogates LRRTM2-induced presynaptic differentiation. These observations indicate that an LRRTM2-Neurexin1 interaction plays a critical role in regulating excitatory synapse development.	[de Wit, Joris; Sylwestrak, Emily; O'Sullivan, Matthew L.; Otto, Stefanie; Tiglio, Katie; Ghosh, Anirvan] Univ Calif San Diego, Neurobiol Sect, Div Biol, La Jolla, CA 92093 USA; [Comoletti, Davide; Taylor, Palmer] Univ Calif San Diego, Dept Pharmacol, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Savas, Jeffrey N.; Yates, John R., III] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Scripps Research Institute	Ghosh, A (corresponding author), Univ Calif San Diego, Neurobiol Sect, Div Biol, La Jolla, CA 92093 USA.	aghosh@ucsd.edu	Sylwestrak, Emily/GSE-3871-2022	O'Sullivan, Matthew/0000-0003-2201-0106; Sylwestrak, Emily/0000-0002-1172-6523; de Wit, Joris/0000-0003-1120-1089	Netherlands Organisation for Scientific Research (NWO); NIH [NS052772]; Autism Speaks [2617]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS067216, R21NS052772] Funding Source: NIH RePORTER	Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Autism Speaks; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank members of the Ghosh lab for comments and helpful discussions and Richard Huganir (Glutamate receptors), Ann-Marie Craig (Neurexins), Matthew Dalva (EphB2-YFP), and Eunjoon Kim (NGL-2) for plasmids. This work was supported by a Rubicon Fellowship from the Netherlands Organisation for Scientific Research (NWO) (J.d.W.), NIH grant NS052772 (A.G.), and an Autism Speaks grant #2617 (D.C.).	Beique JC, 2006, P NATL ACAD SCI USA, V103, P19535, DOI 10.1073/pnas.0608492103; Biederer T, 2002, SCIENCE, V297, P1525, DOI 10.1126/science.1072356; Biederer T, 2007, NAT PROTOC, V2, P670, DOI 10.1038/nprot.2007.92; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; Craig AM, 2007, CURR OPIN NEUROBIOL, V17, P43, DOI 10.1016/j.conb.2007.01.011; Dean C, 2003, NAT NEUROSCI, V6, P708, DOI 10.1038/nn1074; Dosemeci A, 2007, MOL CELL PROTEOMICS, V6, P1749, DOI 10.1074/mcp.M700040-MCP200; Edwards TL, 2009, AM J MED GENET B, V150B, P721, DOI 10.1002/ajmg.b.30899; Elias GM, 2006, NEURON, V52, P307, DOI 10.1016/j.neuron.2006.09.012; Etherton MR, 2009, P NATL ACAD SCI USA, V106, P17998, DOI 10.1073/pnas.0910297106; Francks C, 2007, MOL PSYCHIATR, V12, P1129, DOI 10.1038/sj.mp.4002053; Han K, 2008, PROG NEUROBIOL, V84, P263, DOI 10.1016/j.pneurobio.2007.10.011; ICHTCHENKO K, 1995, CELL, V81, P435, DOI 10.1016/0092-8674(95)90396-8; Jordan BA, 2004, MOL CELL PROTEOMICS, V3, P857, DOI 10.1074/mcp.M400045-MCP200; Kayser MS, 2006, J NEUROSCI, V26, P12152, DOI 10.1523/JNEUROSCI.3072-06.2006; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; Kim S, 2006, NAT NEUROSCI, V9, P1294, DOI 10.1038/nn1763; Lauren J, 2003, GENOMICS, V81, P411, DOI 10.1016/S0888-7543(03)00030-2; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Linhoff MW, 2009, NEURON, V61, P734, DOI 10.1016/j.neuron.2009.01.017; Majercak J, 2006, P NATL ACAD SCI USA, V103, P17967, DOI 10.1073/pnas.0605461103; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Schnell E, 2002, P NATL ACAD SCI USA, V99, P13902, DOI 10.1073/pnas.172511199; Sheng M, 2007, ANNU REV BIOCHEM, V76, P823, DOI 10.1146/annurev.biochem.76.060805.160029; Song JY, 1999, P NATL ACAD SCI USA, V96, P1100, DOI 10.1073/pnas.96.3.1100; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Yoshimura Y, 2004, J NEUROCHEM, V88, P759, DOI 10.1046/j.1471-4159.2003.02136.x	28	279	282	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 24	2009	64	6					799	806		10.1016/j.neuron.2009.12.019	http://dx.doi.org/10.1016/j.neuron.2009.12.019			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	541ON	20064388	Green Published, Green Accepted, Bronze			2022-12-24	WOS:000273425800008
J	Ko, J; Fuccillo, MV; Malenka, RC; Sudhof, TC				Ko, Jaewon; Fuccillo, Marc V.; Malenka, Robert C.; Suedhof, Thomas C.			LRRTM2 Functions as a Neurexin Ligand in Promoting Excitatory Synapse Formation	NEURON			English	Article							CELL-SURFACE PROTEINS; ALPHA-NEUREXINS; BETA-NEUREXINS; SYNAPTOGENIC PROTEINS; ADHESION MOLECULES; CA2+ CHANNELS; SCHIZOPHRENIA; NEUROLIGIN-1; RECEPTOR; FAMILY	Recently, leucine-rich repeat transmembrane proteins (LRRTMs) were found to be synaptic cell-adhesion molecules that, when expressed in nonneuronal cells, induce presynaptic differentiation in contacting axons. We now demonstrate that LRRTM2 induces only excitatory synapses, and that it also acts to induce synapses in transfected neurons similarly to neuroligin-1. Using affinity chromatography, we identified alpha- and beta-neurexins as LRRTM2 ligands, again rendering LRRTM2 similar to neuroligin-1. However, whereas neuroligins bind neurexins containing or lacking an insert in splice site #4, LRRTM2 only binds neurexins lacking an insert in splice site #4. Binding of neurexins to LRRTM2 can produce cell-adhesion junctions, consistent with a trans-interaction regulated by neurexin alternative splicing, and recombinant neurexin-1 beta blocks LRRTM2's ability to promote presynaptic differentiation. Thus, our data suggest that two unrelated postsynaptic cell-adhesion molecules, LRRTMs and neuroligins, unexpectedly bind to neurexins as the same presynaptic receptor, but that their binding is subject to distinct regulatory mechanisms.	[Ko, Jaewon; Fuccillo, Marc V.; Suedhof, Thomas C.] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Palo Alto, CA 94304 USA; [Suedhof, Thomas C.] Stanford Univ, Sch Med, Howard Hughes Med Inst, Palo Alto, CA 94304 USA; [Fuccillo, Marc V.; Malenka, Robert C.] Stanford Univ, Sch Med, Nancy Pritzker Lab, Dept Psychiat & Behav Sci, Palo Alto, CA 94304 USA	Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University	Sudhof, TC (corresponding author), Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, 1050 Arastradero Rd, Palo Alto, CA 94304 USA.	tcs1@stanford.edu		Fuccillo, Marc/0000-0002-6569-706X	NIMH; Simons Foundation; Human Frontier Science Program; NIH; NATIONAL INSTITUTE OF MENTAL HEALTH [F32MH086176] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Simons Foundation; Human Frontier Science Program(Human Frontier Science Program); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank Eunjoon Kim for the gifts of pan-NGL antibody and expression construct (NGL3-EGFP). This work was supported by grants from the NIMH and Simons Foundation (to T.C.S.), and by fellowships from the Human Frontier Science Program (to J.K.) and the NIH (to M.V.F.).	Biederer T, 2002, SCIENCE, V297, P1525, DOI 10.1126/science.1072356; Bierut LJ, 2007, HUM MOL GENET, V16, P24, DOI 10.1093/hmg/ddl441; Boucard AA, 2005, NEURON, V48, P229, DOI 10.1016/j.neuron.2005.08.026; Brose N, 2009, NEURON, V61, P650, DOI 10.1016/j.neuron.2009.02.014; Chubykin AA, 2005, J BIOL CHEM, V280, P22365, DOI 10.1074/jbc.M410723200; Chubykin AA, 2007, NEURON, V54, P919, DOI 10.1016/j.neuron.2007.05.029; Francks C, 2007, MOL PSYCHIATR, V12, P1129, DOI 10.1038/sj.mp.4002053; Graf ER, 2004, CELL, V119, P1013, DOI 10.1016/j.cell.2004.11.035; HATA Y, 1993, NEURON, V10, P307, DOI 10.1016/0896-6273(93)90320-Q; ICHTCHENKO K, 1995, CELL, V81, P435, DOI 10.1016/0092-8674(95)90396-8; Kattenstroth G, 2004, P NATL ACAD SCI USA, V101, P2607, DOI 10.1073/pnas.0308626100; Kim HG, 2008, AM J HUM GENET, V82, P199, DOI 10.1016/j.ajhg.2007.09.011; Kim S, 2006, NAT NEUROSCI, V9, P1294, DOI 10.1038/nn1763; Kirov G, 2009, SCHIZOPHRENIA BULL, V35, P851, DOI 10.1093/schbul/sbp079; Ko J, 2009, EMBO J, V28, P3244, DOI 10.1038/emboj.2009.249; Lauren J, 2003, GENOMICS, V81, P411, DOI 10.1016/S0888-7543(03)00030-2; Linhoff MW, 2009, NEURON, V61, P734, DOI 10.1016/j.neuron.2009.01.017; Ludwig KU, 2009, MOL PSYCHIATR, V14, P743, DOI 10.1038/mp.2009.28; Missler M, 2003, NATURE, V423, P939, DOI 10.1038/nature01755; Nguyen T, 1997, J BIOL CHEM, V272, P26032, DOI 10.1074/jbc.272.41.26032; NOSE A, 1992, CELL, V70, P553, DOI 10.1016/0092-8674(92)90426-D; Reissner C, 2008, P NATL ACAD SCI USA, V105, P15124, DOI 10.1073/pnas.0801639105; Rujescu D, 2009, HUM MOL GENET, V18, P988, DOI 10.1093/hmg/ddn351; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Sugita S, 2001, J CELL BIOL, V154, P435, DOI 10.1083/jcb.200105003; Tabuchi K, 2007, SCIENCE, V318, P71, DOI 10.1126/science.1146221; Torres R, 1998, NEURON, V21, P1453, DOI 10.1016/S0896-6273(00)80663-7; USHKARYOV YA, 1992, SCIENCE, V257, P50, DOI 10.1126/science.1621094; USHKARYOV YA, 1994, J BIOL CHEM, V269, P11987; Varoqueaux F, 2006, NEURON, V51, P741, DOI 10.1016/j.neuron.2006.09.003; Zhang WQ, 2005, J NEUROSCI, V25, P4330, DOI 10.1523/JNEUROSCI.0497-05.2005	32	258	265	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 24	2009	64	6					791	798		10.1016/j.neuron.2009.12.012	http://dx.doi.org/10.1016/j.neuron.2009.12.012			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	541ON	20064387	Green Accepted, Bronze			2022-12-24	WOS:000273425800007
J	Hussar, CR; Pasternak, T				Hussar, Cory R.; Pasternak, Tatiana			Flexibility of Sensory Representations in Prefrontal Cortex Depends on Cell Type	NEURON			English	Article							PRIMARY VISUAL-CORTEX; WORKING-MEMORY; PYRAMIDAL NEURONS; INHIBITORY MECHANISMS; DIRECTION SELECTIVITY; SYNAPTIC MECHANISMS; PARIETAL CORTEX; MACAQUE MONKEY; INTERNEURONS; ATTENTION	Discrimination tasks require processing, interpreting, and linking sensory information to the appropriate motor response. We report that neurons in prefrontal cortex (PFC) represent visual motion with precision comparable to cortical neurons at early stages of motion processing, and readily adapt this representation to behavioral context. We found that direction selectivity, recorded while the monkeys discriminated directions, decreased when they judged motion speed and ignored its direction. This decrease was more pronounced in neurons classified as narrow-spiking (NS) putative interneurons than in broad-spiking (BS) putative pyramidal neurons. However, during passive fixation, when the link between motion and its behavioral relevance was removed, both cell types showed a severe selectivity loss. Our results show that flexible sensory representation during active discrimination tasks is achieved in the PFC by a specialized neuronal network of both NS neurons readily adjusting their selectivity to behavioral context, and BS neurons capable of maintaining relatively stable sensory representation.	[Hussar, Cory R.; Pasternak, Tatiana] Univ Rochester, Dept Neurobiol & Anat, Rochester, NY 14642 USA; [Hussar, Cory R.; Pasternak, Tatiana] Univ Rochester, Ctr Visual Sci, Rochester, NY 14642 USA	University of Rochester; University of Rochester	Pasternak, T (corresponding author), Univ Rochester, Dept Neurobiol & Anat, 601 Elmwood Ave, Rochester, NY 14642 USA.	tania@cvs.rochester.edu			 [EY11749];  [T32 EY07125];  [P30 EY01319]; NATIONAL EYE INSTITUTE [T32EY007125, R01EY011749, P30EY001319] Funding Source: NIH RePORTER	; ; ; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by grants EY11749, T32 EY07125, and P30 EY01319. We thank Marc Mancarella for excellent technical assistance. We would also like to thank Larry Abbott, Mark Churchland, and Greg DeAngelis for helpful suggestions and comments on the earlier version of the manuscript. We also thank John Reynolds and Jude Mitchell for sharing software for waveform analysis.	Asaad WF, 2000, J NEUROPHYSIOL, V84, P451, DOI 10.1152/jn.2000.84.1.451; BARBAS H, 1988, J COMP NEUROL, V276, P313, DOI 10.1002/cne.902760302; Bartho P, 2004, J NEUROPHYSIOL, V92, P600, DOI 10.1152/jn.01170.2003; BRITTEN KH, 1992, J NEUROSCI, V12, P4745; Cardin JA, 2007, J NEUROSCI, V27, P10333, DOI 10.1523/JNEUROSCI.1692-07.2007; Chen Y, 2008, NAT NEUROSCI, V11, P974, DOI 10.1038/nn.2147; Cohen JD, 1996, PHILOS T R SOC B, V351, P1515, DOI 10.1098/rstb.1996.0138; Compte A, 2000, CEREB CORTEX, V10, P910, DOI 10.1093/cercor/10.9.910; CONNORS BW, 1990, TRENDS NEUROSCI, V13, P99, DOI 10.1016/0166-2236(90)90185-D; Constantinidis C, 2002, J NEUROPHYSIOL, V88, P3487, DOI 10.1152/jn.00188.2002; Constantinidis C, 2002, NAT NEUROSCI, V5, P175, DOI 10.1038/nn799; Contreras D, 2003, J NEUROSCI, V23, P6936; CRIST CF, 1988, J NEUROSCI METH, V26, P117, DOI 10.1016/0165-0270(88)90160-4; Diester I, 2008, J NEUROSCI, V28, P7737, DOI 10.1523/JNEUROSCI.1347-08.2008; Efron B., 1994, INTRO BOOTSTRAP; Everling S, 2002, NAT NEUROSCI, V5, P671, DOI 10.1038/nn874; Freedman DJ, 2006, NATURE, V443, P85, DOI 10.1038/nature05078; Freedman DJ, 2001, SCIENCE, V291, P312, DOI 10.1126/science.291.5502.312; Gray CM, 1996, SCIENCE, V274, P109, DOI 10.1126/science.274.5284.109; Green DM, 1966, SIGNAL DETECTION THE; HARTIGAN JA, 1985, ANN STAT, V13, P70, DOI 10.1214/aos/1176346577; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; HUSSAR C, 2008, J VIS, V8, P230; Johnston K, 2009, J NEUROSCI, V29, P5516, DOI 10.1523/JNEUROSCI.5953-08.2009; Luck SJ, 1997, J NEUROPHYSIOL, V77, P24, DOI 10.1152/jn.1997.77.1.24; Mansouri FA, 2007, SCIENCE, V318, P987, DOI 10.1126/science.1146384; Martinez-Trujillo JC, 2004, CURR BIOL, V14, P744, DOI 10.1016/j.cub.2004.04.028; MAUNSELL JHR, 1983, J NEUROPHYSIOL, V49, P1127, DOI 10.1152/jn.1983.49.5.1127; MCCORMICK DA, 1985, J NEUROPHYSIOL, V54, P782, DOI 10.1152/jn.1985.54.4.782; Medalla M, 2006, EUR J NEUROSCI, V23, P161, DOI 10.1111/j.1460-9568.2005.04522.x; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Mitchell JF, 2007, NEURON, V55, P131, DOI 10.1016/j.neuron.2007.06.018; MOUNTCASTLE VB, 1969, J NEUROPHYSIOL, V32, P452, DOI 10.1152/jn.1969.32.3.452; Nowak LG, 2003, J NEUROPHYSIOL, V89, P1541, DOI 10.1152/jn.00580.2002; Nowak LG, 2008, CEREB CORTEX, V18, P1058, DOI 10.1093/cercor/bhm137; PASTERNAK T, 2003, VISUAL INFORM PROCES, P139; Petrides M, 2007, J NEUROSCI, V27, P11573, DOI 10.1523/JNEUROSCI.2419-07.2007; Rainer G, 1998, NATURE, V393, P577, DOI 10.1038/31235; Rao SG, 2000, J NEUROSCI, V20, P485, DOI 10.1523/JNEUROSCI.20-01-00485.2000; Rao SG, 1999, J NEUROPHYSIOL, V81, P1903, DOI 10.1152/jn.1999.81.4.1903; Rivadulla C, 2001, J NEUROSCI, V21, P1710, DOI 10.1523/JNEUROSCI.21-05-01710.2001; SAKAGAMI M, 1994, EXP BRAIN RES, V97, P423; SCHALL JD, 1995, J NEUROSCI, V15, P4464; SILLITO AM, 1975, J PHYSIOL-LONDON, V250, P305, DOI 10.1113/jphysiol.1975.sp011056; Thiele A, 2004, P NATL ACAD SCI USA, V101, P9810, DOI 10.1073/pnas.0307754101; Toth LJ, 2002, NATURE, V415, P165, DOI 10.1038/415165a; White IM, 1999, EXP BRAIN RES, V126, P315, DOI 10.1007/s002210050740; WILSON FAW, 1994, P NATL ACAD SCI USA, V91, P4009, DOI 10.1073/pnas.91.9.4009; Zaksas D, 2006, J NEUROSCI, V26, P11726, DOI 10.1523/JNEUROSCI.3420-06.2006	49	70	70	1	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 10	2009	64	5					730	743		10.1016/j.neuron.2009.11.018	http://dx.doi.org/10.1016/j.neuron.2009.11.018			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	537OW	20005828	Green Accepted, Bronze			2022-12-24	WOS:000273123700017
J	Sehadova, H; Glaser, FT; Gentile, C; Simoni, A; Giesecke, A; Albert, JT; Stanewsky, R				Sehadova, Hana; Glaser, Franz T.; Gentile, Carla; Simoni, Alekos; Giesecke, Astrid; Albert, Joerg T.; Stanewsky, Ralf			Temperature Entrainment of Drosophila's Circadian Clock Involves the Gene nocte and Signaling from Peripheral Sensory Tissues to the Brain	NEURON			English	Article							RHYTHMS; NEURONS; LIGHT; SYNCHRONIZATION; TRANSCRIPTION; CRYPTOCHROME; OSCILLATOR; ENCODES; SYSTEM; PERIOD	Circadian clocks are synchronized by the natural day/night and temperature cycles. Our previous work demonstrated that synchronization by temperature is a tissue autonomous process, similar to synchronization by light. We show here that this is indeed the case, with the important exception of the brain. Using luciferase imaging we demonstrate that brain clock neurons depend on signals from peripheral tissues in order to be synchronized by temperature. Reducing the function of the gene nocte in chordotonal organs changes their structure and function and dramatically interferes with temperature synchronization of behavioral activity. Other mutants known to affect the function of these sensory organs also interfere with temperature synchronization, demonstrating the importance of nocte in this process and identifying the chordotonal organs as relevant sensory structures. Our work reveals surprising and important mechanistic differences between light- and temperature-synchronization and advances our understanding of how clock resetting is accomplished in nature.	[Sehadova, Hana; Gentile, Carla; Simoni, Alekos; Giesecke, Astrid; Stanewsky, Ralf] Queen Mary Univ London, Sch Biol & Chem Sci, London E1 4NS, England; [Glaser, Franz T.; Stanewsky, Ralf] Univ Regensburg, Inst Zool, D-93040 Regensburg, Germany; [Albert, Joerg T.] UCL, Ear Inst, London WC1X 8EE, England	University of London; Queen Mary University London; University of Regensburg; University of London; University College London	Stanewsky, R (corresponding author), Queen Mary Univ London, Sch Biol & Chem Sci, Mile End Rd, London E1 4NS, England.	r.stanewsky@qmul.ac.uk	Sehadova, Hana/G-9329-2014; Stanewsky, Ralf/ABB-9193-2021	Sehadova, Hana/0000-0003-2962-0871; Simoni, Alekos/0000-0001-8629-721X; Stanewsky, Ralf/0000-0001-8238-6864	Deutsche Forschungsgerneinschaft [Sta 421/3-3, Sta 421/6-6]; EUCLOCK; European Commission [FP6]; BBSRC; BBSRC [BB/G004455/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G004455/1] Funding Source: researchfish	Deutsche Forschungsgerneinschaft(German Research Foundation (DFG)); EUCLOCK(European Commission); European Commission(European CommissionEuropean Commission Joint Research Centre); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank OLYMPUS UK Ltd., namely Mr. Alan Kidger and Werner Kammerloher for their generous provision of the LuminoviewLV200, and Ko Fan Chen for help with nocte homology searches. We also thank C. Kim for the F-ga14; P. Hardin for UAS-cyc Delta, U. Tepass for eys; A. Zelhof for spam; D. Eberl for tilB, smet, and gfp-nompA flies; and P. Emery, J. Hall, and J. Levine for critical reading of the manuscript. Confocal imaging was performed with support of the Blizard Advanced Light Microscopy facility at Queen Mary. This work was supported by the Deutsche Forschungsgerneinschaft grants Sta 421/3-3 and Sta 421/6-6 given to R.S. Work in our lab is supported by EUCLOCK, an Integrated Project (FP6) funded by the European Commission and the BBSRC.	Allada R, 1998, CELL, V93, P791, DOI 10.1016/S0092-8674(00)81440-3; BANERJI J, 1990, P NATL ACAD SCI USA, V87, P2374, DOI 10.1073/pnas.87.6.2374; BARRETT RK, 1995, J NEUROSCI, V15, P5681; Benito J, 2008, J BIOL RHYTHM, V23, P296, DOI 10.1177/0748730408318588; Boothroyd CE, 2008, ANN NY ACAD SCI, V1129, P350, DOI 10.1196/annals.1417.006; Brown SA, 2002, CURR BIOL, V12, P1574, DOI 10.1016/S0960-9822(02)01145-4; Busza A, 2007, J NEUROSCI, V27, P10722, DOI 10.1523/JNEUROSCI.2479-07.2007; Caldwell JC, 2003, P NATL ACAD SCI USA, V100, P16053, DOI 10.1073/pnas.2535546100; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; Chung YD, 2001, NEURON, V29, P415, DOI 10.1016/S0896-6273(01)00215-X; Cook B, 2008, NATURE, V452, P361, DOI 10.1038/nature06603; Cox GW, 1996, J BIOL CHEM, V271, P25515, DOI 10.1074/jbc.271.41.25515; Dubruille R, 2008, MOL NEUROBIOL, V38, P129, DOI 10.1007/s12035-008-8035-y; DUNLAP JC, 2004, CHRONOBIOLGY BIOL TI; Eberl DF, 2000, J NEUROSCI, V20, P5981, DOI 10.1523/JNEUROSCI.20-16-05981.2000; Glaser FT, 2007, COLD SH Q B, V72, P233, DOI 10.1101/sqb.2007.72.046; Glaser FT, 2005, CURR BIOL, V15, P1352, DOI 10.1016/j.cub.2005.06.056; Hasemeyer M, 2009, NEURON, V61, P511, DOI 10.1016/j.neuron.2009.01.009; Hall JC, 2003, ADV GENET, V48, P1, DOI 10.1016/S0065-2660(03)48000-0; Hamada FN, 2008, NATURE, V454, P217, DOI 10.1038/nature07001; Herzog ED, 2003, J NEUROPHYSIOL, V90, P763, DOI 10.1152/jn.00129.2003; Husain N, 2006, DEV CELL, V11, P483, DOI 10.1016/j.devcel.2006.08.012; Kalidas S, 2002, NEURON, V33, P177, DOI 10.1016/S0896-6273(02)00560-3; KAVLIE RG, 2007, THESIS U IOWA IOWA C; Kernan MJ, 2007, PFLUG ARCH EUR J PHY, V454, P703, DOI 10.1007/s00424-007-0263-x; Kim J, 2003, NATURE, V424, P81, DOI 10.1038/nature01733; Kornmann B, 2007, PLOS BIOL, V5, P179, DOI 10.1371/journal.pbio.0050034; Lahiri K, 2005, PLOS BIOL, V3, P2005, DOI 10.1371/journal.pbio.0030351; Liu L, 2003, NAT NEUROSCI, V6, P267, DOI 10.1038/nn1009; Miyasako Y, 2007, J BIOL RHYTHM, V22, P115, DOI 10.1177/0748730407299344; MORAN DT, 1977, P NATL ACAD SCI USA, V74, P793, DOI 10.1073/pnas.74.2.793; Picot M, 2009, J NEUROSCI, V29, P8312, DOI 10.1523/JNEUROSCI.0279-08.2009; Plautz JD, 1997, SCIENCE, V278, P1632, DOI 10.1126/science.278.5343.1632; Prolo LM, 2005, J NEUROSCI, V25, P404, DOI 10.1523/JNEUROSCI.4133-04.2005; Riley BE, 2006, GENE DEV, V20, P2183, DOI 10.1101/gad.1436506; Ryder E, 2004, GENETICS, V167, P797, DOI 10.1534/genetics.104.026658; Sayeed O, 1996, P NATL ACAD SCI USA, V93, P6079, DOI 10.1073/pnas.93.12.6079; SEHGAL A, 1994, SCIENCE, V263, P1603, DOI 10.1126/science.8128246; Sheeba V, 2008, CRIT REV BIOCHEM MOL, V43, P37, DOI [10.1080/10409230701829128, 10.1080/10409230701829128 ]; Stanewsky R, 1998, CELL, V95, P681, DOI 10.1016/S0092-8674(00)81638-4; Stanewsky R, 1997, EMBO J, V16, P5006, DOI 10.1093/emboj/16.16.5006; Tanoue S, 2004, CURR BIOL, V14, P638, DOI 10.1016/j.cub.2004.04.009; Tomioka K, 1998, J INSECT PHYSIOL, V44, P587, DOI 10.1016/S0022-1910(98)00046-8; Tweedie S, 2009, NUCLEIC ACIDS RES, V37, pD555, DOI 10.1093/nar/gkn788; Veleri S, 2003, CURR BIOL, V13, P1758, DOI 10.1016/j.cub.2003.09.030; Veraksa A, 2002, GENESIS, V33, P67, DOI 10.1002/gene.10090; WHEELER DA, 1993, J BIOL RHYTHM, V8, P67, DOI 10.1177/074873049300800106; Yoshii T, 2005, EUR J NEUROSCI, V22, P1176, DOI 10.1111/j.1460-9568.2005.04295.x; Yoshii T, 2002, ZOOL SCI, V19, P841, DOI 10.2108/zsj.19.841; Yoshii T, 2008, J COMP NEUROL, V508, P952, DOI 10.1002/cne.21702; Yoshii T, 2007, J BIOL RHYTHM, V22, P103, DOI 10.1177/0748730406298176; Zelhof AC, 2006, NATURE, V443, P696, DOI 10.1038/nature05128; ZERR DM, 1990, J NEUROSCI, V10, P2749	53	108	111	0	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 29	2009	64	2					251	266		10.1016/j.neuron.2009.08.026	http://dx.doi.org/10.1016/j.neuron.2009.08.026			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	521AA	19874792	Green Submitted, Bronze			2022-12-24	WOS:000271889900014
J	van den Pol, AN				van den Pol, Anthony N.			Viral Infection Leading to Brain Dysfunction: More Prevalent Than Appreciated?	NEURON			English	Editorial Material							VIRUS-INFECTION; ENCEPHALITIS; INTERFERON; MICE	Virus infections of the brain can lead to transient or permanent neurologic or psychiatric dysfunction. Some of the complexities in establishing the causal role of viruses in brain disease are explored here.	Yale Univ, Sch Med, Dept Neurosurg, New Haven, CT 06520 USA	Yale University	van den Pol, AN (corresponding author), Yale Univ, Sch Med, Dept Neurosurg, 333 Cedar St, New Haven, CT 06520 USA.	anthony.vandenpol@yale.edu			NCI NIH HHS [R01 CA124737, R01 CA124737-03, CA124737] Funding Source: Medline; NIAID NIH HHS [R01 AI048854-09, AI/NS48854, R01 AI048854] Funding Source: Medline; NINDS NIH HHS [R01 NS034887, R01 NS034887-13] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA124737] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048854] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034887] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Arkwright PD, 2008, CURR OPIN INFECT DIS, V21, P217, DOI 10.1097/QCO.0b013e3282fa1824; Atkins GJ, 2000, REV MED VIROL, V10, P291, DOI 10.1002/1099-1654(200009/10)10:5&lt;291::AID-RMV278&gt;3.0.CO;2-U; Chiocca EA, 2008, CURR OPIN MOL THER, V10, P38; Glass WG, 2006, J EXP MED, V203, P35, DOI 10.1084/jem.20051970; Johnson R. T, 1998, VIRAL INFECTIONS NER; KOCH R, 1890, KLASSIKER MED HERAUS; MOHAMMED AKH, 1992, NEUROBIOL AGING, V13, P83, DOI 10.1016/0197-4580(92)90013-N; Raykov Z, 2008, INT J CANCER, V122, P2880, DOI 10.1002/ijc.23472; Sancho-Shimizu V, 2007, CURR OPIN ALLERGY CL, V7, P495, DOI 10.1097/ACI.0b013e3282f151d2; Sips GJ, 2007, REV MED VIROL, V17, P223, DOI 10.1002/rmv.526; SOUTHAM CM, 1954, AM J TROP MED HYG, V3, P19, DOI 10.4269/ajtmh.1954.3.19; Stojdl DF, 2003, CANCER CELL, V4, P263, DOI 10.1016/S1535-6108(03)00241-1; van den Pol AN, 2007, J VIROL, V81, P332, DOI 10.1128/JVI.01592-06; van den Pol AN, 2009, J VIROL, V83, P420, DOI 10.1128/JVI.01728-08; Yin J, 2009, J VIROL, V83, P10036, DOI 10.1128/JVI.01209-09	15	48	50	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	OCT 15	2009	64	1					17	20		10.1016/j.neuron.2009.09.023	http://dx.doi.org/10.1016/j.neuron.2009.09.023			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	515FY	19840542	Green Accepted, Bronze			2022-12-24	WOS:000271454400004
J	Filosa, A; Paixao, S; Honsek, SD; Carmona, MA; Becker, L; Feddersen, B; Gaitanos, L; Rudhard, Y; Schoepfer, R; Klopstock, T; Kullander, K; Rose, CR; Pasquale, EB; Klein, R				Filosa, Alessandro; Paixao, Sonia; Honsek, Silke D.; Carmona, Maria A.; Becker, Lore; Feddersen, Berend; Gaitanos, Louise; Rudhard, York; Schoepfer, Ralf; Klopstock, Thomas; Kullander, Klas; Rose, Christine R.; Pasquale, Elena B.; Klein, Ruediger			Neuron-glia communication via EphA4/ephrin-A3 modulates LTP through glial glutamate transport	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; HIPPOCAMPAL SYNAPTIC PLASTICITY; DENDRITIC SPINE MORPHOLOGY; MICE LACKING; TRANSGENIC MICE; AMPA RECEPTORS; BRAIN; SYNAPSES; EPHA4; PHOSPHORYLATION	Astrocytes are critical participants in synapse development and function, but their role in synaptic plasticity is unclear. Eph receptors and their ephrin ligands have been suggested to regulate neuron-glia interactions, and EphA4-mediated ephrin reverse signaling is required for synaptic plasticity in the hippocampus. Here we show that long-term potentiation (LTP) at the CA3-CA1 synapse is modulated by EphA4 in the postsynaptic CA1 cell and by ephrin-A3, a ligand of EphA4 that is found in astrocytes. Lack of EphA4 increased the abundance of glial glutamate transporters, and ephrin-A3 modulated transporter currents in astrocytes. Pharmacological inhibition of glial glutamate transporters rescued the LTP defects in EphA4 (Epha4) and ephrin-A3 (Efna3) mutant mice. Transgenic overexpression of ephrin-A3 in astrocytes reduces glutamate transporter levels and produces focal dendritic swellings possibly caused by glutamate excitotoxicity. These results suggest that EphA4/ephrin-A3 signaling is a critical mechanism for astrocytes to regulate synaptic function and plasticity.	[Filosa, Alessandro; Paixao, Sonia; Gaitanos, Louise; Klein, Ruediger] Max Planck Inst Neurobiol, Dept Mol Neurobiol, Martinsried, Germany; [Honsek, Silke D.; Rose, Christine R.] Univ Dusseldorf, Inst Neurobiol, Dusseldorf, Germany; [Carmona, Maria A.; Pasquale, Elena B.] Burnham Inst Med Res, La Jolla, CA USA; [Becker, Lore; Klopstock, Thomas] German Res Ctr Environm Hlth GmbH, German Mouse Clin, Inst Expt Genet, Helmholtz Ctr, Munich, Germany; [Becker, Lore; Feddersen, Berend; Klopstock, Thomas] Univ Munich, Dept Neurol, Friedrich Baur Inst, D-8000 Munich, Germany; [Rudhard, York; Schoepfer, Ralf] UCL, Mol Pharmacol Lab, London, England; [Kullander, Klas] Uppsala Univ, Dept Neurosci, Uppsala, Sweden	Max Planck Society; Heinrich Heine University Dusseldorf; Sanford Burnham Prebys Medical Discovery Institute; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; University of London; University College London; Uppsala University	Klein, R (corresponding author), Max Planck Inst Neurobiol, Dept Mol Neurobiol, Martinsried, Germany.	paixao@neuro.mpg.de; rklein@neuro.mpg.de	Becker, Lore/E-3717-2010; Klein, Ruediger/C-6147-2008; Filosa, Alessandro/A-9448-2008; Becker, Lore/AAJ-1203-2020	Klein, Ruediger/0000-0002-3109-0163; Becker, Lore/0000-0002-6890-4984; Kullander, Klas/0000-0001-6418-5460	Fundacao para a Ciencia e Tecnologia of Portugal; Programa Operacional Ciencia e Inovacao; Fundo Social Europeu; Fundacion Espanola para la Ciencia y la Tecnologia; European Union; Deutsche Forschungsgemeinschaft [SPP1172]; Max-Planck Society; Wellcome Trust; Biotechnology and Biological Sciences Research Council, UK; German National Genome Research Network [01GR0430]; US National Institutes of Health [HD025938]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD025938] Funding Source: NIH RePORTER	Fundacao para a Ciencia e Tecnologia of Portugal(Portuguese Foundation for Science and Technology); Programa Operacional Ciencia e Inovacao; Fundo Social Europeu; Fundacion Espanola para la Ciencia y la Tecnologia(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Union(European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Max-Planck Society(Max Planck SocietyFoundation CELLEX); Wellcome Trust(Wellcome Trust); Biotechnology and Biological Sciences Research Council, UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); German National Genome Research Network; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank M. Bsl and the transgenic core facility for generating transgenic mice; E. Kandel ( Columbia University) and F. Kirchhoff ( Max Planck Institute of Experimental Medicine, Gttingen) for transgenic mice; M. Klein and O. Gkce for technical help; K. Deininger, C. Erlacher, V. Staiger, V. Stein and M. Traut for scientific input and suggestions; M. Korte, I. Kadow, V. Stein, J. Egea and R. Fonseca for critical comments on the manuscript. S. P. was supported by a postdoctoral fellowship from Fundacao para a Ciencia e Tecnologia of Portugal, co-funded by Programa Operacional Ciencia e Inovacao 2010 and Fundo Social Europeu. M. A. C. was supported by a fellowship from Fundacion Espanola para la Ciencia y la Tecnologia. This work was in part supported by grants from the European Union ( Endotrack), the Deutsche Forschungsgemeinschaft ( SPP1172) and the Max-Planck Society ( all to R. K.), the Wellcome Trust and the Biotechnology and Biological Sciences Research Council, UK ( R. S.), the German National Genome Research Network ( NGF N grant 01GR0430) ( T. K.), and US National Institutes of Health grant HD025938 ( E. B. P.).	Albensi BC, 2007, EXP NEUROL, V204, P1, DOI 10.1016/j.expneurol.2006.12.009; Allen NJ, 2005, CURR OPIN NEUROBIOL, V15, P542, DOI 10.1016/j.conb.2005.08.006; Barres BA, 2008, NEURON, V60, P430, DOI 10.1016/j.neuron.2008.10.013; Beart PM, 2007, BRIT J PHARMACOL, V150, P5, DOI 10.1038/sj.bjp.0706949; Bergles DE, 1998, J NEUROSCI, V18, P7709; Bouzioukh F, 2007, J NEUROSCI, V27, P11279, DOI 10.1523/JNEUROSCI.3393-07.2007; Carmona MA, 2009, P NATL ACAD SCI USA, V106, P12524, DOI 10.1073/pnas.0903328106; Dalva MB, 2000, CELL, V103, P945, DOI 10.1016/S0092-8674(00)00197-5; Diamond JS, 2000, J NEUROPHYSIOL, V83, P2835, DOI 10.1152/jn.2000.83.5.2835; Egea J, 2005, NEURON, V47, P515, DOI 10.1016/j.neuron.2005.06.029; Essmann CL, 2008, NAT NEUROSCI, V11, P1035, DOI 10.1038/nn.2171; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Genoud C, 2006, PLOS BIOL, V4, P2057, DOI 10.1371/journal.pbio.0040343; Greenwood SM, 2007, NEUROPHARMACOLOGY, V53, P891, DOI 10.1016/j.neuropharm.2007.10.003; Grunwald IC, 2004, NAT NEUROSCI, V7, P33, DOI 10.1038/nn1164; Grunwald IC, 2001, NEURON, V32, P1027, DOI 10.1016/S0896-6273(01)00550-5; Halassa MM, 2007, TRENDS MOL MED, V13, P54, DOI 10.1016/j.molmed.2006.12.005; Hasbani MJ, 2001, J NEUROSCI, V21, P2393, DOI 10.1523/JNEUROSCI.21-07-02393.2001; Haugeto O, 1996, J BIOL CHEM, V271, P27715, DOI 10.1074/jbc.271.44.27715; Henderson JT, 2001, NEURON, V32, P1041, DOI 10.1016/S0896-6273(01)00553-0; Kayser MS, 2008, NEURON, V59, P56, DOI 10.1016/j.neuron.2008.05.007; Klein R, 2009, NAT NEUROSCI, V12, P15, DOI 10.1038/nn.2231; Kramer ER, 2007, PLOS BIOL, V5, P616, DOI 10.1371/journal.pbio.0050039; Kullander K, 2001, NEURON, V29, P73, DOI 10.1016/S0896-6273(01)00181-7; Lehre KP, 2002, BIOPHYS J, V83, P125, DOI 10.1016/S0006-3495(02)75154-0; Levenson J, 2002, NAT NEUROSCI, V5, P155, DOI 10.1038/nn791; Liu GS, 1999, NEURON, V22, P395, DOI 10.1016/S0896-6273(00)81099-5; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu YM, 1997, J NEUROSCI, V17, P5196; Luscher C, 1998, NEURON, V21, P435, DOI 10.1016/S0896-6273(00)80552-8; Morris RGM, 2003, PHILOS T R SOC B, V358, P773, DOI 10.1098/rstb.2002.1264; Mulholland PJ, 2008, J NEUROSCI, V28, P8801, DOI 10.1523/JNEUROSCI.2405-08.2008; Murai KK, 2003, NAT NEUROSCI, V6, P153, DOI 10.1038/nn994; Nestor MW, 2007, J NEUROSCI, V27, P12817, DOI 10.1523/JNEUROSCI.2442-07.2007; Nikkuni O, 2007, NEUROSCI RES, V59, P296, DOI 10.1016/j.neures.2007.07.006; Nishida H, 2007, J NEUROSCI, V27, P331, DOI 10.1523/JNEUROSCI.4466-06.2007; Nolte C, 2001, GLIA, V33, P72; Oliet SHR, 2001, SCIENCE, V292, P923, DOI 10.1126/science.1059162; Pita-Almenar JD, 2006, J NEUROSCI, V26, P10461, DOI 10.1523/JNEUROSCI.2579-06.2006; Rothstein JD, 1996, NEURON, V16, P675, DOI 10.1016/S0896-6273(00)80086-0; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Tanaka K, 1997, SCIENCE, V276, P1699, DOI 10.1126/science.276.5319.1699; Tremblay ME, 2007, J COMP NEUROL, V501, P691, DOI 10.1002/cne.21263; Tsien JZ, 1996, CELL, V87, P1317, DOI 10.1016/S0092-8674(00)81826-7; Tsuda H, 2008, CELL, V133, P963, DOI 10.1016/j.cell.2008.04.039; Tsukada S, 2005, NEUROPHARMACOLOGY, V48, P479, DOI 10.1016/j.neuropharm.2004.11.006; Tzingounis AV, 2007, NAT REV NEUROSCI, V8, P935, DOI 10.1038/nrn2274; Wadiche JI, 2005, NAT NEUROSCI, V8, P1329, DOI 10.1038/nn1539; Watanabe T, 1999, BRAIN RES, V845, P92, DOI 10.1016/S0006-8993(99)01945-9; Weiergraber M, 2006, EPILEPSIA, V47, P839, DOI 10.1111/j.1528-1167.2006.00541.x	50	200	206	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2009	12	10					1285	U106		10.1038/nn.2394	http://dx.doi.org/10.1038/nn.2394			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	498US	19734893	Green Submitted, Green Accepted			2022-12-24	WOS:000270170200017
J	Kennedy, DP; Glascher, J; Tyszka, JM; Adolphs, R				Kennedy, Daniel P.; Glaescher, Jan; Tyszka, J. Michael; Adolphs, Ralph			Personal space regulation by the human amygdala	NATURE NEUROSCIENCE			English	Article							ANIMAL GROUPS; MULATTA	The amygdala plays key roles in emotion and social cognition, but how this translates to face-to-face interactions involving real people remains unknown. We found that an individual with complete amygdala lesions lacked any sense of personal space. Furthermore, healthy individuals showed amygdala activation upon close personal proximity. The amygdala may be required to trigger the strong emotional reactions normally following personal space violations, thus regulating interpersonal distance in humans.	[Kennedy, Daniel P.; Glaescher, Jan; Adolphs, Ralph] CALTECH, Div Humanities & Social Sci, Pasadena, CA 91125 USA; [Tyszka, J. Michael; Adolphs, Ralph] CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology	Kennedy, DP (corresponding author), CALTECH, Div Humanities & Social Sci, Pasadena, CA 91125 USA.	kennedy@caltech.edu	Tyszka, Julian/O-3498-2014; Gläscher, Jan/H-2930-2019	Tyszka, Julian/0000-0001-9342-9014; Gläscher, Jan/0000-0002-1020-7115	US National Institute of Mental Health; Simons Foundation; Della Martin Foundation; Japanese Ministry of Education, Culture, Sports and Technology; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH080721] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS019632] Funding Source: NIH RePORTER	US National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Simons Foundation; Della Martin Foundation; Japanese Ministry of Education, Culture, Sports and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank C. Holcomb for behavioral data collection, R. Nair and V. Chib for help with the fMRI study, and M. Spezio for discussions. Supported by US National Institute of Mental Health and the Simons Foundation ( R. A.), the Della Martin Foundation ( D. P. K.) and the Tamagawa University global Centers of Excellence program of the Japanese Ministry of Education, Culture, Sports and Technology.	Adolphs R, 1998, NATURE, V393, P470, DOI 10.1038/30982; Buchanan T., 2009, HUMAN AMYGDALA, P289; Couzin ID, 2005, NATURE, V433, P513, DOI 10.1038/nature03236; Couzin ID, 2002, J THEOR BIOL, V218, P1, DOI 10.1006/jtbi.2002.3065; Emery NJ, 2001, BEHAV NEUROSCI, V115, P515, DOI 10.1037/0735-7044.115.3.515; Hall E.T., 1966, HIDDEN DIMENSION, V609; HAYDUK LA, 1978, PSYCHOL BULL, V85, P117, DOI 10.1037/0033-2909.85.1.117; HAYDUK LA, 1983, PSYCHOL BULL, V94, P293, DOI 10.1037/0033-2909.94.2.293; Kluaver H., 1937, AM J PHYSIOL, V119, P352; Mason WA, 2006, EMOTION, V6, P73, DOI 10.1037/1528-3542.6.1.73; Pezawas L, 2005, NAT NEUROSCI, V8, P828, DOI 10.1038/nn1463	11	256	259	0	75	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2009	12	10					1226	1227		10.1038/nn.2381	http://dx.doi.org/10.1038/nn.2381			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	498US	19718035	Green Accepted, Green Submitted			2022-12-24	WOS:000270170200010
J	Mukamel, EA; Nimmerjahn, A; Schnitzer, MJ				Mukamel, Eran A.; Nimmerjahn, Axel; Schnitzer, Mark J.			Automated Analysis of Cellular Signals from Large-Scale Calcium Imaging Data	NEURON			English	Article							INDEPENDENT COMPONENT ANALYSIS; CEREBELLAR ANTERIOR LOBE; IN-VIVO; BLIND SEPARATION; PURKINJE-CELLS; VISUAL-CORTEX; FIRING RATE; FMRI DATA; PROJECTION; AWAKE	Recent advances in fluorescence imaging permit studies of Ca2+ dynamics in large numbers of cells, in anesthetized and awake behaving animals. However, unlike for electrophysiological signals, standardized algorithms for assigning optically recorded signals to individual cells have not yet emerged. Here, we describe an automated sorting procedure that combines independent component analysis and image segmentation for extracting cells' locations and their dynamics with minimal human supervision. In validation studies using simulated data, automated sorting significantly improved estimation of cellular signals compared to conventional analysis based on image regions of interest. We used automated procedures to analyze data recorded by two-photon Ca2+ imaging in the cerebellar vermis of awake behaving mice. Our analysis yielded simultaneous Ca2+ activity traces for up to >100 Purkinje cells and Bergmann glia from single recordings. Using this approach, we found microzones of Purkinje cells that were stable across behavioral states and in which synchronous Ca2+ spiking rose significantly during locomotion.	[Mukamel, Eran A.; Nimmerjahn, Axel; Schnitzer, Mark J.] Stanford Univ, James H Clark Ctr Biomed Engn & Sci, Stanford, CA 94305 USA; [Schnitzer, Mark J.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA	Stanford University; Howard Hughes Medical Institute; Stanford University	Mukamel, EA (corresponding author), Harvard Univ, Ctr Brain Sci, Cambridge, MA 02138 USA.	emukamel@fas.harvard.edu; mschnitz@stanford.edu		Mukamel, Eran/0000-0003-3203-9535	ONR; NSF; NINDS; NIDCD; UBC NIH Nanomedicine Center; Stanford Bio-X program; Klingenstein, Sloan, and Packard Foundations; Alexander von Humboldt-Foundation; International Human Frontier Science Program Organization; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R21DC007902] Funding Source: NIH RePORTER	ONR(Office of Naval Research); NSF(National Science Foundation (NSF)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); UBC NIH Nanomedicine Center; Stanford Bio-X program; Klingenstein, Sloan, and Packard Foundations(Alfred P. Sloan Foundation); Alexander von Humboldt-Foundation(Alexander von Humboldt Foundation); International Human Frontier Science Program Organization(Human Frontier Science Program); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Our work was supported by grants to M.J.S. from ONR, NSF, NINDS, NIDCD, the UBC NIH Nanomedicine Center, the Stanford Bio-X program, and the Klingenstein, Sloan, and Packard Foundations, postdoctoral fellowships to A.N. from the Alexander von Humboldt-Foundation and the International Human Frontier Science Program Organization, and an NSF Graduate Fellowship to E.A.M.	ANDERSSON G, 1978, EXP BRAIN RES, V32, P565; ANDERSSON G, 1987, J PHYSIOL-LONDON, V385, P107, DOI 10.1113/jphysiol.1987.sp016487; Apps R, 2005, NAT REV NEUROSCI, V6, P297, DOI 10.1038/nrn1646; Batista AP, 2007, J NEUROPHYSIOL, V98, P966, DOI 10.1152/jn.00421.2006; Beckmann CF, 2004, IEEE T MED IMAGING, V23, P137, DOI 10.1109/TMI.2003.822821; Beierlein M, 2006, J NEUROSCI, V26, P6958, DOI 10.1523/JNEUROSCI.0613-06.2006; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Brown GD, 2001, TRENDS NEUROSCI, V24, P54, DOI 10.1016/S0166-2236(00)01683-0; Csicsvari J, 1998, NEURON, V21, P179, DOI 10.1016/S0896-6273(00)80525-5; Dombeck DA, 2007, NEURON, V56, P43, DOI 10.1016/j.neuron.2007.08.003; EKEROT CF, 1991, J PHYSIOL-LONDON, V441, P257, DOI 10.1113/jphysiol.1991.sp018750; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Fee MS, 1996, J NEUROSCI METH, V69, P175, DOI 10.1016/S0165-0270(96)00050-7; Fiacco TA, 2006, GLIA, V54, P676, DOI 10.1002/glia.20396; Flusberg BA, 2008, NAT METHODS, V5, P935, DOI 10.1038/nmeth.1256; Fukuda M, 2001, EUR J NEUROSCI, V13, P315, DOI 10.1046/j.0953-816X.2000.01394.x; Gobel W, 2007, PHYSIOLOGY, V22, P358, DOI 10.1152/physiol.00032.2007; Gobel W, 2007, J NEUROPHYSIOL, V98, P3770, DOI 10.1152/jn.00850.2007; Gobel W, 2007, NAT METHODS, V4, P73, DOI 10.1038/NMETH989; Greenberg DS, 2008, NAT NEUROSCI, V11, P749, DOI 10.1038/nn.2140; Grosche J, 1999, NAT NEUROSCI, V2, P139, DOI 10.1038/5692; Guimaraes MP, 2007, IEEE T BIO-MED ENG, V54, P436, DOI 10.1109/TBME.2006.888824; Harris KD, 2000, J NEUROPHYSIOL, V84, P401, DOI 10.1152/jn.2000.84.1.401; Hastie T., 2001, ELEMENTS STAT LEARNI, P22; Helmchen F, 1996, BIOPHYS J, V70, P1069, DOI 10.1016/S0006-3495(96)79653-4; Hoogland TM, 2009, P NATL ACAD SCI USA, V106, P3496, DOI 10.1073/pnas.0809269106; Hyvarinen A, 1999, IEEE T NEURAL NETWOR, V10, P626, DOI 10.1109/72.761722; Hyvarinen A, 2000, NEURAL NETWORKS, V13, P411, DOI 10.1016/S0893-6080(00)00026-5; Jorntell H, 2000, J PHYSIOL-LONDON, V522, P297, DOI 10.1111/j.1469-7793.2000.00297.x; Kerr JND, 2008, NAT REV NEUROSCI, V9, P195, DOI 10.1038/nrn2338; Kerr JND, 2005, P NATL ACAD SCI USA, V102, P14063, DOI 10.1073/pnas.0506029102; Lang EJ, 1999, J NEUROSCI, V19, P2728; Lewicki MS, 1998, NETWORK-COMP NEURAL, V9, pR53, DOI 10.1088/0954-898X/9/4/001; LINAS R, 1991, MOTOR CONTROL CONCEP, P223; LINAS RR, 2004, SYNAPTIC ORG BRAIN, P271; MacKay D. J. C., 2003, INFORM THEORY INFERE; Makeig S, 1997, P NATL ACAD SCI USA, V94, P10979, DOI 10.1073/pnas.94.20.10979; Margrie TW, 2002, PFLUG ARCH EUR J PHY, V444, P491, DOI 10.1007/s00424-002-0831-z; McKeown MJ, 1998, HUM BRAIN MAPP, V6, P160, DOI 10.1002/(SICI)1097-0193(1998)6:3<160::AID-HBM5>3.0.CO;2-1; Meister M, 1996, P NATL ACAD SCI USA, V93, P609, DOI 10.1073/pnas.93.2.609; Mitra PP, 1999, BIOPHYS J, V76, P691, DOI 10.1016/S0006-3495(99)77236-X; Mrsic-Flogel TD, 2007, NEURON, V54, P961, DOI 10.1016/j.neuron.2007.05.028; Niell CM, 2005, NEURON, V45, P941, DOI 10.1016/j.neuron.2005.01.047; Nimmerjahn A, 2009, NEURON, V62, P400, DOI 10.1016/j.neuron.2009.03.019; Ohki K, 2005, NATURE, V433, P597, DOI 10.1038/nature03274; Orger MB, 2008, NAT NEUROSCI, V11, P327, DOI 10.1038/nn2048; Ozden I, 2008, J NEUROPHYSIOL, V100, P495, DOI 10.1152/jn.01310.2007; Palay S. L., 1974, CEREBELLAR CORTEX CY; Piet R, 2007, J NEUROSCI, V27, P4027, DOI 10.1523/JNEUROSCI.0462-07.2007; Reidl J, 2007, NEUROIMAGE, V34, P94, DOI 10.1016/j.neuroimage.2006.08.031; Sasaki T, 2008, J NEUROPHYSIOL, V100, P1668, DOI 10.1152/jn.00084.2008; Servais L, 2004, NEUROSCI LETT, V367, P171, DOI 10.1016/j.neulet.2004.05.109; Siegel RM, 2007, CEREB CORTEX, V17, P378, DOI 10.1093/cercor/bhj155; Stone JV, 2002, NEUROIMAGE, V15, P407, DOI 10.1006/nimg.2001.0986; Stosiek C, 2003, P NATL ACAD SCI USA, V100, P7319, DOI 10.1073/pnas.1232232100; Sugihara I, 2005, J COMP NEUROL, V487, P93, DOI 10.1002/cne.20531; Sullivan MR, 2005, J NEUROPHYSIOL, V94, P1636, DOI 10.1152/jn.01013.2004; Thevenaz P, 1998, IEEE T IMAGE PROCESS, V7, P27, DOI 10.1109/83.650848; Vogelstein JT, 2009, BIOPHYS J, V97, P636, DOI 10.1016/j.bpj.2008.08.005; WELSH JP, 1995, NATURE, V374, P453, DOI 10.1038/374453a0; Yaksi E, 2006, NAT METHODS, V3, P377, DOI 10.1038/NMETH874	61	387	398	2	42	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 24	2009	63	6					747	760		10.1016/j.neuron.2009.08.009	http://dx.doi.org/10.1016/j.neuron.2009.08.009			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	503VP	19778505	Bronze, Green Accepted			2022-12-24	WOS:000270569700009
J	Johnson, JD; McDuff, SGR; Rugg, MD; Norman, KA				Johnson, Jeffrey D.; McDuff, Susan G. R.; Rugg, Michael D.; Norman, Kenneth A.			Recollection, Familiarity, and Cortical Reinstatement: A Multivoxel Pattern Analysis	NEURON			English	Article							COMPLEMENTARY-LEARNING-SYSTEMS; MEDIAL TEMPORAL-LOBE; MRC PSYCHOLINGUISTIC DATABASE; RECOGNITION MEMORY; NEOCORTICAL CONTRIBUTIONS; REMEMBER/KNOW JUDGMENTS; EPISODIC MEMORY; BRAIN ACTIVITY; HIPPOCAMPAL; RETRIEVAL	Episodic memory retrieval is thought to involve reinstatement of the neurocognitive processes engaged when an episode was encoded. Prior fMRI studies and computational models have suggested that reinstatement is limited to instances in which specific episodic details are recollected. We used multivoxel pattern-classification analyses of fMRI data to investigate how reinstatement is associated with different memory judgments, particularly those accompanied by recollection versus a feeling of familiarity (when recollection is absent). Classifiers were trained to distinguish between brain activity patterns associated with different encoding tasks and were subsequently applied to recognition-related fMRI data to determine the degree to which patterns were reinstated. Reinstatement was evident during both recollection- and familiarity-based judgments, providing clear evidence that reinstatement is not sufficient for eliciting a recollective experience. The findings are interpreted as support for a continuous, recollection-related neural signal that has been central to recent debate over the nature of recognition memory processes.	[Johnson, Jeffrey D.; Rugg, Michael D.] Univ Calif Irvine, Ctr Neurobiol Learning & Memory, Irvine, CA 92697 USA; [Johnson, Jeffrey D.; Rugg, Michael D.] Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA 92697 USA; [McDuff, Susan G. R.; Norman, Kenneth A.] Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA; [Norman, Kenneth A.] Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08544 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; Princeton University; Princeton University	Johnson, JD (corresponding author), Univ Calif Irvine, Ctr Neurobiol Learning & Memory, Irvine, CA 92697 USA.	jeff.johnson@uci.edu		Johnson, Jeffrey/0000-0001-7651-6992	National Institutes of Health [R01-MH072966, P50-MH062196]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH072966, P50MH062196] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the National Institutes of Health (R01-MH072966 to M.D.R. and P50-MH062196 to K.A.N.).	ALVAREZ P, 1994, P NATL ACAD SCI USA, V91, P7041, DOI 10.1073/pnas.91.15.7041; Bishop C. M., 1995, NEURAL NETWORKS PATT; COLTHEART M, 1981, Q J EXP PSYCHOL-A, V33, P497, DOI 10.1080/14640748108400805; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; DAMASIO AR, 1989, COGNITION, V33, P25, DOI 10.1016/0010-0277(89)90005-X; Davachi L, 2003, P NATL ACAD SCI USA, V100, P2157, DOI 10.1073/pnas.0337195100; Donaldson W, 1996, MEM COGNITION, V24, P523, DOI 10.3758/BF03200940; Duda R.O., 2006, PATTERN CLASSIFICATI; Dunn JC, 2004, PSYCHOL REV, V111, P524, DOI 10.1037/0033-295X.111.2.524; Duzel E, 2003, J NEUROSCI, V23, P9439; Dzulkifli MA, 2005, NEUROPSYCHOLOGIA, V43, P1152, DOI 10.1016/j.neuropsychologia.2004.11.019; GREENHOUSE GW, 1959, PSYCHOMETRIKA, V49, P95; Haynes JD, 2006, NAT REV NEUROSCI, V7, P523, DOI 10.1038/nrn1931; HOLM S, 1979, SCAND J STAT, V6, P65; Johnson JD, 2008, NEUROIMAGE, V39, P406, DOI 10.1016/j.neuroimage.2007.08.050; Johnson JD, 2007, CEREB CORTEX, V17, P2507, DOI 10.1093/cercor/bhl156; JOHNSON MK, 1993, PSYCHOL BULL, V114, P3, DOI 10.1037/0033-2909.114.1.3; Johnson MK, 1997, NEUROREPORT, V8, P1317, DOI 10.1097/00001756-199703240-00051; Kahn I, 2004, J NEUROSCI, V24, P4172, DOI 10.1523/JNEUROSCI.0624-04.2004; Kriegeskorte N, 2006, P NATL ACAD SCI USA, V103, P3863, DOI 10.1073/pnas.0600244103; Kucera H., 1967, COMPUTATIONAL ANAL P; MANDLER G, 1980, PSYCHOL REV, V87, P252, DOI 10.1037/0033-295X.87.3.252; Maratos EJ, 2001, NEUROPSYCHOLOGIA, V39, P910, DOI 10.1016/S0028-3932(01)00025-2; MCCLELLAND JL, 1995, PSYCHOL REV, V102, P419, DOI 10.1037/0033-295X.102.3.419; McDuff SGR, 2009, J NEUROSCI, V29, P508, DOI 10.1523/JNEUROSCI.3587-08.2009; Mitchell TM, 2004, MACH LEARN, V57, P145, DOI 10.1023/B:MACH.0000035475.85309.1b; Mur M, 2009, SOC COGN AFFECT NEUR, V4, P101, DOI 10.1093/scan/nsn044; Norman KA, 2003, PSYCHOL REV, V110, P611, DOI 10.1037/0033-295X.110.4.611; Norman KA, 2006, TRENDS COGN SCI, V10, P424, DOI 10.1016/j.tics.2006.07.005; O'Reilly RC, 2001, PSYCHOL REV, V108, P311, DOI 10.1037//0033-295X.108.2.311; O'Reilly RC, 2002, TRENDS COGN SCI, V6, P505, DOI 10.1016/S1364-6613(02)02005-3; Polyn SM, 2005, SCIENCE, V310, P1963, DOI 10.1126/science.1117645; Rolls ET, 2000, HIPPOCAMPUS, V10, P380, DOI 10.1002/1098-1063(2000)10:4<380::AID-HIPO4>3.0.CO;2-0; Rubin DC, 1998, P NATL ACAD SCI USA, V95, P5413, DOI 10.1073/pnas.95.9.5413; Rugg MD, 2008, PROG BRAIN RES, V169, P339, DOI 10.1016/S0079-6123(07)00021-0; RUMELHART D, 1996, BACKPROPAGATION THEO, P1; Shastri L, 2002, TRENDS COGN SCI, V6, P162, DOI 10.1016/S1364-6613(02)01868-5; Stark CEL, 2003, J NEUROSCI, V23, P6748; Stern CE, 1996, P NATL ACAD SCI USA, V93, P8660, DOI 10.1073/pnas.93.16.8660; Talairach J., 1988, COPLANAR STEREOTAXIC; TULVING E, 1985, CAN PSYCHOL, V26, P1, DOI 10.1037/h0080017; Wais PE, 2008, J COGNITIVE NEUROSCI, V20, P400, DOI 10.1162/jocn.2008.20041; Wheeler ME, 2004, NEUROIMAGE, V21, P1337, DOI 10.1016/j.neuroimage.2003.11.001; WILSON M, 1988, BEHAV RES METH INSTR, V20, P6, DOI 10.3758/BF03202594; Wixted JT, 2007, PSYCHOL REV, V114, P152, DOI 10.1037/0033-295X.114.1.152; Wixted JT, 2004, PSYCHON B REV, V11, P616, DOI 10.3758/BF03196616; Woodruff CC, 2005, NEUROPSYCHOLOGIA, V43, P1022, DOI 10.1016/j.neuropsychologia.2004.10.013; Worsley KJ, 1996, HUM BRAIN MAPP, V4, P58, DOI 10.1002/(SICI)1097-0193(1996)4:1<58::AID-HBM4>3.0.CO;2-O; Yonelinas AP, 2002, J MEM LANG, V46, P441, DOI 10.1006/jmla.2002.2864; Yonelinas AP, 2005, J NEUROSCI, V25, P3002, DOI 10.1523/JNEUROSCI.5295-04.2005	50	186	189	1	22	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	SEP 10	2009	63	5					697	708		10.1016/j.neuron.2009.08.011	http://dx.doi.org/10.1016/j.neuron.2009.08.011			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	494XH	19755111	Green Accepted, Bronze			2022-12-24	WOS:000269852300015
J	Gao, ZL; Ure, K; Ables, JL; Lagace, DC; Nave, KA; Goebbels, S; Eisch, AJ; Hsieh, J				Gao, Zhengliang; Ure, Kerstin; Ables, Jessica L.; Lagace, Diane C.; Nave, Klaus-Armin; Goebbels, Sandra; Eisch, Amelia J.; Hsieh, Jenny			Neurod1 is essential for the survival and maturation of adult-born neurons	NATURE NEUROSCIENCE			English	Article							TRANSCRIPTION FACTOR; NEUROGENESIS; DIFFERENTIATION; MORPHOGENESIS; CELLS; GENE; MICE	The transcriptional program that controls adult neurogenesis is unknown. We generated mice with an inducible stem cell-specific deletion of Neurod1, resulting in substantially fewer newborn neurons in the hippocampus and olfactory bulb. Thus, Neurod1 is cell-intrinsically required for the survival and maturation of adult-born neurons.	[Gao, Zhengliang; Ure, Kerstin; Hsieh, Jenny] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Gao, Zhengliang; Ure, Kerstin; Hsieh, Jenny] Univ Texas SW Med Ctr Dallas, Cecil H & Ida Green Ctr Reprod Biol Sci, Dallas, TX 75390 USA; [Ables, Jessica L.; Eisch, Amelia J.] Univ Texas SW Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA; [Lagace, Diane C.] Univ Ottawa, Ctr Stroke Recovery, Dept Cellular & Mol Med, Ottawa, ON K1N 6N5, Canada; [Lagace, Diane C.] Univ Ottawa, Ctr Stroke Recovery, Heart & Stroke Fdn, Ottawa, ON K1N 6N5, Canada; [Nave, Klaus-Armin; Goebbels, Sandra] Max Planck Inst Expt Med, Dept Neurogenet, D-37075 Gottingen, Germany	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Ottawa; University of Ottawa; Max Planck Society	Hsieh, J (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA.	jenny.hsieh@utsouthwestern.edu	Nave, Klaus-Armin/C-8883-2011	Ables, Jessica L./0000-0003-1818-3506; Eisch, Amelia/0000-0001-6476-5385	Epilepsy Foundation; US National Institutes of Health training; Texas Advanced Research Program [3594-0029-2007, 10019-0013-2006]; Ellison Medical Foundation [AG-NS-0371-06]; Welch Foundation [I-1660]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA016765, K02DA023555, R21DA023701] Funding Source: NIH RePORTER	Epilepsy Foundation; US National Institutes of Health training(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Texas Advanced Research Program; Ellison Medical Foundation(Lawrence Ellison Foundation); Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank L. Zhang, J. Ma and Y. Jiang for technical assistance and S. Goetsch for artwork. We also thank J. Johnson, C.-L. Zhang and J. Schneider for helpful comments on the manuscript. This work was supported in part by the Epilepsy Foundation ( Z. G.), a US National Institutes of Health training grant ( K. U.), the Texas Advanced Research Program ( grant numbers 3594-0029-2007 and 10019-0013-2006), the Ellison Medical Foundation ( grant number AG-NS-0371-06) and the Welch Foundation ( grant number I-1660, J. H.).	Deisseroth K, 2004, NEURON, V42, P535, DOI 10.1016/S0896-6273(04)00266-1; Gage FH, 2008, ADULT NEUROGENESIS; Gaudilliere B, 2004, NEURON, V41, P229, DOI 10.1016/S0896-6273(03)00841-9; Goebbels S, 2005, GENESIS, V42, P247, DOI 10.1002/gene.20138; Guillemot F, 2007, PROG NEUROBIOL, V83, P37, DOI 10.1016/j.pneurobio.2007.02.009; Kuwabara T, 2009, NAT NEUROSCI, V12, P1097, DOI 10.1038/nn.2360; Lagace DC, 2007, J NEUROSCI, V27, P12623, DOI 10.1523/JNEUROSCI.3812-07.2007; LEE JE, 1995, SCIENCE, V268, P836, DOI 10.1126/science.7754368; NAYA FJ, 1995, GENE DEV, V9, P1009, DOI 10.1101/gad.9.8.1009; Naya FJ, 1997, GENE DEV, V11, P2323, DOI 10.1101/gad.11.18.2323; Pleasure SJ, 2000, J NEUROSCI, V20, P6095, DOI 10.1523/JNEUROSCI.20-16-06095.2000; Schwab MH, 2000, J NEUROSCI, V20, P3714, DOI 10.1523/JNEUROSCI.20-10-03714.2000; Yamaguchi M, 2000, NEUROREPORT, V11, P1991, DOI 10.1097/00001756-200006260-00037	13	310	320	1	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2009	12	9					1090	1092		10.1038/nn.2385	http://dx.doi.org/10.1038/nn.2385			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	487ZD	19701197	Green Accepted			2022-12-24	WOS:000269317300008
J	Al-Anzi, B; Sapin, V; Waters, C; Zinn, K; Wyman, RJ; Benzer, S				Al-Anzi, Bader; Sapin, Viveca; Waters, Christopher; Zinn, Kai; Wyman, Robert J.; Benzer, Seymour			Obesity-Blocking Neurons in Drosophila	NEURON			English	Article							TARGETED GENE-EXPRESSION; MALE COURTSHIP BEHAVIOR; NEUROPEPTIDE-Y; GRYLLUS-BIMACULATUS; SEROTONIN NEURONS; INSULIN-RECEPTOR; NERVOUS-SYSTEM; FRUITLESS GENE; CELL-GROWTH; BODY-WEIGHT	In mammals, fat store levels are communicated by leptin and insulin signaling to brain centers that regulate food intake and metabolism. By using transgenic manipulation of neural activity, we report the isolation of two distinct neuronal populations in flies that perform a similar function, the c673a-Gal4 and fruitless-Gal4 neurons. When either of these neuronal groups is silenced, fat store levels increase. This change is mediated through an increase in food intake and altered metabolism in c673a-Gal4-silenced flies, while silencing fruitless-Gal4 neurons alters only metabolism. Hyperactivation of either neuronal group causes depletion of fat stores by increasing metabolic rate and decreasing fatty acid synthesis. Altering the activities of these neurons causes changes in expression of genes known to regulate fat utilization. Our results show that the fly brain measures fat store levels and can induce changes in food intake and metabolism to maintain them within normal limits.	[Al-Anzi, Bader; Sapin, Viveca; Waters, Christopher; Zinn, Kai; Benzer, Seymour] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Wyman, Robert J.] Yale Univ, MCDB, New Haven, CT 06511 USA	California Institute of Technology; Yale University	Al-Anzi, B (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	alanzi@caltech.edu; zinnk@caltech.edu			 [RO1 DK070154]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK070154] Funding Source: NIH RePORTER	; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We would like to acknowledge M. Brown for providing the anti-DILP antibody. We would also like to acknowledge Erich Schwarz, Louise Nicholson, and Mary Lynn Formanack for their editorial assistance. This work was supported by an RO1 grant to S.B., DK070154.	Barcelo H, 2002, GENESIS, V34, P83, DOI 10.1002/gene.10132; Barsh GS, 2002, NAT REV GENET, V3, P589, DOI [10.1038/nrn902, 10.1038/nrg862]; Berthoud HR, 2008, ANNU REV PSYCHOL, V59, P55, DOI 10.1146/annurev.psych.59.103006.093551; Billeter JC, 2004, J COMP NEUROL, V475, P270, DOI 10.1002/cne.20177; Bohni R, 1999, CELL, V97, P865, DOI 10.1016/S0092-8674(00)80799-0; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brown MR, 1999, PEPTIDES, V20, P1035, DOI 10.1016/S0196-9781(99)00097-2; Bruning JC, 2000, SCIENCE, V289, P2122, DOI 10.1126/science.289.5487.2122; Cao C, 2001, CELL TISSUE RES, V304, P317, DOI 10.1007/s004410100367; Demir E, 2005, CELL, V121, P785, DOI 10.1016/j.cell.2005.04.027; Erickson JC, 1996, SCIENCE, V274, P1704, DOI 10.1126/science.274.5293.1704; Feng GP, 2003, EUR J NEUROSCI, V18, P227, DOI 10.1046/j.1460-9568.2003.02719.x; Friggi-Grelin F, 2003, J NEUROBIOL, V54, P618, DOI 10.1002/neu.10185; Gao XS, 2000, DEV BIOL, V221, P404, DOI 10.1006/dbio.2000.9680; Greer ER, 2008, CELL METAB, V8, P118, DOI 10.1016/j.cmet.2008.06.005; Gronke S, 2005, CELL METAB, V1, P323, DOI 10.1016/j.cmet.2005.04.003; Gutierrez E, 2007, NATURE, V445, P275, DOI 10.1038/nature05382; Hamasaka Y, 2006, J COMP NEUROL, V494, P314, DOI 10.1002/cne.20807; Ikeya T, 2002, CURR BIOL, V12, P1293, DOI 10.1016/S0960-9822(02)01043-6; Jones KT, 2009, DIS MODEL MECH, V2, P224, DOI 10.1242/dmm.001933; Kitamoto T, 2001, J NEUROBIOL, V47, P81, DOI 10.1002/neu.1018; Lee G, 2000, J NEUROBIOL, V43, P404, DOI 10.1002/1097-4695(20000615)43:4<404::AID-NEU8>3.0.CO;2-D; Leevers SJ, 1996, EMBO J, V15, P6584, DOI 10.1002/j.1460-2075.1996.tb01049.x; Li H, 2000, CURR BIOL, V10, P211, DOI 10.1016/S0960-9822(00)00340-7; Lorenz MW, 2004, ARCH INSECT BIOCHEM, V56, P110, DOI 10.1002/arch.20002; Lorenz MW, 2003, COMP BIOCHEM PHYS B, V136, P197, DOI 10.1016/S1096-4959(03)00227-6; Luan HJ, 2006, J NEUROSCI, V26, P573, DOI 10.1523/JNEUROSCI.3916-05.2006; Lundell MJ, 1998, DEVELOPMENT, V125, P463; Luquet S, 2005, SCIENCE, V310, P683, DOI 10.1126/science.1115524; Manoli DS, 2005, NATURE, V436, P395, DOI 10.1038/nature03859; Miura S, 2002, J BIOL CHEM, V277, P32253, DOI 10.1074/jbc.M204410200; Neufeld TP, 2008, METHOD ENZYMOL, V451, P653, DOI 10.1016/S0076-6879(08)03236-9; Ramos EJB, 2005, NUTRITION, V21, P269, DOI 10.1016/j.nut.2004.06.021; Ren DJ, 2001, SCIENCE, V294, P2372, DOI 10.1126/science.1065635; SALWAY J, 1994, METABOLISM GLANCE, V20, P38; Shen P, 2001, J NEUROBIOL, V47, P16, DOI 10.1002/neu.1012; Srinivasan S, 2008, CELL METAB, V7, P533, DOI 10.1016/j.cmet.2008.04.012; Stockinger P, 2005, CELL, V121, P795, DOI 10.1016/j.cell.2005.04.026; Tatar M, 2001, SCIENCE, V292, P107, DOI 10.1126/science.1057987; THOMPSON ED, 1987, ENVIRON MOL MUTAGEN, V10, P357, DOI 10.1002/em.2850100405; VANHANDEL E, 1988, J AM MOSQUITO CONTR, V4, P549; Villella A, 2005, P NATL ACAD SCI USA, V102, P16550, DOI 10.1073/pnas.0507056102; WOODS SC, 1979, NATURE, V282, P503, DOI 10.1038/282503a0; Wu Q, 2005, P NATL ACAD SCI USA, V102, P13289, DOI 10.1073/pnas.0501914102; Wu Q, 2003, NEURON, V39, P147, DOI 10.1016/S0896-6273(03)00396-9	45	70	71	1	17	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	AUG 13	2009	63	3					329	341		10.1016/j.neuron.2009.07.021	http://dx.doi.org/10.1016/j.neuron.2009.07.021			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	487OY	19679073	Green Accepted, Bronze			2022-12-24	WOS:000269285500008
J	Roberts, AC; Diez-Garcia, J; Rodriguiz, RM; Lopez, IP; Lujan, R; Martinez-Turrillas, R; Pico, E; Henson, MA; Bernardo, DR; Jarrett, TM; Clendeninn, DJ; Lopez-Mascaraque, L; Feng, GP; Lo, DC; Wesseling, JF; Wetsel, WC; Philpot, BD; Perez-Otano, I				Roberts, Adam C.; Diez-Garcia, Javier; Rodriguiz, Ramona M.; Lopez, Iciar Paula; Lujan, Rafael; Martinez-Turrillas, Rebeca; Pico, Esther; Henson, Maile A.; Bernardo, Danilo R.; Jarrett, Thomas M.; Clendeninn, Dallis J.; Lopez-Mascaraque, Laura; Feng, Guoping; Lo, Donald C.; Wesseling, John F.; Wetsel, William C.; Philpot, Benjamin D.; Perez-Otano, Isabel			Downregulation of NR3A-Containing NMDARs Is Required for Synapse Maturation and Memory Consolidation	NEURON			English	Article							LONG-TERM POTENTIATION; DENDRITIC SPINES; NR3A SUBUNIT; RECEPTOR TRAFFICKING; MICE LACKING; HIPPOCAMPAL; EXPRESSION; PLASTICITY; AMPA; CA1	NR3A is the only NMDA receptor (NMDAR) subunit that downregulates sharply prior to the onset of sensitive periods for plasticity, yet the functional importance of this transient expression remains unknown. To investigate whether removal/replacement of juvenile NR3A-containing NMDARs is involved in experience-driven synapse maturation, we used a reversible transgenic system that prolonged NR3A expression in the forebrain. We found that removal of NR3A is required to develop strong NMDAR currents, full expression of long-term synaptic plasticity, a mature synaptic organization characterized by more synapses and larger postsynaptic densities, and the ability to form long-term memories. Deficits associated with prolonged NR3A were reversible, as late-onset suppression of transgene expression rescued both synaptic and memory impairments. Our results suggest that NR3A behaves as a molecular brake to prevent the premature strengthening and stabilization of excitatory synapses and that NR3A removal might thereby initiate critical stages of synapse maturation during early postnatal neural development.	[Wesseling, John F.; Perez-Otano, Isabel] Univ Navarra, Dept Neurociencias, CIMA, Neurophysiol Lab, Pamplona 31008, Spain; [Roberts, Adam C.; Henson, Maile A.; Bernardo, Danilo R.; Jarrett, Thomas M.; Clendeninn, Dallis J.; Philpot, Benjamin D.] Univ N Carolina, Dept Cell & Mol Physiol, Ctr Neurosci, Chapel Hill, NC 27599 USA; [Roberts, Adam C.; Henson, Maile A.; Bernardo, Danilo R.; Jarrett, Thomas M.; Clendeninn, Dallis J.; Philpot, Benjamin D.] Univ N Carolina, Neurodev Disorders Res Ctr, Chapel Hill, NC 27599 USA; [Rodriguiz, Ramona M.] Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC 27710 USA; [Rodriguiz, Ramona M.] Duke Univ, Med Ctr, Mouse Behav & Neuroendocrine Anal Core Facil, Durham, NC 27710 USA; [Lujan, Rafael] Univ Castilla La Mancha, Dept Ciencias Med, CRIB Fac Med, Albacete 02006, Spain; [Lopez-Mascaraque, Laura] CSIC, Inst Cajal, Dept Mol Cellular & Dev Biol, E-28002 Madrid, Spain; [Feng, Guoping; Lo, Donald C.; Wetsel, William C.] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; [Lo, Donald C.] Duke Univ, Med Ctr, Ctr Drug Discovery, Durham, NC 27710 USA; [Wetsel, William C.] Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC 27710 USA; [Wetsel, William C.] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; [Wetsel, William C.] Duke Univ, Med Ctr, Mouse Behav & Neuroendocrine Anal Core Facil, Durham, NC 27710 USA	University of Navarra; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Duke University; Duke University; Universidad de Castilla-La Mancha; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Cajal (IC); Duke University; Duke University; Duke University; Duke University; Duke University	Perez-Otano, I (corresponding author), Univ Navarra, Dept Neurociencias, CIMA, Neurophysiol Lab, Pamplona 31008, Spain.	otano@unav.es	Lujan, Rafael/G-2555-2015; Wesseling, John F/AAB-7941-2019; jarrett, thomas merryfield/T-5275-2018; Feng, Guoping/Y-2827-2019; Lopez-Mascaraque, Laura/M-2448-2014; Perez-Otano, Isabel/S-9613-2017; Romo, José A./J-3024-2012	Wesseling, John F/0000-0002-7565-2594; jarrett, thomas merryfield/0000-0002-0753-6129; Lopez-Mascaraque, Laura/0000-0002-7154-5687; Perez-Otano, Isabel/0000-0002-7222-8202; Romo, José A./0000-0003-2907-580X; Martinez, Rebeca/0000-0003-1013-7898; DIEZ-GARCIA, JAVIER/0000-0003-2801-0721; Lujan Miras, Rafael/0000-0003-2001-9545; Roberts, Adam/0000-0001-8596-8552	NARSAD; Marie Curie International Program; CIMA; Spanish Ministry of Education and Science [SAF2006-10025, CSD2008-00005, BFU2006-01896]; Fondo de Investigaciones Sanitarias [PI060103]; Helen Lyng White; NICHD [T32-HD40127]; NIH; National Institute of Neurological Disorders and Stroke; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD040127] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY018323] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R29NS032742] Funding Source: NIH RePORTER; Div Of Biological Infrastructure [0755219] Funding Source: National Science Foundation	NARSAD(NARSAD); Marie Curie International Program(European Commission); CIMA(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Spanish Ministry of Education and Science(Spanish Government); Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); Helen Lyng White; NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank Ana Fernandez-Militino for advice on statistical analysis; Nobuki Nakanishi and Stuart Lipton for kindly providing the NR3A knockout mice; Jim Trimmer for the NR3A antibody; Jiechun Zhou, Aitor Zandueta, Maria Jose Lorente, and Cristina Rodriguez-Vina for excellent technical help; Mike Ehlers, Tom Blanpied, Angel Barco, Jose Esteban, and Rafa Fernandez-Chacon for critical readings of this manuscript. Work was supported by NARSAD, Marie Curie International Program, and LITE project CIMA (to I.P.O.), Spanish Ministry of Education and Science (SAF2006-10025, CSD2008-00005 to LP.O., BFU2006-01896 to R.L.), and Fondo de Investigaciones Sanitarias (PI060103 to J.F.W.), Helen Lyng White, a NICHD training grant T32-HD40127 and NARSAD Fellowships (to A.C.R.), NIH and NARSAD (to B.D.P.), National Institute of Neurological Disorders and Stroke (to D.C.L.) and unrestricted funds W.C.W.).	Ackermann M, 2003, NAT NEUROSCI, V6, P1194, DOI 10.1038/nn1135; Adesnik H, 2008, P NATL ACAD SCI USA, V105, P5597, DOI 10.1073/pnas.0800946105; Al-Hallaq RA, 2002, MOL PHARMACOL, V62, P1119, DOI 10.1124/mol.62.5.1119; Bagni C, 2005, NAT REV NEUROSCI, V6, P376, DOI 10.1038/nrn1667; Bannerman DM, 2008, J NEUROSCI, V28, P3623, DOI 10.1523/JNEUROSCI.3639-07.2008; Barria A, 2002, NEURON, V35, P345, DOI 10.1016/S0896-6273(02)00776-6; Bellone C, 2007, NEURON, V55, P779, DOI 10.1016/j.neuron.2007.07.035; CARMIGNOTO G, 1992, SCIENCE, V258, P1007, DOI 10.1126/science.1279803; Chan SF, 2001, J NEUROSCI, V21, P7985, DOI 10.1523/JNEUROSCI.21-20-07985.2001; Chao HT, 2007, NEURON, V56, P58, DOI 10.1016/j.neuron.2007.08.018; CRAIR MC, 1995, NATURE, V375, P325, DOI 10.1038/375325a0; Cui ZZ, 2004, NEURON, V41, P781, DOI 10.1016/S0896-6273(04)00072-8; Das S, 1998, NATURE, V393, P377, DOI 10.1038/30748; Datwani A, 2002, MOL CELL NEUROSCI, V21, P477, DOI 10.1006/mcne.2002.1195; Day M, 2006, NAT NEUROSCI, V9, P251, DOI 10.1038/nn1632; Durand CM, 2007, NAT GENET, V39, P25, DOI 10.1038/ng1933; Durand GM, 1996, NATURE, V381, P71, DOI 10.1038/381071a0; Ehninger D, 2008, NEURON, V60, P950, DOI 10.1016/j.neuron.2008.12.007; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Eriksson M, 2007, PHYSIOL BEHAV, V92, P54, DOI 10.1016/j.physbeh.2007.05.026; Frankland PW, 2005, NAT REV NEUROSCI, V6, P119, DOI 10.1038/nrn1607; Frankle W. Gordon, 2003, Neuron, V39, P205, DOI 10.1016/S0896-6273(03)00423-9; Frantseva MV, 2008, CEREB CORTEX, V18, P990, DOI 10.1093/cercor/bhm151; Gallinat J, 2007, J COGNITIVE NEUROSCI, V19, P59, DOI 10.1162/jocn.2007.19.1.59; Garey LJ, 1998, J NEUROL NEUROSUR PS, V65, P446, DOI 10.1136/jnnp.65.4.446; Groc L, 2006, P NATL ACAD SCI USA, V103, P18769, DOI 10.1073/pnas.0605238103; Guy J, 2007, SCIENCE, V315, P1143, DOI 10.1126/science.1138389; HARRIS KM, 1992, J NEUROSCI, V12, P2685; HARRIS KM, 1984, J PHYSIOL-LONDON, V346, P27, DOI 10.1113/jphysiol.1984.sp015005; Hayashi ML, 2004, NEURON, V42, P773, DOI 10.1016/j.neuron.2004.05.003; Iwasato T, 2000, NATURE, V406, P726, DOI 10.1038/35021059; JAHR CE, 1990, J NEUROSCI, V10, P1830; Kirov SA, 2004, NEUROPHARMACOLOGY, V47, P640, DOI 10.1016/j.neuropharm.2004.07.039; Lamprecht R, 2004, NAT REV NEUROSCI, V5, P45, DOI 10.1038/nrn1301; Mataga N, 2004, NEURON, V44, P1031, DOI 10.1016/j.neuron.2004.11.028; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Mayford M, 1996, SCIENCE, V274, P1678, DOI 10.1126/science.274.5293.1678; MORRIS RGM, 1989, J NEUROSCI, V9, P3040; Mueller HT, 2004, SCHIZOPHR RES, V71, P361, DOI 10.1016/j.schres.2004.02.016; MULLER D, 1989, DEV BRAIN RES, V49, P105, DOI 10.1016/0165-3806(89)90063-1; Nimchinsky EA, 2001, J NEUROSCI, V21, P5139, DOI 10.1523/JNEUROSCI.21-14-05139.2001; Nusser Z, 1998, NEURON, V21, P545, DOI 10.1016/S0896-6273(00)80565-6; PAN ZZ, 1993, NEURON, V11, P85; Park M, 2006, NEURON, V52, P817, DOI 10.1016/j.neuron.2006.09.040; Perez-Otano I, 2006, NAT NEUROSCI, V9, P611, DOI 10.1038/nn1680; Perez-Otano I, 2004, NEUROSIGNALS, V13, P175, DOI 10.1159/000077524; Perez-Otano I, 2001, J NEUROSCI, V21, P1228; Petralia RS, 1999, NAT NEUROSCI, V2, P31, DOI 10.1038/4532; Philpot BD, 2001, NEURON, V29, P157, DOI 10.1016/S0896-6273(01)00187-8; Plath N, 2006, NEURON, V52, P437, DOI 10.1016/j.neuron.2006.08.024; Rampon C, 2000, NAT NEUROSCI, V3, P238, DOI 10.1038/72945; Rodriguiz RM, 2008, GENES BRAIN BEHAV, V7, P418, DOI 10.1111/j.1601-183X.2007.00365.x; SAKIMURA K, 1995, NATURE, V373, P151, DOI 10.1038/373151a0; Sasaki YF, 2002, J NEUROPHYSIOL, V87, P2052, DOI 10.1152/jn.00531.2001; SHENG M, 1994, NATURE, V368, P144, DOI 10.1038/368144a0; Shimizu E, 2000, SCIENCE, V290, P1170, DOI 10.1126/science.290.5494.1170; Steigerwald F, 2000, J NEUROSCI, V20, P4573, DOI 10.1523/JNEUROSCI.20-12-04573.2000; Takumi Y, 1999, NAT NEUROSCI, V2, P618, DOI 10.1038/10172; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; Tong G, 2008, J NEUROPHYSIOL, V99, P122, DOI 10.1152/jn.01044.2006; Toni N, 2001, J NEUROSCI, V21, P6245, DOI 10.1523/JNEUROSCI.21-16-06245.2001; Tsien JZ, 1996, CELL, V87, P1327, DOI 10.1016/S0092-8674(00)81827-9; Watt AJ, 2000, NEURON, V26, P659, DOI 10.1016/S0896-6273(00)81202-7; West AE, 2002, NAT REV NEUROSCI, V3, P921, DOI 10.1038/nrn987; Wiltgen BJ, 2004, NEURON, V44, P101, DOI 10.1016/j.neuron.2004.09.015; Wong HK, 2002, J COMP NEUROL, V450, P303, DOI 10.1002/cne.10314	66	110	115	1	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 13	2009	63	3					342	356		10.1016/j.neuron.2009.06.016	http://dx.doi.org/10.1016/j.neuron.2009.06.016			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	487OY	19679074	Green Published, Bronze, Green Accepted			2022-12-24	WOS:000269285500009
J	Brack, A				Brack, Andrew			Adult Muscle Stem Cells Avoid Death and Paxes	CELL STEM CELL			English	Editorial Material							POPULATION; RENEWAL	In a recent Nature publication, Lepper et al. (2009) use cell-specific lineage tracing and temporally controllable gene deletion approaches to study muscle stem cell function and reveal age-dependent requirements for Pax gene expression.	Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital	Brack, A (corresponding author), Massachusetts Gen Hosp, Ctr Regenerat Med, 185 Cambridge St,MGH Charles River Plaza N,Room 4, Boston, MA 02114 USA.	brack.andrew@mgh.harvard.edu						Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Collins CA, 2005, CELL, V122, P289, DOI 10.1016/j.cell.2005.05.010; Kassar-Duchossoy L, 2005, GENE DEV, V19, P1426, DOI 10.1101/gad.345505; LEPPER C, 2009, NATURE IN PRESS, DOI DOI 10.1038/NATURE08209; Oustanina S, 2004, EMBO J, V23, P3430, DOI 10.1038/sj.emboj.7600346; Relaix F, 2005, NATURE, V435, P948, DOI 10.1038/nature03594; Relaix F, 2006, J CELL BIOL, V172, P91, DOI 10.1083/jcb.200508044; Schultz E, 1996, DEV BIOL, V175, P84, DOI 10.1006/dbio.1996.0097; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0	10	1	1	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	AUG 7	2009	5	2					132	134		10.1016/j.stem.2009.07.005	http://dx.doi.org/10.1016/j.stem.2009.07.005			3	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	490PB	19664985	Bronze			2022-12-24	WOS:000269511900005
J	Koya, E; Golden, SA; Harvey, BK; Guez-Barber, DH; Berkow, A; Simmons, DE; Bossert, JM; Nair, SG; Uejima, JL; Marin, MT; Mitchell, TB; Farquhar, D; Ghosh, SC; Mattson, BJ; Hope, BT				Koya, Eisuke; Golden, Sam A.; Harvey, Brandon K.; Guez-Barber, Danielle H.; Berkow, Alexander; Simmons, Danielle E.; Bossert, Jennifer M.; Nair, Sunila G.; Uejima, Jamie L.; Marin, Marcelo T.; Mitchell, Timothy B.; Farquhar, David; Ghosh, Sukhen C.; Mattson, Brandi J.; Hope, Bruce T.			Targeted disruption of cocaine-activated nucleus accumbens neurons prevents context-specific sensitization	NATURE NEUROSCIENCE			English	Article							INDUCED LOCOMOTOR-ACTIVITY; FOS EXPRESSION; DRUG-ADDICTION; SEEKING; GENE; DOPAMINE; WITHDRAWAL; ENSEMBLES; MORPHINE; HABITS	Learned associations between effects of abused drugs and the drug administration environment are important in drug addiction. Histochemical and electrophysiological studies suggest that these associations are encoded in sparsely distributed nucleus accumbens neurons that are selectively activated by drugs and drug-associated cues. Although correlations have been observed between nucleus accumbens neuronal activity and responsivity to drugs and drug cues, no technique exists for selectively manipulating these activated neurons and establishing their causal role in behavioral effects of drugs and drug cues. Here we describe a new approach, which we term the 'Daun02 inactivation method', that selectively inactivates a minority of neurons previously activated by cocaine in an environment repeatedly paired with cocaine to demonstrate a causal role for these activated neurons in context-specific cocaine-induced psychomotor sensitization in rats. This method provides a new tool for studying the causal roles of selectively activated neurons in behavioral effects of drugs and drug cues and in other learned behaviors.	[Koya, Eisuke; Golden, Sam A.; Harvey, Brandon K.; Guez-Barber, Danielle H.; Berkow, Alexander; Simmons, Danielle E.; Bossert, Jennifer M.; Nair, Sunila G.; Uejima, Jamie L.; Marin, Marcelo T.; Mitchell, Timothy B.; Mattson, Brandi J.; Hope, Bruce T.] Natl Inst Drug Abuse, Behav Neurosci Branch, Intramural Res Program, NIH,Dept Hlth & Human Serv, Baltimore, MD USA; [Farquhar, David; Ghosh, Sukhen C.] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); NIH National Institute on Drug Abuse (NIDA); University of Texas System; UTMD Anderson Cancer Center	Hope, BT (corresponding author), Natl Inst Drug Abuse, Behav Neurosci Branch, Intramural Res Program, NIH,Dept Hlth & Human Serv, Baltimore, MD USA.	bhope@intra.nida.nih.gov	Harvey, Brandon K/A-5559-2010; Marin, Marcelo Tadeu/AGZ-1077-2022; Harvey, Brandon Keith/AAY-4080-2021; Hope, Bruce T/A-9223-2010; Marin, Marcelo T/K-3256-2013; Nair, Sunila/AAW-7600-2020; Marin, Marcelo/J-3026-2012	Harvey, Brandon Keith/0000-0002-4036-1383; Hope, Bruce T/0000-0001-5804-7061; Marin, Marcelo T/0000-0002-0522-2839; Koya, Eisuke/0000-0002-5039-4875; Golden, Sam/0000-0002-2104-2272; Barber, Danielle/0000-0002-1086-8001; Mitchell, Timothy/0000-0002-1503-4049	Intramural Research Program of the National Institute on Drug Abuse; NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000467, ZIADA000526, F30DA024931] Funding Source: NIH RePORTER	Intramural Research Program of the National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was supported by the Intramural Research Program of the National Institute on Drug Abuse. We thank E. Wentzell for her excellent editorial assistance, K. Knestaut for breeding the cfos-lacZ rats and T. Adams-Deutsch, C. Pickens and K. Wihbey for technical assistance. We are especially thankful to Y. Shaham for his comments over the years and for his help in writing this manuscript, and to R. Wise for providing the inspiration for this study.	Anagnostaras SG, 1996, BEHAV NEUROSCI, V110, P1397, DOI 10.1037/0735-7044.110.6.1397; Badiani A, 2004, BEHAV PHARMACOL, V15, P327, DOI 10.1097/00008877-200409000-00004; BERRETTA S, 1993, PROG BRAIN RES, V99, P201; Bossert JM, 2007, J NEUROSCI, V27, P12655, DOI 10.1523/JNEUROSCI.3926-07.2007; Canales JJ, 2000, ANN NEUROL, V47, pS53; Carelli RM, 2004, CURR OPIN NEUROBIOL, V14, P763, DOI 10.1016/j.conb.2004.10.001; Carelli RM, 2000, SYNAPSE, V35, P238, DOI 10.1002/(SICI)1098-2396(20000301)35:3<238::AID-SYN10>3.0.CO;2-Y; Crombag HS, 2008, PHILOS T R SOC B, V363, P3233, DOI 10.1098/rstb.2008.0090; Crombag HS, 2002, BEHAV BRAIN RES, V136, P455, DOI 10.1016/S0166-4328(02)00196-1; Crombag HS, 2002, BEHAV NEUROSCI, V116, P169, DOI 10.1037//0735-7044.116.1.169; DELFS JM, 1990, J NEUROSCI, V10, P303; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; Farquhar D, 2002, CANCER CHEMOTH PHARM, V50, P65, DOI 10.1007/s00280-002-0438-2; Graybiel AM, 2008, ANNU REV NEUROSCI, V31, P359, DOI 10.1146/annurev.neuro.29.051605.112851; Han JH, 2009, SCIENCE, V323, P1492, DOI 10.1126/science.1164139; Hollander JA, 2007, J NEUROSCI, V27, P3535, DOI 10.1523/JNEUROSCI.3667-06.2007; Hope BT, 2006, EUR J NEUROSCI, V24, P867, DOI 10.1111/j.1460-9568.2006.04969.x; Hyman SE, 2001, NAT REV NEUROSCI, V2, P695, DOI 10.1038/35094560; KASOF GM, 1995, J NEUROSCI, V15, P4238; KOOB GF, 1992, TRENDS PHARMACOL SCI, V13, P177, DOI 10.1016/0165-6147(92)90060-J; Lu L, 2004, NEUROPHARMACOLOGY, V47, P214, DOI 10.1016/j.neuropharm.2004.06.027; Mattson BJ, 2008, EUR J NEUROSCI, V27, P202, DOI 10.1111/j.1460-9568.2007.05984.x; MORGAN JI, 1991, ANNU REV NEUROSCI, V14, P421, DOI 10.1146/annurev.ne.14.030191.002225; Moser EI, 2001, CURR OPIN NEUROBIOL, V11, P745, DOI 10.1016/S0959-4388(01)00279-3; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; PENNARTZ CMA, 1994, PROG NEUROBIOL, V42, P719, DOI 10.1016/0301-0082(94)90025-6; Phelps EA, 2005, NEURON, V48, P175, DOI 10.1016/j.neuron.2005.09.025; Rademacher DJ, 2007, EUR J NEUROSCI, V26, P2661, DOI 10.1111/j.1460-9568.2007.05895.x; ROBERTS DCS, 1977, PHARMACOL BIOCHEM BE, V6, P615, DOI 10.1016/0091-3057(77)90084-3; ROBINSON TE, 1986, BRAIN RES REV, V11, P157, DOI 10.1016/0165-0173(86)90002-0; SANTONE KS, 1986, CANCER RES, V46, P2659; SCHILLING K, 1991, P NATL ACAD SCI USA, V88, P5665, DOI 10.1073/pnas.88.13.5665; Sgambato V, 1997, NEUROSCIENCE, V81, P93, DOI 10.1016/S0306-4522(97)00179-6; SIEGEL S, 1976, SCIENCE, V193, P323, DOI 10.1126/science.935870; STEWART J, 1984, PSYCHOL REV, V91, P251, DOI 10.1037/0033-295X.91.2.251; Todtenkopf MS, 2002, NEUROSCIENCE, V114, P1061, DOI 10.1016/S0306-4522(02)00272-5; Vanderschuren LJMJ, 2000, PSYCHOPHARMACOLOGY, V151, P99, DOI 10.1007/s002130000493; VEZINA P, 1989, PHARMACOL BIOCHEM BE, V32, P581, DOI 10.1016/0091-3057(89)90201-3; Vezina P, 2009, NEUROPHARMACOLOGY, V56, P160, DOI 10.1016/j.neuropharm.2008.06.070; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406	40	189	193	2	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2009	12	8					1069	U152		10.1038/nn.2364	http://dx.doi.org/10.1038/nn.2364			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	475WS	19620976	Green Accepted			2022-12-24	WOS:000268396300023
J	Durstewitz, D; Vittoz, NM; Floresco, SB; Seamans, JK				Durstewitz, Daniel; Vittoz, Nicole M.; Floresco, Stan B.; Seamans, Jeremy K.			Abrupt Transitions between Prefrontal Neural Ensemble States Accompany Behavioral Transitions during Rule Learning	NEURON			English	Article							ANTERIOR CINGULATE CORTEX; TIME-SERIES; TRANSIENT DYNAMICS; RAT; INSIGHT; PERFORMANCE; NEURONS; REWARD; TASK; REPRESENTATIONS	One of the most intriguing aspects of adaptive behavior involves the inference of regularities and rules in ever-changing environments. Rules are often deduced through evidence-based learning which relies on the prefrontal cortex (PFC). This is a highly dynamic process, evolving trial by trial and therefore may not be adequately captured by averaging single-unit responses over numerous repetitions. Here, we employed advanced statistical techniques to visualize the trajectories of ensembles of simultaneously recorded medial PFC neurons on a trial-by-trial basis as rats deduced a novel rule in a set-shifting task. Neural populations formed clearly distinct and lasting representations of familiar and novel rules by entering unique network states. During rule acquisition, the recorded ensembles often exhibited abrupt transitions, rather than evolving continuously, in tight temporal relation to behavioral performance shifts. These results support the idea that rule learning is an evidence-based decision process, perhaps accompanied by moments of sudden insight.	[Durstewitz, Daniel] Univ Heidelberg, RG Computat Neurosci, Cent Inst Mental Hlth, D-68159 Mannheim, Germany; [Durstewitz, Daniel] Univ Heidelberg, Interdisciplinary Ctr Neurosci, D-68159 Mannheim, Germany; [Vittoz, Nicole M.; Seamans, Jeremy K.] Univ British Columbia, Fac Med, Brain Res Ctr, Vancouver, BC V6T 2B5, Canada; [Floresco, Stan B.] Univ British Columbia, Dept Psychol, Vancouver, BC V6T 2B5, Canada	Central Institute of Mental Health; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; University of British Columbia; University of British Columbia	Durstewitz, D (corresponding author), Univ Heidelberg, RG Computat Neurosci, Cent Inst Mental Hlth, J 5, D-68159 Mannheim, Germany.	daniel.durstewitz@zi-mannheim.de; seamans@interchange.ubc.ca	Floresco, Stan B/F-8160-2012	Floresco, Stan B/0000-0002-5633-243X	Deutsche Forschungsgemeinschaft [Du 354/5-1, Du 354/6-1]; Canadian Institute for Health Research; Natural Sciences and Engineering Research Council; NARSAD	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); NARSAD(NARSAD)	This work was funded by grants from the Deutsche Forschungsgemeinschaft to D.D. (Du 354/5-1 and Du 354/6-1), the Canadian Institute for Health Research to J.K.S., the Natural Sciences and Engineering Research Council to S.B.F., and NARSAD to J.K.S. and N.M.V. J.K.S. and S.B.F. are Michael Smith Foundation for Health Research Senior Scholars. Many thanks to Emili Balaguer-Ballester for thorough reading of this manuscript and to Liya Ma and James Hyman for collection of control data.	Asaad WF, 1998, NEURON, V21, P1399, DOI 10.1016/S0896-6273(00)80658-3; Aziz-Zadeh L, 2009, HUM BRAIN MAPP, V30, P908, DOI 10.1002/hbm.20554; Bishop C.M., 2006, PATTERN RECOGNITION; Block AE, 2007, CEREB CORTEX, V17, P1625, DOI 10.1093/cercor/bhl073; Boettiger CA, 2005, J NEUROSCI, V25, P2723, DOI 10.1523/JNEUROSCI.3697-04.2005; Boulougouris V, 2007, BEHAV BRAIN RES, V179, P219, DOI 10.1016/j.bbr.2007.02.005; Bowden EM, 2005, TRENDS COGN SCI, V9, P322, DOI 10.1016/j.tics.2005.05.012; Brown EN, 2004, NAT NEUROSCI, V7, P456, DOI 10.1038/nn1228; Chapin JK, 1999, J NEUROSCI METH, V94, P121, DOI 10.1016/S0165-0270(99)00130-2; Churchland MM, 2007, CURR OPIN NEUROBIOL, V17, P609, DOI 10.1016/j.conb.2007.11.001; Cowen SL, 2007, J NEUROPHYSIOL, V98, P303, DOI 10.1152/jn.00150.2007; Deadwyler SA, 1997, ANNU REV NEUROSCI, V20, P217, DOI 10.1146/annurev.neuro.20.1.217; Durstewitz D, 2003, J NEUROSCI, V23, P5342; Durstewitz D, 2008, BIOL PSYCHIAT, V64, P739, DOI 10.1016/j.biopsych.2008.05.015; Durstewitz D, 2008, EUR J NEUROSCI, V27, P217, DOI 10.1111/j.1460-9568.2007.05976.x; EPSTEIN R, 1984, NATURE, V308, P61, DOI 10.1038/308061a0; Euston DR, 2006, J NEUROSCI, V26, P13143, DOI 10.1523/JNEUROSCI.3803-06.2006; Everling S, 2005, J COGNITIVE NEUROSCI, V17, P1483, DOI 10.1162/0898929054985455; Floresco SB, 2006, NEUROPSYCHOPHARMACOL, V31, P297, DOI 10.1038/sj.npp.1300825; Floresco SB, 2008, BEHAV BRAIN RES, V190, P85, DOI 10.1016/j.bbr.2008.02.008; Genovesio A, 2005, NEURON, V47, P307, DOI 10.1016/j.neuron.2005.06.006; Hastie T., 2009, UNSUPERVISED LEARNIN; Hegger R, 1999, CHAOS, V9, P413, DOI 10.1063/1.166424; Huskova M, 2008, J TIME SER ANAL, V29, P947, DOI 10.1111/j.1467-9892.2008.00589.x; Ito S, 2003, SCIENCE, V302, P120, DOI 10.1126/science.1087847; Jones LM, 2007, P NATL ACAD SCI USA, V104, P18772, DOI 10.1073/pnas.0705546104; Kantz H., 2004, NONLINEAR TIME SERIE; Kim JN, 1999, NAT NEUROSCI, V2, P176, DOI 10.1038/5739; KIRCH C, 2008, STAT DECISIONS, V25, P1001; Kirch C, 2007, J STAT PLAN INFER, V137, P2453, DOI 10.1016/j.jspi.2006.09.026; Krzanowski WJ, 2000, PRINCIPLES MULTIVARI; Landmann C, 2007, CEREB CORTEX, V17, P749, DOI 10.1093/cercor/bhk028; Lapish CC, 2008, P NATL ACAD SCI USA, V105, P11963, DOI 10.1073/pnas.0804045105; Mansouri FA, 2006, J NEUROSCI, V26, P2745, DOI 10.1523/JNEUROSCI.5238-05.2006; Mansouri FA, 2007, SCIENCE, V318, P987, DOI 10.1126/science.1146384; Mazor O, 2005, NEURON, V48, P661, DOI 10.1016/j.neuron.2005.09.032; Milner B., 1963, ARCH NEUROL-CHICAGO, V9, P90, DOI DOI 10.1001/ARCHNEUR.1963.00460070100010; Nakahara K, 2002, SCIENCE, V295, P1532, DOI 10.1126/science.1067653; Narayanan NS, 2008, J NEUROPHYSIOL, V100, P520, DOI 10.1152/jn.00035.2008; Papachristos EB, 2006, J EXP ANAL BEHAV, V85, P293, DOI 10.1901/jeab.2006.71-05; Pasupathy A, 2005, NATURE, V433, P873, DOI 10.1038/nature03287; Procyk E, 2000, NAT NEUROSCI, V3, P502, DOI 10.1038/74880; Ragozzino ME, 1999, J NEUROSCI, V19, P4585; Rich EL, 2007, J NEUROSCI, V27, P4747, DOI 10.1523/JNEUROSCI.0369-07.2007; Rich EL, 2009, J NEUROSCI, V29, P7208, DOI 10.1523/JNEUROSCI.6068-08.2009; Sandkuhler S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001459; Schall JD, 2001, NAT REV NEUROSCI, V2, P33, DOI 10.1038/35049054; Schreiber T, 2000, PHYSICA D, V142, P346, DOI 10.1016/S0167-2789(00)00043-9; Schultz W, 2006, ANNU REV PSYCHOL, V57, P87, DOI 10.1146/annurev.psych.56.091103.070229; Shima K, 1998, SCIENCE, V282, P1335, DOI 10.1126/science.282.5392.1335; Stuss DT, 2000, NEUROPSYCHOLOGIA, V38, P388, DOI 10.1016/S0028-3932(99)00093-7; Wallis JD, 2001, NATURE, V411, P953, DOI 10.1038/35082081; Yu BM, 2009, J NEUROPHYSIOL, V102, P614, DOI 10.1152/jn.90941.2008	53	213	216	0	24	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	MAY 13	2010	66	3					438	448		10.1016/j.neuron.2010.03.029	http://dx.doi.org/10.1016/j.neuron.2010.03.029			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	598HE	20471356	Bronze			2022-12-24	WOS:000277825200012
J	Johnson, PM; Kenny, PJ				Johnson, Paul M.; Kenny, Paul J.			Dopamine D2 receptors in addiction-like reward dysfunction and compulsive eating in obese rats	NATURE NEUROSCIENCE			English	Article							SELF-STIMULATION; LATERAL HYPOTHALAMUS; DRUG-ADDICTION; DARK SIDE; BRAIN; LEPTIN; DIET; FOOD; SENSITIVITY; CONSUMPTION	We found that development of obesity was coupled with emergence of a progressively worsening deficit in neural reward responses. Similar changes in reward homeostasis induced by cocaine or heroin are considered to be crucial in triggering the transition from casual to compulsive drug-taking. Accordingly, we detected compulsive-like feeding behavior in obese but not lean rats, measured as palatable food consumption that was resistant to disruption by an aversive conditioned stimulus. Striatal dopamine D2 receptors (D2Rs) were downregulated in obese rats, as has been reported in humans addicted to drugs. Moreover, lentivirus-mediated knockdown of striatal D2Rs rapidly accelerated the development of addiction-like reward deficits and the onset of compulsive-like food seeking in rats with extended access to palatable high-fat food. These data demonstrate that overconsumption of palatable food triggers addiction-like neuroadaptive responses in brain reward circuits and drives the development of compulsive eating. Common hedonic mechanisms may therefore underlie obesity and drug addiction.	[Johnson, Paul M.; Kenny, Paul J.] Scripps Res Inst Scripps Florida, Dept Mol Therapeut, Lab Behav & Mol Neurosci, Jupiter, FL USA	Scripps Research Institute; State University System of Florida; University of Florida	Kenny, PJ (corresponding author), Scripps Res Inst Scripps Florida, Dept Mol Therapeut, Lab Behav & Mol Neurosci, Jupiter, FL USA.	pjkenny@scripps.edu			Bank of America; Landenberger Foundation; US National Institutes of Health [DA025983]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA025983] Funding Source: NIH RePORTER	Bank of America; Landenberger Foundation; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by a Bank of America Fellowship (P.M.J.), the Landenberger Foundation (P.J.K.) and a grant from the US National Institutes of Health (DA025983; P.J.K.). This is publication number 19,563 from the Scripps Research Institute.	Ahmed SH, 2002, NAT NEUROSCI, V5, P625, DOI 10.1038/nn872; *AM MED ASS, 1994, DIAGN STAT MAN MENT; BALAGURA S, 1967, PHYSIOL BEHAV, V2, P337, DOI 10.1016/0031-9384(67)90048-0; Batterham RL, 2007, NATURE, V450, P106, DOI 10.1038/nature06212; BLUNDELL JE, 1968, NATURE, V219, P627, DOI 10.1038/219627a0; Booth ML, 2008, J PAEDIATR CHILD H, V44, P248, DOI 10.1111/j.1440-1754.2007.01267.x; Clarke HF, 2004, SCIENCE, V304, P878, DOI 10.1126/science.1094987; Cottone P, 2008, NEUROPSYCHOPHARMACOL, V33, P524, DOI 10.1038/sj.npp.1301430; Cottone P, 2009, P NATL ACAD SCI USA, V106, P20016, DOI 10.1073/pnas.0908789106; DAVID C, 1993, BIOCHEMISTRY-US, V32, P8179, DOI 10.1021/bi00083a018; Farooqi IS, 2007, SCIENCE, V317, P1355, DOI 10.1126/science.1144599; FISHBURN CS, 1995, J BIOL CHEM, V270, P29819; Frank GK, 2005, BIOL PSYCHIAT, V58, P908, DOI 10.1016/j.biopsych.2005.05.003; Fulton S, 2000, SCIENCE, V287, P125, DOI 10.1126/science.287.5450.125; Fulton S, 2006, NEURON, V51, P811, DOI 10.1016/j.neuron.2006.09.006; HOEBEL BG, 1969, J COMP PHYSIOL PSYCH, V68, P536, DOI 10.1037/h0027651; HOEBEL BG, 1969, ANN NY ACAD SCI, V157, P758, DOI 10.1111/j.1749-6632.1969.tb12919.x; HOEBEL BG, 1962, SCIENCE, V135, P375, DOI 10.1126/science.135.3501.375; Hommel JD, 2006, NEURON, V51, P801, DOI 10.1016/j.neuron.2006.08.023; Huang XF, 2006, BEHAV BRAIN RES, V175, P415, DOI 10.1016/j.bbr.2006.08.034; Kenny PJ, 2007, TRENDS PHARMACOL SCI, V28, P135, DOI 10.1016/j.tips.2007.01.008; Kenny PJ, 2006, J NEUROSCI, V26, P5894, DOI 10.1523/JNEUROSCI.0740-06.2006; Klein TA, 2007, SCIENCE, V318, P1642, DOI 10.1126/science.1145044; Koob GF, 2005, NAT NEUROSCI, V8, P1442, DOI 10.1038/nn1105-1442; Llado I, 2000, INT J OBESITY, V24, P1396, DOI 10.1038/sj.ijo.0801390; MARKOU A, 1992, PHYSIOL BEHAV, V51, P111, DOI 10.1016/0031-9384(92)90211-J; MARKOU A, 1991, NEUROPSYCHOPHARMACOL, V4, P17; Mastronardi CA, 2001, P NATL ACAD SCI USA, V98, P14720, DOI 10.1073/pnas.251543598; Mount G., 1967, PSYCHON SCI, V9, P265; Neville MJ, 2004, HUM MUTAT, V23, P540, DOI 10.1002/humu.20039; Noble EP, 2000, EUR PSYCHIAT, V15, P79, DOI 10.1016/S0924-9338(00)00208-X; Pellegrino L. J., 1979, STEREOTAXIC ATLAS RA; Puhl RM, 2008, HEALTH EDUC RES, V23, P347, DOI 10.1093/her/cym052; ROLLS BJ, 1980, J PHYSIOL-LONDON, V298, P415, DOI 10.1113/jphysiol.1980.sp013091; Saper CB, 2002, NEURON, V36, P199, DOI 10.1016/S0896-6273(02)00969-8; Stice E, 2008, SCIENCE, V322, P449, DOI 10.1126/science.1161550; Teegarden SL, 2007, BIOL PSYCHIAT, V61, P1021, DOI 10.1016/j.biopsych.2006.09.032; Thanos PK, 2008, SYNAPSE, V62, P50, DOI 10.1002/syn.20468; Vanderschuren LJMJ, 2004, SCIENCE, V305, P1017, DOI 10.1126/science.1098975; Volkow ND, 2005, NAT NEUROSCI, V8, P555, DOI 10.1038/nn1452; Volkow ND, 2007, AM J PSYCHIAT, V164, P708, DOI 10.1176/appi.ajp.164.5.708; Wang GJ, 2008, NEUROIMAGE, V39, P1824, DOI 10.1016/j.neuroimage.2007.11.008; Wang Gene-Jack, 2002, Expert Opin Ther Targets, V6, P601, DOI 10.1517/14728222.6.5.601; Wang GJ, 2001, LANCET, V357, P354, DOI 10.1016/S0140-6736(00)03643-6; Yin HH, 2006, BEHAV BRAIN RES, V166, P189, DOI 10.1016/j.bbr.2005.07.012; Zheng HY, 2007, CURR OPIN PHARMACOL, V7, P607, DOI 10.1016/j.coph.2007.10.011	46	943	970	2	186	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2010	13	5					635	641		10.1038/nn.2519	http://dx.doi.org/10.1038/nn.2519			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	588JM	20348917	Green Accepted			2022-12-24	WOS:000277065700023
J	Migues, PV; Hardt, O; Wu, DC; Gamache, K; Sacktor, TC; Wang, YT; Nader, K				Migues, Paola Virginia; Hardt, Oliver; Wu, Dong Chuan; Gamache, Karine; Sacktor, Todd Charlton; Wang, Yu Tian; Nader, Karim			PKM zeta maintains memories by regulating GluR2-dependent AMPA receptor trafficking	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; TYROSINE PHOSPHORYLATION; SYNAPTIC-TRANSMISSION; HIPPOCAMPAL-NEURONS; RETROGRADE-AMNESIA; PROTEIN-KINASE; GLUR2; NSF; PLASTICITY; AMYGDALA	The maintenance of long-term memory in hippocampus, neocortex and amygdala requires the persistent action of the atypical protein kinase C isoform, protein kinase M zeta (PKM zeta). We found that inactivating PKM zeta in the amygdala impaired fear memory in rats and that the extent of the impairment was positively correlated with a decrease in postsynaptic GluR2. Blocking the GluR2-dependent removal of postsynaptic AMPA receptors abolished the behavioral impairment caused by PKM zeta inhibition and the associated decrease in postsynaptic GluR2 expression, which correlated with performance. Similarly, blocking this pathway for removal of GluR2-containing receptors from postsynaptic sites in amygdala slices prevented the reversal of long-term potentiation caused by inactivating PKM zeta. Similar behavioral results were obtained in the hippocampus for unreinforced recognition memory of object location. Together, these findings indicate that PKM zeta maintains long-term memory by regulating the trafficking of GluR2-containing AMPA receptors, the postsynaptic expression of which directly predicts memory retention.	[Migues, Paola Virginia; Hardt, Oliver; Gamache, Karine; Nader, Karim] McGill Univ, Dept Psychol, Montreal, PQ, Canada; [Wu, Dong Chuan; Wang, Yu Tian] Univ British Columbia, Brain Res Ctr, Vancouver, BC V5Z 1M9, Canada; [Wu, Dong Chuan; Wang, Yu Tian] Univ British Columbia, Dept Med, Vancouver, BC, Canada; [Sacktor, Todd Charlton] Suny Downstate Med Ctr, Robert Furchgott Ctr Neural & Behav Sci, Dept Physiol & Pharmacol, Brooklyn, NY 11203 USA; [Sacktor, Todd Charlton] Suny Downstate Med Ctr, Robert Furchgott Ctr Neural & Behav Sci, Dept Neurol, Brooklyn, NY 11203 USA	McGill University; University of British Columbia; University of British Columbia; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center	Migues, PV (corresponding author), McGill Univ, Dept Psychol, Montreal, PQ, Canada.	virginia.migues@mcgill.ca	Wu, Dong Chuan/O-3909-2015; Wang, Yu Tian/A-4729-2008; Wang, Yu Tian/J-8255-2015	WU, DONG CHUAN/0000-0002-9539-5935	Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council of Canada; E.W.R. Steacie Foundation; US National Institutes of Health [R01 MH53576, MH57068]; German Research Society; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH053576, R37MH057068, R01MH057068] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); E.W.R. Steacie Foundation; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Research Society(German Research Foundation (DFG)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the Canadian Institutes of Health Research and the Natural Sciences and Engineering Research Council of Canada (K.N. and Y.T.W.), the E.W.R. Steacie Foundation (K.N.) and by US National Institutes of Health grants R01 MH53576 and MH57068 (T. C. S.). O.H. was supported by the German Research Society (Deutsche Forschungsgemeinschaft).	Ahmadian G, 2004, EMBO J, V23, P1040, DOI 10.1038/sj.emboj.7600126; Brebner K, 2005, SCIENCE, V310, P1340, DOI 10.1126/science.1116894; Gale GD, 2004, J NEUROSCI, V24, P3810, DOI 10.1523/JNEUROSCI.4100-03.2004; Hanley JG, 2002, NEURON, V34, P53, DOI 10.1016/S0896-6273(02)00638-4; HARDT O, 2009, HIPPOCAMPUS     1005, DOI DOI 10.1002/HIPO.20708; Hayashi T, 2004, J NEUROSCI, V24, P6152, DOI 10.1523/JNEUROSCI.0799-04.2004; Huang YY, 2000, J NEUROSCI, V20, P6317, DOI 10.1523/JNEUROSCI.20-17-06317.2000; Kessels HW, 2009, NEURON, V61, P340, DOI 10.1016/j.neuron.2009.01.015; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; Lee SH, 2004, NEURON, V43, P221, DOI 10.1016/j.neuron.2004.06.015; Ling DSF, 2002, NAT NEUROSCI, V5, P295, DOI 10.1038/nn829; Man HY, 2000, NEURON, V25, P649, DOI 10.1016/S0896-6273(00)81067-3; McCormack SG, 2006, NEURON, V50, P75, DOI 10.1016/j.neuron.2006.02.027; Migues PV, 2006, J NEUROCHEM, V98, P289, DOI 10.1111/j.1471-4159.2006.03876.x; Mumby DG, 2002, LEARN MEMORY, V9, P49, DOI 10.1101/lm.41302; Nishimune A, 1998, NEURON, V21, P87, DOI 10.1016/S0896-6273(00)80517-6; Noel J, 1999, NEURON, V23, P365, DOI 10.1016/S0896-6273(00)80786-2; Osten P, 1998, NEURON, V21, P99, DOI 10.1016/S0896-6273(00)80518-8; Pastalkova E, 2006, SCIENCE, V313, P1141, DOI 10.1126/science.1128657; Rumpel S, 2005, SCIENCE, V308, P83, DOI 10.1126/science.1103944; Saglietti L, 2007, NEURON, V54, P461, DOI 10.1016/j.neuron.2007.04.012; Serrano P, 2008, PLOS BIOL, V6, P2698, DOI 10.1371/journal.pbio.0060318; Shema R, 2007, SCIENCE, V317, P951, DOI 10.1126/science.1144334; Song I, 1998, NEURON, V21, P393, DOI 10.1016/S0896-6273(00)80548-6; Takahashi T, 2003, SCIENCE, V299, P1585, DOI 10.1126/science.1079886; Whitlock JR, 2006, SCIENCE, V313, P1093, DOI 10.1126/science.1128134; WINOCUR G, 1990, BEHAV BRAIN RES, V38, P145, DOI 10.1016/0166-4328(90)90012-4; Xu L, 1998, NATURE, V394, P891, DOI 10.1038/29783; Yao YD, 2008, J NEUROSCI, V28, P7820, DOI 10.1523/JNEUROSCI.0223-08.2008; Yu SY, 2008, J NEUROCHEM, V106, P889, DOI 10.1111/j.1471-4159.2008.05461.x	30	219	226	0	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2010	13	5					630	U147		10.1038/nn.2531	http://dx.doi.org/10.1038/nn.2531			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	588JM	20383136				2022-12-24	WOS:000277065700022
J	Silver, DL; Watkins-Chow, DE; Schreck, KC; Pierfelice, TJ; Larson, DM; Burnetti, AJ; Liaw, HJ; Myung, K; Walsh, CA; Gaiano, N; Pavan, WJ				Silver, Debra L.; Watkins-Chow, Dawn E.; Schreck, Karisa C.; Pierfelice, Tarran J.; Larson, Denise M.; Burnetti, Anthony J.; Liaw, Hung-Jiun; Myung, Kyungjae; Walsh, Christopher A.; Gaiano, Nicholas; Pavan, William J.			The exon junction complex component Magoh controls brain size by regulating neural stem cell division	NATURE NEUROSCIENCE			English	Article							MESSENGER-RNA LOCALIZATION; CEREBRAL CORTICAL SIZE; SPINDLE ORIENTATION; LISSENCEPHALY GENE; HUMAN-CHROMOSOMES; LIS1 EXPRESSION; SECKEL-SYNDROME; PROTEIN; NEUROGENESIS; NASHI	Brain structure and size require precise division of neural stem cells (NSCs), which self-renew and generate intermediate neural progenitors (INPs) and neurons. The factors that regulate NSCs remain poorly understood, and mechanistic explanations of how aberrant NSC division causes the reduced brain size seen in microcephaly are lacking. Here we show that Magoh, a component of the exon junction complex (EJC) that binds RNA, controls mouse cerebral cortical size by regulating NSC division. Magoh haploinsufficiency causes microcephaly because of INP depletion and neuronal apoptosis. Defective mitosis underlies these phenotypes, as depletion of EJC components disrupts mitotic spindle orientation and integrity, chromosome number and genomic stability. In utero rescue experiments showed that a key function of Magoh is to control levels of the microcephaly-associated protein Lis1 during neurogenesis. Our results uncover requirements for the EJC in brain development, NSC maintenance and mitosis, thereby implicating this complex in the pathogenesis of microcephaly.	[Silver, Debra L.; Watkins-Chow, Dawn E.; Larson, Denise M.; Burnetti, Anthony J.; Pavan, William J.] NHGRI, Genet Dis Res Branch, NIH, Bethesda, MD 20892 USA; [Schreck, Karisa C.; Pierfelice, Tarran J.; Gaiano, Nicholas] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD USA; [Liaw, Hung-Jiun; Myung, Kyungjae] NHGRI, Genet & Mol Biol Branch, NIH, Bethesda, MD 20892 USA; [Walsh, Christopher A.] Harvard Univ, Sch Med, Childrens Hosp Boston, Div Genet, Boston, MA USA; [Walsh, Christopher A.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Walsh, Christopher A.] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Pavan, WJ (corresponding author), NHGRI, Genet Dis Res Branch, NIH, Bethesda, MD 20892 USA.	bpavan@mail.nih.gov	Liaw, Hungjiun/G-7034-2014; Schreck, Karisa/Y-4399-2019	Liaw, Hungjiun/0000-0002-3481-709X; Schreck, Karisa/0000-0001-7181-3269; Silver, Debra/0000-0001-9189-844X; Watkins-Chow, Dawn/0000-0002-4355-0868; Pavan, William/0000-0001-8281-5120	National Institute of General Medical Sciences PRAT; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000070, ZIAHG012003] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007754] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R00NS064197, R01NS032457] Funding Source: NIH RePORTER	National Institute of General Medical Sciences PRAT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	For advice, we thank Pavan laboratory members, including L. Baxter for reading the manuscript. For technical assistance, we thank A. Incao (mouse husbandry); G. Elliot and A. Chen (mouse transgenics); A. Dutra, E. Pak and S. Witchovitch (metaphase, SKY, microscopy assistance); S. Anderson and M. Kirby (FACS analysis); B. Bhorate (microarray statistics); M. Bryant (pathology analysis); Harvard Partners Center for Genetics and Genomics (candidate gene sequencing); and J. Fekecs and D. Leja (assistance with figures). This research was funded in part by an National Institute of General Medical Sciences PRAT fellowship and K99/R00 Pathway to Independence Award (to D. L. S.), by the Intramural Research program of NIH/NHGRI (to W. J. P., K. M.) and by the NIH/NHGRI (to N.G.). C.A.W. is an Investigator of the Howard Hughes Medical Institute.	Avides MD, 1999, SCIENCE, V283, P1733, DOI 10.1126/science.283.5408.1733; Azzalin CM, 2006, CURR BIOL, V16, P433, DOI 10.1016/j.cub.2006.01.018; Bi WM, 2009, NAT GENET, V41, P168, DOI 10.1038/ng.302; Bond J, 2006, CURR OPIN CELL BIOL, V18, P95, DOI 10.1016/j.ceb.2005.11.004; Bond J, 2005, NAT GENET, V37, P353, DOI 10.1038/ng1539; Bond J, 2002, NAT GENET, V32, P316, DOI 10.1038/ng995; Brunetti-Pierri N, 2008, NAT GENET, V40, P1466, DOI 10.1038/ng.279; Buac K, 2009, PIGM CELL MELANOMA R, V22, P773, DOI 10.1111/j.1755-148X.2009.00616.x; CHENN A, 1995, CELL, V82, P631, DOI 10.1016/0092-8674(95)90035-7; Diem MD, 2007, NAT STRUCT MOL BIOL, V14, P1173, DOI 10.1038/nsmb1321; Faulkner NE, 2000, NAT CELL BIOL, V2, P784, DOI 10.1038/35041020; Gaiano N, 2000, NEURON, V26, P395, DOI 10.1016/S0896-6273(00)81172-1; Gambello MJ, 2003, J NEUROSCI, V23, P1719; Griffith E, 2008, NAT GENET, V40, P232, DOI 10.1038/ng.2007.80; Haubensak W, 2004, P NATL ACAD SCI USA, V101, P3196, DOI 10.1073/pnas.0308600100; Jackson AP, 2002, AM J HUM GENET, V71, P136, DOI 10.1086/341283; Kataoka N, 2001, EMBO J, V20, P6424, DOI 10.1093/emboj/20.22.6424; Kittler R, 2004, NATURE, V432, P1036, DOI 10.1038/nature03159; Le Hir H, 2001, EMBO REP, V2, P1119, DOI 10.1093/embo-reports/kve245; LICHTER P, 1988, HUM GENET, V80, P224, DOI 10.1007/BF01790090; Liyanage M, 1996, NAT GENET, V14, P312, DOI 10.1038/ng1196-312; LUNDSTEEN C, 1985, CLIN GENET, V28, P260; Matera I, 2008, HUM MOL GENET, V17, P2118, DOI 10.1093/hmg/ddn110; Mefford HC, 2008, NEW ENGL J MED, V359, P1685, DOI 10.1056/NEJMoa0805384; Micklem DR, 1997, CURR BIOL, V7, P468, DOI 10.1016/S0960-9822(06)00218-1; Molyneaux BJ, 2007, NAT REV NEUROSCI, V8, P427, DOI 10.1038/nrn2151; Mulatinho M, 2008, AM J MED GENET A, V146A, P2284, DOI 10.1002/ajmg.a.32454; Nott A, 2004, GENE DEV, V18, P210, DOI 10.1101/gad.1163204; O'Driscoll M, 2003, NAT GENET, V33, P497, DOI 10.1038/ng1129; Palacios IM, 2004, NATURE, V427, P753, DOI 10.1038/nature02351; Pawlisz AS, 2008, HUM MOL GENET, V17, P2441, DOI 10.1093/hmg/ddn144; PINKEL D, 1986, P NATL ACAD SCI USA, V83, P2934, DOI 10.1073/pnas.83.9.2934; Pontious A, 2008, DEV NEUROSCI-BASEL, V30, P24, DOI 10.1159/000109848; Rauch A, 2008, SCIENCE, V319, P816, DOI 10.1126/science.1151174; REINER O, 1993, NATURE, V364, P717, DOI 10.1038/364717a0; Saito T, 2006, NAT PROTOC, V1, P1552, DOI 10.1038/nprot.2006.276; Sanada K, 2005, CELL, V122, P119, DOI 10.1016/j.cell.2005.05.009; Schrock E, 1996, SCIENCE, V273, P494, DOI 10.1126/science.273.5274.494; van der Weele CM, 2007, MOL BIOL CELL, V18, P3711, DOI 10.1091/mbc.E06-11-0979; Visel A, 2004, NUCLEIC ACIDS RES, V32, pD552, DOI 10.1093/nar/gkh029; Yamada M, 2009, NAT MED, V15, P1202, DOI 10.1038/nm.2023; Yingling J, 2008, CELL, V132, P474, DOI 10.1016/j.cell.2008.01.026; Zhong WM, 1996, NEURON, V17, P43, DOI 10.1016/S0896-6273(00)80279-2	43	124	126	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2010	13	5					551	U53		10.1038/nn.2527	http://dx.doi.org/10.1038/nn.2527			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	588JM	20364144	Green Accepted			2022-12-24	WOS:000277065700012
J	Durand, JB; Trotter, Y; Celebrini, S				Durand, Jean-Baptiste; Trotter, Yves; Celebrini, Simona			Privileged Processing of the Straight-Ahead Direction in Primate Area V1	NEURON			English	Article							PRIMARY VISUAL-CORTEX; POSTERIOR PARIETAL CORTEX; EYE POSITION; MACAQUE MONKEY; SELECTIVE ATTENTION; DEPENDENT ACTIVITY; STRIATE CORTEX; NEURONS; GAZE; REPRESENTATION	Gaze direction modulates the gain of neurons in most of the visual cortex, including the primary visual (V1) area. These gain modulations are thought to support a mechanism involved in the spatial localization of objects. In the present study, we show that part of them may reflect an additional function: enhancing the visual processing of the objects located straight ahead. Using single- and multiunit recordings in behaving macaques, we found that in peripheral V1, the gain of most neurons increases as their receptive fields (RF) are brought closer to the straight-ahead direction by changing the direction of gaze. No such tendency was observed in central V1, although the influence of gaze direction is similar in term of strength. This previously unknown organization of the gaze-related gain modulations might insure that objects located straight ahead still receive a privileged processing during eccentric fixation, reflecting the ecological importance of this particular egocentric direction.	[Durand, Jean-Baptiste; Trotter, Yves; Celebrini, Simona] Univ Toulouse, UPS, Ctr Rech Cerveau & Cognit, F-31062 Toulouse, France; [Durand, Jean-Baptiste; Trotter, Yves; Celebrini, Simona] CerCo, CNRS, F-31062 Toulouse, France	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Celebrini, S (corresponding author), Univ Toulouse, UPS, Ctr Rech Cerveau & Cognit, F-31062 Toulouse, France.	simona@cerco.ups-tlse.fr	DURAND, Jean-Baptiste/E-9252-2011; celebrini, simona/H-2169-2011; Durand, Jean-Baptiste/ABE-9090-2020; Trotter, Yves/G-7333-2011	DURAND, Jean-Baptiste/0000-0003-4780-8691; 	Centre National de la Recherche Scientifique (CNRS); Human Frontier Science Program (HFSP); Fondation de France	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Human Frontier Science Program (HFSP)(Human Frontier Science Program); Fondation de France(Fondation de France)	We would like to thank Dr. Simon Thorpe for helpful comments and English proofing of an earlier version of this article. This work was supported by grants from the Centre National de la Recherche Scientifique (CNRS), the Human Frontier Science Program (HFSP), and the Fondation de France (B. Fouassier) (J.-B.D.).	Andersen RA, 2002, ANNU REV NEUROSCI, V25, P189, DOI 10.1146/annurev.neuro.25.112701.142922; ANDERSEN RA, 1985, SCIENCE, V230, P456, DOI 10.1126/science.4048942; ANDERSEN RA, 1983, J NEUROSCI, V3, P532; Andersson F, 2007, HUM BRAIN MAPP, V28, P673, DOI 10.1002/hbm.20296; Angelucci A, 2002, J NEUROSCI, V22, P8633; BATTAGLINI PP, 1993, ARCH ITAL BIOL, V131, P303; Bremmer F, 1997, J NEUROPHYSIOL, V77, P962, DOI 10.1152/jn.1997.77.2.962; Bremmer F, 1997, J NEUROPHYSIOL, V77, P944, DOI 10.1152/jn.1997.77.2.944; Bremmer F, 1998, EUR J NEUROSCI, V10, P153; Bremmer F, 2000, NEUROREPORT, V11, P1277, DOI 10.1097/00001756-200004270-00027; BROTCHIE PR, 1995, NATURE, V375, P232, DOI 10.1038/375232a0; BUISSERET P, 1977, EXP BRAIN RES, V28, P421; Colby CL, 1999, ANNU REV NEUROSCI, V22, P319, DOI 10.1146/annurev.neuro.22.1.319; DANIEL PM, 1961, J PHYSIOL-LONDON, V159, P203, DOI 10.1113/jphysiol.1961.sp006803; DeSouza JFX, 2002, CEREB CORTEX, V12, P991, DOI 10.1093/cercor/12.9.991; Deutschlander A, 2005, NEUROIMAGE, V28, P4, DOI 10.1016/j.neuroimage.2005.06.001; Dobbins AC, 1998, SCIENCE, V281, P552, DOI 10.1126/science.281.5376.552; Durand JB, 2002, J NEUROPHYSIOL, V88, P2874, DOI 10.1152/jn.00291.2002; Durand JB, 2007, CEREB CORTEX, V17, P1260, DOI 10.1093/cercor/bhl050; Fang F, 2008, CURR BIOL, V18, P1707, DOI 10.1016/j.cub.2008.09.025; GALLETTI C, 1989, J NEUROSCI, V9, P1112; Galletti C, 1995, EUR J NEUROSCI, V7, P2486, DOI 10.1111/j.1460-9568.1995.tb01047.x; GOODALE MA, 1992, TRENDS NEUROSCI, V15, P20, DOI 10.1016/0166-2236(92)90344-8; Guo K, 1997, NEUROREPORT, V8, P1405, DOI 10.1097/00001756-199704140-00017; Gur M, 1997, J NEUROSCI, V17, P2914; HAENNY PE, 1988, EXP BRAIN RES, V69, P225, DOI 10.1007/BF00247569; Hays AV, 1982, WESCON C P, V2, P1; LAL R, 1989, SCIENCE, V243, P93, DOI 10.1126/science.2911723; LI CY, 1989, BRAIN RES, V496, P307, DOI 10.1016/0006-8993(89)91078-0; Luck SJ, 1997, J NEUROPHYSIOL, V77, P24, DOI 10.1152/jn.1997.77.1.24; Marcus DS, 2002, J NEUROPHYSIOL, V88, P2648, DOI 10.1152/jn.00916.2001; McAdams CJ, 1999, J NEUROSCI, V19, P431, DOI 10.1523/JNEUROSCI.19-01-00431.1999; MORAN J, 1985, SCIENCE, V229, P782, DOI 10.1126/science.4023713; Nakamura K, 1999, J NEUROPHYSIOL, V81, P2374, DOI 10.1152/jn.1999.81.5.2374; Nowicka A, 2000, EUR J NEUROSCI, V12, P751, DOI 10.1046/j.1460-9568.2000.00943.x; ORBAN GA, 1986, J NEUROPHYSIOL, V56, P462, DOI 10.1152/jn.1986.56.2.462; POUGET A, 1993, J COGNITIVE NEUROSCI, V5, P150, DOI 10.1162/jocn.1993.5.2.150; Pouget A, 2000, NAT NEUROSCI, V3, P1192, DOI 10.1038/81469; ROBINSON DA, 1963, IEEE T BIO-MED ENG, VBM10, P137, DOI 10.1109/TBMEL.1963.4322822; Roelfsema PR, 1998, NATURE, V395, P376, DOI 10.1038/26475; Rosenbluth D, 2002, NEURON, V33, P143, DOI 10.1016/S0896-6273(01)00559-1; Snyder LH, 1998, NATURE, V394, P887, DOI 10.1038/29777; Squatrito S, 1996, VISUAL NEUROSCI, V13, P385, DOI 10.1017/S0952523800007628; TOYAMA K, 1984, J NEUROPHYSIOL, V51, P649, DOI 10.1152/jn.1984.51.4.649; Trotter Y, 1999, NATURE, V398, P239, DOI 10.1038/18444; TROTTER Y, 1992, SCIENCE, V257, P1279, DOI 10.1126/science.1519066; Ungerleider L.G., 1982, ANAL VISUAL BEHAV, P549; WEYAND TG, 1993, J NEUROPHYSIOL, V69, P2258, DOI 10.1152/jn.1993.69.6.2258; ZIPSER D, 1988, NATURE, V331, P679, DOI 10.1038/331679a0; Zipser K, 1996, J NEUROSCI, V16, P7376	50	30	31	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	APR 15	2010	66	1					126	137		10.1016/j.neuron.2010.03.014	http://dx.doi.org/10.1016/j.neuron.2010.03.014			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	587TP	20399734	Bronze			2022-12-24	WOS:000277016200014
J	Bondar, T; Medzhitov, R				Bondar, Tanya; Medzhitov, Ruslan			p53-Mediated Hematopoietic Stem and Progenitor Cell Competition	CELL STEM CELL			English	Article							WILD-TYPE P53; DNA-DAMAGE; RADIATION SENSITIVITY; NICHE OCCUPANCY; B-LYMPHOCYTES; MICE; REPAIR; SELECTION; RADIOSENSITIVITY; COMPARTMENTS	Cell competition was originally described in Drosophila as a process for selection of the fittest cells. It is likely to play an important role in tissue homeostasis in all metazoans, but little is known about its role and regulation in mammals. By using genetic mosaic mouse models and bone marrow chimeras, we describe here a form of cell competition that selects for the least damaged cells. This competition is controlled by p53 but is distinct from the classical p53-mediated DNA damage response: it persists for months, is specific to the hematopoietic stem and progenitor cells, and depends on the relative rather than absolute level of p53 in competing cells. The competition appears to be mediated by a non-cell-autonomous induction of growth arrest and senescence-related gene expression in outcompeted cells with higher p53 activity, p53-mediated cell competition of this type could potentially contribute to the clonal expansion of incipient cancer cells.	[Bondar, Tanya; Medzhitov, Ruslan] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA; [Bondar, Tanya; Medzhitov, Ruslan] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06510 USA	Howard Hughes Medical Institute; Yale University; Yale University	Medzhitov, R (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA.		Bondar, Tanya/T-5576-2017	Bondar, Tanya/0000-0003-4765-8910	Leukemia and Lymphoma Society; the Howard Hughes Medical Institute; Yale Center of Excellence in Molecular Hematology [P30 DK072442]; NIH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI055502, R01AI046688] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071754, P30DK072442] Funding Source: NIH RePORTER	Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); the Howard Hughes Medical Institute(Howard Hughes Medical Institute); Yale Center of Excellence in Molecular Hematology; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Dr Klaus Rajewsky for Rosa26 targeting vector and Bruce4 ESCs, Dr Frank Costantini for providing Rosa26-LSL-eYFP mice, Dr Irving Weissman for providing H<SUP>k</SUP>-Bcl2 mice, Dr Jean-Chnstophe Marine for providing Mdm2<SUP>+/-</SUP> mice, Timothy Nottoli for technical assistance in generating R26-mp53 knockin mice, Charles Anicelli and Sophie Cronin for expert mouse work, Gouzel Tokmulina, Tom Taylor, and Xiao Xiao for FACS sorting, Bohwoo Kim and Sasha Stone for technical assistance. all R M lab members for insightful discussions, and Maya Kotas, Oscar Colegio, Arun Unni, and Dan Stetson for critical reading of the manuscript T B is supported by Leukemia and Lymphoma Society postdoctoral fellowship Supported by the Howard Hughes Medical Institute, Yale Center of Excellence in Molecular Hematology Award P30 DK072442, and grants from NIH	Adachi-Yamada T, 2004, J BIOCHEM, V136, P13, DOI 10.1093/jb/mvh099; ANDERSON RE, 1977, J IMMUNOL, V118, P1191; ARMITAGE P, 1954, BRIT J CANCER, V8, P1, DOI 10.1038/bjc.1954.1; Badea TC, 2003, J NEUROSCI, V23, P2314; Bahar R, 2006, NATURE, V441, P1011, DOI 10.1038/nature04844; Baker NE, 2008, CANCER RES, V68, P5505, DOI 10.1158/0008-5472.CAN-07-6348; Bar J, 2010, SEMIN CELL DEV BIOL, V21, P47, DOI 10.1016/j.semcdb.2009.11.006; Betz UAK, 1996, CURR BIOL, V6, P1307, DOI 10.1016/S0960-9822(02)70717-3; Bracken AP, 2007, GENE DEV, V21, P525, DOI 10.1101/gad.415507; Chambers SM, 2007, PLOS BIOL, V5, P1750, DOI 10.1371/journal.pbio.0050201; Chang HH, 2008, NATURE, V453, P544, DOI 10.1038/nature06965; Christophorou MA, 2006, NATURE, V443, P214, DOI 10.1038/nature05077; Christophorou MA, 2005, NAT GENET, V37, P718, DOI 10.1038/ng1572; Chumakov PM, 2007, BIOCHEMISTRY-MOSCOW+, V72, P1399, DOI 10.1134/S0006297907130019; de la Cova C, 2004, CELL, V117, P107, DOI 10.1016/S0092-8674(04)00214-4; de Vries A, 2002, P NATL ACAD SCI USA, V99, P2948, DOI 10.1073/pnas.052713099; Domen J, 1998, BLOOD, V91, P2272, DOI 10.1182/blood.V91.7.2272.2272_2272_2282; DOWN JD, 1995, BLOOD, V86, P122, DOI 10.1182/blood.V86.1.122.bloodjournal861122; Fitzpatrick MJ, 2007, NATURE, V447, P210, DOI 10.1038/nature05764; Fujikawa K, 2000, J RADIAT RES, V41, P113, DOI 10.1269/jrr.41.113; HODGSON GS, 1984, EXP HEMATOL, V12, P683; Issigonis M, 2009, SCIENCE, V326, P153, DOI 10.1126/science.1176817; Itahana K, 2001, EUR J BIOCHEM, V268, P2784, DOI 10.1046/j.1432-1327.2001.02228.x; Janzen V, 2006, NATURE, V443, P421, DOI 10.1038/nature05159; Jin ZG, 2008, CELL STEM CELL, V2, P39, DOI 10.1016/j.stem.2007.10.021; Johnston LA, 2009, SCIENCE, V324, P1679, DOI 10.1126/science.1163862; Kamminga LM, 2006, BLOOD, V107, P2170, DOI 10.1182/blood-2005-09-3585; KATAOKA Y, 1975, IMMUNOLOGY, V29, P121; Khare A, 2006, NAT REV GENET, V7, P577, DOI 10.1038/nrg1875; Kortlever RM, 2006, NAT CELL BIOL, V8, P877, DOI 10.1038/ncb1448; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Laird DJ, 2005, CELL, V123, P1351, DOI 10.1016/j.cell.2005.10.026; Lang GA, 2004, CELL, V119, P861, DOI 10.1016/j.cell.2004.11.006; Levine AJ, 2006, CELL DEATH DIFFER, V13, P1027, DOI 10.1038/sj.cdd.4401910; Levine AJ, 2009, NAT REV CANCER, V9, P749, DOI 10.1038/nrc2723; LUNA RMD, 1995, NATURE, V378, P203; Marine JC, 2006, CELL DEATH DIFFER, V13, P927, DOI 10.1038/sj.cdd.4401912; Marusyk A, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000324; Marusyk A, 2008, BBA-REV CANCER, V1785, P1, DOI 10.1016/j.bbcan.2007.09.001; MEIJNE EIM, 1991, EXP HEMATOL, V19, P617; Mendrysa SM, 2006, GENE DEV, V20, P16, DOI 10.1101/gad.1378506; Menendez D, 2009, NAT REV CANCER, V9, P724, DOI 10.1038/nrc2730; MORATA G, 1975, DEV BIOL, V42, P211, DOI 10.1016/0012-1606(75)90330-9; Morata G, 2007, DEV CELL, V13, P1, DOI 10.1016/j.devcel.2007.06.002; Moreno E, 2004, CELL, V117, P117, DOI 10.1016/S0092-8674(04)00262-4; Moreno E, 2008, NAT REV CANCER, V8, P141, DOI 10.1038/nrc2252; Nijnik A, 2007, NATURE, V447, P686, DOI 10.1038/nature05875; Oertel M, 2006, GASTROENTEROLOGY, V130, P507, DOI 10.1053/j.gastro.2005.10.049; Olive KP, 2004, CELL, V119, P847, DOI 10.1016/j.cell.2004.11.004; Oliver ER, 2004, DEVELOPMENT, V131, P3907, DOI 10.1242/dev.01268; Papayannopoulou T, 2008, BLOOD, V111, P3923, DOI 10.1182/blood-2007-08-078147; PLOEMACHER RE, 1992, INT J RADIAT BIOL, V61, P489, DOI 10.1080/09553009214551251; RAFF MC, 1992, NATURE, V356, P397, DOI 10.1038/356397a0; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; Randall TD, 1997, BLOOD, V89, P3596, DOI 10.1182/blood.V89.10.3596.3596_3596_3606; Rangarajan A, 2004, CANCER CELL, V6, P171, DOI 10.1016/j.ccr.2004.07.009; Reese JS, 2003, BLOOD, V102, P1626, DOI 10.1182/blood-2002-10-3035; Rhiner C, 2009, DEVELOPMENT, V136, P995, DOI 10.1242/dev.033340; Rossi DJ, 2007, CELL CYCLE, V6, P2371, DOI 10.4161/cc.6.19.4759; Rossi DJ, 2007, NATURE, V447, P725, DOI 10.1038/nature05862; Rossi DJ, 2005, P NATL ACAD SCI USA, V102, P9194, DOI 10.1073/pnas.0503280102; Santorelli LA, 2008, NATURE, V451, P1107, DOI 10.1038/nature06558; Sasaki Y, 2006, IMMUNITY, V24, P729, DOI 10.1016/j.immuni.2006.04.005; Schroeder T, 2010, CELL STEM CELL, V6, P203, DOI 10.1016/j.stem.2010.02.006; Sharpless NE, 2007, NAT REV MOL CELL BIO, V8, P703, DOI 10.1038/nrm2241; Sheng XR, 2009, CELL STEM CELL, V5, P191, DOI 10.1016/j.stem.2009.05.024; SIMPSON P, 1981, DEV BIOL, V85, P299, DOI 10.1016/0012-1606(81)90261-X; Spencer SL, 2009, NATURE, V459, P428, DOI 10.1038/nature08012; SPRENT J, 1991, J EXP MED, V174, P717, DOI 10.1084/jem.174.3.717; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Stirewalt DL, 2009, LEUKEMIA, V23, P391, DOI 10.1038/leu.2008.176; TANG X, 2002, ONCOGENE, V23, P5759; TeKippe M, 2003, EXP HEMATOL, V31, P521, DOI 10.1016/S0301-472X(03)00072-9; Tyler DM, 2007, GENETICS, V175, P643, DOI 10.1534/genetics.106.061929; VANBEKKUM DW, 1991, RADIAT RES, V128, pS4, DOI 10.2307/3577994; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Wang Y, 2006, BLOOD, V107, P358, DOI 10.1182/blood-2005-04-1418; Weisz L, 2007, ONCOGENE, V26, P2202, DOI 10.1038/sj.onc.1210294; Willis A, 2004, ONCOGENE, V23, P2330, DOI 10.1038/sj.onc.1207396; Wlodarski P, 1998, BLOOD, V91, P2998, DOI 10.1182/blood.V91.8.2998.2998_2998_3006; Zhao HQ, 2001, CELL, V104, P651, DOI 10.1016/S0092-8674(02)01107-8	81	227	233	2	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	APR 2	2010	6	4					309	322		10.1016/j.stem.2010.03.002	http://dx.doi.org/10.1016/j.stem.2010.03.002			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	585KD	20362536	Green Accepted, Bronze			2022-12-24	WOS:000276823300010
J	Hopf, FW; Bowers, MS; Chang, SJ; Chen, BT; Martin, M; Seif, T; Cho, SL; Tye, K; Bonci, A				Hopf, F. Woodward; Bowers, M. Scott; Chang, Shao-Ju; Chen, Billy T.; Martin, Miguel; Seif, Taban; Cho, Saemi L.; Tye, Kay; Bonci, Antonello			Reduced Nucleus Accumbens SK Channel Activity Enhances Alcohol Seeking during Abstinence	NEURON			English	Article							CA2+-ACTIVATED K+ CHANNELS; COCAINE-SEEKING; ETHANOL-SEEKING; DRUG-ADDICTION; KAPPA-B; CALCIUM; RAT; MODULATION; DOPAMINE; NEURONS	The cellular mechanisms underlying pathological alcohol seeking remain poorly understood. Here, we show an enhancement of nucleus accumbens (NAcb) core action potential firing ex vivo after protracted abstinence from alcohol but not sucrose self-ad ministration. Increased firing is associated with reduced small-conductance calcium-activated potassium channel (SK) currents and decreased SK3 but not SK2 subunit protein expression. Furthermore, SK activation ex vivo produces greater firing suppression in NAcb core neurons from alcohol-versus sucrose-abstinent rats. Accordingly, SK activation in the NAcb core significantly reduces alcohol but not sucrose seeking after abstinence. In contrast, NAcb shell and lateral dorsal striatal firing ex vivo are not altered after abstinence from alcohol, and SK activation in these regions has little effect on alcohol seeking. Thus, decreased NAcb core SK currents and increased excitability represents a critical mechanism that facilitates motivation to seek alcohol after abstinence.	[Hopf, F. Woodward; Bowers, M. Scott; Chang, Shao-Ju; Chen, Billy T.; Martin, Miguel; Seif, Taban; Cho, Saemi L.; Tye, Kay; Bonci, Antonello] Univ Calif San Francisco, Ernest Gallo Clin & Res Ctr, San Francisco, CA 94608 USA; [Bonci, Antonello] Univ Calif San Francisco, Program Neurosci, San Francisco, CA 94608 USA; [Bonci, Antonello] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94608 USA; [Bonci, Antonello] Univ Calif San Francisco, Wheeler Ctr Neurobiol Addict, San Francisco, CA 94608 USA	University of California System; University of California San Francisco; Ernest Gallo Clinic & Research Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Hopf, FW (corresponding author), Univ Calif San Francisco, Ernest Gallo Clin & Res Ctr, San Francisco, CA 94608 USA.	woody@gallo.ucsf.edu	Tye, Kay/J-6158-2013	Tye, Kay/0000-0002-2435-0182; Bowers, M Scott/0000-0003-0047-6765	NIAAA [RO1AA015358]; ABMRF [F32 AA015464]; State of California; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [DP2DK102256] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [F32AA015464, R01AA015358] Funding Source: NIH RePORTER	NIAAA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); ABMRF; State of California; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	We thank L. Wang for assistance with histology; D. Harada, G. Brush, and J. Chou for custom-designed analysis software; G. Stuber and D. Sparta for helpful comments; and M. Mohammedi for technical assistance. This work was supported by NIAAA RO1AA015358 (F.W.H.), F32 AA015464 (M.S.B.), funds from the ABMRF (F.W.H.) and funds provided by the State of California for medical research on alcohol and substance abuse through the University of California, San Francisco (A.B.).	Abel HJ, 2004, J NEUROPHYSIOL, V91, P324, DOI 10.1152/jn.00583.2003; Avena NM, 2008, NEUROSCI BIOBEHAV R, V32, P20, DOI 10.1016/j.neubiorev.2007.04.019; Bargas J, 1999, NEUROSCIENCE, V88, P479, DOI 10.1016/S0306-4522(98)00211-5; Bari AA, 2005, NEUROSCIENCE, V135, P959, DOI 10.1016/j.neuroscience.2005.06.048; Belin D, 2008, NEURON, V57, P432, DOI 10.1016/j.neuron.2007.12.019; Bell RL, 2006, ADDICT BIOL, V11, P270, DOI 10.1111/j.1369-1600.2005.00029.x; Bennett BD, 2000, J NEUROSCI, V20, P8493, DOI 10.1523/JNEUROSCI.20-22-08493.2000; Bosch MA, 2002, ENDOCRINOLOGY, V143, P1097, DOI 10.1210/en.143.3.1097; Bowers MS, 2008, P NATL ACAD SCI USA, V105, P12533, DOI 10.1073/pnas.0706999105; Bowers MS, 2004, NEURON, V42, P269, DOI 10.1016/S0896-6273(04)00159-X; Brosh I, 2007, EUR J NEUROSCI, V26, P3253, DOI 10.1111/j.1460-9568.2007.05936.x; Cao YJ, 2001, J PHARMACOL EXP THER, V296, P683; Cardinal RN, 2002, NEUROSCI BIOBEHAV R, V26, P321, DOI 10.1016/S0149-7634(02)00007-6; Carelli RM, 2004, CURR OPIN NEUROBIOL, V14, P763, DOI 10.1016/j.conb.2004.10.001; Chou R, 2004, J PAIN SYMPTOM MANAG, V28, P140, DOI 10.1016/j.jpainsymman.2004.05.002; Dees WL, 2000, ENDOCRINOLOGY, V141, P1325, DOI 10.1210/en.141.4.1325; Dong DL, 2006, EUR J PHARMACOL, V545, P161, DOI 10.1016/j.ejphar.2006.06.063; Epstein DH, 2006, PSYCHOPHARMACOLOGY, V189, P1, DOI 10.1007/s00213-006-0529-6; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; Ford MM, 2004, ALCOHOL CLIN EXP RES, V28, P20, DOI 10.1097/01.ALC.0000108647.62718.5A; Heyser CJ, 1997, ALCOHOL CLIN EXP RES, V21, P784; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Hollander JA, 2007, J NEUROSCI, V27, P3535, DOI 10.1523/JNEUROSCI.3667-06.2007; Hopf FW, 2007, J NEUROPHYSIOL, V98, P2297, DOI 10.1152/jn.00824.2007; Hopf FW, 2003, J NEUROSCI, V23, P5079; Ishikawa M, 2009, J NEUROSCI, V29, P5820, DOI 10.1523/JNEUROSCI.5703-08.2009; Jacobsen JPR, 2008, GENES BRAIN BEHAV, V7, P836, DOI 10.1111/j.1601-183X.2008.00416.x; Jacobson D, 2003, BIOCHEM BIOPH RES CO, V303, P660, DOI 10.1016/S0006-291X(03)00408-X; Janak PH, 1999, BRAIN RES, V817, P172, DOI 10.1016/S0006-8993(98)01245-1; Kalivas PW, 2003, PSYCHOPHARMACOLOGY, V168, P44, DOI 10.1007/s00213-003-1393-2; Kareken DA, 2004, ALCOHOL CLIN EXP RES, V28, P550, DOI 10.1097/01.ALC.0000122764.60626.AF; Katner SN, 1999, ALCOHOL CLIN EXP RES, V23, P1751, DOI 10.1111/j.1530-0277.1999.tb04070.x; Kelley AE, 2004, NEUROSCI BIOBEHAV R, V27, P765, DOI 10.1016/j.neubiorev.2003.11.015; Kye MJ, 2007, MOL CELL BIOCHEM, V300, P9, DOI 10.1007/s11010-006-9320-6; Larimer ME, 1999, ALCOHOL RES HEALTH, V23, P151; Martin M, 2006, NAT NEUROSCI, V9, P868, DOI 10.1038/nn1713; MODELL JG, 1995, J NEUROPSYCH CLIN N, V7, P15; MOGENSON GJ, 1980, PROG NEUROBIOL, V14, P69, DOI 10.1016/0301-0082(80)90018-0; Nicola SM, 2007, PSYCHOPHARMACOLOGY, V191, P521, DOI 10.1007/s00213-006-0510-4; Okvist A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000930; Paul K, 2003, NEUROSCI LETT, V348, P180, DOI 10.1016/S0304-3940(03)00747-X; Pedersen KA, 1999, BBA-BIOMEMBRANES, V1420, P231, DOI 10.1016/S0005-2736(99)00110-8; PINEDA JC, 1992, J NEUROPHYSIOL, V68, P287, DOI 10.1152/jn.1992.68.1.287; Roberts DCS, 2007, PROG NEURO-PSYCHOPH, V31, P1614, DOI 10.1016/j.pnpbp.2007.08.028; Sah P, 2002, PROG NEUROBIOL, V66, P345, DOI 10.1016/S0301-0082(02)00004-7; Sailer CA, 2004, MOL CELL NEUROSCI, V26, P458, DOI 10.1016/j.mcn.2004.03.002; Sailer CA, 2002, J NEUROSCI, V22, P9698; Sanchis-Segura C, 2006, ADDICT BIOL, V11, P2, DOI 10.1111/j.1369-1600.2006.00012.x; Schmidt HD, 2005, EUR J PHARMACOL, V526, P65, DOI 10.1016/j.ejphar.2005.09.068; Schneider F, 2001, AM J PSYCHIAT, V158, P1075, DOI 10.1176/appi.ajp.158.7.1075; Schultz W, 2004, CURR OPIN NEUROBIOL, V14, P139, DOI 10.1016/j.conb.2004.03.017; SINCLAIR JD, 1968, Q J STUD ALCOHOL, V29, P863; Spanagel R, 2009, PHYSIOL REV, V89, P649, DOI 10.1152/physrev.00013.2008; Stocker M, 2000, MOL CELL NEUROSCI, V15, P476, DOI 10.1006/mcne.2000.0842; Walter JT, 2006, NAT NEUROSCI, V9, P389, DOI 10.1038/nn1648; Zavala-Tecuapetla C, 2008, EUR J NEUROSCI, V27, P2871, DOI 10.1111/j.1460-9568.2008.06214.x	56	71	71	1	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 11	2010	65	5					682	694		10.1016/j.neuron.2010.02.015	http://dx.doi.org/10.1016/j.neuron.2010.02.015			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	571NF	20223203	Green Accepted, Bronze			2022-12-24	WOS:000275758000011
J	Challen, GA; Boles, NC; Chambers, SM; Goodell, MA				Challen, Grant A.; Boles, Nathan C.; Chambers, Stuart M.; Goodell, Margaret A.			Distinct Hematopoietic Stem Cell Subtypes Are Differentially Regulated by TGF-beta 1	CELL STEM CELL			English	Article							SELF-RENEWAL CAPACITY; TGF-BETA; IN-VITRO; IDENTIFICATION; PROGENITOR; MECHANISM; QUANTIFICATION; HETEROGENEITY; REPOPULATION; COMPARTMENT	The traditional view of hematopoiesis has been that all the cells of the peripheral blood are the progeny of a unitary homogeneous pool of hematopoietic stem cells (HSCs). Recent evidence suggests that the hematopoietic system is actually maintained by a consortium of HSC subtypes with distinct functional characteristics. We show here that myeloid-biased HSCs (My-HSCs) and lymphoid-biased HSCs (Ly-HSCs) can be purified according to their capacity for Hoechst dye efflux in combination with canonical HSC markers. These phenotypes are stable under natural (aging) or artificial (serial transplantation) stress and are exacerbated in the presence of competing HSCs. My- and Ly-HSCs' respond differently to TGF-beta 1, presenting a possible mechanism for differential regulation of HSC subtype activation. This study demonstrates definitive isolation of lineage-biased HSC subtypes and contributes to the fundamental change in view that the hematopoietic system is maintained by a continuum of HSC subtypes, rather than a functionally uniform pool.	[Challen, Grant A.; Boles, Nathan C.; Chambers, Stuart M.; Goodell, Margaret A.] Baylor Coll Med, Stem Cells & Regenerat Med Ctr, Houston, TX 77030 USA; [Challen, Grant A.; Boles, Nathan C.; Chambers, Stuart M.; Goodell, Margaret A.] Baylor Coll Med, Ctr Cell & Gene Therapy, Houston, TX 77030 USA; [Goodell, Margaret A.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Challen, Grant A.] Monash Univ, Dept Anat & Cell Biol, Clayton, Vic 3800, Australia	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Monash University	Goodell, MA (corresponding author), Baylor Coll Med, Stem Cells & Regenerat Med Ctr, Houston, TX 77030 USA.	goodell@bcm.edu		Goodell, Margaret A./0000-0003-1111-2932	Australian National Health and Medical Research Council (NHMRC) [384369]; NIH [HL081007, EB005173, DK58192]; Ellison foundation [AGSS178706]; American Heart Association [0740020N]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U54HL081007, R01HL096360] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB005173] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058192] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG034451] Funding Source: NIH RePORTER	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison foundation(Lawrence Ellison Foundation); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors have no financial conflicts of interest to disclose. The authors would like to thank all members of the Goodell lab for scientific advice, Jonathan Berg and Katherine King for manuscript review, and Chris Threeton for flow cytometric sorting and analysis. G.A.C. was supported by an Australian National Health and Medical Research Council (NHMRC) CJ Martin Fellowship (384369). This work was also supported by NIH grants HL081007, EB005173, and DK58192, the Ellison foundation (AGSS178706), and the American Heart Association (0740020N).	Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Benveniste P, 2010, CELL STEM CELL, V6, P48, DOI 10.1016/j.stem.2009.11.014; Buonamici S, 2003, BLOOD CELL MOL DIS, V31, P206, DOI 10.1016/S1079-9796(03)00159-1; Camargo FD, 2006, BLOOD, V107, P501, DOI 10.1182/blood-2005-02-0655; Chabanon A, 2008, STEM CELLS, V26, P3150, DOI 10.1634/stemcells.2008-0219; Challen GA, 2009, CYTOM PART A, V75A, P14, DOI 10.1002/cyto.a.20674; Chambers SM, 2007, PLOS BIOL, V5, P1750, DOI 10.1371/journal.pbio.0050201; Cho RH, 2008, BLOOD, V111, P5553, DOI 10.1182/blood-2007-11-123547; COSENZA SC, 1994, J CELL BIOCHEM, V55, P503, DOI 10.1002/jcb.240550410; Dykstra B, 2007, CELL STEM CELL, V1, P218, DOI 10.1016/j.stem.2007.05.015; Dykstra B, 2006, P NATL ACAD SCI USA, V103, P8185, DOI 10.1073/pnas.0602548103; Ema H, 2005, DEV CELL, V8, P907, DOI 10.1016/j.devcel.2005.03.019; Fortunel N, 2000, STEM CELLS, V18, P102, DOI 10.1634/stemcells.18-2-102; Goodell MA, 1997, NAT MED, V3, P1337, DOI 10.1038/nm1297-1337; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; GRZEGORZEWSKI K, 1994, J EXP MED, V180, P1047, DOI 10.1084/jem.180.3.1047; JORDAN CT, 1990, GENE DEV, V4, P220, DOI 10.1101/gad.4.2.220; Kale VP, 2004, STEM CELLS DEV, V13, P536, DOI 10.1089/1547328042417390; Kale VP, 2004, STEM CELLS DEV, V13, P27, DOI 10.1089/154732804773099236; Kent DG, 2009, BLOOD, V113, P6342, DOI 10.1182/blood-2008-12-192054; Kiel MJ, 2009, CELL STEM CELL, V4, P170, DOI 10.1016/j.stem.2008.10.005; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kim M, 2003, ANN NY ACAD SCI, V996, P195, DOI 10.1111/j.1749-6632.2003.tb03247.x; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Larsson J, 2005, EXP HEMATOL, V33, P592, DOI 10.1016/j.exphem.2005.02.003; Lemieux ME, 1996, BLOOD, V88, P1639; LEMISCHKA IR, 1986, CELL, V45, P917, DOI 10.1016/0092-8674(86)90566-0; Liang Y, 2005, BLOOD, V106, P1479, DOI 10.1182/blood-2004-11-4282; Matsuzaki Y, 2004, IMMUNITY, V20, P87, DOI 10.1016/S1074-7613(03)00354-6; Miller CL, 1997, P NATL ACAD SCI USA, V94, P13648, DOI 10.1073/pnas.94.25.13648; Morrison SJ, 1996, NAT MED, V2, P1011, DOI 10.1038/nm0996-1011; Muller-Sieburg CE, 2004, BLOOD, V103, P4111, DOI 10.1182/blood-2003-10-3448; Muller-Sieburg CE, 2002, BLOOD, V100, P1302, DOI 10.1182/blood.V100.4.1302.h81602001302_1302_1309; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Ramalho-Santos Miguel, 2007, Cell Stem Cell, V1, P35, DOI 10.1016/j.stem.2007.05.013; Roeder I, 2008, BLOOD, V112, P4874, DOI 10.1182/blood-2008-05-155374; Rossi DJ, 2007, EXP GERONTOL, V42, P385, DOI 10.1016/j.exger.2006.11.019; Rossi DJ, 2005, P NATL ACAD SCI USA, V102, P9194, DOI 10.1073/pnas.0503280102; Sieburg HB, 2006, BLOOD, V107, P2311, DOI 10.1182/blood-2005-07-2970; SMITH LG, 1991, P NATL ACAD SCI USA, V88, P2788, DOI 10.1073/pnas.88.7.2788; SPANGRUDE GJ, 1995, BLOOD, V85, P1006, DOI 10.1182/blood.V85.4.1006.bloodjournal8541006; Sudo K, 2000, J EXP MED, V192, P1273, DOI 10.1084/jem.192.9.1273; SZILVASSY SJ, 1990, P NATL ACAD SCI USA, V87, P8736, DOI 10.1073/pnas.87.22.8736; Takano H, 2004, J EXP MED, V199, P295, DOI 10.1084/jem.20030929; Uchida N, 2003, EXP HEMATOL, V31, P1338, DOI 10.1016/j.exphem.2003.09.001; Venezia TA, 2004, PLOS BIOL, V2, P1640, DOI 10.1371/journal.pbio.0020301; Weksberg DC, 2008, BLOOD, V111, P2444, DOI 10.1182/blood-2007-09-115006; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Wineman J, 1996, BLOOD, V87, P4082, DOI 10.1182/blood.V87.10.4082.bloodjournal87104082; Yamazaki S, 2009, BLOOD, V113, P1250, DOI 10.1182/blood-2008-04-146480; Zhou S, 2001, NAT MED, V7, P1028, DOI 10.1038/nm0901-1028	51	394	401	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAR 5	2010	6	3					265	278		10.1016/j.stem.2010.02.002	http://dx.doi.org/10.1016/j.stem.2010.02.002			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	577WL	20207229	Green Accepted, Bronze			2022-12-24	WOS:000276254600013
J	Ji, YY; Lu, Y; Yang, F; Shen, WH; Tang, TTT; Feng, LY; Duan, SM; Lu, B				Ji, Yuanyuan; Lu, Yuan; Yang, Feng; Shen, Wanhua; Tang, Tina Tze-Tsang; Feng, Linyin; Duan, Shumin; Lu, Bai			Acute and gradual increases in BDNF concentration elicit distinct signaling and functions in neurons	NATURE NEUROSCIENCE			English	Article							NERVE GROWTH-FACTOR; HIGH-FREQUENCY STIMULATION; NEUROTROPHIC FACTOR BDNF; LONG-TERM POTENTIATION; SYNAPTIC-TRANSMISSION; HIPPOCAMPAL-NEURONS; DIFFERENTIAL REGULATION; KINASE ACTIVATION; ADULT HIPPOCAMPUS; PC12 CELLS	Extracellular factors may act on cells in two distinct modes: an acute increase in concentration as a result of regulated secretion, or a gradual increase in concentration when secreted constitutively or from a distant source. We found that cellular responses to brain-derived neurotrophic factor ( BDNF) differed markedly depending on how BDNF was delivered. In cultured rat hippocampal neurons, acute and gradual increases in BDNF elicited transient and sustained activation of TrkB receptor and its downstream signaling, respectively, leading to differential expression of Homer1 and Arc. Transient TrkB activation promoted neurite elongation and spine head enlargement, whereas sustained TrkB activation facilitated neurite branch and spine neck elongation. In hippocampal slices, fast and slow increases in BDNF enhanced basal synaptic transmission and LTP, respectively. Thus, the kinetics of TrkB activation is critical for cell signaling and functions. This temporal dimension in cellular signaling may also have implications for the therapeutic drug design.	[Ji, Yuanyuan; Lu, Yuan; Yang, Feng; Lu, Bai] NIMH, Gene Cognit & Psychosis Program, Bethesda, MD 20892 USA; [Ji, Yuanyuan; Shen, Wanhua; Feng, Linyin; Duan, Shumin] Chinese Acad Sci, Inst Neurosci, Shanghai, Peoples R China; [Tang, Tina Tze-Tsang] Natl Inst Neurol Disorders & Stroke, Receptor Biol Unit, Bethesda, MD USA; [Tang, Tina Tze-Tsang] Univ Bristol, Sch Med Sci, Dept Anat, MRC,Ctr Synapt Plast, Bristol BS8 1TD, Avon, England; [Ji, Yuanyuan; Lu, Yuan; Yang, Feng; Lu, Bai] NICHHD, Sect Neural Dev & Plast, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Chinese Academy of Sciences; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); University of Bristol; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Lu, B (corresponding author), GlaxoSmithKline Inc, R&D China, Shanghai, Peoples R China.	bai.b.lu@gsk.com	Yang, Feng/C-9530-2011; Shen, Wanhua/B-5554-2011; Lu, Bai/A-4018-2012; tang, tina/GRX-7859-2022	Shen, Wanhua/0000-0002-5178-9561; Lu, Bai/0000-0001-5418-9759; Yang, Feng/0000-0003-1275-6641	National Institute on Child Health and Human Development; National Institute of Mental Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD000714] Funding Source: NIH RePORTER	National Institute on Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank the National Cancer Institute, Center for Cancer Research Fellows Editorial Board and G. Nagappan for the thoughtful comments and suggestions. We thank W. H. Wilson for his innovative research in cancer therapy that helped us conceive this work. This work was supported by the Intramural Research Programs of the National Institute on Child Health and Human Development and the National Institute of Mental Health.	Balkowiec A, 2002, J NEUROSCI, V22, P10399; Canossa M, 1997, P NATL ACAD SCI USA, V94, P13279, DOI 10.1073/pnas.94.24.13279; CARTER BD, 1995, J BIOL CHEM, V270, P21751, DOI 10.1074/jbc.270.37.21751; CHAO MV, 1992, CELL, V68, P995, DOI 10.1016/0092-8674(92)90068-N; Figurov A, 1996, NATURE, V381, P706, DOI 10.1038/381706a0; Finkbeiner S, 1997, NEURON, V19, P1031, DOI 10.1016/S0896-6273(00)80395-5; Frerking M, 1998, J NEUROPHYSIOL, V80, P3383, DOI 10.1152/jn.1998.80.6.3383; Goodman LJ, 1996, MOL CELL NEUROSCI, V7, P222, DOI 10.1006/mcne.1996.0017; Griesbeck O, 1999, MICROSC RES TECHNIQ, V45, P262, DOI 10.1002/(SICI)1097-0029(19990515/01)45:4/5<262::AID-JEMT10>3.0.CO;2-K; Haapasalo A, 2002, J BIOL CHEM, V277, P43160, DOI 10.1074/jbc.M205202200; Hartmann M, 2001, EMBO J, V20, P5887, DOI 10.1093/emboj/20.21.5887; Hering H, 2003, J NEUROSCI, V23, P11759; Huang YZ, 2000, NEURON, V26, P443, DOI 10.1016/S0896-6273(00)81176-9; Ji YY, 2005, NAT NEUROSCI, V8, P164, DOI 10.1038/nn1381; KANG HJ, 1995, SCIENCE, V267, P1658, DOI 10.1126/science.7886457; Kang HJ, 1996, LEARN MEMORY, V3, P188, DOI 10.1101/lm.3.2-3.188; Kao SC, 2001, J BIOL CHEM, V276, P18169, DOI 10.1074/jbc.M008870200; KORTE M, 1995, P NATL ACAD SCI USA, V92, P8856, DOI 10.1073/pnas.92.19.8856; Lessmann V, 2003, PROG NEUROBIOL, V69, P341, DOI 10.1016/S0301-0082(03)00019-4; LESSMANN V, 1994, NEUROREPORT, V6, P21; LEVINE ES, 1995, P NATL ACAD SCI USA, V92, P8074, DOI 10.1073/pnas.92.17.8074; Levine ES, 1998, P NATL ACAD SCI USA, V95, P10235, DOI 10.1073/pnas.95.17.10235; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; MCALLISTER AK, 1995, NEURON, V15, P791, DOI 10.1016/0896-6273(95)90171-X; Mei L, 2008, NAT REV NEUROSCI, V9, P437, DOI 10.1038/nrn2392; Patterson SL, 1996, NEURON, V16, P1137, DOI 10.1016/S0896-6273(00)80140-3; Sato M, 2001, J NEUROSCI, V21, P3797, DOI 10.1523/JNEUROSCI.21-11-03797.2001; Schuman EM, 1999, CURR OPIN NEUROBIOL, V9, P105, DOI 10.1016/S0959-4388(99)80013-0; Segal RA, 2003, ANNU REV NEUROSCI, V26, P299, DOI 10.1146/annurev.neuro.26.041002.131421; Shimada A, 1998, J NEUROSCI, V18, P8559; Sommerfeld MT, 2000, J BIOL CHEM, V275, P8982, DOI 10.1074/jbc.275.12.8982; Tanaka T, 1997, J NEUROSCI, V17, P2959; TRAVERSE S, 1992, BIOCHEM J, V288, P351, DOI 10.1042/bj2880351; Tyler WJ, 2003, J PHYSIOL-LONDON, V553, P497, DOI 10.1113/jphysiol.2003.052639; Yin Y, 2002, P NATL ACAD SCI USA, V99, P2368, DOI 10.1073/pnas.042693699; Ying SW, 2002, J NEUROSCI, V22, P1532, DOI 10.1523/JNEUROSCI.22-05-01532.2002; York RD, 1998, NATURE, V392, P622, DOI 10.1038/33451	37	241	252	1	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2010	13	3					302	U7		10.1038/nn.2505	http://dx.doi.org/10.1038/nn.2505			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	559WW	20173744	Green Accepted			2022-12-24	WOS:000274860100011
J	Niwa, M; Kamiya, A; Murai, R; Kubo, K; Gruber, AJ; Tomita, K; Lu, LL; Tomisato, S; Jaaro-Peled, H; Seshadri, S; Hiyama, H; Huang, B; Kohda, K; Noda, Y; O'Donnell, P; Nakajima, K; Sawa, A; Nabeshima, T				Niwa, Minae; Kamiya, Atsushi; Murai, Rina; Kubo, Ken-ichiro; Gruber, Aaron J.; Tomita, Keni; Lu, Lingling; Tomisato, Shuta; Jaaro-Peled, Hanna; Seshadri, Saurav; Hiyama, Hideki; Huang, Beverly; Kohda, Kazuhisa; Noda, Yukihiro; O'Donnell, Patricio; Nakajima, Kazunori; Sawa, Akira; Nabeshima, Toshitaka			Knockdown of DISC1 by In Utero Gene Transfer Disturbs Postnatal Dopaminergic Maturation in the Frontal Cortex and Leads to Adult Behavioral Deficits	NEURON			English	Article							NEURONAL MIGRATION; PREFRONTAL CORTEX; ANIMAL-MODEL; INHIBITORY NEURONS; PYRAMIDAL NEURONS; BIPOLAR DISORDER; MICE LACKING; SCHIZOPHRENIA; EXPRESSION; SYSTEM	Adult brain function and behavior are influenced by neuronal network formation during development. Genetic susceptibility factors for adult psychiatric illnesses, such as Neuregulin-1 and Disrupted-in-Schizophrenia-1 (DISC1), influence adult high brain functions, including cognition and information processing. These factors have roles during neuro-development and are likely to cooperate, forming pathways or "signalosomes." Here we report the potential to generate an animal model via in utero gene transfer in order to address an important question of how nonlethal deficits in early development may affect postnatal brain maturation and high brain functions in adulthood, which are impaired in various psychiatric illnesses such as schizophrenia. We show that transient knockdown of DISC1 in the pre- and perinatal stages, specifically in a lineage of pyramidal neurons mainly in the prefrontal cortex, leads to selective abnormalities in postnatal mesocortical dopaminergic maturation and behavioral abnormalities associated with disturbed cortical neurocircuitry after puberty.	[Niwa, Minae; Kamiya, Atsushi; Jaaro-Peled, Hanna; Seshadri, Saurav; Hiyama, Hideki; Huang, Beverly; Sawa, Akira] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21287 USA; [Niwa, Minae; Murai, Rina; Lu, Lingling; Nabeshima, Toshitaka] Meijo Univ, Dept Chem Pharmacol, Nagoya, Aichi 4688503, Japan; [Kubo, Ken-ichiro; Tomita, Keni; Nakajima, Kazunori] Keio Univ, Sch Med, Dept Anat, Tokyo 4668560, Japan; [Murai, Rina; Nabeshima, Toshitaka] Nagoya Univ, Grad Sch Med, Dept Neuropsychopharmacol & Hosp Pharm, Nagoya, Aichi 4668560, Japan; [Niwa, Minae] Nagoya Univ, Grad Sch Med, Dept Psychiat, Nagoya, Aichi 4668560, Japan; [Gruber, Aaron J.; O'Donnell, Patricio] Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA; [Tomisato, Shuta; Kohda, Kazuhisa] Keio Univ, Sch Med, Dept Physiol, Tokyo 1608582, Japan; [Noda, Yukihiro] Meijo Univ, Div Clin Sci & Neuropsychopharmacol, Nagoya, Aichi 4688503, Japan; [Sawa, Akira] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21287 USA; [Nabeshima, Toshitaka] Comparat Cognit Sci Inst, Acad Frontier Project Private Univ, Nagoya, Aichi 4688503, Japan	Johns Hopkins University; Meijo University; Keio University; Nagoya University; Nagoya University; University System of Maryland; University of Maryland Baltimore; Keio University; Meijo University; Johns Hopkins University	Sawa, A (corresponding author), Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21287 USA.		Kubo, Ken-ichiro/B-2520-2015; Nakajima, Kazunori/L-3396-2013; Jaaro-Peled, Hanna/D-1046-2012; Kohda, Kazuhisa/L-4731-2013; Niwa, Minae/G-5469-2011; Niwa, Minae/AAV-2639-2021; kamiya, atsushi/L-8550-2016	Kubo, Ken-ichiro/0000-0003-4023-5069; Nakajima, Kazunori/0000-0003-1864-9425; Jaaro-Peled, Hanna/0000-0002-8950-391X; Niwa, Minae/0000-0002-8784-7815; Niwa, Minae/0000-0002-8784-7815; kamiya, atsushi/0000-0002-4274-5567; Gruber, Aaron/0000-0003-2700-5429; O'Donnell, Patricio/0000-0001-7788-624X	US Public Heath Service [MH-069853]; Silvio O Conte Center [MH-084018, MH-088753]; NATIONAL INSTITUTE OF MENTAL HEALTH [RC1MH088753, R01MH069853, P20MH084018] Funding Source: NIH RePORTER	US Public Heath Service; Silvio O Conte Center; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank Dr Pamela Talalay and Dr Eva Anton for critical reading and Ms Yukiko Lema for organizing the manuscript This work was supported by U S Public Heath Service grant MH-069853 (A S), Silvio O Conte Center grants MH-084018 (A S) and MH-088753 (A S). and foundation grants from Stanley (A S), S-R (A S. A K). RUSK (A S), and NARSAD (A S. A K, H J -P) This work was also supported by grants from JSPS (T N. K N, M N). MEXT (T N. K N), MARC (T N). MHLW (T N, K K), Sumitomo (K N), Naito (K N), Academic Frontier Project (T N), and Takeda (T N, K N)	AKBARIAN S, 1995, ARCH GEN PSYCHIAT, V52, P258, DOI 10.1001/archpsyc.1995.03950160008002; Akil M, 1999, AM J PSYCHIAT, V156, P1580, DOI 10.1176/ajp.156.10.1580; Anderson SA, 1997, SCIENCE, V278, P474, DOI 10.1126/science.278.5337.474; Arguello PA, 2006, NEURON, V52, P179, DOI 10.1016/j.neuron.2006.09.023; Benes FM, 2000, CEREB CORTEX, V10, P1014, DOI 10.1093/cercor/10.10.1014; Benes FM, 2001, NEUROPSYCHOPHARMACOL, V25, P1, DOI 10.1016/S0893-133X(01)00225-1; Borrell V, 2005, J NEUROSCI METH, V143, P151, DOI 10.1016/j.jneumeth.2004.09.027; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Buka SL, 1999, SCHIZOPHR RES, V39, P113, DOI 10.1016/S0920-9964(99)00109-7; Cannon TD, 2003, SCHIZOPHRENIA BULL, V29, P653, DOI 10.1093/oxfordjournals.schbul.a007037; Chen JS, 2006, BIOL PSYCHIAT, V59, P1180, DOI 10.1016/j.biopsych.2006.02.024; Glantz LA, 2000, ARCH GEN PSYCHIAT, V57, P65, DOI 10.1001/archpsyc.57.1.65; Goto Y, 2007, INT REV NEUROBIOL, V78, P41, DOI 10.1016/S0074-7742(06)78002-3; Guidotti A, 2000, ARCH GEN PSYCHIAT, V57, P1061, DOI 10.1001/archpsyc.57.11.1061; Harrison PJ, 2005, MOL PSYCHIATR, V10, P40, DOI 10.1038/sj.mp.4001558; Jaaro-Peled H, 2009, TRENDS NEUROSCI, V32, P485, DOI 10.1016/j.tins.2009.05.007; Kamiya A, 2005, NAT CELL BIOL, V7, P1167, DOI 10.1038/ncb1328; Kamiya A, 2008, ARCH GEN PSYCHIAT, V65, P996, DOI 10.1001/archpsyc.65.9.996; Keri S, 2009, PSYCHOL SCI, V20, P1070, DOI 10.1111/j.1467-9280.2009.02398.x; Koshibu K, 2005, J NEUROSCI, V25, P3870, DOI 10.1523/JNEUROSCI.0175-05.2005; Krug A, 2008, EUR PSYCHIAT, V23, P344, DOI 10.1016/j.eurpsy.2008.03.004; Lewis DA, 2005, NAT REV NEUROSCI, V6, P312, DOI 10.1038/nrn1648; Lewis DA, 2002, ANNU REV NEUROSCI, V25, P409, DOI 10.1146/annurev.neuro.25.112701.142754; LIPSKA BK, 1993, NEUROPSYCHOPHARMACOL, V9, P67, DOI 10.1038/npp.1993.44; Lisman JE, 2008, TRENDS NEUROSCI, V31, P234, DOI 10.1016/j.tins.2008.02.005; LoTurco J, 2009, CEREB CORTEX, V19, pI120, DOI 10.1093/cercor/bhp033; Manent JB, 2009, NAT MED, V15, P84, DOI 10.1038/nm.1897; Mao YW, 2009, CELL, V136, P1017, DOI 10.1016/j.cell.2008.12.044; Marin O, 2003, ANNU REV NEUROSCI, V26, P441, DOI 10.1146/annurev.neuro.26.041002.131058; Matsuda T, 2007, P NATL ACAD SCI USA, V104, P1027, DOI 10.1073/pnas.0610155104; MCNEIL TF, 1995, EPIDEMIOL REV, V17, P107, DOI 10.1093/oxfordjournals.epirev.a036165; Miyamoto Y, 2004, EUR J NEUROSCI, V19, P151, DOI 10.1111/j.1460-9568.2004.03086.x; Miyamoto Y, 2002, J NEUROSCI, V22, P2335, DOI 10.1523/JNEUROSCI.22-06-02335.2002; Moore H, 2006, BIOL PSYCHIAT, V60, P253, DOI 10.1016/j.biopsych.2006.01.003; Navarro-Quiroga I, 2007, J NEUROSCI, V27, P5007, DOI 10.1523/JNEUROSCI.0867-07.2007; Niwa M, 2007, J NEUROSCI, V27, P7604, DOI 10.1523/JNEUROSCI.1575-07.2007; Owen MJ, 2005, TRENDS GENET, V21, P518, DOI 10.1016/j.tig.2005.06.011; Ozawa K, 2006, BIOL PSYCHIAT, V59, P546, DOI 10.1016/j.biopsych.2005.07.031; Ozeki Y, 2003, P NATL ACAD SCI USA, V100, P289, DOI 10.1073/pnas.0136913100; Paxinos G., 2007, MOUSE BRAIN STEREOTA, V3rd Edn; Rapoport JL, 2005, MOL PSYCHIATR, V10, P434, DOI 10.1038/sj.mp.4001642; Rayevsky KS, 1995, PROG NEURO-PSYCHOPH, V19, P1285, DOI 10.1016/0278-5846(95)00267-7; ROSENBERG DR, 1995, J COMP NEUROL, V358, P383, DOI 10.1002/cne.903580306; Sauvageot CM, 2002, CURR OPIN NEUROBIOL, V12, P244, DOI 10.1016/S0959-4388(02)00322-7; Savitz J, 2009, NEUROSCI BIOBEHAV R, V33, P699, DOI 10.1016/j.neubiorev.2009.01.004; Selemon LD, 1999, BIOL PSYCHIAT, V45, P17, DOI 10.1016/S0006-3223(98)00281-9; Sesack SR, 2003, ANN NY ACAD SCI, V1003, P36, DOI 10.1196/annals.1300.066; Shu TZ, 2004, NEURON, V44, P263, DOI 10.1016/j.neuron.2004.09.030; Tabata H, 2001, NEUROSCIENCE, V103, P865, DOI 10.1016/S0306-4522(01)00016-1; Tenyi T, 2009, J AFFECT DISORDERS, V112, P11, DOI 10.1016/j.jad.2008.04.025; Tomppo L, 2009, ARCH GEN PSYCHIAT, V66, P134, DOI 10.1001/archgenpsychiatry.2008.524; Tsai JW, 2005, J CELL BIOL, V170, P935, DOI 10.1083/jcb.200505166; Tseng KY, 2008, J NEUROSCI, V28, P12691, DOI 10.1523/JNEUROSCI.4166-08.2008; White T, 2006, AM J PSYCHIAT, V163, P376, DOI 10.1176/appi.ajp.163.3.376; Young-Pearse TL, 2007, J NEUROSCI, V27, P14459, DOI 10.1523/JNEUROSCI.4701-07.2007; Yu ZX, 2003, J NEUROSCI, V23, P2193	56	219	226	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 25	2010	65	4					480	489		10.1016/j.neuron.2010.01.019	http://dx.doi.org/10.1016/j.neuron.2010.01.019			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	566HD	20188653	Green Accepted, Bronze			2022-12-24	WOS:000275359800007
J	Xu, Q; Guo, LH; Moore, H; Waclaw, RR; Campbell, K; Anderson, SA				Xu, Qing; Guo, Lihua; Moore, Holly; Waclaw, Ronald R.; Campbell, Kenneth; Anderson, Stewart A.			Sonic Hedgehog Signaling Confers Ventral Telencephalic Progenitors with Distinct Cortical Interneuron Fates	NEURON			English	Article							GREEN FLUORESCENT PROTEIN; MOUSE TELENCEPHALON; SHH MUTATIONS; GENE-FUNCTION; GSH2; EXPRESSION; FOREBRAIN; ROLES; MICE; SPECIFICATION	Interneurons in the cerebral cortex regulate cortical functions through the actions of distinct subgroups that express parvalbumin, somatostatin, or calretinin. The genesis of the first two subgroups requires the expression of NKX2.1, which is maintained by SHH signaling during neurogenesis. In this paper, we report that mosaic elimination in the medial ganglionic eminence (MGE) of Smo, a key effector of SHH signaling, reveals that MGE progenitors retain a remarkable degree of plasticity during the neurogenic period. SHH signaling prevents the upregulation of GSX2 and conversion of some MGE progenitors to a caudal ganglionic eminence-like, bipolar calretinin-expressing cell fate that is promoted by GSX2. In addition, a higher level of SHH signaling promotes the generation of the somatostatin-expressing interneuron at the expense of parvalbumin-expressing subgroup. These results indicate that cortical interneuron diversity, a major determinant of cortical function, is critically influenced by differential levels of SHH signaling within the ventral telencephalon.	[Xu, Qing; Guo, Lihua; Anderson, Stewart A.] Weill Cornell Med Coll, New York, NY 10065 USA; [Moore, Holly] Columbia Univ, Coll Phys & Surg, New York, NY 10032 USA; [Moore, Holly] New York State Psychiat Inst & Hosp, New York, NY 10032 USA; [Waclaw, Ronald R.; Campbell, Kenneth] Univ Cincinnati, Coll Med, Div Dev Biol, Cincinnati Childrens Hosp,Med Ctr, Cincinnati, OH 45229 USA	Cornell University; Columbia University; New York State Psychiatry Institute; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Anderson, SA (corresponding author), Weill Cornell Med Coll, 1300 York Ave, New York, NY 10065 USA.	saa2007@med.cornell.edu	Campbell, Kenneth/ABC-3570-2021		NARSAD;  [P01 NS048120];  [R01 MH066912];  [K02 MH070031];  [R01 NS044080]; NATIONAL INSTITUTE OF MENTAL HEALTH [K02MH070031, R01MH066912] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS044080, P01NS048120] Funding Source: NIH RePORTER	NARSAD(NARSAD); ; ; ; ; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by P01 NS048120 (S.A.A., H.M.), R01 MH066912 and K02 MH070031 (S.A.A.), R01 NS044080 (K.C.) and NARSAD (Q.X). The authors wish to thank Karin H. Krueger and Ping Song for excellent technical assistance.	Ahn S, 2004, CELL, V118, P505, DOI 10.1016/j.cell.2004.07.023; Anderson SA, 2001, DEVELOPMENT, V128, P353; Butt SJB, 2008, NEURON, V59, P722, DOI 10.1016/j.neuron.2008.07.031; Butt SJB, 2005, NEURON, V48, P591, DOI 10.1016/j.neuron.2005.09.034; CAVANAGH ME, 1989, J COMP NEUROL, V284, P637, DOI 10.1002/cne.902840410; Chen Y, 1996, CELL, V87, P553, DOI 10.1016/S0092-8674(00)81374-4; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Chuang PT, 2003, GENE DEV, V17, P342, DOI 10.1101/gad.1026303; Cobos I, 2005, NAT NEUROSCI, V8, P1059, DOI 10.1038/nn1499; Corbin JG, 2003, DEVELOPMENT, V130, P4895, DOI 10.1242/dev.00717; Corbin JG, 2000, DEVELOPMENT, V127, P5007; Dassule HR, 2000, DEVELOPMENT, V127, P4775; Dessaud E, 2007, NATURE, V450, P717, DOI 10.1038/nature06347; Du TG, 2008, DEVELOPMENT, V135, P1559, DOI 10.1242/dev.015123; ERICSON J, 1995, CELL, V81, P747, DOI 10.1016/0092-8674(95)90536-7; Flames N, 2007, J NEUROSCI, V27, P9682, DOI 10.1523/JNEUROSCI.2750-07.2007; Fogarty M, 2007, J NEUROSCI, V27, P10935, DOI 10.1523/JNEUROSCI.1629-07.2007; FRANKLIN BJK, 1997, MOUSE BRAIN STEREOTA; Freund TF, 2003, TRENDS NEUROSCI, V26, P489, DOI 10.1016/S0166-2236(03)00227-3; Fuccillo M, 2004, DEVELOPMENT, V131, P5031, DOI 10.1242/dev.01349; Fuccillo M, 2006, NAT REV NEUROSCI, V7, P772, DOI 10.1038/nrn1990; Furuta Y, 2000, GENESIS, V26, P130, DOI 10.1002/(SICI)1526-968X(200002)26:2<130::AID-GENE9>3.0.CO;2-I; Gulacsi AA, 2008, NAT NEUROSCI, V11, P1383, DOI 10.1038/nn.2226; Gutin G, 2006, DEVELOPMENT, V133, P2937, DOI 10.1242/dev.02465; Hadjantonakis AK, 1998, MECH DEVELOP, V76, P79, DOI 10.1016/S0925-4773(98)00093-8; Harfe BD, 2004, CELL, V118, P517, DOI 10.1016/j.cell.2004.07.024; Hebert JM, 2008, NAT REV NEUROSCI, V9, P678, DOI 10.1038/nrn2463; Heussler HS, 2002, ARCH DIS CHILD, V86, P293, DOI 10.1136/adc.86.4.293; HSIEHLI HM, 1995, MECH DEVELOP, V50, P177, DOI 10.1016/0925-4773(94)00334-J; KINZLER KW, 1988, NATURE, V332, P371, DOI 10.1038/332371a0; Liodis P, 2007, J NEUROSCI, V27, P3078, DOI 10.1523/JNEUROSCI.3055-06.2007; Lupo G, 2006, NAT REV NEUROSCI, V7, P103, DOI 10.1038/nrn1843; Machold R, 2003, NEURON, V39, P937, DOI 10.1016/S0896-6273(03)00561-0; Marin O, 2000, J NEUROSCI, V20, P6063; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; Miyoshi G, 2007, J NEUROSCI, V27, P7786, DOI 10.1523/JNEUROSCI.1807-07.2007; Nanni L, 1999, HUM MOL GENET, V8, P2479, DOI 10.1093/hmg/8.13.2479; Novak A, 2000, GENESIS, V28, P147, DOI 10.1002/1526-968X(200011/12)28:3/4<147::AID-GENE90>3.0.CO;2-G; Ory DS, 1996, P NATL ACAD SCI USA, V93, P11400, DOI 10.1073/pnas.93.21.11400; Rallu M, 2002, DEVELOPMENT, V129, P4963; Rymar VV, 2007, J COMP NEUROL, V501, P369, DOI 10.1002/cne.21250; Santiago G, 2006, AM J MED GENET A, V140A, P2085, DOI 10.1002/ajmg.a.31311; Shimamura K, 1997, DEVELOPMENT, V124, P2709; Storm EE, 2006, DEVELOPMENT, V133, P1831, DOI 10.1242/dev.02324; Stuhmer T, 2002, DEVELOPMENT, V129, P245; Sussel L, 1999, DEVELOPMENT, V126, P3359; Tamamaki N, 2003, J COMP NEUROL, V467, P60, DOI 10.1002/cne.10905; Toresson H, 2000, DEVELOPMENT, V127, P4361; Waclaw RR, 2009, NEURON, V63, P451, DOI 10.1016/j.neuron.2009.07.015; Waclaw RR, 2004, DEVELOPMENT, V131, P4013, DOI 10.1242/dev.01272; Wichterle H, 2001, DEVELOPMENT, V128, P3759; Wonders CP, 2008, DEV BIOL, V314, P127, DOI 10.1016/j.ydbio.2007.11.018; Xu Q, 2005, DEVELOPMENT, V132, P4987, DOI 10.1242/dev.02090; Xu Q, 2004, J NEUROSCI, V24, P2612, DOI 10.1523/JNEUROSCI.5667-03.2004; Xu Q, 2008, J COMP NEUROL, V506, P16, DOI 10.1002/cne.21529; Xu XM, 2006, J COMP NEUROL, V499, P144, DOI 10.1002/cne.21101; Ying LT, 2000, NAT NEUROSCI, V3, P979, DOI 10.1038/79916; Yu WY, 2009, DEV BIOL, V334, P264, DOI 10.1016/j.ydbio.2009.07.026; Yun K, 2001, DEVELOPMENT, V128, P193	59	153	155	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 11	2010	65	3					328	340		10.1016/j.neuron.2010.01.004	http://dx.doi.org/10.1016/j.neuron.2010.01.004			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	564BF	20159447	Green Accepted, Bronze			2022-12-24	WOS:000275185200007
J	Charles, N; Ozawa, T; Squatrito, M; Bleau, AM; Brennan, CW; Hambardzumyan, D; Holland, EC				Charles, Nikki; Ozawa, Tatsuya; Squatrito, Massimo; Bleau, Anne-Marie; Brennan, Cameron W.; Hambardzumyan, Dolores; Holland, Eric C.			Perivascular Nitric Oxide Activates Notch Signaling and Promotes Stem-like Character in PDGF-Induced Glioma Cells	CELL STEM CELL			English	Article							SIDE POPULATION; SELF-RENEWAL; BRAIN; EXPRESSION; NICHE; SYNTHASE; GROWTH; NEUROGENESIS; INHIBITION; SUBCLASSES	eNOS expression is elevated in human glioblastomas and correlated with increased tumor growth and aggressive character. We investigated the potential role of nitric oxide (NO) activity in the perivascular niche (PVN) using a genetic engineered mouse model of PDGF-induced gliomas. eNOS expression is highly elevated in tumor vascular endothelium adjacent to perivascular glioma cells expressing Nestin, Notch, and the NO receptor, sGC. In addition, the NO/cGMP/PKG pathway drives Notch signaling in PIDGF-induced gliomas in vitro, and induces the side population phenotype in primary glioma cell cultures. NO also increases neurosphere forming capacity of PDGF-driven glioma primary cultures, and enhances their tumorigenic capacity in vivo. Loss of NO activity in these tumors suppresses Notch signaling in vivo and prolongs survival of mice. This mechanism is conserved in human PDGFR amplified gliomas. The NO/cGMP/PKG pathway's promotion of stem cell-like character in the tumor PVN may identify therapeutic targets for this subset of gliomas.	[Charles, Nikki; Ozawa, Tatsuya; Squatrito, Massimo; Bleau, Anne-Marie; Hambardzumyan, Dolores; Holland, Eric C.] Mem Sloan Kettering Canc Ctr, Dept Canc Biol & Genet, New York, NY 10021 USA; [Charles, Nikki; Ozawa, Tatsuya; Squatrito, Massimo; Bleau, Anne-Marie; Brennan, Cameron W.; Hambardzumyan, Dolores; Holland, Eric C.] Mem Sloan Kettering Canc Ctr, Brain Tumor Ctr, New York, NY 10021 USA; [Brennan, Cameron W.; Holland, Eric C.] Mem Sloan Kettering Canc Ctr, Dept Neurosurg & Surg, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Holland, EC (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Canc Biol & Genet, 1275 York Ave, New York, NY 10021 USA.	hollande@mskcc.org	Squatrito, Massimo/F-4149-2016; Brennan, Cameron/R-7082-2019	Squatrito, Massimo/0000-0002-4593-3790; Brennan, Cameron/0000-0003-4064-8891	NIH [U54 CA126518, U54 CA143798]; Litwin Foundation; Leon Levy Foundation; NATIONAL CANCER INSTITUTE [U54CA143798, R01CA100688, U54CA126518] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Litwin Foundation; Leon Levy Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank J. Finney and Q. Zhang for technical assistance and A. Pedraza-Fernandez for providing human tumor neurospheres for analyses. We extend thanks to R. Bish for critical reading and feedback of this manuscript. Sincere thanks to the flow cytometry core facility for acquisition of flow cytometry data. This work was supported by NIH grant U54 CA126518, NIH grant U54 CA143798, and the Litwin Foundation. D.H. is supported by the Leon Levy Foundation.	Bakshi A, 1998, J NEUROL SCI, V155, P196, DOI 10.1016/S0022-510X(97)00315-8; Becher OJ, 2008, CANCER RES, V68, P2241, DOI 10.1158/0008-5472.CAN-07-6350; Bender AT, 2006, PHARMACOL REV, V58, P488, DOI 10.1124/pr.58.3.5; Blaise GA, 2005, TOXICOLOGY, V208, P177, DOI 10.1016/j.tox.2004.11.032; Bleau AM, 2009, CELL STEM CELL, V4, P226, DOI 10.1016/j.stem.2009.01.007; Brennan C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007752; Broholm H, 2003, CLIN NEUROPATHOL, V22, P273; Butt Elke, 2009, V191, P409, DOI 10.1007/978-3-540-68964-5_17; Calabrese C, 2007, CANCER CELL, V11, P69, DOI 10.1016/j.ccr.2006.11.020; Chen JL, 2005, J NEUROSCI, V25, P2366, DOI 10.1523/JNEUROSCI.5071-04.2005; Chua C, 2008, J NEUROSURG, V109, P856, DOI 10.3171/JNS/2008/109/11/0856; Clement V, 2007, CURR BIOL, V17, P165, DOI 10.1016/j.cub.2006.11.033; COBBS CS, 1995, CANCER RES, V55, P727; Doetsch F, 2003, CURR OPIN GENET DEV, V13, P543, DOI 10.1016/j.gde.2003.08.012; Fan X, 2006, CANCER RES, V66, P7445, DOI 10.1158/0008-5472.CAN-06-0858; Folkins C, 2007, CANCER RES, V67, P3560, DOI 10.1158/0008-5472.CAN-06-4238; Franklin K., 2007, MOUSE BRAIN STEREOTA; Fukumura D, 2006, NAT REV CANCER, V6, P521, DOI 10.1038/nrc1910; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Hambardzumyan D, 2008, CELL CYCLE, V7, P1371, DOI 10.4161/cc.7.10.5954; Hambardzumyan D, 2008, GENE DEV, V22, P436, DOI 10.1101/gad.1627008; Harris MA, 2008, CANCER RES, V68, P10051, DOI 10.1158/0008-5472.CAN-08-0786; Holland EC, 2004, MOUSE MODELS HUMAN C; Iwata S, 1999, NEUROSURGERY, V45, P24, DOI 10.1097/00006123-199907000-00006; Jin Y, 2009, J CANCER RES CLIN, V135, P1369, DOI 10.1007/s00432-009-0578-4; KLEIHUES P, 1995, GLIA, V15, P211, DOI 10.1002/glia.440150303; Legler JM, 1999, JNCI-J NATL CANCER I, V91, P1382, DOI 10.1093/jnci/91.16.1382; Lewis HD, 2007, CHEM BIOL, V14, P209, DOI 10.1016/j.chembiol.2006.12.010; Lim KH, 2008, NATURE, V452, P646, DOI 10.1038/nature06778; Louissaint A, 2002, NEURON, V34, P945, DOI 10.1016/S0896-6273(02)00722-5; Madhusoodanan KS, 2007, NEUROCHEM RES, V32, P681, DOI 10.1007/s11064-006-9167-y; OESTERHELD J, 2009, SOME ABC DRUG TRANSP; Palmer TD, 2000, J COMP NEUROL, V425, P479, DOI 10.1002/1096-9861(20001002)425:4<479::AID-CNE2>3.0.CO;2-3; Patrawala L, 2005, CANCER RES, V65, P6207, DOI 10.1158/0008-5472.CAN-05-0592; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Radtke F, 2003, NAT REV CANCER, V3, P756, DOI 10.1038/nrc1186; Ramirez-Castillejo C, 2006, NAT NEUROSCI, V9, P331, DOI 10.1038/nn1657; Riquelme PA, 2008, PHILOS T R SOC B, V363, P123, DOI 10.1098/rstb.2006.2016; Shen Q, 2004, SCIENCE, V304, P1338, DOI 10.1126/science.1095505; Shih AH, 2004, CANCER RES, V64, P4783, DOI 10.1158/0008-5472.CAN-03-3831; Shih AH, 2006, NEOPLASIA, V8, P1072, DOI 10.1593/neo.06526; Singh SK, 2003, CANCER RES, V63, P5821; Taipale J, 2001, NATURE, V411, P349, DOI 10.1038/35077219; Uhrbom L, 2005, CANCER RES, V65, P2065, DOI 10.1158/0008-5472.CAN-04-3588	45	303	319	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	FEB 5	2010	6	2					141	152		10.1016/j.stem.2010.01.001	http://dx.doi.org/10.1016/j.stem.2010.01.001			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	555OC	20144787	Green Accepted, Bronze			2022-12-24	WOS:000274520800009
J	Lourenco, J; Cannich, A; Carta, M; Coussen, F; Mulle, C; Marsicano, G				Lourenco, Joana; Cannich, Astrid; Carta, Mario; Coussen, Francoise; Mulle, Christophe; Marsicano, Giovanni			Synaptic activation of kainate receptors gates presynaptic CB1 signaling at GABAergic synapses	NATURE NEUROSCIENCE			English	Article							ENDOCANNABINOID SYSTEM; METABOTROPIC GLUTAMATE; CANNABINOID RECEPTORS; POSITIVE INTERNEURONS; INHIBITION; TRANSMISSION; EXPRESSION; PLASTICITY; DIVERSITY; INCREASES	Glutamate can control inhibitory synaptic transmission through activation of presynaptic kainate receptors. We found that glutamate released by train stimulation of Schaffer collaterals could lead to either short-term depression or short-term facilitation of inhibitory synaptic transmission in mouse CA1 pyramidal neurons, depending on the presence of cannabinoid type 1 (CB1) receptors on GABAergic afferents. The train-induced depression of inhibition (t-Di) required the mobilization of 2-arachidonoylglycerol through postsynaptic activation of metabotropic glutamate receptors and [Ca2+] rise. GluK1 (GluR5)-dependent depolarization of GABAergic terminals enabled t-Di by facilitating presynaptic CB1 signaling. Thus, concerted activation of presynaptic CB1 receptors and kainate receptors mediates short-term depression of inhibitory synaptic transmission. In contrast, in inhibitory connections expressing GluK1, but not CB1, receptors, train stimulation of Schaffer collaterals led to short-term facilitation. Thus, activation of kainate receptors by synaptically released glutamate gates presynaptic CB1 signaling, which in turn controls the direction of short-term heterosynaptic plasticity.	[Lourenco, Joana; Carta, Mario; Coussen, Francoise; Mulle, Christophe] CNRS, UMR 5091, Lab Physiol Cellulaire Synapse, Bordeaux, France; [Lourenco, Joana] Univ Coimbra, Ctr Neurosci & Cell Biol, Programme Expt Biol & Biomed, Coimbra, Portugal; [Lourenco, Joana; Cannich, Astrid; Marsicano, Giovanni] INSERM, U862, Neuroctr Magendie Endocannabinoids & Neuroadaptat, Bordeaux, France; [Lourenco, Joana; Cannich, Astrid; Carta, Mario; Coussen, Francoise; Mulle, Christophe; Marsicano, Giovanni] Univ Bordeaux, Bordeaux, France	Centre National de la Recherche Scientifique (CNRS); Universidade de Coimbra; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux	Mulle, C (corresponding author), CNRS, UMR 5091, Lab Physiol Cellulaire Synapse, Bordeaux, France.	mulle@u-bordeaux2.fr	Marsicano, Giovanni/I-9603-2016	Mulle, Christophe/0000-0003-2709-6615; Carta, Mario/0000-0003-1225-2742; Marsicano, Giovanni/0000-0003-3804-1951	Institut National de la Sante et de la Recherche Medicale (INSERM); Agence National de la Recherche [ANR-06-NEUR-043-01, ANR-05-NEUR-033-01]; Conseil Regional d'Aquitaine; Fundacao para a Ciencia e a Tecnologia, Portugal; Centre National de la Recherche Scientifique; European Commission Coordination Action Network of European Neuroscience Institutes (ENINET) [LSHM-CT-2005-19063]	Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Agence National de la Recherche(French National Research Agency (ANR)); Conseil Regional d'Aquitaine(Region Nouvelle-Aquitaine); Fundacao para a Ciencia e a Tecnologia, Portugal(Portuguese Foundation for Science and Technology); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); European Commission Coordination Action Network of European Neuroscience Institutes (ENINET)	We thank the members of the laboratories of G. Marsicano and C. Mulle for fruitful discussions, P. Pinheiro for help during the experiments and A. Vimeney, D. Gonzales and the Genotyping Facility of the NeuroCentre Magendie for mouse genotyping. We are grateful to K. Mackie (Indiana University) for providing the CB<INF>1</INF> antiserum. We thank J.P.Mazat, D.Commenges, C.Schwierz and L. Rosinus for help with statistical analyses. We thank K. Nave, J.Rubenstein, M.Ekker and G.Schutz for the use of Cre-expressing mouse lines. We also thank F. Chaouloff and N.Rebola for comments on the manuscript. This work was supported by an AVENIR grant of the Institut National de la Sante et de la Recherche Medicale (INSERM) in partnership with the Foundation Bettencourt-Schueller (G.M.), by the Agence National de la Recherche (ANR-06-NEUR-043-01 to G. M. and ANR-05-NEUR-033-01 to C. M.), by the Conseil Regional d'Aquitaine (G. M. and C.M.), by the Fundacao para a Ciencia e a Tecnologia, Portugal (J.L.), the Centre National de la Recherche Scientifique (C.M.) and European Commission Coordination Action Network of European Neuroscience Institutes (ENINET) (LSHM-CT-2005-19063 to G. M.).	Alger BE, 2002, PROG NEUROBIOL, V68, P247; Ali AB, 2007, J NEUROPHYSIOL, V98, P861, DOI 10.1152/jn.00156.2007; Alle H, 2006, SCIENCE, V311, P1290, DOI 10.1126/science.1119055; Ascoli GA, 2008, NAT REV NEUROSCI, V9, P557, DOI 10.1038/nrn2402; Bacci A, 2004, NATURE, V431, P312, DOI 10.1038/nature02913; Bender VA, 2006, J NEUROSCI, V26, P4166, DOI 10.1523/JNEUROSCI.0176-06.2006; Bureau I, 1999, J NEUROSCI, V19, P653; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Cadas H, 1996, J NEUROSCI, V16, P3934; Chevaleyre V, 2004, NEURON, V43, P871, DOI 10.1016/j.neuron.2004.08.036; Chevaleyre V, 2003, NEURON, V38, P461, DOI 10.1016/S0896-6273(03)00235-6; Christensen JK, 2004, J NEUROSCI, V24, P8986, DOI 10.1523/JNEUROSCI.2156-04.2004; Cossart R, 1998, NAT NEUROSCI, V1, P470, DOI 10.1038/2185; DIMARZO V, 1994, NATURE, V372, P686, DOI 10.1038/372686a0; Edwards DA, 2008, P NATL ACAD SCI USA, V105, P8142, DOI 10.1073/pnas.0803558105; Foldy C, 2006, J NEUROSCI, V26, P1465, DOI 10.1523/JNEUROSCI.4587-05.2006; Frerking M, 1998, NAT NEUROSCI, V1, P479, DOI 10.1038/2194; Frerking M, 1999, P NATL ACAD SCI USA, V96, P12917, DOI 10.1073/pnas.96.22.12917; Freund TF, 2007, NEURON, V56, P33, DOI 10.1016/j.neuron.2007.09.012; Glickfeld LL, 2006, NAT NEUROSCI, V9, P807, DOI 10.1038/nn1688; Heifets BD, 2008, P NATL ACAD SCI USA, V105, P10250, DOI 10.1073/pnas.0711880105; Hudson BD, 2010, MOL PHARMACOL, V77, P1, DOI 10.1124/mol.109.060251; Jiang L, 2001, NEURON, V30, P503, DOI 10.1016/S0896-6273(01)00298-7; Kang J, 1998, NAT NEUROSCI, V1, P683, DOI 10.1038/3684; Kano M, 2009, PHYSIOL REV, V89, P309, DOI 10.1152/physrev.00019.2008; Katona I, 1999, J NEUROSCI, V19, P4544; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Lerma J, 2006, CURR OPIN PHARMACOL, V6, P89, DOI 10.1016/j.coph.2005.08.004; Lujan R, 1996, EUR J NEUROSCI, V8, P1488, DOI 10.1111/j.1460-9568.1996.tb01611.x; Maejima T, 2001, NEURON, V31, P463, DOI 10.1016/S0896-6273(01)00375-0; Marsicano G, 1999, EUR J NEUROSCI, V11, P4213, DOI 10.1046/j.1460-9568.1999.00847.x; Marsicano G, 2003, SCIENCE, V302, P84, DOI 10.1126/science.1088208; Marsicano G, 2002, NATURE, V418, P530, DOI 10.1038/nature00839; Min MY, 1999, P NATL ACAD SCI USA, V96, P9932, DOI 10.1073/pnas.96.17.9932; Monory K, 2006, NEURON, V51, P455, DOI 10.1016/j.neuron.2006.07.006; Monory K, 2007, PLOS BIOL, V5, P2354, DOI 10.1371/journal.pbio.0050269; Mulle C, 2000, NEURON, V28, P475, DOI 10.1016/S0896-6273(00)00126-4; Ohno-Shosaku T, 2007, J PHYSIOL-LONDON, V584, P407, DOI 10.1113/jphysiol.2007.137505; Paternain AV, 2000, J NEUROSCI, V20, P196, DOI 10.1523/JNEUROSCI.20-01-00196.2000; Pawelzik H, 2002, J COMP NEUROL, V443, P346, DOI 10.1002/cne.10118; Pinheiro P, 2006, CELL TISSUE RES, V326, P457, DOI 10.1007/s00441-006-0265-6; PINHEIRO PS, 2008, NAT REV NEUROSCI; Piomelli D, 2003, NAT REV NEUROSCI, V4, P873, DOI 10.1038/nrn1247; Sachidhanandam S, 2009, J NEUROSCI, V29, P5000, DOI 10.1523/JNEUROSCI.5807-08.2009; Sjostrom PJ, 2003, NEURON, V39, P641, DOI 10.1016/S0896-6273(03)00476-8; Sun HY, 2009, J NEUROPHYSIOL, V101, P1043, DOI 10.1152/jn.90286.2008; Tsou K, 1998, NEUROSCIENCE, V83, P393, DOI 10.1016/S0306-4522(97)00436-3; Varma N, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-24-j0003.2001; Varma N, 2002, NEUROPHARMACOLOGY, V43, P550, DOI 10.1016/S0028-3908(02)00168-5; Wilson RI, 2001, NATURE, V410, P588, DOI 10.1038/35069076	50	47	48	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2010	13	2					197	U81		10.1038/nn.2481	http://dx.doi.org/10.1038/nn.2481			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	548SE	20081851				2022-12-24	WOS:000273985800015
J	Twelvetrees, AE; Yuen, EY; Arancibia-Carcamo, IL; MacAskill, AF; Rostaing, P; Lumb, MJ; Humbert, S; Triller, A; Saudou, F; Yan, Z; Kittler, JT				Twelvetrees, Alison E.; Yuen, Eunice Y.; Arancibia-Carcamo, I. Lorena; MacAskill, Andrew F.; Rostaing, Philippe; Lumb, Michael J.; Humbert, Sandrine; Triller, Antoine; Saudou, Frederic; Yan, Zhen; Kittler, Josef T.			Delivery of GABA(A)Rs to Synapses Is Mediated by HAP1-KIF5 and Disrupted by Mutant Huntingtin	NEURON			English	Article							INHIBITORY SYNAPTIC-TRANSMISSION; RECEPTOR MEMBRANE TRAFFICKING; NMDA RECEPTOR; HIPPOCAMPAL-NEURONS; INTRACELLULAR TRAFFICKING; AXONAL-TRANSPORT; MOUSE MODEL; KINESIN; PROTEIN; DISEASE	The density of GABA(A) receptors (GABA(A)Rs) at synapses regulates brain excitability, and altered inhibition may contribute to Huntington's disease, which is caused by a polyglutannine repeat in the protein huntingtin. However, the machinery that delivers GABA(A)Rs to synapses is unknown. We demonstrate that GABA(A)Rs are trafficked to synapses by the kinesin family motor protein 5 (KIF5). We identify the adaptor linking the receptors to KIF5 as the huntingtin-associated protein 1 (HAP1). Disrupting the HAP1-KIF5 complex decreases synaptic GABA(A)R number and reduces the amplitude of inhibitory postsynaptic currents. When huntingtin is mutated, as in Huntington's disease, GABA(A)R transport and inhibitory synaptic currents are reduced. Thus, HAP1-KIF5-dependent GABA(A)R trafficking is a fundamental mechanism controlling the strength of synaptic inhibition in the brain. Its disruption by mutant huntingtin may explain some of the defects in brain information processing occurring in Huntington's disease and provides a molecular target for therapeutic approaches.	[Twelvetrees, Alison E.; Arancibia-Carcamo, I. Lorena; MacAskill, Andrew F.; Lumb, Michael J.; Kittler, Josef T.] UCL, Dept Neurosci Physiol & Pharmacol, London WC1E 6BT, England; [Yuen, Eunice Y.; Yan, Zhen] SUNY Buffalo, Dept Physiol & Biophys, Buffalo, NY 14214 USA; [Rostaing, Philippe; Triller, Antoine] Ecole Normale Super, INSERM, U789, Biol Cellulaire Synapse N&P, F-75005 Paris, France; [Humbert, Sandrine; Saudou, Frederic] CNRS, Unite Mixte Rech 146, Inst Curie, Ctr Univ, F-91405 Orsay, France	University of London; University College London; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Universite Paris Saclay	Kittler, JT (corresponding author), UCL, Dept Neurosci Physiol & Pharmacol, Gower St, London WC1E 6BT, England.	j.kittler@ucl.ac.uk	Twelvetrees, Alison/K-8712-2019; Humbert, Sandrine/S-2981-2016; Kittler, Josef/N-7589-2019; Kittler, Josef T/E-9113-2010; MacAskill, Andrew/AFO-2061-2022; SAUDOU, Frédéric/L-3454-2014	Twelvetrees, Alison/0000-0002-1796-1508; Kittler, Josef/0000-0002-3437-9456; Kittler, Josef T/0000-0002-3437-9456; MacAskill, Andrew/0000-0002-0196-3779; SAUDOU, Frédéric/0000-0001-6107-1046; TRILLER, Antoine/0000-0002-7530-1233; Humbert, Sandrine/0000-0002-9501-2658; Arancibia Carcamo, Irma Lorena/0000-0002-0624-3850	U.K. Medical Research Council; European Commission [LSHM-CT-2005-19063]; Medical Research Council [G0802377] Funding Source: researchfish; MRC [G0802377] Funding Source: UKRI; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH084233] Funding Source: NIH RePORTER	U.K. Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Commission(European CommissionEuropean Commission Joint Research Centre); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	J.T.K. is supported by the U.K. Medical Research Council. We also acknowledge support from the European Commission Coordination Action ENINET (contract number LSHM-CT-2005-19063). We are very grateful to Marcie MacDonald and Elisa Fossale for generously providing the striatal wild-type and 1090 knockin cells and Anne Stephenson for providing the KIF5C-MD and -NMD constructs. We thank James Muir and David Attwell for comments on the manuscript.	Arancibia-Carcamo IL, 2009, PHARMACOL THERAPEUT, V123, P17, DOI 10.1016/j.pharmthera.2009.03.012; BANKER G, 1998, CULTURING NERVE CELL; Ben-Ari Y, 2007, PHYSIOL REV, V87, P1215, DOI 10.1152/physrev.00017.2006; Bi GQ, 1997, J CELL BIOL, V138, P999, DOI 10.1083/jcb.138.5.999; Chen GJ, 2006, J NEUROSCI, V26, P2513, DOI 10.1523/JNEUROSCI.4712-05.2006; Colin I, 1998, J COMP NEUROL, V398, P359; Coulpier M, 2002, J BIOL CHEM, V277, P1991, DOI 10.1074/jbc.M107992200; Dumoulin A, 1999, J CELL SCI, V112, P811; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Engelender S, 1997, HUM MOL GENET, V6, P2205, DOI 10.1093/hmg/6.13.2205; Fan MMY, 2007, PROG NEUROBIOL, V81, P272, DOI 10.1016/j.pneurobio.2006.11.003; Fan MMY, 2007, J NEUROSCI, V27, P3768, DOI 10.1523/JNEUROSCI.4356-06.2007; Gardiol A, 1999, J NEUROSCI, V19, P168, DOI 10.1523/JNEUROSCI.19-01-00168.1999; Gauthier LR, 2004, CELL, V118, P127, DOI 10.1016/j.cell.2004.06.018; Gu XF, 2005, NEURON, V46, P433, DOI 10.1016/j.neuron.2005.03.025; Guillaud L, 2003, J NEUROSCI, V23, P131; Gunawardena S, 2003, NEURON, V40, P25, DOI 10.1016/S0896-6273(03)00594-4; HARPER PS, 2002, HUNTINGTONS DIS, V45; Hirokawa N, 2005, NAT REV NEUROSCI, V6, P201, DOI 10.1038/nrn1624; INGOLD AL, 1988, J CELL BIOL, V107, P2657, DOI 10.1083/jcb.107.6.2657; Jacob TC, 2008, NAT REV NEUROSCI, V9, P331, DOI 10.1038/nrn2370; Jaulin F, 2007, DEV CELL, V13, P511, DOI 10.1016/j.devcel.2007.08.001; Kittler J.T., 2006, DYNAMIC SYNAPSE MOL; Kittler JT, 2000, MOL CELL NEUROSCI, V16, P440, DOI 10.1006/mcne.2000.0882; Kittler JT, 2005, P NATL ACAD SCI USA, V102, P14871, DOI 10.1073/pnas.0506653102; Kittler JT, 2004, P NATL ACAD SCI USA, V101, P12736, DOI 10.1073/pnas.0401860101; Kittler JT, 2000, J NEUROSCI, V20, P7972; Lane JD, 1999, MOL BIOL CELL, V10, P1909, DOI 10.1091/mbc.10.6.1909; Li SH, 1998, J NEUROSCI, V18, P1261, DOI 10.1523/jneurosci.18-04-01261.1998; LI XJ, 1995, NATURE, V378, P398, DOI 10.1038/378398a0; Li XJ, 2005, TRENDS PHARMACOL SCI, V26, P1, DOI 10.1016/j.tips.2004.11.001; Ma YH, 2006, J CELL BIOL, V175, P209, DOI 10.1083/jcb.200606016; MacAskill AF, 2009, NEURON, V61, P541, DOI 10.1016/j.neuron.2009.01.030; McGuire JR, 2006, J BIOL CHEM, V281, P3552, DOI 10.1074/jbc.M509806200; Mielke JG, 2005, J NEUROCHEM, V92, P103, DOI 10.1111/j.1471-4159.2004.02841.x; Miki H, 2001, P NATL ACAD SCI USA, V98, P7004, DOI 10.1073/pnas.111145398; Morris MC, 2001, NAT BIOTECHNOL, V19, P1173, DOI 10.1038/nbt1201-1173; Naylor DE, 2005, J NEUROSCI, V25, P7724, DOI 10.1523/JNEUROSCI.4944-04.2005; Olkkonen VM, 2006, J CELL SCI, V119, P5031, DOI 10.1242/jcs.03303; Romero E, 2008, NEURON, V57, P27, DOI 10.1016/j.neuron.2007.11.025; Setou M, 2000, SCIENCE, V288, P1796, DOI 10.1126/science.288.5472.1796; Smith R, 2005, CELL MOL LIFE SCI, V62, P1901, DOI 10.1007/s00018-005-5084-5; Szebenyi G, 2003, NEURON, V40, P41, DOI 10.1016/S0896-6273(03)00569-5; Trettel F, 2000, HUM MOL GENET, V9, P2799, DOI 10.1093/hmg/9.19.2799; Yuen EY, 2008, J BIOL CHEM, V283, P17194, DOI 10.1074/jbc.M801713200; Yuen EY, 2005, J NEUROSCI, V25, P5488, DOI 10.1523/JNEUROSCI.1187-05.2005; Zeron MM, 2002, NEURON, V33, P849, DOI 10.1016/S0896-6273(02)00615-3	47	175	180	0	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	JAN 14	2010	65	1					53	65		10.1016/j.neuron.2009.12.007	http://dx.doi.org/10.1016/j.neuron.2009.12.007			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	546DZ	20152113	Green Accepted, Bronze			2022-12-24	WOS:000273791200008
J	Pellegrini, G; De Luca, M				Pellegrini, Graziella; De Luca, Michele			Human Embryonic Stem Cell-Derived Keratinocytes: How Close to Clinics?	CELL STEM CELL			English	Editorial Material							DIFFERENTIATION; TRANSPLANTATION; PROGENY		[Pellegrini, Graziella; De Luca, Michele] Univ Modena & Reggio Emilia, Ctr Regenerat Med Stefano Ferrari, I-41100 Modena, Italy	Universita di Modena e Reggio Emilia	De Luca, M (corresponding author), Univ Modena & Reggio Emilia, Ctr Regenerat Med Stefano Ferrari, I-41100 Modena, Italy.	michele.deluca@unimore.it	Pellegrini, Graziella/E-1189-2015; De Luca, Michele/N-5883-2014	Pellegrini, Graziella/0000-0001-9861-0736; De Luca, Michele/0000-0002-0850-8445				Blanpain C, 2007, NAT CELL BIOL, V9, P731, DOI 10.1038/ncb0707-731; Dabelsteen S, 2009, STEM CELLS, V27, P1388, DOI 10.1002/stem.64; De Luca M, 2006, REGEN MED, V1, P45, DOI 10.2217/17460751.1.1.45; Green H, 2003, P NATL ACAD SCI USA, V100, P15625, DOI 10.1073/pnas.0307226100; Guenou H, 2009, LANCET, V374, P1745, DOI 10.1016/S0140-6736(09)61496-3; Iuchi S, 2006, P NATL ACAD SCI USA, V103, P1792, DOI 10.1073/pnas.0510953103; Kiuru M, 2009, CELL STEM CELL, V4, P289, DOI 10.1016/j.stem.2009.03.010; Mavilio F, 2006, NAT MED, V12, P1397, DOI 10.1038/nm1504; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; Pellegrini G, 1999, J CELL BIOL, V145, P769, DOI 10.1083/jcb.145.4.769	10	10	10	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JAN 8	2010	6	1					8	9		10.1016/j.stem.2009.12.002	http://dx.doi.org/10.1016/j.stem.2009.12.002			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	549EW	20085737	Bronze			2022-12-24	WOS:000274029700005
J	Gan, JO; Walton, ME; Phillips, PEM				Gan, Jerylin O.; Walton, Mark E.; Phillips, Paul E. M.			Dissociable cost and benefit encoding of future rewards by mesolimbic dopamine	NATURE NEUROSCIENCE			English	Article							UTILITY	Reward-predicting cues evoke activity in midbrain dopamine neurons that encodes fundamental attributes of economic value, including reward magnitude, delay and uncertainty. We found that dopamine release in rat nucleus accumbens encodes anticipated benefits, but not effort-based response costs unless they are atypically low. This neural separation of costs and benefits indicates that mesolimbic dopamine scales with the value of pending rewards, but does not encode the net utility of the action to obtain them.	[Gan, Jerylin O.; Walton, Mark E.; Phillips, Paul E. M.] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Gan, Jerylin O.; Phillips, Paul E. M.] Univ Washington, Grad Program Neurobiol & Behav, Seattle, WA 98195 USA; [Walton, Mark E.] Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England; [Phillips, Paul E. M.] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Oxford; University of Washington; University of Washington Seattle	Phillips, PEM (corresponding author), Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA.	pemp@uw.edu	Phillips, Paul/E-7813-2013; Phillips, Paul E. M./A-4463-2008	Phillips, Paul/0000-0002-8749-7026; Phillips, Paul E. M./0000-0002-8749-7026	National Institutes of Health [R01-MH079292, R21-AG030775]; Wellcome Trust; National Institute of General Medical Sciences [T32-GM007270]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007270] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH079292] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG030775] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We would like to thank S. Ng-Evans for invaluable technical support, C. Akers and S. Barnes for assistance, and J. Clark, S. Sandberg and M. Wanat for helpful comments. This work was funded by the National Institutes of Health (R01-MH079292 and R21-AG030775 to P. E. M. P.) and a Wellcome Trust Advanced Training Fellowship ( M. E. W.). J.O.G. was supported by the National Institute of General Medical Sciences (T32-GM007270, Kimelman).	Fields HL, 2007, ANNU REV NEUROSCI, V30, P289, DOI 10.1146/annurev.neuro.30.051606.094341; Fiorillo CD, 2003, SCIENCE, V299, P1898, DOI 10.1126/science.1077349; Floresco SB, 2008, COGN AFFECT BEHAV NE, V8, P375, DOI 10.3758/CABN.8.4.375; Glimcher PW, 2005, GAME ECON BEHAV, V52, P213, DOI 10.1016/j.geb.2004.06.011; Knutson B, 2009, NEUROECONOMICS: DECISION MAKING AND THE BRAIN, P389, DOI 10.1016/B978-0-12-374176-9.00025-7; Kobayashi S, 2008, J NEUROSCI, V28, P7837, DOI 10.1523/JNEUROSCI.1600-08.2008; Morris G, 2006, NAT NEUROSCI, V9, P1057, DOI 10.1038/nn1743; Phillips PEM, 2007, PSYCHOPHARMACOLOGY, V191, P483, DOI 10.1007/s00213-006-0626-6; Redgrave P, 2006, NAT REV NEUROSCI, V7, P967, DOI 10.1038/nrn2022; Roesch MR, 2006, NEURON, V51, P509, DOI 10.1016/j.neuron.2006.06.027; Salamone JD, 2007, PSYCHOPHARMACOLOGY, V191, P389, DOI 10.1007/s00213-006-0623-9; Stephens D.W., 1986, pi; Walton ME, 2006, NEURAL NETWORKS, V19, P1302, DOI 10.1016/j.neunet.2006.03.005	13	177	177	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2010	13	1					25	27		10.1038/nn.2460	http://dx.doi.org/10.1038/nn.2460			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	536PM	19904261	Green Accepted, Green Submitted			2022-12-24	WOS:000273056300009
J	Ghosh, A; Haiss, F; Sydekum, E; Schneider, R; Gullo, M; Wyss, MT; Mueggler, T; Baltes, C; Rudin, M; Weber, B; Schwab, ME				Ghosh, Arko; Haiss, Florent; Sydekum, Esther; Schneider, Regula; Gullo, Miriam; Wyss, Matthias T.; Mueggler, Thomas; Baltes, Christof; Rudin, Markus; Weber, Bruno; Schwab, Martin E.			Rewiring of hindlimb corticospinal neurons after spinal cord injury	NATURE NEUROSCIENCE			English	Article							PRIMARY SOMATOSENSORY CORTEX; PYRAMIDAL TRACT CELLS; MOTOR CORTEX; ADULT-RATS; PLASTICITY; REGENERATION; CONNECTIONS; STIMULATION; ACTIVATION; RESPONSES	Little is known about the functional role of axotomized cortical neurons that survive spinal cord injury. Large thoracic spinal cord injuries in adult rats result in impairments of hindlimb function. Using retrograde tracers, we found that axotomized corticospinal axons from the hindlimb sensorimotor cortex sprouted in the cervical spinal cord. Mapping of these neurons revealed the emergence of a new forelimb corticospinal projection from the rostral part of the former hindlimb cortex. Voltage-sensitive dye (VSD) imaging and blood-oxygen-level-dependent functional magnetic resonance imaging (BOLD fMRI) revealed a stable expansion of the forelimb sensory map, covering in particular the former hindlimb cortex containing the rewired neurons. Therefore, axotomised hindlimb corticospinal neurons can be incorporated into the sensorimotor circuits of the unaffected forelimb.	[Ghosh, Arko; Sydekum, Esther; Schneider, Regula; Gullo, Miriam; Mueggler, Thomas; Baltes, Christof; Rudin, Markus; Schwab, Martin E.] Swiss Fed Inst Technol, Zurich, Switzerland; [Haiss, Florent; Wyss, Matthias T.; Rudin, Markus; Weber, Bruno] Univ Zurich, Inst Pharmacol & Toxicol, Zurich, Switzerland; [Sydekum, Esther; Mueggler, Thomas; Baltes, Christof; Rudin, Markus] Univ Zurich, Inst Biomed Engn, Zurich, Switzerland; [Ghosh, Arko; Schneider, Regula; Gullo, Miriam; Schwab, Martin E.] Univ Zurich, Brain Res Inst, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; University of Zurich; University of Zurich	Ghosh, A (corresponding author), Univ Zurich, Inst Neuroinformat, Zurich, Switzerland.	arko@ini.phys.ethz.ch	Haiss, Florent/L-1685-2015; Mueggler, Thomas/AAC-7998-2020; Ghosh, Arko/I-4235-2016; Wyss, Matthias T/A-9659-2012; Wyss, Matthias/F-4095-2011; Rudin, Markus/F-2417-2010; Schwab, Martin E/B-6818-2016; Weber, Bruno/E-4400-2013	Haiss, Florent/0000-0001-8351-3685; Ghosh, Arko/0000-0002-2924-5146; Wyss, Matthias T/0000-0002-2037-3424; 	Swiss National Science Foundation [31-63633.00]; National Center of Competence in Research; Christopher Reeve Paralysis Foundation; European Consortium for Research in Neurodegenerative Diseases	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Center of Competence in Research(Swiss National Science Foundation (SNSF)); Christopher Reeve Paralysis Foundation; European Consortium for Research in Neurodegenerative Diseases	We thank J. Scholl, E. Hochreutener, R. Schob and L. Schnell for technical assistance. We thank A. Buchli, I. Maier, M. Starkey, V. Pernet, D. Margolis and B. Kampa for helpful discussions. This work was supported by the Swiss National Science Foundation, Grant 31-63633.00, the National Center of Competence in Research "Neural Plasticity and Repair" of the Swiss National Science Foundation, the Spinal Cord Consortium of the Christopher Reeve Paralysis Foundation, and NeuroNe, Network of Excellence of the European Consortium for Research in Neurodegenerative Diseases ( Sixth Framework EU Program).	Adrian ED, 1939, J PHYSIOL-LONDON, V97, P153, DOI 10.1113/jphysiol.1939.sp003798; AKINTUNDE A, 1992, BRAIN RES, V575, P86, DOI 10.1016/0006-8993(92)90427-B; AOKI M, 1986, Neuroscience Research, V3, P617, DOI 10.1016/0168-0102(86)90058-1; Bareyre FM, 2004, NAT NEUROSCI, V7, P269, DOI 10.1038/nn1195; Brown CE, 2009, J NEUROSCI, V29, P1719, DOI 10.1523/JNEUROSCI.4249-08.2009; Choi D, 2002, J NEUROSCI METH, V117, P167, DOI 10.1016/S0165-0270(02)00098-5; Curt A, 2002, J NEUROTRAUM, V19, P43, DOI 10.1089/089771502753460222; Doetsch GS, 1996, EXP BRAIN RES, V112, P505; Endo T, 2007, BRAIN, V130, P2951, DOI 10.1093/brain/awm237; Fawcett JW, 1998, TRENDS NEUROSCI, V21, P179, DOI 10.1016/S0166-2236(98)01241-7; Ferezou I, 2007, NEURON, V56, P907, DOI 10.1016/j.neuron.2007.10.007; FOERSTER AP, 1982, J COMP NEUROL, V210, P335, DOI 10.1002/cne.902100403; Fouad K, 2001, CURR BIOL, V11, P1766, DOI 10.1016/S0960-9822(01)00535-8; Ghosh A, 2009, J NEUROSCI, V29, P12210, DOI 10.1523/JNEUROSCI.1828-09.2009; GUILBAUD G, 1992, EXP BRAIN RES, V92, P227; Hains BC, 2003, J COMP NEUROL, V462, P328, DOI 10.1002/cne.10733; HALL RD, 1974, BRAIN RES, V66, P23, DOI 10.1016/0006-8993(74)90076-6; Hamers FPT, 2006, J NEUROTRAUM, V23, P537, DOI 10.1089/neu.2006.23.537; HESS G, 1994, J NEUROPHYSIOL, V71, P2543, DOI 10.1152/jn.1994.71.6.2543; Huntley GW, 1997, CEREB CORTEX, V7, P143, DOI 10.1093/cercor/7.2.143; JACOBS KM, 1991, SCIENCE, V251, P944, DOI 10.1126/science.2000496; JAIN N, 1995, J NEUROPHYSIOL, V73, P1537, DOI 10.1152/jn.1995.73.4.1537; Jain N, 2000, P NATL ACAD SCI USA, V97, P5546, DOI 10.1073/pnas.090572597; Kaas JH, 2008, EXP NEUROL, V209, P407, DOI 10.1016/j.expneurol.2007.06.014; KALIL K, 1975, BRAIN RES, V89, P15, DOI 10.1016/0006-8993(75)90130-4; Kim BG, 2006, EXP NEUROL, V198, P401, DOI 10.1016/j.expneurol.2005.12.010; Liebscher T, 2005, ANN NEUROL, V58, P706, DOI 10.1002/ana.20627; Liu ZHM, 2004, MAGN RESON MED, V52, P277, DOI 10.1002/mrm.20148; Maier IC, 2006, PHILOS T R SOC B, V361, P1611, DOI 10.1098/rstb.2006.1890; MCCOMAS AJ, 1968, J PHYSIOL-LONDON, V194, P271, DOI 10.1113/jphysiol.1968.sp008407; Metz GA, 2002, J NEUROSCI METH, V115, P169, DOI 10.1016/S0165-0270(02)00012-2; NEAFSEY EJ, 1982, BRAIN RES, V232, P151, DOI 10.1016/0006-8993(82)90617-5; Raineteau O, 2001, NAT REV NEUROSCI, V2, P263, DOI 10.1038/35067570; Rosenkranz K, 2007, J NEUROSCI, V27, P5200, DOI 10.1523/JNEUROSCI.0836-07.2007; Salimi I, 2008, J NEUROSCI, V28, P7426, DOI 10.1523/JNEUROSCI.1078-08.2008; SCHREYER DJ, 1988, DEV BRAIN RES, V38, P103, DOI 10.1016/0165-3806(88)90089-2; Schucht P, 2002, EXP NEUROL, V176, P143, DOI 10.1006/exnr.2002.7909; Schwab ME, 1996, PHYSIOL REV, V76, P319, DOI 10.1152/physrev.1996.76.2.319; Sicard KM, 2005, NEUROIMAGE, V25, P850, DOI 10.1016/j.neuroimage.2004.12.010; SIEVERT CF, 1986, BRAIN RES, V381, P15, DOI 10.1016/0006-8993(86)90684-0; SWETT JE, 1967, J PHYSIOL-LONDON, V189, P101, DOI 10.1113/jphysiol.1967.sp008157; Sydekum E, 2009, NEUROIMAGE, V44, P1345, DOI 10.1016/j.neuroimage.2008.10.015; Tseng GF, 1996, J NEUROPHYSIOL, V75, P248, DOI 10.1152/jn.1996.75.1.248; Turner JA, 2003, NEUROREHAB NEURAL RE, V17, P37, DOI 10.1177/0888439002250443; WALL PD, 1971, NATURE, V232, P542, DOI 10.1038/232542a0; Wannier T, 2005, J NEUROTRAUM, V22, P703, DOI 10.1089/neu.2005.22.703; Weidner N, 2001, P NATL ACAD SCI USA, V98, P3513, DOI 10.1073/pnas.051626798	47	123	125	1	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2010	13	1					97	U266		10.1038/nn.2448	http://dx.doi.org/10.1038/nn.2448			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	536PM	20010824				2022-12-24	WOS:000273056300019
J	Madisen, L; Zwingman, TA; Sunkin, SM; Oh, SW; Zariwala, HA; Gu, H; Ng, LL; Palmiter, RD; Hawrylycz, MJ; Jones, AR; Lein, ES; Zeng, HK				Madisen, Linda; Zwingman, Theresa A.; Sunkin, Susan M.; Oh, Seung Wook; Zariwala, Hatim A.; Gu, Hong; Ng, Lydia L.; Palmiter, Richard D.; Hawrylycz, Michael J.; Jones, Allan R.; Lein, Ed S.; Zeng, Hongkui			A robust and high-throughput Cre reporting and characterization system for the whole mouse brain	NATURE NEUROSCIENCE			English	Article							GENE-EXPRESSION; TRANSGENIC MICE; SYNAPTIC-TRANSMISSION; FLUORESCENT PROTEIN; DOPAMINE; NEURONS; RECOMBINATION; MANIPULATION; RECEPTORS	The Cre/lox system is widely used in mice to achieve cell-type-specific gene expression. However, a strong and universally responding system to express genes under Cre control is still lacking. We have generated a set of Cre reporter mice with strong, ubiquitous expression of fluorescent proteins of different spectra. The robust native fluorescence of these reporters enables direct visualization of fine dendritic structures and axonal projections of the labeled neurons, which is useful in mapping neuronal circuitry, imaging and tracking specific cell populations in vivo. Using these reporters and a high-throughput in situ hybridization platform, we are systematically profiling Cre-directed gene expression throughout the mouse brain in several Cre-driver lines, including new Cre lines targeting different cell types in the cortex. Our expression data are displayed in a public online database to help researchers assess the utility of various Cre-driver lines for cell-type-specific genetic manipulation.	[Madisen, Linda; Zwingman, Theresa A.; Sunkin, Susan M.; Oh, Seung Wook; Zariwala, Hatim A.; Gu, Hong; Ng, Lydia L.; Hawrylycz, Michael J.; Jones, Allan R.; Lein, Ed S.; Zeng, Hongkui] Allen Inst Brain Sci, Seattle, WA USA; [Palmiter, Richard D.] Univ Washington, Dept Biochem, Howard Hughes Med Inst, Seattle, WA 98195 USA	Allen Institute for Brain Science; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Zeng, HK (corresponding author), Allen Inst Brain Sci, Seattle, WA USA.	hongkuiz@alleninstitute.org		OH, SEUNG WOOK/0000-0001-7632-6822	Allen Institute for Brain Science; US National Institutes of Health [MH085500]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH085500] Funding Source: NIH RePORTER	Allen Institute for Brain Science; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We are grateful for the professional support of the entire Atlas production team, led by P. Wohnoutka, and the Information Technology team, led by C. Dang, at the Allen Institute, without which the work would have not been possible to accomplish. We are thankful to A. Bernard for her contribution in establishing the DFISH process, L. Kuan for ISH data quantification and R. Hunter for coordinating transgenic mice production. We also gratefully acknowledge the following researchers for providing various research materials: R. Tsien (University of California at San Diego) for the tdTomato DNA construct, L. Luo (Stanford University) for the Rosa-CAG targeting construct, K. Deisseroth (Stanford University) for the WPRE-containing DNA construct, B. Sauer (National Institute of Diabetes and Digestive and Kidney Diseases) via Addgene for the Cre and EGFP-Cre DNA constructs, P. Chambon (Institut de Genetique et de Biologie Moleculaire et Cellulaire) for the CreERT2 DNA construct, P. Soriano (Fred Hutchinson Cancer Research Center) via Addgene for the PhiC31o, FLPo and pPGKneotpAlox2 DNA constructs, A. Nagy (Mount Sinai Hospital in Toronto) for the G4 ES cell line, G. Oliver (St. Jude's Children's Research Hospital) for the Six3-Cre mice, N. Heintz (Rockefeller University) via Mutant Mouse Regional Resource Centers (MMRRC) for the Ntsr1-Cre mice and X. Zhuang (University of Chicago) for the Slc6a3-Cre mice. The authors thank the Allen Institute founders, P. G. Allen and J. Patton, for their vision, encouragement and support. This work was funded by the Allen Institute for Brain Science and a US National Institutes of Health grant (MH085500) to H.Z.	Arenkiel BR, 2007, NEURON, V54, P205, DOI 10.1016/j.neuron.2007.03.005; Atasoy D, 2008, J NEUROSCI, V28, P7025, DOI 10.1523/JNEUROSCI.1954-08.2008; Balthasar N, 2004, NEURON, V42, P983, DOI 10.1016/j.neuron.2004.06.004; Barth AL, 2007, CURR OPIN NEUROBIOL, V17, P567, DOI 10.1016/j.conb.2007.10.003; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Coulter CL, 1996, DEV BRAIN RES, V92, P172, DOI 10.1016/0165-3806(96)00004-1; Dong H.W., 2008, ALLEN REFERENCE ATLA; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Furuta Y, 2000, GENESIS, V26, P130, DOI 10.1002/(SICI)1526-968X(200002)26:2<130::AID-GENE9>3.0.CO;2-I; Garaschuk O, 2006, NAT PROTOC, V1, P380, DOI 10.1038/nprot.2006.58; George SHL, 2007, P NATL ACAD SCI USA, V104, P4455, DOI 10.1073/pnas.0609277104; Gong SC, 2007, J NEUROSCI, V27, P9817, DOI 10.1523/JNEUROSCI.2707-07.2007; Gorski JA, 2002, J NEUROSCI, V22, P6309; Heusner CL, 2008, GENESIS, V46, P357, DOI 10.1002/dvg.20405; Hippenmeyer S, 2005, PLOS BIOL, V3, P878, DOI 10.1371/journal.pbio.0030159; Holtmaat A, 2006, NATURE, V441, P979, DOI 10.1038/nature04783; Karpova AY, 2005, NEURON, V48, P727, DOI 10.1016/j.neuron.2005.11.015; Kellendonk C, 2006, NEURON, V49, P603, DOI 10.1016/j.neuron.2006.01.023; Kuhlman SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002005; Lau C, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-153; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Lewis PM, 2004, DEV BIOL, V270, P393, DOI 10.1016/j.ydbio.2004.03.007; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; Luo L, 2008, NEURON, V57, P634, DOI 10.1016/j.neuron.2008.01.002; Luquet S, 2005, SCIENCE, V310, P683, DOI 10.1126/science.1115524; McHugh TJ, 2007, SCIENCE, V317, P94, DOI 10.1126/science.1140263; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Nakashiba T, 2008, SCIENCE, V319, P1260, DOI 10.1126/science.1151120; Ng L, 2007, IEEE ACM T COMPUT BI, V4, P382, DOI 10.1109/TCBB.2007.1035; Novak A, 2000, GENESIS, V28, P147, DOI 10.1002/1526-968X(200011/12)28:3/4<147::AID-GENE90>3.0.CO;2-G; Raymond CS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000162; Rotolo T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004099; Shaner NC, 2007, J CELL SCI, V120, P4247, DOI 10.1242/jcs.005801; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Sugino K, 2006, NAT NEUROSCI, V9, P99, DOI 10.1038/nn1618; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Thompson CL, 2008, NEURON, V60, P1010, DOI 10.1016/j.neuron.2008.12.008; Tsai PS, 2002, METH NE FRO NEUROSCI, P113; Tsien JZ, 1996, CELL, V87, P1317, DOI 10.1016/S0092-8674(00)81826-7; Xu XM, 2006, J COMP NEUROL, V499, P144, DOI 10.1002/cne.21101; Zhang YM, 1998, NAT GENET, V20, P123, DOI 10.1038/2417; Zhuang XX, 2005, J NEUROSCI METH, V143, P27, DOI 10.1016/j.jneumeth.2004.09.020; Zhuo L, 2001, GENESIS, V31, P85, DOI 10.1002/gene.10008; Zong H, 2005, CELL, V121, P479, DOI 10.1016/j.cell.2005.02.012; Zufferey R, 1999, J VIROL, V73, P2886, DOI 10.1128/JVI.73.4.2886-2892.1999	46	3677	3730	16	305	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2010	13	1					133	U311		10.1038/nn.2467	http://dx.doi.org/10.1038/nn.2467			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	536PM	20023653	Green Published, Green Accepted			2022-12-24	WOS:000273056300024
J	Li, G; Bien-Ly, N; Andrews-Zwilling, Y; Xu, Q; Bernardo, A; Ring, K; Halabisky, B; Deng, CH; Mahley, RW; Huang, YD				Li, Gang; Bien-Ly, Nga; Andrews-Zwilling, Yaisa; Xu, Qin; Bernardo, Aubrey; Ring, Karen; Halabisky, Brian; Deng, Changhui; Mahley, Robert W.; Huang, Yadong			GABAergic Interneuron Dysfunction Impairs Hippocampal Neurogenesis in Adult Apolipoprotein E4 Knockin Mice	CELL STEM CELL			English	Article							POSTNATAL SUBVENTRICULAR ZONE; TARGETED-REPLACEMENT MICE; NEWLY GENERATED NEURONS; CENTRAL-NERVOUS-SYSTEM; NEURAL STEM-CELLS; ALZHEIMERS-DISEASE; TRANSGENIC MICE; HUMAN BRAIN; OLFACTORY-BULB; DENTATE GYRUS	Apolipoprotein (apo) E, a polymorphic protein with three isoforms (apoE2, apoE3, and apoE4), is essential for lipid homeostasis. Carriers of apoE4 are at higher risk for developing Alzheimer's disease. We have investigated adult neurogenesis in mice with knockout (KO) for apoE or with knockin (KI) alleles for human apoE3 or apoE4, and we report that neurogenesis is reduced in both apoE-KO and apoE4-KI mice. In apoE-KO mice, increased BMP signaling promoted glial differentiation at the expense of neurogenesis. In contrast, in apoE4-KI mice, presynaptic GABAergic input-mediated maturation of newborn neurons was diminished. Tau phosphorylation, an Alzheimer's disease characteristic, and levels of neurotoxic apoE fragments were both elevated in apoE4-KI hippocampal neurons concomitant with decreased GABAergic interneuron survival. Potentiating GABAergic signaling restored neuronal maturation and neurogenesis in apoE4-KI mice to normal levels. These findings suggest that GABAergic signaling can be targeted to mitigate the deleterious effects of apoE4 on neurogenesis.	[Li, Gang; Bien-Ly, Nga; Andrews-Zwilling, Yaisa; Xu, Qin; Bernardo, Aubrey; Ring, Karen; Halabisky, Brian; Mahley, Robert W.; Huang, Yadong] Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA; [Li, Gang; Andrews-Zwilling, Yaisa; Huang, Yadong] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Bien-Ly, Nga; Ring, Karen; Huang, Yadong] Univ Calif San Francisco, Biomed Sci Grad Program, San Francisco, CA 94143 USA; [Deng, Changhui] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA; [Mahley, Robert W.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Mahley, Robert W.; Huang, Yadong] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA; [Mahley, Robert W.; Huang, Yadong] Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; The J David Gladstone Institutes	Huang, YD (corresponding author), Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA.	yhuang@gladstone.ucsf.edu	Deng, Changhui/A-1010-2012	Li, Gang/0000-0002-1933-484X	California Institute of Regenerative Medicine [T2-00003, RN2-00952-1]; National Institutes of Health [P01 AG022074]; NATIONAL INSTITUTE ON AGING [P01AG022074] Funding Source: NIH RePORTER	California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the J. David Gladstone Institutes, grants T2-00003 and RN2-00952-1 from the California Institute of Regenerative Medicine, and grant P01 AG022074 from the National Institutes of Health. The retroviral construct encoding GFP was a generous gift of Dr. Fred H. Gage (Salk Institute for Biological Studies, La Jolla, CA). We thank John Carroll and Alisha Wilson for graphics, Linda Turney for manuscript preparation, and Stephen Ordway and Gary Howard for editorial assistance.	Aimone JB, 2006, NAT NEUROSCI, V9, P723, DOI 10.1038/nn1707; ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; Alvarez-Buylla A, 2002, J NEUROSCI, V22, P629, DOI 10.1523/JNEUROSCI.22-03-00629.2002; Alvarez-Buylla A, 2004, NEURON, V41, P683, DOI 10.1016/S0896-6273(04)00111-4; Aoki K, 2003, STROKE, V34, P875, DOI 10.1161/01.STR.0000064320.73388.C6; Bolteus AJ, 2004, J NEUROSCI, V24, P7623, DOI 10.1523/JNEUROSCI.1999-04.2004; Bour A, 2008, BEHAV BRAIN RES, V193, P174, DOI 10.1016/j.bbr.2008.05.008; Brecht WJ, 2004, J NEUROSCI, V24, P2527, DOI 10.1523/JNEUROSCI.4315-03.2004; Brewer GJ, 2007, NAT PROTOC, V2, P1490, DOI 10.1038/nprot.2007.207; CAMERON HA, 1993, NEUROSCIENCE, V56, P337, DOI 10.1016/0306-4522(93)90335-D; Carleton A, 2003, NAT NEUROSCI, V6, P507, DOI 10.1038/nn1048; Caselli RJ, 2009, NEW ENGL J MED, V361, P255, DOI 10.1056/NEJMoa0809437; Chang SJ, 2005, P NATL ACAD SCI USA, V102, P18694, DOI 10.1073/pnas.0508254102; Chen J, 2005, J BIOL CHEM, V280, P40364, DOI 10.1074/jbc.M509329200; Christie BR, 2006, HIPPOCAMPUS, V16, P199, DOI 10.1002/hipo.20151; Cohen RM, 2001, NEUROLOGY, V57, P2223, DOI 10.1212/WNL.57.12.2223; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Duan X, 2007, CELL, V130, P1146, DOI 10.1016/j.cell.2007.07.010; Earnheart JC, 2007, J NEUROSCI, V27, P3845, DOI 10.1523/JNEUROSCI.3609-06.2007; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Esposito MS, 2005, J NEUROSCI, V25, P10074, DOI 10.1523/JNEUROSCI.3114-05.2005; Fan XT, 2003, DEV BRAIN RES, V146, P51, DOI 10.1016/j.devbrainres.2003.09.007; Galvao RP, 2008, J NEUROSCI, V28, P13368, DOI 10.1523/JNEUROSCI.2918-08.2008; Ganguly K, 2001, CELL, V105, P521, DOI 10.1016/S0092-8674(01)00341-5; Ge SY, 2007, TRENDS NEUROSCI, V30, P1, DOI 10.1016/j.tins.2006.11.001; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; GOTZ J, 1995, EMBO J, V14, P1304, DOI 10.1002/j.1460-2075.1995.tb07116.x; Grootendorst J, 2005, BEHAV BRAIN RES, V159, P1, DOI 10.1016/j.bbr.2004.09.019; Harris FM, 2004, J BIOL CHEM, V279, P3862, DOI 10.1074/jbc.M309475200; Harris FM, 2003, P NATL ACAD SCI USA, V100, P10966, DOI 10.1073/pnas.1434398100; Huang Y, 2006, CURR OPIN DRUG DISC, V9, P627; Huang YD, 2004, J MOL NEUROSCI, V23, P189, DOI 10.1385/JMN:23:3:189; Huang YD, 2006, NEUROLOGY, V66, pS79, DOI 10.1212/01.wnl.0000192102.41141.9e; Huang YD, 2001, P NATL ACAD SCI USA, V98, P8838, DOI 10.1073/pnas.151254698; Ishihara T, 1999, NEURON, V24, P751, DOI 10.1016/S0896-6273(00)81127-7; Jacobs S, 2006, P NATL ACAD SCI USA, V103, P3902, DOI 10.1073/pnas.0511294103; KAPLAN MS, 1984, J NEUROSCI, V4, P1429; Kempermann G, 2003, DEVELOPMENT, V130, P391, DOI 10.1242/dev.00203; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Lie DC, 2004, ANNU REV PHARMACOL, V44, P399, DOI 10.1146/annurev.pharmtox.44.101802.121631; Lim DA, 2000, NEURON, V28, P713, DOI 10.1016/S0896-6273(00)00148-3; Liu XX, 2005, NAT NEUROSCI, V8, P1179, DOI 10.1038/nn1522; Liu ZP, 2006, SCIENCE, V314, P1610, DOI 10.1126/science.1134246; Mahley RW, 2006, P NATL ACAD SCI USA, V103, P5644, DOI 10.1073/pnas.0600549103; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Moffat SD, 2000, NEUROLOGY, V55, P134, DOI 10.1212/WNL.55.1.134; Owens DF, 2002, NAT REV NEUROSCI, V3, P715, DOI 10.1038/nrn919; Raber J, 1998, P NATL ACAD SCI USA, V95, P10914, DOI 10.1073/pnas.95.18.10914; Raber J, 2000, NATURE, V404, P352, DOI 10.1038/35006165; Ray J, 2006, MOL CELL NEUROSCI, V31, P560, DOI 10.1016/j.mcn.2005.11.010; Rochefort C, 2002, J NEUROSCI, V22, P2679, DOI 10.1523/JNEUROSCI.22-07-02679.2002; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; SELKOE DJ, 1991, NEURON, V6, P487, DOI 10.1016/0896-6273(91)90052-2; Song SH, 2002, NATURE, V417, P39, DOI 10.1038/417039a; Suh H, 2007, CELL STEM CELL, V1, P515, DOI 10.1016/j.stem.2007.09.002; Suh H, 2009, ANNU REV CELL DEV BI, V25, P253, DOI 10.1146/annurev.cellbio.042308.113256; Sullivan PM, 2004, NEUROSCIENCE, V124, P725, DOI 10.1016/j.neuroscience.2003.10.011; Sullivan PM, 1997, J BIOL CHEM, V272, P17972, DOI 10.1074/jbc.272.29.17972; Tang J, 2009, BIOCHEM BIOPH RES CO, V385, P341, DOI 10.1016/j.bbrc.2009.05.067; Tanzi RE, 2001, NEURON, V32, P181, DOI 10.1016/S0896-6273(01)00476-7; Tozuka Y, 2005, NEURON, V47, P803, DOI 10.1016/j.neuron.2005.08.023; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Villasana L, 2006, RADIAT RES, V166, P883, DOI 10.1667/RR0642.1; Xu PT, 1999, AM J PATHOL, V154, P601, DOI 10.1016/S0002-9440(10)65305-9; Xu Q, 2008, J NEUROSCI, V28, P1452, DOI 10.1523/JNEUROSCI.3253-07.2008; Xu Q, 2006, J NEUROSCI, V26, P4985, DOI 10.1523/JNEUROSCI.5476-05.2006; Zhang CL, 2008, NATURE, V451, P1004, DOI 10.1038/nature06562; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Zhao CM, 2006, J NEUROSCI, V26, P3, DOI 10.1523/JNEUROSCI.3648-05.2006	69	174	177	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	DEC 4	2009	5	6					634	645		10.1016/j.stem.2009.10.015	http://dx.doi.org/10.1016/j.stem.2009.10.015			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	543YH	19951691	Bronze, Green Accepted			2022-12-24	WOS:000273616700011
J	Andreu-Agullo, C; Morante-Redolat, JM; Delgado, AC; Farinas, I				Andreu-Agullo, Celia; Manuel Morante-Redolat, Jose; Delgado, Ana C.; Farinas, Isabel			Vascular niche factor PEDF modulates Notch-dependent stemness in the adult subependymal zone	NATURE NEUROSCIENCE			English	Article							EPITHELIUM-DERIVED FACTOR; NF-KAPPA-B; AMYLOID PRECURSOR PROTEIN; NEURAL DEVELOPMENT; MAMMALIAN NOTCH; GENE-EXPRESSION; CELLS; RECEPTOR; SIGNAL; BRAIN	We sought to address the fundamental question of how stem cell microenvironments can regulate self-renewal. We found that Notch was active in astroglia-like neural stem cells (NSCs), but not in transit-amplifying progenitors of the murine subependymal zone, and that the level of Notch transcriptional activity correlated with self-renewal and multipotency. Moreover, dividing NSCs appeared to balance renewal with commitment via controlled segregation of Notch activity, leading to biased expression of known (Hes1) and previously unknown (Egfr) Notch target genes in daughter cells. Pigment epithelium-derived factor (PEDF) enhanced Notch-dependent transcription in cells with low Notch signaling, thereby subverting the output of an asymmetrical division to the production of two highly self-renewing cells. Mechanistically, PEDF induced a non-canonical activation of the NF-kappa B pathway, leading to the dismissal of the transcriptional co-repressor N-CoR from specific Notch-responsive promoters. Our data provide a basis for stemness regulation in vascular niches and indicate that Notch and PEDF cooperate to regulate self-renewal.	[Andreu-Agullo, Celia; Manuel Morante-Redolat, Jose; Delgado, Ana C.; Farinas, Isabel] Univ Valencia, Dept Biol Celular, E-46100 Burjassot, Spain; [Andreu-Agullo, Celia; Manuel Morante-Redolat, Jose; Delgado, Ana C.; Farinas, Isabel] Univ Valencia, CIBER Enfermedades Neurodegenerat, E-46100 Burjassot, Spain	University of Valencia; University of Valencia	Farinas, I (corresponding author), Univ Valencia, Dept Biol Celular, E-46100 Burjassot, Spain.	isabel.farinas@uv.es	Fariñas, Isabel/L-7118-2014; Morante-Redolat, Jose Manuel/L-9397-2014	Morante-Redolat, Jose Manuel/0000-0003-0610-1665	Ministerio de Ciencia e Innovacion; Ministerio de Sanidad; Generalitat Valenciana; Fundacion 'la Caixa'; Formacion del Profesorado Universitario predoctoral fellowship; CIBERNED	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Ministerio de Sanidad(Instituto de Salud Carlos IIISpanish Government); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); Fundacion 'la Caixa'(La Caixa Foundation); Formacion del Profesorado Universitario predoctoral fellowship; CIBERNED(Instituto de Salud Carlos III)	We are grateful to A. Bigas, J.L. de la Pompa, N. Gaiano, W. C. Greene, O. Hermanson, S. Hitoshi, A. Israel, K. Jepsen, M. Karin, R. Kopan, G. Leclercq, M. G. Rosenfeld, S. Sun, D. van der Kooy, Y. Zhan and V. Meni for kindly providing constructs and reagents. We also thank E. Porlan and H. Mira for technical advice, M. P. Rubio for excellent technical assistance, and E. Porlan and S. R. Ferron for critical reading of the manuscript and valuable discussions. We gratefully acknowledge the help of M. A. Marques-Torrejon with the infusion experiments and of A. Martinez and D. Gil with cytometry. We are also grateful to E. Lai for comments on the manuscript. This work was supported by grants from Ministerio de Ciencia e Innovacion (SAF Program), Ministerio de Sanidad (Red Tercel, Centro de Investigacion Biomeica en Red sobre Enfermedades Neurodegenerativas, CIBERNED), Generalitat Valenciana (Programa Prometeo) and Fundacion 'la Caixa'. C. A.-A. was a recipient of a Formacion del Profesorado Universitario predoctoral fellowship. J. M. M.-R. and A. C. D. were funded by CIBERNED.	Alexson TO, 2006, DEV NEUROSCI-BASEL, V28, P34, DOI 10.1159/000090751; Androutsellis-Theotokis A, 2006, NATURE, V442, P823, DOI 10.1038/nature04940; Ang HL, 2007, BIOESSAYS, V29, P1039, DOI 10.1002/bies.20647; Baek SH, 2002, CELL, V110, P55, DOI 10.1016/S0092-8674(02)00809-7; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Breunig JJ, 2007, P NATL ACAD SCI USA, V104, P20558, DOI 10.1073/pnas.0710156104; Cai J, 2006, J BIOL CHEM, V281, P3604, DOI 10.1074/jbc.M507401200; Campos LS, 2006, J BIOL CHEM, V281, P5300, DOI 10.1074/jbc.M511886200; Carlen M, 2009, NAT NEUROSCI, V12, P259, DOI 10.1038/nn.2268; Chen LF, 2004, NAT REV MOL CELL BIO, V5, P392, DOI 10.1038/nrm1368; Chiba S, 2006, STEM CELLS, V24, P2437, DOI 10.1634/stemcells.2005-0661; Chung C, 2008, J HEPATOL, V48, P471, DOI 10.1016/j.jhep.2007.10.012; Ciccolini F, 2005, DEV BIOL, V284, P112, DOI 10.1016/j.ydbio.2005.05.007; Denis-Donini S, 2005, DEV BRAIN RES, V154, P81, DOI 10.1016/j.devbrainres.2004.10.010; DiDonato J, 1996, MOL CELL BIOL, V16, P1295; Doetsch F, 2002, NEURON, V36, P1021, DOI 10.1016/S0896-6273(02)01133-9; Duncan AW, 2005, NAT IMMUNOL, V6, P314, DOI 10.1038/ni1164; Espinosa L, 2002, J CELL SCI, V115, P1295; Ferron SR, 2007, NAT PROTOC, V2, P849, DOI 10.1038/nprot.2007.104; Givogri MI, 2006, DEV NEUROSCI-BASEL, V28, P81, DOI 10.1159/000090755; Harhaj EW, 1999, MOL CELL BIOL, V19, P7088; Hermanson O, 2002, NATURE, V419, P934, DOI 10.1038/nature01156; Hitoshi S, 2002, GENE DEV, V16, P846, DOI 10.1101/gad.975202; Hsieh J, 2005, CURR OPIN CELL BIOL, V17, P664, DOI 10.1016/j.ceb.2005.09.002; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Kao HY, 1998, GENE DEV, V12, P2269, DOI 10.1101/gad.12.15.2269; Louvi A, 2006, NAT REV NEUROSCI, V7, P93, DOI 10.1038/nrn1847; Mizutani K, 2007, NATURE, V449, P351, DOI 10.1038/nature06090; Mori T, 2006, GLIA, V54, P21, DOI 10.1002/glia.20350; Morrison SJ, 2006, NATURE, V441, P1068, DOI 10.1038/nature04956; Notari L, 2006, J BIOL CHEM, V281, P38022, DOI 10.1074/jbc.M600353200; Ohtsuka T, 2001, J BIOL CHEM, V276, P30467, DOI 10.1074/jbc.M102420200; Palmer TD, 2000, J COMP NEUROL, V425, P479, DOI 10.1002/1096-9861(20001002)425:4<479::AID-CNE2>3.0.CO;2-3; Ramirez-Castillejo C, 2006, NAT NEUROSCI, V9, P331, DOI 10.1038/nn1657; Reizis B, 2002, GENE DEV, V16, P295, DOI 10.1101/gad.960702; Riquelme PA, 2008, PHILOS T R SOC B, V363, P123, DOI 10.1098/rstb.2006.2016; Rosenfeld MG, 2006, GENE DEV, V20, P1405, DOI 10.1101/gad.1424806; Sang LY, 2008, SCIENCE, V321, P1095, DOI 10.1126/science.1155998; Shen Q, 2004, SCIENCE, V304, P1338, DOI 10.1126/science.1095505; Shen Q, 2008, CELL STEM CELL, V3, P289, DOI 10.1016/j.stem.2008.07.026; Sun Y, 2005, NEURON, V45, P873, DOI 10.1016/j.neuron.2005.01.045; Tavazoie M, 2008, CELL STEM CELL, V3, P279, DOI 10.1016/j.stem.2008.07.025; Tombran-Tink J, 2003, NAT REV NEUROSCI, V4, P628, DOI 10.1038/nrn1176; Wu MF, 2007, CELL STEM CELL, V1, P541, DOI 10.1016/j.stem.2007.08.009; Yabe T, 2005, GLIA, V50, P223, DOI 10.1002/glia.20171; Yabe T, 2001, J BIOL CHEM, V276, P43313, DOI 10.1074/jbc.M107831200; Yoon K, 2005, NAT NEUROSCI, V8, P709, DOI 10.1038/nn1475; Zhang YW, 2007, P NATL ACAD SCI USA, V104, P10613, DOI 10.1073/pnas.0703903104; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	49	162	168	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2009	12	12					1514	U57		10.1038/nn.2437	http://dx.doi.org/10.1038/nn.2437			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	523II	19898467				2022-12-24	WOS:000272065600011
J	Ikushima, H; Todo, T; Ino, Y; Takahashi, M; Miyazawa, K; Miyazono, K				Ikushima, Hiroaki; Todo, Tomoki; Ino, Yasushi; Takahashi, Masamichi; Miyazawa, Keiji; Miyazono, Kohei			Autocrine TGF-beta Signaling Maintains Tumorigenicity of Glioma-Initiating Cells through Sry-Related HMG-Box Factors	CELL STEM CELL			English	Article							GROWTH-FACTOR-BETA; SEX-DETERMINING REGION; EMBRYONIC STEM-CELLS; MESENCHYMAL TRANSITION; GENE-EXPRESSION; SOX4 EXPRESSION; SELF-RENEWAL; CANCER; IDENTIFICATION; GLIOBLASTOMA	Despite aggressive surgery, radiotherapy, and chemotherapy, treatment of malignant glioma remains formidable. Although the concept of cancer stem cells reveals a new framework of cancer therapeutic strategies against malignant glioma, it remains unclear how glioma stem cells could be eradicated. Here, we demonstrate that autocrine TGF-beta signaling plays an essential role in retention of sternness of glioma-initiating cells (GICs) and describe the underlying mechanism for it. TGF-beta-induced expression of Sox2, a stemness gene, and this induction was mediated by Sox4, a direct TGF-beta target gene. Inhibitors of TGF-beta signaling drastically deprived tumorigenicity of GICs by promoting their differentiation, and these effects were attenuated in GICs transduced with Sox2 or Sox4. Furthermore, GICs pretreated with TGF-beta signaling inhibitor exhibited less lethal potency in intracranial transplantation assay. These results identify an essential pathway for GICs, the TGF-beta-Sox4-Sox2 pathway, whose disruption would be a therapeutic strategy against gliomas.	[Ikushima, Hiroaki; Miyazawa, Keiji; Miyazono, Kohei] Univ Tokyo, Grad Sch Med, Dept Mol Pathol, Tokyo 1130033, Japan; [Todo, Tomoki; Ino, Yasushi; Takahashi, Masamichi] Univ Tokyo, Grad Sch Med, Dept Neurosurg, Tokyo 1130033, Japan; [Todo, Tomoki; Ino, Yasushi] Univ Tokyo, Grad Sch Med, Translat Res Ctr, Tokyo 1130033, Japan	University of Tokyo; University of Tokyo; University of Tokyo	Miyazono, K (corresponding author), Univ Tokyo, Grad Sch Med, Dept Mol Pathol, Tokyo 1130033, Japan.	miyazono@m.u-tokyo.ac.jp	MIYAZAWA, KEIJI/I-9713-2014; Takahashi, Masamichi/GRJ-2866-2022	Todo, Tomoki/0000-0003-0523-8010; Takahashi, Masamichi/0000-0001-8792-1993	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japan Society for the Promotion of Science for Young Scientists	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	We are grateful to Yasuyuki Morishita, Daisuke Itoh, Hiroshi Yoshida, and Chihana Fujita for skilled technical assistance. This work was supported by KAKENHI (Grant-in-aid for Scientific Research) and Global COE Program (integrative Life Science Based on the Study of Biosignaling Mechanisms) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. H.I. has been supported by a Tetsumon-scholarship for the Ph.D.-M.D. program of the University of Tokyo and by a research fellowship of the Japan Society for the Promotion of Science for Young Scientists.	Aaboe M, 2006, CANCER RES, V66, P3434, DOI 10.1158/0008-5472.CAN-05-3456; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Beier D, 2007, CANCER RES, V67, P4010, DOI 10.1158/0008-5472.CAN-06-4180; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Bruna A, 2007, CANCER CELL, V11, P147, DOI 10.1016/j.ccr.2006.11.023; Cheung M, 2000, MOL BRAIN RES, V79, P180, DOI 10.1016/S0169-328X(00)00109-1; Chew JL, 2005, MOL CELL BIOL, V25, P6031, DOI 10.1128/MCB.25.14.6031-6046.2005; Clement V, 2007, CURR BIOL, V17, P165, DOI 10.1016/j.cub.2006.11.033; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Ehata S, 2007, CANCER RES, V67, P9694, DOI 10.1158/0008-5472.CAN-07-1522; Ferri ALM, 2004, DEVELOPMENT, V131, P3805, DOI 10.1242/dev.01204; Golestaneh N, 2005, ONCOGENE, V24, P5722, DOI 10.1038/sj.onc.1208925; Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5; GUBBAY J, 1990, NATURE, V346, P245, DOI 10.1038/346245a0; Gunther HS, 2008, ONCOGENE, V27, P2897, DOI 10.1038/sj.onc.1210949; Hirschmann-Jax C, 2004, P NATL ACAD SCI USA, V101, P14228, DOI 10.1073/pnas.0400067101; Ikushima H, 2008, EMBO J, V27, P2955, DOI 10.1038/emboj.2008.218; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Kamachi Y, 2000, TRENDS GENET, V16, P182, DOI 10.1016/S0168-9525(99)01955-1; Koinuma D, 2009, MOL CELL BIOL, V29, P172, DOI 10.1128/MCB.01038-08; Kondo T, 2004, P NATL ACAD SCI USA, V101, P781, DOI 10.1073/pnas.0307618100; Lee CJ, 2002, J NEURO-ONCOL, V57, P201, DOI 10.1023/A:1015773818302; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Liao YL, 2008, ONCOGENE, V27, P5578, DOI 10.1038/onc.2008.168; Lim DA, 2000, NEURON, V28, P713, DOI 10.1016/S0896-6273(00)00148-3; Liu GT, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-67; Liu PB, 2006, CANCER RES, V66, P4011, DOI 10.1158/0008-5472.CAN-05-3055; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Matsuyama S, 2003, CANCER RES, V63, P7791; Miyazawa K, 2002, GENES CELLS, V7, P1191, DOI 10.1046/j.1365-2443.2002.00599.x; Munoz-Sanjuan I, 2002, NAT REV NEUROSCI, V3, P271, DOI 10.1038/nrn786; Penuelas S, 2009, CANCER CELL, V15, P315, DOI 10.1016/j.ccr.2009.02.011; Piccirillo SGM, 2006, NATURE, V444, P761, DOI 10.1038/nature05349; Pramoonjago P, 2006, ONCOGENE, V25, P5626, DOI 10.1038/sj.onc.1209566; Sanchez-Capelo A, 2005, CYTOKINE GROWTH F R, V16, P15, DOI 10.1016/j.cytogfr.2004.11.002; Sawyer JS, 2003, J MED CHEM, V46, P3953, DOI 10.1021/jm0205705; Schlingensiepen KH, 2006, CYTOKINE GROWTH F R, V17, P129, DOI 10.1016/j.cytogfr.2005.09.002; Schmitz M, 2007, BRIT J CANCER, V96, P1293, DOI 10.1038/sj.bjc.6603696; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Surawicz TS, 1998, J NEURO-ONCOL, V40, P151, DOI 10.1023/A:1006091608586; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tojo M, 2005, CANCER SCI, V96, P791, DOI 10.1111/j.1349-7006.2005.00103.x; Tomioka M, 2002, NUCLEIC ACIDS RES, V30, P3202, DOI 10.1093/nar/gkf435; Tso CL, 2006, MOL CANCER RES, V4, P607, DOI 10.1158/1541-7786.MCR-06-0005; Vescovi AL, 2006, NAT REV CANCER, V6, P425, DOI 10.1038/nrc1889; Xu RH, 2008, CELL STEM CELL, V3, P196, DOI 10.1016/j.stem.2008.07.001; Yokota N, 2004, ONCOGENE, V23, P3444, DOI 10.1038/sj.onc.1207475	49	409	424	5	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	NOV 6	2009	5	5					504	514		10.1016/j.stem.2009.08.018	http://dx.doi.org/10.1016/j.stem.2009.08.018			11	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	522SR	19896441	Bronze			2022-12-24	WOS:000272019500012
J	Ferrera, VP; Yanike, M; Cassanello, C				Ferrera, Vincent P.; Yanike, Marianna; Cassanello, Carlos			Frontal eye field neurons signal changes in decision criteria	NATURE NEUROSCIENCE			English	Article							VISUAL CATEGORIZATION; FEATURE SELECTIVITY; SHAPE SELECTIVITY; CORTEX; MACAQUE; REPRESENTATION; MICROSTIMULATION; EXPERIENCE; ATTENTION; TASKS	Flexible links between sensory stimuli and behavioral responses underlie many cognitive processes. One process that contributes to flexible decision-making is categorization. Some categories are innate or overlearned, but, in many cases, category boundaries represent flexible decision criteria that can shift on the fly to adapt to changes in the environment. The ability to shift category boundaries allows decision-making to adapt to changing circumstances. We found that monkeys were able to switch rapidly between two category boundaries when classifying the speed of a moving dot pattern and that neurons in monkey frontal eye field (FEF) changed their activity when the boundary changed. The responses of a subpopulation of FEF neurons that were sensitive to both stimulus and boundary speed were used to classify the stimuli as accurately as the monkeys' performance.	[Ferrera, Vincent P.; Yanike, Marianna; Cassanello, Carlos] Columbia Univ, Dept Neurosci, New York, NY 10027 USA; [Ferrera, Vincent P.] Columbia Univ, Dept Psychiat, New York, NY USA	Columbia University; Columbia University	Ferrera, VP (corresponding author), Columbia Univ, Dept Neurosci, New York, NY 10027 USA.	vpf3@columbia.edu		Cassanello, Carlos/0000-0003-1591-8802; Ferrera, Vincent/0000-0002-6599-7740	US National Institutes of Health [MH59244]; Gatsby Institute; National Alliance for Research on Schizophrenia and Depression; Robert Leet and Clara Guthrie Patterson Trust; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059244] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gatsby Institute; National Alliance for Research on Schizophrenia and Depression(NARSAD); Robert Leet and Clara Guthrie Patterson Trust; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We would like to thank J. Schall, R. Ratcliff, F. Pestilli, J. Grinband, T. Teichert, C. Barberini and M. Phillips for comments on a preliminary version of this manuscript. This research was supported by US National Institutes of Health grant MH59244 (V. P. F.), the Gatsby Institute (V. P. F.), the National Alliance for Research on Schizophrenia and Depression (V. P. F.) and the Robert Leet and Clara Guthrie Patterson Trust (M. Y.).	Ashby EG, 2005, ANNU REV PSYCHOL, V56, P149, DOI 10.1146/annurev.psych.56.091103.070217; Bichot NP, 1996, NATURE, V381, P697, DOI 10.1038/381697a0; Blair MR, 2009, J EXP PSYCHOL LEARN, V35, P1196, DOI 10.1037/a0016272; BRUCE CJ, 1985, J NEUROPHYSIOL, V54, P714, DOI 10.1152/jn.1985.54.3.714; CAMPBELL RN, 1994, ENCY LANGUAGE LINGUI, V4, P1899; Farah M., 2004, VISUAL AGNOSIA; Ferrera VP, 1999, NEUROREPORT, V10, P1315, DOI 10.1097/00001756-199904260-00030; Ferrier D, 1876, FUNCTIONS BRAIN; Freedman DJ, 2006, NATURE, V443, P85, DOI 10.1038/nature05078; Freedman DJ, 2001, SCIENCE, V291, P312, DOI 10.1126/science.291.5502.312; Freedman DJ, 2003, J NEUROSCI, V23, P5235; GOPNIK A, 1987, CHILD DEV, V58, P1523, DOI 10.2307/1130692; Horwitz GD, 2004, J NEUROPHYSIOL, V91, P2281, DOI 10.1152/jn.00872.2003; Kreiman G, 2000, NAT NEUROSCI, V3, P946, DOI 10.1038/78868; MAUNSELL JHR, 1987, ANNU REV NEUROSCI, V10, P363, DOI 10.1146/annurev.ne.10.030187.002051; Miller EK, 2003, CURR OPIN NEUROBIOL, V13, P198, DOI 10.1016/S0959-4388(03)00037-0; Moore T, 2003, NATURE, V421, P370, DOI 10.1038/nature01341; Opris I, 2001, EXP BRAIN RES, V138, P1, DOI 10.1007/s002210100686; Peng XM, 2008, J NEUROPHYSIOL, V100, P796, DOI 10.1152/jn.01188.2007; Ratcliff R, 2008, NEURAL COMPUT, V20, P873, DOI 10.1162/neco.2008.12-06-420; SCHALL JD, 1995, J NEUROSCI, V15, P6905; SCHALL JD, 1995, J NEUROSCI, V15, P4464; Sereno AB, 1998, NATURE, V395, P500, DOI 10.1038/26752; Sigala N, 2002, NATURE, V415, P318, DOI 10.1038/415318a; Thompson KG, 2005, J NEUROSCI, V25, P9479, DOI 10.1523/JNEUROSCI.0741-05.2005; Xiao Q, 2006, VISUAL NEUROSCI, V23, P49, DOI 10.1017/S0952523806231055	26	58	58	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2009	12	11					1458	1462		10.1038/nn.2434	http://dx.doi.org/10.1038/nn.2434			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	511UE	19855389	Green Accepted			2022-12-24	WOS:000271194100020
J	Haase, A; Olmer, R; Schwanke, K; Wunderlich, S; Merkert, S; Hess, C; Zweigerdt, R; Gruh, I; Meyer, J; Wagner, S; Maier, LS; Han, DW; Glage, S; Miller, K; Fischer, P; Scholer, HR; Martin, U				Haase, Alexandra; Olmer, Ruth; Schwanke, Kristin; Wunderlich, Stephanie; Merkert, Sylvia; Hess, Christian; Zweigerdt, Robert; Gruh, Ina; Meyer, Johann; Wagner, Stefan; Maier, Lars S.; Han, Dong Wook; Glage, Silke; Miller, Konstantin; Fischer, Philipp; Schoeler, Hans R.; Martin, Ulrich			Generation of Induced Pluripotent Stem Cells from Human Cord Blood	CELL STEM CELL			English	Article								Induced pluripotent stem cells (iPSCs) may represent an ideal cell source for future regenerative therapies. A critical issue concerning the clinical use of patient-specific iPSCs is the accumulation of mutations in somatic (stem) cells over an organism's lifetime. Acquired somatic mutations are passed onto iPSCs during reprogramming and may be associated with loss of cellular functions and cancer formation. Here we report the generation of human iPSCs from cord blood (CB) as a juvenescent cell source. CBiPSCs show characteristics typical of embryonic stem cells and can be differentiated into derivatives of all three germ layers, including functional cardiomyocytes. For future therapeutic production of autologous and allogeneic iPSC derivatives, CB could be routinely harvested for public and commercial CB banks without any donor risk. CB could readily become available for pediatric patients and, in particular, for newborns with genetic diseases or congenital malformations.	[Haase, Alexandra; Olmer, Ruth; Schwanke, Kristin; Wunderlich, Stephanie; Merkert, Sylvia; Hess, Christian; Zweigerdt, Robert; Gruh, Ina; Martin, Ulrich] Hannover Med Sch, Dept Cardiac Thorac Transplantat & Vasc Surg, Leibniz Res Labs Biotechnol & Artificial Organs, D-30625 Hannover, Germany; [Meyer, Johann] Hannover Med Sch, Dept Expt Hematol, D-30625 Hannover, Germany; [Glage, Silke] Hannover Med Sch, Inst Lab Anim Sci, D-30625 Hannover, Germany; [Miller, Konstantin] Hannover Med Sch, Dept Human Genet, D-30625 Hannover, Germany; [Fischer, Philipp] Hannover Med Sch, Dept Cardiol & Angiol, D-30625 Hannover, Germany; [Han, Dong Wook; Schoeler, Hans R.] Max Planck Inst Mol Biomed, Dept Cell & Dev Biol, D-48149 Munster, Germany; [Wagner, Stefan; Maier, Lars S.] Univ Gottingen, Dept Cardiol & Pneumol, D-37075 Gottingen, Germany	Hannover Medical School; Hannover Medical School; Hannover Medical School; Hannover Medical School; Hannover Medical School; Max Planck Society; University of Gottingen	Martin, U (corresponding author), Hannover Med Sch, Dept Cardiac Thorac Transplantat & Vasc Surg, Leibniz Res Labs Biotechnol & Artificial Organs, D-30625 Hannover, Germany.	martin.ulrich@mh-hannover.de	, HS/AAB-4434-2019; Wagner, Stefan/AAE-3721-2021; Martin, Ulrich/F-4888-2017; Maier, Lars/AAQ-8313-2021; Han, Dong Wook/D-6041-2011	, HS/0000-0003-2643-5136; Wagner, Stefan/0000-0002-9471-1166; Martin, Ulrich/0000-0003-1058-4540; Maier, Lars/0000-0001-9915-4429; Haase, Alexandra/0000-0003-2666-4297; Merkert, Sylvia/0000-0001-7275-4205	Nordcleutsches Knochenmarks- und Stammzellspender-Register (NKR); German Federal Ministry of Education and Research [01GN0522, 0313926A, 01GN0816]; Excellence Cluster REBIRTH	Nordcleutsches Knochenmarks- und Stammzellspender-Register (NKR); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Excellence Cluster REBIRTH	The authors are grateful to S. Dorfman for revising the manuscript, C. Mauritz, T. Schnick, J. Beier, S. Schubert, and S.L. Weber for providing technical assistance, and J. Thomson for providing the reprogramming plasmids via Addgene. We thank the Nordcleutsches Knochenmarks- und Stammzellspender-Register (NKR) for providing cord blood samples. This work has been supported by the German Federal Ministry of Education and Research (01GN0522; 0313926A; 01GN0816) as well as by the Excellence Cluster REBIRTH.	Cashen AF, 2007, BONE MARROW TRANSPL, V39, P577, DOI 10.1038/sj.bmt.1705616; Guan K, 2007, CIRC RES, V100, P1615, DOI 10.1161/01.RES.0000269182.22798.d9; Hofmeister CC, 2007, BONE MARROW TRANSPL, V39, P11, DOI 10.1038/sj.bmt.1705538; Ingram DA, 2004, BLOOD, V104, P2752, DOI 10.1182/blood-2004-04-1396; Loh YH, 2009, BLOOD, V113, P5476, DOI 10.1182/blood-2009-02-204800; Maherali N, 2008, CELL STEM CELL, V3, P340, DOI 10.1016/j.stem.2008.08.003; Marion RM, 2009, CELL STEM CELL, V4, P141, DOI 10.1016/j.stem.2008.12.010; Mauritz C, 2008, CIRCULATION, V118, P507, DOI 10.1161/CIRCULATIONAHA.108.778795; Murohara T, 2000, J CLIN INVEST, V105, P1527, DOI 10.1172/JCI8296; Ono T, 2002, MECH AGEING DEV, V123, P1543, DOI 10.1016/S0047-6374(02)00090-8; Rohde E, 2007, STEM CELLS, V25, P1746, DOI 10.1634/stemcells.2006-0833; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Trifunovic A, 2008, J INTERN MED, V263, P167, DOI 10.1111/j.1365-2796.2007.01905.x; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	14	354	384	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	OCT 2	2009	5	4					434	441		10.1016/j.stem.2009.08.021	http://dx.doi.org/10.1016/j.stem.2009.08.021			8	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	514NP	19796623	Bronze			2022-12-24	WOS:000271401900014
J	Tang, JR; Dani, JA				Tang, Jianrong; Dani, John A.			Dopamine Enables In Vivo Synaptic Plasticity Associated with the Addictive Drug Nicotine	NEURON			English	Article							LONG-TERM POTENTIATION; VENTRAL TEGMENTAL AREA; CONDITIONED PLACE PREFERENCE; NUCLEUS-ACCUMBENS; DORSAL HIPPOCAMPUS; PERFORANT PATH; ACETYLCHOLINE-RECEPTORS; MOLECULAR-MECHANISMS; DEFICIENT MICE; BASAL GANGLIA	Addictive drugs induce a dopamine signal that contributes to the initiation of addiction, and the dopamine signal influences drug-associated memories that perpetuate drug use. The addiction process shares many commonalities with the synaptic plasticity mechanisms normally attributed to learning and memory. Environmental stimuli repeatedly linked to addictive drugs become learned associations, an those stimuli come to elicit memories or sensations that motivate continued drug use. Applying in vivo recording techniques to freely moving mice, we show that physiologically relevant concentrations of the addictive drug nicotine directly cause in vivo hippocampal synaptic potentiation of the kind that underlies learning and memory. The drug-induced long-term synaptic. plasticity required a local hippocampal dopamine signal. Disrupting general dopamine signaling prevented the nicotine-induced synaptic plasticity and conditioned place preference. These results suggest that dopaminergic signaling serves as a functional label of salient events by enabling and scaling synaptic plasticity that underlies drug-induced associative memory.	[Tang, Jianrong; Dani, John A.] Baylor Coll Med, Dept Neurosci, Menninger Dept Psychiat & Behav Sci, Houston, TX 77030 USA	Baylor College of Medicine	Dani, JA (corresponding author), Baylor Coll Med, Dept Neurosci, Menninger Dept Psychiat & Behav Sci, Houston, TX 77030 USA.	jdani@bcm.tmc.edu			National Institute of Neurological Disorders and Stroke [R01 NS021229]; National Institute on Drug Abuse [R01 DA009411]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS021229] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA009411] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The work was supported by Award Numbers and from the National Institute of Neurological Disorders and Stroke (R01 NS021229) and the National Institute on Drug Abuse (R01 DA009411), respectively. The content is solely the responsibility of the authors and does not necessarily represent the official views of NINDS, NIDA, or the National Institutes of Health. We gratefully acknowledge the advice of Dr. Mariella De Biasi throughout this study and her student, Ms. Erica Perez, during the CPP experiments.	Biala G, 2005, EUR J NEUROSCI, V21, P3089, DOI 10.1111/j.1460-9568.2005.04132.x; Bonson KR, 2002, NEUROPSYCHOPHARMACOL, V26, P376, DOI 10.1016/S0893-133X(01)00371-2; Brady AM, 2004, J NEUROSCI, V24, P1040, DOI 10.1523/JNEUROSCI.4178-03.2004; Caine SB, 2007, J NEUROSCI, V27, P13140, DOI 10.1523/JNEUROSCI.2284-07.2007; Corrigall W A, 1999, Nicotine Tob Res, V1, P11, DOI 10.1080/14622299050011121; Dani JA, 2005, NAT NEUROSCI, V8, P1465, DOI 10.1038/nn1580; Dani JA, 2007, NAT NEUROSCI, V10, P403, DOI 10.1038/nn0407-403; Dani JA, 2007, ANNU REV PHARMACOL, V47, P699, DOI 10.1146/annurev.pharmtox.47.120505.105214; Davis JA, 2007, J NEUROSCI, V27, P10870, DOI 10.1523/JNEUROSCI.3242-07.2007; Davis S, 1997, J NEUROSCI METH, V75, P75, DOI 10.1016/S0165-0270(97)00053-8; DEADWYLER SA, 1979, BRAIN RES, V169, P29, DOI 10.1016/0006-8993(79)90371-8; Doyere V, 2003, EUR J NEUROSCI, V17, P2703, DOI 10.1046/j.1460-9568.2003.02707.x; Everitt BJ, 2001, BRAIN RES REV, V36, P129, DOI 10.1016/S0165-0173(01)00088-1; Franceschini D, 2002, MOL BRAIN RES, V98, P29, DOI 10.1016/S0169-328X(01)00309-6; Franklin KBJ, 2008, MOUSE BRAIN STEREOTA, V3rd; Gould TJ, 1999, BEHAV BRAIN RES, V102, P31, DOI 10.1016/S0166-4328(98)00157-0; Grabus SD, 2006, PSYCHOPHARMACOLOGY, V184, P456, DOI 10.1007/s00213-006-0305-7; GRENHOFF J, 1986, ACTA PHYSIOL SCAND, V128, P351, DOI 10.1111/j.1748-1716.1986.tb07988.x; Hara K, 2002, ANESTH ANALG, V94, P313, DOI 10.1097/00000539-200202000-00015; Hargreaves EL, 2005, SCIENCE, V308, P1792, DOI 10.1126/science.1110449; HJORTHSIMONSEN A, 1972, J COMP NEUROL, V144, P215, DOI 10.1002/cne.901440206; HUANG Q, 1992, P NATL ACAD SCI USA, V89, P11988, DOI 10.1073/pnas.89.24.11988; Hyman SE, 2006, ANNU REV NEUROSCI, V29, P565, DOI 10.1146/annurev.neuro.29.051605.113009; Izzo E, 2001, PHARMACOL BIOCHEM BE, V68, P701, DOI 10.1016/S0091-3057(01)00472-5; Jay TM, 2003, PROG NEUROBIOL, V69, P375, DOI 10.1016/S0301-0082(03)00085-6; Ji D, 2001, NEURON, V31, P131, DOI 10.1016/S0896-6273(01)00332-4; Job MO, 2006, SYNAPSE, V60, P158, DOI 10.1002/syn.20283; Jones S, 2005, CURR OPIN PHARMACOL, V5, P20, DOI 10.1016/j.coph.2004.08.011; Kauer JA, 2004, ANNU REV PHYSIOL, V66, P447, DOI 10.1146/annurev.physiol.66.032102.112534; Kelley AE, 2004, NEURON, V44, P161, DOI 10.1016/j.neuron.2004.09.016; Kenny PJ, 2005, J NEUROSCI, V25, P6208, DOI 10.1523/JNEUROSCI.4785-04.2005; Kilts CD, 2001, ARCH GEN PSYCHIAT, V58, P334, DOI 10.1001/archpsyc.58.4.334; Lavenex P, 2000, HIPPOCAMPUS, V10, P420, DOI 10.1002/1098-1063(2000)10:4<420::AID-HIPO8>3.3.CO;2-X; Legault M, 2000, J NEUROSCI, V20, P1635; Lisman JE, 2005, NEURON, V46, P703, DOI 10.1016/j.neuron.2005.05.002; Lynch MA, 2004, PHYSIOL REV, V84, P87, DOI 10.1152/physrev.00014.2003; Mameli-Engvall M, 2006, NEURON, V50, P911, DOI 10.1016/j.neuron.2006.05.007; MARKS MJ, 1986, J PHARMACOL EXP THER, V237, P809; Martinez JL, 1996, ANNU REV PSYCHOL, V47, P173, DOI 10.1146/annurev.psych.47.1.173; Matsuyama S, 2000, EUR J NEUROSCI, V12, P3741, DOI 10.1046/j.1460-9568.2000.00259.x; McHugh TJ, 2007, SCIENCE, V317, P94, DOI 10.1126/science.1140263; Meyers RA, 2006, BEHAV NEUROSCI, V120, P401, DOI 10.1037/0735-7044.120.2.401; Meyers RA, 2003, NEUROREPORT, V14, P2127, DOI 10.1097/00001756-200311140-00023; MINER LL, 1989, PHARMACOL BIOCHEM BE, V33, P469, DOI 10.1016/0091-3057(89)90532-7; Nashmi R, 2007, J NEUROSCI, V27, P8202, DOI 10.1523/JNEUROSCI.2199-07.2007; Nestler EJ, 2004, NEUROPHARMACOLOGY, V47, P24, DOI 10.1016/j.neuropharm.2004.06.031; NISELL M, 1994, PHARMACOL TOXICOL, V75, P348, DOI 10.1111/j.1600-0773.1994.tb00373.x; Packard MG, 2002, ANNU REV NEUROSCI, V25, P563, DOI 10.1146/annurev.neuro.25.112701.142937; Paterson NE, 2005, NEUROPSYCHOPHARMACOL, V30, P119, DOI 10.1038/sj.npp.1300524; PETERSEN DR, 1984, DRUG METAB DISPOS, V12, P725; Pontieri FE, 1996, NATURE, V382, P255, DOI 10.1038/382255a0; Rezayof A, 2003, J PSYCHOPHARMACOL, V17, P415, DOI 10.1177/0269881103174005; Robinson S, 2004, P NATL ACAD SCI USA, V101, P13329, DOI 10.1073/pnas.0405084101; Rumpel S, 2005, SCIENCE, V308, P83, DOI 10.1126/science.1103944; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schultz W, 2001, NEUROSCIENTIST, V7, P293, DOI 10.1177/107385840100700406; Smolka MN, 2006, PSYCHOPHARMACOLOGY, V184, P577, DOI 10.1007/s00213-005-0080-x; STOLERMAN IP, 1991, TRENDS PHARMACOL SCI, V12, P467, DOI 10.1016/0165-6147(91)90638-9; Tang JR, 2001, BRAIN RES, V919, P232, DOI 10.1016/S0006-8993(01)03020-7; Tropea TF, 2008, J NEUROCHEM, V106, P1780, DOI 10.1111/j.1471-4159.2008.05518.x; Ungless MA, 2004, SCIENCE, V303, P2040, DOI 10.1126/science.1093360; USHIJIMA I, 1995, EUR J PHARMACOL, V285, P55, DOI 10.1016/0014-2999(95)00382-U; Walters CL, 2006, PSYCHOPHARMACOLOGY, V184, P339, DOI 10.1007/s00213-005-0295-x; Whitlock JR, 2006, SCIENCE, V313, P1093, DOI 10.1126/science.1128134; Winder Danny G., 2002, Current Molecular Medicine (Hilversum), V2, P667, DOI 10.2174/1566524023361961; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406; Zhang T, 2009, J NEUROSCI, V29, P4035, DOI 10.1523/JNEUROSCI.0261-09.2009	67	79	81	2	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 10	2009	63	5					673	682		10.1016/j.neuron.2009.07.025	http://dx.doi.org/10.1016/j.neuron.2009.07.025			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	494XH	19755109	Green Accepted, Bronze			2022-12-24	WOS:000269852300013
J	Zhang, YV; Cheong, J; Ciapurin, N; McDermitt, DJ; Tumbar, T				Zhang, Ying V.; Cheong, Janice; Ciapurin, Nichita; McDermitt, David J.; Tumbar, Tudorita			Distinct Self-Renewal and Differentiation Phases in the Niche of Infrequently Dividing Hair Follicle Stem Cells	CELL STEM CELL			English	Article							ACTIVATION; SKIN; KERATINOCYTES; REGENERATION; EXPRESSION; EPIDERMIS; DEFECTS; LGR5	In homeostasis of adult vertebrate tissues, stem cells are thought to self-renew by infrequent and asymmetric divisions that generate another stem cell daughter and a progenitor daughter cell committed to differentiate. This model is based largely on in vivo invertebrate or in vitro mammal studies. Here, we examine the dynamic behavior of adult hair follicle stem cells in their normal setting by employing mice with repressible H2B-GFP expression to track cell divisions and Cre-inducible mice to perform long-term single-cell lineage tracing. We provide direct evidence for the infrequent stem cell division model in intact tissue. Moreover, we find that differentiation of progenitor cells occurs at different times and tissue locations than self-renewal of stem cells. Distinct fates of differentiation or self-renewal are assigned to individual cells in a temporal-spatial manner. We propose that large clusters of tissue stem cells behave as populations whose maintenance involves unidirectional daughter-cell-fate decisions.	[Zhang, Ying V.; Cheong, Janice; Ciapurin, Nichita; McDermitt, David J.; Tumbar, Tudorita] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA	Cornell University	Tumbar, T (corresponding author), Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA.	tt252@cornell.edu	; Tumbar, Tudorita/A-1916-2014	Chapurin, Nikita/0000-0002-3744-0451; Tumbar, Tudorita/0000-0002-2273-1889	NIH/NIAMS [AR053201]; NYSTEM; Cornell Vertebrate Genomics Institute; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R56AR053201, R01AR053201] Funding Source: NIH RePORTER	NIH/NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NYSTEM; Cornell Vertebrate Genomics Institute; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank Dr. Jim Smith and Jie Zhao for help with FACS and microarray data generation and Dr. Wei Wang and Dr. Jeff Pleiss for help with microarray data analysis. We thank our colleagues for critical reading of the manuscript. Funding was provided by NIH/NIAMS AR053201 and NYSTEM (2008 Award) grants to T. T and a Cornell Vertebrate Genomics Institute fellowship to Y.V.Z.	Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Clayton E, 2007, NATURE, V446, P185, DOI 10.1038/nature05574; Cotsarelis G, 2006, J INVEST DERMATOL, V126, P1459, DOI 10.1038/sj.jid.5700376; Fuchs E, 2009, CELL, V137, P811, DOI 10.1016/j.cell.2009.05.002; Greco V, 2009, CELL STEM CELL, V4, P155, DOI 10.1016/j.stem.2008.12.009; Horsley V, 2006, CELL, V126, P597, DOI 10.1016/j.cell.2006.06.048; Jaks V, 2008, NAT GENET, V40, P1291, DOI 10.1038/ng.239; Jones CL, 1997, ARCH BIOCHEM BIOPHYS, V347, P163, DOI 10.1006/abbi.1997.0350; Lansdorp PM, 2007, CELL, V129, P1244, DOI 10.1016/j.cell.2007.06.017; Legue E, 2005, DEVELOPMENT, V132, P4143, DOI 10.1242/dev.01975; Luong MX, 2002, MOL CELL BIOL, V22, P1424, DOI 10.1128/MCB.22.5.1424-1437.2002; Morrison SJ, 2006, NATURE, V441, P1068, DOI 10.1038/nature04956; Oshima H, 2001, CELL, V104, P233, DOI 10.1016/S0092-8674(01)00208-2; Osorio KM, 2008, DEVELOPMENT, V135, P1059, DOI 10.1242/dev.012799; Plikus MV, 2008, NATURE, V451, P340, DOI 10.1038/nature06457; Rendl M, 2005, PLOS BIOL, V3, P1910, DOI 10.1371/journal.pbio.0030331; RIEGER E, 1994, J INVEST DERMATOL, V103, P341, DOI 10.1111/1523-1747.ep12394888; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Sur I, 2006, J CELL SCI, V119, P3593, DOI 10.1242/jcs.03070; Tanahashi H, 2000, ANAL BIOCHEM, V279, P122, DOI 10.1006/abio.1999.4444; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Vasioukhin V, 1999, P NATL ACAD SCI USA, V96, P8551, DOI 10.1073/pnas.96.15.8551; Waghmare SK, 2008, EMBO J, V27, P1309, DOI 10.1038/emboj.2008.72	24	156	160	1	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	SEP 4	2009	5	3					267	278		10.1016/j.stem.2009.06.004	http://dx.doi.org/10.1016/j.stem.2009.06.004			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	529VA	19664980	Green Accepted, Bronze			2022-12-24	WOS:000272545700013
J	Kazama, H; Wilson, RI				Kazama, Hokto; Wilson, Rachel I.			Origins of correlated activity in an olfactory circuit	NATURE NEUROSCIENCE			English	Article							DROSOPHILA ANTENNAL LOBE; RETINAL GANGLION-CELLS; BULB MITRAL CELLS; LATERAL GENICULATE-NUCLEUS; ODOR REPRESENTATIONS; NEUROBLAST LINEAGE; MUSHROOM BODY; SPIKE TRAINS; NEURONS; OSCILLATIONS	Multineuronal recordings often reveal synchronized spikes in different neurons. The manner in which correlated spike timing affects neural codes depends on the statistics of correlations, which in turn reflects the connectivity that gives rise to correlations. However, determining the connectivity of neurons recorded in vivo can be difficult. We investigated the origins of correlated activity in genetically labeled neurons of the Drosophila antennal lobe. Dual recordings showed synchronized spontaneous spikes in projection neurons (PNs) postsynaptic to the same type of olfactory receptor neuron (ORN). Odors increased these correlations. The primary origin of correlations lies in the divergence of each ORN onto every PN in its glomerulus. Reciprocal PN-PN connections make a smaller contribution to correlations and PN spike trains in different glomeruli were only weakly correlated. PN axons from the same glomerulus reconverge in the lateral horn, where pooling redundant signals may allow lateral horn neurons to average out noise that arises independently in these PNs.	[Kazama, Hokto; Wilson, Rachel I.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Wilson, RI (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA.	rachel_wilson@hms.harvard.edu	Kazama, Hokto/N-7505-2015	Kazama, Hokto/0000-0002-3239-1873; Wilson, Rachel/0000-0001-8573-9266	US National Institutes of Health [F32DC009538, R01DC008174]; Pew Scholar Award; McKnight Scholar Award; Sloan Foundation Research Fellowship; Beckman Young Investigator Award; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC008174, F32DC009538] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pew Scholar Award; McKnight Scholar Award; Sloan Foundation Research Fellowship(Alfred P. Sloan Foundation); Beckman Young Investigator Award; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank K. Ito, L. Luo and B. J. Dickson for gifts of fly stocks, and B. P. Bean for the loan of equipment. We are grateful to V. Jayaraman, A. W. Liu, O. Mazor, M. Meister, M. Stopfer and members of the Wilson laboratory for comments on the manuscript. This work was funded by a postdoctoral fellowship (F32DC009538 to H. K.) and a research project grant (R01DC008174) from the US National Institutes of Health, a Pew Scholar Award, a McKnight Scholar Award, a Sloan Foundation Research Fellowship, and a Beckman Young Investigator Award ( to R. I. W.).	Adrian ED, 1942, J PHYSIOL-LONDON, V100, P459, DOI 10.1113/jphysiol.1942.sp003955; Alonso JM, 1996, NATURE, V383, P815, DOI 10.1038/383815a0; Averbeck BB, 2006, NAT REV NEUROSCI, V7, P358, DOI 10.1038/nrn1888; Bhandawat V, 2007, NAT NEUROSCI, V10, P1474, DOI 10.1038/nn1976; Brivanlou IH, 1998, NEURON, V20, P527, DOI 10.1016/S0896-6273(00)80992-7; Chen TW, 2009, P NATL ACAD SCI USA, V106, P2401, DOI 10.1073/pnas.0810151106; Christie JM, 2005, NEURON, V46, P761, DOI 10.1016/j.neuron.2005.04.030; Dan Y, 1998, NAT NEUROSCI, V1, P501, DOI 10.1038/2217; Das A, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-33; de Bruyne M, 2001, NEURON, V30, P537, DOI 10.1016/S0896-6273(01)00289-6; de la Rocha J, 2007, NATURE, V448, P802, DOI 10.1038/nature06028; Fantana AL, 2008, NEURON, V59, P802, DOI 10.1016/j.neuron.2008.07.039; Friedrich RW, 2004, NAT NEUROSCI, V7, P862, DOI 10.1038/nn1292; Galan RF, 2006, NEURAL COMPUT, V18, P10, DOI 10.1162/089976606774841558; Galan RF, 2006, J NEUROSCI, V26, P3646, DOI 10.1523/JNEUROSCI.4605-05.2006; GELPERIN A, 1990, NATURE, V345, P437, DOI 10.1038/345437a0; Gouwens NW, 2009, J NEUROSCI, V29, P6239, DOI 10.1523/JNEUROSCI.0764-09.2009; Kazama H, 2008, NEURON, V58, P401, DOI 10.1016/j.neuron.2008.02.030; Lagier S, 2004, J NEUROSCI, V24, P4382, DOI 10.1523/JNEUROSCI.5570-03.2004; Lai SL, 2008, DEVELOPMENT, V135, P2883, DOI 10.1242/dev.024380; LAURENT G, 1994, J NEUROSCI, V14, P2993; Lei H, 2002, NAT NEUROSCI, V5, P557, DOI 10.1038/nn859; Lin HH, 2007, CELL, V128, P1205, DOI 10.1016/j.cell.2007.03.006; MALUN D, 1991, HISTOCHEMISTRY, V96, P197, DOI 10.1007/BF00271538; Marin EC, 2002, CELL, V109, P243, DOI 10.1016/S0092-8674(02)00700-6; MEISTER M, 1995, SCIENCE, V270, P1207, DOI 10.1126/science.270.5239.1207; Olsen SR, 2007, NEURON, V54, P89, DOI 10.1016/j.neuron.2007.03.010; Pelz C, 1997, J EXP BIOL, V200, P837; Perez-Orive J, 2002, SCIENCE, V297, P359, DOI 10.1126/science.1070502; PERKEL DH, 1967, BIOPHYS J, V7, P419, DOI 10.1016/S0006-3495(67)86597-4; Puchalla JL, 2005, NEURON, V46, P493, DOI 10.1016/j.neuron.2005.03.026; Romo R, 2003, NEURON, V38, P649, DOI 10.1016/S0896-6273(03)00287-3; Salinas E, 2001, NAT REV NEUROSCI, V2, P539, DOI 10.1038/35086012; Schoppa NE, 2006, NEURON, V49, P271, DOI 10.1016/j.neuron.2005.11.038; Schoppa NE, 2002, NAT NEUROSCI, V5, P1194, DOI 10.1038/nn953; Shlens J, 2008, CURR OPIN NEUROBIOL, V18, P396, DOI 10.1016/j.conb.2008.09.010; Silbering AF, 2008, J NEUROSCI, V28, P13075, DOI 10.1523/JNEUROSCI.2973-08.2008; Stocker RF, 1997, J NEUROBIOL, V32, P443, DOI 10.1002/(SICI)1097-4695(199705)32:5<443::AID-NEU1>3.0.CO;2-5; STOCKER RF, 1990, CELL TISSUE RES, V262, P9, DOI 10.1007/BF00327741; Stopfer M, 1997, NATURE, V390, P70, DOI 10.1038/36335; Tanaka NK, 2009, J NEUROSCI, V29, P8595, DOI 10.1523/JNEUROSCI.1455-09.2009; Trong PK, 2008, NAT NEUROSCI, V11, P1343, DOI 10.1038/nn.2199; Turner GC, 2008, J NEUROPHYSIOL, V99, P734, DOI 10.1152/jn.01283.2007; Urban NN, 2002, J PHYSIOL-LONDON, V542, P355, DOI 10.1113/jphysiol.2001.013491; Usrey WM, 1999, ANNU REV PHYSIOL, V61, P435, DOI 10.1146/annurev.physiol.61.1.435; Vosshall LB, 1999, CELL, V96, P725, DOI 10.1016/S0092-8674(00)80582-6; Wilson RI, 2005, J NEUROSCI, V25, P9069, DOI 10.1523/JNEUROSCI.2070-05.2005; Wilson RI, 2004, SCIENCE, V303, P366, DOI 10.1126/science.1090782; Wong AM, 2002, CELL, V109, P229, DOI 10.1016/S0092-8674(02)00707-9; ZOHARY E, 1994, NATURE, V370, P140, DOI 10.1038/370140a0	50	95	95	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2009	12	9					1136	U15		10.1038/nn.2376	http://dx.doi.org/10.1038/nn.2376			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	487ZD	19684589	Green Accepted			2022-12-24	WOS:000269317300015
J	Kim, JC; Cook, MN; Carey, MR; Shen, C; Regehr, WG; Dymecki, SM				Kim, Jun Chul; Cook, Melloni N.; Carey, Megan R.; Shen, Chung; Regehr, Wade G.; Dymecki, Susan M.			Linking Genetically Defined Neurons to Behavior through a Broadly Applicable Silencing Allele	NEURON			English	Article							DORSAL RAPHE NUCLEUS; PREPULSE INHIBITION; CRE RECOMBINASE; BRAIN-STEM; EXPRESSION; MICE; RECEPTOR; LOCALIZATION; DISRUPTION; TRANSMISSION	Tools for suppressing synaptic transmission gain power when able to target highly selective neuron sub-types, thereby sharpening attainable links between neuron type, behavior, and disease; and when able to silence most any neuron subtype, thereby offering broad applicability. Here, we present such a tool, RC::PFtox, that harnesses breadth in scope along with high cell-type selection via combinatorial gene expression to deliver tetanus toxin light chain (tox), an inhibitor of vesicular neurotransmission. When applied in mice, we observed cell-type-specific disruption of vesicle exocytosis accompanied by loss of excitatory postsynaptic currents and commensurately perturbed behaviors. Among various test populations, we applied RC::PFtox to silence serotonergic neurons, en masse or a subset defined combinatorially. Of the behavioral phenotypes observed upon en masse serotonergic silencing, only one mapped to the combinatorially defined subset. These findings provide evidence for separability by genetic lineage of serotonin-modulated behaviors; collectively, these findings demonstrate broad utility of RC::PFtox for dissecting neuron functions.	[Kim, Jun Chul; Dymecki, Susan M.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Cook, Melloni N.; Shen, Chung] Univ Memphis, Dept Psychol, Memphis, TN 38152 USA; [Carey, Megan R.; Regehr, Wade G.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; University of Memphis; Harvard University; Harvard Medical School	Dymecki, SM (corresponding author), Harvard Univ, Sch Med, Dept Genet, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	dymecki@genetics.med.harvard.edu		Carey, Megan/0000-0002-4499-1657	Dymecki lab and SIDS Program Project [P01 HD036379]; Foundation for Fighting Blindness - Canada; Helen Hay Whitney Foundation; US National Institutes of Health, NIH [P01 HD036379, R01 DK067826, R21 MH083613-01, R37 NS032405, R01 DA020677]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD036379] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067826] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH083613] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS032405] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA023643, R01DA020677] Funding Source: NIH RePORTER	Dymecki lab and SIDS Program Project; Foundation for Fighting Blindness - Canada; Helen Hay Whitney Foundation; US National Institutes of Health, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank members of the Dymecki lab and SIDS Program Project Grant (P01 HD036379) for input, Drs Sweeney and Yamamoto for plasmids encoding tetanus toxin light chain, Dr. D. Rowitch for providing the Math1-cre transgenic, Dr. Alexandra Joyner for providing the En1<SUP>Cki</SUP>. This work was supported by grants from the Foundation for Fighting Blindness - Canada (to J.C.K.), the Helen Hay Whitney Foundation (to M.R.C.), and from the US National Institutes of Health (R01 DK067826, R21 MH083613-01, and NIH P01 HD036379 to S.M.D.; R37 NS032405 to W.G.R.; and R01 DA020677 with subcontract to M.N.C.).	Agnati LF, 2006, ACTA PHYSIOL, V187, P329, DOI 10.1111/j.1748-1716.2006.01579.x; Ansorge MS, 2004, SCIENCE, V306, P879, DOI 10.1126/science.1101678; Avanzi V, 1998, BRAIN RES, V790, P178, DOI 10.1016/S0006-8993(97)01538-2; Awatramani R, 2003, NAT GENET, V35, P70, DOI 10.1038/ng1228; Barski JJ, 2000, GENESIS, V28, P93, DOI 10.1002/1526-968X(200011/12)28:3/4<93::AID-GENE10>3.3.CO;2-N; Bengel D, 1998, MOL PHARMACOL, V53, P649, DOI 10.1124/mol.53.4.649; Braff DL, 2001, PSYCHOPHARMACOLOGY, V156, P234, DOI 10.1007/s002130100810; Cook MN, 2007, MAMM GENOME, V18, P559, DOI 10.1007/s00335-007-9035-3; Dahlstroem A., 1964, ACTA PHYSL SCAND S, V232, P231; Dittman JS, 2000, J NEUROSCI, V20, P1374; Dulawa S C, 1996, Chin J Physiol, V39, P139; Dulawa SC, 2000, NEUROPSYCHOPHARMACOL, V22, P650, DOI 10.1016/S0893-133X(99)00164-5; Dulawa SC, 1997, PSYCHOPHARMACOLOGY, V132, P125, DOI 10.1007/s002130050328; Dymecki SM, 2007, NEURON, V54, P17, DOI 10.1016/j.neuron.2007.03.009; Farago AF, 2006, NEURON, V50, P205, DOI 10.1016/j.neuron.2006.03.014; Foster KA, 2002, NEURON, V36, P1115, DOI 10.1016/S0896-6273(02)01106-6; Garakani A, 2006, MT SINAI J MED, V73, P941; Gong SC, 2007, J NEUROSCI, V27, P9817, DOI 10.1523/JNEUROSCI.2707-07.2007; Hendricks T, 1999, J NEUROSCI, V19, P10348; Holmes A, 2003, GENES BRAIN BEHAV, V2, P365, DOI 10.1046/j.1601-1848.2003.00050.x; Jensen P, 2008, NAT NEUROSCI, V11, P417, DOI 10.1038/nn2050; Kadotani H, 1996, J NEUROSCI, V16, P7859; Kimmel RA, 2000, GENE DEV, V14, P1377; KONNERTH A, 1990, P NATL ACAD SCI USA, V87, P2662, DOI 10.1073/pnas.87.7.2662; Kusljic S, 2003, NEUROPSYCHOPHARMACOL, V28, P2138, DOI 10.1038/sj.npp.1300277; Lerch-Haner JK, 2008, NAT NEUROSCI, V11, P1001, DOI 10.1038/nn.2176; Luo L, 2008, NEURON, V57, P634, DOI 10.1016/j.neuron.2008.01.002; MAIER SF, 1995, BEHAV NEUROSCI, V109, P404, DOI 10.1037/0735-7044.109.3.404; MAIER SF, 1993, BEHAV NEUROSCI, V107, P377, DOI 10.1037/0735-7044.107.2.377; MALEY B, 1982, J NEUROSCI, V2, P1499; Malleret G, 1999, J NEUROSCI, V19, P6157, DOI 10.1523/JNEUROSCI.19-14-06157.1999; MAROTEAUX L, 1992, P NATL ACAD SCI USA, V89, P3020, DOI 10.1073/pnas.89.7.3020; Matei V, 2005, DEV DYNAM, V234, P633, DOI 10.1002/dvdy.20551; Melik E, 2000, BEHAV BRAIN RES, V112, P145, DOI 10.1016/S0166-4328(00)00175-3; Moret C, 2000, EUR J PHARMACOL, V404, P1, DOI 10.1016/S0014-2999(00)00581-1; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Nakashiba T, 2008, SCIENCE, V319, P1260, DOI 10.1126/science.1151120; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; SAUDOU F, 1994, SCIENCE, V265, P1875, DOI 10.1126/science.8091214; SAUER B, 1993, METHOD ENZYMOL, V225, P890; Schiavo G, 2000, PHYSIOL REV, V80, P717, DOI 10.1152/physrev.2000.80.2.717; SIPES TA, 1995, PSYCHOPHARMACOLOGY, V117, P41, DOI 10.1007/BF02245096; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Wang VY, 2005, NEURON, V48, P31, DOI 10.1016/j.neuron.2005.08.024; Yamamoto M, 2003, J NEUROSCI, V23, P6759; Yu CR, 2004, NEURON, V42, P553, DOI 10.1016/S0896-6273(04)00224-7; Zambrowicz BP, 1997, P NATL ACAD SCI USA, V94, P3789, DOI 10.1073/pnas.94.8.3789; Zervas M, 2004, NEURON, V43, P345, DOI 10.1016/j.neuron.2004.07.010; Zhuang XX, 1999, NEUROPSYCHOPHARMACOL, V21, pS52, DOI 10.1016/S0893-133X(99)00047-0; Zong H, 2005, CELL, V121, P479, DOI 10.1016/j.cell.2005.02.012	51	87	87	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 13	2009	63	3					305	315		10.1016/j.neuron.2009.07.010	http://dx.doi.org/10.1016/j.neuron.2009.07.010			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	487OY	19679071	Green Accepted, Bronze			2022-12-24	WOS:000269285500006
J	Sperling, RA; LaViolette, PS; O'Keefe, K; O'Brien, J; Rentz, DM; Pihlajamaki, M; Marshall, G; Hyman, BT; Selkoe, DJ; Hedden, T; Buckner, RL; Becker, JA; Johnson, KA				Sperling, Reisa A.; LaViolette, Peter S.; O'Keefe, Kelly; O'Brien, Jacqueline; Rentz, Dorene M.; Pihlajamaki, Maija; Marshall, Gad; Hyman, Bradley T.; Selkoe, Dennis J.; Hedden, Trey; Buckner, Randy L.; Becker, J. Alex; Johnson, Keith A.			Amyloid Deposition Is Associated with Impaired Default Network Function in Older Persons without Dementia	NEURON			English	Article							MILD COGNITIVE IMPAIRMENT; POSITRON-EMISSION-TOMOGRAPHY; RESTING-STATE NETWORKS; ALZHEIMERS-DISEASE; HIPPOCAMPAL ACTIVATION; MODE NETWORK; PARIETAL DEACTIVATION; CINGULATE CORTEX; GENETIC RISK; MOUSE MODEL	Alzheimer's disease (AD) has been associated with functional alterations in a distributed network of brain regions linked to memory function, with a recent focus on the cortical regions collectively known as the default network. Posterior components of the default network, including the precuneus and posterior cingulate, are particularly vulnerable to early deposition of amyloid beta-protein, one of the hallmark pathologies of AD. In this study, we use in vivo amyloid imaging to demonstrate that high levels of amyloid deposition are associated with aberrant default network functional magnetic resonance imaging (fMRI) activity in asymptomatic and minimally impaired older individuals, similar to the pattern of dysfunction reported in AD patients. These findings suggest that amyloid pathology is linked to neural dysfunction in brain regions supporting memory function and provide support for the hypothesis that cognitively intact older individuals with evidence of amyloid pathology may be in early stages of AD.	[Sperling, Reisa A.; O'Keefe, Kelly; O'Brien, Jacqueline; Rentz, Dorene M.; Pihlajamaki, Maija; Marshall, Gad; Selkoe, Dennis J.; Johnson, Keith A.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Neurol,Ctr Alzheimer Res & Treatment, Boston, MA 02115 USA; [Sperling, Reisa A.; Rentz, Dorene M.; Marshall, Gad; Hyman, Bradley T.; Johnson, Keith A.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02115 USA; [LaViolette, Peter S.; Buckner, Randy L.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02115 USA; [Hedden, Trey; Buckner, Randy L.] Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA; [Hedden, Trey; Buckner, Randy L.] Harvard Univ, Ctr Brain Sci, Cambridge, MA 02138 USA; [Sperling, Reisa A.; LaViolette, Peter S.; Hedden, Trey; Buckner, Randy L.] Athinoula A Martinos Ctr Biomed Imaging, Boston, MA 02114 USA; [Buckner, Randy L.] Howard Hughes Med Inst, Chevy Chase, MD USA; [Buckner, Randy L.; Becker, J. Alex; Johnson, Keith A.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard University; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Massachusetts General Hospital	Sperling, RA (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Neurol,Ctr Alzheimer Res & Treatment, Boston, MA 02115 USA.	reisa@rics.bwh.harvard.edu	Kennedy, Kristen M/B-4699-2008; Becker, John Alex/AAI-4060-2021; Hedden, Trey/AAA-7653-2021	Kennedy, Kristen M/0000-0001-5373-9026; Becker, John Alex/0000-0001-7435-1338; 	National Institute on Aging [R01AG027435]; Massachusetts Alzheimer's Disease Research Center [P50AG005134]; Anonymous Medical Foundation; Howard Hughes Medical Institute; Alzheimer's Association; NATIONAL INSTITUTE ON AGING [R01AG027435, P50AG005134, R01AG021910, R01AG034556] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Massachusetts Alzheimer's Disease Research Center; Anonymous Medical Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Alzheimer's Association(Alzheimer's Association); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Mary Foley, Larry White, and the Athinoula A. Martinos Center MRI Core for assistance with MRI imaging. The Massachusetts General Hospital Molecular Imaging PET Core provided assistance with PiB PET amyloid imaging. Bill Klunk and Chef Mathis from the University of Pittsburgh generously provided expertise in PiB imaging and analyses. We thank the Massaschuseffs Alzheimer's Disease Research Center (ADRC) and Sarah Rastegar for assistance with subject recruitment. We thank Meghan Frey, Elisha Eng, and Lauren Olson for assistance with neuropsychological testing. We thank Bill Klunk, Brad Dickerson, Akram Bakkour, Deborah Blacker, Ali Atri, and Patrizia Vannini for assistance with analyses and insightful comments. This work was supported by the National Institute on Aging R01AG027435 (R.A.S. and K.A.J.), the Massachusetts Alzheimer's Disease Research Center P50AG005134 (R.A.S., K.A.J., B.T.H., D.J.S.), an Anonymous Medical Foundation (R.A.S.), the Howard Hughes Medical Institute (R.L.B.), and the Alzheimer's Association (R.A.S.). Dr. Keith Johnson has consulted for GE Healthcare, who holds the commercial licensing and distribution rights for PiB PET imaging.	Aizenstein HJ, 2008, ARCH NEUROL-CHICAGO, V65, P1509, DOI 10.1001/archneur.65.11.1509; Andrews-Hanna JR, 2007, NEURON, V56, P924, DOI 10.1016/j.neuron.2007.10.038; ARRIAGADA PV, 1992, NEUROLOGY, V42, P1681, DOI 10.1212/WNL.42.9.1681; Bai F, 2008, NEUROSCI LETT, V438, P111, DOI 10.1016/j.neulet.2008.04.021; Baig S, 2005, ACTA NEUROPATHOL, V110, P393, DOI 10.1007/s00401-005-1060-2; Bennett DA, 2006, NEUROLOGY, V66, P1837, DOI 10.1212/01.wnl.0000219668.47116.e6; Bondi MW, 2005, NEUROLOGY, V64, P501, DOI 10.1212/01.WNL.0000150885.00929.7E; Bookheimer SY, 2000, NEW ENGL J MED, V343, P450, DOI 10.1056/NEJM200008173430701; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Buckner RL, 2005, J NEUROSCI, V25, P7709, DOI 10.1523/JNEUROSCI.2177-05.2005; Busche MA, 2008, SCIENCE, V321, P1686, DOI 10.1126/science.1162844; Celone KA, 2006, J NEUROSCI, V26, P10222, DOI 10.1523/JNEUROSCI.2250-06.2006; Chua EF, 2006, NEUROIMAGE, V29, P1150, DOI 10.1016/j.neuroimage.2005.09.058; Cirrito JR, 2005, NEURON, V48, P913, DOI 10.1016/j.neuron.2005.10.028; Daselaar SM, 2003, BRAIN, V126, P43, DOI 10.1093/brain/awg005; Daselaar SM, 2004, NEUROIMAGE, V23, P921, DOI 10.1016/j.neuroimage.2004.07.031; Dickerson BC, 2004, ANN NEUROL, V56, P27, DOI 10.1002/ana.20163; Dickerson BC, 2005, NEUROLOGY, V65, P404, DOI 10.1212/01.wnl.0000171450.97464.49; Dickerson BC, 2009, CEREB CORTEX, V19, P497, DOI 10.1093/cercor/bhn113; Duverne S, 2009, CEREB CORTEX, V19, P733, DOI 10.1093/cercor/bhn122; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fotenos AF, 2008, ARCH NEUROL-CHICAGO, V65, P113, DOI 10.1001/archneurol.2007.27; Fransson P, 2008, NEUROIMAGE, V42, P1178, DOI 10.1016/j.neuroimage.2008.05.059; Freire L, 2001, NEUROIMAGE, V14, P709, DOI 10.1006/nimg.2001.0869; Gomperts SN, 2008, NEUROLOGY, V71, P903, DOI 10.1212/01.wnl.0000326146.60732.d6; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Greicius MD, 2009, CEREB CORTEX, V19, P72, DOI 10.1093/cercor/bhn059; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; HYMAN BT, 1984, SCIENCE, V225, P1168, DOI 10.1126/science.6474172; HYMAN BT, 1992, ANN NEUROL, V32, P818, DOI 10.1002/ana.410320618; Jagust W, 2006, ANN NEUROL, V59, P673, DOI 10.1002/ana.20799; Johnson KA, 1998, NEUROLOGY, V50, P1563, DOI 10.1212/WNL.50.6.1563; Johnson KA, 2000, NEUROBIOL AGING, V21, P289, DOI 10.1016/S0197-4580(00)00137-8; Johnson KA, 2007, ANN NEUROL, V62, P229, DOI 10.1002/ana.21164; Johnson NA, 2005, RADIOLOGY, V234, P851, DOI 10.1148/radiol.2343040197; Kircher TT, 2007, J NEUROL NEUROSUR PS, V78, P812, DOI 10.1136/jnnp.2006.104877; Klunk WE, 2004, ANN NEUROL, V55, P306, DOI 10.1002/ana.20009; Lustig C, 2003, P NATL ACAD SCI USA, V100, P14504, DOI 10.1073/pnas.2235925100; Mathis CA, 2002, BIOORG MED CHEM LETT, V12, P295, DOI 10.1016/S0960-894X(01)00734-X; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Meyer-Luehmann M, 2008, NATURE, V451, P720, DOI 10.1038/nature06616; Miller SL, 2008, J NEUROL NEUROSUR PS, V79, P630, DOI 10.1136/jnnp.2007.124149; Miller SL, 2008, P NATL ACAD SCI USA, V105, P2181, DOI 10.1073/pnas.0706818105; MILLER SL, 2007, J NEUROL NEUROSUR PS, V79, P365; Minoshima S, 1997, ANN NEUROL, V42, P85, DOI 10.1002/ana.410420114; Mintun MA, 2006, NEUROLOGY, V67, P446, DOI 10.1212/01.wnl.0000228230.26044.a4; Mormino EC, 2009, BRAIN, V132, P1310, DOI 10.1093/brain/awn320; Morris JC, 1996, NEUROLOGY, V46, P707, DOI 10.1212/WNL.46.3.707; Morris JC, 2006, ALZ DIS ASSOC DIS, V20, P210, DOI 10.1097/01.wad.0000213865.09806.92; Otten LJ, 2001, CEREB CORTEX, V11, P1150, DOI 10.1093/cercor/11.12.1150; Palop JJ, 2007, NEURON, V55, P697, DOI 10.1016/j.neuron.2007.07.025; Persson J, 2008, NEUROPSYCHOLOGIA, V46, P1679, DOI 10.1016/j.neuropsychologia.2008.01.026; Petersen RC, 2001, ARCH NEUROL-CHICAGO, V58, P1985, DOI 10.1001/archneur.58.12.1985; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; Petrella JR, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001104; Pihlajamaki M, 2008, AM J GERIAT PSYCHIAT, V16, P283, DOI 10.1097/JGP.0b013e318162a0a9; Pihlajamaki M, 2010, ALZ DIS ASSOC DIS, V24, P28, DOI 10.1097/WAD.0b013e3181a785c9; Pike KE, 2007, BRAIN, V130, P2837, DOI 10.1093/brain/awm238; Price JC, 2005, J CEREBR BLOOD F MET, V25, P1528, DOI 10.1038/sj.jcbfm.9600146; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Reiman EM, 2001, P NATL ACAD SCI USA, V98, P3334, DOI 10.1073/pnas.061509598; Rombouts SARB, 2005, HUM BRAIN MAPP, V26, P231, DOI 10.1002/hbm.20160; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shulman GL, 1997, J COGNITIVE NEUROSCI, V9, P648, DOI 10.1162/jocn.1997.9.5.648; Sojkova J, 2008, J NUCL MED, V49, P1465, DOI 10.2967/jnumed.108.051946; Sorg C, 2007, P NATL ACAD SCI USA, V104, P18760, DOI 10.1073/pnas.0708803104; Sperling R, 2003, NEUROIMAGE, V20, P1400, DOI 10.1016/S1053-8119(03)00391-4; Svoboda E, 2006, NEUROPSYCHOLOGIA, V44, P2189, DOI 10.1016/j.neuropsychologia.2006.05.023; Vincent JL, 2006, J NEUROPHYSIOL, V96, P3517, DOI 10.1152/jn.00048.2006; Vul E, 2009, PERSPECT PSYCHOL SCI, V4, P274, DOI 10.1111/j.1745-6924.2009.01125.x; Wagner AD, 2005, TRENDS COGN SCI, V9, P445, DOI 10.1016/j.tics.2005.07.001; Walsh DM, 2004, NEURON, V44, P181, DOI 10.1016/j.neuron.2004.09.010	73	712	728	1	74	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 30	2009	63	2					178	188		10.1016/j.neuron.2009.07.003	http://dx.doi.org/10.1016/j.neuron.2009.07.003			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	479IS	19640477	Green Accepted, Bronze			2022-12-24	WOS:000268653500007
J	Verstreken, P; Ohyama, T; Haueter, C; Habets, RLP; Lin, YQ; Swan, LE; Ly, CV; Venken, KJT; De Camilli, P; Bellen, HJ				Verstreken, Patrik; Ohyama, Tonnoko; Haueter, Claire; Habets, Ron L. P.; Lin, Yong Q.; Swan, Laura E.; Ly, Cindy V.; Venken, Koen J. T.; De Camilli, Pietro; Bellen, Hugo J.			Tweek, an Evolutionarily Conserved Protein, Is Required for Synaptic Vesicle Recycling	NEURON			English	Article							VESICULAR GLUTAMATE TRANSPORTER; CLATHRIN-MEDIATED ENDOCYTOSIS; PHOSPHOINOSITIDE METABOLISM; MOLECULAR-CLONING; LATE STEP; ENDOPHILIN; DOMAIN; SYNAPTOJANIN; MUTATIONS; SUBUNIT	Synaptic vesicle endocytosis is critical for maintaining synaptic communication during intense stimulation. Here we describe Tweek, a conserved protein that is required for synaptic vesicle recycling. tweek mutants show reduced FM1-43 uptake, cannot maintain release during intense stimulation, and harbor larger than normal synaptic vesicles, implicating it in vesicle recycling at the synapse. Interestingly, the levels of a fluorescent PI(4,5)P-2 reporter are reduced at tweek mutant synapses, and the probe is aberrantly localized during stimulation. In addition, various endocytic adaptors known to bind PI(4,5)P2 are mislocalized and the defects in FM1-43 dye uptake and adaptor localization are partially suppressed by removing one copy of the phosphoinositide phosphatase synaptojanin, suggesting a role for Tweek in maintaining proper phosphoinositide levels at synapses. Our data implicate Tweek in regulating synaptic vesicle recycling via an action mediated at least in part by the regulation of PI(4,5)P-2 levels or availability at the synapse.	[Verstreken, Patrik; Ohyama, Tonnoko; Haueter, Claire; Lin, Yong Q.; Venken, Koen J. T.; Bellen, Hugo J.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Verstreken, Patrik; Ohyama, Tonnoko; Haueter, Claire; Lin, Yong Q.; Venken, Koen J. T.; Bellen, Hugo J.] Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA; [Ly, Cindy V.; Bellen, Hugo J.] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [Venken, Koen J. T.; Bellen, Hugo J.] Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA; [Verstreken, Patrik; Habets, Ron L. P.] Catholic Univ Louvain VIB, Dept Mol & Dev Genet, Program Mol & Dev Genet, Program Cognit & Mol Neurosci,Lab Neuronal Commun, B-3000 Louvain, Belgium; [Verstreken, Patrik; Habets, Ron L. P.] Katholieke Univ Leuven, Ctr Human Genet, Program Mol & Dev Genet, Program Cognit & Mol Neurosci,Lab Neuronal Commun, B-3000 Louvain, Belgium; [Swan, Laura E.; De Camilli, Pietro] Yale Univ, Sch Med, Kavli Inst Neurosci, Howard Hughes Med Inst,Dept Cell Biol, New Haven, CT 06510 USA	Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute; Baylor College of Medicine; Baylor College of Medicine; Flanders Institute for Biotechnology (VIB); KU Leuven; Howard Hughes Medical Institute; Yale University	Bellen, HJ (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, 1 Baylor Plaza, Houston, TX 77030 USA.	hbellen@bcm.tmc.edu	Venken, Koen/B-9909-2013; Verstreken, Patrik/AAC-7591-2022	Venken, Koen/0000-0003-0741-4698; Verstreken, Patrik/0000-0002-5073-5393; Bellen, Hugo/0000-0001-5992-5989; Ohyama, Tomoko/0000-0003-1697-1138; Swan, Laura/0000-0002-6312-6263	Baylor College of Medicine Intellectual and Developmental Disabilities Research Center; K.U.Leuven Light Microscopy Network (LiMoNe); R.L. Kirchstein NRS award; Marie Curie Excellence Grant [MEXT-CT-2006-042267]; Research Fund K.U.Leuven, FWO [G.0747.09]; NRS; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P30DA018343] Funding Source: NIH RePORTER	Baylor College of Medicine Intellectual and Developmental Disabilities Research Center; K.U.Leuven Light Microscopy Network (LiMoNe); R.L. Kirchstein NRS award; Marie Curie Excellence Grant(European Commission); Research Fund K.U.Leuven, FWO(KU LeuvenFWO); NRS; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Confocal microscopy was supported by the Baylor College of Medicine Intellectual and Developmental Disabilities Research Center and the K.U.Leuven Light Microscopy Network (LiMoNe). P.V. was supported by an R.L. Kirchstein NRS award, a Marie Curie Excellence Grant (MEXT-CT-2006-042267), the Research Fund K.U.Leuven, FWO grant G.0747.09, and VIB; C.V.L. was supported by an NRS award: and P.D.C. and H.J.B. are HHMI investigators.	Achiriloaie M, 1999, MOL CELL BIOL, V19, P1410; Babcock MC, 2003, GENETICS, V165, P171; Bai JH, 2004, NAT STRUCT MOL BIOL, V11, P36, DOI 10.1038/nsmb709; Bellen HJ, 2004, GENETICS, V167, P761, DOI 10.1534/genetics.104.026427; BETZ WJ, 1992, SCIENCE, V255, P200, DOI 10.1126/science.1553547; Cao YW, 2006, BIOMED ENVIRON SCI, V19, P392; Chen H, 1998, NATURE, V394, P793, DOI 10.1038/29555; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; Cremona O, 1999, CELL, V99, P179, DOI 10.1016/S0092-8674(00)81649-9; Daniels RW, 2006, NEURON, V49, P11, DOI 10.1016/j.neuron.2005.11.032; Daniels RW, 2004, J NEUROSCI, V24, P10466, DOI 10.1523/JNEUROSCI.3001-04.2004; Davis GW, 2006, ANNU REV NEUROSCI, V29, P307, DOI 10.1146/annurev.neuro.28.061604.135751; DAVIS MEN, 1990, J NEUROCHEM, V54, P662, DOI 10.1111/j.1471-4159.1990.tb01922.x; Di Paolo G, 2004, NATURE, V431, P415, DOI 10.1038/nature02896; Di Paolo G, 2002, NATURE, V420, P85, DOI 10.1038/nature01147; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Fabian-Fine R, 2003, J NEUROSCI, V23, P10732; Fergestad T, 1999, J NEUROSCI, V19, P5847, DOI 10.1523/JNEUROSCI.19-14-05847.1999; Ferguson SM, 2007, SCIENCE, V316, P570, DOI 10.1126/science.1140621; Gaidarov I, 1996, J BIOL CHEM, V271, P20922, DOI 10.1074/jbc.271.34.20922; Golub T, 2005, J CELL BIOL, V169, P151, DOI 10.1083/jcb.200407058; Gong LW, 2005, P NATL ACAD SCI USA, V102, P5204, DOI 10.1073/pnas.0501412102; GonzalezGaitan M, 1997, CELL, V88, P767, DOI 10.1016/S0092-8674(00)81923-6; Harris TW, 2000, J CELL BIOL, V150, P589, DOI 10.1083/jcb.150.3.589; Hassan BA, 1998, GENETICS, V150, P1527; Haucke V, 2003, DEV CELL, V4, P153, DOI 10.1016/S1534-5807(03)00026-1; Hiesinger PR, 2005, CELL, V121, P607, DOI 10.1016/j.cell.2005.03.012; HORN R, 2005, SCI STKE, pPE50; Jost M, 1998, CURR BIOL, V8, P1399, DOI 10.1016/S0960-9822(98)00022-0; Jung N, 2007, TRAFFIC, V8, P1129, DOI 10.1111/j.1600-0854.2007.00595.x; Kasprowicz J, 2008, J CELL BIOL, V182, P1007, DOI 10.1083/jcb.200804162; Koh TW, 2007, J CELL BIOL, V178, P309, DOI 10.1083/jcb.200701030; Koh TW, 2004, NEURON, V43, P193, DOI 10.1016/j.neuron.2004.06.029; Kuo MT, 2006, BIOCHEM BIOPH RES CO, V340, P887, DOI 10.1016/j.bbrc.2005.12.088; Lemmon MA, 2003, TRAFFIC, V4, P201, DOI 10.1034/j.1600-0854.2004.00071.x; Majumdar A, 2006, EXP CELL RES, V312, P2288, DOI 10.1016/j.yexcr.2006.03.030; Manak JR, 2006, NAT GENET, V38, P1151, DOI 10.1038/ng1875; Mani M, 2007, NEURON, V56, P1004, DOI 10.1016/j.neuron.2007.10.032; Marie B, 2004, NEURON, V43, P207, DOI 10.1016/j.neuron.2004.07.001; Marrus SB, 2004, J NEUROSCI, V24, P1406, DOI 10.1523/JNEUROSCI.1575-03.2004; Martin TFJ, 1998, ANNU REV CELL DEV BI, V14, P231, DOI 10.1146/annurev.cellbio.14.1.231; McKay RM, 2003, DEV CELL, V4, P131, DOI 10.1016/S1534-5807(02)00411-2; Micheva KD, 2001, J CELL BIOL, V154, P355, DOI 10.1083/jcb.200102098; Milosevic I, 2005, J NEUROSCI, V25, P2557, DOI 10.1523/JNEUROSCI.3761-04.2005; Newsome TP, 2000, DEVELOPMENT, V127, P851; Nonet ML, 1999, MOL BIOL CELL, V10, P2343, DOI 10.1091/mbc.10.7.2343; Parks AL, 2004, NAT GENET, V36, P288, DOI 10.1038/ng1312; Parnas D, 2001, NEURON, V32, P415, DOI 10.1016/S0896-6273(01)00485-8; Phillips AM, 2000, J NEUROSCI, V20, P8254, DOI 10.1523/JNEUROSCI.20-22-08254.2000; Poskanzer KE, 2003, NATURE, V426, P559, DOI 10.1038/nature02184; RAMASWAMI M, 1994, NEURON, V13, P363, DOI 10.1016/0896-6273(94)90353-0; Rhee JS, 2002, CELL, V108, P121, DOI 10.1016/S0092-8674(01)00635-3; Roos J, 1999, CURR BIOL, V9, P1411, DOI 10.1016/S0960-9822(00)80087-1; Schiavo G, 1996, P NATL ACAD SCI USA, V93, P13327, DOI 10.1073/pnas.93.23.13327; Schuske KR, 2003, NEURON, V40, P749, DOI 10.1016/S0896-6273(03)00667-6; SCHUSTER CM, 1991, SCIENCE, V254, P112, DOI 10.1126/science.1681587; SLADECZEK F, 1987, BIOCHIMIE, V69, P287, DOI 10.1016/0300-9084(87)90019-8; Stahelin RV, 2003, J BIOL CHEM, V278, P28993, DOI 10.1074/jbc.M302865200; Stimson DT, 2001, J NEUROSCI, V21, P3034, DOI 10.1523/JNEUROSCI.21-09-03034.2001; Stowers RS, 1999, GENETICS, V152, P1631; Van Epps HA, 2004, J NEUROSCI, V24, P8641, DOI 10.1523/JNEUROSCI.2892-04.2004; VANDERBLIEK AM, 1991, NATURE, V351, P411, DOI 10.1038/351411a0; Varnai P, 1998, J CELL BIOL, V143, P501, DOI 10.1083/jcb.143.2.501; Varnai P, 2006, BBA-MOL CELL BIOL L, V1761, P957, DOI 10.1016/j.bbalip.2006.03.019; Venken KJT, 2006, SCIENCE, V314, P1747, DOI 10.1126/science.1134426; Verstreken P, 2002, CELL, V109, P101, DOI 10.1016/S0092-8674(02)00688-8; Verstreken P, 2003, NEURON, V40, P733, DOI 10.1016/S0896-6273(03)00644-5; Verstreken Patrik, 2008, V440, P349, DOI 10.1007/978-1-59745-178-9_26; Vicinanza M, 2008, EMBO J, V27, P2457, DOI 10.1038/emboj.2008.169; Voronov SV, 2008, P NATL ACAD SCI USA, V105, P9415, DOI 10.1073/pnas.0803756105; Wenk MR, 2004, P NATL ACAD SCI USA, V101, P8262, DOI 10.1073/pnas.0401874101; Wucherpfennig T, 2003, J CELL BIOL, V161, P609, DOI 10.1083/jcb.200211087; York JD, 2006, BBA-MOL CELL BIOL L, V1761, P552, DOI 10.1016/j.bbalip.2006.04.014; Zhai RG, 2003, P NATL ACAD SCI USA, V100, P10860, DOI 10.1073/pnas.1832753100; Zhang B, 1998, NEURON, V21, P1465, DOI 10.1016/S0896-6273(00)80664-9; Zoncu R, 2007, P NATL ACAD SCI USA, V104, P3793, DOI 10.1073/pnas.0611733104	76	71	72	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 30	2009	63	2					203	215		10.1016/j.neuron.2009.06.017	http://dx.doi.org/10.1016/j.neuron.2009.06.017			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	479IS	19640479	Bronze, Green Accepted			2022-12-24	WOS:000268653500009
J	Alexander, GM; Rogan, SC; Abbas, AI; Armbruster, BN; Pei, Y; Allen, JA; Nonneman, RJ; Hartmann, J; Moy, SS; Nicolelis, MA; McNamara, JO; Roth, BL				Alexander, Georgia M.; Rogan, Sarah C.; Abbas, Atheir I.; Armbruster, Blaine N.; Pei, Ying; Allen, John A.; Nonneman, Randal J.; Hartmann, John; Moy, Sheryl S.; Nicolelis, Miguel A.; McNamara, James O.; Roth, Bryan L.			Remote Control of Neuronal Activity in Transgenic Mice Expressing Evolved G Protein-Coupled Receptors	NEURON			English	Article							CONDITIONAL EXPRESSION; IN-VIVO; G(I)-COUPLED RECEPTOR; MAMMALIAN NEURONS; M-CHANNEL; OSCILLATIONS; INHIBITION; LIGAND	Examining the behavioral consequences of selective CNS neuronal activation is a powerful tool for elucidating mammalian brain function in health and disease. Newly developed genetic, pharmacological, and optical tools allow activation of neurons with exquisite spatiotemporal resolution; however, the inaccessibility to light of widely distributed neuronal populations and the invasiveness required for activation by light or infused ligands limit the utility of these methods. To overcome these barriers, we created transgenic mice expressing an evolved G protein-coupled receptor (hM3Dq) selectively activated by the pharmacologically inert, orally bioavailable drug clozapine-N-oxide (CNO). Here, we expressed hM3Dq in forebrain principal neurons. Local field potential and single-neuron recordings revealed that peripheral administration of CNO activated hippocampal neurons selectively in h1M3Dq-expressing mice. Behavioral correlates of neuronal activation included increased locomotion, stereotypy, and limbic seizures. These results demonstrate a powerful chemical-genetic tool for remotely controlling the activity of discrete populations of neurons in vivo.	[Alexander, Georgia M.; Nicolelis, Miguel A.; McNamara, James O.] Duke Univ, Dept Neurobiol, Durham, NC 27710 USA; [Abbas, Atheir I.] Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA; [Roth, Bryan L.] Duke Univ, NIMH, Psychoact Drug Screening Program, Durham, NC 27710 USA; [Roth, Bryan L.] Univ N Carolina, Sch Pharm, Dept Med Chem & Nat Prod, Chapel Hill, NC 27599 USA; [Hartmann, John] Univ N Carolina, Sch Med, Chapel Hill, NC 27599 USA; [Rogan, Sarah C.; Armbruster, Blaine N.; Pei, Ying; Allen, John A.; Roth, Bryan L.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Moy, Sheryl S.; Roth, Bryan L.] Univ N Carolina, Dept Psychiat, Chapel Hill, NC 27599 USA; [Roth, Bryan L.] Univ N Carolina, Program Neurosci, Chapel Hill, NC 27599 USA; [Roth, Bryan L.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Roth, Bryan L.] Univ N Carolina, Carolina Integrated Chem Biol & Drug Discovery Ct, Chapel Hill, NC 27599 USA; [Allen, John A.; Nonneman, Randal J.; Moy, Sheryl S.; Roth, Bryan L.] Univ N Carolina, Neurodev Disorders Res Ctr, Chapel Hill, NC 27599 USA	Duke University; Case Western Reserve University; Duke University; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	McNamara, JO (corresponding author), Duke Univ, Dept Neurobiol, Durham, NC 27710 USA.	jmc@neuro.duke.edu; bryan_roth@med.unc.edu	Allen, John A/D-6141-2011; Abbas, Atheir/AAI-2158-2019; Roth, Bryan L/F-3928-2010; Roth, Bryan/ABE-7032-2020	Roth, Bryan/0000-0002-0561-6520; Abbas, Atheir/0000-0002-7080-3509; Alexander, Georgia/0000-0003-4245-4417	National Institute of Neurological Disease and Stroke [NS060326, NS049534, NS056217]; National Institute of General Medical Sciences [GM07040-34, GM008719, GM007250, GM074554]; National Institute of Child Health and Human Development [H0040127, HD03110]; National Institute of Mental Health [MHO82441-02]; NARSAD Distinguished InvestigatorAward; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD040127, P30HD003110] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008719, T32GM007040, T32GM007250, F32GM074554] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U19MH082441] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R33NS049534, R01NS056217, F32NS060326, R21NS049534] Funding Source: NIH RePORTER	National Institute of Neurological Disease and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NARSAD Distinguished InvestigatorAward(NARSAD); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the following awards from the National Institutes of Health: NS060326 from the National Institute of Neurological Disease and Stroke (G.M.A.), GM07040-34 and GM008719 from the National Institute of General Medical Sciences (S.C.R.), GM007250 from the National Institute of General Medical Sciences (A.I.A.), GM074554 from the National Institute of General Medical Sciences (B.N.A.), H0040127 from the National Institute of Child Health and Human Development (J.A.A.), HD03110 from the National Institute of Child Health and Human Development (R.J.N., S.S.M.), NS049534 from the National Institutes of Neurological Disorders and Stroke (M.A.N.), NS056217 from the National Institute of Neurological Disease and Stroke (J.O.M.), and MHO82441-02 from the National Institute of Mental Health (B.L.R.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Health. This work is also supported by a NARSAD Distinguished InvestigatorAward (B.L.R.).	Airan RD, 2009, NATURE, V458, P1025, DOI 10.1038/nature07926; Arenkiel BR, 2008, NAT METHODS, V5, P299, DOI [10.1038/NMETH.1190, 10.1038/nmeth.1190]; Armbruster BN, 2007, P NATL ACAD SCI USA, V104, P5163, DOI 10.1073/pnas.0700293104; Bartos M, 2007, NAT REV NEUROSCI, V8, P45, DOI 10.1038/nrn2044; BENDER D, 1994, NUCL MED BIOL, V21, P921, DOI 10.1016/0969-8051(94)90080-9; Berndt A, 2009, NAT NEUROSCI, V12, P229, DOI 10.1038/nn.2247; Biervert C, 1998, SCIENCE, V279, P403, DOI 10.1126/science.279.5349.403; Borges K, 2003, EXP NEUROL, V182, P21, DOI 10.1016/S0014-4886(03)00086-4; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Brown BS, 2000, PROG BIOPHYS MOL BIO, V73, P135, DOI 10.1016/S0079-6107(00)00004-3; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Conklin BR, 2008, NAT METHODS, V5, P673, DOI 10.1038/nmeth.1232; Fisahn A, 1998, NATURE, V394, P186, DOI 10.1038/28179; HANSON PI, 1992, ANNU REV BIOCHEM, V61, P559, DOI 10.1146/annurev.bi.61.070192.003015; Henze DA, 2002, NAT NEUROSCI, V5, P790, DOI 10.1038/nn887; Hsiao EC, 2008, P NATL ACAD SCI USA, V105, P1209, DOI 10.1073/pnas.0707457105; Lechner HAE, 2002, J NEUROSCI, V22, P5287; Li X, 2005, P NATL ACAD SCI USA, V102, P17816, DOI 10.1073/pnas.0509030102; Luo L, 2008, NEURON, V57, P634, DOI 10.1016/j.neuron.2008.01.002; Mayford M, 1996, SCIENCE, V274, P1678, DOI 10.1126/science.274.5293.1678; MUNSON PJ, 1980, ANAL BIOCHEM, V107, P220, DOI 10.1016/0003-2697(80)90515-1; Nawaratne V, 2008, MOL PHARMACOL, V74, P1119, DOI 10.1124/mol.108.049353; Pei Y, 2008, PHYSIOLOGY, V23, P313, DOI 10.1152/physiol.00025.2008; Penfield W, 1954, EPILEPSY FUNCTIONAL; Peng J, 2008, ENDOCRINOLOGY, V149, P1329, DOI 10.1210/en.2007-0235; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Redfern CH, 2000, P NATL ACAD SCI USA, V97, P4826, DOI 10.1073/pnas.97.9.4826; Redfern CH, 1999, NAT BIOTECHNOL, V17, P165, DOI 10.1038/6165; Scearce-Levie K, 2001, TRENDS PHARMACOL SCI, V22, P414, DOI 10.1016/S0165-6147(00)01743-0; Sweger EJ, 2007, J NEUROSCI, V27, P2309, DOI 10.1523/JNEUROSCI.4565-06.2007; Tan EM, 2006, NEURON, V51, P157, DOI 10.1016/j.neuron.2006.06.018; Wang HS, 1998, SCIENCE, V282, P1890, DOI 10.1126/science.282.5395.1890; Zhang F, 2008, NAT NEUROSCI, V11, P631, DOI 10.1038/nn.2120; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744; Zhang HL, 2003, NEURON, V37, P963, DOI 10.1016/S0896-6273(03)00125-9; Zhao GQ, 2003, CELL, V115, P255, DOI 10.1016/S0092-8674(03)00844-4	36	618	626	2	69	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 16	2009	63	1					27	39		10.1016/j.neuron.2009.06.014	http://dx.doi.org/10.1016/j.neuron.2009.06.014			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	473EX	19607790	Green Submitted, Bronze, Green Accepted			2022-12-24	WOS:000268189900006
J	Sen, N; Hara, MR; Ahmad, AS; Cascio, MB; Kamiya, A; Ehmsen, JT; Aggrawal, N; Hester, L; Dore, S; Snyder, SH; Sawa, A				Sen, Nilkantha; Hara, Makoto R.; Ahmad, Abdullah Shafique; Cascio, Matthew B.; Kamiya, Atsushi; Ehmsen, Jeffrey T.; Aggrawal, Nishant; Hester, Lynda; Dore, Sylvain; Snyder, Solomon H.; Sawa, Akira			GOSPEL: A Neuroprotective Protein that Binds to GAPDH upon S-Nitrosylation	NEURON			English	Article							GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; APOPTOSIS; NO; NEUROTOXICITY; STIMULATION; CULTURES; DISEASE; STRESS; SENSOR; DEATH	We recently reported a cell death cascade whereby cellular stressors activate nitric oxide formation leading to S-nitrosylation of GAPDH that binds to Siah and translocates to the nucleus. The nuclear GAPDH/Siah complex augments p300/CBP-associated acetylation of nuclear proteins, including p53, which mediate cell death. We report a 52 kDa cytosolic protein, GOSPEL, which physiologically binds GAPDH, in competition with Siah, retaining GAPDH in the cytosol and preventing its nuclear translocation. GOSPEL is neuroprotective, as its overexpression prevents NMDA-glutamate excitotoxicity while its depletion enhances death in primary neuron cultures. S-nitrosylation of GOSPEL at cysteine 47 enhances GAPDH-GOSPEL binding and the neuroprotective actions of GOSPEL. In intact mice, virally delivered GOSPEL selectively diminishes NMDA neurotoxicity. Thus, GOSPEL may physiologically regulate the viability of neurons and other cells.	[Sen, Nilkantha; Hara, Makoto R.; Cascio, Matthew B.; Ehmsen, Jeffrey T.; Aggrawal, Nishant; Hester, Lynda; Dore, Sylvain; Snyder, Solomon H.; Sawa, Akira] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA; [Ahmad, Abdullah Shafique; Dore, Sylvain] Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA; [Kamiya, Atsushi; Snyder, Solomon H.; Sawa, Akira] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA; [Snyder, Solomon H.] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Snyder, SH (corresponding author), Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA.	ssnyder@jhmi.edu; asawa1@jhmi.edu	kamiya, atsushi/L-8550-2016; Dore, Sylvain/AAG-1470-2020; Sen, Nilkantha/AAW-9788-2020	kamiya, atsushi/0000-0002-4274-5567; Dore, Sylvain/0000-0003-3771-5109; Ahmad, Abdullah Shafique/0000-0002-8368-2443	United States Public Health [MH-084018, MH-069853, DA-00266, DA-00074]; Stanley, National Alliance for Research in Schizophrenia and Affective Disorders; Core Huntington's Disease Initiative; S-R Foundations; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH069853, P20MH084018] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K05DA000074, P50DA000266] Funding Source: NIH RePORTER	United States Public Health; Stanley, National Alliance for Research in Schizophrenia and Affective Disorders(NARSAD); Core Huntington's Disease Initiative; S-R Foundations; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by United States Public Health Service grants MH-084018 and MH-069853 (A.S.); DA-00266 (S.H.S.); and Research Scientist Award DA-00074 (S.H.S.); and grants from the Stanley, National Alliance for Research in Schizophrenia and Affective Disorders, Core Huntington's Disease Initiative, and S-R Foundations (A.S.). We thank Yukiko L. Lema for preparing figures and organizing the manuscript. We appreciate technical assistance by Mr. S. Seshadri, Mr. J. Park, Ms. X. Luo, and Ms. L. Hanle.	Ahmad AS, 2006, J NEUROTRAUM, V23, P1895, DOI 10.1089/neu.2006.23.1895; Ahmad M, 2007, J NEUROIMMUNOL, V184, P172, DOI 10.1016/j.jneuroim.2006.12.012; Bae BI, 2005, NEURON, V47, P29, DOI 10.1016/j.neuron.2005.06.005; Bae Y, 2006, P NATL ACAD SCI USA, V103, P3405, DOI 10.1073/pnas.0511316103; Benhar M, 2005, NAT CELL BIOL, V7, P645, DOI 10.1038/ncb0705-645; BONFOCO E, 1995, P NATL ACAD SCI USA, V92, P7162, DOI 10.1073/pnas.92.16.7162; Bridge AJ, 2003, NAT GENET, V34, P263, DOI 10.1038/ng1173; Burnett PE, 1998, P NATL ACAD SCI USA, V95, P8351, DOI 10.1073/pnas.95.14.8351; Carlile GW, 2000, MOL PHARMACOL, V57, P2; Choi YB, 2000, NAT NEUROSCI, V3, P15, DOI 10.1038/71090; Chuang DM, 2005, ANNU REV PHARMACOL, V45, P269, DOI 10.1146/annurev.pharmtox.45.120403.095902; Chvanov M, 2006, EMBO J, V25, P3024, DOI 10.1038/sj.emboj.7601207; Dawson VL, 1996, J NEUROSCI, V16, P2479; Forrester MT, 2007, J BIOL CHEM, V282, P13977, DOI 10.1074/jbc.M609684200; Hara MR, 2006, BBA-MOL BASIS DIS, V1762, P502, DOI 10.1016/j.bbadis.2006.01.012; Hara MR, 2006, P NATL ACAD SCI USA, V103, P3887, DOI 10.1073/pnas.0511321103; Hara MR, 2005, NAT CELL BIOL, V7, P665, DOI 10.1038/ncb1268; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Jaffrey S R, 2001, Sci STKE, V2001, ppl1, DOI 10.1126/stke.2001.86.pl1; Kamiya A, 2005, NAT CELL BIOL, V7, P1167, DOI 10.1038/ncb1328; Kim WK, 1999, NEURON, V24, P461, DOI 10.1016/S0896-6273(00)80859-4; NAGY E, 1995, J BIOL CHEM, V270, P2755, DOI 10.1074/jbc.270.6.2755; Sawa A, 1999, NAT MED, V5, P1194, DOI 10.1038/13518; Sen N, 2008, NAT CELL BIOL, V10, P866, DOI 10.1038/ncb1747; Sirover MA, 2005, J CELL BIOCHEM, V95, P45, DOI 10.1002/jcb.20399; Sirover MA, 1999, BBA-PROTEIN STRUCT M, V1432, P159, DOI 10.1016/S0167-4838(99)00119-3; Takahashi H, 2007, NEURON, V53, P53, DOI 10.1016/j.neuron.2006.11.023; Tatton W, 2003, J NEURAL TRANSM, V110, P509, DOI 10.1007/s00702-002-0827-z; Waldmeier PC, 2000, ADV RES NEURODEGENER, V8, P197	29	106	112	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 16	2009	63	1					81	91		10.1016/j.neuron.2009.05.024	http://dx.doi.org/10.1016/j.neuron.2009.05.024			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	473EX	19607794	Green Accepted, Bronze			2022-12-24	WOS:000268189900010
J	Johnson, HA; Goel, A; Buonomano, DV				Johnson, Hope A.; Goel, Anubhuthi; Buonomano, Dean V.			Neural dynamics of in vitro cortical networks reflects experienced temporal patterns	NATURE NEUROSCIENCE			English	Article							DEPENDENT PLASTICITY; CULTURES	Learning ultimately relies on changes in the flow of activity in neural microcircuits. The plasticity of neural dynamics is particularly relevant for the processing of temporal information. Chronic stimulation of cultured rat cortical networks revealed experience-dependent plasticity in neural dynamics. We observed changes in the temporal structure of activity that reflected the intervals used during training, suggesting that cortical circuits are inherently capable of temporal processing on short timescales.	[Goel, Anubhuthi; Buonomano, Dean V.] Univ Calif Los Angeles, Brain Res Inst, Dept Neurobiol, Los Angeles, CA 90024 USA; [Goel, Anubhuthi; Buonomano, Dean V.] Univ Calif Los Angeles, Brain Res Inst, Dept Psychol, Los Angeles, CA 90024 USA; [Johnson, Hope A.] Inst Gulbenkian Ciencias, Champalimaud Neurosci Programme, Oeiras, Portugal	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Fundacao Champalimaud; Instituto Gulbenkian de Ciencia	Buonomano, DV (corresponding author), Univ Calif Los Angeles, Brain Res Inst, Dept Neurobiol, Los Angeles, CA 90024 USA.	dbuono@ucla.edu			National Institute of Mental Health [MH60163]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060163] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank T. Carvalho, J. Feldman, T. O'Dell and F. Schweizer for helpful discussion and comments on this manuscript. We thank K. Gurley, J. Lee and T. Lee for technical assistance. This work was supported by the National Institute of Mental Health (MH60163).	Bi GQ, 1999, NATURE, V401, P792, DOI 10.1038/44573; Buonomano DV, 2003, P NATL ACAD SCI USA, V100, P4897, DOI 10.1073/pnas.0736909100; Fiete IR, 2010, NEURON, V65, P563, DOI 10.1016/j.neuron.2010.02.003; Ivry RB, 2008, TRENDS COGN SCI, V12, P273, DOI 10.1016/j.tics.2008.04.002; Jimbo Y, 1999, BIOPHYS J, V76, P670, DOI 10.1016/S0006-3495(99)77234-6; Johnson HA, 2009, J NEUROSCI METH, V176, P136, DOI 10.1016/j.jneumeth.2008.08.037; Karmarkar UR, 2006, NEURON, V52, P577, DOI 10.1016/j.neuron.2006.11.001; Liu JK, 2009, J NEUROSCI, V29, P13172, DOI 10.1523/JNEUROSCI.2358-09.2009; MacLean JN, 2005, NEURON, V48, P811, DOI 10.1016/j.neuron.2005.09.035; MAUK MD, 2004, ANNU REV NEUROSCI, V307, P340; Pratt KG, 2008, NAT NEUROSCI, V11, P467, DOI 10.1038/nn2076; Ruaro ME, 2005, IEEE T BIO-MED ENG, V52, P371, DOI 10.1109/TBME.2004.842975; Shahaf G, 2001, J NEUROSCI, V21, P8782, DOI 10.1523/JNEUROSCI.21-22-08782.2001; Wagenaar DA, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-11; Wagenaar DA, 2006, J NEGAT RESULTS BIOM, V5, DOI 10.1186/1477-5751-5-16	15	56	56	1	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2010	13	8					917	919		10.1038/nn.2579	http://dx.doi.org/10.1038/nn.2579			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	632DK	20543842	Green Accepted			2022-12-24	WOS:000280400600007
J	Brown, MR; Kronengold, J; Gazula, VR; Chen, Y; Strumbos, JG; Sigworth, FJ; Navaratnam, D; Kaczmarek, LK				Brown, Maile R.; Kronengold, Jack; Gazula, Valeswara-Rao; Chen, Yi; Strumbos, John G.; Sigworth, Fred J.; Navaratnam, Dhasakumar; Kaczmarek, Leonard K.			Fragile X mental retardation protein controls gating of the sodium-activated potassium channel Slack	NATURE NEUROSCIENCE			English	Article							AUDITORY NEURONS; TRANSLATION; GENE; RNA	In humans, the absence of Fragile X mental retardation protein (FMRP), an RNA-binding protein, results in Fragile X syndrome, the most common inherited form of intellectual disability. Using biochemical and electrophysiological studies, we found that FMRP binds to the C terminus of the Slack sodium-activated potassium channel to activate the channel in mice. Our findings suggest that Slack activity provides a link between patterns of neuronal firing and changes in protein translation.	[Brown, Maile R.; Kronengold, Jack; Gazula, Valeswara-Rao; Strumbos, John G.; Kaczmarek, Leonard K.] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06510 USA; [Chen, Yi; Sigworth, Fred J.; Kaczmarek, Leonard K.] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06510 USA; [Navaratnam, Dhasakumar] Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06510 USA; [Navaratnam, Dhasakumar] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06510 USA	Yale University; Yale University; Yale University; Yale University	Kaczmarek, LK (corresponding author), Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06510 USA.	leonard.kaczmarek@yale.edu			US National Institutes of Health [NS61479, DC008449, DC01919]; FRAXA Research Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS018492, F32NS061479] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [F32DC008449, R01DC001919] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FRAXA Research Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This research was supported by US National Institutes of Health grants NS61479 (M.R.B.), DC008449 (J.K.), DC01919 and the FRAXA Research Foundation (L.K.K.).	Bhattacharjee A, 2003, J NEUROSCI, V23, P11681; DRYER SE, 1994, TRENDS NEUROSCI, V17, P155, DOI 10.1016/0166-2236(94)90093-0; Lu R, 2004, P NATL ACAD SCI USA, V101, P15201, DOI 10.1073/pnas.0404995101; Pfeiffer BE, 2009, NEUROSCIENTIST, V15, P549, DOI 10.1177/1073858409333075; Ramos A, 2006, STRUCTURE, V14, P21, DOI 10.1016/j.str.2005.09.018; SIOMI H, 1993, CELL, V74, P291, DOI 10.1016/0092-8674(93)90420-U; Sjekloca L, 2009, BIOCHEM J, V419, P347, DOI 10.1042/BJ20082197; Wang LG, 2009, NATURE, V461, P292, DOI 10.1038/nature08291; Wang LY, 1998, J PHYSIOL-LONDON, V509, P183, DOI 10.1111/j.1469-7793.1998.183bo.x; Yang B, 2007, J NEUROSCI, V27, P2617, DOI 10.1523/JNEUROSCI.5308-06.2007; Zalfa F, 2003, CELL, V112, P317, DOI 10.1016/S0092-8674(03)00079-5; Zhang YQ, 2001, CELL, V107, P591, DOI 10.1016/S0092-8674(01)00589-X; Zukin RS, 2009, FRONT NEURAL CIRCUIT, V3, DOI 10.3389/neuro.04.014.2009	13	169	179	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2010	13	7					819	821		10.1038/nn.2563	http://dx.doi.org/10.1038/nn.2563			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	615YF	20512134	Green Accepted			2022-12-24	WOS:000279173900012
J	Chatzigeorgiou, M; Yoo, S; Watson, JD; Lee, WH; Spencer, WC; Kindt, KS; Hwang, SW; Miller, DM; Treinin, M; Driscoll, M; Schafer, WR				Chatzigeorgiou, Marios; Yoo, Sungjae; Watson, Joseph D.; Lee, Wei-Hsiang; Spencer, W. Clay; Kindt, Katie S.; Hwang, Sun Wook; Miller, David M., III; Treinin, Millet; Driscoll, Monica; Schafer, William R.			Specific roles for DEG/ENaC and TRP channels in touch and thermosensation in C. elegans nociceptors	NATURE NEUROSCIENCE			English	Article							CAPSAICIN RECEPTOR; GENE-EXPRESSION; MOTOR-NEURONS; ION-CHANNEL; ASH NEURONS; PAIN; MECHANOSENSATION; IDENTIFICATION; ADAPTATION; BEHAVIOR	Polymodal nociceptors detect noxious stimuli, including harsh touch, toxic chemicals and extremes of heat and cold. The molecular mechanisms by which nociceptors are able to sense multiple qualitatively distinct stimuli are not well understood. We found that the C. elegans PVD neurons are mulitidendritic nociceptors that respond to harsh touch and cold temperatures. The harsh touch modality specifically required the DEG/ENaC proteins MEC-10 and DEGT-1, which represent putative components of a harsh touch mechanotransduction complex. In contrast, responses to cold required the TRPA-1 channel and were MEC-10 and DEGT-1 independent. Heterologous expression of C. elegans TRPA-1 conferred cold responsiveness to other C. elegans neurons and to mammalian cells, indicating that TRPA-1 is a cold sensor. Our results suggest that C. elegans nociceptors respond to thermal and mechanical stimuli using distinct sets of molecules and identify DEG/ENaC channels as potential receptors for mechanical pain.	[Chatzigeorgiou, Marios; Schafer, William R.] MRC Lab Mol Biol, Div Cell Biol, Cambridge, England; [Yoo, Sungjae; Hwang, Sun Wook] Korea Univ, Grad Sch Med, Seoul, South Korea; [Watson, Joseph D.; Spencer, W. Clay; Miller, David M., III] Vanderbilt Univ, Dept Cell & Dev Biol, Nashville, TN USA; [Lee, Wei-Hsiang; Driscoll, Monica] Rutgers State Univ, Dept Mol Biol & Biochem, Nelson Biol Labs, Piscataway, NJ 08855 USA; [Kindt, Katie S.; Schafer, William R.] Univ Calif San Diego, Div Biol, La Jolla, CA 92093 USA; [Treinin, Millet] Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Med Neurobiol, Inst Med Res Israel Canada, IL-91010 Jerusalem, Israel	MRC Laboratory Molecular Biology; Korea University; Korea University Medicine (KU Medicine); Vanderbilt University; Rutgers State University New Brunswick; University of California System; University of California San Diego; Hebrew University of Jerusalem	Schafer, WR (corresponding author), MRC Lab Mol Biol, Div Cell Biol, Cambridge, England.	wschafer@mrc-lmb.cam.ac.uk	Spencer, William/E-8529-2010; Kindt, Katie/AAS-3275-2020	Hwang, Sun Wook/0000-0001-8460-7480; Schafer, William/0000-0002-6676-8034	Medical Research Council; National Institute on Drug Abuse; National Institute of Neurological Disorders and Stroke; Ministry of Education, Science and Technology of Korea [M103KV010015-06K2201-01510]; National Research Foundation of Korea [KRF-2008-331-E00457, 2009-0076543]; US-Israel Binational Science Foundation [2005036]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034435, R01NS026115] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA016445] Funding Source: NIH RePORTER; Medical Research Council [MC_U105185857] Funding Source: researchfish; MRC [MC_U105185857] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Ministry of Education, Science and Technology of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); National Research Foundation of Korea(National Research Foundation of Korea); US-Israel Binational Science Foundation(US-Israel Binational Science Foundation); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank the Caenorhabditis Genetics Center, the National Bioresource Project and the Mitani laboratory for worm strains, N. Barry for help with microscopy, I. Rabinowitz for writing software to analyze averaged ratio traces, D. Cattermole and P. Heard in the LMB technical workshop for designing and building thermal controllers, the Vanderbilt Functional Genomics Shared Resource for help with microarray experiments and R. Branicky for comments on the manuscript. This research was supported by the Medical Research Council and grants from the National Institute on Drug Abuse (W.R.S.) and the National Institute of Neurological Disorders and Stroke (M.D. and D.M.M.), from the Brain Research Center of the 21st Century Frontier Research Program funded by the Ministry of Education, Science and Technology of Korea (code M103KV010015-06K2201-01510) and National Research Foundation of Korea (codes KRF-2008-331-E00457 and 2009-0076543) to S.W.H., and from the US-Israel Binational Science Foundation (grant 2005036 to M.T. and D.M.M.).	Bandell M, 2004, NEURON, V41, P849, DOI 10.1016/S0896-6273(04)00150-3; Bautista DM, 2006, CELL, V124, P1269, DOI 10.1016/j.cell.2006.02.023; Bianchi L, 2004, NAT NEUROSCI, V7, P1337, DOI 10.1038/nn1347; Bounoutas A, 2007, PFLUG ARCH EUR J PHY, V454, P691, DOI 10.1007/s00424-006-0187-x; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Chelur DS, 2002, NATURE, V420, P669, DOI 10.1038/nature01205; Christensen AP, 2007, NAT REV NEUROSCI, V8, P510, DOI 10.1038/nrn2149; Colbert HA, 1997, J NEUROSCI, V17, P8259; CROLL NA, 1975, J ZOOL, V176, P159, DOI 10.1111/j.1469-7998.1975.tb03191.x; DRISCOLL M, 1991, NATURE, V349, P588, DOI 10.1038/349588a0; Esposito G, 2007, GENE, V395, P170, DOI 10.1016/j.gene.2007.03.002; Fox RM, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-42; GarciaAnoveros J, 1997, ANNU REV NEUROSCI, V20, P567, DOI 10.1146/annurev.neuro.20.1.567; Goodman MB, 2002, NATURE, V415, P1039, DOI 10.1038/4151039a; Goodman Miriam B, 2006, WormBook, P1; Gray JM, 2005, P NATL ACAD SCI USA, V102, P3184, DOI 10.1073/pnas.0409009101; Hall DH., 2008, C ELEGANS ATLAS; Hilliard MA, 2005, EMBO J, V24, P63, DOI 10.1038/sj.emboj.7600493; Hilliard MA, 2004, EMBO J, V23, P1101, DOI 10.1038/sj.emboj.7600107; HUANG MX, 1994, NATURE, V367, P467, DOI 10.1038/367467a0; Kahn-Kirby AH, 2006, ANNU REV PHYSIOL, V68, P719, DOI 10.1146/annurev.physiol.68.040204.100715; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; Kang K, 2010, NATURE, V464, P597, DOI 10.1038/nature08848; KAPLAN JM, 1993, P NATL ACAD SCI USA, V90, P2227, DOI 10.1073/pnas.90.6.2227; Kerr R, 2000, NEURON, V26, P583, DOI 10.1016/S0896-6273(00)81196-4; Kerr Rex A, 2006, WormBook, P1; Kindt KS, 2007, NAT NEUROSCI, V10, P568, DOI 10.1038/nn1886; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; O'Hagan R, 2005, NAT NEUROSCI, V8, P43, DOI 10.1038/nn1362; Patapoutian A, 2009, NAT REV DRUG DISCOV, V8, P55, DOI 10.1038/nrd2757; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Price MP, 2001, NEURON, V32, P1071, DOI 10.1016/S0896-6273(01)00547-5; SMITH CJ, DEV BIOL IN PRESS; Sonnichsen B, 2005, NATURE, V434, P462, DOI 10.1038/nature03353; Srivastava N, 2009, J NEUROPHYSIOL, V102, P1172, DOI 10.1152/jn.90952.2008; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Suzuki H, 2003, NEURON, V39, P1005, DOI 10.1016/j.neuron.2003.08.015; Tobin DM, 2002, NEURON, V35, P307, DOI 10.1016/S0896-6273(02)00757-2; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; Tsalik EL, 2003, DEV BIOL, V263, P81, DOI 10.1016/S0012-1606(03)00447-0; Von Stetina SE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r135; Von Stetina SE, 2007, GENE DEV, V21, P332, DOI 10.1101/gad.1502107; Watson JD, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-84; WAY JC, 1989, GENE DEV, V3, P1823, DOI 10.1101/gad.3.12a.1823; Wemmie JA, 2006, TRENDS NEUROSCI, V29, P578, DOI 10.1016/j.tins.2006.06.014; Yassin L, 2002, BIOCHEMISTRY-US, V41, P12329, DOI 10.1021/bi020193y; Zhang SF, 2004, CURR BIOL, V14, P1888, DOI 10.1016/j.cub.2004.10.030; Zhong LX, 2010, CURR BIOL, V20, P429, DOI 10.1016/j.cub.2009.12.057	48	157	163	1	45	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2010	13	7					861	U106		10.1038/nn.2581	http://dx.doi.org/10.1038/nn.2581			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	615YF	20512132	Green Accepted			2022-12-24	WOS:000279173900019
J	McKnight, KD; Wang, P; Kim, SK				McKnight, Kristen D.; Wang, Pei; Kim, Seung K.			Deconstructing Pancreas Development to Reconstruct Human Islets from Pluripotent Stem Cells	CELL STEM CELL			English	Article							MULTIPLE ENDOCRINE NEOPLASIA; CONGENITAL MALABSORPTIVE DIARRHEA; NEONATAL DIABETES-MELLITUS; ADULT-MOUSE PANCREAS; BETA-CELL; PROGENITOR CELLS; HUMAN FETAL; ES CELLS; MUTANT NEUROGENIN-3; EXPRESSION ANALYSIS	There is considerable excitement about harnessing the potential of human stem cells to replace pancreatic islets that are destroyed in type 1 diabetes mellitus. However, our current understanding of the mechanisms underlying pancreas and islet ontogeny has come largely from the powerful genetic, developmental, and embryological approaches available in nonhuman organisms. Successful islet reconstruction from human pluripotent cells will require greater attention to "deconstructing" human pancreas and islet developmental biology and consistent application of conditional genetics, lineage tracing, and cell purification to stem cell biology.	[McKnight, Kristen D.; Wang, Pei; Kim, Seung K.] Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA; [Kim, Seung K.] Stanford Univ, Sch Med, Dept Med, Div Oncol, Stanford, CA 94305 USA; [Kim, Seung K.] Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA	Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University	Kim, SK (corresponding author), Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA.			Wang, Pei/0000-0003-2373-7315; Kim, Seung/0000-0001-6135-7810	Juvenile Diabetes Research Foundation (JDRF); Larry L Hillblom Foundation (LLHF); Mead Foundation; Snyder Foundation; Stinehart Foundation; Harry and Leona Helmsley Foundation; JDRF; LLHF; California Institute of Regenerative Medicine; U S National Institutes of Health; Howard Hughes Medical Institute (HHMI); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075919] Funding Source: NIH RePORTER	Juvenile Diabetes Research Foundation (JDRF)(Juvenile Diabetes Research Foundation); Larry L Hillblom Foundation (LLHF); Mead Foundation; Snyder Foundation; Stinehart Foundation; Harry and Leona Helmsley Foundation; JDRF(Juvenile Diabetes Research Foundation); LLHF; California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); U S National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute (HHMI)(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank members of the S K K group for advice and assistance K D M is supported by a Juvenile Diabetes Research Foundation (JDRF) fellowship and P W was supported by a Larry L Hillblom Foundation (LLHF) fellowship The S K K group was supported by the Mead Foundation, Snyder Foundation, Stinehart Foundation, Harry and Leona Helmsley Foundation, JDRF, LLHF, California Institute of Regenerative Medicine, the U S National Institutes of Health, and the Howard Hughes Medical Institute (HHMI) S K K is an Investigator of the HHMI We apologize to colleagues whose work we could not cite because of space constraints	Agarwal SK, 2009, J CLIN ENDOCR METAB, V94, P1826, DOI 10.1210/jc.2008-2083; Alexander CM, 2009, CELL STEM CELL, V5, P579, DOI 10.1016/j.stem.2009.11.008; Apelqvist A, 1999, NATURE, V400, P877, DOI 10.1038/23716; Bhushan A, 2001, DEVELOPMENT, V128, P5109; Borowiak M, 2009, CELL STEM CELL, V4, P348, DOI 10.1016/j.stem.2009.01.014; Bouwens L, 2006, CURR DIABETES REV, V2, P3, DOI 10.2174/157339906775473644; Bu L, 2009, NATURE, V460, P113, DOI 10.1038/nature08191; Cabrera O, 2006, P NATL ACAD SCI USA, V103, P2334, DOI 10.1073/pnas.0510790103; Castaing M, 2005, DEV DYNAM, V234, P339, DOI 10.1002/dvdy.20547; Cernea S, 2008, DIABETIC MED, V25, P1259, DOI 10.1111/j.1464-5491.2008.02556.x; Chandrasekharappa SC, 1997, SCIENCE, V276, P404, DOI 10.1126/science.276.5311.404; Chen HA, 2009, GENE DEV, V23, P975, DOI 10.1101/gad.1742509; Cirulli V, 1998, J CELL BIOL, V140, P1519, DOI 10.1083/jcb.140.6.1519; CIRULLI V, 1994, J CELL SCI, V107, P1429; Cirulli V, 1995, TRANSPLANT P, V27, P3335; Cirulli V, 2000, J CELL BIOL, V150, P1445, DOI 10.1083/jcb.150.6.1445; Collombat P, 2003, GENE DEV, V17, P2591, DOI 10.1101/gad.269003; Collombat P, 2009, CELL CYCLE, V8, P3450, DOI 10.4161/cc.8.21.9791; Cozar-Castellano I, 2006, ENDOCR REV, V27, P356, DOI 10.1210/er.2006-0004; Crabtree JS, 2001, P NATL ACAD SCI USA, V98, P1118, DOI 10.1073/pnas.98.3.1118; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; Desgraz R, 2009, DEVELOPMENT, V136, P3567, DOI 10.1242/dev.039214; Deutsch G, 2001, DEVELOPMENT, V128, P871; Dhawan S, 2009, GENE DEV, V23, P906, DOI 10.1101/gad.1742609; Dorrell C, 2008, STEM CELL RES, V1, P183, DOI 10.1016/j.scr.2008.04.001; Dufour JM, 2005, TISSUE ENG, V11, P1323, DOI 10.1089/ten.2005.11.1323; Dugas JC, 2008, J NEUROSCI, V28, P8294, DOI 10.1523/JNEUROSCI.2010-08.2008; Eizirik DL, 2009, NAT REV ENDOCRINOL, V5, P219, DOI 10.1038/nrendo.2009.21; FAJANS SS, 1989, DIABETES METAB REV, V5, P579, DOI 10.1002/dmr.5610050705; Fajans SS, 2001, NEW ENGL J MED, V345, P971, DOI 10.1056/NEJMra002168; FOSTER JW, 1994, NATURE, V372, P525, DOI 10.1038/372525a0; Gadue P, 2009, STEM CELLS, V27, P2103, DOI 10.1002/stem.147; Gittes GK, 2009, DEV BIOL, V326, P4, DOI 10.1016/j.ydbio.2008.10.024; Gloyn AL, 2004, NEW ENGL J MED, V350, P1838, DOI 10.1056/NEJMoa032922; GOLOSOW N, 1962, DEV BIOL, V4, P242, DOI 10.1016/0012-1606(62)90042-8; Gradwohl G, 2000, P NATL ACAD SCI USA, V97, P1607, DOI 10.1073/pnas.97.4.1607; Gu GQ, 2004, DEVELOPMENT, V131, P165, DOI 10.1242/dev.00921; Gu GQ, 2002, DEVELOPMENT, V129, P2447; HAYEK A, 1992, METABOLISM, V41, P1367, DOI 10.1016/0026-0495(92)90109-N; Hayek A, 1997, J CLIN ENDOCR METAB, V82, P2471, DOI 10.1210/jc.82.8.2471; Heit JJ, 2006, ANNU REV CELL DEV BI, V22, P311, DOI 10.1146/annurev.cellbio.22.010305.104425; Horikawa Y, 1997, NAT GENET, V17, P384, DOI 10.1038/ng1297-384; Huppert SS, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.283pe50; Jensen J, 2000, NAT GENET, V24, P36, DOI 10.1038/71657; Jensen JN, 2007, NEW ENGL J MED, V356, P1781; Jeon J, 2009, J HISTOCHEM CYTOCHEM, V57, P811, DOI 10.1369/jhc.2009.953307; JONSSON J, 1994, NATURE, V371, P606, DOI 10.1038/371606a0; Kania G, 2005, STEM CELLS, V23, P791, DOI 10.1634/stemcells.2004-0232; Kawaguchi J, 2010, DEVELOPMENT, V137, P693, DOI 10.1242/dev.046896; Kawaguchi Y, 2002, NAT GENET, V32, P128, DOI 10.1038/ng959; Kawasaki H, 2000, NEURON, V28, P31, DOI 10.1016/S0896-6273(00)00083-0; Kitamura K, 2002, NAT GENET, V32, P359, DOI 10.1038/ng1009; Krapp A, 1998, GENE DEV, V12, P3752, DOI 10.1101/gad.12.23.3752; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; Kutlu B, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-3; Lammert E, 2001, SCIENCE, V294, P564, DOI 10.1126/science.1064344; Lee CS, 2002, GENE DEV, V16, P1488, DOI 10.1101/gad.985002; Lutolf MP, 2009, INTEGR BIOL, V1, P59, DOI 10.1039/b815718a; Lyttle BM, 2008, DIABETOLOGIA, V51, P1169, DOI 10.1007/s00125-008-1006-z; Malecki MT, 1999, NAT GENET, V23, P323, DOI 10.1038/15500; Mayhew CN, 2010, CURR OPIN ORGAN TRAN, V15, P54, DOI 10.1097/MOT.0b013e3283337e1c; Murtaugh LC, 2007, DEVELOPMENT, V134, P427, DOI 10.1242/dev.02770; Mutskov V, 2009, P NATL ACAD SCI USA, V106, P17419, DOI 10.1073/pnas.0909288106; Njolstad PR, 2001, NEW ENGL J MED, V344, P1588, DOI 10.1056/NEJM200105243442104; Oliver-Krasinski JM, 2008, GENE DEV, V22, P1998, DOI 10.1101/gad.1670808; OUTZEN HC, 1981, TRANSPLANTATION, V32, P101, DOI 10.1097/00007890-198108000-00004; Pellegata NS, 2006, P NATL ACAD SCI USA, V103, P15558, DOI 10.1073/pnas.0603877103; Piper K, 2004, J ENDOCRINOL, V181, P11, DOI 10.1677/joe.0.1810011; Plengvidhya N, 2007, J CLIN ENDOCR METAB, V92, P2821, DOI 10.1210/jc.2006-1927; Polak M, 2000, DIABETES, V49, P225, DOI 10.2337/diabetes.49.2.225; Porteus MH, 2003, SCIENCE, V300, P763, DOI 10.1126/science.1078395; Puri S, 2010, DEV CELL, V18, P342, DOI 10.1016/j.devcel.2010.02.005; Robbins RD, 2010, CURR OPIN ORGAN TRAN, V15, P61, DOI 10.1097/MOT.0b013e3283337196; Sarkar SA, 2008, DIABETOLOGIA, V51, P285, DOI 10.1007/s00125-007-0880-0; Seaberg RM, 2004, NAT BIOTECHNOL, V22, P1115, DOI 10.1038/nbt1004; Sellick GS, 2004, NAT GENET, V36, P1301, DOI 10.1038/ng1475; Senee V, 2006, NAT GENET, V38, P682, DOI 10.1038/ng1802; Seymour PA, 2008, DEV BIOL, V323, P19, DOI 10.1016/j.ydbio.2008.07.034; Seymour PA, 2007, P NATL ACAD SCI USA, V104, P1865, DOI 10.1073/pnas.0609217104; Smith SB, 2010, NATURE, V463, P775, DOI 10.1038/nature08748; Sosa-Pineda B, 2004, MOL CELLS, V18, P289; Stoffers DA, 1997, NAT GENET, V15, P106, DOI 10.1038/ng0197-106; Stoffers DA, 1997, NAT GENET, V17, P138, DOI 10.1038/ng1097-138; Sugiyama T, 2007, P NATL ACAD SCI USA, V104, P175, DOI 10.1073/pnas.0609490104; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Thomas P, 1996, HUM MOL GENET, V5, P1809, DOI 10.1093/hmg/5.11.1809; Van Hoof D, 2009, STEM CELL RES, V3, P73, DOI 10.1016/j.scr.2009.08.003; VIONNET N, 1992, NATURE, V356, P721, DOI 10.1038/356721a0; Wandzioch E, 2009, SCIENCE, V324, P1707, DOI 10.1126/science.1174497; Wang JF, 2006, NEW ENGL J MED, V355, P270, DOI 10.1056/NEJMoa054288; Wang S, 2009, P NATL ACAD SCI USA, V106, P9715, DOI 10.1073/pnas.0904247106; White P, 2008, DIABETES, V57, P654, DOI 10.2337/db07-1362; White P, 2009, METHODS MOL BIOL, V560, P239, DOI 10.1007/978-1-59745-448-3_16; Xu XB, 2008, CELL, V132, P197, DOI 10.1016/j.cell.2007.12.015; Yamagata K, 1996, NATURE, V384, P455, DOI 10.1038/384455a0; Yang L, 2008, NATURE, V453, P524, DOI 10.1038/nature06894; Yasunaga M, 2005, NAT BIOTECHNOL, V23, P1542, DOI 10.1038/nbt1167; Yoshitomi H, 2004, DEVELOPMENT, V131, P807, DOI 10.1242/dev.00960; Zhang DH, 2009, CELL RES, V19, P429, DOI 10.1038/cr.2009.28; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314; Zhou Q, 2007, DEV CELL, V13, P103, DOI 10.1016/j.devcel.2007.06.001; Zou JZ, 2009, CELL STEM CELL, V5, P97, DOI 10.1016/j.stem.2009.05.023; Zwaka TP, 2003, NAT BIOTECHNOL, V21, P319, DOI 10.1038/nbt788	103	51	54	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	APR 2	2010	6	4					300	308		10.1016/j.stem.2010.03.003	http://dx.doi.org/10.1016/j.stem.2010.03.003			9	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	585KD	20362535	Bronze, Green Accepted			2022-12-24	WOS:000276823300009
J	Banerjee, S; Neveu, P; Kosik, KS				Banerjee, Sourav; Neveu, Pierre; Kosik, Kenneth S.			A Coordinated Local Translational Control Point at the Synapse Involving Relief from Silencing and MOV10 Degradation	NEURON			English	Article							UBIQUITIN-PROTEASOME SYSTEM; ACYL-PROTEIN THIOESTERASE; MESSENGER-RNA TRANSLATION; HIPPOCAMPAL-NEURONS; FLUORESCENT PROTEIN; PYRAMIDAL NEURONS; GROWTH CONES; PALMITOYLATION; IDENTIFICATION; DROSOPHILA	Persistent changes in synaptic strength are locally regulated by both protein degradation and synthesis; however, the coordination of these opposing limbs is poorly understood. Here, we found that the RISC protein MOV10 was present at synapses and was rapidly degraded by the proteasome in an NMDA-receptor-mediated activity-dependent manner. We designed a translational trap to capture those mRNAs whose spatiotemporal translation is regulated by MOV10. When MOV10 was suppressed, a set of mRNAs-including alpha-CaMKII, Limk1, and the depalmitoylating enzyme lysophospholipase1 (Lypla1)-selectively entered the polysome compartment. We also observed that Lypla1 mRNA is associated with the brain-enriched microRNA miR-138. Using a photoconvertible translation reporter, Kaede, we analyzed the activity-dependent protein synthesis driven by Lypia1 and alpha-CaMKII 3'UTRs. We established this protein synthesis to be MOV10 and proteasome dependent. These results suggest a unifying picture of a local translational regulatory mechanism during synaptic plasticity.	[Banerjee, Sourav; Neveu, Pierre; Kosik, Kenneth S.] Univ Calif Santa Barbara, Neurosci Res Inst, Santa Barbara, CA 93106 USA; [Banerjee, Sourav; Neveu, Pierre; Kosik, Kenneth S.] Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA; [Neveu, Pierre] Univ Calif Santa Barbara, Kavli Inst Theoret Phys, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Kosik, KS (corresponding author), Univ Calif Santa Barbara, Neurosci Res Inst, Santa Barbara, CA 93106 USA.	kosik@lifesci.ucsb.edu	Neveu, Pierre/C-1170-2009	Neveu, Pierre/0000-0003-4939-3418	W.M. Keck Foundation [SB 060811]; National Science Foundation [PHY05-51164]	W.M. Keck Foundation(W.M. Keck Foundation); National Science Foundation(National Science Foundation (NSF))	We thank Jennifer Lippincott-Schwartz for providing PA-GFP construct, Addgene for lentiviral vectors, NeuroMab for PSD95 antibody, Zissimos Mourelatos for pan Argonaute antibody (2A8), Snigdha Chatterjee for preparing hippocampal cultures, Boris Shraiman and the members of the Kosik lab for their insightful discussion and generosity. This work was funded by W.M. Keck Foundation Grant to K.S.K. (SB 060811). P.N. research is supported in part by the National Science Foundation under Grant No. PHY05-51164.	Aakalu G, 2001, NEURON, V30, P489, DOI 10.1016/S0896-6273(01)00295-1; Ageta H, 2001, MOL BRAIN RES, V97, P186, DOI 10.1016/S0169-328X(01)00303-5; Ando R, 2002, P NATL ACAD SCI USA, V99, P12651, DOI 10.1073/pnas.202320599; Ashraf SI, 2006, CELL, V124, P191, DOI 10.1016/j.cell.2005.12.017; Bergink S, 2006, GENE DEV, V20, P1343, DOI 10.1101/gad.373706; Bingol B, 2005, CURR OPIN NEUROBIOL, V15, P536, DOI 10.1016/j.conb.2005.08.016; Bingol B, 2006, NATURE, V441, P1144, DOI 10.1038/nature04769; Chendrimada TP, 2007, NATURE, V447, P823, DOI 10.1038/nature05841; Cook HA, 2004, CELL, V116, P817, DOI 10.1016/S0092-8674(04)00250-8; Costa-Mattioli M, 2009, NEURON, V61, P10, DOI 10.1016/j.neuron.2008.10.055; DiAntonio A, 2001, NATURE, V412, P449, DOI 10.1038/35086595; Dittrich PS, 2005, BIOPHYS J, V89, P3446, DOI 10.1529/biophysj.105.061713; Duncan JA, 1998, J BIOL CHEM, V273, P15830, DOI 10.1074/jbc.273.25.15830; Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013; El-Husseini AED, 2002, NAT REV NEUROSCI, V3, P791, DOI 10.1038/nrn940; Fonseca R, 2006, NEURON, V52, P239, DOI 10.1016/j.neuron.2006.08.015; FUJIMURO M, 1994, FEBS LETT, V349, P173, DOI 10.1016/0014-5793(94)00647-4; Fulga TA, 2008, NEURON, V57, P339, DOI 10.1016/j.neuron.2008.01.016; Goslin K., 1991, CULTURING NERVE CELL, P251; Hegde AN, 1997, CELL, V89, P115, DOI 10.1016/S0092-8674(00)80188-9; Jiang YH, 1998, NEURON, V21, P799, DOI 10.1016/S0896-6273(00)80596-6; Kang RJ, 2008, NATURE, V456, P904, DOI 10.1038/nature07605; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Leung KM, 2006, NAT NEUROSCI, V9, P1247, DOI 10.1038/nn1775; Lopez-Salon M, 2001, EUR J NEUROSCI, V14, P1820, DOI 10.1046/j.0953-816x.2001.01806.x; Major G, 2008, J NEUROPHYSIOL, V99, P2584, DOI 10.1152/jn.00011.2008; Meister G, 2005, CURR BIOL, V15, P2149, DOI 10.1016/j.cub.2005.10.048; Mukai J, 2008, NAT NEUROSCI, V11, P1302, DOI 10.1038/nn.2204; Murase S, 2002, NEURON, V35, P91, DOI 10.1016/S0896-6273(02)00764-X; Nelson PT, 2007, RNA, V13, P1787, DOI 10.1261/rna.646007; Ostroff LE, 2002, NEURON, V35, P535, DOI 10.1016/S0896-6273(02)00785-7; Pak DTS, 2003, SCIENCE, V302, P1368, DOI 10.1126/science.1082475; Patrick GN, 2006, CURR OPIN NEUROBIOL, V16, P90, DOI 10.1016/j.conb.2006.01.007; Patterson GH, 2002, SCIENCE, V297, P1873, DOI 10.1126/science.1074952; Poon MM, 2006, J NEUROSCI, V26, P13390, DOI 10.1523/JNEUROSCI.3432-06.2006; Raab-Graham KF, 2006, SCIENCE, V314, P144, DOI 10.1126/science.1131693; RAO A, 1991, J NEUROSCI, V11, P2881; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Siegel G, 2009, NAT CELL BIOL, V11, P705, DOI 10.1038/ncb1876; Stefani G, 2004, J NEUROSCI, V24, P7272, DOI 10.1523/JNEUROSCI.2306-04.2004; Tai HC, 2008, NAT REV NEUROSCI, V9, P826, DOI 10.1038/nrn2499; Tomari Y, 2004, CELL, V116, P831, DOI 10.1016/S0092-8674(04)00218-1; Wu L, 1998, NEURON, V21, P1129, DOI 10.1016/S0896-6273(00)80630-3; Yeh DC, 1999, J BIOL CHEM, V274, P33148, DOI 10.1074/jbc.274.46.33148; Yi JJ, 2007, PHARMACOL REV, V59, P14, DOI 10.1124/pr.59.1.4; Yi JJ, 2005, NEURON, V47, P629, DOI 10.1016/j.neuron.2005.07.008; Zhong J, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-17	47	180	188	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 24	2009	64	6					871	884		10.1016/j.neuron.2009.11.023	http://dx.doi.org/10.1016/j.neuron.2009.11.023			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	541ON	20064393	Bronze			2022-12-24	WOS:000273425800013
J	Carter, BC; Bean, BP				Carter, Brett C.; Bean, Bruce P.			Sodium Entry during Action Potentials of Mammalian Neurons: Incomplete Inactivation and Reduced Metabolic Efficiency in Fast-Spiking Neurons	NEURON			English	Article							CEREBELLAR PURKINJE NEURONS; ELECTRO-PHYSIOLOGICAL PROPERTIES; PRIMARY VISUAL-CORTEX; MOSSY FIBER BOUTONS; RAT FRONTAL-CORTEX; K+ CHANNELS; POTASSIUM CONDUCTANCE; NEOCORTICAL NEURONS; NONPYRAMIDAL CELLS; IONIC CURRENTS	We measured the time course of sodium entry during action potentials of mouse central neurons at 37 degrees C to examine how efficiently sodium entry is coupled to depolarization. In cortical pyramidal neurons, sodium entry was nearly completely confined to the rising phase of the spike: only similar to 25% more sodium enters than the theoretical minimum necessary for spike depolarization. However, in fast-spiking GABAergic neurons (cerebellar Purkinje cells and cortical interneurons), twice as much sodium enters as the theoretical minimum. The extra entry occurs because sodium channel inactivation is incomplete during the failing phase of the spike. The efficiency of sodium entry in different cell types is primarily a function of action potential shape and not cell-type-specific differences in sodium channel kinetics. The narrow spikes of fast-spiking GABAergic neurons result in incomplete inactivation of sodium channels; this reduces metabolic efficiency but likely enhances the ability to fire spikes at high frequency.	[Carter, Brett C.; Bean, Bruce P.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Carter, BC (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA.	brett_carter@hms.harvard.edu		Carter, Brett/0000-0001-6474-6571	National Institutes of Health [R01-NS36855, F31-NS064630]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036855, F31NS064630] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Thanks to Zayd Khaliq and Gary Yellen for helpful suggestions and to Gui-lan Yao for help with mouse breeding. Supported by the National Institutes of Health (R01-NS36855). B.C.C. was supported by an NIH predoctoral fellowship (F31-NS064630).	Alle H, 2009, SCIENCE, V325, P1405, DOI 10.1126/science.1174331; Attwell D, 2001, J CEREBR BLOOD F MET, V21, P1133, DOI 10.1097/00004647-200110000-00001; ATWATER I, 1970, J PHYSIOL-LONDON, V211, P753, DOI 10.1113/jphysiol.1970.sp009302; Bean BP, 2007, NAT REV NEUROSCI, V8, P451, DOI 10.1038/nrn2148; BEZANILLA F, 1970, J PHYSIOL-LONDON, V211, P729, DOI 10.1113/jphysiol.1970.sp009301; Chattopadhyaya B, 2004, J NEUROSCI, V24, P9598, DOI 10.1523/JNEUROSCI.1851-04.2004; CONNORS BW, 1982, J NEUROPHYSIOL, V48, P1302, DOI 10.1152/jn.1982.48.6.1302; CONNORS BW, 1990, TRENDS NEUROSCI, V13, P99, DOI 10.1016/0166-2236(90)90185-D; Contreras D, 2003, J NEUROSCI, V23, P6936; DEHAAS V, 1989, EUR BIOPHYS J BIOPHY, V17, P49, DOI 10.1007/BF00257145; Do MTH, 2003, NEURON, V39, P109, DOI 10.1016/S0896-6273(03)00360-X; Engel D, 2005, NEURON, V45, P405, DOI 10.1016/j.neuron.2004.12.048; Enomoto A, 2007, J NEUROPHYSIOL, V98, P710, DOI 10.1152/jn.00292.2007; Erisir A, 1999, J NEUROPHYSIOL, V82, P2476, DOI 10.1152/jn.1999.82.5.2476; FRANKENHAEUSER B, 1964, J PHYSIOL-LONDON, V171, P302, DOI 10.1113/jphysiol.1964.sp007378; Geiger JRP, 2000, NEURON, V28, P927, DOI 10.1016/S0896-6273(00)00164-1; Hausser M, 1997, NEURON, V19, P665, DOI 10.1016/S0896-6273(00)80379-7; HILLE B, 1966, NATURE, V210, P1220, DOI 10.1038/2101220a0; HODGKIN AL, 1952, J PHYSIOL-LONDON, V116, P424, DOI 10.1113/jphysiol.1952.sp004716; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Jackson AC, 2004, J NEUROSCI, V24, P7985, DOI 10.1523/JNEUROSCI.2146-04.2004; KAWAGUCHI Y, 1993, J NEUROPHYSIOL, V70, P387, DOI 10.1152/jn.1993.70.1.387; KAWAGUCHI Y, 1995, J NEUROSCI, V15, P2638; KAWAGUCHI Y, 1993, J NEUROSCI, V13, P4908; KEYNES RD, 1951, J PHYSIOL-LONDON, V114, P151, DOI 10.1113/jphysiol.1951.sp004609; Kole MHP, 2007, NEURON, V55, P633, DOI 10.1016/j.neuron.2007.07.031; LATHAM A, 1971, J PHYSIOL-LONDON, V213, P135, DOI 10.1113/jphysiol.1971.sp009373; Laughlin SB, 2003, SCIENCE, V301, P1870, DOI 10.1126/science.1089662; Lennie P, 2003, CURR BIOL, V13, P493, DOI 10.1016/S0960-9822(03)00135-0; Lien CC, 2003, J NEUROSCI, V23, P2058; LLINAS R, 1980, J PHYSIOL-LONDON, V305, P171, DOI 10.1113/jphysiol.1980.sp013357; Martina M, 1997, J PHYSIOL-LONDON, V505, P593, DOI 10.1111/j.1469-7793.1997.593ba.x; MCCORMICK DA, 1985, J NEUROPHYSIOL, V54, P782, DOI 10.1152/jn.1985.54.4.782; MOUNTCASTLE VB, 1969, J NEUROPHYSIOL, V32, P452, DOI 10.1152/jn.1969.32.3.452; NEHER E, 1992, METHOD ENZYMOL, V207, P123; Nowak LG, 2003, J NEUROPHYSIOL, V89, P1541, DOI 10.1152/jn.00580.2002; OTIS TS, 1990, P NATL ACAD SCI USA, V87, P2911, DOI 10.1073/pnas.87.8.2911; Raman IM, 1997, J NEUROSCI, V17, P4517, DOI 10.1523/jneurosci.17-12-04517.1997; Raman IM, 2001, BIOPHYS J, V80, P729, DOI 10.1016/S0006-3495(01)76052-3; Raman IM, 2000, J NEUROSCI, V20, P9004; Raman IM, 1999, J NEUROSCI, V19, P1663; Rudy B, 2001, TRENDS NEUROSCI, V24, P517, DOI 10.1016/S0166-2236(00)01892-0; SHAW TI, 1966, J PHYSIOL-LONDON, V182, P209, DOI 10.1113/jphysiol.1966.sp007819; Shu YS, 2007, P NATL ACAD SCI USA, V104, P11453, DOI 10.1073/pnas.0702041104; SIMONS DJ, 1978, J NEUROPHYSIOL, V41, P798, DOI 10.1152/jn.1978.41.3.798; Taddese A, 2002, NEURON, V33, P587, DOI 10.1016/S0896-6273(02)00574-3; THACH WT, 1968, J NEUROPHYSIOL, V31, P785, DOI 10.1152/jn.1968.31.5.785; Wang LY, 1998, J PHYSIOL-LONDON, V509, P183, DOI 10.1111/j.1469-7793.1998.183bo.x	48	139	139	0	18	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	DEC 24	2009	64	6					898	909		10.1016/j.neuron.2009.12.011	http://dx.doi.org/10.1016/j.neuron.2009.12.011			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	541ON	20064395	Bronze, Green Accepted			2022-12-24	WOS:000273425800015
J	Luo, WQ; Enomoto, H; Rice, FL; Milbrandt, J; Ginty, DD				Luo, Wenqin; Enomoto, Hideki; Rice, Frank L.; Milbrandt, Jeffrey; Ginty, David D.			Molecular Identification of Rapidly Adapting Mechanoreceptors and Their Developmental Dependence on Ret Signaling	NEURON			English	Article							CUTANEOUS MECHANORECEPTORS; SENSORY NEURONS; GDNF FAMILY; RAT; EXPRESSION; NEUROPEPTIDES; AFFERENTS; RECEPTORS; CORPUSCLE; NEURTURIN	In mammals, the first step in the perception of form and texture is the activation of trigeminal or dorsal root ganglion (DRG) mechanosensory neurons, which are classified as either rapidly (RA) or slowly adapting (SA) according to their rates of adaptation to sustained stimuli. The molecular identities and mechanisms of development of RA and SA mechanoreceptors are largely unknown. We found that the "early Ret(+)" DRG neurons are RA mechanoreceptors, which form Meissner corpuscles, Pacinian corpuscles, and longitudinal lanceolate endings. The central projections of these RA mechanoreceptors innervate layers III through V of the spinal cord and terminate within discrete subdomains of the dorsal column nuclei. Moreover, mice lacking Ret signaling components are devoid of Pacinian corpuscles and exhibit a dramatic disruption of RA mechanoreceptor projections to both the spinal cord and medulla. Thus, the early Re+ neurons are RA mechanoreceptors and Ret signaling is required for the assembly of neural circuits underlying touch perception.	[Luo, Wenqin; Ginty, David D.] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA; [Enomoto, Hideki] RIKEN, Ctr Dev Biol, Lab Neuronal Differentiat & Regenerat, Kobe, Hyogo 6500047, Japan; [Rice, Frank L.] Albany Med Coll, Ctr Neuropharmacol & Neurosci, Albany, NY 12208 USA; [Rice, Frank L.] Integrated Tissue Dynam LLC, Rensselaer, NY 12144 USA; [Milbrandt, Jeffrey] Washington Univ, Sch Med, Dept Pathol, St Louis, MO 63110 USA	Howard Hughes Medical Institute; Johns Hopkins University; RIKEN; Albany Medical College; Washington University (WUSTL)	Ginty, DD (corresponding author), Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA.	dginty@jhmi.edu		Milbrandt, Jeffrey/0000-0002-5477-7689	National Institutes of Health [NS34814, AG13730]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034814, R29NS034814, R37NS034814] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG013730] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thanks S. Arber and G. Fishell for providing Tau<SUP>f(mGFP)</SUP> mice, F. Wang for providing Avil<SUP>AP</SUP> mice, and M. Caterina for the TRPV3 antibody. We thank X. Dong, A. Kolodkin, R. Koerber, R. Krimm, D. Molliver, M. Caterina, and members of the Ginty laboratory for helpful discussions and comments on the manuscript. We thank M. Rutlin, Y. Liu, A. Strickland, and H. Guo for reagents and technical support. This work was supported by National Institutes of Health grants NS34814 (D.D.G.) and AG13730 (J.M.). D.D.G. is an investigator of the Howard Hughes Medical Institute.	Airaksinen MS, 1999, MOL CELL NEUROSCI, V13, P313, DOI 10.1006/mcne.1999.0754; Airaksinen MS, 2002, NAT REV NEUROSCI, V3, P383, DOI 10.1038/nrn812; Airaksinen MS, 1996, NEURON, V16, P287, DOI 10.1016/S0896-6273(00)80047-1; ALBRECHT PJ, 2008, CUTANEOUS MECH TACTI, P1; Brown AG, 1981, ORG SPINAL CORD; Carpenter M., 1983, HUMAN NEUROANATOMY; CARR PA, 1989, NEUROSCIENCE, V33, P363, DOI 10.1016/0306-4522(89)90216-9; Carroll P, 1998, NAT NEUROSCI, V1, P42, DOI 10.1038/242; Chen AI, 2006, NEURON, V49, P395, DOI 10.1016/j.neuron.2005.12.028; CROWLEY C, 1994, CELL, V76, P1001, DOI 10.1016/0092-8674(94)90378-6; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; Darian-Smith, 1984, HDB PHYSL 2 1, V3, P789; Durbec P, 1996, NATURE, V381, P789, DOI 10.1038/381789a0; DYKES RW, 1983, BRAIN RES REV, V6, P47, DOI 10.1016/0165-0173(83)90004-8; DYKES RW, 1982, J NEUROPHYSIOL, V47, P389, DOI 10.1152/jn.1982.47.3.389; Feil R, 1997, BIOCHEM BIOPH RES CO, V237, P752, DOI 10.1006/bbrc.1997.7124; Fundin BT, 1997, DEV BIOL, V190, P94, DOI 10.1006/dbio.1997.8658; Golden JP, 1999, EXP NEUROL, V158, P504, DOI 10.1006/exnr.1999.7127; Gonzalez-Martinez T, 2005, NEUROSCI LETT, V377, P12, DOI 10.1016/j.neulet.2004.11.078; Gonzalez-Martinez T, 2004, BRAIN RES, V1002, P120, DOI 10.1016/j.brainres.2004.01.003; Hasegawa H, 2007, J NEUROSCI, V27, P14404, DOI 10.1523/JNEUROSCI.4908-07.2007; Heuckeroth RO, 1999, NEURON, V22, P253, DOI 10.1016/S0896-6273(00)81087-9; Hippenmeyer S, 2005, PLOS BIOL, V3, P878, DOI 10.1371/journal.pbio.0030159; HOKFELT T, 1991, NEURON, V7, P867, DOI 10.1016/0896-6273(91)90333-U; Hughes DI, 2007, J NEUROSCI, V27, P2035, DOI 10.1523/JNEUROSCI.5401-06.2007; Hughes DI, 2004, BRAIN RES, V1017, P69, DOI 10.1016/j.brainres.2004.05.054; IDE C, 1976, AM J ANAT, V147, P329, DOI 10.1002/aja.1001470307; IGGO A, 1977, J PHYSIOL-LONDON, V266, P275, DOI 10.1113/jphysiol.1977.sp011768; IGGO A, 1969, J PHYSIOL-LONDON, V200, P763, DOI 10.1113/jphysiol.1969.sp008721; IGGO A, 1982, ANNU REV NEUROSCI, V5, P1, DOI 10.1146/annurev.ne.05.030182.000245; Imai T, 2009, SCIENCE, V325, P585, DOI 10.1126/science.1173596; Jing SQ, 1997, J BIOL CHEM, V272, P33111, DOI 10.1074/jbc.272.52.33111; JOHANSSON RS, 1979, J PHYSIOL-LONDON, V286, P283, DOI 10.1113/jphysiol.1979.sp012619; KLEIN R, 1994, NATURE, V368, P249, DOI 10.1038/368249a0; Kramer I, 2006, NEURON, V49, P379, DOI 10.1016/j.neuron.2006.01.008; LAWSON SN, 1974, CELL TISSUE RES, V153, P399; LAWSON SN, 1993, BRAIN RES BULL, V30, P239, DOI 10.1016/0361-9230(93)90250-F; Lawson SN., 1992, MORPHOLOGICAL BIOCH; LeMaster AM, 1999, J NEUROSCI, V19, P5919, DOI 10.1523/JNEUROSCI.19-14-05919.1999; Lindahl M, 2000, MOL CELL NEUROSCI, V15, P522, DOI 10.1006/mcne.2000.0845; Liu Q, 2007, NAT NEUROSCI, V10, P946, DOI 10.1038/nn1937; Luo WQ, 2007, NEURON, V54, P739, DOI 10.1016/j.neuron.2007.04.027; Marmigere F, 2007, NAT REV NEUROSCI, V8, P114, DOI 10.1038/nrn2057; McDonagh SC, 2007, AM J PHYSIOL-GASTR L, V293, pG461, DOI 10.1152/ajpgi.00424.2006; Molliver DC, 1997, NEURON, V19, P849, DOI 10.1016/S0896-6273(00)80966-6; MOUNTCASTLE VB, 1957, J NEUROPHYSIOL, V20, P408, DOI 10.1152/jn.1957.20.4.408; Oliveira ALR, 2003, SYNAPSE, V50, P117, DOI 10.1002/syn.10249; Ozaki S, 1997, J COMP NEUROL, V380, P215; Pare M, 2002, J COMP NEUROL, V445, P347, DOI 10.1002/cne.10196; Patel TD, 2000, NEURON, V25, P345, DOI 10.1016/S0896-6273(00)80899-5; Perez-Pinera P, 2008, NEUROSCI LETT, V433, P43, DOI 10.1016/j.neulet.2007.12.035; Rasmusson DD, 1997, J NEUROPHYSIOL, V78, P2924, DOI 10.1152/jn.1997.78.6.2924; SMEYNE RJ, 1994, NATURE, V368, P246, DOI 10.1038/368246a0; Trupp M, 1996, NATURE, V381, P785, DOI 10.1038/381785a0; Uesaka T, 2008, J CLIN INVEST, V118, P1890, DOI 10.1172/JCI34425; WHITSEL BL, 1969, BRAIN RES, V15, P67, DOI 10.1016/0006-8993(69)90310-2; Zelena J, 1976, Prog Brain Res, V43, P59; Zelena J, 1994, NERVES MECHANORECEPT	58	148	150	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 24	2009	64	6					841	856		10.1016/j.neuron.2009.11.003	http://dx.doi.org/10.1016/j.neuron.2009.11.003			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	541ON	20064391	Bronze, Green Accepted			2022-12-24	WOS:000273425800011
J	Kim, J; Castellano, JM; Jiang, H; Basak, JM; Parsadanian, M; Pham, V; Mason, SM; Paul, SM; Holtzman, DM				Kim, Jungsu; Castellano, Joseph M.; Jiang, Hong; Basak, Jacob M.; Parsadanian, Maia; Pham, Vi; Mason, Stephanie M.; Paul, Steven M.; Holtzman, David M.			Overexpression of Low-Density Lipoprotein Receptor in the Brain Markedly Inhibits Amyloid Deposition and Increases Extracellular A beta Clearance	NEURON			English	Article							TRANSGENIC MOUSE MODEL; CENTRAL-NERVOUS-SYSTEM; ALZHEIMERS-DISEASE; APOLIPOPROTEIN-E; PLAQUE-FORMATION; GAMMA-SECRETASE; IN-VIVO; CHOLESTEROL HOMEOSTASIS; GENETIC ASSOCIATION; GENDER-DIFFERENCES	Apolipoprotein E (APOE) is the strongest genetic risk factor for Alzheimer's disease (AD). Previous studies suggest that the effect of apoE on amyloid-beta (A beta) accumulation plays a major role in AD pathogenesis. Therefore, understanding proteins that control apoE metabolism may provide new targets for regulating A beta levels. LDLR, a member of the LDL receptor family, binds to apoE, yet its potential role in AD pathogenesis remains unclear. We hypothesized that LDLR overexpression in the brain would decrease apoE levels, enhance A beta clearance, and decrease A beta deposition. To test our hypothesis, we created several transgenic mice that overexpress LDLR in the brain and found that apoE levels in these mice decreased by 50%-90%. Furthermore, LDLR overexpression dramatically reduced A beta aggregation and enhanced A beta clearance from the brain extracellular space. Plaque-associated neuroinflammatory responses were attenuated in LDLR transgenic mice. These findings suggest that increasing LDLR levels may represent a novel AD treatment strategy.	[Kim, Jungsu; Castellano, Joseph M.; Jiang, Hong; Basak, Jacob M.; Parsadanian, Maia; Pham, Vi; Mason, Stephanie M.; Holtzman, David M.] Washington Univ, Sch Med, Dept Neurol, Hope Ctr Neurol Disorders,Alzheimers Dis Res Ctr, St Louis, MO 63110 USA; [Paul, Steven M.] Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA	Washington University (WUSTL); Eli Lilly	Holtzman, DM (corresponding author), Washington Univ, Sch Med, Dept Neurol, Hope Ctr Neurol Disorders,Alzheimers Dis Res Ctr, St Louis, MO 63110 USA.	holtzman@neuro.wustl.edu	Kim, Jungsu/F-2457-2012; Castellano, Joseph M/ABD-7639-2021; Paul, Steve/ABE-5400-2020	Kim, Jungsu/0000-0002-6931-8581; Castellano, Joseph/0000-0002-8026-6292	American Health Assistance Foundation; NIH [AG13956, AG034004-01A1, P30 NS057105]; Alalfi Neuroimaging Laboratory; Eli Lilly; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056341] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS032636, P30NS057105] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F31AG034004, R01AG013956, K01AG029524, R37AG013956] Funding Source: NIH RePORTER	American Health Assistance Foundation(BrightFocus Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alalfi Neuroimaging Laboratory; Eli Lilly(Eli Lilly); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the American Health Assistance Foundation (J.K. and D.M.H.), NIH grants AG13956 (D.M.H.), AG034004-01A1 (J.M.C.), NIH Neuroscience Blueprint Center Core Grant P30 NS057105, the Alalfi Neuroimaging Laboratory, and Eli Lilly. S.M.P. is an employee of Eli Lilly & Company. This work was supported in part by a grant from Eli Lilly to Washington University.	Andersen K, 1999, NEUROLOGY, V53, P1992, DOI 10.1212/WNL.53.9.1992; Bales KR, 1999, P NATL ACAD SCI USA, V96, P15233, DOI 10.1073/pnas.96.26.15233; Bales KR, 1997, NAT GENET, V17, P263, DOI 10.1038/ng1197-263; Bell RD, 2007, J CEREBR BLOOD F MET, V27, P909, DOI 10.1038/sj.jcbfm.9600419; Bertram L, 2007, NAT GENET, V39, P17, DOI 10.1038/ng1934; Bertram L, 2007, NEUROBIOL AGING, V28, P18, DOI 10.1016/j.neurobiolaging.2005.11.005; Borchelt DR, 1996, GENET ANAL-BIOMOL E, V13, P159, DOI 10.1016/S1050-3862(96)00167-2; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; Callahan MJ, 2001, AM J PATHOL, V158, P1173, DOI 10.1016/S0002-9440(10)64064-3; Cam JA, 2006, MOL NEURODEGENER, V1, DOI 10.1186/1750-1326-1-8; Cao DF, 2006, NEUROBIOL AGING, V27, P1632, DOI 10.1016/j.neurobiolaging.2005.09.011; Carroll JC, 2007, J NEUROSCI, V27, P13357, DOI 10.1523/JNEUROSCI.2718-07.2007; Cheng D, 2005, J MED GENET, V42, P129, DOI 10.1136/jmg.2004.024968; Cirrito JR, 2003, J NEUROSCI, V23, P8844; Cole SL, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-22; Deane R, 2008, J CLIN INVEST, V118, P4002, DOI 10.1172/JCI36663; DeMattos RB, 2004, NEURON, V41, P193, DOI 10.1016/S0896-6273(03)00850-X; DeMattos RB, 2002, P NATL ACAD SCI USA, V99, P10843, DOI 10.1073/pnas.162228299; Elder GA, 2007, J NEUROCHEM, V102, P1220, DOI 10.1111/j.1471-4159.2007.04614.x; FILIPOVIC I, 1989, J BIOL CHEM, V264, P8815; Fryer JD, 2005, J BIOL CHEM, V280, P25754, DOI 10.1074/jbc.M502143200; Golde TE, 2006, J NEUROCHEM, V99, P689, DOI 10.1111/j.1471-4159.2006.04211.x; Gopalraj RK, 2005, NEUROBIOL AGING, V26, P1, DOI 10.1016/j.neurobiolaging.2004.09.001; Halford RW, 2009, P NATL ACAD SCI USA, V106, P3502, DOI 10.1073/pnas.0813349106; Hardy J, 2006, NEURON, V52, P3, DOI 10.1016/j.neuron.2006.09.016; Herz J, 2002, ANNU REV BIOCHEM, V71, P405, DOI 10.1146/annurev.biochem.71.110601.135342; Herz J, 2009, CURR OPIN LIPIDOL, V20, P190, DOI 10.1097/MOL.0b013e32832d3a10; Hirsch-Reinshagen V, 2005, J BIOL CHEM, V280, P43243, DOI 10.1074/jbc.M508781200; HOFMANN SL, 1988, SCIENCE, V239, P1277, DOI 10.1126/science.3344433; Holtzman DM, 2000, ANN NEUROL, V47, P739, DOI 10.1002/1531-8249(200006)47:6<739::AID-ANA6>3.0.CO;2-8; Holtzman DM, 2000, P NATL ACAD SCI USA, V97, P2892, DOI 10.1073/pnas.050004797; Jankowsky JL, 2004, HUM MOL GENET, V13, P159, DOI 10.1093/hmg/ddh019; Jiang Q, 2008, NEURON, V58, P681, DOI 10.1016/j.neuron.2008.04.010; Kim HJ, 2007, LIVER INT, V27, P633, DOI 10.1111/j.1478-3231.2007.01481.x; Kim J, 2009, NEURON, V63, P287, DOI 10.1016/j.neuron.2009.06.026; Koldamova R, 2005, J BIOL CHEM, V280, P43224, DOI 10.1074/jbc.M504513200; KRUL ES, 1988, J LIPID RES, V29, P1309; Lamsa R, 2008, NEUROBIOL AGING, V29, P848, DOI 10.1016/j.neurobiolaging.2006.12.009; Liu Q, 2007, NEURON, V56, P66, DOI 10.1016/j.neuron.2007.08.008; Mahley RW, 1999, J LIPID RES, V40, P1; MENACHERRY S, 1992, ANAL CHEM, V64, P577, DOI 10.1021/ac00030a003; Meyer-Luehmann M, 2003, NAT NEUROSCI, V6, P370, DOI 10.1038/nn1022; Meyer-Luehmann M, 2008, NATURE, V451, P720, DOI 10.1038/nature06616; Pietrzik CU, 2002, EMBO J, V21, P5691, DOI 10.1093/emboj/cdf568; Quan G, 2003, DEV BRAIN RES, V146, P87, DOI 10.1016/j.devbrainres.2003.09.015; Retz W, 2001, PSYCHIATR GENET, V11, P115, DOI 10.1097/00041444-200109000-00002; Rodriguez E, 2006, AM J MED GENET B, V141B, P541, DOI 10.1002/ajmg.b.30341; Sisodia SS, 2002, NAT REV NEUROSCI, V3, P281, DOI 10.1038/nrn785; Soutar AK, 2007, NAT CLIN PRACT CARD, V4, P214, DOI 10.1038/ncpcardio0836; Steiner H, 2000, NAT REV MOL CELL BIO, V1, P217, DOI 10.1038/35043065; Taha AY, 2009, NEUROCHEM RES, V34, P311, DOI 10.1007/s11064-008-9777-7; Tamboli IY, 2008, J NEUROSCI, V28, P12097, DOI 10.1523/JNEUROSCI.2635-08.2008; Ulery PG, 2000, J BIOL CHEM, V275, P7410, DOI 10.1074/jbc.275.10.7410; Wahrle SE, 2005, J BIOL CHEM, V280, P43236, DOI 10.1074/jbc.M508780200; Wahrle SE, 2008, J CLIN INVEST, V118, P671, DOI 10.1172/JCI33622; Wang J, 2003, NEUROBIOL DIS, V14, P318, DOI 10.1016/j.nbd.2003.08.009; Wouters K, 2005, CLIN CHEM LAB MED, V43, P470, DOI 10.1515/CCLM.2005.085; Wyss-Coray T, 2006, NAT MED, V12, P1005, DOI 10.1038/nml1484; YOKODE M, 1990, SCIENCE, V250, P1273, DOI 10.1126/science.2244210; Yue X, 2005, P NATL ACAD SCI USA, V102, P19198, DOI 10.1073/pnas.0505203102; Zerbinatti CV, 2006, J BIOL CHEM, V281, P36180, DOI 10.1074/jbc.M604436200; Zerbinatti CV, 2004, P NATL ACAD SCI USA, V101, P1075, DOI 10.1073/pnas.0305803101; Zou FG, 2008, HUM MOL GENET, V17, P929, DOI 10.1093/hmg/ddm365	63	182	187	1	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 10	2009	64	5					632	644		10.1016/j.neuron.2009.11.013	http://dx.doi.org/10.1016/j.neuron.2009.11.013			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	537OW	20005821	Green Accepted, Bronze			2022-12-24	WOS:000273123700010
J	Khalsa, SS; Rudrauf, D; Feinstein, JS; Tranel, D				Khalsa, Sahib S.; Rudrauf, David; Feinstein, Justin S.; Tranel, Daniel			The pathways of interoceptive awareness	NATURE NEUROSCIENCE			English	Article							FEEL	A network of cortical brain regions, including the insula and anterior cingulate cortex (ACC), has been proposed as the critical and sole substrate for interoceptive awareness. Combining lesion and pharmacological approaches in humans, we found that the insula and ACC were not critical for awareness of heartbeat sensations. Instead, this awareness was mediated by both somatosensory afferents from the skin and a network that included the insula and ACC. Together, these pathways enable the core human experience of the cardiovascular state of the body.	[Khalsa, Sahib S.; Rudrauf, David; Tranel, Daniel] Univ Iowa, Dept Neurol, Iowa City, IA 52242 USA; [Khalsa, Sahib S.; Rudrauf, David; Tranel, Daniel] Univ Iowa, Neurosci Program, Iowa City, IA 52242 USA; [Khalsa, Sahib S.] Univ Iowa, Med Sci Training Program, Iowa City, IA 52242 USA; [Feinstein, Justin S.; Tranel, Daniel] Univ Iowa, Dept Psychol, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa; University of Iowa	Khalsa, SS (corresponding author), Univ Iowa, Dept Neurol, Iowa City, IA 52242 USA.	skhalsa@mednet.ucla.edu	Khalsa, Sahib S./ABA-8359-2020; Khalsa, Sahib S. S/Q-1434-2018	Khalsa, Sahib S./0000-0003-2124-8585; Khalsa, Sahib S. S/0000-0003-2124-8585; Tranel, Daniel/0000-0002-1338-1389	US National Center for Complementary & Alternative Medicine [F31-AT003061]; US National Institute on Drug Abuse [R01-DA022549]; US National Center for Research Resources, General Clinical Research Center Program [M01-RR-59]; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [F31AT003061] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000059] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007337] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA022549] Funding Source: NIH RePORTER	US National Center for Complementary & Alternative Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); US National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); US National Center for Research Resources, General Clinical Research Center Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank J. Bruss for figure assistance, S. Schubert and M. Bosch for isoproterenol administration, C. Sandesara, E. St. Louis, B. Olshansky and H. Shim for medical supervision, T. Grabowski for neurological expertise and J. Martins for safety monitoring. This work was supported by the US National Center for Complementary & Alternative Medicine (F31-AT003061), the US National Institute on Drug Abuse (R01-DA022549) and the US National Center for Research Resources, General Clinical Research Center Program (M01-RR-59).	Bechara A, 2004, NAT NEUROSCI, V7, P102, DOI 10.1038/nn0204-102; Cameron OG, 2001, PSYCHOSOM MED, V63, P697, DOI 10.1097/00006842-200109000-00001; Cameron OG, 2002, PSYCHOSOM MED, V64, P851, DOI 10.1097/01.PSY.0000038939.33335.32; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; Critchley HD, 2004, NAT NEUROSCI, V7, P189, DOI 10.1038/nn1176; Damasio A. R., 1999, FEELING WHAT HAPPENS; Dworkin BR, 2007, HANDBOOK OF PSYCHOPHYSIOLOGY, 3RD EDITION, P482, DOI 10.1017/CBO9780511546396.021; Feinstein JS, 2010, J CLIN EXP NEUROPSYC, V32, P88, DOI 10.1080/13803390903066873; Jones G.E., 1994, PERCEPTION VISCERAL; KHALSA S, 2009, PSYCHOPHYSIOLOG 0706, DOI DOI 10.1111/J.1469-8986.2009.00859.X; Khalsa SS, 2009, INT J PSYCHOPHYSIOL, V72, P34, DOI 10.1016/j.ijpsycho.2008.08.010; Pollatos O, 2007, BRAIN RES, V1141, P178, DOI 10.1016/j.brainres.2007.01.026; Rudrauf D, 2009, INT J PSYCHOPHYSIOL, V72, P13, DOI 10.1016/j.ijpsycho.2008.03.015; Van Oudenhove L, 2004, BEST PRACT RES CL GA, V18, P663, DOI 10.1016/j.bpg.2004.04.010	15	222	224	1	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2009	12	12					1494	1496		10.1038/nn.2411	http://dx.doi.org/10.1038/nn.2411			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	523II	19881506	Green Accepted			2022-12-24	WOS:000272065600008
J	Ichida, JK; Blanchard, J; Lam, K; Son, EY; Chung, JE; Egli, D; Loh, KM; Carter, AC; Di Giorgio, FP; Koszka, K; Huangfu, DW; Akutsu, H; Liu, DR; Rubin, LL; Eggan, K				Ichida, Justin K.; Blanchard, Joel; Lam, Kelvin; Son, Esther Y.; Chung, Julia E.; Egli, Dieter; Loh, Kyle M.; Carter, Ava C.; Di Giorgio, Francesco P.; Koszka, Kathryn; Huangfu, Danwei; Akutsu, Hidenori; Liu, David R.; Rubin, Lee L.; Eggan, Kevin			A Small-Molecule Inhibitor of Tgf-beta Signaling Replaces Sox2 in Reprogramming by Inducing Nanog	CELL STEM CELL			English	Article							PLURIPOTENT STEM-CELLS; HUMAN FIBROBLASTS; INDUCTION; GENERATION; MOUSE; POTENT; DIFFERENTIATION; OCT4	The combined activity of three transcription factors can reprogram adult cells into induced pluripotent stem cells (iPSCs). However, the transgenic methods used for delivering reprogramming factors have raised concerns regarding the future utility of the resulting stem cells. These uncertainties could be overcome if each transgenic factor were replaced with a small molecule that either directly activated its expression from the somatic genome or in some way compensated for its activity. To this end, we have used high-content chemical screening to identify small molecules that can replace Sox2 in reprogramming. We show that one of these molecules functions in reprogramming by inhibiting Tgf-beta signaling in a stable and trapped intermediate cell type that forms during the process. We find that this inhibition promotes the completion of reprogramming through induction of the transcription factor Nanog.	[Ichida, Justin K.; Blanchard, Joel; Lam, Kelvin; Son, Esther Y.; Chung, Julia E.; Egli, Dieter; Loh, Kyle M.; Carter, Ava C.; Di Giorgio, Francesco P.; Koszka, Kathryn; Huangfu, Danwei; Rubin, Lee L.; Eggan, Kevin] Harvard Univ, Harvard Stem Cell Inst, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Son, Esther Y.; Chung, Julia E.; Eggan, Kevin] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Ichida, Justin K.; Son, Esther Y.; Chung, Julia E.; Egli, Dieter; Carter, Ava C.; Di Giorgio, Francesco P.; Koszka, Kathryn; Eggan, Kevin] Stowers Med Inst, Kansas City, MO 64110 USA; [Akutsu, Hidenori] Natl Res Inst Child Hlth & Dev, Dept Reprod Biol, Setagaya Ku, Tokyo 1578535, Japan; [Son, Esther Y.; Liu, David R.] Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA; [Son, Esther Y.; Liu, David R.] Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA	Harvard University; Harvard University; Stowers Institute for Medical Research; National Center for Child Health & Development - Japan; Harvard University; Howard Hughes Medical Institute; Harvard University	Rubin, LL (corresponding author), Harvard Univ, Harvard Stem Cell Inst, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA.	lee_rubin@harvard.edu; eggan@mcb.harvard.edu	Eggan, Kevin/P-7119-2018; TCW, Julia/AED-4001-2022	TCW, Julia/0000-0002-3054-9374; Loh, Kyle/0000-0002-8042-0149; Carter, Ava/0000-0002-1892-8742; Huangfu, Danwei/0000-0002-1145-6199	Harvard Stem Cell Institute; NIH [R01 HD046732-01A1, GM065400]; NYSCF; Howard Hughes Medical Institute; Sankyo Foundation of Life Science; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD046732] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065400] Funding Source: NIH RePORTER	Harvard Stem Cell Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NYSCF; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Sankyo Foundation of Life Science; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Noggle, E. Kiskinis, A. Arvanites, S. Bobrowicz, L. Weisenthal, R. Maehr, A. Kweudjeu, R. Gali, M. Yamaki, E. Massassa, R. Martinez, and K. Rosowski for technical assistance and S. Sullivan, K. Niakan, K. Rodolfa, S. Mekhoubad, I. Tabansky, C. Sasaki, D. Melton, and S. Chen for helpful discussions. This work was made possible by support provided by the Harvard Stem Cell Institute to L.R. and K.E., by support from the NIH grant R01 HD046732-01A1 to K.E., and by an innovation grant from the NYSCF to L.R. E.S. and D.L. acknowledge support from the NIH (GM065400) and from the Howard Hughes Medical Institute. J.K.I. and F.P.D. are New York Stem Cell Foundation postdoctoral fellows. D.H. is a Helen Hay Whitney postdoctoral fellow. K.E. is a fellow of the John D. and Catherine T. MacArthur Foundation. H.A. was funded by the Sankyo Foundation of Life Science. The authors are filing a patent based on the results reported in this paper. L.L.R. is a founder of iPierian and a member of its scientific advisory board. K.E. is a member of the iPierian scientific advisory board.	Amabile G, 2009, TRENDS MOL MED, V15, P59, DOI 10.1016/j.molmed.2008.12.003; Attisano L, 2002, SCIENCE, V296, P1646, DOI 10.1126/science.1071809; Boiani M, 2004, METH MOL B, V254, P1; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P1269, DOI 10.1038/nbt.1502; Gellibert FO, 2004, J MED CHEM, V47, P4494, DOI 10.1021/jm0400247; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Kaji K, 2009, NATURE, V458, P771, DOI 10.1038/nature07864; Kim D, 2009, CELL STEM CELL, V4, P472, DOI 10.1016/j.stem.2009.05.005; Marson A, 2008, CELL STEM CELL, V3, P132, DOI 10.1016/j.stem.2008.06.019; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; Meissner A, 2007, NAT BIOTECHNOL, V25, P1177, DOI 10.1038/nbt1335; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Shi Y, 2008, CELL STEM CELL, V3, P568, DOI 10.1016/j.stem.2008.10.004; Shi Y, 2008, CELL STEM CELL, V2, P525, DOI 10.1016/j.stem.2008.05.011; Silva J, 2006, NATURE, V441, P997, DOI 10.1038/nature04914; Silva J, 2009, CELL, V138, P722, DOI 10.1016/j.cell.2009.07.039; Silva J, 2008, PLOS BIOL, V6, P2237, DOI 10.1371/journal.pbio.0060253; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Suzuki A, 2006, P NATL ACAD SCI USA, V103, P10294, DOI 10.1073/pnas.0506945103; Takahashi K, 2007, NAT PROTOC, V2, P3081, DOI 10.1038/nprot.2007.418; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; THRASHER A, 2007, SEVERE ADVERSE EVENT; Utikal J, 2009, J CELL SCI, V122, P3502, DOI 10.1242/jcs.054783; Vallier L, 2009, DEVELOPMENT, V136, P1339, DOI 10.1242/dev.033951; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Xu RH, 2008, CELL STEM CELL, V3, P196, DOI 10.1016/j.stem.2008.07.001; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	40	593	678	1	83	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	NOV 6	2009	5	5					491	503		10.1016/j.stem.2009.09.012	http://dx.doi.org/10.1016/j.stem.2009.09.012			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	522SR	19818703	Green Accepted, Green Published, Bronze			2022-12-24	WOS:000272019500011
J	Enomoto, A; Asai, N; Namba, T; Wang, Y; Kato, T; Tanaka, M; Tatsumi, H; Taya, S; Tsuboi, D; Kuroda, K; Kaneko, N; Sawamoto, K; Miyamoto, R; Jijiwa, M; Murakumo, Y; Sokabe, M; Seki, T; Kaibuchi, K; Takahashi, M				Enomoto, Atsushi; Asai, Naoya; Namba, Takashi; Wang, Yun; Kato, Takuya; Tanaka, Motoki; Tatsumi, Hitoshi; Taya, Shinichiro; Tsuboi, Daisuke; Kuroda, Keisuke; Kaneko, Naoko; Sawamoto, Kazunobu; Miyamoto, Rieko; Jijiwa, Mayumi; Murakumo, Yoshiki; Sokabe, Masahiro; Seki, Tatsunori; Kaibuchi, Kozo; Takahashi, Masahide			Roles of Disrupted-In-Schizophrenia 1-Interacting Protein Girdin in Postnatal Development of the Dentate Gyrus	NEURON			English	Article							NEURONAL POLARITY; DISC1; ADULT; DISRUPTED-IN-SCHIZOPHRENIA-1; NEUROGENESIS; MECHANISMS; EXPRESSION; MIGRATION; TRANSPORT; MOTILITY	Disrupted-in-Schizophrenia 1 (DISC1), a susceptibility gene for major psychiatric disorders, regulates neuronal migration and differentiation during mammalian brain development. Although roles for DISC1 in postnatal neurogenesis in the dentate gyrus (DG) have recently emerged, it is not known how DISC1 and its interacting proteins govern the migration, positioning, and differentiation of dentate granule cells (DGCs). Here, we report that DISC1 interacts with the actin-binding protein girdin to regulate axonal development. DGCs in girdin-deficient neonatal mice exhibit deficits in axonal sprouting in the cornu ammonis 3 region of the hippocampus.' Girdin deficiency, RNA interference-mediated knockdown, and inhibition of the DISC1/girdin interaction lead to overextended migration and mispositioning of the DGCs resulting in profound cytoarchitectural disorganization of the DG. These findings identify girdin as an intrinsic factor in postnatal development of the DG and provide insights into the critical role of the DISC1/girdin interaction in postnatal neurogenesis in the DG.	[Enomoto, Atsushi; Asai, Naoya; Wang, Yun; Kato, Takuya; Miyamoto, Rieko; Jijiwa, Mayumi; Murakumo, Yoshiki; Takahashi, Masahide] Nagoya Univ, Grad Sch Med, Dept Pathol, Showa Ku, Nagoya, Aichi 4668550, Japan; [Tatsumi, Hitoshi; Sokabe, Masahiro] Nagoya Univ, Grad Sch Med, Dept Physiol, Showa Ku, Nagoya, Aichi 4668550, Japan; [Taya, Shinichiro; Tsuboi, Daisuke; Kuroda, Keisuke; Kaibuchi, Kozo] Nagoya Univ, Grad Sch Med, Dept Cell Pharmacol, Showa Ku, Nagoya, Aichi 4668550, Japan; [Enomoto, Atsushi] Nagoya Univ, Inst Adv Res, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Namba, Takashi] Natl Inst Neurosci, Dept Neurochem, Kodaira, Tokyo 1878502, Japan; [Namba, Takashi; Seki, Tatsunori] Juntendo Univ, Sch Med, Dept Anat, Bunkyo Ku, Tokyo 1138421, Japan; [Tanaka, Motoki; Sokabe, Masahiro] Japan Sci & Technol Agcy, Int Cooperat Res Project Solut Oriented Res Sci &, Cell Mechanosensing, Nagoya, Aichi 4668550, Japan; [Taya, Shinichiro; Tsuboi, Daisuke; Kuroda, Keisuke; Kaibuchi, Kozo] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320012, Japan; [Kaneko, Naoko; Sawamoto, Kazunobu] Nagoya City Univ, Grad Sch Med Sci, Inst Mol Med, Dept Dev & Regenerat Biol,Mizuho Ku, Nagoya, Aichi 4678601, Japan; [Enomoto, Atsushi; Seki, Tatsunori] Tohoku Univ, Grad Sch Med, Ctr Translat & Adv Anim Res, Div Dev Neurosci,Aoba Ku, Sendai, Miyagi 9808575, Japan	Nagoya University; Nagoya University; Nagoya University; Nagoya University; National Center for Neurology & Psychiatry - Japan; Juntendo University; Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST); Nagoya City University; Tohoku University	Enomoto, A (corresponding author), Nagoya Univ, Grad Sch Med, Dept Pathol, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	enomoto@iar.nagoya-u.ac.jp; mtakaha@med.nagoya-u.ac.jp	Enomoto, Atsushi/I-7272-2014; Namba, Takashi/AAE-4439-2022; Sokabe, Masahiro/I-1565-2012; Kuroda, Keisuke/K-5255-2013; Takahashi, Masahide/AAN-4770-2020; TANAKA, Motoki/I-7299-2014; Namba, Takashi/ABF-4571-2020; Kaneko, Naoko/P-2054-2019; TAKAHASHI, Masahide/I-7244-2014; ASAI, Naoya/I-7377-2014	Enomoto, Atsushi/0000-0002-9206-6116; Kuroda, Keisuke/0000-0002-6715-5125; Takahashi, Masahide/0000-0002-2803-2683; Namba, Takashi/0000-0003-4875-666X; Kaneko, Naoko/0000-0003-3121-7117; Sawamoto, Kazunobu/0000-0003-1984-5129	Special Coordination Funds for Promoting Science and Technology (SCF)	Special Coordination Funds for Promoting Science and Technology (SCF)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We gratefully acknowledge A. Sawa (Johns Hopkins University School of Medicine) for providing cDNA for mouse DISC1 and T. Akiyama (Tokyo University, Japan) for providing anti-DISC1 antibody. We thank M. Sugiyama and T. Yoshimura (Nagoya University) for assistance with culturing of hippocampal neurons, and T. Miyata (Nagoya University), T. Shinoda (Aichi Human Service Center), and T. Hikita (Nagoya City University) for helpful discussions. This work was supported by Grants-in-Aid for Global Center of Excellence (GCOE) Research, Scientific Research (A), and Scientific Research on Priority Area 'Cancer' (to M.T.); the Program for Improvement of Research Environment for Young Researchers from Special Coordination Funds for Promoting Science and Technology (SCF) (to A.E.) commissioned by the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; and the Uehara Memorial Foundation (to A.E.).	ALTMAN J, 1990, J COMP NEUROL, V301, P365, DOI 10.1002/cne.903010304; Anai M, 2005, J BIOL CHEM, V280, P18525, DOI 10.1074/jbc.M500586200; Arimura N, 2007, NAT REV NEUROSCI, V8, P194, DOI 10.1038/nrn2056; Austin CP, 2004, NEUROSCIENCE, V124, P3, DOI 10.1016/j.neuroscience.2003.11.010; Brandon NJ, 2007, BIOCHEM SOC T, V35, P1283, DOI 10.1042/BST0351283; Camargo LM, 2007, MOL PSYCHIATR, V12, P74, DOI 10.1038/sj.mp.4001880; Dranovsky A, 2007, CELL, V130, P981, DOI 10.1016/j.cell.2007.09.004; Duan X, 2007, CELL, V130, P1146, DOI 10.1016/j.cell.2007.07.010; Enomoto A, 2005, DEV CELL, V9, P389, DOI 10.1016/j.devcel.2005.08.001; Faulkner RL, 2008, P NATL ACAD SCI USA, V105, P14157, DOI 10.1073/pnas.0806658105; Galichet C, 2008, DEVELOPMENT, V135, P2031, DOI 10.1242/dev.015115; Garcia-Marcos M, 2009, P NATL ACAD SCI USA, V106, P3178, DOI 10.1073/pnas.0900294106; Ishizuka K, 2006, BIOL PSYCHIAT, V59, P1189, DOI 10.1016/j.biopsych.2006.03.065; Jiang H, 2005, CELL, V120, P123, DOI 10.1016/j.cell.2004.12.033; Jiang P, 2008, CANCER RES, V68, P1310, DOI 10.1158/0008-5472.CAN-07-5111; Kamiya A, 2005, NAT CELL BIOL, V7, P1167, DOI 10.1038/ncb1328; Kitamura T, 2008, NAT CELL BIOL, V10, P329, DOI 10.1038/ncb1695; Koike H, 2006, P NATL ACAD SCI USA, V103, P3693, DOI 10.1073/pnas.0511189103; Kvajo M, 2008, P NATL ACAD SCI USA, V105, P7076, DOI 10.1073/pnas.0802615105; Laplagne DA, 2006, PLOS BIOL, V4, P2349, DOI 10.1371/journal.pbio.0040409; Le-Niculescu H, 2005, J BIOL CHEM, V280, P22012, DOI 10.1074/jbc.M501833200; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Li GN, 2007, PROG BRAIN RES, V163, P143, DOI 10.1016/S0079-6123(07)63008-8; Mackie S, 2007, CURR OPIN NEUROBIOL, V17, P95, DOI 10.1016/j.conb.2007.01.007; Mao YW, 2009, CELL, V136, P1017, DOI 10.1016/j.cell.2008.12.044; Millar JK, 2005, SCIENCE, V310, P1187, DOI 10.1126/science.1112915; Millar JK, 2000, HUM MOL GENET, V9, P1415, DOI 10.1093/hmg/9.9.1415; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Miyoshi K, 2003, MOL PSYCHIATR, V8, P685, DOI 10.1038/sj.mp.4001352; Namba T, 2005, EUR J NEUROSCI, V22, P1928, DOI 10.1111/j.1460-9568.2005.04396.x; Ozeki Y, 2003, P NATL ACAD SCI USA, V100, P289, DOI 10.1073/pnas.0136913100; Schurov IL, 2004, MOL PSYCHIATR, V9, P1100, DOI 10.1038/sj.mp.4001574; Seki T, 2007, J COMP NEUROL, V502, P275, DOI 10.1002/cne.21301; Shinoda T, 2007, J NEUROSCI, V27, P4, DOI 10.1523/JNEUROSCI.3825-06.2007; Simpson F, 2005, TRAFFIC, V6, P442, DOI 10.1111/j.1600-0854.2005.00289.x; Tashiro A, 2006, NAT PROTOC, V1, P3049, DOI 10.1038/nprot.2006.473; Taya S, 2007, J NEUROSCI, V27, P15, DOI 10.1523/JNEUROSCI.3826-06.2006; van Praag H, 2005, J NEUROSCI, V25, P8680, DOI 10.1523/JNEUROSCI.1731-05.2005; Yamashita T, 2006, J NEUROSCI, V26, P6627, DOI 10.1523/JNEUROSCI.0149-06.2006; Yoshimura T, 2006, BIOCHEM BIOPH RES CO, V340, P62, DOI 10.1016/j.bbrc.2005.11.147; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	41	133	141	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 24	2009	63	6					774	787		10.1016/j.neuron.2009.08.015	http://dx.doi.org/10.1016/j.neuron.2009.08.015			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	503VP	19778507	Bronze			2022-12-24	WOS:000270569700011
J	Yuasa-Kawada, J; Kinoshita-Kawada, M; Wu, G; Rao, Y; Wu, JY				Yuasa-Kawada, Junichi; Kinoshita-Kawada, Mariko; Wu, Guan; Rao, Yi; Wu, Jane Y.			Midline crossing and Slit responsiveness of commissural axons require USP33	NATURE NEUROSCIENCE			English	Article							LINDAU TUMOR-SUPPRESSOR; GUIDANCE; MECHANISMS; ROLES; PROTEINS; RECEPTOR	Commissural axons cross the ventral midline of the neural tube in a Slit-dependent manner. The underlying molecular mechanisms remain unclear. We found that the deubiquitinating enzyme USP33 interacts with the Robo1 receptor. USP33 was essential for midline crossing by commissural axons and for their response to Slit. Our results reveal a previously unknown role for USP33 in vertebrate commissural axon guidance and in Slit signaling.	[Yuasa-Kawada, Junichi; Kinoshita-Kawada, Mariko; Wu, Jane Y.] Northwestern Univ, Feinberg Sch Med, Lurie Comprehens Canc Ctr, Ctr Genet Med,Dept Neurol, Chicago, IL 60611 USA; [Wu, Guan] Univ Rochester, Med Ctr, Dept Urol, Rochester, NY 14642 USA; [Rao, Yi] Peking Univ, Sch Life Sci, Beijing 100871, Peoples R China	Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center; University of Rochester; Peking University	Rao, Y (corresponding author), Northwestern Univ, Feinberg Sch Med, Lurie Comprehens Canc Ctr, Ctr Genet Med,Dept Neurol, Chicago, IL 60611 USA.	yrao@pku.edu.cn; jane-wu@northwestern.edu		Yuasa-Kawada, Junichi/0000-0002-1382-3159	James S. McDonnell Foundation [220020180]; US National Institutes of Health [CA114197, CA107193]; NATIONAL CANCER INSTITUTE [R01CA114197, R01CA107193] Funding Source: NIH RePORTER	James S. McDonnell Foundation; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Y. Zou and F. Murakami for generously providing the Sema3F construct and the antibody to Robo1, respectively, M. Katakura for support during this work and X. Chen for excellent technical support. This work has been supported by the James S. McDonnell Foundation (grant JSMF 220020180 to J. Y. W.) and the US National Institutes of Health (grants CA114197 and CA107193 to J. Y. W.).	Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Guan KL, 2003, NAT REV NEUROSCI, V4, P941, DOI 10.1038/nrn1254; KeinoMasu K, 1996, CELL, V87, P175, DOI 10.1016/S0092-8674(00)81336-7; Li ZB, 2002, BIOCHEM BIOPH RES CO, V294, P700, DOI 10.1016/S0006-291X(02)00534-X; Li ZB, 2002, J BIOL CHEM, V277, P4656, DOI 10.1074/jbc.M108269200; Long H, 2004, NEURON, V42, P213, DOI 10.1016/S0896-6273(04)00179-5; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Okada A, 2006, NATURE, V444, P369, DOI 10.1038/nature05246; Piper M, 2006, NEURON, V49, P215, DOI 10.1016/j.neuron.2005.12.008; Sabatier C, 2004, CELL, V117, P157, DOI 10.1016/S0092-8674(04)00303-4; STOECKLI ET, 1995, NEURON, V14, P1165, DOI 10.1016/0896-6273(95)90264-3; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Wong K, 2001, CELL, V107, P209, DOI 10.1016/S0092-8674(01)00530-X; Wu JY, 2001, NATURE, V410, P948, DOI 10.1038/35073616; Zoo YM, 2000, CELL, V102, P363, DOI 10.1016/S0092-8674(00)00041-6	15	41	44	1	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2009	12	9					1087	1089		10.1038/nn.2382	http://dx.doi.org/10.1038/nn.2382			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	487ZD	19684588	Green Accepted			2022-12-24	WOS:000269317300007
J	Buschman, TJ; Miller, EK				Buschman, Timothy J.; Miller, Earl K.			Serial, Covert Shifts of Attention during Visual Search Are Reflected by the Frontal Eye Fields and Correlated with Population Oscillations	NEURON			English	Article							DORSOLATERAL PREFRONTAL CORTEX; LATERAL INTRAPARIETAL AREA; TOP-DOWN CONTROL; NEURAL MECHANISMS; NEURONAL SYNCHRONIZATION; SPATIAL ATTENTION; PARIETAL CORTEX; MODULATION; MACAQUE; MICROSTIMULATION	Attention regulates the flood of sensory information into a manageable stream, and so understanding how attention is controlled is central to understanding cognition. Competing theories suggest visual search involves serial and/or parallel allocation of attention, but there is little direct, neural evidence for either mechanism. Two monkeys were trained to covertly search an array for a target stimulus under visual search (endogenous) and pop-out (exogenous) conditions. Here, we present neural evidence in the frontal eye fields (FEF) for serial, covert shifts of attention during search but not pop-out. Furthermore, attention shifts reflected in FEF spiking activity were correlated with 18-34 Hz oscillations in the local field potential, suggesting a "clocking" signal. This provides direct neural evidence that primates can spontaneously adopt a serial search strategy and that these serial covert shifts of attention are directed by the FEF. It also suggests that neuron population oscillations may regulate the timing of cognitive processing.	[Buschman, Timothy J.; Miller, Earl K.] MIT, Picower Inst Learning & Memory, Cambridge, MA 02139 USA; [Buschman, Timothy J.; Miller, Earl K.] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Northwell Health; Massachusetts Institute of Technology (MIT)	Buschman, TJ (corresponding author), MIT, Picower Inst Learning & Memory, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	buschman@mit.edu	Buschman, Timothy J/B-3056-2009; Miller, Earl K./AAE-8187-2019	Buschman, Timothy J/0000-0003-1298-2761; Miller, Earl K./0000-0002-0582-6958	NSF CELEST [SBE0354378]; National Institute of Neurological Disorders and Stroke [R01NS035145]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035145] Funding Source: NIH RePORTER	NSF CELEST; National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NSF CELEST grant SBE0354378 and National Institute of Neurological Disorders and Stroke grant R01NS035145. We thank S. Henrickson and M. Wicherski for comments on the manuscript; W. Asaad, J. Roy, M. Siegel, and K. Maccully for technical and other support.	Armstrong KM, 2007, P NATL ACAD SCI USA, V104, P9499, DOI 10.1073/pnas.0701104104; Barcelo F, 2000, NAT NEUROSCI, V3, P399, DOI 10.1038/73975; Bichot NP, 2005, SCIENCE, V308, P529, DOI 10.1126/science.1109676; Bichot NP, 1999, NAT NEUROSCI, V2, P549, DOI 10.1038/9205; Bisley JW, 2003, SCIENCE, V299, P81, DOI 10.1126/science.1077395; Bressler SL, 2008, J NEUROSCI, V28, P10056, DOI 10.1523/JNEUROSCI.1776-08.2008; BRUCE CJ, 1985, J NEUROPHYSIOL, V53, P607; Buschman TJ, 2007, SCIENCE, V315, P1860, DOI 10.1126/science.1138071; Busse L, 2008, P NATL ACAD SCI USA, V105, P16380, DOI 10.1073/pnas.0707369105; Casey BJ, 2001, HUM BRAIN MAPP, V13, P26, DOI 10.1002/hbm.1022; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; DUNCAN J, 1989, PSYCHOL REV, V96, P433, DOI 10.1037/0033-295X.96.3.433; DUNCAN J, 1994, NATURE, V369, P313, DOI 10.1038/369313a0; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; Fries P, 2008, J NEUROSCI, V28, P4823, DOI 10.1523/JNEUROSCI.4499-07.2008; FUNAHASHI S, 1989, J NEUROPHYSIOL, V61, P331, DOI 10.1152/jn.1989.61.2.331; FUSTER JM, 1971, SCIENCE, V173, P652, DOI 10.1126/science.173.3997.652; Fuster JM, 2008, PREFRONTAL CORTEX, 4TH EDITION, P1; HIKOSAKA O, 1993, VISION RES, V33, P1219, DOI 10.1016/0042-6989(93)90210-N; Hopfinger JB, 2000, NAT NEUROSCI, V3, P284, DOI 10.1038/72999; INHOFF AW, 1989, Q J EXP PSYCHOL-A, V41, P63, DOI 10.1080/14640748908402353; Ipata AE, 2006, J NEUROSCI, V26, P3656, DOI 10.1523/JNEUROSCI.5074-05.2006; Kline K, 2004, VISION RES, V44, P2653, DOI 10.1016/j.visres.2004.05.030; Kusunoki M, 2010, J COGNITIVE NEUROSCI, V22, P751, DOI 10.1162/jocn.2009.21216; Landau AN, 2007, J NEUROSCI, V27, P11986, DOI 10.1523/JNEUROSCI.3092-07.2007; Maunsell JHR, 2006, TRENDS NEUROSCI, V29, P317, DOI 10.1016/j.tins.2006.04.001; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Miller EK, 1996, J NEUROSCI, V16, P5154; Moore T, 2004, J NEUROPHYSIOL, V91, P152, DOI 10.1152/jn.00741.2002; Moore T, 2003, NATURE, V421, P370, DOI 10.1038/nature01341; Opris I, 2005, J COGNITIVE NEUROSCI, V17, P893, DOI 10.1162/0898929054021120; Pesaran B, 2008, NATURE, V453, P406, DOI 10.1038/nature06849; Pessoa L, 2003, J NEUROSCI, V23, P3990; Peterson MS, 2004, PERCEPT PSYCHOPHYS, V66, P398, DOI 10.3758/BF03194888; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; Reynolds JH, 2004, ANNU REV NEUROSCI, V27, P611, DOI 10.1146/annurev.neuro.26.041002.131039; RIZZOLATTI G, 1987, NEUROPSYCHOLOGIA, V25, P31, DOI 10.1016/0028-3932(87)90041-8; Rossi AF, 2007, J NEUROSCI, V27, P11306, DOI 10.1523/JNEUROSCI.2939-07.2007; Ruff CC, 2008, CEREB CORTEX, V18, P817, DOI 10.1093/cercor/bhm128; Siegel M, 2008, NEURON, V60, P709, DOI 10.1016/j.neuron.2008.09.010; Taylor PCJ, 2008, J NEUROPHYSIOL, V100, P1397, DOI 10.1152/jn.90241.2008; Thompson KG, 1997, J NEUROPHYSIOL, V77, P1046, DOI 10.1152/jn.1997.77.2.1046; Thornton TL, 2007, PSYCHOL REV, V114, P71, DOI 10.1037/0033-295X.114.1.71; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; VanRullen R, 2005, P NATL ACAD SCI USA, V102, P5291, DOI 10.1073/pnas.0409172102; VanRullen R, 2003, TRENDS COGN SCI, V7, P207, DOI 10.1016/S1364-6613(03)00095-0; VanRullen R, 2007, P NATL ACAD SCI USA, V104, P19204, DOI 10.1073/pnas.0707316104; WOLFE JM, 1989, J EXP PSYCHOL HUMAN, V15, P419, DOI 10.1037/0096-1523.15.3.419; Wolfe JM, 2004, NAT REV NEUROSCI, V5, P495, DOI 10.1038/nrn1411; Womelsdorf T, 2007, CURR OPIN NEUROBIOL, V17, P154, DOI 10.1016/j.conb.2007.02.002; Woodman GF, 1999, NATURE, V400, P867, DOI 10.1038/23698	53	167	200	0	22	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 13	2009	63	3					386	396		10.1016/j.neuron.2009.06.020	http://dx.doi.org/10.1016/j.neuron.2009.06.020			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	487OY	19679077	Green Accepted, Bronze, Green Submitted			2022-12-24	WOS:000269285500012
J	Hu, WQ; Tian, CP; Li, T; Yang, MP; Hou, H; Shu, YS				Hu, Wenqin; Tian, Cuiping; Li, Tun; Yang, Mingpo; Hou, Han; Shu, Yousheng			Distinct contributions of Na(v)1.6 and Na(v)1.2 in action potential initiation and backpropagation	NATURE NEUROSCIENCE			English	Article							SODIUM-CHANNELS; ION CHANNELS; SEGMENT; ACTIVATION; NEURONS; MODEL; SITE; PROPAGATION; CHANDELIER; RECEPTORS	The distal end of the axon initial segment (AIS) is the preferred site for action potential initiation in cortical pyramidal neurons because of its high Na+ channel density. However, it is not clear why action potentials are not initiated at the proximal AIS, which has a similarly high Na+ channel density. We found that low-threshold Na(v)1.6 and high-threshold Na(v)1.2 channels preferentially accumulate at the distal and proximal AIS, respectively, and have distinct functions in action potential initiation and backpropagation. Patch-clamp recording from the axon cut end of pyramidal neurons in the rat prefrontal cortex revealed a high density of Na+ current and a progressive reduction in the half-activation voltage (up to 14 mV) with increasing distance from the soma at the AIS. Further modeling studies and simultaneous somatic and axonal recordings showed that distal Na(v)1.6 promotes action potential initiation, whereas proximal Na(v)1.2 promotes its backpropagation to the soma.	[Hu, Wenqin; Tian, Cuiping; Li, Tun; Yang, Mingpo; Hou, Han; Shu, Yousheng] Chinese Acad Sci, Shanghai Inst Biol Sci, State Key Lab Neurosci, Inst Neurosci, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Shu, YS (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, State Key Lab Neurosci, Inst Neurosci, Shanghai, Peoples R China.	shu@ion.ac.cn	Shu, Yousheng/AAC-3881-2020; Li, Tun/F-8928-2018; Hou, Han/GLR-4583-2022	Shu, Yousheng/0000-0002-2834-2876; Hou, Han/0000-0002-4590-7891; Li, Tun/0000-0002-6424-8051	973 Program [2006CB806600]; Shanghai Commission of Science and Technology [06DJ14010]; Shanghai Pujiang Program [07PJ14108]; Chinese Academy of Sciences [KSCX2-YW-R-102]; Scientific Research Foundation of the State Human Resource Ministry and the Education Ministry	973 Program(National Basic Research Program of China); Shanghai Commission of Science and Technology(Shanghai Science & Technology Committee); Shanghai Pujiang Program(Shanghai Pujiang Program); Chinese Academy of Sciences(Chinese Academy of Sciences); Scientific Research Foundation of the State Human Resource Ministry and the Education Ministry	We thank M. M. Poo, D. A. McCormick and M. H. Kole for their valuable comments on this work. We are also grateful to Y. Yu for his help in computer modeling. This work was supported by the 973 Program (2006CB806600), a Shanghai Commission of Science and Technology grant (06DJ14010), the Shanghai Pujiang Program (07PJ14108), the Hundreds of Talents Program and Knowledge Innovation Project from Chinese Academy of Sciences (KSCX2-YW-R-102), and Projects of the Scientific Research Foundation of the State Human Resource Ministry and the Education Ministry.	Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Boiko T, 2001, NEURON, V30, P91, DOI 10.1016/S0896-6273(01)00265-3; Boiko T, 2003, J NEUROSCI, V23, P2306; Clark BA, 2005, NAT NEUROSCI, V8, P137, DOI 10.1038/nn1390; Colbert CM, 1996, J NEUROSCI, V16, P6676; Colbert CM, 1998, J NEUROPHYSIOL, V79, P491, DOI 10.1152/jn.1998.79.1.491; Colbert CM, 2002, NAT NEUROSCI, V5, P533, DOI 10.1038/nn857; COOMBS JS, 1957, J PHYSIOL-LONDON, V139, P198, DOI 10.1113/jphysiol.1957.sp005887; DODGE FA, 1973, IBM J RES DEV, V17, P219, DOI 10.1147/rd.173.0219; Duflocq A, 2008, MOL CELL NEUROSCI, V39, P180, DOI 10.1016/j.mcn.2008.06.008; Eccles J. C, 1957, PHYSL NERVE CELLS; Engel D, 2005, NEURON, V45, P405, DOI 10.1016/j.neuron.2004.12.048; FATT P, 1957, J NEUROPHYSIOL, V20, P61, DOI 10.1152/jn.1957.20.1.61; FUORTES MGF, 1957, J GEN PHYSIOL, V40, P735, DOI 10.1085/jgp.40.5.735; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Howard A, 2005, TRENDS NEUROSCI, V28, P310, DOI 10.1016/j.tins.2005.04.004; Inda MC, 2006, P NATL ACAD SCI USA, V103, P2920, DOI 10.1073/pnas.0511197103; Kampa BM, 2006, J PHYSIOL-LONDON, V574, P283, DOI 10.1113/jphysiol.2006.111062; Kampa BM, 2004, J PHYSIOL-LONDON, V556, P337, DOI 10.1113/jphysiol.2003.058842; Kaplan MR, 2001, NEURON, V30, P105, DOI 10.1016/S0896-6273(01)00266-5; Kole MHP, 2008, NAT NEUROSCI, V11, P1253, DOI 10.1038/nn.2203; Kole MHP, 2008, NAT NEUROSCI, V11, P178, DOI 10.1038/nn2040; Kole MHP, 2007, NEURON, V55, P633, DOI 10.1016/j.neuron.2007.07.031; Komai S, 2006, NAT NEUROSCI, V9, P1125, DOI 10.1038/nn1752; Lorincz A, 2008, J NEUROSCI, V28, P14329, DOI 10.1523/JNEUROSCI.4833-08.2008; Mainen ZF, 1995, NEURON, V15, P1427, DOI 10.1016/0896-6273(95)90020-9; Mainen ZF, 1996, NATURE, V382, P363, DOI 10.1038/382363a0; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; McCormick DA, 2007, NATURE, V445, pE1, DOI 10.1038/nature05523; Meeks JP, 2007, J NEUROPHYSIOL, V97, P3460, DOI 10.1152/jn.01288.2006; Milojkovic BA, 2005, J MEMBRANE BIOL, V208, P155, DOI 10.1007/s00232-005-0827-7; MOORE JW, 1983, J PHYSIOL-LONDON, V336, P301, DOI 10.1113/jphysiol.1983.sp014582; Naundorf B, 2006, NATURE, V440, P1060, DOI 10.1038/nature04610; Palmer LM, 2006, J NEUROSCI, V26, P1854, DOI 10.1523/JNEUROSCI.4812-05.2006; Rapp M, 1996, P NATL ACAD SCI USA, V93, P11985, DOI 10.1073/pnas.93.21.11985; Royeck M, 2008, J NEUROPHYSIOL, V100, P2361, DOI 10.1152/jn.90332.2008; Rush AM, 2005, J PHYSIOL-LONDON, V564, P803, DOI 10.1113/jphysiol.2005.083089; SATHER W, 1992, J PHYSIOL-LONDON, V450, P643, DOI 10.1113/jphysiol.1992.sp019148; Shu YS, 2007, P NATL ACAD SCI USA, V104, P11453, DOI 10.1073/pnas.0702041104; Shu YS, 2007, J NEUROPHYSIOL, V97, P746, DOI 10.1152/jn.00922.2006; Shu YS, 2006, NATURE, V441, P761, DOI 10.1038/nature04720; Shu YS, 2003, NATURE, V423, P288, DOI 10.1038/nature01616; SJORSTROM PJ, 2001, NEURON, V32, P1149; STERIADE M, 1993, J NEUROSCI, V13, P3252, DOI 10.1523/jneurosci.13-08-03252.1993; Stuart G, 1997, TRENDS NEUROSCI, V20, P125, DOI 10.1016/S0166-2236(96)10075-8; Stuart G, 1997, J PHYSIOL-LONDON, V505, P617, DOI 10.1111/j.1469-7793.1997.617ba.x; Van Wart A, 2007, J COMP NEUROL, V500, P339, DOI 10.1002/cne.21173; WOLLNER DA, 1986, P NATL ACAD SCI USA, V83, P8424, DOI 10.1073/pnas.83.21.8424; Yu YG, 2008, J NEUROSCI, V28, P7260, DOI 10.1523/JNEUROSCI.1613-08.2008	50	447	460	1	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2009	12	8					996	U61		10.1038/nn.2359	http://dx.doi.org/10.1038/nn.2359			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	475WS	19633666				2022-12-24	WOS:000268396300013
J	Alexandre, P; Reugels, AM; Barker, D; Blanc, E; Clarke, JDW				Alexandre, Paula; Reugels, Alexander M.; Barker, David; Blanc, Eric; Clarke, Jonathan D. W.			Neurons derive from the more apical daughter in asymmetric divisions in the zebrafish neural tube	NATURE NEUROSCIENCE			English	Article							INTERKINETIC NUCLEAR MIGRATION; NEUROEPITHELIAL CELLS; SPINDLE ORIENTATION; PROGENITOR CELLS; VERTEBRATE RETINOGENESIS; MAMMALIAN NEUROGENESIS; CORTICAL NEUROGENESIS; PLANAR DIVISIONS; CEREBRAL-CORTEX; STEM-CELLS	In the developing CNS, asymmetric cell division is critical for maintaining the balanced production of differentiating neurons while renewing the population of neural progenitors. In invertebrates, this process depends on asymmetric inheritance of fate determinants during progenitor divisions. A similar mechanism is widely believed to underlie asymmetrically fated divisions in vertebrates, but compelling evidence for this is missing. We used live imaging of individual progenitors in the intact zebrafish embryo CNS to test this hypothesis. We found that asymmetric inheritance of a subcellular domain is strongly correlated with asymmetric daughter fates and our results reveal an unexpected feature of this process. The daughter cell destined to become a neuron was derived from the more apical of the two daughters, whereas the more basal daughter inherited the basal process and replenished the apical progenitor pool.	[Alexandre, Paula; Barker, David; Blanc, Eric; Clarke, Jonathan D. W.] Kings Coll London, MRC Ctr Dev Neurobiol, London WC2R 2LS, England; [Reugels, Alexander M.] Univ Cologne, Inst Entwicklungsphysiol, D-5000 Cologne, Germany	University of London; King's College London; University of Cologne	Clarke, JDW (corresponding author), Kings Coll London, MRC Ctr Dev Neurobiol, London WC2R 2LS, England.	jon.clarke@kcl.ac.uk	Alexandre, Paula/ABE-7203-2020; Zebrafish, UCL/A-3125-2009; Alexandre, Paula/D-8187-2012; Barker, David JP/A-5671-2013	Alexandre, Paula/0000-0002-6333-6199; 	European Molecular Biology Organization [ALTF-764-2005]; EU [IEF 039695]; Medical Research Council [G0901899B, G0900650] Funding Source: researchfish; MRC [G0900650] Funding Source: UKRI	European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); EU(European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank C. Araya, C. Buckley, K. Cerveny, G. Girdler, A. Lumsden, X. Ren, M. Tada, M. Tawk and M. Wassef for discussions and comments on the manuscript and the University College London and King's College London fish facilities for providing and taking care of the fish. We thank F. Mahmood for the aPKC immunostaining. P.A. was supported by an European Molecular Biology Organization fellowship (ALTF-764-2005) and an EU Marie Curie fellowship (IEF 039695).	Afonso C, 2006, J CELL SCI, V119, P4293, DOI 10.1242/jcs.03170; Attardo A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002388; Baye LM, 2007, J NEUROSCI, V27, P10143, DOI 10.1523/JNEUROSCI.2754-07.2007; Bultje RS, 2009, NEURON, V63, P189, DOI 10.1016/j.neuron.2009.07.004; Calegari F, 2005, J NEUROSCI, V25, P6533, DOI 10.1523/JNEUROSCI.0778-05.2005; Cayouette M, 2003, NEURON, V40, P897, DOI 10.1016/S0896-6273(03)00756-6; Cayouette M, 2003, DEVELOPMENT, V130, P2329, DOI 10.1242/dev.00446; CHENN A, 1995, CELL, V82, P631, DOI 10.1016/0092-8674(95)90035-7; Costa MR, 2008, DEVELOPMENT, V135, P11, DOI 10.1242/dev.009951; Coumailleau F, 2009, NATURE, V458, P1051, DOI 10.1038/nature07854; Cui S, 2007, MOL CELL NEUROSCI, V34, P431, DOI 10.1016/j.mcn.2006.11.016; Del Bene F, 2008, CELL, V134, P1055, DOI 10.1016/j.cell.2008.07.017; Georgiou M, 2008, CURR BIOL, V18, P1631, DOI 10.1016/j.cub.2008.09.029; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Henrique D, 1997, CURR BIOL, V7, P661, DOI 10.1016/S0960-9822(06)00293-4; Hodge RD, 2004, J NEUROSCI, V24, P10201, DOI 10.1523/JNEUROSCI.3246-04.2004; Huttner WB, 1997, CURR OPIN NEUROBIOL, V7, P29, DOI 10.1016/S0959-4388(97)80117-1; Iacopetti P, 1999, P NATL ACAD SCI USA, V96, P4639, DOI 10.1073/pnas.96.8.4639; Konno D, 2008, NAT CELL BIOL, V10, P93, DOI 10.1038/ncb1673; Kosodo Y, 2004, EMBO J, V23, P2314, DOI 10.1038/sj.emboj.7600223; Kosodo Y, 2008, EMBO J, V27, P3151, DOI 10.1038/emboj.2008.227; Langevin J, 2005, CURR BIOL, V15, P955, DOI 10.1016/j.cub.2005.04.054; Le Borgne R, 2006, CURR OPIN CELL BIOL, V18, P213, DOI 10.1016/j.ceb.2006.02.011; Leibfried A, 2008, CURR BIOL, V18, P1639, DOI 10.1016/j.cub.2008.09.063; Manabe N, 2002, DEV DYNAM, V225, P61, DOI 10.1002/dvdy.10139; Marthiens V, 2009, EMBO REP, V10, P515, DOI 10.1038/embor.2009.36; McCaffrey LM, 2009, GENE DEV, V23, P1450, DOI 10.1101/gad.1795909; Miyata T, 2001, NEURON, V31, P727, DOI 10.1016/S0896-6273(01)00420-2; Morin X, 2007, NAT NEUROSCI, V10, P1440, DOI 10.1038/nn1984; Nakayama Y, 2009, DEV CELL, V16, P889, DOI 10.1016/j.devcel.2009.04.009; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Park HC, 2000, DEV BIOL, V227, P279, DOI 10.1006/dbio.2000.9898; Petersen PH, 2004, NAT NEUROSCI, V7, P803, DOI 10.1038/nn1289; Rasin MR, 2007, NAT NEUROSCI, V10, P819, DOI 10.1038/nn1924; Reugels AM, 2006, DEV DYNAM, V235, P934, DOI 10.1002/dvdy.20699; Sanada K, 2005, CELL, V122, P119, DOI 10.1016/j.cell.2005.05.009; Schwamborn JC, 2009, CELL, V136, P913, DOI 10.1016/j.cell.2008.12.024; Shen Q, 2002, DEVELOPMENT, V129, P4843; Tawk M, 2007, NATURE, V446, P797, DOI 10.1038/nature05722; von Trotha JW, 2006, DEV DYNAM, V235, P967, DOI 10.1002/dvdy.20715; Wei XY, 2004, DEV BIOL, V269, P286, DOI 10.1016/j.ydbio.2004.01.017; Wilcock AC, 2007, DEVELOPMENT, V134, P1943, DOI 10.1242/dev.002519; Xie ZG, 2007, NEURON, V56, P79, DOI 10.1016/j.neuron.2007.08.026; Zigman M, 2005, NEURON, V48, P539, DOI 10.1016/j.neuron.2005.09.030	45	103	103	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2010	13	6					673	U38		10.1038/nn.2547	http://dx.doi.org/10.1038/nn.2547			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	600QY	20453852	Green Submitted			2022-12-24	WOS:000278003300011
J	Tissir, F; Qu, YB; Montcouquiol, M; Zhou, LB; Komatsu, K; Shi, DB; Fujimori, T; Labeau, J; Tyteca, D; Courtoy, P; Poumay, Y; Uemura, T; Goffinet, AM				Tissir, Fadel; Qu, Yibo; Montcouquiol, Mireille; Zhou, Libing; Komatsu, Kouji; Shi, Dongbo; Fujimori, Toshihiko; Labeau, Jason; Tyteca, Donatienne; Courtoy, Pierre; Poumay, Yves; Uemura, Tadashi; Goffinet, Andre M.			Lack of cadherins Celsr2 and Celsr3 impairs ependymal ciliogenesis, leading to fatal hydrocephalus	NATURE NEUROSCIENCE			English	Article							PLANAR CELL POLARITY; NEURAL STEM-CELLS; TISSUE POLARITY; GENES; EXPRESSION; CILIA; POLARIZATION; MUTATION; DEFECTS; MORPHOGENESIS	Ependymal cells form the epithelial lining of cerebral ventricles. Their apical surface is covered by cilia that beat in a coordinated fashion to facilitate circulation of the cerebrospinal fluid (CSF). The genetic factors that govern the development and function of ependymal cilia remain poorly understood. We found that the planar cell polarity cadherins Celsr2 and Celsr3 control these processes. In Celsr2-deficient mice, the development and planar organization of ependymal cilia are compromised, leading to defective CSF dynamics and hydrocephalus. In Celsr2 and Celsr3 double mutant ependyma, ciliogenesis is markedly impaired, resulting in lethal hydrocephalus. The membrane distribution of Vangl2 and Fzd3, two key planar cell polarity proteins, was disturbed in Celsr2 mutants, and even more so in Celsr2 and Celsr3 double mutants. Our findings suggest that planar cell polarity signaling is involved in ependymal cilia development and in the pathophysiology of hydrocephalus, with possible implications in other ciliopathies.	[Tissir, Fadel; Qu, Yibo; Zhou, Libing; Labeau, Jason; Goffinet, Andre M.] Catholic Univ Louvain, Inst Neurosci, B-1200 Brussels, Belgium; [Montcouquiol, Mireille] Neuroctr Magendie, INSERM, U862, Mol Basis Planar Polar Grp, Bordeaux, France; [Komatsu, Kouji; Fujimori, Toshihiko] Natl Inst Basic Biol, Div Embryol, Okazaki, Japan; [Komatsu, Kouji; Shi, Dongbo; Fujimori, Toshihiko; Uemura, Tadashi] Japan Sci & Technol Agcy, CREST, Tokyo, Japan; [Shi, Dongbo; Uemura, Tadashi] Kyoto Univ, Grad Sch Biostudies, Kyoto, Japan; [Tyteca, Donatienne; Courtoy, Pierre] Catholic Univ Louvain, de Duve Inst, B-1200 Brussels, Belgium; [Poumay, Yves] Fac Univ Notre Dame Paix, B-5000 Namur, Belgium	Universite Catholique Louvain; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Japan Science & Technology Agency (JST); Kyoto University; Universite Catholique Louvain; University of Namur	Tissir, F (corresponding author), Catholic Univ Louvain, Inst Neurosci, B-1200 Brussels, Belgium.	fadel.tissir@uclouvain.be; andre.goffinet@uclouvain.be	Fujimori, Toshihiko/L-7711-2016; Poumay, Yves/G-4525-2016; Shi, Dongbo/AAB-9994-2020; Komatsu, Kouji/R-6087-2019; montcouquiol, mireille/L-6199-2017	Fujimori, Toshihiko/0000-0001-5200-4634; Poumay, Yves/0000-0001-5200-3367; Shi, Dongbo/0000-0002-4408-3042; montcouquiol, mireille/0000-0001-8739-6519; Zhou, Libing/0000-0002-8975-5228; Komatsu, Kouji/0000-0003-3137-4569; Tissir, Fadel/0000-0002-9292-6622; UEMURA, Tadashi/0000-0001-7204-3606	Actions de Recherches Concertees [ARC-186]; FRFC [2.1501.01]; FRSM [3.4501.07]; Fondation medicale Reine Elisabeth; Wallonne and Bruxelloise regions; Japan Science and Technology Corporation; Interuniversity Poles of Attraction (SSTC) [PAI p6/20]	Actions de Recherches Concertees; FRFC(Fonds de la Recherche Scientifique - FNRS); FRSM(Fonds de la Recherche Scientifique - FNRS); Fondation medicale Reine Elisabeth; Wallonne and Bruxelloise regions; Japan Science and Technology Corporation(Japan Science & Technology Agency (JST)); Interuniversity Poles of Attraction (SSTC)	We thank K. Jones for Emx1-Cre mice, G. Meyer for the antibody to SCO-spondin, and K.-A. Nave for NEX-Cre mice. We also thank V. Bonte, I. Lambermont and E. Paitre for technical assistance and M. F. Boulanger, Y. Houbion, M.- J. Vertez and R. Vigneron for help with electron microscopy. This work was supported by grants from the Actions de Recherches Concertees (ARC-186), FRFC 2.1501.01, FRSM 3.4501.07, Interuniversity Poles of Attraction (SSTC, PAI p6/20), the Fondation medicale Reine Elisabeth, the Wallonne and Bruxelloise regions from Belgium and from the Japan Science and Technology Corporation. F.T. is a research associate at the Belgian Fonds National de la Recherche Scientifique.	Banizs B, 2005, DEVELOPMENT, V132, P5329, DOI 10.1242/dev.02153; BOISVIEUXULRICH E, 1987, CELL MOTIL CYTOSKEL, V8, P333, DOI 10.1002/cm.970080406; BOISVIEUXULRICH E, 1990, CELL TISSUE RES, V259, P443, DOI 10.1007/BF01740770; BOISVIEUXULRICH E, 1991, BIOL CELL, V72, P3, DOI 10.1016/0248-4900(91)90072-U; Brody SL, 2000, AM J RESP CELL MOL, V23, P45, DOI 10.1165/ajrcmb.23.1.4070; Chen JC, 1998, J CLIN INVEST, V102, P1077, DOI 10.1172/JCI4786; Curtin JA, 2003, CURR BIOL, V13, P1129, DOI 10.1016/S0960-9822(03)00374-9; Danilov AI, 2009, GLIA, V57, P136, DOI 10.1002/glia.20741; Davenport JR, 2005, AM J PHYSIOL-RENAL, V289, pF1159, DOI 10.1152/ajprenal.00118.2005; Davy BE, 2003, HUM MOL GENET, V12, P1163, DOI 10.1093/hmg/ddg122; Dawe HR, 2007, J CELL SCI, V120, P7, DOI 10.1242/jcs.03305; Devenport D, 2008, NAT CELL BIOL, V10, P1257, DOI 10.1038/ncb1784; Formstone CJ, 2001, MECH DEVELOP, V109, P91, DOI 10.1016/S0925-4773(01)00515-9; Goebbels S, 2006, GENESIS, V44, P611, DOI 10.1002/dvg.20256; Gomperts BN, 2004, J CELL SCI, V117, P1329, DOI 10.1242/jcs.00978; Guo N, 2004, P NATL ACAD SCI USA, V101, P9277, DOI 10.1073/pnas.0402802101; Ibanez-Tallon I, 2004, HUM MOL GENET, V13, P2133, DOI 10.1093/hmg/ddh219; Jones C, 2008, NAT GENET, V40, P69, DOI 10.1038/ng.2007.54; Kibar Z, 2001, NAT GENET, V28, P251, DOI 10.1038/90081; Lechtreck KF, 2008, J CELL BIOL, V180, P633, DOI 10.1083/jcb.200710162; Marshall WF, 2008, CURR OPIN CELL BIOL, V20, P48, DOI 10.1016/j.ceb.2007.11.009; Marshall WF, 2008, J CELL BIOL, V180, P17, DOI 10.1083/jcb.200710085; Mirzadeh Z, 2008, CELL STEM CELL, V3, P265, DOI 10.1016/j.stem.2008.07.004; Mirzadeh Z, 2010, J NEUROSCI, V30, P2600, DOI 10.1523/JNEUROSCI.3744-09.2010; Mitchell B, 2007, NATURE, V447, P97, DOI 10.1038/nature05771; Montcouquiol M, 2006, J NEUROSCI, V26, P5265, DOI 10.1523/JNEUROSCI.4680-05.2006; Pan JH, 2007, J CELL SCI, V120, P1868, DOI 10.1242/jcs.005306; Park TJ, 2008, NAT GENET, V40, P871, DOI 10.1038/ng.104; Park TJ, 2006, NAT GENET, V38, P303, DOI 10.1038/ng1753; Ravni A, 2009, J INVEST DERMATOL, V129, P2507, DOI 10.1038/jid.2009.84; Ropper A.H. a.B., 2005, ADAMS VICTORS PRINCI; Ross AJ, 2005, NAT GENET, V37, P1135, DOI 10.1038/ng1644; Salathe M, 2007, ANNU REV PHYSIOL, V69, P401, DOI 10.1146/annurev.physiol.69.040705.141253; Sawamoto K, 2006, SCIENCE, V311, P629, DOI 10.1126/science.1119133; Sharma N, 2008, CURR TOP DEV BIOL, V85, P371, DOI 10.1016/S0070-2153(08)00813-2; Shima Y, 2002, DEV DYNAM, V223, P321, DOI 10.1002/dvdy.10054; Shima Y, 2007, NAT NEUROSCI, V10, P963, DOI 10.1038/nn1933; Simons M, 2008, ANNU REV GENET, V42, P517, DOI 10.1146/annurev.genet.42.110807.091432; Spassky N, 2005, J NEUROSCI, V25, P10, DOI 10.1523/JNEUROSCI.1108-04.2005; Strutt DI, 1997, NATURE, V387, P292, DOI 10.1038/387292a0; Tissir F, 2006, EUR J NEUROSCI, V23, P597, DOI 10.1111/j.1460-9568.2006.04596.x; Tissir F, 2005, NAT NEUROSCI, V8, P451, DOI 10.1038/nn1428; Tissir F, 2002, MECH DEVELOP, V112, P157, DOI 10.1016/S0925-4773(01)00623-2; Town T, 2008, P NATL ACAD SCI USA, V105, P2853, DOI 10.1073/pnas.0712385105; Voronina VA, 2009, J CELL BIOL, V185, P225, DOI 10.1083/jcb.200809144; Wang YS, 2007, DEVELOPMENT, V134, P647, DOI 10.1242/dev.02772; Wang YH, 2006, J NEUROSCI, V26, P2147, DOI 10.1523/JNEUROSCI.4698-05.2005; Wang YS, 2002, J NEUROSCI, V22, P8563; WONG LL, 1993, J CELL BIOL, V123, P209, DOI 10.1083/jcb.123.1.209; Zhou LB, 2008, SCIENCE, V320, P946, DOI 10.1126/science.1155244	50	228	233	2	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2010	13	6					700	U71		10.1038/nn.2555	http://dx.doi.org/10.1038/nn.2555			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	600QY	20473291				2022-12-24	WOS:000278003300014
J	He, BYJ; Zempel, JM; Snyder, AZ; Raichle, ME				He, Biyu J.; Zempel, John M.; Snyder, Abraham Z.; Raichle, Marcus E.			The Temporal Structures and Functional Significance of Scale-free Brain Activity	NEURON			English	Article							SELF-ORGANIZED CRITICALITY; CONTINGENT NEGATIVE-VARIATION; PRIMARY VISUAL-CORTEX; 1/F NOISE; POWER SPECTRA; NEURONAL OSCILLATIONS; SENSORY RESPONSES; FIELD POTENTIALS; SINGLE-NEURON; FREE DYNAMICS	Scale-free dynamics, with a power spectrum following P alpha f(-beta), are an intrinsic feature of many complex processes in nature. In neural systems, scale-free activity is often neglected in electrophysiological research. Here, we investigate scale-free dynamics in human brain and show that it contains extensive nested frequencies, with the phase of lower frequencies modulating the amplitude of higher frequencies in an upward progression across the frequency spectrum. The functional significance of scale-free brain activity is indicated by task performance modulation and regional variation, with 13 being larger in default network and visual cortex and smaller in hippocampus and cerebellum. The precise patterns of nested frequencies in the brain differ from other scale-free dynamics in nature, such as earth seismic waves and stock market fluctuations, suggesting system-specific generative mechanisms. Our findings reveal robust temporal structures and behavioral significance of scale-free brain activity and should motivate future study on its physiological mechanisms and cognitive implications.	[He, Biyu J.; Snyder, Abraham Z.; Raichle, Marcus E.] Washington Univ, Sch Med, Dept Radiol, St Louis, MO 63110 USA; [Zempel, John M.; Snyder, Abraham Z.; Raichle, Marcus E.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Raichle, Marcus E.] Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; [Raichle, Marcus E.] Washington Univ, Sch Med, Dept Biomed Engn, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	He, BYJ (corresponding author), Washington Univ, Sch Med, Dept Radiol, 4525 Scott Ave, St Louis, MO 63110 USA.	biyu.jade.he@gmail.com		He, Biyu/0000-0003-1549-1351	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS006833, P50NS006833] Funding Source: NIH RePORTER; NINDS NIH HHS [P50 NS006833, P50 NS006833-430032] Funding Source: Medline; PHS HHS [06833] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		BAK P, 1987, PHYS REV LETT, V59, P381, DOI 10.1103/PhysRevLett.59.381; Bak P., 1996, NATURE WORKS; Balboa RM, 2003, VISION RES, V43, P2527, DOI 10.1016/S0042-6989(03)00471-1; Belitski A, 2008, J NEUROSCI, V28, P5696, DOI 10.1523/JNEUROSCI.0009-08.2008; Berger H, 1929, ARCH PSYCHIAT NERVEN, V87, P527, DOI 10.1007/BF01797193; BIRBAUMER N, 1990, PHYSIOL REV, V70, P1, DOI 10.1152/physrev.1990.70.1.1; Bok S. T., 1959, HISTONOMY CEREBRAL C; BRAGIN A, 1995, J NEUROSCI, V15, P47; BRESSLER SL, 1993, NATURE, V366, P153, DOI 10.1038/366153a0; Buiatti M, 2007, NEUROSCIENCE, V146, P1400, DOI 10.1016/j.neuroscience.2007.02.048; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Bullmore ET, 2001, HUM BRAIN MAPP, V12, P61, DOI 10.1002/1097-0193(200102)12:2<61::AID-HBM1004>3.0.CO;2-W; BULLOCK TH, 1995, P NATL ACAD SCI USA, V92, P11568, DOI 10.1073/pnas.92.25.11568; Bullock TH, 2003, NEUROSCIENCE, V121, P233, DOI 10.1016/S0306-4522(03)00208-2; BULLOCK TH, 1988, BRAIN RES REV, V13, P57, DOI 10.1016/0165-0173(88)90005-7; Buzsaki G., 2006, RHYTHMS BRAIN, P119; Canolty RT, 2006, SCIENCE, V313, P1626, DOI 10.1126/science.1128115; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Cash SS, 2009, SCIENCE, V324, P1084, DOI 10.1126/science.1169626; CHAFER N, 1999, COGNITION, V69, pB17; Chklovskii DB, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-18; Cho A, 2009, SCIENCE, V325, P408, DOI 10.1126/science.325_408; de Arcangelis L, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.028107; De Los Rios P, 1999, PHYS REV LETT, V82, P472, DOI 10.1103/PhysRevLett.82.472; ECKHORN R, 1994, PROG BRAIN RES, V102, P405; Eguiluz VM, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.018102; ELBERT T, 1991, PSYCHOPHYSIOLOGY, V28, P648, DOI 10.1111/j.1469-8986.1991.tb01009.x; Erland S, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.031114; Ermentrout GB, 2008, TRENDS NEUROSCI, V31, P428, DOI 10.1016/j.tins.2008.06.002; Faisal AA, 2008, NAT REV NEUROSCI, V9, P292, DOI 10.1038/nrn2258; Fox MD, 2007, NEURON, V56, P171, DOI 10.1016/j.neuron.2007.08.023; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Frank SA, 2009, J EVOLUTION BIOL, V22, P1563, DOI 10.1111/j.1420-9101.2009.01775.x; Freeman WJ, 2009, COGN NEURODYNAMICS, V3, P97, DOI 10.1007/s11571-008-9064-y; Freeman WJ, 2007, SCHOLARPEDIA, V2, P1357, DOI DOI 10.4249/SCHOLARPEDIA.1357; Gilden DL, 2001, PSYCHOL REV, V108, P33, DOI 10.1037/0033-295X.108.1.33; GRANGER CWJ, 1980, J ECONOMETRICS, V14, P227, DOI 10.1016/0304-4076(80)90092-5; GRUNEIS F, 1989, BIOL CYBERN, V60, P161, DOI 10.1007/BF00207284; He BYJ, 2008, P NATL ACAD SCI USA, V105, P16039, DOI 10.1073/pnas.0807010105; He BJ, 2009, TRENDS COGN SCI, V13, P302, DOI 10.1016/j.tics.2009.04.004; Henrie JA, 2005, J NEUROPHYSIOL, V94, P479, DOI 10.1152/jn.00919.2004; HSU KJ, 1991, P NATL ACAD SCI USA, V88, P3507, DOI 10.1073/pnas.88.8.3507; Jensen O, 2007, TRENDS COGN SCI, V11, P267, DOI 10.1016/j.tics.2007.05.003; Khader P, 2008, INT J PSYCHOPHYSIOL, V67, P252, DOI 10.1016/j.ijpsycho.2007.05.018; Koch C, 1997, NATURE, V385, P207, DOI 10.1038/385207a0; KORNHUBE.HH, 1965, PFLUG ARCH GES PHYS, V284, P1, DOI 10.1007/BF00412364; Kramer MA, 2008, J NEUROSCI METH, V170, P352, DOI 10.1016/j.jneumeth.2008.01.020; Lakatos P, 2005, J NEUROPHYSIOL, V94, P1904, DOI 10.1152/jn.00263.2005; Leopold DA, 2003, CEREB CORTEX, V13, P422, DOI 10.1093/cercor/13.4.422; Levina A, 2007, NAT PHYS, V3, P857, DOI 10.1038/nphys758; Lin M, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.016133; Linkenkaer-Hansen K, 2001, J NEUROSCI, V21, P1370; Logothetis NK, 2007, NEURON, V55, P809, DOI 10.1016/j.neuron.2007.07.027; Logothetis NK, 2002, PHILOS T R SOC B, V357, P1003, DOI 10.1098/rstb.2002.1114; Lowen SB, 1997, J NEUROSCI, V17, P5666; Maimon G, 2009, NEURON, V62, P426, DOI 10.1016/j.neuron.2009.03.021; Mandelbrot B., 1999, MULTIFRACTALS 1 F NO; MANDELBROT BB, 1968, SIAM REV, V10, P422, DOI 10.1137/1010093; Manning JR, 2009, J NEUROSCI, V29, P13613, DOI 10.1523/JNEUROSCI.2041-09.2009; Maye A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000443; Maylor EA, 2001, PSYCHON B REV, V8, P162, DOI 10.3758/BF03196153; Melloni L, 2009, TRENDS COGN SCI, V13, P239, DOI 10.1016/j.tics.2009.03.007; Miller KJ, 2009, J NEUROSCI, V29, P3132, DOI 10.1523/JNEUROSCI.5506-08.2009; Miller KJ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000609; Milstein J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004338; Mitra PP, 1999, BIOPHYS J, V76, P691, DOI 10.1016/S0006-3495(99)77236-X; Montemurro MA, 2008, CURR BIOL, V18, P375, DOI 10.1016/j.cub.2008.02.023; Monto S, 2008, J NEUROSCI, V28, P8268, DOI 10.1523/JNEUROSCI.1910-08.2008; Nagai Y, 2004, NEUROIMAGE, V21, P1232, DOI 10.1016/j.neuroimage.2003.10.036; Onton J, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.061.2009; Panzeri S, 2010, TRENDS NEUROSCI, V33, P111, DOI 10.1016/j.tins.2009.12.001; Petermann T, 2009, P NATL ACAD SCI USA, V106, P15921, DOI 10.1073/pnas.0904089106; Petersen CCH, 2003, P NATL ACAD SCI USA, V100, P13638, DOI 10.1073/pnas.2235811100; Plenz D, 2007, TRENDS NEUROSCI, V30, P101, DOI 10.1016/j.tins.2007.01.005; ROCKSTROH B, 1989, SLOW BRAIN POTENTIAL, V2; Schroeder CE, 2009, TRENDS NEUROSCI, V32, P9, DOI 10.1016/j.tins.2008.09.012; Shin CW, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.045101; Siegel M, 2003, J NEUROSCI, V23, P4251; Stam CJ, 2004, HUM BRAIN MAPP, V22, P97, DOI 10.1002/hbm.20016; Stewart CV, 2006, J NEUROSCI, V26, P8148, DOI 10.1523/JNEUROSCI.0723-06.2006; Takahashi K, 2004, NEUROSCI RES, V48, P203, DOI 10.1016/j.neures.2003.10.015; Thivierge JP, 2008, J NEUROSCI, V28, P7968, DOI 10.1523/JNEUROSCI.0870-08.2008; Tort ABL, 2008, P NATL ACAD SCI USA, V105, P20517, DOI 10.1073/pnas.0810524105; van den Heuvel MP, 2008, NEUROIMAGE, V43, P528, DOI 10.1016/j.neuroimage.2008.08.010; Vanhatalo S, 2004, P NATL ACAD SCI USA, V101, P5053, DOI 10.1073/pnas.0305375101; VOSS RF, 1975, NATURE, V258, P317, DOI 10.1038/258317a0; Vyazovskiy VV, 2009, NEURON, V63, P865, DOI 10.1016/j.neuron.2009.08.024; Wagenmakers EJ, 2004, PSYCHON B REV, V11, P579, DOI 10.3758/BF03196615; WALTER WG, 1964, NATURE, V203, P380, DOI 10.1038/203380a0; Ward L. M., 2007, SCHOLARPEDIA, V2, P1537, DOI [DOI 10.4249/SCH0LARPEDIA.1537, 10.4249/scholarpedia.1537, DOI 10.4249/SCHOLARPEDIA.1537]; Ward L. M., 2002, DYNAMICAL COGNITIVE; WEISSMAN MB, 1988, REV MOD PHYS, V60, P537, DOI 10.1103/RevModPhys.60.537; YAMAMOTO M, 1991, Frontiers of Medical and Biological Engineering, V3, P135; YAMAMOTO Y, 1991, J APPL PHYSIOL, V71, P1143, DOI 10.1152/jappl.1991.71.3.1143; YOUNG MP, 1992, J NEUROPHYSIOL, V67, P1464, DOI 10.1152/jn.1992.67.6.1464; Yuval-Greenberg S, 2008, NEURON, V58, P429, DOI 10.1016/j.neuron.2008.03.027; Zarahn E, 1997, NEUROIMAGE, V5, P179, DOI 10.1006/nimg.1997.0263	97	548	554	2	79	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	MAY 13	2010	66	3					353	369		10.1016/j.neuron.2010.04.020	http://dx.doi.org/10.1016/j.neuron.2010.04.020			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	598HE	20471349	Green Accepted, Bronze			2022-12-24	WOS:000277825200005
J	Crocker, A; Shahidullah, M; Levitan, IB; Sehgal, A				Crocker, Amanda; Shahidullah, Mohammad; Levitan, Irwin B.; Sehgal, Amita			Identification of a Neural Circuit that Underlies the Effects of Octopamine on Sleep:Wake Behavior	NEURON			English	Article							CHANNEL-BINDING-PROTEIN; REPRESSIBLE CELL MARKER; FUNCTIONAL DISSECTION; CIRCADIAN CLOCK; MOSAIC ANALYSIS; DROSOPHILA; NEURONS; MODULATION; RECEPTOR; GROWTH	An understanding of sleep requires the identification of distinct cellular circuits that mediate the action of specific sleep:wake-regulating molecules, but such analysis has been very limited. We identify here a circuit that underlies the wake-promoting effects of octopamine in Drosophila. Using MARCM, we identified the ASM cells in the medial protocerebrum as the wake-promoting octopaminergic cells. We then blocked octopamine signaling in random areas of the fly brain and mapped the postsynaptic effect to insulin-secreting neurons of the pars intercerebralis (PI). These PI neurons show altered potassium channel function as well as an increase in cAMP in response to octopamine, and genetic manipulation of their electrical excitability alters sleep:wake behavior. Effects of octopamine on sleep:wake are mediated by the cAMP-dependent isoform of the OAMB receptor. These studies define the cellular and molecular basis of octopamine action and suggest that the PI is a sleep:wake-regulating neuroendocrine structure like the mammalian hypothalamus.	[Crocker, Amanda; Shahidullah, Mohammad; Levitan, Irwin B.; Sehgal, Amita] Univ Penn, Sch Med, Dept Neurosci, Philadelphia, PA 19104 USA; [Sehgal, Amita] Univ Penn, Sch Med, Howard Hughes Med Inst, Philadelphia, PA 19104 USA	University of Pennsylvania; Howard Hughes Medical Institute; University of Pennsylvania	Sehgal, A (corresponding author), Univ Penn, Sch Med, Dept Neurosci, Philadelphia, PA 19104 USA.	amita@mail.med.upenn.edu			National Institutes on Aging; Center for Sleep and Respiratory Neurobiology at the University of Pennsylvania; National Institute of Mental Health; National Institutes of Health; NATIONAL INSTITUTE ON AGING [P01AG017628] Funding Source: NIH RePORTER	National Institutes on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Center for Sleep and Respiratory Neurobiology at the University of Pennsylvania; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was partially supported by a program project grant from the National Institutes on Aging. A.C. was supported by a training grant to the Center for Sleep and Respiratory Neurobiology at the University of Pennsylvania and by a National Research Service Award from the National Institute of Mental Health. M.S. is supported by a grant to I.B.L. from the National Institutes of Health. We thank Drs. Kyung-An Han, Ralph Greenspan, Ulrike Heberlein, Ben White, Bill Joiner, and Paul Taghert for providing flies used in this study. We thank Dr. Eric Rulifson for the Dilp2 antibody. We also thank K. Luu, Z. Yue, A. Joseph, and M. Sowcik for assisting with animal maintenance. We also would like to thank Andrea Stout for comments and advice on confocal and FRET experiments, and Dr. Tom Jongens for his comments on this project and manuscript.	Agosto J, 2008, NAT NEUROSCI, V11, P354, DOI 10.1038/nn2046; Andretic R, 2005, CURR BIOL, V15, P1165, DOI 10.1016/j.cub.2005.05.025; Brogiolo W, 2001, CURR BIOL, V11, P213, DOI 10.1016/S0960-9822(01)00068-9; Busch S, 2009, J COMP NEUROL, V513, P643, DOI 10.1002/cne.21966; Chung BY, 2009, CURR BIOL, V19, P386, DOI 10.1016/j.cub.2009.01.040; CHUNG SK, 1991, SCIENCE, V253, P560, DOI 10.1126/science.1857986; Cirelli C, 1996, SCIENCE, V274, P1211, DOI 10.1126/science.274.5290.1211; Cole SH, 2005, J BIOL CHEM, V280, P14948, DOI 10.1074/jbc.M414197200; Crocker A, 2008, J NEUROSCI, V28, P9377, DOI 10.1523/JNEUROSCI.3072-08a.2008; DEPEYER JE, 1982, P NATL ACAD SCI-BIOL, V79, P4207; Douglas NJ, 2005, PRINCIPLES PRACTICE; EVANS PD, 1993, NEUROCHEM RES, V18, P869, DOI 10.1007/BF00998270; EWALD DA, 1985, NATURE, V315, P503, DOI 10.1038/315503a0; Flier J, 1996, NEW ENGL J MED, V334, P580, DOI 10.1056/NEJM199602293340907; Foltenyi K, 2007, NAT NEUROSCI, V10, P1160, DOI 10.1038/nn1957; Gilestro GF, 2009, BIOINFORMATICS, V25, P1466, DOI 10.1093/bioinformatics/btp237; Graves LA, 2003, J NEUROPHYSIOL, V90, P1152, DOI 10.1152/jn.00882.2002; Han KA, 1998, J NEUROSCI, V18, P3650; Hendricks JC, 2004, SLEEP, V27, P334, DOI 10.1093/sleep/27.2.334; Hendricks JC, 2000, NEURON, V25, P129, DOI 10.1016/S0896-6273(00)80877-6; Hendricks JC, 2001, NAT NEUROSCI, V4, P1108, DOI 10.1038/nn743; Hendricks JC, 2000, PROG NEUROBIOL, V61, P339, DOI 10.1016/S0301-0082(99)00048-9; Jaramillo AM, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-3; Joiner WJ, 2006, NATURE, V441, P757, DOI 10.1038/nature04811; Kanyshkova T, 2009, J NEUROSCI, V29, P8847, DOI 10.1523/JNEUROSCI.0689-09.2009; Knutson KL, 2008, ANN NY ACAD SCI, V1129, P287, DOI 10.1196/annals.1417.033; Kume K, 2005, J NEUROSCI, V25, P7377, DOI 10.1523/JNEUROSCI.2048-05.2005; Laposky AD, 2008, AM J PHYSIOL-REG I, V295, pR2059, DOI 10.1152/ajpregu.00026.2008; Laposky AD, 2006, AM J PHYSIOL-REG I, V290, pR894, DOI 10.1152/ajpregu.00304.2005; Lee HG, 2003, DEV BIOL, V264, P179, DOI 10.1016/j.ydbio.2003.07.018; Lee HG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007172; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Luan HJ, 2006, J NEUROSCI, V26, P573, DOI 10.1523/JNEUROSCI.3916-05.2006; MALLICK BN, 1992, BRAIN RES, V591, P8, DOI 10.1016/0006-8993(92)90972-C; Maqueira B, 2005, J NEUROCHEM, V94, P547, DOI 10.1111/j.1471-4159.2005.03251.x; Nitabach MN, 2006, J NEUROSCI, V26, P479, DOI 10.1523/JNEUROSCI.3915-05.2006; Ousley A, 1998, GENETICS, V148, P815; Parisky KM, 2008, NEURON, V60, P672, DOI 10.1016/j.neuron.2008.10.042; Pitman JL, 2006, NATURE, V441, P753, DOI 10.1038/nature04739; Rodan AR, 2002, J NEUROSCI, V22, P9490; Roeder T, 2005, ANNU REV ENTOMOL, V50, P447, DOI 10.1146/annurev.ento.50.071803.130404; Rulifson EJ, 2002, SCIENCE, V296, P1118, DOI 10.1126/science.1070058; Saper CB, 2005, NATURE, V437, P1257, DOI 10.1038/nature04284; Sara SJ, 2009, NAT REV NEUROSCI, V10, P211, DOI 10.1038/nrn2573; SASSIN JF, 1969, SCIENCE, V165, P513, DOI 10.1126/science.165.3892.513; Shafer OT, 2008, NEURON, V58, P223, DOI 10.1016/j.neuron.2008.02.018; Shahidullah M, 2009, J NEUROSCI, V29, P13328, DOI 10.1523/JNEUROSCI.3024-09.2009; Shao LR, 1999, J PHYSIOL-LONDON, V521, P135, DOI 10.1111/j.1469-7793.1999.00135.x; Shaw P, 2003, J BIOL RHYTHM, V18, P4, DOI 10.1177/0748730402239672; Shaw PJ, 2000, SCIENCE, V287, P1834, DOI 10.1126/science.287.5459.1834; Sheeba V, 2008, CURR BIOL, V18, P1537, DOI 10.1016/j.cub.2008.08.033; SHEN KZ, 1994, PFLUG ARCH EUR J PHY, V426, P440, DOI 10.1007/BF00388308; Siegmund T, 2001, J COMP NEUROL, V431, P481, DOI 10.1002/1096-9861(20010319)431:4<481::AID-CNE1084>3.0.CO;2-7; Sinakevitch I, 2006, J COMP NEUROL, V494, P460, DOI 10.1002/cne.20799; Spiegel K, 2009, NAT REV ENDOCRINOL, V5, P253, DOI 10.1038/nrendo.2009.23; TAKAHASHI Y, 1968, J CLIN INVEST, V47, P2079, DOI 10.1172/JCI105893; Tanaka NK, 2008, J COMP NEUROL, V508, P711, DOI 10.1002/cne.21692; Tobler I., 2005, PRINCIPLES PRACTICE, V4th ed, P77; Toivonen JM, 2009, MOL CELL ENDOCRINOL, V299, P39, DOI 10.1016/j.mce.2008.07.005; Trenell MI, 2007, CLIN EXP PHARMACOL P, V34, P1, DOI 10.1111/j.1440-1681.2007.04541.x; White BH, 2001, NEURON, V31, P699, DOI 10.1016/S0896-6273(01)00415-9; Wu JS, 2006, NAT PROTOC, V1, P2583, DOI 10.1038/nprot.2006.320; Yuan Q, 2006, CURR BIOL, V16, P1051, DOI 10.1016/j.cub.2006.04.032; Zamboni G, 1999, ARCH ITAL BIOL, V137, P249; Zheng X, 2007, P NATL ACAD SCI USA, V104, P15899, DOI 10.1073/pnas.0701599104; Zhou Y, 2002, J NEUROSCI, V22, P3855, DOI 10.1523/JNEUROSCI.22-10-03855.2002	66	183	187	2	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 11	2010	65	5					670	681		10.1016/j.neuron.2010.01.032	http://dx.doi.org/10.1016/j.neuron.2010.01.032			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	571NF	20223202	Green Accepted, Bronze			2022-12-24	WOS:000275758000010
J	Gupta, AS; van der Meer, MAA; Touretzky, DS; Redish, AD				Gupta, Anoopum S.; van der Meer, Matthijs A. A.; Touretzky, David S.; Redish, A. David			Hippocampal Replay Is Not a Simple Function of Experience	NEURON			English	Article							CA1 PYRAMIDAL CELLS; PLACE CELLS; SEQUENTIAL EXPERIENCE; MEMORY CONSOLIDATION; SPATIAL MEMORY; NETWORK MODEL; SHARP WAVES; REACTIVATION; SEQUENCES; SLEEP	Replay of behavioral sequences in the hippocampus during sharp wave ripple complexes (SWRs) provides a potential mechanism for memory consolidation and the learning of knowledge structures. Current hypotheses imply that replay should straightforwardly reflect recent experience. However, we find these hypotheses to be incompatible with the content of replay on a task with two distinct behavioral sequences (A and B). We observed forward and backward replay of B even when rats had been performing A for >10 min. Furthermore, replay of nonlocal sequence B occurred more often when B was infrequently experienced. Neither forward nor backward sequences preferentially represented highly experienced trajectories within a session. Additionally, we observed the construction of never-experienced novel-path sequences. These observations challenge the idea that sequence activation during SWRs is a simple replay of recent experience. Instead, replay reflected all physically available trajectories within the environment, suggesting a potential role in active learning and maintenance of the cognitive map.	[Gupta, Anoopum S.] Carnegie Mellon Univ, Inst Robot, Pittsburgh, PA 15213 USA; [Gupta, Anoopum S.; Touretzky, David S.] Carnegie Mellon Univ, Ctr Neural Basis Cognit, Pittsburgh, PA 15213 USA; [van der Meer, Matthijs A. A.; Redish, A. David] Univ Minnesota, Dept Neurosci, Minneapolis, MN USA; [Touretzky, David S.] Carnegie Mellon Univ, Dept Comp Sci, Pittsburgh, PA 15213 USA	Carnegie Mellon University; Carnegie Mellon University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Minnesota System; University of Minnesota Twin Cities; Carnegie Mellon University	Gupta, AS (corresponding author), Carnegie Mellon Univ, Inst Robot, Pittsburgh, PA 15213 USA.	anoopum@cmu.edu; redish@umn.edu	van der Meer, Matthijs/E-5856-2010	van der Meer, Matthijs/0000-0002-2206-4473	NIH [R01 MH-080381]; Pennsylvania Department of Health; NSF [IGERT DGE-0549352]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH080318] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pennsylvania Department of Health; NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank Chris Boldt and Adam Steiner for technical assistance, Adam Johnson for comments on a previous version of the manuscript, and the members of the Redish lab for discussion. This work was funded by NIH grant R01 MH-080381, the Pennsylvania Department of Health, and NSF IGERT DGE-0549352.	Ainge JA, 2007, J NEUROSCI, V27, P9769, DOI 10.1523/JNEUROSCI.2011-07.2007; ALVAREZ P, 1994, P NATL ACAD SCI USA, V91, P7041, DOI 10.1073/pnas.91.15.7041; Alvernhe A, 2008, J NEUROSCI, V28, P7324, DOI 10.1523/JNEUROSCI.1909-08.2008; Buckner RL, 2007, TRENDS COGN SCI, V11, P49, DOI 10.1016/j.tics.2006.11.004; BUZSAKI G, 1983, BRAIN RES REV, V6, P139, DOI 10.1016/0165-0173(83)90037-1; BUZSAKI G, 1989, NEUROSCIENCE, V31, P551, DOI 10.1016/0306-4522(89)90423-5; Cheng S, 2008, NEURON, V57, P303, DOI 10.1016/j.neuron.2007.11.035; Cohen N. J., 1993, MEMORY AMNESIA HIPPO; Csicsvari J, 2007, EUR J NEUROSCI, V26, P704, DOI 10.1111/j.1460-9568.2007.05684.x; Davidson TJ, 2009, NEURON, V63, P497, DOI 10.1016/j.neuron.2009.07.027; Diba K, 2007, NAT NEUROSCI, V10, P1241, DOI 10.1038/nn1961; Ego-Stengel V, 2010, HIPPOCAMPUS, V20, P1, DOI 10.1002/hipo.20707; Euston DR, 2007, SCIENCE, V318, P1147, DOI 10.1126/science.1148979; Ferbinteanu J, 2003, NEURON, V40, P1227, DOI 10.1016/S0896-6273(03)00752-9; Foster DJ, 2006, NATURE, V440, P680, DOI 10.1038/nature04587; Gallistel C. R., 1990, ORG LEARNING; Gelbard-Sagiv H, 2008, SCIENCE, V322, P96, DOI 10.1126/science.1164685; Girardeau G, 2009, NAT NEUROSCI, V12, P1222, DOI 10.1038/nn.2384; Hassabis D, 2007, P NATL ACAD SCI USA, V104, P1726, DOI 10.1073/pnas.0610561104; HASSELMO ME, 1993, TRENDS NEUROSCI, V16, P218, DOI 10.1016/0166-2236(93)90159-J; Hoffman KL, 2002, SCIENCE, V297, P2070, DOI 10.1126/science.1073538; Jackson JC, 2006, J NEUROSCI, V26, P12415, DOI 10.1523/JNEUROSCI.4118-06.2006; Jensen O, 2000, J NEUROPHYSIOL, V83, P2602, DOI 10.1152/jn.2000.83.5.2602; Ji DY, 2007, NAT NEUROSCI, V10, P100, DOI 10.1038/nn1825; Johnson A, 2008, MECH INFORM PROCESSI, P95; Johnson A, 2007, J NEUROSCI, V27, P12176, DOI 10.1523/JNEUROSCI.3761-07.2007; Karlsson MP, 2009, NAT NEUROSCI, V12, P913, DOI 10.1038/nn.2344; Kudrimoti HS, 1999, J NEUROSCI, V19, P4090; Lee AK, 2002, NEURON, V36, P1183, DOI 10.1016/S0896-6273(02)01096-6; Levy WB, 1996, HIPPOCAMPUS, V6, P579, DOI 10.1002/(SICI)1098-1063(1996)6:6<579::AID-HIPO3>3.0.CO;2-C; MARR D, 1971, PHILOS T ROY SOC B, V262, P23, DOI 10.1098/rstb.1971.0078; Maviel T, 2004, SCIENCE, V305, P96, DOI 10.1126/science.1098180; MCCLELLAND JL, 1995, PSYCHOL REV, V102, P419, DOI 10.1037/0033-295X.102.3.419; McNaughton BL, 1998, HIPPOCAMPUS, V8, P438; Mehta MR, 1997, P NATL ACAD SCI USA, V94, P8918, DOI 10.1073/pnas.94.16.8918; Nadasdy Z, 1999, J NEUROSCI, V19, P9497; Nakashiba T, 2009, NEURON, V62, P781, DOI 10.1016/j.neuron.2009.05.013; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; O'Neill J, 2006, NEURON, V49, P143, DOI 10.1016/j.neuron.2005.10.037; O'Neill J, 2008, NAT NEUROSCI, V11, P209, DOI 10.1038/nn2037; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; OREILLY RC, 1994, HIPPOCAMPUS, V4, P661, DOI 10.1002/hipo.450040605; Pomerleau DA, 1991, NEURAL COMPUT, V3, P88, DOI 10.1162/neco.1991.3.1.88; Redish A. D., 1999, COGNITIVE MAP PLACE, DOI DOI 10.1038/nature14445; Redish AD, 1998, NEURAL COMPUT, V10, P73, DOI 10.1162/089976698300017908; Samsonovich AV, 2005, LEARN MEMORY, V12, P193, DOI 10.1101/lm.85205; Schmitzer-Torbert N, 2004, J NEUROPHYSIOL, V91, P2259, DOI 10.1152/jn.00687.2003; Skaggs WE, 1996, SCIENCE, V271, P1870, DOI 10.1126/science.271.5257.1870; Skaggs WE, 1996, HIPPOCAMPUS, V6, P149, DOI 10.1002/(SICI)1098-1063(1996)6:2<149::AID-HIPO6>3.0.CO;2-K; Squire L. R., 1987, MEMORY BRAIN; Squire L. R., 1984, MEMORY CONSOLIDATION, P185; Sutherland GR, 2000, CURR OPIN NEUROBIOL, V10, P180, DOI 10.1016/S0959-4388(00)00079-9; TOLMAN EC, 1948, PSYCHOL REV, V55, P189, DOI 10.1037/h0061626; TOLMAN EC, 1946, J EXP PSYCHOL, V36, P13, DOI 10.1037/h0053944; Tse D, 2007, SCIENCE, V316, P76, DOI 10.1126/science.1135935; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517; Wood ER, 2000, NEURON, V27, P623, DOI 10.1016/S0896-6273(00)00071-4; YLINEN A, 1995, J NEUROSCI, V15, P30; Zhang KC, 1998, J NEUROPHYSIOL, V79, P1017, DOI 10.1152/jn.1998.79.2.1017	59	384	387	1	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 11	2010	65	5					695	705		10.1016/j.neuron.2010.01.034	http://dx.doi.org/10.1016/j.neuron.2010.01.034			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	571NF	20223204	Bronze, Green Accepted			2022-12-24	WOS:000275758000012
J	Popescu, MV; Polley, DB				Popescu, Maria V.; Polley, Daniel B.			Monaural Deprivation Disrupts Development of Binaural Selectivity in Auditory Midbrain and Cortex	NEURON			English	Article							CONDUCTIVE HEARING-LOSS; CRITICAL-PERIOD PLASTICITY; RAT BARREL CORTEX; BRAIN-STEM; VISUAL-CORTEX; FREQUENCY ORGANIZATION; INFERIOR COLLICULUS; LEVEL DIFFERENCES; RECEPTIVE-FIELDS; COCHLEAR LESIONS	Degraded sensory experience during critical periods of development can have adverse effects on brain function. In the auditory system, conductive hearing loss associated with childhood ear infections can produce long-lasting deficits in auditory perceptual acuity, much like amblyopia in the visual system. Here we explore the neural mechanisms that may underlie "amblyaudio" by inducing reversible monaural deprivation (MD) in infant, juvenile, and adult rats. MD distorted tonotopic maps, weakened the deprived ear's representation, strengthened the open ear's representation, and disrupted binaural integration of interaural level differences (ILD). Bidirectional plasticity effects were strictly governed by critical periods, were more strongly expressed in primary auditory cortex than inferior colliculus, and directly impacted neural coding accuracy. These findings highlight a remarkable degree of competitive plasticity between aural representations and suggest that the enduring perceptual sequelae of childhood hearing loss might be traced to maladaptive plasticity during critical periods of auditory cortex development.	[Popescu, Maria V.; Polley, Daniel B.] Vanderbilt Univ, Sch Med, Vanderbilt Kennedy Ctr Res Human Dev, Nashville, TN 37232 USA; [Polley, Daniel B.] Vanderbilt Univ, Sch Med, Vanderbilt Bill Wilkerson Ctr Otolaryngol & Commu, Dept Hearing & Speech Sci, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University	Polley, DB (corresponding author), Vanderbilt Univ, Sch Med, Vanderbilt Kennedy Ctr Res Human Dev, Nashville, TN 37232 USA.	daniel_polley@meei.harvard.edu		Polley, Daniel/0000-0002-5120-2409	Vanderbilt Kennedy Center; National Organization of Hearing Research Foundation; NIH [DC009836]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009836] Funding Source: NIH RePORTER	Vanderbilt Kennedy Center; National Organization of Hearing Research Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We are grateful to Z. Barnett for his invaluable technical assistance and to Drs. D. Blake and V. Khatri for commenting on an earlier version of manuscript. D.B.P. designed the experiment, collected data, analyzed data, and wrote the manuscript. M.V.P. collected data, implemented the computational model, and analyzed data. This work is supported by development funds from the Vanderbilt Kennedy Center, a Robin and Michael Fox Grant in Auditory Science from the National Organization of Hearing Research Foundation, and NIH grant DC009836 to D.B.P.	Atiani S, 2009, NEURON, V61, P467, DOI 10.1016/j.neuron.2008.12.027; Bajo VM, 2010, NAT NEUROSCI, V13, P253, DOI 10.1038/nn.2466; Bendor D, 2007, NAT NEUROSCI, V10, P763, DOI 10.1038/nn1888; Chang EF, 2003, SCIENCE, V300, P498, DOI 10.1126/science.1082163; CLEMENTS M, 1978, J COMP PHYSIOL PSYCH, V92, P34, DOI 10.1037/h0077424; Dahmen JC, 2007, CURR OPIN NEUROBIOL, V17, P456, DOI 10.1016/j.conb.2007.07.004; Davis-Gunter MJ, 2001, SCAND AUDIOL, V30, P50, DOI 10.1080/010503901750069572; de Villers-Sidani E, 2007, J NEUROSCI, V27, P180, DOI 10.1523/JNEUROSCI.3227-06.2007; EGGERMONT JJ, 1980, J ACOUST SOC AM, V68, P1671, DOI 10.1121/1.385199; Engineer ND, 2004, J NEUROPHYSIOL, V92, P73, DOI 10.1152/jn.00059.2004; Fagiolini M, 2003, P NATL ACAD SCI USA, V100, P2854, DOI 10.1073/pnas.0536089100; Fagiolini M, 2000, NATURE, V404, P183, DOI 10.1038/35004582; Foffani G, 2004, J NEUROSCI METH, V135, P107, DOI 10.1016/j.jneumeth.2003.12.011; FOX K, 1992, J NEUROSCI, V12, P1826; Friauf E, 2000, AUDIOL NEURO-OTOL, V5, P251, DOI 10.1159/000013889; Fritz JB, 2005, J NEUROSCI, V25, P7623, DOI 10.1523/JNEUROSCI.1318-05.2005; Froemke RC, 2007, NATURE, V450, P425, DOI 10.1038/nature06289; Glazewski S, 1998, EUR J NEUROSCI, V10, P2107, DOI 10.1046/j.1460-9568.1998.00222.x; Glazewski S, 1996, SCIENCE, V272, P421, DOI 10.1126/science.272.5260.421; GRAY L, 1982, BRAIN RES, V244, P360, DOI 10.1016/0006-8993(82)90098-1; Green JS, 2005, J NEUROPHYSIOL, V94, P3826, DOI 10.1152/jn.00601.2005; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Hogan SCM, 2003, JARO, V4, P123, DOI 10.1007/s10162-002-3007-9; Hutson KA, 2007, HEARING RES, V233, P124, DOI 10.1016/j.heares.2007.08.003; Insanally MN, 2009, J NEUROSCI, V29, P5456, DOI 10.1523/JNEUROSCI.5311-08.2009; Irvine DRF, 2003, J COMP NEUROL, V467, P354, DOI 10.1002/cne.10921; Kacelnik O, 2006, PLOS BIOL, V4, P627, DOI 10.1371/journal.pbio.0040071; Kamke MR, 2003, J COMP NEUROL, V459, P355, DOI 10.1002/cne.10586; Keuroghlian AS, 2007, PROG NEUROBIOL, V82, P109, DOI 10.1016/j.pneurobio.2007.03.005; Kim G, 2003, NAT NEUROSCI, V6, P282, DOI 10.1038/nn1015; Kujawa SG, 2009, J NEUROSCI, V29, P14077, DOI 10.1523/JNEUROSCI.2845-09.2009; Lanphear BP, 1997, PEDIATRICS, V99, part. no., DOI 10.1542/peds.99.3.e1; Li RW, 2008, J NEUROSCI, V28, P14223, DOI 10.1523/JNEUROSCI.4271-08.2008; McRae PA, 2007, J NEUROSCI, V27, P5405, DOI 10.1523/JNEUROSCI.5425-06.2007; Melcher JR, 1996, HEARING RES, V93, P52, DOI 10.1016/0378-5955(95)00200-6; MIOCHE L, 1989, J NEUROPHYSIOL, V62, P185, DOI 10.1152/jn.1989.62.1.185; MOGDANS J, 1993, BRAIN RES, V619, P29, DOI 10.1016/0006-8993(93)91593-H; MOORE DR, 1991, AUDIOLOGY, V30, P91; Moore DR, 1999, J NEUROSCI, V19, P8704; Nodal FR, 2010, J NEUROPHYSIOL, V103, P1209, DOI 10.1152/jn.00991.2009; Petkov CI, 2007, NEURON, V54, P153, DOI 10.1016/j.neuron.2007.02.031; PILLSBURY HC, 1991, ARCH OTOLARYNGOL, V117, P718; Polley DB, 2007, J NEUROPHYSIOL, V97, P3621, DOI 10.1152/jn.01298.2006; Polley DB, 2008, J AM ACAD AUDIOL, V19, P780, DOI 10.3766/jaaa.19.10.6; Polley DB, 2006, J NEUROSCI, V26, P4970, DOI 10.1523/JNEUROSCI.3771-05.2006; POON PWF, 1992, BRAIN RES, V585, P391, DOI 10.1016/0006-8993(92)91243-8; Razak KA, 2008, P NATL ACAD SCI USA, V105, P4465, DOI 10.1073/pnas.0709504105; Razak KA, 2007, HEARING RES, V228, P69, DOI 10.1016/j.heares.2007.01.020; ROBERTSON D, 1989, J COMP NEUROL, V282, P456, DOI 10.1002/cne.902820311; Sanes DH, 2009, CURR OPIN NEUROBIOL, V19, P188, DOI 10.1016/j.conb.2009.05.014; SANES DH, 1985, J NEUROSCI, V5, P1152; Sawtell NB, 2003, NEURON, V38, P977, DOI 10.1016/S0896-6273(03)00323-4; SCHAPPERT S, 1992, NATL CTR HLTH CARE S, V214; SILVERMAN MS, 1977, J NEUROPHYSIOL, V40, P1266, DOI 10.1152/jn.1977.40.6.1266; SMITH ZDJ, 1983, J COMP NEUROL, V220, P199, DOI 10.1002/cne.902200207; Suga N, 2008, LEARN MEMORY, V15, P198, DOI 10.1101/lm.791408; Sumner CJ, 2005, J NEUROPHYSIOL, V94, P4234, DOI 10.1152/jn.00401.2005; SUR M, 1988, J NEUROSCI, V8, P874; Tucci DL, 1999, LARYNGOSCOPE, V109, P1359, DOI 10.1097/00005537-199909000-00001; Tzounopoulos T, 2009, NEURON, V62, P463, DOI 10.1016/j.neuron.2009.05.002; Wang BS, 2010, NEURON, V65, P246, DOI 10.1016/j.neuron.2010.01.002; Weinberger NM, 2007, HEARING RES, V229, P54, DOI 10.1016/j.heares.2007.01.004; Xu H, 2007, J NEUROSCI, V27, P9417, DOI 10.1523/JNEUROSCI.1992-07.2007; Xu H, 2010, J NEUROSCI, V30, P331, DOI 10.1523/JNEUROSCI.4554-09.2010; Yu X, 2007, P NATL ACAD SCI USA, V104, P12193, DOI 10.1073/pnas.0700960104; Zhang LI, 2001, NAT NEUROSCI, V4, P1123, DOI 10.1038/nn745; Zhang LI, 2002, P NATL ACAD SCI USA, V99, P2309, DOI 10.1073/pnas.261707398; Zhang YF, 2008, CEREB CORTEX, V18, P1521, DOI 10.1093/cercor/bhm188; Zhou X, 2008, NEUROSCIENCE, V154, P390, DOI 10.1016/j.neuroscience.2008.01.026	69	145	147	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 11	2010	65	5					718	731		10.1016/j.neuron.2010.02.019	http://dx.doi.org/10.1016/j.neuron.2010.02.019			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	571NF	20223206	Bronze, Green Accepted			2022-12-24	WOS:000275758000014
J	Andrews-Hanna, JR; Reidler, JS; Sepulcre, J; Poulin, R; Buckner, RL				Andrews-Hanna, Jessica R.; Reidler, Jay S.; Sepulcre, Jorge; Poulin, Renee; Buckner, Randy L.			Functional-Anatomic Fractionation of the Brain's Default Network	NEURON			English	Article							MONKEY RETROSPLENIAL CORTEX; CONSCIOUS RESTING STATE; MACAQUE MONKEY; PARAHIPPOCAMPAL CORTICES; SOCIAL COGNITION; EPISODIC MEMORY; WANDERING MINDS; MODE NETWORK; BASE-LINE; SELF	One of the most consistent observations in human functional imaging is that a network of brain regions referred to as the "default network" increases its activity during passive states. Here we explored the anatomy and function of the default network across three studies to resolve divergent hypotheses about its contributions to spontaneous cognition and active forms of decision making. Analysis of intrinsic activity revealed the network comprises multiple, dissociated components. A midline core (posterior cingulate and anterior medial prefrontal cortex) is active when people make self-relevant, affective decisions. In contrast, a medial temporal lobe subsystem becomes engaged when decisions involve constructing a mental scene based on memory. During certain experimentally directed and spontaneous acts of future-oriented thought, these dissociated components are simultaneously engaged, presumably to facilitate construction of mental models of personally significant events.	[Andrews-Hanna, Jessica R.; Reidler, Jay S.; Sepulcre, Jorge; Poulin, Renee; Buckner, Randy L.] Harvard Univ, Ctr Brain Sci, Cambridge, MA 02138 USA; [Andrews-Hanna, Jessica R.; Sepulcre, Jorge; Buckner, Randy L.] Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA 02129 USA; [Buckner, Randy L.] Massachusetts Gen Hosp, Dept Psychiat, Charlestown, MA 02129 USA; [Buckner, Randy L.] Massachusetts Gen Hosp, Dept Radiol, Charlestown, MA 02129 USA; [Sepulcre, Jorge; Buckner, Randy L.] Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA; [Andrews-Hanna, Jessica R.; Reidler, Jay S.; Sepulcre, Jorge; Poulin, Renee; Buckner, Randy L.] Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA	Harvard University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Howard Hughes Medical Institute; Harvard University	Andrews-Hanna, JR (corresponding author), Univ Colorado, Dept Psychol & Neurosci, Boulder, CO 80309 USA.		白, 纯歌/V-1853-2017; Sepulcre, Jorge/ABE-6375-2020	Reidler, Jay/0000-0002-9615-5351; Sepulcre, Jorge/0000-0002-4199-2304	NATIONAL INSTITUTE ON AGING [R01AG034556, R01AG021910] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIA NIH HHS [R01 AG034556-01, R01 AG021910-05, R01 AG034556-03, AG-021910, R01 AG034556-02, R01 AG021910] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Addis DR, 2009, NEUROPSYCHOLOGIA, V47, P2222, DOI 10.1016/j.neuropsychologia.2008.10.026; Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; ANDREASEN NC, 1995, AM J PSYCHIAT, V152, P1576; Andrews-Hanna JR, 2007, NEURON, V56, P924, DOI 10.1016/j.neuron.2007.10.038; Bar M, 2007, TRENDS COGN SCI, V11, P280, DOI 10.1016/j.tics.2007.05.005; Barbas H, 1999, J COMP NEUROL, V410, P343, DOI 10.1002/(SICI)1096-9861(19990802)410:3<343::AID-CNE1>3.0.CO;2-1; Binder JR, 2009, CEREB CORTEX, V19, P2767, DOI 10.1093/cercor/bhp055; Binder JR, 1999, J COGNITIVE NEUROSCI, V11, P80, DOI 10.1162/089892999563265; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Broyd SJ, 2009, NEUROSCI BIOBEHAV R, V33, P279, DOI 10.1016/j.neubiorev.2008.09.002; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Christoff K, 2009, P NATL ACAD SCI USA, V106, P8719, DOI 10.1073/pnas.0900234106; D'Argembeau A, 2005, NEUROIMAGE, V25, P616, DOI 10.1016/j.neuroimage.2004.11.048; D'Argembeau A, 2010, J COGNITIVE NEUROSCI, V22, P1701, DOI 10.1162/jocn.2009.21314; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Fransson P, 2008, NEUROIMAGE, V42, P1178, DOI 10.1016/j.neuroimage.2008.05.059; FREEMAN LC, 1977, SOCIOMETRY, V40, P35, DOI 10.2307/3033543; Frith U, 2003, PHILOS T R SOC B, V358, P459, DOI 10.1098/rstb.2002.1218; Gallagher HL, 2000, NEUROPSYCHOLOGIA, V38, P11, DOI 10.1016/S0028-3932(99)00053-6; Gilbert SJ, 2007, SCIENCE, V317, P43, DOI 10.1126/science.1140801; Goldman A.I., 1992, MIND LANG, V7, P104, DOI [10.1111/j.1468-0017.1992.tb00200.x, DOI 10.1111/J.1468-0017.1992.TB00200.X]; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Gusnard DA, 2001, P NATL ACAD SCI USA, V98, P4259, DOI 10.1073/pnas.071043098; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Hassabis D, 2007, J NEUROSCI, V27, P14365, DOI 10.1523/JNEUROSCI.4549-07.2007; Hassabis D, 2007, TRENDS COGN SCI, V11, P299, DOI 10.1016/j.tics.2007.05.001; Hassabis D, 2007, P NATL ACAD SCI USA, V104, P1726, DOI 10.1073/pnas.0610561104; Heatherton TF, 2006, SOC COGN AFFECT NEUR, V1, P18, DOI 10.1093/scan/nsl001; James W., 1890, PRINCIPLES PSYCHOL; Johnson SC, 2002, BRAIN, V125, P1808, DOI 10.1093/brain/awf181; Kahn I, 2008, J NEUROPHYSIOL, V100, P129, DOI 10.1152/jn.00077.2008; KAMADA T, 1989, INFORM PROCESS LETT, V31, P7, DOI 10.1016/0020-0190(89)90102-6; Kelley WM, 2002, J COGNITIVE NEUROSCI, V14, P785, DOI 10.1162/08989290260138672; Klinger E., 1971, STRUCTURE FUNCTIONS; Klinger E., 1987, IMAG COGN PERS, V7, P105, DOI [DOI 10.2190/7K24-G343-MTQW-115V, 10.2190/7k24-g343-mtqw-115v]; Kobayashi Y, 2003, J COMP NEUROL, V466, P48, DOI 10.1002/cne.10883; Kobayashi Y, 2007, J COMP NEUROL, V502, P810, DOI 10.1002/cne.21346; Kondo H, 2005, J COMP NEUROL, V493, P479, DOI 10.1002/cne.20796; Lane RD, 1997, NEUROREPORT, V8, P3969, DOI 10.1097/00001756-199712220-00024; Lavenex P, 2002, J COMP NEUROL, V447, P394, DOI 10.1002/cne.10243; Liu HS, 2009, P NATL ACAD SCI USA, V106, P20499, DOI 10.1073/pnas.0908073106; LOMBARDO MV, 2009, J COGNITIVE NEUROSCI, DOI DOI 10.1162/JOCN.2009.21287; Lou HC, 2004, P NATL ACAD SCI USA, V101, P6827, DOI 10.1073/pnas.0400049101; Margulies DS, 2007, NEUROIMAGE, V37, P579, DOI 10.1016/j.neuroimage.2007.05.019; Margulies DS, 2009, P NATL ACAD SCI USA, V106, P20069, DOI 10.1073/pnas.0905314106; MARKS DF, 1973, BRIT J PSYCHOL, V64, P17, DOI 10.1111/j.2044-8295.1973.tb01322.x; Mason MF, 2007, SCIENCE, V315, P393, DOI 10.1126/science.1131295; Mazoyer B, 2001, BRAIN RES BULL, V54, P287, DOI 10.1016/S0361-9230(00)00437-8; McKiernan KA, 2006, NEUROIMAGE, V29, P1185, DOI 10.1016/j.neuroimage.2005.09.030; McKiernan KA, 2003, J COGNITIVE NEUROSCI, V15, P394, DOI 10.1162/089892903321593117; Mitchell JP, 2006, BRAIN RES, V1079, P66, DOI 10.1016/j.brainres.2005.12.113; Mitchell JP, 2006, NEURON, V50, P655, DOI 10.1016/j.neuron.2006.03.040; Morcom AM, 2007, NEUROIMAGE, V37, P1073, DOI 10.1016/j.neuroimage.2006.09.013; Morecraft RJ, 2004, J COMP NEUROL, V469, P37, DOI 10.1002/cne.10980; Ochsner KN, 2005, NEUROIMAGE, V28, P797, DOI 10.1016/j.neuroimage.2005.06.069; Ochsner KN, 2004, J COGNITIVE NEUROSCI, V16, P1746, DOI 10.1162/0898929042947829; Olsson A, 2008, TRENDS COGN SCI, V12, P65, DOI 10.1016/j.tics.2007.11.010; Price JL, 2007, ANN NY ACAD SCI, V1121, P54, DOI 10.1196/annals.1401.008; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Saxe R, 2003, NEUROIMAGE, V19, P1835, DOI 10.1016/S1053-8119(03)00230-1; Saxe R, 2006, SOC COGN AFFECT NEUR, V1, P229, DOI 10.1093/scan/nsl034; Schacter DL, 2007, NAT REV NEUROSCI, V8, P657, DOI 10.1038/nrn2213; Schacter DL, 2007, PHILOS T R SOC B, V362, P773, DOI 10.1098/rstb.2007.2087; Schilbach L, 2008, CONSCIOUS COGN, V17, P457, DOI 10.1016/j.concog.2008.03.013; Shulman GL, 1997, J COGNITIVE NEUROSCI, V9, P648, DOI 10.1162/jocn.1997.9.5.648; Singer J.L., 1966, DAYDREAMING INTRO EX; Spreng RN, 2009, J COGNITIVE NEUROSCI, V21, P489, DOI 10.1162/jocn.2008.21029; SUZUKI WA, 1994, J COMP NEUROL, V350, P497, DOI 10.1002/cne.903500402; Szpunar KK, 2009, CEREB CORTEX, V19, P1539, DOI 10.1093/cercor/bhn191; Van Dijk KRA, 2010, J NEUROPHYSIOL, V103, P297, DOI 10.1152/jn.00783.2009; Van Essen DC, 2005, NEUROIMAGE, V28, P635, DOI 10.1016/j.neuroimage.2005.06.058; Vanderwal T, 2008, NEUROIMAGE, V41, P1437, DOI 10.1016/j.neuroimage.2008.03.058; Vincent JL, 2006, J NEUROPHYSIOL, V96, P3517, DOI 10.1152/jn.00048.2006; Wicker B, 2003, BRAIN RES REV, V43, P224, DOI 10.1016/j.brainresrev.2003.08.003	76	1689	1725	5	216	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 25	2010	65	4					550	562		10.1016/j.neuron.2010.02.005	http://dx.doi.org/10.1016/j.neuron.2010.02.005			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	566HD	20188659	Green Accepted, Bronze			2022-12-24	WOS:000275359800013
J	Saleh, M; Reimer, J; Penn, R; Ojakangas, CL; Hatsopoulos, NG				Saleh, Maryam; Reimer, Jacob; Penn, Richard; Ojakangas, Catherine L.; Hatsopoulos, Nicholas G.			Fast and Slow Oscillations in Human Primary Motor Cortex Predict Oncoming Behaviorally Relevant Cues	NEURON			English	Article							LOCAL-FIELD POTENTIALS; GAMMA-BAND ACTIVITY; VISUAL AREA V4; NEURONAL OSCILLATIONS; SPATIAL ATTENTION; SELECTIVE ATTENTION; SENSORIMOTOR CORTEX; CORTICAL AREAS; BRAIN RHYTHMS; BETA-ACTIVITY	Beta oscillations (12-30 Hz) in local field potentials are prevalent in the motor system, yet their functional role within the context of planning a movement is still debated. In this study, a human participant implanted with a multielectrode array in the hand area of primary motor cortex (MI) was instructed to plan a movement using either the second or fourth of five sequentially presented instruction cues. The beta amplitude increased from the start of the trial until the informative (second or fourth) cue, and was diminished afterwards. Moreover, the beta amplitude peaked just prior to each instruction cue and the delta frequency (0.5-1.5 Hz) entrained to the interval between the cues-but only until the informative cue. This result suggests that the beta amplitude and delta phase in MI reflect the subject's engagement with the rhythmically presented cues and work together to enhance sensitivity to predictable and task-relevant visual cues.	[Hatsopoulos, Nicholas G.] Univ Chicago, Dept Organismal Biol & Anat, Chicago, IL 60637 USA; [Saleh, Maryam; Hatsopoulos, Nicholas G.] Univ Chicago, Comm Computat Neurosci, Chicago, IL 60637 USA; [Reimer, Jacob; Hatsopoulos, Nicholas G.] Univ Chicago, Comm Neurobiol, Chicago, IL 60637 USA; [Penn, Richard; Ojakangas, Catherine L.] Univ Chicago, Neurosurg Sect, Dept Surg, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago; University of Chicago	Hatsopoulos, NG (corresponding author), Univ Chicago, Dept Organismal Biol & Anat, Chicago, IL 60637 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K01NS049040, R01NS045853] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS045853, K01 NS049040-05] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Baker SN, 1999, EXP BRAIN RES, V128, P109, DOI 10.1007/s002210050825; Bauer M, 2006, J NEUROSCI, V26, P490, DOI 10.1523/JNEUROSCI.5228-04.2006; Bauer M, 2009, VISION RES, V49, P931, DOI 10.1016/j.visres.2009.03.014; Berens P, 2009, J STAT SOFTW, V31, P1, DOI 10.18637/jss.v031.i10; BOUYER JJ, 1987, NEUROSCIENCE, V22, P863, DOI 10.1016/0306-4522(87)92965-4; Buschman TJ, 2007, SCIENCE, V315, P1860, DOI 10.1126/science.1138071; Buschman TJ, 2009, NEURON, V63, P386, DOI 10.1016/j.neuron.2009.06.020; Contreras D, 1996, J PHYSIOL-LONDON, V494, P251, DOI 10.1113/jphysiol.1996.sp021488; Courtemanche R, 2002, J NEUROPHYSIOL, V88, P771, DOI 10.1152/jn.2002.88.2.771; Donoghue JP, 1998, J NEUROPHYSIOL, V79, P159, DOI 10.1152/jn.1998.79.1.159; Fell J, 2003, BRAIN RES REV, V42, P265, DOI 10.1016/S0165-0173(03)00178-4; Fischer H, 2003, BRAIN RES BULL, V59, P387, DOI 10.1016/S0361-9230(02)00940-1; Fischer H, 2000, NEUROREPORT, V11, P123, DOI 10.1097/00001756-200001170-00024; Fries P, 2002, J NEUROSCI, V22, P3739; Fries P, 2008, J NEUROSCI, V28, P4823, DOI 10.1523/JNEUROSCI.4499-07.2008; Handel B, 2009, NEUROIMAGE, V45, P1040, DOI 10.1016/j.neuroimage.2008.12.013; Hochberg LR, 2006, NATURE, V442, P164, DOI 10.1038/nature04970; Isler JR, 2008, BRAIN RES, V1232, P163, DOI 10.1016/j.brainres.2008.07.030; Kay LM, 2009, TRENDS NEUROSCI, V32, P207, DOI 10.1016/j.tins.2008.11.008; Kuhn AA, 2008, EXP NEUROL, V214, P140, DOI 10.1016/j.expneurol.2008.07.023; Kuhn AA, 2008, J NEUROSCI, V28, P6165, DOI 10.1523/JNEUROSCI.0282-08.2008; Lakatos P, 2008, SCIENCE, V320, P110, DOI 10.1126/science.1154735; Lakatos P, 2007, NEURON, V53, P279, DOI 10.1016/j.neuron.2006.12.011; Martin C, 2007, J NEUROPHYSIOL, V98, P2196, DOI 10.1152/jn.00524.2007; Mitchell JF, 2007, NEURON, V55, P131, DOI 10.1016/j.neuron.2007.06.018; Munk MHJ, 1996, SCIENCE, V272, P271, DOI 10.1126/science.272.5259.271; MURTHY VN, 1992, P NATL ACAD SCI USA, V89, P5670, DOI 10.1073/pnas.89.12.5670; Murthy VN, 1996, J NEUROPHYSIOL, V76, P3949, DOI 10.1152/jn.1996.76.6.3949; O'Leary JG, 2006, J NEUROPHYSIOL, V96, P1492, DOI 10.1152/jn.00106.2006; Palva JM, 2005, J NEUROSCI, V25, P3962, DOI 10.1523/JNEUROSCI.4250-04.2005; Pfaff D. W., 2006, BRAIN AROUSAL INFORM; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Ravden D, 1998, INT J PSYCHOPHYSIOL, V30, P359, DOI 10.1016/S0167-8760(98)00039-7; Ray S, 2008, CLIN NEUROPHYSIOL, V119, P116, DOI 10.1016/j.clinph.2007.09.136; Riehle A, 1997, SCIENCE, V278, P1950, DOI 10.1126/science.278.5345.1950; Roelfsema PR, 1997, NATURE, V385, P157, DOI 10.1038/385157a0; Roux S, 2006, BEHAV BRAIN RES, V169, P335, DOI 10.1016/j.bbr.2006.02.004; Rubino D, 2006, NAT NEUROSCI, V9, P1549, DOI 10.1038/nn1802; Sanchez-Vives MV, 2000, NAT NEUROSCI, V3, P1027, DOI 10.1038/79848; SANES JN, 1993, P NATL ACAD SCI USA, V90, P4470, DOI 10.1073/pnas.90.10.4470; Sauseng P, 2008, NEUROIMAGE, V40, P308, DOI 10.1016/j.neuroimage.2007.11.032; Schroeder CE, 2009, TRENDS NEUROSCI, V32, P9, DOI 10.1016/j.tins.2008.09.012; Schwartz S, 2005, CEREB CORTEX, V15, P770, DOI 10.1093/cercor/bhh178; Siegel M, 2008, NEURON, V60, P709, DOI 10.1016/j.neuron.2008.09.010; Steriade M, 1996, SCIENCE, V272, P225, DOI 10.1126/science.272.5259.225; Steriade M, 2006, NEUROSCIENCE, V137, P1087, DOI 10.1016/j.neuroscience.2005.10.029; Steriade M, 1996, J NEUROSCI, V16, P2788; STERIADE M, 1993, J NEUROSCI, V13, P3252, DOI 10.1523/jneurosci.13-08-03252.1993; Sundberg KA, 2009, NEURON, V61, P952, DOI 10.1016/j.neuron.2009.02.023; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; Vidal JR, 2006, J COGNITIVE NEUROSCI, V18, P1850, DOI 10.1162/jocn.2006.18.11.1850; Wilder JD, 2009, VISION RES, V49, P1017, DOI 10.1016/j.visres.2008.04.032; Williams ER, 2009, J NEUROPHYSIOL, V102, P1296, DOI 10.1152/jn.90996.2008; Zhang Y, 2008, NEUROSCIENCE, V156, P238, DOI 10.1016/j.neuroscience.2008.06.061	54	173	176	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 25	2010	65	4					461	471		10.1016/j.neuron.2010.02.001	http://dx.doi.org/10.1016/j.neuron.2010.02.001			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	566HD	20188651	Green Accepted, Bronze			2022-12-24	WOS:000275359800005
J	Hall, J; Guo, G; Wray, J; Eyres, I; Nichols, J; Grotewold, L; Morfopoulou, S; Humphreys, P; Mansfield, W; Walker, R; Tomlinson, S; Smith, A				Hall, John; Guo, Ge; Wray, Jason; Eyres, Isobel; Nichols, Jennifer; Grotewold, Lars; Morfopoulou, Sofia; Humphreys, Peter; Mansfield, William; Walker, Rachael; Tomlinson, Simon; Smith, Austin			Oct4 and LIF/Stat3 Additively Induce Kruppel Factors to Sustain Embryonic Stem Cell Self-Renewal	CELL STEM CELL			English	Article							TRANSCRIPTIONAL NETWORK; SIGNALING PATHWAYS; GROUND-STATE; DIFFERENTIATION; PLURIPOTENCY; MOUSE; NANOG; ACTIVATION; EXPRESSION; GENE	Embryonic stem cell (ESC) pluripotency is dependent on an intrinsic gene regulatory network centered on Oct4. Propagation of the pluripotent state is stimulated by the cytokine leukemia inhibitory factor (LIF) acting through the transcriptional regulator Stat3. Here, we show that this extrinsic stimulus converges with the intrinsic circuitry in Kruppel-factor activation. Oct4 primarily induces Klf2 while LIF/Stat3 selectively enhances Klf4 expression. Overexpression of either factor reduces LIF dependence, but with quantitative and qualitative differences. Unlike Klf4, Klf2 increases ESC clonogenicity, maintains undifferentiated ESCs in the genetic absence of Stat3, and confers resistance to BMP-induced differentiation. ESCs expanded with Klf2 remain capable of contributing to adult chimeras. Postimplantation-embryo-derived EpiSCs lack both Klf2 and KIN and expression of either can reinstate naive pluripotency. These findings indicate that Oct4 and Stat3 intersect in directing expression of Klf transcriptional regulators with overlapping properties that additively reinforce ground-state ESC pluripotency, identity, and self-renewal.	[Grotewold, Lars; Morfopoulou, Sofia; Tomlinson, Simon] Univ Edinburgh, Sch Biol Sci, MRC Ctr Regenerat Med, Inst Stem Cell Res, Edinburgh EH9 3JQ, Midlothian, Scotland; [Hall, John; Guo, Ge; Wray, Jason; Eyres, Isobel; Nichols, Jennifer; Humphreys, Peter; Mansfield, William; Walker, Rachael; Smith, Austin] Univ Cambridge, Wellcome Trust Ctr Stem Cell Res, Cambridge CB2 1QR, England; [Hall, John; Guo, Ge; Wray, Jason; Eyres, Isobel; Smith, Austin] Univ Cambridge, Dept Biochem, Cambridge CB2 1QR, England; [Nichols, Jennifer] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 1QR, England	University of Edinburgh; University of Cambridge; University of Cambridge; University of Cambridge	Tomlinson, S (corresponding author), Univ Edinburgh, Sch Biol Sci, MRC Ctr Regenerat Med, Inst Stem Cell Res, Kings Bldg,W Mains Rd, Edinburgh EH9 3JQ, Midlothian, Scotland.	simon.tomlinson@ed.ac.uk; austin.smith@cscr.cam.ac.uk	Kumar, Rajesh/E-7957-2010	Smith, Austin/0000-0002-3029-4682; Morfopoulou, Sofia/0000-0001-8181-4548; Nichols, Jennifer/0000-0002-8650-1388	Biotechnology and Biological Sciences Research Council; European Commission; Medical Research Council; Wellcome Trust; Pfizer; Human Frontier Sciences Program Fellow; Medical Research Council Stem Cell Fellow; Medical Research Council [G9806702, G0700665, G0300723B, G0700711B] Funding Source: researchfish; MRC [G0700665, G9806702] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Commission(European CommissionEuropean Commission Joint Research Centre); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Pfizer(Pfizer); Human Frontier Sciences Program Fellow(Human Frontier Science Program); Medical Research Council Stem Cell Fellow(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank Nigel Miller for flow cytometry, Douglas Colby, and Sameera Patel for ESC culture, and Marko Hyvonen for recombinant proteins. This research was supported by the Biotechnology and Biological Sciences Research Council, the European Commission Framework 7 integrated project "EuroSystem," the Medical Research Council and the Wellcome Trust. In initial stages of this work, J.H. was supported by a collaborative PhD studentship sponsored by Pfizer. LG was a Human Frontier Sciences Program Fellow, G.G. is a Medical Research Council Stem Cell Fellow and A.S. is a Medical Research Council Professor. J.H. performed, analyzed and interpreted experiments, G.G. reprogrammed EpiSCs, J.W. generated Stat3 null ESC and luciferase data, I.E. provided real-time PCR and ChIP data, J.N. derived EpiSCs, L.G. contributed to ZHBTc4 and RCN studies, S.M. analyzed public datasets, B.M. generated chimaeras and with R.W. carried out Cre excision, P.H. designed image analysis software, S.T. supervised bioinformatics analyses, and A.S. supervised the experimental studies and wrote the paper with J.H. Please contact S.T. for bioinformatics and A.S. for other matters.	Bourillot PY, 2009, STEM CELLS, V27, P1760, DOI 10.1002/stem.110; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Bruce SJ, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-365; Burdon T, 1999, DEV BIOL, V210, P30, DOI 10.1006/dbio.1999.9265; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Dani C, 1998, DEV BIOL, V203, P149, DOI 10.1006/dbio.1998.9026; Ema M, 2008, CELL STEM CELL, V3, P555, DOI 10.1016/j.stem.2008.09.003; Fisher CL, 1997, BIOTECHNIQUES, V23, P570, DOI 10.2144/97234bm01; Guo G, 2009, DEVELOPMENT, V136, P1063, DOI 10.1242/dev.030957; Hanna J, 2009, CELL STEM CELL, V4, P513, DOI 10.1016/j.stem.2009.04.015; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jiang JM, 2008, NAT CELL BIOL, V10, P353, DOI 10.1038/ncb1698; Kawai-Kowase K, 1999, CIRC RES, V85, P787, DOI 10.1161/01.RES.85.9.787; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Kunath T, 2007, DEVELOPMENT, V134, P2895, DOI 10.1242/dev.02880; Kuo CT, 1997, SCIENCE, V277, P1986, DOI 10.1126/science.277.5334.1986; Kurimoto K, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl050; Kuroda T, 2005, MOL CELL BIOL, V25, P2475, DOI 10.1128/MCB.25.6.2475-2485.2005; Li Y, 2005, BLOOD, V105, P635, DOI 10.1182/blood-2004-07-2681; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Matoba R, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000026; Matsuda T, 1999, EMBO J, V18, P4261, DOI 10.1093/emboj/18.15.4261; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Nakatake Y, 2006, MOL CELL BIOL, V26, P7772, DOI 10.1128/MCB.00468-06; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Nichols J, 2001, DEVELOPMENT, V128, P2333; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Niwa H, 2005, CELL, V123, P917, DOI 10.1016/j.cell.2005.08.040; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Niwa H, 2007, DEVELOPMENT, V134, P635, DOI 10.1242/dev.02787; Niwa H, 2009, NATURE, V460, P118, DOI 10.1038/nature08113; Ovcharenko I, 2004, NUCLEIC ACIDS RES, V32, pW280, DOI 10.1093/nar/gkh355; Peitz M, 2002, P NATL ACAD SCI USA, V99, P4489, DOI 10.1073/pnas.032068699; RATHJEN PD, 1990, GENE DEV, V4, P2308, DOI 10.1101/gad.4.12b.2308; Rodda DJ, 2005, J BIOL CHEM, V280, P24731, DOI 10.1074/jbc.M502573200; SCHUH R, 1986, CELL, V47, P1025, DOI 10.1016/0092-8674(86)90817-2; Segre JA, 1999, NAT GENET, V22, P356, DOI 10.1038/11926; Silva J, 2006, NATURE, V441, P997, DOI 10.1038/nature04914; Silva J, 2008, PLOS BIOL, V6, P2237, DOI 10.1371/journal.pbio.0060253; Smith A, 2001, COLD SPRING HARBOR M, P205; Smith AG, 2001, ANNU REV CELL DEV BI, V17, P435, DOI 10.1146/annurev.cellbio.17.1.435; SMITH AG, 1988, NATURE, V336, P688, DOI 10.1038/336688a0; Smith AG., 1991, J TISSUE CULT METHOD, V13, P89, DOI [10.1007/BF01666137, DOI 10.1007/BF01666137, 10.1007/bf01666137]; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Starr R, 1997, NATURE, V387, P917, DOI 10.1038/43206; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; WILLIAMS RL, 1988, NATURE, V336, P684, DOI 10.1038/336684a0; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; YOSHIDA K, 1994, MECH DEVELOP, V45, P163, DOI 10.1016/0925-4773(94)90030-2	54	272	278	0	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	DEC 4	2009	5	6					597	609		10.1016/j.stem.2009.11.003	http://dx.doi.org/10.1016/j.stem.2009.11.003			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	543YH	19951688	Bronze			2022-12-24	WOS:000273616700008
J	Pouille, F; Marin-Burgin, A; Adesnik, H; Atallah, BV; Scanziani, M				Pouille, Frederic; Marin-Burgin, Antonia; Adesnik, Hillel; Atallah, Bassam V.; Scanziani, Massimo			Input normalization by global feedforward inhibition expands cortical dynamic range	NATURE NEUROSCIENCE			English	Article							BARREL CORTEX; SOMATOSENSORY CORTEX; DENDRITIC INHIBITION; PYRAMIDAL CELLS; IN-VITRO; NEURONS; INTERNEURONS; RAT; NEOCORTEX; NETWORKS	The cortex is sensitive to weak stimuli, but responds to stronger inputs without saturating. The mechanisms that enable this wide range of operation are not fully understood. We found that the amplitude of excitatory synaptic currents necessary to fire rodent pyramidal cells, the threshold excitatory current, increased with stimulus strength. Consequently, the relative contribution of individual afferents in firing a neuron was inversely proportional to the total number of active afferents. Feedforward inhibition, acting homogeneously across pyramidal cells, ensured that threshold excitatory currents increased with stimulus strength. In contrast, heterogeneities in the distribution of excitatory currents in the neuronal population determined the specific set of pyramidal cells recruited. Together, these mechanisms expand the range of afferent input strengths that neuronal populations can represent.	[Pouille, Frederic; Marin-Burgin, Antonia; Adesnik, Hillel; Atallah, Bassam V.; Scanziani, Massimo] Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA; [Pouille, Frederic; Marin-Burgin, Antonia; Adesnik, Hillel; Atallah, Bassam V.; Scanziani, Massimo] Univ Calif San Diego, Neurobiol Sect, La Jolla, CA 92093 USA	Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego	Scanziani, M (corresponding author), Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA.	massimo@ucsd.edu	Marin-Burgin, Antonia/V-6602-2019	Marin-Burgin, Antonia/0000-0003-0684-9796; Atallah, Bassam/0000-0003-2315-7126	US National Institutes of Health [MH71401, NS061521]; Helen Hay Whithney Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH071401] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS061521] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Helen Hay Whithney Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank P. Abelkop for anatomical reconstructions of biocytin filled neurons, F. Frhlich for developing the initial versions of model, M. Carandini and J. Isaacson for comments and suggestions during the entire course of the project, C. Poo and F. Bertaso for inputs on the manuscript, and all of the members of the Scanziani laboratory for their input on the project and the manuscript. M. S. thanks C. Staub for the original discussions leading to the project. This work was funded in part by the US National Institutes of Health (MH71401 to M. S. and NS061521 to B. V. A.). H. A. is a fellow of the Helen Hay Whithney Foundation. M. S. is an investigator of the Howard Hughes Medical Institute.	AGMON A, 1991, NEUROSCIENCE, V41, P365, DOI 10.1016/0306-4522(91)90333-J; ALGER BE, 1982, J PHYSIOL-LONDON, V328, P105, DOI 10.1113/jphysiol.1982.sp014255; Arabzadeh E, 2005, PLOS BIOL, V3, P155, DOI 10.1371/journal.pbio.0030017; Beierlein M, 2003, J NEUROPHYSIOL, V90, P2987, DOI 10.1152/jn.00283.2003; Blitz DM, 2005, NEURON, V45, P917, DOI 10.1016/j.neuron.2005.01.033; Bruno RM, 2006, SCIENCE, V312, P1622, DOI 10.1126/science.1124593; BUHL EH, 1994, NATURE, V368, P823, DOI 10.1038/368823a0; BUZSAKI G, 1984, PROG NEUROBIOL, V22, P131, DOI 10.1016/0301-0082(84)90023-6; Carvalho TP, 2009, NEURON, V61, P774, DOI 10.1016/j.neuron.2009.01.013; Chance FS, 2002, NEURON, V35, P773, DOI 10.1016/S0896-6273(02)00820-6; Cruikshank SJ, 2007, NAT NEUROSCI, V10, P462, DOI 10.1038/nn1861; Csicsvari J, 2000, NEURON, V28, P585, DOI 10.1016/S0896-6273(00)00135-5; Daw MI, 2007, NAT NEUROSCI, V10, P453, DOI 10.1038/nn1866; Diesmann M, 1999, NATURE, V402, P529, DOI 10.1038/990101; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Gabernet L, 2005, NEURON, V48, P315, DOI 10.1016/j.neuron.2005.09.022; Geiger JRP, 1997, NEURON, V18, P1009, DOI 10.1016/S0896-6273(00)80339-6; Glickfeld LL, 2006, NAT NEUROSCI, V9, P807, DOI 10.1038/nn1688; Helmstaedter M, 2008, J NEUROSCI, V28, P8273, DOI 10.1523/JNEUROSCI.5701-07.2008; Holmgren C, 2003, J PHYSIOL-LONDON, V551, P139, DOI 10.1113/jphysiol.2003.044784; Lefort S, 2009, NEURON, V61, P301, DOI 10.1016/j.neuron.2008.12.020; Maccaferri G, 2002, J NEUROSCI, V22, P5462; MARR D, 1969, J PHYSIOL-LONDON, V202, P437, DOI 10.1113/jphysiol.1969.sp008820; Mitchell SJ, 2003, NEURON, V38, P433, DOI 10.1016/S0896-6273(03)00200-9; Mittmann W, 2005, J PHYSIOL-LONDON, V563, P369, DOI 10.1113/jphysiol.2004.075028; Nakamura M, 2007, J NEUROSCI, V27, P1365, DOI 10.1523/JNEUROSCI.4672-06.2007; NICOLL RA, 1980, NATURE, V287, P22, DOI 10.1038/287022a0; OTMAKHOV N, 1993, NEURON, V10, P1101, DOI 10.1016/0896-6273(93)90058-Y; Petreanu L, 2007, NAT NEUROSCI, V10, P663, DOI 10.1038/nn1891; Poo C, 2009, NEURON, V62, P850, DOI 10.1016/j.neuron.2009.05.022; Porter JT, 2001, J NEUROSCI, V21, P2699, DOI 10.1523/JNEUROSCI.21-08-02699.2001; Pouille F, 2001, SCIENCE, V293, P1159, DOI 10.1126/science.1060342; Saito T, 2001, DEV BIOL, V240, P237, DOI 10.1006/dbio.2001.0439; SAYER RJ, 1990, J NEUROSCI, V10, P826; Shadlen MN, 1998, J NEUROSCI, V18, P3870; Shu YS, 2003, J NEUROSCI, V23, P10388; Sneider JT, 2006, NEUROSCIENCE, V141, P1665, DOI 10.1016/j.neuroscience.2006.05.052; Somogyi P, 2005, J PHYSIOL-LONDON, V562, P9, DOI 10.1113/jphysiol.2004.078915; STEIGER JH, 1980, PSYCHOL BULL, V87, P245, DOI 10.1037/0033-2909.87.2.245; Thomson AM, 2002, CEREB CORTEX, V12, P936, DOI 10.1093/cercor/12.9.936; Vaillend C, 2002, J NEUROPHYSIOL, V88, P2963, DOI 10.1152/jn.00244.2002; Vogels TP, 2005, J NEUROSCI, V25, P10786, DOI 10.1523/JNEUROSCI.3508-05.2005; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; Winegar BD, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-5	44	199	199	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2009	12	12					1577	U131		10.1038/nn.2441	http://dx.doi.org/10.1038/nn.2441			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	523II	19881502				2022-12-24	WOS:000272065600018
J	Gordon, GRJ; Iremonger, KJ; Kantevari, S; Ellis-Davies, GCR; MacVicar, BA; Bains, JS				Gordon, Grant R. J.; Iremonger, Karl J.; Kantevari, Srinivas; Ellis-Davies, Graham C. R.; MacVicar, Brian A.; Bains, Jaideep S.			Astrocyte-Mediated Distributed Plasticity at Hypothalamic Glutamate Synapses	NEURON			English	Article							P2X(2) RECEPTOR IMMUNOREACTIVITY; IN-SITU RESPOND; GLIAL TNF-ALPHA; RAT HYPOTHALAMUS; CALCIUM WAVES; ATP RELEASE; PARAVENTRICULAR NUCLEUS; HIPPOCAMPAL ASTROCYTES; EXCITATORY SYNAPSES; SUPRAOPTIC NEURONS	Afferent activity can induce fast, feed-forward changes in synaptic efficacy that are synapse specific. Using combined electrophysiology, caged molecule photolysis, and Ca2+ imaging, we describe a plasticity in which the recruitment of astrocytes in response to afferent activity causes a fast and feed-forward, yet distributed increase in the amplitude of quantal synaptic currents at multiple glutamate synapses on magnocellular neurosecretory cells in the hypothalamic paraventricular nucleus. The plasticity is largely multiplicative, consistent with a proportional increase or "scaling" in the strength of all synapses on the neuron. This effect requires a metabotropic glutamate receptor-mediated rise in Ca2+ in the astrocyte processes surrounding the neuron and the release of the gliotransmitter ATP, which acts on postsynaptic purinergic receptors. These data provide evidence for a form of distributed synaptic plasticity that is feed-forward, expressed quickly, and mediated by the synaptic activation of neighboring astrocytes.	[Gordon, Grant R. J.; Iremonger, Karl J.; Bains, Jaideep S.] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada; [Gordon, Grant R. J.; Iremonger, Karl J.; Bains, Jaideep S.] Univ Calgary, Dept Physiol & Pharmacol, Calgary, AB, Canada; [Gordon, Grant R. J.; MacVicar, Brian A.] Univ British Columbia, Dept Psychiat, Brain Res Ctr, Vancouver, BC V5Z 1M9, Canada; [Kantevari, Srinivas; Ellis-Davies, Graham C. R.] Drexel Univ, Coll Med, Dept Physiol & Pharmacol, Philadelphia, PA 19104 USA	University of Calgary; University of Calgary; University of British Columbia; Drexel University	Bains, JS (corresponding author), Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada.	jsbains@ucalgary.ca	MacVicar, Brian/P-1553-2015; MacVicar, Brian/AAI-7729-2020; Kantevari, Srinivas/B-3221-2008; Kantevari, Srinivas/AAG-3892-2020	MacVicar, Brian/0000-0003-4596-4623; MacVicar, Brian/0000-0003-4596-4623; Bains, Jaideep/0000-0002-3634-6463; Iremonger, Karl/0000-0002-8976-2401	Alberta Heritage Foundation for Medical Research (AHFMR); Heart and Stroke Foundation of Canada (HSFC); Michael Smith Foundation for Health Research (MSFHR); Natural Sciences and Engineering Council of Canada (NSERC); AHFMR; HSFC; NIH [GM53395]; Canadian Institutes for Health Research (CIHR); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053395] Funding Source: NIH RePORTER	Alberta Heritage Foundation for Medical Research (AHFMR)(Alberta Heritage Foundation for Medical Research); Heart and Stroke Foundation of Canada (HSFC)(Heart & Stroke Foundation of Canada); Michael Smith Foundation for Health Research (MSFHR)(Michael Smith Foundation for Health Research); Natural Sciences and Engineering Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); AHFMR(Alberta Heritage Foundation for Medical Research); HSFC(Heart & Stroke Foundation of Canada); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the lab and Dr. Quentin Pittman for comments on an earlier version of the manuscript, Dr. D.V. Baimoukhametova who participated in pilot experiments, and Ms C. Sank for technical assistance. During the course of this work, G.R.J.G. was supported by the Alberta Heritage Foundation for Medical Research (AHFMR), the Heart and Stroke Foundation of Canada (HSFC), the Michael Smith Foundation for Health Research (MSFHR), and the Natural Sciences and Engineering Council of Canada (NSERC). K.J.I. is supported by studentships from AHFMR and HSFC. B.A.M. is a Canada Research Chair and a MSFHR Distinguished Scholar. G.C.R.E.-D. is supported through an NIH operating grant #GM53395. J.S.B. is an AHFMR Senior Scholar. This research was funded by operating grants from the Canadian Institutes for Health Research (CIHR) and the HSFC. G.R.J.G. performed the majority of the experiments and analysis described and wrote the manuscript. K.J.I. assisted in astrocyte recordings, analysis of astrocyte membrane properties, and performed some of the afferent stimulation experiments. G.C.R.E.-D. and S.K. synthesized and provided the NV-IP3/AM. B.A.M. supervised and contributed to the design of the two-photon experiments. J.S.B. supervised the project, performed some of the multiplicative scaling analysis, and wrote the manuscript. All authors helped edit the manuscript.	Abbott LF, 2004, NATURE, V431, P796, DOI 10.1038/nature03010; Agulhon C, 2008, NEURON, V59, P932, DOI 10.1016/j.neuron.2008.09.004; Anderson CM, 2004, J NEUROCHEM, V88, P246, DOI 10.1046/j.1471-4159.2003.02204.x; Araque A, 2000, J NEUROSCI, V20, P666, DOI 10.1523/JNEUROSCI.20-02-00666.2000; Bal-Price A, 2002, GLIA, V40, P312, DOI 10.1002/glia.10124; Beattie EC, 2002, SCIENCE, V295, P2282, DOI 10.1126/science.1067859; BELIN V, 1984, EXP BRAIN RES, V57, P201, DOI 10.1007/BF00231147; Braet K, 2003, J CELL PHYSIOL, V197, P205, DOI 10.1002/jcp.10365; Braet K, 2003, CELL CALCIUM, V33, P37, DOI 10.1016/S0143-4160(02)00180-X; Bushong EA, 2002, J NEUROSCI, V22, P183, DOI 10.1523/JNEUROSCI.22-01-00183.2002; CLARKE DD, 1991, NEUROCHEM RES, V16, P1055, DOI 10.1007/BF00965850; Coco S, 2003, J BIOL CHEM, V278, P1354, DOI 10.1074/jbc.M209454200; CORNELLBELL AH, 1990, SCIENCE, V247, P470, DOI 10.1126/science.1967852; Cotrina ML, 1998, P NATL ACAD SCI USA, V95, P15735, DOI 10.1073/pnas.95.26.15735; Cotrina ML, 2000, J NEUROSCI, V20, P2835; Cowan AI, 1998, J NEUROPHYSIOL, V79, P13, DOI 10.1152/jn.1998.79.1.13; Darby M, 2003, J NEUROPHYSIOL, V89, P1870, DOI 10.1152/jn.00510.2002; DENK W, 1994, P NATL ACAD SCI USA, V91, P6629, DOI 10.1073/pnas.91.14.6629; Duan SM, 2006, GLIA, V54, P738, DOI 10.1002/glia.20397; Fellin T, 2004, NEURON, V43, P729, DOI 10.1016/j.neuron.2004.08.011; FERGUSON AV, 1987, REGUL PEPTIDES, V18, P93, DOI 10.1016/0167-0115(87)90039-5; FERGUSON AV, 1986, AM J PHYSIOL, V251, pR425, DOI 10.1152/ajpregu.1986.251.2.R425; FERGUSON AV, 1984, NEUROENDOCRINOLOGY, V39, P423, DOI 10.1159/000124015; Fiacco TA, 2004, J NEUROSCI, V24, P722, DOI 10.1523/JNEUROSCI.2859-03.2004; Fiacco TA, 2007, NEURON, V54, P611, DOI 10.1016/j.neuron.2007.04.032; Fiacco TA, 2006, GLIA, V54, P676, DOI 10.1002/glia.20396; Gobel W, 2007, NAT METHODS, V4, P73, DOI 10.1038/NMETH989; Gordon GRJ, 2005, NAT NEUROSCI, V8, P1078, DOI 10.1038/nn1498; Gordon GRJ, 2003, J NEUROSCI, V23, P6223; Halassa MM, 2009, NEURON, V61, P213, DOI 10.1016/j.neuron.2008.11.024; Harvey CD, 2008, SCIENCE, V321, P136, DOI 10.1126/science.1159675; Inenaga K, 1998, J NEUROENDOCRINOL, V10, P1, DOI 10.1046/j.1365-2826.1998.00662.x; Jourdain P, 2007, NAT NEUROSCI, V10, P331, DOI 10.1038/nn1849; Kang J, 1998, NAT NEUROSCI, V1, P683, DOI 10.1038/3684; Kantevari S, 2006, CHEMBIOCHEM, V7, P174, DOI 10.1002/cbic.200500345; Latchford KJ, 2004, AM J PHYSIOL-REG I, V286, pR894, DOI 10.1152/ajpregu.00603.2003; Latour I, 2001, HIPPOCAMPUS, V11, P132, DOI 10.1002/hipo.1031; Lin SC, 2004, GLIA, V47, P290, DOI 10.1002/glia.20060; Liu QS, 2004, P NATL ACAD SCI USA, V101, P3172, DOI 10.1073/pnas.0306731101; Loesch A, 1999, J NEUROCYTOL, V28, P495, DOI 10.1023/A:1007009222518; MIYATA S, 1994, BRAIN RES BULL, V34, P169, DOI 10.1016/0361-9230(94)90057-4; Mulligan SJ, 2004, NATURE, V431, P195, DOI 10.1038/nature02827; Newman EA, 2001, J NEUROSCI, V21, P2215, DOI 10.1523/JNEUROSCI.21-07-02215.2001; Nimmerjahn A, 2004, NAT METHODS, V1, P31, DOI 10.1038/nmeth706; Oliet SHR, 2001, SCIENCE, V292, P923, DOI 10.1126/science.1059162; Panatier A, 2006, CELL, V125, P775, DOI 10.1016/j.cell.2006.02.051; Parpura V, 2000, P NATL ACAD SCI USA, V97, P8629, DOI 10.1073/pnas.97.15.8629; Pascual O, 2005, SCIENCE, V310, P113, DOI 10.1126/science.1116916; Pasti L, 1997, J NEUROSCI, V17, P7817; Perea G, 2007, SCIENCE, V317, P1083, DOI 10.1126/science.1144640; Petravicz J, 2008, J NEUROSCI, V28, P4967, DOI 10.1523/JNEUROSCI.5572-07.2008; Piet R, 2004, P NATL ACAD SCI USA, V101, P2151, DOI 10.1073/pnas.0308408100; Porter JT, 1996, J NEUROSCI, V16, P5073; PORTER JT, 1995, GLIA, V13, P101, DOI 10.1002/glia.440130204; Rose J, 2009, NEURON, V61, P351, DOI 10.1016/j.neuron.2008.12.030; Scemes E, 2006, GLIA, V54, P716, DOI 10.1002/glia.20374; Schummers J, 2008, SCIENCE, V320, P1638, DOI 10.1126/science.1156120; Serrano A, 2006, J NEUROSCI, V26, P5370, DOI 10.1523/JNEUROSCI.5255-05.2006; Shibuya I, 1999, J PHYSIOL-LONDON, V514, P351, DOI 10.1111/j.1469-7793.1999.351ae.x; Shigetomi E, 2008, J NEUROSCI, V28, P6659, DOI 10.1523/JNEUROSCI.1717-08.2008; Stellwagen D, 2006, NATURE, V440, P1054, DOI 10.1038/nature04671; TASKER JG, 1991, J PHYSIOL-LONDON, V434, P271, DOI 10.1113/jphysiol.1991.sp018469; THEODOSIS DT, 1984, NEUROSCIENCE, V11, P183, DOI 10.1016/0306-4522(84)90222-7; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; TWEEDLE CD, 1977, CELL TISSUE RES, V181, P59; WAKERLEY JB, 1978, BRAIN RES, V148, P425, DOI 10.1016/0006-8993(78)90730-8; Wang XH, 2006, NAT NEUROSCI, V9, P816, DOI 10.1038/nn1703; Washburn DLS, 2000, J PHYSIOL-LONDON, V529, P359, DOI 10.1111/j.1469-7793.2000.00359.x; Xiang ZH, 1998, BRAIN RES, V813, P390, DOI 10.1016/S0006-8993(98)01073-7; Xu C, 1996, P NATL ACAD SCI USA, V93, P10763, DOI 10.1073/pnas.93.20.10763; Zhang JM, 2003, NEURON, V40, P971, DOI 10.1016/S0896-6273(03)00717-7; Zonta M, 2003, NAT NEUROSCI, V6, P43, DOI 10.1038/nn980	72	155	157	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 12	2009	64	3					391	403		10.1016/j.neuron.2009.10.021	http://dx.doi.org/10.1016/j.neuron.2009.10.021			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	521MF	19914187	Green Accepted, Bronze			2022-12-24	WOS:000271924800013
J	Stafford, BK; Sher, A; Litke, AM; Feldheim, DA				Stafford, Ben K.; Sher, Alexander; Litke, Alan M.; Feldheim, David A.			Spatial-Temporal Patterns of Retinal Waves Underlying Activity-Dependent Refinement of Retinofugal Projections	NEURON			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; EYE-SPECIFIC SEGREGATION; DEVELOPING MAMMALIAN RETINA; RETINOTOPIC MAP REFINEMENT; MICE LACKING; SUPERIOR COLLICULUS; RETINOGENICULATE PROJECTIONS; VISUAL EXPERIENCE; ACTION-POTENTIALS; INSTRUCTIVE ROLE	During development, retinal axons project coarsely within their visual targets before refining to form organized synaptic connections. Spontaneous retinal activity, in the form of acetylcholine-driven retinal waves, is proposed to be necessary for establishing these projection patterns. In particular, both axonal terminations of retinal ganglion cells (RGCs) and the size of receptive fields of target neurons are larger in mice that lack the beta 2 subunit of the nicotinic acetylcholine receptor (beta 2KO). Here, using a large-scale, high-density multielectrode array to record activity from hundreds of RGCs simultaneously, we present analysis of early postnatal retinal activity from both wild-type (WT) and beta 2KO retinas. We find that beta 2KO retinas have correlated patterns of activity, but many aspects of these patterns differ from those of WT retina. Quantitative analysis suggests that wave directionality, coupled with short-range correlated bursting patterns of RGCs, work together to refine retinofugal projections.	[Sher, Alexander; Litke, Alan M.] Univ Calif Santa Cruz, Santa Cruz Inst Particle Phys, Santa Cruz, CA 95064 USA; [Stafford, Ben K.; Feldheim, David A.] Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA; [Sher, Alexander] Univ Calif Santa Cruz, Dept Phys, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz	Litke, AM (corresponding author), Univ Calif Santa Cruz, Santa Cruz Inst Particle Phys, Santa Cruz, CA 95064 USA.	alan.litke@cern.ch; feldheim@biology.ucsc.edu		Sher, Alexander/0000-0001-6655-6456	US National Institutes of Health (NIH) [EY014689]; QB3 Seed Grant; National Science Foundation [PHY-0750525]; Burroughs Wellcome Career Award at Scientific Interface; LIC Santa Cruz Chancellor's Fellowship; NATIONAL EYE INSTITUTE [R01EY014689] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); QB3 Seed Grant; National Science Foundation(National Science Foundation (NSF)); Burroughs Wellcome Career Award at Scientific Interface(Burroughs Wellcome Fund); LIC Santa Cruz Chancellor's Fellowship; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank M. Feller, A.D. Huberman, and J. Yamada for discussions and critical reading of the manuscript. We gratefully acknowledge the technical contributions of W. Dabrowski, A. Grillo, M. Grivich, P. Grybos, P. Hottowy, S. Kachiguine, and D. Petrusca. This work was supported by a US National Institutes of Health (NIH) grant EY014689 (D.A.F), a QB3 Seed Grant (D.A.F.), a National Science Foundation grant PHY-0750525 (A.M.L.), a Burroughs Wellcome Career Award at Scientific Interface (A.S.), and a LIC Santa Cruz Chancellor's Fellowship (B.K.S.).	Bansal A, 2000, J NEUROSCI, V20, P7672; Bjartmar L, 2006, J NEUROSCI, V26, P6269, DOI 10.1523/jneurosci.4212-05.2006; Butts DA, 2001, J NEUROSCI, V21, P961, DOI 10.1523/JNEUROSCI.21-03-00961.2001; Butts DA, 2007, PLOS BIOL, V5, P651, DOI 10.1371/journal.pbio.0050061; Cang JH, 2005, NEURON, V48, P797, DOI 10.1016/j.neuron.2005.09.015; Chalupa LM, 2007, BRAIN RES REV, V55, P228, DOI 10.1016/j.brainresrev.2007.03.003; Champagne FA, 2007, PHYSIOL BEHAV, V91, P325, DOI 10.1016/j.physbeh.2007.03.014; Chandrasekaran AR, 2007, J NEUROSCI, V27, P1746, DOI 10.1523/JNEUROSCI.4383-06.2007; Chandrasekaran AR, 2005, J NEUROSCI, V25, P6929, DOI 10.1523/JNEUROSCI.1470-05.2005; Chen CF, 2000, NEURON, V28, P955, DOI 10.1016/S0896-6273(00)00166-5; CHEN YH, 1993, J MEMBRANE BIOL, V136, P125, DOI 10.1007/BF02505757; Dan Y, 2006, PHYSIOL REV, V86, P1033, DOI 10.1152/physrev.00030.2005; Demas J, 2003, J NEUROSCI, V23, P2851; Demas J, 2006, NEURON, V50, P247, DOI 10.1016/j.neuron.2006.03.033; DRAGER UC, 1976, J NEUROPHYSIOL, V39, P91, DOI 10.1152/jn.1976.39.1.91; Elstrott J, 2008, NEURON, V58, P499, DOI 10.1016/j.neuron.2008.03.013; Feller MB, 1996, SCIENCE, V272, P1182, DOI 10.1126/science.272.5265.1182; Feller MB, 1997, NEURON, V19, P293, DOI 10.1016/S0896-6273(00)80940-X; GODEMENT P, 1984, J COMP NEUROL, V230, P552, DOI 10.1002/cne.902300406; Grubb MS, 2003, NEURON, V40, P1161, DOI 10.1016/S0896-6273(03)00789-X; Huberman AD, 2008, ANNU REV NEUROSCI, V31, P479, DOI 10.1146/annurev.neuro.31.060407.125533; Huberman AD, 2007, CURR OPIN NEUROBIOL, V17, P73, DOI 10.1016/j.conb.2007.01.005; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; LEGENDY CR, 1985, J NEUROPHYSIOL, V53, P926, DOI 10.1152/jn.1985.53.4.926; Litke AM, 2004, IEEE T NUCL SCI, V51, P1434, DOI 10.1109/TNS.2004.832706; McLaughlin T, 2003, NEURON, V40, P1147, DOI 10.1016/S0896-6273(03)00790-6; MEISTER M, 1991, SCIENCE, V252, P939, DOI 10.1126/science.2035024; Mrsic-Flogel TD, 2005, J NEUROSCI, V25, P6921, DOI 10.1523/JNEUROSCI.1555-05.2005; Muir-Robinson G, 2002, J NEUROSCI, V22, P5259; Pauluhn J, 2003, J APPL TOXICOL, V23, P9, DOI 10.1002/jat.873; Penn AA, 1998, SCIENCE, V279, P2108, DOI 10.1126/science.279.5359.2108; Petrusca D, 2007, J NEUROSCI, V27, P11019, DOI 10.1523/JNEUROSCI.2836-07.2007; Pfeiffenberger C, 2005, NAT NEUROSCI, V8, P1022, DOI 10.1038/nn1508; PICCIOTTO MR, 1995, NATURE, V374, P65, DOI 10.1038/374065a0; Plas DT, 2005, J COMP NEUROL, V491, P305, DOI 10.1002/cne.20694; REMTULLA S, 1985, VISION RES, V25, P21, DOI 10.1016/0042-6989(85)90076-8; Schmucker C, 2004, VISION RES, V44, P1857, DOI 10.1016/j.visres.2004.03.011; SHATZ CJ, 1988, SCIENCE, V242, P87, DOI 10.1126/science.3175636; Shlens J, 2006, J NEUROSCI, V26, P8254, DOI 10.1523/JNEUROSCI.1282-06.2006; SIMON DK, 1992, J NEUROSCI, V12, P1212; Singer JH, 2001, J NEUROSCI, V21, P8514, DOI 10.1523/JNEUROSCI.21-21-08514.2001; Sjostrom PJ, 2001, NEURON, V32, P1149, DOI 10.1016/S0896-6273(01)00542-6; SO KF, 1990, J EXP BIOL, V153, P85; Stacy RC, 2005, J NEUROSCI, V25, P9347, DOI 10.1523/JNEUROSCI.1800-05.2005; Stellwagen D, 2002, NEURON, V33, P357, DOI 10.1016/S0896-6273(02)00577-9; Sun C, 2008, P NATL ACAD SCI USA, V105, P13638, DOI 10.1073/pnas.0807178105; Sun C, 2008, J NEUROPHYSIOL, V100, P3253, DOI 10.1152/jn.90303.2008; Torborg CL, 2005, NAT NEUROSCI, V8, P72, DOI 10.1038/nn1376; Torborg CL, 2005, PROG NEUROBIOL, V76, P213, DOI 10.1016/j.pneurobio.2005.09.002; Usrey WM, 1998, NATURE, V395, P384, DOI 10.1038/26487; Valiunas V, 1999, J PHYSIOL-LONDON, V519, P631, DOI 10.1111/j.1469-7793.1999.0631n.x; Volgyi B, 2009, J COMP NEUROL, V512, P664, DOI 10.1002/cne.21912; WONG ROL, 1993, NEURON, V11, P923, DOI 10.1016/0896-6273(93)90122-8; Xu W, 1999, J NEUROSCI, V19, P9298	54	99	99	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	OCT 29	2009	64	2					200	212		10.1016/j.neuron.2009.09.021	http://dx.doi.org/10.1016/j.neuron.2009.09.021			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	521AA	19874788	Bronze, Green Accepted			2022-12-24	WOS:000271889900010
J	Abou-Khalil, R; Le Grand, F; Pallafacchina, G; Valable, S; Authier, FJ; Rudnicki, MA; Gherardi, RK; Germain, S; Chretien, F; Sotiropoulos, A; Lafuste, P; Montarras, D; Chazaud, B				Abou-Khalil, Rana; Le Grand, Fabien; Pallafacchina, Giorgia; Valable, Samuel; Authier, Francois-Jerome; Rudnicki, Michael A.; Gherardi, Romain K.; Germain, Stephane; Chretien, Fabrice; Sotiropoulos, Athanassia; Lafuste, Peggy; Montarras, Didier; Chazaud, Benedicte			Autocrine and Paracrine Angiopoietin 1/Tie-2 Signaling Promotes Muscle Satellite Cell Self-Renewal	CELL STEM CELL			English	Article							STEM-CELL; POTENTIAL MECHANISM; M-CADHERIN; EXPRESSION; TIE2; ROLES; NOTCH; MYOD	Mechanisms governing muscle satellite cell withdrawal from cell cycle to enter into quiescence remain poorly understood. We studied the role of angiopoietin 1 (Ang1) and its receptor Tie-2 in the regulation of myogenic precursor cell (mpc) fate. In human and mouse, Tie-2 was preferentially expressed by quiescent satellite cells in vivo and reserve cells (RCs) in vitro. Ang1/Tie-2 signaling, through ERK1/2 pathway, decreased mpc proliferation and differentiation, increased the number of cells in G0, increased expression of RC-associated markers (p130, Pax7, Myf-5, M-cadherin), and downregulated expression of differentiation-associated markers. Silencing Tie-2 had opposite effects. Cells located in the satellite cell neighborhood (smooth muscle cells, fibroblasts) upregulated RC-associated markers by secreting Ang1 in vitro. In vivo, Tie-2 blockade and Ang1 overexpression increased the number of cycling and quiescent satellite cells, respectively. We propose that Ang1/Tie-2 signaling regulates mpc self-renewal by controlling the return to quiescence of a subset of satellite cells.	[Chazaud, Benedicte] Univ Paris 05, CNRS, INSERM, Inst COCHIN,Dept Genet & Dev,U567,UMR8104, F-75014 Paris, France; [Abou-Khalil, Rana; Authier, Francois-Jerome; Gherardi, Romain K.; Chretien, Fabrice; Lafuste, Peggy; Chazaud, Benedicte] Univ Paris 12, F-94000 Creteil, France; [Le Grand, Fabien; Rudnicki, Michael A.] Sprott Ctr Stem Cell Res, Ottawa Hlth Res Inst, Ottawa, ON K1H 8L6, Canada; [Pallafacchina, Giorgia; Montarras, Didier] Inst Pasteur, CNRS, URA 2578, F-75015 Paris, France; [Valable, Samuel] CYCERON, CNRS, UMR6185, F-14074 Caen, France; [Germain, Stephane] INSERM, U833, F-75005 Paris, France; [Sotiropoulos, Athanassia] Coll France, F-75005 Paris, France; [Abou-Khalil, Rana; Authier, Francois-Jerome; Gherardi, Romain K.; Chretien, Fabrice; Lafuste, Peggy; Chazaud, Benedicte] INSERM, U955, F-94000 Creteil, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); University of Ottawa; Ottawa Hospital Research Institute; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Universite de Caen Normandie; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC)	Chazaud, B (corresponding author), Univ Paris 05, CNRS, INSERM, Inst COCHIN,Dept Genet & Dev,U567,UMR8104, 24 Rue Faubourg St Jacques, F-75014 Paris, France.	benedicte.chazaud@inserm.fr	Chretien, fabrice B/D-4035-2018; valable, samuel/B-7578-2008; Le Grand, Fabien/D-8803-2019; Germain, Stephane/E-2301-2016; Pallafacchina, Giorgia/K-4056-2016; Chazaud, Benedicte/N-9291-2017; Sotiropoulos, Athanassia/P-4269-2017	Chretien, fabrice B/0000-0002-2794-1383; valable, samuel/0000-0003-0355-0270; Le Grand, Fabien/0000-0002-7843-3899; Germain, Stephane/0000-0001-5992-1275; Pallafacchina, Giorgia/0000-0001-9766-5970; Chazaud, Benedicte/0000-0002-1262-502X; AUTHIER, Francois Jerome/0000-0002-0182-2052; Rudnicki, Michael/0000-0002-3866-5249; Sotiropoulos, Athanassia/0000-0002-7265-1473; Lafuste, Peggy/0000-0001-8239-3482	AFM; ANR; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044031] Funding Source: NIH RePORTER	AFM(Association Francaise contre les Myopathies); ANR(French National Research Agency (ANR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank G. Bassez, R. Mounier, E. Petit, S. Tajbakhsh, and C. Torre for their precious help. Cell sorting was performed on cytometry facility of Institut Jacques Monod, CNRS, Paris, France, and IM3, IMRB, INSERM, Creteil, France. This work was supported by AFM and ANR.	Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Arnold L, 2007, J EXP MED, V204, P1057, DOI 10.1084/jem.20070075; Beauchamp JR, 2000, J CELL BIOL, V151, P1221, DOI 10.1083/jcb.151.6.1221; Black EJ, 2000, CURR BIOL, V10, P1119, DOI 10.1016/S0960-9822(00)00699-0; Brack AS, 2008, CELL STEM CELL, V2, P50, DOI 10.1016/j.stem.2007.10.006; Brown C, 2004, J BIOL CHEM, V279, P12794, DOI 10.1074/jbc.M308593200; Carnac G, 2000, CURR BIOL, V10, P543, DOI 10.1016/S0960-9822(00)00471-1; Charrasse S, 2006, MOL BIOL CELL, V17, P749, DOI 10.1091/mbc.E05-04-0284; Chazaud B, 2003, J CELL BIOL, V163, P1133, DOI 10.1083/jcb.200212046; Christensen RA, 2002, J CELL BIOCHEM, V85, P505, DOI 10.1002/jcb.10148; Christov C, 2007, MOL BIOL CELL, V18, P1397, DOI 10.1091/mbc.E06-08-0693; Collins CA, 2005, CELL, V122, P289, DOI 10.1016/j.cell.2005.05.010; Cornelison DDW, 2001, DEV BIOL, V239, P79, DOI 10.1006/dbio.2001.0416; Dallabrida SM, 2005, CIRC RES, V96, DOI 10.1161/01.RES.0000158285.57191.60; Fiedler U, 2006, TRENDS IMMUNOL, V27, P552, DOI 10.1016/j.it.2006.10.004; Foulstone EJ, 2004, EXP CELL RES, V294, P223, DOI 10.1016/j.yexcr.2003.10.034; Friday BB, 2001, J CELL SCI, V114, P303; Fukada SI, 2007, STEM CELLS, V25, P2448, DOI 10.1634/stemcells.2007-0019; Fukuhara S, 2008, NAT CELL BIOL, V10, P513, DOI 10.1038/ncb1714; Harfouche R, 2005, FASEB J, V19, P1728, DOI 10.1096/fj.04-3621fje; Hawke TJ, 2001, J APPL PHYSIOL, V91, P534, DOI 10.1152/jappl.2001.91.2.534; ILLA I, 1992, ANN NEUROL, V31, P46, DOI 10.1002/ana.410310109; IRINTCHEV A, 1994, DEV DYNAM, V199, P326, DOI 10.1002/aja.1001990407; Kitzmann M, 1998, J CELL BIOL, V142, P1447, DOI 10.1083/jcb.142.6.1447; Kitzmann M, 2006, J CELL PHYSIOL, V208, P538, DOI 10.1002/jcp.20688; Kuang SH, 2007, CELL, V129, P999, DOI 10.1016/j.cell.2007.03.044; Montarras D, 2005, SCIENCE, V309, P2064, DOI 10.1126/science.1114758; Olguin HC, 2004, DEV BIOL, V275, P375, DOI 10.1016/j.ydbio.2004.08.015; Oustanina S, 2004, EMBO J, V23, P3430, DOI 10.1038/sj.emboj.7600346; Perez-Ruiz A, 2008, J CELL SCI, V121, P1373, DOI 10.1242/jcs.024885; Perez-Ruiz A, 2007, CELL SIGNAL, V19, P1671, DOI 10.1016/j.cellsig.2007.03.003; Reed SA, 2007, J CELL BIOCHEM, V101, P1394, DOI 10.1002/jcb.21256; Reynaud EG, 2000, J BIOL CHEM, V275, P18767, DOI 10.1074/jbc.M907412199; Saharinen P, 2008, NAT CELL BIOL, V10, P527, DOI 10.1038/ncb1715; Shefer G, 2006, DEV BIOL, V294, P50, DOI 10.1016/j.ydbio.2006.02.022; Shim WSN, 2007, MOL CANCER RES, V5, P655, DOI 10.1158/1541-7786.MCR-07-0072; Shinin V, 2006, NAT CELL BIOL, V8, P677, DOI 10.1038/ncb1425; Zammit PS, 2006, J HISTOCHEM CYTOCHEM, V54, P1177, DOI 10.1369/jhc.6R6995.2006; Zammit PS, 2004, J CELL BIOL, V166, P347, DOI 10.1083/jcb.200312007	39	154	157	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	SEP 4	2009	5	3					298	309		10.1016/j.stem.2009.06.001	http://dx.doi.org/10.1016/j.stem.2009.06.001			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	529VA	19733541	Green Accepted, Bronze			2022-12-24	WOS:000272545700016
J	Colman, A; Dreesen, O				Colman, Alan; Dreesen, Oliver			Pluripotent Stem Cells and Disease Modeling	CELL STEM CELL			English	Editorial Material							MOTOR-NEURONS; ALS		[Colman, Alan; Dreesen, Oliver] Inst Med Biol, Singapore 138648, Singapore; [Colman, Alan] Kings Coll London, London SE1 1UL, England	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB); University of London; King's College London	Colman, A (corresponding author), Inst Med Biol, Singapore 138648, Singapore.	alan.colman@imb.a-star.edu.sg; oliver.dreesen@imb.a-star.edu.sg	Dreesen, Oliver/AAJ-2132-2020					Burke B, 2006, ANNU REV GENOM HUM G, V7, P369, DOI 10.1146/annurev.genom.7.080505.115732; Chin MH, 2009, CELL STEM CELL, V5, P111, DOI 10.1016/j.stem.2009.06.008; Clement AM, 2003, SCIENCE, V302, P113, DOI 10.1126/science.1086071; Di Giorgio FP, 2007, NAT NEUROSCI, V10, P608, DOI 10.1038/nn1885; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Ebert AD, 2009, NATURE, V457, P277, DOI 10.1038/nature07677; Eiges R, 2007, CELL STEM CELL, V1, P568, DOI 10.1016/j.stem.2007.09.001; Feng B, 2009, CELL STEM CELL, V4, P301, DOI 10.1016/j.stem.2009.03.005; Kang L, 2009, CELL STEM CELL, V5, P135, DOI 10.1016/j.stem.2009.07.001; Kim D, 2009, CELL STEM CELL, V4, P472, DOI 10.1016/j.stem.2009.05.005; LEE G, 2009, NATURE IN PRESS, DOI DOI 10.1038/NATURE08320; Osafune K, 2008, NAT BIOTECHNOL, V26, P313, DOI 10.1038/nbt1383; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Rubin LL, 2008, CELL, V132, P549, DOI 10.1016/j.cell.2008.02.010; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Urbach A, 2004, STEM CELLS, V22, P635, DOI 10.1634/stemcells.22-4-635; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482; ZHAO Y, 2009, NATURE IN PRESS, DOI DOI 10.1038/NATURE08267; Zou JZ, 2009, CELL STEM CELL, V5, P97, DOI 10.1016/j.stem.2009.05.023	20	73	76	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	SEP 4	2009	5	3					244	247		10.1016/j.stem.2009.08.010	http://dx.doi.org/10.1016/j.stem.2009.08.010			4	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	529VA	19733533	Bronze			2022-12-24	WOS:000272545700008
J	Mahon, BZ; Anzellotti, S; Schwarzbach, J; Zampini, M; Caramazza, A				Mahon, Bradford Z.; Anzellotti, Stefano; Schwarzbach, Jens; Zampini, Massimiliano; Caramazza, Alfonso			Category-Specific Organization in the Human Brain Does Not Require Visual Experience	NEURON			English	Article							OBJECT REPRESENTATIONS; TEMPORAL CORTEX; CORTICAL AREA; KNOWLEDGE; DISSOCIATION; IMPAIRMENT; MECHANISMS; ANIMALS; FACES; SHAPE	Distinct regions within the ventral visual pathway show neural specialization for nonliving and living stimuli (e.g., tools, houses versus animals, faces). The causes of these category preferences are widely debated. Using functional magnetic resonance imaging, we find that the same regions of the ventral stream that show category preferences for nonliving stimuli and animals in sighted adults show the same category preferences in adults who are blind since birth. Both blind and sighted participants had larger blood oxygen-level dependent (BOLD) responses in the medial fusiform gyrus for nonliving stimuli compared to animal stimuli and differential BOLD responses in lateral occipital cortex for animal stimuli compared to nonliving stimuli. These findings demonstrate that the medial-to-lateral bias by conceptual domain in the ventral visual pathway does not require visual experience in order to develop and suggest the operation of innately determined domain-specific constraints on the organization of object knowledge.	[Mahon, Bradford Z.; Anzellotti, Stefano; Schwarzbach, Jens; Zampini, Massimiliano; Caramazza, Alfonso] Univ Trento, Ctr Mind Brain Sci CIMeC, I-38068 Rovereto, TN, Italy; [Mahon, Bradford Z.; Anzellotti, Stefano; Caramazza, Alfonso] Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA; [Mahon, Bradford Z.] Univ Rochester, Dept Brain & Cognit Sci, Rochester, NY 14627 USA; [Schwarzbach, Jens; Zampini, Massimiliano] Univ Trento, Dept Cognit Sci & Educ, I-38068 Rovereto, TN, Italy	University of Trento; Harvard University; University of Rochester; University of Trento	Mahon, BZ (corresponding author), Univ Trento, Ctr Mind Brain Sci CIMeC, I-38068 Rovereto, TN, Italy.	mahon@rcbi.rochester.edu; caram@wjh.harvard.edu	Schwarzbach, Jens/D-1776-2010; Zampini, Massimiliano/AAR-1311-2020; Zampini, Massimiliano/E-4434-2010	Zampini, Massimiliano/0000-0001-5950-7365; Anzellotti, Stefano/0000-0002-8964-6988	NSF; Eliot Dissertation Completion Grant; National Institute on Deafness and Other Communication Disorders [DC006842]; Fondazione Cassa di Risparmio di Trento e Rovereto; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006842] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); Eliot Dissertation Completion Grant; National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Fondazione Cassa di Risparmio di Trento e Rovereto(Fondazione Caritro); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank Jorge Almeida, Randy Buckner, Jessica Cantlon, Marc Hauser, Alex Martin, and Ken Nakayama for their comments; Gianpaolo Basso and Manuela Orsini for technical assistance with the MR; Jessica Cantlon for her insights on analyses; Angelika Lingnau for her help with segmentation; and the Unione Italian Ciechi sezione di Trento for their help in recruiting blind participants. B.Z.M. was supported in part by an NSF Graduate Research Grant and an Eliot Dissertation Completion Grant. The research was supported in part by grant DC006842 from the National Institute on Deafness and Other Communication Disorders (A.C.) and by a grant from the Fondazione Cassa di Risparmio di Trento e Rovereto. B.Z.M. is now at the Rochester Center for Brain Imaging and the Department of Brain and Cognitive Sciences, University of Rochester, Rochester, NY, USA.	ALLISON T, 1994, J NEUROPHYSIOL, V71, P821, DOI 10.1152/jn.1994.71.2.821; Amedi A, 2004, NAT NEUROSCI, V7, P1266, DOI 10.1038/nn1328; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Capitani E, 2003, COGN NEUROPSYCHOL, V20, P213, DOI 10.1080/02643290244000266; Caramazza A, 2003, TRENDS COGN SCI, V7, P354, DOI 10.1016/S1364-6613(03)00159-1; Caramazza A, 1998, J COGNITIVE NEUROSCI, V10, P1, DOI 10.1162/089892998563752; Carey S., 1994, MAPPING MIND DOMAIN, P169, DOI DOI 10.1017/CB09780511752902.008; Chao LL, 1999, NAT NEUROSCI, V2, P913, DOI 10.1038/13217; De Volder AG, 2001, NEUROIMAGE, V14, P129, DOI 10.1006/nimg.2001.0782; Dilks DD, 2009, J NEUROSCI, V29, P2768, DOI 10.1523/JNEUROSCI.5258-08.2009; Dobbins IG, 2004, NATURE, V428, P316, DOI 10.1038/nature02400; Downing PE, 2006, CEREB CORTEX, V16, P1453, DOI 10.1093/cercor/bhj086; Downing PE, 2001, SCIENCE, V293, P2470, DOI 10.1126/science.1063414; Duchaine BC, 2006, COGN NEUROPSYCHOL, V23, P714, DOI 10.1080/02643290500441296; Farah MJ, 2003, COGN NEUROPSYCHOL, V20, P401, DOI 10.1080/02643290244000293; Gallistel C. R., 1990, ORG LEARNING; GOODALE MA, 1992, TRENDS NEUROSCI, V15, P20, DOI 10.1016/0166-2236(92)90344-8; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; Kahn DM, 2002, P NATL ACAD SCI USA, V99, P11429, DOI 10.1073/pnas.162342799; KEIL FC, 1981, PSYCHOL REV, V88, P197, DOI 10.1037/0033-295X.88.3.197; Kiani R, 2007, J NEUROPHYSIOL, V97, P4296, DOI 10.1152/jn.00024.2007; Kriegeskorte N, 2008, NEURON, V60, P1126, DOI 10.1016/j.neuron.2008.10.043; Levy I, 2001, NAT NEUROSCI, V4, P533, DOI 10.1038/87490; Mahon BZ, 2007, NEURON, V55, P507, DOI 10.1016/j.neuron.2007.07.011; Mahon BZ, 2009, ANNU REV PSYCHOL, V60, P27, DOI 10.1146/annurev.psych.60.110707.163532; Martin A, 2007, ANNU REV PSYCHOL, V58, P25, DOI 10.1146/annurev.psych.57.102904.190143; Miceli G, 2001, NAT NEUROSCI, V4, P662, DOI 10.1038/88497; Miceli G, 2000, COGN NEUROPSYCHOL, V17, P489, DOI 10.1080/02643290050110629; New J, 2007, P NATL ACAD SCI USA, V104, P16598, DOI 10.1073/pnas.0703913104; Noppeney U, 2006, CEREB CORTEX, V16, P437, DOI 10.1093/cercor/bhi123; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Op de Beeck HP, 2008, NAT REV NEUROSCI, V9, P123, DOI 10.1038/nrn2314; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Pietrini P, 2004, P NATL ACAD SCI USA, V101, P5658, DOI 10.1073/pnas.0400707101; Pitcher D, 2009, CURR BIOL, V19, P319, DOI 10.1016/j.cub.2009.01.007; Polk TA, 2007, J NEUROSCI, V27, P13921, DOI 10.1523/JNEUROSCI.4001-07.2007; Rogers TT, 2005, J COGNITIVE NEUROSCI, V17, P434, DOI 10.1162/0898929053279531; Talairach J., 1988, COPLANAR STEREOTAXIC; Tarr MJ, 2000, NAT NEUROSCI, V3, P764, DOI 10.1038/77666; Thomas C, 2009, NAT NEUROSCI, V12, P29, DOI 10.1038/nn.2224; Tsao DY, 2006, SCIENCE, V311, P670, DOI 10.1126/science.1119983; Ungerleider L.G., 1982, ANAL VISUAL BEHAV, P549; WARRINGTON EK, 1987, BRAIN, V110, P1273, DOI 10.1093/brain/110.5.1273	43	222	223	0	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 13	2009	63	3					397	405		10.1016/j.neuron.2009.07.012	http://dx.doi.org/10.1016/j.neuron.2009.07.012			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	487OY	19679078	Green Accepted, Bronze			2022-12-24	WOS:000269285500013
J	Rokers, B; Cormack, LK; Huk, AC				Rokers, Bas; Cormack, Lawrence K.; Huk, Alexander C.			Disparity- and velocity-based signals for three-dimensional motion perception in human MT	NATURE NEUROSCIENCE			English	Article							VISUAL AREA; IN-DEPTH; NEURONS; DIRECTION; CORTEX; ORIENTATION; MECHANISMS; STEREOPSIS; RESPONSIVENESS; SENSITIVITY	How does the primate visual system encode three-dimensional motion? The macaque middle temporal area (MT) and the human MT complex (MT1) have well-established sensitivity to two-dimensional frontoparallel motion and static disparity. However, evidence for sensitivity to three-dimensional motion has remained elusive. We found that human MT1 encodes two binocular cues to three-dimensional motion: changing disparities over time and interocular comparisons of retinal velocities. By varying important properties of moving dot displays, we distinguished these three-dimensional motion signals from their constituents, instantaneous binocular disparity and monocular retinal motion. An adaptation experiment confirmed direction selectivity for three-dimensional motion. Our results indicate that MT1 carries critical binocular signals for three-dimensional motion processing, revealing an important and previously overlooked role for this well-studied brain area.	[Rokers, Bas] Univ Texas Austin, Inst Neurosci, Ctr Perceptual Syst, Austin, TX 78712 USA; Univ Texas Austin, Imaging Res Ctr, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Rokers, B (corresponding author), Univ Texas Austin, Inst Neurosci, Ctr Perceptual Syst, Austin, TX 78712 USA.	rokers@mail.utexas.edu	Huk, Alexander/A-8031-2016	Huk, Alexander/0000-0003-1430-6935; Rokers, Bas/0000-0003-0573-5332	National Science Foundation CAREER Award [BCS-0748413]; Mind Science Foundation Research; University of Texas at Austin Imaging Research Center; Netherlands Organisation for Scientific Research [2006/11353/ALW]; Division Of Behavioral and Cognitive Sci [0748413] Funding Source: National Science Foundation	National Science Foundation CAREER Award(National Science Foundation (NSF)); Mind Science Foundation Research; University of Texas at Austin Imaging Research Center; Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Division Of Behavioral and Cognitive Sci(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	We thank D. Ress and T. Czuba for assistance with magnetic resonance imaging and comments on the manuscript and P. Neri for commenting on an earlier version of the manuscript. This work was supported by a National Science Foundation CAREER Award (BCS-0748413), a Mind Science Foundation Research Grant, and a pilot scanning grant from the University of Texas at Austin Imaging Research Center to A. C. H., and a Netherlands Organisation for Scientific Research grant to B. R. (2006/11353/ALW).	Akase E, 1998, EXP BRAIN RES, V122, P214, DOI 10.1007/s002210050509; ALBRIGHT TD, 1984, J NEUROPHYSIOL, V52, P1106, DOI 10.1152/jn.1984.52.6.1106; BARLOW HB, 1967, J PHYSIOL-LONDON, V193, P327, DOI 10.1113/jphysiol.1967.sp008360; BEVERLEY KI, 1973, J PHYSIOL-LONDON, V235, P17, DOI 10.1113/jphysiol.1973.sp010376; Born RT, 2005, ANNU REV NEUROSCI, V28, P157, DOI 10.1146/annurev.neuro.26.041002.131052; BRADLEY DC, 1995, NATURE, V373, P609, DOI 10.1038/373609a0; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Bridge H, 2007, J VISION, V7, DOI 10.1167/7.14.15; Brooks KR, 2002, J VISION, V2, DOI 10.1167/2.3.2; CUMMING BG, 1994, VISION RES, V34, P483, DOI 10.1016/0042-6989(94)90162-7; Cumming BG, 1997, NATURE, V389, P280, DOI 10.1038/38487; Cumming BG, 2001, ANNU REV NEUROSCI, V24, P203, DOI 10.1146/annurev.neuro.24.1.203; CYNADER M, 1982, VISION RES, V22, P967, DOI 10.1016/0042-6989(82)90033-5; DeAngelis GC, 2004, PLOS BIOL, V2, P394, DOI 10.1371/journal.pbio.0020077; DeAngelis GC, 1999, J NEUROSCI, V19, P1398; Dodd JV, 2001, J NEUROSCI, V21, P4809, DOI 10.1523/JNEUROSCI.21-13-04809.2001; ENGEL SA, 1994, NATURE, V369, P525, DOI 10.1038/369525a0; Fernandez JM, 2006, VISION RES, V46, P1307, DOI 10.1016/j.visres.2005.10.025; Glover GH, 1998, MAGN RESON MED, V39, P361, DOI 10.1002/mrm.1910390305; Harris JM, 2003, VISION RES, V43, P385, DOI 10.1016/S0042-6989(02)00570-9; Heeger DJ, 1999, J NEUROSCI, V19, P7162, DOI 10.1523/JNEUROSCI.19-16-07162.1999; HUBEL DH, 1968, J PHYSIOL-LONDON, V195, P215, DOI 10.1113/jphysiol.1968.sp008455; Huk AC, 2001, NEURON, V32, P161, DOI 10.1016/S0896-6273(01)00452-4; Huk AC, 2002, J NEUROSCI, V22, P7195; Julesz B., 1971, FDN CYCLOPEAN PERCEP; Larsson J, 2006, J NEUROPHYSIOL, V95, P862, DOI 10.1152/jn.00668.2005; Likova LT, 2007, NEUROIMAGE, V38, P293, DOI 10.1016/j.neuroimage.2007.06.039; MAJAJ NJ, 2007, J VIS, V7, pA96; MAUNSELL JHR, 1983, J NEUROPHYSIOL, V49, P1148, DOI 10.1152/jn.1983.49.5.1148; Nadler JW, 2008, NATURE, V452, P642, DOI 10.1038/nature06814; Nestares O, 2000, MAGNET RESON MED, V43, P705, DOI 10.1002/(SICI)1522-2594(200005)43:5<705::AID-MRM13>3.0.CO;2-R; Nguyenkim JD, 2003, J NEUROSCI, V23, P7117, DOI 10.1523/JNEUROSCI.23-18-07117.2003; NORCIA AM, 1984, VISION RES, V24, P395, DOI 10.1016/0042-6989(84)90037-3; Orban GA, 1999, NEURON, V24, P929, DOI 10.1016/S0896-6273(00)81040-5; Perrone JA, 2002, VISION RES, V42, P1035, DOI 10.1016/S0042-6989(02)00029-9; POGGIO GF, 1981, J PHYSIOL-LONDON, V315, P469, DOI 10.1113/jphysiol.1981.sp013759; Ponce CR, 2008, NAT NEUROSCI, V11, P216, DOI 10.1038/nn2039; QIAN N, 1994, J NEUROSCI, V14, P7357; REGAN D, 1982, INVEST OPHTH VIS SCI, V22, P535; Rokers B, 2008, J VISION, V8, DOI 10.1167/8.4.6; Rust NC, 2006, NAT NEUROSCI, V9, P1421, DOI 10.1038/nn1786; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; Shioiri S, 2000, VISION RES, V40, P2565, DOI 10.1016/S0042-6989(00)00130-9; Simoncelli EP, 1998, VISION RES, V38, P743, DOI 10.1016/S0042-6989(97)00183-1; Smith AT, 2008, J VISION, V8, DOI 10.1167/8.10.1; TAILBY C, 2007, J VIS, V7, pA95; TOYAMA K, 1985, VISION RES, V25, P407, DOI 10.1016/0042-6989(85)90066-5; Tsao DY, 2003, NEURON, V39, P555, DOI 10.1016/S0896-6273(03)00459-8; Wandell BA, 2000, J COGNITIVE NEUROSCI, V12, P739, DOI 10.1162/089892900562561; ZEKI SM, 1974, J PHYSIOL-LONDON, V242, P827, DOI 10.1113/jphysiol.1974.sp010736	50	82	82	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2009	12	8					1050	U126		10.1038/nn.2343	http://dx.doi.org/10.1038/nn.2343			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	475WS	19578382				2022-12-24	WOS:000268396300020
J	Fietz, SA; Kelava, I; Vogt, J; Wilsch-Brauninger, M; Stenzel, D; Fish, JL; Corbeil, D; Riehn, A; Distler, W; Nitsch, R; Huttner, WB				Fietz, Simone A.; Kelava, Iva; Vogt, Johannes; Wilsch-Braeuninger, Michaela; Stenzel, Denise; Fish, Jennifer L.; Corbeil, Denis; Riehn, Axel; Distler, Wolfgang; Nitsch, Robert; Huttner, Wieland B.			OSVZ progenitors of human and ferret neocortex are epithelial-like and expand by integrin signaling	NATURE NEUROSCIENCE			English	Article							MAMMALIAN NEUROEPITHELIAL CELLS; MOUSE CEREBRAL-CORTEX; RADIAL GLIA; NEURAL STEM; CORTICAL NEUROGENESIS; SUBVENTRICULAR ZONE; DIVISIONS; DIFFERENTIATION; EVOLUTION; BRAIN	A major cause of the cerebral cortex expansion that occurred during evolution is the increase in subventricular zone (SVZ) progenitors. We found that progenitors in the outer SVZ (OSVZ) of developing human neocortex retain features of radial glia, in contrast to rodent SVZ progenitors, which have limited proliferation potential. Although delaminating from apical adherens junctions, OSVZ progenitors maintained a basal process contacting the basal lamina, a canonical epithelial property. OSVZ progenitor divisions resulted in asymmetric inheritance of their basal process. Notably, OSVZ progenitors are also found in the ferret, a gyrencephalic nonprimate. Functional disruption of integrins, expressed on the basal process of ferret OSVZ progenitors, markedly decreased the OSVZ progenitor population size, but not that of other, process-lacking SVZ progenitors, in slice cultures of ferret neocortex. Our findings suggest that maintenance of this epithelial property allows integrin-mediated, repeated asymmetric divisions of OSVZ progenitors, providing a basis for neocortical expansion.	[Fietz, Simone A.; Kelava, Iva; Wilsch-Braeuninger, Michaela; Stenzel, Denise; Fish, Jennifer L.; Huttner, Wieland B.] Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany; [Vogt, Johannes; Nitsch, Robert] Charite, Ctr Anat, Inst Cell Biol & Neurobiol, Berlin, Germany; [Corbeil, Denis] Tech Univ Dresden, BIOTEC, Dresden, Germany; [Riehn, Axel; Distler, Wolfgang] Tech Univ Dresden, Univ Klinikum Carl Gustav Carus, Klin & Poliklin Frauenheilkunde & Geburtshilfe, Dresden, Germany	Max Planck Society; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Technische Universitat Dresden; Technische Universitat Dresden; Carl Gustav Carus University Hospital; University of Hamburg; University Medical Center Hamburg-Eppendorf	Huttner, WB (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany.	huttner@mpi-cbg.de	Corbeil, Denis/AFL-1008-2022; Huttner, Wieland B./P-4080-2018; Vogt, Johannes/O-4289-2019; Corbeil, Denis/A-6519-2010; Nitsch, Robert/AAI-9129-2021; Corbeil, Denis/L-2340-2019; Vogt, Johannes/K-2278-2015	Corbeil, Denis/0000-0003-1181-3659; Fish, Jennifer/0000-0002-2654-2583; Vogt, Johannes/0000-0003-2439-8247	Deutsche Forschungsgemeinschaft (DFG) [SFB 655, A2]; Fonds der Chemischen Industrie	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission)	We thank J. Helppi and other members of the animal facility, and the light microscopy facility, of the Max Planck Institute of Molecular Cell Biology and Genetics for excellent support, A.-M. Marzesco and E. Taverna for experimental advice, C. Haffner for excellent technical assistance, S. Preibisch for developing the Fiji plug-in, and J. Pulvers for his helpful comments on the manuscript. We are grateful to the Bundesinstitut fur Risikobewertung and Biotie Therapies for ferret housing. S.A.F., I.K. and J.L.F. were members of the International Max Planck Research School for Molecular Cell Biology and Bioengineering. W.B.H. was supported by a grant from the Deutsche Forschungsgemeinschaft (DFG) (SFB 655, A2) and by the DFG-funded Center for Regenerative Therapies Dresden and by the Fonds der Chemischen Industrie.	AakuSaraste E, 1996, DEV BIOL, V180, P664, DOI 10.1006/dbio.1996.0336; Abdel-Mannan O, 2008, BRAIN RES BULL, V75, P398, DOI 10.1016/j.brainresbull.2007.10.047; Attardo A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002388; Bayatti N, 2008, CEREB CORTEX, V18, P1536, DOI 10.1093/cercor/bhm184; Calvete JJ, 2005, TOXICON, V45, P1063, DOI 10.1016/j.toxicon.2005.02.024; Carney RSE, 2007, BRAIN STRUCT FUNCT, V212, P37, DOI 10.1007/s00429-007-0142-4; Chenn A, 1998, MOL CELL NEUROSCI, V11, P183, DOI 10.1006/mcne.1998.0680; Costa MR, 2008, DEVELOPMENT, V135, P11, DOI 10.1242/dev.009951; Englund C, 2005, J NEUROSCI, V25, P247, DOI 10.1523/JNEUROSCI.2899-04.2005; Fish JL, 2008, J CELL SCI, V121, P2783, DOI 10.1242/jcs.023465; Fish JL, 2006, P NATL ACAD SCI USA, V103, P10438, DOI 10.1073/pnas.0604066103; Flanagan LA, 2006, J NEUROSCI RES, V83, P845, DOI 10.1002/jnr.20778; Fuchs E, 2009, CELL STEM CELL, V4, P499, DOI 10.1016/j.stem.2009.05.001; Giebel B, 2004, BLOOD, V104, P2332, DOI 10.1182/blood-2004-02-0511; Gotz M, 1998, NEURON, V21, P1031, DOI 10.1016/S0896-6273(00)80621-2; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Hansen DV, 2010, NATURE, V464, P554, DOI 10.1038/nature08845; Haubst N, 2006, DEVELOPMENT, V133, P3245, DOI 10.1242/dev.02486; HIRSCH E, 1994, DEV DYNAM, V201, P108, DOI 10.1002/aja.1002010203; Kamei Y, 1998, GLIA, V23, P191, DOI 10.1002/(SICI)1098-1136(199807)23:3<191::AID-GLIA2>3.0.CO;2-8; Karbanova J, 2008, J HISTOCHEM CYTOCHEM, V56, P977, DOI 10.1369/jhc.2008.951897; Konno D, 2008, NAT CELL BIOL, V10, P93, DOI 10.1038/ncb1673; Kosodo Y, 2004, EMBO J, V23, P2314, DOI 10.1038/sj.emboj.7600223; Kosodo Y, 2008, EMBO J, V27, P3151, DOI 10.1038/emboj.2008.227; Kowalczyk T, 2009, CEREB CORTEX, V19, P2439, DOI 10.1093/cercor/bhn260; Kriegstein AR, 2003, GLIA, V43, P37, DOI 10.1002/glia.10250; Kriegstein A, 2006, NAT REV NEUROSCI, V7, P883, DOI 10.1038/nrn2008; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Lathia JD, 2007, DEV DYNAM, V236, P3267, DOI 10.1002/dvdy.21319; Lechler T, 2005, NATURE, V437, P275, DOI 10.1038/nature03922; LEVITT P, 1980, J COMP NEUROL, V193, P815, DOI 10.1002/cne.901930316; Lukaszewicz A, 2005, NEURON, V47, P353, DOI 10.1016/j.neuron.2005.06.032; Manabe N, 2002, DEV DYNAM, V225, P61, DOI 10.1002/dvdy.10139; Middeldorp J, 2010, DEVELOPMENT, V137, P313, DOI 10.1242/dev.041632; Miyata T, 2001, NEURON, V31, P727, DOI 10.1016/S0896-6273(01)00420-2; Mo ZC, 2008, CEREB CORTEX, V18, P1455, DOI 10.1093/cercor/bhm181; Molnar Z, 2006, EUR J NEUROSCI, V23, P921, DOI 10.1111/j.1460-9568.2006.04611.x; Murphy WJ, 2007, GENOME RES, V17, P413, DOI 10.1101/gr.5918807; Neal J, 2007, J ANAT, V210, P66, DOI 10.1111/j.1469-7580.2006.00674.x; Noctor SC, 2008, J COMP NEUROL, V508, P28, DOI 10.1002/cne.21669; Preibisch S, 2009, BIOINFORMATICS, V25, P1463, DOI 10.1093/bioinformatics/btp184; Radakovits R, 2009, J NEUROSCI, V29, P7694, DOI 10.1523/JNEUROSCI.5537-08.2009; Rakic P, 2009, NAT REV NEUROSCI, V10, P724, DOI 10.1038/nrn2719; Schmid RS, 2003, CEREB CORTEX, V13, P219, DOI 10.1093/cercor/13.3.219; SMART IHM, 1986, J ANAT, V146, P141; Smart IHM, 2002, CEREB CORTEX, V12, P37, DOI 10.1093/cercor/12.1.37; Weigmann A, 1997, P NATL ACAD SCI USA, V94, P12425, DOI 10.1073/pnas.94.23.12425; Wierzbicka-Patynowski I, 1999, J BIOL CHEM, V274, P37809, DOI 10.1074/jbc.274.53.37809; WOODHAMS PL, 1981, ANAT EMBRYOL, V163, P331, DOI 10.1007/BF00315709; Yoshida N, 2003, EXP CELL RES, V287, P262, DOI 10.1016/S0014-4827(03)00158-7	50	527	534	4	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2010	13	6					690	U62		10.1038/nn.2553	http://dx.doi.org/10.1038/nn.2553			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	600QY	20436478				2022-12-24	WOS:000278003300013
J	Vialou, V; Robison, AJ; LaPlant, QC; Covington, HE; Dietz, DM; Ohnishi, YN; Mouzon, E; Rush, AJ; Watts, EL; Wallace, DL; Iniguez, SD; Ohnishi, YH; Steiner, MA; Warren, BL; Krishnan, V; Bolanos, CA; Neve, RL; Ghose, S; Berton, O; Tamminga, CA; Nestler, EJ				Vialou, Vincent; Robison, Alfred J.; LaPlant, Quincey C.; Covington, Herbert E., III; Dietz, David M.; Ohnishi, Yoshinori N.; Mouzon, Ezekiell; Rush, Augustus J., III; Watts, Emily L.; Wallace, Deanna L.; Iniguez, Sergio D.; Ohnishi, Yoko H.; Steiner, Michel A.; Warren, Brandon L.; Krishnan, Vaishnav; Bolanos, Carlos A.; Neve, Rachael L.; Ghose, Subroto; Berton, Olivier; Tamminga, Carol A.; Nestler, Eric J.			Delta FosB in brain reward circuits mediates resilience to stress and antidepressant responses	NATURE NEUROSCIENCE			English	Article							SOCIAL DEFEAT STRESS; NUCLEUS-ACCUMBENS NEURONS; VENTRAL TEGMENTAL AREA; CHROMATIN REGULATION; EXCITATORY SYNAPSES; SYNAPTIC PLASTICITY; BEHAVIORAL DEFICITS; GENE-EXPRESSION; AMPA RECEPTORS; MESSENGER-RNA	In contrast with the many studies of stress effects on the brain, relatively little is known about the molecular mechanisms of resilience, the ability of some individuals to escape the deleterious effects of stress. We found that the transcription factor Delta FosB mediates an essential mechanism of resilience in mice. Induction of Delta FosB in the nucleus accumbens, an important brain reward-associated region, in response to chronic social defeat stress was both necessary and sufficient for resilience. Delta FosB induction was also required for the standard antidepressant fluoxetine to reverse behavioral pathology induced by social defeat. Delta FosB produced these effects through induction of the GluR2 AMPA glutamate receptor subunit, which decreased the responsiveness of nucleus accumbens neurons to glutamate, and through other synaptic proteins. Together, these findings establish a previously unknown molecular pathway underlying both resilience and antidepressant action.	[Vialou, Vincent; Robison, Alfred J.; LaPlant, Quincey C.; Covington, Herbert E., III; Dietz, David M.; Ohnishi, Yoshinori N.; Mouzon, Ezekiell; Watts, Emily L.; Ohnishi, Yoko H.; Nestler, Eric J.] Mt Sinai Sch Med, Fishberg Dept Neurosci, New York, NY 10029 USA; [Rush, Augustus J., III; Wallace, Deanna L.; Krishnan, Vaishnav; Ghose, Subroto; Berton, Olivier; Tamminga, Carol A.] Univ Texas SW Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA; [Rush, Augustus J., III; Wallace, Deanna L.; Krishnan, Vaishnav; Ghose, Subroto; Berton, Olivier; Tamminga, Carol A.] Univ Texas SW Med Ctr Dallas, Ctr Basic Neurosci, Dallas, TX 75390 USA; [Iniguez, Sergio D.; Warren, Brandon L.; Bolanos, Carlos A.] Florida State Univ, Dept Psychol, Tallahassee, FL 32306 USA; [Steiner, Michel A.] Max Planck Inst Psychiat, D-80804 Munich, Germany; [Neve, Rachael L.] MIT, Cambridge, MA 02139 USA	Icahn School of Medicine at Mount Sinai; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; State University System of Florida; Florida State University; Max Planck Society; Massachusetts Institute of Technology (MIT)	Nestler, EJ (corresponding author), Mt Sinai Sch Med, Fishberg Dept Neurosci, New York, NY 10029 USA.	eric.nestler@mssm.edu	Yan, Shuo/B-8381-2009; Ghose, Subroto/J-6732-2016; Robison, Alfred J/P-8521-2018; Dietz, David/AAW-4574-2021; Dietz, David/J-9458-2015; vialou, vincent/F-2968-2013; Iniguez, Sergio D/J-2410-2015	Robison, Alfred J/0000-0002-4150-9570; Dietz, David/0000-0002-6927-9236; Dietz, David/0000-0002-6927-9236; vialou, vincent/0000-0002-8212-751X; Iniguez, Sergio D/0000-0001-5748-4219; Krishnan, Vaishnav/0000-0002-2847-0069	National Institute of Mental Health; AstraZeneca; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH051399, P50MH066172] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); AstraZeneca(AstraZeneca); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by grants from the National Institute of Mental Health and by a research alliance with AstraZeneca. We thank P. McKinnon and H. Russell for the SC1 cDNA; and I. Maze, R. Oosting, S. Gautron and D. Vialou for discussion and comments on the manuscript.	Anderson SM, 2008, NAT NEUROSCI, V11, P344, DOI 10.1038/nn2054; Becker C, 2001, J NEUROSCI, V21, P262, DOI 10.1523/JNEUROSCI.21-01-00262.2001; Berton O, 2006, SCIENCE, V311, P864, DOI 10.1126/science.1120972; Boudreau AC, 2007, J NEUROSCI, V27, P10621, DOI 10.1523/JNEUROSCI.2163-07.2007; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Campioni MR, 2009, J NEUROPHYSIOL, V101, P3192, DOI 10.1152/jn.91111.2008; Chen JS, 1998, MOL PHARMACOL, V54, P495, DOI 10.1124/mol.54.3.495; Churchill L, 1999, J NEUROCHEM, V72, P2397, DOI 10.1046/j.1471-4159.1999.0722397.x; Conrad KL, 2008, NATURE, V454, P118, DOI 10.1038/nature06995; Covington HE, 2009, J NEUROSCI, V29, P11451, DOI 10.1523/JNEUROSCI.1758-09.2009; De Kloet ER, 2004, ANN NY ACAD SCI, V1018, P1, DOI 10.1196/annals.1296.001; DETKE MJ, 1995, PSYCHOPHARMACOLOGY, V121, P66, DOI 10.1007/BF02245592; Feder A, 2009, NAT REV NEUROSCI, V10, P446, DOI 10.1038/nrn2649; Frischknecht R, 2009, NAT NEUROSCI, V12, P897, DOI 10.1038/nn.2338; Grace AA, 2007, TRENDS NEUROSCI, V30, P220, DOI 10.1016/j.tins.2007.03.003; HANEY M, 1995, BRAIN RES, V698, P46, DOI 10.1016/0006-8993(95)00788-R; Kalivas PW, 2005, NEURON, V45, P647, DOI 10.1016/j.neuron.2005.02.005; Kelz MB, 1999, NATURE, V401, P272, DOI 10.1038/45790; Kollack-Walker S, 1999, J NEUROENDOCRINOL, V11, P547; Koob GF, 2008, NEURON, V59, P11, DOI 10.1016/j.neuron.2008.06.012; Koolhaas JM, 1997, NEUROSCI BIOBEHAV R, V21, P775, DOI 10.1016/S0149-7634(96)00057-7; Krishnan V, 2008, NATURE, V455, P894, DOI 10.1038/nature07455; Krishnan V, 2007, CELL, V131, P391, DOI 10.1016/j.cell.2007.09.018; Lively S, 2008, J NEUROSCI RES, V86, P2895, DOI 10.1002/jnr.21735; Martinez M, 2002, STRESS, V5, P3, DOI 10.1080/102538902900012369; McClung CA, 2003, NAT NEUROSCI, V6, P1208, DOI 10.1038/nn1143; McEwen BS, 2007, PHYSIOL REV, V87, P873, DOI 10.1152/physrev.00041.2006; Nestler EJ, 2008, PHILOS T R SOC B, V363, P3245, DOI 10.1098/rstb.2008.0067; Nikulina EM, 2008, EUR J NEUROSCI, V27, P2272, DOI 10.1111/j.1460-9568.2008.06176.x; Nikulina EM, 2004, NEUROSCIENCE, V123, P857, DOI 10.1016/j.neuroscience.2003.10.029; Peakman MC, 2003, BRAIN RES, V970, P73, DOI 10.1016/S0006-8993(03)02230-3; Perrotti LI, 2004, J NEUROSCI, V24, P10594, DOI 10.1523/JNEUROSCI.2542-04.2004; Rada P, 2003, NEUROSCIENCE, V119, P557, DOI 10.1016/S0306-4522(03)00162-3; Renthal W, 2009, NEURON, V62, P335, DOI 10.1016/j.neuron.2009.03.026; Ressler KJ, 2007, NAT NEUROSCI, V10, P1116, DOI 10.1038/nn1944; Reynolds SM, 2003, EUR J NEUROSCI, V17, P2187, DOI 10.1046/j.1460-9568.2003.02642.x; Roitman MF, 2005, NEURON, V45, P587, DOI 10.1016/j.neuron.2004.12.055; Rygula R, 2005, BEHAV BRAIN RES, V162, P127, DOI 10.1016/j.bbr.2005.03.009; Rygula R, 2006, BEHAV BRAIN RES, V174, P188, DOI 10.1016/j.bbr.2006.07.017; Schlaepfer TE, 2008, NEUROPSYCHOPHARMACOL, V33, P368, DOI 10.1038/sj.npp.1301408; Sesack SR, 2010, NEUROPSYCHOPHARMACOL, V35, P27, DOI 10.1038/npp.2009.93; Taha SA, 2006, J NEUROSCI, V26, P217, DOI 10.1523/JNEUROSCI.3227-05.2006; Tidey JW, 1997, PSYCHOPHARMACOLOGY, V130, P203, DOI 10.1007/s002130050230; Todtenkopf MS, 2006, J NEUROSCI, V26, P11665, DOI 10.1523/JNEUROSCI.3070-06.2006; TORNATZKY W, 1993, PHYSIOL BEHAV, V53, P983, DOI 10.1016/0031-9384(93)90278-N; Tremblay LK, 2005, ARCH GEN PSYCHIAT, V62, P1228, DOI 10.1001/archpsyc.62.11.1228; Vythilingam M, 2009, PSYCHIAT RES-NEUROIM, V172, P75, DOI 10.1016/j.pscychresns.2008.06.008; Wallace DL, 2009, NAT NEUROSCI, V12, P200, DOI 10.1038/nn.2257; Wilkinson MB, 2009, J NEUROSCI, V29, P7820, DOI 10.1523/JNEUROSCI.0932-09.2009; Yehuda R, 2006, ANN NY ACAD SCI, V1071, P379, DOI 10.1196/annals.1364.028	50	341	346	3	42	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2010	13	6					745	U126		10.1038/nn.2551	http://dx.doi.org/10.1038/nn.2551			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	600QY	20473292	Green Accepted			2022-12-24	WOS:000278003300020
J	Zhang, C; Atasoy, D; Arac, D; Yang, XF; Fucillo, MV; Robison, AJ; Ko, JW; Brunger, AT; Sudhof, TC				Zhang, Chen; Atasoy, Deniz; Arac, Demet; Yang, Xiaofei; Fucillo, Marc V.; Robison, Alfred J.; Ko, Jaewon; Brunger, Axel T.; Sudhof, Thomas C.			Neurexins Physically and Functionally Interact with GABA(A) Receptors	NEURON			English	Article							EXCITATORY SYNAPSE FORMATION; AUTISM SPECTRUM DISORDER; CELL-SURFACE PROTEINS; ALPHA-NEUREXINS; BETA-NEUREXINS; DROSOPHILA NEUREXIN; INHIBITORY SYNAPSES; SUBUNIT GENES; CA2+ CHANNELS; NEUROLIGIN 1	Neurexins are presynaptic cell-adhesion molecules that form trans-synaptic complexes with postsynaptic neuroligins. When overexpressed in nonneuronal cells, neurexins induce formation of postsynaptic specializations in cocultured neurons, suggesting that neurexins are synaptogenic. However, we find that when overexpressed in neurons, neurexins do not increase synapse density, but instead selectively suppressed GABAergic synaptic transmission without decreasing GABAergic synapse numbers. This suppression was mediated by all subtypes of neurexins tested, in a cell-autonomous and neuroligin-independent manner. Strikingly, addition of recombinant neurexin to cultured neurons at submicromolar concentrations induced the same suppression of GABAergic synaptic transmission as neurexin overexpression. Moreover, experiments with native brain proteins and purified recombinant proteins revealed that neurexins directly and stoichiometrically bind to GABA(A) receptors, suggesting that they decrease GABAergic synaptic responses by interacting with GABA(A) receptors. Our findings suggest that besides their other well-documented interactions, presynaptic neurexins directly act on postsynaptic GABA(A) receptors, which may contribute to regulate the excitatory/inhibitory balance in brain.	[Zhang, Chen; Arac, Demet; Yang, Xiaofei; Fucillo, Marc V.; Ko, Jaewon; Brunger, Axel T.; Sudhof, Thomas C.] Stanford Univ, Dept Mol & Cellular Physiol, Palo Alto, CA 94304 USA; [Atasoy, Deniz; Brunger, Axel T.; Sudhof, Thomas C.] Stanford Univ, Howard Hughes Med Inst, Palo Alto, CA 94304 USA; [Arac, Demet; Brunger, Axel T.] Stanford Univ, Dept Neurol & Neurol Sci, Palo Alto, CA 94304 USA; [Arac, Demet; Brunger, Axel T.] Stanford Univ, Dept Biol Struct, Palo Alto, CA 94304 USA; [Arac, Demet; Brunger, Axel T.] Stanford Univ, Dept Photon Sci, Palo Alto, CA 94304 USA; [Sudhof, Thomas C.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Sudhof, Thomas C.] Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA; [Zhang, Chen; Atasoy, Deniz; Yang, Xiaofei; Robison, Alfred J.; Sudhof, Thomas C.] Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA	Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Sudhof, TC (corresponding author), Stanford Univ, Dept Mol & Cellular Physiol, 1050 Arastradero Rd, Palo Alto, CA 94304 USA.	tcs1@stanford.edu	Atasoy, Deniz/AAR-7917-2020; Atasoy, Deniz/B-3414-2018; Robison, Alfred J/P-8521-2018	Atasoy, Deniz/0000-0002-3325-8820; Robison, Alfred J/0000-0002-4150-9570; Brunger, Axel/0000-0001-5121-2036	NIMH [MH52804]; Simons Foundation; Life Sciences Research Foundation; Human Frontier Science Program Organization; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH052804, R01MH052804] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Simons Foundation; Life Sciences Research Foundation; Human Frontier Science Program Organization(Human Frontier Science Program); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We would like to thank Dr. Robert L. Macdonald (Vanderbilt University) and Dr. Stephen Moss (Tufts University) for gifts of valuable reagents. This paper was supported by grants from the NIMH (MH52804 to T.C.S.) and the Simons Foundation (to T.C.S.), and fellowships from the Life Sciences Research Foundation (to D.A.) and the Human Frontier Science Program Organization (to J.K.).	Arac D, 2007, NEURON, V56, P992, DOI 10.1016/j.neuron.2007.12.002; Baumgartner S, 1996, CELL, V87, P1059, DOI 10.1016/S0092-8674(00)81800-0; Biswas S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003542; Boucard AA, 2005, NEURON, V48, P229, DOI 10.1016/j.neuron.2005.08.026; Chih B, 2004, HUM MOL GENET, V13, P1471, DOI 10.1093/hmg/ddh158; Chih B, 2006, NEURON, V51, P171, DOI 10.1016/j.neuron.2006.06.005; Chubykin AA, 2005, J BIOL CHEM, V280, P22365, DOI 10.1074/jbc.M410723200; Chubykin AA, 2007, NEURON, V54, P919, DOI 10.1016/j.neuron.2007.05.029; Colavita A, 2003, SCIENCE, V302, P293, DOI 10.1126/science.1089163; Collins AL, 2006, NEUROGENETICS, V7, P167, DOI 10.1007/s10048-006-0045-1; Comoletti D, 2006, BIOCHEMISTRY-US, V45, P12816, DOI 10.1021/bi0614131; de Wit J, 2009, NEURON, V64, P799, DOI 10.1016/j.neuron.2009.12.019; Etherton MR, 2009, P NATL ACAD SCI USA, V106, P17998, DOI 10.1073/pnas.0910297106; Fatemi SH, 2009, J AUTISM DEV DISORD, V39, P223, DOI 10.1007/s10803-008-0646-7; Gallagher MJ, 2005, J BIOL CHEM, V280, P37995, DOI 10.1074/jbc.M508305200; Garboczi DN, 1996, J IMMUNOL, V157, P5403; Graf ER, 2004, CELL, V119, P1013, DOI 10.1016/j.cell.2004.11.035; Hata Y, 1996, J NEUROSCI, V16, P2488; Hishimoto A, 2007, HUM MOL GENET, V16, P2880, DOI 10.1093/hmg/ddm247; Ichtchenko K, 1996, J BIOL CHEM, V271, P2676, DOI 10.1074/jbc.271.5.2676; ICHTCHENKO K, 1995, CELL, V81, P435, DOI 10.1016/0092-8674(95)90396-8; Irie M, 1997, SCIENCE, V277, P1511, DOI 10.1126/science.277.5331.1511; Kattenstroth G, 2004, P NATL ACAD SCI USA, V101, P2607, DOI 10.1073/pnas.0308626100; Kim HG, 2008, AM J HUM GENET, V82, P199, DOI 10.1016/j.ajhg.2007.09.011; Ko J, 2009, NEURON, V64, P791, DOI 10.1016/j.neuron.2009.12.012; Ko J, 2009, EMBO J, V28, P3244, DOI 10.1038/emboj.2009.249; Lachman HM, 2007, HUM MOL GENET, V16, P1327, DOI 10.1093/hmg/ddm081; Li J, 2007, NEURON, V55, P741, DOI 10.1016/j.neuron.2007.08.002; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; Maximov A, 2005, NEURON, V48, P547, DOI 10.1016/j.neuron.2005.09.006; Maximov A, 2007, J NEUROSCI METH, V161, P75, DOI 10.1016/j.jneumeth.2006.10.009; Missler M, 2003, NATURE, V423, P939, DOI 10.1038/nature01755; Missler M, 1998, J NEUROCHEM, V71, P1339; Missler M, 1998, J BIOL CHEM, V273, P34716, DOI 10.1074/jbc.273.52.34716; Nam CI, 2005, P NATL ACAD SCI USA, V102, P6137, DOI 10.1073/pnas.0502038102; Nguyen T, 1997, J BIOL CHEM, V272, P26032, DOI 10.1074/jbc.272.41.26032; Patzke H, 2000, MOL CELL NEUROSCI, V15, P561, DOI 10.1006/mcne.2000.0853; Peles E, 1997, CELL, V88, P745, DOI 10.1016/S0092-8674(00)81920-0; Petrenko AG, 1996, J NEUROSCI, V16, P4360; Petryshen TL, 2005, MOL PSYCHIATR, V10, P1074, DOI 10.1038/sj.mp.4001739; Reissner C, 2008, P NATL ACAD SCI USA, V105, P15124, DOI 10.1073/pnas.0801639105; Rissone A, 2007, MOL BIOL EVOL, V24, P236, DOI 10.1093/molbev/msl147; Rozic-Kotliroff G, 2007, BIOCHEM BIOPH RES CO, V352, P226, DOI 10.1016/j.bbrc.2006.11.008; Rujescu D, 2009, HUM MOL GENET, V18, P988, DOI 10.1093/hmg/ddn351; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Song JY, 1999, P NATL ACAD SCI USA, V96, P1100, DOI 10.1073/pnas.96.3.1100; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Sugita S, 2001, J CELL BIOL, V154, P435, DOI 10.1083/jcb.200105003; Sugita S, 1999, NEURON, V22, P489, DOI 10.1016/S0896-6273(00)80704-7; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; Tabuchi K, 2002, GENOMICS, V79, P849, DOI 10.1006/geno.2002.6780; Tabuchi K, 2007, SCIENCE, V318, P71, DOI 10.1126/science.1146221; Taniguchi H, 2007, J NEUROSCI, V27, P2815, DOI 10.1523/JNEUROSCI.0032-07.2007; ULLRICH B, 1995, NEURON, V14, P497, DOI 10.1016/0896-6273(95)90306-2; USHKARYOV YA, 1992, SCIENCE, V257, P50, DOI 10.1126/science.1621094; USHKARYOV YA, 1994, J BIOL CHEM, V269, P11987; USHKARYOV YA, 1993, P NATL ACAD SCI USA, V90, P6410, DOI 10.1073/pnas.90.14.6410; Varoqueaux F, 2004, EUR J CELL BIOL, V83, P449, DOI 10.1078/0171-9335-00410; Varoqueaux F, 2006, NEURON, V51, P741, DOI 10.1016/j.neuron.2006.09.003; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; WONG G, 1994, MOL PHARMACOL, V46, P1056; Yan J, 2008, NEUROSCI LETT, V438, P368, DOI 10.1016/j.neulet.2008.04.074; Zahir FR, 2008, J MED GENET, V45, P239, DOI 10.1136/jmg.2007.054437; Zeng XK, 2007, FEBS LETT, V581, P2509, DOI 10.1016/j.febslet.2007.04.068; Zeng ZH, 2006, INT J DEV BIOL, V50, P39, DOI 10.1387/ijdb.052068zz; Zhang C, 2009, J NEUROSCI, V29, P10843, DOI 10.1523/JNEUROSCI.1248-09.2009; Zhang WQ, 2005, J NEUROSCI, V25, P4330, DOI 10.1523/JNEUROSCI.0497-05.2005	67	116	120	0	21	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	MAY 13	2010	66	3					403	416		10.1016/j.neuron.2010.04.008	http://dx.doi.org/10.1016/j.neuron.2010.04.008			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	598HE	20471353	Bronze, Green Accepted			2022-12-24	WOS:000277825200009
J	Golding, MC; Zhang, LY; Mann, MRW				Golding, Michael C.; Zhang, Liyue; Mann, Mellissa R. W.			Multiple Epigenetic Modifiers Induce Aggressive Viral Extinction in Extraembryonic Endoderm Stem Cells	CELL STEM CELL			English	Article							EMBRYONAL CARCINOMA-CELLS; DNA METHYLATION; RETROVIRAL GENOMES; GENE-EXPRESSION; MOUSE OOCYTES; SMALL RNAS; PROTEIN; VIRUS; CHROMATIN; IDENTIFICATION	To prevent insertional mutagenesis arising from retroviral reactivation, cells of embryonic origin possess a unique capacity to silence retroviruses. Given the distinct modes of X chromosome inactivation between embryonic and extraembryonic lineages, we investigated paradigms of viral extinction. We show that trophectoderm stem cells do not silence retroviral transcription, whereas extraembryonic endoderm stem cells aggressively extinguish proviral transcription, even more rapidly than do embryonic stem cells. By using a short hairpin RNA library, we identified epigenetic modifiers of retroviral extinction in extraembryonic endoderm stem cells. Multiple chromatin remodeling and polycomb repressor complex proteins act to modulate integrated, as well as endogenous, retroviral element silencing, with a subset of factors displaying differential effects between stem cell types. Furthermore, our data suggest that small RNAs play a role in this process through interactions with the Argonaute family. Our results further the understanding of mechanisms regulating retroviral transcription in different stem cell lineages.	[Golding, Michael C.; Mann, Mellissa R. W.] Univ Western Ontario, Schulich Sch Med & Dent, Dept Obstet & Gynecol, London, ON N6A 4V2, Canada; [Golding, Michael C.; Mann, Mellissa R. W.] Univ Western Ontario, Schulich Sch Med & Dent, Dept Biochem, London, ON N6A 4V2, Canada; [Golding, Michael C.; Zhang, Liyue; Mann, Mellissa R. W.] Childrens Hlth Res Inst, London, ON N6C 2V5, Canada; [Golding, Michael C.] Texas A&M Univ, Coll Vet Med, Dept Vet Physiol, College Stn, TX 77843 USA; [Zhang, Liyue; Mann, Mellissa R. W.] Lawson Hlth Res Inst, London, ON N6C 2V5, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Texas A&M University System; Texas A&M University College Station; Western University (University of Western Ontario)	Mann, MRW (corresponding author), Univ Western Ontario, Schulich Sch Med & Dent, Dept Obstet & Gynecol, London, ON N6A 4V2, Canada.	mmann22@uwo.ca	Mann, Mellissa/L-9006-2015	Mann, Mellissa/0000-0002-8075-3824; GOLDING, MICHAEL/0000-0003-1631-2175	Canadian Institute of Health Research [MOP-81167]; Lawson Health Research Institute; Department of Obstetrics and Gynecology; University of Western Ontario; Ontario Women's Health Council/CIHR Institute of Gender and Health New Investigator; Ontario Women's Health Council/CIHR Institute of Gender and Health	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Lawson Health Research Institute; Department of Obstetrics and Gynecology; University of Western Ontario; Ontario Women's Health Council/CIHR Institute of Gender and Health New Investigator(Canadian Institutes of Health Research (CIHR)); Ontario Women's Health Council/CIHR Institute of Gender and Health(Canadian Institutes of Health Research (CIHR))	The authors thank Joe Mymryk and Peter Pelka for critical review of the manuscript and Morgan McWilliam, Michelle Gabriel, and Fatima Bab'bad for technical assistance. Authors would also like to thank G.J. Hannon for reagents. This work was supported by Research Grant MOP-81167 from the Canadian Institute of Health Research and grants from Lawson Health Research Institute and Department of Obstetrics and Gynecology, University of Western Ontario. M.R.W.M. was supported by the Ontario Women's Health Council/CIHR Institute of Gender and Health New Investigator Award. M.C.G. was supported by the Ontario Women's Health Council/CIHR Institute of Gender and Health Fellowship Award and the Dr. David Whaley Postdoctoral Fellowship in Maternal/Fetal and Neonatal Research.	Aravin AA, 2007, SCIENCE, V318, P761, DOI 10.1126/science.1146484; Best S, 1996, NATURE, V382, P826, DOI 10.1038/382826a0; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Carmell MA, 2002, GENE DEV, V16, P2733, DOI 10.1101/gad.1026102; Cherry SR, 2000, MOL CELL BIOL, V20, P7419, DOI 10.1128/MCB.20.20.7419-7426.2000; Chong SY, 2007, NAT GENET, V39, P614, DOI 10.1038/ng2031; Cohen CJ, 2009, GENE, V448, P105, DOI 10.1016/j.gene.2009.06.020; De la Fuente R, 2006, NAT CELL BIOL, V8, P1448, DOI 10.1038/ncb1513; Dong KB, 2008, EMBO J, V27, P2691, DOI 10.1038/emboj.2008.193; Gao GX, 2002, SCIENCE, V297, P1703, DOI 10.1126/science.1074276; GREZ M, 1990, P NATL ACAD SCI USA, V87, P9202, DOI 10.1073/pnas.87.23.9202; GROSS L, 1975, P NATL ACAD SCI USA, V72, P3240, DOI 10.1073/pnas.72.8.3240; HARBERS K, 1981, P NATL ACAD SCI-BIOL, V78, P7609, DOI 10.1073/pnas.78.12.7609; Hu G, 2009, GENE DEV, V23, P837, DOI 10.1101/gad.1769609; JAHNER D, 1982, NATURE, V298, P623, DOI 10.1038/298623a0; Janowski BA, 2006, NAT STRUCT MOL BIOL, V13, P787, DOI 10.1038/nsmb1140; Kaiser SM, 2007, SCIENCE, V316, P1756, DOI 10.1126/science.1140579; KALTER SS, 1973, SCIENCE, V179, P1332, DOI 10.1126/science.179.4080.1332; Kazazian HH, 2004, SCIENCE, V303, P1626, DOI 10.1126/science.1089670; Kazazian HH, 2002, CELL, V110, P277, DOI 10.1016/S0092-8674(02)00868-1; Keedy KS, 2009, J VIROL, V83, P4749, DOI 10.1128/JVI.02585-08; Kim DH, 2006, NAT STRUCT MOL BIOL, V13, P793, DOI 10.1038/nsmb1142; Kondo Y, 2004, P NATL ACAD SCI USA, V101, P7398, DOI 10.1073/pnas.0306641101; Kunath T, 2005, DEVELOPMENT, V132, P1649, DOI 10.1242/dev.01715; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Laker C, 1998, J VIROL, V72, P339, DOI 10.1128/JVI.72.1.339-348.1998; Lee MG, 2007, CELL, V128, P877, DOI 10.1016/j.cell.2007.02.004; LOH TP, 1990, MOL CELL BIOL, V10, P4045, DOI 10.1128/MCB.10.8.4045; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Malone CD, 2009, CELL, V136, P656, DOI 10.1016/j.cell.2009.01.045; Mamo S, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-14; Mandal PK, 2008, CELL, V135, DOI 10.1016/j.cell.2008.09.028; Market-Velker BA, 2010, HUM MOL GENET, V19, P36, DOI 10.1093/hmg/ddp465; Martens JHA, 2005, EMBO J, V24, P800, DOI 10.1038/sj.emboj.7600545; MATSUI T, 2010, NATURE IN PRESS, V17, DOI DOI 10.1038/NATURE08858; MCCLINTOCK B, 1956, COLD SPRING HARB SYM, V21, P197, DOI 10.1101/SQB.1956.021.01.017; Mi S, 2000, NATURE, V403, P785, DOI 10.1038/35001608; Mukhopadhyay A, 2008, NAT PROTOC, V3, P698, DOI 10.1038/nprot.2008.38; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; NIWA O, 1983, CELL, V32, P1105, DOI 10.1016/0092-8674(83)90294-5; Pannell D, 2000, EMBO J, V19, P5884, DOI 10.1093/emboj/19.21.5884; Poleshko A, 2008, J VIROL, V82, P2313, DOI 10.1128/JVI.01882-07; Rawn SM, 2008, ANNU REV CELL DEV BI, V24, P159, DOI 10.1146/annurev.cellbio.24.110707.175418; Roberts CWM, 2004, NAT REV CANCER, V4, P133, DOI 10.1038/nrc1273; Rowe HM, 2010, NATURE, V463, P237, DOI 10.1038/nature08674; Schwartz YB, 2007, NAT REV GENET, V8, P9, DOI 10.1038/nrg1981; Sewalt RGAB, 2002, MOL CELL BIOL, V22, P5539, DOI 10.1128/MCB.22.15.5539-5553.2002; Sharif J, 2007, NATURE, V450, P908, DOI 10.1038/nature06397; Silva JM, 2005, NAT GENET, V37, P1281, DOI 10.1038/ng1650; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; STEWART CL, 1982, P NATL ACAD SCI-BIOL, V79, P4098, DOI 10.1073/pnas.79.13.4098; TAKAGI N, 1975, NATURE, V256, P640, DOI 10.1038/256640a0; Tam OH, 2008, NATURE, V453, P534, DOI 10.1038/nature06904; Tanaka S, 1998, SCIENCE, V282, P2072, DOI 10.1126/science.282.5396.2072; TEICH NM, 1977, CELL, V12, P973, DOI 10.1016/0092-8674(77)90162-3; Turelli P, 2001, MOL CELL, V7, P1245, DOI 10.1016/S1097-2765(01)00255-6; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; Watanabe T, 2006, GENE DEV, V20, P1732, DOI 10.1101/gad.1425706; Wolf D, 2009, NATURE, V458, P1201, DOI 10.1038/nature07844; Xue YT, 1998, MOL CELL, V2, P851, DOI 10.1016/S1097-2765(00)80299-3	60	30	31	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	MAY 7	2010	6	5					457	467		10.1016/j.stem.2010.03.014	http://dx.doi.org/10.1016/j.stem.2010.03.014			11	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	598NO	20452320	Bronze			2022-12-24	WOS:000277844800013
J	Pardo, M; Lang, B; Yu, L; Prosser, H; Bradley, A; Babu, MM; Choudhary, J				Pardo, Mercedes; Lang, Benjamin; Yu, Lu; Prosser, Haydn; Bradley, Allan; Babu, M. Madan; Choudhary, Jyoti			An Expanded Oct4 Interaction Network: Implications for Stem Cell Biology, Development, and Disease	CELL STEM CELL			English	Article							TRANSCRIPTION FACTORS; SELF-RENEWAL; EARLY DIFFERENTIATION; GENOMIC ANALYSIS; O-GLYCOSYLATION; RNAI SCREEN; ES CELLS; PLURIPOTENCY; EXPRESSION; FIBROBLASTS	The transcription factor Oct4 is key in embryonic stem cell identity and reprogramming. Insight into its partners should illuminate how the pluripotent state is established and regulated. Here, we identify a considerably expanded set of Oct4-binding proteins in mouse embryonic stem cells. We find that Oct4 associates with a varied set of proteins including regulators of gene expression and modulators of Oct4 function. Half of its partners are transcriptionally regulated by Oct4 itself or other stem cell transcription factors, whereas one-third display a significant change in expression upon cell differentiation. The majority of Oct4-associated proteins studied to date show an early lethal phenotype when mutated. A fraction of the human orthologs is associated with inherited developmental disorders or causative of cancer. The Oct4 interactome provides a resource for dissecting mechanisms of Oct4 function, enlightening the basis of pluripotency and development, and identifying potential additional reprogramming factors.	[Pardo, Mercedes; Yu, Lu; Prosser, Haydn; Bradley, Allan; Choudhary, Jyoti] Wellcome Trust Sanger Inst, Hinxton CB10 1SA, Cambs, England; [Lang, Benjamin; Babu, M. Madan] MRC, Mol Biol Lab, Cambridge CB2 0QH, England	Wellcome Trust Sanger Institute; MRC Laboratory Molecular Biology	Pardo, M (corresponding author), Wellcome Trust Sanger Inst, Hinxton CB10 1SA, Cambs, England.		Mohan, Babu P./I-7362-2019; Choudhary, Jyoti/S-1232-2017; Lang, Benjamin/C-5036-2009	Choudhary, Jyoti/0000-0003-0881-5477; Lang, Benjamin/0000-0001-6358-8380; Pardo, Mercedes/0000-0002-3477-9695; Bradley, Allan/0000-0002-2349-8839	Wellcome Trust; Herchel Smith Research Studentship Fund; Medical Research Council [MC_U105185859] Funding Source: researchfish; MRC [MC_U105185859] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Herchel Smith Research Studentship Fund; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We would like to thank Frances Law and Alastair Beasley for technical assistance and Sajani Swamy and Parthiban Vijayarangakannan for informatics support The work described here was supported by the Wellcome Trust and the Herchel Smith Research Studentship Fund (B L)	Amabile G, 2009, TRENDS MOL MED, V15, P59, DOI 10.1016/j.molmed.2008.12.003; Ambrosetti DC, 1997, MOL CELL BIOL, V17, P6321, DOI 10.1128/MCB.17.11.6321; Anton R, 2007, FEBS LETT, V581, P5247, DOI 10.1016/j.febslet.2007.10.012; Apweiler R, 2010, NUCLEIC ACIDS RES, V38, pD142, DOI 10.1093/nar/gkp846; Araki K, 1997, J BIOCHEM, V122, P977, DOI 10.1093/oxfordjournals.jbchem.a021860; Babaie Y, 2007, STEM CELLS, V25, P500, DOI 10.1634/stemcells.2006-0426; Babu MM, 2004, CURR OPIN STRUC BIOL, V14, P283, DOI 10.1016/j.sbi.2004.05.004; Barsnes H, 2009, NAT BIOTECHNOL, V27, P598, DOI 10.1038/nbt0709-598; Blake JA, 2009, NUCLEIC ACIDS RES, V37, pD712, DOI 10.1093/nar/gkn886; Bourc'his D, 2001, SCIENCE, V294, P2536, DOI 10.1126/science.1065848; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brill LM, 2009, CELL STEM CELL, V5, P204, DOI 10.1016/j.stem.2009.06.002; Campbell PA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000553; Chambers I, 2009, DEVELOPMENT, V136, P2311, DOI 10.1242/dev.024398; Chew JL, 2005, MOL CELL BIOL, V25, P6031, DOI 10.1128/MCB.25.14.6031-6046.2005; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; de Boer E, 2003, P NATL ACAD SCI USA, V100, P7480, DOI 10.1073/pnas.1332608100; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Ding L, 2009, CELL STEM CELL, V4, P403, DOI 10.1016/j.stem.2009.03.009; Donohoe ME, 2009, NATURE, V460, P128, DOI 10.1038/nature08098; Doyon Y, 2006, MOL CELL, V21, P51, DOI 10.1016/j.molcel.2005.12.007; Fernandez E, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.27; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Gao FR, 2009, J BIOL CHEM, V284, P22263, DOI 10.1074/jbc.M109.033118; Gowher H, 2005, J BIOL CHEM, V280, P13341, DOI 10.1074/jbc.M413412200; Hamosh A, 2005, NUCLEIC ACIDS RES, V33, pD514; Hu G, 2009, GENE DEV, V23, P837, DOI 10.1101/gad.1769609; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; JACKSON SP, 1988, CELL, V55, P125, DOI 10.1016/0092-8674(88)90015-3; Jothi R, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.52; Kaji K, 2009, NATURE, V458, P771, DOI 10.1038/nature07864; Kalmar T, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000149; Kamemura K, 2003, PROG NUCLEIC ACID RE, V73, P107, DOI 10.1016/S0079-6603(03)01004-3; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Lauberth SM, 2006, J BIOL CHEM, V281, P23922, DOI 10.1074/jbc.M513461200; Li XQ, 2008, J GENET GENOMICS, V35, P723, DOI 10.1016/S1673-8527(08)60227-1; Liang J, 2008, NAT CELL BIOL, V10, P731, DOI 10.1038/ncb1736; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Luscombe NM, 2004, NATURE, V431, P308, DOI 10.1038/nature02782; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Martens L, 2005, PROTEOMICS, V5, P3537, DOI 10.1002/pmic.200401303; Matoba R, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000026; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Orkin SH, 2008, COLD SH Q B, V73, P195, DOI 10.1101/sqb.2008.72.001; Pan GJ, 2006, FASEB J, V20, P1730, DOI 10.1096/fj.05-5543fje; Poser I, 2008, NAT METHODS, V5, P409, DOI 10.1038/NMETH.1199; Prosser HM, 2008, MOL CELL BIOL, V28, P1702, DOI 10.1128/MCB.01282-07; RAMIREZSOLIS R, 1993, CELL, V73, P279, DOI 10.1016/0092-8674(93)90229-J; Reimand J, 2007, NUCLEIC ACIDS RES, V35, pW193, DOI 10.1093/nar/gkm226; Rhodes DR, 2007, NEOPLASIA, V9, P166, DOI 10.1593/neo.07112; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Rowley A, 2000, METHODS, V20, P383, DOI 10.1006/meth.2000.0951; Sandie Reatha, 2009, BMC Res Notes, V2, P39, DOI 10.1186/1756-0500-2-39; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Schaft J, 2001, GENESIS, V31, P6, DOI 10.1002/gene.1076; Shimozaki K, 2003, DEVELOPMENT, V130, P2505, DOI 10.1242/dev.00476; Sterner DE, 2000, MICROBIOL MOL BIOL R, V64, P435, DOI 10.1128/MMBR.64.2.435-459.2000; Sun CH, 2009, MOL CELL BIOL, V29, P4574, DOI 10.1128/MCB.01863-08; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takao Y, 2007, BIOCHEM BIOPH RES CO, V353, P699, DOI 10.1016/j.bbrc.2006.12.072; Thomas PD, 2003, NUCLEIC ACIDS RES, V31, P334, DOI 10.1093/nar/gkg115; van den Berg DLC, 2008, MOL CELL BIOL, V28, P5986, DOI 10.1128/MCB.00301-08; Van Hoof D, 2009, CELL STEM CELL, V5, P214, DOI 10.1016/j.stem.2009.05.021; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Wang ZX, 2008, STEM CELLS, V26, P2791, DOI 10.1634/stemcells.2008-0443; Webster DM, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-28; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863; Xu HM, 2004, J BIOL CHEM, V279, P23495, DOI 10.1074/jbc.M400516200; Xu HM, 2009, CELL RES, V19, P561, DOI 10.1038/cr.2009.31; Yu HB, 2009, J BIOL CHEM, V284, P31327, DOI 10.1074/jbc.M109.016162; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zeghouf M, 2004, J PROTEOME RES, V3, P463, DOI 10.1021/pr034084x	78	284	296	0	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	APR 2	2010	6	4					382	395		10.1016/j.stem.2010.03.004	http://dx.doi.org/10.1016/j.stem.2010.03.004			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	585KD	20362542	hybrid, Green Published			2022-12-24	WOS:000276823300016
J	Hagglund, M; Borgius, L; Dougherty, KJ; Kiehn, O				Hagglund, Martin; Borgius, Lotta; Dougherty, Kimberly J.; Kiehn, Ole			Activation of groups of excitatory neurons in the mammalian spinal cord or hindbrain evokes locomotion	NATURE NEUROSCIENCE			English	Article							VITRO NEONATAL-RAT; IN-VITRO; TRANSGENIC MICE; COMMISSURAL INTERNEURONS; VENTROLATERAL FUNICULUS; NEURAL CIRCUITRY; RHYTHM; SPEED; MOUSE; CHANNELRHODOPSIN-2	Central pattern generators (CPGs) are spinal neuronal networks required for locomotion. Glutamatergic neurons have been implicated as being important for intrinsic rhythm generation in the CPG and for the command signal for initiating locomotion, although this has not been demonstrated directly. We used a newly generated vesicular glutamate transporter 2-channelrhodopsin2-yellow fluorescent protein (Vglut2-ChR2-YFP) mouse to directly examine the functional role of glutamatergic neurons in rhythm generation and initiation of locomotion. This mouse line expressed ChR2-YFP in the spinal cord and hindbrain. ChR2-YFP was reliably expressed in Vglut2-positive cells and YFP-expressing cells could be activated by light. Photo-stimulation of either the lumbar spinal cord or the caudal hindbrain was sufficient to both initiate and maintain locomotor-like activity. Our results indicate that glutamatergic neurons in the spinal cord are critical for initiating or maintaining the rhythm and that activation of hindbrain areas containing the locomotor command regions is sufficient to directly activate the spinal locomotor network.	[Hagglund, Martin; Borgius, Lotta; Dougherty, Kimberly J.; Kiehn, Ole] Karolinska Inst, Dept Neurosci, Mammalian Locomotor Lab, Stockholm, Sweden	Karolinska Institutet	Kiehn, O (corresponding author), Karolinska Inst, Dept Neurosci, Mammalian Locomotor Lab, Stockholm, Sweden.	o.kiehn@ki.se	kiehn, ole/AAB-1262-2019; kiehn, ole/AAT-7881-2021	Hagglund, Martin/0000-0003-1921-8563; Kiehn, Ole/0000-0002-5954-469X; Dougherty, Kimberly/0000-0002-0807-574X	US National Institutes of Health [R01NS040795-08]; European Union; National Science Foundation [0701166]; Swedish Medical Research Council; Karolinska Institutet's foundation; Soderbergs Foundation; Friends of Karolinska Intitutet; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040795] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Union(European Commission); National Science Foundation(National Science Foundation (NSF)); Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Karolinska Institutet's foundation; Soderbergs Foundation; Friends of Karolinska Intitutet; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank K. Deisseroth for providing us with the ChR2 construct, D. Engblom for technical assistance with BAC cloning and the Karolinska Center for Transgenic Technologies for pronuclear injection. This work was supported by grants from the US National Institutes of Health (R01NS040795-08), the European Union (SPINAL CORD REPAIR), the National Science Foundation (0701166 to K.J.D.), and by the Swedish Medical Research Council, the Karolinska Institutet's foundation for support of graduate students (M.H.) and postdocs (L.B.), Soderbergs Foundation, and Friends of Karolinska Intitutet.	Adamantidis AR, 2007, NATURE, V450, P420, DOI 10.1038/nature06310; Aravanis AM, 2007, J NEURAL ENG, V4, pS143, DOI 10.1088/1741-2560/4/3/S02; Arenkiel BR, 2007, NEURON, V54, P205, DOI 10.1016/j.neuron.2007.03.005; Bonnot A, 2002, BRAIN RES REV, V40, P141, DOI 10.1016/S0165-0173(02)00197-2; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Bracci E, 1996, J NEUROPHYSIOL, V75, P640, DOI 10.1152/jn.1996.75.2.640; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Clarac F, 2004, J COMP PHYSIOL A, V190, P343, DOI 10.1007/s00359-004-0499-2; Crone SA, 2008, NEURON, V60, P70, DOI 10.1016/j.neuron.2008.08.009; Crone SA, 2009, J NEUROSCI, V29, P7098, DOI 10.1523/JNEUROSCI.1206-09.2009; Douglass AD, 2008, CURR BIOL, V18, P1133, DOI 10.1016/j.cub.2008.06.077; Dubuc R, 2008, BRAIN RES REV, V57, P172, DOI 10.1016/j.brainresrev.2007.07.016; Feldman JL, 2006, NAT REV NEUROSCI, V7, P232, DOI 10.1038/nrn1871; Fremeau RT, 2001, NEURON, V31, P247, DOI 10.1016/S0896-6273(01)00344-0; Fremeau RT, 2004, TRENDS NEUROSCI, V27, P98, DOI 10.1016/j.tins.2003.11.005; Gosgnach S, 2006, NATURE, V440, P215, DOI 10.1038/nature04545; Gradinaru V, 2009, SCIENCE, V324, P354, DOI 10.1126/science.1167093; Grillner S, 2003, NAT REV NEUROSCI, V4, P573, DOI 10.1038/nrn1137; Huber D, 2008, NATURE, V451, P61, DOI 10.1038/nature06445; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Jordan LM, 2008, BRAIN RES REV, V57, P183, DOI 10.1016/j.brainresrev.2007.07.019; Kiehn O, 1996, J NEUROPHYSIOL, V75, P1472, DOI 10.1152/jn.1996.75.4.1472; Kiehn O, 2000, BRAIN RES BULL, V53, P649, DOI 10.1016/S0361-9230(00)00398-1; Kiehn O, 1998, ANN NY ACAD SCI, V860, P110, DOI 10.1111/j.1749-6632.1998.tb09043.x; Kiehn O, 2006, ANNU REV NEUROSCI, V29, P279, DOI 10.1146/annurev.neuro.29.051605.112910; Kullander K, 2003, SCIENCE, V299, P1889, DOI 10.1126/science.1079641; Lanuza GM, 2004, NEURON, V42, P375, DOI 10.1016/S0896-6273(04)00249-1; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Liewald JF, 2008, NAT METHODS, V5, P895, DOI 10.1038/NMETH.1252; Liu J, 2005, J NEUROPHYSIOL, V94, P1392, DOI 10.1152/jn.00136.2005; Lundfald L, 2007, EUR J NEUROSCI, V26, P2989, DOI 10.1111/j.1460-9568.2007.05906.x; Magnuson DSK, 1997, J NEUROPHYSIOL, V77, P200, DOI 10.1152/jn.1997.77.1.200; Marchetti C, 2001, J PHYSIOL-LONDON, V530, P105, DOI 10.1111/j.1469-7793.2001.0105m.x; McLean DL, 2008, NAT NEUROSCI, V11, P1419, DOI 10.1038/nn.2225; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Nishimaru H, 2000, BRAIN RES BULL, V53, P661, DOI 10.1016/S0361-9230(00)00399-3; Parkitna Jan Rodriguez, 2009, V530, P325, DOI 10.1007/978-1-59745-471-1_17; Pulver SR, 2009, J NEUROPHYSIOL, V101, P3075, DOI 10.1152/jn.00071.2009; Reed WR, 2008, NEUROSCIENCE, V151, P505, DOI 10.1016/j.neuroscience.2007.10.025; Restrepo CE, 2009, J COMP NEUROL, V517, P177, DOI 10.1002/cne.22144; Roberts A, 1998, ANN NY ACAD SCI, V860, P19, DOI 10.1111/j.1749-6632.1998.tb09036.x; Schmidt BJ, 2000, BRAIN RES BULL, V53, P689, DOI 10.1016/S0361-9230(00)00402-0; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; Stornetta RL, 2002, J COMP NEUROL, V444, P191, DOI 10.1002/cne.10141; Wang H, 2007, P NATL ACAD SCI USA, V104, P8143, DOI 10.1073/pnas.0700384104; Wilson JM, 2005, J NEUROSCI, V25, P5710, DOI 10.1523/JNEUROSCI.0274-05.2005; Zaporozhets E, 2006, J PHYSIOL-LONDON, V572, P443, DOI 10.1113/jphysiol.2005.102376; Zhang F, 2007, NAT REV NEUROSCI, V8, P577, DOI 10.1038/nrn2192; Zhang Y, 2008, NEURON, V60, P84, DOI 10.1016/j.neuron.2008.09.027; Zhong GS, 2006, J NEUROPHYSIOL, V95, P1545, DOI 10.1152/jn.01103.2005	50	182	187	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2010	13	2					246	U143		10.1038/nn.2482	http://dx.doi.org/10.1038/nn.2482			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	548SE	20081850				2022-12-24	WOS:000273985800021
J	Mann, EO; Mody, I				Mann, Edward O.; Mody, Istvan			Control of hippocampal gamma oscillation frequency by tonic inhibition and excitation of interneurons	NATURE NEUROSCIENCE			English	Article							PARVALBUMIN-POSITIVE INTERNEURONS; FAST NETWORK OSCILLATIONS; LONG-TERM POTENTIATION; IN-VITRO; GABA(A) RECEPTORS; NMDA RECEPTORS; RAT HIPPOCAMPUS; BEHAVING RAT; SUBUNITS; ACTIVATION	Gamma-frequency oscillations depend on phasic synaptic GABA(A) receptor (GABA(A)R)-mediated inhibition to synchronize spike timing. The spillover of synaptically released GABA can also activate extrasynaptic GABA(A)Rs, and such tonic inhibition may also contribute to modulating network dynamics. In many neuronal cell types, tonic inhibition is mediated by delta subunit-containing GABA(A)Rs. We found that the frequency of in vitro cholinergically induced gamma oscillations in the mouse hippocampal CA3 region was increased by the activation of NMDA receptors (NMDARs) on interneurons. The NMDAR-dependent increase of gamma oscillation frequency was counteracted by the tonic inhibition of the interneurons mediated by delta subunit-containing GABA(A)Rs. Recordings of synaptic currents during gamma activity revealed that NMDAR-mediated increases in oscillation frequency correlated with a progressive synchronization of phasic excitation and inhibition in the network. Thus, the balance between tonic excitation and tonic inhibition of interneurons may modulate gamma frequency by shaping interneuronal synchronization.	[Mann, Edward O.; Mody, Istvan] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Mody, I (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA.	mody@ucla.edu		Mann, Edward/0000-0002-2468-7148	Epilepsy Foundation Postdoctoral Fellowship; US National Institutes of Health [NS30549, NS02808]; Coelho Endowment; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS030549, P01NS002808, R37NS030549] Funding Source: NIH RePORTER	Epilepsy Foundation Postdoctoral Fellowship; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Coelho Endowment; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was funded by a Epilepsy Foundation Postdoctoral Fellowship to E.O.M. and US National Institutes of Health grants NS30549 and NS02808 and the Coelho Endowment to I.M.	Alle H, 2006, SCIENCE, V311, P1290, DOI 10.1126/science.1119055; Banke TG, 2006, J NEUROSCI, V26, P11720, DOI 10.1523/JNEUROSCI.2887-06.2006; Bartos M, 2007, NAT REV NEUROSCI, V8, P45, DOI 10.1038/nrn2044; BRAGIN A, 1995, J NEUROSCI, V15, P47; Brunel N, 2003, J NEUROPHYSIOL, V90, P415, DOI 10.1152/jn.01095.2002; Csicsvari J, 2003, NEURON, V37, P311, DOI 10.1016/S0896-6273(02)01169-8; Csicsvari J, 1999, J NEUROSCI, V19, P274, DOI 10.1523/JNEUROSCI.19-01-00274.1999; Farrant M, 2005, NAT REV NEUROSCI, V6, P215, DOI 10.1038/nrn1625; Fell J, 2001, NAT NEUROSCI, V4, P1259, DOI 10.1038/nn759; Fisahn A, 1998, NATURE, V394, P186, DOI 10.1038/28179; Fisahn A, 2004, J NEUROSCI, V24, P9658, DOI 10.1523/JNEUROSCI.2973-04.2004; Fuchs EC, 2007, NEURON, V53, P591, DOI 10.1016/j.neuron.2007.01.031; Glykys J, 2008, J NEUROSCI, V28, P1421, DOI 10.1523/JNEUROSCI.4751-07.2008; Glykys J, 2007, NEURON, V56, P763, DOI 10.1016/j.neuron.2007.11.002; Glykys J, 2007, J PHYSIOL-LONDON, V582, P1163, DOI 10.1113/jphysiol.2007.134460; Hajos N, 2000, EUR J NEUROSCI, V12, P3239, DOI 10.1046/j.1460-9568.2000.00217.x; Hajos N, 2004, J NEUROSCI, V24, P9127, DOI 10.1523/JNEUROSCI.2113-04.2004; Harney SC, 2008, J NEUROSCI, V28, P11685, DOI 10.1523/JNEUROSCI.3035-08.2008; Hasenstaub A, 2005, NEURON, V47, P423, DOI 10.1016/j.neuron.2005.06.016; Hormuzdi SG, 2001, NEURON, V31, P487, DOI 10.1016/S0896-6273(01)00387-7; Hrabetova S, 2000, J NEUROSCI, V20, DOI 10.1523/JNEUROSCI.20-12-j0002.2000; Lamsa K, 2007, J PHYSIOL-LONDON, V584, P885, DOI 10.1113/jphysiol.2007.137380; LAURIE DJ, 1992, J NEUROSCI, V12, P4151; LISMAN JE, 1995, SCIENCE, V267, P1512, DOI 10.1126/science.7878473; Lozovaya NA, 2004, J PHYSIOL-LONDON, V558, P451, DOI 10.1113/jphysiol.2004.063792; MACDONALD JF, 1991, J PHYSIOL-LONDON, V432, P483, DOI 10.1113/jphysiol.1991.sp018396; Mann EO, 2007, TRENDS NEUROSCI, V30, P343, DOI 10.1016/j.tins.2007.05.003; Mann EO, 2005, NEURON, V45, P105, DOI 10.1016/j.neuron.2004.12.016; Middleton S, 2008, P NATL ACAD SCI USA, V105, P18572, DOI 10.1073/pnas.0809302105; Misra C, 2000, J PHYSIOL-LONDON, V524, P147, DOI 10.1111/j.1469-7793.2000.00147.x; Mitchell SJ, 2003, NEURON, V38, P433, DOI 10.1016/S0896-6273(03)00200-9; Montgomery SM, 2007, P NATL ACAD SCI USA, V104, P14495, DOI 10.1073/pnas.0701826104; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; Nagy J, 2008, CURR NEUROPHARMACOL, V6, P39, DOI 10.2174/157015908783769662; Oren I, 2006, J NEUROSCI, V26, P9923, DOI 10.1523/JNEUROSCI.1580-06.2006; Peng Z, 2002, J COMP NEUROL, V446, P179, DOI 10.1002/cne.10210; Semyanov A, 2004, TRENDS NEUROSCI, V27, P262, DOI 10.1016/j.tins.2004.03.005; Semyanov A, 2003, NAT NEUROSCI, V6, P484, DOI 10.1038/nn1043; SINGER W, 1993, ANNU REV PHYSIOL, V55, P349, DOI 10.1146/annurev.physiol.55.1.349; Standaert DG, 1996, MOL BRAIN RES, V42, P89, DOI 10.1016/S0169-328X(96)00117-9; Steriade M, 1996, J NEUROSCI, V16, P392, DOI 10.1523/jneurosci.16-01-00392.1996; Towers SK, 2004, J PHYSIOL-LONDON, V559, P721, DOI 10.1113/jphysiol.2004.071191; Traub RD, 2000, EUR J NEUROSCI, V12, P4093, DOI 10.1046/j.1460-9568.2000.00300.x; Trigo FF, 2008, EUR J NEUROSCI, V28, P841, DOI 10.1111/j.1460-9568.2008.06404.x; Tukker JJ, 2007, J NEUROSCI, V27, P8184, DOI 10.1523/JNEUROSCI.1685-07.2007; Vida I, 2006, NEURON, V49, P107, DOI 10.1016/j.neuron.2005.11.036; Wang XJ, 1996, J NEUROSCI, V16, P6402; WHITTINGTON MA, 1995, NATURE, V373, P612, DOI 10.1038/373612a0; Wulff P, 2009, P NATL ACAD SCI USA, V106, P3561, DOI 10.1073/pnas.0813176106; Zar JH, 1999, BIOSTATISTICAL ANAL	50	147	148	1	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2010	13	2					205	U90		10.1038/nn.2464	http://dx.doi.org/10.1038/nn.2464			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	548SE	20023655	Green Accepted			2022-12-24	WOS:000273985800016
J	Richardson-Jones, JW; Craige, CP; Guiard, BP; Stephen, A; Metzger, KL; Kung, HF; Gardier, AM; Dranovsky, A; David, DJ; Beck, SG; Hen, R; Leonardo, ED				Richardson-Jones, Jesse W.; Craige, Caryne P.; Guiard, Bruno P.; Stephen, Alisson; Metzger, Kayla L.; Kung, Hank F.; Gardier, Alain M.; Dranovsky, Alex; David, Denis J.; Beck, Sheryl G.; Hen, Rene; Leonardo, E. David			5-HT1A Autoreceptor Levels Determine Vulnerability to Stress and Response to Antidepressants	NEURON			English	Article							DORSAL RAPHE NEURONS; KNOCK-OUT MICE; MAJOR DEPRESSION; ANIMAL-MODEL; HIPPOCAMPAL NEUROGENESIS; SEROTONIN(1A) RECEPTOR; INDUCED HYPERTHERMIA; SYNAPTIC PLASTICITY; AMYGDALA REACTIVITY; DEFICIENT MICE	Most depressed patients don't respond to their first drug treatment, and the reasons for this treatment resistance remain enigmatic. Human studies implicate a polymorphism in the promoter of the serotonin-1A (5-HT1A) receptor gene in increased susceptibility to depression and decreased treatment response. Here we develop a new strategy to manipulate 5-HT1A autoreceptors in raphe nuclei without affecting 5-H(T1)A heteroreceptors, generating mice with higher (1A-High) or lower (1A-Low) autoreceptor levels. We show that this robustly affects raphe firing rates, but has no effect on either basal forebrain serotonin levels or conflict-anxiety measures. However, compared to 1A-Low mice, 1A-High mice show a blunted physiological response to acute stress, increased behavioral despair, and no behavioral response to antidepressant, modeling patients with the 5-HT1A risk allele. Furthermore, reducing 5-HT1A autoreceptor levels prior to antidepressant treatment is sufficient to convert nonresponders into responders. These results establish a causal relationship between 5-HT1A autoreceptor levels, resilience under stress, and response to antidepressants.	[Richardson-Jones, Jesse W.; Hen, Rene] Columbia Univ, Dept Pharmacol, New York, NY 10032 USA; [Richardson-Jones, Jesse W.; Dranovsky, Alex; Hen, Rene; Leonardo, E. David] Columbia Univ, Dept Psychiat, New York, NY 10032 USA; [Hen, Rene] Columbia Univ, Dept Neurosci, New York, NY 10032 USA; [Craige, Caryne P.; Stephen, Alisson; Metzger, Kayla L.; Beck, Sheryl G.] Childrens Hosp Philadelphia, Dept Anesthesiol, Philadelphia, PA 19312 USA; [Craige, Caryne P.; Stephen, Alisson; Metzger, Kayla L.; Beck, Sheryl G.] Univ Penn, Philadelphia, PA 19312 USA; [Guiard, Bruno P.; Gardier, Alain M.; David, Denis J.] Univ Paris Sud, Fac Pharm, EA 3544, F-92296 Chatenay Malabry, France; [Kung, Hank F.] Univ Penn, Dept Radiol, Philadelphia, PA 19104 USA	Columbia University; Columbia University; Columbia University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; UDICE-French Research Universities; Universite Paris Saclay; University of Pennsylvania	Hen, R (corresponding author), Columbia Univ, Dept Pharmacol, New York, NY 10032 USA.	rh95@columbia.edu	Dranovsky, Alex/P-4357-2018; Leonardo, Eduardo/AAH-1525-2020; Guiard, Bruno/A-3955-2016; DAVID, Denis/K-1173-2014	Dranovsky, Alex/0000-0001-7896-3243; Leonardo, Eduardo/0000-0001-7426-0217; DAVID, Denis/0000-0002-0506-6688	National Institutes of Health [K08 MH076083, R01 MH075047, R01 MH068542]; AstraZeneca [CU08-8439]; NATIONAL INSTITUTE OF MENTAL HEALTH [K08MH076083, K08MH079088, R01MH091844, T32MH015174, R01MH075047, R01MH068542, P01MH048125, R21MH099488, RC1MH089800, R37MH068542] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AstraZeneca(AstraZeneca); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The authors gratefully acknowledge Moises Mallo for providing the beta-actin tTS mouse line and the tTS construct and thank Evan Deneris for providing the Pet-1 mini-BAC. We thank Randall Sewell for technical assistance. Adaure Akanwa is acknowledged for performing the immunohistochemistry on the brain slices used for electrophysiology. Finally, we are grateful to Joshua Gordon, Susanne Ahmari, and Jay Gingrich for helpful discussions and critical reading of the manuscript. This work was supported by National Institutes of Health grants K08 MH076083 to E.D.L., R01 MH075047 to S.G.B, and R01 MH068542 to R.H. and AstraZeneca grant CU08-8439 to R.H. R.H. receives compensation as a consultant for Braincells, Inc., and AstraZeneca in relation to the generation of novel antidepressants.	Albert PR, 2004, NEUROSCIENTIST, V10, P575, DOI 10.1177/1073858404267382; Anttila S, 2007, J NEURAL TRANSM, V114, P1065, DOI 10.1007/s00702-007-0705-9; Artigas F, 1996, TRENDS NEUROSCI, V19, P378, DOI 10.1016/S0166-2236(96)10037-0; Audero E, 2008, SCIENCE, V321, P130, DOI 10.1126/science.1157871; Beck SG, 2004, J NEUROPHYSIOL, V91, P994, DOI 10.1152/jn.00744.2003; BECK SG, 1992, J PHARMACOL EXP THER, V263, P350; Blier P, 1998, ANN NY ACAD SCI, V861, P204, DOI 10.1111/j.1749-6632.1998.tb10192.x; Bouwknecht JA, 2007, NEUROSCI BIOBEHAV R, V31, P41, DOI 10.1016/j.neubiorev.2006.02.002; Buccafusco JJ, 2009, FRONT NEUROSCI, P1; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Cryan JF, 2005, NEUROSCI BIOBEHAV R, V29, P571, DOI 10.1016/j.neubiorev.2005.03.009; Dalm S, 2008, J NEUROSCI METH, V170, P77, DOI 10.1016/j.jneumeth.2007.12.021; David DJ, 2007, J PHARMACOL EXP THER, V321, P237, DOI 10.1124/jpet.106.109678; DEUSCHLE U, 1995, MOL CELL BIOL, V15, P1907; Dietrich P, 2000, MAMM GENOME, V11, P196, DOI 10.1007/s003350010037; Drevets WC, 2007, NUCL MED BIOL, V34, P865, DOI 10.1016/j.nucmedbio.2007.06.008; Dulawa SC, 2005, NEUROSCI BIOBEHAV R, V29, P771, DOI 10.1016/j.neubiorev.2005.03.017; Fakra E, 2009, ARCH GEN PSYCHIAT, V66, P33, DOI 10.1001/archpsyc.66.1.33; Fava M, 2000, NEURON, V28, P335, DOI 10.1016/S0896-6273(00)00112-4; Fisher PM, 2006, NAT NEUROSCI, V9, P1362, DOI 10.1038/nn1780; Franklin KBJ, 2008, MOUSE BRAIN STEREOTA, V3rd; Gardier AM, 1996, FUND CLIN PHARMACOL, V10, P16, DOI 10.1111/j.1472-8206.1996.tb00145.x; GROENINK L, 1994, PHYSIOL BEHAV, V56, P747, DOI 10.1016/0031-9384(94)90237-2; Gross C, 2002, NATURE, V416, P396, DOI 10.1038/416396a; Gross C, 2000, BIOL PSYCHIAT, V48, P1157, DOI 10.1016/S0006-3223(00)01041-6; Guiard BP, 2008, INT J NEUROPSYCHOPH, V11, P79, DOI 10.1017/S1461145707007857; HAMON M, 1990, NEUROPSYCHOPHARMACOL, V3, P349; Heisler LK, 1998, P NATL ACAD SCI USA, V95, P15049, DOI 10.1073/pnas.95.25.15049; Holmes A, 2008, NEUROSCI BIOBEHAV R, V32, P1293, DOI 10.1016/j.neubiorev.2008.03.006; Ibarguen-Vargas Y, 2008, PSYCHONEUROENDOCRINO, V33, P1357, DOI 10.1016/j.psyneuen.2008.07.010; KENDLER KS, 1992, ARCH GEN PSYCHIAT, V49, P716; Klemenhagen KC, 2006, NEUROPSYCHOPHARMACOL, V31, P101, DOI 10.1038/sj.npp.1300774; Kraus MR, 2007, GASTROENTEROLOGY, V132, P1279, DOI 10.1053/j.gastro.2007.02.053; KUNG MP, 1995, J PHARMACOL EXP THER, V272, P429; Lanfumey L, 2008, NEUROSCI BIOBEHAV R, V32, P1174, DOI 10.1016/j.neubiorev.2008.04.006; Le Francois B, 2008, NEUROPHARMACOLOGY, V55, P977, DOI 10.1016/j.neuropharm.2008.06.046; Lemonde S, 2003, J NEUROSCI, V23, P8788; Leonardo ED, 2006, ANNU REV PSYCHOL, V57, P117, DOI 10.1146/annurev.psych.57.102904.190118; Lesch KP, 2004, INT J NEUROPSYCHOPH, V7, P381, DOI 10.1017/S1461145704004845; Lira A, 2003, BIOL PSYCHIAT, V54, P960, DOI 10.1016/S0006-3223(03)00696-6; Lo Iacono L, 2008, J NEUROSCI, V28, P6250, DOI 10.1523/JNEUROSCI.5219-07.2008; Lucki I, 2001, PSYCHOPHARMACOLOGY, V155, P315, DOI 10.1007/s002130100694; Lucki I, 1997, BEHAV PHARMACOL, V8, P523, DOI 10.1097/00008877-199711000-00010; Mallo M, 2003, GENOMICS, V81, P356, DOI 10.1016/S0888-7543(03)00032-6; MARTIN KF, 1992, BRIT J PHARMACOL, V107, P15, DOI 10.1111/j.1476-5381.1992.tb14457.x; National Center for Health Statistics, 2007, HLTH US 2007 CHARTB; Neff CD, 2009, MOL PSYCHIATR, V14, P621, DOI 10.1038/mp.2008.8; Parks CL, 1998, P NATL ACAD SCI USA, V95, P10734, DOI 10.1073/pnas.95.18.10734; Parsey RV, 2006, NEUROPSYCHOPHARMACOL, V31, P1745, DOI 10.1038/sj.npp.1300992; PORSOLT RD, 1977, ARCH INT PHARMACOD T, V229, P327; Ramboz S, 1998, P NATL ACAD SCI USA, V95, P14476, DOI 10.1073/pnas.95.24.14476; Rattiner LM, 2004, LEARN MEMORY, V11, P727, DOI 10.1101/lm.83304; Ressler KJ, 2002, J NEUROSCI, V22, P7892; Riad N, 2000, J COMP NEUROL, V417, P181, DOI 10.1002/(SICI)1096-9861(20000207)417:2<181::AID-CNE4>3.0.CO;2-A; Rush AJ, 2006, AM J PSYCHIAT, V163, P1905, DOI 10.1176/appi.ajp.163.11.1905; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Schatzberg AF, 2009, AMERICAN PSYCHIATRIC PUBLISHING TEXTBOOK OF PSYCHOPHARMACOLOGY, 4TH EDITION, P1; Scott MM, 2005, P NATL ACAD SCI USA, V102, P16472, DOI 10.1073/pnas.0504510102; Strobel A, 2003, J NEURAL TRANSM, V110, P1445, DOI 10.1007/s00702-003-0072-0; Van Bogaert M, 2006, EUR J PHARMACOL, V550, P84, DOI 10.1016/j.ejphar.2006.08.058; VANDERMAELEN CP, 1983, BRAIN RES, V289, P109, DOI 10.1016/0006-8993(83)90011-2; Wang JW, 2008, J NEUROSCI, V28, P1374, DOI 10.1523/JNEUROSCI.3632-07.2008; Weisstaub NV, 2006, SCIENCE, V313, P536, DOI 10.1126/science.1123432; Wellman CL, 2007, J NEUROSCI, V27, P684, DOI 10.1523/JNEUROSCI.4595-06.2007	65	315	331	0	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 14	2010	65	1					40	52		10.1016/j.neuron.2009.12.003	http://dx.doi.org/10.1016/j.neuron.2009.12.003			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	546DZ	20152112	Green Accepted, Bronze			2022-12-24	WOS:000273791200007
J	Zagoraiou, L; Akay, T; Martin, JF; Brownstone, RM; Jessell, TM; Miles, GB				Zagoraiou, Laskaro; Akay, Turgay; Martin, James F.; Brownstone, Robert M.; Jessell, Thomas M.; Miles, Gareth B.			A Cluster of Cholinergic Premotor Interneurons Modulates Mouse Locomotor Activity	NEURON			English	Article							RAT SPINAL-CORD; IN-VITRO; FICTIVE LOCOMOTION; V2-DERIVED INTERNEURONS; POSTNATAL-DEVELOPMENT; LUMBAR MOTONEURONS; HB9 INTERNEURONS; HINDLIMB MUSCLE; C-TERMINALS; NEURONS	Mammalian motor programs are controlled by networks of spinal interneurons that set the rhythm and intensity of motor neuron firing. Motor neurons have long been known to receive prominent "C bouton" cholinergic inputs from spinal interneurons, but the source and function of these synaptic inputs have remained obscure. We show here that the transcription factor Pitx2 marks a small cluster of spinal cholinergic interneurons, V0(C) neurons, that represents the sole source of C bouton inputs to motor neurons. The activity of these cholinergic interneurons is tightly phase locked with motor neuron bursting during fictive locomotor activity, suggesting a role in the modulation of motor neuron firing frequency. Genetic inactivation of the output of these neurons impairs a locomotor task-dependent increase in motor neuron firing and muscle activation. Thus, V0(C) interneurons represent a defined class of spinal cholinergic interneurons with an intrinsic neuromodulatory role in the control of locomotor behavior.	[Zagoraiou, Laskaro; Akay, Turgay; Jessell, Thomas M.] Columbia Univ, Howard Hughes Med Inst, Kavli Inst Brain Sci, Dept Neurosci, New York, NY 10032 USA; [Zagoraiou, Laskaro; Akay, Turgay; Jessell, Thomas M.] Columbia Univ, Howard Hughes Med Inst, Kavli Inst Brain Sci, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Martin, James F.] Texas A&M Syst Hlth Sci Ctr, Inst Biosci & Technol, Houston, TX 77030 USA; [Brownstone, Robert M.] Dalhousie Univ, Inst Neurosci, Dept Surg, Halifax, NS B3H 1X5, Canada; [Brownstone, Robert M.] Dalhousie Univ, Inst Neurosci, Dept Anat & Neurobiol, Halifax, NS B3H 1X5, Canada; [Miles, Gareth B.] Univ St Andrews, Sch Biol, St Andrews KY16 9TS, Fife, Scotland	Columbia University; Howard Hughes Medical Institute; Columbia University; Howard Hughes Medical Institute; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Dalhousie University; Dalhousie University; University of St Andrews	Jessell, TM (corresponding author), Columbia Univ, Howard Hughes Med Inst, Kavli Inst Brain Sci, Dept Neurosci, New York, NY 10032 USA.	tmj1@columbia.edu		Miles, Gareth/0000-0002-8624-4625; Akay, Turgay/0000-0002-0466-2285; Brownstone, Robert/0000-0001-5135-2725	BBSRC UK; Project A.L.S.; Medical Research Scotland; NIH [R01 DE/HD12324, DE16329, RO1 NS33245]; Harold and Leila Mathers Foundation; Wellcome Trust; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE012324] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE016329] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033245] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BB/E019803/1] Funding Source: researchfish; BBSRC [BB/E019803/1] Funding Source: UKRI	BBSRC UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Project A.L.S.; Medical Research Scotland; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harold and Leila Mathers Foundation; Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We are grateful to Staceyann Doobar, Elizabeth Hwang, Qiaolian Liu, and Natasha Permaul for technical assistance; Barbara Han, Monica Mendelsohn, Jennifer Kirkland, and Susan Kales for help in the generation and upkeep of mice; and Susan Morton for antibody generation. We thank Lieven van der Veken for pseudorabies virus tracing, Silvia Arber for the Tau.lsl.mGFP line, Joshua Sanes for the ChAT<SUP>fl/fl</SUP> line, Alessandra Pierani for advice on Dbx1::Cre mice, Tord Hjalt for an aliquot of anti-Pitx2 antibody, and Apostolos Klinakis for DNA constructs. Frederic Bretzner, Christopher Henderson, John Martin, Joriene de Nooij, Sebastian Poliak, Victor Rafuse, and Keith Sillar provided helpful comments on the manuscript. L.Z. was supported by a Helen Hay Whitney Foundation Fellowship. T.A. is an HHMI research specialist. R.M.B. is supported by grants from ProjectALS and the Canadian Institutes of Health Research. G.B.M. is supported by grants from BBSRC UK, Project A.L.S., and Medical Research Scotland. J.F.M. is supported by NIH grants R01 DE/HD12324 and DE16329. T.M.J. is supported by grants from Project ALS, The Harold and Leila Mathers Foundation, The Wellcome Trust, NIH RO1 NS33245, and is an HHMI Investigator.	Akay T, 2006, J NEUROPHYSIOL, V96, P642, DOI 10.1152/jn.00174.2006; Al-Mosawie A, 2007, EUR J NEUROSCI, V26, P3003, DOI 10.1111/j.1460-9568.2007.05907.x; Alvarez FJ, 2005, J COMP NEUROL, V493, P177, DOI 10.1002/cne.20711; Alvarez FJ, 2007, J PHYSIOL-LONDON, V584, P31, DOI 10.1113/jphysiol.2007.136200; Banfield BW, 2003, J VIROL, V77, P10106, DOI 10.1128/JVI.77.18.10106-10112.2003; Bannatyne BA, 2009, J PHYSIOL-LONDON, V587, P379, DOI 10.1113/jphysiol.2008.159129; BARBER RP, 1984, J COMP NEUROL, V229, P329, DOI 10.1002/cne.902290305; Bareyre FM, 2005, NAT MED, V11, P1355, DOI 10.1038/nm1331; Bennett BD, 2000, J NEUROSCI, V20, P8493, DOI 10.1523/JNEUROSCI.20-22-08493.2000; Betley JN, 2009, CELL, V139, P161, DOI 10.1016/j.cell.2009.08.027; Bielle F, 2005, NAT NEUROSCI, V8, P1002, DOI 10.1038/nn1511; BROWNSTONE RM, 1992, EXP BRAIN RES, V90, P441; Brownstone RM, 2008, BRAIN RES REV, V57, P64, DOI 10.1016/j.brainresrev.2007.06.025; Buffelli M, 2003, NATURE, V424, P430, DOI 10.1038/nature01844; Butt SJB, 2005, P NATL ACAD SCI USA, V102, P14098, DOI 10.1073/pnas.0503317102; Butt SJB, 2003, NEURON, V38, P953, DOI 10.1016/S0896-6273(03)00353-2; Butt SJB, 2002, J NEUROSCI, V22, P9961; Cattaert D, 1995, J PHYSIOL-PARIS, V89, P209, DOI 10.1016/0928-4257(96)83637-0; Cazalets JR, 1996, J NEUROSCI, V16, P298; Chattopadhyaya B, 2007, NEURON, V54, P889, DOI 10.1016/j.neuron.2007.05.015; Conradi S, 1969, Acta Physiol Scand Suppl, V333, P5; COWLEY KC, 1994, NEUROSCI LETT, V171, P147, DOI 10.1016/0304-3940(94)90626-2; Crone SA, 2008, NEURON, V60, P70, DOI 10.1016/j.neuron.2008.08.009; Dasen JS, 2009, CURR TOP DEV BIOL, V88, P169, DOI 10.1016/S0070-2153(09)88006-X; Dasen JS, 2005, CELL, V123, P477, DOI 10.1016/j.cell.2005.09.009; DELEON R, 1994, BRAIN RES, V654, P241, DOI 10.1016/0006-8993(94)90485-5; Fagiolini M, 2000, NATURE, V404, P183, DOI 10.1038/35004582; Fetcho JR, 2008, BRAIN RES REV, V57, P86, DOI 10.1016/j.brainresrev.2007.06.018; Gillis GB, 2001, J EXP BIOL, V204, P2717; Giocomo LM, 2007, MOL NEUROBIOL, V36, P184, DOI 10.1007/s12035-007-0032-z; Goulding M, 2009, NAT REV NEUROSCI, V10, P507, DOI 10.1038/nrn2608; Grillner S, 2006, NEURON, V52, P751, DOI 10.1016/j.neuron.2006.11.008; Hanson MG, 2003, J NEUROSCI, V23, P587, DOI 10.1523/JNEUROSCI.23-02-00587.2003; Hellstrom J, 1999, J COMP NEUROL, V411, P578; Hellstrom J, 2003, J COMP NEUROL, V460, P476, DOI 10.1002/cne.10648; HELLSTROM J, 2004, THESIS KAROLINSKA I; Herrero JL, 2008, NATURE, V454, P1110, DOI 10.1038/nature07141; Hinckley CA, 2005, J NEUROPHYSIOL, V93, P1439, DOI 10.1152/jn.00647.2004; Hippenmeyer S, 2005, PLOS BIOL, V3, P878, DOI 10.1371/journal.pbio.0030159; Hochman S, 1998, J NEUROPHYSIOL, V79, P743, DOI 10.1152/jn.1998.79.2.743; Huang A, 2000, J NEUROPHYSIOL, V83, P3537, DOI 10.1152/jn.2000.83.6.3537; HUTCHISON DL, 1989, BRAIN RES, V502, P233, DOI 10.1016/0006-8993(89)90618-5; Jankowska E, 2001, J PHYSIOL-LONDON, V533, P31, DOI 10.1111/j.1469-7793.2001.0031b.x; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Jiang ZY, 1999, BRAIN RES, V816, P493, DOI 10.1016/S0006-8993(98)01199-8; Jordan LM, 2008, BRAIN RES REV, V57, P183, DOI 10.1016/j.brainresrev.2007.07.019; Joshua M, 2008, J NEUROSCI, V28, P11673, DOI 10.1523/JNEUROSCI.3839-08.2008; Katz PS, 1995, CURR OPIN NEUROBIOL, V5, P799, DOI 10.1016/0959-4388(95)80109-X; Kjaerulff O, 1996, J NEUROSCI, V16, P5777; Krieger P, 1998, EUR J NEUROSCI, V10, P3333, DOI 10.1046/j.1460-9568.1998.00337.x; Kwan AC, 2009, J NEUROSCI, V29, P11601, DOI 10.1523/JNEUROSCI.1612-09.2009; LAGERBACK PA, 1981, BRAIN RES, V207, P247, DOI 10.1016/0006-8993(81)90363-2; Lanuza GM, 2004, NEURON, V42, P375, DOI 10.1016/S0896-6273(04)00249-1; Lawrence JJ, 2008, TRENDS NEUROSCI, V31, P317, DOI 10.1016/j.tins.2008.03.008; LI W, 1995, NEUROSCIENCE, V65, P879, DOI 10.1016/0306-4522(94)00511-3; Li YW, 1998, CLIN EXP PHARMACOL P, V25, P468, DOI 10.1111/j.1440-1681.1998.tb02237.x; Liu J, 2009, J NEUROPHYSIOL, V102, P337, DOI 10.1152/jn.91239.2008; Liu W, 2003, DEVELOPMENT, V130, P6375, DOI 10.1242/dev.00849; Lundfald L, 2007, EUR J NEUROSCI, V26, P2989, DOI 10.1111/j.1460-9568.2007.05906.x; Machacek DW, 2006, J NEUROSCI, V26, P5920, DOI 10.1523/JNEUROSCI.4623-05.2006; Maskos U, 2005, NATURE, V436, P103, DOI 10.1038/nature03694; MASUKO S, 1986, J NEUROSCI, V6, P3229; McCrea DA, 2008, BRAIN RES REV, V57, P134, DOI 10.1016/j.brainresrev.2007.08.006; MCHANWELL S, 1981, PHILOS T ROY SOC B, V293, P477, DOI 10.1098/rstb.1981.0082; MCLAUGHLIN BJ, 1972, J COMP NEUROL, V144, P475, DOI 10.1002/cne.901440406; Mena-Segovia J, 2008, BRAIN RES REV, V58, P265, DOI 10.1016/j.brainresrev.2008.02.003; Miles GB, 2007, P NATL ACAD SCI USA, V104, P2448, DOI 10.1073/pnas.0611134104; Misgeld T, 2002, NEURON, V36, P635, DOI 10.1016/S0896-6273(02)01020-6; Mizuguchi R, 2006, NAT NEUROSCI, V9, P770, DOI 10.1038/nn1706; Moran-Rivard L, 2001, NEURON, V29, P385, DOI 10.1016/S0896-6273(01)00213-6; Muennich EAL, 2004, J PHYSIOL-LONDON, V554, P673, DOI 10.1113/jphysiol.2003.056192; Myers CP, 2005, NEURON, V46, P37, DOI 10.1016/j.neuron.2005.02.022; NAGY JI, 1993, SYNAPSE, V15, P17, DOI 10.1002/syn.890150103; Nicholson LFB, 2001, CELL BIOL INT, V25, P351, DOI 10.1006/cbir.2000.0638; ORSAL D, 1986, EXP BRAIN RES, V64, P217; Pauli WM, 2008, BRAIN RES, V1202, P43, DOI 10.1016/j.brainres.2007.06.097; Pearson KG, 2005, J NEUROSCI METH, V148, P36, DOI 10.1016/j.jneumeth.2005.04.006; Peng CY, 2007, NEURON, V53, P813, DOI 10.1016/j.neuron.2007.02.019; PHELPS PE, 1984, J COMP NEUROL, V229, P347, DOI 10.1002/cne.902290306; Pierani A, 2001, NEURON, V29, P367, DOI 10.1016/S0896-6273(01)00212-4; Polgar E, 2007, EUR J NEUROSCI, V26, P1587, DOI 10.1111/j.1460-9568.2007.05793.x; Quinlan KA, 2004, J NEUROPHYSIOL, V92, P1536, DOI 10.1152/jn.01053.2003; Roberts A, 2008, BRAIN RES REV, V57, P22, DOI 10.1016/j.brainresrev.2007.06.015; ROY RR, 1985, BRAIN RES, V337, P175, DOI 10.1016/0006-8993(85)91627-0; Sapir T, 2004, J NEUROSCI, V24, P1255, DOI 10.1523/JNEUROSCI.3187-03.2004; Semina EV, 1996, NAT GENET, V14, P392, DOI 10.1038/ng1296-392; SHEFCHYK SJ, 1985, J NEUROPHYSIOL, V54, P1101, DOI 10.1152/jn.1985.54.5.1101; Smith BN, 2000, P NATL ACAD SCI USA, V97, P9264, DOI 10.1073/pnas.97.16.9264; Stacy RC, 2005, J NEUROSCI, V25, P9347, DOI 10.1523/JNEUROSCI.1800-05.2005; VanderHorst VGJM, 2006, J CHEM NEUROANAT, V31, P2, DOI 10.1016/j.jchemneu.2005.08.003; Wang ZF, 2006, NEURON, V50, P443, DOI 10.1016/j.neuron.2006.04.010; Wess J, 2003, TRENDS PHARMACOL SCI, V24, P414, DOI 10.1016/S0165-6147(03)00195-0; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; WILLIS WD, 1971, BRAIN BEHAV EVOLUT, V4, P5, DOI 10.1159/000125422; Wilson JM, 2005, J NEUROSCI, V25, P5710, DOI 10.1523/JNEUROSCI.0274-05.2005; Wilson JM, 2004, J COMP NEUROL, V474, P13, DOI 10.1002/cne.20089; Winkowski DE, 2008, NEURON, V60, P698, DOI 10.1016/j.neuron.2008.09.013	97	276	278	1	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 10	2009	64	5					645	662		10.1016/j.neuron.2009.10.017	http://dx.doi.org/10.1016/j.neuron.2009.10.017			18	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	537OW	20005822	Green Submitted, Bronze, Green Accepted			2022-12-24	WOS:000273123700011
J	Scholz, J; Klein, MC; Behrens, TEJ; Johansen-Berg, H				Scholz, Jan; Klein, Miriam C.; Behrens, Timothy E. J.; Johansen-Berg, Heidi			Training induces changes in white-matter architecture	NATURE NEUROSCIENCE			English	Article							VISUAL-CORTEX; MYELINATION; SKILLS; RAT	Although experience-dependent structural changes have been found in adult gray matter, there is little evidence for such changes in white matter. Using diffusion imaging, we detected a localized increase in fractional anisotropy, a measure of microstructure, in white matter underlying the intraparietal sulcus following training of a complex visuo-motor skill. This provides, to the best of our knowledge, the first evidence for training-related changes in white-matter structure in the healthy human adult brain.	[Scholz, Jan; Klein, Miriam C.; Behrens, Timothy E. J.; Johansen-Berg, Heidi] Oxford Ctr Funct Magnet Resonance Imaging Brain, Oxford, England; [Klein, Miriam C.; Behrens, Timothy E. J.] Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England	University of Oxford; University of Oxford	Scholz, J (corresponding author), Oxford Ctr Funct Magnet Resonance Imaging Brain, Oxford, England.	jscholz@fmrib.ox.ac.uk	Kennedy, Kristen M/B-4699-2008	Kennedy, Kristen M/0000-0001-5373-9026; Behrens, Timothy/0000-0003-0048-1177; Johansen-Berg, Heidi/0000-0002-4134-9730; Klein-Flugge, Miriam/0000-0002-5156-9833	Wellcome Trust; UK Medical Research Council; MRC [G0800578, G0501316] Funding Source: UKRI; Medical Research Council [G0501316, G0800578] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank J. Anderson, M. Jenkinson, G. Douaud and M. Woolrich for technical assistance, M. Rushworth for useful discussions on functional anatomy, R. Mars for providing additional control data, and M. Mangham for juggling support. We are grateful for financial support from the Wellcome Trust (H. J.- B. and J. S.) and the UK Medical Research Council (J. S. and T. E. J. B.).	Beaulieu C, 2009, DIFFUSION MRI: FROM QUANTITATIVE MEASUREMENT TO IN VIVO NEUROANATOMY, P105, DOI 10.1016/B978-0-12-374709-9.00006-7; Bengtsson SL, 2005, NAT NEUROSCI, V8, P1148, DOI 10.1038/nn1516; Dancause N, 2005, J NEUROSCI, V25, P10167, DOI 10.1523/JNEUROSCI.3256-05.2005; Demerens C, 1996, P NATL ACAD SCI USA, V93, P9887, DOI 10.1073/pnas.93.18.9887; Draganski B, 2004, NATURE, V427, P311, DOI 10.1038/427311a; Draganski B, 2006, J NEUROSCI, V26, P6314, DOI 10.1523/JNEUROSCI.4628-05.2006; Driemeyer J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002669; Fields RD, 2008, TRENDS NEUROSCI, V31, P361, DOI 10.1016/j.tins.2008.04.001; Hihara S, 2006, NEUROPSYCHOLOGIA, V44, P2636, DOI 10.1016/j.neuropsychologia.2005.11.020; Ishibashi T, 2006, NEURON, V49, P823, DOI 10.1016/j.neuron.2006.02.006; Johansen-Berg H, 2007, NEUROIMAGE, V36, pT16, DOI 10.1016/j.neuroimage.2007.03.041; Tuch DS, 2005, P NATL ACAD SCI USA, V102, P12212, DOI 10.1073/pnas.0407259102; TURNER AM, 1985, BRAIN RES, V329, P195, DOI 10.1016/0006-8993(85)90525-6; VOLKMAR FR, 1972, SCIENCE, V176, P1445, DOI 10.1126/science.176.4042.1445	14	980	996	0	108	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2009	12	11					1370	1371		10.1038/nn.2412	http://dx.doi.org/10.1038/nn.2412			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	511UE	19820707	Green Accepted			2022-12-24	WOS:000271194100008
J	Rempe, DA; Takano, T; Nedergaard, M				Rempe, David A.; Takano, Takahiro; Nedergaard, Maiken			TR(I)Pping towards treatment for ischemia	NATURE NEUROSCIENCE			English	Editorial Material							HYDROGEN-PEROXIDE; MG2+ HOMEOSTASIS; TRPM7 CHANNELS; CELL-DEATH; CURRENTS; FLOW	A study in this issue found that suppressing expression of TRPM7 in hippocampal CA1 neurons conferred resistance to ischemic cell death, preserved cell function and prevented ischemia-induced deficits in memory.	[Rempe, David A.] Univ Rochester, Dept Neurol, Rochester, NY 14627 USA; [Takano, Takahiro; Nedergaard, Maiken] Univ Rochester, Dept Neurosurg, Rochester, NY USA	University of Rochester; University of Rochester	Rempe, DA (corresponding author), Univ Rochester, Dept Neurol, Rochester, NY 14627 USA.	david_rempe@urmc.rochester.edu; maiken_nedergaard@urmc.rochester.edu		Takano, Takahiro/0000-0002-6235-6673	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS050315] Funding Source: NIH RePORTER; NINDS NIH HHS [P01 NS050315] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aarts M, 2003, CELL, V115, P863, DOI 10.1016/S0092-8674(03)01017-1; Besancon E, 2008, TRENDS PHARMACOL SCI, V29, P268, DOI 10.1016/j.tips.2008.02.003; Bond CE, 2007, GLIA, V55, P1348, DOI 10.1002/glia.20547; Fonfria E, 2005, J NEUROCHEM, V95, P715, DOI 10.1111/j.1471-4159.2005.03396.x; Gerzanich V, 2009, NAT MED, V15, P185, DOI 10.1038/nm.1899; Jin J, 2008, SCIENCE, V322, P756, DOI 10.1126/science.1163493; Kraft R, 2004, AM J PHYSIOL-CELL PH, V286, pC129, DOI 10.1152/ajpcell.00331.2003; Krapivinsky G, 2006, NEURON, V52, P485, DOI 10.1016/j.neuron.2006.09.033; McNulty S, 2005, PFLUG ARCH EUR J PHY, V451, P235, DOI 10.1007/s00424-005-1440-4; Nilius B, 2005, PFLUG ARCH EUR J PHY, V451, P1, DOI 10.1007/s00424-005-1462-y; Oancea E, 2006, CIRC RES, V98, P245, DOI 10.1161/01.RES.0000200179.29375.cc; Olah ME, 2009, J PHYSIOL-LONDON, V587, P965, DOI 10.1113/jphysiol.2008.162289; Reading SA, 2007, STROKE, V38, P2322, DOI 10.1161/STROKEAHA.107.483404; Schmitz C, 2003, CELL, V114, P191, DOI 10.1016/S0092-8674(03)00556-7; Sun HS, 2009, NAT NEUROSCI, V12, P1300, DOI 10.1038/nn.2395	15	8	9	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2009	12	10					1215	1216		10.1038/nn1009-1215	http://dx.doi.org/10.1038/nn1009-1215			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	498US	19783978				2022-12-24	WOS:000270170200005
J	Crowley, JJ; Fioravante, D; Regehr, WG				Crowley, John J.; Fioravante, Diasynou; Regehr, Wade G.			Dynamics of Fast and Slow Inhibition from Cerebellar Golgi Cells Allow Flexible Control of Synaptic Integration	NEURON			English	Article							GRANULE CELLS; RAT CEREBELLUM; GABA(A) RECEPTORS; GABAERGIC INTERNEURONS; MOSSY FIBER; MEDIATED TRANSMISSION; NEURONAL-ACTIVITY; PONTINE NUCLEI; SYNAPSES; HIPPOCAMPUS	Throughout the brain, multiple interneuron types influence distinct aspects of synaptic processing. Interneuron diversity can thereby promote differential firing from neurons receiving common excitation. In contrast, Golgi cells are the sole interneurons regulating granule cell spiking evoked by mossy fibers, thereby gating inputs to the cerebellar cortex. Here, we examine how this single interneuron class modifies activity in its targets. We find that GABA(A)-mediated transmission at unitary Golgi cell --> granule cell synapses consists of varying contributions of fast synaptic currents and sustained inhibition. Fast IPSCs depress and slow IPSCs gradually build during high-frequency Golgi cell activity. Consequently, fast and slow inhibition differentially influence granule cell spike timing during persistent mossy fiber input. Furthermore, slow inhibition reduces the gain of the mossy fiber --> granule cell input-output curve, while fast inhibition increases the threshold. Thus, a lack of interneuron diversity need not prevent flexible inhibitory control of synaptic processing.	[Crowley, John J.; Fioravante, Diasynou; Regehr, Wade G.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Regehr, WG (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, 220 Longwood Ave, Boston, MA 02115 USA.	wade_regehr@hms.harvard.edu			NIH [R37 NS032405]; HMS Neurobiology [T32NS007484]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007484, R37NS032405, R01NS032405] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HMS Neurobiology; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Miklos Antal, Aaron Best, Megan Carey, Court Hull, Andreas Liu, Michael Myoga, and Todd Pressler for comments on the manuscript. We thank Bernardo Sabatini and his laboratory for assistance with the preparation of lentivirus. This work was supported by NIH grant R37 NS032405 (W.G.R.) and the HMS Neurobiology training grant T32NS007484 (J.J.C.).	AITKIN LM, 1978, HEARING RES, V1, P67, DOI 10.1016/0378-5955(78)90010-2; Bacci A, 2003, J NEUROSCI, V23, P9664; Balakrishnan V, 2009, NAT NEUROSCI, V12, P286, DOI 10.1038/nn.2265; Banks MI, 2000, NEURON, V25, P449, DOI 10.1016/S0896-6273(00)80907-1; Best AR, 2009, NEURON, V62, P555, DOI 10.1016/j.neuron.2009.04.018; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Brickley SG, 1996, J PHYSIOL-LONDON, V497, P753, DOI 10.1113/jphysiol.1996.sp021806; Brickley SG, 2001, NATURE, V409, P88, DOI 10.1038/35051086; Cathala L, 2000, J NEUROSCI, V20, P5899, DOI 10.1523/JNEUROSCI.20-16-05899.2000; Chance FS, 2002, NEURON, V35, P773, DOI 10.1016/S0896-6273(02)00820-6; COBB SR, 1995, NATURE, V378, P75, DOI 10.1038/378075a0; Dieudonne S, 1998, J PHYSIOL-LONDON, V510, P845, DOI 10.1111/j.1469-7793.1998.845bj.x; DiGregorio DA, 2002, NEURON, V35, P521, DOI 10.1016/S0896-6273(02)00787-0; Dugue GP, 2005, J NEUROSCI, V25, P6490, DOI 10.1523/JNEUROSCI.1500-05.2005; Dugue GP, 2009, NEURON, V61, P126, DOI 10.1016/j.neuron.2008.11.028; Eccles JC, 1967, CEREBELLUM NEURONAL; Farrant M, 2003, NEUROPHARMACOLOGY, V44, P181, DOI 10.1016/S0028-3908(02)00363-5; Forti L, 2006, J PHYSIOL-LONDON, V574, P711, DOI 10.1113/jphysiol.2006.110858; Freeman JH, 2003, LEARN MEMORY, V10, P337, DOI 10.1101/lm.63703; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Geurts FJ, 2001, NEUROSCIENCE, V104, P499, DOI 10.1016/S0306-4522(01)00058-6; Glickfeld LL, 2006, NAT NEUROSCI, V9, P807, DOI 10.1038/nn1688; Glykys J, 2007, NEURON, V56, P763, DOI 10.1016/j.neuron.2007.11.002; Glykys J, 2007, J PHYSIOL-LONDON, V582, P1163, DOI 10.1113/jphysiol.2007.134460; Gupta A, 2000, SCIENCE, V287, P273, DOI 10.1126/science.287.5451.273; Hamann M, 2002, NEURON, V33, P625, DOI 10.1016/S0896-6273(02)00593-7; HAMORI J, 1983, J COMP NEUROL, V220, P365, DOI 10.1002/cne.902200402; Hefft S, 2005, NAT NEUROSCI, V8, P1319, DOI 10.1038/nn1542; Holtzman T, 2006, J PHYSIOL-LONDON, V577, P69, DOI 10.1113/jphysiol.2006.117218; JAKAB RL, 1988, ANAT EMBRYOL, V179, P81, DOI 10.1007/BF00305102; KANEDA M, 1995, J PHYSIOL-LONDON, V485, P419, DOI 10.1113/jphysiol.1995.sp020739; Klausberger T, 2003, NATURE, V421, P844, DOI 10.1038/nature01374; KORPI ER, 1995, MOL PHARMACOL, V47, P283; Lu T, 2000, NEURON, V26, P683, DOI 10.1016/S0896-6273(00)81204-0; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; McBain CJ, 2001, NAT REV NEUROSCI, V2, P11, DOI 10.1038/35049047; Medina JF, 2000, CURR OPIN NEUROBIOL, V10, P717, DOI 10.1016/S0959-4388(00)00154-9; Miles R, 1996, NEURON, V16, P815, DOI 10.1016/S0896-6273(00)80101-4; Mitchell SJ, 2000, NATURE, V404, P498, DOI 10.1038/35006649; Mitchell SJ, 2003, NEURON, V38, P433, DOI 10.1016/S0896-6273(03)00200-9; Mitchell SJ, 2000, J NEUROSCI, V20, P8651; Neki A, 1996, NEUROSCIENCE, V75, P815, DOI 10.1016/0306-4522(96)00316-8; Nielsen TA, 2004, NEURON, V42, P757, DOI 10.1016/j.neuron.2004.04.003; Nusser Z, 1998, J NEUROSCI, V18, P1693; NUSSER Z, 1995, J NEUROSCI, V15, P2948; OTTERSEN OP, 1988, BRAIN RES, V450, P342, DOI 10.1016/0006-8993(88)91573-9; Palay S. L., 1974, CEREBELLAR CORTEX CY; Park JB, 2007, J PHYSIOL-LONDON, V582, P539, DOI 10.1113/jphysiol.2007.133223; Payne JA, 1997, AM J PHYSIOL-CELL PH, V273, pC1516, DOI 10.1152/ajpcell.1997.273.5.C1516; Pouille F, 2001, SCIENCE, V293, P1159, DOI 10.1126/science.1060342; Pouille F, 2004, NATURE, V429, P717, DOI 10.1038/nature02615; Price CJ, 2005, J NEUROSCI, V25, P6775, DOI 10.1523/JNEUROSCI.1135-05.2005; Rossi DJ, 1998, NEURON, V20, P783, DOI 10.1016/S0896-6273(00)81016-8; Rossi DJ, 2003, J PHYSIOL-LONDON, V548, P97, DOI 10.1113/jphysiol.2002.036459; Rothman JS, 2009, NATURE, V457, P1015, DOI 10.1038/nature07604; Sceniak MP, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-8; Silver RA, 1996, J PHYSIOL-LONDON, V494, P231, DOI 10.1113/jphysiol.1996.sp021487; Simat M, 2007, J COMP NEUROL, V500, P71, DOI 10.1002/cne.21142; Somogyi P, 2005, J PHYSIOL-LONDON, V562, P9, DOI 10.1113/jphysiol.2004.078915; Szabadics J, 2007, P NATL ACAD SCI USA, V104, P14831, DOI 10.1073/pnas.0707204104; Tamas G, 2003, SCIENCE, V299, P1902, DOI 10.1126/science.1082053; VANKAN PLE, 1993, J NEUROPHYSIOL, V69, P74, DOI 10.1152/jn.1993.69.1.74; Vogels TP, 2009, NAT NEUROSCI, V12, P483, DOI 10.1038/nn.2276; Vos BP, 1999, EUR J NEUROSCI, V11, P2621, DOI 10.1046/j.1460-9568.1999.00678.x; Wall MJ, 2002, NEUROPHARMACOLOGY, V43, P737, DOI 10.1016/S0028-3908(02)00085-0; Wall MJ, 1997, EUR J NEUROSCI, V9, P533, DOI 10.1111/j.1460-9568.1997.tb01630.x; Watanabe D, 1998, CELL, V95, P17, DOI 10.1016/S0092-8674(00)81779-1; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116; Xu-Friedman MA, 2003, J NEUROSCI, V23, P2182	69	55	55	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 24	2009	63	6					843	853		10.1016/j.neuron.2009.09.004	http://dx.doi.org/10.1016/j.neuron.2009.09.004			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	503VP	19778512	Green Accepted, Bronze			2022-12-24	WOS:000270569700016
J	Saab, BJ; Georgiou, J; Nath, A; Lee, FJS; Wang, M; Michalon, A; Liu, F; Mansuy, IM; Roder, JC				Saab, Bechara J.; Georgiou, John; Nath, Arup; Lee, Frank J. S.; Wang, Min; Michalon, Aubin; Liu, Fang; Mansuy, Isabelle M.; Roder, John C.			NCS-1 in the Dentate Gyrus Promotes Exploration, Synaptic Plasticity, and Rapid Acquisition of Spatial Memory	NEURON			English	Article							LONG-TERM POTENTIATION; NEURONAL CALCIUM SENSOR-1; D2 DOPAMINE-RECEPTOR; PATTERN SEPARATION; PREFRONTAL CORTEX; BINDING-PROTEIN; NMDA RECEPTORS; HIPPOCAMPUS; RAT; CA3	The molecular underpinnings of exploration and its link to learning and memory remain poorly understood. Here we show that inducible, modest overexpression of neuronal calcium sensor 1 (Ncs1) selectively in the adult murine dentate gyrus (DG) promotes a specific form of exploratory behavior. The mice also display a selective facilitation of long-term potentiation (LTP) in the medial perforant path and a selective enhancement in rapid-acquisition spatial memory, phenotypes that are reversed by direct application of a cell-permeant peptide (DNIP) designed to interfere with NCS-1 binding to the dopamine type-2 receptor (D2R). Moreover, the DNIP and the D2R-selective antagonist L-741,626 attenuated exploratory behavior, DG LTP, and spatial memory in control mice. These data demonstrate a role for NCS-1 and D2R in DG plasticity and provide insight for understanding how the DG contributes to the origin of exploration and spatial memory acquisition.	[Saab, Bechara J.; Georgiou, John; Nath, Arup; Roder, John C.] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Saab, Bechara J.; Roder, John C.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Roder, John C.] Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada; [Lee, Frank J. S.; Wang, Min; Liu, Fang] Ctr Addict & Mental Hlth, Clarke Div, Dept Neurosci, Toronto, ON M5T 1R8, Canada; [Michalon, Aubin] Univ Bordeaux, Ctr Neurosci Integrat & Cognit, Bordeaux, France; [Mansuy, Isabelle M.] Univ Zurich, Brain Res Inst, Swiss Fed Inst Technol, CH-8057 Zurich, Switzerland	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; UDICE-French Research Universities; Universite de Bordeaux; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich	Saab, BJ (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada.	saab@lunenfeld.ca	Lee, Frank J.S./D-5899-2017; Mansuy, Isabelle M/N-3042-2015; Georgiou, John/ABA-1687-2020; Roder, John/G-6468-2013; Georgiou, John/E-9873-2013	Lee, Frank J.S./0000-0002-5768-3776; Mansuy, Isabelle M/0000-0001-7785-5371; Georgiou, John/0000-0003-4503-6384; Georgiou, John/0000-0003-4503-6384; Michalon, Aubin/0000-0002-5246-4881; Saab, Bechara/0000-0003-1673-129X	CIHR [MOP-13239, CTP-79858]	CIHR(Canadian Institutes of Health Research (CIHR))	We are indebted to Shenna A. Josselyn, Roderick McInnes, Robert Gerlai and Karine Nader for excellent advice on the manuscript. This work was funded by a grant through the CIHR (MOP-13239 and CTP-79858). B.J.S. holds a CIHR doctoral research award. J.G. holds a NARSAD Young Investigator Award. A.N. holds a SLRI Summer Student Fellowship. J.C.R. holds a Tier One CRC Chair in Learning and Memory.	Abe K, 2008, NEUROPHARMACOLOGY, V55, P1419, DOI 10.1016/j.neuropharm.2008.09.005; Armstrong NJ, 2006, MAMM GENOME, V17, P273, DOI 10.1007/s00335-005-0123-y; Bakker A, 2008, SCIENCE, V319, P1640, DOI 10.1126/science.1152882; Barry C, 2006, REV NEUROSCIENCE, V17, P71; Berke JD, 2000, NEURON, V25, P515, DOI 10.1016/S0896-6273(00)81056-9; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Bramham CR, 1996, J NEUROSCI, V16, P8123; Burgoyne RD, 2007, NAT REV NEUROSCI, V8, P182, DOI 10.1038/nrn2093; Cain SW, 2008, NEUROBIOL LEARN MEM, V89, P591, DOI 10.1016/j.nlm.2007.07.011; Clapcote SJ, 2007, NEURON, V54, P387, DOI 10.1016/j.neuron.2007.04.015; Coukell B, 2004, DEV GROWTH DIFFER, V46, P449; Coulter DA, 2007, PROG BRAIN RES, V163, P235, DOI 10.1016/S0079-6123(07)63014-3; Genin A, 2001, NEUROSCIENCE, V106, P571, DOI 10.1016/S0306-4522(01)00301-3; Gerdeman GL, 2003, TRENDS NEUROSCI, V26, P184, DOI 10.1016/S0166-2236(03)00065-1; Gomez M, 2001, NEURON, V30, P241, DOI 10.1016/S0896-6273(01)00276-8; Goodrich-Hunsaker NJ, 2008, BEHAV NEUROSCI, V122, P16, DOI 10.1037/0735-7044.122.1.16; Guo WN, 2002, J BIOL CHEM, V277, P26436, DOI 10.1074/jbc.M201431200; HANSE E, 1992, EUR J NEUROSCI, V4, P1191, DOI 10.1111/j.1460-9568.1992.tb00144.x; Henderson JT, 2001, NEURON, V32, P1041, DOI 10.1016/S0896-6273(01)00553-0; HETHERINGTON PA, 1990, SEQUENTIAL LEARNING; Hilfiker S, 2003, BIOCHEM SOC T, V31, P828, DOI 10.1042/BST0310828; Hui K, 2007, DEVELOPMENT, V134, P4479, DOI 10.1242/dev.008979; Jo J, 2008, NEURON, V60, P1095, DOI 10.1016/j.neuron.2008.10.050; JOYCE JN, 1993, NEUROSCI LETT, V154, P171, DOI 10.1016/0304-3940(93)90199-U; Kabbani N, 2006, NEUROREPORT, V17, P299, DOI 10.1097/01.wnr.0000199460.24412.04; Kabbani N, 2002, J NEUROSCI, V22, P8476; Kandel Eric. R., 2006, SEARCH MEMORY EMERGE; Kellendonk C, 2006, NEURON, V49, P603, DOI 10.1016/j.neuron.2006.01.023; Kesner RP, 2007, PROG BRAIN RES, V163, P567, DOI 10.1016/S0079-6123(07)63030-1; Kesner RP, 2007, LEARN MEMORY, V14, P771, DOI 10.1101/lm.688207; Kesner RP, 2004, REV NEUROSCIENCE, V15, P333; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Koh PO, 2003, P NATL ACAD SCI USA, V100, P313, DOI 10.1073/pnas.232693499; Korz V, 2007, LEARN MEMORY, V14, P160, DOI 10.1101/lm.459807; KOVACS GL, 1979, BRAIN RES, V175, P303, DOI 10.1016/0006-8993(79)91009-6; Kumaran D, 2007, HIPPOCAMPUS, V17, P735, DOI 10.1002/hipo.20326; Lee FJS, 2002, CELL, V111, P219, DOI 10.1016/S0092-8674(02)00962-5; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Leutgeb JK, 2007, SCIENCE, V315, P961, DOI 10.1126/science.1135801; Lever C, 2006, REV NEUROSCIENCE, V17, P111; Malleret G, 2001, CELL, V104, P675, DOI 10.1016/S0092-8674(01)00264-1; Man HY, 2000, NEURON, V25, P649, DOI 10.1016/S0896-6273(00)81067-3; Manahan-Vaughan D, 2003, CEREB CORTEX, V13, P123, DOI 10.1093/cercor/13.2.123; MARR D, 1971, PHILOS T ROY SOC B, V262, P23, DOI 10.1098/rstb.1971.0078; McHugh TJ, 2007, SCIENCE, V317, P94, DOI 10.1126/science.1140263; MCNAUGHTON BL, 1987, TRENDS NEUROSCI, V10, P408, DOI 10.1016/0166-2236(87)90011-7; MCNAUGHTON BL, 1980, BRAIN RES, V199, P1, DOI 10.1016/0006-8993(80)90226-7; Michalon A, 2005, GENESIS, V43, P205, DOI 10.1002/gene.20175; Mineur YS, 2002, HIPPOCAMPUS, V12, P39, DOI 10.1002/hipo.10005; Nakazawa K, 2004, NAT REV NEUROSCI, V5, P361, DOI 10.1038/nrn1385; OREILLY RC, 1994, HIPPOCAMPUS, V4, P661, DOI 10.1002/hipo.450040605; PONGS O, 1993, NEURON, V11, P15, DOI 10.1016/0896-6273(93)90267-U; Rick JT, 1996, HIPPOCAMPUS, V6, P118; Saab BJ, 2007, HYPOTHESIS, V5, P23; SANDNER G, 1987, PHYSIOL BEHAV, V39, P333, DOI 10.1016/0031-9384(87)90231-9; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; Setlow B, 2000, LEARN MEMORY, V7, P187, DOI 10.1101/lm.7.3.187; Sigala S, 1997, EUR J PHARMACOL, V336, P107, DOI 10.1016/S0014-2999(97)01235-1; SILVEIRA MCL, 1992, BEHAV NEURAL BIOL, V57, P226, DOI 10.1016/0163-1047(92)90192-7; Souza Bruno R, 2006, Dialogues Clin Neurosci, V8, P95; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; TIEDTKE PI, 1990, J NEURAL TRANSM-GEN, V81, P173, DOI 10.1007/BF01245040; Tsujimoto T, 2002, SCIENCE, V295, P2276, DOI 10.1126/science.1068278; Valentinuzzi VS, 2008, NEUROBIOL LEARN MEM, V89, P604, DOI 10.1016/j.nlm.2007.08.002; Wang CY, 2001, NEURON, V32, P99, DOI 10.1016/S0896-6273(01)00434-2; Weinshenker D, 2008, NATURE, V455, P607, DOI 10.1038/455607a; Wilkerson A, 1999, NEUROSCIENCE, V89, P743, DOI 10.1016/S0306-4522(98)00346-7	67	137	145	1	23	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	SEP 10	2009	63	5					643	656		10.1016/j.neuron.2009.08.014	http://dx.doi.org/10.1016/j.neuron.2009.08.014			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	494XH	19755107	Bronze			2022-12-24	WOS:000269852300011
J	Field, GD; Greschner, M; Gauthier, JL; Rangel, C; Shlens, J; Sher, A; Marshak, DW; Litke, AM; Chichilnisky, EJ				Field, Greg D.; Greschner, Martin; Gauthier, Jeffrey L.; Rangel, Carolina; Shlens, Jonathon; Sher, Alexander; Marshak, David W.; Litke, Alan M.; Chichilnisky, E. J.			High-sensitivity rod photoreceptor input to the blue-yellow color opponent pathway in macaque retina	NATURE NEUROSCIENCE			English	Article							GANGLION-CELLS; PRIMATE RETINA; RECEPTIVE-FIELD; SPECTRAL SENSITIVITY; SPATIAL PROPERTIES; LIGHT ADAPTATION; AMACRINE CELLS; CATS RETINA; S-CONE; DISCRIMINATION	Small bistratified cells (SBCs) in the primate retina carry a major blue-yellow opponent signal to the brain. We found that SBCs also carry signals from rod photoreceptors, with the same sign as S cone input. SBCs exhibited robust responses under low scotopic conditions. Physiological and anatomical experiments indicated that this rod input arose from the AII amacrine cell-mediated rod pathway. Rod and cone signals were both present in SBCs at mesopic light levels. These findings have three implications. First, more retinal circuits may multiplex rod and cone signals than were previously thought to, efficiently exploiting the limited number of optic nerve fibers. Second, signals from AII amacrine cells may diverge to most or all of the similar to 20 retinal ganglion cell types in the peripheral primate retina. Third, rod input to SBCs may be the substrate for behavioral biases toward perception of blue at mesopic light levels.	[Field, Greg D.; Greschner, Martin; Gauthier, Jeffrey L.; Shlens, Jonathon; Chichilnisky, E. J.] Salk Inst Biol Studies, La Jolla, CA 92037 USA; [Rangel, Carolina; Marshak, David W.] Univ Texas Houston, Sch Med, Dept Neurobiol & Anat, Houston, TX 77225 USA; [Shlens, Jonathon] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Sher, Alexander; Litke, Alan M.] Univ Calif Santa Cruz, Santa Cruz Inst Particle Phys, Santa Cruz, CA 95064 USA	Salk Institute; University of Texas System; University of Texas Health Science Center Houston; University of California System; University of California Berkeley; University of California System; University of California Santa Cruz	Field, GD (corresponding author), Salk Inst Biol Studies, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	gfield@salk.edu	Field, Greg/AAI-1428-2021	Field, Greg/0000-0001-5942-2679; Chichilnisky, E.J./0000-0002-5613-0248; Gauthier, Jeffrey/0000-0002-0509-8532; Sher, Alexander/0000-0001-6655-6456	National Science Foundation [05253071, 0438741, PHY-0750525]; Helen Hay Whitney Foundation; Deutsche Forschungsgemeinschaft; US National Institutes of Health National Research Service Award [NS054519-01, EY13150, EY06472, EY10608]; Chapman Foundation; Miller Institute for Basic Research in Science; University of California at Berkeley; Burroughs Wellcome Fund Career Award at Scientific Interface; McKnight Foundation; Sloan Research Fellowship; NATIONAL EYE INSTITUTE [P30EY010608, R01EY006472, R01EY013150] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS054519] Funding Source: NIH RePORTER; Division Of Physics [0750525] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Helen Hay Whitney Foundation; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); US National Institutes of Health National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chapman Foundation; Miller Institute for Basic Research in Science; University of California at Berkeley; Burroughs Wellcome Fund Career Award at Scientific Interface(Burroughs Wellcome Fund); McKnight Foundation; Sloan Research Fellowship(Alfred P. Sloan Foundation); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Division Of Physics(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We thank C. K. Hulse for technical assistance; M. I. Grivich, D. Petrusca, W. Dabrowski, A. Grillo, P. Grybos, P. Hottowy and S. Kachiguine for technical development; H. Fox, M. Taffe, E. Callaway and K. Osborn for providing access to retinas; H. Wassle and J. O'Brien for providing antibodies; and S. Barry for machining. We thank the San Diego Supercomputer Center and the National Science Foundation ( Cooperative Agreements 05253071 and 0438741) for large-scale data storage. This work was supported by the Helen Hay Whitney Foundation ( G. D. F.), Deutsche Forschungsgemeinschaft ( M. G.), a US National Institutes of Health National Research Service Award (NS054519-01), the Chapman Foundation ( J. L. G.), the Miller Institute for Basic Research in Science, the University of California at Berkeley ( J. S.), a Burroughs Wellcome Fund Career Award at Scientific Interface ( A. S.), the McKnight Foundation ( A. M. L. and E. J. C.), National Science Foundation grant PHY-0750525 ( A. M. L.), a Sloan Research Fellowship and US National Institutes of Health grants EY13150 ( E. J. C.), EY06472 ( D. W. M.) and EY10608 ( D. W. M.).	BARLOW HB, 1957, J PHYSIOL-LONDON, V137, P338, DOI 10.1113/jphysiol.1957.sp005817; BAYLOR DA, 1984, J PHYSIOL-LONDON, V357, P575, DOI 10.1113/jphysiol.1984.sp015518; BAYLOR DA, 1987, J PHYSIOL-LONDON, V390, P145, DOI 10.1113/jphysiol.1987.sp016691; Bloomfield SA, 2001, PROG RETIN EYE RES, V20, P351, DOI 10.1016/S1350-9462(00)00031-8; Buck S. L., 2004, VISUAL NEUROSCIENCES, V1, P863; Buck SL, 2000, VISION RES, V40, P3333, DOI 10.1016/S0042-6989(00)00191-7; Calkins DJ, 1998, J NEUROSCI, V18, P3373; Cao D, 2008, VISUAL NEUROSCI, V25, P399, DOI 10.1017/S0952523808080425; Cao DC, 2008, VISION RES, V48, P2586, DOI 10.1016/j.visres.2008.05.001; Chichilnisky EJ, 1999, NAT NEUROSCI, V2, P889, DOI 10.1038/13189; Chichilnisky EJ, 2001, NETWORK-COMP NEURAL, V12, P199, DOI 10.1088/0954-898X/12/2/306; CLELAND BG, 1974, J PHYSIOL-LONDON, V240, P457, DOI 10.1113/jphysiol.1974.sp010618; COHEN E, 1990, PHILOS T R SOC B, V330, P305, DOI 10.1098/rstb.1990.0201; Dacey D, 2004, COGNITIVE NEUROSCIENCES III, THIRD EDITION, P281; Dacey DM, 2005, NATURE, V433, P749, DOI 10.1038/nature03387; DACEY DM, 1994, NATURE, V367, P731, DOI 10.1038/367731a0; Dacey DM, 2003, CURR OPIN NEUROBIOL, V13, P421, DOI 10.1016/S0959-4388(03)00103-X; Dunn FA, 2007, NATURE, V449, P603, DOI 10.1038/nature06150; Field GD, 2007, ANNU REV NEUROSCI, V30, P1, DOI 10.1146/annurev.neuro.30.051606.094252; Field GD, 2005, ANNU REV PHYSIOL, V67, P491, DOI 10.1146/annurev.physiol.67.031103.151256; Field GD, 2007, J NEUROSCI, V27, P13261, DOI 10.1523/JNEUROSCI.3437-07.2007; GOURAS P, 1966, J PHYSIOL-LONDON, V184, P499, DOI 10.1113/jphysiol.1966.sp007928; Grunert U, 1997, EUR J NEUROSCI, V9, P617, DOI 10.1111/j.1460-9568.1997.tb01638.x; Hornstein EP, 2005, J NEUROSCI, V25, P11201, DOI 10.1523/JNEUROSCI.3416-05.2005; Jacoby RA, 2000, J COMP NEUROL, V416, P19, DOI 10.1002/(SICI)1096-9861(20000103)416:1<19::AID-CNE3>3.0.CO;2-H; Knight R, 1998, VISION RES, V38, P3477, DOI 10.1016/S0042-6989(97)00414-8; KOLB H, 1974, SCIENCE, V186, P47, DOI 10.1126/science.186.4158.47; Lee BB, 1997, VISION RES, V37, P2813, DOI 10.1016/S0042-6989(97)00108-9; Litke AM, 2004, IEEE T NUCL SCI, V51, P1434, DOI 10.1109/TNS.2004.832706; Lyubarsky AL, 2004, VISION RES, V44, P3235, DOI 10.1016/j.visres.2004.09.019; MARSHAK DW, 1990, J NEUROSCI, V10, P3045; Masland RH, 2001, NAT NEUROSCI, V4, P877, DOI 10.1038/nn0901-877; Mills SL, 2001, J COMP NEUROL, V436, P336; MULLER F, 1988, J NEUROPHYSIOL, V59, P1657, DOI 10.1152/jn.1988.59.6.1657; Murphy GJ, 2006, NEURON, V52, P511, DOI 10.1016/j.neuron.2006.09.014; PEICHL L, 1983, J PHYSIOL-LONDON, V341, P309, DOI 10.1113/jphysiol.1983.sp014807; Petrides A, 2008, J COMP NEUROL, V507, P1653, DOI 10.1002/cne.21617; Rodieck R.W., 1998, 1 STEPS SEEING; Schein S, 2004, J NEUROSCI, V24, P8366, DOI 10.1523/JNEUROSCI.1063-04.2004; SCHNAPF JL, 1990, J PHYSIOL-LONDON, V427, P681, DOI 10.1113/jphysiol.1990.sp018193; Sharpe LT, 1999, TRENDS NEUROSCI, V22, P497, DOI 10.1016/S0166-2236(99)01458-7; SLAUGHTER MM, 1981, SCIENCE, V211, P182, DOI 10.1126/science.6255566; Szmajda BA, 2008, J COMP NEUROL, V510, P251, DOI 10.1002/cne.21783; Troy JB, 1999, VISUAL NEUROSCI, V16, P1089, DOI 10.1017/S0952523899166094; Veruki ML, 2002, J NEUROSCI, V22, P10558; VIRSU V, 1983, J NEUROPHYSIOL, V50, P864, DOI 10.1152/jn.1983.50.4.864; Volgyi B, 2004, J NEUROSCI, V24, P11182, DOI 10.1523/JNEUROSCI.3096-04.2004; VONKRIES J, 1896, Z PSYCH PHYSL SINNES, V12, P1; WASSLE H, 1995, J COMP NEUROL, V361, P537, DOI 10.1002/cne.903610315; WIESEL TN, 1966, J NEUROPHYSIOL, V29, P1115, DOI 10.1152/jn.1966.29.6.1115	50	79	79	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2009	12	9					1159	U20		10.1038/nn.2353	http://dx.doi.org/10.1038/nn.2353			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	487ZD	19668201	Green Published, Green Accepted			2022-12-24	WOS:000269317300018
J	Genovesio, A; Tsujimoto, S; Wise, SP				Genovesio, Aldo; Tsujimoto, Satoshi; Wise, Steven P.			Feature- and Order-Based Timing Representations in the Frontal Cortex	NEURON			English	Article							DURATION-DISCRIMINATION TASK; MONKEY PREFRONTAL NEURONS; TIME PERCEPTION; ELAPSED TIME; TEMPORAL INFORMATION; STIMULUS-DURATION; BRAIN ACTIVATION; PREMOTOR CORTEX; WORKING-MEMORY; BASAL GANGLIA	We examined activity in the frontal cortex as monkeys performed a duration-discrimination task. Two stimuli, one red and the other blue, appeared sequentially on a video screen-in either order. Later, both stimuli reappeared, and to receive a reward the monkeys had to choose the stimulus that had lasted longer during its initial presentation. Some neurons encoded stimulus duration, but a larger number of cells represented their relative duration, which was encoded in three ways: whether the first or second stimulus had lasted longer; whether the red or blue stimulus had lasted longer; or, less commonly, as the difference between the two durations. As the monkeys' choice approached, the signal encoding which stimulus (red or blue) had lasted longer increased as the order-based signal dissipated. By representing stimulus durations and relative durations-both bound to Stimulus features and event order-the frontal cortex could contribute to both temporal perception and episodic memory.	[Genovesio, Aldo; Tsujimoto, Satoshi; Wise, Steven P.] NIMH, Lab Syst Neurosci, Bethesda, MD 20892 USA; [Genovesio, Aldo] Univ Rome, Dept Physiol & Pharmacol, I-00185 Rome, Italy; [Tsujimoto, Satoshi] Kobe Univ, Grad Sch Human Dev & Environm, Dev Cognit Neurosci Lab, Kobe, Hyogo 6578501, Japan	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Sapienza University Rome; Kobe University	Genovesio, A (corresponding author), NIMH, Lab Syst Neurosci, Bethesda, MD 20892 USA.	aldo.genovesio@uniroma1.it	Tsujimoto, Satoshi/B-8223-2011	Genovesio, Aldo/0000-0003-2521-143X	Division of Intramural Research of the National Institute of Mental Health [Z01MH-01092]; NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002878, Z01MH001092] Funding Source: NIH RePORTER	Division of Intramural Research of the National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the Division of Intramural Research of the National Institute of Mental Health (Z01MH-01092). We thank Dr. Andrew Mitz, Mr. James Fellows, and Ms. Ping Yu for technical support.	Battellil L, 2008, CURR OPIN NEUROBIOL, V18, P120, DOI 10.1016/j.conb.2008.08.004; Brasted PJ, 2003, BRAIN, V126, P1202, DOI 10.1093/brain/awg103; Brody CD, 2003, CEREB CORTEX, V13, P1196, DOI 10.1093/cercor/bhg100; Charles DP, 2004, J NEUROSCI, V24, P2037, DOI 10.1523/JNEUROSCI.3796-03.2004; Chiba A, 2008, EXP BRAIN RES, V186, P671, DOI 10.1007/s00221-008-1347-3; Coull JT, 2004, SCIENCE, V303, P1506, DOI 10.1126/science.1091573; Durstewitz D, 2004, NEUROREPORT, V15, P745, DOI 10.1097/00001756-200404090-00001; Duysens J, 1996, VISION RES, V36, P3243, DOI 10.1016/0042-6989(96)00040-5; Genovesio A, 2006, J NEUROPHYSIOL, V95, P3281, DOI 10.1152/jn.01011.2005; Gibbon J., 1984, TIMING TIME PERCEPTI, P52; GREEN CG, 1966, SIGNAL DETECTION THE; Hanakawa T, 2002, CEREB CORTEX, V12, P1157, DOI 10.1093/cercor/12.11.1157; Harrington DL, 1998, NEUROPSYCHOLOGY, V12, P3, DOI 10.1037/0894-4105.12.1.3; Ivry RB, 2008, TRENDS COGN SCI, V12, P273, DOI 10.1016/j.tics.2008.04.002; Janssen P, 2005, NAT NEUROSCI, V8, P234, DOI 10.1038/nn1386; Lebedev MA, 2001, EUR J NEUROSCI, V13, P1002, DOI 10.1046/j.0953-816x.2001.01457.x; Lebedev MA, 2008, J NEUROPHYSIOL, V99, P166, DOI 10.1152/jn.00734.2007; Lejeune H, 1997, NEUROSCI LETT, V235, P21, DOI 10.1016/S0304-3940(97)00698-8; Leon MI, 2003, NEURON, V38, P317, DOI 10.1016/S0896-6273(03)00185-5; Lucchetti C, 2001, EXP BRAIN RES, V141, P254, DOI 10.1007/s002210100818; Maimon G, 2006, NAT NEUROSCI, V9, P948, DOI 10.1038/nn1716; Mangels JA, 1998, COGNITIVE BRAIN RES, V7, P15, DOI 10.1016/S0926-6410(98)00005-6; Maquet P, 1996, NEUROIMAGE, V3, P119, DOI 10.1006/nimg.1996.0014; Mita A, 2009, NAT NEUROSCI, V12, P502, DOI 10.1038/nn.2272; Nenadic I, 2003, EXP BRAIN RES, V148, P238, DOI 10.1007/s00221-002-1188-4; NIKI H, 1979, BRAIN RES, V171, P213, DOI 10.1016/0006-8993(79)90328-7; Ninokura Y, 2004, J NEUROPHYSIOL, V91, P555, DOI 10.1152/jn.00694.2003; Ohmae S, 2008, EXP BRAIN RES, V184, P593, DOI 10.1007/s00221-007-1234-3; Onoe H, 2001, NEUROIMAGE, V13, P37, DOI 10.1006/nimg.2000.0670; Oshio KI, 2006, EUR J NEUROSCI, V23, P2779, DOI 10.1111/j.1460-9568.2006.04781.x; Oshio K, 2008, EUR J NEUROSCI, V28, P2333, DOI 10.1111/j.1460-9568.2008.06509.x; Rao SM, 2001, NAT NEUROSCI, V4, P317, DOI 10.1038/85191; Reutimann J, 2004, J NEUROSCI, V24, P3295, DOI 10.1523/JNEUROSCI.4098-03.2004; Roux S, 2003, EUR J NEUROSCI, V18, P1011, DOI 10.1046/j.1460-9568.2003.02792.x; Sakurai Y, 2004, EUR J NEUROSCI, V20, P1069, DOI 10.1111/j.1460-9568.2004.03525.x; Tsujimoto S, 2007, NEUROREPORT, V18, P703, DOI 10.1097/WNR.0b013e3280d943a1	36	74	74	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	JUL 30	2009	63	2					254	266		10.1016/j.neuron.2009.06.018	http://dx.doi.org/10.1016/j.neuron.2009.06.018			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	479IS	19640483	Green Accepted, Bronze			2022-12-24	WOS:000268653500013
J	Goldman, N; Chen, M; Fujita, T; Xu, QW; Peng, WG; Liu, W; Jensen, TK; Pei, Y; Wang, FS; Han, XN; Chen, JF; Schnermann, J; Takano, T; Bekar, L; Tieu, K; Nedergaard, M				Goldman, Nanna; Chen, Michael; Fujita, Takumi; Xu, Qiwu; Peng, Weiguo; Liu, Wei; Jensen, Tina K.; Pei, Yong; Wang, Fushun; Han, Xiaoning; Chen, Jiang-Fan; Schnermann, Jurgen; Takano, Takahiro; Bekar, Lane; Tieu, Kim; Nedergaard, Maiken			Adenosine A1 receptors mediate local anti-nociceptive effects of acupuncture	NATURE NEUROSCIENCE			English	Article							PROSTATIC ACID-PHOSPHATASE; ADENOSINE A(1) RECEPTOR; TUBULOGLOMERULAR FEEDBACK; INFLAMMATORY PAIN; CINGULATE CORTEX; DORSAL-HORN; SPINAL-CORD; MICE; RAT; ELECTROACUPUNCTURE	Acupuncture is an invasive procedure commonly used to relieve pain. Acupuncture is practiced worldwide, despite difficulties in reconciling its principles with evidence-based medicine. We found that adenosine, a neuromodulator with anti-nociceptive properties, was released during acupuncture in mice and that its anti-nociceptive actions required adenosine A1 receptor expression. Direct injection of an adenosine A1 receptor agonist replicated the analgesic effect of acupuncture. Inhibition of enzymes involved in adenosine degradation potentiated the acupuncture-elicited increase in adenosine, as well as its anti-nociceptive effect. These observations indicate that adenosine mediates the effects of acupuncture and that interfering with adenosine metabolism may prolong the clinical benefit of acupuncture.	[Goldman, Nanna; Chen, Michael; Fujita, Takumi; Xu, Qiwu; Peng, Weiguo; Liu, Wei; Jensen, Tina K.; Pei, Yong; Wang, Fushun; Han, Xiaoning; Takano, Takahiro; Bekar, Lane; Tieu, Kim; Nedergaard, Maiken] Univ Rochester, Med Ctr, Ctr Translat Neuromed, Rochester, NY 14642 USA; [Chen, Jiang-Fan] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Schnermann, Jurgen] NIDDKD, US Natl Inst Hlth, Bethesda, MD USA	University of Rochester; Boston University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Nedergaard, M (corresponding author), Univ Rochester, Med Ctr, Ctr Translat Neuromed, Rochester, NY 14642 USA.	nedergaard@urmc.rochester.edu	Tieu, Kim/F-5426-2012; Bekar, Lane K./AAI-2645-2021; Tieu, Kim/AAG-7336-2019	Tieu, Kim/0000-0001-6606-4371; Tieu, Kim/0000-0001-6606-4371; Chen, Jiang-Fan/0000-0002-0446-3956; Bekar, Lane/0000-0001-5083-0967; Takano, Takahiro/0000-0002-6235-6673	US National Institutes of Health; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES017470, R01ES014899] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS075177] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by a grant from the US National Institutes of Health to M.N. and K.T.	Abbracchio MP, 2009, TRENDS NEUROSCI, V32, P19, DOI 10.1016/j.tins.2008.10.001; Bekar L, 2008, NAT MED, V14, P75, DOI 10.1038/nm1693; Bonafede M, 2008, MED CARE, V46, P41, DOI 10.1097/MLR.0b013e3181589b7d; Burnstock G, 2007, PHYSIOL REV, V87, P659, DOI 10.1152/physrev.00043.2006; Burnstock G, 2009, MED HYPOTHESES, V73, P470, DOI 10.1016/j.mehy.2009.05.031; Castrop H, 2004, J CLIN INVEST, V114, P634, DOI 10.1172/JCI200421851; Chen JF, 1999, J NEUROSCI, V19, P9192, DOI 10.1523/jneurosci.19-21-09192.1999; Cui M, 2010, J BIOL CHEM, V285, P11740, DOI 10.1074/jbc.M109.066662; CULLITON BJ, 1972, SCIENCE, V177, P592, DOI 10.1126/science.177.4049.592; CUNHA RA, 1991, EUR J PHARMACOL, V197, P83, DOI 10.1016/0014-2999(91)90368-Z; Davis KD, 1997, J NEUROPHYSIOL, V77, P3370, DOI 10.1152/jn.1997.77.6.3370; Eisenach JC, 2004, J PAIN, V5, P64, DOI 10.1016/j.jpain.2003.10.001; Fredholm BB, 2007, CELL DEATH DIFFER, V14, P1315, DOI 10.1038/sj.cdd.4402132; Fredholm BB, 2001, PHARMACOL REV, V53, P527; GOLEMBIOWSKA K, 1995, BRAIN RES, V699, P315, DOI 10.1016/0006-8993(95)00926-H; Han JS, 2004, NEUROSCI LETT, V361, P258, DOI 10.1016/j.neulet.2003.12.019; Huang C, 2002, BRAIN RES, V945, P20, DOI 10.1016/S0006-8993(02)02503-9; KARLSTEN R, 1992, Pharmacology and Toxicology, V70, P434; Kelly RB, 2009, AM FAM PHYSICIAN, V80, P481; Lamanna Nicole, 2009, Clin Adv Hematol Oncol, V7, P386; Lao LX, 2004, BRAIN RES, V1020, P18, DOI 10.1016/j.brainres.2004.01.092; Li JH, 2005, CIRCULATION, V111, P2748, DOI 10.1161/CIRCULATIONAHA.104.510669; Li JH, 2003, J APPL PHYSIOL, V95, P577, DOI 10.1152/japplphysiol.00185.2003; Li WM, 2005, JPN J PHYSIOL, V55, P339, DOI 10.2170/jjphysiol.RP001505; LOHSE MJ, 1988, N-S ARCH PHARMACOL, V337, P687; Maione S, 2007, PAIN, V131, P281, DOI 10.1016/j.pain.2007.01.013; Martucci C, 2008, PAIN, V137, P81, DOI 10.1016/j.pain.2007.08.017; POORTMANS JR, 2003, PRINCIPLES EXERCISE; Quintero IB, 2007, CANCER RES, V67, P6549, DOI 10.1158/0008-5472.CAN-07-1651; Raghavendra V, 2004, EUR J NEUROSCI, V20, P467, DOI 10.1111/j.1460-9568.2004.03514.x; Ramsay DJ, 1998, JAMA-J AM MED ASSOC, V280, P1518; REEVE AJ, 1995, NEUROSCI LETT, V194, P81, DOI 10.1016/0304-3940(95)11732-C; SALTER MW, 1987, NEUROSCIENCE, V22, P631, DOI 10.1016/0306-4522(87)90359-9; Sawynok J, 1998, EUR J PHARMACOL, V347, P1, DOI 10.1016/S0014-2999(97)01605-1; Sawynok J, 1998, PAIN, V74, P75, DOI 10.1016/S0304-3959(97)00153-X; Sichardt K, 2007, PURINERG SIGNAL, V3, P285, DOI 10.1007/s11302-007-9065-z; Sjolund KF, 1999, ANESTH ANALG, V88, P605, DOI 10.1097/00000539-199903000-00027; Sun DQ, 2001, P NATL ACAD SCI USA, V98, P9983, DOI 10.1073/pnas.171317998; Takakura Nobuari, 2009, Open Med, V3, pe54; Volonte MG, 2004, J PHARMACEUT BIOMED, V35, P647, DOI 10.1016/j.jpba.2004.02.002; Wei F, 2001, J PHYSIOL-LONDON, V532, P823, DOI 10.1111/j.1469-7793.2001.0823e.x; Weidenhammer W, 2007, CLIN J PAIN, V23, P128, DOI 10.1097/01.ajp.0000210952.09127.df; Zhao ZQ, 2008, PROG NEUROBIOL, V85, P355, DOI 10.1016/j.pneurobio.2008.05.004; Zijlstra FJ, 2003, MEDIAT INFLAMM, V12, P59, DOI 10.1080/0962935031000114943; Zylka MJ, 2008, NEURON, V60, P111, DOI 10.1016/j.neuron.2008.08.024	45	503	578	10	193	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2010	13	7					883	U130		10.1038/nn.2562	http://dx.doi.org/10.1038/nn.2562			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	615YF	20512135	Green Accepted			2022-12-24	WOS:000279173900022
J	Hines, JH; Abu-Rub, M; Henley, JR				Hines, Jacob H.; Abu-Rub, Mohammad; Henley, John R.			Asymmetric endocytosis and remodeling of beta(1)-integrin adhesions during growth cone chemorepulsion by MAG	NATURE NEUROSCIENCE			English	Article							MYELIN-ASSOCIATED GLYCOPROTEIN; NERVE GROWTH; INTEGRIN ENDOCYTOSIS; CELL-MIGRATION; RECEPTOR; MECHANISMS; INHIBITORS; EXPRESSION; TRANSPORT; GUIDANCE	Gradients of chemorepellent factors released from myelin may impair axon pathfinding and neuroregeneration after injury. We found that, analogously to the process of chemotaxis in invasive tumor cells, axonal growth cones of Xenopus spinal neurons modulate the functional distribution of integrin receptors during chemorepulsion induced by myelin-associated glycoprotein (MAG). A focal MAG gradient induced polarized endocytosis and concomitant asymmetric loss of beta(1)-integrin and vinculin-containing adhesions on the repellent side during repulsive turning. Loss of symmetrical beta(1)-integrin function was both necessary and sufficient for chemorepulsion, which required internalization by clathrin-mediated endocytosis. Induction of repulsive Ca2+ signals was necessary and sufficient for the stimulated rapid endocytosis of beta(1)-integrin. Altogether, these findings identify beta(1)-integrin as an important functional cargo during Ca2+-dependent rapid endocytosis stimulated by a diffusible guidance cue. Such dynamic redistribution allows the growth cone to rapidly adjust adhesiveness across its axis, an essential feature for initiating chemotactic turning.	[Abu-Rub, Mohammad; Henley, John R.] Mayo Clin, Dept Neurol Surg, Rochester, MN 55905 USA; [Hines, Jacob H.] Mayo Clin, Mayo Grad Sch, Rochester, MN USA; [Henley, John R.] Mayo Clin, Dept Physiol & Biomed Engn, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic	Henley, JR (corresponding author), Mayo Clin, Dept Neurol Surg, Rochester, MN 55905 USA.	henley.john@mayo.edu	Henley, John/D-7171-2011; Abu Rub, Mohammad/AAI-2255-2020	Hines, Jacob/0000-0003-1557-3795; Henley, John/0000-0003-1846-5941	Mayo Clinic; Craig Neilsen Foundation; Robert D. and Patricia E. Kern Predoctoral Fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS067311] Funding Source: NIH RePORTER	Mayo Clinic; Craig Neilsen Foundation; Robert D. and Patricia E. Kern Predoctoral Fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank K. Yamada (US National Institutes of Health), D. DeSimone (University of Virginia) and M. McNiven (Mayo Clinic) for generous gifts of antibodies to beta<INF>1</INF>-integrin, alpha<INF>5</INF>-integrin and dynamin (MC64 control rabbit IgG), respectively. The pFLAG-CMV2-AP180-C plasmid was from M. McNiven (Mayo Clinic) and the pCS2+RFP plasmid (Addgene) was from R. Moon (University of Washington). We also thank R. Muthu for assistance with beta<INF>1</INF> Fab purification; T. Gomez, B. Horazdovsky, C. Howe, M. McNiven, R. Pagano and members of the Henley group for critical comments; A. Windebank for sharing laboratory space at the beginning of these studies; and J. Tarara, S. Henle, E. Liang, J. Nesbitt, Z. Chen, B.-Y. Lin, V. Petrov and D. Triner for technical assistance. This work was supported by a John M. Nasseff, Sr., Career Development Award in Neurologic Surgery Research from the Mayo Clinic (J.R.H.) and career development funds from the Craig Neilsen Foundation (J.R.H.). A Robert D. and Patricia E. Kern Predoctoral Fellowship award supported J.H.H.	Akiyama H, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000196; Atwal JK, 2008, SCIENCE, V322, P967, DOI 10.1126/science.1161151; Bechara A, 2008, EMBO J, V27, P1549, DOI 10.1038/emboj.2008.86; Bonanomi D, 2008, J CELL SCI, V121, P3757, DOI 10.1242/jcs.033803; Caswell P, 2008, TRENDS CELL BIOL, V18, P257, DOI 10.1016/j.tcb.2008.03.004; CHENG TPO, 1985, J CELL BIOL, V101, P1473, DOI 10.1083/jcb.101.4.1473; Condic ML, 2001, J NEUROSCI, V21, P4782, DOI 10.1523/JNEUROSCI.21-13-04782.2001; Condic ML, 1997, NATURE, V389, P852, DOI 10.1038/39878; Conklin MW, 2005, DEV BIOL, V287, P201, DOI 10.1016/j.ydbio.2005.09.006; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Diefenbach TJ, 1999, J NEUROSCI, V19, P9436; Domeniconi M, 2002, NEURON, V35, P283, DOI 10.1016/S0896-6273(02)00770-5; Ezratty EJ, 2009, J CELL BIOL, V187, P733, DOI 10.1083/jcb.200904054; Filbin MT, 2008, NEURON, V60, P740, DOI 10.1016/j.neuron.2008.12.001; Fournier AE, 2000, J CELL BIOL, V149, P411, DOI 10.1083/jcb.149.2.411; GAILIT J, 1988, J BIOL CHEM, V263, P12927; Goh ELK, 2008, MOL BRAIN, V1, DOI 10.1186/1756-6606-1-10; Hanley JG, 2005, EMBO J, V24, P3266, DOI 10.1038/sj.emboj.7600801; Henley JR, 2004, NEURON, V44, P909, DOI 10.1016/j.neuron.2004.11.030; Hong K, 2000, NATURE, V403, P93, DOI 10.1038/47507; Jin M, 2005, J NEUROSCI, V25, P2338, DOI 10.1523/JNEUROSCI.4889-04.2005; Kamiguchi H, 2001, J NEUROSCI, V21, P9194, DOI 10.1523/JNEUROSCI.21-23-09194.2001; Leung KM, 2006, NAT NEUROSCI, V9, P1247, DOI 10.1038/nn1775; Liu BP, 2002, SCIENCE, V297, P1190, DOI 10.1126/science.1073031; LIU JP, 1994, SCIENCE, V265, P970, DOI 10.1126/science.8052858; Ming GI, 1999, NEURON, V23, P139, DOI 10.1016/S0896-6273(00)80760-6; Niederost B, 2002, J NEUROSCI, V22, P10368; Nishimura T, 2007, DEV CELL, V13, P15, DOI 10.1016/j.devcel.2007.05.003; Piper M, 2005, NAT NEUROSCI, V8, P179, DOI 10.1038/nn1380; Piper M, 2006, NEURON, V49, P215, DOI 10.1016/j.neuron.2005.12.008; Poinat P, 2002, CURR BIOL, V12, P622, DOI 10.1016/S0960-9822(02)00764-9; Robles E, 2006, NAT NEUROSCI, V9, P1274, DOI 10.1038/nn1762; Serini G, 2003, NATURE, V424, P391, DOI 10.1038/nature01784; Song HJ, 1998, SCIENCE, V281, P1515, DOI 10.1126/science.281.5382.1515; Stevens A, 2002, J NEUROSCI, V22, P4448, DOI 10.1523/JNEUROSCI.22-11-04448.2002; Sydor AM, 1996, J CELL BIOL, V134, P1197, DOI 10.1083/jcb.134.5.1197; Tang S, 1997, MOL CELL NEUROSCI, V9, P333, DOI 10.1006/mcne.1997.0633; Tojima T, 2007, NAT NEUROSCI, V10, P58, DOI 10.1038/nn1814; Tysseling-Mattiace VM, 2008, J NEUROSCI, V28, P3814, DOI 10.1523/JNEUROSCI.0143-08.2008; Wen ZX, 2007, J CELL BIOL, V178, P107, DOI 10.1083/jcb.200703055; Wong ST, 2002, NAT NEUROSCI, V5, P1302, DOI 10.1038/nn975; Woo S, 2006, J NEUROSCI, V26, P1418, DOI 10.1523/JNEUROSCI.4209-05.2006; Wu XS, 2009, NAT NEUROSCI, V12, P1003, DOI 10.1038/nn.2355; Yamashita T, 2002, J CELL BIOL, V157, P565, DOI 10.1083/jcb.200202010; Zhao XH, 2001, J CELL SCI, V114, P353; Zheng JQ, 2007, ANNU REV CELL DEV BI, V23, P375, DOI 10.1146/annurev.cellbio.23.090506.123221; Zheng JQ, 2000, NATURE, V403, P89, DOI 10.1038/47501; ZHENG JQ, 1994, NATURE, V368, P140, DOI 10.1038/368140a0	48	61	63	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2010	13	7					829	U68		10.1038/nn.2554	http://dx.doi.org/10.1038/nn.2554			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	615YF	20512137	Green Accepted			2022-12-24	WOS:000279173900015
J	Muller, FJ; Goldmann, J; Loser, P; Loring, JF				Mueller, Franz-Josef; Goldmann, Johanna; Loeser, Peter; Loring, Jeanne F.			A Call to Standardize Teratoma Assays Used to Define Human Pluripotent Cell Lines	CELL STEM CELL			English	Editorial Material							TERATOCARCINOMA	The teratoma assay is the gold standard for documenting pluripotency of human stem cells. However, reports of new human ESC and iPSC lines vary widely in both methods and analysis of teratoma data. We call for consensus standards to be established to make this assay worthy of its "golden" status.	[Mueller, Franz-Josef; Goldmann, Johanna; Loring, Jeanne F.] Scripps Res Inst, Dept Physiol Chem, Ctr Regenerat Med, La Jolla, CA 92037 USA; [Mueller, Franz-Josef] Zentrum Integrat Psychiat, D-24105 Kiel, Germany; [Loeser, Peter] Robert Koch Inst, D-13353 Berlin, Germany	Scripps Research Institute; Robert Koch Institute	Muller, FJ (corresponding author), Scripps Res Inst, Dept Physiol Chem, Ctr Regenerat Med, La Jolla, CA 92037 USA.	fj.mueller@zip.kiel.de; jloring@scripps.edu	Müller, Franz-Josef/E-3336-2010; Loring, Jeanne F/A-1620-2011	Müller, Franz-Josef/0000-0001-9478-8430; Loring, Jeanne F/0000-0001-6226-9767	Else Kroner-Fresenius-Stiftung; California Institute of Regenerative Medicine; NIH; Bill and Melinda Gates Foundation; O'Keeffe Foundation	Else Kroner-Fresenius-Stiftung; California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); O'Keeffe Foundation	F.-J.M. is supported by an Else Kroner-Fresenius-Stiftung fellowship, and J.F.L. by grants from the California Institute of Regenerative Medicine, the NIH, The Bill and Melinda Gates Foundation, and the O'Keeffe Foundation. We are in debt to Jacqueline Schirm and Steven Posselt for their help with database searches. Dr. Mana Parast helped us with expert advice on the histopathological assessment of teratoma tissue. We would also like to thank Anja Fritz and David Barker for helpful discussions. The authors are grateful to Louise Laurent, Suzanne Peterson, and Ha Tran for their intellectual input in the early planning of this manuscript.	BRADLEY A, 1984, NATURE, V309, P255, DOI 10.1038/309255a0; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Chan EM, 2009, NAT BIOTECHNOL, V27, P1033, DOI 10.1038/nbt.1580; Daley GQ, 2009, CELL STEM CELL, V4, P200, DOI 10.1016/j.stem.2009.02.009; Damjanov I, 2005, STEM CELL REV, V1, P273, DOI 10.1385/SCR:1:3:273; Ellis J, 2009, CELL STEM CELL, V4, P198, DOI 10.1016/j.stem.2009.02.010; Gertow K, 2007, CURR PROTOC STEM CEL; Loring JF, 2006, NEUROBIOL AGING, V27, P1084, DOI 10.1016/j.neurobiolaging.2005.06.014; Maherali N, 2008, CELL STEM CELL, V3, P595, DOI 10.1016/j.stem.2008.11.008	9	96	96	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAY 7	2010	6	5					412	414		10.1016/j.stem.2010.04.009	http://dx.doi.org/10.1016/j.stem.2010.04.009			3	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	598NO	20452314	Bronze			2022-12-24	WOS:000277844800007
J	Heng, JCD; Feng, B; Han, JY; Jiang, JM; Kraus, P; Ng, JH; Orlov, YL; Huss, M; Yang, L; Lufkin, T; Lim, B; Ng, HH				Heng, Jian-Chien Dominic; Feng, Bo; Han, Jianyong; Jiang, Jianming; Kraus, Petra; Ng, Jia-Hui; Orlov, Yuriy L.; Huss, Mikael; Yang, Lin; Lufkin, Thomas; Lim, Bing; Ng, Huck-Hui			The Nuclear Receptor Nr5a2 Can Replace Oct4 in the Reprogramming of Murine Somatic Cells to Pluripotent Cells	CELL STEM CELL			English	Article							STEM-CELLS; DOMAIN; LRH-1; MOUSE; MYC	Somatic cells can be reprogrammed to induced pluripotent stem cells (iPSGs) with the introduction of Oct4, Sox2, Klf4, and c-Myc. Among these four factors, Oct4 is critical in inducing pluripotency because no transcription factor can substitute for Oct4, whereas Sox2, Klf4, and c-Myc can be replaced by other factors. Here we show that the orphan nuclear receptor Nr5a2 (also known as Lrh-1) can replace Oct4 in the derivation of iPSCs from mouse somatic cells, and it can also enhance reprogramming efficiency. Sumoylation mutants of Nr5a2 with enhanced transcriptional activity can further increase reprogramming efficiency. Genome-wide location analysis reveals that Nr5a2 shares many common gene targets with Sox2 and Klf4, which suggests that the transcription factor trio works in concert to mediate reprogramming. We also show that Nr5a2 works in part through activating Nanog. Together, we show that unrelated transcription factors can replace Oct4 and uncovers an exogenous Oct4-free reprogramming code.	[Heng, Jian-Chien Dominic; Feng, Bo; Jiang, Jianming; Ng, Jia-Hui; Yang, Lin; Ng, Huck-Hui] Genome Inst Singapore, Gene Regulat Lab, Singapore 138672, Singapore; [Orlov, Yuriy L.; Huss, Mikael] Genome Inst Singapore, Computat & Syst Biol Grp, Singapore 138672, Singapore; [Heng, Jian-Chien Dominic; Ng, Jia-Hui; Ng, Huck-Hui] NUS, Grad Sch Integrat Sci & Engn, Singapore 117597, Singapore; [Lufkin, Thomas; Ng, Huck-Hui] Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore; [Lim, Bing] Harvard Univ, Sch Med, Ctr Life Sci, Boston, MA 02115 USA	Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); National University of Singapore; National University of Singapore; Harvard University; Harvard Medical School	Ng, HH (corresponding author), Genome Inst Singapore, Gene Regulat Lab, Singapore 138672, Singapore.	nghh@gis.a-star.edu.sg	Feng, Bo/D-7831-2014; Lufkin, Thomas/B-5352-2011; Orlov, Yuriy L/F-1520-2013; Ng, Huck Hui/A-1135-2009; Lufkin, Thomas/AAG-7476-2019; Kraus, Petra/I-5849-2014; jiang, jianming/B-3421-2012	Feng, Bo/0000-0002-4018-3257; Lufkin, Thomas/0000-0002-7902-4771; Orlov, Yuriy L/0000-0003-0587-1609; Lufkin, Thomas/0000-0002-7902-4771; Kraus, Petra/0000-0002-6716-5550; jiang, jianming/0000-0003-3251-2716; Huss, Mikael/0000-0003-0839-2451	Biomedical Research Council, Agency for Science, Technology and Research and Singapore Stem Cell Consortium; NUS Graduate School for Integrative Sciences and Engineering; A STAR	Biomedical Research Council, Agency for Science, Technology and Research and Singapore Stem Cell Consortium(Agency for Science Technology & Research (A*STAR)); NUS Graduate School for Integrative Sciences and Engineering(National University of Singapore); A STAR(Agency for Science Technology & Research (A*STAR))	We are grateful to the Biomedical Research Council, Agency for Science, Technology and Research and Singapore Stem Cell Consortium for funding. J.H. is supported by the NUS Graduate School for Integrative Sciences and Engineering Scholarship. J.-H.N. is supported by the A STAR graduate scholarship. We thank Xiangling Ng and Kuee-Theng Kuay for technical support and Meng-Chun Hu for plasmids. We acknowledge Valere Cacheux-Rataboul for karyotype analysis and GTB group for sequencing. We thank Andrew Hutchins and Felicia Huimei Hong for comments to the manuscript.	Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Feng B, 2009, CELL STEM CELL, V4, P301, DOI 10.1016/j.stem.2009.03.005; Feng B, 2009, NAT CELL BIOL, V11, P197, DOI 10.1038/ncb1827; Gu PL, 2005, MOL CELL BIOL, V25, P3492, DOI 10.1128/MCB.25.9.3492-3505.2005; Ichida JK, 2009, CELL STEM CELL, V5, P491, DOI 10.1016/j.stem.2009.09.012; Kim JB, 2009, NATURE, V461, P649, DOI 10.1038/nature08436; Lewitzky M, 2007, CURR OPIN BIOTECH, V18, P467, DOI 10.1016/j.copbio.2007.09.007; Maherali N, 2009, CURR BIOL, V19, P1718, DOI 10.1016/j.cub.2009.08.025; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Pare JF, 2004, J BIOL CHEM, V279, P21206, DOI 10.1074/jbc.M401523200; Sablin EP, 2003, MOL CELL, V11, P1575, DOI 10.1016/S1097-2765(03)00236-3; SCHOLER HR, 1990, NATURE, V344, P435, DOI 10.1038/344435a0; Silva J, 2009, CELL, V138, P722, DOI 10.1016/j.cell.2009.07.039; Solomon IH, 2005, J MOL BIOL, V354, P1091, DOI 10.1016/j.jmb.2005.10.009; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Wernig M, 2008, CELL STEM CELL, V2, P10, DOI 10.1016/j.stem.2007.12.001; Yang FM, 2009, FEBS J, V276, P425, DOI 10.1111/j.1742-4658.2008.06785.x; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	19	339	378	0	54	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	FEB 5	2010	6	2					167	174		10.1016/j.stem.2009.12.009	http://dx.doi.org/10.1016/j.stem.2009.12.009			8	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	555OC	20096661	Bronze			2022-12-24	WOS:000274520800011
J	Case, M; Soltesz, I				Case, Marianne; Soltesz, Ivan			Discreet Charm of the GABAergic Bourgeoisie: Superconnected Cells Conduct Developmental Symphonies	NEURON			English	Editorial Material							NETWORKS; SYNCHRONY; DIVERSITY	In an exciting study in the December 4(th) issue of Science, Bonifazi and colleagues demonstrated the existence and importance of exceedingly rare but unusually richly connected cells in the developing hippocampus. Manipulating the activity of single GABAergic hub cells modulated network activity patterns, demonstrating their importance for coordinating synchronous activity.	[Case, Marianne; Soltesz, Ivan] Univ Calif Irvine, Dept Anat & Neurobiol, Irvine, CA 92697 USA	University of California System; University of California Irvine	Case, M (corresponding author), Univ Calif Irvine, Dept Anat & Neurobiol, Irvine, CA 92697 USA.	marianne.case@uci.edu; isoltesz@hs.uci.edu		Bezaire, Marianne/0000-0001-6040-3520				Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Ben-Ari Y, 2001, TRENDS NEUROSCI, V24, P353, DOI 10.1016/S0166-2236(00)01813-0; Bonifazi P, 2009, SCIENCE, V326, P1419, DOI 10.1126/science.1175509; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Buzsaki G, 2004, TRENDS NEUROSCI, V27, P186, DOI 10.1016/j.tins.2004.02.007; Crepel V, 2007, NEURON, V54, P105, DOI 10.1016/j.neuron.2007.03.007; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Morgan RJ, 2008, P NATL ACAD SCI USA, V105, P6179, DOI 10.1073/pnas.0801372105; Nielsen T, 2001, J MICROSC-OXFORD, V201, P368, DOI 10.1046/j.1365-2818.2001.00852.x; Song S, 2005, PLOS BIOL, V3, P507, DOI 10.1371/journal.pbio.0030068; Yu S, 2008, CEREB CORTEX, V18, P2891, DOI 10.1093/cercor/bhn047	11	5	5	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	DEC 24	2009	64	6					780	782		10.1016/j.neuron.2009.12.013	http://dx.doi.org/10.1016/j.neuron.2009.12.013			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	541ON	20064385	Bronze			2022-12-24	WOS:000273425800005
J	Graf, ER; Daniels, RW; Burgess, RW; Schwarz, TL; DiAntonio, A				Graf, Ethan R.; Daniels, Richard W.; Burgess, Robert W.; Schwarz, Thomas L.; DiAntonio, Aaron			Rab3 Dynamically Controls Protein Composition at Active Zones	NEURON			English	Article							REGULATING NEUROTRANSMITTER RELEASE; DROSOPHILA NEUROMUSCULAR-JUNCTION; VESICULAR GLUTAMATE TRANSPORTER; TERM SYNAPTIC PLASTICITY; GTP-BINDING PROTEIN; IN-VIVO; CAENORHABDITIS-ELEGANS; GENETIC-ANALYSIS; LIPRIN-ALPHA; SMG P25A	Synaptic transmission requires the localization of presynaptic release machinery to active zones. Mechanisms regulating the abundance of such synaptic proteins at individual release sites are likely determinants of site-specific synaptic efficacy. We now identify a role for the small GTPase Rab3 in regulating the distribution of presynaptic components to active zones. At Drosophila rab3 mutant NMJs, the presynaptic protein Bruchpilot, calcium channels, and electron-dense T bars are concentrated at a fraction of available active zones, leaving the majority of sites devoid of these key presynaptic release components. Late addition of Rab3 to mutant NMJs rapidly reverses this phenotype by recruiting Brp to sites previously lacking the protein, demonstrating that Rab3 can dynamically control the composition of the presynaptic release machinery. While previous studies of Rab3 have focused on its role in the synaptic vesicle cycle, these findings demonstrate an additional and unexpected function for Rab3 in the localization of presynaptic proteins to active zones.	[Graf, Ethan R.; Daniels, Richard W.; DiAntonio, Aaron] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63110 USA; [Burgess, Robert W.] Jackson Lab, Bar Harbor, ME 04609 USA; [Schwarz, Thomas L.] Harvard Univ, Childrens Hosp, Boston, MA 02115 USA; [Schwarz, Thomas L.] Harvard Univ, Dept Neurobiol, Boston, MA 02115 USA	Washington University (WUSTL); Jackson Laboratory; Harvard University; Boston Children's Hospital; Harvard University	DiAntonio, A (corresponding author), Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63110 USA.	diantonio@wustl.edu		DiAntonio, Aaron/0000-0002-7262-0968; Burgess, Robert/0000-0002-9229-3407	NIH [F32 NS056765, NS043171]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS056765, R01NS043171] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We wish to thank members of the DiAntonio lab for helpful discussions and Xiaolu Sun and Howard Wynder for technical assistance. We also thank Stephan Sigrist, Barry Ganetzky, Haig Keshishian, and Nicholas Harden for gifts of fly strains and antibodies. E.R.G. was supported by NIH training grant F32 NS056765. This work was supported by a grant from the NIH (NS043171) to A.D.	Albin SD, 2004, J NEUROSCI, V24, P6871, DOI 10.1523/JNEUROSCI.1538-04.2004; ARAKI S, 1990, J BIOL CHEM, V265, P13007; ATWOOD HL, 1993, J NEUROBIOL, V24, P1008, DOI 10.1002/neu.480240803; Bellen HJ, 2004, GENETICS, V167, P761, DOI 10.1534/genetics.104.026427; BRAND AH, 1993, DEVELOPMENT, V118, P401; Dai Y, 2006, NAT NEUROSCI, V9, P1479, DOI 10.1038/nn1808; Daniels RW, 2008, J COMP NEUROL, V508, P131, DOI 10.1002/cne.21670; Daniels RW, 2006, NEURON, V49, P11, DOI 10.1016/j.neuron.2005.11.032; Daniels RW, 2004, J NEUROSCI, V24, P10466, DOI 10.1523/JNEUROSCI.3001-04.2004; DIANTONIO A, 1993, J NEUROSCI, V13, P4924; Dickman DK, 2006, CURR BIOL, V16, P591, DOI 10.1016/j.cub.2006.02.058; Eaton BA, 2002, NEURON, V34, P729, DOI 10.1016/S0896-6273(02)00721-3; Fejtova Anna, 2006, V43, P49, DOI 10.1007/012; Fouquet W, 2009, J CELL BIOL, V186, P129, DOI 10.1083/jcb.200812150; Fukui K, 1997, J BIOL CHEM, V272, P4655, DOI 10.1074/jbc.272.8.4655; Harden N, 1996, MOL CELL BIOL, V16, P1896; Iwasaki K, 1997, NEURON, V18, P613, DOI 10.1016/S0896-6273(00)80302-5; JOHNSTON PA, 1991, NEURON, V7, P101, DOI 10.1016/0896-6273(91)90078-E; Kaufmann N, 2002, NEURON, V34, P27, DOI 10.1016/S0896-6273(02)00643-8; Kawasaki F, 2004, J NEUROSCI, V24, P282, DOI 10.1523/JNEUROSCI.3553-03.2004; Kittel RJ, 2006, SCIENCE, V312, P1051, DOI 10.1126/science.1126308; Li J, 2007, NEURON, V55, P741, DOI 10.1016/j.neuron.2007.08.002; Mahoney TR, 2006, MOL BIOL CELL, V17, P2617, DOI 10.1091/mbc.E05-12-1170; Marrus SB, 2004, J NEUROSCI, V24, P1406, DOI 10.1523/JNEUROSCI.1575-03.2004; Marrus SB, 2004, CURR BIOL, V14, P924, DOI 10.1016/j.cub.2004.05.047; Mosca TJ, 2005, P NATL ACAD SCI USA, V102, P3477, DOI 10.1073/pnas.0406164102; Nonet ML, 1997, J NEUROSCI, V17, P8061; Ohtsuka T, 2002, J CELL BIOL, V158, P577, DOI 10.1083/jcb.200202083; Osterwalder T, 2001, P NATL ACAD SCI USA, V98, P12596, DOI 10.1073/pnas.221303298; Owald D, 2009, CURR OPIN NEUROBIOL, V19, P311, DOI 10.1016/j.conb.2009.03.003; Patel MR, 2009, SCIENCE, V323, P1500, DOI 10.1126/science.1169025; Pelkey KA, 2007, CURR OPIN NEUROBIOL, V17, P366, DOI 10.1016/j.conb.2007.04.008; Petersen SA, 1997, NEURON, V19, P1237, DOI 10.1016/S0896-6273(00)80415-8; Pielage J, 2006, J CELL BIOL, V175, P491, DOI 10.1083/jcb.200607036; Rasse TM, 2005, NAT NEUROSCI, V8, P898, DOI 10.1038/nn1484; Schluter OM, 2006, J NEUROSCI, V26, P1239, DOI 10.1523/JNEUROSCI.3553-05.2006; Schluter OM, 2004, J NEUROSCI, V24, P6629, DOI 10.1523/JNEUROSCI.1610-04.2004; Schluter OM, 1999, J NEUROSCI, V19, P5834, DOI 10.1523/JNEUROSCI.19-14-05834.1999; Schmid A, 2008, NAT NEUROSCI, V11, P659, DOI 10.1038/nn.2122; Schoch S, 2002, NATURE, V415, P321, DOI 10.1038/415321a; SHIRATAKI H, 1993, MOL CELL BIOL, V13, P2061, DOI 10.1128/MCB.13.4.2061; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Takao-Rikitsu E, 2004, J CELL BIOL, V164, P301, DOI 10.1083/jcb.200307101; Viquez NM, 2009, J NEUROSCI, V29, P11484, DOI 10.1523/JNEUROSCI.5584-08.2009; Wada M, 1997, J BIOL CHEM, V272, P3875, DOI 10.1074/jbc.272.7.3875; Wagh DA, 2006, NEURON, V49, P833, DOI 10.1016/j.neuron.2006.02.008; Wairkar YP, 2009, J NEUROSCI, V29, P517, DOI 10.1523/JNEUROSCI.3848-08.2009; Wang Y, 1997, NATURE, V388, P593, DOI 10.1038/41580; Weber E, 1996, J BIOL CHEM, V271, P6963, DOI 10.1074/jbc.271.12.6963; WU CF, 1978, P NATL ACAD SCI USA, V75, P4047, DOI 10.1073/pnas.75.8.4047; Wu MN, 1998, EMBO J, V17, P127, DOI 10.1093/emboj/17.1.127; Wu SY, 2005, NAT STRUCT MOL BIOL, V12, P879, DOI 10.1038/nsmb987; YAO KM, 1994, J NEUROCHEM, V63, P41; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	54	97	98	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 10	2009	64	5					663	677		10.1016/j.neuron.2009.11.002	http://dx.doi.org/10.1016/j.neuron.2009.11.002			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	537OW	20005823	Bronze, Green Accepted			2022-12-24	WOS:000273123700012
J	Girardeau, G; Benchenane, K; Wiener, SI; Buzsaki, G; Zugaro, MB				Girardeau, Gabrielle; Benchenane, Karim; Wiener, Sidney I.; Buzsaki, Gyoergy; Zugaro, Michael B.			Selective suppression of hippocampal ripples impairs spatial memory	NATURE NEUROSCIENCE			English	Article							SLOW-WAVE SLEEP; REACTIVATION; OSCILLATIONS; STATE	Sharp wave-ripple (SPW-R) complexes in the hippocampus-entorhinal cortex are believed to be important for transferring labile memories from the hippocampus to the neocortex for long-term storage. We found that selective elimination of SPW-Rs during post-training consolidation periods resulted in performance impairment in rats trained on a hippocampus-dependent spatial memory task. Our results provide evidence for a prominent role of hippocampal SPW-Rs in memory consolidation.	[Girardeau, Gabrielle; Benchenane, Karim; Wiener, Sidney I.; Zugaro, Michael B.] CNRS, Coll France, Lab Physiol Percept & Act, Paris, France; [Buzsaki, Gyoergy] Rutgers State Univ, Ctr Mol & Behav Neurosci, Newark, NJ 07102 USA	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; College de France; Rutgers State University Newark; Rutgers State University New Brunswick	Zugaro, MB (corresponding author), CNRS, Coll France, Lab Physiol Percept & Act, Paris, France.	buzsaki@axon.rutgers.edu; michael.zugaro@college-de-france.fr	benchenane, karim/D-8023-2015	benchenane, karim/0000-0001-7118-0748; Zugaro, Michael/0000-0002-6199-2635; Wiener, Sidney/0000-0002-5819-1319; Buzsaki, Gyorgy/0000-0002-3100-4800; Girardeau, Gabrielle/0000-0002-5265-9697	International Human Frontiers Science Program Organization [CDA0061/2007-C]; US National Institutes of Health [NS34994]; European Projects NeuroProbes [IST-027017]; Integrating Cognition, Emotion and Autonomy [FP6-IST 027819]; College de France Visiting Professor Fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034994] Funding Source: NIH RePORTER	International Human Frontiers Science Program Organization(Human Frontier Science Program); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Projects NeuroProbes; Integrating Cognition, Emotion and Autonomy; College de France Visiting Professor Fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank S. Sara, A. Larrieu, L. Hazan, A. Fruchart, P. Ruther, S. Kisban, S. Herwik, S. Doutremer, M.- A. Thomas, Y. Dupraz, M. Ehrette and S. Rateau for advice and technical support. This work was supported by the International Human Frontiers Science Program Organization (CDA0061/2007-C), the US National Institutes of Health (NS34994), European Projects NeuroProbes (IST-027017) and Integrating Cognition, Emotion and Autonomy (FP6-IST 027819), and a College de France Visiting Professor Fellowship.	Battaglia FP, 2004, LEARN MEMORY, V11, P697, DOI 10.1101/lm.73504; BUZSAKI G, 1989, NEUROSCIENCE, V31, P551, DOI 10.1016/0306-4522(89)90423-5; Chrobak JJ, 1996, J NEUROSCI, V16, P3056; Eschenko O, 2008, LEARN MEMORY, V15, P222, DOI 10.1101/lm.726008; Jarrard LE, 1995, BEHAV BRAIN RES, V71, P1, DOI 10.1016/0166-4328(95)00034-8; Kudrimoti HS, 1999, J NEUROSCI, V19, P4090; Marshall L, 2006, NATURE, V444, P610, DOI 10.1038/nature05278; Maviel T, 2004, SCIENCE, V305, P96, DOI 10.1126/science.1098180; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; Peyrache A, 2009, NAT NEUROSCI, V12, P919, DOI 10.1038/nn.2337; Siapas AG, 1998, NEURON, V21, P1123, DOI 10.1016/S0896-6273(00)80629-7; Sirota A, 2003, P NATL ACAD SCI USA, V100, P2065, DOI 10.1073/pnas.0437938100; Squire LR, 2007, CURR OPIN NEUROBIOL, V17, P185, DOI 10.1016/j.conb.2007.02.006; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517; Zugaro MB, 2005, NAT NEUROSCI, V8, P67, DOI 10.1038/nn1369	15	801	809	5	88	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2009	12	10					1222	1223		10.1038/nn.2384	http://dx.doi.org/10.1038/nn.2384			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	498US	19749750				2022-12-24	WOS:000270170200008
J	Pearson, J; Platt, ML				Pearson, John; Platt, Michael L.			Confidence and Corrections: How We Make and Un-Make Up Our Minds	NEURON			English	Editorial Material							NEURAL BASIS; DECISION; NEURONS; AREA	Single neurons in several brain areas intervening between sensation and action signal the accumulation of sensory evidence favoring a particular behavioral response. Two new studies show that these same neurons encode decision confidence and that decision makers continue to process relevant sensory information even after a choice has been made.	[Pearson, John; Platt, Michael L.] Duke Univ, Ctr Cognit Neurosci, Durham, NC 27708 USA; [Pearson, John; Platt, Michael L.] Duke Univ, Dept Neurobiol, Durham, NC 27708 USA	Duke University; Duke University	Pearson, J (corresponding author), Duke Univ, Ctr Cognit Neurosci, Durham, NC 27708 USA.	pearson@neuro.duke.edu; platt@neuro.duke.edu		Pearson, John/0000-0002-9876-7837	NATIONAL EYE INSTITUTE [R01EY019303] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH086712] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY019303] Funding Source: Medline; NIMH NIH HHS [R01 MH086712] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Gold JI, 2002, NEURON, V36, P299, DOI 10.1016/S0896-6273(02)00971-6; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; Hanks TD, 2006, BAYESIAN BRAIN PROBA, P209, DOI [10.7551/mitpress/9780262042383.003.0010, DOI 10.7551/MITPRESS/9780262042383.003.0010]; Hayden BY, 2008, NEURON, V60, P19, DOI 10.1016/j.neuron.2008.09.012; Kepecs A, 2008, NATURE, V455, P227, DOI 10.1038/nature07200; Kiani R, 2009, SCIENCE, V324, P759, DOI 10.1126/science.1169405; RATCLIFF R, 1978, PSYCHOL REV, V85, P59, DOI 10.1037//0033-295X.85.2.59; RESULAJ A, 2009, NATURE IN PRESS, DOI DOI 10.1038/NATURE08275; Roitman JD, 2002, J NEUROSCI, V22, P9475; Shadlen MN, 2001, J NEUROPHYSIOL, V86, P1916, DOI 10.1152/jn.2001.86.4.1916; Shadmehr R., 2005, COMPUTATIONAL NEUROB; Smith PL, 2004, TRENDS NEUROSCI, V27, P161, DOI 10.1016/j.tins.2004.01.006; Stephens D.W., 1986, pi	13	4	4	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 24	2009	63	6					724	726		10.1016/j.neuron.2009.09.011	http://dx.doi.org/10.1016/j.neuron.2009.09.011			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	503VP	19778502	Bronze			2022-12-24	WOS:000270569700006
J	Tain, LS; Mortiboys, H; Tao, RN; Ziviani, E; Bandmann, O; Whitworth, AJ				Tain, Luke S.; Mortiboys, Heather; Tao, Ran N.; Ziviani, Elena; Bandmann, Oliver; Whitworth, Alexander J.			Rapamycin activation of 4E-BP prevents parkinsonian dopaminergic neuron loss	NATURE NEUROSCIENCE			English	Article							MITOCHONDRIAL PATHOLOGY; LIFE-SPAN; OXIDATIVE STRESS; DROSOPHILA; PHOSPHORYLATION; TRANSLATION; DISEASE; PINK1; INITIATION; DOWNSTREAM	Mutations in PINK1 and PARK2 cause autosomal recessive parkinsonism, a neurodegenerative disorder that is characterized by the loss of dopaminergic neurons. To discover potential therapeutic pathways, we identified factors that genetically interact with Drosophila park and Pink1. We found that overexpression of the translation inhibitor Thor (4E-BP) can suppress all of the pathologic phenotypes, including degeneration of dopaminergic neurons in Drosophila. 4E-BP is activated in vivo by the TOR inhibitor rapamycin, which could potently suppress pathology in Pink1 and park mutants. Rapamycin also ameliorated mitochondrial defects in cells from individuals with PARK2 mutations. Recently, 4E-BP was shown to be inhibited by the most common cause of parkinsonism, dominant mutations in LRRK2. We also found that loss of the Drosophila LRRK2 homolog activated 4E-BP and was also able to suppress Pink1 and park pathology. Thus, in conjunction with recent findings, our results suggest that pharmacologic stimulation of 4E-BP activity may represent a viable therapeutic approach for multiple forms of parkinsonism.	[Tain, Luke S.; Mortiboys, Heather; Tao, Ran N.; Ziviani, Elena; Bandmann, Oliver; Whitworth, Alexander J.] Univ Sheffield, MRC, Ctr Dev & Biomed Genet, Sheffield, S Yorkshire, England; [Tain, Luke S.; Tao, Ran N.; Ziviani, Elena; Whitworth, Alexander J.] Univ Sheffield, Dept Biomed Sci, Sheffield S10 2TN, S Yorkshire, England; [Mortiboys, Heather; Bandmann, Oliver] Univ Sheffield, Acad Neurol Unit, Sheffield S10 2TN, S Yorkshire, England	University of Sheffield; University of Sheffield; University of Sheffield	Whitworth, AJ (corresponding author), Univ Sheffield, MRC, Ctr Dev & Biomed Genet, Sheffield, S Yorkshire, England.	a.whitworth@sheffield.ac.uk	tain, luke/A-6388-2009; Whitworth, Alexander/D-3969-2009; Mortiboys, Heather/E-8838-2010	Mortiboys, Heather/0000-0001-6439-0579; Tain, Luke/0000-0002-5845-7383; Bandmann, Oliver/0000-0003-3149-0252; Ziviani, Elena/0000-0002-0864-8309; Whitworth, Alexander/0000-0002-1154-6629	Parkinson's Disease Society UK [G-4063, G-0713, G-0715]; Royal Society and Wellcome Trust [081987]; MRC Centre for Developmental and Biomedical Genetics [G070091]; Wellcome Trust [GR077544AIA]; Light Microscopy Facility; Medical Research Council [G0700091B] Funding Source: researchfish; Parkinson&quot;s UK [G-0715, G-0713] Funding Source: researchfish	Parkinson's Disease Society UK(Parkinson's UK); Royal Society and Wellcome Trust; MRC Centre for Developmental and Biomedical Genetics(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Light Microscopy Facility; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Parkinson&quot;s UK(Parkinson&apos;s UK)	We would like to thank L. Pallanck, P. Ingham and L. Partridge for critical reading of the manuscript and discussions. We would also like to thank J. Chung, S. Birman, L. Partridge, N. Sonenberg and T. Neufeld for Drosophila lines, H. Benes. for the antibody to GstS1 and I. Bjedov for Atg5 qPCR primer sequences. We also acknowledge the Department of Biomedical Science Centre for Electron Microscopy for technical assistance. This work was supported by grants from the Parkinson's Disease Society UK (G-4063 and G-0713 to A. J. W. and G-0715 to O. B.) and the Royal Society and Wellcome Trust ( 081987) to A. J. W. The MRC Centre for Developmental and Biomedical Genetics is supported by grant G070091. The Wellcome Trust ( grant number GR077544AIA) supports the Light Microscopy Facility.	Abou-Sleiman PM, 2006, NAT REV NEUROSCI, V7, P207, DOI 10.1038/nrn1868; Beretta L, 1996, EMBO J, V15, P658, DOI 10.1002/j.1460-2075.1996.tb00398.x; Bernal A, 2000, P NATL ACAD SCI USA, V97, P6019, DOI 10.1073/pnas.100391597; Brunn GJ, 1997, SCIENCE, V277, P99, DOI 10.1126/science.277.5322.99; Burnett PE, 1998, P NATL ACAD SCI USA, V95, P1432, DOI 10.1073/pnas.95.4.1432; Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779; Clemens MJ, 2001, J CELL MOL MED, V5, P221, DOI 10.1111/j.1582-4934.2001.tb00157.x; De Vos KJ, 2007, METHOD CELL BIOL, V80, P627, DOI 10.1016/S0091-679X(06)80030-0; Exner N, 2007, J NEUROSCI, V27, P12413, DOI 10.1523/JNEUROSCI.0719-07.2007; Farrer MJ, 2006, NAT REV GENET, V7, P306, DOI 10.1038/nrg1831; Giannakou ME, 2004, SCIENCE, V305, P361, DOI 10.1126/science.1098219; Gingras AC, 2001, GENE DEV, V15, P807, DOI 10.1101/gad.887201; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Gingras AC, 2001, GENE DEV, V15, P2852; Gloeckner CJ, 2006, HUM MOL GENET, V15, P223, DOI 10.1093/hmg/ddi439; Greene JC, 2005, HUM MOL GENET, V14, P799, DOI 10.1093/hmg/ddi074; Greene JC, 2003, P NATL ACAD SCI USA, V100, P4078, DOI 10.1073/pnas.0737556100; Holcik M, 2000, TRENDS GENET, V16, P469, DOI 10.1016/S0168-9525(00)02106-5; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; Hwangbo DS, 2004, NATURE, V429, P562, DOI 10.1038/nature02549; Imai Y, 2008, EMBO J, V27, P2432, DOI 10.1038/emboj.2008.163; Junger Martin A, 2003, J Biol, V2, P20, DOI 10.1186/1475-4924-2-20; Kapahi P, 2004, CURR BIOL, V14, P885, DOI 10.1016/j.cub.2004.03.059; King MA, 2008, MOL PHARMACOL, V73, P1052, DOI 10.1124/mol.107.043398; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Li YP, 2009, NAT NEUROSCI, V12, P826, DOI 10.1038/nn.2349; McElwee JJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r132; Miron M, 2001, NAT CELL BIOL, V3, P596, DOI 10.1038/35078571; Mortiboys H, 2008, ANN NEUROL, V64, P555, DOI 10.1002/ana.21492; Muftuoglu M, 2004, MOVEMENT DISORD, V19, P544, DOI 10.1002/mds.10695; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788; Poole AC, 2008, P NATL ACAD SCI USA, V105, P1638, DOI 10.1073/pnas.0709336105; Puig O, 2003, GENE DEV, V17, P2006, DOI 10.1101/gad.1098703; Richter JD, 2005, NATURE, V433, P477, DOI 10.1038/nature03205; Scott RC, 2004, DEV CELL, V7, P167, DOI 10.1016/j.devcel.2004.07.009; Singh SP, 2001, EUR J BIOCHEM, V268, P2912, DOI 10.1046/j.1432-1327.2001.02179.x; Southgate RJ, 2007, J BIOL CHEM, V282, P21176, DOI 10.1074/jbc.M702039200; Tain LS, 2009, CELL DEATH DIFFER, V16, P1118, DOI 10.1038/cdd.2009.23; Teleman AA, 2005, GENE DEV, V19, P1844, DOI 10.1101/gad.341505; Tettweiler G, 2005, GENE DEV, V19, P1840, DOI 10.1101/gad.1311805; West AB, 2005, P NATL ACAD SCI USA, V102, P16842, DOI 10.1073/pnas.0507360102; Whitworth AJ, 2006, DRUG DISCOV TODAY, V11, P119, DOI 10.1016/S1359-6446(05)03693-7; Whitworth AJ, 2005, P NATL ACAD SCI USA, V102, P8024, DOI 10.1073/pnas.0501078102; Whitworth AJ, 2008, DIS MODEL MECH, V1, P168, DOI 10.1242/dmm.000109; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Wyttenbach A, 2008, AUTOPHAGY, V4, P542, DOI 10.4161/auto.6059; Yamaguchi S, 2008, CELL METAB, V7, P269, DOI 10.1016/j.cmet.2008.01.008; Yang YF, 2008, P NATL ACAD SCI USA, V105, P7070, DOI 10.1073/pnas.0711845105; Yang YF, 2006, P NATL ACAD SCI USA, V103, P10793, DOI 10.1073/pnas.0602493103	50	234	242	0	15	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2009	12	9					1129	U13		10.1038/nn.2372	http://dx.doi.org/10.1038/nn.2372			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	487ZD	19684592	Green Accepted			2022-12-24	WOS:000269317300014
J	Sheng, XR; Brawley, CM; Matunis, EL				Sheng, X. Rebecca; Brawley, Crista M.; Matunis, Erika L.			Dedifferentiating Spermatogonia Outcompete Somatic Stem Cells for Niche Occupancy in the Drosophila Testis	CELL STEM CELL			English	Article							BAG-OF-MARBLES; MALE GERM-LINE; SELF-RENEWAL; UNDIFFERENTIATED SPERMATOGONIA; CONTRACTILE RING; CYST FORMATION; IN-VIVO; PROLIFERATION; PROTEIN; SPERMATOGENESIS	Differentiating cells can dedifferentiate to replace stem cells in aged or damaged tissues, but the underlying mechanisms are unknown. In the Drosophila testis, a cluster of stromal cells called the hub creates a niche by locally activating Janus kinase-signal transducer and activator of transcription (Jak-STAT) signaling in adjacent germline and somatic stem cells. Here, we establish a system to study spermatogonial dedifferentiation. Ectopically expressing the differentiation factor bag-of-marbles (Bam) removes germline stem cells from the niche. However, withdrawing ectopic Bam causes interconnected spermatogonia. to fragment, move into the niche, exchange positions with resident somatic stem cells, and establish contact with the hub. Concomitantly, actin-based protrusions appear on subsets of spermatogonia, suggesting acquired motility. Furthermore, global downregulation of Jak-STAT signaling inhibits dedifferentiation, indicating that normal levels of pathway activation are required to promote movement of spermatogonia into the niche during dedifferentiation, where they outcompete somatic stem cells for niche occupancy.	[Sheng, X. Rebecca; Brawley, Crista M.; Matunis, Erika L.] Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA	Johns Hopkins University	Matunis, EL (corresponding author), Johns Hopkins Univ, Sch Med, Dept Cell Biol, 725 N Wolfe St, Baltimore, MD 21205 USA.	matunis@jhmi.edu			NIH [HD052937, HD040307-07]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD052937, R01HD040307] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank our colleagues who have supplied us with stocks, technical assistance, suggestions, and insightful comments during the course of this work. We thank Dr. M. de Cuevas and anonymous reviewers for comments and the Andrew lab for use of their Zeiss Axiophot. This work was supported by NIH grants HD052937 and HD040307-07 (to E.L.M.).	Arbouzova NI, 2006, DEVELOPMENT, V133, P2605, DOI 10.1242/dev.02411; BARROCA V, 2008, NAT CELL BIOL, V11, P118; Bhattacharya D, 2008, EUR J IMMUNOL, V38, P2060, DOI 10.1002/eji.200838383; Bloor JW, 2001, DEV BIOL, V239, P215, DOI 10.1006/dbio.2001.0452; Boyle M, 2007, CELL STEM CELL, V1, P470, DOI 10.1016/j.stem.2007.08.002; Brawley C, 2004, SCIENCE, V304, P1331, DOI 10.1126/science.1097676; Brown S, 2006, DEV DYNAM, V235, P958, DOI 10.1002/dvdy.20709; Buszczak M, 2007, GENETICS, V175, P1505, DOI 10.1534/genetics.106.065961; Callus BA, 2002, ONCOGENE, V21, P4812, DOI 10.1038/sj.onc.1205618; Chen DH, 2003, CURR BIOL, V13, P1786, DOI 10.1016/j.cub.2003.09.033; Chen HW, 2002, GENE DEV, V16, P388, DOI 10.1101/gad.955202; Cheng J, 2008, NATURE, V456, P599, DOI 10.1038/nature07386; de Cuevas M, 1997, ANNU REV GENET, V31, P405, DOI 10.1146/annurev.genet.31.1.405; de Cuevas M, 1998, DEVELOPMENT, V125, P2781; Dutta D, 2002, GENESIS, V34, P146, DOI 10.1002/gene.10113; Fabrizio JJ, 2003, DEV BIOL, V258, P117, DOI 10.1016/S0012-1606(03)00127-1; FIELD CM, 1995, J CELL BIOL, V131, P165, DOI 10.1083/jcb.131.1.165; Flatt T, 2008, P NATL ACAD SCI USA, V105, P6368, DOI 10.1073/pnas.0709128105; Fuller MT, 2007, SCIENCE, V316, P402, DOI 10.1126/science.1140861; Fuller MT, 1998, SEMIN CELL DEV BIOL, V9, P433, DOI 10.1006/scdb.1998.0227; Gonczy P, 1996, DEVELOPMENT, V122, P2437; Gonczy P, 1997, DEVELOPMENT, V124, P4361; HARDY RW, 1979, J ULTRA MOL STRUCT R, V69, P180, DOI 10.1016/S0022-5320(79)90108-4; Hime GR, 1996, J CELL SCI, V109, P2779; Kai T, 2004, NATURE, V428, P564, DOI 10.1038/nature02436; Kai TS, 2003, P NATL ACAD SCI USA, V100, P4633, DOI 10.1073/pnas.0830856100; Kanatsu-Shinohara M, 2008, CELL STEM CELL, V3, P533, DOI 10.1016/j.stem.2008.08.002; Kawase E, 2004, DEVELOPMENT, V131, P1365, DOI 10.1242/dev.01025; Kiger AA, 2001, SCIENCE, V294, P2542, DOI 10.1126/science.1066707; Kunwar PS, 2006, ANNU REV CELL DEV BI, V22, P237, DOI 10.1146/annurev.cellbio.22.010305.103337; LAI ZC, 1991, MECH DEVELOP, V34, P123, DOI 10.1016/0925-4773(91)90049-C; LASKO PF, 1990, GENE DEV, V4, P905, DOI 10.1101/gad.4.6.905; Leatherman JL, 2008, CELL STEM CELL, V3, P44, DOI 10.1016/j.stem.2008.05.001; Li JH, 2003, DEV CELL, V5, P787, DOI 10.1016/S1534-5807(03)00328-9; Li LH, 2005, ANNU REV CELL DEV BI, V21, P605, DOI 10.1146/annurev.cellbio.21.012704.131525; Li WX, 2004, CELL CYCLE, V3, P249; LIN HF, 1994, DEVELOPMENT, V120, P947; Matunis E, 1997, DEVELOPMENT, V124, P4383; MCKEARIN D, 1995, DEVELOPMENT, V121, P2937; MCKEARIN DM, 1990, GENE DEV, V4, P2242, DOI 10.1101/gad.4.12b.2242; Meng XJ, 2000, SCIENCE, V287, P1489, DOI 10.1126/science.287.5457.1489; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Nakagawa T, 2007, DEV CELL, V12, P195, DOI 10.1016/j.devcel.2007.01.002; Neufeld TP, 1998, CELL, V93, P1183, DOI 10.1016/S0092-8674(00)81462-2; Nishikawa S, 2008, NAT REV MOL CELL BIO, V9, P725, DOI 10.1038/nrm2466; Nystul T, 2007, CELL STEM CELL, V1, P277, DOI 10.1016/j.stem.2007.07.009; Oatley JA, 2008, ANNU REV CELL DEV BI, V24, P263, DOI 10.1146/annurev.cellbio.24.110707.175355; Ohlstein B, 1997, DEVELOPMENT, V124, P3651; Pignoni F, 1997, DEVELOPMENT, V124, P271; Raff M, 2003, ANNU REV CELL DEV BI, V19, P1, DOI 10.1146/annurev.cellbio.19.111301.143037; Schulz C, 2004, GENETICS, V167, P707, DOI 10.1534/genetics.103.023184; Silver DL, 2001, CELL, V107, P831, DOI 10.1016/S0092-8674(01)00607-9; Straube WL, 2006, ARTIF ORGANS, V30, P743, DOI 10.1111/j.1525-1594.2006.00296.x; Terry NA, 2006, DEV BIOL, V294, P246, DOI 10.1016/j.ydbio.2006.02.048; Tulina N, 2001, SCIENCE, V294, P2546, DOI 10.1126/science.1066700; Van Doren M, 1998, CURR BIOL, V8, P243; Wallenfang MR, 2006, AGING CELL, V5, P297, DOI 10.1111/j.1474-9726.2006.00221.x; Yamashita YM, 2003, SCIENCE, V301, P1547, DOI 10.1126/science.1087795; Yoshida S, 2007, SCIENCE, V317, P1722, DOI 10.1126/science.1144885	59	105	105	1	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	AUG 7	2009	5	2					191	203		10.1016/j.stem.2009.05.024	http://dx.doi.org/10.1016/j.stem.2009.05.024			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	490PB	19664993	Green Accepted, Bronze			2022-12-24	WOS:000269511900012
J	Trounson, A; Baum, E; Gibbons, D; Tekamp-Olson, P				Trounson, Alan; Baum, Elona; Gibbons, Don; Tekamp-Olson, Patricia			Developing a Case Study Model for Successful Translation of Stem Cell Therapies	CELL STEM CELL			English	Editorial Material								Cell therapies derived from pluripotent stem cells are entering the preclinical and early clinical development phase, but eventual translation faces many challenges. We describe a new approach by California to form global public-private "disease team" partnerships to enable new clinical opportunities to be evaluated in the complex regulatory environment.	[Trounson, Alan; Baum, Elona; Gibbons, Don; Tekamp-Olson, Patricia] Calif Inst Regenerat Med, San Francisco, CA 94107 USA		Trounson, A (corresponding author), Calif Inst Regenerat Med, 210 King St, San Francisco, CA 94107 USA.	atrounson@cirm.ca.gov		Trounson, Alan/0000-0001-5469-0500				*BRAINL INC, 2010, WHIT PAP SEAML LIF S; *CAMBR HLTH I, 2010, C 2 ANN COLL INN BIO; Cuende N, 2010, CELL STEM CELL, V6, P508, DOI 10.1016/j.stem.2010.05.005; Health Economics Research Group Office of Health Economics RAND Europe, 2008, MED RES WHATS IT WOR; KLEIN RN, 2010, DELIVERY RE IN PRESS; McKernan R, 2010, CELL STEM CELL, V6, P517, DOI 10.1016/j.stem.2010.05.012; Munos B, 2009, NAT REV DRUG DISCOV, V8, P959, DOI 10.1038/nrd2961; Murphy KM, 2003, MEASURING THE GAINS FROM MEDICAL RESEARCH, P41; Plagnol AC, 2009, REGEN MED, V4, P549, DOI 10.2217/RME.09.21	9	20	20	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	JUN 4	2010	6	6					513	516		10.1016/j.stem.2010.05.008	http://dx.doi.org/10.1016/j.stem.2010.05.008			4	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	611SB	20569687	Bronze			2022-12-24	WOS:000278840700010
J	Miller, CA; Gavin, CF; White, JA; Parrish, RR; Honasoge, A; Yancey, CR; Rivera, IM; Rubio, MD; Rumbaugh, G; Sweatt, JD				Miller, Courtney A.; Gavin, Cristin F.; White, Jason A.; Parrish, R. Ryley; Honasoge, Avinash; Yancey, Christopher R.; Rivera, Ivonne M.; Rubio, Maria D.; Rumbaugh, Gavin; Sweatt, J. David			Cortical DNA methylation maintains remote memory	NATURE NEUROSCIENCE			English	Article							LONG-TERM-MEMORY; NEUROBIOLOGY; INVOLVEMENT; PLASTICITY	A behavioral memory's lifetime represents multiple molecular lifetimes, suggesting the necessity for a self-perpetuating signal. One candidate is DNA methylation, a transcriptional repression mechanism that maintains cellular memory throughout development. We found that persistent, gene-specific cortical hypermethylation was induced in rats by a single, hippocampus-dependent associative learning experience and pharmacologic inhibition of methylation 1 month after learning disrupted remote memory. We propose that the adult brain utilizes DNA methylation to preserve long-lasting memories.	[Miller, Courtney A.; Gavin, Cristin F.; White, Jason A.; Parrish, R. Ryley; Honasoge, Avinash; Yancey, Christopher R.; Rivera, Ivonne M.; Rubio, Maria D.; Rumbaugh, Gavin; Sweatt, J. David] Univ Alabama, Sch Med, Evelyn F McKnight Brain Inst, Birmingham, AL USA; [Miller, Courtney A.; Gavin, Cristin F.; White, Jason A.; Parrish, R. Ryley; Honasoge, Avinash; Yancey, Christopher R.; Rivera, Ivonne M.; Rubio, Maria D.; Rumbaugh, Gavin; Sweatt, J. David] Univ Alabama, Sch Med, Dept Neurobiol, Birmingham, AL USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Miller, CA (corresponding author), Scripps Inst, Dept Metab & Aging, Jupiter, FL USA.	cmiller@scripps.edu; dsweatt@nrc.uab.edu	Miller, Courtney A/E-8651-2010	Miller, Courtney A/0000-0001-8628-4902; Sweatt, J. David/0000-0003-3567-485X; Gavin, Cristin/0000-0001-7113-5015; Parrish, R Ryley/0000-0001-6798-6140	National Institute of Mental Health; National Institute of Neurological Disorders and Stroke; National Institute on Aging; National Institute on Drug Abuse; American Health Assistance Foundation; Evelyn F. McKnight Brain Research Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS061788, R01NS064079, F32NS057953] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K99DA024761, R00DA024761] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); American Health Assistance Foundation; Evelyn F. McKnight Brain Research Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The authors would like to thank O.S. Ahmed for technical assistance and M. Han of the UAB Genomics Core Facility. This work was supported by the National Institute of Mental Health, the National Institute of Neurological Disorders and Stroke, the National Institute on Aging, the National Institute on Drug Abuse, the American Health Assistance Foundation, the Evelyn F. McKnight Brain Research Foundation and Philip Morris.	BENVENGA MJ, 1988, PHARMACOL BIOCHEM BE, V30, P205, DOI 10.1016/0091-3057(88)90445-5; BIRD AP, 1986, NATURE, V321, P209, DOI 10.1038/321209a0; CRICK F, 1984, NATURE, V312, P101, DOI 10.1038/312101a0; Dudai Y, 2004, ANNU REV PSYCHOL, V55, P51, DOI 10.1146/annurev.psych.55.090902.142050; Frankland PW, 2004, SCIENCE, V304, P881, DOI 10.1126/science.1094804; Holliday R, 1999, J THEOR BIOL, V200, P339, DOI 10.1006/jtbi.1999.0995; Kasai H, 2010, TRENDS NEUROSCI, V33, P121, DOI 10.1016/j.tins.2010.01.001; Kessels HW, 2009, NEURON, V61, P340, DOI 10.1016/j.neuron.2009.01.015; Malleret G, 2001, CELL, V104, P675, DOI 10.1016/S0092-8674(01)00264-1; Miller CA, 2007, NEURON, V53, P857, DOI 10.1016/j.neuron.2007.02.022; MULKEY RM, 1994, NATURE, V369, P486, DOI 10.1038/369486a0; Roberson ED, 1999, LEARN MEMORY, V6, P381; Sacktor TC, 2008, PROG BRAIN RES, V169, P27, DOI 10.1016/S0079-6123(07)00002-7; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; Weeber EJ, 2002, J BIOL CHEM, V277, P39944, DOI 10.1074/jbc.M205147200	15	374	385	0	64	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2010	13	6					664	666		10.1038/nn.2560	http://dx.doi.org/10.1038/nn.2560			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	600QY	20495557	Green Accepted			2022-12-24	WOS:000278003300008
J	Debiec, J; Diaz-Mataix, L; Bush, DEA; Doyere, V; LeDoux, JE				Debiec, Jacek; Diaz-Mataix, Llorenc; Bush, David E. A.; Doyere, Valerie; LeDoux, Joseph E.			The amygdala encodes specific sensory features of an aversive reinforcer	NATURE NEUROSCIENCE			English	Article							FEAR MEMORIES; RECONSOLIDATION; MECHANISMS; RETRIEVAL	Studies of reconsolidation, in which retrieved memories are altered and restored, offer an approach for exploring the associative structure of fear memory. We found that exposure to the unconditioned stimulus initiates an unconditioned stimulus-specific reconsolidation of learned fear in rats that depended on the amygdala. Thus, specific features of the unconditioned stimulus appear to be encoded in the amygdala as part of fear memories stored there.	[Debiec, Jacek; Diaz-Mataix, Llorenc; Bush, David E. A.; Doyere, Valerie; LeDoux, Joseph E.] NYU, Ctr Neural Sci, WM Keck Fdn, Neurobiol Lab, New York, NY 10003 USA; [Debiec, Jacek] NYU, Sch Med, Dept Psychiat, Bellevue Hosp Ctr, New York, NY USA; [Debiec, Jacek] Copernicus Ctr Interdisciplinary Studies, Krakow, Poland; [Doyere, Valerie] Univ Paris 11, CNRS, UMR8195, Ctr Neurosci Paris Sud, F-91405 Orsay, France; [LeDoux, Joseph E.] Nathan S Kline Inst Psychiat Res, Emot Brain Inst, Orangeburg, NY 10962 USA	New York University; Bellevue Hospital Center; New York University; Jagiellonian University; Collegium Medicum Jagiellonian University; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Universite Jean Monnet; Nathan Kline Institute for Psychiatric Research	Debiec, J (corresponding author), NYU, Ctr Neural Sci, WM Keck Fdn, Neurobiol Lab, New York, NY 10003 USA.	jacek@cns.nyu.edu	Debiec, Jacek/B-6820-2008; Diaz-Mataix, Lorenzo/O-7593-2016	Debiec, Jacek/0000-0002-8473-1534; Diaz-Mataix, Lorenzo/0000-0001-6766-9479; Doyere, Valerie/0000-0002-3851-669X	National Science Foundation Centre National de la Recherche Scientifique (NSF-CNRS); CNRS; CNRS-UPS-NYU; Fulbright/Spanish Ministry of Education;  [R01 MH046516];  [R37 MH038774];  [P50 MH058911]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH046516, P50MH058911, R37MH038774] Funding Source: NIH RePORTER	National Science Foundation Centre National de la Recherche Scientifique (NSF-CNRS)(Centre National de la Recherche Scientifique (CNRS)); CNRS(Centre National de la Recherche Scientifique (CNRS)); CNRS-UPS-NYU; Fulbright/Spanish Ministry of Education(Spanish Government); ; ; ; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The authors thank C. Farb and J. Erlich for their advice and S. Kadakia for her technical assistance. This research was supported by grants R01 MH046516, R37 MH038774 and P50 MH058911 to J. E. L. and a National Science Foundation Centre National de la Recherche Scientifique (NSF-CNRS) International Cooperative grant, a CNRS Project International de la Cooperation Scientifique grant and a CNRS-UPS-NYU collaboration grant EmoTime to V. D. and J. E. L. L. D.-M. was supported by a Fulbright/Spanish Ministry of Education postdoctoral fellowship.	DAVIS M, 1992, ANNU REV NEUROSCI, V15, P353, DOI 10.1146/annurev.neuro.15.1.353; Debiec J, 2006, P NATL ACAD SCI USA, V103, P3428, DOI 10.1073/pnas.0507168103; Doyere V, 2007, NAT NEUROSCI, V10, P414, DOI 10.1038/nn1871; Everitt BJ, 2003, ANN NY ACAD SCI, V985, P233; Fanselow MS, 2005, ANNU REV PSYCHOL, V56, P207, DOI 10.1146/annurev.psych.56.091103.070213; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Maren S, 2005, NEURON, V47, P783, DOI 10.1016/j.neuron.2005.08.009; Milekic MH, 2006, J NEUROSCI, V26, P3010, DOI 10.1523/JNEUROSCI.4818-05.2006; MILLER RR, 1972, PHYSIOL BEHAV, V8, P645, DOI 10.1016/0031-9384(72)90089-3; Nader K, 2000, NATURE, V406, P722, DOI 10.1038/35021052; Sara SJ, 2000, LEARN MEMORY, V7, P73, DOI 10.1101/lm.7.2.73; Spear NE, 1976, CODING PROCESSES ANI, P135; Tronson NC, 2007, NAT REV NEUROSCI, V8, P262, DOI 10.1038/nrn2090	13	65	72	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2010	13	5					536	537		10.1038/nn.2520	http://dx.doi.org/10.1038/nn.2520			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	588JM	20348916	Green Accepted			2022-12-24	WOS:000277065700009
J	Martinez-Vicente, M; Talloczy, Z; Wong, E; Tang, GM; Koga, H; Kaushik, S; de Vries, R; Arias, E; Harris, S; Sulzer, D; Cuervo, AM				Martinez-Vicente, Marta; Talloczy, Zsolt; Wong, Esther; Tang, Guomei; Koga, Hiroshi; Kaushik, Susmita; de Vries, Rosa; Arias, Esperanza; Harris, Spike; Sulzer, David; Cuervo, Ana Maria			Cargo recognition failure is responsible for inefficient autophagy in Huntington's disease	NATURE NEUROSCIENCE			English	Article							MUTANT HUNTINGTIN; MONITORING AUTOPHAGY; ALPHA-SYNUCLEIN; DEGRADATION; POLYGLUTAMINE; AGGREGATION; CLEARANCE; PROTEINS; MODELS; CELL	Continuous turnover of intracellular components by autophagy is necessary to preserve cellular homeostasis in all tissues. Alterations in macroautophagy, the main process responsible for bulk autophagic degradation, have been proposed to contribute to pathogenesis in Huntington's disease (HD), a genetic neurodegenerative disorder caused by an expanded polyglutamine tract in the huntingtin protein. However, the precise mechanism behind macroautophagy malfunction in HD is poorly understood. In this work, using cellular and mouse models of HD and cells from humans with HD, we have identified a primary defect in the ability of autophagic vacuoles to recognize cytosolic cargo in HD cells. Autophagic vacuoles form at normal or even enhanced rates in HD cells and are adequately eliminated by lysosomes, but they fail to efficiently trap cytosolic cargo in their lumen. We propose that inefficient engulfment of cytosolic components by autophagosomes is responsible for their slower turnover, functional decay and accumulation inside HD cells.	[Martinez-Vicente, Marta; Wong, Esther; Koga, Hiroshi; Kaushik, Susmita; Arias, Esperanza; Cuervo, Ana Maria] Albert Einstein Coll Med, Dept Dev & Mol Biol, Inst Aging Studies, Bronx, NY 10467 USA; [Talloczy, Zsolt; Tang, Guomei; de Vries, Rosa; Harris, Spike; Sulzer, David] Columbia Univ, Dept Neurol, Sch Med, New York, NY USA; [Talloczy, Zsolt; Tang, Guomei; de Vries, Rosa; Harris, Spike; Sulzer, David] Columbia Univ, Dept Psychiat, Sch Med, New York, NY USA; [Talloczy, Zsolt; Tang, Guomei; de Vries, Rosa; Harris, Spike; Sulzer, David] Columbia Univ, Dept Pharmacol, Sch Med, New York, NY USA	Yeshiva University; Albert Einstein College of Medicine; Columbia University; Columbia University; Columbia University	Cuervo, AM (corresponding author), Albert Einstein Coll Med, Dept Dev & Mol Biol, Inst Aging Studies, Bronx, NY 10467 USA.	ds43@columbia.edu; ana-maria.cuervo@einstein.yu.edu	Wong, Esther/E-1344-2011; Martinez-Vicente, Marta/K-4312-2014; Kaushik, Susmita/GVS-3186-2022	Martinez-Vicente, Marta/0000-0001-7053-2625; Kaushik, Susmita/0000-0002-6096-5387; Arias, Esperanza/0000-0002-7836-5072; Wong, Esther/0000-0003-2421-7346; Cuervo, Ana Maria/0000-0002-0771-700X	Huntington Disease Society of America; US National Institutes of Health National Institute on Aging [AG021904, AG031782, DK041918, T32AG023475]; National Institute of Neurological Disorders and Stroke Udall Center of Excellence; Glenn Foundation; Picower and Simons foundation; Hereditary Disease Foundation; Fulbright fellowship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK041918] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS038370] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG021904, T32AG023475, R01AG021904, P01AG031782] Funding Source: NIH RePORTER	Huntington Disease Society of America; US National Institutes of Health National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Neurological Disorders and Stroke Udall Center of Excellence(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Glenn Foundation; Picower and Simons foundation; Hereditary Disease Foundation; Fulbright fellowship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank R. Singh and B. Patel for technical assistance. Mouse fibroblasts expressing <SUP>146</SUP>Q-htt exon 1 and human lymphoblasts from unaffected controls and individuals with HD were gifts from N. Wexler (Hereditary Disease Foundation), M. Andresen (Massachusetts Institute of Technology) and J. Gusella (Massachusetts General Hospital). The antibodies to mannose-6-phosphate receptor and Rab5 were a gift from A. Wolkoff (Albert Einstein College of Medicine). This work was supported by a Huntington Disease Society of America grant (D. S., A. M. C.); US National Institutes of Health National Institute on Aging grants AG021904, AG031782, DK041918 (A. M. C.) and National Institute of Neurological Disorders and Stroke Udall Center of Excellence grant (D. S.); and the Glenn Foundation (A. M. C.), and Picower and Simons foundation (D. S.). E. W. is supported by the Hereditary Disease Foundation. E. A. is supported by a Fulbright fellowship. S. K. is supported by US National Institutes of Health National Institute on Aging grant T32AG023475.	Atwal RS, 2007, HUM MOL GENET, V16, P2600, DOI 10.1093/hmg/ddm217; Bae Y, 2006, P NATL ACAD SCI USA, V103, P3405, DOI 10.1073/pnas.0511316103; Browne SE, 1999, BRAIN PATHOL, V9, P147; Browne SE, 2008, ANN NY ACAD SCI, V1147, P358, DOI 10.1196/annals.1427.018; Chu CT, 2009, METHOD ENZYMOL, V453, P217, DOI 10.1016/S0076-6879(08)04011-1; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; Filimonenko M, 2007, J CELL BIOL, V179, P485, DOI 10.1083/jcb.200702115; Garfield AS, 2010, METHODS MOL BIOL, V633, P19, DOI 10.1007/978-1-59745-019-5_2; Iwata A, 2009, J BIOL CHEM, V284, P9796, DOI 10.1074/jbc.M809739200; Jeong H, 2009, CELL, V137, P60, DOI 10.1016/j.cell.2009.03.018; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kegel KB, 2000, J NEUROSCI, V20, P7268, DOI 10.1523/jneurosci.20-19-07268.2000; Kim J, 2002, J BIOL CHEM, V277, P763, DOI 10.1074/jbc.M109134200; Kim PK, 2008, P NATL ACAD SCI USA, V105, P20567, DOI 10.1073/pnas.0810611105; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Klionsky DJ, 2007, AUTOPHAGY, V3, P181, DOI 10.4161/auto.3678; Larsen KE, 2002, J NEUROSCI, V22, P8951; Martin-Aparicio E, 2001, J NEUROSCI, V21, P8772, DOI 10.1523/JNEUROSCI.21-22-08772.2001; MARZELLA L, 1982, J CELL BIOL, V93, P144, DOI 10.1083/jcb.93.1.144; Massey AC, 2006, P NATL ACAD SCI USA, V103, P5805, DOI 10.1073/pnas.0507436103; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108; Nagata E, 2004, NEUROREPORT, V15, P1325, DOI 10.1097/01.wnr.0000127073.66692.8f; OHSUMI Y, 1983, J BIOCHEM, V93, P547; Petersen A, 2001, HUM MOL GENET, V10, P1243, DOI 10.1093/hmg/10.12.1243; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Ravikumar B, 2002, HUM MOL GENET, V11, P1107, DOI 10.1093/hmg/11.9.1107; Ravikumar B, 2008, J CELL SCI, V121, P1649, DOI 10.1242/jcs.025726; Rubinszfein DC, 2005, AUTOPHAGY, V1, P11, DOI 10.4161/auto.1.1.1513; Rubinsztein DC, 2002, TRENDS GENET, V18, P202, DOI 10.1016/S0168-9525(01)02625-7; Sapp E, 1997, ANN NEUROL, V42, P604, DOI 10.1002/ana.410420411; Sarkar S, 2008, FEBS J, V275, P4263, DOI 10.1111/j.1742-4658.2008.06562.x; Sarkar S, 2007, J BIOL CHEM, V282, P5641, DOI 10.1074/jbc.M609532200; Shibata M, 2006, J BIOL CHEM, V281, P14474, DOI 10.1074/jbc.M600364200; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Stefanis L, 2001, J NEUROSCI, V21, P9549, DOI 10.1523/JNEUROSCI.21-24-09549.2001; STORRIE B, 1990, METHOD ENZYMOL, V182, P203; Sulzer D, 2000, P NATL ACAD SCI USA, V97, P11869, DOI 10.1073/pnas.97.22.11869; Trettel F, 2000, HUM MOL GENET, V9, P2799, DOI 10.1093/hmg/9.19.2799; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; Wang HM, 2009, HUM MOL GENET, V18, P737, DOI 10.1093/hmg/ddn404; Wang YP, 2009, HUM MOL GENET, V18, P4153, DOI 10.1093/hmg/ddp367; Wheeler VC, 1999, HUM MOL GENET, V8, P115, DOI 10.1093/hmg/8.1.115; Yu WH, 2005, J CELL BIOL, V171, P87, DOI 10.1083/jcb.200505082	45	581	593	1	66	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2010	13	5					567	U74		10.1038/nn.2528	http://dx.doi.org/10.1038/nn.2528			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	588JM	20383138	Green Accepted			2022-12-24	WOS:000277065700014
J	Trigo, FF; Bouhours, B; Rostaing, P; Papageorgiou, G; Corrie, JET; Triller, A; Ogden, D; Marty, A				Trigo, Federico F.; Bouhours, Brice; Rostaing, Philippe; Papageorgiou, George; Corrie, John E. T.; Triller, Antoine; Ogden, David; Marty, Alain			Presynaptic Miniature Gabaergic Currents in Developing Interneurons	NEURON			English	Article							AXONAL GABA(A) RECEPTORS; POSTNATAL SUBVENTRICULAR ZONE; INHIBITORY SYNAPTIC CURRENTS; RAT CEREBELLAR SLICES; TRANSMITTER RELEASE; LASER PHOTOLYSIS; MINI AMPLITUDE; PURKINJE-CELLS; STELLATE CELLS; BASKET CELLS	Miniature synaptic currents have long been known to represent random transmitter release under resting conditions, but much remains to be learned about their nature and function in central synapses. In this work, we describe a new class of miniature currents ("preminis") that arise by the autocrine activation of axonal receptors following random vesicular release. Preminis are prominent in gabaergic synapses made by cerebellar interneurons during the development of the molecular layer. Unlike ordinary miniature postsynaptic currents in the same cells, premini frequencies are strongly enhanced by subthreshold depolarization, suggesting that the membrane depolarization they produce belongs to a feedback loop regulating neurotransmitter release. Thus, preminis could guide the formation of the interneuron network by enhancing neurotransmitter release at recently formed synaptic contacts.	[Trigo, Federico F.; Bouhours, Brice; Ogden, David; Marty, Alain] Univ Paris 05, CNRS, Unite 8118, F-75006 Paris, France; [Rostaing, Philippe; Triller, Antoine] Ecole Normale Super, CNRS, Unite 789, F-75005 Paris, France; [Papageorgiou, George; Corrie, John E. T.] Natl Inst Med Res, MRC, London NW7 1AA, England	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); MRC National Institute for Medical Research	Marty, A (corresponding author), Univ Paris 05, CNRS, Unite 8118, F-75006 Paris, France.	alain.marty@univ-paris5.fr	Papageorgiou, George/L-1765-2016	Papageorgiou, George/0000-0002-8960-5836; TRILLER, Antoine/0000-0002-7530-1233	CNRS; IBRO; Agence Nationale pour la Recherche [BLAN08-2_313083]; Fondation pour la Recherche Medicale; EU [LSHM-CT-2007-037765]; UK Medical Research Council; Medical Research Council [MC_U117592730, U117512659, MC_U117532185] Funding Source: researchfish; MRC [MC_U117532185, MC_U117592730] Funding Source: UKRI	CNRS(Centre National de la Recherche Scientifique (CNRS)); IBRO; Agence Nationale pour la Recherche(French National Research Agency (ANR)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); EU(European Commission); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank CNRS and IBRO for supporting F.F.T. This work was supported by Agence Nationale pour la Recherche (project BLAN08-2_313083), Fondation pour la Recherche Medicale, the EU (Photolysis' LSHM-CT-2007-037765) and UK Medical Research Council. We thank M. Hausser for a conversation that led us to the search for preminis, Jason Rothman for making his Neuromatic analysis program available to us, and Christophe Pouzat for help in the calculations of Figure 8.	Alle H, 2006, SCIENCE, V311, P1290, DOI 10.1126/science.1119055; Alle H, 2007, J NEUROSCI, V27, P942, DOI 10.1523/JNEUROSCI.4996-06.2007; Auger C, 1997, NEURON, V19, P139, DOI 10.1016/S0896-6273(00)80354-2; Awatramani GB, 2005, NEURON, V48, P109, DOI 10.1016/j.neuron.2005.08.038; Ben-Ari Y, 2002, NAT REV NEUROSCI, V3, P728, DOI 10.1038/nrn920; Bolteus AJ, 2004, J NEUROSCI, V24, P7623, DOI 10.1523/JNEUROSCI.1999-04.2004; CAPOGNA M, 1995, J NEUROSCI, V15, P1249; Carter AG, 2002, NAT NEUROSCI, V5, P1309, DOI 10.1038/nn970; Chattopadhyaya B, 2007, NEURON, V54, P889, DOI 10.1016/j.neuron.2007.05.015; Chavas J, 2003, J NEUROSCI, V23, P2019; Clements JD, 1997, BIOPHYS J, V73, P220, DOI 10.1016/S0006-3495(97)78062-7; Duguid IC, 2007, J NEUROSCI, V27, P12464, DOI 10.1523/JNEUROSCI.0178-07.2007; Duguid IC, 2004, NAT NEUROSCI, V7, P525, DOI 10.1038/nn1227; FATT P, 1952, J PHYSIOL-LONDON, V117, P109; Frank CA, 2006, NEURON, V52, P663, DOI 10.1016/j.neuron.2006.09.029; FRERKING M, 1995, NEURON, V15, P885, DOI 10.1016/0896-6273(95)90179-5; Fritschy JM, 2006, J NEUROSCI, V26, P3245, DOI 10.1523/JNEUROSCI.5118-05.2006; Hori T, 2009, J PHYSIOL-LONDON, V587, P2987, DOI 10.1113/jphysiol.2009.168765; Huang H, 2008, NEURON, V60, P975, DOI 10.1016/j.neuron.2008.10.052; Kennedy HJ, 2002, J PHYSIOL-LONDON, V539, P15, DOI 10.1113/jphysiol.2001.013171; Khirug S, 2008, J NEUROSCI, V28, P4635, DOI 10.1523/JNEUROSCI.0908-08.2008; Kondo S, 1998, J PHYSIOL-LONDON, V509, P221, DOI 10.1111/j.1469-7793.1998.221bo.x; Kullmann DM, 2005, PROG BIOPHYS MOL BIO, V87, P33, DOI 10.1016/j.pbiomolbio.2004.06.003; Liu XX, 2005, NAT NEUROSCI, V8, P1179, DOI 10.1038/nn1522; LLANO I, 1993, J PHYSIOL-LONDON, V468, P177, DOI 10.1113/jphysiol.1993.sp019766; Llano I, 2000, NAT NEUROSCI, V3, P1256, DOI 10.1038/81781; Mann-Metzer P, 1999, J NEUROSCI, V19, P3298; McKinney RA, 1999, NAT NEUROSCI, V2, P44, DOI 10.1038/4548; Mejia-Gervacio S, 2006, J PHYSIOL-LONDON, V571, P43, DOI 10.1113/jphysiol.2005.101675; Mejia-Gervacio S, 2007, NEURON, V53, P843, DOI 10.1016/j.neuron.2007.02.023; Neher E, 2008, NEURON, V59, P861, DOI 10.1016/j.neuron.2008.08.019; Nusser Z, 1997, NEURON, V19, P697, DOI 10.1016/S0896-6273(00)80382-7; Pinheiro PS, 2008, NAT REV NEUROSCI, V9, P423, DOI 10.1038/nrn2379; Pouzat C, 1999, J NEUROSCI, V19, P1675; Pouzat C, 1997, J NEUROSCI, V17, P9104; Price GD, 2006, J NEUROSCI, V26, P11432, DOI 10.1523/JNEUROSCI.1660-06.2006; RALL W, 1985, VOLTAGE PATCH CLAMPI, P191; Sahara Y, 2001, J PHYSIOL-LONDON, V536, P189, DOI 10.1111/j.1469-7793.2001.00189.x; Sakaba T, 2008, NEURON, V57, P406, DOI 10.1016/j.neuron.2007.11.029; Sara Y, 2005, NEURON, V45, P563, DOI 10.1016/j.neuron.2004.12.056; Scott R, 2008, J NEUROSCI, V28, P7765, DOI 10.1523/JNEUROSCI.1296-08.2008; Shu YS, 2006, NATURE, V441, P761, DOI 10.1038/nature04720; Southan AP, 2000, J PHYSIOL-LONDON, V526, P91, DOI 10.1111/j.1469-7793.2000.t01-1-00091.x; Sultan F, 1998, J COMP NEUROL, V393, P353; Sutton MA, 2004, SCIENCE, V304, P1979, DOI 10.1126/science.1096202; Szabadics J, 2006, SCIENCE, V311, P233, DOI 10.1126/science.1121325; Trigo FF, 2008, EUR J NEUROSCI, V28, P841, DOI 10.1111/j.1460-9568.2008.06404.x; Trigo FF, 2007, J NEUROSCI, V27, P12452, DOI 10.1523/JNEUROSCI.3413-07.2007; Trigo FF, 2009, J NEUROSCI METH, V181, P159, DOI 10.1016/j.jneumeth.2009.04.022; Trigo FF, 2009, J NEUROSCI METH, V180, P9, DOI 10.1016/j.jneumeth.2009.01.032; Turecek R, 2001, NATURE, V411, P587, DOI 10.1038/35079084; VAUTRIN J, 1994, J PHYSIOL-LONDON, V479, P53, DOI 10.1113/jphysiol.1994.sp020277; Vicini S, 2001, J NEUROSCI, V21, P3009, DOI 10.1523/JNEUROSCI.21-09-03009.2001; Wang DD, 2009, J PHYSIOL-LONDON, V587, P1873, DOI 10.1113/jphysiol.2008.167635	54	37	37	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 29	2010	66	2					235	247		10.1016/j.neuron.2010.03.030	http://dx.doi.org/10.1016/j.neuron.2010.03.030			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	591NQ	20435000	Bronze			2022-12-24	WOS:000277308200009
J	Liu, Y; Formisano, L; Savtchouk, I; Takayasu, Y; Szabo, G; Zukin, RS; Liu, SJ				Liu, Yu; Formisano, Luigi; Savtchouk, Iaroslav; Takayasu, Yukihiro; Szabo, Gabor; Zukin, R. Suzanne; Liu, Siqiong June			A single fear-inducing stimulus induces a transcription-dependent switch in synaptic AMPAR phenotype	NATURE NEUROSCIENCE			English	Article							CEREBELLAR STELLATE CELLS; LONG-TERM POTENTIATION; RECEPTOR TRAFFICKING; EXCITATORY SYNAPSES; CA2+ PERMEABILITY; MESSENGER-RNAS; PLASTICITY; ACTIVATION; EXPRESSION; CHANNELS	Changes in emotional state are known to alter neuronal excitability and can modify learning and memory formation. Such experience-dependent neuronal plasticity can be long-lasting and is thought to involve the regulation of gene transcription. We found that a single fear-inducing stimulus increased GluR2 (also known as Gria2) mRNA abundance and promoted synaptic incorporation of GluR2-containing AMPA receptors (AMPARs) in mouse cerebellar stellate cells. The switch in synaptic AMPAR phenotype was mediated by noradrenaline and action potential prolongation. The subsequent rise in intracellular Ca2+ and activation of Ca2+-sensitive ERK/MAPK signaling triggered new GluR2 gene transcription and a switch in the synaptic AMPAR phenotype from GluR2-lacking, Ca2+-permeable receptors to GluR2-containing, Ca2+-impermeable receptors on the order of hours. The change in glutamate receptor phenotype altered synaptic efficacy in cerebellar stellate cells. Thus, a single fear-inducing stimulus can induce a long-term change in synaptic receptor phenotype and may alter the activity of an inhibitory neural network.	[Liu, Yu; Savtchouk, Iaroslav; Liu, Siqiong June] Penn State Univ, Dept Biol, University Pk, PA 16802 USA; [Formisano, Luigi; Takayasu, Yukihiro] Albert Einstein Coll Med, Dominick P Purpura Dept Neurosci, Bronx, NY 10467 USA; [Savtchouk, Iaroslav; Liu, Siqiong June] Louisiana State Univ, Hlth Sci Ctr, Ctr Neurosci, Dept Cell Biol & Anat, New Orleans, LA USA; [Szabo, Gabor] Hungarian Acad Sci, Inst Expt Med, Lab Mol Biol & Genet, Budapest, Hungary	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Yeshiva University; Albert Einstein College of Medicine; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine	Liu, SJ (corresponding author), Penn State Univ, Dept Biol, University Pk, PA 16802 USA.	sliu@lsuhsc.edu		Formisano, Luigi/0000-0001-7294-8595; Savtchouk, Iaroslav (Alex)/0000-0001-8197-7232	National Science Foundation [IBN-0344559]; US National Institutes of Health [NS58867, NS46742]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS058867, R01NS046742] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank D. Grove and S. Acharjee for scientific input, and M.V.L. Bennett, B. Luscher, P.E. Castillo, L.K. Kaczmarek and M. Whim for helpful discussions and comments on the manuscript. This work was supported by National Science Foundation grant IBN-0344559 and US National Institutes of Health grant NS58867 (S.Q.J.L.) and by US National Institutes of Health grant NS46742 (R.S.Z.). R.S.Z. is the F. M. Kirby Professor in Neural Repair and Protection.	Barco A, 2002, CELL, V108, P689, DOI 10.1016/S0092-8674(02)00657-8; Barry MF, 2002, CURR OPIN NEUROBIOL, V12, P279, DOI 10.1016/S0959-4388(02)00329-X; BICKFORDWIMER P, 1991, BRAIN RES, V558, P305, DOI 10.1016/0006-8993(91)90782-Q; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; CAHILL L, 1994, NATURE, V371, P702, DOI 10.1038/371702a0; Calderone A, 2003, J NEUROSCI, V23, P2112; Cartford MC, 2004, LEARN MEMORY, V11, P732, DOI 10.1101/lm.83104; Chowdhury S, 2006, NEURON, V52, P445, DOI 10.1016/j.neuron.2006.08.033; Cull-Candy S, 2006, CURR OPIN NEUROBIOL, V16, P288, DOI 10.1016/j.conb.2006.05.012; Deisseroth K, 1998, NATURE, V392, P198, DOI 10.1038/32448; Dolmetsch RE, 2001, SCIENCE, V294, P333, DOI 10.1126/science.1063395; Fuchs EC, 2001, P NATL ACAD SCI USA, V98, P3571, DOI 10.1073/pnas.051631898; Gardner SM, 2005, NEURON, V45, P903, DOI 10.1016/j.neuron.2005.02.026; GEIGER JRP, 1995, NEURON, V15, P193, DOI 10.1016/0896-6273(95)90076-4; Hayley S, 2001, BRAIN RES, V892, P293, DOI 10.1016/S0006-8993(00)03262-5; Hu HL, 2007, CELL, V131, P160, DOI 10.1016/j.cell.2007.09.017; Ibata K, 2008, NEURON, V57, P819, DOI 10.1016/j.neuron.2008.02.031; Isaac JTR, 2007, NEURON, V54, P859, DOI 10.1016/j.neuron.2007.06.001; Jonas P, 2004, TRENDS NEUROSCI, V27, P30, DOI 10.1016/j.tins.2003.10.010; Ju W, 2004, NAT NEUROSCI, V7, P244, DOI 10.1038/nn1189; Kandel ER, 2001, BIOSCIENCE REP, V21, P565, DOI 10.1023/A:1014775008533; Kondo S, 1998, J PHYSIOL-LONDON, V509, P233, DOI 10.1111/j.1469-7793.1998.233bo.x; Kopec CD, 2007, NEUROPHARMACOLOGY, V52, P228, DOI 10.1016/j.neuropharm.2006.07.028; Liu SH, 2004, NEURON, V43, P43, DOI 10.1016/j.neuron.2004.06.017; Liu SJ, 2007, TRENDS NEUROSCI, V30, P126, DOI 10.1016/j.tins.2007.01.006; Liu SJ, 2006, J NEUROSCI, V26, P9332, DOI 10.1523/JNEUROSCI.2929-06.2006; Liu SQJ, 2005, NAT NEUROSCI, V8, P768, DOI 10.1038/nn1468; Liu SQJ, 2000, NATURE, V405, P454, DOI 10.1038/35013064; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Mameli M, 2007, SCIENCE, V317, P530, DOI 10.1126/science.1142365; Menuz K, 2007, SCIENCE, V318, P815, DOI 10.1126/science.1146317; Myers SJ, 1998, J NEUROSCI, V18, P6723; PERNEY TM, 1992, J NEUROPHYSIOL, V68, P756, DOI 10.1152/jn.1992.68.3.756; Rozov A, 1999, NATURE, V401, P594, DOI 10.1038/44151; Rudy B, 2001, TRENDS NEUROSCI, V24, P517, DOI 10.1016/S0166-2236(00)01892-0; Sacchetti B, 2004, NEURON, V42, P973, DOI 10.1016/j.neuron.2004.05.012; Sacchetti B, 2002, P NATL ACAD SCI USA, V99, P8406, DOI 10.1073/pnas.112660399; Saitow F, 2000, J NEUROPHYSIOL, V84, P2016, DOI 10.1152/jn.2000.84.4.2016; Saitow F, 2000, J NEUROPHYSIOL, V84, P2026, DOI 10.1152/jn.2000.84.4.2026; Salkoff L, 2006, NAT REV NEUROSCI, V7, P921, DOI 10.1038/nrn1992; Scelfo B, 2008, P NATL ACAD SCI USA, V105, P769, DOI 10.1073/pnas.0706342105; Seol GH, 2007, NEURON, V55, P919, DOI 10.1016/j.neuron.2007.08.013; SIGGINS GR, 1971, NATURE, V233, P481, DOI 10.1038/233481a0; Song I, 2002, TRENDS NEUROSCI, V25, P578, DOI 10.1016/S0166-2236(02)02270-1; Soto D, 2007, NAT NEUROSCI, V10, P1260, DOI 10.1038/nn1966; Sugino K, 2006, NAT NEUROSCI, V9, P99, DOI 10.1038/nn1618; Sun L, 2007, J PHYSIOL-LONDON, V583, P537, DOI 10.1113/jphysiol.2007.136788; Sutton MA, 2006, CELL, V125, P785, DOI 10.1016/j.cell.2006.03.040; Verde EMR, 2006, NEURON, V52, P461, DOI 10.1016/j.neuron.2006.09.031; West AE, 2002, NAT REV NEUROSCI, V3, P921, DOI 10.1038/nrn987	50	64	66	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2010	13	2					223	U112		10.1038/nn.2474	http://dx.doi.org/10.1038/nn.2474			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	548SE	20037575	Green Accepted			2022-12-24	WOS:000273985800018
J	Nagoshi, E; Sugino, K; Kula, E; Okazaki, E; Tachibana, T; Nelson, S; Rosbash, M				Nagoshi, Emi; Sugino, Ken; Kula, Ela; Okazaki, Etsuko; Tachibana, Taro; Nelson, Sacha; Rosbash, Michael			Dissecting differential gene expression within the circadian neuronal circuit of Drosophila	NATURE NEUROSCIENCE			English	Article							TRANSLATIONAL PROFILING APPROACH; CNS CELL-TYPES; PACEMAKER NEURONS; TIMELESS GENES; CLOCK NEURONS; PERIOD; MELANOGASTER; BEHAVIOR; BRAIN; CRYPTOCHROME	Behavioral circadian rhythms are controlled by a neuronal circuit consisting of diverse neuronal subgroups. To understand the molecular mechanisms underlying the roles of neuronal subgroups within the Drosophila circadian circuit, we used cell-type specific gene-expression profiling and identified a large number of genes specifically expressed in all clock neurons or in two important subgroups. Moreover, we identified and characterized two circadian genes, which are expressed specifically in subsets of clock cells and affect different aspects of rhythms. The transcription factor Fer2 is expressed in ventral lateral neurons; it is required for the specification of lateral neurons and therefore their ability to drive locomotor rhythms. The Drosophila melanogaster homolog of the vertebrate circadian gene nocturnin is expressed in a subset of dorsal neurons and mediates the circadian light response. The approach should also enable the molecular dissection of many different Drosophila neuronal circuits.	[Nagoshi, Emi; Kula, Ela; Rosbash, Michael] Brandeis Univ, Howard Hughes Med Inst, Waltham, MA 02254 USA; [Nagoshi, Emi; Sugino, Ken; Kula, Ela; Nelson, Sacha; Rosbash, Michael] Brandeis Univ, Dept Biol, Natl Ctr Behav Genom, Waltham, MA 02254 USA; [Okazaki, Etsuko; Tachibana, Taro] Osaka City Univ, Grad Sch Engn, Dept Bioengn, Osaka 558, Japan	Brandeis University; Howard Hughes Medical Institute; Brandeis University; Osaka Metropolitan University	Rosbash, M (corresponding author), Brandeis Univ, Howard Hughes Med Inst, Waltham, MA 02254 USA.	rosbash@brandeis.edu		Nagoshi, Emi/0000-0002-6365-4074; Nelson, Sacha/0000-0002-0108-8599	Charles A. King Trust; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH066338] Funding Source: NIH RePORTER	Charles A. King Trust; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank P. Hardin ( Texas A&M University) for antisera to CLK as well as the Bloomington Stock Center, National Institute of Genetics of Japan (NIG) and Vienna Drosophila RNAi Center (VDRC) for fly stocks. We are grateful to J. Menet, W. Luo, K. Abruzzi, S. Bradley, L. Griffith, P. Garrity, S. Waddell, R. Allada, Y. Shang, P. Emery and J. Blau for comments on the manuscript. Y. Shang also provided the protocol for culture media preparation, and N. Francis helped with brain dissections. Some of this work was supported by a fellowship to E. N. from the Charles A. King Trust.	Bahn JH, 2009, GENETICS, V181, P965, DOI 10.1534/genetics.108.099069; Ceriani MF, 2002, J NEUROSCI, V22, P9305, DOI 10.1523/jneurosci.22-21-09305.2002; Claridge-Chang A, 2001, NEURON, V32, P657, DOI 10.1016/S0896-6273(01)00515-3; Doyle JP, 2008, CELL, V135, P749, DOI 10.1016/j.cell.2008.10.029; Emery P, 2000, NEURON, V26, P493, DOI 10.1016/S0896-6273(00)81181-2; Finkel T, 1998, CURR OPIN CELL BIOL, V10, P248, DOI 10.1016/S0955-0674(98)80147-6; Gallego M, 2007, NAT REV MOL CELL BIO, V8, P139, DOI 10.1038/nrm2106; Garbarino-Pico E, 2007, RNA, V13, P745, DOI 10.1261/rna.286507; Green CB, 2007, P NATL ACAD SCI USA, V104, P9888, DOI 10.1073/pnas.0702448104; Green CB, 1996, P NATL ACAD SCI USA, V93, P14884, DOI 10.1073/pnas.93.25.14884; Grima B, 2004, NATURE, V431, P869, DOI 10.1038/nature02935; Gronke S, 2009, GENETICS, V183, P219, DOI 10.1534/genetics.109.105601; Heiman M, 2008, CELL, V135, P738, DOI 10.1016/j.cell.2008.10.028; Hempel CM, 2007, NAT PROTOC, V2, P2924, DOI 10.1038/nprot.2007.416; Hoopfer ED, 2008, J NEUROSCI, V28, P6092, DOI 10.1523/JNEUROSCI.0677-08.2008; Hoshino M, 2005, NEURON, V47, P201, DOI 10.1016/j.neuron.2005.06.007; Houl JH, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-119; Jiang SJA, 2005, J NEUROPHYSIOL, V94, P491, DOI 10.1152/jn.00096.2005; Kadener S, 2007, GENE DEV, V21, P1675, DOI 10.1101/gad.1552607; Kaneko M, 2000, J COMP NEUROL, V422, P66, DOI 10.1002/(SICI)1096-9861(20000619)422:1<66::AID-CNE5>3.0.CO;2-2; Kaneko M, 1997, J NEUROSCI, V17, P6745; Keegan KP, 2007, PLOS COMPUT BIOL, V3, P2087, DOI 10.1371/journal.pcbi.0030208; KISHIRO Y, 1995, CELL STRUCT FUNCT, V20, P151, DOI 10.1247/csf.20.151; Klarsfeld A, 2004, J NEUROSCI, V24, P1468, DOI 10.1523/JNEUROSCI.3661-03.2004; Kloss B, 1998, CELL, V94, P97, DOI 10.1016/S0092-8674(00)81225-8; KONOPKA RJ, 1989, J NEUROGENET, V6, P1, DOI 10.3109/01677068909107096; Krapp A, 1998, GENE DEV, V12, P3752, DOI 10.1101/gad.12.23.3752; Kuppers-Munther B, 2004, DEV BIOL, V269, P459, DOI 10.1016/j.ydbio.2004.01.038; Lin FJ, 2001, MOL CELL BIOL, V21, P7287, DOI 10.1128/MCB.21.21.7287-7294.2001; Lin Y, 2002, P NATL ACAD SCI USA, V99, P9562, DOI 10.1073/pnas.132269699; Mazzoni EO, 2005, NEURON, V45, P293, DOI 10.1016/j.neuron.2004.12.038; McDonald MJ, 2001, CELL, V107, P567, DOI 10.1016/S0092-8674(01)00545-1; Moore AW, 2000, P NATL ACAD SCI USA, V97, P10436, DOI 10.1073/pnas.170301897; Murad A, 2007, NEURON, V53, P689, DOI 10.1016/j.neuron.2007.01.034; Park JH, 2000, P NATL ACAD SCI USA, V97, P3608, DOI 10.1073/pnas.070036197; Picot M, 2007, PLOS BIOL, V5, P2513, DOI 10.1371/journal.pbio.0050315; Rieger D, 2006, J NEUROSCI, V26, P2531, DOI 10.1523/JNEUROSCI.1234-05.2006; Roy PJ, 2002, NATURE, V418, P975, DOI 10.1038/nature01012; Rutila JE, 1998, CELL, V93, P805, DOI 10.1016/S0092-8674(00)81441-5; Sathyanarayanan S, 2008, GENE DEV, V22, P1522, DOI 10.1101/gad.1652308; Shafer OT, 2002, J NEUROSCI, V22, P5946; Stoleru D, 2004, NATURE, V431, P862, DOI 10.1038/nature02926; Stoleru D, 2007, CELL, V129, P207, DOI 10.1016/j.cell.2007.02.038; Sugino K, 2006, NAT NEUROSCI, V9, P99, DOI 10.1038/nn1618; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Ueda HR, 2002, J BIOL CHEM, V277, P14048, DOI 10.1074/jbc.C100765200; Wang Y, 2001, BMC Dev Biol, V1, P9, DOI 10.1186/1471-213X-1-9; Yang ZY, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni149; Yoshii T, 2008, J COMP NEUROL, V508, P952, DOI 10.1002/cne.21702; Yu WJ, 2006, J CELL SCI, V119, P4793, DOI 10.1242/jcs.03174	50	109	111	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2010	13	1					60	U220		10.1038/nn.2451	http://dx.doi.org/10.1038/nn.2451			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	536PM	19966839	Green Accepted			2022-12-24	WOS:000273056300014
J	Busse, L; Wade, AR; Carandini, M				Busse, Laura; Wade, Alex R.; Carandini, Matteo			Representation of Concurrent Stimuli by Population Activity in Visual Cortex	NEURON			English	Article							CONTRAST-RESPONSE FUNCTION; AREA MT; STRIATE CORTEX; SIMPLE CELLS; HUMAN-VISION; ORIENTATION SELECTIVITY; ATTENTIONAL MODULATION; NEURONAL RESPONSES; SPATIAL SUMMATION; RECEPTIVE-FIELDS	How do neuronal populations represent concurrent stimuli? We measured population responses in cat primary visual cortex (V1) using electrode arrays. Population responses to two superimposed gratings were weighted sums of the individual grating responses. The weights depended strongly on the relative contrasts of the gratings. When the contrasts were similar, the population performed an approximately equal summation. When the contrasts differed markedly, however, the population performed approximately a winner-take-all competition. Stimuli that were intermediate to these extremes elicited intermediate responses. This entire range of behaviors was explained by a single model of contrast normalization. Normalization captured both the spike responses and the local field potential responses; it even predicted visually evoked currents source-localized to V1 in human subjects. Normalization has profound effects on V1 population responses and is likely to shape the interpretation of these responses by higher cortical areas.	[Busse, Laura; Carandini, Matteo] UCL, Inst Ophthalmol, London EC1V 9EL, England; [Busse, Laura; Wade, Alex R.; Carandini, Matteo] Smith Kettlewell Eye Res Inst, San Francisco, CA 94115 USA; [Wade, Alex R.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94117 USA	University of London; University College London; The Smith-Kettlewell Eye Research Institute; University of California System; University of California San Francisco	Busse, L (corresponding author), UCL, Inst Ophthalmol, London EC1V 9EL, England.	laura.busse@cin.uni-tuebingen.de	Wade, Alex/B-5473-2010; Carandini, Matteo/ABD-8296-2021	Carandini, Matteo/0000-0003-4880-7682; Wade, Alexander Robert/0000-0003-4871-2747	National Institutes of Health [EY-17396, EY-18157]; UK charity Fight for Sight; European Research Council; German Academy of Sciences Leopoldina [BMBF-LPD9901/8-165]; NATIONAL EYE INSTITUTE [R01EY017396, R01EY018157] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UK charity Fight for Sight; European Research Council(European Research Council (ERC)European Commission); German Academy of Sciences Leopoldina; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We are grateful to S. Katzner and A. Benucci for help with the experiments in cat, J. Rowland for help with the experiments in humans, and D. Fitzpatrick and S. MacEvoy for helpful discussions. This work was supported by National Institutes of Health (grants EY-17396 to M.C. and EY-18157 to A.R.W.), by a Project Grant from the UK charity Fight for Sight (to M.C.), by an Advanced Investigator Award to M.C. from the European Research Council, and by a postdoctoral fellowship of the German Academy of Sciences Leopoldina (BMBF-LPD9901/8-165 to L.B.). M.C. holds the GlaxoSmithKline/Fight for Sight Chair in Visual Neuroscience.	ALBRECHT DG, 1982, J NEUROPHYSIOL, V48, P217, DOI 10.1152/jn.1982.48.1.217; ALBRECHT DG, 1991, VISUAL NEUROSCI, V7, P531, DOI 10.1017/S0952523800010336; Appelbaum LG, 2006, J NEUROSCI, V26, P11695, DOI 10.1523/JNEUROSCI.2741-06.2006; Britten KH, 1999, J NEUROSCI, V19, P5074; BURR DC, 1987, J PHYSIOL-LONDON, V389, P1; Candy TR, 2001, J NEUROSCI, V21, P4530, DOI 10.1523/JNEUROSCI.21-12-04530.2001; Carandini M, 1997, J NEUROSCI, V17, P8621; Carandini M, 2004, J VISION, V4, P130, DOI 10.1167/4.3.1; Carandini M, 2002, J NEUROSCI, V22, P10053; Chance FS, 2002, NEURON, V35, P773, DOI 10.1016/S0896-6273(02)00820-6; Chen YZ, 2006, NAT NEUROSCI, V9, P1412, DOI 10.1038/nn1792; DEANGELIS GC, 1992, J NEUROPHYSIOL, V68, P144, DOI 10.1152/jn.1992.68.1.144; Engel SA, 1997, CEREB CORTEX, V7, P181, DOI 10.1093/cercor/7.2.181; Finn IM, 2007, NEURON, V54, P137, DOI 10.1016/j.neuron.2007.02.029; Freeman TCB, 2002, NEURON, V35, P759, DOI 10.1016/S0896-6273(02)00819-X; GEORGOPOULOS AP, 1986, SCIENCE, V233, P1416, DOI 10.1126/science.3749885; GEORGOPOULOS AP, 1982, J NEUROSCI, V2, P1527; Ghose GM, 2008, J NEUROSCI, V28, P5115, DOI 10.1523/JNEUROSCI.0138-08.2008; HAMALAINEN MS, 1994, MED BIOL ENG COMPUT, V32, P35, DOI 10.1007/BF02512476; Heeger D. J., 1991, COMPUTATIONAL MODELS, P119; HEEGER DJ, 1992, VISUAL NEUROSCI, V9, P181, DOI 10.1017/S0952523800009640; Heuer HW, 2002, J NEUROPHYSIOL, V88, P3398, DOI 10.1152/jn.00255.2002; Katzner S, 2009, NEURON, V61, P35, DOI 10.1016/j.neuron.2008.11.016; Keller CH, 2005, J NEUROSCI, V25, P10446, DOI 10.1523/JNEUROSCI.2093-05.2005; Kouh M, 2008, NEURAL COMPUT, V20, P1427, DOI 10.1162/neco.2008.02-07-466; KUMBHANI RD, 2008, 2008 NEUR M PLANN WA; Lee DK, 1999, NAT NEUROSCI, V2, P375, DOI 10.1038/7286; MacEvoy SP, 2009, NAT NEUROSCI, V12, P637, DOI 10.1038/nn.2310; Martinez-Trujillo JC, 2004, CURR BIOL, V14, P744, DOI 10.1016/j.cub.2004.04.028; Martinez-Trujillo JC, 2002, NEURON, V35, P365, DOI 10.1016/S0896-6273(02)00778-X; MCILWAIN JT, 1986, TRENDS NEUROSCI, V9, P354; MORAN J, 1985, SCIENCE, V229, P782, DOI 10.1126/science.4023713; MORRONE MC, 1982, PROC R SOC SER B-BIO, V216, P335, DOI 10.1098/rspb.1982.0078; MORRONE MC, 1986, NATURE, V321, P235, DOI 10.1038/321235a0; Movshon JA, 1985, STUDY GROUP PATTERN, P117, DOI [DOI 10.1007/978-3-662-09224-8_7., DOI 10.1007/978-3-662-09224-8_]; NICOLELIS MAL, 1995, SCIENCE, V268, P1353, DOI 10.1126/science.7761855; Pasupathy A, 2002, NAT NEUROSCI, V5, P1332, DOI 10.1038/nn972; Petrov Y, 2005, J NEUROSCI, V25, P8704, DOI 10.1523/JNEUROSCI.2871-05.2005; Pouget A, 2000, NAT REV NEUROSCI, V1, P125, DOI 10.1038/35039062; Priebe NJ, 2006, NAT NEUROSCI, V9, P552, DOI 10.1038/nn1660; Purushothaman G, 2005, NAT NEUROSCI, V8, P99, DOI 10.1038/nn1373; Regan D., 1989, HUMAN BRAIN ELECTROP, P70; Reynolds JH, 1999, J NEUROSCI, V19, P1736; Reynolds JH, 2000, NEURON, V26, P703, DOI 10.1016/S0896-6273(00)81206-4; Reynolds JH, 2009, NEURON, V61, P168, DOI 10.1016/j.neuron.2009.01.002; Ringach DL, 2002, J NEUROSCI, V22, P5639; ROSS J, 1991, P ROY SOC B-BIOL SCI, V246, P61, DOI 10.1098/rspb.1991.0125; Rust NC, 2006, NAT NEUROSCI, V9, P1421, DOI 10.1038/nn1786; SCHROEDER CE, 1991, VISION RES, V31, P1143, DOI 10.1016/0042-6989(91)90040-C; SCLAR G, 1982, EXP BRAIN RES, V46, P457; Sheliga BM, 2006, VISION RES, V46, P2041, DOI 10.1016/j.visres.2005.11.033; Simoncelli EP, 1998, VISION RES, V38, P743, DOI 10.1016/S0042-6989(97)00183-1; STONE LS, 1990, VISION RES, V30, P1049, DOI 10.1016/0042-6989(90)90114-Z; Treue S, 1999, NATURE, V399, P575, DOI 10.1038/21176; Treue S, 2000, NAT NEUROSCI, V3, P270, DOI 10.1038/72985	55	137	141	2	19	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	DEC 24	2009	64	6					931	942		10.1016/j.neuron.2009.11.004	http://dx.doi.org/10.1016/j.neuron.2009.11.004			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	541ON	20064398	Bronze, Green Accepted			2022-12-24	WOS:000273425800018
J	Abramov, E; Dolev, I; Fogel, H; Ciccotosto, GD; Ruff, E; Slutsky, I				Abramov, Efrat; Dolev, Iftach; Fogel, Hilla; Ciccotosto, Giuseppe D.; Ruff, Eyal; Slutsky, Inna			Amyloid-beta as a positive endogenous regulator of release probability at hippocampal synapses	NATURE NEUROSCIENCE			English	Article							SYNAPTIC PLASTICITY; ALZHEIMERS-DISEASE; ELECTROPHYSIOLOGICAL CHANGES; MICE LACKING; MOUSE MODEL; A-BETA; PROTEIN; DEFICITS; PEPTIDE; MEMORY	Accumulation of cerebral amyloid-beta peptide (A Beta) is essential for developing synaptic and cognitive deficits in Alzheimer's disease. However, the physiological functions of A beta, as well as the primary mechanisms that initiate early A beta-mediated synaptic dysfunctions, remain largely unknown. Here we examine the acute effects of endogenously released A beta peptides on synaptic transfer at single presynaptic terminals and synaptic connections in rodent hippocampal cultures and slices. Increasing extracellular A beta by inhibiting its degradation enhanced release probability, boosting ongoing activity in the hippocampal network. Presynaptic enhancement mediated by A beta was found to depend on the history of synaptic activation, with lower impact at higher firing rates. Notably, both elevation and reduction in A beta levels attenuated short-term synaptic facilitation during bursts in excitatory synaptic connections. These observations suggest that endogenous A beta peptides have a crucial role in activity-dependent regulation of synaptic vesicle release and might point to the primary pathological events that lead to compensatory synapse loss in Alzheimer's disease.	[Abramov, Efrat; Dolev, Iftach; Fogel, Hilla; Ruff, Eyal; Slutsky, Inna] Tel Aviv Univ, Sackler Fac Med, Dept Physiol & Pharmacol, IL-69978 Tel Aviv, Israel; [Ciccotosto, Giuseppe D.] Univ Melbourne, Dept Pathol, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic 3052, Australia; [Ciccotosto, Giuseppe D.] Univ Melbourne, Mental Hlth Res Inst, Parkville, Vic 3052, Australia	Tel Aviv University; Sackler Faculty of Medicine; University of Melbourne; Florey Institute of Neuroscience & Mental Health; University of Melbourne	Slutsky, I (corresponding author), Tel Aviv Univ, Sackler Fac Med, Dept Physiol & Pharmacol, IL-69978 Tel Aviv, Israel.	islutsky@post.tau.ac.il		Slutsky, Inna/0000-0002-0700-2266	Rosalinde and Arthur Gilbert Foundation/American Federation for Aging Research research grant; Legacy Heritage Biomedical Program of the Israel Science Foundation; Israel Ministry of Health; National Institute of Psychobiology in Israel founded by the Charles E. Smith family; Center for Nanoscience and Nanotechnology of Tel Aviv University	Rosalinde and Arthur Gilbert Foundation/American Federation for Aging Research research grant; Legacy Heritage Biomedical Program of the Israel Science Foundation; Israel Ministry of Health; National Institute of Psychobiology in Israel founded by the Charles E. Smith family; Center for Nanoscience and Nanotechnology of Tel Aviv University	We thank A. Lee and M. Wilson for sharing unpublished data on 'natural' spike sequence, D. M. Holtzman for providing the HJ5.1 hybridoma cell line, A. I. Bush, R. Cappai and H. Zheng for App<SUP>-/-</SUP> mice, C. Kaether for the human APP695-YFP cDNA construct, and the members of our laboratory for comments on the manuscript. We thank A. I. Bush and E. Gazit for discussions. This work was supported by a Rosalinde and Arthur Gilbert Foundation/American Federation for Aging Research research grant (I. S.), the Legacy Heritage Biomedical Program of the Israel Science Foundation (I. S.), the Israel Ministry of Health (I. S.), the National Institute of Psychobiology in Israel founded by the Charles E. Smith family (I. S.), and the Center for Nanoscience and Nanotechnology of Tel Aviv University (I. D.).	Abbott LF, 2004, NATURE, V431, P796, DOI 10.1038/nature03010; Brody DL, 2008, SCIENCE, V321, P1221, DOI 10.1126/science.1161591; Buckner RL, 2005, J NEUROSCI, V25, P7709, DOI 10.1523/JNEUROSCI.2177-05.2005; Cirrito JR, 2008, NEURON, V58, P42, DOI 10.1016/j.neuron.2008.02.003; Cirrito JR, 2005, NEURON, V48, P913, DOI 10.1016/j.neuron.2005.10.028; Dawson GR, 1999, NEUROSCIENCE, V90, P1, DOI 10.1016/S0306-4522(98)00410-2; De Strooper B, 2000, J CELL SCI, V113, P1857; Debanne D, 1996, J PHYSIOL-LONDON, V491, P163, DOI 10.1113/jphysiol.1996.sp021204; DEKOSKY ST, 1990, ANN NEUROL, V27, P457, DOI 10.1002/ana.410270502; DEVAULT A, 1987, EMBO J, V6, P1317, DOI 10.1002/j.1460-2075.1987.tb02370.x; Dobrunz LE, 1997, NEURON, V18, P995, DOI 10.1016/S0896-6273(00)80338-4; HAASS C, 1992, NATURE, V359, P322, DOI 10.1038/359322a0; Haass C, 2004, EMBO J, V23, P483, DOI 10.1038/sj.emboj.7600061; Hartley DM, 1999, J NEUROSCI, V19, P8876, DOI 10.1523/JNEUROSCI.19-20-08876.1999; Hsia AY, 1999, P NATL ACAD SCI USA, V96, P3228, DOI 10.1073/pnas.96.6.3228; Hsieh H, 2006, NEURON, V52, P831, DOI 10.1016/j.neuron.2006.10.035; Iwata N, 2005, PHARMACOL THERAPEUT, V108, P129, DOI 10.1016/j.pharmthera.2005.03.010; Iwata N, 2004, J NEUROSCI, V24, P991, DOI 10.1523/JNEUROSCI.4792-03.2004; Iwata N, 2000, NAT MED, V6, P143, DOI 10.1038/72237; Iwata N, 2001, SCIENCE, V292, P1550, DOI 10.1126/science.1059946; Jacobsen JS, 2006, P NATL ACAD SCI USA, V103, P5161, DOI 10.1073/pnas.0600948103; Kaether C, 2000, MOL BIOL CELL, V11, P1213, DOI 10.1091/mbc.11.4.1213; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; KATZ B, 1968, J PHYSIOL-LONDON, V195, P481, DOI 10.1113/jphysiol.1968.sp008469; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Lisman JE, 1997, TRENDS NEUROSCI, V20, P38, DOI 10.1016/S0166-2236(96)10070-9; Lisman JE, 2007, NAT REV NEUROSCI, V8, P597, DOI 10.1038/nrn2191; Lou XL, 2005, NATURE, V435, P497, DOI 10.1038/nature03568; Murthy VN, 1997, NEURON, V18, P599, DOI 10.1016/S0896-6273(00)80301-3; Nimmrich V, 2008, J NEUROSCI, V28, P788, DOI 10.1523/JNEUROSCI.4771-07.2008; Ohno M, 2004, NEURON, V41, P27, DOI 10.1016/S0896-6273(03)00810-9; Palop JJ, 2007, NEURON, V55, P697, DOI 10.1016/j.neuron.2007.07.025; Puzzo D, 2008, J NEUROSCI, V28, P14537, DOI 10.1523/JNEUROSCI.2692-08.2008; RYAN TA, 1993, NEURON, V11, P713, DOI 10.1016/0896-6273(93)90081-2; Saura CA, 2004, NEURON, V42, P23, DOI 10.1016/S0896-6273(04)00182-5; SCHEFF SW, 1990, NEUROBIOL AGING, V11, P29, DOI 10.1016/0197-4580(90)90059-9; Seabrook GR, 1999, NEUROPHARMACOLOGY, V38, P349, DOI 10.1016/S0028-3908(98)00204-4; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Selkoe DJ, 2001, NEURON, V32, P177, DOI 10.1016/S0896-6273(01)00475-5; SEUBERT P, 1992, NATURE, V359, P325, DOI 10.1038/359325a0; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007; Shirotani K, 2001, J BIOL CHEM, V276, P21895, DOI 10.1074/jbc.M008511200; SHOJI M, 1992, SCIENCE, V258, P126, DOI 10.1126/science.1439760; Slutsky I, 2004, NEURON, V44, P835, DOI 10.1016/j.neuron.2004.11.013; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Ye CP, 2004, NEUROSCI LETT, V366, P320, DOI 10.1016/j.neulet.2004.05.060; Zakharenko SS, 2001, NAT NEUROSCI, V4, P711, DOI 10.1038/89498; ZHENG H, 1995, CELL, V81, P525, DOI 10.1016/0092-8674(95)90073-X; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	50	366	379	0	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2009	12	12					1567	U120		10.1038/nn.2433	http://dx.doi.org/10.1038/nn.2433			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	523II	19935655				2022-12-24	WOS:000272065600017
J	Leinders-Zufall, T; Ishii, T; Mombaerts, P; Zufall, F; Boehm, T				Leinders-Zufall, Trese; Ishii, Tomohiro; Mombaerts, Peter; Zufall, Frank; Boehm, Thomas			Structural requirements for the activation of vomeronasal sensory neurons by MHC peptides	NATURE NEUROSCIENCE			English	Article							PUTATIVE PHEROMONE RECEPTORS; MAJOR HISTOCOMPATIBILITY COMPLEX; PATCH-CLAMP ANALYSIS; OLFACTORY SYSTEM; MULTIGENE FAMILY; T-CELLS; ODORANT; ORGAN; EXPRESSION; GENES	In addition to their role in the immune response, peptide ligands of major histocompatibility complex (MHC) molecules function as olfactory cues for subsets of vomeronasal sensory neurons (VSNs) in the mammalian nose. How MHC peptide diversity is recognized and encoded by these cells is unclear. We found that mouse VSNs expressing the vomeronasal receptor gene V2r1b (also known as Vmn2r26) detected MHC peptides at subpicomolar concentrations and exhibited combinatorial activation with overlapping specificities. In a given cell, peptide responsiveness was broad, but highly specific; peptides differing by a single amino-acid residue could be distinguished. Cells transcribing a V2r1b locus that has been disrupted by gene targeting no longer showed such peptide responses. Our results reveal fundamental parameters governing the response to MHC peptides by VSNs. We suggest that the peptide presentation system provided by MHC molecules co-evolves with the peptide recognition systems expressed by T cells and VSNs.	[Leinders-Zufall, Trese; Zufall, Frank] Univ Saarland, Sch Med, Dept Physiol, D-6650 Homburg, Germany; [Ishii, Tomohiro; Mombaerts, Peter] Rockefeller Univ, New York, NY 10021 USA; [Ishii, Tomohiro; Mombaerts, Peter] Max Planck Inst Biophys, D-6000 Frankfurt, Germany; [Boehm, Thomas] Max Planck Inst Immunobiol, D-7800 Freiburg, Germany	Saarland University; Rockefeller University; Max Planck Society; Max Planck Society	Zufall, F (corresponding author), Univ Saarland, Sch Med, Dept Physiol, D-6650 Homburg, Germany.	frank.zufall@uks.eu; boehm@immunbio.mpg.de	Zufall, Frank/AAE-5290-2021; Leinders-Zufall, Trese/B-4103-2009; Leinders-Zufall, Trese/S-3664-2019	Zufall, Frank/0000-0002-4383-8618; Leinders-Zufall, Trese/0000-0002-0678-362X; Leinders-Zufall, Trese/0000-0002-0678-362X	Volkswagen Foundation; Deutsche Forschungsgemeinschaft [Sonderforschungsbereich 530, Schwerpunktprogramm 1392]; Max Planck Society; US National Institutes of Health	Volkswagen Foundation(Volkswagen); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Max Planck Society(Max Planck Society); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank M. Konzmann for excellent technical assistance, R. Escher for peptide synthesis, K. Del Punta for a backbone plasmid of the gene targeting vector, W. Tang for blastocyst injections of ES cells and B. Bufe for comments and discussion. This work was supported by the Volkswagen Foundation (T. L.-Z.), Deutsche Forschungsgemeinschaft grants Sonderforschungsbereich 530 (F. Z.) and Schwerpunktprogramm 1392 (F. Z. and P. M.), the Max Planck Society (T. I., P. M. and T. B.), and the US National Institutes of Health (F. Z. and P. M.).	Boehm T, 2006, TRENDS NEUROSCI, V29, P100, DOI 10.1016/j.tins.2005.11.006; Boehm T, 2006, CELL, V125, P845, DOI 10.1016/j.cell.2006.05.017; Boschat C, 2002, NAT NEUROSCI, V5, P1261, DOI 10.1038/nn978; Bozza T, 2002, J NEUROSCI, V22, P3033, DOI 10.1523/JNEUROSCI.22-08-03033.2002; Brennan PA, 2006, NATURE, V444, P308, DOI 10.1038/nature05404; Chandrashekar J, 2006, NATURE, V444, P288, DOI 10.1038/nature05401; Cooper MD, 2006, CELL, V124, P815, DOI 10.1016/j.cell.2006.02.001; Davis MM, 2007, ANNU REV IMMUNOL, V25, P681, DOI 10.1146/annurev.immunol.24.021605.090600; DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0; Del Punta K, 2002, NEURON, V35, P1057, DOI 10.1016/S0896-6273(02)00904-2; Eason DD, 2004, SEMIN IMMUNOL, V16, P215, DOI 10.1016/j.smim.2004.08.001; Feinstein P, 2004, CELL, V117, P833, DOI 10.1016/j.cell.2004.05.013; Firestein S, 2001, NATURE, V413, P211, DOI 10.1038/35093026; Garcia KC, 2009, NAT IMMUNOL, V10, P143, DOI 10.1038/ni.f.219; Grosmaitre X, 2006, P NATL ACAD SCI USA, V103, P1970, DOI 10.1073/pnas.0508491103; Grus WE, 2009, MOL BIOL EVOL, V26, P407, DOI 10.1093/molbev/msn262; He J, 2008, SCIENCE, V320, P535, DOI 10.1126/science.1154476; Herrada G, 1997, CELL, V90, P763, DOI 10.1016/S0092-8674(00)80536-X; Huh GS, 2000, SCIENCE, V290, P2155, DOI 10.1126/science.290.5499.2155; Ishii T, 2008, J NEUROSCI, V28, P2332, DOI 10.1523/JNEUROSCI.4807-07.2008; Krogsgaard M, 2007, SEMIN IMMUNOL, V19, P236, DOI 10.1016/j.smim.2007.04.003; Leinders-Zufall T, 2004, SCIENCE, V306, P1033, DOI 10.1126/science.1102818; Leinders-Zufall T, 2000, NATURE, V405, P792, DOI 10.1038/35015572; Lucas P, 2003, NEURON, V40, P551, DOI 10.1016/S0896-6273(03)00675-5; Luo MM, 2004, CURR OPIN NEUROBIOL, V14, P428, DOI 10.1016/j.conb.2004.07.001; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Marrack P, 2008, ANNU REV IMMUNOL, V26, P171, DOI 10.1146/annurev.immunol.26.021607.090421; Matsunami H, 1997, CELL, V90, P775, DOI 10.1016/S0092-8674(00)80537-1; McConnell MJ, 2009, P NATL ACAD SCI USA, V106, P6784, DOI 10.1073/pnas.0902018106; Milinski M, 2006, ANNU REV ECOL EVOL S, V37, P159, DOI 10.1146/annurev.ecolsys.37.091305.110242; Mombaerts P, 2004, NAT REV NEUROSCI, V5, P263, DOI 10.1038/nrn1365; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; MOURITSEN S, 1992, J IMMUNOL, V149, P1987; PADOVAN E, 1993, SCIENCE, V262, P422, DOI 10.1126/science.8211163; RAMMENSEE HG, 1997, MHC LIGANDS PEPTIDE; Ryba NJP, 1997, NEURON, V19, P371, DOI 10.1016/S0896-6273(00)80946-0; Silvotti L, 2007, J NEUROCHEM, V103, P1753, DOI 10.1111/j.1471-4159.2007.04877.x; Slev PR, 2006, CURR OPIN IMMUNOL, V18, P608, DOI 10.1016/j.coi.2006.07.012; Spehr J, 2009, J NEUROSCI, V29, P2125, DOI 10.1523/JNEUROSCI.5416-08.2009; Spehr M, 2006, J NEUROSCI, V26, P1961, DOI 10.1523/JNEUROSCI.4939-05.2006; Ukhanov K, 2007, J NEUROPHYSIOL, V98, P2357, DOI 10.1152/jn.00642.2007; Wucherpfennig KW, 2005, CURR TOP MICROBIOL, V296, P19; Young JM, 2007, TRENDS GENET, V23, P212, DOI 10.1016/j.tig.2007.03.004	43	99	99	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2009	12	12					1551	U98		10.1038/nn.2452	http://dx.doi.org/10.1038/nn.2452			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	523II	19935653				2022-12-24	WOS:000272065600015
J	Zhang, YW; Liu, SJ; Zhang, X; Li, WB; Chen, YM; Huang, XM; Sun, LW; Luo, WJ; Netzer, WJ; Threadgill, R; Wiegand, G; Wang, RS; Cohen, SN; Greengard, P; Liao, FF; Li, LM; Xu, HX				Zhang, Yun-wu; Liu, Shijie; Zhang, Xue; Li, Wu-Bo; Chen, Yaomin; Huang, Xiumei; Sun, Liangwu; Luo, Wenjie; Netzer, William J.; Threadgill, Richard; Wiegand, Gordon; Wang, Ruishan; Cohen, Stanley N.; Greengard, Paul; Liao, Francesca-Fang; Li, Limin; Xu, Huaxi			A Functional Mouse Retroposed Gene Rps23r1 Reduces Alzheimer's beta-Amyloid Levels and Tau Phosphorylation	NEURON			English	Article							PROTEIN-KINASE-A; PRECURSOR PROTEIN; NEOPLASTIC TRANSFORMATION; PROCESSED PSEUDOGENES; RIBOSOMAL-PROTEIN; GSK-3 INHIBITORS; DISEASE; GENERATION; SECRETASE; DEFICIENCY	Senile plaques consisting of beta-amyloid (A beta) and neurofibrillary tangles composed of hyperphosphorylated tau are major pathological hallmarks of Alzheimer's disease (AD). Elucidation of factors that modulate A beta generation and tau hyperphosphorylation is crucial for AD intervention. Here, we identify a mouse gene Rps23r1 that originated through retroposition of ribosomal protein S23. We demonstrate that RPS23R1 protein reduces the levels of A beta and tau phosphorylation by interacting with adenylate cyclases to activate cAMP/PKA and thus inhibit GSK-3 activity. The function of Rps23r1 is demonstrated in cells of various species including human, and in transgenic mice overexpressing RPS23R1. Furthermore, the AD-like pathologies of triple transgenic AD mice were improved and levels of synaptic maker proteins increased after crossing them with Rps23r1 transgenic mice. Our studies reveal a new target/pathway for regulating AD pathologies and uncover a retrogene and its role in regulating protein kinase pathways.	[Li, Wu-Bo; Threadgill, Richard; Wiegand, Gordon; Li, Limin] Funct Genet Inc, Gaithersburg, MD 20878 USA; [Zhang, Yun-wu; Huang, Xiumei; Wang, Ruishan] Xiamen Univ, Inst Biomed Res, Xiamen 361005, Peoples R China; [Zhang, Yun-wu; Huang, Xiumei; Wang, Ruishan] Xiamen Univ, Fujian Prov Key Lab Neurodegenerat Dis & Aging Re, Xiamen 361005, Peoples R China; [Zhang, Yun-wu; Liu, Shijie; Zhang, Xue; Chen, Yaomin; Huang, Xiumei; Sun, Liangwu; Wang, Ruishan; Liao, Francesca-Fang; Xu, Huaxi] Burnham Inst Med Res, Neurodegenerat Dis Res Program, La Jolla, CA 92037 USA; [Luo, Wenjie; Netzer, William J.; Greengard, Paul] Rockefeller Univ, Mol & Cellular Neurosci Lab, New York, NY 10065 USA; [Cohen, Stanley N.] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; [Li, Limin] Chinese Acad Med Sci, Inst Basic Med Sci, Dept Pathol, Beijing 100005, Peoples R China; [Li, Limin] Peking Union Med Coll, Beijing 100005, Peoples R China; [Liao, Francesca-Fang] Univ Tennessee, Dept Pharmacol, Hlth Sci Ctr, Coll Med, Memphis, TN 38163 USA	Xiamen University; Xiamen University; Sanford Burnham Prebys Medical Discovery Institute; Rockefeller University; Stanford University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; University of Tennessee System; University of Tennessee Health Science Center	Li, LM (corresponding author), Funct Genet Inc, Gaithersburg, MD 20878 USA.	limin@liminli.com; xuh@burnham.org	Xu, Huaxi/AAV-7177-2021; Zhang, YW/G-3999-2010; Chen, Yaomin/I-6192-2013; Luo, Wenjie/ABF-8451-2020; Chen, Yaomin/H-5205-2013	Greengard, Paul/0000-0002-4437-0893; Zhang, Yun-wu/0000-0002-7152-7630; Huang, Xiumei/0000-0002-7306-0288	National Institutes of Health [R01 AG021173, R01 NS046673, R01 AG030197, R01 NS054880, P01 AG009464]; Alzheimer's Association; American Health Assistance Foundation; US Department of Health and Human Services [AOA 90AZ2791]; Fisher Center for Alzheimer's Research Foundation; Cure Alzheimer's Fund; National Natural Science Foundation of China [30672198, 30840036]; National ST Major Project [2009ZX09103-731]; Natural Science Funds for Distinguished Young Scholar of Fujian Province [2009J06022]; New Century Excellent Talents in Universities (NCEI); Program for the New Century Excellent Talents in Fujian Province Universities (NCETFJ); Ministry of Education of China [111]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054880, R01NS046673] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG009464, R01AG030197, R01AG021173] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Association(Alzheimer's Association); American Health Assistance Foundation; US Department of Health and Human Services; Fisher Center for Alzheimer's Research Foundation; Cure Alzheimer's Fund; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National ST Major Project; Natural Science Funds for Distinguished Young Scholar of Fujian Province; New Century Excellent Talents in Universities (NCEI)(Program for New Century Excellent Talents in University (NCET)); Program for the New Century Excellent Talents in Fujian Province Universities (NCETFJ)(Program for New Century Excellent Talents in University (NCET)); Ministry of Education of China(Ministry of Education, China); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank H. Zheng for providing the pHZ04 construct and helpful discussion, Y.M. Li for technical help, F. LaFerla for providing the 3XTg AD mice, F. Checler for providing the FCA18 antibody, and P. Davies for providing the PHF-1 tau antibody. This work was supported in part by National Institutes of Health grants (R01 AG021173 to H.X. and L.L.; R01 NS046673 and R01 AG030197 to HX; R01 NS054880 to F.-F.L.; P01 AG009464 to P.G.), and grants from the Alzheimer's Association (to H.X. and F.-F.L.), the American Health Assistance Foundation (to HX), US Department of Health and Human Services (AOA 90AZ2791 to P.G.), Fisher Center for Alzheimer's Research Foundation (to P.G.), Cure Alzheimer's Fund (to P.G.), National Natural Science Foundation of China (30672198 and 30840036 to Y.-w.Z.), National S&T Major Project (2009ZX09103-731 to Y.-w.Z.), and Natural Science Funds for Distinguished Young Scholar of Fujian Province (2009J06022 to Y.-w.Z.). Y.-w.Z. is supported by the Program for New Century Excellent Talents in Universities (NCEI) and the Program for the New Century Excellent Talents in Fujian Province Universities (NCETFJ). L.L. was supported by 111 project, Ministry of Education of China.	Ancolio K, 1999, P NATL ACAD SCI USA, V96, P4119, DOI 10.1073/pnas.96.7.4119; Babushok DV, 2007, CELL MOL LIFE SCI, V64, P542, DOI 10.1007/s00018-006-6453-4; Barelli HL, 1997, MOL MED, V3, P695, DOI 10.1007/BF03401708; Buee L, 2000, BRAIN RES REV, V33, P95, DOI 10.1016/S0165-0173(00)00019-9; BUXBAUM JD, 1994, P NATL ACAD SCI USA, V91, P4489, DOI 10.1073/pnas.91.10.4489; Cai HB, 2001, NAT NEUROSCI, V4, P233, DOI 10.1038/85064; Chen FS, 2000, J BIOL CHEM, V275, P36794, DOI 10.1074/jbc.M006986200; Cole SL, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-22; De Strooper B, 2003, NEURON, V38, P9, DOI 10.1016/S0896-6273(03)00205-8; DESTROOPER B, 1995, EMBO J, V14, P4932, DOI 10.1002/j.1460-2075.1995.tb00176.x; Fang XJ, 2000, P NATL ACAD SCI USA, V97, P11960, DOI 10.1073/pnas.220413597; Flaherty DB, 2000, J NEUROSCI RES, V62, P463, DOI 10.1002/1097-4547(20001101)62:3<463::AID-JNR16>3.0.CO;2-7; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Gasparini L, 2001, J NEUROSCI, V21, P2561, DOI 10.1523/JNEUROSCI.21-08-02561.2001; Halagappa VKM, 2007, NEUROBIOL DIS, V26, P212, DOI 10.1016/j.nbd.2006.12.019; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; HOLLIS GF, 1982, NATURE, V296, P321, DOI 10.1038/296321a0; HORI N, 1993, NUCLEIC ACIDS RES, V21, P4394, DOI 10.1093/nar/21.18.4394; Jankowsky JL, 2004, HUM MOL GENET, V13, P159, DOI 10.1093/hmg/ddh019; Jankowsky JL, 2007, J BIOL CHEM, V282, P22707, DOI 10.1074/jbc.M611050200; JEFFS P, 1991, P ROY SOC B-BIOL SCI, V244, P151, DOI 10.1098/rspb.1991.0064; JOHNSTONE EM, 1991, MOL BRAIN RES, V10, P299, DOI 10.1016/0169-328X(91)90088-F; Kaessmann H, 2009, NAT REV GENET, V10, P19, DOI 10.1038/nrg2487; Kamenetsky M, 2006, J MOL BIOL, V362, P623, DOI 10.1016/j.jmb.2006.07.045; KARIN M, 1982, NATURE, V299, P797, DOI 10.1038/299797a0; Kopan R, 2000, GENE DEV, V14, P2799, DOI 10.1101/gad.836900; Lazarov O, 2005, CELL, V120, P701, DOI 10.1016/j.cell.2005.01.015; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Li LM, 1996, CELL, V85, P319, DOI 10.1016/S0092-8674(00)81111-3; Lih CJ, 2006, GENE DEV, V20, P2082, DOI 10.1101/gad.1441306; Lin P, 2007, J NEUROCHEM, V100, P1505, DOI 10.1111/j.1471-4159.2006.07336.x; Liu K, 2000, J BIOL CHEM, V275, P40195, DOI 10.1074/jbc.M006194200; Liu KY, 1999, MOL CELL BIOL, V19, P3696; Liu KY, 2000, J BIOL CHEM, V275, P31093, DOI 10.1074/jbc.M005451200; Long M, 2003, NAT REV GENET, V4, P865, DOI 10.1038/nrg1204; Martinez A, 2002, MED RES REV, V22, P373, DOI 10.1002/med.10011; Mathern GW, 1997, NEUROSCIENCE, V77, P1003, DOI 10.1016/S0306-4522(96)00516-7; Medina M, 2008, CURR OPIN DRUG DISC, V11, P533; Mighell AJ, 2000, FEBS LETT, V468, P109, DOI 10.1016/S0014-5793(00)01199-6; Naviglio S, 2009, EXPERT OPIN THER TAR, V13, P83, DOI [10.1517/14728220802602349, 10.1517/14728220802602349 ]; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Phiel CJ, 2003, NATURE, V423, P435, DOI 10.1038/nature01640; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; TAKASHIMA A, 1995, NEUROSCI LETT, V198, P83, DOI 10.1016/0304-3940(95)11964-X; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008; Taylor SS, 2008, BBA-PROTEINS PROTEOM, V1784, P16, DOI 10.1016/j.bbapap.2007.10.002; UEDA S, 1982, EMBO J, V1, P1539, DOI 10.1002/j.1460-2075.1982.tb01352.x; Vinckenbosch N, 2006, P NATL ACAD SCI USA, V103, P3220, DOI 10.1073/pnas.0511307103; Wang RS, 2006, FASEB J, V20, P1275, DOI 10.1096/fj.06-5839fje; Xu HX, 1998, NAT MED, V4, P447, DOI 10.1038/nm0498-447; Xu HX, 1997, P NATL ACAD SCI USA, V94, P3748, DOI 10.1073/pnas.94.8.3748; Xu HX, 1996, P NATL ACAD SCI USA, V93, P4081, DOI 10.1073/pnas.93.9.4081; York RD, 2000, MOL CELL BIOL, V20, P8069, DOI 10.1128/MCB.20.21.8069-8083.2000; Zhang X, 2007, J BIOL CHEM, V282, P10873, DOI 10.1074/jbc.M608856200; Zhang YW, 2007, CURR MOL MED, V7, P687, DOI 10.2174/156652407782564462; Zhang ZL, 2004, TRENDS GENET, V20, P62, DOI 10.1016/j.tig.2003.12.005; Zhang ZL, 2002, GENOME RES, V12, P1466, DOI 10.1101/gr.331902	57	31	35	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 12	2009	64	3					328	340		10.1016/j.neuron.2009.08.036	http://dx.doi.org/10.1016/j.neuron.2009.08.036			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	521MF	19914182	Green Accepted, Bronze			2022-12-24	WOS:000271924800008
J	Whittingstall, K; Logothetis, NK				Whittingstall, Kevin; Logothetis, Nikos K.			Frequency-Band Coupling in Surface EEG Reflects Spiking Activity in Monkey Visual Cortex	NEURON			English	Article							SINGLE CORTICAL-CELLS; NEURONAL OSCILLATIONS; GAMMA-OSCILLATIONS; BOLD FMRI; POTENTIALS; INFORMATION; HIPPOCAMPUS; GENERATORS; MECHANISMS; RESPONSES	Although the electroencephalogram (EEG) is widely used in research and clinical settings, its link to the underlying neural activity during sensory processing remains poorly understood. To investigate this, we made simultaneous recordings of surface EEG, intracortical local field potential, and multiunit activity (MUA) in the alert monkey visual cortex during presentation of natural movies. Using a general linear model, we show that in single trials, EEG power in the gamma band (30-100 Hz) and phase in delta band (2-4 Hz) are significant predictors of the MUA response. Specifically, we found that the MUA response was strongest only when increases in EEG gamma power occurred during the negative-going phase of the delta wave, thus revealing a frequency-and coupling mechanism that can be exploited to infer population spiking activity. This finding may open up a new dimension in the use and interpretation of EEG in normal and pathological conditions.	[Whittingstall, Kevin; Logothetis, Nikos K.] Max Planck Inst Biol Cybernet, D-72076 Tubingen, Germany; [Logothetis, Nikos K.] Univ Manchester, Div Imaging Sci & Biomed Engn, Manchester M13 9PT, Lancs, England	Max Planck Society; University of Manchester	Whittingstall, K (corresponding author), Max Planck Inst Biol Cybernet, Spemannstr 38, D-72076 Tubingen, Germany.	kevin.whittingstall@tuebingen.mpg.de	Logothetis, Nikos/U-9282-2019		Max Planck Society	Max Planck Society(Max Planck Society)	We would like to thank Stefano Panzeri and Andreas Bartels for helpful discussions on data analysis and statistics; Yusuke Murayama, Joachim Werner, and Axel Oeltermann for help in the acquisition of data; Stefan Weber for finemechanic work, and Ulrich Schridde, Matthias Munk, and Jozien Goense for comments on an earlier version of the manuscript. This research was supported by the Max Planck Society.	Andersson T, 1995, Electromyogr Clin Neurophysiol, V35, P77; Bartos M, 2007, NAT REV NEUROSCI, V8, P45, DOI 10.1038/nrn2044; Belitski A, 2008, J NEUROSCI, V28, P5696, DOI 10.1523/JNEUROSCI.0009-08.2008; Berens P, 2008, FRONT SYST NEUROSCI, V2, DOI 10.3389/neuro.06.002.2008; BUZSAKI G, 1995, CURR OPIN NEUROBIOL, V5, P504, DOI 10.1016/0959-4388(95)80012-3; Buzsaki G, 2003, NEUROSCIENCE, V116, P201, DOI 10.1016/S0306-4522(02)00669-3; Canolty RT, 2006, SCIENCE, V313, P1626, DOI 10.1126/science.1128115; Chrobak JJ, 1998, J NEUROSCI, V18, P388; COENEN AML, 1995, NEUROSCI BIOBEHAV R, V19, P447, DOI 10.1016/0149-7634(95)00010-C; CREUTZFELDT OD, 1966, ELECTROEN CLIN NEURO, V20, P1, DOI 10.1016/0013-4694(66)90136-2; CREUTZFELDT OD, 1966, ELECTROEN CLIN NEURO, V20, P19, DOI 10.1016/0013-4694(66)90137-4; Csicsvari J, 2003, NEURON, V37, P311, DOI 10.1016/S0896-6273(02)01169-8; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; ECCLES JC, 1951, ELECTROEN CLIN NEURO, V3, P449, DOI 10.1016/0013-4694(51)90033-8; ENGEL AK, 1990, EUR J NEUROSCI, V2, P588, DOI 10.1111/j.1460-9568.1990.tb00449.x; Fiser J, 2004, NATURE, V431, P573, DOI 10.1038/nature02907; Goense JBM, 2008, CURR BIOL, V18, P631, DOI 10.1016/j.cub.2008.03.054; Handel B, 2009, NEUROIMAGE, V45, P1040, DOI 10.1016/j.neuroimage.2008.12.013; Hasenstaub A, 2005, NEURON, V47, P423, DOI 10.1016/j.neuron.2005.06.016; Jefferys JGR, 1996, TRENDS NEUROSCI, V19, P202, DOI 10.1016/S0166-2236(96)10023-0; Jung TP, 2001, HUM BRAIN MAPP, V14, P166, DOI 10.1002/hbm.1050; Kandel A, 1997, J NEUROSCI, V17, P6783; Kayser C, 2004, CURR OPIN NEUROBIOL, V14, P468, DOI 10.1016/j.conb.2004.06.002; Kenet T, 2003, NATURE, V425, P954, DOI 10.1038/nature02078; KLEE MR, 1965, SCIENCE, V147, P519, DOI 10.1126/science.147.3657.519; Kocsis B, 1999, J NEUROSCI, V19, P6200, DOI 10.1523/JNEUROSCI.19-14-06200.1999; KRAUT MA, 1985, ELECTROEN CLIN NEURO, V62, P300, DOI 10.1016/0168-5597(85)90007-3; Lakatos P, 2005, J NEUROPHYSIOL, V94, P1904, DOI 10.1152/jn.00263.2005; Lakatos P, 2008, SCIENCE, V320, P110, DOI 10.1126/science.1154735; Lisman J, 2005, HIPPOCAMPUS, V15, P913, DOI 10.1002/hipo.20121; Logothetis NK, 2002, NEURON, V35, P227, DOI 10.1016/S0896-6273(02)00775-4; Lopes da Silva F., 1987, ELECTROENCEPHALOGRAP, P15; Mann EO, 2005, J PHYSIOL-LONDON, V562, P55, DOI 10.1113/jphysiol.2004.078758; Mazzoni A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000239; Montemurro MA, 2008, CURR BIOL, V18, P375, DOI 10.1016/j.cub.2008.02.023; Murakami S, 2006, J PHYSIOL-LONDON, V575, P925, DOI 10.1113/jphysiol.2006.105379; Nir Y, 2007, CURR BIOL, V17, P1275, DOI 10.1016/j.cub.2007.06.066; Nunez P.L, 1981, ELECT FIELDS BRAIN N; Quiroga RQ, 2004, NEURAL COMPUT, V16, P1661, DOI 10.1162/089976604774201631; Rasch MJ, 2008, J NEUROPHYSIOL, V99, P1461, DOI 10.1152/jn.00919.2007; SCHROEDER CE, 1991, VISION RES, V31, P1143, DOI 10.1016/0042-6989(91)90040-C; SCHROEDER CE, 1990, BRAIN RES, V515, P326, DOI 10.1016/0006-8993(90)90617-K; Schroeder CE, 2008, TRENDS COGN SCI, V12, P106, DOI 10.1016/j.tics.2008.01.002; Schroeder CE, 2009, TRENDS NEUROSCI, V32, P9, DOI 10.1016/j.tins.2008.09.012; Sheinberg DL, 2001, J NEUROSCI, V21, P1340; Steriade M, 2006, NEUROSCIENCE, V137, P1087, DOI 10.1016/j.neuroscience.2005.10.029; TENKE CE, 1993, EXP BRAIN RES, V94, P183; Wang XJ, 1996, J NEUROSCI, V16, P6402; Whittingstall K, 2007, HUM BRAIN MAPP, V28, P134, DOI 10.1002/hbm.20265; WHITTINGTON MA, 1995, NATURE, V373, P612, DOI 10.1038/373612a0	50	237	238	0	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 29	2009	64	2					281	289		10.1016/j.neuron.2009.08.016	http://dx.doi.org/10.1016/j.neuron.2009.08.016			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	521AA	19874794	Bronze			2022-12-24	WOS:000271889900016
J	Todd, RM; Anderson, AK				Todd, Rebecca M.; Anderson, Adam K.			Six degrees of separation: the amygdala regulates social behavior and perception	NATURE NEUROSCIENCE			English	Editorial Material							FACIAL EXPRESSIONS; KNOWLEDGE; AROUSAL	Recent human imaging work has expanded the view of amygdala function beyond early findings in animals, but two studies of an individual with bilateral amygdala damage now suggest that we should be thinking even more broadly.	[Todd, Rebecca M.; Anderson, Adam K.] Univ Toronto, Dept Psychol, Toronto, ON M5S 1A1, Canada; [Todd, Rebecca M.; Anderson, Adam K.] Univ Toronto, Rotman Res Inst, Toronto, ON, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; Baycrest	Todd, RM (corresponding author), Univ Toronto, Dept Psychol, Toronto, ON M5S 1A1, Canada.	rtodd@rotman-baycrest.on.ca; anderson@psych.utoronto.ca						Adolphs R, 2005, NATURE, V433, P68, DOI 10.1038/nature03086; Anderson AK, 2006, LEARN MEMORY, V13, P711, DOI 10.1101/lm.388906; Anderson AK, 2001, NATURE, V411, P305, DOI 10.1038/35077083; Anderson AK, 2003, NAT NEUROSCI, V6, P196, DOI 10.1038/nn1001; BECHARA A, 1995, SCIENCE, V269, P1115, DOI 10.1126/science.7652558; Davis FC, 2010, CEREB CORTEX, V20, P612, DOI 10.1093/cercor/bhp126; Glascher J, 2003, J NEUROSCI, V23, P10274; KAPP BS, 1994, BEHAV NEUROSCI, V108, P81, DOI 10.1037/0735-7044.108.1.81; Kennedy DP, 2009, NAT NEUROSCI, V12, P1226, DOI 10.1038/nn.2381; Pessoa L, 2002, COGNITIVE BRAIN RES, V15, P31, DOI 10.1016/S0926-6410(02)00214-8; Schyns PG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005625; Sergerie K, 2008, NEUROSCI BIOBEHAV R, V32, P811, DOI 10.1016/j.neubiorev.2007.12.002; Tsuchiya N, 2009, NAT NEUROSCI, V12, P1224, DOI 10.1038/nn.2380; Van Bavel JJ, 2008, PSYCHOL SCI, V19, P1131, DOI 10.1111/j.1467-9280.2008.02214.x; Whalen PJ, 1998, J NEUROSCI, V18, P411	15	30	30	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2009	12	10					1217	1218		10.1038/nn1009-1217	http://dx.doi.org/10.1038/nn1009-1217			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	498US	19783979				2022-12-24	WOS:000270170200006
J	Wulff, P; Schonewille, M; Renzi, M; Viltono, L; Sassoe-Pognetto, M; Badura, A; Gao, ZY; Hoebeek, FE; van Dorp, S; Wisden, W; Farrant, M; De Zeeuw, CI				Wulff, Peer; Schonewille, Martijn; Renzi, Massimiliano; Viltono, Laura; Sassoe-Pognetto, Marco; Badura, Aleksandra; Gao, Zhenyu; Hoebeek, Freek E.; van Dorp, Stijn; Wisden, William; Farrant, Mark; De Zeeuw, Chris I.			Synaptic inhibition of Purkinje cells mediates consolidation of vestibulo-cerebellar motor learning	NATURE NEUROSCIENCE			English	Article							TEMPORAL FIDELITY; GABA(A) RECEPTORS; SPIKE OUTPUT; PLASTICITY; LTD; EXPRESSION; SYNAPSES; PATTERN; INPUT; INTERNEURONS	Although feedforward inhibition onto Purkinje cells was first documented 40 years ago, we understand little of how inhibitory interneurons contribute to cerebellar function in behaving animals. Using a mouse line (PC-Delta gamma 2) in which GABA(A) receptor mediated synaptic inhibition is selectively removed from Purkinje cells, we examined how feedforward inhibition from molecular layer interneurons regulates adaptation of the vestibulo-ocular reflex. Although impairment of baseline motor performance was relatively mild, the ability to adapt the phase of the vestibulo-ocular reflex and to consolidate gain adaptations was strongly compromised. Purkinje cells showed abnormal patterns of simple spikes, both during and in the absence of evoked compensatory eye movements. On the basis of modeling our experimental data, we propose that feedforward inhibition, by controlling the fine-scale patterns of Purkinje cell activity, enables the induction of plasticity in neurons of the cerebellar and vestibular nuclei.	[Badura, Aleksandra; Gao, Zhenyu; Hoebeek, Freek E.; De Zeeuw, Chris I.] Erasmus MC, Dept Neurosci, Rotterdam, Netherlands; [Wulff, Peer; Wisden, William] Univ Aberdeen, Inst Med Sci, Aberdeen, Scotland; [Renzi, Massimiliano; Farrant, Mark] UCL, Dept Neurosci Physiol & Pharmacol, London, England; [Viltono, Laura; Sassoe-Pognetto, Marco] Univ Turin, Dept Anat Pharmacol & Forens Med, Turin, Italy; [Viltono, Laura; Sassoe-Pognetto, Marco] Natl Inst Neurosci Italy, Turin, Italy; [van Dorp, Stijn; De Zeeuw, Chris I.] Royal Acad Sci, Netherlands Inst Neurosci, Amsterdam, Netherlands; [Wisden, William] Univ London Imperial Coll Sci Technol & Med, Div Cell & Mol Biol, London, England	Erasmus University Rotterdam; Erasmus MC; University of Aberdeen; University of London; University College London; University of Turin; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); Imperial College London	De Zeeuw, CI (corresponding author), Erasmus MC, Dept Neurosci, Rotterdam, Netherlands.	w.wisden@imperial.ac.uk; m.farrant@ucl.ac.uk; c.dezeeuw@erasmusmc.nl	Sassoe-Pognetto, Marco/AAE-3536-2022; Wisden, William/A-4071-2011; Badura, Aleksandra/ABC-5427-2020; Schonewille, Martijn/E-6170-2013	Wisden, William/0000-0003-4743-0334; Badura, Aleksandra/0000-0002-0119-5108; Farrant, Mark/0000-0002-9918-0376; Sassoe-Pognetto, Marco/0000-0001-8906-0613; Wulff, Peer/0000-0002-0282-7832; RENZI, MASSIMILIANO/0000-0001-6973-3569	Medical Research Council [G0800399]; Royal Society; Institute Pasteur-Fondazione Cenci Bolognetti; Wellcome Trust program; Regione Piemonte; Compagnia di San Paolo; Dutch Organization for Medical Sciences; Prinses Beatrix Fonds; SENSOPAC; European Community; MRC [G0800399, G0601498] Funding Source: UKRI; Medical Research Council [G0601498] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Royal Society(Royal Society of London); Institute Pasteur-Fondazione Cenci Bolognetti(Istituto Pasteur Italia Fondazione Cenci Bolognetti); Wellcome Trust program(Wellcome Trust); Regione Piemonte(Regione Piemonte); Compagnia di San Paolo(Compagnia di San Paolo); Dutch Organization for Medical Sciences; Prinses Beatrix Fonds; SENSOPAC; European Community(European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank L. Cheyne, D. Massie, M. Rutteman, R. Avila Freire, E. Dalm and J. v. d. Burg for their excellent technical assistance, and D. Andersson and L. Kelly for their participation in the initial electrophysiological studies. This work was supported by the J. Ernest Tait Estate Aberdeen (W. W.), a Medical Research Council program grant G0800399 (P. W. and W. W.), the Royal Society (P. W.), the Institute Pasteur-Fondazione Cenci Bolognetti (M. R.), a Wellcome Trust program grant (M. F.), Regione Piemonte (Ricerca Scientifica Applicata A218 and Ricerca Sanitaria Finalizzata 2006) and Compagnia di San Paolo (M. S.-P.), the Dutch Organization for Medical Sciences (C. I. D. Z.), Life Sciences (C. I. D. Z.), Senter (Neuro-Bsik, C. I. D. Z.), Prinses Beatrix Fonds (C. I. D. Z.), and the SENSOPAC (SENSOrimotor structuring of Perception and Action for Emerging Cognition) program of the European Community (C. I. D. Z.).	Barmack NH, 2008, J NEUROSCI, V28, P1140, DOI 10.1523/JNEUROSCI.3942-07.2008; Barski JJ, 2000, GENESIS, V28, P93, DOI 10.1002/1526-968X(200011/12)28:3/4<93::AID-GENE10>3.3.CO;2-N; Blazquez PM, 2006, J NEUROPHYSIOL, V95, P1812, DOI 10.1152/jn.01061.2005; Boyden ES, 2006, NEURON, V51, P823, DOI 10.1016/j.neuron.2006.08.026; Brickley SG, 1999, J NEUROSCI, V19, P2960; Brunel N, 2004, NEURON, V43, P745, DOI 10.1016/j.neuron.2004.08.023; Clements JD, 1997, BIOPHYS J, V73, P220, DOI 10.1016/S0006-3495(97)78062-7; Coesmans M, 2004, NEURON, V44, P691, DOI 10.1016/j.neuron.2004.10.031; Davie JT, 2008, J NEUROSCI, V28, P7599, DOI 10.1523/JNEUROSCI.0559-08.2008; de Solages C, 2008, NEURON, V58, P775, DOI 10.1016/j.neuron.2008.05.008; De Zeeuw CI, 1998, NEURON, V20, P495, DOI 10.1016/S0896-6273(00)80990-3; Duguid IC, 2004, NAT NEUROSCI, V7, P525, DOI 10.1038/nn1227; Eccles JC, 1967, CEREBELLUM NEURONAL; Feil R, 2003, J CELL BIOL, V163, P295, DOI 10.1083/jcb.200306148; Gittis AH, 2006, CURR OPIN NEUROBIOL, V16, P385, DOI 10.1016/j.conb.2006.06.012; Hansel C, 2006, NEURON, V51, P835, DOI 10.1016/j.neuron.2006.08.013; Hausser M, 1997, NEURON, V19, P665, DOI 10.1016/S0896-6273(00)80379-7; Hoebeek FE, 2005, NEURON, V45, P953, DOI 10.1016/j.neuron.2005.02.012; ITO M, 1993, NATURE, V363, P24, DOI 10.1038/363024b0; Jorntell H, 2002, NEURON, V34, P797, DOI 10.1016/S0896-6273(02)00713-4; KANO M, 1992, NATURE, V356, P601, DOI 10.1038/356601a0; Kassardjian CD, 2005, J NEUROSCI, V25, P7979, DOI 10.1523/JNEUROSCI.2215-05.2005; Kullmann DM, 2007, NAT REV NEUROSCI, V8, P687, DOI 10.1038/nrn2207; Lamsa K, 2005, NAT NEUROSCI, V8, P916, DOI 10.1038/nn1486; Likhtik E, 2008, NATURE, V454, P642, DOI 10.1038/nature07167; Lisberger SG, 1998, CELL, V92, P701, DOI 10.1016/S0092-8674(00)81397-5; Lorez N, 2000, J PHYSIOL-LONDON, V527, P11; Mann-Metzer P, 1999, J NEUROSCI, V19, P3298; Medina JF, 2008, NAT NEUROSCI, V11, P1185, DOI 10.1038/nn.2197; Medina JF, 2000, NAT NEUROSCI, V3, P1205, DOI 10.1038/81486; Medina JF, 2002, NATURE, V416, P330, DOI 10.1038/416330a; Mittmann W, 2005, J PHYSIOL-LONDON, V563, P369, DOI 10.1113/jphysiol.2004.075028; Mittmann W, 2007, J NEUROSCI, V27, P5559, DOI 10.1523/JNEUROSCI.5117-06.2007; MIYASHITA Y, 1984, J PHYSIOL-LONDON, V351, P251, DOI 10.1113/jphysiol.1984.sp015243; Orduz D, 2007, P NATL ACAD SCI USA, V104, P17831, DOI 10.1073/pnas.0707489104; Pouille F, 2001, SCIENCE, V293, P1159, DOI 10.1126/science.1060342; Raman IM, 1997, J NEUROSCI, V17, P4517, DOI 10.1523/jneurosci.17-12-04517.1997; Santamaria F, 2007, J NEUROPHYSIOL, V97, P248, DOI 10.1152/jn.01098.2005; Scelfo B, 2008, P NATL ACAD SCI USA, V105, P769, DOI 10.1073/pnas.0706342105; Schonewille M, 2006, J COMP NEUROL, V497, P670, DOI 10.1002/cne.21036; Schweizer C, 2003, MOL CELL NEUROSCI, V24, P442, DOI 10.1016/S1044-7431(03)00202-1; Shin SL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000485; Shutoh F, 2006, NEUROSCIENCE, V139, P767, DOI 10.1016/j.neuroscience.2005.12.035; Smith SL, 2005, P NATL ACAD SCI USA, V102, P14901, DOI 10.1073/pnas.0505028102; Stahl JS, 2000, J NEUROSCI METH, V99, P101, DOI 10.1016/S0165-0270(00)00218-1; Steuber V, 2007, NEURON, V54, P121, DOI 10.1016/j.neuron.2007.03.015; Van Der Giessen RS, 2006, J COMP NEUROL, V495, P173, DOI 10.1002/cne.20873; Walter JT, 2006, NAT NEUROSCI, V9, P389, DOI 10.1038/nn1648; Watt AJ, 2009, NAT NEUROSCI, V12, P463, DOI 10.1038/nn.2285; Wulff P, 2007, NAT NEUROSCI, V10, P923, DOI 10.1038/nn1927	50	194	194	0	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2009	12	8					1042	U118		10.1038/nn.2348	http://dx.doi.org/10.1038/nn.2348			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	475WS	19578381	Green Accepted			2022-12-24	WOS:000268396300019
J	Dinstein, I; Thomas, C; Humphreys, K; Minshew, N; Behrmann, M; Heeger, DJ				Dinstein, Ilan; Thomas, Cibu; Humphreys, Kate; Minshew, Nancy; Behrmann, Marlene; Heeger, David J.			Normal Movement Selectivity in Autism	NEURON			English	Article							MIRROR-NEURON SYSTEM; FUNCTIONAL MAGNETIC-RESONANCE; SPECTRUM DISORDERS; CORTICAL ACTIVATION; IMITATION; ADAPTATION; FMRI; REPRESENTATION; CHILDREN; CORTEX	It has been proposed that individuals with autism have difficulties understanding the goals and intentions of others because of a fundamental dysfunction in the mirror neuron system. Here, however, we show that individuals with autism exhibited not only normal fMRI responses in mirror system areas during observation and execution of hand movements but also exhibited typical movement-selective adaptation (repetition suppression) when observing or executing the same movement repeatedly. Movement selectivity is a defining characteristic of neurons involved in movement perception, including mirror neurons, and, as such, these findings argue against a mirror system dysfunction in autism.	[Dinstein, Ilan; Heeger, David J.] NYU, Ctr Neural Sci, New York, NY 10003 USA; [Heeger, David J.] NYU, Dept Psychol, New York, NY 10003 USA; [Thomas, Cibu; Humphreys, Kate; Behrmann, Marlene] Carnegie Mellon Univ, Dept Psychol, Pittsburgh, PA 15213 USA; [Minshew, Nancy] Univ Pittsburgh, Dept Neurol, Pittsburgh, PA 15213 USA	New York University; New York University; Carnegie Mellon University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Dinstein, I (corresponding author), NYU, Ctr Neural Sci, 6 Washington Pl, New York, NY 10003 USA.	ilan.dinstein@weizmann.ac.il	Dinstein, Ilan/AAW-4400-2020; Dinstein, Ilan/L-3325-2016	Dinstein, Ilan/0000-0001-8106-5209; Dinstein, Ilan/0000-0001-8106-5209; Behrmann, Marlene/0000-0002-3814-1015	National Institutes of Health [R01-MH069880]; NICHD/NIDCD [PO1/U19]; Pennsylvania Department of Health [SAP 4100047862]; Cure Autism Now (Young Investigator Award);  [F31-MH080457]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD035469, P50HD055748, U19HD035469] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH069880, F31MH080457] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NICHD/NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)NIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Pennsylvania Department of Health; Cure Autism Now (Young Investigator Award); ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Supported by National Institutes of Health Grants R01-MH069880 (D.J.H.), NICHD/NIDCD PO1/U19 (M.B.; PI: Nancy Minshew), F31-MH080457 (ID.), Pennsylvania Department of Health grant SAP 4100047862, and Cure Autism Now (Young Investigator Award, K.H.).	[Anonymous], 2000, DIAGNOSTIC STAT MANU, V4th; Avikainen S, 1999, NEUROREPORT, V10, P3467, DOI 10.1097/00001756-199911260-00001; Aziz-Zadeh L, 2006, J NEUROSCI, V26, P2964, DOI 10.1523/JNEUROSCI.2921-05.2006; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; Carr L, 2003, P NATL ACAD SCI USA, V100, P5497, DOI 10.1073/pnas.0935845100; Chong TTJ, 2008, CURR BIOL, V18, P1576, DOI 10.1016/j.cub.2008.08.068; Dapretto M, 2006, NAT NEUROSCI, V9, P28, DOI 10.1038/nn1611; Dinstein I, 2008, CURR BIOL, V18, pR956, DOI 10.1016/j.cub.2008.09.007; Dinstein I, 2008, CURR BIOL, V18, pR13, DOI 10.1016/j.cub.2007.11.004; Dinstein I, 2007, J NEUROPHYSIOL, V98, P1415, DOI 10.1152/jn.00238.2007; Fecteau S, 2006, CURR BIOL, V16, pR131, DOI 10.1016/j.cub.2006.02.008; Ferrari PF, 2006, PLOS BIOL, V4, P1501, DOI 10.1371/journal.pbio.0040302; Fogassi L, 2005, SCIENCE, V308, P662, DOI 10.1126/science.1106138; Friston K.J., 1994, HUM BRAIN MAPP, V1, P153, DOI DOI 10.1002/HBM.460010207; Friston KJ, 1999, NEUROIMAGE, V10, P385, DOI 10.1006/nimg.1999.0484; Gardner JL, 2005, NEURON, V47, P607, DOI 10.1016/j.neuron.2005.07.016; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Grill-Spector K, 2001, ACTA PSYCHOL, V107, P293, DOI 10.1016/S0001-6918(01)00019-1; Hamilton AFD, 2006, J NEUROSCI, V26, P1133, DOI 10.1523/JNEUROSCI.4551-05.2006; Hamilton AFD, 2007, NEUROPSYCHOLOGIA, V45, P1859, DOI 10.1016/j.neuropsychologia.2006.11.022; Hasson U, 2009, AUTISM RES, V2, P220, DOI 10.1002/aur.89; Hickok G, 2009, J COGNITIVE NEUROSCI, V21, P1229, DOI 10.1162/jocn.2009.21189; Humphreys K, 2008, AUTISM RES, V1, P52, DOI 10.1002/aur.1; Iacoboni M, 2006, NAT REV NEUROSCI, V7, P942, DOI 10.1038/nrn2024; Kilner JM, 2009, J NEUROSCI, V29, P10153, DOI 10.1523/JNEUROSCI.2668-09.2009; Kohler E, 2002, SCIENCE, V297, P846, DOI 10.1126/science.1070311; Lingnau A, 2009, P NATL ACAD SCI USA, V106, P9925, DOI 10.1073/pnas.0902262106; Lord C, 2000, J AUTISM DEV DISORD, V30, P205, DOI 10.1023/A:1005592401947; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Martineau J, 2008, INT J PSYCHOPHYSIOL, V68, P35, DOI 10.1016/j.ijpsycho.2008.01.002; Muller RA, 2003, AM J PSYCHIAT, V160, P1847, DOI 10.1176/appi.ajp.160.10.1847; Muller RA, 2001, BIOL PSYCHIAT, V49, P665, DOI 10.1016/S0006-3223(00)01004-0; Nishitani N, 2004, ANN NEUROL, V55, P558, DOI 10.1002/ana.20031; Oberman LM, 2008, NEUROPSYCHOLOGIA, V46, P1558, DOI 10.1016/j.neuropsychologia.2008.01.010; Oberman LM, 2007, PSYCHOL BULL, V133, P310, DOI 10.1037/0033-2909.133.2.310; Oberman LM, 2005, COGNITIVE BRAIN RES, V24, P190, DOI 10.1016/j.cogbrainres.2005.01.014; Raymaekers R, 2009, BRAIN RES, V1304, P113, DOI 10.1016/j.brainres.2009.09.068; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Rizzolatti G, 2009, NAT CLIN PRACT NEURO, V5, P24, DOI 10.1038/ncpneuro0990; Rubenstein JLR, 2003, GENES BRAIN BEHAV, V2, P255, DOI 10.1034/j.1601-183X.2003.00037.x; Shmuelof L, 2005, NEURON, V47, P457, DOI 10.1016/j.neuron.2005.06.034; Southgate V, 2008, TRENDS COGN SCI, V12, P225, DOI 10.1016/j.tics.2008.03.005; Talairach J., 1988, COPLANAR STEREOTAXIC; Theoret H, 2005, CURR BIOL, V15, pR84, DOI 10.1016/j.cub.2005.01.022; Tuchman R, 2002, LANCET NEUROL, V1, P352, DOI 10.1016/S1474-4422(02)00160-6; Umilta MA, 2001, NEURON, V31, P155, DOI 10.1016/S0896-6273(01)00337-3; Williams JHG, 2001, NEUROSCI BIOBEHAV R, V25, P287, DOI 10.1016/S0149-7634(01)00014-8; Williams JHG, 2006, NEUROPSYCHOLOGIA, V44, P610, DOI 10.1016/j.neuropsychologia.2005.06.010	48	106	110	1	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 13	2010	66	3					461	469		10.1016/j.neuron.2010.03.034	http://dx.doi.org/10.1016/j.neuron.2010.03.034			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	598HE	20471358	Green Accepted, Bronze			2022-12-24	WOS:000277825200014
J	Heimel, JA; Saiepour, MH; Chakravarthy, S; Hermans, JM; Levelt, CN				Heimel, J. Alexander; Saiepour, M. Hadi; Chakravarthy, Sridhara; Hermans, Josephine M.; Levelt, Christiaan N.			Contrast gain control and cortical TrkB signaling shape visual acuity	NATURE NEUROSCIENCE			English	Article							MONOCULAR DEPRIVATION DECREASES; CROSS-ORIENTATION SUPPRESSION; NERVE GROWTH-FACTOR; NEUROTROPHIC FACTOR; ENVIRONMENTAL ENRICHMENT; RESPONSE FUNCTION; CRITICAL PERIOD; STRIATE CORTEX; NEURONS; CAT	During development and aging and in amblyopia, visual acuity is far below the limitations set by the retina. Expression of brain-derived neurotrophic factor (BDNF) in the visual cortex is reduced in these situations. We asked whether neurotrophic tyrosine kinase receptor, type 2 (TrkB) regulates cortical visual acuity in adult mice. We found that genetically interfering with TrkB/BDNF signaling in pyramidal cells in the mature visual cortex reduced synaptic strength and resulted in a loss of neural responses to high spatial-frequency stimuli. Responses to low spatial-frequency stimuli were unaffected. This selective loss was not accompanied by a change in receptive field sizes or plasticity, but apparent contrast was reduced. Our results indicate that a dependence on spatial frequency in the Heeger normalization model explains this selective effect of contrast reduction on high-resolution vision and suggest that it involves contrast gain control operating in the visual cortex.	[Heimel, J. Alexander; Saiepour, M. Hadi; Chakravarthy, Sridhara; Hermans, Josephine M.; Levelt, Christiaan N.] Royal Netherlands Acad Arts & Sci, Netherlands Inst Neurosci, Mol Visual Plast Grp, Amsterdam, Netherlands	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW)	Heimel, JA (corresponding author), Royal Netherlands Acad Arts & Sci, Netherlands Inst Neurosci, Mol Visual Plast Grp, Amsterdam, Netherlands.	heimel@nin.knaw.nl	Heimel, J.Alexander/F-5782-2012	Heimel, J.Alexander/0000-0002-5291-4184	SenterNovem BSIK [03053]; Rotterdamse Vereniging Blindenbelangen; Algemeen Nederlandse Vereeniging ter Voorkoming van Blindheid; Stichting Blindenhulp; ZonMW Vidi	SenterNovem BSIK; Rotterdamse Vereniging Blindenbelangen; Algemeen Nederlandse Vereeniging ter Voorkoming van Blindheid; Stichting Blindenhulp; ZonMW Vidi(Netherlands Organization for Health Research and Development)	We thank S. Nelson for reading the manuscript and, together with S. Van Hooser, for visual stimulation software, A. Maffei and C. de Zeeuw for discussions, R. Hartman for assistance with monocular deprivation, S. Skulj-Zivkovic, S. Scheltinga and S. Riahi for genotyping and C. Pool and J. van Heerikhuize for puncta analysis macros. C.N.L., J. A. H. and J. M. H. were supported by SenterNovem BSIK grant 03053. S. C. was supported by Rotterdamse Vereniging Blindenbelangen, Algemeen Nederlandse Vereeniging ter Voorkoming van Blindheid and Stichting Blindenhulp. C.N.L. and M. H. S. were supported by a ZonMW Vidi grant.	ALBRECHT DG, 1982, J NEUROPHYSIOL, V48, P217, DOI 10.1152/jn.1982.48.1.217; Albrecht DG, 2002, J NEUROPHYSIOL, V88, P888, DOI 10.1152/jn.2002.88.2.888; Barrett BT, 2004, NEUROSCIENTIST, V10, P106, DOI 10.1177/1073858403262153; Bartoletti A, 2002, J NEUROSCI, V22, P10072; Bartoletti A, 2004, NAT NEUROSCI, V7, P215, DOI 10.1038/nn1201; Binzegger T, 2004, J NEUROSCI, V24, P8441, DOI 10.1523/JNEUROSCI.1400-04.2004; BOZZI Y, 1995, NEUROSCIENCE, V69, P1133, DOI 10.1016/0306-4522(95)00321-9; BRADLEY A, 1981, INVEST OPHTH VIS SCI, V21, P467; BRADLEY A, 1987, J NEUROPHYSIOL, V57, P755, DOI 10.1152/jn.1987.57.3.755; CARANDINI M, 1994, SCIENCE, V264, P1333, DOI 10.1126/science.8191289; Carandini M, 1997, J NEUROSCI, V17, P8621; Carandini M, 2002, J NEUROSCI, V22, P10053; Carmignoto G, 1997, J PHYSIOL-LONDON, V498, P153, DOI 10.1113/jphysiol.1997.sp021848; Chakravarthy S, 2006, P NATL ACAD SCI USA, V103, P1071, DOI 10.1073/pnas.0506305103; Chance FS, 1998, J NEUROSCI, V18, P4785; Dahlhaus M, 2008, J NEUROSCI, V28, P10794, DOI 10.1523/JNEUROSCI.1348-08.2008; Eide FF, 1996, J NEUROSCI, V16, P3123; Gianfranceschi L, 1999, VISION RES, V39, P569, DOI 10.1016/S0042-6989(98)00169-2; Gianfranceschi L, 2003, P NATL ACAD SCI USA, V100, P12486, DOI 10.1073/pnas.1934836100; Gordon JA, 1996, J NEUROSCI, V16, P3274; HEEGER DJ, 1992, VISUAL NEUROSCI, V9, P181, DOI 10.1017/S0952523800009640; Heimel JA, 2007, EUR J NEUROSCI, V25, P795, DOI 10.1111/j.1460-9568.2007.05333.x; Heimel JA, 2005, J NEUROPHYSIOL, V94, P3538, DOI 10.1152/jn.00106.2005; Heynen AJ, 2003, NAT NEUROSCI, V6, P854, DOI 10.1038/nn1100; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Huang ZJ, 1999, CELL, V98, P739, DOI 10.1016/S0092-8674(00)81509-3; Issa NP, 2000, J NEUROSCI, V20, P8504, DOI 10.1523/JNEUROSCI.20-22-08504.2000; Kaneko M, 2008, NAT NEUROSCI, V11, P497, DOI 10.1038/nn2068; Katoh-Semba R, 1998, NEUROSCI RES, V31, P227, DOI 10.1016/S0168-0102(98)00040-6; Kayser A, 2001, J NEUROPHYSIOL, V85, P2130, DOI 10.1152/jn.2001.85.5.2130; Kohara K, 2007, J NEUROSCI, V27, P7234, DOI 10.1523/JNEUROSCI.1943-07.2007; Li BW, 2006, J NEUROPHYSIOL, V96, P1755, DOI 10.1152/jn.00425.2006; Lu B, 2004, PROG BRAIN RES, V146, P137, DOI 10.1016/S0079-6123(03)46010-X; Maya-Vetencourt JF, 2008, SCIENCE, V320, P385, DOI 10.1126/science.1150516; McAllister AK, 1999, ANNU REV NEUROSCI, V22, P295, DOI 10.1146/annurev.neuro.22.1.295; MORRONE MC, 1987, EXP BRAIN RES, V67, P635; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; Priebe NJ, 2006, NAT NEUROSCI, V9, P552, DOI 10.1038/nn1660; Ress D, 2003, NAT NEUROSCI, V6, P414, DOI 10.1038/nn1024; Rossi FM, 1999, NEUROSCIENCE, V90, P363, DOI 10.1016/S0306-4522(98)00463-1; Sale A, 2007, NAT NEUROSCI, V10, P679, DOI 10.1038/nn1899; Sawtell NB, 2003, NEURON, V38, P977, DOI 10.1016/S0896-6273(03)00323-4; Sceniak MP, 2002, J NEUROPHYSIOL, V88, P1363, DOI 10.1152/jn.2002.88.3.1363; SKOTTUN BC, 1986, EXP BRAIN RES, V63, P431; SPEAR PD, 1993, VISION RES, V33, P2589, DOI 10.1016/0042-6989(93)90218-L; SPEKREIJSE H, 1983, BEHAV BRAIN RES, V10, P107, DOI 10.1016/0166-4328(83)90156-0; van Rossum MCW, 2008, NEURAL COMPUT, V20, P1847, DOI 10.1162/neco.2008.06-07-546	47	32	32	1	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2010	13	5					642	U165		10.1038/nn.2534	http://dx.doi.org/10.1038/nn.2534			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	588JM	20400960				2022-12-24	WOS:000277065700024
J	Gervasi, N; Tchenio, P; Preat, T				Gervasi, Nicolas; Tchenio, Paul; Preat, Thomas			PKA Dynamics in a Drosophila Learning Center: Coincidence Detection by Rutabaga Adenylyl Cyclase and Spatial Regulation by Dunce Phosphodiesterase	NEURON			English	Article							PROTEIN-KINASE-A; LONG-TERM-MEMORY; CYCLIC-AMP PHOSPHODIESTERASE; MUSHROOM BODY NEURONS; PREFERENTIAL EXPRESSION; GENETIC DISSECTION; DOPAMINERGIC-NEURONS; CONSOLIDATED MEMORY; OLFACTORY MEMORY; CAMP	The dynamics of PKA activity in the olfactory learning and memory center, the mushroom bodies (MBs), are still poorly understood. We addressed this issue in vivo using a PKA FRET probe. Application of dopamine, the main neuromodulator involved in aversive learning, resulted in PKA activation specifically in the vertical lobe, whereas octopamine, involved in appetitive learning, stimulated PKA in all MB lobes. Strikingly, MB lobes were homogeneously activated by dopamine in the learning mutant dunce, showing that Dunce phosphodiesterase plays a major role in the spatial regulation of cAMP dynamics. Furthermore, costimulation with acetylcholine and either dopamine or octopamine led to a synergistic activation of PKA in the MBs that depends on Rutabaga adenylyl cyclase. Our results suggest that Rutabaga acts as a coincidence detector and demonstrate the existence of subcellular domains of PKA activity that could underlie the functional specialization of MB lobes in aversive and appetitive learning.	[Gervasi, Nicolas; Tchenio, Paul; Preat, Thomas] Ecole Super Phys & Chim Ind Ville Paris, CNRS, Genes & Dynam Memory Syst Neurobiol Unit, F-75005 Paris, France; [Tchenio, Paul] Univ Paris 11, CNRS, UPR 3321, F-91400 Orsay, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Superieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Preat, T (corresponding author), Ecole Super Phys & Chim Ind Ville Paris, CNRS, Genes & Dynam Memory Syst Neurobiol Unit, 10 Rue Vauquelin, F-75005 Paris, France.		Gervasi, Nicolas/P-6047-2017	Gervasi, Nicolas/0000-0002-1924-2443; Preat, Thomas/0000-0001-9976-1763	Agence Nationale pour la Recherche; Fondation Bettencourt-Schueller; Fondation pour la Recherche Medicale; Fondation pour la Recherche Medicale and Neuropole Francilien (NeRF)	Agence Nationale pour la Recherche(French National Research Agency (ANR)); Fondation Bettencourt-Schueller; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Fondation pour la Recherche Medicale and Neuropole Francilien (NeRF)	We thank Jin Zhang for providing the AKAR2 plasmid. and Dierk Reiff and Oliver Gnesbeck for UAS-TN-XXL flies We thank Jean-Marc Goaillard, Pierre Vincent. and members of our laboratory for helpful discussion and critical reading of the article We thank Severine Trannoy for her help with the appetitive conditioning experiment This work was supported by grants from the Agence Nationale pour la Recherche (to T P and P T), the Fondation Bettencourt-Schueller (to T P), and the Fondation pour la Recherche Medicale (to T P) N G was supported by the Fondation pour la Recherche Medicale and Neuropole Francilien (NeRF)	ABRAMS TW, 1988, TRENDS NEUROSCI, V11, P128, DOI 10.1016/0166-2236(88)90137-3; Akalal DBG, 2006, LEARN MEMORY, V13, P659, DOI 10.1101/lm.221206; BACSKAI BJ, 1993, SCIENCE, V260, P222, DOI 10.1126/science.7682336; Beavo JA, 2002, NAT REV MOL CELL BIO, V3, P710, DOI 10.1038/nrm911; BEAVO JA, 1970, MOL PHARMACOL, V6, P597; Blum AL, 2009, CURR BIOL, V19, P1341, DOI 10.1016/j.cub.2009.07.016; Busch S, 2009, J COMP NEUROL, V513, P643, DOI 10.1002/cne.21966; BYERS D, 1981, NATURE, V289, P79, DOI 10.1038/289079a0; Claridge-Chang A, 2009, CELL, V139, P405, DOI 10.1016/j.cell.2009.08.034; Colomb J, 2009, GENES BRAIN BEHAV, V8, P407, DOI 10.1111/j.1601-183X.2009.00482.x; Connolly JB, 1996, SCIENCE, V274, P2104, DOI 10.1126/science.274.5295.2104; Conti M, 2007, ANNU REV BIOCHEM, V76, P481, DOI 10.1146/annurev.biochem.76.060305.150444; Crittenden JR, 1998, LEARN MEMORY, V5, P38; DAVIS RL, 1981, J CELL BIOL, V90, P101, DOI 10.1083/jcb.90.1.101; DEBELLE JS, 1994, SCIENCE, V263, P692, DOI 10.1126/science.8303280; DESOUZA NJ, 1983, MED RES REV, V3, P201, DOI 10.1002/med.2610030205; Dodge KL, 2001, EMBO J, V20, P1921, DOI 10.1093/emboj/20.8.1921; Dodge-Kafka KL, 2005, NATURE, V437, P574, DOI 10.1038/nature03966; DRAIN P, 1991, NEURON, V6, P71, DOI 10.1016/0896-6273(91)90123-H; Dubnau J, 2001, NATURE, V411, P476, DOI 10.1038/35078077; DUDAI Y, 1985, FEBS LETT, V191, P165, DOI 10.1016/0014-5793(85)80001-6; DUDAI Y, 1976, P NATL ACAD SCI USA, V73, P1684, DOI 10.1073/pnas.73.5.1684; Dunn TA, 2006, J NEUROSCI, V26, P12807, DOI 10.1523/JNEUROSCI.3238-06.2006; FIALA A, 2003, SCI STKE, pPL6; Gerber B, 2004, CURR OPIN NEUROBIOL, V14, P737, DOI 10.1016/j.conb.2004.10.014; Gervasi N, 2007, J NEUROSCI, V27, P2744, DOI 10.1523/JNEUROSCI.5352-06.2007; GJERTSEN BT, 1995, J BIOL CHEM, V270, P20599, DOI 10.1074/jbc.270.35.20599; Han KA, 1998, J NEUROSCI, V18, P3650; Han KA, 1996, NEURON, V16, P1127, DOI 10.1016/S0896-6273(00)80139-7; HAN PL, 1992, NEURON, V9, P619, DOI 10.1016/0896-6273(92)90026-A; HEISENBERG M, 1985, J NEUROGENET, V2, P1, DOI 10.3109/01677068509100140; Hempel CM, 1996, NATURE, V384, P166, DOI 10.1038/384166a0; Horiuchi J, 2008, P NATL ACAD SCI USA, V105, P20976, DOI 10.1073/pnas.0810119105; Isabel G, 2004, SCIENCE, V304, P1024, DOI 10.1126/science.1094932; Keene AC, 2007, NAT REV NEUROSCI, V8, P341, DOI 10.1038/nrn2098; Kim YC, 2003, GENE EXPR PATTERNS, V3, P237, DOI 10.1016/S1567-133X(02)00098-4; Krashes MJ, 2008, J NEUROSCI, V28, P3103, DOI 10.1523/JNEUROSCI.5333-07.2008; Krashes MJ, 2007, NEURON, V53, P103, DOI 10.1016/j.neuron.2006.11.021; Krashes MJ, 2009, CELL, V139, P416, DOI 10.1016/j.cell.2009.08.035; LEVIN LR, 1992, CELL, V68, P479, DOI 10.1016/0092-8674(92)90185-F; Lissandron V, 2007, CELL SIGNAL, V19, P2296, DOI 10.1016/j.cellsig.2007.07.004; Liu X, 2006, CURR OPIN NEUROBIOL, V16, P679, DOI 10.1016/j.conb.2006.09.003; LIVINGSTONE MS, 1985, P NATL ACAD SCI USA, V82, P5992, DOI 10.1073/pnas.82.17.5992; LIVINGSTONE MS, 1984, CELL, V37, P205, DOI 10.1016/0092-8674(84)90316-7; Makos MA, 2009, ANAL CHEM, V81, P1848, DOI 10.1021/ac802297b; Mank M, 2008, NAT METHODS, V5, P805, DOI 10.1038/NMETH.1243; Mao ZM, 2009, FRONT NEURAL CIRCUIT, V3, DOI 10.3389/neuro.04.005.2009; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; NARAHASHI T, 1964, J GEN PHYSIOL, V47, P965, DOI 10.1085/jgp.47.5.965; NASSEL DR, 1992, CELL TISSUE RES, V267, P147, DOI 10.1007/BF00318701; Neves SR, 2008, CELL, V133, P666, DOI 10.1016/j.cell.2008.04.025; NIGHORN A, 1991, NEURON, V6, P455, DOI 10.1016/0896-6273(91)90253-V; Nikolaev VO, 2004, J BIOL CHEM, V279, P37215, DOI 10.1074/jbc.C400302200; Pascual A, 2001, SCIENCE, V294, P1115, DOI 10.1126/science.1064200; QIU YH, 1993, GENE DEV, V7, P1447, DOI 10.1101/gad.7.7b.1447; Riemensperger T, 2005, CURR BIOL, V15, P1953, DOI 10.1016/j.cub.2005.09.042; Saucerman JJ, 2006, P NATL ACAD SCI USA, V103, P12923, DOI 10.1073/pnas.0600137103; Saucerman JJ, 2003, J BIOL CHEM, V278, P47997, DOI 10.1074/jbc.M308362200; Schroll C, 2006, CURR BIOL, V16, P1741, DOI 10.1016/j.cub.2006.07.023; Schwaerzel M, 2003, J NEUROSCI, V23, P10495, DOI 10.1523/jneurosci.23-33-10495.2003; Schwaerzel M, 2007, J NEUROSCI, V27, P1229, DOI 10.1523/JNEUROSCI.4622-06.2007; Shafer OT, 2008, NEURON, V58, P223, DOI 10.1016/j.neuron.2008.02.018; Sinakevitch I, 2006, J COMP NEUROL, V494, P460, DOI 10.1002/cne.20799; SKOULAKIS EMC, 1993, NEURON, V11, P197, DOI 10.1016/0896-6273(93)90178-T; Tanaka NK, 2008, J COMP NEUROL, V508, P711, DOI 10.1002/cne.21692; TAYLOR SS, 1990, ANNU REV BIOCHEM, V59, P971, DOI 10.1146/annurev.bi.59.070190.004543; TEMPEL BL, 1983, P NATL ACAD SCI-BIOL, V80, P1482, DOI 10.1073/pnas.80.5.1482; Thum AS, 2007, J NEUROSCI, V27, P11132, DOI 10.1523/JNEUROSCI.2712-07.2007; Tomchik SM, 2009, NEURON, V64, P510, DOI 10.1016/j.neuron.2009.09.029; TULLY T, 1994, CELL, V79, P35, DOI 10.1016/0092-8674(94)90398-0; TULLY T, 1985, J COMP PHYSIOL A, V157, P263, DOI 10.1007/BF01350033; Vincent P, 2008, BRAIN CELL BIOL, V36, P3, DOI 10.1007/s11068-008-9035-6; Wang YL, 2008, J NEUROSCI, V28, P4368, DOI 10.1523/JNEUROSCI.2958-07.2008; Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527; WU ZL, 1995, P NATL ACAD SCI USA, V92, P220, DOI 10.1073/pnas.92.1.220; Yamazaki D, 2007, NAT NEUROSCI, V10, P478, DOI 10.1038/nn1863; YANG MY, 1995, NEURON, V15, P45; YIN JCP, 1994, CELL, V79, P49, DOI 10.1016/0092-8674(94)90399-9; Yu DH, 2005, CELL, V123, P945, DOI 10.1016/j.cell.2005.09.037; Yu DH, 2006, NEURON, V52, P845, DOI 10.1016/j.neuron.2006.10.030; Zars T, 2000, SCIENCE, V288, P672, DOI 10.1126/science.288.5466.672; Zhang J, 2005, NATURE, V437, P569, DOI 10.1038/nature04140; Zhang J, 2001, P NATL ACAD SCI USA, V98, P14997, DOI 10.1073/pnas.211566798; Zhong Y, 2004, J NEUROSCI, V24, P1439, DOI 10.1523/JNEUROSCI.0740-02.2004; ZHONG Y, 1991, SCIENCE, V251, P198, DOI 10.1126/science.1670967; Zipfel Warren R., 2003, Nature Biotechnology, V21, P1369, DOI 10.1038/nbt899	86	159	163	1	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 25	2010	65	4					516	529		10.1016/j.neuron.2010.01.014	http://dx.doi.org/10.1016/j.neuron.2010.01.014			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	566HD	20188656	Bronze			2022-12-24	WOS:000275359800010
J	Lorber, B; Howe, ML; Benowitz, LI; Irwin, N				Lorber, Barbara; Howe, Mariko L.; Benowitz, Larry I.; Irwin, Nina			Mst3b, an Ste20-like kinase, regulates axon regeneration in mature CNS and PNS pathways	NATURE NEUROSCIENCE			English	Article							RETINAL GANGLION-CELLS; CILIARY NEUROTROPHIC FACTOR; OPTIC-NERVE REGENERATION; GENE-EXPRESSION; SENSORY NEURONS; IN-VIVO; PERIPHERAL-NERVE; PROTEIN-KINASE; GROWTH-STATE; SPINAL-CORD	Mammalian sterile 20-like kinase-3b (Mst3b, encoded by Stk24), regulates axon outgrowth in embryonic cortical neurons in culture, but its role in vivo and in neural repair is unknown. Here we show that Mst3b mediates the axon-promoting effects of trophic factors in mature rat retinal ganglion cells (RGCs) and dorsal root ganglion (DRG) neurons, and is essential for axon regeneration in vivo. Reducing Mst3b levels using short hairpin RNA prevented RGCs and DRG neurons from regenerating axons in response to growth factors in culture, as did expression of a kinase-dead Mst3b mutant. Conversely, expression of constitutively active Mst3b enabled both types of neurons to extend axons without growth factors. In vivo, RGCs lacking Mst3b failed to regenerate injured axons when stimulated by intraocular inflammation. DRG neurons regenerating axons in vivo showed elevated Mst3b activity, and reducing Mst3b expression attenuated regeneration and p42/44 MAPK activation. Thus, Mst3b regulates axon regeneration in both CNS and PNS neurons.	[Lorber, Barbara; Howe, Mariko L.; Benowitz, Larry I.; Irwin, Nina] Childrens Hosp, Labs Neurosci Res Neurosurg, Boston, MA 02115 USA; [Lorber, Barbara; Howe, Mariko L.; Benowitz, Larry I.; Irwin, Nina] Childrens Hosp, FM Kirby Neurobiol Ctr, Boston, MA 02115 USA; [Benowitz, Larry I.] Harvard Univ, Sch Med, Program Neurosci, Boston, MA 02115 USA; [Lorber, Barbara; Benowitz, Larry I.; Irwin, Nina] Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Benowitz, LI (corresponding author), Childrens Hosp, Labs Neurosci Res Neurosurg, 300 Longwood Ave, Boston, MA 02115 USA.	larry.benowitz@childrens.harvard.edu; nina.irwin@childrens.harvard.edu		Bennett, Mariko/0000-0002-1642-2887; Lorber, Barbara/0000-0001-9986-4543; Benowitz, Larry/0000-0002-0277-7222	US National Institutes of Health (NIH) [P30 HD018655, EY05690]; European Union (Marie Curie Outgoing International Fellowship [MOIF-CT-2004-008424]; Alseres, Inc.; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; NATIONAL EYE INSTITUTE [R01EY005690] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Union (Marie Curie Outgoing International Fellowship(European Commission); Alseres, Inc.; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank A. Logan and M. Berry for advice on DRG injections and use of facilities, Y. Yin for surgical assistance in the preliminary optic nerve studies, D. Kim and L. Zai for surgical assistance in the Mst3b activation studies, M. T. Henzl (University of Missouri) for oncomodulin, and the Developmental Disabilities Research Center of Children's Hospital (US National Institutes of Health (NIH) P30 HD018655) for use of core facilities and expertise. We are grateful for the support of the NIH (EY05690 to L. I. B.), the European Union (Marie Curie Outgoing International Fellowship MOIF-CT-2004-008424 to B. L.), Alseres, Inc. and the Dr. Miriam and Sheldon G. Adelson Medical Research Foundation.	AGUAYO AJ, 1991, PHILOS T R SOC B, V331, P337, DOI 10.1098/rstb.1991.0025; Barrette B, 2008, J NEUROSCI, V28, P9363, DOI 10.1523/JNEUROSCI.1447-08.2008; BENOWITZ LI, 1988, J NEUROSCI, V8, P339; Benowitz LI, 1998, J BIOL CHEM, V273, P29626, DOI 10.1074/jbc.273.45.29626; BERKELAAR M, 1994, J NEUROSCI, V14, P4368, DOI 10.1523/jneurosci.14-07-04368.1994; Berry M, 1996, J NEUROCYTOL, V25, P147, DOI 10.1007/BF02284793; Bonilla IE, 2002, J NEUROSCI, V22, P1303, DOI 10.1523/JNEUROSCI.22-04-01303.2002; Bontioti EN, 2003, J PERIPHER NERV SYST, V8, P159, DOI 10.1046/j.1529-8027.2003.03023.x; Cajal S., 1991, DEGENERATION REGENER; Cen LP, 2007, INVEST OPHTH VIS SCI, V48, P4257, DOI 10.1167/iovs.06-0791; Chen P, 2002, P NATL ACAD SCI USA, V99, P9031, DOI 10.1073/pnas.132076299; Costigan M, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-16; COWLEY S, 1994, CELL, V77, P841, DOI 10.1016/0092-8674(94)90133-3; Cui Q, 2003, MOL CELL NEUROSCI, V22, P49, DOI 10.1016/S1044-7431(02)00037-4; Dan I, 2001, TRENDS CELL BIOL, V11, P220, DOI 10.1016/S0962-8924(01)01980-8; Fan M, 2001, CELL MOL NEUROBIOL, V21, P497, DOI 10.1023/A:1013867306555; Fischer D, 2004, J NEUROSCI, V24, P1646, DOI 10.1523/JNEUROSCI.5119-03.2004; Fischer D, 2004, J NEUROSCI, V24, P8726, DOI 10.1523/JNEUROSCI.2774-04.2004; Fischer D, 2001, EXP NEUROL, V172, P257, DOI 10.1006/exnr.2001.7822; Gavazzi I, 1999, EUR J NEUROSCI, V11, P3405, DOI 10.1046/j.1460-9568.1999.00756.x; GREENE LA, 1990, J NEUROSCI, V10, P1479; HERSKOWITZ I, 1995, CELL, V80, P187, DOI 10.1016/0092-8674(95)90402-6; Irwin N, 2006, P NATL ACAD SCI USA, V103, P18320, DOI 10.1073/pnas.0605135103; Kaplan DR, 2000, CURR OPIN NEUROBIOL, V10, P381, DOI 10.1016/S0959-4388(00)00092-1; Kermer P, 2000, MOL BRAIN RES, V85, P144, DOI 10.1016/S0169-328X(00)00256-4; Leclere PG, 2005, J NEUROSCI METH, V142, P137, DOI 10.1016/j.jneumeth.2004.08.012; Leon S, 2000, J NEUROSCI, V20, P4615, DOI 10.1523/JNEUROSCI.20-12-04615.2000; Li YM, 2003, J NEUROSCI, V23, P7830; Lorber B, 2005, EUR J NEUROSCI, V21, P2029, DOI 10.1111/j.1460-9568.2005.04034.x; Lu TJ, 2006, J BIOL CHEM, V281, P38405, DOI 10.1074/jbc.M605035200; Makwana M, 2005, FEBS J, V272, P2628, DOI 10.1111/j.1742-4658.2005.04699.x; Markus A, 2002, NEURON, V35, P65, DOI 10.1016/S0896-6273(02)00752-3; Martin KRG, 2002, METHODS, V28, P267, DOI 10.1016/S1046-2023(02)00232-3; MOSKOWITZ PF, 1995, J NEUROSCI, V15, P1545; Pernet V, 2006, BRAIN, V129, P1014, DOI 10.1093/brain/awl015; Sapieha PS, 2003, MOL CELL NEUROSCI, V24, P656, DOI 10.1016/S1044-7431(03)00228-8; SCHADEN H, 1994, J NEUROBIOL, V25, P1570, DOI 10.1002/neu.480251209; Schwab ME, 2002, SCIENCE, V295, P1029, DOI 10.1126/science.1067840; SCHWALB JM, 1995, J NEUROSCI, V15, P5514; Smith JM, 2007, BRAIN, V130, P915, DOI 10.1093/brain/awl393; Tucker BA, 2005, BRAIN RES PROTOC, V16, P50, DOI 10.1016/j.brainresprot.2005.10.004; VOLONTE C, 1992, J BIOL CHEM, V267, P21663; YGGE J, 1989, J COMP NEUROL, V279, P199, DOI 10.1002/cne.902790204; YIN Y, P NATL ACAD IN PRESS; Yin YQ, 2003, J NEUROSCI, V23, P2284; Yin YQ, 2006, NAT NEUROSCI, V9, P843, DOI 10.1038/nn1701; Yudin D, 2008, NEURON, V59, P241, DOI 10.1016/j.neuron.2008.05.029; Zai LL, 2009, J NEUROSCI, V29, P8187, DOI 10.1523/JNEUROSCI.0414-09.2009; Zhong J, 2007, NAT NEUROSCI, V10, P598, DOI 10.1038/nn1898; ZURN AD, 1988, P NATL ACAD SCI USA, V85, P8301, DOI 10.1073/pnas.85.21.8301	50	65	71	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2009	12	11					1407	1414		10.1038/nn.2414	http://dx.doi.org/10.1038/nn.2414			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	511UE	19855390	Green Accepted			2022-12-24	WOS:000271194100013
J	Kadoya, K; Tsukada, S; Lu, P; Coppola, G; Geschwind, D; Filbin, MT; Blesch, A; Tuszynski, MH				Kadoya, Ken; Tsukada, Shingo; Lu, Paul; Coppola, Giovanni; Geschwind, Dan; Filbin, Marie T.; Blesch, Armin; Tuszynski, Mark H.			Combined Intrinsic and Extrinsic Neuronal Mechanisms Facilitate Bridging Axonal Regeneration One Year after Spinal Cord Injury	NEURON			English	Article							FUNCTIONAL RECOVERY; CORTICOSPINAL AXONS; GROWTH; RATS; CAMP; NEUROTROPHINS; TRANSECTION; ELEVATION; THERAPY; GRAFTS	Despite advances in promoting axonal regeneration after acute spinal cord injury (SCI), elicitation of bridging axon regeneration after chronic SCI remains a formidable challenge. We report that combinatorial therapies administered 6 weeks, and as long as 15 months, after SCI promote axonal regeneration into and beyond a midcervical lesion site. Provision of peripheral nerve conditioning lesions, grafts of marrow stromal cells, and establishment of NT-3 gradients supports bridging regeneration. Controls receiving partial components of the full combination fail to exhibit bridging. Notably, intraneuronal molecular mechanisms recruited by delayed therapies mirror those of acute injury, including activation of transcriptional activators and regeneration-associated genes. Collectively, these findings provide evidence that regeneration is achievable at unprecedented postinjury time points.	[Kadoya, Ken; Tsukada, Shingo; Lu, Paul; Blesch, Armin; Tuszynski, Mark H.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Lu, Paul; Tuszynski, Mark H.] Vet Affairs Med Ctr, San Diego, CA 92161 USA; [Coppola, Giovanni; Geschwind, Dan] Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90095 USA; [Filbin, Marie T.] CUNY Hunter Coll, Dept Biol, New York, NY 10065 USA	University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of California System; University of California Los Angeles; City University of New York (CUNY) System; Hunter College (CUNY)	Tuszynski, MH (corresponding author), Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA.	mtuszynski@ucsd.edu		Blesch, Armin/0000-0003-1133-1174	NIH [R01 NS09881, NS054883]; Veterans Administration, International Spinal Research Trust; Bernard and Anne Spitzer Charitable Trust; Dr. Miriam and Sheldon G Adelson Medical Research Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS049881, F31NS009881, R01NS054883] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Administration, International Spinal Research Trust(US Department of Veterans Affairs); Bernard and Anne Spitzer Charitable Trust; Dr. Miriam and Sheldon G Adelson Medical Research Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Maya Culbertson, Lori Graham, and Fuying Gao for experimental assistance. This work was funded by the NIH (R01 NS09881 and NS054883), the Veterans Administration, International Spinal Research Trust, the Bernard and Anne Spitzer Charitable Trust, and the Dr. Miriam and Sheldon G Adelson Medical Research Foundation.	Azizi SA, 1998, P NATL ACAD SCI USA, V95, P3908, DOI 10.1073/pnas.95.7.3908; Bunge MB, 2001, NEUROSCIENTIST, V7, P325, DOI 10.1177/107385840100700409; Busch SA, 2007, CURR OPIN NEUROBIOL, V17, P120, DOI 10.1016/j.conb.2006.09.004; Coumans JV, 2001, J NEUROSCI, V21, P9334, DOI 10.1523/JNEUROSCI.21-23-09334.2001; Fawcett JW, 2006, J NEUROTRAUM, V23, P371, DOI 10.1089/neu.2006.23.371; Filbin MT, 2003, NAT REV NEUROSCI, V4, P703, DOI 10.1038/nrn1195; Houle JD, 2003, EXP NEUROL, V182, P247, DOI 10.1016/S0014-4886(03)00029-3; Houle JD, 2006, J NEUROSCI, V26, P7405, DOI 10.1523/JNEUROSCI.1166-06.2006; Jin Y, 2000, NEUROREHAB NEURAL RE, V14, P311, DOI 10.1177/154596830001400407; Jones LL, 2001, J PHYSIOL-LONDON, V533, P83, DOI 10.1111/j.1469-7793.2001.0083b.x; Jones TB, 2005, CURR PHARM DESIGN, V11, P1223, DOI 10.2174/1381612053507468; Kwon BK, 2002, P NATL ACAD SCI USA, V99, P3246, DOI 10.1073/pnas.052308899; Lu P, 2004, J NEUROSCI, V24, P6402, DOI 10.1523/JNEUROSCI.1492-04.2004; Neumann S, 2002, NEURON, V34, P885, DOI 10.1016/S0896-6273(02)00702-X; Neumann S, 1999, NEURON, V23, P83, DOI 10.1016/S0896-6273(00)80755-2; PALLINI R, 1988, J NEUROSURG, V68, P124, DOI 10.3171/jns.1988.68.1.0124; Pearse DD, 2004, NAT MED, V10, P610, DOI 10.1038/nm1056; Qiu J, 2005, J NEUROSCI, V25, P1645, DOI 10.1523/JNEUROSCI.3269-04.2005; Qiu J, 2002, NEURON, V34, P895, DOI 10.1016/S0896-6273(02)00730-4; Raivich G, 2004, NEURON, V43, P57, DOI 10.1016/j.neuron.2004.06.005; Smith DS, 1997, J NEUROSCI, V17, P646; Taylor L, 2006, J NEUROSCI, V26, P9713, DOI 10.1523/JNEUROSCI.0734-06.2006; Tuszynski MH, 2003, EXP NEUROL, V181, P47, DOI 10.1016/S0014-4886(02)00055-9	23	156	164	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 29	2009	64	2					165	172		10.1016/j.neuron.2009.09.016	http://dx.doi.org/10.1016/j.neuron.2009.09.016			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	521AA	19874785	Bronze, Green Accepted			2022-12-24	WOS:000271889900007
J	Cibelli, J				Cibelli, Jose			The Human Egg Is Back	CELL STEM CELL			English	Editorial Material								In a recent issue of Nature, Tachibana et al. (2009) conducted chromosomal transfer into recipient primate oocytes to yield live offspring or monkey ESCs with no contribution of donor mitochondria. The success of this technique may increase demand for human oocyte donation for research.	[Cibelli, Jose] Michigan State Univ, Dept Anim Sci, E Lansing, MI 48824 USA; [Cibelli, Jose] Michigan State Univ, Dept Physiol, E Lansing, MI 48824 USA; [Cibelli, Jose] Consejeria Salud, Programa Andaluz Terapia Celular & Med Regenerati, Seville 41092, Spain	Michigan State University; Michigan State University	Cibelli, J (corresponding author), Michigan State Univ, Dept Anim Sci, E Lansing, MI 48824 USA.	cibelli@msu.edu		Cibelli, Jose/0000-0002-2176-3854				Cibelli J.B., 2001, J REGEN MED, V2, P25, DOI [10.1089/152489001753262168, DOI 10.1089/152489001753262168]; Rinaudo P, 2004, REPRODUCTION, V128, P301, DOI 10.1530/rep.1.00297; TACHIBANA M, 2009, NATURE IN PRESS, DOI DOI 10.1038/NATURE08368; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	6	3	3	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	OCT 2	2009	5	4					345	346		10.1016/j.stem.2009.09.009	http://dx.doi.org/10.1016/j.stem.2009.09.009			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	514NP	19796610	Bronze			2022-12-24	WOS:000271401900002
J	Hosoi, N; Holt, M; Sakaba, T				Hosoi, Nobutake; Holt, Matthew; Sakaba, Takeshi			Calcium Dependence of Exo- and Endocytotic Coupling at a Glutamatergic Synapse	NEURON			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; KISS-AND-RUN; FROG NEUROMUSCULAR-JUNCTION; TRANSMITTER RELEASE RATES; RETINAL BIPOLAR CELLS; FAST CNS SYNAPSE; VESICLE ENDOCYTOSIS; NEUROTRANSMITTER RELEASE; NERVE-TERMINALS; HIPPOCAMPAL SYNAPSES	The mechanism coupling exocytosis and endocytosis remains to be elucidated at central synapses. Here, we show that the mechanism linking these two processes is dependent on microdomain-[Ca2+](i) similar to that which triggers exocytosis, as well as the exocytotic protein synaptobrevin/VAMP. Furthermore, block of endocytosis has a limited, retrograde action on exocytosis, delaying recruitment of release-ready vesicles and enhancing short-term depression. This effect sets in so rapidly that it cannot be explained by the nonavailability of recycled vesicles. Rather, we postulate that perturbation of a step linking exocytosis and endocytosis temporarily prevents new vesicles from clocking at specialized sites for exocytosis.	[Hosoi, Nobutake; Sakaba, Takeshi] Max Planck Inst Biophys Chem, Independent Jr Res Grp Biophys Synapt Transmiss, D-37077 Gottingen, Germany; [Holt, Matthew] Max Planck Inst Biophys Chem, Dept Neurobiol, D-37077 Gottingen, Germany	Max Planck Society; Max Planck Society	Sakaba, T (corresponding author), Max Planck Inst Biophys Chem, Independent Jr Res Grp Biophys Synapt Transmiss, D-37077 Gottingen, Germany.	tsakaba@gwdg.de	Holt, Matthew/AAJ-1813-2020	Holt, Matthew/0000-0002-8958-4027; Sakaba, Takeshi/0000-0003-0688-7717; Hosoi, Nobutake/0000-0002-7889-2542				ADLER EM, 1991, J NEUROSCI, V11, P1496; Ales E, 1999, NAT CELL BIOL, V1, P40, DOI 10.1038/9012; Awatramani GB, 2005, NEURON, V48, P109, DOI 10.1016/j.neuron.2005.08.038; Balaji J, 2008, J NEUROSCI, V28, P6742, DOI 10.1523/JNEUROSCI.1082-08.2008; Balaji J, 2007, P NATL ACAD SCI USA, V104, P20576, DOI 10.1073/pnas.0707574105; Beutner D, 2001, NEURON, V29, P681, DOI 10.1016/S0896-6273(01)00243-4; Bollmann JH, 2000, SCIENCE, V289, P953, DOI 10.1126/science.289.5481.953; Borst JGG, 1996, NATURE, V383, P431, DOI 10.1038/383431a0; CORNILLE F, 1995, J BIOL CHEM, V270, P16826, DOI 10.1074/jbc.270.28.16826; Cousin MA, 2000, J NEUROSCI, V20, P949, DOI 10.1523/JNEUROSCI.20-03-00949.2000; Daly C, 2002, J BIOL CHEM, V277, P9010, DOI 10.1074/jbc.M110815200; Daly C, 2000, P NATL ACAD SCI USA, V97, P6120, DOI 10.1073/pnas.97.11.6120; Deak F, 2004, NAT CELL BIOL, V6, P1102, DOI 10.1038/ncb1185; Dickman DK, 2005, CELL, V123, P521, DOI 10.1016/j.cell.2005.09.026; Ertunc M, 2007, J NEUROSCI, V27, P341, DOI 10.1523/JNEUROSCI.4051-06.2007; Ferguson SM, 2007, SCIENCE, V316, P570, DOI 10.1126/science.1140621; Fernandez-Alfonso T, 2004, NEURON, V41, P943, DOI 10.1016/S0896-6273(04)00113-8; Fernandez-Alfonso T, 2006, TRENDS CELL BIOL, V16, P413, DOI 10.1016/j.tcb.2006.06.007; Fernandez-Alfonso T, 2006, NEURON, V51, P179, DOI 10.1016/j.neuron.2006.06.008; FORSYTHE ID, 1994, J PHYSIOL-LONDON, V479, P381, DOI 10.1113/jphysiol.1994.sp020303; Gad H, 1998, NEURON, V21, P607, DOI 10.1016/S0896-6273(00)80570-X; Gandhi SP, 2003, NATURE, V423, P607, DOI 10.1038/nature01677; Granseth B, 2008, J PHYSIOL-LONDON, V586, P5969, DOI 10.1113/jphysiol.2008.159715; Grass I, 2004, J BIOL CHEM, V279, P54872, DOI 10.1074/jbc.M409995200; Hayashi M, 2008, P NATL ACAD SCI USA, V105, P2175, DOI 10.1073/pnas.0712171105; He LM, 2006, NATURE, V444, P102, DOI 10.1038/nature05250; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; Hosoi N, 2007, J NEUROSCI, V27, P14286, DOI 10.1523/JNEUROSCI.4122-07.2007; Iwasaki S, 2001, J PHYSIOL-LONDON, V534, P861, DOI 10.1111/j.1469-7793.2001.00861.x; Jockusch WJ, 2005, NEURON, V46, P869, DOI 10.1016/j.neuron.2005.05.004; Joshi I, 2002, J PHYSIOL-LONDON, V540, P861; Kawasaki F, 2000, NAT NEUROSCI, V3, P859, DOI 10.1038/78753; Klyachko VA, 2002, NATURE, V418, P89, DOI 10.1038/nature00852; Li ZY, 2001, NEURON, V31, P593, DOI 10.1016/S0896-6273(01)00398-1; LINDAU M, 1988, PFLUG ARCH EUR J PHY, V411, P137, DOI 10.1007/BF00582306; Lou XL, 2008, P NATL ACAD SCI USA, V105, P17555, DOI 10.1073/pnas.0809621105; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Marks B, 1998, CURR BIOL, V8, P740, DOI 10.1016/S0960-9822(98)70297-0; Neher E, 2001, J NEUROSCI, V21, P444, DOI 10.1523/JNEUROSCI.21-02-00444.2001; Neher E, 2008, NEURON, V59, P861, DOI 10.1016/j.neuron.2008.08.019; Neher E, 2006, PFLUG ARCH EUR J PHY, V453, P261, DOI 10.1007/s00424-006-0143-9; Neves G, 2001, P NATL ACAD SCI USA, V98, P15282, DOI 10.1073/pnas.261311698; Newton AJ, 2006, P NATL ACAD SCI USA, V103, P17955, DOI 10.1073/pnas.0606212103; Nicholson-Tomishima K, 2004, P NATL ACAD SCI USA, V101, P16648, DOI 10.1073/pnas.0406968101; Olesen LE, 2008, J BIOL CHEM, V283, P5099, DOI 10.1074/jbc.M708621200; Peters C, 2004, CELL, V119, P667, DOI 10.1016/j.cell.2004.11.023; Poskanzer KE, 2003, NATURE, V426, P559, DOI 10.1038/nature02184; RAMASWAMI M, 1994, NEURON, V13, P363, DOI 10.1016/0896-6273(94)90353-0; Renden R, 2007, J NEUROPHYSIOL, V98, P3349, DOI 10.1152/jn.00898.2007; Ringstad N, 1999, NEURON, V24, P143, DOI 10.1016/S0896-6273(00)80828-4; Roos J, 1999, CURR BIOL, V9, P1411, DOI 10.1016/S0960-9822(00)80087-1; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; Ryan TA, 1996, P NATL ACAD SCI USA, V93, P5567, DOI 10.1073/pnas.93.11.5567; Ryan TA, 2006, CURR OPIN CELL BIOL, V18, P416, DOI 10.1016/j.ceb.2006.06.013; Sakaba T, 2006, J NEUROSCI, V26, P5863, DOI 10.1523/JNEUROSCI.0182-06.2006; Sakaba T, 2005, SCIENCE, V309, P491, DOI 10.1126/science.1112645; Sakaba T, 2003, NATURE, V424, P775, DOI 10.1038/nature01859; Sakaba T, 2001, NEURON, V32, P1119, DOI 10.1016/S0896-6273(01)00543-8; Sakaba T, 2001, P NATL ACAD SCI USA, V98, P331, DOI 10.1073/pnas.021541098; Satzler K, 2002, J NEUROSCI, V22, P10567; Scheuss V, 2002, J NEUROSCI, V22, P728, DOI 10.1523/JNEUROSCI.22-03-00728.2002; Schiavo G, 2000, PHYSIOL REV, V80, P717, DOI 10.1152/physrev.2000.80.2.717; Schmid EM, 2007, NATURE, V448, P883, DOI 10.1038/nature06031; Schneggenburger R, 2000, NATURE, V406, P889, DOI 10.1038/35022702; Shupliakov O, 1997, SCIENCE, V276, P259, DOI 10.1126/science.276.5310.259; Smith SM, 2008, TRENDS NEUROSCI, V31, P559, DOI 10.1016/j.tins.2008.08.005; Srinivasan G, 2008, J NEUROPHYSIOL, V99, P1810, DOI 10.1152/jn.00949.2007; Stevens CF, 1999, NEURON, V24, P1017, DOI 10.1016/S0896-6273(00)81047-8; Stevens CF, 1998, NEURON, V21, P415, DOI 10.1016/S0896-6273(00)80550-4; Stevens CF, 2003, NEURON, V40, P381, DOI 10.1016/S0896-6273(03)00643-3; Sun J, 2007, NATURE, V450, P676, DOI 10.1038/nature06308; Sun JY, 2002, NATURE, V417, P555, DOI 10.1038/417555a; Takahashi T, 2000, SCIENCE, V289, P460, DOI 10.1126/science.289.5478.460; Taschenberger H, 2000, J NEUROSCI, V20, P9162; Teng HB, 2005, J PHYSIOL-LONDON, V565, P743, DOI 10.1113/jphysiol.2005.087296; Verstreken P, 2002, CELL, V109, P101, DOI 10.1016/S0092-8674(02)00688-8; Voglmaier SM, 2006, NEURON, V51, P71, DOI 10.1016/j.neuron.2006.05.027; VONGERSDORFF H, 1994, NATURE, V370, P652, DOI 10.1038/370652a0; Wadel K, 2007, NEURON, V53, P563, DOI 10.1016/j.neuron.2007.01.021; Wienisch M, 2006, NAT NEUROSCI, V9, P1019, DOI 10.1038/nn1739; Wolfel M, 2007, J NEUROSCI, V27, P3198, DOI 10.1523/JNEUROSCI.4471-06.2007; Wu LG, 2004, TRENDS NEUROSCI, V27, P548, DOI 10.1016/j.tins.2004.07.001; Wu LG, 1996, NEURON, V17, P769, DOI 10.1016/S0896-6273(00)80208-1; Wu LG, 2007, J NEUROSCI, V27, P11793, DOI 10.1523/JNEUROSCI.3471-07.2007; Wu W, 2005, J NEUROSCI, V25, P11676, DOI 10.1523/JNEUROSCI.2972-05.2005; Xu JH, 2008, NAT NEUROSCI, V11, P45, DOI 10.1038/nn2021; Yamashita T, 2005, SCIENCE, V307, P124, DOI 10.1126/science.1103631; Zefirov AL, 2006, NEUROSCIENCE, V143, P905, DOI 10.1016/j.neuroscience.2006.08.025; Zenisek D, 2000, NATURE, V406, P849, DOI 10.1038/35022500; ZHANG JZ, 1994, CELL, V78, P751, DOI 10.1016/S0092-8674(94)90442-1; Zhang Q, 2009, SCIENCE, V323, P1448, DOI 10.1126/science.1167373; Zhu YL, 2009, NEURON, V61, P397, DOI 10.1016/j.neuron.2008.12.024; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	93	183	184	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 30	2009	63	2					216	229		10.1016/j.neuron.2009.06.010	http://dx.doi.org/10.1016/j.neuron.2009.06.010			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	479IS	19640480	Bronze			2022-12-24	WOS:000268653500010
J	Bromberg-Martin, ES; Hikosaka, O				Bromberg-Martin, Ethan S.; Hikosaka, Okihide			Midbrain Dopamine Neurons Signal Preference for Advance Information about Upcoming Rewards	NEURON			English	Article							INTERTEMPORAL CHOICE; OBSERVING RESPONSES; DECISION-MAKING; UNCERTAINTY; REINFORCEMENT; RESOLUTION; PREDICTION; ENCODE; ACQUISITION; MOTIVATION	The desire to know what the future holds is a powerful motivator in everyday life, but it is unknown how this desire is created by neurons in the brain. Here we show that when macaque monkeys are offered a water reward of variable magnitude, they seek advance information about its size. Furthermore, the same midbrain dopamine neurons that signal the expected amount of water also signal the expectation of information, in a manner that is correlated with the strength of the animal's preference. Our data show that single dopamine neurons process both primitive and cognitive rewards, and suggest that current theories of reward-seeking must be revised to include information-seeking.	[Bromberg-Martin, Ethan S.; Hikosaka, Okihide] NEI, Sensorimotor Res Lab, NIH, Bethesda, MD 20892 USA; [Bromberg-Martin, Ethan S.] Brown Univ, Dept Neurosci, Brown NIH Grad Partnership Program, Providence, RI 02906 USA	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); Brown University; National Institutes of Health (NIH) - USA	Hikosaka, O (corresponding author), NEI, Sensorimotor Res Lab, NIH, Bethesda, MD 20892 USA.	oh@lsr.nei.nih.gov			intramural research program at the National Eye Institute; NATIONAL EYE INSTITUTE [ZIAEY000415] Funding Source: NIH RePORTER	intramural research program at the National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank M. Matsumoto, G. La Camera, B.J. Richmond, D. Sheinberg, and V. Stuphorn for valuable discussions, and G. Tansey, D. Parker, M. Lawson, B. Nagy, J.W. McClurkin, A.M. Nichols, T.W. Ruffner, L.P. Jensen, and M.K. Smith for technical assistance. This work was supported by the intramural research program at the National Eye Institute.	Ahlbrecht M, 1996, J INST THEOR ECON, V152, P593; BADIA P, 1979, PSYCHOL BULL, V86, P1107, DOI 10.1037/0033-2909.86.5.1107; BARTO AG, 2004, P 3 INT C DEV LEARN, P112; Bayer HM, 2005, NEURON, V47, P129, DOI 10.1016/j.neuron.2005.05.020; Behrens TEJ, 2007, NAT NEUROSCI, V10, P1214, DOI 10.1038/nn1954; Caplin A, 2001, Q J ECON, V116, P55, DOI 10.1162/003355301556347; CHEW SH, 1994, J RISK UNCERTAINTY, V8, P267, DOI 10.1007/BF01064045; DALY HB, 1992, LEARNING AND MEMORY : THE BEHAVIORAL AND BIOLOGICAL SUBSTRATES, P81; Day JJ, 2007, NAT NEUROSCI, V10, P1020, DOI 10.1038/nn1923; DINSMOOR JA, 1983, BEHAV BRAIN SCI, V6, P693, DOI 10.1017/S0140525X00017969; Efron B., 1994, INTRO BOOTSTRAP; Eliaz K, 2007, AM ECON REV, V97, P166, DOI 10.1257/aer.97.2.166; FANSELOW MS, 1979, PHYSIOL PSYCHOL, V7, P70; Fantino E., 1977, HDB OPERANT BEHAV; Fiorillo CD, 2003, SCIENCE, V299, P1898, DOI 10.1126/science.1077349; Fiorillo CD, 2008, NAT NEUROSCI, V11, P966, DOI 10.1038/nn.2159; Frank MJ, 2004, SCIENCE, V306, P1940, DOI 10.1126/science.1102941; Green DM, 1966, SIGNAL DETECTION THE; Hayden BY, 2007, CURR BIOL, V17, P49, DOI 10.1016/j.cub.2006.10.055; HAYS AV, 1982, WESCON C P, P1; Herry C, 2007, J NEUROSCI, V27, P5958, DOI 10.1523/JNEUROSCI.5218-06.2007; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI 10.1037/0033-295X.109.4.679; Horvitz JC, 2000, NEUROSCIENCE, V96, P651, DOI 10.1016/S0306-4522(00)00019-1; Joshua M, 2008, J NEUROSCI, V28, P11673, DOI 10.1523/JNEUROSCI.3839-08.2008; Kakade S, 2002, NEURAL NETWORKS, V15, P549, DOI 10.1016/S0893-6080(02)00048-5; Kawagoe R, 2004, J NEUROPHYSIOL, V91, P1013, DOI 10.1152/jn.00721.2003; Kim S, 2008, NEURON, V59, P161, DOI 10.1016/j.neuron.2008.05.010; Kobayashi S, 2008, J NEUROSCI, V28, P7837, DOI 10.1523/JNEUROSCI.1600-08.2008; KREPS DM, 1978, ECONOMETRICA, V46, P185, DOI 10.2307/1913656; Lauwereyns J, 2002, NEURON, V33, P463, DOI 10.1016/S0896-6273(02)00571-8; LIEBERMAN DA, 1997, LEARN MOTIV, V28, P213; Lovallo D, 2000, J BEHAV DECIS MAKING, V13, P179, DOI 10.1002/(SICI)1099-0771(200004/06)13:2<179::AID-BDM332>3.0.CO;2-J; Luhmann CC, 2008, J NEUROSCI, V28, P14459, DOI 10.1523/JNEUROSCI.5058-08.2008; Matsumoto M, 2007, NATURE, V447, P1111, DOI 10.1038/nature05860; Matsumoto M, 2009, NATURE, V459, P837, DOI 10.1038/nature08028; McCoy AN, 2005, NAT NEUROSCI, V8, P1220, DOI 10.1038/nn1523; MILLER SM, 1987, J PERS SOC PSYCHOL, V52, P345, DOI 10.1037/0022-3514.52.2.345; MITCHELL KM, 1965, J COMP PHYSIOL PSYCH, V60, P435, DOI 10.1037/h0022578; Montague PR, 2004, NATURE, V431, P760, DOI 10.1038/nature03015; Morris G, 2006, NAT NEUROSCI, V9, P1057, DOI 10.1038/nn1743; Nakamura K, 2006, J NEUROPHYSIOL, V96, P478, DOI 10.1152/jn.01326.2005; PERKINS CC, 1955, PSYCHOL REV, V62, P341, DOI 10.1037/h0040520; Platt ML, 2008, NAT NEUROSCI, V11, P398, DOI 10.1038/nn2062; PROKASY WF, 1956, J COMP PHYSIOL PSYCH, V49, P131, DOI 10.1037/h0046740; Redgrave P, 2006, NAT REV NEUROSCI, V7, P967, DOI 10.1038/nrn2022; Redish AD, 2004, SCIENCE, V306, P1944, DOI 10.1126/science.1102384; Roesch MR, 2007, NAT NEUROSCI, V10, P1615, DOI 10.1038/nn2013; Satoh T, 2003, J NEUROSCI, V23, P9913; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; SCHULTZ W, 1990, J NEUROPHYSIOL, V63, P607, DOI 10.1152/jn.1990.63.3.607; Schultz W, 2000, NAT REV NEUROSCI, V1, P199, DOI 10.1038/35044563; Seo H, 2009, J NEUROSCI, V29, P3627, DOI 10.1523/JNEUROSCI.4726-08.2009; Shidara M, 2002, SCIENCE, V296, P1709, DOI 10.1126/science.1069504; Sutton R.S., 2015, REINFORCEMENT LEARNI, V2nd ed.; SUTTON RS, 1981, PSYCHOL REV, V88, P135, DOI 10.1037/0033-295X.88.2.135; Tobler PN, 2003, J NEUROSCI, V23, P10402; Torrance G W, 1989, Int J Technol Assess Health Care, V5, P559; TSUDA A, 1989, PHARMACOL BIOCHEM BE, V32, P569, DOI 10.1016/0091-3057(89)90198-6; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406; Wu G, 1999, THEOR DECIS, V46, P159, DOI 10.1023/A:1004990410083; WYCKOFF LB, 1952, PSYCHOL REV, V59, P431, DOI 10.1037/h0053932; WYCKOFF LB, 1959, PSYCHOL REV, V66, P68, DOI 10.1037/h0046882	62	272	275	2	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 16	2009	63	1					119	126		10.1016/j.neuron.2009.06.009	http://dx.doi.org/10.1016/j.neuron.2009.06.009			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	473EX	19607797	Green Accepted, Bronze			2022-12-24	WOS:000268189900013
J	Shigetomi, E; Kracun, S; Sofroniew, MV; Khakh, BS				Shigetomi, Eiji; Kracun, Sebastian; Sofroniew, Michael V.; Khakh, Baljit S.			A genetically targeted optical sensor to monitor calcium signals in astrocyte processes	NATURE NEUROSCIENCE			English	Article							IN-SITU; HIPPOCAMPAL ASTROCYTES; NEURAL ACTIVITY; CA2+ INDICATOR; GLUTAMATE; GLIA; ACTIVATION; OSCILLATIONS; NEURONS; MICE	Calcium signaling is studied as a potential form of astrocyte excitability that may control astrocyte involvement in synaptic and cerebrovascular regulation. Fundamental questions remain unanswered about astrocyte calcium signaling, as current methods can not resolve calcium in small volume compartments, such as near the cell membrane and in distal cell processes. We modified the genetically encoded calcium sensor GCaMP2 with a membrane-tethering domain, Lck, increasing the level of Lck-GCaMP2 near the plasma membrane tenfold as compared with conventional GCaMP2. Using Lck-GCaMP2 in rat hippocampal astrocyte-neuron cocultures, we measured near-membrane calcium signals that were evoked pharmacologically or by single action potential-mediated neurotransmitter release. Moreover, we identified highly localized and frequent spontaneous calcium signals in astrocyte somata and processes that conventional GCaMP2 failed to detect. Lck-GCaMP2 acts as a genetically targeted calcium sensor for monitoring calcium signals in previously inaccessible parts of astrocytes, including fine processes.	[Shigetomi, Eiji; Kracun, Sebastian; Khakh, Baljit S.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Los Angeles, CA 90095 USA; [Sofroniew, Michael V.; Khakh, Baljit S.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Khakh, BS (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Los Angeles, CA 90095 USA.	bkhakh@mednet.ucla.edu	SHIGETOMI, EIJI/I-2372-2012; Sofroniew, Michael/ABE-8857-2020	Shigetomi, Eiji/0000-0002-5267-6155	National Institutes of Health [NS060677, NS057624]; Whitehall Foundation; S&R Foundation Ryuji Ueno Award; Stein-Oppenheimer Foundation Endowment Award; Uehara Memorial Foundation Fellowship of Japan; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060677, R01NS057624, R21NS071292] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Whitehall Foundation; S&R Foundation Ryuji Ueno Award; Stein-Oppenheimer Foundation Endowment Award; Uehara Memorial Foundation Fellowship of Japan(Uehara Memorial Foundation); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank L. Looger for a preprint of a manuscript on GCaMP3, A. Sagasti for the GCaMP2 plasmid, D.E. Bergles for insightful discussions and for the Lck domain plasmid, and M. Simon for MrgA1-EGFP. Our work was supported by the National Institutes of Health (NS060677 and NS057624), the Whitehall Foundation, a S&R Foundation Ryuji Ueno Award for Ion Channels or Barrier Function Research and a Stein-Oppenheimer Foundation Endowment Award (B.S.K.). E.S. was partly supported by the Uehara Memorial Foundation Fellowship of Japan.	Agulhon C, 2008, NEURON, V59, P932, DOI 10.1016/j.neuron.2008.09.004; Araque A, 1999, TRENDS NEUROSCI, V22, P208, DOI 10.1016/S0166-2236(98)01349-6; Atkin SD, 2009, J NEUROSCI METH, V181, P212, DOI 10.1016/j.jneumeth.2009.05.006; Barres BA, 2008, NEURON, V60, P430, DOI 10.1016/j.neuron.2008.10.013; Bekar LK, 2008, CEREB CORTEX, V18, P2789, DOI 10.1093/cercor/bhn040; Benediktsson AM, 2005, J NEUROSCI METH, V141, P41, DOI 10.1016/j.jneumeth.2004.05.013; Bush TG, 1998, CELL, V93, P189, DOI 10.1016/S0092-8674(00)81571-8; Bushong EA, 2002, J NEUROSCI, V22, P183, DOI 10.1523/JNEUROSCI.22-01-00183.2002; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; CORNELLBELL AH, 1990, SCIENCE, V247, P470, DOI 10.1126/science.1967852; Dombeck DA, 2007, NEURON, V56, P43, DOI 10.1016/j.neuron.2007.08.003; Fellin T, 2004, NEURON, V43, P729, DOI 10.1016/j.neuron.2004.08.011; Fiacco TA, 2007, NEURON, V54, P611, DOI 10.1016/j.neuron.2007.04.032; Fiacco TA, 2009, ANNU REV PHARMACOL, V49, P151, DOI 10.1146/annurev.pharmtox.011008.145602; GOBEL W, 2001, NAT METHODS, V4, P13; GOLDMAN JE, 1990, BRAIN RES, V528, P189, DOI 10.1016/0006-8993(90)91657-3; Gordon GRJ, 2007, GLIA, V55, P1214, DOI 10.1002/glia.20543; Gordon GRJ, 2009, NEURON, V64, P391, DOI 10.1016/j.neuron.2009.10.021; Grosche J, 1999, NAT NEUROSCI, V2, P139, DOI 10.1038/5692; Halassa MM, 2007, J NEUROSCI, V27, P6473, DOI 10.1523/JNEUROSCI.1419-07.2007; Hirase H, 2004, PLOS BIOL, V2, P494, DOI 10.1371/journal.pbio.0020096; Iadecola C, 2007, NAT NEUROSCI, V10, P1369, DOI 10.1038/nn2003; Jaiswal JK, 2007, NAT CHEM BIOL, V3, P92, DOI 10.1038/nchembio855; Kofuji P, 2004, NEUROSCIENCE, V129, P1045, DOI 10.1016/j.neurscience.2004.06.008; Lee CJ, 2007, J PHYSIOL-LONDON, V581, P1057, DOI 10.1113/jphysiol.2007.130377; Lee SY, 2007, J PHYSIOL-LONDON, V581, P887, DOI 10.1113/jphysiol.2007.134676; Magistretti PJ, 2006, J EXP BIOL, V209, P2304, DOI 10.1242/jeb.02208; Mao T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001796; Nakai J, 2001, NAT BIOTECHNOL, V19, P137, DOI 10.1038/84397; Nett WJ, 2002, J NEUROPHYSIOL, V87, P528, DOI 10.1152/jn.00268.2001; Oberheim NA, 2008, J NEUROSCI, V28, P3264, DOI 10.1523/JNEUROSCI.4980-07.2008; Oberheim NA, 2009, J NEUROSCI, V29, P3276, DOI 10.1523/JNEUROSCI.4707-08.2009; Parpura V, 2000, P NATL ACAD SCI USA, V97, P8629, DOI 10.1073/pnas.97.15.8629; PARPURA V, 1994, NATURE, V369, P744, DOI 10.1038/369744a0; Pascual O, 2005, SCIENCE, V310, P113, DOI 10.1126/science.1116916; Pasti L, 1997, J NEUROSCI, V17, P7817; Perea G, 2009, TRENDS NEUROSCI, V32, P421, DOI 10.1016/j.tins.2009.05.001; Petravicz J, 2008, J NEUROSCI, V28, P4967, DOI 10.1523/JNEUROSCI.5572-07.2008; Porter JT, 1996, J NEUROSCI, V16, P5073; Reyes RC, 2009, NEUROCHEM INT, V55, P2, DOI 10.1016/j.neuint.2008.12.018; Richler E, 2008, NAT METHODS, V5, P87, DOI 10.1038/NMETH1144; Schummers J, 2008, SCIENCE, V320, P1638, DOI 10.1126/science.1156120; Shigetomi E, 2008, J NEUROSCI, V28, P6659, DOI 10.1523/JNEUROSCI.1717-08.2008; Shigetomi Eiji, 2009, J Vis Exp, DOI 10.3791/1142; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Tallini YN, 2006, P NATL ACAD SCI USA, V103, P4753, DOI 10.1073/pnas.0509378103; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Tritsch NX, 2007, NEURON, V54, P497, DOI 10.1016/j.neuron.2007.05.008; Wang P, 2006, J COASTAL RES, P816; Zlatkine P, 1997, J CELL SCI, V110, P673	50	173	178	1	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2010	13	6					759	U143		10.1038/nn.2557	http://dx.doi.org/10.1038/nn.2557			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	600QY	20495558	Green Accepted			2022-12-24	WOS:000278003300022
J	Buchman, JJ; Tseng, HC; Zhou, Y; Frank, CL; Xie, ZG; Tsai, LH				Buchman, Joshua J.; Tseng, Huan-Chung; Zhou, Ying; Frank, Christopher L.; Xie, Zhigang; Tsai, Li-Huei			Cdk5rap2 Interacts with Pericentrin to Maintain the Neural Progenitor Pool in the Developing Neocortex	NEURON			English	Article							GAMMA-TUBULIN COMPLEXES; RECESSIVE MICROCEPHALY MAPS; MICROTUBULE ORGANIZATION; SPINDLE ORGANIZATION; PRIMORDIAL DWARFISM; CENTROSOMAL PROTEIN; NEURONAL MIGRATION; RNA INTERFERENCE; BRAIN SIZE; CELL-CYCLE	Primary autosomal-recessive microcephaly (MCPH) and Majewski osteodysplastic primordial dwarfism type II (MOPDII) are both genetic diseases that result in decreased brain size at birth. MCPH is thought to arise from alterations in the size of the neural progenitor pool, but the cause of this defect has not been thoroughly explored. We find that one of the genes associated with MCPH, Cdk5rap2, is highly expressed in the neural progenitor pool and that its loss results in a depletion of apical progenitors and increased cell-cycle exit leading to premature neuronal differentiation. We link Cdk5rap2 function to the pericentriolar material protein pericentrin, loss of function of which is associated with MOPDII. Depletion of pericentrin in neural progenitors phenocopies effects of Cdk5rap2 knockdown and results in decreased recruitment of Cdk5rap2 to the centrosome. Our findings uncover a common mechanism, involving aberrations in the neurogenesis program, that may underlie the development of microcephaly in multiple diseases.	[Buchman, Joshua J.; Tseng, Huan-Chung; Zhou, Ying; Frank, Christopher L.; Tsai, Li-Huei] MIT, Picower Inst Learning & Memory, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Buchman, Joshua J.; Zhou, Ying; Frank, Christopher L.; Tsai, Li-Huei] Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Buchman, Joshua J.] Harvard Univ, Sch Med, Program Neurosci, Boston, MA 02115 USA; [Tsai, Li-Huei] Broad Inst Harvard, Stanley Ctr Psychiat Res, Cambridge, MA 02139 USA; [Xie, Zhigang] Boston Univ, Sch Med, Dept Neurosurg, Dept Pharmacol & Expt Therapeut, Boston, MA 02118 USA	Massachusetts Institute of Technology (MIT); Northwell Health; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Boston University	Tsai, LH (corresponding author), MIT, Picower Inst Learning & Memory, Dept Brain & Cognit Sci, 77 Massachusetts Ave,Bldg 46,Room 4235A, Cambridge, MA 02139 USA.	lhtsai@mit.edu		Xie, Zhigang/0000-0002-5794-2977	National Institutes of Health [NS37007]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037007] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to thank Y. Mao, K. Singh, and D. Kim for helpful comments and criticism of the manuscript. Thanks to X. Ge for preparing and contributing perfused embryonic brains. Thanks to Dr. Stephen Doxsey for providing human Kendrin cDNA. The Pax6 antibody developed by A. Kawakami was obtained from the Developmental Studies Hybridoma Bank developed under the auspices of the NICHD and maintained by The University of Iowa, Department of Biology, Iowa City, IA 52242. This work was supported by grant NS37007 from the National Institutes of Health. L.-H.T. is an investigator of the Howard Hughes Medical Institute and the director of the neurobiology program at the Stanley Center for Psychiatric Research.	Aicardi J, 1998, DIS NERVOUS SYSTEM C; Andersen JS, 2003, NATURE, V426, P570, DOI 10.1038/nature02166; ANGEVINE JB, 1961, NATURE, V192, P766, DOI 10.1038/192766b0; Bond J, 2006, CURR OPIN CELL BIOL, V18, P95, DOI 10.1016/j.ceb.2005.11.004; Bond J, 2005, NAT GENET, V37, P353, DOI 10.1038/ng1539; Bond J, 2002, NAT GENET, V32, P316, DOI 10.1038/ng995; Buchman JJ, 2007, NAT REV NEUROSCI, V8, P89, DOI 10.1038/nrn2058; Busson S, 1998, CURR BIOL, V8, P541, DOI 10.1016/S0960-9822(98)70208-8; Calegari F, 2003, J CELL SCI, V116, P4947, DOI 10.1242/jcs.00825; Cox J, 2006, TRENDS MOL MED, V12, P358, DOI 10.1016/j.molmed.2006.06.006; Dammermann A, 2002, J CELL BIOL, V159, P255, DOI 10.1083/jcb.200204023; Desir J, 2008, AM J MED GENET A, V146A, P1439, DOI 10.1002/ajmg.a.32312; Dictenberg JB, 1998, J CELL BIOL, V141, P163, DOI 10.1083/jcb.141.1.163; Doxsey S, 2001, NAT REV MOL CELL BIO, V2, P688, DOI 10.1038/35089575; DOXSEY SJ, 1994, CELL, V76, P639, DOI 10.1016/0092-8674(94)90504-5; Endoh-Yamagami S, 2010, DEV BIOL, V340, P41, DOI 10.1016/j.ydbio.2010.01.017; Farkas LM, 2008, CURR OPIN CELL BIOL, V20, P707, DOI 10.1016/j.ceb.2008.09.008; Faulkner NE, 2000, NAT CELL BIOL, V2, P784, DOI 10.1038/35041020; Ferland RJ, 2003, J COMP NEUROL, V460, P266, DOI 10.1002/cne.10654; Fish JL, 2006, P NATL ACAD SCI USA, V103, P10438, DOI 10.1073/pnas.0604066103; Fong KW, 2008, MOL BIOL CELL, V19, P115, DOI 10.1091/mbc.E07-04-0371; Graser S, 2007, J CELL SCI, V120, P4321, DOI 10.1242/jcs.020248; Haren L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005976; Hassan MJ, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-58; Higginbotham HR, 2007, TRENDS NEUROSCI, V30, P276, DOI 10.1016/j.tins.2007.04.001; Jackson AP, 1998, AM J HUM GENET, V63, P541, DOI 10.1086/301966; Jamieson CR, 2000, AM J HUM GENET, V67, P1575, DOI 10.1086/316909; Jamieson CR, 1999, AM J HUM GENET, V65, P1465, DOI 10.1086/302640; Jurczyk A, 2004, J CELL BIOL, V166, P637, DOI 10.1083/jcb.200405023; Kumar A, 2009, AM J HUM GENET, V84, P286, DOI 10.1016/j.ajhg.2009.01.017; Leal GF, 2003, J MED GENET, V40, P540, DOI 10.1136/jmg.40.7.540; Luders J, 2007, NAT REV MOL CELL BIO, V8, P161, DOI 10.1038/nrm2100; Magdaleno S, 2006, PLOS BIOL, V4, P497, DOI 10.1371/journal.pbio.0040086; MAJEWSKI F, 1982, AM J MED GENET, V12, P23, DOI 10.1002/ajmg.1320120104; Matsuda T, 2004, P NATL ACAD SCI USA, V101, P16, DOI 10.1073/pnas.2235688100; Miyoshi K, 2009, FASEB J, V23, P3289, DOI 10.1096/fj.08-124420; Moynihan L, 2000, AM J HUM GENET, V66, P724, DOI 10.1086/302777; Noctor SC, 2008, J COMP NEUROL, V508, P28, DOI 10.1002/cne.21669; Pattison L, 2000, AM J HUM GENET, V67, P1578, DOI 10.1086/316910; Pfaff KL, 2007, MOL CELL BIOL, V27, P5887, DOI 10.1128/MCB.00175-07; Rauch A, 2008, SCIENCE, V319, P816, DOI 10.1126/science.1151174; Raynaud-Messina B, 2007, CURR OPIN CELL BIOL, V19, P24, DOI 10.1016/j.ceb.2006.12.008; Rimol LM, 2010, P NATL ACAD SCI USA, V107, P384, DOI 10.1073/pnas.0908454107; Roberts E, 1999, EUR J HUM GENET, V7, P815, DOI 10.1038/sj.ejhg.5200385; Roberts E, 2002, J MED GENET, V39, P718, DOI 10.1136/jmg.39.10.718; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; TAKAHASHI T, 1995, J NEUROSCI, V15, P6046; Tsai LH, 2005, NEURON, V46, P383, DOI 10.1016/j.neuron.2005.04.013; Woods CG, 2005, AM J HUM GENET, V76, P717, DOI 10.1086/429930; Xie ZG, 2003, CELL, V114, P469, DOI 10.1016/S0092-8674(03)00605-6; Xie ZG, 2007, NEURON, V56, P79, DOI 10.1016/j.neuron.2007.08.026; Xu XZ, 2004, J BIOL CHEM, V279, P34091, DOI 10.1074/jbc.C400139200; Yingling J, 2008, CELL, V132, P474, DOI 10.1016/j.cell.2008.01.026; Zhong XY, 2006, CELL CYCLE, V5, P457, DOI 10.4161/cc.5.4.2481; Zimmerman WC, 2004, MOL BIOL CELL, V15, P3642, DOI 10.1091/mbc.E03-11-0796; Zmuda JF, 1998, CELL MOTIL CYTOSKEL, V41, P18, DOI 10.1002/(SICI)1097-0169(1998)41:1<18::AID-CM2>3.0.CO;2-B	56	131	134	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	MAY 13	2010	66	3					386	402		10.1016/j.neuron.2010.03.036	http://dx.doi.org/10.1016/j.neuron.2010.03.036			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	598HE	20471352	Green Published, Bronze			2022-12-24	WOS:000277825200008
J	An, SJ; Grabner, CP; Zenisek, D				An, Seong J.; Grabner, Chad P.; Zenisek, David			Real-time visualization of complexin during single exocytic events	NATURE NEUROSCIENCE			English	Article							MEMBRANE-FUSION; CA2+-TRIGGERED EXOCYTOSIS; SNARE COMPLEX; NEUROTRANSMITTER RELEASE; VESICLE EXOCYTOSIS; CHROMAFFIN CELLS; ENDOCRINE-CELLS; PORE; BINDING; SYNAPTOTAGMIN	Understanding the fundamental role of soluble NSF attachment protein receptor (SNARE) complexes in membrane fusion requires knowledge of the spatiotemporal dynamics of their assembly. We visualized complexin (cplx), a cytosolic protein that binds assembled SNARE complexes, during single exocytic events in live cells. We found that cplx appeared briefly during full fusion. However, a truncated version of cplx containing only the SNARE-complex binding region persisted at fusion sites for seconds and caused fusion to be transient. Resealing pores with the mutant cplx only partially released transmitter and lipid probes, indicating that the pores are narrow and not purely lipidic in structure. Depletion of cplx similarly caused secretory cargo to be retained. These data suggest that cplx is recruited at a late step in exocytosis and modulates fusion pores composed of SNARE complexes.	[An, Seong J.; Grabner, Chad P.; Zenisek, David] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06510 USA	Yale University	An, SJ (corresponding author), Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06510 USA.	seong.an@yale.edu	Zenisek, David/C-6555-2011		McKnight and Kinship Foundations; US National Institutes of Health [EY000785, EY018111]; NATIONAL EYE INSTITUTE [R01EY014990, P30EY000785, R21EY018111] Funding Source: NIH RePORTER	McKnight and Kinship Foundations; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank F. Rivera-Molina and S. Viviano for technical assistance and P. De Camilli and D. Toomre for comments on the manuscript. This work was supported by McKnight and Kinship Foundations and US National Institutes of Health grants EY000785 and EY018111.	Abderrahmani A, 2004, J CELL SCI, V117, P2239, DOI 10.1242/jcs.01041; An S, 2004, CURR OPIN NEUROBIOL, V14, P522, DOI 10.1016/j.conb.2004.08.008; An SJ, 2004, SCIENCE, V306, P1042, DOI 10.1126/science.1102559; Archer DA, 2002, J BIOL CHEM, V277, P18249, DOI 10.1074/jbc.C200166200; AXELROD D, 1976, BIOPHYS J, V16, P1055, DOI 10.1016/S0006-3495(76)85755-4; Bracher A, 2002, J BIOL CHEM, V277, P26517, DOI 10.1074/jbc.M203460200; Bretou M, 2008, J NEUROSCI, V28, P8470, DOI 10.1523/JNEUROSCI.0860-08.2008; Cai HJ, 2008, P NATL ACAD SCI USA, V105, P19538, DOI 10.1073/pnas.0810232105; Chapman ER, 2002, NAT REV MOL CELL BIO, V3, P498, DOI 10.1038/nrm855; Chen XC, 2002, NEURON, V33, P397, DOI 10.1016/S0896-6273(02)00583-4; CORCORAN JJ, 1984, J BIOL CHEM, V259, P6208; Edwardson JM, 2003, J BIOL CHEM, V278, P30849, DOI 10.1074/jbc.M304615200; Fang QH, 2008, P NATL ACAD SCI USA, V105, P15388, DOI 10.1073/pnas.0805377105; Giraudo CG, 2006, SCIENCE, V313, P676, DOI 10.1126/science.1129450; Giraudo CG, 2009, SCIENCE, V323, P512, DOI 10.1126/science.1166500; Gong LW, 2007, NAT CELL BIOL, V9, P915, DOI 10.1038/ncb1617; Grabner CP, 2005, J NEUROPHYSIOL, V94, P2093, DOI 10.1152/jn.00316.2005; Guan R, 2008, BIOCHEMISTRY-US, V47, P1474, DOI 10.1021/bi702345m; Han X, 2004, SCIENCE, V304, P289, DOI 10.1126/science.1095801; Huntwork S, 2007, NAT NEUROSCI, V10, P1235, DOI 10.1038/nn1980; Itakura M, 1999, BIOCHEM BIOPH RES CO, V265, P691, DOI 10.1006/bbrc.1999.1756; Jackson MB, 2006, ANNU REV BIOPH BIOM, V35, P135, DOI 10.1146/annurev.biophys.35.040405.101958; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Kesavan J, 2007, CELL, V131, P351, DOI 10.1016/j.cell.2007.09.025; Li YL, 2007, BIOPHYS J, V93, P2178, DOI 10.1529/biophysj.106.101220; Maximov A, 2009, SCIENCE, V323, P516, DOI 10.1126/science.1166505; MCMAHON HT, 1995, CELL, V83, P111, DOI 10.1016/0092-8674(95)90239-2; Merrifield CJ, 2002, NAT CELL BIOL, V4, P691, DOI 10.1038/ncb837; Pabst S, 2002, J BIOL CHEM, V277, P7838, DOI 10.1074/jbc.M109507200; Perrais D, 2004, J PHYSIOL-LONDON, V560, P413, DOI 10.1113/jphysiol.2004.064410; Peters C, 2001, NATURE, V409, P581, DOI 10.1038/35054500; Pucadyil TJ, 2006, CHEM PHYS LIPIDS, V143, P11, DOI 10.1016/j.chemphyslip.2006.04.003; Reim K, 2001, CELL, V104, P71, DOI 10.1016/S0092-8674(01)00192-1; Ryan TA, 1996, P NATL ACAD SCI USA, V93, P5567, DOI 10.1073/pnas.93.11.5567; Schaub JR, 2006, NAT STRUCT MOL BIOL, V13, P748, DOI 10.1038/nsmb1124; Schmoranzer J, 2000, J CELL BIOL, V149, P23, DOI 10.1083/jcb.149.1.23; Tadokoro S, 2005, J CELL SCI, V118, P2239, DOI 10.1242/jcs.02338; Tang J, 2006, CELL, V126, P1175, DOI 10.1016/j.cell.2006.08.030; Taraska JW, 2004, P NATL ACAD SCI USA, V101, P8780, DOI 10.1073/pnas.0401316101; Taraska JW, 2003, P NATL ACAD SCI USA, V100, P2070, DOI 10.1073/pnas.0337526100; Ungermann C, 1998, NATURE, V396, P543, DOI 10.1038/25069; Wang CT, 2003, NATURE, V424, P943, DOI 10.1038/nature01857; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Weninger K, 2008, STRUCTURE, V16, P308, DOI 10.1016/j.str.2007.12.010; Wu Y, 2009, BIOPHYS J, V97, P101, DOI 10.1016/j.bpj.2009.04.028; Xue M, 2007, NAT STRUCT MOL BIOL, V14, P949, DOI 10.1038/nsmb1292; Yoon TY, 2008, NAT STRUCT MOL BIOL, V15, P707, DOI 10.1038/nsmb.1446	47	30	30	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2010	13	5					577	U83		10.1038/nn.2532	http://dx.doi.org/10.1038/nn.2532			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	588JM	20383135	Green Accepted			2022-12-24	WOS:000277065700015
J	Park, KJ; Grosso, CA; Aubert, I; Kaplan, DR; Miller, FD				Park, Katya J.; Grosso, Carlos Ayala; Aubert, Isabelle; Kaplan, David R.; Miller, Freda D.			p75NTR-dependent, myelin-mediated axonal degeneration regulates neural connectivity in the adult brain	NATURE NEUROSCIENCE			English	Article							P75 NEUROTROPHIN RECEPTOR; FOREBRAIN CHOLINERGIC NEURONS; RAT SYMPATHETIC NEURONS; NERVE GROWTH-FACTOR; WALLERIAN DEGENERATION; COMPARTMENTED CULTURES; TARGET INNERVATION; NEURITE GROWTH; WHITE MATTER; GRAY-MATTER	Axonal degeneration is important during development but has not been thought to function in the intact mature nervous system. Here, we provide evidence that degeneration of adult axons occurs in the intact rodent brain through a p75 neurotrophin receptor (p75NTR)- and myelin-dependent mechanism. Specifically, we show that p75NTR-mediated axonal degeneration prevents septal cholinergic axons from aberrantly growing onto myelinated tracts in vivo or on a myelin substrate in culture. Myelin also triggers local degeneration of p75NTR-expressing sympathetic axons that is rescued by increasing TrkA signaling or elevating intracellular cyclic AMP. Myelin-mediated degeneration occurs when neurotrophins bind to p75NTR, and involves p75NTR-dependent sequestration of Rho guanine nucleotide dissociation inhibitor (Rho-GDI). Moreover, degeneration, but not growth inhibition, requires downstream activation of Rho and caspase-6. These data indicate that p75NTR maintains the specificity of neural connectivity by preventing inappropriate sprouting onto myelinated tracts and provide a physiological explanation for myelin inhibition after neural injury.	[Park, Katya J.; Kaplan, David R.; Miller, Freda D.] Hosp Sick Children, Cell Biol Programs, Toronto, ON M5G 1X8, Canada; [Park, Katya J.; Kaplan, David R.; Miller, Freda D.] Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A1, Canada; [Grosso, Carlos Ayala; Aubert, Isabelle] Sunnybrook Res Inst, Toronto, ON, Canada; [Grosso, Carlos Ayala] Cent Univ Venezuela, Fac Farm, Caracas, Venezuela; [Aubert, Isabelle] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Kaplan, David R.; Miller, Freda D.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Miller, Freda D.] Univ Toronto, Dept Physiol, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Central Venezuela; University of Toronto; University of Toronto; University of Toronto	Miller, FD (corresponding author), Hosp Sick Children, Cell Biol Programs, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	dkaplan@sickkids.ca; fredam@sickkids.ca	Aubert, Isabelle/AAG-4001-2019; Ayala-Grosso, Carlos/ABD-5221-2020	Aubert, Isabelle/0000-0001-5163-9961; Ayala-Grosso, Carlos/0000-0003-3079-1109	Canadian Institutes of Health Research; Canada Research Chairs program; Howard Hughes Medical Institute; Ontario Graduate Scholarship	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chairs program(Canada Research Chairs); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Ontario Graduate Scholarship(Ontario Graduate Scholarship)	We thank J. Laver for helping with the time-course degeneration experiments, members of the Miller/Kaplan laboratory, J. Atwal, K. Coultes, L. Weng and J. Jordao for advice and technical assistance and P. Barker (McGill University) for p75NTR adenovirus. This work was supported by a grant from the Canadian Institutes of Health Research to F. D. M. and D. R. K. F. D. M. and D. R. K. are supported by the Canada Research Chairs program and F. D. M. by the Howard Hughes Medical Institute. K. J. P. was supported by an Ontario Graduate Scholarship.	AKTORIES K, 1989, BIOCHEM BIOPH RES CO, V158, P209, DOI 10.1016/S0006-291X(89)80199-8; Aloyz RS, 1998, J CELL BIOL, V143, P1691, DOI 10.1083/jcb.143.6.1691; Atwal JK, 2008, SCIENCE, V322, P967, DOI 10.1126/science.1161151; Atwal JK, 2000, NEURON, V27, P265, DOI 10.1016/S0896-6273(00)00035-0; Atwal JK, 2003, J NEUROSCI, V23, P7602; Aubert I, 1998, J COMP NEUROL, V399, P1; Bamji SX, 1998, J CELL BIOL, V140, P911, DOI 10.1083/jcb.140.4.911; Belliveau DJ, 1997, J CELL BIOL, V136, P375, DOI 10.1083/jcb.136.2.375; Cai DM, 1999, NEURON, V22, P89, DOI 10.1016/S0896-6273(00)80681-9; CAMPENOT RB, 1991, J NEUROSCI, V11, P1126; Campenot RB, 2009, NAT PROTOC, V4, P1869, DOI 10.1038/nprot.2009.210; Cao LX, 2007, CURR BIOL, V17, P911, DOI 10.1016/j.cub.2007.04.040; CASTREN E, 1995, NEUROSCIENCE, V64, P71, DOI 10.1016/0306-4522(94)00386-J; Causing CG, 1997, NEURON, V18, P257, DOI 10.1016/S0896-6273(00)80266-4; CRUTCHER KA, 1989, EXP NEUROL, V104, P39, DOI 10.1016/0014-4886(89)90007-1; Deppmann CD, 2008, SCIENCE, V320, P369, DOI 10.1126/science.1152677; Filbin MT, 2003, NAT REV NEUROSCI, V4, P703, DOI 10.1038/nrn1195; Hibbert AP, 2006, MOL CELL NEUROSCI, V32, P387, DOI 10.1016/j.mcn.2006.06.001; Kanamoto T, 2000, MOL CELL BIOL, V20, P196, DOI 10.1128/MCB.20.1.196-204.2000; Kim AH, 2002, NEURON, V35, P697, DOI 10.1016/S0896-6273(02)00821-8; Kohn J, 1999, J NEUROSCI, V19, P5393; Kokaia Z, 1998, NEUROSCIENCE, V84, P1113, DOI 10.1016/S0306-4522(97)00579-4; LEE KF, 1994, SCIENCE, V263, P1447, DOI 10.1126/science.8128229; Lowry KS, 2001, AMYOTROPH LATERAL SC, V2, P127, DOI 10.1080/146608201753275463; Luo LQ, 2005, ANNU REV NEUROSCI, V28, P127, DOI 10.1146/annurev.neuro.28.061604.135632; LYON MF, 1993, P NATL ACAD SCI USA, V90, P9717, DOI 10.1073/pnas.90.20.9717; MA Y, 1992, J CELL BIOL, V117, P135, DOI 10.1083/jcb.117.1.135; Mack TGA, 2001, NAT NEUROSCI, V4, P1199, DOI 10.1038/nn770; Majdan M, 2001, J CELL BIOL, V155, P1275, DOI 10.1083/jcb.200110017; Marinissen MJ, 2004, MOL CELL, V14, P29, DOI 10.1016/S1097-2765(04)00153-4; Naumann T, 2002, J NEUROSCI, V22, P2409, DOI 10.1523/JNEUROSCI.22-07-02409.2002; Nikolaev A, 2009, NATURE, V457, P981, DOI 10.1038/nature07767; Park YJ, 2009, CELL SIGNAL, V21, P356, DOI 10.1016/j.cellsig.2008.11.009; Plachta N, 2007, NAT NEUROSCI, V10, P712, DOI 10.1038/nn1897; Roux PP, 1999, J NEUROSCI, V19, P6887, DOI 10.1523/JNEUROSCI.19-16-06887.1999; Salehi AH, 2002, J BIOL CHEM, V277, P48043, DOI 10.1074/jbc.M205324200; SAVIO T, 1989, J NEUROSCI, V9, P1126; Schnitzler AC, 2008, NAT PROTOC, V3, P34, DOI 10.1038/nprot.2007.477; SCHWAB ME, 1991, J NEUROSCI, V11, P709; SCHWAB ME, 1988, J NEUROSCI, V8, P2381; Singh KK, 2008, NAT NEUROSCI, V11, P649, DOI 10.1038/nn.2114; Singh KK, 2005, NEURON, V45, P837, DOI 10.1016/j.neuron.2005.01.049; Vaillant AR, 1999, J CELL BIOL, V146, P955, DOI 10.1083/jcb.146.5.955; Walsh GS, 1999, J NEUROSCI, V19, P4155; Wong ST, 2002, NAT NEUROSCI, V5, P1302, DOI 10.1038/nn975; WOOLF NJ, 1991, PROG NEUROBIOL, V37, P475, DOI 10.1016/0301-0082(91)90006-M; Yamashita T, 2003, NAT NEUROSCI, V6, P461, DOI 10.1038/nn1045; Yeo TT, 1997, J NEUROSCI, V17, P7594; Yiu G, 2006, NAT REV NEUROSCI, V7, P617, DOI 10.1038/nrn1956; Zhai QW, 2003, NEURON, V39, P217, DOI 10.1016/S0896-6273(03)00429-X	50	87	90	1	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2010	13	5					559	U2		10.1038/nn.2513	http://dx.doi.org/10.1038/nn.2513			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	588JM	20348920				2022-12-24	WOS:000277065700013
J	Chalifoux, JR; Carter, AG				Chalifoux, Jason R.; Carter, Adam G.			GABA(B) Receptors Modulate NMDA Receptor Calcium Signals in Dendritic Spines	NEURON			English	Article							CENTRAL-NERVOUS-SYSTEM; DEPENDENT PROTEIN-KINASE; PYRAMIDAL CELLS-INVITRO; LONG-TERM DEPRESSION; HIPPOCAMPAL-NEURONS; MULTIVESICULAR RELEASE; SYNAPTIC-TRANSMISSION; PRESYNAPTIC INHIBITION; MEDIATED INHIBITION; RAT HIPPOCAMPUS	Metabotropic GABA(B) receptors play a fundamental role in modulating the excitability of neurons and circuits throughout the brain. These receptors influence synaptic transmission by inhibiting presynaptic release or activating postsynaptic potassium channels. However, their ability to directly influence different types of postsynaptic glutamate receptors remains unresolved. Here we examine GABA(B) receptor modulation in layer 2/3 pyramidal neurons from the mouse prefrontal cortex. We use two-photon laser-scanning microscopy to study synaptic modulation at individual dendritic spines. Using two-photon optical quantal analysis, we first demonstrate robust presynaptic modulation of multivesicular release at single synapses. Using two-photon glutamate uncaging, we then reveal that GABA(B) receptors strongly inhibit NMDA receptor calcium signals. This postsynaptic modulation occurs via the PICA pathway and does not affect synaptic currents mediated by AMPA or NMDA receptors. This form of GABA(B) receptor modulation has widespread implications for the control of calcium-dependent neuronal function.	[Chalifoux, Jason R.; Carter, Adam G.] NYU, Ctr Neural Sci, New York, NY 10003 USA	New York University	Carter, AG (corresponding author), NYU, Ctr Neural Sci, 4 Washington Pl, New York, NY 10003 USA.	adam.carter@nyu.edu			NARSAD; Klingenstein Fund; National Institutes of Health [R01-MH085974]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH085974] Funding Source: NIH RePORTER	NARSAD(NARSAD); Klingenstein Fund(Klingenstein Philanthropies); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank members of the Carter lab, Michael Beierlein, Alex Reyes, and Eric Klann for helpful discussions and comments on the manuscript. This work was supported by NARSAD, the Klingenstein Fund, and National Institutes of Health Grant R01-MH085974. The authors declare that they have no financial conflicts of interests.	ALGER BE, 1984, J NEUROPHYSIOL, V52, P892, DOI 10.1152/jn.1984.52.5.892; BENARDO LS, 1994, J PHYSIOL-LONDON, V476, P203, DOI 10.1113/jphysiol.1994.sp020124; Berridge MJ, 1998, NEURON, V21, P13, DOI 10.1016/S0896-6273(00)80510-3; Bettler B, 2004, PHYSIOL REV, V84, P835, DOI 10.1152/physrev.00036.2003; Bettler B, 1998, CURR OPIN NEUROBIOL, V8, P345, DOI 10.1016/S0959-4388(98)80059-7; Bito H, 1997, CURR OPIN NEUROBIOL, V7, P419, DOI 10.1016/S0959-4388(97)80072-4; Bloodgood BL, 2007, NEURON, V53, P249, DOI 10.1016/j.neuron.2006.12.017; Bowery NG, 2002, PHARMACOL REV, V54, P247, DOI 10.1124/pr.54.2.247; Carter AG, 2007, J NEUROSCI, V27, P8967, DOI 10.1523/JNEUROSCI.2798-07.2007; Carter AG, 2004, NEURON, V44, P483, DOI 10.1016/j.neuron.2004.10.013; COLLINGRIDGE GL, 1983, J PHYSIOL-LONDON, V334, P33, DOI 10.1113/jphysiol.1983.sp014478; Cummings JA, 1996, NEURON, V16, P825, DOI 10.1016/S0896-6273(00)80102-6; Dingledine R, 1999, PHARMACOL REV, V51, P7; Dittman JS, 1996, J NEUROSCI, V16, P1623; Dittman JS, 1997, J NEUROSCI, V17, P9048; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; DUTAR P, 1988, NATURE, V332, P156, DOI 10.1038/332156a0; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Foster KA, 2005, J NEUROSCI, V25, P11655, DOI 10.1523/JNEUROSCI.4029-05.2005; GAHWILER BH, 1985, P NATL ACAD SCI USA, V82, P1558, DOI 10.1073/pnas.82.5.1558; Garaschuk O, 1996, J PHYSIOL-LONDON, V491, P757, DOI 10.1113/jphysiol.1996.sp021255; GREENGARD P, 1991, SCIENCE, V253, P1135, DOI 10.1126/science.1716001; Higley MJ, 2009, NAT NEUROSCI, V12, P1121, DOI 10.1038/nn.2368; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; ISAACSON JS, 1993, NEURON, V10, P165, DOI 10.1016/0896-6273(93)90308-E; Kaupmann K, 1997, NATURE, V386, P239, DOI 10.1038/386239a0; Kennedy MB, 2000, SCIENCE, V290, P750, DOI 10.1126/science.290.5492.750; Knight AR, 1996, NEUROPHARMACOLOGY, V35, P703, DOI 10.1016/0028-3908(96)84642-9; Kovalchuk Y, 2000, J NEUROSCI, V20, P1791; Kulik A, 2003, J NEUROSCI, V23, P11026; LARKMAN AU, 1991, J COMP NEUROL, V306, P332, DOI 10.1002/cne.903060209; Larkum ME, 2007, J NEUROSCI, V27, P8999, DOI 10.1523/JNEUROSCI.1717-07.2007; Luscher C, 1997, NEURON, V19, P687, DOI 10.1016/S0896-6273(00)80381-5; Mainen ZF, 1999, NATURE, V399, P151, DOI 10.1038/20187; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; MINTZ IM, 1993, NEURON, V10, P889, DOI 10.1016/0896-6273(93)90204-5; MISGELD U, 1995, PROG NEUROBIOL, V46, P423, DOI 10.1016/0301-0082(95)00012-K; MORRISETT RA, 1991, J NEUROSCI, V11, P203; MOTT DD, 1994, INT REV NEUROBIOL, V36, P97, DOI 10.1016/S0074-7742(08)60304-9; NEWBERRY NR, 1984, J PHYSIOL-LONDON, V348, P239, DOI 10.1113/jphysiol.1984.sp015107; Oertner TG, 2002, NAT NEUROSCI, V5, P657, DOI 10.1038/nn867; Otmakhova NA, 2004, J NEUROPHYSIOL, V92, P2027, DOI 10.1152/jn.00427.2004; Perez-Garci E, 2006, NEURON, V50, P603, DOI 10.1016/j.neuron.2006.04.019; PFRIEGER FW, 1994, NEURON, V12, P97, DOI 10.1016/0896-6273(94)90155-4; Raman IM, 1996, NEURON, V16, P415, DOI 10.1016/S0896-6273(00)80059-8; Sabatini BL, 2000, NATURE, V408, P589, DOI 10.1038/35046076; Sakaba T, 2003, NATURE, V424, P775, DOI 10.1038/nature01859; SCANZIANI M, 1992, NEURON, V9, P919, DOI 10.1016/0896-6273(92)90244-8; SCHNEGGENBURGER R, 1993, NEURON, V11, P133, DOI 10.1016/0896-6273(93)90277-X; SCHOLZ KP, 1991, J PHYSIOL-LONDON, V444, P669, DOI 10.1113/jphysiol.1991.sp018900; SIVILOTTI L, 1991, PROG NEUROBIOL, V36, P35, DOI 10.1016/0301-0082(91)90036-Z; Skeberdis VA, 2006, NAT NEUROSCI, V9, P501, DOI 10.1038/nn1664; Sobczyk A, 2007, NEURON, V53, P17, DOI 10.1016/j.neuron.2006.11.016; Sodickson DL, 1996, J NEUROSCI, V16, P6374; Somjen G. G., 2004, IONS BRAIN NORMAL FU; Takahashi T, 1998, J NEUROSCI, V18, P3138; Tamas G, 2003, SCIENCE, V299, P1902, DOI 10.1126/science.1082053; TONG G, 1994, NEURON, V12, P51, DOI 10.1016/0896-6273(94)90151-1; Vanhoutte P, 2003, CURR OPIN NEUROBIOL, V13, P366, DOI 10.1016/S0959-4388(03)00073-4; Vigot R, 2006, NEURON, V50, P589, DOI 10.1016/j.neuron.2006.04.014; Wadiche JI, 2001, NEURON, V32, P301, DOI 10.1016/S0896-6273(01)00488-3; WOJCIK WJ, 1984, MOL PHARMACOL, V25, P24; WU LG, 1995, J PHYSIOL-LONDON, V485, P649, DOI 10.1113/jphysiol.1995.sp020759; YASUDA R, 2004, SCI STKE; Zucker RS, 1999, CURR OPIN NEUROBIOL, V9, P305, DOI 10.1016/S0959-4388(99)80045-2	66	113	117	1	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	APR 15	2010	66	1					101	113		10.1016/j.neuron.2010.03.012	http://dx.doi.org/10.1016/j.neuron.2010.03.012			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	587TP	20399732	Green Accepted, Bronze			2022-12-24	WOS:000277016200012
J	Kim, S; Lehtinen, MK; Sessa, A; Zappaterra, MW; Cho, SH; Gonzalez, D; Boggan, B; Austin, CA; Wijnholds, J; Gambello, MJ; Malicki, J; LaMantia, AS; Broccoli, V; Walsh, CA				Kim, Seonhee; Lehtinen, Maria K.; Sessa, Alessandro; Zappaterra, Mauro W.; Cho, Seo-Hee; Gonzalez, Dilenny; Boggan, Brigid; Austin, Christina A.; Wijnholds, Jan; Gambello, Michael J.; Malicki, Jarema; LaMantia, Anthony S.; Broccoli, Vania; Walsh, Christopher A.			The Apical Complex Couples Cell Fate and Cell Survival to Cerebral Cortical Development	NEURON			English	Article							CENTRAL-NERVOUS-SYSTEM; TUBEROUS SCLEROSIS COMPLEX; LIPID PHOSPHATASE PTEN; RADIAL GLIA; PROGENITOR CELLS; NEURAL STEM; NEOCORTICAL NEURONOGENESIS; NEURONAL DIFFERENTIATION; ASYMMETRIC INHERITANCE; RETINITIS-PIGMENTOSA	Cortical development depends upon tightly controlled cell fate and cell survival decisions that generate a functional neuronal population, but the coordination of these two processes is poorly understood. Here we show that conditional removal of a key apical complex protein, Pals1, causes premature withdrawal from the cell cycle, inducing excessive generation of early-born postmitotic neurons followed by surprisingly massive and rapid cell death, leading to the abrogation of virtually the entire cortical structure. Pals1 loss shows exquisite dosage sensitivity, so that heterozygote mutants show an intermediate phenotype on cell fate and cell death. Loss of Pals1 blocks essential cell survival signals, including the mammalian target of rapamycin (mTOR) pathway, while mTORC1 activation partially rescues Pals1 deficiency. These data highlight unexpected roles of the apical complex protein Pals1 in cell survival through interactions with mTOR signaling.	[Sessa, Alessandro; Broccoli, Vania] Ist Sci San Raffaele, Div Neurosci, Stem Cells & Neurogenesis Unit, I-20132 Milan, Italy; [Kim, Seonhee; Lehtinen, Maria K.; Zappaterra, Mauro W.; Gonzalez, Dilenny; Austin, Christina A.; Walsh, Christopher A.] Beth Israel Deaconess Med Ctr, Howard Hughes Med Inst, Div Genet, Boston, MA 02115 USA; [Kim, Seonhee; Lehtinen, Maria K.; Gonzalez, Dilenny; Austin, Christina A.; Walsh, Christopher A.] Harvard Univ, Sch Med, Manton Ctr Orphan Dis Res, Childrens Hosp Boston, Boston, MA 02115 USA; [Kim, Seonhee; Cho, Seo-Hee; Boggan, Brigid] Univ Texas Hlth Sci Ctr Houston, Dept Pediat, Div Pediat, Res Ctr, Houston, TX 77030 USA; [Wijnholds, Jan] Royal Netherlands Acad Arts & Sci, Netherlands Inst Neurosci, Dept Neuromed Genet, Amsterdam, Netherlands; [Gambello, Michael J.] Univ Texas Hlth Sci Ctr Houston, Dept Pediat, Div Med Genet, Houston, TX 77030 USA; [Malicki, Jarema] Harvard Univ, Sch Med, Dept Ophthalmol, Boston, MA 02114 USA; [LaMantia, Anthony S.] Univ N Carolina, Sch Med, Dept Cell & Mol Physiol, Univ N Carolina Neurosci Ctr, Chapel Hill, NC 27599 USA	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Harvard University; Beth Israel Deaconess Medical Center; Howard Hughes Medical Institute; Harvard University; Boston Children's Hospital; Harvard Medical School; University of Texas System; University of Texas Health Science Center Houston; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); University of Texas System; University of Texas Health Science Center Houston; Harvard University; Harvard Medical School; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Broccoli, V (corresponding author), Ist Sci San Raffaele, Div Neurosci, Stem Cells & Neurogenesis Unit, Via Olgettina 58, I-20132 Milan, Italy.	broccoli.vania@hsr.it; Christopher.walsh@childrens.harvard.edu	Sessa, Alessandro/AAB-8777-2019; malicki, jarema/G-8611-2014; Wijnholds, Jan/V-3896-2018; Broccoli, Vania/K-3464-2016	malicki, jarema/0000-0002-5947-8805; Wijnholds, Jan/0000-0003-0099-460X; Broccoli, Vania/0000-0003-4050-0926; Walsh, Christopher/0000-0002-0156-2238; Sessa, Alessandro/0000-0003-3611-5056; Gonzalez, Dilenny/0000-0003-0661-5930	Helen Hay Whitney Post-doctoral Fellowship; Department of Pediatrics, University of Texas, Health Science Center at Houston; Sigrid Juselius Foundation; Stuart H.Q. & Victoria Quan Fellowship; NIH MSTP; NIH [HD029178]; UNC-CH Reynolds Faculty Fellowship; EC [QLG3-CT-2002-01266)]; Telethon [GGP07181]; Children's Hospital Boston [P30HD018655]; NINDS [R01NS32457, P01 NS40043]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD029178, R29HD029178] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038097, P01NS040043, R01NS032457] Funding Source: NIH RePORTER	Helen Hay Whitney Post-doctoral Fellowship; Department of Pediatrics, University of Texas, Health Science Center at Houston; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Stuart H.Q. & Victoria Quan Fellowship; NIH MSTP(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UNC-CH Reynolds Faculty Fellowship; EC(European CommissionEuropean Commission Joint Research Centre); Telethon(Fondazione Telethon); Children's Hospital Boston; NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to members of the Walsh laboratory for critical reading of the manuscript. We thank K. Jones for Emx1-Cre mice, the Developmental Studies Hybridoma Bank for Nestin and Pax6 antisera, B. Margolis for Pals1 antisera, A. Le Bivic for Crb2, Crb3, and Patj antibodies, T. Thomson for blastocyst injections and ES cell work, S. White for histology, the Harvard EM facility for scanning and transmission EM, D. Burstein and R. Akhavan for MRI scans, and A. Hafner, D. Sinclair, and L. Goodrich for use of their mouse behavioral equipment. This work is supported by a Helen Hay Whitney Post-doctoral Fellowship and institutional funding from the Department of Pediatrics, University of Texas, Health Science Center at Houston to S.K, a Sigrid Juselius Foundation Fellowship to M.K.L., the Stuart H.Q. & Victoria Quan Fellowship and a NIH MSTP grant (M.W.Z.); a NIH grant (HD029178) and an UNC-CH Reynolds Faculty Fellowship (A.S.L.); EC (QLG3-CT-2002-01266) and Telethon grant (GGP07181) to V.B., a IDDRC (P30HD018655) from the Children's Hospital Boston and R01NS32457 and P01 NS40043 grants from the NINDS to C.A.W. C.A.W. is an Investigator of the Howard Hughes Medical Institute.	Anthony TE, 2004, NEURON, V41, P881, DOI 10.1016/S0896-6273(04)00140-0; Bachmann A, 2001, NATURE, V414, P638, DOI 10.1038/414638a; Buller CL, 2008, AM J PHYSIOL-CELL PH, V295, pC836, DOI 10.1152/ajpcell.00554.2007; Bultje RS, 2009, NEURON, V63, P189, DOI 10.1016/j.neuron.2009.07.004; Cappello S, 2006, NAT NEUROSCI, V9, P1099, DOI 10.1038/nn1744; Caspary T, 2007, DEV CELL, V12, P767, DOI 10.1016/j.devcel.2007.03.004; CAVINESS VS, 1995, TRENDS NEUROSCI, V18, P379, DOI 10.1016/0166-2236(95)93933-O; Chae TH, 2004, NAT GENET, V36, P264, DOI 10.1038/ng1302; Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; Costa MR, 2008, DEVELOPMENT, V135, P11, DOI 10.1242/dev.009951; Crawley JN, 2008, NEURON, V57, P809, DOI 10.1016/j.neuron.2008.03.001; den Hollander AI, 1999, NAT GENET, V23, P217, DOI 10.1038/13848; Depaepe V, 2005, NATURE, V435, P1244, DOI 10.1038/nature03651; Doe CQ, 2008, DEVELOPMENT, V135, P1575, DOI 10.1242/dev.014977; Eggenschwiler JT, 2007, ANNU REV CELL DEV BI, V23, P345, DOI 10.1146/annurev.cellbio.23.090506.123249; Fairbanks CA, 1997, J PHARMACOL EXP THER, V282, P1408; Farkas LM, 2008, CURR OPIN CELL BIOL, V20, P707, DOI 10.1016/j.ceb.2008.09.008; Feng W, 2008, J BIOL CHEM, V283, P23440, DOI 10.1074/jbc.M802482200; Feng YY, 2006, P NATL ACAD SCI USA, V103, P19836, DOI 10.1073/pnas.0609628104; Feng ZH, 2005, P NATL ACAD SCI USA, V102, P8204, DOI 10.1073/pnas.0502857102; Finlay BL, 2001, BEHAV BRAIN SCI, V24, P263, DOI 10.1017/S0140525X01003958; FISCHMAN MW, 1965, J COMP PHYSIOL PSYCH, V59, P193, DOI 10.1037/h0021811; Fishell G, 2003, CURR OPIN NEUROBIOL, V13, P34, DOI 10.1016/S0959-4388(03)00013-8; Freilinger A, 2006, ONCOGENE, V25, P6467, DOI 10.1038/sj.onc.1209660; Gleeson JG, 1999, NEURON, V23, P257, DOI 10.1016/S0896-6273(00)80778-3; Gorski JA, 2002, J NEUROSCI, V22, P6309; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Hatakeyama J, 2004, DEVELOPMENT, V131, P5539, DOI 10.1242/dev.01436; Haubensak W, 2004, P NATL ACAD SCI USA, V101, P3196, DOI 10.1073/pnas.0308600100; Hernandez O, 2007, GENESIS, V45, P101, DOI 10.1002/dvg.20271; Hong Y, 2001, NATURE, V414, P634, DOI 10.1038/414634a; Hurd TW, 2003, NAT CELL BIOL, V5, P137, DOI 10.1038/ncb923; Huttner WB, 2005, CURR OPIN CELL BIOL, V17, P648, DOI 10.1016/j.ceb.2005.10.005; Imai F, 2006, DEVELOPMENT, V133, P1735, DOI 10.1242/dev.02330; Inoki K, 2006, CELL, V126, P955, DOI 10.1016/j.cell.2006.06.055; Ishiuchi T, 2009, J CELL BIOL, V185, P959, DOI 10.1083/jcb.200811030; Kamberov E, 2000, J BIOL CHEM, V275, P11425, DOI 10.1074/jbc.275.15.11425; Karbowniczek M, 2010, J CLIN INVEST, V120, P93, DOI 10.1172/JCI40221; Klezovitch O, 2004, GENE DEV, V18, P559, DOI 10.1101/gad.1178004; Kowalczyk T, 2009, CEREB CORTEX, V19, P2439, DOI 10.1093/cercor/bhn260; Li HS, 2003, NEURON, V40, P1105, DOI 10.1016/S0896-6273(03)00755-4; Lien WH, 2006, SCIENCE, V311, P1609, DOI 10.1126/science.1121449; Mason HA, 2006, DEV NEUROSCI-BASEL, V28, P49, DOI 10.1159/000090752; Massey-Harroche D, 2007, HUM MOL GENET, V16, P529, DOI 10.1093/hmg/ddl485; Miyata T, 2004, DEVELOPMENT, V131, P3133, DOI 10.1242/dev.01173; Miyata T, 2001, NEURON, V31, P727, DOI 10.1016/S0896-6273(01)00420-2; Nguyen L, 2006, GENE DEV, V20, P1511, DOI 10.1101/gad.377106; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Noctor SC, 2002, J NEUROSCI, V22, P3161, DOI 10.1523/JNEUROSCI.22-08-03161.2002; Noctor SC, 2008, J COMP NEUROL, V508, P28, DOI 10.1002/cne.21669; Ohtsuka T, 1999, EMBO J, V18, P2196, DOI 10.1093/emboj/18.8.2196; Petersen PH, 2004, NAT NEUROSCI, V7, P803, DOI 10.1038/nn1289; Petersen PH, 2002, NATURE, V419, P929, DOI 10.1038/nature01124; Pinal N, 2006, CURR BIOL, V16, P140, DOI 10.1016/j.cub.2005.11.068; Punzo C, 2009, NAT NEUROSCI, V12, P44, DOI 10.1038/nn.2234; Rasin MR, 2007, NAT NEUROSCI, V10, P819, DOI 10.1038/nn1924; Roegiers F, 2004, CURR OPIN CELL BIOL, V16, P195, DOI 10.1016/j.ceb.2004.02.010; Roh MH, 2002, J BIOL CHEM, V277, P27501, DOI 10.1074/jbc.M201177200; Roh MH, 2002, J CELL BIOL, V157, P161, DOI 10.1083/jcb.200109010; Rohatgi R, 2007, SCIENCE, V317, P372, DOI 10.1126/science.1139740; Saito T, 2006, NAT PROTOC, V1, P1552, DOI 10.1038/nprot.2006.276; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; Srinivasan K, 2008, DEVELOPMENT, V135, P1781, DOI 10.1242/dev.013847; STAMBOLIC V, 1994, BIOCHEM J, V303, P701, DOI 10.1042/bj3030701; Straight SW, 2004, MOL BIOL CELL, V15, P1981, DOI 10.1091/mbc.E03-08-0620; Takahashi T, 1996, J NEUROSCI, V16, P6183; Tamamaki N, 2001, NEUROSCI RES, V41, P51, DOI 10.1016/S0168-0102(01)00259-0; Tonelli DD, 2008, DEVELOPMENT, V135, P3911, DOI 10.1242/dev.025080; van Rossum AGSH, 2006, HUM MOL GENET, V15, P2659, DOI 10.1093/hmg/ddl194; von Stein W, 2005, DEVELOPMENT, V132, P1675, DOI 10.1242/dev.01720; Wang Q, 2007, MOL BIOL CELL, V18, P874, DOI 10.1091/mbc.E06-07-0651; Way SW, 2009, HUM MOL GENET, V18, P1252, DOI 10.1093/hmg/ddp025; Wei XY, 2002, NAT GENET, V31, P150, DOI 10.1038/ng883; WEISKRANTZ L, 1974, BRAIN, V97, P709, DOI 10.1093/brain/97.1.709; Wodarz A, 2005, CURR OPIN CELL BIOL, V17, P475, DOI 10.1016/j.ceb.2005.08.005; Zechner D, 2003, DEV BIOL, V258, P406, DOI 10.1016/S0012-1606(03)00123-4	77	81	81	0	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	APR 15	2010	66	1					69	84		10.1016/j.neuron.2010.03.019	http://dx.doi.org/10.1016/j.neuron.2010.03.019			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	587TP	20399730	Green Submitted, Green Accepted, Bronze			2022-12-24	WOS:000277016200010
J	Stanford, TR; Shankar, S; Massoglia, DP; Costello, MG; Salinas, E				Stanford, Terrence R.; Shankar, Swetha; Massoglia, Dino P.; Costello, M. Gabriela; Salinas, Emilio			Perceptual decision making in less than 30 milliseconds	NATURE NEUROSCIENCE			English	Article							GRADUAL SPECIFICATION; DIFFUSION-MODEL; REACTION-TIME; INTEGRATION; MASKING; NEURONS; SPEED; DISCRIMINATION; MECHANISM; STRENGTH	In perceptual discrimination tasks, a subject's response time is determined by both sensory and motor processes. Measuring the time consumed by the perceptual evaluation step alone is therefore complicated by factors such as motor preparation, task difficulty and speed-accuracy tradeoffs. Here we present a task design that minimizes these confounding factors and allows us to track a subject's perceptual performance with unprecedented temporal resolution. We find that monkeys can make accurate color discriminations in less than 30 ms. Furthermore, our simple task design provides a tool for elucidating how neuronal activity relates to sensory as opposed to motor processing, as demonstrated with neural data from cortical oculomotor neurons. In these cells, perceptual information acts by accelerating and decelerating the ongoing motor plans associated with correct and incorrect choices, as predicted by a race-to-threshold model, and the time course of these neural events parallels the time course of the subject's choice accuracy.	[Stanford, Terrence R.; Shankar, Swetha; Massoglia, Dino P.; Costello, M. Gabriela; Salinas, Emilio] Wake Forest Univ, Bowman Gray Sch Med, Dept Neurobiol & Anat, Winston Salem, NC 27106 USA	Wake Forest University; Wake Forest Baptist Medical Center	Salinas, E (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Dept Neurobiol & Anat, Winston Salem, NC 27106 USA.	esalinas@wfubmc.edu		Costello, M. Gabriela/0000-0003-2990-3011; Salinas, Emilio/0000-0001-7411-5693; Stanford, Terrence/0000-0003-0759-5599	National Institutes of Health/National Eye Institute [R01 EY12389]; NATIONAL EYE INSTITUTE [R01EY012389] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA030750] Funding Source: NIH RePORTER	National Institutes of Health/National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Research was supported by the National Institutes of Health/National Eye Institute grant R01 EY12389 to T. R. S.	Beck JM, 2008, NEURON, V60, P1142, DOI 10.1016/j.neuron.2008.09.021; BERGEN JR, 1983, NATURE, V303, P696, DOI 10.1038/303696a0; Bodelon C, 2007, J NEUROSCI, V27, P725, DOI 10.1523/JNEUROSCI.3860-06.2007; Boucher L, 2007, PSYCHOL REV, V114, P376, DOI 10.1037/0033-295X.114.2.376; Breitmeyer BG, 2004, CONSCIOUS COGN, V13, P829, DOI 10.1016/j.concog.2004.08.007; Breitmeyer BG, 2000, PERCEPT PSYCHOPHYS, V62, P1572, DOI 10.3758/BF03212157; BRITTEN KH, 1992, J NEUROSCI, V12, P4745; BRUCE CJ, 1985, J NEUROPHYSIOL, V53, P603, DOI 10.1152/jn.1985.53.3.603; CARPENTER RHS, 1995, NATURE, V377, P59, DOI 10.1038/377059a0; Castellan NJ, 1988, NONPARAMETRIC STAT B; Churchland AK, 2008, NAT NEUROSCI, V11, P693, DOI 10.1038/nn.2123; Davison A.C., 2006, BOOTSTRAP METHODS TH; de Lafuente V, 2005, NAT NEUROSCI, V8, P1698, DOI 10.1038/nn1587; Dodd JV, 2001, J NEUROSCI, V21, P4809, DOI 10.1523/JNEUROSCI.21-13-04809.2001; DONDERS FC, 1969, ACTA PSYCHOL, V30, P412, DOI 10.1016/0001-6918(69)90065-1; Efron B., 1982, JACKKNIFE BOOTSTRAP; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Feng S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000284; GHEZ C, 1989, BRAIN BEHAV EVOLUT, V33, P69, DOI 10.1159/000115902; Ghose GM, 2006, J VISION, V6, P429, DOI 10.1167/6.4.10; Gu Y, 2008, NAT NEUROSCI, V11, P1201, DOI 10.1038/nn.2191; Hanes DP, 1996, SCIENCE, V274, P427, DOI 10.1126/science.274.5286.427; HENING W, 1988, EXP BRAIN RES, V71, P116, DOI 10.1007/BF00247527; HERRNSTEIN RJ, 1961, J EXP ANAL BEHAV, V4, P267, DOI 10.1901/jeab.1961.4-267; Horwitz GD, 1999, SCIENCE, V284, P1158, DOI 10.1126/science.284.5417.1158; Kiani R, 2008, J NEUROSCI, V28, P3017, DOI 10.1523/JNEUROSCI.4761-07.2008; Lo CC, 2006, NAT NEUROSCI, V9, P956, DOI 10.1038/nn1722; Luce RD, 1986, RESPONSE TIMES THEIR; Ludwig CJH, 2005, J NEUROSCI, V25, P9907, DOI 10.1523/JNEUROSCI.2197-05.2005; Matsumora T, 2008, J NEUROPHYSIOL, V100, P3361, DOI 10.1152/jn.90551.2008; McCoy AN, 2005, NAT NEUROSCI, V8, P1220, DOI 10.1038/nn1523; MEYER DE, 1988, BIOL PSYCHOL, V26, P3, DOI 10.1016/0301-0511(88)90013-0; Nieder A, 2007, J NEUROSCI, V27, P5986, DOI 10.1523/JNEUROSCI.1056-07.2007; Palmer J, 2005, J VISION, V5, P376, DOI 10.1167/5.5.1; Pare M, 1996, J NEUROPHYSIOL, V76, P3666, DOI 10.1152/jn.1996.76.6.3666; Posner M.I., 1978, CHRONOMETRIC EXPLORA; Ratcliff R, 2000, J EXP PSYCHOL HUMAN, V26, P127, DOI 10.1037/0096-1523.26.1.127; Ratcliff R, 2007, J NEUROPHYSIOL, V97, P1756, DOI 10.1152/jn.00393.2006; Salinas E, 2008, NEURON, V60, P946, DOI 10.1016/j.neuron.2008.12.011; Sanders A.F., 1998, ELEMENTS HUMAN PERFO, DOI 10.4324/9780203774250; Schall JD, 2003, CURR OPIN NEUROBIOL, V13, P182, DOI 10.1016/S0959-4388(03)00039-4; Smith PL, 2004, TRENDS NEUROSCI, V27, P161, DOI 10.1016/j.tins.2004.01.006; Soltani A, 2006, J NEUROSCI, V26, P3731, DOI 10.1523/JNEUROSCI.5159-05.2006; STERNBERG S, 1966, SCIENCE, V153, P652, DOI 10.1126/science.153.3736.652; Sugrue LP, 2004, SCIENCE, V304, P1782, DOI 10.1126/science.1094765; Thompson KG, 1996, J NEUROPHYSIOL, V76, P4040, DOI 10.1152/jn.1996.76.6.4040; Wang XJ, 2002, NEURON, V36, P955, DOI 10.1016/S0896-6273(02)01092-9; Wong KF, 2006, J NEUROSCI, V26, P1314, DOI 10.1523/JNEUROSCI.3733-05.2006; [No title captured]	49	137	137	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2010	13	3					379	U26		10.1038/nn.2485	http://dx.doi.org/10.1038/nn.2485			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	559WW	20098418	Green Accepted			2022-12-24	WOS:000274860100021
J	Bourane, S; Garces, A; Venteo, S; Pattyn, A; Hubert, T; Fichard, A; Puech, S; Boukhaddaoui, H; Baudet, C; Takahashi, S; Valmier, J; Carroll, P				Bourane, Steeve; Garces, Alain; Venteo, Stephanie; Pattyn, Alexandre; Hubert, Thomas; Fichard, Agnes; Puech, Sylvie; Boukhaddaoui, Hassan; Baudet, Christel; Takahashi, Satoru; Valmier, Jean; Carroll, Patrick			Low-Threshold Mechanoreceptor Subtypes Selectively Express MafA and Are Specified by Ret Signaling	NEURON			English	Article							DORSAL-ROOT GANGLION; DEVELOPING SPINAL-CORD; DRG NEURONS; DYNAMIC REGULATION; SENSORY AXONS; GDNF; FAMILY; RECEPTORS; MOUSE; MICE	Low-threshold mechanoreceptor neurons (LTMs) of the dorsal root ganglia (DRG) are essential for touch sensation. They form highly specialized terminations in the skin and display stereotyped projections in the spinal cord. Functionally defined LTMs depend on neurotrophin signaling for their postnatal survival and functioning, but how these neurons arise during development is unknown. Here, we show that specific types of LTMs can be identified shortly after DRG genesis by unique expression of the MafA transcription factor, the Ret receptor and coreceptor GFR alpha 2, and find that their specification is Ngn2 dependent. In mice lacking Ret, these LTMs display early differentiation defects, as revealed by reduced MafA expression, and at later stages their central and peripheral projections are compromised. Moreover, in MafA mutants, a discrete subset of LTMs display altered expression of neurotrophic factor receptors. Our results provide evidence that genetic interactions involving Pet and MafA progressively promote the differentiation and diversification of LTMs.	[Bourane, Steeve; Garces, Alain; Venteo, Stephanie; Pattyn, Alexandre; Hubert, Thomas; Fichard, Agnes; Puech, Sylvie; Boukhaddaoui, Hassan; Valmier, Jean; Carroll, Patrick] INSERM, U583, F-34091 Montpellier, France; [Fichard, Agnes; Puech, Sylvie; Valmier, Jean] Univ Montpellier 2, F-34091 Montpellier, France; [Baudet, Christel] EA 2406, F-33076 Bordeaux, France; [Takahashi, Satoru] Univ Tsukuba, Dept Anat & Embryol, Tsukuba, Ibaraki 3058577, Japan	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; UDICE-French Research Universities; Universite de Bordeaux; University of Tsukuba	Carroll, P (corresponding author), INSERM, U583, F-34091 Montpellier, France.	carroll@univ-montp2.fr	Carroll, Patrick/AAL-7773-2021; Carroll, Patrick/C-2933-2012; Alexandre, Pattyn/ABF-1346-2020; Bourane, Steeve/AAI-6143-2020	Carroll, Patrick/0000-0003-3287-8195; Bourane, Steeve/0000-0002-9805-2196; Garces, Alain/0000-0001-6252-9995; BOUKHADDAOUI, HASSAN/0000-0003-1808-7901; Pattyn, Alexandre/0000-0003-1215-1482	INSERM; CNRS; Agence Nationale pour la Recherche (ANR); AFM (Association contre les Myopathies)	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale pour la Recherche (ANR)(French National Research Agency (ANR)); AFM (Association contre les Myopathies)(Association Francaise contre les Myopathies)	We thank Patrik Ernfors, Martyn Goulding, Frederic Marmigere, and Gary Lewin for critical reading of the manuscript and members of the Alex team for helpful discussions. We thank M. Airaksinen and F. Helmbacher for Gfr alpha 2 and Gfr alpha 1 probes. Neurogenin mutant mice were kindly provided by Francois Guillemot. This work was funded by INSERM, CNRS, Agence Nationale pour la Recherche (ANR), and AFM (Association contre les Myopathies). A.G. is supported by a CDD Fellowship (INSERM).	Airaksinen MS, 1996, NEURON, V16, P287, DOI 10.1016/S0896-6273(00)80047-1; Aramata S, 2007, ENDOCR J, V54, P659, DOI 10.1507/endocrj.KR-101; Baudet C, 2000, DEVELOPMENT, V127, P4335; Baudet C, 2008, J NEUROSCI, V28, P963, DOI 10.1523/JNEUROSCI.4489-07.2008; Bourane S, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-97; Carroll P, 2001, MOL CELL NEUROSCI, V17, P611, DOI 10.1006/mcne.2001.0966; Chai Y, 2000, DEVELOPMENT, V127, P1671; Chen AI, 2006, NEURON, V49, P395, DOI 10.1016/j.neuron.2005.12.028; Chen CL, 2006, NEURON, V49, P365, DOI 10.1016/j.neuron.2005.10.036; Chinenov Y, 2001, ONCOGENE, V20, P2438, DOI 10.1038/sj.onc.1204385; Ernfors P, 2001, CELL MOL LIFE SCI, V58, P1036, DOI 10.1007/PL00000918; Ernsberger U, 2008, CELL TISSUE RES, V333, P353, DOI 10.1007/s00441-008-0634-4; Eychene A, 2008, NAT REV CANCER, V8, P683, DOI 10.1038/nrc2460; Fundin BT, 1999, DEVELOPMENT, V126, P2597; Golden JP, 1999, EXP NEUROL, V158, P504, DOI 10.1006/exnr.1999.7127; Gonzalez-Martinez T, 2005, NEUROSCI LETT, V377, P12, DOI 10.1016/j.neulet.2004.11.078; Haase G, 2002, NEURON, V35, P893, DOI 10.1016/S0896-6273(02)00864-4; IGGO A, 1985, REV NEUROL, V141, P599; KATAOKA K, 1993, J VIROL, V67, P2133, DOI 10.1128/JVI.67.4.2133-2141.1993; KATAOKA K, 1994, MOL CELL BIOL, V14, P7581, DOI 10.1128/MCB.14.11.7581; Kataoka K, 2007, J BIOCHEM, V141, P775, DOI 10.1093/jb/mvm105; KORTE M, 1995, P NATL ACAD SCI USA, V92, P8856, DOI 10.1073/pnas.92.19.8856; Kramer I, 2006, NEURON, V49, P379, DOI 10.1016/j.neuron.2006.01.008; Ladle DR, 2007, NEURON, V56, P270, DOI 10.1016/j.neuron.2007.09.026; Lecoin L, 2004, GENE EXPR PATTERNS, V4, P35, DOI 10.1016/S1567-133X(03)00152-2; Lewin GR, 1996, ANNU REV NEUROSCI, V19, P289, DOI 10.1146/annurev.ne.19.030196.001445; Lewin GR, 2004, J NEUROBIOL, V61, P30, DOI 10.1002/neu.20078; Luo WQ, 2007, NEURON, V54, P739, DOI 10.1016/j.neuron.2007.04.027; Ma QF, 1999, GENE DEV, V13, P1717, DOI 10.1101/gad.13.13.1717; Marmigere F, 2007, NAT REV NEUROSCI, V8, P114, DOI 10.1038/nrn2057; Molliver DC, 1997, NEURON, V19, P849, DOI 10.1016/S0896-6273(00)80966-6; Nakamura S, 2008, DEVELOPMENT, V135, P1703, DOI 10.1242/dev.015248; Ozaki S, 1997, J COMP NEUROL, V380, P215; PACHNIS V, 1993, DEVELOPMENT, V119, P1005; Patel TD, 2003, NEURON, V38, P403, DOI 10.1016/S0896-6273(03)00261-7; Perez-Pinera P, 2008, NEUROSCI LETT, V433, P43, DOI 10.1016/j.neulet.2007.12.035; SILOSSANTIAGO I, 1995, J NEUROSCI, V15, P5929; SMEYNE RJ, 1994, NATURE, V368, P246, DOI 10.1038/368246a0; Stucky CL, 1998, J NEUROSCI, V18, P7040; Stucky CL, 2002, CURR BIOL, V12, P1401, DOI 10.1016/S0960-9822(02)01072-2; Vinson C, 2002, MOL CELL BIOL, V22, P6321, DOI 10.1128/MCB.22.18.6321-6335.2002; Vrieseling E, 2006, CELL, V127, P1439, DOI 10.1016/j.cell.2006.10.042; Yoshikawa M, 2007, DEV BIOL, V303, P663, DOI 10.1016/j.ydbio.2006.12.007; Zhang C, 2005, MOL CELL BIOL, V25, P4969, DOI 10.1128/MCB.25.12.4969-4976.2005	44	84	87	1	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 24	2009	64	6					857	870		10.1016/j.neuron.2009.12.004	http://dx.doi.org/10.1016/j.neuron.2009.12.004			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	541ON	20064392	Bronze			2022-12-24	WOS:000273425800012
J	Smith, PD; Sun, F; Park, KK; Cai, B; Wang, C; Kuwako, K; Martinez-Carrasco, I; Connolly, L; He, ZG				Smith, Patrice D.; Sun, Fang; Park, Kevin Kyungsuk; Cai, Bin; Wang, Chen; Kuwako, Kenichiro; Martinez-Carrasco, Irene; Connolly, Lauren; He, Zhigang			SOCS3 Deletion Promotes Optic Nerve Regeneration In Vivo	NEURON			English	Article							STIMULATES AXON REGENERATION; RETINAL GANGLION-CELLS; SURVIVAL; INJURY; CNTF; EXPRESSION; ABILITY; GROWTH; CNS; INFLAMMATION	Axon regeneration failure accounts for permanent functional deficits following CNS injury in adult mammals. However, the underlying mechanisms remain elusive. In analyzing axon regeneration in different mutant mouse lines, we discovered that deletion of suppressor of cytokine signaling 3 (SOCS3) in adult retinal ganglion cells (RGCs) promotes robust regeneration of injured optic nerve axons. This regeneration-promoting effect is efficiently blocked in SOCS3-gp130 double-knockout mice, suggesting that SOCS3 deletion promotes axon regeneration via a gp130-dependent pathway. Consistently, a transient upregulation of ciliary neurotrophic factor (CNTF) was observed within the retina following optic nerve injury. Intravitreal application of CNTF further enhances axon regeneration from SOCS3-deleted RGCs. Together, our results suggest that compromised responsiveness to injury-induced growth factors in mature neurons contributes significantly to regeneration failure. Thus, developing strategies to modulate negative signaling regulators may be an efficient strategy of promoting axon regeneration after CNS injury.	[Smith, Patrice D.; Sun, Fang; Park, Kevin Kyungsuk; Cai, Bin; Wang, Chen; Kuwako, Kenichiro; Martinez-Carrasco, Irene; Connolly, Lauren; He, Zhigang] Harvard Univ, Childrens Hosp, FM Kirby Neurobiol Ctr, Sch Med, Boston, MA 02115 USA; [Smith, Patrice D.; Sun, Fang; Park, Kevin Kyungsuk; Cai, Bin; Wang, Chen; Kuwako, Kenichiro; Martinez-Carrasco, Irene; Connolly, Lauren; He, Zhigang] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; [Smith, Patrice D.] Carleton Univ, Inst Neurosci, Ottawa, ON K1S 5B6, Canada	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Carleton University	He, ZG (corresponding author), Harvard Univ, Childrens Hosp, FM Kirby Neurobiol Ctr, Sch Med, 300 Longwood Ave, Boston, MA 02115 USA.	zhigang.he@childrens.harvard.edu	Kuwako, Ken-ichiro/L-1237-2013	Kuwako, Ken-iihiro/0000-0002-1380-3035; Smith, Patrice/0000-0002-0731-2803	Canadian Institutes of Health Research; Craig Nelson Foundation; NINDS; Wings for Life; Adelson Medical Research Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051788] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Craig Nelson Foundation; NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Wings for Life; Adelson Medical Research Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Dr. K. Rajewsky for providing gp130<SUP>f/f</SUP> mice and A. Yoshimura for providing SOCS3<SUP>f/f</SUP> mice. This study was supported by grants from the Canadian Institutes of Health Research (to P.D.S.), Craig Nelson Foundation (to K.K.P.), NINDS, Wings for Life, and Adelson Medical Research Foundation (to Z.H.).	Betz UAK, 1998, J EXP MED, V188, P1955, DOI 10.1084/jem.188.10.1955; Cacalano NA, 2001, NAT CELL BIOL, V3, P460, DOI 10.1038/35074525; Cafferty WBJ, 2001, J NEUROSCI, V21, P7161, DOI 10.1523/JNEUROSCI.21-18-07161.2001; Cai D, 2001, J NEUROSCI, V21, P4731, DOI 10.1523/JNEUROSCI.21-13-04731.2001; Cao ZX, 2006, J NEUROSCI, V26, P5565, DOI 10.1523/JNEUROSCI.0815-06.2006; Case LC, 2005, CURR BIOL, V15, pR749, DOI 10.1016/j.cub.2005.09.008; Cho KS, 2005, J CELL SCI, V118, P863, DOI 10.1242/jcs.01658; Croker BA, 2008, EXP HEMATOL, V36, P786, DOI 10.1016/j.exphem.2008.02.008; Cui Q, 1999, INVEST OPHTH VIS SCI, V40, P760; Cui Q, 2008, BRAIN, V131, DOI 10.1093/brain/awn027; Dewachter I, 2002, J NEUROSCI, V22, P3445; Filbin MT, 2006, PHILOS T R SOC B, V361, P1565, DOI 10.1098/rstb.2006.1885; Fischer D, 2000, INVEST OPHTH VIS SCI, V41, P3943; Fitch MT, 2008, EXP NEUROL, V209, P294, DOI 10.1016/j.expneurol.2007.05.014; Goldberg JL, 2000, ANNU REV NEUROSCI, V23, P579, DOI 10.1146/annurev.neuro.23.1.579; Goldberg JL, 2002, SCIENCE, V296, P1860, DOI 10.1126/science.1068428; Habecker BA, 2009, DEV NEUROBIOL, V69, P392, DOI 10.1002/dneu.20706; Hanz S, 2003, NEURON, V40, P1095, DOI 10.1016/S0896-6273(03)00770-0; Harel NY, 2006, NAT REV NEUROSCI, V7, P603, DOI 10.1038/nrn1957; Lacroix S, 2002, J COMP NEUROL, V454, P213, DOI 10.1002/cne.10407; Leaver SG, 2006, EUR J NEUROSCI, V24, P3323, DOI 10.1111/j.1460-9568.2006.05230.x; Leon S, 2000, J NEUROSCI, V20, P4615, DOI 10.1523/JNEUROSCI.20-12-04615.2000; Liu RY, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-17-j0003.2001; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Miao T, 2006, J NEUROSCI, V26, P9512, DOI 10.1523/JNEUROSCI.2160-06.2006; Mori H, 2004, NAT MED, V10, P739, DOI 10.1038/nm1071; Muller A, 2007, BRAIN, V130, P3308, DOI 10.1093/brain/awm257; Muller A, 2009, MOL CELL NEUROSCI, V41, P233, DOI 10.1016/j.mcn.2009.03.002; Neumann S, 1999, NEURON, V23, P83, DOI 10.1016/S0896-6273(00)80755-2; Park K, 2004, J NEUROSCI, V24, P10806, DOI 10.1523/JNEUROSCI.3532-04.2004; Park KK, 2009, MOL CELL NEUROSCI, V41, P313, DOI 10.1016/j.mcn.2009.04.002; Park KK, 2008, SCIENCE, V322, P963, DOI 10.1126/science.1161566; Pennica D, 1996, NEURON, V17, P63, DOI 10.1016/S0896-6273(00)80281-0; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; Schobitz B, 1992, Endocr Regul, V26, P103; Schwab ME, 1996, PHYSIOL REV, V76, P319, DOI 10.1152/physrev.1996.76.2.319; Schweizer U, 2002, J CELL BIOL, V156, P287, DOI 10.1083/jcb.200107009; Watanabe M, 2003, NEUROSCIENCE, V116, P733, DOI 10.1016/S0306-4522(02)00562-6; Yiu G, 2006, NAT REV NEUROSCI, V7, P617, DOI 10.1038/nrn1956; Zhou FQ, 2006, PHILOS T R SOC B, V361, P1575, DOI 10.1098/rstb.2006.1882; Zigmond RE, 1996, PERSPECT DEV NEUROBI, V4, P75	41	326	341	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 10	2009	64	5					617	623		10.1016/j.neuron.2009.11.021	http://dx.doi.org/10.1016/j.neuron.2009.11.021			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	537OW	20005819	Green Accepted, Bronze			2022-12-24	WOS:000273123700008
J	Marinelli, S; Pacioni, S; Cannich, A; Marsicano, G; Bacci, A				Marinelli, Silvia; Pacioni, Simone; Cannich, Astrid; Marsicano, Giovanni; Bacci, Alberto			Self-modulation of neocortical pyramidal neurons by endocannabinoids	NATURE NEUROSCIENCE			English	Article							INTERNEURONS; INHIBITION; INPUTS	Control of pyramidal neuron excitability is vital for the functioning of the neocortex. Somatodendritic slow self-inhibition (SSI) allows inhibitory neurons to regulate their own activity, but the existence of similar mechanisms in excitatory cells has not been shown. We found that in rodents endocannabinoids mediated SSI and long-term modulation of inhibitory connections in layer 2/3 pyramidal neurons with a distinct dendritic morphology, suggesting that a glutamatergic network in cortical circuits is self-regulated.	[Marinelli, Silvia; Pacioni, Simone; Bacci, Alberto] European Brain Res Inst, Rome, Italy; [Cannich, Astrid; Marsicano, Giovanni] Univ Bordeaux 2, Endocannabinoids & Neuroadaptat Grp, INSERM NeuroCtr Magendie U862, F-33076 Bordeaux, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux	Bacci, A (corresponding author), European Brain Res Inst, Rome, Italy.	a.bacci@ebri.it	Marsicano, Giovanni/I-9603-2016	Bacci, Alberto/0000-0002-3355-5892; Marsicano, Giovanni/0000-0003-3804-1951				Bacci A, 2004, NATURE, V431, P312, DOI 10.1038/nature02913; Carandini M, 1997, SCIENCE, V276, P949, DOI 10.1126/science.276.5314.949; Chevaleyre V, 2006, ANNU REV NEUROSCI, V29, P37, DOI 10.1146/annurev.neuro.29.051605.112834; Fortin DA, 2007, CEREB CORTEX, V17, P163, DOI 10.1093/cercor/bhj133; Freund TF, 2003, PHYSIOL REV, V83, P1017, DOI 10.1152/physrev.00004.2003; Hashimotodani Y, 2008, NEUROPHARMACOLOGY, V54, P58, DOI 10.1016/j.neuropharm.2007.06.002; Hill EL, 2007, J NEUROPHYSIOL, V97, P2580, DOI 10.1152/jn.00603.2006; Kano M, 2009, PHYSIOL REV, V89, P309, DOI 10.1152/physrev.00019.2008; Kellogg R, 2009, J NEUROPHYSIOL, V102, P1160, DOI 10.1152/jn.00266.2009; LEFF P, 1995, TRENDS PHARMACOL SCI, V16, P89, DOI 10.1016/S0165-6147(00)88989-0; Marinelli S, 2008, J NEUROSCI, V28, P13532, DOI 10.1523/JNEUROSCI.0847-08.2008; Spruston N, 2008, NAT REV NEUROSCI, V9, P206, DOI 10.1038/nrn2286; Stella N, 1997, NATURE, V388, P773, DOI 10.1038/42015; Trettel J, 2004, J PHYSIOL-LONDON, V556, P95, DOI 10.1113/jphysiol.2003.058198; Watanabe M, 1998, EUR J NEUROSCI, V10, P478, DOI 10.1046/j.1460-9568.1998.00063.x	15	76	77	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2009	12	12					1488	1490		10.1038/nn.2430	http://dx.doi.org/10.1038/nn.2430			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	523II	19915567				2022-12-24	WOS:000272065600006
J	Nam, HS; Benezra, R				Nam, Hyung-song; Benezra, Robert			High Levels of Id1 Expression Define B1 Type Adult Neural Stem Cells	CELL STEM CELL			English	Article							SUBVENTRICULAR ZONE; PROGENITOR CELLS; MAMMALIAN FOREBRAIN; HEMATOPOIETIC STEM; GRANULE NEURONS; EPENDYMAL CELLS; VASCULAR NICHE; MIGRATION; DIFFERENTIATION; NEUROGENESIS	Defining the molecular identity of stem cells may be critical for formulating a rational strategy for the therapeutic intervention of stem cell dysfunction. We find that high expression of Id1, a dominant-negative helix-loop-helix transcriptional regulator, identifies a rare population of GFAP(+) astrocytes with stem cell attributes among the subventricular astrocytes in the adult brain. The rare, long-lived, and relatively quiescent Id1(high) astrocytes with morphology characteristic of B1 type astrocytes self-renew and generate migratory neuroblasts that differentiate into olfactory bulb interneurons. Cultured Id1(high) neural stem cells can self-renew asymmetrically and generate a stem and a differentiated cell expressing progressively lower levels of Id1, revealing an Id1 gradient in unperturbed cells of subventricular neurogenic lineages. Moreover, Id genes are necessary to confer self-renewal capacity, a characteristic of stem cell identity. We suggest that high expression of a single transcriptional regulator, Id1, molecularly defines the long-sought-after B1 type adult neural stem cells.	[Nam, Hyung-song; Benezra, Robert] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center	Nam, HS (corresponding author), Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, 1275 York Ave, New York, NY 10065 USA.	hyn2001@med.cornell.edu; r-benezra@ski.mskcc.org	Wilson, Matthew H/K-3193-2013	, namhyeongsong/0000-0002-0429-5446	NIGMS MSTP [T32GM07739]; NIDCD [F30DC008707]; MSKCC; NIH; Starr Foundation Tri-Institutional Stem Cell Initiative; NATIONAL CANCER INSTITUTE [R01CA107429] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [F30DC008707] Funding Source: NIH RePORTER	NIGMS MSTP(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); MSKCC; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Starr Foundation Tri-Institutional Stem Cell Initiative; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank K. Anderson, F. Doetsch, P. Mombaerts, and L. Studer for helpful discussions; M. Khan for assistance with the generation of the Id1<SUP>IRES-creERT2</SUP> allele; S. Anderson for critical review of the manuscript; S. Arber, M. Barbacid, A. Chenn, N. Copeland, R. DePinho, K. Hadjantonakis, and A. Joyner for reagents; C. Yang at the RU Gene Targeting Core; W. Mark at the Mouse Genetics Core; J. Hendrikx at the Flow Cytometry Core; and A. Viale at the Genomics Core. H.-S.N. designed and characterized the mice and performed the experiments. H.-S.N. and R.B. designed the experiments, interpreted the results, and wrote the manuscript. H.-S.N. and R.B. are coinventors on a US patent application entitled "Identification and Isolation of Adult Stem Cells and Related Methods of Use." H.-S.N. is an NIGMS MSTP (T32GM07739), NIDCD Ruth L. Kirschstein (F30DC008707), and MSKCC Geoffrey Beene Fellow. Grants from the NIH (R.B.) and the Starr Foundation Tri-Institutional Stem Cell Initiative (H.-S.N. and R.B.) supported this work.	Ahn S, 2005, NATURE, V437, P894, DOI 10.1038/nature03994; ALTMAN J, 1969, J COMP NEUROL, V137, P433, DOI 10.1002/cne.901370404; ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; BENEZRA R, 1990, CELL, V61, P49, DOI 10.1016/0092-8674(90)90214-Y; Bochkov YA, 2006, BIOTECHNIQUES, V41, P283, DOI 10.2144/000112243; Capela A, 2002, NEURON, V35, P865, DOI 10.1016/S0896-6273(02)00835-8; Carlen M, 2009, NAT NEUROSCI, V12, P259, DOI 10.1038/nn.2268; Carleton A, 2003, NAT NEUROSCI, V6, P507, DOI 10.1038/nn1048; Casper KB, 2006, MOL CELL NEUROSCI, V31, P676, DOI 10.1016/j.mcn.2005.12.006; Chiasson BJ, 1999, J NEUROSCI, V19, P4462; Coskun V, 2008, P NATL ACAD SCI USA, V105, P1026, DOI 10.1073/pnas.0710000105; Denise A, 2004, NAT NEUROSCI, V7, P1233, DOI 10.1038/nn1340; Doetsch F, 1999, P NATL ACAD SCI USA, V96, P11619, DOI 10.1073/pnas.96.20.11619; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Doetsch F, 2002, NEURON, V36, P1021, DOI 10.1016/S0896-6273(02)01133-9; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Glaser T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000298; GOLDMAN SA, 1983, P NATL ACAD SCI-BIOL, V80, P2390, DOI 10.1073/pnas.80.8.2390; Golmohammadi MG, 2008, STEM CELLS, V26, P979, DOI 10.1634/stemcells.2007-0919; Hippenmeyer S, 2005, PLOS BIOL, V3, P878, DOI 10.1371/journal.pbio.0030159; Ihrie RA, 2008, CELL TISSUE RES, V331, P179, DOI 10.1007/s00441-007-0461-z; Jeon HM, 2008, GENE DEV, V22, P2028, DOI 10.1101/gad.1668708; Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3; KAPLAN MS, 1985, J COMP NEUROL, V239, P117, DOI 10.1002/cne.902390110; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kornack DR, 2001, P NATL ACAD SCI USA, V98, P4752, DOI 10.1073/pnas.081074998; Kuhbandner S, 2000, GENESIS, V28, P15, DOI 10.1002/1526-968X(200009)28:1<15::AID-GENE20>3.0.CO;2-C; Kuo CT, 2006, CELL, V127, P1253, DOI 10.1016/j.cell.2006.10.041; Laywell ED, 2000, P NATL ACAD SCI USA, V97, P13883, DOI 10.1073/pnas.250471697; Liu HK, 2008, GENE DEV, V22, P2473, DOI 10.1101/gad.479308; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; LUSKIN MB, 1993, NEURON, V11, P173, DOI 10.1016/0896-6273(93)90281-U; Maslov AY, 2004, J NEUROSCI, V24, P1726, DOI 10.1523/JNEUROSCI.4608-03.2004; Merkle FT, 2007, SCIENCE, V317, P381, DOI 10.1126/science.1144914; Mirzadeh Z, 2008, CELL STEM CELL, V3, P265, DOI 10.1016/j.stem.2008.07.004; Morshead CM, 1998, DEVELOPMENT, V125, P2251; MORSHEAD CM, 1994, NEURON, V13, P1071, DOI 10.1016/0896-6273(94)90046-9; Nacher J, 2001, EUR J NEUROSCI, V14, P629, DOI 10.1046/j.0953-816x.2001.01683.x; Pastrana E, 2009, P NATL ACAD SCI USA, V106, P6387, DOI 10.1073/pnas.0810407106; PATON JA, 1984, SCIENCE, V225, P1046, DOI 10.1126/science.6474166; Perk J, 2005, NAT REV CANCER, V5, P603, DOI 10.1038/nrc1673; Perk J, 2006, CANCER RES, V66, P10870, DOI 10.1158/0008-5472.CAN-06-2643; Petreanu L, 2002, J NEUROSCI, V22, P6106; Pollard SM, 2006, CEREB CORTEX, V16, pI112, DOI 10.1093/cercor/bhj167; Reumers V, 2008, STEM CELLS, V26, P2382, DOI 10.1634/stemcells.2007-1062; Shen Q, 2008, CELL STEM CELL, V3, P289, DOI 10.1016/j.stem.2008.07.026; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; Spassky N, 2005, J NEUROSCI, V25, P10, DOI 10.1523/JNEUROSCI.1108-04.2005; Tavazoie M, 2008, CELL STEM CELL, V3, P279, DOI 10.1016/j.stem.2008.07.025; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X	51	189	195	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	NOV 6	2009	5	5					515	526		10.1016/j.stem.2009.08.017	http://dx.doi.org/10.1016/j.stem.2009.08.017			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	522SR	19896442	Green Published, Green Accepted, Bronze			2022-12-24	WOS:000272019500013
J	Chen, Y; Wu, H; Wang, SZ; Koito, H; Li, JR; Ye, F; Hoang, J; Escobar, SS; Gow, A; Arnett, HA; Trapp, BD; Karandikar, NJ; Hsieh, J; Lu, QR				Chen, Ying; Wu, Heng; Wang, Shuzong; Koito, Hisami; Li, Jianrong; Ye, Feng; Hoang, Jenny; Escobar, Sabine S.; Gow, Alexander; Arnett, Heather A.; Trapp, Bruce D.; Karandikar, Nitin J.; Hsieh, Jenny; Lu, Q. Richard			The oligodendrocyte-specific G protein-coupled receptor GPR17 is a cell-intrinsic timer of myelination	NATURE NEUROSCIENCE			English	Article							MULTIPLE-SCLEROSIS; PROGENITOR CELLS; PRECURSOR CELLS; CRUCIAL ROLE; STEM-CELLS; DIFFERENTIATION; TRANSCRIPTION; EXPRESSION; LESIONS; BRAIN	The basic helix-loop-helix transcription factor Olig1 promotes oligodendrocyte maturation and is required for myelin repair. We characterized an Olig1-regulated G protein-coupled receptor, GPR17, whose function is to oppose the action of Olig1. Gpr17 was restricted to oligodendrocyte lineage cells, but was downregulated during the peak period of myelination and in adulthood. Transgenic mice with sustained Gpr17 expression in oligodendrocytes exhibited stereotypic features of myelinating disorders in the CNS. Gpr17 overexpression inhibited oligodendrocyte differentiation and maturation both in vivo and in vitro. Conversely, Gpr17 knockout mice showed early onset of oligodendrocyte myelination. The opposing action of Gpr17 on oligodendrocyte maturation reflects, at least partially, upregulation and nuclear translocation of the potent oligodendrocyte differentiation inhibitors ID2/4. Collectively, these findings suggest that GPR17 orchestrates the transition between immature and myelinating oligodendrocytes via an ID protein-mediated negative regulation and may serve as a potential therapeutic target for CNS myelin repair.	[Chen, Ying; Wu, Heng; Wang, Shuzong; Ye, Feng; Hoang, Jenny; Lu, Q. Richard] Univ Texas SW Med Ctr Dallas, Dept Dev Biol, Dallas, TX 75390 USA; [Chen, Ying; Wu, Heng; Wang, Shuzong; Ye, Feng; Hoang, Jenny; Lu, Q. Richard] Univ Texas SW Med Ctr Dallas, Kent Waldrep Fdn Ctr Basic Neurosci Res Nerve Gro, Dallas, TX 75390 USA; [Koito, Hisami; Li, Jianrong] Texas A&M Univ, Dept Vet Integrat Biosci, College Stn, TX USA; [Escobar, Sabine S.; Arnett, Heather A.] Amgen Inc, Dept Inflammat, Seattle, WA USA; [Gow, Alexander] Wayne State Univ, Ctr Mol Med & Genet, Detroit, MI USA; [Trapp, Bruce D.] Cleveland Clin, Lerner Res Inst, Dept Neurosci, Cleveland, OH 44106 USA; [Karandikar, Nitin J.; Lu, Q. Richard] Univ Texas SW Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA; [Hsieh, Jenny; Lu, Q. Richard] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Texas A&M University System; Texas A&M University College Station; Amgen; Wayne State University; Cleveland Clinic Foundation; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Lu, QR (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Dev Biol, Dallas, TX 75390 USA.	qrichard.lu@utsouthwestern.edu	Li, Jianrong/C-4126-2011	Li, Jianrong/0000-0002-8232-9322; gow, alexander/0000-0001-7446-8990; Karandikar, Nitin/0000-0002-6867-6950	US National Institutes of Health [NS050389, NS060017]; National Multiple Sclerosis Society [RG3978, RG2891]; Harry Weaver Neuroscience Scholar; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K24AI079272] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050389, R01NS060017] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Multiple Sclerosis Society(National Multiple Sclerosis Society); Harry Weaver Neuroscience Scholar(National Multiple Sclerosis Society); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank C. Stiles, J. Chan, J. Johnson, R. Bassel-Duby, E. Hurlock and T. Hu for critical comments; M. Gravel for the Cnp1 promoter; M. Yanagisawa for ligand analysis; J. Koch for preliminary injury study; J. Cai, T. Hu, X. Xu and T. Yue for technical assistance; L. Cai for microarray analysis; and T. Januszewski and L. Mueller for electron microscopy. This study was funded by grants from the US National Institutes of Health (NS050389 to Q. R. L. and NS060017 to J. L.) and the National Multiple Sclerosis Society (RG3978 to Q. R. L. and RG2891 to A. G.). Q. R. L. is a Harry Weaver Neuroscience Scholar.	Arnett HA, 2004, SCIENCE, V306, P2111, DOI 10.1126/science.1103709; BARRES BA, 1994, DEVELOPMENT, V120, P1097; Berger J, 2001, CURR OPIN NEUROL, V14, P305, DOI 10.1097/00019052-200106000-00007; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Cai J, 2007, DEVELOPMENT, V134, P1887, DOI 10.1242/dev.02847; Campagnoni A.T., 2005, NEUROGLIA, P253; Casaccia-Bonnefil P, 1999, DEVELOPMENT, V126, P4027; CasacciaBonnefil P, 1997, GENE DEV, V11, P2335, DOI 10.1101/gad.11.18.2335; Chang A, 2002, NEW ENGL J MED, V346, P165, DOI 10.1056/NEJMoa010994; Chang A, 2000, J NEUROSCI, V20, P6404, DOI 10.1523/JNEUROSCI.20-17-06404.2000; Chen Y, 2007, NAT PROTOC, V2, P1044, DOI 10.1038/nprot.2007.149; Ciana P, 2006, EMBO J, V25, P4615, DOI 10.1038/sj.emboj.7601341; Dugas JC, 2007, J NEUROSCI, V27, P6185, DOI 10.1523/JNEUROSCI.0628-07.2007; Durand B, 2000, BIOESSAYS, V22, P64; Durand B, 1997, EMBO J, V16, P306, DOI 10.1093/emboj/16.2.306; Franklin RJM, 2002, NAT REV NEUROSCI, V3, P705, DOI 10.1038/nrn917; Gabay L, 2003, NEURON, V40, P485, DOI 10.1016/S0896-6273(03)00637-8; Gokhan S, 2005, J NEUROSCI, V25, P8311, DOI 10.1523/JNEUROSCI.1850-05.2005; GOW A, 1992, J CELL BIOL, V119, P605, DOI 10.1083/jcb.119.3.605; Gravel M, 1998, J NEUROSCI RES, V53, P393; Hsieh J, 2004, J CELL BIOL, V164, P111, DOI 10.1083/jcb.200308101; Hu QD, 2003, CELL, V115, P163, DOI 10.1016/S0092-8674(03)00810-9; Ito D, 1998, MOL BRAIN RES, V57, P1, DOI 10.1016/S0169-328X(98)00040-0; John GR, 2002, NAT MED, V8, P1115, DOI 10.1038/nm781; Karandikar NJ, 1998, J IMMUNOL, V161, P192; Kondo T, 2000, EMBO J, V19, P1998, DOI 10.1093/emboj/19.9.1998; Lecca D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003579; Levine JM, 1999, EXP NEUROL, V160, P333, DOI 10.1006/exnr.1999.7224; Li HL, 2007, J NEUROSCI, V27, P14375, DOI 10.1523/JNEUROSCI.4456-07.2007; Lu QR, 2000, NEURON, V25, P317, DOI 10.1016/S0896-6273(00)80897-1; Lu QR, 2002, CELL, V109, P75, DOI 10.1016/S0092-8674(02)00678-5; Marin-Husstege M, 2006, GLIA, V54, P285, DOI 10.1002/glia.20385; Megason SG, 2002, DEVELOPMENT, V129, P2087; Mi S, 2005, NAT NEUROSCI, V8, P745, DOI 10.1038/nn1460; NAVE KA, 1994, J NEUROSCI RES, V38, P607, DOI 10.1002/jnr.490380602; Navel KA, 2006, CURR OPIN NEUROBIOL, V16, P492, DOI 10.1016/j.conb.2006.08.008; Parravicini C, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-263; Pfeiffer Steve E., 1993, Trends in Cell Biology, V3, P191, DOI 10.1016/0962-8924(93)90213-K; Ross SE, 2003, NEURON, V39, P13, DOI 10.1016/S0896-6273(03)00365-9; Samanta J, 2004, DEVELOPMENT, V131, P4131, DOI 10.1242/dev.01273; Tokumoto YM, 2002, DEV BIOL, V245, P224, DOI 10.1006/dbio.2002.0626; Trapp BD, 1998, NEW ENGL J MED, V338, P278, DOI 10.1056/NEJM199801293380502; Vartanian T, 1997, J CELL BIOL, V137, P211, DOI 10.1083/jcb.137.1.211; Wang SZ, 2006, DEVELOPMENT, V133, P3389, DOI 10.1242/dev.02522; Wang SL, 2001, NEURON, V29, P603, DOI 10.1016/S0896-6273(01)00237-9; Wang SL, 1998, NEURON, V21, P63, DOI 10.1016/S0896-6273(00)80515-2; Xin M, 2005, J NEUROSCI, V25, P1354, DOI 10.1523/JNEUROSCI.3034-04.2005; Yue T, 2006, J NEUROSCI, V26, P1275, DOI 10.1523/JNEUROSCI.4717-05.2006; Zhou Q, 2002, CELL, V109, P61, DOI 10.1016/S0092-8674(02)00677-3	50	220	234	1	45	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2009	12	11					1398	1406		10.1038/nn.2410	http://dx.doi.org/10.1038/nn.2410			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	511UE	19838178	Green Accepted			2022-12-24	WOS:000271194100012
J	Kim, WY; Wang, XS; Wu, YH; Doble, BW; Patel, S; Woodgett, JR; Snider, WD				Kim, Woo-Yang; Wang, Xinshuo; Wu, Yaohong; Doble, Bradley W.; Patel, Satish; Woodgett, James R.; Snider, William D.			GSK-3 is a master regulator of neural progenitor homeostasis	NATURE NEUROSCIENCE			English	Article							CELL SELF-RENEWAL; NERVOUS-SYSTEM; STEM-CELLS; N-MYC; NEUROGENESIS; NOTCH; DIFFERENTIATION; PROLIFERATION; KINASE; PLURIPOTENCY	The development of the brain requires the exquisite coordination of progenitor proliferation and differentiation to achieve complex circuit assembly. It has been suggested that glycogen synthase kinase 3 (GSK-3) acts as an integrating molecule for multiple proliferation and differentiation signals because of its essential role in the RTK, Wnt and Shh signaling pathways. We created conditional mutations that deleted both the. and. forms of GSK-3 in mouse neural progenitors. GSK-3 deletion resulted in massive hyperproliferation of neural progenitors along the entire neuraxis. Generation of both intermediate neural progenitors and postmitotic neurons was markedly suppressed. These effects were associated with the dysregulation of beta-catenin, Sonic Hedgehog, Notch and fibroblast growth factor signaling. Our results indicate that GSK-3 signaling is an essential mediator of homeostatic controls that regulate neural progenitors during mammalian brain development.	[Kim, Woo-Yang; Wang, Xinshuo; Wu, Yaohong; Snider, William D.] Univ N Carolina, Sch Med, Ctr Neurosci, Chapel Hill, NC 27515 USA; [Doble, Bradley W.] McMaster Univ, McMaster Stem Cell & Canc Res Inst, Hamilton, ON, Canada; [Patel, Satish; Woodgett, James R.] Univ Toronto, Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Patel, Satish; Woodgett, James R.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; McMaster University; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto	Snider, WD (corresponding author), Univ N Carolina, Sch Med, Ctr Neurosci, Chapel Hill, NC 27515 USA.	wsnider@med.unc.edu	Woodgett, Jim/F-1087-2010; , UNC Neuroscience Microscopy Core/AAE-8305-2022; Doble, Bradley/V-7848-2019; Doble, Brad/L-7551-2016	Woodgett, Jim/0000-0003-3731-5797; Doble, Bradley/0000-0002-0260-2983; Doble, Brad/0000-0002-0260-2983	US National Institutes of Health [NS050968, NS045892]; University of North Carolina Neuroscience Center; Canadian Institutes of Health Research (MOP) [74711]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS045892, R01NS050968] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of North Carolina Neuroscience Center; Canadian Institutes of Health Research (MOP)(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank F. Polleux, L. Pevny and E. Anton for valuable advice and comments on the manuscript. We are also grateful to L. Goins and A. McKell for animal care and M. Aita for technical support. This research was supported by grants from the US National Institutes of Health (NS050968 to W. D. S. and NS045892, which supports the Confocal and Multiphoton Imaging and Expression Localization Cores of University of North Carolina Neuroscience Center) and Canadian Institutes of Health Research (MOP 74711 to J.R.W.).	Beaulieu JM, 2007, TRENDS PHARMACOL SCI, V28, P166, DOI 10.1016/j.tips.2007.02.006; Bechard M, 2009, MOL CELL BIOL, V29, P2092, DOI 10.1128/MCB.01405-08; Bone HK, 2009, CHEM BIOL, V16, P15, DOI 10.1016/j.chembiol.2008.11.003; Calvisi DF, 2004, CARCINOGENESIS, V25, P901, DOI 10.1093/carcin/bgh083; Cappello S, 2006, NAT NEUROSCI, V9, P1099, DOI 10.1038/nn1744; Chen SQ, 2001, J CELL BIOL, V152, P87, DOI 10.1083/jcb.152.1.87; Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; Corbin JG, 2008, J NEUROCHEM, V106, P2272, DOI 10.1111/j.1471-4159.2008.05522.x; Dehay C, 2007, NAT REV NEUROSCI, V8, P438, DOI 10.1038/nrn2097; Ding Q, 1998, DEVELOPMENT, V125, P2533; Doble BW, 2009, CELL STEM CELL, V4, P98, DOI 10.1016/j.stem.2009.01.005; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Eilers M, 2008, GENE DEV, V22, P2755, DOI 10.1101/gad.1712408; Espinosa L, 2003, J BIOL CHEM, V278, P32227, DOI 10.1074/jbc.M304001200; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Gulacsi AA, 2008, NAT NEUROSCI, V11, P1383, DOI 10.1038/nn.2226; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Jia JH, 2002, NATURE, V416, P548, DOI 10.1038/nature733; Jin YH, 2009, MOL CELLS, V27, P15, DOI 10.1007/s10059-009-0001-7; Kim WY, 2006, NEURON, V52, P981, DOI 10.1016/j.neuron.2006.10.031; Knoepfler PS, 2006, CELL CYCLE, V5, P47, DOI 10.4161/cc.5.1.2292; Kockeritz L, 2006, CURR DRUG TARGETS, V7, P1377, DOI 10.2174/1389450110607011377; MacAulay K, 2007, CELL METAB, V6, P329, DOI 10.1016/j.cmet.2007.08.013; Machon O, 2007, DEV BIOL, V311, P223, DOI 10.1016/j.ydbio.2007.08.038; Mao YW, 2009, CELL, V136, P1017, DOI 10.1016/j.cell.2008.12.044; Mizutani K, 2007, NATURE, V449, P351, DOI 10.1038/nature06090; Otto T, 2009, CANCER CELL, V15, P67, DOI 10.1016/j.ccr.2008.12.005; Patel S, 2008, MOL CELL BIOL, V28, P6314, DOI 10.1128/MCB.00763-08; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Sessa A, 2008, NEURON, V60, P56, DOI 10.1016/j.neuron.2008.09.028; Shimizu T, 2008, MOL CELL BIOL, V28, P7427, DOI 10.1128/MCB.01962-07; Shimojo H, 2008, NEURON, V58, P52, DOI 10.1016/j.neuron.2008.02.014; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Uemura K, 2007, J BIOL CHEM, V282, P15823, DOI 10.1074/jbc.M610708200; Woodhead GJ, 2006, J NEUROSCI, V26, P12620, DOI 10.1523/JNEUROSCI.3180-06.2006; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Yokota Y, 2009, NEURON, V61, P42, DOI 10.1016/j.neuron.2008.10.053; Yoon K, 2005, NAT NEUROSCI, V8, P709, DOI 10.1038/nn1475; Zechner D, 2003, DEV BIOL, V258, P406, DOI 10.1016/S0012-1606(03)00123-4	39	299	313	1	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2009	12	11					1390	1397		10.1038/nn.2408	http://dx.doi.org/10.1038/nn.2408			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	511UE	19801986	Green Accepted, Green Submitted			2022-12-24	WOS:000271194100011
J	Tsuchiya, N; Moradi, F; Felsen, C; Yamazaki, M; Adolphs, R				Tsuchiya, Naotsugu; Moradi, Farshad; Felsen, Csilla; Yamazaki, Madoka; Adolphs, Ralph			Intact rapid detection of fearful faces in the absence of the amygdala	NATURE NEUROSCIENCE			English	Article							CONTINUOUS FLASH SUPPRESSION; AWARENESS; RECOGNITION; RESPONSES; DAMAGE	The amygdala is thought to process fear-related stimuli rapidly and nonconsciously. We found that an individual with complete bilateral amygdala lesions, who cannot recognize fear from faces, nonetheless showed normal rapid detection and nonconscious processing of those same fearful faces. We conclude that the amygdala is not essential for early stages of fear processing but, instead, modulates recognition and social judgment.	[Tsuchiya, Naotsugu; Moradi, Farshad; Felsen, Csilla; Adolphs, Ralph] CALTECH, Div Humanities & Social Sci, Pasadena, CA 91125 USA; [Tsuchiya, Naotsugu] Tamagawa Univ, Brain Sci Inst, Tokyo, Japan; [Adolphs, Ralph] CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology	Tsuchiya, N (corresponding author), CALTECH, Div Humanities & Social Sci, Pasadena, CA 91125 USA.	naotsu@gmail.com	Tsuchiya, Naotsugu/N-8153-2014	Tsuchiya, Naotsugu/0000-0003-4216-8701	National Institute of Mental Health; Simons Foundation; Japanese Ministry of Education, Culture, Sports and Technology; Japan Society for the Promotion of Science; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH080721] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS019632] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Simons Foundation; Japanese Ministry of Education, Culture, Sports and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank C. Holcomb for help with recruiting and testing subjects. This work was funded by grants from the National Institute of Mental Health and the Simons Foundation to R. A. and was supported, in part, by Tamagawa University global Center of Excellence program of the Japanese Ministry of Education, Culture, Sports and Technology. N. T. is supported by the Japan Society for the Promotion of Science.	Adolphs R, 2005, NATURE, V433, P68, DOI 10.1038/nature03086; ADOLPHS R, 1994, NATURE, V372, P669, DOI 10.1038/372669a0; Adolphs R, 2008, CURR OPIN NEUROBIOL, V18, P166, DOI 10.1016/j.conb.2008.06.006; Jiang Y, 2006, CURR BIOL, V16, P2023, DOI 10.1016/j.cub.2006.08.084; Lin JY, 2009, CURR BIOL, V19, P1118, DOI 10.1016/j.cub.2009.05.021; Mormann F, 2008, J NEUROSCI, V28, P8865, DOI 10.1523/JNEUROSCI.1640-08.2008; Ohman A, 2007, PHYSIOL BEHAV, V92, P180, DOI 10.1016/j.physbeh.2007.05.057; Pegna AJ, 2005, NAT NEUROSCI, V8, P24, DOI 10.1038/nn1364; Pessoa L, 2006, CEREB CORTEX, V16, P366, DOI 10.1093/cercorbhi115; Rotshtein P, 2005, NAT NEUROSCI, V8, P107, DOI 10.1038/nn1370; Sander D, 2003, REV NEUROSCIENCE, V14, P303, DOI 10.1515/REVNEURO.2003.14.4.303; Tsuchiya N, 2005, NAT NEUROSCI, V8, P1096, DOI 10.1038/nn1500; Whalen PJ, 1998, J NEUROSCI, V18, P411; Yang E, 2007, EMOTION, V7, P882, DOI 10.1037/1528-3542.7.4.882	14	150	156	1	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2009	12	10					1224	1225		10.1038/nn.2380	http://dx.doi.org/10.1038/nn.2380			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	498US	19718036	Green Accepted			2022-12-24	WOS:000270170200009
J	Glykys, J; Dzhala, VI; Kuchiblhotla, KV; Feng, GP; Kuner, T; Augustine, G; Bacskai, BJ; Staley, KJ				Glykys, Joseph; Dzhala, Volodymyr I.; Kuchiblhotla, Kishore V.; Feng, Guoping; Kuner, Thomas; Augustine, George; Bacskai, Brian J.; Staley, Kevin J.			Differences in Cortical versus Subcortical GABAergic Signaling: A Candidate Mechanism of Electroclinical Uncoupling of Neonatal Seizures	NEURON			English	Article							GRAMICIDIN-PERFORATED-PATCH; HIGH-FREQUENCY OSCILLATIONS; CATION-CHLORIDE COTRANSPORTERS; IMAGING SYNAPTIC INHIBITION; GABA(A) RECEPTOR FUNCTION; RAT NEOCORTICAL NEURONS; TEMPORAL-LOBE EPILEPSY; K+-CL-COTRANSPORTER; RHYTHMS IN-VITRO; INTRACELLULAR CHLORIDE	Electroclinical uncoupling of neonatal seizures refers to electrographic seizure activity that is not clinically manifest. Uncoupling increases after treatment with Phenobarbital, which enhances the GABA(A) receptor (GABA(A)R) conductance. The effects of GABAAR activation depend on the intracellular Cl- concentration ([Cl-](i)) that is determined by the inward Cl- transporter NKCC1 and the outward Cl- transporter KCC2. Differential maturation of Cl- transport observed in cortical versus subcortical regions should alter the efficacy of GABA-mediated inhibition. In perinatal rat pups, most thalamic neurons maintained low [Cl-](i) and were inhibited by GABA. Phenobarbital suppressed thalamic seizure activity. Most neocortical neurons maintained higher [Cl-](i), and were excited by GABAAR activation. Phenobarbital had insignificant anticonvulsant responses in the neocortex until NKCC1 was blocked. Regional differences in the ontogeny of Cl- transport may thus explain why seizure activity in the cortex is not suppressed by anticonvulsants that block the transmission of seizure activity through subcortical networks.	[Glykys, Joseph; Dzhala, Volodymyr I.; Kuchiblhotla, Kishore V.; Bacskai, Brian J.; Staley, Kevin J.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02144 USA; [Feng, Guoping; Augustine, George] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; [Augustine, George] Duke Natl Univ Singapore, Grad Sch Med, Program Neurosci & Behav Disorders, Singapore 169547, Singapore; [Kuner, Thomas] Heidelberg Univ, Inst Anat & Cell Biol, D-69120 Heidelberg, Germany; [Kuchiblhotla, Kishore V.] Harvard Univ, Program Biophys, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Duke University; National University of Singapore; Ruprecht Karls University Heidelberg; Harvard University	Staley, KJ (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02144 USA.	kstaley@partners.org	Bacskai, Brian/AAE-9583-2021; Feng, Guoping/Y-2827-2019	Glykys, Joseph/0000-0002-1499-9172	American Epilepsy Society; NIH [NS580752, NS040109, EB000768]; DFG [KU1983/1-2]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB000768] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034360, R01NS040109] Funding Source: NIH RePORTER	American Epilepsy Society; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DFG(German Research Foundation (DFG)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We give our thanks to the Staley lab for helpful discussion. This work was supported by the American Epilepsy Society (J.G.), NIH NS580752 (K.V.K.), NIH NS040109 (K.J.S.), NIH EB000768 (B.J.B.), and DFG grant KU1983/1-2 (T.K.). J.G. was responsible for the design, electrophysiology, two-photon imaging, analysis, and writing; K.K. and D.V., for two-photon imaging and analysis; G.F., T.K., and G.A., for mice generation; BJB., for two-photon imaging; and K.J.S., for design and writing.	Achilles K, 2007, J NEUROSCI, V27, P8616, DOI 10.1523/JNEUROSCI.5041-06.2007; AGMON A, 1991, NEUROSCIENCE, V41, P365, DOI 10.1016/0306-4522(91)90333-J; Ben-Ari Y, 2007, PHYSIOL REV, V87, P1215, DOI 10.1152/physrev.00017.2006; Berglund K, 2006, BRAIN CELL BIOL, V35, P207, DOI 10.1007/s11068-008-9019-6; Berglund K, 2008, BRAIN CELL BIOL, V36, P101, DOI 10.1007/s11068-008-9031-x; Blumenfeld H, 2002, ARCH NEUROL-CHICAGO, V59, P135, DOI 10.1001/archneur.59.1.135; Blumenfeld H, 2009, BRAIN, V132, P999, DOI 10.1093/brain/awp028; Bonnet U, 1998, BRAIN RES, V796, P161, DOI 10.1016/S0006-8993(98)00341-2; Boylan GB, 2002, ARCH DIS CHILD-FETAL, V86, P165; Boylan GB, 1999, DEV MED CHILD NEUROL, V41, P819, DOI 10.1017/S0012162299001632; Bragin A, 2004, EPILEPSIA, V45, P1017, DOI 10.1111/j.0013-9580.2004.17004.x; Bragin A, 1999, HIPPOCAMPUS, V9, P137; BRIGHT GR, 1989, METHOD CELL BIOL, V30, P157; Brumback AC, 2008, J NEUROSCI, V28, P1301, DOI 10.1523/JNEUROSCI.3378-07.2008; Cancedda L, 2007, J NEUROSCI, V27, P5224, DOI 10.1523/JNEUROSCI.5169-06.2007; Carmo KB, 2005, J PAEDIATR CHILD H, V41, P313, DOI 10.1111/j.1440-1754.2005.00638.x; Chen LM, 2008, NEUROSCIENCE, V153, P162, DOI 10.1016/j.neuroscience.2008.02.018; CLANCY RR, 1988, EPILEPSIA, V29, P256, DOI 10.1111/j.1528-1157.1988.tb03715.x; Clayton GH, 1998, DEV BRAIN RES, V109, P281, DOI 10.1016/S0165-3806(98)00078-9; Cohen I, 2000, J PHYSIOL-LONDON, V524, P485, DOI 10.1111/j.1469-7793.2000.00485.x; Conde JRC, 2005, NEUROLOGY, V64, P876; CONNELL J, 1989, ARCH DIS CHILD-FETAL, V64, P459, DOI 10.1136/adc.64.4_Spec_No.459; DeFazio RA, 2000, J NEUROSCI, V20, P8069; Duebel J, 2006, NEURON, V49, P81, DOI 10.1016/j.neuron.2005.10.035; Dulla CG, 2009, J NEUROPHYSIOL, V102, P1984, DOI 10.1152/jn.90695.2008; Dzhala VI, 2005, NAT MED, V11, P1205, DOI 10.1038/nm1301; Dzhala VI, 2003, J NEUROSCI, V23, P1840; Dzhala VI, 2008, ANN NEUROL, V63, P222, DOI 10.1002/ana.21229; EBIHARA S, 1995, J PHYSIOL-LONDON, V484, P77, DOI 10.1113/jphysiol.1995.sp020649; Fiumelli H, 2005, NEURON, V48, P773, DOI 10.1016/j.neuron.2005.10.025; Galanopoulou AS, 2008, J NEUROSCI, V28, P1557, DOI 10.1523/JNEUROSCI.5180-07.2008; GALE K, 1992, J CLIN NEUROPHYSIOL, V9, P264, DOI 10.1097/00004691-199204010-00007; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Gonzalez-Islas C, 2009, J NEUROPHYSIOL, V101, P507, DOI 10.1152/jn.90986.2008; Hammami S, 2009, J PHYSIOL-LONDON, V587, P2225, DOI 10.1113/jphysiol.2008.163550; Hannaert P, 2002, N-S ARCH PHARMACOL, V365, P193, DOI 10.1007/s00210-001-0521-y; Hosford DA, 1997, EPILEPSY RES, V27, P55, DOI 10.1016/S0920-1211(97)01023-1; Huberfeld G, 2007, J NEUROSCI, V27, P9866, DOI 10.1523/JNEUROSCI.2761-07.2007; Hubner CA, 2001, NEURON, V30, P515, DOI 10.1016/S0896-6273(01)00297-5; Hughes JR, 2009, EPILEPSY BEHAV, V15, P404, DOI 10.1016/j.yebeh.2009.06.007; HUGUENARD JR, 1986, J NEUROPHYSIOL, V56, P1; IADAROLA MJ, 1982, SCIENCE, V218, P1237, DOI 10.1126/science.7146907; Ikeda M, 2003, BRAIN RES, V984, P149, DOI 10.1016/S0006-8993(03)03126-3; Kahle KT, 2008, NAT CLIN PRACT NEURO, V4, P490, DOI 10.1038/ncpneuro0883; Kahle KT, 2009, J CHILD NEUROL, V24, P572, DOI 10.1177/0883073809333526; Khalilov I, 2003, NAT NEUROSCI, V6, P1079, DOI 10.1038/nn1125; Khosravani H, 2005, EPILEPSIA, V46, P1188, DOI 10.1111/j.1528-1167.2005.65604.x; Kilb W, 2007, NEUROPHARMACOLOGY, V53, P524, DOI 10.1016/j.neuropharm.2007.06.015; Kitayama M, 2002, N-S ARCH PHARMACOL, V366, P246, DOI 10.1007/s00210-002-0590-6; KRAPF R, 1988, BIOPHYS J, V53, P955, DOI 10.1016/S0006-3495(88)83176-X; KREINDLER A, 1958, J NEUROPHYSIOL, V21, P430, DOI 10.1152/jn.1958.21.5.430; Kuner T, 2000, NEURON, V27, P447, DOI 10.1016/S0896-6273(00)00056-8; KYROZIS A, 1995, J NEUROSCI METH, V57, P27, DOI 10.1016/0165-0270(94)00116-X; Li H, 2002, EUR J NEUROSCI, V16, P2358, DOI 10.1046/j.1460-9568.2002.02419.x; LopezSamblas AM, 1997, BIOL NEONATE, V72, P265; MacDonald R L, 1992, Ion Channels, V3, P315; Mann EO, 2007, TRENDS NEUROSCI, V30, P343, DOI 10.1016/j.tins.2007.05.003; MARKS DA, 1992, ELECTROEN CLIN NEURO, V82, P23, DOI 10.1016/0013-4694(92)90178-K; MISGELD U, 1986, SCIENCE, V232, P1413, DOI 10.1126/science.2424084; MIZRAHI EM, 1987, NEUROLOGY, V37, P1837, DOI 10.1212/WNL.37.12.1837; Murray DM, 2008, ARCH DIS CHILD-FETAL, V93, pF187, DOI 10.1136/adc.2005.086314; Oddo M, 2009, CRIT CARE MED, V37, P2051, DOI 10.1097/CCM.0b013e3181a00604; Owens DF, 1996, J NEUROSCI, V16, P6414; Painter MJ, 1999, NEW ENGL J MED, V341, P485, DOI 10.1056/NEJM199908123410704; Palma E, 2006, P NATL ACAD SCI USA, V103, P8465, DOI 10.1073/pnas.0602979103; Payne JA, 2003, TRENDS NEUROSCI, V26, P199, DOI 10.1016/S0166-2236(03)00068-7; Plotkin MD, 1997, J NEUROBIOL, V33, P781, DOI 10.1002/(SICI)1097-4695(19971120)33:6<781::AID-NEU6>3.0.CO;2-5; Pond BB, 2006, J NEUROSCI, V26, P1396, DOI 10.1523/JNEUROSCI.1421-05.2006; Quilichini PP, 2003, EPILEPSIA, V44, P1365, DOI 10.1046/j.1528-1157.2003.19503.x; Rennie JM, 2003, CURR OPIN NEUROL, V16, P177, DOI 10.1097/00019052-200304000-00010; Rennie JM, 1997, EUR J PEDIATR, V156, P83, DOI 10.1007/s004310050559; Rheims S, 2008, J NEUROPHYSIOL, V100, P620, DOI 10.1152/jn.90403.2008; Rheims S, 2008, J NEUROPHYSIOL, V100, P609, DOI 10.1152/jn.90402.2008; Rheims S, 2009, J NEUROCHEM, V110, P1330, DOI 10.1111/j.1471-4159.2009.06230.x; Rivera C, 1999, NATURE, V397, P251, DOI 10.1038/16697; Romero MF, 2004, PFLUG ARCH EUR J PHY, V447, P495, DOI 10.1007/s00424-003-1180-2; ROOS A, 1981, PHYSIOL REV, V61, P296, DOI 10.1152/physrev.1981.61.2.296; Scher MS, 2003, PEDIATR NEUROL, V28, P277, DOI 10.1016/S0887-8994(02)00621-5; Shimizu-Okabe C, 2002, NEUROREPORT, V13, P2433, DOI 10.1097/00001756-200212200-00012; Sipila ST, 2006, J PHYSIOL-LONDON, V573, P765, DOI 10.1113/jphysiol.2006.107086; STALEY K, 1994, J NEUROPHYSIOL, V72, P273, DOI 10.1152/jn.1994.72.1.273; Staley K, 1996, NEURON, V17, P543, DOI 10.1016/S0896-6273(00)80186-5; Staley KJ, 1999, J PHYSIOL-LONDON, V519, P693, DOI 10.1111/j.1469-7793.1999.0693n.x; Stein V, 2004, J COMP NEUROL, V468, P57, DOI 10.1002/cne.10983; Sullivan JE, 1996, CLIN PHARMACOL THER, V60, P405, DOI 10.1016/S0009-9236(96)90197-6; Sung KW, 2000, J NEUROSCI, V20, P7531; Tekgul H, 2006, PEDIATRICS, V117, P1270, DOI 10.1542/peds.2005-1178; THOMPSON SM, 1989, J NEUROPHYSIOL, V61, P501, DOI 10.1152/jn.1989.61.3.501; TWYMAN RE, 1989, ANN NEUROL, V25, P213, DOI 10.1002/ana.410250302; Tyzio R, 2003, J NEUROPHYSIOL, V90, P2964, DOI 10.1152/jn.00172.2003; Tyzio R, 2007, EPILEPSIA, V48, P96, DOI 10.1111/j.1528-1167.2007.01295.x; Wang C, 2002, DEV BRAIN RES, V139, P59, DOI 10.1016/S0165-3806(02)00536-9; Wang DD, 2008, J NEUROSCI, V28, P5547, DOI 10.1523/JNEUROSCI.5599-07.2008; WEINER SP, 1991, PEDIATR NEUROL, V7, P363, DOI 10.1016/0887-8994(91)90067-U; Wells JE, 2000, J NEUROSCI, V20, P8822; WHITE LE, 1993, J NEUROSCI, V13, P4787; Yamada J, 2004, J PHYSIOL-LONDON, V557, P829, DOI 10.1113/jphysiol.2004.062471; Yan YP, 2003, BRAIN RES, V961, P22, DOI 10.1016/S0006-8993(02)03832-5; Zar J, 1999, BIOSTAT ANAL, P360; Zhang YF, 1996, EPILEPSY RES, V23, P55, DOI 10.1016/0920-1211(95)00081-X; Zhang YF, 1996, EPILEPSY RES, V23, P15, DOI 10.1016/0920-1211(95)00079-8; Zhu L, 2005, J NEUROPHYSIOL, V93, P1557, DOI 10.1152/jn.00616.2004	102	107	109	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 10	2009	63	5					657	672		10.1016/j.neuron.2009.08.022	http://dx.doi.org/10.1016/j.neuron.2009.08.022			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	494XH	19755108	Green Accepted, Bronze			2022-12-24	WOS:000269852300012
J	Poulopoulos, A; Aramuni, G; Meyer, G; Soykan, T; Hoon, M; Papadopoulos, T; Zhang, MY; Paarmann, I; Fuchs, C; Harvey, K; Jedlicka, P; Schwarzacher, SW; Betz, H; Harvey, RJ; Brose, N; Zhang, WQ; Varoqueaux, F				Poulopoulos, Alexandros; Aramuni, Gayane; Meyer, Guido; Soykan, Tolga; Hoon, Mrinalini; Papadopoulos, Theofilos; Zhang, Mingyue; Paarmann, Ingo; Fuchs, Celine; Harvey, Kirsten; Jedlicka, Peter; Schwarzacher, Stephan W.; Betz, Heinrich; Harvey, Robert J.; Brose, Nils; Zhang, Weiqi; Varoqueaux, Frederique			Neuroligin 2 Drives Postsynaptic Assembly at Perisomatic Inhibitory Synapses through Gephyrin and Collybistin	NEURON			English	Article							EXCHANGE FACTOR COLLYBISTIN; GABA(A) RECEPTOR SUBTYPES; CELL-ADHESION MOLECULE; BETA-NEUREXINS; GLUTAMATERGIC SYNAPSES; SYNAPTOGENIC PROTEINS; SYNAPTIC ORGANIZERS; GABAERGIC SYNAPSES; SURFACE PROTEINS; DEFICIENT MICE	In the mammalian CNS, each neuron typically receives thousands of synaptic inputs from diverse classes of neurons. Synaptic transmission to the postsynaptic neuron relies on localized and transmitter-specific differentiation of the plasma membrane with postsynaptic receptor, scaffolding, and adhesion proteins accumulating in precise apposition to presynaptic sites of transmitter release. We identified protein interactions of the synaptic adhesion molecule neuroligin 2 that drive postsynaptic differentiation at inhibitory synapses. Neuroligin 2 binds the scaffolding protein gephyrin through a conserved cytoplasmic motif and functions as a specific activator of collybistin, thus guiding membrane tethering of the inhibitory postsynaptic scaffold. Complexes of neuroligin 2, gephyrin and collybistin are sufficient for cell-autonomous clustering of inhibitory neurotransmitter receptors. Deletion of neuroligin 2 in mice perturbs GABAergic and glycinergic synaptic transmission and leads to a loss of postsynaptic specializations specifically at perisomatic inhibitory synapses.	[Poulopoulos, Alexandros; Meyer, Guido; Soykan, Tolga; Hoon, Mrinalini; Brose, Nils; Varoqueaux, Frederique] Max Planck Inst Expt Med, Dept Mol Neurobiol, D-37075 Gottingen, Germany; [Aramuni, Gayane; Zhang, Mingyue; Zhang, Weiqi] Univ Gottingen, Ctr Physiol & Pathophysiol, Gottingen, Germany; [Brose, Nils; Zhang, Weiqi; Varoqueaux, Frederique] DFG Ctr Mol Physiol Brain, Gottingen, Germany; [Papadopoulos, Theofilos; Paarmann, Ingo; Betz, Heinrich] Max Planck Inst Brain Res, Dept Neurochem, D-60496 Frankfurt, Germany; [Fuchs, Celine; Harvey, Kirsten; Harvey, Robert J.] Univ London, Sch Pharm, Dept Pharmacol, London WC1N 1AX, England; [Jedlicka, Peter; Schwarzacher, Stephan W.] Goethe Univ Frankfurt, Dept Clin Neuroanat, Frankfurt, Germany	Max Planck Society; University of Gottingen; German Research Foundation (DFG); Max Planck Society; University of London; University College London; University of London School of Pharmacy; Goethe University Frankfurt	Zhang, WQ (corresponding author), Univ Munster, Dept Psychiat, Lab Mol Psychiat, Munster, Germany.	wzhang@uni-muenster.de; varoqueaux@em.mpg.de	Jedlicka, Peter/B-6094-2012; Jedlicka, Peter/AAW-4207-2020; Harvey, Robert/D-3994-2016; Varoqueaux, Frederique/AAC-1834-2021; Poulopoulos, Alexandros/C-3659-2008	Jedlicka, Peter/0000-0001-6571-5742; Jedlicka, Peter/0000-0001-6571-5742; Harvey, Robert/0000-0001-5956-6664; Varoqueaux, Frederique/0000-0002-3614-3121; Poulopoulos, Alexandros/0000-0002-5318-7388; Jedlicka, Peter/0000-0003-2077-5332; Papadopoulos, Theofilos/0000-0002-0684-2407	Max Planck Society; German Research Foundation [GRK 521, FZT 103]; DFG-Research Center for Molecular Physiology of the Brain; European Commission [LSHMCT-2005-019055, MEST-CT-2004-504193]; Cure Autism Now Foundation; Medical Research Council [G0500833, G0501258, G0800498]; MRC [G0501258, G0500833, G0601585, G0800498] Funding Source: UKRI; Medical Research Council [G0601585] Funding Source: researchfish	Max Planck Society(Max Planck SocietyFoundation CELLEX); German Research Foundation(German Research Foundation (DFG)); DFG-Research Center for Molecular Physiology of the Brain(German Research Foundation (DFG)); European Commission(European CommissionEuropean Commission Joint Research Centre); Cure Autism Now Foundation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We are grateful to A.M. Craig (Vancouver, BC, Canada) for her constructive experimental advice. We thank K. Hellmann and A. Galinski (Gottingen) for excellent technical assistance. This work was supported by the Max Planck Society, the German Research Foundation (GRK 521 and FZT 103, F.V. and N.B.), the DFG-Research Center for Molecular Physiology of the Brain (F.V., N.B., and W.Z.), grants from the European Commission (EUSynapse, LSHMCT-2005-019055; N.B.), (NEUREST, MEST-CT-2004-504193; M.H.), the Cure Autism Now Foundation (F.V.), and the Medical Research Council (G0500833, G0501258 and G0800498; K.H., R.J.H.).	Betz A, 1997, J BIOL CHEM, V272, P2520; Blundell J, 2009, GENES BRAIN BEHAV, V8, P114, DOI 10.1111/j.1601-183X.2008.00455.x; Brose N, 2009, NEURON, V61, P650, DOI 10.1016/j.neuron.2009.02.014; Budreck EC, 2007, EUR J NEUROSCI, V26, P1738, DOI 10.1111/j.1460-9568.2007.05842.x; Chih B, 2005, SCIENCE, V307, P1324, DOI 10.1126/science.1107470; Chih B, 2006, NEURON, V51, P171, DOI 10.1016/j.neuron.2006.06.005; Chubykin AA, 2007, NEURON, V54, P919, DOI 10.1016/j.neuron.2007.05.029; Comoletti D, 2006, BIOCHEMISTRY-US, V45, P12816, DOI 10.1021/bi0614131; Connolly CN, 1996, J BIOL CHEM, V271, P89, DOI 10.1074/jbc.271.1.89; Craig AM, 2007, CURR OPIN NEUROBIOL, V17, P43, DOI 10.1016/j.conb.2007.01.011; Dean C, 2003, NAT NEUROSCI, V6, P708, DOI 10.1038/nn1074; Dong N, 2007, MOL CELL NEUROSCI, V35, P14, DOI 10.1016/j.mcn.2007.01.013; Essrich C, 1998, NAT NEUROSCI, V1, P563, DOI 10.1038/2798; Feng GP, 1998, SCIENCE, V282, P1321, DOI 10.1126/science.282.5392.1321; Fritschy JM, 2008, TRENDS NEUROSCI, V31, P257, DOI 10.1016/j.tins.2008.02.006; Graf ER, 2004, CELL, V119, P1013, DOI 10.1016/j.cell.2004.11.035; Harvey K, 2004, J NEUROSCI, V24, P5816, DOI 10.1523/JNEUROSCI.1184-04.2004; Hirao K, 1998, J BIOL CHEM, V273, P21105, DOI 10.1074/jbc.273.33.21105; Hoon M, 2009, J NEUROSCI, V29, P8039, DOI 10.1523/JNEUROSCI.0534-09.2009; Ichtchenko K, 1996, J BIOL CHEM, V271, P2676, DOI 10.1074/jbc.271.5.2676; ICHTCHENKO K, 1995, CELL, V81, P435, DOI 10.1016/0092-8674(95)90396-8; Irie M, 1997, SCIENCE, V277, P1511, DOI 10.1126/science.277.5331.1511; Jamain S, 2008, P NATL ACAD SCI USA, V105, P1710, DOI 10.1073/pnas.0711555105; Kalscheuer VM, 2009, HUM MUTAT, V30, P61, DOI 10.1002/humu.20814; Kang YH, 2008, J BIOL CHEM, V283, P2323, DOI 10.1074/jbc.M703957200; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; Kins S, 2000, NAT NEUROSCI, V3, P22, DOI 10.1038/71096; KIRSCH J, 1993, NATURE, V366, P745, DOI 10.1038/366745a0; Kneussel M, 1999, J NEUROSCI, V19, P9289, DOI 10.1523/jneurosci.19-21-09289.1999; Kneussel M, 2001, EUR J NEUROSCI, V13, P487, DOI 10.1046/j.0953-816x.2000.01411.x; Leonard AS, 1998, J BIOL CHEM, V273, P19518, DOI 10.1074/jbc.273.31.19518; Levinson JN, 2005, J BIOL CHEM, V280, P17312, DOI 10.1074/jbc.M413812200; Linhoff MW, 2009, NEURON, V61, P734, DOI 10.1016/j.neuron.2009.01.017; Low K, 2000, SCIENCE, V290, P131, DOI 10.1126/science.290.5489.131; Meyer G, 2004, NEUROPHARMACOLOGY, V47, P724, DOI 10.1016/j.neuropharm.2004.06.023; MEYER G, 1995, NEURON, V15, P563, DOI 10.1016/0896-6273(95)90145-0; Miles R, 1996, NEURON, V16, P815, DOI 10.1016/S0896-6273(00)80101-4; Moss SJ, 2001, NAT REV NEUROSCI, V2, P240, DOI 10.1038/35067500; Nusser Z, 1996, P NATL ACAD SCI USA, V93, P11939, DOI 10.1073/pnas.93.21.11939; Papadopoulos T, 2008, MOL CELL NEUROSCI, V39, P161, DOI 10.1016/j.mcn.2008.06.006; Papadopoulos T, 2007, EMBO J, V26, P3888, DOI 10.1038/sj.emboj.7601819; PRIOR P, 1992, NEURON, V8, P1161, DOI 10.1016/0896-6273(92)90136-2; Richter DW, 2001, TRENDS NEUROSCI, V24, P464, DOI 10.1016/S0166-2236(00)01867-1; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Sola M, 2004, EMBO J, V23, P2510, DOI 10.1038/sj.emboj.7600256; Song JY, 1999, P NATL ACAD SCI USA, V96, P1100, DOI 10.1073/pnas.96.3.1100; Tretter V, 2008, J NEUROSCI, V28, P1356, DOI 10.1523/JNEUROSCI.5050-07.2008; ULLRICH B, 1995, NEURON, V14, P497, DOI 10.1016/0896-6273(95)90306-2; USHKARYOV YA, 1992, SCIENCE, V257, P50, DOI 10.1126/science.1621094; USHKARYOV YA, 1994, J BIOL CHEM, V269, P11987; Varoqueaux F, 2004, EUR J CELL BIOL, V83, P449, DOI 10.1078/0171-9335-00410; Varoqueaux F, 2006, NEURON, V51, P741, DOI 10.1016/j.neuron.2006.09.003; Yamagata M, 2003, CURR OPIN CELL BIOL, V15, P621, DOI 10.1016/S0955-0674(03)00107-8	53	329	339	1	24	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	SEP 10	2009	63	5					628	642		10.1016/j.neuron.2009.08.023	http://dx.doi.org/10.1016/j.neuron.2009.08.023			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	494XH	19755106	Bronze			2022-12-24	WOS:000269852300010
J	McGuire, LMM; Sabes, PN				McGuire, Leah M. M.; Sabes, Philip N.			Sensory transformations and the use of multiple reference frames for reach planning	NATURE NEUROSCIENCE			English	Article							DIRECT VISUOMOTOR TRANSFORMATIONS; POSTERIOR PARIETAL CORTEX; 3-DIMENSIONAL SPACE; PREMOTOR CORTEX; LIMB MOVEMENT; EYE-POSITION; VISUAL SPACE; REPRESENTATIONS; INFORMATION; TARGETS	The sensory signals that drive movement planning arrive in a variety of 'reference frames', and integrating or comparing them requires sensory transformations. We propose a model in which the statistical properties of sensory signals and their transformations determine how these signals are used. This model incorporates the patterns of gaze-dependent errors that we found in our human psychophysics experiment when the sensory signals available for reach planning were varied. These results challenge the widely held ideas that error patterns directly reflect the reference frame of the underlying neural representation and that it is preferable to use a single common reference frame for movement planning. We found that gaze-dependent error patterns, often cited as evidence for retinotopic reach planning, can be explained by a transformation bias and are not exclusively linked to retinotopic representations. Furthermore, the presence of multiple reference frames allows for optimal use of available sensory information and explains task-dependent reweighting of sensory signals.	[Sabes, Philip N.] Univ Calif San Francisco, Dept Physiol, WM Keck Ctr Integrat Neurosci, San Francisco, CA 94143 USA; Univ Calif San Francisco, Grad Program Neurosci, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Sabes, PN (corresponding author), Univ Calif San Francisco, Dept Physiol, WM Keck Ctr Integrat Neurosci, San Francisco, CA 94143 USA.	sabes@phy.ucsf.edu			National Eye Institute [R01 EY-015679]; National Institute of Mental Health [P50 MH77970]; McKnight Endowment Fund for Neuroscience; National Science Foundation; NATIONAL EYE INSTITUTE [R01EY015679] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH077970] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); McKnight Endowment Fund for Neuroscience; National Science Foundation(National Science Foundation (NSF)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We would like to thank S. M. Beurze, S. van Pelt, W. P. Medendorp and S. J. Sober for generously providing their data for model comparison. This work was supported by the National Eye Institute (R01 EY-015679), the National Institute of Mental Health (P50 MH77970) and the McKnight Endowment Fund for Neuroscience. L. M. M. M. was supported by a graduate fellowship from the National Science Foundation.	Ahmed AA, 2008, CURR BIOL, V18, P763, DOI 10.1016/j.cub.2008.04.061; Avillac M, 2005, NAT NEUROSCI, V8, P941, DOI 10.1038/nn1480; Balslev D, 2008, J NEUROSCI, V28, P8968, DOI 10.1523/JNEUROSCI.1513-08.2008; Batista AP, 2007, J NEUROPHYSIOL, V98, P966, DOI 10.1152/jn.00421.2006; Batista AP, 1999, SCIENCE, V285, P257, DOI 10.1126/science.285.5425.257; Battaglia-Mayer A, 2003, CEREB CORTEX, V13, P1009, DOI 10.1093/cercor/13.10.1009; Battaglia-Mayer A, 2001, CEREB CORTEX, V11, P528, DOI 10.1093/cercor/11.6.528; Beurze SM, 2006, J NEUROPHYSIOL, V96, P352, DOI 10.1152/jn.01362.2005; Blohm G, 2007, J VISION, V7, DOI 10.1167/7.5.4; BOCK O, 1986, EXP BRAIN RES, V64, P476, DOI 10.1007/BF00340484; Buneo CA, 2002, NATURE, V416, P632, DOI 10.1038/416632a; Buneo CA, 2006, NEUROPSYCHOLOGIA, V44, P2594, DOI 10.1016/j.neuropsychologia.2005.10.011; Burnod Y, 1999, EXP BRAIN RES, V129, P325, DOI 10.1007/s002210050902; Caminiti R, 1998, CURR OPIN NEUROBIOL, V8, P753, DOI 10.1016/S0959-4388(98)80118-9; CARROZZO M, 1994, NEUROREPORT, V5, P453, DOI 10.1097/00001756-199401120-00021; Carrozzo M, 1999, EXP BRAIN RES, V129, P201, DOI 10.1007/s002210050890; Cohen YE, 2002, NAT REV NEUROSCI, V3, P553, DOI 10.1038/nrn873; Cohen YE, 2000, NEURON, V27, P647, DOI 10.1016/S0896-6273(00)00073-8; Engel KC, 2002, ARCH ITAL BIOL, V140, P211; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Good P, 2000, PERMUTATION TESTS PR; Helbig HB, 2007, EXP BRAIN RES, V179, P595, DOI 10.1007/s00221-006-0814-y; Henriques DYP, 1998, J NEUROSCI, V18, P1583; Henriques DYP, 2002, J NEUROPHYSIOL, V87, P1677, DOI 10.1152/jn.00509.2001; Henriques DYP, 2000, EXP BRAIN RES, V132, P179, DOI 10.1007/s002210000340; Kluzik J, 2008, J NEUROPHYSIOL, V100, P1455, DOI 10.1152/jn.90334.2008; Knill DC, 2004, TRENDS NEUROSCI, V27, P712, DOI 10.1016/j.tins.2004.10.007; Kording Konrad P, 2006, Novartis Found Symp, V270, P191; KORDING KP, 2006, NIPS, P737; Lacquaniti F, 1998, EUR J NEUROSCI, V10, P195; LACQUANITI F, 1995, CEREB CORTEX, V5, P391, DOI 10.1093/cercor/5.5.391; Land MF, 2001, VISION RES, V41, P3559, DOI 10.1016/S0042-6989(01)00102-X; Lewald J, 2000, VISION RES, V40, P539, DOI 10.1016/S0042-6989(99)00197-2; McIntyre J, 1998, J NEUROSCI, V18, P8423, DOI 10.1523/JNEUROSCI.18-20-08423.1998; McIntyre J, 1997, J NEUROPHYSIOL, V78, P1601, DOI 10.1152/jn.1997.78.3.1601; Medendorp WP, 2003, J NEUROSCI, V23, P6209; Mullette-Gillman OA, 2005, J NEUROPHYSIOL, V94, P2331, DOI 10.1152/jn.00021.2005; Pesaran B, 2006, NEURON, V51, P125, DOI 10.1016/j.neuron.2006.05.025; Pouget A, 2002, COGNITION, V83, pB1, DOI 10.1016/S0010-0277(01)00163-9; Schlicht EJ, 2007, J NEUROPHYSIOL, V97, P4203, DOI 10.1152/jn.00160.2007; Sober SJ, 2005, NAT NEUROSCI, V8, P490, DOI 10.1038/nn1427; SOECHTING JF, 1989, J NEUROPHYSIOL, V62, P582, DOI 10.1152/jn.1989.62.2.582; SOECHTING JF, 1989, J NEUROPHYSIOL, V62, P595, DOI 10.1152/jn.1989.62.2.595; van Beers RJ, 1999, J NEUROPHYSIOL, V81, P1355, DOI 10.1152/jn.1999.81.3.1355; van Beers RJ, 1998, EXP BRAIN RES, V122, P367, DOI 10.1007/s002210050525; Van Pelt S, 2008, J NEUROPHYSIOL, V99, P2281, DOI 10.1152/jn.01281.2007; Vindras P, 1998, J NEUROPHYSIOL, V79, P3290, DOI 10.1152/jn.1998.79.6.3290; Wu W, 2007, EXP BRAIN RES, V176, P652, DOI 10.1007/s00221-006-0818-7; Wu W, 2006, EXP BRAIN RES, V175, P197, DOI 10.1007/s00221-006-0556-x; Yuille AL, 1996, PERCEPTION BAYESIAN, P123, DOI DOI 10.1017/CBO9780511984037.006	50	151	153	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2009	12	8					1056	U134		10.1038/nn.2357	http://dx.doi.org/10.1038/nn.2357			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	475WS	19597495	Green Accepted, Green Submitted			2022-12-24	WOS:000268396300021
J	Varga, C; Lee, SY; Soltesz, I				Varga, Csaba; Lee, Soo Yeun; Soltesz, Ivan			Target-selective GABAergic control of entorhinal cortex output	NATURE NEUROSCIENCE			English	Article							RAT; HIPPOCAMPUS; CELLS	The medial entorhinal cortex (MEC) is a major center for spatial navigation and memory. We found that cannabinoid type 1 receptor-expressing GABAergic basket cells selectively innervated principal cells in layer II of the rat MEC that projected outside the hippocampus but avoided neighboring cells that give rise to the perforant pathway to the dentate gyrus. These results indicate that the organization of GABAergic microcircuits reflects the long-distance axonal targets of principal neurons.	[Varga, Csaba; Lee, Soo Yeun; Soltesz, Ivan] Univ Calif Irvine, Dept Anat & Neurobiol, Irvine, CA 92717 USA	University of California System; University of California Irvine	Varga, C (corresponding author), Univ Calif Irvine, Dept Anat & Neurobiol, Irvine, CA 92717 USA.	cvarga@uci.edu		Varga, Csaba/0000-0002-9188-1282	US National Institutes of Health [NS35915]; American Epilepsy Society; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R29NS035915, R01NS035915, R37NS035915] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Epilepsy Society; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank R. Zhu and M. Cid for technical assistance and I. Sears-Kraxberger and H.S. Keirstead for their generous support with electron microscopy. This work was supported by the US National Institutes of Health grant NS35915 (I.S.) and the American Epilepsy Society (S.Y.L.).	Adelmann G, 1996, ANAT EMBRYOL, V193, P481; Bodor AL, 2005, J NEUROSCI, V25, P6845, DOI 10.1523/JNEUROSCI.0442-05.2005; Brown SP, 2009, NATURE, V457, P1133, DOI 10.1038/nature07658; Chin J, 2007, J NEUROSCI, V27, P2727, DOI 10.1523/JNEUROSCI.3758-06.2007; Deng PY, 2009, NEURON, V63, P230, DOI 10.1016/j.neuron.2009.06.022; Freund TF, 2007, NEURON, V56, P33, DOI 10.1016/j.neuron.2007.09.012; Fujimaru Y, 1996, NEUROSCI RES, V24, P329, DOI 10.1016/0168-0102(95)01008-4; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Jinno S, 2007, J NEUROSCI, V27, P8790, DOI 10.1523/JNEUROSCI.1847-07.2007; Kano M, 2009, PHYSIOL REV, V89, P309, DOI 10.1152/physrev.00019.2008; Mizuseki K, 2009, NEURON, V64, P267, DOI 10.1016/j.neuron.2009.08.037; Solstad T, 2008, SCIENCE, V322, P1865, DOI 10.1126/science.1166466; Somogyi J, 2004, EUR J NEUROSCI, V19, P552, DOI 10.1111/j.0953-816X.2003.03091.x; STEWARD O, 1976, J COMP NEUROL, V169, P347, DOI 10.1002/cne.901690306; van Strien NM, 2009, NAT REV NEUROSCI, V10, P272, DOI 10.1038/nrn2614	15	143	144	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2010	13	7					822	824		10.1038/nn.2570	http://dx.doi.org/10.1038/nn.2570			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	615YF	20512133	Green Submitted, Green Accepted			2022-12-24	WOS:000279173900013
J	Grandl, J; Kim, SE; Uzzell, V; Bursulaya, B; Petrus, M; Bandell, M; Patapoutian, A				Grandl, Joerg; Kim, Sung Eun; Uzzell, Valerie; Bursulaya, Badry; Petrus, Matt; Bandell, Michael; Patapoutian, Ardem			Temperature-induced opening of TRPV1 ion channel is stabilized by the pore domain	NATURE NEUROSCIENCE			English	Article							CAPSAICIN RECEPTOR; HEAT ACTIVATION; COLD RECEPTOR; THERMOSENSATION; VOLTAGE; SENSITIVITY; SENSATION; STIMULI; THERMODYNAMICS; REVEALS	TRPV1 is the founding and best-studied member of the family of temperature-activated transient receptor potential ion channels (thermoTRPs). Voltage, chemicals and heat allosterically gate TRPV1. Molecular determinants of TRPV1 activation by capsaicin, allicin, acid, ammonia and voltage have been identified. However, the structures and mechanisms mediating TRPV1's pronounced temperature sensitivity remain unclear. Recent studies of the related channel TRPV3 identified residues in the pore region that are required for heat activation. We used both random and targeted mutagenesis screens of rat TRPV1 and identified point mutations in the outer pore region that specifically impair temperature activation. Single-channel analysis indicated that TRPV1 mutations disrupted heat sensitivity by ablating long channel openings, which are part of the temperature-gating pathway. We propose that sequential occupancy of short and long open states on activation provides a mechanism for enhancing temperature sensitivity. Our results suggest that the outer pore is important for the heat sensitivity of thermoTRPs.	[Grandl, Joerg; Kim, Sung Eun; Uzzell, Valerie; Patapoutian, Ardem] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; [Bursulaya, Badry; Petrus, Matt; Bandell, Michael; Patapoutian, Ardem] Novartis Res Fdn, Genom Inst, San Diego, CA USA	Scripps Research Institute; Novartis	Patapoutian, A (corresponding author), Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA.	apatapou@gnf.org	KIM, SUNG EUN/E-4918-2011	Grandl, Jorg/0000-0001-7179-7609	US National Institutes of Health; Novartis Research Foundation; American Heart Association; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046303] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Novartis Research Foundation; American Heart Association(American Heart Association); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank A. Marelli and T. Orth for preparing mini-prep DNA, M. Caterina for providing rat TRPV1 plasmid DNA, and B. Coste for critical reading of the manuscript. This research was supported by the US National Institutes of Health, the Novartis Research Foundation and a fellowship to J.G. from the American Heart Association.	Ahern GP, 2005, J NEUROSCI, V25, P5109, DOI 10.1523/JNEUROSCI.0237-05.2005; Brauchi S, 2006, J NEUROSCI, V26, P4835, DOI 10.1523/JNEUROSCI.5080-05.2006; Brauchi S, 2004, P NATL ACAD SCI USA, V101, P15494, DOI 10.1073/pnas.0406773101; Brauchi S, 2007, P NATL ACAD SCI USA, V104, P10246, DOI 10.1073/pnas.0703420104; Caterina MJ, 2007, AM J PHYSIOL-REG I, V292, pR64, DOI 10.1152/ajpregu.00446.2006; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Davis JB, 2000, NATURE, V405, P183, DOI 10.1038/35012076; Dhaka A, 2006, ANNU REV NEUROSCI, V29, P135, DOI 10.1146/annurev.neuro.29.051605.112958; Dhaka A, 2009, J NEUROSCI, V29, P153, DOI 10.1523/JNEUROSCI.4901-08.2009; Gavva NR, 2004, J BIOL CHEM, V279, P20283, DOI 10.1074/jbc.M312577200; Grandl J, 2008, NAT NEUROSCI, V11, P1007, DOI 10.1038/nn.2169; Guler AD, 2002, J NEUROSCI, V22, P6408; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Hui KK, 2003, BIOPHYS J, V84, P2957, DOI 10.1016/S0006-3495(03)70022-8; Jordt SE, 2000, P NATL ACAD SCI USA, V97, P8134, DOI 10.1073/pnas.100129497; Jordt SE, 2002, CELL, V108, P421, DOI 10.1016/S0092-8674(02)00637-2; Kern D, 2003, CURR OPIN STRUC BIOL, V13, P748, DOI 10.1016/j.sbi.2003.10.008; Latorre R, 2007, CELL CALCIUM, V42, P427, DOI 10.1016/j.ceca.2007.04.004; Liu BY, 2003, BIOPHYS J, V85, P2988, DOI 10.1016/S0006-3495(03)74719-5; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Matta JA, 2007, J PHYSIOL-LONDON, V585, P469, DOI 10.1113/jphysiol.2007.144287; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Myers BR, 2008, NEURON, V58, P362, DOI 10.1016/j.neuron.2008.04.012; Nilius B, 2005, J PHYSIOL-LONDON, V567, P35, DOI 10.1113/jphysiol.2005.088377; Peier AM, 2002, SCIENCE, V296, P2046, DOI 10.1126/science.1073140; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Premkumar LS, 2002, J PHYSIOL-LONDON, V545, P107, DOI 10.1113/jphysiol.2002.016352; Ryu SJ, 2007, J NEUROSCI, V27, P12797, DOI 10.1523/JNEUROSCI.2324-07.2007; Salazar H, 2008, NAT NEUROSCI, V11, P255, DOI 10.1038/nn2056; Smith GD, 2002, NATURE, V418, P186, DOI 10.1038/nature00894; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Talavera K, 2005, NATURE, V438, P1022, DOI 10.1038/nature04248; Talavera K, 2008, TRENDS NEUROSCI, V31, P287, DOI 10.1016/j.tins.2008.03.002; Togashi K, 2006, EMBO J, V25, P1804, DOI 10.1038/sj.emboj.7601083; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; Voets T, 2004, NATURE, V430, P748, DOI 10.1038/nature02732; Voets T, 2007, NAT CHEM BIOL, V3, P174, DOI 10.1038/nchembio862; Xu HX, 2002, NATURE, V418, P181, DOI 10.1038/nature00882; Yang F, 2010, P NATL ACAD SCI USA, V107, P7083, DOI 10.1073/pnas.1000357107	40	148	149	3	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2010	13	6					708	714		10.1038/nn.2552	http://dx.doi.org/10.1038/nn.2552			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	600QY	20414199	Green Accepted			2022-12-24	WOS:000278003300015
J	Remme, MWH; Lengyel, M; Gutkin, BS				Remme, Michiel W. H.; Lengyel, Mate; Gutkin, Boris S.			Democracy-Independence Trade-Off in Oscillating Dendrites and Its Implications for Grid Cells	NEURON			English	Article							MEDIAL ENTORHINAL CORTEX; MEMBRANE-POTENTIAL OSCILLATIONS; CA1 PYRAMIDAL NEURONS; SUBTHRESHOLD OSCILLATIONS; LAYER-II; PATH-INTEGRATION; STELLATE CELLS; ONE BRANCH; IN-VITRO; MODEL	Dendritic democracy and independence have been characterized for near-instantaneous processing of synaptic inputs. However, a wide class of neuronal computations requires input integration on long timescales. As a paradigmatic example, entorhinal grid fields have been thought to be generated by the democratic summation of independent dendritic oscillations performing direction-selective path integration. We analyzed how multiple dendritic oscillators embedded in the same neuron integrate inputs separately and determine somatic membrane voltage jointly. We found that the interaction of dendritic oscillations leads to phase locking, which sets an upper limit on the timescale for independent input integration. Factors that increase this timescale also decrease the influence that the dendritic oscillations exert on somatic voltage. In entorhinal stellate cells, interdendritic coupling dominates and causes these cells to act as single oscillators. Our results suggest a fundamental trade-off between local and global processing in dendritic trees integrating ongoing signals.	[Remme, Michiel W. H.; Gutkin, Boris S.] Ecole Normale Super, Dept Etud Cognit, Grp Neural Theory, F-75005 Paris, France; [Lengyel, Mate] Univ Cambridge, Dept Engn, Computat & Biol Learning Lab, Cambridge CB2 1PZ, England	UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); University of Cambridge	Remme, MWH (corresponding author), Ecole Normale Super, Dept Etud Cognit, Grp Neural Theory, 29 Rue Ulm, F-75005 Paris, France.	michiel.remme@nyu.edu	Gutkin, Boris/ABC-5754-2020; Lengyel, Mate/A-6665-2013; Gutkin, Boris/A-7420-2014	Gutkin, Boris/0000-0001-6409-979X; Lengyel, Mate/0000-0001-7266-0049; Remme, Michiel/0000-0003-0400-6074	Marie Curie Team of Excellence [BIND MEXT-CT-2005-024831]; Gatsby Charitable Foundation; Alliance France-UK collaborative grant; IST European consortium; Wellcome Trust; CNRS	Marie Curie Team of Excellence(European Commission); Gatsby Charitable Foundation; Alliance France-UK collaborative grant; IST European consortium; Wellcome Trust(Wellcome Trust); CNRS(Centre National de la Recherche Scientifique (CNRS))	This work was supported by a Marie Curie Team of Excellence Grant (BIND MEXT-CT-2005-024831) (M.W.H.R., B.S.G.), the Gatsby Charitable Foundation (M.L.), an Alliance France-UK collaborative grant (M.W.H.R., ML., and B.S.G.), the CNRS (B.S.G.), the IST European consortium project BACS (B.S.G.), and the Wellcome Trust (M.L.).	ALONSO A, 1989, NATURE, V342, P175, DOI 10.1038/342175a0; ALONSO A, 1993, J NEUROPHYSIOL, V70, P128, DOI 10.1152/jn.1993.70.1.128; Burgess N, 2007, HIPPOCAMPUS, V17, P801, DOI 10.1002/hipo.20327; CARNEVALE NT, 1982, J NEUROPHYSIOL, V47, P606, DOI 10.1152/jn.1982.47.4.606; Chapman CA, 1999, J NEUROPHYSIOL, V81, P1296, DOI 10.1152/jn.1999.81.3.1296; DEFELIPE J, 1992, PROG NEUROBIOL, V39, P563, DOI 10.1016/0301-0082(92)90015-7; Dickson CT, 2000, J NEUROPHYSIOL, V83, P2562, DOI 10.1152/jn.2000.83.5.2562; Fransen E, 2004, HIPPOCAMPUS, V14, P368, DOI 10.1002/hipo.10198; Fuhs MC, 2006, J NEUROSCI, V26, P4266, DOI 10.1523/JNEUROSCI.4353-05.2006; Fyhn M, 2007, NATURE, V446, P190, DOI 10.1038/nature05601; Gasparini S, 2004, J NEUROSCI, V24, P11046, DOI 10.1523/JNEUROSCI.2520-04.2004; Giocomo LM, 2007, SCIENCE, V315, P1719, DOI 10.1126/science.1139207; Goldberg JA, 2007, J NEUROPHYSIOL, V97, P208, DOI 10.1152/jn.00810.2006; Golding NL, 1998, NEURON, V21, P1189, DOI 10.1016/S0896-6273(00)80635-2; GUTFREUND Y, 1995, J PHYSIOL-LONDON, V483, P621, DOI 10.1113/jphysiol.1995.sp020611; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Hasselmo ME, 2007, HIPPOCAMPUS, V17, P1252, DOI 10.1002/hipo.20374; Hasselmo ME, 2007, LEARN MEMORY, V14, P782, DOI 10.1101/lm.686607; Hausser M, 2001, CURR BIOL, V11, pR10, DOI 10.1016/S0960-9822(00)00034-8; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; Huhn Z, 2005, HIPPOCAMPUS, V15, P950, DOI 10.1002/hipo.20112; Izhikevich E., 2007, DYNAMICAL SYSTEMS NE; Klink R, 1997, HIPPOCAMPUS, V7, P571; Kropff E, 2008, HIPPOCAMPUS, V18, P1256, DOI 10.1002/hipo.20520; Larkum ME, 2009, SCIENCE, V325, P756, DOI 10.1126/science.1171958; Lengyel M, 2003, HIPPOCAMPUS, V13, P700, DOI 10.1002/hipo.10116; LEUNG LWS, 1991, BRAIN RES, V553, P261, DOI 10.1016/0006-8993(91)90834-I; London M, 2001, NAT NEUROSCI, V4, P853, DOI 10.1038/nn0901-853; Losonczy A, 2006, NEURON, V50, P291, DOI 10.1016/j.neuron.2006.03.016; McCulloch Warren S., 1943, BULL MATH BIOPHYS, V5, P115, DOI 10.1007/BF02459570; McNaughton BL, 2006, NAT REV NEUROSCI, V7, P663, DOI 10.1038/nrn1932; Nevian T, 2007, NAT NEUROSCI, V10, P206, DOI 10.1038/nn1826; O'Keefe J, 2005, HIPPOCAMPUS, V15, P853, DOI 10.1002/hipo.20115; Pape HC, 1998, J NEUROPHYSIOL, V79, P205, DOI 10.1152/jn.1998.79.1.205; Poirazi P, 2003, NEURON, V37, P989, DOI 10.1016/S0896-6273(03)00149-1; Polsky A, 2004, NAT NEUROSCI, V7, P621, DOI 10.1038/nn1253; RALL W, 1973, BIOPHYS J, V13, P648, DOI 10.1016/S0006-3495(73)86014-X; Remme MWH, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000493; RINZEL J, 1974, BIOPHYS J, V14, P759, DOI 10.1016/S0006-3495(74)85948-5; ROSENBLATT F, 1958, PSYCHOL REV, V65, P386, DOI 10.1037/h0042519; Rotstein HG, 2006, J COMPUT NEUROSCI, V21, P271, DOI 10.1007/s10827-006-8096-8; Rudolph M, 2003, J NEUROSCI, V23, P2466; Rumelhart D., 1986, PARALLEL DISTRIBUTED; Sanhueza M, 2005, EUR J NEUROSCI, V22, P1618, DOI 10.1111/j.1460-9568.2005.04341.x; Sargolini F, 2006, SCIENCE, V312, P758, DOI 10.1126/science.1125572; Stuart G, 2007, DENDRITES; Wei DS, 2001, SCIENCE, V293, P2272, DOI 10.1126/science.1061198; WHITE JA, 1995, BIOPHYS J, V69, P1203, DOI 10.1016/S0006-3495(95)79995-7	49	44	43	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	MAY 13	2010	66	3					429	437		10.1016/j.neuron.2010.04.027	http://dx.doi.org/10.1016/j.neuron.2010.04.027			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	598HE	20471355	Green Published, hybrid			2022-12-24	WOS:000277825200011
J	Fasano, CA; Chambers, SM; Lee, G; Tomishima, MJ; Studer, L				Fasano, Christopher A.; Chambers, Stuart M.; Lee, Gabsang; Tomishima, Mark J.; Studer, Lorenz			Efficient Derivation of Functional Floor Plate Tissue from Human Embryonic Stem Cells	CELL STEM CELL			English	Article							SONIC HEDGEHOG; DIRECTED DIFFERENTIATION; SELF-RENEWAL; DOPAMINE NEURONS; MOTOR-NEURONS; SPINAL-CORD; HUMAN ES; MOUSE; INDUCTION; SPECIFICATION	The floor plate (FP) is a critical signaling center during neural development located along the ventral midline of the embryo. Little is known about human FP development because of the lack of tissue accessibility. Here we report the efficient derivation of human embryonic stem cell (hESC)-derived FP tissue capable of secreting Netrin-1 and SHH and patterning primary and hESC derived tissues. FP induction in hESCs is dependent on early SHH exposure and occurs at the expense of anterior neurectoderm (AN). Global gene expression and functional studies identify SHH-mediated inhibition of Dkk-1 as key factor in FP versus AN specification. hESC-derived FP tissue is shown to be of anterior SIX6+ character but is responsive to caudalizing factors suppressing SIX6 expression and inducing a shift in usage of region-specific SHH enhancers. These data define the early signals that drive human FP versus AN specification and determine regional identity in hESC-derived FP.	[Fasano, Christopher A.; Chambers, Stuart M.; Lee, Gabsang; Studer, Lorenz] Sloan Kettering Inst, Dev Biol Program, New York, NY 10065 USA; [Tomishima, Mark J.] Sloan Kettering Inst, SKI Stem Cell Res Facil, New York, NY 10065 USA; [Studer, Lorenz] Sloan Kettering Inst, Dept Neurosurg, New York, NY 10065 USA; [Fasano, Christopher A.] New York Neural Stem Cell Inst, Rensselaer, NY 12144 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Fasano, CA (corresponding author), Sloan Kettering Inst, Dev Biol Program, 1275 York Ave, New York, NY 10065 USA.		Studer, Lorenz/ABH-1491-2021	Studer, Lorenz/0000-0003-0741-7987	New York Stem Cell Foundation; NINDS/NIH [NS052671]; Starr Foundation; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052671] Funding Source: NIH RePORTER	New York Stem Cell Foundation; NINDS/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Starr Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Marysia Plazcek for advice on Floor Plate markers, Doug Epstein for providing the Sonic Enhancers, and Sally Temple for critical reading of the manuscript We also thank Agnete Kirkeby for providing data on Sonic C25II C A F is supported by the New York Stem Cell Foundation, S A C is Starr Stem Cell Scholar, M J T is supported in part by the Starr Foundation. and the work is supported in part through grant NS052671 from NINDS/NIH and grant support to L S from the Starr Foundation C A F designed and performed all experiments, interpreted the data, and wrote the manuscript S M C helped with design and experiments for the microarray study and performed all array analysis G L helped with floor plate functional studies M T was instrumental in the conception of the project and helped with experimental design and data interpretations L S supervised design and execution of the entire study, helped with data interpretations and analysis, and writing of manuscript	Barberi T, 2003, NAT BIOTECHNOL, V21, P1200, DOI 10.1038/nbt870; Briscoe J, 1999, SEMIN CELL DEV BIOL, V10, P353, DOI 10.1006/scdb.1999.0295; Burns CJ, 2008, DEV DYNAM, V237, P1614, DOI 10.1002/dvdy.21565; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Charrier JB, 2002, DEVELOPMENT, V129, P4785; Charron F, 2003, CELL, V113, P11, DOI 10.1016/S0092-8674(03)00199-5; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; Dale K, 1999, DEVELOPMENT, V126, P397; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Eiraku M, 2008, CELL STEM CELL, V3, P519, DOI 10.1016/j.stem.2008.09.002; Elkabetz Y, 2008, GENE DEV, V22, P152, DOI 10.1101/gad.1616208; Ericson J, 1996, CELL, V87, P661, DOI 10.1016/S0092-8674(00)81386-0; Fasano CA, 2007, CELL STEM CELL, V1, P87, DOI 10.1016/j.stem.2007.04.001; Fasano CA, 2009, GENE DEV, V23, P561, DOI 10.1101/gad.1743709; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; HUNTER K, 1991, P NATL ACAD SCI USA, V88, P3666, DOI 10.1073/pnas.88.9.3666; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Jeong Y, 2003, DEVELOPMENT, V130, P3891, DOI 10.1242/dev.00590; Jeong Y, 2008, NAT GENET, V40, P1348, DOI 10.1038/ng.230; Jeong YS, 2006, DEVELOPMENT, V133, P761, DOI 10.1242/dev.02239; JESSELL TM, 1989, CIBA F SYMP, V144, P255; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; JESSELL TM, 1989, CIBA F SYMP, V144, P290; JESSELL TM, 1989, CIBA F SYMP, V144, P276; Joksimovic M, 2009, NAT NEUROSCI, V12, P125, DOI 10.1038/nn.2243; Kapsimali M, 2004, DEVELOPMENT, V131, P5923, DOI 10.1242/dev.01453; Kim AS, 2001, MECH DEVELOP, V103, P167, DOI 10.1016/S0925-4773(01)00342-2; Kimura-Yoshida C, 2007, P NATL ACAD SCI USA, V104, P5919, DOI 10.1073/pnas.0607779104; Kittappa R, 2007, PLOS BIOL, V5, P2875, DOI 10.1371/journal.pbio.0050325; Li XJ, 2008, STEM CELLS, V26, P886, DOI 10.1634/stemcells.2007-0620; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; LYUKSYUTOVA AI, 1998, DEVELOPMENT, V125, P2759; Matise MP, 1998, DEVELOPMENT, V125, P2759; Mizuseki K, 2003, P NATL ACAD SCI USA, V100, P5828, DOI 10.1073/pnas.1037282100; Mukhopadhyay M, 2001, DEV CELL, V1, P423, DOI 10.1016/S1534-5807(01)00041-7; Mullor JL, 2002, TRENDS CELL BIOL, V12, P562, DOI 10.1016/S0962-8924(02)02405-4; Ono Y, 2007, DEVELOPMENT, V134, P3213, DOI 10.1242/dev.02879; Patten I, 2003, DEVELOPMENT, V130, P4809, DOI 10.1242/dev.00694; Perrier AL, 2004, P NATL ACAD SCI USA, V101, P12543, DOI 10.1073/pnas.0404700101; Placzek M, 2005, NAT REV NEUROSCI, V6, P230, DOI 10.1038/nrn1628; PLACZEK M, 1993, DEVELOPMENT, V117, P205; PLACZEK M, 1995, CURR OPIN GENET DEV, V5, P499, DOI 10.1016/0959-437X(95)90055-L; ROELINK H, 1994, CELL, V76, P761, DOI 10.1016/0092-8674(94)90514-2; Shen Q, 2006, NAT NEUROSCI, V9, P743, DOI 10.1038/nn1694; SHIRASAKI R, 1995, NEURON, V14, P961, DOI 10.1016/0896-6273(95)90334-8; Venezia TA, 2004, PLOS BIOL, V2, P1640, DOI 10.1371/journal.pbio.0020301; Watanabe K, 2005, NAT NEUROSCI, V8, P288, DOI 10.1038/nn1402; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; Zoltewicz JS, 1999, DEVELOPMENT, V126, P5085	49	167	181	1	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	APR 2	2010	6	4					336	347		10.1016/j.stem.2010.03.001	http://dx.doi.org/10.1016/j.stem.2010.03.001			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	585KD	20362538	Green Accepted, Bronze			2022-12-24	WOS:000276823300012
J	Liu, LP; Belkadi, A; Darnall, L; Hu, TF; Drescher, C; Cotleur, AC; Padovani-Claudio, D; He, T; Choi, K; Lane, TE; Miller, RH; Ransohoff, RM				Liu, LiPing; Belkadi, Abdelmadjid; Darnall, Lindsey; Hu, Taofang; Drescher, Caitlin; Cotleur, Anne C.; Padovani-Claudio, Dolly; He, Tao; Choi, Karen; Lane, Thomas E.; Miller, Robert H.; Ransohoff, Richard M.			CXCR2-positive neutrophils are essential for cuprizone-induced demyelination: relevance to multiple sclerosis	NATURE NEUROSCIENCE			English	Article							CENTRAL-NERVOUS-SYSTEM; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; BLOOD-BRAIN-BARRIER; INTERFERON-GAMMA; CHEMOKINE RECEPTORS; CNS DEMYELINATION; SPINAL-CORD; DISEASE; LESIONS; MICE	Multiple sclerosis is an inflammatory demyelinating disorder of the CNS. Recent studies have suggested diverse mechanisms as underlying demyelination, including a subset of lesions induced by an interaction between metabolic insult to oligodendrocytes and inflammatory mediators. For mice of susceptible strains, cuprizone feeding results in oligodendrocyte cell loss and demyelination of the corpus callosum. Remyelination ensues and has been extensively studied. Cuprizone-induced demyelination remains incompletely characterized. We found that mice lacking the type 2 CXC chemokine receptor (CXCR2) were relatively resistant to cuprizone-induced demyelination and that circulating CXCR2-positive neutrophils were important for cuprizone-induced demyelination. Our findings support a two-hit process of cuprizone-induced demyelination, supporting the idea that multiple sclerosis pathogenesis features extensive oligodendrocyte cell loss. These data suggest that cuprizone-induced demyelination is useful for modeling certain aspects of multiple sclerosis pathogenesis.	[Liu, LiPing; Darnall, Lindsey; Hu, Taofang; Drescher, Caitlin; Cotleur, Anne C.; He, Tao; Choi, Karen; Ransohoff, Richard M.] Cleveland Clin, Lerner Res Inst, Neuroinflammat Res Ctr, Dept Neurosci, Cleveland, OH 44106 USA; [Belkadi, Abdelmadjid; Padovani-Claudio, Dolly; Miller, Robert H.] Case Western Reserve Univ, Sch Med, Dept Neurosci, Ctr Stem Cells, Cleveland, OH 44106 USA; [Belkadi, Abdelmadjid; Padovani-Claudio, Dolly; Miller, Robert H.] Case Western Reserve Univ, Sch Med, Dept Neurosci, Ctr Regenerat Med, Cleveland, OH 44106 USA; [Lane, Thomas E.] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92717 USA	Cleveland Clinic Foundation; Case Western Reserve University; Case Western Reserve University; University of California System; University of California Irvine	Ransohoff, RM (corresponding author), Cleveland Clin, Lerner Res Inst, Neuroinflammat Res Ctr, Dept Neurosci, Cleveland, OH 44106 USA.	ransohr@ccf.org	liu, li/HGC-0900-2022		National Multiple Sclerosis Society [RG 3580]; US National Institutes of Health [NS32151, NS36674]; Myelin Repair Foundation; Nancy Davis Center Without Walls; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007250] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032151, R01NS036674, R37NS036674] Funding Source: NIH RePORTER	National Multiple Sclerosis Society(National Multiple Sclerosis Society); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Myelin Repair Foundation; Nancy Davis Center Without Walls; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank W. Stallcup for generously providing antibodies to PDGF receptor alpha and G. Kidd (Cleveland Clinic) for assistance with imaging. We thank G. Matsushima (University of North Carolina Chapel Hill) for helpful discussions regarding the cuprizone model. We thank X. Qu (Cleveland Clinic) for help with TUNEL staining. This research was supported by grants from the National Multiple Sclerosis Society (RG 3580 to R. M. R.), the US National Institutes of Health (NS32151 to R. M. R. and NS36674 to R. H. M.), the Myelin Repair Foundation (R. H. M.) and the Nancy Davis Center Without Walls (R. M. R.).	Aboul-Enein F, 2005, ACTA NEUROPATHOL, V109, P49, DOI 10.1007/s00401-004-0954-8; Armstrong RC, 2002, J NEUROSCI, V22, P8574; CACALANO G, 1994, SCIENCE, V265, P682, DOI 10.1126/science.8036519; Cammer W, 1999, J NEUROL SCI, V168, P116, DOI 10.1016/S0022-510X(99)00181-1; Cardona AE, 2008, BLOOD, V112, P256, DOI 10.1182/blood-2007-10-118497; Cardona AE, 2006, NAT NEUROSCI, V9, P917, DOI 10.1038/nn1715; Carlson T, 2008, J EXP MED, V205, P811, DOI 10.1084/jem.20072404; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; Chaturvedi RK, 2008, ANN NY ACAD SCI, V1147, P395, DOI 10.1196/annals.1427.027; Fuller ML, 2007, ANN NEUROL, V62, P288, DOI 10.1002/ana.21179; Gao X, 2000, MOL CELL NEUROSCI, V16, P338, DOI 10.1006/mcne.2000.0883; Glabinski AR, 1999, J NEUROVIROL, V5, P95, DOI 10.3109/13550289909029750; Iocca HA, 2008, J NEUROIMMUNOL, V194, P97, DOI 10.1016/j.jneuroim.2007.12.003; Jurevics H, 2002, J NEUROCHEM, V82, P126, DOI 10.1046/j.1471-4159.2002.00954.x; Kelchtermans H, 2008, TRENDS IMMUNOL, V29, P479, DOI 10.1016/j.it.2008.07.002; Kerstetter AE, 2009, EXP NEUROL, V220, P44, DOI 10.1016/j.expneurol.2009.07.010; Krakowski M, 1996, EUR J IMMUNOL, V26, P1641, DOI 10.1002/eji.1830260735; Lassmann H, 2007, REV NEUROL-FRANCE, V163, P651, DOI 10.1016/S0035-3787(07)90474-9; Lassmann H, 2001, TRENDS MOL MED, V7, P115, DOI 10.1016/S1471-4914(00)01909-2; Lin WS, 2006, BRAIN, V129, P1306, DOI 10.1093/brain/awl044; Linares D, 2006, J NEUROSCI, V26, P12672, DOI 10.1523/JNEUROSCI.0294-06.2006; Lindner M, 2009, GLIA, V57, P465, DOI 10.1002/glia.20833; Liu LP, 2006, J IMMUNOL, V176, P4399, DOI 10.4049/jimmunol.176.7.4399; Lucchinetti C, 1999, BRAIN, V122, P2279, DOI 10.1093/brain/122.12.2279; Lucchinetti C, 2000, ANN NEUROL, V47, P707, DOI 10.1002/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q; LUDWIN SK, 1981, ANN NEUROL, V9, P301; Mahad DJ, 2004, J NEUROPATH EXP NEUR, V63, P262, DOI 10.1093/jnen/63.3.262; Mahad D, 2008, BRAIN, V131, P1722, DOI 10.1093/brain/awn105; Mason JL, 2000, J NEUROSCI, V20, P5703, DOI 10.1523/JNEUROSCI.20-15-05703.2000; Matsushima GK, 2001, BRAIN PATHOL, V11, P107; McMahon EJ, 2002, J NEUROIMMUNOL, V130, P32, DOI 10.1016/S0165-5728(02)00205-9; McMahon EJ, 2001, J IMMUNOL, V167, P2964, DOI 10.4049/jimmunol.167.5.2964; Miller RH, 2007, NAT NEUROSCI, V10, P1351, DOI 10.1038/nn1995; Pasquini LA, 2007, NEUROCHEM RES, V32, P279, DOI 10.1007/s11064-006-9165-0; Pernet V, 2008, J NEUROSCI, V28, P7435, DOI 10.1523/JNEUROSCI.0727-08.2008; Ransohoff RM, 2007, NAT NEUROSCI, V10, P1507, DOI 10.1038/nn1207-1507; Ransohoff RM, 2009, ANNU REV IMMUNOL, V27, P119, DOI 10.1146/annurev.immunol.021908.132528; Remington LT, 2007, AM J PATHOL, V170, P1713, DOI 10.2353/ajpath.2007.060783; Savarin C, 2008, J VIROL, V82, P12432, DOI 10.1128/JVI.01267-08; Schreiber RC, 2001, NEUROREPORT, V12, P601, DOI 10.1097/00001756-200103050-00034; Shea-Donohue T, 2008, INNATE IMMUN-LONDON, V14, P117, DOI 10.1177/1753425908088724; Smith KJ, 2007, BRAIN PATHOL, V17, P230, DOI 10.1111/j.1750-3639.2007.00066.x; Storch MK, 1998, BRAIN PATHOL, V8, P681, DOI 10.1111/j.1750-3639.1998.tb00194.x; Tran EH, 2000, J IMMUNOL, V164, P2759, DOI 10.4049/jimmunol.164.5.2759; Trapp BD, 2004, ANN NEUROL, V55, P455, DOI 10.1002/ana.20087; Tsai HH, 2002, CELL, V110, P373, DOI 10.1016/S0092-8674(02)00838-3; WAGNER T, 1977, EXP CELL RES, V107, P1, DOI 10.1016/0014-4827(77)90379-2; WAXMAN SG, 1979, J NEUROL SCI, V44, P45, DOI 10.1016/0022-510X(79)90221-1	48	152	156	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2010	13	3					319	U10		10.1038/nn.2491	http://dx.doi.org/10.1038/nn.2491			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	559WW	20154684	Green Accepted			2022-12-24	WOS:000274860100013
J	Feinberg, K; Eshed-Eisenbach, Y; Frechter, S; Amor, V; Salomon, D; Sabanay, H; Dupree, JL; Grumet, M; Brophy, PJ; Shrager, P; Peles, E				Feinberg, Konstantin; Eshed-Eisenbach, Yael; Frechter, Shahar; Amor, Veronique; Salomon, Daniela; Sabanay, Helena; Dupree, Jeffrey L.; Grumet, Martin; Brophy, Peter J.; Shrager, Peter; Peles, Elior			A Glial Signal Consisting of Gliomedin and NrCAM Clusters Axonal Na+ Channels during the Formation of Nodes of Ranvier	NEURON			English	Article							CELL-ADHESION MOLECULES; PERIPHERAL NERVOUS-SYSTEM; BETA-IV-SPECTRIN; MYELINATED AXONS; INITIAL SEGMENTS; SODIUM-CHANNELS; ANKYRIN-G; K+ CHANNELS; NR-CAM; NEUROFASCIN	Saltatory conduction requires high-density accumulation of Na+ channels at the nodes of Ranvier. Nodal Na+ channel clustering in the peripheral nervous system is regulated by myelinating Schwann cells through unknown mechanisms. During development, Na+ channels are first clustered at heminodes that border each myelin segment, and later in the mature nodes that are formed by the fusion of two heminodes. Here, we show that initial clustering of Na+ channels at heminodes requires glial NrCAM and gliomedin, as well as their axonal receptor neurofascin 186 (NF186). We further demonstrate that heminodal clustering coincides with a second, paranodal junction (PNJ)-dependent mechanism that allows Na+ channels to accumulate at mature nodes by restricting their distribution between two growing myelin internodes. We propose that Schwann cells assemble the nodes of Ranvier by capturing Na+ channels at heminodes and by constraining their distribution to the nodal gap. Together, these two cooperating mechanisms ensure fast and efficient conduction in myelinated nerves.	[Feinberg, Konstantin; Eshed-Eisenbach, Yael; Frechter, Shahar; Amor, Veronique; Salomon, Daniela; Sabanay, Helena; Peles, Elior] Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel; [Dupree, Jeffrey L.] Virginia Commonwealth Univ, Dept Anat & Neurobiol, Richmond, VA 23298 USA; [Grumet, Martin] Rutgers State Univ, WM Keck Ctr Collaborat Neurosci, Piscataway, NJ 08854 USA; [Brophy, Peter J.] Univ Edinburgh, Neurosci Res Ctr, Edinburgh EH9 1QH, Midlothian, Scotland; [Shrager, Peter] Univ Rochester, Med Ctr, Dept Neurobiol & Anat, Rochester, NY 14642 USA	Weizmann Institute of Science; Virginia Commonwealth University; Rutgers State University New Brunswick; University of Edinburgh; University of Rochester	Peles, E (corresponding author), Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel.		grumet, martin/ABC-6462-2020	Peles, Elior/0000-0002-3325-0597	National Multiple Sclerosis Society [RG3594-A-4]; NIH; NINDS [NS50220, NS17965]; Sheldon G Adelson Medical Research Foundation; European Community's Seventh Framework Programme [FP7/2007-2013]; Shapell Family Biomedical Research Foundation [HEALTH-F2-2008-201535]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050220, R01NS017965] Funding Source: NIH RePORTER; Medical Research Council [G0301172] Funding Source: researchfish; MRC [G0301172] Funding Source: UKRI	National Multiple Sclerosis Society(National Multiple Sclerosis Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Sheldon G Adelson Medical Research Foundation; European Community's Seventh Framework Programme; Shapell Family Biomedical Research Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We would like to thank Matt Rasband and Rock Levinson for their generous gift of antibodies and valuable comments This work was supported by grants from the National Multiple Sclerosis Society (RG3594-A-4), the NIH (NINDS grants NS50220 (E P) and NS17965 (P S), NYS CORE 19772-3784 (P S). the Dr Miriam and Sheldon G Adelson Medical Research Foundation, the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement No HEALTH-F2-2008-201535, the Shapell Family Biomedical Research Foundation at the Weizmann Institute, the Moskowitz Center for Imaging, and the Wolgin Prize for Scientific Excellence E P is the Incumbent of the Hanna Hertz Professorial Chair for Multiple Sclerosis and Neuroscience	Arroyo EJ, 2004, J COMP NEUROL, V479, P424, DOI 10.1002/cne.20321; Berghs S, 2000, J CELL BIOL, V151, P985, DOI 10.1083/jcb.151.5.985; BERTHOLD CH, 1983, J NEUROCYTOL, V12, P475, DOI 10.1007/BF01159386; Bhat MA, 2001, NEURON, V30, P369, DOI 10.1016/S0896-6273(01)00294-X; Boyle MET, 2001, NEURON, V30, P385, DOI 10.1016/S0896-6273(01)00296-3; Ching W, 1999, J NEUROCYTOL, V28, P295, DOI 10.1023/A:1007053411667; Coman I, 2006, BRAIN, V129, P3186, DOI 10.1093/brain/awl144; Craner MJ, 2003, BRAIN, V126, P1552, DOI 10.1093/brain/awg153; Custer AW, 2003, J NEUROSCI, V23, P10032; Davis JQ, 1996, J CELL BIOL, V135, P1355, DOI 10.1083/jcb.135.5.1355; DAVIS JQ, 1994, J BIOL CHEM, V269, P27163; DUGANDZIJANOVAKOVIC S, 1995, J NEUROSCI, V15, P492; Dupree JL, 1999, J CELL BIOL, V147, P1145, DOI 10.1083/jcb.147.6.1145; Dzhashiashvili Y, 2007, J CELL BIOL, V177, P857, DOI 10.1083/jcb.200612012; Eshed Y, 2005, NEURON, V47, P215, DOI 10.1016/j.neuron.2005.06.026; Eshed Y, 2007, J CELL BIOL, V177, P551, DOI 10.1083/jcb.200612139; Gatto CL, 2003, J CELL BIOL, V162, P489, DOI 10.1083/jcb.200303039; Gollan L, 2003, J CELL BIOL, V163, P1213, DOI 10.1083/jcb.200309147; Grumet M, 1997, CELL TISSUE RES, V290, P423, DOI 10.1007/s004410050949; Horresh I, 2010, J NEUROSCI, V30, P2480, DOI 10.1523/JNEUROSCI.5225-09.2010; Ishibashi T, 2002, J NEUROSCI, V22, P6507; KAYYEM JF, 1992, J CELL BIOL, V118, P1259, DOI 10.1083/jcb.118.5.1259; Komada M, 2002, J CELL BIOL, V156, P337, DOI 10.1083/jcb.200110003; KORDELI E, 1990, J CELL BIOL, V110, P1341, DOI 10.1083/jcb.110.4.1341; Lambert S, 1997, J NEUROSCI, V17, P7025; Lasiecka ZM, 2009, INT REV CEL MOL BIO, V272, P303, DOI 10.1016/S1937-6448(08)01607-9; Lemaillet G, 2003, J BIOL CHEM, V278, P27333, DOI 10.1074/jbc.M303327200; Lonigro A, 2009, BRAIN, V132, P260, DOI 10.1093/brain/awn281; Lustig M, 2001, CURR BIOL, V11, P1864, DOI 10.1016/S0960-9822(01)00586-3; Maertens B, 2007, J BIOL CHEM, V282, P10647, DOI 10.1074/jbc.M611339200; Malhotra JD, 2000, J BIOL CHEM, V275, P11383, DOI 10.1074/jbc.275.15.11383; McEwen DP, 2004, J BIOL CHEM, V279, P52744, DOI 10.1074/jbc.M405990200; Melendez-Vasquez CV, 2001, P NATL ACAD SCI USA, V98, P1235, DOI 10.1073/pnas.98.3.1235; Occhi S, 2005, J NEUROSCI, V25, P9418, DOI 10.1523/JNEUROSCI.2068-05.2005; Ogawa Y, 2006, J NEUROSCI, V26, P5230, DOI 10.1523/JNEUROSCI.0425-06.2006; Pedraza L, 2001, NEURON, V30, P335, DOI 10.1016/S0896-6273(01)00306-3; Peles E, 1997, EMBO J, V16, P978, DOI 10.1093/emboj/16.5.978; Pillai AM, 2009, J NEUROSCI RES, V87, P1773, DOI 10.1002/jnr.22015; Poliak S, 2003, J CELL BIOL, V162, P1149, DOI 10.1083/jcb.200305018; Poliak S, 1999, NEURON, V24, P1037, DOI 10.1016/S0896-6273(00)81049-1; Poliak S, 2003, NAT REV NEUROSCI, V4, P968, DOI 10.1038/nrn1253; Rasband MN, 1999, J NEUROSCI, V19, P7516, DOI 10.1523/JNEUROSCI.19-17-07516.1999; Ratcliffe CF, 2001, J CELL BIOL, V154, P427, DOI 10.1083/jcb.200102086; Rios JC, 2003, J NEUROSCI, V23, P7001, DOI 10.1523/JNEUROSCI.23-18-07001.2003; Rios JC, 2000, J NEUROSCI, V20, P8354, DOI 10.1523/JNEUROSCI.20-22-08354.2000; ROSENBLUTH J, 1976, J NEUROCYTOL, V5, P731, DOI 10.1007/BF01181584; Rosenbluth J, 2009, J NEUROSCI RES, V87, P3250, DOI 10.1002/jnr.22013; Saito F, 2003, NEURON, V38, P747, DOI 10.1016/S0896-6273(03)00301-5; Salzer JL, 2008, GLIA, V56, P1532, DOI 10.1002/glia.20750; Schafer DP, 2006, NEURON GLIA BIOL, V2, P69, DOI 10.1017/S1740925X06000093; Scherer SS, 2001, J NEUROSCI RES, V65, P150, DOI 10.1002/jnr.1138; Sherman DL, 2005, NEURON, V48, P737, DOI 10.1016/j.neuron.2005.10.019; Spiegel I, 2007, NAT NEUROSCI, V10, P861, DOI 10.1038/nn1915; Susuki K, 2008, CURR OPIN CELL BIOL, V20, P616, DOI 10.1016/j.ceb.2008.09.007; SUTER DM, 1995, J CELL BIOL, V131, P1067, DOI 10.1083/jcb.131.4.1067; Tait S, 2000, J CELL BIOL, V150, P657, DOI 10.1083/jcb.150.3.657; TAOCHENG JH, 1983, DEV BRAIN RES, V9, P251, DOI 10.1016/0165-3806(83)90023-8; Vabnick I, 1996, J NEUROSCI, V16, P4914; WAXMAN SG, 1993, ANN NEUROL, V33, P121, DOI 10.1002/ana.410330202; Zonta B, 2008, J CELL BIOL, V181, P1169, DOI 10.1083/jcb.200712154	60	141	145	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 25	2010	65	4					490	502		10.1016/j.neuron.2010.02.004	http://dx.doi.org/10.1016/j.neuron.2010.02.004			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	566HD	20188654	Green Accepted, Bronze			2022-12-24	WOS:000275359800008
J	Benveniste, P; Frelin, C; Janmohamed, S; Barbara, M; Herrington, R; Hyam, D; Iscove, NN				Benveniste, Patricia; Frelin, Catherine; Janmohamed, Salima; Barbara, Mary; Herrington, Robert; Hyam, Deborah; Iscove, Norman N.			Intermediate-Term Hematopoietic Stem Cells with Extended but Time-Limited Reconstitution Potential	CELL STEM CELL			English	Article							LONG-TERM; SELF-RENEWAL; IN-VIVO; PROGENITOR CELLS; EXPRESSION; IDENTIFICATION; DIFFERENTIATION; COMPARTMENT; EXPANSION; CULTURE	Sustained blood cell production depends on divisions by hematopoietic stem cells (HSCs) that yield both differentiating progeny as well as new HSCs via self-renewal. Differentiating progeny remain capable of self-renewal, but only HSCs sustain self-renewal through successive divisions securely enough to maintain clones that persist life-long. Until recently, the first identified next stage consisted of "short-term" reconstituting cells able to sustain clones of differentiating cells for only 4-6 weeks. Here we expand evidence for a numerically dominant "intermediate-term" multipotent HSC stage in mice whose clones persist for 6-8 months before becoming extinct and that are separable from both short-term as well as permanently reconstituting "long-term" HSCs. The findings suggest that the first step in stem cell differentiation consists not in loss of initial capacity for serial self-renewal divisions, but rather in loss of mechanisms that stabilize self-renewing behavior throughout successive future stem cell divisions.	[Benveniste, Patricia; Frelin, Catherine; Janmohamed, Salima; Barbara, Mary; Herrington, Robert; Hyam, Deborah; Iscove, Norman N.] Ontario Canc Inst, Toronto, ON M5G 2M9, Canada; [Benveniste, Patricia; Frelin, Catherine; Janmohamed, Salima; Barbara, Mary; Herrington, Robert; Hyam, Deborah; Iscove, Norman N.] Univ Toronto, Dept Med Biophys, Toronto, ON M5S 1A8, Canada; [Benveniste, Patricia; Frelin, Catherine; Janmohamed, Salima; Barbara, Mary; Herrington, Robert; Hyam, Deborah; Iscove, Norman N.] Univ Toronto, Dept Immunol, Toronto, ON M5S 1A8, Canada; [Benveniste, Patricia; Frelin, Catherine; Janmohamed, Salima; Barbara, Mary; Herrington, Robert; Hyam, Deborah; Iscove, Norman N.] McEwen Ctr Regenerat Med, Toronto, ON M5G 1L7, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto	Iscove, NN (corresponding author), Ontario Canc Inst, Toronto, ON M5G 2M9, Canada.	iscove@uhnresearch.ca		Benveniste, Patricia/0000-0002-5673-0542	Terry Fox Foundation [015005]; National Cancer Institute of Canada; Canadian Institutes of Health Research; Stem Cell Network; National Institutes of Health; McEwen Centre for Regenerative Medicine	Terry Fox Foundation; National Cancer Institute of Canada(Canadian Cancer Society (CCS)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Stem Cell Network; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); McEwen Centre for Regenerative Medicine	We thank Giselle Knowles and Pier-Andree Penttila for assistance with flow cytometry and Maria-Fernanda Monroy for help with animal procedures. The work was funded by grants from the Terry Fox Foundation (#015005), the National Cancer Institute of Canada, Canadian Institutes of Health Research, the Stem Cell Network, and the National Institutes of Health, and additional support came from the McEwen Centre for Regenerative Medicine.	Adolfsson J, 2001, IMMUNITY, V15, P659, DOI 10.1016/S1074-7613(01)00220-5; Adolfsson J, 2005, CELL, V121, P295, DOI 10.1016/j.cell.2005.02.013; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Benveniste P, 2003, NAT IMMUNOL, V4, P708, DOI 10.1038/ni940; Christensen JL, 2001, P NATL ACAD SCI USA, V98, P14541, DOI 10.1073/pnas.261562798; Dai XM, 2002, BLOOD, V99, P111, DOI 10.1182/blood.V99.1.111; Dykstra B, 2007, CELL STEM CELL, V1, P218, DOI 10.1016/j.stem.2007.05.015; Ema H, 2005, DEV CELL, V8, P907, DOI 10.1016/j.devcel.2005.03.019; Forsberg EC, 2006, CELL, V126, P415, DOI 10.1016/j.cell.2006.06.037; Foudi A, 2009, NAT BIOTECHNOL, V27, P84, DOI 10.1038/nbt.1517; HARRISON DE, 1991, EXP HEMATOL, V19, P374; Hasumura M, 2003, EXP HEMATOL, V31, P1331, DOI 10.1016/j.exphem.2003.09.004; Haug JS, 2008, CELL STEM CELL, V2, P367, DOI 10.1016/j.stem.2008.01.017; Iscove NN, 1997, CURR BIOL, V7, P805, DOI 10.1016/S0960-9822(06)00341-1; Iscove NN, 2002, NAT BIOTECHNOL, V20, P940, DOI 10.1038/nbt729; Kent DG, 2009, BLOOD, V113, P6342, DOI 10.1182/blood-2008-12-192054; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; LI CL, 1995, BLOOD, V85, P1472, DOI 10.1182/blood.V85.6.1472.bloodjournal8561472; MORRISON SJ, 1994, IMMUNITY, V1, P661, DOI 10.1016/1074-7613(94)90037-X; Morshead CM, 2002, NAT MED, V8, P268, DOI 10.1038/nm0302-268; Muro EM, 2008, P NATL ACAD SCI USA, V105, P20286, DOI 10.1073/pnas.0807813105; Nakauchi H, 1999, ANN NY ACAD SCI, V872, P57, DOI 10.1111/j.1749-6632.1999.tb08453.x; Nakauchi H, 1999, ANN NY ACAD SCI, V872, P66; Nibley WE, 1998, BONE MARROW TRANSPL, V21, P345, DOI 10.1038/sj.bmt.1701097; NOCKA K, 1990, EMBO J, V9, P1805, DOI 10.1002/j.1460-2075.1990.tb08305.x; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Pawliuk R, 1996, BLOOD, V88, P2852, DOI 10.1182/blood.V88.8.2852.bloodjournal8882852; Perez-Iratxeta C, 2005, FEBS LETT, V579, P1795, DOI 10.1016/j.febslet.2005.02.020; Porter Christopher J., 2007, V407, P137, DOI 10.1007/978-1-59745-536-7_11; Ramsfjell V, 1999, BLOOD, V94, P4093, DOI 10.1182/blood.V94.12.4093.424k09_4093_4102; Sieburg HB, 2006, BLOOD, V107, P2311, DOI 10.1182/blood-2005-07-2970; TILL JE, 1964, P NATL ACAD SCI USA, V51, P29, DOI 10.1073/pnas.51.1.29; Trevisan M, 1996, BLOOD, V88, P4149, DOI 10.1182/blood.V88.11.4149.bloodjournal88114149; TREVISAN M, 1995, J EXP MED, V181, P93, DOI 10.1084/jem.181.1.93; Uchida N, 2003, EXP HEMATOL, V31, P1338, DOI 10.1016/j.exphem.2003.09.001; Wagers AJ, 2002, EXP HEMATOL, V30, P176, DOI 10.1016/S0301-472X(01)00777-9; Wagers AJ, 2006, STEM CELLS, V24, P1087, DOI 10.1634/stemcells.2005-0396; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Yang LP, 2005, BLOOD, V105, P2717, DOI 10.1182/blood-2004-06-2159; Zhao Y, 2000, BLOOD, V96, P3016; Zhong JF, 2005, P NATL ACAD SCI USA, V102, P2448, DOI 10.1073/pnas.0409459102	41	131	135	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JAN 8	2010	6	1					48	58		10.1016/j.stem.2009.11.014	http://dx.doi.org/10.1016/j.stem.2009.11.014			11	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	549EW	20074534	Bronze			2022-12-24	WOS:000274029700011
J	Nguyen, QT; Schroeder, LF; Mank, M; Muller, A; Taylor, P; Griesbeck, O; Kleinfeld, D				Nguyen, Quoc-Thang; Schroeder, Lee F.; Mank, Marco; Muller, Arnaud; Taylor, Palmer; Griesbeck, Oliver; Kleinfeld, David			An in vivo biosensor for neurotransmitter release and in situ receptor activity	NATURE NEUROSCIENCE			English	Article							CORTICAL ACETYLCHOLINE-RELEASE; ATYPICAL ANTIPSYCHOTICS; CHOLINERGIC-RECEPTORS; NUCLEUS-ACCUMBENS; BRAIN; PROTEINS; DRUGS; ACTIVATION; CORTEX; CELLS	Tools from molecular biology, combined with in vivo optical imaging techniques, provide new mechanisms for noninvasively observing brain processes. Current approaches primarily probe cell-based variables, such as cytosolic calcium or membrane potential, but not cell-to-cell signaling. We devised cell-based neurotransmitter fluorescent engineered reporters (CNiFERs) to address this challenge and monitor in situ neurotransmitter receptor activation. CNiFERs are cultured cells that are engineered to express a chosen metabotropic receptor, use the G(q) protein-coupled receptor cascade to transform receptor activity into a rise in cytosolic [Ca2+] and report [Ca2+] with a genetically encoded fluorescent Ca2+ sensor. The initial realization of CNiFERs detected acetylcholine release via activation of M1 muscarinic receptors. We used chronic implantation of M1-CNiFERs in frontal cortex of the adult rat to elucidate the muscarinic action of the atypical neuroleptics clozapine and olanzapine. We found that these drugs potently inhibited in situ muscarinic receptor activity.	[Nguyen, Quoc-Thang; Muller, Arnaud; Kleinfeld, David] Univ Calif San Diego, Dept Phys, La Jolla, CA 92093 USA; [Schroeder, Lee F.] Univ Calif San Diego, Med Scientist Training Program, La Jolla, CA 92093 USA; [Schroeder, Lee F.; Kleinfeld, David] Univ Calif San Diego, Grad Program Neurosci, La Jolla, CA 92093 USA; [Mank, Marco; Griesbeck, Oliver] Max Planck Inst Neurobiol, Martinsried, Germany; [Taylor, Palmer] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Kleinfeld, David] Univ Calif San Diego, Ctr Neural Circuits & Behav, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Max Planck Society; University of California System; University of California San Diego; University of California System; University of California San Diego	Kleinfeld, D (corresponding author), Univ Calif San Diego, Dept Phys, La Jolla, CA 92093 USA.	dk@physics.ucsd.edu		Griesbeck, Oliver/0000-0001-5883-5594	US National Institutes of Health [DA024206, EB003832, MH085499, GM18360, DA19372, MH070655]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB003832] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM018360, R37GM018360] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH085499] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [U01DA019372, R01DA029706, R21DA024206] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We are grateful to T. Bartfai, D. K. Berg, J.-P. Changeux, J.M. Edeline, A. L. Fairhall, B. Hille, H.J. Karten, R. Metherate, P. A. Slesinger, T. Talley, R.Y. Tsien and M. Tuszynski for valuable discussions. We thank R. Figueroa for maintaining the cell culture facility, J. Groisman for preparing the artwork in Figure 2a and A. Miyanohara ( Vector Development Laboratory, Human Gene Therapy Program, University of California San Diego) for producing the lentiviruses. This work was supported by the US National Institutes of Health Medical Scientist Training Program ( L. F. S.), the Max Planck Society (O.G.) and grants from the US National Institutes of Health (DA024206, EB003832 and MH085499 to D. K., GM18360 and DA19372 to P. T., and MH070655 to Q.-T.N.).	Agnati LF, 2006, ACTA PHYSIOL, V187, P329, DOI 10.1111/j.1748-1716.2006.01579.x; BEAUDET A, 1978, NEUROSCIENCE, V3, P851, DOI 10.1016/0306-4522(78)90115-X; Berg RW, 2005, J NEUROPHYSIOL, V94, P699, DOI 10.1152/jn.01125.2004; BOLDEN C, 1992, J PHARMACOL EXP THER, V260, P576; Bymaster FP, 2003, PROG NEURO-PSYCHOPH, V27, P1125, DOI 10.1016/j.pnpbp.2003.09.008; Chew ML, 2006, SCHIZOPHR RES, V88, P63, DOI 10.1016/j.schres.2006.07.011; Coward P, 1999, ANAL BIOCHEM, V270, P242, DOI 10.1006/abio.1999.4061; Davies MA, 2005, PSYCHOPHARMACOLOGY, V178, P451, DOI 10.1007/s00213-004-2017-1; Davis MD, 2000, J NEUROSCI METH, V99, P9, DOI 10.1016/S0165-0270(00)00209-0; Day JC, 2001, METHODS, V23, P21, DOI 10.1006/meth.2000.1103; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; DiMatteo I, 2001, BIOMETRIKA, V88, P1055, DOI 10.1093/biomet/88.4.1055; Drobizhev M, 2009, J PHYS CHEM B, V113, P855, DOI 10.1021/jp8087379; Everitt BJ, 1997, ANNU REV PSYCHOL, V48, P649, DOI 10.1146/annurev.psych.48.1.649; Gray JA, 2007, SCHIZOPHRENIA BULL, V33, P1100, DOI 10.1093/schbul/sbm074; Haas B, 2006, CEREB CORTEX, V16, P237, DOI 10.1093/cercor/bhi101; Hires SA, 2008, P NATL ACAD SCI USA, V105, P4411, DOI 10.1073/pnas.0712008105; Horowitz LF, 2005, J GEN PHYSIOL, V126, P243, DOI 10.1085/jgp.200509309; Ichikawa J, 2002, NEUROPSYCHOPHARMACOL, V26, P325, DOI 10.1016/S0893-133X(01)00312-8; Johnson DE, 2005, EUR J PHARMACOL, V506, P209, DOI 10.1016/j.ejphar.2004.11.015; KAWAJA MD, 1992, J COMP NEUROL, V317, P102, DOI 10.1002/cne.903170108; Kostenis E, 2005, TRENDS PHARMACOL SCI, V26, P595, DOI 10.1016/j.tips.2005.09.007; Krasel C, 2004, BIOCHEM SOC T, V32, P1029, DOI 10.1042/BST0321029; LEVEY AI, 1991, J NEUROSCI, V11, P3218; Mank M, 2008, NAT METHODS, V5, P805, DOI 10.1038/NMETH.1243; Meltzer HY, 2004, CURR OPIN PHARMACOL, V4, P53, DOI 10.1016/j.coph.2003.09.010; METHERATE R, 1993, J NEUROSCI, V13, P5312, DOI 10.1523/JNEUROSCI.13-12-05312.1993; Nguyen QT, 2002, NEUROPHARMACOLOGY, V42, P670, DOI 10.1016/S0028-3908(02)00018-7; NGUYEN QT, 2009, METHODS IN VIVO OPTI, P117; Nishimura N, 2006, NAT METHODS, V3, P99, DOI 10.1038/NMETH844; Okumoto S, 2005, P NATL ACAD SCI USA, V102, P8740, DOI 10.1073/pnas.0503274102; Parada MA, 1997, J PHARMACOL EXP THER, V281, P582; Raedler TJ, 2007, MOL PSYCHIATR, V12, P232, DOI 10.1038/sj.mp.4001924; RASMUSSON DD, 1992, BRAIN RES, V594, P150, DOI 10.1016/0006-8993(92)91041-C; RASMUSSON DD, 1994, NEUROSCIENCE, V60, P665, DOI 10.1016/0306-4522(94)90495-2; Schaffer CB, 2006, PLOS BIOL, V4, P258, DOI 10.1371/journal.pbio.0040022; SCHROEDER KS, 1995, J BIOMOL SCREEN, V1, P75; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shirazi-Southall S, 2002, NEUROPSYCHOPHARMACOL, V26, P583, DOI 10.1016/S0893-133X(01)00400-6; Snyder EM, 2008, NAT REV DRUG DISCOV, V7, P471, DOI 10.1038/nrd2571; SNYDER S, 1974, ARCH GEN PSYCHIAT, V31, P58; Tani Y, 1998, EUR J PHARMACOL, V351, P181, DOI 10.1016/S0014-2999(98)00314-8; Tsai PS, 2009, FRONT NEUROSCI, P59; Tsien RY, 2005, FEBS LETT, V579, P927, DOI 10.1016/j.febslet.2004.11.025; UMBRIACO D, 1994, J COMP NEUROL, V348, P351, DOI 10.1002/cne.903480304; Vilardaga JP, 2003, NAT BIOTECHNOL, V21, P807, DOI 10.1038/nbt838; Vogler O, 1998, J BIOL CHEM, V273, P12155, DOI 10.1074/jbc.273.20.12155; WILLARS GB, 1995, BRIT J PHARMACOL, V114, P1133, DOI 10.1111/j.1476-5381.1995.tb13325.x; YOUNG SH, 1983, NATURE, V305, P634, DOI 10.1038/305634a0; Zhang J, 2005, NATURE, V437, P569, DOI 10.1038/nature04140	50	88	105	1	45	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2010	13	1					127	U301		10.1038/nn.2469	http://dx.doi.org/10.1038/nn.2469			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	536PM	20010818	Green Accepted, Green Submitted			2022-12-24	WOS:000273056300023
J	Theyel, BB; Llano, DA; Sherman, M				Theyel, Brian B.; Llano, Daniel A.; Sherman, Murray			The corticothalamocortical circuit drives higher-order cortex in the mouse	NATURE NEUROSCIENCE			English	Article							LATERAL GENICULATE-NUCLEUS; AUDITORY-CORTEX; IN-VITRO; FLAVOPROTEIN AUTOFLUORESCENCE; LASER PHOTOSTIMULATION; ANTEROGRADE TRACER; VISUAL-SYSTEM; BARREL CORTEX; RAT THALAMUS; SINGLE-FIBER	An unresolved question in neuroscience relates to the extent to which corticothalamocortical circuits emanating from layer 5B are involved in information transfer through the cortical hierarchy. Using a new form of optical imaging in a brain slice preparation, we found that the corticothalamocortical pathway drove robust activity in higher-order somatosensory cortex. When the direct corticocortical pathway was interrupted, secondary somatosensory cortex showed robust activity in response to stimulation of the barrel field in primary somatosensory cortex (S1BF), which was eliminated after subsequently cutting the somatosensory thalamus, suggesting a highly efficacious corticothalamocortical circuit. Furthermore, after chemically inhibiting the thalamus, activation in secondary somatosensory cortex was eliminated, with a subsequent return after washout. Finally, stimulation of layer 5B in S1BF, and not layer 6, drove corticothalamocortical activation. These findings suggest that the corticothalamocortical circuit is a physiologically viable candidate for information transfer to higher-order cortical areas.	[Theyel, Brian B.; Sherman, Murray] Univ Chicago, Dept Neurobiol, Chicago, IL 60637 USA; [Llano, Daniel A.] Univ Chicago, Dept Neurol, Med Ctr, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago Medical Center	Theyel, BB (corresponding author), Univ Chicago, Dept Neurobiol, Chicago, IL 60637 USA.	btheyel@uchicago.edu	Llano, Daniel/X-8184-2019	Llano, Daniel/0000-0003-0933-1837	US Public Health Service; US National Institutes of Health [DC008320, EY03038, DC008794]; NATIONAL EYE INSTITUTE [R01EY003038] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC008794, K08DC008320] Funding Source: NIH RePORTER	US Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank N. Issa, T. Husson and A. Mallik for technical assistance with flavoprotein autofluorescence imaging. This work was supported by the US Public Health Service and US National Institutes of Health grants DC008320 ( D. A. L.), EY03038 and DC008794 ( S. M. S.).	AGMON A, 1991, NEUROSCIENCE, V41, P365, DOI 10.1016/0306-4522(91)90333-J; BAJO VM, 1995, HEARING RES, V83, P161, DOI 10.1016/0378-5955(94)00199-Z; BENDER DB, 1983, BRAIN RES, V279, P258, DOI 10.1016/0006-8993(83)90188-9; BOURASSA J, 1995, EUR J NEUROSCI, V7, P19, DOI 10.1111/j.1460-9568.1995.tb01016.x; BOURASSA J, 1995, NEUROSCIENCE, V66, P253, DOI 10.1016/0306-4522(95)00009-8; CALLAWAY EM, 1993, P NATL ACAD SCI USA, V90, P7661, DOI 10.1073/pnas.90.16.7661; Cox CL, 2000, NEURON, V27, P597, DOI 10.1016/S0896-6273(00)00069-6; Cruikshank SJ, 2002, J NEUROPHYSIOL, V87, P361, DOI 10.1152/jn.00549.2001; DIAMOND ME, 1992, J COMP NEUROL, V319, P66, DOI 10.1002/cne.903190108; Franklin K.B.J., 2008, MOUSE BRAIN STEREOTA; Groh A, 2008, J NEUROSCI, V28, P9652, DOI 10.1523/JNEUROSCI.1554-08.2008; Guillery RW, 2003, J NEUROPHYSIOL, V90, P539, DOI 10.1152/jn.00337.2003; Guillery RW, 2002, PHILOS T R SOC B, V357, P1809, DOI 10.1098/rstb.2002.1171; Guillery RW, 2002, NEURON, V33, P163, DOI 10.1016/S0896-6273(01)00582-7; Guillery RW, 2001, J COMP NEUROL, V438, P66, DOI 10.1002/cne.1302; Hazama M, 2004, NEUROSCIENCE, V124, P655, DOI 10.1016/j.neuroscience.2003.12.027; KAAS JH, 1987, ANNU REV PSYCHOL, V38, P129, DOI 10.1146/annurev.ps.38.020187.001021; KATO N, 1990, BRAIN RES, V509, P150, DOI 10.1016/0006-8993(90)90323-4; Lam YW, 2007, J NEUROPHYSIOL, V98, P2903, DOI 10.1152/jn.00782.2007; Lam YW, 2006, J NEUROPHYSIOL, V96, P2593, DOI 10.1152/jn.00555.2006; Lam YW, 2005, J NEUROPHYSIOL, V94, P2472, DOI 10.1152/jn.00206.2005; Lee CC, 2008, J NEUROPHYSIOL, V100, P317, DOI 10.1152/jn.90391.2008; Llano DA, 2009, J NEUROPHYSIOL, V101, P3325, DOI 10.1152/jn.91291.2008; Llano DA, 2008, J COMP NEUROL, V507, P1209, DOI 10.1002/cne.21602; MacLean JN, 2006, NAT METHODS, V3, P129, DOI 10.1038/NMETH849; MATHERS LH, 1972, J COMP NEUROL, V146, P43, DOI 10.1002/cne.901460104; OJIMA H, 1994, CEREB CORTEX, V4, P646, DOI 10.1093/cercor/4.6.646; OLSHAUSEN BA, 1993, J NEUROSCI, V13, P4700; Reichova I, 2004, J NEUROPHYSIOL, V92, P2185, DOI 10.1152/jn.00322.2004; Reinert KC, 2004, J NEUROPHYSIOL, V92, P199, DOI 10.1152/jn.01275.2003; ROUILLER EM, 1991, HEARING RES, V56, P179, DOI 10.1016/0378-5955(91)90168-9; Shepherd GMG, 2003, NEURON, V38, P277, DOI 10.1016/S0896-6273(03)00152-1; Sherer DM, 2001, GYNECOL OBSTET INVES, V51, P69, DOI 10.1159/000052896; Sherman, 2006, EXPLORING THALAMUS I, P357; Sherman SM, 1996, J NEUROPHYSIOL, V76, P1367, DOI 10.1152/jn.1996.76.3.1367; Sherman SM, 2002, PHILOS T R SOC B, V357, P1695, DOI 10.1098/rstb.2002.1161; Sherman SM, 1998, P NATL ACAD SCI USA, V95, P7121, DOI 10.1073/pnas.95.12.7121; Shibuki K, 2003, J PHYSIOL-LONDON, V549, P919, DOI 10.1113/jphysiol.2003.040709; SPREAFICO R, 1987, SOMATOSENS MOT RES, V4, P359, DOI 10.3109/07367228709144614; Staiger JF, 1999, ANAT EMBRYOL, V199, P357, DOI 10.1007/s004290050234; Van Horn SC, 2004, J COMP NEUROL, V475, P406, DOI 10.1002/cne.20187; VANESSEN DC, 1992, SCIENCE, V255, P419, DOI 10.1126/science.1734518; WILSON JR, 1984, PROC R SOC SER B-BIO, V221, P411, DOI 10.1098/rspb.1984.0042; Winer JA, 1999, J COMP NEUROL, V413, P181	44	231	233	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2010	13	1					84	U246		10.1038/nn.2449	http://dx.doi.org/10.1038/nn.2449			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	536PM	19966840	Green Accepted			2022-12-24	WOS:000273056300017
J	Lebreton, M; Jorge, S; Michel, V; Thirion, B; Pessiglione, M				Lebreton, Mael; Jorge, Soledad; Michel, Vincent; Thirion, Bertrand; Pessiglione, Mathias			An Automatic Valuation System in the Human Brain: Evidence from Functional Neuroimaging	NEURON			English	Article							HUMAN ORBITOFRONTAL CORTEX; DECISION-MAKING; CINGULATE CORTEX; BASAL GANGLIA; PREFERENCE JUDGMENTS; MONETARY REWARDS; NEURAL BASIS; CHOICE; REPRESENTATIONS; OBJECTS	According to economic theories, preference for one item over others reveals its rank value on a common scale. Previous studies identified brain regions encoding such values. Here we verify that these regions can valuate various categories of objects and further test whether they still express preferences when attention is diverted to another task. During functional neuroimaging, participants rated either the pleasantness (explicit task) or the age (distractive task) of pictures from different categories (face, house, and painting). After scanning, the same pictures were presented in pairs, and subjects had to choose the one they preferred. We isolated brain regions that reflect both values (pleasantness ratings) and preferences (binary choices). Preferences were encoded whatever the stimulus (face, house, or painting) and task (explicit or distractive). These regions may therefore constitute a brain system that automatically engages in valuating the various components of our environment so as to influence our future choices.	[Lebreton, Mael; Jorge, Soledad; Pessiglione, Mathias] INSERM, Inst Cerveau & Moelle Epiniere CR ICM, UMR 975, F-75013 Paris, France; [Pessiglione, Mathias] Hop La Pitie Salpetriere, Ctr Neuroimagerie Rech CENIR, F-75013 Paris, France; [Lebreton, Mael; Jorge, Soledad; Pessiglione, Mathias] Univ Paris 06, F-75005 Paris, France; [Michel, Vincent; Thirion, Bertrand] INRIA, CEA, NeuroSpin, F-91191 Gif Sur Yvette, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; CEA; Inria	Pessiglione, M (corresponding author), INSERM, Inst Cerveau & Moelle Epiniere CR ICM, UMR 975, F-75013 Paris, France.	mathias.pessiglione@gmail.com	Pessiglione, Mathias/E-2141-2017; Lebreton, Maël/J-3179-2019	Pessiglione, Mathias/0000-0002-6992-3677; Lebreton, Maël/0000-0002-2071-4890	Fyssen Foundation	Fyssen Foundation	We wish to thank Nathalie George for her useful advices on the experimental design and Hilke Plassmann for her helpful suggestions on an earlier version of the manuscript. We are also grateful to the CENIR staff (Eric Bardinet, Eric Bertasi, Kevin Nigaud, and Romain Valabregue) for their skilful assistance in MRI data acquisition and analysis. The study was funded by the Fyssen Foundation.	ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Beckmann M, 2009, J NEUROSCI, V29, P1175, DOI 10.1523/JNEUROSCI.3328-08.2009; Brown RG, 2000, TRENDS NEUROSCI, V23, P412, DOI 10.1016/S0166-2236(00)01626-X; Chaudhry AM, 2009, EUR J NEUROSCI, V29, P1047, DOI 10.1111/j.1460-9568.2009.06646.x; Colman AM, 2003, BEHAV BRAIN SCI, V26, P139, DOI 10.1017/S0140525X03000050; Daw ND, 2006, CURR OPIN NEUROBIOL, V16, P199, DOI 10.1016/j.conb.2006.03.006; Dehaene S, 2007, NEURON, V56, P384, DOI 10.1016/j.neuron.2007.10.004; Deichmann R, 2003, NEUROIMAGE, V19, P430, DOI 10.1016/S1053-8119(03)00073-9; Di Dio C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001201; Draganski B, 2008, J NEUROSCI, V28, P7143, DOI 10.1523/JNEUROSCI.1486-08.2008; FitzGerald THB, 2009, J NEUROSCI, V29, P8388, DOI 10.1523/JNEUROSCI.0717-09.2009; Friston KJ, 2005, NEUROIMAGE, V25, P661, DOI 10.1016/j.neuroimage.2005.01.013; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; Grill-Spector K, 2004, ANNU REV NEUROSCI, V27, P649, DOI 10.1146/annurev.neuro.27.070203.144220; Haber SN, 2003, J CHEM NEUROANAT, V26, P317, DOI 10.1016/j.jchemneu.2003.10.003; Harbaugh WT, 2007, SCIENCE, V316, P1622, DOI 10.1126/science.1140738; Hare TA, 2009, SCIENCE, V324, P646, DOI 10.1126/science.1168450; Izuma K, 2008, NEURON, V58, P284, DOI 10.1016/j.neuron.2008.03.020; Kable JW, 2007, NAT NEUROSCI, V10, P1625, DOI 10.1038/nn2007; Kahneman D, 2003, AM PSYCHOL, V58, P697, DOI 10.1037/0003-066X.58.9.697; Kawabata H, 2004, J NEUROPHYSIOL, V91, P1699, DOI 10.1152/jn.00696.2003; Kim H, 2007, P NATL ACAD SCI USA, V104, P18253, DOI 10.1073/pnas.0703101104; Knutson B, 2005, CURR OPIN NEUROL, V18, P411, DOI 10.1097/01.wco.0000173463.24758.f6; Knutson B, 2007, NEURON, V53, P147, DOI 10.1016/j.neuron.2006.11.010; Lehericy S, 2004, ANN NEUROL, V55, P522, DOI 10.1002/ana.20030; McClure SM, 2004, NEURON, V44, P379, DOI 10.1016/j.neuron.2004.09.019; Mcclure SM, 2004, NEUROSCIENTIST, V10, P260, DOI 10.1177/1073858404263526; McClure SM, 2004, SCIENCE, V306, P503, DOI 10.1126/science.1100907; Mellers BA, 1998, ANNU REV PSYCHOL, V49, P447, DOI 10.1146/annurev.psych.49.1.447; Minear M, 2004, BEHAV RES METH INS C, V36, P630, DOI 10.3758/BF03206543; Montague PR, 2002, NEURON, V36, P265, DOI 10.1016/S0896-6273(02)00974-1; Neumann J., 1944, THEORY GAMES EC BEHA; O'Doherty J, 2001, NAT NEUROSCI, V4, P95, DOI 10.1038/82959; O'Doherty J, 2003, NEUROPSYCHOLOGIA, V41, P147, DOI 10.1016/S0028-3932(02)00145-8; O'Doherty J, 2004, SCIENCE, V304, P452, DOI 10.1126/science.1094285; O'Doherty JP, 2007, ANN NY ACAD SCI, V1104, P35, DOI 10.1196/annals.1390.022; Padoa-Schioppa C, 2007, ANN NY ACAD SCI, V1121, P232, DOI 10.1196/annals.1401.011; Paulus MP, 2003, NEUROREPORT, V14, P1311, DOI 10.1097/01.wnr.0000078543.07662.02; Plassmann H, 2008, P NATL ACAD SCI USA, V105, P1050, DOI 10.1073/pnas.0706929105; Plassmann H, 2007, J NEUROSCI, V27, P9984, DOI 10.1523/JNEUROSCI.2131-07.2007; Rangel A, 2008, NAT REV NEUROSCI, V9, P545, DOI 10.1038/nrn2357; Reddy L, 2006, CURR OPIN NEUROBIOL, V16, P408, DOI 10.1016/j.conb.2006.06.004; Rushworth MFS, 2008, NAT NEUROSCI, V11, P389, DOI 10.1038/nn2066; Samuelson PA, 1938, REV ECON STUD, V6, P65, DOI 10.2307/2967540; Schiller D, 2009, NAT NEUROSCI, V12, P508, DOI 10.1038/nn.2278; Seymour B, 2008, CURR OPIN NEUROBIOL, V18, P173, DOI 10.1016/j.conb.2008.07.010; Sharot T, 2009, J NEUROSCI, V29, P3760, DOI 10.1523/JNEUROSCI.4972-08.2009; Sugiura M, 2005, J COGNITIVE NEUROSCI, V17, P183, DOI 10.1162/0898929053124956; Sugrue LP, 2005, NAT REV NEUROSCI, V6, P363, DOI 10.1038/nrn1666; Yue XM, 2007, NEUROREPORT, V18, P525, DOI 10.1097/WNR.0b013e328091c1f9	50	264	266	2	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 12	2009	64	3					431	439		10.1016/j.neuron.2009.09.040	http://dx.doi.org/10.1016/j.neuron.2009.09.040			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	521MF	19914190	Bronze			2022-12-24	WOS:000271924800016
J	Wizenmann, A; Brunet, I; Lam, JSY; Sonnier, L; Beurdeley, M; Zarbalis, K; Weisenhorn-Vogt, D; Weinl, C; Dwivedy, A; Joliot, A; Wurst, W; Holt, C; Prochiantz, A				Wizenmann, Andrea; Brunet, Isabelle; Lam, Joyce S. Y.; Sonnier, Laure; Beurdeley, Marine; Zarbalis, Konstantinos; Weisenhorn-Vogt, Daniela; Weinl, Christine; Dwivedy, Asha; Joliot, Alain; Wurst, Wolfgang; Holt, Christine; Prochiantz, Alain			Extracellular Engrailed Participates in the Topographic Guidance of Retinal Axons In Vivo	NEURON			English	Article							GANGLION-CELL AXONS; VISUAL-SYSTEM; OPTIC TECTUM; GROWTH CONE; EPHRIN-AS; NASOTEMPORAL POLARITY; TRANSCRIPTION FACTOR; TYROSINE KINASES; MAP DEVELOPMENT; MESSENGER-RNA	Engrailed transcription factors regulate the expression of guidance cues that pattern retinal axon terminals in the dorsal midbrain. They also act directly to guide axon growth in vitro. We show here that an extracellular En gradient exists in the tectum along the anterior-posterior axis. Neutralizing extracellular Engrailed in vivo with antibodies expressed in the tectum causes temporal axons to map aberrantly to the posterior tectum in chick and Xenopus. Furthermore, posterior membranes from wild-type tecta incubated with anti-Engrailed antibodies or posterior membranes from Engrailed-1 knockout mice exhibit diminished repulsive activity for temporal axons. Since EphrinAs play a major role in anterior-posterior mapping, we tested whether Engrailed cooperates with EphrinA5 in vitro. We find that Engrailed restores full repulsion to axons given subthreshold doses of EphrinA5. Collectively, our results indicate that extracellular Engrailed contributes to retinotectal mapping in vivo by modulating the sensitivity of growth cones to EphrinA.	[Wizenmann, Andrea; Zarbalis, Konstantinos; Weisenhorn-Vogt, Daniela; Wurst, Wolfgang] Helmholtz Zentrum Munich, Inst Dev Genet, D-89675 Neuherberg, Germany; [Wizenmann, Andrea; Zarbalis, Konstantinos; Weisenhorn-Vogt, Daniela; Wurst, Wolfgang] MPI Psychiat, D-8004 Munich, Germany; [Brunet, Isabelle; Sonnier, Laure; Beurdeley, Marine; Prochiantz, Alain] Coll France, CNRS ENS CDF, Grp Dev & Neuropharmacol, Equipe FRM,UMR 8542, F-75231 Paris 05, France; [Wurst, Wolfgang] Tech Univ Munich, Dept Dev Genet, German Ctr Neurodegenerat Dis, Munich, Germany; [Joliot, Alain] Coll France, CNRS ENS CDF, Grp Cell Biol Homeoprot, UMR 8542, F-75231 Paris 05, France	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Max Planck Society; UDICE-French Research Universities; PSL Research University Paris; College de France; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Technical University of Munich; UDICE-French Research Universities; PSL Research University Paris; College de France	Holt, C (corresponding author), Univ Cambridge, Dept Physiol Dev & Neurosci, Downing St, Cambridge CB2 3DY, England.	ceh@mole.biol.cam.ac.uk; alain.prochiantz@ens.fr		Holt, Christine Elizabeth/0000-0003-2829-121X; Wurst, Wolfgang/0000-0003-4422-7410	Agence Nationale de la Recherche [ANR06, Neuro-013-01]; Wellcome Trust [WT070568, WT085314]; Deutsche Forschungsgemeinschaft [WU164/4-1, WU164/3-2]; EU [HPRN-CT-2001-00242]; Fondation pour la Recherche Medicale [FDT20061209092]	Agence Nationale de la Recherche(French National Research Agency (ANR)); Wellcome Trust(Wellcome Trust); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); EU(European Commission); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	We thank Drs. William Harris, Kenneth Moya, and Michel Volovitch for useful discussions. We are indebted to Raoul Torero-Ibad for En1/2 production, to Louis Leung for his blind analyses of turning assay results, and to Julien Falk, Kimmy Leung, Patricia Jusuf, and Hosung Jung for image analysis. Dr. Sophie Layalle provided a protocol to visualize extracellular proteins in Xenopus embryos. This work was supported by Agence Nationale de la Recherche (ANR06, Neuro-013-01), a Wellcome Trust Programme Grant (WT070568 & WT085314), the Deutsche Forschungsgemeinschaft (Forderkennzeichen WU164/4-1; WU164/3-2) and the EU-project HPRN-CT-2001-00242. I.B. was financed by Fondation pour la Recherche Medicale (FDT20061209092).	AUERBACH R, 1974, DEV BIOL, V41, P391, DOI 10.1016/0012-1606(74)90316-9; Bovolenta P, 2005, J NEUROBIOL, V64, P405, DOI 10.1002/neu.20161; Brunet I, 2005, NATURE, V438, P94, DOI 10.1038/nature04110; Brunet I, 2007, TRENDS NEUROSCI, V30, P260, DOI 10.1016/j.tins.2007.03.010; Buhusi M, 2008, J NEUROSCI, V28, P177, DOI 10.1523/JNEUROSCI.3573-07.2008; CHENG HJ, 1995, CELL, V82, P371, DOI 10.1016/0092-8674(95)90426-3; CHIEN CB, 1993, NEURON, V11, P237, DOI 10.1016/0896-6273(93)90181-P; Ciossek T, 1998, EUR J NEUROSCI, V10, P1574, DOI 10.1046/j.1460-9568.1998.00180.x; Claudepierre T, 2008, DEV DYNAM, V237, P3394, DOI 10.1002/dvdy.21759; Di Nardo AA, 2007, MOL CELL NEUROSCI, V35, P230, DOI 10.1016/j.mcn.2007.02.015; DRESCHER U, 1995, CELL, V82, P359, DOI 10.1016/0092-8674(95)90425-5; Dutting D, 1995, INT J DEV BIOL, V39, P921; Falk J, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-107; Feldheim DA, 2004, J NEUROSCI, V24, P2542, DOI 10.1523/JNEUROSCI.0239-03.2004; Feldheim DA, 2000, NEURON, V25, P563, DOI 10.1016/S0896-6273(00)81060-0; Flanagan JG, 2006, CURR OPIN NEUROBIOL, V16, P59, DOI 10.1016/j.conb.2006.01.010; Friedman GC, 1996, J NEUROSCI, V16, P5498; Frisen J, 1998, NEURON, V20, P235, DOI 10.1016/S0896-6273(00)80452-3; Furrer MP, 2007, DEVELOPMENT, V134, P3795, DOI 10.1242/dev.02882; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Haas K, 2001, NEURON, V29, P583, DOI 10.1016/S0896-6273(01)00235-5; HANKS M, 1995, SCIENCE, V269, P679, DOI 10.1126/science.7624797; Hansen MJ, 2004, NEURON, V42, P717, DOI 10.1016/j.neuron.2004.05.009; HEMMATIBRIVANLOU A, 1991, DEVELOPMENT, V111, P715; Holman D, 2007, J THEOR BIOL, V249, P503, DOI 10.1016/j.jtbi.2007.07.026; Hornberger MR, 1999, NEURON, V22, P731, DOI 10.1016/S0896-6273(00)80732-1; Itasaki N, 1996, NEURON, V16, P55, DOI 10.1016/S0896-6273(00)80023-9; Joliot A, 2004, NAT CELL BIOL, V6, P189, DOI 10.1038/ncb0304-189; Joliot A, 1997, DEVELOPMENT, V124, P1865; JOYNER AL, 1991, SEMINAR DEV BIOL, V2, P736; Knoll B, 2007, NAT PROTOC, V2, P1216, DOI 10.1038/nprot.2007.157; Lesaffre B, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-2; Logan C, 1996, CURR BIOL, V6, P1006, DOI 10.1016/S0960-9822(02)00645-0; Mann F, 2002, NEURON, V35, P461, DOI 10.1016/S0896-6273(02)00786-9; Maur AAD, 2004, METHODS, V34, P215, DOI 10.1016/j.ymeth.2004.04.004; McFarlane S, 1996, NEURON, V17, P245, DOI 10.1016/S0896-6273(00)80156-7; McLaughlin T, 2005, ANNU REV NEUROSCI, V28, P327, DOI 10.1146/annurev.neuro.28.061604.135714; Mueller BK, 1998, MECH DEVELOP, V74, P15, DOI 10.1016/S0925-4773(98)00058-6; Nakamura N, 1997, CELL, V89, P445, DOI 10.1016/S0092-8674(00)80225-1; O'Leary DDM, 2005, PROG BRAIN RES, V147, P43, DOI 10.1016/S0079-6123(04)47005-8; O'Leary DDM, 2002, CURR OPIN NEUROBIOL, V12, P14, DOI 10.1016/S0959-4388(02)00285-4; Pfeiffenberger C, 2006, J NEUROSCI, V26, P12873, DOI 10.1523/JNEUROSCI.3595-06.2006; RAPER JA, 1990, NEURON, V4, P21, DOI 10.1016/0896-6273(90)90440-Q; SAKAGUCHI DS, 1989, DEV BIOL, V134, P158, DOI 10.1016/0012-1606(89)90086-9; Schmickl R, 2008, PLANT ECOL DIVERS, V1, P245, DOI 10.1080/17550870802349138; Shigetani Y, 1997, NEUROSCI RES, V27, P211, DOI 10.1016/S0168-0102(96)01151-0; Sonnier L, 2007, J NEUROSCI, V27, P1063, DOI 10.1523/JNEUROSCI.4583-06.2007; SPERRY RW, 1963, P NATL ACAD SCI USA, V50, P703, DOI 10.1073/pnas.50.4.703; Strochlic L, 2008, DEVELOPMENT, V135, P333, DOI 10.1242/dev.009563; Strube RW, 2004, METHODS, V34, P179, DOI 10.1016/j.ymeth.2004.04.003; Sugiyama S, 2008, CELL, V134, P508, DOI 10.1016/j.cell.2008.05.054; Swartz M, 2001, DEV BIOL, V233, P13, DOI 10.1006/dbio.2001.0181; THANOS S, 1991, NEUROSCI LETT, V127, P108, DOI 10.1016/0304-3940(91)90906-A; VIELMETTER J, 1990, EXP BRAIN RES, V81, P283; WALTER J, 1987, DEVELOPMENT, V101, P685; WALTER J, 1987, DEVELOPMENT, V101, P909; Weinl C, 2005, J NEUROBIOL, V62, P219, DOI 10.1002/neu.20101; WILKINSON DG, 1993, METHOD ENZYMOL, V225, P361; WURST W, 1994, DEVELOPMENT, V120, P2065; Yates PA, 2001, J NEUROSCI, V21, P8548, DOI 10.1523/JNEUROSCI.21-21-08548.2001	60	76	77	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 12	2009	64	3					355	366		10.1016/j.neuron.2009.09.018	http://dx.doi.org/10.1016/j.neuron.2009.09.018			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	521MF	19914184	Bronze, Green Accepted			2022-12-24	WOS:000271924800010
J	Grathwohl, SA; Kalin, RE; Bolmont, T; Prokop, S; Winkelmann, G; Kaeser, SA; Odenthal, J; Radde, R; Eldh, T; Gandy, S; Aguzzi, A; Staufenbiel, M; Mathews, PM; Wolburg, H; Heppner, FL; Jucker, M				Grathwohl, Stefan A.; Kaelin, Roland E.; Bolmont, Tristan; Prokop, Stefan; Winkelmann, Georg; Kaeser, Stephan A.; Odenthal, Joerg; Radde, Rebecca; Eldh, Therese; Gandy, Sam; Aguzzi, Adriano; Staufenbiel, Matthias; Mathews, Paul M.; Wolburg, Hartwig; Heppner, Frank L.; Jucker, Mathias			Formation and maintenance of Alzheimer's disease beta-amyloid plaques in the absence of microglia	NATURE NEUROSCIENCE			English	Article							TRANSGENIC MICE; PATHOLOGY; BRAIN; CELLS	In Alzheimer's disease, microglia cluster around beta-amyloid deposits, suggesting that these cells are important for amyloid plaque formation, maintenance and/or clearance. We crossed two distinct APP transgenic mouse strains with CD11b-HSVTK mice, in which nearly complete ablation of microglia was achieved for up to 4 weeks after ganciclovir application. Neither amyloid plaque formation and maintenance nor amyloid-associated neuritic dystrophy depended on the presence of microglia.	[Kaelin, Roland E.; Prokop, Stefan; Winkelmann, Georg; Heppner, Frank L.] Charite, Dept Neuropathol, D-13353 Berlin, Germany; [Grathwohl, Stefan A.; Bolmont, Tristan; Kaeser, Stephan A.; Odenthal, Joerg; Radde, Rebecca; Jucker, Mathias] Univ Tubingen, Hertie Inst Clin Brain Res, Dept Cellular Neurol, Tubingen, Germany; [Grathwohl, Stefan A.; Bolmont, Tristan; Kaeser, Stephan A.; Odenthal, Joerg; Radde, Rebecca; Jucker, Mathias] German Ctr Neurodegenerat Dis, Tubingen, Germany; [Grathwohl, Stefan A.] Univ Tubingen, Grad Sch Cellular & Mol Neurosci, Tubingen, Germany; [Eldh, Therese] Univ Tubingen, Dept Radiat Oncol, Tubingen, Germany; [Gandy, Sam] Mt Sinai Sch Med, Dept Neurol, New York, NY USA; [Aguzzi, Adriano] Univ Zurich Hosp, Dept Pathol, Inst Neuropathol, CH-8091 Zurich, Switzerland; [Staufenbiel, Matthias] Novartis Inst Biomed Res, Basel, Switzerland; [Mathews, Paul M.] Nathan S Kline Inst Psychiat Res, Orangeburg, NY USA; [Mathews, Paul M.] NYU, Sch Med, Dept Psychiat, New York, NY USA; [Wolburg, Hartwig] Univ Tubingen, Dept Pathol, Tubingen, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Icahn School of Medicine at Mount Sinai; University of Zurich; University Zurich Hospital; Novartis; Nathan Kline Institute for Psychiatric Research; New York University; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Heppner, FL (corresponding author), Charite, Dept Neuropathol, D-13353 Berlin, Germany.	frank.heppner@charite.de; mathias.jucker@uni-tuebingen.de	Kälin, Roland/AAG-9161-2020; Heppner, Frank/ABH-8393-2020	Heppner, Frank/0000-0001-9816-8917; Prokop, Stefan/0000-0002-5633-2149; Mathews, Paul/0000-0003-1742-7687; Aguzzi, Adriano/0000-0002-0344-6708	National Institutes of Neurological Disorders and Stroke [R01 NS046006]; US National Institutes of Health [AG017617, NS045205];  [BMBF-01GI0705];  [SFB-TR43, Exc 25]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045205, R01NS046006] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG017617, P01AG010491] Funding Source: NIH RePORTER	National Institutes of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants to M.J. (BMBF-01GI0705), F. L. H. (SFB-TR43, Exc 25 and National Institutes of Neurological Disorders and Stroke R01 NS046006) and P. M. M. (US National Institutes of Health AG017617 and NS045205).	Bolmont T, 2008, J NEUROSCI, V28, P4283, DOI 10.1523/JNEUROSCI.4814-07.2008; El Khoury J, 2008, TRENDS PHARMACOL SCI, V29, P626, DOI 10.1016/j.tips.2008.08.004; GRUYS E, 1979, LAB ANIM-UK, V13, P1, DOI 10.1258/002367779781071230; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Heppner FL, 2005, NAT MED, V11, P146, DOI 10.1038/nm1177; Jucker M, 2008, NEURON, V59, P8, DOI 10.1016/j.neuron.2008.06.014; Meyer-Luehmann M, 2008, NATURE, V451, P720, DOI 10.1038/nature06616; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Radde R, 2006, EMBO REP, V7, P940, DOI 10.1038/sj.embor.7400784; Schenk D, 2002, NAT REV NEUROSCI, V3, P824, DOI 10.1038/nrn938; Simard AR, 2006, NEURON, V49, P489, DOI 10.1016/j.neuron.2006.01.022; Stalder M, 1999, AM J PATHOL, V154, P1673, DOI 10.1016/S0002-9440(10)65423-5; SturchlerPierrat C, 1997, P NATL ACAD SCI USA, V94, P13287, DOI 10.1073/pnas.94.24.13287; Town T, 2008, NAT MED, V14, P681, DOI 10.1038/nm1781; Wyss-Coray T, 2006, NAT MED, V12, P1005, DOI 10.1038/nml1484	15	317	323	1	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2009	12	11					1361	1363		10.1038/nn.2432	http://dx.doi.org/10.1038/nn.2432			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	511UE	19838177	Green Accepted			2022-12-24	WOS:000271194100005
J	Trowbridge, JJ; Snow, JW; Kim, J; Orkin, SH				Trowbridge, Jennifer J.; Snow, Jonathan W.; Kim, Jonghwan; Orkin, Stuart H.			DNA Methyltransferase 1 Is Essential for and Uniquely Regulates Hematopoietic Stem and Progenitor Cells	CELL STEM CELL			English	Article							SELF-RENEWAL; METHYLATION; DIFFERENTIATION; MAINTENANCE; SURVIVAL; DNMT3B	DNA methylation is essential for development and in diverse biological processes. The DNA methyltransferase Dnmt1 maintains parental cell methylation patterns on daughter DNA strands in mitotic cells; however, the precise role of Dnmt1 in regulation of quiescent adult stem cells is not known. To examine the role of Dnmt1 in adult hematopoietic stem cells (HSCs), we conditionally disrupted Dnmt1 in the hematopoietic system. Defects were observed in Dnmt1 deficient HSC self-renewal, niche retention, and in the ability of Dnmt1-deficient HSCs to give rise to multilineage hematopoiesis. Loss of Dnmt1 also had specific impact on myeloid progenitor cells, causing enhanced cell cycling and inappropriate expression of mature lineage genes. Dnmt1 regulates distinct patterns of methylation and expression of discrete gene families in long-term HSCs and multipotent and lineage-restricted progenitors, suggesting that Dnmt1 differentially controls these populations. These findings establish a unique and critical role for Dnmt1 in the primitive hematopoietic compartment.	[Trowbridge, Jennifer J.; Snow, Jonathan W.; Kim, Jonghwan; Orkin, Stuart H.] Harvard Univ, Sch Med, Dept Pediat Oncol, Dana Farber Canc Inst, Boston, MA 02115 USA; [Kim, Jonghwan; Orkin, Stuart H.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Dana Farber Canc Inst, Boston, MA 02115 USA; [Trowbridge, Jennifer J.; Snow, Jonathan W.; Kim, Jonghwan; Orkin, Stuart H.] Harvard Univ, Sch Med, Childrens Hosp Boston,Div Hematol Oncol, Harvard Stem Cell Inst,Dept Pediat Oncol, Boston, MA 02115 USA; [Kim, Jonghwan; Orkin, Stuart H.] Harvard Univ, Sch Med, Childrens Hosp Boston,Div Hematol Oncol, Harvard Stem Cell Inst,Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Howard Hughes Medical Institute	Orkin, SH (corresponding author), Harvard Univ, Sch Med, Dept Pediat Oncol, Dana Farber Canc Inst, Boston, MA 02115 USA.	orkin@bloodgroup.tch.harvard.edu	Kim, Jonghwan/AAR-2815-2021	Kim, Jonghwan/0000-0002-9919-9843	Fellows of the Leukemia & Lymphoma Society; HHMI Research Associate; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK049216] Funding Source: NIH RePORTER	Fellows of the Leukemia & Lymphoma Society; HHMI Research Associate(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Drs. C.R. Walkley, L.E. Purton, J. Xu, D.A. Williams, G.C. Yuan, and M.D. Kiers for helpful discussion and critical comments; J. Chong for technical assistance; Children's Hospital Animal Facility Staff for care of experimental animals; and J. Daley and S. Lazo-Kallanian of the DFCI HemNeo Flow Facility for cell sorting. J.J.T. and J.W.S. are Fellows of the Leukemia & Lymphoma Society, J.K. is a HHMI Research Associate, and S.H.O. is an Investigator of the HHMI.	Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Fan GP, 2001, J NEUROSCI, V21, P788, DOI 10.1523/JNEUROSCI.21-03-00788.2001; Gaudet F, 2004, MOL CELL BIOL, V24, P1640, DOI 10.1128/MCB.24.4.1640-1648.2004; Hock H, 2004, GENE DEV, V18, P2336, DOI 10.1101/gad.1239604; Jackson-Grusby L, 2001, NAT GENET, V27, P31, DOI 10.1038/83730; Jaenisch R, 1997, TRENDS GENET, V13, P323, DOI 10.1016/S0168-9525(97)01180-3; Jasinski M, 2001, BLOOD, V98, P2248, DOI 10.1182/blood.V98.7.2248; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Lei H, 1996, DEVELOPMENT, V122, P3195; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Schadt EE, 2001, J CELL BIOCHEM, V84, P120, DOI 10.1002/jcb.10073; Tadokoro Y, 2007, J EXP MED, V204, P715, DOI 10.1084/jem.20060750; Tsumura A, 2006, GENES CELLS, V11, P805, DOI 10.1111/j.1365-2443.2006.00984.x; VILLEVAL JL, 1985, BLOOD, V66, P1162; Walkley CR, 2007, CELL, V129, P1081, DOI 10.1016/j.cell.2007.03.055	16	258	261	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	OCT 2	2009	5	4					442	449		10.1016/j.stem.2009.08.016	http://dx.doi.org/10.1016/j.stem.2009.08.016			8	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	514NP	19796624	Green Accepted, Bronze			2022-12-24	WOS:000271401900015
J	Van Hoof, D; Munoz, J; Braam, SR; Pinkse, MWH; Linding, R; Heck, AJR; Mummery, CL; Krijgsveld, J				Van Hoof, Dennis; Munoz, Javier; Braam, Stefan R.; Pinkse, Martijn W. H.; Linding, Rune; Heck, Albert J. R.; Mummery, Christine L.; Krijgsveld, Jeroen			Phosphorylation Dynamics during Early Differentiation of Human Embryonic Stem Cells	CELL STEM CELL			English	Article							TRANSCRIPTIONAL REGULATORY CIRCUITRY; SELF-RENEWAL; IN-VIVO; PLURIPOTENCY; PROTEIN; SOX2; NANOG; EXPRESSION; TARGET; METHYLATION	Pluripotent stem cells, self-renew indefinitely and possess characteristic protein-protein networks that remodel during differentiation. How this occurs is poorly understood. Using quantitative mass spectrometry, we analyzed the (phospho)proteome of human embryonic stem cells (hESCs) during differentiation induced by bone morphogenetic protein (BMP) and removal of hESC growth factors. Of 5222 proteins identified, 1399 were phosphorylated on 3067 residues. Approximately 50% of these phosphosites were regulated within 1 hr of differentiation induction, revealing a complex interplay of phosphorylation networks spanning different signaling pathways and kinase activities. Among the phosphorylated proteins was the pluripotency-associated protein SOX2, which was SUMOylated as a result of phosphorylation. Using the data to predict kinase-substrate relationships, we reconstructed the hESC kinome, CDK1/2 emerged as central in controlling se renewal and lineage specification. The findings provide new insights into how hESCs exit the pluripotent state and present the hESC (phospho)proteome resource as a complement to existing pluripotency network databases.	[Van Hoof, Dennis; Munoz, Javier; Pinkse, Martijn W. H.; Heck, Albert J. R.; Krijgsveld, Jeroen] Univ Utrecht, Biomol Mass Spectrometry & Prote Grp, Bijvoet Ctr Biomol Res, NL-3584 CH Utrecht, Netherlands; [Van Hoof, Dennis; Munoz, Javier; Pinkse, Martijn W. H.; Heck, Albert J. R.; Krijgsveld, Jeroen] Univ Utrecht, Utrecht Inst Pharmaceut Sci, NL-3584 CH Utrecht, Netherlands; [Van Hoof, Dennis; Braam, Stefan R.; Mummery, Christine L.] Hubrecht Inst, NL-3584 CT Utrecht, Netherlands; [Braam, Stefan R.; Mummery, Christine L.] Leiden Univ, Med Ctr, Dept Anat & Embryol, NL-2333 ZC Leiden, Netherlands; [Linding, Rune] Inst Canc Res, Sect Cell & Mol Biol, Cellular & Mol Log Team, London SW3 6JB, England	Utrecht University; Utrecht University; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	Heck, AJR (corresponding author), Univ Utrecht, Biomol Mass Spectrometry & Prote Grp, Bijvoet Ctr Biomol Res, Padualaan 8, NL-3584 CH Utrecht, Netherlands.	a.j.r.heck@uu.nl; c.l.mummery@lumc.nl; jeroen.krijgsveld@embl.de	Krijgsveld, Jeroen/F-5974-2011; Munoz, Javier/I-4891-2012; Heck, Albert/D-7098-2011	Munoz, Javier/0000-0003-3288-3496; Heck, Albert/0000-0002-2405-4404; Linding, Rune/0000-0003-0420-4839; Krijgsveld, Jeroen/0000-0001-7549-9326; Mummery, Christine/0000-0002-4549-6535	Bsik programmes "Dutch Platform for Tissue Engineering," Stem Cells in Development and Disease; Netherlands Proteomic Center; FP6 EU Programme Heart Development and Heart Repair; Netherlands Organisation for Scientific Research (NWO)	Bsik programmes "Dutch Platform for Tissue Engineering," Stem Cells in Development and Disease; Netherlands Proteomic Center; FP6 EU Programme Heart Development and Heart Repair; Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	We thank Dr. A.C.O. Vertegaal for the nickel-nitrilotriacetic acid-agarose bead purification experiments; Dr. D. Melton for HUES-7; Dr. N.A. Hanley for pcDNA3.1/Zeo-hSox2; Dr. C. Denning for pCAG-GFP-IRES-Puror; Dr. M.J. Goumans for p-GSK3 beta and p-4EIFEBP1 antibodies; S. Mohammed for mass spectrometry support; and J. Gouw, B. van Breukelen, and H. van den Toorn for in-house software development. This work was supported by the Bsik programmes "Dutch Platform for Tissue Engineering," Stem Cells in Development and Disease; by the Netherlands Proteomic Center; by the FP6 EU Programme Heart Development and Heart Repair; and by the Netherlands Organisation for Scientific Research (NWO).	Adewumi O, 2007, NAT BIOTECHNOL, V25, P803, DOI 10.1038/nbt1318; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Binetruy B, 2007, STEM CELLS, V25, P1090, DOI 10.1634/stemcells.2006-0612; Botuyan MV, 2006, CELL, V127, P1361, DOI 10.1016/j.cell.2006.10.043; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Braam SR, 2008, NAT METHODS, V5, P389, DOI 10.1038/NMETH.1200; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chen GQ, 2000, GENE, V249, P1, DOI 10.1016/S0378-1119(00)00161-X; Chew JL, 2005, MOL CELL BIOL, V25, P6031, DOI 10.1128/MCB.25.14.6031-6046.2005; Diella F, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-79; Eckert JJ, 2008, BBA-BIOMEMBRANES, V1778, P717, DOI 10.1016/j.bbamem.2007.09.031; Efroni S, 2008, CELL STEM CELL, V2, P437, DOI 10.1016/j.stem.2008.03.021; Feldman N, 2006, NAT CELL BIOL, V8, P188, DOI 10.1038/ncb1353; Fong HL, 2008, STEM CELLS, V26, P1931, DOI 10.1634/stemcells.2007-1002; Freund C, 2008, STEM CELLS, V26, P724, DOI 10.1634/stemcells.2007-0617; Fujita J, 2008, CELL STEM CELL, V2, P595, DOI 10.1016/j.stem.2008.04.001; Gruhler A, 2005, MOL CELL PROTEOMICS, V4, P310, DOI 10.1074/mcp.M400219-MCP200; GU Y, 1992, EMBO J, V11, P3995, DOI 10.1002/j.1460-2075.1992.tb05493.x; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Hietakangas V, 2006, P NATL ACAD SCI USA, V103, P45, DOI 10.1073/pnas.0503698102; Irvine K, 2004, INT J DEV BIOL, V48, P1065, DOI 10.1387/ijdb.041893ki; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Jelier R, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-6-r96; Kopp JL, 2008, STEM CELLS, V26, P903, DOI 10.1634/stemcells.2007-0951; Kratchmarova I, 2005, SCIENCE, V308, P1472, DOI 10.1126/science.1107627; Linding R, 2007, CELL, V129, P1415, DOI 10.1016/j.cell.2007.05.052; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; Mi HY, 2007, NUCLEIC ACIDS RES, V35, pD247, DOI 10.1093/nar/gkl869; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Miller-Jensen K, 2007, NATURE, V448, P604, DOI 10.1038/nature06001; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Muller FJ, 2008, NATURE, V455, P401, DOI 10.1038/nature07213; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Pan GJ, 2007, CELL STEM CELL, V1, P299, DOI 10.1016/j.stem.2007.08.003; Pera MF, 2004, J CELL SCI, V117, P1269, DOI 10.1242/jcs.00970; Pinkse MWH, 2008, J PROTEOME RES, V7, P687, DOI 10.1021/pr700605z; Sampath P, 2008, CELL STEM CELL, V2, P448, DOI 10.1016/j.stem.2008.03.013; Schimmel J, 2008, MOL CELL PROTEOMICS, V7, P2107, DOI 10.1074/mcp.M800025-MCP200; Shao ZL, 2006, CIRC RES, V98, P111, DOI 10.1161/01.RES.0000197781.20524.b9; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tsuruzoe S, 2006, BIOCHEM BIOPH RES CO, V351, P920, DOI 10.1016/j.bbrc.2006.10.130; Vallier L, 2005, J CELL SCI, V118, P4495, DOI 10.1242/jcs.02553; van den Boom V, 2007, J CELL BIOL, V178, P913, DOI 10.1083/jcb.200702058; Van Hoof D, 2007, NAT METHODS, V4, P677, DOI 10.1038/nmeth0907-677; Van Hoof D, 2006, MOL CELL PROTEOMICS, V5, P1261, DOI 10.1074/mcp.M500405-MCP200; Van Hoof D, 2008, STEM CELLS, V26, P2777, DOI 10.1634/stemcells.2008-0365; Vertegaal ACO, 2004, J BIOL CHEM, V279, P33791, DOI 10.1074/jbc.M404201200; Vertegaal ACO, 2006, MOL CELL PROTEOMICS, V5, P2298, DOI 10.1074/mcp.M600212-MCP200; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Xu RH, 2008, CELL STEM CELL, V3, P196, DOI 10.1016/j.stem.2008.07.001; Xu RH, 2002, NAT BIOTECHNOL, V20, P1261, DOI 10.1038/nbt761; Xu RH, 2005, NAT METHODS, V2, P185, DOI 10.1038/NMETH744; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; YUAN HB, 1995, GENE DEV, V9, P2635, DOI 10.1101/gad.9.21.2635	64	253	258	0	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	AUG 7	2009	5	2					214	226		10.1016/j.stem.2009.05.021	http://dx.doi.org/10.1016/j.stem.2009.05.021			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	490PB	19664995	Bronze			2022-12-24	WOS:000269511900014
J	Chin, MH; Mason, MJ; Xie, W; Volinia, S; Singer, M; Peterson, C; Ambartsumyan, G; Aimiuwu, O; Richter, L; Zhang, J; Khvorostov, I; Ott, V; Grunstein, M; Lavon, N; Benvenisty, N; Croce, CM; Clark, AT; Baxter, T; Pyle, AD; Teitell, MA; Pelegrini, M; Plath, K; Lowry, WE				Chin, Mark H.; Mason, Mike J.; Xie, Wei; Volinia, Stefano; Singer, Mike; Peterson, Cory; Ambartsumyan, Gayane; Aimiuwu, Otaren; Richter, Laura; Zhang, Jin; Khvorostov, Ivan; Ott, Vanessa; Grunstein, Michael; Lavon, Neta; Benvenisty, Nissim; Croce, Carlo M.; Clark, Amander T.; Baxter, Tim; Pyle, April D.; Teitell, Mike A.; Pelegrini, Matteo; Plath, Kathrin; Lowry, William E.			Induced Pluripotent Stem Cells and Embryonic Stem Cells Are Distinguished by Gene Expression Signatures	CELL STEM CELL			English	Article							DIFFERENTIATION; FIBROBLASTS; GENERATION; INDUCTION; SKIN; DERIVATION	Induced pluripotent stem cells (iPSCs) outwardly appear to be indistinguishable from embryonic stem cells (ESCs). A study of gene expression profiles of mouse and human ESCs and iPSCs suggests that, while iPSCs are quite similar to their embryonic counterparts, a recurrent gene expression signature appears in iPSCs regardless of their origin or the method by which they were generated. Upon extended culture, hiPSCs adopt a gene expression profile more similar to hESCs; however, they still retain a gene expression signature unique from hESCs that extends to miRNA expression. Genome-wide data suggested that the iPSC signature gene expression differences are due to differential promoter binding by the reprogramming factors. High-resolution array profiling demonstrated that there is no common specific subkaryotypic alteration that is required for reprogramming and that reprogramming does not lead to genomic instability. Together, these data suggest that iPSCs should be considered a unique subtype of pluripotent cell.	[Chin, Mark H.; Mason, Mike J.; Xie, Wei; Grunstein, Michael; Plath, Kathrin] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA; [Ambartsumyan, Gayane; Aimiuwu, Otaren; Richter, Laura; Clark, Amander T.; Pelegrini, Matteo; Lowry, William E.] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; [Peterson, Cory; Pyle, April D.] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Zhang, Jin; Khvorostov, Ivan; Teitell, Mike A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol, Los Angeles, CA 90095 USA; [Zhang, Jin; Khvorostov, Ivan; Teitell, Mike A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Los Angeles, CA 90095 USA; [Clark, Amander T.; Pyle, April D.; Teitell, Mike A.; Plath, Kathrin; Lowry, William E.] Univ Calif Los Angeles, Broad Stem Cell Ctr, Los Angeles, CA 90095 USA; [Clark, Amander T.; Pyle, April D.; Teitell, Mike A.; Plath, Kathrin; Lowry, William E.] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA; [Clark, Amander T.; Pyle, April D.; Teitell, Mike A.; Pelegrini, Matteo; Plath, Kathrin; Lowry, William E.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; [Mason, Mike J.] Univ Calif Los Angeles, Dept Stat, Los Angeles, CA 90095 USA; [Lavon, Neta; Benvenisty, Nissim] Hebrew Univ Jerusalem, Dept Genet, IL-91904 Jerusalem, Israel; [Volinia, Stefano; Croce, Carlo M.] Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [Singer, Mike; Ott, Vanessa; Baxter, Tim] Roche NimbleGen Inc, Madison, WI 53719 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Hebrew University of Jerusalem; University System of Ohio; Ohio State University; Roche Holding	Plath, K (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA.	kplath@mednet.ucla.edu; blowry@ucla.edu	Xie, Wei/J-1380-2017; ZHANG, JIN/D-1435-2013; Young, Richard A/F-6495-2012; Volinia, Stefano/AAA-9264-2019; Volinia, Stefano/A-3029-2010	Xie, Wei/0000-0003-2126-3849; Young, Richard A/0000-0001-8855-8647; Volinia, Stefano/0000-0003-0910-3893; Volinia, Stefano/0000-0003-0910-3893; Plath, Kathrin/0000-0001-7796-3372; Mason, Michael/0000-0002-5652-7739	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K12HD001281] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [T32CA009056, P01CA129242] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM081621, R37GM023674, R01GM023674] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD001686] Funding Source: NIH RePORTER; NCI NIH HHS [P01 CA129242, T32 CA009056, #T32 CA009056] Funding Source: Medline; NICHD NIH HHS [K12 HD001281, 5 K12 HD001281] Funding Source: Medline; NIGMS NIH HHS [P01 GM081621-01A1, R01 GM023674, P01 GM081621, R37 GM023674, GM23674] Funding Source: Medline; NIH HHS [DP2 OD001686-01, DP2 OD001686] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Cao R, 2004, CURR OPIN GENET DEV, V14, P155, DOI 10.1016/j.gde.2004.02.001; Card DAG, 2008, MOL CELL BIOL, V28, P6426, DOI 10.1128/MCB.00359-08; Choi KD, 2009, STEM CELLS, V27, P559, DOI 10.1634/stemcells.2008-0922; Gokhale PJ, 2006, SEMIN REPROD MED, V24, P289, DOI 10.1055/s-2006-952151; Gurdon JB, 2008, SCIENCE, V322, P1811, DOI 10.1126/science.1160810; Hochedlinger K, 2009, DEVELOPMENT, V136, P509, DOI 10.1242/dev.020867; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Judson RL, 2009, NAT BIOTECHNOL, V27, P459, DOI 10.1038/nbt.1535; Kaji K, 2009, NATURE, V458, P771, DOI 10.1038/nature07864; Karumbayaram S, 2009, STEM CELLS, V27, P806, DOI 10.1002/stem.31; Keller G, 2005, GENE DEV, V19, P1129, DOI 10.1101/gad.1303605; Krutzfeldt J, 2006, NAT GENET, V38, pS14, DOI 10.1038/ng1799; Laurent LC, 2008, STEM CELLS, V26, P1506, DOI 10.1634/stemcells.2007-1081; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Maherali N, 2008, CELL STEM CELL, V3, P340, DOI 10.1016/j.stem.2008.08.003; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Markoulaki S, 2008, METHODS, V45, P101, DOI 10.1016/j.ymeth.2008.04.002; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Ng RK, 2008, NAT CELL BIOL, V10, P102, DOI 10.1038/ncb1674; Nishikawa S, 2008, NAT REV MOL CELL BIO, V9, P725, DOI 10.1038/nrm2466; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Osafune K, 2008, NAT BIOTECHNOL, V26, P313, DOI 10.1038/nbt1383; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Park TS, 2009, STEM CELLS, V27, P783, DOI 10.1002/stem.13; Selzer RR, 2005, GENE CHROMOSOME CANC, V44, P305, DOI 10.1002/gcc.20243; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Stadtfeld M, 2008, SCIENCE, V322, P945, DOI 10.1126/science.1162494; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tang GL, 2005, TRENDS BIOCHEM SCI, V30, P106, DOI 10.1016/j.tibs.2004.12.007; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Wilson KD, 2009, STEM CELLS DEV, V18, P749, DOI 10.1089/scd.2008.0247; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863; Yi R, 2006, NAT GENET, V38, P356, DOI 10.1038/ng1744; Yi R, 2008, NATURE, V452, P225, DOI 10.1038/nature06642; Yi R, 2009, P NATL ACAD SCI USA, V106, P498, DOI 10.1073/pnas.0810766105; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482; Zhang JH, 2009, CIRC RES, V104, pE30, DOI 10.1161/CIRCRESAHA.108.192237; Zhang L, 2008, P NATL ACAD SCI USA, V105, P7004, DOI 10.1073/pnas.0801615105	41	758	827	0	130	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUL 2	2009	5	1					111	123		10.1016/j.stem.2009.06.008	http://dx.doi.org/10.1016/j.stem.2009.06.008			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	469ET	19570518	Bronze, Green Accepted			2022-12-24	WOS:000267879200015
J	Dugas, JC; Cuellar, TL; Scholze, A; Ason, B; Ibrahim, A; Emery, B; Zamanian, JL; Foo, LC; McManus, MT; Barres, BA				Dugas, Jason C.; Cuellar, Trinna L.; Scholze, Anja; Ason, Brandon; Ibrahim, Adiljan; Emery, Ben; Zamanian, Jennifer L.; Foo, Lynette C.; McManus, Michael T.; Barres, Ben A.			Dicer1 and miR-219 Are Required for Normal Oligodendrocyte Differentiation and Myelination	NEURON			English	Article							GLIAL PROGENITOR-CELL; MICRORNA EXPRESSION; GROWTH-FACTOR; TRANSCRIPTION FACTORS; NERVOUS-SYSTEM; CYCLE EXIT; PROTEIN; IDENTIFICATION; LINEAGE; NEURONS	To investigate the role of microRNAs in regulating oligodendrocyte (OL) differentiation and myelination, we utilized transgenic mice in which microRNA processing was disrupted in OL precursor cells (OPCs) and OLs by targeted deletion of Dicer1. We found that inhibition of OPC-OL miRNA processing disrupts normal CNS myelination and that OPCs lacking mature miRNAs fail to differentiate normally in vitro. We identified three miRNAs (miR-219, miR-138, and miR-338) that are induced 10-100x during OL differentiation; the most strongly induced of these, miR-219, is necessary and sufficient to promote OL differentiation, and partially rescues OL differentiation defects caused by total miRNA loss. miR-219 directly represses the expression of PDGFR alpha, Sox6, FoxJ3, and ZFP238 proteins, all of which normally help to promote OPC proliferation. Together, these findings show that miR-219 plays a critical role in coupling differentiation to proliferation arrest in the OL lineage, enabling the rapid transition from proliferating OPCs to myelinating OLs.	[Dugas, Jason C.; Scholze, Anja; Ibrahim, Adiljan; Emery, Ben; Zamanian, Jennifer L.; Foo, Lynette C.; Barres, Ben A.] Stanford Univ, Dept Neurobiol, Sch Med, Stanford, CA 94305 USA; [Cuellar, Trinna L.; Ason, Brandon; McManus, Michael T.] Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA	Stanford University; University of California System; University of California San Francisco	Dugas, JC (corresponding author), Stanford Univ, Dept Neurobiol, Sch Med, Stanford, CA 94305 USA.	jcdugas@alum.mit.edu	Emery, Ben/I-6223-2013; mcmanus, michael/AAB-1239-2020	mcmanus, michael/0000-0003-3013-6569; Cuellar, Trinna/0000-0002-9991-9505; Emery, Ben/0000-0002-9132-3045; Zamanian, Jennifer/0000-0003-1256-7496	Myelin Repair Foundation; NIH [5R03DA022201]; NATIONAL INSTITUTE ON DRUG ABUSE [R03DA022201] Funding Source: NIH RePORTER	Myelin Repair Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank Prof. Klaus-Armin Nave for kindly providing the CNP-Cre mouse line. Prof. David Flowitch for providing the Olig2-Cre mouse line, and Prof. Chang-Zheng Chen for providing the floxed-Dicer mouse line. We would also like to thank Prof. Michael Wegner for generously providing the Sox6 antibody, This work was funded by the Myelin Repair Foundation and by NIH grant 5R03DA022201.	Aoki K, 1998, J BIOL CHEM, V273, P26698, DOI 10.1074/jbc.273.41.26698; Assanah MC, 2009, GLIA, V57, P1835, DOI 10.1002/glia.20895; Assanah M, 2006, J NEUROSCI, V26, P6781, DOI 10.1523/JNEUROSCI.0514-06.2006; BARRES BA, 1994, NEURON, V12, P935, DOI 10.1016/0896-6273(94)90305-0; BARRES BA, 1993, DEVELOPMENT, V118, P283; BARRES BA, 1994, DEVELOPMENT, V120, P1097; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baumann N, 2001, PHYSIOL REV, V81, P871, DOI 10.1152/physrev.2001.81.2.871; BESNARD F, 1987, NEUROSCI LETT, V73, P287, DOI 10.1016/0304-3940(87)90260-6; Buttitta LA, 2007, CURR OPIN CELL BIOL, V19, P697, DOI 10.1016/j.ceb.2007.10.004; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Calver AR, 1998, NEURON, V20, P869, DOI 10.1016/S0896-6273(00)80469-9; Carleton M, 2007, CELL CYCLE, V6, P2127, DOI 10.4161/cc.6.17.4641; Casaccia-Bonnefil P, 2003, J NEUROSCI RES, V72, P1, DOI 10.1002/jnr.10565; Cheng HYM, 2007, NEURON, V54, P813, DOI 10.1016/j.neuron.2007.05.017; Cuellar TL, 2008, P NATL ACAD SCI USA, V105, P5614, DOI 10.1073/pnas.0801689105; Davis TH, 2008, J NEUROSCI, V28, P4322, DOI 10.1523/JNEUROSCI.4815-07.2008; Dugas JC, 2006, J NEUROSCI, V26, P10967, DOI 10.1523/JNEUROSCI.2572-06.2006; Durand B, 2000, BIOESSAYS, V22, P64; Emery B, 2009, CELL, V138, P172, DOI 10.1016/j.cell.2009.04.031; Ferretti E, 2009, INT J CANCER, V124, P568, DOI 10.1002/ijc.23948; Harfe BD, 2005, P NATL ACAD SCI USA, V102, P10898, DOI 10.1073/pnas.0504834102; Izzotti A, 2009, FASEB J, V23, P806, DOI 10.1096/fj.08-121384; Kim J, 2004, P NATL ACAD SCI USA, V101, P360, DOI 10.1073/pnas.2333854100; Kitzmann M, 2001, CELL MOL LIFE SCI, V58, P571, DOI 10.1007/PL00000882; Kocerha J, 2009, P NATL ACAD SCI USA, V106, P3507, DOI 10.1073/pnas.0805854106; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Landgren H, 2004, DEV DYNAM, V231, P396, DOI 10.1002/dvdy.20131; Lang D, 2007, BIOCHEM PHARMACOL, V73, P1, DOI 10.1016/j.bcp.2006.06.024; Lappe-Siefke C, 2003, NAT GENET, V33, P366, DOI 10.1038/ng1095; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lynn FC, 2007, DIABETES, V56, P2938, DOI 10.2337/db07-0175; MATTHIEU JM, 1980, J NEUROCHEM, V35, P1345, DOI 10.1111/j.1471-4159.1980.tb09008.x; Okado H, 2009, DEV BIOL, V331, P140, DOI 10.1016/j.ydbio.2009.04.030; Politis PK, 2008, CELL CYCLE, V7, P691, DOI 10.4161/cc.7.6.5550; RAFF MC, 1983, NATURE, V303, P390, DOI 10.1038/303390a0; Raff MC, 1998, INT J DEV BIOL, V42, P263; Ruby JG, 2007, GENOME RES, V17, P1850, DOI 10.1101/gr.6597907; Schuller U, 2008, CANCER CELL, V14, P123, DOI 10.1016/j.ccr.2008.07.005; Shi L, 2008, BRAIN RES, V1236, P185, DOI 10.1016/j.brainres.2008.07.085; Stolt CC, 2006, DEV CELL, V11, P697, DOI 10.1016/j.devcel.2006.08.011; Takebayashi H, 2000, MECH DEVELOP, V99, P143, DOI 10.1016/S0925-4773(00)00466-4; TEMPLE S, 1986, CELL, V44, P773, DOI 10.1016/0092-8674(86)90843-3; TEMPLE S, 1985, NATURE, V313, P223, DOI 10.1038/313223a0; Tokumoto YM, 2001, EMBO J, V20, P5261, DOI 10.1093/emboj/20.18.5261; Truong AB, 2007, CELL CYCLE, V6, P295, DOI 10.4161/cc.6.3.3753; Uhrbom L, 2000, INT J CANCER, V85, P398, DOI 10.1002/(SICI)1097-0215(20000201)85:3<398::AID-IJC17>3.0.CO;2-L; Wang SL, 2001, NEURON, V29, P603, DOI 10.1016/S0896-6273(01)00237-9; Watkins TA, 2008, NEURON, V60, P555, DOI 10.1016/j.neuron.2008.09.011; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; Wong TS, 2008, CLIN CANCER RES, V14, P2588, DOI 10.1158/1078-0432.CCR-07-0666; Wu L, 2008, MOL CELL, V29, P1, DOI 10.1016/j.molcel.2007.12.010; Yuan XQ, 2002, J NEUROSCI RES, V70, P529, DOI 10.1002/jnr.10368; Zhao XH, 2010, NEURON, V65, P612, DOI 10.1016/j.neuron.2010.02.018; Zhou Q, 2000, NEURON, V25, P331, DOI 10.1016/S0896-6273(00)80898-3; Zhou Q, 2002, CELL, V109, P61, DOI 10.1016/S0092-8674(02)00677-3	57	406	427	1	66	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	MAR 11	2010	65	5					597	611		10.1016/j.neuron.2010.01.027	http://dx.doi.org/10.1016/j.neuron.2010.01.027			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	571NF	20223197	Bronze, Green Accepted			2022-12-24	WOS:000275758000005
J	Butler, JM; Nolan, DJ; Vertes, EL; Varnum-Finney, B; Kobayashi, H; Hooper, AT; Seandel, M; Shido, K; White, IA; Kobayashi, M; Witte, L; May, C; Shawber, C; Kimura, Y; Kitajewski, J; Rosenwaks, Z; Bernstein, ID; Rafii, S				Butler, Jason M.; Nolan, Daniel J.; Vertes, Eva L.; Varnum-Finney, Barbara; Kobayashi, Hideki; Hooper, Andrea T.; Seandel, Marco; Shido, Koji; White, Ian A.; Kobayashi, Mariko; Witte, Larry; May, Chad; Shawber, Carrie; Kimura, Yuki; Kitajewski, Jan; Rosenwaks, Zev; Bernstein, Irwin D.; Rafii, Shahin			Endothelial Cells Are Essential for the Self-Renewal and Repopulation of Notch-Dependent Hematopoietic Stem Cells	CELL STEM CELL			English	Article							BONE-MARROW NICHE; PROGENITOR CELLS; VASCULAR NICHE; TUMOR-GROWTH; IN-VITRO; EX-VIVO; GENE; EXPANSION; SURVIVAL; ANGIOGENESIS	Bone marrow endothelial cells (ECs) are essential for reconstitution of hematopoiesis, but their role in self-renewal of long-term hematopoietic stem cells (LT-HSCs) is unknown. We have developed angiogenic models to demonstrate that EC-derived angiocrine growth factors support in vitro self-renewal and in vivo repopulation of authentic LT-HSCs. In serum/cytokine-free cocultures, ECs, through direct cellular contact, stimulated incremental expansion of repopulating CD34(-)F1t3(-)cKit(+)Lineage(-)Sca1(+) LT-HSCs, which retained their self-renewal ability, as determined by single-cell and serial transplantation assays. Angiocrine expression of Notch ligands by ECs promoted proliferation and prevented exhaustion of LT-HSCs derived from wild-type, but not Notch1/Notch2-deficient, mice. In transgenic notch-reporter (TNR.Gfp) mice, regenerating TNR.Gfp(+) LT-HSCs were detected in cellular contact with sinusoidal ECs. Interference with angiocrine, but not perfusion, function of SECs impaired repopulation of TNR.Gfp(+) LT-HSCs. ECs establish an instructive vascular niche for clinical-scale expansion of LT-HSCs and a cellular platform to identify stem cellactive trophogens.	[Butler, Jason M.; Nolan, Daniel J.; Vertes, Eva L.; Kobayashi, Hideki; Hooper, Andrea T.; Seandel, Marco; Shido, Koji; White, Ian A.; Kobayashi, Mariko; Kimura, Yuki; Rafii, Shahin] Weill Cornell Med Coll, Dept Med Genet, Howard Hughes Med Inst, New York, NY 10065 USA; [Butler, Jason M.; Nolan, Daniel J.; Vertes, Eva L.; Kobayashi, Hideki; Hooper, Andrea T.; Seandel, Marco; Shido, Koji; White, Ian A.; Kobayashi, Mariko; Kimura, Yuki; Rafii, Shahin] Weill Cornell Med Coll, Ansary Stem Cell Inst, New York, NY 10065 USA; [Seandel, Marco] Weill Cornell Med Coll, Dept Surg, New York, NY 10065 USA; [Varnum-Finney, Barbara; Rosenwaks, Zev] ImClone Syst Inc, New York, NY 10014 USA; [Witte, Larry; May, Chad] Ronald O Perelman & Claudia Cohen Ctr Reprod Med, New York, NY 10065 USA; [Shawber, Carrie; Kitajewski, Jan] Columbia Univ, Med Ctr, Dept OB GYN, New York, NY 10032 USA; [Kitajewski, Jan] Columbia Univ, Med Ctr, Dept Pathol, New York, NY 10032 USA; [Bernstein, Irwin D.] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98109 USA	Cornell University; Howard Hughes Medical Institute; Cornell University; Cornell University; Eli Lilly; Columbia University; Columbia University; Fred Hutchinson Cancer Center	Rafii, S (corresponding author), Weill Cornell Med Coll, Dept Med Genet, Howard Hughes Med Inst, New York, NY 10065 USA.	srafii@med.cornell.edu		Hooper, Andrea/0000-0003-1131-1229	Starr Stem Cell; Kirschstein National Research Service; Howard Hughes Medical Institute; Ansary Stem Cell Institute; Anbinder and Newmans Own Foundation; National Heart Lung and Blood Institute [HL075234, HL097797]; Qatar National Priorities; Empire State Stem Cell Board; New York State Department of Health [NYS C024180]; NATIONAL CANCER INSTITUTE [R01CA136673] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL083222, P01HL067839, U01HL066952, R01HL075234, R01HL097797, P01HL084205, P50HL084936, P01HL059312] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [RC1AI080309] Funding Source: NIH RePORTER	Starr Stem Cell; Kirschstein National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Ansary Stem Cell Institute; Anbinder and Newmans Own Foundation; National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Qatar National Priorities; Empire State Stem Cell Board; New York State Department of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	J.M.B. is supported by Starr Stem Cell Scholars Fellowship and Ruth L. Kirschstein National Research Service Award Institutional Research Training Grant. M.S. is a Fiona and Stanley Druckenmiller Fellow of the New York Stem Cell Foundation. S.R. is supported by Howard Hughes Medical Institute, Ansary Stem Cell Institute, Anbinder and Newmans Own Foundation, National Heart Lung and Blood Institute grants HL075234 and HL097797, Qatar National Priorities Research Program, Empire State Stem Cell Board, and the New York State Department of Health grant NYS C024180.	Antonchuk J, 2002, CELL, V109, P39, DOI 10.1016/S0092-8674(02)00697-9; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Avecilla ST, 2004, NAT MED, V10, P64, DOI 10.1038/nm973; Butler JM, 2010, NAT REV CANCER, V10, P138, DOI 10.1038/nrc2791; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Carmeliet P, 1999, CELL, V98, P147, DOI 10.1016/S0092-8674(00)81010-7; Duncan AW, 2005, NAT IMMUNOL, V6, P314, DOI 10.1038/ni1164; Fernandez L, 2008, EXP HEMATOL, V36, P545, DOI 10.1016/j.exphem.2007.12.012; Funahashi Y, 2008, CANCER RES, V68, P4727, DOI 10.1158/0008-5472.CAN-07-6499; Gerber HP, 2002, NATURE, V417, P954, DOI 10.1038/nature00821; Hadland BK, 2004, BLOOD, V104, P3097, DOI 10.1182/blood-2004-03-1224; Heissig B, 2002, CELL, V109, P625, DOI 10.1016/S0092-8674(02)00754-7; Hooper AT, 2009, CELL STEM CELL, V4, P263, DOI 10.1016/j.stem.2009.01.006; Karanu FN, 2000, J EXP MED, V192, P1365, DOI 10.1084/jem.192.9.1365; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kollet O, 2006, NAT MED, V12, P657, DOI 10.1038/nm1417; Kopp HG, 2006, J CLIN INVEST, V116, P3277, DOI 10.1172/JCI29314; Krosl J, 2003, NAT MED, V9, P1428, DOI 10.1038/nm951; Maillard I, 2008, CELL STEM CELL, V2, P356, DOI 10.1016/j.stem.2008.02.011; Mancini SJC, 2005, BLOOD, V105, P2340, DOI 10.1182/blood-2004-08-3207; Miller CL, 1997, P NATL ACAD SCI USA, V94, P13648, DOI 10.1073/pnas.94.25.13648; Mizutani K, 2007, NATURE, V449, P351, DOI 10.1038/nature06090; RAFII S, 1995, BLOOD, V86, P3353, DOI 10.1182/blood.V86.9.3353.bloodjournal8693353; Ramalingam R, 1999, BLOOD, V93, P2936; Seandel M, 2008, P NATL ACAD SCI USA, V105, P19288, DOI 10.1073/pnas.0805980105; TILL JE, 1964, P NATL ACAD SCI USA, V51, P29, DOI 10.1073/pnas.51.1.29; Varnum-Finney B, 2000, NAT MED, V6, P1278, DOI 10.1038/81390; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Wolfe MS, 1999, BIOCHEMISTRY-US, V38, P4720, DOI 10.1021/bi982562p; Wu MF, 2007, CELL STEM CELL, V1, P541, DOI 10.1016/j.stem.2007.08.009; Zhang CC, 2006, NAT MED, V12, P240, DOI 10.1038/nm1342; Zhang F, 2005, CIRC RES, V96, P950, DOI 10.1161/01.RES.0000165867.95291.7b; Zhang F, 2004, J BIOL CHEM, V279, P11760, DOI 10.1074/jbc.M312221200; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	34	458	483	0	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAR 5	2010	6	3					251	264		10.1016/j.stem.2010.02.001	http://dx.doi.org/10.1016/j.stem.2010.02.001			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	577WL	20207228	Green Accepted, Bronze			2022-12-24	WOS:000276254600012
J	Bandyopadhyay, S; Shamma, SA; Kanold, PO				Bandyopadhyay, Sharba; Shamma, Shihab A.; Kanold, Patrick O.			Dichotomy of functional organization in the mouse auditory cortex	NATURE NEUROSCIENCE			English	Article							TONOTOPIC ORGANIZATION; VISUAL-CORTEX; MODULAR ORGANIZATION; RESPONSE PROPERTIES; CORTICAL-NEURONS; MACAQUE MONKEY; IN-VIVO; CAT; REPRESENTATION; FREQUENCY	The sensory areas of the cerebral cortex possess multiple topographic representations of sensory dimensions. The gradient of frequency selectivity (tonotopy) is the dominant organizational feature in the primary auditory cortex, whereas other feature-based organizations are less well established. We probed the topographic organization of the mouse auditory cortex at the single-cell level using in vivo two-photon Ca2+ imaging. Tonotopy was present on a large scale but was fractured on a fine scale. Intensity tuning, which is important in level-invariant representation, was observed in individual cells, but was not topographically organized. The presence or near absence of putative subthreshold responses revealed a dichotomy in topographic organization. Inclusion of subthreshold responses revealed a topographic clustering of neurons with similar response properties, whereas such clustering was absent in supra-threshold responses. This dichotomy indicates that groups of nearby neurons with locally shared inputs can perform independent parallel computations in the auditory cortex.	[Bandyopadhyay, Sharba; Kanold, Patrick O.] Univ Maryland, Dept Biol, College Pk, MD 20742 USA; [Bandyopadhyay, Sharba; Shamma, Shihab A.; Kanold, Patrick O.] Univ Maryland, Syst Res Inst, College Pk, MD 20742 USA; [Shamma, Shihab A.] Univ Maryland, Dept Elect & Comp Engn, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park	Kanold, PO (corresponding author), Univ Maryland, Dept Biol, College Pk, MD 20742 USA.	pkanold@umd.edu	Shamma, Shihab A/F-9852-2012	Kanold, Patrick/0000-0002-7529-5435	National Institute on Deafness and Other Communications Disorders [R21DC009454, R01DC009607, RO1DC005779]; Air Force Office of Scientific Research Defense University Research Instrumentation Program; ISR Seed; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R21DC009454, R01DC009607, R01DC005779] Funding Source: NIH RePORTER	National Institute on Deafness and Other Communications Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Air Force Office of Scientific Research Defense University Research Instrumentation Program; ISR Seed; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	The authors thank D. Winkowski for many helpful comments and help with imaging and J. Zemskova and A. Sheikh for histological help. This work was supported by the National Institute on Deafness and Other Communications Disorders (R21DC009454 and R01DC009607 to P.O.K., and RO1DC005779 to S. A. S.), Air Force Office of Scientific Research Defense University Research Instrumentation Program (S. A. S. and P.O.K.) and an ISR Seed Grant (S. A. S. and P.O.K.).	Bandyopadhyay S, 2004, J NEUROSCI, V24, P531, DOI 10.1523/JNEUROSCI.4234-03.2004; Barbour DL, 2003, SCIENCE, V299, P1073, DOI 10.1126/science.1080425; Bizley JK, 2005, CEREB CORTEX, V15, P1637, DOI 10.1093/cercor/bhi042; BLASDEL GG, 1986, NATURE, V321, P579, DOI 10.1038/321579a0; deCharms RC, 1998, SCIENCE, V280, P1439, DOI 10.1126/science.280.5368.1439; Ehret G, 1997, J COMP PHYSIOL A, V181, P547, DOI 10.1007/s003590050139; EVANS EF, 1965, J PHYSIOL-LONDON, V179, P238, DOI 10.1113/jphysiol.1965.sp007659; Galindo-Leon EE, 2009, NEURON, V62, P705, DOI 10.1016/j.neuron.2009.05.001; GOLDSTEIN MH, 1975, BRAIN RES, V100, P188, DOI 10.1016/0006-8993(75)90258-9; GOLDSTEIN MH, 1970, J NEUROPHYSIOL, V33, P188, DOI 10.1152/jn.1970.33.1.188; Hromadka T, 2008, PLOS BIOL, V6, P124, DOI 10.1371/journal.pbio.0060016; HUBEL DH, 1977, PROC R SOC SER B-BIO, V198, P1, DOI 10.1098/rspb.1977.0085; Kalatsky VA, 2005, P NATL ACAD SCI USA, V102, P13325, DOI 10.1073/pnas.0505592102; KEIFER J, 1992, J NEUROSCI, V12, P3187, DOI 10.1523/JNEUROSCI.12-08-03187.1992; Koulakov AA, 2009, J NEUROSCI, V29, P3685, DOI 10.1523/JNEUROSCI.4500-08.2009; Kowalski N, 1996, J NEUROPHYSIOL, V76, P3503, DOI 10.1152/jn.1996.76.5.3503; Li Y, 2008, NATURE, V456, P952, DOI 10.1038/nature07417; MERZENICH MM, 1973, BRAIN RES, V63, P343, DOI 10.1016/0006-8993(73)90101-7; Moreaux L, 2008, FRONT NEUROSCI-SWITZ, V2, P176, DOI 10.3389/neuro.01.032.2008; Mountcastle VB, 1997, BRAIN, V120, P701, DOI 10.1093/brain/120.4.701; Nelken I, 2004, J NEUROPHYSIOL, V92, P2574, DOI 10.1152/jn.00276.2004; Nelken I, 1999, NATURE, V397, P154, DOI 10.1038/16456; Nimmerjahn A, 2004, NAT METHODS, V1, P31, DOI 10.1038/nmeth706; Ohki K, 2005, NATURE, V433, P597, DOI 10.1038/nature03274; Paredes RM, 2008, METHODS, V46, P143, DOI 10.1016/j.ymeth.2008.09.025; Polley DB, 2007, J NEUROPHYSIOL, V97, P3621, DOI 10.1152/jn.01298.2006; Recanzone GH, 1999, J COMP NEUROL, V415, P460, DOI 10.1002/(SICI)1096-9861(19991227)415:4<460::AID-CNE4>3.0.CO;2-F; Recanzone GH, 2000, J NEUROPHYSIOL, V83, P2315, DOI 10.1152/jn.2000.83.4.2315; Sadagopan S, 2008, J NEUROSCI, V28, P3415, DOI 10.1523/JNEUROSCI.2743-07.2008; Sato TR, 2007, PLOS BIOL, V5, P1440, DOI 10.1371/journal.pbio.0050189; Schreiner CE, 2000, ANNU REV NEUROSCI, V23, P501, DOI 10.1146/annurev.neuro.23.1.501; Schreiner CE, 2007, NEURON, V56, P356, DOI 10.1016/j.neuron.2007.10.013; Schummers J, 2008, SCIENCE, V320, P1638, DOI 10.1126/science.1156120; Shoham S, 2006, J COMP PHYSIOL A, V192, P777, DOI 10.1007/s00359-006-0117-6; Smetters D, 1999, METHODS, V18, P215, DOI 10.1006/meth.1999.0774; Song S, 2005, PLOS BIOL, V3, P507, DOI 10.1371/journal.pbio.0030068; Stiebler I, 1997, J COMP PHYSIOL A, V181, P559, DOI 10.1007/s003590050140; Stosiek C, 2003, P NATL ACAD SCI USA, V100, P7319, DOI 10.1073/pnas.1232232100; Stronks HC, 2010, HEARING RES, V260, P20, DOI 10.1016/j.heares.2009.10.015; Svoboda K, 2006, NEURON, V50, P823, DOI 10.1016/j.neuron.2006.05.019; Thomas D, 2000, CELL CALCIUM, V28, P213, DOI 10.1054/ceca.2000.0152; Tsytsarev Vassiliy, 2009, Front Neuroeng, V2, P2, DOI 10.3389/neuro.16.002.2009; Wallace MN, 2008, EXP BRAIN RES, V184, P179, DOI 10.1007/s00221-007-1092-z; Wang XQ, 2005, NATURE, V435, P341, DOI 10.1038/nature03565; Wang XQ, 2001, J NEUROPHYSIOL, V86, P2616, DOI 10.1152/jn.2001.86.5.2616; YASUDA R, 2004, SCI STKE, P15; Yoshimura Y, 2005, NATURE, V433, P868, DOI 10.1038/nature03252; Yoshimura Y, 2005, NAT NEUROSCI, V8, P1552, DOI 10.1038/nn1565; YOUNG ED, 1979, J ACOUST SOC AM, V66, P1381, DOI 10.1121/1.383532; Zhao CP, 2009, J NEUROSCI, V29, P15479, DOI 10.1523/JNEUROSCI.4471-09.2009	50	166	168	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2010	13	3					361	U23		10.1038/nn.2490	http://dx.doi.org/10.1038/nn.2490			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	559WW	20118924	Green Accepted			2022-12-24	WOS:000274860100019
J	Bottjer, SW; Altenau, B				Bottjer, Sarah W.; Altenau, Brie			Parallel pathways for vocal learning in basal ganglia of songbirds	NATURE NEUROSCIENCE			English	Article							TELENCEPHALIC NUCLEUS; ZEBRA FINCHES; SONG; LESIONS; BRAIN	The cortical nucleus LMAN (lateral magnocellular nucleus of the anterior nidopallium) provides the output of a basal ganglia pathway that is necessary for vocal learning in juvenile songbirds. The shell subregion of LMAN (LMAN(shell)) gives rise to recurrent loops that may subserve specific learning-related functions. We found that lesions in the LMAN(shell) pathway caused no immediate disruption of vocal behavior, but prevented the development of stable vocal sequences and the ability to imitate vocal sounds.	[Bottjer, Sarah W.; Altenau, Brie] Univ So Calif, Neurobiol Sect, Los Angeles, CA 90089 USA	University of Southern California	Bottjer, SW (corresponding author), Univ So Calif, Neurobiol Sect, Los Angeles, CA 90089 USA.	bottjer@usc.edu			US National Institutes of Health [NS037547]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037547] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to V. Miller-Sims and F. Johnson for assistance with data analysis. This work was supported by US National Institutes of Health grant NS037547.	ALEXANDER GE, 1990, TRENDS NEUROSCI, V13, P266, DOI 10.1016/0166-2236(90)90107-L; Aronov D, 2008, SCIENCE, V320, P630, DOI 10.1126/science.1155140; BOTTJER SW, 1984, SCIENCE, V224, P901, DOI 10.1126/science.6719123; Bottjer SW, 2004, ANN NY ACAD SCI, V1016, P395, DOI 10.1196/annals.1298.037; Braun K, 1999, BEHAV BRAIN RES, V98, P211, DOI 10.1016/S0166-4328(98)00086-2; Doupe AJ, 1999, ANNU REV NEUROSCI, V22, P567, DOI 10.1146/annurev.neuro.22.1.567; Doyon J, 2009, BEHAV BRAIN RES, V199, P61, DOI 10.1016/j.bbr.2008.11.012; Foster EF, 2001, J NEUROBIOL, V46, P142, DOI 10.1002/1097-4695(20010205)46:2<142::AID-NEU60>3.0.CO;2-R; Graybiel AM, 2008, ANNU REV NEUROSCI, V31, P359, DOI 10.1146/annurev.neuro.29.051605.112851; Hikosaka O, 1999, TRENDS NEUROSCI, V22, P464, DOI 10.1016/S0166-2236(99)01439-3; Long MA, 2008, NATURE, V456, P189, DOI 10.1038/nature07448; MORRISON RG, 1993, J NEUROBIOL, V24, P1045, DOI 10.1002/neu.480240805; Person AL, 2008, J COMP NEUROL, V508, P840, DOI 10.1002/cne.21699; Seger CA, 2006, NEUROSCIENTIST, V12, P285, DOI 10.1177/1073858405285632; Tchernichovski O, 2000, ANIM BEHAV, V59, P1167, DOI 10.1006/anbe.1999.1416	15	57	57	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2010	13	2					153	155		10.1038/nn.2472	http://dx.doi.org/10.1038/nn.2472			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	548SE	20023650	Green Accepted			2022-12-24	WOS:000273985800008
J	Nie, D; Di Nardo, A; Han, JM; Baharanyi, H; Kramvis, I; Huynh, T; Dabora, S; Codeluppi, S; Pandolfi, PP; Pasquale, EB; Sahin, M				Nie, Duyu; Di Nardo, Alessia; Han, Juliette M.; Baharanyi, Hasani; Kramvis, Ioannis; Huynh, ThanhThao; Dabora, Sandra; Codeluppi, Simone; Pandolfi, Pier Paolo; Pasquale, Elena B.; Sahin, Mustafa			Tsc2-Rheb signaling regulates EphA-mediated axon guidance	NATURE NEUROSCIENCE			English	Article							TUBEROUS SCLEROSIS COMPLEX; PATTERNED RETINAL ACTIVITY; LOCAL PROTEIN-SYNTHESIS; EPHRIN-AS; TRANSLATION; MECHANISMS; RESPONSES; AUTISM; TSC2; PHOSPHORYLATION	Tuberous sclerosis complex is a disease caused by mutations in the TSC1 or TSC2 genes, which encode a protein complex that inhibits mTOR kinase signaling by inactivating the Rheb GTPase. Activation of mTOR promotes the formation of benign tumors in various organs and the mechanisms underlying the neurological symptoms of the disease remain largely unknown. We found that Tsc2 haploinsufficiency in mice caused aberrant retinogeniculate projections that suggest defects in EphA receptor-dependent axon guidance. We also found that EphA receptor activation by ephrin-A ligands in neurons led to inhibition of extracellular signal-regulated kinase 1/2 (ERK1/2) activity and decreased inhibition of Tsc2 by ERK1/2. Thus, ephrin stimulation inactivates the mTOR pathway by enhancing Tsc2 activity. Furthermore, Tsc2 deficiency and hyperactive Rheb constitutively activated mTOR and inhibited ephrin-induced growth cone collapse. Our results indicate that TSC2-Rheb-mTOR signaling cooperates with the ephrin-Eph receptor system to control axon guidance in the visual system.	[Nie, Duyu; Di Nardo, Alessia; Han, Juliette M.; Baharanyi, Hasani; Kramvis, Ioannis; Huynh, ThanhThao; Sahin, Mustafa] Harvard Univ, Sch Med, Childrens Hosp Boston, FM Kirby Neurobiol Ctr,Dept Neurol, Boston, MA 02115 USA; [Dabora, Sandra] Brigham & Womens Hosp, Dept Med, Translat Med Div, Boston, MA 02115 USA; [Codeluppi, Simone; Pasquale, Elena B.] Burnham Inst Med Res, La Jolla, CA USA; [Codeluppi, Simone; Pasquale, Elena B.] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; [Pandolfi, Pier Paolo] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr,Dept Med, Canc Genet Program,Beth Israel Deaconess Canc Ctr, Boston, MA USA; [Pandolfi, Pier Paolo] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Sanford Burnham Prebys Medical Discovery Institute; University of California System; University of California San Diego; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Sahin, M (corresponding author), Harvard Univ, Sch Med, Childrens Hosp Boston, FM Kirby Neurobiol Ctr,Dept Neurol, Boston, MA 02115 USA.	mustafa.sahin@childrens.harvard.edu	SAHIN, MUSTAFA/I-8653-2019; Nie, Duyu A./AAR-6211-2020; codeluppi, simone/I-4143-2012	SAHIN, MUSTAFA/0000-0001-7044-2953; Nie, Duyu A./0000-0002-4280-6956; codeluppi, simone/0000-0002-7053-0520; Di Nardo, Alessia/0000-0002-0025-7290	US National Institutes of Health [NS58956, HD025938]; John Merck Scholars Fund; Tuberous Sclerosis Alliance; Manton Foundation; Children's Hospital Boston Translational Research Program; Children's Hospital Boston Mental Retardation and Developmental Disabilities Research Center [P01 HD18655]; Mentor Based Postdoctoral Fellowship; Hearst Foundation; Howard Hughes Medical Institute Research Training Fellowship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD025938] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS058956] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); John Merck Scholars Fund; Tuberous Sclerosis Alliance; Manton Foundation; Children's Hospital Boston Translational Research Program; Children's Hospital Boston Mental Retardation and Developmental Disabilities Research Center; Mentor Based Postdoctoral Fellowship; Hearst Foundation; Howard Hughes Medical Institute Research Training Fellowship(Howard Hughes Medical Institute); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank B. Stevens and D. Shafer for assistance with multi-threshold LGN analysis, J.Twiss and T.Merianda for assistance with fluorescence recovery after photobleaching and M. Bear, E. Osterweil and D. Krueger for assistance with metabolic labeling experiments. The Tsc2<SUP>loxP/loxP</SUP> mice were a gift from M. Gambello, and the Tsc1<SUP>loxP/loxP</SUP> mice were gift of D. Kwiatkowski. We are also grateful to B. Stevens, C. Chen, Z. He and members of the Sahin laboratory for critical reading of the manuscript and to L. Mariani, A. Sadowski and S. Goldman for technical assistance. This work was supported in part by grants from the US National Institutes of Health (NS58956 to M. S. and HD025938 to E. B. P.), the John Merck Scholars Fund, Tuberous Sclerosis Alliance, the Manton Foundation and Children's Hospital Boston Translational Research Program to M.S. and the Children's Hospital Boston Mental Retardation and Developmental Disabilities Research Center (P01 HD18655). D.N. is supported by a Mentor Based Postdoctoral Fellowship from Autism Speaks. A.D.N. is supported by a grant from the Hearst Foundation. H.B. is supported by an Howard Hughes Medical Institute Research Training Fellowship for Medical Students.	Aakalu G, 2001, NEURON, V30, P489, DOI 10.1016/S0896-6273(01)00295-1; Barnea-Goraly N, 2004, BIOL PSYCHIAT, V55, P323, DOI 10.1016/j.biopsych.2003.10.022; Benson MD, 2005, P NATL ACAD SCI USA, V102, P10694, DOI 10.1073/pnas.0504021102; Bolton PF, 2002, BRAIN, V125, P1247, DOI 10.1093/brain/awf124; Brittis PA, 2002, CELL, V110, P223, DOI 10.1016/S0092-8674(02)00813-9; Campbell DS, 2001, NEURON, V32, P1013, DOI 10.1016/S0896-6273(01)00551-7; Choi YJ, 2008, GENE DEV, V22, P2485, DOI 10.1101/gad.1685008; Courchesne E, 2001, NEUROLOGY, V57, P245, DOI 10.1212/WNL.57.2.245; Crino PB, 2006, NEW ENGL J MED, V355, P1345, DOI 10.1056/NEJMra055323; Di Nardo A, 2009, J NEUROSCI, V29, P5926, DOI 10.1523/JNEUROSCI.0778-09.2009; Ehninger D, 2008, NAT MED, V14, P843, DOI 10.1038/nm1788; Ellsworth CA, 2005, J COMP NEUROL, V488, P140, DOI 10.1002/cne.20602; Feldheim DA, 1998, NEURON, V21, P1303, DOI 10.1016/S0896-6273(00)80650-9; Filosa A, 2009, NAT NEUROSCI, V12, P1285, DOI 10.1038/nn.2394; Flanagan JG, 2006, CURR OPIN NEUROBIOL, V16, P59, DOI 10.1016/j.conb.2006.01.010; Goorden SMI, 2007, ANN NEUROL, V62, P648, DOI 10.1002/ana.21317; Henske EP, 1996, AM J HUM GENET, V59, P400; Hernandez O, 2007, GENESIS, V45, P101, DOI 10.1002/dvg.20271; Huberman AD, 2005, NAT NEUROSCI, V8, P1013, DOI 10.1038/nn1505; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Leung KM, 2006, NAT NEUROSCI, V9, P1247, DOI 10.1038/nn1775; Lin AC, 2008, CURR OPIN NEUROBIOL, V18, P60, DOI 10.1016/j.conb.2008.05.004; Ma L, 2005, CELL, V121, P179, DOI 10.1016/j.cell.2005.02.031; Manning BD, 2002, MOL CELL, V10, P151, DOI 10.1016/S1097-2765(02)00568-3; Merianda TT, 2009, MOL CELL NEUROSCI, V40, P128, DOI 10.1016/j.mcn.2008.09.008; Miao H, 2001, NAT CELL BIOL, V3, P527, DOI 10.1038/35074604; Onda H, 1999, J CLIN INVEST, V104, P687, DOI 10.1172/JCI7319; Park KK, 2008, SCIENCE, V322, P963, DOI 10.1126/science.1161566; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; Pfeiffenberger C, 2005, NAT NEUROSCI, V8, P1022, DOI 10.1038/nn1508; Pfeiffenberger C, 2006, J NEUROSCI, V26, P12873, DOI 10.1523/JNEUROSCI.3595-06.2006; Piper M, 2006, NEURON, V49, P215, DOI 10.1016/j.neuron.2005.12.008; Roche FK, 2009, J NEUROSCI, V29, P638, DOI 10.1523/JNEUROSCI.3845-08.2009; Sahin M, 2005, NEURON, V46, P191, DOI 10.1016/j.neuron.2005.01.030; Shamah SM, 2001, CELL, V105, P233, DOI 10.1016/S0092-8674(01)00314-2; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; SUTULA T, 1989, ANN NEUROL, V26, P321, DOI 10.1002/ana.410260303; Tavazoie SF, 2005, NAT NEUROSCI, V8, P1727, DOI 10.1038/nn1566; Torborg CL, 2005, PROG NEUROBIOL, V76, P213, DOI 10.1016/j.pneurobio.2005.09.002; Torborg CL, 2004, J NEUROSCI METH, V135, P17, DOI 10.1016/j.jneumeth.2003.11.019; Torii M, 2009, NATURE, V461, P524, DOI 10.1038/nature08362; VOLPE JJ, 2001, NEUROLOGY NEWBORN, P45; Weber AM, 2000, J AUTISM DEV DISORD, V30, P511, DOI 10.1023/A:1005679108529; Willis DE, 2007, J CELL BIOL, V178, P965, DOI 10.1083/jcb.200703209; Wong M, 2008, EPILEPSIA, V49, P8, DOI 10.1111/j.1528-1167.2007.01270.x; Wong V, 2006, J CHILD NEUROL, V21, P99, DOI 10.1177/08830738060210020901; Wu KY, 2005, NATURE, V436, P1020, DOI 10.1038/nature03885; Yang Q, 2006, P NATL ACAD SCI USA, V103, P6811, DOI 10.1073/pnas.0602282103; Yao JQ, 2006, NAT NEUROSCI, V9, P1265, DOI 10.1038/nn1773; Yudin D, 2008, NEURON, V59, P241, DOI 10.1016/j.neuron.2008.05.029	50	186	188	1	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2010	13	2					163	U43		10.1038/nn.2477	http://dx.doi.org/10.1038/nn.2477			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	548SE	20062052	Green Accepted			2022-12-24	WOS:000273985800011
J	Nemani, VM; Lu, W; Berge, V; Nakamura, K; Onoa, B; Lee, MK; Chaudhry, FA; Nicoll, RA; Edwards, RH				Nemani, Venu M.; Lu, Wei; Berge, Victoria; Nakamura, Ken; Onoa, Bibiana; Lee, Michael K.; Chaudhry, Farrukh A.; Nicoll, Roger A.; Edwards, Robert H.			Increased Expression of alpha-Synuclein Reduces Neurotransmitter Release by Inhibiting Synaptic Vesicle Reclustering after Endocytosis	NEURON			English	Article							FAMILIAL PARKINSONS-DISEASE; MICE LACKING; HIPPOCAMPAL SYNAPSES; BETA-SYNUCLEIN; INCLUSION FORMATION; LOCUS TRIPLICATION; GAMMA-SYNUCLEIN; TRANSGENIC MICE; CSP-ALPHA; PROTEIN	The protein alpha-synuclein accumulates in the brain of patients with sporadic Parkinson's disease (PD), and increased gene dosage causes a severe, dominantly inherited form of PD, but we know little about the effects of synuclein that precede degeneration. alpha-Synuclein localizes to the nerve terminal, but the knockout has little if any effect on synaptic transmission. In contrast, we now find that the modest overexpression of alpha-synuclein, in the range predicted for gene multiplication and in the absence of overt toxicity, markedly inhibits neurotransmitter release. The mechanism, elucidated by direct imaging of the synaptic vesicle cycle, involves a specific reduction in size of the synaptic vesicle recycling pool. Ultrastructural analysis demonstrates reduced synaptic vesicle density at the active zone, and imaging further reveals a defect in the reclustering of synaptic vesicles after endocytosis. Increased levels of alpha-synuclein thus produce a specific, physiological defect in synaptic vesicle recycling that precedes detectable neuropathology.	[Nemani, Venu M.; Nakamura, Ken; Onoa, Bibiana; Edwards, Robert H.] Univ Calif San Francisco, Dept Neurol, Grad Program Neurosci, San Francisco, CA 94158 USA; [Nemani, Venu M.; Nakamura, Ken; Onoa, Bibiana; Edwards, Robert H.] Univ Calif San Francisco, Dept Physiol, Grad Program Neurosci, San Francisco, CA 94158 USA; [Lu, Wei; Nicoll, Roger A.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Berge, Victoria; Chaudhry, Farrukh A.] Univ Oslo, Biotechnol Ctr Oslo, Ctr Mol Biol & Neurosci, Oslo, Norway; [Lee, Michael K.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Oslo; Johns Hopkins University	Edwards, RH (corresponding author), Univ Calif San Francisco, Dept Neurol, Grad Program Neurosci, San Francisco, CA 94158 USA.	robert.edwards@ucsf.edu	Lu, Wei/S-5617-2018; Lee, Michael K/D-9491-2013; Lu, Wei/E-8110-2011	Lu, Wei/0000-0001-6668-8432; Lee, Michael K/0000-0001-5865-9682; Nemani, Venu/0000-0001-8895-7090; Nakamura, Ken/0000-0002-9192-182X	Hilliblom Foundation; Burroughs-Wellcome Medical Scientist Fund Career Award; American Heart Association; University of Oslo; Norwegian Research Council; National Institutes of Mental Health; National Parkinson Foundation; Michael J. Fox Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH038256] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS062954] Funding Source: NIH RePORTER	Hilliblom Foundation; Burroughs-Wellcome Medical Scientist Fund Career Award(Burroughs Wellcome Fund); American Heart Association(American Heart Association); University of Oslo; Norwegian Research Council(Research Council of NorwayEuropean Commission); National Institutes of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Parkinson Foundation; Michael J. Fox Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank E. Wallender and B. Mukherjee for technical support, K. Thorn and the UCSF Nikon Center for assistance with the imaging, M. Larsson for help with the electron microscopy, A. Frigessi for guidance in the statistical analysis, and R. Tsien for thoughtful suggestions. This work was supported by the UCSF MSTP and a predoctoral fellowship from the Hilliblom Foundation (to V.M.N.), a postdoctoral fellowship from the Hillblom Foundation and a Burroughs-Wellcome Medical Scientist Fund Career Award (to K.N.), the American Heart Association (W.L.), the University of Oslo (V.B.), the Norwegian Research Council (F.A.C.), the National Institutes of Mental Health (R.A.N. and R.H.E.), the National Parkinson Foundation, and the Michael J. Fox Foundation (R.H.E.).	Abeliovich A, 2000, NEURON, V25, P239, DOI 10.1016/S0896-6273(00)80886-7; Augustin I, 2001, J NEUROSCI, V21, P10, DOI 10.1523/JNEUROSCI.21-01-00010.2001; BANKER G, 1998, CULTURING NERVE CELL; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Bussell R, 2004, BIOCHEMISTRY-US, V43, P4810, DOI 10.1021/bi036135+; Bussell R, 2003, J MOL BIOL, V329, P763, DOI 10.1016/S0022-2836(03)00520-5; Cabin DE, 2002, J NEUROSCI, V22, P8797; Chandra S, 2005, CELL, V123, P383, DOI 10.1016/j.cell.2005.09.028; Chandra S, 2004, P NATL ACAD SCI USA, V101, P14966, DOI 10.1073/pnas.0406283101; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Chen L, 2005, NAT NEUROSCI, V8, P657, DOI 10.1038/nn1443; Chiba-Falek O, 2006, MOVEMENT DISORD, V21, P1703, DOI 10.1002/mds.21007; Cooper AA, 2006, SCIENCE, V313, P324, DOI 10.1126/science.1129462; Dal Bo G, 2004, J NEUROCHEM, V88, P1398, DOI 10.1046/j.1471-4159.2003.02277.x; Davidson WS, 1998, J BIOL CHEM, V273, P9443, DOI 10.1074/jbc.273.16.9443; Dickson DW, 2001, CURR OPIN NEUROL, V14, P423, DOI 10.1097/00019052-200108000-00001; Ellis CE, 2001, J BIOL CHEM, V276, P3879, DOI 10.1074/jbc.M010316200; Ferguson SM, 2007, SCIENCE, V316, P570, DOI 10.1126/science.1140621; Fernandez-Chacon R, 2004, NEURON, V42, P237, DOI 10.1016/S0896-6273(04)00190-4; Fortin DL, 2004, J NEUROSCI, V24, P6715, DOI 10.1523/JNEUROSCI.1594-04.2004; Fortin DL, 2005, J NEUROSCI, V25, P10913, DOI 10.1523/JNEUROSCI.2922-05.2005; Fredenburg RA, 2007, BIOCHEMISTRY-US, V46, P7107, DOI 10.1021/bi7000246; Fujiwara H, 2002, NAT CELL BIOL, V4, P160, DOI 10.1038/ncb748; GEORGE JM, 1995, NEURON, V15, P361, DOI 10.1016/0896-6273(95)90040-3; Giasson BI, 2002, NEURON, V34, P521, DOI 10.1016/S0896-6273(02)00682-7; Gitler AD, 2008, P NATL ACAD SCI USA, V105, P145, DOI 10.1073/pnas.0710685105; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hashimoto M, 2001, NEURON, V32, P213, DOI 10.1016/S0896-6273(01)00462-7; Hilfiker S, 1999, PHILOS T ROY SOC B, V354, P269, DOI 10.1098/rstb.1999.0378; IWAI A, 1995, NEURON, V14, P467, DOI 10.1016/0896-6273(95)90302-X; Jo EJ, 2002, J MOL BIOL, V315, P799, DOI 10.1006/jmbi.2001.5269; Kruger R, 2001, NEUROLOGY, V56, P1355, DOI 10.1212/WNL.56.10.1355; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Kubo S, 2005, J BIOL CHEM, V280, P31664, DOI 10.1074/jbc.M504894200; Larsen KE, 2006, J NEUROSCI, V26, P11915, DOI 10.1523/JNEUROSCI.3821-06.2006; Lee MK, 2002, P NATL ACAD SCI USA, V99, P8968, DOI 10.1073/pnas.132197599; Li HY, 2005, NEURON, V48, P619, DOI 10.1016/j.neuron.2005.09.033; Lu W, 2009, NEURON, V62, P254, DOI 10.1016/j.neuron.2009.02.027; Manning-Bog AB, 2003, J NEUROSCI, V23, P3095; Maraganore DM, 2006, JAMA-J AM MED ASSOC, V296, P661, DOI 10.1001/jama.296.6.661; MAROTEAUX L, 1988, J NEUROSCI, V8, P2804; Matsuoka Y, 2001, NEUROBIOL DIS, V8, P535, DOI 10.1006/nbdi.2001.0392; McFarland MA, 2008, MOL CELL PROTEOMICS, V7, P2123, DOI 10.1074/mcp.M800116-MCP200; Mena MA, 1997, J NEUROCHEM, V69, P21; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Miller DW, 2004, NEUROLOGY, V62, P1835, DOI 10.1212/01.WNL.0000127517.33208.F4; Mozhayeva MG, 2002, J NEUROSCI, V22, P654, DOI 10.1523/JNEUROSCI.22-03-00654.2002; Okochi M, 2000, J BIOL CHEM, V275, P390, DOI 10.1074/jbc.275.1.390; Outeiro TF, 2003, SCIENCE, V302, P1772, DOI 10.1126/science.1090439; Park JY, 2003, BIOCHEMISTRY-US, V42, P3696, DOI 10.1021/bi020604a; Park SM, 2002, BLOOD, V100, P2506, DOI 10.1182/blood.V100.7.2506; Payton JE, 2004, J MOL BIOL, V337, P1001, DOI 10.1016/j.jmb.2004.02.014; Petrucelli L, 2002, NEURON, V36, P1007, DOI 10.1016/S0896-6273(02)01125-X; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Pyle JL, 2000, NEURON, V28, P221, DOI 10.1016/S0896-6273(00)00098-2; Quilty MC, 2006, EXP NEUROL, V199, P249, DOI 10.1016/j.expneurol.2005.10.018; ROSAHL TW, 1995, NATURE, V375, P488, DOI 10.1038/375488a0; ROSAHL TW, 1993, CELL, V75, P661, DOI 10.1016/0092-8674(93)90487-B; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; Ryan TA, 1996, J CELL BIOL, V134, P1219, DOI 10.1083/jcb.134.5.1219; Senior SL, 2008, EUR J NEUROSCI, V27, P947, DOI 10.1111/j.1460-9568.2008.06055.x; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Smith WW, 2005, J NEUROSCI, V25, P5544, DOI 10.1523/JNEUROSCI.0482-05.2005; Soper JH, 2008, MOL BIOL CELL, V19, P1093, DOI 10.1091/mbc.E07-08-0827; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Sulzer D, 1998, J NEUROSCI, V18, P4588, DOI 10.1523/jneurosci.18-12-04588.1998; Uversky VN, 2002, J BIOL CHEM, V277, P11970, DOI 10.1074/jbc.M109541200; Vila M, 2000, J NEUROCHEM, V74, P721, DOI 10.1046/j.1471-4159.2000.740721.x; Voglmaier SM, 2006, NEURON, V51, P71, DOI 10.1016/j.neuron.2006.05.027; Willingham S, 2003, SCIENCE, V302, P1769, DOI 10.1126/science.1090389; Yavich L, 2004, J NEUROSCI, V24, P11165, DOI 10.1523/JNEUROSCI.2559-04.2004; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795; Zhou WB, 2000, BRAIN RES, V866, P33, DOI 10.1016/S0006-8993(00)02215-0	74	729	744	1	93	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 14	2010	65	1					66	79		10.1016/j.neuron.2009.12.023	http://dx.doi.org/10.1016/j.neuron.2009.12.023			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	546DZ	20152114	Green Accepted, Bronze			2022-12-24	WOS:000273791200009
J	Soltani, A; Wang, XJ				Soltani, Alireza; Wang, Xiao-Jing			Synaptic computation underlying probabilistic inference	NATURE NEUROSCIENCE			English	Article							DECISION-MAKING; INFEROTEMPORAL CORTEX; BAYESIAN-INFERENCE; MATCHING BEHAVIOR; POPULATION CODES; CHOICE; SYNAPSES; MODEL; PLASTICITY; MECHANISM	We propose that synapses may be the workhorse of the neuronal computations that underlie probabilistic reasoning. We built a neural circuit model for probabilistic inference in which information provided by different sensory cues must be integrated and the predictive powers of individual cues about an outcome are deduced through experience. We found that bounded synapses naturally compute, through reward-dependent plasticity, the posterior probability that a choice alternative is correct given that a cue is presented. Furthermore, a decision circuit endowed with such synapses makes choices on the basis of the summed log posterior odds and performs near-optimal cue combination. The model was validated by reproducing salient observations of, and provides insights into, a monkey experiment using a categorization task. Our model thus suggests a biophysical instantiation of the Bayesian decision rule, while predicting important deviations from it similar to the 'base-rate neglect' observed in human studies when alternatives have unequal prior probabilities.	[Soltani, Alireza; Wang, Xiao-Jing] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06520 USA; [Soltani, Alireza; Wang, Xiao-Jing] Yale Univ, Sch Med, Kavli Inst Neurosci, New Haven, CT USA; [Soltani, Alireza] CALTECH, Div Biol, Pasadena, CA 91125 USA	Yale University; Yale University; California Institute of Technology	Soltani, A (corresponding author), Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06520 USA.	soltani@caltech.edu; xjwang@yale.edu	Wang, Xiao-Jing/D-2722-2009	Soltani, Alireza/0000-0003-4386-8486	US National Institutes of Health [2-R01-MH062349, MH073246]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH062349, R01MH073246] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by US National Institutes of Health grants 2-R01-MH062349 and MH073246. We are thankful to D. Andrieux, S. Ardid, A. Bernacchia and R. Wilson for comments on the manuscript.	AMIT DJ, 1994, NEURAL COMPUT, V6, P957, DOI 10.1162/neco.1994.6.5.957; Ashby EG, 2005, ANNU REV PSYCHOL, V56, P149, DOI 10.1146/annurev.psych.56.091103.070217; Beck JM, 2008, NEURON, V60, P1142, DOI 10.1016/j.neuron.2008.09.021; Fera F, 2005, J NEUROSCI, V25, P11340, DOI 10.1523/JNEUROSCI.2736-05.2005; Furman M, 2008, NEURON, V60, P1153, DOI 10.1016/j.neuron.2008.12.003; Fusi S, 2005, NEURON, V45, P599, DOI 10.1016/j.neuron.2005.02.001; Fusi S, 2002, BIOL CYBERN, V87, P459, DOI 10.1007/s00422-002-0356-8; Fusi S, 2007, NEURON, V54, P319, DOI 10.1016/j.neuron.2007.03.017; Fusi S, 2007, NAT NEUROSCI, V10, P485, DOI 10.1038/nn1859; Glimcher PW, 2003, ANNU REV NEUROSCI, V26, P133, DOI 10.1146/annurev.neuro.26.010302.081134; GLUCK MA, 1988, J EXP PSYCHOL GEN, V117, P227, DOI 10.1037/0096-3445.117.3.227; Gold JI, 2001, TRENDS COGN SCI, V5, P10, DOI 10.1016/S1364-6613(00)01567-9; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; KAHNEMAN D, 1973, PSYCHOL REV, V80, P237, DOI 10.1037/h0034747; Kahneman Daniel, 1982, JUDGMENT UNCERTAINTY, P153, DOI DOI 10.1017/CBO9780511809477.011; Knowlton B J, 1994, Learn Mem, V1, P106; Knowlton BJ, 1996, SCIENCE, V273, P1399, DOI 10.1126/science.273.5280.1399; KRUSCHKE JK, 1992, PSYCHOL REV, V99, P22, DOI 10.1037/0033-295X.99.1.22; Lau B, 2008, NEURON, V58, P451, DOI 10.1016/j.neuron.2008.02.021; Lauwereyns J, 2002, NATURE, V418, P413, DOI 10.1038/nature00892; Lee KM, 2008, J NEUROSCI, V28, P2242, DOI 10.1523/JNEUROSCI.3596-07.2008; Liu F, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000253; Ma WJ, 2008, CURR OPIN NEUROBIOL, V18, P217, DOI 10.1016/j.conb.2008.07.004; Ma WJ, 2006, NAT NEUROSCI, V9, P1432, DOI 10.1038/nn1790; Meeter M, 2006, LEARN MEMORY, V13, P230, DOI 10.1101/lm.43006; Moody TD, 2004, BEHAV NEUROSCI, V118, P438, DOI 10.1037/0735-7044.118.2.438; Myers J. L., 1976, HDB LEARNING COGNITI, P171; O'Connor DH, 2005, P NATL ACAD SCI USA, V102, P9679, DOI 10.1073/pnas.0502332102; Petersen CCH, 1998, P NATL ACAD SCI USA, V95, P4732, DOI 10.1073/pnas.95.8.4732; Poldrack RA, 2001, NATURE, V414, P546, DOI 10.1038/35107080; Reynolds JNJ, 2001, NATURE, V413, P67, DOI 10.1038/35092560; Rushworth MFS, 2008, NAT NEUROSCI, V11, P389, DOI 10.1038/nn2066; Samejima K, 2005, SCIENCE, V310, P1337, DOI 10.1126/science.1115270; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Schultz W, 2007, ANNU REV NEUROSCI, V30, P259, DOI 10.1146/annurev.neuro.28.061604.135722; Shanks DR, 2002, J BEHAV DECIS MAKING, V15, P233, DOI 10.1002/bdm.413; Shen WX, 2008, SCIENCE, V321, P848, DOI 10.1126/science.1160575; Soltani A, 2006, J NEUROSCI, V26, P3731, DOI 10.1523/JNEUROSCI.5159-05.2006; Soltani A, 2008, CURR OPIN NEUROBIOL, V18, P209, DOI 10.1016/j.conb.2008.07.003; Soltani A, 2006, NEURAL NETWORKS, V19, P1075, DOI 10.1016/j.neunet.2006.05.044; Sugrue LP, 2004, SCIENCE, V304, P1782, DOI 10.1126/science.1094765; Sugrue LP, 2005, NAT REV NEUROSCI, V6, P363, DOI 10.1038/nrn1666; Tanaka K, 1996, ANNU REV NEUROSCI, V19, P109, DOI 10.1146/annurev.ne.19.030196.000545; Tsunoda K, 2001, NAT NEUROSCI, V4, P832, DOI 10.1038/90547; Vulkan N, 2000, J ECON SURV, V14, P101, DOI 10.1111/1467-6419.00106; Wang XJ, 2008, NEURON, V60, P215, DOI 10.1016/j.neuron.2008.09.034; Wang XJ, 2002, NEURON, V36, P955, DOI 10.1016/S0896-6273(02)01092-9; Wong KF, 2006, J NEUROSCI, V26, P1314, DOI 10.1523/JNEUROSCI.3733-05.2006; Wong KF, 2007, FRONT COMPUT NEUROSC, V1, DOI 10.3389/neuro.10.006.2007; Yang T, 2007, NATURE, V447, P1075, DOI 10.1038/nature05852	50	75	76	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2010	13	1					112	U285		10.1038/nn.2450	http://dx.doi.org/10.1038/nn.2450			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	536PM	20010823	Green Accepted			2022-12-24	WOS:000273056300021
J	Kraskov, A; Dancause, N; Quallo, MM; Shepherd, S; Lemon, RN				Kraskov, Alexander; Dancause, Numa; Quallo, Marsha M.; Shepherd, Samantha; Lemon, Roger N.			Corticospinal Neurons in Macaque Ventral Premotor Cortex with Mirror Properties: A Potential Mechanism for Action Suppression?	NEURON			English	Article							MOTOR CORTEX; GRASP REPRESENTATIONS; TOOL-USE; FACILITATION; MODULATION; HAND; EXCITABILITY; ORGANIZATION; PROJECTIONS; MONKEYS	The discovery of "mirror neurons" in area F5 of the ventral premotor cortex has prompted many theories as to their possible function. However, the identity of mirror neurons remains unknown. Here, we investigated whether identified pyramidal tract neurons (PTNs) in area F5 of two adult macaques exhibited "mirror-like" activity. About half of the 64 PTNs tested showed significant modulation of their activity while monkeys observed precision grip of an object carried out by an experimenter, with somewhat fewer showing modulation during precision grip without an object or grasping concealed from the monkey. Therefore, mirror-like activity can be transmitted directly to the spinal cord via PTNs. A novel finding is that many PTNs (17/64) showed complete suppression of discharge during action observation, while firing actively when the monkey grasped food rewards. We speculate that this suppression of PTN discharge might be involved in the inhibition of self-movement during action observation.	[Kraskov, Alexander; Dancause, Numa; Quallo, Marsha M.; Shepherd, Samantha; Lemon, Roger N.] UCL, Inst Neurol, Sobell Dept Motor Neurosci & Movement Disorders, London WC1N 3BG, England	University of London; University College London	Lemon, RN (corresponding author), UCL, Inst Neurol, Sobell Dept Motor Neurosci & Movement Disorders, London WC1N 3BG, England.	rlemon@ion.ucl.ac.uk	Kraskov, Alexander/J-7964-2012; Shepherd, Samantha/HHN-5424-2022	Kraskov, Alexander/0000-0002-3576-4719; Dancause, Numa/0000-0002-0424-9730	Wellcome Trust; Centre for NC3Rs; MRC	Wellcome Trust(Wellcome TrustEuropean Commission); Centre for NC3Rs; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Wellcome Trust, Centre for NC3Rs, and the MRC. We thank Atsushi Iriki, Thomas Brochier, and Marco Davare for advice and Jim Dick, Victor Bailer, Ed Bye, David MacManus, Robin Richards, and Chris Seers for their technical assistance.	Baker SN, 1999, J NEUROSCI METH, V94, P5, DOI 10.1016/S0165-0270(99)00121-1; Baker SN, 2001, J NEUROPHYSIOL, V85, P869, DOI 10.1152/jn.2001.85.2.869; Baldissera F, 2001, EUR J NEUROSCI, V13, P190, DOI 10.1046/j.0953-816x.2000.01368.x; Boudrias MH, 2010, CEREB CORTEX, V20, P169, DOI 10.1093/cercor/bhp084; Brochier T, 2004, J NEUROPHYSIOL, V92, P1770, DOI 10.1152/jn.00976.2003; Caggiano V, 2009, SCIENCE, V324, P403, DOI 10.1126/science.1166818; Cattaneo L, 2009, J NEUROSCI, V29, P11134, DOI 10.1523/JNEUROSCI.2605-09.2009; Cerri G, 2003, J NEUROPHYSIOL, V90, P832, DOI 10.1152/jn.01026.2002; CHENEY PD, 1985, J NEUROPHYSIOL, V53, P805, DOI 10.1152/jn.1985.53.3.805; Cisek P, 2004, NATURE, V431, P993, DOI 10.1038/nature03005; DIPELLEGRINO G, 1992, EXP BRAIN RES, V91, P176, DOI 10.1007/BF00230027; DUM RP, 1991, J NEUROSCI, V11, P667; Fabbri-Destro M, 2008, PHYSIOLOGY, V23, P171, DOI 10.1152/physiol.00004.2008; FADIGA L, 1995, J NEUROPHYSIOL, V73, P2608, DOI 10.1152/jn.1995.73.6.2608; Ferrari PF, 2005, J COGNITIVE NEUROSCI, V17, P212, DOI 10.1162/0898929053124910; Ferrari PF, 2003, EUR J NEUROSCI, V17, P1703, DOI 10.1046/j.1460-9568.2003.02601.x; Ferrari PF, 2006, PLOS BIOL, V4, P1501, DOI 10.1371/journal.pbio.0040302; Fogassi L, 2005, SCIENCE, V308, P662, DOI 10.1126/science.1106138; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; Grafton ST, 1996, EXP BRAIN RES, V112, P103; HE SQ, 1993, J NEUROSCI, V13, P952; HUMPHREY DR, 1978, J NEUROPHYSIOL, V41, P216, DOI 10.1152/jn.1978.41.1.216; Iacoboni M, 2009, ANNU REV PSYCHOL, V60, P653, DOI 10.1146/annurev.psych.60.110707.163604; Iriki A, 2008, PHILOS T R SOC B, V363, P2229, DOI 10.1098/rstb.2008.2274; Isa T, 2007, PHYSIOLOGY, V22, P145, DOI 10.1152/physiol.00045.2006; Ishibashi H, 2000, CAN J PHYSIOL PHARM, V78, P958, DOI 10.1139/cjpp-78-11-958; Keysers C, 2003, EXP BRAIN RES, V153, P628, DOI 10.1007/s00221-003-1603-5; Kohler E, 2002, SCIENCE, V297, P846, DOI 10.1126/science.1070311; Lemon RN, 1984, METHODS NEURONAL REC; Lemon RN, 2008, ANNU REV NEUROSCI, V31, P195, DOI 10.1146/annurev.neuro.31.060407.125547; Matelli M, 1996, J COMP NEUROL, V372, P59; Merchant H, 2008, J NEUROSCI, V28, P9164, DOI 10.1523/JNEUROSCI.1898-08.2008; Montagna M, 2005, EUR J NEUROSCI, V22, P1513, DOI 10.1111/j.1460-9568.2005.04336.x; Olivier E, 2001, J NEUROPHYSIOL, V86, P1573, DOI 10.1152/jn.2001.86.4.1573; Prabhu G, 2009, J PHYSIOL-LONDON, V587, P1057, DOI 10.1113/jphysiol.2008.165571; Prut Y, 1999, NATURE, V401, P590, DOI 10.1038/44145; Quallo MM, 2009, P NATL ACAD SCI USA, V106, P18379, DOI 10.1073/pnas.0909751106; Quiroga RQ, 2004, NEURAL COMPUT, V16, P1661, DOI 10.1162/089976604774201631; Rathelot JA, 2006, P NATL ACAD SCI USA, V103, P8257, DOI 10.1073/pnas.0602933103; Rathelot JA, 2009, P NATL ACAD SCI USA, V106, P918, DOI 10.1073/pnas.0808362106; Rizzolatti G, 1996, EXP BRAIN RES, V111, P246; Rizzolatti G, 1996, COGNITIVE BRAIN RES, V3, P131, DOI 10.1016/0926-6410(95)00038-0; Rizzolatti G, 2009, NAT CLIN PRACT NEURO, V5, P24, DOI 10.1038/ncpneuro0990; Rozzi S, 2008, EUR J NEUROSCI, V28, P1569, DOI 10.1111/j.1460-9568.2008.06395.x; Schmidlin E, 2008, J NEUROSCI, V28, P5772, DOI 10.1523/JNEUROSCI.0944-08.2008; Shimazu H, 2004, J NEUROSCI, V24, P1200, DOI 10.1523/JNEUROSCI.4731-03.2004; Spinks RL, 2003, J NEUROPHYSIOL, V90, P1324, DOI 10.1152/jn.00169.2003; Strafella AP, 2000, NEUROREPORT, V11, P2289, DOI 10.1097/00001756-200007140-00044; Tkach D, 2007, J NEUROSCI, V27, P13241, DOI 10.1523/JNEUROSCI.2895-07.2007; Umilta MA, 2001, NEURON, V31, P155, DOI 10.1016/S0896-6273(01)00337-3; Visalberghi E, 2002, FROM ANIM ANIMAT, P471	51	202	206	0	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 24	2009	64	6					922	930		10.1016/j.neuron.2009.12.010	http://dx.doi.org/10.1016/j.neuron.2009.12.010			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	541ON	20064397	hybrid, Green Published			2022-12-24	WOS:000273425800017
J	Isomura, Y; Harukuni, R; Takekawa, T; Aizawa, H; Fukai, T				Isomura, Yoshikazu; Harukuni, Rie; Takekawa, Takashi; Aizawa, Hidenori; Fukai, Tomoki			Microcircuitry coordination of cortical motor information in self-initiation of voluntary movements	NATURE NEUROSCIENCE			English	Article							PYRAMIDAL TRACT NEURONS; PRIMATE MOTOR; IN-VIVO; SOMATOSENSORY CORTEX; PREFRONTAL CORTEX; NEURAL ACTIVITY; SPINAL-CORD; CELLS; RAT; INTERNEURONS	Motor cortex neurons are activated at different times during self-initiated voluntary movement. However, the manner in which excitatory and inhibitory neurons in distinct cortical layers help to organize voluntary movement is poorly understood. We carried out juxtacellular and multiunit recordings from actively behaving rats and found temporally and functionally distinct activations of excitatory pyramidal cells and inhibitory fast-spiking interneurons. Across cortical layers, pyramidal cells were activated diversely for sequential motor phases (for example, preparation, initiation and execution). In contrast, fast-spiking interneurons, including parvalbumin-positive basket cells, were recruited predominantly for motor execution, with pyramidal cells producing a command-like activity. Thus, fast-spiking interneurons may underlie command shaping by balanced inhibition or recurrent inhibition, rather than command gating by temporally alternating excitation and inhibition. Furthermore, initiation-associated pyramidal cells excited similar and different functional classes of neurons through putative monosynaptic connections. This suggests that these cells may temporally integrate information to initiate and coordinate voluntary movement.	[Isomura, Yoshikazu; Harukuni, Rie; Takekawa, Takashi; Aizawa, Hidenori; Fukai, Tomoki] RIKEN Brain Sci Inst, Saitama, Japan; [Fukai, Tomoki] Univ Tokyo, Chiba, Japan; [Fukai, Tomoki] Tamagawa Univ, Brain Res Ctr, Tokyo, Japan	RIKEN; University of Tokyo	Isomura, Y (corresponding author), RIKEN Brain Sci Inst, Saitama, Japan.	isomura@brain.riken.jp	Fukai, Tomoki/A-3936-2015	Fukai, Tomoki/0000-0001-6977-5638; Aizawa, Hidenori/0000-0002-2896-1298; Takekawa, Takashi/0000-0002-0821-9109	RIKEN; Ministry of Education, Culture, Sports, Science and Technology [18019041, 18700386, 40218871]; Grants-in-Aid for Scientific Research [21680036] Funding Source: KAKEN	RIKEN; Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank G. Buzsaki and J. Tanji for helpful comments and discussion, M. Fujii, K. Ishii, M. Kobayashi, R. Nakatomi and S. Tanaka for technical assistance, and K. O'hara for developing the multi-rat task-training system. This work was supported by the institutional research grants from RIKEN (T. F.) and by Grants-in-Aid for Scientific Research from Ministry of Education, Culture, Sports, Science and Technology (18019041 and 18700386 to Y. I. and 40218871 to T. F.).	Bartho P, 2004, J NEUROPHYSIOL, V92, P600, DOI 10.1152/jn.01170.2003; BAUSWEIN E, 1989, BRAIN RES, V493, P198, DOI 10.1016/0006-8993(89)91018-4; Beloozerova IN, 2003, J NEUROSCI, V23, P1087; Brecht M, 2004, J COMP NEUROL, V479, P360, DOI 10.1002/cne.20306; Brecht M, 2004, NATURE, V427, P704, DOI 10.1038/nature02266; Cauli B, 1997, J NEUROSCI, V17, P3894; Chapin JK, 1999, NAT NEUROSCI, V2, P664, DOI 10.1038/10223; Cho RH, 2004, NEUROSCI RES, V50, P381, DOI 10.1016/j.neures.2004.08.006; Cho RH, 2004, NEUROSCI RES, V50, P395, DOI 10.1016/j.neures.2004.08.007; Constantinidis C, 2002, NAT NEUROSCI, V5, P175, DOI 10.1038/nn799; Csicsvari J, 1998, NEURON, V21, P179, DOI 10.1016/S0896-6273(00)80525-5; de Kock CPJ, 2007, J PHYSIOL-LONDON, V581, P139, DOI 10.1113/jphysiol.2006.124321; DEECKE L, 1969, EXP BRAIN RES, V7, P158; Dombeck DA, 2007, NEURON, V56, P43, DOI 10.1016/j.neuron.2007.08.003; DONOGHUE JP, 1982, J COMP NEUROL, V212, P76, DOI 10.1002/cne.902120106; EVARTS EV, 1968, J NEUROPHYSIOL, V31, P14, DOI 10.1152/jn.1968.31.1.14; Ferezou I, 2007, NEURON, V56, P907, DOI 10.1016/j.neuron.2007.10.007; Fromm C, 1983, Adv Neurol, V39, P329; FROMM C, 1981, J NEUROSCI, V1, P453; GEORGOPOULOS AP, 1982, J NEUROSCI, V2, P1527; Georgopoulos AP, 2007, BRAIN RES REV, V55, P383, DOI 10.1016/j.brainresrev.2007.05.001; Harris KD, 2000, J NEUROPHYSIOL, V84, P401, DOI 10.1152/jn.2000.84.1.401; HASHIMOTO S, 1980, BRAIN RES, V197, P415, DOI 10.1016/0006-8993(80)91126-9; Hazan L, 2006, J NEUROSCI METH, V155, P207, DOI 10.1016/j.jneumeth.2006.01.017; Houweling AR, 2008, NATURE, V451, P65, DOI 10.1038/nature06447; HUMPHREY DR, 1970, SCIENCE, V170, P758, DOI 10.1126/science.170.3959.758; Hyland B, 1998, BEHAV BRAIN RES, V94, P255, DOI 10.1016/S0166-4328(97)00157-5; Isomura Y, 2003, J NEUROSCI, V23, P8002; Isomura Y, 2006, NEURON, V52, P871, DOI 10.1016/j.neuron.2006.10.023; Klausberger T, 2003, NATURE, V421, P844, DOI 10.1038/nature01374; Laubach M, 2000, NATURE, V405, P567, DOI 10.1038/35014604; Lee MG, 2004, J NEUROPHYSIOL, V92, P1182, DOI 10.1152/jn.01003.2003; Mallet N, 2006, J NEUROSCI, V26, P3875, DOI 10.1523/JNEUROSCI.4439-05.2006; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; MATSUMURA M, 1992, J NEUROPHYSIOL, V68, P692, DOI 10.1152/jn.1992.68.3.692; Matsumura M, 1996, J NEUROSCI, V16, P7757; Merchant H, 2008, J NEUROSCI, V28, P9164, DOI 10.1523/JNEUROSCI.1898-08.2008; Okamoto H, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000404; OKANO K, 1987, EXP BRAIN RES, V66, P155; Okun M, 2008, NAT NEUROSCI, V11, P535, DOI 10.1038/nn.2105; Pinault D, 1996, J NEUROSCI METH, V65, P113, DOI 10.1016/0165-0270(95)00144-1; Rao SG, 1999, J NEUROPHYSIOL, V81, P1903, DOI 10.1152/jn.1999.81.4.1903; ROUILLER EM, 1993, SOMATOSENS MOT RES, V10, P269, DOI 10.3109/08990229309028837; Sirota A, 2008, NEURON, V60, P683, DOI 10.1016/j.neuron.2008.09.014; STEFANIS C, 1964, J NEUROPHYSIOL, V27, P855, DOI 10.1152/jn.1964.27.5.855; TANJI J, 1976, J NEUROPHYSIOL, V39, P1062, DOI 10.1152/jn.1976.39.5.1062; Turner RS, 2000, J NEUROSCI, V20, P7096, DOI 10.1523/JNEUROSCI.20-18-07096.2000; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116; Weiler N, 2008, NAT NEUROSCI, V11, P360, DOI 10.1038/nn2049; WILSON FAW, 1994, P NATL ACAD SCI USA, V91, P4009, DOI 10.1073/pnas.91.9.4009	50	150	150	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2009	12	12					1586	U140		10.1038/nn.2431	http://dx.doi.org/10.1038/nn.2431			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	523II	19898469				2022-12-24	WOS:000272065600019
J	Wu, HH; Bellmunt, E; Scheib, JL; Venegas, V; Burkert, C; Reichardt, LF; Zhou, Z; Farinas, I; Carter, BD				Wu, Hsiao-Huei; Bellmunt, Elena; Scheib, Jami L.; Venegas, Victor; Burkert, Cornelia; Reichardt, Louis F.; Zhou, Zheng; Farinas, Isabel; Carter, Bruce D.			Glial precursors clear sensory neuron corpses during development via Jedi-1, an engulfment receptor	NATURE NEUROSCIENCE			English	Article							APOPTOTIC CELL ENGULFMENT; IMMUNOHISTOCHEMICAL LOCALIZATION; NERVOUS-SYSTEM; PHAGOCYTOSIS; DRAPER; DEATH; DEGENERATION; DIFFERENTIATION; NEUROGENESIS; MACROPHAGES	During the development of peripheral ganglia, 50% of the neurons that are generated undergo apoptosis. How the massive numbers of corpses are removed is unknown. We found that satellite glial cell precursors are the primary phagocytic cells for apoptotic corpse removal in developing mouse dorsal root ganglia (DRG). Confocal and electron microscopic analysis revealed that glial precursors, rather than macrophages, were responsible for clearing most of the dead DRG neurons. Moreover, we identified Jedi-1, an engulfment receptor, and MEGF10, a purported engulfment receptor, as homologs of the invertebrate engulfment receptors Draper and CED-1 expressed in the glial precursor cells. Expression of Jedi-1 or MEGF10 in fibroblasts facilitated binding to dead neurons, and knocking down either protein in glial cells or overexpressing truncated forms lacking the intracellular domain inhibited engulfment of apoptotic neurons. Together, these results suggest a cellular and molecular mechanism by which neuronal corpses are culled during DRG development.	[Wu, Hsiao-Huei; Scheib, Jami L.; Burkert, Cornelia; Carter, Bruce D.] Vanderbilt Univ, Sch Med, Ctr Mol Neurosci, Kennedy Ctr Human Dev, Nashville, TN 37212 USA; [Wu, Hsiao-Huei; Scheib, Jami L.; Burkert, Cornelia; Carter, Bruce D.] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37212 USA; [Bellmunt, Elena; Farinas, Isabel] Univ Valencia, Dept Biol Celular, E-46100 Burjassot, Spain; [Bellmunt, Elena; Farinas, Isabel] Univ Valencia, CIBERNED, E-46100 Burjassot, Spain; [Venegas, Victor; Zhou, Zheng] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Reichardt, Louis F.] Univ Calif San Francisco, Dept Physiol, San Francisco, CA USA	Vanderbilt University; Vanderbilt University; University of Valencia; CIBERNED; University of Valencia; Baylor College of Medicine; University of California System; University of California San Francisco	Carter, BD (corresponding author), Vanderbilt Univ, Sch Med, Ctr Mol Neurosci, Kennedy Ctr Human Dev, Nashville, TN 37212 USA.	bruce.carter@vanderbilt.edu	Fariñas, Isabel/L-7118-2014		US National Institutes of Health [NS048249, NS064278, GM067848]; Muscular Dystrophy Association Development grant [MDA4023]; US National Institutes of Health Minority Access to Research Careers Predoctoral Fellowship [GM079911]; Ministerio de Ciencia e Innovacion; Ministerio de Sanidad; Fundacion la Caixa; Generalitat Valenciana; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067848, F31GM079911] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048249, R01NS064278] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association Development grant(Muscular Dystrophy Association); US National Institutes of Health Minority Access to Research Careers Predoctoral Fellowship; Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Ministerio de Sanidad(Instituto de Salud Carlos IIISpanish Government); Fundacion la Caixa(La Caixa Foundation); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank the Statistics and Methodology Services at the Vanderbilt Kennedy Center for assistance on statistical analysis and C. Yoon, C. Jones and other members of the Carter laboratory for technical assistance and helpful suggestions. This work was supported by grants from the US National Institutes of Health (NS048249 and NS064278 to B. D. C., GM067848 to Z. Z.), a Muscular Dystrophy Association Development grant (MDA4023) to H.-H. W., a US National Institutes of Health Minority Access to Research Careers Predoctoral Fellowship (GM079911) to V. V., and the Ministerio de Ciencia e Innovacion (SAF), Ministerio de Sanidad (TerCel and Ciberned), Fundacion la Caixa, and Generalitat Valenciana (Prometeo) to I. F.	ALDSKOGIUS H, 1978, J NEUROCYTOL, V7, P229, DOI 10.1007/BF01217921; Awasaki T, 2006, NEURON, V50, P855, DOI 10.1016/j.neuron.2006.04.027; Bennett MR, 2002, AUTON NEUROSCI-BASIC, V95, P1, DOI 10.1016/S1566-0702(01)00358-7; Bishop DL, 2004, NEURON, V44, P651, DOI 10.1016/j.neuron.2004.10.026; Bratton DL, 2008, CURR BIOL, V18, pR76, DOI 10.1016/j.cub.2007.11.024; Britsch S, 2001, GENE DEV, V15, P66, DOI 10.1101/gad.186601; ERNFORS P, 1994, CELL, V77, P503, DOI 10.1016/0092-8674(94)90213-5; Farinas I, 2002, BRAIN RES BULL, V57, P809, DOI 10.1016/S0361-9230(01)00767-5; Farinas I, 1996, NEURON, V17, P1065, DOI 10.1016/S0896-6273(00)80240-8; Fenzi F, 2001, ARCH ITAL BIOL, V139, P357; Freeman MR, 2003, NEURON, V38, P567, DOI 10.1016/S0896-6273(03)00289-7; Gregory CD, 2005, NAT CELL BIOL, V7, P1161, DOI 10.1038/ncb1205-1161; GRIFFIN JW, 1993, J NEUROPATH EXP NEUR, V52, P553, DOI 10.1097/00005072-199311000-00001; Grimsley C, 2003, TRENDS CELL BIOL, V13, P648, DOI 10.1016/j.tcb.2003.10.004; HAMBURGER V, 1949, J EXP ZOOL, V111, P457, DOI 10.1002/jez.1401110308; Hamon Y, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000120; Hanani M, 2005, BRAIN RES REV, V48, P457, DOI 10.1016/j.brainresrev.2004.09.001; Henson PM, 2006, TRENDS IMMUNOL, V27, P244, DOI 10.1016/j.it.2006.03.005; Hirata K, 2002, MICROSC RES TECHNIQ, V57, P541, DOI 10.1002/jemt.10108; Hoopfer ED, 2006, NEURON, V50, P883, DOI 10.1016/j.neuron.2006.05.013; HUME DA, 1983, J CELL BIOL, V97, P253, DOI 10.1083/jcb.97.1.253; Jin YS, 1999, J NEUROSCI, V19, P539; Kurant E, 2008, CELL, V133, P498, DOI 10.1016/j.cell.2008.02.052; KURTZ A, 1994, DEVELOPMENT, V120, P2637; MacDonald JM, 2006, NEURON, V50, P869, DOI 10.1016/j.neuron.2006.04.028; Manaka J, 2004, J BIOL CHEM, V279, P48466, DOI 10.1074/jbc.M408597200; Maro GS, 2004, NAT NEUROSCI, V7, P930, DOI 10.1038/nn1299; Murphy P, 1996, DEVELOPMENT, V122, P2847; Nagata S, 2007, IMMUNOL REV, V220, P237, DOI 10.1111/j.1600-065X.2007.00571.x; OCONNOR TM, 1974, J CELL BIOL, V60, P448, DOI 10.1083/jcb.60.2.448; Okada A, 1999, EXP NEUROL, V156, P394, DOI 10.1006/exnr.1999.7033; PANNESE E, 1978, CELL TISSUE RES, V190, P1; PERRY VH, 1985, NEUROSCIENCE, V15, P313, DOI 10.1016/0306-4522(85)90215-5; Ravichandran KS, 2007, NAT REV IMMUNOL, V7, P964, DOI 10.1038/nri2214; Reddien PW, 2001, NATURE, V412, P198, DOI 10.1038/35084096; Savill J, 2002, NAT REV IMMUNOL, V2, P965, DOI 10.1038/nri957; Savill J, 2000, NATURE, V407, P784, DOI 10.1038/35037722; Schreiner S, 2007, DEVELOPMENT, V134, P3271, DOI 10.1242/dev.003350; Silva MT, 2008, APOPTOSIS, V13, P463, DOI 10.1007/s10495-008-0187-8; Suzuki E, 2007, EXP CELL RES, V313, P3729, DOI 10.1016/j.yexcr.2007.06.015; Taylor MK, 2007, DEVELOPMENT, V134, P2435, DOI 10.1242/dev.005520; TESSAROLLO L, 1994, P NATL ACAD SCI USA, V91, P11844, DOI 10.1073/pnas.91.25.11844; White FA, 1996, J NEUROSCI, V16, P4662; Woodhoo A, 2004, MOL CELL NEUROSCI, V25, P30, DOI 10.1016/j.mcn.2003.09.006; Wu HH, 2003, NEURON, V37, P197, DOI 10.1016/S0896-6273(02)01172-8; Yu XM, 2008, PLOS BIOL, V6, P581, DOI 10.1371/journal.pbio.0060061; Yuan J, 2003, NEURON, V40, P401, DOI 10.1016/S0896-6273(03)00601-9; Zhou Z, 2001, CELL, V104, P43, DOI 10.1016/S0092-8674(01)00190-8; Ziegenfuss JS, 2008, NATURE, V453, P935, DOI 10.1038/nature06901	49	125	125	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2009	12	12					1534	U79		10.1038/nn.2446	http://dx.doi.org/10.1038/nn.2446			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	523II	19915564	Green Accepted			2022-12-24	WOS:000272065600013
J	Xue, MS; Lin, YQ; Pan, HL; Reim, K; Deng, H; Bellen, HJ; Rosenmund, C				Xue, Mingshan; Lin, Yong Qi; Pan, Hongling; Reim, Kerstin; Deng, Hui; Bellen, Hugo J.; Rosenmund, Christian			Tilting the Balance between Facilitatory and Inhibitory Functions of Mammalian and Drosophila Complexins Orchestrates Synaptic Vesicle Exocytosis	NEURON			English	Article							NEUROTRANSMITTER RELEASE; SNARE COMPLEX; SINGLE-MOLECULE; MEMBRANE-FUSION; BINDING; SYNAPSES; PROTEINS; EXPRESSION; DOMAIN; TRANSMISSION	SNARE-mediated synaptic exocytosis is orchestrated by facilitatory and inhibitory mechanisms. Genetic ablations of Complexins, a family of SNARE-complex-binding proteins, in mice and Drosophila cause apparently opposite effects on neurotransmitter release, leading to contradictory hypotheses of Complexin function. Reconstitution experiments with different fusion assays and Complexins also yield conflicting results. We therefore performed cross-species rescue experiments to compare the functions of murine and Drosophila Complexins in both mouse and fly synapses. We found that murine and Drosophila Complexins employ conserved mechanisms to regulate exocytosis despite their strikingly different overall effects on neurotransmitter release. Both Complexins contain distinct domains that facilitate or inhibit synaptic vesicle fusion, and the strength of each facilitatory or inhibitory function differs significantly between murine and Drosophila Complexins. Our results show that a relative shift in the balance of facilitatory and inhibitory functions results in differential regulation of neurotransmitter release by murine and Drosophila Complexins in vivo, reconciling previous incompatible findings.	[Lin, Yong Qi; Pan, Hongling; Bellen, Hugo J.] Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA; [Deng, Hui; Bellen, Hugo J.; Rosenmund, Christian] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Bellen, Hugo J.] Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA; [Reim, Kerstin] Max Planck Inst Expt Med, Dept Mol Neurobiol, D-37075 Gottingen, Germany; [Reim, Kerstin] Max Planck Inst Expt Med, Ctr Mol Physiol Brain, D-37075 Gottingen, Germany; [Rosenmund, Christian] Charite, Neurosci Res Ctr, D-10117 Berlin, Germany; [Xue, Mingshan; Bellen, Hugo J.; Rosenmund, Christian] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA	Baylor College of Medicine; Howard Hughes Medical Institute; Baylor College of Medicine; Baylor College of Medicine; Max Planck Society; Max Planck Society; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Baylor College of Medicine	Xue, MS (corresponding author), Univ Calif San Diego, Div Biol Sci, San Diego, CA 92093 USA.	mxue@ucsd.edu; rosenmun@bcm.tmc.edu	Rosenmund, Christian/AAC-3596-2020	Rosenmund, Christian/0000-0002-3905-2444; Bellen, Hugo/0000-0001-5992-5989; Xue, Mingshan/0000-0003-1463-8884	Baylor College of Medicine Mental Retardation and Developmental Disabilities Research Center; National Institutes of Health [NS50655]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051262, R01NS050655] Funding Source: NIH RePORTER	Baylor College of Medicine Mental Retardation and Developmental Disabilities Research Center; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Hongmei Chen and Thea Hellmann for technical assistance; J. Troy Littleton for providing dmCplx antibody and dmCplx null mutant flies; Barry Dickson for nSyb-GAL4 flies before publication; Feng Liu and Kimberley Tolias for sharing transfection protocol and reagents; and Carlos Lois and Ralf Nehring for providing lentiviral vectors. The Brp and Dlg monoclonal antibodies developed by Erich Buchner and Corey Goodman, respectively, were obtained from the Developmental Studies Hybridoma Bank developed under the auspices of the NICHD and maintained by The University of Iowa, Department of Biological Sciences, Iowa City, IA 52242. We are grateful to John Clements for assistance with AxoGraph X, Josep Rizo for comments, and Nils Brose for support. This work was supported by Baylor College of Medicine Mental Retardation and Developmental Disabilities Research Center and National Institutes of Health (NS50655 to C.R.). H.J.B. is a HHMI investigator.	Bowen ME, 2005, BIOPHYS J, V89, P690, DOI 10.1529/biophysj.104.054064; Bracher A, 2002, J BIOL CHEM, V277, P26517, DOI 10.1074/jbc.M203460200; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brose N, 2008, TRAFFIC, V9, P1403, DOI 10.1111/j.1600-0854.2008.00758.x; Brunger AT, 2005, Q REV BIOPHYS, V38, P1, DOI 10.1017/S0033583505004051; Cai HJ, 2008, P NATL ACAD SCI USA, V105, P19538, DOI 10.1073/pnas.0810232105; Chen XC, 2002, NEURON, V33, P397, DOI 10.1016/S0896-6273(02)00583-4; Clements JD, 1997, BIOPHYS J, V73, P220, DOI 10.1016/S0006-3495(97)78062-7; Giraudo CG, 2006, SCIENCE, V313, P676, DOI 10.1126/science.1129450; Giraudo CG, 2009, SCIENCE, V323, P512, DOI 10.1126/science.1166500; Guan R, 2008, BIOCHEMISTRY-US, V47, P1474, DOI 10.1021/bi702345m; Huntwork S, 2007, NAT NEUROSCI, V10, P1235, DOI 10.1038/nn1980; ISHIZUKA T, 1995, BIOCHEM BIOPH RES CO, V213, P1107, DOI 10.1006/bbrc.1995.2241; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Li YL, 2007, BIOPHYS J, V93, P2178, DOI 10.1529/biophysj.106.101220; LIN DM, 1994, NEURON, V13, P507, DOI 10.1016/0896-6273(94)90022-1; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Malsam J, 2009, P NATL ACAD SCI USA, V106, P2001, DOI 10.1073/pnas.0812813106; Maximov A, 2009, SCIENCE, V323, P516, DOI 10.1126/science.1166505; MCMAHON HT, 1995, CELL, V83, P111, DOI 10.1016/0092-8674(95)90239-2; Neher E, 2008, NEURON, V59, P861, DOI 10.1016/j.neuron.2008.08.019; Pabst S, 2002, J BIOL CHEM, V277, P7838, DOI 10.1074/jbc.M109507200; Pabst S, 2000, J BIOL CHEM, V275, P19808, DOI 10.1074/jbc.M002571200; Reim K, 2005, J CELL BIOL, V169, P669, DOI 10.1083/jcb.200502115; Reim K, 2001, CELL, V104, P71, DOI 10.1016/S0092-8674(01)00192-1; Rizo J, 2008, NAT STRUCT MOL BIOL, V15, P665, DOI 10.1038/nsmb.1450; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; Schaub JR, 2006, NAT STRUCT MOL BIOL, V13, P748, DOI 10.1038/nsmb1124; Strenzke N, 2009, J NEUROSCI, V29, P7991, DOI 10.1523/JNEUROSCI.0632-09.2009; TAKAHASHI S, 1995, FEBS LETT, V368, P455, DOI 10.1016/0014-5793(95)00713-J; Tang J, 2006, CELL, V126, P1175, DOI 10.1016/j.cell.2006.08.030; Weninger K, 2008, STRUCTURE, V16, P308, DOI 10.1016/j.str.2007.12.010; Xia ZG, 1996, J NEUROSCI, V16, P5425; Xue MS, 2008, NAT STRUCT MOL BIOL, V15, P1160, DOI 10.1038/nsmb.1508; Xue MS, 2008, P NATL ACAD SCI USA, V105, P7875, DOI 10.1073/pnas.0803012105; Xue M, 2007, NAT STRUCT MOL BIOL, V14, P949, DOI 10.1038/nsmb1292; Yoon TY, 2008, NAT STRUCT MOL BIOL, V15, P707, DOI 10.1038/nsmb.1446	38	83	83	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	NOV 12	2009	64	3					367	380		10.1016/j.neuron.2009.09.043	http://dx.doi.org/10.1016/j.neuron.2009.09.043			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	521MF	19914185	Green Accepted, Bronze			2022-12-24	WOS:000271924800011
J	Hannula, DE; Ranganath, C				Hannula, Deborah E.; Ranganath, Charan			The Eyes Have It: Hippocampal Activity Predicts Expression of Memory in Eye Movements	NEURON			English	Article							MEDIAL TEMPORAL-LOBE; RELATIONAL MEMORY; FMRI ANALYSIS; RECOGNITION; AWARENESS; IMPLICIT; AMNESIA; DISSOCIATION; RECOLLECTION; FAMILIARITY	Although there is widespread agreement that the hippocampus is critical for explicit episodic memory retrieval, it is controversial whether this region can also support indirect expressions of relational memory when explicit retrieval fails. Here, using functional magnetic resonance imaging (fMRI) with concurrent indirect, eye-movement-based memory measures, we obtained evidence that hippocampal activity predicted expressions of relational memory in subsequent patterns of viewing, even when explicit, conscious retrieval failed. Additionally, activity in the lateral prefrontal cortex and functional connectivity between the hippocampus and prefrontal cortex were greater for correct than for incorrect trials. Together, these results suggest that hippocampal activity can support the expression of relational memory even when explicit retrieval fails and that recruitment of a broader cortical network may be required to support explicit associative recognition.	[Hannula, Deborah E.; Ranganath, Charan] Univ Calif Davis, Ctr Neurosci, Davis, CA 95618 USA	University of California System; University of California Davis	Hannula, DE (corresponding author), Univ Calif Davis, Ctr Neurosci, 1544 Newton Court, Davis, CA 95618 USA.	dehannula@ucdavis.edu			National Institute of Mental Health [F32MH075513]; National Institutes of Health [MH68721]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH068721, F32MH075513] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by a National Institute of Mental Health Fellowship F32MH075513 (D.E.H.) and a National Institutes of Health Grant MH68721 (C.R.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Mental Health or the National Institutes of Health. We are very grateful to Dr. Neal Cohen for insightful comments and for sharing the materials that were used in this experiment. Many thanks as well to Charlie Newer and Evan Katsuranis for technical guidance and assistance with data collection.	Aggleton JP, 1999, BEHAV BRAIN SCI, V22, P425; Aguirre GK, 1998, NEUROIMAGE, V8, P360, DOI 10.1006/nimg.1998.0369; Chun MM, 1999, NAT NEUROSCI, V2, P844, DOI 10.1038/12222; COHEN NJ, 1980, SCIENCE, V210, P207, DOI 10.1126/science.7414331; Davachi L, 2006, CURR OPIN NEUROBIOL, V16, P693, DOI 10.1016/j.conb.2006.10.012; Degonda N, 2005, NEURON, V46, P505, DOI 10.1016/j.neuron.2005.02.030; Desjardins AE, 2001, NEUROIMAGE, V13, P751, DOI 10.1006/nimg.2000.0719; Dobbins IG, 2006, J COGNITIVE NEUROSCI, V18, P1439, DOI 10.1162/jocn.2006.18.9.1439; Duarte A, 2005, J NEUROSCI, V25, P8333, DOI 10.1523/JNEUROSCI.1392-05.2005; Eichenbaum H, 2007, ANNU REV NEUROSCI, V30, P123, DOI 10.1146/annurev.neuro.30.051606.094328; EICHENBAUM H, 1994, BEHAV BRAIN SCI, V17, P449, DOI 10.1017/S0140525X00035391; Eichenbaum H, 1999, NAT NEUROSCI, V2, P775, DOI 10.1038/12137; FIETCHER PC, 2001, BRAIN, V124, P849; Greene AJ, 2007, LEARN MEMORY, V14, P548, DOI 10.1101/lm.609807; Greene AJ, 2006, J COGNITIVE NEUROSCI, V18, P1156, DOI 10.1162/jocn.2006.18.7.1156; Hannula DE, 2007, J COGNITIVE NEUROSCI, V19, P1690, DOI 10.1162/jocn.2007.19.10.1690; Hayhoe MM, 1998, VISION RES, V38, P125, DOI 10.1016/S0042-6989(97)00116-8; Henderson JM, 2003, PERCEPT PSYCHOPHYS, V65, P58, DOI 10.3758/BF03194783; Henson R, 2005, Q J EXP PSYCHOL-B, V58, P340, DOI 10.1080/02724990444000113; Holm L, 2008, J VISION, V8, DOI 10.1167/8.4.14; Insausti R, 1998, AM J NEURORADIOL, V19, P659; Jemel Boutheina, 2010, J COGNITIVE NEUROSCI, V22, P2289, DOI [10.1162/jocn.2009.21039, DOI 10.1162/JOCN.2009.21034, 10.1162/jocn.2009.21320]; Manns JR, 2001, HIPPOCAMPUS, V11, P776, DOI 10.1002/hipo.1093; MOSCOVITCH M, 1995, J CLIN EXP NEUROPSYC, V17, P276, DOI 10.1080/01688639508405123; Moscovitch M, 2008, CAN J EXP PSYCHOL, V62, P62, DOI 10.1037/1196-1961.62.1.62; Preston AR, 2008, CEREB CORTEX, V18, P2192, DOI 10.1093/cercor/bhm245; Ranganath C, 2000, J NEUROSCI, V20, DOI 10.1523/JNEUROSCI.20-22-j0005.2000; Richmond J, 2009, DEVELOPMENTAL SCI, V12, P549, DOI 10.1111/j.1467-7687.2009.00795.x; Rissman J, 2004, NEUROIMAGE, V23, P752, DOI 10.1016/j.neuroimage.2004.06.035; Ryan JD, 2000, PSYCHOL SCI, V11, P454, DOI 10.1111/1467-9280.00288; Ryan JD, 2007, MEMORY, V15, P508, DOI 10.1080/09658210701391022; Schendan HE, 2003, NEURON, V37, P1013, DOI 10.1016/S0896-6273(03)00123-5; Smith CN, 2006, J NEUROSCI, V26, P11304, DOI 10.1523/JNEUROSCI.3071-06.2006; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; TULVING E, 1990, SCIENCE, V247, P301, DOI 10.1126/science.2296719; Yonelinas AP, 2002, J MEM LANG, V46, P441, DOI 10.1006/jmla.2002.2864; Zarahn E, 1997, NEUROIMAGE, V6, P122, DOI 10.1006/nimg.1997.0279	37	214	214	1	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 10	2009	63	5					592	599		10.1016/j.neuron.2009.08.025	http://dx.doi.org/10.1016/j.neuron.2009.08.025			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	494XH	19755103	Green Accepted, Bronze			2022-12-24	WOS:000269852300007
J	Ginestier, C; Liu, SL; Wicha, MS				Ginestier, Christophe; Liu, Suling; Wicha, Max S.			Getting to the Root of BRCA1-Deficient Breast Cancer	CELL STEM CELL			English	Editorial Material							STEM-CELLS; BRCA1; MICE		[Liu, Suling; Wicha, Max S.] Univ Michigan, Dept Internal Med, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA; [Ginestier, Christophe] Inst J Paoli I Calmettes, Oncol Mol Lab, INSERM, Ctr Rech Cancerol Marseille,UMR891, F-13009 Marseille, France	University of Michigan System; University of Michigan; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC)	Wicha, MS (corresponding author), Univ Michigan, Dept Internal Med, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA.	mwicha@med.umich.edu	Ginestier, Christophe/M-8828-2017; Wicha, Max/AAE-7268-2019; Liu, Suling/N-2796-2013; liu, suling/AAF-5249-2019	Ginestier, Christophe/0000-0002-7477-3837; Liu, Suling/0000-0002-0475-0242; liu, suling/0000-0002-0475-0242				Creighton CJ, 2009, P NATL ACAD SCI USA, V106, P13820, DOI 10.1073/pnas.0905718106; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Lim E, 2009, NAT MED, V15, P907, DOI 10.1038/nm.2000; Liu S, 2008, P NATL ACAD SCI USA, V105, P1680, DOI 10.1073/pnas.0711613105; Liu X, 2007, P NATL ACAD SCI USA, V104, P12111, DOI 10.1073/pnas.0702969104; Narod SA, 2004, NAT REV CANCER, V4, P665, DOI 10.1038/nrc1431; Poole AJ, 2006, SCIENCE, V314, P1467, DOI 10.1126/science.1130471; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Turner NC, 2006, ONCOGENE, V25, P5846, DOI 10.1038/sj.onc.1209876; Wicha MS, 2006, CANCER RES, V66, P1883, DOI 10.1158/0008-5472.CAN-05-3153	10	19	19	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	SEP 4	2009	5	3					229	230		10.1016/j.stem.2009.08.007	http://dx.doi.org/10.1016/j.stem.2009.08.007			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	529VA	19733528	Bronze			2022-12-24	WOS:000272545700002
J	Selak, S; Paternain, AV; Aller, IM; Pico, E; Rivera, R; Lerma, J				Selak, Sanja; Paternain, Ana V.; Aller, Isabel M.; Pico, Esther; Rivera, Rocio; Lerma, Juan			A Role for SNAP25 in Internalization of Kainate Receptors and Synaptic Plasticity	NEURON			English	Article							MOSSY-FIBER SYNAPSES; LONG-TERM DEPRESSION; BIMOLECULAR FLUORESCENCE COMPLEMENTATION; KINASE-C-ALPHA; AMPA RECEPTOR; BOTULINUM NEUROTOXINS; PROTEIN INTERACTIONS; HIPPOCAMPAL-NEURONS; SUBUNIT COMPOSITION; FUSION SPECIFICITY	Regulation of surface insertion and internalization of AMPA and NMDA receptors has emerged as a key mechanism for the control of synaptic strength. Regulatory elements for synaptic kainate receptors (KARs) are, however, largely undetermined. We have found that SNAP25 is critical for the synaptic removal of KARs, acting via GluK5 (i.e., KA2) sub-units. SNAP25 coimmunoprecipitates with protein complexes containing PICK1, GRIP1, and GluK5 and colocalizes with GluK5 in both hippocampal neurons and transfected HEK293 cells. In hippocampal slices, purified SNAP25 antibodies and blocking peptides caused a GluK5-dependent run-up of KARs-mediated EPSC (EPSCKAR) recorded from CA3 pyramidal neurons when included in the patch pipette and prevented activity-dependent long-term depression of EPSCKAR. As EPSCKAR LTD, SNAP25/PICK1/GluK5 interactions are dynamically regulated by PKC.	[Selak, Sanja; Paternain, Ana V.; Aller, Isabel M.; Pico, Esther; Rivera, Rocio; Lerma, Juan] CSIC UMH, Inst Neurociencias Alicante, Alacant 03550, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Miguel Hernandez de Elche; CSIC-UMH - Instituto de Neurociencias de Alicante (IN)	Lerma, J (corresponding author), CSIC UMH, Inst Neurociencias Alicante, Alacant 03550, Spain.	jlerma@umh.es	Aller, Isabel/AAY-8409-2020; Lerma, Juan/G-7907-2015	Lerma, Juan/0000-0001-7838-5199; Aller, M.Isabel/0000-0002-6447-9896	Ministry of Education and Science [BFI2003-00161, BFU2006-007138]; Consolider-Ingenio 2010 Programme [CSD2007-0023]	Ministry of Education and Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Consolider-Ingenio 2010 Programme(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	We warmly thank S.F. Heinemann for providing GluK5 KO mice; L. Garcia-Gutierrez, J. Marshal, P.H. Seeburg, J.C. Smith, and T. Sudhof for plasmids; M. Darstein for a sample of GluK5 polyclonal antibody; J. Blasi for samples of clostridal toxins; A. Ferrer-Montiel for SNAP25 N-terminal peptide; M.V.L. Bennett for critical reading of the manuscript; and M. Llinares for technical help. S.S. and M.I.A. are IP3 Program CSIC Research Fellows, and R.R. is a FPI fellow. This work was supported by grants to J.L. from the Ministry of Education and Science (BFI2003-00161 and BFU2006-007138) and the Consolider-Ingenio 2010 Programme #CSD2007-0023. S.S. conducted the biochemical and cellular biology experiments and contributed to the writing of the manuscript. A.V.P. performed the electrophysiological experiments and analyses. R.R. performed some cellular biology experiments. E.P. contributed to biochemical data generation. M.I.A. carried out BiFC experiments. J.L. contributed to the design of the experiments, analysis, and interpretation of results and writing of the manuscript.	Barry MF, 2002, CURR OPIN NEUROBIOL, V12, P279, DOI 10.1016/S0959-4388(02)00329-X; BASHIR ZI, 1993, NATURE, V363, P347, DOI 10.1038/363347a0; BAUMERT M, 1989, EMBO J, V8, P379, DOI 10.1002/j.1460-2075.1989.tb03388.x; Blanes-Mira C, 2004, J NEUROCHEM, V88, P124, DOI 10.1046/j.1471-4159.2003.02133.x; Brandhorst D, 2006, P NATL ACAD SCI USA, V103, P2701, DOI 10.1073/pnas.0511138103; Cho K, 2000, NAT NEUROSCI, V3, P150, DOI 10.1038/72093; Christensen JK, 2004, J NEUROSCI, V24, P8986, DOI 10.1523/JNEUROSCI.2156-04.2004; Collingridge GL, 2009, NEUROPHARMACOLOGY, V56, P2, DOI 10.1016/j.neuropharm.2008.06.063; Contractor A, 2003, J NEUROSCI, V23, P422, DOI 10.1523/JNEUROSCI.23-02-00422.2003; Coussen F, 2005, NEURON, V47, P555, DOI 10.1016/j.neuron.2005.06.033; Cui CH, 1999, J NEUROSCI, V19, P8281; Darstein M, 2003, J NEUROSCI, V23, P8013; Derkach VA, 2007, NAT REV NEUROSCI, V8, P101, DOI 10.1038/nrn2055; Garcia EP, 1998, NEURON, V21, P727, DOI 10.1016/S0896-6273(00)80590-5; Gardner SM, 2005, NEURON, V45, P903, DOI 10.1016/j.neuron.2005.02.026; HERB A, 1992, NEURON, V8, P775, DOI 10.1016/0896-6273(92)90098-X; Hirbec H, 2003, NEURON, V37, P625, DOI 10.1016/S0896-6273(02)01191-1; Huettner JE, 2003, PROG NEUROBIOL, V70, P387, DOI 10.1016/S0301-0082(03)00122-9; Jaskolski F, 2004, J NEUROSCI, V24, P2506, DOI 10.1523/JNEUROSCI.5116-03.2004; Jo J, 2008, NEURON, V60, P1095, DOI 10.1016/j.neuron.2008.10.050; Kerppola TK, 2008, METHOD CELL BIOL, V85, P431, DOI 10.1016/S0091-679X(08)85019-4; Kerppola TK, 2006, NAT PROTOC, V1, P1278, DOI 10.1038/nprot.2006.201; Kidd FL, 1999, NATURE, V400, P569, DOI 10.1038/23040; Kwon HB, 2008, NEURON, V57, P108, DOI 10.1016/j.neuron.2007.11.024; Lan JY, 2001, NAT NEUROSCI, V4, P382, DOI 10.1038/86028; Lerma J, 2003, NAT REV NEUROSCI, V4, P481, DOI 10.1038/nrn1118; Lu J, 2007, NEURON, V55, P874, DOI 10.1016/j.neuron.2007.06.041; Martin S, 2004, EMBO J, V23, P4749, DOI 10.1038/sj.emboj.7600483; Matsuda S, 1999, J NEUROCHEM, V73, P1765, DOI 10.1046/j.1471-4159.1999.731765.x; MULKEY RM, 1992, NEURON, V9, P967, DOI 10.1016/0896-6273(92)90248-C; Mulle C, 1998, NATURE, V392, P601, DOI 10.1038/33408; Nakashiba T, 2008, SCIENCE, V319, P1260, DOI 10.1126/science.1151120; Nicoll RA, 2005, NAT REV NEUROSCI, V6, P863, DOI 10.1038/nrn1786; Niemann Heiner, 1994, Trends in Cell Biology, V4, P179, DOI 10.1016/0962-8924(94)90203-8; O'Connor V, 2002, NAT NEUROSCI, V5, P823, DOI 10.1038/nn0902-823; Osten P, 2000, NEURON, V27, P313, DOI 10.1016/S0896-6273(00)00039-8; Park YY, 2006, NEURON, V49, P95, DOI 10.1016/j.neuron.2005.11.035; Paternain AV, 2000, J NEUROSCI, V20, P196, DOI 10.1523/JNEUROSCI.20-01-00196.2000; Pelham HRB, 2001, TRENDS CELL BIOL, V11, P99, DOI 10.1016/S0962-8924(01)01929-8; Perez JL, 2001, J NEUROSCI, V21, P5417, DOI 10.1523/JNEUROSCI.21-15-05417.2001; Pooley RD, 2006, MOL BIOL CELL, V17, P3176, DOI 10.1091/mbc.E05-12-1127; Rebola N, 2008, NEURON, V57, P121, DOI 10.1016/j.neuron.2007.11.023; REHM H, 1986, EMBO J, V5, P535, DOI 10.1002/j.1460-2075.1986.tb04243.x; Ren Z, 2003, J NEUROSCI, V23, P6608; Rivera R, 2007, EMBO J, V26, P4359, DOI 10.1038/sj.emboj.7601865; Rossetto O, 2001, TOXICON, V39, P27, DOI 10.1016/S0041-0101(00)00163-X; Saka Y, 2008, METHODS, V45, P192, DOI 10.1016/j.ymeth.2008.06.005; Saka Y, 2007, DEVELOPMENT, V134, P4209, DOI 10.1242/dev.010645; SAMPEDRO MN, 1981, J CELL BIOL, V90, P675, DOI 10.1083/jcb.90.3.675; Schiavo G, 2000, PHYSIOL REV, V80, P717, DOI 10.1152/physrev.2000.80.2.717; SCHIAVO G, 1993, FEBS LETT, V335, P99, DOI 10.1016/0014-5793(93)80448-4; Selak S, 2006, NEUROSCIENCE, V143, P953, DOI 10.1016/j.neuroscience.2006.10.014; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Song I, 2002, TRENDS NEUROSCI, V25, P578, DOI 10.1016/S0166-2236(02)02270-1; Sorkin A, 2004, CURR OPIN CELL BIOL, V16, P392, DOI 10.1016/j.ceb.2004.06.001; Staudinger J, 1997, J BIOL CHEM, V272, P32019, DOI 10.1074/jbc.272.51.32019; Sun W, 2003, J CELL BIOL, V162, P125, DOI 10.1083/jcb.200302083; Tao-Cheng JH, 2000, J NEUROCYTOL, V29, P67, DOI 10.1023/A:1007168231323; Terashima A, 2004, J NEUROSCI, V24, P5381, DOI 10.1523/JNEUROSCI.4378-03.2004; WIEDENMANN B, 1985, CELL, V41, P1017, DOI 10.1016/S0092-8674(85)80082-9; Xia J, 1999, NEURON, V22, P179, DOI 10.1016/S0896-6273(00)80689-3; Xue Y, 2005, NUCLEIC ACIDS RES, V33, pW184, DOI 10.1093/nar/gki393; Yan Q, 2004, J BIOL CHEM, V279, P18270, DOI 10.1074/jbc.M400093200; Yang B, 1999, J BIOL CHEM, V274, P5649, DOI 10.1074/jbc.274.9.5649	64	71	73	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 13	2009	63	3					357	371		10.1016/j.neuron.2009.07.017	http://dx.doi.org/10.1016/j.neuron.2009.07.017			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	487OY	19679075	Green Submitted, Bronze			2022-12-24	WOS:000269285500010
J	Hawkins, RD; Hon, GC; Lee, LK; Ngo, Q; Lister, R; Pelizzola, M; Edsall, LE; Kuan, S; Luu, Y; Klugman, S; Antosiewicz-Bourget, J; Ye, Z; Espinoza, C; Agarwahl, S; Shen, L; Ruotti, V; Wang, W; Stewart, R; Thomson, JA; Ecker, JR; Ren, B				Hawkins, R. David; Hon, Gary C.; Lee, Leonard K.; Ngo, QueMinh; Lister, Ryan; Pelizzola, Mattia; Edsall, Lee E.; Kuan, Samantha; Luu, Ying; Klugman, Sarit; Antosiewicz-Bourget, Jessica; Ye, Zhen; Espinoza, Celso; Agarwahl, Saurabh; Shen, Li; Ruotti, Victor; Wang, Wei; Stewart, Ron; Thomson, James A.; Ecker, Joseph R.; Ren, Bing			Distinct Epigenomic Landscapes of Pluripotent and Lineage-Committed Human Cells	CELL STEM CELL			English	Article							EMBRYONIC STEM-CELLS; H3K9ME2 CHROMATIN DOMAINS; DNA METHYLATION; HISTONE H3; LYSINE-9 METHYLATION; GENE-EXPRESSION; POLYCOMB; GENOME; FIBROBLASTS; SIGNATURES	Human embryonic stem cells (hESCs) share an identical genome with lineage-committed cells, yet possess the remarkable properties of self-renewal and pluripotency. The diverse cellular properties in different cells have been attributed to their distinct epigenomes, but how much epigenomes differ remains unclear. Here, we report that epigenomic landscapes in hESCs and lineage-committed cells are drastically different. By comparing the chromatin-modification profiles and DNA methylomes in hESCs and primary fibroblasts, we find that nearly one-third of the genome differs in chromatin structure. Most changes arise from dramatic redistributions of repressive H3K9me3 and H3K27me3 marks, which form blocks that significantly expand in fibroblasts. A large number of potential regulatory sequences also exhibit a high degree of dynamics in chromatin modifications and DNA methylation. Additionally, we observe novel, context-dependent relationships between DNA methylation and chromatin modifications. Our results provide new insights into epigenetic mechanisms underlying properties of pluripotency and cell fate commitment.	[Hawkins, R. David; Hon, Gary C.; Lee, Leonard K.; Ngo, QueMinh; Edsall, Lee E.; Kuan, Samantha; Luu, Ying; Klugman, Sarit; Ye, Zhen; Espinoza, Celso; Agarwahl, Saurabh; Ren, Bing] Ludwig Inst Canc Res, La Jolla, CA 92093 USA; [Lister, Ryan; Pelizzola, Mattia; Ecker, Joseph R.] Salk Inst Biol Studies, Genom Anal Lab, La Jolla, CA 92037 USA; [Antosiewicz-Bourget, Jessica; Ruotti, Victor; Stewart, Ron; Thomson, James A.] Morgridge Inst Res, Madison, WI 53707 USA; [Shen, Li; Wang, Wei] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Ren, Bing] Univ Calif San Diego, Inst Genom Med, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Ren, Bing] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA; [Ruotti, Victor; Stewart, Ron; Thomson, James A.] Genome Ctr Wisconsin, Madison, WI 53706 USA; [Thomson, James A.] Univ Wisconsin, Wisconsin Natl Primate Res Ctr, Madison, WI 53706 USA; [Thomson, James A.] Univ Wisconsin, Dept Anat, Madison, WI 53715 USA	Ludwig Institute for Cancer Research; Salk Institute; University of Wisconsin System; University of Wisconsin Madison; The Morgridge Institute for Research, Inc.; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Ren, B (corresponding author), Ludwig Inst Canc Res, La Jolla, CA 92093 USA.	biren@ucsd.edu	Shen, Li/B-3562-2008; Ecker, Joseph R/B-9144-2008; Lister, Ryan/B-5168-2012	Shen, Li/0000-0002-5190-2851; Ecker, Joseph R/0000-0001-5799-5895; Lister, Ryan/0000-0001-6637-7239; Pelizzola, Mattia/0000-0001-6672-9636; Edsall, Lee Elizabeth/0000-0002-0326-2829	American Cancer Society; Human Frontier Science; NIH; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES017166] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); Human Frontier Science(Human Frontier Science Program); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We acknowledge Bradley Bernstein and the ENCODE Chromatin Group at Broad Institute and MGH for generating the H3K27me3 data sets for HUVEC, NHEK, GM, and K562 cell types. These data were used for validation during the revision and were under embargo until October 7, 2009. R.D.H. is supported by an American Cancer Society Postdoctoral Fellowship. R.L. is supported by a Human Frontier Science Program Long-term Fellowship. This work was supported by the following: NIH Epigenomics Roadmap Project (to B.R., J.A.T., J.R.E., and W.W.), the California Institute for Regenerative Medicine (B.R.), the Ludwig Institute for Cancer Research (B.R.), the Mary K. Chapman Foundation (J.R.E.), and the J.T.F. Morgridge Institute for Research (J.A.T.). This study was carried out as part of the NIH Roadmap Epigenomics Program (http://nihroadmap.nih.gov/epigenomics/referenceepigenomeconsortium.asp).	Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Ball MP, 2009, NAT BIOTECHNOL, V27, P361, DOI 10.1038/nbt.1533; Barrand S, 2010, BIOCHEM BIOPH RES CO, V391, P762, DOI 10.1016/j.bbrc.2009.11.134; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; BENSHUSHAN E, 1993, MOL CELL BIOL, V13, P891, DOI 10.1128/MCB.13.2.891; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bilodeau S, 2009, GENE DEV, V23, P2484, DOI 10.1101/gad.1837309; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Brunner AL, 2009, GENOME RES, V19, P1044, DOI 10.1101/gr.088773.108; Caswell PT, 2007, DEV CELL, V13, P496, DOI 10.1016/j.devcel.2007.08.012; Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; Chin MH, 2009, CELL STEM CELL, V5, P111, DOI 10.1016/j.stem.2009.06.008; Cuddapah S, 2009, GENOME RES, V19, P24, DOI 10.1101/gr.082800.108; Deb-Rinker P, 2005, J BIOL CHEM, V280, P6257, DOI 10.1074/jbc.C400479200; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dodge JE, 2004, MOL CELL BIOL, V24, P2478, DOI 10.1128/MCB.24.6.2478-2486.2004; Dong KB, 2008, EMBO J, V27, P2691, DOI 10.1038/emboj.2008.193; Faust C, 1998, DEVELOPMENT, V125, P4495; Filion GJ, 2010, NAT GENET, V42, P4, DOI 10.1038/ng0110-4; Fuks F, 2003, NUCLEIC ACIDS RES, V31, P2305, DOI 10.1093/nar/gkg332; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Hellman A, 2007, SCIENCE, V315, P1141, DOI 10.1126/science.1136352; Hon G, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000201; Humburg P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-343; Jackson JP, 2002, NATURE, V416, P556, DOI 10.1038/nature731; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Jones PA, 1999, TRENDS GENET, V15, P34, DOI 10.1016/S0168-9525(98)01636-9; Kharchenko PV, 2008, NAT BIOTECHNOL, V26, P1351, DOI 10.1038/nbt.1508; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; Kolasinska-Zwierz P, 2009, NAT GENET, V41, P376, DOI 10.1038/ng.322; Krogan NJ, 2003, MOL CELL BIOL, V23, P4207, DOI 10.1128/MCB.23.12.4207-4218.2003; Lehnertz B, 2003, CURR BIOL, V13, P1192, DOI 10.1016/S0960-9822(03)00432-9; Li HW, 2006, J BIOL CHEM, V281, P19489, DOI 10.1074/jbc.M513249200; Li JX, 2002, J BIOL CHEM, V277, P49383, DOI 10.1074/jbc.M209294200; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Loh YH, 2007, GENE DEV, V21, P2545, DOI 10.1101/gad.1588207; Ludwig TE, 2006, NAT BIOTECHNOL, V24, P185, DOI 10.1038/nbt1177; Ludwig TE, 2006, NAT METHODS, V3, P637, DOI 10.1038/NMETH902; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Meshorer E, 2006, NAT REV MOL CELL BIO, V7, P540, DOI 10.1038/nrm1938; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Mohn F, 2008, MOL CELL, V30, P755, DOI 10.1016/j.molcel.2008.05.007; O'Carroll D, 2001, MOL CELL BIOL, V21, P4330, DOI 10.1128/MCB.21.13.4330-4336.2001; Ohm JE, 2007, NAT GENET, V39, P237, DOI 10.1038/ng1972; Pan GJ, 2007, CELL STEM CELL, V1, P299, DOI 10.1016/j.stem.2007.08.003; Pasini D, 2007, MOL CELL BIOL, V27, P3769, DOI 10.1128/MCB.01432-06; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Pilia G, 1996, NAT GENET, V12, P241, DOI 10.1038/ng0396-241; Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907; Ryan AK, 1997, GENE DEV, V11, P1207, DOI 10.1101/gad.11.10.1207; Schlesinger Y, 2007, NAT GENET, V39, P232, DOI 10.1038/ng1950; Shi Y, 2008, CELL STEM CELL, V3, P568, DOI 10.1016/j.stem.2008.10.004; Shi Y, 2008, CELL STEM CELL, V2, P525, DOI 10.1016/j.stem.2008.05.011; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Tachibana M, 2002, GENE DEV, V16, P1779, DOI 10.1101/gad.989402; Tachibana M, 2008, EMBO J, V27, P2681, DOI 10.1038/emboj.2008.192; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tamaru H, 2001, NATURE, V414, P277, DOI 10.1038/35104508; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; Wen B, 2010, NAT GENET, V42, P5, DOI 10.1038/ng0110-5; Wen B, 2009, NAT GENET, V41, P246, DOI 10.1038/ng.297; Wendt KS, 2008, NATURE, V451, P796, DOI 10.1038/nature06634; Widschwendter M, 2007, NAT GENET, V39, P157, DOI 10.1038/ng1941; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	72	580	599	4	56	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAY 7	2010	6	5					479	491		10.1016/j.stem.2010.03.018	http://dx.doi.org/10.1016/j.stem.2010.03.018			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	598NO	20452322	Bronze, Green Accepted			2022-12-24	WOS:000277844800015
J	Staras, K; Branco, T; Burden, JJ; Pozo, K; Darcy, K; Marra, V; Ratnayaka, A; Goda, Y				Staras, Kevin; Branco, Tiago; Burden, Jemima J.; Pozo, Karine; Darcy, Kevin; Marra, Vincenzo; Ratnayaka, Arjuna; Goda, Yukiko			A Vesicle Superpool Spans Multiple Presynaptic Terminals in Hippocampal Neurons	NEURON			English	Article							FROG NEUROMUSCULAR-JUNCTION; RECYCLING SYNAPTIC VESICLES; NEUROTRANSMITTER RELEASE; TRANSMITTER RELEASE; DENDRITIC SPINES; AMPA RECEPTORS; BETA-CATENIN; SYNAPSES; PROBABILITY; POOL	Synapse-specific vesicle pools have been widely characterized at central terminals. Here, we demonstrate a vesicle pool that is not confined to a synapse but spans multiple terminals. Using fluorescence imaging, correlative electron microscopy, and modeling of vesicle dynamics, we show that some recycling pool vesicles at synapses form part of a larger vesicle "superpool." The vesicles within this superpool are highly mobile and are rapidly exchanged between terminals (turnover: similar to 4% of total pool/min), significantly changing vesicular composition at synapses over time. In acute hippocampal slices we show that the mobile vesicle pool is also a feature of native brain tissue. We also demonstrate that superpool vesicles are available to synapses during stimulation, providing an extension of the classical recycling pool. Experiments using focal BDNF application suggest the involvement of a local TrkB-receptor-dependent mechanism for synapse-specific regulation of presynaptic vesicle pools through control of vesicle release and capture to or from the extrasynaptic pool.	[Staras, Kevin; Marra, Vincenzo; Ratnayaka, Arjuna] Univ Sussex, Sch Life Sci, Brighton BN1 9QG, E Sussex, England; [Branco, Tiago] UCL, Wolfson Inst Biomed Res, London WC1E 6BT, England; [Branco, Tiago; Goda, Yukiko] UCL, Dept Neurosci Physiol & Pharmacol, London WC1E 6BT, England; [Burden, Jemima J.; Pozo, Karine; Darcy, Kevin; Goda, Yukiko] UCL, MRC, Mol Cell Biol Lab, London WC1E 6BT, England; [Burden, Jemima J.; Pozo, Karine; Darcy, Kevin; Goda, Yukiko] Univ Sussex, Cell Biol Unit, Brighton BN1 9QG, E Sussex, England	University of Sussex; University of London; University College London; University of London; University College London; University of London; University College London; University of Sussex	Staras, K (corresponding author), Univ Sussex, Sch Life Sci, Brighton BN1 9QG, E Sussex, England.	k.staras@sussex.ac.uk	Goda, Yukiko/AAR-5641-2020; Branco, Tiago/C-1503-2008; Goda, Yukiko/A-6576-2016; Pozo, Karine/J-2943-2019; Burden, Jemima/Q-1228-2017	Goda, Yukiko/0000-0003-0352-9498; Goda, Yukiko/0000-0003-0352-9498; Burden, Jemima/0000-0001-5894-7043; Ratnayaka, J. Arjuna/0000-0002-1027-6938; Staras, Kevin/0000-0003-4141-339X	Wellcome Trust [WT084357MF]; BBSRC [BB/F018371]; Medical Research Council; European Commission [LSHM-CT-2005-019055]; BBSRC [BB/F018371/1] Funding Source: UKRI; MRC [MC_U122669937] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F018371/1] Funding Source: researchfish; Medical Research Council [MC_U122669937] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Commission(European CommissionEuropean Commission Joint Research Centre); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We gratefully acknowledge Michael Hausser for access to his two-photon microscope setup, David Elliott for help in making the Sypl-Dendra2 construct, and Joe Atherton for assistance in EM. This research was supported by Wellcome Trust (WT084357MF) and BBSRC (BB/F018371) grants to K.S. and Medical Research Council and European Commission Framework VI (EUSynapse project, LSHM-CT-2005-019055) to Y.G.	Ashby MC, 2006, J NEUROSCI, V26, P7046, DOI 10.1523/JNEUROSCI.1235-06.2006; Bamji SX, 2006, J CELL BIOL, V174, P289, DOI 10.1083/jcb.200601087; Bamji SX, 2003, NEURON, V40, P719, DOI 10.1016/S0896-6273(03)00718-9; Bannai H, 2009, NEURON, V62, P670, DOI 10.1016/j.neuron.2009.04.023; BETZ WJ, 1992, SCIENCE, V255, P200, DOI 10.1126/science.1553547; Branco T, 2008, NEURON, V59, P475, DOI 10.1016/j.neuron.2008.07.006; Branco T, 2010, J STRUCT BIOL, V172, P203, DOI 10.1016/j.jsb.2009.10.014; Branco T, 2009, NAT REV NEUROSCI, V10, P373, DOI 10.1038/nrn2634; CECCARELLI B, 1973, J CELL BIOL, V57, P499, DOI 10.1083/jcb.57.2.499; Chen X, 2008, J NEUROSCI, V28, P1894, DOI 10.1523/JNEUROSCI.4518-07.2008; Darcy KJ, 2006, NAT PROTOC, V1, P988, DOI 10.1038/nprot.2006.146; Darcy KJ, 2006, NAT NEUROSCI, V9, P315, DOI 10.1038/nn1640; Ehlers MD, 2007, NEURON, V54, P447, DOI 10.1016/j.neuron.2007.04.010; Fernandez-Alfonso T, 2008, BRAIN CELL BIOL, V36, P87, DOI 10.1007/s11068-008-9030-y; Fredj NB, 2009, NAT NEUROSCI, V12, P751, DOI 10.1038/nn.2317; Frischknecht R, 2008, J NEUROSCI, V28, P1568, DOI 10.1523/JNEUROSCI.3398-07.2008; Frischknecht R, 2009, NAT NEUROSCI, V12, P897, DOI 10.1038/nn.2338; Futai K, 2007, NAT NEUROSCI, V10, P186, DOI 10.1038/nn1837; GODA Y, 1994, P NATL ACAD SCI USA, V91, P12942, DOI 10.1073/pnas.91.26.12942; Gray NW, 2006, PLOS BIOL, V4, P2065, DOI 10.1371/journal.pbio.0040370; Gurskaya NG, 2006, NAT BIOTECHNOL, V24, P461, DOI 10.1038/nbt1191; Harata N, 2001, P NATL ACAD SCI USA, V98, P12748, DOI 10.1073/pnas.171442798; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; Hopf FW, 2002, J NEUROSCI, V22, P775, DOI 10.1523/JNEUROSCI.22-03-00775.2002; Kalla S, 2006, J NEUROSCI, V26, P13054, DOI 10.1523/JNEUROSCI.4330-06.2006; Krueger SR, 2003, NEURON, V40, P945, DOI 10.1016/S0896-6273(03)00729-3; Li ZY, 2001, NEURON, V31, P593, DOI 10.1016/S0896-6273(01)00398-1; Lu Y, 2008, NEUROBIOL LEARN MEM, V89, P312, DOI 10.1016/j.nlm.2007.08.018; Murthy VN, 1997, NEURON, V18, P599, DOI 10.1016/S0896-6273(00)80301-3; Okabe S, 2001, J NEUROSCI, V21, P9561, DOI 10.1523/JNEUROSCI.21-24-09561.2001; Olsen O, 2005, J CELL BIOL, V170, P1127, DOI 10.1083/jcb.200503011; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; Regehr WG, 2009, NEURON, V63, P154, DOI 10.1016/j.neuron.2009.06.021; Rizzoli SO, 2005, NAT REV NEUROSCI, V6, P57, DOI 10.1038/nrn1583; Rizzoli SO, 2004, SCIENCE, V303, P2037, DOI 10.1126/science.1094682; RYAN TA, 1993, NEURON, V11, P713, DOI 10.1016/0896-6273(93)90081-2; Sara Y, 2005, NEURON, V45, P563, DOI 10.1016/j.neuron.2004.12.056; Schikorski T, 2001, NAT NEUROSCI, V4, P391, DOI 10.1038/86042; Sharma K, 2006, MOL CELL NEUROSCI, V31, P702, DOI 10.1016/j.mcn.2006.01.010; Shen WH, 2006, NEURON, V50, P401, DOI 10.1016/j.neuron.2006.03.017; Star EN, 2005, J PHYSIOL-LONDON, V569, P103, DOI 10.1113/jphysiol.2005.092528; Staras K, 2007, TRENDS NEUROSCI, V30, P292, DOI 10.1016/j.tins.2007.04.005; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Sun J, 2007, NATURE, V450, P676, DOI 10.1038/nature06308; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Tsuriel S, 2006, PLOS BIOL, V4, P1572, DOI 10.1371/journal.pbio.0040271; Tsuriel S, 2009, J NEUROSCI, V29, P351, DOI 10.1523/JNEUROSCI.4777-08.2009; Tyler WJ, 2006, J PHYSIOL-LONDON, V574, P787, DOI 10.1113/jphysiol.2006.111310; Westphal V, 2008, SCIENCE, V320, P246, DOI 10.1126/science.1154228; Zakharenko SS, 2001, NAT NEUROSCI, V4, P711, DOI 10.1038/89498	50	104	107	0	17	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	APR 15	2010	66	1					37	44		10.1016/j.neuron.2010.03.020	http://dx.doi.org/10.1016/j.neuron.2010.03.020			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	587TP	20399727	Green Published, hybrid			2022-12-24	WOS:000277016200007
J	Niell, CM; Stryker, MP				Niell, Cristopher M.; Stryker, Michael P.			Modulation of Visual Responses by Behavioral State in Mouse Visual Cortex	NEURON			English	Article							LATERAL GENICULATE-NUCLEUS; RECEPTIVE-FIELD PROPERTIES; MONKEY STRIATE CORTEX; NEURONS IN-VIVO; CHOLINERGIC MODULATION; BARREL CORTEX; ELECTROPHYSIOLOGICAL CLASSES; FUNCTIONAL ARCHITECTURE; ATTENTIONAL MODULATION; NEOCORTICAL NEURONS	Studies of visual processing in rodents have conventionally been performed on anesthetized animals, precluding examination of the effects of behavior on visually evoked responses. We have now studied the response properties of neurons in primary visual cortex of awake mice that were allowed to run on a freely rotating spherical treadmill with their heads fixed. Most neurons showed more than a doubling of visually evoked firing rate as the animal transitioned from standing still to running, without changes in spontaneous firing or stimulus selectivity. Tuning properties in the awake animal were similar to those measured previously in anesthetized animals. Response magnitude in the lateral geniculate nucleus did not increase with locomotion, demonstrating that the striking change in responsiveness did not result from peripheral effects at the eye. Interestingly, some narrow-spiking cells were spontaneously active during running but suppressed by visual stimuli. These results demonstrate powerful cell-type-specific modulation of visual processing by behavioral state in awake mice.	[Niell, Cristopher M.; Stryker, Michael P.] Univ Calif San Francisco, WM Keck Fdn Ctr Integrat Neurosci, Dept Physiol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Stryker, MP (corresponding author), Univ Calif San Francisco, WM Keck Fdn Ctr Integrat Neurosci, Dept Physiol, San Francisco, CA 94143 USA.			Stryker, Michael/0000-0003-1546-5831	NIH [R01-EY02874]; Helen Hay Whitney Foundation Post-doctoral Fellowship; NATIONAL EYE INSTITUTE [T32EY007120, R01EY002874] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Helen Hay Whitney Foundation Post-doctoral Fellowship; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We would like to thank Drs Loren Frank and Jonathan Horton for critical reading of the manuscript and members of the Stryker lab for insightful discussions and assistance This work was supported by NIH grant R01-EY02874, a Sandler Program in Basic Sciences New Technology Award, and a Helen Hay Whitney Foundation Post-doctoral Fellowship	Bartho P, 2004, J NEUROPHYSIOL, V92, P600, DOI 10.1152/jn.01170.2003; Bezdudnaya T, 2006, NEURON, V49, P421, DOI 10.1016/j.neuron.2006.01.010; Brecht M, 2003, J PHYSIOL-LONDON, V553, P243, DOI 10.1113/jphysiol.2003.044222; BUZSAKI G, 1988, J NEUROSCI, V8, P4007; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Cano M, 2006, NAT NEUROSCI, V9, P1240, DOI 10.1038/nn1760; Cardin JA, 2008, NEURON, V59, P150, DOI 10.1016/j.neuron.2008.05.002; Cardin JA, 2007, J NEUROSCI, V27, P10333, DOI 10.1523/JNEUROSCI.1692-07.2007; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Chen Y, 2008, NAT NEUROSCI, V11, P974, DOI 10.1038/nn.2147; Contreras D, 2004, NEURAL NETWORKS, V17, P633, DOI 10.1016/j.neunet.2004.04.003; Dombeck DA, 2007, NEURON, V56, P43, DOI 10.1016/j.neuron.2007.08.003; Fanselow EE, 1999, J NEUROSCI, V19, P7603, DOI 10.1523/JNEUROSCI.19-17-07603.1999; Ferezou I, 2007, NEURON, V56, P907, DOI 10.1016/j.neuron.2007.10.007; Fontanini A, 2008, J NEUROPHYSIOL, V100, P1160, DOI 10.1152/jn.90592.2008; FOSTER TC, 1989, SCIENCE, V244, P1580, DOI 10.1126/science.2740902; Friedberg MH, 1999, J NEUROPHYSIOL, V81, P2243, DOI 10.1152/jn.1999.81.5.2243; FRIEDMAN WA, 1992, PHYSIOL BEHAV, V52, P97, DOI 10.1016/0031-9384(92)90438-8; Goard M, 2009, NAT NEUROSCI, V12, P1444, DOI 10.1038/nn.2402; Greenberg DS, 2008, NAT NEUROSCI, V11, P749, DOI 10.1038/nn.2140; Grubb MS, 2005, J NEUROPHYSIOL, V93, P3224, DOI 10.1152/jn.00445.2004; Grubb MS, 2003, J NEUROPHYSIOL, V90, P3594, DOI 10.1152/jn.00699.2003; Haider B, 2009, NEURON, V62, P171, DOI 10.1016/j.neuron.2009.04.008; Harvey CD, 2009, NATURE, V461, P941, DOI 10.1038/nature08499; Hasselmo ME, 2006, J MOL NEUROSCI, V30, P133, DOI 10.1385/JMN:30:1:133; Herrero JL, 2008, NATURE, V454, P1110, DOI 10.1038/nature07141; Hromadka T, 2008, PLOS BIOL, V6, P124, DOI 10.1371/journal.pbio.0060016; HUBEL DH, 1968, J PHYSIOL-LONDON, V195, P215, DOI 10.1113/jphysiol.1968.sp008455; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Hubener M, 2003, CURR OPIN NEUROBIOL, V13, P413, DOI 10.1016/S0959-4388(03)00102-8; Jadhav SP, 2009, NAT NEUROSCI, V12, P792, DOI 10.1038/nn.2328; Kerr JND, 2007, J NEUROSCI, V27, P13316, DOI 10.1523/JNEUROSCI.2210-07.2007; LU SM, 1992, J NEUROPHYSIOL, V68, P2185, DOI 10.1152/jn.1992.68.6.2185; Luo L, 2008, NEURON, V57, P634, DOI 10.1016/j.neuron.2008.01.002; Maunsell JHR, 2002, PHILOS T ROY SOC B, V357, P1063, DOI 10.1098/rstb.2002.1107; Maya-Vetencourt JF, 2008, SCIENCE, V320, P385, DOI 10.1126/science.1150516; MCCORMICK DA, 1985, J NEUROPHYSIOL, V54, P782, DOI 10.1152/jn.1985.54.4.782; MELHERATE R, 1992, J NEUROSCI, V12, P4701; Mitchell JF, 2007, NEURON, V55, P131, DOI 10.1016/j.neuron.2007.06.018; Niell CM, 2008, J NEUROSCI, V28, P7520, DOI 10.1523/JNEUROSCI.0623-08.2008; Nowak LG, 2003, J NEUROPHYSIOL, V89, P1541, DOI 10.1152/jn.00580.2002; Otazu GH, 2009, NAT NEUROSCI, V12, P646, DOI 10.1038/nn.2306; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Poulet JFA, 2008, NATURE, V454, P881, DOI 10.1038/nature07150; Ramcharan EJ, 2005, P NATL ACAD SCI USA, V102, P12236, DOI 10.1073/pnas.0502843102; Reynolds JH, 2004, ANNU REV NEUROSCI, V27, P611, DOI 10.1146/annurev.neuro.26.041002.131039; RODIECK RW, 1967, SCIENCE, V157, P90, DOI 10.1126/science.157.3784.90; Rodriguez R, 2004, J NEUROSCI, V24, P10369, DOI 10.1523/JNEUROSCI.1839-04.2004; Sale A, 2007, NAT NEUROSCI, V10, P679, DOI 10.1038/nn1899; SATO H, 1987, J NEUROPHYSIOL, V58, P765, DOI 10.1152/jn.1987.58.4.765; Sawinski J, 2009, P NATL ACAD SCI USA, V106, P19557, DOI 10.1073/pnas.0903680106; Sherman SM, 2001, TRENDS NEUROSCI, V24, P122, DOI 10.1016/S0166-2236(00)01714-8; SHIN HC, 1994, NEUROSCI RES, V19, P419, DOI 10.1016/0168-0102(94)90083-3; Shuler MG, 2006, SCIENCE, V311, P1606, DOI 10.1126/science.1123513; SILLITO AM, 1983, BRAIN RES, V289, P143, DOI 10.1016/0006-8993(83)90015-X; Sirota A, 2008, NEURON, V60, P683, DOI 10.1016/j.neuron.2008.09.014; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; Tailby C, 2007, J NEUROSCI, V27, P3904, DOI 10.1523/JNEUROSCI.5343-06.2007; Usrey WM, 2002, CURR OPIN NEUROBIOL, V12, P411, DOI 10.1016/S0959-4388(02)00339-2; Weinberger NM, 2007, LEARN MEMORY, V14, P1, DOI 10.1101/lm.421807; Weyand TG, 2001, J NEUROPHYSIOL, V85, P1107, DOI 10.1152/jn.2001.85.3.1107; WURTZ RH, 1969, J NEUROPHYSIOL, V32, P727, DOI 10.1152/jn.1969.32.5.727; WURTZ RH, 1976, J NEUROPHYSIOL, V39, P766, DOI 10.1152/jn.1976.39.4.766; Wurtz RH, 2009, J PHYSIOL-LONDON, V587, P2817, DOI 10.1113/jphysiol.2009.170209	64	779	782	1	91	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	FEB 25	2010	65	4					472	479		10.1016/j.neuron.2010.01.033	http://dx.doi.org/10.1016/j.neuron.2010.01.033			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	566HD	20188652	Bronze, Green Accepted			2022-12-24	WOS:000275359800006
J	Serrats, J; Schiltz, JC; Garcia-Bueno, B; van Rooijen, N; Reyes, TM; Sawchenko, PE				Serrats, Jordi; Schiltz, Jennifer C.; Garcia-Bueno, Borja; van Rooijen, Nico; Reyes, Teresa M.; Sawchenko, Paul E.			Dual Roles for Perivascular Macrophages in Immune-to-Brain Signaling	NEURON			English	Article							PITUITARY-ADRENAL AXIS; LIPOPOLYSACCHARIDE-INDUCED FEVER; CENTRAL-NERVOUS-SYSTEM; RAT-BRAIN; ENDOTHELIAL-CELLS; INFLAMMATORY RESPONSE; EXPRESS CYCLOOXYGENASE-2; MENINGEAL MACROPHAGES; GENE-EXPRESSION; MESSENGER-RNA	Cytokines produced during infection/inflammation activate adaptive central nervous system (CNS) Tesponses, including acute stress responses mediated by the hypothalamo-pituitary-adrenal (HPA) axis. The mechanisms by which cytokines engage HPA control circuitry remain unclear, though stimulated release of prostanoids from neighboring vascular cells has been implicated in this regard. How specific vascular cell types, endothelial cells (ECs) versus perivascular cells (PVCs; a subset of brain-resident macrophages), participate in this response remains unsettled. We exploited the phagocytic activity of PVCs to deplete them in rats by central injection of a liposome-encapsulated proapoptotic drug. This manipulation abrogated CNS and hormonal indices of HPA activation under immune challenge conditions (interieukin-1) that activated prostanoid synthesis only in PVCs, while enhancing these responses to stimuli (lipopolysaccharide) that engaged prostanoid production by ECs as well. Thus, PVCs provide both prostanoid-mediated drive to the HPA axis and an anti-inflammatory action that constrains endothelial and overall CNS responses to inflammatory insults.	[Serrats, Jordi; Schiltz, Jennifer C.; Garcia-Bueno, Borja; Reyes, Teresa M.; Sawchenko, Paul E.] Salk Inst Biol Studies, Neuronal Struct & Funct Lab, La Jolla, CA 92037 USA; [Serrats, Jordi; Schiltz, Jennifer C.; Garcia-Bueno, Borja; Reyes, Teresa M.; Sawchenko, Paul E.] Clayton Med Res Fdn, La Jolla, CA 92037 USA; [van Rooijen, Nico] Vrije Univ Amsterdam, Med Ctr, Dept Mol Cell Biol, NL-1007 MB Amsterdam, Netherlands	Salk Institute; Vrije Universiteit Amsterdam	Sawchenko, PE (corresponding author), Salk Inst Biol Studies, Neuronal Struct & Funct Lab, La Jolla, CA 92037 USA.	sawchenko@salk.edu	Van Rooijen, Nico/Z-1578-2019; Garcia-Bueno, Borja/ABG-7536-2020; Reyes, Teresa/GYI-8942-2022	Reyes, Teresa/0000-0003-3009-3749; Garcia Bueno, Borja/0000-0001-7320-1530	Clayton Medical Research Foundation [NS-21182]; National Institutes of Health [NS10695, DK064086]; Spanish Ministry of Education and Science; CIBERsam; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK064086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS021182, R01NS021182, F32NS010695] Funding Source: NIH RePORTER	Clayton Medical Research Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Spanish Ministry of Education and Science(Spanish Government); CIBERsam; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank Carlos Arias, Kris Trulock, and Casey Peto for excellent assistance with surgery/histology, imaging/graphics, and electron microscopy, respectively. This research was supported by NS-21182 and was conducted in part by the Clayton Medical Research Foundation. P.E.S. is a Senior Investigator of the Clayton Medical Research Foundation. Fellowship support was provided by the National Institutes of Health (NS10695 to J.C.S. and DK064086 to T.M.R.), IBRO (J.S.), and the Spanish Ministry of Education and Science (J.S. and B.G.B.) and CIBERsam (B.G.B.).	Bechmann I, 2001, EXP NEUROL, V168, P242, DOI 10.1006/exnr.2000.7618; Bechmann I, 2001, EUR J NEUROSCI, V14, P1651, DOI 10.1046/j.0953-816x.2001.01793.x; BERNTON EW, 1987, SCIENCE, V238, P519, DOI 10.1126/science.2821620; Bianchi A, 2005, ARTHRITIS RES THER, V7, pR1325, DOI 10.1186/ar1830; Blais V, 2001, J NEUROPATH EXP NEUR, V60, P893, DOI 10.1093/jnen/60.9.893; Byler SL, 2009, BEHAV BRAIN RES, V198, P434, DOI 10.1016/j.bbr.2008.11.027; Cao CY, 1996, BRAIN RES, V733, P263, DOI 10.1016/0006-8993(96)00575-6; CHAN RKW, 1993, J NEUROSCI, V13, P5126, DOI 10.1523/JNEUROSCI.13-12-05126.1993; Ching S, 2007, J NEUROSCI, V27, P10476, DOI 10.1523/JNEUROSCI.3357-07.2007; Choi SH, 2008, FASEB J, V22, P1491, DOI 10.1096/fj.07-9411com; Choi SH, 2009, TRENDS PHARMACOL SCI, V30, P174, DOI 10.1016/j.tips.2009.01.002; Cunningham C, 2005, J NEUROSCI, V25, P9275, DOI 10.1523/JNEUROSCI.2614-05.2005; Dantzer R, 2007, BRAIN BEHAV IMMUN, V21, P153, DOI 10.1016/j.bbi.2006.09.006; DEVRIES HE, 1995, J NEUROIMMUNOL, V59, P1, DOI 10.1016/0165-5728(95)00009-Q; DIJKSTRA CD, 1985, IMMUNOLOGY, V54, P589; DINARELLO CA, 1991, BLOOD, V77, P1627; Ek M, 2000, J COMP NEUROL, V428, P5, DOI 10.1002/1096-9861(20001204)428:1<5::AID-CNE2>3.0.CO;2-M; Elander L, 2009, J NEUROSCI, V29, P1404, DOI 10.1523/JNEUROSCI.5247-08.2009; Elmquist JK, 1997, TRENDS NEUROSCI, V20, P565, DOI 10.1016/S0166-2236(97)01138-7; Engstrom L, 2008, ENDOCRINOLOGY, V149, P1436, DOI 10.1210/en.2007-1456; Ericsson A, 1997, J NEUROSCI, V17, P7166; ERICSSON A, 1995, J COMP NEUROL, V361, P681, DOI 10.1002/cne.903610410; ERICSSON A, 1994, J NEUROSCI, V14, P897; Fabriek BO, 2007, BLOOD, V109, P5223, DOI 10.1182/blood-2006-08-036467; Garcia-Bueno B, 2009, J NEUROSCI, V29, P12970, DOI 10.1523/JNEUROSCI.2373-09.2009; GEHRMANN J, 1995, BRAIN RES REV, V20, P269, DOI 10.1016/0165-0173(94)00015-H; Gosselin D, 2008, MOL PSYCHIATR, V13, P480, DOI 10.1038/sj.mp.4002122; Hahn CN, 1998, P NATL ACAD SCI USA, V95, P14880, DOI 10.1073/pnas.95.25.14880; Harbuz MS, 1997, ANN NY ACAD SCI, V823, P214, DOI 10.1111/j.1749-6632.1997.tb48393.x; HART BL, 1988, NEUROSCI BIOBEHAV R, V12, P123, DOI 10.1016/S0149-7634(88)80004-6; Hawkes CA, 2009, P NATL ACAD SCI USA, V106, P1261, DOI 10.1073/pnas.0805453106; Hickey WF, 2001, GLIA, V36, P118, DOI 10.1002/glia.1101; HICKEY WF, 1988, SCIENCE, V239, P290, DOI 10.1126/science.3276004; HOLMES MC, 1986, NATURE, V319, P326, DOI 10.1038/319326a0; Inoue H, 2000, J BIOL CHEM, V275, P28028; Ivanov AI, 2004, FRONT BIOSCI-LANDMRK, V9, P1977, DOI 10.2741/1383; KATSUURA G, 1988, ENDOCRINOLOGY, V122, P1773, DOI 10.1210/endo-122-5-1773; Kitazawa M, 2005, J NEUROSCI, V25, P8843, DOI 10.1523/JNEUROSCI.2868-05.2005; Konsman JP, 2002, TRENDS NEUROSCI, V25, P154, DOI 10.1016/S0166-2236(00)02088-9; Lacroix S, 1998, J NEUROCHEM, V70, P452, DOI 10.1046/j.1471-4159.1998.70020452.x; Laflamme N, 2001, FASEB J, V15, P155, DOI 10.1096/fj.00-0339com; Letiembre M, 2009, NEUROBIOL AGING, V30, P759, DOI 10.1016/j.neurobiolaging.2007.08.018; Mackowiak PA, 1998, ARCH INTERN MED, V158, P1870, DOI 10.1001/archinte.158.17.1870; Matsumura K, 1998, J NEUROSCI, V18, P6279; Matsuoka Y, 2003, P NATL ACAD SCI USA, V100, P4132, DOI 10.1073/pnas.0633341100; Mouihate A, 2004, J NEUROSCI, V24, P1312, DOI 10.1523/JNEUROSCI.3145-03.2004; OTTERNESS IG, 1991, CYTOKINE, V3, P333, DOI 10.1016/1043-4666(91)90502-5; Phillis JW, 2006, BRAIN RES REV, V52, P201, DOI 10.1016/j.brainresrev.2006.02.002; Polfliet MMJ, 2002, J NEUROIMMUNOL, V122, P1, DOI 10.1016/S0165-5728(01)00445-3; Polfliet MMJ, 2001, J NEUROIMMUNOL, V116, P188, DOI 10.1016/S0165-5728(01)00282-X; Polfliet MMJ, 2001, J IMMUNOL, V167, P4644, DOI 10.4049/jimmunol.167.8.4644; Priller J, 2001, NAT MED, V7, P1356, DOI 10.1038/nm1201-1356; Qin LY, 2007, GLIA, V55, P453, DOI 10.1002/glia.20467; Quan N, 1998, BRAIN RES, V802, P189, DOI 10.1016/S0006-8993(98)00402-8; Quan N, 2008, MOL NEUROBIOL, V37, P142, DOI 10.1007/s12035-008-8026-z; Romanovsky AA, 2005, FRONT BIOSCI-LANDMRK, V10, P2193, DOI 10.2741/1690; SAWCHENKO PE, 1990, METHODS NEUROSCI, V3, P247; Schiltz JC, 2003, FRONT BIOSCI-LANDMRK, V8, pS1321, DOI 10.2741/1211; Schiltz JC, 2002, J NEUROSCI, V22, P5606; Schiltz JC, 2007, J COMP NEUROL, V502, P455, DOI 10.1002/cne.21329; Sehic E, 1996, BRAIN RES BULL, V39, P391, DOI 10.1016/0361-9230(96)00037-8; SHANKS N, 1995, J NEUROSCI, V15, P376, DOI 10.1523/jneurosci.15-01-00376.1995; SIMMONS DM, 1989, J HISTOTECHNOL, V12, P169; Simonin MA, 2002, AM J PHYSIOL-CELL PH, V282, pC125, DOI 10.1152/ajpcell.2002.282.1.C125; Stoll G, 1999, PROG NEUROBIOL, V58, P233, DOI 10.1016/S0301-0082(98)00083-5; Thomas WE, 1999, BRAIN RES REV, V31, P42, DOI 10.1016/S0165-0173(99)00024-7; Turnbull AV, 1999, PHYSIOL REV, V79, P1, DOI 10.1152/physrev.1999.79.1.1; ULEVITCH RJ, 1995, ANNU REV IMMUNOL, V13, P437, DOI 10.1146/annurev.iy.13.040195.002253; Vallieres L, 2003, J NEUROSCI, V23, P5197; vanderMeer MJM, 1996, J ENDOCRINOL INVEST, V19, P175, DOI 10.1007/BF03349862; VANROOIJEN N, 1994, J IMMUNOL METHODS, V174, P83; Wang DR, 2009, P NATL ACAD SCI USA, V106, P7548, DOI 10.1073/pnas.0805806106; WATANABE T, 1990, EXPERIENTIA, V46, P481, DOI 10.1007/BF01954238; Webster JI, 2002, ANNU REV IMMUNOL, V20, P125, DOI 10.1146/annurev.immunol.20.082401.104914; WICK G, 1993, ENDOCR REV, V14, P539, DOI 10.1210/edrv-14-5-539; Wieczorek M, 2006, BRAIN BEHAV IMMUN, V20, P477, DOI 10.1016/j.bbi.2005.10.001; Williams K, 2001, GLIA, V36, P156, DOI 10.1002/glia.1105; Wong ML, 1996, NAT MED, V2, P581, DOI 10.1038/nm0596-581; Wong ML, 1996, NEUROREPORT, V7, P2445, DOI 10.1097/00001756-199611040-00008; Zhang YH, 2003, J COMP NEUROL, V463, P3, DOI 10.1002/cne.10743	80	182	182	0	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 14	2010	65	1					94	106		10.1016/j.neuron.2009.11.032	http://dx.doi.org/10.1016/j.neuron.2009.11.032			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	546DZ	20152116	Bronze, Green Accepted			2022-12-24	WOS:000273791200011
J	Broxmeyer, HE				Broxmeyer, Hal E.			Will iPS Cells Enhance Therapeutic Applicability of Cord Blood Cells and Banking?	CELL STEM CELL			English	Editorial Material							PLURIPOTENT STEM-CELLS; GENERATION; PROGENITOR		Indiana Univ, Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis	Broxmeyer, HE (corresponding author), Indiana Univ, Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA.	hbroxmey@iupui.edu						Broxmeyer HE, 2003, P NATL ACAD SCI USA, V100, P645, DOI 10.1073/pnas.0237086100; BROXMEYER HE, 1989, P NATL ACAD SCI USA, V86, P3828, DOI 10.1073/pnas.86.10.3828; BROXMEYER HE, 2009, CORD BLOOD HEMATOPOI, P559; Feng B, 2009, CELL STEM CELL, V4, P301, DOI 10.1016/j.stem.2009.03.005; Giorgetti A, 2009, CELL STEM CELL, V5, P353, DOI 10.1016/j.stem.2009.09.008; GLUCKMAN E, 1989, NEW ENGL J MED, V321, P1174, DOI 10.1056/NEJM198910263211707; Haase A, 2009, CELL STEM CELL, V5, P434, DOI 10.1016/j.stem.2009.08.021; Kaimal AJ, 2009, OBSTET GYNECOL, V114, P848, DOI 10.1097/AOG.0b013e3181b8fc0d; Maherali N, 2008, CELL STEM CELL, V3, P595, DOI 10.1016/j.stem.2008.11.008; Mantel C, 2007, BLOOD, V109, P4518, DOI 10.1182/blood-2006-10-054247; Prockop DJ, 2009, MOL THER, V17, P939, DOI 10.1038/mt.2009.62; Saha K, 2009, CELL STEM CELL, V5, P584, DOI 10.1016/j.stem.2009.11.009; Yamanaka S, 2009, CELL, V137, P13, DOI 10.1016/j.cell.2009.03.034; YE Z, 2009, BLOOD IN PRESS, DOI DOI 10.1182/BLOOD-2009-04-217406; Yoder MI, 2009, CURR OPIN HEMATOL, V16, P269, DOI 10.1097/MOH.0b013e32832bbcab	15	31	33	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	JAN 8	2010	6	1					21	24		10.1016/j.stem.2009.12.008	http://dx.doi.org/10.1016/j.stem.2009.12.008			4	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	549EW	20074533	Bronze			2022-12-24	WOS:000274029700008
J	Esteban, MA; Wang, T; Qin, BM; Yang, JY; Qin, DJ; Cai, JL; Li, W; Weng, ZH; Chen, JK; Ni, S; Chen, KS; Li, Y; Liu, XP; Xu, JY; Zhang, SQ; Li, F; He, WZ; Labuda, K; Song, YC; Peterbauer, A; Wolbank, S; Redl, H; Zhong, M; Cai, DZ; Zeng, LW; Pei, DQ				Esteban, Miguel Angel; Wang, Tao; Qin, Baoming; Yang, Jiayin; Qin, Dajiang; Cai, Jinglei; Li, Wen; Weng, Zhihui; Chen, Jiekai; Ni, Su; Chen, Keshi; Li, Yuan; Liu, Xiaopeng; Xu, Jianyong; Zhang, Shiqiang; Li, Feng; He, Wenzhi; Labuda, Krystyna; Song, Yancheng; Peterbauer, Anja; Wolbank, Susanne; Redl, Heinz; Zhong, Mei; Cai, Daozhang; Zeng, Lingwen; Pei, Duanqing			Vitamin C Enhances the Generation of Mouse and Human Induced Pluripotent Stem Cells	CELL STEM CELL			English	Article							DEMETHYLASES; FIBROBLASTS; EFFICIENCY; INDUCTION; LIMITS; MYC	Somatic cells can be reprogrammed into induced pluripotent stem cells (iPSCs) by defined factors. However, the low efficiency and slow kinetics of the reprogramming process have hampered progress with this technology. Here we report that a natural compound, vitamin C (Vc), enhances iPSC: generation from both mouse and human somatic cells. Vc acts at least in part by alleviating cell senescence, a recently identified roadblock for reprogramming. In addition, Vc accelerates gene expression changes and promotes the transition of pre-iPSC colonies to a fully reprogrammed state. Our results therefore highlight a straightforward method for improving the speed and efficiency of iPSC generation and provide additional insights into the mechanistic basis of the reprogramming process.	[Esteban, Miguel Angel; Wang, Tao; Qin, Baoming; Yang, Jiayin; Qin, Dajiang; Cai, Jinglei; Li, Wen; Weng, Zhihui; Chen, Jiekai; Ni, Su; Chen, Keshi; Li, Yuan; Liu, Xiaopeng; Xu, Jianyong; Zhang, Shiqiang; Li, Feng; He, Wenzhi; Zeng, Lingwen; Pei, Duanqing] Chinese Acad Sci, Guangzhou Inst Biomed, S China Inst Stem Cell Biol & Regenerat Med, Stem Cell & Canc Biol Grp,Key Lab Regenerat Biol, Guangzhou 510663, Guangdong, Peoples R China; [Esteban, Miguel Angel; Wang, Tao; Qin, Baoming; Yang, Jiayin; Qin, Dajiang; Cai, Jinglei; Li, Wen; Weng, Zhihui; Chen, Jiekai; Ni, Su; Chen, Keshi; Li, Yuan; Liu, Xiaopeng; Xu, Jianyong; Zhang, Shiqiang; Li, Feng; He, Wenzhi; Zeng, Lingwen; Pei, Duanqing] Chinese Acad Sci, Guangzhou Inst Hlth, Guangzhou 510663, Guangdong, Peoples R China; [Labuda, Krystyna; Wolbank, Susanne; Redl, Heinz] Ludwig Boltzmann Inst Clin & Expt Traumatol, A-1200 Vienna, Austria; [Song, Yancheng; Cai, Daozhang] Sun Yat Sen Univ, Affiliated Hosp 3, Guangzhou 510630, Guangdong, Peoples R China; [Peterbauer, Anja] Red Cross Blood Transfus Serv Upper Austria, A-4020 Linz, Austria; [Zhong, Mei] Nanfang Hosp, Ctr Prenatal & Hereditary Dis Diag, Guangzhou 510515, Guangdong, Peoples R China	Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Chinese Academy of Sciences; Ludwig Boltzmann Institute; Sun Yat Sen University; Southern Medical University - China	Pei, DQ (corresponding author), Chinese Acad Sci, Guangzhou Inst Biomed, S China Inst Stem Cell Biol & Regenerat Med, Stem Cell & Canc Biol Grp,Key Lab Regenerat Biol, Guangzhou 510663, Guangdong, Peoples R China.	pei_duanqing@gibh.ac.cn	NI, Su/AAH-8267-2020; Gabriel, Christian/A-1689-2014; Qin, Baoming/G-1553-2015; Redl, Heinz/AAD-8157-2019; Chen, Keshi/AAE-4600-2020; wang, tom/M-6808-2014; zhou, xingru/G-4442-2012	Gabriel, Christian/0000-0003-2043-9320; Qin, Baoming/0000-0001-7652-161X; Ni, Su/0000-0003-2883-574X; Yang, Jiayin/0000-0001-9134-1959; Chen, Jiekai/0000-0001-5168-7074; Wolbank, Susanne/0000-0002-1244-5854; Chen, Keshi/0000-0003-0402-4555	National Natural Science Foundation of China [30630039, 90813033]; National Science Fund for Distinguished Young Scholars [30725012]; Knowledge Innovation Project of The Chinese Academy of Sciences [KSCX2-YW-R-48, KSCX1-YW-02-1]; Bureau of Science and Technology of Guangzhou Municipality, China [2008A1-E4011]; Key Technologies R&D Program, 973 Program of China [2006CB701504, 2006CB943600, 2007CB948002, 2009CB941102, 2009CB940902]; EFBIC RED travel grant; Chinese Academy of Sciences/SAFEA International Partnership [230725012]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); Knowledge Innovation Project of The Chinese Academy of Sciences(Knowledge Innovation Program of the Chinese Academy of Sciences); Bureau of Science and Technology of Guangzhou Municipality, China; Key Technologies R&D Program, 973 Program of China(National Basic Research Program of ChinaNational Key Technology R&D Program); EFBIC RED travel grant; Chinese Academy of Sciences/SAFEA International Partnership(Chinese Academy of Sciences)	Supported by National Natural Science Foundation of China (grant numbers 30630039 and 90813033), National Science Fund for Distinguished Young Scholars (30725012), Knowledge Innovation Project of The Chinese Academy of Sciences (grant numbers KSCX2-YW-R-48, KSCX1-YW-02-1), Bureau of Science and Technology of Guangzhou Municipality, China (grant 2008A1-E4011), Key Technologies R&D Program, 973 Program of China (grant numbers 2006CB701504, 2006CB943600, 2007CB948002, 2009CB941102, 2009CB940902), an EFBIC RED travel grant, and the Chinese Academy of Sciences/SAFEA International Partnership Program for Creative Research Teams (grant number 230725012). We wish to thank members of our laboratories for their support.	Arrigoni O, 2002, BBA-GEN SUBJECTS, V1569, P1, DOI 10.1016/S0304-4165(01)00235-5; Cloos PAC, 2008, GENE DEV, V22, P1115, DOI 10.1101/gad.1652908; Esteban MA, 2009, J BIOL CHEM, V284, P17634, DOI 10.1074/jbc.M109.008938; Garcia-Gonzalo FR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001384; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Kang L, 2009, CELL STEM CELL, V5, P135, DOI 10.1016/j.stem.2009.07.001; Kawamura T, 2009, NATURE, V460, P1140, DOI 10.1038/nature08311; Kim D, 2009, CELL STEM CELL, V4, P472, DOI 10.1016/j.stem.2009.05.005; Li H, 2009, NATURE, V460, P1136, DOI 10.1038/nature08290; Marion RM, 2009, NATURE, V460, P1149, DOI 10.1038/nature08287; MASSIP L, 2009, FASEB J; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Parrinello S, 2003, NAT CELL BIOL, V5, P741, DOI 10.1038/ncb1024; Qin DJ, 2008, J BIOL CHEM, V283, P33730, DOI 10.1074/jbc.M806788200; Shi Y, 2007, NAT REV GENET, V8, P829, DOI 10.1038/nrg2218; Silva J, 2008, PLOS BIOL, V6, P2237, DOI 10.1371/journal.pbio.0060253; Sun N, 2009, P NATL ACAD SCI USA, V106, P15720, DOI 10.1073/pnas.0908450106; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Utikal J, 2009, NATURE, V460, P1145, DOI 10.1038/nature08285; Wernig M, 2008, CELL STEM CELL, V2, P10, DOI 10.1016/j.stem.2007.12.001; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Yamanaka S, 2009, CELL, V137, P13, DOI 10.1016/j.cell.2009.03.034; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482; Zhao XY, 2009, NATURE, V461, P86, DOI 10.1038/nature08267; Zhao Y, 2008, CELL STEM CELL, V3, P475, DOI 10.1016/j.stem.2008.10.002	32	726	826	7	231	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JAN 8	2010	6	1					71	79		10.1016/j.stem.2009.12.001	http://dx.doi.org/10.1016/j.stem.2009.12.001			9	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	549EW	20036631	Bronze			2022-12-24	WOS:000274029700013
J	Xu, JY; Xiao, N; Xia, J				Xu, Junyu; Xiao, Nan; Xia, Jun			Thrombospondin 1 accelerates synaptogenesis in hippocampal neurons through neuroligin 1	NATURE NEUROSCIENCE			English	Article							SYNAPSE FORMATION; RECEPTOR; CNS	In cultured rat hippocampal neurons, we found that thrombospondin 1 (TSP1) increased the speed of synapse formation in young neurons, but not the final density of synapses in mature neurons. TSP1 interacted with neuroligin 1 (NL1) and application of the NL1 extracellular domain blocked TSP1-induced synaptogenesis. Furthermore, knocking down endogenous NL1 inhibited TSP1's effect. Our results indicate that TSP1 accelerates the speed of synaptogenesis through NL1 in hippocampal neurons.	[Xu, Junyu; Xiao, Nan; Xia, Jun] Hong Kong Univ Sci & Technol, Dept Biochem, Kowloon, Hong Kong, Peoples R China	Hong Kong University of Science & Technology	Xia, J (corresponding author), Hong Kong Univ Sci & Technol, Dept Biochem, Kowloon, Hong Kong, Peoples R China.	jxia@ust.hk	Xiao, Nan/A-4775-2012; Xia, Jun/C-7234-2009	Xia, Jun/0000-0001-9308-2188; Xiao, Nan/0000-0001-7264-3046	Research Grants Council of Hong Kong [HKUST6429/06M, N_HKUST605/07, HKUST6/CRF/08, 663107, AoE/B-15/01]	Research Grants Council of Hong Kong(Hong Kong Research Grants Council)	We thank W. Tung, C. He, P. Ieong and C. Sheng for technical assistance, A. M. Craig for YFP-NL1/2 and neurexin, P. Scheiffele for HA-NL1 and D. Comoletti for Flag-NL1-ECD cDNA constructs. This work was supported in part by grants from the Research Grants Council of Hong Kong (HKUST6429/06M, N_HKUST605/07, HKUST6/CRF/08, 663107 and AoE/B-15/01).	Adams JC, 2001, ANNU REV CELL DEV BI, V17, P25, DOI 10.1146/annurev.cellbio.17.1.25; Blake SM, 2008, EMBO J, V27, P3069, DOI 10.1038/emboj.2008.223; Chih B, 2005, SCIENCE, V307, P1324, DOI 10.1126/science.1107470; Christopherson KS, 2005, CELL, V120, P421, DOI 10.1016/j.cell.2004.12.020; Comoletti D, 2003, J BIOL CHEM, V278, P50497, DOI 10.1074/jbc.M306803200; Craig AM, 2007, CURR OPIN NEUROBIOL, V17, P43, DOI 10.1016/j.conb.2007.01.011; Graf ER, 2004, CELL, V119, P1013, DOI 10.1016/j.cell.2004.11.035; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Nam CI, 2005, P NATL ACAD SCI USA, V102, P6137, DOI 10.1073/pnas.0502038102; Scheiffele P, 2003, ANNU REV NEUROSCI, V26, P485, DOI 10.1146/annurev.neuro.26.043002.094940; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Washbourne P, 2004, J NEUROSCI, V24, P9244, DOI 10.1523/JNEUROSCI.3339-04.2004; Zoghbi HY, 2003, SCIENCE, V302, P826, DOI 10.1126/science.1089071	13	146	149	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2010	13	1					22	24		10.1038/nn.2459	http://dx.doi.org/10.1038/nn.2459			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	536PM	19915562				2022-12-24	WOS:000273056300008
J	Brill, MS; Ninkovic, J; Winpenny, E; Hodge, RD; Ozen, I; Yang, R; Lepier, A; Gascon, S; Erdelyi, F; Szabo, G; Parras, C; Guillemot, F; Frotscher, M; Berninger, B; Hevner, RF; Raineteau, O; Gotz, M				Brill, Monika S.; Ninkovic, Jovica; Winpenny, Eleanor; Hodge, Rebecca D.; Ozen, Ilknur; Yang, Roderick; Lepier, Alexandra; Gascon, Sergio; Erdelyi, Ferenc; Szabo, Gabor; Parras, Carlos; Guillemot, Francois; Frotscher, Michael; Berninger, Benedikt; Hevner, Robert F.; Raineteau, Olivier; Goetz, Magdalena			Adult generation of glutamatergic olfactory bulb interneurons	NATURE NEUROSCIENCE			English	Article							NEURAL STEM-CELLS; CORTICAL INTERNEURONS; PRONEURAL GENES; CEREBRAL-CORTEX; NEUROGENESIS; NEURONS; BRAIN; SPECIFICATION; PROGENITORS; MICE	The adult mouse subependymal zone (SEZ) harbors neural stem cells that are thought to exclusively generate GABAergic interneurons of the olfactory bulb. We examined the adult generation of glutamatergic juxtaglomerular neurons, which had dendritic arborizations that projected into adjacent glomeruli, identifying them as short-axon cells. Fate mapping revealed that these originate from Neurog2- and Tbr2-expressing progenitors located in the dorsal region of the SEZ. Examination of the progenitors of these glutamatergic interneurons allowed us to determine the sequential expression of transcription factors in these cells that are thought to be hallmarks of glutamatergic neurogenesis in the developing cerebral cortex and adult hippocampus. Indeed, the molecular specification of these SEZ progenitors allowed for their recruitment into the cerebral cortex after a lesion was induced. Taken together, our data indicate that SEZ progenitors not only produce a population of adult-born glutamatergic juxtaglomerular neurons, but may also provide a previously unknown source of progenitors for endogenous repair.	[Hodge, Rebecca D.; Yang, Roderick; Hevner, Robert F.] Univ Washington, Seattle Childrens Hosp, Res Inst, Dept Neurol Surg, Seattle, WA 98195 USA; [Hodge, Rebecca D.; Yang, Roderick; Hevner, Robert F.] Univ Washington, Seattle Childrens Hosp, Res Inst, Dept Pathol, Seattle, WA 98195 USA; [Brill, Monika S.; Lepier, Alexandra; Gascon, Sergio; Berninger, Benedikt; Goetz, Magdalena] Univ Munich, Inst Physiol, Dept Physiol Genom, D-8000 Munich, Germany; [Brill, Monika S.; Ninkovic, Jovica; Gascon, Sergio; Berninger, Benedikt; Goetz, Magdalena] German Res Ctr Environm Hlth, Inst Stem Cell Res, Helmholtz Zentrum Munchen, Neuherberg, Germany; [Brill, Monika S.; Ninkovic, Jovica; Goetz, Magdalena] Munich Ctr Integrated Prot Sci CiPSM, Munich, Germany; [Winpenny, Eleanor; Ozen, Ilknur; Raineteau, Olivier] Cambridge Ctr Brain Repair, Cambridge, England; [Erdelyi, Ferenc; Szabo, Gabor] Hungarian Acad Sci, Inst Expt Med, Lab Mol Biol & Genet, Budapest, Hungary; [Parras, Carlos; Guillemot, Francois] Natl Inst Med Res, Div Mol Neurobiol, MRC, London NW7 1AA, England; [Frotscher, Michael] Univ Freiburg, Inst Anat & Cell Biol, Freiburg, Germany	Seattle Children's Hospital; University of Washington; University of Washington Seattle; Seattle Children's Hospital; University of Washington; University of Washington Seattle; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; University of Cambridge; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine; MRC National Institute for Medical Research; University of Freiburg	Hevner, RF (corresponding author), Univ Washington, Seattle Childrens Hosp, Res Inst, Dept Neurol Surg, Seattle, WA 98195 USA.	rhevner@u.washington.edu; raineteau@hifo.uzh.ch; magdalena.goetz@helmholtz-meunchen.de	Guillemot, Francois/AAV-1482-2021; Ninkovic, Jovica/AAH-5220-2019; Parras, Carlos/G-6611-2017; Raineteau, Olivier/I-1190-2014; Szabo, Gabor/A-5087-2008; Berninger, Benedikt/H-4098-2019	Ninkovic, Jovica/0000-0002-4381-0041; Parras, Carlos/0000-0003-0248-1752; Raineteau, Olivier/0000-0003-4294-2496; Szabo, Gabor/0000-0001-5438-5151; Berninger, Benedikt/0000-0003-2652-2782; Brill, Monika/0000-0001-5422-9175; Gascon, Sergio/0000-0001-8756-7082; Winpenny, Eleanor/0000-0003-1933-0168	Deutsche Forschungsgemeinschaft,; European Union; Bundesministerium fur Bildung und Forschung; Bavarian State Ministry of Sciences, Research and the Arts; Medical Research Council; John & Lucille van Geest Foundation; Dr. Scholl Foundation; European Commission Research and Technological Development program; Institut national de la sante et de la recherche medicale and Fondation de France; Canada Research Fellowship; US National Institutes of Health [R01 NS050248, R01 MH080766]; MRC [MC_U117570528] Funding Source: UKRI; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH080766] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050248] Funding Source: NIH RePORTER; Medical Research Council [MC_U117570528] Funding Source: researchfish	Deutsche Forschungsgemeinschaft,(German Research Foundation (DFG)); European Union(European Commission); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Bavarian State Ministry of Sciences, Research and the Arts; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); John & Lucille van Geest Foundation; Dr. Scholl Foundation; European Commission Research and Technological Development program(European CommissionEuropean Commission Joint Research Centre); Institut national de la sante et de la recherche medicale and Fondation de France(Institut National de la Sante et de la Recherche Medicale (Inserm)); Canada Research Fellowship; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We would like to thank F. Bedogni for invaluable advice on methods and we are particularly grateful to Y. Yanagawa for the Gad67::gfp mice. We would also like to thank T. Simon-Ebert, A. Steiner, T. Ozturk and S. Nestel for excellent technical assistance and S. Bauer for retroviral production. We would also like to thank A. Saghatelyan for invaluable discussions and comments on the manuscript. This work was supported by grants from the Deutsche Forschungsgemeinschaft, including the excellence cluster Center for Integrated Protein Science Munich, by European Transcriptome, Regulome and Cellular Commitment Consortium from the European Union and the Bundesministerium fur Bildung und Forschung to M. G., and the Bavarian State Ministry of Sciences, Research and the Arts (ForNeuroCell) to B. B. and M. G. E. W. was supported by a fellowship from the Medical Research Council, I. O. by a fellowship from the John & Lucille van Geest Foundation and O. R. by a grant from the Dr. Scholl Foundation. Research in the laboratory of F. G. is supported by funds from the Medical Research Council and grants from the European Commission Research and Technological Development program. C. P. is presently supported by an AVENIR-contract from Institut national de la sante et de la recherche medicale and Fondation de France. R. D. H. is supported by a Heart and Stroke Fund of Canada Research Fellowship. Work done in the laboratory of R. F. H. was supported by grants from the US National Institutes of Health (R01 NS050248 and R01 MH080766).	Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Aungst JL, 2003, NATURE, V426, P623, DOI 10.1038/nature02185; Berger J, 2004, GENESIS, V40, P195, DOI 10.1002/gene.20081; Berninger B, 2007, EUR J NEUROSCI, V25, P2581, DOI 10.1111/j.1460-9568.2007.05509.x; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; Brill MS, 2008, J NEUROSCI, V28, P6439, DOI 10.1523/JNEUROSCI.0700-08.2008; Chen JH, 2004, P NATL ACAD SCI USA, V101, P16357, DOI 10.1073/pnas.0406795101; Dellovade TL, 1998, J COMP NEUROL, V402, P402; Eyre MD, 2009, EUR J NEUROSCI, V29, P1397, DOI 10.1111/j.1460-9568.2009.06703.x; Faiz M, 2008, MOL CELL NEUROSCI, V38, P170, DOI 10.1016/j.mcn.2008.02.002; Gabellec MM, 2007, EUR J NEUROSCI, V25, P1373, DOI 10.1111/j.1460-9568.2007.05400.x; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Gascon S, 2008, J NEUROSCI METH, V168, P104, DOI 10.1016/j.jneumeth.2007.09.023; Geschwind D, 2004, LANCET NEUROL, V3, P82, DOI 10.1016/S1474-4422(03)00658-6; Goings GE, 2004, BRAIN RES, V996, P213, DOI 10.1016/j.brainres.2003.10.034; Hack MA, 2005, NAT NEUROSCI, V8, P865, DOI 10.1038/nn1479; Hevner RF, 2001, NEURON, V29, P353, DOI 10.1016/S0896-6273(01)00211-2; Hevner RF, 2006, NEUROSCI RES, V55, P223, DOI 10.1016/j.neures.2006.03.004; Israsena N, 2004, DEV BIOL, V268, P220, DOI 10.1016/j.ydbio.2003.12.024; Jessberger S, 2007, J NEUROSCI, V27, P9400, DOI 10.1523/JNEUROSCI.2002-07.2007; Kohwi M, 2007, J NEUROSCI, V27, P6878, DOI 10.1523/JNEUROSCI.0254-07.2007; Kokaia Z, 2003, CURR OPIN NEUROBIOL, V13, P127, DOI 10.1016/S0959-4388(03)00017-5; Kowalczyk T, 2009, CEREB CORTEX, V19, P2439, DOI 10.1093/cercor/bhn260; Kroll TT, 2005, P NATL ACAD SCI USA, V102, P7374, DOI 10.1073/pnas.0500819102; Liu XX, 2005, NAT NEUROSCI, V8, P1179, DOI 10.1038/nn1522; Lledo PM, 2006, NAT REV NEUROSCI, V7, P179, DOI 10.1038/nrn1867; Lopez-Bendito G, 2004, CEREB CORTEX, V14, P1122, DOI 10.1093/cercor/bhh072; Magavi SS, 2000, NATURE, V405, P951, DOI 10.1038/35016083; Magavi SSP, 2005, J NEUROSCI, V25, P10729, DOI 10.1523/JNEUROSCI.2250-05.2005; Merkle FT, 2007, SCIENCE, V317, P381, DOI 10.1126/science.1144914; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Mori T, 2006, GLIA, V54, P21, DOI 10.1002/glia.20350; Mouret A, 2008, J NEUROSCI, V28, P11511, DOI 10.1523/JNEUROSCI.2954-08.2008; Murphy GJ, 2003, NEURON, V37, P639, DOI 10.1016/S0896-6273(03)00057-6; Nikoletopoulou V, 2007, CELL STEM CELL, V1, P529, DOI 10.1016/j.stem.2007.08.011; Ninkovic J, 2007, J NEUROSCI, V27, P10906, DOI 10.1523/JNEUROSCI.2572-07.2007; Ohmomo H, 2009, NEUROSCIENCE, V160, P419, DOI 10.1016/j.neuroscience.2009.02.048; Parras CM, 2004, EMBO J, V23, P4495, DOI 10.1038/sj.emboj.7600447; Parras CM, 2002, GENE DEV, V16, P324, DOI 10.1101/gad.940902; PINCHING AJ, 1971, J CELL SCI, V9, P305; Roybon L, 2009, EUR J NEUROSCI, V29, P232, DOI 10.1111/j.1460-9568.2008.06595.x; Scardigli R, 2003, DEVELOPMENT, V130, P3269, DOI 10.1242/dev.00539; Schuurmans C, 2004, EMBO J, V23, P2892, DOI 10.1038/sj.emboj.7600278; Seibt J, 2003, NEURON, V39, P439, DOI 10.1016/S0896-6273(03)00435-5; Sohur US, 2006, PHILOS T R SOC B, V361, P1477, DOI 10.1098/rstb.2006.1887; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Tamamaki N, 2003, J COMP NEUROL, V467, P60, DOI 10.1002/cne.10905; Waclaw RR, 2006, NEURON, V49, P503, DOI 10.1016/j.neuron.2006.01.018; Wonders CP, 2006, NAT REV NEUROSCI, V7, P687, DOI 10.1038/nrn1954; Young KM, 2007, J NEUROSCI, V27, P8286, DOI 10.1523/JNEUROSCI.0476-07.2007	50	250	257	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2009	12	12					1524	U69		10.1038/nn.2416	http://dx.doi.org/10.1038/nn.2416			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	523II	19881504	Green Accepted			2022-12-24	WOS:000272065600012
J	Murgatroyd, C; Patchev, AV; Wu, Y; Micale, V; Bockmuhl, Y; Fischer, D; Holsboer, F; Wotjak, CT; Almeida, OFX; Spengler, D				Murgatroyd, Chris; Patchev, Alexandre V.; Wu, Yonghe; Micale, Vincenzo; Bockmuehl, Yvonne; Fischer, Dieter; Holsboer, Florian; Wotjak, Carsten T.; Almeida, Osborne F. X.; Spengler, Dietmar			Dynamic DNA methylation programs persistent adverse effects of early-life stress	NATURE NEUROSCIENCE			English	Article							PITUITARY-ADRENAL AXIS; GENE-EXPRESSION; MOUSE MODEL; EPIGENETIC REGULATION; BDNF TRANSCRIPTION; RETT-SYNDROME; DISORDERS; ANXIETY; MECP2; BRAIN	Adverse early life events can induce long-lasting changes in physiology and behavior. We found that early-life stress (ELS) in mice caused enduring hypersecretion of corticosterone and alterations in passive stress coping and memory. This phenotype was accompanied by a persistent increase in arginine vasopressin (AVP) expression in neurons of the hypothalamic paraventricular nucleus and was reversed by an AVP receptor antagonist. Altered Avp expression was associated with sustained DNA hypomethylation of an important regulatory region that resisted age-related drifts in methylation and centered on those CpG residues that serve as DNA-binding sites for the methyl CpG-binding protein 2 (MeCP2). We found that neuronal activity controlled the ability of MeCP2 to regulate activity-dependent transcription of the Avp gene and induced epigenetic marking. Thus, ELS can dynamically control DNA methylation in postmitotic neurons to generate stable changes in Avp expression that trigger neuroendocrine and behavioral alterations that are frequent features in depression.	[Murgatroyd, Chris; Patchev, Alexandre V.; Wu, Yonghe; Micale, Vincenzo; Bockmuehl, Yvonne; Fischer, Dieter; Holsboer, Florian; Wotjak, Carsten T.; Almeida, Osborne F. X.; Spengler, Dietmar] Max Planck Inst Psychiat, Munich, Germany	Max Planck Society	Spengler, D (corresponding author), Max Planck Inst Psychiat, Munich, Germany.	spengler@mpipsykl.mpg.de	Wu, Yonghe/N-2269-2019; Wotjak, Carsten T./S-3200-2019; micale, vincenzo/D-7272-2012	Wu, Yonghe/0000-0001-9667-8198; Murgatroyd, Chris/0000-0002-6885-7794; Almeida, Osborne F.X./0000-0001-7331-6928	European Union [LSHM-CT-2005-018652]; Deutsche Forschungsgemeinschaft [SP 386/4-2]	European Union(European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank A. Hoffmann and R. Stoffel for their excellent technical assistance, A. Varga and B. Wrle for help with animal care, N. Sousa, J.-P. Schulke, T. Bettecken, F. Roselli and R. Spanagel for support. We thank S. Aventis for supplying SSR149415. This work was funded by the European Union (CRESCENDO-European Union contract number LSHM-CT-2005-018652 to O.F.X.A. and D.S.) and the Deutsche Forschungsgemeinschaft (SP 386/4-2 to D. S.).	Aguilera G, 2000, REGUL PEPTIDES, V96, P23, DOI 10.1016/S0167-0115(00)00196-8; ALLIS C.D., 2007, EPIGENETICS; Bachli H, 2008, BEHAV BRAIN RES, V187, P67, DOI 10.1016/j.bbr.2007.08.029; Barz T, 2006, CANCER RES, V66, P11975, DOI 10.1158/0008-5472.CAN-06-1529; Belsham DD, 2004, ENDOCRINOLOGY, V145, P393, DOI 10.1210/en.2003-0946; Bessa JM, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.001.2009; Chahrour M, 2007, NEURON, V56, P422, DOI 10.1016/j.neuron.2007.10.001; Charmandari E, 2005, ANNU REV PHYSIOL, V67, P259, DOI 10.1146/annurev.physiol.67.040403.120816; Chen WG, 2003, SCIENCE, V302, P885, DOI 10.1126/science.1086446; Cryan JF, 2007, CURR OPIN PSYCHIATR, V20, P1, DOI 10.1097/YCO.0b013e3280117733; de Kloet ER, 2005, NAT REV NEUROSCI, V6, P463, DOI 10.1038/nrn1683; Engelmann M, 2004, FRONT NEUROENDOCRIN, V25, P132, DOI 10.1016/j.yfrne.2004.09.001; Fields RL, 2003, J NEUROSCI, V23, P7801; Flavell SW, 2008, ANNU REV NEUROSCI, V31, P563, DOI 10.1146/annurev.neuro.31.060407.125631; Fuks F, 2003, J BIOL CHEM, V278, P4035, DOI 10.1074/jbc.M210256200; Fumagalli F, 2007, PROG NEUROBIOL, V81, P197, DOI 10.1016/j.pneurobio.2007.01.002; Gainer H, 2001, EXP NEUROL, V171, P190, DOI 10.1006/exnr.2001.7769; Ghoshal K, 2004, J BIOL CHEM, V279, P6783, DOI 10.1074/jbc.M309393200; Gluckman PD, 2008, NEW ENGL J MED, V359, P61, DOI 10.1056/NEJMra0708473; HANSON PI, 1994, NEURON, V12, P943, DOI 10.1016/0896-6273(94)90306-9; Hoffmann A, 2003, MOL CELL BIOL, V23, P988, DOI 10.1128/MCB.23.3.988-1003.2003; Holmes A, 2003, TRENDS PHARMACOL SCI, V24, P580, DOI 10.1016/j.tips.2003.09.011; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jirtle RL, 2007, NAT REV GENET, V8, P253, DOI 10.1038/nrg2045; Kalueff AV, 2007, BEHAV BRAIN RES, V179, P1, DOI 10.1016/j.bbr.2007.01.023; Klose RJ, 2005, MOL CELL, V19, P667, DOI 10.1016/j.molcel.2005.07.021; Kriaucionis S, 2004, NUCLEIC ACIDS RES, V32, P1818, DOI 10.1093/nar/gkh349; Levine S, 2005, PSYCHONEUROENDOCRINO, V30, P939, DOI 10.1016/j.psyneuen.2005.03.013; Lupien SJ, 2009, NAT REV NEUROSCI, V10, P434, DOI 10.1038/nrn2639; Malaspina D, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-71; Martinowich K, 2003, SCIENCE, V302, P890, DOI 10.1126/science.1090842; McGill BE, 2006, P NATL ACAD SCI USA, V103, P18267, DOI 10.1073/pnas.0608702103; McGowan PO, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002085; McGowan PO, 2009, NAT NEUROSCI, V12, P342, DOI 10.1038/nn.2270; Meaney MJ, 2001, ANNU REV NEUROSCI, V24, P1161, DOI 10.1146/annurev.neuro.24.1.1161; Miller CA, 2007, NEURON, V53, P857, DOI 10.1016/j.neuron.2007.02.022; Muller MB, 2003, NAT NEUROSCI, V6, P1100, DOI 10.1038/nn1123; Murgatroyd C, 2004, J NEUROSCI, V24, P7762, DOI 10.1523/JNEUROSCI.1614-04.2004; Patchev AV, 2007, FASEB J, V21, P231, DOI 10.1096/fj.06-6952com; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; Renthal W, 2007, NEURON, V56, P517, DOI 10.1016/j.neuron.2007.09.032; Serradeil-Le Gal C, 2005, CNS DRUG REV, V11, P53; Siegmund A, 2007, J PSYCHIATR RES, V41, P848, DOI 10.1016/j.jpsychires.2006.07.017; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Touma C, 2008, PSYCHONEUROENDOCRINO, V33, P839, DOI 10.1016/j.psyneuen.2008.03.013; Tsankova N, 2007, NAT REV NEUROSCI, V8, P355, DOI 10.1038/nrn2132; Tsankova NM, 2006, NAT NEUROSCI, V9, P519, DOI 10.1038/nn1659; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Zhou ZL, 2006, NEURON, V52, P255, DOI 10.1016/j.neuron.2006.09.037	50	817	841	3	165	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2009	12	12					1559	U108		10.1038/nn.2436	http://dx.doi.org/10.1038/nn.2436			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	523II	19898468				2022-12-24	WOS:000272065600016
J	Rose, MF; Ren, J; Ahmad, KA; Chao, HT; Klisch, TJ; Flora, A; Greer, JJ; Zoghbi, HY				Rose, Matthew F.; Ren, Jun; Ahmad, Kaashif A.; Chao, Hsiao-Tuan; Klisch, Tiemo J.; Flora, Adriano; Greer, John J.; Zoghbi, Huda Y.			Math1 Is Essential for the Development of Hindbrain Neurons Critical for Perinatal Breathing	NEURON			English	Article							CONGENITAL CENTRAL HYPOVENTILATION; BRAIN-STEM; PREBOTZINGER COMPLEX; RESPIRATORY RHYTHM; NEONATAL-RAT; GLUTAMATE RECEPTORS; VENTRAL MEDULLA; NITRIC-OXIDE; INFANT-DEATH; IN-VITRO	Mice lacking the proneural transcription factor Math 1 (Atoh1) lack multiple neurons of the proprioceptive and arousal systems and die shortly after birth from an apparent inability to initiate respiration. We sought to determine whether Math1 was necessary for the development of hindbrain nuclei involved in respiratory rhythm generation, such as the parafacial respiratory group/retrotrapezoid nucleus (pFRG/RTN), defects in which are associated with congenital central hypoventilation syndrome (CCHS). We generated a Math1-GFP fusion allele to trace the development of Math 1-expressing pFRG/RTN and paratrigeminal neurons and found that loss of Math1 did indeed disrupt their migration and differentiation. We also identified Math1-dependent neurons and their projections near the pre-Botzinger complex, a structure critical for respiratory rhythmogenesis, and found that glutamatergic modulation re-established a rhythm in the absence of Math1. This study identifies Math1-dependent neurons that are critical for perinatal breathing that may link proprioception and arousal with respiration.	[Rose, Matthew F.; Zoghbi, Huda Y.] Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA; [Rose, Matthew F.; Zoghbi, Huda Y.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Chao, Hsiao-Tuan; Zoghbi, Huda Y.] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [Klisch, Tiemo J.; Flora, Adriano; Zoghbi, Huda Y.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Klisch, Tiemo J.; Zoghbi, Huda Y.] Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA; [Ren, Jun; Greer, John J.] Univ Alberta, Dept Physiol, Edmonton, AB, Canada	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute; University of Alberta	Zoghbi, HY (corresponding author), Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA.	hzoghbi@bcm.edu		Zoghbi, Huda/0000-0002-0700-3349; Rose, Matthew/0000-0002-1148-4130; Klisch, Tiemo/0000-0001-8182-384X; Ahmad, Kaashif/0000-0002-5970-6791	NINDS [5F31-NS051046]; NIMH [1F31-MH078678]; NICHD [K12-HD000850]; Baylor Research Advocates for Student Scientists Scholarships; McNair Fellowship; Gene Expression and Microscopy Cores of the Baylor IDDRC [HD024064]; Howard Hughes Medical Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD000850, P30HD024064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [F31MH078678] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS051046] Funding Source: NIH RePORTER	NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Baylor Research Advocates for Student Scientists Scholarships; McNair Fellowship; Gene Expression and Microscopy Cores of the Baylor IDDRC; Howard Hughes Medical Institute(Howard Hughes Medical Institute); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank R. Atkinson, A. Liang, B. Antalffy, N. Ao, and Y. Liu (Baylor College of Medicine, BCM) for assistance with histological preparations, C. Birchmeier for kindly providing the Lbx1 antibody, and B. Jusiak (BCM) for comments on the manuscript. This work was supported by National Research Service Award Kirschstein Predoctoral Fellowships from NINDS (M.F.R., 5F31-NS051046) and NIMH (H.-T.C., 1F31-MH078678), a Pediatric Scientist Development Program Award from NICHD (K.A.A., K12-HD000850), Baylor Research Advocates for Student Scientists Scholarships (M.F.R. and H.-T.C.), a McNair Fellowship (H.-T.C.), and the Gene Expression and Microscopy Cores of the Baylor IDDRC (HD024064). H.Y.Z. is an Investigator of the Howard Hughes Medical Institute.	Amiel J, 2003, NAT GENET, V33, P459, DOI 10.1038/ng1130; Ben-Arie N, 2000, DEVELOPMENT, V127, P1039; BenArie N, 1997, NATURE, V390, P169, DOI 10.1038/36579; BENNET L, 1990, J PHYSIOL-LONDON, V421, P1; CHAMBERLIN NL, 1994, J NEUROSCI, V14, P6500; Chamberlin NL, 1998, J NEUROSCI, V18, P6048; Dubreuil V, 2008, P NATL ACAD SCI USA, V105, P1067, DOI 10.1073/pnas.0709115105; Farley FW, 2000, GENESIS, V28, P106, DOI 10.1002/1526-968X(200011/12)28:3/4<106::AID-GENE30>3.0.CO;2-T; Gray PA, 1999, SCIENCE, V286, P1566, DOI 10.1126/science.286.5444.1566; GREER JJ, 1992, J NEUROPHYSIOL, V67, P996, DOI 10.1152/jn.1992.67.4.996; GREER JJ, 1991, J PHYSIOL-LONDON, V437, P727, DOI 10.1113/jphysiol.1991.sp018622; Guyenet PG, 2002, J NEUROSCI, V22, P3806; Hippenmeyer S, 2005, PLOS BIOL, V3, P878, DOI 10.1371/journal.pbio.0030159; HIRSCH DB, 1993, CURR BIOL, V3, P749, DOI 10.1016/0960-9822(93)90022-G; Jacquin TD, 1996, NEURON, V17, P747, DOI 10.1016/S0896-6273(00)80206-8; Janczewski WA, 2006, J PHYSIOL-LONDON, V570, P407, DOI 10.1113/jphysiol.2005.098848; Kato I, 2003, AM J RESP CRIT CARE, V168, P1298, DOI 10.1164/rccm.200301-134OC; Kubin L, 2004, RESP PHYSIOL NEUROBI, V143, P235, DOI 10.1016/j.resp.2004.04.017; Lavezzi AM, 2006, CURR MOL MED, V6, P429, DOI 10.2174/156652406777435381; Luo PF, 2001, J COMP NEUROL, V435, P341, DOI 10.1002/cne.1034; Machold R, 2005, NEURON, V48, P17, DOI 10.1016/j.neuron.2005.08.028; McNamara F, 1998, J APPL PHYSIOL, V85, P2314, DOI 10.1152/jappl.1998.85.6.2314; Meyers EN, 1998, NAT GENET, V18, P136, DOI 10.1038/ng0298-136; Nattie EE, 2002, J PHYSIOL-LONDON, V544, P603, DOI 10.1113/jphysiol.2002.020032; Onimaru H, 2003, J NEUROSCI, V23, P1478, DOI 10.1523/JNEUROSCI.23-04-01478.2003; Onimaru H, 2008, J NEUROSCI, V28, P12845, DOI 10.1523/JNEUROSCI.3625-08.2008; Pace RW, 2007, J PHYSIOL-LONDON, V582, P113, DOI 10.1113/jphysiol.2007.133660; Pace RW, 2008, EUR J NEUROSCI, V28, P2434, DOI 10.1111/j.1460-9568.2008.06540.x; Pagliardini S, 2008, J NEUROSCI, V28, P11030, DOI 10.1523/JNEUROSCI.1648-08.2008; PEARCE RA, 1989, NEUROSCI LETT, V101, P138, DOI 10.1016/0304-3940(89)90520-X; PHILLIPSON EA, 1978, AM REV RESPIR DIS, V118, P807; Pierrefiche O, 2002, NEUROPHARMACOLOGY, V43, P85, DOI 10.1016/S0028-3908(02)00073-4; REESE NB, 1995, PROG NEUROBIOL, V47, P105, DOI 10.1016/0301-0082(95)00023-O; ROSE MF, 2009, P NATL ACAD IN PRESS; Rouzade-Dominguez ML, 2003, EUR J NEUROSCI, V18, P3325, DOI 10.1111/j.1460-9568.2003.03072.x; Sawaguchi T, 2002, FORENSIC SCI INT, V130, pS21; Severinghaus JE, 1962, CLIN RES, V10, P122; Shao XM, 2005, NEUROSCIENCE, V130, P1069, DOI 10.1016/j.neuroscience.2004.10.028; Shirasawa S, 2000, NAT GENET, V24, P287, DOI 10.1038/73516; SMITH JC, 1989, J COMP NEUROL, V281, P69, DOI 10.1002/cne.902810107; SMITH JC, 1991, SCIENCE, V254, P726, DOI 10.1126/science.1683005; SMITH JC, 1990, J NEUROPHYSIOL, V64, P1149, DOI 10.1152/jn.1990.64.4.1149; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Stornetta RL, 2006, J NEUROSCI, V26, P10305, DOI 10.1523/JNEUROSCI.2917-06.2006; Tan WB, 2008, NAT NEUROSCI, V11, P538, DOI 10.1038/nn.2104; Thoby-Brisson M, 2009, NAT NEUROSCI, V12, P1028, DOI 10.1038/nn.2354; Wang VY, 2005, NEURON, V48, P31, DOI 10.1016/j.neuron.2005.08.024; Weston MC, 2004, J COMP NEUROL, V473, P73, DOI 10.1002/cne.20076	48	122	122	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 12	2009	64	3					341	354		10.1016/j.neuron.2009.10.023	http://dx.doi.org/10.1016/j.neuron.2009.10.023			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	521MF	19914183	Green Accepted, Bronze			2022-12-24	WOS:000271924800009
J	Goaillard, JM; Taylor, AL; Schulz, DJ; Marder, E				Goaillard, Jean-Marc; Taylor, Adam L.; Schulz, David J.; Marder, Eve			Functional consequences of animal-to-animal variation in circuit parameters	NATURE NEUROSCIENCE			English	Article							LOBSTER STOMATOGASTRIC GANGLION; ELECTRICALLY COUPLED NEURONS; RHYTHMICALLY ACTIVE NEURONS; TRANSIENT POTASSIUM CURRENT; PREMOTOR SYNAPTIC INPUT; HEART MOTOR-NEURONS; PATTERN GENERATOR; PYLORIC NEURONS; PHASE-SHIFTS; ALTERNATIVE OUTPUTS	How different are the neuronal circuits for a given behavior across individual animals? To address this question, we measured multiple cellular and synaptic parameters in individual preparations to see how they correlated with circuit function, using neurons and synapses in the pyloric circuit of the stomatogastric ganglion of the crab Cancer borealis. There was considerable preparation-to-preparation variability in the strength of two identified synapses, in the amplitude of a modulator-evoked current and in the expression of six ion channel genes. Nonetheless, we found strong correlations across preparations among these parameters and attributes of circuit performance. These data illustrate the importance of making multidimensional measurements from single preparations for understanding how variability in circuit output is related to the variability of multiple circuit parameters.	[Goaillard, Jean-Marc; Taylor, Adam L.; Marder, Eve] Brandeis Univ, Volen Ctr, Waltham, MA USA; [Goaillard, Jean-Marc; Taylor, Adam L.; Marder, Eve] Brandeis Univ, Dept Biol, Waltham, MA USA; [Schulz, David J.] Univ Missouri, Columbia, MO USA	Brandeis University; Brandeis University; University of Missouri System; University of Missouri Columbia	Goaillard, JM (corresponding author), Univ Aix Marseille 2, Fac Med Secteur Nord, INSERM, UMR 641, Marseille, France.	goaillard@univmed.fr	Marder, Eve/A-5713-2012	Schulz, David/0000-0003-4532-5362	US National Institutes of Health [NS17813, MH46742, NS50928]; James S. McDonnell Foundation [220020065]; National Science Foundation [IOB-0615160]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH046742, R37MH046742] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS050928, R01NS017813, R37NS017813] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); James S. McDonnell Foundation; National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank S. R. Pulver and L. S. Tang for contributing data. This work was supported by US National Institutes of Health grants NS17813 (E. M.), MH46742 (E. M.) and NS50928 (A. L. T.), James S. McDonnell Foundation grant 220020065 (E. M.) and National Science Foundation grant IOB-0615160 (D. J. S.).	Achard P, 2006, PLOS COMPUT BIOL, V2, P794, DOI 10.1371/journal.pcbi.0020094; Bucher D, 2005, J NEUROSCI, V25, P1611, DOI 10.1523/JNEUROSCI.3679-04.2005; BUCHHOLTZ F, 1992, J NEUROPHYSIOL, V67, P332, DOI 10.1152/jn.1992.67.2.332; Chouard T, 2008, NATURE, V456, P300, DOI 10.1038/456300a; EISEN JS, 1982, J NEUROPHYSIOL, V48, P1392, DOI 10.1152/jn.1982.48.6.1392; EISEN JS, 1984, J NEUROPHYSIOL, V51, P1375, DOI 10.1152/jn.1984.51.6.1375; Goldman MS, 2001, J NEUROSCI, V21, P5229, DOI 10.1523/JNEUROSCI.21-14-05229.2001; GOLOWASCH J, 1992, J NEUROPHYSIOL, V67, P318, DOI 10.1152/jn.1992.67.2.318; GOLOWASCH J, 1992, J NEUROSCI, V12, P810; Golowasch J, 1999, J NEUROSCI, V19, part. no., DOI 10.1523/JNEUROSCI.19-20-j0004.1999; Greenspan RJ, 2001, NAT REV GENET, V2, P383, DOI 10.1038/35072018; HARRISWARRICK RM, 1995, J NEUROSCI, V15, P342; HARRISWARRICK RM, 1995, J NEUROPHYSIOL, V74, P1404, DOI 10.1152/jn.1995.74.4.1404; HOOPER SL, 1987, J NEUROSCI, V7, P2097; HOOPER SL, 1986, J COMP PHYSIOL A, V159, P227, DOI 10.1007/BF00612305; Lien CC, 2003, J NEUROSCI, V23, P2058; Liss B, 2004, TRENDS NEUROSCI, V27, P475, DOI 10.1016/j.tins.2004.06.007; Liss B, 2001, EMBO J, V20, P5715, DOI 10.1093/emboj/20.20.5715; Luthi A, 1998, NEURON, V21, P9, DOI 10.1016/S0896-6273(00)80509-7; MacLean JN, 2005, J NEUROPHYSIOL, V94, P3601, DOI 10.1152/jn.00281.2005; MacLean JN, 2003, NEURON, V37, P109, DOI 10.1016/S0896-6273(02)01104-2; MARDER E, 1984, J NEUROPHYSIOL, V51, P1345, DOI 10.1152/jn.1984.51.6.1345; Marder E, 2006, NAT REV NEUROSCI, V7, P563, DOI 10.1038/nrn1949; Marder E, 2007, ANNU REV PHYSIOL, V69, P291, DOI 10.1146/annurev.physiol.69.031905.161516; Miller J.P., 1987, P109; Nadim F, 1999, P NATL ACAD SCI USA, V96, P8206, DOI 10.1073/pnas.96.14.8206; Norris BJ, 2007, J NEUROPHYSIOL, V98, P2992, DOI 10.1152/jn.00877.2007; Norris BJ, 2007, J NEUROPHYSIOL, V98, P2983, DOI 10.1152/jn.00407.2007; Nusbaum MP, 2001, TRENDS NEUROSCI, V24, P146, DOI 10.1016/S0166-2236(00)01723-9; Prinz AA, 2004, NAT NEUROSCI, V7, P1345, DOI 10.1038/nn1352; Prinz AA, 2003, J NEUROSCI, V23, P943; Rabbah P, 2007, J NEUROPHYSIOL, V97, P2239, DOI 10.1152/jn.01161.2006; Schulz DJ, 2007, P NATL ACAD SCI USA, V104, P13187, DOI 10.1073/pnas.0705827104; Schulz DJ, 2006, NAT NEUROSCI, V9, P356, DOI 10.1038/nn1639; Swensen AM, 2005, J NEUROSCI, V25, P3509, DOI 10.1523/JNEUROSCI.3929-04.2005; Swensen AM, 2001, J NEUROSCI, V21, P4050, DOI 10.1523/JNEUROSCI.21-11-04050.2001; Swensen AM, 2000, J NEUROSCI, V20, P6752, DOI 10.1523/JNEUROSCI.20-18-06752.2000; Taylor AL, 2009, J NEUROSCI, V29, P5573, DOI 10.1523/JNEUROSCI.4438-08.2009; Thirumalai V, 2006, J NEUROPHYSIOL, V95, P1762, DOI 10.1152/jn.00764.2005; Thuma JB, 2007, J COMP PHYSIOL A, V193, P1101, DOI 10.1007/s00359-007-0261-7; TIERNEY AJ, 1992, J NEUROPHYSIOL, V67, P599, DOI 10.1152/jn.1992.67.3.599; van Welie I, 2004, P NATL ACAD SCI USA, V101, P5123, DOI 10.1073/pnas.0307711101; Weimann JM, 1997, J NEUROSCI, V17, P1748; WEIMANN JM, 1991, J NEUROPHYSIOL, V65, P111, DOI 10.1152/jn.1991.65.1.111	44	177	177	1	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2009	12	11					1424	1430		10.1038/nn.2404	http://dx.doi.org/10.1038/nn.2404			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	511UE	19838180	Green Accepted, Green Submitted			2022-12-24	WOS:000271194100015
J	Shatz, CJ				Shatz, Carla J.			MHC Class I: An Unexpected Role in Neuronal Plasticity	NEURON			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; CENTRAL-NERVOUS-SYSTEM; OCULAR-DOMINANCE PLASTICITY; DEVELOPING VISUAL-CORTEX; FRAGILE-X-SYNDROME; SYNAPTIC PLASTICITY; GENE-EXPRESSION; COMMON VARIANTS; MESSENGER-RNAS; MOUSE MODEL	For the nervous system to translate experience into memory and behavior, lasting structural change at synapses must occur. This requirement is clearly evident during critical periods of activity-dependent neural development, and accumulating evidence has established a surprising role for the major histocompatibility complex class I (MHCI) proteins in this process.	[Shatz, Carla J.] Stanford Univ, James H Clark Ctr, Dept Biol, Stanford, CA 94305 USA; [Shatz, Carla J.] Stanford Univ, James H Clark Ctr, Dept Neurobiol, Stanford, CA 94305 USA	Stanford University; Stanford University	Shatz, CJ (corresponding author), Stanford Univ, James H Clark Ctr, Dept Biol, 318 Campus Dr W1-1, Stanford, CA 94305 USA.	cshatz@stanford.edu			NIH [R01 EY02858, R01 MH071666]; Charitable Foundation; Dana Foundation; NATIONAL EYE INSTITUTE [R01EY002858] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH071666] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Charitable Foundation; Dana Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	I wish to thank the many members of my lab both past and present for their contributions to work cited here, which was supported by NIH R01 EY02858, NIH R01 MH071666, the G. Harold and Leila Y. Mathers Charitable Foundation and the Dana Foundation.	Amadou C, 1999, IMMUNOL REV, V167, P211, DOI 10.1111/j.1600-065X.1999.tb01394.x; Atwal JK, 2008, SCIENCE, V322, P967, DOI 10.1126/science.1161151; Barco A, 2005, NEURON, V48, P123, DOI 10.1016/j.neuron.2005.09.005; Baudouin SJ, 2008, MOL BIOL CELL, V19, P2444, DOI 10.1091/mbc.E07-09-0947; Beattie EC, 2002, SCIENCE, V295, P2282, DOI 10.1126/science.1067859; Bennett MJ, 2000, NATURE, V403, P46, DOI 10.1038/47417; Bhat R, 2009, NEURON, V64, P123, DOI 10.1016/j.neuron.2009.09.015; Boulanger LM, 2009, NEURON, V64, P93, DOI 10.1016/j.neuron.2009.09.001; Boulanger LM, 2004, NAT REV NEUROSCI, V5, P521, DOI 10.1038/nrn1428; Brown V, 2001, CELL, V107, P477, DOI 10.1016/S0092-8674(01)00568-2; Bryceson YT, 2005, J NEUROIMMUNOL, V161, P177, DOI 10.1016/j.jneuroim.2004.11.018; Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252; Corriveau RA, 1998, NEURON, V21, P505, DOI 10.1016/S0896-6273(00)80562-0; Dolen G, 2007, NEURON, V56, P955, DOI 10.1016/j.neuron.2007.12.001; Dorfman JR, 1997, J IMMUNOL, V159, P5219; Dustin ML, 2002, SCIENCE, V298, P785, DOI 10.1126/science.1076386; Goddard CA, 2007, P NATL ACAD SCI USA, V104, P6828, DOI 10.1073/pnas.0702023104; Hensch TK, 2004, ANNU REV NEUROSCI, V27, P549, DOI 10.1146/annurev.neuro.27.070203.144327; Huber KM, 2002, P NATL ACAD SCI USA, V99, P7746, DOI 10.1073/pnas.122205699; Huberman AD, 2008, ANNU REV NEUROSCI, V31, P479, DOI 10.1146/annurev.neuro.31.060407.125533; Huh GS, 2000, SCIENCE, V290, P2155, DOI 10.1126/science.290.5499.2155; Ishii T, 2008, J NEUROSCI, V28, P2332, DOI 10.1523/JNEUROSCI.4807-07.2008; JOLY E, 1991, SCIENCE, V253, P1283, DOI 10.1126/science.1891717; Kane LP, 2000, CURR OPIN IMMUNOL, V12, P242, DOI 10.1016/S0952-7915(00)00083-2; Kaneko M, 2008, NEURON, V58, P673, DOI 10.1016/j.neuron.2008.04.023; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; LAMPSON LA, 1995, MICROSC RES TECHNIQ, V32, P267, DOI 10.1002/jemt.1070320402; Linda H, 1999, J NEUROIMMUNOL, V101, P76, DOI 10.1016/S0165-5728(99)00135-6; Loconto J, 2003, CELL, V112, P607, DOI 10.1016/S0092-8674(03)00153-3; Maenaka K, 1999, CURR OPIN STRUC BIOL, V9, P745, DOI 10.1016/S0959-440X(99)00039-1; McConnell MJ, 2009, P NATL ACAD SCI USA, V106, P6784, DOI 10.1073/pnas.0902018106; McGee AW, 2005, SCIENCE, V309, P2222, DOI 10.1126/science.1114362; Miralves J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001354; Moretti P, 2006, J NEUROSCI, V26, P319, DOI 10.1523/JNEUROSCI.2623-05.2006; Neumann H, 1997, J EXP MED, V185, P305, DOI 10.1084/jem.185.2.305; Oliveira ALR, 2004, P NATL ACAD SCI USA, V101, P17843, DOI 10.1073/pnas.0408154101; Patterson PH, 2009, BEHAV BRAIN RES, V204, P313, DOI 10.1016/j.bbr.2008.12.016; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; RALL GF, 1995, J EXP MED, V182, P1201, DOI 10.1084/jem.182.5.1201; SHAWAR SM, 1994, ANNU REV IMMUNOL, V12, P839, DOI 10.1146/annurev.immunol.12.1.839; Shi JX, 2009, NATURE, V460, P753, DOI 10.1038/nature08192; SRETAVAN DW, 1988, NATURE, V336, P468, DOI 10.1038/336468a0; Stefansson H, 2009, NATURE, V460, P744, DOI 10.1038/nature08186; Stellwagen D, 2002, NEURON, V33, P357, DOI 10.1016/S0896-6273(02)00577-9; Syken J, 2003, P NATL ACAD SCI USA, V100, P13048, DOI 10.1073/pnas.1735415100; Syken J, 2006, SCIENCE, V313, P1795, DOI 10.1126/science.1128232; Tagawa Y, 2005, NAT NEUROSCI, V8, P380, DOI 10.1038/nn1410; Taha SA, 2005, PROG BRAIN RES, V147, P103, DOI 10.1016/S0079-6123(04)47008-3; Takai T, 2005, IMMUNOLOGY, V115, P433, DOI 10.1111/j.1365-2567.2005.02177.x; Thams S, 2008, BRAIN RES REV, V57, P265, DOI 10.1016/j.brainresrev.2007.06.016; Tourne S, 1996, P NATL ACAD SCI USA, V93, P1464, DOI 10.1073/pnas.93.4.1464; Zhong J, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-17; ZIJILSTRA M, 1990, NATURE, V344, P742; Zohar O, 2008, J IMMUNOL, V180, P6447, DOI 10.4049/jimmunol.180.10.6447	55	254	261	0	22	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	OCT 15	2009	64	1					40	45		10.1016/j.neuron.2009.09.044	http://dx.doi.org/10.1016/j.neuron.2009.09.044			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	515FY	19840547	Green Accepted, Bronze			2022-12-24	WOS:000271454400009
J	Favaro, R; Valotta, M; Ferri, ALM; Latorre, E; Mariani, J; Giachino, C; Lancini, C; Tosetti, V; Ottolenghi, S; Taylor, V; Nicolis, SK				Favaro, Rebecca; Valotta, Menella; Ferri, Anna L. M.; Latorre, Elisa; Mariani, Jessica; Giachino, Claudio; Lancini, Cesare; Tosetti, Valentina; Ottolenghi, Sergio; Taylor, Verdon; Nicolis, Silvia K.			Hippocampal development and neural stem cell maintenance require Sox2-dependent regulation of Shh	NATURE NEUROSCIENCE			English	Article							ADULT-MOUSE BRAIN; SONIC-HEDGEHOG; SELF-RENEWAL; SUBVENTRICULAR ZONE; IN-VIVO; SOX2; EXPRESSION; MICE; PLURIPOTENCY; MUTATIONS	Neural stem cells (NSCs) are controlled by diffusible factors. The transcription factor Sox2 is expressed by NSCs and Sox2 mutations in humans cause defects in the brain and, in particular, in the hippocampus. We deleted Sox2 in the mouse embryonic brain. At birth, the mice showed minor brain defects; shortly afterwards, however, NSCs and neurogenesis were completely lost in the hippocampus, leading to dentate gyrus hypoplasia. Deletion of Sox2 in adult mice also caused hippocampal neurogenesis loss. The hippocampal developmental defect resembles that caused by late sonic hedgehog (Shh) loss. In mutant mice, Shh and Wnt3a were absent from the hippocampal primordium. A SHH pharmacological agonist partially rescued the hippocampal defect. Chromatin immunoprecipitation identified Shh as a Sox2 target. Sox2-deleted NSCs did not express Shh in vitro and were rapidly lost. Their replication was partially rescued by the addition of SHH and was almost fully rescued by conditioned medium from normal cells. Thus, NSCs control their status, at least partly, through Sox2-dependent autocrine mechanisms.	[Favaro, Rebecca; Valotta, Menella; Ferri, Anna L. M.; Latorre, Elisa; Mariani, Jessica; Lancini, Cesare; Tosetti, Valentina; Ottolenghi, Sergio; Nicolis, Silvia K.] Univ Milan, Dept Biotechnol & Biosci, Milan, Italy; [Giachino, Claudio; Taylor, Verdon] Max Planck Inst Immunobiol, Dept Mol Embryol, D-7800 Freiburg, Germany	University of Milan; University of Milano-Bicocca; Max Planck Society	Nicolis, SK (corresponding author), Univ Milan, Dept Biotechnol & Biosci, Milan, Italy.	silvia.nicolis@unimib.it	Ferri, Luca Angelo/AAC-5890-2022; Favaro, Rebecca/HHZ-8978-2022; tosetti, valentina/B-6811-2013	Ferri, Luca Angelo/0000-0001-9031-6284; Favaro, Rebecca/0000-0002-6195-5711; Taylor, Verdon/0000-0003-3497-5976; Latorre, Elisa/0000-0002-8297-1219; NICOLIS, SILVIA KIRSTEN/0000-0003-0378-3808; GIACHINO, Claudio/0000-0002-8332-0899	Telethon [GGP05122]; European Economic Community; Fondazione Cariplo; Associazione Italiana Ricerca sul Cancro; Fondazione Banca del Monte di Lombardia; Ministero Istruzione Universita e Ricerca; Max Planck Gesellschaft	Telethon(Fondazione Telethon); European Economic Community; Fondazione Cariplo(Fondazione Cariplo); Associazione Italiana Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Fondazione Banca del Monte di Lombardia; Ministero Istruzione Universita e Ricerca(Ministry of Education, Universities and Research (MIUR)); Max Planck Gesellschaft(Max Planck Society)	We thank G. Deh and S. Zangrossi for the pcnB. Tn10 recA. cat C5507 E. coli C strain, S. Dymecki for the pLM- FLRT- 3 vector and the FLPeR mouse strain, R. Klein through Jackson Laboratories for the nestin- cre mouse strain, P. Chambon for the creERT2 gene, Curis for the 1.2 SHH agonist18, S. Lugert for help with the Notch pathway expression studies, J. Cozzi and GenOway for help with ES cell targeting, C. Tiveron and Layline Genomics for blastocyst injections, C. Tiveron and L. Tatangelo for Sox2- creERT2 pronuclear injections, R. Caccia for help with in situ hybridization, E. Bagnaresi and A. Marinelli for help with constructs, A. Ronchi for advice on EMSAs and ChIP and D. Santoni for animal care. The monoclonal antibody to SHH developed by T. M. Jessell was obtained from the Developmental Studies Hybridoma Bank developed under the auspices of the US National Institute of Child Health and Human Development and maintained by the University of Iowa. This work was supported by Telethon ( GGP05122), the European Economic Community ( STEMBRIDGE), Fondazione Cariplo, Associazione Italiana Ricerca sul Cancro, Fondazione Banca del Monte di Lombardia, the Ministero Istruzione Universita e Ricerca ( Cofin) and FAR 20047 grants to S. K. N., and by the Max Planck Gesellschaft through V. Taylor.	Ahn S, 2005, NATURE, V437, P894, DOI 10.1038/nature03994; Akagi K, 1997, NUCLEIC ACIDS RES, V25, P1766, DOI 10.1093/nar/25.9.1766; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Balordi F, 2007, J NEUROSCI, V27, P5936, DOI 10.1523/JNEUROSCI.1040-07.2007; Cavallaro M, 2008, DEVELOPMENT, V135, P541, DOI 10.1242/dev.010801; Clement V, 2007, CURR BIOL, V17, P165, DOI 10.1016/j.cub.2006.11.033; CONLON RA, 1993, METHOD ENZYMOL, V225, P373; Doetsch F, 2003, NAT NEUROSCI, V6, P1127, DOI 10.1038/nn1144; ECHELARD Y, 1993, CELL, V75, P1417, DOI 10.1016/0092-8674(93)90627-3; Fantes J, 2003, NAT GENET, V33, P461, DOI 10.1038/ng1120; Farley FW, 2000, GENESIS, V28, P106, DOI 10.1002/1526-968X(200011/12)28:3/4<106::AID-GENE30>3.0.CO;2-T; Fasano CA, 2007, CELL STEM CELL, V1, P87, DOI 10.1016/j.stem.2007.04.001; Ferri ALM, 2004, DEVELOPMENT, V131, P3805, DOI 10.1242/dev.01204; Frank-Kamenetsky Maria, 2002, J Biol, V1, P10, DOI 10.1186/1475-4924-1-10; Gilbertson RJ, 2007, NAT REV CANCER, V7, P733, DOI 10.1038/nrc2246; Gritti A, 1996, J NEUROSCI, V16, P1091; Jeong YS, 2006, DEVELOPMENT, V133, P761, DOI 10.1242/dev.02239; Kelberman D, 2006, J CLIN INVEST, V116, P2442, DOI 10.1172/JCI28658; Kempermann G, 2004, TRENDS NEUROSCI, V27, P447, DOI 10.1016/j.tins.2004.05.013; Lai K, 2003, NAT NEUROSCI, V6, P21, DOI 10.1038/nn983; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Lee SMK, 2000, DEVELOPMENT, V127, P457; Machold R, 2003, NEURON, V39, P937, DOI 10.1016/S0896-6273(03)00561-0; Marson A, 2008, CELL STEM CELL, V3, P132, DOI 10.1016/j.stem.2008.06.019; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; Medina DL, 2004, EMBO J, V23, P3803, DOI 10.1038/sj.emboj.7600399; Merkle FT, 2004, P NATL ACAD SCI USA, V101, P17528, DOI 10.1073/pnas.0407893101; Miyagi S, 2008, FEBS LETT, V582, P2811, DOI 10.1016/j.febslet.2008.07.011; Nyfeler Y, 2005, EMBO J, V24, P3504, DOI 10.1038/sj.emboj.7600816; Palma V, 2005, DEVELOPMENT, V132, P335, DOI 10.1242/dev.01567; Palma V, 2004, DEVELOPMENT, V131, P337, DOI 10.1242/dev.00930; Riquelme PA, 2008, PHILOS T R SOC B, V363, P123, DOI 10.1098/rstb.2006.2016; Roelink H, 2000, CURR BIOL, V10, pR279, DOI 10.1016/S0960-9822(00)00407-3; Romer JT, 2004, CANCER CELL, V6, P229, DOI 10.1016/j.ccr.2004.08.019; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Schmitz M, 2007, BRIT J CANCER, V96, P1293, DOI 10.1038/sj.bjc.6603696; Shi YH, 2004, NATURE, V427, P78, DOI 10.1038/nature02211; Sisodiya SM, 2006, EPILEPSIA, V47, P534, DOI 10.1111/j.1528-1167.2006.00464.x; Suh H, 2007, CELL STEM CELL, V1, P515, DOI 10.1016/j.stem.2007.09.002; Szutorisz H, 2005, MOL CELL BIOL, V25, P1804, DOI 10.1128/MCB.25.5.1804-1820.2005; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Taranova OV, 2006, GENE DEV, V20, P1187, DOI 10.1101/gad.1407906; Wang Y, 2007, CURR OPIN CELL BIOL, V19, P159, DOI 10.1016/j.ceb.2007.02.005; Weber P, 2001, EUR J NEUROSCI, V14, P1777, DOI 10.1046/j.0953-816x.2001.01803.x; Weinmann AS, 2002, METHODS, V26, P37, DOI 10.1016/S1046-2023(02)00006-3; Zappone MV, 2000, DEVELOPMENT, V127, P2367	47	348	363	1	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2009	12	10					1248	U62		10.1038/nn.2397	http://dx.doi.org/10.1038/nn.2397			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	498US	19734891				2022-12-24	WOS:000270170200013
J	Palazzolo, I; Stack, C; Kong, LL; Musaro, A; Adachi, H; Katsuno, M; Sobue, G; Taylor, JP; Sumner, CJ; Fischbeck, KH; Pennuto, M				Palazzolo, Isabella; Stack, Conor; Kong, Lingling; Musaro, Antonio; Adachi, Hiroaki; Katsuno, Masahisa; Sobue, Gen; Taylor, J. Paul; Sumner, Charlotte J.; Fischbeck, Kenneth H.; Pennuto, Maria			Overexpression of IGF-1 in Muscle Attenuates Disease in a Mouse Model of Spinal and Bulbar Muscular Atrophy	NEURON			English	Article							GROWTH-FACTOR-I; FOXO TRANSCRIPTION FACTORS; ANDROGEN RECEPTOR; SKELETAL-MUSCLE; KENNEDY-DISEASE; INSULIN; EXPRESSION; HYPERTROPHY; SURVIVAL; DEGRADATION	Expansion of a polyglutamine tract in the androgen receptor (AR) causes spinal and bulbar muscular atrophy (SBMA). We previously showed that Akt-mediated phosphorylation of AR reduces ligand binding and attenuates the mutant AR toxicity. Here, we show that in culture insulin-like growth factor 1 (IGF-1) reduces AR aggregation and increases AR clearance via the ubiquitin-proteasome system through phosphorylation of AR by Akt. In vivo, SBMA transgenic mice overexpressing a muscle-specific isoform of IGF-1 selectively in skeletal muscle show evidence of increased Akt activation and AR phosphorylation and decreased AR aggregation. Augmentation of IGF-1/Akt signaling rescues behavioral and histopathological abnormalities, extends the life span, and reduces both muscle and spinal cord pathology of SBMA mice. This study establishes IGF-1/Akt-mediated inactivation of mutant AR as a strategy to counteract disease in vivo and demonstrates that skeletal muscle is a viable target tissue for therapeutic intervention in SBMA.	[Pennuto, Maria] Univ Penn, Sch Med, Dept Neurol, Philadelphia, PA 19104 USA; [Palazzolo, Isabella; Stack, Conor; Fischbeck, Kenneth H.] NINDS, Neurogenet Branch, NIH, Bethesda, MD 20892 USA; [Palazzolo, Isabella] Univ Milan, Ist Endocrinol, I-20133 Milan, Italy; [Kong, Lingling; Sumner, Charlotte J.] Johns Hopkins Sch Med, Dept Neurol, Baltimore, MD USA; [Musaro, Antonio] Univ Roma La Sapienza, Inst Pasteur Cenci Bolognetti, Dept Histol & Med Embryol, IIM, I-00161 Rome, Italy; [Adachi, Hiroaki; Katsuno, Masahisa; Sobue, Gen] Nagoya Univ, Grad Sch Med, Dept Neurol, Nagoya, Aichi 4668550, Japan; [Katsuno, Masahisa] Nagoya Univ, Inst Adv Res, Nagoya, Aichi 4668550, Japan; [Taylor, J. Paul] St Jude Childrens Hosp, Dept Dev Neurobiol, Memphis, TN 38105 USA; [Pennuto, Maria] Italian Inst Technol, Dept Neurosci & Brain Technol, I-16163 Genoa, Italy	University of Pennsylvania; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Consiglio Nazionale delle Ricerche (CNR); Istituto per Endocrinologia e Oncologia "Gaetano Salvatore" (IEOS-CNR); University of Milan; Johns Hopkins University; Johns Hopkins Medicine; Fondazione Cenci Bolognetti; Sapienza University Rome; Nagoya University; Nagoya University; St Jude Children's Research Hospital; Istituto Italiano di Tecnologia - IIT	Pennuto, M (corresponding author), Univ Penn, Sch Med, Dept Neurol, Philadelphia, PA 19104 USA.	maria.pennuto@iit.it	Taylor, J. Paul/N-2482-2018; Musaro, Antonio/P-2953-2019; Musarò, Antonio/K-9598-2016; Adachi, Hiroaki/AAM-7812-2020; Pennuto, Maria/E-3270-2019; Adachi, Hiroaki/I-2669-2012; KATSUNO, MASAHISA/I-7502-2014	Taylor, J. Paul/0000-0002-5794-0349; Musaro, Antonio/0000-0002-2944-9739; Musarò, Antonio/0000-0002-2944-9739; Adachi, Hiroaki/0000-0002-9302-4663; Pennuto, Maria/0000-0001-8634-0767; Adachi, Hiroaki/0000-0002-9302-4663; KATSUNO, MASAHISA/0000-0001-9453-9311	NINDS; Telethon-Italy [GFP04005]; Kennedy's Disease Association; Muscular Dystrophy Association; NIH [NS053825]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003038, R01NS053825, R01NS062869] Funding Source: NIH RePORTER	NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Telethon-Italy(Fondazione Telethon); Kennedy's Disease Association; Muscular Dystrophy Association(Muscular Dystrophy Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank G. Harmison for skillful technical assistance, Dr. S. Ranganathan and the other members of Dr. Fischbeck's lab for advice and discussion, Dr. A. Lieberman for providing us with control tissue samples, Dr. J. Crawley for advice about mouse behavioral studies, Drs. L. Wrabetz and S. Previtali for kindly providing us with muscle samples from denervated mice, Dr A. Antignani for instructions for size-exclusion chromatography, and Dr. F. Sambataro for statistical analysis. This work was supported by NINDS intramural funds and by grants from Telethon-Italy (GFP04005, M.P.; A.M.), the Kennedy's Disease Association (M.P.), Muscular Dystrophy Association (Development Grant, M.P.; Research Grant, J.P.T.), and the NIH (NS053825, J.P.T.).	Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Bagriantsev SN, 2006, METHOD ENZYMOL, V412, P33, DOI 10.1016/S0076-6879(06)12003-0; Banno H, 2009, ANN NEUROL, V65, P140, DOI 10.1002/ana.21540; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Bonuccelli G, 2007, CELL CYCLE, V6, P1242, DOI 10.4161/cc.6.10.4182; Borasio GD, 1998, NEUROLOGY, V51, P583, DOI 10.1212/WNL.51.2.583; CARONI P, 1990, J CELL BIOL, V110, P1307, DOI 10.1083/jcb.110.4.1307; Cary GA, 2008, PHYS MED REH CLIN N, V19, P479, DOI 10.1016/j.pmr.2008.03.002; COLEMAN ME, 1995, J BIOL CHEM, V270, P12109, DOI 10.1074/jbc.270.20.12109; Crawley JN, 2008, NEURON, V57, P809, DOI 10.1016/j.neuron.2008.03.001; DISTEFANO PS, 1992, NEURON, V8, P983, DOI 10.1016/0896-6273(92)90213-W; Dobrowolny G, 2005, J CELL BIOL, V168, P193, DOI 10.1083/jcb.200407021; Florini JR, 1996, ENDOCR REV, V17, P481, DOI 10.1210/edrv-17-5-481; HUGHES RA, 1993, J NEUROSCI RES, V36, P663, DOI 10.1002/jnr.490360607; Humbert S, 2002, DEV CELL, V2, P831, DOI 10.1016/S1534-5807(02)00188-0; Jordan CL, 2008, CURR OPIN PHARMACOL, V8, P752, DOI 10.1016/j.coph.2008.08.006; Kaspar BK, 2003, SCIENCE, V301, P839, DOI 10.1126/science.1086137; Katsuno M, 2003, NAT MED, V9, P768, DOI 10.1038/nm878; Katsuno M, 2002, NEURON, V35, P843, DOI 10.1016/S0896-6273(02)00834-6; Katsuno M, 2006, EXP NEUROL, V200, P8, DOI 10.1016/j.expneurol.2006.01.021; Kostrominova TY, 2005, PHYSIOL GENOMICS, V22, P227, DOI 10.1152/physiolgenomics.00210.2004; LA SA, 1991, NATURE, V352, P77; Lai EC, 1997, NEUROLOGY, V49, P1621, DOI 10.1212/WNL.49.6.1621; Lawlor MA, 2001, J CELL SCI, V114, P2903; Li M, 2007, J BIOL CHEM, V282, P3157, DOI 10.1074/jbc.M609972200; Lin HK, 2002, EMBO J, V21, P4037, DOI 10.1093/emboj/cdf406; Lin HK, 2001, P NATL ACAD SCI USA, V98, P7200, DOI 10.1073/pnas.121173298; Monks DA, 2007, P NATL ACAD SCI USA, V104, P18259, DOI 10.1073/pnas.0705501104; Musaro A, 2001, NAT GENET, V27, P195, DOI 10.1038/84839; NEFF NT, 1993, J NEUROBIOL, V24, P1578, DOI 10.1002/neu.480241203; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; Palazzolo I, 2007, HUM MOL GENET, V16, P1593, DOI 10.1093/hmg/ddm109; Pennuto M, 2008, NEURON, V57, P393, DOI 10.1016/j.neuron.2007.12.021; Rommel C, 2001, NAT CELL BIOL, V3, P1009, DOI 10.1038/ncb1101-1009; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Rusmini P, 2007, NEUROBIOL AGING, V28, P1099, DOI 10.1016/j.neurobiolaging.2006.05.015; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Sandri M, 2008, PHYSIOLOGY, V23, P160, DOI 10.1152/physiol.00041.2007; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; Schmidt BJ, 2002, NEUROLOGY, V59, P770, DOI 10.1212/WNL.59.5.770; Soraru G, 2008, J NEUROL SCI, V264, P100, DOI 10.1016/j.jns.2007.08.012; Sorenson EJ, 2008, NEUROLOGY, V71, P1770, DOI 10.1212/01.wnl.0000335970.78664.36; Stenoien DL, 1999, HUM MOL GENET, V8, P731, DOI 10.1093/hmg/8.5.731; Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4; Taylor JP, 2003, HUM MOL GENET, V12, P749, DOI 10.1093/hmg/ddg074; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Williams AJ, 2009, NEUROBIOL DIS, V33, P342, DOI 10.1016/j.nbd.2008.10.016; Yu Z, 2006, J CLIN INVEST, V116, P2663, DOI 10.1172/JCI28773; Zhao J, 2007, CELL METAB, V6, P472, DOI 10.1016/j.cmet.2007.11.004; ZHU XJ, 1994, MOL CELL BIOL, V14, P8051, DOI 10.1128/MCB.14.12.8051	50	166	167	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 13	2009	63	3					316	328		10.1016/j.neuron.2009.07.019	http://dx.doi.org/10.1016/j.neuron.2009.07.019			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	487OY	19679072	Green Submitted, Green Accepted, Bronze			2022-12-24	WOS:000269285500007
J	Pocock, R; Hobert, O				Pocock, Roger; Hobert, Oliver			Hypoxia activates a latent circuit for processing gustatory information in C. elegans	NATURE NEUROSCIENCE			English	Article							CAENORHABDITIS-ELEGANS; TRYPTOPHAN-HYDROXYLASE; CHEMOSENSORY NEURONS; 5-HT7-LIKE RECEPTOR; INDUCIBLE FACTOR-1; SOCIAL-BEHAVIOR; STRESS; SEROTONIN; OXYGEN; BRAIN	Dedicated neuronal circuits enable animals to engage in specific behavioral responses to environmental stimuli. We found that hypoxic stress enhanced gustatory sensory perception via previously unknown circuitry in Caenorhabditis elegans. The hypoxia-inducible transcription factor HIF-1 upregulated serotonin (5-HT) expression in specific sensory neurons that are not normally required for chemosensation. 5-HT subsequently promoted hypoxia-enhanced sensory perception by signaling through the metabotropic G protein-coupled receptor SER-7 in an unusual peripheral neuron, the M4 motor neuron. M4 relayed this information back into the CNS via the FMRFamide-related neuropeptide FLP-21 and its cognate receptor, NPR-1. Thus, physiological detection of hypoxia results in the activation of an additional, previously unrecognized circuit for processing sensory information that is not required for sensory processing under normoxic conditions.	[Pocock, Roger; Hobert, Oliver] Columbia Univ, Howard Hughes Med Inst, Med Ctr, Dept Biochem & Mol Biophys, New York, NY 10032 USA	Columbia University; Howard Hughes Medical Institute	Pocock, R (corresponding author), Columbia Univ, Howard Hughes Med Inst, Med Ctr, Dept Biochem & Mol Biophys, New York, NY 10032 USA.	roger.pocock@bric.ku.dk	Pocock, Roger/AAQ-8526-2020	Pocock, Roger/0000-0002-5515-3608; Hobert, Oliver/0000-0002-7634-2854	Howard Hughes Medical Institute; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050266] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank A. Boyanov and G. Baison for technical assistance, Q. Chen for expert microinjection help, I. Greenwald, M. De Bono and members of the Hobert laboratory for comments on the manuscript, and the Caenorhabditis Genetics Center and C. Bargmann for providing strains. This work was supported by the Howard Hughes Medical Institute.	ALBERTSON DG, 1976, PHILOS T ROY SOC B, V275, P299, DOI 10.1098/rstb.1976.0085; Aspock G, 2003, DEVELOPMENT, V130, P3369, DOI 10.1242/dev.00551; AVERY L, 1989, NEURON, V3, P473, DOI 10.1016/0896-6273(89)90206-7; BARGMANN CI, 1991, NEURON, V7, P729, DOI 10.1016/0896-6273(91)90276-6; Bishop T, 2004, PLOS BIOL, V2, P1549, DOI 10.1371/journal.pbio.0020289; BRENNER S, 1974, GENETICS, V77, P71; Chang AJ, 2008, P NATL ACAD SCI USA, V105, P7321, DOI 10.1073/pnas.0802164105; Chang AJ, 2006, PLOS BIOL, V4, P1588, DOI 10.1371/journal.pbio.0040274; Chaouloff F, 2000, J PSYCHOPHARMACOL, V14, P139, DOI 10.1177/026988110001400203; Cheung BHH, 2005, CURR BIOL, V15, P905, DOI 10.1016/j.cub.2005.04.017; Coates JC, 2002, NATURE, V419, P925, DOI 10.1038/nature01170; de Bono M, 1998, CELL, V94, P679, DOI 10.1016/S0092-8674(00)81609-8; de Kloet ER, 2005, NAT REV NEUROSCI, V6, P463, DOI 10.1038/nrn1683; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Gloria-Soria A, 2008, CURR BIOL, V18, P1694, DOI 10.1016/j.cub.2008.09.043; Hapiak VM, 2009, GENETICS, V181, P153, DOI 10.1534/genetics.108.096891; Hobson RJ, 2006, GENETICS, V172, P159, DOI 10.1534/genetics.105.044495; Hobson RJ, 2003, J NEUROCHEM, V87, P22, DOI 10.1046/j.1471-4159.2003.01967.x; Hukema RK, 2008, LEARN MEMORY, V15, P829, DOI 10.1101/lm.994408; Hukema RK, 2006, EMBO J, V25, P312, DOI 10.1038/sj.emboj.7600940; Joels M, 2009, NAT REV NEUROSCI, V10, P459, DOI 10.1038/nrn2632; Kim K, 2004, J COMP NEUROL, V475, P540, DOI 10.1002/cne.20189; Liang B, 2006, CELL METAB, V4, P429, DOI 10.1016/j.cmet.2006.11.004; Macosko EZ, 2009, NATURE, V458, P1171, DOI 10.1038/nature07886; McEwen BS, 2007, PHYSIOL REV, V87, P873, DOI 10.1152/physrev.00041.2006; Mehta R, 2009, SCIENCE, V324, P1196, DOI 10.1126/science.1173507; Pierce-Shimomura JT, 1999, J NEUROSCI, V19, P9557; Pocock R, 2008, NAT NEUROSCI, V11, P894, DOI 10.1038/nn.2152; Poncet L, 1997, BRAIN RES, V765, P122, DOI 10.1016/S0006-8993(97)00520-9; Poncet L, 1996, BRAIN RES, V733, P64, DOI 10.1016/S0006-8993(96)00539-2; Rahman MS, 2009, NEUROSCIENCE, V158, P751, DOI 10.1016/j.neuroscience.2008.10.029; Ray P, 2008, DEV NEUROBIOL, V68, P421, DOI 10.1002/dneu.20599; Sarafi-Reinach TR, 2001, DEVELOPMENT, V128, P3269; Semenza GL, 1996, J BIOL CHEM, V271, P32529, DOI 10.1074/jbc.271.51.32529; Semenza GL, 2001, TRENDS MOL MED, V7, P345, DOI 10.1016/S1471-4914(01)02090-1; Shen C, 2005, J BIOL CHEM, V280, P20580, DOI 10.1074/jbc.M501894200; Sze JY, 2000, NATURE, V403, P560, DOI 10.1038/35000609; Uchida O, 2003, DEVELOPMENT, V130, P1215, DOI 10.1242/dev.00341; Zhang Y, 2005, NATURE, V438, P179, DOI 10.1038/nature04216	39	79	88	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2010	13	5					610	U121		10.1038/nn.2537	http://dx.doi.org/10.1038/nn.2537			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	588JM	20400959	Green Accepted			2022-12-24	WOS:000277065700019
J	Bellon, A; Luchino, J; Haigh, K; Rougon, G; Haigh, J; Chauvet, S; Mann, F				Bellon, Anais; Luchino, Jonathan; Haigh, Katharina; Rougon, Genevieve; Haigh, Jody; Chauvet, Sophie; Mann, Fanny			VEGFR2 (KDR/Flk1) Signaling Mediates Axon Growth in Response to Semaphorin 3E in the Developing Brain	NEURON			English	Article							ENDOTHELIAL-CELLS; NERVOUS-SYSTEM; NEURAL PROGENITORS; ADAPTER PROTEIN; RECEPTOR; RAT; NEUROPILIN-1; PROJECTIONS; ACTIVATION; MIGRATION	Common factors are thought to control vascular and neuronal patterning. Here we report an in vivo requirement for the vascular endothelial growth factor receptor type 2 (VEGFR2) in axon tract formation in the mouse brain. We show that VEGFR2 is expressed by neurons of the subiculum and mediates axonal elongation in response to the semaphorin (Sema) family molecule, Sema3E. We further show that VEGFR2 associates with the PlexinD1/Neuropilin-1 (Nrp1) receptor complex for Sema3E and becomes tyrosine-phosphorylated upon Sema3E stimulation. In subicular neurons, Sema3E triggers VEGFR2-dependent activation of the phosphatidylinositol-3 kinase (PI3K)/Akt pathway that is required for the increase in axonal growth. These results implicate VEGFR2 in axonal wiring through a mechanism dependent on Sema3E and independent of vascular endothelial growth factor (VEGF) ligands. This mechanism provides an explanation as to how a semaphorin can activate an axon growth promoting response in developing neurons.	[Bellon, Anais; Luchino, Jonathan; Rougon, Genevieve; Chauvet, Sophie; Mann, Fanny] Univ Aix Marseille 2, CNRS, UMR 6216, Dev Biol Inst Marseille Luminy, F-13288 Marseille 09, France; [Haigh, Katharina; Haigh, Jody] Univ Ghent VIB, Vasc Cell Biol Unit, Dept Mol Biomed Res, B-9000 Ghent, Belgium; [Haigh, Katharina; Haigh, Jody] Univ Ghent, Dept Biomed Mol Biol, B-9000 Ghent, Belgium	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University	Mann, F (corresponding author), Univ Aix Marseille 2, CNRS, UMR 6216, Dev Biol Inst Marseille Luminy, Case 907,Parc Sci Luminy, F-13288 Marseille 09, France.	mann@ibdml.univ-mrs.fr	ROUGON, Genevieve/G-2578-2013; Mann, Fanny/G-2786-2016	Mann, Fanny/0000-0003-4839-4347; ROUGON, Genevieve/0000-0003-1316-8200; Anais, Bellon/0000-0002-0198-8538; haigh, jody/0000-0002-7319-8922	Centre National de la Recherche Scientifique (CNRS); Universite de la Mediterranee; Agence Nationale de la Recherche [ANR-06-JCJC-0094-0]; Federation pour la Recherche sur le Cerveau (FRC); Association pour la Recherche sur le Cancer (ARC); Association Francaise contre les Myopathies (AFM); Fondation NRJ-Institut de France; French Ministry of Research; Region PACA	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Universite de la Mediterranee; Agence Nationale de la Recherche(French National Research Agency (ANR)); Federation pour la Recherche sur le Cerveau (FRC); Association pour la Recherche sur le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); Fondation NRJ-Institut de France(Fondation de France); French Ministry of Research(Ministry of Research, FranceEuropean Commission); Region PACA(Region Provence-Alpes-Cote d'Azur)	We thank Samia Cohen, Floriane Bertaina, Lylia Fekrane, and Dominique Massey Harroche for great help with the experiments and Robert Kelly for critical reading of this manuscript. This work was supported by Centre National de la Recherche Scientifique (CNRS), Universite de la Mediterranee. F.M. is supported by grants from Agence Nationale de la Recherche (ANR-06-JCJC-0094-01), Federation pour la Recherche sur le Cerveau (FRC), Association pour la Recherche sur le Cancer (ARC), Association Francaise contre les Myopathies (AFM), and Fondation NRJ-Institut de France. A.B. is supported by a doctoral grant from the French Ministry of Research and J.L. by a doctoral grant from Region PACA.	Acevedo LM, 2008, BLOOD, V111, P2674, DOI 10.1182/blood-2007-08-110205; Bagnard D, 2001, CEREB CORTEX, V11, P278, DOI 10.1093/cercor/11.3.278; Cao L, 2004, NAT GENET, V36, P827, DOI 10.1038/ng1395; Carmeliet P, 2005, NATURE, V436, P193, DOI 10.1038/nature03875; Carmeliet P, 2003, NAT REV GENET, V4, P710, DOI 10.1038/nrg1158; Cenquizca LA, 2006, J COMP NEUROL, V497, P101, DOI 10.1002/cne.20985; Chauvet S, 2007, NEURON, V56, P807, DOI 10.1016/j.neuron.2007.10.019; Cosker KE, 2007, BIOCHEM SOC T, V35, P207, DOI 10.1042/BST0350207; Feiner L, 1997, NEURON, V19, P539, DOI 10.1016/S0896-6273(00)80370-0; Forstreuter F, 2002, J NEUROIMMUNOL, V132, P93, DOI 10.1016/S0165-5728(02)00315-6; Franco M, 2008, EMBO REP, V9, P865, DOI 10.1038/embor.2008.139; Gu CH, 2005, SCIENCE, V307, P265, DOI 10.1126/science.1105416; Haigh JJ, 2003, DEV BIOL, V262, P225, DOI 10.1016/S0012-1606(03)00356-7; Hashimoto T, 2003, GENE EXPR PATTERNS, V3, P109, DOI 10.1016/S1567-133X(02)00065-0; Holmqvist K, 2004, J BIOL CHEM, V279, P22267, DOI 10.1074/jbc.M312729200; Kawamura H, 2008, BLOOD, V112, P3638, DOI 10.1182/blood-2007-12-125856; Kim HY, 2007, NEUROSCI LETT, V425, P131, DOI 10.1016/j.neulet.2007.08.040; Kim WY, 2006, NEURON, V52, P981, DOI 10.1016/j.neuron.2006.10.031; Kishi T, 2000, J COMP NEUROL, V419, P205, DOI 10.1002/(SICI)1096-9861(20000403)419:2<205::AID-CNE5>3.0.CO;2-0; Larrivee B, 2009, CIRC RES, V104, P428, DOI 10.1161/CIRCRESAHA.108.188144; Le Bras B, 2006, NAT NEUROSCI, V9, P340, DOI 10.1038/nn1646; Learte AR, 2008, GLIA, V56, P164, DOI 10.1002/glia.20601; Makita T, 2008, NATURE, V452, P759, DOI 10.1038/nature06859; Marko SB, 2008, AM J PHYSIOL-HEART C, V294, pH2646, DOI 10.1152/ajpheart.00291.2008; Meyer RD, 2003, J BIOL CHEM, V278, P16347, DOI 10.1074/jbc.M300259200; O'Mara S, 2005, J ANAT, V207, P271, DOI 10.1111/j.1469-7580.2005.00446.x; Raab S, 2007, ACTA NEUROPATHOL, V113, P607, DOI 10.1007/s00401-007-0228-3; Rahimi N, 2000, J BIOL CHEM, V275, P16986, DOI 10.1074/jbc.M000528200; Sakurai Y, 2005, P NATL ACAD SCI USA, V102, P1076, DOI 10.1073/pnas.0404984102; Schwarz Q, 2004, GENE DEV, V18, P2822, DOI 10.1101/gad.322904; Shintani Y, 2006, EMBO J, V25, P3045, DOI 10.1038/sj.emboj.7601188; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; STANFIELD BB, 1987, J NEUROSCI, V7, P3350, DOI 10.1523/jneurosci.07-10-03350.1987; Takahashi T, 2001, EMBO J, V20, P2768, DOI 10.1093/emboj/20.11.2768; Toyofuku T, 2005, NAT NEUROSCI, V8, P1712, DOI 10.1038/nn1596; Toyofuku T, 2004, GENE DEV, V18, P435, DOI 10.1101/gad.1167304; Toyofuku T, 2007, EMBO J, V26, P1373, DOI 10.1038/sj.emboj.7601589; Uesugi K, 2009, J BIOL CHEM, V284, P6743, DOI 10.1074/jbc.M805213200; Vieira JM, 2007, DEVELOPMENT, V134, P1833, DOI 10.1242/dev.002402; Wittko IM, 2009, J NEUROSCI, V29, P8704, DOI 10.1523/JNEUROSCI.5527-08.2009; Wu LW, 2000, J BIOL CHEM, V275, P6059, DOI 10.1074/jbc.275.9.6059; Yang SZ, 2003, ANAT REC PART A, V274A, P851, DOI 10.1002/ar.a.10103	42	100	101	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 29	2010	66	2					205	219		10.1016/j.neuron.2010.04.006	http://dx.doi.org/10.1016/j.neuron.2010.04.006			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	591NQ	20434998	Bronze			2022-12-24	WOS:000277308200007
J	Clopath, C; Busing, L; Vasilaki, E; Gerstner, W				Clopath, Claudia; Buesing, Lars; Vasilaki, Eleni; Gerstner, Wulfram			Connectivity reflects coding: a model of voltage-based STDP with homeostasis	NATURE NEUROSCIENCE			English	Article							TIMING-DEPENDENT PLASTICITY; LONG-TERM POTENTIATION; SYNAPTIC PLASTICITY; DENDRITIC SPIKES; INDUCTION; LTD; DEPOLARIZATION; SYNCHRONY; NETWORK; SWITCH	Electrophysiological connectivity patterns in cortex often have a few strong connections, which are sometimes bidirectional, among a lot of weak connections. To explain these connectivity patterns, we created a model of spike timing-dependent plasticity (STDP) in which synaptic changes depend on presynaptic spike arrival and the postsynaptic membrane potential, filtered with two different time constants. Our model describes several nonlinear effects that are observed in STDP experiments, as well as the voltage dependence of plasticity. We found that, in a simulated recurrent network of spiking neurons, our plasticity rule led not only to development of localized receptive fields but also to connectivity patterns that reflect the neural code. For temporal coding procedures with spatio-temporal input correlations, strong connections were predominantly unidirectional, whereas they were bidirectional under rate-coded input with spatial correlations only. Thus, variable connectivity patterns in the brain could reflect different coding principles across brain areas; moreover, our simulations suggested that plasticity is fast.	[Clopath, Claudia; Buesing, Lars; Vasilaki, Eleni; Gerstner, Wulfram] Ecole Polytech Fed Lausanne, Lab Computat Neurosci, Brain Mind Inst, Lausanne, Switzerland; [Clopath, Claudia; Buesing, Lars; Vasilaki, Eleni; Gerstner, Wulfram] Ecole Polytech Fed Lausanne, Sch Comp & Commun Sci, Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Clopath, C (corresponding author), Ecole Polytech Fed Lausanne, Lab Computat Neurosci, Brain Mind Inst, Lausanne, Switzerland.	claudia.clopath@epfl.ch		Vasilaki, Eleni/0000-0003-3705-7070	FACETS; Swiss National Science Foundation	FACETS(European Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by the European project FACETS and the Swiss National Science Foundation.	ARTOLA A, 1990, NATURE, V347, P69, DOI 10.1038/347069a0; Badel L, 2008, J NEUROPHYSIOL, V99, P656, DOI 10.1152/jn.01107.2007; Blais BS, 1998, NEURAL COMPUT, V10, P1797, DOI 10.1162/089976698300017142; Brader JM, 2007, NEURAL COMPUT, V19, P2881, DOI 10.1162/neco.2007.19.11.2881; Brette R, 2005, J NEUROPHYSIOL, V94, P3637, DOI 10.1152/jn.00686.2005; Buonomano DV, 1998, ANNU REV NEUROSCI, V21, P149, DOI 10.1146/annurev.neuro.21.1.149; Clopath C, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000248; Cooper L., 2004, THEORY CORTICAL PLAS; Dan Y, 2004, NEURON, V44, P23, DOI 10.1016/j.neuron.2004.09.007; DUDEK SM, 1993, J NEUROSCI, V13, P2910; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; Gerstner W, 1996, NATURE, V383, P76, DOI 10.1038/383076a0; Gerstner W., 2002, SPIKING NEURON MODEL; Golding NL, 2002, NATURE, V418, P326, DOI 10.1038/nature00854; Hardie J, 2009, J NEUROSCI, V29, P3233, DOI 10.1523/JNEUROSCI.6000-08.2009; Hebb Donald O., 1949, ORG BEHAV; Hyvarinen A, 2001, INDEPENDENT COMPONENT ANALYSIS: PRINCIPLES AND PRACTICE, P71; Izhikevich EM, 2008, P NATL ACAD SCI USA, V105, P3593, DOI 10.1073/pnas.0712231105; JADHAV SP, 2009, NAT NEUROSCI; Kampa BM, 2006, J PHYSIOL-LONDON, V574, P283, DOI 10.1113/jphysiol.2006.111062; Kozloski J, 2008, TOPOLOGICAL EFFECTS; Lefort S, 2009, NEURON, V61, P301, DOI 10.1016/j.neuron.2008.12.020; Legenstein R, 2005, NEURAL COMPUT, V17, P2337, DOI 10.1162/0899766054796888; Levy N, 2001, NEURAL NETWORKS, V14, P815, DOI 10.1016/S0893-6080(01)00044-2; Lisman J, 2005, NAT NEUROSCI, V8, P839, DOI 10.1038/nn0705-839; Lisman JE, 2001, NEURON, V31, P191, DOI 10.1016/S0896-6273(01)00364-6; Lubenov EV, 2008, NEURON, V58, P118, DOI 10.1016/j.neuron.2008.01.036; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; MILLER KD, 1994, J NEUROSCI, V14, P409; Morrison A, 2007, NEURAL COMPUT, V19, P1437, DOI 10.1162/neco.2007.19.6.1437; Nevian T, 2006, J NEUROSCI, V26, P11001, DOI 10.1523/JNEUROSCI.1749-06.2006; Ngezahayo A, 2000, J NEUROSCI, V20, P2451; O'Connor DH, 2005, J NEUROPHYSIOL, V94, P1565, DOI 10.1152/jn.00047.2005; OJA E, 1982, J MATH BIOL, V15, P267, DOI 10.1007/BF00275687; Olshausen BA, 1996, NATURE, V381, P607, DOI 10.1038/381607a0; Pfister JP, 2006, J NEUROSCI, V26, P9673, DOI 10.1523/JNEUROSCI.1425-06.2006; Remy S, 2007, P NATL ACAD SCI USA, V104, P17192, DOI 10.1073/pnas.0707919104; Saudargiene A, 2004, NEURAL COMPUT, V16, P595, DOI 10.1162/089976604772744929; Senn W, 2001, NEURAL COMPUT, V13, P35, DOI 10.1162/089976601300014628; Shouval HZ, 2002, P NATL ACAD SCI USA, V99, P10831, DOI 10.1073/pnas.152343099; Sjostrom PJ, 2006, NEURON, V51, P227, DOI 10.1016/j.neuron.2006.06.017; Sjostrom PJ, 2003, NEURON, V39, P641, DOI 10.1016/S0896-6273(03)00476-8; Sjostrom PJ, 2001, NEURON, V32, P1149, DOI 10.1016/S0896-6273(01)00542-6; Song S, 2005, PLOS BIOL, V3, P1838, DOI 10.1371/journal.pbio.0030350; Song S, 2001, NEURON, V32, P339, DOI 10.1016/S0896-6273(01)00451-2; Tsodyks MV, 1997, P NATL ACAD SCI USA, V94, P719, DOI 10.1073/pnas.94.2.719; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Wang HX, 2005, NAT NEUROSCI, V8, P187, DOI 10.1038/nn1387; Yuste R, 2004, NAT REV NEUROSCI, V5, P24, DOI 10.1038/nrn1300	50	357	366	3	60	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2010	13	3					344	U19		10.1038/nn.2479	http://dx.doi.org/10.1038/nn.2479			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	559WW	20098420	Green Submitted, Green Published			2022-12-24	WOS:000274860100017
J	Kawabe, H; Neeb, A; Dimova, K; Young, SM; Takeda, M; Katsurabayashi, S; Mitkovski, M; Malakhova, OA; Zhang, DE; Ulmilkawa, M; Kariya, K; Goebbels, S; Nave, KA; Rosenmund, C; Jahn, O; Rhee, J; Brose, N				Kawabe, Hiroshi; Neeb, Antje; Dimova, Kalina; Young, Samuel M., Jr.; Takeda, Michiko; Katsurabayashi, Shutaro; Mitkovski, Miso; Malakhova, Oxana A.; Zhang, Dong-Er; Ulmilkawa, Masato; Kariya, Ken-ichi; Goebbels, Sandra; Nave, Klaus-Armin; Rosenmund, Christian; Jahn, Olaf; Rhee, JeongSeop; Brose, Nils			Regulation of Rap2A by the Ubiquitin Ligase Nedd4-1 Controls Neurite Development	NEURON			English	Article							NUCLEOTIDE EXCHANGE FACTOR; SYNAPSE ELIMINATION; HIPPOCAMPAL-NEURONS; PUTATIVE EFFECTOR; PYRAMIDAL NEURONS; ANGELMAN SYNDROME; CORTICAL-NEURONS; PROTEIN-KINASE; WW DOMAINS; PHOSPHORYLATION	Nedd4-1 is a "neuronal precursor cell expressed and developmentally downregulated protein" and among the most abundant E3 ubiquitin ligases in mammalian neurons. In analyses of conventional and conditional Nedd4-1-deficient mice, we found that Nedd4-1 plays a critical role in dendrite formation. Nedd4-1, the serine/threonine kinase TNIK, and Rap2A form a complex that controls Nedd4-1-mediated ubiquitination of Rap2A. Ubiquitination by Nedd4-1 inhibits Rap2A function, which reduces the activity of Rap2 effector kinases of the TNIK family and promotes dendrite growth. We conclude that a Nedd4-1/Rap2A/TNIK signaling pathway regulates neurite growth and arborization in mammalian neurons.	[Kawabe, Hiroshi; Neeb, Antje; Dimova, Kalina; Takeda, Michiko; Rhee, JeongSeop; Brose, Nils] Max Planck Inst Expt Med, Dept Mol Neurobiol, D-37075 Gottingen, Germany; [Dimova, Kalina; Jahn, Olaf] Max Planck Inst Expt Med, Prote Grp, D-37075 Gottingen, Germany; [Dimova, Kalina; Jahn, Olaf] DFG CMPB, D-37075 Gottingen, Germany; [Young, Samuel M., Jr.; Katsurabayashi, Shutaro; Rosenmund, Christian; Rhee, JeongSeop] Max Planck Inst Biophys Chem, Dept Membrane Biophys, D-37077 Gottingen, Germany; [Mitkovski, Miso] Max Planck Inst Expt Med, Imaging Facil, D-37075 Gottingen, Germany; [Malakhova, Oxana A.; Zhang, Dong-Er] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA; [Zhang, Dong-Er] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; [Zhang, Dong-Er] Univ Calif San Diego, Div Biol, La Jolla, CA 92093 USA; [Ulmilkawa, Masato; Kariya, Ken-ichi] Univ Ryukyus, Div Cell Biol, Grad Sch Med, Nishihara, Okinawa 9030215, Japan; [Goebbels, Sandra; Nave, Klaus-Armin] Max Planck Inst Expt Med, Dept Neurogenet, D-37075 Gottingen, Germany	Max Planck Society; Max Planck Society; Max Planck Society; Max Planck Society; Scripps Research Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of the Ryukyus; Max Planck Society	Kawabe, H (corresponding author), Max Planck Inst Expt Med, Dept Mol Neurobiol, D-37075 Gottingen, Germany.	kawabe@em.mp.de; brose@em.mpg.de	Rosenmund, Christian/AAC-3596-2020; Jahn, Olaf/AAD-8212-2020	Rosenmund, Christian/0000-0002-3905-2444; Jahn, Olaf/0000-0002-3397-8924; Young, Samuel/0000-0002-7589-7612; Neeb, Antje/0000-0002-6516-2938; Mitkovski, Miso/0000-0001-9195-2434; Kawabe, Hiroshi/0000-0001-5650-8696	Deutsche Forschungsgemeinschaft [SFB271/B11]; Japan Society for the Promotion of Science Postdoctoral Fellowship for Research Abroad; Yamanouchi Foundation for Research on Metabolic Disorders; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Alexander von Humboldt Foundation; National Institutes of Health [NIH R01GM66955]; Max Planck Society; European Commission [LSHM-CT-2005-019055]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066955] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Japan Society for the Promotion of Science Postdoctoral Fellowship for Research Abroad(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Yamanouchi Foundation for Research on Metabolic Disorders; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Max Planck Society(Max Planck SocietyFoundation CELLEX); European Commission(European CommissionEuropean Commission Joint Research Centre); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank B. Hesse-Niessen, S. Wenger, S. Handt, F. Scheve, F. Benseler, I. Thanhauser, D. Schwerdtfeger, A. Zeuch, M. Dorre, A. Galinski, I. Herfort, and T. Wiles for excellent technical assistance, and the staff of the animal facility at the Max Planck Institute of Experimental Medicine for maintenance of the mouse colony. We are grateful to D.A. Gray, R. Nehring, A. Betz, T. Nagase, A. Kusumi, P. Osten, R.L. Huganir, M. Matsuda, R. Brandt, A. Wittinghofer, and N. Ziv for reagents and software, and to G. Meyer, S. Bungers, M. Kishimoto-Suga, V. Tarabylkin, K. Chowdhury, D. Sargin, M. Scheffner, S. Yamagishi, F. Nakamura, I. Vetter, A. Puschel, D. Rotin, S. Okabe, D. Yokomaku, and A.M. Craig for discussions and advice. This study was supported by the Deutsche Forschungsgemeinschaft (SFB271/B11; N.B.), the Japan Society for the Promotion of Science Postdoctoral Fellowship for Research Abroad (H.K.), the Yamanouchi Foundation for Research on Metabolic Disorders (H.K.), the Mochida Memorial Foundation for Medical and Pharmaceutical Research (H.K.), the Alexander von Humboldt Foundation (S.M.Y.), National Institutes of Health grants NIH R01GM66955 (D.E.Z.), the Max Planck Society (N.B.) and the European Commission (EU Synapse grant LSHM-CT-2005-019055; S.M.Y. and N.B.).	Arevalo JC, 2006, NEURON, V50, P549, DOI 10.1016/j.neuron.2006.03.044; Barnes AP, 2007, CELL, V129, P549, DOI 10.1016/j.cell.2007.03.025; BEKKERS JM, 1991, P NATL ACAD SCI USA, V88, P7834, DOI 10.1073/pnas.88.17.7834; Bloom AJ, 2007, GENE DEV, V21, P2593, DOI 10.1101/gad.1592107; Cao XR, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1160940; Cherfils J, 1997, EMBO J, V16, P5582, DOI 10.1093/emboj/16.18.5582; Dan I, 2000, FEBS LETT, V469, P19, DOI 10.1016/S0014-5793(00)01247-3; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Dittgen T, 2004, P NATL ACAD SCI USA, V101, P18206, DOI 10.1073/pnas.0407976101; Dresbach T, 2003, MOL CELL NEUROSCI, V23, P279, DOI 10.1016/S1044-7431(03)00015-0; Fouladkou F, 2008, P NATL ACAD SCI USA, V105, P8585, DOI 10.1073/pnas.0803233105; Fu CA, 1999, J BIOL CHEM, V274, P30729, DOI 10.1074/jbc.274.43.30729; Fu ZY, 2007, J NEUROCHEM, V100, P118, DOI 10.1111/j.1471-4159.2006.04195.x; FUJIMURO M, 1994, FEBS LETT, V349, P173, DOI 10.1016/0014-5793(94)00647-4; Goebbels S, 2006, GENESIS, V44, P611, DOI 10.1002/dvg.20256; Guo L, 2007, NEUROSCIENCE, V145, P100, DOI 10.1016/j.neuroscience.2006.11.042; Hand R, 2005, NEURON, V48, P45, DOI 10.1016/j.neuron.2005.08.032; Herrmann C, 1996, J BIOL CHEM, V271, P6794, DOI 10.1074/jbc.271.12.6794; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; HUME RI, 1981, NATURE, V293, P469, DOI 10.1038/293469a0; Ingham RJ, 2005, MOL CELL BIOL, V25, P7092, DOI 10.1128/MCB.25.16.7092-7106.2005; Jahn O, 2006, ANAL BIOANAL CHEM, V386, P92, DOI 10.1007/s00216-006-0592-1; Jaworski J, 2005, J NEUROSCI, V25, P11300, DOI 10.1523/JNEUROSCI.2270-05.2005; Jiang YH, 1998, NEURON, V21, P799, DOI 10.1016/S0896-6273(00)80596-6; Jockusch WJ, 2007, CELL, V131, P796, DOI 10.1016/j.cell.2007.11.002; Jura N, 2006, MOL CELL, V21, P679, DOI 10.1016/j.molcel.2006.02.011; Kim AH, 2009, CELL, V136, P322, DOI 10.1016/j.cell.2008.11.050; Kishino T, 1997, NAT GENET, V15, P70, DOI 10.1038/ng0197-70; KOLCH W, 1991, NATURE, V349, P426, DOI 10.1038/349426a0; KUZUHARA S, 1988, ACTA NEUROPATHOL, V75, P345, DOI 10.1007/BF00687787; Kwon CH, 2006, NEURON, V50, P377, DOI 10.1016/j.neuron.2006.03.023; Leykauf K, 2006, J CELL SCI, V119, P3634, DOI 10.1242/jcs.03149; Lotz K, 2004, MOL CELL BIOL, V24, P9339, DOI 10.1128/MCB.24.21.9339-9350.2004; LUNA RMD, 1995, NATURE, V378, P203; Matsuura T, 1997, NAT GENET, V15, P74, DOI 10.1038/ng0197-74; Mochizuki N, 2001, NATURE, V411, P1065, DOI 10.1038/35082594; Murdaca J, 2004, J BIOL CHEM, V279, P26754, DOI 10.1074/jbc.M311802200; Newton K, 2008, CELL, V134, P668, DOI 10.1016/j.cell.2008.07.039; Nonaka H, 2008, BIOCHEM BIOPH RES CO, V377, P573, DOI 10.1016/j.bbrc.2008.10.038; Ohba Y, 2000, MOL CELL BIOL, V20, P6074, DOI 10.1128/MCB.20.16.6074-6083.2000; Parrish JZ, 2007, ANNU REV NEUROSCI, V30, P399, DOI 10.1146/annurev.neuro.29.051605.112907; Pham N, 2001, J BIOL CHEM, V276, P46995, DOI 10.1074/jbc.M108373200; Pyott SJ, 2002, J PHYSIOL-LONDON, V539, P523, DOI 10.1113/jphysiol.2001.013277; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; Sakata T, 2004, CURR BIOL, V14, P2228, DOI 10.1016/j.cub.2004.12.028; Sasaki Y, 2002, NEURON, V35, P907, DOI 10.1016/S0896-6273(02)00857-7; Schwamborn JC, 2004, NAT NEUROSCI, V7, P923, DOI 10.1038/nn1295; Schwamborn JC, 2007, EMBO J, V26, P1410, DOI 10.1038/sj.emboj.7601580; SHOLL DA, 1953, J ANAT, V87, P387; SNIDER WD, 1987, J NEUROSCI, V7, P1760; Spruston N, 2008, NAT REV NEUROSCI, V9, P206, DOI 10.1038/nrn2286; Staub O, 1996, EMBO J, V15, P2371, DOI 10.1002/j.1460-2075.1996.tb00593.x; Taira K, 2004, J BIOL CHEM, V279, P49488, DOI 10.1074/jbc.M406370200; Takemoto-Kimura S, 2007, NEURON, V54, P755, DOI 10.1016/j.neuron.2007.05.021; Varoqueaux F, 2006, NEURON, V51, P741, DOI 10.1016/j.neuron.2006.09.003; Wang HR, 2003, SCIENCE, V302, P1775, DOI 10.1126/science.1090772; Wang XJ, 2007, CELL, V128, P129, DOI 10.1016/j.cell.2006.11.039; Wilkin MB, 2004, CURR BIOL, V14, P2237, DOI 10.1016/j.cub.2004.11.030; Yamashita M, 2005, CELL, V121, P101, DOI 10.1016/j.cell.2005.01.035; Yamashita N, 2007, J NEUROSCI, V27, P12546, DOI 10.1523/JNEUROSCI.3463-07.2007; Yao I, 2007, CELL, V130, P943, DOI 10.1016/j.cell.2007.06.052	61	139	151	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	FEB 11	2010	65	3					358	372		10.1016/j.neuron.2010.01.007	http://dx.doi.org/10.1016/j.neuron.2010.01.007			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	564BF	20159449	Green Submitted, Green Accepted, Bronze			2022-12-24	WOS:000275185200009
J	Shea, KL; Xiang, WY; LaPorta, VS; Licht, JD; Keller, C; Basson, MA; Brack, AS				Shea, Kelly L.; Xiang, Wanyi; LaPorta, Vincent S.; Licht, Jonathan D.; Keller, Charles; Basson, M. Albert; Brack, Andrew S.			Sprouty1 Regulates Reversible Quiescence of a Self-Renewing Adult Muscle Stem Cell Pool during Regeneration	CELL STEM CELL			English	Article							SATELLITE CELLS; GENE-EXPRESSION; PAX7; PROLIFERATION; DISTINCT; FGF; DIFFERENTIATION; HETEROGENEITY; PROGENITORS; COMMITMENT	Satellite cells are skeletal muscle stem cells capable of self-renewal and differentiation after transplantation, but whether they contribute to endogenous muscle fiber repair has been unclear. The transcription factor Pax7 marks satellite cells and is critical for establishing the adult satellite cell pool. By using a lineage tracing approach, we show that after injury, quiescent adult Pax7(+) cells enter the cell cycle; a subpopulation returns to quiescence to replenish the satellite cell compartment, while others contribute to muscle fiber formation. We demonstrate that Sprouty1 (Spry1), a receptor tyrosine kinase signaling inhibitor, is expressed in quiescent Pax7(+) satellite cells in uninjured muscle, downregulated in proliferating myogenic cells after injury, and reinduced as Pax7(+) cells re-enter quiescence. We show that Spry1 is required for the return to quiescence and homeostasis of the satellite cell pool during repair. Our results therefore define a role for Spry1 in adult muscle stem cell biology and tissue repair.	[Shea, Kelly L.; Xiang, Wanyi; LaPorta, Vincent S.; Brack, Andrew S.] Harvard Univ, Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA; [Xiang, Wanyi] Massachusetts Gen Hosp, Dept Orthoped Surg, Boston, MA 02114 USA; [Licht, Jonathan D.] Northwestern Univ, Feinberg Sch Med, Robert H Lurie Comprehens Canc Ctr, Div Hematol Oncol, Chicago, IL 60611 USA; [Keller, Charles] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA; [Basson, M. Albert] Kings Coll London, Dept Craniofacial Dev, London SE1 9RT, England	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center; University of Texas System; University of Texas Health San Antonio; University of London; King's College London	Brack, AS (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA.	brack.andrew@mgh.harvard.edu	Basson, M. Albert/C-5565-2009; Licht, Jonathan/L-4239-2019; Licht, Jonathan/AAL-9184-2020	Licht, Jonathan/0000-0002-3942-1369; Keller, Charles/0000-0003-2505-7487; Basson, M. Albert/0000-0001-9834-7528	MGH; Orthopedic Department (NIGH); Wellcome Trust [WT080470]; Medical Research Council [G0601104]; NIH [R01 CA059998]; NIH/NCI [1K08CA90438]; MRC [G0601104] Funding Source: UKRI; NATIONAL CANCER INSTITUTE [R01CA059998, K08CA090438] Funding Source: NIH RePORTER	MGH; Orthopedic Department (NIGH); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors would like to thank Brad Olwin (University of Colorado), Prajakta Ghatpande, Gail Martin (USCF), and Thomas Rando (Stanford University) for the generous provision of reagents. Supported by MGH start-up funds to A.S.B., Orthopedic Department (NIGH) to W.X., Wellcome Trust (WT080470) and Medical Research Council (G0601104) to M.A.B., NIH (R01 CA059998) to J.D.L., and NIH/NCI (1K08CA90438) to C.K.	Abou-Khalil R, 2009, CELL STEM CELL, V5, P298, DOI 10.1016/j.stem.2009.06.001; ALLEN RE, 1984, EXP CELL RES, V152, P154, DOI 10.1016/0014-4827(84)90239-8; Basson MA, 2005, DEV CELL, V8, P229, DOI 10.1016/j.devcel.2004.12.004; Bockhold KJ, 1998, MUSCLE NERVE, V21, P173, DOI 10.1002/(SICI)1097-4598(199802)21:2<173::AID-MUS4>3.0.CO;2-8; Brack AS, 2008, CELL STEM CELL, V2, P50, DOI 10.1016/j.stem.2007.10.006; Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090; Brack AS, 2009, DEV BIOL, V335, P93, DOI 10.1016/j.ydbio.2009.08.014; Casci T, 1999, CELL, V96, P655, DOI 10.1016/S0092-8674(00)80576-0; Cerletti M, 2008, CELL, V134, P37, DOI 10.1016/j.cell.2008.05.049; CLEGG CH, 1987, J CELL BIOL, V105, P949, DOI 10.1083/jcb.105.2.949; Collins CA, 2005, CELL, V122, P289, DOI 10.1016/j.cell.2005.05.010; Conboy MJ, 2007, PLOS BIOL, V5, P1120, DOI 10.1371/journal.pbio.0050102; Fedorov YV, 1998, MOL CELL BIOL, V18, P5780, DOI 10.1128/MCB.18.10.5780; Fukada SI, 2007, STEM CELLS, V25, P2448, DOI 10.1634/stemcells.2007-0019; Hanafusa H, 2002, NAT CELL BIOL, V4, P850, DOI 10.1038/ncb867; JOHNSON RL, 1994, CURR OPIN GENET DEV, V4, P535, DOI 10.1016/0959-437X(94)90069-F; Jones NC, 2005, J CELL BIOL, V169, P105, DOI 10.1083/jcb.200408066; Jones NC, 2001, J CELL PHYSIOL, V186, P104, DOI 10.1002/1097-4652(200101)186:1<104::AID-JCP1015>3.0.CO;2-0; Kanisicak O, 2009, DEV BIOL, V332, P131, DOI 10.1016/j.ydbio.2009.05.554; Kim HJ, 2004, NAT REV MOL CELL BIO, V5, P441, DOI 10.1038/nrm1400; Kramer S, 1999, DEVELOPMENT, V126, P2515; Kuang S, 2006, J CELL BIOL, V172, P103, DOI 10.1083/jcb.200508001; Kuang SH, 2007, CELL, V129, P999, DOI 10.1016/j.cell.2007.03.044; Lagha M, 2008, GENE DEV, V22, P1828, DOI 10.1101/gad.477908; Laziz I, 2007, GROWTH FACTORS, V25, P151, DOI 10.1080/08977190701723166; Le Grand F, 2009, CELL STEM CELL, V4, P535, DOI 10.1016/j.stem.2009.03.013; Lee Y, 2005, DEVELOPMENT, V132, P5173, DOI 10.1242/dev.02101; Lepper C, 2009, NATURE, V460, P627, DOI 10.1038/nature08209; Mason JM, 2006, TRENDS CELL BIOL, V16, P45, DOI 10.1016/j.tcb.2005.11.004; Montarras D, 2005, SCIENCE, V309, P2064, DOI 10.1126/science.1114758; Nishijo K, 2009, FASEB J, V23, P2681, DOI 10.1096/fj.08-128116; Orford KW, 2008, NAT REV GENET, V9, P115, DOI 10.1038/nrg2269; Oustanina S, 2004, EMBO J, V23, P3430, DOI 10.1038/sj.emboj.7600346; Perez-Ruiz A, 2008, J CELL SCI, V121, P1373, DOI 10.1242/jcs.024885; Perez-Ruiz A, 2007, CELL SIGNAL, V19, P1671, DOI 10.1016/j.cellsig.2007.03.003; Poss FD, 2000, DEV BIOL, V222, P347, DOI 10.1006/dbio.2000.9722; Reich A, 1999, DEVELOPMENT, V126, P4139; Relaix F, 2006, J CELL BIOL, V172, P91, DOI 10.1083/jcb.200508044; Sacco A, 2008, NATURE, V456, P502, DOI 10.1038/nature07384; Sang LY, 2008, SCIENCE, V321, P1095, DOI 10.1126/science.1155998; Schienda J, 2006, P NATL ACAD SCI USA, V103, P945, DOI 10.1073/pnas.0510164103; Schuh K, 2009, BIOCHEM PHARMACOL, V77, P1827, DOI 10.1016/j.bcp.2009.03.012; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Sheehan SM, 1999, J CELL PHYSIOL, V181, P499, DOI 10.1002/(SICI)1097-4652(199912)181:3<499::AID-JCP14>3.0.CO;2-1; Shinin Vasily, 2009, V482, P295, DOI 10.1007/978-1-59745-060-7_19; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; Yablonka-Reuveni Z, 1999, J HISTOCHEM CYTOCHEM, V47, P23, DOI 10.1177/002215549904700104; Yoshida N, 1998, J CELL SCI, V111, P769; Zammit PS, 2004, J CELL BIOL, V166, P347, DOI 10.1083/jcb.200312007	50	207	213	1	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	FEB 5	2010	6	2					117	129		10.1016/j.stem.2009.12.015	http://dx.doi.org/10.1016/j.stem.2009.12.015			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	555OC	20144785	Green Submitted, Green Accepted, hybrid			2022-12-24	WOS:000274520800007
J	Wu, MN; Joiner, WJ; Dean, T; Yue, ZF; Smith, CJ; Chen, DC; Hoshi, T; Sehgal, A; Koh, K				Wu, Mark N.; Joiner, William J.; Dean, Terry; Yue, Zhifeng; Smith, Corinne J.; Chen, Dechun; Hoshi, Toshinori; Sehgal, Amita; Koh, Kyunghee			SLEEPLESS, a Ly-6/neurotoxin family member, regulates the levels, localization and activity of Shaker	NATURE NEUROSCIENCE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTORS; POTASSIUM CHANNELS; DROSOPHILA-MELANOGASTER; MUSHROOM BODIES; REDUCED SLEEP; PDF CELLS; EXPRESSION; MUTANTS; AROUSAL; COMPLEX	Sleep is a whole-organism phenomenon accompanied by global changes in neural activity. We previously identified SLEEPLESS (SSS) as a glycosylphosphatidyl inositol-anchored protein required for sleep in Drosophila. Here we found that SSS is critical for regulating the sleep-modulating potassium channel Shaker. SSS and Shaker shared similar expression patterns in the brain and specifically affected each other's expression levels. sleepless (sss) loss-of-function mutants exhibited altered Shaker localization, reduced Shaker current density and slower Shaker current kinetics. Transgenic expression of sss in sss mutants rescued defects in Shaker expression and activity cell-autonomously and suggested that SSS functions in wake-promoting, cholinergic neurons. In heterologous cells, SSS accelerated the kinetics of Shaker currents and was co-immunoprecipitated with Shaker, suggesting that SSS modulates Shaker activity via a direct interaction. SSS is predicted to belong to the Ly-6/neurotoxin superfamily, suggesting a mechanism for regulation of neuronal excitability by endogenous toxin-like molecules.	[Joiner, William J.; Dean, Terry; Chen, Dechun; Sehgal, Amita; Koh, Kyunghee] Univ Penn, Dept Neurosci, Philadelphia, PA 19104 USA; [Wu, Mark N.] Univ Penn, Dept Neurol, Div Sleep Med, Philadelphia, PA 19104 USA; [Joiner, William J.; Yue, Zhifeng; Smith, Corinne J.; Sehgal, Amita] Univ Penn, Howard Hughes Med Inst, Philadelphia, PA 19104 USA; [Hoshi, Toshinori] Univ Penn, Dept Physiol, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; Howard Hughes Medical Institute; University of Pennsylvania; University of Pennsylvania	Koh, K (corresponding author), Univ Penn, Dept Neurosci, Philadelphia, PA 19104 USA.	kkoh@mail.med.upenn.edu		Koh, Kyunghee/0000-0003-0847-8204	Burroughs-Wellcome Fund; US National Institutes of Health [K08NS059671, T32HL007953, R01GM057654, R01GM078579, P01AG017628, R01GM088221]; University of Pennsylvania; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007953] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078579, R01GM057654, R01GM088221] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS072431, K08NS059671] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG017628] Funding Source: NIH RePORTER	Burroughs-Wellcome Fund(Burroughs Wellcome Fund); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Pennsylvania; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank I. Levitan, J. Simpson, D. Bushey, B. Ganetzky, E. Rulifson, K. Kume, G. Korge and the Bloomington Stock Center for providing antibodies and fly stocks. We are grateful to T. Ferguson for help with oocyte preparation and M. Sowcik and R. Xu for technical assistance. This work was funded by a Burroughs-Wellcome Fund Career Award for Medical Scientists ( M.N.W.), grants from the US National Institutes of Health (K08NS059671 to M.N.W., T32HL007953 to A. Pack, who supported T. D., R01GM057654 and R01GM078579 to T. H., P01AG017628 to A. S. and K. K., and R01GM088221 to K. K.), and a University Research Foundation Award from the University of Pennsylvania ( K. K.). A. S. is an Investigator of the Howard Hughes Medical Institute.	Abbott G W, 2001, Mol Interv, V1, P95; ALBRAND JP, 1995, BIOCHEMISTRY-US, V34, P5923, DOI 10.1021/bi00017a022; Anderson MP, 2005, P NATL ACAD SCI USA, V102, P1743, DOI 10.1073/pnas.0409644102; Andretic R, 2005, CURR BIOL, V15, P1165, DOI 10.1016/j.cub.2005.05.025; Boussy T, 2008, CARDIOL CLIN, V26, P335, DOI 10.1016/j.ccl.2008.03.005; Bushey D, 2007, J NEUROSCI, V27, P5384, DOI 10.1523/JNEUROSCI.0108-07.2007; Catterall WA, 2008, J NEUROSCI, V28, P11768, DOI 10.1523/JNEUROSCI.3901-08.2008; Chung BY, 2009, CURR BIOL, V19, P386, DOI 10.1016/j.cub.2009.01.040; Cirelli C, 2005, NATURE, V434, P1087, DOI 10.1038/nature03486; Crocker A, 2008, J NEUROSCI, V28, P9377, DOI 10.1523/JNEUROSCI.3072-08a.2008; Cueni L, 2008, NAT NEUROSCI, V11, P683, DOI 10.1038/nn.2124; Douglas SD, 2007, J NEUROIMMUNE PHARM, V2, P5, DOI 10.1007/s11481-006-9058-7; Elliott David A., 2008, V420, P79, DOI 10.1007/978-1-59745-583-1_5; Eriksson MAL, 2002, BIOPHYS J, V83, P2595, DOI 10.1016/S0006-3495(02)75270-3; Espinosa F, 2004, GENES BRAIN BEHAV, V3, P90, DOI 10.1046/j.1601-183x.2003.00054.x; Espinosa F, 2008, J NEUROSCI, V28, P5570, DOI 10.1523/JNEUROSCI.0747-08.2008; Feng YF, 2004, J NEUROGENET, V18, P377, DOI 10.1080/01677060490894522; Foltenyi K, 2007, NAT NEUROSCI, V10, P1160, DOI 10.1038/nn1957; Greenwald J, 1999, NAT STRUCT BIOL, V6, P18; GUMLEY TP, 1995, IMMUNOL CELL BIOL, V73, P277, DOI 10.1038/icb.1995.45; Harvey AL, 2001, TOXICON, V39, P15, DOI 10.1016/S0041-0101(00)00162-8; Hendricks JC, 2000, NEURON, V25, P129, DOI 10.1016/S0896-6273(00)80877-6; Hendricks JC, 2003, J BIOL RHYTHM, V18, P12, DOI 10.1177/0748730402239673; Huai Q, 2006, SCIENCE, V311, P656, DOI 10.1126/science.1121143; Ibanez-Tallon I, 2002, NEURON, V33, P893, DOI 10.1016/S0896-6273(02)00632-3; Joiner WJ, 2006, NATURE, V441, P757, DOI 10.1038/nature04811; KAPLAN WD, 1969, GENETICS, V61, P399; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Klein DE, 2008, NATURE, V453, P1271, DOI 10.1038/nature06978; Koh K, 2008, SCIENCE, V321, P372, DOI 10.1126/science.1155942; Kume K, 2005, J NEUROSCI, V25, P7377, DOI 10.1523/JNEUROSCI.2048-05.2005; Li Y, 2006, NEUROSCIENTIST, V12, P199, DOI 10.1177/1073858406287717; Misonou H, 2004, CRIT REV BIOCHEM MOL, V39, P125, DOI 10.1080/10409230490475417; Miwa JM, 1999, NEURON, V23, P105, DOI 10.1016/S0896-6273(00)80757-6; Nitz DA, 2002, CURR BIOL, V12, P1934, DOI 10.1016/S0960-9822(02)01300-3; Parisky KM, 2008, NEURON, V60, P672, DOI 10.1016/j.neuron.2008.10.042; Pitman JL, 2006, NATURE, V441, P753, DOI 10.1038/nature04739; Rogero O, 1997, J NEUROSCI, V17, P5108; Saper CB, 2005, NATURE, V437, P1257, DOI 10.1038/nature04284; Schopperle WM, 1998, NEURON, V20, P565, DOI 10.1016/S0896-6273(00)80995-2; Shang YH, 2008, P NATL ACAD SCI USA, V105, P19587, DOI 10.1073/pnas.0809577105; Shaw PJ, 2000, SCIENCE, V287, P1834, DOI 10.1126/science.287.5459.1834; Sheeba V, 2008, CURR BIOL, V18, P1537, DOI 10.1016/j.cub.2008.08.033; TANOUYE MA, 1981, P NATL ACAD SCI-BIOL, V78, P6548, DOI 10.1073/pnas.78.10.6548; Tsetlin V, 1999, EUR J BIOCHEM, V264, P281, DOI 10.1046/j.1432-1327.1999.00623.x; Vacher H, 2007, FASEB J, V21, P906, DOI 10.1096/fj.06-7229com; Wang JW, 2000, J NEUROSCI, V20, P5958, DOI 10.1523/JNEUROSCI.20-16-05958.2000; Wu MN, 2008, SLEEP, V31, P465, DOI 10.1093/sleep/31.4.465; Yuan Q, 2006, CURR BIOL, V16, P1051, DOI 10.1016/j.cub.2006.04.032; Zheng X, 2007, P NATL ACAD SCI USA, V104, P15899, DOI 10.1073/pnas.0701599104	50	78	79	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2010	13	1					69	U229		10.1038/nn.2454	http://dx.doi.org/10.1038/nn.2454			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	536PM	20010822	Green Accepted			2022-12-24	WOS:000273056300015
J	Gu, XF; Greiner, ER; Mishra, R; Kodali, R; Osmand, A; Finkbeiner, S; Steffan, JS; Thompson, LM; Wetzel, R; Yang, XW				Gu, Xiaofeng; Greiner, Erin R.; Mishra, Rakesh; Kodali, Ravindra; Osmand, Alex; Finkbeiner, Steven; Steffan, Joan S.; Thompson, Leslie Michels; Wetzel, Ronald; Yang, X. William			Serines 13 and 16 Are Critical Determinants of Full-Length Human Mutant Huntingtin Induced Disease Pathogenesis in HD Mice	NEURON			English	Article							NEURONAL INTRANUCLEAR INCLUSIONS; TRANSGENIC MOUSE MODEL; TRINUCLEOTIDE REPEAT; AGGREGATION; TOXICITY; NEURODEGENERATION; PHOSPHORYLATION; EXPANSION; PATHOLOGY; NUCLEAR	The N-terminal 17 amino acids of huntingtin (NT17) can be phosphorylated on serines 13 and 16; however, the significance of these modifications in Huntington's disease pathogenesis remains unknown. In this study, we developed BAC transgenic mice expressing full-length mutant huntingtin (fl-mhtt) with serines 13 and 16 mutated to either aspartate (phosphomimetic or SID) or alanine (phosphoresistant or SA). Both mutant proteins preserve the essential function of huntingtin in rescuing knockout mouse phenotypes. However, fl-mhtt-induced disease pathogenesis, including motor and psych iatric-like behavioral deficits, mhtt aggregation, and selective neurodegeneration are abolished in SD but preserved in SA mice. Moreover, modification of these serines in expanded repeat huntingtin peptides modulates aggregation and amyloid fibril formation in vitro. Together, our findings demonstrate that serines 13 and 16 are critical determinants of fl-mhtt-induced disease pathogenesis in vivo, supporting the targeting of huntingtin NT17 domain and its modifications in HD therapy.	[Gu, Xiaofeng; Greiner, Erin R.; Yang, X. William] Univ Calif Los Angeles, David Geffen Sch Med, Ctr Neurobehav Genet, Jane & Terry Semel Inst Neurosci & Human Behav, Los Angeles, CA 90095 USA; [Gu, Xiaofeng; Yang, X. William] Univ Calif Los Angeles, David Geffen Sch Med, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA; [Gu, Xiaofeng; Yang, X. William] Univ Calif Los Angeles, David Geffen Sch Med, Brain Res Inst, Los Angeles, CA 90095 USA; [Greiner, Erin R.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Mishra, Rakesh; Kodali, Ravindra; Wetzel, Ronald] Univ Pittsburgh, Sch Med, Dept Biol Struct, Pittsburgh, PA 15260 USA; [Mishra, Rakesh; Kodali, Ravindra; Wetzel, Ronald] Univ Pittsburgh, Sch Med, Pittsburgh Inst Neurodegenerat Dis, Pittsburgh, PA 15260 USA; [Osmand, Alex] Univ Tennessee, Grad Sch Med, Dept Med, Knoxville, TN 37920 USA; [Finkbeiner, Steven] Univ Calif San Francisco, Gladstone Inst Neurol Dis, Taube Koret Ctr Huntingtons Dis Res, Dept Neurol, San Francisco, CA 94158 USA; [Finkbeiner, Steven] Univ Calif San Francisco, Gladstone Inst Neurol Dis, Taube Koret Ctr Huntingtons Dis Res, Dept Physiol, San Francisco, CA 94158 USA; [Steffan, Joan S.; Thompson, Leslie Michels] Univ Calif Irvine, Dept Psychiat & Human Behav, Irvine, CA 92697 USA; [Thompson, Leslie Michels] Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA 92697 USA; [Thompson, Leslie Michels] Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92697 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Tennessee System; University of Tennessee Health Science Center; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Yang, XW (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Ctr Neurobehav Genet, Jane & Terry Semel Inst Neurosci & Human Behav, Los Angeles, CA 90095 USA.	xwyang@mednet.ucla.edu	Wetzel, Ronald/G-7453-2011; kodali, ravindra/D-1543-2010; kodali, ravi/D-1148-2011		HDF; NINDS/NIH [R01NS049501, 3R01NS049501-05S1]; CHDI Foundation; Huntington Society of Canada; Huntington's Disease Society of America (HDSA); NIH [R01 AG019322, NS52789, NS045283]; Fox Family Foundation; HDSA; CHDI; Taube-Koret Center for HD Research;  [2R01NS39074];  [2R01NS45491];  [2P01AG022074]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045283, R24NS045491, R01NS052789, R01NS039074, R01NS049501] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG019322, P01AG022074] Funding Source: NIH RePORTER	HDF; NINDS/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); CHDI Foundation; Huntington Society of Canada; Huntington's Disease Society of America (HDSA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fox Family Foundation; HDSA; CHDI; Taube-Koret Center for HD Research; ; ; ; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We would like to thank Nancy Wexler, Carl Johnson, and the Hereditary Disease Foundation (HDF) for their tremendous support of this project. HD research in X.W.Y. lab at UCLA is supported by a contract from HDF, and by grants from NINDS/NIH (R01NS049501; 3R01NS049501-05S1) and CHDI Foundation. R.W. was supported by a research grant from the Huntington Society of Canada and the Huntington's Disease Society of America (HDSA), and by NIH R01 grant AG019322. The work of J.S.S. and L.M.T. was supported by HDF, the Fox Family Foundation (J.S.S.), the CHDI Foundation, the HDSA, and NIH awards NS52789 and NS045283 (L.M.T.). S.F. was supported by 2R01NS39074, 2R01NS45491, 2P01AG022074, CHDI, and the Taube-Koret Center for HD Research. A.P.O. was supported by HDF. We also would like to thank Scott Zeitlin for the Hdh Knockout mice; M.A. Hickey, M.F. Chesselet, and M.S. Levine for providing R6/2 and CAG140 brain sections, R. Truant for sharing unpublished studies, and members of the Yang Lab, particularly X.H. Lu, M. Gray, J.P. Cantle, Y. Cui, and T.K. Murphy for discussions and critical reading of the manuscript.	Aiken CT, 2009, J BIOL CHEM, V284, P29427, DOI 10.1074/jbc.M109.013193; Anne SL, 2007, J NEUROSCI, V27, P7318, DOI 10.1523/JNEUROSCI.1831-07.2007; Atwal RS, 2007, HUM MOL GENET, V16, P2600, DOI 10.1093/hmg/ddm217; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; Bates G, 2003, LANCET, V361, P1642, DOI 10.1016/S0140-6736(03)13304-1; Beal MF, 2004, NAT REV NEUROSCI, V5, P373, DOI 10.1038/nrn1386; Bossy-Wetzel E, 2004, NAT MED, V10, pS2, DOI 10.1038/nm1067; Chen HK, 2003, CELL, V113, P457, DOI 10.1016/S0092-8674(03)00349-0; Cornett J, 2005, NAT GENET, V37, P198, DOI 10.1038/ng1503; Crawley JN, 2008, NEURON, V57, P809, DOI 10.1016/j.neuron.2008.03.001; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Dragatsis I, 2000, NAT GENET, V26, P300, DOI 10.1038/81593; Duennwald ML, 2006, P NATL ACAD SCI USA, V103, P11045, DOI 10.1073/pnas.0604547103; Emamian ES, 2003, NEURON, V38, P375, DOI 10.1016/S0896-6273(03)00258-7; FILE SE, 1997, CURRENT PROTOCOLS NE, V8; Fujiwara H, 2002, NAT CELL BIOL, V4, P160, DOI 10.1038/ncb748; Gatchel JR, 2005, NAT REV GENET, V6, P743, DOI 10.1038/nrg1691; Gong SC, 2002, GENOME RES, V12, P1992, DOI 10.1101/gr.476202; Graham RK, 2006, CELL, V125, P1179, DOI 10.1016/j.cell.2006.04.026; Gray M, 2008, J NEUROSCI, V28, P6182, DOI 10.1523/JNEUROSCI.0857-08.2008; Gu XF, 2005, NEURON, V46, P433, DOI 10.1016/j.neuron.2005.03.025; Gusella JF, 2000, NAT REV NEUROSCI, V1, P109, DOI 10.1038/35039051; Gutekunst CA, 1999, J NEUROSCI, V19, P2522; Harper PS, 1996, J ROY COLL PHYS LOND, V30, P221; Humbert S, 2002, DEV CELL, V2, P831, DOI 10.1016/S1534-5807(02)00188-0; Jeong H, 2009, CELL, V137, P60, DOI 10.1016/j.cell.2009.03.018; Katsuno M, 2002, NEURON, V35, P843, DOI 10.1016/S0896-6273(02)00834-6; Li SH, 2006, MOL NEURODEGENER, V1, DOI 10.1186/1750-1326-1-19; MacDonald Marcy E, 2003, Sci STKE, V2003, ppe48; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Menalled LB, 2003, J COMP NEUROL, V465, P11, DOI 10.1002/cne.10776; Menalled L, 2009, NEUROBIOL DIS, V35, P319, DOI 10.1016/j.nbd.2009.05.007; O'Nuallain B, 2006, METHOD ENZYMOL, V413, P34, DOI 10.1016/S0076-6879(06)13003-7; Omi K, 2008, NEUROSCI LETT, V431, P45, DOI 10.1016/j.neulet.2007.11.018; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; Osmand AP, 2006, METHOD ENZYMOL, V412, P106, DOI 10.1016/S0076-6879(06)12008-X; Rockabrand E, 2007, HUM MOL GENET, V16, P61, DOI 10.1093/hmg/ddl440; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Schilling B, 2006, J BIOL CHEM, V281, P23686, DOI 10.1074/jbc.M513507200; Slow EJ, 2003, HUM MOL GENET, V12, P1555, DOI 10.1093/hmg/ddg169; Southwell AL, 2008, J NEUROSCI, V28, P9013, DOI 10.1523/JNEUROSCI.2747-08.2008; Spampanato J, 2008, NEUROSCIENCE, V157, P606, DOI 10.1016/j.neuroscience.2008.09.020; Steffan JS, 2004, SCIENCE, V304, P100, DOI 10.1126/science.1092194; Subramaniam S, 2009, SCIENCE, V324, P1327, DOI 10.1126/science.1172871; Thakur AK, 2009, NAT STRUCT MOL BIOL, V16, P380, DOI 10.1038/nsmb.1570; THOMPSON LM, 2009, J CELL BIOL IN PRESS; Vonsattel JPG, 1998, J NEUROPATH EXP NEUR, V57, P369; Wang YS, 2009, J EUR ACAD DERMATOL, V23, P451, DOI 10.1111/j.1468-3083.2008.02895.x; White JK, 1997, NAT GENET, V17, P404, DOI 10.1038/ng1297-404; Williams AJ, 2008, TRENDS NEUROSCI, V31, P521, DOI 10.1016/j.tins.2008.07.004; Wolfgang WJ, 2005, P NATL ACAD SCI USA, V102, P11563, DOI 10.1073/pnas.0505321102; Yanai A, 2006, NAT NEUROSCI, V9, P824, DOI 10.1038/nn1702; Yang XDW, 1997, NAT BIOTECHNOL, V15, P859, DOI 10.1038/nbt0997-859; Yang XW, 2005, CURR PROTOC NEUROSCI, DOI [DOI 10.1002/0471142301.NS0520S31.CHAPTER, 10.1002/0471142301.ns0520s31, DOI 10.1002/0471142301.NS0520S31]; ZEITLIN S, 1995, NAT GENET, V11, P155, DOI 10.1038/ng1095-155	56	233	239	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 24	2009	64	6					828	840		10.1016/j.neuron.2009.11.020	http://dx.doi.org/10.1016/j.neuron.2009.11.020			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	541ON	20064390	Green Accepted, Bronze			2022-12-24	WOS:000273425800010
J	Kirilly, D; Gu, Y; Huang, YF; Wu, ZH; Bashirullah, A; Low, BC; Kolodkin, AL; Wang, HY; Yu, FW				Kirilly, Daniel; Gu, Ying; Huang, Yafen; Wu, Zhuhao; Bashirullah, Arash; Low, Boon Chuan; Kolodkin, Alex L.; Wang, Hongyan; Yu, Fengwei			A genetic pathway composed of Sox14 and Mical governs severing of dendrites during pruning	NATURE NEUROSCIENCE			English	Article							DROSOPHILA MUSHROOM BODIES; PROGRAMMED CELL-DEATH; B ECDYSONE RECEPTOR; SENSORY NEURONS; UBIQUITIN-PROTEASOME; TIME-LAPSE; METAMORPHOSIS; DEGENERATION; MECHANISMS; ENGULFMENT	Pruning that selectively eliminates neuronal processes is crucial for the refinement of neural circuits during development. In Drosophila, the class IV dendritic arborization neuron (ddaC) undergoes pruning to remove its larval dendrites during metamorphosis. We identified Sox14 as a transcription factor that was necessary and sufficient to mediate dendrite severing during pruning in response to ecdysone signaling. We found that Sox14 mediated dendrite pruning by directly regulating the expression of the target gene mical. mical encodes a large cytosolic protein with multiple domains that are known to associate with cytoskeletal components. mical mutants had marked severing defects during dendrite pruning that were similar to those of sox14 mutants. Overexpression of Mical could significantly rescue pruning defects in sox14 mutants, suggesting that Mical is a major downstream target of Sox14 during pruning. Thus, our findings indicate that a previously unknown pathway composed of Sox14 and its cytoskeletal target Mical governs dendrite severing.	[Kirilly, Daniel; Gu, Ying; Huang, Yafen; Yu, Fengwei] Natl Univ Singapore, Temasek Life Sci Lab, Singapore 117548, Singapore; [Gu, Ying; Low, Boon Chuan; Yu, Fengwei] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Wu, Zhuhao; Kolodkin, Alex L.] Johns Hopkins Sch Med, Solomon H Snyder Dept Neurosci, Howard Hughes Med Inst, Baltimore, MD USA; [Bashirullah, Arash] Univ Wisconsin, Div Pharmaceut Sci, Madison, WI USA; [Wang, Hongyan; Yu, Fengwei] Duke Natl Univ Singapore, Grad Med Sch Singapore, Neurosci & Behav Disorder Program, Singapore 117548, Singapore; [Wang, Hongyan] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Physiol, Singapore 117548, Singapore	National University of Singapore; National University of Singapore; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins Medicine; University of Wisconsin System; University of Wisconsin Madison; National University of Singapore; National University of Singapore	Yu, FW (corresponding author), Natl Univ Singapore, Temasek Life Sci Lab, Singapore 117548, Singapore.	fengwei@tll.org.sg	Low, Boon Chuan/H-8049-2012; Wu, Zhuhao/I-5852-2018; Wang, Hongyan/AAB-3030-2019; Low, Boon Chuan/AAU-7685-2021	Low, Boon Chuan/0000-0003-0756-096X; Wang, Hongyan/0000-0003-4623-1878; Low, Boon Chuan/0000-0003-0756-096X; Wu, Zhuhao/0000-0002-2471-0555; Yu, Fengwei/0000-0003-0268-199X	Temasek Life Sciences Laboratory; Duke-National University of Singapore [MOE2008-T2-1-048, NRF-RF2009-02]; US National Institutes of Health; National Institute of Neurological Disorders and Stroke [RO1NS35165]; Howard Hughes Medical Institute; Singapore Millennium Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035165] Funding Source: NIH RePORTER	Temasek Life Sciences Laboratory(National University of Singapore); Duke-National University of Singapore(National University of Singapore); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Singapore Millennium Foundation(Singapore Millennium Foundation); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank H. Aberle, R. Barrio, Y. N. Jan, W. A. Johnson, the Bloomington Stock Center, Developmental Studies Hybridoma Bank (University of Iowa) and Vienna Drosophila RNAi Center for generously providing antibodies and fly stocks. We thank members of the Yu and Wang laboratories for stimulating discussions and Z. L. Ong for technical assistance. We thank W. Chia, S. Cohen, P. Rorth, S. Roy, J. Varghese and G. Feng for helpful discussions and for reading the manuscript. This work was supported by Temasek Life Sciences Laboratory (F. Y.), Duke-National University of Singapore (MOE2008-T2-1-048 and NRF-RF2009-02 to H. W.), and grants from the US National Institutes of Health and the National Institute of Neurological Disorders and Stroke (RO1NS35165) and the Howard Hughes Medical Institute (A. L. K.). D. K. is supported by the Singapore Millennium Foundation.	Ainsley JA, 2003, CURR BIOL, V13, P1557, DOI 10.1016/S0960-9822(03)00596-7; Avery MA, 2009, J CELL BIOL, V184, P501, DOI 10.1083/jcb.200808042; Awasaki T, 2006, NEURON, V50, P855, DOI 10.1016/j.neuron.2006.04.027; Awasaki T, 2004, CURR BIOL, V14, P668, DOI 10.1016/j.cub.2004.04.001; Beckstead RB, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-12-r99; Beuchle D, 2007, MECH DEVELOP, V124, P390, DOI 10.1016/j.mod.2007.01.006; Brown HLD, 2006, DEVELOPMENT, V133, P275, DOI 10.1242/dev.02191; Chittaranjan S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000379; Cremazy F, 2001, MECH DEVELOP, V109, P371, DOI 10.1016/S0925-4773(01)00529-9; Defilippi P, 2006, TRENDS CELL BIOL, V16, P257, DOI 10.1016/j.tcb.2006.03.003; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Grueber WB, 2003, CELL, V112, P805, DOI 10.1016/S0092-8674(03)00160-0; Grueber WB, 2003, CURR BIOL, V13, P618, DOI 10.1016/S0960-9822(03)00207-0; Hoopfer ED, 2006, NEURON, V50, P883, DOI 10.1016/j.neuron.2006.05.013; Huang ZY, 2007, DEVELOPMENT, V134, P2337, DOI 10.1242/dev.004242; Kuo CT, 2006, NEURON, V51, P283, DOI 10.1016/j.neuron.2006.07.014; Kuo CT, 2005, P NATL ACAD SCI USA, V102, P15230, DOI 10.1073/pnas.0507393102; Lee CY, 2003, CURR BIOL, V13, P350, DOI 10.1016/S0960-9822(03)00085-X; Lee HH, 2009, P NATL ACAD SCI USA, V106, P6363, DOI 10.1073/pnas.0902051106; Lee T, 1999, DEVELOPMENT, V126, P4065; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lee T, 2000, NEURON, V28, P807, DOI 10.1016/S0896-6273(00)00155-0; Lefebvre V, 2007, INT J BIOCHEM CELL B, V39, P2195, DOI 10.1016/j.biocel.2007.05.019; Li H, 2001, J NEUROSCI, V21, P8473, DOI 10.1523/JNEUROSCI.21-21-08473.2001; Li TR, 2003, DEV CELL, V5, P59, DOI 10.1016/S1534-5807(03)00192-8; Luo LQ, 2005, ANNU REV NEUROSCI, V28, P127, DOI 10.1146/annurev.neuro.28.061604.135632; MacDonald JM, 2006, NEURON, V50, P869, DOI 10.1016/j.neuron.2006.04.028; Marin EC, 2005, DEVELOPMENT, V132, P725, DOI 10.1242/dev.01614; Mccarthy MM, 2008, PHYSIOL REV, V88, P91, DOI 10.1152/physrev.00010.2007; Ndozangue-Touriguine O, 2008, BIOCHEM PHARMACOL, V76, P11, DOI 10.1016/j.bcp.2008.03.016; OLEARY DDM, 1993, NEURON, V10, P991, DOI 10.1016/0896-6273(93)90049-W; Pauli A, 2008, DEV CELL, V14, P239, DOI 10.1016/j.devcel.2007.12.009; Schubiger M, 1998, DEVELOPMENT, V125, P2053; Schuldiner O, 2008, DEV CELL, V14, P227, DOI 10.1016/j.devcel.2007.11.001; Sparkes AC, 2001, GENE, V272, P121, DOI 10.1016/S0378-1119(01)00557-1; Suzuki T, 2002, J BIOL CHEM, V277, P14933, DOI 10.1074/jbc.M111842200; Terman JR, 2002, CELL, V109, P887, DOI 10.1016/S0092-8674(02)00794-8; Thummel CS, 1996, TRENDS GENET, V12, P306, DOI 10.1016/0168-9525(96)10032-9; Toran-Allerand CD, 1999, FRONT NEUROENDOCRIN, V20, P97, DOI 10.1006/frne.1999.0177; TRUMAN JW, 1990, J NEUROBIOL, V21, P1072, DOI 10.1002/neu.480210711; Tsai J, 2004, NAT NEUROSCI, V7, P1181, DOI 10.1038/nn1335; Wang L, 2008, GENETICS, V180, P269, DOI 10.1534/genetics.108.092478; Watts RJ, 2003, NEURON, V38, P871, DOI 10.1016/S0896-6273(03)00295-2; Watts RJ, 2004, CURR BIOL, V14, P678, DOI 10.1016/j.cub.2004.03.035; Williams DW, 2006, NAT NEUROSCI, V9, P1234, DOI 10.1038/nn1774; Williams DW, 2005, DEVELOPMENT, V132, P3631, DOI 10.1242/dev.01928; Zheng XY, 2003, CELL, V112, P303, DOI 10.1016/S0092-8674(03)00072-2; Zhu SJ, 2003, DEVELOPMENT, V130, P2603, DOI 10.1242/dev.00466	48	95	96	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2009	12	12					1497	U35		10.1038/nn.2415	http://dx.doi.org/10.1038/nn.2415			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	523II	19881505	Green Accepted			2022-12-24	WOS:000272065600009
J	Paik, JH; Ding, ZH; Narurkar, R; Ramkissoon, S; Muller, F; Kamoun, WS; Chae, SS; Zheng, HW; Ying, HQ; Mahoney, J; Hiller, D; Jiang, S; Protopopov, A; Wong, WH; Chin, L; Ligon, KL; DePinho, RA				Paik, Ji-hye; Ding, Zhihu; Narurkar, Rujuta; Ramkissoon, Shakti; Muller, Florian; Kamoun, Walid S.; Chae, Sung-Suk; Zheng, Hongwu; Ying, Haoqiang; Mahoney, Jed; Hiller, David; Jiang, Shan; Protopopov, Alexei; Wong, Wing H.; Chin, Lynda; Ligon, Keith L.; DePinho, Ronald A.			FoxOs Cooperatively Regulate Diverse Pathways Governing Neural Stem Cell Homeostasis	CELL STEM CELL			English	Article							FORKHEAD TRANSCRIPTION FACTORS; SELF-RENEWAL; OXIDATIVE STRESS; DOWN-REGULATION; DIFFERENTIATION; PROLIFERATION; NEUROGENESIS; ASPM; EXPRESSION; FOREBRAIN	The PI3K-AKT-FoxO pathway is integral to lifespan regulation in lower organisms and essential for the stability of long-lived cells in mammals. Here, we report the impact of combined FoxO1, 3, and 4 deficiencies on mammalian brain physiology with a particular emphasis on the study of the neural stem/progenitor cell (NSC) pool. We show that the FoxO family plays a prominent role in NSC proliferation and renewal. FoxO-deficient mice show initial increased brain size and proliferation of neural progenitor cells during early postnatal life, followed by precocious significant decline in the NSC pool and accompanying neurogenesis in adult brains. Mechanistically, integrated transcriptomic, promoter, and functional analyses of FoxO-deficient NSC cultures identified direct gene targets with known links to the regulation of human brain size and the control of cellular proliferation, differentiation, and oxidative defense. Thus, the FoxO family coordinately regulates diverse genes and pathways to govern key aspects of NSC homeostasis in the mammalian brain.	[Paik, Ji-hye; Ding, Zhihu; Narurkar, Rujuta; Muller, Florian; Zheng, Hongwu; Ying, Haoqiang; Mahoney, Jed; Jiang, Shan; Protopopov, Alexei; Chin, Lynda; DePinho, Ronald A.] Dana Farber Canc Inst, Belfer Inst Appl Canc Sci, Dept Med Oncol, Boston, MA 02115 USA; [Paik, Ji-hye; Ding, Zhihu; Narurkar, Rujuta; Muller, Florian; Zheng, Hongwu; Ying, Haoqiang; Mahoney, Jed; Jiang, Shan; Protopopov, Alexei; Chin, Lynda; DePinho, Ronald A.] Dana Farber Canc Inst, Belfer Inst Appl Canc Sci, Dept Med, Boston, MA 02115 USA; [Paik, Ji-hye; Ding, Zhihu; Narurkar, Rujuta; Muller, Florian; Zheng, Hongwu; Ying, Haoqiang; Mahoney, Jed; Jiang, Shan; Protopopov, Alexei; Chin, Lynda; DePinho, Ronald A.] Dana Farber Canc Inst, Belfer Inst Appl Canc Sci, Dept Genet, Boston, MA 02115 USA; [Ramkissoon, Shakti; Ligon, Keith L.] Dana Farber Canc Inst, Dept Med Oncol, Ctr Mol Oncol Pathol, Boston, MA 02115 USA; [Ramkissoon, Shakti; Ligon, Keith L.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Kamoun, Walid S.; Chae, Sung-Suk] Massachusetts Gen Hosp, Dept Radiat Oncol, Boston, MA 02114 USA; [Kamoun, Walid S.; Chae, Sung-Suk] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Hiller, David; Wong, Wing H.] Stanford Univ, Dept Stat, Stanford, CA 94305 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Stanford University	DePinho, RA (corresponding author), Dana Farber Canc Inst, Belfer Inst Appl Canc Sci, Dept Med Oncol, Boston, MA 02115 USA.	ron_depinho@dfci.harvard.edu	Ying, Haoqiang/AAK-4325-2020	DePinho, Ronald/0000-0002-5625-577X; Muller, Florian/0000-0001-7568-2948; Zheng, Hongwu/0000-0002-5823-4913	Damon Runyon Cancer Research Foundation [DRG 1900-06]; Claudia Adam Barr Foundation; ACS; ABTA; Ellison Medical Foundation; Robert A. and Renee E. Belfer Foundation Institute for Applied Cancer Science;  [5P01CA95616]; NATIONAL CANCER INSTITUTE [P01CA095616] Funding Source: NIH RePORTER	Damon Runyon Cancer Research Foundation; Claudia Adam Barr Foundation; ACS(American Cancer Society); ABTA; Ellison Medical Foundation(Lawrence Ellison Foundation); Robert A. and Renee E. Belfer Foundation Institute for Applied Cancer Science; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	J.-h.P. is Damon Runyon Fellow was supported by the Damon Runyon Cancer Research Foundation (DRG 1900-06). Grant support includes the Claudia Adam Barr Foundation (J.-h.P.), ACS fellowship (F.M.), ABTA fellowship (H.Y.), Ellison Medical Foundation (R.A.D.), and 5P01CA95616 (R.A.D., K.L.L., L.C.). R.A.D. is an American Cancer Society Research Professor and supported by the Robert A. and Renee E. Belfer Foundation Institute for Applied Cancer Science. We thank D. Pellman and S. Yoshida for the deconvolution microscope use and advice, R. Maser for MSCV-puro-v5 gateway vector, W. Hahn for shRNA constructs, and J. Ling for technical assistance.	Alvarez B, 2001, NATURE, V413, P744, DOI 10.1038/35099574; Battista D, 2006, EUR J NEUROSCI, V23, P83, DOI 10.1111/j.1460-9568.2005.04539.x; Birkenkamp KU, 2007, J BIOL CHEM, V282, P2211, DOI 10.1074/jbc.M606669200; Bond J, 2002, NAT GENET, V32, P316, DOI 10.1038/ng995; Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090; Cheng T, 2000, NAT MED, V6, P1235, DOI 10.1038/81335; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; Doetsch F, 2002, J NEUROSCI, V22, P2255, DOI 10.1523/JNEUROSCI.22-06-02255.2002; Doetsch F, 2002, NEURON, V36, P1021, DOI 10.1016/S0896-6273(02)01133-9; Fish JL, 2006, P NATL ACAD SCI USA, V103, P10438, DOI 10.1073/pnas.0604066103; Gan B, 2008, P NATL ACAD SCI USA, V105, P19384, DOI 10.1073/pnas.0810584105; Gorczyca W, 2001, METHOD CELL BIOL, V64, P421; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; Groszer M, 2006, P NATL ACAD SCI USA, V103, P111, DOI 10.1073/pnas.0509939103; Groszer M, 2001, SCIENCE, V294, P2186, DOI 10.1126/science.1065518; Hameyer D, 2007, PHYSIOL GENOMICS, V31, P32, DOI 10.1152/physiolgenomics.00019.2007; Hoekman MFM, 2006, GENE EXPR PATTERNS, V6, P134, DOI 10.1016/j.modgep.2005.07.003; Horvath S, 2006, P NATL ACAD SCI USA, V103, P17402, DOI 10.1073/pnas.0608396103; Hosaka T, 2004, P NATL ACAD SCI USA, V101, P2975, DOI 10.1073/pnas.0400093101; Hu P, 2008, DEV CELL, V15, P534, DOI 10.1016/j.devcel.2008.08.018; Imayoshi I, 2008, NAT NEUROSCI, V11, P1153, DOI 10.1038/nn.2185; Ito K, 2006, NAT MED, V12, P446, DOI 10.1038/nm1388; Ito K, 2004, NATURE, V431, P997, DOI 10.1038/nature02989; Jin KL, 2003, AGING CELL, V2, P175, DOI 10.1046/j.1474-9728.2003.00046.x; Kippin TE, 2005, GENE DEV, V19, P756, DOI 10.1101/gad.1272305; Kitamura T, 2007, J CLIN INVEST, V117, P2477, DOI 10.1172/JCI32054; Kozar K, 2004, CELL, V118, P477, DOI 10.1016/j.cell.2004.07.025; Krishnamurthy J, 2006, NATURE, V443, P453, DOI 10.1038/nature05092; Lim DA, 2009, NATURE, V458, P529, DOI 10.1038/nature07726; Liu HJ, 2007, SCIENCE, V317, P803, DOI 10.1126/science.1143578; Malumbres M, 2004, CELL, V118, P493, DOI 10.1016/j.cell.2004.08.002; Miyamoto K, 2007, CELL STEM CELL, V1, P101, DOI 10.1016/j.stem.2007.02.001; Molofsky AV, 2006, NATURE, V443, P448, DOI 10.1038/nature05091; MORSHEAD CM, 1994, NEURON, V13, P1071, DOI 10.1016/0896-6273(94)90046-9; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Paling NRD, 2004, J BIOL CHEM, V279, P48063, DOI 10.1074/jbc.M406467200; Palma V, 2005, DEVELOPMENT, V132, P335, DOI 10.1242/dev.01567; Puig O, 2003, GENE DEV, V17, P2006, DOI 10.1101/gad.1098703; Renault VM, 2009, CELL STEM CELL, V5, P527, DOI 10.1016/j.stem.2009.09.014; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Schmidt M, 2002, MOL CELL BIOL, V22, P7842, DOI 10.1128/MCB.22.22.7842-7852.2002; Seoane J, 2004, CELL, V117, P211, DOI 10.1016/S0092-8674(04)00298-3; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; Wang F, 2007, AGING CELL, V6, P505, DOI 10.1111/j.1474-9726.2007.00304.x; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703; Yuan YZ, 2004, NAT CELL BIOL, V6, P436, DOI 10.1038/ncb1126; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Zheng HW, 2008, NATURE, V455, P1129, DOI 10.1038/nature07443; Zhuo L, 2001, GENESIS, V31, P85, DOI 10.1002/gene.10008	50	333	341	1	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	NOV 6	2009	5	5					540	553		10.1016/j.stem.2009.09.013	http://dx.doi.org/10.1016/j.stem.2009.09.013			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	522SR	19896444	Bronze, Green Accepted			2022-12-24	WOS:000272019500015
J	Kurshan, PT; Oztan, A; Schwarz, TL				Kurshan, Peri T.; Oztan, Asli; Schwarz, Thomas L.			Presynaptic alpha(2)delta-3 is required for synaptic morphogenesis independent of its Ca2+-channel functions	NATURE NEUROSCIENCE			English	Article							CA2+ CHANNEL ALPHA(2)DELTA; SENSITIVE CALCIUM-CHANNEL; BETA-SUBUNITS; ACTIVE ZONES; DROSOPHILA; PROTEIN; ADHESION; EXPRESSION; SYNAPSES; DOMAINS	Synaptogenesis involves the transformation of a growth cone into synaptic boutons specialized for transmitter release. In Drosophila embryos lacking the. alpha(2)delta-3 subunit of presynaptic, voltage-dependent Ca2+ channels, we found that motor neuron terminals failed to develop synaptic boutons and cytoskeletal abnormalities arose, including the loss of ankyrin2. Nevertheless, functional presynaptic specializations were present and apposed to clusters of postsynaptic glutamate receptors. The alpha(2)delta-3 protein has been thought to function strictly as an auxiliary subunit of the Ca2+ channel, but the phenotype of alpha(2)delta-3 (also known as stj) mutations cannot be explained by a channel defect; embryos lacking the pore-forming alpha(1) subunit cacophony formed boutons. The synaptogenic function of. alpha(2)delta-3 required only the alpha(2) peptide, whose expression sufficed to rescue bouton formation. Our results indicate that alpha(2)delta proteins have functions that are independent of their roles in the biophysics and localization of Ca2+ channels and that synaptic architecture depends on these functions.	[Kurshan, Peri T.; Oztan, Asli; Schwarz, Thomas L.] Childrens Hosp Boston, FM Kirby Neurobiol Ctr, Boston, MA USA; [Kurshan, Peri T.; Oztan, Asli; Schwarz, Thomas L.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Schwarz, TL (corresponding author), Childrens Hosp Boston, FM Kirby Neurobiol Ctr, Boston, MA USA.	Thomas.schwarz@childrens.harvard.edu			US National Institutes of Health [RO1 NS041062, MH075058]; National Defense Science and Engineering Graduate Fellowship; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH075058] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041062] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Defense Science and Engineering Graduate Fellowship; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank H. Kazama for assistance with the electrophysiology, R. Ordway, J. T. Littleton, L. Hall, H. Aberle, K. Basler and the Bloomington Stock Center for stocks and reagents, D. Featherstone, T. Littleton, N. Reese and A. Goldstein for helpful discussions, L. Bu and M. Liana of the MRDDRC Imaging and Histology Cores, the Harvard Medical School electron microscopy facility, and E. Pogoda for assistance. This work was supported by US National Institutes of Health grants RO1 NS041062 and MH075058 (T. L. S.) and a National Defense Science and Engineering Graduate Fellowship (P. T. K.).	Anantharaman V, 2000, TRENDS BIOCHEM SCI, V25, P535, DOI 10.1016/S0968-0004(00)01672-8; Arikkath J, 2003, CURR OPIN NEUROBIOL, V13, P298, DOI 10.1016/S0959-4388(03)00066-7; Bangalore R, 1996, AM J PHYSIOL-HEART C, V270, pH1521, DOI 10.1152/ajpheart.1996.270.5.H1521; Barclay J, 2001, J NEUROSCI, V21, P6095, DOI 10.1523/JNEUROSCI.21-16-06095.2001; Bennett V, 2001, CURR OPIN CELL BIOL, V13, P61, DOI 10.1016/S0955-0674(00)00175-7; Bernstein GM, 2007, CELL CALCIUM, V41, P27, DOI 10.1016/j.ceca.2006.04.010; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; BORK P, 1991, BIOCHEM J, V279, P908, DOI 10.1042/bj2790908; Brodbeck J, 2002, J BIOL CHEM, V277, P7684, DOI 10.1074/jbc.M109404200; Canti C, 2005, P NATL ACAD SCI USA, V102, P11230, DOI 10.1073/pnas.0504183102; De Waard M, 1996, Ion Channels, V4, P41; Dickman DK, 2008, J NEUROSCI, V28, P31, DOI 10.1523/JNEUROSCI.4498-07.2008; Dolphin AC, 2003, J BIOENERG BIOMEMBR, V35, P599, DOI 10.1023/B:JOBB.0000008026.37790.5a; Dolphin AC, 1999, J PHYSIOL-LONDON, V519, P35, DOI 10.1111/j.1469-7793.1999.0035o.x; Felix R, 2005, J RECEPT SIG TRANSD, V25, P57, DOI 10.1081/RRS-200068102; Felix R, 1997, J NEUROSCI, V17, P6884; Gurnett CA, 1997, J BIOL CHEM, V272, P18508, DOI 10.1074/jbc.272.29.18508; Gurnett CA, 1996, NEURON, V16, P431, DOI 10.1016/S0896-6273(00)80061-6; Hortsch M, 1998, CELL ADHES COMMUN, V5, P61, DOI 10.3109/15419069809005599; Hou J, 2008, J NEUROPHYSIOL, V100, P2833, DOI 10.1152/jn.90342.2008; JAY SD, 1991, J BIOL CHEM, V266, P3287; JOHANSEN J, 1989, J NEUROSCI, V9, P710; Kawasaki F, 2004, J NEUROSCI, V24, P282, DOI 10.1523/JNEUROSCI.3553-03.2004; Kawasaki F, 2000, J NEUROSCI, V20, P4885; Klugbauer N, 2003, J BIOENERG BIOMEMBR, V35, P639, DOI 10.1023/B:JOBB.0000008028.41056.58; Koch I, 2008, NEURON, V58, P210, DOI 10.1016/j.neuron.2008.03.019; Kuromi H, 2004, NEURON, V41, P101, DOI 10.1016/S0896-6273(03)00815-8; Lardi-Studler B, 2007, NEUROSCIENTIST, V13, P115, DOI 10.1177/1073858406296803; Littleton JT, 2000, NEURON, V26, P35, DOI 10.1016/S0896-6273(00)81135-6; Ly CV, 2008, J CELL BIOL, V181, P157, DOI 10.1083/jcb.200712152; Nishimune H, 2004, NATURE, V432, P580, DOI 10.1038/nature03112; Pack-Chung E, 2007, NAT NEUROSCI, V10, P980, DOI 10.1038/nn1936; Pielage J, 2008, NEURON, V58, P195, DOI 10.1016/j.neuron.2008.02.017; Qin N, 2002, MOL PHARMACOL, V62, P485, DOI 10.1124/mol.62.3.485; Rieckhof GE, 2003, J BIOL CHEM, V278, P41099, DOI 10.1074/jbc.M306417200; ROBITAILLE R, 1990, NEURON, V5, P773, DOI 10.1016/0896-6273(90)90336-E; Roos J, 2000, NEURON, V26, P371, DOI 10.1016/S0896-6273(00)81170-8; Ruiz-Canada C, 2006, INT REV NEUROBIOL, V75, P1, DOI 10.1016/S0074-7742(06)75001-2; SHISTIK E, 1995, J PHYSIOL-LONDON, V489, P55, DOI 10.1113/jphysiol.1995.sp021029; SINK H, 1991, J NEUROBIOL, V22, P298, DOI 10.1002/neu.480220309; Smith LA, 1996, J NEUROSCI, V16, P7868; Stowers RS, 1999, GENETICS, V152, P1631; VANVACTOR D, 1993, CELL, V73, P1137, DOI 10.1016/0092-8674(93)90643-5; Wagh DA, 2006, NEURON, V49, P833, DOI 10.1016/j.neuron.2006.02.008; Whittaker CA, 2002, MOL BIOL CELL, V13, P3369, DOI 10.1091/mbc.E02-05-0259; Wiser O, 1996, FEBS LETT, V379, P15, DOI 10.1016/0014-5793(95)01475-6; Wolf M, 2003, J MOL BIOL, V332, P171, DOI 10.1016/S0022-2836(03)00899-4; Wycisk KA, 2006, INVEST OPHTH VIS SCI, V47, P3523, DOI 10.1167/iovs.06-0271; XU T, 1993, DEVELOPMENT, V117, P1223; Yoshihara M, 1997, J NEUROSCI, V17, P8408	50	102	103	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2009	12	11					1415	1423		10.1038/nn.2417	http://dx.doi.org/10.1038/nn.2417			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	511UE	19820706	Green Accepted			2022-12-24	WOS:000271194100014
J	Ellman, LM; Susser, ES				Ellman, Lauren M.; Susser, Ezra S.			The Promise of Epidemiologic Studies: Neuroimmune Mechanisms in the Etiologies of Brain Disorders	NEURON			English	Editorial Material							FETAL EXPOSURE; SCHIZOPHRENIA; INFECTION; PSYCHOSIS; INFLUENZA; STRESS; RISK	We present our views on current and past epidemiological contributions to our understanding of neuroimmune mechanisms for neurodevelopmental disorders, such as schizophrenia. We also discuss future directions for epidemiological studies and ways in which newer cohorts are well positioned to address questions that were previously not feasible to explore.	[Ellman, Lauren M.] Temple Univ, Dept Psychol, Philadelphia, PA 19122 USA; [Susser, Ezra S.] Columbia Univ, Coll Phys & Surg, Dept Psychiat, New York, NY 10032 USA; [Susser, Ezra S.] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY 10032 USA; [Susser, Ezra S.] New York State Psychiat Inst & Hosp, New York, NY 10032 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Columbia University; Columbia University; New York State Psychiatry Institute	Ellman, LM (corresponding author), Temple Univ, Dept Psychol, Philadelphia, PA 19122 USA.	ellman@temple.edu						Brown AS, 2006, SCHIZOPHRENIA BULL, V32, P200, DOI 10.1093/schbul/sbj052; Brown AS, 2004, ARCH GEN PSYCHIAT, V61, P774, DOI 10.1001/archpsyc.61.8.774; Brown AS, 2004, AM J PSYCHIAT, V161, P889, DOI 10.1176/appi.ajp.161.5.889; Buka SL, 2001, BRAIN BEHAV IMMUN, V15, P411, DOI 10.1006/brbi.2001.0644; Cannon M, 2002, AM J PSYCHIAT, V159, P1080, DOI 10.1176/appi.ajp.159.7.1080; Clarke MC, 2009, AM J PSYCHIAT, V166, P1025, DOI 10.1176/appi.ajp.2009.08010031; Ellman LM, 2008, DEV PSYCHOBIOL, V50, P232, DOI 10.1002/dev.20293; Ellman LM, 2009, BIOL PSYCHIAT, V65, P1040, DOI 10.1016/j.biopsych.2008.12.015; Irwin MR, 2008, BIOL PSYCHIAT, V64, P538, DOI 10.1016/j.biopsych.2008.05.004; March D, 2006, AM J EPIDEMIOL, V163, P979, DOI 10.1093/aje/kwj170; Patterson PH, 2009, BEHAV BRAIN RES, V204, P313, DOI 10.1016/j.bbr.2008.12.016; Segerstrom SC, 2004, PSYCHOL BULL, V130, P601, DOI 10.1037/0033-2909.130.4.601; Susser E, 2000, PAEDIATR PERINAT EP, V14, P98, DOI 10.1046/j.1365-3016.2000.00249.x; Susser E, 2006, PSYCHIAT EPIDEMIOLOG; Susser E, 2008, ANN NY ACAD SCI, V1136, P185, DOI 10.1196/annals.1425.024	15	29	31	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	OCT 15	2009	64	1					25	27		10.1016/j.neuron.2009.09.024	http://dx.doi.org/10.1016/j.neuron.2009.09.024			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	515FY	19840544	Bronze			2022-12-24	WOS:000271454400006
J	Azim, E; Jabaudon, D; Fame, RM; Macklis, JD				Azim, Eiman; Jabaudon, Denis; Fame, Ryann M.; Macklis, Jeffrey D.			SOX6 controls dorsal progenitor identity and interneuron diversity during neocortical development	NATURE NEUROSCIENCE			English	Article							RAT OCCIPITAL CORTEX; CEREBRAL-CORTEX; CORTICAL INTERNEURONS; IMMUNOREACTIVE NEURONS; MOUSE TELENCEPHALON; GENE SOX6; SPECIFICATION; EXPRESSION; MIGRATION; SUBTYPE	The neuronal diversity of the CNS emerges largely from controlled spatial and temporal segregation of cell type-specific molecular regulators. We found that the transcription factor SOX6 controls the molecular segregation of dorsal (pallial) from ventral (subpallial) telencephalic progenitors and the differentiation of cortical interneurons, regulating forebrain progenitor and interneuron heterogeneity. During corticogenesis in mice, SOX6 and SOX5 were largely mutually exclusively expressed in pallial and subpallial progenitors, respectively, and remained mutually exclusive in a reverse pattern in postmitotic neuronal progeny. Loss of SOX6 from pallial progenitors caused their inappropriate expression of normally subpallium-restricted developmental controls, conferring mixed dorsal-ventral identity. In postmitotic cortical interneurons, loss of SOX6 disrupted the differentiation and diversity of cortical interneuron subtypes, analogous to SOX5 control over cortical projection neuron development. These data indicate that SOX6 is a central regulator of both progenitor and cortical interneuron diversity during neocortical development.	[Azim, Eiman; Jabaudon, Denis; Fame, Ryann M.; Macklis, Jeffrey D.] Harvard Univ, Massachusetts Gen Hosp, Sch Med,Program Neurosci, Ctr Nervous Syst Repair,Dept Neurosurg, Boston, MA 02115 USA; [Azim, Eiman; Jabaudon, Denis; Fame, Ryann M.; Macklis, Jeffrey D.] Harvard Univ, Massachusetts Gen Hosp, Sch Med,Program Neurosci, Ctr Nervous Syst Repair,Dept Neurol, Boston, MA USA; [Azim, Eiman; Jabaudon, Denis; Fame, Ryann M.; Macklis, Jeffrey D.] Massachusetts Gen Hosp, Nayef Al Rodhan Labs, Boston, MA 02114 USA; [Azim, Eiman; Jabaudon, Denis; Fame, Ryann M.; Macklis, Jeffrey D.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Azim, Eiman; Jabaudon, Denis; Fame, Ryann M.; Macklis, Jeffrey D.] Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Fame, Ryann M.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Harvard University	Macklis, JD (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med,Program Neurosci, Ctr Nervous Syst Repair,Dept Neurosurg, Boston, MA 02115 USA.	jeffrey_macklis@hms.harvard.edu	Jabaudon, Denis/B-8802-2014	Jabaudon, Denis/0000-0003-2438-4769; Azim, Eiman/0000-0002-1015-1772; Fame, Ryann/0000-0002-8244-2624	US National Institutes of Health [NS49553, NS45523, NS41590, F31 NS060421]; Travis Roy Foundation; Spastic Paraplegia Foundation; Massachusetts Spinal Cord Injury research program; Harvard Stem Cell Institute; Swiss National Science Foundation; Holcim Foundation; National Science Foundation Graduate Research Fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS049553, R01NS045523, R37NS041590, F31NS060421, R01NS041590] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Travis Roy Foundation; Spastic Paraplegia Foundation; Massachusetts Spinal Cord Injury research program; Harvard Stem Cell Institute; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Holcim Foundation; National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank K. Billmers, A. Palmer, L. Pasquina, K. Quinn, D. Schuback, E. Sievert, A. Wheeler and T. Yamamoto for superb technical assistance, G. Fishell, R. BatistaBrito, G. Miyoshi, P. Arlotta, B. Molyneaux, H. Padmanabhan, F. Guillemot, Q. Ma, C. Cepko and L. Goodrich for helpful discussions and input, U. Berger for technical assistance with in situ hybridization, C. Lois, R. Hevner, V. Lefebvre, F. Guillemot, V. Pachnis and Y. Yanagawa for generously sharing mice, antibodies and reagents, and current and past members of our laboratory for helpful suggestions. This work was partially supported by grants from the US National Institutes of Health ( NS49553 and NS45523; additional infrastructure supported by NS41590), the Travis Roy Foundation, the Spastic Paraplegia Foundation, the Massachusetts Spinal Cord Injury research program, and the Harvard Stem Cell Institute to J. D. M., and by the Jane and Lee Seidman Fund for CNS Research, and the Emily and Robert Pearlstein Fund for Nervous System Repair. E. A. was partially supported by a US National Institutes of Health individual predoctoral National Research Service Award fellowship ( F31 NS060421). D. J. was partially supported by fellowships from the Swiss National Science Foundation and the Holcim Foundation. R. M. F. was partially supported by a National Science Foundation Graduate Research Fellowship.	Alcamo EA, 2008, NEURON, V57, P364, DOI 10.1016/j.neuron.2007.12.012; Arlotta P, 2005, NEURON, V45, P207, DOI 10.1016/j.neuron.2004.12.036; Armijo JA, 2002, REV NEUROLOGIA, V34, P409, DOI 10.33588/rn.3405.2001404; Ascoli GA, 2008, NAT REV NEUROSCI, V9, P557, DOI 10.1038/nrn2402; Batista-Brito R, 2008, CEREB CORTEX, V18, P2306, DOI 10.1093/cercor/bhm258; Britan A, 2006, SHOCK WAVES, V16, P1, DOI 10.1007/s00193-006-0019-0; Britanova O, 2008, NEURON, V57, P378, DOI 10.1016/j.neuron.2007.12.028; Butt SJB, 2008, NEURON, V59, P722, DOI 10.1016/j.neuron.2008.07.031; Butt SJB, 2005, NEURON, V48, P591, DOI 10.1016/j.neuron.2005.09.034; Carney RSE, 2006, J NEUROSCI, V26, P11562, DOI 10.1523/JNEUROSCI.3092-06.2006; CAVANAGH ME, 1988, J COMP NEUROL, V268, P1, DOI 10.1002/cne.902680102; CAVANAGH ME, 1990, J COMP NEUROL, V297, P553, DOI 10.1002/cne.902970408; Chen B, 2005, P NATL ACAD SCI USA, V102, P17184, DOI 10.1073/pnas.0508732102; Chen JG, 2005, P NATL ACAD SCI USA, V102, P17792, DOI 10.1073/pnas.0509032102; Cobos I, 2005, NAT NEUROSCI, V8, P1059, DOI 10.1038/nn1499; CONNOR F, 1995, NUCLEIC ACIDS RES, V23, P3365, DOI 10.1093/nar/23.17.3365; Corbin JG, 2001, NAT NEUROSCI, V4, P1177, DOI 10.1038/nn749; Du TG, 2008, DEVELOPMENT, V135, P1559, DOI 10.1242/dev.015123; Flames N, 2005, NEURON, V46, P377, DOI 10.1016/j.neuron.2005.04.020; Flames N, 2007, J NEUROSCI, V27, P9682, DOI 10.1523/JNEUROSCI.2750-07.2007; Fode C, 2000, GENE DEV, V14, P67; Fogarty M, 2007, J NEUROSCI, V27, P10935, DOI 10.1523/JNEUROSCI.1629-07.2007; Holm PC, 2007, MOL CELL NEUROSCI, V34, P99, DOI 10.1016/j.mcn.2006.10.008; Joshi PS, 2008, NEURON, V60, P258, DOI 10.1016/j.neuron.2008.08.006; Kwan KY, 2008, P NATL ACAD SCI USA, V105, P16021, DOI 10.1073/pnas.0806791105; Lai T, 2008, NEURON, V57, P232, DOI 10.1016/j.neuron.2007.12.023; Levitt P, 2004, TRENDS NEUROSCI, V27, P400, DOI 10.1016/j.tins.2004.05.008; Lewis DA, 2000, BRAIN RES REV, V31, P270, DOI 10.1016/S0165-0173(99)00042-9; Liodis P, 2007, J NEUROSCI, V27, P3078, DOI 10.1523/JNEUROSCI.3055-06.2007; Ma QF, 1997, J NEUROSCI, V17, P3644; Miyoshi G, 2007, J NEUROSCI, V27, P7786, DOI 10.1523/JNEUROSCI.1807-07.2007; Molnar Z, 2002, BIOESSAYS, V24, P530, DOI 10.1002/bies.10100; Molyneaux BJ, 2007, NAT REV NEUROSCI, V8, P427, DOI 10.1038/nrn2151; Narahara M, 2002, BIOL PHARM BULL, V25, P705, DOI 10.1248/bpb.25.705; Nobrega-Pereira S, 2008, NEURON, V59, P733, DOI 10.1016/j.neuron.2008.07.024; Parras CM, 2002, GENE DEV, V16, P324, DOI 10.1101/gad.940902; Puelles L, 2000, J COMP NEUROL, V424, P409, DOI 10.1002/1096-9861(20000828)424:3<409::AID-CNE3>3.0.CO;2-7; Rubenstein JLR, 2003, GENES BRAIN BEHAV, V2, P255, DOI 10.1034/j.1601-183X.2003.00037.x; Scardigli R, 2003, DEVELOPMENT, V130, P3269, DOI 10.1242/dev.00539; Schuurmans C, 2002, CURR OPIN NEUROBIOL, V12, P26, DOI 10.1016/S0959-4388(02)00286-6; Smits P, 2001, DEV CELL, V1, P277, DOI 10.1016/S1534-5807(01)00003-X; Stolt CC, 2006, DEV CELL, V11, P697, DOI 10.1016/j.devcel.2006.08.011; Tamamaki N, 2003, J COMP NEUROL, V467, P60, DOI 10.1002/cne.10905; Vega CJ, 2005, NAT METHODS, V2, P167, DOI 10.1038/NMETH741; Wegner M, 2005, TRENDS NEUROSCI, V28, P583, DOI 10.1016/j.tins.2005.08.008; Wegner M, 1999, NUCLEIC ACIDS RES, V27, P1409, DOI 10.1093/nar/27.6.1409; Wonders CP, 2008, DEV BIOL, V314, P127, DOI 10.1016/j.ydbio.2007.11.018; Wonders CP, 2006, NAT REV NEUROSCI, V7, P687, DOI 10.1038/nrn1954; Zhao Y, 2008, J COMP NEUROL, V510, P79, DOI 10.1002/cne.21772	49	142	144	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2009	12	10					1238	U51		10.1038/nn.2387	http://dx.doi.org/10.1038/nn.2387			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	498US	19657336	Green Submitted, Green Accepted			2022-12-24	WOS:000270170200012
J	de Nijs, L; Leon, C; Nguyen, L; LoTurco, JJ; Delgado-Escueta, AV; Grisar, T; Lakaye, B				de Nijs, Laurence; Leon, Christine; Nguyen, Laurent; LoTurco, Joseph J.; Delgado-Escueta, Antonio V.; Grisar, Thierry; Lakaye, Bernard			EFHC1 interacts with microtubules to regulate cell division and cortical development	NATURE NEUROSCIENCE			English	Article							JUVENILE MYOCLONIC EPILEPSY; NEURONAL MIGRATION; RNA INTERFERENCE; MITOTIC SPINDLE; CEREBRAL-CORTEX; GENERALIZED EPILEPSY; CYTOPLASMIC DYNEIN; NEOCORTEX; MUTATIONS; PROTEIN	Mutations in the EFHC1 gene are linked to juvenile myoclonic epilepsy (JME), one of the most frequent forms of idiopathic generalized epilepsies. JME is associated with subtle alterations of cortical and subcortical architecture, but the underlying pathological mechanism remains unknown. We found that EFHC1 is a microtubule-associated protein involved in the regulation of cell division. In vitro, EFHC1 loss of function disrupted mitotic spindle organization, impaired M phase progression, induced microtubule bundling and increased apoptosis. EFHC1 impairment in the rat developing neocortex by ex vivo and in utero electroporation caused a marked disruption of radial migration. We found that this effect was a result of cortical progenitors failing to exit the cell cycle and defects in the radial glia scaffold organization and in the locomotion of postmitotic neurons. Therefore, we propose that EFHC1 is a regulator of cell division and neuronal migration during cortical development and that disruption of its functions leads to JME.	[de Nijs, Laurence; Leon, Christine; Nguyen, Laurent; Grisar, Thierry; Lakaye, Bernard] Univ Liege, GIGA Neurosci, Liege, Belgium; [LoTurco, Joseph J.] Univ Connecticut, Dept Physiol & Neurobiol, Storrs, CT 06269 USA; [Delgado-Escueta, Antonio V.] Univ Calif Los Angeles, David Geffen Sch Med, Epilepsy Genet Genom Labs, Vet Affairs Greater Los Angeles Healthcare Syst, Los Angeles, CA USA	University of Liege; University of Connecticut; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System	Grisar, T (corresponding author), Univ Liege, GIGA Neurosci, Liege, Belgium.	tgrisar@ulg.ac.be	Nguyen, Laurent/E-9882-2016	Nguyen, Laurent/0000-0002-8560-3008; Delgado-Escueta, Antonio V./0000-0002-1581-6999	FNRS (Fonds de la Recherche Scientifique Medicale) [3.4565.03]; Leon Fredericq Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD055655, P01HD057853] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH056524] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055057] Funding Source: NIH RePORTER; Veterans Affairs [I01CX000743] Funding Source: NIH RePORTER	FNRS (Fonds de la Recherche Scientifique Medicale)(Fonds de la Recherche Scientifique - FNRS); Leon Fredericq Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Veterans Affairs(US Department of Veterans Affairs)	We thank B. Coumans for skillful technical assistance, J. Bai for help with in utero electroporation processing and S. Ormenese from the GIGA-Imaging and Flow Cytometry platform for support with flow cytometry. We are also grateful to A. Adamantidis for critical reading of the manuscript. We thank F. Polleux for the NeuroD-IRES-GFP plasmid. This work was supported by grants from the F. R. S.- FNRS (Fonds de la Recherche Scientifique Medicale 3.4565.03 to T. G. and B. L.) and the Leon Fredericq Foundation (to L. d. N.). L. N. and B. L. are research associates at the F. R. S.- FNRS.	Annesi F, 2007, EPILEPSIA, V48, P1686, DOI 10.1111/j.1528-1167.2007.01173.x; Aonuma M, 2005, CELL STRUCT FUNCT, V30, P7, DOI 10.1247/csf.30.7; Bai JL, 2003, NAT NEUROSCI, V6, P1277, DOI 10.1038/nn1153; Corbo JC, 2002, J NEUROSCI, V22, P7548; Cossette P, 2002, NAT GENET, V31, P184, DOI 10.1038/ng885; de Nijs L, 2006, EXP CELL RES, V312, P2872, DOI 10.1016/j.yexcr.2006.05.011; Delgado-Escueta A V, 1999, Adv Neurol, V79, P351; Delgado-Escueta Antonio V, 2007, Epilepsy Curr, V7, P61, DOI 10.1111/j.1535-7511.2007.00171.x; DELGADOESCUETA AV, 1984, NEUROLOGY, V34, P285, DOI 10.1212/WNL.34.3.285; Faulkner NE, 2000, NAT CELL BIOL, V2, P784, DOI 10.1038/35041020; Feng YY, 2004, NEURON, V44, P279, DOI 10.1016/j.neuron.2004.09.023; Grisar T, 2006, NEUROPHYSIOL CLIN, V36, P271, DOI 10.1016/j.neucli.2006.11.002; Gupta A, 2002, NAT REV GENET, V3, P342, DOI 10.1038/nrg799; Halfter W, 2002, J NEUROSCI, V22, P6029; Hand R, 2005, NEURON, V48, P45, DOI 10.1016/j.neuron.2005.08.032; Hartfuss E, 2003, DEVELOPMENT, V130, P4597, DOI 10.1242/dev.00654; Haug K, 2003, NAT GENET, V33, P527, DOI 10.1038/ng1121; Heng JIT, 2008, NATURE, V455, P114, DOI 10.1038/nature07198; Ikeda T, 2005, FEBS LETT, V579, P819, DOI 10.1016/j.febslet.2004.12.070; King SM, 2006, CELL MOTIL CYTOSKEL, V63, P245, DOI 10.1002/cm.20129; Kowalczyk T, 2009, CEREB CORTEX, V19, P2439, DOI 10.1093/cercor/bhn260; LoTurco JJ, 2006, TRENDS NEUROSCI, V29, P407, DOI 10.1016/j.tins.2006.05.006; Ma SC, 2006, EPILEPSY RES, V71, P129, DOI 10.1016/j.eplepsyres.2006.06.001; Martinez-Lopez MJ, 2005, MOL CELL NEUROSCI, V28, P599, DOI 10.1016/j.mcn.2004.09.016; Medina MT, 2008, NEUROLOGY, V70, P2137, DOI 10.1212/01.wnl.0000313149.73035.99; MEENCKE HJ, 1984, EPILEPSIA, V25, P8, DOI 10.1111/j.1528-1157.1984.tb04149.x; Nadarajah B, 2002, NAT REV NEUROSCI, V3, P423, DOI 10.1038/nrn845; Nguyen L, 2006, GENE DEV, V20, P1511, DOI 10.1101/gad.377106; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Ohnuma S, 2003, NEURON, V40, P199, DOI 10.1016/S0896-6273(03)00632-9; Pontious A, 2008, DEV NEUROSCI-BASEL, V30, P24, DOI 10.1159/000109848; RAKIC P, 1972, J COMP NEUROL, V145, P61, DOI 10.1002/cne.901450105; Ramos RL, 2006, CEREB CORTEX, V16, P1323, DOI 10.1093/cercor/bhj074; Roegiers F, 2004, CURR OPIN CELL BIOL, V16, P195, DOI 10.1016/j.ceb.2004.02.010; Saffin JM, 2005, P NATL ACAD SCI USA, V102, P11302, DOI 10.1073/pnas.0500964102; Shu TZ, 2004, NEURON, V44, P263, DOI 10.1016/j.neuron.2004.09.030; Shu TZ, 2006, NEURON, V49, P25, DOI 10.1016/j.neuron.2005.10.039; Stogmann E, 2006, NEUROLOGY, V67, P2029, DOI 10.1212/01.wnl.0000250254.67042.1b; Suzuki T, 2004, NAT GENET, V36, P842, DOI 10.1038/ng1393; Suzuki T, 2008, BIOCHEM BIOPH RES CO, V367, P226, DOI 10.1016/j.bbrc.2007.12.126; Suzuki T, 2009, HUM MOL GENET, V18, P1099, DOI 10.1093/hmg/ddp006; Tanaka T, 2004, J CELL BIOL, V165, P709, DOI 10.1083/jcb.200309025; Tsai JW, 2005, J CELL BIOL, V170, P935, DOI 10.1083/jcb.200505166; Tsai LH, 2005, NEURON, V46, P383, DOI 10.1016/j.neuron.2005.04.013; Wakefield JG, 2003, J CELL SCI, V116, P637, DOI 10.1242/jcs.00273; Woermann FG, 1999, BRAIN, V122, P2101, DOI 10.1093/brain/122.11.2101; Yamashita YM, 2003, SCIENCE, V301, P1547, DOI 10.1126/science.1087795; Yingling J, 2008, CELL, V132, P474, DOI 10.1016/j.cell.2008.01.026; Young-Pearse TL, 2007, J NEUROSCI, V27, P14459, DOI 10.1523/JNEUROSCI.4701-07.2007	50	58	59	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2009	12	10					1266	U84		10.1038/nn.2390	http://dx.doi.org/10.1038/nn.2390			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	498US	19734894				2022-12-24	WOS:000270170200015
J	Oesch, N; Diamond, J				Oesch, Nicholas; Diamond, Jeffrey			A night vision neuron gets a day job	NATURE NEUROSCIENCE			English	Editorial Material							INNER PLEXIFORM LAYER; AII AMACRINE CELLS; MOUSE RETINA; GANGLION-CELLS; RABBIT RETINA; DEPOLARIZING BIPOLAR; CAT RETINA; ROD; RESPONSES; PATHWAY	During the day, certain retinal ganglion cells respond specifically to dark, approaching stimuli. A study finds that the retinal circuit that gives rise to this response makes use of an amacrine cell that was previously known for its role in night vision circuitry, demonstrating that some neurons lead double lives.	[Oesch, Nicholas; Diamond, Jeffrey] US Natl Inst Neurol Disorders & Stroke, US Natl Inst Hlth, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Oesch, N (corresponding author), US Natl Inst Neurol Disorders & Stroke, US Natl Inst Hlth, Bethesda, MD USA.	diamondj@ninds.nih.gov		Oesch, Nicholas/0000-0001-6972-0741	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003039] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		DACHEUX RF, 1986, J NEUROSCI, V6, P331; Dedek K, 2009, EUR J NEUROSCI, V30, P217, DOI 10.1111/j.1460-9568.2009.06808.x; FAMIGLIETTI EV, 1975, BRAIN RES, V84, P293, DOI 10.1016/0006-8993(75)90983-X; KOLB H, 1974, SCIENCE, V186, P47, DOI 10.1126/science.186.4158.47; KOLB H, 1979, J NEUROCYTOL, V8, P295, DOI 10.1007/BF01236124; Manookin MB, 2008, J NEUROSCI, V28, P4136, DOI 10.1523/JNEUROSCI.4274-07.2008; MCGUIRE BA, 1986, J NEUROSCI, V6, P907; Munch TA, 2009, NAT NEUROSCI, V12, P1308, DOI 10.1038/nn.2389; Murphy GJ, 2008, NAT NEUROSCI, V11, P318, DOI 10.1038/nn2045; Pang JJ, 2007, J PHYSIOL-LONDON, V580, P397, DOI 10.1113/jphysiol.2006.120790; Pang JJ, 2004, J PHYSIOL-LONDON, V558, P897, DOI 10.1113/jphysiol.2003.059543; STRETTOI E, 1992, J COMP NEUROL, V325, P152, DOI 10.1002/cne.903250203; Van Wyk M, 2009, VISUAL NEUROSCI, V26, P297, DOI 10.1017/S0952523809990137; Xin DY, 1999, VISUAL NEUROSCI, V16, P653, DOI 10.1017/S0952523899164058	14	4	4	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2009	12	10					1209	1211		10.1038/nn1009-1209	http://dx.doi.org/10.1038/nn1009-1209			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	498US	19783975				2022-12-24	WOS:000270170200002
J	Mandai, K; Guo, T; Hillaire, CS; Meabon, JS; Kanning, KC; Bothwell, M; Ginty, DD				Mandai, Kenji; Guo, Ting; Hillaire, Coryse St.; Meabon, James S.; Kanning, Kevin C.; Bothwell, Mark; Ginty, David D.			LIG Family Receptor Tyrosine Kinase-Associated Proteins Modulate Growth Factor Signals during Neural Development	NEURON			English	Article							DORSAL-ROOT GANGLIA; BAX-DEFICIENT MICE; SENSORY NEURONS; TARGET INNERVATION; NEGATIVE REGULATOR; GDNF FAMILY; MOTOR; GENE; SURVIVAL; LRIG1	Genome-wide screens were performed to identify transmembrane proteins that mediate axonal growth, guidance and target field innervation of somatosensory neurons. One gene, Linx (alias lslr2), encoding a leucine-rich repeat and immunoglobulin (LIG) family protein, is expressed in a subset of developing sensory and motor neurons. Domain and genomic structures of Linx and other LIG family members suggest that they are evolutionarily related to Trk receptor tyrosine kinases (RTKs). Several LIGs, including Linx, are expressed in subsets of somatosensory and motor neurons, and select members interact with TrkA and Ret RTKs. Moreover, axonal projection defects in mice harboring a null mutation in Linx resemble those in mice lacking Ngf, TrkA, and Ret. In addition, Linx modulates NGF-TrkA- and GDNF-GFR alpha 1/Ret-mediated axonal extension in cultured sensory and motor neurons, respectively. These findings show that LIGs physically interact with RTKs and modulate their activities to control axonal extension, guidance and branching.	[Mandai, Kenji; Guo, Ting; Hillaire, Coryse St.; Ginty, David D.] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA; [Meabon, James S.; Kanning, Kevin C.; Bothwell, Mark] Univ Washington, Sch Med, Dept Physiol & Biophys, Seattle, WA 98195 USA	Howard Hughes Medical Institute; Johns Hopkins University; University of Washington; University of Washington Seattle	Ginty, DD (corresponding author), Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Solomon H Snyder Dept Neurosci, 725 N Wolfe St,PCTB 1015, Baltimore, MD 21205 USA.	dginty@jhmi.edu		Mandai, Kenji/0000-0002-0115-6635; Bothwell, Mark/0000-0001-5423-2702	National Institutes of Health [NS34814, NS47348]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034814, R01NS047348, R37NS034814, R29NS034814] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Dr. Frank Rice and members of the Ginty laboratory for helpful discussions and comments on this manuscript. We thank Christopher Deppmann, Nikhil Sharma, Wenqin Luo, Joseph Savitt, Qingguang Jiang, Anthony Harrington, and Michael Rutlin for reagents, technical support, and valuable comments; Narendrakumar Ramanan for help with targeting vector design; Dorothy Reimert for ES cell work; Charles Hawkins and the Johns Hopkins Transgenic Facility for blastocyst injections; Francisco Marifnez-Murillo, Chunfa Jie, and the Johns Hopkins Microarray Core Facility for microarray analysis. This work was supported by National Institutes of Health grants NS34814 (D.D.G.) and NS47348 (M.B). D.D.G. is an investigator of the Howard Hughes Medical Institute.	Airaksinen MS, 2002, NAT REV NEUROSCI, V3, P383, DOI 10.1038/nrn812; Airaksinen MS, 1996, NEURON, V16, P287, DOI 10.1016/S0896-6273(00)80047-1; Akopian AN, 1996, NATURE, V379, P257, DOI 10.1038/379257a0; Baloh RH, 2000, CURR OPIN NEUROBIOL, V10, P103, DOI 10.1016/S0959-4388(99)00048-3; Bennett DLH, 1998, J NEUROSCI, V18, P3059; Chen CL, 2006, NEURON, V49, P365, DOI 10.1016/j.neuron.2005.10.036; CROWLEY C, 1994, CELL, V76, P1001, DOI 10.1016/0092-8674(94)90378-6; ERNFORS P, 1994, CELL, V77, P503, DOI 10.1016/0092-8674(94)90213-5; Fu QL, 2008, INVEST OPHTH VIS SCI, V49, P975, DOI 10.1167/iovs.07-1199; Gallarda BW, 2008, SCIENCE, V320, P233, DOI 10.1126/science.1153758; Garces A, 2000, J NEUROSCI, V20, P4992; Gejima R, 2006, GENE EXPR PATTERNS, V6, P235, DOI 10.1016/j.modgep.2005.08.005; Gould TW, 2008, J NEUROSCI, V28, P2131, DOI 10.1523/JNEUROSCI.5185-07.2008; Gur G, 2004, EMBO J, V23, P3270, DOI 10.1038/sj.emboj.7600342; Hedman H, 2007, EUR J CANCER, V43, P676, DOI 10.1016/j.ejca.2006.10.021; Helmbacher F, 2000, DEVELOPMENT, V127, P3313; HIGGINS DG, 1992, COMPUT APPL BIOSCI, V8, P189; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Huber AB, 2005, NEURON, V48, P949, DOI 10.1016/j.neuron.2005.12.003; Inoue H, 2007, P NATL ACAD SCI USA, V104, P14430, DOI 10.1073/pnas.0700901104; Kim S, 2006, NAT NEUROSCI, V9, P1294, DOI 10.1038/nn1763; KNUDSON CM, 1995, SCIENCE, V270, P96, DOI 10.1126/science.270.5233.96; Kramer ER, 2006, NEURON, V50, P35, DOI 10.1016/j.neuron.2006.02.020; Kramer I, 2006, NEURON, V49, P379, DOI 10.1016/j.neuron.2006.01.008; Kuja-Panula J, 2003, J CELL BIOL, V160, P963, DOI 10.1083/jcb.200209074; Laederich MB, 2004, J BIOL CHEM, V279, P47050, DOI 10.1074/jbc.M409703200; Ledda F, 2008, J NEUROSCI, V28, P39, DOI 10.1523/JNEUROSCI.2196-07.2008; Lentz SI, 1999, J NEUROSCI, V19, P1038; Lin JC, 2003, NAT NEUROSCI, V6, P1270, DOI 10.1038/nn1148; Lin JH, 1998, CELL, V95, P393, DOI 10.1016/S0092-8674(00)81770-5; Luo WQ, 2007, NEURON, V54, P739, DOI 10.1016/j.neuron.2007.04.027; MacLaren CM, 2004, DEV GENES EVOL, V214, P360, DOI 10.1007/s00427-004-0414-4; Markus A, 2002, CURR OPIN NEUROBIOL, V12, P523, DOI 10.1016/S0959-4388(02)00372-0; Marmigere F, 2006, NAT NEUROSCI, V9, P180, DOI 10.1038/nn1631; Meijering E, 2004, CYTOM PART A, V58A, P167, DOI 10.1002/cyto.a.20022; Mi S, 2004, NAT NEUROSCI, V7, P221, DOI 10.1038/nn1188; Moqrich A, 2004, NAT NEUROSCI, V7, P812, DOI 10.1038/nn1283; MU XJ, 1993, J NEUROSCI, V13, P4029; Nagasawa A, 1997, GENOMICS, V44, P273, DOI 10.1006/geno.1997.4889; Ono T, 2003, J NEUROSCI, V23, P5887; Paratcha G, 2008, TRENDS NEUROSCI, V31, P384, DOI 10.1016/j.tins.2008.05.003; Patel TD, 2000, NEURON, V25, P345, DOI 10.1016/S0896-6273(00)80899-5; Patel TD, 2003, NEURON, V38, P403, DOI 10.1016/S0896-6273(03)00261-7; POVLSEN B, 1994, ANAT EMBRYOL, V189, P393; Segal RA, 2003, ANNU REV NEUROSCI, V26, P299, DOI 10.1146/annurev.neuro.26.041002.131421; Shattuck DL, 2007, MOL CELL BIOL, V27, P1934, DOI 10.1128/MCB.00757-06; SMEYNE RJ, 1994, NATURE, V368, P246, DOI 10.1038/368246a0; TESSAROLLO L, 1994, P NATL ACAD SCI USA, V91, P11844, DOI 10.1073/pnas.91.25.11844; Tran TS, 2007, ANNU REV CELL DEV BI, V23, P263, DOI 10.1146/annurev.cellbio.22.010605.093554; White FA, 1998, J NEUROSCI, V18, P1428; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; Wickramasinghe SR, 2008, NEURON, V58, P532, DOI 10.1016/j.neuron.2008.03.006; Wu MH, 2006, MOL BIOL CELL, V17, P3534, DOI 10.1091/mbc.E05-11-1082; Zhao H, 2008, DEVELOPMENT, V135, P1283, DOI 10.1242/dev.015073	54	62	63	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 10	2009	63	5					614	627		10.1016/j.neuron.2009.07.031	http://dx.doi.org/10.1016/j.neuron.2009.07.031			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	494XH	19755105	Bronze, Green Accepted			2022-12-24	WOS:000269852300009
J	Lacoste, A; Berenshteyn, F; Brivanlou, AH				Lacoste, Arnaud; Berenshteyn, Frada; Brivanlou, Ali H.			An Efficient and Reversible Transposable System for Gene Delivery and Lineage-Specific Differentiation in Human Embryonic Stem Cells	CELL STEM CELL			English	Article							STABLE TRANSGENE EXPRESSION; PIGGYBAC TRANSPOSON; BACULOVIRUS GENOME; LENTIVIRAL VECTORS; HUMAN BLASTOCYSTS; IN-VITRO; MOUSE; EXCISION; DNA; PLURIPOTENCY	Unraveling the therapeutic potential of human embryonic stem cells (hESC) requires tools to modify their genome. We have engineered the PiggyBac transposable element to create an efficient system for gene delivery in hESCs. This redesigned system, named "ePiggyBac," can deliver up to 18 Kb inserts, and transgene expression is observed in almost 90% of hES cells. ePiggyBac transposons can also carry insulators, inducible expression cassettes, and short hairpin RNAs for gain-and loss-of-function approaches. In hES cells, ePiggyBac's efficiency is superior to that of viral vectors and previously described transposons, including other PiggyBac-based systems. In addition, ePiggyBac transgenes can be removed from the hESC genome without leaving any mutation. We used this system to direct hESC differentiation toward a neuronal phenotype. We then removed the transposons to obtain transgene-free neuronal precursors and neurons. The ability to create fully reversible genetic modifications represents an important step toward clinical applications of hESCs.	[Lacoste, Arnaud; Berenshteyn, Frada; Brivanlou, Ali H.] Rockefeller Univ, Mol Embryol Lab, New York, NY 10021 USA	Rockefeller University	Brivanlou, AH (corresponding author), Rockefeller Univ, Mol Embryol Lab, 1230 York Ave, New York, NY 10021 USA.	brvnlou@rockefeller.edu	Wilson, Matthew H/K-3193-2013		Rockefeller University; Starr foundation; NIH [5RO1 GM073379]; Emerald Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073379] Funding Source: NIH RePORTER	Rockefeller University; Starr foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Emerald Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. Scott A. Noggle for advice during the design of the experiments and Shalini Jaiswal for outstanding technical assistance. This work was supported by private funding from The Rockefeller University, The Starr foundation, NIH grant 5RO1 GM073379 (for work on hESC lines H1 and BGN1) to A. H. B., and by a grant from the Emerald Foundation to A. L.	Ben-Dor I, 2006, MOL THER, V14, P255, DOI 10.1016/j.ymthe.2006.02.010; Braam SR, 2008, NAT METHODS, V5, P389, DOI 10.1038/NMETH.1200; BRUNAK S, 1991, J MOL BIOL, V220, P49, DOI 10.1016/0022-2836(91)90380-O; Cadinanos J, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm446; CARY LC, 1989, VIROLOGY, V172, P156, DOI 10.1016/0042-6822(89)90117-7; Cowan CA, 2004, NEW ENGL J MED, V350, P1353, DOI 10.1056/NEJMsr040330; Ding S, 2005, CELL, V122, P473, DOI 10.1016/j.cell.2005.07.013; Elick TA, 1996, GENETICA, V98, P33, DOI 10.1007/BF00120216; FRASER MJ, 1995, VIROLOGY, V211, P397, DOI 10.1006/viro.1995.1422; Fraser MJ, 1996, INSECT MOL BIOL, V5, P141, DOI 10.1111/j.1365-2583.1996.tb00048.x; Gerrard L, 2005, STEM CELLS, V23, P124, DOI 10.1634/stemcells.2004-0102; James D, 2006, DEV BIOL, V295, P90, DOI 10.1016/j.ydbio.2006.03.026; Kaji K, 2009, NATURE, V458, P771, DOI 10.1038/nature07864; Li X, 2005, INSECT MOL BIOL, V14, P17, DOI 10.1111/j.1365-2583.2004.00525.x; Maragathavally KJ, 2006, FASEB J, V20, P1880, DOI 10.1096/fj.05-5485fje; McCarty DM, 2004, ANNU REV GENET, V38, P819, DOI 10.1146/annurev.genet.37.110801.143717; Metcalf WW, 1996, PLASMID, V35, P1, DOI 10.1006/plas.1996.0001; Mitalipova M, 2003, STEM CELLS, V21, P521, DOI 10.1634/stemcells.21-5-521; Pfeifer A, 2002, P NATL ACAD SCI USA, V99, P2140, DOI 10.1073/pnas.251682798; Recillas-Targa F, 2002, P NATL ACAD SCI USA, V99, P6883, DOI 10.1073/pnas.102179399; Siemen H, 2005, STEM CELLS DEV, V14, P378, DOI 10.1089/scd.2005.14.378; Silva JM, 2005, NAT GENET, V37, P1281, DOI 10.1038/ng1650; THOMSON JA, 1995, P NATL ACAD SCI USA, V92, P7844, DOI 10.1073/pnas.92.17.7844; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Thyagarajan B, 2008, STEM CELLS, V26, P119, DOI 10.1634/stemcells.2007-0283; Wang W, 2008, P NATL ACAD SCI USA, V105, P9290, DOI 10.1073/pnas.0801017105; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Wilber A, 2007, STEM CELLS, V25, P2919, DOI 10.1634/stemcells.2007-0026; Wilson MH, 2007, MOL THER, V15, P139, DOI 10.1038/sj.mt.6300028; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863; Yin B, 2007, BIOTECHNIQUES, V43, P79, DOI 10.2144/000112474; Yusa K, 2009, NAT METHODS, V6, P363, DOI [10.1038/NMETH.1323, 10.1038/nmeth.1323]; Zeng JM, 2007, STEM CELLS, V25, P1055, DOI 10.1634/stemcells.2006-0616; Zhang SC, 2001, NAT BIOTECHNOL, V19, P1129, DOI 10.1038/nbt1201-1129	34	117	128	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	SEP 4	2009	5	3					332	342		10.1016/j.stem.2009.07.011	http://dx.doi.org/10.1016/j.stem.2009.07.011			11	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	529VA	19733544	Bronze			2022-12-24	WOS:000272545700019
J	Lugert, S; Basak, O; Knuckles, P; Haussler, U; Fabel, K; Gotz, M; Haas, CA; Kempermann, G; Taylor, V; Giachino, C				Lugert, Sebastian; Basak, Onur; Knuckles, Philip; Haussler, Ute; Fabel, Klaus; Goetz, Magdalena; Haas, Carola A.; Kempermann, Gerd; Taylor, Verdon; Giachino, Claudio			Quiescent and Active Hippocampal Neural Stem Cells with Distinct Morphologies Respond Selectively to Physiological and Pathological Stimuli and Aging	CELL STEM CELL			English	Article							DENTATE GYRUS; STEM/PROGENITOR CELLS; INDUCED NEUROGENESIS; PHYSICAL-ACTIVITY; PRECURSOR CELLS; NEURONAL FATE; OLD-AGE; ADULT; PROLIFERATION; NOTCH1	New neurons are generated in the adult hippocampus throughout life by neural stem/progenitor cells (NSCs), and neurogenesis is a plastic process responsive to external stimuli. We show that canonical Notch signaling through RBP-J is required for hippocampal neurogenesis. Notch signaling distinguishes morphologically distinct Sox2(+) NSCs, and within these pools subpopulations can shuttle between mitotically active or quiescent. Radial and horizontal NSCs respond selectively to neurogenic stimuli. Physical exercise activates the quiescent radial population whereas epileptic seizures induce expansion of the horizontal NSC pool. Surprisingly, reduced neurogenesis correlates with a loss of active horizontal NSCs in aged mice rather than a total loss of stem cells, and the transition to a quiescent state is reversible to rejuvenate neurogenesis in the brain. The discovery of multiple NSC populations with Notch dependence but selective responses to stimuli and reversible quiescence has important implications for the mechanisms of adaptive learning and also for regenerative therapy.	[Lugert, Sebastian; Basak, Onur; Knuckles, Philip; Taylor, Verdon; Giachino, Claudio] Max Planck Inst Immunobiol, Dept Mol Embryol, D-79108 Freiburg, Germany; [Haussler, Ute; Haas, Carola A.] Univ Freiburg, Neuroctr, D-79106 Freiburg, Germany; [Fabel, Klaus; Kempermann, Gerd] Ctr Regenerat Therapies Dresden, D-01307 Dresden, Germany; [Goetz, Magdalena] Helmholtz Zentrum Munchen, Inst Stem Cell Res, D-85764 Munich, Germany; [Goetz, Magdalena] Univ Munich, Inst Physiol, Dept Physiol Genom, D-80336 Munich, Germany; [Taylor, Verdon] Univ Sheffield, Dept Biomed Sci, Ctr Stem Cell Biol, Sheffield S10 2TN, S Yorkshire, England	Max Planck Society; University of Freiburg; Technische Universitat Dresden; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; University of Sheffield	Taylor, V (corresponding author), Max Planck Inst Immunobiol, Dept Mol Embryol, Stubeweg 51, D-79108 Freiburg, Germany.	taylor@immunbio.mpg.de	Häussler, Ute/GPF-8944-2022; Kempermann, Gerd/F-5416-2010; Basak, Onur/GLV-6113-2022	Kempermann, Gerd/0000-0002-5304-4061; Basak, Onur/0000-0002-6864-3403; GIACHINO, Claudio/0000-0002-8332-0899; Haussler, Ute/0000-0001-5601-9833; Taylor, Verdon/0000-0003-3497-5976; Knuckles, Philip/0000-0001-5254-8244	Deutsche Forschungsgemeinschaft [SPP1109, TA-310-1, TA-310-2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank Drs. T. Honjo and P. Soriano for mice, S. Jessberger and J. Gilthorpe for comments on the manuscript, members of the Taylor lab for helpful discussions, and Frank Sager for excellent technical assistance. S.L. and P.K. are IMPRS-MCB PhD students of the Faculty of Biology, University of Freiburg, Germany. This work was supported by the Deutsche Forschungsgemeinschaft (SPP1109; TA-310-1; TA-310-2).	Amrein I, 2009, BIOL LETTERS, V5, P141, DOI 10.1098/rsbl.2008.0511; Androutsellis-Theotokis A, 2006, NATURE, V442, P823, DOI 10.1038/nature04940; Babu H, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000388; Basak O, 2007, EUR J NEUROSCI, V25, P1006, DOI 10.1111/j.1460-9568.2007.05370.x; Ben Abdallah NMB, 2010, NEUROBIOL AGING, V31, P151, DOI 10.1016/j.neurobiolaging.2008.03.002; Breunig JJ, 2007, P NATL ACAD SCI USA, V104, P20558, DOI 10.1073/pnas.0710156104; Carlson ME, 2008, NATURE, V454, P528, DOI 10.1038/nature07034; Clelland CD, 2009, SCIENCE, V325, P210, DOI 10.1126/science.1173215; COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; delaPompa J, 1997, DEVELOPMENT, V124, P1139; Doetsch F, 1999, P NATL ACAD SCI USA, V96, P11619, DOI 10.1073/pnas.96.20.11619; Fabel K, 2008, NEUROMOL MED, V10, P59, DOI 10.1007/s12017-008-8031-4; Favaro R, 2009, NAT NEUROSCI, V12, P1248, DOI 10.1038/nn.2397; Filippov V, 2003, MOL CELL NEUROSCI, V23, P373, DOI 10.1016/S1044-7431(03)00060-5; Garthe A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005464; Hattiangady B, 2008, AGING CELL, V7, P207, DOI 10.1111/j.1474-9726.2007.00363.x; Hattiangady B, 2008, NEUROBIOL AGING, V29, P129, DOI 10.1016/j.neurobiolaging.2006.09.015; Huttmann K, 2003, EUR J NEUROSCI, V18, P2769, DOI 10.1111/j.1460-9568.2003.03002.x; Jessberger S, 2005, EXP NEUROL, V196, P342, DOI 10.1016/j.expneurol.2005.08.010; Kempermann G, 1998, J NEUROSCI, V18, P3206; Kempermann G, 2004, TRENDS NEUROSCI, V27, P447, DOI 10.1016/j.tins.2004.05.013; Kempermann G, 2002, ANN NEUROL, V52, P135, DOI 10.1002/ana.10262; Kim EJ, 2008, MOL CELL NEUROSCI, V38, P595, DOI 10.1016/j.mcn.2008.05.008; Kronenberg G, 2003, J COMP NEUROL, V467, P455, DOI 10.1002/cne.10945; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Kuwabara T, 2009, NAT NEUROSCI, V12, P1097, DOI 10.1038/nn.2360; Leung CT, 2007, NAT NEUROSCI, V10, P720, DOI 10.1038/nn1882; Louvi A, 2006, NAT REV NEUROSCI, V7, P93, DOI 10.1038/nrn1847; LUMBAR T, 2004, SCIENCE, V303, P359; Lutolf S, 2002, DEVELOPMENT, V129, P373; Mizutani K, 2007, NATURE, V449, P351, DOI 10.1038/nature06090; Mumm JS, 2000, DEV BIOL, V228, P151, DOI 10.1006/dbio.2000.9960; Parent JM, 2008, EPILEPSIA, V49, P19, DOI 10.1111/j.1528-1167.2008.01634.x; Parent JM, 2007, PROG BRAIN RES, V163, P529, DOI 10.1016/S0079-6123(07)63028-3; Petrus DS, 2009, EUR J NEUROSCI, V29, P244, DOI 10.1111/j.1460-9568.2008.06579.x; Rao MS, 2005, EUR J NEUROSCI, V21, P464, DOI 10.1111/j.1460-9568.2005.03853.x; Rao MS, 2008, HIPPOCAMPUS, V18, P931, DOI 10.1002/hipo.20449; Roybon L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004779; Scharfman HE, 2007, EPILEPSIA, V48, P33, DOI 10.1111/j.1528-1167.2007.01065.x; Seri B, 2001, J NEUROSCI, V21, P7153, DOI 10.1523/JNEUROSCI.21-18-07153.2001; Sestan N, 1999, SCIENCE, V286, P741, DOI 10.1126/science.286.5440.741; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; Sibbe M, 2009, J NEUROSCI, V29, P8578, DOI 10.1523/JNEUROSCI.0958-09.2009; Steiner B, 2008, NEUROSCIENCE, V154, P521, DOI 10.1016/j.neuroscience.2008.04.023; Steiner B, 2006, GLIA, V54, P805, DOI 10.1002/glia.20407; Stump G, 2002, MECH DEVELOP, V114, P153, DOI 10.1016/S0925-4773(02)00043-6; Suh H, 2007, CELL STEM CELL, V1, P515, DOI 10.1016/j.stem.2007.09.002; van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427; van Praag H, 2005, J NEUROSCI, V25, P8680, DOI 10.1523/JNEUROSCI.1731-05.2005; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	52	499	515	0	47	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAY 7	2010	6	5					445	456		10.1016/j.stem.2010.03.017	http://dx.doi.org/10.1016/j.stem.2010.03.017			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	598NO	20452319	Bronze			2022-12-24	WOS:000277844800012
J	Peters, J; Buchel, C				Peters, Jan; Buechel, Christian			Episodic Future Thinking Reduces Reward Delay Discounting through an Enhancement of Prefrontal-Mediotemporal Interactions	NEURON			English	Article							DECISION-MAKING; BASOLATERAL AMYGDALA; ORBITOFRONTAL CORTEX; LOBE CONTRIBUTIONS; IMPULSIVE CHOICE; SUBJECTIVE VALUE; PARIETAL CORTEX; HIPPOCAMPAL; MEMORY; RATS	Humans discount the value of future rewards over time. Here we show using functional magnetic resonance imaging (fMRI) and neural coupling analyses that episodic future thinking reduces the rate of delay discounting through a modulation of neural decision-making and episodic future thinking networks. In addition to a standard control condition, real subject-specific episodic event cues were presented during a delay discounting task. Spontaneous episodic imagery during cue processing predicted how much subjects changed their preferences toward more future-minded choice behavior. Neural valuation signals in the anterior cingulate cortex and functional coupling of this region with hippocampus and amygdala predicted the degree to which future thinking modulated individual preference functions. A second experiment replicated the behavioral effects and ruled out alternative explanations such as date-based processing and temporal focus. The present data reveal a mechanism through which neural decision-making and prospection networks can interact to generate future-minded choice behavior.	[Peters, Jan; Buechel, Christian] Univ Med Ctr Hamburg Eppendorf, Dept Syst Neurosci, D-20246 Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf	Peters, J (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Syst Neurosci, D-20246 Hamburg, Germany.	j.peters@uke.uni-hamburg.de	Peters, Jan/V-2910-2019; Peters, Jan/GWC-6713-2022	Peters, Jan/0000-0002-0195-5357; Peters, Jan/0000-0002-0195-5357				Addis DR, 2007, NEUROPSYCHOLOGIA, V45, P1363, DOI 10.1016/j.neuropsychologia.2006.10.016; Addis DR, 2009, NEUROPSYCHOLOGIA, V47, P2222, DOI 10.1016/j.neuropsychologia.2008.10.026; Bar M, 2009, PHILOS T R SOC B, V364, P1235, DOI 10.1098/rstb.2008.0310; Beauducel A, 2003, DIAGNOSTICA, V49, P61, DOI 10.1026//0012-1924.49.2.61; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Bechara A, 1999, J NEUROSCI, V19, P5473; Boyer P, 2008, TRENDS COGN SCI, V12, P219, DOI 10.1016/j.tics.2008.03.003; Cabeza R, 2008, NAT REV NEUROSCI, V9, P613, DOI 10.1038/nrn2459; Camus M, 2009, EUR J NEUROSCI, V30, P1980, DOI 10.1111/j.1460-9568.2009.06991.x; Carmichael ST, 1995, J COMP NEUROL, V363, P615, DOI 10.1002/cne.903630408; CARVER CS, 1994, J PERS SOC PSYCHOL, V67, P319, DOI 10.1037/0022-3514.67.2.319; Cheung THC, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-36; De Martino B, 2006, SCIENCE, V313, P684, DOI 10.1126/science.1128356; Dorris MC, 2004, NEURON, V44, P365, DOI 10.1016/j.neuron.2004.09.009; Ersner-Hershfield H, 2009, SOC COGN AFFECT NEUR, V4, P85, DOI 10.1093/scan/nsn042; Figner B, 2010, NAT NEUROSCI, V13, P538, DOI 10.1038/nn.2516; Floresco SB, 2007, CEREB CORTEX, V17, P251, DOI 10.1093/cercor/bhj143; Friston KJ, 1997, NEUROIMAGE, V6, P218, DOI 10.1006/nimg.1997.0291; Ghods-Sharifi S, 2009, J NEUROSCI, V29, P5251, DOI 10.1523/JNEUROSCI.0315-09.2009; Green L, 1997, MEM COGNITION, V25, P715, DOI 10.3758/BF03211314; Green L, 2004, PSYCHOL BULL, V130, P769, DOI 10.1037/0033-2909.130.5.769; Gupta R, 2009, NEUROPSYCHOLOGIA, V47, P1686, DOI 10.1016/j.neuropsychologia.2009.02.007; Hare TA, 2009, SCIENCE, V324, P646, DOI 10.1126/science.1168450; Hassabis D, 2007, P NATL ACAD SCI USA, V104, P1726, DOI 10.1073/pnas.0610561104; Ishikawa A, 2006, J NEUROPHYSIOL, V96, P2134, DOI 10.1152/jn.00069.2006; Johnson A, 2007, CURR OPIN NEUROBIOL, V17, P692, DOI 10.1016/j.conb.2008.01.003; Johnson A, 2007, J NEUROSCI, V27, P12176, DOI 10.1523/JNEUROSCI.3761-07.2007; Johnson MW, 2008, EXP CLIN PSYCHOPHARM, V16, P264, DOI 10.1037/1064-1297.16.3.264; Kable JW, 2007, NAT NEUROSCI, V10, P1625, DOI 10.1038/nn2007; Kable JW, 2010, J NEUROPHYSIOL, V103, P2513, DOI 10.1152/jn.00177.2009; Kim S, 2008, NEURON, V59, P161, DOI 10.1016/j.neuron.2008.05.010; Kumaran D, 2009, NEURON, V63, P889, DOI 10.1016/j.neuron.2009.07.030; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Manes F, 2002, BRAIN, V125, P624, DOI 10.1093/brain/awf049; Mariano TY, 2009, EUR J NEUROSCI, V30, P472, DOI 10.1111/j.1460-9568.2009.06837.x; Mazur J.E., 1987, QUANTITATIVE ANAL BE, V5, P55; McClure SM, 2007, J NEUROSCI, V27, P5796, DOI 10.1523/JNEUROSCI.4246-06.2007; McClure SM, 2004, SCIENCE, V306, P503, DOI 10.1126/science.1100907; McDonald AJ, 1996, NEUROSCIENCE, V71, P55, DOI 10.1016/0306-4522(95)00417-3; MCDONALD AJ, 1991, NEUROSCIENCE, V44, P1, DOI 10.1016/0306-4522(91)90247-L; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Naccache L, 2005, NEUROPSYCHOLOGIA, V43, P1318, DOI 10.1016/j.neuropsychologia.2004.11.024; Nichols T, 2005, NEUROIMAGE, V25, P653, DOI 10.1016/j.neuroimage.2004.12.005; Pearson JM, 2009, CURR BIOL, V19, P1532, DOI 10.1016/j.cub.2009.07.048; Peters J, 2009, J NEUROSCI, V29, P15727, DOI 10.1523/JNEUROSCI.3489-09.2009; Peters J, 2009, HIPPOCAMPUS, V19, P141, DOI 10.1002/hipo.20490; Phan KL, 2004, CNS SPECTRUMS, V9, P258, DOI 10.1017/S1092852900009196; Pine A, 2009, J NEUROSCI, V29, P9575, DOI 10.1523/JNEUROSCI.1126-09.2009; Platt ML, 1999, NATURE, V400, P233, DOI 10.1038/22268; RAWLINS JNP, 1985, BEHAV BRAIN RES, V15, P191, DOI 10.1016/0166-4328(85)90174-3; Read D, 2005, MANAGE SCI, V51, P1326, DOI 10.1287/mnsc.1050.0412; Roiser JP, 2009, J NEUROSCI, V29, P5985, DOI 10.1523/JNEUROSCI.0407-09.2009; Rushworth MFS, 2008, NAT NEUROSCI, V11, P389, DOI 10.1038/nn2066; Schacter DL, 2007, NAT REV NEUROSCI, V8, P657, DOI 10.1038/nrn2213; Schacter DL, 2009, PHILOS T R SOC B, V364, P1245, DOI 10.1098/rstb.2008.0308; Sharot T, 2007, NATURE, V450, P102, DOI 10.1038/nature06280; Szpunar KK, 2007, P NATL ACAD SCI USA, V104, P642, DOI 10.1073/pnas.0610082104; Tanaka SC, 2004, NAT NEUROSCI, V7, P887, DOI 10.1038/nn1279; Thierry AM, 2000, HIPPOCAMPUS, V10, P411, DOI 10.1002/1098-1063(2000)10:4<411::AID-HIPO7>3.0.CO;2-A; Vann SD, 2009, NAT REV NEUROSCI, V10, P792, DOI 10.1038/nrn2733; Wagner AD, 2005, TRENDS COGN SCI, V9, P445, DOI 10.1016/j.tics.2005.07.001; Walton ME, 2007, NEUROIMAGE, V36, pT142, DOI 10.1016/j.neuroimage.2007.03.029; Weber EU, 2009, ANNU REV PSYCHOL, V60, P53, DOI 10.1146/annurev.psych.60.110707.163633; Winstanley CA, 2004, J NEUROSCI, V24, P4718, DOI 10.1523/JNEUROSCI.5606-03.2004; Zuckerman M, 1996, PERS INDIV DIFFER, V20, P515, DOI 10.1016/0191-8869(95)00195-6	65	563	583	9	142	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 15	2010	66	1					138	148		10.1016/j.neuron.2010.03.026	http://dx.doi.org/10.1016/j.neuron.2010.03.026			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	587TP	20399735	Bronze			2022-12-24	WOS:000277016200015
J	Lo, B; Parham, L; Alvarez-Buylla, A; Cedars, M; Conklin, B; Fisher, S; Gates, E; Giudice, L; Halme, DG; Hershon, W; Kriegstein, A; Kwok, PY; Wagner, R				Lo, Bernard; Parham, Lindsay; Alvarez-Buylla, Arturo; Cedars, Marcelle; Conklin, Bruce; Fisher, Susan; Gates, Elena; Giudice, Linda; Halme, Dina Gould; Hershon, William; Kriegstein, Arnold; Kwok, Pui-Yan; Wagner, Richard			Cloning Mice and Men: Prohibiting the Use of iPS Cells for Human Reproductive Cloning	CELL STEM CELL			English	Editorial Material							PLURIPOTENT STEM-CELLS		[Lo, Bernard; Parham, Lindsay] Univ Calif San Francisco, Program Med Eth, San Francisco, CA 94143 USA; [Lo, Bernard; Conklin, Bruce] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Lo, Bernard; Alvarez-Buylla, Arturo; Cedars, Marcelle; Conklin, Bruce; Fisher, Susan; Gates, Elena; Giudice, Linda; Kriegstein, Arnold] Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA; [Alvarez-Buylla, Arturo] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA; [Cedars, Marcelle; Fisher, Susan; Gates, Elena; Giudice, Linda] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA 94143 USA; [Halme, Dina Gould] Univ Calif San Francisco, Sch Med, Off Dean, San Francisco, CA 94143 USA; [Kriegstein, Arnold] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Kwok, Pui-Yan] Univ Calif San Francisco, Dept Dermatol, San Francisco, CA 94143 USA; [Wagner, Richard] Univ Calif San Francisco, Human Res Protect Program, San Francisco, CA 94143 USA; [Conklin, Bruce] Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA; [Hershon, William] Disabil Rights Calif, Oakland, CA 94612 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; The J David Gladstone Institutes	Lo, B (corresponding author), Univ Calif San Francisco, Program Med Eth, San Francisco, CA 94143 USA.	bernie@medicine.ucsf.edu	Kwok, Pui-Yan/F-7725-2014; Conklin, Bruce/E-4738-2019	Kwok, Pui-Yan/0000-0002-5087-3059; Alvarez-Buylla, Arturo/0000-0003-4426-8925; Conklin, Bruce/0000-0003-1463-6061	NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024131] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS028478] Funding Source: NIH RePORTER; NCRR NIH HHS [1 UL1 RR024131-04, UL1 RR024131] Funding Source: Medline; NINDS NIH HHS [R01 NS028478] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Boland MJ, 2009, NATURE, V461, P91, DOI 10.1038/nature08310; Brock DW, 2002, SCIENCE, V296, P314, DOI 10.1126/science.1070371; DeChiara Thomas M., 2009, V530, P311, DOI 10.1007/978-1-59745-471-1_16; Denker HW, 2009, NATURE, V461, P341, DOI 10.1038/461341b; Denker HW, 2009, REPROD BIOMED ONLINE, V19, P34, DOI 10.1016/S1472-6483(10)60062-4; Greely H, 2002, HASTINGS LAW J, V53, P1085; Kang L, 2009, CELL STEM CELL, V5, P135, DOI 10.1016/j.stem.2009.07.001; National Bioethics Advisory Commission, 1997, CLON HUM BEINGS; National Bioethics Advisory Commission, 1999, ETH ISS HUM STEM CEL; National Research Council, 2002, SCI MED ASP HUM REPR; Poueymirou WT, 2007, NAT BIOTECHNOL, V25, P91, DOI 10.1038/nbt1263; Sunstein CR, 2002, HASTINGS LAW J, V53, P987; The President's Council on Bioethics, 2002, HUM CLON HUM DIGN ET; United Nations General Assembly, 2005, UN DECL HUM CLON; Zhao XY, 2009, NATURE, V461, P86, DOI 10.1038/nature08267	15	21	21	0	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	JAN 8	2010	6	1					16	20		10.1016/j.stem.2009.12.004	http://dx.doi.org/10.1016/j.stem.2009.12.004			5	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	549EW	20085739	Bronze, Green Accepted			2022-12-24	WOS:000274029700007
J	Tark, KJ; Curtis, CE				Tark, Kyeong-Jin; Curtis, Clayton E.			Persistent neural activity in the human frontal cortex when maintaining space that is off the map	NATURE NEUROSCIENCE			English	Article							DORSOLATERAL PREFRONTAL CORTEX; POSTERIOR PARIETAL CORTEX; MEMORY-GUIDED SACCADES; EYE-FIELD; WORKING-MEMORY; SPATIAL ATTENTION; AREA LIP; MONKEY; MAINTENANCE; FMRI	During the maintenance of visuospatial information, neural activity in the frontal eye field ( FEF) persists and is thought to be an important neural mechanism for visual working memory. We used functional magnetic resonance imaging to examine whether human FEF activity persists when maintaining auditory space and whether it is selective for retinal versus extra-retinal space. Subjects performed an audiospatial working-memory task using sounds recorded from microphones placed in each subject's ear canals, which preserved the interaural time and level differences that are critical for sound localization. Putative FEF activity persisted when maintaining auditory-cued space, even for locations behind the head to which it is impossible to make saccades. Therefore, human FEF activity represents both retinal and extra-retinal space.	[Tark, Kyeong-Jin; Curtis, Clayton E.] NYU, Dept Psychol, New York, NY 10003 USA; [Curtis, Clayton E.] NYU, Ctr Neural Sci, New York, NY 10003 USA	New York University; New York University	Curtis, CE (corresponding author), NYU, Dept Psychol, 6 Washington Pl, New York, NY 10003 USA.	clayton.curtis@nyu.edu			US National Institutes of Health [R01 EY016407]; NATIONAL EYE INSTITUTE [R01EY016407] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank R. Srimal, L. Deouell, S. Inati and K. Sanzenbach for technical support and anonymous reviewers for helpful suggestions. This work was funded by the US National Institutes of Health (R01 EY016407).	ANDERSEN RA, 1988, CAN J PHYSIOL PHARM, V66, P488, DOI 10.1139/y88-078; Artchakov D, 2007, EXP BRAIN RES, V180, P469, DOI 10.1007/s00221-007-0873-8; Biswal BB, 1997, MAGNET RESON MED, V38, P470, DOI 10.1002/mrm.1910380315; Brown MRG, 2004, J NEUROPHYSIOL, V91, P873, DOI 10.1152/jn.00382.2003; BRUCE CJ, 1985, J NEUROPHYSIOL, V53, P603, DOI 10.1152/jn.1985.53.3.603; Chafee MV, 1998, J NEUROPHYSIOL, V79, P2919, DOI 10.1152/jn.1998.79.6.2919; Chen LLT, 2006, J NEUROPHYSIOL, V95, P3528, DOI 10.1152/jn.01320.2005; Curtis CE, 2003, TRENDS COGN SCI, V7, P415, DOI 10.1016/S1364-6613(03)00197-9; Curtis CE, 2004, J NEUROSCI, V24, P3944, DOI 10.1523/JNEUROSCI.5640-03.2004; Curtis CE, 2008, J NEUROPHYSIOL, V99, P133, DOI 10.1152/jn.00899.2007; Curtis Clayton E., 2004, Cognitive Affective & Behavioral Neuroscience, V4, P528, DOI 10.3758/CABN.4.4.528; Curtis CE, 2006, J NEUROPHYSIOL, V95, P3923, DOI 10.1152/jn.01120.2005; Dias EC, 1999, J NEUROPHYSIOL, V81, P2191, DOI 10.1152/jn.1999.81.5.2191; Elsley JK, 2007, J NEUROPHYSIOL, V98, P1333, DOI 10.1152/jn.00386.2007; FUNAHASHI S, 1993, J NEUROSCI, V13, P1479; FUNAHASHI S, 1989, J NEUROPHYSIOL, V61, P331, DOI 10.1152/jn.1989.61.2.331; Garg A, 2007, NEUROPSYCHOLOGIA, V45, P2307, DOI 10.1016/j.neuropsychologia.2007.02.015; GOLDBERG ME, 1990, J NEUROPHYSIOL, V64, P489, DOI 10.1152/jn.1990.64.2.489; Holmes AP, 1996, J CEREBR BLOOD F MET, V16, P7, DOI 10.1097/00004647-199601000-00002; Ikkai A, 2008, CEREB CORTEX, V18, P1384, DOI 10.1093/cercor/bhm171; Kikuchi-Yorioka Y, 2000, NAT NEUROSCI, V3, P1075, DOI 10.1038/80581; Knight TA, 2007, J NEUROPHYSIOL, V97, P618, DOI 10.1152/jn.00256.2006; Mazzoni P, 1996, J NEUROPHYSIOL, V75, P1233, DOI 10.1152/jn.1996.75.3.1233; Mullette-Gillman OA, 2009, CEREB CORTEX, V19, P1761, DOI 10.1093/cercor/bhn207; Mullette-Gillman OA, 2005, J NEUROPHYSIOL, V94, P2331, DOI 10.1152/jn.00021.2005; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Paus T, 1996, NEUROPSYCHOLOGIA, V34, P475, DOI 10.1016/0028-3932(95)00134-4; Ploner CJ, 1999, J NEUROPHYSIOL, V82, P1086; RIVAUD S, 1994, EXP BRAIN RES, V102, P110; RUSSO GS, 1994, J NEUROPHYSIOL, V71, P1250, DOI 10.1152/jn.1994.71.3.1250; RUSSO GS, 1993, J NEUROPHYSIOL, V69, P800, DOI 10.1152/jn.1993.69.3.800; SCHALL JD, 1995, J NEUROSCI, V15, P4464; Schlack A, 2005, J NEUROSCI, V25, P4616, DOI 10.1523/JNEUROSCI.0455-05.2005; SOECHTING JF, 1992, ANNU REV NEUROSCI, V15, P167, DOI 10.1146/annurev.ne.15.030192.001123; Sommer MA, 2001, J NEUROPHYSIOL, V85, P1673, DOI 10.1152/jn.2001.85.4.1673; Srimal R, 2008, NEUROIMAGE, V39, P455, DOI 10.1016/j.neuroimage.2007.08.040; Stricanne B, 1996, J NEUROPHYSIOL, V76, P2071, DOI 10.1152/jn.1996.76.3.2071; Tehovnik EJ, 2000, BRAIN RES REV, V32, P413, DOI 10.1016/S0165-0173(99)00092-2; TREUTWEIN B, 1995, VISION RES, V35, P2503, DOI 10.1016/0042-6989(95)00016-X; Umeno MM, 2001, J NEUROPHYSIOL, V86, P2344, DOI 10.1152/jn.2001.86.5.2344; Van Essen DC, 2005, NEUROIMAGE, V28, P635, DOI 10.1016/j.neuroimage.2005.06.058; WORSLEY KJ, 1995, NEUROIMAGE, V2, P173, DOI 10.1006/nimg.1995.1023; Xing J, 2000, J COGNITIVE NEUROSCI, V12, P601, DOI 10.1162/089892900562363; Zarahn E, 1997, NEUROIMAGE, V6, P122, DOI 10.1006/nimg.1997.0279	44	46	46	1	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2009	12	11					1463	1468		10.1038/nn.2406	http://dx.doi.org/10.1038/nn.2406			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	511UE	19801987	Green Accepted			2022-12-24	WOS:000271194100021
J	Katsuki, T; Ailani, D; Hiramoto, M; Hiromi, Y				Katsuki, Takeo; Ailani, Deepak; Hiramoto, Masaki; Hiromi, Yasushi			Intra-axonal Patterning: Intrinsic Compartmentalization of the Axonal Membrane in Drosophila Neurons	NEURON			English	Article							TARGETED GENE-EXPRESSION; GROWTH CONE GUIDANCE; LONG-RANGE GUIDANCE; ROBO RECEPTORS; FASCICLIN-II; INTERMEDIATE TARGET; DIFFUSION-BARRIERS; POLARIZED NEURONS; LATERAL POSITION; INITIAL SEGMENT	In the developing nervous system, distribution of membrane molecules, particularly axon guidance receptors, is often restricted to specific segments of axons. Such localization of membrane molecules can be important for the formation and function of neural networks; however, how this patterning within axons is achieved remains elusive. Here we show that Drosophila neurons in culture establish intra-axonal patterns in a cell-autonomous manner; several membrane molecules localize to either proximal or distal axon segments without cell-cell contacts. This distinct patterning of membrane proteins is not explained by a simple temporal control of expression, and likely involves spatially controlled vesicular targeting or retrieval. Mobility of transmembrane molecules is restricted at the boundary of intra-axonal segments, indicating that the axonal membrane is compartmentalized by a barrier mechanism. We propose that this intraaxonal compartmentalization is an intrinsic property of Drosophila neurons that provides a basis for the structural and functional development of the nervous system.	[Katsuki, Takeo; Ailani, Deepak; Hiramoto, Masaki; Hiromi, Yasushi] Natl Inst Genet, Dept Dev Genet, Mishima, Shizuoka 4118540, Japan; [Katsuki, Takeo; Ailani, Deepak; Hiromi, Yasushi] SOKENDAI, Dept Genet, Mishima, Shizuoka 4118540, Japan	Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Graduate University for Advanced Studies - Japan	Hiromi, Y (corresponding author), Natl Inst Genet, Dept Dev Genet, 1111 Yata, Mishima, Shizuoka 4118540, Japan.	yhiromi@lab.nig.ac.jp		Katsuki, Takeo/0000-0003-2366-2990	JSPS; JST; Takeda Science Foundation; Grants-in-Aid for Scientific Research [21370100] Funding Source: KAKEN	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JST(Japan Science & Technology Agency (JST)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank J. Simpson, S. Yoshikawa, S. Eaton, A. Nose, B. Dickson, the Bloomington Drosophila Stock Center, DGRC Kyoto, and DSHB for providing materials. We thank N. Patel for advice on culture experiments; K. Fukatsu for advice on FRAP experiments; T. Takano-Shimizu for advice on statistical analyses; T. Yoshimon for advice on shi experiments; T. Hirata and T. De Falco for comments on the manuscript; members of the Suzuki, Emoto, Hirose, and Hiromi laboratories for discussions; and M. Aono, C. Asaka, E. Suzuki, Y. Iketani, H. Hatanaka, and Y. Noguchi for technical assistance. This work was supported by the grants from the JSPS (T.K.), the PRIEST program of JST (M.H.), the CREST program of JST, and the Takeda Science Foundation (Y.H.). The authors declare no competing financial interests.	Ai HW, 2007, BIOCHEMISTRY-US, V46, P5904, DOI 10.1021/bi700199g; Ango F, 2004, CELL, V119, P257, DOI 10.1016/j.cell.2004.10.004; BASTIANI MJ, 1987, CELL, V48, P745, DOI 10.1016/0092-8674(87)90072-9; Bonkowsky JL, 1999, NATURE, V402, P540, DOI 10.1038/990122; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brittis PA, 2002, CELL, V110, P223, DOI 10.1016/S0092-8674(02)00813-9; CALLAHAN CA, 1995, NATURE, V376, P171, DOI 10.1038/376171a0; Chen Z, 2008, NEURON, V58, P325, DOI 10.1016/j.neuron.2008.02.016; Clark IE, 1997, DEVELOPMENT, V124, P461; Dickson BJ, 2006, ANNU REV CELL DEV BI, V22, P651, DOI 10.1146/annurev.cellbio.21.090704.151234; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; DODD J, 1988, NEURON, V1, P105, DOI 10.1016/0896-6273(88)90194-8; Furrer MP, 2007, DEVELOPMENT, V134, P3795, DOI 10.1242/dev.02882; Garrido JJ, 2003, SCIENCE, V300, P2091, DOI 10.1126/science.1085167; GOODMAN CS, 1984, SCIENCE, V225, P1271, DOI 10.1126/science.6474176; Greco V, 2001, CELL, V106, P633, DOI 10.1016/S0092-8674(01)00484-6; GRIGLIATTI TA, 1973, MOL GEN GENET, V120, P107, DOI 10.1007/BF00267238; Guha A, 2003, J CELL SCI, V116, P3373, DOI 10.1242/jcs.00637; Halfon MS, 1997, P NATL ACAD SCI USA, V94, P6255, DOI 10.1073/pnas.94.12.6255; Hassan BA, 2000, NEURON, V25, P549, DOI 10.1016/S0896-6273(00)81059-4; Hayashi S, 2002, GENESIS, V34, P58, DOI 10.1002/gene.10137; Hiramoto M, 2000, NATURE, V406, P886, DOI 10.1038/35022571; James PS, 2004, J CELL SCI, V117, P6485, DOI 10.1242/jcs.01578; Keleman K, 2002, CELL, V110, P415, DOI 10.1016/S0092-8674(02)00901-7; Kidd T, 1998, CELL, V92, P205, DOI 10.1016/S0092-8674(00)80915-0; KOBAYASHI T, 1992, NATURE, V359, P647, DOI 10.1038/359647a0; Kohsaka H, 2007, J CELL BIOL, V179, P1289, DOI 10.1083/jcb.200705154; KOSAKA T, 1983, J NEUROBIOL, V14, P207, DOI 10.1002/neu.480140305; KOSAKA T, 1983, J CELL BIOL, V97, P499, DOI 10.1083/jcb.97.2.499; Kraut R, 2004, CURR BIOL, V14, P1319, DOI 10.1016/j.cub.2004.07.052; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; LIN DM, 1994, NEURON, V13, P507, DOI 10.1016/0896-6273(94)90022-1; LIN DM, 1994, NEURON, V13, P1055, DOI 10.1016/0896-6273(94)90045-0; Lippincott-Schwartz J, 1999, METHOD CELL BIOL, V58, P261; LITTLETON JT, 1993, DEVELOPMENT, V118, P1077; Lohr R, 2002, J NEUROSCI, V22, P10357; Long H, 2004, NEURON, V42, P213, DOI 10.1016/S0896-6273(04)00179-5; Nakada C, 2003, NAT CELL BIOL, V5, P626, DOI 10.1038/ncb1009; Osterwalder T, 2001, P NATL ACAD SCI USA, V98, P12596, DOI 10.1073/pnas.221303298; Pan ZM, 2006, J NEUROSCI, V26, P2599, DOI 10.1523/JNEUROSCI.4314-05.2006; PATEL NH, 1994, METHOD CELL BIOL, V44, P445, DOI 10.1016/S0091-679X(08)60927-9; PATEL NH, 1987, CELL, V48, P975, DOI 10.1016/0092-8674(87)90706-9; Rajagopalan S, 2000, CELL, V103, P1033, DOI 10.1016/S0092-8674(00)00207-5; Rajagopalan S, 2000, NEURON, V28, P767, DOI 10.1016/S0896-6273(00)00152-5; RAPER JA, 1984, J NEUROSCI, V4, P2329; Sabatier C, 2004, CELL, V117, P157, DOI 10.1016/S0092-8674(04)00303-4; Sanchez-Soriano N, 2005, DEV BIOL, V288, P126, DOI 10.1016/j.ydbio.2005.09.026; Schmidt K, 2004, CURR BIOL, V14, P1002, DOI 10.1016/j.cub.2004.05.044; SEEGER M, 1993, NEURON, V10, P409, DOI 10.1016/0896-6273(93)90330-T; Shin K, 2006, ANNU REV CELL DEV BI, V22, P207, DOI 10.1146/annurev.cellbio.22.010305.104219; Shirasaki R, 1998, SCIENCE, V279, P105, DOI 10.1126/science.279.5347.105; Simpson JH, 2000, CELL, V103, P1019, DOI 10.1016/S0092-8674(00)00206-3; Simpson JH, 2000, NEURON, V28, P753, DOI 10.1016/S0896-6273(00)00151-3; Takizawa PA, 2000, SCIENCE, V290, P341, DOI 10.1126/science.290.5490.341; Winckler B, 1999, NATURE, V397, P698, DOI 10.1038/17789; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zhang YQ, 2002, GENESIS, V34, P142, DOI 10.1002/gene.10144	57	38	39	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 29	2009	64	2					188	199		10.1016/j.neuron.2009.08.019	http://dx.doi.org/10.1016/j.neuron.2009.08.019			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	521AA	19874787	Bronze			2022-12-24	WOS:000271889900009
J	Woolfrey, KM; Srivastava, DP; Photowala, H; Yamashita, M; Barbolina, MV; Cahill, ME; Xie, Z; Jones, KA; Quilliam, LA; Prakriya, M; Penzes, P				Woolfrey, Kevin M.; Srivastava, Deepak P.; Photowala, Huzefa; Yamashita, Megumi; Barbolina, Maria V.; Cahill, Michael E.; Xie, Zhong; Jones, Kelly A.; Quilliam, Lawrence A.; Prakriya, Murali; Penzes, Peter			Epac2 induces synapse remodeling and depression and its disease-associated forms alter spines	NATURE NEUROSCIENCE			English	Article							LONG-TERM DEPRESSION; DENDRITIC SPINES; HIPPOCAMPAL-NEURONS; PREFRONTAL CORTEX; EXCHANGE PROTEIN; D1 RECEPTORS; MAP KINASE; CYCLIC-AMP; CAMP; PLASTICITY	Dynamic remodeling of spiny synapses is crucial for cortical circuit development, refinement and plasticity, whereas abnormal morphogenesis is associated with neuropsychiatric disorders. We found that activation of Epac2, a PKA-independent cAMP target and Rap guanine-nucleotide exchange factor (GEF), in cultured rat cortical neurons induced spine shrinkage, increased spine motility, removed synaptic GluR2/3-containing AMPA receptors and depressed excitatory transmission, whereas its inhibition promoted spine enlargement and stabilization. Epac2 was required for dopamine D1-like receptor-dependent spine shrinkage and GluR2 removal from spines. Epac2 interaction with neuroligin promoted its membrane recruitment and enhanced its GEF activity. Rare missense mutations in the EPAC2 (also known as RAPGEF4) gene, previously found in individuals with autism, affected basal and neuroligin-stimulated GEF activity, dendritic Rap signaling, synaptic protein distribution and spine morphology. Thus, we identify a previously unknown mechanism that promotes dynamic remodeling and depression of spiny synapses, disruption of which may contribute to some aspects of disease.	[Woolfrey, Kevin M.; Srivastava, Deepak P.; Photowala, Huzefa; Cahill, Michael E.; Xie, Zhong; Jones, Kelly A.; Penzes, Peter] Northwestern Univ, Dept Physiol, Feinberg Sch Med, Chicago, IL 60611 USA; [Yamashita, Megumi; Prakriya, Murali] Northwestern Univ, Dept Biol Chem & Mol Pharmacol, Feinberg Sch Med, Chicago, IL 60611 USA; [Barbolina, Maria V.] Univ Illinois, Dept Biopharmaceut Sci, Chicago, IL USA; [Quilliam, Lawrence A.] Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN USA; [Quilliam, Lawrence A.] Walther Canc Inst, Indianapolis, IN USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Indiana University System; Indiana University-Purdue University Indianapolis; Walther Cancer Institute	Penzes, P (corresponding author), Northwestern Univ, Dept Physiol, Feinberg Sch Med, Chicago, IL 60611 USA.	p-penzes@northwestern.edu	Quilliam, Lawrence/B-6447-2015; Quilliam, Lawrence/Q-4987-2019; Penzes, Peter/L-3987-2016; Xie, Zhong/B-6829-2011	Penzes, Peter/0000-0001-5449-1640; Xie, Zhong/0000-0002-8348-4455; Prakriya, Murali/0000-0003-0781-4480; Cahill, Michael/0000-0003-0574-2655; Yamashita, Megumi/0000-0003-0196-0428; Srivastava, Deepak Prakash/0000-0001-6512-9065	National Alliance for Autism Research; National Alliance for Research on Schizophrenia and Depression; Alzheimer's Association; US National Institutes of Health [MH 071316, NS057499, CA108647]; American Heart Association; NATIONAL CANCER INSTITUTE [R01CA108647] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH071316] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS057499, R01NS057499] Funding Source: NIH RePORTER	National Alliance for Autism Research; National Alliance for Research on Schizophrenia and Depression(NARSAD); Alzheimer's Association(Alzheimer's Association); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank R. L. Huganir ( Johns Hopkins University) for antibodies to AMPAR and NMDAR subunits, J. Bos ( Utrecht University) and P. Stork ( Vollum Institute) for plasmids, A. El- Husseini ( University of British Columbia) and P. Scheiffele ( University of Basel) for antibodies to neuroligin and plasmid constructs, and G. Borisy and S.- I. Kojima ( Northwestern University) for the pGSuper plasmid. We thank A. K. Srivastava ( J. C. Self Research Institute of Human Genetics) and G. Swanson ( Northwestern University) for thoughtful discussion. This work was supported by the National Alliance for Autism Research, the National Alliance for Research on Schizophrenia and Depression, the Alzheimer's Association, grants from the US National Institutes of Health ( MH 071316 to P. P., NS057499 to M. P. and CA108647 to L. A. Q.), a pre- doctoral American Heart Association fellowship to K. M. W. and a post- doctoral American Heart Association fellowship to D. P. S.	Abrahams BS, 2008, NAT REV GENET, V9, P341, DOI 10.1038/nrg2346; Bacchelli E, 2003, MOL PSYCHIATR, V8, P916, DOI 10.1038/sj.mp.4001340; Bos JL, 2006, TRENDS BIOCHEM SCI, V31, P680, DOI 10.1016/j.tibs.2006.10.002; Chen ZX, 1996, RECEPTOR CHANNEL, V4, P1; Cheung U, 2006, J NEUROBIOL, V66, P273, DOI 10.1002/neu.20218; Chih B, 2005, SCIENCE, V307, P1324, DOI 10.1126/science.1107470; Chih B, 2004, HUM MOL GENET, V13, P1471, DOI 10.1093/hmg/ddh158; Craig AM, 2007, CURR OPIN NEUROBIOL, V17, P43, DOI 10.1016/j.conb.2007.01.011; Dunaevsky A, 1999, P NATL ACAD SCI USA, V96, P13438, DOI 10.1073/pnas.96.23.13438; Enserink JM, 2002, NAT CELL BIOL, V4, P901, DOI 10.1038/ncb874; FREY U, 1993, SCIENCE, V260, P1661, DOI 10.1126/science.8389057; Gekel I, 2008, J NEUROSCI, V28, P7991, DOI 10.1523/JNEUROSCI.0268-08.2008; Gelinas JN, 2008, LEARN MEMORY, V15, P403, DOI 10.1101/lm.830008; GEREAU RW, 1994, NEURON, V12, P1121, DOI 10.1016/0896-6273(94)90319-0; Holtmaat AJGD, 2005, NEURON, V45, P279, DOI 10.1016/j.neuron.2005.01.003; Huang YY, 2004, P NATL ACAD SCI USA, V101, P3236, DOI 10.1073/pnas.0308280101; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; Jordan BA, 2004, MOL CELL PROTEOMICS, V3, P857, DOI 10.1074/mcp.M400045-MCP200; Kang GX, 2003, J BIOL CHEM, V278, P8279, DOI 10.1074/jbc.M211682200; Kasai H, 2003, TRENDS NEUROSCI, V26, P360, DOI 10.1016/S0166-2236(03)00162-0; Kawasaki H, 1998, SCIENCE, V282, P2275, DOI 10.1126/science.282.5397.2275; Kayser MS, 2008, NEURON, V59, P56, DOI 10.1016/j.neuron.2008.05.007; Kelly MP, 2009, MOL PSYCHIATR, V14, P398, DOI 10.1038/mp.2008.124; Kojima SI, 2004, BIOTECHNIQUES, V36, P74, DOI 10.2144/04361ST02; Li Y, 2006, J BIOL CHEM, V281, P2506, DOI 10.1074/jbc.M508165200; Luthi A, 1999, NEURON, V24, P389, DOI 10.1016/S0896-6273(00)80852-1; Morozov A, 2003, NEURON, V39, P309, DOI 10.1016/S0896-6273(03)00404-5; Nagerl UV, 2004, NEURON, V44, P759, DOI 10.1016/j.neuron.2004.11.016; Oray S, 2004, NEURON, V44, P1021, DOI 10.1016/j.neuron.2004.12.001; Otani S, 1998, NEUROSCIENCE, V85, P669, DOI 10.1016/S0306-4522(97)00677-5; Otmakhov N, 2002, J NEUROPHYSIOL, V87, P3018, DOI 10.1152/jn.2002.87.6.3018; Ouyang M, 2008, P NATL ACAD SCI USA, V105, P11993, DOI 10.1073/pnas.0804172105; Peng JM, 2004, J BIOL CHEM, V279, P21003, DOI 10.1074/jbc.M400103200; Pickett J, 2005, J NEUROPATH EXP NEUR, V64, P925, DOI 10.1097/01.jnen.0000186921.42592.6c; Smith WB, 2005, NEURON, V45, P765, DOI 10.1016/j.neuron.2005.01.015; Srivastava DP, 2008, P NATL ACAD SCI USA, V105, P14650, DOI 10.1073/pnas.0801581105; Ster J, 2009, J PHYSIOL-LONDON, V587, P101, DOI 10.1113/jphysiol.2008.157461; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Tada T, 2006, CURR OPIN NEUROBIOL, V16, P95, DOI 10.1016/j.conb.2005.12.001; Ulucan C, 2007, AM J PHYSIOL-HEART C, V293, pH1662, DOI 10.1152/ajpheart.00159.2007; Vossler MR, 1997, CELL, V89, P73, DOI 10.1016/S0092-8674(00)80184-1; Xia J, 2000, NEURON, V28, P499, DOI 10.1016/S0896-6273(00)00128-8; York RD, 1998, NATURE, V392, P622, DOI 10.1038/33451; Zhong N, 2005, J NEUROSCI, V25, P208, DOI 10.1523/JNEUROSCI.3703-04.2005; Zhou Q, 2004, NEURON, V44, P749, DOI 10.1016/j.neuron.2004.11.011; Zhu JJ, 2002, CELL, V110, P443, DOI 10.1016/S0092-8674(02)00897-8; Zhu YH, 2005, NEURON, V46, P905, DOI 10.1016/j.neuron.2005.04.037	48	123	123	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2009	12	10					1275	U96		10.1038/nn.2386	http://dx.doi.org/10.1038/nn.2386			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	498US	19734897	Green Accepted			2022-12-24	WOS:000270170200016
J	Parrish, JZ; Xu, PZ; Kim, CC; Jan, LY; Jan, YN				Parrish, Jay Z.; Xu, Peizhang; Kim, Charles C.; Jan, Lily Yeh; Jan, Yuh Nung			The microRNA bantam Functions in Epithelial Cells to Regulate Scaling Growth of Dendrite Arbors in Drosophila Sensory Neurons	NEURON			English	Article							PATHWAY; HIPPO; PROLIFERATION; MORPHOGENESIS; TARGET; STABILITY; FLIES; SIZE	In addition to establishing dendritic coverage of the receptive field, neurons need to adjust their dendritic arbors to match changes of the receptive field. Here, we show that dendrite arborization (da) sensory neurons establish dendritic coverage of the body wall early in Drosophila larval development and then grow in precise proportion to their substrate, the underlying body wall epithelium, as the larva more than triples in length. This phenomenon, referred to as scaling growth of dendrites, requires the function of the microRNA (miRNA) bantam (ban) in the epithelial cells rather than the da neurons themselves. We further show that ban in epithelial cells dampens Akt kinase activity in adjacent neurons to influence dendrite growth. This signaling between epithelial cells and neurons receiving sensory input from the body wall synchronizes their growth to ensure proper dendritic coverage of the receptive field.	[Parrish, Jay Z.; Xu, Peizhang; Kim, Charles C.; Jan, Lily Yeh; Jan, Yuh Nung] Univ Calif San Francisco, Howard Hughes Med Inst, Dept Physiol, San Francisco, CA 94158 USA; [Parrish, Jay Z.; Xu, Peizhang; Kim, Charles C.; Jan, Lily Yeh; Jan, Yuh Nung] Univ Calif San Francisco, Howard Hughes Med Inst, Dept Biochem, San Francisco, CA 94158 USA; [Parrish, Jay Z.; Xu, Peizhang; Kim, Charles C.; Jan, Lily Yeh; Jan, Yuh Nung] Univ Calif San Francisco, Howard Hughes Med Inst, Dept Biophys, San Francisco, CA 94158 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Jan, YN (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Physiol, San Francisco, CA 94158 USA.	yuhnung.jan@ucsf.edu		Kim, Charles/0000-0001-6474-8227; Jan, Yuh Nung/0000-0003-1367-6299; Jan, Lily/0000-0003-3938-8498	NIH [5K99MH084277, R01 NS40929]; Investigators of the Howard Hughes Medical Institute; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH084234, K99MH084277] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040929, R37NS040929] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Investigators of the Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Chun Han, Peter Soba, and Li Cheng for experimental advice; Joe DeRisi for use of his laboratory and equipment for microarray experiments; Susan Younger for help with genetics; Stephen Cohen, Tian Xu, Yang Hong, Chun Han, Rebecca Yang, Sabina Zimmerman, and Quan Yuan for fly stocks; and members of the Jan lab for helpful comments. This work was supported by NIH grants 5K99MH084277 (J.Z.P) and R01 NS40929 (Y.N.J). L.Y.J. and Y.N.J. are Investigators of the Howard Hughes Medical Institute.	BENTLEY D, 1981, J COMP NEUROL, V201, P507, DOI 10.1002/cne.902010404; Berdnik D, 2008, CURR BIOL, V18, P1754, DOI 10.1016/j.cub.2008.09.045; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Bucher D, 2000, J INSECT PHYSIOL, V46, P1545, DOI 10.1016/S0022-1910(00)00078-0; Caygill EE, 2008, CURR BIOL, V18, P943, DOI 10.1016/j.cub.2008.06.020; Colombani J, 2003, CELL, V114, P739, DOI 10.1016/S0092-8674(03)00713-X; Edgar BA, 2003, COLD SPRING HARBOR M, V42, P23; Edgar BA, 2006, NAT REV GENET, V7, P907, DOI 10.1038/nrg1989; Emoto K, 2004, CELL, V119, P245, DOI 10.1016/j.cell.2004.09.036; Emoto K, 2006, NATURE, V443, P210, DOI 10.1038/nature05090; Gao FB, 2008, TRENDS NEUROSCI, V31, P20, DOI 10.1016/j.tins.2007.10.004; Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020; Grueber WB, 2003, CELL, V112, P805, DOI 10.1016/S0092-8674(03)00160-0; Grueber WB, 2003, CURR BIOL, V13, P618, DOI 10.1016/S0960-9822(03)00207-0; Grueber WB, 2002, DEVELOPMENT, V129, P2867; Hipfner DR, 2002, GENETICS, V161, P1527; Holtmaat AJGD, 2005, NEURON, V45, P279, DOI 10.1016/j.neuron.2005.01.003; Jaworski J, 2005, J NEUROSCI, V25, P11300, DOI 10.1523/JNEUROSCI.2270-05.2005; Kosik KS, 2005, NEURON, V47, P779, DOI 10.1016/j.neuron.2005.08.019; Krichevsky AM, 2003, RNA, V9, P1274, DOI 10.1261/rna.5980303; Kumar V, 2005, J NEUROSCI, V25, P11288, DOI 10.1523/JNEUROSCI.2284-05.2005; Layalle S, 2008, DEV CELL, V15, P568, DOI 10.1016/j.devcel.2008.08.003; Lee S, 2007, P NATL ACAD SCI USA, V104, P12931, DOI 10.1073/pnas.0705469104; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Li Y, 2005, J COMP NEUROL, V483, P304, DOI 10.1002/cne.20438; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Majewska AK, 2006, J NEUROSCI, V26, P3021, DOI 10.1523/JNEUROSCI.4454-05.2006; McBrayer Z, 2007, DEV CELL, V13, P857, DOI 10.1016/j.devcel.2007.11.003; Mizrahi A, 2003, NAT NEUROSCI, V6, P1201, DOI 10.1038/nn1133; Nolo R, 2006, CURR BIOL, V16, P1895, DOI 10.1016/j.cub.2006.08.057; Parrish JZ, 2007, GENE DEV, V21, P956, DOI 10.1101/gad.1514507; Pasquinelli AE, 2002, ANNU REV CELL DEV BI, V18, P495, DOI 10.1146/annurev.cellbio.18.012502.105832; Raisin S, 2003, GENETICS, V164, P1015; Rulifson EJ, 2002, SCIENCE, V296, P1118, DOI 10.1126/science.1070058; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Sokol NS, 2008, GENE DEV, V22, P1591, DOI 10.1101/gad.1671708; Sugimura K, 2003, J NEUROSCI, V23, P3752; Thompson BJ, 2006, CELL, V126, P767, DOI 10.1016/j.cell.2006.07.013; TRUMAN JW, 1988, J NEUROSCI, V8, P765; Wayman GA, 2008, P NATL ACAD SCI USA, V105, P9093, DOI 10.1073/pnas.0803072105; Ye B, 2007, CELL, V130, P717, DOI 10.1016/j.cell.2007.06.032; Yoo AS, 2009, NATURE, V460, P642, DOI 10.1038/nature08139; Zuo Y, 2005, NEURON, V46, P181, DOI 10.1016/j.neuron.2005.04.001	43	118	119	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 24	2009	63	6					788	802		10.1016/j.neuron.2009.08.006	http://dx.doi.org/10.1016/j.neuron.2009.08.006			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	503VP	19778508	Green Accepted, Bronze			2022-12-24	WOS:000270569700012
J	Yoshida, Y; Takahashi, K; Okita, K; Ichisaka, T; Yamanaka, S				Yoshida, Yoshinori; Takahashi, Kazutoshi; Okita, Keisuke; Ichisaka, Tomoko; Yamanaka, Shinya			Hypoxia Enhances the Generation of Induced Pluripotent Stem Cells	CELL STEM CELL			English	Article							SMALL-MOLECULE COMPOUNDS; HUMAN FIBROBLASTS; DEFINED FACTORS; INDUCTION; MOUSE; DIFFERENTIATION		[Yoshida, Yoshinori; Takahashi, Kazutoshi; Okita, Keisuke; Yamanaka, Shinya] Kyoto Univ, Inst Integrated Cell Mat Sci, Ctr iPS Cell Res & Applicat, Kyoto 6068507, Japan; [Ichisaka, Tomoko; Yamanaka, Shinya] Japan Sci & Technol Agcy, Yamanaka iPS Cell Special Project, Kawaguchi, Saitama 3320012, Japan; [Yamanaka, Shinya] Kyoto Univ, Inst Frontier Med Sci, Dept Stem Cell Biol, Kyoto 6068507, Japan; [Yamanaka, Shinya] Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA	Kyoto University; Japan Science & Technology Agency (JST); Kyoto University; University of California System; University of California San Francisco; The J David Gladstone Institutes	Yoshida, Y (corresponding author), Kyoto Univ, Inst Integrated Cell Mat Sci, Ctr iPS Cell Res & Applicat, Kyoto 6068507, Japan.	yoshinor@frontier.kyoto-u.ac.jp; yamanaka@frontier.kyoto-u.ac.jp	Yoshida, Yoshinori/AAY-6009-2020; Takahashi, Kazutoshi/ABE-5504-2020	Yoshida, Yoshinori/0000-0001-5511-9090; Takahashi, Kazutoshi/0000-0002-5329-8395; Okita, Keisuke/0000-0001-5806-1090				Danet GH, 2003, J CLIN INVEST, V112, P126, DOI 10.1172/JCI200317669; Ezashi T, 2005, P NATL ACAD SCI USA, V102, P4783, DOI 10.1073/pnas.0501283102; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Kaji K, 2009, NATURE, V458, P771, DOI 10.1038/nature07864; Kim JB, 2008, NATURE, V454, P646, DOI 10.1038/nature07061; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Meissner A, 2007, NAT BIOTECHNOL, V25, P1177, DOI 10.1038/nbt1335; Morrison SJ, 2000, J NEUROSCI, V20, P7370; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Shi Y, 2008, CELL STEM CELL, V3, P568, DOI 10.1016/j.stem.2008.10.004; Shi Y, 2008, CELL STEM CELL, V2, P525, DOI 10.1016/j.stem.2008.05.011; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863	17	563	637	4	68	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	SEP 4	2009	5	3					237	241		10.1016/j.stem.2009.08.001	http://dx.doi.org/10.1016/j.stem.2009.08.001			5	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	529VA	19716359	Bronze, Green Published			2022-12-24	WOS:000272545700006
J	Ke, MC; Guo, CC; Raymond, JL				Ke, Michael C.; Guo, Cong C.; Raymond, Jennifer L.			Elimination of climbing fiber instructive signals during motor learning	NATURE NEUROSCIENCE			English	Article							CEREBELLAR PURKINJE-CELLS; PURSUIT EYE-MOVEMENTS; VESTIBULOOCULAR REFLEX; INFERIOR OLIVE; PARALLEL FIBERS; PLASTICITY MECHANISMS; SYNAPTIC PLASTICITY; BEHAVIORAL-ANALYSIS; MEMORY TRACE; NEURAL BASIS	The climbing fiber input to the cerebellum from the inferior olive is thought to act as a teacher whose activity controls the induction of motor learning. We designed training conditions that did not elicit instructive signals in the climbing fibers, but nevertheless induced robust and consistent motor learning in the vestibulo-ocular reflex of rhesus monkeys. Our results indicate that instructive signals in the climbing fibers are not necessary for cerebellum-dependent learning. Instead, instructive signals carried by either the climbing fibers or Purkinje cell simple spikes may be sufficient to induce motor learning, with additive effects occurring when both instructive signals are present during training.	[Ke, Michael C.; Guo, Cong C.; Raymond, Jennifer L.] Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA	Stanford University	Raymond, JL (corresponding author), Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA.	jennifer.raymond@stanford.edu	Guo, Christine/F-4006-2017	Guo, Christine/0000-0003-1530-0172; Raymond, Jennifer/0000-0002-8145-747X	US National Institutes of Health [R01 DC004154, F31 DC008078]; Howard Hughes Medical Institute fellowship for Medical Students; Stanford Medical Scientist Training Program; Stanford Graduate Fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS072406] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004154, F31DC008078] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute fellowship for Medical Students(Howard Hughes Medical Institute); Stanford Medical Scientist Training Program; Stanford Graduate Fellowship(Stanford University); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank P. Louderback and R. Levine for technical assistance, and E. Knudsen, D. Angelaki, M. Goldman, D. Fisher, I. Witten, E. Mukamel, A. Katoh, R. Kimpo, B. Nguyen-Vu and S.-L. Shin for their comments on the manuscript. This work was supported by the US National Institutes of Health (grants R01 DC004154 to J.L.R. and F31 DC008078 to M. C. K.), a Howard Hughes Medical Institute fellowship for Medical Students and the Stanford Medical Scientist Training Program to M. C. K. and a Stanford Graduate Fellowship to C. C. G.	ALBUS J S, 1971, Mathematical Biosciences, V10, P25, DOI 10.1016/0025-5564(71)90051-4; Boyden ES, 2006, NEURON, V51, P823, DOI 10.1016/j.neuron.2006.08.026; Boyden ES, 2004, ANNU REV NEUROSCI, V27, P581, DOI 10.1146/annurev.neuro.27.070203.144238; Coesmans M, 2004, NEURON, V44, P691, DOI 10.1016/j.neuron.2004.10.031; COHEN H, 1992, EXP BRAIN RES, V90, P526; COLIN F, 1980, BRAIN RES, V187, P3, DOI 10.1016/0006-8993(80)90491-6; De Zeeuw CI, 2005, CURR OPIN NEUROBIOL, V15, P667, DOI 10.1016/j.conb.2005.10.008; ECCLES JC, 1966, J PHYSIOL-LONDON, V182, P268, DOI 10.1113/jphysiol.1966.sp007824; Evans GJO, 2007, BIOL CELL, V99, P363, DOI 10.1042/BC20070010; GILBERT PFC, 1977, BRAIN RES, V128, P309, DOI 10.1016/0006-8993(77)90997-0; HADDAD GM, 1980, BRAIN RES, V185, P265, DOI 10.1016/0006-8993(80)91067-7; Han VZ, 2007, J NEUROSCI, V27, P13499, DOI 10.1523/JNEUROSCI.2613-07.2007; Hartell NA, 1996, NEURON, V16, P601, DOI 10.1016/S0896-6273(00)80079-3; Hirata Y, 2001, J NEUROPHYSIOL, V85, P2267, DOI 10.1152/jn.2001.85.5.2267; Ilg UJ, 1996, EUR J NEUROSCI, V8, P92, DOI 10.1111/j.1460-9568.1996.tb01170.x; ITO M, 1977, J PHYSIOL-LONDON, V265, P833, DOI 10.1113/jphysiol.1977.sp011747; ITO M, 1982, EXP BRAIN RES, V45, P233; ITO M, 1972, BRAIN RES, V40, P81, DOI 10.1016/0006-8993(72)90110-2; ITO M, 1982, NEUROSCI LETT, V33, P253, DOI 10.1016/0304-3940(82)90380-9; Jirenhed DA, 2007, J NEUROSCI, V27, P2493, DOI 10.1523/JNEUROSCI.4202-06.2007; Jorntell H, 2002, NEURON, V34, P797, DOI 10.1016/S0896-6273(02)00713-4; Lev-Ram V, 2003, P NATL ACAD SCI USA, V100, P15989, DOI 10.1073/pnas.2636935100; LISBERGER SG, 1992, NATURE, V360, P159, DOI 10.1038/360159a0; LISBERGER SG, 1994, J NEUROPHYSIOL, V72, P928, DOI 10.1152/jn.1994.72.2.928; LISBERGER SG, 1994, J NEUROPHYSIOL, V72, P974, DOI 10.1152/jn.1994.72.2.974; LISBERGER SG, 1978, J NEUROPHYSIOL, V41, P733, DOI 10.1152/jn.1978.41.3.733; MAEKAWA K, 1979, BRAIN RES, V172, P393, DOI 10.1016/0006-8993(79)90574-2; MARR D, 1969, J PHYSIOL-LONDON, V202, P437, DOI 10.1113/jphysiol.1969.sp008820; Medina JF, 2001, J NEUROSCI, V21, P4081, DOI 10.1523/JNEUROSCI.21-11-04081.2001; Medina JF, 2000, CURR OPIN NEUROBIOL, V10, P717, DOI 10.1016/S0959-4388(00)00154-9; MILES FA, 1981, ANNU REV NEUROSCI, V4, P273, DOI 10.1146/annurev.ne.04.030181.001421; MILES FA, 1980, J NEUROPHYSIOL, V43, P1437, DOI 10.1152/jn.1980.43.5.1437; MINTZ M, 1994, BEHAV NEURAL BIOL, V61, P218, DOI 10.1016/S0163-1047(05)80004-4; Mittmann W, 2007, J NEUROSCI, V27, P5559, DOI 10.1523/JNEUROSCI.5117-06.2007; MUSTARI MJ, 1990, J NEUROPHYSIOL, V64, P77, DOI 10.1152/jn.1990.64.1.77; Ohyama T, 2006, J NEUROSCI, V26, P12656, DOI 10.1523/JNEUROSCI.4023-06.2006; Rambold H, 2002, J NEUROPHYSIOL, V87, P912, DOI 10.1152/jn.00768.2000; Rancillac A, 2004, J PHYSIOL-LONDON, V554, P707, DOI 10.1113/jphysiol.2003.055871; Raymond JL, 1998, J NEUROSCI, V18, P9112; Raymond JL, 1996, J NEUROSCI, V16, P7791; ROBINSON DA, 1976, J NEUROPHYSIOL, V39, P954, DOI 10.1152/jn.1976.39.5.954; ROBINSON DA, 1963, IEEE T BIO-MED ENG, VBM10, P137, DOI 10.1109/TBMEL.1963.4322822; Shinoda Y, 2000, PROG BRAIN RES, V124, P173; Shutoh F, 2006, NEUROSCIENCE, V139, P767, DOI 10.1016/j.neuroscience.2005.12.035; SIMPSON JI, 1974, BRAIN RES, V82, P302, DOI 10.1016/0006-8993(74)90610-6; TORTE MP, 1994, EXP BRAIN RES, V99, P441; Zbarska S, 2008, J NEUROSCI, V28, P10, DOI 10.1523/JNEUROSCI.3403-07.2008	47	79	80	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2009	12	9					1171	U23		10.1038/nn.2366	http://dx.doi.org/10.1038/nn.2366			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	487ZD	19684593	Green Accepted			2022-12-24	WOS:000269317300020
J	Yu, XJ; Xu, XX; He, SG; He, JF				Yu, Xiong-Jie; Xu, Xin-Xiu; He, Shigang; He, Jufang			Change detection by thalamic reticular neurons	NATURE NEUROSCIENCE			English	Article							GUINEA-PIG; AUDITORY THALAMUS; NOVELTY DETECTION; IN-VITRO; NUCLEUS; CAT; SYNCHRONIZATION; MECHANISMS; SYNAPSES; COMPLEX	The thalamic reticular nucleus (TRN) is thought to function in the attentional searchlight. We analyzed the detection of deviant acoustic stimuli by TRN neurons and the consequences of deviance detection on the TRN target, the medial geniculate body (MGB) of the rat. TRN neurons responded more strongly to pure-tone stimuli presented as deviant stimuli ( low appearance probability) than those presented as standard stimuli ( high probability) (deviance-detection index = 0.321). MGB neurons also showed deviance detection in this procedure, albeit to a smaller extent (deviance-detection index = 0.154). TRN neuron deviance detection either enhanced ( 14 neurons) or suppressed ( 27 neurons) MGB neuronal responses to a probe stimulus. Both effects were neutralized by inactivation of the auditory TRN. Deviance modulation effects were cross-modal. Deviance detection probably causes TRN neurons to transiently deactivate surrounding TRN neurons in response to a fresh stimulus, altering auditory thalamus responses and inducing attention shift.	[Yu, Xiong-Jie; Xu, Xin-Xiu; He, Shigang; He, Jufang] Chinese Acad Sci, Inst Biophys, CAS Hong Kong Joint Res Lab Visuo Auditory Integr, Beijing 100080, Peoples R China; [Yu, Xiong-Jie; He, Jufang] Hong Kong Polytech Univ, Dept Rehabil Sci, Lab Appl Neurosci, Kowloon, Hong Kong, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Hong Kong Polytechnic University	He, JF (corresponding author), Chinese Acad Sci, Inst Biophys, CAS Hong Kong Joint Res Lab Visuo Auditory Integr, Beijing 100080, Peoples R China.	shiganghe@moon.ibp.ac.cn; rsjufang@polyu.edu.hk		HE, Jufang/0000-0002-4288-5957	Natural Science Foundation of China ( Overseas Cooperation Fund); Hong Kong Grants Council [PolyU 5412/06M]	Natural Science Foundation of China ( Overseas Cooperation Fund)(National Natural Science Foundation of China (NSFC)); Hong Kong Grants Council(Hong Kong Research Grants Council)	The authors thank A. Palmer and M. Wallace for their critical readings and comments. This work was supported by the Natural Science Foundation of China ( Overseas Cooperation Fund) and the Hong Kong Grants Council (PolyU 5412/06M).	BAL T, 1993, J PHYSIOL-LONDON, V468, P669, DOI 10.1113/jphysiol.1993.sp019794; CARPENTER GA, 1993, TRENDS NEUROSCI, V16, P131, DOI 10.1016/0166-2236(93)90118-6; Crabtree JW, 2002, J NEUROSCI, V22, P8754; CRICK F, 1984, P NATL ACAD SCI-BIOL, V81, P4586, DOI 10.1073/pnas.81.14.4586; DESCHENES M, 1985, BRAIN RES, V334, P165, DOI 10.1016/0006-8993(85)90580-3; Guillery RW, 2002, NEURON, V33, P163, DOI 10.1016/S0896-6273(01)00582-7; Guo YP, 2007, P NATL ACAD SCI USA, V104, P11802, DOI 10.1073/pnas.0701302104; He JF, 2002, J NEUROPHYSIOL, V88, P1040, DOI 10.1152/jn.2002.88.2.1040; He JF, 2001, J NEUROSCI, V21, P8672, DOI 10.1523/JNEUROSCI.21-21-08672.2001; HOUSER CR, 1980, BRAIN RES, V200, P341, DOI 10.1016/0006-8993(80)90925-7; JAHNSEN H, 1984, J PHYSIOL-LONDON, V349, P227, DOI 10.1113/jphysiol.1984.sp015154; JAHNSEN H, 1984, J PHYSIOL-LONDON, V349, P205, DOI 10.1113/jphysiol.1984.sp015153; JONES EG, 1975, J COMP NEUROL, V162, P285, DOI 10.1002/cne.901620302; Knight RT, 1996, NATURE, V383, P256, DOI 10.1038/383256a0; Landisman CE, 2002, J NEUROSCI, V22, P1002, DOI 10.1523/JNEUROSCI.22-03-01002.2002; LLINAS R, 1997, THALAMUS, P501; LLINAS RR, 1991, NEUROSCIENCE, V44, P521, DOI 10.1016/0306-4522(91)90075-Y; Long MA, 2004, J NEUROSCI, V24, P341, DOI 10.1523/JNEUROSCI.3358-03.2004; Malone BJ, 2001, J NEUROPHYSIOL, V86, P1113, DOI 10.1152/jn.2001.86.3.1113; MCCORMICK DA, 1986, NATURE, V319, P402, DOI 10.1038/319402a0; Muhlau M, 2006, CEREB CORTEX, V16, P1283, DOI 10.1093/cercor/bhj070; Paxinos G., 2005, RAT BRAIN STEREOTAXI, V5th Edn, DOI 10.1016/c2009-0-63235-9; Perez-Gonzalez D, 2005, EUR J NEUROSCI, V22, P2879, DOI 10.1111/j.1460-9568.2005.04472.x; Sherman SM, 2001, NAT NEUROSCI, V4, P344, DOI 10.1038/85973; SHOSAKU A, 1983, EXP BRAIN RES, V49, P432; SIMM GM, 1990, J NEUROPHYSIOL, V63, P1010, DOI 10.1152/jn.1990.63.5.1010; STERIADE M, 1984, BRAIN RES REV, V8, P1, DOI 10.1016/0165-0173(84)90017-1; Steriade M, 1997, THALAMUS ORG FUNCTIO; TIITINEN H, 1994, NATURE, V372, P90, DOI 10.1038/372090a0; Ulanovsky N, 2003, NAT NEUROSCI, V6, P391, DOI 10.1038/nn1032; WARREN RA, 1994, J NEUROPHYSIOL, V72, P1993, DOI 10.1152/jn.1994.72.4.1993; Xiong Y, 2004, J PHYSIOL-LONDON, V560, P207, DOI 10.1113/jphysiol.2004.067686; YEN CT, 1985, J NEUROSCI, V5, P2254; Yu XJ, 2009, J NEUROPHYSIOL, V101, P980, DOI 10.1152/jn.91130.2008; Zhang Z, 2008, J NEUROPHYSIOL, V99, P2938, DOI 10.1152/jn.00002.2008; Zikopoulos B, 2006, J NEUROSCI, V26, P7348, DOI 10.1523/JNEUROSCI.5511-05.2006	36	112	114	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2009	12	9					1165	U21		10.1038/nn.2373	http://dx.doi.org/10.1038/nn.2373			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	487ZD	19684591				2022-12-24	WOS:000269317300019
J	Neppl, RL; Wang, DZ				Neppl, Ronald L.; Wang, Da-Zhi			Smooth(ing) Muscle Differentiation by MicroRNAs	CELL STEM CELL			English	Editorial Material							EMBRYONIC STEM-CELLS; GENE-EXPRESSION; MYOCARDIN	In a recent report in Nature, Cordes et al. (2009) demonstrate that miR-143 and miR-145 modulate smooth muscle cell (SMC) plasticity in part by regulating key transcription factors involved in SMC fate determination.	[Neppl, Ronald L.; Wang, Da-Zhi] Harvard Univ, Sch Med, Childrens Hosp Boston, Dept Cardiol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School	Wang, DZ (corresponding author), Harvard Univ, Sch Med, Childrens Hosp Boston, Dept Cardiol, Enders 1260,320 Longwood Ave, Boston, MA 02115 USA.	dwang@enders.tch.harvard.edu	Neppl, Ronald L/AAW-1257-2020	Neppl, Ronald L/0000-0003-1497-6058	NHLBI NIH HHS [R01 HL075251, R01 HL085635, T32 HL007572, U01 HL063411] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007572, U01HL063411, R01HL075251, R01HL085635] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Cheng YH, 2009, CIRC RES, V105, P158, DOI 10.1161/CIRCRESAHA.109.197517; CORDES KR, 2009, NATURE IN PRESS, DOI DOI 10.1038/NATURE08195; Ivey KN, 2008, CELL STEM CELL, V2, P219, DOI 10.1016/j.stem.2008.01.016; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; van Rooij E, 2007, SCIENCE, V316, P575, DOI 10.1126/science.1139089; Wang DZ, 2001, CELL, V105, P851, DOI 10.1016/S0092-8674(01)00404-4; Wang ZG, 2004, NATURE, V428, P185, DOI 10.1038/nature02382; Xu N, 2009, CELL, V137, P647, DOI 10.1016/j.cell.2009.02.038; Zhao Y, 2007, CELL, V129, P303, DOI 10.1016/j.cell.2007.03.030	10	8	9	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	AUG 7	2009	5	2					130	132		10.1016/j.stem.2009.07.004	http://dx.doi.org/10.1016/j.stem.2009.07.004			3	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	490PB	19664984	Green Accepted, Bronze			2022-12-24	WOS:000269511900004
J	Hashimoto, K; Ichikawa, R; Kitamura, K; Watanabe, M; Kano, M				Hashimoto, Kouichi; Ichikawa, Ryoichi; Kitamura, Kazuo; Watanabe, Masahiko; Kano, Masanobu			Translocation of a "Winner" Climbing Fiber to the Purkinje Cell Dendrite and Subsequent Elimination of "Losers" from the Soma in Developing Cerebellum	NEURON			English	Article							CENTRAL-NERVOUS-SYSTEM; DEVELOPING MOUSE CEREBELLUM; PATCH-CLAMP RECORDINGS; SYNAPSE ELIMINATION; POSTNATAL-DEVELOPMENT; GLUTAMATE RECEPTORS; MOTOR COORDINATION; CRITICAL PERIOD; MUTANT MICE; RAT	Functional neural circuits are formed by eliminating early-formed redundant synapses and strengthening necessary connections during development. In newborn mouse cerebellum, each Purkinje cell (PC) is innervated by multiple climbing fibers (CFs) with similar strengths. Subsequently, a single CF is selectively strengthened by postnatal day 7 (P7). We find that this competition among multiple CFs occurs on the soma before CFs form synapses along dendrites. Notably, inmost PCs, the single CF that has been functionally strengthened (the "winner" CF) undergoes translocation to dendrites while keeping its synapses on the soma. Synapses of the weaker CFs (the "loser" CFs) remain around the soma and form "pericellular nests" with synapses of the winner CFs. Then most perisomatic synapses are eliminated nonselectively by P15. Thus, our results suggest that the selective translocation of the winner CF to dendrites in each PC determines the single CF that survives subsequent synapse elimination and persistently innervates the PC.	[Hashimoto, Kouichi; Kitamura, Kazuo; Kano, Masanobu] Univ Tokyo, Grad Sch Med, Dept Neurophysiol, Tokyo 1130033, Japan; [Hashimoto, Kouichi; Kitamura, Kazuo; Kano, Masanobu] Osaka Univ, Grad Sch Med, Dept Cellular Neurosci, Suita, Osaka 5650871, Japan; [Hashimoto, Kouichi] Japan Sci & Technol Agcy, CREST, Tokyo 1028666, Japan; [Ichikawa, Ryoichi] Sapporo Med Univ, Sch Med, Dept Anat, Sapporo, Hokkaido 0608556, Japan; [Watanabe, Masahiko] Hokkaido Univ, Sch Med, Dept Anat, Sapporo, Hokkaido 0608638, Japan	University of Tokyo; Osaka University; Japan Science & Technology Agency (JST); Sapporo Medical University; Hokkaido University	Kano, M (corresponding author), Univ Tokyo, Grad Sch Med, Dept Neurophysiol, 7-3-1 Hongo, Tokyo 1130033, Japan.	mkano-tky@m.u-tokyo.ac.jp	WATANABE, Masahiko/A-4055-2012; Kitamura, Kazuo/F-3379-2013; Watanabe, Masahiko/S-3614-2019	WATANABE, Masahiko/0000-0001-5037-7138; Kitamura, Kazuo/0000-0002-8956-4122; Watanabe, Masahiko/0000-0001-5037-7138; Hashimoto, Kouichi/0000-0002-3884-8213; Kano, Masanobu/0000-0002-0725-3292	Ministry of Education, Science, Sports, Culture, and Technology of Japan [117023021, 17100004, 17023001]; Takeda Science Foundation	Ministry of Education, Science, Sports, Culture, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported by Grants-in-Aid for Scientific Research (117023021 and 17100004 to M.K., and 17023001 to M.W.) from the Ministry of Education, Science, Sports, Culture, and Technology of Japan. This work was also supported by Takeda Science Foundation (K.H.).	ALTMAN J, 1972, J COMP NEUROL, V145, P399, DOI 10.1002/cne.901450402; Bayer, 1997, RELATION ITS EVOLUTI; BRAVIN M, 1995, J COMP NEUROL, V357, P395, DOI 10.1002/cne.903570306; CAJAL S, 1911, HIST SYSTEME NERVEUX, V2; Callaway JC, 1997, J NEUROPHYSIOL, V77, P145, DOI 10.1152/jn.1997.77.1.145; CHEDOTAL A, 1992, EUR J NEUROSCI, V4, P1159, DOI 10.1111/j.1460-9568.1992.tb00142.x; CREPEL F, 1982, TRENDS NEUROSCI, V5, P266, DOI 10.1016/0166-2236(82)90168-0; EDMONDS B, 1995, ANNU REV PHYSIOL, V57, P495; EDWARDS FA, 1989, PFLUG ARCH EUR J PHY, V414, P600, DOI 10.1007/BF00580998; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Hashimoto K, 2005, NEUROSCI RES, V53, P221, DOI 10.1016/j.neures.2005.07.007; Hashimoto K, 2003, NEURON, V38, P785, DOI 10.1016/S0896-6273(03)00298-8; Hashimoto K, 2001, J NEUROSCI, V21, P9701, DOI 10.1523/JNEUROSCI.21-24-09701.2001; HASHIMOTO K, NEUROSCIENC IN PRESS, DOI DOI 10.1016/J.NEUROSCIENCE.2008.12.037; Hensch TK, 2004, ANNU REV NEUROSCI, V27, P549, DOI 10.1146/annurev.neuro.27.070203.144327; Ichise T, 2000, SCIENCE, V288, P1832, DOI 10.1126/science.288.5472.1832; Kakizawa S, 2000, J NEUROSCI, V20, P4954; Kano M, 1995, CELL, V83, P1223, DOI 10.1016/0092-8674(95)90147-7; Kano M, 1997, NEURON, V18, P71, DOI 10.1016/S0896-6273(01)80047-7; Kano M, 1998, P NATL ACAD SCI USA, V95, P15724, DOI 10.1073/pnas.95.26.15724; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kiyohara Y, 2003, J ELECTRON MICROSC, V52, P327, DOI 10.1093/jmicro/52.3.327; Knopfel T, 2000, EUR J NEUROSCI, V12, P2199, DOI 10.1046/j.1460-9568.2000.00122.x; Larramendi LMH, 1969, NEUROBIOLOGY CEREBEL, P803; Lichtman JW, 2000, NEURON, V25, P269, DOI 10.1016/S0896-6273(00)80893-4; Lisman JE, 2007, NAT REV NEUROSCI, V8, P597, DOI 10.1038/nrn2191; Lohof AM, 1996, REV NEUROSCIENCE, V7, P85; MARINPADILLA M, 1985, J COMP NEUROL, V235, P82, DOI 10.1002/cne.902350107; MASON CA, 1990, J COMP NEUROL, V297, P77, DOI 10.1002/cne.902970106; MASON CA, 1984, J NEUROSCI, V4, P1715; Miura E, 2006, J NEUROCHEM, V97, P1431, DOI 10.1111/j.1471-4159.2006.03835.x; Miyazaki T, 2004, J NEUROSCI, V24, P1734, DOI 10.1523/JNEUROSCI.4208-03.2004; Miyazaki T, 2003, EUR J NEUROSCI, V17, P2563, DOI 10.1046/j.1460-9568.2003.02698.x; Miyazaki T, 2006, FEBS LETT, V580, P4057, DOI 10.1016/j.febslet.2006.06.043; Nakagama S, 1998, J COMP NEUROL, V395, P112, DOI 10.1002/(SICI)1096-9861(19980525)395:1<112::AID-CNE8>3.0.CO;2-3; Neale SA, 2001, NEUROPHARMACOLOGY, V41, P42, DOI 10.1016/S0028-3908(01)00046-6; Offermanns S, 1997, P NATL ACAD SCI USA, V94, P14089, DOI 10.1073/pnas.94.25.14089; Palay S.L., 1974, CEREBELLAR CORTEX; PURVES D, 1980, SCIENCE, V210, P153, DOI 10.1126/science.7414326; Roth A, 2001, J PHYSIOL-LONDON, V535, P445, DOI 10.1111/j.1469-7793.2001.00445.x; Scelfo B, 2003, J NEUROPHYSIOL, V89, P2555, DOI 10.1152/jn.00884.2002; Smith MA, 2003, J PHYSIOL-LONDON, V548, P245, DOI 10.1113/jphysiol.2002.036376; Sugihara I, 2005, J COMP NEUROL, V487, P93, DOI 10.1002/cne.20531; Wadiche JI, 2001, NEURON, V32, P301, DOI 10.1016/S0896-6273(01)00488-3; Walsh MK, 2003, NEURON, V37, P67, DOI 10.1016/S0896-6273(02)01142-X; Yamasaki M, 2006, J NEUROSCI, V26, P86, DOI 10.1523/JNEUROSCI.2258-05.2006	46	112	113	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 16	2009	63	1					106	118		10.1016/j.neuron.2009.06.008	http://dx.doi.org/10.1016/j.neuron.2009.06.008			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	473EX	19607796	Bronze			2022-12-24	WOS:000268189900012
J	Clayton, EL; Sue, N; Smillie, KJ; O'Leary, T; Bache, N; Cheung, G; Cole, AR; Wyllie, DJ; Sutherland, C; Robinson, PJ; Cousin, MA				Clayton, Emma L.; Sue, Nancy; Smillie, Karen J.; O'Leary, Timothy; Bache, Nicolai; Cheung, Giselle; Cole, Adam R.; Wyllie, David J.; Sutherland, Calum; Robinson, Phillip J.; Cousin, Michael A.			Dynamin I phosphorylation by GSK3 controls activity-dependent bulk endocytosis of synaptic vesicles	NATURE NEUROSCIENCE			English	Article							GLYCOGEN-SYNTHASE KINASE-3; MEMBRANE RETRIEVAL; STIMULATION; INHIBITORS; DISCOVERY; CDK5; VIVO; WNT	Glycogen synthase kinase 3 (GSK3) is a critical enzyme in neuronal physiology; however, it is not yet known whether it has any specific role in presynaptic function. We found that GSK3 phosphorylates a residue on the large GTPase dynamin I (Ser-774) both in vitro and in primary rat neuronal cultures. This was dependent on prior phosphorylation of Ser-778 by cyclin-dependent kinase 5. Using both acute inhibition with pharmacological antagonists and silencing of expression with short hairpin RNA, we found that GSK3 was specifically required for activity-dependent bulk endocytosis (ADBE) but not clathrin-mediated endocytosis. Moreover we found that the specific phosphorylation of Ser-774 on dynamin I by GSK3 was both necessary and sufficient for ADBE. These results demonstrate a presynaptic role for GSK3 and they indicate that a protein kinase signaling cascade prepares synaptic vesicles for retrieval during elevated neuronal activity.	[Clayton, Emma L.; Smillie, Karen J.; O'Leary, Timothy; Cheung, Giselle; Wyllie, David J.; Cousin, Michael A.] Univ Edinburgh, Ctr Integrat Physiol, Edinburgh, Midlothian, Scotland; [Sue, Nancy; Bache, Nicolai; Robinson, Phillip J.] Univ Sydney, Childrens Med Res Inst, Sydney, NSW 2006, Australia; [Cole, Adam R.; Sutherland, Calum] Univ Dundee, Ninewells Hosp & Med Sch, Biomed Res Inst, Dundee DD1 9SY, Scotland	University of Edinburgh; Children's Medical Research Institute - Australia; University of Sydney; University of Dundee	Cousin, MA (corresponding author), Univ Edinburgh, Ctr Integrat Physiol, Edinburgh, Midlothian, Scotland.	m.cousin@ed.ac.uk	Robinson, Phillip J/G-4008-2011; Cole, Adam/B-9785-2011; Wyllie, David J A/AAK-4678-2021	Robinson, Phillip J/0000-0002-7878-0313; Wyllie, David J A/0000-0002-4957-6049; Smillie, Karen/0000-0003-4369-0470; O'Leary, Timothy/0000-0002-1029-0158; Clayton, Emma/0000-0003-0937-2874; Sutherland, Calum/0000-0003-4398-7434; Cheung, Giselle/0000-0001-8457-2572; Cousin, Michael/0000-0002-1762-160X	Wellcome Trust [070569, 084277]; Epilepsy Research UK [0503]; Cancer Institute NSW; Ramaciotti Foundation; Australian National Health and Medical Research Council; Alzheimer's Research Trust [ART/PG2007/4]; MRC [88158]; Danish Agency for Science, Technology and Innovation [274-08-0066]; Australian NHMRC [454886]; Alzheimers Research UK [ART-PG2005-1] Funding Source: researchfish; Biotechnology and Biological Sciences Research Council [C18727] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Epilepsy Research UK; Cancer Institute NSW; Ramaciotti Foundation; Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Alzheimer's Research Trust; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Danish Agency for Science, Technology and Innovation; Australian NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We wish to thank A. Prescott and J. James (both University of Dundee) for excellent technical assistance. This work was supported by grants from the Wellcome Trust (Ref: 070569 & 084277), Epilepsy Research UK (0503), Cancer Institute NSW, The Ramaciotti Foundation, and the Australian National Health and Medical Research Council. C.S. is supported by the Alzheimer's Research Trust (ART/PG2007/4) and the MRC (88158). N.B. is supported by the Danish Agency for Science, Technology and Innovation (grant 274-08-0066). A.R.C. is supported by an Australian NH&MRC Peter Doherty Fellowship (454886).	Ahmad-Annuar A, 2006, J CELL BIOL, V174, P127, DOI 10.1083/jcb.200511054; Andersson F, 2008, J NEUROSCI, V28, P3925, DOI 10.1523/JNEUROSCI.1754-07.2008; Anggono V, 2006, NAT NEUROSCI, V9, P752, DOI 10.1038/nn1695; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Bhat R, 2003, J BIOL CHEM, V278, P45937, DOI 10.1074/jbc.M306268200; Chen Y, 2003, CELL, V115, P37, DOI 10.1016/S0092-8674(03)00726-8; Clayton EL, 2008, J NEUROSCI, V28, P6627, DOI 10.1523/JNEUROSCI.1445-08.2008; Clayton EL, 2009, J NEUROSCI, V29, P7706, DOI 10.1523/JNEUROSCI.1976-09.2009; Cole AR, 2006, J BIOL CHEM, V281, P16591, DOI 10.1074/jbc.M513344200; Cousin MA, 2001, TRENDS NEUROSCI, V24, P659, DOI 10.1016/S0166-2236(00)01930-5; Dhavan R, 2001, NAT REV MOL CELL BIO, V2, P749, DOI 10.1038/35096019; Eldar-Finkelman H, 2002, TRENDS MOL MED, V8, P126, DOI 10.1016/S1471-4914(01)02266-3; Evans GJO, 2007, J NEUROSCI, V27, P401, DOI 10.1523/JNEUROSCI.3809-06.2007; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Graham ME, 2007, J BIOL CHEM, V282, P14695, DOI 10.1074/jbc.M609713200; Granseth B, 2006, NEURON, V51, P773, DOI 10.1016/j.neuron.2006.08.029; Holt M, 2003, J NEUROSCI, V23, P1329, DOI 10.1523/JNEUROSCI.23-04-01329.2003; Hongisto V, 2008, MOL CELL BIOL, V28, P1515, DOI 10.1128/MCB.02227-06; Hooper C, 2008, J NEUROCHEM, V104, P1433, DOI 10.1111/j.1471-4159.2007.05194.x; Koh TW, 2007, J CELL BIOL, V178, P309, DOI 10.1083/jcb.200701030; Larsen MR, 2005, MOL CELL PROTEOMICS, V4, P873, DOI 10.1074/mcp.T500007-MCP200; Ma YC, 2008, NEURON, V58, P65, DOI 10.1016/j.neuron.2008.01.037; Newton AJ, 2006, P NATL ACAD SCI USA, V103, P17955, DOI 10.1073/pnas.0606212103; Peineau S, 2007, NEURON, V53, P703, DOI 10.1016/j.neuron.2007.01.029; Richards DA, 2000, NEURON, V27, P551, DOI 10.1016/S0896-6273(00)00065-9; Shupliakov O, 1997, SCIENCE, V276, P259, DOI 10.1126/science.276.5310.259; Tan TC, 2003, NAT CELL BIOL, V5, P701, DOI 10.1038/ncb1020; Teng HB, 2007, J PHYSIOL-LONDON, V582, P243, DOI 10.1113/jphysiol.2007.130989; Wagman AS, 2004, CURR PHARM DESIGN, V10, P1105, DOI 10.2174/1381612043452668; WOODGETT JR, 1990, EMBO J, V9, P2431, DOI 10.1002/j.1460-2075.1990.tb07419.x; Zhu YL, 2009, NEURON, V61, P397, DOI 10.1016/j.neuron.2008.12.024	31	119	123	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2010	13	7					845	U85		10.1038/nn.2571	http://dx.doi.org/10.1038/nn.2571			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	615YF	20526333	Green Accepted, Green Submitted			2022-12-24	WOS:000279173900017
J	Perez-Tilve, D; Hofmann, SM; Basford, J; Nogueiras, R; Pfluger, PT; Patterson, JT; Grant, E; Wilson-Perez, HE; Granholm, NA; Arnold, M; Trevaskis, JL; Butler, AA; Davidson, WS; Woods, SC; Benoit, SC; Sleeman, MW; DiMarchi, RD; Hui, DY; Tschop, MH				Perez-Tilve, Diego; Hofmann, Susanna M.; Basford, Joshua; Nogueiras, Ruben; Pfluger, Paul T.; Patterson, James T.; Grant, Erin; Wilson-Perez, Hilary E.; Granholm, Norman A.; Arnold, Myrtha; Trevaskis, James L.; Butler, Andrew A.; Davidson, William S.; Woods, Stephen C.; Benoit, Stephen C.; Sleeman, Mark W.; DiMarchi, Richard D.; Hui, David Y.; Tschoep, Matthias H.			Melanocortin signaling in the CNS directly regulates circulating cholesterol	NATURE NEUROSCIENCE			English	Article							RECEPTOR CLASS-B; DENSITY-LIPOPROTEIN HDL; I SR-BI; MICE LACKING; TARGETED MUTATION; SELECTIVE UPTAKE; LEPTIN; OBESE; EXPRESSION; MECHANISM	Cholesterol circulates in the blood in association with triglycerides and other lipids, and elevated blood low-density lipoprotein cholesterol carries a risk for metabolic and cardiovascular disorders, whereas high-density lipoprotein (HDL) cholesterol in the blood is thought to be beneficial. Circulating cholesterol is the balance among dietary cholesterol absorption, hepatic synthesis and secretion, and the metabolism of lipoproteins by various tissues. We found that the CNS is also an important regulator of cholesterol in rodents. Inhibiting the brain's melanocortin system by pharmacological, genetic or endocrine mechanisms increased circulating HDL cholesterol by reducing its uptake by the liver independent of food intake or body weight. Our data suggest that a neural circuit in the brain is directly involved in the control of cholesterol metabolism by the liver.	[Perez-Tilve, Diego; Hofmann, Susanna M.; Nogueiras, Ruben; Pfluger, Paul T.; Grant, Erin; Wilson-Perez, Hilary E.; Woods, Stephen C.; Benoit, Stephen C.; Tschoep, Matthias H.] Univ Cincinnati, Coll Med, Dept Med, Div Endocrinol,Metab Dis Inst, Cincinnati, OH 45221 USA; [Perez-Tilve, Diego; Hofmann, Susanna M.; Nogueiras, Ruben; Pfluger, Paul T.; Grant, Erin; Wilson-Perez, Hilary E.; Woods, Stephen C.; Benoit, Stephen C.; Tschoep, Matthias H.] Univ Cincinnati, Coll Med, Dept Psychiat, Div Endocrinol,Metab Dis Inst, Cincinnati, OH USA; [Basford, Joshua; Granholm, Norman A.; Davidson, William S.; Hui, David Y.] Univ Cincinnati, Coll Med, Dept Pathol, Lipid Res Ctr, Cincinnati, OH USA; [Patterson, James T.; DiMarchi, Richard D.] Indiana Univ, Dept Chem, Bloomington, IN USA; [Arnold, Myrtha] Swiss Fed Inst Technol, Inst Anim Sci, Schwerzenbach, Switzerland; [Trevaskis, James L.; Butler, Andrew A.] Pennington Biomed Res Ctr, Neuropeptides Lab, Baton Rouge, LA USA; [Sleeman, Mark W.] Regeneron Pharmaceut Inc, Tarrytown, NY USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; Indiana University System; Indiana University Bloomington; Swiss Federal Institutes of Technology Domain; ETH Zurich; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Regeneron	Tschop, MH (corresponding author), Univ Cincinnati, Coll Med, Dept Med, Div Endocrinol,Metab Dis Inst, Cincinnati, OH 45221 USA.	matthias.tschoep@uc.edu	Hofmann, Susanna/F-2654-2014; Pfluger, Paul T/A-3770-2019; Tschoep, Matthias H/I-5443-2014; Nogueiras, Ruben/AAS-9427-2021	Hofmann, Susanna/0000-0001-7682-5840; Pfluger, Paul T/0000-0002-8118-7588; Nogueiras, Ruben/0000-0002-9976-9930; Perez-Tilve, Diego/0000-0002-0351-4133; Butler, Andrew/0000-0001-7196-0170; Patterson, James/0000-0001-6006-7184; Trevaskis, James/0000-0002-5356-6118; Tschoep, Matthias/0000-0002-4744-371X; Davidson, William/0000-0003-2756-2989	US National Institute of Health [NIDDK56863, 5R01DK077975, R01 DK076907, HL67093]; American Heart Association [0635079N]; American Diabetes Association [1-10-BS-72]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067093, R21HL104136] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK077975, R01DK073189, R01DK076907] Funding Source: NIH RePORTER	US National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); American Diabetes Association(American Diabetes Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by US National Institute of Health grants NIDDK56863 (S. C. W. and M. H. T.), 5R01DK077975 (M. H. T.), R01 DK076907 (D.Y.H.) and HL67093 (W. S. D.). S. M. H. is the recipient of a Scientist Development Award from the American Heart Association (#0635079N). S. M. H. is a recipient of a Basic Science Award (1-10-BS-72) from the American Diabetes Association.	Ahren B, 2000, DIABETOLOGIA, V43, P393, DOI 10.1007/s001250051322; ARAI T, 1994, ARTERIOSCLER THROMB, V14, P1129, DOI 10.1161/01.ATV.14.7.1129; Bluher S, 2004, DIABETES, V53, P82, DOI 10.2337/diabetes.53.1.82; Castaneda TR, 2005, J NUTR, V135, P1314, DOI 10.1093/jn/135.5.1314; Cettour-Rose P, 2002, ENDOCRINOLOGY, V143, P2277, DOI 10.1210/en.143.6.2277; Chen AS, 2000, NAT GENET, V26, P97, DOI 10.1038/79254; Coll AP, 2007, CELL, V129, P251, DOI 10.1016/j.cell.2007.04.001; Cone RD, 2006, ENDOCR REV, V27, P736, DOI 10.1210/er.2006-0034; Cowley MA, 2003, NEURON, V37, P649, DOI 10.1016/S0896-6273(03)00063-1; Cummings DE, 2007, J CLIN INVEST, V117, P13, DOI 10.1172/JCI30227; Cummings DE, 2006, PHYSIOL BEHAV, V89, P71, DOI 10.1016/j.physbeh.2006.05.022; Engelking LJ, 2005, J CLIN INVEST, V115, P2489, DOI 10.1172/JCI25614; Enriori PJ, 2007, CELL METAB, V5, P181, DOI 10.1016/j.cmet.2007.02.004; Ford ES, 2002, JAMA-J AM MED ASSOC, V287, P356, DOI 10.1001/jama.287.3.356; Ginsberg HN, 2000, J CLIN INVEST, V106, P453, DOI 10.1172/JCI10762; Gruen ML, 2005, J LIPID RES, V46, P2007, DOI 10.1194/jlr.M500181-JLR200; Grundy SM, 2007, J CLIN ENDOCR METAB, V92, P399, DOI 10.1210/jc.2006-0513; Hasty AH, 2001, J BIOL CHEM, V276, P37402, DOI 10.1074/jbc.M010176200; Horton JD, 2002, COLD SPRING HARB SYM, V67, P491, DOI 10.1101/sqb.2002.67.491; Huby T, 2006, J CLIN INVEST, V116, P2767, DOI 10.1172/JCI26893; Lam TKT, 2007, NAT MED, V13, P171, DOI 10.1038/nm1540; Lambert G, 2003, J BIOL CHEM, V278, P2563, DOI 10.1074/jbc.M209525200; Lowell BB, 2000, NATURE, V404, P652, DOI 10.1038/35007527; Lundasen T, 2003, J BIOL CHEM, V278, P43224, DOI 10.1074/jbc.M302645200; Ma XS, 2007, J NEUROSCI, V27, P7125, DOI 10.1523/JNEUROSCI.1025-07.2007; Morton GJ, 2006, NATURE, V443, P289, DOI 10.1038/nature05026; Nogueiras R, 2007, J CLIN INVEST, V117, P3475, DOI 10.1172/JCI31743; PITTMAN RC, 1987, J BIOL CHEM, V262, P2443; Pocai A, 2005, CELL METAB, V1, P53, DOI 10.1016/j.cmet.2004.11.001; Rader DJ, 2006, J CLIN INVEST, V116, P3090, DOI 10.1172/JCI30163; Rigotti A, 1997, P NATL ACAD SCI USA, V94, P12610, DOI 10.1073/pnas.94.23.12610; SCHNOLZER M, 1992, INT J PEPT PROT RES, V40, P180; Schoonjans K, 2002, EMBO REP, V3, P1181, DOI 10.1093/embo-reports/kvf238; Shetty S, 2006, ARTERIOSCL THROM VAS, V26, P2125, DOI 10.1161/01.ATV.0000233335.26362.37; Silver DL, 2000, J CLIN INVEST, V105, P151, DOI 10.1172/JCI8087; Silver DL, 1999, J BIOL CHEM, V274, P4140, DOI 10.1074/jbc.274.7.4140; Sutton GM, 2006, ENDOCRINOLOGY, V147, P2183, DOI 10.1210/en.2005-1209; Tondu AL, 2005, J BIOL CHEM, V280, P33536, DOI 10.1074/jbc.M502392200; Tschop M, 2000, NATURE, V407, P908, DOI 10.1038/35038090; Vaisse C, 2000, J CLIN INVEST, V106, P253, DOI 10.1172/JCI9238; Varban ML, 1998, P NATL ACAD SCI USA, V95, P4619, DOI 10.1073/pnas.95.8.4619; Zhang YZ, 2005, J CLIN INVEST, V115, P2870, DOI 10.1172/JCI25327	42	73	77	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2010	13	7					877	U123		10.1038/nn.2569	http://dx.doi.org/10.1038/nn.2569			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	615YF	20526334	Green Accepted			2022-12-24	WOS:000279173900021
J	Mak, GK; Weiss, S				Mak, Gloria K.; Weiss, Samuel			Paternal recognition of adult offspring mediated by newly generated CNS neurons	NATURE NEUROSCIENCE			English	Article							INBREEDING AVOIDANCE; OLFACTORY-BULB; STIMULATED NEUROGENESIS; KIN RECOGNITION; NEWBORN NEURONS; BEHAVIOR; MICE; DISCRIMINATION; PROLACTIN; EXPOSURE	In mammals, olfaction is often used to distinguish individuals on the basis of their unique odor types (genetically programmed body odors). Parental-offspring recognition behavior is mediated, in part, by learning and processing of different odor types and is crucial for reproductive success. Maternal recognition behavior and associated brain plasticity has been well characterized, but paternal recognition behavior and brain plasticity is poorly understood. We found that paternal-adult offspring recognition behavior in mice was dependent on postnatal offspring interaction and was associated with increased neurogenesis in the paternal olfactory bulb and hippocampus. Newly generated paternal olfactory interneurons were preferentially activated by adult offspring odors. Disrupting prolactin signaling abolished increased paternal neurogenesis and adult offspring recognition. Rescuing this neurogenesis restored recognition behavior. Thus, neurogenesis in the paternal brain may be involved in offspring recognition.	[Mak, Gloria K.; Weiss, Samuel] Univ Calgary, Fac Med, Dept Cell Biol & Anat, Hotchkiss Brain Inst, Calgary, AB, Canada	University of Calgary	Weiss, S (corresponding author), Univ Calgary, Fac Med, Dept Cell Biol & Anat, Hotchkiss Brain Inst, Calgary, AB, Canada.	weiss@ucalgary.ca			Canadian Institutes of Health Research; Alberta Heritage Foundation for Medical Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Heritage Foundation for Medical Research(Alberta Heritage Foundation for Medical ResearchGeneral Electric)	We are grateful to K. Markham for her helpful instruction and mentorship. We thank C. Gregg, B. Kolb, K. Lukowiak and D. van der Kooy for comments on earlier versions of this manuscript. This work was supported by the Canadian Institutes of Health Research and studentship (G.K.M.) and scientist (S.W.) awards from the Alberta Heritage Foundation for Medical Research.	Brennan PA, 2006, PHILOS T R SOC B, V361, P2061, DOI 10.1098/rstb.2006.1931; Buchan JC, 2003, NATURE, V425, P179, DOI 10.1038/nature01866; Curtis MA, 2007, SCIENCE, V315, P1243, DOI 10.1126/science.1136281; DEWSBURY DA, 1988, BEHAV GENET, V18, P525, DOI 10.1007/BF01065519; Dubas JS, 2009, HUM NATURE-INT BIOS, V20, P80, DOI 10.1007/s12110-009-9058-4; Enwere E, 2004, J NEUROSCI, V24, P8354, DOI 10.1523/JNEUROSCI.2751-04.2004; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Gregg C, 2007, J NEUROSCI, V27, P1812, DOI 10.1523/JNEUROSCI.4441-06.2007; Hurst JL, 2005, P ROY SOC B-BIOL SCI, V272, P715, DOI 10.1098/rspb.2004.3004; JIMENEZ JA, 1994, SCIENCE, V266, P271, DOI 10.1126/science.7939661; Kelly PA, 2001, FRONT NEUROENDOCRIN, V22, P140, DOI 10.1006/frne.2001.0212; Ling C, 2000, ENDOCRINOLOGY, V141, P3564, DOI 10.1210/en.141.10.3564; Lledo PM, 2005, PHYSIOL REV, V85, P281, DOI 10.1152/physrev.00008.2004; Lonstein JS, 2000, NEUROSCI BIOBEHAV R, V24, P669, DOI 10.1016/S0149-7634(00)00036-1; Lonstein JS, 2002, CURR PROTOC NEUROSCI, V8; Magavi SSP, 2005, J NEUROSCI, V25, P10729, DOI 10.1523/JNEUROSCI.2250-05.2005; Mak GK, 2007, NAT NEUROSCI, V10, P1003, DOI 10.1038/nn1928; MAKIN JW, 1984, BEHAV NEURAL BIOL, V41, P135, DOI 10.1016/S0163-1047(84)90513-2; MANNING CJ, 1992, NATURE, V360, P581, DOI 10.1038/360581a0; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Ormandy CJ, 1997, J MAMMARY GLAND BIOL, V2, P355, DOI 10.1023/A:1026395229025; OSTERMEYER MC, 1983, DEV PSYCHOBIOL, V16, P75, DOI 10.1002/dev.420160202; Pillay N, 2002, MAMM BIOL, V67, P212, DOI 10.1078/1616-5047-00032; Porter RH, 1998, GENETICA, V104, P259, DOI 10.1023/A:1026404319384; Pusey A, 1996, TRENDS ECOL EVOL, V11, P201, DOI 10.1016/0169-5347(96)10028-8; PUSEY AE, 1987, TRENDS ECOL EVOL, V2, P295, DOI 10.1016/0169-5347(87)90081-4; Restrepo D, 2006, TRENDS NEUROSCI, V29, P604, DOI 10.1016/j.tins.2006.08.001; Rochefort C, 2005, EUR J NEUROSCI, V22, P2863, DOI 10.1111/j.1460-9568.2005.04486.x; Rochefort C, 2002, J NEUROSCI, V22, P2679, DOI 10.1523/JNEUROSCI.22-07-02679.2002; Ruscio MG, 2008, BEHAV BRAIN RES, V187, P9, DOI 10.1016/j.bbr.2007.08.028; Sanchez-Andrade G, 2005, J REPROD DEVELOP, V51, P547, DOI 10.1262/jrd.17031; Sherborne AL, 2007, CURR BIOL, V17, P2061, DOI 10.1016/j.cub.2007.10.041; Shingo T, 2003, SCIENCE, V299, P117, DOI 10.1126/science.1076647; Singh PB, 2001, REPRODUCTION, V121, P529, DOI 10.1530/reprod/121.4.529; Trinh K, 2003, NAT NEUROSCI, V6, P519, DOI 10.1038/nn1039; WOODROFFE R, 1994, TRENDS ECOL EVOL, V9, P294, DOI 10.1016/0169-5347(94)90033-7; Yamazaki K, 2000, P NATL ACAD SCI USA, V97, P10500, DOI 10.1073/pnas.180320997	37	147	151	0	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2010	13	6					753	U134		10.1038/nn.2550	http://dx.doi.org/10.1038/nn.2550			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	600QY	20453850				2022-12-24	WOS:000278003300021
J	Meeks, JP; Arnson, HA; Holy, TE				Meeks, Julian P.; Arnson, Hannah A.; Holy, Timothy E.			Representation and transformation of sensory information in the mouse accessory olfactory system	NATURE NEUROSCIENCE			English	Article							AXONAL PROJECTIONS; VOMERONASAL ORGAN; ODORANT RECEPTOR; MITRAL CELLS; BULB; NEURONS; RESPONSES; PATTERNS; SPARSE; INPUT	In mice, nonvolatile social cues are detected and analyzed by the accessory olfactory system (AOS). Here we provide a first view of information processing in the AOS with respect to individual chemical cues. 12 sulfated steroids, recently discovered mouse AOS ligands, caused widespread activity among vomeronasal sensory neurons (VSNs), yet VSN responses clustered into a small number of repeated functional patterns or processing streams. Downstream neurons in the accessory olfactory bulb (AOB) responded to these ligands with enhanced signal/noise compared to VSNs. Although the dendritic connectivity of AOB mitral cells suggests the capacity for broad integration, most sulfated steroid responses were well-modeled by linear excitatory drive from just one VSN processing stream. However, a substantial minority demonstrated multi-stream integration. Most VSN excitation patterns were also observed in the AOB, but excitation by estradiol sulfate processing streams was rare, suggesting AOB circuit organization is specific to the biological relevance of sensed cues.	[Meeks, Julian P.; Arnson, Hannah A.; Holy, Timothy E.] Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; [Arnson, Hannah A.] Washington Univ, Grad Program Neurosci, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Holy, TE (corresponding author), Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA.	holy@wustl.edu	Meeks, Julian/ABE-4361-2020	Meeks, Julian/0000-0002-7537-4491	G. Harold and Leila Y. Mathers Foundation; US National Institute for Deafness and Other Communication Disorders [R01DC005964, R01DC010381, F32DC009352]; W.M. Keck Foundation; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005964, F32DC009352, R01DC010381] Funding Source: NIH RePORTER	G. Harold and Leila Y. Mathers Foundation; US National Institute for Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); W.M. Keck Foundation(W.M. Keck Foundation); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank D. Kerschensteiner for comments and suggestions and all members of the Holy laboratory for helpful feedback. We acknowledge the generous support of the G. Harold and Leila Y. Mathers Foundation (T.E.H.), the US National Institute for Deafness and Other Communication Disorders (R01DC005964 and R01DC010381 to T.E.H.; F32DC009352 to J.P.M.) and the W.M. Keck Foundation (J.P.M.).	Belluscio L, 1999, CELL, V97, P209, DOI 10.1016/S0092-8674(00)80731-X; Bhandawat V, 2007, NAT NEUROSCI, V10, P1474, DOI 10.1038/nn1976; Bozza T, 2004, NEURON, V42, P9, DOI 10.1016/S0896-6273(04)00144-8; Comaniciu D, 2002, IEEE T PATTERN ANAL, V24, P603, DOI 10.1109/34.1000236; Davison IG, 2007, J NEUROSCI, V27, P2091, DOI 10.1523/JNEUROSCI.3779-06.2007; Del Punta K, 2002, NEURON, V35, P1057, DOI 10.1016/S0896-6273(02)00904-2; Del Punta K, 2002, NATURE, V419, P70, DOI 10.1038/nature00955; DUCHAMPVIRET P, 1989, J NEUROPHYSIOL, V61, P1085, DOI 10.1152/jn.1989.61.5.1085; Dulac C, 2007, CURR OPIN NEUROBIOL, V17, P675, DOI 10.1016/j.conb.2008.01.009; Fantana AL, 2008, NEURON, V59, P802, DOI 10.1016/j.neuron.2008.07.039; Fletcher ML, 2003, J NEUROSCI, V23, P6946; Friedrich RW, 2004, J NEUROPHYSIOL, V91, P2658, DOI 10.1152/jn.01143.2003; Friedrich RW, 1997, NEURON, V18, P737, DOI 10.1016/S0896-6273(00)80314-1; Grosmaitre X, 2009, J NEUROSCI, V29, P14545, DOI 10.1523/JNEUROSCI.2752-09.2009; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; Hendrickson RC, 2008, J NEUROSCI, V28, P12523, DOI 10.1523/JNEUROSCI.2715-08.2008; Holekamp TF, 2008, NEURON, V57, P661, DOI 10.1016/j.neuron.2008.01.011; Holy TE, 2000, SCIENCE, V289, P1569, DOI 10.1126/science.289.5484.1569; Keller M, 2009, BEHAV BRAIN RES, V200, P268, DOI 10.1016/j.bbr.2009.01.020; Laariva-Sahd J, 2008, J COMP NEUROL, V510, P309, DOI 10.1002/cne.21790; Luo MM, 2003, SCIENCE, V299, P1196, DOI 10.1126/science.1082133; Martini S, 2001, J NEUROSCI, V21, P843, DOI 10.1523/JNEUROSCI.21-03-00843.2001; Meeks JP, 2009, J NEUROSCI METH, V177, P440, DOI 10.1016/j.jneumeth.2008.11.013; Nodari F, 2008, J NEUROSCI, V28, P6407, DOI 10.1523/JNEUROSCI.1425-08.2008; Ramon y Cajal S, 1995, HISTOLOGY NERVOUS SY; Rodriguez I, 2002, NAT NEUROSCI, V5, P134, DOI 10.1038/nn795; Rodriguez I, 1999, CELL, V97, P199, DOI 10.1016/S0092-8674(00)80730-8; Segev R, 2004, NAT NEUROSCI, V7, P1155, DOI 10.1038/nn1323; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Soucy ER, 2009, NAT NEUROSCI, V12, P210, DOI 10.1038/nn.2262; Stopfer M, 2003, NEURON, V39, P991, DOI 10.1016/j.neuron.2003.08.011; Touhara K, 2009, ANNU REV PHYSIOL, V71, P307, DOI 10.1146/annurev.physiol.010908.163209; Tsuboi A, 1999, J NEUROSCI, V19, P8409; Wachowiak M, 2003, J NEUROPHYSIOL, V89, P1623, DOI 10.1152/jn.00747.2002; Wagner S, 2006, NEURON, V50, P697, DOI 10.1016/j.neuron.2006.04.033; Willmore B, 2001, NETWORK-COMP NEURAL, V12, P255, DOI 10.1088/0954-898X/12/3/302; Yonekura J, 2008, MOL CELL NEUROSCI, V37, P708, DOI 10.1016/j.mcn.2007.12.016; Zhang JJ, 2007, CHEM SENSES, V32, P355, DOI 10.1093/chemse/bjm005	39	61	62	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2010	13	6					723	U98		10.1038/nn.2546	http://dx.doi.org/10.1038/nn.2546			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	600QY	20453853	Green Accepted			2022-12-24	WOS:000278003300017
J	Liu, CM; Teng, ZQ; Santistevan, NJ; Szulwach, KE; Guo, WX; Jin, P; Zhao, XY				Liu, Changmei; Teng, Zhao-Qian; Santistevan, Nicholas J.; Szulwach, Keith E.; Guo, Weixiang; Jin, Peng; Zhao, Xinyu			Epigenetic Regulation of miR-184 by MBD1 Governs Neural Stem Cell Proliferation and Differentiation	CELL STEM CELL			English	Article							METHYL-CPG BINDING-PROTEIN-1; ADULT NEUROGENESIS; PROGENITOR CELLS; MATURE MIR-184; NUMB; MICRORNA; EXPRESSION; MECHANISMS; CARCINOMA; TARGETS	Methyl-CpG binding protein 1 (MBD1) regulates gene expression via a DNA methylation-mediated epigenetic mechanism. We have previously demonstrated that MBD1 deficiency impairs adult neural stem/ progenitor cell (aNSC) differentiation and neurogenesis, but the underlying mechanism was unclear. Here, we show that MBD1 regulates the expression of several microRNAs in aNSCs and, specifically, that miR-184 is directly repressed by MBD1. High levels of miR-184 promoted proliferation but inhibited differentiation of aNSCs, whereas inhibition of miR-184 rescued the phenotypes associated with MBD1 deficiency. We further found that miR-184 regulates the expression of Numb like (Numbl), a known regulator of brain development, by binding to the 3'-UTR of Numbl mRNA and affecting its translation. Expression of exogenous Numbl could rescue the aNSC defects that result from either miR-184 overexpression or MBD1 deficiency. Therefore, MBD1, miR-184, and Numbl form a regulatory network that helps control the balance between proliferation and differentiation of aNSCs.	[Liu, Changmei; Teng, Zhao-Qian; Santistevan, Nicholas J.; Guo, Weixiang; Zhao, Xinyu] Univ New Mexico, Sch Med, Dept Neurosci, Albuquerque, NM 87131 USA; [Szulwach, Keith E.; Jin, Peng] Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA; [Szulwach, Keith E.; Jin, Peng] Emory Univ, Sch Med, Grad Program Genet & Mol Biol, Atlanta, GA 30322 USA	University of New Mexico; Emory University; Emory University	Zhao, XY (corresponding author), Univ New Mexico, Sch Med, Dept Neurosci, Albuquerque, NM 87131 USA.	xzhao@salud.unm.edu	Santistevan, Nicholas/L-3233-2015; Teng, Zhao-Qian/J-6260-2015; Liu, Changmei/H-9600-2012; Jin, Peng/B-5977-2012; Teng, Zhao-Qian/AAD-1033-2021	Santistevan, Nicholas/0000-0002-4657-6860; Teng, Zhao-Qian/0000-0002-7232-3381; Jin, Peng/0000-0001-6137-6659; Teng, Zhao-Qian/0000-0002-7232-3381	International Rett Syndrome Foundation; NIH [MH080434, MH078972]; Autism Speaks Postdoctoral Fellowship; MARC [NIH/T34GM00851]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008490] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH080434, R01MH078972] Funding Source: NIH RePORTER	International Rett Syndrome Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Autism Speaks Postdoctoral Fellowship; MARC; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank Dr. M.C. Wilson, Dr. T. Xie, and Ms. C.T. Strauss for editing the manuscript and Dr. W. Zhong for providing Numbl antibody. Images were generated in the UNM Cancer Center Fluorescence Microscopy Facility. This work was supported by grants from the International Rett Syndrome Foundation and the NIH (MH080434 and MH078972) to X.Z., an Autism Speaks Postdoctoral Fellowship to CL., and a MARC fellowship to N.J.S. (NIH/T34GM00851).	Adams BD, 2007, MOL ENDOCRINOL, V21, P1132, DOI 10.1210/me.2007-0022; Allan AM, 2008, HUM MOL GENET, V17, P2047, DOI 10.1093/hmg/ddn102; Babu H, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000388; Barkho BZ, 2006, STEM CELLS DEV, V15, P407, DOI 10.1089/scd.2006.15.407; Barkho BZ, 2008, STEM CELLS, V26, P3139, DOI 10.1634/stemcells.2008-0519; Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; Chapman G, 2006, J CELL BIOL, V175, P535, DOI 10.1083/jcb.200602009; Chen YX, 2007, CANCER RES, V67, P976, DOI 10.1158/0008-5472.CAN-06-3667; Cheng LC, 2009, NAT NEUROSCI, V12, P399, DOI 10.1038/nn.2294; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Iovino N, 2009, DEV CELL, V17, P123, DOI 10.1016/j.devcel.2009.06.008; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Johnson JE, 2003, TRENDS NEUROSCI, V26, P395, DOI 10.1016/S0166-2236(03)00166-8; Jorgensen HF, 2004, MOL CELL BIOL, V24, P3387, DOI 10.1128/MCB.24.8.3387-3395.2004; Keverne EB, 2008, FRONT NEUROENDOCRIN, V29, P398, DOI 10.1016/j.yfrne.2008.03.001; Kishino T, 2006, CYTOGENET GENOME RES, V113, P209, DOI 10.1159/000090834; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Li HS, 2003, NEURON, V40, P1105, DOI 10.1016/S0896-6273(03)00755-4; Li XK, 2008, J BIOL CHEM, V283, P27644, DOI 10.1074/jbc.M804899200; Li XK, 2008, STEM CELLS DEV, V17, P1043, DOI 10.1089/scd.2008.0036; Liu CM, 2009, NEUROMOL MED, V11, P141, DOI 10.1007/s12017-009-8077-y; Nomura T, 2008, HUM MOL GENET, V17, P1192, DOI 10.1093/hmg/ddn011; Pandey DP, 2009, MOL CELL BIOL, V29, P3783, DOI 10.1128/MCB.01875-08; Petersen PH, 2004, NAT NEUROSCI, V7, P803, DOI 10.1038/nn1289; Petersen PH, 2006, DEV NEUROSCI-BASEL, V28, P156, DOI 10.1159/000090761; Petersen PH, 2002, NATURE, V419, P929, DOI 10.1038/nature01124; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Sansom OJ, 2007, NAT CLIN PRACT ONCOL, V4, P305, DOI 10.1038/ncponc0812; Schaefer A, 2010, INT J CANCER, V126, P1166, DOI 10.1002/ijc.24827; Shen Q, 2002, DEVELOPMENT, V129, P4843; Shen Q, 2009, NAT NEUROSCI, V12, P369, DOI 10.1038/nn0409-369; Silahtaroglu AN, 2007, NAT PROTOC, V2, P2520, DOI 10.1038/nprot.2007.313; Smrt RD, 2007, NEUROBIOL DIS, V27, P77, DOI 10.1016/j.nbd.2007.04.005; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Wong TS, 2008, CLIN CANCER RES, V14, P2588, DOI 10.1158/1078-0432.CCR-07-0666; Wong TS, 2009, THESCIENTIFICWORLDJO, V9, P130, DOI 10.1100/tsw.2009.12; Yu J, 2008, P NATL ACAD SCI USA, V105, P19300, DOI 10.1073/pnas.0803992105; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Zhao C, 2009, NAT STRUCT MOL BIOL, V16, P365, DOI 10.1038/nsmb.1576; Zhao XY, 2003, P NATL ACAD SCI USA, V100, P6777, DOI 10.1073/pnas.1131928100; Zhong WM, 1997, DEVELOPMENT, V124, P1887	44	235	250	0	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAY 7	2010	6	5					433	444		10.1016/j.stem.2010.02.017	http://dx.doi.org/10.1016/j.stem.2010.02.017			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	598NO	20452318	Green Accepted, Bronze			2022-12-24	WOS:000277844800011
J	van den Berg, DLC; Snoek, T; Mullin, NP; Yates, A; Bezstarosti, K; Demmers, J; Chambers, I; Poot, RA				van den Berg, Debbie L. C.; Snoek, Tim; Mullin, Nick P.; Yates, Adam; Bezstarosti, Karel; Demmers, Jeroen; Chambers, Ian; Poot, Raymond A.			An Oct4-Centered Protein Interaction Network in Embryonic Stem Cells	CELL STEM CELL			English	Article							REGULATES SELF-RENEWAL; TRANSCRIPTIONAL REGULATION; RECEPTOR-BETA; PLURIPOTENCY; OCT4; NANOG; COMPLEX; MOUSE; SOX2; COACTIVATOR	Transcription factors, such as Oct4, are critical for establishing and maintaining pluripotent cell identity. Whereas the genomic locations of several pluripotency transcription factors have been reported, the spectrum of their interaction partners is underexplored. Here, we use an improved affinity protocol to purify Oct4-interacting proteins from mouse embryonic stem cells (ESCs). Subsequent purification of Oct4 partners Sall4, Tcfcp2l1, Dax1, and Esrrb resulted in an Oct4 interactome of 166 proteins, including transcription factors and chromatin-modifying complexes with documented roles in self-renewal, but also many factors not previously associated with the ESC network. We find that Esrrb associated with the basal transcription machinery and also detect interactions between transcription factors and components of the TGF-beta, Notch, and Wnt signaling pathways. Acute depletion of Oct4 reduced binding of Tcfcp2l1, Dax1, and Esrrb to several target genes. In conclusion, our purification protocol allowed us to bring greater definition to the circuitry controlling pluripotent cell identity.	[van den Berg, Debbie L. C.; Snoek, Tim; Poot, Raymond A.] Erasmus MC, Dept Cell Biol, NL-3015 GE Rotterdam, Netherlands; [Bezstarosti, Karel; Demmers, Jeroen] Erasmus MC, Prote Ctr, NL-3015 GE Rotterdam, Netherlands; [Mullin, Nick P.; Yates, Adam; Chambers, Ian] Univ Edinburgh, Sch Biol Sci, Inst Stem Cell Res, MRC Ctr Regenerat Med, Edinburgh EH9 3JQ, Midlothian, Scotland	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of Edinburgh	Poot, RA (corresponding author), Erasmus MC, Dept Cell Biol, Dr Molewaterpl 50, NL-3015 GE Rotterdam, Netherlands.		Chambers, Ian/H-5416-2011; Demmers, Jeroen AA/F-4046-2016	Chambers, Ian/0000-0003-2605-1597; Demmers, Jeroen AA/0000-0002-8757-9611; van den Berg, Debbie L.C./0000-0001-6026-8808; Mullin, Nicholas/0000-0003-4802-440X; Snoek, Tim/0000-0002-5395-9034	NWO; EuTRACC consortium; Wellcome Trust; Juvenile Diabetes Research Foundation; Medical Research Council of the UK; Medical Research Council [G0700711B] Funding Source: researchfish	NWO(Netherlands Organization for Scientific Research (NWO)); EuTRACC consortium; Wellcome Trust(Wellcome TrustEuropean Commission); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Medical Research Council of the UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank Erik Engelen for technical advice, Rooda Abdillahi Ibrahim for technical assistance, Nicola Festuccia for Dax1 cDNA. Drs Paul Wade and Matthias :Treir for antibodies. and Drs Austin Smith and Hitoshi Niwa for 46C and ZHBTc4 ESCs, respectively This work was supported by an NWO Vidi grant to the R A P lab, by the EuTRACC consortium, by the Wellcome Trust. by the Juvenile Diabetes Research Foundation, and by the Medical Research Council of the UK	Ambrosetti DC, 1997, MOL CELL BIOL, V17, P6321, DOI 10.1128/MCB.17.11.6321; Andersson T, 2009, J BIOL CHEM, V284, P3672, DOI 10.1074/jbc.M808119200; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Chambers I, 2009, DEVELOPMENT, V136, P2311, DOI 10.1242/dev.024398; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Chen X, 2008, STEM CELLS, V26, P2759, DOI 10.1634/stemcells.2008-0398; deCelis JF, 1996, NATURE, V381, P421, DOI 10.1038/381421a0; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Dupont S, 2009, CELL, V136, P123, DOI 10.1016/j.cell.2008.10.051; Endoh M, 2008, DEVELOPMENT, V135, P1513, DOI 10.1242/dev.014340; Feng B, 2009, NAT CELL BIOL, V11, P197, DOI 10.1038/ncb1827; Fujiki R, 2009, NATURE, V459, P455, DOI 10.1038/nature07954; Ho LN, 2009, P NATL ACAD SCI USA, V106, P5187, DOI 10.1073/pnas.0812888106; Hochedlinger K, 2009, DEVELOPMENT, V136, P509, DOI 10.1242/dev.020867; Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200; Issad T, 2008, TRENDS ENDOCRIN MET, V19, P380, DOI 10.1016/j.tem.2008.09.001; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Jiang JM, 2008, NAT CELL BIOL, V10, P353, DOI 10.1038/ncb1698; Kang YK, 2002, P NATL ACAD SCI USA, V99, P2642, DOI 10.1073/pnas.261715899; Kidder BL, 2009, STEM CELLS, V27, P317, DOI 10.1634/stemcells.2008-0710; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Ku M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000242; Kuroda T, 2005, MOL CELL BIOL, V25, P2475, DOI 10.1128/MCB.25.6.2475-2485.2005; Levasseur DN, 2008, GENE DEV, V22, P575, DOI 10.1101/gad.1606308; Liang J, 2008, NAT CELL BIOL, V10, P731, DOI 10.1038/ncb1736; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Mo R, 2006, J BIOL CHEM, V281, P15714, DOI 10.1074/jbc.M513245200; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Niakan KK, 2006, MOL GENET METAB, V88, P261, DOI 10.1016/j.ymgme.2005.12.010; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Niwa H, 2007, DEVELOPMENT, V134, P635, DOI 10.1242/dev.02787; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Parisi S, 2008, J CELL SCI, V121, P2629, DOI 10.1242/jcs.027599; Remenyi A, 2003, GENE DEV, V17, P2048, DOI 10.1101/gad.269303; Ren B, 2002, GENE DEV, V16, P245, DOI 10.1101/gad.949802; Rodda DJ, 2005, J BIOL CHEM, V280, P24731, DOI 10.1074/jbc.M502573200; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Sharov AA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-269; Sikorski TW, 2009, CURR OPIN CELL BIOL, V21, P344, DOI 10.1016/j.ceb.2009.03.006; Smith AG, 2001, ANNU REV CELL DEV BI, V17, P435, DOI 10.1146/annurev.cellbio.17.1.435; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; van den Berg DLC, 2008, MOL CELL BIOL, V28, P5986, DOI 10.1128/MCB.00301-08; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Webster DM, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-28; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Wilanowski T, 2002, MECH DEVELOP, V114, P37, DOI 10.1016/S0925-4773(02)00046-1; Williams DC, 2004, J BIOL CHEM, V279, P1449, DOI 10.1074/jbc.M309790200; Wissmuller S, 2006, NUCLEIC ACIDS RES, V34, P1735, DOI 10.1093/nar/gkl105; Yamanaka S, 2009, CELL, V137, P13, DOI 10.1016/j.cell.2009.03.034; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Yuri S, 2009, STEM CELLS, V27, P796, DOI 10.1002/stem.14; Zhang JQ, 2006, NAT CELL BIOL, V8, P1114, DOI 10.1038/ncb1481; Zhang XF, 2008, J BIOL CHEM, V283, P35825, DOI 10.1074/jbc.M803481200; Zhang Y, 1999, GENE DEV, V13, P1924, DOI 10.1101/gad.13.15.1924	57	418	424	0	48	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	APR 2	2010	6	4					369	381		10.1016/j.stem.2010.02.014	http://dx.doi.org/10.1016/j.stem.2010.02.014			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	585KD	20362541	Green Submitted, Green Published, hybrid			2022-12-24	WOS:000276823300015
J	Tong, YR; Shen, J				Tong, Youren; Shen, Jie			alpha-Synuclein and LRRK2: Partners in Crime	NEURON			English	Editorial Material							FAMILIAL PARKINSONS-DISEASE; TRANSGENIC MICE; MUTATION; ROLES	In this issue of Neuron, Lin et al. report that LRRK2 modulates age-related neurodegeneration caused by overexpression of alpha-synuclein in the forebrain of transgenic mice. Overexpression of LRRK2 accelerates the progression of alpha-synuclein-mediated neuropathological changes, whereas deletion of LRRK2 alleviates these alterations. The results reveal an interesting interaction between alpha-synuclein and LRRK2, two gene products linked to dominantly inherited Parkinson's disease.	[Tong, Youren; Shen, Jie] Harvard Univ, Sch Med, Program Neurosci, Brigham & Womens Hosp,Ctr Neurol Dis, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Shen, J (corresponding author), Harvard Univ, Sch Med, Program Neurosci, Brigham & Womens Hosp,Ctr Neurol Dis, Boston, MA 02115 USA.	jshen@rics.bwh.harvard.edu	Shen, Jie/GXH-9449-2022		NINDS NIH HHS [R37 NS071251, P50 NS038375, R01 NS041779-09S1, R01 NS041779-09, R01 NS041779, R01 NS052745, P50 NS038375-100003, R01 NS052745-05] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052745, P50NS038375, R01NS041779] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Chandra S, 2005, CELL, V123, P383, DOI 10.1016/j.cell.2005.09.028; Cookson MR, 2007, J NEUROSCI, V27, P11865, DOI 10.1523/JNEUROSCI.3695-07.2007; Cooper AA, 2006, SCIENCE, V313, P324, DOI 10.1126/science.1129462; Giasson BI, 2002, NEURON, V34, P521, DOI 10.1016/S0896-6273(02)00682-7; Gosavi N, 2002, J BIOL CHEM, V277, P48984, DOI 10.1074/jbc.M208194200; Lee MK, 2002, P NATL ACAD SCI USA, V99, P8968, DOI 10.1073/pnas.132197599; Li YP, 2009, NAT NEUROSCI, V12, P826, DOI 10.1038/nn.2349; Lin X, 2009, NEURON, V64, P807, DOI 10.1016/j.neuron.2009.11.006; Shen J, 2004, NEURON, V43, P301, DOI 10.1016/j.neuron.2004.07.012; Singleton AB, 2005, TRENDS NEUROSCI, V28, P416, DOI 10.1016/j.tins.2005.05.009; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Tong YR, 2009, P NATL ACAD SCI USA, V106, P14622, DOI 10.1073/pnas.0906334106	12	17	17	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 24	2009	64	6					771	773		10.1016/j.neuron.2009.12.017	http://dx.doi.org/10.1016/j.neuron.2009.12.017			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	541ON	20064381	Green Accepted, Bronze			2022-12-24	WOS:000273425800001
J	Chang, SWC; Papadimitriou, C; Snyder, LH				Chang, Steve W. C.; Papadimitriou, Charalampos; Snyder, Lawrence H.			Using a Compound Gain Field to Compute a Reach Plan	NEURON			English	Article							POSTERIOR PARIETAL CORTEX; LATERAL INTRAPARIETAL AREA; EYE POSITION INFORMATION; DORSAL PREMOTOR CORTEX; NEURAL-NETWORK MODEL; ARM MOVEMENTS; VISUAL SPACE; VISUOMOTOR TRANSFORMATIONS; CORTICAL REPRESENTATION; MOTOR TRANSFORMATIONS	A gain field, the scaling of a tuned neuronal response by a postural signal, may help support neuronal computation. Here, we characterize eye and hand position gain fields in the parietal reach region (PRR). Eye and hand gain fields in individual PRR neurons are similar in magnitude but opposite in sign to one another. This systematic arrangement produces a compound gain field that is proportional to the distance between gaze location and initial hand position. As a result, the visual response to a target for an upcoming reach is scaled by the initial gaze-to-hand distance. Such a scaling is similar to what would be predicted in a neural network that mediates between eye- and hand-centered representations of target location. This systematic arrangement supports a role of PRR in visually guided reaching and provides strong evidence that gain fields are used for neural computations.	[Chang, Steve W. C.; Papadimitriou, Charalampos; Snyder, Lawrence H.] Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA	Washington University (WUSTL)	Chang, SWC (corresponding author), Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA.	steve@eye-hand.wustl.edu	Snyder, Lawrence H/A-4593-2017	Papadimitriou, Charalampos/0000-0002-5093-1749; Chang, Steve Wohn Chul/0000-0003-4160-7549	National Eye Institute; National Institute of Mental Health; NATIONAL EYE INSTITUTE [R01EY012135] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Eye Institute and the National Institute of Mental Health. We thank J. Douglas Crawford for helpful discussions regarding reference frame transformations, Greg DeAngelis assistance in experimental design, Aaron Batista, Krishna Shenoy, and Chris Fetsch for comments on the manuscript, and Michael Goldberg for discussions on gain fields. We also thank Jason Vytlacil and Justin Baker for MR imaging, and Tom Malone, Emelia Proctor, and Trevor Shew for technical assistance.	ANDERSEN RA, 1990, J NEUROSCI, V10, P1176; ANDERSEN RA, 1983, J NEUROSCI, V3, P532; Andersen RA, 1998, NOVART FDN SYMP, V218, P109; ANDERSEN RA, 1998, NOVART FDN SYMP, V218, P122; ANDERSEN RA, 1998, NOVART FDN SYMP, V218, P171; Avillac M, 2005, NAT NEUROSCI, V8, P941, DOI 10.1038/nn1480; Batista AP, 2007, J NEUROPHYSIOL, V98, P966, DOI 10.1152/jn.00421.2006; Batista AP, 1999, SCIENCE, V285, P257, DOI 10.1126/science.285.5425.257; BATISTA AP, 1999, THESIS CALTECH, P81; Battaglia-Mayer A, 2001, CEREB CORTEX, V11, P528, DOI 10.1093/cercor/11.6.528; Blohm G, 2007, J VISION, V7, DOI 10.1167/7.5.4; Blohm G, 2009, CEREB CORTEX, V19, P1372, DOI 10.1093/cercor/bhn177; BOCK O, 1986, EXP BRAIN RES, V64, P476, DOI 10.1007/BF00340484; Boussaoud D, 1998, J NEUROPHYSIOL, V80, P1132, DOI 10.1152/jn.1998.80.3.1132; Boynton GM, 2009, VISION RES, V49, P1129, DOI 10.1016/j.visres.2008.11.001; Bradley DC, 1996, SCIENCE, V273, P1544, DOI 10.1126/science.273.5281.1544; Bremmer F, 1998, EUR J NEUROSCI, V10, P153; BROTCHIE PR, 1995, NATURE, V375, P232, DOI 10.1038/375232a0; Brozovic M, 2007, J NEUROSCI, V27, P10588, DOI 10.1523/JNEUROSCI.2685-07.2007; BULLOCK D, 1988, PSYCHOL REV, V95, P49, DOI 10.1037/0033-295X.95.1.49; Buneo CA, 2002, NATURE, V416, P632, DOI 10.1038/416632a; BURNOD Y, 1992, J NEUROSCI, V12, P1435; Calton JL, 2002, NAT NEUROSCI, V5, P580, DOI 10.1038/nn862; Caminiti R, 1996, CEREB CORTEX, V6, P319, DOI 10.1093/cercor/6.3.319; CAMINITI R, 1991, J NEUROSCI, V11, P1182; Chang SWC, 2008, J NEUROSCI, V28, P6128, DOI 10.1523/JNEUROSCI.1442-08.2008; Cohen YE, 2000, NEURON, V27, P647, DOI 10.1016/S0896-6273(00)00073-8; Connor CE, 1996, J NEUROPHYSIOL, V75, P1306, DOI 10.1152/jn.1996.75.3.1306; Crawford JD, 2004, J NEUROPHYSIOL, V92, P10, DOI 10.1152/jn.00117.2004; CRAWFORD JD, 1991, J NEUROPHYSIOL, V65, P407, DOI 10.1152/jn.1991.65.3.407; Crawford JD, 2000, J NEUROSCI, V20, P2360; Crawford JD, 1997, J NEUROPHYSIOL, V78, P1447, DOI 10.1152/jn.1997.78.3.1447; CRAWFORD JD, 1991, SCIENCE, V252, P1551, DOI 10.1126/science.2047862; Desmurget M, 1999, NAT NEUROSCI, V2, P563, DOI 10.1038/9219; Dickinson AR, 2003, J NEUROPHYSIOL, V90, P2460, DOI 10.1152/jn.00788.2002; Dobbins AC, 1998, SCIENCE, V281, P552, DOI 10.1126/science.281.5376.552; ENRIGHT JT, 1995, VISION RES, V35, P1611, DOI 10.1016/0042-6989(94)00260-S; Fattori P, 2001, EUR J NEUROSCI, V13, P2309, DOI 10.1046/j.0953-816x.2001.01618.x; GALLETTI C, 1989, J NEUROSCI, V9, P1112; Galletti C, 1997, EUR J NEUROSCI, V9, P410, DOI 10.1111/j.1460-9568.1997.tb01410.x; Galletti C, 1999, EUR J NEUROSCI, V11, P575, DOI 10.1046/j.1460-9568.1999.00467.x; Galletti C, 1995, EUR J NEUROSCI, V7, P2486, DOI 10.1111/j.1460-9568.1995.tb01047.x; Goldberg ME, 2002, ANN NY ACAD SCI, V956, P205, DOI 10.1111/j.1749-6632.2002.tb02820.x; Gottlieb JP, 1998, NATURE, V391, P481, DOI 10.1038/35135; Graziano MSA, 1999, P NATL ACAD SCI USA, V96, P10418, DOI 10.1073/pnas.96.18.10418; Graziano MSA, 2000, SCIENCE, V290, P1782, DOI 10.1126/science.290.5497.1782; Groh JM, 1996, J NEUROPHYSIOL, V75, P439, DOI 10.1152/jn.1996.75.1.439; Groh JM, 2001, NEURON, V29, P509, DOI 10.1016/S0896-6273(01)00222-7; GUTHRIE BL, 1983, SCIENCE, V221, P1193, DOI 10.1126/science.6612334; Henriques DYP, 1998, J NEUROSCI, V18, P1583; Herter TM, 2007, J NEUROPHYSIOL, V97, P2887, DOI 10.1152/jn.00757.2006; Kusunoki M, 2000, VISION RES, V40, P1459, DOI 10.1016/S0042-6989(99)00212-6; Lacquaniti F, 1998, EUR J NEUROSCI, V10, P195; LAL R, 1990, J NEUROPHYSIOL, V63, P502, DOI 10.1152/jn.1990.63.3.502; Lewald J, 2000, VISION RES, V40, P539, DOI 10.1016/S0042-6989(99)00197-2; Lewis JW, 2000, J COMP NEUROL, V428, P112, DOI 10.1002/1096-9861(20001204)428:1<112::AID-CNE8>3.0.CO;2-9; Lewis JW, 2000, J COMP NEUROL, V428, P79, DOI 10.1002/1096-9861(20001204)428:1<79::AID-CNE7>3.0.CO;2-Q; Lewis RF, 1998, J NEUROPHYSIOL, V80, P1605, DOI 10.1152/jn.1998.80.3.1605; Marzocchi N, 2008, EUR J NEUROSCI, V27, P775, DOI 10.1111/j.1460-9568.2008.06021.x; MAYS LE, 1980, J NEUROPHYSIOL, V43, P207, DOI 10.1152/jn.1980.43.1.207; MAZZONI P, 1991, P NATL ACAD SCI USA, V88, P4433, DOI 10.1073/pnas.88.10.4433; McIntyre J, 1997, J NEUROPHYSIOL, V78, P1601, DOI 10.1152/jn.1997.78.3.1601; Medendorp WP, 2002, NEUROREPORT, V13, P633, DOI 10.1097/00001756-200204160-00019; Mullette-Gillman OA, 2009, CEREB CORTEX, V19, P1761, DOI 10.1093/cercor/bhn207; Nakamura K, 1999, J NEUROPHYSIOL, V81, P2374, DOI 10.1152/jn.1999.81.5.2374; Pare M, 1998, J NEUROPHYSIOL, V79, P3060, DOI 10.1152/jn.1998.79.6.3060; Pesaran B, 2006, NEURON, V51, P125, DOI 10.1016/j.neuron.2006.05.025; POGGIO T, 1990, COLD SPRING HARB SYM, V55, P899; POUGET A, 1994, CEREB CORTEX, V4, P314, DOI 10.1093/cercor/4.3.314; Pouget A, 2002, NAT REV NEUROSCI, V3, P741, DOI 10.1038/nrn914; Pouget A, 2000, NAT NEUROSCI, V3, P1192, DOI 10.1038/81469; Prevosto V, 2009, EUR J NEUROSCI, V30, P1151, DOI 10.1111/j.1460-9568.2009.06885.x; Quiroga RQ, 2006, J NEUROSCI, V26, P3615, DOI 10.1523/JNEUROSCI.3468-05.2006; Ren L, 2006, J NEUROPHYSIOL, V96, P1464, DOI 10.1152/jn.01012.2005; ROBINSON DL, 1990, EXP BRAIN RES, V82, P235; Salinas E, 1996, P NATL ACAD SCI USA, V93, P11956, DOI 10.1073/pnas.93.21.11956; SALINAS E, 1995, J NEUROSCI, V15, P6461; Salinas E, 2001, NEUROSCIENTIST, V7, P430, DOI 10.1177/107385840100700512; Salinas Emilio, 2000, Neuron, V27, P15, DOI 10.1016/S0896-6273(00)00004-0; Scott SH, 1997, J NEUROPHYSIOL, V78, P2413, DOI 10.1152/jn.1997.78.5.2413; Shadmehr R., 2005, COMPUTATIONAL NEUROB; Siegel RM, 2003, J NEUROPHYSIOL, V90, P1279, DOI 10.1152/jn.01179.2002; Smith MA, 2005, J NEUROPHYSIOL, V93, P1742, DOI 10.1152/jn.00306.2004; Snyder LH, 2006, J NEUROSCI, V26, P10091, DOI 10.1523/JNEUROSCI.0513-06.2006; Snyder LH, 1998, NATURE, V394, P887, DOI 10.1038/29777; Snyder LH, 1997, NATURE, V386, P167, DOI 10.1038/386167a0; Sober SJ, 2005, NAT NEUROSCI, V8, P490, DOI 10.1038/nn1427; Sober SJ, 2003, J NEUROSCI, V23, P6982, DOI 10.1523/JNEUROSCI.23-18-06982.2003; SOECHTING JF, 1992, ANNU REV NEUROSCI, V15, P167, DOI 10.1146/annurev.ne.15.030192.001123; TWEED D, 1987, J NEUROPHYSIOL, V58, P832, DOI 10.1152/jn.1987.58.4.832; VANOPSTAL AJ, 1995, J NEUROPHYSIOL, V74, P1593, DOI 10.1152/jn.1995.74.4.1593; Wang XL, 2007, NAT NEUROSCI, V10, P640, DOI 10.1038/nn1878; WEYAND TG, 1993, J NEUROPHYSIOL, V69, P2258, DOI 10.1152/jn.1993.69.6.2258; White RL, 2004, J NEUROPHYSIOL, V91, P1608, DOI 10.1152/jn.00277.2003; Xing J, 2000, J COGNITIVE NEUROSCI, V12, P601, DOI 10.1162/089892900562363; ZIPSER D, 1988, NATURE, V331, P679, DOI 10.1038/331679a0	96	80	81	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 10	2009	64	5					744	755		10.1016/j.neuron.2009.11.005	http://dx.doi.org/10.1016/j.neuron.2009.11.005			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	537OW	20005829	Green Accepted, Bronze			2022-12-24	WOS:000273123700018
J	Biernaskie, J; Paris, M; Morozova, O; Fagan, BM; Marra, M; Pevny, L; Miller, FD				Biernaskie, Jeffrey; Paris, Maryline; Morozova, Olena; Fagan, B. Matthew; Marra, Marco; Pevny, Larysa; Miller, Freda D.			SKPs Derive from Hair Follicle Precursors and Exhibit Properties of Adult Dermal Stem Cells	CELL STEM CELL			English	Article							SKIN; GROWTH; GENERATION; MOUSE; RAT; DIFFERENTIATE; IMPLANTATION; ASTROCYTES; CONTRIBUTE; INDUCTION	Despite the remarkable regenerative capacity of mammalian skin, an adult dermal stem cell has not yet been identified. Here, we investigated whether skin-derived precursors (SKPs) might fulfill such a role. We show that SKPs derive from Sox2(+) hair follicle dermal cells and that these two cell populations are similar with regard to their transcriptome and functional properties. Both clonal SKPs and endogenous Sox2(+) cells induce hair morphogenesis, differentiate into dermal cell types, and home to a hair follicle niche upon transplantation. Moreover, hair follicle-derived SKPs; self-renew, maintain their multipotency, and serially reconstitute hair follicles. Finally, grafting experiments show that follicle-associated dermal cells move out of their niche to contribute cells for dermal maintenance and wound-healing. Thus, SKPs derive from Sox2(+) follicle-associated dermal precursors and display functional properties predicted of a dermal stem cell, contributing to dermal maintenance, wound-healing, and hair follicle morphogenesis.	[Miller, Freda D.] Univ Toronto, Dept Mol Genet, Toronto, ON M5G 1X5, Canada; [Miller, Freda D.] Univ Toronto, Dept Physiol, Toronto, ON M5G 1X5, Canada; [Morozova, Olena; Marra, Marco] BC Canc Agcy, Genome Sci Ctr, Vancouver, BC V5Z 4S6, Canada; [Fagan, B. Matthew; Pevny, Larysa] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Biernaskie, Jeffrey; Paris, Maryline; Miller, Freda D.] Univ Toronto, Hosp Sick Children, Dev & Stem Cell Biol Grp, Toronto, ON M5G 1X5, Canada	University of Toronto; University of Toronto; British Columbia Cancer Agency; University of North Carolina; University of North Carolina Chapel Hill; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Biernaskie, J (corresponding author), Univ Calgary, Fac Vet Med, Dept Comparat Biol & Expt Med, 3300 Hosp Dr, Calgary, AB T2N 4N1, Canada.	jeff.biernaskie@ucalgary.ca; fredam@sickkids.ca	Marra, Marco A/B-5987-2008	Marra, Marco A/0000-0001-7146-7175; Vaske, Olena/0000-0002-1677-417X; Fagan, Barry Matthew/0000-0003-2267-886X	CIHR; Canadian Stem Cell Network; HHMI; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH071822] Funding Source: NIH RePORTER	CIHR(Canadian Institutes of Health Research (CIHR)); Canadian Stem Cell Network; HHMI(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was funded by grants from CIHR, the Canadian Stem Cell Network, and HHMI. F.D.M. is an HHMI International Research Scholar and CRC chair-holder, and J.B. was funded by a CIHR fellowship during the course of this work. We thank Fabio Rossi (U.B.C.) for supplying MSCs, Ben Alman and Sophia Cheon (H.S.C.) for help with skin wounding assays, Akitsu Hotta and James Ellis for supplying RFP retrovirus, and Richard LeBaron (U.T.S.A.) and Pierre Coulombe (Johns Hopkins) for providing antibodies. We also thank Dennis Aquino and Sherry Zhao for valuable technical assistance.	Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Biernaskie JA, 2006, NAT PROTOC, V1, P2803, DOI 10.1038/nprot.2006.422; Driskell RR, 2009, DEVELOPMENT, V136, P2815, DOI 10.1242/dev.038620; Ellis P, 2004, DEV NEUROSCI-BASEL, V26, P148, DOI 10.1159/000082134; Fernandes KJL, 2006, EXP NEUROL, V201, P32, DOI 10.1016/j.expneurol.2006.03.018; Fernandes KJL, 2004, NAT CELL BIOL, V6, P1082, DOI 10.1038/ncb1181; FUCHS E, 2003, EXP DERMATOL, V12, P126; Hadjantonakis AK, 1998, MECH DEVELOP, V76, P79, DOI 10.1016/S0925-4773(98)00093-8; Hunt DPJ, 2008, STEM CELLS, V26, P163, DOI 10.1634/stemcells.2007-0281; IBRAHIM L, 1982, J EMBRYOL EXP MORPH, V72, P209; JAHODA CAB, 1984, NATURE, V311, P560, DOI 10.1038/311560a0; Jahoda CAB, 2003, EXP DERMATOL, V12, P849, DOI 10.1111/j.0906-6705.2003.00161.x; Joannides A, 2004, LANCET, V364, P172, DOI 10.1016/S0140-6736(04)16630-0; Kragl M, 2009, NATURE, V460, P60, DOI 10.1038/nature08152; Lavoie JF, 2009, STEM CELLS DEV, V18, P893, DOI 10.1089/scd.2008.0260; McElwee KJ, 2003, J INVEST DERMATOL, V121, P1267, DOI 10.1111/j.1523-1747.2003.12568.x; McKenzie IA, 2006, J NEUROSCI, V26, P6651, DOI 10.1523/JNEUROSCI.1007-06.2006; MUNEOKA K, 1986, DEV BIOL, V116, P256, DOI 10.1016/0012-1606(86)90062-X; Nishimura EK, 2005, SCIENCE, V307, P720, DOI 10.1126/science.1099593; OLIVER RF, 1967, J EMBRYOL EXP MORPH, V18, P43; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Tobin DJ, 2003, J INVEST DERMATOL, V120, P895, DOI 10.1046/j.1523-1747.2003.12237.x; Vickaryous MK, 2008, J MORPHOL, V269, P398, DOI 10.1002/jmor.10575; Waters JM, 2007, SEMIN CELL DEV BIOL, V18, P245, DOI 10.1016/j.semcdb.2007.02.003; Wojciechowicz K, 2008, EXP DERMATOL, V17, P675, DOI 10.1111/j.1600-0625.2007.00689.x; Zheng Y, 2005, J INVEST DERMATOL, V124, P867, DOI 10.1111/j.0022-202X.2005.23716.x	27	254	267	0	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	DEC 4	2009	5	6					610	623		10.1016/j.stem.2009.10.019	http://dx.doi.org/10.1016/j.stem.2009.10.019			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	543YH	19951689	Green Accepted, Bronze, Green Submitted			2022-12-24	WOS:000273616700009
J	Hirabayashi, Y; Suzki, N; Tsuboi, M; Endo, TA; Toyoda, T; Shinga, J; Koseki, H; Vidal, M; Gotoh, Y				Hirabayashi, Yusuke; Suzki, Nao; Tsuboi, Masafumi; Endo, Takaho A.; Toyoda, Tetsuro; Shinga, Jun; Koseki, Haruhiko; Vidal, Miguel; Gotoh, Yukiko			Polycomb Limits the Neurogenic Competence of Neural Precursor Cells to Promote Astrogenic Fate Transition	NEURON			English	Article							CENTRAL-NERVOUS-SYSTEM; EMBRYONIC STEM-CELLS; GROUP PROTEINS RING1A/B; DNA METHYLATION; CEREBRAL-CORTEX; ASTROCYTIC DIFFERENTIATION; DEVELOPMENTAL REGULATORS; NEURONAL DIFFERENTIATION; TEMPORAL SPECIFICATION; SIGNALING PATHWAY	During neocortical development, neural precursor cells (NPCs, or neural stem cells) produce neurons first and astrocytes later. Although the timing of the fate switch from neurogenic to astrogenic is critical for determining the number of neurons, the mechanisms are not fully understood. Here, we show that the polycomb group complex (PcG) restricts neurogenic competence of NPCs and promotes the transition of NPC fate from neurogenic to astrogenic. Inactivation of PcG by knockout of the Ring1B or Ezh2 gene or Eed knockdown prolonged the neurogenic phase of NPCs and delayed the onset of the astrogenic phase. Moreover, PcG was found to repress the promoter of the proneural gene neurogenin1 in a developmental-stage-dependent manner. These results demonstrate a role of PcG: the temporal regulation of NPC fate.	[Hirabayashi, Yusuke; Suzki, Nao; Tsuboi, Masafumi; Gotoh, Yukiko] Univ Tokyo, Inst Mol & Cellular Biosci, Tokyo, Japan; [Endo, Takaho A.; Toyoda, Tetsuro] RIKEN, Genom Sci Ctr, Kanagawa, Japan; [Shinga, Jun; Koseki, Haruhiko; Vidal, Miguel] RIKEN, Ctr Allergy & Immunol, Kanagawa, Japan; [Vidal, Miguel] CSIC, Ctr Invest Biol, Madrid, Spain	University of Tokyo; RIKEN; RIKEN; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB)	Gotoh, Y (corresponding author), Univ Tokyo, Inst Mol & Cellular Biosci, Tokyo, Japan.	ygotoh@iam.u-tokyo.ac.jp	Koseki, Haruhiko/I-3825-2014; Endo, Takaho/B-5763-2017	Koseki, Haruhiko/0000-0001-8424-5854; Endo, Takaho/0000-0002-2801-2463; Hirabayashi, Yusuke/0000-0003-3950-6781	MEXT of Japan [20022010]	MEXT of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Nestin-CreERT2 mice were kindly provided by Dr. Ryoichiro Kageyama. We thank Drs J.A. Cooper, M.E. Greenberg, and M. Lamphier for critical reading and Dr M. Higuchi for technical assistance. This work was supported by Grant-in-Aid for Scientific Research (A) and on Priority Areas-Molecular Brain Science from the MEXT of Japan (20022010).	Aulehla A, 2003, DEV CELL, V4, P395, DOI 10.1016/S1534-5807(03)00055-8; Barnabe-Heider F, 2005, NEURON, V48, P253, DOI 10.1016/j.neuron.2005.08.037; Berger SL, 2002, CURR OPIN GENET DEV, V12, P142, DOI 10.1016/S0959-437X(02)00279-4; Bonni A, 1997, SCIENCE, V278, P477, DOI 10.1126/science.278.5337.477; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Brill MS, 2008, J NEUROSCI, V28, P6439, DOI 10.1523/JNEUROSCI.0700-08.2008; Britan A, 2006, SHOCK WAVES, V16, P1, DOI 10.1007/s00193-006-0019-0; Cai L, 2000, DEVELOPMENT, V127, P3021; CALES C, 2007, MOL CELL BIOL, V28, P1018; Cao R, 2004, CURR OPIN GENET DEV, V14, P155, DOI 10.1016/j.gde.2004.02.001; CLARK SJ, 1994, NUCLEIC ACIDS RES, V22, P2990, DOI 10.1093/nar/22.15.2990; Cohen P, 2004, NAT REV DRUG DISCOV, V3, P479, DOI 10.1038/nrd1415; de Napoles M, 2004, DEV CELL, V7, P663, DOI 10.1016/j.devcel.2004.10.005; Desai AR, 2000, DEVELOPMENT, V127, P2863; Endoh M, 2008, DEVELOPMENT, V135, P1513, DOI 10.1242/dev.014340; Fan GP, 2005, DEVELOPMENT, V132, P3345, DOI 10.1242/dev.01912; Fasano CA, 2007, CELL STEM CELL, V1, P87, DOI 10.1016/j.stem.2007.04.001; Gaiano N, 2002, ANNU REV NEUROSCI, V25, P471, DOI 10.1146/annurev.neuro.25.030702.130823; Gottlicher M, 2001, EMBO J, V20, P6969, DOI 10.1093/emboj/20.24.6969; Guillemot F, 2007, DEVELOPMENT, V134, P3771, DOI 10.1242/dev.006379; He F, 2005, NAT NEUROSCI, V8, P616, DOI 10.1038/nn1440; Hirabayashi Y, 2004, DEVELOPMENT, V131, P2791, DOI 10.1242/dev.01165; Hirabayashi Y, 2005, NEUROSCI RES, V51, P331, DOI 10.1016/j.neures.2005.01.004; Imayoshi I, 2006, GENESIS, V44, P233, DOI 10.1002/dvg.20212; Israsena N, 2004, DEV BIOL, V268, P220, DOI 10.1016/j.ydbio.2003.12.024; Johe KK, 1996, GENE DEV, V10, P3129, DOI 10.1101/gad.10.24.3129; Kamakura S, 2004, NAT CELL BIOL, V6, P547, DOI 10.1038/ncb1138; Kaykas A, 2004, NAT CELL BIOL, V6, P52, DOI 10.1038/ncb1081; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Lessard J, 1999, GENE DEV, V13, P2691, DOI 10.1101/gad.13.20.2691; Levers TE, 2001, J NEUROBIOL, V48, P265, DOI 10.1002/neu.1056; Lim DA, 2009, NATURE, V458, P529, DOI 10.1038/nature07726; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Miller FD, 2007, NEURON, V54, P357, DOI 10.1016/j.neuron.2007.04.019; Mohn F, 2008, MOL CELL, V30, P755, DOI 10.1016/j.molcel.2008.05.007; Molne M, 2000, J NEUROSCI RES, V59, P301, DOI 10.1002/(SICI)1097-4547(20000201)59:3<301::AID-JNR3>3.0.CO;2-H; Naka H, 2008, NAT NEUROSCI, V11, P1014, DOI 10.1038/nn.2168; Nakashima K, 1999, SCIENCE, V284, P479, DOI 10.1126/science.284.5413.479; Nieto M, 2001, NEURON, V29, P401, DOI 10.1016/S0896-6273(01)00214-8; Nieto M, 2004, J COMP NEUROL, V479, P168, DOI 10.1002/cne.20322; Panganiban G, 2002, DEVELOPMENT, V129, P4371; Pasini D, 2007, MOL CELL BIOL, V27, P3769, DOI 10.1128/MCB.01432-06; Pietersen AM, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2214; Qian XM, 2000, NEURON, V28, P69, DOI 10.1016/S0896-6273(00)00086-6; Rajan P, 1998, J NEUROSCI, V18, P3620; Sardi SP, 2006, CELL, V127, P185, DOI 10.1016/j.cell.2006.07.037; Schuurmans C, 2004, EMBO J, V23, P2892, DOI 10.1038/sj.emboj.7600278; Schwartz YB, 2007, NAT REV GENET, V8, P9, DOI 10.1038/nrg1981; Shen XH, 2008, MOL CELL, V32, P491, DOI 10.1016/j.molcel.2008.10.016; Shimogori T, 2004, J COMP NEUROL, V473, P496, DOI 10.1002/cne.20135; Song MR, 2004, NAT NEUROSCI, V7, P229, DOI 10.1038/nn1192; Spivakov M, 2007, NAT REV GENET, V8, P263, DOI 10.1038/nrg2046; Sun Y, 2001, CELL, V104, P365, DOI 10.1016/S0092-8674(01)00224-0; Takahashi T, 1999, J NEUROSCI, V19, P10357; Takizawa T, 2001, DEV CELL, V1, P749, DOI 10.1016/S1534-5807(01)00101-0; Tomita K, 2000, EMBO J, V19, P5460, DOI 10.1093/emboj/19.20.5460; Valk-Lingbeek ME, 2004, CELL, V118, P409, DOI 10.1016/j.cell.2004.08.005; van der Stoop P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002235; Verney C, 2000, DEV NEUROSCI-BASEL, V22, P125, DOI 10.1159/000017434; Voncken JW, 2003, P NATL ACAD SCI USA, V100, P2468, DOI 10.1073/pnas.0434312100; Zhou CJ, 2006, NEUROSCIENCE, V142, P1119, DOI 10.1016/j.neuroscience.2006.07.007	62	317	326	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 10	2009	63	5					600	613		10.1016/j.neuron.2009.08.021	http://dx.doi.org/10.1016/j.neuron.2009.08.021			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	494XH	19755104	Green Submitted, Bronze			2022-12-24	WOS:000269852300008
J	Siegert, S; Scherf, BG; Del Punta, K; Didkovsky, N; Heintz, N; Roska, B				Siegert, Sandra; Scherf, Brigitte Gross; Del Punta, Karina; Didkovsky, Nick; Heintz, Nathaniel; Roska, Botond			Genetic address book for retinal cell types	NATURE NEUROSCIENCE			English	Article							STARBURST AMACRINE CELLS; GANGLION-CELLS; MOUSE RETINA; BIPOLAR CELLS; DIRECTIONAL SELECTIVITY; MAMMALIAN RETINA; CAT RETINA; IN-VIVO; EXPRESSION; LIGHT	The mammalian brain is assembled from thousands of neuronal cell types that are organized in distinct circuits to perform behaviorally relevant computations. Transgenic mouse lines with selectively marked cell types would facilitate our ability to dissect functional components of complex circuits. We carried out a screen for cell type-specific green fluorescent protein expression in the retina using BAC transgenic mice from the GENSAT project. Among others, we identified mouse lines in which the inhibitory cell types of the night vision and directional selective circuit were selectively labeled. We quantified the stratification patterns to predict potential synaptic connectivity between marked cells of different lines and found that some of the lines enabled targeted recordings and imaging of cell types from developing or mature retinal circuits. Our results suggest the potential use of a stratification-based screening approach for characterizing neuronal circuitry in other layered brain structures, such as the neocortex.	[Siegert, Sandra; Scherf, Brigitte Gross; Roska, Botond] Friedrich Miescher Inst Biomed Res, Neural Circuit Labs, Basel, Switzerland; [Del Punta, Karina; Didkovsky, Nick; Heintz, Nathaniel] Rockefeller Univ, GENSAT Project, New York, NY 10021 USA; [Heintz, Nathaniel] Rockefeller Univ, Howard Hughes Med Inst, Mol Biol Lab, New York, NY 10021 USA	Friedrich Miescher Institute for Biomedical Research; Rockefeller University; Howard Hughes Medical Institute; Rockefeller University	Roska, B (corresponding author), Friedrich Miescher Inst Biomed Res, Neural Circuit Labs, Basel, Switzerland.	botond.roska@fmi.ch	Roska, Botond/AAD-7268-2021; Siegert, Sandra/GWC-4507-2022	Siegert, Sandra/0000-0001-8635-0877	Friedrich Miescher Institute funds; US Office of Naval Research Naval International Cooperative Opportunities in Science and Technology; Marie Curie Excellence; National Center for Competence in Research in Genetics; European Union [HEALTH-F2-223156]; National Institute of Neurological Disorders and Stroke [N01NS02331, HHSN271200723701C]; Howard Hughes Medical Institute	Friedrich Miescher Institute funds; US Office of Naval Research Naval International Cooperative Opportunities in Science and Technology; Marie Curie Excellence(European Commission); National Center for Competence in Research in Genetics; European Union(European Commission); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute)	We thank M. Ciminelli, P. Dyer, S. Djaffer, J. Hall and Y. Shimada for technical assistance, and F. Rijli, P. S. Lagali and K. Farrow for comments on the manuscript. This study was supported by Friedrich Miescher Institute funds, a US Office of Naval Research Naval International Cooperative Opportunities in Science and Technology Program grant, a Marie Curie Excellence grant, a National Center for Competence in Research in Genetics grant and a European Union HEALTH-F2-223156 grant to B. R., and by National Institute of Neurological Disorders and Stroke contracts N01NS02331 and HHSN271200723701C to N. H. N. H. is an Howard Hughes Medical Institute investigator.	Arlotta P, 2005, NEURON, V45, P207, DOI 10.1016/j.neuron.2004.12.036; Balse E, 2006, J PHYSIOL-LONDON, V571, P391, DOI 10.1113/jphysiol.2005.100891; CARTERDAWSON LD, 1979, J COMP NEUROL, V188, P245, DOI 10.1002/cne.901880204; Dowling J. E., 1987, RETINA APPROACHABLE; FAMIGLIETTI EV, 1983, BRAIN RES, V261, P138, DOI 10.1016/0006-8993(83)91293-3; FREED MA, 1988, J NEUROSCI, V8, P2303; Fried SI, 2002, NATURE, V420, P411, DOI 10.1038/nature01179; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; Haverkamp S, 2000, J COMP NEUROL, V424, P1; Huberman AD, 2008, NEURON, V59, P425, DOI 10.1016/j.neuron.2008.07.018; Jeon CJ, 1998, J NEUROSCI, V18, P8936; Kim DS, 2008, J COMP NEUROL, V507, P1795, DOI 10.1002/cne.21639; Kim DS, 2008, J NEUROSCI, V28, P7748, DOI 10.1523/JNEUROSCI.0397-08.2008; Kim IJ, 2008, NATURE, V452, P478, DOI 10.1038/nature06739; Lagali PS, 2008, NAT NEUROSCI, V11, P667, DOI 10.1038/nn.2117; Manookin MB, 2008, J NEUROSCI, V28, P4136, DOI 10.1523/JNEUROSCI.4274-07.2008; Masland RH, 2004, CURR BIOL, V14, pR497, DOI 10.1016/j.cub.2004.06.035; Masland RH, 2001, NAT NEUROSCI, V4, P877, DOI 10.1038/nn0901-877; MCGUIRE BA, 1986, J NEUROSCI, V6, P907; Morgan JL, 2006, NAT NEUROSCI, V9, P85, DOI 10.1038/nn1615; Nelson SB, 2006, TRENDS NEUROSCI, V29, P339, DOI 10.1016/j.tins.2006.05.004; Rice DS, 2000, J COMP NEUROL, V424, P327, DOI 10.1002/1096-9861(20000821)424:2<327::AID-CNE10>3.0.CO;2-6; Roska B, 2001, NATURE, V410, P583, DOI 10.1038/35069068; Rotolo T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004099; Schmidt TM, 2008, J NEUROPHYSIOL, V100, P371, DOI 10.1152/jn.00062.2008; Stevens CF, 1998, CURR BIOL, V8, pR708, DOI 10.1016/S0960-9822(98)70454-3; Tomomura M, 2001, EUR J NEUROSCI, V14, P57, DOI 10.1046/j.0953-816x.2001.01624.x; Trimarchi JM, 2007, J COMP NEUROL, V502, P1047, DOI 10.1002/cne.21368; Walsh MK, 2008, J NEUROSCI METH, V169, P214, DOI 10.1016/j.jneumeth.2007.11.029; Wassle H, 2004, NAT REV NEUROSCI, V5, P747, DOI 10.1038/nrn1497; Yonehara K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001533; Yoshida K, 2001, NEURON, V30, P771, DOI 10.1016/S0896-6273(01)00316-6	33	146	150	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2009	12	9					1197	U30		10.1038/nn.2370	http://dx.doi.org/10.1038/nn.2370			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	487ZD	19648912				2022-12-24	WOS:000269317300024
J	Petrini, EM; Lu, JY; Cognet, L; Lounis, B; Ehlers, MD; Choquet, D				Petrini, Enrica Maria; Lu, Jiuyi; Cognet, Laurent; Lounis, Brahim; Ehlers, Michael D.; Choquet, Daniel			Endocytic Trafficking and Recycling Maintain a Pool of Mobile Surface AMPA Receptors Required for Synaptic Potentiation	NEURON			English	Article							LONG-TERM POTENTIATION; GLUTAMATE RECEPTORS; HIPPOCAMPAL-NEURONS; NMDA RECEPTORS; POSTSYNAPTIC MEMBRANE; LATERAL MOVEMENTS; DENDRITIC SPINES; LTP; ACTIVATION; PLASTICITY	At excitatory glutamatergic synapses, postsynaptic endocytic zones (EZs), which are adjacent to the postsynaptic density (PSD), mediate clathrin-dependent endocytosis of surface AMPA receptors (AMPAR) as a first step to receptor recycling or degradation. However, it remains unknown whether receptor recycling influences AMPAR lateral diffusion and whether EZs are important for the expression of synaptic potentiation. Here, we demonstrate that the presence of both EZs and AMPAR recycling maintain a large pool of mobile AMPARs at synapses. In addition, we find that synaptic potentiation is accompanied by an accumulation and immobilization of AMPARs at synapses resulting from both their exocytosis and stabilization at the PSD. Displacement of Us from the postsynaptic region impairs the expression of synaptic potentiation by blocking AMPAR recycling. Thus, receptor recycling is crucial for maintaining a mobile population of surface AMPARs that can be delivered to synapses for increases in synaptic strength.	[Petrini, Enrica Maria; Choquet, Daniel] Univ Bordeaux, Lab Physiol Cellulaire Synapse, F-33077 Bordeaux, France; [Petrini, Enrica Maria; Choquet, Daniel] CNRS, F-33077 Bordeaux, France; [Petrini, Enrica Maria] Italian Inst Technol, Dept Neurosci & Brain Technol, Genoa, Italy; [Lu, Jiuyi; Ehlers, Michael D.] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; [Cognet, Laurent; Lounis, Brahim] Univ Bordeaux, Ctr Phys Mol Opt & Hertzienne, F-33405 Talence, France; [Cognet, Laurent; Lounis, Brahim] CNRS, F-33405 Talence, France; [Ehlers, Michael D.] Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA	UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); Istituto Italiano di Tecnologia - IIT; Duke University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); Duke University; Howard Hughes Medical Institute	Choquet, D (corresponding author), Univ Bordeaux, Lab Physiol Cellulaire Synapse, F-33077 Bordeaux, France.	daniel.choquet@u-bordeaux2.fr	Choquet, Daniel/K-7893-2018; Choquet, Daniel/E-4203-2013; Cognet, Laurent/M-4505-2019; Lounis, Brahim/I-7862-2016; Choquet, Daniel/GOJ-8825-2022; Cognet, Laurent/F-4163-2011	Choquet, Daniel/0000-0003-4726-9763; Lounis, Brahim/0000-0001-7501-0236; Choquet, Daniel/0000-0003-4726-9763; Cognet, Laurent/0000-0002-3573-5387	Centre National cle la Recherche Scientifique; Conseil Regional d'Aquitaine; Ministere de la Recherche; Fondation pour la Recherche Medicale; The Human Frontier Science Program; European Community [FP6]; NIH; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047574] Funding Source: NIH RePORTER	Centre National cle la Recherche Scientifique; Conseil Regional d'Aquitaine(Region Nouvelle-Aquitaine); Ministere de la Recherche(Ministry of Science and Innovation, Spain (MICINN)Ministry of Research, France); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); The Human Frontier Science Program(Human Frontier Science Program); European Community(European Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank C. Breillat, D. Bouchet, and B. Tessier for help in molecular biology and cell cultures; C. Poujol and P. Legros from the PICIN for support in confocal imaging. We thank R. Huganir for generous gift of he anti-GluAl antibody. We thank T. Newpher for carefully editing the manuscript. This work was supported by grants from the Centre National cle la Recherche Scientifique, the Conseil Regional d'Aquitaine, the Ministere de la Recherche, the Fondation pour la Recherche Medicale, The Human Frontier Science Program to D.C and the European Community's Sixth Framework Programme (FP6) through an OF Fellowship awarded to E.M.P., and by grants from the NIH to M.D.E.	Ashby MC, 2004, J NEUROSCI, V24, P5172, DOI 10.1523/JNEUROSCI.1042-04.2004; Bats C, 2007, NEURON, V53, P719, DOI 10.1016/j.neuron.2007.01.030; Blanpied TA, 2002, NEURON, V36, P435, DOI 10.1016/S0896-6273(02)00979-0; Boehm J, 2006, NEURON, V51, P213, DOI 10.1016/j.neuron.2006.06.013; Borgdorff AJ, 2002, NATURE, V417, P649, DOI 10.1038/nature00780; Brown TC, 2005, NEURON, V45, P81, DOI 10.1016/j.neuron.2004.12.023; Carroll RC, 1999, NAT NEUROSCI, V2, P454, DOI 10.1038/8123; Carroll RC, 1999, P NATL ACAD SCI USA, V96, P14112, DOI 10.1073/pnas.96.24.14112; Choquet D, 2003, NAT REV NEUROSCI, V4, P251, DOI 10.1038/nrn1077; Chowdhury S, 2006, NEURON, V52, P445, DOI 10.1016/j.neuron.2006.08.033; Correia SS, 2008, NAT NEUROSCI, V11, P457, DOI 10.1038/nn2063; Cottrell JR, 2004, NEURON, V44, P677, DOI 10.1016/j.neuron.2004.10.025; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Ehlers MD, 2007, NEURON, V54, P447, DOI 10.1016/j.neuron.2007.04.010; Ehrlich M, 2004, CELL, V118, P591, DOI 10.1016/j.cell.2004.08.017; Elias GM, 2006, NEURON, V52, P307, DOI 10.1016/j.neuron.2006.09.012; Gerges NZ, 2006, EMBO J, V25, P1623, DOI 10.1038/sj.emboj.7601065; Gray NW, 2003, CURR BIOL, V13, P510, DOI 10.1016/S0960-9822(03)00136-2; Groc L, 2004, NAT NEUROSCI, V7, P695, DOI 10.1038/nn1270; Groc L, 2007, J NEUROSCI, V27, P12433, DOI 10.1523/JNEUROSCI.3349-07.2007; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Heine M, 2008, SCIENCE, V320, P201, DOI 10.1126/science.1152089; Lee SH, 2004, NEURON, V43, P221, DOI 10.1016/j.neuron.2004.06.015; Lee SH, 2002, NEURON, V36, P661, DOI 10.1016/S0896-6273(02)01024-3; Lu J, 2007, NEURON, V55, P874, DOI 10.1016/j.neuron.2007.06.041; Lu WY, 2001, NEURON, V29, P243, DOI 10.1016/S0896-6273(01)00194-5; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Man HY, 2000, NEURON, V25, P649, DOI 10.1016/S0896-6273(00)81067-3; Newpher TM, 2008, NEURON, V58, P472, DOI 10.1016/j.neuron.2008.04.030; Oh MC, 2006, J BIOL CHEM, V281, P752, DOI 10.1074/jbc.M509677200; Park M, 2004, SCIENCE, V305, P1972, DOI 10.1126/science.1102026; Park M, 2006, NEURON, V52, P817, DOI 10.1016/j.neuron.2006.09.040; Passafaro M, 2001, NAT NEUROSCI, V4, P917, DOI 10.1038/nn0901-917; Petralia RS, 2003, EUR J NEUROSCI, V18, P3207, DOI 10.1111/j.1460-9568.2003.03074.x; Pickard L, 2001, NEUROPHARMACOLOGY, V41, P700, DOI 10.1016/S0028-3908(01)00127-7; Racine V, 2007, J MICROSC-OXFORD, V225, P214, DOI 10.1111/j.1365-2818.2007.01723.x; Racz B, 2004, NAT NEUROSCI, V7, P917, DOI 10.1038/nn1303; Shepherd JD, 2007, ANNU REV CELL DEV BI, V23, P613, DOI 10.1146/annurev.cellbio.23.090506.123516; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Tardin C, 2003, EMBO J, V22, P4656, DOI 10.1093/emboj/cdg463; Triller A, 2008, NEURON, V59, P359, DOI 10.1016/j.neuron.2008.06.022; Turrigiano GG, 2000, NEURON, V26, P5, DOI 10.1016/S0896-6273(00)81131-9; Wang ZP, 2008, CELL, V135, P535, DOI 10.1016/j.cell.2008.09.057; Yudowski GA, 2007, J NEUROSCI, V27, P11112, DOI 10.1523/JNEUROSCI.2465-07.2007	44	207	210	2	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 16	2009	63	1					92	105		10.1016/j.neuron.2009.05.025	http://dx.doi.org/10.1016/j.neuron.2009.05.025			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	473EX	19607795	Green Accepted, Bronze			2022-12-24	WOS:000268189900011
J	Sahara, S; O'Leary, DDM				Sahara, Setsuko; O'Leary, Dennis D. M.			Fgf10 Regulates Transition Period of Cortical Stem Cell Differentiation to Radial Glia Controlling Generation of Neurons and Basal Progenitors	NEURON			English	Article							FIBROBLAST-GROWTH-FACTOR; DEVELOPING CEREBRAL-CORTEX; DEVELOPING NEOCORTEX; TELENCEPHALIC PROGENITORS; REGIONAL DIFFERENCES; FACTOR FAMILY; NEUROGENESIS; EXPRESSION; BRAIN; RECEPTORS	Radial glia (RG), the progenitors of cortical neurons and basal progenitors (BPs), differentiate from neuroepithelial cells (NCs) with stem cell properties. We show that the morphogen Fgf10 is transiently expressed by NCs coincident with the transition period of NC differentiation into RG. Targeted deletion of Fgf10 delays RG differentiation, whereas overexpression has opposing effects. Delayed RG differentiation in Fgf10 mutants occurs selectively in rostral cortex, paralleled by an extended period of symmetric NC divisions increasing progenitor number, coupled with delayed and initially diminished production of neurons and BPs. RG eventually differentiate in excess number and overproduce neurons and BPs rostrally resulting in tangential expansion of frontal areas and increased laminar thickness. Thus, transient Fgf10 expression regulates timely differentiation of RG, and through this function, determines both length of the early progenitor expansion phase and onset of neurogenesis and ultimately the number of progenitors and neurons fated to specific cortical areas.	[Sahara, Setsuko; O'Leary, Dennis D. M.] Salk Inst Biol Studies, Mol Neurobiol Lab, La Jolla, CA 92037 USA	Salk Institute	O'Leary, DDM (corresponding author), Salk Inst Biol Studies, Mol Neurobiol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	doleary@salk.edu		Sahara, Setsuko/0000-0002-8332-323X	NIH [R37 NS31558, R01 MH086147]; JSPS; Uehara Memorial Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH086147] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS031558] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Uehara Memorial Foundation(Uehara Memorial Foundation); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Todd McLaughlin and Chuck Stevens for comments on the manuscript, Yasuhiko Kawakami and Juan Carlos Belmonte for materials, Haydee Gutierrez and Berta Higgins for technical assistance, Scott Simonet for Fgf10 mutant mice, Robert Hevner for Tbrl antibody, and Stephen Noctor and Arnold Kriegstein for sharing unpublished observations. This work was supported by NIH grants R37 NS31558 and R01 MH086147 (D.D.M.O.). S.S. was supported by fellowships from the JSPS Fellowships for Research Abroad and the Uehara Memorial Foundation.	AakuSaraste E, 1996, DEV BIOL, V180, P664, DOI 10.1006/dbio.1996.0336; Anthony TE, 2004, NEURON, V41, P881, DOI 10.1016/S0896-6273(04)00140-0; Anthony TE, 2005, GENE DEV, V19, P1028, DOI 10.1101/gad.1302105; Assimacopoulos S, 2003, J NEUROSCI, V23, P6399; Bachler M, 2001, MECH DEVELOP, V100, P313, DOI 10.1016/S0925-4773(00)00518-9; Bishop KM, 2002, J NEUROSCI, V22, P7627; Borello U, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-17; Bulchand S, 2003, DEV DYNAM, V226, P460, DOI 10.1002/dvdy.10235; CAVINESS VS, 1995, TRENDS NEUROSCI, V18, P379, DOI 10.1016/0166-2236(95)93933-O; Caviness VS, 2003, CEREB CORTEX, V13, P592, DOI 10.1093/cercor/13.6.592; Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; Cholfin JA, 2007, P NATL ACAD SCI USA, V104, P7652, DOI 10.1073/pnas.0702225104; Crossley PH, 1996, NATURE, V380, P66, DOI 10.1038/380066a0; Englund C, 2005, J NEUROSCI, V25, P247, DOI 10.1523/JNEUROSCI.2899-04.2005; Ever L, 2008, DEV NEUROSCI-BASEL, V30, P306, DOI 10.1159/000112521; Fukuchi-Shimogori T, 2001, SCIENCE, V294, P1071, DOI 10.1126/science.1064252; Gaiano N, 2000, NEURON, V26, P395, DOI 10.1016/S0896-6273(00)81172-1; Ghashghaei HT, 2007, GENE DEV, V21, P3258, DOI 10.1101/gad.1580407; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Grove EA, 1998, DEVELOPMENT, V125, P2315; Gutin G, 2006, DEVELOPMENT, V133, P2937, DOI 10.1242/dev.02465; Hartfuss E, 2001, DEV BIOL, V229, P15, DOI 10.1006/dbio.2000.9962; Hevner RF, 2001, NEURON, V29, P353, DOI 10.1016/S0896-6273(01)00211-2; Hill RS, 2005, NATURE, V437, P64, DOI 10.1038/nature04103; KORNACK DR, 1995, NEURON, V15, P311, DOI 10.1016/0896-6273(95)90036-5; Krubitzer L, 2007, NEURON, V56, P201, DOI 10.1016/j.neuron.2007.10.002; Kuida K, 1998, CELL, V94, P325, DOI 10.1016/S0092-8674(00)81476-2; Kuida K, 1996, NATURE, V384, P368, DOI 10.1038/384368a0; LUSKIN MB, 1988, NEURON, V1, P635, DOI 10.1016/0896-6273(88)90163-8; Mackarehtschian K, 1999, CEREB CORTEX, V9, P601, DOI 10.1093/cercor/9.6.601; Malatesta P, 2003, NEURON, V37, P751, DOI 10.1016/S0896-6273(03)00116-8; Maric D, 2007, J NEUROSCI, V27, P1836, DOI 10.1523/JNEUROSCI.5141-06.2007; Min HS, 1998, GENE DEV, V12, P3156, DOI 10.1101/gad.12.20.3156; MURPHY M, 1990, J NEUROSCI RES, V25, P463, DOI 10.1002/jnr.490250404; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; O'Leary DDM, 2007, NEURON, V56, P252, DOI 10.1016/j.neuron.2007.10.010; Ornitz DM, 1996, J BIOL CHEM, V271, P15292, DOI 10.1074/jbc.271.25.15292; Patten BA, 2003, J NEUROSCI, V23, P6132, DOI 10.1523/JNEUROSCI.23-14-06132.2003; Qian XM, 1998, DEVELOPMENT, V125, P3143; Raballo R, 2000, J NEUROSCI, V20, P5012; RAKIC P, 1995, TRENDS NEUROSCI, V18, P383, DOI 10.1016/0166-2236(95)93934-P; Sahara S, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-10; Sardi SP, 2006, CELL, V127, P185, DOI 10.1016/j.cell.2006.07.037; Schmid RS, 2003, P NATL ACAD SCI USA, V100, P4251, DOI 10.1073/pnas.0630496100; Sessa A, 2008, NEURON, V60, P56, DOI 10.1016/j.neuron.2008.09.028; Storm EE, 2006, DEVELOPMENT, V133, P1831, DOI 10.1242/dev.02324; Storm EE, 2003, P NATL ACAD SCI USA, V100, P1757, DOI 10.1073/pnas.0337736100; Suzuki SC, 1997, MOL CELL NEUROSCI, V9, P433, DOI 10.1006/mcne.1997.0626; Takahashi T, 1999, J NEUROSCI, V19, P10357; Treier M, 2001, DEVELOPMENT, V128, P377; Vaccarino FM, 1999, NAT NEUROSCI, V2, P246, DOI 10.1038/6350; Yoon KJ, 2004, J NEUROSCI, V24, P9497, DOI 10.1523/JNEUROSCI.0993-04.2004	52	144	144	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 16	2009	63	1					48	62		10.1016/j.neuron.2009.06.006	http://dx.doi.org/10.1016/j.neuron.2009.06.006			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	473EX	19607792	Green Accepted, Bronze			2022-12-24	WOS:000268189900008
J	Cherry, CM; Matunis, EL				Cherry, Christopher M.; Matunis, Erika L.			Epigenetic Regulation of Stem Cell Maintenance in the Drosophila Testis via the Nucleosome-Remodeling Factor NURF	CELL STEM CELL			English	Article							SELF-RENEWAL; JAK/STAT PATHWAY; CHROMATIN-STRUCTURE; BAM TRANSCRIPTION; GENE-EXPRESSION; GERM-CELLS; IN-VIVO; PROTEIN; DIFFERENTIATION; NICHE	Regulation of stem cells depends on both tissue-specific transcriptional regulators and changes in chromatin organization, yet the coordination of these events in endogenous niches is poorly understood. In the Drosophila testis, local JAK-STAT signaling maintains germline and somatic stem cells (GSCs and cyst progenitor cells, or CPCs) in a single niche. Here we show that epigenetic regulation via the nucleosome-remodeling factor (NURF) complex ensures GSC and CPC maintenance by positively regulating JAK-STAT signaling, thereby preventing premature differentiation. Conversely, NURF is not required in early differentiating daughter cells of either lineage. Because three additional ATP-dependent chromatin remodelers (ACF, CHRAC, and dMi-2/NuRD) are dispensable for stem cell maintenance in the testis, epigenetic regulation of stem cells within this niche may rely primarily on NURF. Thus, local signals cooperate with specific chromatin-remodeling complexes in intact niches to coordinately regulate a common set of target genes to prevent premature stem cell differentiation.	[Cherry, Christopher M.; Matunis, Erika L.] Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA	Johns Hopkins University	Matunis, EL (corresponding author), Johns Hopkins Univ, Sch Med, Dept Cell Biol, 725 N Wolfe St, Baltimore, MD 21205 USA.	matunis@jhmi.edu			NIH [HD052937, HD040307-07]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD040307, R01HD052937] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank our colleagues who have generously supplied us with reagents, Dr. K. Hohenstein for the initial characterization of nurf301 mutant larval gonads, and Dr. M. de Cuevas and M. lssigonis for comments on the manuscript. This work was supported by NIH grants HD052937 and HD040307-07 (E.L.M.).	Arbouzova NI, 2006, CURR BIOL, V16, P80, DOI 10.1016/j.cub.2005.11.033; Arney KL, 2004, J CELL SCI, V117, P4355, DOI 10.1242/jcs.01390; Badenhorst P, 2005, GENE DEV, V19, P2540, DOI 10.1101/gad.1342605; Becker PB, 2002, ANNU REV BIOCHEM, V71, P247, DOI 10.1146/annurev.biochem.71.110601.135400; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Bouazoune K, 2006, CHROMOSOME RES, V14, P433, DOI 10.1007/s10577-006-1067-0; Buaas FW, 2004, NAT GENET, V36, P647, DOI 10.1038/ng1366; Buszczak M, 2007, GENETICS, V175, P1505, DOI 10.1534/genetics.106.065961; Callus BA, 2002, ONCOGENE, V21, P4812, DOI 10.1038/sj.onc.1205618; Chen DH, 2003, CURR BIOL, V13, P1786, DOI 10.1016/j.cub.2003.09.033; Chen HW, 2002, GENE DEV, V16, P388, DOI 10.1101/gad.955202; Chen X, 2005, SCIENCE, V310, P869, DOI 10.1126/science.1118101; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; Decotto E, 2005, DEV CELL, V9, P501, DOI 10.1016/j.devcel.2005.08.012; Deuring R, 2000, MOL CELL, V5, P355, DOI 10.1016/S1097-2765(00)80430-X; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Elfring LK, 1998, GENETICS, V148, P251; Flaherty MS, 2010, DEV CELL, V18, P556, DOI 10.1016/j.devcel.2010.02.006; Francastel C, 2000, NAT REV MOL CELL BIO, V1, P137, DOI 10.1038/35040083; Fuller MT, 2007, SCIENCE, V316, P402, DOI 10.1126/science.1140861; Fyodorov DV, 2004, GENE DEV, V18, P170, DOI 10.1101/gad.1139604; Gregory L, 2008, SEMIN CELL DEV BIOL, V19, P407, DOI 10.1016/j.semcdb.2008.06.003; Issigonis M, 2009, SCIENCE, V326, P153, DOI 10.1126/science.1176817; Kai TS, 2003, P NATL ACAD SCI USA, V100, P4633, DOI 10.1073/pnas.0830856100; Karsten P, 2002, MECH DEVELOP, V117, P343, DOI 10.1016/S0925-4773(02)00216-2; Kawase E, 2004, DEVELOPMENT, V131, P1365, DOI 10.1242/dev.01025; Kehle J, 1998, SCIENCE, V282, P1897, DOI 10.1126/science.282.5395.1897; Kiger AA, 2000, NATURE, V407, P750, DOI 10.1038/35037606; Kiger AA, 2001, SCIENCE, V294, P2542, DOI 10.1126/science.1066707; Kwon SY, 2008, DEV BIOL, V316, P538, DOI 10.1016/j.ydbio.2008.01.033; Kwon SY, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000574; Landry J, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000241; Leatherman JL, 2008, CELL STEM CELL, V3, P44, DOI 10.1016/j.stem.2008.05.001; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Loden M, 2005, CHROMOSOME RES, V13, P289, DOI 10.1007/s10577-005-2166-z; Matunis E, 1997, DEVELOPMENT, V124, P4383; Meshorer E, 2006, NAT REV MOL CELL BIO, V7, P540, DOI 10.1038/nrm1938; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Silver DL, 2005, DEVELOPMENT, V132, P3483, DOI 10.1242/dev.01910; Terry NA, 2006, DEV BIOL, V294, P246, DOI 10.1016/j.ydbio.2006.02.048; Tulina N, 2001, SCIENCE, V294, P2546, DOI 10.1126/science.1066700; Van Doren M, 1998, CURR BIOL, V8, P243; Voog J, 2008, NATURE, V454, P1132, DOI 10.1038/nature07173; Wang WD, 2004, DEVELOPMENT, V131, P5367, DOI 10.1242/dev.01413; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815; Xi RW, 2005, SCIENCE, V310, P1487, DOI 10.1126/science.1120140; Xiao H, 2001, MOL CELL, V8, P531, DOI 10.1016/S1097-2765(01)00345-8; Xie T, 1998, CELL, V94, P251, DOI 10.1016/S0092-8674(00)81424-5; XU T, 1993, DEVELOPMENT, V117, P1223; Yamasaki Y, 2006, DEV GROWTH DIFFER, V48, P411, DOI 10.1111/j.1440-169x.2006.00880.x	53	50	51	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUN 4	2010	6	6					557	567		10.1016/j.stem.2010.04.018	http://dx.doi.org/10.1016/j.stem.2010.04.018			11	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	611SB	20569693	Green Accepted, Bronze			2022-12-24	WOS:000278840700016
J	Chalasani, SH; Kato, S; Albrecht, DR; Nakagawa, T; Abbott, LF; Bargmann, CI				Chalasani, Sreekanth H.; Kato, Saul; Albrecht, Dirk R.; Nakagawa, Takao; Abbott, L. F.; Bargmann, Cornelia I.			Neuropeptide feedback modifies odor-evoked dynamics in Caenorhabditis elegans olfactory neurons	NATURE NEUROSCIENCE			English	Article							CIS-REGULATORY ARCHITECTURE; C-ELEGANS; IN-VIVO; RECEPTOR NEURONS; SENSORY NEURONS; NERVOUS-SYSTEM; NEURAL CIRCUIT; GENE FAMILIES; ADAPTATION; PROTEIN	Many neurons release classical transmitters together with neuropeptide co-transmitters whose functions are incompletely understood. Here we define the relationship between two transmitters in the olfactory system of C. elegans, showing that a neuropeptide-to-neuropeptide feedback loop alters sensory dynamics in primary olfactory neurons. The AWC olfactory neuron is glutamatergic and also expresses the peptide NLP-1. Worms with nlp-1 mutations show increased AWC-dependent behaviors, suggesting that NLP-1 limits the normal response. The receptor for NLP-1 is the G protein-coupled receptor NPR-11, which acts in postsynaptic AIA interneurons. Feedback from AIA interneurons modulates odor-evoked calcium dynamics in AWC olfactory neurons and requires INS-1, a neuropeptide released from AIA. The neuropeptide feedback loop dampens behavioral responses to odors on short and long timescales. Our results point to neuronal dynamics as a site of behavioral regulation and reveal the ability of neuropeptide feedback to remodel sensory networks on multiple timescales.	[Chalasani, Sreekanth H.; Kato, Saul; Albrecht, Dirk R.; Nakagawa, Takao; Bargmann, Cornelia I.] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA; [Kato, Saul; Abbott, L. F.] Columbia Univ, Coll Phys & Surg, Dept Neurosci, Dept Physiol & Cellular Biophys, New York, NY USA	Howard Hughes Medical Institute; Rockefeller University; Columbia University	Bargmann, CI (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA.	cori@rockefeller.edu	Oka, Yoshitaka/C-9670-2010; Albrecht, Dirk/B-9941-2011	Oka, Yoshitaka/0000-0002-3482-3051; Bargmann, Cornelia/0000-0002-8484-0618	Mathers Foundation; Howard Hughes Medical Institute; Burroughs Wellcome Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007430] Funding Source: NIH RePORTER	Mathers Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Burroughs Wellcome Fund(Burroughs Wellcome Fund); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank the C. elegans knockout consortium and the Caenorhabditis Genetic Center (CGC) for strains, Y.H. Wang for the alpha 16Z chimera, L. Looger for GCaMP2.2b, Y.Iino for discussions about ins-1, and L. Vosshall, G. Lee, E. Feinberg, M. Tsunozaki, J. Gray, J. Garrison, P. McGrath and members of the Bargmann laboratory for critical help, advice and insights. Peptide synthesis was performed by the Proteomics Resource Center of the Rockefeller University. This work was funded by the Mathers Foundation and by the Howard Hughes Medical Institute (C. I. B.). D. R. A. holds a Career Award at the Scientific Interface from the Burroughs Wellcome Fund.	Bargmann C. I., 2006, WORMBOOK; BARGMANN CI, 1993, CELL, V74, P515, DOI 10.1016/0092-8674(93)80053-H; BRENNER S, 1974, GENETICS, V77, P71; Burnstock G, 2004, CURR OPIN PHARMACOL, V4, P47, DOI 10.1016/j.coph.2003.08.001; Chalasani SH, 2007, NATURE, V450, P63, DOI 10.1038/nature06292; CHALFIE M, 1985, J NEUROSCI, V5, P956; Chronis N, 2007, NAT METHODS, V4, P727, DOI 10.1038/NMETH1075; Clark DA, 2006, J NEUROSCI, V26, P7444, DOI 10.1523/JNEUROSCI.1137-06.2006; COLBERT HA, 1995, NEURON, V14, P803, DOI 10.1016/0896-6273(95)90224-4; Colbert HA, 1997, J NEUROSCI, V17, P8259; Demb JB, 2008, J PHYSIOL-LONDON, V586, P4377, DOI 10.1113/jphysiol.2008.156638; Etchberger JF, 2007, GENE DEV, V21, P1653, DOI 10.1101/gad.1560107; Gomez C, 2005, J CHEM NEUROANAT, V29, P238, DOI 10.1016/j.jchemneu.2005.01.005; Gray JM, 2005, P NATL ACAD SCI USA, V102, P3184, DOI 10.1073/pnas.0409009101; Horoszok L, 2001, BRIT J PHARMACOL, V132, P1247, DOI 10.1038/sj.bjp.0703937; Ignell R, 2009, P NATL ACAD SCI USA, V106, P13070, DOI 10.1073/pnas.0813004106; Ivell R, 2002, TRENDS ENDOCRIN MET, V13, P343, DOI 10.1016/S1043-2760(02)00664-1; Kaye JA, 2009, NEURON, V61, P57, DOI 10.1016/j.neuron.2008.11.012; Kindt KS, 2007, NEURON, V55, P662, DOI 10.1016/j.neuron.2007.07.023; Kodama E, 2006, GENE DEV, V20, P2955, DOI 10.1101/gad.1479906; L'Etoile ND, 2002, NEURON, V36, P1079, DOI 10.1016/S0896-6273(02)01066-8; Lee RYN, 1999, J NEUROSCI, V19, P159, DOI 10.1523/JNEUROSCI.19-01-00159.1999; Li C, 1999, ANN NY ACAD SCI, V897, P239, DOI 10.1111/j.1749-6632.1999.tb07895.x; Li C, 2008, WORMBOOK; Lockery SR, 2009, NAT NEUROSCI, V12, P377, DOI 10.1038/nn0409-377; Macosko EZ, 2009, NATURE, V458, P1171, DOI 10.1038/nature07886; Marder E, 2007, ANNU REV PHYSIOL, V69, P291, DOI 10.1146/annurev.physiol.69.031905.161516; Matsuki M, 2006, P NATL ACAD SCI USA, V103, P1112, DOI 10.1073/pnas.0506954103; Mellem JE, 2002, NEURON, V36, P933, DOI 10.1016/S0896-6273(02)01088-7; Mody SM, 2000, MOL PHARMACOL, V57, P13; Nathoo AN, 2001, P NATL ACAD SCI USA, V98, P14000, DOI 10.1073/pnas.241231298; O'Hagan R, 2005, NAT NEUROSCI, V8, P43, DOI 10.1038/nn1362; Palmitessa A, 2005, J BIOL CHEM, V280, P24649, DOI 10.1074/jbc.M502637200; Pierce SB, 2001, GENE DEV, V15, P672, DOI 10.1101/gad.867301; Pierce-Shimomura JT, 1999, J NEUROSCI, V19, P9557; Ramot D, 2008, NAT NEUROSCI, V11, P908, DOI 10.1038/nn.2157; Sieburth D, 2007, NAT NEUROSCI, V10, P49, DOI 10.1038/nn1810; Stein C, 2009, BRAIN RES REV, V60, P90, DOI 10.1016/j.brainresrev.2008.12.017; Stein W, 2007, EUR J NEUROSCI, V26, P1148, DOI 10.1111/j.1460-9568.2007.05744.x; Suzuki H, 2003, NEURON, V39, P1005, DOI 10.1016/j.neuron.2003.08.015; Tallini YN, 2006, P NATL ACAD SCI USA, V103, P4753, DOI 10.1073/pnas.0509378103; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Tomioka M, 2006, NEURON, V51, P613, DOI 10.1016/j.neuron.2006.07.024; Tsunozaki M, 2008, NEURON, V59, P959, DOI 10.1016/j.neuron.2008.07.038; Wachowiak M, 2009, ANN NY ACAD SCI, V1170, P286, DOI 10.1111/j.1749-6632.2009.04015.x; Wakabayashi T, 2004, NEUROSCI RES, V50, P103, DOI 10.1016/j.neures.2004.06.005; Wenick AS, 2004, DEV CELL, V6, P757, DOI 10.1016/j.devcel.2004.05.004; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Yamada K, 2009, GENETICS, V181, P1347, DOI 10.1534/genetics.108.099002	49	140	145	0	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2010	13	5					615	U130		10.1038/nn.2526	http://dx.doi.org/10.1038/nn.2526			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	588JM	20364145	Green Published, Green Accepted			2022-12-24	WOS:000277065700020
J	Magalhaes, AC; Holmes, KD; Dale, LB; Comps-Agrar, L; Lee, D; Yadav, PN; Drysdale, L; Poulter, MO; Roth, BL; Pin, JP; Anisman, H; Ferguson, SSG				Magalhaes, Ana C.; Holmes, Kevin D.; Dale, Lianne B.; Comps-Agrar, Laetitia; Lee, Dennis; Yadav, Prem N.; Drysdale, Linsay; Poulter, Michael O.; Roth, Bryan L.; Pin, Jean-Philippe; Anisman, Hymie; Ferguson, Stephen S. G.			CRF receptor 1 regulates anxiety behavior via sensitization of 5-HT2 receptor signaling	NATURE NEUROSCIENCE			English	Article							CORTICOTROPIN-RELEASING-FACTOR; CENTRAL-NERVOUS-SYSTEM; SEROTONIN RECEPTORS; RAT; DESENSITIZATION; TRAFFICKING; PSD-95; INTERNALIZATION; ENDOCYTOSIS; LOCALIZATION	Stress and anxiety disorders are risk factors for depression and these behaviors are modulated by corticotrophin-releasing factor receptor 1 (CRFR1) and serotonin receptor (5-HT2R). However, the potential behavioral and cellular interaction between these two receptors is unclear. We found that pre-administration of corticotrophin-releasing factor (CRF) into the prefrontal cortex of mice enhanced 5-HT2R-mediated anxiety behaviors in response to 2,5-dimethoxy-4-iodoamphetamine. In both heterologous cell cultures and mouse cortical neurons, activation of CRFR1 also enhanced 5-HT2 receptor-mediated inositol phosphate formation. CRFR1-mediated increases in 5-HT2R signaling were dependent on receptor internalization and receptor recycling via rapid recycling endosomes, resulting in increased expression of 5-HT2R on the cell surface. Sensitization of 5-HT2R signaling by CRFR1 required intact PDZ domain-binding motifs at the end of the C-terminal tails of both receptor types. These data suggest a mechanism by which CRF, a peptide known to be released by stress, enhances anxiety-related behavior via sensitization of 5-HT2R signaling.	[Magalhaes, Ana C.; Holmes, Kevin D.; Dale, Lianne B.; Lee, Dennis; Drysdale, Linsay; Poulter, Michael O.; Ferguson, Stephen S. G.] Univ Western Ontario, J Allyn Taylor Ctr Cell Biol, Mol Brain Res Grp, Robarts Res & Dept Physiol & Pharmacol, London, ON, Canada; [Comps-Agrar, Laetitia; Pin, Jean-Philippe] Univ Montpellier I & II, INSERM, U661, Inst Genom Fonct,Dept Pharmacol Mol,CNRS,UMR 5203, Montpellier, France; [Yadav, Prem N.; Roth, Bryan L.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC USA; [Anisman, Hymie] Carleton Univ, Inst Neurosci, Ctr Res Stress Coping & Wellbeing, Life Sci Res Ctr, Ottawa, ON K1S 5B6, Canada	Western University (University of Western Ontario); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; University of North Carolina; University of North Carolina Chapel Hill; Carleton University	Ferguson, SSG (corresponding author), Univ Western Ontario, J Allyn Taylor Ctr Cell Biol, Mol Brain Res Grp, Robarts Res & Dept Physiol & Pharmacol, London, ON, Canada.	ferguson@robarts.ca	Poulter, Michael/K-3909-2013; Roth, Bryan/ABE-7032-2020; Pin, Jean-Philippe/Y-6668-2019; Yadav, Prem N./R-1197-2019; Roth, Bryan L/F-3928-2010	Poulter, Michael/0000-0001-7469-8462; Roth, Bryan/0000-0002-0561-6520; Pin, Jean-Philippe/0000-0002-1423-345X; Comps-Agrar, Laetitia/0000-0002-5260-6536	Canadian Institutes for Health Research (CIHR) [MOP 62738, MOP 81118]; Ontario Mental Health Foundation; CisBio; French government; CNRS; INSERM; Agence Nationale de la Recherche [Blan06-3_135092]; US National Institutes of Health [R01MH61887, U19MH82441]; Michael Hooker Distinguished Chair of Pharmacology; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH061887, U19MH082441] Funding Source: NIH RePORTER	Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Ontario Mental Health Foundation; CisBio; French government; CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Agence Nationale de la Recherche(French National Research Agency (ANR)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Michael Hooker Distinguished Chair of Pharmacology; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	A. C. M. and D. L. received Canadian Institutes for Health Research (CIHR) fellowships. K. D. H. received a fellowship from the Ontario Mental Health Foundation. L. C.-A. was supported by a Conventions Industrielles de Formation par la Recherche fellowship from CisBio and the French government. J.-P.P. was supported by CNRS, INSERM, the Agence Nationale de la Recherche grant Blan06-3_135092 and CisBio. S. S. G. F. and H. A. hold Tier I Canada Research Chairs, and S. S. G. F. is a Heart and Stroke Foundation of Ontario Career Investigator. This research was funded by CIHR grant MOP 62738 to S. S. G. F., CIHR grant MOP 81118 to H. A., US National Institutes of Health grants R01MH61887 and U19MH82441 and the Michael Hooker Distinguished Chair of Pharmacology to B. L. R.	Abbas AI, 2009, J NEUROSCI, V29, P7124, DOI 10.1523/JNEUROSCI.1090-09.2009; Anisman H, 2008, PROG NEUROBIOL, V85, P1, DOI 10.1016/j.pneurobio.2008.01.004; Anisman H, 2008, NEUROSCI BIOBEHAV R, V32, P1185, DOI 10.1016/j.neubiorev.2008.03.001; Becamel C, 2004, J BIOL CHEM, V279, P20257, DOI 10.1074/jbc.M312106200; Becamel C, 2002, EMBO J, V21, P2332, DOI 10.1093/emboj/21.10.2332; Bhatnagar A, 2001, J BIOL CHEM, V276, P8269, DOI 10.1074/jbc.M006968200; Bockaert J, 2006, CELL TISSUE RES, V326, P553, DOI 10.1007/s00441-006-0286-1; Celada P, 2004, J PSYCHIATR NEUROSCI, V29, P252; CHALMERS DT, 1995, J NEUROSCI, V15, P6340; CHEN RP, 1993, P NATL ACAD SCI USA, V90, P8967, DOI 10.1073/pnas.90.19.8967; Collingridge GL, 2004, NAT REV NEUROSCI, V5, P952, DOI 10.1038/nrn1556; CONN PJ, 1985, J PHARMACOL EXP THER, V234, P195; CUMMINGS S, 1983, J NEUROSCI, V3, P1355; DAVIS M, 1992, ANNU REV NEUROSCI, V15, P353, DOI 10.1146/annurev.neuro.15.1.353; DESOUZA EB, 1985, J NEUROSCI, V5, P3189; Dhami GK, 2004, J BIOL CHEM, V279, P16614, DOI 10.1074/jbc.M314090200; Doherty MD, 2000, BRAIN RES, V864, P176, DOI 10.1016/S0006-8993(00)02062-X; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; Ferguson Stephen S. G., 2003, V237, P121; Franklin KBJ, 2008, MOUSE BRAIN STEREOTA, V3rd; Gavarini S, 2006, MOL BIOL CELL, V17, P4619, DOI 10.1091/mbc.E06-03-0218; Gray JA, 2001, MOL PHARMACOL, V60, P1020, DOI 10.1124/mol.60.5.1020; Heisler LK, 2007, GENES BRAIN BEHAV, V6, P491, DOI 10.1111/j.1601-183X.2007.00316.x; Holmes A, 2003, TRENDS PHARMACOL SCI, V24, P580, DOI 10.1016/j.tips.2003.09.011; Holmes KD, 2006, J NEUROCHEM, V96, P934, DOI 10.1111/j.1471-4159.2005.03603.x; Holsboer Florian, 2003, Curr Opin Investig Drugs, V4, P46; HOYER D, 1994, PHARMACOL REV, V46, P157; Hu LYA, 2000, J BIOL CHEM, V275, P38659, DOI 10.1074/jbc.M005938200; Leonard BE, 2005, EUR PSYCHIAT, V20, pS302, DOI 10.1016/S0924-9338(05)80180-4; LOVENBERG TW, 1995, P NATL ACAD SCI USA, V92, P836, DOI 10.1073/pnas.92.3.836; Marion S, 2004, J BIOL CHEM, V279, P2945, DOI 10.1074/jbc.M308742200; Merali Z, 2004, EUR J NEUROSCI, V20, P229, DOI 10.1111/j.1460-9568.2004.03468.x; Merali Z, 2006, J NEUROSCI, V26, P10387, DOI 10.1523/JNEUROSCI.1219-06.2006; Millan MJ, 2008, TRENDS PHARMACOL SCI, V29, P454, DOI 10.1016/j.tips.2008.06.007; Millan MJ, 2005, THERAPIE, V60, P441, DOI 10.2515/therapie:2005065; Muller MB, 2003, NAT NEUROSCI, V6, P1100, DOI 10.1038/nn1123; Nestler EJ, 2002, NEURON, V34, P13, DOI 10.1016/S0896-6273(02)00653-0; OWENS MJ, 1991, PHARMACOL REV, V43, P425; Pillay NS, 2007, EXPERT OPIN EMERG DR, V12, P541, DOI 10.1517/14728214.12.4.541; Schlag BD, 2004, J PHARMACOL EXP THER, V310, P865, DOI 10.1124/jpet.104.067306; Seachrist JL, 2000, J BIOL CHEM, V275, P27221; Tan HB, 2004, J NEUROSCI, V24, P5000, DOI 10.1523/JNEUROSCI.0143-04.2004; Trimble N, 2007, NEUROGASTROENT MOTIL, V19, P754, DOI 10.1111/j.1365-2982.2007.00951.x; Valdez GR, 2006, CNS DRUGS, V20, P887, DOI 10.2165/00023210-200620110-00002; VALE W, 1981, SCIENCE, V213, P1394, DOI 10.1126/science.6267699; Weisstaub NV, 2006, SCIENCE, V313, P536, DOI 10.1126/science.1123432; Xia Z, 2003, NEUROSCIENCE, V122, P907, DOI 10.1016/S0306-4522(03)00589-X; Xia ZQ, 2003, J BIOL CHEM, V278, P21901, DOI 10.1074/jbc.M301905200	48	145	151	1	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2010	13	5					622	U140		10.1038/nn.2529	http://dx.doi.org/10.1038/nn.2529			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	588JM	20383137	Green Submitted, Green Accepted			2022-12-24	WOS:000277065700021
J	Hnasko, TS; Chuhma, N; Zhang, H; Goh, GY; Sulzer, D; Palmiter, RD; Rayport, S; Edwards, RH				Hnasko, Thomas S.; Chuhma, Nao; Zhang, Hui; Goh, Germaine Y.; Sulzer, David; Palmiter, Richard D.; Rayport, Stephen; Edwards, Robert H.			Vesicular Glutamate Transport Promotes Dopamine Storage and Glutamate Corelease In Vivo	NEURON			English	Article							VENTRAL TEGMENTAL AREA; BRAIN SYNAPTIC VESICLES; CLC CL-CHANNELS; CHROMAFFIN GRANULES; RAT-BRAIN; CATECHOLAMINE TRANSPORT; MONOAMINE TRANSPORTERS; PHOSPHATE TRANSPORTER; CHLORIDE CONDUCTANCE; EXCITATORY NEURONS	Dopamine neurons in the ventral tegmental area (VTA) play an important role in the motivational systems underlying drug addiction, and recent work has suggested that they also release the excitatory neurotransmitter glutamate. To assess a physiological role for glutamate corelease, we disrupted the expression of vesicular glutamate transporter 2 selectively in dopamine neurons. The conditional knockout abolishes glutamate release from midbrain dopamine neurons in culture and severely reduces their excitatory synaptic output in mesoaccumbens slices. Baseline motor behavior is not affected, but stimulation of locomotor activity by cocaine is impaired, apparently through a selective reduction of dopamine stores in the projection of VTA neurons to ventral striatum. Glutamate co-entry promotes monoamine storage by increasing the pH gradient that drives vesicular monoamine transport. Remarkably, low concentrations of glutamate acidify synaptic vesicles more slowly but to a greater extent than equimolar Cl-, indicating a distinct, presynaptic mechanism to regulate quantal size.	[Hnasko, Thomas S.; Goh, Germaine Y.; Edwards, Robert H.] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94158 USA; [Hnasko, Thomas S.; Goh, Germaine Y.; Edwards, Robert H.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USA; [Chuhma, Nao; Rayport, Stephen] Columbia Univ, Dept Psychiat, New York, NY 10032 USA; [Chuhma, Nao; Sulzer, David; Rayport, Stephen] New York State Psychiat Inst & Hosp, Dept Mol Therapeut, New York, NY 10032 USA; [Zhang, Hui; Sulzer, David] Columbia Univ, Dept Neurol, New York, NY 10032 USA; [Zhang, Hui; Sulzer, David] Columbia Univ, Dept Psychiat, New York, NY 10032 USA; [Zhang, Hui; Sulzer, David] Columbia Univ, Dept Pharmacol, New York, NY 10032 USA; [Palmiter, Richard D.] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Palmiter, Richard D.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Columbia University; New York State Psychiatry Institute; Columbia University; Columbia University; Columbia University; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Edwards, RH (corresponding author), Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94158 USA.	robert.edwards@ucsf.edu		Hnasko, Thomas/0000-0001-6176-8513; Chuhma, Nao/0000-0002-6846-3461; Rayport, Stephen/0000-0001-9755-7486	A.P. Giannini Foundation; Wheeler Center for the Neurobiology of Addiction; NIDA; NIMH; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH050712] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K01DA026504, P01DA010154, K02DA000356, R01DA017978] Funding Source: NIH RePORTER	A.P. Giannini Foundation; Wheeler Center for the Neurobiology of Addiction; NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the A.P. Giannini Foundation and the Wheeler Center for the Neurobiology of Addiction (T.S.H.), NIDA (D.S., S.R., R.H.E. and NIMH (R.H.E.). We thank Kurt Thorn and the Nikon Imaging Center at UCSF for access to microscopes, GENSAT and MMRRC for providing BAC VGLUT2-GFP mice, Laurence Tecott and Allan Basbaum for access to behavioral monitoring equipment, and Ray Johnson at the Vanderbilt University CMN/KC for catecholamine measurements.	Accardi A, 2004, NATURE, V427, P803, DOI 10.1038/nature02314; Awatramani GB, 2005, J NEUROPHYSIOL, V93, P819, DOI 10.1152/jn.00798.2004; Bankston LA, 1996, J BIOL CHEM, V271, P17132, DOI 10.1074/jbc.271.29.17132; Bellocchio EE, 2000, SCIENCE, V289, P957, DOI 10.1126/science.289.5481.957; Berube-Carriere N, 2009, J COMP NEUROL, V517, P873, DOI 10.1002/cne.22194; Broer S, 1998, J MEMBRANE BIOL, V164, P71, DOI 10.1007/s002329900394; Busch AE, 1996, P NATL ACAD SCI USA, V93, P5347, DOI 10.1073/pnas.93.11.5347; Chuhma N, 2004, J NEUROSCI, V24, P972, DOI 10.1523/JNEUROSCI.4317-03.2004; Chuhma N, 2009, NEUROSCIENCE, V164, P1068, DOI 10.1016/j.neuroscience.2009.08.057; CIDON S, 1989, J BIOL CHEM, V264, P8281; Dal Bo G, 2008, NEUROSCIENCE, V156, P59, DOI 10.1016/j.neuroscience.2008.07.032; Dal Bo G, 2004, J NEUROCHEM, V88, P1398, DOI 10.1046/j.1471-4159.2003.02277.x; Descarries L, 2008, BRAIN RES REV, V58, P290, DOI 10.1016/j.brainresrev.2007.10.005; ERICKSON JD, 1990, BRAIN RES, V516, P155, DOI 10.1016/0006-8993(90)90912-U; Farley FW, 2000, GENESIS, V28, P106, DOI 10.1002/1526-968X(200011/12)28:3/4<106::AID-GENE30>3.0.CO;2-T; Fon EA, 1997, NEURON, V19, P1271, DOI 10.1016/S0896-6273(00)80418-3; Fremeau RT, 2002, P NATL ACAD SCI USA, V99, P14488, DOI 10.1073/pnas.222546799; Fremeau RT, 2004, TRENDS NEUROSCI, V27, P98, DOI 10.1016/j.tins.2003.11.005; Fujiyama F, 2006, EUR J NEUROSCI, V24, P2813, DOI 10.1111/j.1460-9568.2006.05177.x; Geisler S, 2007, J NEUROSCI, V27, P5730, DOI 10.1523/JNEUROSCI.0012-07.2007; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Gras C, 2002, J NEUROSCI, V22, P5442; Gras C, 2008, NAT NEUROSCI, V11, P292, DOI 10.1038/nn2052; Graves AR, 2008, NATURE, V453, P788, DOI 10.1038/nature06907; Gutierrez R, 2000, J NEUROPHYSIOL, V84, P3088, DOI 10.1152/jn.2000.84.6.3088; HARTINGER J, 1993, J BIOL CHEM, V268, P23122; Hnasko TS, 2007, J NEUROSCI, V27, P12484, DOI 10.1523/JNEUROSCI.3133-07.2007; Ikemoto S, 2007, BRAIN RES REV, V56, P27, DOI 10.1016/j.brainresrev.2007.05.004; Jentsch TJ, 2005, ANNU REV PHYSIOL, V67, P779, DOI 10.1146/annurev.physiol.67.032003.153245; JOHNSON MD, 1994, NEURON, V12, P433, DOI 10.1016/0896-6273(94)90283-6; JOHNSON RG, 1979, J BIOL CHEM, V254, P3750; JOHNSON RG, 1988, PHYSIOL REV, V68, P232, DOI 10.1152/physrev.1988.68.1.232; JOHNSON RG, 1985, ANN NY ACAD SCI, V456, P254, DOI 10.1111/j.1749-6632.1985.tb14874.x; Jonas P, 1998, SCIENCE, V281, P419, DOI 10.1126/science.281.5375.419; Joyce MP, 2000, NEUROSCIENCE, V99, P445, DOI 10.1016/S0306-4522(00)00219-0; Kawano M, 2006, J COMP NEUROL, V498, P581, DOI 10.1002/cne.21054; Lavin A, 2005, J NEUROSCI, V25, P5013, DOI 10.1523/JNEUROSCI.0557-05.2005; Margolis EB, 2006, J PHYSIOL-LONDON, V577, P907, DOI 10.1113/jphysiol.2006.117069; MAYCOX PR, 1988, J BIOL CHEM, V263, P15423; Mendez JA, 2008, J NEUROSCI, V28, P6309, DOI 10.1523/JNEUROSCI.1331-08.2008; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Mitchell SJ, 2004, J NEUROSCI, V24, P4884, DOI 10.1523/JNEUROSCI.0174-04.2004; Moechars D, 2006, J NEUROSCI, V26, P12055, DOI 10.1523/JNEUROSCI.2556-06.2006; Nabekura J, 2004, NAT NEUROSCI, V7, P17, DOI 10.1038/nn1170; NAITO S, 1985, J NEUROCHEM, V44, P99, DOI 10.1111/j.1471-4159.1985.tb07118.x; Nguyen ML, 1998, BIOCHEMISTRY-US, V37, P13400, DOI 10.1021/bi9802263; Omelchenko N, 2007, NEUROSCIENCE, V146, P1259, DOI 10.1016/j.neuroscience.2007.02.016; Perez FA, 2005, P NATL ACAD SCI USA, V102, P2174, DOI 10.1073/pnas.0409598102; Picollo A, 2005, NATURE, V436, P420, DOI 10.1038/nature03720; POIRIER LJ, 1975, J NEURAL TRANSM, V37, P209, DOI 10.1007/BF01670129; Price GD, 2006, J NEUROSCI, V26, P11432, DOI 10.1523/JNEUROSCI.1660-06.2006; Reimer RJ, 2004, PFLUG ARCH EUR J PHY, V447, P629, DOI 10.1007/s00424-003-1087-y; Sankaranarayanan S, 2000, BIOPHYS J, V79, P2199, DOI 10.1016/S0006-3495(00)76468-X; Schafer MKH, 2002, J BIOL CHEM, V277, P50734, DOI 10.1074/jbc.M206738200; Scheel O, 2005, NATURE, V436, P424, DOI [10.1038/nature03860, 10.1038/nature0386O]; Schenck S, 2009, NAT NEUROSCI, V12, P156, DOI 10.1038/nn.2248; SCHULDINER S, 1972, EUR J BIOCHEM, V25, P64, DOI 10.1111/j.1432-1033.1972.tb01667.x; SPYRAKI C, 1982, BRAIN RES, V253, P195, DOI 10.1016/0006-8993(82)90686-2; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Stornetta RL, 2002, J COMP NEUROL, V444, P191, DOI 10.1002/cne.10141; Sulzer D, 1998, J NEUROSCI, V18, P4588, DOI 10.1523/jneurosci.18-12-04588.1998; TABB JS, 1992, J BIOL CHEM, V267, P15412; Takamori S, 2000, NATURE, V407, P189, DOI 10.1038/35025070; Takamori S, 2006, NEUROSCI RES, V55, P343, DOI 10.1016/j.neures.2006.04.016; Tallquist MD, 2000, GENESIS, V26, P113, DOI 10.1002/(SICI)1526-968X(200002)26:2<113::AID-GENE3>3.0.CO;2-2; Torres GE, 2003, NAT REV NEUROSCI, V4, P13, DOI 10.1038/nrn1008; Uhl GR, 2002, MOL PSYCHIATR, V7, P21, DOI 10.1038/sj/mp/4000964; Ungless MA, 2004, SCIENCE, V303, P2040, DOI 10.1126/science.1093360; Wallen-Mackenzie A, 2006, J NEUROSCI, V26, P12294, DOI 10.1523/JNEUROSCI.3855-06.2006; WIGHTMAN RM, 1990, BRAIN RES REV, V15, P135, DOI 10.1016/0165-0173(90)90015-G; Wojcik SM, 2006, NEURON, V50, P575, DOI 10.1016/j.neuron.2006.04.016; Wolosker H, 1996, J BIOL CHEM, V271, P11726, DOI 10.1074/jbc.271.20.11726; Yamaguchi T, 2007, EUR J NEUROSCI, V25, P106, DOI 10.1111/j.1460-9568.2006.05263.x; Zhang H, 2003, J NEUROSCI, V23, P10585; ZHANG H, 2002, J NUCL RADIOCHEM SCI, V3, P99; Zhou FM, 2005, NEURON, V46, P65, DOI 10.1016/j.neuron.2005.02.010; Zhuang XX, 2005, J NEUROSCI METH, V143, P27, DOI 10.1016/j.jneumeth.2004.09.020	77	269	271	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 11	2010	65	5					643	656		10.1016/j.neuron.2010.02.012	http://dx.doi.org/10.1016/j.neuron.2010.02.012			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	571NF	20223200	Green Accepted, Bronze			2022-12-24	WOS:000275758000008
J	Greber, B; Wu, GM; Bernemann, C; Joo, JY; Han, DW; Ko, K; Tapia, N; Sabour, D; Sterneckert, J; Tesar, P; Scholer, HR				Greber, Boris; Wu, Guangming; Bernemann, Christof; Joo, Jin Young; Han, Dong Wook; Ko, Kinarm; Tapia, Natalia; Sabour, Davood; Sterneckert, Jared; Tesar, Paul; Schoeler, Hans R.			Conserved and Divergent Roles of FGF Signaling in Mouse Epiblast Stem Cells and Human Embryonic Stem Cells	CELL STEM CELL			English	Article							FEEDER-FREE GROWTH; HUMAN ES CELLS; SELF-RENEWAL; TRANSCRIPTIONAL NETWORK; MAINTAINS PLURIPOTENCY; DEFINED CONDITIONS; HUMAN BLASTOCYSTS; WNT/BETA-CATENIN; RNA INTERFERENCE; FATE DECISIONS	Mouse epiblast stem cells (EpiSCs) are cultured with FGF2 and Activin A, like human embryonic stem cells (hESCs), but the action of the associated pathways in EpiSCs has not been well characterized. Here, we show that activation of the Activin pathway promotes self-renewal of EpiSCs via direct activation of Nanog, whereas inhibition of this pathway induces neuroectodermal differentiation, like in hESCs. In contrast, the different roles of FGF signaling appear to be only partially conserved in the mouse. Our data suggest that FGF2 fails to cooperate with SMAD2/3 signaling in actively promoting EpiSC self-renewal through Nanog, in contrast to its role in hESCs. Rather, FGF appears to stabilize the epiblast state by dual inhibition of differentiation to neuroectoderm and of media-induced reversion to a mouse embryonic stem cell-like state. Our data extend the current model of cell fate decisions concerning EpiSCs by clarifying the distinct roles played by FGF signaling.	[Greber, Boris; Wu, Guangming; Bernemann, Christof; Joo, Jin Young; Han, Dong Wook; Ko, Kinarm; Tapia, Natalia; Sabour, Davood; Sterneckert, Jared; Schoeler, Hans R.] Max Planck Inst Mol Biomed, Dept Cell & Dev Biol, D-48149 Munster, Germany; [Tesar, Paul] Case Western Reserve Univ, Dept Genet, Ctr Stem Cell & Regenerat Med, Sch Med, Cleveland, OH 44106 USA; [Schoeler, Hans R.] Univ Munster, Fac Med, D-48149 Munster, Germany	Max Planck Society; Case Western Reserve University; University of Munster	Scholer, HR (corresponding author), Max Planck Inst Mol Biomed, Dept Cell & Dev Biol, Rontgenstr 20, D-48149 Munster, Germany.	office@mpi-muenster.mpg.de	Tesar, Paul J/C-9848-2014; Sterneckert, Jared/E-6802-2015; Tesar, Paul/GPK-5942-2022; Han, Dong Wook/D-6041-2011; , HS/AAB-4434-2019; Tapia, Natalia/H-5500-2012	Tesar, Paul J/0000-0003-1532-3155; Tesar, Paul/0000-0003-1532-3155; , HS/0000-0003-2643-5136; Greber, Boris/0000-0002-9404-7293; Sterneckert, Jared/0000-0002-7688-3124; Tapia, Natalia/0000-0003-0226-1952; Wu, Guangming/0000-0003-1923-7609	Max Planck Society; German Federal Ministry of Education and Research BMBF [01GN0934]	Max Planck Society(Max Planck Society); German Federal Ministry of Education and Research BMBF(Federal Ministry of Education & Research (BMBF))	We thank Sandra Heising, Martina BleidiBel, Philipp Trepte, and Barbel Schafer for technical assistance, as well as Rebekka Schneider, University Hospital Aachen, for help with the teratoma analysis. This work was supported by the Max Planck Society and partly funded by a grant of the German Federal Ministry of Education and Research BMBF (01GN0934).	Adjaye J, 2005, STEM CELLS, V23, P1514, DOI 10.1634/stemcells.2005-0113; Amit M, 2004, BIOL REPROD, V70, P837, DOI 10.1095/biolreprod.103.021147; Arnold SJ, 2000, MECH DEVELOP, V91, P249, DOI 10.1016/S0925-4773(99)00309-3; Bao SQ, 2009, NATURE, V461, P1292, DOI 10.1038/nature08534; Bendall SC, 2007, NATURE, V448, P1015, DOI 10.1038/nature06027; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Camus A, 2006, DEV BIOL, V295, P743, DOI 10.1016/j.ydbio.2006.03.047; CHAN KK, 2001, STEM CELLS, V27, P2114; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Cowan CA, 2004, NEW ENGL J MED, V350, P1353, DOI 10.1056/NEJMsr040330; Daheron L, 2004, STEM CELLS, V22, P770, DOI 10.1634/stemcells.22-5-770; Darr H, 2006, DEVELOPMENT, V133, P1193, DOI 10.1242/dev.02286; Dvorak P, 2005, STEM CELLS, V23, P1200, DOI 10.1634/stemcells.2004-0303; Eiselleova L, 2009, STEM CELLS, V27, P1847, DOI 10.1002/stem.128; Fong HL, 2008, STEM CELLS, V26, P1931, DOI 10.1634/stemcells.2007-1002; Furue MK, 2008, P NATL ACAD SCI USA, V105, P13409, DOI 10.1073/pnas.0806136105; Greber B, 2007, STEM CELLS, V25, P455, DOI 10.1634/stemcells.2006-0476; Greber B, 2008, STEM CELLS DEV, V17, P1065, DOI 10.1089/scd.2008.0035; Guo G, 2009, DEVELOPMENT, V136, P1063, DOI 10.1242/dev.030957; Hall J, 2009, CELL STEM CELL, V5, P597, DOI 10.1016/j.stem.2009.11.003; Hanna J, 2009, CELL STEM CELL, V4, P513, DOI 10.1016/j.stem.2009.04.015; Hay DC, 2004, STEM CELLS, V22, P225, DOI 10.1634/stemcells.22-2-225; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; James D, 2005, DEVELOPMENT, V132, P1273, DOI 10.1242/dev.01706; Jiang JM, 2008, NAT CELL BIOL, V10, P353, DOI 10.1038/ncb1698; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Kunath T, 2007, DEVELOPMENT, V134, P2895, DOI 10.1242/dev.02880; Larsen WJ, 2001, HUMAN EMBRYOLOGY, V3; Lee TI, 2006, NAT PROTOC, V1, P729, DOI 10.1038/nprot.2006.98; Levenstein ME, 2006, STEM CELLS, V24, P568, DOI 10.1634/stemcells.2005-0247; Li J, 2007, DIFFERENTIATION, V75, P299, DOI 10.1111/j.1432-0436.2006.00143.x; Ludwig TE, 2006, NAT BIOTECHNOL, V24, P185, DOI 10.1038/nbt1177; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; Nagy A., 2003, MANIPULATING MOUSE E; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Niwa H, 2009, NATURE, V460, P118, DOI 10.1038/nature08113; Pelton TA, 2002, J CELL SCI, V115, P329; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Smith JR, 2008, DEV BIOL, V313, P107, DOI 10.1016/j.ydbio.2007.10.003; Sumi T, 2008, DEVELOPMENT, V135, P2969, DOI 10.1242/dev.021121; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Vallier L, 2005, J CELL SCI, V118, P4495, DOI 10.1242/jcs.02553; Vallier L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006082; Vallier L, 2009, DEVELOPMENT, V136, P1339, DOI 10.1242/dev.033951; Wang XF, 2009, J BIOL CHEM, V284, P34054, DOI 10.1074/jbc.M109.052290; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Xu CH, 2005, STEM CELLS, V23, P315, DOI 10.1634/stemcells.2004-0211; Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971; Xu RH, 2008, CELL STEM CELL, V3, P196, DOI 10.1016/j.stem.2008.07.001; Yao S, 2006, P NATL ACAD SCI USA, V103, P6907, DOI 10.1073/pnas.0602280103; Yeom YI, 1996, DEVELOPMENT, V122, P881; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Yoshimizu T, 1999, DEV GROWTH DIFFER, V41, P675; Zaehres H, 2005, STEM CELLS, V23, P299, DOI 10.1634/stemcells.2004-0252	58	259	273	0	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAR 5	2010	6	3					215	226		10.1016/j.stem.2010.01.003	http://dx.doi.org/10.1016/j.stem.2010.01.003			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	577WL	20207225	Bronze			2022-12-24	WOS:000276254600009
J	Noseda, R; Kainz, V; Jakubowski, M; Gooley, JJ; Saper, CB; Digre, K; Burstein, R				Noseda, Rodrigo; Kainz, Vanessa; Jakubowski, Moshe; Gooley, Joshua J.; Saper, Clifford B.; Digre, Kathleen; Burstein, Rami			A neural mechanism for exacerbation of headache by light	NATURE NEUROSCIENCE			English	Article							RETINAL GANGLION-CELLS; CUTANEOUS ALLODYNIA; NOCICEPTIVE NEURONS; NON-CONE; NON-ROD; MELANOPSIN; STIMULATION; MIGRAINE; CORTEX; PROJECTIONS	The perception of migraine headache, which is mediated by nociceptive signals transmitted from the cranial dura mater to the brain, is uniquely exacerbated by exposure to light. We found that exacerbation of migraine headache by light is prevalent among blind individuals who maintain non-image-forming photoregulation in the face of massive rod/cone degeneration. Using single-unit recording and neural tract tracing in the rat, we identified dura-sensitive neurons in the posterior thalamus whose activity was distinctly modulated by light and whose axons projected extensively across layers I-V of somatosensory, visual and associative cortices. The cell bodies and dendrites of such dura/light-sensitive neurons were apposed by axons originating from retinal ganglion cells (RGCs), predominantly from intrinsically photosensitive RGCs, the principle conduit of non-image-forming photoregulation. We propose that photoregulation of migraine headache is exerted by a non-image-forming retinal pathway that modulates the activity of dura-sensitive thalamocortical neurons.	[Noseda, Rodrigo; Kainz, Vanessa; Jakubowski, Moshe; Burstein, Rami] Harvard Univ, Sch Med, Dept Anesthesia, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA; [Gooley, Joshua J.; Saper, Clifford B.] Harvard Univ, Sch Med, Dept Neurol, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA; [Saper, Clifford B.; Burstein, Rami] Harvard Univ, Sch Med, Program Neurosci, Boston, MA 02115 USA; [Digre, Kathleen] Univ Utah, Moran Eye Ctr, Dept Neurol & Ophthalmol, Salt Lake City, UT USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Harvard Medical School; Utah System of Higher Education; University of Utah	Burstein, R (corresponding author), Harvard Univ, Sch Med, Dept Anesthesia, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA.	rburstei@bidmc.harvard.edu	Noseda, Rodrigo/AAN-1761-2020	Noseda, Rodrigo/0000-0002-9641-4691; Jakubowski, Moshe/0000-0001-5245-1258	US National Institutes of Health [NS-051484, NS-035611]; Research to Prevent Blindness; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS035611, R01NS051484, R01NS033987] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank D. Friedman, A. Recober, M. Carmen-Wilson and A. Mauskop for sharing their blind migraine patients, and L. Villanueva and J.-F. Bernard for teaching us the juxtacellular labeling technique. This research was supported by US National Institutes of Health grants NS-051484 and NS-035611. K.D. was supported in part by an unrestricted grant from Research to Prevent Blindness.	Aurora SK, 1999, HEADACHE, V39, P469, DOI 10.1046/j.1526-4610.1999.3907469.x; Berson DM, 2007, PFLUG ARCH EUR J PHY, V454, P849, DOI 10.1007/s00424-007-0242-2; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Burstein R, 2000, ANN NEUROL, V47, P614, DOI 10.1002/1531-8249(200005)47:5<614::AID-ANA9>3.3.CO;2-E; Burstein R, 2000, BRAIN, V123, P1703, DOI 10.1093/brain/123.8.1703; Burstein R, 1998, J NEUROPHYSIOL, V79, P964, DOI 10.1152/jn.1998.79.2.964; Burstein R, 2004, ANN NEUROL, V55, P27, DOI 10.1002/ana.10785; Dacey DM, 2005, NATURE, V433, P749, DOI 10.1038/nature03387; DAVIS KD, 1988, BRAIN RES, V454, P89, DOI 10.1016/0006-8993(88)90806-2; Donchin O, 1998, NATURE, V395, P274, DOI 10.1038/26220; Freedman MS, 1999, SCIENCE, V284, P502, DOI 10.1126/science.284.5413.502; Gauriau C, 2004, J NEUROSCI, V24, P752, DOI 10.1523/JNEUROSCI.3272-03.2004; Gooley JJ, 2003, J NEUROSCI, V23, P7093, DOI 10.1523/JNEUROSCI.23-18-07093.2003; Guler AD, 2008, NATURE, V453, P102, DOI 10.1038/nature06829; Hannibal J, 2004, INVEST OPHTH VIS SCI, V45, P4202, DOI 10.1167/iovs.04-0313; Hannibal J, 2004, CELL TISSUE RES, V316, P99, DOI 10.1007/s00441-004-0858-x; Hattar S, 2003, NATURE, V424, P76, DOI 10.1038/nature01761; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; Hattar S, 2006, J COMP NEUROL, V497, P326, DOI 10.1002/cne.20970; HERKENHAM M, 1980, SCIENCE, V207, P532, DOI 10.1126/science.7352263; INGVAR M, 1999, TXB PAIN, P215; Kawasaki A, 2002, J NEURO-OPHTHALMOL, V22, P3, DOI 10.1097/00041327-200203000-00002; KLEIN DC, 1972, SCIENCE, V177, P532, DOI 10.1126/science.177.4048.532; LAMONTE M, 1995, HEADACHE, V35, P520, DOI 10.1111/j.1526-4610.1995.hed3509520.x; LEBENSOHN JE, 1951, AM J OPHTHALMOL, V34, P1294, DOI 10.1016/0002-9394(51)91866-1; Living E., 1873, MEGRIM SICK HEADACHE; LIVINGSTONE MS, 1984, J NEUROSCI, V4, P309; LOWEL S, 1992, SCIENCE, V255, P209, DOI 10.1126/science.1372754; Lowenfeld I., 1993, DAZZLING SYNDROME; Lucas RJ, 2001, NAT NEUROSCI, V4, P621, DOI 10.1038/88443; Lucas RJ, 1999, SCIENCE, V284, P505, DOI 10.1126/science.284.5413.505; Malick A, 2001, P NATL ACAD SCI USA, V98, P9930, DOI 10.1073/pnas.171616898; MARKOWITZ S, 1988, CEPHALALGIA, V8, P83, DOI 10.1046/j.1468-2982.1988.0802083.x; MILLER NR, 1985, WALSH HOYTS CLIN NEU, V2, P1099; MOUNTCASTLE VB, 1975, J NEUROPHYSIOL, V38, P871, DOI 10.1152/jn.1975.38.4.871; Panda S, 2003, SCIENCE, V301, P525, DOI 10.1126/science.1086179; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Penfield W, 1940, ARCH NEURO PSYCHIATR, V44, P43, DOI 10.1001/archneurpsyc.1940.02280070051003; Pinault D, 1996, J NEUROSCI METH, V65, P113, DOI 10.1016/0165-0270(95)00144-1; Provencio I, 2000, J NEUROSCI, V20, P600, DOI 10.1523/JNEUROSCI.20-02-00600.2000; Provencio I, 1998, P NATL ACAD SCI USA, V95, P340, DOI 10.1073/pnas.95.1.340; SELBY G, 1960, J NEUROL NEUROSUR PS, V23, P23, DOI 10.1136/jnnp.23.1.23; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; Strassman AM, 1996, NATURE, V384, P560, DOI 10.1038/384560a0; Tu DC, 2005, NEURON, V48, P987, DOI 10.1016/j.neuron.2005.09.031; VALENSTEIN E, 1987, BRAIN, V110, P1631, DOI 10.1093/brain/110.6.1631; WELTY TE, 1990, CLIN PHARMACY, V9, P35; Wong KY, 2007, J PHYSIOL-LONDON, V582, P279, DOI 10.1113/jphysiol.2007.133751; Yamamura H, 1999, J NEUROPHYSIOL, V81, P479, DOI 10.1152/jn.1999.81.2.479; ZAGAMI AS, 1990, EXP BRAIN RES, V81, P552, DOI 10.1007/BF02423504	50	338	360	1	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2010	13	2					239	U128		10.1038/nn.2475	http://dx.doi.org/10.1038/nn.2475			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	548SE	20062053	Green Accepted			2022-12-24	WOS:000273985800020
J	Fries, P				Fries, Pascal			The Model- and the Data-Gamma	NEURON			English	Editorial Material							BAND SYNCHRONIZATION; OSCILLATIONS; FREQUENCY	Brain regions that are structurally connected might become functionally connected by synchronization in the gamma-frequency band. In a recent issue of Nature, Colgin et al. show spatially and temporally fine-grained gamma-band synchronization between different parts of the rat hippocampal formation, suggesting a theta-modulated switching of gamma-mediated communication.	Max Planck Gesell, Ernst Strungmann Inst Cooperat, D-60528 Frankfurt, Germany	Max Planck Society	Fries, P (corresponding author), Max Planck Gesell, Ernst Strungmann Inst Cooperat, D-60528 Frankfurt, Germany.	pascal.fries@esi-frankfurt.de	Fries, Pascal/E-3196-2010	Fries, Pascal/0000-0002-4270-1468				Berg RW, 2006, J NEUROSCI, V26, P6518, DOI 10.1523/JNEUROSCI.0190-06.2006; Buzsaki G., 2006, RHYTHMS BRAIN; Canolty RT, 2006, SCIENCE, V313, P1626, DOI 10.1126/science.1128115; Colgin LL, 2009, NATURE, V462, P353, DOI 10.1038/nature08573; Fries P, 2009, ANNU REV NEUROSCI, V32, P209, DOI 10.1146/annurev.neuro.051508.135603; Hoogenboom N, 2006, NEUROIMAGE, V29, P764, DOI 10.1016/j.neuroimage.2005.08.043; Jutras MJ, 2009, J NEUROSCI, V29, P12521, DOI 10.1523/JNEUROSCI.0640-09.2009; Lakatos P, 2005, J NEUROPHYSIOL, V94, P1904, DOI 10.1152/jn.00263.2005; Otero-Millan J, 2008, J VISION, V8, DOI 10.1167/8.14.21; Swettenham JB, 2009, J NEUROPHYSIOL, V102, P1241, DOI 10.1152/jn.91044.2008; Tiesinga P, 2009, NEURON, V63, P727, DOI 10.1016/j.neuron.2009.09.009; Whittington MA, 2000, INT J PSYCHOPHYSIOL, V38, P315, DOI 10.1016/S0167-8760(00)00173-2	12	32	32	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 10	2009	64	5					601	602		10.1016/j.neuron.2009.11.024	http://dx.doi.org/10.1016/j.neuron.2009.11.024			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	537OW	20005817	Bronze			2022-12-24	WOS:000273123700005
J	Schaefer, A; Sampath, SC; Intrator, A; Min, A; Gertler, TS; Surmeier, DJ; Tarakhovsky, A; Greengard, P				Schaefer, Anne; Sampath, Srihari C.; Intrator, Adam; Min, Alice; Gertler, Tracy S.; Surmeier, D. James; Tarakhovsky, Alexander; Greengard, Paul			Control of Cognition and Adaptive Behavior by the GLP/G9a Epigenetic Suppressor Complex	NEURON			English	Article							HISTONE METHYLTRANSFERASE G9A; TRANSLATIONAL PROFILING APPROACH; CHROMATIN MODIFICATIONS; ALPHA-FETOPROTEIN; GENE-EXPRESSION; TARGET GENES; METHYLATION; DELETION; PROTEIN; SYSTEM	The genetic basis of cognition and behavioral adaptation to the environment remains poorly understood. Here we demonstrate that the histone methyltransferase complex GLP/G9a controls cognition and adaptive responses in a region-specific fashion in the adult brain. Using conditional mutagenesis in mice, we show that postnatal, neuron-specific deficiency of GLP/G9a leads to derepression of numerous nonneuronal and neuron progenitor genes in adult neurons. This transcriptional alteration is associated with complex behavioral abnormalities, including defects in learning, motivation, and environmental adaptation. The behavioral changes triggered by GLP/G9a deficiency are similar to key symptoms of the human 9q34 mental retardation syndrome that is associated with structural alterations of the GLP/EHMT1 gene. The likely causal role of GLP/G9a in mental retardation in mice and humans suggests a key role for the GLP/G9a-controlled histone H3K9 dimethylation in regulation of brain function through maintenance of the transcriptional homeostasis in adult neurons.	[Sampath, Srihari C.; Tarakhovsky, Alexander] Rockefeller Univ, Lab Lymphocyte Signaling, New York, NY 10021 USA; [Schaefer, Anne; Intrator, Adam; Min, Alice; Greengard, Paul] Rockefeller Univ, Mol & Cellular Neurosci Lab, New York, NY 10021 USA; [Gertler, Tracy S.; Surmeier, D. James] Northwestern Univ, Feinberg Sch Med, Dept Physiol, Chicago, IL 60611 USA	Rockefeller University; Rockefeller University; Northwestern University; Feinberg School of Medicine	Tarakhovsky, A (corresponding author), Rockefeller Univ, Lab Lymphocyte Signaling, 1230 York Ave, New York, NY 10021 USA.	tarakho@rockefeller.edu; greengd@rockvax.rockefeller.edu			NIH [AG09464, AI068058, DA025962, GM07739, MH074866]; DFG postdoctoral fellowship [SCHA 1482/1-1]; NRSA award [MH082522]; Rudin Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068058] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739, R01GM112811] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH074866, F30MH082522] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS013742] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG009464] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R03DA025962] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DFG postdoctoral fellowship(German Research Foundation (DFG)); NRSA award; Rudin Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We would like to thank Myriam Heiman and Nathaniel Heintz for providing the Drd1-bacTRAP and Drd2-bacTRAP mice, Nathaniel Heintz and Gensat for providing the Drd2-eGFP and Drd1- and Drd2-Cre mice, Guenther Schuetz for providing the Camk2a-Cre mice, Donal O'Carroll for providing vectors for conditional gene targeting of GLP, Ayse Begum Tekinay for her help with the behavioral analysis, Selina Riddick and Sharon Kuca for animal work, Fekrije Selimi and Lars Brichta for critical reading of the manuscript, and Elisabeth Griggs and Debra Poulter for help in the preparation of the manuscript. This work was supported in part by NIH grants AG09464 (P.G.), AI068058 (A.T.), DA025962 (A.S.), GM07739 (S.C.S.) and MH074866 (D.J.S.). A.S. was a recipient of a DFG postdoctoral fellowship SCHA 1482/1-1). T.S.G. was recipient of NRSA award MH082522. S.C.S. was supported by the Rudin Foundation.	American Psychiatric Association (APA), 2000, DIAGN STAT MAN MENT; Bailey CM, 2006, J CELL PHYSIOL, V209, P617, DOI 10.1002/jcp.20782; Benarafa C, 2002, J BIOL CHEM, V277, P42028, DOI 10.1074/jbc.M207080200; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Cao R, 2004, CURR OPIN GENET DEV, V14, P155, DOI 10.1016/j.gde.2004.02.001; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Casanova E, 2001, GENESIS, V31, P37, DOI 10.1002/gene.1078; Chelly J, 2006, EUR J HUM GENET, V14, P701, DOI 10.1038/sj.ejhg.5201595; Chen HB, 2006, CANCER RES, V66, P9009, DOI 10.1158/0008-5472.CAN-06-0101; Cormier-Daire V, 2003, J MED GENET, V40, P300, DOI 10.1136/jmg.40.4.300; Davis RJ, 2001, MECH DEVELOP, V102, P169, DOI 10.1016/S0925-4773(01)00307-0; Ding N, 2008, MOL CELL, V31, P347, DOI 10.1016/j.molcel.2008.05.023; Doyle JP, 2008, CELL, V135, P749, DOI 10.1016/j.cell.2008.10.029; Fyffe SL, 2008, NEURON, V59, P947, DOI 10.1016/j.neuron.2008.07.030; Gertler TS, 2008, J NEUROSCI, V28, P10814, DOI 10.1523/JNEUROSCI.2660-08.2008; Goldstone AP, 2008, FRONT HORM RES, V36, P37, DOI 10.1159/000115336; Gong SC, 2007, J NEUROSCI, V27, P9817, DOI 10.1523/JNEUROSCI.2707-07.2007; Heiman M, 2008, CELL, V135, P738, DOI 10.1016/j.cell.2008.10.028; Heintz N, 2004, NAT NEUROSCI, V7, P483, DOI 10.1038/nn0504-483; Hirabayashi Y, 2009, NEURON, V63, P600, DOI 10.1016/j.neuron.2009.08.021; Holmes RS, 2008, COMP BIOCHEM PHYS D, V3, P195, DOI 10.1016/j.cbd.2008.05.002; Inlow JK, 2004, GENETICS, V166, P835, DOI 10.1534/genetics.166.2.835; Jensen EV, 2010, PHYSIOL BEHAV, V99, P151, DOI 10.1016/j.physbeh.2009.08.013; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kleefstra T, 2009, J MED GENET, V46, P598, DOI 10.1136/jmg.2008.062950; Kleefstra T, 2006, AM J HUM GENET, V79, P370, DOI 10.1086/505693; Kondo Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002037; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kramer JM, 2009, INT J BIOCHEM CELL B, V41, P96, DOI 10.1016/j.biocel.2008.08.009; Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451; LICHENSTEIN HS, 1994, J BIOL CHEM, V269, P18149; Nguyen TT, 2005, MOL CELL BIOL, V25, P2147, DOI 10.1128/MCB.25.6.2147-2157.2005; Niyonsaba F, 2005, J IMMUNOL, V175, P1776, DOI 10.4049/jimmunol.175.3.1776; Ogawa H, 2002, SCIENCE, V296, P1132, DOI 10.1126/science.1069861; Oien KA, 2004, J PATHOL, V203, P789, DOI 10.1002/path.1583; Peters AHFM, 2003, MOL CELL, V12, P1577, DOI 10.1016/S1097-2765(03)00477-5; Ramocki MB, 2008, NATURE, V455, P912, DOI 10.1038/nature07457; Rice JC, 2003, MOL CELL, V12, P1591, DOI 10.1016/S1097-2765(03)00479-9; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Roopra A, 2004, MOL CELL, V14, P727, DOI 10.1016/j.molcel.2004.05.026; Sampath SC, 2007, MOL CELL, V27, P596, DOI 10.1016/j.molcel.2007.06.026; Schaefer A, 2007, J EXP MED, V204, P1553, DOI 10.1084/jem.20070823; Scheele S, 2007, J MOL MED, V85, P825, DOI 10.1007/s00109-007-0182-5; Shi YJ, 2003, NATURE, V422, P735, DOI 10.1038/nature01550; Shirato H, 2009, J BIOL CHEM, V284, P733, DOI 10.1074/jbc.M804994200; Su IH, 2003, NAT IMMUNOL, V4, P124, DOI 10.1038/ni876; Tachibana M, 2005, GENE DEV, V19, P815, DOI 10.1101/gad.1284005; Tachibana M, 2002, GENE DEV, V16, P1779, DOI 10.1101/gad.989402; Tachibana M, 2001, J BIOL CHEM, V276, P25309, DOI 10.1074/jbc.M101914200; Tahiliani M, 2007, NATURE, V447, P601, DOI 10.1038/nature05823; Thomas LR, 2008, J IMMUNOL, V181, P485, DOI 10.4049/jimmunol.181.1.485; Torres RM, 1997, LAB PROTOCOLS CONDIT; VERHOEVEN WM, 2009, AM J MED B IN PRESS, DOI DOI 10.1002/AJMG.B.31015; Wagschal A, 2008, MOL CELL BIOL, V28, P1104, DOI 10.1128/MCB.01111-07; Yu DG, 2000, P NATL ACAD SCI USA, V97, P5978, DOI 10.1073/pnas.100127597; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301; Zhang ZW, 2004, GENESIS, V40, P82, DOI 10.1002/gene.20068	57	230	237	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 10	2009	64	5					678	691		10.1016/j.neuron.2009.11.019	http://dx.doi.org/10.1016/j.neuron.2009.11.019			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	537OW	20005824	Green Accepted, Bronze			2022-12-24	WOS:000273123700013
J	Sun, BG; Halabisky, B; Zhou, YG; Palop, JJ; Yu, GQ; Mucke, L; Gan, L				Sun, Binggui; Halabisky, Brian; Zhou, Yungui; Palop, Jorge J.; Yu, Guiqiu; Mucke, Lennart; Gan, Li			Imbalance between GABAergic and Glutamatergic Transmission Impairs Adult Neurogenesis in an Animal Model of Alzheimer's Disease	CELL STEM CELL			English	Article							NEWLY GENERATED NEURONS; ENHANCED SYNAPTIC PLASTICITY; HIPPOCAMPAL NEUROGENESIS; AMYLOID-BETA; TRANSGENIC MICE; DENTATE GYRUS; MOUSE MODEL; MEMORY; BRAIN; INTEGRATION	Adult neurogenesis regulates plasticity and function in the hippocampus, which is critical for memory and vulnerable to Alzheimer's disease (AD). Promoting neurogenesis may improve hippocampal function in AD brains. However, how amyloid 0 (AD), the key AD pathogen, affects the development and function of adult-born neurons remains unknown. Adult-born granule cells (GCs) in human amyloid precursor protein (hAPP) transgenic mice, an AD model, showed greater dendritic length, spine density, and functional responses than did controls early in development, but were impaired morphologically and functionally during later maturation. Early inhibition of GABA(A) receptors to suppress GABAergic signaling or late inhibition of calcineurin to enhance glutamatergic signaling normalized the development of adult-born GCs in hAPP mice with high A beta levels. A beta-induced increases in GABAergic neurotransmission or an imbalance between GABAergic and glutamatergic neurotransmission may contribute to impaired neurogenesis in AD.	[Sun, Binggui; Halabisky, Brian; Zhou, Yungui; Palop, Jorge J.; Yu, Guiqiu; Mucke, Lennart; Gan, Li] Univ Calif San Francisco, Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA; [Sun, Binggui; Halabisky, Brian; Palop, Jorge J.; Mucke, Lennart; Gan, Li] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco	Gan, L (corresponding author), Univ Calif San Francisco, Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA.	lgan@gladstone.ucsf.edu	Sun, Binggui/J-9028-2016; Palop, Jorge J./D-8128-2011; Sun, Binggui/B-2739-2010; Palop, Jorge/AAH-9014-2020	Sun, Binggui/0000-0002-0386-6569; Palop, Jorge/0000-0001-6086-1070	Whittier Foundation; NIH [AG022074, NS041787]; NIH/NCRR [C06 RRO18928]; Elan; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041787] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG022074, P01AG004342] Funding Source: NIH RePORTER	Whittier Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Elan; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Chunmei Zhao, Xinyu Zhao, and Fred Gage for the CAG-EGFP retroviral vector, Sarah Mueller-Steiner for viral preparations, Robert W. Mahley and Anatol Kreitzer for insightful discussions, Xin Wang for excellent technical support, Stephen Ordway and Gary Howard for editorial review, and Kelley Nelson for administrative assistance. This work was supported in part by a grant from Whittier Foundation (to L.G.), NIH grants AG022074 and NS041787 (to L.M.), and NIH/NCRR C06 RRO18928 (a facility grant to the J. David Gladstone Institutes). L.G. has received research funding from Elan. L.M. consults for Merck, has received research funding from Elan, and serves on the scientific board of iPierian.	AGHAJANIAN GK, 1989, SYNAPSE, V3, P331, DOI 10.1002/syn.890030406; ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; Ben-Ari Y, 2002, NAT REV NEUROSCI, V3, P728, DOI 10.1038/nrn920; Boekhoorn K, 2006, NEUROBIOL DIS, V24, P1, DOI 10.1016/j.nbd.2006.04.017; Cheng IH, 2007, J BIOL CHEM, V282, P23818, DOI 10.1074/jbc.M701078200; Clelland CD, 2009, SCIENCE, V325, P210, DOI 10.1126/science.1173215; Dineley KT, 2007, NEUROBIOL LEARN MEM, V88, P217, DOI 10.1016/j.nlm.2007.03.010; Donovan MH, 2006, J COMP NEUROL, V495, P70, DOI 10.1002/cne.20840; Duan X, 2007, CELL, V130, P1146, DOI 10.1016/j.cell.2007.07.010; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Fernandez F, 2007, NAT NEUROSCI, V10, P411, DOI 10.1038/nn1860; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Gan L, 2008, NEUROBIOL DIS, V29, P71, DOI 10.1016/j.nbd.2007.08.002; Ganguly K, 2001, CELL, V105, P521, DOI 10.1016/S0092-8674(01)00341-5; Ge SY, 2008, J PHYSIOL-LONDON, V586, P3759, DOI 10.1113/jphysiol.2008.155655; Ge SY, 2007, NEURON, V54, P559, DOI 10.1016/j.neuron.2007.05.002; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Haughey NJ, 2002, J NEUROCHEM, V83, P1509, DOI 10.1046/j.1471-4159.2002.01267.x; Hsieh H, 2006, NEURON, V52, P831, DOI 10.1016/j.neuron.2006.10.035; Imayoshi I, 2008, NAT NEUROSCI, V11, P1153, DOI 10.1038/nn.2185; Jin KL, 2004, P NATL ACAD SCI USA, V101, P13363, DOI 10.1073/pnas.0403678101; Jin KL, 2004, P NATL ACAD SCI USA, V101, P343, DOI 10.1073/pnas.2634794100; JohnsonWood K, 1997, P NATL ACAD SCI USA, V94, P1550, DOI 10.1073/pnas.94.4.1550; Li B, 2008, J NEUROPATH EXP NEUR, V67, P78, DOI 10.1097/nen.0b013e318160c5db; Lopez-Toledano MA, 2007, J ALZHEIMERS DIS, V12, P229; McGowan E, 2005, NEURON, V47, P191, DOI 10.1016/j.neuron.2005.06.030; Moolman DL, 2004, J NEUROCYTOL, V33, P377, DOI 10.1023/B:NEUR.0000044197.83514.64; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Mueller-Steiner S, 2006, NEURON, V51, P703, DOI 10.1016/j.neuron.2006.07.027; Owens DF, 2002, NAT REV NEUROSCI, V3, P715, DOI 10.1038/nrn919; Palop JJ, 2007, NEURON, V55, P697, DOI 10.1016/j.neuron.2007.07.025; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Saxe MD, 2006, P NATL ACAD SCI USA, V103, P17501, DOI 10.1073/pnas.0607207103; Scheff SW, 2003, NEUROBIOL AGING, V24, P1029, DOI 10.1016/j.neurobiolaging.2003.08.002; Schmidt-Hieber C, 2004, NATURE, V429, P184, DOI 10.1038/nature02553; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503; Snyder JS, 2005, NEUROSCIENCE, V130, P843, DOI 10.1016/j.neuroscience.2004.10.009; Taglialatela G, 2009, BEHAV BRAIN RES, V200, P95, DOI 10.1016/j.bbr.2008.12.034; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008; Tashiro A, 2006, NAT PROTOC, V1, P3049, DOI 10.1038/nprot.2006.473; Tashiro A, 2006, NATURE, V442, P929, DOI 10.1038/nature05028; Tozuka Y, 2005, NEURON, V47, P803, DOI 10.1016/j.neuron.2005.08.023; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Verret L, 2007, PSYCHONEUROENDOCRINO, V32, pS26, DOI 10.1016/j.psyneuen.2007.04.014; Yoshiike Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003029; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Zhao CM, 2006, J NEUROSCI, V26, P3, DOI 10.1523/JNEUROSCI.3648-05.2006	51	146	150	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	DEC 4	2009	5	6					624	633		10.1016/j.stem.2009.10.003	http://dx.doi.org/10.1016/j.stem.2009.10.003			10	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	543YH	19951690	Green Accepted, Bronze			2022-12-24	WOS:000273616700010
J	Hayashi, T; Thomas, GM; Huganir, RL				Hayashi, Takashi; Thomas, Gareth M.; Huganir, Richard L.			Dual Palmitoylation of NR2 Subunits Regulates NMDA Receptor Trafficking	NEURON			English	Article							DEPENDENT PROTEIN-KINASE; D-ASPARTATE RECEPTORS; SYNAPTIC PLASTICITY; AMPA RECEPTOR; TYROSINE PHOSPHORYLATION; SF9 CELLS; DIFFERENTIAL REGULATION; GABA(A) RECEPTORS; DIFFERENT SITES; ION CHANNELS	Modification of NMDA receptor function and trafficking contributes to the regulation of synaptic transmission and is important for several forms of synaptic plasticity. Here, we report that NMDA receptor subunits NR2A and NR2B have two distinct clusters of palmitoylation sites in their C-terminal region. Palmitoylation within the first cluster on a membrane-proximal region increases tyrosine phosphorylation of tyrosine-based internalization motifs by Src family protein tyrosine kinases, leading to enhanced stable surface expression of NMDA receptors. In addition, palmitoylation of these sites regulates constitutive internalization of the NMDA receptor in developing neurons. In marked contrast, palmitoylation of the second cluster in the middle of C terminus by distinct palmitoyl transferases causes receptors to accumulate in the Golgi apparatus and reduces receptor surface expression. These data suggest that regulated palmitoylation of NR2 subunits differentially modulates receptor trafficking and might be important for NMDA-receptor-dependent synaptic plasticity.	[Hayashi, Takashi; Thomas, Gareth M.; Huganir, Richard L.] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Neurosci, Baltimore, MD 21205 USA	Howard Hughes Medical Institute; Johns Hopkins University	Huganir, RL (corresponding author), Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Neurosci, 725 N Wolfe St, Baltimore, MD 21205 USA.	rhuganir@jhmi.edu		Hayashi, Takashi/0000-0003-3591-2109	HHMI; NIMH; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH064856] Funding Source: NIH RePORTER	HHMI(Howard Hughes Medical Institute); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We are grateful to Dr. V. Anggono for valuable discussion, encouragement, and critical reading of manuscript, Ms. M. Coulter for antibody preparation, and Ms. K. Searcy-Goldberg and Lisa Hamm for excellent administrative assistance. GODZ cDNAs were special gifts from Dr. M. Mishina. This work was supported by research grants from HHMI and NIMH.; Undera licensing agreement between Millipore, Inc. and The Johns Hopkins University, R.L.H. is entitled to a share ofroyalties received bythe Universityon sales of products described in this article. R.L.H. is a paid consultant to Millipore, Inc. The terms of this arrangement are being managed by the Johns Hopkins University in accordance with its conflict of interest policies.	Abe M, 2004, J NEUROSCI, V24, P7292, DOI 10.1523/JNEUROSCI.1261-04.2004; ALALUF S, 1995, J NEUROCHEM, V64, P1548; Bijlmakers MJ, 2003, TRENDS CELL BIOL, V13, P32, DOI 10.1016/S0962-8924(02)00008-9; BIZZOZERO OA, 1995, METHOD ENZYMOL, V250, P361; Carroll RC, 2002, TRENDS NEUROSCI, V25, P571, DOI 10.1016/S0166-2236(02)02272-5; Cavara NA, 2008, MOL NEUROBIOL, V38, P16, DOI 10.1007/s12035-008-8029-9; Chien AJ, 1996, J BIOL CHEM, V271, P26465, DOI 10.1074/jbc.271.43.26465; Collingridge GL, 2004, NAT REV NEUROSCI, V5, P952, DOI 10.1038/nrn1556; CONSTANTINEPATON M, 1990, ANNU REV NEUROSCI, V13, P129, DOI 10.1146/annurev.neuro.13.1.129; Cull-Candy Stuart G, 2004, Sci STKE, V2004, pre16, DOI 10.1126/stke.2552004re16; Derkach VA, 2007, NAT REV NEUROSCI, V8, P101, DOI 10.1038/nrn2055; Dietrich LEP, 2004, EMBO REP, V5, P1053, DOI 10.1038/sj.embor.7400277; Dietrich LEP, 2004, EMBO J, V23, P45, DOI 10.1038/sj.emboj.7600015; Dingledine R, 1999, PHARMACOL REV, V51, P7; Drisdel RC, 2004, J NEUROSCI, V24, P10502, DOI 10.1523/JNEUROSCI.3315-04.2004; Drisdel RC, 2006, METHODS, V40, P127, DOI 10.1016/j.ymeth.2006.04.015; El-Husseini AED, 2002, NAT REV NEUROSCI, V3, P791, DOI 10.1038/nrn940; Fukata M, 2004, NEURON, V44, P987, DOI 10.1016/j.neuron.2004.12.005; Hayashi T, 2004, J NEUROSCI, V24, P6152, DOI 10.1523/JNEUROSCI.0799-04.2004; Hayashi T, 2005, NEURON, V47, P709, DOI 10.1016/j.neuron.2005.06.035; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Huang K, 2004, NEURON, V44, P977, DOI 10.1016/j.neuron.2004.11.027; Kang RJ, 2008, NATURE, V456, P904, DOI 10.1038/nature07605; Keller CA, 2004, J NEUROSCI, V24, P5881, DOI 10.1523/JNEUROSCI.1037-04.2004; Lan JY, 2001, NAT NEUROSCI, V4, P382, DOI 10.1038/86028; Lau CG, 2007, NAT REV NEUROSCI, V8, P413, DOI 10.1038/nrn2153; Lavezzari G, 2004, J NEUROSCI, V24, P6383, DOI 10.1523/JNEUROSCI.1890-04.2004; Leonard AS, 1997, J BIOL CHEM, V272, P12107, DOI 10.1074/jbc.272.18.12107; Li B, 2002, NAT NEUROSCI, V5, P833, DOI 10.1038/nn912; Lin DT, 2009, NAT NEUROSCI, V12, P879, DOI 10.1038/nn.2351; Lobo S, 2002, J BIOL CHEM, V277, P41268, DOI 10.1074/JBC.M206573200; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; MORI H, 1995, NEUROPHARMACOLOGY, V34, P1219, DOI 10.1016/0028-3908(95)00109-J; Nakazawa T, 2001, J BIOL CHEM, V276, P693, DOI 10.1074/jbc.M008085200; Nakazawa T, 2006, EMBO J, V25, P2867, DOI 10.1038/sj.emboj.7601156; NG GYK, 1994, J NEUROCHEM, V63, P1589; NG GYK, 1994, EUR J PHARM-MOLEC PH, V267, P7, DOI 10.1016/0922-4106(94)90219-4; NG GYK, 1993, BIOCHEMISTRY-US, V32, P11727, DOI 10.1021/bi00094a032; Ohno Y, 2006, BBA-MOL CELL BIOL L, V1761, P474, DOI 10.1016/j.bbalip.2006.03.010; Omkumar RV, 1996, J BIOL CHEM, V271, P31670, DOI 10.1074/jbc.271.49.31670; Pickering DS, 1995, P NATL ACAD SCI USA, V92, P12090, DOI 10.1073/pnas.92.26.12090; Ponimaskin EG, 2002, J BIOL CHEM, V277, P2534, DOI 10.1074/jbc.M106529200; Ponimaskin EG, 2001, BIOCHEM J, V353, P627, DOI 10.1042/0264-6021:3530627; Prybylowski K, 2005, NEURON, V47, P845, DOI 10.1016/j.neuron.2005.08.016; Qin N, 1998, P NATL ACAD SCI USA, V95, P4690, DOI 10.1073/pnas.95.8.4690; Rathenberg J, 2004, MOL CELL NEUROSCI, V26, P251, DOI 10.1016/j.mcn.2004.01.012; Resh MD, 1999, BBA-MOL CELL RES, V1451, P1, DOI 10.1016/S0167-4889(99)00075-0; Roche KW, 2001, NAT NEUROSCI, V4, P794, DOI 10.1038/90498; Roth AF, 2002, J CELL BIOL, V159, P23, DOI 10.1083/jcb.200206120; SCHMIDT JW, 1987, J BIOL CHEM, V262, P13713; Scott DB, 2003, NEUROPHARMACOLOGY, V45, P755, DOI 10.1016/S0028-3908(03)00250-8; Scott DB, 2001, J NEUROSCI, V21, P3063, DOI 10.1523/JNEUROSCI.21-09-03063.2001; Scott DB, 2004, J NEUROSCI, V24, P7096, DOI 10.1523/JNEUROSCI.0780-04.2004; SEEBURG PH, 1993, TRENDS PHARMACOL SCI, V14, P297, DOI 10.1016/0165-6147(93)90047-N; Shepherd JD, 2007, ANNU REV CELL DEV BI, V23, P613, DOI 10.1146/annurev.cellbio.23.090506.123516; Skeberdis VA, 2001, P NATL ACAD SCI USA, V98, P3561, DOI 10.1073/pnas.051634698; Song I, 2002, TRENDS NEUROSCI, V25, P578, DOI 10.1016/S0166-2236(02)02270-1; Stephenson FA, 2001, CURR DRUG TARGETS, V2, P233, DOI 10.2174/1389450013348461; Swope SL, 1999, ADV SEC MESS PHOSPH, V33, P49; Uemura T, 2002, BIOCHEM BIOPH RES CO, V296, P492, DOI 10.1016/S0006-291X(02)00900-2; Vissel B, 2001, NAT NEUROSCI, V4, P587, DOI 10.1038/88404; Wan J, 2007, NAT PROTOC, V2, P1573, DOI 10.1038/nprot.2007.225; Wenthold RJ, 2003, BIOCHEM SOC T, V31, P885, DOI 10.1042/BST0310885; Wenthold RJ, 2003, ANNU REV PHARMACOL, V43, P335, DOI 10.1146/annurev.pharmtox.43.100901.135803; Yaka R, 2002, P NATL ACAD SCI USA, V99, P5710, DOI 10.1073/pnas.062046299	66	155	157	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 29	2009	64	2					213	226		10.1016/j.neuron.2009.08.017	http://dx.doi.org/10.1016/j.neuron.2009.08.017			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	521AA	19874789	Bronze, Green Accepted			2022-12-24	WOS:000271889900011
J	Kaeser, PS; Deng, LB; Chavez, AE; Liu, XR; Castillo, PE; Sudhof, TC				Kaeser, Pascal S.; Deng, Lunbin; Chavez, Andres E.; Liu, Xinran; Castillo, Pablo E.; Suedhof, Thomas C.			ELKS2 alpha/CAST Deletion Selectively Increases Neurotransmitter Release at Inhibitory Synapses	NEURON			English	Article							PRESYNAPTIC ACTIVE ZONE; PAPILLARY THYROID-CARCINOMA; SYNAPTIC VESICLE FUSION; RIM-BINDING PROTEINS; LIPRIN-ALPHA; FUNCTIONAL INTERACTION; EXCITATORY SYNAPSES; TRANSMITTER RELEASE; TERM PLASTICITY; C-ELEGANS	The presynaptic active zone is composed of a protein network that contains ELKS2 alpha (a.k.a. CAST) as a central component. Here we demonstrate that in mice, deletion of ELKS2 alpha caused a large increase in inhibitory, but not excitatory, neurotransmitter release, and potentiated the size, but not the properties, of the readily-releasable pool of vesicles at inhibitory synapses. Quantitative electron microscopy revealed that the ELKS2 alpha deletion did not change the number of docked vesicles or other ultrastructural parameters of synapses, except for a small decrease in synaptic vesicle numbers. The ELKS2 alpha deletion did, however, alter the excitatory/inhibitory balance and exploratory behaviors, possibly as a result of the increased synaptic inhibition. Thus, as opposed to previous studies indicating that ELKS2 alpha is essential for mediating neurotransmitter release, our results suggest that ELKS2 alpha normally restricts release and limits the size of the readily-releasable pool of synaptic vesicles at the active zone of inhibitory synapses.	[Kaeser, Pascal S.; Deng, Lunbin; Suedhof, Thomas C.] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Palo Alto, CA 94304 USA; [Suedhof, Thomas C.] Stanford Univ, Sch Med, Howard Hughes Med Inst, Palo Alto, CA 94304 USA; [Kaeser, Pascal S.; Deng, Lunbin; Liu, Xinran; Suedhof, Thomas C.] Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA; [Suedhof, Thomas C.] Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA; [Suedhof, Thomas C.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Chavez, Andres E.; Castillo, Pablo E.] Albert Einstein Coll Med, Dominick P Purpura Dept Neurosci, Bronx, NY 10461 USA	Stanford University; Howard Hughes Medical Institute; Stanford University; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; Yeshiva University; Albert Einstein College of Medicine	Sudhof, TC (corresponding author), Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, 1050 Arastradero Rd, Palo Alto, CA 94304 USA.	tcs1@stanford.edu		Castillo, Pablo/0000-0002-9834-1801	NIH NINDS [33564, DA17392]; Swiss National Science Foundation; Irma T. Hirschl Career Scientist Award; NARSAD Young Investigator Award; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA017392] Funding Source: NIH RePORTER	NIH NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Irma T. Hirschl Career Scientist Award; NARSAD Young Investigator Award(NARSAD); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We would like to thank E. Borowicz, J. Mitchell, I. Komblum, and L. Fan for excellent technical assistance; Dr. Nils Brose for Munc13 antibodies; Dr. Stephen C. Fowler for advice with the force-plate actometer experiments; and Dr. Robert Hammer for blastocyst injections of ES cells. We are grateful to members of the Sudhof lab for comments and advice. This work was supported by grants from the NIH (NINDS 33564 to T.C.S. and DA17392 to P.E.C.), a Swiss National Science Foundation Postdoctoral Fellowship (to P.S.K.), the Irma T. Hirschl Career Scientist Award (to P.E.C.), and a NARSAD Young Investigator Award (to P.S.K.).	Altrock WD, 2003, NEURON, V37, P787, DOI 10.1016/S0896-6273(03)00088-6; Aravamudan B, 1999, NAT NEUROSCI, V2, P965, DOI 10.1038/14764; Augustin I, 1999, NATURE, V400, P457, DOI 10.1038/22768; Betz A, 2001, NEURON, V30, P183, DOI 10.1016/S0896-6273(01)00272-0; Bronk P, 2007, J NEUROPHYSIOL, V98, P794, DOI 10.1152/jn.00226.2007; Calakos N, 2004, NEURON, V42, P889, DOI 10.1016/j.neuron.2004.05.014; Cao YQ, 2004, NEURON, V43, P387, DOI 10.1016/j.neuron.2004.07.014; Castillo PE, 2002, NATURE, V415, P327, DOI 10.1038/415327a; Chevaleyre V, 2003, NEURON, V38, P461, DOI 10.1016/S0896-6273(03)00235-6; Chevaleyre V, 2007, NEURON, V54, P801, DOI 10.1016/j.neuron.2007.05.020; Dai Y, 2006, NAT NEUROSCI, V9, P1479, DOI 10.1038/nn1808; Deak F, 2004, NAT CELL BIOL, V6, P1102, DOI 10.1038/ncb1185; Deak F, 2009, J CELL BIOL, V184, P751, DOI 10.1083/jcb.200812026; Deken SL, 2005, J NEUROSCI, V25, P5975, DOI 10.1523/JNEUROSCI.0804-05.2005; Fowler SC, 2001, J NEUROSCI METH, V107, P107, DOI 10.1016/S0165-0270(01)00359-4; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; Gerber SH, 2008, SCIENCE, V321, P1507, DOI 10.1126/science.1163174; Gracheva EO, 2006, PLOS BIOL, V4, P1426, DOI 10.1371/journal.pbio.0040261; Ho A, 2006, J NEUROSCI, V26, P13089, DOI 10.1523/JNEUROSCI.2855-06.2006; Jockusch WJ, 2007, CELL, V131, P796, DOI 10.1016/j.cell.2007.11.002; Junge HJ, 2004, CELL, V118, P389, DOI 10.1016/j.cell.2004.06.029; Kaeser PS, 2008, J NEUROSCI, V28, P13435, DOI 10.1523/JNEUROSCI.3235-08.2008; Kaufmann N, 2002, NEURON, V34, P27, DOI 10.1016/S0896-6273(02)00643-8; Kittel RJ, 2006, SCIENCE, V312, P1051, DOI 10.1126/science.1126308; Ko J, 2003, J BIOL CHEM, V278, P42377, DOI 10.1074/jbc.M307561200; Ko JW, 2006, J NEUROSCI, V26, P963, DOI 10.1523/JNEUROSCI.4475-05.2006; Koushika SP, 2001, NAT NEUROSCI, V4, P997, DOI 10.1038/nn732; Lu J, 2005, J MOL BIOL, V352, P455, DOI 10.1016/j.jmb.2005.07.047; Maximov A, 2005, NEURON, V48, P547, DOI 10.1016/j.neuron.2005.09.006; Maximov A, 2007, J NEUROSCI METH, V161, P75, DOI 10.1016/j.jneumeth.2006.10.009; Megias M, 2001, NEUROSCIENCE, V102, P527, DOI 10.1016/S0306-4522(00)00496-6; Monier S, 2002, TRAFFIC, V3, P289, DOI 10.1034/j.1600-0854.2002.030406.x; Nakata T, 2002, GENE CHROMOSOME CANC, V35, P30, DOI 10.1002/gcc.10095; Nakata T, 1999, GENE CHROMOSOME CANC, V25, P97, DOI 10.1002/(SICI)1098-2264(199906)25:2<97::AID-GCC4>3.0.CO;2-L; Ohara-Imaizumi M, 2005, MOL BIOL CELL, V16, P3289, DOI 10.1091/mbc.E04-09-0816; Ohtsuka T, 2002, J CELL BIOL, V158, P577, DOI 10.1083/jcb.200202083; Pang ZPP, 2006, J NEUROSCI, V26, P13493, DOI 10.1523/JNEUROSCI.3519-06.2006; Patel MR, 2006, NAT NEUROSCI, V9, P1488, DOI 10.1038/nn1806; Pobbati AV, 2004, J BIOL CHEM, V279, P47192, DOI 10.1074/jbc.M408767200; Rhee JS, 2002, CELL, V108, P121, DOI 10.1016/S0092-8674(01)00635-3; Richmond JE, 1999, NAT NEUROSCI, V2, P959, DOI 10.1038/12160; ROSAHL TW, 1995, NATURE, V375, P488, DOI 10.1038/375488a0; Rosenmund C, 2002, NEURON, V33, P411, DOI 10.1016/S0896-6273(02)00568-8; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; Sakisaka T, 2008, J CELL BIOL, V183, P323, DOI 10.1083/jcb.200805150; Schoch S, 2001, SCIENCE, V294, P1117, DOI 10.1126/science.1064335; Schoch S, 2002, NATURE, V415, P321, DOI 10.1038/415321a; Schoch S, 2006, CELL TISSUE RES, V326, P379, DOI 10.1007/s00441-006-0244-y; Serra-Pages C, 1998, J BIOL CHEM, V273, P15611, DOI 10.1074/jbc.273.25.15611; Sigala JLD, 2004, SCIENCE, V304, P1963, DOI 10.1126/science.1098387; Siksou L, 2007, J NEUROSCI, V27, P6868, DOI 10.1523/JNEUROSCI.1773-07.2007; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Takao-Rikitsu E, 2004, J CELL BIOL, V164, P301, DOI 10.1083/jcb.200307101; Varoqueaux F, 2002, P NATL ACAD SCI USA, V99, P9037, DOI 10.1073/pnas.122623799; Wagh DA, 2006, NEURON, V49, P833, DOI 10.1016/j.neuron.2006.02.008; Wang Y, 2002, P NATL ACAD SCI USA, V99, P14464, DOI 10.1073/pnas.182532999; Zhen M, 1999, NATURE, V401, P371, DOI 10.1038/43886	57	75	76	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 29	2009	64	2					227	239		10.1016/j.neuron.2009.09.019	http://dx.doi.org/10.1016/j.neuron.2009.09.019			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	521AA	19874790	Green Accepted, Bronze			2022-12-24	WOS:000271889900012
J	Vyazovskiy, VV; Olcese, U; Lazimy, YM; Faraguna, U; Esser, SK; Williams, JC; Cirelli, C; Tononi, G				Vyazovskiy, Vladyslav V.; Olcese, Umberto; Lazimy, Yaniv M.; Faraguna, Ugo; Esser, Steve K.; Williams, Justin C.; Cirelli, Chiara; Tononi, Giulio			Cortical Firing and Sleep Homeostasis	NEURON			English	Article							SLOW-WAVE SLEEP; DEPENDENT SYNAPTIC PLASTICITY; LESS-THAN-1 HZ OSCILLATION; DEVELOPING VISUAL-CORTEX; ACTIVITY IN-VIVO; NEOCORTICAL NEURONS; ASSOCIATION CORTEX; CEREBRAL-CORTEX; EEG; RAT	The need to sleep grows with the duration of wakefulness and dissipates with time spent asleep, a process called sleep homeostasis. What are the consequences of staying awake on brain cells, and why is sleep needed? Surprisingly, we do not know whether the firing of cortical neurons is affected by how long an animal has been awake or asleep. Here, we found that after sustained wakefulness cortical neurons fire at higher frequencies in all behavioral states. During early NREM sleep after sustained wakefulness, periods of population activity (ON) are short, frequent, and associated with synchronous firing, while periods of neuronal silence are long and frequent. After sustained sleep, firing rates and synchrony decrease, while the duration of ON periods increases. Changes in firing patterns in NREM sleep correlate with changes in slow-wave activity, a marker of sleep homeostasis. Thus, the systematic increase of firing during wakefulness is counterbalanced by staying asleep.	[Vyazovskiy, Vladyslav V.; Olcese, Umberto; Lazimy, Yaniv M.; Faraguna, Ugo; Esser, Steve K.; Cirelli, Chiara; Tononi, Giulio] Univ Wisconsin, Dept Psychiat, Madison, WI 53719 USA; [Williams, Justin C.] Univ Wisconsin, Dept Biomed Engn, Madison, WI 53719 USA; [Olcese, Umberto] Scuola Super Sant Anna, PERCRO Lab, I-56217 Pisa, Italy	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Scuola Superiore Sant'Anna	Tononi, G (corresponding author), Univ Wisconsin, Dept Psychiat, Madison, WI 53719 USA.	gtononi@wisc.edu	Faraguna, Ugo/J-6805-2012	Faraguna, Ugo/0000-0002-4814-7218; Olcese, Umberto/0000-0001-6968-2503; Vyazovskiy, Vladyslav/0000-0002-4336-6681	NIMH [P20 MH077967]; NIH; AFOSR [FA9550-08-1-0244]; NATIONAL INSTITUTE OF MENTAL HEALTH [P20MH077967] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000579] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AFOSR(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by NIMH P20 MH077967 (C.C.), NIH Director's Pioneer award (G.T.), and AFOSR FA9550-08-1-0244 (G.T.). We thank Tom Richner and Dr. Silvestro Micera for help with data analysis, Aaron Nelson for help with the experiments, Dr. Yuval Nir for helpful comments on the manuscript, and Dr. Lisa Krugner-Higby for advice about surgical procedures.	Achermann P, 2003, FRONT BIOSCI-LANDMRK, V8, pS683, DOI 10.2741/1064; Amzica F, 1998, ELECTROEN CLIN NEURO, V107, P69, DOI 10.1016/S0013-4694(98)00051-0; Aton SJ, 2009, NEURON, V61, P454, DOI 10.1016/j.neuron.2009.01.007; Attwell D, 2001, J CEREBR BLOOD F MET, V21, P1133, DOI 10.1097/00004647-200110000-00001; Badawy RAB, 2006, NEUROLOGY, V67, P1018, DOI 10.1212/01.wnl.0000237392.64230.f7; Bartho P, 2004, J NEUROPHYSIOL, V92, P600, DOI 10.1152/jn.01170.2003; Bazhenov M, 2002, J NEUROSCI, V22, P8691; Bellina V, 2008, J SLEEP RES, V17, P39; BURNS BD, 1979, PROC R SOC SER B-BIO, V206, P281, DOI 10.1098/rspb.1979.0105; Buzsaki G, 2007, NEURON, V56, P771, DOI 10.1016/j.neuron.2007.11.008; Cajochen C, 1999, Sleep Res Online, V2, P65; CALVET J, 1973, BRAIN RES, V52, P173, DOI 10.1016/0006-8993(73)90657-4; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; Cirelli C, 2008, PLOS BIOL, V6, P1605, DOI 10.1371/journal.pbio.0060216; Civardi C, 2001, J NEUROL NEUROSUR PS, V71, P809, DOI 10.1136/jnnp.71.6.809; CONTRERAS D, 1995, J NEUROSCI, V15, P604; Czarnecki A, 2007, J PHYSIOL-LONDON, V578, P471, DOI 10.1113/jphysiol.2006.123588; Dadvand L, 2006, NEUROSCIENCE, V143, P815, DOI 10.1016/j.neuroscience.2006.08.029; Dash MB, 2009, J NEUROSCI, V29, P580, DOI 10.1523/JNEUROSCI.5486-08.2009; Deboer T, 2003, NAT NEUROSCI, V6, P1086, DOI 10.1038/nn1122; Desai NS, 2002, NAT NEUROSCI, V5, P783, DOI 10.1038/nn878; DESIRAJU T, 1972, BRAIN RES, V47, P69, DOI 10.1016/0006-8993(72)90252-1; Destexhe A, 1999, J NEUROSCI, V19, P4595, DOI 10.1523/jneurosci.19-11-04595.1999; DIJK D J, 1987, Journal of Biological Rhythms, V2, P207, DOI 10.1177/074873048700200304; Dragoi G, 2003, NEURON, V39, P843, DOI 10.1016/S0896-6273(03)00465-3; Esser SK, 2007, SLEEP, V30, P1617, DOI 10.1093/sleep/30.12.1617; Faraguna U, 2008, J NEUROSCI, V28, P4088, DOI 10.1523/JNEUROSCI.5510-07.2008; Frank MG, 2001, NEURON, V30, P275, DOI 10.1016/S0896-6273(01)00279-3; Galarreta M, 1998, NAT NEUROSCI, V1, P587, DOI 10.1038/2822; Gil Z, 1997, NEURON, V19, P679, DOI 10.1016/S0896-6273(00)80380-3; Gilestro GF, 2009, SCIENCE, V324, P109, DOI 10.1126/science.1166673; Haider B, 2006, J NEUROSCI, V26, P4535, DOI 10.1523/JNEUROSCI.5297-05.2006; Hirase H, 2001, P NATL ACAD SCI USA, V98, P9386, DOI 10.1073/pnas.161274398; HOBSON JA, 1971, ELECTROEN CLIN NEURO, V30, P97, DOI 10.1016/0013-4694(71)90271-9; Huber R, 2004, NATURE, V430, P78, DOI 10.1038/nature02663; Huber R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000276; Huber R, 2007, SLEEP, V30, P129, DOI 10.1093/sleep/30.2.129; Huber R, 2006, NAT NEUROSCI, V9, P1169, DOI 10.1038/nn1758; Isomura Y, 2006, NEURON, V52, P871, DOI 10.1016/j.neuron.2006.10.023; Ji DY, 2007, NAT NEUROSCI, V10, P100, DOI 10.1038/nn1825; Jones BE, 2005, TRENDS PHARMACOL SCI, V26, P578, DOI 10.1016/j.tips.2005.09.009; Karlsson MP, 2008, J NEUROSCI, V28, P14271, DOI 10.1523/JNEUROSCI.4261-08.2008; KATTLER H, 1994, J SLEEP RES, V3, P159, DOI 10.1111/j.1365-2869.1994.tb00123.x; Kudrimoti HS, 1999, J NEUROSCI, V19, P4090; Laughlin SB, 1998, NAT NEUROSCI, V1, P36, DOI 10.1038/236; Lubenov EV, 2008, NEURON, V58, P118, DOI 10.1016/j.neuron.2008.01.036; Luczak A, 2007, P NATL ACAD SCI USA, V104, P347, DOI 10.1073/pnas.0605643104; Marder E, 2002, NEURAL NETWORKS, V15, P479, DOI 10.1016/S0893-6080(02)00043-6; Massimini M, 2004, J NEUROSCI, V24, P6862, DOI 10.1523/JNEUROSCI.1318-04.2004; MCCORMICK DA, 1985, J NEUROPHYSIOL, V54, P782, DOI 10.1152/jn.1985.54.4.782; McCormick DA, 2001, ANNU REV PHYSIOL, V63, P815, DOI 10.1146/annurev.physiol.63.1.815; Molle M, 2006, J NEUROPHYSIOL, V96, P62, DOI 10.1152/jn.00014.2006; Mukovski M, 2007, CEREB CORTEX, V17, P400, DOI 10.1093/cercor/bhj157; MURATA K, 1963, Arch Ital Biol, V101, P306; NODA H, 1970, J NEUROPHYSIOL, V33, P672, DOI 10.1152/jn.1970.33.5.672; NODA H, 1973, BRAIN RES, V54, P243, DOI 10.1016/0006-8993(73)90047-4; Oleksenko A.I., 1992, Journal of Sleep Research, V1, P40; PAVLIDES C, 1989, J NEUROSCI, V9, P2907; Rao Y, 2007, J CLIN INVEST, V117, P4022, DOI 10.1172/JCI32829; Riedner BA, 2007, SLEEP, V30, P1643, DOI 10.1093/sleep/30.12.1643; ROWAN AJ, 1982, ELECTROEN CLIN NEURO, V54, P357, DOI 10.1016/0013-4694(82)90199-7; Scalise A, 2006, SLEEP, V29, P1595, DOI 10.1093/sleep/29.12.1595; Seol GH, 2007, NEURON, V55, P919, DOI 10.1016/j.neuron.2007.08.013; SOKOLOFF L, 1977, J NEUROCHEM, V28, P897, DOI 10.1111/j.1471-4159.1977.tb10649.x; STERIADE M, 1993, J NEUROSCI, V13, P3284; STERIADE M, 1993, J NEUROSCI, V13, P3266; STERIADE M, 1993, J NEUROPHYSIOL, V70, P1385, DOI 10.1152/jn.1993.70.4.1385; Steriade M, 2001, J NEUROPHYSIOL, V85, P1969, DOI 10.1152/jn.2001.85.5.1969; STERIADE M, 1993, J NEUROSCI, V13, P3252, DOI 10.1523/jneurosci.13-08-03252.1993; TOBLER I, 1986, ELECTROEN CLIN NEURO, V64, P74, DOI 10.1016/0013-4694(86)90044-1; Tononi G, 2006, SLEEP MED REV, V10, P49, DOI 10.1016/j.smrv.2005.05.002; Turrigiano GG, 1999, TRENDS NEUROSCI, V22, P221, DOI 10.1016/S0166-2236(98)01341-1; van Welie I, 2004, P NATL ACAD SCI USA, V101, P5123, DOI 10.1073/pnas.0307711101; VERZEANO M, 1960, J Gen Physiol, V43(6)Suppl, P177, DOI 10.1085/jgp.43.6.177; Vyazovskiy VV, 2008, BRAIN RES BULL, V75, P591, DOI 10.1016/j.brainresbull.2007.10.040; Vyazovskiy VV, 2008, J NEUROPHYSIOL, V99, P969, DOI 10.1152/jn.01154.2007; Vyazovskiy VV, 2008, NAT NEUROSCI, V11, P200, DOI 10.1038/nn2035; Vyazovskiy VV, 2007, SLEEP, V30, P1631, DOI 10.1093/sleep/30.12.1631; Vyazovskiy VV, 2009, J NEUROPHYSIOL, V101, P1921, DOI 10.1152/jn.91157.2008; Vyazovskiy VV, 2006, CEREB CORTEX, V16, P328, DOI 10.1093/cercorbhi110; Werth E, 1996, AM J PHYSIOL-REG I, V271, pR501, DOI 10.1152/ajpregu.1996.271.3.R501; Werth E, 1996, NEUROREPORT, V8, P123, DOI 10.1097/00001756-199612200-00025; Williams JC, 1999, NEUROCOMPUTING, V26-7, P1069, DOI 10.1016/S0925-2312(99)00106-X	83	464	470	1	50	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 24	2009	63	6					865	878		10.1016/j.neuron.2009.08.024	http://dx.doi.org/10.1016/j.neuron.2009.08.024			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	503VP	19778514	hybrid, Green Accepted			2022-12-24	WOS:000270569700018
J	Lorincz, ML; Kekesi, KA; Juhasz, G; Crunelli, V; Hughes, SW				Loerincz, Magor L.; Kekesi, Katalin A.; Juhasz, Gabor; Crunelli, Vincenzo; Hughes, Stuart W.			Temporal Framing of Thalamic Relay-Mode Firing by Phasic Inhibition during the Alpha Rhythm	NEURON			English	Article							LATERAL GENICULATE-NUCLEUS; NEURONS IN-VITRO; CELLULAR MECHANISMS; AXON COLLATERALS; REACTION TIME; PERCEPTION; INTERNEURONS; OSCILLATION; POTENTIALS; DYNAMICS	Several aspects of perception, particularly those pertaining to vision, are closely linked to the occipital alpha (alpha) rhythm. However, how the alpha rhythm relates to the activity of neurons that convey primary visual information is unknown. Here we show that in behaving cats, thalamocortical neurons in the lateral geniculate nucleus (LGN) that operate in a conventional relay-mode form two groups where the cumulative firing is subject to a cyclic suppression that is centered on the negative alpha rhythm peak in one group and on the positive peak in the other. This leads to an effective temporal framing of relay-mode output and results from phasic inhibition from LGN interneurons, which in turn are rhythmically excited by thalamocortical neurons that exhibit high-threshold bursts. These results provide a potential cellular substrate for linking the alpha rhythm to perception and further underscore the central role of inhibition in controlling spike timing during cognitively relevant brain oscillations.	[Kekesi, Katalin A.] Eotvos Lorand Univ, Dept Physiol & Neurobiol, H-1117 Budapest, Hungary; [Kekesi, Katalin A.; Juhasz, Gabor] Eotvos Lorand Univ, Inst Biol, Lab Prote, H-1117 Budapest, Hungary; [Loerincz, Magor L.; Crunelli, Vincenzo; Hughes, Stuart W.] Cardiff Univ, Sch Biosci, Cardiff CF10 3AX, S Glam, Wales	Eotvos Lorand University; Eotvos Lorand University; Cardiff University	Hughes, SW (corresponding author), Eli Lilly UK, Erl Wood Manor, Windlesham GU20 6PH, Surrey, England.	hughes_stuart@lilly.com	Lőrincz, Magor L/C-7746-2012; Crunelli, Vincenzo/A-7258-2010; Jovicich, Jorge/D-2293-2010; Juhász, Gábor/I-7781-2017; Kékesi, Katalin Adrienna A/H-3484-2017	Lőrincz, Magor L/0000-0001-5240-1904; Juhász, Gábor/0000-0002-0849-6931; Kékesi, Katalin Adrienna A/0000-0003-3042-4878; Crunelli, Vincenzo/0000-0001-7154-9752; Hughes, Stuart/0000-0003-0423-777X	Wellcome Trust [71436, 78403, 78311, OTKATS044711, MEDICHEM 811]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Wellcome Trust grants 71436 and 78403 (awarded toV.C.), 78311 (awarded to S.W.H.), and OTKATS044711 and MEDICHEM 811 (awarded to G.J.). We wish to thank Mr. Tim Gould for excellent technical assistance.	Acuna-Goycolea C, 2008, NEURON, V57, P420, DOI 10.1016/j.neuron.2007.12.022; ANLIKER J, 1966, SCIENCE, V153, P316, DOI 10.1126/science.153.3733.316; ANLIKER J, 1963, SCIENCE, V140, P1307, DOI 10.1126/science.140.3573.1307; [Anonymous], [No title captured]; Bartley SH, 1940, J EXP PSYCHOL, V27, P624, DOI 10.1037/h0054429; Berman AL, 1982, THALAMUS BASAL TELEN; Bickford ME, 2008, J COMP NEUROL, V508, P264, DOI 10.1002/cne.21671; Busch NA, 2009, J NEUROSCI, V29, P7869, DOI 10.1523/JNEUROSCI.0113-09.2009; CHATILA M, 1993, CR ACAD SCI III-VIE, V316, P51; Cox CL, 2003, J NEUROSCI, V23, P7642; Crick F, 2003, NAT NEUROSCI, V6, P119, DOI 10.1038/nn0203-119; CRUNELLI V, 1988, J PHYSIOL-LONDON, V399, P153; DOMICH L, 1986, J PHYSIOL-LONDON, V379, P429, DOI 10.1113/jphysiol.1986.sp016262; EFRON R, 1970, NEUROPSYCHOLOGIA, V8, P57, DOI 10.1016/0028-3932(70)90025-4; Fingelkurts Andrew A, 2006, Cogn Process, V7, P135, DOI 10.1007/s10339-006-0035-0; Hughes SW, 2004, NEURON, V42, P253, DOI 10.1016/S0896-6273(04)00191-6; Hughes SW, 2002, NEURON, V33, P947, DOI 10.1016/S0896-6273(02)00623-2; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; KRISTOFF.AB, 1967, SCIENCE, V158, P1337, DOI 10.1126/science.158.3806.1337; LANSING RW, 1957, ELECTROEN CLIN NEURO, V9, P497, DOI 10.1016/0013-4694(57)90037-8; LINDSLEY DB, 1952, ELECTROEN CLIN NEURO, V4, P443, DOI 10.1016/0013-4694(52)90075-8; LLINAS R, 1982, NATURE, V297, P406, DOI 10.1038/297406a0; LLINAS RR, 1988, SCIENCE, V242, P1654, DOI 10.1126/science.3059497; LOPESDASILVA FH, 1973, ELECTROEN CLIN NEURO, V35, P627, DOI 10.1016/0013-4694(73)90216-2; Lorincz ML, 2008, J NEUROSCI, V28, P660, DOI 10.1523/JNEUROSCI.4468-07.2008; Mathewson KE, 2009, J NEUROSCI, V29, P2725, DOI 10.1523/JNEUROSCI.3963-08.2009; NUNN CMH, 1974, PSYCHOPHYSIOLOGY, V11, P294, DOI 10.1111/j.1469-8986.1974.tb00547.x; PAPE HC, 1994, J PHYSIOL-LONDON, V478, P403, DOI 10.1113/jphysiol.1994.sp020261; RougeulBuser A, 1997, INT J PSYCHOPHYSIOL, V26, P191, DOI 10.1016/S0167-8760(97)00764-2; Stroud J.M., 1956, INFORMATION THEORY P, P174; SURWILLO WW, 1961, NATURE, V191, P823, DOI 10.1038/191823a0; Uchida N, 2006, NAT REV NEUROSCI, V7, P485, DOI 10.1038/nrn1933; VanRullen R, 2003, TRENDS COGN SCI, V7, P207, DOI 10.1016/S1364-6613(03)00095-0; VARELA FJ, 1981, NEUROPSYCHOLOGIA, V19, P675; VONKROSIGK M, 1993, SCIENCE, V261, P361, DOI 10.1126/science.8392750; WIENER N, 1985, N WIENER COLLECTED W, V4; Zhu JJ, 1999, NEUROSCIENCE, V91, P1445, DOI 10.1016/S0306-4522(98)00665-4; Zhu JJ, 1999, J NEUROPHYSIOL, V81, P702, DOI 10.1152/jn.1999.81.2.702	38	209	213	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 10	2009	63	5					683	696		10.1016/j.neuron.2009.08.012	http://dx.doi.org/10.1016/j.neuron.2009.08.012			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	494XH	19755110	Green Published, hybrid			2022-12-24	WOS:000269852300014
J	Fox, DT; Spradling, AC				Fox, Donald T.; Spradling, Allan C.			The Drosophila Hindgut Lacks Constitutively Active Adult Stem Cells but Proliferates in Response to Tissue Damage	CELL STEM CELL			English	Article							BETA-CELLS; REGENERATION; REPOPULATION; MELANOGASTER; MAINTENANCE; GENERATION; EPITHELIUM; PANCREAS; ABLATION; BEHAVIOR	The adult Drosophila hindgut was recently reported to contain active, tissue-replenishing stem cells, like those of the midgut, but located within an anterior ring so as to comprise a single giant crypt. In contrast to this view, we observed no active stem cells and little cell turnover in adult hindgut tissue based on clonal marking and BrdU incorporation studies. Again contradicting the previous proposal, we showed that the adult hindgut is not generated by anterior stem cells during larval/pupal development. However, severe tissue damage within the hindgut elicits cell proliferation within a ring of putative quiescent stem cells at the anterior of the pylorus. Thus, the hindgut does not provide a model of tissue maintenance by constitutively active stem cells, but has great potential to illuminate mechanisms of stress-induced tissue repair.	[Fox, Donald T.; Spradling, Allan C.] Carnegie Inst, Howard Hughes Med Inst, Dept Embryol, Baltimore, MD 21218 USA	Carnegie Institution for Science; Howard Hughes Medical Institute	Spradling, AC (corresponding author), Carnegie Inst, Howard Hughes Med Inst, Dept Embryol, 3520 San Martin Dr, Baltimore, MD 21218 USA.	spradling@ciwemb.edu		Fox, Donald/0000-0002-0436-179X	Jane Coffin Childs Memorial Fund	Jane Coffin Childs Memorial Fund	We thank Ben Ohlstein for discussions and Shigeo Takashima, Toshie Kai, Hugo Bellen, and Jessica Treisman for stocks. Joe Gall, Lucy Morris, and Todd Nystul provided useful comments on the manuscript. D. T. F. is a fellow of the Jane Coffin Childs Memorial Fund.	Ahmad K, 1996, GENETICS, V144, P657; Amcheslavsky A, 2009, CELL STEM CELL, V4, P49, DOI 10.1016/j.stem.2008.10.016; Buchon N, 2009, CELL HOST MICROBE, V5, P200, DOI 10.1016/j.chom.2009.01.003; Casali A, 2009, CELL STEM CELL, V4, P124, DOI 10.1016/j.stem.2009.01.009; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Fausto N, 2003, MECH DEVELOP, V120, P117, DOI 10.1016/S0925-4773(02)00338-6; Fox DT, 2009, STEMBOOK, DOI DOI 10.3824/STEMBOOK.1.33.1; Fuller MT, 2007, SCIENCE, V316, P402, DOI 10.1126/science.1140861; Han DD, 2000, DEVELOPMENT, V127, P573; HARRISON DA, 1993, CURR BIOL, V3, P424, DOI 10.1016/0960-9822(93)90349-S; HIDALGO A, 1995, DEVELOPMENT, V121, P3703; Hong A, 2007, EMBO J, V26, P2071, DOI 10.1038/sj.emboj.7601648; Lee TM, 2001, TRENDS NEUROSCI, V24, P251, DOI 10.1016/S0166-2236(00)01791-4; Lengyel JA, 2002, DEV BIOL, V243, P1, DOI 10.1006/dbio.2002.0577; MARGOLIS J, 1995, DEVELOPMENT, V121, P3797; Micchelli CA, 2006, NATURE, V439, P475, DOI 10.1038/nature04371; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Ohlstein B, 2006, NATURE, V439, P470, DOI 10.1038/nature04333; Overturf K, 1999, AM J PATHOL, V155, P2135, DOI 10.1016/S0002-9440(10)65531-9; Pitsouli C, 2008, NATURE, V454, P592, DOI 10.1038/454592a; Rawlins EL, 2006, DEVELOPMENT, V133, P2455, DOI 10.1242/dev.02407; Rawlins EL, 2009, CELL STEM CELL, V4, P525, DOI 10.1016/j.stem.2009.04.002; Robertson CW, 1936, J MORPHOL, V59, P351, DOI 10.1002/jmor.1050590207; Snodgrass RE, 1935, PRINCIPLES INSECT MO; STRUHL G, 1993, CELL, V72, P527, DOI 10.1016/0092-8674(93)90072-X; Takashima S, 2008, NATURE, V454, P651, DOI 10.1038/nature07156; Teta M, 2005, DIABETES, V54, P2557, DOI 10.2337/diabetes.54.9.2557; Vaillant F, 2007, STEM CELL REV, V3, P114, DOI 10.1007/s12015-007-0018-2; Xu XB, 2008, CELL, V132, P197, DOI 10.1016/j.cell.2007.12.015; Zaret KS, 2008, SCIENCE, V322, P1490, DOI 10.1126/science.1161431; Zhou L, 1997, P NATL ACAD SCI USA, V94, P5131, DOI 10.1073/pnas.94.10.5131	31	78	80	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	SEP 4	2009	5	3					290	297		10.1016/j.stem.2009.06.003	http://dx.doi.org/10.1016/j.stem.2009.06.003			8	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	529VA	19699165	Bronze, Green Accepted			2022-12-24	WOS:000272545700015
J	Lange, C; Huttner, WB; Calegari, F				Lange, Christian; Huttner, Wieland B.; Calegari, Federico			Cdk4/CyclinD1 Overexpression in Neural Stem Cells Shortens G1, Delays Neurogenesis, and Promotes the Generation and Expansion of Basal Progenitors	CELL STEM CELL			English	Article							CYCLIN-DEPENDENT KINASES; FIBROBLAST-GROWTH-FACTOR; NEURONAL DIFFERENTIATION; RNA INTERFERENCE; CEREBRAL-CORTEX; EXIT; INHIBITION; INDUCTION; EVOLUTION; MIGRATION	During mouse embryonic development, neural progenitors lengthen the G1 phase of the cell cycle and this has been suggested to be a cause, rather than a consequence, of neurogenesis. To investigate whether G1 lengthening alone may cause the switch of cortical progenitors from proliferation to neurogenesis, we manipulated the expression of cdk/cyclin complexes and found that cdk4/cyclinD1 overexpression prevents G1 lengthening without affecting cell growth, cleavage plane, or cell cycle synchrony with interkinetic nuclearmigration. Specifically, overexpression of cdk4/cyclinD1 inhibited neurogenesis while increasing the generation and expansion of basal ( intermediate) progenitors, resulting in a thicker subventricular zone and larger surface area of the postnatal cortex originating from cdk4/cyclinD1-transfected progenitors. Conversely, lengthening of G1 by cdk4/cyclinD1-RNAi displayed the opposite effects. Thus, G1 lengthening is necessary and sufficient to switch neural progenitors to neurogenesis, and overexpression of cdk4/cyclinD1 can be used to increase progenitor expansion and, perhaps, cortical surface area.	[Lange, Christian; Calegari, Federico] Tech Univ Dresden, Fac Med, DFG Res Ctr, D-01307 Dresden, Germany; [Lange, Christian; Calegari, Federico] Tech Univ Dresden, Fac Med, Cluster Excellence Regenerat Therapies Dresden, D-01307 Dresden, Germany; [Lange, Christian; Huttner, Wieland B.; Calegari, Federico] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany	Technische Universitat Dresden; Technische Universitat Dresden; Max Planck Society	Calegari, F (corresponding author), Tech Univ Dresden, Fac Med, DFG Res Ctr, Pfotenhauerstr 108, D-01307 Dresden, Germany.	federico.calegari@crt-dresden.de	Huttner, Wieland B./P-4080-2018; Calegari, Federico/N-7827-2019; Lange, Christian/F-6631-2013; Calegari, Federico/A-2422-2009	calegari, federico/0000-0002-3703-2802; Lange, Christian/0000-0002-7582-0076	DFG [249168.11-9-2007-1/2]	DFG(German Research Foundation (DFG))	We thank Dr. Charles J. Sherr and Dr. Pumin Zhang for cyclinD1 and cyclinD1-shRNA plasmids, respectively; Ina Nusslein, Christiane Rubbert, and the staff of the MPI-CBG animal house for excellent support; and Jeremy N. Pulvers for discussions. Animal experiments were approved by local authorities (249168.11-9-2007-1/2). C. L. and F. C. were supported by the DFG-funded Center for Regenerative Therapies and Medical Faculty of the Technical University, Dresden. Authors' contribution is as follows (C.L.-W. B. H.-F. C.): planning experiments 30%-5%-65%; performing experiments 95%-0%-5%; data analyses 45%-5%-50%, preparation of the manuscript 15%-5%-80%. Authors have no financial interest related to this work.	Abdel-Mannan O, 2008, BRAIN RES BULL, V75, P398, DOI 10.1016/j.brainresbull.2007.10.047; Attardo A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002388; Bally-Cuif L, 2003, CURR OPIN NEUROBIOL, V13, P16, DOI 10.1016/S0959-4388(03)00015-1; Calegari F, 2003, J CELL SCI, V116, P4947, DOI 10.1242/jcs.00825; Calegari F, 2005, J NEUROSCI, V25, P6533, DOI 10.1523/JNEUROSCI.0778-05.2005; Calegari F, 2004, DIFFERENTIATION, V72, P92, DOI 10.1111/j.1432-0436.2004.07202002.x; Canzoniere D, 2004, J NEUROSCI, V24, P3355, DOI 10.1523/JNEUROSCI.3860-03.2004; CAVINESS VS, 1995, TRENDS NEUROSCI, V18, P379, DOI 10.1016/0166-2236(95)93933-O; Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; Datar SA, 2006, CELL CYCLE, V5, P647; Dehay C, 2007, NAT REV NEUROSCI, V8, P438, DOI 10.1038/nrn2097; Ekholm SV, 2000, CURR OPIN CELL BIOL, V12, P676, DOI 10.1016/S0955-0674(00)00151-4; Englund C, 2005, J NEUROSCI, V25, P247, DOI 10.1523/JNEUROSCI.2899-04.2005; Fish JL, 2008, J CELL SCI, V121, P2783, DOI 10.1242/jcs.023465; Fu MF, 2004, ENDOCRINOLOGY, V145, P5439, DOI 10.1210/en.2004-0959; Georgopoulou N, 2006, J BIOL CHEM, V281, P33606, DOI 10.1074/jbc.M602689200; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Haubensak W, 2004, P NATL ACAD SCI USA, V101, P3196, DOI 10.1073/pnas.0308600100; Hodge RD, 2004, J NEUROSCI, V24, P10201, DOI 10.1523/JNEUROSCI.3246-04.2004; Iacopetti P, 1999, P NATL ACAD SCI USA, V96, P4639, DOI 10.1073/pnas.96.8.4639; Jorgensen P, 2004, CURR BIOL, V14, pR1014, DOI 10.1016/j.cub.2004.11.027; Kriegstein A, 2006, NAT REV NEUROSCI, V7, P883, DOI 10.1038/nrn2008; Lukaszewicz A, 2005, NEURON, V47, P353, DOI 10.1016/j.neuron.2005.06.032; Lukaszewicz AS, 2002, J NEUROSCI, V22, P6610; Maric D, 2007, J NEUROSCI, V27, P1836, DOI 10.1523/JNEUROSCI.5141-06.2007; MCCONNELL SK, 1995, NEURON, V15, P761, DOI 10.1016/0896-6273(95)90168-X; McEvilly RJ, 2002, SCIENCE, V295, P1528, DOI 10.1126/science.1067132; Miyata T, 2004, DEVELOPMENT, V131, P3133, DOI 10.1242/dev.01173; Nguyen L, 2006, GENE DEV, V20, P1511, DOI 10.1101/gad.377106; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Noctor SC, 2008, J COMP NEUROL, V508, P28, DOI 10.1002/cne.21669; Ohnuma S, 1999, CELL, V99, P499, DOI 10.1016/S0092-8674(00)81538-X; Ohnuma S, 2003, NEURON, V40, P199, DOI 10.1016/S0896-6273(03)00632-9; Peng SH, 2006, P NATL ACAD SCI USA, V103, P2252, DOI 10.1073/pnas.0511034103; Politis PK, 2007, P NATL ACAD SCI USA, V104, P17861, DOI 10.1073/pnas.0610973104; Pontious A, 2008, DEV NEUROSCI-BASEL, V30, P24, DOI 10.1159/000109848; Popken GJ, 2004, EUR J NEUROSCI, V19, P2056, DOI 10.1111/j.0953-816X.2004.03320.x; RAKIC P, 1995, TRENDS NEUROSCI, V18, P383, DOI 10.1016/0166-2236(95)93934-P; Regad T, 2009, NAT NEUROSCI, V12, P132, DOI 10.1038/nn.2251; Reis T, 2004, CELL, V117, P253, DOI 10.1016/S0092-8674(04)00247-8; SHERR CJ, 1994, CELL, V79, P551, DOI 10.1016/0092-8674(94)90540-1; TAKAHASHI T, 1995, J NEUROSCI, V15, P6046; Tapon N, 2001, CURR OPIN CELL BIOL, V13, P731, DOI 10.1016/S0955-0674(00)00284-2; Tonelli DDP, 2006, BIOTECHNIQUES, V41, P727, DOI 10.2144/000112296	44	391	409	0	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	SEP 4	2009	5	3					320	331		10.1016/j.stem.2009.05.026	http://dx.doi.org/10.1016/j.stem.2009.05.026			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	529VA	19733543	Bronze			2022-12-24	WOS:000272545700018
J	Alto, LT; Havton, LA; Conner, JM; Hollis, ER; Blesch, A; Tuszynski, MH				Alto, Laura Taylor; Havton, Leif A.; Conner, James M.; Hollis, Edmund R., II; Blesch, Armin; Tuszynski, Mark H.			Chemotropic guidance facilitates axonal regeneration and synapse formation after spinal cord injury	NATURE NEUROSCIENCE			English	Article							NERVE GROWTH-FACTOR; RETINAL GANGLION-CELLS; ADULT-RAT; FUNCTIONAL RECOVERY; SUPERIOR COLLICULUS; NEUROTROPHIC FACTOR; CHONDROITINASE ABC; PRIMARY AFFERENTS; SENSORY NEURONS; GENE DELIVERY	A principal objective of spinal cord injury (SCI) research is the restoration of axonal connectivity to denervated targets. We tested the hypothesis that chemotropic mechanisms would guide regenerating spinal cord axons to appropriate brainstem targets. We subjected rats to cervical level 1 (C1) lesions and combinatorial treatments to elicit axonal bridging into and beyond lesion sites. Lentiviral vectors expressing neurotrophin-3 (NT-3) were then injected into an appropriate brainstem target, the nucleus gracilis, and an inappropriate target, the reticular formation. NT-3 expression in the correct target led to reinnervation of the nucleus gracilis in a dose-related fashion, whereas NT-3 expression in the reticular formation led to mistargeting of regenerating axons. Axons regenerating into the nucleus gracilis formed axodendritic synapses containing rounded vesicles, reflective of pre-injury synaptic architecture. Thus, we report for the first time, to the best of our knowledge, the reinnervation of brainstem targets after SCI and an essential role for chemotropic axon guidance in target selection.	[Alto, Laura Taylor; Conner, James M.; Hollis, Edmund R., II; Blesch, Armin; Tuszynski, Mark H.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Havton, Leif A.] Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90024 USA; [Tuszynski, Mark H.] Vet Adm Med Ctr, Los Angeles, CA 91343 USA	University of California System; University of California San Diego; University of California System; University of California Los Angeles; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Tuszynski, MH (corresponding author), Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA.	ablesch@ucsd.edu; mtuszynski@ucsd.edu		Hollis, Edmund/0000-0002-4535-4668; Blesch, Armin/0000-0003-1133-1174	US National Institutes of Health [NS09881, NS54883]; Veterans Administration; International Spinal Research Trust, Wings for Life; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; Bernard and Anne Spitzer Charitable Trust; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS009881, R01NS054883, R01NS049881] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Administration(US Department of Veterans Affairs); International Spinal Research Trust, Wings for Life; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; Bernard and Anne Spitzer Charitable Trust; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank L. Ma and B. Sjorstrand for technical assistance and J. Silver for helpful suggestions. This work was supported by the US National Institutes of Health (NS09881 and NS54883), the Veterans Administration, the International Spinal Research Trust, Wings for Life, the Dr. Miriam and Sheldon G. Adelson Medical Research Foundation and the Bernard and Anne Spitzer Charitable Trust.	Arevalo JC, 2005, CURR OPIN CELL BIOL, V17, P112, DOI 10.1016/j.ceb.2005.01.004; Azizi SA, 1998, P NATL ACAD SCI USA, V95, P3908, DOI 10.1073/pnas.95.7.3908; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; CABELLI RJ, 1995, SCIENCE, V267, P1662, DOI 10.1126/science.7886458; Chen DF, 1997, NATURE, V385, P434, DOI 10.1038/385434a0; COHENCORY S, 1995, NATURE, V378, P192, DOI 10.1038/378192a0; Dancause N, 2005, J NEUROSCI, V25, P10167, DOI 10.1523/JNEUROSCI.3256-05.2005; DEBIASI S, 1994, J COMP NEUROL, V347, P275, DOI 10.1002/cne.903470209; Garner CC, 2002, TRENDS NEUROSCI, V25, P243, DOI 10.1016/S0166-2236(02)02152-5; Genc B, 2004, PLOS BIOL, V2, P2112, DOI 10.1371/journal.pbio.0020403; Goldberg JL, 2002, SCIENCE, V296, P1860, DOI 10.1126/science.1068428; GUNDERSEN RW, 1980, J CELL BIOL, V87, P546, DOI 10.1083/jcb.87.3.546; Havton LA, 2005, J NEUROSCI METH, V149, P101, DOI 10.1016/j.jneumeth.2005.03.014; Hofstetter CP, 2002, P NATL ACAD SCI USA, V99, P2199, DOI 10.1073/pnas.042678299; Houle JD, 2006, J NEUROSCI, V26, P7405, DOI 10.1523/JNEUROSCI.1166-06.2006; Hwang SJ, 2001, NEUROSCI LETT, V312, P137, DOI 10.1016/S0304-3940(01)02204-2; KEIRSTEAD SA, 1989, SCIENCE, V246, P255, DOI 10.1126/science.2799387; Kohama I, 2001, J NEUROSCI, V21, P944, DOI 10.1523/JNEUROSCI.21-03-00944.2001; LAMOTTE CC, 1991, J COMP NEUROL, V311, P546, DOI 10.1002/cne.903110409; LETOURNEAU PC, 1978, DEV BIOL, V66, P183, DOI 10.1016/0012-1606(78)90283-X; Lu P, 2004, J NEUROSCI, V24, P6402, DOI 10.1523/JNEUROSCI.1492-04.2004; Ma L, 2002, NEURON, V36, P623, DOI 10.1016/S0896-6273(02)01021-8; Markus A, 2002, CURR OPIN NEUROBIOL, V12, P523, DOI 10.1016/S0959-4388(02)00372-0; McAllister AK, 1997, NEURON, V18, P767, DOI 10.1016/S0896-6273(00)80316-5; MCQUARRIE IG, 1977, BRAIN RES, V132, P443, DOI 10.1016/0006-8993(77)90193-7; Moon LDF, 2001, NAT NEUROSCI, V4, P465, DOI 10.1038/87415; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Neumann S, 2002, NEURON, V34, P885, DOI 10.1016/S0896-6273(02)00702-X; Neumann S, 1999, NEURON, V23, P83, DOI 10.1016/S0896-6273(00)80755-2; NIEUWENHUYS R, 1994, ANAT EMBRYOL, V190, P307; Pearse DD, 2004, NAT MED, V10, P610, DOI 10.1038/nm1056; Peters A, 1996, J NEUROCYTOL, V25, P687, DOI 10.1007/BF02284835; Postigo A, 2002, GENE DEV, V16, P633, DOI 10.1101/gad.217902; Qiu J, 2002, NEURON, V34, P895, DOI 10.1016/S0896-6273(02)00730-4; Ramer MS, 1999, EUR J NEUROSCI, V11, P837, DOI 10.1046/j.1460-9568.1999.00491.x; RICHARDSON PM, 1984, NATURE, V309, P791, DOI 10.1038/309791a0; RUSTIONI A, 1974, J COMP NEUROL, V155, P441, DOI 10.1002/cne.901550406; SCHNELL L, 1990, NATURE, V343, P269, DOI 10.1038/343269a0; SCHREYER DJ, 1993, J NEUROBIOL, V24, P959, DOI 10.1002/neu.480240709; Steward O, 2003, J COMP NEUROL, V459, P1, DOI 10.1002/cne.10593; Tan AM, 2007, EXP NEUROL, V206, P257, DOI 10.1016/j.expneurol.2007.05.013; Taylor L, 2006, J NEUROSCI, V26, P9713, DOI 10.1523/JNEUROSCI.0734-06.2006; Tessarollo L, 2004, J NEUROSCI, V24, P2575, DOI 10.1523/JNEUROSCI.5514-03.2004; Thuret S, 2006, NAT REV NEUROSCI, V7, P628, DOI 10.1038/nrn1955; Totoiu MO, 2005, J COMP NEUROL, V486, P373, DOI 10.1002/cne.20517; TUSZYNSKI MH, 1995, P NATL ACAD SCI USA, V92, P4621, DOI 10.1073/pnas.92.10.4621; VIDALSANZ M, 1987, J NEUROSCI, V7, P2894; Yiu G, 2006, NAT REV NEUROSCI, V7, P617, DOI 10.1038/nrn1956; ZHANG L, 1994, J NEUROSCI, V14, P5187; Zhou XF, 2000, EUR J NEUROSCI, V12, P100, DOI 10.1046/j.1460-9568.2000.00884.x	50	159	164	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2009	12	9					1106	U8		10.1038/nn.2365	http://dx.doi.org/10.1038/nn.2365			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	487ZD	19648914	Green Submitted, Green Accepted			2022-12-24	WOS:000269317300011
J	Brill, LM; Xiong, W; Lee, KB; Ficarro, SB; Crain, A; Xu, Y; Terskikh, A; Snyder, EY; Ding, S				Brill, Laurence M.; Xiong, Wen; Lee, Ki-Bum; Ficarro, Scott B.; Crain, Andrew; Xu, Yue; Terskikh, Alexey; Snyder, Evan Y.; Ding, Sheng			Phosphoproteomic Analysis of Human Embryonic Stem Cells	CELL STEM CELL			English	Article							GENE-EXPRESSION PATTERNS; GROWTH-FACTOR; MASS-SPECTROMETRY; MAMMALIAN TARGET; SELF-RENEWAL; PHOSPHORYLATION; PLURIPOTENCY; MAINTENANCE; ACTIVATION; INHIBITOR	Protein phosphorylation, while critical to cellular behavior, has been undercharacterized in pluripotent cells. Therefore, we performed phosphoproteomic analyses of human embryonic stem cells (hESCs) and their differentiated derivatives. A total of 2546 phosphorylation sites were identified on 1602 phosphoproteins; 389 proteins contained more phosphorylation site identifications in undifferentiated hESCs, whereas 540 contained more such identifications in differentiated derivatives. Phosphoproteins in receptor tyrosine kinase (RTK) signaling pathways were numerous in undifferentiated hESCs. Cellular assays corroborated this observation by showing that multiple RTKs cooperatively supported undifferentiated hESCs. In addition to bFGF, EGFR, VEGFR, and PDGFR activation was critical to the undifferentiated state of hESCs. PDGF-AA complemented a subthreshold bFGF concentration to maintain undifferentiated hESCs. Also consistent with phosphoproteomics, JNK activity participated in maintenance of undifferentiated hESCs. These results support the utility of phosphoproteomic data, provide guidance for investigating protein function in hESCs, and complement transcriptomics/epigenetics for broadening our understanding of hESC fate determination.	[Brill, Laurence M.; Ficarro, Scott B.] Novartis Res Fdn, Genom Inst, San Diego, CA 92109 USA; [Brill, Laurence M.; Crain, Andrew; Terskikh, Alexey; Snyder, Evan Y.] Burnham Inst Med Res, La Jolla, CA 92037 USA; [Xiong, Wen; Lee, Ki-Bum; Xu, Yue; Ding, Sheng] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; [Crain, Andrew] Univ Calif San Diego, Biomed Sci Grad Program, La Jolla, CA 92093 USA	Novartis; Sanford Burnham Prebys Medical Discovery Institute; Scripps Research Institute; University of California System; University of California San Diego	Brill, LM (corresponding author), Novartis Res Fdn, Genom Inst, 10675 John Jay Hopkins Dr, San Diego, CA 92109 USA.	lbrill@burnham.org; esnyder@burnham.org; sding@scripps.edu	Lee, KiBum/F-3702-2012; Lee, Ki-Bum/G-7503-2015; Terskikh, Alexey/U-8407-2019	LEE, Ki-Bum/0000-0002-8164-0047	California Institute for Regenerative Medicine (CIRM); Genomics Institute of the Novartis Research Foundation (GNF) [1 P20 GM 075059-01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM075059] Funding Source: NIH RePORTER	California Institute for Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine); Genomics Institute of the Novartis Research Foundation (GNF); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Lesperance, and Brandon Nelson for technical assistance. Support was from a postdoctoral fellowship from the California Institute for Regenerative Medicine (CIRM) (K.-B.L), the Genomics Institute of the Novartis Research Foundation (GNF), and the 1 P20 GM 075059-01.	Adewumi O, 2007, NAT BIOTECHNOL, V25, P803, DOI 10.1038/nbt1318; Armstrong L, 2006, HUM MOL GENET, V15, P1894, DOI 10.1093/hmg/ddl112; Beattie GM, 2005, STEM CELLS, V23, P489, DOI 10.1634/stemcells.2004-0279; Belotserkovskaya R, 2003, SCIENCE, V301, P1090, DOI 10.1126/science.1085703; Bendall SC, 2007, NATURE, V448, P1015, DOI 10.1038/nature06027; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bernstein E, 2008, P NATL ACAD SCI USA, V105, P1533, DOI 10.1073/pnas.0711632105; Bodenmiller B, 2007, NAT METHODS, V4, P231, DOI 10.1038/nmeth1005; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brandenberger R, 2004, NAT BIOTECHNOL, V22, P707, DOI 10.1038/nbt971; Brill LM, 2004, ANAL CHEM, V76, P2763, DOI 10.1021/ac035352d; Cha TL, 2005, SCIENCE, V310, P306, DOI 10.1126/science.1118947; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chiang GG, 2005, J BIOL CHEM, V280, P25485, DOI 10.1074/jbc.M501707200; Chu BY, 2005, BIOCHEM J, V392, P589, DOI 10.1042/BJ20050542; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Ficarro SB, 2005, RAPID COMMUN MASS SP, V19, P57, DOI 10.1002/rcm.1746; Gruhler A, 2005, MOL CELL PROTEOMICS, V4, P310, DOI 10.1074/mcp.M400219-MCP200; Han ZN, 2001, J CLIN INVEST, V108, P73, DOI 10.1172/JCI12466; Holzberg D, 2003, J BIOL CHEM, V278, P40213, DOI 10.1074/jbc.M304058200; James D, 2005, DEVELOPMENT, V132, P1273, DOI 10.1242/dev.01706; Kratchmarova I, 2005, SCIENCE, V308, P1472, DOI 10.1126/science.1107627; Kruger M, 2008, P NATL ACAD SCI USA, V105, P2451, DOI 10.1073/pnas.0711713105; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Li J, 2007, DIFFERENTIATION, V75, P299, DOI 10.1111/j.1432-0436.2006.00143.x; Li SW, 2003, MOL CARCINOGEN, V37, P98, DOI 10.1002/mc.10125; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; Liu JD, 2005, NAT CELL BIOL, V7, P1261, DOI 10.1038/ncb1333; Liu Y, 2006, J BIOL CHEM, V281, P31359, DOI 10.1074/jbc.M604478200; Mann M, 2002, TRENDS BIOTECHNOL, V20, P261, DOI 10.1016/S0167-7799(02)01944-3; McCool KW, 2007, J BIOL CHEM, V282, P6696, DOI 10.1074/jbc.M609519200; Mukherji M, 2006, BIOCHEMISTRY-US, V45, P15529, DOI 10.1021/bi060971c; Pebay A, 2005, STEM CELLS, V23, P1541, DOI 10.1634/stemcells.2004-0338; Peponi E, 2006, AM J PATHOL, V169, P2171, DOI 10.2353/ajpath.2006.051078; Reubinoff BE, 2000, NAT BIOTECHNOL, V18, P399, DOI 10.1038/74447; Rosner M, 2003, ONCOGENE, V22, P4786, DOI 10.1038/sj.onc.1206776; Sato N, 2003, DEV BIOL, V260, P404, DOI 10.1016/S0012-1606(03)00256-2; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Shin M, 2002, BBA-MOL CELL RES, V1589, P311, DOI 10.1016/S0167-4889(02)00195-7; Sperger JM, 2003, P NATL ACAD SCI USA, V100, P13350, DOI 10.1073/pnas.2235735100; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tan BCM, 2006, EMBO J, V25, P3975, DOI 10.1038/sj.emboj.7601271; Thingholm TE, 2008, J PROTEOME RES, V7, P3304, DOI 10.1021/pr800099y; Thingholm TE, 2008, MOL CELL PROTEOMICS, V7, P661, DOI 10.1074/mcp.M700362-MCP200; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Van Hoof D, 2006, MOL CELL PROTEOMICS, V5, P1261, DOI 10.1074/mcp.M500405-MCP200; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Wang L, 2007, BLOOD, V110, P4111, DOI 10.1182/blood-2007-03-082586; Washburn MP, 2003, ANAL CHEM, V75, P5054, DOI 10.1021/ac034120b; Western P, 2005, STEM CELLS, V23, P1436, DOI 10.1634/stemcells.2005-0146; Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971; Xu RH, 2005, NAT METHODS, V2, P185, DOI 10.1038/NMETH744; Yao S, 2006, P NATL ACAD SCI USA, V103, P6907, DOI 10.1073/pnas.0602280103; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang Peilin, 2003, Mol Cancer, V2, P1	57	154	160	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	AUG 7	2009	5	2					204	213		10.1016/j.stem.2009.06.002	http://dx.doi.org/10.1016/j.stem.2009.06.002			10	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	490PB	19664994	Bronze, Green Accepted			2022-12-24	WOS:000269511900013
J	Renstrom, J; Istvanffy, R; Gauthier, K; Shimono, A; Mages, J; Jardon-Alvarez, A; Kroger, M; Schiemann, M; Busch, DH; Esposito, I; Lang, R; Peschel, C; Oostendorp, RAJ				Renstroem, Jonas; Istvanffy, Rouzanna; Gauthier, Kerstin; Shimono, Akihiko; Mages, Joerg; Jardon-Alvarez, Ana; Kroeger, Monika; Schiemann, Matthias; Busch, Dirk H.; Esposito, Irene; Lang, Roland; Peschel, Christian; Oostendorp, Robert A. J.			Secreted Frizzled-Related Protein 1 Extrinsically Regulates Cycling Activity and Maintenance of Hematopoietic Stem Cells	CELL STEM CELL			English	Article							CANONICAL WNT PATHWAY; BETA-CATENIN; SELF-RENEWAL; LONG-TERM; TUMOR-SUPPRESSOR; DOWN-REGULATION; STROMAL CELLS; RECEPTOR; ACTIVATION; SFRP1	Secreted frizzled-related protein 1 (Sfrp1) is highly expressed by stromal cells maintaining hematopoietic stem cells (HSCs). Sfrp1 loss in stromal cells increases production of hematopoietic progenitors, and in knockout mice, dysregulates hemostasis and increases FIk2- Cd34- Lin- Sca1+ Kit+ (LSK) cell numbers in bone marrow. Also, LSK and multipotent progenitors (MPPs) resided mainly in the G0/G1 phase of cell cycle, with an accompanying decrease in intracellular beta-catenin levels. Gene-expression studies showed a concomitant decrease Ccnd1 and Dkk1 in Cd34- LSK cells and increased expression of Pparg, Hes1, and Runx1 in MPP. Transplantation experiments showed no intrinsic effect of Sfrp1 loss on the number of HSCs or their ability to engraft irradiated recipients. In contrast, serial transplantations of wild-type HSCs into Sfrp1(-/-) mice show a progressive decrease of wild-type LSK and MPP numbers. Our results demonstrate that Sfrp1 is required to maintain HSC homeostasis through extrinsic regulation of beta-catenin.	[Renstroem, Jonas; Istvanffy, Rouzanna; Gauthier, Kerstin; Jardon-Alvarez, Ana; Kroeger, Monika; Peschel, Christian; Oostendorp, Robert A. J.] Klinikum Rechts Der Isar, Dept Internal Med 3, D-81675 Munich, Germany; [Shimono, Akihiko] Natl Univ Singapore, Oncol Res Inst, Singapore 117456, Singapore; [Mages, Joerg; Schiemann, Matthias; Busch, Dirk H.; Lang, Roland] Tech Univ Munich, Dept Microbiol & Immunol, D-81675 Munich, Germany; [Schiemann, Matthias; Busch, Dirk H.] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Clin Cooperat Grp Antigen Specif Immunotherapy, D-85764 Neuherberg, Germany; [Schiemann, Matthias; Busch, Dirk H.] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Clin Cooperat Grp Immune Monitoring, D-85764 Neuherberg, Germany; [Esposito, Irene] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Pathol, D-85764 Neuherberg, Germany	Technical University of Munich; University of Munich; National University of Singapore; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Oostendorp, RAJ (corresponding author), Klinikum Rechts Der Isar, Dept Internal Med 3, D-81675 Munich, Germany.	oostendorp@lrz.tum.de	Oostendorp, Robert A. J./K-9841-2018; Lang, Roland/C-3287-2011; Tuluc, Petronel/C-2527-2011	Oostendorp, Robert A. J./0000-0002-4947-0412; Lang, Roland/0000-0003-0502-3677	German Research Foundation [SFB456-B2, OO 8/2-1, and -2]	German Research Foundation(German Research Foundation (DFG))	The authors would like to thank Dr. Ulrich Keller for critical reading of the manuscript, Dr. T. Brill, the animal caretakers of the Centre for Preclinical Research for mouse colony maintenance, S. Schill for help with irradiating the animals used in this procedure, and finally K. Gotsch for technical assistance. The authors gratefully acknowledge the financial support of the German Research Foundation (DFG, grants SFB456-B2, OO 8/2-1, and -2).	Altiok S, 1997, GENE DEV, V11, P1987, DOI 10.1101/gad.11.15.1987; Bodine PVN, 2004, MOL ENDOCRINOL, V18, P1222, DOI 10.1210/me.2003-0498; Burns CE, 2005, GENE DEV, V19, P2331, DOI 10.1101/gad.1337005; Christensen JL, 2001, P NATL ACAD SCI USA, V98, P14541, DOI 10.1073/pnas.261562798; Cobas M, 2004, J EXP MED, V199, P221, DOI 10.1084/jem.20031615; Congdon KL, 2008, STEM CELLS, V26, P1202, DOI 10.1634/stemcells.2007-0768; Dufourcq P, 2008, AM J PATHOL, V172, P37, DOI 10.2353/ajpath.2008.070130; Duncan AW, 2005, NAT IMMUNOL, V6, P314, DOI 10.1038/ni1164; Fleming HE, 2008, CELL STEM CELL, V2, P274, DOI 10.1016/j.stem.2008.01.003; Fukuda T, 2008, P NATL ACAD SCI USA, V105, P3047, DOI 10.1073/pnas.0712148105; Girnun GD, 2002, P NATL ACAD SCI USA, V99, P13771, DOI 10.1073/pnas.162480299; Hausler KD, 2004, J BONE MINER RES, V19, P1873, DOI 10.1359/JBMR.040807; Huang J, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-126; Ichikawa M, 2004, CELL CYCLE, V3, P722; Ishitani T, 2003, MOL CELL BIOL, V23, P131, DOI 10.1128/MCB.23.1.131-139.2003; Jeannet G, 2008, BLOOD, V111, P142, DOI 10.1182/blood-2007-07-102558; Kawano Y, 2003, J CELL SCI, V116, P2627, DOI 10.1242/jcs.00623; Keeble TR, 2006, INT J BIOCHEM CELL B, V38, P2011, DOI 10.1016/j.biocel.2006.07.005; Kirstetter P, 2006, NAT IMMUNOL, V7, P1048, DOI 10.1038/ni1381; Koch U, 2008, BLOOD, V111, P160, DOI 10.1182/blood-2007-07-099754; Kortenjann M, 2001, EUR J IMMUNOL, V31, P3580, DOI 10.1002/1521-4141(200112)31:12<3580::AID-IMMU3580>3.0.CO;2-N; Levanon D, 1998, P NATL ACAD SCI USA, V95, P11590, DOI 10.1073/pnas.95.20.11590; Liang HL, 2003, CANCER CELL, V4, P349, DOI 10.1016/S1535-6108(03)00268-X; Luis TC, 2009, BLOOD, V113, P546, DOI 10.1182/blood-2008-06-163774; Matsuyama M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000427; Miyamoto K, 2007, CELL STEM CELL, V1, P101, DOI 10.1016/j.stem.2007.02.001; Moldes M, 2003, BIOCHEM J, V376, P607, DOI 10.1042/BJ20030426; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Murdoch B, 2003, P NATL ACAD SCI USA, V100, P3422, DOI 10.1073/pnas.0130233100; Nemeth MJ, 2007, P NATL ACAD SCI USA, V104, P15436, DOI 10.1073/pnas.0704747104; Nygren MK, 2007, BRIT J HAEMATOL, V136, P400, DOI 10.1111/j.1365-2141.2006.06442.x; Oostendorp RAJ, 2005, STEM CELLS, V23, P842, DOI 10.1634/stemcells.2004-0120; Oostendorp RAJ, 2002, BLOOD, V99, P1183, DOI 10.1182/blood.V99.4.1183; Orelio C, 2003, BLOOD, V101, P2246, DOI 10.1182/blood-2002-07-2260; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Rodriguez J, 2005, NAT NEUROSCI, V8, P1301, DOI 10.1038/nn1547; Satoh W, 2006, DEVELOPMENT, V133, P989, DOI 10.1242/dev.02274; Scheller M, 2006, NAT IMMUNOL, V7, P1037, DOI 10.1038/ni1387; Sharma C, 2004, J BIOL CHEM, V279, P35583, DOI 10.1074/jbc.M403143200; Si JT, 2008, CANCER RES, V68, P3733, DOI 10.1158/0008-5472.CAN-07-2509; Slayton WB, 2007, STEM CELLS, V25, P2945, DOI 10.1634/stemcells.2007-0158; Takada I, 2007, ANN NY ACAD SCI, V1116, P182, DOI 10.1196/annals.1402.034; Topol L, 2003, J CELL BIOL, V162, P899, DOI 10.1083/jcb.200303158; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Yamane T, 2001, J IMMUNOL, V167, P765, DOI 10.4049/jimmunol.167.2.765; Yin T, 2006, J CLIN INVEST, V116, P1195, DOI 10.1172/JCI28568; Yokota T, 2008, J IMMUNOL, V181, P6061, DOI 10.4049/jimmunol.181.9.6061; Yu XB, 2006, STEM CELLS, V24, P876, DOI 10.1634/stemcells.2005-0598	49	62	64	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	AUG 7	2009	5	2					157	167		10.1016/j.stem.2009.05.020	http://dx.doi.org/10.1016/j.stem.2009.05.020			11	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	490PB	19664990	Bronze			2022-12-24	WOS:000269511900009
J	Frank, MJ; Doll, BB; Oas-Terpstra, J; Moreno, F				Frank, Michael J.; Doll, Bradley B.; Oas-Terpstra, Jen; Moreno, Francisco			Prefrontal and striatal dopaminergic genes predict individual differences in exploration and exploitation	NATURE NEUROSCIENCE			English	Article							MIDBRAIN DOPAMINE; DECISION-MAKING; NEUROCOMPUTATIONAL ACCOUNT; SYNAPTIC PLASTICITY; NUCLEUS-ACCUMBENS; NEURONAL-ACTIVITY; POPULATION CODES; COMT GENOTYPE; REINFORCEMENT; REWARD	The basal ganglia support learning to exploit decisions that have yielded positive outcomes in the past. In contrast, limited evidence implicates the prefrontal cortex in the process of making strategic exploratory decisions when the magnitude of potential outcomes is unknown. Here we examine neurogenetic contributions to individual differences in these distinct aspects of motivated human behavior, using a temporal decision-making task and computational analysis. We show that two genes controlling striatal dopamine function, DARPP-32 (also called PPP1R1B) and DRD2, are associated with exploitative learning to adjust response times incrementally as a function of positive and negative decision outcomes. In contrast, a gene primarily controlling prefrontal dopamine function (COMT) is associated with a particular type of 'directed exploration', in which exploratory decisions are made in proportion to Bayesian uncertainty about whether other choices might produce outcomes that are better than the status quo. Quantitative model fits reveal that genetic factors modulate independent parameters of a reinforcement learning system.	[Frank, Michael J.; Doll, Bradley B.] Brown Univ, Brown Inst Brain Sci, Dept Cognit & Linguist Sci, Providence, RI 02912 USA; [Frank, Michael J.; Doll, Bradley B.] Brown Univ, Brown Inst Brain Sci, Dept Psychol, Providence, RI 02912 USA; [Frank, Michael J.; Doll, Bradley B.] Brown Univ, Brown Inst Brain Sci, Dept Psychiat, Providence, RI 02912 USA; [Oas-Terpstra, Jen; Moreno, Francisco] Univ Arizona, Dept Psychiat, Tucson, AZ USA	Brown University; Brown University; Brown University; University of Arizona	Frank, MJ (corresponding author), Brown Univ, Brown Inst Brain Sci, Dept Cognit & Linguist Sci, Providence, RI 02912 USA.	michael_frank@brown.edu			US National Institutes of Mental Health [R01 MH080066-01]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH080066] Funding Source: NIH RePORTER	US National Institutes of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank S. Williamson and E. Carter for help with DNA analysis and administering cognitive tasks to participants, and N. Daw, P. Dayan, and R. O'Reilly for helpful discussions. This research was supported by US National Institutes of Mental Health grant R01 MH080066-01.	Bayer HM, 2007, J NEUROPHYSIOL, V98, P1428, DOI 10.1152/jn.01140.2006; Bayer HM, 2005, NEURON, V47, P129, DOI 10.1016/j.neuron.2005.05.020; Belin D, 2008, SCIENCE, V320, P1352, DOI 10.1126/science.1158136; Calabresi P, 2000, J NEUROSCI, V20, P8443, DOI 10.1523/JNEUROSCI.20-22-08443.2000; Cohen JD, 2007, PHILOS T R SOC B, V362, P933, DOI 10.1098/rstb.2007.2098; Dalley JW, 2007, SCIENCE, V315, P1267, DOI 10.1126/science.1137073; Dalley JW, 2005, P NATL ACAD SCI USA, V102, P6189, DOI 10.1073/pnas.0502080102; Daw ND, 2006, NATURE, V441, P876, DOI 10.1038/nature04766; Daw ND, 2005, NAT NEUROSCI, V8, P1704, DOI 10.1038/nn1560; Dayan P, 1996, MACH LEARN, V25, P5, DOI 10.1023/A:1018357105171; Depue RA, 1999, BEHAV BRAIN SCI, V22, P491; Forbes EE, 2009, MOL PSYCHIATR, V14, P60, DOI 10.1038/sj.mp.4002086; Frank MJ, 2007, P NATL ACAD SCI USA, V104, P16311, DOI 10.1073/pnas.0706111104; Frank MJ, 2006, PSYCHOL REV, V113, P300, DOI 10.1037/0033-295X.113.2.300; Frank MJ, 2005, NEURON, V47, P495, DOI 10.1016/j.neuron.2005.06.020; Frank MJ, 2004, SCIENCE, V306, P1940, DOI 10.1126/science.1102941; Frank MJ, 2005, J COGNITIVE NEUROSCI, V17, P51, DOI 10.1162/0898929052880093; Gittins J., 1974, PROGR STAT, P241; Gogos JA, 1998, P NATL ACAD SCI USA, V95, P9991, DOI 10.1073/pnas.95.17.9991; Graybiel AM, 2008, ANNU REV NEUROSCI, V31, P359, DOI 10.1146/annurev.neuro.29.051605.112851; Hirvonen M, 2005, MOL PSYCHIATR, V10, P889, DOI 10.1038/sj.mp.4001707; Hollerman JR, 1998, NAT NEUROSCI, V1, P304, DOI 10.1038/1124; Hsu M, 2005, SCIENCE, V310, P1680, DOI 10.1126/science.1115327; Kakade S, 2002, NEURAL NETWORKS, V15, P549, DOI 10.1016/S0893-6080(02)00048-5; Klein TA, 2007, SCIENCE, V318, P1642, DOI 10.1126/science.1145044; Ma WJ, 2006, NAT NEUROSCI, V9, P1432, DOI 10.1038/nn1790; Meyer-Lindenberg A, 2005, NAT NEUROSCI, V8, P594, DOI 10.1038/nn1438; Meyer-Lindenberg A, 2007, J CLIN INVEST, V117, P672, DOI 10.1172/JCI30413; Montague PR, 1996, J NEUROSCI, V16, P1936, DOI 10.1523/jneurosci.16-05-01936.1996; Moustafa AA, 2008, J NEUROSCI, V28, P12294, DOI 10.1523/JNEUROSCI.3116-08.2008; Nakamura K, 2006, J NEUROSCI, V26, P5360, DOI 10.1523/JNEUROSCI.4853-05.2006; Niv Y, 2007, PSYCHOPHARMACOLOGY, V191, P507, DOI 10.1007/s00213-006-0502-4; O'Doherty J, 2004, SCIENCE, V304, P452, DOI 10.1126/science.1094285; O'Reilly RC, 2007, BEHAV NEUROSCI, V121, P31, DOI 10.1037/0735-7044.121.1.31; OUIMET CC, 1984, J NEUROSCI, V4, P111; Roesch MR, 2004, SCIENCE, V304, P307, DOI 10.1126/science.1093223; Rudebeck PH, 2006, NAT NEUROSCI, V9, P1161, DOI 10.1038/nn1756; Santesso DL, 2009, HUM BRAIN MAPP, V30, P1963, DOI 10.1002/hbm.20642; Satoh T, 2003, J NEUROSCI, V23, P9913; Scheres Anouk, 2006, Behav Brain Funct, V2, P35, DOI 10.1186/1744-9081-2-35; Shen WX, 2008, SCIENCE, V321, P848, DOI 10.1126/science.1160575; Slifstein M, 2008, MOL PSYCHIATR, V13, P821, DOI 10.1038/mp.2008.19; Stipanovich A, 2008, NATURE, V453, P879, DOI 10.1038/nature06994; Sutton R.S., 2015, REINFORCEMENT LEARNI, V2nd ed.; SUTTON RS, 1990, P 7 INT C MACH LEARN, P216; Wiecki TV, 2009, PSYCHOPHARMACOLOGY, V204, P265, DOI 10.1007/s00213-008-1457-4; YE S, 2001, NUCL ACIDS RES, V29; Yoshida W, 2006, NEURON, V50, P781, DOI 10.1016/j.neuron.2006.05.006; Zemel RS, 1998, NEURAL COMPUT, V10, P403, DOI 10.1162/089976698300017818; Zhang Y, 2007, P NATL ACAD SCI USA, V104, P20552, DOI 10.1073/pnas.0707106104	50	302	302	1	60	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2009	12	8					1062	U145		10.1038/nn.2342	http://dx.doi.org/10.1038/nn.2342			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	475WS	19620978	Green Accepted			2022-12-24	WOS:000268396300022
J	Thoby-Brisson, M; Karlen, M; Wu, N; Charnay, P; Champagnat, J; Fortin, G				Thoby-Brisson, Muriel; Karlen, Mattias; Wu, Ning; Charnay, Patrick; Champagnat, Jean; Fortin, Gilles			Genetic identification of an embryonic parafacial oscillator coupling to the preBotzinger complex	NATURE NEUROSCIENCE			English	Article							CONGENITAL CENTRAL HYPOVENTILATION; RESPIRATORY RHYTHM GENERATION; PRE-BOTZINGER COMPLEX; FATAL CENTRAL APNEA; NEONATAL-RAT; DEVELOPING HINDBRAIN; NERVOUS-SYSTEM; MOUSE EMBRYO; IN-VITRO; NEURONS	The hindbrain transcription factors Phox2b and Egr2 (also known as Krox20) are linked to the development of the autonomic nervous system and rhombomere-related regulation of breathing, respectively. Mutations in these proteins can lead to abnormal breathing behavior as a result of an alteration in an unidentified neuronal system. We characterized a bilateral embryonic parafacial (e-pF) population of rhythmically bursting neurons at embryonic day (E) 14.5 in mice. These cells expressed Phox2b, were derived from Egr2-expressing precursors and their development was dependent on the integrity of the Egr2 gene. Silencing or eliminating the e-pF oscillator, but not the putative inspiratory oscillator (preBotzinger complex, preBotC), led to an abnormally slow rhythm, demonstrating that the e-pF controls the respiratory rhythm. The e-pF oscillator, the only one active at E14.5, entrained and then coupled with the preBotC, which emerged independently at E15.5. These data establish the dual organization of the respiratory rhythm generator at the time of its inception, when it begins to drive fetal breathing.	[Thoby-Brisson, Muriel; Wu, Ning; Champagnat, Jean; Fortin, Gilles] CNRS, Inst Neurobiol Alfred Fessard, UPR2216, Gif Sur Yvette, France; [Karlen, Mattias] Karolinska Inst, Dept Cell & Mol Biol, Stockholm, Sweden; [Charnay, Patrick] Ecole Normale Super, INSERM, U784, F-75231 Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Karolinska Institutet; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	Fortin, G (corresponding author), CNRS, Inst Neurobiol Alfred Fessard, UPR2216, Gif Sur Yvette, France.	gilles.fortin@inaf.cnrs-gif.fr	Thoby-Brisson, Muriel/E-1167-2014	Thoby-Brisson, Muriel/0000-0003-3214-1724; Fortin, Gilles/0000-0002-2123-8603; Charnay, Patrick/0000-0002-3847-6042	Centre National de la Recherche Scientifique; Institut National de la Sante et de la Recherche Medicale; ANR [ANR-07-Neuro-007-01]	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); ANR(French National Research Agency (ANR))	We thank J. F. Brunet and C. Goridis for comments on the manuscript and the Phox2b antibody, and K. Kullander for VGlut2 mutant mice. This work benefited from the facilities and expertise of the Imagif Cell Biology Unit of the Gif campus. This work was supported by the Centre National de la Recherche Scientifique, Institut National de la Sante et de la Recherche Medicale (M. T.-B.) and ANR grant ANR-07-Neuro-007-01 (G. F.).	Amiel J, 2003, NAT GENET, V33, P459, DOI 10.1038/ng1130; Anselmi F, 2008, P NATL ACAD SCI USA, V105, P18770, DOI [10.1073/pnas.0800793105, 10.1073/pnas.080079310S]; Blanchi B, 2003, NAT NEUROSCI, V6, P1091, DOI 10.1038/nn1129; Borday C, 2006, J NEUROBIOL, V66, P1285, DOI 10.1002/neu.20271; Brunet Jean-Francois, 2008, P25, DOI 10.1007/978-0-387-70765-5_3; Chan CS, 2007, NATURE, V447, P1081, DOI 10.1038/nature05865; Cheng LP, 2004, NAT NEUROSCI, V7, P510, DOI 10.1038/nn1221; Contreras JE, 2003, P NATL ACAD SCI USA, V100, P11388, DOI 10.1073/pnas.1434298100; Coutinho AP, 2004, J NEUROSCI, V24, P9383, DOI 10.1523/JNEUROSCI.2408-04.2004; Dauger S, 2003, DEVELOPMENT, V130, P6635, DOI 10.1242/dev.00866; del Toro ED, 2001, J NEUROSCI, V21, P5637, DOI 10.1523/JNEUROSCI.21-15-05637.2001; Dubreuil V, 2008, P NATL ACAD SCI USA, V105, P1067, DOI 10.1073/pnas.0709115105; Feldman JL, 2006, NAT REV NEUROSCI, V7, P232, DOI 10.1038/nrn1871; Feldman JL, 2003, ANNU REV NEUROSCI, V26, P239, DOI 10.1146/annurev.neuro.26.041002.131103; Frere SGA, 2004, MOL NEUROBIOL, V30, P279, DOI 10.1385/MN:30:3:279; Gray PA, 1999, SCIENCE, V286, P1566, DOI 10.1126/science.286.5444.1566; GREER JJ, 1991, J PHYSIOL-LONDON, V437, P727, DOI 10.1113/jphysiol.1991.sp018622; Guyenet PG, 2008, J APPL PHYSIOL, V105, P404, DOI 10.1152/japplphysiol.90452.2008; Jacquin TD, 1996, NEURON, V17, P747, DOI 10.1016/S0896-6273(00)80206-8; Janczewski WA, 2006, J PHYSIOL-LONDON, V570, P407, DOI 10.1113/jphysiol.2005.098848; Kobayashi K, 2001, J APPL PHYSIOL, V91, P316, DOI 10.1152/jappl.2001.91.1.316; Koizumi H, 2008, J NEUROSCI, V28, P2353, DOI 10.1523/JNEUROSCI.3553-07.2008; Koshiya N, 1999, NATURE, V400, P360, DOI 10.1038/22540; Mellen NM, 2003, NEURON, V37, P821, DOI 10.1016/S0896-6273(03)00092-8; Milsom WK, 2008, ADV EXP MED BIOL, V605, P293; Mulkey DK, 2004, NAT NEUROSCI, V7, P1360, DOI 10.1038/nn1357; Onimaru H, 2005, NEUROSCIENCE, V131, P969, DOI 10.1016/j.neuroscience.2004.11.041; Onimaru H, 2003, J NEUROSCI, V23, P1478, DOI 10.1523/JNEUROSCI.23-04-01478.2003; Onimaru H, 2008, J NEUROSCI, V28, P12845, DOI 10.1523/JNEUROSCI.3625-08.2008; Pagliardini S, 2003, J NEUROSCI, V23, P9575; Pagliardini S, 2008, J NEUROSCI, V28, P11030, DOI 10.1523/JNEUROSCI.1648-08.2008; Pattyn A, 1997, DEVELOPMENT, V124, P4065; Ren J, 2006, J NEUROSCI, V26, P3721, DOI 10.1523/JNEUROSCI.0026-06.2006; Rubin JE, 2009, P NATL ACAD SCI USA, V106, P2939, DOI 10.1073/pnas.0808776106; SCHNEIDERMAUNOURY S, 1993, CELL, V75, P1199, DOI 10.1016/0092-8674(93)90329-O; Shirasawa S, 2000, NAT GENET, V24, P287, DOI 10.1038/73516; SMITH JC, 1989, J COMP NEUROL, V281, P69, DOI 10.1002/cne.902810107; SMITH JC, 1991, SCIENCE, V254, P726, DOI 10.1126/science.1683005; Spengler CM, 2001, RESP PHYSIOL, V129, P247, DOI 10.1016/S0034-5687(01)00294-8; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Stornetta RL, 2006, J NEUROSCI, V26, P10305, DOI 10.1523/JNEUROSCI.2917-06.2006; SUZUE T, 1984, J PHYSIOL-LONDON, V354, P173, DOI 10.1113/jphysiol.1984.sp015370; Thoby-Brisson M, 2005, J NEUROSCI, V25, P4307, DOI 10.1523/JNEUROSCI.0551-05.2005; Vasilakos K, 2005, J NEUROBIOL, V62, P369, DOI 10.1002/neu.20102; Voiculescu O, 2000, GENESIS, V26, P123, DOI 10.1002/(SICI)1526-968X(200002)26:2<123::AID-GENE7>3.0.CO;2-O; Voiculescu O, 2001, DEVELOPMENT, V128, P4967; Wallen-Mackenzie A, 2006, J NEUROSCI, V26, P12294, DOI 10.1523/JNEUROSCI.3855-06.2006; Weese-Mayer DE, 2005, RESP PHYSIOL NEUROBI, V149, P73, DOI 10.1016/j.resp.2005.06.010; WILKINSON DG, 1989, NATURE, V337, P461, DOI 10.1038/337461a0	49	156	157	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2009	12	8					1028	U100		10.1038/nn.2354	http://dx.doi.org/10.1038/nn.2354			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	475WS	19578380				2022-12-24	WOS:000268396300017
J	Sumner, P; Edden, RAE; Bompas, A; Evans, CJ; Singh, KD				Sumner, Petroc; Edden, Richard A. E.; Bompas, Aline; Evans, C. John; Singh, Krish D.			More GABA, less distraction: a neurochemical predictor of motor decision speed	NATURE NEUROSCIENCE			English	Article							CORTEX	People vary markedly in the efficiency with which they can resolve competitive action decisions, even simple ones such as shifting gaze to one stimulus rather than another. We found that an individual's ability to rapidly resolve such competition is predicted by the concentration of GABA, the main inhibitory neurotransmitter, in a region of frontal cortex that is relevant for eye movements, but not in a control region (occipital cortex).	[Sumner, Petroc; Edden, Richard A. E.; Bompas, Aline; Evans, C. John; Singh, Krish D.] Cardiff Univ, Sch Psychol, Brain Res Imaging Ctr, Cardiff, S Glam, Wales; [Edden, Richard A. E.] Johns Hopkins Univ, Russell H Morgan Dept Radiol & Radiol Sci, Baltimore, MD USA; [Edden, Richard A. E.] Kennedy Krieger Inst, FM Kirby Res Ctr Funct Magnet Resonance Imaging, Baltimore, MD USA	Cardiff University; Johns Hopkins University; Kennedy Krieger Institute	Sumner, P (corresponding author), Cardiff Univ, Sch Psychol, Brain Res Imaging Ctr, Cardiff, S Glam, Wales.	sumnerp@cardiff.ac.uk	Sumner, Petroc/A-3563-2010; Edden, Richard A/G-5538-2012; Singh, Krish/D-1066-2009; Evans, C. John/A-8054-2010	Evans, C. John/0000-0002-6619-4245; Edden, Richard/0000-0002-0671-7374; Singh, Krishna/0000-0002-3094-2475; Bompas, Aline/0000-0002-6957-2694	ESRC; Wellcome Trust; Wales Institute of Cognitive Neuroscience; Schools of Psychology, Biosciences and Chemistry at Cardiff University; UK Department of Trade and Industry, Cardiff University; Welsh Assembly government; RCUK; Biotechnology and Biological Sciences Research Council [BB/C515271/2, BB/C515271/1] Funding Source: researchfish; Economic and Social Research Council [ES/G032211/1] Funding Source: researchfish; ESRC [ES/G032211/1] Funding Source: UKRI	ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Wales Institute of Cognitive Neuroscience; Schools of Psychology, Biosciences and Chemistry at Cardiff University; UK Department of Trade and Industry, Cardiff University; Welsh Assembly government; RCUK(UK Research & Innovation (UKRI)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	We thank F. Boy, S. Muthukumaraswamy, B. Taud, M. Husain, C. Chambers, T. Freeman, R. Honey and L. Wilkinson. R.A.E.E. thanks G. Barker and D. Shungu for pulse programming advice. This work was supported by the ESRC, the Wellcome Trust, the Wales Institute of Cognitive Neuroscience and the Schools of Psychology, Biosciences and Chemistry at Cardiff University. Cardiff University Brain Research Imaging Centre was established with support from the UK Department of Trade and Industry, Cardiff University and the Welsh Assembly government. R.A.E.E. held an RCUK fellowship.	Bompas A, 2009, J VISION, V9, DOI 10.1167/9.9.17; Evans CJ, 2010, J MAGN RESON IMAGING, V31, P204, DOI 10.1002/jmri.21996; Godijn R, 2002, J EXP PSYCHOL HUMAN, V28, P1039, DOI 10.1037//0096-1523.28.5.1039; Lewis DA, 2005, NAT REV NEUROSCI, V6, P312, DOI 10.1038/nrn1648; McSorley E, 2006, J NEUROPHYSIOL, V96, P1420, DOI 10.1152/jn.00315.2006; Mescher M, 1998, NMR BIOMED, V11, P266, DOI 10.1002/(SICI)1099-1492(199810)11:6<266::AID-NBM530>3.0.CO;2-J; Muthukumaraswamy SD, 2009, P NATL ACAD SCI USA, V106, P8356, DOI 10.1073/pnas.0900728106; Olivier E, 1999, BEHAV BRAIN SCI, V22, P694, DOI 10.1017/S0140525X99432157; Pouget P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005208; Rommelse NNJ, 2008, BRAIN COGNITION, V68, P391, DOI 10.1016/j.bandc.2008.08.025; Schlag J, 1998, J NEUROPHYSIOL, V79, P64, DOI 10.1152/jn.1998.79.1.64; THAKER GK, 1989, BIOL PSYCHIAT, V25, P49, DOI 10.1016/0006-3223(89)90146-7; Walker R, 2000, P ROY SOC B-BIOL SCI, V267, P431, DOI 10.1098/rspb.2000.1018	13	112	116	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2010	13	7					825	827		10.1038/nn.2559	http://dx.doi.org/10.1038/nn.2559			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	615YF	20512136				2022-12-24	WOS:000279173900014
J	Garcia-Moreno, F; Pedraza, M; Di Giovannantonio, LG; Di Salvio, M; Lopez-Mascaraque, L; Simeone, A; De Carlos, JA				Garcia-Moreno, Fernando; Pedraza, Maria; Di Giovannantonio, Luca G.; Di Salvio, Michela; Lopez-Mascaraque, Laura; Simeone, Antonio; De Carlos, Juan A.			A neuronal migratory pathway crossing from diencephalon to telencephalon populates amygdala nuclei	NATURE NEUROSCIENCE			English	Article							LATERAL GANGLIONIC EMINENCE; EXPRESSION PATTERNS; HOMEODOMAIN PROTEIN; CELL LINEAGES; MOUSE; GENES; ORGANIZATION; SPECIFICATION; HYPOTHALAMUS; ORTHOPEDIA	Neurons usually migrate and differentiate in one particular encephalic vesicle. We identified a murine population of diencephalic neurons that colonized the telencephalic amygdaloid complex, migrating along a tangential route that crosses a boundary between developing brain vesicles. The diencephalic transcription factor OTP was necessary for this migratory behavior.	[Garcia-Moreno, Fernando; Pedraza, Maria; Lopez-Mascaraque, Laura; De Carlos, Juan A.] CSIC, Inst Cajal, Mol Cellular & Dev Neurobiol Dept, Lab Telencephal Dev, E-28002 Madrid, Spain; [Di Giovannantonio, Luca G.; Di Salvio, Michela; Simeone, Antonio] CEINGE Biotecnol Avanzate, Naples, Italy; [Simeone, Antonio] Scuola Europea Med Mol, Naples, Italy; [Simeone, Antonio] CNR, Inst Genet & Biophys A Buzzati Traverso, I-80125 Naples, Italy	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Cajal (IC); CEINGE Biotecnologie Avanzate; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR)	De Carlos, JA (corresponding author), CSIC, Inst Cajal, Mol Cellular & Dev Neurobiol Dept, Lab Telencephal Dev, E-28002 Madrid, Spain.	decarlos@cajal.csic.es	Lopez-Mascaraque, Laura/M-2448-2014; Di Salvio, Michela/J-8982-2018; Simeone, Antonio/ABG-5269-2020; De Carlos, Juan A./Q-8999-2018	Lopez-Mascaraque, Laura/0000-0002-7154-5687; Di Salvio, Michela/0000-0002-5817-1297; Simeone, Antonio/0000-0003-2693-9836; De Carlos, Juan A./0000-0001-9096-5372; di giovannantonio, luca giovanni/0000-0003-4348-6082; Pedraza, Maria/0000-0002-1973-3269; Garcia-Moreno, Fernando/0000-0001-9048-4237	Ministerio de Ciencia e Innovacion [BFU2007-60351/BFI]; OLFACTOSENSE Consortium of the Comunidad Autonoma de Madrid [P-SEM-0255-2006]; Castilla-La Mancha Health Research Foundation [FISCAM PI2007-66]; EUTRACC Integrate Project [LSHG-CT-2007-037445]; Fondazione Roma and the Italian Association for Cancer Research; Fundacion Centro de Investigaciones de Enfermedades Neurologicas [PI006-08]	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); OLFACTOSENSE Consortium of the Comunidad Autonoma de Madrid; Castilla-La Mancha Health Research Foundation; EUTRACC Integrate Project; Fondazione Roma and the Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro); Fundacion Centro de Investigaciones de Enfermedades Neurologicas	We thank J. Lerma, A. Nieto, M.L. Ceci, A. Blanchart and J. Garcia-Marques for helpful comments; P. Bovolenta and C. Sanchez-Camacho for their kind gift of the pCAG plasmid; F. Vaccarino and G. Corte for the generous gift of antibodies to Otp and Foxg1; L. Menendez de la Prida for providing the GAD-GFP transgenic mice; A. Kastanauskaite and L. Mar a Suarez for their help with the intracellular injections of Lucifer Yellow and M. Sefton for editorial assistance. This work was supported by grants from the Ministerio de Ciencia e Innovacion (BFU2007-60351/BFI), the OLFACTOSENSE Consortium of the Comunidad Autonoma de Madrid (P-SEM-0255-2006) and the Castilla-La Mancha Health Research Foundation (FISCAM PI2007-66) to J.A.DC., and the FP6 for the EUTRACC Integrate Project (LSHG-CT-2007-037445), the 'Stem Cell Project' of Fondazione Roma and the Italian Association for Cancer Research to A.S.Funding for M.P. was provided by Fundacion Centro de Investigaciones de Enfermedades Neurologicas (PI006-08).	Acampora D, 2000, INT J DEV BIOL, V44, P669; Acampora D, 1999, GENE DEV, V13, P2787, DOI 10.1101/gad.13.21.2787; ALHEID GF, 1988, NEUROSCIENCE, V27, P1, DOI 10.1016/0306-4522(88)90217-5; ALTMAN J, 1978, J COMP NEUROL, V182, P945, DOI 10.1002/cne.901820511; ALTMAN J, 1978, J COMP NEUROL, V182, P973, DOI 10.1002/cne.901820512; Anderson S, 1999, CEREB CORTEX, V9, P646, DOI 10.1093/cercor/9.6.646; Bardet SM, 2008, BRAIN RES BULL, V75, P231, DOI 10.1016/j.brainresbull.2007.10.037; Blechman J, 2007, DEVELOPMENT, V134, P4417, DOI 10.1242/dev.011262; CANTERAS NS, 1995, J COMP NEUROL, V360, P213, DOI 10.1002/cne.903600203; Caqueret A, 2006, DEV BIOL, V298, P95, DOI 10.1016/j.ydbio.2006.06.019; Cassell MD, 1999, ANN NY ACAD SCI, V877, P217, DOI 10.1111/j.1749-6632.1999.tb09270.x; Choi GB, 2005, NEURON, V46, P647, DOI 10.1016/j.neuron.2005.04.011; DeCarlos JA, 1996, J NEUROSCI, V16, P6146; Fan CM, 1996, MOL CELL NEUROSCI, V7, P1, DOI 10.1006/mcne.1996.0001; Flames N, 2007, J NEUROSCI, V27, P9682, DOI 10.1523/JNEUROSCI.2750-07.2007; Moreno FG, 2008, CEREB CORTEX, V18, P1239, DOI 10.1093/cercor/bhm154; Garcia-Lopez M, 2008, J COMP NEUROL, V506, P46, DOI 10.1002/cne.21524; Garcia-Moreno F, 2007, J COMP NEUROL, V500, P419, DOI 10.1002/cne.21128; Hirata T, 2009, NAT NEUROSCI, V12, P141, DOI 10.1038/nn.2241; Holmgren N., 1925, Acta Zoologica Stockholm, V6, pbis; Lavdas AA, 1999, J NEUROSCI, V19, P7881; Letinic K, 2001, NAT NEUROSCI, V4, P931, DOI 10.1038/nn0901-931; Martinez-Garcia F, 2002, BRAIN RES BULL, V57, P463, DOI 10.1016/S0361-9230(01)00665-7; Medina L, 2004, J COMP NEUROL, V474, P504, DOI 10.1002/cne.20141; Medina L, 2005, BRAIN RES BULL, V66, P297, DOI 10.1016/j.brainresbull.2005.02.003; Michaud JL, 1998, GENE DEV, V12, P3264, DOI 10.1101/gad.12.20.3264; Nakai S, 1995, GENE DEV, V9, P3109, DOI 10.1101/gad.9.24.3109; Puelles L, 2000, J COMP NEUROL, V424, P409, DOI 10.1002/1096-9861(20000828)424:3<409::AID-CNE3>3.0.CO;2-7; Puelles L, 2003, TRENDS NEUROSCI, V26, P469, DOI 10.1016/S0166-2236(03)00234-0; Puelles L, 2001, BRAIN RES BULL, V55, P695, DOI 10.1016/S0361-9230(01)00588-3; RAKIC P, 1990, EXPERIENTIA, V46, P882, DOI 10.1007/BF01939380; Remedios R, 2004, J NEUROSCI, V24, P6986, DOI 10.1523/JNEUROSCI.0001-04.2004; Ryu S, 2007, CURR BIOL, V17, P873, DOI 10.1016/j.cub.2007.04.003; Shammah-Lagnado SJ, 2000, J COMP NEUROL, V422, P533, DOI 10.1002/1096-9861(20000710)422:4<533::AID-CNE5>3.0.CO;2-7; Sheng HZ, 1997, DEV DYNAM, V208, P266, DOI 10.1002/(SICI)1097-0177(199702)208:2<266::AID-AJA13>3.0.CO;2-1; SIMEONE A, 1994, NEURON, V13, P83, DOI 10.1016/0896-6273(94)90461-8; Soma M, 2009, J COMP NEUROL, V513, P113, DOI 10.1002/cne.21945; Stenman J, 2003, J NEUROSCI, V23, P167; Swanson L., 2009, DEV DEGENERATION REG, P69; Swanson LW, 2000, BRAIN RES, V886, P113, DOI 10.1016/S0006-8993(00)02905-X; Swanson LW, 1998, TRENDS NEUROSCI, V21, P323, DOI 10.1016/S0166-2236(98)01265-X; Tole S, 2005, J NEUROSCI, V25, P2753, DOI 10.1523/JNEUROSCI.3014-04.2005; Valverde F, 1970, CONT RES METHODS NEU, P12, DOI [10.1007/978-3-642-85986-1_2, DOI 10.1007/978-3-642-85986-1_2]; Wang WD, 2000, DEV BIOL, V227, P432, DOI 10.1006/dbio.2000.9902; Wichterle H, 2001, DEVELOPMENT, V128, P3759; Zhao TY, 2008, EUR J NEUROSCI, V28, P1941, DOI 10.1111/j.1460-9568.2008.06503.x	46	73	73	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2010	13	6					680	U50		10.1038/nn.2556	http://dx.doi.org/10.1038/nn.2556			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	600QY	20495559	Green Submitted			2022-12-24	WOS:000278003300012
J	Xie, KQ; Allen, KL; Kourrich, S; Colon-Saez, J; Thomas, MJ; Wickman, K; Martemyanov, KA				Xie, Keqiang; Allen, Kevin L.; Kourrich, Said; Colon-Saez, Jose; Thomas, Mark J.; Wickman, Kevin; Martemyanov, Kirill A.			G beta 5 recruits R7 RGS proteins to GIRK channels to regulate the timing of neuronal inhibitory signaling	NATURE NEUROSCIENCE			English	Article							MICE LACKING; K+ CHANNEL; SUBUNIT	The type 5 G protein beta subunit (G beta 5) can form complexes with members of the regulator of G protein signaling 7 (RGS7) family, but its relevance to neuronal G protein signaling is unclear. We found that mouse RGS7-G beta 5 complexes bound to G protein-gated potassium channels and facilitated their functional coupling to GABA(B) receptors in neurons. Our findings identify a compartmentalization mechanism that is critical for ensuring high temporal resolution of neuronal G protein signaling.	[Xie, Keqiang; Allen, Kevin L.; Colon-Saez, Jose; Wickman, Kevin; Martemyanov, Kirill A.] Univ Minnesota, Dept Pharmacol, Minneapolis, MN 55455 USA; [Kourrich, Said; Thomas, Mark J.] Univ Minnesota, Dept Neurosci, Minneapolis, MN 55455 USA; [Kourrich, Said; Thomas, Mark J.] Univ Minnesota, Dept Psychol, Minneapolis, MN 55455 USA; [Kourrich, Said; Thomas, Mark J.] Univ Minnesota, Inst Human Genet, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Wickman, K (corresponding author), Univ Minnesota, Dept Pharmacol, 3-249 Millard Hall, Minneapolis, MN 55455 USA.	wickm002@umn.edu; martemyanov@umn.edu	Kourrich, Said/M-3916-2014; Xie, Keqiang/J-9668-2012; Thomas, Mark John/HHC-7509-2022; Xie, Keqiang/D-4437-2015	Thomas, Mark John/0000-0001-5721-5350; Wickman, Kevin/0000-0002-5179-9540; Colon-Saez, Jose/0000-0003-4913-0300	US National Institutes of Health [DA021743, DA026405, EY018139, MH061933, DA011806, DA019666, MII078291]; McKnight Land-Grant Award; Whitehall Foundation; NATIONAL EYE INSTITUTE [R01EY018139] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH061933, F31MH078291] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P50DA011806, R01DA019666, R01DA021743, K02DA026405] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); McKnight Land-Grant Award; Whitehall Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank J. Chen for providing the G beta 5<SUP>-/-</SUP> mice, W. Simonds for the gift of antibodies to G beta 5 and RGS7 and M. Parent for assistance with the hippocampal slicing technique. This work was supported by US National Institutes of Health grants DA021743 (K.A.M.), DA026405 (K.A.M.), EY018139 (K.A.M.), MH061933 (K.W.), DA011806 (K.W.), DA019666 (M.J.T.) and MII078291 (J.C.- S.), a McKnight Land-Grant Award (K.A.M), and an award from the Whitehall Foundation (M.J.T.).	Andernacht M, 2009, ATW-INT J NUCL POWER, V54, P33; Cheever ML, 2008, NAT STRUCT MOL BIOL, V15, P155, DOI 10.1038/nsmb.1377; Chen CK, 2003, P NATL ACAD SCI USA, V100, P6604, DOI 10.1073/pnas.0631825100; Chung HJ, 2009, P NATL ACAD SCI USA, V106, P635, DOI 10.1073/pnas.0811685106; Chung HJ, 2009, P NATL ACAD SCI USA, V106, P629, DOI 10.1073/pnas.0811615106; Costa ACS, 2005, J NEUROSCI, V25, P7801, DOI 10.1523/JNEUROSCI.1699-05.2005; Drenan RM, 2006, J BIOL CHEM, V281, P28222, DOI 10.1074/jbc.M604428200; Karschin C, 1996, J NEUROSCI, V16, P3559; Keren-Raifman T, 2001, FEBS LETT, V492, P20, DOI 10.1016/S0014-5793(01)02220-7; Kovoor A, 2000, J BIOL CHEM, V275, P3397, DOI 10.1074/jbc.275.5.3397; Luscher C, 1997, NEURON, V19, P687, DOI 10.1016/S0896-6273(00)80381-5; Pravetoni M, 2008, GENES BRAIN BEHAV, V7, P523, DOI 10.1111/j.1601-183X.2008.00388.x; Rahman Z, 2003, NEURON, V38, P941, DOI 10.1016/S0896-6273(03)00321-0; Sondek J, 2001, BIOCHEM PHARMACOL, V61, P1329, DOI 10.1016/S0006-2952(01)00633-5; Vacher CM, 2003, CNS NEUROL DISORD-DR, V2, P248, DOI 10.2174/1568007033482814	15	51	52	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2010	13	6					661	663		10.1038/nn.2549	http://dx.doi.org/10.1038/nn.2549			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	600QY	20453851	Green Accepted			2022-12-24	WOS:000278003300007
J	Ortinski, PI; Dong, JH; Mungenast, A; Yue, CY; Takano, H; Watson, DJ; Haydon, PG; Coulter, DA				Ortinski, Pavel I.; Dong, Jinghui; Mungenast, Alison; Yue, Cuiyong; Takano, Hajime; Watson, Deborah J.; Haydon, Philip G.; Coulter, Douglas A.			Selective induction of astrocytic gliosis generates deficits in neuronal inhibition	NATURE NEUROSCIENCE			English	Article							TEMPORAL-LOBE EPILEPSY; NEUROTRANSMITTER GABA SYNTHESIS; GLUTAMATE-GLUTAMINE CYCLE; RAT HIPPOCAMPAL-NEURONS; SYNAPTIC-TRANSMISSION; NEUROLOGICAL DISORDERS; AREA CA1; BRAIN; SYNTHETASE; SUSCEPTIBILITY	Reactive astrocytosis develops in many neurologic diseases, including epilepsy. Astrocytotic contributions to pathophysiology are poorly understood. Studies examining this are confounded by comorbidities accompanying reactive astrocytosis. We found that high-titer transduction of astrocytes with enhanced green fluorescent protein (eGFP) via adeno-associated virus induced reactive astrocytosis without altering the intrinsic properties or anatomy of neighboring neurons. We examined the consequences of selective astrocytosis induction on synaptic transmission in mouse CA1 pyramidal neurons. Neurons near eGFP-labeled reactive astrocytes had reduced inhibitory, but not excitatory, synaptic currents. This inhibitory postsynaptic current (IPSC) erosion resulted from a failure of the astrocytic glutamate-glutamine cycle. Reactive astrocytes downregulated expression of glutamine synthetase. Blockade of this enzyme normally induces rapid synaptic GABA depletion. In astrocytotic regions, residual inhibition lost sensitivity to glutamine synthetase blockade, whereas exogenous glutamine administration enhanced IPSCs. Astrocytosis-mediated deficits in inhibition triggered glutamine-reversible hyperexcitability in hippocampal circuits. Thus, reactive astrocytosis could generate local synaptic perturbations, leading to broader functional deficits associated with neurologic disease.	[Ortinski, Pavel I.; Yue, Cuiyong; Takano, Hajime; Coulter, Douglas A.] Childrens Hosp Philadelphia, Div Neurol, Philadelphia, PA 19104 USA; [Dong, Jinghui; Mungenast, Alison; Haydon, Philip G.] Tufts Univ, Sch Med, Dept Neurosci, Boston, MA 02111 USA; [Watson, Deborah J.] Univ Penn, Sch Med, Dept Neurosurg, Philadelphia, PA 19104 USA; [Coulter, Douglas A.] Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; [Coulter, Douglas A.] Univ Penn, Sch Med, Dept Neurosci, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Tufts University; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Coulter, DA (corresponding author), Childrens Hosp Philadelphia, Div Neurol, Philadelphia, PA 19104 USA.	coulterd@email.chop.edu	Takano, Hajime/AAD-4589-2019; Ortinski, Pavel/N-7195-2017	Ortinski, Pavel/0000-0003-0814-4490; Mungenast, Alison/0000-0003-1020-0471; Coulter, Douglas/0000-0002-1486-119X; Takano, Hajime/0000-0003-3033-2412	US National Institutes of Health [P01 NS054900, P20 MH071705, P01NS054900, R01NS054770, R01NS037585, R01NS040978]; Epilepsy Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [P20MH071705] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037585, R01NS038572, R01NS054770, R01NS040978, P01NS054900] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Epilepsy Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by US National Institutes of Health grants P01 NS054900 and P20 MH071705 to D. A. C., P01NS054900, R01NS054770 and R01NS037585 to P. G. H., R01NS040978 to D. J.W. and by an Epilepsy Foundation Research Fellowship to P.I.O.	Ang CW, 2006, J NEUROSCI, V26, P11850, DOI 10.1523/JNEUROSCI.2354-06.2006; Ang CW, 2005, J NEUROSCI, V25, P9567, DOI 10.1523/JNEUROSCI.2992-05.2005; Bak LK, 2006, J NEUROCHEM, V98, P641, DOI 10.1111/j.1471-4159.2006.03913.x; Barberis A, 2004, EUR J NEUROSCI, V20, P1803, DOI 10.1111/j.1460-9568.2004.03624.x; Binder DK, 2006, GLIA, V54, P358, DOI 10.1002/glia.20394; Burrone J, 2006, NAT PROTOC, V1, P2970, DOI 10.1038/nprot.2006.449; Bushong EA, 2002, J NEUROSCI, V22, P183, DOI 10.1523/JNEUROSCI.22-01-00183.2002; Cameron H.A., 2006, CURRENT PROTOCOLS NE; Chaudhry FA, 2002, J CELL BIOL, V157, P349, DOI 10.1083/jcb.200201070; Cohen AS, 2000, J NEUROPHYSIOL, V84, P2465, DOI 10.1152/jn.2000.84.5.2465; Reis RAD, 2008, NEUROCHEM RES, V33, P1466, DOI 10.1007/s11064-008-9604-1; Eid T, 2004, LANCET, V363, P28, DOI 10.1016/S0140-6736(03)15166-5; Eid T, 2008, EPILEPSIA, V49, P42, DOI 10.1111/j.1528-1167.2008.01492.x; Fricke MN, 2007, J NEUROCHEM, V102, P1895, DOI 10.1111/j.1471-4159.2007.04649.x; Galic MA, 2008, J NEUROSCI, V28, P6904, DOI 10.1523/JNEUROSCI.1901-08.2008; Haydon PG, 2006, PHYSIOL REV, V86, P1009, DOI 10.1152/physrev.00049.2005; Jakubs K, 2008, J NEUROSCI, V28, P12477, DOI 10.1523/JNEUROSCI.3240-08.2008; Kam K, 2007, J NEUROSCI, V27, P9192, DOI 10.1523/JNEUROSCI.1198-07.2007; Liang SL, 2006, J NEUROSCI, V26, P8537, DOI 10.1523/JNEUROSCI.0329-06.2006; Mozrzymas JW, 2007, J PHYSIOL-LONDON, V585, P29, DOI 10.1113/jphysiol.2007.143602; Oliva AA, 2000, J NEUROSCI, V20, P3354, DOI 10.1523/JNEUROSCI.20-09-03354.2000; Ortinski PI, 2004, J NEUROPHYSIOL, V92, P1718, DOI 10.1152/jn.00243.2004; PARPURA V, 1994, NATURE, V369, P744, DOI 10.1038/369744a0; Pascual O, 2005, SCIENCE, V310, P113, DOI 10.1126/science.1116916; Pekny M, 2005, GLIA, V50, P427, DOI 10.1002/glia.20207; Rizzoli SO, 2005, NAT REV NEUROSCI, V6, P57, DOI 10.1038/nrn1583; Robinson SR, 2001, J NEUROSCI RES, V66, P972, DOI 10.1002/jnr.10057; Rosati A, 2009, J NEURO-ONCOL, V93, P319, DOI 10.1007/s11060-008-9794-z; Seifert G, 2006, NAT REV NEUROSCI, V7, P194, DOI 10.1038/nrn1870; Sepkuty JP, 2002, J NEUROSCI, V22, P6372; Steffens M, 2005, NEUROCHEM INT, V47, P379, DOI 10.1016/j.neuint.2005.06.001; Sun HY, 2005, J PHYSIOL-LONDON, V568, P815, DOI 10.1113/jphysiol.2005.093948; Sykova E, 2008, PHYSIOL REV, V88, P1277, DOI 10.1152/physrev.00027.2007; Tilleux S, 2007, J NEUROSCI RES, V85, P2059, DOI 10.1002/jnr.21325; Volterra A, 2005, NAT REV NEUROSCI, V6, P626, DOI 10.1038/nrn1722; Wetherington J, 2008, NEURON, V58, P168, DOI 10.1016/j.neuron.2008.04.002; Wilhelmsson U, 2004, J NEUROSCI, V24, P5016, DOI 10.1523/JNEUROSCI.0820-04.2004	37	308	314	2	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2010	13	5					584	U93		10.1038/nn.2535	http://dx.doi.org/10.1038/nn.2535			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	588JM	20418874	Green Accepted			2022-12-24	WOS:000277065700016
J	Monk, AC; Siddall, NA; Volk, T; Fraser, B; Quinn, LM; McLaughlin, EA; Hime, GR				Monk, Adrian C.; Siddall, Nicole A.; Volk, Talila; Fraser, Barbara; Quinn, Leonie M.; McLaughlin, Eileen A.; Hime, Gary R.			HOW Is Required for Stem Cell Maintenance in the Drosophila Testis and for the Onset of Transit-Amplifying Divisions	CELL STEM CELL			English	Article							RNA-BINDING PROTEIN; DEVELOPMENTAL REGULATORS; SELF-RENEWAL; 2 ISOFORMS; GERM-CELL; CYCLIN-A; DIFFERENTIATION; SPERMATOGENESIS; PROLIFERATION; DEGRADATION	The mechanisms by which germline stem cells (GSCs) in the Drosophila testis undergo asymmetric division to regenerate a stem cell as well as a daughter (gonialblast) that will only undergo a further four mitotic divisions prior to entering premeiotic S phase and differentiating into a cyst of spermatocytes are not fully resolved. Here we demonstrate that the HOW RNA-binding protein is required for maintenance of CycB and therefore mitotic progression in GSCs and gonialblasts as well as determining the timing of the spermatogonial divisions. HOW is normally expressed in a complementary pattern to Barn in the germline and barn mRNA is bound by HOW in vivo. Ectopic expression of the HOW(L) isoform is associated with a delay in accumulation of Barn to the level required for differentiation, resulting in extra mitotic divisions. Spatiotemporal regulation of HOW expression is therefore required to specify the four spermatogonial transit-amplifying divisions.	[Monk, Adrian C.; Siddall, Nicole A.; Quinn, Leonie M.; Hime, Gary R.] Univ Melbourne, Dept Anat & Cell Biol, Melbourne, Vic 3010, Australia; [Monk, Adrian C.; Siddall, Nicole A.; Fraser, Barbara; McLaughlin, Eileen A.; Hime, Gary R.] ARC Ctr Excellence Biotechnol & Dev, Callaghan, NSW 2308, Australia; [Volk, Talila] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel; [Fraser, Barbara; McLaughlin, Eileen A.] Univ Newcastle, Sch Environm & Life Sci, Callaghan, NSW 2308, Australia	University of Melbourne; Weizmann Institute of Science; University of Newcastle	Hime, GR (corresponding author), Univ Melbourne, Dept Anat & Cell Biol, Melbourne, Vic 3010, Australia.		Hime, Gary/B-7162-2015; McLaughlin, Eileen A/G-7620-2013; McLaughlin, Eileen/AAF-5588-2021	Hime, Gary/0000-0003-4732-3184; Quinn, Leonie/0000-0002-3911-6508; McLaughlin, Eileen/0000-0002-5837-3876	ARC Centre of Excellence in Biotechnology and Development; NHMRC	ARC Centre of Excellence in Biotechnology and Development(Australian Research Council); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	We would like to thank the Developmental Studies Hybridoma Bank, Bloomington Drosophila Stock Center, Vienna Drosophila RNAi Centre, Australian Biomedical Drosophila Research Facility, Eric Baehrecke, Dennis McKearin, Helen White-Cooper, Zhi-Chun Lai, Helena Richardson. Ruth Lehmann, Shigeo Hayashi, Ting Xie. and David Glover for fly strains and antibodies We thank Ben Britten Smith for image analysis software We thank members of the G R H laboratory for ideas and technical help This work was supported by the ARC Centre of Excellence in Biotechnology and Development and partly by an NHMRC project grant awarded to G R H	Asaoka-Taguchi M, 1999, NAT CELL BIOL, V1, P431, DOI 10.1038/15666; Baehrecke EH, 1997, DEVELOPMENT, V124, P1323; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Brawley C, 2004, SCIENCE, V304, P1331, DOI 10.1126/science.1097676; Bunt SM, 2004, GENESIS, V39, P84, DOI 10.1002/gene.20030; Chen DH, 2003, DEVELOPMENT, V130, P1159, DOI 10.1242/dev.00325; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Edgar BA, 1996, GENE DEV, V10, P1966, DOI 10.1101/gad.10.15.1966; Fuller Margaret T., 1993, P71; Gonczy P, 1996, DEVELOPMENT, V122, P2437; Grewal SS, 2005, NAT CELL BIOL, V7, P295, DOI 10.1038/ncb1223; Hatfield SD, 2005, NATURE, V435, P974, DOI 10.1038/nature03816; Insco ML, 2009, P NATL ACAD SCI USA, V106, P22311, DOI 10.1073/pnas.0912454106; Kawase E, 2004, DEVELOPMENT, V131, P1365, DOI 10.1242/dev.01025; Kiger AA, 2000, NATURE, V407, P750, DOI 10.1038/35037606; Krause DS, 2002, ONCOGENE, V21, P3262, DOI 10.1038/sj.onc.1205316; Leatherman JL, 2008, CELL STEM CELL, V3, P44, DOI 10.1016/j.stem.2008.05.001; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Lilly MA, 2000, DEV BIOL, V218, P53, DOI 10.1006/dbio.1999.9570; McCall K, 2004, METH MOL B, V247, P431; Nabel-Rosen H, 2005, CURR BIOL, V15, P295, DOI 10.1016/j.cub.2005.01.045; Nabel-Rosen H, 1999, MOL CELL, V4, P573, DOI 10.1016/S1097-2765(00)80208-7; Nabel-Rosen H, 2002, DEV CELL, V2, P183, DOI 10.1016/S1534-5807(01)00118-6; Prout M, 1997, GENETICS, V146, P275; Quinn LM, 2001, GENE DEV, V15, P2741, DOI 10.1101/gad.916201; Sarkar A, 2007, CURR BIOL, V17, P1253, DOI 10.1016/j.cub.2007.06.048; Shivdasani AA, 2003, CURR BIOL, V13, P2065, DOI 10.1016/j.cub.2003.10.063; Siddall NA, 2006, P NATL ACAD SCI USA, V103, P8402, DOI 10.1073/pnas.0600906103; SIGRIST S, 1995, EMBO J, V14, P4827, DOI 10.1002/j.1460-2075.1995.tb00164.x; Su TT, 1998, GENE DEV, V12, P1495, DOI 10.1101/gad.12.10.1495; Toledano-Katchalski H, 2007, DEVELOPMENT, V134, P3473, DOI 10.1242/dev.006080; Tran J, 2000, NATURE, V407, P754, DOI 10.1038/35037613; Van Doren M, 1998, CURR BIOL, V8, P243; Volk T, 2008, TRENDS GENET, V24, P94, DOI 10.1016/j.tig.2007.11.009; White-Cooper H, 1998, DEVELOPMENT, V125, P125; Xie T, 2005, DEV DYNAM, V232, P775, DOI 10.1002/dvdy.20317	36	35	37	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	APR 2	2010	6	4					348	360		10.1016/j.stem.2010.02.016	http://dx.doi.org/10.1016/j.stem.2010.02.016			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	585KD	20362539	Bronze			2022-12-24	WOS:000276823300013
J	Suh, YH; Terashima, A; Petralia, RS; Wenthold, RJ; Isaac, JTR; Roche, KW; Roche, PA				Suh, Young Ho; Terashima, Akira; Petralia, Ronald S.; Wenthold, Robert J.; Isaac, John T. R.; Roche, Katherine W.; Roche, Paul A.			A neuronal role for SNAP-23 in postsynaptic glutamate receptor trafficking	NATURE NEUROSCIENCE			English	Article							SYNAPTOSOMAL-ASSOCIATED PROTEIN; MEMBRANE-FUSION; NMDA RECEPTORS; AMPA; EXOCYTOSIS; MECHANISMS; BINDING; INTERNALIZATION; IDENTIFICATION; LOCALIZATION	Regulated exocytosis is essential for many biological processes and many components of the protein trafficking machinery are ubiquitous. However, there are also exceptions, such as SNAP-25, a neuron-specific SNARE protein that is essential for synaptic vesicle release from presynaptic nerve terminals. In contrast, SNAP-23 is a ubiquitously expressed SNAP-25 homolog that is critical for regulated exocytosis in non-neuronal cells. However, the role of SNAP-23 in neurons has not been elucidated. We found that SNAP-23 was enriched in dendritic spines and colocalized with constituents of the postsynaptic density, whereas SNAP-25 was restricted to axons. In addition, loss of SNAP-23 using genetically altered mice or shRNA targeted to SNAP-23 led to a marked decrease in NMDA receptor surface expression and NMDA receptor currents, whereas loss of SNAP-25 did not. SNAP-23 is therefore important for the functional regulation of postsynaptic glutamate receptors.	[Suh, Young Ho; Roche, Katherine W.] Natl Inst Neurol Disorders & Stroke, Receptor Biol Sect, Bethesda, MD 20824 USA; [Suh, Young Ho; Roche, Paul A.] NCI, Expt Immunol Branch, Bethesda, MD 20892 USA; [Terashima, Akira; Isaac, John T. R.] Natl Inst Neurol Disorders & Stroke, Dev Synapt Plast Sect, Bethesda, MD USA; [Petralia, Ronald S.; Wenthold, Robert J.] Natl Inst Deafness & Other Commun Disorders, NIH, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD)	Roche, KW (corresponding author), Natl Inst Neurol Disorders & Stroke, Receptor Biol Sect, Bethesda, MD 20824 USA.	rochek@ninds.nih.gov; paul.roche@nih.gov	Roche, Katherine/W-9893-2019	Roche, Katherine/0000-0001-7282-6539; Roche, Paul/0000-0002-8949-9172	National Cancer Institute Intramural Research Program; National Institute of Neurological Disorders and Stroke Intramural Research Program; Integrative Neural Immune Program; National Institute on Deafness and other Communication Disorders; NATIONAL CANCER INSTITUTE [ZIABC011035, ZIABC009404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003035, ZIANS002994] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [ZIADC000003] Funding Source: NIH RePORTER	National Cancer Institute Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Neurological Disorders and Stroke Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Integrative Neural Immune Program; National Institute on Deafness and other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank Y.-X. Wang for help with immunogold labeling, J.D. Badger II for preparing primary neuron cultures and M. Park ( Stanford University) for helpful technical comments. We also thank the National Institute of Neurological Disorders and Stroke Light Imaging Facility, particularly C. Smith. In addition, we would like to acknowledge the National Institute of Neurological Disorders and Stroke sequencing facility. This research was supported by the National Cancer Institute Intramural Research Program (P. A. R.), the National Institute of Neurological Disorders and Stroke Intramural Research Program (Y.H.S. and K. W. R.), the Integrative Neural Immune Program (Y.H.S. fellowship), and the intramural program of the National Institute on Deafness and other Communication Disorders (R. S. P. and R.J.W.).	Bragina L, 2007, NEUROSCIENCE, V146, P1829, DOI 10.1016/j.neuroscience.2007.02.060; Cahill AL, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-9; CARLIN RK, 1980, J CELL BIOL, V86, P831, DOI 10.1083/jcb.86.3.831; Chen D, 1999, BRAIN RES, V831, P11, DOI 10.1016/S0006-8993(99)01371-2; Chen D, 2000, BLOOD, V95, P921, DOI 10.1182/blood.V95.3.921.003k17_921_929; DUC C, 1995, J COMP NEUROL, V356, P152, DOI 10.1002/cne.903560111; FOSTER LJ, 1999, AM J PHYSIOL, V276, P1108; Groc L, 2006, CELL TISSUE RES, V326, P423, DOI 10.1007/s00441-006-0254-9; Guo ZH, 1998, CELL, V94, P537, DOI 10.1016/S0092-8674(00)81594-9; HAYASHI T, 1994, EMBO J, V13, P5051, DOI 10.1002/j.1460-2075.1994.tb06834.x; Jahn R, 1999, ANNU REV BIOCHEM, V68, P863, DOI 10.1146/annurev.biochem.68.1.863; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Lan JY, 2001, J NEUROSCI, V21, P6058, DOI 10.1523/JNEUROSCI.21-16-06058.2001; Lan JY, 2001, NAT NEUROSCI, V4, P382, DOI 10.1038/86028; Lau CG, 2007, NAT REV NEUROSCI, V8, P413, DOI 10.1038/nrn2153; Lavezzari G, 2004, J NEUROSCI, V24, P6383, DOI 10.1523/JNEUROSCI.1890-04.2004; Leung SM, 1998, J BIOL CHEM, V273, P17732, DOI 10.1074/jbc.273.28.17732; Lin RC, 2000, ANNU REV CELL DEV BI, V16, P19, DOI 10.1146/annurev.cellbio.16.1.19; Lledo PM, 1998, SCIENCE, V279, P399, DOI 10.1126/science.279.5349.399; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; Mayer A, 2002, ANNU REV CELL DEV BI, V18, P289, DOI 10.1146/annurev.cellbio.18.032202.114809; Nishimune A, 1998, NEURON, V21, P87, DOI 10.1016/S0896-6273(00)80517-6; Osten P, 1998, NEURON, V21, P99, DOI 10.1016/S0896-6273(00)80518-8; OYLER GA, 1991, P NATL ACAD SCI USA, V88, P5247, DOI 10.1073/pnas.88.12.5247; OYLER GA, 1989, J CELL BIOL, V109, P3039, DOI 10.1083/jcb.109.6.3039; Petralia RS, 2005, MOL CELL NEUROSCI, V29, P436, DOI 10.1016/j.mcn.2005.03.013; Petralia RS, 2003, EUR J NEUROSCI, V18, P3207, DOI 10.1111/j.1460-9568.2003.03074.x; Petralia RS, 1999, METH MOL B, V128, P73; Ravichandran V, 1996, J BIOL CHEM, V271, P13300, DOI 10.1074/jbc.271.23.13300; Roche KW, 2001, NAT NEUROSCI, V4, P794, DOI 10.1038/90498; Sadoul K, 1997, J BIOL CHEM, V272, P33023, DOI 10.1074/jbc.272.52.33023; Sans N, 2003, NAT CELL BIOL, V5, P520, DOI 10.1038/ncb990; Schluter OM, 2006, NEURON, V51, P99, DOI 10.1016/j.neuron.2006.05.016; Scott DB, 2004, J NEUROSCI, V24, P7096, DOI 10.1523/JNEUROSCI.0780-04.2004; Selak S, 2009, NEURON, V63, P357, DOI 10.1016/j.neuron.2009.07.017; Song I, 1998, NEURON, V21, P393, DOI 10.1016/S0896-6273(00)80548-6; Suh YH, 2008, NEURON, V58, P736, DOI 10.1016/j.neuron.2008.03.028; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Tao-Cheng JH, 2000, J NEUROCYTOL, V29, P67, DOI 10.1023/A:1007168231323; Terashima A, 2008, NEURON, V57, P872, DOI 10.1016/j.neuron.2008.01.028; Tovar KR, 2002, NEURON, V34, P253; Vaidyanathan VV, 2000, GENE, V247, P181, DOI 10.1016/S0378-1119(00)00100-1; Vaidyanathan VV, 2001, J BIOL CHEM, V276, P25101, DOI 10.1074/jbc.M103536200; Verderio C, 2004, NEURON, V41, P599, DOI 10.1016/S0896-6273(04)00077-7; Washbourne P, 2002, NAT NEUROSCI, V5, P19, DOI 10.1038/nn783; Washbourne P, 2004, J NEUROSCI, V24, P8253, DOI 10.1523/JNEUROSCI.2555-04.2004; Wenthold RJ, 2003, ANNU REV PHARMACOL, V43, P335, DOI 10.1146/annurev.pharmtox.43.100901.135803; Yi ZH, 2007, J NEUROSCI, V27, P11663, DOI 10.1523/JNEUROSCI.3252-07.2007	48	95	95	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2010	13	3					338	U16		10.1038/nn.2488	http://dx.doi.org/10.1038/nn.2488			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	559WW	20118925	Green Accepted			2022-12-24	WOS:000274860100016
J	Axmacher, N; Cohen, MX; Fell, J; Haupt, S; Dumpelmann, M; Elger, CE; Schlaepfer, TE; Lenartz, D; Sturm, V; Ranganath, C				Axmacher, Nikolai; Cohen, Michael X.; Fell, Juergen; Haupt, Sven; Dumpelmann, Matthias; Elger, Christian E.; Schlaepfer, Thomas E.; Lenartz, Doris; Sturm, Volker; Ranganath, Charan			Intracranial EEG Correlates of Expectancy and Memory Formation in the Human Hippocampus and Nucleus Accumbens	NEURON			English	Article							VENTRAL TEGMENTAL AREA; DEEP BRAIN-STIMULATION; TEMPORAL-LOBE EPILEPSY; THETA-RHYTHM; INTRACEREBRAL POTENTIALS; CHOLINERGIC INDUCTION; DECISION-MAKING; VISUAL-STIMULI; RARE TARGET; DOPAMINE	The human brain is adept at anticipating upcoming events, but in a rapidly changing world, it is essential to detect and encode events that violate these expectancies. Unexpected events are more likely to be remembered than predictable events, but the underlying neural mechanisms for these effects remain unclear. We report intracranial EEG recordings from the hippocampus of epilepsy patients, and from the nucleus accumbens of depression patients. We found that unexpected stimuli enhance an early (187 ms) and a late (482 ms) hippocampal potential, and that the late potential is associated with successful memory encoding for these stimuli. Recordings from the nucleus accumbens revealed a late potential (peak at 475 ms), which increases in magnitude during unexpected items, but no subsequent memory effect and no early component. These results are consistent with the hypothesis that activity in a loop involving the hippocampus and the nucleus accumbens promotes encoding of unexpected events.	[Axmacher, Nikolai; Fell, Juergen; Haupt, Sven; Elger, Christian E.] Univ Bonn, Dept Epileptol, D-53105 Bonn, Germany; [Schlaepfer, Thomas E.] Univ Bonn, Dept Psychiat & Psychotherapy, D-53105 Bonn, Germany; [Axmacher, Nikolai; Elger, Christian E.] Life & Brain Ctr Acad Res, D-53105 Bonn, Germany; [Ranganath, Charan] Univ Calif Davis, Dept Psychol, Davis, CA 95616 USA; [Ranganath, Charan] Univ Calif Davis, Ctr Neurosci, Davis, CA 95616 USA; [Dumpelmann, Matthias] Univ Hosp Freiburg, Epilepsy Ctr, D-79106 Freiburg, Germany; [Lenartz, Doris; Sturm, Volker] Univ Cologne, Dept Stereotact Neurosurg, D-50937 Cologne, Germany; [Cohen, Michael X.] Univ Amsterdam, Dept Psychol, NL-1018 WB Amsterdam, Netherlands; [Cohen, Michael X.] Univ Arizona, Dept Physiol, Tucson, AZ 85724 USA; [Schlaepfer, Thomas E.] Johns Hopkins Univ, Dept Mental Hlth, Baltimore, MD 21287 USA; [Schlaepfer, Thomas E.] Johns Hopkins Univ, Dept Psychiat, Baltimore, MD 21287 USA	University of Bonn; University of Bonn; University of California System; University of California Davis; University of California System; University of California Davis; University of Freiburg; University of Cologne; University of Amsterdam; University of Arizona; Johns Hopkins University; Johns Hopkins University	Axmacher, N (corresponding author), Univ Bonn, Dept Epileptol, D-53105 Bonn, Germany.		Cohen, Michael X/H-8748-2019; Cohen, Michael/A-3092-2016; Schlaepfer, Thomas/A-2604-2008; Duempelmann, Matthias/K-2583-2012	Cohen, Michael X/0000-0002-1879-3593; Cohen, Michael/0000-0002-1879-3593; Schlaepfer, Thomas/0000-0003-0612-9692; Duempelmann, Matthias/0000-0002-1476-7777; Axmacher, Nikolai/0000-0002-0475-6492	NIH [MH68721 N A]; Volkswagen Foundation [1/79878]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH068721, R01MH083734] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Volkswagen Foundation(Volkswagen); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank Gregor Rainer for designing the stimuli and Bernhard Staresina for helpful comments during revision C R was supported by NIH grant MH68721 N A. and J F received funding from the Volkswagen Foundation, Grant number 1/79878 The clinical part of the depression study has been partly funded through an IT by Medtronic Inc to T E S and V S The sponsor had no influence on any aspect of design, analysis, interpretation, writing, and submission of this study	ACQUAS E, 1994, EUR J PHARMACOL, V260, P85, DOI 10.1016/0014-2999(94)90013-2; Alain C, 1998, BRAIN RES, V812, P23, DOI 10.1016/S0006-8993(98)00851-8; [Anonymous], 1975, CURRENT DEV PSYCHOPH; Axmacher N, 2009, BEHAV BRAIN RES, V200, P1, DOI 10.1016/j.bbr.2009.01.028; BAUDENA P, 1995, ELECTROEN CLIN NEURO, V94, P251, DOI 10.1016/0013-4694(95)98476-O; Bewernick BH, 2010, BIOL PSYCHIAT, V67, P110, DOI 10.1016/j.biopsych.2009.09.013; Block AE, 2007, CEREB CORTEX, V17, P1625, DOI 10.1093/cercor/bhl073; BRAZHNIK ES, 1993, NEUROSCIENCE, V53, P961, DOI 10.1016/0306-4522(93)90481-T; Bunzeck N, 2006, NEURON, V51, P369, DOI 10.1016/j.neuron.2006.06.021; Buracas GT, 2002, NEUROIMAGE, V16, P801, DOI 10.1006/nimg.2002.1116; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; CAMMANN R, 1990, BEHAV BRAIN SCI, V13, P234, DOI 10.1017/S0140525X00078420; Chapman CA, 1999, J NEUROSCI, V19, P8637; Cohen MX, 2009, J NEUROSCI, V29, P7591, DOI 10.1523/JNEUROSCI.5335-08.2009; Cohen MX, 2009, NEUROPSYCHOPHARMACOL, V34, P1649, DOI 10.1038/npp.2008.222; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Dumpelmann M, 2009, CLIN NEUROPHYSIOL, V120, P1061, DOI 10.1016/j.clinph.2009.03.014; Dunlop BW, 2007, ARCH GEN PSYCHIAT, V64, P327, DOI 10.1001/archpsyc.64.3.327; Fell J, 2004, J COGNITIVE NEUROSCI, V16, P1595, DOI 10.1162/0898929042568514; Fellous JM, 2000, HIPPOCAMPUS, V10, P187, DOI 10.1002/(SICI)1098-1063(2000)10:2<187::AID-HIPO8>3.3.CO;2-D; Fernandez G, 1999, SCIENCE, V285, P1582, DOI 10.1126/science.285.5433.1582; Fitch TE, 2006, J NEUROPHYSIOL, V95, P2808, DOI 10.1152/jn.01210.2005; Floresco SB, 2003, NAT NEUROSCI, V6, P968, DOI 10.1038/nn1103; Floresco SB, 2001, J NEUROSCI, V21, P4915, DOI 10.1523/JNEUROSCI.21-13-04915.2001; Friston KJ, 2005, PHILOS T R SOC B, V360, P815, DOI 10.1098/rstb.2005.1622; Fuchs M, 2007, J CLIN NEUROPHYSIOL, V24, P101, DOI 10.1097/WNP.0b013e318038fb3e; Goto Y, 2005, NAT NEUROSCI, V8, P805, DOI 10.1038/nn1471; GROSSBERG C, 2003, ENCY COGNITIVE SCI; GROSSBERG S, 1976, BIOL CYBERN, V23, P187; Grunwald T, 1999, EUR J NEUROSCI, V11, P1899, DOI 10.1046/j.1460-9568.1999.00613.x; HALGREN E, 1980, SCIENCE, V210, P803, DOI 10.1126/science.7434000; HALGREN E, 1995, ELECTROEN CLIN NEURO, V94, P191, DOI 10.1016/0013-4694(94)00259-N; Hasson U, 2004, SCIENCE, V303, P1634, DOI 10.1126/science.1089506; Huynh H, 1976, J EDUC STATIST, V1, P69, DOI DOI 10.3102/10769986001001069; Knight RT, 1996, NATURE, V383, P256, DOI 10.1038/383256a0; KNIGHT RT, 1984, ELECTROEN CLIN NEURO, V59, P9, DOI 10.1016/0168-5597(84)90016-9; KNIGHT RT, 1989, BRAIN RES, V502, P109, DOI 10.1016/0006-8993(89)90466-6; Knutson B, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-16-j0002.2001; Lansink CS, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000173; Legault M, 2001, EUR J NEUROSCI, V13, P819, DOI 10.1046/j.0953-816x.2000.01448.x; Lemon N, 2006, J NEUROSCI, V26, P7723, DOI 10.1523/JNEUROSCI.1454-06.2006; Li SM, 2003, NAT NEUROSCI, V6, P526, DOI 10.1038/nn1049; Lin SC, 2008, NEURON, V59, P138, DOI 10.1016/j.neuron.2008.04.031; Lin SC, 2006, J NEUROPHYSIOL, V96, P3209, DOI 10.1152/jn.00524.2006; Lindenberger U, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-22; Lisman JE, 2005, NEURON, V46, P703, DOI 10.1016/j.neuron.2005.05.002; MARCIANI MG, 1984, NEUROPHARMACOLOGY, V23, P303, DOI 10.1016/0028-3908(84)90191-6; Montague PR, 1996, J NEUROSCI, V16, P1936, DOI 10.1523/jneurosci.16-05-01936.1996; Munte TF, 2008, FRONT HUM NEUROSCI, V1, DOI 10.3389/neuro.09.011.2007; NAATANEN R, 1978, ACTA PSYCHOL, V42, P313, DOI 10.1016/0001-6918(78)90006-9; Orzel-Gryglewska J, 2006, BRAIN RES BULL, V68, P295, DOI 10.1016/j.brainresbull.2005.08.026; PALLER KA, 1992, ELECTROEN CLIN NEURO, V84, P269, DOI 10.1016/0168-5597(92)90008-Y; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Ranganath C, 2003, NAT REV NEUROSCI, V4, P193, DOI 10.1038/nrn1052; Rescorla R., 1972, CLASSICAL CONDITION, DOI DOI 10.1101/GR.110528.110; Schacter DL, 2007, NAT REV NEUROSCI, V8, P657, DOI 10.1038/nrn2213; Schlaepfer TE, 2008, NEUROPSYCHOPHARMACOL, V33, P368, DOI 10.1038/sj.npp.1301408; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; SMITH ME, 1990, ELECTROEN CLIN NEURO, V76, P235, DOI 10.1016/0013-4694(90)90018-F; Soltani Maryam, 2000, Critical Reviews in Neurobiology, V14, P199; Sturm V, 2003, J CHEM NEUROANAT, V26, P293, DOI 10.1016/j.jchemneu.2003.09.003; SUTTON S, 1965, SCIENCE, V150, P1187, DOI 10.1126/science.150.3700.1187; Tabuchi ET, 2000, HIPPOCAMPUS, V10, P717, DOI 10.1002/1098-1063(2000)10:6<717::AID-HIPO1009>3.0.CO;2-3; Thierry AM, 2000, HIPPOCAMPUS, V10, P411, DOI 10.1002/1098-1063(2000)10:4<411::AID-HIPO7>3.0.CO;2-A; Truccolo WA, 2002, CLIN NEUROPHYSIOL, V113, P206, DOI 10.1016/S1388-2457(01)00739-8; Tulving E, 1996, CEREB CORTEX, V6, P71, DOI 10.1093/cercor/6.1.71; Van Roost D, 1998, NEUROSURGERY, V43, P819, DOI 10.1097/00006123-199810000-00058; Vanni-Mercier G, 2009, J NEUROSCI, V29, P5287, DOI 10.1523/JNEUROSCI.5298-08.2009; von Restorff H, 1933, PSYCHOL FORSCH, V18, P299, DOI 10.1007/BF02409636; Wittmann BC, 2008, NEURON, V58, P967, DOI 10.1016/j.neuron.2008.04.027; Yoder RM, 2005, HIPPOCAMPUS, V15, P381, DOI 10.1002/hipo.20062; Yonelinas AP, 2001, PHILOS T R SOC B, V356, P1363, DOI 10.1098/rstb.2001.0939; Zaghloul KA, 2009, SCIENCE, V323, P1496, DOI 10.1126/science.1167342; Zink CF, 2006, NEUROIMAGE, V29, P977, DOI 10.1016/j.neuroimage.2005.08.006; Zink CF, 2003, J NEUROSCI, V23, P8092	75	118	120	2	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 25	2010	65	4					541	549		10.1016/j.neuron.2010.02.006	http://dx.doi.org/10.1016/j.neuron.2010.02.006			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	566HD	20188658	Bronze			2022-12-24	WOS:000275359800012
J	Drinjakovic, J; Jung, HS; Campbell, DS; Strochlic, L; Dwivedy, A; Holt, CE				Drinjakovic, Jovana; Jung, Hosung; Campbell, Douglas S.; Strochlic, Laure; Dwivedy, Asha; Holt, Christine E.			E3 Ligase Nedd4 Promotes Axon Branching by Downregulating PTEN	NEURON			English	Article							RETINAL GROWTH CONES; RETINOTECTAL SYNAPTIC CONNECTIVITY; UBIQUITIN LIGASE; IN-VIVO; TUMOR-SUPPRESSOR; XENOPUS EMBRYOS; CHEMOTROPIC RESPONSES; PROTEIN-SYNTHESIS; ZEBRAFISH RETINA; VISUAL-SYSTEM	Regulated protein degradation via the ubiquitin-proteasome system (UPS) plays a central role in building synaptic connections, yet little is known about either which specific UPS components are involved or UPS targets in neurons. We report that inhibiting the UPS in developing Xenopus retinal ganglion cells (RGCs) with a dominant-negative ubiquitin mutant decreases terminal branching in the tectum but does not affect long-range navigation to the tectum. We identify Nedd4 as a prominently expressed E3 ligase in RGC axon growth cones and show that disrupting its function severely inhibits terminal branching. We further demonstrate that PTEN, a negative regulator of the PI3K pathway, is a key downstream target of Nedd4: not only does Nedd4 regulate PTEN levels in RGC growth cones, but also, the decrease of PTEN rescues the branching defect caused by Nedd4 inhibition. Together our data suggest that Nedd4-regulated PTEN is a key regulator of terminal arborization in vivo.	[Drinjakovic, Jovana; Jung, Hosung; Campbell, Douglas S.; Strochlic, Laure; Dwivedy, Asha; Holt, Christine E.] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 3DY, England	University of Cambridge	Holt, CE (corresponding author), Univ Cambridge, Dept Physiol Dev & Neurosci, Downing St, Cambridge CB2 3DY, England.	ceh@mole.bio.cam.ac.uk	Strochlic, Laure/J-3610-2017; Jung, Hosung/A-4401-2012	Strochlic, Laure/0000-0001-5373-4284; Jung, Hosung/0000-0002-5059-8050; Holt, Christine Elizabeth/0000-0003-2829-121X; Campbell, Douglas/0000-0002-7371-9484	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	We thank R. Kopito for UbWT and UbK48R constructs; A. Phillbott and B. Eickholt for valuable input on the work; J. Falk, K. Joubin, and G. Stooke-Vaughan for technical assistance; L. Poggi for help with imaging; K.-M. Leung and A. Lin for help with data analysis; J. Alsio for sharing dynamic imaging data; and W. Harris, J, Falk, A. Lin, H. Lynn, and A. Fraser for invaluable insights and critical reading of the manuscript. This work was supported by Wellcome Trust Programme Grants to C.E.H. and by a Wellcome Trust Ph.D. Studentship to J.D.	Ahn Y, 2008, BIOCHEM J, V412, P331, DOI 10.1042/BJ20071403; Alsina B, 2001, NAT NEUROSCI, V4, P1093, DOI 10.1038/nn735; Arevalo JC, 2006, NEURON, V50, P549, DOI 10.1016/j.neuron.2006.03.044; Bloom AJ, 2007, GENE DEV, V21, P2593, DOI 10.1101/gad.1592107; Brose K, 2000, CURR OPIN NEUROBIOL, V10, P95, DOI 10.1016/S0959-4388(99)00066-5; Campbell DS, 2007, NEURON, V55, P231, DOI 10.1016/j.neuron.2007.06.034; Campbell DS, 2003, NEURON, V37, P939, DOI 10.1016/S0896-6273(03)00158-2; Campbell DS, 2001, NEURON, V32, P1013, DOI 10.1016/S0896-6273(01)00551-7; Campbell DS, 2001, J NEUROSCI, V21, P8538, DOI 10.1523/JNEUROSCI.21-21-08538.2001; COHENCORY S, 1994, NEURON, V12, P747, DOI 10.1016/0896-6273(94)90328-X; COHENCORY S, 1995, NATURE, V378, P192, DOI 10.1038/378192a0; Colon-Ramos DA, 2007, SCIENCE, V318, P103, DOI 10.1126/science.1143762; Cosker KE, 2007, BIOCHEM SOC T, V35, P207, DOI 10.1042/BST0350207; Crowder RJ, 2000, J BIOL CHEM, V275, P34266, DOI 10.1074/jbc.M006160200; Das T, 2003, NEURON, V37, P597, DOI 10.1016/S0896-6273(03)00066-7; de la Torre JR, 1997, NEURON, V19, P1211, DOI 10.1016/S0896-6273(00)80413-4; Dent EW, 2004, J NEUROSCI, V24, P3002, DOI 10.1523/JNEUROSCI.4963-03.2004; DiAntonio A, 2001, NATURE, V412, P449, DOI 10.1038/35086595; Dingwell KS, 2000, J NEUROBIOL, V44, P246; Dunn R, 2001, J BIOL CHEM, V276, P25974, DOI 10.1074/jbc.M104113200; Falk J, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-107; FINLEY D, 1994, MOL CELL BIOL, V14, P5501, DOI 10.1128/MCB.14.8.5501; Fotia AB, 2006, INT J BIOCHEM CELL B, V38, P472, DOI 10.1016/j.biocel.2005.11.006; Fouladkou F, 2008, P NATL ACAD SCI USA, V105, P8585, DOI 10.1073/pnas.0803233105; Gitai Z, 2003, NEURON, V37, P53, DOI 10.1016/S0896-6273(02)01149-2; Glickman MH, 2004, PLOS BIOL, V2, P25, DOI 10.1371/journal.pbio.0020013; Guan KL, 2003, NAT REV NEUROSCI, V4, P941, DOI 10.1038/nrn1254; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Harvey KF, 1998, J BIOL CHEM, V273, P13524, DOI 10.1074/jbc.273.22.13524; Hay N, 2005, CANCER CELL, V8, P179, DOI 10.1016/j.ccr.2005.08.008; HOLT CE, 1990, NEURON, V4, P203, DOI 10.1016/0896-6273(90)90095-W; Ing B, 2007, MOL CELL BIOL, V27, P481, DOI 10.1128/MCB.00463-06; Jaworski J, 2005, J NEUROSCI, V25, P11300, DOI 10.1523/JNEUROSCI.2270-05.2005; Kim D, 2007, DEV BIOL, V307, P290, DOI 10.1016/j.ydbio.2007.04.051; Konishi Y, 2004, SCIENCE, V303, P1026, DOI 10.1126/science.1093712; KUMAR S, 1992, BIOCHEM BIOPH RES CO, V185, P1155, DOI 10.1016/0006-291X(92)91747-E; Kumar S, 1997, GENOMICS, V40, P435, DOI 10.1006/geno.1996.4582; Kwon CH, 2006, NEURON, V50, P377, DOI 10.1016/j.neuron.2006.03.023; Lee JRE, 2009, J BIOL CHEM, V284, P32126, DOI 10.1074/jbc.M109.048629; Leung KM, 2006, NAT NEUROSCI, V9, P1247, DOI 10.1038/nn1775; Lewcock JW, 2007, NEURON, V56, P604, DOI 10.1016/j.neuron.2007.09.009; Liu Y, 2009, DEV BIOL, V330, P153, DOI 10.1016/j.ydbio.2009.03.023; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Manitt C, 2009, J NEUROSCI, V29, P11065, DOI 10.1523/JNEUROSCI.0947-09.2009; Marler KJM, 2008, J NEUROSCI, V28, P12700, DOI 10.1523/JNEUROSCI.1915-08.2008; Marshak S, 2007, J NEUROSCI, V27, P2444, DOI 10.1523/JNEUROSCI.4434-06.2007; Meyer MP, 2006, J NEUROSCI, V26, P3604, DOI 10.1523/JNEUROSCI.0223-06.2006; Moody SA, 2000, METH MOL B, V135, P331; Myat A, 2002, NEURON, V35, P447, DOI 10.1016/S0896-6273(02)00795-X; Narimatsu M, 2009, CELL, V137, P295, DOI 10.1016/j.cell.2009.02.025; Nieuwkoop P.D., 1967, NORMAL TABLE XENOPUS; Park KK, 2008, SCIENCE, V322, P963, DOI 10.1126/science.1161566; Patrick GN, 2003, CURR BIOL, V13, P2073, DOI 10.1016/j.cub.2003.10.028; Piper M, 2005, NAT NEUROSCI, V8, P179, DOI 10.1038/nn1380; Piper M, 2006, NEURON, V49, P215, DOI 10.1016/j.neuron.2005.12.008; Plant PJ, 1997, J BIOL CHEM, V272, P32329, DOI 10.1074/jbc.272.51.32329; Poggi L, 2005, J CELL BIOL, V171, P991, DOI 10.1083/jcb.200509098; ROSKIES AL, 1994, SCIENCE, V265, P799, DOI 10.1126/science.8047886; Ruthazer ES, 2006, J NEUROSCI, V26, P3594, DOI 10.1523/JNEUROSCI.0069-06.2006; Schaefer AM, 2000, NEURON, V26, P345, DOI 10.1016/S0896-6273(00)81168-X; Schmitz C, 2007, P NATL ACAD SCI USA, V104, P834, DOI 10.1073/pnas.0510527104; Shewan D, 2002, NAT NEUROSCI, V5, P955, DOI 10.1038/nn919; Sieburth D, 2005, NATURE, V436, P510, DOI 10.1038/nature03809; Smear MC, 2007, NEURON, V53, P65, DOI 10.1016/j.neuron.2006.12.013; THOMAS JB, 1984, J NEUROSCI, V4, P530; Ueno S, 2006, DEV BIOL, V297, P274, DOI 10.1016/j.ydbio.2006.06.001; van Roessel P, 2004, CELL, V119, P707, DOI 10.1016/j.cell.2004.11.028; Vignali R, 2000, DEVELOPMENT, V127, P1455; Walz A, 1997, DEVELOPMENT, V124, P2421; Wan HI, 2000, NEURON, V26, P313, DOI 10.1016/S0896-6273(00)81166-6; Wang GX, 2005, NATURE, V434, P898, DOI 10.1038/nature03478; Wang KH, 1999, CELL, V96, P771, DOI 10.1016/S0092-8674(00)80588-7; Wang XJ, 2008, BIOCHEM J, V414, P221, DOI 10.1042/BJ20080674; Wang XJ, 2007, CELL, V128, P129, DOI 10.1016/j.cell.2006.11.039; Yao JQ, 2006, NAT NEUROSCI, V9, P1265, DOI 10.1038/nn1773; Yi JJ, 2007, PHARMACOL REV, V59, P14, DOI 10.1124/pr.59.1.4; Yim EK, 2009, CANCER CELL, V15, P304, DOI 10.1016/j.ccr.2009.02.012; Zhen M, 2000, NEURON, V26, P331, DOI 10.1016/S0896-6273(00)81167-8	78	152	152	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 11	2010	65	3					341	357		10.1016/j.neuron.2010.01.017	http://dx.doi.org/10.1016/j.neuron.2010.01.017			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	564BF	20159448	hybrid, Green Published			2022-12-24	WOS:000275185200008
J	Crockin, SL				Crockin, Susan L.			A Legal Defense for Compensating Research Egg Donors	CELL STEM CELL			English	Editorial Material							STEM-CELLS; PAYMENT	Given the continued need for human eggs for hESCs, this article analyzes and refutes the legal theories against compensating research egg donors, contrasts the legal histories of compensating reproductive donors and human subjects with noncompensation for ESC donors, and suggests that limited compensation is legally defensible.	Crockin Law & Policy Grp LLC, Newton, MA 02460 USA		Crockin, SL (corresponding author), Crockin Law & Policy Grp LLC, 29 Crafts St,Suite 500, Newton, MA 02460 USA.	scrockin@crockinlaw.com						*AM SOC REPR MED P, 2006, FERTIL STERIL, V86, pS38; Chong S, 2006, SCIENCE, V311, P22, DOI 10.1126/science.311.5757.22; Cibelli J, 2009, CELL STEM CELL, V5, P345, DOI 10.1016/j.stem.2009.09.009; Ethics Comm Amer Soc Reprod Med, 2007, FERTIL STERIL, V88, P305, DOI 10.1016/j.fertnstert2007.01.104; Grady C, 2005, J CLIN INVEST, V115, P1681, DOI 10.1172/JCI25694; Hutt Leah E, 2003, Health Law Rev, V12, P16; Hyun I, 2006, NATURE, V442, P629, DOI 10.1038/442629a; Klitzman R, 2009, REPROD BIOMED ONLINE, V18, P603, DOI 10.1016/S1472-6483(10)60002-8; Vogel G, 2006, SCIENCE, V313, P155	9	10	10	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	FEB 5	2010	6	2					99	102		10.1016/j.stem.2010.01.010	http://dx.doi.org/10.1016/j.stem.2010.01.010			4	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	555OC	20144783	Bronze			2022-12-24	WOS:000274520800005
J	Arendt, KL; Royo, M; Fernandez-Monreal, M; Knafo, S; Petrok, CN; Martens, JR; Esteban, JA				Arendt, Kristin L.; Royo, Maria; Fernandez-Monreal, Monica; Knafo, Shira; Petrok, Cortney N.; Martens, Jeffrey R.; Esteban, Jose A.			PIP3 controls synaptic function by maintaining AMPA receptor clustering at the postsynaptic membrane	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; CULTURED HIPPOCAMPAL-NEURONS; PLECKSTRIN-HOMOLOGY DOMAINS; PHOSPHATIDYLINOSITOL 3-KINASE; GLUTAMATE UPTAKE; TRAFFICKING; PLASTICITY; PROTEIN; SYNAPSES; KINASE	Despite their low abundance, phosphoinositides are critical regulators of intracellular signaling and membrane compartmentalization. However, little is known of phosphoinositide function at the postsynaptic membrane. Here we show that continuous synthesis and availability of phosphatidylinositol-(3,4,5)-trisphosphate (PIP3) at the postsynaptic terminal is necessary for sustaining synaptic function in rat hippocampal neurons. This requirement was specific for synaptic, but not extrasynaptic, AMPA receptors, nor for NMDA receptors. PIP3 downregulation impaired PSD-95 accumulation in spines. Concomitantly, AMPA receptors became more mobile and migrated from the postsynaptic density toward the perisynaptic membrane within the spine, leading to synaptic depression. Notably, these effects were only revealed after prolonged inhibition of PIP3 synthesis or by direct quenching of this phosphoinositide at the postsynaptic cell. Therefore, we conclude that a slow, but constant, turnover of PIP3 at synapses is required for maintaining AMPA receptor clustering and synaptic strength under basal conditions.	[Arendt, Kristin L.; Petrok, Cortney N.; Martens, Jeffrey R.; Esteban, Jose A.] Univ Michigan, Sch Med, Dept Pharmacol, Ann Arbor, MI 48109 USA; [Arendt, Kristin L.; Martens, Jeffrey R.; Esteban, Jose A.] Univ Michigan, Sch Med, Neurosci Program, Ann Arbor, MI 48109 USA; [Royo, Maria; Fernandez-Monreal, Monica; Knafo, Shira; Esteban, Jose A.] Univ Autonoma Madrid, CSIC, Ctr Biol Mol Severo Ochoa, Madrid, Spain	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Esteban, JA (corresponding author), Univ Michigan, Sch Med, Neurosci Program, Ann Arbor, MI 48109 USA.	jaesteban@cbm.uam.es	Monreal, Monica Fernandez/P-6685-2019; MD/PhD, Shira Knafo/AAP-5357-2021; Esteban, Jose/L-4944-2014; Fernandez-Monreal, Mónica/I-7954-2012; Royo Cantabrana, Maria/V-7162-2018	Monreal, Monica Fernandez/0000-0001-7278-448X; MD/PhD, Shira Knafo/0000-0002-4478-7584; Esteban, Jose/0000-0002-3759-3300; Fernandez-Monreal, Mónica/0000-0001-7278-448X; Royo Cantabrana, Maria/0000-0003-3289-2624	US National Institute of Mental Health; Dana Foundation; Spanish Ministry of Science and Innovation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH070417] Funding Source: NIH RePORTER	US National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Dana Foundation; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank R. Holz ( University of Michigan) for the plasmid containing the PH-PLC sequence, A. Lee ( University of Michigan) for the plasmid containing the catalytic domain of mouse PI3K (p110 alpha), C. Dotti ( Katholieke Universiteit Leuven) for themembrane-anchored GFP-CAAX construct, R. Malinow ( University of California, San Diego) for the SEP-GluA2 construct and L. Chen ( University of California, Berkeley) for facilitating some of the experiments carried out by K. L. A. We also thank S. Jurado and members of the Esteban laboratory for critical reading of this manuscript, and S. Fisher, E. Stuenkel, G. Murphy and R. Holz for discussions. This work was supported by grants from the US National Institute of Mental Health (J.A.E. and J.R.M.), the Dana Foundation ( J.A.E.) and the Spanish Ministry of Science and Innovation ( J.A.E.). M. F.-M. and S. K. are supported by postdoctoral contracts, and M. R. by a predoctoral fellowship, from the Spanish Ministry of Science and Innovation.	Bats C, 2007, NEURON, V53, P719, DOI 10.1016/j.neuron.2007.01.030; BRIDGES RJ, 1991, J MED CHEM, V34, P717, DOI 10.1021/jm00106a037; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Collingridge GL, 2009, NEUROPHARMACOLOGY, V56, P2, DOI 10.1016/j.neuropharm.2008.06.063; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Ehrlich I, 2004, J NEUROSCI, V24, P916, DOI 10.1523/JNEUROSCI.4733-03.2004; Elias GM, 2006, NEURON, V52, P307, DOI 10.1016/j.neuron.2006.09.012; Gerges NZ, 2006, EMBO J, V25, P1623, DOI 10.1038/sj.emboj.7601065; HARRIS KM, 1992, J NEUROSCI, V12, P2685; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Helms MN, 2005, J BIOL CHEM, V280, P40885, DOI 10.1074/jbc.M509646200; Heo WD, 2006, SCIENCE, V314, P1458, DOI 10.1126/science.1134389; Horne EA, 2007, J NEUROSCI, V27, P3523, DOI 10.1523/JNEUROSCI.4340-06.2007; Horwood JM, 2006, EUR J NEUROSCI, V23, P3375, DOI 10.1111/j.1460-9568.2006.04859.x; ISAACSON JS, 1993, J NEUROPHYSIOL, V70, P2187, DOI 10.1152/jn.1993.70.5.2187; Jaworski J, 2005, J NEUROSCI, V25, P11300, DOI 10.1523/JNEUROSCI.2270-05.2005; Jin WY, 2006, J NEUROSCI, V26, P2380, DOI 10.1523/JNEUROSCI.3503-05.2006; Kennedy MJ, 2006, ANNU REV NEUROSCI, V29, P325, DOI 10.1146/annurev.neuro.29.051605.112808; Klarlund JK, 2000, J BIOL CHEM, V275, P32816, DOI 10.1074/jbc.M002435200; Klippel A, 1996, MOL CELL BIOL, V16, P4117; Kopec CD, 2006, J NEUROSCI, V26, P2000, DOI 10.1523/JNEUROSCI.3918-05.2006; Kumar V, 2005, J NEUROSCI, V25, P11288, DOI 10.1523/JNEUROSCI.2284-05.2005; Li SM, 2009, NEURON, V62, P788, DOI 10.1016/j.neuron.2009.05.012; Lu W, 2009, NEURON, V62, P254, DOI 10.1016/j.neuron.2009.02.027; MAKI R, 1994, J NEUROSCI, V14, P6754; Malinow R, 2000, CURR OPIN NEUROBIOL, V10, P352, DOI 10.1016/S0959-4388(00)00099-4; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Man HY, 2003, NEURON, V38, P611, DOI 10.1016/S0896-6273(03)00228-9; Menager C, 2004, J NEUROCHEM, V89, P109, DOI 10.1046/j.1471-4159.2004.02302.x; Opazo P, 2003, J NEUROSCI, V23, P3679; PHEND KD, 1995, J HISTOCHEM CYTOCHEM, V43, P283, DOI 10.1177/43.3.7532656; Qin Y, 2005, GENE DEV, V19, P2000, DOI 10.1101/gad.342205; Sanna PP, 2002, J NEUROSCI, V22, P3359; Schnell E, 2002, P NATL ACAD SCI USA, V99, P13902, DOI 10.1073/pnas.172511199; Shepherd JD, 2007, ANNU REV CELL DEV BI, V23, P613, DOI 10.1146/annurev.cellbio.23.090506.123516; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Stein V, 2003, J NEUROSCI, V23, P5503; Sutton G, 2002, J NEUROCHEM, V82, P1097, DOI 10.1046/j.1471-4159.2002.01031.x; Tardin C, 2003, EMBO J, V22, P4656, DOI 10.1093/emboj/cdg463; Tomita S, 2003, J CELL BIOL, V161, P805, DOI 10.1083/jcb.200212116; Tong QS, 2004, J BIOL CHEM, V279, P22654, DOI 10.1074/jbc.M401004200; Vanhaesebroeck B, 2001, ANNU REV BIOCHEM, V70, P535, DOI 10.1146/annurev.biochem.70.1.535; Varnai P, 2005, J CELL SCI, V118, P4879, DOI 10.1242/jcs.02606; Wenk MR, 2004, P NATL ACAD SCI USA, V101, P8262, DOI 10.1073/pnas.0401874101; Wenthold RJ, 1996, J NEUROSCI, V16, P1982; Wu L, 2002, NATURE, V419, P947, DOI 10.1038/nature01118; Zimmermann P, 2006, BBA-MOL CELL BIOL L, V1761, P947, DOI 10.1016/j.bbalip.2006.04.003	48	112	113	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2010	13	1					36	U191		10.1038/nn.2462	http://dx.doi.org/10.1038/nn.2462			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	536PM	20010819	Green Accepted, Green Submitted			2022-12-24	WOS:000273056300011
J	Ohno, M; Hiraoka, Y; Matsuoka, T; Tomimoto, H; Takao, K; Miyakawa, T; Oshima, N; Kiyonari, H; Kimura, T; Kita, T; Nishi, E				Ohno, Mikiko; Hiraoka, Yoshinori; Matsuoka, Tatsuhiko; Tomimoto, Hidekazu; Takao, Keizo; Miyakawa, Tsuyoshi; Oshima, Naoko; Kiyonari, Hiroshi; Kimura, Takeshi; Kita, Toru; Nishi, Eiichiro			Nardilysin regulates axonal maturation and myelination in the central and peripheral nervous system	NATURE NEUROSCIENCE			English	Article							ARGININE DIBASIC CONVERTASE; AMYLOID PRECURSOR PROTEIN; METALLOENDOPEPTIDASE NARDILYSIN; GROWTH-FACTOR; NEUREGULIN-1; ALPHA; BACE1; OLIGODENDROCYTES; ACTIVATION; EXPRESSION	Axonal maturation and myelination are essential processes for establishing an efficient neuronal signaling network. We found that nardilysin (N-arginine dibasic convertase, also known as Nrd1 and NRDc), a metalloendopeptidase enhancer of protein ectodomain shedding, is a critical regulator of these processes. Nrd1(-/-) mice had smaller brains and a thin cerebral cortex, in which there were less myelinated fibers with thinner myelin sheaths and smaller axon diameters. We also found hypomyelination in the peripheral nervous system (PNS) of Nrd1(-/-) mice. Neuron-specific overexpression of NRDc induced hypermyelination, indicating that the level of neuronal NRDc regulates myelin thickness. Consistent with these findings, Nrd1(-/-) mice had impaired motor activities and cognitive deficits. Furthermore, NRDc enhanced ectodomain shedding of neuregulin1 (NRG1), which is a master regulator of myelination in the PNS. On the basis of these data, we propose that NRDc regulates axonal maturation and myelination in the CNS and PNS, in part, through the modulation of NRG1 shedding.	[Ohno, Mikiko; Hiraoka, Yoshinori; Matsuoka, Tatsuhiko; Kimura, Takeshi; Kita, Toru; Nishi, Eiichiro] Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Sakyo Ku, Kyoto, Japan; [Tomimoto, Hidekazu] Mie Univ, Grad Sch Med, Dept Neurol, Tsu, Mie 514, Japan; [Takao, Keizo; Miyakawa, Tsuyoshi] Fujita Hlth Univ, Inst Comprehens Med Sci, Div Syst Med Sci, Aichi, Japan; [Takao, Keizo; Miyakawa, Tsuyoshi] Japan Sci & Technol Agcy, Inst Bioinformat Res & Dev & Core Res Evolut Sci, Saitama, Japan; [Takao, Keizo; Miyakawa, Tsuyoshi] Kyoto Univ, Grad Sch Med, Frontier Technol Ctr, Sakyo Ku, Kyoto, Japan; [Oshima, Naoko; Kiyonari, Hiroshi] RIKEN Kobe, Lab Anim Resources & Genet Engn, Ctr Dev Biol, Chuo Ku, Kobe, Hyogo, Japan	Kyoto University; Mie University; Fujita Health University; Japan Science & Technology Agency (JST); Kyoto University; RIKEN	Nishi, E (corresponding author), Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Sakyo Ku, Kyoto, Japan.	nishi@kuhp.kyoto-u.ac.jp	Messier, Claude/A-2322-2008; Takao, Keizo/B-9527-2008; Nishi, Eiichiro/A-8246-2019; Kiyonari, Hiroshi/N-7936-2015; Miyakawa, Tsuyoshi/A-7741-2008	Messier, Claude/0000-0002-4791-1763; Takao, Keizo/0000-0002-4734-3583; Nishi, Eiichiro/0000-0002-8188-8026; Miyakawa, Tsuyoshi/0000-0003-0137-8200	Ministry of Education, Culture, Sports, Science and Technology of Japan [19041035, 20390255, 20659061, 20200068, IBR-shien]; Takeda Science Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Suzuken Memorial Foundation; Japan Health Foundation; Daiichi Sankyo Sponsored Research Program	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Mochida Memorial Foundation for Medical and Pharmaceutical Research; Suzuken Memorial Foundation; Japan Health Foundation(Japan Health Foundation); Daiichi Sankyo Sponsored Research Program(Daiichi Sankyo Company Limited)	We are grateful to N. Nishimoto and H. Nakabayashi for technical assistance, and K. Matsumoto, E. Kimura, A. Kinoshita and A. Sehara for materials. We thank P. W. Park, T. Nishio, H. Fujiwara, T. Kaneko, F. Fujiyama and H. Kawasaki for critical reading of the manuscript. This study was supported by research grants (19041035, 20390255, 20659061, 20200068 and IBR-shien) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. It was also supported by the Takeda Science Foundation, the Mochida Memorial Foundation for Medical and Pharmaceutical Research, the Suzuken Memorial Foundation, the Japan Health Foundation and the Daiichi Sankyo Sponsored Research Program.	Bernstein HG, 2007, NEUROSCIENCE, V146, P1513, DOI 10.1016/j.neuroscience.2007.02.057; Brinkmann BG, 2008, NEURON, V59, P581, DOI 10.1016/j.neuron.2008.06.028; Calaora V, 2001, J NEUROSCI, V21, P4740, DOI 10.1523/JNEUROSCI.21-13-04740.2001; Carter RJ, 1999, J NEUROSCI, V19, P3248; CHESNEAU V, 1994, BIOCHIMIE, V76, P234, DOI 10.1016/0300-9084(94)90151-1; Dragatsis I, 2000, GENESIS, V26, P133, DOI 10.1002/(SICI)1526-968X(200002)26:2<133::AID-GENE10>3.0.CO;2-V; Falls DL, 2003, EXP CELL RES, V284, P14, DOI 10.1016/S0014-4827(02)00102-7; FIELDS RD, 1986, EXP NEUROL, V92, P61, DOI 10.1016/0014-4886(86)90125-1; Griffiths I, 1998, SCIENCE, V280, P1610, DOI 10.1126/science.280.5369.1610; Hartline DK, 2007, CURR BIOL, V17, pR29, DOI 10.1016/j.cub.2006.11.042; Hiraoka Y, 2008, BIOCHEM BIOPH RES CO, V370, P154, DOI 10.1016/j.bbrc.2008.03.050; Hiraoka Y, 2007, J NEUROCHEM, V102, P1595, DOI 10.1111/j.1471-4159.2007.04685.x; Hospital V, 2002, BIOCHEM J, V367, P229, DOI 10.1042/BJ20020822; Hu XY, 2008, FASEB J, V22, P2970, DOI 10.1096/fj.08-106666; Hu XY, 2006, NAT NEUROSCI, V9, P1520, DOI 10.1038/nn1797; Lappe-Siefke C, 2003, NAT GENET, V33, P366, DOI 10.1038/ng1095; Lu QR, 2002, CELL, V109, P75, DOI 10.1016/S0092-8674(02)00678-5; MAYFORD M, 1995, CELL, V81, P891, DOI 10.1016/0092-8674(95)90009-8; McTigue DM, 2008, J NEUROCHEM, V107, P1, DOI 10.1111/j.1471-4159.2008.05570.x; Mei L, 2008, NAT REV NEUROSCI, V9, P437, DOI 10.1038/nrn2392; Michailov GV, 2004, SCIENCE, V304, P700, DOI 10.1126/science.1095862; Montero JC, 2000, MOL CELL NEUROSCI, V16, P631, DOI 10.1006/mcne.2000.0896; Nave KA, 2008, ANNU REV NEUROSCI, V31, P535, DOI 10.1146/annurev.neuro.30.051606.094309; Navel KA, 2006, CURR OPIN NEUROBIOL, V16, P492, DOI 10.1016/j.conb.2006.08.008; Nishi E, 2001, EMBO J, V20, P3342, DOI 10.1093/emboj/20.13.3342; Nishi E, 2006, J BIOL CHEM, V281, P31164, DOI 10.1074/jbc.M601316200; PIEROTTI AR, 1994, P NATL ACAD SCI USA, V91, P6078, DOI 10.1073/pnas.91.13.6078; Shirakabe K, 2001, J BIOL CHEM, V276, P9352, DOI 10.1074/jbc.M007913200; Simons M, 2007, CURR OPIN NEUROBIOL, V17, P533, DOI 10.1016/j.conb.2007.08.003; Takahashi T, 2008, J HIGH ENERGY PHYS; Taveggia C, 2005, NEURON, V47, P681, DOI 10.1016/j.neuron.2005.08.017; Taveggia C, 2008, GLIA, V56, P284, DOI 10.1002/glia.20612; Thinakaran G, 2008, J BIOL CHEM, V283, P29615, DOI 10.1074/jbc.R800019200; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; Trapp BD, 2008, ANNU REV NEUROSCI, V31, P247, DOI 10.1146/annurev.neuro.30.051606.094313; Wakatsuki S, 2009, J BIOL CHEM, V284, P2957, DOI 10.1074/jbc.M803191200; Willem M, 2006, SCIENCE, V314, P664, DOI 10.1126/science.1132341; YAGI T, 1993, ANAL BIOCHEM, V214, P70, DOI 10.1006/abio.1993.1458; Yamasaki N, 2008, MOL BRAIN, V1, DOI 10.1186/1756-6606-1-6	39	59	61	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2009	12	12					1506	U45		10.1038/nn.2438	http://dx.doi.org/10.1038/nn.2438			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	523II	19935654	Green Published, Green Submitted			2022-12-24	WOS:000272065600010
J	Saheki, Y; Bargmann, CI				Saheki, Yasunori; Bargmann, Cornelia I.			Presynaptic CaV2 calcium channel traffic requires CALF-1 and the alpha(2)delta subunit UNC-36	NATURE NEUROSCIENCE			English	Article							GATED CA2+ CHANNELS; SYNAPTIC VESICLE EXOCYTOSIS; C-ELEGANS; CAENORHABDITIS-ELEGANS; ENDOPLASMIC-RETICULUM; MEMBRANE-PROTEINS; PLASMA-MEMBRANE; DROSOPHILA; EXPRESSION; CACOPHONY	Presynaptic voltage-gated calcium channels provide calcium for synaptic vesicle exocytosis. We show here that a green fluorescent protein-tagged alpha(1) subunit of the Caenorhabditis elegans CaV2 channel, UNC-2, is localized to presynaptic active zones of sensory and motor neurons. Synaptic localization of CaV2 requires the alpha(2)delta subunit UNC-36 and CALF-1 (Calcium Channel Localization Factor-1), a neuronal transmembrane protein that localizes to the endoplasmic reticulum. In calf-1 mutants, UNC-2 is retained in the endoplasmic reticulum, but other active-zone components and synaptic vesicles are delivered to synapses. Acute induction of calf-1 mobilizes preexisting UNC-2 for delivery to synapses, consistent with a direct trafficking role. The alpha(2)delta subunit UNC-36 is likewise required for exit of UNC-2 from endoplasmic reticulum but has additional functions. Genetic and cell biological interactions suggest that CALF-1 couples intracellular traffic to functional maturation of CaV2 presynaptic calcium channels.	[Bargmann, Cornelia I.] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA; Rockefeller Univ, Lab Neural Circuits & Behav, New York, NY 10021 USA	Howard Hughes Medical Institute; Rockefeller University; Rockefeller University	Bargmann, CI (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA.	cori@rockefeller.edu	Saheki, Yasunori/D-5430-2016	Saheki, Yasunori/0000-0002-1229-6668; Bargmann, Cornelia/0000-0002-8484-0618	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Anderson P, 1995, METHOD CELL BIOL, V48, P31; Arikkath J, 2003, CURR OPIN NEUROBIOL, V13, P298, DOI 10.1016/S0959-4388(03)00066-7; Bichet D, 2000, NEURON, V25, P177, DOI 10.1016/S0896-6273(00)80881-8; Bidaud I, 2006, BBA-MOL CELL RES, V1763, P1169, DOI 10.1016/j.bbamcr.2006.08.049; Brooks IM, 2003, GENETICS, V164, P163; Butz S, 1998, CELL, V94, P773, DOI 10.1016/S0092-8674(00)81736-5; Canti C, 2005, P NATL ACAD SCI USA, V102, P11230, DOI 10.1073/pnas.0504183102; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Chalasani SH, 2007, NATURE, V450, P63, DOI 10.1038/nature06292; Chen CCH, 2006, MOL BIOL CELL, V17, P1286, DOI 10.1091/mbc.E05-08-0787; Chudakov DM, 2007, NAT PROTOC, V2, P2024, DOI 10.1038/nprot.2007.291; Crump JG, 2001, NEURON, V29, P115, DOI 10.1016/S0896-6273(01)00184-2; Dickman DK, 2008, J NEUROSCI, V28, P31, DOI 10.1523/JNEUROSCI.4498-07.2008; Frokjaer-Jensen C, 2006, J NEUROBIOL, V66, P1125, DOI 10.1002/neu.20261; Fromme JC, 2008, TRENDS CELL BIOL, V18, P330, DOI 10.1016/j.tcb.2008.04.006; Grunwald ME, 2004, P NATL ACAD SCI USA, V101, P3190, DOI 10.1073/pnas.0306156101; HALL DH, 1991, CELL, V65, P837, DOI 10.1016/0092-8674(91)90391-B; Hallam SJ, 2002, NAT NEUROSCI, V5, P1137, DOI 10.1038/nn959; Hendrich J, 2008, P NATL ACAD SCI USA, V105, P3628, DOI 10.1073/pnas.0708930105; Herrmann JM, 1999, TRENDS CELL BIOL, V9, P5, DOI 10.1016/S0962-8924(98)01414-7; Huang SLB, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-24; Jeziorski MC, 2000, J EXP BIOL, V203, P841; Kawasaki F, 2004, J NEUROSCI, V24, P282, DOI 10.1523/JNEUROSCI.3553-03.2004; Kittel RJ, 2006, SCIENCE, V312, P1051, DOI 10.1126/science.1126308; Kota J, 2005, J CELL BIOL, V168, P79, DOI 10.1083/jcb.200408106; Lai MZ, 2005, NAT NEUROSCI, V8, P435, DOI 10.1038/nn1418; Long AA, 2008, J NEUROSCI, V28, P3668, DOI 10.1523/JNEUROSCI.5553-07.2008; Ly CV, 2008, J CELL BIOL, V181, P157, DOI 10.1083/jcb.200712152; Mathews EA, 2003, J NEUROSCI, V23, P6537; Mello C, 1995, METHOD CELL BIOL, V48, P451; Michelsen K, 2005, EMBO REP, V6, P717, DOI 10.1038/sj.embor.7400480; Nishimune H, 2004, NATURE, V432, P580, DOI 10.1038/nature03112; Patel MR, 2006, NAT NEUROSCI, V9, P1488, DOI 10.1038/nn1806; Richmond JE, 2001, NATURE, V412, P338, DOI 10.1038/35085583; Rolls MM, 2002, MOL BIOL CELL, V13, P1778, DOI 10.1091/mbc.01-10-0514; SCHAFER WR, 1995, NATURE, V375, P73, DOI 10.1038/375073a0; SCHUTZE MP, 1994, EMBO J, V13, P1696, DOI 10.1002/j.1460-2075.1994.tb06434.x; Schwappach B, 2000, NEURON, V26, P155, DOI 10.1016/S0896-6273(00)81146-0; Schwappach B, 2008, MOL MEMBR BIOL, V25, P270, DOI 10.1080/09687680801960998; Smith LA, 1996, J NEUROSCI, V16, P7868; Tallini YN, 2006, P NATL ACAD SCI USA, V103, P4753, DOI 10.1073/pnas.0509378103; Troemel ER, 1999, CELL, V99, P387, DOI 10.1016/S0092-8674(00)81525-1; Viard P, 2004, NAT NEUROSCI, V7, P939, DOI 10.1038/nn1300; Wicks SR, 2001, NAT GENET, V28, P160, DOI 10.1038/88878; Yeh E, 2008, PLOS BIOL, V6, P552, DOI 10.1371/journal.pbio.0060055; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4; Zhen M, 2000, NEURON, V26, P331, DOI 10.1016/S0896-6273(00)81167-8; Zhen M, 1999, NATURE, V401, P371, DOI 10.1038/43886	48	61	86	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2009	12	10					1257	U73		10.1038/nn.2383	http://dx.doi.org/10.1038/nn.2383			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	498US	19718034	Green Accepted			2022-12-24	WOS:000270170200014
J	Kim, JY; Duan, X; Liu, CY; Jang, MH; Guo, JJU; Pow-Anpongkul, N; Kang, EC; Song, HJ; Ming, GL				Kim, Ju Young; Duan, Xin; Liu, Cindy Y.; Jang, Mi-Hyeon; Guo, Junjie U.; Pow-anpongkul, Nattapol; Kang, Eunchai; Song, Hongjun; Ming, Guo-li			DISC1 Regulates New Neuron Development in the Adult Brain via Modulation of AKT-mTOR Signaling through KIAA1212	NEURON			English	Article							NEWLY GENERATED NEURONS; STEM-CELL; BEHAVIORAL ABNORMALITIES; HIPPOCAMPAL NEUROGENESIS; SYNAPTIC INTEGRATION; NEURITE OUTGROWTH; AXON GROWTH; SCHIZOPHRENIA; MICE; EXPRESSION	Disrupted-in-schizophrenia 1 (DISC1), a susceptibility gene for major mental illnesses, regulates multiple aspects of embryonic and adult neurogenesis. Here, we show that DISC1 suppression in newborn neurons of the adult hippocampus leads to overactivated signaling of AKT, another schizophrenia susceptibility gene. Mechanistically, DISC1 directly interacts with KIAA1212, an AKT binding partner that enhances AKT signaling in the absence of DISC1, and DISC1 binding to KIAA1212 prevents AKT activation in vitro. Functionally, multiple genetic manipulations to enhance AKT signaling in adult-born neurons in vivo exhibit similar defects as DISC1 suppression in neuronal development that can be rescued by pharmacological inhibition of mammalian target of rapamycin (mTOR), an AKT downstream effector. Our study identifies the AKT-mTOR signaling pathway as a critical DISC1 target in regulating neuronal development and provides a framework for understanding how multiple susceptibility genes may functionally converge onto a common pathway in contributing to the etiology of certain psychiatric disorders.	[Kim, Ju Young; Duan, Xin; Liu, Cindy Y.; Jang, Mi-Hyeon; Guo, Junjie U.; Pow-anpongkul, Nattapol; Kang, Eunchai; Song, Hongjun; Ming, Guo-li] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21205 USA; [Kim, Ju Young; Duan, Xin; Liu, Cindy Y.; Jang, Mi-Hyeon; Pow-anpongkul, Nattapol; Song, Hongjun; Ming, Guo-li] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Duan, Xin; Guo, Junjie U.; Song, Hongjun; Ming, Guo-li] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA; [Kang, Eunchai; Song, Hongjun] Johns Hopkins Univ, Sch Med, Predoctoral Training Program Human Genet, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Ming, GL (corresponding author), Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21205 USA.	gming1@jhmi.edu	Ming, Guo-li/J-7880-2013	Kang, Eunchai/0000-0001-6884-622X; Ming, Guo-li/0000-0002-2517-6075	NIH [NS047344, AG024984, MH084018, NS048271]; McKnight; NARSAD; IMHRO; March of Dimes; MSCRF; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD069184] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P20MH084018] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047344, R56NS047344, R37NS047344, R01NS048271] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG024984] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); McKnight; NARSAD(NARSAD); IMHRO; March of Dimes(March of Dimes); MSCRF; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank members of Ming and Song Laboratories for help and critical comments, L. Liu and Y. Cai for technical support, and L. Cheng for the cDNA of CA-AKT. This work was supported by NIH (NS047344, AG024984, MH084018), McKnight, NARSAD, and IMHRO to H.S., by NIH (NS048271), March of Dimes, and MSCRF to G-I.M. J.Y.K. was partially supported by a postdoctoral fellowship from MSCRF.	Alvarez-Buylla A, 2004, NEURON, V41, P683, DOI 10.1016/S0896-6273(04)00111-4; Anai M, 2005, J BIOL CHEM, V280, P18525, DOI 10.1074/jbc.M500586200; Atwal JK, 2000, NEURON, V27, P265, DOI 10.1016/S0896-6273(00)00035-0; Beaulieu JM, 2009, ANNU REV PHARMACOL, V49, P327, DOI 10.1146/annurev.pharmtox.011008.145634; Blackwood DHR, 2001, AM J HUM GENET, V69, P428, DOI 10.1086/321969; Camargo LM, 2007, MOL PSYCHIATR, V12, P74, DOI 10.1038/sj.mp.4001880; Chubb JE, 2008, MOL PSYCHIATR, V13, P36, DOI 10.1038/sj.mp.4002106; Clapcote SJ, 2007, NEURON, V54, P387, DOI 10.1016/j.neuron.2007.04.015; Clapcote SJ, 2006, GENETICS, V173, P2407, DOI 10.1534/genetics.106.060749; Duan X, 2008, CURR OPIN NEUROBIOL, V18, P108, DOI 10.1016/j.conb.2008.04.001; Duan X, 2007, CELL, V130, P1146, DOI 10.1016/j.cell.2007.07.010; Emamian ES, 2004, NAT GENET, V36, P131, DOI 10.1038/ng1296; Enomoto A, 2005, DEV CELL, V9, P389, DOI 10.1016/j.devcel.2005.08.001; Enomoto A, 2006, ANN NY ACAD SCI, V1086, P169, DOI 10.1196/annals.1377.016; Farioli-Vecchioli S, 2008, PLOS BIOL, V6, P2188, DOI 10.1371/journal.pbio.0060246; Faulkner RL, 2008, P NATL ACAD SCI USA, V105, P14157, DOI 10.1073/pnas.0806658105; Ge SY, 2008, J PHYSIOL-LONDON, V586, P3759, DOI 10.1113/jphysiol.2008.155655; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Ghashghaei HT, 2006, P NATL ACAD SCI USA, V103, P1930, DOI 10.1073/pnas.0510410103; Hennah W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004906; Hikida T, 2007, P NATL ACAD SCI USA, V104, P14501, DOI 10.1073/pnas.0704774104; Ishizuka K, 2007, MOL PSYCHIATR, V12, P897, DOI 10.1038/sj.mp.4002024; Ishizuka K, 2006, BIOL PSYCHIAT, V59, P1189, DOI 10.1016/j.biopsych.2006.03.065; Jaworski J, 2005, J NEUROSCI, V25, P11300, DOI 10.1523/JNEUROSCI.2270-05.2005; Jessberger S, 2008, NAT NEUROSCI, V11, P888, DOI 10.1038/nn.2148; Jessberger S, 2007, J NEUROSCI, V27, P9400, DOI 10.1523/JNEUROSCI.2002-07.2007; Jiang H, 2005, CELL, V120, P123, DOI 10.1016/j.cell.2004.12.033; Jin KL, 2002, P NATL ACAD SCI USA, V99, P11946, DOI 10.1073/pnas.182296499; Kamiya A, 2005, NAT CELL BIOL, V7, P1167, DOI 10.1038/ncb1328; Kamiya A, 2006, HUM MOL GENET, V15, P3313, DOI 10.1093/hmg/ddl407; Kempermann G, 1997, P NATL ACAD SCI USA, V94, P10409, DOI 10.1073/pnas.94.19.10409; Kitamura T, 2008, NAT CELL BIOL, V10, P329, DOI 10.1038/ncb1695; Kohn AD, 1996, J BIOL CHEM, V271, P31372, DOI 10.1074/jbc.271.49.31372; Koike H, 2006, P NATL ACAD SCI USA, V103, P3693, DOI 10.1073/pnas.0511189103; Kuruvilla R, 2000, NEURON, V27, P499, DOI 10.1016/S0896-6273(00)00061-1; Kvajo M, 2008, P NATL ACAD SCI USA, V105, P7076, DOI 10.1073/pnas.0802615105; Kwon CH, 2006, NEURON, V50, P377, DOI 10.1016/j.neuron.2006.03.023; Law AJ, 2006, P NATL ACAD SCI USA, V103, P6747, DOI 10.1073/pnas.0602002103; Law AJ, 2007, HUM MOL GENET, V16, P129, DOI 10.1093/hmg/ddl449; Le-Niculescu H, 2005, J BIOL CHEM, V280, P22012, DOI 10.1074/jbc.M501833200; Li W, 2007, P NATL ACAD SCI USA, V104, P18280, DOI 10.1073/pnas.0706900104; Li Y, 2008, NEURON, V59, P399, DOI 10.1016/j.neuron.2008.06.023; Lledo PM, 2006, NAT REV NEUROSCI, V7, P179, DOI 10.1038/nrn1867; Ma DK, 2008, STEM CELLS, V26, P2131, DOI 10.1634/stemcells.2008-0388; Ma DK, 2009, SCIENCE, V323, P1074, DOI 10.1126/science.1166859; Ma DK, 2005, CURR OPIN NEUROBIOL, V15, P514, DOI 10.1016/j.conb.2005.08.003; Mackie S, 2007, CURR OPIN NEUROBIOL, V17, P95, DOI 10.1016/j.conb.2007.01.007; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Mao YW, 2009, CELL, V136, P1017, DOI 10.1016/j.cell.2008.12.044; Markus A, 2002, NEURON, V35, P65, DOI 10.1016/S0896-6273(02)00752-3; Mei L, 2008, NAT REV NEUROSCI, V9, P437, DOI 10.1038/nrn2392; Millar JK, 2000, HUM MOL GENET, V9, P1415, DOI 10.1093/hmg/9.9.1415; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Ming GL, 2009, CELL, V136, P990, DOI 10.1016/j.cell.2009.03.005; Ninkovic J, 2007, CURR OPIN NEUROBIOL, V17, P338, DOI 10.1016/j.conb.2007.04.006; Overstreet-Wadiche LS, 2006, J NEUROSCI, V26, P4095, DOI 10.1523/JNEUROSCI.5508-05.2006; Ozeki Y, 2003, P NATL ACAD SCI USA, V100, P289, DOI 10.1073/pnas.0136913100; Pletnikov MV, 2008, MOL PSYCHIATR, V13, P173, DOI [10.1038/sj.mp.4002079, 10.1038/sj.mp.4002144]; Sanna PP, 2002, J NEUROSCI, V22, P3359; Schmidt HD, 2007, BEHAV PHARMACOL, V18, P391, DOI 10.1097/FBP.0b013e3282ee2aa8; Shen SB, 2008, J NEUROSCI, V28, P10893, DOI 10.1523/JNEUROSCI.3299-08.2008; Simpson F, 2005, TRAFFIC, V6, P442, DOI 10.1111/j.1600-0854.2005.00289.x; Song HJ, 2002, NAT NEUROSCI, V5, P438, DOI 10.1038/nn844; Stefansson H, 2002, AM J HUM GENET, V71, P877, DOI 10.1086/342734; Taya S, 2007, J NEUROSCI, V27, P15, DOI 10.1523/JNEUROSCI.3826-06.2006; Thompson CL, 2008, NEURON, V60, P1010, DOI 10.1016/j.neuron.2008.12.008; Tosato S, 2005, SCHIZOPHRENIA BULL, V31, P613, DOI 10.1093/schbul/sbi043; Yoshimura T, 2006, BIOCHEM BIOPH RES CO, V340, P62, DOI 10.1016/j.bbrc.2005.11.147; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Zhou J, 2009, J NEUROSCI, V29, P1773, DOI 10.1523/JNEUROSCI.5685-08.2009	71	254	271	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 24	2009	63	6					761	773		10.1016/j.neuron.2009.08.008	http://dx.doi.org/10.1016/j.neuron.2009.08.008			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	503VP	19778506	Bronze, Green Accepted			2022-12-24	WOS:000270569700010
J	Ahmed, MS; Siegelbaum, SA				Ahmed, Mohsin S.; Siegelbaum, Steven A.			Recruitment of N-Type Ca2+ Channels during LTP Enhances Low Release Efficacy of Hippocampal CA1 Perforant Path Synapses	NEURON			English	Article							LONG-TERM POTENTIATION; OPTICAL QUANTAL ANALYSIS; SYNAPTIC-TRANSMISSION; PYRAMIDAL NEURONS; TRANSMITTER RELEASE; ENTORHINAL CORTEX; DISTAL DENDRITES; NERVE-TERMINALS; AREA CA1; SPATIAL REPRESENTATION	The entorhinal cortex provides both direct and indirect inputs to hippocampal CA1 neurons through the perforant path and Schaffer collateral synapses, respectively. Using both two-photon imaging of synaptic vesicle cycling and electrophysiological recordings, we found that the efficacy of transmitter release at perforant path synapses is lower than at Schaffer collateral inputs. This difference is due to the greater contribution to release by presynaptic N-type voltage-gated Ca2+ channels at the Schaffer collateral than perforant path synapses. Induction of long-term potentiation that depends on activation of NMDA receptors and L-type voltage-gated Ca2+ channels enhances the low efficacy of release at perforant path synapses by increasing the contribution of N-type channels to exocytosis. This represents a previously uncharacterized presynaptic mechanism for fine-tuning release properties of distinct classes of synapses onto a common postsynaptic neuron and for regulating synaptic function during long-term synaptic plasticity.	[Ahmed, Mohsin S.; Siegelbaum, Steven A.] Columbia Univ, Dept Neurosci, New York, NY 10032 USA; [Siegelbaum, Steven A.] Columbia Univ, Dept Pharmacol, New York, NY 10032 USA; [Siegelbaum, Steven A.] Columbia Univ, Howard Hughes Med Inst, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University; Howard Hughes Medical Institute	Siegelbaum, SA (corresponding author), Columbia Univ, Dept Neurosci, 1051 Riverside Dr, New York, NY 10032 USA.	sas8@columbia.edu			Howard Hughes Medical Institute; NIH MSTP; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007367] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH MSTP(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Leonard Zablow for indispensable help with custom-written IDL software, David Tsay and Jayeeta Basu for help with experiments in Figure S2, and Bernardo Sabatini for suggesting the experiments in Figure 8E. We thank Jayeeta Basu, Vivien Chevaleyre, Cindy Lang, Rebecca Piskorowski, and Bina Santoro for comments on the manuscript. This work was supported by the Howard Hughes Medical Institute (S.A.S.) and an NIH MSTP training grant (M.S.A.).	Abbott LF, 2004, NATURE, V431, P796, DOI 10.1038/nature03010; Ang CW, 2005, J NEUROSCI, V25, P9567, DOI 10.1523/JNEUROSCI.2992-05.2005; Bayazitov IT, 2007, J NEUROSCI, V27, P11510, DOI 10.1523/JNEUROSCI.3077-07.2007; BETZ WJ, 1992, SCIENCE, V255, P200, DOI 10.1126/science.1553547; Bloodgood BL, 2007, CURR OPIN NEUROBIOL, V17, P345, DOI 10.1016/j.conb.2007.04.003; BOLSHAKOV VY, 1995, SCIENCE, V269, P1730, DOI 10.1126/science.7569903; Borst JGG, 1996, NATURE, V383, P431, DOI 10.1038/383431a0; Brun VH, 2008, NEURON, V57, P290, DOI 10.1016/j.neuron.2007.11.034; Brun VH, 2002, SCIENCE, V296, P2243, DOI 10.1126/science.1071089; CASTILLO PE, 1994, NEURON, V12, P261, DOI 10.1016/0896-6273(94)90269-0; Catterall WA, 2008, NEURON, V59, P882, DOI 10.1016/j.neuron.2008.09.005; Chevaleyre V, 2007, NEURON, V54, P801, DOI 10.1016/j.neuron.2007.05.020; Choi S, 2000, NAT NEUROSCI, V3, P330, DOI 10.1038/73895; Choi S, 2003, PHILOS T ROY SOC B, V358, P695, DOI 10.1098/rstb.2002.1249; Cunha RA, 2000, NEUROPHARMACOLOGY, V39, P1156, DOI 10.1016/S0028-3908(99)00237-3; Dobrunz LE, 1997, NEURON, V18, P995, DOI 10.1016/S0896-6273(00)80338-4; Dudman JT, 2007, NEURON, V56, P866, DOI 10.1016/j.neuron.2007.10.020; Eichenbaum H, 2000, NAT REV NEUROSCI, V1, P41, DOI 10.1038/35036213; Emptage NJ, 2003, NEURON, V38, P797, DOI 10.1016/S0896-6273(03)00325-8; Enoki R, 2009, NEURON, V62, P242, DOI 10.1016/j.neuron.2009.02.026; Evans RM, 2006, TRENDS NEUROSCI, V29, P617, DOI 10.1016/j.tins.2006.08.006; Fedchyshyn MJ, 2005, J NEUROSCI, V25, P4131, DOI 10.1523/JNEUROSCI.0350-05.2005; Frank LM, 2001, J NEUROPHYSIOL, V86, P2029, DOI 10.1152/jn.2001.86.4.2029; Fyhn M, 2004, SCIENCE, V305, P1258, DOI 10.1126/science.1099901; Golding NL, 2002, NATURE, V418, P326, DOI 10.1038/nature00854; Harata N, 2001, TRENDS NEUROSCI, V24, P637, DOI 10.1016/S0166-2236(00)02030-0; Harata N, 2001, P NATL ACAD SCI USA, V98, P12748, DOI 10.1073/pnas.171442798; Hiscock JJ, 2000, J NEUROSCI METH, V95, P1, DOI 10.1016/S0165-0270(99)00163-6; Jarsky T, 2005, NAT NEUROSCI, V8, P1667, DOI 10.1038/nn1599; Kamiya H, 1998, J PHYSIOL-LONDON, V509, P833, DOI 10.1111/j.1469-7793.1998.833bm.x; Kay AR, 1999, NEURON, V24, P809, DOI 10.1016/S0896-6273(00)81029-6; Kerchner GA, 2008, NAT REV NEUROSCI, V9, P813, DOI 10.1038/nrn2501; Kiyonaka S, 2007, NAT NEUROSCI, V10, P691, DOI 10.1038/nn1904; Li LY, 2007, J NEUROSCI, V27, P13420, DOI 10.1523/JNEUROSCI.1709-07.2007; LIU GS, 1995, NATURE, V375, P404, DOI 10.1038/375404a0; Lonart G, 2002, TRENDS NEUROSCI, V25, P329, DOI 10.1016/S0166-2236(02)02193-8; Lorincz A, 2002, NAT NEUROSCI, V5, P1185, DOI 10.1038/nn962; Maass W, 1999, NEURAL COMPUT, V11, P903, DOI 10.1162/089976699300016494; Mahmoud GS, 2006, J NEUROPHYSIOL, V95, P2962, DOI 10.1152/jn.00947.2005; Megias M, 2001, NEUROSCIENCE, V102, P527, DOI 10.1016/S0306-4522(00)00496-6; MINTZ IM, 1995, NEURON, V15, P675, DOI 10.1016/0896-6273(95)90155-8; Nakashiba T, 2008, SCIENCE, V319, P1260, DOI 10.1126/science.1151120; Nicholson DA, 2006, NEURON, V50, P431, DOI 10.1016/j.neuron.2006.03.022; Nolan MF, 2004, CELL, V119, P719, DOI 10.1016/S0092-8674(04)01055-4; Otmakhova NA, 1999, J NEUROSCI, V19, P1437; Pastalkova E, 2006, SCIENCE, V313, P1141, DOI 10.1126/science.1128657; Qian J, 2000, J NEUROSCI, V20, P163, DOI 10.1523/JNEUROSCI.20-01-00163.2000; Qian J, 2001, J NEUROSCI, V21, P3721, DOI 10.1523/JNEUROSCI.21-11-03721.2001; Remondes M, 2004, NATURE, V431, P699, DOI 10.1038/nature02965; Remondes M, 2003, LEARN MEMORY, V10, P247, DOI 10.1101/lm.59103; Remondes M, 2002, NATURE, V416, P736, DOI 10.1038/416736a; Ryan TA, 1997, NATURE, V388, P478, DOI 10.1038/41335; Santoro B, 2000, J NEUROSCI, V20, P5264, DOI 10.1523/JNEUROSCI.20-14-05264.2000; Speed HE, 2009, HIPPOCAMPUS, V19, P187, DOI 10.1002/hipo.20496; STEVENS CF, 1994, NATURE, V371, P704, DOI 10.1038/371704a0; SWARTZ KJ, 1993, NATURE, V361, P165, DOI 10.1038/361165a0; Takahashi H, 2009, NEURON, V62, P102, DOI 10.1016/j.neuron.2009.03.007; Tsay D, 2007, NEURON, V56, P1076, DOI 10.1016/j.neuron.2007.11.015; Viard P, 2004, NAT NEUROSCI, V7, P939, DOI 10.1038/nn1300; Wang LY, 2008, J NEUROSCI, V28, P14450, DOI 10.1523/JNEUROSCI.4245-08.2008; Ward B, 2006, NEURON, V52, P649, DOI 10.1016/j.neuron.2006.10.007; WHEELER DB, 1994, SCIENCE, V264, P107, DOI 10.1126/science.7832825; Wikstrom MA, 2003, NEUROPHARMACOLOGY, V45, P828, DOI 10.1016/S0028-3908(03)00336-8; Wu LG, 1999, J NEUROSCI, V19, P726; YOON KW, 1991, J NEUROSCI, V11, P1375; Yoshida M, 2007, J NEUROPHYSIOL, V98, P2779, DOI 10.1152/jn.00033.2007; Zakharenko SS, 2003, NEURON, V39, P975, DOI 10.1016/S0896-6273(03)00543-9; Zakharenko SS, 2001, NAT NEUROSCI, V4, P711, DOI 10.1038/89498; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	69	64	65	1	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 13	2009	63	3					372	385		10.1016/j.neuron.2009.07.013	http://dx.doi.org/10.1016/j.neuron.2009.07.013			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	487OY	19679076	Green Accepted, Bronze			2022-12-24	WOS:000269285500011
J	Lee, Y; Katyal, S; Li, Y; El-Khamisy, SF; Russell, HR; Caldecott, KW; McKinnon, PJ				Lee, Youngsoo; Katyal, Sachin; Li, Yang; El-Khamisy, Sherif F.; Russell, Helen R.; Caldecott, Keith W.; McKinnon, Peter J.			The genesis of cerebellar interneurons and the prevention of neural DNA damage require XRCC1	NATURE NEUROSCIENCE			English	Article							STRAND BREAK REPAIR; NERVOUS-SYSTEM; SPINOCEREBELLAR ATAXIA; WHITE-MATTER; NEURODEGENERATIVE DISEASE; GABAERGIC INTERNEURONS; GENETIC-REGULATION; MURINE CEREBELLUM; PROTEIN APRATAXIN; NEUROPEPTIDE-Y	Defective responses to DNA single strand breaks underlie various neurodegenerative diseases. However, the exact role of this repair pathway during the development and maintenance of the nervous system is unclear. Using murine neural-specific inactivation of Xrcc1, a factor that is critical for the repair of DNA single strand breaks, we found a profound neuropathology that is characterized by the loss of cerebellar interneurons. This cell loss was linked to p53-dependent cell cycle arrest and occurred as interneuron progenitors commenced differentiation. Loss of Xrcc1 also led to the persistence of DNA strand breaks throughout the nervous system and abnormal hippocampal function. Collectively, these data detail the in vivo link between DNA single strand break repair and neurogenesis and highlight the diverse consequences of specific types of genotoxic stress in the nervous system.	[Lee, Youngsoo; Katyal, Sachin; Li, Yang; Russell, Helen R.; McKinnon, Peter J.] St Jude Childrens Hosp, Dept Genet & Tumor Cell Biol, Memphis, TN 38105 USA; [El-Khamisy, Sherif F.; Caldecott, Keith W.] Univ Sussex, Genome Damage & Stabil Unit, Brighton, E Sussex, England; [El-Khamisy, Sherif F.] Ain Shams Univ, Fac Pharm, Dept Biochem, Cairo, Egypt	St Jude Children's Research Hospital; University of Sussex; Egyptian Knowledge Bank (EKB); Ain Shams University	McKinnon, PJ (corresponding author), St Jude Childrens Hosp, Dept Genet & Tumor Cell Biol, 332 N Lauderdale St, Memphis, TN 38105 USA.	peter.mckinnon@stjude.org	Caldecott, Keith/S-4245-2019	Katyal, Sachin/0000-0002-7790-4054; Lee, Youngsoo/0000-0003-4773-6464; Caldecott, Keith/0000-0003-4255-9016; , Sherif/0000-0003-2721-7763	US National Institutes of Health [NS-37956, CA-21765]; Cancer Center [P30 CA21765]; American Lebanese and Syrian Associated Charities of St. Jude Children's Research Hospital; Medical Research Council [G0600776, G0400959]; European Union Integrated Project on DNA Repair; Wellcome Trust [085284]; MRC [G0600776, G0400959] Funding Source: UKRI; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS037956, R01NS037956] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center; American Lebanese and Syrian Associated Charities of St. Jude Children's Research Hospital(American Lebanese Syrian Associated Charities (ALSAC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union Integrated Project on DNA Repair; Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the Hartwell Center for biotech support, the Transgenic core facility for blastocyst injections, the Animal Imaging core for magnetic resonance imaging analysis and J. Zhao for genotyping. P. J. M. is supported by the US National Institutes of Health (NS-37956 and CA-21765), the Cancer Center Support Grant (P30 CA21765) and the American Lebanese and Syrian Associated Charities of St. Jude Children's Research Hospital. K. W. C. is supported by the Medical Research Council (Grants G0600776 & G0400959) and by the European Union Integrated Project on DNA Repair. S. K. is a Neoma Boadway AP Endowed Fellow and S. F. E.-K. is supported by the Wellcome Trust (Grant 085284).	Ahel I, 2006, NATURE, V443, P713, DOI 10.1038/nature05164; Aronica E, 2007, NEUROSCIENTIST, V13, P100, DOI 10.1177/1073858406295832; Baraban SC, 2004, NEUROPEPTIDES, V38, P261, DOI 10.1016/j.npep.2004.04.006; Barmack NH, 2008, J NEUROSCI, V28, P1140, DOI 10.1523/JNEUROSCI.3942-07.2008; Caldecott KW, 2003, CELL, V112, P7, DOI 10.1016/S0092-8674(02)01247-3; Caldecott KW, 2003, DNA REPAIR, V2, P955, DOI 10.1016/S1568-7864(03)00118-6; CALDECOTT KW, 1994, MOL CELL BIOL, V14, P68, DOI 10.1128/MCB.14.1.68; ECCLES JC, 1970, P NATL ACAD SCI USA, V66, P294, DOI 10.1073/pnas.66.2.294; El-Khamisy SF, 2005, NATURE, V434, P108, DOI 10.1038/nature03314; Englund C, 2006, J NEUROSCI, V26, P9184, DOI 10.1523/JNEUROSCI.1610-06.2006; Frappart PO, 2007, EMBO J, V26, P2732, DOI 10.1038/sj.emboj.7601703; Frappart PO, 2006, NEUROMOL MED, V8, P495, DOI 10.1385/NMM:8:4:495; Glickstein SB, 2007, DEVELOPMENT, V134, P4083, DOI 10.1242/dev.008524; Goldowitz D, 1998, TRENDS NEUROSCI, V21, P375, DOI 10.1016/S0166-2236(98)01313-7; HATTEN ME, 1985, J CELL BIOL, V100, P384, DOI 10.1083/jcb.100.2.384; Howell OW, 2007, NEUROBIOL DIS, V26, P174, DOI 10.1016/j.nbd.2006.12.014; Huard JMT, 1999, DEVELOPMENT, V126, P1927; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Katyal S, 2007, EMBO J, V26, P4720, DOI 10.1038/sj.emboj.7601869; Kenney AM, 2005, NAT NEUROSCI, V8, P699, DOI 10.1038/nn0605-699; Kulkarni A, 2008, NUCLEIC ACIDS RES, V36, P5111, DOI 10.1093/nar/gkn480; Lee A, 2005, NAT NEUROSCI, V8, P723, DOI 10.1038/nn1473; Lee Y, 2007, NEUROSCIENCE, V145, P1365, DOI 10.1016/j.neuroscience.2006.07.026; Lee Y, 2002, CANCER RES, V62, P6395; Leto K, 2006, J NEUROSCI, V26, P11682, DOI 10.1523/JNEUROSCI.3656-06.2006; Lumpkin EA, 2003, GENE EXPR PATTERNS, V3, P389, DOI 10.1016/S1567-133X(03)00089-9; Maricich SM, 1999, J NEUROBIOL, V41, P281, DOI 10.1002/(SICI)1097-4695(19991105)41:2<281::AID-NEU10>3.0.CO;2-5; McKinnon PJ, 2007, ANNU REV GENOM HUM G, V8, P37, DOI 10.1146/annurev.genom.7.080505.115648; McKinnon PJ, 2009, NAT REV NEUROSCI, V10, P100, DOI 10.1038/nrn2559; MCNAMARA JO, 2006, SCI STKE, pRE12, DOI DOI 10.1126/STKE.3562006RE12; Moreira MC, 2001, NAT GENET, V29, P189, DOI 10.1038/ng1001-189; MORGAN JI, 1987, SCIENCE, V237, P192, DOI 10.1126/science.3037702; Orii KE, 2006, P NATL ACAD SCI USA, V103, P10017, DOI 10.1073/pnas.0602436103; RAKIC P, 1973, J COMP NEUROL, V147, P523, DOI 10.1002/cne.901470407; Rass U, 2007, CELL, V130, P991, DOI 10.1016/j.cell.2007.08.043; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Sedelnikova OA, 2003, CANCER BIOL THER, V2, P233; Shull ERP, 2009, GENE DEV, V23, P171, DOI 10.1101/gad.1746609; Sillitoe RV, 2007, ANNU REV CELL DEV BI, V23, P549, DOI 10.1146/annurev.cellbio.23.090506.123237; Sotelo C, 2004, PROG NEUROBIOL, V72, P295, DOI 10.1016/j.pneurobio.2004.03.004; Soutoglou E, 2008, SCIENCE, V320, P1507, DOI [10.1126/science.1159051, 10.1126/science.ll59051]; Takashima H, 2002, NAT GENET, V32, P267, DOI 10.1038/ng987; Tallquist MD, 2000, GENESIS, V26, P113, DOI 10.1002/(SICI)1526-968X(200002)26:2<113::AID-GENE3>3.0.CO;2-2; Tebbs RS, 1999, DEV BIOL, V208, P513, DOI 10.1006/dbio.1999.9232; Wang VY, 2001, NAT REV NEUROSCI, V2, P484, DOI 10.1038/35081558; Watanabe D, 1998, CELL, V95, P17, DOI 10.1016/S0092-8674(00)81779-1; Weisheit G, 2006, EUR J NEUROSCI, V24, P466, DOI 10.1111/j.1460-9568.2006.04915.x; Weyer A, 2003, J NEUROSCI RES, V73, P400, DOI 10.1002/jnr.10655; Yamanaka H, 2004, NEUROSCI RES, V50, P13, DOI 10.1016/j.neures.2004.06.008; Zhang L, 1996, NEURON, V16, P47, DOI 10.1016/S0896-6273(00)80022-7	50	84	86	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2009	12	8					973	U35		10.1038/nn.2375	http://dx.doi.org/10.1038/nn.2375			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	475WS	19633665	Green Accepted			2022-12-24	WOS:000268396300010
J	Maro, GS; Shen, K; Cheng, HJ				Maro, Geraldine S.; Shen, Kang; Cheng, Hwai-Jong			Deal Breaker: Semaphorin and Specificity in the Spinal Stretch Reflex Circuit	NEURON			English	Editorial Material							ETS GENE PEA3; SYNAPTIC CONNECTIONS; MOTOR-NEURONS; MECHANISMS; MOLECULES; ELEGANS; ABSENCE; DIRECTS; FAMILY; AXONS		[Maro, Geraldine S.; Shen, Kang] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Maro, Geraldine S.; Shen, Kang] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA; [Shen, Kang] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Cheng, Hwai-Jong] Univ Calif Davis, Ctr Neurosci, Davis, CA 95618 USA	Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; University of California System; University of California Davis	Maro, GS (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.	gmaro@stanford.edu	Cheng, Hwai-Jong/AAY-5067-2021	Cheng, Hwai-Jong/0000-0003-0647-0567	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Ango F, 2004, CELL, V119, P257, DOI 10.1016/j.cell.2004.10.004; Bagri A, 2003, CELL, V113, P285, DOI 10.1016/S0092-8674(03)00267-8; Benson DL, 2001, NAT REV NEUROSCI, V2, P899, DOI 10.1038/35104078; Catalano SM, 1998, MOL CELL NEUROSCI, V11, P173, DOI 10.1006/mcne.1998.0687; Chauvet S, 2007, NEURON, V56, P807, DOI 10.1016/j.neuron.2007.10.019; Colon-Ramos DA, 2007, SCIENCE, V318, P103, DOI 10.1126/science.1143762; Erskine L, 2007, DEV BIOL, V308, P1, DOI 10.1016/j.ydbio.2007.05.013; FRANK E, 1990, J NEUROSCI, V10, P2250; Gu CH, 2005, SCIENCE, V307, P265, DOI 10.1126/science.1105416; Klassen MP, 2007, CELL, V130, P704, DOI 10.1016/j.cell.2007.06.046; Klein R, 2009, NAT NEUROSCI, V12, P15, DOI 10.1038/nn.2231; Liu XB, 2005, J NEUROSCI, V25, P9124, DOI 10.1523/JNEUROSCI.2648-05.2005; Livet J, 2002, NEURON, V35, P877, DOI 10.1016/S0896-6273(02)00863-2; Mears SC, 1997, J NEUROSCI, V17, P3128; Paradis S, 2007, NEURON, V53, P217, DOI 10.1016/j.neuron.2006.12.012; Pecho-Vrieseling E, 2009, NATURE, V459, P842, DOI 10.1038/nature08000; Poon VY, 2008, NATURE, V455, P669, DOI 10.1038/nature07291; Ramon, 1954, NEURON THEORY RETICU; Tran TS, 2007, ANNU REV CELL DEV BI, V23, P263, DOI 10.1146/annurev.cellbio.22.010605.093554; Vrieseling E, 2006, CELL, V127, P1439, DOI 10.1016/j.cell.2006.10.042; Winberg ML, 1998, CELL, V93, P581, DOI 10.1016/S0092-8674(00)81187-3; Yamagata M, 2008, NATURE, V451, P465, DOI 10.1038/nature06469; Yoshida Y, 2006, NEURON, V52, P775, DOI 10.1016/j.neuron.2006.10.032	23	4	4	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	JUL 16	2009	63	1					8	11		10.1016/j.neuron.2009.07.002	http://dx.doi.org/10.1016/j.neuron.2009.07.002			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	473EX	19607788	Bronze			2022-12-24	WOS:000268189900004
J	Tost, H; Braus, DF; Hakimi, S; Ruf, M; Vollmert, C; Hohn, F; Meyer-Lindenberg, A				Tost, Heike; Braus, Dieter F.; Hakimi, Shabnam; Ruf, Matthias; Vollmert, Christian; Hohn, Fabian; Meyer-Lindenberg, Andreas			Acute D-2 receptor blockade induces rapid, reversible remodeling in human cortical-striatal circuits	NATURE NEUROSCIENCE			English	Article							HALOPERIDOL; NEURONS; BRAIN; GENE	Structural remodeling has been observed in the human brain over periods of weeks to months, but the molecular mechanisms governing this process remain incompletely characterized. Using multimodal pharmaco-neuroimaging, we found that acute D-2 receptor blockade induced reversible striatal volume changes and structural-functional decoupling in motor circuits within hours; these alterations predicted acute extrapyramidal motor symptoms with high precision. Our findings suggest a role for D-2 receptors in short-term neural plasticity and identify a potential biomarker for neuroleptic side effects in humans.	[Tost, Heike; Braus, Dieter F.; Ruf, Matthias; Vollmert, Christian; Hohn, Fabian; Meyer-Lindenberg, Andreas] Heidelberg Univ, Med Fac Mannheim, Cent Inst Mental Hlth, Dept Psychiat & Psychotherapy, D-6800 Mannheim, Germany; [Tost, Heike; Hakimi, Shabnam] NIMH, Clin Brain Disorders Branch, Genes Cognit & Psychosis Program, NIH,Dept Hlth & Human Serv, Bethesda, MD 20892 USA; [Braus, Dieter F.] Clin Psychiat & Psychotherapy, Dr Horst Schmidt Clin, Wiesbaden, Germany; [Ruf, Matthias] Heidelberg Univ, Med Fac Mannheim, Dept Neuroimaging, Cent Inst Mental Hlth, D-6800 Mannheim, Germany; [Vollmert, Christian] Heidelberg Univ, Med Fac Mannheim, Dept Addict Behav & Addict Med, Cent Inst Mental Hlth, D-6800 Mannheim, Germany	Central Institute of Mental Health; Ruprecht Karls University Heidelberg; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Central Institute of Mental Health; Ruprecht Karls University Heidelberg; Central Institute of Mental Health; Ruprecht Karls University Heidelberg	Tost, H (corresponding author), Heidelberg Univ, Med Fac Mannheim, Cent Inst Mental Hlth, Dept Psychiat & Psychotherapy, D-6800 Mannheim, Germany.	tosth@mail.nih.gov	Tost, med. Dr. phil. Heike/AAX-8305-2020; Meyer-Lindenberg, Andreas/H-1076-2011	Meyer-Lindenberg, Andreas/0000-0001-5619-1123; Hakimi, Shabnam/0000-0003-4122-6041	National Institute of Mental Health; US National Institutes of Health; Deutsche Forschungsgemeinschaft-National Institutes of Health [To 539/1-1]	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft-National Institutes of Health	We thank A. Tenckhoff, J. Rauschenberg, A. Schmitt, M. Hoerst and I. Wolf for research assistance. This research was supported in part by the Intramural Research Program of the National Institute of Mental Health, the US National Institutes of Health and a Deutsche Forschungsgemeinschaft-National Institutes of Health scholarship grant to H. T. (To 539/1-1).	ALEXANDER GE, 1990, PROG BRAIN RES, V85, P119; Chartoff EH, 1999, J PHARMACOL EXP THER, V291, P531; Dawson NM, 2001, SYNAPSE, V39, P70, DOI 10.1002/1098-2396(20010101)39:1<70::AID-SYN10>3.0.CO;2-J; Driemeyer J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002669; Kamin J, 2000, PSYCHIAT SERV, V51, P287, DOI 10.1176/appi.ps.51.3.287; Kovacs KJ, 2001, NEUROPHARMACOLOGY, V40, P383, DOI 10.1016/S0028-3908(00)00163-5; Marchese G, 2002, EUR J NEUROSCI, V15, P1187, DOI 10.1046/j.1460-9568.2002.01944.x; Meyer-Lindenberg A, 2007, J CLIN INVEST, V117, P672, DOI 10.1172/JCI30413; Miyashita T, 2008, NEUROBIOL LEARN MEM, V89, P269, DOI 10.1016/j.nlm.2007.08.012; Parish CL, 2002, EUR J NEUROSCI, V16, P787, DOI 10.1046/j.1460-9568.2002.02132.x; Parish CL, 2001, J NEUROSCI, V21, P5147, DOI 10.1523/JNEUROSCI.21-14-05147.2001; Samaha AN, 2008, BIOL PSYCHIAT, V64, P145, DOI 10.1016/j.biopsych.2008.01.010; Tost H, 2006, BIOL PSYCHIAT, V60, P1196, DOI 10.1016/j.biopsych.2006.04.014; Wong DF, 2007, INT REV PSYCHIATR, V19, P541, DOI 10.1080/09540260701564849; Xu MQ, 2008, PHARMACOGENET GENOM, V18, P449, DOI 10.1097/FPC.0b013e3282f85e26	15	98	98	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2010	13	8					920	922		10.1038/nn.2572	http://dx.doi.org/10.1038/nn.2572			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	632DK	20526332				2022-12-24	WOS:000280400600008
J	Fleidervish, IA; Lasser-Ross, N; Gutnick, MJ; Ross, WN				Fleidervish, Ilya A.; Lasser-Ross, Nechama; Gutnick, Michael J.; Ross, William N.			Na+ imaging reveals little difference in action potential-evoked Na+ influx between axon and soma	NATURE NEUROSCIENCE			English	Article							NEOCORTICAL PYRAMIDAL NEURONS; CEREBELLAR PURKINJE NEURONS; PERSISTENT SODIUM CURRENT; INITIAL SEGMENT; SYNAPTIC EFFICACY; BASAL DENDRITES; OPTIC NERVES; CHANNELS; RAT; CALCIUM	In cortical pyramidal neurons, the axon initial segment (AIS) is pivotal in synaptic integration. It has been asserted that this is because there is a high density of Na+ channels in the AIS. However, we found that action potential-associated Na+ flux, as measured by high-speed fluorescence Na+ imaging, was about threefold larger in the rat AIS than in the soma. Spike-evoked Na+ flux in the AIS and the first node of Ranvier was similar and was eightfold lower in basal dendrites. At near-threshold voltages, persistent Na+ conductance was almost entirely axonal. On a time scale of seconds, passive diffusion, and not pumping, was responsible for maintaining transmembrane Na+ gradients in thin axons during high-frequency action potential firing. In computer simulations, these data were consistent with the known features of action potential generation in these neurons.	[Fleidervish, Ilya A.] Ben Gurion Univ Negev, Fac Hlth Sci, Dept Physiol, Beer Sheva, Israel; [Fleidervish, Ilya A.; Lasser-Ross, Nechama; Gutnick, Michael J.; Ross, William N.] Marine Biol Lab, Woods Hole, MA 02543 USA; [Fleidervish, Ilya A.; Gutnick, Michael J.] Hebrew Univ Jerusalem, Koret Sch Vet Med, IL-76100 Rehovot, Israel; [Lasser-Ross, Nechama; Ross, William N.] New York Med Coll, Dept Physiol, Valhalla, NY 10595 USA	Ben Gurion University; Marine Biological Laboratory - Woods Hole; Hebrew University of Jerusalem; New York Medical College	Fleidervish, IA (corresponding author), Ben Gurion Univ Negev, Fac Hlth Sci, Dept Physiol, Beer Sheva, Israel.	ilya@bgu.ac.il	FLEIDERVISH, Ilya/F-2324-2012; Gutnick, Michael/P-7910-2019	Fleidervish, Ilya/0000-0002-5501-726X; Gutnick, Michael/0000-0003-2564-5094	US-Israel Binational Science Foundation [2003082]; Israel Science Foundation [1376-06]; Marine Biological Laboratory; US National Institutes of Health [NS16295]; Multiple Sclerosis Society [PP1367]; Gruss Lipper Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS016295, R01NS016295] Funding Source: NIH RePORTER	US-Israel Binational Science Foundation(US-Israel Binational Science Foundation); Israel Science Foundation(Israel Science Foundation); Marine Biological Laboratory; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Multiple Sclerosis Society(National Multiple Sclerosis Society); Gruss Lipper Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank S. Manita for excellent help with the preparation of slices. This work was supported by a US-Israel Binational Science Foundation grant (2003082), a grant from the Israel Science Foundation (1376-06), a Grass Faculty grant from the Marine Biological Laboratory, a US National Institutes of Health grant (NS16295), a Multiple Sclerosis Society grant (PP1367) and a fellowship from the Gruss Lipper Foundation.	Acker CD, 2009, J NEUROPHYSIOL, V101, P1524, DOI 10.1152/jn.00651.2007; Alle H, 2009, SCIENCE, V325, P1405, DOI 10.1126/science.1174331; ALZHEIMER C, 1993, J NEUROSCI, V13, P660; Astman N, 2006, J NEUROSCI, V26, P3465, DOI 10.1523/JNEUROSCI.4907-05.2006; Attwell D, 2002, TRENDS NEUROSCI, V25, P621, DOI 10.1016/S0166-2236(02)02264-6; Bean BP, 2007, NAT REV NEUROSCI, V8, P451, DOI 10.1038/nrn2148; Bender KJ, 2009, NEURON, V61, P259, DOI 10.1016/j.neuron.2008.12.004; Callaway JC, 1997, J NEUROPHYSIOL, V77, P145, DOI 10.1152/jn.1997.77.1.145; Carter BC, 2009, NEURON, V64, P898, DOI 10.1016/j.neuron.2009.12.011; Clark BA, 2005, NAT NEUROSCI, V8, P137, DOI 10.1038/nn1390; Colbert CM, 1996, J NEUROSCI, V16, P6676; Colbert CM, 2002, NAT NEUROSCI, V5, P533, DOI 10.1038/nn857; Engel D, 2005, NEURON, V45, P405, DOI 10.1016/j.neuron.2004.12.048; Fleidervish IA, 1996, J NEUROPHYSIOL, V76, P2125, DOI 10.1152/jn.1996.76.3.2125; Helmchen F, 1996, BIOPHYS J, V70, P1069, DOI 10.1016/S0006-3495(96)79653-4; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; HODGKIN AL, 1956, J PHYSIOL-LONDON, V131, P592, DOI 10.1113/jphysiol.1956.sp005485; Hu WQ, 2009, NAT NEUROSCI, V12, P996, DOI 10.1038/nn.2359; Kole MHP, 2008, NAT NEUROSCI, V11, P1253, DOI 10.1038/nn.2203; Kole MHP, 2008, NAT NEUROSCI, V11, P178, DOI 10.1038/nn2040; Kole MHP, 2007, NEURON, V55, P633, DOI 10.1016/j.neuron.2007.07.031; KUSHMERICK MJ, 1969, SCIENCE, V166, P1297, DOI 10.1126/science.166.3910.1297; Larkum ME, 2003, J PHYSIOL-LONDON, V549, P471, DOI 10.1113/jphysiol.2002.037614; LASSERROSS N, 1992, P ROY SOC B-BIOL SCI, V247, P35, DOI 10.1098/rspb.1992.0006; LELIEVRE L, 1979, BIOCHIM BIOPHYS ACTA, V557, P399, DOI 10.1016/0005-2736(79)90338-9; Mainen ZF, 1995, NEURON, V15, P1427, DOI 10.1016/0896-6273(95)90020-9; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; MATA M, 1991, J NEUROCHEM, V57, P184, DOI 10.1111/j.1471-4159.1991.tb02114.x; MINTA A, 1989, J BIOL CHEM, V264, P19449; NEHER E, 1992, J PHYSIOL-LONDON, V450, P273, DOI 10.1113/jphysiol.1992.sp019127; Nevian T, 2007, NAT NEUROSCI, V10, P206, DOI 10.1038/nn1826; Palmer LM, 2006, J NEUROSCI, V26, P1854, DOI 10.1523/JNEUROSCI.4812-05.2006; PETERS A, 1966, Q J EXP PHYSIOL CMS, V51, P229, DOI 10.1113/expphysiol.1966.sp001852; Rose CR, 1999, PFLUG ARCH EUR J PHY, V439, P201, DOI 10.1007/s004240051145; Royeck M, 2008, J NEUROPHYSIOL, V100, P2361, DOI 10.1152/jn.90332.2008; SHRAGER P, 1987, J PHYSIOL-LONDON, V392, P587, DOI 10.1113/jphysiol.1987.sp016798; STUART G, 1995, NEURON, V15, P1065, DOI 10.1016/0896-6273(95)90095-0; Stuart G, 1997, J PHYSIOL-LONDON, V505, P617, DOI 10.1111/j.1469-7793.1997.617ba.x; STUART GJ, 1993, PFLUG ARCH EUR J PHY, V423, P511, DOI 10.1007/BF00374949; SUGIHARA I, 1993, J PHYSIOL-LONDON, V470, P243, DOI 10.1113/jphysiol.1993.sp019857; Zhang CL, 2006, J NEUROPHYSIOL, V96, P695, DOI 10.1152/jn.00083.2006	41	128	130	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2010	13	7					852	U96		10.1038/nn.2574	http://dx.doi.org/10.1038/nn.2574			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	615YF	20543843	Green Accepted, Green Submitted			2022-12-24	WOS:000279173900018
J	Shimogori, T; Lee, DA; Miranda-Angulo, A; Yang, YQ; Wang, H; Jiang, LZ; Yoshida, AC; Kataoka, A; Mashiko, H; Avetisyan, M; Qi, LX; Qian, J; Blackshaw, S				Shimogori, Tomomi; Lee, Daniel A.; Miranda-Angulo, Ana; Yang, Yanqin; Wang, Hong; Jiang, Lizhi; Yoshida, Aya C.; Kataoka, Ayane; Mashiko, Hiromi; Avetisyan, Marina; Qi, Lixin; Qian, Jiang; Blackshaw, Seth			A genomic atlas of mouse hypothalamic development	NATURE NEUROSCIENCE			English	Article							AREA ANTERIOR HYPOTHALAMUS; SONIC-HEDGEHOG; SEX-DIFFERENCES; CIRCADIAN-RHYTHMS; REGIONAL IDENTITY; GENE-EXPRESSION; MICE LACKING; BRAIN; DIENCEPHALON; FOREBRAIN	The hypothalamus is a central regulator of many behaviors that are essential for survival, such as temperature regulation, food intake and circadian rhythms. However, the molecular pathways that mediate hypothalamic development are largely unknown. To identify genes expressed in developing mouse hypothalamus, we performed microarray analysis at 12 different developmental time points. We then conducted developmental in situ hybridization for 1,045 genes that were dynamically expressed over the course of hypothalamic neurogenesis. We identified markers that stably labeled each major hypothalamic nucleus over the entire course of neurogenesis and constructed a detailed molecular atlas of the developing hypothalamus. As a proof of concept of the utility of these data, we used these markers to analyze the phenotype of mice in which Sonic Hedgehog (Shh) was selectively deleted from hypothalamic neuroepithelium and found that Shh is essential for anterior hypothalamic patterning. Our results serve as a resource for functional investigations of hypothalamic development, connectivity, physiology and dysfunction.	[Shimogori, Tomomi; Yoshida, Aya C.; Kataoka, Ayane; Mashiko, Hiromi] RIKEN BSI, Wako, Saitama, Japan; [Lee, Daniel A.; Miranda-Angulo, Ana; Wang, Hong; Jiang, Lizhi; Avetisyan, Marina; Qi, Lixin; Blackshaw, Seth] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD USA; [Yang, Yanqin; Qian, Jiang; Blackshaw, Seth] Johns Hopkins Univ, Sch Med, Dept Ophthalmol, Baltimore, MD 21205 USA; [Blackshaw, Seth] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Blackshaw, Seth] Johns Hopkins Univ, Sch Med, Ctr High Throughput Biol, Baltimore, MD USA; [Blackshaw, Seth] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD USA	RIKEN; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Shimogori, T (corresponding author), RIKEN BSI, 2-1 Hirosawa, Wako, Saitama, Japan.	tshimogori@brain.riken.jp; sblack@jhmi.edu	Shimogori, Tomomi/L-2893-2013	Shimogori, Tomomi/0000-0002-6931-5401; Avetisyan, Marina/0000-0001-9836-5005; Lee, Daniel/0000-0001-7411-2740; Miranda-Angulo, Ana L./0000-0003-4938-3033	RIKEN Brain Science Institute and Human Frontier Science Project; National Science Foundation; March of Dimes; Klingenstein Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS067393] Funding Source: NIH RePORTER	RIKEN Brain Science Institute and Human Frontier Science Project; National Science Foundation(National Science Foundation (NSF)); March of Dimes(March of Dimes); Klingenstein Fund(Klingenstein Philanthropies); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to thank C.-M. Fan for guidance concerning dissection of embryonic hypothalamus and S. Hattar, A. Moore and B. Nelson for comments on the manuscript. This work was supported by the RIKEN Brain Science Institute and Human Frontier Science Project (T.S.), a National Science Foundation Predoctoral Fellowship (D.A L.), a Basil O'Connor Starter Scholar Award from the March of Dimes (S.B.) and an award from the Klingenstein Fund (S.B.). S.B. is a W.M. Keck Distinguished Young Investigator in Medical Science.	Acampora D, 1999, GENE DEV, V13, P2787, DOI 10.1101/gad.13.21.2787; Alvarez-Bolado G, 2006, J PHYSIOL-LONDON, V575, P347, DOI 10.1113/jphysiol.2006.112763; Blackshaw S, 2004, PLOS BIOL, V2, P1411, DOI 10.1371/journal.pbio.0020247; Brown AE, 1999, DEV BRAIN RES, V115, P171, DOI 10.1016/S0165-3806(99)00061-9; Budefeld T, 2008, DEV NEUROBIOL, V68, P981, DOI 10.1002/dneu.20638; Caqueret A, 2005, HORM RES, V64, P222, DOI 10.1159/000088977; Charlton H, 2008, J NEUROENDOCRINOL, V20, P641, DOI 10.1111/j.1365-2826.2008.01718.x; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Dale JK, 1997, CELL, V90, P257, DOI 10.1016/S0092-8674(00)80334-7; Dassule HR, 2000, DEVELOPMENT, V127, P4775; Davis AM, 2004, J NEUROBIOL, V60, P424, DOI 10.1002/neu.20030; Elmquist JK, 1999, NEURON, V22, P221, DOI 10.1016/S0896-6273(00)81084-3; Fuller PM, 2008, SCIENCE, V320, P1074, DOI 10.1126/science.1153277; Fyffe SL, 2008, NEURON, V59, P947, DOI 10.1016/j.neuron.2008.07.030; Goshu E, 2004, MOL ENDOCRINOL, V18, P1251, DOI 10.1210/me.2003-0372; Gray PA, 2004, SCIENCE, V306, P2255, DOI 10.1126/science.1104935; Grove EA, 1998, DEVELOPMENT, V125, P2315; HATINI V, 1994, J NEUROBIOL, V25, P1293, DOI 10.1002/neu.480251010; Herrera E, 2004, DEVELOPMENT, V131, P5727, DOI 10.1242/dev.01431; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Ino H, 2004, J HISTOCHEM CYTOCHEM, V52, P311, DOI 10.1177/002215540405200302; Kataoka A, 2008, DEVELOPMENT, V135, P2873, DOI 10.1242/dev.021618; Kiecker C, 2004, NAT NEUROSCI, V7, P1242, DOI 10.1038/nn1338; Kruk MR, 1998, NEUROSCI BIOBEHAV R, V23, P163, DOI 10.1016/S0149-7634(98)00018-9; Labosky PA, 1997, DEVELOPMENT, V124, P1263; Lee JE, 2006, DEVELOPMENT, V133, P4451, DOI 10.1242/dev.02613; Manning L, 2006, DEV CELL, V11, P873, DOI 10.1016/j.devcel.2006.09.021; Mathieu J, 2002, DEVELOPMENT, V129, P3055; McGill BE, 2006, P NATL ACAD SCI USA, V103, P18267, DOI 10.1073/pnas.0608702103; Michaud JL, 1998, GENE DEV, V12, P3264, DOI 10.1101/gad.12.20.3264; Miura H, 1997, MECH DEVELOP, V65, P99, DOI 10.1016/S0925-4773(97)00062-2; Moga MM, 1997, J COMP NEUROL, V389, P508, DOI 10.1002/(SICI)1096-9861(19971222)389:3<508::AID-CNE11>3.0.CO;2-H; O'Rahilly S, 2009, NATURE, V462, P307, DOI 10.1038/nature08532; Ohyama K, 2008, DEVELOPMENT, V135, P3325, DOI 10.1242/dev.027078; Peinado JR, 2005, ENDOCRINOLOGY, V146, P3438, DOI 10.1210/en.2004-1289; Pera EM, 1998, DEV GENES EVOL, V208, P168, DOI 10.1007/s004270050170; PORTEUS MH, 1994, J NEUROSCI, V14, P6370; Rinn JL, 2005, TRENDS GENET, V21, P298, DOI 10.1016/j.tig.2005.03.005; Saper CB, 2005, NATURE, V437, P1257, DOI 10.1038/nature04284; Scholpp S, 2006, DEVELOPMENT, V133, P855, DOI 10.1242/dev.02248; Schonemann MD, 1995, GENE DEV, V9, P3122, DOI 10.1101/gad.9.24.3122; SHIMADA M, 1973, EXP NEUROL, V41, P163, DOI 10.1016/0014-4886(73)90187-8; Szabo NE, 2009, J NEUROSCI, V29, P6989, DOI 10.1523/JNEUROSCI.1089-09.2009; Szabo NE, 2009, J NEUROSCI, V29, P2453, DOI 10.1523/JNEUROSCI.4524-08.2009; Tobet S, 2009, J NEUROENDOCRINOL, V21, P387, DOI 10.1111/j.1365-2826.2009.01834.x; TOBET SA, 1995, J NEUROBIOL, V26, P75, DOI 10.1002/neu.480260107; Ulrich-Lai YM, 2009, NAT REV NEUROSCI, V10, P397, DOI 10.1038/nrn2647; WATSON SJ, 1977, P NATL ACAD SCI USA, V74, P5155, DOI 10.1073/pnas.74.11.5155; Wehr R, 1997, DEVELOPMENT, V124, P4447; Xu Q, 2008, J COMP NEUROL, V506, P16, DOI 10.1002/cne.21529	50	268	271	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2010	13	6					767	U153		10.1038/nn.2545	http://dx.doi.org/10.1038/nn.2545			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	600QY	20436479	Green Accepted			2022-12-24	WOS:000278003300023
J	Smetana, R; Juvin, L; Dubuc, R; Alford, S				Smetana, Roy; Juvin, Laurent; Dubuc, Rejean; Alford, Simon			A parallel cholinergic brainstem pathway for enhancing locomotor drive	NATURE NEUROSCIENCE			English	Article							LAYER II NEURONS; ENTORHINAL CORTEX; PEDUNCULOPONTINE NUCLEUS; RETICULOSPINAL NEURONS; PERSISTENT ACTIVITY; REGION; STIMULATION; ACTIVATION; PROJECTIONS; INITIATION	The brainstem locomotor system is believed to be organized serially from the mesencephalic locomotor region (MLR) to reticulospinal neurons, which in turn project to locomotor neurons in the spinal cord. We identified brainstem muscarinoceptive neurons in lampreys (Petromyzon marinus) that received parallel inputs from the MLR and projected back to reticulospinal cells to amplify and extend the duration of locomotor output. These cells responded to muscarine with extended periods of excitation, received direct muscarinic excitation from the MLR and projected glutamatergic excitation to reticulospinal neurons. Targeted blockade of muscarine receptors over these neurons profoundly reduced MLR-induced excitation of reticulospinal neurons and markedly slowed MLR-evoked locomotion. The presence of these neurons forces us to rethink the organization of supraspinal locomotor control, to include a sustained feedforward loop that boosts locomotor output.	[Smetana, Roy; Alford, Simon] Univ Illinois, Dept Biol Sci, Chicago, IL 60680 USA; [Smetana, Roy; Alford, Simon] Univ Illinois, Neurobiol Lab, Chicago, IL 60680 USA; [Juvin, Laurent; Dubuc, Rejean] Univ Montreal, Dept Physiol, Grp Rech Syst Nerveux Cent, Montreal, PQ H3C 3J7, Canada; [Dubuc, Rejean] Univ Quebec, Dept Kinanthropol, Montreal, PQ H3C 3P8, Canada	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Universite de Montreal; University of Quebec; University of Quebec Montreal	Alford, S (corresponding author), Univ Illinois, Dept Biol Sci, Chicago, IL 60680 USA.	sta@uic.edu	Juvin, Laurent/K-8532-2016	Juvin, Laurent/0000-0001-8847-1891; Alford, Simon/0000-0002-0454-4246	National Institute of Neurological Disorders and Stroke [R01 NS052699]; Canadian Institutes of Health Research [15129, 15176]; Natural Sciences and Engineering Research Council of Canada [217435-01]; Fonds de la Recherche en Sante du Quebec [5249]; Groupe de recherche sur le systeme nerveux central; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH084874] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052699] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Fonds de la Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec); Groupe de recherche sur le systeme nerveux central; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank D. Veilleux for assistance with experiments, C. Valiquette for his expertise in computer programming and F. Bernard for help with the figures. We also thank E. Hamid and M. Alpert for comments and critical discussion of this manuscript. This work was funded by a grant from the National Institute of Neurological Disorders and Stroke (R01 NS052699) to S. A. and Individual and Group grants from the Canadian Institutes of Health Research (grant numbers 15129 and 15176), the Natural Sciences and Engineering Research Council of Canada (grant number 217435-01) and the Groupe de recherche sur le systeme nerveux central from the Fonds de la Recherche en Sante du Quebec (grant number 5249 to R D.). L.J. received a Jasper fellowship from the Groupe de recherche sur le systeme nerveux central.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; ARMSTRONG DM, 1986, PROG NEUROBIOL, V26, P273, DOI 10.1016/0301-0082(86)90021-3; BERNAU NA, 1991, BRAIN RES, V557, P83, DOI 10.1016/0006-8993(91)90119-G; BLANTON MG, 1989, J NEUROSCI METH, V30, P203, DOI 10.1016/0165-0270(89)90131-3; Brocard F, 2003, J NEUROPHYSIOL, V90, P1714, DOI 10.1152/jn.00202.2003; Brocard F, 2010, J NEUROSCI, V30, P523, DOI 10.1523/JNEUROSCI.3433-09.2010; Cabelguen JM, 2003, J NEUROSCI, V23, P2434; Deliagina TG, 2002, BRAIN RES REV, V40, P166, DOI 10.1016/S0165-0173(02)00199-6; Dickson CT, 2000, J NEUROPHYSIOL, V83, P2562, DOI 10.1152/jn.2000.83.5.2562; Dickson CT, 1997, J NEUROSCI, V17, P6729; DiPrisco GV, 1997, SCIENCE, V278, P1122, DOI 10.1126/science.278.5340.1122; DOSSI RC, 1991, J NEUROPHYSIOL, V65, P393, DOI 10.1152/jn.1991.65.3.393; Dubuc R, 2008, BRAIN RES REV, V57, P172, DOI 10.1016/j.brainresrev.2007.07.016; Egorov AV, 2002, NATURE, V420, P173, DOI 10.1038/nature01171; GARCIARILL E, 1986, BRAIN RES BULL, V17, P33, DOI 10.1016/0361-9230(86)90158-9; GARCIARILL E, 1987, BRAIN RES, V411, P13, DOI 10.1016/0006-8993(87)90676-7; GARCIARILL E, 1987, BRAIN RES, V411, P1, DOI 10.1016/0006-8993(87)90675-5; Grillner S, 1997, SCIENCE, V278, P1087, DOI 10.1126/science.278.5340.1087; Grillner S, 2008, BRAIN RES REV, V57, P2, DOI 10.1016/j.brainresrev.2007.06.027; Homma Y, 2002, J NEUROPHYSIOL, V87, P3033, DOI 10.1152/jn.2002.87.6.3033; Jahn K, 2008, NEUROIMAGE, V39, P786, DOI 10.1016/j.neuroimage.2007.09.047; Jahn K, 2008, PROG BRAIN RES, V171, P353, DOI 10.1016/S0079-6123(08)00652-3; Klink R, 1997, J NEUROPHYSIOL, V77, P1829, DOI 10.1152/jn.1997.77.4.1829; Le Ray D, 2003, EUR J NEUROSCI, V17, P137, DOI 10.1046/j.1460-9568.2003.02417.x; Mamiya K, 2005, J APPL PHYSIOL, V99, P1127, DOI 10.1152/japplphysiol.00253.2005; MCCLELLAN AD, 1994, BRAIN RES, V663, P61, DOI 10.1016/0006-8993(94)90462-6; ORLOVSKY GN, 1970, BIOFIZIKA, V1, P171; Pombal MA, 2001, J COMP NEUROL, V431, P105, DOI 10.1002/1096-9861(20010226)431:1<105::AID-CNE1058>3.0.CO;2-P; ROVAINEN CM, 1967, J NEUROPHYSIOL, V30, P1000, DOI 10.1152/jn.1967.30.5.1000; RYE DB, 1988, J COMP NEUROL, V269, P315, DOI 10.1002/cne.902690302; SHIK M. L., 1966, BLOFIZIKA, V11, P659; SHOLOMENKO GN, 1991, EXP BRAIN RES, V85, P659, DOI 10.1007/BF00231752; Sirota MG, 2000, EUR J NEUROSCI, V12, P4081, DOI 10.1046/j.1460-9568.2000.00301.x; SKINNER RD, 1984, BRAIN RES, V323, P385, DOI 10.1016/0006-8993(84)90319-6; Smetana RW, 2007, J NEUROPHYSIOL, V97, P3181, DOI 10.1152/jn.00954.2006; STEEVES JD, 1984, BRAIN RES, V307, P263, DOI 10.1016/0006-8993(84)90480-3; Tahvildari B, 2008, J NEUROPHYSIOL, V99, P2006, DOI 10.1152/jn.00911.2007	37	45	46	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2010	13	6					731	U108		10.1038/nn.2548	http://dx.doi.org/10.1038/nn.2548			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	600QY	20473293	Green Accepted			2022-12-24	WOS:000278003300018
J	Minamimoto, T; Saunders, RC; Richmond, BJ				Minamimoto, Takafumi; Saunders, Richard C.; Richmond, Barry J.			Monkeys Quickly Learn and Generalize Visual Categories without Lateral Prefrontal Cortex	NEURON			English	Article							TEMPORAL CORTEX; WORKING-MEMORY; FRONTAL-CORTEX; RHESUS-MONKEYS; RHINAL CORTEX; REWARD; REPRESENTATION; IMPAIRMENTS; BEHAVIOR; LESIONS	Categorization is a basic mental process that helps individuals distinguish among groups of negative and positive objects, e.g., poisons and nutrients, or predators and prey. Monkey experiments have suggested that lateral prefrontal cortex (LPFC) participates in learning and processing visual categories. However, in humans category specific visual agnosia follows inferior temporal cortex but not LPFC damage. Here, we use a new behavioral approach to show that both normal monkeys and those with bilateral removal of LPFC learn and generalize perceptual categories of related visual stimuli rapidly without explicit instruction. These results strongly indicate that visual categorization occurs at some earlier stage of feed-forward processing, presumably in temporal cortex, without top-down information from LPFC.	[Minamimoto, Takafumi; Saunders, Richard C.; Richmond, Barry J.] NIMH, Neuropsychol Lab, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA; [Minamimoto, Takafumi] Natl Inst Radiol Sci, Dept Mol Neuroimaging, Mol Imaging Ctr, Chiba 2638555, Japan	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); National Institutes for Quantum Science & Technology	Minamimoto, T (corresponding author), NIMH, Neuropsychol Lab, NIH, Dept Hlth & Human Serv, Bldg 9, Bethesda, MD 20892 USA.	minamoto@nirs.go.jp; bjr@ln.nimh.nih.gov	Minamimoto, Takafumi/AAD-8726-2020; Minamimoto, Takafumi/D-6610-2012	Minamimoto, Takafumi/0000-0003-4305-0174; Minamimoto, Takafumi/0000-0003-4305-0174	National Institute of Mental Health; JSPS Research Fellowship for Japanese Biomedical and Behavioral Researchers at NIH; Takeda Science Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002032] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); JSPS Research Fellowship for Japanese Biomedical and Behavioral Researchers at NIH; Takeda Science Foundation(Takeda Science Foundation (TSF)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank D.P. Soucy, C. Yang, P. Chen, Y. Matsuda, and A. Lerchner for their technical assistance, M. Yamada for advice on literature, and K. Yamamoto, J.S. Simmons, and Y. Sugase-Miyamoto, and N. Matsumoto for the comments on the manuscript, and other helpful comments. This study was supported by the Intramural Research Program of the National Institute of Mental Health. T.M. was partly supported by JSPS Research Fellowship for Japanese Biomedical and Behavioral Researchers at NIH, and by Takeda Science Foundation. The views expressed in this article do not necessarily represent the views of the NIMH, NIH, or the United States Government.	Ashby F Gregory, 2004, Behav Cogn Neurosci Rev, V3, P101, DOI 10.1177/1534582304270782; BACHEVALIER J, 1986, BEHAV BRAIN RES, V20, P249, DOI 10.1016/0166-4328(86)90225-1; Baker CI, 2002, NAT NEUROSCI, V5, P1210, DOI 10.1038/nn960; Buckley MJ, 2009, SCIENCE, V325, P52, DOI 10.1126/science.1172377; BUTTER CM, 1963, EXP NEUROL, V7, P65, DOI 10.1016/0014-4886(63)90094-3; Freedman DJ, 2001, SCIENCE, V291, P312, DOI 10.1126/science.291.5502.312; Freedman DJ, 2002, J NEUROPHYSIOL, V88, P929, DOI 10.1152/jn.2002.88.2.929; Freedman DJ, 2003, J NEUROSCI, V23, P5235; Gainotti G, 2000, CORTEX, V36, P539, DOI 10.1016/S0010-9452(08)70537-9; Green DM, 1966, SIGNAL DETECTION THE; Hampson RE, 2004, P NATL ACAD SCI USA, V101, P3184, DOI 10.1073/pnas.0400162101; Hays AV, 1982, WESCON C P, V2, P1; Hoshi E, 2000, J NEUROPHYSIOL, V83, P2355, DOI 10.1152/jn.2000.83.4.2355; Kiani R, 2007, J NEUROPHYSIOL, V97, P4296, DOI 10.1152/jn.00024.2007; Liu Z, 2004, P NATL ACAD SCI USA, V101, P12336, DOI 10.1073/pnas.0403639101; Liu Z, 2000, NAT NEUROSCI, V3, P1307, DOI 10.1038/81841; Mansouri FA, 2009, NAT REV NEUROSCI, V10, P141, DOI 10.1038/nrn2538; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Minamimoto T, 2009, J NEUROPHYSIOL, V101, P437, DOI 10.1152/jn.90959.2008; Moore TL, 2009, BEHAV NEUROSCI, V123, P231, DOI 10.1037/a0014723; PETRIDES M, 1995, J NEUROSCI, V15, P359; *R DEV COR TEAM, 2004, R LANG ENV STAT COMP; Rushworth MFS, 1997, J NEUROSCI, V17, P4829; Shima K, 2007, NATURE, V445, P315, DOI 10.1038/nature05470; Sigala N, 2002, NATURE, V415, P318, DOI 10.1038/415318a; Tanji J, 2008, PHYSIOL REV, V88, P37, DOI 10.1152/physrev.00014.2007; Vogels R, 1999, EUR J NEUROSCI, V11, P1239, DOI 10.1046/j.1460-9568.1999.00531.x; Walker AE, 1940, J COMP NEUROL, V73, P59, DOI 10.1002/cne.900730106; WEISKRANTZ L, 1984, BRAIN, V107, P1033, DOI 10.1093/brain/107.4.1033	29	38	39	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	MAY 27	2010	66	4					501	507		10.1016/j.neuron.2010.04.010	http://dx.doi.org/10.1016/j.neuron.2010.04.010			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	610WX	20510855	Bronze			2022-12-24	WOS:000278771100006
J	Jiang, B; Huang, SY; de Pasquale, R; Millman, D; Song, LH; Lee, HK; Tsumoto, T; Kirkwood, A				Jiang, Bin; Huang, Shiyong; de Pasquale, Roberto; Millman, Daniel; Song, Lihua; Lee, Hey-Kyoung; Tsumoto, Tadaharu; Kirkwood, Alfredo			The Maturation of GABAergic Transmission in Visual Cortex Requires Endocannabinoid-Mediated LTD of Inhibitory Inputs during a Critical Period	NEURON			English	Article							LONG-TERM DEPRESSION; EXPERIENCE-DEPENDENT PLASTICITY; FAST-SPIKING INTERNEURONS; DARK REARING ALTERS; SYNAPTIC-TRANSMISSION; PYRAMIDAL NEURONS; GABA RELEASE; CANNABINOID RECEPTORS; NEOCORTICAL SYNAPSES; DEVELOPMENTAL SWITCH	Endocannabinoids are widely regarded as negative modulators of presynaptic release. Here, we present evidence that in visual cortex endocannabinoids are crucial for the maturation of GABAergic release. We found that between eye opening and puberty, release changes from an immature state with high release probability, short-term depression (STD), and high release variability during irregular patterned activity, to a mature state with reduced release probability, STD, and variability. This transition requires visual experience and stimulation of CBI cannabinoid receptors as it is mimicked by administration of CBI agonists, blocked by antagonists, and is absent in CB1R KO mice. In immature slices, activation of CBI receptors induces long-term depression of inhibitory responses (iLTD) and a reduction in STD and response variability. Based on these findings, we propose that visually induced endocannabinoid-dependent iLTD mediates the developmental decrease in release probability, STD, and response variability, which are characteristic of maturation of cortical GABAergic inhibition.	[Jiang, Bin; Tsumoto, Tadaharu] RIKEN, Brain Sci Inst, Wako, Saitama 3510198, Japan; [Jiang, Bin; Huang, Shiyong; de Pasquale, Roberto; Millman, Daniel; Kirkwood, Alfredo] Johns Hopkins Univ, Mind Brain Inst, Baltimore, MD 21218 USA; [Kirkwood, Alfredo] Johns Hopkins Univ, Dept Neurosci, Baltimore, MD 21218 USA; [Song, Lihua; Lee, Hey-Kyoung] Univ Maryland, Dept Biol, College Pk, MD 20742 USA	RIKEN; Johns Hopkins University; Johns Hopkins University; University System of Maryland; University of Maryland College Park	Tsumoto, T (corresponding author), RIKEN, Brain Sci Inst, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	tsumoto@brain.riken.jp; kirkwood@jhu.edu	Huang, Shiyong/D-5211-2009; DE PASQUALE, ROBERTO/AAE-2941-2019	Huang, Shiyong/0000-0003-2976-5798; De Pasquale, Roberto/0000-0003-3383-7715; Lee, Hey-Kyoung/0000-0002-5554-983X	 [RO1 EY12124];  [RO1 EY014882]; NATIONAL EYE INSTITUTE [R01EY014882, R01EY012124] Funding Source: NIH RePORTER	; ; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank Dr. E. Quinlan for insightful comments, Drs. J. Pickel and J.Z. Huang for the CB1R KO and the GFP(FS) mice, and Dr. K. Mackey for the CB1R antibody. This work was supported by RO1 EY12124 to A.K. and RO1 EY014882 to H.-K.L.	Abbott LF, 1997, SCIENCE, V275, P220, DOI 10.1126/science.275.5297.221; Bartos M, 2007, NAT REV NEUROSCI, V8, P45, DOI 10.1038/nrn2044; Chattopadhyaya B, 2004, J NEUROSCI, V24, P9598, DOI 10.1523/JNEUROSCI.1851-04.2004; Chevaleyre V, 2004, NEURON, V43, P871, DOI 10.1016/j.neuron.2004.08.036; Chevaleyre V, 2003, NEURON, V38, P461, DOI 10.1016/S0896-6273(03)00235-6; Chevaleyre V, 2006, ANNU REV NEUROSCI, V29, P37, DOI 10.1146/annurev.neuro.29.051605.112834; Choi SY, 2002, J NEUROSCI, V22, P5271; Corlew R, 2007, J NEUROSCI, V27, P9835, DOI 10.1523/JNEUROSCI.5494-06.2007; FABER DS, 1991, BIOPHYS J, V60, P1288, DOI 10.1016/S0006-3495(91)82162-2; Feldmeyer D, 2009, J PHYSIOL-LONDON, V587, P1889, DOI 10.1113/jphysiol.2009.169458; Finnerty GT, 1999, NATURE, V400, P367, DOI 10.1038/22553; Freiman I, 2006, J PHYSIOL-LONDON, V575, P789, DOI 10.1113/jphysiol.2006.114272; Frick A, 2007, J PHYSIOL-LONDON, V585, P103, DOI 10.1113/jphysiol.2007.141788; Galarreta M, 2008, CEREB CORTEX, V18, P2296, DOI 10.1093/cercor/bhm253; Gao WJ, 1999, J COMP NEUROL, V409, P261, DOI 10.1002/(SICI)1096-9861(19990628)409:2<261::AID-CNE7>3.0.CO;2-R; Goldberg EM, 2005, J NEUROSCI, V25, P5230, DOI 10.1523/JNEUROSCI.0722-05.2005; Gonchar Y, 1997, CEREB CORTEX, V7, P347, DOI 10.1093/cercor/7.4.347; Hashimotodani Y, 2007, CURR OPIN NEUROBIOL, V17, P360, DOI 10.1016/j.conb.2007.03.012; Heinen K, 2004, NEUROSCIENCE, V124, P161, DOI 10.1016/j.neuroscience.2003.11.004; Hensch TK, 1998, SCIENCE, V282, P1504, DOI 10.1126/science.282.5393.1504; Hill EL, 2007, J NEUROPHYSIOL, V97, P2580, DOI 10.1152/jn.00603.2006; Huang Y, 2008, J NEUROSCI, V28, P7074, DOI 10.1523/JNEUROSCI.0899-08.2008; Huang ZJ, 2008, CURR OPIN NEUROBIOL, V18, P77, DOI 10.1016/j.conb.2008.05.008; Huang ZJ, 1999, CELL, V98, P739, DOI 10.1016/S0092-8674(00)81509-3; Jiang B, 2005, BRAIN RES REV, V50, P126, DOI 10.1016/j.brainresrev.2005.05.007; Kang-Park MH, 2007, J NEUROPHYSIOL, V98, P1223, DOI 10.1152/jn.00091.2007; Kano M, 2009, PHYSIOL REV, V89, P309, DOI 10.1152/physrev.00019.2008; Katona I, 1999, J NEUROSCI, V19, P4544; KIRKWOOD A, 1994, J NEUROSCI, V14, P1634, DOI 10.1523/JNEUROSCI.14-03-01634.1994; KOMATSU Y, 1994, J NEUROSCI, V14, P6488; Kreczko A, 2009, NEURAL PLAST, V2009, DOI 10.1155/2009/415135; Kruglikov I, 2008, NEURON, V58, P911, DOI 10.1016/j.neuron.2008.04.024; Lovinger David M., 2008, V184, P435; LUHMANN HJ, 1991, J NEUROPHYSIOL, V65, P247, DOI 10.1152/jn.1991.65.2.247; Maffei A, 2004, NAT NEUROSCI, V7, P1353, DOI 10.1038/nn1351; Maffei A, 2006, NATURE, V443, P81, DOI 10.1038/nature05079; Marsicano G, 2002, NATURE, V418, P530, DOI 10.1038/nature00839; McDonald AJ, 2001, NEUROSCIENCE, V107, P641, DOI 10.1016/S0306-4522(01)00380-3; MICHEVA KD, 1995, P NATL ACAD SCI USA, V92, P11834, DOI 10.1073/pnas.92.25.11834; Mitchell JF, 2007, NEURON, V55, P131, DOI 10.1016/j.neuron.2007.06.018; Morales B, 2002, J NEUROSCI, V22, P8084; Narushima M, 2006, EUR J NEUROSCI, V24, P2246, DOI 10.1111/j.1460-9568.2006.05119.x; Nugent FS, 2007, NATURE, V446, P1086, DOI 10.1038/nature05726; Pan B, 2008, J NEUROSCI, V28, P14018, DOI 10.1523/JNEUROSCI.4035-08.2008; PETERS A, 1985, J COMP NEUROL, V234, P242, DOI 10.1002/cne.902340209; Reyes A, 1999, J NEUROSCI, V19, P3827; Sjostrom PJ, 2003, NEURON, V39, P641, DOI 10.1016/S0896-6273(03)00476-8; Spolidoro M, 2009, EXP BRAIN RES, V192, P335, DOI 10.1007/s00221-008-1509-3; Tang AH, 2007, NEUROSCI LETT, V422, P49, DOI 10.1016/j.neulet.2007.05.053; Tsodyks MV, 1997, P NATL ACAD SCI USA, V94, P719, DOI 10.1073/pnas.94.2.719; Uchigashima M, 2007, J NEUROSCI, V27, P3663, DOI 10.1523/JNEUROSCI.0448-07.2007; Wilson RI, 2001, NEURON, V31, P453, DOI 10.1016/S0896-6273(01)00372-5; Yanagisawa T, 2004, EUR J NEUROSCI, V20, P3006, DOI 10.1111/j.1460-9568.2004.03756.x; Zaitsev AV, 2007, J NEUROPHYSIOL, V97, P3567, DOI 10.1152/jn.01293.2006; Zimmer A, 1999, P NATL ACAD SCI USA, V96, P5780, DOI 10.1073/pnas.96.10.5780	55	84	86	0	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	APR 29	2010	66	2					248	259		10.1016/j.neuron.2010.03.021	http://dx.doi.org/10.1016/j.neuron.2010.03.021			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	591NQ	20435001	Green Accepted, Bronze			2022-12-24	WOS:000277308200010
J	Olsen, SR; Bhandawat, V; Wilson, RI				Olsen, Shawn R.; Bhandawat, Vikas; Wilson, Rachel I.			Divisive Normalization in Olfactory Population Codes	NEURON			English	Article							ANTENNAL LOBE; ODOR MIXTURES; GAIN-CONTROL; SIMPLE CELLS; INHIBITION; NEURONS; BULB; CAT; INFORMATION; REPRESENTATIONS	In many regions of the visual system, the activity of a neuron is normalized by the activity of other neurons in the same region. Here we show that a similar normalization occurs during olfactory processing in the Drosophila antennal lobe. We exploit the orderly anatomy of this circuit to independently manipulate feedforward and lateral input to second-order projection neurons (PNs). Lateral inhibition increases the level of feedforward input needed to drive PNs to saturation, and this normalization scales with the total activity of the olfactory receptor neuron (ORN) population. Increasing total ORN activity also makes PN responses more transient. Strikingly, a model with just two variables (feedforward and total ORN activity) accurately predicts PN odor responses. Finally, we show that discrimination by a linear decoder is facilitated by two complementary transformations: the saturating transformation intrinsic to each processing channel boosts weak signals, while normalization helps equalize responses to different stimuli.	[Olsen, Shawn R.; Bhandawat, Vikas; Wilson, Rachel I.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Wilson, RI (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA.	rachel_wilson@hms.harvard.edu	Wilson, Rachel/E-2227-2012	Wilson, Rachel/0000-0001-8573-9266; Olsen, Shawn/0000-0002-9568-7057	Charles A. King Trust; NIH [R01DC008174]; McKnight Scholar Award; Beck-man Young Investigator Award; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC008174] Funding Source: NIH RePORTER	Charles A. King Trust; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); McKnight Scholar Award; Beck-man Young Investigator Award; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	L.F. Abbott and S.X. Luo provided helpful suggestions, and A.W. Liu, J.H. Maunsell, and members of the Wilson Lab provided feedback on the manuscript. We thank K. Ito, L. Luo, L.B. Vosshall, and L.M. Stevens for fly stocks. This work was funded by a fellowship from the Charles A. King Trust (to V.B.), a grant from the NIH (R01DC008174), a McKnight Scholar Award, and Beck-man Young Investigator Award (to R.I.W.). R.I.W. is an HHMI Early Career Scientist. S.R.O., V.B., and R.I.W. designed the experiments/simulations and wrote the paper. S.R.O. and V.B. performed the recordings and analyzed the data. S.R.O. performed the simulations.	ALBRECHT DG, 1982, J NEUROPHYSIOL, V48, P217, DOI 10.1152/jn.1982.48.1.217; ALBRECHT DG, 1991, VISUAL NEUROSCI, V7, P531, DOI 10.1017/S0952523800010336; Asahina Kenta, 2009, J Biol, V8, P9, DOI 10.1186/jbiol108; Aticky JJ, 2011, NETWORK-COMP NEURAL, V22, P4, DOI [10.1088/0954-898X/3/2/009, 10.3109/0954898X.2011.638888]; Bargmann CI, 2006, NATURE, V444, P295, DOI 10.1038/nature05402; BARLOW HB, 1953, J PHYSIOL-LONDON, V119, P69, DOI 10.1113/jphysiol.1953.sp004829; Bhandawat V, 2007, NAT NEUROSCI, V10, P1474, DOI 10.1038/nn1976; BORST A, 1983, J COMP PHYSIOL, V152, P373, DOI 10.1007/BF00606242; CARANDINI M, 1994, SCIENCE, V264, P1333, DOI 10.1126/science.8191289; Carandini M, 1997, J NEUROSCI, V17, P8621; Carandini M, 2002, J NEUROSCI, V22, P10053; Cavanaugh JR, 2002, J NEUROPHYSIOL, V88, P2530, DOI 10.1152/jn.00692.2001; Cleland TA, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-7; Cleland TA, 2007, P NATL ACAD SCI USA, V104, P1953, DOI 10.1073/pnas.0608564104; Das A, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-33; DEAN AF, 1986, EXP BRAIN RES, V62, P143; Deisig N, 2006, EUR J NEUROSCI, V24, P1161, DOI 10.1111/j.1460-9568.2006.04959.x; ENROTHCU.C, 1973, J PHYSIOL-LONDON, V233, P271, DOI 10.1113/jphysiol.1973.sp010308; Fantana AL, 2008, NEURON, V59, P802, DOI 10.1016/j.neuron.2008.07.039; Freeman TCB, 2002, NEURON, V35, P759, DOI 10.1016/S0896-6273(02)00819-X; Giraudet P, 2002, J NEUROPHYSIOL, V88, P829, DOI 10.1152/jn.2002.88.2.829; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; HARTLINE HK, 1956, J GEN PHYSIOL, V39, P651, DOI 10.1085/jgp.39.5.651; HARTLINE HK, 1952, COLD SPRING HARB SYM, V17, P125, DOI 10.1101/SQB.1952.017.01.013; HEEGER DJ, 1992, VISUAL NEUROSCI, V9, P181, DOI 10.1017/S0952523800009640; Johnson BA, 2000, J COMP NEUROL, V422, P496, DOI 10.1002/1096-9861(20000710)422:4<496::AID-CNE2>3.0.CO;2-4; KANG JS, 1995, J NEUROPHYSIOL, V74, P1435, DOI 10.1152/jn.1995.74.4.1435; Kazama H, 2008, NEURON, V58, P401, DOI 10.1016/j.neuron.2008.02.030; KUFFLER SW, 1953, J NEUROPHYSIOL, V16, P37, DOI 10.1152/jn.1953.16.1.37; Lai SL, 2008, DEVELOPMENT, V135, P2883, DOI 10.1242/dev.024380; Laurent G, 2002, NAT REV NEUROSCI, V3, P884, DOI 10.1038/nrn964; Lee J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004651; Lledo PM, 2005, PHYSIOL REV, V85, P281, DOI 10.1152/physrev.00008.2004; LUO SXL, 2008, COSYNE 08 SALT LAK C; MORRONE MC, 1982, PROC R SOC SER B-BIO, V216, P335, DOI 10.1098/rspb.1982.0078; Nagel KI, 2006, NEURON, V51, P845, DOI 10.1016/j.neuron.2006.08.030; NAKA KI, 1966, J PHYSIOL-LONDON, V185, P587, DOI 10.1113/jphysiol.1966.sp008003; Olsen SR, 2008, NATURE, V452, P956, DOI 10.1038/nature06864; Olsen SR, 2007, NEURON, V54, P89, DOI 10.1016/j.neuron.2007.03.010; Reynolds JH, 2009, NEURON, V61, P168, DOI 10.1016/j.neuron.2009.01.002; Root CM, 2008, NEURON, V59, P311, DOI 10.1016/j.neuron.2008.07.003; Root CM, 2007, P NATL ACAD SCI USA, V104, P11826, DOI 10.1073/pnas.0704523104; Sachse S, 2003, EUR J NEUROSCI, V18, P2119, DOI 10.1046/j.1460-9568.2003.02931.x; Schwartz O, 2001, NAT NEUROSCI, V4, P819, DOI 10.1038/90526; Shang YH, 2007, CELL, V128, P601, DOI 10.1016/j.cell.2006.12.034; SHAPLEY R, 1972, NATURE, V236, P352, DOI 10.1038/236352a0; Silbering AF, 2007, J NEUROSCI, V27, P11966, DOI 10.1523/JNEUROSCI.3099-07.2007; Simoncelli EP, 2003, CURR OPIN NEUROBIOL, V13, P144, DOI 10.1016/S0959-4388(03)00047-3; Soucy ER, 2009, NAT NEUROSCI, V12, P210, DOI 10.1038/nn.2262; Stopfer M, 2003, NEURON, V39, P991, DOI 10.1016/j.neuron.2003.08.011; Tabor R, 2004, J NEUROSCI, V24, P6611, DOI 10.1523/JNEUROSCI.1834-04.2004; Turner GC, 2008, J NEUROPHYSIOL, V99, P734, DOI 10.1152/jn.01283.2007; Wachowiak M, 2002, J NEUROPHYSIOL, V87, P1035, DOI 10.1152/jn.00522.2001; Wang YL, 2004, J NEUROSCI, V24, P6507, DOI 10.1523/JNEUROSCI.3727-03.2004; Williford T, 2006, J NEUROPHYSIOL, V96, P40, DOI 10.1152/jn.01207.2005; Zoccolan D, 2005, J NEUROSCI, V25, P8150, DOI 10.1523/JNEUROSCI.2058-05.2005	56	270	273	0	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 29	2010	66	2					287	299		10.1016/j.neuron.2010.04.009	http://dx.doi.org/10.1016/j.neuron.2010.04.009			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	591NQ	20435004	Green Accepted, Bronze			2022-12-24	WOS:000277308200013
J	Franco, CB; Chen, CC; Drukker, M; Weissman, IL; Galli, SJ				Franco, Christopher B.; Chen, Ching-Cheng; Drukker, Micha; Weissman, Irving L.; Galli, Stephen J.			Distinguishing Mast Cell and Granulocyte Differentiation at the Single-Cell Level	CELL STEM CELL			English	Article							HEMATOPOIETIC STEM-CELLS; IN-VITRO; LINEAGES; EXPRESSION; PROGENITOR; IDENTIFICATION; GATA-1; ROLES; MICE	The lineage restriction of prospectively isolated hematopoietic progenitors has been traditionally assessed by bulk in vitro culture and transplantation of large number of cells in vivo. These methods, however, cannot distinguish between homogenous multipotent or heterogeneous lineage-restricted populations. Using clonal assays of 1 or 5 cells in vitro, single-cell quantitative gene expression analyses, and transplantation of mice with low numbers of cells, we show that a common myeloid progenitor (CMP) is Sca-1(lo)lin(-)c-Kit(+)CD27(+)Flk-2(-) (SL-CMP; Sca-1(lo) CMP) and a granulocyte/macrophage progenitor (GMP) is Sca-1(lo)lin(-)c-Kit(+)CD27(+)Flk-2(+)CD150(-/lo) (SL-GMP; Sca-1(lo) GMP). We found that mast cell progenitor potential is present in the SL-CMP fraction, but not in the more differentiated SL-GMP population, and is more closely related to megakaryocyte/erythrocyte specification. Our data provide criteria for the prospective isolation of SL-CMP and SL-GMP and support the conclusion that mast cells are specified during hematopoiesis earlier than and independently from granulocytes.	[Franco, Christopher B.; Chen, Ching-Cheng; Drukker, Micha; Weissman, Irving L.] Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Galli, Stephen J.] Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA; [Franco, Christopher B.; Chen, Ching-Cheng; Weissman, Irving L.; Galli, Stephen J.] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Chen, CC (corresponding author), NGM Biopharmaceut Inc, 630 Gateway Blvd, San Francisco, CA 94080 USA.			Drukker, Micha/0000-0002-4279-1125; Chen, Ching-Cheng/0000-0003-4499-0889	NIH [AI23990, AI070813, CA72074, CA086065, HL058770, 5K99HL087936]; National Science Foundation Graduate Research Fellowship; Human Frontiers Science Program; NATIONAL CANCER INSTITUTE [R01CA086065, R01CA072074] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058770, K99HL087936, R00HL087936] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI023990, R01AI070813, R37AI023990, T32AI007290] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); Human Frontiers Science Program(Human Frontier Science Program); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank members of the I LW and S J G laboratories for helpful discussions, particularly R Lu, T Serwold, and J Seita We also thank L Jerabek for excellent lab management, C Muscat for antibody conjugation, and A Mosely for animal husbandry This work was supported by NIH grants AI23990, AI070813, and CA72074 (to S J G) and CA086065 and HL058770 (to I L W). a National Science Foundation Graduate Research Fellowship (to C B F), an NIH Pathway to Independence award 5K99HL087936 (to C -C C). and a Human Frontiers Science Program postdoctoral fellowship (to M D)	Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Arinobu Y, 2005, P NATL ACAD SCI USA, V102, P18105, DOI 10.1073/pnas.0509148102; Arinobu Y, 2007, CELL STEM CELL, V1, P416, DOI 10.1016/j.stem.2007.07.004; Baroni E, 2007, J LEUKOCYTE BIOL, V81, P250, DOI 10.1189/jlb.0506322; Bischoff SC, 2007, NAT REV IMMUNOL, V7, P93, DOI 10.1038/nri2018; Chen CC, 2005, P NATL ACAD SCI USA, V102, P11408, DOI 10.1073/pnas.0504197102; DVORAK AM, 1994, AM J PATHOL, V144, P160; Feyerabend TB, 2009, IMMUNITY, V30, P67, DOI 10.1016/j.immuni.2008.10.016; Galli SJ, 2005, ANNU REV IMMUNOL, V23, P749, DOI 10.1146/annurev.immunol.21.120601.141025; Iwasaki H, 2003, IMMUNITY, V19, P451, DOI 10.1016/S1074-7613(03)00242-5; Kalesnikoff J, 2008, NAT IMMUNOL, V9, P1215, DOI 10.1038/ni.f.216; KITAMURA Y, 1977, NATURE, V268, P442, DOI 10.1038/268442a0; KITAMURA Y, 1989, ANNU REV IMMUNOL, V7, P59, DOI 10.1146/annurev.iy.07.040189.000423; Laslo P, 2006, CELL, V126, P755, DOI 10.1016/j.cell.2006.06.052; Ling KW, 2004, J EXP MED, V200, P871, DOI 10.1084/jem.20031556; MARTIN DIK, 1990, NATURE, V344, P444, DOI 10.1038/344444a0; Miyamoto T, 2002, DEV CELL, V3, P137, DOI 10.1016/S1534-5807(02)00201-0; NAKANO T, 1994, SCIENCE, V265, P1098, DOI 10.1126/science.8066449; OGAWA M, 1989, HEMATOL ONCOL CLIN N, V3, P453, DOI 10.1016/S0889-8588(18)30541-0; Pronk CJH, 2007, CELL STEM CELL, V1, P428, DOI 10.1016/j.stem.2007.07.005; Rao KN, 2008, ANN NY ACAD SCI, V1143, P83, DOI 10.1196/annals.1443.023; REYNOLDS DS, 1989, J BIOL CHEM, V264, P20094; Rodewald HR, 1996, SCIENCE, V271, P818, DOI 10.1126/science.271.5250.818; Rodrigues NP, 2005, BLOOD, V106, P477, DOI 10.1182/blood-2004-08-2989; Schmitt TM, 2004, NAT IMMUNOL, V5, P410, DOI 10.1038/ni1055; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; SUDA T, 1983, P NATL ACAD SCI-BIOL, V80, P6689, DOI 10.1073/pnas.80.21.6689; Tipping AJ, 2009, BLOOD, V113, P2661, DOI 10.1182/blood-2008-06-161117; Wagers AJ, 2002, EXP HEMATOL, V30, P176, DOI 10.1016/S0301-472X(01)00777-9	29	72	73	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	APR 2	2010	6	4					361	368		10.1016/j.stem.2010.02.013	http://dx.doi.org/10.1016/j.stem.2010.02.013			8	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	585KD	20362540	Green Accepted, Bronze			2022-12-24	WOS:000276823300014
J	Idelson, M; Alper, R; Obolensky, A; Ben-Shushan, E; Hemo, I; Yachimovich-Cohen, N; Khaner, H; Smith, Y; Wiser, O; Gropp, M; Cohen, MA; Even-Ram, S; Berman-Zaken, Y; Matzrafi, L; Rechavi, G; Banin, E; Reubinoff, B				Idelson, Maria; Alper, Ruslana; Obolensky, Alexey; Ben-Shushan, Etti; Hemo, Itzhak; Yachimovich-Cohen, Nurit; Khaner, Hanita; Smith, Yoav; Wiser, Ofer; Gropp, Michal; Cohen, Malkiel A.; Even-Ram, Sharona; Berman-Zaken, Yael; Matzrafi, Limor; Rechavi, Gideon; Banin, Eyal; Reubinoff, Benjamin			Directed Differentiation of Human Embryonic Stem Cells into Functional Retinal Pigment Epithelium Cells	CELL STEM CELL			English	Article							RCS RATS; PHOTORECEPTOR DEGENERATION; EYE DEVELOPMENT; VISUAL FUNCTION; NICOTINAMIDE; TRANSPLANTATION; PRESERVATION; CONTRIBUTES; INHIBITOR; LONGEVITY	Dysfunction and loss of retinal pigment epithelium (RPE) leads to degeneration of photoreceptors in age-related macular degeneration and subtypes of retinitis pigmentosa. Human embryonic stem cells (hESCs) may serve as an unlimited source of RPE cells for transplantation in these blinding conditions. Here we show the directed differentiation of hESCs toward an RPE fate under defined culture conditions. We demonstrate that nicotinamide promotes the differentiation of hESCs to neural and subsequently to RPE fate. In the presence of nicotinamide, factors from the TGF-beta superfamily, which presumably pattern RIDE development during embryogenesis, further direct RPE differentiation. The hESC-derived pigmented cells exhibit the morphology, marker expression, and function of authentic RPE and rescue retinal structure and function after transplantation to an animal model of retinal degeneration caused by RPE dysfunction. These results are an important step toward the future use of hESCs to replenish RPE in blinding diseases.	[Idelson, Maria; Ben-Shushan, Etti; Yachimovich-Cohen, Nurit; Khaner, Hanita; Gropp, Michal; Cohen, Malkiel A.; Even-Ram, Sharona; Berman-Zaken, Yael; Reubinoff, Benjamin] Hadassah Hebrew Univ Med Ctr, Goldyne Savad Inst Gene Therapy, Hadassah Human Embryon Stem Cell Res Ctr, IL-91120 Jerusalem, Israel; [Idelson, Maria; Ben-Shushan, Etti; Yachimovich-Cohen, Nurit; Khaner, Hanita; Gropp, Michal; Cohen, Malkiel A.; Even-Ram, Sharona; Berman-Zaken, Yael; Reubinoff, Benjamin] Hadassah Hebrew Univ Med Ctr, Dept Gynecol, IL-91120 Jerusalem, Israel; [Smith, Yoav] Hadassah Hebrew Univ Med Ctr, Genom Data Anal Unit, IL-91120 Jerusalem, Israel; [Alper, Ruslana; Obolensky, Alexey; Hemo, Itzhak; Banin, Eyal] Hadassah Hebrew Univ Med Ctr, Ctr Retinal & Macular Degenerat, Dept Ophthalmol, IL-91120 Jerusalem, Israel; [Wiser, Ofer; Matzrafi, Limor] CellCure Neurosci Ltd, IL-91120 Jerusalem, Israel; [Rechavi, Gideon] Chaim Sheba Med Ctr, Pediat Hematooncol Dept, IL-52621 Tel Aviv, Israel; [Rechavi, Gideon] Chaim Sheba Med Ctr, Inst Hematol, IL-52621 Tel Aviv, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Chaim Sheba Medical Center; Chaim Sheba Medical Center	Reubinoff, B (corresponding author), Hadassah Hebrew Univ Med Ctr, Goldyne Savad Inst Gene Therapy, Hadassah Human Embryon Stem Cell Res Ctr, IL-91120 Jerusalem, Israel.	benjaminr@ekmd.huji.ac.il	Cohen, Malkiel/AAE-1115-2020	Cohen, Malkiel/0000-0002-4187-691X; Reubinoff, Benjamin/0000-0003-0353-1299; Even-Ram, Sharona/0000-0002-5540-3822	Hadassah Hebrew University Medical Center; Israel Science Foundation [989/07]; Chief Scientist Office of the Israel Ministry of Health [3000003274]; Israel Ministry of Science, Yedidut Research Grant; Sidney Swartz Chair in Human Embryonic Stem Cell Research; CellCure Neurosciences Ltd; CSO of CellCure Neurosciences	Hadassah Hebrew University Medical Center; Israel Science Foundation(Israel Science Foundation); Chief Scientist Office of the Israel Ministry of Health; Israel Ministry of Science, Yedidut Research Grant; Sidney Swartz Chair in Human Embryonic Stem Cell Research; CellCure Neurosciences Ltd; CSO of CellCure Neurosciences	We gratefully acknowledge the following members of the Hadassah Embryonic Stem Cell Research Center: Talia Mordechai, Michal Aharonowiz, and Galit Tzur for technical support and Shelly Tannenbaum for editing the manuscript. We also gratefully acknowledge Vitali Shilo from CellCure Neurosciences Ltd. for helping with cell counting and Temima Schnitzer Perlman from The Goldyne Savad Institute of Gene Therapy for helping with the deposit of the microarray data. We thank Ruth Yaul from the Hadassah Center for Retinal and Macular Degeneration for excellent technical assistance and to Israel Barzel and Marina Schulman from the department of Ophthalmology for their help in fundus imaging in vivo. We thank Michal Lotern (Sharett Institute of Oncology, Hadassah University Hospital) for her kind gift of human melanoma cell line M51 and WiCell Research Institute (Madison, WI) for providing H7 hESCs. Many thanks to John C. Saari (University of Washington, Seattle, WA) for providing the CRALBP antibody, to Micha Spira (Faculty of Science, Hebrew University, Jerusalem) for providing the green fluorescent beads, and to Naomi Feinstein and Hava Glickstein from The Department of Electron Microscopy (Hebrew University, Jerusalem) for their help in obtaining electron microscopy images. This research was supported in part by a grant to Hadassah Hebrew University Medical Center by the Israel Science Foundation (grant No. 989/07), the Chief Scientist Office of the Israel Ministry of Health (grant No. 3000003274), the Israel Ministry of Science, Yedidut Research Grant, and the Sidney Swartz Chair in Human Embryonic Stem Cell Research. N.Y.-C., H.K., M.G., and Y.B.-Z. are partially supported by a grant from CellCure Neurosciences Ltd. O.W. and L.M. are employees of CellCure Neurosciences, and B.R. is a founder, shareholder, and CSO of CellCure Neurosciences.	Aoki H, 2006, EXP EYE RES, V82, P265, DOI 10.1016/j.exer.2005.06.021; Ben-Dor I, 2006, MOL THER, V14, P255, DOI 10.1016/j.ymthe.2006.02.010; Chong ZZ, 2005, CURR NEUROVASC RES, V2, P271, DOI 10.2174/156720205774322584; Cimadamore F, 2009, STEM CELLS, V27, P1772, DOI 10.1002/stem.107; Coffey PJ, 2002, NAT NEUROSCI, V5, P53, DOI 10.1038/nn782; D'Cruz PM, 2000, HUM MOL GENET, V9, P645, DOI 10.1093/hmg/9.4.645; da Cruz L, 2007, PROG RETIN EYE RES, V26, P598, DOI 10.1016/j.preteyeres.2007.07.001; Draghici S, 2003, NUCLEIC ACIDS RES, V31, P3775, DOI 10.1093/nar/gkg624; Fuhrmann S, 2000, DEVELOPMENT, V127, P4599; Gropp M, 2003, MOL THER, V7, P281, DOI 10.1016/S1525-0016(02)00047-3; Harrison CA, 2003, J BIOL CHEM, V278, P21129, DOI 10.1074/jbc.M302015200; Haruta M, 2004, INVEST OPHTH VIS SCI, V45, P1020, DOI 10.1167/iovs.03-1034; Haruta Masathoshi, 2005, Semin Ophthalmol, V20, P17, DOI 10.1080/08820530590921846; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Klimanskaya I, 2004, CLONING STEM CELLS, V6, P217, DOI 10.1089/clo.2004.6.217; Kubota A, 2006, BIOMATERIALS, V27, P3639, DOI 10.1016/j.biomaterials.2006.02.018; Li FQ, 2006, CURR MED CHEM, V13, P883, DOI 10.2174/092986706776361058; Lin N, 1996, CURR EYE RES, V15, P1069, DOI 10.3109/02713689609017657; Little CW, 1996, INVEST OPHTH VIS SCI, V37, P204; Lund RD, 2006, CLONING STEM CELLS, V8, P189, DOI 10.1089/clo.2006.8.189; Martinez-Morales JR, 2004, BIOESSAYS, V26, P766, DOI 10.1002/bies.20064; Osakada F, 2008, NAT BIOTECHNOL, V26, P215, DOI 10.1038/nbt1384; OTONKOSKI T, 1993, J CLIN INVEST, V92, P1459, DOI 10.1172/JCI116723; Pankratz MT, 2007, STEM CELLS, V25, P1511, DOI 10.1634/stemcells.2006-0707; Paquet-Durand F, 2007, J NEUROSCI, V27, P10311, DOI 10.1523/JNEUROSCI.1514-07.2007; Prozorovski T, 2008, NAT CELL BIOL, V10, P385, DOI 10.1038/ncb1700; Reubinoff BE, 2000, NAT BIOTECHNOL, V18, P399, DOI 10.1038/74447; Sauve Y, 2002, NEUROSCIENCE, V114, P389, DOI 10.1016/S0306-4522(02)00271-3; Shen CC, 2004, J BIOMED SCI, V11, P472, DOI [10.1159/000077897, 10.1007/BF02256096]; Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004; Tao W, 2002, INVEST OPHTH VIS SCI, V43, P3292; Taylor RA, 2006, NAT METHODS, V3, P179, DOI 10.1038/nmeth855; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Vugler A, 2008, EXP NEUROL, V214, P347, DOI 10.1016/j.expneurol.2008.09.007	35	335	379	1	51	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	OCT 2	2009	5	4					396	408		10.1016/j.stem.2009.07.002	http://dx.doi.org/10.1016/j.stem.2009.07.002			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	514NP	19796620	Bronze			2022-12-24	WOS:000271401900011
J	Robin, C; Bollerot, K; Mendes, S; Haak, E; Crisan, M; Cerisoli, F; Lauw, I; Kaimakis, P; Jorna, R; Vermeulen, M; Kayser, M; van der Linden, R; Imanirad, P; Verstegen, M; Nawaz-Yousaf, H; Papazian, N; Steegers, E; Cupedo, T; Dzierzak, E				Robin, Catherine; Bollerot, Karine; Mendes, Sandra; Haak, Esther; Crisan, Mihaela; Cerisoli, Francesco; Lauw, Ivoune; Kaimakis, Polynikis; Jorna, Ruud; Vermeulen, Mark; Kayser, Manfred; van der Linden, Reinier; Imanirad, Parisa; Verstegen, Monique; Nawaz-Yousaf, Humaira; Papazian, Natalie; Steegers, Eric; Cupedo, Tom; Dzierzak, Elaine			Human Placenta Is a Potent Hematopoietic Niche Containing Hematopoietic Stem and Progenitor Cells throughout Development	CELL STEM CELL			English	Article							BONE-MARROW; YOLK-SAC; DEFINITIVE HEMATOPOIESIS; CHORIONIC VILLI; BLOOD; MOUSE; LINEAGE; IDENTIFICATION; CIRCULATION; EMERGENCE	Hematopoietic stem cells (HSCs) are responsible for the life-long production of the blood system and are pivotal cells in hematologic transplantation therapies. During mouse and human development, the first HSCs are produced in the aorta-gonad-mesonephros region. Subsequent to this emergence, HSCs are found in other anatomical sites of the mouse conceptus. While the mouse placenta contains abundant HSCs at midgestation, little is known concerning whether HSCs or hematopoietic progenitors are present and supported in the human placenta during development. In this study we show, over a range of developmental times including term, that the human placenta contains hematopoietic progenitors and HSCs. Moreover, stromal cell lines generated from human placenta at several developmental time points are pericyte-like cells and support human hematopoiesis. Immunostaining of placenta sections during development localizes hematopoietic cells in close contact with pericytes/perivascular cells. Thus, the human placenta is a potent hematopoietic niche throughout development.	[Robin, Catherine; Bollerot, Karine; Mendes, Sandra; Haak, Esther; Crisan, Mihaela; Cerisoli, Francesco; Lauw, Ivoune; Kaimakis, Polynikis; Jorna, Ruud; van der Linden, Reinier; Imanirad, Parisa; Nawaz-Yousaf, Humaira; Dzierzak, Elaine] Erasmus Univ, Med Ctr, Dept Cell Biol, Erasmus MC Stem Cell Inst, NL-3000 CA Rotterdam, Netherlands; [Verstegen, Monique; Papazian, Natalie; Cupedo, Tom] Erasmus Univ, Med Ctr, Dept Hematol, NL-3000 CA Rotterdam, Netherlands; [Vermeulen, Mark; Kayser, Manfred] Erasmus Univ, Med Ctr, Dept Forens Mol Biol, NL-3000 CA Rotterdam, Netherlands; [Steegers, Eric] Erasmus Univ, Med Ctr, Dept Obstet & Gynecol, NL-3000 CA Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Dzierzak, E (corresponding author), Erasmus Univ, Med Ctr, Dept Cell Biol, Erasmus MC Stem Cell Inst, NL-3000 CA Rotterdam, Netherlands.	e.dzierzak@erasmusmc.nl	Cupedo, Tom/GQQ-0614-2022	Kaimakis, Polynikis/0000-0002-2928-1729; Verstegen, Monique/0000-0001-9908-6673; van der Linden, Reinier/0000-0001-7437-8901	Landsteiner Society for Blood Research [0614]; NIH [DK51077]; Dutch BSIK Stem Cells in Development and Disease [03038]; Dutch BSIK Tissue Engineering; NWO VIDI [917.76.345]; Marie Curie Fellowship [CT-2006-025333]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK054077] Funding Source: NIH RePORTER	Landsteiner Society for Blood Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dutch BSIK Stem Cells in Development and Disease; Dutch BSIK Tissue Engineering; NWO VIDI(Netherlands Organization for Scientific Research (NWO)); Marie Curie Fellowship(European Commission); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank the research nurses Joke van Rhee-Binkorst and Wilma Keller (Erasmus MC), the staff of the CASA clinics in Leiden and Rotterdam and other clinical personnel, and most importantly, the tissue donors for their pivotal contributions. We also thank Frederik Walberg, Christiane Kuhl, and Tomomasa Yokomizo for experimental assistance and Kay Ballantyne for assistance in the statistical interpretation of STR profiles. Support was kindly provided by the Landsteiner Society for Blood Research (0614), NIH R37 (DK51077), Dutch BSIK Stem Cells in Development and Disease (03038), Dutch BSIK Tissue Engineering, NWO VIDI (917.76.345) (C.R.), and a Marie Curie Fellowship (CT-2006-025333) (K.B.).	Alvarez-Silva M, 2003, DEVELOPMENT, V130, P5437, DOI 10.1242/dev.00755; Bailo M, 2004, TRANSPLANTATION, V78, P1439, DOI 10.1097/01.TP.0000144606.84234.49; Barcena A, 2009, DEV BIOL, V327, P24, DOI 10.1016/j.ydbio.2008.11.017; Becker M, 2002, BRIT J CANCER, V87, P1328, DOI 10.1038/sj.bjc.6600573; Bhatia M, 1998, NAT MED, V4, P1038, DOI 10.1038/2023; Bhatia M, 1997, P NATL ACAD SCI USA, V94, P5320, DOI 10.1073/pnas.94.10.5320; Cashman J, 1997, BRIT J HAEMATOL, V98, P1026, DOI 10.1046/j.1365-2141.1997.3233140.x; Challier JC, 2005, PLACENTA, V26, P282, DOI 10.1016/j.placenta.2004.06.007; Chen YK, 2009, CANCER LETT, V278, P113, DOI 10.1016/j.canlet.2009.01.004; Corbel C, 2007, DEV BIOL, V301, P478, DOI 10.1016/j.ydbio.2006.08.069; Coulombel L, 2004, ONCOGENE, V23, P7210, DOI 10.1038/sj.onc.1207941; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; Cumano A, 1996, CELL, V86, P907, DOI 10.1016/S0092-8674(00)80166-X; de Bruijn MFTR, 2000, EMBO J, V19, P2465, DOI 10.1093/emboj/19.11.2465; Durand C, 2006, HAEMATOLOGICA, V91, P1172; Dzierzak E, 2008, NAT IMMUNOL, V9, P129, DOI 10.1038/ni1560; Ferkowicz MJ, 2003, DEVELOPMENT, V130, P4393, DOI 10.1242/dev.00632; Fukuchi Y, 2004, STEM CELLS, V22, P649, DOI 10.1634/stemcells.22-5-649; Gekas C, 2005, DEV CELL, V8, P365, DOI 10.1016/j.devcel.2004.12.016; Gude NM, 2004, THROMB RES, V114, P397, DOI 10.1016/j.thromres.2004.06.038; HANN IM, 1983, BLOOD, V62, P118; Igura K, 2004, CYTOTHERAPY, V6, P543, DOI 10.1080/14653240410005366-1; in't Anker PS, 2004, STEM CELLS, V22, P1338, DOI 10.1634/stemcells.2004-0058; Kim SJ, 2007, STEM CELLS DEV, V16, P421, DOI 10.1089/scd.2006.0098; Kumaravelu P, 2002, DEVELOPMENT, V129, P4891; Larochelle A, 1996, NAT MED, V2, P1329, DOI 10.1038/nm1296-1329; LI CD, 2005, PLACENTA IN PRESS; Medvinsky A, 1996, CELL, V86, P897, DOI 10.1016/S0092-8674(00)80165-8; Miao ZN, 2006, CELL BIOL INT, V30, P681, DOI 10.1016/j.cellbi.2006.03.009; Miyamoto K, 2004, STEM CELLS, V22, P433, DOI 10.1634/stemcells.22-4-433; Oberlin E, 2002, DEVELOPMENT, V129, P4147; Ottersbach K, 2005, DEV CELL, V8, P377, DOI 10.1016/j.devcel.2005.02.001; Palis J, 1999, DEVELOPMENT, V126, P5073; Parolini O, 2008, STEM CELLS, V26, P300, DOI 10.1634/stemcells.2007-0594; Pflumio F, 1996, BLOOD, V88, P3731, DOI 10.1182/blood.V88.10.3731.bloodjournal88103731; Portmann-Lanz CB, 2006, AM J OBSTET GYNECOL, V194, P664, DOI 10.1016/j.ajog.2006.01.101; Rhodes KE, 2008, CELL STEM CELL, V2, P252, DOI 10.1016/j.stem.2008.01.001; SULLIVAN KM, 1993, BIOTECHNIQUES, V15, P636; SULLIVAN KM, 1990, BIOTECHNIQUES, V15, P643; Tavian M, 2005, INT J DEV BIOL, V49, P243, DOI 10.1387/ijdb.041957mt; Tavian M, 2001, IMMUNITY, V15, P487, DOI 10.1016/S1074-7613(01)00193-5; Tavian M, 1996, BLOOD, V87, P67, DOI 10.1182/blood.V87.1.67.bloodjournal87167; Tavian M, 1999, DEVELOPMENT, V126, P793; Tse W, 2008, CURR OPIN HEMATOL, V15, P279, DOI 10.1097/MOH.0b013e328304ae2c; Wang JCY, 1997, BLOOD, V89, P3919, DOI 10.1182/blood.V89.11.3919; Wang JF, 2003, BLOOD, V101, P2924, DOI 10.1182/blood-2002-09-2782; WEIR BS, 2003, HDB STAT GENETICS, P830; Wulf GG, 2004, TISSUE ENG, V10, P1136, DOI 10.1089/ten.2004.10.1136; Yen BL, 2005, STEM CELLS, V23, P3, DOI 10.1634/stemcells.2004-0098; Zambidis ET, 2006, TRENDS CARDIOVAS MED, V16, P95, DOI 10.1016/j.tcm.2006.01.005; Zeigler BM, 2006, DEVELOPMENT, V133, P4183, DOI 10.1242/dev.02596; Zhang XH, 2006, BIOCHEM BIOPH RES CO, V340, P944, DOI 10.1016/j.bbrc.2005.12.091; Zhang Y, 2004, EXP HEMATOL, V32, P657, DOI 10.1016/j.exphem.2004.04.001	53	134	147	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	OCT 2	2009	5	4					385	395		10.1016/j.stem.2009.08.020	http://dx.doi.org/10.1016/j.stem.2009.08.020			11	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	514NP	19796619	Green Accepted, Bronze			2022-12-24	WOS:000271401900010
J	Stettler, DD; Axel, R				Stettler, Dan D.; Axel, Richard			Representations of Odor in the Piriform Cortex	NEURON			English	Article							OLFACTORY CORTEX; GLOMERULAR LAYER; EVOKED ACTIVITY; ORGANIZATION; MAP; EXPRESSION; SPARSE; BULB; DISCRIMINATION; TOPOGRAPHY	Olfactory perception is initiated by the recognition of odorants by a large repertoire of receptors in the sensory epithelium. A dispersed pattern of neural activity in the nose is converted into a segregated map in the olfactory bulb. How is this representation transformed at the next processing center for olfactory information, the piriform cortex? Optical imaging of odorant responses in the cortex reveals that the piriform discards spatial segregation as well as chemotopy and returns to a highly distributed organization in which different odorants activate unique but dispersed ensembles of cortical neurons. Neurons in piriform cortex, responsive to a given odorant, are not only distributed without apparent spatial preference but exhibit discontinuous receptive fields. This representation suggests organizational principles that differ from those in neocortical sensory areas where cells responsive to similar stimulus features are clustered and response properties vary smoothly across the cortex.	[Stettler, Dan D.; Axel, Richard] Columbia Univ, Coll Phys & Surg, Dept Neurosci, New York, NY 10032 USA; [Stettler, Dan D.; Axel, Richard] Columbia Univ, Coll Phys & Surg, Howard Hughes Med Inst, New York, NY 10032 USA	Columbia University; Columbia University; Howard Hughes Medical Institute	Axel, R (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Neurosci, New York, NY 10032 USA.	ra27@columbia.edu		Axel, Richard/0000-0002-3141-4076	Howard Hughes Medical Institute; Mathers Foundation	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Mathers Foundation	We thank Larry Abbott, Cori Bargmann, Randy Bruno, Charles Gilbert, Adam Hantman, Tom Jessell, Eric Kandel, Tony Movshon, Karel Svoboda, and members of the Axel lab for comments on the manuscript; Dara Sosulski for assistance with early experiments; Ming Zhong for technical assistance with later experiments; Monica Mendelsohn and Jennifer Kirkland for help with the mice; Larry Abbott for help in development of the random connectivity model; Bob Datta and John Rafter for assistance with two-photon microscopy; Kenichi Ohki and Clay Reid for providing advice concerning calcium dye injections; Gary Johnson for making some of the hardware used in these experiments; and Phyllis Kisloff, Miriam Gutierrez, and Adriana Nemes for assistance with general laboratory concerns and the preparation of this manuscript. Financial support was provided by the Howard Hughes Medical Institute and the Mathers Foundation.	[Anonymous], 1941, AM J OPHTHALMOL, DOI [10.1016/S0002-9394(41)91363-6, DOI 10.1016/S0002-9394(41)91363-6]; Araneda RC, 2004, J PHYSIOL-LONDON, V555, P743, DOI 10.1113/jphysiol.2003.058040; Belluscio L, 2001, J NEUROSCI, V21, P2113, DOI 10.1523/JNEUROSCI.21-06-02113.2001; Bozza T, 2004, NEURON, V42, P9, DOI 10.1016/S0896-6273(04)00144-8; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Davison IG, 2007, J NEUROSCI, V27, P2091, DOI 10.1523/JNEUROSCI.3779-06.2007; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Dreumont-Boudreau SE, 2006, PHYSIOL BEHAV, V87, P634, DOI 10.1016/j.physbeh.2006.01.001; Franks KM, 2006, NEURON, V49, P357, DOI 10.1016/j.neuron.2005.12.026; Godfrey PA, 2004, P NATL ACAD SCI USA, V101, P2156, DOI 10.1073/pnas.0308051100; HUBEL DH, 1959, J PHYSIOL-LONDON, V148, P574, DOI 10.1113/jphysiol.1959.sp006308; Illig KR, 2003, J COMP NEUROL, V457, P361, DOI 10.1002/cne.10557; INGARASHI KM, 2005, J NEUROPHYSIOL, V93, P1007; Johnson BA, 2000, J COMP NEUROL, V422, P496, DOI 10.1002/1096-9861(20000710)422:4<496::AID-CNE2>3.0.CO;2-4; Jortner RA, 2007, J NEUROSCI, V27, P1659, DOI 10.1523/JNEUROSCI.4171-06.2007; Kadohisa M, 2006, P NATL ACAD SCI USA, V103, P15206, DOI 10.1073/pnas.0604313103; Kerr JND, 2007, J NEUROSCI, V27, P13316, DOI 10.1523/JNEUROSCI.2210-07.2007; Lin DY, 2006, NEURON, V50, P937, DOI 10.1016/j.neuron.2006.03.021; Linster C, 1999, PHYSIOL BEHAV, V66, P701, DOI 10.1016/S0031-9384(99)00007-4; Litaudon P, 2003, EUR J NEUROSCI, V17, P2457, DOI 10.1046/j.1460-9568.2003.02654.x; MAINIC B, 1999, CELL, V96, P713; Marshall WH, 1941, J NEUROPHYSIOL, V4, P1; Meister M, 2001, J NEUROSCI, V21, P1351; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Murthy M, 2008, NEURON, V59, P1009, DOI 10.1016/j.neuron.2008.07.040; O'Keefe J, 1998, PHILOS T ROY SOC B, V353, P1333, DOI 10.1098/rstb.1998.0287; Ohki K, 2005, NATURE, V433, P597, DOI 10.1038/nature03274; Oka Y, 2006, NEURON, V52, P857, DOI 10.1016/j.neuron.2006.10.019; Poo C, 2009, NEURON, V62, P850, DOI 10.1016/j.neuron.2009.05.022; PRICE JL, 1970, J CELL SCI, V7, P631; Redish AD, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-05-j0004.2001; Rennaker RL, 2007, J NEUROSCI, V27, P1534, DOI 10.1523/JNEUROSCI.4072-06.2007; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; RESSLER KJ, 1993, CELL, V73, P597, DOI 10.1016/0092-8674(93)90145-G; Rubin BD, 1999, NEURON, V23, P499, DOI 10.1016/S0896-6273(00)80803-X; Soucy ER, 2009, NAT NEUROSCI, V12, P210, DOI 10.1038/nn.2262; Spors H, 2002, NEURON, V34, P301, DOI 10.1016/S0896-6273(02)00644-X; Stosiek C, 2003, P NATL ACAD SCI USA, V100, P7319, DOI 10.1073/pnas.1232232100; Sugai T, 2005, NEUROSCIENCE, V130, P769, DOI 10.1016/j.neuroscience.2004.09.059; Takahashi YK, 2004, J NEUROPHYSIOL, V92, P2413, DOI 10.1152/jn.00236.2004; Uchida N, 2000, NAT NEUROSCI, V3, P1035, DOI 10.1038/79857; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; VASSAR R, 1993, CELL, V74, P309, DOI 10.1016/0092-8674(93)90422-M; Wachowiak M, 2001, NEURON, V32, P723, DOI 10.1016/S0896-6273(01)00506-2; Wilson DA, 2003, J NEUROPHYSIOL, V90, P65, DOI 10.1152/jn.00133.2003; Wiltrout C, 2003, BEHAV NEUROSCI, V117, P236, DOI 10.1037/0735-7044.117.2.236; Woolsey CN, 1942, B JOHNS HOPKINS HOSP, V71, P315; Xu FQ, 2003, P NATL ACAD SCI USA, V100, P11029, DOI 10.1073/pnas.1832864100; Yaksi E, 2009, NAT NEUROSCI, V12, P474, DOI 10.1038/nn.2288; Yoshida I, 2007, J NEUROSCI, V27, P9105, DOI 10.1523/JNEUROSCI.2720-07.2007; Zhang XM, 2002, NAT NEUROSCI, V5, P124, DOI 10.1038/nn800	51	357	363	0	45	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 24	2009	63	6					854	864		10.1016/j.neuron.2009.09.005	http://dx.doi.org/10.1016/j.neuron.2009.09.005			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	503VP	19778513	Bronze			2022-12-24	WOS:000270569700017
J	Solecki, DJ; Trivedi, N; Govek, EE; Kerekes, RA; Gleason, SS; Hatten, ME				Solecki, David J.; Trivedi, Niraj; Govek, Eve-Ellen; Kerekes, Ryan A.; Gleason, Shaun S.; Hatten, Mary E.			Myosin II Motors and F-Actin Dynamics Drive the Coordinated Movement of the Centrosome and Soma during CNS Glial-Guided Neuronal Migration	NEURON			English	Article							DENDRITIC SPINE MORPHOGENESIS; DEVELOPING CEREBELLAR CORTEX; CELL-MIGRATION; CYTOPLASMIC DYNEIN; CEREBRAL-CORTEX; LIS1; MICROTUBULE; PROTRUSION; TRANSPORT; POLARITY	Lamination of cortical regions of the vertebrate brain depends on glial-guided neuronal migration. The conserved polarity protein Par6 alpha localizes to the centrosome and coordinates forward movement of the centrosome and soma in migrating neurons. The cytoskeletal components that produce this unique form of cell polarity and their relationship to polarity signaling cascades are unknown. We show that F-actin and Myosin II motors are enriched in the neuronal leading process and that Myosin II activity is necessary for leading process actin dynamics. Inhibition of Myosin II decreased the speed of centrosome and somal movement, whereas Myosin II activation increased coordinated movement. Ectopic expression or silencing of Par6 alpha inhibited Myosin II motors by decreasing Myosin light-chain phosphorylation. These findings suggest leading-process Myosin II may function to "pull" the centrosome and soma forward during glial-guided migration by a mechanism involving the conserved polarity protein Par6 alpha.	[Solecki, David J.; Trivedi, Niraj] St Jude Childrens Res Hosp, Dept Dev Neurobiol, Memphis, TN 38105 USA; [Govek, Eve-Ellen; Hatten, Mary E.] Rockefeller Univ, Dev Neurobiol Lab, New York, NY 10065 USA; [Kerekes, Ryan A.; Gleason, Shaun S.] Oak Ridge Natl Lab, Image Sci & Machine Vis Grp, Measurement Sci & Syst Engn Div, Oak Ridge, TN 37830 USA	St Jude Children's Research Hospital; Rockefeller University; United States Department of Energy (DOE); Oak Ridge National Laboratory	Solecki, DJ (corresponding author), St Jude Childrens Res Hosp, Dept Dev Neurobiol, 262 Danny Thomas Pl, Memphis, TN 38105 USA.	david.solecki@stjude.org	Solecki, David/N-8080-2018		American Lebanese Syrian Associated Charities; NCI [2 P30CA021765-30]; March of Dimes Basil O'Connor Starter Scholar Research Award; NIH [R01-NS15429-26, R01 NS051778-02]; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS015429, R01NS051778] Funding Source: NIH RePORTER	American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); March of Dimes Basil O'Connor Starter Scholar Research Award(March of Dimes); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to Drs. Linda Van Aelst and Bob Adelstein for critically reading the manuscript, Dr. Rick Horwitz for helpful discussions, and Dr. Jakub Famulski for aiding with the shRNA experiments. We are indebted to Dr. Bill Bement for providing the panel of UTRCH-ABD vectors and Dr. Atsushi Miyawaki for providing the Venus reporter. We also thank Dr. Anne Bresnick for the MLCK cDNA, Dr. Shuh Narumiya for the Rockl cDNA, Dr. Gary Banker for the Map2C cDNA, Dr. Ken Jacobson for the Paxillin cDNA, and Greg Law (Perkin Elmer) for the extended use of an Ultraview confocal microscope. We also thank Dr. Regan Baird and Intelligent Imaging Innovations for setting up our Marianas Workstation and developing Slidebook tools for volumetric and line-scanning analysis. This work was supported by American Lebanese Syrian Associated Charities (ALSAC; D.J.S.), NCI 2 P30CA021765-30 (D.J.S.), a March of Dimes Basil O'Connor Starter Scholar Research Award (D.J.S.), and NIH grants R01-NS15429-26 (M.E.H.) and R01 NS051778-02 (M.E.H.).	Bahler M, 2002, FEBS LETT, V513, P107, DOI 10.1016/S0014-5793(01)03239-2; Barros CS, 2003, DEV CELL, V5, P829, DOI 10.1016/S1534-5807(03)00359-9; Bellenchi GC, 2007, GENE DEV, V21, P2347, DOI 10.1101/gad.434307; Bellion A, 2005, J NEUROSCI, V25, P5691, DOI 10.1523/JNEUROSCI.1030-05.2005; Belvindrah R, 2007, J NEUROSCI, V27, P13854, DOI 10.1523/JNEUROSCI.4494-07.2007; Burkel BM, 2007, CELL MOTIL CYTOSKEL, V64, P822, DOI 10.1002/cm.20226; Cai YF, 2006, BIOPHYS J, V91, P3907, DOI 10.1529/biophysj.106.084806; Cramer LP, 1999, CURR BIOL, V9, P1095, DOI 10.1016/S0960-9822(99)80478-3; Doyle AD, 2009, J CELL BIOL, V184, P481, DOI 10.1083/jcb.200810041; Dujardin DL, 2003, J CELL BIOL, V163, P1205, DOI 10.1083/jcb.200310097; Dujardin DL, 2002, CURR OPIN CELL BIOL, V14, P44, DOI 10.1016/S0955-0674(01)00292-7; EDMONDSON JC, 1987, J NEUROSCI, V7, P1928; EDMONDSON JC, 1988, J CELL BIOL, V106, P505, DOI 10.1083/jcb.106.2.505; Faulkner NE, 2000, NAT CELL BIOL, V2, P784, DOI 10.1038/35041020; Feng YY, 2000, NEURON, V28, P665, DOI 10.1016/S0896-6273(00)00145-8; FISHELL G, 1991, DEVELOPMENT, V113, P755; Garces JA, 1999, CURR BIOL, V9, P1497, DOI 10.1016/S0960-9822(00)80122-0; Giannone G, 2004, CELL, V116, P431, DOI 10.1016/S0092-8674(04)00058-3; Gleeson JG, 1999, NEURON, V23, P257, DOI 10.1016/S0896-6273(00)80778-3; Gomes ER, 2005, CELL, V121, P451, DOI 10.1016/j.cell.2005.02.022; GREGORY WA, 1988, J NEUROSCI, V8, P1728; Guan CB, 2007, CELL, V129, P385, DOI 10.1016/j.cell.2007.01.051; Gupton SL, 2002, CURR BIOL, V12, P1891, DOI 10.1016/S0960-9822(02)01276-9; Gupton SL, 2006, CELL, V125, P1361, DOI 10.1016/j.cell.2006.05.029; HATTEN ME, 1985, J CELL BIOL, V100, P384, DOI 10.1083/jcb.100.2.384; Hatten ME, 2002, SCIENCE, V297, P1660, DOI 10.1126/science.1074572; Hirotsune S, 1998, NAT GENET, V19, P333, DOI 10.1038/1221; Holleran EA, 2001, J BIOL CHEM, V276, P36598, DOI 10.1074/jbc.M104838200; Holleran EA, 1996, J CELL BIOL, V135, P1815, DOI 10.1083/jcb.135.6.1815; Hu K, 2007, SCIENCE, V315, P111, DOI 10.1126/science.1135085; Kamm KE, 2001, J BIOL CHEM, V276, P4527, DOI 10.1074/jbc.R000028200; KAWAMOTO S, 1991, J CELL BIOL, V112, P915, DOI 10.1083/jcb.112.5.915; Kholmanskikh SS, 2006, NAT NEUROSCI, V9, P50, DOI 10.1038/nn1619; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Komuro H, 1998, J NEUROSCI, V18, P1478; Le Clainche C, 2008, PHYSIOL REV, V88, P489, DOI 10.1152/physrev.00021.2007; Litman Pninit, 2000, BMC Cell Biology, V1, P1, DOI 10.1186/1471-2121-1-1; Lo CM, 2004, MOL BIOL CELL, V15, P982, DOI 10.1091/mbc.E03-06-0359; Ma XF, 2004, MOL BIOL CELL, V15, P2568, DOI 10.1091/mbc.E03-11-0836; Matsumura F, 2005, TRENDS CELL BIOL, V15, P371, DOI 10.1016/j.tcb.2005.05.004; Mertens AEE, 2006, TRENDS CELL BIOL, V16, P308, DOI 10.1016/j.tcb.2006.04.001; Meshel AS, 2005, NAT CELL BIOL, V7, P157, DOI 10.1038/ncb1216; MITTAL B, 1987, J CELL BIOL, V105, P1753, DOI 10.1083/jcb.105.4.1753; MOUSSAVI RS, 1993, MOL CELL BIOCHEM, V128, P219, DOI 10.1007/BF01076773; Myers KA, 2006, NEUROSCIENTIST, V12, P107, DOI 10.1177/1073858405283428; Niethammer M, 2000, NEURON, V28, P697, DOI 10.1016/S0896-6273(00)00147-1; Nishimura T, 2005, NAT CELL BIOL, V7, P270, DOI 10.1038/ncb1227; OROURKE NA, 1992, SCIENCE, V258, P299, DOI 10.1126/science.1411527; Piel M, 2001, SCIENCE, V291, P1550, DOI 10.1126/science.1057330; Ponti A, 2004, SCIENCE, V305, P1782, DOI 10.1126/science.1100533; RAKIC P, 1971, J COMP NEUROL, V141, P283, DOI 10.1002/cne.901410303; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; RIVAS RJ, 1995, J NEUROSCI, V15, P981; ROCHLIN MW, 1995, J CELL SCI, V108, P3661; Roger B, 2004, CURR BIOL, V14, P363, DOI 10.1016/j.cub.2004.01.058; Rosenblatt J, 2004, CELL, V117, P361, DOI 10.1016/S0092-8674(04)00341-1; Salmon WC, 2002, J CELL BIOL, V158, P31, DOI 10.1083/jcb.200203022; Schaar BT, 2005, P NATL ACAD SCI USA, V102, P13652, DOI 10.1073/pnas.0506008102; Schaefer AW, 2008, DEV CELL, V15, P146, DOI 10.1016/j.devcel.2008.05.003; Schaefer AW, 2002, J CELL BIOL, V158, P139, DOI 10.1083/jcb.200203038; Smith DS, 2000, NAT CELL BIOL, V2, P767, DOI 10.1038/35041000; Solecki DJ, 2004, NAT NEUROSCI, V7, P1195, DOI 10.1038/nn1332; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; Tanaka T, 2004, J CELL BIOL, V165, P709, DOI 10.1083/jcb.200309025; Tsai JW, 2007, NAT NEUROSCI, V10, P970, DOI 10.1038/nn1934; Tsai JW, 2005, J CELL BIOL, V170, P935, DOI 10.1083/jcb.200505166; Umeshima H, 2007, P NATL ACAD SCI USA, V104, P16182, DOI 10.1073/pnas.0708047104; Vicente-Manzanares M, 2007, J CELL BIOL, V176, P573, DOI 10.1083/jcb.200612043; Vicente-Manzanares M, 2009, J CELL SCI, V122, P199, DOI 10.1242/jcs.018564; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Zhang HY, 2008, DEV CELL, V14, P216, DOI 10.1016/j.devcel.2007.11.020; Zhang HY, 2006, NAT CELL BIOL, V8, P227, DOI 10.1038/ncb1368	72	171	174	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 16	2009	63	1					63	80		10.1016/j.neuron.2009.05.028	http://dx.doi.org/10.1016/j.neuron.2009.05.028			18	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	473EX	19607793	Bronze, Green Accepted			2022-12-24	WOS:000268189900009
J	Mathews, PJ; Jercog, PE; Rinzel, J; Scott, LL; Golding, NL				Mathews, Paul J.; Jercog, Pablo E.; Rinzel, John; Scott, Luisa L.; Golding, Nace L.			Control of submillisecond synaptic timing in binaural coincidence detectors by K(v)1 channels	NATURE NEUROSCIENCE			English	Article							MEDIAL SUPERIOR OLIVE; VENTRAL COCHLEAR NUCLEUS; THRESHOLD POTASSIUM CURRENTS; INACTIVATING K+ CURRENT; SOUND LOCALIZATION; PRINCIPAL NEURONS; TEMPORAL INTEGRATION; PYRAMIDAL NEURONS; AUDITORY NEURONS; OCTOPUS CELLS	Neurons in the medial superior olive process sound-localization cues via binaural coincidence detection, in which excitatory synaptic inputs from each ear are segregated onto different branches of a bipolar dendritic structure and summed at the soma and axon with submillisecond time resolution. Although synaptic timing and dynamics critically shape this computation, synaptic interactions with intrinsic ion channels have received less attention. Using paired somatic and dendritic patch-clamp recordings in gerbil brainstem slices together with compartmental modeling, we found that activation of K(v)1 channels by dendritic excitatory postsynaptic potentials (EPSPs) accelerated membrane repolarization in a voltage-dependent manner and actively improved the time resolution of synaptic integration. We found that a somatically biased gradient of K(v)1 channels underlies the degree of compensation for passive cable filtering during propagation of EPSPs in dendrites. Thus, both the spatial distribution and properties of K(v)1 channels are important for preserving binaural synaptic timing.	[Mathews, Paul J.; Scott, Luisa L.; Golding, Nace L.] Univ Texas Austin, Neurobiol Sect, Austin, TX 78712 USA; [Mathews, Paul J.; Scott, Luisa L.; Golding, Nace L.] Univ Texas Austin, Inst Neurosci, Austin, TX 78712 USA; [Jercog, Pablo E.; Rinzel, John] NYU, Ctr Neural Sci, New York, NY 10003 USA; [Rinzel, John] NYU, Courant Inst Math Sci, New York, NY USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; New York University; New York University	Golding, NL (corresponding author), Univ Texas Austin, Neurobiol Sect, Austin, TX 78712 USA.	golding@mail.utexas.edu	Jercog, Pablo E/A-8973-2018; MATHEWS, PAUL/ABD-5504-2021; Mathews, Paul J./J-5516-2019	Jercog, Pablo E/0000-0001-7852-5884; MATHEWS, PAUL/0000-0002-1991-0798; 	US National Institutes of Health [DC006877, DC008543]; Ruth Kirschstein National Research Service; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006877, R01DC008543] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth Kirschstein National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank D. Johnston and A. Reyes for their comments on a previous version of the manuscript. This work was supported by grants from the US National Institutes of Health (DC006877 to N.L.G. and DC008543 to J.R.) and Ruth Kirschstein National Research Service Awards to P.J.M and L. L. S.	Agmon-Snir H, 1998, NATURE, V393, P268, DOI 10.1038/30505; Allen PD, 2008, HEARING RES, V246, P52, DOI 10.1016/j.heares.2008.09.009; Ashida G, 2007, J NEUROPHYSIOL, V97, P2267, DOI 10.1152/jn.00399.2006; Barnes-Davies M, 2004, EUR J NEUROSCI, V19, P325, DOI 10.1111/j.0953-816X.2003.03133.x; Bekkers JM, 2001, J NEUROSCI, V21, P6553, DOI 10.1523/JNEUROSCI.21-17-06553.2001; Brand A, 2002, NATURE, V417, P543, DOI 10.1038/417543a; Brew HM, 2003, J PHYSIOL-LONDON, V548, P1, DOI 10.1113/jphysiol.2002.035568; Brew HM, 1995, J NEUROSCI, V15, P8011; Caporale N, 2008, ANNU REV NEUROSCI, V31, P25, DOI 10.1146/annurev.neuro.31.060407.125639; CARR CE, 1993, ANNU REV NEUROSCI, V16, P223, DOI 10.1146/annurev.ne.16.030193.001255; Dasika VK, 2007, J NEUROPHYSIOL, V97, P3449, DOI 10.1152/jn.00669.2005; Ferragamo MJ, 2002, J NEUROPHYSIOL, V87, P2262, DOI 10.1152/jn.00587.2001; Goldberg EM, 2008, NEURON, V58, P387, DOI 10.1016/j.neuron.2008.03.003; Grau-Serrat V, 2003, BIOL CYBERN, V89, P388, DOI 10.1007/s00422-003-0444-4; GRISSMER S, 1994, MOL PHARMACOL, V45, P1227; Grothe B, 2003, NAT REV NEUROSCI, V4, P540, DOI 10.1038/nrn1136; HOPKINS WF, 1994, PFLUG ARCH EUR J PHY, V428, P382, DOI 10.1007/BF00724522; JEFFRESS LA, 1948, J COMP PHYSIOL PSYCH, V41, P35, DOI 10.1037/h0061495; Joris P, 2007, TRENDS NEUROSCI, V30, P70, DOI 10.1016/j.tins.2006.12.004; Koch C., 1998, METHODS NEURONAL MOD, DOI 10.1016/s0898-1221(98)91179-8; Kole MHP, 2007, NEURON, V55, P633, DOI 10.1016/j.neuron.2007.07.031; Martina M, 2000, SCIENCE, V287, P295, DOI 10.1126/science.287.5451.295; Mauk MD, 2004, ANNU REV NEUROSCI, V27, P307, DOI 10.1146/annurev.neuro.27.070203.144247; McAlpine D, 2001, NAT NEUROSCI, V4, P396, DOI 10.1038/86049; McGinley MJ, 2006, HEARING RES, V216, P52, DOI 10.1016/j.heares.2006.02.006; McKay BE, 2005, J NEUROSCI, V25, P1481, DOI 10.1523/JNEUROSCI.3523-04.2005; Metz AE, 2007, J PHYSIOL-LONDON, V581, P175, DOI 10.1113/jphysiol.2006.127068; Oertel D, 2000, P NATL ACAD SCI USA, V97, P11773, DOI 10.1073/pnas.97.22.11773; Rathouz M, 1998, J NEUROPHYSIOL, V80, P2824, DOI 10.1152/jn.1998.80.6.2824; REYES AD, 1994, J NEUROSCI, V14, P5352; RINZEL J, 1974, BIOPHYS J, V14, P759, DOI 10.1016/S0006-3495(74)85948-5; Rothman JS, 2003, J NEUROPHYSIOL, V89, P3083, DOI 10.1152/jn.00126.2002; Scott LL, 2005, J NEUROSCI, V25, P7887, DOI 10.1523/JNEUROSCI.1016-05.2005; Scott LL, 2007, J PHYSIOL-LONDON, V583, P647, DOI 10.1113/jphysiol.2007.136366; Scott LL, 2010, J NEUROSCI, V30, P2039, DOI 10.1523/JNEUROSCI.2385-09.2010; Segev I, 2000, SCIENCE, V290, P744, DOI 10.1126/science.290.5492.744; SHENG M, 1994, J NEUROSCI, V14, P2408; Shu YS, 2007, P NATL ACAD SCI USA, V104, P11453, DOI 10.1073/pnas.0702041104; Sokolov MV, 2007, NEUROPHARMACOLOGY, V53, P272, DOI 10.1016/j.neuropharm.2007.05.008; STORM JF, 1988, NATURE, V336, P379, DOI 10.1038/336379a0; STOTLER WA, 1953, J COMP NEUROL, V98, P401, DOI 10.1002/cne.900980303; STUHMER W, 1989, EMBO J, V8, P3235, DOI 10.1002/j.1460-2075.1989.tb08483.x; Svirskis G, 2004, J NEUROPHYSIOL, V91, P2465, DOI 10.1152/jn.00717.2003; Svirskis G, 2002, J NEUROSCI, V22, P11019; WANG H, 1994, J NEUROSCI, V14, P4588; Willms AR, 2002, J NEUROSCI METH, V121, P139, DOI 10.1016/S0165-0270(02)00227-3; Yamada R, 2005, J NEUROSCI, V25, P8867, DOI 10.1523/JNEUROSCI.2541-05.2005; Zhou Y, 2005, J NEUROSCI, V25, P3046, DOI 10.1523/JNEUROSCI.3064-04.2005	48	119	119	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2010	13	5					601	U115		10.1038/nn.2530	http://dx.doi.org/10.1038/nn.2530			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	588JM	20364143	Green Accepted			2022-12-24	WOS:000277065700018
J	Delaloy, C; Liu, L; Lee, JA; Su, H; Shen, FX; Yang, GY; Young, WL; Ivey, KN; Gao, FB				Delaloy, Celine; Liu, Lei; Lee, Jin-A; Su, Hua; Shen, Fanxia; Yang, Guo-Yuan; Young, William L.; Ivey, Kathy N.; Gao, Fen-Biao			MicroRNA-9 Coordinates Proliferation and Migration of Human Embryonic Stem Cell-Derived Neural Progenitors	CELL STEM CELL			English	Article							IN-VITRO DIFFERENTIATION; POSTTRANSCRIPTIONAL REGULATION; TRANSCRIPTION FACTORS; ADULT NEUROGENESIS; EXPRESSION; STATHMIN; MECHANISMS; PRECURSORS; IDENTIFICATION; REPRESSION	Human pluripotent stem cells offer promise for use in cell-based therapies for brain injury and diseases. However, their cellular behavior is poorly understood. Here we show that the expression of the brain-specific microRNA-9 (miR-9) is turned on in human neural progenitor cells (hNPCs) derived from human embryonic stem cells. Loss of miR-9 suppressed proliferation but promoted migration of hNPCs cultured in vitro. hNPCs without miR-9 activity also showed enhanced migration when transplanted into mouse embryonic brains or adult brains of a mouse model of stroke. These effects were not due to precocious differentiation of hNPCs. One of the key targets directly regulated by miR-9 encodes stathmin, which increases microtubule instability and whose expression in hNPCs correlates inversely with that of miR-9. Partial inhibition of stathmin activity suppressed the effects of miR-9 loss on proliferation and migration of human or embryonic rat neural progenitors. These results identify miR-9 as a novel regulator that coordinates the proliferation and migration of hNPCs.	[Delaloy, Celine; Liu, Lei; Lee, Jin-A; Gao, Fen-Biao] Univ Calif San Francisco, Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA; [Delaloy, Celine; Liu, Lei; Lee, Jin-A; Gao, Fen-Biao] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USA; [Su, Hua; Shen, Fanxia; Yang, Guo-Yuan; Young, William L.] Univ Calif San Francisco, Cerebrovasc Res Ctr, Dept Anesthesia, San Francisco, CA 94110 USA; [Su, Hua; Shen, Fanxia; Yang, Guo-Yuan; Young, William L.] Univ Calif San Francisco, Cerebrovasc Res Ctr, Dept Perioperat Care, San Francisco, CA 94110 USA; [Su, Hua; Shen, Fanxia; Yang, Guo-Yuan; Young, William L.] Univ Calif San Francisco, Cerebrovasc Res Ctr, Dept Neurol & Neurosurg, San Francisco, CA 94110 USA; [Ivey, Kathy N.] Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA; [Gao, Fen-Biao] Univ Massachusetts, Sch Med, Dept Neurol, Worcester, MA 01605 USA; [Gao, Fen-Biao] Univ Massachusetts, Sch Med, Dept Neurobiol, Worcester, MA 01605 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Gao, FB (corresponding author), Univ Calif San Francisco, Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA.			DELALOY, Celine/0000-0003-1510-6484	California Institute for Regenerative Medicine (CIRM); NIH; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS066586] Funding Source: NIH RePORTER	California Institute for Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank J Rubenstein, D Srivastava. and our lab members for discussions and comments, G Howard and S Ordway for editorial assistance, and S Mitchell for administrative assistance C D would like to thank Bettencourt Schueller Foundation for help with relocation to San Francisco C D and J -A L are supported by fellowships from the California Institute for Regenerative Medicine (CIRM) This work is supported by grants from the CIRM (F -B G) and the NIH (F -B G and W L Y)	Ambros V, 2001, CELL, V107, P823, DOI 10.1016/S0092-8674(01)00616-X; Ambros V, 2007, DEVELOPMENT, V134, P1635, DOI 10.1242/dev.002006; Ayala R, 2007, CELL, V128, P29, DOI 10.1016/j.cell.2006.12.021; Baldassarre G, 2005, CANCER CELL, V7, P51, DOI 10.1016/j.ccr.2004.11.025; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Belletti B, 2008, MOL BIOL CELL, V19, P2003, DOI 10.1091/mbc.E07-09-0894; Belmont LD, 1996, CELL, V84, P623, DOI 10.1016/S0092-8674(00)81037-5; Biryukova I, 2009, DEV BIOL, V327, P487, DOI 10.1016/j.ydbio.2008.12.036; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Cobos I, 2007, NEURON, V54, P873, DOI 10.1016/j.neuron.2007.05.024; Delaloy C, 2008, NAT NEUROSCI, V11, P625, DOI 10.1038/nn0608-625; Deo M, 2006, DEV DYNAM, V235, P2538, DOI 10.1002/dvdy.20847; Duan X, 2008, CURR OPIN NEUROBIOL, V18, P108, DOI 10.1016/j.conb.2008.04.001; Elkabetz Y, 2008, GENE DEV, V22, P152, DOI 10.1101/gad.1616208; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Fish JE, 2008, DEV CELL, V15, P272, DOI 10.1016/j.devcel.2008.07.008; Gadea G, 2007, J CELL BIOL, V178, P23, DOI 10.1083/jcb.200701120; Gao FB, 2008, TRENDS NEUROSCI, V31, P20, DOI 10.1016/j.tins.2007.10.004; Giampietro C, 2005, ENDOCRINOLOGY, V146, P1825, DOI 10.1210/en.2004-0972; Hobert O, 2008, SCIENCE, V319, P1785, DOI 10.1126/science.1151651; Hochedlinger K, 2003, NEW ENGL J MED, V349, P275, DOI 10.1056/NEJMra035397; Jin KL, 2004, FASEB J, V18, P287, DOI 10.1096/fj.03-0973com; Kosik KS, 2006, NAT REV NEUROSCI, V7, P911, DOI 10.1038/nrn2037; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Leucht C, 2008, NAT NEUROSCI, V11, P641, DOI 10.1038/nn.2115; Li XJ, 2006, METH MOL B, V331, P169; Li Y, 2006, GENE DEV, V20, P2793, DOI 10.1101/gad.1466306; Mao YW, 2009, CELL, V136, P1017, DOI 10.1016/j.cell.2008.12.044; Pietrzykowski AZ, 2008, NEURON, V59, P274, DOI 10.1016/j.neuron.2008.05.032; Politz JCR, 2006, P NATL ACAD SCI USA, V103, P18957, DOI 10.1073/pnas.0609466103; Rosenfeld N, 2008, NAT BIOTECHNOL, V26, P462, DOI 10.1038/nbt1392; Rubin CI, 2004, J CELL BIOCHEM, V93, P242, DOI 10.1002/jcb.20187; Shibata M, 2008, J NEUROSCI, V28, P10415, DOI 10.1523/JNEUROSCI.3219-08.2008; Suh MR, 2004, DEV BIOL, V270, P488, DOI 10.1016/j.ydbio.2004.02.019; Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Wichterle H, 1999, NAT NEUROSCI, V2, P461, DOI 10.1038/8131; Yamanaka S, 2007, CELL STEM CELL, V1, P39, DOI 10.1016/j.stem.2007.05.012; Yu JY, 2008, GENE DEV, V22, P1987, DOI 10.1101/gad.1689808; Zhang SC, 2001, NAT BIOTECHNOL, V19, P1129, DOI 10.1038/nbt1201-1129; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Zhao C, 2009, NAT STRUCT MOL BIOL, V16, P365, DOI 10.1038/nsmb.1576; Zhao Y, 2007, TRENDS BIOCHEM SCI, V32, P189, DOI 10.1016/j.tibs.2007.02.006; Zhu W, 2008, STROKE, V39, P1254, DOI 10.1161/STROKEAHA.107.500801	44	254	273	1	38	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	APR 2	2010	6	4					323	335		10.1016/j.stem.2010.02.015	http://dx.doi.org/10.1016/j.stem.2010.02.015			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	585KD	20362537	Bronze, Green Accepted			2022-12-24	WOS:000276823300011
J	Hosokawa, K; Arai, F; Yoshihara, H; Iwasaki, H; Hembree, M; Yin, T; Nakamura, Y; Gomei, Y; Takubo, K; Shiama, H; Matsuoka, S; Li, L; Suda, T				Hosokawa, Kentaro; Arai, Fumio; Yoshihara, Hiroki; Iwasaki, Hiroko; Hembree, Mark; Yin, Tong; Nakamura, Yuka; Gomei, Yumiko; Takubo, Keiyo; Shiama, Haruko; Matsuoka, Sahoko; Li, Linheng; Suda, Toshio			Cadherin-Based Adhesion Is a Potential Target for Niche Manipulation to Protect Hematopoietic Stem Cells in Adult Bone Marrow	CELL STEM CELL			English	Article							N-CADHERIN; QUIESCENCE; EXPRESSION; CATENIN		[Hosokawa, Kentaro; Arai, Fumio; Yoshihara, Hiroki; Iwasaki, Hiroko; Nakamura, Yuka; Gomei, Yumiko; Takubo, Keiyo; Shiama, Haruko; Matsuoka, Sahoko; Suda, Toshio] Keio Univ, Sch Med, Sakaguchi Lab Dev Biol, Dept Cell Differentiat,Shinjuku Ku, Tokyo 1608582, Japan; [Hembree, Mark; Yin, Tong; Li, Linheng] Stowers Inst Med Res, Kansas City, MO 64110 USA	Keio University; Stowers Institute for Medical Research	Arai, F (corresponding author), Keio Univ, Sch Med, Sakaguchi Lab Dev Biol, Dept Cell Differentiat,Shinjuku Ku, 35 Shinano Machi, Tokyo 1608582, Japan.	farai@sc.itc.keio.ac.jp; sudato@sc.itc.keio.ac.jp	Iwasaki, Hiroko/D-1702-2009; Suda, Toshio/H-6761-2013; Takubo, Keiyo/AAX-5546-2020; Arai, Fumio/J-5241-2013	Iwasaki, Hiroko/0000-0001-9661-0919; Suda, Toshio/0000-0001-7540-1771; Takubo, Keiyo/0000-0002-1736-7592; Arai, Fumio/0000-0003-1936-4907; Li, Linheng/0000-0001-9963-430X; Yoshihara, Hiroki/0000-0001-5128-4515	The Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; Takeda Science Foundation	The Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF))	We thank Dr. Masatoshi Takeichi (Center for Developmental Biology, RIKEN Kobe, Kobe, Japan) for providing the cDNAs of wild-type and mutant N-cads. We also thank Ayako Kumakubo and Kana Fukushima for technical assistance. This work was supported by a Grant-in-Aid for Specially Promoted Research and a Grant-in-Aid for Young Scientists (A) from The Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan and by the Takeda Science Foundation.	Adams GB, 2007, NAT BIOTECHNOL, V25, P238, DOI 10.1038/nbt1281; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Colmone A, 2008, SCIENCE, V322, P1861, DOI 10.1126/science.1164390; Fleming HE, 2008, CELL STEM CELL, V2, P274, DOI 10.1016/j.stem.2008.01.003; Foudi A, 2009, NAT BIOTECHNOL, V27, P84, DOI 10.1038/nbt.1517; FUJIMORI T, 1993, MOL BIOL CELL, V4, P37, DOI 10.1091/mbc.4.1.37; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; Haug JS, 2008, CELL STEM CELL, V2, P367, DOI 10.1016/j.stem.2008.01.017; Ireton RC, 2002, J CELL BIOL, V159, P465, DOI 10.1083/jcb.200205115; Ishikawa F, 2007, NAT BIOTECHNOL, V25, P1315, DOI 10.1038/nbt1350; Jin LQ, 2006, NAT MED, V12, P1167, DOI 10.1038/nm1483; Kiel MJ, 2007, CELL STEM CELL, V1, P204, DOI 10.1016/j.stem.2007.06.001; Kiel MJ, 2009, CELL STEM CELL, V4, P170, DOI 10.1016/j.stem.2008.10.005; Kirstetter P, 2006, NAT IMMUNOL, V7, P1048, DOI 10.1038/ni1381; Li PL, 2010, CELL STEM CELL, V6, P199, DOI 10.1016/j.stem.2010.02.007; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Scheller M, 2006, NAT IMMUNOL, V7, P1037, DOI 10.1038/ni1387; Wilson A, 2006, NAT REV IMMUNOL, V6, P93, DOI 10.1038/nri1779; Xie YC, 2009, NATURE, V457, P97, DOI 10.1038/nature07639; Yin T, 2006, J CLIN INVEST, V116, P1195, DOI 10.1172/JCI28568; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	21	71	73	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAR 5	2010	6	3					194	198		10.1016/j.stem.2009.04.013	http://dx.doi.org/10.1016/j.stem.2009.04.013			5	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	577WL	20207221	Bronze			2022-12-24	WOS:000276254600007
J	Churchland, MM; Yu, BM; Cunningham, JP; Sugrue, LP; Cohen, MR; Corrado, GS; Newsome, WT; Clark, AM; Hosseini, P; Scott, BB; Bradley, DC; Smith, MA; Kohn, A; Movshon, JA; Armstrong, KM; Moore, T; Chang, SW; Snyder, LH; Lisberger, SG; Priebe, NJ; Finn, IM; Ferster, D; Ryu, SI; Santhanam, G; Sahani, M; Shenoy, KV				Churchland, Mark M.; Yu, Byron M.; Cunningham, John P.; Sugrue, Leo P.; Cohen, Marlene R.; Corrado, Greg S.; Newsome, William T.; Clark, Andrew M.; Hosseini, Paymon; Scott, Benjamin B.; Bradley, David C.; Smith, Matthew A.; Kohn, Adam; Movshon, J. Anthony; Armstrong, Katherine M.; Moore, Tirin; Chang, Steve W.; Snyder, Lawrence H.; Lisberger, Stephen G.; Priebe, Nicholas J.; Finn, Ian M.; Ferster, David; Ryu, Stephen I.; Santhanam, Gopal; Sahani, Maneesh; Shenoy, Krishna V.			Stimulus onset quenches neural variability: a widespread cortical phenomenon	NATURE NEUROSCIENCE			English	Article							TO-TRIAL VARIABILITY; RESPONSE VARIABILITY; AREA MT; NEURONS; DIRECTION; CORTEX; MODULATION; DYNAMICS; INFORMATION; MICROSTIMULATION	Neural responses are typically characterized by computing the mean firing rate, but response variability can exist across trials. Many studies have examined the effect of a stimulus on the mean response, but few have examined the effect on response variability. We measured neural variability in 13 extracellularly recorded datasets and one intracellularly recorded dataset from seven areas spanning the four cortical lobes in monkeys and cats. In every case, stimulus onset caused a decline in neural variability. This occurred even when the stimulus produced little change in mean firing rate. The variability decline was observed in membrane potential recordings, in the spiking of individual neurons and in correlated spiking variability measured with implanted 96-electrode arrays. The variability decline was observed for all stimuli tested, regardless of whether the animal was awake, behaving or anaesthetized. This widespread variability decline suggests a rather general property of cortex, that its state is stabilized by an input.	[Churchland, Mark M.; Yu, Byron M.; Cunningham, John P.; Ryu, Stephen I.; Santhanam, Gopal; Shenoy, Krishna V.] Stanford Univ, Dept Elect Engn, Sch Med, Stanford, CA 94305 USA; [Churchland, Mark M.; Yu, Byron M.; Sugrue, Leo P.; Cohen, Marlene R.; Corrado, Greg S.; Newsome, William T.; Armstrong, Katherine M.; Moore, Tirin; Shenoy, Krishna V.] Stanford Univ, Neurosci Program, Sch Med, Stanford, CA 94305 USA; [Yu, Byron M.; Sahani, Maneesh] UCL, Gatsby Computat Neurosci Unit, London, England; [Sugrue, Leo P.; Cohen, Marlene R.; Corrado, Greg S.; Newsome, William T.] Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA; [Newsome, William T.; Armstrong, Katherine M.; Moore, Tirin] Stanford Univ, Dept Neurobiol, Sch Med, Stanford, CA 94305 USA; [Clark, Andrew M.; Hosseini, Paymon; Scott, Benjamin B.; Bradley, David C.] Univ Chicago, Dept Psychol, Chicago, IL 60637 USA; [Clark, Andrew M.; Hosseini, Paymon; Scott, Benjamin B.; Bradley, David C.] Univ Chicago, Comm Computat Neurosci, Chicago, IL 60637 USA; [Smith, Matthew A.] Univ Pittsburgh, Dept Neurosci, Pittsburgh, PA USA; [Smith, Matthew A.] Univ Pittsburgh, Ctr Neural Basis Cognit, Pittsburgh, PA USA; [Kohn, Adam] Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10467 USA; [Kohn, Adam; Movshon, J. Anthony] NYU, Ctr Neural Sci, New York, NY 10003 USA; [Chang, Steve W.; Snyder, Lawrence H.] Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; [Lisberger, Stephen G.] Univ Calif San Francisco, Howard Hughes Med Inst, WM Keck Fdn, Ctr Integrat Neurosci, San Francisco, CA 94143 USA; [Lisberger, Stephen G.] Univ Calif San Francisco, Dept Physiol, San Francisco, CA USA; [Priebe, Nicholas J.] Univ Texas Austin, Neurobiol Sect, Sch Biol Sci, Austin, TX 78712 USA; [Finn, Ian M.; Ferster, David] Northwestern Univ, Dept Neurobiol & Physiol, Evanston, IL 60208 USA; [Ryu, Stephen I.] Stanford Univ, Sch Med, Dept Neurosurg, Stanford, CA 94305 USA; [Shenoy, Krishna V.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA	Stanford University; Stanford University; University of London; University College London; Howard Hughes Medical Institute; Stanford University; Stanford University; University of Chicago; University of Chicago; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Yeshiva University; Albert Einstein College of Medicine; New York University; Washington University (WUSTL); Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Texas System; University of Texas Austin; Northwestern University; Stanford University; Stanford University	Churchland, MM (corresponding author), Stanford Univ, Dept Elect Engn, Sch Med, Stanford, CA 94305 USA.	church@stanford.edu	Snyder, Lawrence H/A-4593-2017; Newsome, William T./W-7171-2019	Chang, Steve Wohn Chul/0000-0003-4160-7549; Smith, Matthew A/0000-0003-1192-9942	Helen Hay Whitney; Burroughs Welcome Fund Career Awards in the Biomedical Sciences; US National Institutes of Health (NIH) [EY05603, EY014924, EY015958, EY018894, EY02017, EY04440, EY016774, 1 EY13138-01, EY019288]; National Institute of Neurological Disorders and Stroke Collaborative Research in Computational Neuroscience [R01-NS054283]; Michael Flynn Stanford Graduate Fellowship; Howard Hughes Medical Institute; Sloan FoundationPew Charitable Trust; US National Defense Science and Engineering Graduate Fellowships; National Science Foundation Graduate Research Fellowships; Christopher and Dana Reeve Foundation; Stanford Center for Integrated Systems; National Science Foundation Center for Neuromorphic Systems Engineering at Caltech; Office of Naval Research; NIH Director's Pioneer Award [1DP1OD006409]; Whitaker Foundation; NATIONAL EYE INSTITUTE [R01EY014924, R37EY005603, R01EY002017, R01EY013138, R00EY018894, R01EY004440, R01EY016774, R56EY014924, R01EY003878, R01EY005603, R01EY019288, R01EY012135, K99EY018894, R01EY004726, R37EY004440, F32EY015958] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054283] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD006409] Funding Source: NIH RePORTER	Helen Hay Whitney; Burroughs Welcome Fund Career Awards in the Biomedical Sciences(Burroughs Wellcome Fund); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Neurological Disorders and Stroke Collaborative Research in Computational Neuroscience(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Michael Flynn Stanford Graduate Fellowship; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Sloan FoundationPew Charitable Trust; US National Defense Science and Engineering Graduate Fellowships; National Science Foundation Graduate Research Fellowships(National Science Foundation (NSF)); Christopher and Dana Reeve Foundation; Stanford Center for Integrated Systems; National Science Foundation Center for Neuromorphic Systems Engineering at Caltech; Office of Naval Research(Office of Naval Research); NIH Director's Pioneer Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Whitaker Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by a Helen Hay Whitney postdoctoral fellowship (M. M. C.), Burroughs Welcome Fund Career Awards in the Biomedical Sciences (M. M. C. and K. V. S.), Gatsby Charitable Foundation (M. S. and B.M.Y.), US National Institutes of Health (NIH), National Institute of Neurological Disorders and Stroke Collaborative Research in Computational Neuroscience grant R01-NS054283 (K. V. S. and M. S.), the Michael Flynn Stanford Graduate Fellowship (J.P.C.), the Howard Hughes Medical Institute and NIH grant EY05603 (W.T.N., L. P. S., M. R. C. and G. S. C.), a Howard Hughes Medical Institute predoctoral fellowship (M. R. C.), NIH grant EY014924 (T. M. and K. M. A.), Sloan Foundation (T. M. and K. V. S.), Pew Charitable Trust (T. M.), NIH EY015958 and EY018894 (M. A. S.), NIH EY02017 and EY04440 (J.A.M.), NIH EY016774 (A. K.), NIH 1 EY13138-01 (D. C. B., A. M. C., P. H. and B. B. S.), NIH EY019288 (N.J.P.), the Pew Charitable Trust (N.J.P.), EY04726 (D. F.), US National Defense Science and Engineering Graduate Fellowships (B.M.Y. and G. S.), National Science Foundation Graduate Research Fellowships (B.M.Y. and G. S.), the Christopher and Dana Reeve Foundation (K. V. S. and S. I. R.), and the awards from Stanford Center for Integrated Systems, National Science Foundation Center for Neuromorphic Systems Engineering at Caltech, Office of Naval Research, NIH Director's Pioneer Award 1DP1OD006409 and Whitaker Foundation (K. V. S.).	ABBOTT LF, NEURONAL VA IN PRESS; Arieli A, 1996, SCIENCE, V273, P1868, DOI 10.1126/science.273.5283.1868; Armstrong KM, 2007, P NATL ACAD SCI USA, V104, P9499, DOI 10.1073/pnas.0701104104; Armstrong KM, 2006, NEURON, V50, P791, DOI 10.1016/j.neuron.2006.05.010; Azouz R, 1999, J NEUROSCI, V19, P2209; BOCH R, 1983, EXP BRAIN RES, V50, P201; Briggman KL, 2005, SCIENCE, V307, P896, DOI 10.1126/science.1103736; Britten KH, 1996, VISUAL NEUROSCI, V13, P87, DOI 10.1017/S095252380000715X; Carandini M, 2004, PLOS BIOL, V2, P1483, DOI 10.1371/journal.pbio.0020264; Chang SWC, 2008, J NEUROSCI, V28, P6128, DOI 10.1523/JNEUROSCI.1442-08.2008; Churchland MM, 2007, CURR OPIN NEUROBIOL, V17, P609, DOI 10.1016/j.conb.2007.11.001; Churchland MM, 2006, NEURON, V52, P1085, DOI 10.1016/j.neuron.2006.10.034; Churchland MM, 2006, J NEUROSCI, V26, P3697, DOI 10.1523/JNEUROSCI.3762-05.2006; Cohen JY, 2007, J NEUROPHYSIOL, V98, P2580, DOI 10.1152/jn.00522.2007; Cohen MR, 2008, NEURON, V60, P162, DOI 10.1016/j.neuron.2008.08.007; Cohen MR, 2009, NAT NEUROSCI, V12, P1594, DOI 10.1038/nn.2439; Everitt B., 1984, INTRO LATENT VARIABL; Finn IM, 2007, NEURON, V54, P137, DOI 10.1016/j.neuron.2007.02.029; Fiser J, 2004, NATURE, V431, P573, DOI 10.1038/nature02907; FORTIER PA, 1993, J NEUROPHYSIOL, V69, P1136, DOI 10.1152/jn.1993.69.4.1136; Gur M, 1997, J NEUROSCI, V17, P2914; Horwitz GD, 2001, J NEUROPHYSIOL, V86, P2543, DOI 10.1152/jn.2001.86.5.2543; Kao MH, 2005, NATURE, V433, P638, DOI 10.1038/nature03127; Kara P, 2000, NEURON, V27, P635, DOI 10.1016/S0896-6273(00)00072-6; KIHLBERG JK, 1972, APPL STAT, V21, P76; Kisley MA, 1999, J NEUROSCI, V19, P10451; Kohn A, 2009, CURR OPIN NEUROBIOL, V19, P434, DOI 10.1016/j.conb.2009.06.007; LEE D, NEURONAL VA IN PRESS; MAINEN ZF, 1995, SCIENCE, V268, P1503, DOI 10.1126/science.7770778; Mandelblat-Cerf Y, 2009, J NEUROSCI, V29, P15053, DOI 10.1523/JNEUROSCI.3011-09.2009; Mitchell JF, 2007, NEURON, V55, P131, DOI 10.1016/j.neuron.2007.06.018; Monier C, 2008, J NEUROSCI METH, V169, P323, DOI 10.1016/j.jneumeth.2007.11.008; Monier C, 2003, NEURON, V37, P663, DOI 10.1016/S0896-6273(03)00064-3; Nauhaus I, 2009, NAT NEUROSCI, V12, P70, DOI 10.1038/nn.2232; Nawrot MP, 2008, J NEUROSCI METH, V169, P374, DOI 10.1016/j.jneumeth.2007.10.013; Oram MW, 2001, J NEUROPHYSIOL, V86, P1700, DOI 10.1152/jn.2001.86.4.1700; Osborne LC, 2004, J NEUROSCI, V24, P3210, DOI 10.1523/JNEUROSCI.5305-03.2004; Poulet JFA, 2008, NATURE, V454, P881, DOI 10.1038/nature07150; Priebe NJ, 2002, J NEUROPHYSIOL, V88, P354, DOI 10.1152/jn.00852.2001; Rickert J, 2009, J NEUROSCI, V29, P13870, DOI 10.1523/JNEUROSCI.5441-08.2009; Roweis S, 1999, NEURAL COMPUT, V11, P305, DOI 10.1162/089976699300016674; Shadlen MN, 1998, J NEUROSCI, V18, P3870; Smith MA, 2008, J NEUROSCI, V28, P12591, DOI 10.1523/JNEUROSCI.2929-08.2008; Sugrue LP, 2004, SCIENCE, V304, P1782, DOI 10.1126/science.1094765; Sussillo D, 2009, NEURON, V63, P544, DOI 10.1016/j.neuron.2009.07.018; TOLHURST DJ, 1983, VISION RES, V23, P775, DOI 10.1016/0042-6989(83)90200-6; vanVreeswijk C, 1996, SCIENCE, V274, P1724, DOI 10.1126/science.274.5293.1724; Wang XJ, 2008, NEURON, V60, P215, DOI 10.1016/j.neuron.2008.09.034; WERNER G, 1963, J NEUROPHYSIOL, V26, P958, DOI 10.1152/jn.1963.26.6.958; Yu BM, 2009, J NEUROPHYSIOL, V102, P614, DOI 10.1152/jn.90941.2008	50	610	615	1	64	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2010	13	3					369	U25		10.1038/nn.2501	http://dx.doi.org/10.1038/nn.2501			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	559WW	20173745	Green Accepted, Green Submitted			2022-12-24	WOS:000274860100020
J	Urgesi, C; Aglioti, SM; Skrap, M; Fabbro, F				Urgesi, Cosimo; Aglioti, Salvatore M.; Skrap, Miran; Fabbro, Franco			The Spiritual Brain: Selective Cortical Lesions Modulate Human Self-Transcendence	NEURON			English	Article							MINI-MENTAL-STATE; MEDITATION PRACTITIONERS; RELIGIOUS BELIEF; PERSONALITY; TEMPERAMENT; EXPERIENCE; CHARACTER; BODY; MINDFULNESS; DISORDERS	The predisposition of human beings toward spiritual feeling, thinking, and behaviors is measured by a supposedly stable personality trait called self-transcendence. Although a few neuroimaging studies suggest that neural activation of a large fronto-parieto-temporal network may underpin a variety of spiritual experiences, information on the causative link between such a network and spirituality is lacking. Combining pre- and post-neurosurgery personality assessment with advanced brain-lesion mapping techniques, we found that selective damage to left and right inferior posterior parietal regions induced a specific increase of self-transcendence. Therefore, modifications of neural activity in temporoparietal areas may induce unusually fast modulations of a stable personality trait related to transcendental self-referential awareness. These results hint at the active, crucial role of left and right parietal systems in determining self-transcendence and cast new light on the neurobiological bases of altered spiritual and religious attitudes and behaviors in neurological and mental disorders.	[Urgesi, Cosimo; Fabbro, Franco] Univ Udine, Dipartimento Filosofia, I-33100 Udine, Italy; [Urgesi, Cosimo; Fabbro, Franco] Ist Ricovero & Cura Carattere Sci Eugenio Medea, I-33078 San Vito Al Tagliamento, Pordenone, Italy; [Aglioti, Salvatore M.] Univ Roma La Sapienza, Dipartimento Psicol, I-00185 Rome, Italy; [Aglioti, Salvatore M.] Fdn S Lucia, Ist Ricovero & Cura Carattere Sci, I-00179 Rome, Italy; [Skrap, Miran] Univ Santa Maria Misericordi, Azienda Osped, I-33100 Udine, Italy	University of Udine; IRCCS Eugenio Medea; Sapienza University Rome; IRCCS Santa Lucia; Hospital Santa Maria della Misericordia	Urgesi, C (corresponding author), Univ Udine, Dipartimento Filosofia, Via Margreth 3, I-33100 Udine, Italy.	cosimo.urgesi@uniud.it; salvatoremaria.aglioti@uniroma1.it	Urgesi, Cosimo/K-4688-2016; Aglioti, Salvatore M/E-9829-2012; Skrap, Miran/J-2092-2012; skrap, miran/AAB-1708-2022	Urgesi, Cosimo/0000-0003-0572-1328; skrap, miran/0000-0002-6592-6416; Aglioti, Salvatore Maria/0000-0001-8175-7563; FABBRO, Franco/0000-0003-3476-6867	Fondazione Cassa di Risparmio di Udine e Pordenone; Udine and Istituto di Ricovero e Cura a Carattere Scientifico Eugenio Medea; Ministero Italiano Universita e Ricerca, Italy; Sapienza University of Rome; Istituto di Ricovero e Cura a Carattere Scientifico Fondazione Santa Lucia	Fondazione Cassa di Risparmio di Udine e Pordenone; Udine and Istituto di Ricovero e Cura a Carattere Scientifico Eugenio Medea; Ministero Italiano Universita e Ricerca, Italy; Sapienza University of Rome; Istituto di Ricovero e Cura a Carattere Scientifico Fondazione Santa Lucia	This research was supported by grants from the Fondazione Cassa di Risparmio di Udine e Pordenone (to F.F). C.U. is funded by the University of Udine and Istituto di Ricovero e Cura a Carattere Scientifico Eugenio Medea. S.M.A is funded by the Ministero Italiano Universita e Ricerca, Italy, Sapienza University of Rome and Istituto di Ricovero e Cura a Carattere Scientifico Fondazione Santa Lucia.	Aglioti S, 1996, NEUROREPORT, V8, P293, DOI 10.1097/00001756-199612200-00058; Azari NP, 2001, EUR J NEUROSCI, V13, P1649, DOI 10.1046/j.0953-816x.2001.01527.x; Bates E, 2003, NAT NEUROSCI, V6, P448, DOI 10.1038/nn1050; Beauregard M, 2006, NEUROSCI LETT, V405, P186, DOI 10.1016/j.neulet.2006.06.060; Berlucchi G, 1997, TRENDS NEUROSCI, V20, P560, DOI 10.1016/S0166-2236(97)01136-3; Blanke O, 2004, BRAIN, V127, P243, DOI 10.1093/brain/awh040; Boeker H, 2006, COMPR PSYCHIAT, V47, P7, DOI 10.1016/j.comppsych.2005.04.003; Borg J, 2003, AM J PSYCHIAT, V160, P1965, DOI 10.1176/appi.ajp.160.11.1965; Brefczynski-Lewis JA, 2007, P NATL ACAD SCI USA, V104, P11483, DOI 10.1073/pnas.0606552104; Brett M, 2001, NEUROIMAGE, V14, P486, DOI 10.1006/nimg.2001.0845; Brown KW, 2003, J PERS SOC PSYCHOL, V84, P822, DOI 10.1037/0022-3514.84.4.822; Brugger P, 2006, CORTEX, V42, P666, DOI 10.1016/S0010-9452(08)70403-9; Cahn BR, 2006, PSYCHOL BULL, V132, P180, DOI 10.1037/0033-2909.132.2.180; Cloninger C. R., 1994, TEMPERAMENT CHARACTE; Cloninger CR, 2006, J AFFECT DISORDERS, V92, P35, DOI 10.1016/j.jad.2005.12.034; CLONINGER CR, 1994, CURR OPIN NEUROBIOL, V4, P266, DOI 10.1016/0959-4388(94)90083-3; Cohen MX, 2009, NAT NEUROSCI, V12, P32, DOI 10.1038/nn.2228; Comings DE, 2000, PSYCHIATR GENET, V10, P185, DOI 10.1097/00041444-200010040-00006; Davidson RJ, 2003, PSYCHOPHYSIOLOGY, V40, P655, DOI 10.1111/1469-8986.00067; Desmurget M, 2007, BRAIN, V130, P898, DOI 10.1093/brain/awl300; Devinsky O, 2008, EPILEPSY BEHAV, V12, P636, DOI 10.1016/j.yebeh.2007.11.011; Emmons RA, 2003, ANNU REV PSYCHOL, V54, P377, DOI 10.1146/annurev.psych.54.101601.145024; Farmer A, 2003, ARCH GEN PSYCHIAT, V60, P490, DOI 10.1001/archpsyc.60.5.490; Felician O, 2008, NEUROPHYSIOL CLIN, V38, P183, DOI 10.1016/j.neucli.2008.02.003; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fuller Robert C., 2008, SPIRITUALITY FLESH B; Giovagnoli AR, 1996, ITAL J NEUROL SCI, V17, P305, DOI 10.1007/BF01997792; Gusnard DA, 2003, P NATL ACAD SCI USA, V100, P3479, DOI 10.1073/pnas.0538050100; HALLIGAN PW, 1995, CORTEX, V31, P173, DOI 10.1016/S0010-9452(13)80115-3; Halvorsen M, 2009, CLIN PSYCHOL PSYCHOT, V16, P394, DOI 10.1002/cpp.618; Ham BJ, 2004, NEUROSCI LETT, V354, P2, DOI 10.1016/S0304-3940(03)00753-5; Han SH, 2008, SOC NEUROSCI-UK, V3, P1, DOI 10.1080/17470910701469681; Holzel BK, 2008, SOC COGN AFFECT NEUR, V3, P55, DOI 10.1093/scan/nsm038; Holzel BK, 2007, NEUROSCI LETT, V421, P16, DOI 10.1016/j.neulet.2007.04.074; Inzlicht M, 2009, PSYCHOL SCI, V20, P385, DOI 10.1111/j.1467-9280.2009.02305.x; Jha AP, 2007, COGN AFFECT BEHAV NE, V7, P109, DOI 10.3758/CABN.7.2.109; Kaasinen V, 2005, NEUROIMAGE, V24, P315, DOI 10.1016/j.neuroimage.2004.09.017; Kapogiannis D, 2009, P NATL ACAD SCI USA, V106, P4876, DOI 10.1073/pnas.0811717106; Kirk K M, 1999, Twin Res, V2, P81, DOI 10.1375/twin.2.2.81; Lazar SW, 2005, NEUROREPORT, V16, P1893, DOI 10.1097/01.wnr.0000186598.66243.19; Lazar SW, 2000, NEUROREPORT, V11, P1581, DOI 10.1097/00001756-200005150-00041; Lorenzi C, 2005, AM J MED GENET B, V137B, P33, DOI 10.1002/ajmg.b.30111; Lutz A, 2004, P NATL ACAD SCI USA, V101, P16369, DOI 10.1073/pnas.0407401101; Lutz A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001897; Lutz A, 2008, TRENDS COGN SCI, V12, P163, DOI 10.1016/j.tics.2008.01.005; MEASSO G, 1993, DEV NEUROPSYCHOL, V9, P77, DOI 10.1080/87565649109540545; Miller BL, 2001, NEUROLOGY, V57, P817, DOI 10.1212/WNL.57.5.817; Morin A, 2006, CONSCIOUS COGN, V15, P358, DOI 10.1016/j.concog.2005.09.006; Newberg A, 2001, PSYCHIAT RES-NEUROIM, V106, P113, DOI 10.1016/S0925-4927(01)00074-9; Newberg AB, 2003, MED HYPOTHESES, V61, P282, DOI 10.1016/S0306-9877(03)00175-0; Nilsson KW, 2007, NEUROSCI LETT, V411, P233, DOI 10.1016/j.neulet.2006.10.051; ORSINI A, 1987, ITAL J NEUROL SCI, V8, P539; Paloutzian R. F, 2005, HDB PSYCHOL RELIG SP; Raven J. C., 1954, STANDARD PROGR MATRI; Riddoch M. J., 1993, BORB BIRMINGHAM OBJE; Rorden C, 2007, J COGNITIVE NEUROSCI, V19, P1081, DOI 10.1162/jocn.2007.19.7.1081; Rorden C, 2007, NEUROIMAGE, V35, P1531, DOI 10.1016/j.neuroimage.2006.12.043; Rubia K, 2009, BIOL PSYCHOL, V82, P1, DOI 10.1016/j.biopsycho.2009.04.003; Schjoedt U, 2009, SOC COGN AFFECT NEUR, V4, P199, DOI 10.1093/scan/nsn050; Schneider EW, 2008, VARIETIES OF ENGLISH 2: THE AMERICAS AND THE CARIBBEAN, P1; Schwoebel J, 2005, J COGNITIVE NEUROSCI, V17, P543, DOI 10.1162/0898929053467587; Shahabi L, 2002, ANN BEHAV MED, V24, P59, DOI 10.1207/S15324796ABM2401_07; Spilka B., 2003, PSYCHOL RELIG EMPIRI; SPINNLER H, 1987, ITAL J NEUROL SCI S6, V8, P7; Svrakic DM, 2002, ACTA PSYCHIAT SCAND, V106, P189, DOI 10.1034/j.1600-0447.2002.02196.x; Turner RM, 2003, NEUROIMAGE, V19, P1145, DOI 10.1016/S1053-8119(03)00171-X	66	115	117	1	35	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	FEB 11	2010	65	3					309	319		10.1016/j.neuron.2010.01.026	http://dx.doi.org/10.1016/j.neuron.2010.01.026			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	564BF	20159445	Bronze			2022-12-24	WOS:000275185200005
J	Ohira, K; Furuta, T; Hioki, H; Nakamura, KC; Kuramoto, E; Tanaka, Y; Funatsu, N; Shimizu, K; Oishi, T; Hayashi, M; Miyakawa, T; Kaneko, T; Nakamura, S				Ohira, Koji; Furuta, Takahiro; Hioki, Hiroyuki; Nakamura, Kouichi C.; Kuramoto, Eriko; Tanaka, Yasuyo; Funatsu, Nobuo; Shimizu, Keiko; Oishi, Takao; Hayashi, Motoharu; Miyakawa, Tsuyoshi; Kaneko, Takeshi; Nakamura, Shun			Ischemia-induced neurogenesis of neocortical layer 1 progenitor cells	NATURE NEUROSCIENCE			English	Article							SUBVENTRICULAR ZONE; ADULT NEUROGENESIS; CORTICAL NEUROGENESIS; GABAERGIC NEURONS; CEREBRAL-CORTEX; EXPRESSION; PROLIFERATION; MIGRATION; RATS; SOMATOSTATIN	Adult mammalian neurogenesis occurs in the hippocampus and the olfactory bulb, whereas neocortical adult neurogenesis remains controversial. Several occurrences of neocortical adult neurogenesis in injured neocortex were recently reported, suggesting that neural stem cells (NSCs) or neuronal progenitor cells (NPCs) that can be activated by injury are maintained in the adult brain. However, it is not clear whether or where neocortical NSCs/NPCs exist in the brain. We found NPCs in the neocortical layer 1 of adult rats and observed that their proliferation was highly activated by global forebrain ischemia. Using retrovirus-mediated labeling of layer 1 proliferating cells with membrane-targeted green fluorescent protein, we found that the newly generated neurons were GABAergic and that the neurons were functionally integrated into the neuronal circuitry. Our results suggest that layer 1 NPCs are a source of adult neurogenesis under ischemic conditions.	[Ohira, Koji; Miyakawa, Tsuyoshi] Fujita Hlth Univ, Inst Comprehens Med Sci, Div Syst Med Sci, Aichi, Japan; [Ohira, Koji; Furuta, Takahiro; Hioki, Hiroyuki; Nakamura, Kouichi C.; Kuramoto, Eriko; Tanaka, Yasuyo; Kaneko, Takeshi] Kyoto Univ, Grad Sch Med, Dept Morphol Brain Sci, Kyoto, Japan; [Funatsu, Nobuo; Nakamura, Shun] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Biochem & Cellular Biol, Tokyo, Japan; [Ohira, Koji; Nakamura, Kouichi C.; Miyakawa, Tsuyoshi; Kaneko, Takeshi; Nakamura, Shun] Japan Sci & Technol Agcy, Kawaguchi, Saitama, Japan; [Shimizu, Keiko; Oishi, Takao; Hayashi, Motoharu] Kyoto Univ, Primate Res Inst, Dept Cellular & Mol Biol, Aichi, Japan; [Miyakawa, Tsuyoshi] Natl Inst Physiol Sci, Ctr Genet Anal Behav, Aichi, Japan; [Nakamura, Shun] Tokyo Univ Agr & Technol, Dept Biotechnol & Life Sci, Tokyo, Japan	Fujita Health University; Kyoto University; National Center for Neurology & Psychiatry - Japan; Japan Science & Technology Agency (JST); Kyoto University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Tokyo University of Agriculture & Technology	Ohira, K (corresponding author), Fujita Hlth Univ, Inst Comprehens Med Sci, Div Syst Med Sci, Aichi, Japan.	ohira@fujita-hu.ac.jp; kaneko@mbs.med.kyoto-u.ac.jp	Nakamura, Kouichi C./S-7099-2019; Nakamura, Shun/GVN-8593-2022; Hioki, Hiroyuki/J-9412-2017; Miyakawa, Tsuyoshi/A-7741-2008; Nakamura, Kouichi/B-3425-2008	Hioki, Hiroyuki/0000-0002-0152-7854; Miyakawa, Tsuyoshi/0000-0003-0137-8200; Nakamura, Kouichi/0000-0001-7053-0507; Ohira, Koji/0000-0003-0170-8652; Oishi, Takao/0000-0003-1067-3746				Abrous DN, 2005, PHYSIOL REV, V85, P523, DOI 10.1152/physrev.00055.2003; Adams RD, 1977, PRINCIPLES NEUROLOGY; ALTMAN J, 1963, ANAT REC, V145, P573, DOI 10.1002/ar.1091450409; Bernier PJ, 2002, P NATL ACAD SCI USA, V99, P11464, DOI 10.1073/pnas.172403999; Carlen M, 2002, CURR BIOL, V12, P606, DOI 10.1016/S0960-9822(02)00771-6; Cobos I, 2006, CEREB CORTEX, V16, pI82, DOI 10.1093/cercor/bhk003; Dayer AG, 2005, J CELL BIOL, V168, P415, DOI 10.1083/jcb.200407053; Ehninger D, 2003, CEREB CORTEX, V13, P845, DOI 10.1093/cercor/13.8.845; Flames N, 2007, J NEUROSCI, V27, P9682, DOI 10.1523/JNEUROSCI.2750-07.2007; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; GASS P, 1995, J CEREBR BLOOD F MET, V15, P989, DOI 10.1038/jcbfm.1995.125; Gould E, 1999, SCIENCE, V286, P548, DOI 10.1126/science.286.5439.548; Gross CG, 2000, NAT REV NEUROSCI, V1, P67, DOI 10.1038/35036235; Gu WG, 2000, J CEREBR BLOOD F MET, V20, P1166, DOI 10.1097/00004647-200008000-00002; Hioki H, 2007, GENE THER, V14, P872, DOI 10.1038/sj.gt.3302924; Jiang W, 2001, STROKE, V32, P1201, DOI 10.1161/01.STR.32.5.1201; Jimenez D, 2003, DEV NEUROSCI-BASEL, V25, P105, DOI 10.1159/000072260; Jin K, 2003, MOL CELL NEUROSCI, V24, P171, DOI 10.1016/S1044-7431(03)00159-3; Jin KL, 2006, P NATL ACAD SCI USA, V103, P13198, DOI 10.1073/pnas.0603512103; Kameda H, 2008, NEUROSCI RES, V61, P79, DOI 10.1016/j.neures.2008.01.014; KAPLAN MS, 1981, J COMP NEUROL, V195, P323, DOI 10.1002/cne.901950211; Kee N, 2007, NAT NEUROSCI, V10, P355, DOI 10.1038/nn1847; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Koketsu D, 2003, J NEUROSCI, V23, P937; Kornack DR, 2001, SCIENCE, V294, P2127, DOI 10.1126/science.1065467; Kress GJ, 2009, NEUROSCIENCE, V158, P211, DOI 10.1016/j.neuroscience.2008.03.021; KUBOTA Y, 1994, BRAIN RES, V649, P159, DOI 10.1016/0006-8993(94)91060-X; Lavdas AA, 1999, J NEUROSCI, V19, P7881; Leker RR, 2007, STROKE, V38, P153, DOI 10.1161/01.STR.0000252156.65953.a9; Magavi SS, 2000, NATURE, V405, P951, DOI 10.1038/35016083; Marin O, 2003, ANNU REV NEUROSCI, V26, P441, DOI 10.1146/annurev.neuro.26.041002.131058; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Nag S, 1996, J NEUROPATH EXP NEUR, V55, P880, DOI 10.1097/00005072-199608000-00003; Nery S, 2003, CEREB CORTEX, V13, P895, DOI 10.1093/cercor/13.9.895; Nunes MC, 2003, NAT MED, V9, P439, DOI 10.1038/nm837; Ohira K, 2005, J NEUROSCI, V25, P1343, DOI 10.1523/JNEUROSCI.4436-04.2005; REN JQ, 1992, EXP BRAIN RES, V92, P1; Richichi C, 2004, J NEUROSCI, V24, P3051, DOI 10.1523/JNEUROSCI.4056-03.2004; Sairanen TR, 2001, J NEUROL SCI, V186, P87, DOI 10.1016/S0022-510X(01)00508-1; Spalding KL, 2005, CELL, V122, P133, DOI 10.1016/j.cell.2005.04.028; Staiger JF, 2000, NEUROSCIENCE, V99, P7, DOI 10.1016/S0306-4522(00)00166-4; Stewart RR, 2002, J NEUROBIOL, V50, P305, DOI 10.1002/neu.10038; Sundholm-Peters NL, 2005, J NEUROPATH EXP NEUR, V64, P1089, DOI 10.1097/01.jnen.0000190066.13312.8f; Tallent MK, 1999, J NEUROPHYSIOL, V81, P1626, DOI 10.1152/jn.1999.81.4.1626; Tashiro A, 2007, J NEUROSCI, V27, P3252, DOI 10.1523/JNEUROSCI.4941-06.2007; Tonchev AB, 2005, J NEUROSCI RES, V81, P776, DOI 10.1002/jnr.20604; Tozuka Y, 2005, NEURON, V47, P803, DOI 10.1016/j.neuron.2005.08.023; Xu XM, 2006, J COMP NEUROL, V499, P144, DOI 10.1002/cne.21101; Yang ZG, 2007, ANN NEUROL, V61, P199, DOI 10.1002/ana.21068; Zecevic N, 2001, J NEUROSCI, V21, P5607, DOI 10.1523/JNEUROSCI.21-15-05607.2001	50	173	182	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2010	13	2					173	U51		10.1038/nn.2473	http://dx.doi.org/10.1038/nn.2473			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	548SE	20037576				2022-12-24	WOS:000273985800012
J	Tsujimoto, S; Genovesio, A; Wise, SP				Tsujimoto, Satoshi; Genovesio, Aldo; Wise, Steven P.			Evaluating self-generated decisions in frontal pole cortex of monkeys	NATURE NEUROSCIENCE			English	Article							ROSTRAL PREFRONTAL CORTEX; MACAQUE MONKEYS; HUMAN COGNITION; BRAIN-FUNCTION; DEFAULT MODE; AREA-10; TASK; FMRI; REPRESENTATION; HUMANS	The frontal pole cortex (FPC) expanded markedly during human evolution, but its function remains uncertain in both monkeys and humans. Accordingly, we examined single-cell activity in this area. On every trial, monkeys decided between two response targets on the basis of a 'stay' or 'shift' cue. Feedback followed at a fixed delay. FPC cells did not encode the monkeys' decisions when they were made, but did so later on, as feedback approached. This finding indicates that the FPC is involved in monitoring or evaluating decisions. Using a control task and delayed feedback, we found that decision coding lasted until feedback only when the monkeys combined working memory with sensory cues to 'self-generate' decisions, as opposed to when they simply followed trial-by-trial instructions. A role in monitoring or evaluating self-generated decisions could account for FPC's expansion during human evolution.	[Tsujimoto, Satoshi; Genovesio, Aldo; Wise, Steven P.] NIMH, Lab Syst Neurosci, US Natl Inst Hlth, Bethesda, MD 20892 USA; [Tsujimoto, Satoshi] Kobe Univ, Grad Sch Human Dev & Environm, Dev Cognit Neurosci Lab, Nada Ku, Kobe, Hyogo 657, Japan; [Genovesio, Aldo] Univ Roma La Sapienza, Dept Physiol & Pharmacol, Rome, Italy	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Kobe University; Sapienza University Rome	Tsujimoto, S (corresponding author), NIMH, Lab Syst Neurosci, US Natl Inst Hlth, Bethesda, MD 20892 USA.	tsujimoto@ruby.kobe-u.ac.jp	Tsujimoto, Satoshi/B-8223-2011	Genovesio, Aldo/0000-0003-2521-143X	National Institute of Mental Health [Z01MH-01092]; Ministry of Education, Culture, Sports, Science and Technology, Japan [21119513]; Japan Society for the Promotion of Science; NATIONAL INSTITUTE OF MENTAL HEALTH [Z01MH001092, ZIAMH001092] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank S. Bunge, G. di Pellegrino, E. Murray, R. Passingham, N. Ramnani and P. Rudebeck for comments on drafts of this manuscript. A. Mitz, J. Fellows and P.-Y. Chen provided technical support. This work was supported by the Division of Intramural Research of the National Institute of Mental Health (Z01MH-01092) and by a Grant-in-Aid for Scientific Research on Innovative Areas (21119513) from the Ministry of Education, Culture, Sports, Science and Technology, Japan. S. T. was supported by a research fellowship from the Japan Society for the Promotion of Science.	Bengtsson SL, 2009, CEREB CORTEX, V19, P1929, DOI 10.1093/cercor/bhn222; Boorman ED, 2009, NEURON, V62, P733, DOI 10.1016/j.neuron.2009.05.014; Bunge Silvia A., 2004, Cognitive Affective & Behavioral Neuroscience, V4, P564; Bunge SA, 2009, NEUROIMAGE, V46, P338, DOI 10.1016/j.neuroimage.2009.01.064; Burgess PW, 2007, TRENDS COGN SCI, V11, P290, DOI 10.1016/j.tics.2007.05.004; Burgess PW, 2007, PHILOS T R SOC B, V362, P887, DOI 10.1098/rstb.2007.2095; BURGESS PW, 2009, MEASURING MIND SPEED, P215; Carmichael ST, 1996, J COMP NEUROL, V371, P179, DOI 10.1002/(SICI)1096-9861(19960722)371:2<179::AID-CNE1>3.0.CO;2-#; Christoff K, 2004, CORTEX, V40, P623, DOI 10.1016/S0010-9452(08)70158-8; Christoff K, 2003, BEHAV NEUROSCI, V117, P1161, DOI 10.1037/0735-7044.117.6.1161; Daw ND, 2006, NATURE, V441, P876, DOI 10.1038/nature04766; Forstmann BU, 2005, NEUROPSYCHOLOGIA, V43, P943, DOI 10.1016/j.neuropsychologia.2004.08.008; Ganis G, 2003, CEREB CORTEX, V13, P830, DOI 10.1093/cercor/13.8.830; Genovesio A, 2005, NEURON, V47, P307, DOI 10.1016/j.neuron.2005.06.006; Genovesio A, 2008, EUR J NEUROSCI, V27, P984, DOI 10.1111/j.1460-9568.2008.06048.x; Genovesio A, 2006, J NEUROSCI, V26, P7305, DOI 10.1523/JNEUROSCI.0699-06.2006; Gilbert SJ, 2006, J COGNITIVE NEUROSCI, V18, P932, DOI 10.1162/jocn.2006.18.6.932; Gusnard DA, 2001, P NATL ACAD SCI USA, V98, P4259, DOI 10.1073/pnas.071043098; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Jacobs B, 2001, CEREB CORTEX, V11, P558, DOI 10.1093/cercor/11.6.558; JONES EG, 1970, BRAIN, V93, P37, DOI 10.1093/brain/93.1.37; Karim AA, 2010, CEREB CORTEX, V20, P205, DOI 10.1093/cercor/bhp090; Kepecs A, 2008, NATURE, V455, P227, DOI 10.1038/nature07200; Kiani R, 2009, SCIENCE, V324, P759, DOI 10.1126/science.1169405; Koechlin E, 1999, NATURE, V399, P148, DOI 10.1038/20178; Kroger JK, 2002, CEREB CORTEX, V12, P477, DOI 10.1093/cercor/12.5.477; Lawrence NS, 2009, CEREB CORTEX, V19, P1134, DOI 10.1093/cercor/bhn154; Mason MF, 2007, SCIENCE, V315, P393, DOI 10.1126/science.1131295; McClure SM, 2007, J NEUROSCI, V27, P5796, DOI 10.1523/JNEUROSCI.4246-06.2007; Mithen S., 1996, PREHISTORY MIND; Mitz AR, 2009, J NEUROSCI METH, V177, P60, DOI 10.1016/j.jneumeth.2008.09.032; Mitz AR, 2005, J NEUROSCI METH, V148, P19, DOI 10.1016/j.jneumeth.2005.07.012; Okuda J, 2007, INT J PSYCHOPHYSIOL, V64, P233, DOI 10.1016/j.ijpsycho.2006.09.009; Ongur D, 2003, J COMP NEUROL, V460, P425, DOI 10.1002/cne.10609; Petrides M, 2007, J NEUROSCI, V27, P11573, DOI 10.1523/JNEUROSCI.2419-07.2007; Pochon JB, 2002, P NATL ACAD SCI USA, V99, P5669, DOI 10.1073/pnas.082111099; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Ramnani N, 2004, NAT REV NEUROSCI, V5, P184, DOI 10.1038/nrn1343; Ramnani N, 2004, NEUROIMAGE, V23, P777, DOI 10.1016/j.neuroimage.2004.07.028; Sakai K, 2006, J NEUROSCI, V26, P1211, DOI 10.1523/JNEUROSCI.3887-05.2006; Sakai K, 2008, ANNU REV NEUROSCI, V31, P219, DOI 10.1146/annurev.neuro.31.060407.125642; Schall JD, 2002, NEURON, V36, P309, DOI 10.1016/S0896-6273(02)00964-9; Semendeferi K, 2001, AM J PHYS ANTHROPOL, V114, P224, DOI 10.1002/1096-8644(200103)114:3<224::AID-AJPA1022>3.0.CO;2-I; Soon CS, 2008, NAT NEUROSCI, V11, P543, DOI 10.1038/nn.2112; Tsujimoto S, 2008, CEREB CORTEX, V18, P2748, DOI 10.1093/cercor/bhn033; van Duijvenvoorde ACK, 2008, J NEUROSCI, V28, P9495, DOI 10.1523/JNEUROSCI.1485-08.2008; Walker AE, 1940, J COMP NEUROL, V73, P59, DOI 10.1002/cne.900730106; Walsh ND, 2010, CEREB CORTEX, V20, P271, DOI 10.1093/cercor/bhp098; Wise SP, 2008, TRENDS NEUROSCI, V31, P599, DOI 10.1016/j.tins.2008.08.008; Zysset S, 2002, NEUROIMAGE, V15, P983, DOI 10.1006/nimg.2001.1008	50	121	122	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2010	13	1					120	U293		10.1038/nn.2453	http://dx.doi.org/10.1038/nn.2453			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	536PM	19966838	Green Accepted			2022-12-24	WOS:000273056300022
J	Yamahachi, H; Marik, SA; McManus, JNJ; Denk, W; Gilbert, CD				Yamahachi, Homare; Marik, Sally A.; McManus, Justin N. J.; Denk, Winfried; Gilbert, Charles D.			Rapid Axonal Sprouting and Pruning Accompany Functional Reorganization in Primary Visual Cortex	NEURON			English	Article							TOPOGRAPHIC MAP REORGANIZATION; HORIZONTAL CONNECTIONS; ADULT CAT; CORTICAL REORGANIZATION; DENDRITIC SPINES; STRIATE CORTEX; AREA 17; PLASTICITY; DYNAMICS; LESIONS	The functional architecture of adult cerebral cortex retains a capacity for experience-dependent change. This is seen following focal binocular lesions, which induce rapid changes in receptive field size and position. To follow the dynamics of the circuitry underlying these changes, we imaged the intrinsic long-range horizontal connections within the lesion projection zone (LPZ) in adult macaque primary visual cortex. To image the same axons over time, we combined viral vector-mediated EGFP transfer and two-photon microscopy. The lesion triggered, within the first week, an similar to 2-fold outgrowth of axons toward the center of the LPZ. Over the subsequent month, axonal density declined due to a parallel process of pruning and sprouting but maintained a net increase relative to prelesion levels. The rate of turnover of axonal boutons also increased. The axonal restructuring recapitulates the pattern of exuberance and pruning seen in early development and correlates well with the functional changes following retinal lesions.	[Yamahachi, Homare; Marik, Sally A.; McManus, Justin N. J.; Gilbert, Charles D.] Rockefeller Univ, New York, NY 10065 USA; [Denk, Winfried] Max Planck Inst Med Res, Heidelberg, Germany	Rockefeller University; Max Planck Society	Gilbert, CD (corresponding author), Rockefeller Univ, New York, NY 10065 USA.	gilbert@rockefeller.edu	denk, winfried/I-6627-2012	Marik, Sally/0000-0002-1247-6001	NIH [EY018119]; NATIONAL EYE INSTITUTE [R01EY018119] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by NIH grant EY018119. The authors would like to thank Matthew Isakson for technical assistance.	ANTONINI A, 1993, SCIENCE, V260, P1819, DOI 10.1126/science.8511592; Arieli A, 2002, J NEUROSCI METH, V114, P119, DOI 10.1016/S0165-0270(01)00507-6; Baker CI, 2005, J NEUROSCI, V25, P614, DOI 10.1523/JNEUROSCI.3476-04.2005; Brunner E, 2000, BIOMETRICAL J, V42, P17, DOI 10.1002/(SICI)1521-4036(200001)42:1<17::AID-BIMJ17>3.0.CO;2-U; Calford MB, 2000, J PHYSIOL-LONDON, V524, P587, DOI 10.1111/j.1469-7793.2000.t01-1-00587.x; Calford MB, 2005, NATURE, V438, pE3, DOI 10.1038/nature04359; CALLAWAY EM, 1990, J NEUROSCI, V10, P1134; Chen JB, 2010, CEREB CORTEX, V20, P650, DOI 10.1093/cercor/bhp131; CHINO YM, 1992, VISION RES, V32, P789, DOI 10.1016/0042-6989(92)90021-A; CHINO YM, 1995, J NEUROSCI, V15, P2417, DOI 10.1523/JNEUROSCI.15-03-02417.1995; Crist RE, 2001, NAT NEUROSCI, V4, P519, DOI 10.1038/87470; DARIANSMITH C, 1995, J NEUROSCI, V15, P1631, DOI 10.1523/JNEUROSCI.15-03-01631.1995; DARIANSMITH C, 1994, NATURE, V368, P737, DOI 10.1038/368737a0; DAS A, 1995, NATURE, V375, P780, DOI 10.1038/375780a0; De Paola V, 2006, NEURON, V49, P861, DOI 10.1016/j.neuron.2006.02.017; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Efron B., 1994, INTRO BOOTSTRAP; FERSTER D, 1978, J COMP NEUROL, V182, P923, DOI 10.1002/cne.901820510; Florence SL, 1998, SCIENCE, V282, P1117, DOI 10.1126/science.282.5391.1117; Giannikopoulos DV, 2006, P NATL ACAD SCI USA, V103, P10805, DOI 10.1073/pnas.0604539103; GILBERT CD, 1990, COLD SPRING HARB SYM, V55, P663; GILBERT CD, 1979, NATURE, V280, P120, DOI 10.1038/280120a0; GILBERT CD, 1992, NATURE, V356, P150, DOI 10.1038/356150a0; HEINEN SJ, 1991, EXP BRAIN RES, V83, P670; Hickmott PW, 2005, NAT NEUROSCI, V8, P140, DOI 10.1038/nn1384; HIRSCH JA, 1991, J NEUROSCI, V11, P1800; Hu TT, 2009, CEREB CORTEX, V19, P2982, DOI 10.1093/cercor/bhp069; KAAS JH, 1990, SCIENCE, V248, P229, DOI 10.1126/science.2326637; Kasthuri N, 2004, CURR OPIN NEUROBIOL, V14, P105, DOI 10.1016/j.conb.2004.01.013; Keck T, 2008, NAT NEUROSCI, V11, P1162, DOI 10.1038/nn.2181; Knott GW, 2002, NEURON, V34, P265, DOI 10.1016/S0896-6273(02)00663-3; Kossut M, 1999, NEUROSCIENCE, V92, P807, DOI 10.1016/S0306-4522(98)00722-2; LEVAY S, 1980, J COMP NEUROL, V191, P1, DOI 10.1002/cne.901910102; LEVAY S, 1979, SOC NEUROSCI S, V4; Li W, 2004, NAT NEUROSCI, V7, P651, DOI 10.1038/nn1255; Li W, 2006, NEURON, V50, P951, DOI 10.1016/j.neuron.2006.04.035; Low LK, 2006, PHILOS T R SOC B, V361, P1531, DOI 10.1098/rstb.2006.1883; Low LK, 2005, CURR OPIN NEUROBIOL, V15, P549, DOI 10.1016/j.conb.2005.08.007; Luo LQ, 2005, ANNU REV NEUROSCI, V28, P127, DOI 10.1146/annurev.neuro.28.061604.135632; Majewska AK, 2006, J NEUROSCI, V26, P3021, DOI 10.1523/JNEUROSCI.4454-05.2006; Massie A, 2003, BRAIN RES, V976, P100, DOI 10.1016/S0006-8993(03)02717-3; Massie A, 2003, J NEUROCHEM, V84, P1387, DOI 10.1046/j.1471-4159.2003.01636.x; Mataga N, 2004, NEURON, V44, P1031, DOI 10.1016/j.neuron.2004.11.028; McManus JNJ, 2008, J NEUROPHYSIOL, V99, P2086, DOI 10.1152/jn.00871.2007; Niell CM, 2004, NAT NEUROSCI, V7, P254, DOI 10.1038/nn1191; Palagina G, 2009, P NATL ACAD SCI USA, V106, P8743, DOI 10.1073/pnas.0900068106; Portera-Cailliau C, 2005, PLOS BIOL, V3, P1473, DOI 10.1371/journal.pbio.0030272; Reimsnider S, 2007, MOL THER, V15, P1504, DOI 10.1038/sj.mt.6300227; ROSE JE, 1960, J COMP NEUROL, V115, P243, DOI 10.1002/cne.901150303; Ruthazer ES, 2006, J NEUROSCI, V26, P3594, DOI 10.1523/JNEUROSCI.0069-06.2006; Schoups A, 2001, NATURE, V412, P549, DOI 10.1038/35087601; Smirnakis SM, 2005, NATURE, V435, P300, DOI 10.1038/nature03495; Stettler DD, 2002, NEURON, V36, P739, DOI 10.1016/S0896-6273(02)01029-2; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Trachtenberg JT, 2001, J NEUROSCI, V21, P3476, DOI 10.1523/JNEUROSCI.21-10-03476.2001; Witte S, 1996, J NEUROBIOL, V31, P219, DOI 10.1002/(SICI)1097-4695(199610)31:2<219::AID-NEU7>3.0.CO;2-E	57	135	139	1	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 10	2009	64	5					719	729		10.1016/j.neuron.2009.11.026	http://dx.doi.org/10.1016/j.neuron.2009.11.026			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	537OW	20005827	Bronze, Green Accepted			2022-12-24	WOS:000273123700016
J	van Veen, V; Krug, MK; Schooler, JW; Carter, CS				van Veen, Vincent; Krug, Marie K.; Schooler, Jonathan W.; Carter, Cameron S.			Neural activity predicts attitude change in cognitive dissonance	NATURE NEUROSCIENCE			English	Article							HUMAN ORBITOFRONTAL CORTEX; BRAIN ACTIVITY; NEGATIVE AFFECT; RESPONSE CONFLICT; FORCED COMPLIANCE; CINGULATE CORTEX; CHOICE; MODEL; PAIN; MECHANISMS	When our actions conflict with our prior attitudes, we often change our attitudes to be more consistent with our actions. This phenomenon, known as cognitive dissonance, is considered to be one of the most influential theories in psychology. However, the neural basis of this phenomenon is unknown. Using a Solomon four-group design, we scanned participants with functional MRI while they argued that the uncomfortable scanner environment was nevertheless a pleasant experience. We found that cognitive dissonance engaged the dorsal anterior cingulate cortex and anterior insula; furthermore, we found that the activation of these regions tightly predicted participants' subsequent attitude change. These effects were not observed in a control group. Our findings elucidate the neural representation of cognitive dissonance, and support the role of the anterior cingulate cortex in detecting cognitive conflict and the neural prediction of attitude change.	[van Veen, Vincent] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; [van Veen, Vincent; Krug, Marie K.; Carter, Cameron S.] Univ Calif Davis, Imaging Res Ctr, Sacramento, CA 95817 USA; [Schooler, Jonathan W.] Univ Calif Santa Barbara, Dept Psychol, Santa Barbara, CA 93106 USA	University of California System; University of California Berkeley; University of California System; University of California Davis; University of California System; University of California Santa Barbara	van Veen, V (corresponding author), Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA.	vanveen@berkeley.edu; cameron.carter@ucdmc.ucdavis.edu	Schooler, Jonathan/ABE-6434-2020; Schooler, Jonathan/AAZ-3977-2020		US National Institute of Mental Health; Burroughs-Wellcome Foundation	US National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Burroughs-Wellcome Foundation(Burroughs Wellcome Fund)	We are grateful to M. Greenberg, G. Hein and K. Ochsner for discussions, and to S. Ravizza, D. Tamir, S. Ursu and A. Watrous for help with data collection. This research was supported by grants from the US National Institute of Mental Health and the Burroughs-Wellcome Foundation to C. S. C.	Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; Batson CD, 2003, PERS SOC PSYCHOL B, V29, P1190, DOI 10.1177/0146167203254600; BEM DJ, 1967, PSYCHOL REV, V74, P183, DOI 10.1037/h0024835; Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; BRAVER MCW, 1988, PSYCHOL BULL, V104, P150, DOI 10.1037/0033-2909.104.1.150; Brewer JB, 1998, SCIENCE, V281, P1185, DOI 10.1126/science.281.5380.1185; COOPER J, 1984, ADV EXP SOC PSYCHOL, V17, P229, DOI 10.1016/S0065-2601(08)60121-5; Coricelli G, 2005, NAT NEUROSCI, V8, P1255, DOI 10.1038/nn1514; Craig AD, 1996, NATURE, V384, P258, DOI 10.1038/384258a0; Critchley HD, 2005, J COMP NEUROL, V493, P154, DOI 10.1002/cne.20749; Critchley HD, 2003, BRAIN, V126, P2139, DOI 10.1093/brain/awg216; CROYLE RT, 1983, J PERS SOC PSYCHOL, V45, P782, DOI 10.1037/0022-3514.45.4.782; Delgado MR, 2003, COGN AFFECT BEHAV NE, V3, P27, DOI 10.3758/CABN.3.1.27; Eisenberger NI, 2003, SCIENCE, V302, P290, DOI 10.1126/science.1089134; ELLIOT AJ, 1994, J PERS SOC PSYCHOL, V67, P382, DOI 10.1037/0022-3514.67.3.382; FESTINGER L, 1959, J ABNORM SOC PSYCH, V58, P203, DOI 10.1037/h0041593; Festinger L., 1957, THEORY COGNITIVE DIS, V2; Goebel R, 2006, HUM BRAIN MAPP, V27, P392, DOI 10.1002/hbm.20249; Hajcak G, 2004, BRAIN COGNITION, V56, P189, DOI 10.1016/j.bandc.2003.11.001; Harmon-Jones E, 2004, BIOL PSYCHOL, V67, P51, DOI 10.1016/j.biopsycho.2004.03.003; Harmon-Jones E., 1999, COGNITIVE DISSONANCE; Harmon-Jones E, 2008, EUR J SOC PSYCHOL, V38, P35, DOI 10.1002/ejsp.399; Harmon-Jones E, 2008, SOC PERSONAL PSYCHOL, V2, P1518, DOI 10.1111/j.1751-9004.2008.00110.x; Hein G, 2008, CURR OPIN NEUROBIOL, V18, P153, DOI 10.1016/j.conb.2008.07.012; HOYT MF, 1972, J PERS SOC PSYCHOL, V23, P205, DOI 10.1037/h0033034; Immordino-Yang MH, 2009, P NATL ACAD SCI USA, V106, P8021, DOI 10.1073/pnas.0810363106; Jones AD, 2002, COGN AFFECT BEHAV NE, V2, P300, DOI 10.3758/CABN.2.4.300; Jones E. E., 1985, HDB SOCIAL PSYCHOL, P47; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; Kirchhoff BA, 2000, J NEUROSCI, V20, P6173, DOI 10.1523/JNEUROSCI.20-16-06173.2000; Lamm C, 2007, J COGNITIVE NEUROSCI, V19, P42, DOI 10.1162/jocn.2007.19.1.42; Langleben DD, 2002, NEUROIMAGE, V15, P727, DOI 10.1006/nimg.2001.1003; Lieberman MD, 2001, PSYCHOL SCI, V12, P135, DOI 10.1111/1467-9280.00323; LINDER DE, 1967, J PERS SOC PSYCHOL, V6, P245, DOI 10.1037/h0021220; LOSCH ME, 1990, J EXP SOC PSYCHOL, V26, P289, DOI 10.1016/0022-1031(90)90040-S; Luu P, 2000, J EXP PSYCHOL GEN, V129, P43, DOI 10.1037//0096-3445.129.1.43; Nunez JM, 2005, NEUROIMAGE, V25, P267, DOI 10.1016/j.neuroimage.2004.10.041; Sharot T, 2009, J NEUROSCI, V29, P3760, DOI 10.1523/JNEUROSCI.4972-08.2009; Shultz TR, 1996, PSYCHOL REV, V103, P219, DOI 10.1037/0033-295X.103.2.219; Singer T, 2004, SCIENCE, V303, P1157, DOI 10.1126/science.1093535; SOLOMON RL, 1949, PSYCHOL BULL, V46, P137, DOI 10.1037/h0062958; Takahashi H, 2009, SCIENCE, V323, P937, DOI 10.1126/science.1165604; Ursu S, 2005, COGNITIVE BRAIN RES, V23, P51, DOI 10.1016/j.cogbrainres.2005.01.004; Ursu S, 2008, BRAIN RES, V1227, P110, DOI 10.1016/j.brainres.2008.06.033; Van Overwalle F, 2002, PERS SOC PSYCHOL REV, V6, P204, DOI 10.1207/S15327957PSPR0603_6; van Veen V, 2005, NEUROIMAGE, V27, P497, DOI 10.1016/j.neuroimage.2005.04.042; van Veen V, 2006, CURR DIR PSYCHOL SCI, V15, P237, DOI 10.1111/j.1467-8721.2006.00443.x; Wagner AD, 1998, SCIENCE, V281, P1188, DOI 10.1126/science.281.5380.1188; Westen D, 2006, J COGNITIVE NEUROSCI, V18, P1947, DOI 10.1162/jocn.2006.18.11.1947	50	157	157	2	112	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2009	12	11					1469	1474		10.1038/nn.2413	http://dx.doi.org/10.1038/nn.2413			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	511UE	19759538				2022-12-24	WOS:000271194100022
J	Dunfield, D; Haas, K				Dunfield, Derek; Haas, Kurt			Metaplasticity Governs Natural Experience-Driven Plasticity of Nascent Embryonic Brain Circuits	NEURON			English	Article							LONG-TERM POTENTIATION; DEVELOPING RETINOTECTAL SYNAPSES; TIMING-DEPENDENT PLASTICITY; OFF-CENTER INPUTS; IN-VIVO; VISUAL-CORTEX; NEURONAL POPULATIONS; RECEPTIVE-FIELDS; SYNAPTIC MODIFICATIONS; DENDRITIC INTEGRATION	During embryogenesis, brain neurons receiving the same sensory input may undergo potentiation or depression. While the origin of variable plasticity in vivo is unknown, it plays a key role in shaping dynamic neural circuit refinement. Here, we investigate effects of natural visual stimuli on neuronal firing within the intact, awake, developing brain using calcium imaging of 100 s of central neurons in the Xenopus retinotectal system. We find that specific patterns of visual stimuli shift population responses toward either potentiation or depression in an N-methyl-D-aspartate receptor (NMDA-R)-dependent manner. In agreement with Bienenstock-Cooper-Munro metaplasticity, our results show that functional potentiation or depression can be predicted by individual neurons' specific receptive field properties and historic firing rates. Interestingly, this activity-dependent metaplasticity is itself NMDA-R dependent. Furthermore, network analysis reveals increased correlated firing of neurons that undergo potentiation. These findings implicate metaplasticity as a natural property regulating experience-dependent refinement of nascent embryonic brain circuits.	[Dunfield, Derek; Haas, Kurt] Univ British Columbia, Dept Cellular & Physiol Sci, Vancouver, BC V6T 2B5, Canada; [Dunfield, Derek; Haas, Kurt] Univ British Columbia, Brain Res Ctr, Vancouver, BC V6T 2B5, Canada	University of British Columbia; University of British Columbia	Haas, K (corresponding author), Univ British Columbia, Dept Cellular & Physiol Sci, Vancouver, BC V6T 2B5, Canada.	kurt.haas@ubc.ca	Haas, Kurt/B-3812-2009	Haas, Kurt/0000-0003-4754-1560	National Scienceand Engineering Council of Canada; Canadian Institute of Health Research; Michael Smith Foundation for Health Research; Canadian Foundation for Innovation	National Scienceand Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); Canadian Foundation for Innovation(Canada Foundation for Innovation)	We thank K. Podgorski for help with correlation and clustering analysis, and D. Allan, S. Bamji, B. Chen, T. Murphy, and C. Rankin for comments on the manuscript. This work was supported by the National Scienceand Engineering Council of Canada, the Canadian Institute of Health Research, the Michael Smith Foundation for Health Research, the Canadian Foundation for Innovation, The EJL6 Foundation, and the Human Early Learning Project.	Abbott LF, 2000, NAT NEUROSCI, V3, P1178, DOI 10.1038/81453; Abraham WC, 2001, P NATL ACAD SCI USA, V98, P10924, DOI 10.1073/pnas.181342098; Abraham WC, 1997, PROG NEUROBIOL, V52, P303, DOI 10.1016/S0301-0082(97)00018-X; Abraham WC, 2008, NAT REV NEUROSCI, V9, P387, DOI 10.1038/nrn2356; Aizenman CD, 2003, NEURON, V39, P831, DOI 10.1016/S0896-6273(03)00527-0; Aizenman CD, 2002, NEURON, V34, P623, DOI 10.1016/S0896-6273(02)00674-8; BEAR MF, 1987, SCIENCE, V237, P42, DOI 10.1126/science.3037696; Bear MF, 2003, PHILOS T ROY SOC B, V358, P649, DOI 10.1098/rstb.2002.1255; Beggs JM, 2001, NEURAL COMPUT, V13, P87, DOI 10.1162/089976601300014646; BIENENSTOCK EL, 1982, J NEUROSCI, V2, P32, DOI 10.1523/jneurosci.02-01-00032.1982; Brustein E, 2003, PFLUG ARCH EUR J PHY, V446, P766, DOI 10.1007/s00424-003-1138-4; Campanac E, 2008, J PHYSIOL-LONDON, V586, P779, DOI 10.1113/jphysiol.2007.147017; Daoudal G, 2003, LEARN MEMORY, V10, P456, DOI 10.1101/lm.64103; Daoudal G, 2002, P NATL ACAD SCI USA, V99, P14512, DOI 10.1073/pnas.222546399; Debanne D, 2003, J PHYSIOLOGY-PARIS, V97, P403, DOI 10.1016/j.jphysparis.2004.01.004; Engert F, 2002, NATURE, V419, P470, DOI 10.1038/nature00988; Fetcho JR, 1998, HISTOCHEM J, V30, P153, DOI 10.1023/A:1003243302777; FREEMAN RD, 1981, J NEUROPHYSIOL, V45, P1074, DOI 10.1152/jn.1981.45.6.1074; Garaschuk O, 2006, NAT PROTOC, V1, P380, DOI 10.1038/nprot.2006.58; GAZE RM, 1974, PROC R SOC SER B-BIO, V185, P301, DOI 10.1098/rspb.1974.0021; Haas K, 2006, P NATL ACAD SCI USA, V103, P12127, DOI 10.1073/pnas.0602670103; HUANG YY, 1992, SCIENCE, V255, P730, DOI 10.1126/science.1346729; Jin JZ, 2008, NAT NEUROSCI, V11, P88, DOI 10.1038/nn2029; Johenning FW, 2007, CELL CALCIUM, V41, P271, DOI 10.1016/j.ceca.2006.07.005; MILLER KD, 1992, NEUROREPORT, V3, P73, DOI 10.1097/00001756-199201000-00019; MILLER KD, 1994, J NEUROSCI, V14, P409; Niell CM, 2005, NEURON, V45, P941, DOI 10.1016/j.neuron.2005.01.047; Nieuwkoop P.D., 1967, NORMAL TABLE XENOPUS; Pantev C, 1998, NATURE, V392, P811, DOI 10.1038/33918; POWERS RK, 1992, J NEUROPHYSIOL, V68, P964, DOI 10.1152/jn.1992.68.3.964; Pratt KG, 2008, NAT NEUROSCI, V11, P467, DOI 10.1038/nn2076; Prusky GT, 2000, EUR J NEUROSCI, V12, P3781, DOI 10.1046/j.1460-9568.2000.00236.x; Ramdya P, 2008, NAT NEUROSCI, V11, P1083, DOI 10.1038/nn.2166; Ramdya P, 2006, J NEUROSCI METH, V157, P230, DOI 10.1016/j.jneumeth.2006.04.021; Rittenhouse CD, 1999, NATURE, V397, P347, DOI 10.1038/16922; RODGERS JL, 1988, AM STAT, V42, P59, DOI 10.2307/2685263; Ruthazer ES, 2003, SCIENCE, V301, P66, DOI 10.1126/science.1082545; Schoups A, 2001, NATURE, V412, P549, DOI 10.1038/35087601; Sengpiel F, 1999, NAT NEUROSCI, V2, P727, DOI 10.1038/11192; Sin WC, 2002, NATURE, V419, P475, DOI 10.1038/nature00987; Smetters D, 1999, METHODS, V18, P215, DOI 10.1006/meth.1999.0774; Stosiek C, 2003, P NATL ACAD SCI USA, V100, P7319, DOI 10.1073/pnas.1232232100; Sumbre G, 2008, NATURE, V456, P102, DOI 10.1038/nature07351; Tao HW, 2005, NEURON, V45, P829, DOI 10.1016/j.neuron.2005.01.046; Tao HZW, 2001, NEURON, V31, P569, DOI 10.1016/S0896-6273(01)00393-2; Thevenaz P, 1998, IEEE T IMAGE PROCESS, V7, P27, DOI 10.1109/83.650848; Vislay-Meltzer R, 2006, NEURON, V50, P101, DOI 10.1016/j.neuron.2006.02.016; Voigt T, 2005, J NEUROSCI, V25, P4605, DOI 10.1523/JNEUROSCI.3803-04.2005; Wade Nicholas, 2001, VISUAL PERCEPTION IN; Wang ZR, 2003, NEURON, V37, P463, DOI 10.1016/S0896-6273(02)01189-3; Yaksi E, 2006, NAT METHODS, V3, P377, DOI 10.1038/NMETH874; YASUDA R, 2004, SCI STKE, pP15; ZAHS KR, 1988, J NEUROPHYSIOL, V59, P1410, DOI 10.1152/jn.1988.59.5.1410; Zhang LI, 2001, NAT NEUROSCI, V4, P1123, DOI 10.1038/nn745; Zhang LI, 1998, NATURE, V395, P37, DOI 10.1038/25665; Zhang LI, 2000, NAT NEUROSCI, V3, P708, DOI 10.1038/76665; Zhou Q, 2003, SCIENCE, V300, P1953, DOI 10.1126/science.1082212	57	24	24	1	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 29	2009	64	2					240	250		10.1016/j.neuron.2009.08.034	http://dx.doi.org/10.1016/j.neuron.2009.08.034			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	521AA	19874791	Bronze			2022-12-24	WOS:000271889900013
J	Mizuseki, K; Sirota, A; Pastalkova, E; Buzsaki, G				Mizuseki, Kenji; Sirota, Anton; Pastalkova, Eva; Buzsaki, Gyoergy			Theta Oscillations Provide Temporal Windows for Local Circuit Computation in the Entorhinal-Hippocampal Loop	NEURON			English	Article							SOURCE DENSITY ANALYSIS; FREELY BEHAVING RAT; PHASE-PRECESSION; PYRAMIDAL CELLS; GRID CELLS; PLACE CELLS; FREQUENCY OSCILLATIONS; LAMINAR DISTRIBUTION; CELLULAR MECHANISMS; ELECTRICAL ACTIVITY	Theta oscillations are believed to play an important role in the coordination of neuronal firing in the entorhinal (EC)-hippocampal system but the underlying mechanisms are not known. We simultaneously recorded from neurons in multiple regions of the EC-ippocampal loop and examined their temporal relationships. Theta-coordinated synchronous spiking of EC neuronal populations predicted the timing of current sinks in target layers in the hippocampus. However, the temporal delays between population activities in successive anatomical stages were longer (typically by a half theta cycle) than expected from axon conduction velocities and passive synaptic integration of feed-forward excitatory inputs. We hypothesize that the temporal windows set by the theta cycles allow for local circuit interactions and thus a considerable degree of computational independence in subdivisions of the EC-hippocampal loop.	[Mizuseki, Kenji; Sirota, Anton; Pastalkova, Eva; Buzsaki, Gyoergy] Rutgers State Univ, Ctr Mol & Behav Neurosci, Newark, NJ 07102 USA	Rutgers State University Newark; Rutgers State University New Brunswick	Buzsaki, G (corresponding author), Rutgers State Univ, Ctr Mol & Behav Neurosci, 197 Univ Ave, Newark, NJ 07102 USA.	buzsaki@axon.rutgers.edu	Mizuseki, Kenji/A-9214-2011; Sirota, Anton/G-1395-2011	Mizuseki, Kenji/0000-0002-1456-2149; Buzsaki, Gyorgy/0000-0002-3100-4800	National Institutes of Health [NS034994, MH54671]; National Science Foundation [SBE 0542013]; J.D. McDonnell Foundation; Uehara Memorial Foundation; Astellas Foundation; Japan Society; Robert Leet & Clara Guthrie Patterson Trust; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH054671] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034994] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); J.D. McDonnell Foundation; Uehara Memorial Foundation(Uehara Memorial Foundation); Astellas Foundation(Astellas Pharmaceuticals); Japan Society(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Robert Leet & Clara Guthrie Patterson Trust; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank A. Amarasingham, K. Diba, S. Fujisawa, C. Geisler, A. Grosmark, S.M. Montgomery, S. Ozen, J. Patel, P. Quilichini, S. Sakata, E. Stark, D. Sullivan, and D. Robbe for valuable discussions and comments on the manuscript. Supported by National Institutes of Health (NS034994; MH54671), National Science Foundation (SBE 0542013), the J.D. McDonnell Foundation, Uehara Memorial Foundation, Astellas Foundation for Research on Metabolic Disorders, Japan Society for the Promotion of Science, and the Robert Leet & Clara Guthrie Patterson Trust.	Abeles M, 1991, CORTICONICS NEURAL C, DOI DOI 10.1017/CBO9780511574566; ALONSO A, 1989, NATURE, V342, P175, DOI 10.1038/342175a0; ALONSO A, 1987, EXP BRAIN RES, V67, P493, DOI 10.1007/BF00247282; Amaral DaL P, 2007, HIPPOCAMPUS BOOK, P37; AMARAL DG, 1989, NEUROSCIENCE, V31, P571, DOI 10.1016/0306-4522(89)90424-7; ANDERSEN P, 1969, ACTA PHYSIOL SCAND, V76, pA4; Ang CW, 2005, J NEUROSCI, V25, P9567, DOI 10.1523/JNEUROSCI.2992-05.2005; Bartho P, 2004, J NEUROPHYSIOL, V92, P600, DOI 10.1152/jn.01170.2003; BLAND BH, 1986, PROG NEUROBIOL, V26, P1, DOI 10.1016/0301-0082(86)90019-5; BRAGIN A, 1995, J NEUROSCI, V15, P47; BRANKACK J, 1993, BRAIN RES, V615, P310, DOI 10.1016/0006-8993(93)90043-M; Brun VH, 2002, SCIENCE, V296, P2243, DOI 10.1126/science.1071089; Burgess N, 2007, HIPPOCAMPUS, V17, P801, DOI 10.1002/hipo.20327; BUZSAKI G, 1983, BRAIN RES REV, V6, P139, DOI 10.1016/0165-0173(83)90037-1; BUZSAKI G, 1984, PROG NEUROBIOL, V22, P131, DOI 10.1016/0301-0082(84)90023-6; BUZSAKI G, 1986, BRAIN RES, V365, P125, DOI 10.1016/0006-8993(86)90729-8; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Buzsaki G., 2006, RHYTHMS BRAIN; CHROBAK JJ, 1994, J NEUROSCI, V14, P6160; Chrobak JJ, 1998, J NEUROSCI, V18, P388; Chrobak JJ, 1996, J NEUROSCI, V16, P3056; Constantinidis C, 2002, NAT NEUROSCI, V5, P175, DOI 10.1038/nn799; Csicsvari J, 1999, J NEUROSCI, V19, P274, DOI 10.1523/JNEUROSCI.19-01-00274.1999; Csicsvari J, 1998, NEURON, V21, P179, DOI 10.1016/S0896-6273(00)80525-5; Diba K, 2008, J NEUROSCI, V28, P13448, DOI 10.1523/JNEUROSCI.3824-08.2008; Dragoi G, 2006, NEURON, V50, P145, DOI 10.1016/j.neuron.2006.02.023; EMPSON RM, 1995, J PHYSIOL-LONDON, V484, P707, DOI 10.1113/jphysiol.1995.sp020697; FOX SE, 1989, EXP BRAIN RES, V77, P283, DOI 10.1007/BF00274985; Frank LM, 2001, J NEUROPHYSIOL, V86, P2029, DOI 10.1152/jn.2001.86.4.2029; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Fujisawa S, 2008, NAT NEUROSCI, V11, P823, DOI 10.1038/nn.2134; Geisler C, 2007, P NATL ACAD SCI USA, V104, P8149, DOI 10.1073/pnas.0610121104; Giocomo LM, 2007, SCIENCE, V315, P1719, DOI 10.1126/science.1139207; GRASTYAN E, 1959, ELECTROEN CLIN NEURO, V11, P409, DOI 10.1016/0013-4694(59)90040-9; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Hafting T, 2008, NATURE, V453, P1248, DOI 10.1038/nature06957; Hargreaves EL, 2005, SCIENCE, V308, P1792, DOI 10.1126/science.1110449; Harris KD, 2002, NATURE, V417, P738, DOI 10.1038/nature00808; Hasselmo ME, 2002, NEURAL COMPUT, V14, P793, DOI 10.1162/089976602317318965; Hasselmo ME, 2005, HIPPOCAMPUS, V15, P936, DOI 10.1002/hipo.20116; Hasselmo ME, 2007, LEARN MEMORY, V14, P782, DOI 10.1101/lm.686607; Hasselmo ME, 2008, HIPPOCAMPUS, V18, P1213, DOI 10.1002/hipo.20512; HOLMES JE, 1960, AM J PHYSIOL, V199, P741, DOI 10.1152/ajplegacy.1960.199.5.741; HUERTA PT, 1995, NEURON, V15, P1053, DOI 10.1016/0896-6273(95)90094-2; Huxter JR, 2008, NAT NEUROSCI, V11, P587, DOI 10.1038/nn.2106; Isomura Y, 2006, NEURON, V52, P871, DOI 10.1016/j.neuron.2006.10.023; Jeewajee A, 2008, HIPPOCAMPUS, V18, P1175, DOI 10.1002/hipo.20510; Jensen O, 2005, TRENDS NEUROSCI, V28, P67, DOI 10.1016/j.tins.2004.12.001; Kamondi A, 1998, HIPPOCAMPUS, V8, P244, DOI 10.1002/(SICI)1098-1063(1998)8:3<244::AID-HIPO7>3.0.CO;2-J; Kiss J, 1996, HIPPOCAMPUS, V6, P239, DOI 10.1002/(SICI)1098-1063(1996)6:3<239::AID-HIPO3>3.0.CO;2-I; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Kocsis B, 1999, J NEUROSCI, V19, P6200, DOI 10.1523/JNEUROSCI.19-14-06200.1999; KONOPACKI J, 1987, BRAIN RES, V405, P196, DOI 10.1016/0006-8993(87)91009-2; Lengyel M, 2003, HIPPOCAMPUS, V13, P700, DOI 10.1002/hipo.10116; LEUNG LWS, 1984, J NEUROPHYSIOL, V52, P1051, DOI 10.1152/jn.1984.52.6.1051; Losonczy A, 2008, NATURE, V452, P436, DOI 10.1038/nature06725; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; Maurer AP, 2007, TRENDS NEUROSCI, V30, P325, DOI 10.1016/j.tins.2007.05.002; Maurer AP, 2006, J NEUROSCI, V26, P13485, DOI 10.1523/JNEUROSCI.2882-06.2006; Maurer AP, 2006, HIPPOCAMPUS, V16, P785, DOI 10.1002/hipo.20202; Mehta MR, 2002, NATURE, V417, P741, DOI 10.1038/nature00807; MILES R, 1986, J PHYSIOL-LONDON, V373, P397, DOI 10.1113/jphysiol.1986.sp016055; MITCHELL SJ, 1980, BRAIN RES, V189, P49, DOI 10.1016/0006-8993(80)90006-2; MIZUMORI SJY, 1990, BRAIN RES, V528, P12, DOI 10.1016/0006-8993(90)90188-H; Molter C, 2008, HIPPOCAMPUS, V18, P919, DOI 10.1002/hipo.20450; Montgomery SM, 2008, J NEUROSCI, V28, P6731, DOI 10.1523/JNEUROSCI.1227-08.2008; Montgomery SM, 2009, J NEUROSCI, V29, P1381, DOI 10.1523/JNEUROSCI.4339-08.2009; Moser EI, 2008, ANNU REV NEUROSCI, V31, P69, DOI 10.1146/annurev.neuro.31.061307.090723; O'Keefe J, 2005, HIPPOCAMPUS, V15, P853, DOI 10.1002/hipo.20115; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; Orban G, 2006, J NEUROPHYSIOL, V96, P2889, DOI 10.1152/jn.01233.2005; Otmakhova NA, 1999, J NEUROSCI, V19, P1437; Pastalkova E, 2008, SCIENCE, V321, P1322, DOI 10.1126/science.1159775; PAVLIDES C, 1988, BRAIN RES, V439, P383, DOI 10.1016/0006-8993(88)91499-0; PETSCHE H, 1962, ELECTROEN CLIN NEURO, V14, P202, DOI 10.1016/0013-4694(62)90030-5; RANCK JB, 1973, EXP NEUROL, V41, P462, DOI 10.1016/0014-4886(73)90290-2; Remondes M, 2002, NATURE, V416, P736, DOI 10.1038/416736a; Rotstein HG, 2005, J NEUROPHYSIOL, V94, P1509, DOI 10.1152/jn.00957.2004; Siapas AG, 2005, NEURON, V46, P141, DOI 10.1016/j.neuron.2005.02.028; Sirota A, 2008, NEURON, V60, P683, DOI 10.1016/j.neuron.2008.09.014; Skaggs WE, 1996, HIPPOCAMPUS, V6, P149, DOI 10.1002/(SICI)1098-1063(1996)6:2<149::AID-HIPO6>3.0.CO;2-K; SOLLESZ I, 1993, J NEUROPHYSIOL, V70, P97; Somogyi P, 2005, J PHYSIOL-LONDON, V562, P9, DOI 10.1113/jphysiol.2004.078915; STEWARD O, 1976, J COMP NEUROL, V167, P285, DOI 10.1002/cne.901670303; STEWARD O, 1976, J COMP NEUROL, V169, P347, DOI 10.1002/cne.901690306; STEWART M, 1992, EXP BRAIN RES, V90, P21; STEWART M, 1990, TRENDS NEUROSCI, V13, P163, DOI 10.1016/0166-2236(90)90040-H; Traub RD, 2004, ANNU REV NEUROSCI, V27, P247, DOI 10.1146/annurev.neuro.27.070203.144303; Tsodyks MV, 1996, HIPPOCAMPUS, V6, P271, DOI 10.1002/(SICI)1098-1063(1996)6:3<271::AID-HIPO5>3.3.CO;2-Q; VANDERWOLF CH, 1988, INT REV NEUROBIOL, V30, P225; VANDERWOLF CH, 1969, ELECTROEN CLIN NEURO, V26, P407, DOI 10.1016/0013-4694(69)90092-3; Wallenstein GV, 1997, J NEUROPHYSIOL, V78, P393, DOI 10.1152/jn.1997.78.1.393; WINSON J, 1978, SCIENCE, V201, P160, DOI 10.1126/science.663646	94	424	429	1	38	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 29	2009	64	2					267	280		10.1016/j.neuron.2009.08.037	http://dx.doi.org/10.1016/j.neuron.2009.08.037			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	521AA	19874793	Bronze, Green Accepted			2022-12-24	WOS:000271889900015
J	Sun, HS; Jackson, MF; Martin, LJ; Jansen, K; Teves, L; Cui, H; Kiyonaka, S; Mori, Y; Jones, M; Forder, JP; Golde, TE; Orser, BA; MacDonald, JF; Tymianski, M				Sun, Hong-Shuo; Jackson, Michael F.; Martin, Loren J.; Jansen, Karen; Teves, Lucy; Cui, Hong; Kiyonaka, Shigeki; Mori, Yasuo; Jones, Michael; Forder, Joan P.; Golde, Todd E.; Orser, Beverley A.; MacDonald, John F.; Tymianski, Michael			Suppression of hippocampal TRPM7 protein prevents delayed neuronal death in brain ischemia	NATURE NEUROSCIENCE			English	Article							CELL-DEATH; CATION CHANNEL; RECEPTORS; DAMAGE; MODULATION; MAGNESIUM; KINASE; MODEL; NMDA	Cardiac arrest victims may experience transient brain hypoperfusion leading to delayed death of hippocampal CA1 neurons and cognitive impairment. We prevented this in adult rats by inhibiting the expression of transient receptor potential melastatin 7 (TRPM7), a transient receptor potential channel that is essential for embryonic development, is necessary for cell survival and trace ion homeostasis in vitro, and whose global deletion in mice is lethal. TRPM7 was suppressed in CA1 neurons by intrahippocampal injections of viral vectors bearing shRNA specific for TRPM7. This had no ill effect on animal survival, neuronal and dendritic morphology, neuronal excitability, or synaptic plasticity, as exemplified by robust long-term potentiation (LTP). However, TRPM7 suppression made neurons resistant to ischemic death after brain ischemia and preserved neuronal morphology and function. Also, it prevented ischemia-induced deficits in LTP and preserved performance in fear-associated and spatial-navigational memory tasks. Thus, regional suppression of TRPM7 is feasible, well tolerated and inhibits delayed neuronal death in vivo.	[Sun, Hong-Shuo; Teves, Lucy; Cui, Hong; Jones, Michael; Forder, Joan P.; Tymianski, Michael] Toronto Western Hosp, Res Inst, Toronto, ON M5T 2S8, Canada; [Jackson, Michael F.; Orser, Beverley A.; MacDonald, John F.; Tymianski, Michael] Univ Toronto, Dept Physiol, Toronto, ON, Canada; [Jackson, Michael F.; MacDonald, John F.] Univ Western Ontario, Robarts Res Inst, London, ON, Canada; [Martin, Loren J.; Orser, Beverley A.; Tymianski, Michael] Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A1, Canada; [Jansen, Karen; Golde, Todd E.] Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA; [Kiyonaka, Shigeki; Mori, Yasuo] Kyoto Univ, Mol Biol Lab, Dept Synthet Chem & Biol Chem, Grad Sch Engn, Kyoto, Japan; [Orser, Beverley A.] Sunnybrook Hlth Sci Ctr, Dept Anesthesia, Toronto, ON M4N 3M5, Canada; [Tymianski, Michael] Univ Toronto, Dept Surg, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; Western University (University of Western Ontario); University of Toronto; Mayo Clinic; Kyoto University; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto	Tymianski, M (corresponding author), Toronto Western Hosp, Res Inst, Toronto, ON M5T 2S8, Canada.	mike.tymianski@uhn.on.ca	Jackson, Mike/H-5573-2012; Kiyonaka, Shigeki/AAM-7303-2021	Jackson, Mike/0000-0002-4730-201X; Martin, Loren/0000-0003-0579-2441; Tymianski, Mike/0000-0002-6311-9565	Canadian Institute of Health Research [MOP68939, MOP89720, MOP15514]; US National Institutes of Health [NS048956]; Canadian Stroke Networks; Krembil Seed fund; Heart and Stroke Foundation of Canada Focus; Grants-in-Aid for Scientific Research [20249015] Funding Source: KAKEN; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048956] Funding Source: NIH RePORTER	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Stroke Networks; Krembil Seed fund; Heart and Stroke Foundation of Canada Focus(Heart & Stroke Foundation of Canada); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank M. Aarts and W. Czerwinski for technical information, J. C. Roder for advice on MWM testing, and A. Fleig, C. Montell, A. Scharenberg and E. Lo for a critical review of the manuscript. This work was supported by grants from the Canadian Institute of Health Research ( MOP68939 and MOP89720 to M. T. and MOP15514 to J. F. M.), the US National Institutes of Health ( NS048956 to M. T.), the Canadian Stroke Networks ( M. T., J. F. M. and M. F. J.) and the Krembil Seed fund ( M. T.). H.- S. S. is a recipient of Postdoctoral Fellowship Awards from the Heart and Stroke Foundation of Canada Focus on Stroke Training Initiative Program.	Aarts M, 2003, CELL, V115, P863, DOI 10.1016/S0092-8674(03)01017-1; Bennett MVL, 1996, COLD SPRING HARB SYM, V61, P373; Besancon E, 2008, TRENDS PHARMACOL SCI, V29, P268, DOI 10.1016/j.tips.2008.02.003; Block F, 1999, PROG NEUROBIOL, V58, P279, DOI 10.1016/S0301-0082(98)00085-9; Bridge AJ, 2003, NAT GENET, V34, P263, DOI 10.1038/ng1173; Cheng VY, 2006, J NEUROSCI, V26, P3713, DOI 10.1523/JNEUROSCI.5024-05.2006; Corish P, 1999, PROTEIN ENG, V12, P1035, DOI 10.1093/protein/12.12.1035; Davis SM, 1997, LANCET, V349, P32, DOI 10.1016/S0140-6736(05)62166-6; FANSELOW MS, 1980, PAVLOVIAN J BIOL SCI, V15, P177; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Hausenloy DJ, 2007, CLIN PHARMACOL THER, V82, P370, DOI 10.1038/sj.clpt.6100352; Ji JZ, 2007, HIPPOCAMPUS, V17, P749, DOI 10.1002/hipo.20331; Jin J, 2008, SCIENCE, V322, P756, DOI 10.1126/science.1163493; Kaneko S, 2006, J PHARMACOL SCI, V101, P66, DOI 10.1254/jphs.FP0060128; Kozak JA, 2002, J GEN PHYSIOL, V120, P221, DOI 10.1085/jgp.20028601; Kumar R, 2001, J NEUROCHEM, V77, P1418, DOI 10.1046/j.1471-4159.2001.00387.x; Lawlor PA, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-11; Lin MC, 2004, J AM COLL NUTR, V23, p556S, DOI 10.1080/07315724.2004.10719403; Lipton P, 1999, PHYSIOL REV, V79, P1431, DOI 10.1152/physrev.1999.79.4.1431; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; Mastakov MY, 2001, MOL THER, V3, P225, DOI 10.1006/mthe.2001.0246; Monteilh-Zoller MK, 2003, J GEN PHYSIOL, V121, P49, DOI 10.1085/jgp.20028740; Montell C, 2002, CELL, V108, P595, DOI 10.1016/S0092-8674(02)00670-0; Morris GF, 1999, J NEUROSURG, V91, P737, DOI 10.3171/jns.1999.91.5.0737; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Nadler MJS, 2001, NATURE, V411, P590, DOI 10.1038/35079092; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; PETITO CK, 1987, NEUROLOGY, V37, P1281, DOI 10.1212/WNL.37.8.1281; PULSINELLI WA, 1979, STROKE, V10, P267, DOI 10.1161/01.STR.10.3.267; PULSINELLI WA, 1982, ANN NEUROL, V11, P491, DOI 10.1002/ana.410110509; Runnels LW, 2001, SCIENCE, V291, P1043, DOI 10.1126/science.1058519; Saito A, 2005, MOL NEUROBIOL, V31, P105, DOI 10.1385/MN:31:1-3:105; Schmitz C, 2005, J BIOL CHEM, V280, P37763, DOI 10.1074/jbc.M509175200; Schmitz C, 2003, CELL, V114, P191, DOI 10.1016/S0092-8674(03)00556-7; SIESJO BK, 1994, ADV NEUROLOGY CELLUL; SILVER IA, 1990, J GEN PHYSIOL, V95, P837, DOI 10.1085/jgp.95.5.837; Sledz CA, 2003, NAT CELL BIOL, V5, P834, DOI 10.1038/ncb1038; Stoll G, 1998, PROG NEUROBIOL, V56, P149, DOI 10.1016/S0301-0082(98)00034-3; Sun HS, 2006, J NEUROPHYSIOL, V95, P2590, DOI 10.1152/jn.00970.2005; Thompson RJ, 2006, SCIENCE, V312, P924, DOI 10.1126/science.1126241; VOLPE BT, 1984, STROKE, V15, P558, DOI 10.1161/01.STR.15.3.558; VOLPE BT, 1985, NEUROLOGY, V35, P1793, DOI 10.1212/WNL.35.12.1793; WANG LY, 1995, J PHYSIOL-LONDON, V486, P83, DOI 10.1113/jphysiol.1995.sp020792; Wei WL, 2007, P NATL ACAD SCI USA, V104, P16323, DOI 10.1073/pnas.0701149104; Whitlock JR, 2006, SCIENCE, V313, P1093, DOI 10.1126/science.1128134; Xiong ZG, 2004, CELL, V118, P687, DOI 10.1016/j.cell.2004.08.026; Xiong ZG, 2001, J NEUROPHYSIOL, V86, P2520, DOI 10.1152/jn.2001.86.5.2520; Xiong ZG, 1997, P NATL ACAD SCI USA, V94, P7012, DOI 10.1073/pnas.94.13.7012	49	220	229	1	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2009	12	10					1300	U124		10.1038/nn.2395	http://dx.doi.org/10.1038/nn.2395			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	498US	19734892				2022-12-24	WOS:000270170200019
J	Corsini, NS; Sancho-Martinez, I; Laudenklos, S; Glagow, D; Kumar, S; Letellier, E; Koch, P; Teodorczyk, M; Kleber, S; Klussmann, S; Wiestler, B; Brustle, O; Mueller, W; Gieffers, C; Hill, O; Thiemann, M; Seedorf, M; Gretz, N; Sprengel, R; Celikel, T; Martin-Villalba, A				Corsini, Nina S.; Sancho-Martinez, Ignacio; Laudenklos, Sabrina; Glagow, Desiree; Kumar, Sachin; Letellier, Elisabeth; Koch, Philipp; Teodorczyk, Marcin; Kleber, Susanne; Klussmann, Stefan; Wiestler, Benedict; Bruestle, Oliver; Mueller, Wolf; Gieffers, Christian; Hill, Oliver; Thiemann, Meinolf; Seedorf, Matthias; Gretz, Norbert; Sprengel, Rolf; Celikel, Tansu; Martin-Villalba, Ana			The Death Receptor CD95 Activates Adult Neural Stem Cells for Working Memory Formation and Brain Repair	CELL STEM CELL			English	Article							FAS-INDUCED APOPTOSIS; HIPPOCAMPAL NEUROGENESIS; SUBVENTRICULAR ZONE; MICE; NEURONS; PROGENITORS; DIFFERENTIATION; REGENERATION; TRANSLATION; REPLACEMENT	Adult neurogenesis persists in the subventricular zone and the dentate gyrus and can be induced upon central nervous system injury. However, the final contribution of newborn neurons to neuronal networks is limited. Here we show that in neural stem cells, stimulation of the "death receptor" CD95 does not trigger apoptosis but unexpectedly leads to increased stem cell survival and neuronal specification. These effects are mediated via activation of the Src/PI3K/AKT/mTOR signaling pathway, ultimately leading to a global increase in protein translation. Induction of neurogenesis by CD95 was further confirmed in the ischemic CA1 region, in the naive dentate gyrus, and after forced expression of CD95L in the adult subventricular zone. Lack of hippocampal CD95 resulted in a reduction in neurogenesis and working memory deficits. Following global ischemia, CD95-mediated brain repair rescued behavioral impairment. Thus, we identify the CD95/CD95L system as an instructive signal for ongoing and injury-induced neurogenesis.	[Corsini, Nina S.; Sancho-Martinez, Ignacio; Laudenklos, Sabrina; Glagow, Desiree; Kumar, Sachin; Letellier, Elisabeth; Teodorczyk, Marcin; Kleber, Susanne; Klussmann, Stefan; Wiestler, Benedict; Martin-Villalba, Ana] German Canc Res Ctr, D-69120 Heidelberg, Germany; [Seedorf, Matthias] Univ Heidelberg, Zentrum Mol Biol, D-69120 Heidelberg, Germany; [Sprengel, Rolf] Max Planck Inst Med Res, Dept Mol Neurobiol, D-69120 Heidelberg, Germany; [Celikel, Tansu] Univ So Calif, Lab Neural Circuits & Plast, Los Angeles, CA 90089 USA; [Gieffers, Christian; Hill, Oliver; Thiemann, Meinolf] Apogenix GmbH, D-69120 Heidelberg, Germany; [Koch, Philipp; Bruestle, Oliver] Univ Bonn, Life & Brain Ctr, Inst Reconstruct Neurobiol, D-53127 Bonn, Germany; [Koch, Philipp; Bruestle, Oliver] Hertie Fdn, D-53127 Bonn, Germany; [Gretz, Norbert] Univ Heidelberg, Med Res Ctr, Med Fac Mannheim, D-68135 Mannheim, Germany; [Mueller, Wolf] Univ Heidelberg, Inst Pathol, Dept Neuropathol, D-69120 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Max Planck Society; University of Southern California; University of Bonn; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Martin-Villalba, A (corresponding author), German Canc Res Ctr, D-69120 Heidelberg, Germany.	a.martin-villalba@dkfz.de	Letellier, Elisabeth/I-9515-2016; Koch, Philipp/AAZ-3751-2020; Koch, Philipp/M-1186-2016; Seib, Desiree/AAF-2801-2021; Celikel, Tansu/P-4235-2018	Letellier, Elisabeth/0000-0001-8242-9393; Seib, Desiree/0000-0001-9953-8270; Corsini, Nina/0000-0001-6731-3544; Koch, Philipp/0000-0003-3713-8786; Martin-Villalba, Ana/0000-0002-9405-8910; Wiestler, Benedikt/0000-0002-2963-7772; Sancho-Martinez, Ignacio/0000-0003-4348-1038	DKFZ Light Microscopy Facility and the Nikon Imaging Center at the University of Heidelberg; German Research Foundation (DFG); German Federal Ministry of Education and Research (BMBF); Systems Biology of Signaling in Cancer (Helmholtz Alliance on Systems Biology)	DKFZ Light Microscopy Facility and the Nikon Imaging Center at the University of Heidelberg; German Research Foundation (DFG)(German Research Foundation (DFG)); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Systems Biology of Signaling in Cancer (Helmholtz Alliance on Systems Biology)	We thank Gunther Schutz for the Nestin-Cre and Nestin-CreERT2 mouse lines. We thank Klaus Rajewski for the CD95flox mouse line. Support by the DKFZ Light Microscopy Facility and the Nikon Imaging Center at the University of Heidelberg is gratefully acknowledged. We thank Trevor C. Dale and Till Wenger for plasmid constructs. We further thank Alexandra Beisel and Jennifer Hermes for excellent technical support. This work was supported by the German Research Foundation (DFG), the German Federal Ministry of Education and Research (BMBF), and Systems Biology of Signaling in Cancer (Helmholtz Alliance on Systems Biology).	ADACHI M, 1993, P NATL ACAD SCI USA, V90, P1756, DOI 10.1073/pnas.90.5.1756; Aimone JB, 2006, NAT NEUROSCI, V9, P723, DOI 10.1038/nn1707; ANDREWS BS, 1978, J EXP MED, V148, P1198, DOI 10.1084/jem.148.5.1198; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Daigle I, 2002, NAT MED, V8, P61, DOI 10.1038/nm0102-61; Deacon RMJ, 2006, NAT PROTOC, V1, P7, DOI 10.1038/nprot.2006.2; Demjen D, 2004, NAT MED, V10, P389, DOI 10.1038/nm1007; Desbarats J, 2003, NAT CELL BIOL, V5, P118, DOI 10.1038/ncb916; Diehn M, 2000, NAT GENET, V25, P58, DOI 10.1038/75603; Drapeau E, 2003, P NATL ACAD SCI USA, V100, P14385, DOI 10.1073/pnas.2334169100; Dupret D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001959; Dupret D, 2007, PLOS BIOL, V5, P1683, DOI 10.1371/journal.pbio.0050214; EISCHEN CM, 1994, J IMMUNOL, V153, P1947; Emsley JG, 2005, PROG NEUROBIOL, V75, P321, DOI 10.1016/j.pneurobio.2005.04.002; Ferron SR, 2007, NAT PROTOC, V2, P849, DOI 10.1038/nprot.2007.104; Gingras AC, 2001, GENE DEV, V15, P807, DOI 10.1101/gad.887201; Gould E, 1999, NAT NEUROSCI, V2, P260, DOI 10.1038/6365; Kleber S, 2008, CANCER CELL, V13, P235, DOI 10.1016/j.ccr.2008.02.003; Krammer PH, 2000, NATURE, V407, P789, DOI 10.1038/35037728; Lindvall O, 2004, NAT MED, V10, pS42, DOI 10.1038/nm1064; Lledo PM, 2006, NAT REV NEUROSCI, V7, P179, DOI 10.1038/nrn1867; LOIS C, 1993, P NATL ACAD SCI USA, V90, P2074, DOI 10.1073/pnas.90.5.2074; Magavi SS, 2000, NATURE, V405, P951, DOI 10.1038/35016083; Martin LJ, 2000, J CEREBR BLOOD F MET, V20, P153, DOI 10.1097/00004647-200001000-00020; Martin-Villalba A, 1999, J NEUROSCI, V19, P3809; Nakatomi H, 2002, CELL, V110, P429, DOI 10.1016/S0092-8674(02)00862-0; Parent JM, 2002, ANN NEUROL, V52, P802, DOI 10.1002/ana.10393; Ricci-Vitiani L, 2004, J EXP MED, V200, P1257, DOI 10.1084/jem.20040921; Sairanen M, 2005, J NEUROSCI, V25, P1089, DOI 10.1523/JNEUROSCI.3741-04.2005; Sakic B, 1997, NEUROSCI BIOBEHAV R, V21, P327; Sampath P, 2008, CELL STEM CELL, V2, P448, DOI 10.1016/j.stem.2008.03.013; Sancho-Martinez I, 2009, CELL CYCLE, V8, P838, DOI 10.4161/cc.8.6.7906; Schlottmann KE, 1996, J LEUKOCYTE BIOL, V60, P546, DOI 10.1002/jlb.60.4.546; Shors TJ, 2002, HIPPOCAMPUS, V12, P578, DOI 10.1002/hipo.10103; Shors TJ, 2008, CELL STEM CELL, V3, P253, DOI 10.1016/j.stem.2008.08.010; Singec I, 2006, NAT METHODS, V3, P801, DOI 10.1038/nmeth926; Sisti HM, 2007, LEARN MEMORY, V14, P368, DOI 10.1101/lm.488707; Sun Y, 2001, CELL, V104, P365, DOI 10.1016/S0092-8674(01)00224-0; Van der Borght K, 2007, BEHAV NEUROSCI, V121, P324, DOI 10.1037/0735-7044.121.2.324; van Praag H, 2005, J NEUROSCI, V25, P8680, DOI 10.1523/JNEUROSCI.1731-05.2005; Whishaw IQ, 1996, PHYSIOL BEHAV, V60, P1191, DOI 10.1016/S0031-9384(96)00176-X; Yang Z, 2006, NEUROSCIENCE, V139, P555, DOI 10.1016/j.neuroscience.2005.12.059; Zhang CL, 2008, NATURE, V451, P1004, DOI 10.1038/nature06562; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Zuliani C, 2006, CELL DEATH DIFFER, V13, P31, DOI 10.1038/sj.cdd.4401720	45	98	102	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	AUG 7	2009	5	2					178	190		10.1016/j.stem.2009.05.004	http://dx.doi.org/10.1016/j.stem.2009.05.004			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	490PB	19664992	Bronze, Green Submitted			2022-12-24	WOS:000269511900011
J	Zawadzka, M; Rivers, LE; Fancy, SPJ; Zhao, C; Tripathi, R; Jamen, F; Young, K; Goncharevich, A; Pohl, H; Rizzi, M; Rowitch, DH; Kessaris, N; Suter, U; Richardson, WD; Franklin, RJM				Zawadzka, Malgorzata; Rivers, Leanne E.; Fancy, Stephen P. J.; Zhao, Chao; Tripathi, Richa; Jamen, Francoise; Young, Kaylene; Goncharevich, Alexander; Pohl, Hartmut; Rizzi, Matteo; Rowitch, David H.; Kessaris, Nicoletta; Suter, Ueli; Richardson, William D.; Franklin, Robin J. M.			CNS-Resident Glial Progenitor/Stem Cells Produce Schwann Cells as well as Oligodendrocytes during Repair of CNS Demyelination	CELL STEM CELL			English	Article							MULTIPLE-SCLEROSIS LESIONS; CENTRAL-NERVOUS-SYSTEM; EMBRYONIC SPINAL-CORD; PDGF ALPHA-RECEPTOR; NEURAL PROGENITOR; PRECURSOR CELLS; RAT-BRAIN; INTRASPINAL INJECTION; REMYELINATION OCCURS; NG2 PROTEOGLYCAN	After central nervous system (CNS) demyelination such as occurs during multiple sclerosis there is often spontaneous regeneration of myelin sheaths, mainly by oligodendrocytes but also by Schwann cells. The origins of the remyelinating cells have not previously been established. We have used Cre-lox fate mapping in transgenic mice to show that PDGFRA/NG2-expressing glia, a distributed population of stem/progenitor cells in the adult CNS, produce the remyelinating oligodendrocytes and almost all of the Schwann cells in chemically induced demyelinated lesions. In contrast, the great majority of reactive astrocytes in the vicinity of the lesions are derived from preexisting FGFR3-expressing cells, likely to be astrocytes. These data resolve a long-running debate about the origins of the main players in CNS remyelination and reveal a surprising capacity of CNS precursors to generate Schwann cells, which normally develop from the embryonic neural crest and are restricted to the peripheral nervous system.	[Rivers, Leanne E.; Tripathi, Richa; Jamen, Francoise; Young, Kaylene; Rizzi, Matteo; Kessaris, Nicoletta; Richardson, William D.] UCL, Wolfson Inst Biomed Res, London WC1E 6BT, England; [Rivers, Leanne E.; Tripathi, Richa; Young, Kaylene; Kessaris, Nicoletta; Richardson, William D.] UCL, Res Dept Cell & Dev Biol, London WC1E 6BT, England; [Rizzi, Matteo] UCL, Res Dept Neurosci Physiol & Pharmacol, London WC1E 6BT, England; [Fancy, Stephen P. J.; Rowitch, David H.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; [Fancy, Stephen P. J.; Rowitch, David H.] Univ Calif San Francisco, Inst Regenerat Med, Dept Pediat, San Francisco, CA 94143 USA; [Pohl, Hartmut; Suter, Ueli] ETH, Inst Cell Biol, Dept Biol, CH-8093 Zurich, Switzerland; [Zawadzka, Malgorzata] M Nencki Inst Expt Biol, Lab Transcript Regulat, Dept Cell Biol, PL-02093 Warsaw, Poland; [Zawadzka, Malgorzata; Fancy, Stephen P. J.; Zhao, Chao; Goncharevich, Alexander; Franklin, Robin J. M.] Univ Cambridge, MRC Cambridge Ctr Stem Cell Biol & Regenerat Med, Cambridge CB3 0ES, England; [Zawadzka, Malgorzata; Fancy, Stephen P. J.; Zhao, Chao; Goncharevich, Alexander; Franklin, Robin J. M.] Univ Cambridge, Dept Vet Med, Cambridge CB3 0ES, England	University of London; University College London; University of London; University College London; University of London; University College London; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Swiss Federal Institutes of Technology Domain; ETH Zurich; Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences; University of Cambridge; University of Cambridge	Richardson, WD (corresponding author), UCL, Wolfson Inst Biomed Res, Gower St, London WC1E 6BT, England.	w.richardson@ucl.ac.uk; rjf1000@cam.ac.uk	Kessaris, Nicoletta/AAD-6774-2019; Messier, Claude/A-2322-2008; Zawadzka, Malgorzata/AAB-1979-2020; Suter, Ueli/A-1624-2010; Zawadzka, Malgorzata/A-5297-2012; Richardson FMedSci FRS, William D/C-1762-2008	Kessaris, Nicoletta/0000-0003-1191-6009; Messier, Claude/0000-0002-4791-1763; Zawadzka, Malgorzata/0000-0002-3637-2709; Zawadzka, Malgorzata/0000-0002-3637-2709; Richardson FMedSci FRS, William D/0000-0001-7261-2485; Jamen, Francoise/0000-0003-4116-395X; Pohl, Hartmut/0000-0001-6827-1665; Young, Kaylene/0000-0002-1686-3463; Rowitch, David/0000-0002-0079-0060; Tripathi, Richa/0000-0002-3810-0328; Franklin, Robin/0000-0001-6522-2104; Rizzi, Matteo/0000-0003-4922-397X	European Union (EU); Biotechnology and Biological Sciences Research Council with Eisai Research London; Wellcome Trust; Swiss National Science Foundation; National Competence Center in Research (NCCR); UK Medical Research Council; UK MS Society; National MS Society; MRC [G9708005, G0501173, G0800575] Funding Source: UKRI; Medical Research Council [G0800575, G9708005, G0501173] Funding Source: researchfish	European Union (EU)(CGIAREuropean Commission); Biotechnology and Biological Sciences Research Council with Eisai Research London(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Competence Center in Research (NCCR)(Swiss National Science Foundation (SNSF)); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK MS Society; National MS Society(National Multiple Sclerosis Society); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	M.Z. was supported by a Marie Curie Fellowship from the European Union (EU). L.E.R. was supported by a studentship from the Biotechnology and Biological Sciences Research Council with Eisai Research London, M.R. by a Wellcome Trust Prize Studentship, and F.J. by an EU Marie Curie Fellowship. D.H.R. is an HHMI investigator. U.S. is supported by the Swiss National Science Foundation and the National Competence Center in Research (NCCR) "Neural Plasticity and Repair." N.K. and W.D.R. are funded by the UK Medical Research Council and The Wellcome Trust. S.P.J.F., C.Z., and R.J.M.F. are supported by grants from the UK MS Society and the National MS Society.	Arnett HA, 2004, SCIENCE, V306, P2111, DOI 10.1126/science.1103709; BaronVanEvercooren A, 1996, GLIA, V16, P147, DOI 10.1002/(SICI)1098-1136(199602)16:2<147::AID-GLIA7>3.0.CO;2-0; Belachew S, 2003, J CELL BIOL, V161, P169, DOI 10.1083/jcb.200210110; Blakemore WF, 2008, CURR TOP MICROBIOL, V318, P193; BLAKEMORE WF, 1975, J NEUROCYTOL, V4, P745, DOI 10.1007/BF01181634; Buffo A, 2008, P NATL ACAD SCI USA, V105, P3581, DOI 10.1073/pnas.0709002105; Cassiani-Ingoni R, 2006, EXP NEUROL, V201, P349, DOI 10.1016/j.expneurol.2006.04.030; CAVANAGH JB, 1970, J ANAT, V106, P471; Chandran S, 2004, GLIA, V47, P314, DOI 10.1002/glia.20011; Chen Y, 2008, J NEUROSCI, V28, P10983, DOI 10.1523/JNEUROSCI.3545-08.2008; Crang AJ, 2004, EUR J NEUROSCI, V20, P1445, DOI 10.1111/j.1460-9568.2004.03606.x; Danilov AI, 2006, EUR J NEUROSCI, V23, P394, DOI 10.1111/j.1460-9568.2005.04563.x; Dimou L, 2008, J NEUROSCI, V28, P10434, DOI 10.1523/JNEUROSCI.2831-08.2008; Duncan ID, 1997, J ANAT, V190, P35, DOI 10.1046/j.1469-7580.1997.19010035.x; DUSART I, 1992, NEUROSCIENCE, V51, P137, DOI 10.1016/0306-4522(92)90478-K; Fancy SPJ, 2004, MOL CELL NEUROSCI, V27, P247, DOI 10.1016/j.mcn.2004.06.015; Felts PA, 2005, BRAIN, V128, P1649, DOI 10.1093/brain/awh516; FRANKLIN RJM, 1993, INT J DEV NEUROSCI, V11, P641, DOI 10.1016/0736-5748(93)90052-F; Franklin RJM, 2008, NAT REV NEUROSCI, V9, P839, DOI 10.1038/nrn2480; Gensert JM, 1997, NEURON, V19, P197, DOI 10.1016/S0896-6273(00)80359-1; GILLESPIE CS, 1994, NEURON, V12, P497, DOI 10.1016/0896-6273(94)90208-9; Gudino-Cabrera G, 2000, GLIA, V30, P49, DOI 10.1002/(SICI)1098-1136(200003)30:1<49::AID-GLIA6>3.0.CO;2-M; ITOYAMA Y, 1985, ACTA NEUROPATHOL, V65, P217, DOI 10.1007/BF00687001; ITOYAMA Y, 1983, ANN NEUROL, V14, P339, DOI 10.1002/ana.410140313; Keirstead HS, 1999, J NEUROSCI, V19, P7529, DOI 10.1523/JNEUROSCI.19-17-07529.1999; Keirstead HS, 1997, J NEUROPATH EXP NEUR, V56, P1191, DOI 10.1097/00005072-199711000-00003; Kessaris N, 2006, NAT NEUROSCI, V9, P173, DOI 10.1038/nn1620; Kondo T, 2004, DEV BIOL, V267, P242, DOI 10.1016/j.ydbio.2003.11.013; Lee MJ, 1997, MOL CELL NEUROSCI, V8, P336, DOI 10.1006/mcne.1996.0589; Leone DP, 2003, MOL CELL NEUROSCI, V22, P430, DOI 10.1016/S1044-7431(03)00029-0; LEVISON SW, 1993, NEURON, V10, P201, DOI 10.1016/0896-6273(93)90311-E; Ligon KL, 2006, P NATL ACAD SCI USA, V103, P7853, DOI 10.1073/pnas.0511001103; Magnus T, 2007, J NEUROSCI RES, V85, P2126, DOI 10.1002/jnr.21368; Masahira N, 2006, DEV BIOL, V293, P358, DOI 10.1016/j.ydbio.2006.02.029; Mujtaba T, 1998, DEV BIOL, V200, P1, DOI 10.1006/dbio.1998.8913; Nagelhus EA, 1998, J NEUROSCI, V18, P2506; Nave KA, 2008, ANNU REV NEUROSCI, V31, P535, DOI 10.1146/annurev.neuro.30.051606.094309; Nishiyama A, 1996, J NEUROSCI RES, V43, P299, DOI 10.1002/(SICI)1097-4547(19960201)43:3<299::AID-JNR5>3.0.CO;2-E; Nunes MC, 2003, NAT MED, V9, P439, DOI 10.1038/nm837; Patrikios P, 2006, BRAIN, V129, P3165, DOI 10.1093/brain/awl217; PRINGLE NP, 1992, DEVELOPMENT, V115, P535; RAFF MC, 1983, NATURE, V303, P390, DOI 10.1038/303390a0; RAIVICH G, 1987, J NEUROCYTOL, V16, P701, DOI 10.1007/BF01637661; Rivers LE, 2008, NAT NEUROSCI, V11, P1392, DOI 10.1038/nn.2220; Shields SA, 1999, GLIA, V28, P77, DOI 10.1002/(SICI)1098-1136(199910)28:1<77::AID-GLIA9>3.0.CO;2-F; Sim FJ, 2002, MOL CELL NEUROSCI, V20, P669, DOI 10.1006/mcne.2002.1145; Sim FJ, 2002, J NEUROSCI, V22, P2451, DOI 10.1523/JNEUROSCI.22-07-02451.2002; SMITH KJ, 1979, NATURE, V280, P395, DOI 10.1038/280395a0; SNYDER DH, 1975, J NEUROPATH EXP NEUR, V34, P209, DOI 10.1097/00005072-197505000-00001; Steindler DA, 2003, GLIA, V43, P62, DOI 10.1002/glia.10242; Talbott JF, 2006, GLIA, V54, P147, DOI 10.1002/glia.20369; Talbott JF, 2005, EXP NEUROL, V192, P11, DOI 10.1016/j.expneurol.2004.05.038; Trapp BD, 2008, ANNU REV NEUROSCI, V31, P247, DOI 10.1146/annurev.neuro.30.051606.094313; Watanabe M, 2002, J NEUROSCI RES, V69, P826, DOI 10.1002/jnr.10338; Woodruff RH, 1999, GLIA, V25, P216, DOI 10.1002/(SICI)1098-1136(19990201)25:3<216::AID-GLIA2>3.0.CO;2-L; YOUNG KM, 2010, GLIA IN PRESS; Zhang SC, 1999, P NATL ACAD SCI USA, V96, P4089, DOI 10.1073/pnas.96.7.4089; Zhu XQ, 2008, DEVELOPMENT, V135, P145, DOI 10.1242/dev.004895	58	426	435	1	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUN 4	2010	6	6					578	590		10.1016/j.stem.2010.04.002	http://dx.doi.org/10.1016/j.stem.2010.04.002			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	611SB	20569695	Bronze, Green Accepted			2022-12-24	WOS:000278840700018
J	Lall, GS; Revell, VL; Momiji, H; Al Enezi, J; Altimus, CM; Guler, AD; Aguilar, C; Cameron, MA; Allender, S; Hankins, MW; Lucas, RJ				Lall, Gurprit S.; Revell, Victoria L.; Momiji, Hiroshi; Al Enezi, Jazi; Altimus, Cara M.; Gueler, Ali D.; Aguilar, Carlos; Cameron, Morven A.; Allender, Susan; Hankins, Mark W.; Lucas, Robert J.			Distinct Contributions of Rod, Cone, and Melanopsin Photoreceptors to Encoding Irradiance	NEURON			English	Article							RETINAL GANGLION-CELLS; DARK-ADAPTED MOUSE; SUPRACHIASMATIC NUCLEUS; SPECTRAL SENSITIVITY; CIRCADIAN RESPONSES; LIGHT ADAPTATION; AMACRINE CELLS; BIPOLAR CELLS; IN-SITU; MICE	Photoreceptive, melanopsin-expressing retinal ganglion cells (mRGCs) encode ambient light (irradiance) for the circadian clock, the pupillomotor system, and other influential behavioral/physiological responses. mRGCs are activated both by their intrinsic phototransduction cascade and by the rods and cones. However, the individual contribution of each photoreceptor class to irradiance responses remains unclear. We address this deficit using mice expressing human red cone opsin, in which rod-, cone-, and melanopsin-dependent responses can be identified by their distinct spectral sensitivity. Our data reveal an unexpectedly important role for rods. These photoreceptors define circadian responses at very dim "scotopic" light levels but also at irradiances at which pattern vision relies heavily on cones. By contrast, cone input to irradiance responses dissipates following light adaptation to the extent that these receptors make a very limited contribution to circadian and pupillary light responses under these conditions. Our data provide new insight into retinal circuitry upstream of mRGCs and optimal stimuli for eliciting irradiance responses.	[Lall, Gurprit S.; Revell, Victoria L.; Al Enezi, Jazi; Aguilar, Carlos; Cameron, Morven A.; Allender, Susan; Lucas, Robert J.] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England; [Momiji, Hiroshi] Univ Sheffield, Dept Comp Sci, Sheffield S1 4DP, S Yorkshire, England; [Altimus, Cara M.; Gueler, Ali D.] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA; [Altimus, Cara M.; Gueler, Ali D.] Johns Hopkins Univ, Dept Neurosci JHMI, Baltimore, MD 21218 USA; [Hankins, Mark W.] Univ Oxford, John Radcliffe Hosp, Nuffield Lab Ophthalmol, Oxford OX3 9DU, England	University of Manchester; University of Sheffield; Johns Hopkins University; Johns Hopkins University; University of Oxford	Lucas, RJ (corresponding author), Univ Manchester, Fac Life Sci, AV Hill Bldg, Manchester M13 9PT, Lancs, England.	robert.lucas@manchester.ac.uk	Cameron, Morven/B-4128-2012	Allender, Steven/0000-0002-4842-3294; Guler, Ali Deniz/0000-0001-8218-850X; Momiji, Hiroshi/0000-0002-3015-5770; Lucas, Robert/0000-0002-1088-8029; Cameron, Morven/0000-0002-2277-7035; Lall, Gurprit/0000-0003-3725-4795	Wellcome Trust; BBSRC	Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by grants from the Wellcome Trust (R.L.) and the BBSRC (R.L. and M.H.). C.A. and A.G. collected entrainment data for Opn4<SUP>-/-</SUP> Gnat1<SUP>-/-</SUP> and Opn4<SUP>-/-</SUP> mice in the laboratory of Samer Hattar, Departments of Biology and Neuroscience, Johns Hopkins University. Lab-view development was provided by Dr. Adam Huffman.	Abd-El-Barr MM, 2009, J NEUROPHYSIOL, V102, P1945, DOI 10.1152/jn.00142.2009; Aggelopoulos NC, 2000, J PHYSIOL-LONDON, V523, P211, DOI 10.1111/j.1469-7793.2000.t01-1-00211.x; ALPERN M, 1971, J PHYSIOL-LONDON, V217, P447, DOI 10.1113/jphysiol.1971.sp009580; Altimus CM, 2008, P NATL ACAD SCI USA, V105, P19998, DOI 10.1073/pnas.0808312105; Bachleitner W, 2007, P NATL ACAD SCI USA, V104, P3538, DOI 10.1073/pnas.0606870104; Baver SB, 2008, EUR J NEUROSCI, V27, P1763, DOI 10.1111/j.1460-9568.2008.06149.x; Belenky MA, 2003, J COMP NEUROL, V460, P380, DOI 10.1002/cne.10652; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; BURKHARDT DA, 1994, J NEUROSCI, V14, P1091, DOI 10.1523/JNEUROSCI.14-03-01091.1994; Calvert PD, 2000, P NATL ACAD SCI USA, V97, P13913, DOI 10.1073/pnas.250478897; DAAN S, 1976, J COMP PHYSIOL, V106, P267, DOI 10.1007/BF01417858; Dacey DM, 2005, NATURE, V433, P749, DOI 10.1038/nature03387; Deans MR, 2002, NEURON, V36, P703, DOI 10.1016/S0896-6273(02)01046-2; Dkhissi-Benyahya O, 2007, NEURON, V53, P677, DOI 10.1016/j.neuron.2007.02.005; Do MTH, 2009, NATURE, V457, P281, DOI 10.1038/nature07682; Drouyer E, 2007, J NEUROSCI, V27, P9623, DOI 10.1523/JNEUROSCI.1391-07.2007; Dumitrescu ON, 2009, J COMP NEUROL, V517, P226, DOI 10.1002/cne.22158; Evans JA, 2009, CURR BIOL, V19, pR156, DOI 10.1016/j.cub.2009.01.023; Figueiro MG, 2004, NEUROREPORT, V15, P313, DOI 10.1097/00001756-200402090-00020; Freedman MS, 1999, SCIENCE, V284, P502, DOI 10.1126/science.284.5413.502; Gamlin PDR, 2007, VISION RES, V47, P946, DOI 10.1016/j.visres.2006.12.015; Goz D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003153; Govardovskii VI, 2000, VISUAL NEUROSCI, V17, P509, DOI 10.1017/S0952523800174036; Guler AD, 2008, NATURE, V453, P102, DOI 10.1038/nature06829; Hatori M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002451; Hattar S, 2003, NATURE, V424, P76, DOI 10.1038/nature01761; Haverkamp S, 2005, J NEUROSCI, V25, P5438, DOI 10.1523/JNEUROSCI.1117-05.2005; Hoshi H, 2009, J NEUROSCI, V29, P8875, DOI 10.1523/JNEUROSCI.0912-09.2009; Jacobs GH, 2007, SCIENCE, V315, P1723, DOI 10.1126/science.1138838; Lucas RJ, 2001, NAT NEUROSCI, V4, P621, DOI 10.1038/88443; Lucas RJ, 2003, SCIENCE, V299, P245, DOI 10.1126/science.1077293; Lucas RJ, 1999, SCIENCE, V284, P505, DOI 10.1126/science.284.5413.505; Lupi D, 2008, NAT NEUROSCI, V11, P1068, DOI 10.1038/nn.2179; Lyubarsky AL, 2004, VISION RES, V44, P3235, DOI 10.1016/j.visres.2004.09.019; McDougal DH, 2010, VISION RES, V50, P72, DOI 10.1016/j.visres.2009.10.012; Melyan Z, 2005, NATURE, V433, P741, DOI 10.1038/nature03344; Mrosovsky N, 2005, J COMP PHYSIOL A, V191, P1011, DOI 10.1007/s00359-005-0017-1; Mrosovsky N, 2003, J COMP PHYSIOL A, V189, P69, DOI 10.1007/s00359-002-0378-7; Nathan J, 2006, PHOTOCHEM PHOTOBIOL, V82, P1489, DOI 10.1562/2006-02-27-RA-818; NELSON DE, 1991, J PHYSIOL-LONDON, V439, P115, DOI 10.1113/jphysiol.1991.sp018660; Nikonov SS, 2006, J GEN PHYSIOL, V127, P359, DOI 10.1085/jgp.200609490; NORMANN RA, 1979, J PHYSIOL-LONDON, V286, P491, DOI 10.1113/jphysiol.1979.sp012633; Ostergaard J, 2007, INVEST OPHTH VIS SCI, V48, P3812, DOI 10.1167/iovs.06-1322; Panda S, 2005, SCIENCE, V307, P600, DOI 10.1126/science.1105121; Panda S, 2003, SCIENCE, V301, P525, DOI 10.1126/science.1086179; Panda S, 2002, SCIENCE, V298, P2213, DOI 10.1126/science.1076848; Pang JJ, 2004, J PHYSIOL-LONDON, V558, P897, DOI 10.1113/jphysiol.2003.059543; Pennesi ME, 1998, INVEST OPHTH VIS SCI, V39, P2148; Perez-Leon JA, 2006, EUR J NEUROSCI, V24, P1117, DOI 10.1111/j.1460-9568.2006.04999.x; PROVENCIO I, 1995, BRAIN RES, V694, P183, DOI 10.1016/0006-8993(95)00694-L; Riemersma-van Der Lek RF, 2008, JAMA-J AM MED ASSOC, V299, P2642, DOI 10.1001/jama.299.22.2642; Rollag MD, 2008, J BIOL RHYTHM, V23, P396, DOI 10.1177/0748730408323067; Ruby NF, 2002, SCIENCE, V298, P2211, DOI 10.1126/science.1076701; Sampath AP, 2005, NEURON, V46, P413, DOI 10.1016/j.neuron.2005.04.006; Schmidt TM, 2008, J NEUROPHYSIOL, V100, P371, DOI 10.1152/jn.00062.2008; Smallwood PM, 2003, P NATL ACAD SCI USA, V100, P11706, DOI 10.1073/pnas.1934712100; TAKAHASHI JS, 1984, NATURE, V308, P186, DOI 10.1038/308186a0; Tsai JW, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000125; Tsujimura S, 2010, P ROY SOC B-BIOL SCI, V277, P2485, DOI 10.1098/rspb.2010.0330; VALETON JM, 1983, VISION RES, V23, P1539, DOI 10.1016/0042-6989(83)90167-0; Van Gelder RN, 2003, SCIENCE, V299, P222, DOI 10.1126/science.1079536; Viney TJ, 2007, CURR BIOL, V17, P981, DOI 10.1016/j.cub.2007.04.058; Viola AU, 2008, SCAND J WORK ENV HEA, V34, P297, DOI 10.5271/sjweh.1268; Williams GA, 2005, VISUAL NEUROSCI, V22, P807, DOI 10.1017/S095252380522610X; Wong KY, 2007, J PHYSIOL-LONDON, V582, P279, DOI 10.1113/jphysiol.2007.133751; Yoshimura T, 1996, J COMP PHYSIOL A, V178, P797; Young RSL, 2008, VISION RES, V48, P862, DOI 10.1016/j.visres.2007.12.016; Zhu YL, 2007, INVEST OPHTH VIS SCI, V48, P1268, DOI 10.1167/iovs.06-0925	68	208	213	3	38	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 13	2010	66	3					417	428		10.1016/j.neuron.2010.04.037	http://dx.doi.org/10.1016/j.neuron.2010.04.037			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	598HE	20471354	hybrid, Green Published			2022-12-24	WOS:000277825200010
J	Tojima, T; Itofusa, R; Kamiguchi, H				Tojima, Takuro; Itofusa, Rurika; Kamiguchi, Hiroyuki			Asymmetric Clathrin-Mediated Endocytosis Drives Repulsive Growth Cone Guidance	NEURON			English	Article							NERVE GROWTH; AXON GUIDANCE; COATED PITS; RECEPTOR; ACTIN; CELL; INTERNALIZATION; INVAGINATION; RECRUITMENT; MOLECULES	Asymmetric Ca2+ elevations across the axonal growth cone mediate its turning responses to attractive and repulsive guidance cues. Here we show that clathrin-mediated endocytosis acts downstream of Ca2+ signals as driving machinery for growth cone turning. In dorsal root ganglion neurons, the formation of clathrin-coated pits is facilitated asymmetrically across the growth cone by a directionally applied chemorepellent, semaphorin 3A, or by Ca2+ signals that mediate repulsive guidance. In contrast, coated pit formation remains symmetric in the presence of attractive Ca2+ signals. Inhibition of clathrin-mediated endocytosis abolishes growth cone repulsion, but not attraction, induced by Ca2+ or extracellular physiological cues. Furthermore, asymmetric perturbation of the balance of endocytosis and exocytosis in the growth cone is sufficient to initiate its turning toward the side with less endocytosis or more exocytosis. With our previous finding that growth cone attraction involves asymmetric exocytosis, we propose that the balance between membrane addition and removal dictates bidirectional axon guidance.	[Tojima, Takuro; Itofusa, Rurika; Kamiguchi, Hiroyuki] RIKEN, Brain Sci Inst, Lab Neuronal Growth Mech, Wako, Saitama 3510198, Japan	RIKEN	Kamiguchi, H (corresponding author), RIKEN, Brain Sci Inst, Lab Neuronal Growth Mech, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	kamiguchi@brain.riken.jp	Kamiguchi, Hiroyuki/N-5409-2015; Tojima, Takuro/C-3667-2017	Kamiguchi, Hiroyuki/0000-0003-1802-6324; Tojima, Takuro/0000-0002-9140-3205	MEXT [20700302, 21200009]	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We are grateful to A.T. Guy and H. Akiyama for critical reading of this manuscript. We thank J.H. Keen, M.A. McNiven, H.T. McMahon, and R.Y. Tsien for plasmid constructs. We also thank RIKEN BSI Research Resources Center for DNA sequencing. This work was partially supported by Grants-in-Aid for Young Scientists (B) (20700302, T.T.) and Scientific Research on Innovative Areas (21200009, H.K.) from MEXT.	Akiyama H, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000196; Banbury AN, 2003, J BIOL CHEM, V278, P12022, DOI 10.1074/jbc.M211966200; Bartoe JL, 2006, J NEUROSCI, V26, P3192, DOI 10.1523/JNEUROSCI.3469-05.2006; Castellani V, 2004, MOL CELL NEUROSCI, V26, P89, DOI 10.1016/j.mcn.2004.01.010; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; Cousin MA, 2001, TRENDS NEUROSCI, V24, P659, DOI 10.1016/S0166-2236(00)01930-5; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; Dequidt C, 2007, MOL BIOL CELL, V18, P3131, DOI 10.1091/mbc.E06-12-1101; Diestel S, 2007, J CELL SCI, V120, P4035, DOI 10.1242/jcs.019729; Ehrlich M, 2004, CELL, V118, P591, DOI 10.1016/j.cell.2004.08.017; Ezratty EJ, 2009, J CELL BIOL, V187, P733, DOI 10.1083/jcb.200904054; Ford MGJ, 2001, SCIENCE, V291, P1051, DOI 10.1126/science.291.5506.1051; Fournier AE, 2000, J CELL BIOL, V149, P411, DOI 10.1083/jcb.149.2.411; Henley JR, 2004, NEURON, V44, P909, DOI 10.1016/j.neuron.2004.11.030; Hong K, 2000, NATURE, V403, P93, DOI 10.1038/47507; Jin M, 2005, J NEUROSCI, V25, P2338, DOI 10.1523/JNEUROSCI.4889-04.2005; Kolpak AL, 2009, J NEUROSCI, V29, P10488, DOI 10.1523/JNEUROSCI.2355-09.2009; Marks B, 1998, CURR BIOL, V8, P740, DOI 10.1016/S0960-9822(98)70297-0; Medeiros NA, 2006, NAT CELL BIOL, V8, P215, DOI 10.1038/ncb1367; Merrifield CJ, 2002, NAT CELL BIOL, V4, P691, DOI 10.1038/ncb837; Merrifield CJ, 2005, CELL, V121, P593, DOI 10.1016/j.cell.2005.03.015; Ooashi N, 2005, J CELL BIOL, V170, P1159, DOI 10.1083/jcb.200503157; Pfenninger KH, 2009, NAT REV NEUROSCI, V10, P251, DOI 10.1038/nrn2593; Piper M, 2005, NAT NEUROSCI, V8, P179, DOI 10.1038/nn1380; Piper M, 2006, NEURON, V49, P215, DOI 10.1016/j.neuron.2005.12.008; Rappoport JZ, 2003, J CELL SCI, V116, P847, DOI 10.1242/jcs.00289; Ray E, 1996, FEBS LETT, V378, P235, DOI 10.1016/0014-5793(95)01462-4; Schutze S, 1999, J BIOL CHEM, V274, P10203, DOI 10.1074/jbc.274.15.10203; Sorkin A, 2002, NAT REV MOL CELL BIO, V3, P600, DOI 10.1038/nrm883; Togashi K, 2008, NEURON, V58, P694, DOI 10.1016/j.neuron.2008.03.017; Tojima T, 2007, NAT NEUROSCI, V10, P58, DOI 10.1038/nn1814; Ushkaryov YA, 2004, TOXICON, V43, P527, DOI 10.1016/j.toxicon.2004.02.008; Wen ZX, 2007, J CELL BIOL, V178, P107, DOI 10.1083/jcb.200703055; Wen ZX, 2004, NEURON, V43, P835, DOI 10.1016/j.neuron.2004.08.037; Zheng JQ, 2000, NATURE, V403, P89, DOI 10.1038/47501	35	76	76	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 13	2010	66	3					370	377		10.1016/j.neuron.2010.04.007	http://dx.doi.org/10.1016/j.neuron.2010.04.007			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	598HE	20471350	Bronze			2022-12-24	WOS:000277825200006
J	Jablonska, B; Aguirre, A; Raymond, M; Szabo, G; Kitabatake, Y; Sailor, KA; Ming, GL; Song, HJ; Gallo, V				Jablonska, Beata; Aguirre, Adan; Raymond, Matthew; Szabo, Gabor; Kitabatake, Yasuji; Sailor, Kurt A.; Ming, Guo-Li; Song, Hongjun; Gallo, Vittorio			Chordin-induced lineage plasticity of adult SVZ neuroblasts after demyelination	NATURE NEUROSCIENCE			English	Article							BONE MORPHOGENETIC PROTEIN; NEURAL STEM-CELLS; CENTRAL-NERVOUS-SYSTEM; OLIG GENE-FUNCTION; SUBVENTRICULAR ZONE; PROGENITOR CELLS; MULTIPLE-SCLEROSIS; SPINAL-CORD; BRAIN; MOUSE	The mechanisms that regulate the developmental potential of adult neural progenitor populations under physiological and pathological conditions remain poorly defined. Glutamic acid decarboxylase 65 (GAD65)- and Doublecortin (Dcx)-expressing cells constitute major progenitor populations in the adult mouse subventricular zone (SVZ). Under normal physiological conditions, SVZ-derived GAD65-positive and Dcx-positive cells expressed the transcription factor Pax6 and migrated along the rostral migratory stream to the olfactory bulb to generate interneurons. After lysolecithin-induced demyelination of corpus callosum, however, these cells altered their molecular and cellular properties and migratory path. Demyelination upregulated chordin in the SVZ, which redirected GAD65-positive and Dcx-positive progenitors from neuronal to glial fates, generating new oligodendrocytes in the corpus callosum. Our findings suggest that the lineage plasticity of SVZ progenitor cells could be a potential therapeutic strategy for diseased or injured brain.	[Jablonska, Beata; Aguirre, Adan; Raymond, Matthew; Gallo, Vittorio] Childrens Natl Med Ctr, Ctr Neurosci Res, Washington, DC 20010 USA; [Raymond, Matthew] George Washington Univ, Inst Biomed Sci, Washington, DC USA; [Szabo, Gabor] Hungarian Acad Sci, Inst Expt Med, Dept Gene Technol & Dev Neurobiol, Budapest, Hungary; [Kitabatake, Yasuji; Sailor, Kurt A.; Ming, Guo-Li; Song, Hongjun] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA	Children's National Health System; George Washington University; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine; Johns Hopkins University	Gallo, V (corresponding author), Childrens Natl Med Ctr, Ctr Neurosci Res, Washington, DC 20010 USA.	vgallo@cnmcresearch.org	Ming, Guo-li/J-7880-2013; Sailor, Kurt/GSO-2237-2022; Szabo, Gabor/A-5087-2008; Sailor, Kurt Andrew/AFN-4046-2022	Sailor, Kurt/0000-0002-9574-6838; Szabo, Gabor/0000-0001-5438-5151; Sailor, Kurt Andrew/0000-0002-9574-6838; Kitabatake, Yasuji/0000-0002-2907-9512; Ming, Guo-li/0000-0002-2517-6075	US National Institutes of Health [R01NS045702, R01NS056427, K99NS057944, R01NS047344, R01AG024984, R01NS048271]; Hungarian National Office for Research and Technology [GVOP-3.1.1.-2004-05-0230-/3.0]; US National Institutes of Health Intellectual and Developmental Disabilities Research Center [P30HD40677]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD040677] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [T32EY017203] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES021957] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P20MH084018, R21MH087874, R33MH087874] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS047344, R56NS047344, R01NS048271, R01NS045702, K99NS057944, R01NS047344, R01NS056427] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG024984] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hungarian National Office for Research and Technology(National Office for Research and Technology); US National Institutes of Health Intellectual and Developmental Disabilities Research Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank F. Gage (Salk Institute) and J. Goldman (Columbia University) for the gift of pNIT-GFP and dS-Red retrovirus and D. Rowitch (University of California San Francisco) for the gift of antibodies to Olig2. We thank T. Hawley for assistance with FACS sorting. We are particularly grateful to J. Corbin for discussion. This work was supported by US National Institutes of Health grants R01NS045702 and R01NS056427 to V. G., K99NS057944 to A. A., R01NS047344 and R01AG024984 to H. S. and R01NS048271 to G. M. and by the Hungarian National Office for Research and Technology GVOP-3.1.1.-2004-05-0230-/3.0 to G. S. and US National Institutes of Health Intellectual and Developmental Disabilities Research Center P30HD40677 to V. G.	Aguirre A, 2005, J NEUROSCI, V25, P11092, DOI 10.1523/JNEUROSCI.2981-05.2005; Aguirre AA, 2004, J CELL BIOL, V165, P575, DOI 10.1083/jcb.200311141; Aguirre A, 2007, NAT NEUROSCI, V10, P990, DOI 10.1038/nn1938; Alvarez-Buylla A, 2002, J NEUROSCI, V22, P629, DOI 10.1523/JNEUROSCI.22-03-00629.2002; Alvarez-Buylla A, 2004, NEURON, V41, P683, DOI 10.1016/S0896-6273(04)00111-4; Ara J, 2008, J NEUROSCI RES, V86, P125, DOI 10.1002/jnr.21462; Bani-Yaghoub M, 2008, BIOCHEM CELL BIOL, V86, P361, DOI [10.1139/O08-116, 10.1139/o08-116]; Baumann N, 2001, PHYSIOL REV, V81, P871, DOI 10.1152/physrev.2001.81.2.871; Buffo A, 2005, P NATL ACAD SCI USA, V102, P18183, DOI 10.1073/pnas.0506535102; Canoll P, 2008, ACTA NEUROPATHOL, V116, P465, DOI 10.1007/s00401-008-0432-9; Chang A, 2008, BRAIN, V131, P2366, DOI 10.1093/brain/awn157; Chen HL, 2007, STEM CELLS, V25, P63, DOI 10.1634/stemcells.2006-0339; Chou J, 2006, J NEUROL SCI, V240, P21, DOI 10.1016/j.jns.2005.08.015; Colak D, 2008, J NEUROSCI, V28, P434, DOI 10.1523/JNEUROSCI.4374-07.2008; Coskun V, 2002, J NEUROSCI RES, V69, P795, DOI 10.1002/jnr.10336; DEININGER M, 1995, ACTA NEUROPATHOL, V90, P76; Doetsch F, 1999, P NATL ACAD SCI USA, V96, P11619, DOI 10.1073/pnas.96.20.11619; Franklin RJM, 2008, NAT REV NEUROSCI, V9, P839, DOI 10.1038/nrn2480; Fuller ML, 2007, ANN NEUROL, V62, P288, DOI 10.1002/ana.21179; Goings GE, 2004, BRAIN RES, V996, P213, DOI 10.1016/j.brainres.2003.10.034; Gomes WA, 2003, DEV BIOL, V255, P164, DOI 10.1016/S0012-1606(02)00037-4; Hack MA, 2005, NAT NEUROSCI, V8, P865, DOI 10.1038/nn1479; Hampton DW, 2007, EUR J NEUROSCI, V26, P3024, DOI 10.1111/j.1460-9568.2007.05940.x; Heins N, 2002, NAT NEUROSCI, V5, P308, DOI 10.1038/nn828; Israelsson C, 2006, J NEUROSCI RES, V84, P47, DOI 10.1002/jnr.20856; Jablonska B, 2007, J CELL BIOL, V179, P1231, DOI 10.1083/jcb.200702031; Jessberger S, 2008, NAT NEUROSCI, V11, P888, DOI 10.1038/nn.2148; Kim Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008122; Kondo Toru, 2009, Brain and Nerve (Tokyo), V61, P741; Levine JM, 2001, TRENDS NEUROSCI, V24, P39, DOI 10.1016/S0166-2236(00)01691-X; Ligon KL, 2006, GLIA, V54, P1, DOI 10.1002/glia.20273; Ligon KL, 2006, P NATL ACAD SCI USA, V103, P7853, DOI 10.1073/pnas.0511001103; Mehler MF, 2000, DEV NEUROSCI-BASEL, V22, P74, DOI 10.1159/000017429; Mekki-Dauriac S, 2002, DEVELOPMENT, V129, P5117; Menn B, 2006, J NEUROSCI, V26, P7907, DOI 10.1523/JNEUROSCI.1299-06.2006; Nait-Oumesmar B, 2008, J NEUROL SCI, V265, P26, DOI 10.1016/j.jns.2007.09.032; Nait-Oumesmar B, 1999, EUR J NEUROSCI, V11, P4357, DOI 10.1046/j.1460-9568.1999.00873.x; Palmer TD, 1999, J NEUROSCI, V19, P8487; Palmer TD, 2000, J COMP NEUROL, V425, P479, DOI 10.1002/1096-9861(20001002)425:4<479::AID-CNE2>3.0.CO;2-3; Samanta J, 2007, J NEUROSCI, V27, P7397, DOI 10.1523/JNEUROSCI.1434-07.2007; Schuurmans C, 2002, CURR OPIN NEUROBIOL, V12, P26, DOI 10.1016/S0959-4388(02)00286-6; See J, 2007, MOL CELL NEUROSCI, V35, P171, DOI 10.1016/j.mcn.2007.02.012; See JM, 2009, J NEUROPATH EXP NEUR, V68, P595, DOI 10.1097/NEN.0b013e3181a66ad9; Shen H, 2008, NEUROSCI LETT, V442, P15, DOI 10.1016/j.neulet.2008.06.052; Shen Q, 2002, DEVELOPMENT, V129, P4843; Staugaitis SM, 2009, NEURON GLIA BIOL, V5, P35, DOI 10.1017/S1740925X09990342; Temple S, 2001, NATURE, V414, P112, DOI 10.1038/35102174; Walker TL, 2007, J NEUROSCI, V27, P3734, DOI 10.1523/JNEUROSCI.5060-06.2007; Wang Y, 2001, STROKE, V32, P2170, DOI 10.1161/hs0901.095650; Zhao C, 2005, J NEUROL SCI, V233, P87, DOI 10.1016/j.jns.2005.03.008	50	162	167	1	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2010	13	5					541	U43		10.1038/nn.2536	http://dx.doi.org/10.1038/nn.2536			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	588JM	20418875	Green Accepted			2022-12-24	WOS:000277065700011
J	Chen, AJW; D'Esposito, M				Chen, Anthony J. -W.; D'Esposito, Mark			Traumatic Brain Injury: From Bench to Beside to Society	NEURON			English	Editorial Material							COGNITIVE REHABILITATION; ALZHEIMERS-DISEASE	Traumatic injury to the brain is a problem as old as humanity, but advances in cognitive neuroscience and a long-term view of the dynamic nature of the brain across the lifespan may change how the disorder is understood and treated.	[D'Esposito, Mark] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; [Chen, Anthony J. -W.] VA Med Ctr, Dept Neurol, San Francisco, CA USA; [Chen, Anthony J. -W.] Univ Calif San Francisco, San Francisco, CA 94143 USA	University of California System; University of California Berkeley; University of California System; University of California San Francisco	D'Esposito, M (corresponding author), Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA.	despo@berkeley.edu						Cicerone K, 2006, J COGNITIVE NEUROSCI, V18, P1212, DOI 10.1162/jocn.2006.18.7.1212; D'Esposito M, 2006, PROG BRAIN RES, V157, P123, DOI 10.1016/S0079-6123(06)57008-6; DESPOSITO M, 2006, NEURAL REHABILITATIO, P475; Kesler SR, 2003, APPL NEUROPSYCHOL, V10, P153, DOI 10.1207/S15324826AN1003_04; Levine B, 2000, J INT NEUROPSYCH SOC, V6, P299, DOI 10.1017/S1355617700633052; McDowell S, 1997, NEUROPSYCHOLOGIA, V35, P1341, DOI 10.1016/S0028-3932(97)00082-1; McDowell S, 1998, BRAIN, V121, P1155, DOI 10.1093/brain/121.6.1155; Mesulam M., 2002, PRINCIPLES FRONTAL L, P8, DOI DOI 10.1093/ACPROF:OSO/9780195134971.003.0002; PETRIDES M, 2002, PRINCIPLES FRONTAL L, P31, DOI DOI 10.1093/ACPROF:OSO/9780195134971.003.0003; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Prigatano GP, 1999, ARCH PHYS MED REHAB, V80, P77, DOI 10.1016/S0003-9993(99)90311-8; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; SCHWARTZ A, 2009, NEW SIGN BRAIN DAMAG; Van Den Heuvel C, 2007, PROG BRAIN RES, V161, P303, DOI 10.1016/S0079-6123(06)61021-2; Warden DL, 2006, J NEUROTRAUM, V23, P1468, DOI 10.1089/neu.2006.23.1468	15	43	45	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	APR 15	2010	66	1					11	14		10.1016/j.neuron.2010.04.004	http://dx.doi.org/10.1016/j.neuron.2010.04.004			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	587TP	20399725	Bronze			2022-12-24	WOS:000277016200005
J	Galimberti, I; Bednarek, E; Donato, F; Caroni, P				Galimberti, Ivan; Bednarek, Ewa; Donato, Flavio; Caroni, Pico			EphA4 Signaling in Juveniles Establishes Topographic Specificity of Structural Plasticity in the Hippocampus	NEURON			English	Article							CELL-ADHESION MOLECULE; LONG-TERM-MEMORY; POLYSIALIC ACID; MOSSY FIBERS; RAT; SYNAPTOGENESIS; CA3; ORGANIZATION; CONNECTIVITY; TRANSMISSION	The formation and loss of synapses is involved in learning and memory. Distinct subpopulations of permanent and plastic synapses coexist in the adult brain, but the principles and mechanisms underlying the establishment of these distinctions remain unclear. Here we show that in the hippocampus, terminal arborizations (TAs) with high plasticity properties are specified at juvenile stages, and account for most synapse turnover of adult mossy fibers. Out of 9-12 giant terminals along CA3, distinct subpopulations of granule neurons revealed by mouse reporter lines exhibit 0, 1, or >2 TAs. TA specification involves a topographic rule based on cell body position and EphA4 signaling. Upon disruption of EphA4 signaling or PSA-NCAM in juvenile circuits, single-TA mossy fibers establish >2 TAs, suggesting that intraaxonal competition influences plasticity site selection. Therefore, plastic synapse specification in juveniles defines sites of synaptic remodeling in the adult, and hippocampal circuit plasticity follows unexpected topographic principles.	[Galimberti, Ivan; Bednarek, Ewa; Donato, Flavio; Caroni, Pico] Friedrich Miescher Inst, CH-4058 Basel, Switzerland	Friedrich Miescher Institute for Biomedical Research	Caroni, P (corresponding author), Friedrich Miescher Inst, Maulbeerstr 66, CH-4058 Basel, Switzerland.	caroni@fmi.ch		Donato, Flavio/0000-0002-0732-1654	European Commission	European Commission(European CommissionEuropean Commission Joint Research Centre)	We are grateful to Patrick Schwarb, Aaron Ponti, and Jens Rietdorf for help with the imaging experiments; to Erik Cabuy for help with the identified cell genomics experiments; to Thomas Oertner for help with the gene gun transfection experiments; to Sarah Ruediger for the mGFP lentivirus construct; to Yuichi Deguchi for help with the in situ hybridization experiments: and to Markus Sigrist and Silvia Arber (FMI and Biozentrum, Basel) for generating and sharing Lsi3 transgenic mice. We thank Dominique Muller (CMU, University of Geneva), Jan Pielage (FMI, Basel), and Silvia Arber for valuable comments on the manuscript. This study is partially funded by the European Commission under the 7th Framework Programme (Collaborative Project Plasticise). The Friedrich Miescher Institut is part of the Novartis Research Foundation.	Acsady L, 1998, J NEUROSCI, V18, P3386; Alvarez VA, 2007, ANNU REV NEUROSCI, V30, P79, DOI 10.1146/annurev.neuro.30.051606.094222; Bisaz R, 2009, NEUROBIOL LEARN MEM, V91, P333, DOI 10.1016/j.nlm.2008.11.003; Bonfanti L, 2009, CELL ADHES MIGR, V3, P43, DOI 10.4161/cam.3.1.7258; Chklovskii DB, 2004, NATURE, V431, P782, DOI 10.1038/nature03012; CLAIBORNE BJ, 1986, J COMP NEUROL, V246, P435, DOI 10.1002/cne.902460403; Cline H, 2008, J PHYSIOL-LONDON, V586, P1509, DOI 10.1113/jphysiol.2007.150029; CREMER H, 1994, NATURE, V367, P455, DOI 10.1038/367455a0; Cremer H, 1998, P NATL ACAD SCI USA, V95, P13242, DOI 10.1073/pnas.95.22.13242; De Paola V, 2006, NEURON, V49, P861, DOI 10.1016/j.neuron.2006.02.017; De Paola V, 2003, NAT NEUROSCI, V6, P491, DOI 10.1038/nn1046; De Roo M, 2008, PROG BRAIN RES, V169, P199, DOI 10.1016/S0079-6123(07)00011-8; De Roo M, 2008, PLOS BIOL, V6, P1850, DOI 10.1371/journal.pbio.0060219; Di Cristo G, 2007, NAT NEUROSCI, V10, P1569, DOI 10.1038/nn2008; Dieck ST, 1998, J CELL BIOL, V142, P499, DOI 10.1083/jcb.142.2.499; Dittgen T, 2004, P NATL ACAD SCI USA, V101, P18206, DOI 10.1073/pnas.0407976101; Dolorfo CL, 1998, J COMP NEUROL, V398, P25; Fitzsimonds RM, 1998, PHYSIOL REV, V78, P143, DOI 10.1152/physrev.1998.78.1.143; Fyhn M, 2004, SCIENCE, V305, P1258, DOI 10.1126/science.1099901; Galimberti I, 2006, NEURON, V50, P749, DOI 10.1016/j.neuron.2006.04.026; Gogolla N, 2007, CURR OPIN NEUROBIOL, V17, P516, DOI 10.1016/j.conb.2007.09.002; Gogolla N, 2006, NAT PROTOC, V1, P1223, DOI 10.1038/nprot.2006.169; Gogolla N, 2009, NEURON, V62, P510, DOI 10.1016/j.neuron.2009.04.022; Govindarajan A, 2006, NAT REV NEUROSCI, V7, P575, DOI 10.1038/nrn1937; Grunwald IC, 2004, NAT NEUROSCI, V7, P33, DOI 10.1038/nn1164; Hanson MG, 2004, NEURON, V43, P687, DOI 10.1016/j.neuron.2004.08.018; Harvey CD, 2007, NATURE, V450, P1195, DOI 10.1038/nature06416; Henze DA, 2000, NEUROSCIENCE, V98, P407, DOI 10.1016/S0306-4522(00)00146-9; Henze DA, 2002, NAT NEUROSCI, V5, P790, DOI 10.1038/nn887; Holtmaat A, 2006, NATURE, V441, P979, DOI 10.1038/nature04783; ISHIZUKA N, 1990, J COMP NEUROL, V295, P580, DOI 10.1002/cne.902950407; Kasthuri N, 2003, NATURE, V424, P426, DOI 10.1038/nature01836; Kessels HW, 2009, NEURON, V61, P340, DOI 10.1016/j.neuron.2009.01.015; Klein R, 2009, NAT NEUROSCI, V12, P15, DOI 10.1038/nn.2231; Kopec CD, 2007, J NEUROSCI, V27, P13706, DOI 10.1523/JNEUROSCI.3503-07.2007; Leutgeb JK, 2007, SCIENCE, V315, P961, DOI 10.1126/science.1135801; Lim BK, 2008, NAT NEUROSCI, V11, P160, DOI 10.1038/nn2033; Lopez-Fernandez MA, 2007, J NEUROSCI, V27, P4552, DOI 10.1523/JNEUROSCI.0396-07.2007; Magarinos AM, 2006, P NATL ACAD SCI USA, V103, P18775, DOI 10.1073/pnas.0608785103; McBain CJ, 2008, PROG BRAIN RES, V169, P225, DOI 10.1016/S0079-6123(07)00013-1; Meyer MP, 2006, J NEUROSCI, V26, P3604, DOI 10.1523/JNEUROSCI.0223-06.2006; Mori M, 2004, NATURE, V431, P453, DOI 10.1038/nature02854; Murai KK, 2003, MOL CELL NEUROSCI, V24, P1000, DOI 10.1016/j.mcn.2003.08.006; Murai KK, 2003, NAT NEUROSCI, V6, P153, DOI 10.1038/nn994; Nikonenko I, 2008, J CELL BIOL, V183, P1115, DOI 10.1083/jcb.200805132; O'Leary DDM, 2005, PROG BRAIN RES, V147, P43, DOI 10.1016/S0079-6123(04)47005-8; Pleskacheva MG, 2000, HIPPOCAMPUS, V10, P17, DOI 10.1002/(SICI)1098-1063(2000)10:1<17::AID-HIPO2>3.0.CO;2-O; Portera-Cailliau C, 2005, PLOS BIOL, V3, P1473, DOI 10.1371/journal.pbio.0030272; Ramirez-Amaya V, 2001, J NEUROSCI, V21, P7340; Rollenhagen A, 2007, J NEUROSCI, V27, P10434, DOI 10.1523/JNEUROSCI.1946-07.2007; Rutishauser U, 2008, NAT REV NEUROSCI, V9, P26, DOI 10.1038/nrn2285; Saxena S, 2009, NAT NEUROSCI, V12, P627, DOI 10.1038/nn.2297; Seki T, 1998, J NEUROSCI, V18, P3757; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Tashiro A, 2006, NAT PROTOC, V1, P3049, DOI 10.1038/nprot.2006.473; Tremblay ME, 2009, J COMP NEUROL, V512, P798, DOI 10.1002/cne.21922; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558	58	50	51	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 11	2010	65	5					627	642		10.1016/j.neuron.2010.02.016	http://dx.doi.org/10.1016/j.neuron.2010.02.016			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	571NF	20223199	Bronze			2022-12-24	WOS:000275758000007
J	Maimon, G; Straw, AD; Dickinson, MH				Maimon, Gaby; Straw, Andrew D.; Dickinson, Michael H.			Active flight increases the gain of visual motion processing in Drosophila	NATURE NEUROSCIENCE			English	Article							LOBULA PLATE; OLFACTORY REPRESENTATIONS; COLLISION-AVOIDANCE; RESPONSE PROPERTIES; INTERNEURONS; SYSTEM; FLY; NEURONS; LOCUST; ORGANIZATION	We developed a technique for performing whole-cell patch-clamp recordings from genetically identified neurons in behaving Drosophila. We focused on the properties of visual interneurons during tethered flight, but this technique generalizes to different cell types and behaviors. We found that the peak-to-peak responses of a class of visual motion-processing interneurons, the vertical-system visual neurons ( VS cells), doubled when flies were flying compared with when they were at rest. Thus, the gain of the VS cells is not fixed, but is instead behaviorally flexible and changes with locomotor state. Using voltage clamp, we found that the passive membrane resistance of VS cells was reduced during flight, suggesting that the elevated gain was a result of increased synaptic drive from upstream motion-sensitive inputs. The ability to perform patch-clamp recordings in behaving Drosophila promises to help unify the understanding of behavior at the gene, cell and circuit levels.	[Maimon, Gaby] CALTECH, Div Biol, Pasadena, CA 91125 USA; CALTECH, Div Engn & Appl Sci, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology	Maimon, G (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	maimon@caltech.edu	Straw, Andrew D/A-1244-2007	Straw, Andrew D/0000-0001-8381-0858	National Science Foundation [0623527]; Caltech Della Martin	National Science Foundation(National Science Foundation (NSF)); Caltech Della Martin	We thank J. Assad, V. Bhandawat, G. Card, C. Chiu, M. Do, T. Herrington, W. Korff, G. Laurent, M. Murthy, P. Polidoro, G. Turner and R. Wilson for helpful discussion, comments and aid in developing the preparation. We are grateful to L. Luo for the Gal4-3a fly line. This work was supported by a National Science Foundation Frontiers in Integrative Biological Research 0623527 award (M. H. D.) and a Caltech Della Martin fellowship (G. M.).	Balint CN, 2001, J EXP BIOL, V204, P4213; BARRY PH, 1991, J MEMBRANE BIOL, V121, P101, DOI 10.1007/BF01870526; BENZER S, 1967, P NATL ACAD SCI USA, V58, P1112, DOI 10.1073/pnas.58.3.1112; Borst A, 2002, J COMP PHYSIOL A, V188, P419, DOI 10.1007/s00359-002-0316-8; Brembs B, 2007, J NEUROSCI, V27, P11122, DOI 10.1523/JNEUROSCI.2704-07.2007; Budick SA, 2006, J EXP BIOL, V209, P3001, DOI 10.1242/jeb.02305; Busch S, 2009, J COMP NEUROL, V513, P643, DOI 10.1002/cne.21966; Fetcho JR, 2008, BRAIN RES REV, V57, P86, DOI 10.1016/j.brainresrev.2007.06.018; Fry SN, 2003, SCIENCE, V300, P495, DOI 10.1126/science.1081944; FRYE MA, 2007, AVANCES INVERTEBRATE; Gordon S, 2006, P NATL ACAD SCI USA, V103, P4311, DOI 10.1073/pnas.0510109103; GOTZ KG, 1968, KYBERNETIK, V4, P199, DOI 10.1007/BF00272517; GOTZ KG, 1987, J EXP BIOL, V128, P35; Graetzel CF, 2006, P IEEE RAS-EMBS INT, P1, DOI 10.1109/ISTAS.2006.4375883; Haag J, 2004, NAT NEUROSCI, V7, P628, DOI 10.1038/nn1245; Haag J, 1997, J COMPUT NEUROSCI, V4, P349, DOI 10.1023/A:1008804117334; Harris RA, 2000, NEURON, V28, P595, DOI 10.1016/S0896-6273(00)00136-7; Hausen K., 1984, PHOTORECEPTION VISIO; Hausen Klaus, 1993, Reviews of Oculomotor Research, V5, P203; HEISENBERG M, 1978, J COMP PHYSIOL, V124, P287, DOI 10.1007/BF00661379; HENGSTENBERG R, 1982, J COMP PHYSIOL, V149, P179, DOI 10.1007/BF00619212; HENGSTENBERG R, 1977, NATURE, V270, P338, DOI 10.1038/270338a0; Joesch M, 2008, CURR BIOL, V18, P368, DOI 10.1016/j.cub.2008.02.022; Krapp HG, 1998, J NEUROPHYSIOL, V79, P1902, DOI 10.1152/jn.1998.79.4.1902; Krapp HG, 1996, NATURE, V384, P463, DOI 10.1038/384463a0; KRAPP HG, 2008, SENSES COMPREHENSIVE, P131; Liu G, 2006, NATURE, V439, P551, DOI 10.1038/nature04381; Longden KD, 2009, J NEUROPHYSIOL, V102, P3606, DOI 10.1152/jn.00395.2009; Maimon G, 2008, CURR BIOL, V18, P464, DOI 10.1016/j.cub.2008.02.054; Neuser K, 2008, NATURE, V453, P1244, DOI 10.1038/nature07003; Niven JE, 2008, J EXP BIOL, V211, P1792, DOI 10.1242/jeb.017574; NORTH RA, 1989, J PHYSIOL-LONDON, V417, P1; ORCHARD I, 1993, ANNU REV ENTOMOL, V38, P227, DOI 10.1146/annurev.en.38.010193.001303; RAMIREZ JM, 1993, J NEUROPHYSIOL, V70, P2148, DOI 10.1152/jn.1993.70.5.2148; Reiser MB, 2008, J NEUROSCI METH, V167, P127, DOI 10.1016/j.jneumeth.2007.07.019; Rind FC, 2008, J NEUROPHYSIOL, V100, P670, DOI 10.1152/jn.01055.2007; Rosner R, 2010, J EXP BIOL, V213, P331, DOI 10.1242/jeb.035386; ROWELL CHF, 1971, J EXP BIOL, V55, P727; Schmidt MF, 1998, NAT NEUROSCI, V1, P513, DOI 10.1038/2232; Scott EK, 2002, J COMP NEUROL, V454, P470, DOI 10.1002/cne.10467; STRAUSFELD N J, 1976, P214; Strausfeld NJ, 2007, DEV NEUROBIOL, V67, P1267, DOI 10.1002/dneu.20396; Straw AD, 2009, SOURCE CODE BIOL MED, V4, DOI 10.1186/1751-0473-4-5; Tammero LF, 2002, J EXP BIOL, V205, P2785; Taylor GK, 2007, ADV INSECT PHYSIOL, V34, P231, DOI 10.1016/S0065-2806(07)34005-8; TOMIOKA K, 1984, ZOOL SCI, V1, P169; Treue S, 1996, NATURE, V382, P539, DOI 10.1038/382539a0; Turner GC, 2008, J NEUROPHYSIOL, V99, P734, DOI 10.1152/jn.01283.2007; Wilson RI, 2005, J NEUROSCI, V25, P9069, DOI 10.1523/JNEUROSCI.2070-05.2005; Wilson RI, 2004, SCIENCE, V303, P366, DOI 10.1126/science.1090782	50	258	258	1	46	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2010	13	3					393	U29		10.1038/nn.2492	http://dx.doi.org/10.1038/nn.2492			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	559WW	20154683				2022-12-24	WOS:000274860100023
J	Scholl, B; Gao, X; Wehr, M				Scholl, Ben; Gao, Xiang; Wehr, Michael			Nonoverlapping Sets of Synapses Drive On Responses and Off Responses in Auditory Cortex	NEURON			English	Article							MEDIAL GENICULATE-BODY; PRIMARY VISUAL-CORTEX; OFFSET RESPONSES; ONSET RESPONSES; SIMPLE CELLS; BRAIN-STEM; GUINEA-PIG; NEURONS; CAT; TONES	Neurons in visual, somatosensory, and auditory cortex can respond to the termination as well as the onset of a sensory stimulus. In auditory cortex, these off responses may underlie the ability of the auditory system to use sound offsets as cues for perceptual grouping. Off responses have been widely proposed to arise from postinhibitory rebound, but this hypothesis has never been directly tested. We used in vivo whole-cell recordings to measure the synaptic inhibition evoked by sound onset. We find that inhibition is invariably transient, indicating that off responses are not caused by postinhibitory rebound in auditory cortical neurons. Instead, on and off responses appear to be driven by distinct sets of synapses, because they have distinct frequency tuning and different excitatory-inhibitory balance. Furthermore, an on-on sequence causes complete forward suppression, whereas an off-on sequence causes no suppression at all. We conclude that on and off responses are driven by largely nonoverlapping sets of synaptic inputs.	[Scholl, Ben; Gao, Xiang; Wehr, Michael] Univ Oregon, Inst Neurosci, Dept Psychol, Eugene, OR 97403 USA	University of Oregon	Wehr, M (corresponding author), Univ Oregon, Inst Neurosci, Dept Psychol, Eugene, OR 97403 USA.	wehr@uoregon.edu			NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC011379] Funding Source: NIH RePORTER; NIDCD NIH HHS [R01 DC011379] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Bregman A.S., 1990, AUDITORY SCENE ANAL; BREGMAN AS, 1994, J ACOUST SOC AM, V96, P2694, DOI 10.1121/1.411277; BRUGGE JF, 1973, J NEUROPHYSIOL, V36, P1138, DOI 10.1152/jn.1973.36.6.1138; CALFORD MB, 1983, J NEUROSCI, V3, P2350; CALFORD MB, 1981, J NEUROPHYSIOL, V45, P1013, DOI 10.1152/jn.1981.45.6.1013; Chimoto S, 2002, BRAIN RES, V934, P34, DOI 10.1016/S0006-8993(02)02316-8; Chung S, 2002, NEURON, V34, P437, DOI 10.1016/S0896-6273(02)00659-1; DeWeese MR, 2003, J NEUROSCI, V23, P7940; EVANS EF, 1964, J PHYSIOL-LONDON, V171, P476, DOI 10.1113/jphysiol.1964.sp007391; FERSTER D, 1988, J NEUROSCI, V8, P1172; Fishman YI, 2009, HEARING RES, V254, P64, DOI 10.1016/j.heares.2009.04.010; He JF, 1997, J NEUROSCI, V17, P2615; He JF, 2002, J NEUROPHYSIOL, V88, P2377, DOI 10.1152/jn.00083.2002; He JF, 2001, J NEUROSCI, V21, P8672, DOI 10.1523/JNEUROSCI.21-21-08672.2001; HEIL P, 1992, J COMP PHYSIOL A, V171, P583; HENRY KR, 1985, HEARING RES, V19, P115, DOI 10.1016/0378-5955(85)90115-7; HENRY KR, 1985, HEARING RES, V18, P245, DOI 10.1016/0378-5955(85)90041-3; Hille B., 1992, IONIC CHANNELS EXCIT; Jin JZ, 2008, NAT NEUROSCI, V11, P88, DOI 10.1038/nn2029; Kuwada S, 1999, J NEUROSCI, V19, P2273; Lee CC, 2008, J COMP NEUROL, V507, P1879, DOI 10.1002/cne.21611; Liang Z, 2008, NEUROSCIENCE, V156, P365, DOI 10.1016/j.neuroscience.2008.07.046; Luthi A, 1998, NEURON, V21, P9, DOI 10.1016/S0896-6273(00)80509-7; METHERATE R, 1994, J PHYSIOL-LONDON, V481, P331, DOI 10.1113/jphysiol.1994.sp020443; Moshitch D, 2006, J NEUROPHYSIOL, V95, P3756, DOI 10.1152/jn.00822.2005; PELLEGTOIBA R, 1989, EXP BRAIN RES, V74, P353; Perez-Gonzalez D, 2006, J NEUROPHYSIOL, V95, P823, DOI 10.1152/jn.00741.2005; PFINGST BE, 1981, J NEUROPHYSIOL, V45, P16, DOI 10.1152/jn.1981.45.1.16; Phillips DP, 2002, HEARING RES, V167, P192, DOI 10.1016/S0378-5955(02)00393-3; Plack CJ, 2000, J ACOUST SOC AM, V108, P1162, DOI 10.1121/1.1287022; Polley DB, 2007, J NEUROPHYSIOL, V97, P3621, DOI 10.1152/jn.01298.2006; Qin L, 2007, J NEUROPHYSIOL, V97, P3421, DOI 10.1152/jn.00184.2007; Recanzone GH, 2000, HEARING RES, V150, P104, DOI 10.1016/S0378-5955(00)00194-5; SUGA N, 1975, J EXP BIOL, V63, P161; Takahashi H, 2004, NEUROREPORT, V15, P1565, DOI 10.1097/01.wnr.0000134848.63755.5c; Talbot MJ, 1996, J NEUROPHYSIOL, V76, P2120, DOI 10.1152/jn.1996.76.3.2120; VOLKOV IO, 1991, NEUROSCIENCE, V43, P307, DOI 10.1016/0306-4522(91)90295-Y; Wang XQ, 2005, NATURE, V435, P341, DOI 10.1038/nature03565; Wehr M, 2005, NEURON, V47, P437, DOI 10.1016/j.neuron.2005.06.009; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116; YOUNG ED, 1976, J NEUROPHYSIOL, V39, P282, DOI 10.1152/jn.1976.39.2.282	41	98	101	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 11	2010	65	3					412	421		10.1016/j.neuron.2010.01.020	http://dx.doi.org/10.1016/j.neuron.2010.01.020			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	564BF	20159453	Bronze, Green Accepted			2022-12-24	WOS:000275185200013
J	Wei, W; Nguyen, LN; Kessels, HW; Hagiwara, H; Sisodia, S; Malinow, R				Wei, Wei; Nguyen, Louis N.; Kessels, Helmut W.; Hagiwara, Hiroaki; Sisodia, Sangram; Malinow, Roberto			Amyloid beta from axons and dendrites reduces local spine number and plasticity	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; NICOTINIC ACETYLCHOLINE-RECEPTORS; PROTEIN TRANSGENIC MICE; ALZHEIMERS-DISEASE; A-BETA; SYNAPTIC PLASTICITY; PRECURSOR PROTEIN; IN-VIVO; HIPPOCAMPAL-NEURONS; RAT HIPPOCAMPUS	Excessive synaptic loss is thought to be one of the earliest events in Alzheimer's disease. Amyloid beta (A beta), a peptide secreted in an activity-modulated manner by neurons, has been implicated in the pathogenesis of Alzheimer's disease by removing dendritic spines, sites of excitatory synaptic transmission. However, issues regarding the subcellular source of A beta, as well as the mechanisms of its production and actions that lead to synaptic loss, remain poorly understood. In rat organotypic slices, we found that acute overproduction of either axonal or dendritic A beta reduced spine density and plasticity at nearby (similar to 5-10 mu m) dendrites. The production of A beta and its effects on spines were sensitive to blockade of action potentials or nicotinic receptors; the effects of A beta (but not its production) were sensitive to NMDA receptor blockade. Notably, only 30-60 min blockade of A beta overproduction permitted induction of plasticity. Our results indicate that continuous overproduction of A beta at dendrites or axons acts locally to reduce the number and plasticity of synapses.	[Wei, Wei; Malinow, Roberto] Cold Spring Harbor Lab, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA; [Nguyen, Louis N.; Kessels, Helmut W.; Hagiwara, Hiroaki; Malinow, Roberto] Univ Calif San Diego, Ctr Neural Circuits & Behav, Dept Neurosci, La Jolla, CA 92093 USA; [Nguyen, Louis N.; Kessels, Helmut W.; Hagiwara, Hiroaki; Malinow, Roberto] Univ Calif San Diego, Ctr Neural Circuits & Behav, Dept Biol, La Jolla, CA 92093 USA; [Sisodia, Sangram] Univ Chicago, Dept Neurobiol, Chicago, IL 60637 USA	Cold Spring Harbor Laboratory; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Chicago	Malinow, R (corresponding author), Cold Spring Harbor Lab, Watson Sch Biol Sci, POB 100, Cold Spring Harbor, NY 11724 USA.	rmalinow@ucsd.edu		Kessels, Helmut/0000-0002-1122-745X	US National Institutes of Health; Cure Alzheimer's Fund; Eisai; Leslie C. Quick Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008444] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH049159, R37MH049159, R29MH049159] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032827] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG032132] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cure Alzheimer's Fund; Eisai(Eisai Co Ltd); Leslie C. Quick Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank members of the Malinow laboratory for helpful discussions, J. Huang for careful reading of the manuscript and N. Dawkins and I. Hunton for expert technical assistance. This work was supported by grants from the US National Institutes of Health (R.M.), the Cure Alzheimer's Fund (R.M.), Eisai (H.H.) and the Leslie C. Quick Fellowship (W.W.).	Almeida CG, 2005, NEUROBIOL DIS, V20, P187, DOI 10.1016/j.nbd.2005.02.008; Buckner RL, 2005, J NEUROSCI, V25, P7709, DOI 10.1523/JNEUROSCI.2177-05.2005; Buxbaum JD, 1998, J NEUROSCI, V18, P9629; Calabrese B, 2007, MOL CELL NEUROSCI, V35, P183, DOI 10.1016/j.mcn.2007.02.006; CHANGEUX JP, 1970, P NATL ACAD SCI USA, V67, P1241, DOI 10.1073/pnas.67.3.1241; Chapman PF, 1999, NAT NEUROSCI, V2, P271, DOI 10.1038/6374; Cirrito JR, 2005, NEURON, V48, P913, DOI 10.1016/j.neuron.2005.10.028; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; COAN EJ, 1989, NEUROSCI LETT, V105, P205, DOI 10.1016/0304-3940(89)90038-4; Dani JA, 2007, ANNU REV PHARMACOL, V47, P699, DOI 10.1146/annurev.pharmtox.47.120505.105214; Dineley KT, 2002, J BIOL CHEM, V277, P25056, DOI 10.1074/jbc.M200066200; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Evans NA, 2008, J NEUROSCI METH, V175, P96, DOI 10.1016/j.jneumeth.2008.08.001; Fabian-Fine R, 2001, J NEUROSCI, V21, P7993, DOI 10.1523/JNEUROSCI.21-20-07993.2001; FERREIRA A, 1993, J NEUROSCI, V13, P3112; Hartman RE, 2005, J NEUROSCI, V25, P6213, DOI 10.1523/JNEUROSCI.0664-05.2005; Hsieh H, 2006, NEURON, V52, P831, DOI 10.1016/j.neuron.2006.10.035; Jacobsen JS, 2006, P NATL ACAD SCI USA, V103, P5161, DOI 10.1073/pnas.0600948103; Jones IW, 2004, J NEUROSCI METH, V134, P65, DOI 10.1016/j.jneumeth.2003.11.001; Kaether C, 2000, MOL BIOL CELL, V11, P1213, DOI 10.1091/mbc.11.4.1213; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; Klyubin I, 2005, NAT MED, V11, P556, DOI 10.1038/nm1234; Klyubin I, 2008, J NEUROSCI, V28, P4231, DOI 10.1523/JNEUROSCI.5161-07.2008; KOO EH, 1990, P NATL ACAD SCI USA, V87, P1561, DOI 10.1073/pnas.87.4.1561; Kopec CD, 2006, J NEUROSCI, V26, P2000, DOI 10.1523/JNEUROSCI.3918-05.2006; Lacor PN, 2007, J NEUROSCI, V27, P796, DOI 10.1523/JNEUROSCI.3501-06.2007; Lacor PN, 2004, J NEUROSCI, V24, P10191, DOI 10.1523/JNEUROSCI.3432-04.2004; Lanz TA, 2003, NEUROBIOL DIS, V13, P246, DOI 10.1016/S0969-9961(03)00079-2; Lazarov O, 2002, J NEUROSCI, V22, P9785; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Molnar Z, 2004, NEUROREPORT, V15, P1649, DOI 10.1097/01.wnr.0000134471.06244.d2; Morgan D, 2000, NATURE, V408, P982, DOI 10.1038/35050116; Otmakhov N, 2004, J NEUROPHYSIOL, V91, P1955, DOI 10.1152/jn.00941.2003; Raschetti R, 2007, PLOS MED, V4, P1818, DOI 10.1371/journal.pmed.0040338; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007; Sheng JG, 2002, J NEUROSCI, V22, P9794; Shrestha BR, 2006, MOL CELL NEUROSCI, V33, P274, DOI 10.1016/j.mcn.2006.07.011; SISODIA SS, 1993, J NEUROSCI, V13, P3136; Small SA, 2006, NEURON, V52, P15, DOI 10.1016/j.neuron.2006.09.001; Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503; Spires TL, 2005, J NEUROSCI, V25, P7278, DOI 10.1523/JNEUROSCI.1879-05.2005; Stephan A, 2001, J NEUROSCI, V21, P5703, DOI 10.1523/JNEUROSCI.21-15-05703.2001; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Ting JT, 2007, P NATL ACAD SCI USA, V104, P353, DOI 10.1073/pnas.0608807104; Walsh DM, 2004, NEURON, V44, P181, DOI 10.1016/j.neuron.2004.09.010; Walsh DM, 2005, J NEUROSCI, V25, P2455, DOI 10.1523/JNEUROSCI.4391-04.2005; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Xia WM, 2009, ARCH NEUROL-CHICAGO, V66, P190, DOI 10.1001/archneurol.2008.565	50	239	248	0	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2010	13	2					190	U71		10.1038/nn.2476	http://dx.doi.org/10.1038/nn.2476			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	548SE	20037574	Green Accepted			2022-12-24	WOS:000273985800014
J	Song, H; Chung, SK; Xu, Y				Song, Hoseok; Chung, Sun-Ku; Xu, Yang			Modeling Disease in Human ESCs Using an Efficient BAC-Based Homologous Recombination System	CELL STEM CELL			English	Article							EMBRYONIC STEM-CELLS; ATAXIA-TELANGIECTASIA; HUMAN BLASTOCYSTS; DEFICIENT MICE; DNA-DAMAGE; P53; ATM; PROTEIN; GENOME; GENE	Although mouse models have been valuable for studying human disease, the cellular and physiological differences between mouse and human have made it increasingly important to develop more relevant human disease models for mechanistic studies and drug discovery. Human embryonic stem cells (hESCs), which can undergo unlimited self-renewal and retain the potential to differentiate into all cell types, present a possible solution. To improve the efficiency of genetic manipulation of hESCs, we have developed bacterial artificial chromosome (BAC) based approach that enables high efficiency homologous recombination. By sequentially disrupting both alleles of ATM or p53 with BAC targeting vectors, we have established ATM(-/-) and p53(-/-) hESCs as models for two major human genetic instability syndromes and used the generated cells to reveal the importance of p53 in maintaining genome stability of hESCs. Our findings suggest that it will be feasible to develop genetically modified hESCs as relevant human disease models.	[Song, Hoseok; Chung, Sun-Ku; Xu, Yang] Univ Calif San Diego, Div Biol Sci, Mol Biol Sect, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Xu, Y (corresponding author), Univ Calif San Diego, Div Biol Sci, Mol Biol Sect, 9500 Gilman Dr, La Jolla, CA 92093 USA.	yangxu@ucsd.edu		Song, Hoseok/0000-0001-5723-3057; Xu, Yang/0000-0001-5574-921X	California Institute of Regenerative Medicine [RC1-148]	California Institute of Regenerative Medicine(California Institute for Regenerative Medicine)	We thank Dr. Melton's lab and Harvard University for providing the HUES cell lines and Drs. T. Zhao and J.-Y. Jung for technical help. This work was supported by a grant from California Institute of Regenerative Medicine to YX (RC1-148).	Barlow C, 1996, CELL, V86, P159, DOI 10.1016/S0092-8674(00)80086-0; Chao C, 2006, EMBO J, V25, P2615, DOI 10.1038/sj.emboj.7601167; Copeland NG, 2001, NAT REV GENET, V2, P769, DOI 10.1038/35093556; Costa M, 2007, NAT PROTOC, V2, P792, DOI 10.1038/nprot.2007.105; Cowan CA, 2004, NEW ENGL J MED, V350, P1353, DOI 10.1056/NEJMsr040330; Davis RP, 2008, BLOOD, V111, P1876, DOI 10.1182/blood-2007-06-093609; Deng WB, 2009, TRENDS GENET, V25, P425, DOI 10.1016/j.tig.2009.09.004; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Ebert AD, 2009, NATURE, V457, P277, DOI 10.1038/nature07677; Elson A, 1996, P NATL ACAD SCI USA, V93, P13084, DOI 10.1073/pnas.93.23.13084; Hockemeyer D, 2009, NAT BIOTECHNOL, V27, P851, DOI 10.1038/nbt.1562; Irion S, 2007, NAT BIOTECHNOL, V25, P1477, DOI 10.1038/nbt1362; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Johnson BV, 2008, MOL HUM REPROD, V14, P513, DOI 10.1093/molehr/gan048; Ko LJ, 1996, GENE DEV, V10, P1054, DOI 10.1101/gad.10.9.1054; Krizhanovsky V, 2009, NATURE, V460, P1085, DOI 10.1038/4601085a; Lara-Tejero M, 2000, SCIENCE, V290, P354, DOI 10.1126/science.290.5490.354; Lin TX, 2005, NAT CELL BIOL, V7, P165, DOI 10.1038/ncb1211; Mills AA, 2005, GENE DEV, V19, P2091, DOI 10.1101/gad.1362905; Osoegawa K, 2001, GENOME RES, V11, P483, DOI 10.1101/gr.169601; Ruby KM, 2009, STEM CELLS, V27, P1496, DOI 10.1002/stem.73; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Shiloh Y, 2001, ADV CANCER RES, V83, P209, DOI 10.1016/S0065-230X(01)83007-4; SHILOH Y, 1995, EUR J HUM GENET, V3, P116; Song H, 2007, NAT CELL BIOL, V9, P573, DOI 10.1038/ncb1571; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Urbach A, 2004, STEM CELLS, V22, P635, DOI 10.1634/stemcells.22-4-635; Warming S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni035; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Xu Y, 2006, NAT REV IMMUNOL, V6, P261, DOI 10.1038/nri1804; Xu Y, 2005, CELL CYCLE, V4, P363, DOI 10.4161/cc.4.3.1529; Xu Y, 1996, GENE DEV, V10, P2401, DOI 10.1101/gad.10.19.2401; Xu Y, 1996, GENE DEV, V10, P2411, DOI 10.1101/gad.10.19.2411; Xue HP, 2009, STEM CELLS, V27, P1836, DOI 10.1002/stem.129; Zou JZ, 2009, CELL STEM CELL, V5, P97, DOI 10.1016/j.stem.2009.05.023; Zwaka TP, 2003, NAT BIOTECHNOL, V21, P319, DOI 10.1038/nbt788	39	133	139	0	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	JAN 8	2010	6	1					80	89		10.1016/j.stem.2009.11.016	http://dx.doi.org/10.1016/j.stem.2009.11.016			10	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	549EW	20074536	Bronze			2022-12-24	WOS:000274029700014
J	Yamada, Y; Aoki, H; Kunisada, T; Hara, A				Yamada, Yasuhiro; Aoki, Hitomi; Kunisada, Takahiro; Hara, Akira			Rest Promotes the Early Differentiation of Mouse ESCs but Is Not Required for Their Maintenance	CELL STEM CELL			English	Article							EMBRYONIC STEM-CELLS; RESTRICTIVE SILENCER FACTOR; SELF-RENEWAL; GENE-EXPRESSION; TARGET GENES; IN-VITRO; PLURIPOTENCY; ENDODERM; NANOG; NEUROGENESIS		[Yamada, Yasuhiro; Hara, Akira] Gifu Univ, Grad Sch Med, Dept Tumor Pathol, Gifu 5011194, Japan; [Aoki, Hitomi; Kunisada, Takahiro] Gifu Univ, Grad Sch Med, Dept Tissue & Organ Dev Regenerat & Adv Med Sci, Gifu 5011194, Japan; [Yamada, Yasuhiro] Kyoto Univ, Inst Integrated Cell Mat Sci, Ctr iPS Cell Res & Applicat CiRA, Kyoto 6068507, Japan; [Yamada, Yasuhiro] Japan Sci & Technol Agcy, PRESTO, Saitama, Japan	Gifu University; Gifu University; Kyoto University; Japan Science & Technology Agency (JST)	Yamada, Y (corresponding author), Gifu Univ, Grad Sch Med, Dept Tumor Pathol, Gifu 5011194, Japan.	y-yamada@cira.kyoto-u.ac.jp		Kunisada, Takahiro/0000-0003-1651-2716	PRESTO; Ministry of Health, Labour and Welfare of Japan; Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Science and Technology Agency (JST)	PRESTO; Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST))	We would like to thank Hitoshi Niwa for helpful discussions, comments on the manuscript, and a plasmid expressing EGFP-ires-Zeocin. We would also like to thank HongQiang Sheng, Takeru Oyama, and Huilan Zhi for generating the Rest floxed ESCs. We thank Caroline Beard for a Colla-tetOP-cre allele, Konrad Hochedlinger for a targeting plasmid containing ires-GFP, Kazutoshi Takahashi and Shinya Yamanaka for a Nanog-expressing plasmid, and Gail Mandel for a REST-expressing plasmid and a protocol for Rest western blot. We also thank Kyoko Takahashi, Ayako Suga, and Yoshitaka Kinjyo for their valuable technical assistance. This study was supported by grants from PRESTO, from the Ministry of Health, Labour and Welfare of Japan, from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and from the Japan Science and Technology Agency (JST).	Andres ME, 1999, P NATL ACAD SCI USA, V96, P9873, DOI 10.1073/pnas.96.17.9873; Ballas N, 2005, CELL, V121, P645, DOI 10.1016/j.cell.2005.03.013; Beard C, 2006, GENESIS, V44, P23, DOI 10.1002/gene.20180; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Buckley NJ, 2009, NATURE, V457, pE5, DOI 10.1038/nature07784; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chazaud C, 2006, DEV CELL, V10, P615, DOI 10.1016/j.devcel.2006.02.020; CHONG JHA, 1995, CELL, V80, P949, DOI 10.1016/0092-8674(95)90298-8; Fujikura J, 2002, GENE DEV, V16, P784, DOI 10.1101/gad.968802; Grimes JA, 2000, J BIOL CHEM, V275, P9461, DOI 10.1074/jbc.275.13.9461; Hochedlinger K, 2005, CELL, V121, P465, DOI 10.1016/j.cell.2005.02.018; Johnson R, 2008, PLOS BIOL, V6, P2205, DOI 10.1371/journal.pbio.0060256; Jorgensen HF, 2009, NATURE, V457, pE4, DOI 10.1038/nature07783; Jorgensen HF, 2009, DEVELOPMENT, V136, P715, DOI 10.1242/dev.028548; Koutsourakis M, 1999, DEVELOPMENT, V126, P723; Kunath T, 2007, DEVELOPMENT, V134, P2895, DOI 10.1242/dev.02880; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Niwa H, 2007, DEVELOPMENT, V134, P635, DOI 10.1242/dev.02787; SCHOENHERR CJ, 1995, SCIENCE, V267, P1360, DOI 10.1126/science.7871435; Schoenherr CJ, 1996, P NATL ACAD SCI USA, V93, P9881, DOI 10.1073/pnas.93.18.9881; Shimoda M, 2007, J CELL SCI, V120, P3859, DOI 10.1242/jcs.007856; Singh SK, 2008, NATURE, V453, P223, DOI 10.1038/nature06863; SOUDAIS C, 1995, DEVELOPMENT, V121, P3877; Sun YM, 2005, MOL BIOL CELL, V16, P5630, DOI 10.1091/mbc.E05-07-0687; Yamada M, 2004, NEUROSCIENCE, V124, P173, DOI 10.1016/j.neuroscience.2003.10.040; Yang DH, 2002, DEV BIOL, V251, P27, DOI 10.1006/dbio.2002.0810	29	44	45	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	JAN 8	2010	6	1					10	15		10.1016/j.stem.2009.12.003	http://dx.doi.org/10.1016/j.stem.2009.12.003			6	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	549EW	20085738	Bronze, Green Published			2022-12-24	WOS:000274029700006
J	Pulver, SR; Griffith, LC				Pulver, Stefan R.; Griffith, Leslie C.			Spike integration and cellular memory in a rhythmic network from Na+/K+ pump current dynamics	NATURE NEUROSCIENCE			English	Article							TACTILE SENSORY NEURONS; SLOW AFTERHYPERPOLARIZATION; CALCIUM; INHIBITION; COORDINATION; MODULATION; LOCOMOTION; CHANNELS; TYRAMINE; LAMPREY	The output of a neural circuit results from an interaction between the intrinsic properties of neurons in the circuit and the features of the synaptic connections between them. The plasticity of intrinsic properties has been primarily attributed to modification of ion channel function and/or number. We have found a mechanism for intrinsic plasticity in rhythmically active Drosophila neurons that was not based on changes in ion conductance. Larval motor neurons had a long-lasting, sodium-dependent afterhyperpolarization (AHP) following bursts of action potentials that was mediated by the electrogenic activity of Na+/K+ ATPase. This AHP persisted for multiple seconds following volleys of action potentials and was able to function as a pattern-insensitive integrator of spike number that was independent of external calcium. This current also interacted with endogenous Shal K+ conductances to modulate spike timing for multiple seconds following rhythmic activity, providing a cellular memory of network activity on a behaviorally relevant timescale.	[Griffith, Leslie C.] Brandeis Univ, Dept Biol, Natl Ctr Behav Genom, Waltham, MA 02254 USA; Brandeis Univ, Dept Biol, Volen Ctr Complex Syst, Waltham, MA 02254 USA	Brandeis University; Brandeis University	Griffith, LC (corresponding author), Brandeis Univ, Dept Biol, Natl Ctr Behav Genom, Waltham, MA 02254 USA.	griffith@brandeis.edu		Pulver, Stefan/0000-0001-5170-7522; Griffith, Leslie/0000-0003-3164-9876	US National Institutes of Health [R01 MH067284]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067284] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We would like to thank E. Marder, B. Trimmer and P. Miller for helpful discussions and critical reading of the manuscript. This work was supported by US National Institutes of Health grant R01 MH067284 to L. C. G.	Arganda S, 2007, NAT NEUROSCI, V10, P1467, DOI 10.1038/nn1982; Baines RA, 2001, J NEUROSCI, V21, P1523, DOI 10.1523/JNEUROSCI.21-05-01523.2001; Bhattacharjee A, 2005, TRENDS NEUROSCI, V28, P422, DOI 10.1016/j.tins.2005.06.003; BRAND AH, 1993, DEVELOPMENT, V118, P401; Canepari M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004011; Canepari M, 2008, CELL MOL NEUROBIOL, V28, P1079, DOI 10.1007/s10571-008-9285-y; CATARSI S, 1993, J PHYSIOL-LONDON, V462, P229, DOI 10.1113/jphysiol.1993.sp019552; Cattaert D, 2001, J NEUROBIOL, V48, P58, DOI 10.1002/neu.1042; Cavazzini M, 2005, CELL CALCIUM, V38, P355, DOI 10.1016/j.ceca.2005.06.013; Chaudhuri D, 2004, J NEUROSCI, V24, P6334, DOI 10.1523/JNEUROSCI.1712-04.2004; Choi JC, 2004, J NEUROPHYSIOL, V91, P2353, DOI 10.1152/jn.01115.2003; Cudmore RH, 2004, J NEUROPHYSIOL, V92, P341, DOI 10.1152/jn.01059.2003; Darbon P, 2002, J NEUROPHYSIOL, V88, P1461, DOI 10.1152/jn.2002.88.3.1461; Fox LE, 2006, J NEUROSCI, V26, P1486, DOI 10.1523/JNEUROSCI.4749-05.2006; Heyward P, 2001, J NEUROSCI, V21, P5311, DOI 10.1523/JNEUROSCI.21-14-05311.2001; Hoang B, 2001, DEV BIOL, V229, P55, DOI 10.1006/dbio.2000.9983; JOHNSON SW, 1992, SCIENCE, V258, P665, DOI 10.1126/science.1329209; Kim U, 1998, J NEUROPHYSIOL, V80, P1222, DOI 10.1152/jn.1998.80.3.1222; Koch Christof, 1999, P1; Koh HY, 2007, J NEUROPHYSIOL, V97, P1862, DOI 10.1152/jn.01230.2006; Liu Z, 1998, J NEUROSCI, V18, P2309; Marder E, 1996, P NATL ACAD SCI USA, V93, P13481, DOI 10.1073/pnas.93.24.13481; Marder E, 2007, ANNU REV PHYSIOL, V69, P291, DOI 10.1146/annurev.physiol.69.031905.161516; Masino MA, 2002, J NEUROSCI, V22, P4418, DOI 10.1523/JNEUROSCI.22-11-04418.2002; McClellan AD, 1999, EXP BRAIN RES, V126, P93, DOI 10.1007/s002210050719; MCCORMICK DA, 1990, J PHYSIOL-LONDON, V431, P291, DOI 10.1113/jphysiol.1990.sp018331; Oestreich J, 2006, NEURON, V49, P577, DOI 10.1016/j.neuron.2006.01.027; Pedarzani P, 2008, CELL MOL LIFE SCI, V65, P3196, DOI 10.1007/s00018-008-8216-x; Pulver SR, 2005, J NEUROBIOL, V62, P47, DOI 10.1002/neu.20066; Pulver SR, 2009, J NEUROPHYSIOL, V101, P3075, DOI 10.1152/jn.00071.2009; RICHTER DW, 1982, J EXP BIOL, V100, P93; Rose CR, 2002, NEUROSCIENTIST, V8, P532, DOI 10.1177/1073858402238512; Rossignol S, 2008, BRAIN RES REV, V57, P228, DOI 10.1016/j.brainresrev.2007.06.019; Rozzo A, 2002, J NEUROPHYSIOL, V88, P676, DOI 10.1152/jn.2002.88.2.676; Sanchez-Vives MV, 2000, J NEUROSCI, V20, P4286; Saraswati S, 2004, J NEUROBIOL, V58, P425, DOI 10.1002/neu.10298; Scuri R, 2007, EUR J NEUROSCI, V25, P159, DOI 10.1111/j.1460-9568.2006.05257.x; STENT GS, 1978, SCIENCE, V200, P1348, DOI 10.1126/science.663615; Sun BH, 2001, COMP BIOCHEM PHYS B, V130, P521, DOI 10.1016/S1096-4959(01)00470-5; TURRIGIANO G, 1994, SCIENCE, V264, P974, DOI 10.1126/science.8178157; Turrigiano GG, 1996, J NEUROPHYSIOL, V75, P963, DOI 10.1152/jn.1996.75.2.963; Wallen P, 2007, J PHYSIOL-LONDON, V585, P75, DOI 10.1113/jphysiol.2007.138156; Winograd M, 2008, P NATL ACAD SCI USA, V105, P7298, DOI 10.1073/pnas.0800360105; Wu Y, 2008, PLOS BIOL, V6, P2512, DOI 10.1371/journal.pbio.0060273	44	75	75	1	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2010	13	1					53	U209		10.1038/nn.2444	http://dx.doi.org/10.1038/nn.2444			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	536PM	19966842	Green Accepted			2022-12-24	WOS:000273056300013
J	Chandrasekaran, B; Hornickel, J; Skoe, E; Nicol, T; Kraus, N				Chandrasekaran, Bharath; Hornickel, Jane; Skoe, Erika; Nicol, Trent; Kraus, Nina			Context-Dependent Encoding in the Human Auditory Brainstem Relates to Hearing Speech in Noise: Implications for Developmental Dyslexia	NEURON			English	Article							CORTICOFUGAL MODULATION; MUSICAL EXPERIENCE; PLASTICITY; PITCH; PERCEPTION; DEFICITS; AMPLIFICATION; RESPONSES	We examined context-dependent encoding of speech in children with and without developmental dyslexia by measuring auditory brainstem responses to a speech syllable presented in a repetitive or variable context. Typically developing children showed enhanced brainstem representation of features related to voice pitch in the repetitive context, relative to the variable context. In contrast, children with developmental dyslexia exhibited impairment in their ability to modify representation in predictable contexts. From a functional perspective, we found that the extent of context-dependent encoding in the auditory brainstem correlated positively with behavioral indices of speech perception in noise. The ability to sharpen representation of repeating elements is crucial to speech perception in noise, since it allows superior "tagging" of voice pitch, an important cue for segregating sound streams in background noise. The disruption of this mechanism contributes to a critical deficit in noise-exclusion, a hallmark symptom in developmental dyslexia.	[Chandrasekaran, Bharath; Hornickel, Jane; Skoe, Erika; Nicol, Trent; Kraus, Nina] Northwestern Univ, Auditory Neurosci Lab, Evanston, IL 60208 USA; [Chandrasekaran, Bharath; Hornickel, Jane; Skoe, Erika; Nicol, Trent; Kraus, Nina] Northwestern Univ, Roxelyn & Richard Pepper Dept Commun Sci, Evanston, IL 60208 USA; [Chandrasekaran, Bharath] Northwestern Univ, Commun Neural Syst Res Grp, Evanston, IL 60208 USA; [Kraus, Nina] Northwestern Univ, Inst Neurosci, Evanston, IL 60208 USA	Northwestern University; Northwestern University; Northwestern University; Northwestern University	Kraus, N (corresponding author), Northwestern Univ, Auditory Neurosci Lab, 2240 Campus Dr, Evanston, IL 60208 USA.	nkraus@northwestern.edu		Chandrasekaran, Bharath/0000-0002-3673-9435	NIH/NIDCD [RO1-01510, F32DC008052]; NSF [BCS-544846]; Hugh Knowles Center at Northwestern University; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC001510, F32DC008052] Funding Source: NIH RePORTER	NIH/NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NSF(National Science Foundation (NSF)); Hugh Knowles Center at Northwestern University; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We would like to thank Steve Zecker, Brad Wible, Patrick Wong, and Ed Rubel for their comments on earlier versions of the manuscript. We would like to thank the members of the Auditory Neuroscience Laboratory who aided in data collection, and the children and their families who participated in the study. This work was supported by Grants NIH/NIDCD RO1-01510, F32DC008052, and NSF BCS-544846, and by the Hugh Knowles Center at Northwestern University.	Ahissar M, 2007, TRENDS COGN SCI, V11, P458, DOI 10.1016/j.tics.2007.08.015; Ahissar M, 2006, NAT NEUROSCI, V9, P1558, DOI 10.1038/nn1800; Atiani S, 2009, NEURON, V61, P467, DOI 10.1016/j.neuron.2008.12.027; Banai K, 2009, CEREB CORTEX, V19, P2699, DOI 10.1093/cercor/bhp024; Bregman A.S., 1994, AUDITORY SCENE ANAL; BROKX JPL, 1982, J PHONETICS, V10, P23, DOI 10.1016/S0095-4470(19)30909-X; CHANDRASEKARAN B, 2009, PSYCHOPHYSI IN PRESS, DOI DOI 10.1111/J.1469-8986.2009.00928.X; Demonet JF, 2004, LANCET, V363, P1451, DOI 10.1016/S0140-6736(04)16106-0; Elhilali M, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000129; ELLIOTT LL, 1989, J SPEECH HEAR RES, V32, P112, DOI 10.1044/jshr.3201.112; Everatt J., 1999, DYSLEXIA, V5, P28, DOI [DOI 10.1002/(SICI)1099-0909(199903)5, 10.1002/(SICI)1099-0909 (199903)5:13.0.CO;2-K, DOI 10.1002/(SICI)1099-0909(199903)5:13.0.CO;2-K]; Galbraith GC, 1995, NEUROREPORT, V6, P2363, DOI 10.1097/00001756-199511270-00021; Gao E, 1998, P NATL ACAD SCI USA, V95, P12663, DOI 10.1073/pnas.95.21.12663; Gao EQ, 2000, P NATL ACAD SCI USA, V97, P8081, DOI 10.1073/pnas.97.14.8081; Hornickel J, 2009, P NATL ACAD SCI USA, V106, P13022, DOI 10.1073/pnas.0901123106; Johnson KL, 2008, J NEUROSCI, V28, P4000, DOI 10.1523/JNEUROSCI.0012-08.2008; KLATT DH, 1980, J ACOUST SOC AM, V67, P971, DOI 10.1121/1.383940; Kraus N, 2005, TRENDS NEUROSCI, V28, P176, DOI 10.1016/j.tins.2005.02.003; Krishnan A, 2005, COGNITIVE BRAIN RES, V25, P161, DOI 10.1016/j.cogbrainres.2005.05.004; Krishnan A, 2009, BRAIN LANG, V110, P135, DOI 10.1016/j.bandl.2009.03.005; Krishnan A, 2009, J COGNITIVE NEUROSCI, V21, P1092, DOI 10.1162/jocn.2009.21077; Luo F, 2008, J NEUROSCI, V28, P11615, DOI 10.1523/JNEUROSCI.3972-08.2008; Musacchia G, 2007, P NATL ACAD SCI USA, V104, P15894, DOI 10.1073/pnas.0701498104; Nahum M, 2008, PLOS BIOL, V6, P978, DOI 10.1371/journal.pbio.0060126; Psychological Corporation, 1999, WECHSL ABBR SCAL INT; Ramus F, 2003, BRAIN, V126, P841, DOI 10.1093/brain/awg076; Ramus F, 2001, NATURE, V412, P393, DOI 10.1038/35086683; Ramus F, 2008, Q J EXP PSYCHOL, V61, P129, DOI 10.1080/17470210701508822; Sayles M, 2008, NEURON, V58, P789, DOI 10.1016/j.neuron.2008.03.029; Song JH, 2008, J COGNITIVE NEUROSCI, V20, P1892, DOI 10.1162/jocn.2008.20131; Sperling AJ, 2005, NAT NEUROSCI, V8, P862, DOI 10.1038/nn1474; Sperling AJ, 2006, PSYCHOL SCI, V17, P1047, DOI 10.1111/j.1467-9280.2006.01825.x; Strait DL, 2009, EUR J NEUROSCI, V29, P661, DOI 10.1111/j.1460-9568.2009.06617.x; Suga N, 2002, NEURON, V36, P9, DOI 10.1016/S0896-6273(02)00933-9; Suga N, 2003, NAT REV NEUROSCI, V4, P783, DOI 10.1038/nrn1222; Suga N, 2000, P NATL ACAD SCI USA, V97, P11807, DOI 10.1073/pnas.97.22.11807; Suga N, 2008, J COMP PHYSIOL A, V194, P169, DOI 10.1007/s00359-007-0274-2; TALLAL P, 1980, BRAIN LANG, V9, P182, DOI 10.1016/0093-934X(80)90139-X; TALLAL P, 1975, Cortex, V11, P196; Torgesen J.K., 1999, TOWRE TEST WORD READ; Tzounopoulos T, 2009, NEURON, V62, P463, DOI 10.1016/j.neuron.2009.05.002; Winer JA, 2005, HEARING RES, V207, P1, DOI 10.1016/j.heares.2005.06.007; Wong PCM, 2007, NAT NEUROSCI, V10, P420, DOI 10.1038/nn1872; Yan J, 1999, J NEUROPHYSIOL, V81, P817, DOI 10.1152/jn.1999.81.2.817; Zhang YF, 1997, NATURE, V387, P900, DOI 10.1038/43180; Zhang YF, 1997, J NEUROPHYSIOL, V78, P3489, DOI 10.1152/jn.1997.78.6.3489; Ziegler JC, 2009, DEVELOPMENTAL SCI, V12, P732, DOI 10.1111/j.1467-7687.2009.00817.x	47	174	179	0	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 12	2009	64	3					311	319		10.1016/j.neuron.2009.10.006	http://dx.doi.org/10.1016/j.neuron.2009.10.006			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	521MF	19914180	Green Accepted, Bronze			2022-12-24	WOS:000271924800006
J	Renault, VM; Rafalski, VA; Morgan, AA; Salih, DAM; Brett, JO; Webb, AE; Villeda, SA; Thekkat, PU; Guillerey, C; Denko, NC; Palmer, TD; Bufte, AJ; Brunet, A				Renault, Valerie M.; Rafalski, Victoria A.; Morgan, Alex A.; Salih, Dervis A. M.; Brett, Jamie O.; Webb, Ashley E.; Villeda, Saul A.; Thekkat, Pramod U.; Guillerey, Camille; Denko, Nicholas C.; Palmer, Theo D.; Bufte, Atul J.; Brunet, Anne			FoxO3 Regulates Neural Stem Cell Homeostasis	CELL STEM CELL			English	Article							SELF-RENEWAL; VASCULAR NICHE; DENTATE GYRUS; NEUROGENESIS; PROLIFERATION; PTEN; DIFFERENTIATION; SURVIVAL; HYPOXIA; MAINTENANCE	In the nervous system, neural stem cells (NSCs) are necessary for the generation of new neurons and for cognitive function. Here we show that FoxO3, a member of a transcription factor family known to extend lifespan in invertebrates, regulates the NSC pool. We find that adult FoxO3(-/-) mice have fewer NSCs in vivo than wild-type counterparts. NSCs isolated from adult FoxO3(-/-) mice have decreased self-renewal and an impaired ability to generate different neural lineages. Identification of the FoxO3-dependent gene expression profile in NSCs suggests that FoxO3 regulates the NSC pool by inducing a program of genes that preserves quiescence, prevents premature differentiation, and controls oxygen metabolism. The ability of FoxO3 to prevent the premature depletion of NSCs; might have important implications for counteracting brain aging in long-lived species.	[Renault, Valerie M.; Rafalski, Victoria A.; Salih, Dervis A. M.; Brett, Jamie O.; Webb, Ashley E.; Villeda, Saul A.; Thekkat, Pramod U.; Guillerey, Camille; Brunet, Anne] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Rafalski, Victoria A.; Villeda, Saul A.; Brunet, Anne] Stanford Univ, Neurosci Program, Stanford, CA 94305 USA; [Morgan, Alex A.; Bufte, Atul J.] Stanford Univ, Biomed Informat Program, Stanford, CA 94305 USA; [Denko, Nicholas C.] Stanford Univ, Dept Radiat Oncol, Stanford, CA 94305 USA; [Palmer, Theo D.] Stanford Univ, Dept Neurosurg, Stanford, CA 94305 USA; [Morgan, Alex A.; Bufte, Atul J.] Stanford Univ, Lucile Packard Childrens Hosp, Dept Pediat, Stanford, CA 94304 USA; [Morgan, Alex A.; Bufte, Atul J.] Stanford Univ, Lucile Packard Childrens Hosp, Dept Med, Stanford, CA 94304 USA	Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Lucile Packard Children's Hospital (LPCH); Stanford University; Lucile Packard Children's Hospital (LPCH); Stanford University	Brunet, A (corresponding author), Stanford Univ, Dept Genet, Stanford, CA 94305 USA.	anne.brunet@stanford.edu	Guillerey, Camille/N-1061-2014; denko, nicholas/F-8444-2010; Palmer, Theo/GSI-6635-2022	Guillerey, Camille/0000-0002-7917-2432; Palmer, Theo/0000-0002-6266-1862; Salih, Dervis/0000-0001-7651-8998	NIH/NIA [R01 AG026648]; CIRM; Brain Tumor Society; Klingenstein Fellowship; AFAR; Stanford University; NSF; NIH/NRSA [5T32 CA09302]; Lucile Packard Foundation for Children's Health; NLM [R01 LM009719, T15 LM007033]; NATIONAL CANCER INSTITUTE [T32CA009302] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG026648] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM007033, R01LM009719] Funding Source: NIH RePORTER	NIH/NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); CIRM(California Institute for Regenerative Medicine); Brain Tumor Society; Klingenstein Fellowship(Klingenstein Philanthropies); AFAR; Stanford University(Stanford University); NSF(National Science Foundation (NSF)); NIH/NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lucile Packard Foundation for Children's Health; NLM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	Work supported by an NIH/NIA grant R01 AG026648, a CIRM grant, a Brain Tumor Society grant, a Klingenstein Fellowship, and an AFAR grant (A.B.), a Stanford University Dean's fellowship (V.M.R.), an NSF graduate fellowship (V.A.R.), an NIH/NRSA 5T32 CA09302 (A.E.W.), the Lucile Packard Foundation for Children's Health and NLM grant R01 LM009719 (A.J.B.), and NLM grant T15 LM007033 (A.A.M.). We thank Kimmi Hoang for help with mouse colony management, Michael Stadler for help with Luxol blue staining, Ben Barres for the generous gift of the 04 antibody, Brandon Cord (T.D.P.'s lab) for help in NSC; cultures, and Nathan Woodling (Katrin Andreasson's lab) for help with the BrdU protocol. We thank Ioanna Papandreou (N.C.D.'s lab) for her help with low-oxygen experiments. We thank Ron DePinho for the generous gift of the FoxO3<SUP>-/-</SUP> and FoxO3<SUP>lox/lox</SUP> mice and for discussing results prepublication. We thank Steve Artandi, Michael Greenberg, Tom Rando, Julien Sage, and members of the Brunet lab for critically reading the manuscript.	Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Alvarez-Buylla A, 1998, J NEUROBIOL, V36, P105, DOI 10.1002/(SICI)1097-4695(199808)36:2<105::AID-NEU1>3.0.CO;2-5; Bakker WJ, 2007, MOL CELL, V28, P941, DOI 10.1016/j.molcel.2007.10.035; Bondolfi L, 2004, NEUROBIOL AGING, V25, P333, DOI 10.1016/S0197-4580(03)00083-6; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Clelland CD, 2009, SCIENCE, V325, P210, DOI 10.1126/science.1173215; Emerling BM, 2008, P NATL ACAD SCI USA, V105, P2622, DOI 10.1073/pnas.0706790105; Fasano CA, 2007, CELL STEM CELL, V1, P87, DOI 10.1016/j.stem.2007.04.001; Flachsbart F, 2009, P NATL ACAD SCI USA, V106, P2700, DOI 10.1073/pnas.0809594106; Gheusi C, 2000, P NATL ACAD SCI USA, V97, P1823, DOI 10.1073/pnas.97.4.1823; Groszer M, 2006, P NATL ACAD SCI USA, V103, P111, DOI 10.1073/pnas.0509939103; Imayoshi I, 2008, NAT NEUROSCI, V11, P1153, DOI 10.1038/nn.2185; Johnson MA, 2009, BMB REP, V42, P245, DOI 10.5483/BMBRep.2009.42.5.245; Keith B, 2007, CELL, V129, P465, DOI 10.1016/j.cell.2007.04.019; Kempermann G, 1998, J NEUROSCI, V18, P3206; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; Kinney BA, 2001, HORM BEHAV, V39, P277, DOI 10.1006/hbeh.2001.1654; Kippin TE, 2005, GENE DEV, V19, P756, DOI 10.1101/gad.1272305; Li L, 2002, MOL CELL NEUROSCI, V20, P21, DOI 10.1006/mcne.2002.1115; McElwee JJ, 2004, J BIOL CHEM, V279, P44533, DOI 10.1074/jbc.M406207200; Mirzadeh Z, 2008, CELL STEM CELL, V3, P265, DOI 10.1016/j.stem.2008.07.004; Miyamoto K, 2007, CELL STEM CELL, V1, P101, DOI 10.1016/j.stem.2007.02.001; Molofsky AV, 2006, NATURE, V443, P448, DOI 10.1038/nature05091; Molofsky AV, 2005, GENE DEV, V19, P1432, DOI 10.1101/gad.1299505; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Paik JH, 2009, CELL STEM CELL, V5, P540, DOI 10.1016/j.stem.2009.09.013; Palmer TD, 1997, MOL CELL NEUROSCI, V8, P389, DOI 10.1006/mcne.1996.0595; Reynolds BA, 2005, NAT METHODS, V2, P333, DOI 10.1038/nmeth758; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Salih DAM, 2008, CURR OPIN CELL BIOL, V20, P126, DOI 10.1016/j.ceb.2008.02.005; Shen Q, 2008, CELL STEM CELL, V3, P289, DOI 10.1016/j.stem.2008.07.026; Sinor AD, 2004, J NEUROSCI, V24, P8531, DOI 10.1523/JNEUROSCI.1470-04.2004; Studer L, 2000, J NEUROSCI, V20, P7377; Sun LY, 2005, ENDOCRINOLOGY, V146, P1138, DOI 10.1210/en.2004-1115; Tavazoie M, 2008, CELL STEM CELL, V3, P279, DOI 10.1016/j.stem.2008.07.025; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Tropepe V, 1997, J NEUROSCI, V17, P7850; Wilicox BJ, 2008, P NATL ACAD SCI USA, V105, P13987, DOI 10.1073/pnas.0801030105; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703; Zhang CL, 2008, NATURE, V451, P1004, DOI 10.1038/nature06562; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Zhu LL, 2005, MOL NEUROBIOL, V31, P231, DOI 10.1385/MN:31:1-3:231	43	414	423	0	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	NOV 6	2009	5	5					527	539		10.1016/j.stem.2009.09.014	http://dx.doi.org/10.1016/j.stem.2009.09.014			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	522SR	19896443	Green Accepted, Bronze			2022-12-24	WOS:000272019500014
J	Sacchetti, P; Sousa, KM; Hall, AC; Liste, I; Steffensen, KR; Theofilopoulos, S; Parish, CL; Hazenberg, C; Ahrlund-Richter, L; Hovatta, O; Gustafsson, JA; Arenas, E				Sacchetti, Paola; Sousa, Kyle M.; Hall, Anita C.; Liste, Isabel; Steffensen, Knut R.; Theofilopoulos, Spyridon; Parish, Clare L.; Hazenberg, Carin; Ahrlund-Richter, Lars; Hovatta, Outti; Gustafsson, Jan-Ake; Arenas, Ernest			Liver X Receptors and Oxysterols Promote Ventral Midbrain Neurogenesis In Vivo and in Human Embryonic Stem Cells	CELL STEM CELL			English	Article							DOPAMINERGIC NEURON DEVELOPMENT; CENTRAL-NERVOUS-SYSTEM; NUCLEAR RECEPTOR; PROGENITOR CELLS; LXR-ALPHA; BETA; FATE; DEGENERATION; METABOLISM; EXPRESSION	Control over progenitor proliferation and neurogenesis remains a key challenge for stem cell neurobiology and a prerequisite for successful stem cell replacement therapies for neurodegenerative diseases like Parkinson's disease (PD). Here, we examined the function of two nuclear receptors, liver X receptors (Lxroc and P) and their ligands, oxysterols, as regulators of cell division, ventral midbrain (VM) neurogenesis, and dopaminergic (DA) neuron development. Deletion of Lxrs reduced cell cycle progression and VM neurogenesis, resulting in decreased DA neurons at birth. Activation of Lxrs with oxysterol ligands increased the number of DA neurons in mouse embryonic stem cells (ESCs) and in wildtype but not Lxr alpha beta(-/-) VM progenitor cultures. Likewise, oxysterol treatment of human ESCs (hESCs) during DA differentiation increased neurogenesis and the number of mature DA neurons, while reducing proliferating progenitors. Thus, Lxr ligands may improve current hESC replacement strategies for PD by selectively augmenting the generation of DA neurons.	[Sacchetti, Paola; Sousa, Kyle M.; Hall, Anita C.; Liste, Isabel; Theofilopoulos, Spyridon; Hazenberg, Carin; Arenas, Ernest] Karolinska Inst, Ctr Dev Biol & Regenerat Med, Dept Med Biochem & Biophys, Mol Neurobiol Lab, S-17177 Stockholm, Sweden; [Sousa, Kyle M.] Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Hall, Anita C.] Univ London Imperial Coll Sci Technol & Med, Div Cell & Mol Biol, London SW7 2AY, England; [Steffensen, Knut R.; Gustafsson, Jan-Ake] Karolinska Inst, Dept Biosci & Nutr Novum, S-14157 Huddinge, Sweden; [Parish, Clare L.] Univ Melbourne, Florey Neurosci Inst, Parkville, Vic 3010, Australia; [Parish, Clare L.] Univ Melbourne, Ctr Neurosci, Parkville, Vic 3010, Australia; [Ahrlund-Richter, Lars] Karolinska Inst, Dept Woman & Child Hlth, S-17176 Stockholm, Sweden; [Hovatta, Outti] Karolinska Univ Hosp, Dept Clin Sci Intervent & Technol, S-14186 Huddinge, Sweden; [Gustafsson, Jan-Ake] Univ Houston, Dept Biol & Biochem, Ctr Nucl Receptors & Cell Signaling, Houston, TX 77004 USA	Karolinska Institutet; University of Michigan System; University of Michigan; Imperial College London; Karolinska Institutet; Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of Melbourne; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; University of Houston System; University of Houston	Arenas, E (corresponding author), Karolinska Inst, Ctr Dev Biol & Regenerat Med, Dept Med Biochem & Biophys, Mol Neurobiol Lab, S-17177 Stockholm, Sweden.	ernest.arenas@ki.se	Theofilopoulos, Spyridon/B-2075-2015; Parish, Clare/A-3380-2014; Theofilopoulos, Spyridon/E-1508-2011; Arenas, Ernest/AAO-5231-2020; Sacchetti, Paola/ABC-8884-2021	Theofilopoulos, Spyridon/0000-0003-1986-0943; Arenas, Ernest/0000-0003-0197-6577; Sacchetti, Paola/0000-0002-6390-2744; Parish, Clare/0000-0001-8212-9884; Steffensen, Knut/0000-0001-6093-2801; Liste, Isabel/0000-0002-3294-9558	Michael J. Fox Foundation; Swedish Foundation for Strategic Research (INGVAR and CEDB); European Union (Strokemap, NeuroStemCell); Petrus and Augusta Hedlunds Foundation; Swedish Research Council [VR2008:3287]; Norwegian Research Council; Swedish Royal Academy of Sciences and Knut and Alice Wallenberg Foundation; Australian National Health and Medical Research Council (NHMRC); CJ Martin Fellowship and NHMRC Career Development Award	Michael J. Fox Foundation; Swedish Foundation for Strategic Research (INGVAR and CEDB)(Swedish Foundation for Strategic Research); European Union (Strokemap, NeuroStemCell); Petrus and Augusta Hedlunds Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Norwegian Research Council(Research Council of NorwayEuropean Commission); Swedish Royal Academy of Sciences and Knut and Alice Wallenberg Foundation; Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); CJ Martin Fellowship and NHMRC Career Development Award(National Health and Medical Research Council (NHMRC) of Australia)	The authors are grateful to Drs. Magdalena Gbtz, Weimin Zhong, and Franqois Guillemot for their invaluable comments and critical support of this work. We also thank Heider Andre for comments and suggestions on the manuscript, Dr. Ruani Fernando for invaluable discussion and technical help on histology and imaging, and Johnny Soderlund for technical assistance. This work was supported by the Michael J. Fox Foundation, Swedish Foundation for Strategic Research (INGVAR and CEDB), European Union (Strokemap, NeuroStemCell), Karolinska Institutet, Petrus and Augusta Hedlunds Foundation, Swedish Research Council (VR2008:3287 and DBRM), and Norwegian Research Council to E.A., and grants from VIR to O.H., L.A.R., and J.-A.G. E.A. was supported by Swedish Royal Academy of Sciences and Knut and Alice Wallenberg Foundation, P.S. was supported by Norwegian Research Council, and A.C.H. was supported by Human Frontiers Science Program. C.L.P. was supported by an Australian National Health and Medical Research Council (NHMRC) CJ Martin Fellowship and NHMRC Career Development Award. J.-A.G. is shareholder and consultant of KaroBio AB and was supported by a grant from KaroBio AB.	Alberti S, 2001, J CLIN INVEST, V107, P565, DOI 10.1172/JCI9794; Andersson E, 2006, CELL, V124, P393, DOI [10.1016/j.cell.2005.10.037, 10.1016/J.CELL.2005.10.037]; Andersson E, 2006, DEVELOPMENT, V133, P507, DOI 10.1242/dev.02224; Andersson S, 2005, P NATL ACAD SCI USA, V102, P3857, DOI 10.1073/pnas.0500634102; Barberi T, 2003, NAT BIOTECHNOL, V21, P1200, DOI 10.1038/nbt870; Bensinger SJ, 2008, CELL, V134, P97, DOI 10.1016/j.cell.2008.04.052; Bonilla S, 2008, GLIA, V56, P809, DOI 10.1002/glia.20654; Castelo-Branco GA, 2003, P NATL ACAD SCI USA, V100, P12747, DOI 10.1073/pnas.1534900100; Cho MS, 2008, P NATL ACAD SCI USA, V105, P3392, DOI 10.1073/pnas.0712359105; Dehay C, 2007, NAT REV NEUROSCI, V8, P438, DOI 10.1038/nrn2097; Fan X, 2008, P NATL ACAD SCI USA, V105, P13445, DOI 10.1073/pnas.0806974105; Ferri ALM, 2007, DEVELOPMENT, V134, P2761, DOI 10.1242/dev.000141; Goto T, 2004, DEV NEUROSCI-BASEL, V26, P208, DOI 10.1159/000082138; Huang X, 2005, CELL PROLIFERAT, V38, P223, DOI 10.1111/j.1365-2184.2005.00344.x; Imreh MP, 2006, J CELL BIOCHEM, V99, P508, DOI 10.1002/jcb.20897; Janowski BA, 1996, NATURE, V383, P728, DOI 10.1038/383728a0; Joseph SB, 2003, NAT MED, V9, P213, DOI 10.1038/nm820; Kele J, 2006, DEVELOPMENT, V133, P495, DOI 10.1242/dev.02223; Kim HJ, 2008, P NATL ACAD SCI USA, V105, P2094, DOI 10.1073/pnas.0711599105; Kittappa R, 2007, PLOS BIOL, V5, P2875, DOI 10.1371/journal.pbio.0050325; Levine EM, 2000, DEV BIOL, V219, P299, DOI 10.1006/dbio.2000.9622; Matsunaga E, 2002, DEVELOPMENT, V129, P5269; Miller FD, 2007, NEURON, V54, P357, DOI 10.1016/j.neuron.2007.04.019; Nguyen L, 2006, GENE DEV, V20, P1511, DOI 10.1101/gad.377106; Nieto M, 2001, NEURON, V29, P401, DOI 10.1016/S0896-6273(01)00214-8; Ohnuma S, 1999, CELL, V99, P499, DOI 10.1016/S0092-8674(00)81538-X; Parish CL, 2007, NEURODEGENER DIS, V4, P339, DOI 10.1159/000101892; Perrier AL, 2004, P NATL ACAD SCI USA, V101, P12543, DOI 10.1073/pnas.0404700101; Prakash N, 2006, DEVELOPMENT, V133, P89, DOI 10.1242/dev.02181; Prakash N, 2006, J PHYSIOL-LONDON, V575, P403, DOI 10.1113/jphysiol.2006.113464; Rawal N, 2006, EXP CELL RES, V312, P1626, DOI 10.1016/j.yexcr.2006.01.032; Repa JJ, 2002, J BIOL CHEM, V277, P18793, DOI 10.1074/jbc.M109927200; Roy NS, 2006, NAT MED, V12, P1259, DOI 10.1038/nm1495; Schultz JR, 2000, GENE DEV, V14, P2831, DOI 10.1101/gad.850400; Shen Q, 2006, NAT NEUROSCI, V9, P743, DOI 10.1038/nn1694; Smidt MP, 2000, NAT NEUROSCI, V3, P337, DOI 10.1038/73902; Sun Y, 2001, CELL, V104, P365, DOI 10.1016/S0092-8674(01)00224-0; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tomita K, 2000, EMBO J, V19, P5460, DOI 10.1093/emboj/19.20.5460; van den Munckhof P, 2003, DEVELOPMENT, V130, P2535, DOI 10.1242/dev.00464; Venkateswaran A, 2000, P NATL ACAD SCI USA, V97, P12097, DOI 10.1073/pnas.200367697; Wang L, 2002, P NATL ACAD SCI USA, V99, P13878, DOI 10.1073/pnas.172510899; WILKINSON DG, 1993, METHOD ENZYMOL, V225, P361; WILLY PJ, 1995, GENE DEV, V9, P1033, DOI 10.1101/gad.9.9.1033; Willy PJ, 1997, GENE DEV, V11, P289, DOI 10.1101/gad.11.3.289; Yang DL, 2008, STEM CELLS, V26, P55, DOI 10.1634/stemcells.2007-0494; Ye WL, 1998, CELL, V93, P755, DOI 10.1016/S0092-8674(00)81437-3; Ye WL, 2001, NAT NEUROSCI, V4, P1175, DOI 10.1038/nn761; Zelcer N, 2006, J CLIN INVEST, V116, P607, DOI 10.1172/JCI27883; Zervas M, 2004, NEURON, V43, P345, DOI 10.1016/j.neuron.2004.07.010	50	101	108	1	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	OCT 2	2009	5	4					409	419		10.1016/j.stem.2009.08.019	http://dx.doi.org/10.1016/j.stem.2009.08.019			11	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	514NP	19796621	Bronze			2022-12-24	WOS:000271401900012
J	Kwag, J; Paulsen, O				Kwag, Jeehyun; Paulsen, Ole			The timing of external input controls the sign of plasticity at local synapses	NATURE NEUROSCIENCE			English	Article							SYNAPTIC PLASTICITY; PYRAMIDAL NEURONS; CA1; HIPPOCAMPUS; OSCILLATIONS	The method by which local networks in the brain store information from extrinsic afferent inputs is not well understood. We found that the timing of afferent input can bidirectionally control the sign of spike timing-dependent plasticity at local synapses in rat hippocampus. This mechanism provides a means by which temporal information in external input can be encoded in the local matrix of synaptic weights.	[Kwag, Jeehyun; Paulsen, Ole] Univ Oxford, Dept Physiol Anat & Genet, Oxford, England	University of Oxford	Paulsen, O (corresponding author), Univ Oxford, Dept Physiol Anat & Genet, Oxford, England.	ole.paulsen@dpag.ox.ac.uk	Paulsen, Ole/ABB-4843-2020	Paulsen, Ole/0000-0002-2258-5455	Biotechnology and Biological Sciences Research Council [BB/D0157581]; Kwanjeong Foundation; BBSRC [BB/D015758/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D015758/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Kwanjeong Foundation; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council (grant number BB/D0157581) and the Kwanjeong Foundation.	Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Buzsaki G., 2006, RHYTHMS BRAIN; Caporale N, 2008, ANNU REV NEUROSCI, V31, P25, DOI 10.1146/annurev.neuro.31.060407.125639; Cassenaer S, 2007, NATURE, V448, P709, DOI 10.1038/nature05973; Debanne D, 1998, J PHYSIOL-LONDON, V507, P237, DOI 10.1111/j.1469-7793.1998.237bu.x; HASSELMO ME, 1994, J NEUROSCI, V14, P3898; Hebb Donald O., 1949, ORG BEHAV; HUERTA PT, 1993, NATURE, V364, P723, DOI 10.1038/364723a0; Kocsis B, 1999, J NEUROSCI, V19, P6200, DOI 10.1523/JNEUROSCI.19-14-06200.1999; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Neves G, 2008, NAT REV NEUROSCI, V9, P65, DOI 10.1038/nrn2303; Otmakhova NA, 2004, J NEUROPHYSIOL, V92, P2027, DOI 10.1152/jn.00427.2004; Remondes M, 2002, NATURE, V416, P736, DOI 10.1038/416736a; SOLTESZ I, 1993, J NEUROPHYSIOL, V70, P97, DOI 10.1152/jn.1993.70.1.97	15	40	40	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2009	12	10					1219	1221		10.1038/nn.2388	http://dx.doi.org/10.1038/nn.2388			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	498US	19734896				2022-12-24	WOS:000270170200007
J	Kussius, CL; Popescu, GK				Kussius, Cassandra L.; Popescu, Gabriela K.			Kinetic basis of partial agonism at NMDA receptors	NATURE NEUROSCIENCE			English	Article							D-ASPARTATE RECEPTORS; GLUTAMATE-RECEPTOR; CRYSTAL-STRUCTURES; ACTIVATION; MECHANISM; SUBUNIT; CHANNELS; GLYCINE; SPECIFICITY; POTENCY	Activation of ligand-gated channels is initiated by the binding of small molecules at extracellular sites and culminates with the opening of a membrane-embedded pore. To investigate how perturbations at ligand-binding domains influence the gating reaction, we examined current traces recorded from individual NMDA receptors in the presence of several subunit-specific partial agonists. We found that low-efficacy agonists acting at either the glycine-binding or the glutamate-binding NMDA receptor subunits had very similar effects on the receptor's activation reaction, possibly reflecting a high degree of coupling between the two subunit types during gating. In addition, we found that partial agonists increased the height of all energy barriers encountered by NMDA receptors during activation. This result stands in sharp contrast to the localized effects that have been observed for pentameric ligand-gated channels and may represent a previously unknown mechanism by which partial agonists reduce receptor activity.	[Kussius, Cassandra L.; Popescu, Gabriela K.] Univ Buffalo, Dept Biochem, Buffalo, NY 14222 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Popescu, GK (corresponding author), Univ Buffalo, Dept Biochem, Buffalo, NY 14222 USA.	popescu@buffalo.edu	popescu, gabriela k/AAB-6155-2022	popescu, gabriela k/0000-0003-4658-2002	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052669] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R03DA024795] Funding Source: NIH RePORTER; NIDA NIH HHS [R03 DA024795, R03 DA024795-02, R03 DA024795-01] Funding Source: Medline; NINDS NIH HHS [R01 NS052669-01A1, R01 NS052669, R01 NS052669-02, R01 NS052669-04, R01 NS052669-03] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Armstrong N, 2000, NEURON, V28, P165, DOI 10.1016/S0896-6273(00)00094-5; Armstrong N, 1998, NATURE, V395, P913, DOI 10.1038/27692; Banke TG, 2003, NAT NEUROSCI, V6, P144, DOI 10.1038/nn1000; Blanke ML, 2008, MOL PHARMACOL, V74, P454, DOI 10.1124/mol.107.044115; Chen PE, 2008, J PHYSIOL-LONDON, V586, P227, DOI 10.1113/jphysiol.2007.143172; Collingridge GL, 2009, NEUROPHARMACOLOGY, V56, P2, DOI 10.1016/j.neuropharm.2008.06.063; Colquhoun D, 2007, J PHYSIOL-LONDON, V581, P425, DOI 10.1113/jphysiol.2007.131656; Cull-Candy S, 2001, CURR OPIN NEUROBIOL, V11, P327, DOI 10.1016/S0959-4388(00)00215-4; DeCarvalho LP, 1996, NEUROCHEM INT, V28, P445; Dravid SM, 2008, J PHYSIOL-LONDON, V586, P4425, DOI 10.1113/jphysiol.2008.158634; Erreger K, 2005, J NEUROSCI, V25, P7858, DOI 10.1523/JNEUROSCI.1613-05.2005; Erreger K, 2005, J PHYSIOL-LONDON, V563, P345, DOI 10.1113/jphysiol.2004.080028; Erreger K, 2007, MOL PHARMACOL, V72, P907, DOI 10.1124/mol.107.037333; Furukawa H, 2005, NATURE, V438, P185, DOI 10.1038/nature04089; Furukawa H, 2003, EMBO J, V22, P2873, DOI 10.1093/emboj/cdg303; GIBB AJ, 1992, J PHYSIOL-LONDON, V456, P143, DOI 10.1113/jphysiol.1992.sp019331; GIBB AJ, 1991, P ROY SOC B-BIOL SCI, V243, P39, DOI 10.1098/rspb.1991.0007; Grosman C, 2000, NATURE, V403, P773, DOI 10.1038/35001586; Howe JR, 2006, ACS CHEM BIOL, V1, P623, DOI 10.1021/cb6004382; HOWE JR, 1991, J PHYSIOL-LONDON, V432, P143, DOI 10.1113/jphysiol.1991.sp018381; HOWE JR, 1988, PROC R SOC SER B-BIO, V233, P407, DOI 10.1098/rspb.1988.0030; Inanobe A, 2005, NEURON, V47, P71, DOI 10.1016/j.neuron.2005.05.022; JAHR CE, 1992, SCIENCE, V255, P470, DOI 10.1126/science.1346477; Jin RS, 2003, NAT NEUROSCI, V6, P803, DOI 10.1038/nn1091; JOHNSON JW, 1987, NATURE, V325, P529, DOI 10.1038/325529a0; KLECKNER NW, 1988, SCIENCE, V241, P835, DOI 10.1126/science.2841759; Lape R, 2008, NATURE, V454, P722, DOI 10.1038/nature07139; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; Mukhtasimova N, 2009, NATURE, V459, P451, DOI 10.1038/nature07923; Popescu G, 2004, NATURE, V430, P790, DOI 10.1038/nature02775; Popescu G, 2003, NAT NEUROSCI, V6, P476, DOI 10.1038/nn1044; PRIESTLEY T, 1995, MOL PHARMACOL, V48, P841; Robert A, 2005, J NEUROSCI, V25, P3752, DOI 10.1523/JNEUROSCI.0188-05.2005; Rosenmund C, 1998, SCIENCE, V280, P1596, DOI 10.1126/science.280.5369.1596; Schorge S, 2005, J PHYSIOL-LONDON, V569, P395, DOI 10.1113/jphysiol.2005.095349; Schorge S, 2003, J NEUROSCI, V23, P1151, DOI 10.1523/JNEUROSCI.23-04-01151.2003; Sheinin A, 2001, NEUROPHARMACOLOGY, V41, P151, DOI 10.1016/S0028-3908(01)00073-9; Shelley C, 2008, J GEN PHYSIOL, V132, P295, DOI 10.1085/jgp.200810008; Sun Y, 2002, NATURE, V417, P245, DOI 10.1038/417245a; Vicini S, 1998, J NEUROPHYSIOL, V79, P555, DOI 10.1152/jn.1998.79.2.555; Zhang W, 2008, J NEUROSCI, V28, P932, DOI 10.1523/JNEUROSCI.3309-07.2008; Zhang W, 2006, BIOPHYS J, V91, P1336, DOI 10.1529/biophysj.106.084426; Zhang W, 2008, NAT NEUROSCI, V11, P1373, DOI 10.1038/nn.2214; Zhou Y, 2005, J NEUROSCI, V25, P7914, DOI 10.1523/JNEUROSCI.1471-05.2005	44	57	57	1	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2009	12	9					1114	U10		10.1038/nn.2361	http://dx.doi.org/10.1038/nn.2361			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	487ZD	19648915	Green Accepted			2022-12-24	WOS:000269317300012
J	Hoey, T; Yen, WC; Axelrod, F; Basi, J; Donigian, L; Dylla, S; Fitch-Bruhns, M; Lazetic, S; Park, IK; Sato, A; Satyal, S; Wang, XH; Clarke, MF; Lewicki, J; Gurney, A				Hoey, Timothy; Yen, Wan-Ching; Axelrod, Fumiko; Basi, Jesspreet; Donigian, Lucas; Dylla, Scott; Fitch-Bruhns, Maureen; Lazetic, Sasha; Park, In-Kyung; Sato, Aaron; Satyal, Sanjeev; Wang, Xinhao; Clarke, Michael F.; Lewicki, John; Gurney, Austin			DLL4 Blockade Inhibits Tumor Growth and Reduces Tumor-Initiating Cell Frequency	CELL STEM CELL			English	Article							ACUTE MYELOID-LEUKEMIA; CANCER STEM-CELLS; NOTCH; IDENTIFICATION; TRANSCRIPTION; DELTA; CATENIN/TCF; LETHALITY; VESSELS; LIGAND	Previous studies have shown that blocking DLL4 signaling reduced tumor growth by disrupting productive angiogenesis. We developed selective anti-human and anti-mouse DLL4 antibodies to dissect the mechanisms involved by analyzing the contributions of selectively targeting DLL4 in the tumor or in the host vasculature and stroma in xenograft models derived from primary human tumors. We found that each antibody inhibited tumor growth and that the combination of the two antibodies was more effective than either alone. Treatment with anti-human DLL4 inhibited the expression of Notch target genes and reduced proliferation of tumor cells. Furthermore, we found that specifically inhibiting human DLL4 in the tumor, either alone or in combination with the chemotherapeutic agent irinotecan, reduced cancer stem cell frequency, as shown by flow cytometric and in vivo tumorigenicity studies.	[Hoey, Timothy; Yen, Wan-Ching; Axelrod, Fumiko; Basi, Jesspreet; Donigian, Lucas; Dylla, Scott; Fitch-Bruhns, Maureen; Lazetic, Sasha; Park, In-Kyung; Sato, Aaron; Satyal, Sanjeev; Wang, Xinhao; Lewicki, John; Gurney, Austin] OncoMed Pharmaceut Inc, Redwood City, CA 94063 USA; [Clarke, Michael F.] Stanford Univ, Stanford Inst Stem Cell Biol & Regenerat Med, Palo Alto, CA 94063 USA	Stanford University	Hoey, T (corresponding author), OncoMed Pharmaceut Inc, Redwood City, CA 94063 USA.	timothy.hoey@oncomed.com	Nam, Jae Do/F-2201-2013					Ailles LE, 2007, CURR OPIN BIOTECH, V18, P460, DOI 10.1016/j.copbio.2007.10.007; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Bossuyt W, 2009, PLOS BIOL, V7, P311, DOI 10.1371/journal.pbio.1000039; BREEMS DA, 1994, LEUKEMIA, V8, P1095; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Costello RT, 2000, CANCER RES, V60, P4403; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; Duarte A, 2004, GENE DEV, V18, P2474, DOI 10.1101/gad.1239004; Dylla SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002428; Gale NW, 2004, P NATL ACAD SCI USA, V101, P15949, DOI 10.1073/pnas.0407290101; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; HENDY GN, 1995, CLIN INVEST MED, V18, P47; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Krebs LT, 2004, GENE DEV, V18, P2469, DOI 10.1101/gad.1239204; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Matsui W, 2004, BLOOD, V103, P2332, DOI 10.1182/blood-2003-09-3064; Noguera-Troise I, 2006, NATURE, V444, P1032, DOI 10.1038/nature05355; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Parks AL, 2006, GENETICS, V174, P1947, DOI 10.1534/genetics.106.061630; Patel NS, 2005, CANCER RES, V65, P8690, DOI 10.1158/0008-5472.CAN-05-1208; Patrawala L, 2006, ONCOGENE, V25, P1696, DOI 10.1038/sj.onc.1209327; Phillips TM, 2006, JNCI-J NATL CANCER I, V98, P1777, DOI 10.1093/jnci/djj495; Phng LK, 2009, DEV CELL, V16, P70, DOI 10.1016/j.devcel.2008.12.009; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Ridgway J, 2006, NATURE, V444, P1083, DOI 10.1038/nature05313; Rothe C, 2008, J MOL BIOL, V376, P1182, DOI 10.1016/j.jmb.2007.12.018; Sainson RCA, 2007, TRENDS MOL MED, V13, P389, DOI 10.1016/j.molmed.2007.07.002; Sang LY, 2008, SCIENCE, V321, P1095, DOI 10.1126/science.1155998; Scehnet JS, 2007, BLOOD, V109, P4753, DOI 10.1182/blood-2006-12-063933; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; TAX FE, 1994, NATURE, V368, P150, DOI 10.1038/368150a0; Thurston G, 2007, NAT REV CANCER, V7, P327, DOI 10.1038/nrc2130; Tothova Z, 2007, CELL STEM CELL, V1, P140, DOI 10.1016/j.stem.2007.07.017; van Es JH, 2005, NATURE, V435, P959, DOI 10.1038/nature03659; Wang JCY, 1997, BLOOD, V89, P3919, DOI 10.1182/blood.V89.11.3919; Wang Q, 2008, ONCOGENE, V27, P1527, DOI 10.1038/sj.onc.1210793; Wicha MS, 2006, CANCER RES, V66, P1883, DOI 10.1158/0008-5472.CAN-05-3153; Wilson A, 2006, FEBS LETT, V580, P2860, DOI 10.1016/j.febslet.2006.03.024; Yan XQ, 2001, BLOOD, V98, P3793, DOI 10.1182/blood.V98.13.3793; Zhang L, 2006, J BIOL CHEM, V281, P8607, DOI 10.1074/jbc.M600274200	45	316	357	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	AUG 7	2009	5	2					168	177		10.1016/j.stem.2009.05.019	http://dx.doi.org/10.1016/j.stem.2009.05.019			10	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	490PB	19664991	Bronze			2022-12-24	WOS:000269511900010
J	Bond, AM; VanGompel, MJW; Sametsky, EA; Clark, MF; Savage, JC; Disterhoft, JF; Kohtz, JD				Bond, Allison M.; VanGompel, Michael J. W.; Sametsky, Evgeny A.; Clark, Mary F.; Savage, Julie C.; Disterhoft, John F.; Kohtz, Jhumku D.			Balanced gene regulation by an embryonic brain ncRNA is critical for adult hippocampal GABA circuitry	NATURE NEUROSCIENCE			English	Article							RETT-SYNDROME; BASAL FOREBRAIN; HOMEOBOX GENES; SONIC HEDGEHOG; CELL-MIGRATION; DLX GENES; INTERNEURON MIGRATION; HUMAN GENOME; MOUSE MODEL; NEURONS	Genomic studies demonstrate that, although the majority of the mammalian genome is transcribed, only about 2% of these transcripts are code for proteins. We investigated how the long, polyadenylated Evf2 noncoding RNA regulates transcription of the homeodomain transcription factors DLX5 and DLX6 in the developing mouse forebrain. We found that, in developing ventral forebrain, Evf2 recruited DLX and MECP2 transcription factors to important DNA regulatory elements in the Dlx5/6 intergenic region and controlled Dlx5, Dlx6 and Gad1 expression through trans and cis-acting mechanisms. Evf2 mouse mutants had reduced numbers of GABAergic interneurons in early postnatal hippocampus and dentate gyrus. Although the numbers of GABAergic interneurons and Gad1 RNA levels returned to normal in Evf2 mutant adult hippocampus, reduced synaptic inhibition occurred. These results suggest that noncoding RNA-dependent balanced gene regulation in embryonic brain is critical for proper formation of GABA-dependent neuronal circuitry in adult brain.	[Bond, Allison M.; VanGompel, Michael J. W.; Clark, Mary F.; Savage, Julie C.; Kohtz, Jhumku D.] Northwestern Univ, Childrens Mem Hosp, Dev Biol & Dept Pediat, Chicago, IL 60614 USA; [Sametsky, Evgeny A.; Disterhoft, John F.] Northwestern Univ, Feinberg Sch Med, Dept Physiol, Chicago, IL 60614 USA	Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Northwestern University; Feinberg School of Medicine	Kohtz, JD (corresponding author), Northwestern Univ, Childrens Mem Hosp, Dev Biol & Dept Pediat, Chicago, IL 60614 USA.	j-kohtz@northwestern.edu	; Bond, Alan/Y-7128-2018	Disterhoft, John/0000-0002-8817-7913; Bond, Alan/0000-0002-1113-5205	National Institute of Child Health and Human Development [RO1 HD044745, R21 HD049875]; Illinois Regenerative Medicine Institute; Illinois Excellence in Academic Medicine; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD049875, R01HD044745] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH047340] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG008796, R01AG017139] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Illinois Regenerative Medicine Institute; Illinois Excellence in Academic Medicine; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank K. Campbell for providing early passage W4 embryonic stem cells, and training and guidance in ES cell manipulation, M. Ekker for Dlx5/6 BAC, P. Lui and N. Copeland for PL253, PL452, bacterial strains and protocols for BAC recombineering, G. Taborn and P. Iannaccone for blastocyst injections, D. Eisentstat for antibody specific to DLX2, A. Joyner for the triple polyadenylation construct, J. Rubenstein for Gad1 probe, and Q. Ma for v-Glut1 probe. We thank K. Jones (Northwestern University) for establishing the conditions for embryonic tissue ChIP. This work was funded by National Institute of Child Health and Human Development grants RO1 HD044745 and R21 HD049875, the Illinois Regenerative Medicine Institute, and an Illinois Excellence in Academic Medicine grant to J. D. K.	Anderson SA, 1997, SCIENCE, V278, P474, DOI 10.1126/science.278.5337.474; Anderson SA, 1997, NEURON, V19, P27, DOI 10.1016/S0896-6273(00)80345-1; Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; Bienvenu T, 2006, NAT REV GENET, V7, P415, DOI 10.1038/nrg1878; Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252; Chahrour M, 2007, NEURON, V56, P422, DOI 10.1016/j.neuron.2007.10.001; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Cobos I, 2005, NAT NEUROSCI, V8, P1059, DOI 10.1038/nn1499; Cowles CR, 2002, NAT GENET, V32, P432, DOI 10.1038/ng992; Cuzon VC, 2006, CEREB CORTEX, V16, P1377, DOI 10.1093/cercor/bhj084; Dani VS, 2005, P NATL ACAD SCI USA, V102, P12560, DOI 10.1073/pnas.0506071102; Di Cristo G, 2007, CLIN GENET, V72, P1, DOI 10.1111/j.1399-0004.2007.00822.x; Doss S, 2005, GENOME RES, V15, P681, DOI 10.1101/gr.3216905; Feng J, 2004, DEVELOPMENT, V131, P4357, DOI 10.1242/dev.01301; Feng JC, 2006, GENE DEV, V20, P1470, DOI 10.1101/gad.1416106; Giacometti E, 2007, P NATL ACAD SCI USA, V104, P1931, DOI 10.1073/pnas.0610593104; Gilligan P, 2002, GENE, V294, P35, DOI 10.1016/S0378-1119(02)00793-X; Guy J, 2007, SCIENCE, V315, P1143, DOI 10.1126/science.1138389; Heng JIT, 2007, EUR J NEUROSCI, V26, P537, DOI 10.1111/j.1460-9568.2007.05694.x; Horike S, 2005, NAT GENET, V37, P31, DOI 10.1038/ng1491; Kishi N, 2004, MOL CELL NEUROSCI, V27, P306, DOI 10.1016/j.mcn.2004.07.006; Kohtz JD, 2001, DEVELOPMENT, V128, P2351; Kohtz JD, 1998, DEVELOPMENT, V125, P5079; Le TN, 2007, J BIOL CHEM, V282, P19071, DOI 10.1074/jbc.M607486200; Lewis DA, 2005, NAT REV NEUROSCI, V6, P312, DOI 10.1038/nrn1648; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Lopez-Bendito G, 2003, CEREB CORTEX, V13, P932, DOI 10.1093/cercor/13.9.932; Mancini-DiNardo D, 2006, GENE DEV, V20, P1268, DOI 10.1101/gad.1416906; Marin O, 2003, ANNU REV NEUROSCI, V26, P441, DOI 10.1146/annurev.neuro.26.041002.131058; Mattick JS, 2007, J EXP BIOL, V210, P1526, DOI 10.1242/jeb.005017; Mercer TR, 2008, P NATL ACAD SCI USA, V105, P716, DOI 10.1073/pnas.0706729105; Moretti P, 2006, CURR OPIN GENET DEV, V16, P276, DOI 10.1016/j.gde.2006.04.009; Nan XS, 1997, CELL, V88, P471, DOI 10.1016/S0092-8674(00)81887-5; Panganiban G, 2002, DEVELOPMENT, V129, P4371; PANGANIBAN G, 1995, SCIENCE, V270, P1363, DOI 10.1126/science.270.5240.1363; Pleasure SJ, 2000, NEURON, V28, P727, DOI 10.1016/S0896-6273(00)00149-5; Potier B, 2006, NEUROSCIENCE, V142, P187, DOI 10.1016/j.neuroscience.2006.06.040; Prasanth KV, 2007, GENE DEV, V21, P11, DOI 10.1101/gad.1484207; Santini S, 2003, GENOME RES, V13, P1111, DOI 10.1101/gr.700503; Schule B, 2007, AM J HUM GENET, V81, P492, DOI 10.1086/520063; SHAMOVSKY I, 2006, SCI STKE, pPE40, DOI DOI 10.1126/STKE.3552006PE40; Sleutels F, 2002, NATURE, V415, P810, DOI 10.1038/415810a; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Stuhmer T, 2002, DEVELOPMENT, V129, P245; Wichterle H, 2001, DEVELOPMENT, V128, P3759; XU C, 2009, HIPPOCAMPUS; Yan H, 2002, SCIENCE, V297, P1143, DOI 10.1126/science.1072545; Yelin R, 2003, NAT BIOTECHNOL, V21, P379, DOI 10.1038/nbt808; Zerucha T, 2000, J NEUROSCI, V20, P709, DOI 10.1523/JNEUROSCI.20-02-00709.2000; Zhou QP, 2004, NUCLEIC ACIDS RES, V32, P884, DOI 10.1093/nar/gkh233	50	296	325	0	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2009	12	8					1020	U91		10.1038/nn.2371	http://dx.doi.org/10.1038/nn.2371			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	475WS	19620975	Green Accepted			2022-12-24	WOS:000268396300016
J	Dux, PE; Tombu, MN; Harrison, S; Rogers, BP; Tong, F; Marois, R				Dux, Paul E.; Tombu, Michael N.; Harrison, Stephenie; Rogers, Baxter P.; Tong, Frank; Marois, Rene			Training Improves Multitasking Performance by Increasing the Speed of Information Processing in Human Prefrontal Cortex	NEURON			English	Article							DUAL-TASK PERFORMANCE; IMAGING BRAIN PLASTICITY; TIME-RESOLVED FMRI; RESPONSE-SELECTION; FUNCTIONAL NEUROANATOMY; CENTRAL MECHANISMS; ATTENTIONAL BLINK; NEURAL MECHANISMS; COGNITIVE CONTROL; MENTAL ROTATION	Our ability to multitask is severely limited: task performance deteriorates when we attempt to undertake two or more tasks simultaneously. Remarkably, extensive training can greatly reduce such multitasking costs. While it is not known how training alters the brain to solve the multitasking problem, it likely involves the prefrontal cortex given this brain region's purported role in limiting multitasking performance. Here, we show that the reduction of multitasking interference with training is not achieved by diverting the flow of information processing away from the prefrontal cortex or by segregating prefrontal cells into independent task-specific neuronal ensembles, but rather by increasing the speed of information processing in this brain region, thereby allowing multiple tasks to be processed in rapid succession. These results not only reveal how training leads to efficient multitasking, they also provide a mechanistic account of multitasking limitations, namely the poor speed of information processing in human prefrontal cortex.	[Dux, Paul E.; Tombu, Michael N.; Harrison, Stephenie; Tong, Frank; Marois, Rene] Vanderbilt Univ, Dept Psychol, Vanderbilt Vis Res Ctr, Ctr Integrat & Cognit Neurosci, Nashville, TN 37240 USA; [Rogers, Baxter P.] Vanderbilt Univ, Inst Imaging Sci, Nashville, TN 37240 USA; [Rogers, Baxter P.] Vanderbilt Univ, Dept Radiol & Radiol Sci, Nashville, TN 37240 USA; [Dux, Paul E.] Univ Queensland, Sch Psychol, Brisbane, Qld 4072, Australia	Vanderbilt University; Vanderbilt University; Vanderbilt University; University of Queensland	Dux, PE (corresponding author), Vanderbilt Univ, Dept Psychol, Vanderbilt Vis Res Ctr, Ctr Integrat & Cognit Neurosci, Nashville, TN 37240 USA.	paul.e.dux@gmail.com; rene.marois@vanderbilt.edu	Dux, Paul/I-1098-2014; Rogers, Baxter P/B-7897-2010	Dux, Paul/0000-0002-4270-2583; Rogers, Baxter/0000-0002-5666-2797	NIMH [R01MH70776]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH070776] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The research was supported by an NIMH grant (R01MH70776) to R.M.	Adcock RA, 2000, P NATL ACAD SCI USA, V97, P3567, DOI 10.1073/pnas.060588897; Asaad WF, 2000, J NEUROPHYSIOL, V84, P451, DOI 10.1152/jn.2000.84.1.451; BERRY WD, 1984, NONRECURSIVE CAUSAL; Birn RM, 2004, NEUROIMAGE, V23, P1046, DOI 10.1016/j.neuroimage.2004.07.039; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Buchel C, 1999, SCIENCE, V283, P1538, DOI 10.1126/science.283.5407.1538; Buchel C, 1997, CEREB CORTEX, V7, P768, DOI 10.1093/cercor/7.8.768; CARRIER LM, 1995, J EXP PSYCHOL LEARN, V21, P1339, DOI 10.1037/0278-7393.21.5.1339; Chein JM, 2005, COGNITIVE BRAIN RES, V25, P607, DOI 10.1016/j.cogbrainres.2005.08.013; CHUN MM, 1995, J EXP PSYCHOL HUMAN, V21, P109; DESPOSITO M, 1995, NATURE, V378, P279, DOI 10.1038/378279a0; Dosenbach NUF, 2006, NEURON, V50, P799, DOI 10.1016/j.neuron.2006.04.031; Duncan J, 2001, NAT REV NEUROSCI, V2, P820, DOI 10.1038/35097575; Dux PE, 2006, NEURON, V52, P1109, DOI 10.1016/j.neuron.2006.11.009; Erickson KI, 2007, CEREB CORTEX, V17, P192, DOI 10.1093/cercor/bhj137; Freedman DJ, 2001, SCIENCE, V291, P312, DOI 10.1126/science.291.5502.312; Fuster J. M., 2015, PREFRONTAL CORTEX, V5th; HAIER RJ, 1992, BRAIN RES, V570, P134, DOI 10.1016/0006-8993(92)90573-R; Haynes JD, 2006, NAT REV NEUROSCI, V7, P523, DOI 10.1038/nrn1931; Hazeltine E, 2006, COGNITIVE PSYCHOL, V52, P291, DOI 10.1016/j.cogpsych.2005.11.001; Heekeren HR, 2004, NATURE, V431, P859, DOI 10.1038/nature02966; Henson RNA, 2002, NEUROIMAGE, V15, P83, DOI 10.1006/nimg.2001.0940; Hikosaka O, 2002, CURR OPIN NEUROBIOL, V12, P217, DOI 10.1016/S0959-4388(02)00307-0; Jansma JM, 2001, J COGNITIVE NEUROSCI, V13, P730, DOI 10.1162/08989290152541403; Jiang YH, 2003, J COGNITIVE NEUROSCI, V15, P1095, DOI 10.1162/089892903322598076; Jiang YH, 2003, J COGNITIVE NEUROSCI, V15, P1080, DOI 10.1162/089892903322598067; Jolicoeur P, 1999, J EXP PSYCHOL HUMAN, V25, P1097, DOI 10.1037/0096-1523.25.4.1097; Jonides J, 2004, NAT NEUROSCI, V7, P10, DOI 10.1038/nn0104-10; Kamitani Y, 2005, NAT NEUROSCI, V8, P679, DOI 10.1038/nn1444; Kamitani Y, 2006, CURR BIOL, V16, P1096, DOI 10.1016/j.cub.2006.04.003; Karni A, 1998, P NATL ACAD SCI USA, V95, P861, DOI 10.1073/pnas.95.3.861; Kelly AMC, 2005, CEREB CORTEX, V15, P1089, DOI 10.1093/cercor/bhi005; Koechlin E, 2003, SCIENCE, V302, P1181, DOI 10.1126/science.1088545; Koechlin E, 2007, TRENDS COGN SCI, V11, P229, DOI 10.1016/j.tics.2007.04.005; Li W, 2008, SCIENCE, V319, P1842, DOI 10.1126/science.1152837; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; Marois R, 2005, TRENDS COGN SCI, V9, P296, DOI 10.1016/j.tics.2005.04.010; Marois R, 2005, PSYCHOL RES, V11, P1; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; PASHLER H, 1994, PSYCHOL BULL, V116, P220, DOI 10.1037/0033-2909.116.2.220; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Petersen SE, 1998, P NATL ACAD SCI USA, V95, P853, DOI 10.1073/pnas.95.3.853; Poldrack RA, 2005, J NEUROSCI, V25, P5356, DOI 10.1523/JNEUROSCI.3880-04.2005; Poldrack RA, 2001, BRAIN, V124, P67, DOI 10.1093/brain/124.1.67; Poldrack RA, 2000, NEUROIMAGE, V12, P1, DOI 10.1006/nimg.2000.0596; RAYMOND JE, 1992, J EXP PSYCHOL HUMAN, V18, P849, DOI 10.1037/0096-1523.18.3.849; Richter W, 1997, NEUROREPORT, V8, P3697, DOI 10.1097/00001756-199712010-00008; Rioult-Pedotti MS, 1998, NAT NEUROSCI, V1, P230, DOI 10.1038/678; Rioult-Pedotti MS, 2000, SCIENCE, V290, P533, DOI 10.1126/science.290.5491.533; Rogers BP, 2004, NEUROIMAGE, V22, P855, DOI 10.1016/j.neuroimage.2004.02.027; Rowe J, 2002, NEUROIMAGE, V17, P988, DOI 10.1006/nimg.2002.1156; RUTHRUFF E, 1995, J EXP PSYCHOL HUMAN, V21, P552, DOI 10.1037/0096-1523.21.3.552; Ruthruff E, 2003, J EXP PSYCHOL HUMAN, V29, P280, DOI 10.1037/0096-1523.29.2.280; Ruthruff E, 2001, J EXP PSYCHOL HUMAN, V27, P3, DOI 10.1037/0096-1523.27.1.3; Sakai K, 1998, J NEUROSCI, V18, P1827; Schubert T, 2003, COGNITIVE BRAIN RES, V17, P733, DOI 10.1016/S0926-6410(03)00198-8; Schumacher EH, 2001, PSYCHOL SCI, V12, P101, DOI 10.1111/1467-9280.00318; Szameitat AJ, 2002, J COGNITIVE NEUROSCI, V14, P1184, DOI 10.1162/089892902760807195; Talairach J., 1988, COPLANAR STEREOTAXIC; Tombu M, 2004, J EXP PSYCHOL HUMAN, V30, P795, DOI 10.1037/0096-1523.30.5.795; Ulrich R, 2008, COGNITIVE PSYCHOL, V57, P75, DOI 10.1016/j.cogpsych.2007.06.004; Ulrich R, 2006, PSYCHOL SCI, V17, P788, DOI 10.1111/j.1467-9280.2006.01783.x; Ungerleider LG, 2002, NEUROBIOL LEARN MEM, V78, P553, DOI 10.1006/nlme.2002.4091; Van Selst M, 1999, J EXP PSYCHOL HUMAN, V25, P1268, DOI 10.1037/0096-1523.25.5.1268; Vapnik V., 1998, STAT LEARNING THEORY; White LE, 2007, NEURON, V56, P327, DOI 10.1016/j.neuron.2007.10.011; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P1003, DOI 10.1152/jn.1963.26.6.1003; Wise SP, 2000, TRENDS NEUROSCI, V23, P271, DOI 10.1016/S0166-2236(00)01570-8	68	184	202	2	76	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 16	2009	63	1					127	138		10.1016/j.neuron.2009.06.005	http://dx.doi.org/10.1016/j.neuron.2009.06.005			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	473EX	19607798	Green Accepted, Bronze			2022-12-24	WOS:000268189900014
J	Meyer, K; Kaplan, JT; Essex, R; Webber, C; Damasio, H; Damasio, A				Meyer, Kaspar; Kaplan, Jonas T.; Essex, Ryan; Webber, Cecelia; Damasio, Hanna; Damasio, Antonio			Predicting visual stimuli on the basis of activity in auditory cortices	NATURE NEUROSCIENCE			English	Article							MUSICAL IMAGERY; CORTEX; ACTIVATION; ILLUSION; AREAS; SOUND	Using multivariate pattern analysis of functional magnetic resonance imaging data, we found that the subjective experience of sound, in the absence of auditory stimulation, was associated with content-specific activity in early auditory cortices in humans. As subjects viewed sound-implying, but silent, visual stimuli, activity in auditory cortex differentiated among sounds related to various animals, musical instruments and objects. These results support the idea that early sensory cortex activity reflects perceptual experience, rather than sensory stimulation alone.	[Meyer, Kaspar; Kaplan, Jonas T.; Essex, Ryan; Webber, Cecelia; Damasio, Hanna; Damasio, Antonio] Univ So Calif, Brain & Creat Inst, Los Angeles, CA 90089 USA	University of Southern California	Damasio, A (corresponding author), Univ So Calif, Brain & Creat Inst, Los Angeles, CA 90089 USA.	damasio@usc.edu	Damasio, Antonio/AAD-1342-2019		Mathers Foundation; US National Institutes of Health [5P50NS019632-25]	Mathers Foundation; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	H.D. and A.D. are supported by the Mathers Foundation and the US National Institutes of Health (5P50NS019632-25).	Blankenburg F, 2006, PLOS BIOL, V4, P459, DOI 10.1371/journal.pbio.0040069; Calvert GA, 1997, SCIENCE, V276, P593, DOI 10.1126/science.276.5312.593; Chen LM, 2003, SCIENCE, V302, P881, DOI 10.1126/science.1087846; Dierks T, 1999, NEURON, V22, P615, DOI 10.1016/S0896-6273(00)80715-1; Formisano E, 2008, SCIENCE, V322, P970, DOI 10.1126/science.1164318; Harrison SA, 2009, NATURE, V458, P632, DOI 10.1038/nature07832; KOSSLYN SM, 1995, NATURE, V378, P496, DOI 10.1038/378496a0; Kraemer DJM, 2005, NATURE, V434, P158, DOI 10.1038/434158a; Macknik SL, 1999, P NATL ACAD SCI USA, V96, P15208, DOI 10.1073/pnas.96.26.15208; Serences JT, 2009, PSYCHOL SCI, V20, P207, DOI 10.1111/j.1467-9280.2009.02276.x; Slotnick SD, 2005, CEREB CORTEX, V15, P1570, DOI 10.1093/cercor/bhi035; Staeren N, 2009, CURR BIOL, V19, P498, DOI 10.1016/j.cub.2009.01.066; Thirion B, 2006, NEUROIMAGE, V33, P1104, DOI 10.1016/j.neuroimage.2006.06.062; Watkins S, 2006, NEUROIMAGE, V31, P1247, DOI 10.1016/j.neuroimage.2006.01.016; Zatorre RJ, 2005, NEURON, V47, P9, DOI 10.1016/j.neuron.2005.06.013	15	85	85	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2010	13	6					667	668		10.1038/nn.2533	http://dx.doi.org/10.1038/nn.2533			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	600QY	20436482				2022-12-24	WOS:000278003300009
J	Urbach, A; Bar-Nur, O; Daley, GQ; Benvenisty, N				Urbach, Achia; Bar-Nur, Ori; Daley, George Q.; Benvenisty, Nissim			Differential Modeling of Fragile X Syndrome by Human Embryonic Stem Cells and Induced Pluripotent Stem Cells	CELL STEM CELL			English	Article							FMR1 GENE; METHYLATION; INSTABILITY; DISEASE; ALLELE; GENERATION; LENGTH		[Urbach, Achia; Daley, George Q.] Childrens Hosp, Howard Hughes Med Inst, Manton Ctr Orphan Dis Res, Stem Cell Transplantat Program,Div Pediat Hematol, Boston, MA 02115 USA; [Urbach, Achia; Daley, George Q.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Urbach, Achia; Daley, George Q.] Brigham & Womens Hosp, Div Hematol, Boston, MA 02115 USA; [Bar-Nur, Ori; Benvenisty, Nissim] Hebrew Univ Jerusalem, Dept Genet, Inst Life Sci, Stem Cell Unit, IL-91904 Jerusalem, Israel; [Urbach, Achia; Daley, George Q.] Harvard Univ, Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Urbach, Achia; Daley, George Q.] Harvard Stem Cell Inst, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Hebrew University of Jerusalem; Harvard University; Harvard Medical School; Harvard University	Daley, GQ (corresponding author), Childrens Hosp, Howard Hughes Med Inst, Manton Ctr Orphan Dis Res, Stem Cell Transplantat Program,Div Pediat Hematol, Boston, MA 02115 USA.	george.daley@childrens.harvard.edu; nissimb@cc.huji.ac.il	/GLR-9975-2022; Bar-Nur, Ori/GWQ-5917-2022	Urbach, Achia/0000-0001-9393-4504	Israel Science Foundation [227/06]; European Community [018739]; Legacy Heritage Fund of New York; National Institutes of Health; Howard Hughes Medical Institute; Manton Center for Orphan Disease Research; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK070055] Funding Source: NIH RePORTER	Israel Science Foundation(Israel Science Foundation); European Community(European Commission); Legacy Heritage Fund of New York; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Manton Center for Orphan Disease Research; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We would like to thank Tamar Lev-Golan and Inbal Caspi for technical assistance and Phil Manos for help with IHC. A.U. is an EMBO fellow. N.B. is the Herbert Cohn Chair in Cancer Research. This research was partially supported by funds from the Israel Science Foundation (Grant number 227/06) and the European Community (ESTOOLS, Grant number 018739). We gratefully acknowledge support for this project provided by a grant from the Legacy Heritage Fund of New York. G.Q.D. was supported by grants from the National Institutes of Health, the Howard Hughes Medical Institute, and the Manton Center for Orphan Disease Research. G.Q.D. is a member of the Scientific Advisory Boards of iPierian, Inc., Epizyme, and MPM Capital.	Amabile G, 2009, TRENDS MOL MED, V15, P59, DOI 10.1016/j.molmed.2008.12.003; Baker DEC, 2007, NAT BIOTECHNOL, V25, P207, DOI 10.1038/nbt1285; Belmonte JCI, 2009, NAT REV GENET, V10, P878, DOI 10.1038/nrg2700; Bontekoe CJM, 1997, EUR J HUM GENET, V5, P293, DOI 10.1159/000484780; Brakensiek K, 2007, CLIN CHEM, V53, P17, DOI 10.1373/clinchem.2007.072629; Burman RW, 1999, HUM MOL GENET, V8, P2293, DOI 10.1093/hmg/8.12.2293; Burman RW, 1999, AM J HUM GENET, V65, P1375, DOI 10.1086/302628; Chan EM, 2009, NAT BIOTECHNOL, V27, P1033, DOI 10.1038/nbt.1580; Coffee B, 2002, AM J HUM GENET, V71, P923, DOI 10.1086/342931; Coffee B, 1999, NAT GENET, V22, P98, DOI 10.1038/8807; Crawford DC, 2001, GENET MED, V3, P359, DOI 10.1097/00125817-200109000-00006; Daley GQ, 2009, CELL STEM CELL, V4, P200, DOI 10.1016/j.stem.2009.02.009; Dupont JM, 2004, ANAL BIOCHEM, V333, P119, DOI 10.1016/j.ab.2004.05.007; Eiges R, 2007, CELL STEM CELL, V1, P568, DOI 10.1016/j.stem.2007.09.001; Lavedan CN, 1997, HUM GENET, V100, P407, DOI 10.1007/s004390050525; Lefort N, 2008, NAT BIOTECHNOL, V26, P1364, DOI 10.1038/nbt.1509; Lengerke C, 2009, ANN NY ACAD SCI, V1176, P191, DOI 10.1111/j.1749-6632.2009.04962.x; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Maitra A, 2005, NAT GENET, V37, P1099, DOI 10.1038/ng1631; Muller LUW, 2009, MOL THER, V17, P947, DOI 10.1038/mt.2009.72; Nishikawa S, 2008, NAT REV MOL CELL BIO, V9, P725, DOI 10.1038/nrm2466; O'Donnell WT, 2002, ANNU REV NEUROSCI, V25, P315, DOI 10.1146/annurev.neuro.25.112701.142909; OBERLE I, 1991, SCIENCE, V252, P1097, DOI 10.1126/science.252.5009.1097; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Park IH, 2008, NAT PROTOC, V3, P1180, DOI 10.1038/nprot.2008.92; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Pearson CE, 2005, NAT REV GENET, V6, P729, DOI 10.1038/nrg1689; Pietrobono R, 2005, HUM MOL GENET, V14, P267, DOI 10.1093/hmg/ddi024; Rousseau Francois, 1992, Human Mutation, V1, P91, DOI 10.1002/humu.1380010202; Schuldiner M, 2000, P NATL ACAD SCI USA, V97, P11307, DOI 10.1073/pnas.97.21.11307; Shaw RJ, 2006, BRIT J CANCER, V94, P561, DOI 10.1038/sj.bjc.6602972; Spits C, 2008, NAT BIOTECHNOL, V26, P1361, DOI 10.1038/nbt.1510; Stoyanova V, 2004, FASEB J, V18, P1964, DOI 10.1096/fj.04-2499fje; Sutcliffe James S., 1992, Human Molecular Genetics, V1, P397, DOI 10.1093/hmg/1.6.397; Tabolacci E, 2005, EUR J HUM GENET, V13, P641, DOI 10.1038/sj.ejhg.5201393; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tost J, 2007, NAT PROTOC, V2, P2265, DOI 10.1038/nprot.2007.314; Urbach A, 2004, STEM CELLS, V22, P635, DOI 10.1634/stemcells.22-4-635; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; Willemsen R, 2002, HUM GENET, V110, P601, DOI 10.1007/s00439-002-0723-5; Wohrle D, 2001, AM J HUM GENET, V69, P504, DOI 10.1086/322739; Wong HL, 2006, BIOTECHNIQUES, V41, P734, DOI 10.2144/000112305; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	44	306	318	0	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAY 7	2010	6	5					407	411		10.1016/j.stem.2010.04.005	http://dx.doi.org/10.1016/j.stem.2010.04.005			5	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	598NO	20452313	Bronze, Green Accepted			2022-12-24	WOS:000277844800006
J	Luna, VM; Pettit, DL				Luna, Victor M.; Pettit, Diana L.			Asymmetric rostro-caudal inhibition in the primary olfactory cortex	NATURE NEUROSCIENCE			English	Article							PIRIFORM CORTEX; STIMULUS SELECTIVITY; CELLS	The importance of intracortical inhibitory circuits in setting the feature-selective spatial organization of primary sensory cortices remains controversial. To address this issue, we examined the strength of interneuron-to-pyramidal cell connections across the rat anterior piriform cortex (aPC) and found a pronounced gradient of increasing pyramidal cell inhibition along the aPC rostro-caudal axis. This functional heterogeneity could govern aPC spatial activation in response to varying odor identities and features.	[Luna, Victor M.; Pettit, Diana L.] Yeshiva Univ, Albert Einstein Coll Med, Dept Neurosci, New York, NY 10033 USA	Yeshiva University	Pettit, DL (corresponding author), Yeshiva Univ, Albert Einstein Coll Med, Dept Neurosci, New York, NY 10033 USA.	diana.pettit@einstein.yu.edu			National Institutes of Health [NS 044399]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS044399] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank Drs. Adam Kohn, Scott Nawy and Ellen Yang for helpful input on the manuscript. This work was supported by the National Institutes of Health (NS 044399).	Ekstrand JJ, 2001, J COMP NEUROL, V434, P308; Hirsch JA, 1998, J NEUROSCI, V18, P9517; Johnson BA, 2007, J COMP NEUROL, V503, P1, DOI 10.1002/cne.21396; Loscher W, 1998, BRAIN RES, V800, P21, DOI 10.1016/S0006-8993(98)00488-0; Luna VM, 2008, J NEUROSCI, V28, P8851, DOI 10.1523/JNEUROSCI.2385-08.2008; Neville K.R., 2004, SYNAPTIC ORG BRAIN, P415, DOI DOI 10.1093/ACPR0F:0S0/9780195159561.003.0010; Poo C, 2009, NEURON, V62, P850, DOI 10.1016/j.neuron.2009.05.022; Priebe NJ, 2008, NEURON, V57, P482, DOI 10.1016/j.neuron.2008.02.005; Sugai T, 2005, NEUROSCIENCE, V130, P769, DOI 10.1016/j.neuroscience.2004.09.059; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116; Wilent WB, 2005, NAT NEUROSCI, V8, P1364, DOI 10.1038/nn1545	11	30	30	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2010	13	5					533	535		10.1038/nn.2524	http://dx.doi.org/10.1038/nn.2524			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	588JM	20348915	Green Accepted			2022-12-24	WOS:000277065700008
J	Baliki, MN; Geha, PY; Fields, HL; Apkarian, AV				Baliki, Marwan N.; Geha, Paul Y.; Fields, Howard L.; Apkarian, A. Vania			Predicting Value of Pain and Analgesia: Nucleus Accumbens Response to Noxious Stimuli Changes in the Presence of Chronic Pain	NEURON			English	Article							VENTRAL TEGMENTAL AREA; MIDBRAIN DOPAMINERGIC-NEURONS; AVERSIVE STIMULI; HUMAN BRAIN; POSITIVE REINFORCEMENT; SUBSTANTIA-NIGRA; REWARD; ACTIVATION; PERCEPTION; INHIBITION	We compared brain activations in response to acute noxious thermal stimuli in controls and chronic back pain (CBP) patients. Pain perception and related cortical activation patterns were similar in the two groups. However, nucleus accumbens (NAc) activity differentiated the groups at a very high accuracy, exhibiting phasic and tonic responses with distinct properties. Positive phasic NAc activations at stimulus onset and offset tracked stimulus salience and, in normal subjects, predicted reward (pain relief) magnitude at stimulus offset. In CBP, NAc activity correlated with different cortical circuitry from that of normals and phasic activity at stimulus offset was negative in polarity, suggesting that the acute pain relieves the ongoing back pain. The relieving effect was confirmed in a separate psychophysical study in CBP. Therefore, in contrast to somatosensory pathways, which reflect sensory properties of acute noxious stimuli, NAc activity in humans encodes its predicted value and anticipates its analgesic potential on chronic pain.	[Baliki, Marwan N.; Geha, Paul Y.; Apkarian, A. Vania] Northwestern Univ, Feinberg Sch Med, Dept Physiol, Chicago, IL 60611 USA; [Apkarian, A. Vania] Northwestern Univ, Feinberg Sch Med, Dept Anesthesia, Chicago, IL 60611 USA; [Apkarian, A. Vania] Northwestern Univ, Feinberg Sch Med, Dept Surg, Chicago, IL 60611 USA; [Apkarian, A. Vania] Northwestern Univ, Feinberg Sch Med, Rehabil Inst Chicago, Chicago, IL 60611 USA; [Fields, Howard L.] Univ Calif San Francisco, Dept Neurol, Emeryville, CA 94608 USA; [Fields, Howard L.] Univ Calif San Francisco, Ernest Gallo Clin & Res Ctr, Emeryville, CA 94608 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Shirley Ryan AbilityLab; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Ernest Gallo Clinic & Research Center	Apkarian, AV (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Physiol, 303 E Chicago Ave,Ward 4-334, Chicago, IL 60611 USA.	a-apkarian@northwestern.edu	Fields, Howard/ABG-9073-2020	Geha, Paul/0000-0002-0537-7216; Apkarian, A. Vania/0000-0002-9788-7458	NIH, NINDS [NS 35115]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035115] Funding Source: NIH RePORTER	NIH, NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to dedicate this study to the memory of Prof. Oscar Calvo who recently passed away. He made these experiments possible by building the thermal stimulator as well as parts of the finger-span device. We also thank all patients and healthy subjects for volunteering their time for this study. We are grateful for the technical help provided by Maria Virginia Centeno, Rami Jabakhanji, and Prof. Dante Chialvo. The study was funded by an NIH grant, NINDS NS 35115.	Ambroggi F, 2008, NEURON, V59, P648, DOI 10.1016/j.neuron.2008.07.004; Apkarian AV, 2009, PROG NEUROBIOL, V87, P81, DOI 10.1016/j.pneurobio.2008.09.018; Apkarian AV, 2008, CURR OPIN NEUROBIOL, V18, P464, DOI 10.1016/j.conb.2008.09.012; Apkarian AV, 2005, EUR J PAIN, V9, P463, DOI 10.1016/j.ejpain.2004.11.001; Baliki MN, 2009, J NEUROPHYSIOL, V101, P875, DOI 10.1152/jn.91100.2008; Baliki MN, 2008, J NEUROSCI, V28, P1398, DOI 10.1523/JNEUROSCI.4123-07.2008; Baliki MN, 2006, J NEUROSCI, V26, P12165, DOI 10.1523/JNEUROSCI.3576-06.2006; Bassareo V, 2002, J NEUROSCI, V22, P4709, DOI 10.1523/JNEUROSCI.22-11-04709.2002; Becerra L, 2001, NEURON, V32, P927, DOI 10.1016/S0896-6273(01)00533-5; Becerra L, 2008, EUR J PAIN, V12, P866, DOI 10.1016/j.ejpain.2007.12.007; Berridge KC, 2007, PSYCHOPHARMACOLOGY, V191, P391, DOI 10.1007/s00213-006-0578-x; Brischoux F, 2009, P NATL ACAD SCI USA, V106, P4894, DOI 10.1073/pnas.0811507106; Carlezon WA, 2009, NEUROPHARMACOLOGY, V56, P122, DOI 10.1016/j.neuropharm.2008.06.075; Coizet V, 2006, NEUROSCIENCE, V139, P1479, DOI 10.1016/j.neuroscience.2006.01.030; Delgado MR, 2008, PHILOS T R SOC B, V363, P3787, DOI 10.1098/rstb.2008.0161; Fields H, 2004, NAT REV NEUROSCI, V5, P565, DOI 10.1038/nrn1431; Fields H., 2006, P 11 WORLD C PAIN SE, P449; Fields HL, 2007, ANNU REV NEUROSCI, V30, P289, DOI 10.1146/annurev.neuro.30.051606.094341; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Glimcher PW, 2009, NEUROECONOMICS: DECISION MAKING AND THE BRAIN, P1; Glimcher PW, 2003, BRADFORD BOOKS, P1; GOEDERS NE, 1983, SCIENCE, V221, P773, DOI 10.1126/science.6879176; Harris RE, 2007, J NEUROSCI, V27, P10000, DOI 10.1523/JNEUROSCI.2849-07.2007; Horvitz JC, 2000, NEUROSCIENCE, V96, P651, DOI 10.1016/S0306-4522(00)00019-1; Jensen J, 2003, NEURON, V40, P1251, DOI 10.1016/S0896-6273(03)00724-4; Jensen J, 2007, HUM BRAIN MAPP, V28, P294, DOI 10.1002/hbm.20274; Johansen JP, 2004, NAT NEUROSCI, V7, P398, DOI 10.1038/nn1207; Joshua M, 2008, J NEUROSCI, V28, P11673, DOI 10.1523/JNEUROSCI.3839-08.2008; KALIVAS PW, 1995, BRAIN RES, V675, P325, DOI 10.1016/0006-8993(95)00013-G; Kriegeskorte N, 2009, NAT NEUROSCI, V12, P535, DOI 10.1038/nn.2303; Liu ZH, 2008, NEUROPSYCHOPHARMACOL, V33, P3010, DOI 10.1038/npp.2008.4; MAEDA H, 1982, BRAIN RES BULL, V8, P7, DOI 10.1016/0361-9230(82)90021-1; MEYER RA, 2006, PERIPHERAL MECH CUTA; MILLER G, 2009, SCIENCE, V324, P335; MILNER PM, 1991, CAN J PSYCHOL, V45, P1, DOI 10.1037/h0084275; Mirenowicz J, 1996, NATURE, V379, P449, DOI 10.1038/379449a0; Montague PR, 2006, ANNU REV NEUROSCI, V29, P417, DOI 10.1146/annurev.neuro.29.051605.112903; Montague PR, 2002, NEURON, V36, P265, DOI 10.1016/S0896-6273(02)00974-1; Montague PR, 1996, J NEUROSCI, V16, P1936, DOI 10.1523/jneurosci.16-05-01936.1996; Niva Y, 2007, ANN NY ACAD SCI, V1104, P357, DOI 10.1196/annals.1390.018; O'Doherty JP, 2004, CURR OPIN NEUROBIOL, V14, P769, DOI 10.1016/j.conb.2004.10.016; OLDS J, 1954, J COMP PHYSIOL PSYCH, V47, P419, DOI 10.1037/h0058775; Platt ML, 2008, NAT NEUROSCI, V11, P398, DOI 10.1038/nn2062; Poldrack RA, 2009, SOC COGN AFFECT NEUR, V4, P208, DOI 10.1093/scan/nsp011; Rolls E. T., 2005, EMOTION EXPLAINED; Salamone JD, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.013.2009; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; SCHULTZ W, 1990, J NEUROPHYSIOL, V63, P607, DOI 10.1152/jn.1990.63.3.607; Schultz W, 2006, ANNU REV PSYCHOL, V57, P87, DOI 10.1146/annurev.psych.56.091103.070229; SCHULTZ W, 1987, J NEUROPHYSIOL, V57, P201, DOI 10.1152/jn.1987.57.1.201; Schultz W, 2007, ANNU REV NEUROSCI, V30, P259, DOI 10.1146/annurev.neuro.28.061604.135722; Scott DJ, 2007, NEURON, V55, P325, DOI 10.1016/j.neuron.2007.06.028; Scott DJ, 2006, J NEUROSCI, V26, P10789, DOI 10.1523/JNEUROSCI.2577-06.2006; Seymour B, 2004, NATURE, V429, P664, DOI 10.1038/nature02581; Seymour B, 2005, NAT NEUROSCI, V8, P1234, DOI 10.1038/nn1527; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Sutton R.S., 1998, INTRO REINFORCEMENT, DOI [10.1109/TNN.1998.712192, DOI 10.1109/TNN.1998.712192]; TSAI CT, 1980, BRAIN RES, V195, P299, DOI 10.1016/0006-8993(80)90066-9; Ungless MA, 2004, SCIENCE, V303, P2040, DOI 10.1126/science.1093360; YOUNG AMJ, 1993, NEUROSCIENCE, V54, P5, DOI 10.1016/0306-4522(93)90378-S; Zubieta JK, 2005, J NEUROSCI, V25, P7754, DOI 10.1523/JNEUROSCI.0439-05.2005	61	370	377	0	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 15	2010	66	1					149	160		10.1016/j.neuron.2010.03.002	http://dx.doi.org/10.1016/j.neuron.2010.03.002			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	587TP	20399736	Green Accepted, Bronze			2022-12-24	WOS:000277016200016
J	Rothschild, G; Nelken, I; Mizrahi, A				Rothschild, Gideon; Nelken, Israel; Mizrahi, Adi			Functional organization and population dynamics in the mouse primary auditory cortex	NATURE NEUROSCIENCE			English	Article							IN-VIVO; VISUAL-CORTEX; TONOTOPIC ORGANIZATION; SINGLE NEURONS; FREQUENCY; RAT; REPRESENTATION; RECORDINGS; RESPONSES; MICROARCHITECTURE	Cortical processing of auditory stimuli involves large populations of neurons with distinct individual response profiles. However, the functional organization and dynamics of local populations in the auditory cortex have remained largely unknown. Using in vivo two-photon calcium imaging, we examined the response profiles and network dynamics of layer 2/3 neurons in the primary auditory cortex (A1) of mice in response to pure tones. We found that local populations in A1 were highly heterogeneous in the large-scale tonotopic organization. Despite the spatial heterogeneity, the tendency of neurons to respond together ( measured as noise correlation) was high on average. This functional organization and high levels of noise correlations are consistent with the existence of partially overlapping cortical subnetworks. Our findings may account for apparent discrepancies between ordered large-scale organization and local heterogeneity.	[Rothschild, Gideon; Nelken, Israel; Mizrahi, Adi] Hebrew Univ Jerusalem, Inst Life Sci, Dept Neurobiol, IL-91904 Jerusalem, Israel; [Rothschild, Gideon; Nelken, Israel; Mizrahi, Adi] Hebrew Univ Jerusalem, Interdisciplinary Ctr Neural Computat, Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem	Mizrahi, A (corresponding author), Hebrew Univ Jerusalem, Inst Life Sci, Dept Neurobiol, IL-91904 Jerusalem, Israel.	mizrahia@cc.huji.ac.il	Nelken, Israel/B-7753-2011	Nelken, Israel/0000-0002-6645-107X	Citizens United for Research in Epilepsy; European Research Council [203994]; European Union	Citizens United for Research in Epilepsy; European Research Council(European Research Council (ERC)European Commission); European Union(European Commission)	We thank H. Sompolinsky and E. Zohary for critically commenting on early versions of this manuscript. We thank N. Taaseh and A. Yaron-Jakoubovitch for their kind technical assistance during the early stages of this project. We thank Y. Rubin and J. Schiller for the software module of the line scan. We thank J. Linden for her help on cortical recordings in mice. We thank all the members of the Mizrahi laboratory and A. Eban-Rothschild for their helpful comments and discussions. This work was supported in part by a grant from Citizens United for Research in Epilepsy and by a European Research Council grant to A. M. (#203994), and by a grant of the European Union FP6 to I. N. (NOVELTUNE consortium).	ABELES M, 1970, J NEUROPHYSIOL, V33, P172, DOI 10.1152/jn.1970.33.1.172; Averbeck BB, 2006, NAT REV NEUROSCI, V7, P358, DOI 10.1038/nrn1888; Bizley JK, 2005, CEREB CORTEX, V15, P1637, DOI 10.1093/cercor/bhi042; Chakraborty S, 2007, EXP BRAIN RES, V182, P491, DOI 10.1007/s00221-007-1008-y; Chechik G, 2006, NEURON, V51, P359, DOI 10.1016/j.neuron.2006.06.030; Cohen MR, 2008, NEURON, V60, P162, DOI 10.1016/j.neuron.2008.08.007; DeWeese MR, 2003, J NEUROSCI, V23, P7940; EVANS EF, 1965, J PHYSIOL-LONDON, V179, P238, DOI 10.1113/jphysiol.1965.sp007659; GOLDSTEIN MH, 1970, J NEUROPHYSIOL, V33, P188, DOI 10.1152/jn.1970.33.1.188; Greenberg DS, 2008, NAT NEUROSCI, V11, P749, DOI 10.1038/nn.2140; Henze DA, 2000, J NEUROPHYSIOL, V84, P390, DOI 10.1152/jn.2000.84.1.390; Holmgren C, 2003, J PHYSIOL-LONDON, V551, P139, DOI 10.1113/jphysiol.2003.044784; Houweling AR, 2008, NATURE, V451, P65, DOI 10.1038/nature06447; Hromadka T, 2008, PLOS BIOL, V6, P124, DOI 10.1371/journal.pbio.0060016; Kerr JND, 2005, P NATL ACAD SCI USA, V102, P14063, DOI 10.1073/pnas.0506029102; Kilgard MP, 1999, HEARING RES, V134, P16, DOI 10.1016/S0378-5955(99)00061-1; Kisley MA, 1999, J NEUROSCI, V19, P10451; Komai S, 2006, NAT PROTOC, V1, P648, DOI 10.1038/nprot.2006.100; Linden JF, 2003, J NEUROPHYSIOL, V90, P2660, DOI 10.1152/jn.00751.2002; Llano DA, 2008, J COMP NEUROL, V507, P1209, DOI 10.1002/cne.21602; Margrie TW, 2002, PFLUG ARCH EUR J PHY, V444, P491, DOI 10.1007/s00424-002-0831-z; MERZENICH MM, 1975, J NEUROPHYSIOL, V38, P231, DOI 10.1152/jn.1975.38.2.231; Moshitch D, 2006, J NEUROPHYSIOL, V95, P3756, DOI 10.1152/jn.00822.2005; Mrsic-Flogel TD, 2006, EUR J NEUROSCI, V23, P780, DOI 10.1111/j.1460-9568.2006.04609.x; Mrsic-Flogel TD, 2007, NEURON, V54, P961, DOI 10.1016/j.neuron.2007.05.028; Nelken I, 2004, J NEUROPHYSIOL, V92, P2574, DOI 10.1152/jn.00276.2004; Ohki K, 2005, NATURE, V433, P597, DOI 10.1038/nature03274; Ohki K, 2006, NATURE, V442, P925, DOI 10.1038/nature05019; Philibert B, 2005, J COMP NEUROL, V487, P391, DOI 10.1002/cne.20581; REALE RA, 1980, J COMP NEUROL, V192, P265, DOI 10.1002/cne.901920207; Recanzone GH, 2000, J NEUROPHYSIOL, V83, P2315, DOI 10.1152/jn.2000.83.4.2315; Sadagopan S, 2008, J NEUROSCI, V28, P3415, DOI 10.1523/JNEUROSCI.2743-07.2008; Sadagopan S, 2009, J NEUROSCI, V29, P11192, DOI 10.1523/JNEUROSCI.1286-09.2009; SALLY SL, 1988, J NEUROPHYSIOL, V59, P1627, DOI 10.1152/jn.1988.59.5.1627; Sato TR, 2007, PLOS BIOL, V5, P1440, DOI 10.1371/journal.pbio.0050189; Schneidman E, 2006, NATURE, V440, P1007, DOI 10.1038/nature04701; SCHREINER CE, 1992, J NEUROPHYSIOL, V68, P1487, DOI 10.1152/jn.1992.68.5.1487; Schulze H, 1997, J COMP PHYSIOL A, V181, P651, DOI 10.1007/s003590050147; Sohya K, 2007, J NEUROSCI, V27, P2145, DOI 10.1523/JNEUROSCI.4641-06.2007; Sompolinsky H, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.051904; Song S, 2005, PLOS BIOL, V3, P507, DOI 10.1371/journal.pbio.0030068; Stiebler I, 1997, J COMP PHYSIOL A, V181, P559, DOI 10.1007/s003590050140; Stosiek C, 2003, P NATL ACAD SCI USA, V100, P7319, DOI 10.1073/pnas.1232232100; Thomson AM, 2002, CEREB CORTEX, V12, P936, DOI 10.1093/cercor/12.9.936; Wallace DJ, 2008, NAT METHODS, V5, P797, DOI 10.1038/NMETH.1242; Wang XQ, 2005, NATURE, V435, P341, DOI 10.1038/nature03565; Yoshimura Y, 2005, NATURE, V433, P868, DOI 10.1038/nature03252; ZOHARY E, 1994, NATURE, V370, P140, DOI 10.1038/370140a0; ZURITA P, 1994, NEUROSCI RES, V19, P303, DOI 10.1016/0168-0102(94)90043-4	49	242	246	2	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2010	13	3					353	U21		10.1038/nn.2484	http://dx.doi.org/10.1038/nn.2484			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	559WW	20118927				2022-12-24	WOS:000274860100018
J	Lei, HM; Mooney, R				Lei, Huimeng; Mooney, Richard			Manipulation of a Central Auditory Representation Shapes Learned Vocal Output	NEURON			English	Article							ADULT ZEBRA FINCHES; GANGLIA-FOREBRAIN CIRCUIT; IDENTIFIED HVC NEURONS; AVIAN SONG SYSTEM; ANTERIOR FOREBRAIN; NEURAL ACTIVITY; NUCLEUS HVC; BEHAVIORAL STATE; ERROR-CORRECTION; SYNAPTIC BASIS	Learned vocalizations depend on the ear's ability to monitor and ultimately instruct the voice. Where is auditory feedback processed in the brain, and how does it modify motor networks for learned vocalizations? Here we addressed these questions using singing-triggered microstimulation and chronic recording methods in the singing zebra finch, a small songbird that relies on auditory feedback to learn and maintain its species-typical vocalizations. Manipulating the singing-related activity of feedback-sensitive thalamic neurons subsequently triggered vocal plasticity, constraining the central pathway and functional mechanisms through which feed back-related information shapes vocalization.	[Lei, Huimeng; Mooney, Richard] Duke Univ, Sch Med, Dept Neurobiol, Durham, NC 27710 USA	Duke University	Mooney, R (corresponding author), Duke Univ, Sch Med, Dept Neurobiol, Durham, NC 27710 USA.	mooney@neuro.duke.edu		Mooney, Richard/0000-0002-3308-1367	NIH [DC02524]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC002524] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank Drs. M. Ehlers, D. Fitzpatrick, W. Grill, S. Shea, S. Nowicki, and members of the Mooney Lab for their comments on earlier versions of this manuscript. We also thank E. Tumer, M. Brainard, and S. Saar for technical assistance. These studies were supported by grant NIH DC02524 (to R.M.).	Andalman AS, 2009, P NATL ACAD SCI USA, V106, P12518, DOI 10.1073/pnas.0903214106; Bauer EE, 2008, J NEUROSCI, V28, P1509, DOI 10.1523/JNEUROSCI.3838-07.2008; BOTTJER SW, 1984, SCIENCE, V224, P901, DOI 10.1126/science.6719123; Brainard MS, 2000, NAT REV NEUROSCI, V1, P31, DOI 10.1038/35036205; Brainard MS, 2000, NATURE, V404, P762, DOI 10.1038/35008083; BRENOWITZ EA, 1991, SCIENCE, V251, P303, DOI 10.1126/science.1987645; Burt JM, 2000, J NEUROBIOL, V42, P1, DOI 10.1002/(SICI)1097-4695(200001)42:1<1::AID-NEU1>3.0.CO;2-6; Cardin JA, 2005, J NEUROPHYSIOL, V93, P2157, DOI 10.1152/jn.01001.2004; Cardin JA, 2004, J NEUROPHYSIOL, V91, P2148, DOI 10.1152/jn.00918.2003; Cardin JA, 2003, J NEUROPHYSIOL, V90, P2884, DOI 10.1152/jn.00391.2003; Cohen DA, 2005, P NATL ACAD SCI USA, V102, P18237, DOI 10.1073/pnas.0506072102; Coleman MJ, 2007, J NEUROSCI, V27, P10024, DOI 10.1523/JNEUROSCI.2215-07.2007; Coleman MJ, 2005, J NEUROBIOL, V63, P70, DOI 10.1002/neu.20122; Coleman MJ, 2004, J NEUROSCI, V24, P7251, DOI 10.1523/JNEUROSCI.0947-04.2004; CYNX J, 1992, P NATL ACAD SCI USA, V89, P1372, DOI 10.1073/pnas.89.4.1372; Dave AS, 1998, SCIENCE, V282, P2250, DOI 10.1126/science.282.5397.2250; Deregnaucourt S, 2005, NATURE, V433, P710, DOI 10.1038/nature03275; DOUPE AJ, 1991, P NATL ACAD SCI USA, V88, P11339, DOI 10.1073/pnas.88.24.11339; Doupe AJ, 1997, J NEUROSCI, V17, P1147; Doupe AJ, 1999, ANNU REV NEUROSCI, V22, P567, DOI 10.1146/annurev.neuro.22.1.567; Farries MA, 2002, J NEUROSCI, V22, P3776; FORTUNE ES, 1995, J COMP NEUROL, V360, P413, DOI 10.1002/cne.903600305; Gale SD, 2006, J NEUROPHYSIOL, V96, P2295, DOI 10.1152/jn.01040.2005; Gentner TQ, 2003, NATURE, V424, P669, DOI 10.1038/nature01731; Gentner TQ, 2000, J NEUROBIOL, V42, P117, DOI 10.1002/(SICI)1097-4695(200001)42:1<117::AID-NEU11>3.0.CO;2-M; Hessler NA, 1999, NAT NEUROSCI, V2, P209, DOI 10.1038/6306; Hessler NA, 1999, J NEUROSCI, V19, P10461; Kao MH, 2005, NATURE, V433, P638, DOI 10.1038/nature03127; Kao MH, 2006, J NEUROPHYSIOL, V96, P1441, DOI 10.1152/jn.01138.2005; KATZ LC, 1981, BRAIN RES, V221, P192, DOI 10.1016/0006-8993(81)91073-8; Keller GB, 2009, NATURE, V457, P187, DOI 10.1038/nature07467; Konishi M., 1965, Zeitschrift fuer Tierpsychologie, V22, P770; Konishi M, 1965, Z Tierpsychol, V22, P584; Kozhevnikov AA, 2007, J NEUROPHYSIOL, V97, P4271, DOI 10.1152/jn.00952.2006; Leonardo A, 2004, P NATL ACAD SCI USA, V101, P16935, DOI 10.1073/pnas.0407870101; Leonardo A, 1999, NATURE, V399, P466, DOI 10.1038/20933; LEWIS JW, 1981, J COMP NEUROL, V196, P347, DOI 10.1002/cne.901960212; Lombardino AJ, 2000, J NEUROSCI, V20, P5054; MARGOLIASH D, 1985, P NATL ACAD SCI USA, V82, P5997, DOI 10.1073/pnas.82.17.5997; MARGOLIASH D, 1983, J NEUROSCI, V3, P1039; MARLER P, 1981, SCIENCE, V213, P780, DOI 10.1126/science.213.4509.780; MCCASLAND JS, 1981, P NATL ACAD SCI-BIOL, V78, P7815, DOI 10.1073/pnas.78.12.7815; Mooney R, 2005, J NEUROSCI, V25, P1952, DOI 10.1523/JNEUROSCI.3726-04.2005; Mooney R, 2000, J NEUROSCI, V20, P5420, DOI 10.1523/JNEUROSCI.20-14-05420.2000; Nick TA, 2001, P NATL ACAD SCI USA, V98, P14012, DOI 10.1073/pnas.251525298; NORDEEN KW, 1992, BEHAV NEURAL BIOL, V57, P58, DOI 10.1016/0163-1047(92)90757-U; NOTTEBOHM F, 1976, J COMP NEUROL, V165, P457, DOI 10.1002/cne.901650405; NOTTEBOHM F, 1982, J COMP NEUROL, V207, P344, DOI 10.1002/cne.902070406; OKUHATA S, 1987, BRAIN RES BULL, V18, P35, DOI 10.1016/0361-9230(87)90031-1; Olveczky BP, 2005, PLOS BIOL, V3, P902, DOI 10.1371/journal.pbio.0030153; Prather JF, 2008, NATURE, V451, P305, DOI 10.1038/nature06492; Prather JF, 2009, NAT NEUROSCI, V12, P221, DOI 10.1038/nn.2246; PRICE PH, 1979, J COMP PHYSIOL PSYCH, V93, P260, DOI 10.1037/h0077553; Rauske PL, 2003, J NEUROPHYSIOL, V89, P1688, DOI 10.1152/jn.00655.2002; Rosen MJ, 2006, J NEUROPHYSIOL, V95, P1158, DOI 10.1152/jn.00100.2005; Rosen MJ, 2003, NEURON, V39, P177, DOI 10.1016/S0896-6273(03)00357-X; Roy A, 2007, J NEUROSCI, V27, P6374, DOI 10.1523/JNEUROSCI.0894-07.2007; Roy A, 2009, J NEUROPHYSIOL, V102, P979, DOI 10.1152/jn.00293.2009; Sakata JT, 2008, J NEUROSCI, V28, P11378, DOI 10.1523/JNEUROSCI.3254-08.2008; Scharff C, 1998, J NEUROBIOL, V36, P81, DOI 10.1002/(SICI)1097-4695(199807)36:1<81::AID-NEU7>3.3.CO;2-8; SCHARFF C, 1991, J NEUROSCI, V11, P2896; Sober SJ, 2009, NAT NEUROSCI, V12, P927, DOI 10.1038/nn.2336; Theunissen FE, 1998, J NEUROSCI, V18, P3786; Troyer TW, 2000, J NEUROPHYSIOL, V84, P1204, DOI 10.1152/jn.2000.84.3.1204; Tumer EC, 2007, NATURE, V450, P1240, DOI 10.1038/nature06390; Vates GE, 1996, J COMP NEUROL, V366, P613, DOI 10.1002/(SICI)1096-9861(19960318)366:4<613::AID-CNE5>3.0.CO;2-7; Walker MP, 2002, NEURON, V35, P205, DOI 10.1016/S0896-6273(02)00746-8; Williams H, 1999, J NEUROBIOL, V39, P14, DOI 10.1002/(SICI)1097-4695(199904)39:1<14::AID-NEU2>3.0.CO;2-X	68	20	21	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 14	2010	65	1					122	134		10.1016/j.neuron.2009.12.008	http://dx.doi.org/10.1016/j.neuron.2009.12.008			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	546DZ	20152118	Green Accepted, Bronze			2022-12-24	WOS:000273791200013
J	Sit, YF; Chen, YZ; Geisler, WS; Miikkulainen, R; Seidemann, E				Sit, Yiu Fai; Chen, Yuzhi; Geisler, Wilson S.; Miikkulainen, Risto; Seidemann, Eyal			Complex Dynamics of V1 Population Responses Explained by a Simple Gain-Control Model	NEURON			English	Article							HORIZONTAL SYNAPTIC CONNECTIONS; VISUAL-CORTEX NEURONS; STRIATE CORTEX; SIMPLE CELLS; SPATIAL SUMMATION; TEMPORAL PHASE; MACAQUE MONKEY; FIELD SIZE; CAT; ORIENTATION	To understand sensory encoding and decoding, it is essential to characterize the dynamics of population responses in sensory cortical areas. Using voltage-sensitive dye imaging in awake, fixating monkeys, we obtained complete quantitative measurements of the spatiotemporal dynamics of V1 responses over the entire region activated by small, briefly presented stimuli. The responses exhibit several complex properties: they begin to rise approximately simultaneously over the entire active region, but reach their peak more rapidly at the center. However, at stimulus offset the responses fall simultaneously and at the same rate at all locations. Although response onset depends on stimulus contrast, both the peak spatial profile and the offset dynamics are independent of contrast. We show that these results are consistent with a simple population gain-control model that generalizes earlier single-neuron contrast gain-control models. This model provides valuable insight and is likely to be applicable to other brain areas.	[Chen, Yuzhi; Geisler, Wilson S.; Seidemann, Eyal] Univ Texas Austin, Dept Psychol, Austin, TX 78712 USA; [Chen, Yuzhi; Geisler, Wilson S.; Seidemann, Eyal] Univ Texas Austin, Ctr Perceptual Syst, Austin, TX 78712 USA; [Sit, Yiu Fai; Miikkulainen, Risto] Univ Texas Austin, Dept Comp Sci, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Seidemann, E (corresponding author), Univ Texas Austin, Dept Psychol, 1 Univ Stn,A8000, Austin, TX 78712 USA.	eyal@mail.cps.utexas.edu		Seidemann, Eyal/0000-0003-2841-5948; Geisler, Wilson/0000-0003-4630-6614	National Eye Institute [EY-016454, EY-016752, EY-02688]; Sloan Foundation; NATIONAL EYE INSTITUTE [R01EY016454, R01EY002688, R01EY016752] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Sloan Foundation(Alfred P. Sloan Foundation); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank W. Bosking, C. Michelson, C. Palmer, and Z. Yang for assistance with experiments and for discussions, and T. Cakic for technical support. This work was supported by National Eye Institute Grants EY-016454 and EY-016752 (to E.S.) and EY-02688 (to W.S.G.) and by a Sloan Foundation Fellowship (to E.S.).	Abbott LF, 1997, SCIENCE, V275, P220, DOI 10.1126/science.275.5297.221; ALBRECHT DG, 1995, VISUAL NEUROSCI, V12, P1191, DOI 10.1017/S0952523800006817; ALBRECHT DG, 1982, J NEUROPHYSIOL, V48, P217, DOI 10.1152/jn.1982.48.1.217; Albrecht DG, 2002, J NEUROPHYSIOL, V88, P888, DOI 10.1152/jn.2002.88.2.888; ALBRECHT DG, 1991, VISUAL NEUROSCI, V7, P531, DOI 10.1017/S0952523800010336; Anderson JS, 2000, SCIENCE, V290, P1968, DOI 10.1126/science.290.5498.1968; Angelucci A, 2002, J NEUROSCI, V22, P8633; Bair W, 2002, J NEUROSCI, V22, P3189, DOI 10.1523/JNEUROSCI.22-08-03189.2002; Benucci A, 2007, NEURON, V55, P103, DOI 10.1016/j.neuron.2007.06.017; Blasdel G, 2001, J NEUROSCI, V21, P8286, DOI 10.1523/JNEUROSCI.21-20-08286.2001; Bonin V, 2005, J NEUROSCI, V25, P10844, DOI 10.1523/JNEUROSCI.3562-05.2005; CARANDINI M, 1994, SCIENCE, V264, P1333, DOI 10.1126/science.8191289; Carandini M, 1997, J NEUROSCI, V17, P8621; Carandini M, 2004, COGNITIVE NEUROSCIENCES III, THIRD EDITION, P313; Cavanaugh JR, 2002, J NEUROPHYSIOL, V88, P2530, DOI 10.1152/jn.00692.2001; Chen YZ, 2008, J NEUROPHYSIOL, V99, P1366, DOI 10.1152/jn.00698.2007; Chen YZ, 2006, NAT NEUROSCI, V9, P1412, DOI 10.1038/nn1792; DEAN AF, 1986, EXP BRAIN RES, V62, P143; DERRINGTON AM, 1984, J PHYSIOL-LONDON, V357, P219, DOI 10.1113/jphysiol.1984.sp015498; DOW BM, 1981, EXP BRAIN RES, V44, P213; Finn IM, 2007, NEURON, V54, P137, DOI 10.1016/j.neuron.2007.02.029; GILBERT CD, 1979, NATURE, V280, P120, DOI 10.1038/280120a0; Gonzalez-Burgos G, 2000, CEREB CORTEX, V10, P82, DOI 10.1093/cercor/10.1.82; GRINVALD A, 1994, J NEUROSCI, V14, P2545; Grinvald A, 2004, NAT REV NEUROSCI, V5, P874, DOI 10.1038/nrn1536; Heeger D. J., 1991, COMPUTATIONAL MODELS, P119; HEEGER DJ, 1992, VISUAL NEUROSCI, V9, P181, DOI 10.1017/S0952523800009640; HIRSCH JA, 1991, J NEUROSCI, V11, P1800; HUBEL DH, 1974, J COMP NEUROL, V158, P295, DOI 10.1002/cne.901580305; Jancke D, 2004, NATURE, V428, P423, DOI 10.1038/nature02396; Kaplan E, 2001, PROG BRAIN RES, V134, P17; Kayser A, 2001, J NEUROPHYSIOL, V85, P2130, DOI 10.1152/jn.2001.85.5.2130; Levitt JB, 2002, VISUAL NEUROSCI, V19, P439, DOI 10.1017/S0952523802194065; Levitt JB, 2001, J NEUROPHYSIOL, V85, P2111, DOI 10.1152/jn.2001.85.5.2111; Mante V, 2008, NEURON, V58, P625, DOI 10.1016/j.neuron.2008.03.011; MARTIN KAC, 1984, J PHYSIOL-LONDON, V353, P463, DOI 10.1113/jphysiol.1984.sp015347; MCILWAIN JT, 1986, TRENDS NEUROSCI, V9, P354; MURAKOSHI T, 1993, NEUROSCI LETT, V163, P211, DOI 10.1016/0304-3940(93)90385-X; NELSON DA, 1995, NEURON, V15, P23, DOI 10.1016/0896-6273(95)90061-6; Parker AJ, 1998, ANNU REV NEUROSCI, V21, P227, DOI 10.1146/annurev.neuro.21.1.227; Purushothaman G, 2005, NAT NEUROSCI, V8, P99, DOI 10.1038/nn1373; ROCKLAND KS, 1983, J COMP NEUROL, V216, P303, DOI 10.1002/cne.902160307; Sceniak MP, 2006, J NEUROPHYSIOL, V96, P3474, DOI 10.1152/jn.00734.2006; Sceniak MP, 1999, NAT NEUROSCI, V2, P733, DOI 10.1038/11197; Sceniak MP, 2001, J NEUROPHYSIOL, V85, P1873, DOI 10.1152/jn.2001.85.5.1873; SCLAR G, 1990, VISION RES, V30, P1, DOI 10.1016/0042-6989(90)90123-3; SCLAR G, 1982, EXP BRAIN RES, V46, P457; Seidemann E, 2002, SCIENCE, V295, P862, DOI 10.1126/science.1066641; SEIDEMANN E, 2009, COGNITIVE NEUROSCIEN, V4; SHAPLEY RM, 1978, J PHYSIOL-LONDON, V285, P275, DOI 10.1113/jphysiol.1978.sp012571; SKOTTUN BC, 1987, J NEUROPHYSIOL, V57, P773, DOI 10.1152/jn.1987.57.3.773; Tsodyks MV, 1997, P NATL ACAD SCI USA, V94, P719, DOI 10.1073/pnas.94.2.719; VANESSEN DC, 1984, VISION RES, V24, P429, DOI 10.1016/0042-6989(84)90041-5; VICTOR JD, 1987, J PHYSIOL-LONDON, V386, P219, DOI 10.1113/jphysiol.1987.sp016531; Witkovsky P, 1997, J NEUROSCI, V17, P7297; Yang ZY, 2007, J NEUROPHYSIOL, V98, P1002, DOI 10.1152/jn.00417.2007	56	55	56	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 24	2009	64	6					943	956		10.1016/j.neuron.2009.08.041	http://dx.doi.org/10.1016/j.neuron.2009.08.041			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	541ON	20064399	Green Accepted, Bronze			2022-12-24	WOS:000273425800019
J	Makara, JK; Losonczy, A; Wen, Q; Magee, JC				Makara, Judit K.; Losonczy, Attila; Wen, Quan; Magee, Jeffrey C.			Experience-dependent compartmentalized dendritic plasticity in rat hippocampal CA1 pyramidal neurons	NATURE NEUROSCIENCE			English	Article							OBLIQUE DENDRITES; ACTION-POTENTIALS; PROPAGATION; SPIKES	The excitability of individual dendritic branches is a plastic property of neurons. We found that experience in an enriched environment increased propagation of dendritic Na+ spikes in a subset of individual dendritic branches in rat hippocampal CA1 pyramidal neurons and that this effect was mainly mediated by localized downregulation of A-type K+ channel function. Thus, dendritic plasticity might be used to store recent experience in individual branches of the dendritic arbor.	[Makara, Judit K.; Losonczy, Attila; Wen, Quan; Magee, Jeffrey C.] Howard Hughes Med Inst, Ashburn, VA USA	Howard Hughes Medical Institute	Makara, JK (corresponding author), Howard Hughes Med Inst, Janelia Farm Res Campus, Ashburn, VA USA.	makaraj@janelia.hhmi.org; mageej@janelia.hhmi.org			Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Ariav G, 2003, J NEUROSCI, V23, P7750; Gasparini S, 2007, J PHYSIOL-LONDON, V580, P787, DOI 10.1113/jphysiol.2006.121343; Golding NL, 1998, NEURON, V21, P1189, DOI 10.1016/S0896-6273(00)80635-2; Losonczy A, 2006, NEURON, V50, P291, DOI 10.1016/j.neuron.2006.03.016; Losonczy A, 2008, NATURE, V452, P436, DOI 10.1038/nature06725; Migliore M, 2005, J NEUROPHYSIOL, V94, P4145, DOI 10.1152/jn.00521.2005; Nadasdy Z, 1999, J NEUROSCI, V19, P9497; Nithianantharajah J, 2006, NAT REV NEUROSCI, V7, P697, DOI 10.1038/nrn1970; O'Neill J, 2006, NEURON, V49, P143, DOI 10.1016/j.neuron.2005.10.037; Rampon C, 2000, HIPPOCAMPUS, V10, P605, DOI 10.1002/1098-1063(2000)10:5<605::AID-HIPO11>3.0.CO;2-3; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; Vetter P, 2001, J NEUROPHYSIOL, V85, P926, DOI 10.1152/jn.2001.85.2.926; Wen Q, 2009, P NATL ACAD SCI USA, V106, P12536, DOI 10.1073/pnas.0901530106; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517	14	93	93	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2009	12	12					1485	1487		10.1038/nn.2428	http://dx.doi.org/10.1038/nn.2428			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	523II	19898470				2022-12-24	WOS:000272065600005
J	Courtine, G; Gerasimenko, Y; van den Brand, R; Yew, A; Musienko, P; Zhong, H; Song, BB; Ao, Y; Ichiyama, RM; Lavrov, I; Roy, RR; Sofroniew, MV; Edgerton, VR				Courtine, Gregoire; Gerasimenko, Yury; van den Brand, Rubia; Yew, Aileen; Musienko, Pavel; Zhong, Hui; Song, Bingbing; Ao, Yan; Ichiyama, Ronaldo M.; Lavrov, Igor; Roy, Roland R.; Sofroniew, Michael V.; Edgerton, V. Reggie			Transformation of nonfunctional spinal circuits into functional states after the loss of brain input	NATURE NEUROSCIENCE			English	Article							HINDLIMB-STEPPING ABILITY; CENTRAL PATTERN GENERATOR; CORD STIMULATION; INTRASPINAL MICROSTIMULATION; EPIDURAL STIMULATION; ADULT RATS; LOCOMOTION; INJURY; CATS; RECOVERY	After complete spinal cord transections that removed all supraspinal inputs in adult rats, combinations of serotonergic agonists and epidural electrical stimulation were able to acutely transform spinal networks from nonfunctional to highly functional and adaptive states as early as 1 week after injury. Using kinematics, physiological and anatomical analyses, we found that these interventions could recruit specific populations of spinal circuits, refine their control via sensory input and functionally remodel these locomotor pathways when combined with training. The emergence of these new functional states enabled full weight-bearing treadmill locomotion in paralyzed rats that was almost indistinguishable from voluntary stepping. We propose that, in the absence of supraspinal input, spinal locomotion can emerge from a combination of central pattern-generating capability and the ability of these spinal circuits to use sensory afferent input to control stepping. These findings provide a strategy by which individuals with spinal cord injuries could regain substantial levels of motor control.	[Courtine, Gregoire; van den Brand, Rubia; Musienko, Pavel] Univ Zurich, Dept Neurol, Zurich, Switzerland; [Courtine, Gregoire; van den Brand, Rubia; Musienko, Pavel] Ctr Zurich, Rehabil Inst & Technol, Zurich, Switzerland; [Gerasimenko, Yury; Zhong, Hui; Ichiyama, Ronaldo M.; Lavrov, Igor; Roy, Roland R.; Edgerton, V. Reggie] Univ Calif Los Angeles, Dept Physiol Sci, Los Angeles, CA USA; [Gerasimenko, Yury; Musienko, Pavel] IP Pavlov Physiol Inst, Motor Physiol Lab, St Petersburg 199034, Russia; [Yew, Aileen; Sofroniew, Michael V.; Edgerton, V. Reggie] Univ Calif Los Angeles, Dept Neurobiol, Los Angeles, CA USA; [Song, Bingbing; Ao, Yan; Roy, Roland R.; Sofroniew, Michael V.; Edgerton, V. Reggie] Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90024 USA	University of Zurich; University of California System; University of California Los Angeles; Russian Academy of Sciences; St. Petersburg Scientific Centre of the Russian Academy of Sciences; Pavlov Institute of Physiology Russian Academy of Sciences; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Courtine, G (corresponding author), Univ Zurich, Dept Neurol, Zurich, Switzerland.	gregoire.courtine@bli.uzh.ch	courtine, gregoire/AAJ-1694-2020; Gerasimenko, Yury/A-3655-2017; Ichiyama, Ronaldo/B-7856-2009; Lavrov, Igor/E-4334-2016; Sofroniew, Michael/ABE-8857-2020; Musienko, Pavel/L-6677-2015	courtine, gregoire/0000-0002-5744-4142; Lavrov, Igor/0000-0002-3885-4509; Musienko, Pavel/0000-0002-7324-9021; Ichiyama, Ronaldo/0000-0002-7640-8032	Craig H. Nielsen Foundation [20062668]; International Paraplegic Foundation [P106]; Swiss National Science Foundation; Christopher and Dana Reeve Foundation [VEC2007]; US National Institute of Neurological Disorders and Stroke [NS16333]; US Civilian Research and Development Foundation [RUB1287207]; Roman Reed Spinal Cord Injury Research Fund of California; Russian Foundation for Basic Research [07-04-00526, 08-04-00688]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB007615] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS016333] Funding Source: NIH RePORTER	Craig H. Nielsen Foundation; International Paraplegic Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Christopher and Dana Reeve Foundation; US National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); US Civilian Research and Development Foundation; Roman Reed Spinal Cord Injury Research Fund of California; Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to acknowledge the excellent technical help provided by S. Zdunowski, L. Friedli, J. Heutschi and O. M rzendorfer for data collection and analysis, as well as M. Herrera for his expert assistance and guidance involving the care and handling of the animals. This work was supported by the Craig H. Nielsen Foundation (#20062668), the International Paraplegic Foundation (P106), the National Center of Competence in Research 'Neural Plasticity and Repair' of the Swiss National Science Foundation, the Christopher and Dana Reeve Foundation (VEC2007), the US National Institute of Neurological Disorders and Stroke (NS16333), the US Civilian Research and Development Foundation (RUB1287207), the Roman Reed Spinal Cord Injury Research Fund of California and the Russian Foundation for Basic Research (07-04-00526 and 08-04-00688).	Antri M, 2003, EUR J NEUROSCI, V18, P1963, DOI 10.1046/j.1460-9568.2003.02916.x; Barriere G, 2008, J NEUROSCI, V28, P3976, DOI 10.1523/JNEUROSCI.5692-07.2008; Barthelemy D, 2007, J NEUROPHYSIOL, V97, P1986, DOI 10.1152/jn.00818.2006; Barthelemy D, 2006, J NEUROPHYSIOL, V96, P3273, DOI 10.1152/jn.00203.2006; Beres-Jones JA, 2004, BRAIN, V127, P2232, DOI 10.1093/brain/awh252; Bouyer LJG, 2003, J NEUROPHYSIOL, V90, P3640, DOI 10.1152/jn.00497.2003; Carhart MR, 2004, IEEE T NEUR SYS REH, V12, P32, DOI 10.1109/TNSRE.2003.822763; Chau C, 1998, J NEUROPHYSIOL, V79, P392, DOI 10.1152/jn.1998.79.1.392; Cote MP, 2004, J NEUROSCI, V24, P11317, DOI 10.1523/JNEUROSCI.1486-04.2004; Courtine G, 2005, BRAIN, V128, P2338, DOI 10.1093/brain/awh604; Courtine G, 2004, J NEUROPHYSIOL, V91, P1524, DOI 10.1152/jn.00817.2003; Courtine G, 2008, NAT MED, V14, P69, DOI 10.1038/nm1682; Courtine G, 2007, NAT MED, V13, P561, DOI 10.1038/nm1595; de Leon RD, 1999, J NEUROPHYSIOL, V81, P85, DOI 10.1152/jn.1999.81.1.85; Dietz V, 2004, BRAIN, V127, P2221, DOI 10.1093/brain/awh255; Dimitrijevic MR, 1998, ANN NY ACAD SCI, V860, P360, DOI 10.1111/j.1749-6632.1998.tb09062.x; Engesser-Cesar C, 2007, EUR J NEUROSCI, V25, P1931, DOI 10.1111/j.1460-9568.2007.05469.x; Fuentes R, 2009, SCIENCE, V323, P1578, DOI 10.1126/science.1164901; Gaunt RA, 2006, J NEUROPHYSIOL, V96, P2995, DOI 10.1152/jn.00061.2006; Gerasimenko YP, 2007, J NEUROPHYSIOL, V98, P2525, DOI 10.1152/jn.00836.2007; Gerasimenko YP, 2006, J NEUROSCI METH, V157, P253, DOI 10.1016/j.jneumeth.2006.05.004; GISZTER SF, 1993, J NEUROSCI, V13, P467; Grillner S, 2002, BRAIN RES REV, V40, P92, DOI 10.1016/S0165-0173(02)00193-5; Grillner S, 2006, NEURON, V52, P751, DOI 10.1016/j.neuron.2006.11.008; Guevremont L, 2006, IEEE T NEUR SYS REH, V14, P266, DOI 10.1109/TNSRE.2006.881592; Gurfinkel VS, 1998, EUR J NEUROSCI, V10, P1608, DOI 10.1046/j.1460-9568.1998.00179.x; Harkema SJ, 1997, J NEUROPHYSIOL, V77, P797, DOI 10.1152/jn.1997.77.2.797; Harkema SJ, 2008, BRAIN RES REV, V57, P255, DOI 10.1016/j.brainresrev.2007.07.012; Hochman S, 2001, METH NE FRO NEUROSCI, P47; Ichiyama RM, 2005, NEUROSCI LETT, V383, P339, DOI 10.1016/j.neulet.2005.04.049; Ichiyama RM, 2008, J NEUROSCI, V28, P7370, DOI 10.1523/JNEUROSCI.1881-08.2008; Ivanenko YP, 2007, J NEUROSCI, V27, P11149, DOI 10.1523/JNEUROSCI.2644-07.2007; IWAHARA T, 1992, BRAIN RES BULL, V28, P99, DOI 10.1016/0361-9230(92)90235-P; Kiehn O, 2006, ANNU REV NEUROSCI, V29, P279, DOI 10.1146/annurev.neuro.29.051605.112910; Kubasak MD, 2008, BRAIN, V131, P264, DOI 10.1093/brain/awm267; Landry ES, 2006, EUR J NEUROSCI, V24, P535, DOI 10.1111/j.1460-9568.2006.04917.x; Lavrov I, 2008, J NEUROSCI, V28, P6022, DOI 10.1523/JNEUROSCI.0080-08.2008; Lavrov I, 2008, J NEUROSCI, V28, P7774, DOI 10.1523/JNEUROSCI.1069-08.2008; Lavrov I, 2006, J NEUROPHYSIOL, V96, P1699, DOI 10.1152/jn.00325.2006; Lemay MA, 2004, J NEUROPHYSIOL, V91, P502, DOI 10.1152/jn.00235.2003; Liu J, 2005, J NEUROPHYSIOL, V94, P1392, DOI 10.1152/jn.00136.2005; Maier IC, 2009, BRAIN, V132, P1426, DOI 10.1093/brain/awp085; Pearson KG, 2004, PROG BRAIN RES, V143, P123, DOI 10.1016/S0079-6123(03)43012-4; Petruska JC, 2007, J NEUROSCI, V27, P4460, DOI 10.1523/JNEUROSCI.2302-06.2007; Rattay F, 2000, SPINAL CORD, V38, P473, DOI 10.1038/sj.sc.3101039; Rioult-Pedotti MS, 2000, SCIENCE, V290, P533, DOI 10.1126/science.290.5491.533; Rossignol S, 2006, PHYSIOL REV, V86, P89, DOI 10.1152/physrev.00028.2005; Rudomin P, 2002, PROG BRAIN RES, V136, P409; Tillakaratne NJK, 2002, J NEUROSCI, V22, P3130, DOI 10.1523/JNEUROSCI.22-08-03130.2002; Tresch MC, 1999, EXP BRAIN RES, V129, P401, DOI 10.1007/s002210050908	50	475	505	4	90	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2009	12	10					1333	U167		10.1038/nn.2401	http://dx.doi.org/10.1038/nn.2401			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	498US	19767747	Green Accepted			2022-12-24	WOS:000270170200023
J	Derdikman, D; Whitlock, JR; Tsao, A; Fyhn, M; Hafting, T; Moser, MB; Moser, EI				Derdikman, Dori; Whitlock, Jonathan R.; Tsao, Albert; Fyhn, Marianne; Hafting, Torkel; Moser, May-Britt; Moser, Edvard I.			Fragmentation of grid cell maps in a multicompartment environment	NATURE NEUROSCIENCE			English	Article							FREELY-MOVING RATS; HIPPOCAMPAL ENSEMBLE CODE; MEDIAL ENTORHINAL CORTEX; SPATIAL FIRING PATTERNS; HEAD DIRECTION SIGNAL; COMPLEX-SPIKE CELLS; PATH-INTEGRATION; PLACE CELLS; NEURAL ENSEMBLES; UNIT-ACTIVITY	To determine whether entorhinal spatial representations are continuous or fragmented, we recorded neural activity in grid cells while rats ran through a stack of interconnected, zig-zagged compartments of equal shape and orientation (a hairpin maze). The distribution of spatial firing fields was markedly similar across all compartments in which running occurred in the same direction, implying that the grid representation was fragmented into repeating submaps. Activity at neighboring positions was least correlated at the transitions between different arms, indicating that the map split regularly at the turning points. We saw similar discontinuities among place cells in the hippocampus. No fragmentation was observed when the rats followed similar trajectories in the absence of internal walls, implying that stereotypic behavior alone cannot explain the compartmentalization. These results indicate that spatial environments are represented in entorhinal cortex and hippocampus as a mosaic of discrete submaps that correspond to the geometric structure of the space.	[Derdikman, Dori; Whitlock, Jonathan R.; Tsao, Albert; Fyhn, Marianne; Hafting, Torkel; Moser, May-Britt; Moser, Edvard I.] Norwegian Univ Sci & Technol, Kavli Inst Syst Neurosci, MTFS, N-7034 Trondheim, Norway; [Derdikman, Dori; Whitlock, Jonathan R.; Tsao, Albert; Fyhn, Marianne; Hafting, Torkel; Moser, May-Britt; Moser, Edvard I.] Norwegian Univ Sci & Technol, Ctr Biol Memory, MTFS, N-7034 Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Moser, EI (corresponding author), Norwegian Univ Sci & Technol, Kavli Inst Syst Neurosci, MTFS, N-7034 Trondheim, Norway.	edvard.moser@ntnu.no		Hafting, Torkel/0000-0002-0928-3487	Kavli Foundation; Norwegian Research Council	Kavli Foundation; Norwegian Research Council(Research Council of NorwayEuropean Commission)	We thank A. M. Amundgord, I. Hammer, K. Haugen, K. Jenssen, R. Skjerpeng and H. Waade for technical assistance and T. Bonnevie and G. Pfuhl for help with animal training. We thank A. D. Redish and members of the Kavli Institute for Systems Neuroscience and the Centre for the Biology of Memory for useful discussions. This work was supported by the Kavli Foundation and a Centre of Excellence grant from the Norwegian Research Council.	Barry C, 2007, NAT NEUROSCI, V10, P682, DOI 10.1038/nn1905; Biegler R, 2000, ANIM LEARN BEHAV, V28, P257, DOI 10.3758/BF03200260; Bostock E, 1991, Hippocampus, V1, P193, DOI 10.1002/hipo.450010207; CHENG K, 1986, COGNITION, V23, P149, DOI 10.1016/0010-0277(86)90041-7; Colgin LL, 2008, TRENDS NEUROSCI, V31, P469, DOI 10.1016/j.tins.2008.06.008; Eichenbaum H, 1999, NEURON, V23, P209, DOI 10.1016/S0896-6273(00)80773-4; Frank LM, 2000, NEURON, V27, P169, DOI 10.1016/S0896-6273(00)00018-0; Fyhn M, 2004, SCIENCE, V305, P1258, DOI 10.1126/science.1099901; Fyhn M, 2007, NATURE, V446, P190, DOI 10.1038/nature05601; Gothard KM, 1996, J NEUROSCI, V16, P8027; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Hafting T, 2008, NATURE, V453, P1248, DOI 10.1038/nature06957; HAMPSON RE, 1993, BEHAV NEUROSCI, V107, P715, DOI 10.1037/0735-7044.107.5.715; Hargreaves EL, 2007, HIPPOCAMPUS, V17, P826, DOI 10.1002/hipo.20316; Hasselmo ME, 2008, HIPPOCAMPUS, V18, P1213, DOI 10.1002/hipo.20512; Johnson A, 2005, HIPPOCAMPUS, V15, P86, DOI 10.1002/hipo.20033; Jones PM, 2007, BEHAV NEUROSCI, V121, P1258, DOI 10.1037/0735-7044.121.6.1258; Kjelstrup KB, 2008, SCIENCE, V321, P140, DOI 10.1126/science.1157086; Leutgeb S, 2004, SCIENCE, V305, P1295, DOI 10.1126/science.1100265; MARKUS EJ, 1995, J NEUROSCI, V15, P7079; McGregor A, 2004, BEHAV NEUROSCI, V118, P1011, DOI 10.1037/0735-7044.118.5.1011; McNaughton BL, 1996, J EXP BIOL, V199, P173; MCNAUGHTON BL, 1983, EXP BRAIN RES, V52, P41; McNaughton BL, 2006, NAT REV NEUROSCI, V7, P663, DOI 10.1038/nrn1932; Moser EI, 2008, HIPPOCAMPUS, V18, P1142, DOI 10.1002/hipo.20483; MULLER RU, 1987, J NEUROSCI, V7, P1951; MULLER RU, 1987, J NEUROSCI, V7, P1935; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; OKeefe J, 1996, NATURE, V381, P425, DOI 10.1038/381425a0; Pastalkova E, 2008, SCIENCE, V321, P1322, DOI 10.1126/science.1159775; Pearce JM, 2004, J EXP PSYCHOL ANIM B, V30, P135, DOI 10.1037/0097-7403.30.2.135; Ranck J.B., 1985, ELECT ACTIVITY ARCHI, P217; Redish AD, 2000, J NEUROSCI, V20, P9298; Redish AD, 2000, NEUROCOMPUTING, V32, P235, DOI 10.1016/S0925-2312(00)00169-7; Samsonovich A, 1997, J NEUROSCI, V17, P5900; Sargolini F, 2006, SCIENCE, V312, P758, DOI 10.1126/science.1125572; Savelli F, 2008, HIPPOCAMPUS, V18, P1270, DOI 10.1002/hipo.20511; Sharp PE, 1997, BEHAV BRAIN RES, V85, P71, DOI 10.1016/S0166-4328(96)00165-9; Solstad T, 2008, SCIENCE, V322, P1865, DOI 10.1126/science.1166466; Taube JS, 2007, ANNU REV NEUROSCI, V30, P181, DOI 10.1146/annurev.neuro.29.051605.112854; TAUBE JS, 1990, J NEUROSCI, V10, P420; TAUBE JS, 1990, J NEUROSCI, V10, P436; Touretzky DS, 1996, HIPPOCAMPUS, V6, P247; Whishaw IQ, 1998, NEUROSCI BIOBEHAV R, V22, P209, DOI 10.1016/S0149-7634(97)00002-X; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; Wood ER, 2000, NEURON, V27, P623, DOI 10.1016/S0896-6273(00)00071-4; Wood ER, 1999, NATURE, V397, P613, DOI 10.1038/17605; Yoganarasimha D, 2006, J NEUROSCI, V26, P622, DOI 10.1523/JNEUROSCI.3885-05.2006; YOUNG BJ, 1994, J NEUROSCI, V14, P6553	50	194	195	2	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2009	12	10					1325	U155		10.1038/nn.2396	http://dx.doi.org/10.1038/nn.2396			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	498US	19749749				2022-12-24	WOS:000270170200022
J	Munch, TA; da Silveira, RA; Siegert, S; Viney, TJ; Awatramani, GB; Roska, B				Muench, Thomas A.; da Silveira, Rava Azeredo; Siegert, Sandra; Viney, Tim James; Awatramani, Gautam B.; Roska, Botond			Approach sensitivity in the retina processed by a multifunctional neural circuit	NATURE NEUROSCIENCE			English	Article							AII AMACRINE CELLS; LOOMING VISUAL-STIMULI; MAMMALIAN RETINA; GANGLION-CELLS; RABBIT RETINA; MOUSE RETINA; ELECTRICAL SYNAPSES; OBJECT APPROACH; BIPOLAR CELLS; CAT RETINA	The detection of approaching objects, such as looming predators, is necessary for survival. Which neurons and circuits mediate this function? We combined genetic labeling of cell types, two-photon microscopy, electrophysiology and theoretical modeling to address this question. We identify an approach-sensitive ganglion cell type in the mouse retina, resolve elements of its afferent neural circuit, and describe how these confer approach sensitivity on the ganglion cell. The circuit's essential building block is a rapid inhibitory pathway: it selectively suppresses responses to non-approaching objects. This rapid inhibitory pathway, which includes All amacrine cells connected to bipolar cells through electrical synapses, was previously described in the context of night-time vision. In the daytime conditions of our experiments, the same pathway conveys signals in the reverse direction. The dual use of a neural pathway in different physiological conditions illustrates the efficiency with which several functions can be accommodated in a single circuit.	[Muench, Thomas A.; Siegert, Sandra; Viney, Tim James; Awatramani, Gautam B.; Roska, Botond] Friedrich Miescher Inst Biomed Res, Neural Circuit Labs, Basel, Switzerland; [da Silveira, Rava Azeredo] Ecole Normale Super, Dept Phys, F-75231 Paris, France; [da Silveira, Rava Azeredo] Ecole Normale Super, Dept Cognit Studies, F-75231 Paris, France	Friedrich Miescher Institute for Biomedical Research; UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	Roska, B (corresponding author), Friedrich Miescher Inst Biomed Res, Neural Circuit Labs, Basel, Switzerland.	botond.roska@fmi.ch	Siegert, Sandra/GWC-4507-2022; Roska, Botond/AAD-7268-2021	Siegert, Sandra/0000-0001-8635-0877; Munch, Thomas/0000-0002-8884-6961; Viney, Tim/0000-0001-6444-1188	Friedrich Miescher Institute; US Office of Naval Research Naval International Cooperative Opportunities in Science and Technology; Marie Curie Excellence Grant, a Human Frontier Science Program; National Centers of Competence in Research in Genetics; European Union [HEALTH-F2-223156]; Marie Curie Postdoctoral Fellowship; Centre National de la Recherche Scientifique through the Unite Mixte de Recherche [8550]	Friedrich Miescher Institute; US Office of Naval Research Naval International Cooperative Opportunities in Science and Technology; Marie Curie Excellence Grant, a Human Frontier Science Program; National Centers of Competence in Research in Genetics; European Union(European Commission); Marie Curie Postdoctoral Fellowship(European Commission); Centre National de la Recherche Scientifique through the Unite Mixte de Recherche(Centre National de la Recherche Scientifique (CNRS))	We are grateful to S. Arber ( Friedrich Miescher Institute), D. Paul ( Harvard Medical School) and J. Sanes ( Harvard University) for providing mouse lines and Robert Margolskee ( Mount Sinai School of Medicine) for providing the G.13 antibody. We are grateful for the technical assistance of S. Djaffer, B. Gross Scherf and Y. Shimada. We thank members of the Roska lab, P. Lagali, P. Caroni, R. Friedrich and A. Luthi for comments on the manuscript. The study was supported by Friedrich Miescher Institute funds, a US Office of Naval Research Naval International Cooperative Opportunities in Science and Technology program grant, a Marie Curie Excellence Grant, a Human Frontier Science Program Young Investigator grant, a National Centers of Competence in Research in Genetics grant and a European Union HEALTH-F2-223156 grant to B. R., a Marie Curie Postdoctoral Fellowship to T. A. M., the Centre National de la Recherche Scientifique through the Unite Mixte de Recherche 8550 to R.A.d.S.	BALL W, 1971, SCIENCE, V171, P818, DOI 10.1126/science.171.3973.818; BELGUM JH, 1987, J PHYSIOL-LONDON, V388, P233, DOI 10.1113/jphysiol.1987.sp016612; Bloomfield SA, 2001, PROG RETIN EYE RES, V20, P351, DOI 10.1016/S1350-9462(00)00031-8; Bradley DC, 2008, NAT REV NEUROSCI, V9, P686, DOI 10.1038/nrn2472; Buffelli M, 2003, NATURE, V424, P430, DOI 10.1038/nature01844; Cohen ED, 1999, BRAIN RES, V831, P206, DOI 10.1016/S0006-8993(99)01448-1; Deans MR, 2001, NEURON, V31, P477, DOI 10.1016/S0896-6273(01)00373-7; Feigenspan A, 2001, J NEUROSCI, V21, P230, DOI 10.1523/JNEUROSCI.21-01-00230.2001; Franconeri SL, 2003, PERCEPT PSYCHOPHYS, V65, P999, DOI 10.3758/BF03194829; Fried SI, 2002, NATURE, V420, P411, DOI 10.1038/nature01179; Gabbiani F, 2005, J NEUROPHYSIOL, V94, P2150, DOI 10.1152/jn.00411.2005; Gabbiani F, 1999, J NEUROSCI, V19, P1122; Geraghty RJ, 1998, SCIENCE, V280, P1618, DOI 10.1126/science.280.5369.1618; GREFERATH U, 1990, J COMP NEUROL, V301, P433, DOI 10.1002/cne.903010308; HATSOPOULOS N, 1995, SCIENCE, V270, P1000, DOI 10.1126/science.270.5238.1000; Haverkamp S, 2000, J COMP NEUROL, V424, P1; Hippenmeyer S, 2005, PLOS BIOL, V3, P878, DOI 10.1371/journal.pbio.0030159; Huang LQ, 2003, J COMP NEUROL, V455, P1, DOI 10.1002/cne.10396; Huberman AD, 2008, NEURON, V59, P425, DOI 10.1016/j.neuron.2008.07.018; Ishikane H, 2005, NAT NEUROSCI, V8, P1087, DOI 10.1038/nn1497; Kim IJ, 2008, NATURE, V452, P478, DOI 10.1038/nature06739; King JG, 1999, BRAIN RES, V841, P20, DOI 10.1016/S0006-8993(99)01764-3; KING SM, 1992, NEUROPSYCHOLOGIA, V30, P1017, DOI 10.1016/0028-3932(92)90053-O; KING SM, 1992, PERCEPTION, V21, P245, DOI 10.1068/p210245; Manookin MB, 2008, J NEUROSCI, V28, P4136, DOI 10.1523/JNEUROSCI.4274-07.2008; Massey SC, 2003, CELL COMMUN ADHES, V10, P425, DOI 10.1080/15419060390264343; MCGUIRE BA, 1986, J NEUROSCI, V6, P907; Metzger D, 1999, CURR OPIN BIOTECH, V10, P470, DOI 10.1016/S0958-1669(99)00012-9; Mills SL, 2001, J COMP NEUROL, V436, P336; Murphy GJ, 2008, NAT NEUROSCI, V11, P318, DOI 10.1038/nn2045; Olveczky BP, 2003, NATURE, V423, P401, DOI 10.1038/nature01652; OYSTER CW, 1968, J PHYSIOL-LONDON, V199, P613, DOI 10.1113/jphysiol.1968.sp008671; Pang JJ, 2007, J PHYSIOL-LONDON, V580, P397, DOI 10.1113/jphysiol.2006.120790; POURCHO RG, 1985, J COMP NEUROL, V233, P473, DOI 10.1002/cne.902330406; Rice DS, 2000, J COMP NEUROL, V424, P327, DOI 10.1002/1096-9861(20000821)424:2<327::AID-CNE10>3.0.CO;2-6; Roska B, 1998, J NEUROSCI, V18, P3451; Roska B, 2001, NATURE, V410, P583, DOI 10.1038/35069068; Roska B, 2006, J NEUROPHYSIOL, V95, P3810, DOI 10.1152/jn.00113.2006; SCHIFF W, 1962, SCIENCE, V136, P982, DOI 10.1126/science.136.3520.982; SLAUGHTER MM, 1981, SCIENCE, V211, P182, DOI 10.1126/science.6255566; Sun HJ, 1998, NAT NEUROSCI, V1, P296, DOI 10.1038/1110; Veruki ML, 2002, J NEUROSCI, V22, P10558; Volgyi B, 2002, J PHYSIOL-LONDON, V539, P603, DOI 10.1013/jphysiol.2001.013133; WALDECK RF, 1995, BRAIN BEHAV EVOLUT, V46, P84, DOI 10.1159/000113261; Wassle H, 2004, NAT REV NEUROSCI, V5, P747, DOI 10.1038/nrn1497; Xin DY, 1999, VISUAL NEUROSCI, V16, P653, DOI 10.1017/S0952523899164058	46	225	226	0	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2009	12	10					1308	U135		10.1038/nn.2389	http://dx.doi.org/10.1038/nn.2389			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	498US	19734895				2022-12-24	WOS:000270170200020
J	Haswell, CC; Izawa, J; Dowell, LR; Mostofsky, SH; Shadmehr, R				Haswell, Courtney C.; Izawa, Jun; Dowell, Lauren R.; Mostofsky, Stewart H.; Shadmehr, Reza			Representation of internal models of action in the autistic brain	NATURE NEUROSCIENCE			English	Article							DIFFERENT ARM ORIENTATIONS; SIMILAR HAND PATHS; MOTOR CORTEX; SPECTRUM DISORDERS; REACHING MOVEMENTS; INDIVIDUAL CELLS; IMITATION; DYSPRAXIA; CHILDREN; DORSAL	Children with autism spectrum disorder (ASD) have deficits in motor control, imitation and social function. Does a dysfunction in the neural basis of representing internal models of action contribute to these problems? We measured patterns of generalization as children learned to control a novel tool and found that the autistic brain built a stronger than normal association between self-generated motor commands and proprioceptive feedback; furthermore, the greater the reliance on proprioception, the greater the child's impairments in social function and imitation.	[Haswell, Courtney C.; Izawa, Jun; Shadmehr, Reza] Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA; [Dowell, Lauren R.; Mostofsky, Stewart H.] Johns Hopkins Univ, Sch Med, Kennedy Krieger Inst, Baltimore, MD 21205 USA; [Mostofsky, Stewart H.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Mostofsky, Stewart H.] Johns Hopkins Univ, Sch Med, Dept Psychiat, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Kennedy Krieger Institute; Johns Hopkins University; Johns Hopkins University	Shadmehr, R (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA.	shadmehr@jhu.edu			NCRR NIH HHS [UL1 RR025005, UL1-RR025005] Funding Source: Medline; NIGMS NIH HHS [T32 GM007057] Funding Source: Medline; NIMH NIH HHS [R01 MH085328, R01 MH078160] Funding Source: Medline; NINDS NIH HHS [K02 NS044850-04, K02 NS044850-02, R01 NS048527, K02 NS044850, R01 NS048527-05, K02 NS044850-03, K02 NS044850-01A2, R01 NS037422, R01 NS048527-02, K02 NS044850-05, R01 NS048527-03, R01 NS037422-11, R01 NS048527-01A2, R01 NS048527-06A1, R01 NS048527-04] Funding Source: Medline; Autism Speaks [AS1739, AS2384, AS2506] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH078160, R01MH085328] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K02NS044850, R01NS048527, R01NS037422] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Autism Speaks; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Dziuk MA, 2007, DEV MED CHILD NEUROL, V49, P734, DOI 10.1111/j.1469-8749.2007.00734.x; Herbert MR, 2004, ANN NEUROL, V55, P530, DOI 10.1002/ana.20032; Hwang EJ, 2005, J NEURAL ENG, V2, DOI 10.1088/1741-2560/2/3/S09; Jansiewicz EM, 2006, J AUTISM DEV DISORD, V36, P613, DOI 10.1007/s10803-006-0109-y; Li CSR, 2001, NEURON, V30, P593, DOI 10.1016/S0896-6273(01)00301-4; Mattar AAG, 2005, NEURON, V46, P153, DOI 10.1016/j.neuron.2005.02.009; Mostofsky SH, 2007, BRAIN, V130, P2117, DOI 10.1093/brain/awm129; Mostofsky SH, 2006, J INT NEUROPSYCH SOC, V12, P314, DOI 10.1017/S1355617706060437; Oztop E, 2006, NEURAL NETWORKS, V19, P254, DOI 10.1016/j.neunet.2006.02.002; Rogers SJ, 1996, CHILD DEV, V67, P2060, DOI 10.2307/1131609; Scott SH, 1997, J NEUROPHYSIOL, V78, P2413, DOI 10.1152/jn.1997.78.5.2413; Scott SH, 1997, J NEUROPHYSIOL, V77, P826, DOI 10.1152/jn.1997.77.2.826; Shadmehr R, 2004, HUM MOVEMENT SCI, V23, P543, DOI 10.1016/j.humov.2004.04.003; Shadmehr R, 2008, EXP BRAIN RES, V185, P359, DOI 10.1007/s00221-008-1280-5; Xiao J, 2006, EXP BRAIN RES, V168, P106, DOI 10.1007/s00221-005-0074-2	15	198	202	3	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2009	12	8					970	972		10.1038/nn.2356	http://dx.doi.org/10.1038/nn.2356			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	475WS	19578379	Green Accepted			2022-12-24	WOS:000268396300009
J	Dieterich, DC; Hodas, JJL; Gouzer, G; Shadrin, IY; Ngo, JT; Triller, A; Tirrell, DA; Schuman, EM				Dieterich, Daniela C.; Hodas, Jennifer J. L.; Gouzer, Geraldine; Shadrin, Ilya Y.; Ngo, John T.; Triller, Antoine; Tirrell, David A.; Schuman, Erin M.			In situ visualization and dynamics of newly synthesized proteins in rat hippocampal neurons	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; MAMMALIAN-CELLS; TRANSLATION MACHINERY; SYNAPTIC PLASTICITY; TETANIC STIMULATION; LATE-PHASE; KINASE-II; MEMBRANE; MEMORY; IDENTIFICATION	Protein translation has been implicated in different forms of synaptic plasticity, but direct in situ visualization of new proteins is limited to one or two proteins at a time. Here we describe a metabolic labeling approach based on incorporation of noncanonical amino acids into proteins followed by chemoselective fluorescence tagging by means of 'click chemistry'. After a brief incubation with azidohomoalanine or homopropargylglycine, a robust fluorescent signal was detected in somata and dendrites. Pulse-chase application of azidohomoalanine and homopropargylglycine allowed visualization of proteins synthesized in two sequential time periods. This technique can be used to detect changes in protein synthesis and to evaluate the fate of proteins synthesized in different cellular compartments. Moreover, using strain-promoted cycloaddition, we explored the dynamics of newly synthesized membrane proteins using single-particle tracking and quantum dots. The newly synthesized proteins showed a broad range of diffusive behaviors, as would be expected for a pool of labeled proteins that is heterogeneous.	[Dieterich, Daniela C.; Hodas, Jennifer J. L.; Shadrin, Ilya Y.; Schuman, Erin M.] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Dieterich, Daniela C.] Leibniz Inst Neurobiol, Magdeburg, Germany; [Gouzer, Geraldine; Triller, Antoine] Ecole Normale Super, CNRS, INSERM, Inst Biol,U1024,UMR8197, Paris, France; [Ngo, John T.; Tirrell, David A.] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA; [Schuman, Erin M.] Max Planck Inst Brain Res, D-60528 Frankfurt, Germany	California Institute of Technology; Leibniz Institut fur Neurobiologie (LIN); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); California Institute of Technology; Max Planck Society	Schuman, EM (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	schumane@brain.mpg.de	Schuman, Erin M/D-6204-2011	Gouzer, Geraldine/0000-0002-4578-6567; Dieterich, Daniela C./0000-0002-9880-1214; Ngo, John/0000-0003-3508-1915; TRILLER, Antoine/0000-0002-7530-1233; Shadrin, Ilya/0000-0002-4501-0400	German Academy for Natural Scientists Leopoldina; US National Institutes of Health; Howard Hughes Medical Institute; Ministere de l'Enseignement Superieur et de la Recherche; Nationale de la Recherche MorphoSynDiff-INSERM; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062523] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA020589] Funding Source: NIH RePORTER	German Academy for Natural Scientists Leopoldina; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Ministere de l'Enseignement Superieur et de la Recherche; Nationale de la Recherche MorphoSynDiff-INSERM; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank L. Chen for making beautiful cultured hippocampal neurons. We thank A.J. Link for discussions and help with the tag syntheses. We are grateful to O. Kobler for help with Imaris software. We are extremely grateful to both C. Bertozzi and J. Baskin for providing the difluorinated cyclooctyne-biotin and advising on its use. This work was supported by the German Academy for Natural Scientists Leopoldina (D.C.D.), the US National Institutes of Health (E.M.S. and D.A.T.), the Howard Hughes Medical Institute (E.M.S.), the Ministere de l'Enseignement Superieur et de la Recherche (G.G.) and the Nationale de la Recherche MorphoSynDiff-INSERM (A.T.).	Aakalu G, 2001, NEURON, V30, P489, DOI 10.1016/S0896-6273(01)00295-1; Agard NJ, 2004, J AM CHEM SOC, V126, P15046, DOI 10.1021/ja044996f; AGRANOFF BW, 1964, SCIENCE, V146, P952, DOI 10.1126/science.146.3646.952; Alcor D, 2009, EUR J NEUROSCI, V30, P987, DOI 10.1111/j.1460-9568.2009.06927.x; Bannai H, 2006, NAT PROTOC, V1, P2628, DOI 10.1038/nprot.2006.429; Baskin JM, 2007, P NATL ACAD SCI USA, V104, P16793, DOI 10.1073/pnas.0707090104; Beatty KE, 2008, BIOORG MED CHEM LETT, V18, P5995, DOI 10.1016/j.bmcl.2008.08.046; Beatty KE, 2006, ANGEW CHEM INT EDIT, V45, P7364, DOI 10.1002/anie.200602114; Bito H, 1996, CELL, V87, P1203, DOI 10.1016/S0092-8674(00)81816-4; Casadio A, 1999, CELL, V99, P221, DOI 10.1016/S0092-8674(00)81653-0; Dahan M, 2003, SCIENCE, V302, P442, DOI 10.1126/science.1088525; Dieterich DC, 2007, NAT PROTOC, V2, P532, DOI 10.1038/nprot.2007.52; Dieterich DC, 2006, P NATL ACAD SCI USA, V103, P9482, DOI 10.1073/pnas.0601637103; FLEXNER JB, 1963, SCIENCE, V141, P57, DOI 10.1126/science.141.3575.57; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; Gogolla N, 2006, NAT PROTOC, V1, P1223, DOI 10.1038/nprot.2006.169; Huang T, 2006, EUR J CELL BIOL, V85, P635, DOI 10.1016/j.ejcb.2006.02.005; Kang HJ, 1996, SCIENCE, V273, P1402, DOI 10.1126/science.273.5280.1402; Kiick KL, 2002, P NATL ACAD SCI USA, V99, P19, DOI 10.1073/pnas.012583299; Lewin GR, 1996, ANNU REV NEUROSCI, V19, P289, DOI 10.1146/annurev.ne.19.030196.001445; Liao L, 2007, J PROTEOME RES, V6, P1059, DOI 10.1021/pr060358f; Lin MZ, 2008, P NATL ACAD SCI USA, V105, P7744, DOI 10.1073/pnas.0803060105; Link AJ, 2003, CURR OPIN BIOTECH, V14, P603, DOI 10.1016/j.copbio.2003.10.011; Link AJ, 2003, J AM CHEM SOC, V125, P11164, DOI 10.1021/ja036765z; Macchi P, 2003, MOL BIOL CELL, V14, P1570, DOI 10.1091/mbc.E02-08-0505; Manadas B, 2009, J PROTEOME RES, V8, P4536, DOI 10.1021/pr900366x; Martin KC, 1997, CELL, V91, P927, DOI 10.1016/S0092-8674(00)80484-5; NGUYEN PV, 1994, SCIENCE, V265, P1104, DOI 10.1126/science.8066450; Ouyang Y, 1997, J NEUROSCI, V17, P5416; Ouyang Y, 1999, J NEUROSCI, V19, P7823; RENNER M, 2005, NEURON IN PRESS; Renner M, 2009, J NEUROSCI, V29, P2926, DOI 10.1523/JNEUROSCI.4445-08.2009; Renner M, 2008, CURR OPIN NEUROBIOL, V18, P532, DOI 10.1016/j.conb.2008.09.009; Renner ML, 2009, NEUROPHARMACOLOGY, V56, P30, DOI 10.1016/j.neuropharm.2008.07.022; Rostovtsev VV, 2002, ANGEW CHEM INT EDIT, V41, P2596, DOI 10.1002/1521-3773(20020715)41:14<2596::AID-ANIE2596>3.0.CO;2-4; Sajikumar S, 2007, J NEUROSCI, V27, P5068, DOI 10.1523/JNEUROSCI.4940-06.2007; Serge A, 2002, J NEUROSCI, V22, P3910, DOI 10.1523/JNEUROSCI.22-10-03910.2002; Steward O, 1997, NEURON, V18, P9, DOI 10.1016/S0896-6273(01)80041-6; Sutton MA, 2006, CELL, V127, P49, DOI 10.1016/j.cell.2006.09.014; Takei N, 2004, J NEUROSCI, V24, P9760, DOI 10.1523/JNEUROSCI.1427-04.2004; Taylor AM, 2010, NEURON, V66, P57, DOI 10.1016/j.neuron.2010.03.022; Villareal G, 2007, CURR BIOL, V17, P2073, DOI 10.1016/j.cub.2007.10.053; Wang DO, 2009, SCIENCE, V324, P1536, DOI 10.1126/science.1173205; Wang Q, 2003, J AM CHEM SOC, V125, P3192, DOI 10.1021/ja021381e; Waung MW, 2008, NEURON, V59, P84, DOI 10.1016/j.neuron.2008.05.014; WEILER IJ, 1994, PROG BRAIN RES, V100, P189; WHITAKER JE, 1992, ANAL BIOCHEM, V207, P267, DOI 10.1016/0003-2697(92)90011-U; Zhang ZW, 2003, BIOCHEMISTRY-US, V42, P6735, DOI 10.1021/bi0300231	48	302	309	5	76	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2010	13	7					897	U149		10.1038/nn.2580	http://dx.doi.org/10.1038/nn.2580			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	615YF	20543841	Green Accepted			2022-12-24	WOS:000279173900024
J	Cohen, JR; Asarnow, RF; Sabb, FW; Bilder, RM; Bookheimer, SY; Knowlton, BJ; Poldrack, RA				Cohen, Jessica R.; Asarnow, Robert F.; Sabb, Fred W.; Bilder, Robert M.; Bookheimer, Susan Y.; Knowlton, Barbara J.; Poldrack, Russell A.			A unique adolescent response to reward prediction errors	NATURE NEUROSCIENCE			English	Article							ORBITOFRONTAL CORTEX; DECISION; BRAIN; RISK; ACCUMBENS; STRIATUM; VALUES; ADULTS	Previous work has shown that human adolescents may be hypersensitive to rewards, but it is not known which aspect of reward processing is responsible for this. We separated decision value and prediction error signals and found that neural prediction error signals in the striatum peaked in adolescence, whereas neural decision value signals varied depending on how value was modeled. This suggests that heightened dopaminergic prediction error responsivity contributes to adolescent reward seeking.	[Asarnow, Robert F.; Sabb, Fred W.; Bilder, Robert M.; Bookheimer, Susan Y.; Poldrack, Russell A.] Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90024 USA; [Sabb, Fred W.; Bilder, Robert M.; Bookheimer, Susan Y.; Knowlton, Barbara J.; Poldrack, Russell A.] Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90024 USA; [Cohen, Jessica R.; Bilder, Robert M.; Bookheimer, Susan Y.; Knowlton, Barbara J.; Poldrack, Russell A.] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Cohen, JR (corresponding author), Univ Calif Berkeley, Berkeley, CA 94720 USA.	jrcohen@berkeley.edu	Bilder, Robert M/A-8894-2008	Bilder, Robert M/0000-0001-5085-7852; Bookheimer, Susan/0000-0002-3417-5891; Poldrack, Russell/0000-0001-6755-0259	National Institute of Mental Health [(5R24 MH072697]; National Institute of Drug Abuse [5F31 DA024534]; James S. McDonnell Foundation; Della Martin Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R24MH072697] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [F31DA024534] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); James S. McDonnell Foundation; Della Martin Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was supported by the National Institute of Mental Health (5R24 MH072697), the National Institute of Drug Abuse (5F31 DA024534), the James S. McDonnell Foundation and the Della Martin Foundation.	Berridge KC, 1998, BRAIN RES REV, V28, P309, DOI 10.1016/S0165-0173(98)00019-8; Bjork JM, 2004, J NEUROSCI, V24, P1793, DOI 10.1523/JNEUROSCI.4862-03.2004; Casey BJ, 2008, DEV REV, V28, P62, DOI [10.1016/j.dr.2007.08.003, 10.1196/annals.1440.010]; Chib VS, 2009, J NEUROSCI, V29, P12315, DOI 10.1523/JNEUROSCI.2575-09.2009; D'Ardenne K, 2008, SCIENCE, V319, P1264, DOI 10.1126/science.1150605; Ernst M, 2005, NEUROIMAGE, V25, P1279, DOI 10.1016/j.neuroimage.2004.12.038; Galvan A, 2006, J NEUROSCI, V26, P6885, DOI 10.1523/JNEUROSCI.1062-06.2006; Hare TA, 2008, J NEUROSCI, V28, P5623, DOI 10.1523/JNEUROSCI.1309-08.2008; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Knowlton BJ, 1996, SCIENCE, V273, P1399, DOI 10.1126/science.273.5280.1399; May JC, 2004, BIOL PSYCHIAT, V55, P359, DOI 10.1016/j.biopsych.2003.11.008; Pagnoni G, 2002, NAT NEUROSCI, V5, P97, DOI 10.1038/nn802; Rescorla R., 1972, CLASSICAL CONDITION, DOI DOI 10.1101/GR.110528.110; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Tom SM, 2007, SCIENCE, V315, P515, DOI 10.1126/science.1134239	15	189	189	3	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2010	13	6					669	671		10.1038/nn.2558	http://dx.doi.org/10.1038/nn.2558			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	600QY	20473290	Green Submitted, Green Accepted			2022-12-24	WOS:000278003300010
J	Figner, B; Knoch, D; Johnson, EJ; Krosch, AR; Lisanby, SH; Fehr, E; Weber, EU				Figner, Bernd; Knoch, Daria; Johnson, Eric J.; Krosch, Amy R.; Lisanby, Sarah H.; Fehr, Ernst; Weber, Elke U.			Lateral prefrontal cortex and self-control in intertemporal choice	NATURE NEUROSCIENCE			English	Article							REWARDS; IMMEDIATE	Disruption of function of left, but not right, lateral prefrontal cortex (LPFC) with low-frequency repetitive transcranial magnetic stimulation (rTMS) increased choices of immediate rewards over larger delayed rewards. rTMS did not change choices involving only delayed rewards or valuation judgments of immediate and delayed rewards, providing causal evidence for a neural lateral-prefrontal cortex-based self-control mechanism in intertemporal choice.	[Figner, Bernd; Johnson, Eric J.; Krosch, Amy R.; Weber, Elke U.] Columbia Univ, Ctr Decis Sci, New York, NY 10027 USA; [Figner, Bernd; Weber, Elke U.] Columbia Univ, Dept Psychol, New York, NY 10027 USA; [Knoch, Daria] Univ Basel, Dept Psychol, Basel, Switzerland; [Johnson, Eric J.; Weber, Elke U.] Columbia Univ, Grad Sch Business, New York, NY 10027 USA; [Krosch, Amy R.] NYU, Dept Psychol, New York, NY 10003 USA; [Lisanby, Sarah H.] Columbia Univ, Div Brain Stimulat & Therapeut Modulat, New York, NY USA; [Fehr, Ernst] Univ Zurich, Inst Empir Res Econ, Zurich, Switzerland	Columbia University; Columbia University; University of Basel; Columbia University; New York University; Columbia University; University of Zurich	Figner, B (corresponding author), Columbia Univ, Ctr Decis Sci, New York, NY 10027 USA.	bf2151@columbia.edu	Lisanby, Sarah Hollingsworth/ABE-9003-2020; Johnson, Eric/C-5668-2012; Krosch, Amy/B-9175-2009; Lisanby, Sarah Hollingsworth/T-3918-2019; Knoch, Daria/H-7324-2012	Lisanby, Sarah Hollingsworth/0000-0003-2037-6470; Johnson, Eric/0000-0001-7797-8347; Lisanby, Sarah Hollingsworth/0000-0003-2037-6470; 	Swiss National Science Foundation [PA001-15327, PBZH1-110268, PP00P1-123381]; US National Science Foundation [SES-0720932, SES-0922743]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); US National Science Foundation(National Science Foundation (NSF))	We thank P. Glimcher, A. Rangel and T. Hare for valuable comments on an earlier draft of this manuscript. This research was supported by Swiss National Science Foundation fellowships (PA001-15327 and PBZH1-110268) to B.F., US National Science Foundation grants (SES-0720932 and SES-0922743) to B.F. and E.U.W. and a Swiss National Science Foundation grant (PP00P1-123381) to D. K.	Ballard K, 2009, NEUROIMAGE, V45, P143, DOI 10.1016/j.neuroimage.2008.11.004; Eisenegger C, 2008, NEUROIMAGE, V42, P379, DOI 10.1016/j.neuroimage.2008.04.172; Green L, 2004, PSYCHOL BULL, V130, P769, DOI 10.1037/0033-2909.130.5.769; Hare TA, 2009, SCIENCE, V324, P646, DOI 10.1126/science.1168450; Kable JW, 2007, NAT NEUROSCI, V10, P1625, DOI 10.1038/nn2007; Knoch D, 2007, ANN NY ACAD SCI, V1104, P123, DOI 10.1196/annals.1390.004; Luo S, 2009, J NEUROSCI, V29, P14820, DOI 10.1523/JNEUROSCI.4261-09.2009; McClure SM, 2004, SCIENCE, V306, P503, DOI 10.1126/science.1100907; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167	9	432	467	9	159	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2010	13	5					538	539		10.1038/nn.2516	http://dx.doi.org/10.1038/nn.2516			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	588JM	20348919	Green Accepted			2022-12-24	WOS:000277065700010
J	Fritsch, B; Reis, J; Martinowich, K; Schambra, HM; Ji, YY; Cohen, LG; Lu, B				Fritsch, Brita; Reis, Janine; Martinowich, Ken; Schambra, Heidi M.; Ji, Yuanyuan; Cohen, Leonardo G.; Lu, Bai			Direct Current Stimulation Promotes BDNF-Dependent Synaptic Plasticity: Potential Implications for Motor Learning	NEURON			English	Article							LONG-TERM POTENTIATION; NONINVASIVE CORTICAL STIMULATION; VAL66MET POLYMORPHISM; NEUROTROPHIC FACTOR; EXCITABILITY SHIFTS; CEREBRAL-CORTEX; MEMORY; MODULATION; MECHANISMS; NEURONS	Despite its increasing use in experimental and clinical settings, the cellular and molecular mechanisms underlying transcranial direct current stimulation (tDCS) remain unknown. Anodal tDCS applied to the human motor cortex (M1) improves motor skill learning. Here, we demonstrate in mouse M1 slices that DCS induces a long-lasting synaptic potentiation (DCS-LTP), which is polarity specific, NMDA receptor dependent, and requires coupling of DCS with repetitive low-frequency synaptic activation (LFS). Combined DCS and LFS enhance BDNF-secretion and TrkB activation, and DCS-LTP is absent in BDNF and TrkB mutant mice, suggesting that BDNF is a key mediator of this phenomenon. Moreover, the BDNF val66met polymorphism known to partially affect activity-dependent BDNF secretion impairs motor skill acquisition in humans and mice. Motor learning is enhanced by anodal tDCS, as long as activity-dependent BDNF secretion is in place. We propose that tDCS may improve motor skill learning through augmentation of synaptic plasticity that requires BDNF secretion and TrkB activation within M1.	[Reis, Janine; Schambra, Heidi M.; Cohen, Leonardo G.] NINDS, Human Cort Physiol & Stroke Neurorehabil Sect, NIH, Bethesda, MD 20892 USA; [Fritsch, Brita] NINDS, Epilepsy Res Sect, NIH, Bethesda, MD 20892 USA; [Fritsch, Brita; Reis, Janine] Univ Freiburg, Dept Neurol, D-79106 Freiburg, Germany; [Ji, Yuanyuan; Lu, Bai] NICHHD, Lab Cellular & Synapt Neurophysiol, Bethesda, MD 20892 USA; [Martinowich, Ken; Lu, Bai] NIMH, Gene Cognit & Psychosis Program GCAP, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); University of Freiburg; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Cohen, LG (corresponding author), NINDS, Human Cort Physiol & Stroke Neurorehabil Sect, NIH, Bethesda, MD 20892 USA.	cohenl@ninds.nih.gov; bai.b.lu@gsk.com	Lu, Bai/A-4018-2012; Martinowich, Keri/F-9841-2012	Fritsch, Brita/0000-0003-4884-9049; Lu, Bai/0000-0001-5418-9759; Martinowich, Keri/0000-0002-5237-0789	NINDS, NIH; Alexander von Humboldt Foundation Germany; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS002978] Funding Source: NIH RePORTER	NINDS, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Alexander von Humboldt Foundation Germany(Alexander von Humboldt Foundation); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by the NINDS Intramural Research Program, NIH (B.F., JR., H.M.S.), and the Alexander von Humboldt Foundation Germany (JR.). We thank J.W. Krakauer and P.A. Celnik for helpful comments and for their involvement in the previous characterization of the motor task utilized. We thank F. Lee, A. Morozov, and D. Ginty (transgenic animals), D. Ide and A. Mitz (field measurements), and D. Brandsch and K. Spies (data analysis).	Akaneya Y, 1997, J NEUROSCI, V17, P6707; Balkowiec A, 2002, J NEUROSCI, V22, P10399; BINDMAN LJ, 1962, NATURE, V196, P584, DOI 10.1038/196584a0; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; CASTROALAMANCOS MA, 1995, J NEUROSCI, V15, P5324; Cheeran B, 2008, J PHYSIOL-LONDON, V586, P5717, DOI 10.1113/jphysiol.2008.159905; Chen X, 2005, NEURON, V46, P13, DOI 10.1016/j.neuron.2005.03.009; Chen ZY, 2006, SCIENCE, V314, P140, DOI 10.1126/science.1129663; CREUTZFELDT O, 1962, EXP NEUROL, V5, P436, DOI 10.1016/0014-4886(62)90056-0; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; Ferrucci R, 2008, NEUROLOGY, V71, P493, DOI 10.1212/01.wnl.0000317060.43722.a3; GARTSIDE IB, 1968, NATURE, V220, P382, DOI 10.1038/220382a0; Hess G, 1996, J NEUROPHYSIOL, V75, P1765, DOI 10.1152/jn.1996.75.5.1765; Hummel F, 2005, BRAIN, V128, P490, DOI 10.1093/brain/awh369; Kleim JA, 2006, NAT NEUROSCI, V9, P735, DOI 10.1038/nn1699; Lu B, 2003, NEURON, V39, P735, DOI 10.1016/S0896-6273(03)00538-5; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; Mattson MP, 2008, ANN NY ACAD SCI, V1144, P97, DOI 10.1196/annals.1418.005; McHughen SA, 2010, CEREB CORTEX, V20, P1254, DOI 10.1093/cercor/bhp189; Miranda PC, 2006, CLIN NEUROPHYSIOL, V117, P1623, DOI 10.1016/j.clinph.2006.04.009; Muellbacher W, 2002, NATURE, V415, P640, DOI 10.1038/nature712; Nagappan G, 2009, P NATL ACAD SCI USA, V106, P1267, DOI 10.1073/pnas.0807322106; Nitsche MA, 2004, EUR J NEUROSCI, V19, P2720, DOI 10.1111/j.0953-816X.2004.03398.x; Nitsche MA, 2003, J COGNITIVE NEUROSCI, V15, P619, DOI 10.1162/089892903321662994; Nitsche MA, 2000, J PHYSIOL-LONDON, V527, P633, DOI 10.1111/j.1469-7793.2000.t01-1-00633.x; Nitsche MA, 2003, J PHYSIOL-LONDON, V553, P293, DOI 10.1113/jphysiol.2003.049916; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; Pang PT, 2004, SCIENCE, V306, P487, DOI 10.1126/science.1100135; PURPURA DP, 1965, J NEUROPHYSIOL, V28, P166, DOI 10.1152/jn.1965.28.1.166; Radman T, 2007, J NEUROSCI, V27, P3030, DOI 10.1523/JNEUROSCI.0095-07.2007; Radman T, 2009, BRAIN STIMUL, V2, P215, DOI 10.1016/j.brs.2009.03.007; Reis J, 2009, P NATL ACAD SCI USA, V106, P1590, DOI 10.1073/pnas.0805413106; Rioult-Pedotti MS, 2000, SCIENCE, V290, P533, DOI 10.1126/science.290.5491.533; Spruston N, 2008, NAT REV NEUROSCI, V9, P206, DOI 10.1038/nrn2286; Stagg CJ, 2009, J NEUROSCI, V29, P5202, DOI 10.1523/JNEUROSCI.4432-08.2009; Tanaka JI, 2008, SCIENCE, V319, P1683, DOI 10.1126/science.1152864; UNGERLEIDER LG, 1995, SCIENCE, V270, P769, DOI 10.1126/science.270.5237.769; Wagner T, 2007, NEUROIMAGE, V35, P1113, DOI 10.1016/j.neuroimage.2007.01.027; Wassermann EM, 2005, TRENDS COGN SCI, V9, P503, DOI 10.1016/j.tics.2005.09.001; Zakharenko SS, 2003, NEURON, V39, P975, DOI 10.1016/S0896-6273(03)00543-9	41	867	913	3	157	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 29	2010	66	2					198	204		10.1016/j.neuron.2010.03.035	http://dx.doi.org/10.1016/j.neuron.2010.03.035			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	591NQ	20434997	Green Accepted, Bronze			2022-12-24	WOS:000277308200006
J	Juntti, SA; Tollkuhn, J; Wu, MV; Fraser, EJ; Soderborg, T; Tan, S; Honda, S; Harada, N; Shah, NM				Juntti, Scott A.; Tollkuhn, Jessica; Wu, Melody V.; Fraser, Eleanor J.; Soderborg, Taylor; Tan, Stella; Honda, Shin-ichiro; Harada, Nobuhiro; Shah, Nirao M.			The Androgen Receptor Governs the Execution, but Not Programming, of Male Sexual and Territorial Behaviors	NEURON			English	Article							MESSENGER-RIBONUCLEIC-ACID; MICE LACKING; TESTICULAR FEMINIZATION; PREOPTIC AREA; BED NUCLEUS; INTERMALE AGGRESSION; STRIA TERMINALIS; MATING-BEHAVIOR; MOUSE-BRAIN; FEMALE MICE	Testosterone and estrogen are essential for male behaviors in vertebrates. How these two signaling pathways interact to control masculinization of the brain and behavior remains to be established. Circulating testosterone activates the androgen receptor (AR) and also serves as the source of estrogen in the brain. We have used a genetic strategy to delete AR specifically in the mouse nervous system. This approach permits us to determine the function of AR in sexually dimorphic behaviors in males while maintaining circulating testosterone levels within the normal range. We find that AR mutant males exhibit masculine sexual and territorial displays, but they have striking deficits in specific components of these behaviors. Taken together with the surprisingly limited expression of AR in the developing brain, our findings indicate that testosterone acts as a precursor to estrogen to masculinize the brain and behavior, and signals via AR to control the levels of male behavioral displays.	[Juntti, Scott A.; Wu, Melody V.; Shah, Nirao M.] Univ Calif San Francisco, Grad Program Neurosci, San Francisco, CA 94158 USA; [Fraser, Eleanor J.; Shah, Nirao M.] Univ Calif San Francisco, Grad Program Genet, San Francisco, CA 94158 USA; [Tollkuhn, Jessica; Soderborg, Taylor; Tan, Stella; Shah, Nirao M.] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94158 USA; [Shah, Nirao M.] Univ Calif San Francisco, Ctr Reprod Sci, San Francisco, CA 94158 USA; [Honda, Shin-ichiro; Harada, Nobuhiro] Fujita Hlth Univ, Dept Biochem, Aichi 4701192, Japan	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Fujita Health University	Shah, NM (corresponding author), Univ Calif San Francisco, Grad Program Neurosci, MC2722, San Francisco, CA 94158 USA.	nms@ucsf.edu		Tollkuhn, Jessica/0000-0001-5991-7620; Juntti, Scott/0000-0001-7634-1395; Wu, Melody/0000-0002-5246-2659	NSF; NIH NRSA [HD0612472]; Edward Mallinckrodt, Jr. Foundation; McKnight Foundation for Neuroscience; NIH [R01NS049488, DP1OD006425]; Grants-in-Aid for Scientific Research [22591019] Funding Source: KAKEN; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS049488] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD006425] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Edward Mallinckrodt, Jr. Foundation; McKnight Foundation for Neuroscience; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank K. de Gendt, G. Verhoeven, and M. Breedlove for providing us with the AIR<SUP>loxP/+</SUP> mouse strain; and L. Frank and E. Tumer for advice on statistics. We thank T. Clandinin, D. Julius, H. Ingraham, and S. Lomvardas for comments on the manuscript; and D. Anderson, R. Axel, and members of the Shah laboratory for discussions. Histological images were acquired at the UCSF Nikon Imaging Center. This work was supported by NSF graduate fellowships (S.A.J., E.J.F.); NIH NRSA F32 (J.T.; #HD0612472); the Edward Mallinckrodt, Jr. Foundation; the McKnight Foundation for Neuroscience; and NIH (N.M.S.; #R01NS049488, DP1OD006425).	AlShamma HA, 1996, J NEUROBIOL, V29, P91, DOI 10.1002/(SICI)1097-4695(199601)29:1<91::AID-NEU7>3.0.CO;2-2; Amateau SK, 2004, NAT NEUROSCI, V7, P643, DOI 10.1038/nn1254; Arai Y, 1996, NEUROSCI RES, V25, P403; Arnold AP, 2003, ANN NY ACAD SCI, V1007, P176, DOI 10.1196/annals.1286.018; Bakker J, 2006, NAT NEUROSCI, V9, P220, DOI 10.1038/nn1624; Balthazart J, 1998, TRENDS NEUROSCI, V21, P243, DOI 10.1016/S0166-2236(97)01221-6; BAYER SA, 1987, J COMP NEUROL, V265, P65, DOI 10.1002/cne.902650106; BAYER SA, 1980, J COMP NEUROL, V194, P845, DOI 10.1002/cne.901940409; Bodo C, 2008, ENDOCRINOLOGY, V149, P4142, DOI 10.1210/en.2008-0183; Bodo C, 2007, EUR J NEUROSCI, V25, P2182, DOI 10.1111/j.1460-9568.2007.05484.x; COMMINS D, 1984, BRAIN RES BULL, V13, P185, DOI 10.1016/0361-9230(84)90020-0; Crocoll A, 1998, MECH DEVELOP, V72, P175, DOI 10.1016/S0925-4773(98)00007-0; Davis EC, 1996, BRAIN RES, V734, P10, DOI 10.1016/0006-8993(96)00298-3; De Gendt K, 2004, P NATL ACAD SCI USA, V101, P1327, DOI 10.1073/pnas.0308114100; DESJARDINS C, 1973, SCIENCE, V182, P939, DOI 10.1126/science.182.4115.939; Dugger BN, 2007, HORM BEHAV, V51, P195, DOI 10.1016/j.yhbeh.2006.10.001; Dupont S, 2000, DEVELOPMENT, V127, P4277; EDWARDS DA, 1971, HORM BEHAV, V2, P49, DOI 10.1016/0018-506X(71)90037-7; FINNEY HC, 1976, HORM BEHAV, V7, P391, DOI 10.1016/0018-506X(76)90010-6; Forger NG, 2009, J NEUROENDOCRINOL, V21, P393, DOI 10.1111/j.1365-2826.2009.01825.x; Goy R. W., 1980, SEXUAL DIFFERENTIATI; Han TM, 2003, J NEUROBIOL, V54, P502, DOI 10.1002/neu.10157; HARADA N, 1992, ENDOCRINOLOGY, V131, P2306, DOI 10.1210/en.131.5.2306; Hoch RV, 2009, SEMIN CELL DEV BIOL, V20, P378, DOI 10.1016/j.semcdb.2009.02.005; Holmes MM, 2009, NEUROSCIENCE, V158, P1251, DOI 10.1016/j.neuroscience.2008.11.020; Honda S, 1998, BIOCHEM BIOPH RES CO, V252, P445, DOI 10.1006/bbrc.1998.9672; Ishikawa T, 2006, J STEROID BIOCHEM, V98, P133, DOI 10.1016/j.jsbmb.2005.09.004; Juntti SA, 2008, HORM BEHAV, V53, P627, DOI 10.1016/j.yhbeh.2007.12.012; Jyotika J, 2007, DEV NEUROBIOL, V67, P1511, DOI 10.1002/dneu.20525; Keverne EB, 2004, PHYSIOL BEHAV, V83, P177, DOI 10.1016/j.physbeh.2004.08.013; Kim YH, 2004, J COMP NEUROL, V469, P535, DOI 10.1002/cne.11033; Kimchi T, 2007, NATURE, V448, P1009, DOI 10.1038/nature06089; KIMURA T, 1985, HORM BEHAV, V19, P64, DOI 10.1016/0018-506X(85)90006-6; Kondo Y, 1998, BEHAV BRAIN RES, V91, P213; Liu YC, 1997, J NEUROSCI, V17, P5245; LYON MF, 1970, NATURE, V227, P1217, DOI 10.1038/2271217a0; MACLUSKY NJ, 1981, SCIENCE, V211, P1294, DOI 10.1126/science.6163211; Mandiyan VS, 2005, NAT NEUROSCI, V8, P1660, DOI 10.1038/nn1589; Martel KL, 2009, J NEUROSCI, V29, P7658, DOI 10.1523/JNEUROSCI.1311-09.2009; McAbee MD, 1999, ENDOCRINOLOGY, V140, P1807, DOI 10.1210/en.140.4.1807; McAbee MD, 1999, ENDOCRINOLOGY, V140, P3674, DOI 10.1210/en.140.8.3674; McAbee MD, 1998, ENDOCRINOLOGY, V139, P1738, DOI 10.1210/en.139.4.1738; Mccarthy MM, 2008, PHYSIOL REV, V88, P91, DOI 10.1152/physrev.00010.2007; McGILL THOMAS E., 1962, BEHAVIOUR, V19, P341, DOI 10.1163/156853962X00087; Meisel Robert L., 1994, P3; Miczek KA, 2001, BEHAV BRAIN RES, V125, P167, DOI 10.1016/S0166-4328(01)00298-4; Morris JA, 2004, NAT NEUROSCI, V7, P1034, DOI 10.1038/nn1325; MOTELICAHEINO I, 1993, PHYSIOL BEHAV, V53, P1017, DOI 10.1016/0031-9384(93)90284-M; MOTELICAHEINO I, 1988, J STEROID BIOCHEM, V31, P283, DOI 10.1016/0022-4731(88)90351-2; NAFTOLIN F, 1975, J STEROID BIOCHEM, V6, P993, DOI 10.1016/0022-4731(75)90340-4; NYBY J, 1977, ANIM BEHAV, V25, P333, DOI 10.1016/0003-3472(77)90009-4; Ogawa S, 1997, P NATL ACAD SCI USA, V94, P1476, DOI 10.1073/pnas.94.4.1476; Ogawa S, 2000, P NATL ACAD SCI USA, V97, P14737, DOI 10.1073/pnas.250473597; OHNO S, 1974, CELL, V3, P235, DOI 10.1016/0092-8674(74)90137-8; Olsen Kathie L., 1992, V11, P1; Pak TR, 2005, ENDOCRINOLOGY, V146, P147, DOI 10.1210/en.2004-0871; Pankevich DE, 2004, J NEUROSCI, V24, P9451, DOI 10.1523/JNEUROSCI.2376-04.2004; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Paxinos G., 2007, ATLAS DEV MOUSE BRAI; Perez SE, 2003, DEV BRAIN RES, V145, P117, DOI 10.1016/S0165-3806(03)00223-2; PETERS PJ, 1972, PHYSIOL BEHAV, V8, P265, DOI 10.1016/0031-9384(72)90371-X; PHOENIX CH, 1959, ENDOCRINOLOGY, V65, P369, DOI 10.1210/endo-65-3-369; Raskin K, 2009, J NEUROSCI, V29, P4461, DOI 10.1523/JNEUROSCI.0296-09.2009; Roselli CE, 2009, SEMIN REPROD MED, V27, P207, DOI 10.1055/s-0029-1216274; Sato T, 2004, P NATL ACAD SCI USA, V101, P1673, DOI 10.1073/pnas.0305303101; Schulz KM, 2009, HORM BEHAV, V55, P597, DOI 10.1016/j.yhbeh.2009.03.010; Scordalakes EM, 2004, GENES BRAIN BEHAV, V3, P20, DOI 10.1111/j.1601-183X.2004.00036.x; Shah NM, 2004, NEURON, V43, P313, DOI 10.1016/j.neuron.2004.07.008; Sikora MJ, 2009, BREAST CANCER RES TR, V115, P289, DOI 10.1007/s10549-008-0080-8; SIMERLY RB, 1990, J COMP NEUROL, V294, P76, DOI 10.1002/cne.902940107; Simerly RB, 1997, P NATL ACAD SCI USA, V94, P14077, DOI 10.1073/pnas.94.25.14077; Stowers L, 2002, SCIENCE, V295, P1493, DOI 10.1126/science.1069259; Toda K, 2001, J ENDOCRINOL, V168, P455, DOI 10.1677/joe.0.1680455; Toda K, 2001, J ENDOCRINOL, V168, P217, DOI 10.1677/joe.0.1680217; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; WALLIS CJ, 1975, J ENDOCRINOL, V66, P257, DOI 10.1677/joe.0.0660257; Waters EM, 2009, J NEUROSCI, V29, P9714, DOI 10.1523/JNEUROSCI.0135-09.2009; Weihua Zhang, 2001, Proceedings of the National Academy of Sciences of the United States of America, V98, P6330, DOI 10.1073/pnas.111150898; Wersinger SR, 1997, HORM BEHAV, V32, P176, DOI 10.1006/hbeh.1997.1419; WHALEN RE, 1963, SCIENCE, V141, P273, DOI 10.1126/science.141.3577.273; Wolfe CA, 2005, DEV BRAIN RES, V157, P34, DOI 10.1016/j.devbrainres.2005.03.001; Wu MV, 2009, CELL, V139, P61, DOI 10.1016/j.cell.2009.07.036; Yoon HY, 2005, CELL, V123, P669, DOI 10.1016/j.cell.2005.08.039; Zuloaga DG, 2008, HORM BEHAV, V54, P758, DOI 10.1016/j.yhbeh.2008.08.004; Zuloaga DG, 2008, HORM BEHAV, V53, P613, DOI 10.1016/j.yhbeh.2008.01.013	85	151	154	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 29	2010	66	2					260	272		10.1016/j.neuron.2010.03.024	http://dx.doi.org/10.1016/j.neuron.2010.03.024			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	591NQ	20435002	Green Accepted, Bronze			2022-12-24	WOS:000277308200011
J	Abraham, NM; Egger, V; Shimshek, DR; Renden, R; Fukunaga, I; Sprengel, R; Seeburg, PH; Klugmann, M; Margrie, TW; Schaefer, AT; Kuner, T				Abraham, Nixon M.; Egger, Veronica; Shimshek, Derya R.; Renden, Robert; Fukunaga, Izumi; Sprengel, Rolf; Seeburg, Peter H.; Klugmann, Matthias; Margrie, Troy W.; Schaefer, Andreas T.; Kuner, Thomas			Synaptic Inhibition in the Olfactory Bulb Accelerates Odor Discrimination in Mice	NEURON			English	Article							GRANULE CELLS; DENDRODENDRITIC INHIBITION; LATERAL INHIBITION; NMDA RECEPTORS; AMPA RECEPTORS; GABA RELEASE; GLUR-B; GLUTAMATE RECEPTORS; RECIPROCAL SYNAPSES; CALCIUM INFLUX	Local inhibitory circuits are thought to shape neuronal information processing in the central nervous system, but it remains unclear how specific properties of inhibitory neuronal interactions translate into behavioral performance. In the olfactory bulb, inhibition of mitral/tufted cells via granule cells may contribute to odor discrimination behavior by refining neuronal representations of odors. Here we show that selective deletion of the AMPA receptor subunit GluA2 in granule cells boosted synaptic Ca2+ influx, increasing inhibition of mitral cells. On a behavioral level, discrimination of similar odor mixtures was accelerated while leaving learning and memory unaffected. In contrast, selective removal of NMDA receptors in granule cells slowed discrimination of similar odors. Our results demonstrate that inhibition of mitral cells controlled by granule cell glutamate receptors results in fast and accurate discrimination of similar odors. Thus, spatiotemporally defined molecular perturbations of olfactory bulb granule cells directly link stimulus similarity, neuronal processing time, and discrimination behavior to synaptic inhibition.	[Abraham, Nixon M.; Schaefer, Andreas T.; Kuner, Thomas] Max Planck Inst Med Res, WIN Olfactory Dynam Grp, D-69120 Heidelberg, Germany; [Shimshek, Derya R.; Sprengel, Rolf; Seeburg, Peter H.] Max Planck Inst Med Res, Dept Mol Neurobiol, D-69120 Heidelberg, Germany; [Fukunaga, Izumi; Schaefer, Andreas T.] Max Planck Inst Med Res, SNWG Behav Neurophysiol, D-69120 Heidelberg, Germany; [Abraham, Nixon M.; Renden, Robert; Kuner, Thomas] Univ Heidelberg, Inst Anat & Cell Biol, D-69120 Heidelberg, Germany; [Egger, Veronica] LMU, Inst Physiol, D-80336 Munich, Germany; [Klugmann, Matthias] Univ Auckland, Dept Mol Med & Pathol, Auckland 1, New Zealand; [Margrie, Troy W.; Schaefer, Andreas T.] UCL, Dept Neurosci Physiol & Pharmacol, London WC1E 6JJ, England	Max Planck Society; Max Planck Society; Max Planck Society; Ruprecht Karls University Heidelberg; University of Munich; University of Auckland; University of London; University College London	Schaefer, AT (corresponding author), Max Planck Inst Med Res, WIN Olfactory Dynam Grp, Jahnstr 29, D-69120 Heidelberg, Germany.	schaefer@mpimf-heidelberg.mpg.de; kuner@uni-heidelberg.de	Renden, Robert/AAC-8294-2020; Abraham, Nixon/R-8381-2016	Renden, Robert/0000-0001-7905-4789; Abraham, Nixon/0000-0001-8523-716X; Shimshek, Derya/0000-0001-8602-7850; Schaefer, Andreas/0000-0002-4677-8788	Heidelberger Akademie der Wissenschaften; University of Heidelberg; Leopoldina Akademie der Naturforscher; EMBO; Bauer-Foundation; BBSRC; DFG [KU1983/2]; Max-Planck-Gesellschaft; MRC [MC_U117597156] Funding Source: UKRI; Medical Research Council [MC_U117597156] Funding Source: researchfish	Heidelberger Akademie der Wissenschaften; University of Heidelberg; Leopoldina Akademie der Naturforscher; EMBO(European Molecular Biology Organization (EMBO)); Bauer-Foundation; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); DFG(German Research Foundation (DFG)); Max-Planck-Gesellschaft(Max Planck Society); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank Bert Sakmann for generous support and hosting the WIN Olfactory Dynamics Group during the initial part of the project, Hartwig Spors for discussions and comments on earlier versions of the manuscript, Tansu Celikel for discussions, Bhavana Shrivastava for help with morphological analysis, Olga Stroh for performing some of the electrophysiological recordings in granule cells, Heinz Horstmann, Michaela Kaiser, Claudia Kocksch for technical assistance, Thorsten Bus for pilot experiments and help with breeding mice, and Kevin Martin for comments. This work was supported by the Heidelberger Akademie der Wissenschaften, a Medical Faculty of the University of Heidelberg Postdoctoral Fellowship, the Leopoldina Akademie der Naturforscher, EMBO, the Bauer-Foundation, the BBSRC, the DFG (research grant KU1983/2 (FOR 643)) and the Max-Planck-Gesellschaft. P.H.S., A.T.S., and T.K. are members of the CellNetworks - Cluster of Excellence (EXC81).	Abraham NM, 2004, NEURON, V44, P865, DOI 10.1016/j.neuron.2004.11.017; Aungst JL, 2003, NATURE, V426, P623, DOI 10.1038/nature02185; Balu R, 2007, J NEUROSCI, V27, P5621, DOI 10.1523/JNEUROSCI.4630-06.2007; BRUSA R, 1995, SCIENCE, V270, P1677, DOI 10.1126/science.270.5242.1677; Chavez AE, 2006, NATURE, V443, P705, DOI 10.1038/nature05123; Chen WR, 2000, NEURON, V25, P625, DOI 10.1016/S0896-6273(00)81065-X; Cleland TA, 2005, CHEM SENSES, V30, P801, DOI 10.1093/chemse/bji072; Collingridge GL, 2009, NEUROPHARMACOLOGY, V56, P2, DOI 10.1016/j.neuropharm.2008.06.063; Doucette W, 2007, LEARN MEMORY, V14, P539, DOI 10.1101/lm.606407; Egger V, 2005, J NEUROSCI, V25, P3521, DOI 10.1523/JNEUROSCI.4746-04.2005; Egger V, 2003, J NEUROSCI, V23, P7551; Eyre MD, 2009, EUR J NEUROSCI, V29, P1397, DOI 10.1111/j.1460-9568.2009.06703.x; Feldmeyer D, 1999, NAT NEUROSCI, V2, P57, DOI 10.1038/4561; Halabisky B, 2000, J NEUROSCI, V20, P5124; Isaacson JS, 2001, P NATL ACAD SCI USA, V98, P337, DOI 10.1073/pnas.021445798; Isaacson JS, 1998, NEURON, V20, P749, DOI 10.1016/S0896-6273(00)81013-2; JAHR CE, 1982, NATURE, V297, P227, DOI 10.1038/297227a0; JAHR CE, 1980, SCIENCE, V207, P1473, DOI 10.1126/science.7361098; JAHR CE, 1982, J PHYSIOL-LONDON, V326, P213, DOI 10.1113/jphysiol.1982.sp014187; Jardemark K, 1997, J NEUROPHYSIOL, V77, P702, DOI 10.1152/jn.1997.77.2.702; Jia ZP, 1996, NEURON, V17, P945, DOI 10.1016/S0896-6273(00)80225-1; Kauer JS, 2001, ANNU REV NEUROSCI, V24, P963, DOI 10.1146/annurev.neuro.24.1.963; Khan RM, 2004, NEURON, V44, P744, DOI 10.1016/j.neuron.2004.11.024; Klugmann M, 2005, MOL CELL NEUROSCI, V28, P347, DOI 10.1016/j.mcn.2004.10.002; Laurent G, 2001, ANNU REV NEUROSCI, V24, P263, DOI 10.1146/annurev.neuro.24.1.263; Leon M, 2003, BRAIN RES REV, V42, P23, DOI 10.1016/S0165-0173(03)00142-5; Luce R. D., 1986, RESPONSE TIMES; Margrie TW, 2002, PFLUG ARCH EUR J PHY, V444, P491, DOI 10.1007/s00424-002-0831-z; Margrie TW, 2001, P NATL ACAD SCI USA, V98, P319, DOI 10.1073/pnas.011523098; Margrie TW, 2003, J PHYSIOL-LONDON, V546, P363, DOI 10.1113/jphysiol.2002.031245; Monory K, 2006, NEURON, V51, P455, DOI 10.1016/j.neuron.2006.07.006; Montague AA, 1999, J COMP NEUROL, V405, P233, DOI 10.1002/(SICI)1096-9861(19990308)405:2<233::AID-CNE7>3.0.CO;2-A; Mori K, 1999, SCIENCE, V286, P711, DOI 10.1126/science.286.5440.711; NICOLL RA, 1969, BRAIN RES, V14, P157, DOI 10.1016/0006-8993(69)90037-7; NOWYCKY MC, 1981, J NEUROPHYSIOL, V46, P639, DOI 10.1152/jn.1981.46.3.639; Nusser Z, 2001, J NEUROPHYSIOL, V86, P2823, DOI 10.1152/jn.2001.86.6.2823; Passafaro M, 2003, NATURE, V424, P677, DOI 10.1038/nature01781; PHILLIPS CG, 1963, J PHYSIOL-LONDON, V168, P65, DOI 10.1113/jphysiol.1963.sp007178; Pressler RT, 2006, NEURON, V49, P889, DOI 10.1016/j.neuron.2006.02.019; Rinberg D, 2006, NEURON, V51, P351, DOI 10.1016/j.neuron.2006.07.013; Saglietti L, 2007, NEURON, V54, P461, DOI 10.1016/j.neuron.2007.04.012; Sassoe-Pognetto M, 2000, J NEUROSCI, V20, P2192; Schaefer AT, 2007, TRENDS NEUROSCI, V30, P92, DOI 10.1016/j.tins.2007.01.001; Schaefer AT, 2006, PLOS BIOL, V4, P1010, DOI 10.1371/journal.pbio.0040163; SCHILD D, 1988, BIOPHYS J, V54, P1001, DOI 10.1016/S0006-3495(88)83038-8; Seeburg PH, 2001, BRAIN RES, V907, P233, DOI 10.1016/S0006-8993(01)02445-3; SHEPHERD GM, 1990, OLFACTORY BULB SYNAP, P133; Shepherd GM, 2007, BRAIN RES REV, V55, P373, DOI 10.1016/j.brainresrev.2007.03.005; Shimshek DR, 2005, PLOS BIOL, V3, P2017, DOI 10.1371/journal.pbio.0030354; Shimshek DR, 2006, MOL ENDOCRINOL, V20, P219, DOI 10.1210/me.2005-0262; Spors H, 2002, NEURON, V34, P301, DOI 10.1016/S0896-6273(02)00644-X; Tang W, 2009, J NEUROSCI, V29, P8621, DOI 10.1523/JNEUROSCI.0359-09.2009; Uchida N, 2003, NAT NEUROSCI, V6, P1224, DOI 10.1038/nn1142; Urban NN, 2002, PHYSIOL BEHAV, V77, P607, DOI 10.1016/S0031-9384(02)00895-8; WELLIS DP, 1994, J PHYSIOL-LONDON, V475, P419, DOI 10.1113/jphysiol.1994.sp020082; WELLIS DP, 1993, J PHYSIOL-LONDON, V469, P315, DOI 10.1113/jphysiol.1993.sp019816; Wimmer VC, 2004, PFLUG ARCH EUR J PHY, V449, P319, DOI 10.1007/s00424-004-1327-9; YOKOI M, 1995, P NATL ACAD SCI USA, V92, P3371, DOI 10.1073/pnas.92.8.3371	58	169	169	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 11	2010	65	3					399	411		10.1016/j.neuron.2010.01.009	http://dx.doi.org/10.1016/j.neuron.2010.01.009			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	564BF	20159452	Green Accepted, Bronze			2022-12-24	WOS:000275185200012
J	Edbauer, D; Neilson, JR; Foster, KA; Wang, CF; Seeburg, DP; Batterton, MN; Tada, T; Dolan, BM; Sharp, PA; Sheng, M				Edbauer, Dieter; Neilson, Joel R.; Foster, Kelly A.; Wang, Chi-Fong; Seeburg, Daniel P.; Batterton, Matthew N.; Tada, Tomoko; Dolan, Bridget M.; Sharp, Phillip A.; Sheng, Morgan			Regulation of Synaptic Structure and Function by FMRP-Associated MicroRNAs miR-125b and miR-132	NEURON			English	Article							X MENTAL-RETARDATION; DENDRITIC SPINE MORPHOGENESIS; GTPASE-ACTIVATING-PROTEIN; NMDA RECEPTORS; KNOCKOUT MICE; MOUSE MODEL; SUBUNIT COMPOSITION; NONCODING RNAS; MESSENGER-RNAS; AMPA RECEPTOR	MicroRNAs (miRNAs) are noncoding RNAs that suppress translation of specific mRNAs. The miRNA machinery interacts with fragile X mental retardation protein (FMRP), which functions as translational repressor. We show that miR-125b and miR-1 32, as well as several other miRNAs, are associated with FMRP in mouse brain. miR-125b and miR-132 had largely opposing effects on dendritic spine morphology and synaptic physiology in hippocampal neurons. FMRP knockdown ameliorates the effect of miRNA overexpression on spine morphology. We identified NMDA receptor subunit NR2A as a target of miR-125b and show that NR2A mRNA is specifically associated with FMRP in brain. In hippocampal neurons, NR2A expression is negatively regulated through its 3' UTR by FMRP, miR-125b, and Argonaute 1. Regulation of NR2A 3'UTR by FMRP depends in part on miR-125b. Because NMDA receptor subunit composition profoundly affects synaptic plasticity, these observations have implications for the pathophysiology of fragile X syndrome, in which plasticity is altered.	[Edbauer, Dieter; Foster, Kelly A.; Wang, Chi-Fong; Seeburg, Daniel P.; Batterton, Matthew N.; Tada, Tomoko; Dolan, Bridget M.; Sharp, Phillip A.; Sheng, Morgan] MIT, Dept Biol, Cambridge, MA 02319 USA; [Neilson, Joel R.; Sharp, Phillip A.] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02319 USA; [Edbauer, Dieter; Foster, Kelly A.; Wang, Chi-Fong; Seeburg, Daniel P.; Batterton, Matthew N.; Tada, Tomoko; Dolan, Bridget M.; Sheng, Morgan] MIT, Picower Inst Learning & Memory, Dept Brain & Cognit Sci, Cambridge, MA 02319 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Northwell Health	Edbauer, D (corresponding author), German Ctr Neurodegenerat Dis DZNE, D-80336 Munich, Germany.	dieter.edbauer@med.uni-muenchen.de; msheng@mit.edu	Xie, Huangming/B-2260-2012; Huang, H/E-9490-2010; Edbauer, Dieter/M-9906-2019	Edbauer, Dieter/0000-0002-7186-4653; Neilson, Joel R./0000-0002-3408-608X; Sheng, Morgan/0000-0002-8703-5366	Deutsche Forschungsgemeinschaft [ED157/1]; NCI [PO1-CA42063, P30-CA14051, K99-CA131474]; Investigator of the Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [P01CA042063, K99CA131474, P30CA014051] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Investigator of the Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are grateful for brain tissue from FMR1 KO mice provided by S. Tonegawa. We thank G. Bassell, J. Jaworski, T. Nakazawa, R. Tsien, and T. Yamamoto for reagents. We thank B. Bingol, Y. Chen, Y. Hayashi, H. Hsin, C. Nelson, and L.-H. Tsai for critical reading of the manuscript, D.E. received a postdoctoral fellowship from Deutsche Forschungsgemeinschaft (ED157/1) J.R.N. and P.A.S. were supported by NCI PO1-CA42063 to P.A.S. and partially by NCI P30-CA14051 Cancer Center Support (Core) Grant. J.R.N. was additionally supported by NCI K99-CA131474. M.S. was Investigator of the Howard Hughes Medical Institute.	Alvarez VA, 2007, J NEUROSCI, V27, P7365, DOI 10.1523/JNEUROSCI.0956-07.2007; Antar LN, 2004, J NEUROSCI, V24, P2648, DOI 10.1523/JNEUROSCI.0099-04.2004; Bagni C, 2005, NAT REV NEUROSCI, V6, P376, DOI 10.1038/nrn1667; BAKKER CE, 1994, CELL, V78, P23; Barria A, 2005, NEURON, V48, P289, DOI 10.1016/j.neuron.2005.08.034; Bassell GJ, 2008, NEURON, V60, P201, DOI 10.1016/j.neuron.2008.10.004; Bolduc FV, 2008, NAT NEUROSCI, V11, P1143, DOI 10.1038/nn.2175; Brown V, 2001, CELL, V107, P477, DOI 10.1016/S0092-8674(01)00568-2; Cao XW, 2006, ANNU REV NEUROSCI, V29, P77, DOI 10.1146/annurev.neuro.29.051605.112839; Caudy AA, 2002, GENE DEV, V16, P2491, DOI 10.1101/gad.1025202; Cheever A, 2009, RNA, V15, P362, DOI 10.1261/rna.1500809; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; Comery TA, 1997, P NATL ACAD SCI USA, V94, P5401, DOI 10.1073/pnas.94.10.5401; Darnell JC, 2005, GENES BRAIN BEHAV, V4, P341, DOI 10.1111/j.1601-183X.2005.00144.x; Darnell JC, 2005, GENE DEV, V19, P903, DOI 10.1101/gad.1276805; Desai NS, 2006, J NEUROPHYSIOL, V96, P1734, DOI 10.1152/jn.00221.2006; Dolen G, 2007, NEURON, V56, P955, DOI 10.1016/j.neuron.2007.12.001; Eacker SM, 2009, NAT REV NEUROSCI, V10, P837, DOI 10.1038/nrn2726; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Futai K, 2007, NAT NEUROSCI, V10, P186, DOI 10.1038/nn1837; Giuffrida R, 2005, J NEUROSCI, V25, P8908, DOI 10.1523/JNEUROSCI.0932-05.2005; Hock J, 2007, EMBO REP, V8, P1052, DOI 10.1038/sj.embor.7401088; Irwin SA, 2001, AM J MED GENET, V98, P161, DOI 10.1002/1096-8628(20010115)98:2<161::AID-AJMG1025>3.0.CO;2-B; Ishizuka A, 2002, GENE DEV, V16, P2497, DOI 10.1101/gad.1022002; Jin P, 2004, NAT CELL BIOL, V6, P1048, DOI 10.1038/ncb1104-1048; Jin P, 2004, NAT NEUROSCI, V7, P113, DOI 10.1038/nn1174; Kim MJ, 2005, NEURON, V46, P745, DOI 10.1016/j.neuron.2005.04.031; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Le MTN, 2009, MOL CELL BIOL, V29, P5290, DOI 10.1128/MCB.01694-08; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li JX, 2002, MOL CELL NEUROSCI, V19, P138, DOI 10.1006/mcne.2001.1085; Lu JI, 2005, BIOCHEM BIOPH RES CO, V334, P319, DOI 10.1016/j.bbrc.2005.05.206; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Meister G, 2004, RNA, V10, P544, DOI 10.1261/rna.5235104; Meredith RM, 2007, NEURON, V54, P627, DOI 10.1016/j.neuron.2007.04.028; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; Muddashetty RS, 2007, J NEUROSCI, V27, P5338, DOI 10.1523/JNEUROSCI.0937-07.2007; Murai KK, 2003, NAT NEUROSCI, V6, P153, DOI 10.1038/nn994; Nakagawa T, 2006, J NEUROSCI METH, V152, P1, DOI 10.1016/j.jneumeth.2005.08.001; Nakazawa T, 2003, MOL BIOL CELL, V14, P2921, DOI 10.1091/mbc.e02-09-0623; Nakazawa T, 2008, J NEUROCHEM, V105, P1384, DOI 10.1111/j.1471-4159.2008.05335.x; Nimchinsky EA, 2001, J NEUROSCI, V21, P5139, DOI 10.1523/JNEUROSCI.21-14-05139.2001; Okamura K, 2004, GENE DEV, V18, P1655, DOI 10.1101/gad.1210204; Pena JTG, 2009, NAT METHODS, V6, P139, DOI [10.1038/NMETH.1294, 10.1038/nmeth.1294]; Pfeiffer BE, 2007, J NEUROSCI, V27, P3120, DOI 10.1523/JNEUROSCI.0054-07.2007; Philpot BD, 2007, NEURON, V53, P495, DOI 10.1016/j.neuron.2007.01.027; Pilpel Y, 2009, J PHYSIOL-LONDON, V587, P787, DOI 10.1113/jphysiol.2008.160929; Plante I, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/64347; Rana TM, 2007, NAT REV MOL CELL BIO, V8, P23, DOI 10.1038/nrm2085; Schratt G, 2009, NAT REV NEUROSCI, V10, P842, DOI 10.1038/nrn2763; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Seeburg DP, 2008, NEURON, V58, P571, DOI 10.1016/j.neuron.2008.03.021; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; SHENG M, 1994, NATURE, V368, P144, DOI 10.1038/368144a0; Siegel G, 2009, NAT CELL BIOL, V11, P705, DOI 10.1038/ncb1876; Stefani G, 2008, NAT REV MOL CELL BIO, V9, P219, DOI 10.1038/nrm2347; Tada T, 2007, CURR BIOL, V17, P1752, DOI 10.1016/j.cub.2007.09.039; Tiscornia G, 2006, NAT PROTOC, V1, P241, DOI 10.1038/nprot.2006.37; Ultanir SK, 2007, P NATL ACAD SCI USA, V104, P19553, DOI 10.1073/pnas.0704031104; Vo N, 2005, P NATL ACAD SCI USA, V102, P16426, DOI 10.1073/pnas.0508448102; Wayman GA, 2008, P NATL ACAD SCI USA, V105, P9093, DOI 10.1073/pnas.0803072105; Yang YY, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000444; Yashiro K, 2008, NEUROPHARMACOLOGY, V55, P1081, DOI 10.1016/j.neuropharm.2008.07.046; Zeng Y, 2005, METHOD ENZYMOL, V392, P371, DOI 10.1016/S0076-6879(04)92022-8; Zhang HY, 2006, NAT CELL BIOL, V8, P227, DOI 10.1038/ncb1368; Zhao MG, 2005, J NEUROSCI, V25, P7385, DOI 10.1523/JNEUROSCI.1520-05.2005	68	547	572	0	58	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	FEB 11	2010	65	3					373	384		10.1016/j.neuron.2010.01.005	http://dx.doi.org/10.1016/j.neuron.2010.01.005			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	564BF	20159450	Green Published, Green Accepted, Bronze			2022-12-24	WOS:000275185200010
J	Bajo, VM; Nodal, FR; Moore, DR; King, AJ				Bajo, Victoria M.; Nodal, Fernando R.; Moore, David R.; King, Andrew J.			The descending corticocollicular pathway mediates learning-induced auditory plasticity	NATURE NEUROSCIENCE			English	Article							CORTICAL MAP REORGANIZATION; SOUND-LOCALIZATION BEHAVIOR; CORTICOFUGAL MODULATION; INFERIOR COLLICULUS; BRAIN-STEM; SUPERIOR COLLICULUS; RECEPTIVE-FIELDS; CORTEX; PROJECTIONS; MIDBRAIN	Descending projections from sensory areas of the cerebral cortex are among the largest pathways in the brain, suggesting that they are important for subcortical processing. Although corticofugal inputs have been shown to modulate neuronal responses in the thalamus and midbrain, the behavioral importance of these changes remains unknown. In the auditory system, one of the major descending pathways is from cortical layer V pyramidal cells to the inferior colliculus in the midbrain. We examined the role of these neurons in experience-dependent recalibration of sound localization in adult ferrets by selectively killing the neurons using chromophore-targeted laser photolysis. When provided with appropriate training, animals normally relearn to localize sound accurately after altering the spatial cues available by reversibly occluding one ear. However, this ability was lost after eliminating corticocollicular neurons, whereas normal sound-localization accuracy was unaffected. The integrity of this descending pathway is therefore critical for learning-induced localization plasticity.	[Bajo, Victoria M.; Nodal, Fernando R.; Moore, David R.; King, Andrew J.] Univ Oxford, Dept Physiol Anat & Genet, Oxford, England	University of Oxford	King, AJ (corresponding author), Univ Oxford, Dept Physiol Anat & Genet, Oxford, England.	andrew.king@dpag.ox.ac.uk	Nodal, Fernando/U-5700-2019; King, Andrew J/M-6708-2013	Nodal, Fernando/0000-0002-1039-6032; King, Andrew J/0000-0001-5180-7179; Bajo, Victoria/0000-0002-3612-2048	Wellcome Trust through a Principal Research Fellowship [WT076508AIA];  [WT069600/Z/02/Z]; Medical Research Council [MC_U135079236] Funding Source: researchfish; MRC [MC_U135079236] Funding Source: UKRI	Wellcome Trust through a Principal Research Fellowship(Wellcome Trust); ; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We are grateful to J.D. Macklis and R.Fricker-Gates for helping us to set up the chromophore-targeted laser photolysis technique and to B. Willmore for statistical advice. K. Allen and A. Fieger assisted with the early stages of the project, and J. Bizley, R. Campbell, D. Kumpik and S. Spires contributed to the behavioral testing and provided valuable discussion. This work was supported by the Wellcome Trust through a Principal Research Fellowship to A. J. K. (WT076508AIA) and a project grant to A.J.K. and D.R.M. (WT069600/Z/02/Z).	Alvarado JC, 2007, J NEUROSCI, V27, P12775, DOI 10.1523/JNEUROSCI.3524-07.2007; Bajo VM, 2007, CEREB CORTEX, V17, P475, DOI 10.1093/cercor/bhj164; BAUER RW, 1966, J ACOUST SOC AM, V40, P441, DOI 10.1121/1.1910093; Chase SM, 2008, J NEUROPHYSIOL, V99, P1672, DOI 10.1152/jn.00644.2007; Dahmen JC, 2007, CURR OPIN NEUROBIOL, V17, P456, DOI 10.1016/j.conb.2007.07.004; Davis KA, 1999, J NEUROPHYSIOL, V82, P164, DOI 10.1152/jn.1999.82.1.164; EDELINE JM, 1991, BEHAV NEUROSCI, V105, P618, DOI 10.1037/0735-7044.105.5.618; Eyding D, 2003, J NEUROSCI, V23, P7021, DOI 10.1523/JNEUROSCI.23-18-07021.2003; Florentine M, 1976, J Am Audiol Soc, V1, P243; Gilbert CD, 2009, J PHYSIOL-LONDON, V587, P2743, DOI 10.1113/jphysiol.2009.171488; HEFFNER HE, 1990, J NEUROPHYSIOL, V64, P915, DOI 10.1152/jn.1990.64.3.915; Hofman PM, 2003, EXP BRAIN RES, V148, P458, DOI 10.1007/s00221-002-1320-5; JENKINS WM, 1984, J NEUROPHYSIOL, V52, P819, DOI 10.1152/jn.1984.52.5.819; Jiang W, 2002, J COGNITIVE NEUROSCI, V14, P1240, DOI 10.1162/089892902760807230; Jin C, 2004, J ACOUST SOC AM, V115, P3124, DOI 10.1121/1.1736649; Kacelnik O, 2006, PLOS BIOL, V4, P627, DOI 10.1371/journal.pbio.0040071; KAVANAGH GL, 1987, J NEUROPHYSIOL, V57, P1746, DOI 10.1152/jn.1987.57.6.1746; Kilgard MP, 1998, SCIENCE, V279, P1714, DOI 10.1126/science.279.5357.1714; King AJ, 2001, TRENDS COGN SCI, V5, P261, DOI 10.1016/S1364-6613(00)01660-0; King AJ, 1998, J COMP NEUROL, V390, P342; King AJ, 2000, P NATL ACAD SCI USA, V97, P11821, DOI 10.1073/pnas.97.22.11821; KNUDSEN EI, 1984, J NEUROSCI, V4, P1001; Krupa DJ, 1999, P NATL ACAD SCI USA, V96, P8200, DOI 10.1073/pnas.96.14.8200; Lomber SG, 2001, J COMP NEUROL, V441, P44, DOI 10.1002/cne.1396; Luo F, 2008, J NEUROSCI, V28, P11615, DOI 10.1523/JNEUROSCI.3972-08.2008; Ma XF, 2001, P NATL ACAD SCI USA, V98, P14060, DOI 10.1073/pnas.241517098; Ma XF, 2001, J NEUROPHYSIOL, V85, P1078, DOI 10.1152/jn.2001.85.3.1078; MACKLIS JD, 1993, J NEUROSCI, V13, P3848; Magavi SS, 2000, NATURE, V405, P951, DOI 10.1038/35016083; Mrsic-Flogel TD, 2005, J NEUROPHYSIOL, V93, P3489, DOI 10.1152/jn.00748.2004; Nakamoto KT, 2008, J NEUROPHYSIOL, V99, P2347, DOI 10.1152/jn.01326.2007; Nodal FR, 2008, NEUROSCIENCE, V154, P397, DOI 10.1016/j.neuroscience.2007.12.022; Oliver DL, 2005, INFERIOR COLLICULUS, P69, DOI 10.1007/0-387-27083-3_2; Perrot X, 2006, CEREB CORTEX, V16, P941, DOI 10.1093/cercor/bhj035; Pollak GD, 2002, HEARING RES, V168, P60, DOI 10.1016/S0378-5955(02)00362-3; Polley DB, 2006, J NEUROSCI, V26, P4970, DOI 10.1523/JNEUROSCI.3771-05.2006; SILLITO AM, 1994, NATURE, V369, P479, DOI 10.1038/369479a0; Spierer L, 2007, J NEUROSCI, V27, P5474, DOI 10.1523/JNEUROSCI.0764-07.2007; Suga N, 2003, NAT REV NEUROSCI, V4, P783, DOI 10.1038/nrn1222; Suga N, 2008, J COMP PHYSIOL A, V194, P169, DOI 10.1007/s00359-007-0274-2; THOMPSON GC, 1978, J NEUROPHYSIOL, V41, P1183, DOI 10.1152/jn.1978.41.5.1183; Tzounopoulos T, 2009, NEURON, V62, P463, DOI 10.1016/j.neuron.2009.05.002; Van Wanrooij MM, 2007, J NEUROPHYSIOL, V97, P715, DOI 10.1152/jn.00260.2006; Weinberger NM, 2004, NAT REV NEUROSCI, V5, P279, DOI 10.1038/nrn1366; Winer JA, 1998, J COMP NEUROL, V400, P147; Woods TM, 2006, J NEUROPHYSIOL, V96, P3323, DOI 10.1152/jn.00392.2006; Xiao ZJ, 2002, NAT NEUROSCI, V5, P57, DOI 10.1038/nn786; Yan J, 2002, EUR J NEUROSCI, V16, P119, DOI 10.1046/j.1460-9568.2002.02046.x; Yan J, 2005, J NEUROPHYSIOL, V93, P71, DOI 10.1152/jn.00348.2004; Zhou XM, 2005, HEARING RES, V203, P201, DOI 10.1016/j.heares.2004.12.008	50	222	224	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2010	13	2					253	U146		10.1038/nn.2466	http://dx.doi.org/10.1038/nn.2466			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	548SE	20037578	Green Accepted			2022-12-24	WOS:000273985800022
J	Kim, JY; Shen, S; Dietz, K; He, Y; Howell, O; Reynolds, R; Casaccia, P				Kim, Jin Young; Shen, Siming; Dietz, Karen; He, Ye; Howell, Owain; Reynolds, Richard; Casaccia, Patrizia			HDAC1 nuclear export induced by pathological conditions is essential for the onset of axonal damage	NATURE NEUROSCIENCE			English	Article							MULTIPLE-SCLEROSIS; HISTONE DEACETYLASES; NEURONAL DAMAGE; CELL-DEATH; TRANSPORT; INHIBITORS; PROTEIN; DEMYELINATION; DISEASE; INJURY	Histone deacetylase 1 (HDAC1) is a nuclear enzyme involved in transcriptional repression. We detected cytosolic HDAC1 in damaged axons in brains of humans with multiple sclerosis and of mice with cuprizone-induced demyelination, in ex vivo models of demyelination and in cultured neurons exposed to glutamate and tumor necrosis factor-alpha. Nuclear export of HDAC1 was mediated by the interaction with the nuclear receptor CRM-1 and led to impaired mitochondrial transport. The formation of complexes between exported HDAC1 and members of the kinesin family of motor proteins hindered the interaction with cargo molecules, thereby inhibiting mitochondrial movement and inducing localized beading. This effect was prevented by inhibiting HDAC1 nuclear export with leptomycin B, treating neurons with pharmacological inhibitors of HDAC activity or silencing HDAC1 but not other HDAC isoforms. Together these data identify nuclear export of HDAC1 as a critical event for impaired mitochondrial transport in damaged neurons.	[Kim, Jin Young; Shen, Siming; Casaccia, Patrizia] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Grad Sch Biomed Sci, Grad Program Neurosci, Piscataway, NJ 08854 USA; [Kim, Jin Young; Dietz, Karen; He, Ye; Casaccia, Patrizia] Mt Sinai Sch Med, Dept Neurosci & Genet & Genom, New York, NY USA; [Howell, Owain; Reynolds, Richard] Univ London Imperial Coll Sci Technol & Med, Fac Med, Charing Cross Hosp Campus, Dept Cellular & Mol Neurosci,Div Neurosci & Menta, London, England	Rutgers State University New Brunswick; Rutgers State University Medical Center; Icahn School of Medicine at Mount Sinai; Imperial College London	Casaccia, P (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Grad Sch Biomed Sci, Grad Program Neurosci, Piscataway, NJ 08854 USA.	patrizia.casaccia@mssm.edu	He, Ye/G-7500-2011	KIM, Jin Young/0000-0003-4438-1872; Howell, Owain/0000-0003-2157-9157; He, Ye/0000-0002-3936-4958	New Jersey Multiple Sclerosis Research Foundation; NMSS [RG-3957]; New Jersey Commission [07-3203-BIR-E-0]; Christopher and Dana Reeve Foundation [CB1-0704-2];  [NIH-RO1 NS-42925]; MRC [G0700356] Funding Source: UKRI; Medical Research Council [G0700356] Funding Source: researchfish; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042925] Funding Source: NIH RePORTER	New Jersey Multiple Sclerosis Research Foundation; NMSS(National Multiple Sclerosis Society); New Jersey Commission; Christopher and Dana Reeve Foundation; ; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the University of California Los Angeles Brain Bank and the UK MS Tissue Bank at Imperial College of London for providing the multiple sclerosis tissue samples, C. Seiser (University of Vienna) for providing the antibodies to the N-terminal domain of HDAC1, R. Bansal (University of Connecticut Health Science Center at Farmington) for anti-O4 hybridoma supernatant, X. Pedre and J. Li for rodent handling, S. Schreiber (Broad Institute, Massachusetts Institute of Technology) for tubacin, E. Nestler and H. Covington (Mount Sinai School of Medicine) for MS-275, S. Lagger for sharing unpublished results and critical comments on the manuscript, P. Lobel for discussions regarding MALDI-TOF data, J. Zheng and K. Teng for helpful discussion and R. Rosa for the support of the New Jersey Multiple Sclerosis Research Foundation. The study was supported by NIH-RO1 NS-42925 (P.C.) and NMSS RG-3957. J.Y.K.'s salary was supported in part also by grant no. 07-3203-BIR-E-0 from the New Jersey Commission on Traumatic Brain injury and CB1-0704-2 from the Christopher and Dana Reeve Foundation to P. C.	ADAMS JH, 1991, J NEUROL NEUROSUR PS, V54, P481, DOI 10.1136/jnnp.54.6.481; Ballas N, 2001, NEURON, V31, P353, DOI 10.1016/S0896-6273(01)00371-3; Beirowski B, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-6; Birgbauer E, 2004, J NEUROSCI RES, V78, P157, DOI 10.1002/jnr.20248; Bitsch A, 2000, BRAIN, V123, P1174, DOI 10.1093/brain/123.6.1174; Bolger TA, 2005, J NEUROSCI, V25, P9544, DOI 10.1523/JNEUROSCI.1826-05.2005; Bruck W, 2005, J NEUROL, V252, pV3, DOI 10.1007/s00415-005-5002-7; Chawla S, 2003, J NEUROCHEM, V85, P151, DOI 10.1046/j.1471-4159.2003.01648.x; Chen ZX, 2002, CANCER LETT, V188, P127, DOI 10.1016/S0304-3835(02)00322-1; Dasmahapatra G, 2006, MOL PHARMACOL, V69, P288, DOI 10.1124/mol.105.016154; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; Dompierre JP, 2007, J NEUROSCI, V27, P3571, DOI 10.1523/JNEUROSCI.0037-07.2007; Dutta R, 2007, NEUROLOGY, V68, pS22, DOI 10.1212/01.wnl.0000275229.13012.32; Ferguson B, 1997, BRAIN, V120, P393, DOI 10.1093/brain/120.3.393; Fisher E, 2007, ANN NEUROL, V62, P219, DOI 10.1002/ana.21113; Galvin JE, 1999, P NATL ACAD SCI USA, V96, P13450, DOI 10.1073/pnas.96.23.13450; Gu HD, 2005, P NATL ACAD SCI USA, V102, P7571, DOI 10.1073/pnas.0502658102; Hoshino M, 2003, J NEUROCHEM, V87, P257, DOI 10.1046/j.1471-4159.2003.01991.x; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Kawaguchi Y, 2003, CELL, V115, P727, DOI 10.1016/S0092-8674(03)00939-5; Kiaei M, 2005, NEURODEGENER DIS, V2, P246, DOI 10.1159/000090364; King AE, 2007, EUR J NEUROSCI, V26, P2151, DOI 10.1111/j.1460-9568.2007.05845.x; Kurnellas MP, 2007, BIOCHEM SOC T, V35, P923, DOI 10.1042/BST0350923; Li JD, 2008, J NEUROSCI, V28, P6118, DOI 10.1523/JNEUROSCI.0184-08.2008; Morfini GA, 2009, J NEUROSCI, V29, P12776, DOI 10.1523/JNEUROSCI.3463-09.2009; Morrison BE, 2006, MOL CELL BIOL, V26, P3550, DOI 10.1128/MCB.26.9.3550-3564.2006; Ouardouz M, 2009, ANN NEUROL, V65, P160, DOI 10.1002/ana.21539; PANT HC, 1988, BIOCHEM J, V256, P665, DOI 10.1042/bj2560665; Perez-Olle R, 2005, J NEUROCHEM, V93, P861, DOI 10.1111/j.1471-4159.2005.03095.x; Pitt D, 2000, NAT MED, V6, P67, DOI 10.1038/71555; Schumacher PA, 1999, NEUROSCIENCE, V91, P733, DOI 10.1016/S0306-4522(98)00552-1; Shen SM, 2008, NAT NEUROSCI, V11, P1024, DOI 10.1038/nn.2172; Song SK, 2005, NEUROIMAGE, V26, P132, DOI 10.1016/j.neuroimage.2005.01.028; Stokin GB, 2005, SCIENCE, V307, P1282, DOI 10.1126/science.1105681; Stone JR, 2004, EXP NEUROL, V190, P59, DOI 10.1016/j.expneurol.2004.05.022; Trapp BD, 1998, NEW ENGL J MED, V338, P278, DOI 10.1056/NEJM199801293380502; Trapp BD, 2009, LANCET NEUROL, V8, P280, DOI 10.1016/S1474-4422(09)70043-2; Uo T, 2009, J NEUROSCI, V29, P2824, DOI 10.1523/JNEUROSCI.6186-08.2009; Viatour P, 2003, J BIOL CHEM, V278, P46541, DOI 10.1074/jbc.M306381200; WATSON DF, 1991, BRAIN RES, V539, P103, DOI 10.1016/0006-8993(91)90691-N; Wegner C, 2006, NEUROLOGY, V67, P960, DOI 10.1212/01.wnl.0000237551.26858.39; WEN W, 1995, CELL, V82, P463, DOI 10.1016/0092-8674(95)90435-2; Williamson TL, 1999, NAT NEUROSCI, V2, P50, DOI 10.1038/4553; Wolff B, 1997, CHEM BIOL, V4, P139, DOI 10.1016/S1074-5521(97)90257-X; Yabe JT, 1999, J CELL SCI, V112, P3799; Yang XJ, 2005, MOL CELL BIOL, V25, P2873, DOI 10.1128/MCB.25.8.2873-2884.2005; Yao YL, 2001, MOL CELL BIOL, V21, P5979, DOI 10.1128/MCB.21.17.5979-5991.2001; Zhang Y, 2003, EMBO J, V22, P1168, DOI 10.1093/emboj/cdg115; Zhang YG, 2001, J VIROL, V75, P9571, DOI 10.1128/JVI.75.20.9571-9578.2001	49	156	161	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2010	13	2					180	U63		10.1038/nn.2471	http://dx.doi.org/10.1038/nn.2471			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	548SE	20037577	Green Accepted			2022-12-24	WOS:000273985800013
J	Johnson, SL; Franz, C; Kuhn, S; Furness, DN; Ruttiger, L; Munkner, S; Rivolta, MN; Seward, EP; Herschman, HR; Engel, J; Knipper, M; Marcotti, W				Johnson, Stuart L.; Franz, Christoph; Kuhn, Stephanie; Furness, David N.; Ruettiger, Lukas; Muenkner, Stefan; Rivolta, Marcelo N.; Seward, Elizabeth P.; Herschman, Harvey R.; Engel, Jutta; Knipper, Marlies; Marcotti, Walter			Synaptotagmin IV determines the linear Ca2+ dependence of vesicle fusion at auditory ribbon synapses	NATURE NEUROSCIENCE			English	Article							INNER HAIR-CELLS; FAST SYNAPTIC-TRANSMISSION; NEUROTRANSMITTER RELEASE; TRANSMITTER RELEASE; CALCIUM-DEPENDENCE; NERVE-TERMINALS; EXOCYTOSIS; MOUSE; OTOFERLIN; CHANNELS	Mammalian cochlear inner hair cells (IHCs) are specialized for the dynamic coding of continuous and finely graded sound signals. This ability is largely conferred by the linear Ca2+ dependence of neurotransmitter release at their synapses, which is also a feature of visual and olfactory systems. The prevailing hypothesis is that linearity in IHCs occurs through a developmental change in the Ca2+ sensitivity of synaptic vesicle fusion from the nonlinear (high order) Ca2+ dependence of immature spiking cells. However, the nature of the Ca2+ sensor(s) of vesicle fusion at hair cell synapses is unknown. We found that synaptotagmin IV was essential for establishing the linear exocytotic Ca2+ dependence in adult rodent IHCs and immature outer hair cells. Moreover, the expression of the hitherto undetected synaptotagmins I and II correlated with a high-order Ca2+ dependence in IHCs. We propose that the differential expression of synaptotagmins determines the characteristic Ca2+ sensitivity of vesicle fusion at hair cell synapses.	[Johnson, Stuart L.; Rivolta, Marcelo N.; Seward, Elizabeth P.; Marcotti, Walter] Univ Sheffield, Dept Biomed Sci, Sheffield S10 2TN, S Yorkshire, England; [Franz, Christoph; Ruettiger, Lukas; Knipper, Marlies] Univ Tubingen, Lab Mol Physiol Hearing, Tubingen Hearing Res Ctr, Dept Otolaryngol, Tubingen, Germany; [Kuhn, Stephanie; Muenkner, Stefan; Engel, Jutta] Univ Tubingen, Inst Physiol 2, Tubingen Hearing Res Ctr, Tubingen, Germany; [Furness, David N.] Univ Keele, Inst Sci & Technol Med, Keele ST5 5BG, Staffs, England; [Muenkner, Stefan; Engel, Jutta] Univ Saarland, Dept Biophys, D-6650 Homburg, Germany; [Herschman, Harvey R.] Univ Calif Los Angeles, Ctr Hlth Sci, Dept Biol Chem, Los Angeles, CA 90024 USA	University of Sheffield; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Keele University; Saarland University; University of California System; University of California Los Angeles	Marcotti, W (corresponding author), Univ Sheffield, Dept Biomed Sci, Sheffield S10 2TN, S Yorkshire, England.	w.marcotti@sheffield.ac.uk		, Stephanie/0000-0001-6633-9478; Seward, Elizabeth/0000-0001-5311-1343	Wellcome Trust; Deafness Research UK; University of Sheffield Devolved Funds; Royal Society; Deutsche Forschungsgameinschft [316-4-1]; Baden-Wurttemberg Graduate Programme of the University of Tubingen	Wellcome Trust(Wellcome Trust); Deafness Research UK; University of Sheffield Devolved Funds; Royal Society(Royal Society of London); Deutsche Forschungsgameinschft(German Research Foundation (DFG)); Baden-Wurttemberg Graduate Programme of the University of Tubingen	We would like to thank M. C. Holley and E. Smythe for their critical feedback on an earlier version of the manuscript. We would also like to thank A. Catapang for help with genotyping, M. Cardwell and A. Davids for their assistance with the breeding of Syt IV animals, and K. Rohbock and S. Kasperek for their technical assistance with the immunolabeling experiments. The rSytIV pIE construct was obtained from Addgene. This work was supported by grants from the Wellcome Trust, Deafness Research UK, University of Sheffield Devolved Funds and The Royal Society to W. M., Deutsche Forschungsgameinschft 316-4-1 to M. K., and the Baden-Wurttemberg Graduate Programme of the University of Tubingen to M. K. and J.E. W. M. is a Royal Society University Research Fellow.	Beurg M, 2008, J NEUROSCI, V28, P1798, DOI 10.1523/JNEUROSCI.4653-07.2008; Brandt A, 2005, J NEUROSCI, V25, P11577, DOI 10.1523/JNEUROSCI.3411-05.2005; Brandt N, 2007, J NEUROSCI, V27, P3174, DOI 10.1523/JNEUROSCI.3965-06.2007; Chapman ER, 1998, J BIOL CHEM, V273, P32966, DOI 10.1074/jbc.273.49.32966; DALLOS P, 1992, J NEUROSCI, V12, P4575; Dean C, 2009, NAT NEUROSCI, V12, P767, DOI 10.1038/nn.2315; Dulon D, 2009, J NEUROSCI, V29, P10474, DOI 10.1523/JNEUROSCI.1009-09.2009; Ferguson GD, 2000, P NATL ACAD SCI USA, V97, P5598, DOI 10.1073/pnas.100104597; Fuchs PA, 2005, J PHYSIOL-LONDON, V566, P7, DOI 10.1113/jphysiol.2004.082214; FURNESS DN, 1985, HEARING RES, V18, P177, DOI 10.1016/0378-5955(85)90010-3; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; Glowatzki E, 2002, NAT NEUROSCI, V5, P147, DOI 10.1038/nn796; Glowatzki E, 2008, CURR OPIN NEUROBIOL, V18, P389, DOI 10.1016/j.conb.2008.09.006; GU XN, 1995, NATURE, V375, P784, DOI 10.1038/375784a0; Heidrych P, 2009, HUM MOL GENET, V18, P2779, DOI 10.1093/hmg/ddp213; Johnson SL, 2005, J PHYSIOL-LONDON, V563, P177, DOI 10.1113/jphysiol.2004.074740; Johnson SL, 2008, J NEUROSCI, V28, P7670, DOI 10.1523/JNEUROSCI.0785-08.2008; Johnson SL, 2007, J PHYSIOL-LONDON, V583, P631, DOI 10.1113/jphysiol.2007.136630; Johnson SL, 2009, J PHYSIOL-LONDON, V587, P1715, DOI 10.1113/jphysiol.2009.168542; Juusola M, 1996, TRENDS NEUROSCI, V19, P292, DOI 10.1016/S0166-2236(96)10028-X; Knirsch M, 2007, J NEUROSCI, V27, P6442, DOI 10.1523/JNEUROSCI.5364-06.2007; Lenzi D, 1999, J NEUROSCI, V19, P119, DOI 10.1523/JNEUROSCI.19-01-00119.1999; Lenzi D, 2001, BIOESSAYS, V23, P831, DOI 10.1002/bies.1118; LITTLETON JT, 1994, P NATL ACAD SCI USA, V91, P10888, DOI 10.1073/pnas.91.23.10888; Littleton JT, 1999, NATURE, V400, P757, DOI 10.1038/23462; Mackler JM, 2002, NATURE, V418, P340, DOI 10.1038/nature00846; Marcotti W, 1999, J PHYSIOL-LONDON, V520, P653, DOI 10.1111/j.1469-7793.1999.00653.x; Marcotti W, 2003, J PHYSIOL-LONDON, V548, P383, DOI 10.1113/jphysiol.2002.034801; Moody WJ, 2005, PHYSIOL REV, V85, P883, DOI 10.1152/physrev.00017.2004; Moser T, 2006, J PHYSIOL-LONDON, V576, P55, DOI 10.1113/jphysiol.2006.114835; Murphy GJ, 2004, J NEUROSCI, V24, P3023, DOI 10.1523/JNEUROSCI.5745-03.2004; Nagy G, 2006, J NEUROSCI, V26, P632, DOI 10.1523/JNEUROSCI.2589-05.2006; Pang ZPP, 2006, J NEUROSCI, V26, P13493, DOI 10.1523/JNEUROSCI.3519-06.2006; Roux I, 2006, CELL, V127, P277, DOI 10.1016/j.cell.2006.08.040; Safieddine S, 1999, EUR J NEUROSCI, V11, P803, DOI 10.1046/j.1460-9568.1999.00487.x; Shin OH, 2009, P NATL ACAD SCI USA, V106, P16469, DOI 10.1073/pnas.0908798106; Singer JH, 2004, NAT NEUROSCI, V7, P826, DOI 10.1038/nn1280; SOBKOWICZ HM, 1982, J NEUROSCI, V2, P942; Sterling P, 2005, TRENDS NEUROSCI, V28, P20, DOI 10.1016/j.tins.2004.11.009; Stevens CF, 2003, NEURON, V39, P299, DOI 10.1016/S0896-6273(03)00432-X; Sudhof TC, 2002, J BIOL CHEM, V277, P7629, DOI 10.1074/jbc.R100052200; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Thomas DM, 1999, MOL BIOL CELL, V10, P2285, DOI 10.1091/mbc.10.7.2285; Thoreson WB, 2004, NEURON, V42, P595, DOI 10.1016/S0896-6273(04)00254-5; Ting JT, 2006, J NEUROSCI, V26, P372, DOI 10.1523/JNEUROSCI.3997-05.2006; VICIAN L, 1995, P NATL ACAD SCI USA, V92, P2164, DOI 10.1073/pnas.92.6.2164; Wang CT, 2003, NATURE, V424, P943, DOI 10.1038/nature01857; Xu J, 2007, NEURON, V54, P567, DOI 10.1016/j.neuron.2007.05.004; Zhang Q, 2004, P NATL ACAD SCI USA, V101, P9441, DOI 10.1073/pnas.0401960101; Zhang ZJ, 2009, NAT NEUROSCI, V12, P163, DOI 10.1038/nn.2252	50	89	91	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2010	13	1					45	U201		10.1038/nn.2456	http://dx.doi.org/10.1038/nn.2456			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	536PM	20010821	Green Accepted			2022-12-24	WOS:000273056300012
J	Lin, X; Parisiadou, L; Gu, XL; Wang, LZ; Shim, H; Sun, LX; Xie, CS; Long, CX; Yang, WJ; Ding, JH; Chen, ZZ; Gallant, PE; Tao-Cheng, JH; Rudow, G; Troncoso, JC; Liu, ZH; Li, Z; Cai, HB				Lin, Xian; Parisiadou, Loukia; Gu, Xing-Long; Wang, Lizhen; Shim, Hoon; Sun, Lixin; Xie, Chengsong; Long, Cai-Xia; Yang, Wan-Jou; Ding, Jinhui; Chen, Zsu Zsu; Gallant, Paul E.; Tao-Cheng, Jung-Hwa; Rudow, Gay; Troncoso, Juan C.; Liu, Zhihua; Li, Zheng; Cai, Huaibin			Leucine-Rich Repeat Kinase 2 Regulates the Progression of Neuropathology Induced by Parkinson's-Disease-Related Mutant alpha-synuclein	NEURON			English	Article							COMMON LRRK2 MUTATION; LEWY BODIES; EXPRESSION; PROTEIN; BRAIN; MICE; LEUCINE-RICH-REPEAT-KINASE-2; LOCALIZATION; MICROTUBULES; GENE	Mutations in alpha-synuclein and Leucine-rich repeat kinase 2 (LRRK2) are linked to autosomal dominant forms of Parkinson's disease (PD). However, little is known about any potential pathophysiological interplay between these two PD-related genes. Here we show in transgenic mice that although overexpression of LRRK2 alone did not cause neurodegeneration, the presence of excess LRRK2 greatly accelerated the progression of neuropathological abnormalities developed in PD-related A53T alpha-synuclein transgenic mice. Moreover, we found that LRRK2 promoted the abnormal aggregation and somatic accumulation of alpha-synuclein in A53T mice, which likely resulted from the impairment of microtubule dynamics, Golgi organization, and the ubiquitin-proteasome pathway. Conversely, genetic ablation of LRRK2 preserved the Golgi structure and suppressed the aggregation and somatic accumulation of alpha-synuclein, and thereby delayed the progression of neuropathology in A53T mice. These findings demonstrate that overexpression of LRRK2 enhances alpha-synuclein-mediated cytotoxicity and suggest inhibition of LRRK2 expression as a potential therapeutic option for ameliorating alpha-synuclein-induced neurodegeneration.	[Lin, Xian; Parisiadou, Loukia; Gu, Xing-Long; Wang, Lizhen; Shim, Hoon; Sun, Lixin; Xie, Chengsong; Long, Cai-Xia; Yang, Wan-Jou; Cai, Huaibin] NIA, Unit Transgenesis, Neurogenet Lab, NIH, Bethesda, MD 20892 USA; [Ding, Jinhui] NIA, Unit Bioinformat Core, Neurogenet Lab, NIH, Bethesda, MD 20892 USA; [Gallant, Paul E.] Natl Inst Neurol Disorders & Stroke, Neurobiol Lab, NIH, Bethesda, MD 20892 USA; [Tao-Cheng, Jung-Hwa] Natl Inst Neurol Disorders & Stroke, EM Facil, NIH, Bethesda, MD 20892 USA; [Liu, Zhihua] NIAID, Immunol Lab, NIH, Bethesda, MD 20892 USA; [Li, Zheng] NIMH, Unit Synapse Dev & Plast, Cognit & Psychosis Program, NIH, Bethesda, MD 20892 USA; [Chen, Zsu Zsu] Univ Alabama, Dept Biol, Birmingham, AL 35233 USA; [Rudow, Gay; Troncoso, Juan C.] Johns Hopkins Univ, Sch Med, Dept Pathol, Div Neuropathol, Baltimore, MD 21205 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); University of Alabama System; University of Alabama Birmingham; Johns Hopkins University	Cai, HB (corresponding author), NIA, Unit Transgenesis, Neurogenet Lab, NIH, Bethesda, MD 20892 USA.	caih@mail.nih.gov	Cai, Huaibin/H-3359-2013; Li, Zheng/I-8016-2014; gu, xinglong/A-3054-2011	Cai, Huaibin/0000-0002-8596-6108; Li, Zheng/0000-0002-2978-2531; gu, xinglong/0000-0002-0437-5606; Chen, Zsu-Zsu/0000-0001-9441-675X; Parisiadou, Loukia/0000-0002-2569-4200	National Institute on Aging; National Human Genome Research Institute (NHGRI); National Institute of Mental Health (NIMH); National Institutes of Health; Henry Jackson Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS038377] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000944, ZIAAG000959] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Henry Jackson Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by the intramural research programs of the National Institute on Aging, National Human Genome Research Institute (NHGRI), National Institute of Mental Health (NIMH), and National Institute of Neurological Disorders and Stroke (NINDS) at the National Institutes of Health and the Henry Jackson Foundation. We thank the NHGRI and NIMH transgenic mouse facilities for blastocystic and pronuclear injections; the NINDS DNA Sequence Facility for sequencing DNA constructs; Dr. David Borchelt for kindly providing the tetO expression vector; Drs. Darren Moore, Valina Dawson, Ted Dawson (of the Johns Hopkins University School of Medicine), and Jean-Marc Taymans (Universiteit Leuven) for kindly providing LRRK2 antibodies; Drs. John Hardy and Andy Singleton for their helpful suggestions; and the NIH Fellows Editorial Board for editing this manuscript.	Arlotta P, 2008, J NEUROSCI, V28, P622, DOI 10.1523/JNEUROSCI.2986-07.2008; Biskup S, 2006, ANN NEUROL, V60, P557, DOI 10.1002/ana.21019; Conway KA, 1998, NAT MED, V4, P1318, DOI 10.1038/3311; Cooper AA, 2006, SCIENCE, V313, P324, DOI 10.1126/science.1129462; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; Galter D, 2006, ANN NEUROL, V59, P714, DOI 10.1002/ana.20808; Gandhi PN, 2008, J NEUROSCI RES, V86, P1711, DOI 10.1002/jnr.21622; Gilks WP, 2005, LANCET, V365, P415, DOI 10.1016/S0140-6736(05)17830-1; Gillardon F, 2009, J NEUROCHEM, V110, P1514, DOI 10.1111/j.1471-4159.2009.06235.x; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Gosavi N, 2002, J BIOL CHEM, V277, P48984, DOI 10.1074/jbc.M208194200; Greggio E, 2006, NEUROBIOL DIS, V23, P329, DOI 10.1016/j.nbd.2006.04.001; Hardy J, 2006, ANN NEUROL, V60, P389, DOI 10.1002/ana.21022; Higashi S, 2007, BRAIN RES, V1155, P208, DOI 10.1016/j.brainres.2007.04.034; Hsu LJ, 2000, AM J PATHOL, V157, P401, DOI 10.1016/S0002-9440(10)64553-1; Imai Y, 2008, EMBO J, V27, P2432, DOI 10.1038/emboj.2008.163; Ishihara T, 1999, NEURON, V24, P751, DOI 10.1016/S0896-6273(00)81127-7; Jaleel M, 2007, BIOCHEM J, V405, P307, DOI 10.1042/BJ20070209; Jankowsky JL, 2005, PLOS MED, V2, P1318, DOI 10.1371/journal.pmed.0020355; Lee HJ, 2006, EUR J NEUROSCI, V24, P3153, DOI 10.1111/j.1460-9568.2006.05210.x; Lee HJ, 2005, J NEUROSCI, V25, P6016, DOI 10.1523/JNEUROSCI.0692-05.2005; Li XT, 2007, J NEUROCHEM, V103, P238, DOI 10.1111/j.1471-4159.2007.04743.x; Li YP, 2009, NAT NEUROSCI, V12, P826, DOI 10.1038/nn.2349; Liu Z, 2008, P NATL ACAD SCI USA, V105, P2693, DOI 10.1073/pnas.0708452105; MAROTEAUX L, 1988, J NEUROSCI, V8, P2804; MAROTEAUX L, 1991, MOL BRAIN RES, V11, P335, DOI 10.1016/0169-328X(91)90043-W; Martin LJ, 2006, J NEUROSCI, V26, P41, DOI 10.1523/JNEUROSCI.4308-05.2006; Mayford M, 1996, SCIENCE, V274, P1678, DOI 10.1126/science.274.5293.1678; Narhi L, 1999, J BIOL CHEM, V274, P9843, DOI 10.1074/jbc.274.14.9843; Nichols WC, 2005, LANCET, V365, P410, DOI 10.1016/S0140-6736(05)17828-3; Nussbaum RL, 1997, HUM MOL GENET, V6, P1687, DOI 10.1093/hmg/6.10.1687; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Parisiadou L, 2009, J NEUROSCI, V29, P13971, DOI 10.1523/JNEUROSCI.3799-09.2009; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Robinson KM, 2006, P NATL ACAD SCI USA, V103, P15038, DOI 10.1073/pnas.0601945103; Roy S, 2008, J NEUROSCI, V28, P5248, DOI 10.1523/JNEUROSCI.0309-08.2008; Savitt JM, 2006, J CLIN INVEST, V116, P1744, DOI 10.1172/JCI29178; Smith WLW, 2006, NAT NEUROSCI, V9, P1231, DOI 10.1038/nn1776; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Tanaka Y, 2001, HUM MOL GENET, V10, P919, DOI 10.1093/hmg/10.9.919; Tao-Cheng JH, 2006, NEUROSCIENCE, V141, P1217, DOI 10.1016/j.neuroscience.2006.04.061; Thyberg J, 1999, EXP CELL RES, V246, P263, DOI 10.1006/excr.1998.4326; Tong YR, 2009, P NATL ACAD SCI USA, V106, P14622, DOI 10.1073/pnas.0906334106; Trojanowski JQ, 1998, CELL DEATH DIFFER, V5, P832, DOI 10.1038/sj.cdd.4400432; Valiron O, 2001, CELL MOL LIFE SCI, V58, P2069, DOI 10.1007/PL00000837; Wang LZ, 2008, J NEUROSCI, V28, P3384, DOI 10.1523/JNEUROSCI.0185-08.2008; WEHLAND J, 1983, P NATL ACAD SCI-BIOL, V80, P4286, DOI 10.1073/pnas.80.14.4286; WEINGARTEN MD, 1975, P NATL ACAD SCI USA, V72, P1858, DOI 10.1073/pnas.72.5.1858; West AB, 2005, P NATL ACAD SCI USA, V102, P16842, DOI 10.1073/pnas.0507360102; Westerlund M, 2008, MOL CELL NEUROSCI, V39, P586, DOI 10.1016/j.mcn.2008.08.001; Zabetian CP, 2005, NEUROLOGY, V65, P741, DOI 10.1212/01.WNL.0000172630.22804.73; Zhu XW, 2006, ANN NEUROL, V60, P617, DOI 10.1002/ana.20928; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005	53	373	380	1	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 24	2009	64	6					807	827		10.1016/j.neuron.2009.11.006	http://dx.doi.org/10.1016/j.neuron.2009.11.006			21	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	541ON	20064389	Green Accepted, Bronze			2022-12-24	WOS:000273425800009
J	Cohen, MR; Maunsell, JHR				Cohen, Marlene R.; Maunsell, John H. R.			Attention improves performance primarily by reducing interneuronal correlations	NATURE NEUROSCIENCE			English	Article							NEURONAL CORRELATION; NORMALIZATION MODEL; SPATIAL ATTENTION; SINGLE NEURONS; MACAQUE; MODULATION; V4; STIMULUS; RELIABILITY; SENSITIVITY	Visual attention can improve behavioral performance by allowing observers to focus on the important information in a complex scene. Attention also typically increases the firing rates of cortical sensory neurons. Rate increases improve the signal-to-noise ratio of individual neurons, and this improvement has been assumed to underlie attention-related improvements in behavior. We recorded dozens of neurons simultaneously in visual area V4 and found that changes in single neurons accounted for only a small fraction of the improvement in the sensitivity of the population. Instead, over 80% of the attentional improvement in the population signal was caused by decreases in the correlations between the trial-to-trial fluctuations in the responses of pairs of neurons. These results suggest that the representation of sensory information in populations of neurons and the way attention affects the sensitivity of the population may only be understood by considering the interactions between neurons.	[Cohen, Marlene R.] Howard Hughes Med Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Howard Hughes Medical Institute; Harvard University; Harvard Medical School	Cohen, MR (corresponding author), Howard Hughes Med Inst, Boston, MA 02115 USA.	marlene_cohen@hms.harvard.edu	Maunsell, John/G-5702-2010	Maunsell, John/0000-0003-0018-4439	US National Institutes of Health [R01EY005911]; Howard Hughes Medical Institute; NATIONAL EYE INSTITUTE [R01EY005911, P30EY012196] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank D. Ruff for spike sorting and monkey training assistance, M. Churchland for code and advice regarding mean-matching and Fano factor analysis, and M. Histed for many helpful discussions. They, A. Ni and A. Smolyanskaya provided comments on an earlier version of the manuscript. This work was supported by US National Institutes of Health grant R01EY005911 and the Howard Hughes Medical Institute.	Abbott LF, 1999, NEURAL COMPUT, V11, P91, DOI 10.1162/089976699300016827; Assad JA, 2003, CURR OPIN NEUROBIOL, V13, P194, DOI 10.1016/S0959-4388(03)00045-X; Averbeck BB, 2006, NAT REV NEUROSCI, V7, P358, DOI 10.1038/nrn1888; Babiloni C, 2004, COGNITIVE BRAIN RES, V19, P259, DOI 10.1016/j.cogbrainres.2003.12.010; Bair W, 2001, J NEUROSCI, V21, P1676, DOI 10.1523/JNEUROSCI.21-05-01676.2001; Bastiaansen MCM, 2001, CLIN NEUROPHYSIOL, V112, P393, DOI 10.1016/S1388-2457(00)00537-X; Beck JM, 2008, NEURON, V60, P1142, DOI 10.1016/j.neuron.2008.09.021; Boynton GM, 2009, VISION RES, V49, P1129, DOI 10.1016/j.visres.2008.11.001; Churchland MM, 2007, CURR OPIN NEUROBIOL, V17, P609, DOI 10.1016/j.conb.2007.11.001; CHURCHLAND MM, 2009, FRONT SYST NEUROSCI, DOI DOI 10.3389/CONF.NEURO.06.2009.03.295; Cohen MR, 2008, NEURON, V60, P162, DOI 10.1016/j.neuron.2008.08.007; de la Rocha J, 2007, NATURE, V448, P802, DOI 10.1038/nature06028; DESIMONE R, 1987, J NEUROPHYSIOL, V57, P835, DOI 10.1152/jn.1987.57.3.835; Foxe JJ, 1998, NEUROREPORT, V9, P3929, DOI 10.1097/00001756-199812010-00030; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; GATTASS R, 1988, J NEUROSCI, V8, P1831; Kohn A, 2005, J NEUROSCI, V25, P3661, DOI 10.1523/JNEUROSCI.5106-04.2005; Kohn A, 2009, CURR OPIN NEUROBIOL, V19, P434, DOI 10.1016/j.conb.2009.06.007; Lee J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004651; Maunsell JHR, 2006, TRENDS NEUROSCI, V29, P317, DOI 10.1016/j.tins.2006.04.001; McAdams CJ, 1999, NEURON, V23, P765, DOI 10.1016/S0896-6273(01)80034-9; McAdams CJ, 1999, J NEUROSCI, V19, P431, DOI 10.1523/JNEUROSCI.19-01-00431.1999; Mitchell JF, 2007, NEURON, V55, P131, DOI 10.1016/j.neuron.2007.06.018; Mitchell JF, 2009, NEURON, V63, P879, DOI 10.1016/j.neuron.2009.09.013; MOTTER BC, 1993, J NEUROPHYSIOL, V70, P909, DOI 10.1152/jn.1993.70.3.909; Pillow JW, 2008, NATURE, V454, P995, DOI 10.1038/nature07140; Poort J, 2009, CEREB CORTEX, V19, P543, DOI 10.1093/cercor/bhn103; Pouget A, 2008, NAT NEUROSCI, V11, P1371, DOI 10.1038/nn1208-1371; Reynolds JH, 2004, ANNU REV NEUROSCI, V27, P611, DOI 10.1146/annurev.neuro.26.041002.131039; Reynolds JH, 2000, NEURON, V26, P703, DOI 10.1016/S0896-6273(00)81206-4; Reynolds JH, 2009, NEURON, V61, P168, DOI 10.1016/j.neuron.2009.01.002; Roelfsema PR, 2001, NEURON, V31, P853, DOI 10.1016/S0896-6273(01)00408-1; Schneidman E, 2006, NATURE, V440, P1007, DOI 10.1038/nature04701; Series P, 2004, NAT NEUROSCI, V7, P1129, DOI 10.1038/nn1321; Shadlen MN, 1996, J NEUROSCI, V16, P1486; Shadlen MN, 1998, J NEUROSCI, V18, P3870; Shlens J, 2006, J NEUROSCI, V26, P8254, DOI 10.1523/JNEUROSCI.1282-06.2006; Smith MA, 2008, J NEUROSCI, V28, P12591, DOI 10.1523/JNEUROSCI.2929-08.2008; Sundberg KA, 2009, NEURON, V61, P952, DOI 10.1016/j.neuron.2009.02.023; Thut G, 2006, J NEUROSCI, V26, P9494, DOI 10.1523/JNEUROSCI.0875-06.2006; TOLHURST DJ, 1983, VISION RES, V23, P775, DOI 10.1016/0042-6989(83)90200-6; Treue S, 1999, NATURE, V399, P575, DOI 10.1038/21176; Williford T, 2006, J NEUROPHYSIOL, V96, P40, DOI 10.1152/jn.01207.2005; Yantis S, 2003, CURR OPIN NEUROBIOL, V13, P187, DOI 10.1016/S0959-4388(03)00033-3; ZOHARY E, 1994, NATURE, V370, P140, DOI 10.1038/370140a0	45	671	675	1	58	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2009	12	12					1594	U148		10.1038/nn.2439	http://dx.doi.org/10.1038/nn.2439			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	523II	19915566	Green Accepted			2022-12-24	WOS:000272065600020
J	Goutagny, R; Jackson, J; Williams, S				Goutagny, Romain; Jackson, Jesse; Williams, Sylvain			Self-generated theta oscillations in the hippocampus	NATURE NEUROSCIENCE			English	Article							RAT; INTERNEURONS; RHYTHM; URETHANE; CA1	Hippocampal theta rhythm is crucial for spatial memory and is thought to be generated by extrinsic inputs. In contrast, using a complete rat hippocampus in vitro, we found several intrinsic, atropine-resistant theta generators in CA1. These oscillators were organized along the septotemporal axis and arose independently from CA3. Our results suggest that CA1 theta rhythm can emerge from the coupling of multiple autonomous hippocampal theta oscillators.	[Goutagny, Romain; Jackson, Jesse; Williams, Sylvain] McGill Univ, Dept Psychiat, Douglas Mental Hlth Univ Inst, Montreal, PQ, Canada	McGill University	Williams, S (corresponding author), McGill Univ, Dept Psychiat, Douglas Mental Hlth Univ Inst, Montreal, PQ, Canada.	sylvain.williams@douglas.mcgill.ca	goutagny, romain/C-1461-2018	goutagny, romain/0000-0002-1268-533X	Natural Sciences and Engineering Research Council of Canada; Fonds de la recherche en sante du Quebec chercheur boursier "senior."	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Fonds de la recherche en sante du Quebec chercheur boursier "senior."	We thank M. Danik, G. Ducharme, C. K. Young, C. T. Dickson and G. Buzsaki for their comments on the manuscript. This work was supported by the Canadian Institute of Health Research, the Natural Sciences and Engineering Research Council of Canada and the Fonds de la Recherche en Sante du Quebec. R. G. was supported by the Conrad F. Harrington post-doctoral fellowship from the McGill Faculty of Medicine. J. J. received a Canadian Graduate Scholarship from the Natural Sciences and Engineering Research Council of Canada and S. W. is a Fonds de la recherche en sante du Quebec chercheur boursier "senior."	AMARAL DG, 1989, NEUROSCIENCE, V31, P571, DOI 10.1016/0306-4522(89)90424-7; ANDERSEN P, 1962, NATURE, V196, P645, DOI 10.1038/196645a0; BLAND BH, 1986, PROG NEUROBIOL, V26, P1, DOI 10.1016/0301-0082(86)90019-5; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; COBB SR, 1995, NATURE, V378, P75, DOI 10.1038/378075a0; Crepel V, 1997, J NEUROPHYSIOL, V77, P2071, DOI 10.1152/jn.1997.77.4.2071; Csicsvari J, 1999, J NEUROSCI, V19, P274, DOI 10.1523/JNEUROSCI.19-01-00274.1999; FOX SE, 1986, EXP BRAIN RES, V62, P495; Hasselmo ME, 2005, HIPPOCAMPUS, V15, P936, DOI 10.1002/hipo.20116; KRAMIS R, 1975, EXP NEUROL, V49, P58, DOI 10.1016/0014-4886(75)90195-8; Leutgeb S, 2004, SCIENCE, V305, P1295, DOI 10.1126/science.1100265; Lubenov EV, 2009, NATURE, V459, P534, DOI 10.1038/nature08010; TRAUB RD, 1989, SCIENCE, V243, P1319, DOI 10.1126/science.2646715; VANDERWOLF CH, 1969, ELECTROEN CLIN NEURO, V26, P407, DOI 10.1016/0013-4694(69)90092-3; White JA, 2000, P NATL ACAD SCI USA, V97, P8128, DOI 10.1073/pnas.100124097	15	179	181	2	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2009	12	12					1491	1493		10.1038/nn.2440	http://dx.doi.org/10.1038/nn.2440			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	523II	19881503				2022-12-24	WOS:000272065600007
J	Sakata, S; Harris, KD				Sakata, Shuzo; Harris, Kenneth D.			Laminar Structure of Spontaneous and Sensory-Evoked Population Activity in Auditory Cortex	NEURON			English	Article							DEPENDENT SYNAPTIC PLASTICITY; LAYER-V NEURONS; VISUAL-CORTEX; IN-VIVO; BARREL CORTEX; RECEPTIVE-FIELDS; PYRAMIDAL CELLS; SUSPECTED INTERNEURONS; RESPONSE PROPERTIES; EFFERENT NEURONS	Spontaneous activity plays an important role in the function of neural circuits. Although many similarities between spontaneous and sensory-evoked neocortical activity have been reported, little is known about consistent differences between them. Here, using simultaneously recorded cortical populations and morphologically identified pyramidal cells, we compare the laminar structure of spontaneous and sensory-evoked population activity in rat auditory cortex. Spontaneous and evoked patterns both exhibited sparse, spatially localized activity in layer 2/3 pyramidal cells, with densely distributed activity in larger layer 5 pyramidal cells and putative interneurons. However, the propagation of spontaneous and evoked activity differed, with spontaneous activity spreading upward from deep layers and slowly across columns, but sensory responses initiating in presumptive thalamorecipient layers, spreading rapidly across columns. The similarity of sparseness patterns for both neural events and distinct spread of activity may reflect similarity of local processing and differences in the flow of information through cortical circuits, respectively.	[Sakata, Shuzo; Harris, Kenneth D.] Rutgers State Univ, Ctr Mol & Behav Neurosci, Newark, NJ 07102 USA	Rutgers State University Newark; Rutgers State University New Brunswick	Harris, KD (corresponding author), Rutgers State Univ, Ctr Mol & Behav Neurosci, 197 Univ Ave, Newark, NJ 07102 USA.	kdharris@andromeda.rutgers.edu		Sakata, Shuzo/0000-0001-6796-411X; Harris, Kenneth/0000-0002-5930-6456	NIH [MH073245, DC009947]; NSF [SBE-0542013]; Alfred P Sloan Foundation; Japan Society for the Promotion of Science Postdoctoral Fellowships for Research Abroad and the Sound Technology Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH073245] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009947] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Alfred P Sloan Foundation(Alfred P. Sloan Foundation); Japan Society for the Promotion of Science Postdoctoral Fellowships for Research Abroad and the Sound Technology Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank S. Marguet, P. Bartho, T. Klausberger, A. Luczak, and N. Lee for outstanding technical advice and assistance; G. Buzsaki, D. Pare, P. Chadderton, A. Renart, and J. de la Rocha for their generous support, advice, and comments on the manuscript; B. Krekelberg and members of the Harris lab for discussion. This work was supported by NIH (MH073245 and DC009947), NSF (SBE-0542013 to the Temporal Dynamics of Learning Center, an NSF Science of Learning Center), the Alfred P Sloan Foundation to K.D.H, and the Japan Society for the Promotion of Science Postdoctoral Fellowships for Research Abroad and the Sound Technology Foundation to S.S.	Averbeck BB, 2006, NAT REV NEUROSCI, V7, P358, DOI 10.1038/nrn1888; Barlow H B, 1972, Perception, V1, P371, DOI 10.1068/p010371; BARNES CA, 1990, PROG BRAIN RES, V83, P287; Berger T, 2007, J NEUROPHYSIOL, V97, P3751, DOI 10.1152/jn.01178.2006; Bitterman Y, 2008, NATURE, V451, P197, DOI 10.1038/nature06476; Brecht M, 2003, J PHYSIOL-LONDON, V553, P243, DOI 10.1113/jphysiol.2003.044222; Brecht M, 2007, CURR OPIN NEUROBIOL, V17, P408, DOI 10.1016/j.conb.2007.07.008; Bureau I, 2006, PLOS BIOL, V4, P2361, DOI 10.1371/journal.pbio.0040382; BUZSAKI G, 1989, NEUROSCIENCE, V31, P551, DOI 10.1016/0306-4522(89)90423-5; Buzsaki G, 1998, J NEUROPHYSIOL, V79, P1587, DOI 10.1152/jn.1998.79.3.1587; Caporale N, 2008, ANNU REV NEUROSCI, V31, P25, DOI 10.1146/annurev.neuro.31.060407.125639; CONSUL PC, 1973, TECHNOMETRICS, V15, P791, DOI 10.2307/1267389; COOGAN TA, 1993, J NEUROSCI, V13, P3749; CRICK F, 1983, NATURE, V304, P111, DOI 10.1038/304111a0; Csicsvari J, 2003, J NEUROPHYSIOL, V90, P1314, DOI 10.1152/jn.00116.2003; Curto C, 2009, J NEUROSCI, V29, P10600, DOI 10.1523/JNEUROSCI.2053-09.2009; de Kock CPJ, 2007, J PHYSIOL-LONDON, V581, P139, DOI 10.1113/jphysiol.2006.124321; deCharms RC, 2000, ANNU REV NEUROSCI, V23, P613, DOI 10.1146/annurev.neuro.23.1.613; DeWeese MR, 2006, J NEUROSCI, V26, P12206, DOI 10.1523/JNEUROSCI.2813-06.2006; Deweese MR, 2004, J NEUROPHYSIOL, V92, P1840, DOI 10.1152/jn.00197.2004; Dierks T, 1999, NEURON, V22, P615, DOI 10.1016/S0896-6273(00)80715-1; Douglas RJ, 2004, ANNU REV NEUROSCI, V27, P419, DOI 10.1146/annurev.neuro.27.070203.144152; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; Feldmeyer D, 2006, J PHYSIOL-LONDON, V575, P583, DOI 10.1113/jphysiol.2006.105106; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Ferezou I, 2007, NEURON, V56, P907, DOI 10.1016/j.neuron.2007.10.007; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Froemke RC, 2005, NATURE, V434, P221, DOI 10.1038/nature03366; Ganguli S, 2008, NEURON, V58, P15, DOI 10.1016/j.neuron.2008.01.038; GAWNE TJ, 1993, J NEUROSCI, V13, P2758; GILBERT CD, 1983, ANNU REV NEUROSCI, V6, P217, DOI 10.1146/annurev.ne.06.030183.001245; Greenberg DS, 2008, NAT NEUROSCI, V11, P749, DOI 10.1038/nn.2140; Harris KD, 2000, J NEUROPHYSIOL, V84, P401, DOI 10.1152/jn.2000.84.1.401; Harris KD, 2005, NAT REV NEUROSCI, V6, P399, DOI 10.1038/nrn1669; Harris KD, 2003, NATURE, V424, P552, DOI 10.1038/nature01834; Harris KD, 2001, NEURON, V32, P141, DOI 10.1016/S0896-6273(01)00447-0; Hazan L, 2006, J NEUROSCI METH, V155, P207, DOI 10.1016/j.jneumeth.2006.01.017; Hefti BJ, 2000, J NEUROPHYSIOL, V83, P2626, DOI 10.1152/jn.2000.83.5.2626; Henze DA, 2000, J NEUROPHYSIOL, V84, P390, DOI 10.1152/jn.2000.84.1.390; Hoffman KL, 2007, J NEUROSCI, V27, P11838, DOI 10.1523/JNEUROSCI.3501-07.2007; Holmgren C, 2003, J PHYSIOL-LONDON, V551, P139, DOI 10.1113/jphysiol.2003.044784; Hromadka T, 2008, PLOS BIOL, V6, P124, DOI 10.1371/journal.pbio.0060016; Hunter MD, 2006, P NATL ACAD SCI USA, V103, P189, DOI 10.1073/pnas.0506268103; Itskov V, 2008, NEURAL COMPUT, V20, P644, DOI 10.1162/neco.2007.3179; Ji DY, 2007, NAT NEUROSCI, V10, P100, DOI 10.1038/nn1825; Kampa BM, 2007, TRENDS NEUROSCI, V30, P456, DOI 10.1016/j.tins.2007.06.010; Kaur S, 2005, NEUROSCIENCE, V134, P1033, DOI 10.1016/j.neuroscience.2005.04.052; Kenet T, 2003, NATURE, V425, P954, DOI 10.1038/nature02078; Kilgard MP, 1999, HEARING RES, V134, P16, DOI 10.1016/S0378-5955(99)00061-1; Kimura A, 2003, NEUROSCIENCE, V117, P1003, DOI 10.1016/S0306-4522(02)00949-1; Kjaer T W, 1994, J Comput Neurosci, V1, P109, DOI 10.1007/BF00962721; Kraemer DJM, 2005, NATURE, V434, P158, DOI 10.1038/434158a; Laurent G, 2002, NAT REV NEUROSCI, V3, P884, DOI 10.1038/nrn964; Levy WB, 1996, NEURAL COMPUT, V8, P531, DOI 10.1162/neco.1996.8.3.531; Liu BH, 2007, NAT NEUROSCI, V10, P1594, DOI 10.1038/nn2012; Luczak A, 2007, P NATL ACAD SCI USA, V104, P347, DOI 10.1073/pnas.0605643104; Luczak A, 2009, NEURON, V62, P413, DOI 10.1016/j.neuron.2009.03.014; MacLean JN, 2005, NEURON, V48, P811, DOI 10.1016/j.neuron.2005.09.035; MARR D, 1969, J PHYSIOL-LONDON, V202, P437, DOI 10.1113/jphysiol.1969.sp008820; MARR D, 1971, PHILOS T ROY SOC B, V262, P23, DOI 10.1098/rstb.1971.0078; Nelson SB, 2006, CURR OPIN NEUROBIOL, V16, P571, DOI 10.1016/j.conb.2006.08.006; OJIMA H, 1992, CEREB CORTEX, V2, P197, DOI 10.1093/cercor/2.3.197; Olshausen BA, 2004, CURR OPIN NEUROBIOL, V14, P481, DOI 10.1016/j.conb.2004.07.007; Oswald AMM, 2008, J NEUROPHYSIOL, V99, P2998, DOI 10.1152/jn.01160.2007; Paxinos G., 1998, RAT BRAIN STEROTAXIC; Petersen CCH, 2003, P NATL ACAD SCI USA, V100, P13638, DOI 10.1073/pnas.2235811100; Pinault D, 1996, J NEUROSCI METH, V65, P113, DOI 10.1016/0165-0270(95)00144-1; Poulet JFA, 2008, NATURE, V454, P881, DOI 10.1038/nature07150; Quiroga RQ, 2005, NATURE, V435, P1102, DOI 10.1038/nature03687; Rieke F., 1997, SPIKES EXPLORING NEU; ROMANSKI LM, 1993, CEREB CORTEX, V3, P499, DOI 10.1093/cercor/3.6.499; ROUILLER EM, 1991, EXP BRAIN RES, V86, P483, DOI 10.1007/BF00230523; Sanchez-Vives MV, 2000, NAT NEUROSCI, V3, P1027, DOI 10.1038/79848; Schmitzer-Torbert N, 2005, NEUROSCIENCE, V131, P1, DOI 10.1016/j.neuroscience.2004.09.066; Schreiner CE, 2000, ANNU REV NEUROSCI, V23, P501, DOI 10.1146/annurev.neuro.23.1.501; Schubert D, 2007, BRAIN STRUCT FUNCT, V212, P107, DOI 10.1007/s00429-007-0147-z; SIMONS DJ, 1978, J NEUROPHYSIOL, V41, P798, DOI 10.1152/jn.1978.41.3.798; Sirota A, 2008, NEURON, V60, P683, DOI 10.1016/j.neuron.2008.09.014; Smith PH, 2001, J COMP NEUROL, V436, P508, DOI 10.1002/cne.1084; Sohya K, 2007, J NEUROSCI, V27, P2145, DOI 10.1523/JNEUROSCI.4641-06.2007; STERIADE M, 1993, J NEUROSCI, V13, P3252, DOI 10.1523/jneurosci.13-08-03252.1993; SWADLOW HA, 1988, J NEUROPHYSIOL, V59, P1162, DOI 10.1152/jn.1988.59.4.1162; SWADLOW HA, 1994, J NEUROPHYSIOL, V71, P437, DOI 10.1152/jn.1994.71.2.437; SWADLOW HA, 1989, J NEUROPHYSIOL, V62, P288, DOI 10.1152/jn.1989.62.1.288; SZENTAGOTHAI J, 1983, REV PHYSIOL BIOCH P, V98, P11, DOI 10.1007/BFb0033866; Thomson AM, 2007, FRONT NEUROSCI-SWITZ, V1, P19, DOI 10.3389/neuro.01.1.1.002.2007; Timofeev I, 2000, CEREB CORTEX, V10, P1185, DOI 10.1093/cercor/10.12.1185; Turner JG, 2005, HEARING RES, V202, P129, DOI 10.1016/j.heares.2004.09.011; VANBREDERODE JFM, 1995, J NEUROPHYSIOL, V74, P1149, DOI 10.1152/jn.1995.74.3.1149; Vinje WE, 2000, SCIENCE, V287, P1273, DOI 10.1126/science.287.5456.1273; Wallace MN, 2008, EXP BRAIN RES, V184, P179, DOI 10.1007/s00221-007-1092-z; Wang X, 2008, NEUROSCIENCE, V154, P294, DOI 10.1016/j.neuroscience.2008.03.065; Willmore B, 2001, NETWORK-COMP NEURAL, V12, P255, DOI 10.1088/0954-898X/12/3/302; Winer JA, 2007, HEARING RES, V229, P3, DOI 10.1016/j.heares.2007.01.017; Wu GK, 2008, NEURON, V58, P132, DOI 10.1016/j.neuron.2008.01.035	95	416	419	0	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 12	2009	64	3					404	418		10.1016/j.neuron.2009.09.020	http://dx.doi.org/10.1016/j.neuron.2009.09.020			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	521MF	19914188	Green Accepted, Bronze			2022-12-24	WOS:000271924800014
J	Zhou, Y; Won, J; Karlsson, MG; Zhou, M; Rogerson, T; Balaji, J; Neve, R; Poirazi, P; Silva, AJ				Zhou, Yu; Won, Jaejoon; Karlsson, Mikael Guzman; Zhou, Miou; Rogerson, Thomas; Balaji, Jayaprakash; Neve, Rachael; Poirazi, Panayiota; Silva, Alcino J.			CREB regulates excitability and the allocation of memory to subsets of neurons in the amygdala	NATURE NEUROSCIENCE			English	Article							ELEMENT-BINDING PROTEIN; CONDITIONED TASTE-AVERSION; CA1 PYRAMIDAL NEURONS; LATERAL AMYGDALA; FEAR MEMORY; TRANSCRIPTION FACTORS; MAMMALIAN NEURONS; IN-VITRO; RECEPTOR; RAT	The mechanisms that determine how information is allocated to specific regions and cells in the brain are important for memory capacity, storage and retrieval, but are poorly understood. We manipulated CREB in a subset of lateral amygdala neurons in mice with a modified herpes simplex virus (HSV) and reversibly inactivated transfected neurons with the Drosophila allatostatin G protein-coupled receptor (AlstR)/ligand system. We found that inactivation of the neurons transfected with HSV-CREB during training disrupted memory for tone conditioning, whereas inactivation of a similar proportion of transfected control neurons did not. Whole-cell recordings of fluorescently tagged transfected neurons revealed that neurons with higher CREB levels are more excitable than neighboring neurons and showed larger synaptic efficacy changes following conditioning. Our findings demonstrate that CREB modulates the allocation of fear memory to specific cells in lateral amygdala and suggest that neuronal excitability is important in this process.	[Zhou, Yu; Won, Jaejoon; Karlsson, Mikael Guzman; Zhou, Miou; Rogerson, Thomas; Balaji, Jayaprakash; Silva, Alcino J.] Univ Calif Los Angeles, Dept Neurobiol, Los Angeles, CA 90095 USA; [Zhou, Yu; Won, Jaejoon; Karlsson, Mikael Guzman; Zhou, Miou; Rogerson, Thomas; Balaji, Jayaprakash; Silva, Alcino J.] Univ Calif Los Angeles, Semel Inst, Los Angeles, CA USA; [Zhou, Yu; Won, Jaejoon; Karlsson, Mikael Guzman; Zhou, Miou; Rogerson, Thomas; Balaji, Jayaprakash; Silva, Alcino J.] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90024 USA; [Zhou, Yu; Won, Jaejoon; Karlsson, Mikael Guzman; Zhou, Miou; Rogerson, Thomas; Balaji, Jayaprakash; Silva, Alcino J.] Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90024 USA; [Neve, Rachael] MIT, Picower Inst, Cambridge, MA 02139 USA; [Poirazi, Panayiota] Fdn Res & Technol Hellas, Inst Mol Biol & Biotechnol, Computat Biol Lab, Iraklion, Crete, Greece	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Massachusetts Institute of Technology (MIT); Foundation for Research & Technology - Hellas (FORTH)	Silva, AJ (corresponding author), Univ Calif Los Angeles, Dept Neurobiol, Los Angeles, CA 90095 USA.	silvaa@mednet.ucla.edu	Silva, Alcino/ABD-7684-2021; Zhou, Miou/AAK-1515-2021	Silva, Alcino/0000-0002-1587-4558; Zhou, Miou/0000-0001-8188-7392; Silva, Alcino/0000-0001-5525-0494; Poirazi, Panayiota/0000-0001-6152-595X	US National Institutes of Health [P50-MH0779720, R37-AG13622]; European Commission [PIOF-GA-2008-219622]; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH077972] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG013622, R01AG013622] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Commission(European CommissionEuropean Commission Joint Research Centre); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank T. Carvalho, Y.-S. Lee, P. Golshani, D. Buonomano, B. Wiltgen, W. Tan, J. Shobe, J. Feldman and J. Guzowski for helpful advice, E. Callaway for AlstR cDNA and K. Cai for technical support. This work was supported by grants from the US National Institutes of Health (P50-MH0779720 and R37-AG13622) to A. J. S. and a Marie Curie Outgoing fellowship of the European Commission (PIOF-GA-2008-219622) to P. P.	Barrot M, 2002, P NATL ACAD SCI USA, V99, P11435, DOI 10.1073/pnas.172091899; Birgul N, 1999, EMBO J, V18, P5892, DOI 10.1093/emboj/18.21.5892; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; Carlezon WA, 2005, TRENDS NEUROSCI, V28, P436, DOI 10.1016/j.tins.2005.06.005; Carvalho TP, 2009, NEURON, V61, P774, DOI 10.1016/j.neuron.2009.01.013; Clark MS, 2002, J NEUROSCI, V22, P4550, DOI 10.1523/JNEUROSCI.22-11-04550.2002; Dong Y, 2006, NAT NEUROSCI, V9, P475, DOI 10.1038/nn1661; Faber ESL, 2004, J NEUROSCI, V24, P3031, DOI 10.1523/JNEUROSCI.4496-03.2004; Faber ESL, 2001, J NEUROPHYSIOL, V85, P714, DOI 10.1152/jn.2001.85.2.714; Han JH, 2007, SCIENCE, V316, P457, DOI [10.1126/science.1139438, 10.1126/science.1134697]; Han JH, 2009, SCIENCE, V323, P1492, DOI 10.1126/science.1164139; Han MH, 2006, J NEUROSCI, V26, P4624, DOI 10.1523/JNEUROSCI.4701-05.2006; Huang YY, 1998, NEURON, V21, P169, DOI 10.1016/S0896-6273(00)80524-3; Humeau Y, 2007, J NEUROSCI, V27, P10947, DOI 10.1523/JNEUROSCI.2603-07.2007; Jancic D, 2009, CEREB CORTEX, V19, P2535, DOI 10.1093/cercor/bhp004; Josselyn SA, 2004, NEUROBIOL LEARN MEM, V82, P159, DOI 10.1016/j.nlm.2004.05.008; Karschin C, 1996, J NEUROSCI, V16, P3559; Kida S, 2002, NAT NEUROSCI, V5, P348, DOI 10.1038/nn819; Lamprecht R, 1997, J NEUROSCI, V17, P8443; Lechner HAE, 2002, J NEUROSCI, V22, P5287; Liebmann L, 2008, J NEUROPHYSIOL, V99, P958, DOI 10.1152/jn.01137.2007; LIM F, 1999, CURRENT PROTOCOLS NE; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; Losonczy A, 2008, NATURE, V452, P436, DOI 10.1038/nature06725; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; McKernan MG, 1997, NATURE, V390, P607, DOI 10.1038/37605; Murphy GG, 2004, CURR BIOL, V14, P1907, DOI 10.1016/j.cub.2004.10.021; Oh MM, 2009, P NATL ACAD SCI USA, V106, P1620, DOI 10.1073/pnas.0807708106; Reijmers LG, 2007, SCIENCE, V317, P1230, DOI 10.1126/science.1143839; Repa JC, 2001, NAT NEUROSCI, V4, P724, DOI 10.1038/89512; Rumpel S, 2005, SCIENCE, V308, P83, DOI 10.1126/science.1103944; Santini E, 2008, J NEUROSCI, V28, P4028, DOI 10.1523/JNEUROSCI.2623-07.2008; SassoneCorsi P, 1995, ANNU REV CELL DEV BI, V11, P355, DOI 10.1146/annurev.cellbio.11.1.355; Schafe GE, 2005, J NEUROSCI, V25, P10010, DOI 10.1523/JNEUROSCI.3307-05.2005; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; Silva AJ, 1998, ANNU REV NEUROSCI, V21, P127, DOI 10.1146/annurev.neuro.21.1.127; Staff NP, 2003, HIPPOCAMPUS, V13, P801, DOI 10.1002/hipo.10129; STORM JF, 1990, PROG BRAIN RES, V83, P161; Tan EM, 2006, NEURON, V51, P157, DOI 10.1016/j.neuron.2006.06.018; Tan WB, 2008, NAT NEUROSCI, V11, P538, DOI 10.1038/nn.2104; Viosca J, 2009, LEARN MEMORY, V16, P193, DOI 10.1101/lm.1254209; Won J, 2008, NEUROBIOL LEARN MEM, V89, P285, DOI 10.1016/j.nlm.2007.08.017; YAMAMOTO T, 1994, BEHAV BRAIN RES, V65, P123, DOI 10.1016/0166-4328(94)90097-3	44	322	327	1	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2009	12	11					1438	1443		10.1038/nn.2405	http://dx.doi.org/10.1038/nn.2405			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	511UE	19783993	Green Published, Green Submitted, Green Accepted			2022-12-24	WOS:000271194100017
J	Pinto, L; Drechsel, D; Schmid, MT; Ninkovic, J; Irmler, M; Brill, MS; Restani, L; Gianfranceschi, L; Cerri, C; Weber, SN; Tarabykin, V; Baer, K; Guillemot, F; Beckers, J; Zecevic, N; Dehay, C; Caleo, M; Schorle, H; Gotz, M				Pinto, Luisa; Drechsel, Daniela; Schmid, Marie-Theres; Ninkovic, Jovica; Irmler, Martin; Brill, Monika S.; Restani, Laura; Gianfranceschi, Laura; Cerri, Chiara; Weber, Susanne N.; Tarabykin, Victor; Baer, Kristin; Guillemot, Francois; Beckers, Johannes; Zecevic, Nada; Dehay, Colette; Caleo, Matteo; Schorle, Hubert; Goetz, Magdalena			AP2 gamma regulates basal progenitor fate in a region- and layer-specific manner in the developing cortex	NATURE NEUROSCIENCE			English	Article							RADIAL GLIA; SUBVENTRICULAR ZONE; PYRAMIDAL NEURONS; CELL-CYCLE; WILD-TYPE; PAX6; EXPRESSION; NEUROGENESIS; PRECURSORS; CUX-2	An important feature of the cerebral cortex is its layered organization, which is modulated in an area-specific manner. We found that the transcription factor AP2 gamma regulates laminar fate in a region-specific manner. Deletion of AP2 gamma (also known as Tcfap2c) during development resulted in a specific reduction of upper layer neurons in the occipital cortex, leading to impaired function and enhanced plasticity of the adult visual cortex. AP2 gamma functions in apical progenitors, and its absence resulted in mis-specification of basal progenitors in the occipital cortex at the time at which upper layer neurons were generated. AP2 gamma directly regulated the basal progenitor fate determinants Math3 (also known as Neurod4) and Tbr2, and its overexpression promoted the generation of layer II/III neurons in a time- and region-specific manner. Thus, AP2 gamma acts as a regulator of basal progenitor fate, linking regional and laminar specification in the mouse developing cerebral cortex.	[Pinto, Luisa; Drechsel, Daniela; Schmid, Marie-Theres; Ninkovic, Jovica; Brill, Monika S.; Goetz, Magdalena] Helmholtz Ctr Munich, German Res Ctr Environm Hlth, Inst Stem Cell Res, Neuherberg, Germany; [Drechsel, Daniela; Guillemot, Francois] Natl Inst Med Res, Div Mol Neurobiol, London NW7 1AA, England; [Irmler, Martin; Beckers, Johannes] Helmholtz Ctr Munich German, Res Ctr Environm Hlth, Inst Expt Genet, Neuherberg, Germany; [Brill, Monika S.; Goetz, Magdalena] Univ Munich, Munich, Germany; [Restani, Laura; Gianfranceschi, Laura; Cerri, Chiara] CNR, Ist Neurosci, Pisa, Italy; [Weber, Susanne N.; Schorle, Hubert] Univ Bonn, Inst Pathol, Dept Dev Pathol, Sch Med, D-5300 Bonn, Germany; [Tarabykin, Victor] Max Planck Inst Expt Med, D-37075 Gottingen, Germany; [Baer, Kristin] Swansea Univ, Inst Life Sci, Sch Med, Swansea, W Glam, Wales; [Beckers, Johannes] Tech Univ Munich, Ctr Life & Food Sci Weihenstephan, D-8050 Freising Weihenstephan, Germany; [Zecevic, Nada] Univ Connecticut, Ctr Hlth, Dept Neurosci, Farmington, CT USA; [Dehay, Colette] Stem Cell & Brain Res Inst, INSERM, U846, Bron, France; [Dehay, Colette] Univ Lyon, UMR S 846, Lyon, France; [Goetz, Magdalena] Munich Ctr Integrated Prot Sci Munich, CIPSM, Munich, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; MRC National Institute for Medical Research; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; Consiglio Nazionale delle Ricerche (CNR); Istituto di Neuroscienze (IN-CNR); University of Bonn; Max Planck Society; Swansea University; Technical University of Munich; University of Connecticut; Institut National de la Sante et de la Recherche Medicale (Inserm); University of Munich	Gotz, M (corresponding author), Helmholtz Ctr Munich, German Res Ctr Environm Hlth, Inst Stem Cell Res, Neuherberg, Germany.	luisapinto@ecsaude.uminho.pt; magdalena.goetz@helmholtz-muenchen.de	Tarabykin, Victor/F-9467-2014; Restani, Laura/AAY-5659-2020; Ninkovic, Jovica/AAH-5220-2019; Dehay, Colette/H-4437-2014; Beckers, Johannes/K-7237-2012; Irmler, Martin/B-3317-2013; Pinto, Luisa/GXF-0087-2022; Guillemot, Francois/AAV-1482-2021; Schorle, Hubert/M-5001-2016; Schorle, Hubert/S-1713-2019; Pinto, Luísa/A-7414-2010; Restani, Laura/ABH-1733-2020	Ninkovic, Jovica/0000-0002-4381-0041; Dehay, Colette/0000-0002-5196-1464; Beckers, Johannes/0000-0001-7874-3822; Irmler, Martin/0000-0003-3169-479X; Schorle, Hubert/0000-0001-8272-0076; Pinto, Luísa/0000-0002-7724-0446; RESTANI, LAURA/0000-0002-8295-8452; Tarabykin, Viktor/0000-0001-8931-7263; CALEO, MATTEO/0000-0002-4333-6378; cerri, chiara/0000-0001-9930-7931; Brill, Monika/0000-0001-5422-9175	Deutsche Forschungsgemeinschaft; Bundesministerium fur Bildung und Forschung; Bavarian government; Portuguese Fundacao para a Ciencia e Tecnologia/ European Social Fund; MRC [MC_U117570528] Funding Source: UKRI; Medical Research Council [MC_U117570528] Funding Source: researchfish	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Bavarian government; Portuguese Fundacao para a Ciencia e Tecnologia/ European Social Fund(European Social Fund (ESF)Portuguese Foundation for Science and Technology); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We are very grateful to M. Moser, S. Pfaff, C. Schuurmans and Y. Gotoh for in situ probes and to R. Jager for providing reagents. We thank T. Ozturk, A. Steiner, A. Waiser and D. Franzen for excellent technical assistance. H. S. was supported by the Deutsche Forschungsgemeinschaft. M. G. was supported by the Deutsche Forschungsgemeinschaft, Bundesministerium fur Bildung und Forschung and the Bavarian government. L. P. is supported by the Portuguese Fundacao para a Ciencia e Tecnologia/European Social Fund.	Arnold SJ, 2008, GENE DEV, V22, P2479, DOI 10.1101/gad.475408; Caleo M, 2007, J NEUROSCI, V27, P4530, DOI 10.1523/JNEUROSCI.0772-07.2007; Cancedda L, 2004, J NEUROSCI, V24, P4840, DOI 10.1523/JNEUROSCI.0845-04.2004; Chazaud C, 1996, MECH DEVELOP, V54, P83, DOI 10.1016/0925-4773(95)00463-7; Costa MR, 2009, CEREB CORTEX, V19, pI135, DOI 10.1093/cercor/bhp046; Cubelos B, 2008, CEREB CORTEX, V18, P1758, DOI 10.1093/cercor/bhm199; Cundiff P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005204; Dehay C, 2007, NAT REV NEUROSCI, V8, P438, DOI 10.1038/nrn2097; Englund C, 2005, J NEUROSCI, V25, P247, DOI 10.1523/JNEUROSCI.2899-04.2005; FAGIOLINI M, 1994, VISION RES, V34, P709, DOI 10.1016/0042-6989(94)90210-0; Fan GP, 2005, DEVELOPMENT, V132, P3345, DOI 10.1242/dev.01912; Farkas LM, 2008, NEURON, V60, P40, DOI 10.1016/j.neuron.2008.09.020; Ferrere A, 2006, ANAT REC PART A, V288A, P158, DOI 10.1002/ar.a.20284; Gianfranceschi L, 1999, VISION RES, V39, P569, DOI 10.1016/S0042-6989(98)00169-2; GILLIES K, 1993, EUR J NEUROSCI, V5, P73, DOI 10.1111/j.1460-9568.1993.tb00207.x; Gotz M, 1998, NEURON, V21, P1031, DOI 10.1016/S0896-6273(00)80621-2; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Hand R, 2005, NEURON, V48, P45, DOI 10.1016/j.neuron.2005.08.032; Haubensak W, 2004, P NATL ACAD SCI USA, V101, P3196, DOI 10.1073/pnas.0308600100; Haubst N, 2004, DEVELOPMENT, V131, P6131, DOI 10.1242/dev.01524; Holm PC, 2007, MOL CELL NEUROSCI, V34, P99, DOI 10.1016/j.mcn.2006.10.008; Iwasato T, 2000, NATURE, V406, P726, DOI 10.1038/35021059; Kim EA, 2006, J BIOL CHEM, V281, P7489, DOI 10.1074/jbc.M507227200; Kowalczyk T, 2009, CEREB CORTEX, V19, P2439, DOI 10.1093/cercor/bhn260; Kroll TT, 2005, P NATL ACAD SCI USA, V102, P7374, DOI 10.1073/pnas.0500819102; Li HL, 2006, NEOPLASIA, V8, P568, DOI 10.1593/neo.06367; Lukaszewicz A, 2006, CEREB CORTEX, V16, pI26, DOI 10.1093/cercor/bhk011; Martinez-Cerdeno V, 2006, CEREB CORTEX, V16, pI152, DOI 10.1093/cercor/bhk017; Mattar P, 2008, MOL CELL BIOL, V28, P1456, DOI 10.1128/MCB.01510-07; Miyata T, 2004, DEVELOPMENT, V131, P3133, DOI 10.1242/dev.01173; Molyneaux BJ, 2007, NAT REV NEUROSCI, V8, P427, DOI 10.1038/nrn2151; Nieto M, 2004, J COMP NEUROL, V479, P168, DOI 10.1002/cne.20322; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; O'Leary DDM, 2007, NEURON, V56, P252, DOI 10.1016/j.neuron.2007.10.010; Pinto L, 2008, MOL CELL NEUROSCI, V38, P15, DOI 10.1016/j.mcn.2008.01.012; Polleux F, 2001, CEREB CORTEX, V11, P1027, DOI 10.1093/cercor/11.11.1027; Porciatti V, 1999, VISION RES, V39, P3071, DOI 10.1016/S0042-6989(99)00022-X; Rash BG, 2006, CURR OPIN NEUROBIOL, V16, P25, DOI 10.1016/j.conb.2006.01.004; Roy K, 2004, J NEUROSCI, V24, P8333, DOI 10.1523/JNEUROSCI.1148-04.2004; Schuurmans C, 2004, EMBO J, V23, P2892, DOI 10.1038/sj.emboj.7600278; Sessa A, 2008, NEURON, V60, P56, DOI 10.1016/j.neuron.2008.09.028; Spolidoro M, 2009, EXP BRAIN RES, V192, P335, DOI 10.1007/s00221-008-1509-3; Stoykova A, 2000, J NEUROSCI, V20, P8042; Sur M, 2005, SCIENCE, V310, P805, DOI 10.1126/science.1112070; Tarabykin V, 2001, DEVELOPMENT, V128, P1983; Werling U, 2002, MOL CELL BIOL, V22, P3149, DOI 10.1128/MCB.22.9.3149-3156.2002; Werling Uwe, 2002, Genesis The Journal of Genetics and Development, V32, P127, DOI 10.1002/gene.10057; Wu SX, 2005, P NATL ACAD SCI USA, V102, P17172, DOI 10.1073/pnas.0508560102; Zhao F, 2003, GENE EXPR PATTERNS, V3, P213, DOI 10.1016/S1567-133X(02)00067-4; Zimmer C, 2004, CEREB CORTEX, V14, P1408, DOI 10.1093/cercor/bhh102	50	81	81	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2009	12	10					1229	U38		10.1038/nn.2399	http://dx.doi.org/10.1038/nn.2399			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	498US	19749747				2022-12-24	WOS:000270170200011
J	Kumaran, D; Summerfield, JJ; Hassabis, D; Maguire, EA				Kumaran, Dharshan; Summerfield, Jennifer J.; Hassabis, Demis; Maguire, Eleanor A.			Tracking the Emergence of Conceptual Knowledge during Human Decision Making	NEURON			English	Article							MEDIAL TEMPORAL-LOBE; COMPLEMENTARY-LEARNING-SYSTEMS; HUMAN BRAIN; DECLARATIVE MEMORY; RECOGNITION MEMORY; PREFRONTAL CORTEX; HIPPOCAMPAL PATHOLOGY; ORBITOFRONTAL CORTEX; SINGLE NEURONS; ASSOCIATIONS	Concepts lie at the very heart of intelligence, providing organizing principles with which to comprehend the world. Surprisingly little, however, is understood about how we acquire and deploy concepts. Here, we show that a functionally coupled circuit involving the hippocampus and ventromedial prefrontal cortex (vMPFC) underpins the emergence of conceptual knowledge and its effect on choice behavior. Critically, the hippocampus alone supported the efficient transfer of knowledge to a perceptually novel setting. These findings provide compelling evidence that the hippocampus supports conceptual learning through the networking of discrete memories and reveal the nature of its interaction with downstream valuation modules such as the vMPFC. Our study offers neurobiological insights into the remarkable capacity of humans to discover the conceptual structure of related experiences and use this knowledge to solve exacting decision problems.	[Kumaran, Dharshan; Summerfield, Jennifer J.; Hassabis, Demis; Maguire, Eleanor A.] UCL, Inst Neurol, Wellcome Trust Ctr Neuroimaging, London WC1N 3BG, England; [Kumaran, Dharshan] UCL, Inst Cognit Neurosci, London WC1N 3BG, England; [Kumaran, Dharshan] Stanford Univ, Dept Psychol, Stanford, CA 94305 USA	University of London; University College London; University of London; University College London; Stanford University	Kumaran, D (corresponding author), UCL, Inst Neurol, Wellcome Trust Ctr Neuroimaging, 12 Queen Sq, London WC1N 3BG, England.	d.kumaran@fil.ion.ucl.ac.uk	Kumaran, Dharshan/O-3337-2013		Wellcome Trust Senior Research Fellowship in Basic Biomedical Science	Wellcome Trust Senior Research Fellowship in Basic Biomedical Science(Wellcome Trust)	We thank Ray Dolan, Benedetto De Martino and Hugo Spiers for comments on the manuscript; Sara Bengtsson, Dick Passingham, and Ben Seymour for useful discussions; Hanneke den Ouden and Guillaume Flandin for methodological advice; Debbie Talmi for help with stimuli. The work was funded by a Wellcome Trust Senior Research Fellowship in Basic Biomedical Science to E.A.M.	Ashby EG, 2005, ANNU REV PSYCHOL, V56, P149, DOI 10.1146/annurev.psych.56.091103.070217; Bar M, 2007, TRENDS COGN SCI, V11, P280, DOI 10.1016/j.tics.2007.05.005; Bartlett F.C., 1932, REMEMBERING EXPT SOC; Bayley PJ, 2008, HIPPOCAMPUS, V18, P575, DOI 10.1002/hipo.20417; Behrens TEJ, 2008, NATURE, V456, P245, DOI 10.1038/nature07538; Buckner RL, 2007, TRENDS COGN SCI, V11, P49, DOI 10.1016/j.tics.2006.11.004; Cohen N. J., 1993, MEMORY AMNESIA HIPPO; Davachi L, 2006, CURR OPIN NEUROBIOL, V16, P693, DOI 10.1016/j.conb.2006.10.012; Daw ND, 2005, NAT NEUROSCI, V8, P1704, DOI 10.1038/nn1560; Deichmann R, 2003, NEUROIMAGE, V19, P430, DOI 10.1016/S1053-8119(03)00073-9; Duff MC, 2006, NAT NEUROSCI, V9, P140, DOI 10.1038/nn1601; Eichenbaum H, 2004, NEURON, V44, P109, DOI 10.1016/j.neuron.2004.08.028; Eichenbaum H, 2007, ANNU REV NEUROSCI, V30, P123, DOI 10.1146/annurev.neuro.30.051606.094328; Eichenbaum H, 1999, NEURON, V23, P209, DOI 10.1016/S0896-6273(00)80773-4; Friston KJ, 1997, NEUROIMAGE, V6, P218, DOI 10.1006/nimg.1997.0291; Friston KJ, 1998, NEUROIMAGE, V7, P30, DOI 10.1006/nimg.1997.0306; Gallistel CR, 2004, P NATL ACAD SCI USA, V101, P13124, DOI 10.1073/pnas.0404965101; Greene AJ, 2007, HIPPOCAMPUS, V17, P429, DOI 10.1002/hipo.20296; Gupta R, 2009, NEUROPSYCHOLOGIA, V47, P1686, DOI 10.1016/j.neuropsychologia.2009.02.007; Hampton AN, 2006, J NEUROSCI, V26, P8360, DOI 10.1523/JNEUROSCI.1010-06.2006; Haskins AL, 2008, NEURON, V59, P554, DOI 10.1016/j.neuron.2008.07.035; Hassabis D, 2007, TRENDS COGN SCI, V11, P299, DOI 10.1016/j.tics.2007.05.001; Johnson A, 2007, CURR OPIN NEUROBIOL, V17, P692, DOI 10.1016/j.conb.2008.01.003; Josephs O, 1999, PHILOS T R SOC B, V354, P1215, DOI 10.1098/rstb.1999.0475; Knowlton B J, 1994, Learn Mem, V1, P106; KNOWLTON BJ, 1994, J EXP PSYCHOL LEARN, V20, P79, DOI 10.1037/0278-7393.20.1.79; KNOWLTON BJ, 1993, SCIENCE, V262, P1747, DOI 10.1126/science.8259522; Kumaran D, 2007, NEUROPSYCHOLOGIA, V45, P2699, DOI 10.1016/j.neuropsychologia.2007.04.007; Law JR, 2005, J NEUROSCI, V25, P5720, DOI 10.1523/JNEUROSCI.4935-04.2005; Locke John, 1690, ESSAY HUMANE UNDERST; Martin A, 2007, ANNU REV PSYCHOL, V58, P25, DOI 10.1146/annurev.psych.57.102904.190143; Mayes A, 2007, TRENDS COGN SCI, V11, P126, DOI 10.1016/j.tics.2006.12.003; MCCLELLAND JL, 1995, PSYCHOL REV, V102, P419, DOI 10.1037/0033-295X.102.3.419; Miller EK, 2002, PHILOS T R SOC B, V357, P1123, DOI 10.1098/rstb.2002.1099; Montague PR, 2006, ANNU REV NEUROSCI, V29, P417, DOI 10.1146/annurev.neuro.29.051605.112903; Murphy G., 2004, BIG BOOK CONCEPTS; Murray EA, 2007, J NEUROSCI, V27, P8166, DOI 10.1523/JNEUROSCI.1556-07.2007; Myers CE, 2003, J COGNITIVE NEUROSCI, V15, P185, DOI 10.1162/089892903321208123; Norman KA, 2003, PSYCHOL REV, V110, P611, DOI 10.1037/0033-295X.110.4.611; O'Doherty JP, 2004, CURR OPIN NEUROBIOL, V14, P769, DOI 10.1016/j.conb.2004.10.016; O'Kane G, 2004, HIPPOCAMPUS, V14, P417, DOI 10.1002/hipo.20005; Ongur D, 2003, J COMP NEUROL, V460, P425, DOI 10.1002/cne.10609; OTTO T, 1992, HIPPOCAMPUS, V2, P323, DOI 10.1002/hipo.450020310; Patterson K, 2007, NAT REV NEUROSCI, V8, P976, DOI 10.1038/nrn2277; Phelps EA, 2004, NEURON, V43, P897, DOI 10.1016/j.neuron.2004.08.042; Poldrack RA, 2001, NATURE, V414, P546, DOI 10.1038/35107080; Preston AR, 2004, HIPPOCAMPUS, V14, P148, DOI 10.1002/hipo.20009; Quiroga RQ, 2005, NATURE, V435, P1102, DOI 10.1038/nature03687; Rangel A, 2008, NAT REV NEUROSCI, V9, P545, DOI 10.1038/nrn2357; REBER AS, 1967, J VERB LEARN VERB BE, V6, P855, DOI 10.1016/S0022-5371(67)80149-X; Rogers T. T., 2004, SEMANTIC COGNITION P; Rudebeck PH, 2008, COGN AFFECT BEHAV NE, V8, P485, DOI 10.3758/CABN.8.4.485; RUDY JW, 1989, BEHAV BRAIN RES, V34, P97, DOI 10.1016/S0166-4328(89)80093-2; Rumelhart D. E., 1980, THEORETICAL ISSUES R; Schacter DL, 1999, HIPPOCAMPUS, V9, P7, DOI 10.1002/(SICI)1098-1063(1999)9:1<7::AID-HIPO2>3.0.CO;2-K; Shea N, 2008, COGN AFFECT BEHAV NE, V8, P418, DOI 10.3758/CABN.8.4.418; Shohamy D, 2008, NEURON, V60, P378, DOI 10.1016/j.neuron.2008.09.023; Smith AC, 2004, J NEUROSCI, V24, P447, DOI 10.1523/JNEUROSCI.2908-03.2004; Strange BA, 1999, P NATL ACAD SCI USA, V96, P4034, DOI 10.1073/pnas.96.7.4034; Toni I, 2001, NEUROIMAGE, V14, P1048, DOI 10.1006/nimg.2001.0894; Tse D, 2007, SCIENCE, V316, P76, DOI 10.1126/science.1135935; Tulving E, 1998, HIPPOCAMPUS, V8, P198, DOI 10.1002/(SICI)1098-1063(1998)8:3<198::AID-HIPO2>3.3.CO;2-J; VarghaKhadem F, 1997, SCIENCE, V277, P376, DOI 10.1126/science.277.5324.376; WATKINS CJCH, 1992, MACH LEARN, V8, P279, DOI 10.1007/BF00992698; WEISKOPF N, 2005, P 13 ISMRM 1543; Westmacott R, 2001, NEUROPSYCHOLOGY, V15, P586, DOI 10.1037//0894-4105.15.4.586; Wirth S, 2003, SCIENCE, V300, P1578, DOI 10.1126/science.1084324	68	188	190	0	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 24	2009	63	6					889	901		10.1016/j.neuron.2009.07.030	http://dx.doi.org/10.1016/j.neuron.2009.07.030			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	503VP	19778516	Green Published, hybrid			2022-12-24	WOS:000270569700020
J	Peron, SP; Jones, PW; Gabbiani, F				Peron, Simon P.; Jones, Peter W.; Gabbiani, Fabrizio			Precise Subcellular Input Retinotopy and Its Computational Consequences in an Identified Visual Interneuron	NEURON			English	Article							RECEPTIVE-FIELD PROPERTIES; SPIKE-FREQUENCY ADAPTATION; DIRECTION SELECTIVITY; PYRAMIDAL NEURONS; DENDRITIC INTEGRATION; GAIN-CONTROL; NEURAL MAP; WIDE-FIELD; MECHANISMS; SYSTEM	The Lobula Giant Movement Detector (LGMD) is a higher-order visual interneuron of Orthopteran insects that responds preferentially to objects approaching on a collision course. It receives excitatory input from an entire visual hemifield that anatomical evidence suggests is retinotopic, We show that this excitatory projection activates calcium-permeable nicotinic acetylcholine receptors. In vivo calcium imaging reveals that the excitatory projection preserves retinotopy down to the level of a single ommatidium. Examining the impact of retinotopy on the LGMD's computational properties, we show that sublinear synaptic summation can explain orientation preference in this cell. Exploring retinotopy's impact on directional selectivity leads us to infer that the excitatory input to the LGMD is intrinsically directionally selective. Our results show that precise retinotopy has implications for the dendritic integration of visual information in a single neuron.	[Peron, Simon P.] Howard Hughes Med Inst, Ashburn, VA 20147 USA; [Peron, Simon P.; Jones, Peter W.; Gabbiani, Fabrizio] Baylor Coll Med, Div Neurosci, Houston, TX 77030 USA; [Gabbiani, Fabrizio] Rice Univ, Dept Computat & Appl Math, Houston, TX 77005 USA	Howard Hughes Medical Institute; Baylor College of Medicine; Rice University	Peron, SP (corresponding author), Howard Hughes Med Inst, Janelia Farm Res Campus,19700 Helix Dr, Ashburn, VA 20147 USA.	perons@janelia.hhmi.org; gabbiani@bcm.edu		Jones, Peter/0000-0001-7392-0762; Peron, Simon/0000-0001-8265-6940	National Institute of Mental Health; Keck Center for Interdisciplinary Bioscience Training of the Gulf Coast Consortia [NIBIB 5T32EB006350-02]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB006350] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH065339] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Keck Center for Interdisciplinary Bioscience Training of the Gulf Coast Consortia; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by a grant from the National Institute of Mental Health and by a training fellowship from the Keck Center for Interdisciplinary Bioscience Training of the Gulf Coast Consortia (NIBIB 5T32EB006350-02) to P.W.J.	Anderson JC, 1999, NAT NEUROSCI, V2, P820, DOI 10.1038/12194; Baden T, 2007, DEV NEUROBIOL, V67, P68, DOI 10.1002/dneu.20323; Bollmann JH, 2009, NEURON, V61, P895, DOI 10.1016/j.neuron.2009.01.018; BORST A, 1995, J COMPUT NEUROSCI, V2, P5, DOI 10.1007/BF00962705; BORST A, 1992, P NATL ACAD SCI USA, V89, P4139, DOI 10.1073/pnas.89.9.4139; Burrows M., 1996, NEUROBIOLOGY INSECT; Cash S, 1998, J NEUROSCI, V18, P10; Cash S, 1999, NEURON, V22, P383, DOI 10.1016/S0896-6273(00)81098-3; Chen YC, 2008, J COMP NEUROL, V508, P175, DOI 10.1002/cne.21677; COLONNIER M, 1964, J ANAT, V98, P327; David JA, 1996, J EXP BIOL, V199, P1921; Douglass JK, 2003, J COMP NEUROL, V457, P326, DOI 10.1002/cne.10575; Durr V, 2001, J NEUROBIOL, V46, P289, DOI 10.1002/1097-4695(200103)46:4<289::AID-NEU1009>3.0.CO;2-W; Euler T, 2002, NATURE, V418, P845, DOI 10.1038/nature00931; Fotowat H, 2007, J NEUROSCI, V27, P10047, DOI 10.1523/JNEUROSCI.1515-07.2007; Gabbiani F, 2004, J PHYSIOLOGY-PARIS, V98, P19, DOI 10.1016/j.jphysparis.2004.03.001; Gabbiani F, 2002, NATURE, V420, P320, DOI 10.1038/nature01190; Gabbiani F, 2001, J NEUROSCI, V21, P314, DOI 10.1523/JNEUROSCI.21-01-00314.2001; Gabbiani F, 2006, J NEUROPHYSIOL, V96, P2951, DOI 10.1152/jn.00075.2006; Garel S, 2004, TRENDS NEUROSCI, V27, P533, DOI 10.1016/j.tins.2004.06.014; Haag J, 2004, NAT NEUROSCI, V7, P628, DOI 10.1038/nn1245; HAAG J, 1992, NEUROSCI LETT, V140, P173, DOI 10.1016/0304-3940(92)90095-O; Hausselt SE, 2007, PLOS BIOL, V5, P1474, DOI 10.1371/journal.pbio.0050185; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; Jacobs GA, 1996, J NEUROSCI, V16, P769; Jacobs GA, 2000, J NEUROSCI, V20, P2934; Johnston D, 1996, ANNU REV NEUROSCI, V19, P165, DOI 10.1146/annurev.ne.19.030196.001121; Johnston D, 2008, TRENDS NEUROSCI, V31, P309, DOI 10.1016/j.tins.2008.03.004; Kim IJ, 2008, NATURE, V452, P478, DOI 10.1038/nature06739; Krapp HG, 1998, J NEUROPHYSIOL, V79, P1902, DOI 10.1152/jn.1998.79.4.1902; Krapp HG, 2005, J NEUROPHYSIOL, V93, P2240, DOI 10.1152/jn.00965.2004; Krichmar JL, 2002, BRAIN RES, V941, P11, DOI 10.1016/S0006-8993(02)02488-5; Livingstone MS, 1998, NEURON, V20, P509, DOI 10.1016/S0896-6273(00)80991-5; London M, 2005, ANNU REV NEUROSCI, V28, P503, DOI 10.1146/annurev.neuro.28.061604.135703; Losonczy A, 2006, NEURON, V50, P291, DOI 10.1016/j.neuron.2006.03.016; MARTIN KAC, 1984, J PHYSIOL-LONDON, V356, P291, DOI 10.1113/jphysiol.1984.sp015465; Matheson T, 2004, J NEUROPHYSIOL, V91, P1, DOI 10.1152/jn.00795.2003; Migliore M, 2002, NAT REV NEUROSCI, V3, P362, DOI 10.1038/nrn810; Oertner TG, 2001, J NEUROPHYSIOL, V85, P439, DOI 10.1152/jn.2001.85.1.439; Oertner TG, 1999, NEUROSCI LETT, V274, P95, DOI 10.1016/S0304-3940(99)00694-1; Ogawa H, 2006, J NEUROBIOL, V66, P293, DOI 10.1002/neu.20220; Ogawa H, 2008, J NEUROSCI, V28, P4592, DOI 10.1523/JNEUROSCI.5354-07.2008; OSHEA M, 1976, J EXP BIOL, V65, P289; OSHEA M, 1974, J COMP PHYSIOL, V91, P257, DOI 10.1007/BF00698057; Peron S, 2009, NAT NEUROSCI, V12, P318, DOI 10.1038/nn.2259; Peron SP, 2007, J NEUROPHYSIOL, V97, P159, DOI 10.1152/jn.00660.2006; Peron SP, 2009, BIOL CYBERN, V100, P505, DOI 10.1007/s00422-009-0304-y; Petreanu L, 2009, NATURE, V457, P1142, DOI 10.1038/nature07709; Poirazi P, 2003, NEURON, V37, P989, DOI 10.1016/S0896-6273(03)00149-1; Polsky A, 2004, NAT NEUROSCI, V7, P621, DOI 10.1038/nn1253; RALL W, 1967, J NEUROPHYSIOL, V30, P1169, DOI 10.1152/jn.1967.30.5.1169; RALL W, 1970, EXCITATORY SYNAPTIC, P176; Rind FC, 2000, J COMP NEUROL, V423, P389, DOI 10.1002/1096-9861(20000731)423:3<389::AID-CNE3>3.0.CO;2-S; Rind FC, 1998, J COMP NEUROL, V395, P405; RIND FC, 1992, J NEUROPHYSIOL, V68, P1654, DOI 10.1152/jn.1992.68.5.1654; Ruthazer ES, 2004, J NEUROBIOL, V59, P134, DOI 10.1002/neu.10344; Schaefer AT, 2003, J NEUROPHYSIOL, V89, P3143, DOI 10.1152/jn.00046.2003; SCHLOTTERER GR, 1977, CAN J ZOOL, V55, P1372, DOI 10.1139/z77-179; Single S, 1997, J NEUROSCI, V17, P6023; Single S, 2002, J NEUROPHYSIOL, V87, P1616, DOI 10.1152/jn.00215.2001; SPRUSTON N, 1994, TRENDS NEUROSCI, V17, P161, DOI 10.1016/0166-2236(94)90094-9; Spruston N, 2008, NAT REV NEUROSCI, V9, P206, DOI 10.1038/nrn2286; Stepanyants A, 2005, TRENDS NEUROSCI, V28, P387, DOI 10.1016/j.tins.2005.05.006; Stepanyants A, 2004, NEURON, V43, P251, DOI 10.1016/j.neuron.2004.06.013; STRAUSFELD NJ, 1981, COMP PHYSL EVOLUTION, P1; Thany SH, 2007, TRENDS PHARMACOL SCI, V28, P14, DOI 10.1016/j.tips.2006.11.006; Verkhratsky A, 1996, CELL CALCIUM, V19, P1, DOI 10.1016/S0143-4160(96)90009-3; Vetter P, 2001, J NEUROPHYSIOL, V85, P926, DOI 10.1152/jn.2001.85.2.926; Williams SR, 2003, TRENDS NEUROSCI, V26, P147, DOI 10.1016/S0166-2236(03)00035-3; WILSON M, 1975, J COMP PHYSIOL, V97, P323, DOI 10.1007/BF00631968	71	32	32	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 24	2009	63	6					830	842		10.1016/j.neuron.2009.09.010	http://dx.doi.org/10.1016/j.neuron.2009.09.010			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	503VP	19778511	Green Accepted, Bronze			2022-12-24	WOS:000270569700015
J	Garcia-Alias, G; Barkhuysen, S; Buckle, M; Fawcett, JW				Garcia-Alias, Guillermo; Barkhuysen, Stanley; Buckle, Miranda; Fawcett, James W.			Chondroitinase ABC treatment opens a window of opportunity for task-specific rehabilitation	NATURE NEUROSCIENCE			English	Article							SPINAL-CORD-INJURY; CENTRAL-NERVOUS-SYSTEM; IMPROVES FUNCTIONAL RECOVERY; SENSORIMOTOR CORTEX LESIONS; FORELIMB MOTOR FUNCTION; CORTICOSPINAL TRACT; SYNAPTIC PLASTICITY; PYRAMIDAL TRACT; BRAIN-INJURY; ADULT RATS	Chondroitinase ABC treatment promotes spinal cord plasticity. We investigated whether chondroitinase-induced plasticity combined with physical rehabilitation promotes recovery of manual dexterity in rats with cervical spinal cord injuries. Rats received a C4 dorsal funiculus cut followed by chondroitinase ABC or penicillinase as a control. They were assigned to two alternative rehabilitation procedures, the first reinforcing skilled reaching and the second reinforcing general locomotion. Chondroitinase treatment enhanced sprouting of corticospinal axons independently of the rehabilitation regime. Only the rats receiving the combination of chondroitinase and specific rehabilitation showed improved manual dexterity. Rats that received general locomotor rehabilitation were better at ladder walking, but had worse skilled-reaching abilities than rats that received no treatment. Our results indicate that chondroitinase treatment opens a window during which rehabilitation can promote recovery. However, only the trained skills are improved and other functions may be negatively affected.	[Garcia-Alias, Guillermo; Barkhuysen, Stanley; Buckle, Miranda; Fawcett, James W.] Univ Cambridge, Dept Clin Neurosci, Ctr Brain Repair, Cambridge, England	University of Cambridge	Fawcett, JW (corresponding author), Univ Cambridge, Dept Clin Neurosci, Ctr Brain Repair, Cambridge, England.	jf108@cam.ac.uk	Garcia-Alias, Guillermo/AAB-8595-2021	Buckle, Miranda/0000-0002-6722-7125; Fawcett, James/0000-0002-7990-4568	Medical Research Council; Wellcome Trust; Christopher and Dana Reeve Foundation Consortium; EU Framework 6 Network of Excellence NeuroNE; Henry Smith Charity and Action Medical Research; MRC [G0701518, G9828345] Funding Source: UKRI; Medical Research Council [G9828345, G0701518] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Christopher and Dana Reeve Foundation Consortium; EU Framework 6 Network of Excellence NeuroNE; Henry Smith Charity and Action Medical Research; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The authors acknowledge key advice and assistance from H. Steenson in animal care and testing. This work was funded by grants from the Medical Research Council, The Wellcome Trust, The Christopher and Dana Reeve Foundation Consortium, The EU Framework 6 Network of Excellence NeuroNE, the Henry Smith Charity and Action Medical Research.	Adkins DL, 2008, EXP NEUROL, V212, P14, DOI 10.1016/j.expneurol.2008.01.031; Allred RP, 2008, EXP NEUROL, V210, P172, DOI 10.1016/j.expneurol.2007.10.010; Anderson KD, 2005, EXP NEUROL, V194, P161, DOI 10.1016/j.expneurol.2005.02.006; Anderson KD, 2004, J NEUROTRAUM, V21, P1371, DOI 10.1089/neu.2004.21.1371; Anderson KD, 2007, EXP NEUROL, V206, P318, DOI 10.1016/j.expneurol.2007.05.024; Bareyre FM, 2004, NAT NEUROSCI, V7, P269, DOI 10.1038/nn1195; Beazley LD, 2003, J NEUROTRAUM, V20, P1263, DOI 10.1089/089771503770802925; Benowitz LI, 1999, P NATL ACAD SCI USA, V96, P13486, DOI 10.1073/pnas.96.23.13486; Biernaskie J, 2004, J NEUROSCI, V24, P1245, DOI 10.1523/JNEUROSCI.3834-03.2004; Blochlinger S, 2001, J COMP NEUROL, V433, P426, DOI 10.1002/cne.1150; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; Buchli AD, 2005, ANN MED, V37, P556, DOI 10.1080/07853890500407520; Cho SH, 2007, NEUROSCI LETT, V426, P123, DOI 10.1016/j.neulet.2007.08.049; Courtine G, 2008, NAT MED, V14, P69, DOI 10.1038/nm1682; Courtine G, 2007, NAT MED, V13, P561, DOI 10.1038/nm1595; de Leon RD, 1998, J NEUROPHYSIOL, V79, P1329, DOI 10.1152/jn.1998.79.3.1329; de Leon RD, 1998, J NEUROPHYSIOL, V80, P83; Dobkin B, 2006, NEUROLOGY, V66, P484, DOI 10.1212/01.wnl.0000202600.72018.39; Dunlop SA, 2008, TRENDS NEUROSCI, V31, P410, DOI 10.1016/j.tins.2008.05.004; Fawcett JW, 2007, SPINAL CORD, V45, P190, DOI 10.1038/sj.sc.3102007; Freund P, 2007, J COMP NEUROL, V502, P644, DOI 10.1002/cne.21321; Galtrey CM, 2008, EUR J NEUROSCI, V27, P1373, DOI 10.1111/j.1460-9568.2008.06108.x; Galtrey CM, 2007, BRAIN, V130, P926, DOI 10.1093/brain/awl372; Galtrey CM, 2007, BRAIN RES REV, V54, P1, DOI 10.1016/j.brainresrev.2006.09.006; Garcia-Alias G., 2006, SOC NEUR ABSTR; Garcia-Alias G, 2008, EXP NEUROL, V210, P331, DOI 10.1016/j.expneurol.2007.11.002; Girgis J, 2007, BRAIN, V130, P2993, DOI 10.1093/brain/awm245; Grill R, 1997, J NEUROSCI, V17, P5560; HOVDA DA, 1984, BRAIN RES, V298, P358, DOI 10.1016/0006-8993(84)91437-9; Kozlowski DA, 1996, J NEUROSCI, V16, P4776; Kwok JCF, 2008, RESTOR NEUROL NEUROS, V26, P131; Lemon RN, 2005, MUSCLE NERVE, V32, P261, DOI 10.1002/mus.20333; Lin R, 2008, J NEUROCHEM, V104, P400, DOI 10.1111/j.1471-4159.2007.05066.x; Maier IC, 2006, PHILOS T R SOC B, V361, P1611, DOI 10.1098/rstb.2006.1890; Massey JM, 2006, J NEUROSCI, V26, P4406, DOI 10.1523/JNEUROSCI.5467-05.2006; McKenna JE, 1999, J NEUROSCI, V19, P1885; Petruska JC, 2007, J NEUROSCI, V27, P4460, DOI 10.1523/JNEUROSCI.2302-06.2007; Pettersson LG, 2007, ACTA PHYSIOL, V189, P141, DOI 10.1111/j.1748-1716.2006.01650.x; Pizzorusso T, 2002, SCIENCE, V298, P1248, DOI 10.1126/science.1072699; Plunet WT, 2008, EXP NEUROL, V213, P28, DOI 10.1016/j.expneurol.2008.04.011; Ramanathan D, 2006, P NATL ACAD SCI USA, V103, P11370, DOI 10.1073/pnas.0601065103; Ribotta MGY, 2000, J NEUROSCI, V20, P5144; Starkey ML, 2005, EXP NEUROL, V195, P524, DOI 10.1016/j.expneurol.2005.06.017; Steward O, 2004, J COMP NEUROL, V472, P463, DOI 10.1002/cne.20090; WHISHAW IQ, 1993, BEHAV BRAIN RES, V56, P59, DOI 10.1016/0166-4328(93)90022-I; Whishaw IQ, 1998, BEHAV BRAIN RES, V93, P167, DOI 10.1016/S0166-4328(97)00152-6; Wolf SL, 2006, JAMA-J AM MED ASSOC, V296, P2095, DOI 10.1001/jama.296.17.2095; Yamamoto M, 2009, BRAIN RES, V1265, P47, DOI 10.1016/j.brainres.2009.02.019; Ying Z, 2005, EXP NEUROL, V193, P411, DOI 10.1016/j.expneurol.2005.01.015	49	348	353	1	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2009	12	9					1145	U16		10.1038/nn.2377	http://dx.doi.org/10.1038/nn.2377			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	487ZD	19668200				2022-12-24	WOS:000269317300016
J	Puighermanal, E; Marsicano, G; Busquets-Garcia, A; Lutz, B; Maldonado, R; Ozaita, A				Puighermanal, Emma; Marsicano, Giovanni; Busquets-Garcia, Arnau; Lutz, Beat; Maldonado, Rafael; Ozaita, Andres			Cannabinoid modulation of hippocampal long-term memory is mediated by mTOR signaling	NATURE NEUROSCIENCE			English	Article							FACTOR 4E PHOSPHORYLATION; MAMMALIAN TARGET; SYNAPTIC PLASTICITY; REGULATED KINASE; ENDOCANNABINOID SYSTEM; PROTEIN-SYNTHESIS; SPATIAL MEMORY; P70S6 KINASE; TRANSLATION; RAPAMYCIN	Cognitive impairment is one of the most important negative consequences associated with cannabis consumption. We found that CB1 cannabinoid receptor (CB1R) activation transiently modulated the mammalian target of rapamycin (mTOR)/p70S6K pathway and the protein synthesis machinery in the mouse hippocampus, which correlated with the amnesic properties of delta9-tetrahydrocannabinol (THC). In addition, non-amnesic doses of either the mTOR blocker rapamycin or the protein synthesis inhibitor anisomycin abrogated the amnesic-like effects of THC, pointing to a mechanism involving new protein synthesis. Moreover, using pharmacological and genetic tools, we found that THC long-term memory deficits were mediated by CB1Rs expressed on GABAergic interneurons through a glutamatergic mechanism, as both the amnesic-like effects and p70S6K phosphorylation were reduced in GABA-CB1R knockout mice and by NMDA blockade.	[Puighermanal, Emma; Busquets-Garcia, Arnau; Maldonado, Rafael; Ozaita, Andres] Univ Pompeu Fabra, Fac Ciencies Salut & Vida, Lab Neurofarmacol, Barcelona, Spain; [Marsicano, Giovanni] Univ Bordeaux, INSERM, NeuroCtr Magendie Endocannabinoids & Neuroadap Gr, U862, Bordeaux, France; [Lutz, Beat] Johannes Gutenberg Univ Mainz, Dept Physiol Chem, Mainz, Germany	Pompeu Fabra University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Johannes Gutenberg University of Mainz	Ozaita, A (corresponding author), Univ Pompeu Fabra, Fac Ciencies Salut & Vida, Lab Neurofarmacol, Barcelona, Spain.	andres.ozaita@upf.edu	Busquets-Garcia, Arnau/A-7307-2018; Lutz, Beat/AFK-6229-2022; Busquets-Garcia, Arnau/Y-5856-2019; Puighermanal, Emma/J-4426-2019; Maldonado, Rafael/F-5657-2014; Marsicano, Giovanni/I-9603-2016; Lutz, Beat/AAG-4538-2022; Ozaita, Andres/H-3411-2015	Busquets-Garcia, Arnau/0000-0002-7100-8873; Busquets-Garcia, Arnau/0000-0002-7100-8873; Puighermanal, Emma/0000-0003-4271-9104; Maldonado, Rafael/0000-0002-4359-8773; Ozaita, Andres/0000-0002-2239-7403; Marsicano, Giovanni/0000-0003-3804-1951	European Commission [MIRG-6-CT-2005-014856]; NEWMOOD [LSHM-CT-2004-503474]; GENADDICT [LSHM-CT-2004-05166]; Spanish Ministry of Health [FIS PI041526]; Spanish Ministry of Science and Innovation [SAF200764062]; Generalitat de Catalunya [2005SGR00131]; ICREA Academia; Spanish Ministry of Education and Culture	European Commission(European CommissionEuropean Commission Joint Research Centre); NEWMOOD; GENADDICT; Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya); ICREA Academia(ICREA); Spanish Ministry of Education and Culture(Spanish Government)	We thank C. Fernandez-Avile's for expert technical assistance, J. Bertran-Gonzalez for advice in immunohistochemical techniques and the Laboratori de Neurofarmacologia for helpful discussion. This study was supported by grants from the European Commission (CANSIGWITH (MIRG-6-CT-2005-014856) to A. O. and NEWMOOD (LSHM-CT-2004-503474) and GENADDICT (LSHM-CT-2004-05166) to R. M.), the Spanish Ministry of Health (FIS PI041526) to A. O., the Spanish Ministry of Science and Innovation (Consolider-C #SAF200764062), Generalitat de Catalunya (2005SGR00131) and ICREA Academia to R. M. A. O. is a recipient of a Ramon y Cajal award from the Spanish Ministry of Education and Culture, E. P. is a recipient of a predoctoral fellowship from the Spanish Ministry of Education and Culture and A. B.-G. is a recipient of a fellowship from La Caixa.	Banko JL, 2008, PROG BRAIN RES, V169, P59, DOI 10.1016/S0079-6123(07)00004-0; Banko JL, 2005, J NEUROSCI, V25, P9581, DOI 10.1523/JNEUROSCI.2423-05.2005; Blundell J, 2008, NEUROBIOL LEARN MEM, V90, P28, DOI 10.1016/j.nlm.2007.12.004; Bolduc FV, 2008, NAT NEUROSCI, V11, P1143, DOI 10.1038/nn.2175; Broadbent NJ, 2004, P NATL ACAD SCI USA, V101, P14515, DOI 10.1073/pnas.0406344101; Carracedo A, 2008, J CLIN INVEST, V118, P3065, DOI [10.1172/jCI34739, 10.1172/JCI34739]; Clarke JR, 2008, NEUROBIOL LEARN MEM, V90, P374, DOI 10.1016/j.nlm.2008.04.009; Costa-Mattioli M, 2009, NEURON, V61, P10, DOI 10.1016/j.neuron.2008.10.055; Derkinderen P, 2003, J NEUROSCI, V23, P2371; Duncan RF, 2003, BIOCHEM J, V369, P213, DOI 10.1042/BJ20020435; Ehninger D, 2008, NAT MED, V14, P843, DOI 10.1038/nm1788; ELROYSTEIN O, 2008, TRANSLATIONAL CONTRO; FERRARI S, 1994, CRIT REV BIOCHEM MOL, V29, P385, DOI 10.3109/10409239409083485; Gelinas JN, 2007, J BIOL CHEM, V282, P27527, DOI 10.1074/jbc.M701077200; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Jaworski J, 2006, MOL NEUROBIOL, V34, P205, DOI 10.1385/MN:34:3:205; Jefferies HBJ, 1997, EMBO J, V16, P3693, DOI 10.1093/emboj/16.12.3693; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Kano M, 2009, PHYSIOL REV, V89, P309, DOI 10.1152/physrev.00019.2008; Katona I, 2001, J NEUROSCI, V21, P9506, DOI 10.1523/JNEUROSCI.21-23-09506.2001; Katona I, 1999, J NEUROSCI, V19, P4544; Katona I, 2006, J NEUROSCI, V26, P5628, DOI 10.1523/JNEUROSCI.0309-06.2006; Kawamura Y, 2006, J NEUROSCI, V26, P2991, DOI 10.1523/JNEUROSCI.4872-05.2006; Kelleher RJ, 2008, CELL, V135, P401, DOI 10.1016/j.cell.2008.10.017; Kelleher RJ, 2004, NEURON, V44, P59, DOI 10.1016/j.neuron.2004.09.013; Kim MH, 2009, J NEUROSCI, V29, P1586, DOI 10.1523/JNEUROSCI.4306-08.2009; Lehman JA, 2003, J BIOL CHEM, V278, P28130, DOI 10.1074/jbc.M300376200; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Marsicano G, 2002, NATURE, V418, P530, DOI 10.1038/nature00839; Meyuhas O, 2008, INT REV CEL MOL BIO, V268, P1, DOI 10.1016/S1937-6448(08)00801-0; Monory K, 2006, NEURON, V51, P455, DOI 10.1016/j.neuron.2006.07.006; Ohno-Shosaku T, 2002, J NEUROSCI, V22, P3864, DOI 10.1523/JNEUROSCI.22-10-03864.2002; Ozaita A, 2007, J NEUROCHEM, V102, P1105, DOI 10.1111/j.1471-4159.2007.04642.x; Page G, 2006, NEUROCHEM INT, V49, P413, DOI 10.1016/j.neuint.2006.01.020; Pearson R B, 1995, Prog Cell Cycle Res, V1, P21; Piomelli D, 2006, CNS DRUG REV, V12, P21, DOI 10.1111/j.1527-3458.2006.00021.x; Richter JD, 2009, GENE DEV, V23, P1, DOI 10.1101/gad.1735809; Rubino T, 2004, MOL CELL NEUROSCI, V25, P355, DOI 10.1016/j.mcn.2003.11.003; Sekulic A, 2000, CANCER RES, V60, P3504; Straiker A, 2006, AAPS J, V8, pE272; Swiech L, 2008, BBA-PROTEINS PROTEOM, V1784, P116, DOI 10.1016/j.bbapap.2007.08.015; Takahashi KA, 2006, NEUROSCIENCE, V139, P795, DOI 10.1016/j.neuroscience.2006.01.024; Tsokas P, 2007, J NEUROSCI, V27, P5885, DOI 10.1523/JNEUROSCI.4548-06.2007; Valjent E, 2000, J NEUROSCI, V20, P8701; Varvel SA, 2005, PSYCHOPHARMACOLOGY, V179, P863, DOI 10.1007/s00213-004-2121-2; Wang XR, 2007, MOL CELL BIOL, V27, P7405, DOI 10.1128/MCB.00760-07; Wilson RI, 2001, NATURE, V410, P588, DOI 10.1038/35069076; Wise LE, 2009, NEUROPSYCHOPHARMACOL, V34, P2072, DOI 10.1038/npp.2009.31; Zimmer A, 1999, P NATL ACAD SCI USA, V96, P5780, DOI 10.1073/pnas.96.10.5780	49	275	281	1	45	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2009	12	9					1152	U18		10.1038/nn.2369	http://dx.doi.org/10.1038/nn.2369			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	487ZD	19648913				2022-12-24	WOS:000269317300017
J	Kang, L; Wang, JL; Zhang, Y; Kou, ZH; Gao, SR				Kang, Lan; Wang, Jianle; Zhang, Yu; Kou, Zhaohui; Gao, Shaorong			iPS Cells Can Support Full-Term Development of Tetraploid Blastocyst-Complemented Embryos	CELL STEM CELL			English	Article							PLURIPOTENT STEM-CELLS; FIBROBLASTS; GENERATION; MOUSE		[Kang, Lan; Wang, Jianle; Zhang, Yu; Kou, Zhaohui; Gao, Shaorong] Natl Inst Biol Sci, Beijing 102206, Peoples R China; [Kang, Lan] Chinese Acad Med Sci, Grad Program, Beijing 100730, Peoples R China; [Kang, Lan] Peking Union Med Coll, Beijing 100730, Peoples R China	National Institute of Biological Sciences, Beijing; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Gao, SR (corresponding author), Natl Inst Biol Sci, Beijing 102206, Peoples R China.	gaoshaorong@nibs.ac.cn			Ministry of Science and Technology [2008AA022311, 2006AA02A101, 2009CB941100]; National Science Foundation of China [30670302]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Science Foundation of China(National Natural Science Foundation of China (NSFC))	We thank Professor Rudolf Jaenisch from the Whitehead Institute of the Massachusetts Institute of Technology for generously supplying the vectors for lentiviruses containing the cDNAs of four transcription factors, and Dr. Konrad Hochedlinger for personal communications. We are also grateful to the other colleagues in our laboratory for useful help during experiments and preparation of the manuscript. This project was supported by the Ministry of Science and Technology (grants 2008AA022311, 2006AA02A101, and 2009CB941100) and the National Science Foundation of China (grant 30670302).	Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Ebert AD, 2009, NATURE, V457, P277, DOI 10.1038/nature07677; Glaser V, 2008, REJUV RES, V11, P849, DOI 10.1089/rej.2008.0778; Hanna J, 2007, SCIENCE, V318, P1920, DOI 10.1126/science.1152092; Hayashi K, 2009, CELL STEM CELL, V4, P493, DOI 10.1016/j.stem.2009.05.007; Kim JB, 2008, NATURE, V454, P646, DOI 10.1038/nature07061; Kim JB, 2009, CELL, V136, P411, DOI 10.1016/j.cell.2009.01.023; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Maherali N, 2008, CELL STEM CELL, V3, P595, DOI 10.1016/j.stem.2008.11.008; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Wernig M, 2008, P NATL ACAD SCI USA, V105, P5856, DOI 10.1073/pnas.0801677105; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	20	335	386	1	53	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	AUG 7	2009	5	2					135	138		10.1016/j.stem.2009.07.001	http://dx.doi.org/10.1016/j.stem.2009.07.001			4	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	490PB	19631602	Bronze			2022-12-24	WOS:000269511900006
J	Badre, D; Kayser, AS; D'Esposito, M				Badre, David; Kayser, Andrew S.; D'Esposito, Mark			Frontal Cortex and the Discovery of Abstract Action Rules	NEURON			English	Article							DEPENDENT NEURONAL-ACTIVITY; SURFACE-BASED ANALYSIS; LINKING BASAL GANGLIA; PREFRONTAL CORTEX; PREMOTOR CORTEX; COGNITIVE CONTROL; GRANGER CAUSALITY; HIERARCHICAL ORGANIZATION; NEURAL MECHANISMS; DECISION-MAKING	Although we often encounter circumstances with which we have no prior experience, we rapidly learn how to behave in these novel situations. Such adaptive behavior relies on abstract behavioral rules that are generalizable, rather than concrete rules mapping specific cues to specific responses. Although the frontal cortex is known to support concrete rule learning, less well understood are the neural mechanisms supporting the acquisition of abstract rules. Here, we use a reinforcement learning paradigm to demonstrate that more anterior regions along the rostro-caudal axis of frontal cortex support rule learning at higher levels of abstraction. Moreover, these results indicate that when humans confront new rule learning problems, this rostro-caudal division of labor supports the search for relationships between context and action at multiple levels of abstraction simultaneously.	[Badre, David] Brown Univ, Dept Cognit Linguist & Psychol Sci, Providence, RI 02906 USA; [Kayser, Andrew S.] Univ Calif San Francisco, Dept Neurol, Ernest Gallo Clin & Res Ctr, Emeryville, CA 94608 USA; [D'Esposito, Mark] Univ Calif Berkeley, Dept Psychol, Berkeley, CA 94720 USA; [D'Esposito, Mark] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA	Brown University; University of California System; University of California San Francisco; Ernest Gallo Clinic & Research Center; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Badre, D (corresponding author), Brown Univ, Dept Cognit Linguist & Psychol Sci, Providence, RI 02906 USA.	david_badre@brown.edu; akayser@gallo.ucsf.edu			National Institutes of Health [MH63901, NS40813, NS065046]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH063901] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS040813, R01NS065046] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institutes of Health (MH63901, NS40813, and NS065046). We thank K. Sakanaka and D. Erickson for assistance with data collection. We also thank M. Brett and M. J. Frank for helpful discussions during preparation of this manuscript.	ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Asaad WF, 1998, NEURON, V21, P1399, DOI 10.1016/S0896-6273(00)80658-3; Badre D, 2006, P NATL ACAD SCI USA, V103, P7186, DOI 10.1073/pnas.0509550103; Badre D, 2004, NEURON, V41, P473, DOI 10.1016/S0896-6273(03)00851-1; Badre D, 2008, TRENDS COGN SCI, V12, P193, DOI 10.1016/j.tics.2008.02.004; Badre D, 2007, J COGNITIVE NEUROSCI, V19, P2082, DOI 10.1162/jocn.2007.19.12.2082; Badre D, 2009, NAT NEUROSCI, V12, P515, DOI 10.1038/nn.2277; Boettiger CA, 2005, J NEUROSCI, V25, P2723, DOI 10.1523/JNEUROSCI.3697-04.2005; Botvinick M, 2004, PSYCHOL REV, V111, P395, DOI 10.1037/0033-295X.111.2.395; Botvinick MM, 2008, TRENDS COGN SCI, V12, P201, DOI 10.1016/j.tics.2008.02.009; Botvinick MM, 2007, PHILOS T R SOC B, V362, P1615, DOI 10.1098/rstb.2007.2056; Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Brasted PJ, 2004, EUR J NEUROSCI, V19, P721, DOI 10.1111/j.0953-816X.2003.03181.x; Braver TS, 2003, NEURON, V39, P713, DOI 10.1016/S0896-6273(03)00466-5; Buckner RL, 2003, J NEUROSCI, V23, P3999; Bunge SA, 2006, CURR DIR PSYCHOL SCI, V15, P118, DOI 10.1111/j.0963-7214.2006.00419.x; Bunge Silvia A., 2004, Cognitive Affective & Behavioral Neuroscience, V4, P564; Bussey TJ, 2001, BEHAV NEUROSCI, V115, P971, DOI 10.1037//0735-7044.115.5.971; Chase W., 1973, VISUAL INFORM PROCES, P215, DOI [10.1016/b978-0-12-170150-5.50011-1, DOI 10.1016/B978-0-12-170150-5.50011-1, 10.1016/B978-0-12-170150-5.50011-1]; Christoff K, 2007, PERSPECTIVES RULE GU; Chumbley JR, 2009, NEUROIMAGE, V44, P62, DOI 10.1016/j.neuroimage.2008.05.021; COHEN JD, 1990, PSYCHOL REV, V97, P332, DOI 10.1037/0033-295X.97.3.332; Cohen MX, 2009, BEHAV BRAIN RES, V199, P141, DOI 10.1016/j.bbr.2008.09.029; Cools R, 2002, J NEUROSCI, V22, P4563, DOI 10.1523/JNEUROSCI.22-11-04563.2002; Dale AM, 1999, HUM BRAIN MAPP, V8, P109, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<109::AID-HBM7>3.0.CO;2-W; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Daw ND, 2005, NAT NEUROSCI, V8, P1704, DOI 10.1038/nn1560; Dayan P, 2002, NEURON, V36, P285, DOI 10.1016/S0896-6273(02)00963-7; DESPOSITO M, 1995, NATURE, V378, P279, DOI 10.1038/378279a0; DIPELLEGRINO G, 1993, J NEUROSCI, V13, P1227; Duncan J, 2001, NAT REV NEUROSCI, V2, P820, DOI 10.1038/35097575; Estes W., 1972, CODING PROCESS HUM, P161; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Frank MJ, 2006, PSYCHOL REV, V113, P300, DOI 10.1037/0033-295X.113.2.300; Frank MJ, 2004, SCIENCE, V306, P1940, DOI 10.1126/science.1102941; Fujii N, 2005, P NATL ACAD SCI USA, V102, P9032, DOI 10.1073/pnas.0503541102; GICK ML, 1983, COGNITIVE PSYCHOL, V15, P1, DOI 10.1016/0010-0285(83)90002-6; Goebel R, 2003, MAGN RESON IMAGING, V21, P1251, DOI 10.1016/j.mri.2003.08.026; Grahn JA, 2009, BEHAV BRAIN RES, V199, P53, DOI 10.1016/j.bbr.2008.11.020; Grahn JA, 2008, PROG NEUROBIOL, V86, P141, DOI 10.1016/j.pneurobio.2008.09.004; Graybiel AM, 1998, NEUROBIOL LEARN MEM, V70, P119, DOI 10.1006/nlme.1998.3843; GREENO JG, 1974, PSYCHOL REV, V81, P187, DOI 10.1037/h0036340; Hadj-Bouziane F, 2003, J PHYSIOL-PARIS, V97, P567, DOI 10.1016/j.jphysparis.2004.01.014; Hazy TE, 2007, PHILOS T R SOC B, V362, P1601, DOI 10.1098/rstb.2007.2055; Hoshi E, 2007, CURR OPIN NEUROBIOL, V17, P234, DOI 10.1016/j.conb.2007.02.003; Hoshi E, 2006, J NEUROPHYSIOL, V95, P3596, DOI 10.1152/jn.01126.2005; HOUK JC, 1995, CEREB CORTEX, V5, P95, DOI 10.1093/cercor/5.2.95; Kayser AS, 2009, HUM BRAIN MAPP, V30, P3475, DOI 10.1002/hbm.20771; Koechlin E, 2003, SCIENCE, V302, P1181, DOI 10.1126/science.1088545; Koechlin E, 2007, TRENDS COGN SCI, V11, P229, DOI 10.1016/j.tics.2007.04.005; Koechlin E, 2006, NEURON, V50, P963, DOI 10.1016/j.neuron.2006.05.017; Lashley K., 1951, CEREBRAL MECH BEHAV, P112, DOI DOI 10.1093/RFS/HHQ153; Loh M, 2008, J COGNITIVE NEUROSCI, V20, P421, DOI 10.1162/jocn.2008.20.3.421; Lucchetti C, 2001, EXP BRAIN RES, V141, P254, DOI 10.1007/s002210100818; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Miller GA, 1960, PLANS STRUCTURE BEHA; MITZ AR, 1991, J NEUROSCI, V11, P1855; Murray EA, 2000, EXP BRAIN RES, V133, P114, DOI 10.1007/s002210000406; Newell A., 1990, UNIFIED THEORIES COG; O'Reilly RC, 2007, BEHAV NEUROSCI, V121, P31, DOI 10.1037/0735-7044.121.1.31; O'Reilly RC, 2006, NEURAL COMPUT, V18, P283, DOI 10.1162/089976606775093909; Packard MG, 2002, ANNU REV NEUROSCI, V25, P563, DOI 10.1146/annurev.neuro.25.112701.142937; Paine RW, 2005, ADAPT BEHAV, V13, P211, DOI 10.1177/105971230501300303; PASSINGHAM RE, 1988, EXP BRAIN RES, V70, P590; PASSINGHAM RE, 1989, BRAIN BEHAV EVOLUT, V33, P189, DOI 10.1159/000115927; Passingham RE., 1993, FRONTAL LOBES VOLUNT; Pasupathy A, 2005, NATURE, V433, P873, DOI 10.1038/nature03287; PETRIDES M, 1985, BEHAV BRAIN RES, V16, P95, DOI 10.1016/0166-4328(85)90085-3; PETRIDES M, 1985, NEUROPSYCHOLOGIA, V23, P601, DOI 10.1016/0028-3932(85)90062-4; Petrides M, 2005, PHILOS T ROY SOC B, V360, P781, DOI 10.1098/rstb.2005.1631; PETRIDES M, 2006, MONKEY BRAIN HUMAN B, P293; PETRIDES M, 1987, FRONTAL LOBES REVISI, P91; Race EA, 2009, J COGNITIVE NEUROSCI, V21, P1766, DOI 10.1162/jocn.2009.21132; Roebroeck A, 2005, NEUROIMAGE, V25, P230, DOI 10.1016/j.neuroimage.2004.11.017; Schonberg T, 2007, J NEUROSCI, V27, P12860, DOI 10.1523/JNEUROSCI.2496-07.2007; Seger CA, 2005, J NEUROSCI, V25, P2941, DOI 10.1523/JNEUROSCI.3401-04.2005; Seger CA, 2008, NEUROSCI BIOBEHAV R, V32, P265, DOI 10.1016/j.neubiorev.2007.07.010; Seger CA, 2006, CEREB CORTEX, V16, P1546, DOI 10.1093/cercor/bhj092; Smith AC, 2004, J NEUROSCI, V24, P447, DOI 10.1523/JNEUROSCI.2908-03.2004; Stuss D., 1987, FRONTAL LOBES REVISI, P141; Sutton R.S., 2015, REINFORCEMENT LEARNI, V2nd ed.; Toni I, 1998, NEUROIMAGE, V8, P50, DOI 10.1006/nimg.1998.0349; Tremblay L, 1998, J NEUROPHYSIOL, V80, P964, DOI 10.1152/jn.1998.80.2.964; Wallis JD, 2001, NATURE, V411, P953, DOI 10.1038/35082081; White IM, 1999, EXP BRAIN RES, V126, P315, DOI 10.1007/s002210050740	85	201	219	2	37	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 29	2010	66	2					315	326		10.1016/j.neuron.2010.03.025	http://dx.doi.org/10.1016/j.neuron.2010.03.025			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	591NQ	20435006	Green Accepted, Bronze			2022-12-24	WOS:000277308200015
J	Quyn, AJ; Appleton, PL; Carey, FA; Steele, RJC; Barker, N; Clevers, H; Ridgway, RA; Sansom, OJ; Nathke, IS				Quyn, Aaron J.; Appleton, Paul L.; Carey, Francis A.; Steele, Robert J. C.; Barker, Nick; Clevers, Hans; Ridgway, Rachel A.; Sansom, Owen J.; Naethke, Inke S.			Spindle Orientation Bias in Gut Epithelial Stem Cell Compartments Is Lost in Precancerous Tissue	CELL STEM CELL			English	Article							TUMOR-SUPPRESSOR; SMALL-INTESTINE; DIVISION; APC; CANCER; MICROTUBULES; CENTROSOME; MUTATION; LEAD; MICE	The importance of asymmetric divisions for stem cell function and maintenance is well established in the developing nervous system and the skin; however, its role in gut epithelium and its importance for tumorigenesis is still debated. We demonstrate alignment of mitotic spindles perpendicular to the apical surface specifically in the stem cell compartments of mouse and human intestine and colon. This orientation correlates with the asymmetric retention of label-retaining DNA. Both the preference for perpendicular spindle alignment and asymmetric label retention are lost in precancerous tissue heterozygous for the adenomatous polyposis coli tumor suppressor (Apc). This loss correlates with cell shape changes specifically in the stem cell compartment. Our data suggest that loss of asymmetric division in stem cells might contribute to the oncogenic effect of Apc mutations in gut epithelium.	[Quyn, Aaron J.; Appleton, Paul L.; Naethke, Inke S.] Univ Dundee, Dundee DD1 5EH, Scotland; [Quyn, Aaron J.; Carey, Francis A.; Steele, Robert J. C.] Univ Dundee, Ninewells Hosp & Med Sch, Dundee DD1 9SY, Scotland; [Barker, Nick; Clevers, Hans] Hubrecht Lab, NL-3508 AD Utrecht, Netherlands; [Ridgway, Rachel A.; Sansom, Owen J.] Beatson Inst Canc Res, Glasgow G61 1BD, Lanark, Scotland	University of Dundee; University of Dundee; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Beatson Institute	Nathke, IS (corresponding author), Univ Dundee, Dundee DD1 5EH, Scotland.	i.s.nathke@dundee.ac.uk	Barker, Nick/AAS-2774-2020; Barker, Nick/AAE-9833-2021; Barker, Nick/A-5535-2011	Barker, Nick/0000-0003-3566-4475; Nathke, Inke/0000-0003-2420-4385; Quyn, Aaron/0000-0002-4333-5658; Sansom, Owen J./0000-0001-9540-3010; Steele, Robert JC/0000-0003-4248-6785	Cancer Research UK Bobby Moore Fund; Cancer Research UK; Cancer Research UK [11243] Funding Source: researchfish	Cancer Research UK Bobby Moore Fund; Cancer Research UK(Cancer Research UK); Cancer Research UK(Cancer Research UK)	The authors wish to thank all the members of the Light Microscopy Facility of the University of Dundee for their imaging expertise and Professor Mark Chaplain and Ignacio Ramis-Conde (University of Dundee) for developing the Xcode program used to calculate spindle angles. This work was supported by the Cancer Research UK Bobby Moore Fund (A.J.Q.) and a programme grant from Cancer Research UK (I.S.N.).	Ahringer J, 2003, CURR OPIN CELL BIOL, V15, P73, DOI 10.1016/S0955-0674(02)00018-2; Appleton PL, 2009, J MICROSC-OXFORD, V234, P196, DOI 10.1111/j.1365-2818.2009.03163.x; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; BJERKNES M, 1989, BIOPHYS J, V55, P1011, DOI 10.1016/S0006-3495(89)82899-1; CAIRNS J, 1975, NATURE, V255, P197, DOI 10.1038/255197a0; Caldwell CM, 2007, J CELL BIOL, V178, P1109, DOI 10.1083/jcb.200703186; Fleming ES, 2007, J HISTOCHEM CYTOCHEM, V55, P1173, DOI 10.1369/jhc.7A7234.2007; Fleming ES, 2009, MOL CARCINOGEN, V48, P592, DOI 10.1002/mc.20506; Green RA, 2005, MOL BIOL CELL, V16, P4609, DOI 10.1091/mbc.E05-03-0259; Hans F, 2001, ONCOGENE, V20, P3021, DOI 10.1038/sj.onc.1204326; Judson H, 2006, J PATHOL, V210, P344, DOI 10.1002/path.2044; Li ZY, 2008, J CELL SCI, V121, P1916, DOI 10.1242/jcs.029470; Li ZY, 2005, CANCER RES, V65, P5195, DOI 10.1158/0008-5472.CAN-04-4609; Morrison SJ, 2006, NATURE, V441, P1068, DOI 10.1038/nature04956; Pearson CG, 2004, NAT REV MOL CELL BIO, V5, P481, DOI 10.1038/nrm1402; Potten CS, 2009, CELL PROLIFERAT, V42, P731, DOI 10.1111/j.1365-2184.2009.00642.x; Potten CS, 2002, J CELL SCI, V115, P2381; Schuyler SC, 2001, J CELL SCI, V114, P247; Thery M, 2006, CURR OPIN CELL BIOL, V18, P648, DOI 10.1016/j.ceb.2006.10.001; Yamashita YM, 2003, SCIENCE, V301, P1547, DOI 10.1126/science.1087795; Yamashita YM, 2007, SCIENCE, V315, P518, DOI 10.1126/science.1134910	22	182	184	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	FEB 5	2010	6	2					175	181		10.1016/j.stem.2009.12.007	http://dx.doi.org/10.1016/j.stem.2009.12.007			7	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	555OC	20144789	Bronze			2022-12-24	WOS:000274520800012
J	Barker, N; Huch, M; Kujala, P; van de Wetering, M; Snippert, HJ; van Es, JH; Sato, T; Stange, DE; Begthel, H; van den Born, M; Danenberg, E; van den Brink, S; Korving, J; Abo, A; Peters, PJ; Wright, N; Poulsom, R; Clevers, H				Barker, Nick; Huch, Meritxell; Kujala, Pekka; van de Wetering, Marc; Snippert, Hugo J.; van Es, Johan H.; Sato, Toshiro; Stange, Daniel E.; Begthel, Harry; van den Born, Maaike; Danenberg, Esther; van den Brink, Stieneke; Korving, Jeroen; Abo, Arie; Peters, Peter J.; Wright, Nick; Poulsom, Richard; Clevers, Hans			Lgr5(+ve) Stem Cells Drive Self-Renewal in the Stomach and Build Long-Lived Gastric Units In Vitro	CELL STEM CELL			English	Article							EPITHELIAL-CELLS; MOUSE STOMACH; BETA-CATENIN; SMALL-INTESTINE; DYNAMICS; CANCER; CORPUS; IDENTIFICATION; ACTIVATION; MIGRATION	The study of gastric epithelial homeostasis and cancer has been hampered by the lack of stem cell markers and in vitro culture methods. The Writ target gene Lgr5 marks stem cells in the small intestine, colon, and hair follicle. Here, we investigated Lgr5 expression in the stomach and assessed the stem cell potential of the Lgr5(+ve) cells by using in vivo lineage tracing. In neonatal stomach, Lgr5 was expressed at the base of prospective corpus and pyloric glands, whereas expression in the adult was predominantly restricted to the base of mature pyloric glands. Lineage tracing revealed these Lgr5(+ve) cells to be self-renewing, multipotent stem cells responsible for the long-term renewal of the gastric epithelium. With an in vitro culture system, single Lgr5(+ve) cells efficiently generated long-lived organoids resembling mature pyloric epithelium. The Lgr5 stem cell marker and culture method described here will be invaluable tools for accelerating research into gastric epithelial renewal, inflammation/infection, and cancer.	[Barker, Nick; Huch, Meritxell; van de Wetering, Marc; Snippert, Hugo J.; van Es, Johan H.; Sato, Toshiro; Stange, Daniel E.; Begthel, Harry; van den Born, Maaike; Danenberg, Esther; van den Brink, Stieneke; Korving, Jeroen; Clevers, Hans] Hubrecht Inst Dev Biol & Stem Cell Res, Uppsalalaan 8, NL-3584 CT Utrecht, Netherlands; [Barker, Nick; Huch, Meritxell; van de Wetering, Marc; Snippert, Hugo J.; van Es, Johan H.; Sato, Toshiro; Stange, Daniel E.; Begthel, Harry; van den Born, Maaike; Danenberg, Esther; van den Brink, Stieneke; Korving, Jeroen; Clevers, Hans] Univ Med Ctr Utrecht, Utrecht, Netherlands; [Kujala, Pekka; Peters, Peter J.] Antoni Van Leeuwenhoek Hosp, Netherlands Canc Inst, NL-1066 CX Amsterdam, Netherlands; [Abo, Arie] Nuvelo Inc, San Carlos, CA 94070 USA; [Peters, Peter J.] Delft Univ Technol, Kavli Inst Nanosci, NL-2628 CJ Delft, Netherlands; [Wright, Nick] Barts & London Queen Marys Sch Med & Dent, London E1 2AD, England; [Poulsom, Richard] Canc Res UK London Res Inst, London WC2A 3PX, England	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Netherlands Cancer Institute; Delft University of Technology; University of London; Queen Mary University London; Cancer Research UK	Clevers, H (corresponding author), Hubrecht Inst Dev Biol & Stem Cell Res, Uppsalalaan 8, NL-3584 CT Utrecht, Netherlands.	h.clevers@hubrecht.eu	Barker, Nick/AAS-2774-2020; Wright, Nicholas/HHY-7227-2022; Barker, Nick/A-5535-2011; Stange, Daniel E/O-1837-2015; van+Es, Johan/ABD-5411-2021; Sato, Toshiro/J-3522-2014; Barker, Nick/AAE-9833-2021	Stange, Daniel E/0000-0003-4246-2230; Sato, Toshiro/0000-0001-8353-8137; Barker, Nick/0000-0003-3566-4475; Wright, Nicholas/0000-0002-5525-3457; Danenberg, Esther/0000-0002-1799-4457	KWF [PF-HUBR-2007-3956]; Marie Curie Actions-European commission	KWF; Marie Curie Actions-European commission	N.B. and H.C. are supported by KWF program grant # PF-HUBR-2007-3956. M.H. is supported by an Intra-European Fellowship from Marie Curie Actions-European commission. We thank Rob Vries for help with the BrdU injections and Nico Ong for help with EM imaging and Ramesh Shivdasani for providing reagents.	Barker N, 2008, COLD SH Q B, V73, P351, DOI 10.1101/sqb.2008.72.003; Barker N, 2008, GENE DEV, V22, P1856, DOI 10.1101/gad.1674008; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Batlle E, 2002, CELL, V111, P251, DOI 10.1016/S0092-8674(02)01015-2; Bjerknes M, 2002, AM J PHYSIOL-GASTR L, V283, pG767, DOI 10.1152/ajpgi.00415.2001; Clements WM, 2002, CANCER RES, V62, P3503; Correa P, 1996, CANCER EPIDEM BIOMAR, V5, P477; Gravaghi C, 2008, INT J OBESITY, V32, P1716, DOI 10.1038/ijo.2008.149; HATTORI T, 1976, CELL TISSUE RES, V172, P171; Huch M, 2009, NEOPLASIA, V11, P518, DOI 10.1593/neo.81674; Jaks V, 2008, NAT GENET, V40, P1291, DOI 10.1038/ng.239; KARAM SM, 1993, ANAT RECORD, V236, P280, DOI 10.1002/ar.1092360203; KARAM SM, 1993, ANAT REC, V236, P333, DOI 10.1002/ar.1092360206; KARAM SM, 1993, ANAT REC, V236, P297, DOI 10.1002/ar.1092360204; KARAM SM, 1993, ANAT REC, V236, P259, DOI 10.1002/ar.1092360202; Kim KA, 2005, SCIENCE, V309, P1256, DOI 10.1126/science.1112521; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; LEE ER, 1982, AM J ANAT, V164, P187, DOI 10.1002/aja.1001640302; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; Mcdonald SAC, 2008, GASTROENTEROLOGY, V134, P500, DOI 10.1053/j.gastro.2007.11.035; NAKATSURU S, 1992, HUM MOL GENET, V1, P559, DOI 10.1093/hmg/1.8.559; Nomura S, 1998, DEV BIOL, V204, P124, DOI 10.1006/dbio.1998.9055; OFFERHAUS GJA, 1992, GASTROENTEROLOGY, V102, P1980, DOI 10.1016/0016-5085(92)90322-P; Ootani A, 2003, AM J PATHOL, V162, P1905, DOI 10.1016/S0002-9440(10)64324-6; Park WS, 1999, CANCER RES, V59, P4257; Peters PJ, 2006, CURR PROTOC CELL BIO, DOI [10.1002/0471143030.CB0407S30, DOI 10.1002/0471143030.CB0407S30]; Poulsom R, 1998, EUR J HISTOCHEM, V42, P121; Qiao XT, 2007, GASTROENTEROLOGY, V133, P1989, DOI 10.1053/j.gastro.2007.09.031; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Shibata H, 1997, SCIENCE, V278, P120, DOI 10.1126/science.278.5335.120; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; TATEMATSU M, 1994, CANCER LETT, V83, P37, DOI 10.1016/0304-3835(94)90296-8; Tomita H, 2007, CANCER RES, V67, P4079, DOI 10.1158/0008-5472.CAN-06-4025; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; Van Der Flier LG, 2007, GASTROENTEROLOGY, V132, P628, DOI 10.1053/j.gastro.2006.08.039; van der Flier LG, 2009, CELL, V136, P903, DOI 10.1016/j.cell.2009.01.031; Zhu LQ, 2009, NATURE, V457, P603, DOI 10.1038/nature07589	38	1037	1098	5	123	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JAN 8	2010	6	1					25	36		10.1016/j.stem.2009.11.013	http://dx.doi.org/10.1016/j.stem.2009.11.013			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	549EW	20085740	Bronze			2022-12-24	WOS:000274029700009
J	Lu, YJ; Ma, XY; Sabharwal, R; Snitsarev, V; Morgan, D; Rahmouni, K; Drummond, HA; Whiteis, CA; Costa, V; Price, M; Benson, C; Welsh, MJ; Chapleau, MW; Abboud, FM				Lu, Yongjun; Ma, Xiuying; Sabharwal, Rasna; Snitsarev, Vladislav; Morgan, Donald; Rahmouni, Kamal; Drummond, Heather A.; Whiteis, Carol A.; Costa, Vivian; Price, Margaret; Benson, Christopher; Welsh, Michael J.; Chapleau, Mark W.; Abboud, Francois M.			The Ion Channel ASIC2 Is Required for Baroreceptor and Autonomic Control of the Circulation	NEURON			English	Article							EPITHELIAL NA+ CHANNELS; HEART-RATE-VARIABILITY; NEURONS IN-VITRO; CAENORHABDITIS-ELEGANS; BAROREFLEX SENSITIVITY; SENSORY NEURONS; MECHANOSENSORY TRANSDUCTION; VASCULAR-RESISTANCE; ARTERIAL BAROREFLEX; MICE	Arterial baroreceptors; provide a neural sensory input that reflexly regulates the autonomic drive of circulation. Our goal was to test the hypothesis that a member of the acid-sensing ion channel (ASIC) subfamily of the DEG/ENaC superfamily is an important determinant of the arterial baroreceptor reflex. We found that aortic baroreceptor neurons in the nodose ganglia and their terminals express ASIC2. Conscious ASIC2 null mice developed hypertension, had exaggerated sympathetic and depressed parasympathetic control of the circulation, and a decreased gain of the baroreflex, all indicative of an impaired baroreceptor reflex. Multiple measures of baroreceptor activity each suggest that mechanosensitivity is diminished in ASIC2 null mice. The results define ASIC2 as an important determinant of autonomic circulatory control and of baroreceptor sensitivity. The genetic disruption of ASIC2 recapitulates the pathological dysautonomia seen in heart failure and hypertension and defines a molecular defect that may be relevant to its development.	[Lu, Yongjun; Ma, Xiuying; Sabharwal, Rasna; Snitsarev, Vladislav; Morgan, Donald; Rahmouni, Kamal; Drummond, Heather A.; Whiteis, Carol A.; Costa, Vivian; Price, Margaret; Benson, Christopher; Welsh, Michael J.; Chapleau, Mark W.; Abboud, Francois M.] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA; [Lu, Yongjun; Ma, Xiuying; Sabharwal, Rasna; Snitsarev, Vladislav; Morgan, Donald; Rahmouni, Kamal; Drummond, Heather A.; Whiteis, Carol A.; Costa, Vivian; Price, Margaret; Benson, Christopher; Welsh, Michael J.; Chapleau, Mark W.; Abboud, Francois M.] Univ Iowa, Cardiovasc Res Ctr, Iowa City, IA 52242 USA; [Welsh, Michael J.] Univ Iowa, Howard Hughes Med Inst, Iowa City, IA 52242 USA; [Chapleau, Mark W.] Univ Iowa, Dept Vet Affairs Med Ctr, Iowa City, IA 52242 USA; [Welsh, Michael J.; Chapleau, Mark W.; Abboud, Francois M.] Univ Iowa, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; Howard Hughes Medical Institute; University of Iowa; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System; University of Iowa	Abboud, FM (corresponding author), Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA.	francois-abboud@uiowa.edu	Snitsarev, Vladislav/AAP-5599-2020; Morgan, Donald A/L-6907-2013; Rahmouni, Kamal/Y-1788-2019	Morgan, Donald A/0000-0003-3167-1643; Benson, Christopher/0000-0001-6600-8193; Sabharwal, Rasna/0000-0001-7256-5359; Welsh, Michael/0000-0002-1646-6206; Chapleau, Mark/0000-0001-6961-931X; Rahmouni, Kamal/0000-0001-5136-6748; Abboud, Francois/0000-0002-7284-9148; Snitsarev, Vladislav/0000-0001-5518-5899	National Institutes of Health [HL14388-37]; Department of Veterans Affairs; HHMI; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL014388, T32HL007121] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); HHMI(Howard Hughes Medical Institute); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank Sarah Porter and Courtney Cable for assistance with word processing and manuscript preparation, Shawn Roach for help creating and editing the figures, Rubens Fazan, Jr. for assistance in analyses of data on aortic baroreceptor nerve activity, and David Dellsperger for assisting Donald Morgan in studies of electrical stimulation of the aortic depressor nerve done in the lab of Kamal Rahmouni and Allyn Mark. We also thank the University of Iowa Core DNA Facility, the central microscopy facility and the animal care facility for assistance. Y.L. designed primers and performed molecular studies: X.M. performed neural recordings in vivo; R.S. did the telemetry and bilateral carotid occlusion studies; V.S. performed the EP work on isolated neurons; C.A.W. performed surgical procedures, prepared cultures, and analyzed data; D.M. did the studies on electrical stimulation of aortic depressor nerves in the laboratory of K.R.; H.A.D. contributed to the initial study design; M.P. contributed to concepts and technical approaches; V.C. developed the transgenic mouse; C.B. contributed to concepts and technical approaches; M.J.W. contributed to concepts and edited the manuscript; M.W.C. and F.M.A. designed the study, analyzed the data, and wrote the paper. This work was supported by grant HL14388-37 from the National Institutes of Health (F.M.A. and M.W.C.), the VA Merit Review Award from the Department of Veterans Affairs (M.W.C.), the HHMI (M.J.W.), and Heartland Affiliate Postdoctoral Fellowships from the American Heart Association (R.S.).	Awayda MS, 1998, J GEN PHYSIOL, V112, P97, DOI 10.1085/jgp.112.2.97; Benson CJ, 2002, P NATL ACAD SCI USA, V99, P2338, DOI 10.1073/pnas.032678399; BERTINIERI G, 1988, AM J PHYSIOL, V254, pH377, DOI 10.1152/ajpheart.1988.254.2.H377; Butz GM, 2001, PHYSIOL GENOMICS, V5, P89, DOI 10.1152/physiolgenomics.2001.5.2.89; Carattino MD, 2004, J BIOL CHEM, V279, P4120, DOI 10.1074/jbc.M311783200; CHALFIE M, 1993, NATURE, V361, P504, DOI 10.1038/361504a0; Clapham DE, 2003, PHARMACOL REV, V55, P591, DOI 10.1124/pr.55.4.6; Corey DP, 1996, SCIENCE, V273, P323, DOI 10.1126/science.273.5273.323; CUNNINGHAM JT, 1995, J NEUROPHYSIOL, V73, P2094, DOI 10.1152/jn.1995.73.5.2094; Cunningham JT, 1997, BRAIN RES, V757, P149, DOI 10.1016/S0006-8993(97)00153-4; Desai BN, 2005, PFLUG ARCH EUR J PHY, V451, P11, DOI 10.1007/s00424-005-1429-z; Deval E, 2004, J BIOL CHEM, V279, P19531, DOI 10.1074/jbc.M313078200; Drew LJ, 2004, J PHYSIOL-LONDON, V556, P691, DOI 10.1113/jphysiol.2003.058693; DRISCOLL M, 1991, NATURE, V349, P588, DOI 10.1038/349588a0; Drummond HA, 2004, HYPERTENSION, V44, P643, DOI 10.1161/01.HYP.0000144465.56360.ad; Drummond HA, 1998, NEURON, V21, P1435, DOI 10.1016/S0896-6273(00)80661-3; EPSTEIN SE, 1969, NEW ENGL J MED, V280, P971, DOI 10.1056/NEJM196905012801801; Filippone JD, 2007, CURR OPIN NEPHROL HY, V16, P403; Fricke B, 2000, CELL TISSUE RES, V299, P327; Garcia-Anoveros J, 2001, J NEUROSCI, V21, P2678, DOI 10.1523/JNEUROSCI.21-08-02678.2001; Gillespie PG, 2001, NATURE, V413, P194, DOI 10.1038/35093011; Glazebrook PA, 2005, PFLUG ARCH EUR J PHY, V451, P125, DOI 10.1007/s00424-005-1468-5; Goodman MB, 2003, ANNU REV PHYSIOL, V65, P429, DOI 10.1146/annurev.physiol.65.092101.142659; GUHARAY F, 1984, J PHYSIOL-LONDON, V352, P685, DOI 10.1113/jphysiol.1984.sp015317; GUO GB, 1982, CIRC RES, V50, P554, DOI 10.1161/01.RES.50.4.554; GUO GB, 1984, AM J PHYSIOL, V246, pH720, DOI 10.1152/ajpheart.1984.246.5.H720; GUO GB, 1983, CIRC RES, V53, P223, DOI 10.1161/01.RES.53.2.223; HAJDUCZOK G, 1994, J CLIN INVEST, V94, P2392, DOI 10.1172/JCI117605; HEYMANS C, 1958, REFLEXOGENIC AREAS C, P1; HUANG MX, 1994, NATURE, V367, P467, DOI 10.1038/367467a0; ITURRIAGA R, 1988, ACTA PHYSIOL PHARM L, V38, P27; Jones RCW, 2005, J NEUROSCI, V25, P10981, DOI 10.1523/JNEUROSCI.0703-05.2005; La Rovere MT, 2001, CIRCULATION, V103, P2072; La Rovere MT, 1998, LANCET, V351, P478; LANDGREN S, 1952, ACTA PHYSIOL SCAND, V26, P1; Laude D, 2008, AM J PHYSIOL-REG I, V294, pR142, DOI 10.1152/ajpregu.00319.2007; Lawrence IG, 1997, DIABETIC MED, V14, P82, DOI 10.1002/(SICI)1096-9136(199701)14:1<82::AID-DIA290>3.0.CO;2-3; Li M, 2004, CIRCULATION, V109, P120, DOI 10.1161/01.CIR.0000105721.71640.DA; Li Z, 1997, J PHYSIOL-LONDON, V501, P275, DOI 10.1111/j.1469-7793.1997.275bn.x; Ma XY, 2002, AM J PHYSIOL-REG I, V283, pR1033, DOI 10.1152/ajpregu.00768.2001; Meltzer RH, 2007, J BIOL CHEM, V282, P25548, DOI 10.1074/jbc.M703825200; Mortara A, 1997, CIRCULATION, V96, P3450; O'Hagan R, 2005, NAT NEUROSCI, V8, P43, DOI 10.1038/nn1362; O'Neil RG, 2005, PFLUG ARCH EUR J PHY, V451, P193, DOI 10.1007/s00424-005-1424-4; Page AJ, 2005, GUT, V54, P1408, DOI 10.1136/gut.2005.071084; Price MP, 2000, NATURE, V407, P1007, DOI 10.1038/35039512; Price MP, 1996, J BIOL CHEM, V271, P7879, DOI 10.1074/jbc.271.14.7879; Robinson TG, 2003, STROKE, V34, P705, DOI 10.1161/01.STR.0000058493.94875.9F; Roza C, 2004, J PHYSIOL-LONDON, V558, P659, DOI 10.1113/jphysiol.2004.066001; Schaefer M, 2005, PFLUG ARCH EUR J PHY, V451, P35, DOI 10.1007/s00424-005-1467-6; Snitsarev V, 2007, J PHYSIOL-LONDON, V582, P177, DOI 10.1113/jphysiol.2007.133330; Sullivan MJ, 1997, CIRC RES, V80, P861; Tavernarakis N, 1997, NEURON, V18, P107, DOI 10.1016/S0896-6273(01)80050-7; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; Wemmie JA, 2004, P NATL ACAD SCI USA, V101, P3621, DOI 10.1073/pnas.0308753101; Zucker IH, 2007, HYPERTENSION, V50, P904, DOI 10.1161/HYPERTENSIONAHA.107.095216	56	137	146	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 24	2009	64	6					885	897		10.1016/j.neuron.2009.11.007	http://dx.doi.org/10.1016/j.neuron.2009.11.007			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	541ON	20064394	Bronze, Green Accepted			2022-12-24	WOS:000273425800014
J	Ito, I; Bazhenov, M; Ong, RCY; Raman, B; Stopfer, M				Ito, Iori; Bazhenov, Maxim; Ong, Rose Chik-ying; Raman, Baranidharan; Stopfer, Mark			Frequency Transitions in Odor-Evoked Neural Oscillations	NEURON			English	Article							OLFACTORY NETWORK DYNAMICS; HIPPOCAMPUS IN-VITRO; MOTH MANDUCA-SEXTA; CAT VISUAL-CORTEX; ANTENNAL LOBES; PROJECTION NEURONS; SPHINX MOTH; SYNAPTIC INHIBITION; GAMMA-OSCILLATIONS; OUTPUT NEURONS	In many species, sensory stimuli elicit the oscillatory synchronization of groups of neurons. What determines the properties of these oscillations? In the olfactory system of the moth, we found that odors elicited oscillatory synchronization through a neural mechanism like that described in locust and Drosophila. During responses to long odor pulses, oscillations suddenly slowed as net olfactory receptor neuron (ORN) output decreased; thus, stimulus intensity appeared to determine oscillation frequency. However, changing the concentration of the odor had little effect upon oscillatory frequency. Our recordings in vivo and computational models based on these results suggested that the main effect of increasing odor concentration was to recruit additional, less well-tuned ORNs whose firing rates were tightly constrained by adaptation and saturation. Thus, in the periphery, concentration is encoded mainly by the size of the responsive ORN population, and oscillation frequency is set by the adaptation and saturation of this response.	[Ito, Iori; Ong, Rose Chik-ying; Raman, Baranidharan; Stopfer, Mark] NICHHD, NIH, Bethesda, MD 20892 USA; [Bazhenov, Maxim] Univ Calif Riverside, Dept Cell Biol & Neurosci, Riverside, CA 92521 USA; [Ong, Rose Chik-ying] Chinese Univ Hong Kong, Dept Biochem, Hong Kong, Hong Kong, Peoples R China; [Raman, Baranidharan] Natl Inst Stand & Technol, Chem Sci & Technol Lab, Gaithersburg, MD 20899 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of California System; University of California Riverside; Chinese University of Hong Kong; National Institute of Standards & Technology (NIST) - USA	Stopfer, M (corresponding author), NICHHD, NIH, Bethesda, MD 20892 USA.	stopferm@mail.nih.gov	NAMEKAWA, IORI/A-3172-2009	Stopfer, Mark/0000-0001-9200-1884; Raman, Baranidharan/0000-0002-7866-155X	Japan Society for the Promotion of Science [00169, 70510]; National Research Council; NIH-NIDCD; NIH-NINDS; NIH-NICHD	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Research Council(Consiglio Nazionale delle Ricerche (CNR)); NIH-NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIH-NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH-NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We are grateful to members of the Stopfer and Bazhenov laboratories for helpful discussions and to Dr. Marit Stranden for sensilla lessons. We also thank Dr. Kui Sun for her excellent animal care. Microscopy imaging was performed at the Microscopy & Imaging Core (National Institute of Child Health and Human Development, NIH) with the kind assistance of Dr. Vincent Schram. This work was supported by the Japan Society for the Promotion of Science (00169, 70510) to I.I., Joint NIH-NIST postdoctoral fellowship award by National Research Council to B.R., grants from NIH-NIDCD and NIH-NINDS to M.B. and an intramural grant from NIH-NICHD to M.S.	Adrian ED, 1942, J PHYSIOL-LONDON, V100, P459, DOI 10.1113/jphysiol.1942.sp003955; ANTON S, 1999, INSECT OLFACTION, P101; Assisi C, 2007, NAT NEUROSCI, V10, P1176, DOI 10.1038/nn1947; Bazhenov M, 2008, J NEUROPHYSIOL, V100, P1562, DOI 10.1152/jn.90613.2008; Bazhenov M, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.041903; BELL RA, 1976, ANN ENTOMOL SOC AM, V69, P365, DOI 10.1093/aesa/69.2.365; Borgers C, 2005, P NATL ACAD SCI USA, V102, P7002, DOI 10.1073/pnas.0502366102; Borgers C, 2005, NEURAL COMPUT, V17, P557, DOI 10.1162/0899766053019908; Borgers C, 2003, NEURAL COMPUT, V15, P509, DOI 10.1162/089976603321192059; BRESSLER SL, 1980, ELECTROEN CLIN NEURO, V50, P19, DOI 10.1016/0013-4694(80)90319-3; Bringuier V, 1997, J PHYSIOL-LONDON, V500, P751, DOI 10.1113/jphysiol.1997.sp022056; Brown SL, 2005, NAT NEUROSCI, V8, P1568, DOI 10.1038/nn1559; Brunel N, 2003, J NEUROPHYSIOL, V90, P415, DOI 10.1152/jn.01095.2002; Buck LB, 1996, ANNU REV NEUROSCI, V19, P517, DOI 10.1146/annurev.ne.19.030196.002505; Buhl EH, 1998, J PHYSIOL-LONDON, V513, P117, DOI 10.1111/j.1469-7793.1998.117by.x; BUZSAKI G, 1995, CURR OPIN NEUROBIOL, V5, P504, DOI 10.1016/0959-4388(95)80012-3; CHRISTENSEN TA, 1987, J COMP PHYSIOL A, V160, P553, DOI 10.1007/BF00611929; Christensen TA, 2003, P NATL ACAD SCI USA, V100, P11076, DOI 10.1073/pnas.1934001100; Christensen TA, 2000, NAT NEUROSCI, V3, P927, DOI 10.1038/78840; CLELAND BG, 1983, J PHYSIOL-LONDON, V345, P47, DOI 10.1113/jphysiol.1983.sp014964; Duchamp-Viret P, 2000, J NEUROSCI, V20, P2383; ERNST KD, 1977, CELL TISSUE RES, V176, P285, DOI 10.1007/BF00221789; FIRESTEIN S, 1993, J PHYSIOL-LONDON, V468, P1; Fisahn A, 1998, NATURE, V394, P186, DOI 10.1038/28179; GALAMBOS R, 1981, P NATL ACAD SCI-BIOL, V78, P2643, DOI 10.1073/pnas.78.4.2643; GRAY CM, 1989, P NATL ACAD SCI USA, V86, P1698, DOI 10.1073/pnas.86.5.1698; Gray CM, 1997, J NEUROSCI, V17, P3239; GRAY CM, 1989, NATURE, V338, P334, DOI 10.1038/338334a0; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; Hansson BS, 2000, ANNU REV ENTOMOL, V45, P203, DOI 10.1146/annurev.ento.45.1.203; Heinbockel T, 1998, J COMP PHYSIOL A, V182, P703, DOI 10.1007/s003590050215; HOMBERG U, 1989, ANNU REV ENTOMOL, V34, P477, DOI 10.1146/annurev.en.34.010189.002401; Ito I, 2008, NAT NEUROSCI, V11, P1177, DOI 10.1038/nn.2192; KAISSLING K, 1995, EXPT CELL BIOL TASTE, P367; KAISSLING KE, 1987, ANN NY ACAD SCI, V510, P104; Koulakov A, 2007, J NEUROPHYSIOL, V98, P3134, DOI 10.1152/jn.00560.2007; LAURENT G, 1994, J NEUROSCI, V14, P2993; LAURENT G, 1994, SCIENCE, V265, P1872, DOI 10.1126/science.265.5180.1872; Laurent G, 2002, NAT REV NEUROSCI, V3, P884, DOI 10.1038/nrn964; Lei H, 2002, NAT NEUROSCI, V5, P557, DOI 10.1038/nn859; MacLeod K, 1996, SCIENCE, V274, P976, DOI 10.1126/science.274.5289.976; Mazor O, 2005, NEURON, V48, P661, DOI 10.1016/j.neuron.2005.09.032; Neville KR, 2003, J NEUROPHYSIOL, V90, P3921, DOI 10.1152/jn.00475.2003; Olsen SR, 2007, NEURON, V54, P89, DOI 10.1016/j.neuron.2007.03.010; Perez-Orive J, 2004, J NEUROSCI, V24, P6037, DOI 10.1523/JNEUROSCI.1084-04.2004; Perez-Orive J, 2002, SCIENCE, V297, P359, DOI 10.1126/science.1070502; PEREZORIVE J, 2004, THESIS CALTECH; Pouzat C, 2002, J NEUROSCI METH, V122, P43, DOI 10.1016/S0165-0270(02)00276-5; ROSPARS JP, 1992, CELL TISSUE RES, V270, P205, DOI 10.1007/BF00328007; Rulkov NF, 2004, J COMPUT NEUROSCI, V17, P203, DOI 10.1023/B:JCNS.0000037683.55688.7e; Rulkov NF, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.041922; Rulkov NF, 2008, J BIOL PHYS, V34, P279, DOI 10.1007/s10867-008-9079-y; Salinas E, 2001, NAT REV NEUROSCI, V2, P539, DOI 10.1038/35086012; Schadow J, 2007, INT J PSYCHOPHYSIOL, V65, P152, DOI 10.1016/j.ijpsycho.2007.04.006; STEWART WB, 1979, J COMP NEUROL, V185, P715, DOI 10.1002/cne.901850407; Stopfer M, 1997, NATURE, V390, P70, DOI 10.1038/36335; Stopfer M, 1999, NATURE, V402, P664, DOI 10.1038/45244; Stopfer M, 2003, NEURON, V39, P991, DOI 10.1016/j.neuron.2003.08.011; Tanaka NK, 2009, J NEUROSCI, V29, P8595, DOI 10.1523/JNEUROSCI.1455-09.2009; Traub RD, 1996, J PHYSIOL-LONDON, V493, P471, DOI 10.1113/jphysiol.1996.sp021397; Wachowiak M, 2001, NEURON, V32, P723, DOI 10.1016/S0896-6273(01)00506-2; WALDROP B, 1987, J COMP PHYSIOL A, V161, P23, DOI 10.1007/BF00609452; Wang XJ, 1996, J NEUROSCI, V16, P6402; Whittington MA, 2000, INT J PSYCHOPHYSIOL, V38, P315, DOI 10.1016/S0167-8760(00)00173-2; Whittington MA, 1997, J PHYSIOL-LONDON, V502, P591, DOI 10.1111/j.1469-7793.1997.591bj.x; WHITTINGTON MA, 1995, NATURE, V373, P612, DOI 10.1038/373612a0	66	56	56	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 10	2009	64	5					692	706		10.1016/j.neuron.2009.10.004	http://dx.doi.org/10.1016/j.neuron.2009.10.004			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	537OW	20005825	Green Accepted, Bronze			2022-12-24	WOS:000273123700014
J	Hong, WZ; Zhu, HT; Potter, CJ; Barsh, G; Kurusu, M; Zinn, K; Luo, LQ				Hong, Weizhe; Zhu, Haitao; Potter, Christopher J.; Barsh, Gabrielle; Kurusu, Mitsuhiko; Zinn, Kai; Luo, Liqun			Leucine-rich repeat transmembrane proteins instruct discrete dendrite targeting in an olfactory map	NATURE NEUROSCIENCE			English	Article							DROSOPHILA ANTENNAL LOBE; REPRESSIBLE CELL MARKER; PROJECTION NEURONS; TRANSCRIPTION FACTORS; WIRING SPECIFICITY; BOUNDARY FORMATION; ODORANT RECEPTORS; MOSAIC ANALYSIS; TARTAN; SYSTEM	Olfactory systems utilize discrete neural pathways to process and integrate odorant information. In Drosophila, axons of first-order olfactory receptor neurons (ORNs) and dendrites of second-order projection neurons (PNs) form class-specific synaptic connections at similar to 50 glomeruli. The mechanisms underlying PN dendrite targeting to distinct glomeruli in a three-dimensional discrete neural map are unclear. We found that the leucine-rich repeat (LRR) transmembrane protein Capricious (Caps) was differentially expressed in different classes of PNs. Loss-of-function and gain-of-function studies indicated that Caps instructs the segregation of Caps-positive and Caps-negative PN dendrites to discrete glomerular targets. Moreover, Caps-mediated PN dendrite targeting was independent of presynaptic ORNs and did not involve homophilic interactions. The closely related protein Tartan was partially redundant with Caps. These LRR proteins are probably part of a combinatorial cell-surface code that instructs discrete olfactory map formation.	[Hong, Weizhe; Zhu, Haitao; Potter, Christopher J.; Barsh, Gabrielle; Luo, Liqun] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Hong, Weizhe; Zhu, Haitao; Potter, Christopher J.; Barsh, Gabrielle; Luo, Liqun] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Kurusu, Mitsuhiko; Zinn, Kai] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Kurusu, Mitsuhiko] Grad Univ Adv Studies, Natl Inst Genet, Struct Biol Ctr, Mishima, Shizuoka, Japan; [Kurusu, Mitsuhiko] Grad Univ Adv Studies, Dept Genet, Mishima, Shizuoka, Japan	Howard Hughes Medical Institute; Stanford University; Stanford University; California Institute of Technology; Graduate University for Advanced Studies - Japan; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Graduate University for Advanced Studies - Japan	Luo, LQ (corresponding author), Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA.	lluo@stanford.edu	Hong, Weizhe/AAD-7172-2020; Potter, Christopher John/H-5884-2019; Hong, Weizhe/E-3164-2010	Hong, Weizhe/0000-0003-1523-8575; Potter, Christopher John/0000-0002-5223-8112; Hong, Weizhe/0000-0003-1523-8575; Luo, Liqun/0000-0001-5467-9264	US National Institutes of Health [R01-DC005982]; Howard Hughes Medical Institute; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005982] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank A. Nose (University of Tokyo), S. Cohen (Temasek Life Sciences Laboratory), M. Freeman (Medical Research Council Laboratory of Molecular Biology), S. Hayashi (RIKEN Center for Developmental Biology) and M. Milan (Icrea and Parc Cientific de Barcelona) for fly stocks and reagents; the Bloomington, Szeged, Kyoto and Harvard Stock Centers for fly stocks; M. Spletter for making antennal lobe schemes; and T. Clandinin, K. Miyamichi, M. Spletter, L. Sweeney, J. Wu, X. Yu, D. Berdink and other laboratory members for comments and discussions. This work was supported by US National Institutes of Health grant R01-DC005982. L. L. is an investigator of the Howard Hughes Medical Institute.	Berdnik D, 2008, CURR BIOL, V18, P1754, DOI 10.1016/j.cub.2008.09.045; CHANG Z, 1993, DEV BIOL, V160, P315, DOI 10.1006/dbio.1993.1310; Couto A, 2005, CURR BIOL, V15, P1535, DOI 10.1016/j.cub.2005.07.034; Cutforth T, 2003, CELL, V114, P311, DOI 10.1016/S0092-8674(03)00568-3; Endo K, 2007, NAT NEUROSCI, V10, P153, DOI 10.1038/nn1832; Fishilevich E, 2005, CURR BIOL, V15, P1548, DOI 10.1016/j.cub.2005.07.066; Imai T, 2007, CURR OPIN NEUROBIOL, V17, P507, DOI 10.1016/j.conb.2007.08.002; Imai T, 2006, SCIENCE, V314, P657, DOI 10.1126/science.1131794; Imai T, 2009, SCIENCE, V325, P585, DOI 10.1126/science.1173596; Jefferis GSXE, 2007, CELL, V128, P1187, DOI 10.1016/j.cell.2007.01.040; Jefferis GSXE, 2004, DEVELOPMENT, V131, P117, DOI 10.1242/dev.00896; Jefferis GSXE, 2001, NATURE, V414, P204, DOI 10.1038/35102574; Kaneko-Goto T, 2008, NEURON, V57, P834, DOI 10.1016/j.neuron.2008.01.023; Kohsaka H, 2009, DEVELOPMENT, V136, P1127, DOI 10.1242/dev.027920; Komiyama T, 2004, NAT NEUROSCI, V7, P819, DOI 10.1038/nn1284; Komiyama T, 2003, CELL, V112, P157, DOI 10.1016/S0092-8674(03)00030-8; Komiyama T, 2007, CELL, V128, P399, DOI 10.1016/j.cell.2006.12.028; Komiyama T, 2007, CURR BIOL, V17, P278, DOI 10.1016/j.cub.2006.11.067; Krause C, 2006, DEV BIOL, V296, P253, DOI 10.1016/j.ydbio.2006.04.462; Kreher SA, 2005, NEURON, V46, P445, DOI 10.1016/j.neuron.2005.04.007; Kurusu M, 2008, NEURON, V59, P972, DOI 10.1016/j.neuron.2008.07.037; Laissue PP, 1999, J COMP NEUROL, V405, P543; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Luo LQ, 2007, NEURON, V56, P284, DOI 10.1016/j.neuron.2007.10.014; Mao Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001827; Marin EC, 2002, CELL, V109, P243, DOI 10.1016/S0092-8674(02)00700-6; McLaughlin T, 2005, ANNU REV NEUROSCI, V28, P327, DOI 10.1146/annurev.neuro.28.061604.135714; Milan M, 2005, DEV DYNAM, V233, P804, DOI 10.1002/dvdy.20384; Milan M, 2001, CELL, V106, P785, DOI 10.1016/S0092-8674(01)00489-5; Raymond CS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000162; Sakurai KT, 2007, DEV BIOL, V309, P126, DOI 10.1016/j.ydbio.2007.07.001; Schuldiner O, 2008, DEV CELL, V14, P227, DOI 10.1016/j.devcel.2007.11.001; Schwarting GA, 2000, J NEUROSCI, V20, P7691; Schwarting GA, 2004, EUR J NEUROSCI, V19, P1800, DOI 10.1111/j.1460-9568.2004.03304.x; Serizawa S, 2006, CELL, V127, P1057, DOI 10.1016/j.cell.2006.10.031; Shinza-Kameda M, 2006, NEURON, V49, P205, DOI 10.1016/j.neuron.2005.11.013; Shishido E, 1998, SCIENCE, V280, P2118, DOI 10.1126/science.280.5372.2118; Spletter ML, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-14; Stocker RF, 1997, J NEUROBIOL, V32, P443, DOI 10.1002/(SICI)1097-4695(199705)32:5<443::AID-NEU1>3.0.CO;2-5; Stockinger P, 2005, CELL, V121, P795, DOI 10.1016/j.cell.2005.04.026; Sweeney LB, 2007, NEURON, V53, P185, DOI 10.1016/j.neuron.2006.12.022; Taniguchi M, 2003, J NEUROSCI, V23, P1390, DOI 10.1523/JNEUROSCI.23-04-01390.2003; Toba G, 1999, GENETICS, V151, P725; Wagh DA, 2006, NEURON, V49, P833, DOI 10.1016/j.neuron.2006.02.008; Walz A, 2002, J NEUROSCI, V22, P4025, DOI 10.1523/JNEUROSCI.22-10-04025.2002; Wong AM, 2002, CELL, V109, P229, DOI 10.1016/S0092-8674(02)00707-9; Wu JS, 2006, NAT PROTOC, V1, P2110, DOI 10.1038/nprot.2006.336; Wu JS, 2006, NAT PROTOC, V1, P2583, DOI 10.1038/nprot.2006.320; Zhu HT, 2006, NAT NEUROSCI, V9, P349, DOI 10.1038/nn1652; Zhu HT, 2004, NEURON, V42, P63, DOI 10.1016/S0896-6273(04)00142-4	50	77	77	1	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2009	12	12					1542	U89		10.1038/nn.2442	http://dx.doi.org/10.1038/nn.2442			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	523II	19915565	Green Accepted			2022-12-24	WOS:000272065600014
J	Barr, GA; Moriceau, S; Shionoya, K; Muzny, K; Gao, PH; Wang, SN; Sullivan, RM				Barr, Gordon A.; Moriceau, Stephanie; Shionoya, Kiseko; Muzny, Kyle; Gao, Puhong; Wang, Shaoning; Sullivan, Regina M.			Transitions in infant learning are modulated by dopamine in the amygdala	NATURE NEUROSCIENCE			English	Article							NEURONS; FEAR; ATTRACTION	Behavioral transitions characterize development. Young infant rats paradoxically prefer odors that are paired with shock, but older pups learn aversions. This transition is amygdala and corticosterone dependent. Using microarrays and microdialysis, we found downregulated dopaminergic presynaptic function in the amygdala with preference learning. Corticosterone-injected 8-d-old pups and untreated 12-d-old pups learned aversions and had dopaminergic upregulation in the amygdala. Dopamine injection into the amygdala changed preferences to aversions, whereas dopamine antagonism reinstated preference learning.	[Barr, Gordon A.; Wang, Shaoning] Childrens Hosp Philadelphia, Dept Anesthesiol & Crit Care Med, Philadelphia, PA 19104 USA; [Barr, Gordon A.; Gao, Puhong; Wang, Shaoning] New York State Psychiat Inst & Hosp, Dept Dev Neurosci, New York, NY 10032 USA; [Moriceau, Stephanie; Shionoya, Kiseko; Muzny, Kyle; Sullivan, Regina M.] Univ Oklahoma, Dept Zool, Norman, OK 73019 USA; [Moriceau, Stephanie; Sullivan, Regina M.] Nathan S Kline Inst Psychiat Res, Emot Brain Inst, Orangeburg, NY USA; [Moriceau, Stephanie; Sullivan, Regina M.] NYU, Langone Med Ctr, New York, NY USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; New York State Psychiatry Institute; University of Oklahoma System; University of Oklahoma - Norman; Nathan Kline Institute for Psychiatric Research; New York University; NYU Langone Medical Center	Barr, GA (corresponding author), Childrens Hosp Philadelphia, Dept Anesthesiol & Crit Care Med, Philadelphia, PA 19104 USA.	barrg@email.chop.edu; regina.sullivan@nyumc.org	Barr, Gordon/GRO-3940-2022; Barr, Gordon/N-1288-2013	Moriceau, Stephanie/0000-0002-1413-9359; Barr, Gordon/0000-0003-4751-9937; Sullivan, Regina Marie/0000-0002-2406-8857	Leon Levy Foundation;  [NIH-NICHD-HD33402];  [NSF-IOB-0544406];  [NIH-NIDCD-DC009910];  [NIH-NIDA DA0032];  [NIH-NIMH MH080603]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD033402] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH080603] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009910] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K02DA000325] Funding Source: NIH RePORTER	Leon Levy Foundation; ; ; ; ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank L. Levita and the anonymous reviewers for helpful criticisms. This work was supported by grants NIH-NICHD-HD33402, NSF-IOB-0544406, NIH-NIDCD-DC009910 and the Leon Levy Foundation to R. M. S. and NIH-NIDA DA00325 and NIH-NIMH MH080603 to G. A. B.	Bissiere S, 2003, NAT NEUROSCI, V6, P587, DOI 10.1038/nn1058; Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055; Galter D, 2003, NEUROBIOL DIS, V14, P637, DOI 10.1016/j.nbd.2003.09.001; HARFSTRAND A, 1986, P NATL ACAD SCI USA, V83, P9779, DOI 10.1073/pnas.83.24.9779; Herry C, 2008, NATURE, V454, P600, DOI 10.1038/nature07166; Levine S., 2000, ENCY STRESS, V3, P518; Maestripieri D, 2005, NEUROSCI BIOBEHAV R, V29, P51, DOI 10.1016/j.neubiorev.2004.05.004; Meaney M.J., 1985, BRAIN RES, V350, P159, DOI DOI 10.1016/0165-3806(85)90259-7; Moriceau S, 2006, NAT NEUROSCI, V9, P1004, DOI 10.1038/nn1733; Moriceau S, 2006, J NEUROSCI, V26, P6737, DOI 10.1523/JNEUROSCI.0499-06.2006; Overton PG, 1996, BRAIN RES, V737, P146, DOI 10.1016/0006-8993(96)00722-6; Pollak DD, 2008, NEURON, V60, P149, DOI 10.1016/j.neuron.2008.07.041; Rosenkranz JA, 2002, NATURE, V417, P282, DOI 10.1038/417282a; Sullivan RM, 2000, NATURE, V407, P38, DOI 10.1038/35024156; Sullivan RM, 2009, COGNITIVE NEUROSCIEN, P889	15	81	83	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2009	12	11					1367	1369		10.1038/nn.2403	http://dx.doi.org/10.1038/nn.2403			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	511UE	19783994	Green Published, Green Accepted			2022-12-24	WOS:000271194100007
J	Seuntjens, E; Nityanandam, A; Miquelajauregui, A; Debruyn, J; Stryjewska, A; Goebbels, S; Nave, KA; Huylebroeck, D; Tarabykin, V				Seuntjens, Eve; Nityanandam, Anjana; Miquelajauregui, Amaya; Debruyn, Joke; Stryjewska, Agata; Goebbels, Sandra; Nave, Klaus-Armin; Huylebroeck, Danny; Tarabykin, Victor			Sip1 regulates sequential fate decisions by feedback signaling from postmitotic neurons to progenitors	NATURE NEUROSCIENCE			English	Article							SMAD-INTERACTING PROTEIN-1; CORTICAL-NEURONS; TEMPORAL IDENTITY; CELL PRODUCTION; DIFFERENTIATION; SPECIFICATION; GLIA; GENE; PROLIFERATION; NEUROGENESIS	The fate of cortical progenitors, which progressively generate neurons and glial cells during development, is determined by temporally and spatially regulated signaling mechanisms. We found that the transcription factor Sip1 (Zfhx1b), which is produced at high levels in postmitotic neocortical neurons, regulates progenitor fate non-cell autonomously. Conditional deletion of Sip1 in young neurons induced premature production of upper-layer neurons at the expense of deep layers, precocious and increased generation of glial precursors, and enhanced postnatal astrocytogenesis. The premature upper-layer generation coincided with overexpression of the neurotrophin-3 (Ntf3) gene and upregulation of fibroblast growth factor 9 (Fgf9) gene expression preceded precocious gliogenesis. Exogenous application of Fgf9 to mouse cortical slices induced excessive generation of glial precursors in the germinal zone. Our data suggest that Sip1 restrains the production of signaling factors in postmitotic neurons that feed back to progenitors to regulate the timing of cell fate switch and the number of neurons and glial cells throughout corticogenesis.	[Seuntjens, Eve; Debruyn, Joke; Stryjewska, Agata; Huylebroeck, Danny] KULeuven, Ctr Human Genet, Lab Mol Biol Celgen, Leuven, Belgium; [Seuntjens, Eve; Debruyn, Joke; Stryjewska, Agata; Huylebroeck, Danny] VIB, Dept Mol & Dev Genet, Louvain, Belgium; [Nityanandam, Anjana; Miquelajauregui, Amaya; Goebbels, Sandra; Nave, Klaus-Armin; Tarabykin, Victor] Max Planck Inst Expt Med, D-37075 Gottingen, Germany; [Tarabykin, Victor] Charite, Inst Cell Biol & Neurobiol, D-13353 Berlin, Germany	KU Leuven; Flanders Institute for Biotechnology (VIB); Max Planck Society; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Huylebroeck, D (corresponding author), KULeuven, Ctr Human Genet, Lab Mol Biol Celgen, Leuven, Belgium.	danny.huylebroeck@med.kuleuven.be; tarabykin@em.mpg.de	Miquelajauregui, Amaya/L-5578-2014; Nave, Klaus-Armin/C-8883-2011; Seuntjens, Eve/AAM-2478-2021; Tarabykin, Victor/F-9467-2014	Tarabykin, Viktor/0000-0001-8931-7263; Seuntjens, Eve/0000-0002-0126-461X; Huylebroeck, Danny/0000-0003-4862-1079	Research Foundation Flanders [G.0288.07]; inter-universitary attraction pole network [IUAP-PAI6/20]; EC-FP6 Project Endotrack [LSHG-CT-2006-19050]; Max-Planck Society; Deutsche Forschungsgemeinschaft; Marie Curie Host Fellow For Early Stage Researchers Training (NEUREST) [MEST-CT-2004-504193]	Research Foundation Flanders(FWO); inter-universitary attraction pole network; EC-FP6 Project Endotrack; Max-Planck Society(Max Planck SocietyFoundation CELLEX); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Marie Curie Host Fellow For Early Stage Researchers Training (NEUREST)(European Commission)	We thank the Flanders Institute for Biotechnology Microarray Facility, J. Allemeersch and P. Van Hummelen for their skillful analysis of our samples. We thank R. Hevner, D. Ornitz, L. Lei, J. Alberta and C. Stiles for reagents; P. Vanderhaeghen for advice and G. Fishell for numerous discussions. The D. H. laboratory thanks H. Van den Berghe for continuous support. E. S. was a postdoctoral fellow with the Research Foundation Flanders and the Franqui Foundation. This study was supported by the Research Foundation Flanders (G.0288.07), the inter-universitary attraction pole network (IUAP-PAI6/20) and the EC-FP6 Project Endotrack (LSHG-CT-2006-19050). The V. T. laboratory was supported by Max-Planck Society, Heisenberg Program and Exc 257 of Deutsche Forschungsgemeinschaft, and Fritz Thyssen Foundation. A. N. was a Marie Curie Host Fellow For Early Stage Researchers Training (NEUREST MEST-CT-2004-504193).	Arnold SJ, 2008, GENE DEV, V22, P2479, DOI 10.1101/gad.475408; Barnabe-Heider F, 2005, NEURON, V48, P253, DOI 10.1016/j.neuron.2005.08.037; Barnabe-Heider F, 2003, J NEUROSCI, V23, P5149; Bartkowska K, 2007, DEVELOPMENT, V134, P4369, DOI 10.1242/dev.008227; Bayer S.A., 1991, NEOCORTICAL DEV; Belliveau MJ, 1999, DEVELOPMENT, V126, P555; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BULLOUGH WS, 1964, EXP CELL RES, V33, P176, DOI 10.1016/S0014-4827(64)81025-9; Cinaroglu A, 2005, J NEUROSCI RES, V79, P329, DOI 10.1002/jnr.20363; Desai AR, 2000, DEVELOPMENT, V127, P2863; Eiraku M, 2008, CELL STEM CELL, V3, P519, DOI 10.1016/j.stem.2008.09.002; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; Fukumitsu H, 2006, J NEUROSCI, V26, P13218, DOI 10.1523/JNEUROSCI.4251-06.2006; Gaspard N, 2008, NATURE, V455, P351, DOI 10.1038/nature07287; Goebbels S, 2006, GENESIS, V44, P611, DOI 10.1002/dvg.20256; Gorski JA, 2002, J NEUROSCI, V22, P6309; Grosskortenhaus R, 2005, DEV CELL, V8, P193, DOI 10.1016/j.devcel.2004.11.019; Hartfuss E, 2001, DEV BIOL, V229, P15, DOI 10.1006/dbio.2000.9962; Higashi Y, 2002, GENESIS, V32, P82, DOI 10.1002/gene.10048; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Kaplan DR, 2000, CURR OPIN NEUROBIOL, V10, P381, DOI 10.1016/S0959-4388(00)00092-1; Lander AD, 2009, PLOS BIOL, V7, P84, DOI 10.1371/journal.pbio.1000015; Lee SJ, 1999, CURR OPIN GENET DEV, V9, P604, DOI 10.1016/S0959-437X(99)00004-0; Martynoga B, 2005, DEV BIOL, V283, P113, DOI 10.1016/j.ydbio.2005.04.005; MCCONNELL SK, 1988, J NEUROSCI, V8, P945; Miquelajauregui A, 2007, P NATL ACAD SCI USA, V104, P12919, DOI 10.1073/pnas.0609863104; Moal FDL, 2007, HUM MUTAT, V28, P313, DOI 10.1002/humu.20452; Morrow T, 2001, DEVELOPMENT, V128, P3585; Neophytou C, 1997, DEVELOPMENT, V124, P2345; Nieto M, 2001, NEURON, V29, P401, DOI 10.1016/S0896-6273(01)00214-8; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Pearson BJ, 2004, ANNU REV CELL DEV BI, V20, P619, DOI 10.1146/annurev.cellbio.19.111301.115142; Polleux F, 2002, SCI STKE, V136, P19; Qian XM, 2000, NEURON, V28, P69, DOI 10.1016/S0896-6273(00)00086-6; Remacle JE, 1999, EMBO J, V18, P5073, DOI 10.1093/emboj/18.18.5073; Shen Q, 2006, NAT NEUROSCI, V9, P743, DOI 10.1038/nn1694; Smith KM, 2006, NAT NEUROSCI, V9, P787, DOI 10.1038/nn1705; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Temple S, 2001, NATURE, V414, P112, DOI 10.1038/35102174; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Van de Putte T, 2003, AM J HUM GENET, V72, P465, DOI 10.1086/346092; Van Grunsven LA, 2006, DEV DYNAM, V235, P1491, DOI 10.1002/dvdy.20727; Verschueren K, 1999, J BIOL CHEM, V274, P20489, DOI 10.1074/jbc.274.29.20489; Verstappen G, 2008, HUM MOL GENET, V17, P1175, DOI 10.1093/hmg/ddn007; Waid DK, 1998, DEVELOPMENT, V125, P1059; WILLIAMS BP, 1995, NEURON, V14, P1181, DOI 10.1016/0896-6273(95)90265-1; Wu SX, 2005, P NATL ACAD SCI USA, V102, P17172, DOI 10.1073/pnas.0508560102; Zhang XM, 2001, DEVELOPMENT, V128, P943; Zhao SL, 2001, DEVELOPMENT, V128, P5051	50	165	169	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2009	12	11					1373	1380		10.1038/nn.2409	http://dx.doi.org/10.1038/nn.2409			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	511UE	19838179				2022-12-24	WOS:000271194100009
J	Talavera, K; Gees, M; Karashima, Y; Meseguer, VM; Vanoirbeek, JAJ; Damann, N; Everaerts, W; Benoit, M; Janssens, A; Vennekens, R; Viana, F; Nemery, B; Nilius, B; Voets, T				Talavera, Karel; Gees, Maarten; Karashima, Yuji; Meseguer, Victor M.; Vanoirbeek, Jeroen A. J.; Damann, Nils; Everaerts, Wouter; Benoit, Melissa; Janssens, Annelies; Vennekens, Rudi; Viana, Felix; Nemery, Benoit; Nilius, Bernd; Voets, Thomas			Nicotine activates the chemosensory cation channel TRPA1	NATURE NEUROSCIENCE			English	Article							TRIGEMINAL SUBNUCLEUS CAUDALIS; CROSS-DESENSITIZATION; MENTHOL; NEURONS; COLD; MECAMYLAMINE; RESPONSES; SENSITIZES; RECEPTORS; TARGETS	Topical application of nicotine, as used in nicotine replacement therapies, causes irritation of the mucosa and skin. This reaction has been attributed to activation of nicotinic acetylcholine receptors (nAChRs) in chemosensory neurons. In contrast with this view, we found that the chemosensory cation channel transient receptor potential A1 (TRPA1) is crucially involved in nicotine-induced irritation. We found that micromolar concentrations of nicotine activated heterologously expressed mouse and human TRPA1. Nicotine acted in a membrane-delimited manner, stabilizing the open state(s) and destabilizing the closed state(s) of the channel. In the presence of the general nAChR blocker hexamethonium, nociceptive neurons showed nicotine-induced responses that were strongly reduced in TRPA1-deficient mice. Finally, TRPA1 mediated the mouse airway constriction reflex to nasal instillation of nicotine. The identification of TRPA1 as a nicotine target suggests that existing models of nicotine-induced irritation should be revised and may facilitate the development of smoking cessation therapies with less adverse effects.	[Talavera, Karel; Gees, Maarten; Karashima, Yuji; Damann, Nils; Everaerts, Wouter; Benoit, Melissa; Janssens, Annelies; Vennekens, Rudi; Nilius, Bernd; Voets, Thomas] Katholieke Univ Leuven, Lab Ion Channel Res, Dept Mol Cell Biol, Leuven, Belgium; [Meseguer, Victor M.; Viana, Felix] Univ Miguel Hernandez, Inst Neurociencias Alicante, Consejo Super Invest Cient, Alacant, Spain; [Vanoirbeek, Jeroen A. J.; Nemery, Benoit] Katholieke Univ Leuven, Lab Lung Toxicol, Leuven, Belgium; [Everaerts, Wouter] Katholieke Univ Leuven, Dept Surg, Lab Expt Urol, Leuven, Belgium	KU Leuven; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Miguel Hernandez de Elche; CSIC-UMH - Instituto de Neurociencias de Alicante (IN); KU Leuven; KU Leuven	Talavera, K (corresponding author), Katholieke Univ Leuven, Lab Ion Channel Res, Dept Mol Cell Biol, Leuven, Belgium.	karel.talavera@med.kuleuven.be	Everaerts, Wouter/A-3153-2019; Vanoirbeek, Jeroen/D-5183-2016; Karashima, Yuji/AGY-5391-2022; Voets, Thomas/E-2466-2012; Nemery, Benoit/N-3155-2019; Vennekens, Rudi/AAQ-1664-2020; Talavera, Karel/K-7990-2014; Voets, Thomas/AAD-4389-2019; Nemery, Benoit/D-1224-2013; gees, maarten/H-4185-2011; Viana, Felix/U-8533-2017	Everaerts, Wouter/0000-0002-3157-7115; Vanoirbeek, Jeroen/0000-0001-5508-3518; Karashima, Yuji/0000-0002-2866-8999; Voets, Thomas/0000-0001-5526-5821; Nemery, Benoit/0000-0003-0571-4689; Vennekens, Rudi/0000-0002-2564-5150; Talavera, Karel/0000-0002-3124-138X; Voets, Thomas/0000-0001-5526-5821; Viana, Felix/0000-0003-1439-949X; Janssens, Annelies/0000-0002-6735-8248	Spanish CONSOLIDERINGENIO; Inter- university Attraction Poles Programme [P6/ 28]; FWO [G. 0172.03, G. 0565.07]; Research Council of the KU Leuven [GOA 2004/ 07]; Flemish Government [EF/ 95/ 010]	Spanish CONSOLIDERINGENIO(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Inter- university Attraction Poles Programme(Belgian Federal Science Policy Office); FWO(FWO); Research Council of the KU Leuven(KU Leuven); Flemish Government(European Commission)	We are grateful to K. Y. Kwan for providing us with the Trpa1 knockout mice, M. R. Sep lveda for helpful discussions, and V. De Vooght and P. Hoet for help in some plethysmography experiments. The expert technical assistance of J. Prenen is greatly acknowledged. The mTRPA1 CHO cell line was kindly provided by A. Patapoutian. K. T. and J. A. J. V. were supported by a postdoctoral mandate from KU Leuven and are currently postdoctoral fellows of the Research Foundation Flanders ( Fonds voor Wetenschappelijk Onderzoek, FWO). M. G. and W. E. are doctoral FWO fellows. V. M. M was supported by Spanish CONSOLIDERINGENIO 2010 CSD2007- 00023. This work was supported by grants from Inter- university Attraction Poles Programme ( Belgian Science Policy, P6/ 28), FWO ( G. 0172.03 and G. 0565.07), the Research Council of the KU Leuven ( GOA 2004/ 07) and the Flemish Government ( Excellentiefinanciering, EF/ 95/ 010).	Andre E, 2008, J CLIN INVEST, V118, P2574, DOI 10.1172/JCI34886; BALDWIN IT, 1993, J CHEM ECOL, V19, P1143, DOI 10.1007/BF00987376; Bandell M, 2004, NEURON, V41, P849, DOI 10.1016/S0896-6273(04)00150-3; Bautista DM, 2006, CELL, V124, P1269, DOI 10.1016/j.cell.2006.02.023; Bessac BF, 2008, PHYSIOLOGY, V23, P360, DOI 10.1152/physiol.00026.2008; Carstens E, 1998, J NEUROPHYSIOL, V80, P465, DOI 10.1152/jn.1998.80.2.465; Carstens E, 2007, CHEM SENSES, V32, P811, DOI 10.1093/chemse/bjm048; Chung MK, 2004, J NEUROSCI, V24, P5177, DOI 10.1523/JNEUROSCI.0934-04.2004; Damann N, 2008, CURR BIOL, V18, pR880, DOI 10.1016/j.cub.2008.07.063; Dessirier JM, 2001, PHYSIOL BEHAV, V73, P25, DOI 10.1016/S0031-9384(01)00431-0; Dhaka A, 2007, NEURON, V54, P371, DOI 10.1016/j.neuron.2007.02.024; Dhar P, 2004, J PHARMACEUT BIOMED, V35, P155, DOI 10.1016/j.jpba.2004.01.009; Doerner JF, 2007, J BIOL CHEM, V282, P13180, DOI 10.1074/jbc.M607849200; Dussor GO, 2003, EUR J NEUROSCI, V18, P2515, DOI 10.1046/j.1460-9568.2003.02935.x; Fajardo O, 2008, CHANNELS, V2, P429, DOI 10.4161/chan.2.6.7126; Fucile S, 2005, J PHYSIOL-LONDON, V565, P219, DOI 10.1113/jphysiol.2005.084871; Haberberger RV, 2004, AUTON NEUROSCI-BASIC, V113, P32, DOI 10.1016/j.autneu.2004.05.008; Hajek P, 1999, ARCH INTERN MED, V159, P2033, DOI 10.1001/archinte.159.17.2033; Hatsukami DK, 2008, LANCET, V371, P2027, DOI 10.1016/S0140-6736(08)60871-5; Hinman A, 2006, P NATL ACAD SCI USA, V103, P19564, DOI 10.1073/pnas.0609598103; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; Karashima Y, 2007, J NEUROSCI, V27, P9874, DOI 10.1523/JNEUROSCI.2221-07.2007; Karashima Y, 2009, P NATL ACAD SCI USA, V106, P1273, DOI 10.1073/pnas.0808487106; Kreslake JM, 2008, NICOTINE TOB RES, V10, P705, DOI 10.1080/14622200801979134; Kwan KY, 2006, NEURON, V50, P277, DOI 10.1016/j.neuron.2006.03.042; Lee L. -Y., 2009, V187, P77, DOI 10.1007/978-3-540-79842-2_5; Liu L, 2004, J NEUROPHYSIOL, V91, P1482, DOI 10.1152/jn.00922.2003; Liu L, 1996, AM J PHYSIOL-CELL PH, V270, pC1807, DOI 10.1152/ajpcell.1996.270.6.C1807; Macpherson LJ, 2007, NATURE, V445, P541, DOI 10.1038/nature05544; Macpherson LJ, 2006, MOL CELL NEUROSCI, V32, P335, DOI 10.1016/j.mcn.2006.05.005; Meseguer V, 2008, J NEUROSCI, V28, P576, DOI 10.1523/JNEUROSCI.4772-07.2008; Nides M, 2008, AM J MED, V121, pS20, DOI 10.1016/j.amjmed.2008.01.016; Papke RL, 2001, J PHARMACOL EXP THER, V297, P646; Rask L, 2000, PLANT MOL BIOL, V42, P93, DOI 10.1023/A:1006380021658; Simons CT, 2006, J NEUROPHYSIOL, V96, P1877, DOI 10.1152/jn.00345.2006; Simons CT, 2003, BRAIN RES, V991, P249, DOI 10.1016/S0006-8993(03)03539-X; Southam DS, 2002, AM J PHYSIOL-LUNG C, V282, pL833, DOI 10.1152/ajplung.00173.2001; Stead LF, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000146.pub3; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Talavera K, 2003, J GEN PHYSIOL, V121, P511, DOI 10.1085/jgp.200308793; Talavera K, 2008, TRENDS NEUROSCI, V31, P287, DOI 10.1016/j.tins.2008.03.002; Thuerauf N, 2006, NEUROPSYCHOPHARMACOL, V31, P450, DOI 10.1038/sj.npp.1300842; Togias A, 1999, ALLERGY, V54, P94, DOI 10.1111/j.1398-9995.1999.tb04410.x; Vanoirbeek JAJ, 2004, TOXICOL SCI, V80, P310, DOI 10.1093/toxsci/kfh155; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; Widdicombe J, 2006, J APPL PHYSIOL, V101, P628, DOI 10.1152/japplphysiol.00155.2006; Xiao B, 2008, J NEUROSCI, V28, P9640, DOI 10.1523/JNEUROSCI.2772-08.2008; Xu HX, 2005, J NEUROSCI, V25, P8924, DOI 10.1523/JNEUROSCI.2574-05.2005; Zanotto KL, 2007, J NEUROPHYSIOL, V97, P966, DOI 10.1152/jn.00996.2006; Zurborg S, 2007, NAT NEUROSCI, V10, P277, DOI 10.1038/nn1843	50	187	198	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2009	12	10					1293	U14		10.1038/nn.2379	http://dx.doi.org/10.1038/nn.2379			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	498US	19749751	Green Published, Green Submitted			2022-12-24	WOS:000270170200018
J	Rajasethupathy, P; Fiumara, F; Sheridan, R; Betel, D; Puthanveettil, SV; Russo, JJ; Sander, C; Tuschl, T; Kandel, E				Rajasethupathy, Priyamvada; Fiumara, Ferdinando; Sheridan, Robert; Betel, Doron; Puthanveettil, Sathyanarayanan V.; Russo, James J.; Sander, Chris; Tuschl, Thomas; Kandel, Eric			Characterization of Small RNAs in Aplysia Reveals a Role for miR-124 in Constraining Synaptic Plasticity through CREB	NEURON			English	Article							LONG-TERM FACILITATION; POSTTRANSCRIPTIONAL REGULATION; PROTEIN-SYNTHESIS; FEEDBACK LOOP; MICRORNAS; EXPRESSION; EVOLUTION; NEURONS; GENES; CELL	Memory storage and memory-related synaptic plasticity rely on precise spatiotemporal regulation of gene expression. To explore the role of small regulatory RNAs in learning-related synaptic plasticity, we carried out massive parallel sequencing to profile the small RNAs of Aplysia californica. We identified 170 distinct miRNAs, 13 of which were novel and specific to Aplysia. Nine miRNAs were brain enriched, and several of these were rapidly downregulated by transient exposure to serotonin, a modulatory neurotransmitter released during learning. Further characterization of the brain-enriched miRNAs revealed that miR-124, the most abundant and well-conserved brain-specific miRNA, was exclusively present presynaptically in a sensory-motor synapse where it constrains serotonin-induced synaptic facilitation through regulation of the transcriptional factor CREB. We therefore present direct evidence that a modulatory neurotransmitter important for learning can regulate the levels of small RNAs and present a role for miR-124 in long-term plasticity of synapses in the mature nervous system.	[Tuschl, Thomas] Rockefeller Univ, Howard Hughes Med Inst, Lab RNA Mol Biol, New York, NY 10065 USA; [Rajasethupathy, Priyamvada; Fiumara, Ferdinando; Puthanveettil, Sathyanarayanan V.; Kandel, Eric] Columbia Univ, Dept Neurosci, New York, NY 10032 USA; [Rajasethupathy, Priyamvada; Puthanveettil, Sathyanarayanan V.; Kandel, Eric] Columbia Univ, Howard Hughes Med Inst, New York, NY 10032 USA; [Kandel, Eric] Columbia Univ, Kavli Inst Brain Sci, New York, NY 10032 USA; [Russo, James J.] Columbia Univ, Columbia Genome Ctr, New York, NY 10032 USA; [Fiumara, Ferdinando] Univ Turin, Dept Neurosci, I-10125 Turin, Italy; [Sheridan, Robert; Betel, Doron; Sander, Chris] Mem Sloan Kettering Canc Ctr, Computat & Syst Biol Ctr, New York, NY 10065 USA	Howard Hughes Medical Institute; Rockefeller University; Columbia University; Columbia University; Howard Hughes Medical Institute; Columbia University; Columbia University; University of Turin; Memorial Sloan Kettering Cancer Center	Tuschl, T (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Lab RNA Mol Biol, 1230 York Ave, New York, NY 10065 USA.	ttuschl@rockefeller.edu; erk5@columbia.edu	Sander, Chris/H-1452-2011; Fiumara, Ferdinando/AAE-3074-2022	Sander, Chris/0000-0001-6059-6270; FIUMARA, Ferdinando/0000-0003-0715-7863; Betel, Doron/0000-0002-8006-7752	HHMI [P50 HG002806]; NIH [R01 MH075026, P01 GM073047]; NIH MSTP training grant; Italian Academy for Advanced Studies in America at Columbia University; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG002806] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM073047] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [F30MH086267, R01MH075026] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060762] Funding Source: NIH RePORTER	HHMI(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH MSTP training grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Italian Academy for Advanced Studies in America at Columbia University; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	P.R. would like to thank Amanda Rice for an introduction to the small RNA cloning procedure and Praveen Sethupathy, Jeff Chen, and Li-Chun Cheng for many helpful discussions throughout. We thank Vivian Zhu and Edward Konstantinov for technical assistance with cell cultures and Minchen Chien and David B. Weir for sequencing the Sanger libraries. We are grateful to David Bartel and Eric Lai for sharing unpublished data. This work is supported by an HHMI grant P50 HG002806 and NIH grants R01 MH075026 and P01 GM073047. P.R. is also supported by an NIH MSTP training grant, and F.F. is also supported by the Italian Academy for Advanced Studies in America at Columbia University.	ALBERINI CM, 1994, CELL, V76, P1099, DOI 10.1016/0092-8674(94)90386-7; Aravin AA, 2003, DEV CELL, V5, P337, DOI 10.1016/S1534-5807(03)00228-4; Ashraf SI, 2006, CELL, V124, P191, DOI 10.1016/j.cell.2005.12.017; Barco A, 2002, CELL, V108, P689, DOI 10.1016/S0092-8674(02)00657-8; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartsch D, 1998, CELL, V95, P211, DOI 10.1016/S0092-8674(00)81752-3; Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031; CASTELLUCCI VF, 1980, P NATL ACAD SCI-BIOL, V77, P7492, DOI 10.1073/pnas.77.12.7492; Chen PY, 2005, GENE DEV, V19, P1288, DOI 10.1101/gad.1310605; Cheng LC, 2009, NAT NEUROSCI, V12, P399, DOI 10.1038/nn.2294; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; DASH PK, 1990, NATURE, V345, P718, DOI 10.1038/345718a0; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Grimson A, 2008, NATURE, V455, P1193, DOI 10.1038/nature07415; Hafner M, 2008, METHODS, V44, P3, DOI 10.1016/j.ymeth.2007.09.009; Hegde AN, 1997, CELL, V89, P115, DOI 10.1016/S0092-8674(00)80188-9; Heo I, 2008, MOL CELL, V32, P276, DOI 10.1016/j.molcel.2008.09.014; Ho CK, 2004, STRUCTURE, V12, P327, DOI 10.1016/j.str.2004.01.011; Impey S, 1998, NEURON, V21, P869, DOI 10.1016/S0896-6273(00)80602-9; Johnston RJ, 2003, NATURE, V426, P845, DOI 10.1038/nature02255; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Liu N, 2008, CELL RES, V18, P985, DOI 10.1038/cr.2008.278; Liu RY, 2008, J NEUROSCI, V28, P1970, DOI 10.1523/JNEUROSCI.3848-07.2008; Lu J, 2008, NAT GENET, V40, P351, DOI 10.1038/ng.73; Makeyev EV, 2007, MOL CELL, V27, P435, DOI 10.1016/j.molcel.2007.07.015; Martin KC, 1997, NEURON, V18, P899, DOI 10.1016/S0896-6273(00)80330-X; Martin KC, 2006, J NEUROSCI, V26, P7131, DOI 10.1523/JNEUROSCI.1801-06.2006; Michlewski G, 2008, MOL CELL, V32, P383, DOI 10.1016/j.molcel.2008.10.013; MONTAROLO PG, 1986, SCIENCE, V234, P1249, DOI 10.1126/science.3775383; Moroz LL, 2006, CELL, V127, P1453, DOI 10.1016/j.cell.2006.09.052; Obernosterer G, 2006, RNA, V12, P1161, DOI 10.1261/rna.2322506; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Ruby JG, 2007, GENOME RES, V17, P1850, DOI 10.1101/gr.6597907; Rybak A, 2008, NAT CELL BIOL, V10, P987, DOI 10.1038/ncb1759; SACKTOR TC, 1990, P NATL ACAD SCI USA, V87, P2036, DOI 10.1073/pnas.87.5.2036; SCHACHER S, 1983, J NEUROSCI, V3, P2403; Schratt G, 2009, CURR OPIN NEUROBIOL, V19, P213, DOI 10.1016/j.conb.2009.05.015; Sutton MA, 2006, CELL, V127, P49, DOI 10.1016/j.cell.2006.09.014; Visvanathan J, 2007, GENE DEV, V21, P744, DOI 10.1101/gad.1519107; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4	50	304	321	0	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 24	2009	63	6					803	817		10.1016/j.neuron.2009.05.029	http://dx.doi.org/10.1016/j.neuron.2009.05.029			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	503VP	19778509	Green Accepted, Green Published, Bronze			2022-12-24	WOS:000270569700013
J	Castilho, RM; Squarize, CH; Chodosh, LA; Williams, BO; Gutkind, JS				Castilho, Rogerio M.; Squarize, Cristiane H.; Chodosh, Lewis A.; Williams, Bart O.; Gutkind, J. Silvio			mTOR Mediates Wnt-Induced Epidermal Stem Cell Exhaustion and Aging	CELL STEM CELL			English	Article							HAIR FOLLICLE; BETA-CATENIN; SIGNALING CONTROLS; EXPRESSION; PATHWAY; CANCER; SKIN; TOR; PHOSPHORYLATION; DIFFERENTIATION	Epidermal integrity is a complex process established during embryogenesis and maintained throughout the organism lifespan by epithelial stem cells. Although Wnt regulates normal epithelial stem cell renewal, aberrant Wnt signaling can contribute to cancerous growth. Here, we explored the consequences of persistent expressing Wnt1 in an epidermal compartment that includes the epithelial stem cells. Surprisingly, Wnt caused the rapid growth of the hair follicles, but this was followed by epithelial cell senescence, disappearance of the epidermal stem cell compartment, and progressive hair loss. Although Wnt1 induced the activation of beta-catenin and the mTOR pathway, both hair follicle hyperproliferation and stem cell exhaustion were strictly dependent on mTOR function. These findings suggest that whereas activation of beta-catenin contributes to tumor growth, epithelial stem cells may be endowed with a protective mechanism that results in cell senescence upon the persistent stimulation of proliferative pathways that activate mTOR, ultimately suppressing tumor formation.	[Castilho, Rogerio M.; Squarize, Cristiane H.; Gutkind, J. Silvio] Natl Inst Dent & Craniofacial Res, Oral & Pharyngeal Canc Branch, NIH, Bethesda, MD 20892 USA; [Chodosh, Lewis A.] Univ Penn, Sch Med, Dept Canc Biol, Philadelphia, PA 19104 USA; [Chodosh, Lewis A.] Univ Penn, Sch Med, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; [Williams, Bart O.] Van Andel Res Inst, Lab Cell Signaling & Carcinogenesis, Grand Rapids, MI 49503 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Van Andel Institute	Gutkind, JS (corresponding author), Natl Inst Dent & Craniofacial Res, Oral & Pharyngeal Canc Branch, NIH, Bethesda, MD 20892 USA.	sg39v@nih.gov	Williams, Bart/A-3539-2013; Gutkind, J. Silvio/A-1053-2009; Castilho, Rogerio M/E-4987-2010; Gutkind, J. Silvio/J-1201-2016	Williams, Bart/0000-0002-5261-5301; Castilho, Rogerio M/0000-0001-5358-612X; Gutkind, J. Silvio/0000-0002-5150-4482; Squarize, Cristiane/0000-0002-6782-3429	Intramural Research Program; Craniofacial Tissue Remodeling Initiative of the NIH; NIDCR; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000558, ZIADE000551] Funding Source: NIH RePORTER	Intramural Research Program; Craniofacial Tissue Remodeling Initiative of the NIH; NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	a We are grateful to Dr. R. M. Porter (Wales College of Medicine) for the polyclonal antibody against IRS and to Dr. T. Finkel (National Heart, Lung, and Blood Institute/ National Institutes of Health [NIH]) for critical reading of the manuscript. This research was supported by the Intramural Research Program and the Craniofacial Tissue Remodeling Initiative of the NIH, NIDCR.	Abraham RT, 2002, CELL, V111, P9, DOI 10.1016/S0092-8674(02)01009-7; Alonso L, 2003, GENE DEV, V17, P1189, DOI 10.1101/gad.1086903; Andl T, 2002, DEV CELL, V2, P643, DOI 10.1016/S1534-5807(02)00167-3; Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; Blanpain C, 2009, NAT REV MOL CELL BIO, V10, P207, DOI 10.1038/nrm2636; Blau HM, 2001, CELL, V105, P829, DOI 10.1016/S0092-8674(01)00409-3; Brennan KR, 2004, J MAMMARY GLAND BIOL, V9, P119, DOI 10.1023/B:JOMG.0000037157.94207.33; Cang Y, 2007, P NATL ACAD SCI USA, V104, P2733, DOI 10.1073/pnas.0611311104; Castilho RM, 2007, ONCOGENE, V26, P5078, DOI 10.1038/sj.onc.1210322; Chang CH, 2004, MECH DEVELOP, V121, P157, DOI 10.1016/j.mod.2003.12.004; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; Cho RW, 2008, STEM CELLS, V26, P364, DOI 10.1634/stemcells.2007-0440; Debies MT, 2008, J CLIN INVEST, V118, P51, DOI 10.1172/JCI33320; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Fuchs E, 1995, ANNU REV CELL DEV BI, V11, P123, DOI 10.1146/annurev.cb.11.110195.001011; Gat U, 1998, CELL, V95, P605, DOI 10.1016/S0092-8674(00)81631-1; Greco V, 2009, CELL STEM CELL, V4, P155, DOI 10.1016/j.stem.2008.12.009; Gunther EJ, 2003, GENE DEV, V17, P488, DOI 10.1101/gad.1051603; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; Inoki K, 2006, CELL, V126, P955, DOI 10.1016/j.cell.2006.06.055; ITO M, 1986, ARCH DERMATOL RES, V279, P112, DOI 10.1007/BF00417531; Katoh M, 2007, CLIN CANCER RES, V13, P4042, DOI 10.1158/1078-0432.CCR-06-2316; Kirstetter P, 2006, NAT IMMUNOL, V7, P1048, DOI 10.1038/ni1381; Klaus A, 2008, NAT REV CANCER, V8, P387, DOI 10.1038/nrc2389; Kobielak K, 2007, P NATL ACAD SCI USA, V104, P10063, DOI 10.1073/pnas.0703004104; Li Y, 2000, ONCOGENE, V19, P1002, DOI 10.1038/sj.onc.1203273; Lindvall C, 2007, STEM CELL REV, V3, P157, DOI 10.1007/s12015-007-0025-3; Liu F, 2008, CELL SIGNAL, V20, P999, DOI 10.1016/j.cellsig.2007.11.011; Liu HJ, 2007, SCIENCE, V317, P803, DOI 10.1126/science.1143578; LYNCH MH, 1986, J CELL BIOL, V103, P2593, DOI 10.1083/jcb.103.6.2593; Maretto S, 2003, P NATL ACAD SCI USA, V100, P3299, DOI 10.1073/pnas.0434590100; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Morris RJ, 2004, NAT BIOTECHNOL, V22, P411, DOI 10.1038/nbt950; Motoyama N, 2004, CURR OPIN GENET DEV, V14, P11, DOI 10.1016/j.gde.2003.12.003; Nusse R, 2008, CELL RES, V18, P523, DOI 10.1038/cr.2008.47; Olivera-Martinez I, 2001, MECH DEVELOP, V100, P233, DOI 10.1016/S0925-4773(00)00540-2; Paus R, 1999, J INVEST DERMATOL, V113, P523, DOI 10.1046/j.1523-1747.1999.00740.x; Porter RM, 2004, BRIT J DERMATOL, V150, P195, DOI 10.1111/j.1365-2133.2004.05720.x; Powers RW, 2006, GENE DEV, V20, P174, DOI 10.1101/gad.1381406; Reddy S, 2001, MECH DEVELOP, V107, P69, DOI 10.1016/S0925-4773(01)00452-X; Reddy ST, 2004, J INVEST DERMATOL, V123, P275, DOI 10.1111/j.0022-202X.2004.23215.x; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Sabatini DM, 2006, NAT REV CANCER, V6, P729, DOI 10.1038/nrc1974; Sarin KY, 2005, NATURE, V436, P1048, DOI 10.1038/nature03836; Scheller M, 2006, NAT IMMUNOL, V7, P1037, DOI 10.1038/ni1387; Schieke SM, 2006, BIOL CHEM, V387, P1357, DOI 10.1515/BC.2006.170; Serrano M, 2001, CURR OPIN CELL BIOL, V13, P748, DOI 10.1016/S0955-0674(00)00278-7; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; Squarize CH, 2006, NEOPLASIA, V8, P733, DOI 10.1593/neo.06274; van Noort M, 2002, J BIOL CHEM, V277, P17901, DOI 10.1074/jbc.M111635200; Vitale-Cross L, 2004, CANCER RES, V64, P8804, DOI 10.1158/0008-5472.CAN-04-2623; Wendel HG, 2004, NATURE, V428, P332, DOI 10.1038/nature02369; Xu LF, 2000, GENE DEV, V14, P585; Zechner D, 2003, DEV BIOL, V258, P406, DOI 10.1016/S0012-1606(03)00123-4; Zhu AJ, 1999, DEVELOPMENT, V126, P2285	55	296	312	1	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	SEP 4	2009	5	3					279	289		10.1016/j.stem.2009.06.017	http://dx.doi.org/10.1016/j.stem.2009.06.017			11	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	529VA	19733540	Green Accepted, Bronze			2022-12-24	WOS:000272545700014
J	Freiwald, WA; Tsao, DY; Livingstone, MS				Freiwald, Winrich A.; Tsao, Doris Y.; Livingstone, Margaret S.			A face feature space in the macaque temporal lobe	NATURE NEUROSCIENCE			English	Article							MONKEY INFEROTEMPORAL CORTEX; SINGLE NEURONS; SCHEMATIC FACES; VISUAL-CORTEX; RECOGNITION; SELECTIVITY; PERCEPTION; RESPONSES; OBJECTS; IMAGES	The ability of primates to effortlessly recognize faces has been attributed to the existence of specialized face areas. One such area, the macaque middle face patch, consists almost entirely of cells that are selective for faces, but the principles by which these cells analyze faces are unknown. We found that middle face patch neurons detect and differentiate faces using a strategy that is both part based and holistic. Cells detected distinct constellations of face parts. Furthermore, cells were tuned to the geometry of facial features. Tuning was most often ramp-shaped, with a one-to-one mapping of feature magnitude to firing rate. Tuning amplitude depended on the presence of a whole, upright face and features were interpreted according to their position in a whole, upright face. Thus, cells in the middle face patch encode axes of a face space specialized for whole, upright faces.	[Freiwald, Winrich A.; Tsao, Doris Y.; Livingstone, Margaret S.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Freiwald, Winrich A.; Tsao, Doris Y.] Univ Bremen, Ctr Adv Imaging & Cognit Sci, Bremen, Germany; [Freiwald, Winrich A.; Tsao, Doris Y.] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Freiwald, Winrich A.] Rockefeller Univ, New York, NY 10021 USA; [Tsao, Doris Y.] Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA USA	Harvard University; Harvard Medical School; University of Bremen; California Institute of Technology; Rockefeller University	Freiwald, WA (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA.	winrich.freiwald@googlemail.com		Livingstone, Margaret/0000-0002-1950-0123	US National Institutes of Health [EY16187]; German Science Foundation [FR 1437/3-1]; Alexander von Humboldt Foundation; NATIONAL EYE INSTITUTE [R01EY016187] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Science Foundation(German Research Foundation (DFG)); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We are grateful to the late D. Freeman and N. Nallasamy for stimulus programming; R. Tootell, W. Vanduffel and members of the Massachusetts General Hospital monkey fMRI group for assistance with scanning; A. Dale and A. van der Kouwe for allowing us to use their multi-echo sequence and undistortion algorithm; T. Chuprina and N. Schweers for animal care and Guerbet for providing Sinerem contrast agent. This work was sponsored by US National Institutes of Health grant EY16187 and German Science Foundation grant FR 1437/3-1. D.Y.T. was supported by a Sofja Kovalevskaja Award from the Alexander von Humboldt Foundation.	ANDERSEN RA, 1990, J NEUROSCI, V10, P1176; BARTLETT JC, 1993, COGNITIVE PSYCHOL, V25, P281, DOI 10.1006/cogp.1993.1007; BAYLIS GC, 1985, BRAIN RES, V342, P91, DOI 10.1016/0006-8993(85)91356-3; BENSON P J, 1991, European Journal of Cognitive Psychology, V3, P105, DOI 10.1080/09541449108406222; BIEDERMAN I, 1987, PSYCHOL REV, V94, P115, DOI 10.1037/0033-295X.94.2.115; Brincat SL, 2004, NAT NEUROSCI, V7, P880, DOI 10.1038/nn1278; BRUCE C, 1981, J NEUROPHYSIOL, V46, P369, DOI 10.1152/jn.1981.46.2.369; Brunswik E, 1937, Z PSYCHOL PHYSIOL SI, V142, P67; Cox D, 2004, SCIENCE, V304, P115, DOI 10.1126/science.1093110; De Baene W, 2007, J NEUROPHYSIOL, V97, P2900, DOI 10.1152/jn.00741.2006; EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552; Eurich CW, 2000, NEURAL COMPUT, V12, P1519, DOI 10.1162/089976600300015240; Fabre-Thorpe M, 1998, NEUROREPORT, V9, P303, DOI 10.1097/00001756-199801260-00023; FRASER IH, 1990, PERCEPTION, V19, P661, DOI 10.1068/p190661; FUJITA I, 1992, NATURE, V360, P343, DOI 10.1038/360343a0; Galton F., 1878, J ANTHR I GREAT BRIT, V18, P97, DOI 10.2307/2841021; Grunewald A, 2004, J NEUROSCI, V24, P9185, DOI 10.1523/JNEUROSCI.1884-04.2004; Guigon E, 2003, NEURAL COMPUT, V15, P2115, DOI 10.1162/089976603322297313; HUBEL DH, 1959, J PHYSIOL-LONDON, V148, P574, DOI 10.1113/jphysiol.1959.sp006308; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kayaert G, 2005, EUR J NEUROSCI, V22, P212, DOI 10.1111/j.1460-9568.2005.04202.x; Keysers C, 2001, J COGNITIVE NEUROSCI, V13, P90, DOI 10.1162/089892901564199; Koida K, 2007, NAT NEUROSCI, V10, P108, DOI 10.1038/nn1823; Leopold DA, 2001, NAT NEUROSCI, V4, P89, DOI 10.1038/82947; Leopold DA, 2006, NATURE, V442, P572, DOI 10.1038/nature04951; Liu Y, 2008, J NEUROPHYSIOL, V100, P966, DOI 10.1152/jn.01354.2007; Manly B.F.J, 2007, RANDOMIZATION BOOTST, DOI DOI 10.1201/9780429329203; McAdams CJ, 1999, J NEUROSCI, V19, P431, DOI 10.1523/JNEUROSCI.19-01-00431.1999; McKone E, 2005, J EXP PSYCHOL HUMAN, V31, P1181, DOI 10.1037/0096-1523.31.6.1181; Mel BW, 2000, NEURAL COMPUT, V12, P247, DOI 10.1162/089976600300015772; PERRETT DI, 1985, PROC R SOC SER B-BIO, V223, P293, DOI 10.1098/rspb.1985.0003; Quiroga RQ, 2005, NATURE, V435, P1102, DOI 10.1038/nature03687; RHODES G, 1987, COGNITIVE PSYCHOL, V19, P473, DOI 10.1016/0010-0285(87)90016-8; Rhodes G, 1996, SUPERPORTRAITS CARIC; Salinas Emilio, 2000, Neuron, V27, P15, DOI 10.1016/S0896-6273(00)00004-0; TANAKA JW, 1993, Q J EXP PSYCHOL-A, V46, P225, DOI 10.1080/14640749308401045; TANAKA K, 1991, J NEUROPHYSIOL, V66, P170, DOI 10.1152/jn.1991.66.1.170; THOMPSON P, 1980, PERCEPTION, V9, P483, DOI 10.1068/p090483; Thorpe S, 1996, NATURE, V381, P520, DOI 10.1038/381520a0; Treue S, 1999, NATURE, V399, P575, DOI 10.1038/21176; Tsao DY, 2006, SCIENCE, V311, P670, DOI 10.1126/science.1119983; Tsao DY, 2003, NAT NEUROSCI, V6, P989, DOI 10.1038/nn1111; VALENTINE T, 1991, Q J EXP PSYCHOL-A, V43, P161, DOI 10.1080/14640749108400966; Wang G, 1996, SCIENCE, V272, P1665, DOI 10.1126/science.272.5268.1665; Webster MA, 1999, PSYCHON B REV, V6, P647, DOI 10.3758/BF03212974; YIN RK, 1969, J EXP PSYCHOL, V81, P141, DOI 10.1037/h0027474; YOUNG AW, 1987, PERCEPTION, V16, P747, DOI 10.1068/p160747; Zar, 2011, BIOSTAT ANAL; Zhang KC, 1999, NEURAL COMPUT, V11, P75, DOI 10.1162/089976699300016809; ZIPSER D, 1988, NATURE, V331, P679, DOI 10.1038/331679a0	50	291	293	1	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2009	12	9					1187	U28		10.1038/nn.2363	http://dx.doi.org/10.1038/nn.2363			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	487ZD	19668199	Green Accepted			2022-12-24	WOS:000269317300023
J	Higley, MJ; Soler-Llavina, GJ; Sabatini, BL				Higley, Michael J.; Soler-Llavina, Gilberto J.; Sabatini, Bernardo L.			Cholinergic modulation of multivesicular release regulates striatal synaptic potency and integration	NATURE NEUROSCIENCE			English	Article							MEDIUM SPINY NEURONS; POSTSYNAPTIC RECEPTOR SATURATION; MUSCARINIC RECEPTORS; DENDRITIC SPINES; BASAL GANGLIA; CA2+ CHANNELS; GLUTAMATERGIC AFFERENTS; MOVEMENT-DISORDERS; RAT NEOSTRIATUM; CEREBRAL-CORTEX	The pleiotropic actions of neuromodulators on pre- and postsynaptic targets make disentangling the mechanisms underlying regulation of synaptic transmission challenging. In the striatum, acetylcholine modulates glutamate release via activation of muscarinic receptors (mAchRs), although the consequences for postsynaptic signaling are unclear. Using two-photon microscopy and glutamate uncaging to examine individual synapses in the rat striatum, we found that glutamatergic afferents have a high degree of multivesicular release (MVR) in the absence of postsynaptic receptor saturation. We found that mAchR activation decreased both the probability of release and the concentration of glutamate in the synaptic cleft. The corresponding decrease in synaptic potency reduced the duration of synaptic potentials and limited temporal summation of afferent inputs. These findings reveal a mechanism by which a combination of basal MVR and low receptor saturation allow the presynaptic actions of a neuromodulator to control the engagement of postsynaptic nonlinearities and regulate synaptic integration.	[Higley, Michael J.; Soler-Llavina, Gilberto J.; Sabatini, Bernardo L.] Harvard Univ, Sch Med, Dept Neurobiol, Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Sabatini, BL (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Howard Hughes Med Inst, Boston, MA 02115 USA.	bsabatini@hms.harvard.edu			Parkinson's Disease Foundation Postdoctoral Fellowship; Quan Predoctoral Fellowship; National Institute of Neurological Disorders and Stroke predoctoral National Research Service Award [1 F31 NS049655-01]; McKnight Foundation and National Institute of Neurological Disorders and Stroke [NS046579]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS049655, R01NS046579, F32NS063663] Funding Source: NIH RePORTER	Parkinson's Disease Foundation Postdoctoral Fellowship; Quan Predoctoral Fellowship; National Institute of Neurological Disorders and Stroke predoctoral National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); McKnight Foundation and National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank members of the Sabatini laboratory, A. Carter, W. Regehr and J. Cardin for helpful comments during the preparation of this manuscript. This work was funded by a Parkinson's Disease Foundation Postdoctoral Fellowship ( M. J. H.), a Quan Predoctoral Fellowship and National Institute of Neurological Disorders and Stroke predoctoral National Research Service Award (1 F31 NS049655-01, G. J. S.-L.) and grants from the McKnight Foundation and National Institute of Neurological Disorders and Stroke (NS046579, B. L. S.).	Adermark L, 2009, J NEUROSCI, V29, P1375, DOI 10.1523/JNEUROSCI.3842-08.2009; AKINS PT, 1990, NATURE, V344, P240, DOI 10.1038/344240a0; Apicella P, 2007, TRENDS NEUROSCI, V30, P299, DOI 10.1016/j.tins.2007.03.011; Aznavour N, 2003, J COMP NEUROL, V460, P280, DOI 10.1002/cne.10660; Barral J, 1999, BRAIN RES BULL, V49, P285, DOI 10.1016/S0361-9230(99)00061-1; Berton O, 2006, NAT REV NEUROSCI, V7, P137, DOI 10.1038/nrn1846; Bloodgood BL, 2007, NEURON, V53, P249, DOI 10.1016/j.neuron.2006.12.017; Bolam JP, 2000, J ANAT, V196, P527, DOI 10.1046/j.1469-7580.2000.19640527.x; Busetto G, 2008, J PHYSIOL-LONDON, V586, P1519, DOI 10.1113/jphysiol.2007.149336; Calabresi P, 1998, EUR J NEUROSCI, V10, P3020, DOI 10.1046/j.1460-9568.1998.00348.x; Calabresi P, 1998, EUR J NEUROSCI, V10, P2887, DOI 10.1111/j.1460-9568.1998.00294.x; Calabresi P, 2000, TRENDS NEUROSCI, V23, P120, DOI 10.1016/S0166-2236(99)01501-5; Carter AG, 2007, J NEUROSCI, V27, P8967, DOI 10.1523/JNEUROSCI.2798-07.2007; Carter AG, 2004, NEURON, V44, P483, DOI 10.1016/j.neuron.2004.10.013; Christie JM, 2006, J NEUROSCI, V26, P210, DOI 10.1523/JNEUROSCI.4307-05.2006; DELONG MR, 1990, TRENDS NEUROSCI, V13, P281, DOI 10.1016/0166-2236(90)90110-V; Foster KA, 2005, J NEUROSCI, V25, P11655, DOI 10.1523/JNEUROSCI.4029-05.2005; Foster KA, 2002, NEURON, V36, P1115, DOI 10.1016/S0896-6273(02)01106-6; Galarraga E, 1999, J NEUROSCI, V19, P3629, DOI 10.1523/jneurosci.19-09-03629.1999; Graybiel AM, 2000, CURR BIOL, V10, pR509, DOI 10.1016/S0960-9822(00)00593-5; Hasselmo ME, 2006, CURR OPIN NEUROBIOL, V16, P710, DOI 10.1016/j.conb.2006.09.002; Hernandez-Echeagaray E, 1998, NEUROPHARMACOLOGY, V37, P1493, DOI 10.1016/S0028-3908(98)00131-2; HOWE AR, 1995, J NEUROSCI, V15, P458; Iversen SD, 2007, TRENDS NEUROSCI, V30, P188, DOI 10.1016/j.tins.2007.03.002; IZZO PN, 1988, J COMP NEUROL, V269, P219, DOI 10.1002/cne.902690207; Jones BE, 2004, PROG BRAIN RES, V145, P157, DOI 10.1016/S0079-6123(03)45011-5; Kaneko S, 2000, SCIENCE, V289, P633, DOI 10.1126/science.289.5479.633; KEMP JM, 1971, PHILOS T R SOC B, V262, P429, DOI 10.1098/rstb.1971.0105; Kitabatake Y, 2003, P NATL ACAD SCI USA, V100, P7965, DOI 10.1073/pnas.1032899100; Liu JC, 2004, J NEUROSCI RES, V76, P315, DOI 10.1002/jnr.20079; Llinas R.R., 2004, SYNAPTIC ORG BRAIN; Lucas-Meunier E, 2003, PFLUG ARCH EUR J PHY, V446, P17, DOI 10.1007/s00424-002-0999-2; MALENKA RC, 1988, J NEUROSCI, V8, P3750; MCCORMICK DA, 1993, PROG BRAIN RES, V98, P303; Nimchinsky EA, 2004, J NEUROSCI, V24, P2054, DOI 10.1523/JNEUROSCI.5066-03.2004; Oertner TG, 2002, NAT NEUROSCI, V5, P657, DOI 10.1038/nn867; Olson PA, 2005, J NEUROSCI, V25, P1050, DOI 10.1523/JNEUROSCI.3327-04.2005; Pakhotin P, 2007, J NEUROSCI, V27, P391, DOI 10.1523/JNEUROSCI.3709-06.2007; Perez-Rosello T, 2005, J NEUROPHYSIOL, V93, P2507, DOI 10.1152/jn.00853.2004; Pisani A, 2007, TRENDS NEUROSCI, V30, P545, DOI 10.1016/j.tins.2007.07.008; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; Shen W, 2007, NAT NEUROSCI, V10, P1458, DOI 10.1038/nn1972; Shen WX, 2005, J NEUROSCI, V25, P7449, DOI 10.1523/JNEUROSCI.1381-05.2005; Singer JH, 2004, NAT NEUROSCI, V7, P826, DOI 10.1038/nn1280; STEVENS CF, 1995, NEURON, V14, P795, DOI 10.1016/0896-6273(95)90223-6; SUGITA S, 1991, P NATL ACAD SCI USA, V88, P2608, DOI 10.1073/pnas.88.6.2608; TONG G, 1994, NEURON, V12, P51, DOI 10.1016/0896-6273(94)90151-1; Wadiche JI, 2001, NEURON, V32, P301, DOI 10.1016/S0896-6273(01)00488-3; Wilson CJ, 1996, J NEUROSCI, V16, P2397; WILSON CJ, 1980, J COMP NEUROL, V194, P599, DOI 10.1002/cne.901940308	50	80	80	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2009	12	9					1121	U12		10.1038/nn.2368	http://dx.doi.org/10.1038/nn.2368			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	487ZD	19668198	Green Accepted			2022-12-24	WOS:000269317300013
J	Jeyifous, O; LWaites, C; Specht, CG; Fujisawa, S; Schubert, M; Lin, EI; Marshall, J; Aoki, C; de Silva, T; Montgomery, JM; Garner, CC; Green, WN				Jeyifous, Okunola; LWaites, Clarissa; Specht, Christian G.; Fujisawa, Sho; Schubert, Manja; Lin, Eric I.; Marshall, John; Aoki, Chiye; de Silva, Tharani; Montgomery, Johanna M.; Garner, Craig C.; Green, William N.			SAP97 and CASK mediate sorting of NMDA receptors through a previously unknown secretory pathway	NATURE NEUROSCIENCE			English	Article							SYNAPTIC VESICLE EXOCYTOSIS; HIPPOCAMPAL-NEURONS; AMPA RECEPTORS; ENDOPLASMIC-RETICULUM; EXCITATORY SYNAPSES; SURFACE EXPRESSION; GOLGI TRANSPORT; TRAFFICKING; COMPLEX; DENDRITES	Synaptic plasticity is dependent on the differential sorting, delivery and retention of neurotransmitter receptors, but the mechanisms underlying these processes are poorly understood. We found that differential sorting of glutamate receptor subtypes began in the endoplasmic reticulum of rat hippocampal neurons. As AMPA receptors (AMPARs) were trafficked to the plasma membrane via the conventional somatic Golgi network, NMDA receptors (NMDARs) were diverted from the somatic endoplasmic reticulum into a specialized endoplasmic reticulum subcompartment that bypasses somatic Golgi, merging instead with dendritic Golgi outposts. This endoplasmic reticulum subcompartment was composed of highly mobile vesicles containing the NMDAR subunits NR1 and NR2B, the microtubule-dependent motor protein KIF17, and the postsynaptic adaptor proteins CASK and SAP97. Our data demonstrate that the retention and trafficking of NMDARs in this endoplasmic reticulum subcompartment requires both CASK and SAP97. These findings indicate that NMDARs are sorted away from AMPARs via a non-conventional secretory pathway that utilizes dendritic Golgi outposts.	[Jeyifous, Okunola; LWaites, Clarissa; Specht, Christian G.; Garner, Craig C.] Stanford Univ, Dept Psychiat & Behav Sci, Palo Alto, CA 94304 USA; [Fujisawa, Sho; Aoki, Chiye] NYU, Ctr Neural Sci, New York, NY 10003 USA; [Schubert, Manja; de Silva, Tharani; Montgomery, Johanna M.] Univ Auckland, Dept Physiol, Auckland, New Zealand; [Lin, Eric I.; Green, William N.] Univ Chicago, Dept Neurobiol, Chicago, IL 60637 USA; [Marshall, John] Brown Univ, Dept Mol Pharmacol Physiol & Biotechnol, Providence, RI 02912 USA	Stanford University; New York University; University of Auckland; University of Chicago; Brown University	Garner, CC (corresponding author), Stanford Univ, Dept Psychiat & Behav Sci, Palo Alto, CA 94304 USA.	cgarner@stanford.edu; wgreen@midway.uchicago.edu	Aoki, Chiye/T-9405-2019; Schubert, Manja/AAJ-9575-2021	Aoki, Chiye/0000-0003-4010-9425; Schubert, Manja/0000-0003-3592-2470; Jeyifous, Okunola/0000-0002-4176-4694; Specht, Christian G/0000-0001-6038-7735; Garner, Craig/0000-0003-1970-5417	Nancy Pritzker Family and US National Institutes of Health [DA016758]; Deutsche Forschungsgemeinschaft; US National Institutes of Health [NS043782, DA13602, DA019695]; Albert & Ellen Grass Faculty; NATIONAL EYE INSTITUTE [R01EY013145, P30EY013079] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS043782, R56NS043782, R01NS041091] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA016758, R01DA013602, P01DA019695] Funding Source: NIH RePORTER	Nancy Pritzker Family and US National Institutes of Health; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Albert & Ellen Grass Faculty; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We would like to thank S. Leal-Ortiz for assistance with the generation of lentivirus and shRNA, L. A. Needleman and J. Marks. Also, thanks to B. Margolis for the CASK constructs, J. Lippincott-Schwartz for the Galtase-GFP construct and V. Bindokas for help and advice with imaging protocols. This work was supported by the Nancy Pritzker Family and US National Institutes of Health grant DA016758 to C. C. G., a Deutsche Forschungsgemeinschaft postdoctoral fellowship to C. G. S., The Marsden Fund (Royal Society of New Zealand) to J. M. M., US National Institutes of Health grants NS043782, DA13602 and DA019695 to W. N. G., and the Albert & Ellen Grass Faculty Award to W. N. G. and J. M.	BANKER G, 1988, NATURE, V336, P185, DOI 10.1038/336185a0; Bannai H, 2004, J CELL SCI, V117, P163, DOI 10.1242/jcs.00854; Bassand P, 1999, EUR J NEUROSCI, V11, P2031, DOI 10.1046/j.1460-9568.1999.00611.x; Bresler T, 2004, J NEUROSCI, V24, P1507, DOI 10.1523/JNEUROSCI.3819-03.2004; Butz S, 1998, CELL, V94, P773, DOI 10.1016/S0092-8674(00)81736-5; CLAUDIO T, 1992, METHOD ENZYMOL, V207, P391; Cognet L., 2006, SCI STKE, V2006, ppe13, DOI DOI 10.1126/STKE.3272006PE13; DASCHER C, 1994, J BIOL CHEM, V269, P1437; Dotti CG, 2003, NAT CELL BIOL, V5, P591, DOI 10.1038/ncb0703-591b; Dresbach T, 2006, J BIOL CHEM, V281, P6038, DOI 10.1074/jbc.M508784200; Dumas TC, 2005, PROG NEUROBIOL, V76, P189, DOI 10.1016/j.pneurobio.2005.08.002; Friedman HV, 2000, NEURON, V27, P57, DOI 10.1016/S0896-6273(00)00009-X; Fujisawa S, 2003, NEUROSCIENCE, V121, P51, DOI 10.1016/S0306-4522(03)00341-5; Gardoni F, 2003, J BIOL CHEM, V278, P44745, DOI 10.1074/jbc.M303576200; Greger IH, 2007, CURR OPIN NEUROBIOL, V17, P289, DOI 10.1016/j.conb.2007.04.007; Guillaud L, 2003, J NEUROSCI, V23, P131; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Horton AC, 2003, J NEUROSCI, V23, P6188; Jo K, 1999, J NEUROSCI, V19, P4189, DOI 10.1523/jneurosci.19-11-04189.1999; Kennedy MJ, 2006, ANNU REV NEUROSCI, V29, P325, DOI 10.1146/annurev.neuro.29.051605.112808; Leal-Ortiz S, 2008, J CELL BIOL, V181, P831, DOI 10.1083/jcb.200711167; Lee S, 2002, MOL CELL BIOL, V22, P1778, DOI 10.1128/MCB.22.6.1778-1791.2002; Leonard AS, 1998, J BIOL CHEM, V273, P19518, DOI 10.1074/jbc.273.31.19518; Leonoudakis D, 2004, J BIOL CHEM, V279, P19051, DOI 10.1074/jbc.M400284200; Lise MF, 2006, J BIOL CHEM, V281, P3669, DOI 10.1074/jbc.M511725200; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Mauceri D, 2007, J NEUROCHEM, V100, P1032, DOI 10.1111/j.1471-4159.2006.04267.x; Mironov SL, 2006, J CELL SCI, V119, P4926, DOI 10.1242/jcs.03254; Montgomery JM, 2004, CELL MOL LIFE SCI, V61, P911, DOI 10.1007/s00018-003-3364-5; Nakagawa T, 2004, NEURON, V44, P453, DOI 10.1016/j.neuron.2004.10.012; Park M, 2004, SCIENCE, V305, P1972, DOI 10.1126/science.1102026; Perestenko PV, 2003, J BIOL CHEM, V278, P43525, DOI 10.1074/jbc.M306206200; Pfeffer S, 2003, CELL, V112, P507, DOI 10.1016/S0092-8674(03)00118-1; PHEND KD, 1995, J HISTOCHEM CYTOCHEM, V43, P283, DOI 10.1177/43.3.7532656; Pierce JP, 2001, CURR BIOL, V11, P351, DOI 10.1016/S0960-9822(01)00077-X; Rao A, 1998, J NEUROSCI, V18, P1217; Sans N, 2005, NAT CELL BIOL, V7, P1179, DOI 10.1038/ncb1325; Sans N, 2003, NAT CELL BIOL, V5, P520, DOI 10.1038/ncb990; Sans N, 2001, J NEUROSCI, V21, P7506, DOI 10.1523/JNEUROSCI.21-19-07506.2001; Schuman EM, 2006, J NEUROSCI, V26, P7143, DOI 10.1523/JNEUROSCI.1796-06.2006; Setou M, 2002, NATURE, V417, P83, DOI 10.1038/nature743; Setou M, 2000, SCIENCE, V288, P1796, DOI 10.1126/science.288.5472.1796; Sheng M, 2007, ANNU REV BIOCHEM, V76, P823, DOI 10.1146/annurev.biochem.76.060805.160029; Tang BL, 2001, J NEUROCHEM, V79, P923, DOI 10.1046/j.1471-4159.2001.00674.x; Tiffany AM, 2000, J CELL BIOL, V148, P147, DOI 10.1083/jcb.148.1.147; Washbourne P, 2002, NAT NEUROSCI, V5, P751, DOI 10.1038/nn883; Wu HJ, 1998, J CELL SCI, V111, P2365; Wyszynski M, 2002, NEURON, V34, P39, DOI 10.1016/S0896-6273(02)00640-2; Yudowski GA, 2007, J NEUROSCI, V27, P11112, DOI 10.1523/JNEUROSCI.2465-07.2007	50	157	159	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2009	12	8					1011	U81		10.1038/nn.2362	http://dx.doi.org/10.1038/nn.2362			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	475WS	19620977	Green Accepted			2022-12-24	WOS:000268396300015
J	Staresina, BP; Davachi, L				Staresina, Bernhard P.; Davachi, Lila			Mind the Gap: Binding Experiences across Space and Time in the Human Hippocampus	NEURON			English	Article							MEDIAL TEMPORAL-LOBE; PERIRHINAL CORTEX; ASSOCIATIVE RECOGNITION; EPISODIC MEMORY; ITEM; FAMILIARITY; ACTIVATION; RETRIEVAL; REPRESENTATIONS; RECOLLECTION	A fundamental goal in memory research is to understand what class of learning problem the hippocampus is uniquely designed to solve. While much controversy surrounds the particular types of memories the hippocampus is thought to support, one hypothesized function possibly linking divergent frameworks is the capacity to bind mnemonic representations across spatial and temporal gaps in our experience. In our current functional magnetic resonance imaging (fMRI) study, we systematically controlled the extent to which a target and an event detail have to be integrated across spatiotemporal discontiguities during associative memory formation. Although the encoding task, the type of association, and subsequent memory performance were held constant, engagement of the hippocampus during successful associative binding was directly modulated by increases in spatial and temporal discontiguities across episodic elements. These results suggest that a core mnemonic function of the hippocampus is to bridge representational gaps in our experience.	[Staresina, Bernhard P.; Davachi, Lila] NYU, Dept Psychol, New York, NY 10003 USA; [Davachi, Lila] NYU, Ctr Neural Sci, New York, NY 10003 USA	New York University; New York University	Staresina, BP (corresponding author), NYU, Dept Psychol, 6 Washington Pl, New York, NY 10003 USA.	bernhard.staresina@nyu.edu; lila.davachi@nyu.edu	Staresina, Bernhard P/N-4496-2014	Staresina, Bernhard P/0000-0002-0558-9745; Davachi, Lila/0000-0003-4317-0889	NIMH [MH074692]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH074692] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was funded by NIMH MH074692 to L.D. We thank James C. Gray for help with data acquisition and analysis.	Aggleton JP, 2005, Q J EXP PSYCHOL-B, V58, P218, DOI 10.1080/02724990444000131; Agster KL, 2002, J NEUROSCI, V22, P5760; Bangasser DA, 2006, J NEUROSCI, V26, P8702, DOI 10.1523/JNEUROSCI.1742-06.2006; Bird CM, 2008, NAT REV NEUROSCI, V9, P182, DOI 10.1038/nrn2335; Brett M., 2002, NEUROIMAGE, V16, P1140, DOI DOI 10.1016/S1053-8119(02)90013-3; Brown MW, 2001, NAT REV NEUROSCI, V2, P51, DOI 10.1038/35049064; Buchel C, 1998, NEUROIMAGE, V8, P140, DOI 10.1006/nimg.1998.0351; Cansino S, 2002, CEREB CORTEX, V12, P1048, DOI 10.1093/cercor/12.10.1048; Clark RE, 1998, SCIENCE, V280, P77, DOI 10.1126/science.280.5360.77; Cohen N. J., 1993, MEMORY AMNESIA HIPPO; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; D'Esposito M, 1998, COGNITIVE BRAIN RES, V7, P1, DOI 10.1016/S0926-6410(98)00004-4; Dale AM, 1999, HUM BRAIN MAPP, V8, P109, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<109::AID-HBM7>3.0.CO;2-W; Davachi L, 2003, P NATL ACAD SCI USA, V100, P2157, DOI 10.1073/pnas.0337195100; Davachi L, 2006, CURR OPIN NEUROBIOL, V16, P693, DOI 10.1016/j.conb.2006.10.012; DESPOSITO M, 1995, NATURE, V378, P279, DOI 10.1038/378279a0; Diana RA, 2007, TRENDS COGN SCI, V11, P379, DOI 10.1016/j.tics.2007.08.001; Dobbins IG, 2003, NEUROPSYCHOLOGIA, V41, P318, DOI 10.1016/S0028-3932(02)00164-1; Eichenbaum H, 2004, NEURON, V44, P109, DOI 10.1016/j.neuron.2004.08.028; Eichenbaum H, 2007, ANNU REV NEUROSCI, V30, P123, DOI 10.1146/annurev.neuro.30.051606.094328; EICHENBAUM H, 1992, BEHAV NEURAL BIOL, V57, P2, DOI 10.1016/0163-1047(92)90724-I; EICHENBAUM H, 1990, J NEUROSCI, V10, P3531; Eldridge LL, 2005, J NEUROSCI, V25, P3280, DOI 10.1523/JNEUROSCI.3420-04.2005; Fortin NJ, 2002, NAT NEUROSCI, V5, P458, DOI 10.1038/nn834; Giovanello KS, 2006, NEUROPSYCHOLOGIA, V44, P1859, DOI 10.1016/j.neuropsychologia.2006.03.004; Heckers S, 2004, HIPPOCAMPUS, V14, P153, DOI 10.1002/hipo.10189; Jackson O, 2004, NEUROIMAGE, V21, P456, DOI 10.1016/j.neuroimage.2003.09.050; JACOBY LL, 1991, J MEM LANG, V30, P513, DOI 10.1016/0749-596X(91)90025-F; Kensinger EA, 2006, J NEUROSCI, V26, P2564, DOI 10.1523/JNEUROSCI.5241-05.2006; Kirwan CB, 2004, HIPPOCAMPUS, V14, P919, DOI 10.1002/hipo.20014; Kumaran D, 2006, NEURON, V49, P617, DOI 10.1016/j.neuron.2005.12.024; LEVY WB, 1983, NEUROSCIENCE, V8, P791, DOI 10.1016/0306-4522(83)90010-6; Lisman JE, 1999, NEURON, V22, P233, DOI 10.1016/S0896-6273(00)81085-5; MANDLER G, 1980, PSYCHOL REV, V87, P252, DOI 10.1037/0033-295X.87.3.252; MEUNIER M, 1993, J NEUROSCI, V13, P5418, DOI 10.1523/JNEUROSCI.13-12-05418.1993; Murray EA, 1999, TRENDS COGN SCI, V3, P142, DOI 10.1016/S1364-6613(99)01303-0; Nichols T, 2005, NEUROIMAGE, V25, P653, DOI 10.1016/j.neuroimage.2004.12.005; O'Reilly RC, 2001, PSYCHOL REV, V108, P311, DOI 10.1037//0033-295X.108.2.311; OKEEFE J, 1980, PHYSIOL PSYCHOL, V8, P229; Preston AR, 2004, HIPPOCAMPUS, V14, P148, DOI 10.1002/hipo.20009; Qin SZ, 2007, NEUROIMAGE, V38, P212, DOI 10.1016/j.neuroimage.2007.07.020; Quamme JR, 2007, HIPPOCAMPUS, V17, P192, DOI 10.1002/hipo.20257; Ranganath C, 2004, NEUROPSYCHOLOGIA, V42, P2, DOI 10.1016/j.neuropsychologia.2003.07.006; Ravizza SM, 2004, NEUROIMAGE, V22, P562, DOI 10.1016/j.neuroimage.2004.01.039; Reber PJ, 2002, J NEUROSCI, V22, P9541; Shohamy D, 2008, NEURON, V60, P378, DOI 10.1016/j.neuron.2008.09.023; Smith EE, 1999, SCIENCE, V283, P1657, DOI 10.1126/science.283.5408.1657; SOLOMON PR, 1986, BEHAV NEUROSCI, V100, P729, DOI 10.1037/0735-7044.100.5.729; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; Staresina BP, 2008, J COGNITIVE NEUROSCI, V20, P1478, DOI 10.1162/jocn.2008.20104; Staresina BP, 2006, J NEUROSCI, V26, P9162, DOI 10.1523/JNEUROSCI.2877-06.2006; Staresina BP, 2009, CEREB CORTEX, V19, P1198, DOI 10.1093/cercor/bhn165; Stark CEL, 2001, P NATL ACAD SCI USA, V98, P12760, DOI 10.1073/pnas.221462998; Tendolkar I, 2007, BRAIN RES, V1142, P159, DOI 10.1016/j.brainres.2007.01.040; TULVING E, 1985, CAN PSYCHOL, V26, P1, DOI 10.1037/h0080017; Wager TD, 2003, COGN AFFECT BEHAV NE, V3, P255, DOI 10.3758/CABN.3.4.255; Wallenstein GV, 1998, TRENDS NEUROSCI, V21, P317, DOI 10.1016/S0166-2236(97)01220-4	57	182	185	1	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 30	2009	63	2					267	276		10.1016/j.neuron.2009.06.024	http://dx.doi.org/10.1016/j.neuron.2009.06.024			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	479IS	19640484	Green Accepted, Bronze			2022-12-24	WOS:000268653500014
J	Liao, LJ; McClatchy, DB; Yates, JR				Liao, Lujian; McClatchy, Daniel B.; Yates, John R.			Shotgun Proteomics in Neuroscience	NEURON			English	Review							INTEGRAL MEMBRANE-PROTEINS; TANDEM MASS-SPECTROMETRY; IN-GEL DIGESTION; POSTSYNAPTIC DENSITY FRACTION; LOW ABUNDANCE PROTEINS; LIQUID-CHROMATOGRAPHY; PHOSPHORYLATED PEPTIDES; QUANTITATIVE-ANALYSIS; PLASMA-MEMBRANE; ION-TRAP	Mass spectrometry-based proteomics is increasingly used to address basic and clinical questions in biomedical research through studies of differential protein expression, protein-protein interactions, and posttranslational modifications. The complex structural and functional organization of the human brain warrants the application of high-throughput, systematic approaches to understand the functional alterations under normal physiological conditions and the perturbations of neurological diseases. This primer focuses on shotgun-proteomics-based tandem mass spectrometry for the identification of proteins in a complex mixture. It describes the basic concepts of protein differential expression analysis and posttranslational modification analysis and discusses several strategies to improve the coverage of the proteome.	[Liao, Lujian; McClatchy, Daniel B.; Yates, John R.] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA	Scripps Research Institute	Yates, JR (corresponding author), Scripps Res Inst, Dept Physiol Chem, 10550 N Torrey Pines Rd,SR11, La Jolla, CA 92037 USA.	jyates@scripps.edu	Liao, Lujian/G-5976-2010	Lipton, Stuart/0000-0002-3490-1259	NIH [5R01 MH067880, P41 RR011823, P30 NS057096]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR011823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067880] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS057096] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors would like to acknowledge funding support from NIH grants 5R01 MH067880, P41 RR011823, and P30 NS057096.	Aguilar MI, 1996, METHOD ENZYMOL, V270, P3; America AHP, 2008, PROTEOMICS, V8, P731, DOI 10.1002/pmic.200700694; Anderle M, 2004, BIOINFORMATICS, V20, P3575, DOI 10.1093/bioinformatics/bth446; Anderson L, 2006, MOL CELL PROTEOMICS, V5, P573, DOI 10.1074/mcp.M500331-MCP200; ANDERSSON L, 1986, ANAL BIOCHEM, V154, P250, DOI 10.1016/0003-2697(86)90523-3; Ballif BA, 2004, MOL CELL PROTEOMICS, V3, P1093, DOI 10.1074/mcp.M400085-MCP200; Bantscheff M, 2007, ANAL BIOANAL CHEM, V389, P1017, DOI 10.1007/s00216-007-1486-6; Beausoleil SA, 2004, P NATL ACAD SCI USA, V101, P12130, DOI 10.1073/pnas.0404720101; Bennett EJ, 2007, NATURE, V448, P704, DOI 10.1038/nature06022; Blagoev B, 2003, NAT BIOTECHNOL, V21, P315, DOI 10.1038/nbt790; Blonder J, 2002, J PROTEOME RES, V1, P351, DOI 10.1021/pr0255248; Bodenmiller B, 2007, NAT METHODS, V4, P231, DOI 10.1038/nmeth1005; Bogdanov B, 2005, MASS SPECTROM REV, V24, P168, DOI 10.1002/mas.20015; BOSSERHOFF A, 1989, J CHROMATOGR, V473, P71, DOI 10.1016/S0021-9673(00)91291-3; Breuker K, 2008, J AM SOC MASS SPECTR, V19, P1045, DOI 10.1016/j.jasms.2008.05.013; Brittain SM, 2005, NAT BIOTECHNOL, V23, P463, DOI 10.1038/nbt1076; Bronstrup M, 2004, EXPERT REV PROTEOMIC, V1, P503, DOI 10.1586/14789450.1.4.503; Cagney G, 2002, NAT BIOTECHNOL, V20, P163, DOI 10.1038/nbt0202-163; Cantin GT, 2007, ANAL CHEM, V79, P4666, DOI 10.1021/ac0618730; Cao R, 2006, J PROTEOME RES, V5, P634, DOI 10.1021/pr050387a; Chen CT, 2005, ANAL CHEM, V77, P5912, DOI 10.1021/ac050831t; Chen EI, 2008, ANAL CHEM, V80, P8694, DOI 10.1021/ac800606w; Chen EI, 2007, J PROTEOME RES, V6, P2529, DOI 10.1021/pr060682a; Chen L, 2005, NAT NEUROSCI, V8, P657, DOI 10.1038/nn1443; Chen N, 2008, J BIOL CHEM, V283, P20841, DOI 10.1074/jbc.M802314200; Chen X, 2000, ANAL CHEM, V72, P1134, DOI 10.1021/ac9911600; Choe L, 2007, PROTEOMICS, V7, P3651, DOI 10.1002/pmic.200700316; Chu DS, 2006, NATURE, V443, P101, DOI 10.1038/nature05050; Colinge J, 2005, ANAL CHEM, V77, P596, DOI 10.1021/ac0488513; Colinge J, 2003, PROTEOMICS, V3, P1454, DOI 10.1002/pmic.200300485; Collins MO, 2006, J NEUROCHEM, V97, P16, DOI 10.1111/j.1471-4159.2005.03507.x; Conrads TP, 2001, ANAL CHEM, V73, P2132, DOI 10.1021/ac001487x; Cornett DS, 2007, NAT METHODS, V4, P828, DOI 10.1038/NMETH1094; Corthals GL, 2000, ELECTROPHORESIS, V21, P1104, DOI 10.1002/(SICI)1522-2683(20000401)21:6<1104::AID-ELPS1104>3.3.CO;2-3; Craig R, 2004, BIOINFORMATICS, V20, P1466, DOI 10.1093/bioinformatics/bth092; Dahlquist KD, 2002, NAT GENET, V31, P19, DOI 10.1038/ng0502-19; de Godoy LMF, 2008, NATURE, V455, P1251, DOI 10.1038/nature07341; de Hoog CL, 2004, CELL, V117, P649, DOI 10.1016/S0092-8674(04)00456-8; DeGnore JP, 1998, J AM SOC MASS SPECTR, V9, P1175, DOI 10.1016/S1044-0305(98)00088-9; Delgado JY, 2007, J NEUROSCI, V27, P13210, DOI 10.1523/JNEUROSCI.3056-07.2007; Domon B, 2006, SCIENCE, V312, P212, DOI 10.1126/science.1124619; Elias JE, 2005, NAT METHODS, V2, P667, DOI 10.1038/NMETH785; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Elvira G, 2006, MOL CELL PROTEOMICS, V5, P635, DOI 10.1074/mcp.M500255-MCP200; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Fischer F, 2006, MOL CELL PROTEOMICS, V5, P444, DOI 10.1074/mcp.M500234-MCP200; Fountoulakis M, 1999, J CHROMATOGR A, V833, P157, DOI 10.1016/S0021-9673(98)00929-7; Fountoulakis M, 1999, ELECTROPHORESIS, V20, P2181, DOI 10.1002/(SICI)1522-2683(19990801)20:11<2181::AID-ELPS2181>3.0.CO;2-Q; Gao J, 2005, J AM SOC MASS SPECTR, V16, P1231, DOI 10.1016/j.jasms.2004.12.002; Geer LY, 2004, J PROTEOME RES, V3, P958, DOI 10.1021/pr0499491; Geschwind DH, 2003, NEURON, V40, P457, DOI 10.1016/S0896-6273(03)00681-0; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; GIDDINGS JC, 1984, ANAL CHEM, V56, P1258, DOI 10.1021/ac00276a003; Gilar M, 2005, ANAL CHEM, V77, P6426, DOI 10.1021/ac050923i; Gottschalk A, 2005, EMBO J, V24, P2566, DOI 10.1038/sj.emboj.7600741; Granvogl B, 2007, ANAL BIOANAL CHEM, V389, P991, DOI 10.1007/s00216-007-1451-4; Griffin TJ, 2007, J PROTEOME RES, V6, P4200, DOI 10.1021/pr070291b; Gygi SP, 2000, P NATL ACAD SCI USA, V97, P9390, DOI 10.1073/pnas.160270797; Gygi SP, 1999, NAT BIOTECHNOL, V17, P994, DOI 10.1038/13690; Han GH, 2008, PROTEOMICS, V8, P1346, DOI 10.1002/pmic.200700884; Hanger DP, 2007, J BIOL CHEM, V282, P23645, DOI 10.1074/jbc.M703269200; Hanke S, 2008, J PROTEOME RES, V7, P1118, DOI 10.1021/pr7007175; Hervey WJ, 2007, J PROTEOME RES, V6, P3054, DOI 10.1021/pr070159b; Hey Julie, 2008, V424, P225, DOI 10.1007/978-1-60327-064-9_19; Higgs RE, 2005, J PROTEOME RES, V4, P1442, DOI 10.1021/pr050109b; HOWELL KE, 1982, J CELL BIOL, V92, P822, DOI 10.1083/jcb.92.3.822; Hu QZ, 2005, J MASS SPECTROM, V40, P430, DOI 10.1002/jms.856; Ishihama Y, 2005, NAT BIOTECHNOL, V23, P617, DOI 10.1038/nbt1086; Jalili PR, 2008, J AM SOC MASS SPECTR, V19, P741, DOI 10.1016/j.jasms.2008.02.004; Jordan BA, 2004, MOL CELL PROTEOMICS, V3, P857, DOI 10.1074/mcp.M400045-MCP200; Kanai Y, 2004, NEURON, V43, P513, DOI 10.1016/j.neuron.2004.07.022; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kang RJ, 2008, NATURE, V456, P904, DOI 10.1038/nature07605; Kapp EA, 2005, PROTEOMICS, V5, P3475, DOI 10.1002/pmic.200500126; Keshishian H, 2007, MOL CELL PROTEOMICS, V6, P2212, DOI 10.1074/mcp.M700354-MCP200; Khidekel N, 2007, NAT CHEM BIOL, V3, P339, DOI 10.1038/nchembio881; Klemm C, 2004, RAPID COMMUN MASS SP, V18, P2697, DOI 10.1002/rcm.1676; Krijgsveld J, 2003, NAT BIOTECHNOL, V21, P927, DOI 10.1038/nbt848; Kruger M, 2008, CELL, V134, P353, DOI 10.1016/j.cell.2008.05.033; Kweon HK, 2006, ANAL CHEM, V78, P1743, DOI 10.1021/ac0522355; Larsen MR, 2005, MOL CELL PROTEOMICS, V4, P873, DOI 10.1074/mcp.T500007-MCP200; Lessard J, 2007, NEURON, V55, P201, DOI 10.1016/j.neuron.2007.06.019; Li KW, 2004, J BIOL CHEM, V279, P987, DOI 10.1074/jbc.M303116200; Liao LJ, 2008, J PROTEOME RES, V7, P4743, DOI 10.1021/pr8003198; Liao LJ, 2008, P NATL ACAD SCI USA, V105, P15281, DOI 10.1073/pnas.0804678105; Lim H, 2003, J AM SOC MASS SPECTR, V14, P957, DOI 10.1016/S1044-0305(03)00144-2; Lindstrom DL, 2003, MOL CELL BIOL, V23, P1368, DOI 10.1128/MCB.23.4.1368-1378.2003; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; LOO RRO, 1994, PROTEIN SCI, V3, P1975, DOI 10.1002/pro.5560031109; Lu BW, 2007, ANAL CHEM, V79, P1301, DOI 10.1021/ac061334v; Lunn ML, 2007, NAT NEUROSCI, V10, P1249, DOI 10.1038/nn1953; Mansouri FA, 1997, BRAIN RES, V769, P119, DOI 10.1016/S0006-8993(97)00608-2; McClatchy DB, 2007, GENOME RES, V17, P1378, DOI 10.1101/gr.6375007; Molloy MP, 2000, ANAL BIOCHEM, V280, P1, DOI 10.1006/abio.2000.4514; Moon JI, 1999, NEUROREPORT, V10, P443, DOI 10.1097/00001756-199902250-00001; Motoyama A, 2007, ANAL CHEM, V79, P3623, DOI 10.1021/ac062292d; Motoyama A, 2006, ANAL CHEM, V78, P5109, DOI 10.1021/ac060354u; Munton RP, 2007, MOL CELL PROTEOMICS, V6, P283, DOI 10.1074/mcp.M600046-MCP200; Nesvizhskii AI, 2007, NAT METHODS, V4, P787, DOI 10.1038/NMETH1088; Nielsen PA, 2005, MOL CELL PROTEOMICS, V4, P402, DOI 10.1074/mcp.T500002-MCP200; Oda Y, 1999, P NATL ACAD SCI USA, V96, P6591, DOI 10.1073/pnas.96.12.6591; Oh-Ishi M, 2000, ELECTROPHORESIS, V21, P1653, DOI 10.1002/(SICI)1522-2683(20000501)21:9<1653::AID-ELPS1653>3.0.CO;2-9; Old WM, 2005, MOL CELL PROTEOMICS, V4, P1487, DOI 10.1074/mcp.M500084-MCP200; Olsen JV, 2007, NAT METHODS, V4, P709, DOI 10.1038/NMETH1060; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Panchaud A, 2008, J PROTEOMICS, V71, P19, DOI 10.1016/j.jprot.2007.12.001; Paradela A, 2008, J PROTEOME RES, V7, P1809, DOI 10.1021/pr7006544; Park KS, 2006, SCIENCE, V313, P976, DOI 10.1126/science.1124254; Payne AH, 2005, METHOD ENZYMOL, V402, P109, DOI 10.1016/S0076-6879(05)02004-5; Peng JM, 2003, J PROTEOME RES, V2, P43, DOI 10.1021/pr025556v; Peng JM, 2004, J BIOL CHEM, V279, P21003, DOI 10.1074/jbc.M400103200; Peng JM, 2008, BMB REP, V41, P177, DOI 10.5483/BMBRep.2008.41.3.177; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Petyuk VA, 2007, GENOME RES, V17, P328, DOI 10.1101/gr.5799207; Piomelli D, 2007, NAT REV NEUROSCI, V8, P743, DOI 10.1038/nrn2233; Pu L, 2002, J NEUROSCI, V22, P1914, DOI 10.1523/JNEUROSCI.22-05-01914.2002; Rahbar AM, 2005, J PROTEOME RES, V4, P2148, DOI 10.1021/pr0502370; RAJAGOPALAN K, 1961, J BIOL CHEM, V236, P1059; RANSONE LJ, 1995, METHOD ENZYMOL, V254, P491; Resing KA, 2004, ANAL CHEM, V76, P3556, DOI 10.1021/ac035229m; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Rush J, 2005, NAT BIOTECHNOL, V23, P94, DOI 10.1038/nbt1046; Russell WK, 2001, ANAL CHEM, V73, P2682, DOI 10.1021/ac001332p; Sadygov RG, 2004, NAT METHODS, V1, P195, DOI 10.1038/NMETH725; Sandra K, 2008, J CHROMATOGR B, V866, P48, DOI 10.1016/j.jchromb.2007.10.034; Santoni V, 2000, ELECTROPHORESIS, V21, P1054, DOI 10.1002/(SICI)1522-2683(20000401)21:6<1054::AID-ELPS1054>3.3.CO;2-#; Schindler J, 2006, MOL CELL PROTEOMICS, V5, P390, DOI 10.1074/mcp.T500017-MCP200; Schirmer EC, 2003, SCIENCE, V301, P1380, DOI 10.1126/science.1088176; Schmidt A, 2005, PROTEOMICS, V5, P4, DOI 10.1002/pmic.200400873; Schroeder MJ, 2005, J PROTEOME RES, V4, P1832, DOI 10.1021/pr0502020; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shen YF, 2002, ANAL CHEM, V74, P4235, DOI 10.1021/ac0202280; Shevchenko A, 2001, ANAL BIOCHEM, V296, P279, DOI 10.1006/abio.2001.5321; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060; Shin JB, 2007, NEURON, V53, P371, DOI 10.1016/j.neuron.2006.12.021; Siuti N, 2007, NAT METHODS, V4, P817, DOI 10.1038/NMETH1097; Speers AE, 2007, CHEM REV, V107, P3687, DOI 10.1021/cr068286z; Speers AE, 2007, ANAL CHEM, V79, P4613, DOI 10.1021/ac0700225; Spellman DS, 2008, MOL CELL PROTEOMICS, V7, P1067, DOI 10.1074/mcp.M700387-MCP200; Steen H, 2001, ANAL CHEM, V73, P1440, DOI 10.1021/ac001318c; Steward O, 2003, NEURON, V40, P347, DOI 10.1016/S0896-6273(03)00635-4; STOLZ DB, 1992, J CELL SCI, V103, P39; Strader MB, 2006, ANAL CHEM, V78, P125, DOI 10.1021/ac051348l; Sutton MA, 2005, J NEUROBIOL, V64, P116, DOI 10.1002/neu.20152; Syka JEP, 2004, J PROTEOME RES, V3, P621, DOI 10.1021/pr0499794; Syka JEP, 2004, P NATL ACAD SCI USA, V101, P9528, DOI 10.1073/pnas.0402700101; Tan F, 2008, J PROTEOME RES, V7, P1078, DOI 10.1021/pr700655d; Tannu NS, 2006, PROG BRAIN RES, V158, P41, DOI 10.1016/S0079-6123(06)58003-3; Thiede B, 2005, METHODS, V35, P237, DOI 10.1016/j.ymeth.2004.08.015; Trinidad JC, 2008, MOL CELL PROTEOMICS, V7, P684, DOI 10.1074/mcp.M700170-MCP200; Valera AG, 2005, NEUROSCIENTIST, V11, P583, DOI 10.1177/1073858405280639; Van den Oever MC, 2008, NAT NEUROSCI, V11, P1053, DOI 10.1038/nn.2165; Villen J, 2007, P NATL ACAD SCI USA, V104, P1488, DOI 10.1073/pnas.0609836104; Vissers JPC, 1996, J MASS SPECTROM, V31, P1021, DOI 10.1002/(SICI)1096-9888(199609)31:9<1021::AID-JMS384>3.3.CO;2-7; Walikonis RS, 2000, J NEUROSCI, V20, P4069; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Want EJ, 2007, J PROTEOME RES, V6, P459, DOI 10.1021/pr060505+; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Wells L, 2002, MOL CELL PROTEOMICS, V1, P791, DOI 10.1074/mcp.M200048-MCP200; Wilkins MR, 1996, BIO-TECHNOL, V14, P61, DOI 10.1038/nbt0196-61; Willis D, 2005, J NEUROSCI, V25, P778, DOI 10.1523/JNEUROSCI.4235-04.2005; Wisztorski M, 2008, DEV NEUROBIOL, V68, P845, DOI 10.1002/dneu.20623; Wolters DA, 2001, ANAL CHEM, V73, P5683, DOI 10.1021/ac010617e; Wu CC, 2004, ANAL CHEM, V76, P4951, DOI 10.1021/ac049208j; Wu CC, 2003, NAT BIOTECHNOL, V21, P532, DOI 10.1038/nbt819; Wu LF, 2006, EXPERT REV PROTEOMIC, V3, P611, DOI 10.1586/14789450.3.6.611; Xu T, 2006, MOL CELL PROTEOMICS, V5, pS174; Yao XD, 2001, ANAL CHEM, V73, P2836, DOI 10.1021/ac001404c; Yates JR, 2006, ANAL CHEM, V78, P493, DOI 10.1021/ac0514624; Yates JR, 1997, J PROTEIN CHEM, V16, P495; Yoshimura Y, 2004, J NEUROCHEM, V88, P759, DOI 10.1046/j.1471-4159.2003.02136.x; Zaia J, 2008, CHEM BIOL, V15, P881, DOI 10.1016/j.chembiol.2008.07.016; Zhang XH, 2002, NEURON, V36, P675, DOI 10.1016/S0896-6273(02)01023-1; Zhou Y, 2008, J PROTEOME RES, V7, P2507, DOI 10.1021/pr800108k; Zubarev RA, 2000, ANAL CHEM, V72, P563, DOI 10.1021/ac990811p	178	41	41	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 16	2009	63	1					12	26		10.1016/j.neuron.2009.06.011	http://dx.doi.org/10.1016/j.neuron.2009.06.011			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	473EX	19607789	Green Accepted, Bronze			2022-12-24	WOS:000268189900005
J	Andreassi, C; Zimmermann, C; Mitter, R; Fusco, S; Devita, S; Saiardi, A; Riccio, A				Andreassi, Catia; Zimmermann, Carola; Mitter, Richard; Fusco, Salvatore; Devita, Serena; Saiardi, Adolfo; Riccio, Antonella			An NGF-responsive element targets myo-inositol monophosphatase-1 mRNA to sympathetic neuron axons	NATURE NEUROSCIENCE			English	Article							LOCAL PROTEIN-SYNTHESIS; TRANSCRIPTION FACTOR; GROWTH CONES; TRANSLATION; ACTIN; LOCALIZATION; LITHIUM; SIGNAL; CREB; MECHANISM	mRNA localization is an evolutionary conserved mechanism that underlies the establishment of cellular polarity and specialized cell functions. To identify mRNAs localized in subcellular compartments of developing neurons, we took an original approach that combines compartmentalized cultures of rat sympathetic neurons and sequential analysis of gene expression (SAGE). Unexpectedly, the most abundant transcript in axons was mRNA for myo-inositol monophosphatase-1 (Impa1), a key enzyme that regulates the inositol cycle and the main target of lithium in neurons. A novel localization element within the 3' untranslated region of Impa1 mRNA specifically targeted Impa1 transcript to sympathetic neuron axons and regulated local IMPA1 translation in response to nerve growth factor (NGF). Selective silencing of IMPA1 synthesis in axons decreased nuclear CREB activation and induced axonal degeneration. These results provide insights into mRNA transport in axons and reveal a new NGF-responsive localization element that directs the targeting and local translation of an axonal transcript.	[Andreassi, Catia; Zimmermann, Carola; Fusco, Salvatore; Devita, Serena; Saiardi, Adolfo; Riccio, Antonella] UCL, MRC, Lab Mol & Cell Biol, London, England; [Andreassi, Catia; Zimmermann, Carola; Fusco, Salvatore; Devita, Serena; Riccio, Antonella] UCL, Dept Neurosci Physiol & Pharmacol, London, England; [Mitter, Richard] Canc Res UK, London Res Inst, London, England; [Saiardi, Adolfo] UCL, MRC, Cell Biol Unit, London, England	University of London; University College London; University of London; University College London; Cancer Research UK; University of London; University College London	Riccio, A (corresponding author), UCL, MRC, Lab Mol & Cell Biol, London, England.	a.riccio@ucl.ac.uk	Fusco, Salvatore/AAA-6651-2021; Fusco, Salvatore/K-7867-2018	Fusco, Salvatore/0000-0003-3294-0016; Fusco, Salvatore/0000-0003-3294-0016; Mitter, Richard/0000-0002-1279-3760	UK Medical Research Council (MRC) [G0500/792, G117/533, G0802010]; European Research Council [MIRG-CT-2005-016501]; Medical Research Council [MC_U122680443, G120/934, G0802010] Funding Source: researchfish; MRC [MC_U122680443, G120/934, G0802010] Funding Source: UKRI	UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Research Council(European Research Council (ERC)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We are grateful to R. Kuruvilla, A. Lloyd and M. Raff for insightful comments and to all members of the Riccio laboratory for helpful discussion. CamKII-alpha-5'<INF>myrd</INF>GFP3' expression vector was kindly provided by E. Schuman (California Institute of Technology). We thank A. Garedew for helping with the SAGE assay and statistical analysis. We also thank A. Vaughan for help with microscopy analysis. This work was supported by the UK Medical Research Council (MRC; Research Grant G0500/792) and the European Research Council (Marie Curie International Reintegration Grant MIRG-CT-2005-016501). A. R. is a recipient of a MRC Career Development Award (G117/533) and an MRC Senior Non-Clinical Fellowship (G0802010).	Aakalu G, 2001, NEURON, V30, P489, DOI 10.1016/S0896-6273(01)00295-1; An JJ, 2008, CELL, V134, P175, DOI 10.1016/j.cell.2008.05.045; Andreassi C, 2009, TRENDS CELL BIOL, V19, P465, DOI 10.1016/j.tcb.2009.06.001; Azevedo C, 2006, NAT PROTOC, V1, P2416, DOI 10.1038/nprot.2006.337; Bassell GJ, 1998, J NEUROSCI, V18, P251; Baugh LR, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.5.e29; BERRIDGE MJ, 1989, CELL, V59, P411, DOI 10.1016/0092-8674(89)90026-3; Brittis PA, 2002, CELL, V110, P223, DOI 10.1016/S0092-8674(02)00813-9; Campbell DS, 2001, NEURON, V32, P1013, DOI 10.1016/S0896-6273(01)00551-7; CAMPENOT RB, 1977, P NATL ACAD SCI USA, V74, P4516, DOI 10.1073/pnas.74.10.4516; Chau JFL, 2005, FASEB J, V19, P1887, DOI 10.1096/fj.05-4192fje; Chen ZY, 2006, SCIENCE, V314, P140, DOI 10.1126/science.1129663; Condeelis J, 2005, BIOL CELL, V97, P97; Cox LJ, 2008, NAT CELL BIOL, V10, P149, DOI 10.1038/ncb1677; Cryns K, 2008, NEUROPSYCHOPHARMACOL, V33, P674, DOI 10.1038/sj.npp.1301431; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Eng H, 1999, J NEUROSCI, V19, P1; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Hengst U, 2007, SEMIN CELL DEV BIOL, V18, P209, DOI 10.1016/j.semcdb.2007.01.003; Huang F, 2005, J NEUROSCI, V25, P7199, DOI 10.1523/JNEUROSCI.1779-05.2005; Irvine RF, 2001, NAT REV MOL CELL BIO, V2, P327, DOI 10.1038/35073015; Lee SK, 2003, J CELL SCI, V116, P4467, DOI 10.1242/jcs.00745; Lin AC, 2007, EMBO J, V26, P3729, DOI 10.1038/sj.emboj.7601808; Machado-Vieira R, 2009, BIPOLAR DISORD, V11, P92, DOI 10.1111/j.1399-5618.2009.00714.x; Martin KC, 2009, CELL, V136, P719, DOI 10.1016/j.cell.2009.01.044; Mayford M, 1996, P NATL ACAD SCI USA, V93, P13250, DOI 10.1073/pnas.93.23.13250; Nikolaev A, 2009, NATURE, V457, P981, DOI 10.1038/nature07767; Resnick AC, 2008, FRONT BIOSCI-LANDMRK, V13, P856, DOI 10.2741/2726; Riccio A, 1999, SCIENCE, V286, P2358, DOI 10.1126/science.286.5448.2358; Riccio A, 1997, SCIENCE, V277, P1097, DOI 10.1126/science.277.5329.1097; Silahtaroglu AN, 2007, NAT PROTOC, V2, P2520, DOI 10.1038/nprot.2007.313; Tanizawa Y, 2006, GENE DEV, V20, P3296, DOI 10.1101/gad.1497806; VANCE JE, 1995, NEUROBIOL AGING, V16, P493, DOI 10.1016/0197-4580(94)00180-9; Velculescu VE, 2000, TRENDS GENET, V16, P423, DOI 10.1016/S0168-9525(00)02114-4; Wang SM, 2007, TRENDS GENET, V23, P42, DOI 10.1016/j.tig.2006.11.001; Watson FL, 1999, J NEUROSCI, V19, P7889; Williams RSB, 2002, NATURE, V417, P292, DOI 10.1038/417292a; Willis D, 2005, J NEUROSCI, V25, P778, DOI 10.1523/JNEUROSCI.4235-04.2005; Willis DE, 2007, J CELL BIOL, V178, P965, DOI 10.1083/jcb.200703209; Wu KY, 2005, NATURE, V436, P1020, DOI 10.1038/nature03885; Ye HH, 2003, NEURON, V39, P57, DOI 10.1016/S0896-6273(03)00266-6; Yin HL, 2003, ANNU REV PHYSIOL, V65, P761, DOI 10.1146/annurev.physiol.65.092101.142517; York JD, 2006, BBA-MOL CELL BIOL L, V1761, P552, DOI 10.1016/j.bbalip.2006.04.014; Yudin D, 2008, NEURON, V59, P241, DOI 10.1016/j.neuron.2008.05.029; Zhang HL, 1999, J CELL BIOL, V147, P59, DOI 10.1083/jcb.147.1.59; Zhang XH, 2002, NEURON, V36, P675, DOI 10.1016/S0896-6273(02)01023-1; Zuccato C, 2007, PROG NEUROBIOL, V81, P294, DOI 10.1016/j.pneurobio.2007.01.003; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595; Zweifel LS, 2005, NAT REV NEUROSCI, V6, P615, DOI 10.1038/nrn1727	49	137	138	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2010	13	3					291	U6		10.1038/nn.2486	http://dx.doi.org/10.1038/nn.2486			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	559WW	20118926				2022-12-24	WOS:000274860100010
J	Conroy, JL; Fang, C; Gu, J; Zeitlin, SO; Yang, WZ; Yang, J; VanAlstine, MA; Nalwalk, JW; Albrecht, PJ; Mazurkiewicz, JE; Snyder-Keller, A; Shan, ZX; Zhang, SZ; Wentland, MP; Behr, M; Knapp, BI; Bidlack, JM; Zuiderveld, OP; Leurs, R; Ding, XX; Hough, LB				Conroy, Jennie L.; Fang, Cheng; Gu, Jun; Zeitlin, Scott O.; Yang, Weizhu; Yang, Jun; VanAlstine, Melissa A.; Nalwalk, Julia W.; Albrecht, Phillip J.; Mazurkiewicz, Joseph E.; Snyder-Keller, Abigail; Shan, Zhixing; Zhang, Shao-Zhong; Wentland, Mark P.; Behr, Melissa; Knapp, Brian I.; Bidlack, Jean M.; Zuiderveld, Obbe P.; Leurs, Rob; Ding, Xinxin; Hough, Lindsay B.			Opioids activate brain analgesic circuits through cytochrome P450/epoxygenase signaling	NATURE NEUROSCIENCE			English	Article							ARACHIDONIC-ACID METABOLISM; PERIAQUEDUCTAL GRAY; MORPHINE; MOUSE; ANTINOCICEPTION; DISRUPTION; INHIBITORS	To assess the importance of brain cytochrome P450 (P450) activity in. opioid analgesic action, we generated a mutant mouse with brain neuron-specific reductions in P450 activity; these mice showed highly attenuated morphine antinociception compared with controls. Pharmacological inhibition of brain P450 arachidonate epoxygenases also blocked morphine antinociception in mice and rats. Our findings indicate that a neuronal P450 epoxygenase mediates the pain-relieving properties of morphine.	[Fang, Cheng; Gu, Jun; Yang, Weizhu; Snyder-Keller, Abigail; Behr, Melissa; Ding, Xinxin] New York State Dept Hlth, Wadsworth Ctr, Albany, NY USA; [Fang, Cheng; Gu, Jun; Yang, Weizhu; Snyder-Keller, Abigail; Behr, Melissa; Ding, Xinxin] SUNY Albany, Sch Publ Hlth, Albany, NY USA; [Conroy, Jennie L.; Yang, Jun; VanAlstine, Melissa A.; Nalwalk, Julia W.; Albrecht, Phillip J.; Mazurkiewicz, Joseph E.; Hough, Lindsay B.] Albany Med Coll, Ctr Neuropharmacol & Neurosci, Albany, NY 12208 USA; [Zeitlin, Scott O.] Univ Virginia, Sch Med, Dept Neurosci, Charlottesville, VA 22908 USA; [Albrecht, Phillip J.; Mazurkiewicz, Joseph E.] Integrated Tissue Dynam, Rensselaer, NY USA; [Shan, Zhixing; Zhang, Shao-Zhong; Wentland, Mark P.] Rensselaer Polytech Inst, Dept Chem & Chem Biol, Troy, NY USA; [Knapp, Brian I.; Bidlack, Jean M.] Univ Rochester, Sch Med & Dent, Dept Physiol & Pharmacol, Rochester, NY USA; [Zuiderveld, Obbe P.; Leurs, Rob] Vrije Univ Amsterdam, Leiden Amsterdam Ctr Drug Res, Amsterdam, Netherlands	State University of New York (SUNY) System; Wadsworth Center; State University of New York (SUNY) System; State University of New York (SUNY) Albany; Albany Medical College; University of Virginia; Rensselaer Polytechnic Institute; University of Rochester; Leiden University; Leiden University - Excl LUMC; Vrije Universiteit Amsterdam	Ding, XX (corresponding author), New York State Dept Hlth, Wadsworth Ctr, Albany, NY USA.	xxd01@health.state.ny.us; houghl@mail.amc.edu	Albrecht, Phillip J./AAC-6144-2021; Leurs, Rob/AAC-8508-2022; Zeitlin, Scott/P-5787-2019; Leurs, Rob/ABB-4299-2021	Leurs, Rob/0000-0003-1354-2848; VanAlstine-Parris, Melissa/0000-0001-5209-9282	US National Institutes of Health [ES0746, DA03816, DA00360, NS43466]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES007462] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS043466, R56NS043466] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA027835, R01DA003816, K05DA000360] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The authors gratefully acknowledge the use of the Molecular Genetics and the Biochemistry Cores of the Wadsworth Center. We thank A. Verschoor for reading the manuscript, Y. Weng for assistance with chemical analysis, J. Phillips (Curragh Chemistries) for CC12 and A. Mongin for valuable discussions. This work was supported in part by US National Institutes of Health grants ES07462 (X. D.), DA03816 (L. B. H.), DA00360 (J. M. B.) and NS43466 (S.O.Z.).	Aoki T, 2003, NEUROSCI LETT, V350, P69, DOI 10.1016/S0304-3940(03)00829-2; Christie MJ, 1999, INFLAMM RES, V48, P1, DOI 10.1007/s000110050367; Dragatsis I, 2000, GENESIS, V26, P133, DOI 10.1002/(SICI)1526-968X(200002)26:2<133::AID-GENE10>3.0.CO;2-V; Fukuda K, 1996, J NEUROCHEM, V67, P1309; Heinricher M. M., 2008, SENSES COMPREHENSIVE; Hough LB, 2007, NEUROPHARMACOLOGY, V52, P1244, DOI 10.1016/j.neuropharm.2007.01.004; KUO CK, 1991, J PHARMACOBIO-DYNAM, V14, P187, DOI 10.1248/bpb1978.14.187; Law PY, 2000, ANNU REV PHARMACOL, V40, P389, DOI 10.1146/annurev.pharmtox.40.1.389; Narita M, 2003, BRAIN RES, V970, P140, DOI 10.1016/S0006-8993(03)02301-1; Nigam S, 2004, J BIOL CHEM, V279, P29023, DOI 10.1074/jbc.M307576200; Spector AA, 2009, J LIPID RES, V50, pS52, DOI 10.1194/jlr.R800038-JLR200; Terashvili M, 2008, J PHARMACOL EXP THER, V326, P614, DOI 10.1124/jpet.108.136739; Vaughan CW, 1997, NATURE, V390, P611, DOI 10.1038/37610; Walters CL, 2003, PSYCHOPHARMACOLOGY, V170, P124, DOI 10.1007/s00213-003-1526-7; Wang MH, 1998, J PHARMACOL EXP THER, V284, P966	15	48	48	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2010	13	3					284	286		10.1038/nn.2497	http://dx.doi.org/10.1038/nn.2497			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	559WW	20139973	Green Accepted			2022-12-24	WOS:000274860100008
J	Etxeberria, A; Mangin, JM; Aguirre, A; Gallo, V				Etxeberria, Ainhoa; Mangin, Jean-Marie; Aguirre, Adan; Gallo, Vittorio			Adult-born SVZ progenitors receive transient synapses during remyelination in corpus callosum	NATURE NEUROSCIENCE			English	Article							OLIGODENDROCYTE DEVELOPMENT; SUBVENTRICULAR ZONE; WHITE-MATTER; GLUTAMATE; AXONS; RELEASE	We found that demyelinated axons formed functional glutamatergic synapses onto adult-born NG2(+) oligodendrocyte progenitor cells (OPCs) migrating from the subventricular zone after focal demyelination of adult mice corpus callosum. This glutamatergic input was substantially reduced compared with endogenous callosal OPCs 1 week after lesion and was lost on differentiation into oligodendrocytes. Therefore, axon-oligodendrocyte progenitor synapse formation is a transient and regulated step that occurs during remyelination of callosal axons.	[Etxeberria, Ainhoa; Mangin, Jean-Marie; Aguirre, Adan; Gallo, Vittorio] Childrens Natl Med Ctr, Ctr Neurosci Res, Washington, DC 20010 USA	Children's National Health System	Gallo, V (corresponding author), Childrens Natl Med Ctr, Ctr Neurosci Res, Washington, DC 20010 USA.	vgallo@cnmcresearch.org	Messier, Claude/A-2322-2008	Messier, Claude/0000-0002-4791-1763; Mangin, Jean-Marie/0000-0002-7804-0251	US National Institutes of Health [R01NS045702, K99NS057944, P30HD40677]; Department of Education and Science of the Spanish Government; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD040677] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045702, R00NS057944, K99NS057944] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Education and Science of the Spanish Government; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank F. Gage (Salk Institute) and J. Goldman (Columbia University) for the pNIT-GFP retrovirus, A. Nishiyama (University of Connecticut) for the NG2-dsRed mouse and D. Rowitch (University of California San Francisco) for antibody to Olig2. We are particularly grateful to J. Corbin for discussion and to R. McCarter for help with statistical analysis. This work was supported by grants from the US National Institutes of Health (R01NS045702 and R01NS045702 to V. G., K99NS057944 to A. A. and Intellectual and Developmental Disabilities Research Center P30HD40677). A. E. was supported by a Postdoctoral Fellowship from the Department of Education and Science of the Spanish Government.	Aguirre A, 2007, NAT NEUROSCI, V10, P990, DOI 10.1038/nn1938; Bezzi P, 2004, NAT NEUROSCI, V7, P613, DOI 10.1038/nn1246; Chittajallu R, 2005, J NEUROSCI, V25, P8601, DOI 10.1523/JNEUROSCI.2122-05.2005; Gallo V, 1996, J NEUROSCI, V16, P2659, DOI 10.1523/jneurosci.16-08-02659.1996; Gensert JM, 1997, NEURON, V19, P197, DOI 10.1016/S0896-6273(00)80359-1; Kukley M, 2007, NAT NEUROSCI, V10, P311, DOI 10.1038/nn1850; Menn B, 2006, J NEUROSCI, V26, P7907, DOI 10.1523/JNEUROSCI.1299-06.2006; Nait-Oumesmar B, 1999, EUR J NEUROSCI, V11, P4357, DOI 10.1046/j.1460-9568.1999.00873.x; Yuan XQ, 1998, DEVELOPMENT, V125, P2901; Ziskin JL, 2007, NAT NEUROSCI, V10, P321, DOI 10.1038/nn1854	10	136	138	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2010	13	3					287	289		10.1038/nn.2500	http://dx.doi.org/10.1038/nn.2500			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	559WW	20173746	Green Accepted			2022-12-24	WOS:000274860100009
J	Fiete, IR; Senn, W; Wang, CZH; Hahnloser, RHR				Fiete, Ila R.; Senn, Walter; Wang, Claude Z. H.; Hahnloser, Richard H. R.			Spike-Time-Dependent Plasticity and Heterosynaptic Competition Organize Networks to Produce Long Scale-Free Sequences of Neural Activity	NEURON			English	Article							IDENTIFIED HVC NEURONS; SYNFIRE CHAINS; PROTEIN-SYNTHESIS; CORTICAL ACTIVITY; SONG SELECTIVITY; PERFORANT PATH; GENERATION; MODEL; MOTOR; TERM	Sequential neural activity patterns are as ubiquitous as the outputs they drive, which include motor gestures and sequential cognitive processes. Neural sequences are long, compared to the activation durations of participating neurons, and sequence coding is sparse. Numerous studies demonstrate that spike-time-dependent plasticity (STDP), the primary known mechanism for temporal order learning in neurons, cannot organize networks to generate long sequences, raising the question of how such networks are formed. We show that heterosynaptic competition within single neurons, when combined with STDP, organizes networks to generate long unary activity sequences even without sequential training inputs. The network produces a diversity of sequences with a power law length distribution and exponent -1, independent of cellular time constants. We show evidence for a similar distribution of sequence lengths in the recorded premotor song activity of songbirds. These results suggest that neural sequences may be shaped by synaptic constraints and network circuitry rather than cellular time constants.	[Fiete, Ila R.] Univ Texas Austin, Ctr Learning & Memory, Austin, TX 78712 USA; [Senn, Walter] Univ Bern, Dept Physiol, CH-3012 Bern, Switzerland; [Wang, Claude Z. H.; Hahnloser, Richard H. R.] Univ Zurich, CH-8057 Zurich, Switzerland; [Wang, Claude Z. H.; Hahnloser, Richard H. R.] ETH, Inst Neuroinformat, CH-8057 Zurich, Switzerland	University of Texas System; University of Texas Austin; University of Bern; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Fiete, IR (corresponding author), Univ Texas Austin, Ctr Learning & Memory, Austin, TX 78712 USA.		Senn, Walter/D-6308-2014	Senn, Walter/0000-0003-3622-0497; Hahnloser, Richard/0000-0002-4039-7773; Fiete, Ila/0000-0003-4738-2539	NSF [PHY 99-07949]; Swiss National Science Foundation; Sloan Foundation Fellow	NSF(National Science Foundation (NSF)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Sloan Foundation Fellow	We are grateful to the referees for their helpful comments. This work was partially supported by NSF-PHY 99-07949 to the Kavli Institute for Theoretical Physics, the Broad Fellows program at Caltech, and the Swiss National Science Foundation. I.R.F. is a Sloan Foundation Fellow	Abbott LF, 2000, NAT NEUROSCI, V3, P1178, DOI 10.1038/81453; Abeles M., 1991, CORTICONICS; ABRAHAM WC, 1985, J PHYSIOL-LONDON, V363, P335, DOI 10.1113/jphysiol.1985.sp015714; AMAN SI, 1972, IEEE T COMPUT C, V21, P1197; Andersen RA, 2004, TRENDS COGN SCI, V8, P486, DOI 10.1016/j.tics.2004.09.009; Aviel Y, 2003, NEURAL COMPUT, V15, P1321, DOI 10.1162/089976603321780290; Barnes TD, 2005, NATURE, V437, P1158, DOI 10.1038/nature04053; Bi GQ, 2001, ANNU REV NEUROSCI, V24, P139, DOI 10.1146/annurev.neuro.24.1.139; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; BOTTJER SW, 1984, SCIENCE, V224, P901, DOI 10.1126/science.6719123; Bourne JN, 2011, HIPPOCAMPUS, V21, P354, DOI 10.1002/hipo.20768; Buonomano DV, 2005, J NEUROPHYSIOL, V94, P2275, DOI 10.1152/jn.01250.2004; Buonomano DV, 2003, P NATL ACAD SCI USA, V100, P4897, DOI 10.1073/pnas.0736909100; Davidson TJ, 2009, NEURON, V63, P497, DOI 10.1016/j.neuron.2009.07.027; Doyere V, 1997, J NEUROPHYSIOL, V77, P571, DOI 10.1152/jn.1997.77.2.571; Drew PJ, 2003, J NEUROPHYSIOL, V89, P2697, DOI 10.1152/jn.00801.2002; Fee MS, 2004, ANN NY ACAD SCI, V1016, P153, DOI 10.1196/annals.1298.022; FIETE IR, 2008, NEW ENCY NEUROSCIENC; Fonseca R, 2006, NAT NEUROSCI, V9, P478, DOI 10.1038/nn1667; Fonseca R, 2004, NEURON, V44, P1011, DOI 10.1016/j.neuron.2004.10.033; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; Glaze CM, 2006, J NEUROSCI, V26, P991, DOI 10.1523/JNEUROSCI.3387-05.2006; Hahnloser RHR, 2002, NATURE, V419, P65, DOI 10.1038/nature00974; Hahnloser RHR, 2007, J NEUROPHYSIOL, V97, P423, DOI 10.1152/jn.00547.2006; Harvey CD, 2007, NATURE, V450, P1195, DOI 10.1038/nature06416; Hashimoto K, 2009, NEURON, V63, P106, DOI 10.1016/j.neuron.2009.06.008; Huber KM, 2000, SCIENCE, V288, P1254, DOI 10.1126/science.288.5469.1254; Ikegaya Y, 2004, SCIENCE, V304, P559, DOI 10.1126/science.1093173; Jin DZ, 2007, J COMPUT NEUROSCI, V23, P283, DOI 10.1007/s10827-007-0032-z; Jun JK, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000723; KLEINFELD D, 1988, BIOPHYS J, V54, P1039, DOI 10.1016/S0006-3495(88)83041-8; Kozhevnikov AA, 2007, J NEUROPHYSIOL, V97, P4271, DOI 10.1152/jn.00952.2006; Levy N, 2001, NEURAL NETWORKS, V14, P815, DOI 10.1016/S0893-6080(01)00044-2; Li MR, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.011918; Long MA, 2008, NATURE, V456, P189, DOI 10.1038/nature07448; Louie K, 2001, NEURON, V29, P145, DOI 10.1016/S0896-6273(01)00186-6; Luczak A, 2007, P NATL ACAD SCI USA, V104, P347, DOI 10.1073/pnas.0605643104; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Mokeichev A, 2007, NEURON, V53, P413, DOI 10.1016/j.neuron.2007.01.017; Mooney R, 2005, J NEUROSCI, V25, P1952, DOI 10.1523/JNEUROSCI.3726-04.2005; Mooney R, 2000, J NEUROSCI, V20, P5420, DOI 10.1523/JNEUROSCI.20-14-05420.2000; Nadasdy Z, 1999, J NEUROSCI, V19, P9497; NOTTEBOHM F, 1976, J COMP NEUROL, V165, P457, DOI 10.1002/cne.901650405; NOTTEBOHM F, 1982, J COMP NEUROL, V207, P344, DOI 10.1002/cne.902070406; Nowotny T, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.011908; Pastalkova E, 2008, SCIENCE, V321, P1322, DOI 10.1126/science.1159775; Pulvermuller F, 2009, CEREB CORTEX, V19, P79, DOI 10.1093/cercor/bhn060; Rao RPN, 2003, PHILOS T ROY SOC A, V361, P1149, DOI 10.1098/rsta.2003.1190; Roxin A, 2008, J NEUROSCI, V28, P10734, DOI 10.1523/JNEUROSCI.1016-08.2008; Royer S, 2003, NATURE, V422, P518, DOI 10.1038/nature01530; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Schwartz AB, 1999, J NEUROPHYSIOL, V82, P2705, DOI 10.1152/jn.1999.82.5.2705; Seung HS, 2009, NEURON, V62, P17, DOI 10.1016/j.neuron.2009.03.020; Suri RE, 2002, BIOL CYBERN, V87, P440, DOI 10.1007/s00422-002-0355-9; Tang A, 2008, J NEUROSCI, V28, P505, DOI 10.1523/JNEUROSCI.3359-07.2008; Tanji J, 2001, ANNU REV NEUROSCI, V24, P631, DOI 10.1146/annurev.neuro.24.1.631; Wang CZH, 2008, PLOS BIOL, V6, P2154, DOI 10.1371/journal.pbio.0060250; Weber AP, 2007, PLOS COMPUT BIOL, V3, P2520, DOI 10.1371/journal.pcbi.0030249	58	179	198	2	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 25	2010	65	4					563	576		10.1016/j.neuron.2010.02.003	http://dx.doi.org/10.1016/j.neuron.2010.02.003			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	566HD	20188660	Bronze			2022-12-24	WOS:000275359800014
J	Matter, C; Pribadi, M; Liu, X; Trachtenberg, JT				Matter, Cheryl; Pribadi, Mochtar; Liu, Xin; Trachtenberg, Joshua T.			delta-Catenin Is Required for the Maintenance of Neural Structure and Function in Mature Cortex In Vivo	NEURON			English	Article							DENDRITIC SPINES; MENTAL-RETARDATION; ADHERENS JUNCTION; N-CADHERIN; MORPHOGENESIS; PRESENILIN-1; PROTEIN; FAMILY; MAPS; LOCALIZATION	delta-catenin is a brain-specific member of the adherens junction complex that localizes to the postsynaptic and dendritic compartments. This protein is likely critical for normal cognitive function; its hemizygous loss is linked to the severe mental retardation syndrome Cri-du-Chat and it directly interacts with presenilin-1 (PS1), the protein most frequently mutated in familial Alzheimer's disease. Here we examine dendritic structure and cortical function in vivo in mice lacking delta-catenin. We find that in cerebral cortex of 5-week-old mice, dendritic complexity, spine density, and cortical responsiveness are similar between mutant and littermate controls; thereafter, mutant mice experience progressive dendritic retraction, a reduction in spine density and stability, and concomitant reductions in cortical responsiveness. Our results indicate that delta-catenin regulates the maintenance of dendrites and dendritic spines in mature cortex but does not appear to be necessary for the initial establishment of these structures during development.	[Matter, Cheryl; Pribadi, Mochtar; Liu, Xin] Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Trachtenberg, Joshua T.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Liu, X (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, 650 Charles Young Dr S, Los Angeles, CA 90095 USA.	xinliu@mednet.ucla.edu; jtrachtenberg@mednet.ucla.edu			Brain Tumor Society; National Institutes of Health [NS38489]; Larry L. Hillblom Foundation; U.S. National Eye Institute [EY016052]; NATIONAL EYE INSTITUTE [R01EY016052] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038489] Funding Source: NIH RePORTER	Brain Tumor Society; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Larry L. Hillblom Foundation; U.S. National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank S. Thomas Carmichael for help with laser capture qrtPCR and Hong Wu, Louis Reichardt, and Inbal Israely for helpful comments on the manuscript. This work was supported by grants from the Brain Tumor Society (awarded to X.L.), the National Institutes of Health (NS38489, awarded to X.L.), the Larry L. Hillblom Foundation (awarded to J.T.T.), and the U.S. National Eye Institute (EY016052, awarded to J.T.T.).	Arikkath J, 2008, J NEUROSCI, V28, P7047, DOI 10.1523/JNEUROSCI.0451-08.2008; Benson DL, 1998, J NEUROSCI, V18, P6892; Cang JH, 2005, NEURON, V48, P797, DOI 10.1016/j.neuron.2005.09.015; Chow DK, 2009, NAT NEUROSCI, V12, P116, DOI 10.1038/nn.2255; Elia LP, 2006, NEURON, V51, P43, DOI 10.1016/j.neuron.2006.05.018; Faguet J, 2009, J NEUROPHYSIOL, V101, P855, DOI 10.1152/jn.90893.2008; Fannon AM, 1996, NEURON, V17, P423, DOI 10.1016/S0896-6273(00)80175-0; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; GRINVALD A, 1986, NATURE, V324, P361, DOI 10.1038/324361a0; Hausser M, 2000, SCIENCE, V290, P739, DOI 10.1126/science.290.5492.739; Ho C, 2000, J COMP NEUROL, V420, P261; Holtmaat AJGD, 2005, NEURON, V45, P279, DOI 10.1016/j.neuron.2005.01.003; Ide N, 1999, BIOCHEM BIOPH RES CO, V256, P456, DOI 10.1006/bbrc.1999.0364; Inoue A, 1997, SCIENCE, V276, P1428, DOI 10.1126/science.276.5317.1428; Israely I, 2004, CURR BIOL, V14, P1657, DOI 10.1016/j.cub.2004.08.065; Kalatsky VA, 2003, NEURON, V38, P529, DOI 10.1016/S0896-6273(03)00286-1; Kaufmann WE, 2000, CEREB CORTEX, V10, P981, DOI 10.1093/cercor/10.10.981; Kim H, 2008, J BIOL CHEM, V283, P977, DOI 10.1074/jbc.M707158200; Kim JS, 2006, BIOCHEM BIOPH RES CO, V351, P903, DOI 10.1016/j.bbrc.2006.10.135; Kim K, 2002, EXP CELL RES, V275, P171, DOI 10.1006/excr.2002.5503; Knott GW, 2006, NAT NEUROSCI, V9, P1117, DOI 10.1038/nn1747; Kosik KS, 2005, TRENDS CELL BIOL, V15, P172, DOI 10.1016/j.tcb.2005.01.004; Liauw J, 2002, MOL BRAIN RES, V109, P56, DOI 10.1016/S0169-328X(02)00491-6; Martinez MC, 2003, J CELL BIOL, V162, P99, DOI 10.1083/jcb.200211025; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Medina M, 2000, GENOMICS, V63, P157, DOI 10.1006/geno.1999.6090; Paffenholz R, 1997, DIFFERENTIATION, V61, P293, DOI 10.1046/j.1432-0436.1997.6150293.x; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; Selkoe DJ, 2001, NEURON, V32, P177, DOI 10.1016/S0896-6273(01)00475-5; Silverman JB, 2007, J NEUROSCI, V27, P8505, DOI 10.1523/JNEUROSCI.1395-07.2007; Smith SL, 2007, NAT NEUROSCI, V10, P370, DOI 10.1038/nn1844; Takeichi M, 2005, TRENDS CELL BIOL, V15, P216, DOI 10.1016/j.tcb.2005.02.002; Tanahashi H, 1999, NEUROREPORT, V10, P563, DOI 10.1097/00001756-199902250-00022; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Zhou JH, 1997, NEUROREPORT, V8, P1489, DOI 10.1097/00001756-199704140-00033; Zito K, 2009, NEURON, V61, P247, DOI 10.1016/j.neuron.2008.10.054	37	62	66	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 12	2009	64	3					320	327		10.1016/j.neuron.2009.09.026	http://dx.doi.org/10.1016/j.neuron.2009.09.026			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	521MF	19914181	Green Accepted, Bronze			2022-12-24	WOS:000271924800007
J	Bussmann, LH; Schubert, A; Manh, TPV; De Andres, L; Desbordes, SC; Parra, M; Zimmermann, T; Rapino, F; Rodriguez-Ubreva, J; Ballestar, E; Graf, T				Bussmann, Lars H.; Schubert, Alexis; Vu Manh, Thien Phong; De Andres, Luisa; Desbordes, Sabrina C.; Parra, Maribel; Zimmermann, Timo; Rapino, Francesca; Rodriguez-Ubreva, Javier; Ballestar, Esteban; Graf, Thomas			A Robust and Highly Efficient Immune Cell Reprogramming System	CELL STEM CELL			English	Article							C/EBP-ALPHA; IN-VIVO; TRANSCRIPTIONAL CONTROL; RHO-GTPASES; B-CELLS; GENES; PU.1; DIFFERENTIATION; MACROPHAGES; EXPRESSION	Here we describe a lineage reprogramming system consisting of a B cell line with an estradiol-inducible form of C/EBP alpha where cells can be converted into macrophage-like cells at 100% efficiency within 2 to 3 days. The reprogrammed cells are larger, contain altered organelle and cytoskeletal structures, are phagocytic, and exhibit an inflammatory response. Time-lapse experiments showed that the cells acquire a macrophage morphology and increased migratory activity as early as 10 hr. During induction, thousands of genes become up- or downregulated, including several dozen transcription and chromatin-remodeling factors. Time-limited exposure of cells to the inducer showed that the reprogrammed cells become transgene independent within 1 to 2 days. The reprogramming can be inhibited, at least partially, by perturbation experiments with B cell and macrophage transcription factors. The tightness, robustness, and speed of the system described make it a versatile tool to study biochemical and biological aspects of lineage reprogramming.	[Bussmann, Lars H.; Schubert, Alexis; Vu Manh, Thien Phong; De Andres, Luisa; Desbordes, Sabrina C.; Parra, Maribel; Zimmermann, Timo; Rapino, Francesca; Graf, Thomas] Ctr Genom Regulat, Barcelona 08003, Spain; [Bussmann, Lars H.; Schubert, Alexis; Vu Manh, Thien Phong; De Andres, Luisa; Desbordes, Sabrina C.; Parra, Maribel; Zimmermann, Timo; Rapino, Francesca; Graf, Thomas] Univ Pompeu Fabra, Barcelona 08003, Spain; [Desbordes, Sabrina C.; Rodriguez-Ubreva, Javier; Ballestar, Esteban] Bellvitge Inst Biomed Res IDIBELL, Barcelona 08907, Spain; [Graf, Thomas] Inst Catalana Recerca & Estudis Avancats, Catalonia, Spain	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); ICREA	Graf, T (corresponding author), Ctr Genom Regulat, Barcelona 08003, Spain.	thomas.graf@crg.es	Ballestar, Esteban/ABG-8561-2020; Graf, Thomas/B-4252-2015; Zimmermann, Timo/G-1681-2015	Graf, Thomas/0000-0003-2774-4117; Zimmermann, Timo/0000-0001-7098-0700; RODRIGUEZ-UBREVA, JAVIER/0000-0003-4707-4536; Vu Manh, Thien-Phong/0000-0002-0294-342X; de Andres-Aguayo, Luisa/0000-0001-6717-242X; Parra, Maribel/0000-0002-9072-5763; Ballestar, Esteban/0000-0002-1400-2440	HEROIC; German Academic Exchange Service; Marie Curie; Ramon y Cajal; Juan de la Cierva; ICREA Funding Source: Custom	HEROIC(European Commission); German Academic Exchange Service(Deutscher Akademischer Austausch Dienst (DAAD)); Marie Curie(European Commission); Ramon y Cajal(Spanish Government); Juan de la Cierva(Instituto de Salud Carlos III); ICREA(ICREA)	We thank Drs. C. Murre, R. Grosschedl, and M. Busslinger for the E47, EBf, and Pax5 cDNA constructs, respectively; Dr. H. Xie for the C/EBP alpha ER, E47-GFP, EBF-GFP, and Pax5-EGFP retroviral constructs; Dr. R. Copin for the dsRed E coli strain; and Drs. M. Stadtfeld, C. Gekas, H. Xie, and M. Ye for comments on the manuscript. This work was supported by grants from HEROIC and Consolider to T.G., as well as by fellowships from the German Academic Exchange Service (L.B.), Marie Curie (A.S.), Ramon y Cajal (M.P.), and Juan de la Cierva (S.D.). Salary for T.G. provided by Institucio Catalana de Recerca I Estudis Avancats, Catalonia.	ALESSANDRINI A, 1987, P NATL ACAD SCI USA, V84, P1799, DOI 10.1073/pnas.84.7.1799; Brady G, 2005, J BIOL CHEM, V280, P30723, DOI 10.1074/jbc.M500435200; Busslinger M, 2004, ANNU REV IMMUNOL, V22, P55, DOI 10.1146/annurev.immunol.22.012703.104807; Cai DH, 2008, ONCOGENE, V27, P2772, DOI 10.1038/sj.onc.1210940; COOPER C, 1995, NUCLEIC ACIDS RES, V23, P4371, DOI 10.1093/nar/23.21.4371; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; DeKoter RP, 2000, SCIENCE, V288, P1439, DOI 10.1126/science.288.5470.1439; Dengler HS, 2008, NAT IMMUNOL, V9, P1388, DOI 10.1038/ni.1667; Faust N, 1997, EXP HEMATOL, V25, P432; Feng R, 2008, P NATL ACAD SCI USA, V105, P6057, DOI 10.1073/pnas.0711961105; Friedman AD, 2007, ONCOGENE, V26, P6816, DOI 10.1038/sj.onc.1210764; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Hanna J, 2008, CELL, V133, P250, DOI 10.1016/j.cell.2008.03.028; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Heins N, 2002, NAT NEUROSCI, V5, P308, DOI 10.1038/nn828; Horb ME, 2003, CURR BIOL, V13, P105, DOI 10.1016/S0960-9822(02)01434-3; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; KULESSA H, 1995, GENE DEV, V9, P1250, DOI 10.1101/gad.9.10.1250; Laiosa CV, 2006, IMMUNITY, V25, P731, DOI 10.1016/j.immuni.2006.09.011; Laiosa CV, 2006, ANNU REV IMMUNOL, V24, P705, DOI 10.1146/annurev.immunol.24.021605.090742; Laslo P, 2006, CELL, V126, P755, DOI 10.1016/j.cell.2006.06.052; Lim JP, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-58; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Niwa H, 2005, CELL, V123, P917, DOI 10.1016/j.cell.2005.08.040; Parada LA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-7-r44; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Porse BT, 2001, CELL, V107, P247, DOI 10.1016/S0092-8674(01)00516-5; Pridans C, 2008, J IMMUNOL, V180, P1719, DOI 10.4049/jimmunol.180.3.1719; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; Schebesta A, 2007, IMMUNITY, V27, P49, DOI 10.1016/j.immuni.2007.05.019; Shen CN, 2003, MECH DEVELOP, V120, P107, DOI 10.1016/S0925-4773(02)00337-4; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thomas MD, 2005, IMMUNITY, V23, P275, DOI 10.1016/j.immuni.2005.08.005; Wang W, 2001, LEUKEMIA, V15, P779, DOI 10.1038/sj.leu.2402094; Wang Xia, 2008, Chinese Journal of Zoology, V43, P109; Weigelt K, 2009, BIOCHEM BIOPH RES CO, V380, P308, DOI 10.1016/j.bbrc.2009.01.067; Weigelt K, 2008, BIOTECHNIQUES, V45, P131, DOI 10.2144/000112819; WEINTRAUB H, 1989, P NATL ACAD SCI USA, V86, P5434, DOI 10.1073/pnas.86.14.5434; Wernig M, 2008, NAT BIOTECHNOL, V26, P916, DOI 10.1038/nbt1483; Xie HF, 2004, CELL, V117, P663, DOI 10.1016/S0092-8674(04)00419-2; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	42	105	107	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	NOV 6	2009	5	5					554	566		10.1016/j.stem.2009.10.004	http://dx.doi.org/10.1016/j.stem.2009.10.004			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	522SR	19896445	Bronze			2022-12-24	WOS:000272019500016
J	Mitchell, JF; Sundberg, KA; Reynolds, JH				Mitchell, Jude F.; Sundberg, Kristy A.; Reynolds, John H.			Spatial Attention Decorrelates Intrinsic Activity Fluctuations in Macaque Area V4	NEURON			English	Article							PRIMARY VISUAL-CORTEX; NEURAL POPULATION RESPONSES; PSYCHOPHYSICAL PERFORMANCE; NEURONAL SYNCHRONIZATION; NORMALIZATION MODEL; ACTION-POTENTIALS; CORTICAL-NEURONS; HIGH-FREQUENCY; EYE-MOVEMENTS; SINGLE-UNIT	Attention typically amplifies neuronal responses evoked by task-relevant stimuli while attenuating responses to task-irrelevant distracters. In this context, visual distracters constitute an external source of noise that is diminished to improve attended signal quality. Activity that is internal to the cortex itself, stimulus-independent ongoing correlated fluctuations in firing, might also act as task-irrelevant noise. To examine this, we recorded from area V4 of macaques performing an attention-demanding task. The firing of neurons to identically repeated stimuli was highly variable. Much of this variability originates from ongoing low-frequency (<5 Hz) fluctuations in rate correlated across the neuronal population. When attention is directed to a stimulus inside a neuron's receptive field, these correlated fluctuations in rate are reduced. This attention-dependent reduction of ongoing cortical activity improves the signal-to-noise ratio of pooled neural signals substantially more than attention-dependent increases in firing rate.	[Mitchell, Jude F.; Sundberg, Kristy A.; Reynolds, John H.] Salk Inst Biol Studies, Syst Neurobiol Lab, La Jolla, CA 92037 USA	Salk Institute	Reynolds, JH (corresponding author), Salk Inst Biol Studies, Syst Neurobiol Lab, La Jolla, CA 92037 USA.	reynolds@salk.edu		Mitchell, Jude/0000-0003-0197-7545	National Eye Institute [EY016161]; National Institutes of Health Training Fellowship; National Science Foundation Graduate Research Fellowship; NATIONAL EYE INSTITUTE [R01EY016161] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Institutes of Health Training Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank C. Williams and J. Reyes for help with animals and technical support. We thank John Curtis for helpful discussions on coherence and correlation analyses. This work was supported by a grant from the National Eye Institute (EY016161, J.M. and J.H.R.), a National Institutes of Health Training Fellowship (J.M.), and a National Science Foundation Graduate Research Fellowship (K.A.S.).	Abbott LF, 1999, NEURAL COMPUT, V11, P91, DOI 10.1162/089976699300016827; Angelucci A, 2002, J NEUROSCI, V22, P8633; Arieli A, 1996, SCIENCE, V273, P1868, DOI 10.1126/science.273.5283.1868; Averbeck BB, 2006, NAT REV NEUROSCI, V7, P358, DOI 10.1038/nrn1888; Bair W, 1998, VISUAL NEUROSCI, V15, P779, DOI 10.1017/S0952523898154160; Bair W, 2001, J NEUROSCI, V21, P1676, DOI 10.1523/JNEUROSCI.21-05-01676.2001; BLASDEL GG, 1983, J NEUROSCI, V3, P1389; BRITTEN KH, 1992, J NEUROSCI, V12, P4745; Brumberg JC, 2000, J NEUROSCI, V20, P4829; CALVIN WH, 1967, SCIENCE, V155, P842, DOI 10.1126/science.155.3764.842; Carandini M, 2004, PLOS BIOL, V2, P1483, DOI 10.1371/journal.pbio.0020264; Cavanagh P, 2005, TRENDS COGN SCI, V9, P349, DOI 10.1016/j.tics.2005.05.009; Chen YZ, 2008, J NEUROPHYSIOL, V99, P1366, DOI 10.1152/jn.00698.2007; Chen YZ, 2006, NAT NEUROSCI, V9, P1412, DOI 10.1038/nn1792; Cohen MR, 2008, NEURON, V60, P162, DOI 10.1016/j.neuron.2008.08.007; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; Ghose GM, 2008, J NEUROSCI, V28, P5115, DOI 10.1523/JNEUROSCI.0138-08.2008; GILBERT CD, 1983, J NEUROSCI, V3, P1116; Gregoriou GG, 2009, SCIENCE, V324, P1207, DOI 10.1126/science.1171402; Gur M, 1997, J NEUROSCI, V17, P2914; Gur M, 1999, J NEUROPHYSIOL, V82, P1451, DOI 10.1152/jn.1999.82.3.1451; Gur M, 2006, CEREB CORTEX, V16, P888, DOI 10.1093/cercor/bhj032; Han F, 2008, NEURON, V60, P321, DOI 10.1016/j.neuron.2008.08.026; HIRSCH JA, 1991, J NEUROSCI, V11, P1800; Huang X, 2009, J NEUROPHYSIOL, V101, P3012, DOI 10.1152/jn.00010.2009; James W., 1890, PRINCIPLES PSYCHOL; Jarvis MR, 2001, NEURAL COMPUT, V13, P717, DOI 10.1162/089976601300014312; Jermakowicz WJ, 2009, J NEUROPHYSIOL, V101, P2279, DOI 10.1152/jn.91207.2008; Kenet T, 2003, NATURE, V425, P954, DOI 10.1038/nature02078; Knudsen EI, 2007, ANNU REV NEUROSCI, V30, P57, DOI 10.1146/annurev.neuro.30.051606.094256; Kohn A, 2005, J NEUROSCI, V25, P3661, DOI 10.1523/JNEUROSCI.5106-04.2005; Lampl I, 1999, NEURON, V22, P361, DOI 10.1016/S0896-6273(00)81096-X; Lee J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004651; Leopold DA, 1998, EXP BRAIN RES, V123, P341, DOI 10.1007/s002210050577; LYTTON WW, 1991, J NEUROPHYSIOL, V66, P1059, DOI 10.1152/jn.1991.66.3.1059; McAdams CJ, 1999, J NEUROSCI, V19, P431, DOI 10.1523/JNEUROSCI.19-01-00431.1999; Mitchell JF, 2007, NEURON, V55, P131, DOI 10.1016/j.neuron.2007.06.018; Mitra PP, 1999, BIOPHYS J, V76, P691, DOI 10.1016/S0006-3495(99)77236-X; MOORE GP, 1970, BIOPHYS J, V10, P876, DOI 10.1016/S0006-3495(70)86341-X; Morita K, 2008, J NEUROSCI, V28, P1871, DOI 10.1523/JNEUROSCI.3948-07.2008; Nauhaus I, 2009, NAT NEUROSCI, V12, P70, DOI 10.1038/nn.2232; Parker AJ, 1998, ANNU REV NEUROSCI, V21, P227, DOI 10.1146/annurev.neuro.21.1.227; Pesaran B, 2002, NAT NEUROSCI, V5, P805, DOI 10.1038/nn890; Pillow JW, 2008, NATURE, V454, P995, DOI 10.1038/nature07140; PYLYSHYN Z W, 1988, Spatial Vision, V3, P179, DOI 10.1163/156856888X00122; Reynolds JH, 2004, ANNU REV NEUROSCI, V27, P611, DOI 10.1146/annurev.neuro.26.041002.131039; Reynolds JH, 1999, J NEUROSCI, V19, P1736; Reynolds JH, 2009, NEURON, V61, P168, DOI 10.1016/j.neuron.2009.01.002; Sears CR, 2000, CAN J EXP PSYCHOL, V54, P1, DOI 10.1037/h0087326; Shadlen MN, 1996, J NEUROSCI, V16, P1486; Shadlen MN, 1998, J NEUROSCI, V18, P3870; Shmuel A, 2005, J NEUROSCI, V25, P2117, DOI 10.1523/JNEUROSCI.4137-04.2005; Smith MA, 2008, J NEUROSCI, V28, P12591, DOI 10.1523/JNEUROSCI.2929-08.2008; SOFTKY WR, 1993, J NEUROSCI, V13, P334; WANG Z, 1993, J NEUROSCI, V13, P2199; Womelsdorf T, 2007, CURR OPIN NEUROBIOL, V17, P154, DOI 10.1016/j.conb.2007.02.002; Yanagawa T, 2009, NEUROSCI RES, V64, P177, DOI 10.1016/j.neures.2009.02.011; Zeitler M, 2006, NEURAL COMPUT, V18, P2256, DOI 10.1162/neco.2006.18.9.2256; ZOHARY E, 1994, NATURE, V370, P140, DOI 10.1038/370140a0	59	468	470	0	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 24	2009	63	6					879	888		10.1016/j.neuron.2009.09.013	http://dx.doi.org/10.1016/j.neuron.2009.09.013			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	503VP	19778515	Green Accepted, Bronze, Green Submitted			2022-12-24	WOS:000270569700019
J	Kuwabara, T; Hsieh, J; Muotri, A; Yeo, G; Warashina, M; Lie, DC; Moore, L; Nakashima, K; Asashima, M; Gage, FH				Kuwabara, Tomoko; Hsieh, Jenny; Muotri, Alysson; Yeo, Gene; Warashina, Masaki; Lie, Dieter Chichung; Moore, Lynne; Nakashima, Kinichi; Asashima, Makoto; Gage, Fred H.			Wnt-mediated activation of NeuroD1 and retro-elements during adult neurogenesis	NATURE NEUROSCIENCE			English	Article							DENTATE GYRUS; PROGENITOR CELLS; BETA-CATENIN; HIPPOCAMPAL NEUROGENESIS; LENTIVIRAL VECTOR; CEREBRAL-CORTEX; GRANULE CELLS; STEM-CELLS; IN-VIVO; GENE	In adult hippocampus, new neurons are continuously generated from neural stem cells (NSCs), but the molecular mechanisms regulating adult neurogenesis remain elusive. We found that Wnt signaling, together with the removal of Sox2, triggered the expression of NeuroD1 in mice. This transcriptional regulatory mechanism was dependent on a DNA element containing overlapping Sox2 and T-cell factor/lymphoid enhancer factor (TCF/LEF)-binding sites (Sox/LEF) in the promoter. Notably, Sox/LEF sites were also found in long interspersed nuclear element 1 (LINE-1) elements, consistent with their critical roles in the transition of NSCs to proliferating neuronal progenitors. Our results describe a previously unknown Wnt-mediated regulatory mechanism that simultaneously coordinates activation of NeuroD1 and LINE-1, which is important for adult neurogenesis and survival of neuronal progenitors. Moreover, the discovery that LINE-1 retro-elements embedded in the mammalian genome can function as bi-directional promoters suggests that Sox/LEF regulatory sites may represent a general mechanism, at least in part, for relaying environmental signals to other nearby loci to promote adult hippocampal neurogenesis.	[Kuwabara, Tomoko; Warashina, Masaki; Asashima, Makoto] Natl Inst Adv Ind Sci & Technol, Tsukuba, Japan; [Hsieh, Jenny] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Cecil H & Ida Green Ctr Reprod Biol Sci, Dallas, TX 75390 USA; [Muotri, Alysson] Univ Calif San Diego, Sch Med, Dept Pediat Cellular & Mol Med, Stem Cell Program, La Jolla, CA 92093 USA; [Lie, Dieter Chichung] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Dev Genet, Adult Neurogenesis & Neural Stem Cell Grp, Munich, Germany; [Moore, Lynne; Gage, Fred H.] Salk Inst Biol Studies, Genet Lab, La Jolla, CA USA; [Nakashima, Kinichi] Nara Inst Sci & Technol, Grad Sch Biol Sci, Lab Mol Neurosci, Ikoma, Japan	National Institute of Advanced Industrial Science & Technology (AIST); University of Texas System; University of Texas Southwestern Medical Center Dallas; University of California System; University of California San Diego; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Salk Institute; Nara Institute of Science & Technology	Kuwabara, T (corresponding author), Natl Inst Adv Ind Sci & Technol, Tsukuba, Japan.	t.warashina@aist.go.jp	Yeo, Gene/AAE-7676-2019; Lie, Dieter Chichung/S-7914-2017; Kuwabara, Tomoko/M-1639-2018; Lie, Dieter Chichung/AAS-8604-2020	Yeo, Gene/0000-0002-0799-6037; Lie, Dieter Chichung/0000-0002-6035-6442; Kuwabara, Tomoko/0000-0002-7668-0896; Lie, Dieter Chichung/0000-0002-6035-6442	National Institute of Advanced Industrial Science and Technology; US National Institutes of Health [MH082070]; G. Harold and Leila Y. Mathers Charitable Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R56MH082070] Funding Source: NIH RePORTER	National Institute of Advanced Industrial Science and Technology; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); G. Harold and Leila Y. Mathers Charitable Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank T. Ohtake for assistance with animal care and supporting our in vivo experiments. We thank M. Namihira and J. Kohyama for assistance in obtaining immunostaining data, E. Mosser for the constitutively active beta-catenin construct, and G. Canettieri and M. Montminy for HDAC1. We thank A. Huynh for help with immunohistochemical analysis. We are grateful for the technical assistance of B. Miller and to M. L. Gage for editorial comments. T. K., M. W. and M. A. were supported by various grants from National Institute of Advanced Industrial Science and Technology. T. K. was partly supported by the Grant-in-Aid for Exploratory Research. F. H. G. was supported by grants from the US National Institutes of Health (MH082070) and the G. Harold and Leila Y. Mathers Charitable Foundation.	Ambrosetti DC, 1997, MOL CELL BIOL, V17, P6321, DOI 10.1128/MCB.17.11.6321; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Bani-Yaghoub M, 2006, DEV BIOL, V295, P52, DOI 10.1016/j.ydbio.2006.03.007; Barkho BZ, 2006, STEM CELLS DEV, V15, P407, DOI 10.1089/scd.2006.15.407; Brault V, 2001, DEVELOPMENT, V128, P1253; Bylund M, 2003, NAT NEUROSCI, V6, P1162, DOI 10.1038/nn1131; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Collignon J, 1996, DEVELOPMENT, V122, P509; D'Amour KA, 2003, P NATL ACAD SCI USA, V100, P11866, DOI 10.1073/pnas.1834200100; Deisseroth K, 2004, NEURON, V42, P535, DOI 10.1016/S0896-6273(04)00266-1; Farah MH, 2000, DEVELOPMENT, V127, P693; Ferri ALM, 2004, DEVELOPMENT, V131, P3805, DOI 10.1242/dev.01204; GAGE FH, 1995, P NATL ACAD SCI USA, V92, P11879, DOI 10.1073/pnas.92.25.11879; Galceran J, 2000, DEVELOPMENT, V127, P469; Gao X, 2007, J NEUROSCI, V27, P14317, DOI 10.1523/JNEUROSCI.3206-07.2007; Gao ZL, 2009, NAT NEUROSCI, V12, P1090, DOI 10.1038/nn.2385; Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5; Grove EA, 1998, DEVELOPMENT, V125, P2315; Guillemot F, 1999, EXP CELL RES, V253, P357, DOI 10.1006/excr.1999.4717; Hsieh J, 2004, P NATL ACAD SCI USA, V101, P16659, DOI 10.1073/pnas.0407643101; Hsieh J, 2005, CURR OPIN CELL BIOL, V17, P664, DOI 10.1016/j.ceb.2005.09.002; Jessberger S, 2009, LEARN MEMORY, V16, P147, DOI 10.1101/lm.1172609; Lee SMK, 2000, DEVELOPMENT, V127, P457; Lie DC, 2005, NATURE, V437, P1370, DOI 10.1038/nature04108; Liu M, 2000, P NATL ACAD SCI USA, V97, P865, DOI 10.1073/pnas.97.2.865; Ma QF, 1996, CELL, V87, P43, DOI 10.1016/S0092-8674(00)81321-5; Machon O, 2003, NEUROSCIENCE, V122, P129, DOI 10.1016/S0306-4522(03)00519-0; Miyata T, 1999, GENE DEV, V13, P1647, DOI 10.1101/gad.13.13.1647; Miyoshi H, 1997, P NATL ACAD SCI USA, V94, P10319, DOI 10.1073/pnas.94.19.10319; Muotri AR, 2005, NATURE, V435, P903, DOI 10.1038/nature03663; MUOTRI AR, HIPPOCAMPUS IN PRESS; Nishimoto M, 1999, MOL CELL BIOL, V19, P5453; Pfeifer A, 2001, P NATL ACAD SCI USA, V98, P11450, DOI 10.1073/pnas.201415498; Shimogori T, 2004, J COMP NEUROL, V473, P496, DOI 10.1002/cne.20135; Solberg N, 2008, DEV DYNAM, V237, P1799, DOI 10.1002/dvdy.21586; Song SH, 2002, NATURE, V417, P39, DOI 10.1038/417039a; Suh H, 2007, CELL STEM CELL, V1, P515, DOI 10.1016/j.stem.2007.09.002; Tozuka Y, 2005, NEURON, V47, P803, DOI 10.1016/j.neuron.2005.08.023; van Praag H, 2005, J NEUROSCI, V25, P8680, DOI 10.1523/JNEUROSCI.1731-05.2005; Wexler EM, 2008, MOL PSYCHIATR, V13, P285, DOI 10.1038/sj.mp.4002093; Yang N, 2003, NUCLEIC ACIDS RES, V31, P4929, DOI 10.1093/nar/gkg663; YUAN HB, 1995, GENE DEV, V9, P2635, DOI 10.1101/gad.9.21.2635	42	457	468	1	46	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2009	12	9					1097	U6		10.1038/nn.2360	http://dx.doi.org/10.1038/nn.2360			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	487ZD	19701198	Green Accepted			2022-12-24	WOS:000269317300010
J	Histed, MH; Pasupathy, A; Miller, EK				Histed, Mark H.; Pasupathy, Anitha; Miller, Earl K.			Learning Substrates in the Primate Prefrontal Cortex and Striatum: Sustained Activity Related to Successful Actions	NEURON			English	Article							EFFERENT ASSOCIATION PATHWAYS; MONKEY DOPAMINE NEURONS; LINKING BASAL GANGLIA; DECISION-MAKING; CEREBRAL-CORTEX; SINGLE NEURONS; FRONTAL-LOBE; REWARD; RESPONSES; INNERVATION	Learning from experience requires knowing whether a past action resulted in a desired outcome. The prefrontal cortex and basal ganglia are thought to play key roles in such learning of arbitrary stimulus-response associations. Previous studies have found neural activity in these areas, similar to dopaminergic neurons' signals, that transiently reflect whether a response is correct or incorrect. However, it is unclear how this transient activity, which fades in under a second, influences actions that occur much later. Here, we report that single neurons in both areas show sustained, persistent outcome-related responses. Moreover, single behavioral outcomes influence future neural activity and behavior: behavioral responses are more often correct and single neurons more accurately discriminate between the possible responses when the previous response was correct. These long-lasting signals about trial outcome provide a way to link one action to the next and may allow reward signals to be combined over time to implement successful learning.	[Histed, Mark H.; Pasupathy, Anitha; Miller, Earl K.] MIT, Picower Inst Learning & Memory, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Northwell Health	Histed, MH (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA.	mark_histed@hms.harvard.edu	Miller, Earl K./AAE-8187-2019	Miller, Earl K./0000-0002-0582-6958; Histed, Mark/0000-0001-8235-7908	NINDS; Tourette's Syndrome Association; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH065252] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035145] Funding Source: NIH RePORTER	NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Tourette's Syndrome Association; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the NINDS and the Tourette's Syndrome Association (A.P.).	ALEXANDER GE, 1990, PROG BRAIN RES, V85, P119; ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; ANDEN NE, 1966, ACTA PHYSIOL SCAND, V67, P306, DOI 10.1111/j.1748-1716.1966.tb03317.x; APICELLA P, 1991, EXP BRAIN RES, V85, P491; Asaad WF, 1998, NEURON, V21, P1399, DOI 10.1016/S0896-6273(00)80658-3; Barnes TD, 2005, NATURE, V437, P1158, DOI 10.1038/nature04053; Barraclough DJ, 2004, NAT NEUROSCI, V7, P404, DOI 10.1038/nn1209; BERGER B, 1988, J COMP NEUROL, V273, P99, DOI 10.1002/cne.902730109; BRUCE CJ, 1985, J NEUROPHYSIOL, V53, P603, DOI 10.1152/jn.1985.53.3.603; CHEN LL, 1995, J NEUROPHYSIOL, V73, P1122, DOI 10.1152/jn.1995.73.3.1122; Dayan P., 2001, THEORETICAL NEUROSCI; Doya K, 2008, NAT NEUROSCI, V11, P410, DOI 10.1038/nn2077; Drew PJ, 2006, P NATL ACAD SCI USA, V103, P8876, DOI 10.1073/pnas.0600676103; Fellows LK, 2005, CEREB CORTEX, V15, P58, DOI 10.1093/cercor/bhh108; Frey U, 1996, J PHYSIOL-LONDON, V490, P703, DOI 10.1113/jphysiol.1996.sp021179; Fujii N, 2003, SCIENCE, V301, P1246, DOI 10.1126/science.1086872; FUNAHASHI S, 1989, J NEUROPHYSIOL, V61, P331, DOI 10.1152/jn.1989.61.2.331; Fusi S, 2007, NEURON, V54, P319, DOI 10.1016/j.neuron.2007.03.017; Fuster J. M., 2015, PREFRONTAL CORTEX, V5th; Fuster JM, 2000, NATURE, V405, P347, DOI 10.1038/35012613; FUSTER JM, 1971, SCIENCE, V173, P652, DOI 10.1126/science.173.3997.652; GAFFAN D, 1989, BEHAV BRAIN RES, V31, P207, DOI 10.1016/0166-4328(89)90003-X; Ganguli S, 2008, P NATL ACAD SCI USA, V105, P18970, DOI 10.1073/pnas.0804451105; Green DM, 1966, SIGNAL DETECTION THE; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; HOUK JC, 1995, CEREB CORTEX, V5, P95, DOI 10.1093/cercor/5.2.95; Ichihara-Takeda S, 2006, J COGNITIVE NEUROSCI, V18, P212, DOI 10.1162/089892906775783679; Jackson A, 2006, NATURE, V444, P56, DOI 10.1038/nature05226; Lau B, 2008, NEURON, V58, P451, DOI 10.1016/j.neuron.2008.02.021; Lau B, 2007, J NEUROSCI, V27, P14502, DOI 10.1523/JNEUROSCI.3060-07.2007; LJUNGBERG T, 1992, J NEUROPHYSIOL, V67, P145, DOI 10.1152/jn.1992.67.1.145; Maass W, 2002, NEURAL COMPUT, V14, P2531, DOI 10.1162/089976602760407955; Middleton FA, 2000, BRAIN RES REV, V31, P236, DOI 10.1016/S0165-0173(99)00040-5; Miyachi S, 1997, EXP BRAIN RES, V115, P1, DOI 10.1007/PL00005669; Montague PR, 2002, NEURON, V36, P265, DOI 10.1016/S0896-6273(02)00974-1; Murray EA, 2000, EXP BRAIN RES, V133, P114, DOI 10.1007/s002210000406; Nakamura K, 2006, J NEUROSCI, V26, P5360, DOI 10.1523/JNEUROSCI.4853-05.2006; Nakamura K, 2006, J NEUROSCI, V26, P12885, DOI 10.1523/JNEUROSCI.3688-06.2006; Narayanan NS, 2008, J NEUROPHYSIOL, V100, P520, DOI 10.1152/jn.00035.2008; Otani S, 1999, J NEUROSCI, V19, P9788; Passingham R., 1995, FRONTAL LOBES VOLUNT; Pasupathy A, 2005, NATURE, V433, P873, DOI 10.1038/nature03287; Pavlov I.P., 1927, CONDITIONED REFLEXES; Petrides M, 2006, J COMP NEUROL, V498, P227, DOI 10.1002/cne.21048; PETRIDES M, 1985, NEUROPSYCHOLOGIA, V23, P601, DOI 10.1016/0028-3932(85)90062-4; Petrides M, 2007, J NEUROSCI, V27, P11573, DOI 10.1523/JNEUROSCI.2419-07.2007; Petrides Michael, 1994, Current Opinion in Neurobiology, V4, P207, DOI 10.1016/0959-4388(94)90074-4; Rangel A, 2008, NAT REV NEUROSCI, V9, P545, DOI 10.1038/nrn2357; Rumelhart G.E., 1986, PARALLEL DISTRIBUTED, P318, DOI DOI 10.1016/B978-1-4832-1446-7.50035-2; Rushworth MFS, 2008, NAT NEUROSCI, V11, P389, DOI 10.1038/nn2066; Schmitzer-Torbert N, 2004, J NEUROPHYSIOL, V91, P2259, DOI 10.1152/jn.00687.2003; SCHULTZ W, 1993, PROG BRAIN RES, V99, P227; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; SCHULTZ W, 1993, J NEUROSCI, V13, P900; Seo H, 2007, CEREB CORTEX, V17, pI110, DOI 10.1093/cercor/bhm064; Seo H, 2009, J NEUROSCI, V29, P3627, DOI 10.1523/JNEUROSCI.4726-08.2009; Sidiropoulou K, 2009, NAT NEUROSCI, V12, P190, DOI 10.1038/nn.2245; Sugrue LP, 2005, NAT REV NEUROSCI, V6, P363, DOI 10.1038/nrn1666; THOMSON AM, 1994, TRENDS NEUROSCI, V17, P119, DOI 10.1016/0166-2236(94)90121-X; Tsodyks MV, 1997, P NATL ACAD SCI USA, V94, P719, DOI 10.1073/pnas.94.2.719; Uchida Y, 2007, J NEUROSCI, V27, P13750, DOI 10.1523/JNEUROSCI.2693-07.2007; Wallis JD, 2001, NATURE, V411, P953, DOI 10.1038/35082081; WATANABE M, 1989, NEUROSCI LETT, V101, P113, DOI 10.1016/0304-3940(89)90450-3; WILLIAMS SM, 1993, CEREB CORTEX, V3, P199, DOI 10.1093/cercor/3.3.199; Williams ZM, 2006, NAT NEUROSCI, V9, P562, DOI 10.1038/nn1662; Wirth S, 2009, NEURON, V61, P930, DOI 10.1016/j.neuron.2009.01.012; Wise SP, 1996, CRIT REV NEUROBIOL, V10, P317, DOI 10.1615/CritRevNeurobiol.v10.i3-4.30	67	123	126	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 30	2009	63	2					244	253		10.1016/j.neuron.2009.06.019	http://dx.doi.org/10.1016/j.neuron.2009.06.019			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	479IS	19640482	Green Accepted, Green Submitted, Bronze			2022-12-24	WOS:000268653500012
J	Huang, YHH; Lin, Y; Mu, P; Lee, BR; Brown, TE; Wayman, G; Marie, H; Liu, WH; Yan, Z; Sorg, BA; Schluter, OM; Zukin, RS; Dong, Y				Huang, Yanhua H.; Lin, Ying; Mu, Ping; Lee, Brian R.; Brown, Travis E.; Wayman, Gary; Marie, Helene; Liu, Wenhua; Yan, Zhen; Sorg, Barbara A.; Schlueter, Oliver M.; Zukin, R. Suzanne; Dong, Yan			In Vivo Cocaine Experience Generates Silent Synapses	NEURON			English	Article							LONG-TERM POTENTIATION; NUCLEUS-ACCUMBENS NEURONS; VENTRAL TEGMENTAL AREA; NMDA RECEPTOR; BEHAVIORAL SENSITIZATION; SYNAPTIC PLASTICITY; AMPA RECEPTORS; EXPRESSION; LTP; MECHANISMS	Studies over the past decade have enunciated silent synapses as prominent cellular substrates for synaptic plasticity in the developing brain. However, little is known about whether silent synapses can be generated postdevelopmentally. Here, we demonstrate that highly salient in vivo experience, such as exposure to cocaine, generates silent synapses in the nucleus accumbens (NAc) shell, a key brain region mediating addiction-related learning and memory. Furthermore, this cocaine-induced generation of silent synapses is mediated by membrane insertions of new, NR2B-containing N-methyl-D-aspartic acid receptors (NMDARs). These results provide evidence that silent synapses can be generated de novo by in vivo experience and thus may act as highly efficient neural substrates for the subsequent experience-dependent synaptic plasticity underlying extremely long-lasting memory.	[Huang, Yanhua H.; Mu, Ping; Lee, Brian R.; Brown, Travis E.; Wayman, Gary; Sorg, Barbara A.; Dong, Yan] Washington State Univ, Program Neurosci, Pullman, WA 99164 USA; [Lin, Ying; Zukin, R. Suzanne] Albert Einstein Coll Med, Dominick P Purpura Dept Neurosci, Bronx, NY 10461 USA; [Marie, Helene] European Brain Res Inst, I-00143 Rome, Italy; [Liu, Wenhua; Yan, Zhen] SUNY Buffalo, Dept Physiol, Buffalo, NY 14214 USA; [Schlueter, Oliver M.] European Neurosci Inst, Dept Mol Neurobiol, D-37077 Gottingen, Germany	Washington State University; Yeshiva University; Albert Einstein College of Medicine; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Dong, Y (corresponding author), Washington State Univ, Program Neurosci, Pullman, WA 99164 USA.	yan_dong@wsu.edu	Huang, Yanhua/P-1583-2015; Dong, Yan/A-4154-2016; Marie, Hélène/F-1404-2011	Huang, Yanhua/0000-0003-1770-0196; Dong, Yan/0000-0003-0016-9028; Marie, Hélène/0000-0003-2310-6097; Sorg, Barbara/0000-0002-4913-4910; Lee, Brian/0000-0002-3210-5638	State of Washington Initiative [171]; NIH [DA023206]; Hope Foundation for Depression Research; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA023206] Funding Source: NIH RePORTER	State of Washington Initiative; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hope Foundation for Depression Research; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank Drs. Rob Malenka for inspiring discussions; Andres Barria for providing NR1 constructs; and Roberto Malinow, Roger Nicoll, Dwight Bergles, Terry Robinson, Julie Kauer, Nils Brose, John Williams, Billy Chen, Woody Hopf, Jenny Baylon, and Bryan Slinker for comments on the manuscript. This research was supported by State of Washington Initiative Measure No. 171, NIH DA023206, and the Hope Foundation for Depression Research. Cocaine was supplied in part by the Drug Supply Program of NIH NIDA.	Argilli E, 2008, J NEUROSCI, V28, P9092, DOI 10.1523/JNEUROSCI.1001-08.2008; Baker DA, 2003, NAT NEUROSCI, V6, P743, DOI 10.1038/nn1069; Barria A, 2002, NEURON, V35, P345, DOI 10.1016/S0896-6273(02)00776-6; Barria A, 2005, NEURON, V48, P289, DOI 10.1016/j.neuron.2005.08.034; Boudreau AC, 2005, J NEUROSCI, V25, P9144, DOI 10.1523/JNEUROSCI.2252-05.2005; Boudreau AC, 2007, J NEUROSCI, V27, P10621, DOI 10.1523/JNEUROSCI.2163-07.2007; Conrad KL, 2008, NATURE, V454, P118, DOI 10.1038/nature06995; CULLCANDY SG, 2004, SCI STKE, pRE6; Dong Y, 2006, NAT NEUROSCI, V9, P475, DOI 10.1038/nn1661; Durand GM, 1996, NATURE, V381, P71, DOI 10.1038/381071a0; Gerdeman GL, 2003, TRENDS NEUROSCI, V26, P184, DOI 10.1016/S0166-2236(03)00065-1; Goto Y, 2005, NEURON, V47, P255, DOI 10.1016/j.neuron.2005.06.017; Groc L, 2006, TRENDS NEUROSCI, V29, P132, DOI 10.1016/j.tins.2006.01.005; Hsia AY, 1998, J NEUROPHYSIOL, V79, P2013, DOI 10.1152/jn.1998.79.4.2013; Huang YH, 2008, J BIOL CHEM, V283, P2751, DOI 10.1074/jbc.M706578200; Hyman SE, 2006, ANNU REV NEUROSCI, V29, P565, DOI 10.1146/annurev.neuro.29.051605.113009; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; JAHR CE, 1990, J NEUROSCI, V10, P3178; Kelley AE, 2004, NEURON, V44, P161, DOI 10.1016/j.neuron.2004.09.016; Kerchner GA, 2008, NAT REV NEUROSCI, V9, P813, DOI 10.1038/nrn2501; Kourrich S, 2007, J NEUROSCI, V27, P7921, DOI 10.1523/JNEUROSCI.1859-07.2007; KULLMANN DM, 1994, NEURON, V12, P1111, DOI 10.1016/0896-6273(94)90318-2; Liao DZ, 1996, LEARN MEMORY, V3, P138, DOI 10.1101/lm.3.2-3.138; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; Ma YY, 2007, EXP NEUROL, V203, P309, DOI 10.1016/j.expneurol.2006.08.014; Ma YY, 2006, EXP NEUROL, V200, P343, DOI 10.1016/j.expneurol.2006.02.117; Marie H, 2005, NEURON, V45, P741, DOI 10.1016/j.neuron.2005.01.039; Martin M, 2006, NAT NEUROSCI, V9, P868, DOI 10.1038/nn1713; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; Moussawi K, 2009, NAT NEUROSCI, V12, P182, DOI 10.1038/nn.2250; Petralia RS, 1999, NAT NEUROSCI, V2, P31, DOI 10.1038/4532; Schilstrom B, 2006, J NEUROSCI, V26, P8549, DOI 10.1523/JNEUROSCI.5179-05.2006; Szumlinski KK, 2004, NEURON, V43, P401, DOI 10.1016/j.neuron.2004.07.019; Thomas MJ, 2001, NAT NEUROSCI, V4, P1217, DOI 10.1038/nn757; Waites CL, 2005, ANNU REV NEUROSCI, V28, P251, DOI 10.1146/annurev.neuro.27.070203.144336; Wenthold RJ, 2003, ANNU REV PHARMACOL, V43, P335, DOI 10.1146/annurev.pharmtox.43.100901.135803; Wolf Marina E, 2002, Mol Interv, V2, P146, DOI 10.1124/mi.2.3.146; Wolf ME, 1998, PROG NEUROBIOL, V54, P679, DOI 10.1016/S0301-0082(97)00090-7	38	194	195	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 16	2009	63	1					40	47		10.1016/j.neuron.2009.06.007	http://dx.doi.org/10.1016/j.neuron.2009.06.007			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	473EX	19607791	Green Accepted, Bronze			2022-12-24	WOS:000268189900007
J	Yamashita, T; Eguchi, K; Saitoh, N; von Gersdorff, H; Takahashi, T				Yamashita, Takayuki; Eguchi, Kohgaku; Saitoh, Naoto; von Gersdorff, Henrique; Takahashi, Tomoyuki			Developmental shift to a mechanism of synaptic vesicle endocytosis requiring nanodomain Ca2+	NATURE NEUROSCIENCE			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; ADRENAL CHROMAFFIN CELLS; RETINAL BIPOLAR CELLS; FAST CNS SYNAPSE; TRANSMITTER RELEASE; CALCIUM-DEPENDENCE; RAPID ENDOCYTOSIS; SLOW ENDOCYTOSIS; NERVE-TERMINALS; DYNAMIN	Ca2+ is thought to be essential for the exocytosis and endocytosis of synaptic vesicles. However, the manner in which Ca2+ coordinates these processes remains unclear, particularly at mature synapses. Using membrane capacitance measurements from calyx of Held nerve terminals in rats, we found that vesicle endocytosis is initiated primarily in Ca2+ nanodomains around Ca2+ channels, where exocytosis is triggered. Bulk Ca2+ outside of the domain could also be involved in endocytosis at immature synapses, although only after extensive exocytosis at more mature synapses. This bulk Ca2+-dependent endocytosis required calmodulin and calcineurin activation at immature synapses, but not at more mature synapses. Similarly, GTP-independent endocytosis, which occurred after extensive exocytosis at immature synapses, became negligible after maturation. We propose that nanodomain Ca2+ simultaneously triggers exocytosis and endocytosis of synaptic vesicles and that the molecular mechanisms underlying Ca2+-dependent endocytosis undergo major developmental changes at this fast central synapse.	[Yamashita, Takayuki; Eguchi, Kohgaku; Takahashi, Tomoyuki] Okinawa Inst Sci & Technology Promot Corp, Initial Res Project, Cellular & Mol Synapt Funct Unit, Okinawa, Japan; [Saitoh, Naoto; Takahashi, Tomoyuki] Doshisha Univ, Fac Life & Med Sci, Dept Neurophysiol, Kyoto 602, Japan; [von Gersdorff, Henrique] Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97201 USA	Okinawa Institute of Science & Technology Graduate University; Doshisha University; Oregon Health & Science University	Takahashi, T (corresponding author), Okinawa Inst Sci & Technology Promot Corp, Initial Res Project, Cellular & Mol Synapt Funct Unit, Okinawa, Japan.	tyamashi@oist.jp; ttakahas@mail.doshisha.ac.jp	Eguchi, Kohgaku/C-1402-2015; Yamashita, Takayuki/F-7589-2010; Takahashi, Tomoyuki/G-5951-2015	Eguchi, Kohgaku/0000-0002-6170-2546; Takahashi, Tomoyuki/0000-0002-8771-7666; Yamashita, Takayuki/0000-0002-1849-9837	Core Research for Evolutional Science and Technology of Japan Science and Technology Agency; US National Institutes of Health [EY014043]; Japanese Ministry of Education, Culture, Sports, Science and Technology [20700357]; NATIONAL EYE INSTITUTE [R01EY014043] Funding Source: NIH RePORTER	Core Research for Evolutional Science and Technology of Japan Science and Technology Agency(Core Research for Evolutional Science and Technology (CREST)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank E. Johnson and S. Takamori for helpful comments. This work was supported by the Core Research for Evolutional Science and Technology of Japan Science and Technology Agency (T.T.), US National Institutes of Health grant EY014043 (H.v.G.) and Grant-in-Aid for Young Scientists from the Japanese Ministry of Education, Culture, Sports, Science and Technology #20700357 (T.Y.).	Artalejo CR, 1996, NEURON, V16, P195, DOI 10.1016/S0896-6273(00)80036-7; ARTALEJO CR, 1995, P NATL ACAD SCI USA, V92, P8328, DOI 10.1073/pnas.92.18.8328; Augustine GJ, 2003, NEURON, V40, P331, DOI 10.1016/S0896-6273(03)00639-1; Balaji J, 2008, J NEUROSCI, V28, P6742, DOI 10.1523/JNEUROSCI.1082-08.2008; Beutner D, 2001, NEURON, V29, P681, DOI 10.1016/S0896-6273(01)00243-4; Borst JGG, 1996, NATURE, V383, P431, DOI 10.1038/383431a0; Burgoyne RD, 2007, NAT REV NEUROSCI, V8, P182, DOI 10.1038/nrn2093; Chan SA, 2001, J PHYSIOL-LONDON, V537, P871; Chen Y, 2003, CELL, V115, P37, DOI 10.1016/S0092-8674(03)00726-8; Cousin MA, 2001, TRENDS NEUROSCI, V24, P659, DOI 10.1016/S0166-2236(00)01930-5; Daly C, 2002, J BIOL CHEM, V277, P9010, DOI 10.1074/jbc.M110815200; Engisch KL, 1998, J PHYSIOL-LONDON, V506, P591, DOI 10.1111/j.1469-7793.1998.591bv.x; Fedchyshyn MJ, 2005, J NEUROSCI, V25, P4131, DOI 10.1523/JNEUROSCI.0350-05.2005; Gad H, 1998, NEURON, V21, P607, DOI 10.1016/S0896-6273(00)80570-X; Granseth B, 2006, NEURON, V51, P773, DOI 10.1016/j.neuron.2006.08.029; Heidelberger R, 2001, J NEUROSCI, V21, P6467, DOI 10.1523/JNEUROSCI.21-17-06467.2001; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; Hosoi N, 2009, NEURON, V63, P216, DOI 10.1016/j.neuron.2009.06.010; JEWETT DL, 1972, BRAIN RES, V36, P101, DOI 10.1016/0006-8993(72)90769-X; Jockusch WJ, 2005, NEURON, V46, P869, DOI 10.1016/j.neuron.2005.05.004; Kawasaki F, 2000, NAT NEUROSCI, V3, P859, DOI 10.1038/78753; Kimura M, 2003, J PHYSIOL-LONDON, V553, P415, DOI 10.1113/jphysiol.2003.048371; KOENIG JH, 1989, J NEUROSCI, V9, P3844; Llinas RR, 2004, P NATL ACAD SCI USA, V101, P17855, DOI 10.1073/pnas.0408200101; Lou XL, 2008, P NATL ACAD SCI USA, V105, P17555, DOI 10.1073/pnas.0809621105; Marks B, 1998, CURR BIOL, V8, P740, DOI 10.1016/S0960-9822(98)70297-0; Nakamura T, 2008, J PHYSIOL-LONDON, V586, P2253, DOI 10.1113/jphysiol.2007.142521; Nakamura Y, 2007, NEUROSCI RES, V58, pS71, DOI 10.1016/j.neures.2007.06.415; Naraghi M, 1997, J NEUROSCI, V17, P6961; Neher E, 1998, NEURON, V20, P389, DOI 10.1016/S0896-6273(00)80983-6; Neves G, 2001, P NATL ACAD SCI USA, V98, P15282, DOI 10.1073/pnas.261311698; Newton AJ, 2006, P NATL ACAD SCI USA, V103, P17955, DOI 10.1073/pnas.0606212103; Poskanzer KE, 2003, NATURE, V426, P559, DOI 10.1038/nature02184; Renden R, 2007, J NEUROPHYSIOL, V98, P3349, DOI 10.1152/jn.00898.2007; Roos J, 1999, CURR BIOL, V9, P1411, DOI 10.1016/S0960-9822(00)80087-1; Shifman JM, 2006, P NATL ACAD SCI USA, V103, P13968, DOI 10.1073/pnas.0606433103; Slepnev VI, 1998, SCIENCE, V281, P821, DOI 10.1126/science.281.5378.821; Teng HB, 2000, J NEUROSCI, V20, P7986; Torok K, 1998, BIOCHEMISTRY-US, V37, P6188, DOI 10.1021/bi972773e; VONGERSDORFF H, 1994, NATURE, V370, P652, DOI 10.1038/370652a0; Watanabe H, 2010, J NEUROSCI, V30, P655, DOI 10.1523/JNEUROSCI.3214-09.2010; Wu LG, 2007, J NEUROSCI, V27, P11793, DOI 10.1523/JNEUROSCI.3471-07.2007; Wu W, 2005, J NEUROSCI, V25, P11676, DOI 10.1523/JNEUROSCI.2972-05.2005; Wu XS, 2009, NAT NEUROSCI, V12, P1003, DOI 10.1038/nn.2355; Wu Y, 2005, J NEUROPHYSIOL, V93, P2396, DOI 10.1152/jn.01108.2004; Xu JH, 2005, NEURON, V46, P633, DOI 10.1016/j.neuron.2005.03.024; Xu JH, 2008, NAT NEUROSCI, V11, P45, DOI 10.1038/nn2021; Yamashita T, 2005, SCIENCE, V307, P124, DOI 10.1126/science.1103631	48	69	69	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2010	13	7					838	U76		10.1038/nn.2576	http://dx.doi.org/10.1038/nn.2576			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	615YF	20562869	Green Accepted			2022-12-24	WOS:000279173900016
J	McKernan, R; McNeish, J; Smith, D				McKernan, Ruth; McNeish, John; Smith, Devyn			Pharma's Developing Interest in Stem Cells	CELL STEM CELL			English	Editorial Material								Human stem cell biology is driving the promise of novel regenerative therapies into clinical trials. Although the pharmaceutical industry has embraced stem cells as tools in drug discovery, few companies have taken the risk to deliver stem cell-based medicines. Here, we evaluate the various cell-based opportunities and corporate strategies.	[McKernan, Ruth] Pfizer Regenerat Med, Cambridge CB21 6GP, England; [McNeish, John] Pfizer Regenerat Med, Cambridge, MA 02139 USA; [Smith, Devyn] Pfizer Strateg Management Grp, New London, CT 06340 USA	Pfizer; Pfizer; Pfizer	McKernan, R (corresponding author), Pfizer Regenerat Med, Cambridge CB21 6GP, England.	ruth.mckernan@pfizer.com						Abdel-Latif A, 2007, ARCH INTERN MED, V167, P989, DOI 10.1001/archinte.167.10.989; Chen S, 2009, NAT CHEM BIOL, V5, P258, DOI 10.1038/nchembio.154; Ding S, 2004, NAT BIOTECHNOL, V22, P833, DOI 10.1038/nbt987; Flomenberg N, 2010, BIOL BLOOD MARROW TR, V16, P695, DOI 10.1016/j.bbmt.2009.12.538; Klyushnenkova E, 2005, J BIOMED SCI, V12, P47, DOI 10.1007/s11373-004-8183-7; Martin-Rendon E, 2008, EUR HEART J, V29, P1807, DOI 10.1093/eurheartj/ehn220; ROWNTREE R, 2010, REGEN MED IN PRESS; SMITH D, 2009, WORLD STEM CELL REPO, P131; Trounson A, 2010, CELL STEM CELL, V6, P513, DOI 10.1016/j.stem.2010.05.008; Uccelli A, 2008, NAT REV IMMUNOL, V8, P726, DOI 10.1038/nri2395; Wu X, 2004, J AM CHEM SOC, V126, P1590, DOI 10.1021/ja038950i	11	64	64	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	JUN 4	2010	6	6					517	520		10.1016/j.stem.2010.05.012	http://dx.doi.org/10.1016/j.stem.2010.05.012			4	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	611SB	20569688	Bronze			2022-12-24	WOS:000278840700011
J	Kawakami, M; Sipp, D; Kato, K				Kawakami, Masahiro; Sipp, Douglas; Kato, Kazuto			Regulatory Impacts on Stem Cell Research in Japan	CELL STEM CELL			English	Editorial Material							LINES	Although it is a leader in many fields of stem cell research, Japan's policies on many areas of stem cell research have not been widely reported or analyzed in the international literature. In this report, we provide an overview of Japan's centralized approach to regulation and analyze its policy implementation.	[Kawakami, Masahiro; Kato, Kazuto] Kyoto Univ, Inst Res Humanities, Kyoto 6068501, Japan; [Kato, Kazuto] Kyoto Univ, Grad Sch Biostudies, Lab Sci Commun & Bioeth, Kyoto 6068501, Japan; [Kato, Kazuto] Kyoto Univ, Inst Integrated Cell Mat Sci, Kyoto 6068501, Japan; [Sipp, Douglas] RIKEN, Ctr Dev Biol, Kobe, Hyogo 6500047, Japan	Kyoto University; Kyoto University; Kyoto University; RIKEN	Kato, K (corresponding author), Kyoto Univ, Inst Res Humanities, Kyoto 6068501, Japan.	kato@zinbun.kyoto-u.ac.jp	Sipp, Doug/C-9218-2017	Sipp, Doug/0000-0002-5979-0938; Kato, Kazuto/0000-0001-9006-9551	MEXT, Japan; Research Institute for Science and Technology for Society (RISTEX), Japan	MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Research Institute for Science and Technology for Society (RISTEX), Japan	This work was partly supported by a grant under the Leading Project of MEXT, Japan, to K.K. and the "Development for Deliberation and Cooperation between Citizens and Scientists" project from the Research Institute for Science and Technology for Society (RISTEX), Japan, to Hideyuki Hirakawa (in which K.K. is a collaborator).	Colman A, 2008, CELL, V132, P519, DOI 10.1016/j.cell.2008.01.037; Kato Kazuto, 2005, CROSSING BORDERS CUL, P369; Levine AD, 2008, CELL STEM CELL, V2, P521, DOI 10.1016/j.stem.2008.05.008; Suemori H, 2006, BIOCHEM BIOPH RES CO, V345, P926, DOI 10.1016/j.bbrc.2006.04.135; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145	7	15	16	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	MAY 7	2010	6	5					415	418		10.1016/j.stem.2010.04.010	http://dx.doi.org/10.1016/j.stem.2010.04.010			4	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	598NO	20452315	Bronze			2022-12-24	WOS:000277844800008
J	Kim, J; Alger, BE				Kim, Jimok; Alger, Bradley E.			Reduction in endocannabinoid tone is a homeostatic mechanism for specific inhibitory synapses	NATURE NEUROSCIENCE			English	Article							CB1 CANNABINOID RECEPTOR; HIPPOCAMPAL SLICE CULTURES; SYNAPTIC-TRANSMISSION; GABA RELEASE; RAT HIPPOCAMPUS; AXON TERMINALS; GAIN-CONTROL; MOUSE-BRAIN; PLASTICITY; EXPRESSION	When chronic alterations in neuronal activity occur, network gain is maintained by global homeostatic scaling of synaptic strength, but the stability of microcircuits can be controlled by unique adaptations that differ from the global changes. It is not understood how specificity of synaptic tuning is achieved. We found that, although a large population of inhibitory synapses was homeostatically scaled down after chronic inactivity, decreased endocannabinoid tone specifically strengthened a subset of GABAergic synapses that express cannabinoid receptors. In rat hippocampal slice cultures, a 3-5-d blockade of neuronal firing facilitated uptake and degradation of anandamide. The consequent reduction in basal stimulation of cannabinoid receptors augmented GABA release probability, fostering rapid depression of synaptic inhibition and on-demand disinhibition. This regulatory mechanism, mediated by activity-dependent changes in tonic endocannabinoid level, permits selective local tuning of inhibitory synapses in hippocampal networks. (C) 2010 Nature America, Inc. All rights reserved.	[Kim, Jimok; Alger, Bradley E.] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA; [Alger, Bradley E.] Univ Maryland, Sch Med, Dept Psychiat, Baltimore, MD 21201 USA; [Alger, Bradley E.] Univ Maryland, Sch Med, Program Neurosci, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Alger, BE (corresponding author), Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA.	balgerlab@gmail.com			US Institutes of Health [R01 DA014625, R01 MH077277]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH077277] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA014625] Funding Source: NIH RePORTER	US Institutes of Health; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank T. Abrams and the members of the Alger laboratory for helpful comments and suggestions on this work. We thank T. Gover for expert assistance with the calcium-imaging experiments. This research was supported by US Institutes of Health grants R01 DA014625 and R01 MH077277 to B. E. A.	Alger BE, 2002, PROG NEUROBIOL, V68, P247; Bartley AF, 2008, J NEUROPHYSIOL, V100, P1983, DOI 10.1152/jn.90635.2008; Bausch SB, 2006, J NEUROPHYSIOL, V96, P2151, DOI 10.1152/jn.00355.2006; Bertrand S, 2001, J PHYSIOL-LONDON, V532, P369, DOI 10.1111/j.1469-7793.2001.0369f.x; Buckby LE, 2006, MOL CELL NEUROSCI, V31, P805, DOI 10.1016/j.mcn.2006.01.009; Burrone J, 2003, CURR OPIN NEUROBIOL, V13, P560, DOI 10.1016/j.conb.2003.09.007; Chen K, 2003, NEURON, V39, P599, DOI 10.1016/S0896-6273(03)00499-9; Chevaleyre V, 2003, NEURON, V38, P461, DOI 10.1016/S0896-6273(03)00235-6; Cristino L, 2008, NEUROSCIENCE, V151, P955, DOI 10.1016/j.neuroscience.2007.11.047; Echegoyen J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000700; Egertova M, 2008, J COMP NEUROL, V506, P604, DOI 10.1002/cne.21568; FABER DS, 1991, BIOPHYS J, V60, P1288, DOI 10.1016/S0006-3495(91)82162-2; Falenski KW, 2007, NEUROSCIENCE, V146, P1232, DOI 10.1016/j.neuroscience.2007.01.065; Fernandez-Ruiz J, 2000, TRENDS NEUROSCI, V23, P14, DOI 10.1016/S0166-2236(99)01491-5; Foldy C, 2006, J NEUROSCI, V26, P1465, DOI 10.1523/JNEUROSCI.4587-05.2006; Fortin DA, 2004, J NEUROPHYSIOL, V92, P2105, DOI 10.1152/jn.00351.2004; Giuffrida A, 2001, J PHARMACOL EXP THER, V298, P7; Glickfeld LL, 2006, NAT NEUROSCI, V9, P807, DOI 10.1038/nn1688; Hartman KN, 2006, NAT NEUROSCI, V9, P642, DOI 10.1038/nn1677; Hashimotodani Y, 2007, J NEUROSCI, V27, P1211, DOI 10.1523/JNEUROSCI.4159-06.2007; Houweling AR, 2005, CEREB CORTEX, V15, P834, DOI 10.1093/cercor/bhh184; Hsieh C, 1999, J NEUROCHEM, V73, P493, DOI 10.1046/j.1471-4159.1999.0730493.x; Kano M, 2009, PHYSIOL REV, V89, P309, DOI 10.1152/physrev.00019.2008; Katona I, 1999, J NEUROSCI, V19, P4544; Kawamura Y, 2006, J NEUROSCI, V26, P2991, DOI 10.1523/JNEUROSCI.4872-05.2006; Kilman V, 2002, J NEUROSCI, V22, P1328, DOI 10.1523/JNEUROSCI.22-04-01328.2002; Kim J, 2002, J NEUROSCI, V22, P10182; Kim J, 2004, NAT NEUROSCI, V7, P697, DOI 10.1038/nn1262; Kim J, 2008, NEURON, V58, P925, DOI 10.1016/j.neuron.2008.05.009; Leung D, 2006, BIOCHEMISTRY-US, V45, P4720, DOI 10.1021/bi060163l; Losonczy A, 2004, P NATL ACAD SCI USA, V101, P1362, DOI 10.1073/pnas.0304752101; Luk T, 2004, BRIT J PHARMACOL, V142, P495, DOI 10.1038/sj.bjp.0705792; Maffei A, 2004, NAT NEUROSCI, V7, P1353, DOI 10.1038/nn1351; Marsicano G, 1999, EUR J NEUROSCI, V11, P4213, DOI 10.1046/j.1460-9568.1999.00847.x; McKinney RA, 1997, NAT MED, V3, P990, DOI 10.1038/nm0997-990; Morozov YM, 2004, EUR J NEUROSCI, V20, P459, DOI 10.1111/j.1460-9568.2004.03507.x; Neu A, 2007, J PHYSIOL-LONDON, V578, P233, DOI 10.1113/jphysiol.2006.115691; Nyilas R, 2008, J NEUROSCI, V28, P1058, DOI 10.1523/JNEUROSCI.5102-07.2008; Okamoto Y, 2007, CHEM BIODIVERS, V4, P1842, DOI 10.1002/cbdv.200790155; Piomelli D, 2006, CNS DRUG REV, V12, P21, DOI 10.1111/j.1527-3458.2006.00021.x; Poncer JC, 1997, NEURON, V18, P463, DOI 10.1016/S0896-6273(00)81246-5; Rinaldi-Carmona M, 1998, J PHARMACOL EXP THER, V287, P1038; Sugiura T, 2009, BIOFACTORS, V35, P88, DOI 10.1002/biof.18; Trasande CA, 2007, J CLIN NEUROPHYSIOL, V24, P154, DOI 10.1097/WNP.0b013e318033787f; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Turrigiano GG, 2008, CELL, V135, P422, DOI 10.1016/j.cell.2008.10.008; van der Stelt M, 2005, NEUROMOL MED, V7, P37, DOI 10.1385/NMM:7:1-2:037; Varvel SA, 2007, NEUROPSYCHOPHARMACOL, V32, P1032, DOI 10.1038/sj.npp.1301224; Wilson RI, 2001, NEURON, V31, P453, DOI 10.1016/S0896-6273(01)00372-5	49	113	113	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2010	13	5					592	U104		10.1038/nn.2517	http://dx.doi.org/10.1038/nn.2517			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	588JM	20348918	Green Accepted			2022-12-24	WOS:000277065700017
J	Pfeiffer, BE; Zang, T; Wilkerson, JR; Taniguchi, M; Maksimova, MA; Smith, LN; Cowan, CW; Hubert, KM				Pfeiffer, Brad E.; Zang, Tong; Wilkerson, Julia R.; Taniguchi, Makoto; Maksimova, Marina A.; Smith, Laura N.; Cowan, Christopher W.; Hubert, Kimberly M.			Fragile X Mental Retardation Protein Is Required for Synapse Elimination by the Activity-Dependent Transcription Factor MEF2	NEURON			English	Article							POSTSYNAPTICALLY SILENT SYNAPSES; PRIMARY SOMATOSENSORY CORTEX; DENDRITIC SPINE; PYRAMIDAL NEURONS; VISUAL-CORTEX; MESSENGER-RNA; DIFFERENTIATION; PLASTICITY; GENES; POLYRIBOSOMES	Fragile X syndrome (FXS), the most common genetic form of mental retardation and autism, is caused by loss-of-function mutations in an RNA-binding protein, Fragile X Mental Retardation Protein (FMRP). Neurons from patients and the mouse Fmr1 knockout (KO) model are characterized by an excess of dendritic spines, suggesting a deficit in excitatory synapse elimination. In response to neuronal activity, myocyte enhancer factor 2 (MEF2) transcription factors induce robust synapse elimination. Here, we demonstrate that MEF2 activation fails to eliminate functional or structural excitatory synapses in hippocampal neurons from Fmr1 KO mice. Similarly, inhibition of endogenous MEF2 increases synapse number in wild-type but not Fmr1 KO neurons. MEF2-dependent synapse elimination is rescued in Fmr1 KO neurons by acute postsynaptic expression of wildtype but not RNA-binding mutants of FMRP. Our results reveal that active MEF2 and FMRP function together in an acute, cell-autonomous mechanism to eliminate excitatory synapses	[Taniguchi, Makoto; Smith, Laura N.; Cowan, Christopher W.] Univ Texas SW Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA; [Pfeiffer, Brad E.; Zang, Tong; Wilkerson, Julia R.; Maksimova, Marina A.; Hubert, Kimberly M.] Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Cowan, CW (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA.	christopher.cowan@utsouthwestern.edu; kimberly.huber@utsouthwestern.edu	Smith, Laura/W-2716-2018; Cowan, Christopher W/I-2497-2014; Huber, Kimberly/X-5534-2019; Litvinova, Marina/C-6154-2017	Smith, Laura/0000-0003-3687-3148; Taniguchi, Makoto/0000-0001-6356-2463; Litvinova, Marina/0000-0002-2622-6548; WILKERSON, JULIA/0000-0002-7497-2270	NIH [1F31NS050992, NS045711, HD052731, DA08227, T32DA07290, F32DA27265]; Autism Speaks; Whitehall Foundation; Simons Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD052731] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY018207] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS050992, R01NS045711] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA007290, P01DA008227, F32DA027265] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Autism Speaks; Whitehall Foundation; Simons Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was supported by NIH grants 1F31NS050992 (B.E.P.), NS045711, HD052731 (K.M.H.), DA08227 (C.W.C.), T32DA07290 and F32DA27265 (L.N.S.), and grants from Autism Speaks (K.M.H.), the Whitehall (C.W.C.) and Simons Foundations (K.M.H. and C.W.C.). We would like to thank K. Loerwald and C. Hale for technical assistance; E. Kavalali for helpful discussions; and E. Olson for providing the MEF2-EN construct. K.M.H. is a paid SAB member of Seaside Therapeutics.	Abrahams BS, 2008, NAT REV GENET, V9, P341, DOI 10.1038/nrg2346; Arnold MA, 2007, DEV CELL, V12, P377, DOI 10.1016/j.devcel.2007.02.004; Barbosa AC, 2008, P NATL ACAD SCI USA, V105, P9391, DOI 10.1073/pnas.0802679105; Bassell GJ, 2008, NEURON, V60, P201, DOI 10.1016/j.neuron.2008.10.004; Busetto G, 2008, J PHYSIOL-LONDON, V586, P1519, DOI 10.1113/jphysiol.2007.149336; Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252; Chandrasekaran AR, 2007, J NEUROSCI, V27, P1746, DOI 10.1523/JNEUROSCI.4383-06.2007; Darnell JC, 2005, GENES BRAIN BEHAV, V4, P341, DOI 10.1111/j.1601-183X.2005.00144.x; Darnell JC, 2005, GENE DEV, V19, P903, DOI 10.1101/gad.1276805; Darnell JC, 2001, CELL, V107, P489, DOI 10.1016/S0092-8674(01)00566-9; DEBOULLE K, 1993, NAT GENET, V3, P31, DOI 10.1038/ng0193-31; Feng Y, 1997, J NEUROSCI, V17, P1539; Feng Y, 1997, MOL CELL, V1, P109, DOI 10.1016/S1097-2765(00)80012-X; Flavell SW, 2008, NEURON, V60, P1022, DOI 10.1016/j.neuron.2008.11.029; Galvez R, 2005, AM J MED GENET A, V135A, P155, DOI 10.1002/ajmg.a.30709; Glessner JT, 2009, NATURE, V459, P569, DOI 10.1038/nature07953; Hua JYY, 2004, NAT NEUROSCI, V7, P327, DOI 10.1038/nn1218; Irwin SA, 2002, AM J MED GENET, V111, P140, DOI 10.1002/ajmg.10500; Irwin SA, 2001, AM J MED GENET, V98, P161, DOI 10.1002/1096-8628(20010115)98:2<161::AID-AJMG1025>3.0.CO;2-B; Laggerbauer B, 2001, HUM MOL GENET, V10, P329, DOI 10.1093/hmg/10.4.329; Li H, 2008, P NATL ACAD SCI USA, V105, P9397, DOI 10.1073/pnas.0802876105; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; McAllister A. Kimberley, 2004, V245, P197; McKinsey TA, 2002, TRENDS BIOCHEM SCI, V27, P40, DOI 10.1016/S0968-0004(01)02031-X; Molkentin JD, 1996, MOL CELL BIOL, V16, P2627; Morrow EM, 2008, SCIENCE, V321, P218, DOI 10.1126/science.1157657; Nimchinsky EA, 2001, J NEUROSCI, V21, P5139, DOI 10.1523/JNEUROSCI.21-14-05139.2001; Pfeiffer BE, 2007, J NEUROSCI, V27, P3120, DOI 10.1523/JNEUROSCI.0054-07.2007; Pulipparacharuvil S, 2008, NEURON, V59, P621, DOI 10.1016/j.neuron.2008.06.020; RAKIC P, 1986, SCIENCE, V232, P232, DOI 10.1126/science.3952506; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Schaeffer C, 2001, EMBO J, V20, P4803, DOI 10.1093/emboj/20.17.4803; Shalizi A, 2006, SCIENCE, V311, P1012, DOI 10.1126/science.1122513; Sorra KE, 2000, HIPPOCAMPUS, V10, P501, DOI 10.1002/1098-1063(2000)10:5<501::AID-HIPO1>3.0.CO;2-T; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Turrigiano GG, 2008, CELL, V135, P422, DOI 10.1016/j.cell.2008.10.008; Wang K, 2009, NATURE, V459, P528, DOI 10.1038/nature07999; Wierenga CJ, 2006, J NEUROPHYSIOL, V96, P2127, DOI 10.1152/jn.00107.2006; WIESEL TN, 1982, NATURE, V299, P583, DOI 10.1038/299583a0; Zuo Y, 2005, NATURE, V436, P261, DOI 10.1038/nature03715	40	119	122	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 29	2010	66	2					191	197		10.1016/j.neuron.2010.03.017	http://dx.doi.org/10.1016/j.neuron.2010.03.017			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	591NQ	20434996	Bronze, Green Accepted			2022-12-24	WOS:000277308200005
J	Shimoji, K; Yuasa, S; Onizuka, T; Hattori, F; Tanaka, T; Hara, M; Ohno, Y; Chen, H; Egasgira, T; Seki, T; Yae, K; Koshimizu, U; Ogawa, S; Fukuda, K				Shimoji, Kenichiro; Yuasa, Shinsuke; Onizuka, Takeshi; Hattori, Fumiyuki; Tanaka, Tomofumi; Hara, Mie; Ohno, Yohei; Chen, Hao; Egasgira, Toru; Seki, Tomohisa; Yae, Kojiro; Koshimizu, Uichi; Ogawa, Satoshi; Fukuda, Keiichi			G-CSF Promotes the Proliferation of Developing Cardiomyocytes In Vivo and in Derivation from ESCs and iPSCs	CELL STEM CELL			English	Article							COLONY-STIMULATING FACTOR; STEM-CELLS; MYOCYTE PROLIFERATION; RXR-ALPHA; GRANULOCYTE; DIFFERENTIATION; HEART; DEFICIENCY; PATHWAY; GROWTH	During a screen for humoral factors that promote cardiomyocyte differentiation from embryonic stem cells (ESCs), we found marked elevation of granulocyte colony-stimulating factor receptor (G-CSFR) mRNA in developing cardiomyocytes. We confirmed that both G-CSFR and G-CSF were specifically expressed in embryonic mouse heart at the midgestational stage, and expression levels were maintained throughout embryogenesis. Intrauterine G-CSF administration induced embryonic cardiomyocyte proliferation and caused hyperplasia. In contrast, approximately 50% of csf3r(-/-) mice died during late embryogenesis because of the thinning of atrioventricular walls. ESC-derived developing cardiomyocytes also strongly expressed G-CSFR. When extrinsic G-CSF was administered to the ESC- and human iPSC-derived cardiomyocytes, it markedly augmented their proliferation. Moreover, G-CSF-neutralizing antibody inhibited their proliferation. These findings indicated that G-CSF is critically involved in cardiomyocyte proliferation during development, and may be used to boost the yield of cardiomyocytes from ESCs for their potential application to regenerative medicine.	[Shimoji, Kenichiro; Yuasa, Shinsuke; Onizuka, Takeshi; Hattori, Fumiyuki; Tanaka, Tomofumi; Hara, Mie; Ohno, Yohei; Chen, Hao; Egasgira, Toru; Seki, Tomohisa; Yae, Kojiro; Fukuda, Keiichi] Keio Univ, Sch Med, Dept Regenerat Med & Adv Cardiac Therapeut, Tokyo 1608582, Japan; [Shimoji, Kenichiro; Yuasa, Shinsuke; Onizuka, Takeshi; Ohno, Yohei; Chen, Hao; Egasgira, Toru; Seki, Tomohisa; Ogawa, Satoshi] Keio Univ, Sch Med, Dept Internal Med, Div Cardiol, Tokyo 1608582, Japan; [Hattori, Fumiyuki; Tanaka, Tomofumi; Koshimizu, Uichi] Asubio Pharma Co Ltd, Biomed Res Labs, Tokyo 6188513, Japan	Keio University; Keio University; Asubio Pharma Co., Ltd.	Fukuda, K (corresponding author), Keio Univ, Sch Med, Dept Regenerat Med & Adv Cardiac Therapeut, Tokyo 1608582, Japan.	kfukuda@sc.itc.keio.ac.jp	Shimoji, Kenichiro/U-3203-2019; Seki, Tomohisa/L-3524-2013; Ohno, Yohei/GZA-6285-2022; Fukuda, Keiichi/L-3777-2013; Yuasa, Shinsuke/L-8310-2013	Yuasa, Shinsuke/0000-0001-5593-7552; Seki, Tomohisa/0000-0002-4281-135X	Ministry of Education, Science and Culture, Japan; National Institute of Biomedical Innovation, Japan	Ministry of Education, Science and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institute of Biomedical Innovation, Japan(National Institute of Biomedical Innovation)	This study was supported in part by research grants from the Ministry of Education, Science and Culture, Japan, and by the Program for Promotion of Fundamental Studies in Health Science of the National Institute of Biomedical Innovation, Japan.	Arnold SJ, 2000, MECH DEVELOP, V91, P249, DOI 10.1016/S0925-4773(99)00309-3; Behfar A, 2002, FASEB J, V16, P1558, DOI 10.1096/fj.02-0072com; Chen C, 2006, IMMUNITY, V25, P895, DOI 10.1016/j.immuni.2006.10.013; Chen HY, 2004, DEVELOPMENT, V131, P2219, DOI 10.1242/dev.01094; DEMETRI GD, 1991, BLOOD, V78, P2791; FUKUNAGA R, 1990, P NATL ACAD SCI USA, V87, P8702, DOI 10.1073/pnas.87.22.8702; Goddeeris MM, 2007, DEVELOPMENT, V134, P1593, DOI 10.1242/dev.02824; Grego-Bessa J, 2007, DEV CELL, V12, P415, DOI 10.1016/j.devcel.2006.12.011; Harada M, 2005, NAT MED, V11, P305, DOI 10.1038/nm1199; Hattori F, 2010, NAT METHODS, V7, P61, DOI [10.1038/NMETH.1403, 10.1038/nmeth.1403]; KAJSTURA J, 1994, EXP CELL RES, V215, P273, DOI 10.1006/excr.1994.1343; Kastner P, 1997, DEVELOPMENT, V124, P4749; Kawada H, 2004, BLOOD, V104, P3581, DOI 10.1182/blood-2004-04-1488; Lavine KJ, 2005, DEV CELL, V8, P85, DOI 10.1016/j.devcel.2004.12.002; LIESCHKE GJ, 1994, BLOOD, V84, P1737; Morrison SJ, 1997, P NATL ACAD SCI USA, V94, P1908, DOI 10.1073/pnas.94.5.1908; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Olson EN, 2003, GENE DEV, V17, P1937, DOI 10.1101/gad.1110103; Reiss K, 1996, P NATL ACAD SCI USA, V93, P8630, DOI 10.1073/pnas.93.16.8630; Richards MK, 2003, BLOOD, V102, P3562, DOI 10.1182/blood-2003-02-0593; Sasaki E, 2005, STEM CELLS, V23, P1304, DOI 10.1634/stemcells.2004-0366; Schneider VA, 2001, GENE DEV, V15, P304, DOI 10.1101/gad.855601; SOUZA LM, 1986, SCIENCE, V232, P61, DOI 10.1126/science.2420009; Srivastava D, 2006, CELL, V126, P1037, DOI 10.1016/j.cell.2006.09.003; SUCOV HM, 1994, GENE DEV, V8, P1007, DOI 10.1101/gad.8.9.1007; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tanaka T, 2009, BIOCHEM BIOPH RES CO, V385, P497, DOI 10.1016/j.bbrc.2009.05.073; Welte K, 1996, BLOOD, V88, P1907, DOI 10.1182/blood.V88.6.1907.bloodjournal8861907; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yuasa S, 2005, NAT BIOTECHNOL, V23, P607, DOI 10.1038/nbt1093	31	86	92	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAR 5	2010	6	3					227	237		10.1016/j.stem.2010.01.002	http://dx.doi.org/10.1016/j.stem.2010.01.002			11	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	577WL	20207226	Bronze			2022-12-24	WOS:000276254600010
J	Bellocchio, L; Lafenetre, P; Cannich, A; Cota, D; Puente, N; Grandes, P; Chaouloff, F; Piazza, PV; Marsicano, G				Bellocchio, Luigi; Lafenetre, Pauline; Cannich, Astrid; Cota, Daniela; Puente, Nagore; Grandes, Pedro; Chaouloff, Francis; Piazza, Pier Vincenzo; Marsicano, Giovanni			Bimodal control of stimulated food intake by the endocannabinoid system	NATURE NEUROSCIENCE			English	Article							ENERGY; INTEGRATION; NEURONS	Activation of cannabinoid type-1 receptors (CB1) is universally recognized as a powerful endogenous orexigenic signal, but the detailed underlying neuronal mechanisms are not fully understood. Using combined genetic and pharmacological approaches in mice, we found that ventral striatal CB1 receptors exerted a hypophagic action through inhibition of GABAergic transmission. Conversely, brain CB1 receptors modulating excitatory transmission mediated the well-known orexigenic effects of cannabinoids.	[Bellocchio, Luigi; Lafenetre, Pauline; Cannich, Astrid; Chaouloff, Francis; Marsicano, Giovanni] INSERM, U862, NeuroCtr Magendie Endocannabinoids & Neuroadaptat, Bordeaux, France; [Bellocchio, Luigi; Lafenetre, Pauline; Cannich, Astrid; Cota, Daniela; Chaouloff, Francis; Piazza, Pier Vincenzo; Marsicano, Giovanni] Univ Bordeaux, Bordeaux, France; [Cota, Daniela] INSERM, U862, NeuroCtr Magendie Energy Balance & Obes, Bordeaux, France; [Puente, Nagore] Univ Basque Country, Dept Neurosci, Fac Med & Dent, Leioia, Spain; [Piazza, Pier Vincenzo] INSERM, U862, NeuroCtr Magendie, Bordeaux, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; University of Basque Country; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux	Marsicano, G (corresponding author), INSERM, U862, NeuroCtr Magendie Endocannabinoids & Neuroadaptat, Bordeaux, France.	giovanni.marsicano@inserm.fr	Puente, Nagore/H-7054-2015; Chaouloff, Francis/N-7003-2017; Grandes, Pedro/AAA-1627-2019; Grandes, Pedro/H-7494-2015	Puente, Nagore/0000-0003-0866-5747; Chaouloff, Francis/0000-0001-9036-4067; Grandes, Pedro/0000-0003-3947-4230; Marsicano, Giovanni/0000-0003-3804-1951; Cota, Daniela/0000-0002-6909-2156	AVENIR/INSERMFondation Bettencourt-Schueller; Agence National de la Recherche [ANR-06-NEURO-043-01]; European Foundation; European Union [HEALTH-F2-2008-223713]; European Commission Network of European Neuroscience Institutes (ENINET) [LSHM-CT-2005-19063]; Basque Country Government [GIC07/70-IT-432-07]; Red de Trastornos Adictivos; Instituto de Salud Carlos III; Ministerio de Ciencia e Innovacion; Gobierno de Espana [RD07/0001/2001]; Basque Country University	AVENIR/INSERMFondation Bettencourt-Schueller(Institut National de la Sante et de la Recherche Medicale (Inserm)); Agence National de la Recherche(French National Research Agency (ANR)); European Foundation(European Science Foundation (ESF)); European Union(European Commission); European Commission Network of European Neuroscience Institutes (ENINET); Basque Country Government(Basque Government); Red de Trastornos Adictivos(Instituto de Salud Carlos III); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Gobierno de Espana(Spanish Government); Basque Country University	We thank F. George, P. Ciofi, V. Deroche-Gamonet and O. Moustie for help, D. Gonzales and the Genotyping Platform of the NeuroCentre Magendie for mouse genotyping, S. K. Nave, J. Rubenstein, M. Ekker, G. Schutz, T. Lemberger for providing Cre-expressing mice, and C. T. Wotjak, U. Pagotto, K. Monory, J. Lourenco, M. Vallee, B. Lutz and all the members of the Marsicano laboratory for valuable suggestions. This work was supported by AVENIR/INSERM and Fondation Bettencourt-Schueller (G. M.), Agence National de la Recherche (ANR-06-NEURO-043-01 to G. M.), the European Foundation for the Study of Diabetes (G. M.), European Union Seventh Framework Program (REPROBESITY, HEALTH-F2-2008-223713 to G. M.), European Commission Network of European Neuroscience Institutes (ENINET) (LSHM-CT-2005-19063 to G. M.), the Basque Country Government (GIC07/70-IT-432-07 to P. G.), Red de Trastornos Adictivos, Instituto de Salud Carlos III, Ministerio de Ciencia e Innovacion, Gobierno de Espana (RD07/0001/2001 to P. G.) and Basque Country University (N.P.).	Goebbels S, 2006, GENESIS, V44, P611, DOI 10.1002/dvg.20256; Hudson BD, 2010, MOL PHARMACOL, V77, P1, DOI 10.1124/mol.109.060251; Kano M, 2009, PHYSIOL REV, V89, P309, DOI 10.1152/physrev.00019.2008; Kelley AE, 2005, PHYSIOL BEHAV, V86, P773, DOI 10.1016/j.physbeh.2005.08.066; Marsicano G, 2002, NATURE, V418, P530, DOI 10.1038/nature00839; Marsicano Giovanni, 2008, P161, DOI 10.1007/978-0-387-74349-3_10; Matias I, 2007, TRENDS ENDOCRIN MET, V18, P27, DOI 10.1016/j.tem.2006.11.006; Meena H, 2009, LIFE SCI, V84, P156, DOI 10.1016/j.lfs.2008.11.013; Monory K, 2006, NEURON, V51, P455, DOI 10.1016/j.neuron.2006.07.006; Monory K, 2007, PLOS BIOL, V5, P2354, DOI 10.1371/journal.pbio.0050269; Pagotto U, 2006, ENDOCR REV, V27, P73, DOI 10.1210/er.2005-0009; Piomelli D, 2003, NAT REV NEUROSCI, V4, P873, DOI 10.1038/nrn1247; Shin AC, 2009, PHYSIOL BEHAV, V97, P572, DOI 10.1016/j.physbeh.2009.02.010; Wiley JL, 2005, BRIT J PHARMACOL, V145, P293, DOI 10.1038/sj.bjp.0706157; Yee CL, 2009, J COMP NEUROL, V517, P37, DOI 10.1002/cne.22132	15	211	218	0	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2010	13	3					281	283		10.1038/nn.2494	http://dx.doi.org/10.1038/nn.2494			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	559WW	20139974	Green Published			2022-12-24	WOS:000274860100007
J	Larimer, P; Strowbridge, BW				Larimer, Phillip; Strowbridge, Ben W.			Representing information in cell assemblies: persistent activity mediated by semilunar granule cells	NATURE NEUROSCIENCE			English	Article							RAT HIPPOCAMPAL SLICES; CA3 PYRAMIDAL CELLS; HILAR MOSSY CELLS; NEURAL ACTIVITY; DENTATE GYRUS; THALAMOCORTICAL NEURONS; CALCIUM-CHANNELS; MOLECULAR LAYER; CA2+ CURRENT; TO-SAMPLE	Here we found that perforant path stimulation in rat hippocampal slices evoked long-lasting barrages of synaptic inputs in subpopulations of dentate gyrus mossy cells and hilar interneurons. Synaptic barrages triggered persistent firing in hilar neurons (hilar up-states). We found that synaptic barrages originate from semilunar granule cells (SGCs), glutamatergic neurons in the inner molecular layer that generate long-duration plateau potentials in response to excitatory synaptic input. MK801, nimodipine and nickel all abolished both stimulus-evoked plateau potentials in SGCs and synaptic barrages in downstream hilar neurons without blocking fast synaptic transmission. Hilar up-states triggered functional inhibition in granule cells that persisted for more than 10 s. Hilar cell assemblies, identified by simultaneous triple and paired intracellular recordings, were linked by persistent firing in SGCs. Population responses recorded in hilar neurons accurately encoded stimulus identity. Stimulus-evoked up-states in the dentate gyrus represent a potential cellular basis for hippocampal working memory.	[Larimer, Phillip; Strowbridge, Ben W.] Case Western Reserve Univ, Dept Neurosci, Cleveland, OH 44106 USA	Case Western Reserve University	Strowbridge, BW (corresponding author), Case Western Reserve Univ, Dept Neurosci, Cleveland, OH 44106 USA.	bens@case.edu	Duran, Bonnie m/A-3029-2009	Larimer, Phillip/0000-0001-5276-5732	National Institutes of Health (NIH) [R01-NS33590]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007250] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R29NS033590, R01NS033590] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank T. Pressler and R. Galan for helpful discussions; S. Jones and J. Frazier for helpful comments on the manuscript; and P. Puzerey for technical assistance. This work was supported by National Institutes of Health (NIH) Grant R01-NS33590 to B.W.S.	ABELES M, 1995, P NATL ACAD SCI USA, V92, P8616, DOI 10.1073/pnas.92.19.8616; Acsady L, 1998, J NEUROSCI, V18, P3386; Aksay E, 2001, NAT NEUROSCI, V4, P184, DOI 10.1038/84023; Amit DJ, 2003, NEURAL COMPUT, V15, P565, DOI 10.1162/089976603321192086; Buckmaster PS, 1996, J COMP NEUROL, V366, P270, DOI 10.1002/(SICI)1096-9861(19960304)366:2<270::AID-CNE7>3.0.CO;2-2; Cheng S, 2008, NEURON, V57, P303, DOI 10.1016/j.neuron.2007.11.035; Chow KY, 2003, NEUROUROL URODYNAM, V22, P77, DOI 10.1002/nau.10081; COLOMBO M, 1994, BEHAV NEUROSCI, V108, P443, DOI 10.1037/0735-7044.108.3.443; Egorov AV, 2002, NATURE, V420, P173, DOI 10.1038/nature01171; FOX AP, 1987, J PHYSIOL-LONDON, V394, P149, DOI 10.1113/jphysiol.1987.sp016864; Fraser DD, 1996, J NEUROSCI, V16, P4113; FUNAHASHI S, 1993, NATURE, V365, P753, DOI 10.1038/365753a0; FUNAHASHI S, 1989, J NEUROPHYSIOL, V61, P331, DOI 10.1152/jn.1989.61.2.331; GEORGOPOULOS AP, 1986, SCIENCE, V233, P1416, DOI 10.1126/science.3749885; Goldman MS, 2003, CEREB CORTEX, V13, P1185, DOI 10.1093/cercor/bhg095; HALASY K, 1993, EUR J NEUROSCI, V5, P411, DOI 10.1111/j.1460-9568.1993.tb00508.x; Hampson RE, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-02-j0002.2002; Hebb Donald O., 1949, ORG BEHAV; Hughes SW, 1999, J PHYSIOL-LONDON, V517, P805, DOI 10.1111/j.1469-7793.1999.0805s.x; ISHIZUKA N, 1990, J COMP NEUROL, V295, P580, DOI 10.1002/cne.902950407; JEFFERYS JGR, 1995, PHYSIOL REV, V75, P689, DOI 10.1152/physrev.1995.75.4.689; Koschak A, 2007, J NEUROSCI, V27, P3855, DOI 10.1523/JNEUROSCI.4028-06.2007; Larimer P, 2008, J NEUROSCI, V28, P12212, DOI 10.1523/JNEUROSCI.3612-08.2008; Lo FS, 2002, J NEUROPHYSIOL, V88, P794, DOI 10.1152/jn.2002.88.2.794; LOTHMAN EW, 1992, EPILEPSY RES, P301; MacLean JN, 2005, NEURON, V48, P811, DOI 10.1016/j.neuron.2005.09.035; Major G, 2004, CURR OPIN NEUROBIOL, V14, P675, DOI 10.1016/j.conb.2004.10.017; MARR D, 1971, PHILOS T ROY SOC B, V262, P23, DOI 10.1098/rstb.1971.0078; MAYER ML, 1987, J PHYSIOL-LONDON, V394, P501, DOI 10.1113/jphysiol.1987.sp016883; MCCORMICK DA, 1985, J NEUROPHYSIOL, V54, P782, DOI 10.1152/jn.1985.54.4.782; Miller LM, 2009, P NATL ACAD SCI USA, V106, P5931, DOI 10.1073/pnas.0901023106; Sanchez-Vives MV, 2000, NAT NEUROSCI, V3, P1027, DOI 10.1038/79848; SASS KJ, 1992, J CLIN EXP NEUROPSYC, V14, P662, DOI 10.1080/01688639208402854; SCHARFMAN HE, 1991, J NEUROSCI, V11, P1660; SCHARFMAN HE, 1995, J NEUROPHYSIOL, V74, P179, DOI 10.1152/jn.1995.74.1.179; SCHARFMAN HE, 1994, J NEUROPHYSIOL, V72, P2167, DOI 10.1152/jn.1994.72.5.2167; SCHARFMAN HE, 1993, J NEUROPHYSIOL, V70, P742, DOI 10.1152/jn.1993.70.2.742; Schiller J, 2000, NATURE, V404, P285, DOI 10.1038/35005094; Seung HS, 1996, P NATL ACAD SCI USA, V93, P13339, DOI 10.1073/pnas.93.23.13339; Seung HS, 2000, NEURON, V26, P259, DOI 10.1016/S0896-6273(00)81155-1; SMITH DH, 1994, NEUROSCI LETT, V168, P151, DOI 10.1016/0304-3940(94)90438-3; SORIANO E, 1994, HIPPOCAMPUS, V4, P65, DOI 10.1002/hipo.450040108; SPRUSTON N, 1992, J NEUROPHYSIOL, V67, P508, DOI 10.1152/jn.1992.67.3.508; Strowbridge BW, 1996, J PHYSIOL-LONDON, V494, P493, DOI 10.1113/jphysiol.1996.sp021508; STROWBRIDGE BW, 1992, NEUROSCI LETT, V142, P205, DOI 10.1016/0304-3940(92)90374-G; Talley EM, 1999, J NEUROSCI, V19, P1895; Wei DS, 2001, SCIENCE, V293, P2272, DOI 10.1126/science.1061198; Williams PA, 2007, J NEUROSCI, V27, P13756, DOI 10.1523/JNEUROSCI.4053-07.2007; Williams SR, 1997, J PHYSIOL-LONDON, V505, P689, DOI 10.1111/j.1469-7793.1997.689ba.x; Xu WF, 2001, J NEUROSCI, V21, P5944, DOI 10.1523/JNEUROSCI.21-16-05944.2001	50	58	58	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2010	13	2					213	U101		10.1038/nn.2458	http://dx.doi.org/10.1038/nn.2458			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	548SE	20037579	Green Accepted			2022-12-24	WOS:000273985800017
J	Kranc, KR; Schepers, H; Rodrigues, NP; Bamforth, S; Villadsen, E; Ferry, H; Bouriez-Jones, T; Sigvardsson, M; Bhattacharya, S; Jacobsen, SE; Enver, T				Kranc, Kamil R.; Schepers, Hein; Rodrigues, Neil P.; Bamforth, Simon; Villadsen, Ellen; Ferry, Helen; Bouriez-Jones, Tiphaine; Sigvardsson, Mikael; Bhattacharya, Shoumo; Jacobsen, Sten Eirik; Enver, Tariq			Cited2 Is an Essential Regulator of Adult Hematopoietic Stem Cells	CELL STEM CELL			English	Article							CREB-BINDING-PROTEIN; MULTIPOTENT PROGENITORS; GENE-EXPRESSION; COACTIVATOR; SURVIVAL; MICE; IDENTIFICATION; MAINTENANCE; DEFECTS; PRODUCT	The regulatory pathways necessary for the maintenance of adult hematopoietic stem cells (HSCs) remain poorly defined. By using loss-of-function approaches, we report a selective and cell-autonomous requirement for the p300/CBP-binding transcriptional coactivator Cited2 in adult HSC maintenance. Conditional deletion of Cited2 in the adult mouse results in loss of HSCs causing multilineage bone marrow failure and increased lethality. In contrast, conditional ablation of Cited2 after lineage specification in lymphoid and myeloid lineages has no impact on the maintenance of these lineages. Additional deletion of Ink4a/Arf (encoding p16(Ink4a) and p19(Arf)) or Trp53 (encoding p53, a downstream target of p19(Arf)) in a Cited2-deficient background restores HSC functionality and rescues mice from bone marrow failure. Furthermore, we show that the critical role of Cited2 in primitive hematopoietic cells is conserved in humans. Taken together, our studies provide genetic evidence that Cited2 selectively maintains adult HSC functions, at least in part, via Ink4a/Arf and Trp53.	[Kranc, Kamil R.; Rodrigues, Neil P.; Villadsen, Ellen; Enver, Tariq] Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, MRC Mol Haematol Unit, Oxford OX3 9DS, England; [Kranc, Kamil R.; Schepers, Hein; Villadsen, Ellen; Ferry, Helen; Bouriez-Jones, Tiphaine; Jacobsen, Sten Eirik] Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Haematopoiet Stem Cell Lab, Oxford OX3 9DS, England; [Bamforth, Simon] Newcastle Univ, Int Ctr Life, Inst Human Genet, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England; [Sigvardsson, Mikael] Linkoping Univ, Dept Clin & Expt Res, S-58185 Linkoping, Sweden; [Bhattacharya, Shoumo] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England	University of Oxford; University of Oxford; Newcastle University - UK; Linkoping University; University of Oxford; Wellcome Centre for Human Genetics	Kranc, KR (corresponding author), Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, MRC Mol Haematol Unit, Oxford OX3 9DS, England.	kamil.kranc@ndm.ox.ac.uk	Bamforth, Simon David/I-1277-2019; Jacobsen, Sten Eirik W/D-3974-2018; Bhattacharya, Shoumo/F-4127-2010	Bamforth, Simon David/0000-0002-5666-4485; Jacobsen, Sten Eirik W/0000-0002-1362-3659; Bhattacharya, Shoumo/0000-0002-5571-0478; Sigvardsson, Mikael/0000-0001-8527-7276; Rodrigues, Neil/0000-0002-1925-7733; Schepers, Hein/0000-0002-7731-3318	John Fell OUP Research Fund; Leukaemia Research Fund; Medical Research Council; Wellcome Trust; MRC [MC_U137973817, G0801073, G0501838] Funding Source: UKRI; Medical Research Council [G0501838, MC_U137973817, G0801073] Funding Source: researchfish	John Fell OUP Research Fund; Leukaemia Research Fund; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	K.R.K. is a Beit Memorial Fellow for Medical Research. H.S. is an EMBO long-term fellow. N.P.R. is a MRC Career Development Fellow. The authors' laboratories are supported by John Fell OUP Research Fund (K.R.K.), Leukaemia Research Fund (K.R.K., T.E., S.E.J.), Medical Research Council (S.E.J., T.E.), and Wellcome Trust (K.R.K., S.B.).	Akala OO, 2008, NATURE, V453, P228, DOI 10.1038/nature06869; Bamforth SD, 2001, NAT GENET, V29, P469, DOI 10.1038/ng768; Bhattacharya S, 1999, GENE DEV, V13, P64, DOI 10.1101/gad.13.1.64; Bracken AP, 2007, GENE DEV, V21, P525, DOI 10.1101/gad.415507; Chen Y, 2007, BLOOD, V110, P2889, DOI 10.1182/blood-2007-01-066316; Chou YT, 2006, ONCOGENE, V25, P5547, DOI 10.1038/sj.onc.1209552; Glenn DJ, 1999, J BIOL CHEM, V274, P36159, DOI 10.1074/jbc.274.51.36159; Gomes I, 2002, BLOOD, V100, P107, DOI 10.1182/blood.V100.1.107; Hock H, 2004, GENE DEV, V18, P2336, DOI 10.1101/gad.1239604; Kranc KR, 2003, MOL CELL BIOL, V23, P7658, DOI 10.1128/MCB.23.21.7658-7666.2003; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Kung AL, 2000, GENE DEV, V14, P272; Laurenti E, 2008, CELL STEM CELL, V3, P611, DOI 10.1016/j.stem.2008.09.005; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Liu Y, 2009, CELL STEM CELL, V4, P37, DOI 10.1016/j.stem.2008.11.006; MacDonald ST, 2008, CARDIOVASC RES, V79, P448, DOI 10.1093/cvr/cvn101; Mansson R, 2007, IMMUNITY, V26, P407, DOI 10.1016/j.immuni.2007.02.013; Oguro H, 2006, J EXP MED, V203, P2247, DOI 10.1084/jem.20052477; Opferman JT, 2003, NATURE, V426, P671, DOI 10.1038/nature02067; Opferman JT, 2005, SCIENCE, V307, P1101, DOI 10.1126/science.1106114; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Pomerantz J, 1998, CELL, V92, P713, DOI 10.1016/S0092-8674(00)81400-2; Pritsker M, 2006, P NATL ACAD SCI USA, V103, P6946, DOI 10.1073/pnas.0509861103; Qian ZJ, 2008, J EXP MED, V205, P2163, DOI 10.1084/jem.20080578; Qu X, 2007, EMBO J, V26, P4445, DOI 10.1038/sj.emboj.7601883; Rebel VI, 2002, P NATL ACAD SCI USA, V99, P14789, DOI 10.1073/pnas.232568499; Sperling S, 2005, HUM MUTAT, V26, P575, DOI 10.1002/humu.20262; Sun HB, 1998, P NATL ACAD SCI USA, V95, P13555, DOI 10.1073/pnas.95.23.13555; Tien ES, 2004, J BIOL CHEM, V279, P24053, DOI 10.1074/jbc.M401489200; Yin Z, 2002, P NATL ACAD SCI USA, V99, P10488, DOI 10.1073/pnas.162371799; Zhong JF, 2005, P NATL ACAD SCI USA, V102, P2448, DOI 10.1073/pnas.0409459102	32	85	86	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	DEC 4	2009	5	6					659	665		10.1016/j.stem.2009.11.001	http://dx.doi.org/10.1016/j.stem.2009.11.001			7	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	543YH	19951693	Green Published, hybrid			2022-12-24	WOS:000273616700013
J	Bale, TL				Bale, Tracy L.			Neuroendocrine and Immune Influences on the CNS: It's a Matter of Sex	NEURON			English	Editorial Material							SCHIZOPHRENIA; DEPRESSION; DISORDERS; STRESS; BRAIN; RISK	Most neuropsychiatric diseases have a sex bias in their presentation, age of onset, or treatment response. Yet surprisingly, we have considered very little the contribution of the sexually dimorphic brain when thinking about disease etiology and the important influences of the neuroendocrine and immune systems in programming the CNS.	Univ Penn, Sch Vet Med, Dept Anim Biol, Philadelphia, PA 19104 USA	University of Pennsylvania	Bale, TL (corresponding author), Univ Penn, Sch Vet Med, Dept Anim Biol, Philadelphia, PA 19104 USA.	tbale@vet.upenn.edu			NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH073030] Funding Source: NIH RePORTER; NIMH NIH HHS [R01 MH073030] Funding Source: Medline; PHS HHS [R01 NIHMH073030] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Amateau SK, 2004, NAT NEUROSCI, V7, P643, DOI 10.1038/nn1254; Arnold AP, 2009, FRONT NEUROENDOCRIN, V30, P1, DOI 10.1016/j.yfrne.2008.11.001; Butts CL, 2008, CELL IMMUNOL, V252, P7, DOI 10.1016/j.cellimm.2007.09.009; Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn2297; Fagiolini M, 2009, CURR OPIN NEUROBIOL, V19, P207, DOI 10.1016/j.conb.2009.05.009; Gardener H, 2009, BRIT J PSYCHIAT, V195, P7, DOI 10.1192/bjp.bp.108.051672; Goel N, 2009, J NEUROENDOCRINOL, V21, P415, DOI 10.1111/j.1365-2826.2009.01843.x; Goldstein JM, 2006, HORM BEHAV, V50, P612, DOI 10.1016/j.yhbeh.2006.06.029; Gur RE, 2004, BIOL PSYCHIAT, V55, P512, DOI 10.1016/j.biopsych.2003.10.009; Heim C, 2008, PSYCHONEUROENDOCRINO, V33, P693, DOI 10.1016/j.psyneuen.2008.03.008; Irwin MR, 2007, BRAIN BEHAV IMMUN, V21, P374, DOI 10.1016/j.bbi.2007.01.010; Khashan AS, 2008, ARCH GEN PSYCHIAT, V65, P146, DOI 10.1001/archgenpsychiatry.2007.20; McEwen BS, 2005, METABOLISM, V54, P20, DOI 10.1016/j.metabol.2005.01.008; Mueller BR, 2008, J NEUROSCI, V28, P9055, DOI 10.1523/JNEUROSCI.1424-08.2008; Sorrells SF, 2009, NEURON, V64, P33, DOI 10.1016/j.neuron.2009.09.032	15	51	53	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	OCT 15	2009	64	1					13	16		10.1016/j.neuron.2009.09.036	http://dx.doi.org/10.1016/j.neuron.2009.09.036			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	515FY	19840541	Bronze			2022-12-24	WOS:000271454400003
J	Fernandes, HB; Catches, JS; Petralia, RS; Copits, BA; Xu, J; Russell, TA; Swanson, GT; Contractor, A				Fernandes, Herman B.; Catches, Justin S.; Petralia, Ronald S.; Copits, Bryan A.; Xu, Jian; Russell, Theron A.; Swanson, Geoffrey T.; Contractor, Anis			High-Affinity Kainate Receptor Subunits Are Necessary for Ionotropic but Not Metabotropic Signaling	NEURON			English	Article							MOSSY-FIBER SYNAPSES; EXCITATORY SYNAPTIC-TRANSMISSION; SHORT-TERM PLASTICITY; RAT-BRAIN; HIPPOCAMPUS; MICE; CA3; ACTIVATION; EXPRESSION; NEURONS	Kainate receptors signal through both ionotropic and metabotropic pathways. The high-affinity subunits, GluK4 and GluK5, are unique among the five receptor subunits, as they do not form homomeric receptors but modify the properties of heteromeric assemblies. Disruption of the Grik4 gene locus resulted in a significant reduction in synaptic kainate receptor currents. Moreover, ablation of GluK4 and GluK5 caused complete loss of synaptic ionotropic kainate receptor function. The principal subunits were distributed away from postsynaptic densities and presynaptic active zones. There was also a profound alteration in the activation properties of the remaining kainate receptors. Despite this, kainate receptor-mediated inhibition of the slow afterhyperpolarization current (I-SAHP) which is dependent on metabotropic pathways, was intact in GluK4/GluK5 knockout mice. These results uncover a previously unknown obligatory role for the high-affinity subunits for ionotropic kainate receptor function and further demonstrate that kainate receptor participation in metabotropic signaling pathways does not require their classic role as ion channels.	[Fernandes, Herman B.; Catches, Justin S.; Xu, Jian; Russell, Theron A.; Contractor, Anis] Northwestern Univ, Sch Med, Dept Physiol, Chicago, IL 60611 USA; [Petralia, Ronald S.] Natl Inst Deafness & Other Commun Disorders, Neurochem Lab, NIH, Bethesda, MD 20892 USA; [Copits, Bryan A.; Swanson, Geoffrey T.] Northwestern Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Chicago, IL 60611 USA	Northwestern University; National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); Northwestern University	Contractor, A (corresponding author), Northwestern Univ, Sch Med, Dept Physiol, 303 E Chicago Ave, Chicago, IL 60611 USA.	a-contractor@northwestern.edu		Contractor, Anis/0000-0002-5131-2536	National Institute of Health (NINDS) [R01NS044322, R01NS058894]; NIH intramural support (NIDCD); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS058894, R01NS044322] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [ZIADC000003] Funding Source: NIH RePORTER	National Institute of Health (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH intramural support (NIDCD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We gratefully thank Professor Stephen Heinemann in whose laboratory the floxed GluK4 mice were originally generated. Ashley Westwood provided technical help with mouse husbandry and genotyping and or Ya-Xian Wang contributed to the immunogold labeling. This work was supported by extramural grants from the National Institute of Health (NINDS) (R01NS044322 to G.T.S. and R01NS058894 to A.C.) and NIH intramural support (NIDCD) (to R.S.P.). Justin Catches is a John N. Nicholson Fellow.	Armstrong JN, 2006, J NEUROSCI, V26, P3474, DOI 10.1523/JNEUROSCI.4338-05.2006; BAHN S, 1994, J NEUROSCI, V14, P5525; Barberis A, 2008, J NEUROSCI, V28, P6402, DOI 10.1523/JNEUROSCI.1204-08.2008; Bortolotto ZA, 1999, NATURE, V402, P297, DOI 10.1038/46290; Breustedt J, 2004, J NEUROSCI, V24, P10093, DOI 10.1523/JNEUROSCI.3078-04.2004; Castillo PE, 1997, NATURE, V388, P182, DOI 10.1038/40645; Chittajallu R, 1996, NATURE, V379, P78, DOI 10.1038/379078a0; Contractor A, 2003, J NEUROSCI, V23, P422, DOI 10.1523/JNEUROSCI.23-02-00422.2003; Contractor A, 2002, SCIENCE, V296, P1864, DOI 10.1126/science.1069081; Contractor A, 2000, J NEUROSCI, V20, P8269, DOI 10.1523/JNEUROSCI.20-22-08269.2000; Contractor A, 2001, NEURON, V29, P209, DOI 10.1016/S0896-6273(01)00191-X; Darstein M, 2003, J NEUROSCI, V23, P8013; Fisahn A, 2005, J PHYSIOL-LONDON, V562, P199, DOI 10.1113/jphysiol.2004.077412; Frerking M, 2001, J NEUROSCI, V21, P2958, DOI 10.1523/JNEUROSCI.21-09-02958.2001; Grabauskas G, 2007, J PHYSIOL-LONDON, V579, P363, DOI 10.1113/jphysiol.2006.122051; Greger IH, 2003, NEURON, V40, P763, DOI 10.1016/S0896-6273(03)00668-8; HERB A, 1992, NEURON, V8, P775, DOI 10.1016/0896-6273(92)90098-X; Ji ZX, 2002, NEUROSCI LETT, V331, P71, DOI 10.1016/S0304-3940(02)00865-0; Kamiya H, 2002, J NEUROSCI, V22, P9237; Kask K, 2000, BRAIN RES, V876, P55, DOI 10.1016/S0006-8993(00)02599-3; Kwon HB, 2008, NEURON, V60, P1082, DOI 10.1016/j.neuron.2008.10.045; Lauri SE, 2001, NEURON, V32, P697, DOI 10.1016/S0896-6273(01)00511-6; Melyan Z, 2002, NEURON, V34, P107, DOI 10.1016/S0896-6273(02)00624-4; Melyan Z, 2004, J NEUROSCI, V24, P4530, DOI 10.1523/JNEUROSCI.5356-03.2004; Mulle C, 2000, NEURON, V28, P475, DOI 10.1016/S0896-6273(00)00126-4; Mulle C, 1998, NATURE, V392, P601, DOI 10.1038/33408; O'Gorman S, 1997, P NATL ACAD SCI USA, V94, P14602, DOI 10.1073/pnas.94.26.14602; Petralia RS, 1999, METH MOL B, V128, P73; Pinheiro P, 2006, CELL TISSUE RES, V326, P457, DOI 10.1007/s00441-006-0265-6; Pinheiro PS, 2008, NAT REV NEUROSCI, V9, P423, DOI 10.1038/nrn2379; Pinheiro PS, 2007, P NATL ACAD SCI USA, V104, P12181, DOI 10.1073/pnas.0608891104; Rodriguez-Moreno A, 1998, NEURON, V20, P1211, DOI 10.1016/S0896-6273(00)80501-2; Rodriguez-Moreno A, 2007, TRENDS NEUROSCI, V30, P630, DOI 10.1016/j.tins.2007.10.001; Ruiz A, 2005, J NEUROSCI, V25, P11710, DOI 10.1523/JNEUROSCI.4041-05.2005; Schmitz D, 2000, NEURON, V27, P327, DOI 10.1016/S0896-6273(00)00040-4; Schmitz D, 2001, SCIENCE, V291, P1972, DOI 10.1126/science.1057105; Scott R, 2008, J NEUROSCI, V28, P13139, DOI 10.1523/JNEUROSCI.2932-08.2008; Swanson GT, 1997, NEURON, V19, P913, DOI 10.1016/S0896-6273(00)80972-1; Thomas-Crusells J, 2003, J NEUROSCI METH, V125, P159, DOI 10.1016/S0165-0270(03)00050-5; Vignes M, 1997, NATURE, V388, P179, DOI 10.1038/40639; WERNER P, 1991, NATURE, V351, P742, DOI 10.1038/351742a0; WESTBROOK GL, 1983, BRAIN RES, V273, P97, DOI 10.1016/0006-8993(83)91098-3; WISDEN W, 1993, J NEUROSCI, V13, P3582; Xu J, 2009, J NEUROSCI, V29, P3676, DOI 10.1523/JNEUROSCI.5716-08.2009	44	86	86	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 24	2009	63	6					818	829		10.1016/j.neuron.2009.08.010	http://dx.doi.org/10.1016/j.neuron.2009.08.010			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	503VP	19778510	Green Accepted, Bronze			2022-12-24	WOS:000270569700014
J	Naselaris, T; Prenger, RJ; Kay, KN; Oliver, M; Gallant, JL				Naselaris, Thomas; Prenger, Ryan J.; Kay, Kendrick N.; Oliver, Michael; Gallant, Jack L.			Bayesian Reconstruction of Natural Images from Human Brain Activity	NEURON			English	Article							OBJECT; AREA; REPRESENTATIONS; CORTEX; FMRI	Recent studies have used fMRI signals from early visual areas to reconstruct simple geometric patterns. Here, we demonstrate a new Bayesian decoder that uses fMRI signals from early and anterior visual areas to reconstruct complex natural images. Our decoder combines three elements: a structural encoding model that characterizes responses in early visual areas, a semantic encoding model that characterizes responses in anterior visual areas, and prior information about the structure and semantic content of natural images. By combining all these elements, the decoder produces reconstructions that accurately reflect both the spatial structure and semantic category of the objects contained in the observed natural image. Our results show that prior information has a substantial effect on the quality of natural image reconstructions. We also demonstrate that much of the variance in the responses of anterior visual areas to complex natural images is explained by the semantic category of the image alone.	[Naselaris, Thomas; Gallant, Jack L.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; [Prenger, Ryan J.] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [Kay, Kendrick N.; Gallant, Jack L.] Univ Calif Berkeley, Dept Psychol, Berkeley, CA 94720 USA; [Oliver, Michael; Gallant, Jack L.] Univ Calif Berkeley, Vis Sci Program, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Gallant, JL (corresponding author), Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA.	gallant@berkeley.edu	Gallant, Jack L/C-4426-2011; Kay, Kendrick/A-4344-2009	Kay, Kendrick/0000-0001-6604-9155	NRSA postdoctoral fellowship; National Institutes of Health; University of California, Berkeley; NATIONAL EYE INSTITUTE [R01EY019684, F32EY016941, R01EY012241, R01EY022454] Funding Source: NIH RePORTER	NRSA postdoctoral fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California, Berkeley(University of California System); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by an NRSA postdoctoral fellowship (T.N.), the National Institutes of Health, and University of California, Berkeley, intramural funds. We thank B. Inglis for assistance with MRI, K. Hansen for assistance with retinotopic mapping, D. Woods and X. Kang for acquisition of whole-brain anatomical data, and A. Rokem for assistance with scanner operation. We thank A. Berg for assistance with the natural image database, B. Yu and T. Griffiths for consultation on the mathematical analyses, and S. Nishimoto, and D. Stansbury for their help in various aspects of this research.	[Anonymous], P ADV NEUR INF PROC; BROOKS AC, 2006, P SOC PHOTO-OPT INS, V6057, P299; Carandini M, 2005, J NEUROSCI, V25, P10577, DOI 10.1523/JNEUROSCI.3726-05.2005; Carlson TA, 2003, J COGNITIVE NEUROSCI, V15, P704, DOI 10.1162/089892903322307429; Cox DD, 2003, NEUROIMAGE, V19, P261, DOI 10.1016/S1053-8119(03)00049-1; David SV, 2005, NETWORK-COMP NEURAL, V16, P239, DOI 10.1080/09548980500464030; Downing PE, 2006, CEREB CORTEX, V16, P1453, DOI 10.1093/cercor/bhj086; Downing PE, 2001, SCIENCE, V293, P2470, DOI 10.1126/science.1063414; Epstein R, 1998, NATURE, V392, P598, DOI 10.1038/33402; FIELD DJ, 1994, NEURAL COMPUT, V6, P559, DOI 10.1162/neco.1994.6.4.559; FIELD DJ, 1987, J OPT SOC AM A, V4, P2379, DOI 10.1364/JOSAA.4.002379; GALLANT JL, 1993, SCIENCE, V259, P100, DOI 10.1126/science.8418487; Greene MR, 2009, COGNITIVE PSYCHOL, V58, P137, DOI 10.1016/j.cogpsych.2008.06.001; Grill-Spector K, 1998, HUM BRAIN MAPP, V6, P316, DOI 10.1002/(SICI)1097-0193(1998)6:4<316::AID-HBM9>3.0.CO;2-6; Grill-Spector K, 2004, ANNU REV NEUROSCI, V27, P649, DOI 10.1146/annurev.neuro.27.070203.144220; Hansen KA, 2007, J NEUROSCI, V27, P11896, DOI 10.1523/JNEUROSCI.2991-07.2007; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; Haynes JD, 2005, NAT NEUROSCI, V8, P686, DOI 10.1038/nn1445; Hays J, 2007, ACM T GRAPHIC, V26, DOI [10.1145/1239451.1239455, 10.1145/1276377.1276382]; Kamitani Y, 2005, NAT NEUROSCI, V8, P679, DOI 10.1038/nn1444; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Karklin Y, 2009, NATURE, V457, P83, DOI 10.1038/nature07481; Kay KN, 2008, NATURE, V452, P352, DOI 10.1038/nature06713; Kay KN, 2009, NAT NEUROSCI, V12, P245, DOI 10.1038/nn0309-245; Kriegeskorte N, 2008, NEURON, V60, P1126, DOI 10.1016/j.neuron.2008.10.043; MALACH R, 1995, P NATL ACAD SCI USA, V92, P8135, DOI 10.1073/pnas.92.18.8135; Mitchell TM, 2008, SCIENCE, V320, P1191, DOI 10.1126/science.1152876; Miyawaki Y, 2008, NEURON, V60, P915, DOI 10.1016/j.neuron.2008.11.004; Nevado A, 2004, NEUROIMAGE, V21, P1083, DOI 10.1016/j.neuroimage.2003.10.043; Perona P., 2007, CALTECH256; Thirion B, 2006, NEUROIMAGE, V33, P1104, DOI 10.1016/j.neuroimage.2006.06.062; Torralba A, 2008, IEEE T PATTERN ANAL, V30, P1958, DOI 10.1109/TPAMI.2008.128; Wu MCK, 2006, ANNU REV NEUROSCI, V29, P477, DOI 10.1146/annurev.neuro.29.051605.113024; Zhang KC, 1998, J NEUROPHYSIOL, V79, P1017, DOI 10.1152/jn.1998.79.2.1017	34	325	332	2	45	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 24	2009	63	6					902	915		10.1016/j.neuron.2009.09.006	http://dx.doi.org/10.1016/j.neuron.2009.09.006			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	503VP	19778517	Green Accepted, Bronze			2022-12-24	WOS:000270569700021
J	Kuo, SP; Trussell, LO				Kuo, Sidney P.; Trussell, Laurence O.			A New Ion Channel Blooms at the Synapse	NEURON			English	Editorial Material							FROG NEUROMUSCULAR-JUNCTION; TRANSMITTER RELEASE; CALCIUM; ENDOCYTOSIS	A new study by Yao et al. in the current issue of Cell proposes that a novel vesicular protein, dubbed Flower, regulates endocytosis by controlling presynaptic Ca(2+) levels. This finding is intriguing not only for its implications for vesicle cycling, but also for the multitude of Ca(2+)-dependent processes at play in presynaptic nerve terminals.	[Kuo, Sidney P.; Trussell, Laurence O.] Oregon Hlth & Sci Univ, Oregon Hearing Res Ctr, Portland, OR 97239 USA; [Kuo, Sidney P.; Trussell, Laurence O.] Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA	Oregon Health & Science University; Oregon Health & Science University	Kuo, SP (corresponding author), Oregon Hlth & Sci Univ, Oregon Hearing Res Ctr, Portland, OR 97239 USA.	kuos@ohsu.edu						Awatramani GB, 2005, NEURON, V48, P109, DOI 10.1016/j.neuron.2005.08.038; CECCARELLI B, 1980, J CELL BIOL, V87, P297, DOI 10.1083/jcb.87.1.297; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; Hosoi N, 2009, NEURON, V63, P216, DOI 10.1016/j.neuron.2009.06.010; Neher E, 2008, NEURON, V59, P861, DOI 10.1016/j.neuron.2008.08.019; Sankaranarayanan S, 2001, NAT NEUROSCI, V4, P129, DOI 10.1038/83949; Wu LG, 2007, J NEUROSCI, V27, P11793, DOI 10.1523/JNEUROSCI.3471-07.2007; Wu XS, 2009, NAT NEUROSCI, V12, P1003, DOI 10.1038/nn.2355; YAO CK, 2009, CELL IN PRESS, V138	9	3	3	1	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	SEP 10	2009	63	5					566	567		10.1016/j.neuron.2009.08.031	http://dx.doi.org/10.1016/j.neuron.2009.08.031			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	494XH	19755100	Bronze			2022-12-24	WOS:000269852300004
J	Stanley, ER				Stanley, E. Richard			Lineage Commitment: Cytokines Instruct, At Last!	CELL STEM CELL			English	Editorial Material							HEMATOPOIETIC STEM-CELLS; MAFB		Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine	Stanley, ER (corresponding author), Albert Einstein Coll Med, Dept Dev & Mol Biol, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	rstanley@aecom.yu.edu	Stanley, Evan R/J-9154-2013	Stanley, Evan R/0000-0002-2910-2065	NATIONAL CANCER INSTITUTE [R37CA026504, R01CA032551] Funding Source: NIH RePORTER; NCI NIH HHS [R37 CA026504, R01 CA032551] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Eilken HM, 2009, NATURE, V457, P896, DOI 10.1038/nature07760; Enver T, 1998, BLOOD, V92, P348, DOI 10.1182/blood.V92.2.348.Con3_348_351; Iwasaki H, 2007, IMMUNITY, V26, P726, DOI 10.1016/j.immuni.2007.06.004; Kelly LM, 2000, EMBO J, V19, P1987, DOI 10.1093/emboj/19.9.1987; Kondo M, 2000, NATURE, V407, P383, DOI 10.1038/35030112; Laiosa CV, 2006, ANNU REV IMMUNOL, V24, P705, DOI 10.1146/annurev.immunol.24.021605.090742; Metcalf D, 1998, BLOOD, V92, P345, DOI 10.1182/blood.V92.2.345b.Con2_345_347; Pixley FJ, 2004, TRENDS CELL BIOL, V14, P628, DOI 10.1016/j.tcb.2004.09.016; Rieger MA, 2009, SCIENCE, V325, P217, DOI 10.1126/science.1171461; Sarrazin S, 2009, CELL, V138, P300, DOI 10.1016/j.cell.2009.04.057; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048	11	11	17	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	SEP 4	2009	5	3					234	236		10.1016/j.stem.2009.08.015	http://dx.doi.org/10.1016/j.stem.2009.08.015			4	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	529VA	19733531	Green Accepted, Bronze			2022-12-24	WOS:000272545700005
J	Tamaki, SJ; Jacobs, Y; Dohse, M; Capela, A; Cooper, JD; Reitsma, M; He, DP; Tushinski, R; Belichenko, PV; Salehi, A; Mobley, W; Gage, FH; Huhn, S; Tsukamoto, AS; Weissman, IL; Uchida, N				Tamaki, Stanley J.; Jacobs, Yakop; Dohse, Monika; Capela, Alexandra; Cooper, Jonathan D.; Reitsma, Michael; He, Dongping; Tushinski, Robert; Belichenko, Pavel V.; Salehi, Ahmad; Mobley, William; Gage, Fred H.; Huhn, Stephen; Tsukamoto, Ann S.; Weissman, Irving L.; Uchida, Nobuko			Neuroprotection of Host Cells by Human Central Nervous System Stem Cells in a Mouse Model of Infantile Neuronal Ceroid Lipofuscinosis	CELL STEM CELL			English	Article							TRIPEPTIDYL PEPTIDASE-I; GENE-THERAPY; MURINE MODEL; BRAIN; ACTIVATION; NEURODEGENERATION; DIFFERENTIATE; PURIFICATION; MECHANISMS; DIAGNOSIS	Infantile neuronal ceroid lipofuscinosis (INCL) is a fatal neurodegenerative disease caused by a deficiency in the lysosomal enzyme palmitoyl protein thioesterase-1 (PPT1). Ppt1 knockout mice display hallmarks of INCL and mimic the human pathology: accumulation of lipofuscin, degeneration of CNS neurons, and a shortened life span. Purified non-genetically modified human CNS stem cells, grown as neurospheres (hCNS-SCns), were transplanted into the brains of immunodeficient Ppt1(-/-) mice where they engrafted robustly, migrated extensively, and produced sufficient levels of PPT1 to alter host neuropathology. Grafted mice displayed reduced autofluorescent lipofuscin, significant neuroprotection of host hippocampal and cortical neurons, and delayed loss of motor coordination. Early intervention with cellular transplants of hCNS-SCns into the brains of INCL patients may supply a continuous and long-lasting source of the missing PPT1 and provide some therapeutic benefit through protection of endogenous neurons. These data provide the experimental basis for human clinical trials with these banked hCNS-SCns.	[Tamaki, Stanley J.; Jacobs, Yakop; Dohse, Monika; Capela, Alexandra; Reitsma, Michael; He, Dongping; Tushinski, Robert; Huhn, Stephen; Tsukamoto, Ann S.; Uchida, Nobuko] StemCells Inc, Palo Alto, CA 94304 USA; [Cooper, Jonathan D.] Kings Coll London, Dept Neurosci, Ctr Cellular Basis Behav, MRC Ctr Neurodegenerat Res,Inst Psychiat, London SE5 9NU, England; [Belichenko, Pavel V.; Salehi, Ahmad; Mobley, William] Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; [Weissman, Irving L.] Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Dept Pathol, Stanford, CA 94305 USA; [Weissman, Irving L.] Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA; [Gage, Fred H.] Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA	University of London; King's College London; Stanford University; Stanford University; Stanford University; Salk Institute	Uchida, N (corresponding author), StemCells Inc, 3155 Porter Dr, Palo Alto, CA 94304 USA.	nobuko.uchida@stemcellsinc.com	Salehi, Ahmad/H-2746-2019; Cooper, Jonathan/C-8117-2009; Cooper, Jonathan/V-9962-2019	Salehi, Ahmad/0000-0001-8257-3280; Cooper, Jonathan/0000-0003-1339-4750; Cooper, Jonathan/0000-0003-1339-4750	StemCells, Inc.	StemCells, Inc.	We would like to thank Drs. Sandy Hofmann, Mark Sands, Krystyna Wisniewski, Aileen Anderson, Brian Cummings, and Tonya Bliss for the generous gifts of the Ppt1<SUP>-/-</SUP> mice, the antibody against PPT1, and fibroblasts from Ppt1<SUP>-/-</SUP> mice CLN1 and CLN2 patients and expert advice. S.J.T., Y.J., M. D., A. C., M. R., D. H., R. T., S. H., A. S. T., and N.U. are employees of, J.D.C. and W. M. are past consultants of, and F. H. G. and I. L. W. are scientific founders of StemCells, Inc.	Abbott NJ, 2002, J ANAT, V200, P629, DOI 10.1046/j.1469-7580.2002.00064.x; Alvarez-Buylla A, 2002, J NEUROSCI, V22, P629, DOI 10.1523/JNEUROSCI.22-03-00629.2002; Bible E, 2004, NEUROBIOL DIS, V16, P346, DOI 10.1016/j.nbd.2004.02.010; Cabrera-Salazar MA, 2007, MOL THER, V15, P1782, DOI 10.1038/sj.mt.6300249; Castaneda JA, 2008, ACTA NEUROPATHOL, V115, P159, DOI 10.1007/s00401-007-0296-4; Cummings BJ, 2005, P NATL ACAD SCI USA, V102, P14069, DOI 10.1073/pnas.0507063102; Das AK, 2001, HUM MOL GENET, V10, P1431, DOI 10.1093/hmg/10.13.1431; Das AK, 1998, J CLIN INVEST, V102, P361, DOI 10.1172/JCI3112; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Escolar ML, 2006, PEDIATRICS, V118, pE879, DOI 10.1542/peds.2006-0747; Escolar ML, 2005, NEW ENGL J MED, V352, P2069, DOI 10.1056/NEJMoa042604; Frisella WA, 2001, MOL THER, V3, P351, DOI 10.1006/mthe.2001.0274; Griffey M, 2004, NEUROBIOL DIS, V16, P360, DOI 10.1016/j.nbd.2004.03.005; Griffey M, 2005, MOL THER, V12, P413, DOI 10.1016/j.ymthe.2005.04.018; Griffey MA, 2006, MOL THER, V13, P538, DOI 10.1016/j.ymthe.2005.11.008; Gupta P, 2001, P NATL ACAD SCI USA, V98, P13566, DOI 10.1073/pnas.251485198; Guzman R, 2007, P NATL ACAD SCI USA, V104, P10211, DOI 10.1073/pnas.0608519104; Haskell RE, 2003, GENE THER, V10, P34, DOI 10.1038/sj.gt.3301843; Hofmann SL, 1999, MOL GENET METAB, V66, P234, DOI 10.1006/mgme.1999.2803; Kandel E., 2000, PRINCIPLES NEURAL SC; Kelly S, 2004, P NATL ACAD SCI USA, V101, P11839, DOI 10.1073/pnas.0404474101; Kielar C, 2007, NEUROBIOL DIS, V25, P150, DOI 10.1016/j.nbd.2006.09.001; Lee JP, 2007, NAT MED, V13, P439, DOI 10.1038/nm1548; Mole SE, 2004, BRAIN PATHOL, V14, P70, DOI 10.1111/j.1750-3639.2004.tb00500.x; Oswald MJ, 2005, NEUROBIOL DIS, V20, P49, DOI 10.1016/j.nbd.2005.01.025; PAGE AE, 1993, ARCH BIOCHEM BIOPHYS, V306, P354, DOI 10.1006/abbi.1993.1523; Passini MA, 2007, P NATL ACAD SCI USA, V104, P9505, DOI 10.1073/pnas.0703509104; Pekny M, 2005, GLIA, V50, P427, DOI 10.1002/glia.20207; Pontikis CC, 2004, BRAIN RES, V1023, P231, DOI 10.1016/j.brainres.2004.07.030; Raivich G, 1999, BRAIN RES REV, V30, P77, DOI 10.1016/S0165-0173(99)00007-7; Sanai N, 2004, NATURE, V427, P740, DOI 10.1038/nature02301; Sly WS, 2002, P NATL ACAD SCI USA, V99, P5760, DOI 10.1073/pnas.102175599; Sohar I, 2000, CLIN CHEM, V46, P1005; Tamaki S, 2002, J NEUROSCI RES, V69, P976, DOI 10.1002/jnr.10412; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720; Vines D, 1998, BBA-PROTEIN STRUCT M, V1384, P233, DOI 10.1016/S0167-4838(98)00012-0; Voznyi YV, 1999, J MED GENET, V36, P471; Wisniewski KE, 2001, ADV GENET, V45, P1, DOI 10.1016/S0065-2660(01)45002-4	38	97	100	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	SEP 4	2009	5	3					310	319		10.1016/j.stem.2009.05.022	http://dx.doi.org/10.1016/j.stem.2009.05.022			10	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	529VA	19733542	Bronze			2022-12-24	WOS:000272545700017
J	Anderson, CT; Sheets, PL; Kiritani, T; Shepherd, GMG				Anderson, Charles T.; Sheets, Patrick L.; Kiritani, Taro; Shepherd, Gordon M. G.			Sublayer-specific microcircuits of corticospinal and corticostriatal neurons in motor cortex	NATURE NEUROSCIENCE			English	Article							PRIMARY VISUAL-CORTEX; PYRAMIDAL NEURONS; FLAVOPROTEIN AUTOFLUORESCENCE; CALLOSAL PROJECTIONS; RAT; CONNECTIONS; ORGANIZATION; MORPHOLOGY; NEOCORTEX; CIRCUITS	The mammalian motor system is organized around distinct subcortical subsystems, suggesting that the intracortical circuits immediately upstream of spinal cord and basal ganglia might be functionally differentiated as well. We found that the main excitatory pathway in mouse motor cortex, layer 2/3 -> 5, is fractionated into distinct pathways targeting corticospinal and corticostriatal neurons, which are involved in motor control. However, connections were selective for neurons in certain sublayers: corticospinal neurons in upper layer 5B and corticostriatal neurons in lower 5A. A simple structural combinatorial principle accounts for this highly specific functional circuit architecture: potential connectivity is established by neuronal sublayer positioning and actual connectivity in this framework is determined by long-range axonal projection targets. Thus, intracortical circuits of these pyramidal neurons are specified not only by their long-range axonal targets or their layer or sublayer positions, but by both, in specific combinations.	[Anderson, Charles T.; Sheets, Patrick L.; Kiritani, Taro; Shepherd, Gordon M. G.] Northwestern Univ, Feinberg Sch Med, Dept Physiol, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Shepherd, GMG (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Physiol, Chicago, IL 60611 USA.	g-shepherd@northwestern.edu	Shepherd, Gordon/F-2679-2010	Anderson, Charles/0000-0003-3353-0182	Whitehall Foundation; National Institute of Neurological Disorders and Stroke at the US National Institutes of Health [NS061963]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS061963] Funding Source: NIH RePORTER	Whitehall Foundation; National Institute of Neurological Disorders and Stroke at the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank L. Petreanu and K. Svoboda (Howard Hughes Medical Institute) for plasmids and comments, and D. Buxton for advice on retrograde labeling methods. The work was funded by grants from the Whitehall Foundation and the National Institute of Neurological Disorders and Stroke at the US National Institutes of Health (NS061963).	Alstermark B, 2004, J NEUROPHYSIOL, V92, P1958, DOI 10.1152/jn.00092.2004; Alstermark B, 2004, J NEUROPHYSIOL, V91, P1832, DOI 10.1152/jn.00820.2003; Ayling OGS, 2009, NAT METHODS, V6, P219, DOI [10.1038/NMETH.1303, 10.1038/nmeth.1303]; Ballion B, 2008, EUR J NEUROSCI, V27, P2313, DOI 10.1111/j.1460-9568.2008.06192.x; Binzegger T, 2004, J NEUROSCI, V24, P8441, DOI 10.1523/JNEUROSCI.1400-04.2004; Binzegger T, 2009, NEURAL NETWORKS, V22, P1071, DOI 10.1016/j.neunet.2009.07.011; Brown SP, 2009, CURR OPIN NEUROBIOL, V19, P415, DOI 10.1016/j.conb.2009.07.011; Brown SP, 2009, NATURE, V457, P1133, DOI 10.1038/nature07658; Cheatwood JL, 2005, BRAIN RES, V1036, P90, DOI 10.1016/j.brainres.2004.12.049; Chklovskii DB, 2004, NATURE, V431, P782, DOI 10.1038/nature03012; Dombeck DA, 2009, J NEUROSCI, V29, P13751, DOI 10.1523/JNEUROSCI.2985-09.2009; Douglas RJ, 2004, ANNU REV NEUROSCI, V27, P419, DOI 10.1146/annurev.neuro.27.070203.144152; Gao WJ, 2004, J COMP NEUROL, V476, P174, DOI 10.1002/cne.20224; GERFEN CR, 1989, SCIENCE, V246, P385, DOI 10.1126/science.2799392; Grinevich V, 2005, J NEUROSCI, V25, P8250, DOI 10.1523/JNEUROSCI.2235-05.2005; Groh A, 2010, CEREB CORTEX, V20, P826, DOI 10.1093/cercor/bhp152; Hattox AM, 2007, J NEUROPHYSIOL, V98, P3330, DOI 10.1152/jn.00397.2007; Hazan J, 1999, NAT GENET, V23, P296, DOI 10.1038/15472; Kaneko T, 2000, J COMP NEUROL, V423, P52, DOI 10.1002/1096-9861(20000717)423:1<52::AID-CNE5>3.0.CO;2-F; Larsen DD, 2008, FRONT NEURAL CIRCUIT, V1, DOI 10.3389/neuro.04.005.2007; Levesque M, 1996, BRAIN RES, V709, P311, DOI 10.1016/0006-8993(95)01333-4; LI CX, 1991, CAN J NEUROL SCI, V18, P28, DOI 10.1017/S0317167100031267; Llano DA, 2009, J NEUROPHYSIOL, V101, P3325, DOI 10.1152/jn.91291.2008; Lubke J, 2003, CEREB CORTEX, V13, P1051, DOI 10.1093/cercor/13.10.1051; Miller MN, 2008, J NEUROSCI, V28, P13716, DOI 10.1523/JNEUROSCI.2940-08.2008; Mizuno H, 2007, J NEUROSCI, V27, P6760, DOI 10.1523/JNEUROSCI.1215-07.2007; Molyneaux BJ, 2007, NAT REV NEUROSCI, V8, P427, DOI 10.1038/nrn2151; Morishima M, 2006, J NEUROSCI, V26, P4394, DOI 10.1523/JNEUROSCI.0252-06.2006; Nelson Sacha B., 2002, Neuron, V36, P19, DOI 10.1016/S0896-6273(02)00944-3; Otsuka T, 2008, J NEUROSCI, V28, P11186, DOI 10.1523/JNEUROSCI.1921-08.2008; Pasinelli P, 2006, NAT REV NEUROSCI, V7, P710, DOI 10.1038/nrn1971; Petreanu L, 2007, NAT NEUROSCI, V10, P663, DOI 10.1038/nn1891; Phillips C.G., 1977, MONOGR PHYSL SOC, V34; Rathelot JA, 2006, P NATL ACAD SCI USA, V103, P8257, DOI 10.1073/pnas.0602933103; Rathelot JA, 2009, P NATL ACAD SCI USA, V106, P918, DOI 10.1073/pnas.0808362106; Reiner A, 2003, J COMP NEUROL, V457, P420, DOI 10.1002/cne.10541; Shepherd GMG, 2005, NAT NEUROSCI, V8, P782, DOI 10.1038/nn1447; Shepherd GMG, 2009, FRONT NEUROSCI-SWITZ, V3, P337, DOI 10.3389/neuro.01.030.2009; Shibuki K, 2003, J PHYSIOL-LONDON, V549, P919, DOI 10.1113/jphysiol.2003.040709; Stepanyants A, 2005, TRENDS NEUROSCI, V28, P387, DOI 10.1016/j.tins.2005.05.006; Stepanyants A, 2008, CEREB CORTEX, V18, P13, DOI 10.1093/cercor/bhm027; Stevens CF, 1998, CURR BIOL, V8, pR708, DOI 10.1016/S0960-9822(98)70454-3; Striedter G.F., 2005, PRINCIPLES BRAIN EVO; Thomson AM, 2003, CEREB CORTEX, V13, P5, DOI 10.1093/cercor/13.1.5; Wang CL, 2007, J NEUROSCI, V27, P11334, DOI 10.1523/JNEUROSCI.3380-07.2007; Weiler N, 2008, NAT NEUROSCI, V11, P360, DOI 10.1038/nn2049; WILSON CJ, 1987, J COMP NEUROL, V263, P567, DOI 10.1002/cne.902630408; Wood L, 2009, J NEUROSCI, V29, P12440, DOI 10.1523/JNEUROSCI.3321-09.2009; Yu JN, 2008, FRONT NEURAL CIRCUIT, V2, DOI 10.3389/neuro.04.006.2008; Zarrinpar A, 2006, J NEUROPHYSIOL, V95, P1751, DOI 10.1152/jn.00974.2005	50	181	183	0	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2010	13	6					739	U116		10.1038/nn.2538	http://dx.doi.org/10.1038/nn.2538			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	600QY	20436481	Green Accepted			2022-12-24	WOS:000278003300019
J	Hernandez, A; Nacher, V; Luna, R; Zainos, A; Lemus, L; Alvarez, M; Vazquez, Y; Camarillo, L; Romo, R				Hernandez, Adrian; Nacher, Veronica; Luna, Rogelio; Zainos, Antonio; Lemus, Luis; Alvarez, Manuel; Vazquez, Yuriria; Camarillo, Liliana; Romo, Ranulfo			Decoding a Perceptual Decision Process across Cortex	NEURON			English	Article							SECONDARY SOMATOSENSORY CORTEX; SUBJECTIVE SENSORY EXPERIENCE; PARAMETRIC WORKING-MEMORY; VENTRAL PREMOTOR CORTEX; PRIMATE MOTOR CORTEX; FREE ARM MOVEMENTS; PREFRONTAL CORTEX; NEURAL CODES; PSYCHOPHYSICAL MEASUREMENTS; CORTICOSPINAL PROJECTIONS	Perceptual decisions arise from the activity of neurons distributed across brain circuits. But, decoding the mechanisms behind this cognitive operation across brain circuits has long posed a difficult problem. We recorded the neuronal activity of diverse cortical areas, while monkeys performed a vibrotactile discrimination task. We find that the encoding of the stimuli during the stimulus periods, working memory, and comparison periods is widely distributed across cortical areas. Notably, during the comparison and postponed decision report periods the activity of frontal brain circuits encode both the result of the sensory evaluation that corresponds to the monkey's possible choices and past information on which the decision is based. These results suggest that frontal lobe circuits are more engaged in the readout of sensory information from working memory, when it is required to be compared with other sensory inputs, than simply engaged in motor responses during this task.	[Hernandez, Adrian; Nacher, Veronica; Luna, Rogelio; Zainos, Antonio; Lemus, Luis; Alvarez, Manuel; Vazquez, Yuriria; Camarillo, Liliana; Romo, Ranulfo] Univ Nacl Autonoma Mexico, Inst Fisiol Celular Neurociencias, Mexico City 04510, DF, Mexico	Universidad Nacional Autonoma de Mexico	Romo, R (corresponding author), Univ Nacl Autonoma Mexico, Inst Fisiol Celular Neurociencias, Mexico City 04510, DF, Mexico.	rromo@ifc.unam.mx	Nacher, Veronica/F-4184-2010; Lemus, Luis/E-6760-2019	Lemus, Luis/0000-0002-6608-3684; Alvarez, Manuel/0000-0003-4651-3525; romo, ranulfo/0000-0003-3529-3635; zainos, antonio/0000-0001-6137-1794; Luna, Rogelio/0000-0003-0711-7562	Howard Hughes Medical Institute; Direccion del Personal Academic de la Universidad Nacional Autonoma de Mexico; Consejo Nacional de Ciencia y Tecnologia	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Direccion del Personal Academic de la Universidad Nacional Autonoma de Mexico; Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	The research of R.R. was partially supported by an International Research Scholars Award from the Howard Hughes Medical Institute, and grants from the Direccion del Personal Academic de la Universidad Nacional Autonoma de Mexico and the Consejo Nacional de Ciencia y Tecnologia. We thank Carlos Brody, Andres Ojeda, and Emilio Salinas for invaluable comments.	Britten KH, 1996, VISUAL NEUROSCI, V13, P87, DOI 10.1017/S095252380000715X; Brody CD, 2003, CEREB CORTEX, V13, P1196, DOI 10.1093/cercor/bhg100; Carpenter AF, 1999, SCIENCE, V283, P1752, DOI 10.1126/science.283.5408.1752; Castellan NJ, 1988, NONPARAMETRIC STAT B; Chow SS, 2009, J NEUROSCI, V29, P7238, DOI 10.1523/JNEUROSCI.4856-08.2009; de Lafuente V, 2005, NAT NEUROSCI, V8, P1698, DOI 10.1038/nn1587; de Lafuente V, 2006, P NATL ACAD SCI USA, V103, P14266, DOI 10.1073/pnas.0605826103; Draper NR., 1998, APPL REGRESSION ANAL, DOI [10.1002/9781118625590, DOI 10.1002/9781118625590]; DUM RP, 1991, J NEUROSCI, V11, P667; Fuster JM, 1997, TRENDS NEUROSCI, V20, P451, DOI 10.1016/S0166-2236(97)01128-4; GEORGOPOULOS AP, 1988, J NEUROSCI, V8, P2928; Gold JI, 2000, NATURE, V404, P390, DOI 10.1038/35006062; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; Green DM, 1966, SIGNAL DETECTION THE; HE SQ, 1993, J NEUROSCI, V13, P952; Hernandez A, 1997, J NEUROSCI, V17, P6391; Hernandez A, 2000, P NATL ACAD SCI USA, V97, P6191, DOI 10.1073/pnas.120018597; Hernandez A, 2002, NEURON, V33, P959, DOI 10.1016/S0896-6273(02)00613-X; Hernandez A, 2008, P NATL ACAD SCI USA, V105, P16785, DOI 10.1073/pnas.0808702105; Hoshi E, 2004, J NEUROPHYSIOL, V92, P3482, DOI 10.1152/jn.00547.2004; Jun JK, 2010, J NEUROSCI, V30, P916, DOI 10.1523/JNEUROSCI.2062-09.2010; Kraskov A, 2009, NEURON, V64, P922, DOI 10.1016/j.neuron.2009.12.010; Lamme VAF, 2000, TRENDS NEUROSCI, V23, P571, DOI 10.1016/S0166-2236(00)01657-X; Lemus L, 2007, P NATL ACAD SCI USA, V104, P17174, DOI 10.1073/pnas.0707961104; Luna R, 2005, NAT NEUROSCI, V8, P1210, DOI 10.1038/nn1513; Machens CK, 2005, SCIENCE, V307, P1121, DOI 10.1126/science.1104171; MATSUZAKA Y, 1992, J NEUROPHYSIOL, V68, P653, DOI 10.1152/jn.1992.68.3.653; Mongillo G, 2008, SCIENCE, V319, P1543, DOI 10.1126/science.1150769; MOUNTCASTLE VB, 1990, J NEUROSCI, V10, P3032; Mushiake H, 2006, NEURON, V50, P631, DOI 10.1016/j.neuron.2006.03.045; NEWSOME WT, 1989, NATURE, V341, P52, DOI 10.1038/341052a0; Ohbayashi M, 2003, SCIENCE, V301, P233, DOI 10.1126/science.1084884; Prut Y, 1999, NATURE, V401, P590, DOI 10.1038/44145; Rizzolatti G, 2001, NEURON, V31, P889, DOI 10.1016/S0896-6273(01)00423-8; RIZZOLATTI G, 1988, EXP BRAIN RES, V71, P491, DOI 10.1007/BF00248742; Romo R, 2003, NAT REV NEUROSCI, V4, P203, DOI 10.1038/nrn1058; Romo R, 1999, CURR OPIN NEUROBIOL, V9, P487, DOI 10.1016/S0959-4388(99)80073-7; Romo R, 1999, NATURE, V399, P470, DOI 10.1038/20939; Romo R, 2004, NEURON, V41, P165, DOI 10.1016/S0896-6273(03)00817-1; Romo R, 2003, NEURON, V38, P649, DOI 10.1016/S0896-6273(03)00287-3; Romo R, 2002, NAT NEUROSCI, V5, P1217, DOI 10.1038/nn950; Salinas E, 2000, J NEUROSCI, V20, P5503, DOI 10.1523/JNEUROSCI.20-14-05503.2000; Salinas E, 1998, J NEUROSCI, V18, P499; SCHWARTZ AB, 1988, J NEUROSCI, V8, P2913; Shadlen MN, 1996, P NATL ACAD SCI USA, V93, P628, DOI 10.1073/pnas.93.2.628; Shima K, 2007, NATURE, V445, P315, DOI 10.1038/nature05470; [No title captured]	47	188	188	0	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 29	2010	66	2					300	314		10.1016/j.neuron.2010.03.031	http://dx.doi.org/10.1016/j.neuron.2010.03.031			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	591NQ	20435005	Bronze			2022-12-24	WOS:000277308200014
J	Anderson, D; Mehaffey, WH; Iftinca, M; Rehak, R; Engbers, JDT; Hameed, S; Zamponi, GW; Turner, RW				Anderson, Dustin; Mehaffey, W. Hamish; Iftinca, Mircea; Rehak, Renata; Engbers, Jordan D. T.; Hameed, Shahid; Zamponi, Gerald W.; Turner, Ray W.			Regulation of neuronal activity by Cav3-Kv4 channel signaling complexes	NATURE NEUROSCIENCE			English	Article							CEREBELLAR STELLATE CELLS; A-TYPE; POTASSIUM CHANNELS; K+ CHANNEL; HIPPOCAMPAL-NEURONS; PYRAMIDAL NEURONS; CALCIUM-CHANNELS; CA2+ CHANNELS; CURRENTS; PROTEIN	Kv4 low voltage-activated A-type potassium channels are widely expressed in excitable cells, where they control action potential firing, dendritic activity and synaptic integration. Kv4 channels exist as a complex that includes K+ channel-interacting proteins (KChIPs), which contain calcium-binding domains and therefore have the potential to confer calcium dependence on the Kv4 channel. We found that T-type calcium channels and Kv4 channels form a signaling complex in rat that efficiently couples calcium influx to KChIP3 to modulate Kv4 function. This interaction was critical for allowing Kv4 channels to function in the subthreshold membrane potential range to regulate neuronal firing properties. The widespread expression of these channels and accessory proteins indicates that the Cav3-Kv4 signaling complex is important for the function of a wide range of electrically excitable cells.	[Turner, Ray W.] Univ Calgary, Dept Physiol & Pharmacol, Hotchkiss Brain Inst, Calgary, AB, Canada; Univ Calgary, Dept Cell Biol & Anat, Hotchkiss Brain Inst, Calgary, AB, Canada	University of Calgary; University of Calgary	Turner, RW (corresponding author), Univ Calgary, Dept Physiol & Pharmacol, Hotchkiss Brain Inst, Calgary, AB, Canada.	rwturner@ucalgary.ca	Patten, Scott/B-4434-2011	Patten, Scott/0000-0001-9871-4041; Zamponi, Gerald W./0000-0002-0644-9066	Canadian Institutes of Health Research; Achievers in Medical Sciences and T. Chen Fong Award; Alberta Heritage Foundation for Medical Research (AHFMR); National Sciences and Engineering Research Council	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Achievers in Medical Sciences and T. Chen Fong Award; Alberta Heritage Foundation for Medical Research (AHFMR)(Alberta Heritage Foundation for Medical Research); National Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	We gratefully acknowledge J. McRory and M. L. Molineux for early contributions to protein analysis, H. Jerng and P. Pfaffinger for access to DPLP cDNA clones, and M. Kruskic and L. Chen for expert technical assistance. This work was supported by a grant from Canadian Institutes of Health Research (R. W. T. and G.W.Z.) and studentship support through an Achievers in Medical Sciences and T. Chen Fong Award (D. A.), Alberta Heritage Foundation for Medical Research (AHFMR) (W. H. M., R. R. and J. D. T. E.), Canadian Institutes of Health Research (W. H. M.), National Sciences and Engineering Research Council (R. R.), and an AHFMR Postdoctoral Fellowship (M. I.). R. W. T. is an AHFMR Scientist and G.W.Z. is an AHFMR Scientist and Canada Research Chair.	An WF, 2000, NATURE, V403, P553, DOI 10.1038/35000592; Barmack NH, 2008, J NEUROSCI, V28, P1140, DOI 10.1523/JNEUROSCI.3942-07.2008; Bourdeau ML, 2007, J NEUROSCI, V27, P1942, DOI 10.1523/JNEUROSCI.3208-06.2007; Buxbaum JD, 1998, NAT MED, V4, P1177, DOI 10.1038/2673; Carrion AM, 1999, NATURE, V398, P80, DOI 10.1038/18044; CHEN QX, 1991, J NEUROSCI, V11, P337; CONNOR JA, 1971, J PHYSIOL-LONDON, V213, P31, DOI 10.1113/jphysiol.1971.sp009366; Covarrubias M, 2008, NEUROCHEM RES, V33, P1558, DOI 10.1007/s11064-008-9650-8; Cueni L, 2008, NAT NEUROSCI, V11, P683, DOI 10.1038/nn.2124; Cueni L, 2009, PFLUG ARCH EUR J PHY, V457, P1161, DOI 10.1007/s00424-008-0582-6; EBIHARA S, 1995, J PHYSIOL-LONDON, V484, P77, DOI 10.1113/jphysiol.1995.sp020649; Fakler B, 2008, NEURON, V59, P873, DOI 10.1016/j.neuron.2008.09.001; Hamid J, 2006, NEUROSCIENCE, V143, P717, DOI 10.1016/j.neuroscience.2006.08.023; Hausser M, 1997, NEURON, V19, P665, DOI 10.1016/S0896-6273(00)80379-7; Hoffman DA, 1997, NATURE, V387, P869, DOI 10.1038/43119; Huguenard JR, 1996, ANNU REV PHYSIOL, V58, P329, DOI 10.1146/annurev.physiol.58.1.329; Jerng HH, 2004, MOL CELL NEUROSCI, V27, P343, DOI 10.1016/j.mcn.2004.06.011; Johnston D, 2003, PHILOS T ROY SOC B, V358, P667, DOI 10.1098/rstb.2002.1248; Jung SC, 2008, NEURON, V60, P657, DOI 10.1016/j.neuron.2008.08.029; Khaliq ZM, 2008, J NEUROSCI, V28, P10905, DOI 10.1523/JNEUROSCI.2237-08.2008; Kollo M, 2006, J NEUROSCI, V26, P2684, DOI 10.1523/JNEUROSCI.5257-05.2006; Leclerc GM, 2007, MOL CELL ENDOCRINOL, V267, P70, DOI 10.1016/j.mce.2006.12.040; Losonczy A, 2008, NATURE, V452, P436, DOI 10.1038/nature06725; Lusin JD, 2008, BIOCHEMISTRY-US, V47, P2252, DOI 10.1021/bi7017267; Maffie J, 2008, J PHYSIOL-LONDON, V586, P5609, DOI 10.1113/jphysiol.2008.161620; Marionneau C, 2009, CHANNELS, V3, P284; McDonough SI, 1998, MOL PHARMACOL, V54, P1080, DOI 10.1124/mol.54.6.1080; McKay BE, 2006, EUR J NEUROSCI, V24, P2581, DOI 10.1111/j.1460-9568.2006.05136.x; Molineux ML, 2006, P NATL ACAD SCI USA, V103, P5555, DOI 10.1073/pnas.0601261103; Molineux ML, 2005, J NEUROSCI, V25, P10863, DOI 10.1523/JNEUROSCI.3436-05.2005; Murakoshi H, 1999, J NEUROSCI, V19, P1728; NICHOLSON C, 1978, J NEUROPHYSIOL, V41, P1026, DOI 10.1152/jn.1978.41.4.1026; Patel SP, 2002, J PHYSIOL-LONDON, V545, P5, DOI 10.1113/jphysiol.2002.031856; Pioletti M, 2006, NAT STRUCT MOL BIOL, V13, P987, DOI 10.1038/nsmb1164; Rhodes KJ, 2004, J NEUROSCI, V24, P7903, DOI 10.1523/JNEUROSCI.0776-04.2004; Suter KJ, 2004, NEUROSCIENCE, V124, P305, DOI 10.1016/j.neuroscience.2003.11.015; Tadayonnejad R, 2009, CHANNELS, V3, P149, DOI 10.4161/chan.3.3.8872; Talley EM, 1999, J NEUROSCI, V19, P1895; Venn N, 2008, BIOCHEM J, V413, P71, DOI 10.1042/BJ20080441; Wang LT, 2007, J HIGH ENERGY PHYS, DOI 10.1088/1126-6708/2007/04/032; Wang X, 2005, J NEUROSCI RES, V81, P530, DOI 10.1002/jnr.20576	41	127	128	1	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2010	13	3					333	U14		10.1038/nn.2493	http://dx.doi.org/10.1038/nn.2493			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	559WW	20154682				2022-12-24	WOS:000274860100015
J	Gerdjikov, TV; Bergner, CG; Stuttgen, MC; Waiblinger, C; Schwarz, C				Gerdjikov, Todor V.; Bergner, Caroline G.; Stuttgen, Maik C.; Waiblinger, Christian; Schwarz, Cornelius			Discrimination of Vibrotactile Stimuli in the Rat Whisker System: Behavior and Neurometrics	NEURON			English	Article							PSYCHOPHYSICAL MEASUREMENTS; NEURAL CODES; FREQUENCY; NEURONS; ADAPTATION; SIGNALS; SENSE; DEFLECTION; VIBRATION; AMPLITUDE	Understanding the neural code underlying perception requires the mapping of physical stimulus parameters to both psychophysical decisions and neuronal responses. Here, we employed a novel psychophysical task in head-fixed rats to measure discriminability of vibrotactile whisker deflections. Rats could discriminate 90 Hz from 60 Hz pulsatile stimuli if stimulus intensity covaried with frequency. To pin down the physical parameters used by the rats to discriminate these vibrations, we manipulated stimulus amplitude to arrive at pairs of nondiscriminable stimuli. We found that vibrations matched in intensity (measured as mean absolute velocity), but differing in frequency, were no longer discriminable. Recordings of trigeminal ganglion neurons revealed that the distribution of neurometric sensitivities based on spike counts, but not interspike intervals, matched the rats' inability to discriminate intensity-matched stimuli. In conclusion, we suggest that stimulus mean absolute velocity, encoded in primary afferent spike counts, plays a prominent role for whisker-mediated perception.	[Gerdjikov, Todor V.; Bergner, Caroline G.; Stuttgen, Maik C.; Waiblinger, Christian; Schwarz, Cornelius] Univ Tubingen, Werner Reichardt Ctr Integrat Neurosci, D-72076 Tubingen, Germany; [Gerdjikov, Todor V.; Bergner, Caroline G.; Stuttgen, Maik C.; Waiblinger, Christian; Schwarz, Cornelius] Univ Tubingen, Hertie Inst Clin Brain Res, D-72076 Tubingen, Germany; [Gerdjikov, Todor V.] Univ Leicester, Sch Psychol, Leicester LE1 9HN, Leics, England	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Leicester	Schwarz, C (corresponding author), Univ Tubingen, Werner Reichardt Ctr Integrat Neurosci, D-72076 Tubingen, Germany.		Stüttgen, Maik C./K-1494-2019; Schwarz, Cornelius/B-4174-2014	Stüttgen, Maik C./0000-0002-7031-262X; Schwarz, Cornelius/0000-0003-4725-473X; Waiblinger, Christian/0000-0002-9763-3693; Gerdjikov, Todor/0000-0002-8889-9182	Deutsche Forschungsgemeinschaft [SFB 550-B11, SCHW577/10-1]; IZKF Medical School, University of Tubingen; Hertie Foundation; Hermann and Lilly Schilling Foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); IZKF Medical School, University of Tubingen; Hertie Foundation; Hermann and Lilly Schilling Foundation	This research was supported by grants from the Deutsche Forschungsgemeinschaft (SFB 550-B11 and SCHW577/10-1) T V G was supported by a postdoctoral fellowship from the Hertie Foundation C G B was supported by a stipend from IZKF Medical School, University of Tubingen Further support was provided by the Hertie Foundation and the Hermann and Lilly Schilling Foundation	Arabzadeh E, 2005, PLOS BIOL, V3, P155, DOI 10.1371/journal.pbio.0030017; Arabzadeh E, 2003, J NEUROSCI, V23, P9146; Brecht M, 1997, BEHAV BRAIN RES, V84, P81, DOI 10.1016/S0166-4328(97)83328-1; BRITTEN KH, 1992, J NEUROSCI, V12, P4745; CARVELL GE, 1990, J NEUROSCI, V10, P2638; Deschenes M, 2003, J NEUROSCI, V23, P6778; Ebara S, 2002, J COMP NEUROL, V449, P103, DOI 10.1002/cne.10277; Ewert TAS, 2008, J NEUROSCI, V28, P5359, DOI 10.1523/JNEUROSCI.0089-08.2008; Fraser G, 2006, SOMATOSENS MOT RES, V23, P111, DOI 10.1080/08990220600906589; Garabedian CE, 2003, J NEUROPHYSIOL, V90, P1379, DOI 10.1152/jn.01158.2002; GERDJIKOV TV, 2008, SOC NEUR ABST, V858, P11; GIBSON JM, 1983, SOMATOSENS RES, V1, P95, DOI 10.3109/07367228309144543; GOFF GD, 1967, J EXP PSYCHOL, V74, P294, DOI 10.1037/h0024561; Green DM, 1966, SIGNAL DETECTION THE; Hernandez A, 1997, J NEUROSCI, V17, P6391; Hernandez A, 2000, P NATL ACAD SCI USA, V97, P6191, DOI 10.1073/pnas.120018597; Hipp J, 2006, J NEUROPHYSIOL, V95, P1792, DOI 10.1152/jn.01104.2005; Jadhav SP, 2009, NAT NEUROSCI, V12, P792, DOI 10.1038/nn.2328; Jones LM, 2004, SCIENCE, V304, P1986, DOI 10.1126/science.1097779; Khatri V, 2004, J NEUROPHYSIOL, V92, P3244, DOI 10.1152/jn.00257.2004; LAMOTTE RH, 1975, J NEUROPHYSIOL, V38, P539, DOI 10.1152/jn.1975.38.3.539; Leiser SC, 2006, J NEUROPHYSIOL, V95, P3129, DOI 10.1152/jn.00157.2005; Luna R, 2005, NAT NEUROSCI, V8, P1210, DOI 10.1038/nn1513; MOUNTCASTLE VB, 1990, J NEUROSCI, V10, P3032; Parker AJ, 1998, ANNU REV NEUROSCI, V21, P227, DOI 10.1146/annurev.neuro.21.1.227; Petersen RS, 2008, NEURON, V60, P890, DOI 10.1016/j.neuron.2008.09.041; Pinto DJ, 2000, J NEUROPHYSIOL, V83, P1158, DOI 10.1152/jn.2000.83.3.1158; Ritt JT, 2008, NEURON, V57, P599, DOI 10.1016/j.neuron.2007.12.024; Salinas E, 2000, J NEUROSCI, V20, P5503, DOI 10.1523/JNEUROSCI.20-14-05503.2000; Shoykhet M, 2000, SOMATOSENS MOT RES, V17, P171; Stanislaw H, 1999, BEHAV RES METH INS C, V31, P137, DOI 10.3758/BF03207704; Stuttgen MC, 2008, NAT NEUROSCI, V11, P1091, DOI 10.1038/nn.2162; Stuttgen MC, 2006, J NEUROSCI, V26, P7933, DOI 10.1523/JNEUROSCI.1864-06.2006; Stuttgen MC, 2010, J NEUROSCI, V30, P2060, DOI 10.1523/JNEUROSCI.3943-09.2010; Wolfe J, 2008, PLOS BIOL, V6, P1661, DOI 10.1371/journal.pbio.0060215	35	57	57	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 25	2010	65	4					530	540		10.1016/j.neuron.2010.02.007	http://dx.doi.org/10.1016/j.neuron.2010.02.007			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	566HD	20188657	Bronze			2022-12-24	WOS:000275359800011
J	Gentet, LJ; Avermann, M; Matyas, F; Staiger, JF; Petersen, CCH				Gentet, Luc J.; Avermann, Michael; Matyas, Ferenc; Staiger, Jochen F.; Petersen, Carl C. H.			Membrane Potential Dynamics of GABAergic Neurons in the Barrel Cortex of Behaving Mice	NEURON			English	Article							PRIMARY SOMATOSENSORY CORTEX; WHOLE-CELL RECORDINGS; IN-VIVO; INHIBITORY INTERNEURONS; CORTICAL-NEURONS; AUDITORY-CORTEX; NEOCORTICAL NEURONS; SENSORIMOTOR SYSTEM; VISUAL-CORTEX; WHISKER	Computations in cortical circuits are mediated by synaptic interactions between excitatory and inhibitory neurons, and yet we know little about their activity in awake animals. Here, through single and dual whole-cell recordings combined with two-photon microscopy in the barrel cortex of behaving mice, we directly compare the synaptically driven membrane potential dynamics of inhibitory and excitatory layer 2/3 neurons. We find that inhibitory neurons depolarize synchronously with excitatory neurons, but they are much more active with differential contributions of two classes of inhibitory neurons during different brain states. Fast-spiking GABAergic neurons dominate during quiet wakefulness, but during active wakefulness Non-fast-spiking GABAergic neurons depolarize, firing action potentials at increased rates. Sparse uncorrelated action potential firing in excitatory neurons is driven by fast, large, and cell-specific depolarization. In contrast, inhibitory neurons fire correlated action potentials at much higher frequencies driven by slower, smaller, and broadly synchronized depolarization.	[Gentet, Luc J.; Avermann, Michael; Matyas, Ferenc; Petersen, Carl C. H.] Ecole Polytech Fed Lausanne, Lab Sensory Proc, Brain Mind Inst, Fac Life Sci, CH-1015 Lausanne, Switzerland; [Staiger, Jochen F.] Univ Freiburg, Inst Anat & Cell Biol, Dept Neuroanat, D-79001 Freiburg, Germany	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Freiburg	Petersen, CCH (corresponding author), Ecole Polytech Fed Lausanne, Lab Sensory Proc, Brain Mind Inst, Fac Life Sci, CH-1015 Lausanne, Switzerland.	carl.petersen@epfl.ch	Gentet, Luc/GNN-0460-2022; Petersen, Carl/M-5123-2017; Gentet, Luc J/H-5127-2017	Gentet, Luc/0000-0001-6509-1001; Petersen, Carl/0000-0003-3344-4495; Gentet, Luc J/0000-0001-6509-1001	Swiss National Science Foundation; SystemsX.ch; Human Frontiers in Science Program; EMBO; Deutsche Forschungsgemeinschaft [Sta 431/8-1]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); SystemsX.ch; Human Frontiers in Science Program(Human Frontier Science Program); EMBO(European Molecular Biology Organization (EMBO)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank Sylvain Crochet and James Poulet for useful discussions and critical reading of the manuscript. We thank Kaspar Vogt for GAD67-GFP knockin mice, originally made by Yuchio Yanagawa. This work was funded by grants from the Swiss National Science Foundation (C.C.H.P.), SystemsX.ch (C.C.H.P.), Human Frontiers in Science Program (C.C.H.P.), an EMBO long-term fellowship (F.M.), and Deutsche Forschungsgemeinschaft grant Sta 431/8-1 (J.F.S.).	Ascoli GA, 2008, NAT REV NEUROSCI, V9, P557, DOI 10.1038/nrn2402; Atallah BV, 2009, NEURON, V62, P566, DOI 10.1016/j.neuron.2009.04.027; Bacci A, 2005, TRENDS NEUROSCI, V28, P602, DOI 10.1016/j.tins.2005.08.007; Beloozerova IN, 2003, J NEUROSCI, V23, P1087; Borg-Graham LJ, 1998, NATURE, V393, P369, DOI 10.1038/30735; Bruno RM, 2002, J NEUROSCI, V22, P10966; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Castro-Alamancos MA, 2004, NEURON, V41, P455, DOI 10.1016/S0896-6273(03)00853-5; Crochet S, 2006, NAT NEUROSCI, V9, P608, DOI 10.1038/nn1690; Curtis JC, 2009, NAT NEUROSCI, V12, P492, DOI 10.1038/nn.2283; David C, 2007, EUR J NEUROSCI, V25, P2329, DOI 10.1111/j.1460-9568.2007.05496.x; de Kock CPJ, 2009, P NATL ACAD SCI USA, V106, P16446, DOI 10.1073/pnas.0904143106; Fanselow EE, 1999, J NEUROSCI, V19, P7603, DOI 10.1523/JNEUROSCI.19-17-07603.1999; Fanselow EE, 2008, J NEUROPHYSIOL, V100, P2640, DOI 10.1152/jn.90691.2008; Fee MS, 1997, J NEUROPHYSIOL, V78, P1144, DOI 10.1152/jn.1997.78.2.1144; Ferezou I, 2007, NEURON, V56, P907, DOI 10.1016/j.neuron.2007.10.007; Ferezou I, 2006, NEURON, V50, P617, DOI 10.1016/j.neuron.2006.03.043; Freund TF, 2007, NEURON, V56, P33, DOI 10.1016/j.neuron.2007.09.012; Fuchs EC, 2007, NEURON, V53, P591, DOI 10.1016/j.neuron.2007.01.031; Fujisawa S, 2008, NAT NEUROSCI, V11, P823, DOI 10.1038/nn.2134; Gabernet L, 2005, NEURON, V48, P315, DOI 10.1016/j.neuron.2005.09.022; Galarreta M, 1998, NAT NEUROSCI, V1, P587, DOI 10.1038/2822; Gibson JR, 1999, NATURE, V402, P75, DOI 10.1038/47035; Gonchar Yuri, 2007, Front Neuroanat, V1, P3, DOI 10.3389/neuro.05.003.2007; Gulledge AT, 2007, J NEUROPHYSIOL, V97, P2215, DOI 10.1152/jn.00493.2006; Gupta A, 2000, SCIENCE, V287, P273, DOI 10.1126/science.287.5451.273; Haider B, 2006, J NEUROSCI, V26, P4535, DOI 10.1523/JNEUROSCI.5297-05.2006; Haider B, 2009, NEURON, V62, P171, DOI 10.1016/j.neuron.2009.04.008; Hentschke H, 2006, CEREB CORTEX, V16, P1142, DOI 10.1093/cercor/bhj056; Jadhav SP, 2009, NAT NEUROSCI, V12, P792, DOI 10.1038/nn.2328; Kapfer C, 2007, NAT NEUROSCI, V10, P743, DOI 10.1038/nn1909; Kitamura K, 2008, NAT METHODS, V5, P61, DOI 10.1038/NMETH1150; Klausberger T, 2003, NATURE, V421, P844, DOI 10.1038/nature01374; Kleinfeld D, 2006, CURR OPIN NEUROBIOL, V16, P435, DOI 10.1016/j.conb.2006.06.009; Knutsen PM, 2005, J NEUROPHYSIOL, V93, P2294, DOI 10.1152/jn.00718.2004; Kole MHP, 2008, NAT NEUROSCI, V11, P1253, DOI 10.1038/nn.2203; Krupa DJ, 2004, SCIENCE, V304, P1989, DOI 10.1126/science.1093318; Lampl I, 1999, NEURON, V22, P361, DOI 10.1016/S0896-6273(00)81096-X; Lee AK, 2006, NEURON, V51, P399, DOI 10.1016/j.neuron.2006.07.004; Lee S, 2008, NAT NEUROSCI, V11, P1430, DOI 10.1038/nn.2227; Lefort S, 2009, NEURON, V61, P301, DOI 10.1016/j.neuron.2008.12.020; Liu BH, 2009, J NEUROSCI, V29, P10520, DOI 10.1523/JNEUROSCI.1915-09.2009; Losonczy A, 2008, NATURE, V452, P436, DOI 10.1038/nature06725; Margrie TW, 2003, NEURON, V39, P911, DOI 10.1016/j.neuron.2003.08.012; Mitchell JF, 2007, NEURON, V55, P131, DOI 10.1016/j.neuron.2007.06.018; MOUNTCASTLE VB, 1969, J NEUROPHYSIOL, V32, P452, DOI 10.1152/jn.1969.32.3.452; Nevian T, 2007, NAT NEUROSCI, V10, P206, DOI 10.1038/nn1826; Okun M, 2008, NAT NEUROSCI, V11, P535, DOI 10.1038/nn.2105; Otazu GH, 2009, NAT NEUROSCI, V12, P646, DOI 10.1038/nn.2306; Petersen CCH, 2007, NEURON, V56, P339, DOI 10.1016/j.neuron.2007.09.017; Petreanu L, 2009, NATURE, V457, P1142, DOI 10.1038/nature07709; Poulet JFA, 2008, NATURE, V454, P881, DOI 10.1038/nature07150; Reyes A, 1998, NAT NEUROSCI, V1, P279, DOI 10.1038/1092; Sakata S, 2009, NEURON, V64, P404, DOI 10.1016/j.neuron.2009.09.020; Shu YS, 2003, NATURE, V423, P288, DOI 10.1038/nature01616; Silberberg G, 2007, NEURON, V53, P735, DOI 10.1016/j.neuron.2007.02.012; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; Sohya K, 2007, J NEUROSCI, V27, P2145, DOI 10.1523/JNEUROSCI.4641-06.2007; Song S, 2005, PLOS BIOL, V3, P507, DOI 10.1371/journal.pbio.0030068; Stuttgen MC, 2008, NAT NEUROSCI, V11, P1091, DOI 10.1038/nn.2162; Swadlow HA, 2002, NAT NEUROSCI, V5, P403, DOI 10.1038/nn847; Tamamaki N, 2003, J COMP NEUROL, V467, P60, DOI 10.1002/cne.10905; Tan ZJ, 2008, P NATL ACAD SCI USA, V105, P2187, DOI 10.1073/pnas.0710628105; Volgushev M, 2006, J NEUROSCI, V26, P5665, DOI 10.1523/JNEUROSCI.0279-06.2006; Von Heimendahl M, 2007, PLOS BIOL, V5, P2696, DOI 10.1371/journal.pbio.0050305; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116; Xu XM, 2009, J NEUROSCI, V29, P70, DOI 10.1523/JNEUROSCI.4104-08.2009; Yoshimura Y, 2005, NAT NEUROSCI, V8, P1552, DOI 10.1038/nn1565	69	307	308	1	37	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 11	2010	65	3					422	435		10.1016/j.neuron.2010.01.006	http://dx.doi.org/10.1016/j.neuron.2010.01.006			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	564BF	20159454	Bronze			2022-12-24	WOS:000275185200014
J	Walker, E; Chang, WY; Hunkapiller, J; Cagney, G; Garcha, K; Torchia, J; Krogan, NJ; Reiter, JF; Stanford, WL				Walker, Emily; Chang, Wing Y.; Hunkapiller, Julie; Cagney, Gerard; Garcha, Kamal; Torchia, Joseph; Krogan, Nevan J.; Reiter, Jeremy F.; Stanford, William L.			Polycomb-like 2 Associates with PRC2 and Regulates Transcriptional Networks during Mouse Embryonic Stem Cell Self-Renewal and Differentiation	CELL STEM CELL			English	Article							HISTONE METHYLTRANSFERASE ACTIVITY; LEFT-RIGHT ASYMMETRY; ES CELLS; DEVELOPMENTAL REGULATORS; PROTEIN COMPLEXES; RNA INTERFERENCE; ZESTE PROTEIN; PLURIPOTENCY; EXPRESSION; DROSOPHILA	Polycomb group (PcG) proteins are conserved epigenetic transcriptional repressors that control numerous developmental gene expression programs and have recently been implicated in modulating embryonic stem cell (ESC) fate. We identified the PcG protein PCL2 (polycomb-like 2) in a genome-wide screen for regulators of self-renewal and pluri-potency and predicted that it would play an important role in mouse ESC-fate determination. Using multiple biochemical strategies, we provide evidence that PCL2 is a Polycomb Repressive Complex 2 (PRC2)-associated protein in mouse ESCs. Knockdown of Pcl2 in ESCs resulted in heightened self-renewal characteristics, defects in differentiation, and altered patterns of histone methylation. Integration of global gene expression and promoter occupancy analyses allowed us to identify PCL2 and PRC2 transcriptional targets and draft regulatory networks. We describe the role of PCL2 in both modulating transcription of ESC self-renewal genes in undifferentiated ESCs as well as developmental regulators during early commitment and differentiation.	[Walker, Emily; Chang, Wing Y.; Garcha, Kamal; Stanford, William L.] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON M5S 3G9, Canada; [Stanford, William L.] Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A8, Canada; [Stanford, William L.] Univ Toronto, Dept Chem Engn & Appl Chem, Toronto, ON M5S 3E5, Canada; [Hunkapiller, Julie; Reiter, Jeremy F.] Univ Calif San Francisco, Cardiovasc Res Inst, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Cagney, Gerard; Krogan, Nevan J.] Univ Calif San Francisco, Calif Inst Quantitat Biomed Res, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Cagney, Gerard] Natl Univ Ireland Univ Coll Dublin, Conway Inst, Dublin 4, Ireland; [Torchia, Joseph] Lawson Hlth Res Inst, London Reg Canc Program, Dept Oncol & Biochem, London, ON N6A 4L6, Canada; [Torchia, Joseph] Univ Western Ontario, London, ON N6A 4L6, Canada; [Stanford, William L.] Inst Syst Biol, Seattle, WA 98103 USA	University of Toronto; University of Toronto; University of Toronto; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University College Dublin; Western University (University of Western Ontario); Western University (University of Western Ontario); Institute for Systems Biology (ISB)	Stanford, WL (corresponding author), Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON M5S 3G9, Canada.	william.stanford@utoronto.ca		Cagney, Gerard/0000-0001-7189-9496; Stanford, William/0000-0002-5813-8016	CIHR [MOP-74528]; Canadian Cancer Society [19122]; NIH [RO1AR054396]; CIRM [RN2-00919]; Burroughs Wellcome Fund; Packard Foundation; Sandler Family Supporting Foundation; Keck Foundation; Searle Foundation; Ontario Graduate Studentship in Science and Technology; MRI; Canada Research Chair; NCIC; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR054396] Funding Source: NIH RePORTER	CIHR(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society(Canadian Cancer Society (CCS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CIRM(California Institute for Regenerative Medicine); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Packard Foundation(The David & Lucile Packard Foundation); Sandler Family Supporting Foundation; Keck Foundation(W.M. Keck Foundation); Searle Foundation; Ontario Graduate Studentship in Science and Technology; MRI; Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); NCIC(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank H. Bolouri and J. Wysocka for critical reading of the manuscript; B. Panning for critical reading of the manuscript and the generous gift of the Eed antibody; D. Pasini and K. Helin for providing the Suz12 microarray data sets; T. Reid, Q. Lan, C. To, P. Cassar, A. Omelyanenko, and J. Manias of the Stanford lab; and J. Zhang, X. Wang, Z. Hu, and C. Lu at TCAG and J. Gu for technical expertise. The mass spectrometry analysis was carried out in the UCSF mass spectrometry facility, which is headed by A. Burlingame. This work was supported by operating grants from CIHR (MOP-74528) and Canadian Cancer Society (19122) and infrastructure from Genome Canada, CA, and Ontario (MRI) to W.L.S. The Suz12 affinity tag targeting, mass spectrometry analysis, and confirmation studies were supported by NIH (RO1AR054396), CIRM (RN2-00919), the Burroughs Wellcome Fund, the Packard Foundation, and the Sandler Family Supporting Foundation grants to J.F.R. and NIH, Keck Foundation, and Searle Foundation grants to N.J.K. E.W. was supported by from Ontario Graduate Studentship in Science and Technology and a CIHR Banting and Best CGS Doctoral Research Award; W.Y.C. was supported by a MRI Postdoctoral Fellowship; and W.L.S. was supported by a Canada Research Chair. J.T. is supported by operating grant from the CIHR and NCIC.	Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Ambrosetti DC, 1997, MOL CELL BIOL, V17, P6321, DOI 10.1128/MCB.17.11.6321; Beissbarth T, 2004, BIOINFORMATICS, V20, P1464, DOI 10.1093/bioinformatics/bth088; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Chamberlain SJ, 2008, STEM CELLS, V26, P1496, DOI 10.1634/stemcells.2008-0102; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; Davey RE, 2006, STEM CELLS, V24, P2538, DOI 10.1634/stemcells.2006-0216; Deng CH, 2009, MOL CELL PROTEOMICS, V8, P1413, DOI 10.1074/mcp.M800397-MCP200; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; DUNCAN IM, 1982, GENETICS, V102, P49; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; FAUST C, 1995, DEVELOPMENT, V121, P273; Furuyama T, 2003, GENESIS, V35, P114, DOI 10.1002/gene.10173; Guo G, 2009, DEVELOPMENT, V136, P1063, DOI 10.1242/dev.030957; Hanna LA, 2002, GENE DEV, V16, P2650, DOI 10.1101/gad.1020502; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Kaji K, 2006, NAT CELL BIOL, V8, P285, DOI 10.1038/ncb1372; KIM H, 2002, NUCLEIC ACIDS RES, V37, P2940; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Kitaguchi T, 2001, DEV GENES EVOL, V211, P309, DOI 10.1007/s004270100157; Ku M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000242; Kunath T, 2003, NAT BIOTECHNOL, V21, P559, DOI 10.1038/nbt813; Kuzmichev A, 2005, P NATL ACAD SCI USA, V102, P1859, DOI 10.1073/pnas.0409875102; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Lund AH, 2004, CURR OPIN CELL BIOL, V16, P239, DOI 10.1016/j.ceb.2004.03.010; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Morrison GM, 2006, DEVELOPMENT, V133, P2011, DOI 10.1242/dev.02362; Nekrasov M, 2007, EMBO J, V26, P4078, DOI 10.1038/sj.emboj.7601837; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Niwa H, 2009, NATURE, V460, P118, DOI 10.1038/nature08113; O'Carroll D, 2001, MOL CELL BIOL, V21, P4330, DOI 10.1128/MCB.21.13.4330-4336.2001; O'Connell S, 2001, J BIOL CHEM, V276, P43065, DOI 10.1074/jbc.M104294200; Oktaba K, 2008, DEV CELL, V15, P877, DOI 10.1016/j.devcel.2008.10.005; Pasini D, 2004, EMBO J, V23, P4061, DOI 10.1038/sj.emboj.7600402; Pasini D, 2007, MOL CELL BIOL, V27, P3769, DOI 10.1128/MCB.01432-06; Peerani Raheem, 2009, V482, P21, DOI 10.1007/978-1-59745-060-7_2; Remondelli P, 1997, BIOCHEM J, V323, P79, DOI 10.1042/bj3230079; Remondelli P, 1997, FEBS LETT, V416, P254, DOI 10.1016/S0014-5793(97)01212-X; Rodda DJ, 2005, J BIOL CHEM, V280, P24731, DOI 10.1074/jbc.M502573200; Savla U, 2008, DEVELOPMENT, V135, P813, DOI 10.1242/dev.016006; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Schwartz YB, 2007, NAT REV GENET, V8, P9, DOI 10.1038/nrg1981; Shen XH, 2008, MOL CELL, V32, P491, DOI 10.1016/j.molcel.2008.10.016; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Silva J, 2003, DEV CELL, V4, P481, DOI 10.1016/S1534-5807(03)00068-6; Singla V, 2010, NAT METHODS, V7, P50, DOI [10.1038/NMETH.1406, 10.1038/nmeth.1406]; SMITH AG, 1987, DEV BIOL, V121, P1, DOI 10.1016/0012-1606(87)90132-1; SMITH AG, 1988, NATURE, V336, P688, DOI 10.1038/336688a0; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tie F, 2003, MOL CELL BIOL, V23, P3352, DOI 10.1128/MCB.23.9.3352-3362.2003; Walker E, 2007, CELL STEM CELL, V1, P71, DOI 10.1016/j.stem.2007.04.002; Wang SS, 2007, DEV DYNAM, V236, P853, DOI 10.1002/dvdy.21070; Wang SS, 2004, DEVELOPMENT, V131, P4381, DOI 10.1242/dev.01269; WILLIAMS RL, 1988, NATURE, V336, P684, DOI 10.1038/336684a0; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863; Yi F, 2008, STEM CELLS, V26, P1951, DOI 10.1634/stemcells.2008-0229; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; YUAN HB, 1995, GENE DEV, V9, P2635, DOI 10.1101/gad.9.21.2635; Yun JJ, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl400; Zhang W, 2006, NUCLEIC ACIDS RES, V34, P4780, DOI 10.1093/nar/gkl631	70	143	156	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	FEB 5	2010	6	2					153	166		10.1016/j.stem.2009.12.014	http://dx.doi.org/10.1016/j.stem.2009.12.014			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	555OC	20144788	Green Accepted, Bronze			2022-12-24	WOS:000274520800010
J	Lovejoy, LP; Krauzlis, RJ				Lovejoy, Lee P.; Krauzlis, Richard J.			Inactivation of primate superior colliculus impairs covert selection of signals for perceptual judgments	NATURE NEUROSCIENCE			English	Article							SPATIAL ATTENTION; REVERSIBLE INACTIVATION; NEURONAL RESPONSES; NEURAL MECHANISMS; VISUAL-ATTENTION; TARGET SELECTION; EYE-MOVEMENTS; NEGLECT; DEFICITS; MACAQUE	Primates base perceptual judgments on some sensory inputs while ignoring others. The covert selection of sensory information for perception is often thought to be accomplished mostly by the cerebral cortex, whereas the overt orienting toward relevant stimuli involves various additional structures such as the superior colliculus, a subcortical region involved in the control of eye movements. Contrary to this view, we show that the superior colliculus is necessary for determining which stimuli will inform perceptual judgments, even in the absence of orienting movements. Reversible inactivation of the superior colliculus in monkeys performing a motion discrimination task caused profound inattention for stimuli in the affected visual field, but only when distracters containing counterinformative signals appeared in the unaffected field. When distracting stimuli contained no information, discrimination performance was largely unaffected. Thus, the superior colliculus is a bottleneck in the covert selection of signals for perceptual judgments.	[Lovejoy, Lee P.; Krauzlis, Richard J.] Salk Inst Biol Studies, Syst Neurobiol Lab, La Jolla, CA 92037 USA; [Lovejoy, Lee P.] Univ Calif San Diego, Grad Program Neurosci, La Jolla, CA 92093 USA	Salk Institute; University of California System; University of California San Diego	Lovejoy, LP (corresponding author), Salk Inst Biol Studies, Syst Neurobiol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	lovejoy@salk.edu		Richard, Krauzlis/0000-0002-1826-0447	Simons Foundation; Institute for Neural Computation; Aginsky Scholars Award; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH020002] Funding Source: NIH RePORTER	Simons Foundation; Institute for Neural Computation; Aginsky Scholars Award; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank E. Boehle and N. Dill for technical assistance. This work was supported by the Simons Foundation (R.J.K.), the Institute for Neural Computation (L.P.L.) and an Aginsky Scholars Award (L.P.L.).	Berman RA, 2008, PROG BRAIN RES, V171, P467, DOI 10.1016/S0079-6123(08)00668-7; Bisley JW, 2003, SCIENCE, V299, P81, DOI 10.1126/science.1077395; Carello CD, 2004, NEURON, V43, P575, DOI 10.1016/j.neuron.2004.07.026; Cavanaugh J, 2004, J NEUROSCI, V24, P11236, DOI 10.1523/JNEUROSCI.3724-04.2004; Chen LTL, 2001, J NEUROSCI METH, V107, P81, DOI 10.1016/S0165-0270(01)00354-5; Cook EP, 2002, J NEUROSCI, V22, P1994, DOI 10.1523/JNEUROSCI.22-05-01994.2002; Corbetta M, 2005, NAT NEUROSCI, V8, P1603, DOI 10.1038/nn1574; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; De Weerd P, 2003, EUR J NEUROSCI, V18, P1671, DOI 10.1046/j.1460-9568.2003.02862.x; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Dosher BA, 2000, VISION RES, V40, P1269, DOI 10.1016/S0042-6989(00)00019-5; Driver J, 1998, NAT NEUROSCI, V1, P17, DOI 10.1038/217; Fecteau JH, 2004, J NEUROPHYSIOL, V92, P1728, DOI 10.1152/jn.00184.2004; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; GOLDBERG ME, 1972, J NEUROPHYSIOL, V35, P560, DOI 10.1152/jn.1972.35.4.560; Hafed ZM, 2008, J NEUROSCI, V28, P8124, DOI 10.1523/JNEUROSCI.1317-08.2008; HALLIGAN PW, 1994, COGNITIVE NEUROPSYCH, V11, P167, DOI 10.1080/02643299408251973; Heilman KM, 2004, FRONT BIOSCI-LANDMRK, V9, P694, DOI 10.2741/1261; Ignashchenkova A, 2004, NAT NEUROSCI, V7, P56, DOI 10.1038/nn1169; JOANETTE Y, 1984, BRAIN COGNITION, V3, P152, DOI 10.1016/0278-2626(84)90014-9; Kustov AA, 1996, NATURE, V384, P74, DOI 10.1038/384074a0; Law CT, 2008, NAT NEUROSCI, V11, P505, DOI 10.1038/nn2070; Luck SJ, 1997, J NEUROPHYSIOL, V77, P24, DOI 10.1152/jn.1997.77.1.24; MCCULLAH P, 1990, GEN LINEAR MODELS; McPeek RM, 2004, NAT NEUROSCI, V7, P757, DOI 10.1038/nn1269; Moore T, 2001, P NATL ACAD SCI USA, V98, P1273, DOI 10.1073/pnas.021549498; Moore T, 2003, NATURE, V421, P370, DOI 10.1038/nature01341; Mort DJ, 2003, BRAIN, V126, P1986, DOI 10.1093/brain/awg200; Muller JR, 2005, P NATL ACAD SCI USA, V102, P524, DOI 10.1073/pnas.0408311101; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Quaia C, 1998, J NEUROPHYSIOL, V79, P2097, DOI 10.1152/jn.1998.79.4.2097; RAFAL RD, 1994, CURR OPIN NEUROBIOL, V4, P231, DOI 10.1016/0959-4388(94)90078-7; Reynolds JH, 2004, ANNU REV NEUROSCI, V27, P611, DOI 10.1146/annurev.neuro.26.041002.131039; Reynolds JH, 1999, J NEUROSCI, V19, P1736; Reynolds JH, 2009, NEURON, V61, P168, DOI 10.1016/j.neuron.2009.01.002; RODMAN HR, 1990, J NEUROSCI, V10, P1154; Rossi AF, 2007, J NEUROSCI, V27, P11306, DOI 10.1523/JNEUROSCI.2939-07.2007; Snyder LH, 1997, NATURE, V386, P167, DOI 10.1038/386167a0; Sparks DL, 1999, CURR OPIN NEUROBIOL, V9, P698, DOI 10.1016/S0959-4388(99)00039-2; SPRAGUE JM, 1966, SCIENCE, V153, P1544, DOI 10.1126/science.153.3743.1544; Treue S, 1996, NATURE, V382, P539, DOI 10.1038/382539a0; Wardak C, 2006, J NEUROSCI, V26, P4228, DOI 10.1523/JNEUROSCI.3336-05.2006; Williford T, 2006, J NEUROPHYSIOL, V96, P40, DOI 10.1152/jn.01207.2005; WURTZ RH, 1980, ANNU REV NEUROSCI, V3, P189, DOI 10.1146/annurev.ne.03.030180.001201; Yeshurun Y, 1998, NATURE, V396, P72, DOI 10.1038/23936	45	191	191	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2010	13	2					261	U153		10.1038/nn.2470	http://dx.doi.org/10.1038/nn.2470			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	548SE	20023651	Green Accepted			2022-12-24	WOS:000273985800023
J	Lin, CW; Sim, S; Ainsworth, A; Okada, M; Kelsch, W; Lois, C				Lin, Chia-Wei; Sim, Shuyin; Ainsworth, Alice; Okada, Masayoshi; Kelsch, Wolfgang; Lois, Carlos			Genetically Increased Cell-intrinsic Excitability Enhances Neuronal Integration into Adult Brain Circuits	NEURON			English	Article							GENERATED GRANULE CELLS; OLFACTORY-BULB; NEWBORN NEURONS; CRITICAL PERIOD; DENTATE GYRUS; NEUROGENESIS; SURVIVAL; PLASTICITY; DEATH; INHIBITION	New neurons are added to the adult brain throughout life, but only half ultimately integrate into existing circuits. Sensory experience is an important regulator of the selection of new neurons but it remains unknown whether experience provides specific patterns of synaptic input or simply a minimum level of overall membrane depolarization critical for integration. To investigate this issue, we genetically modified intrinsic electrical properties of adult-generated neurons in the mammalian olfactory bulb. First, we observed that suppressing levels of cell-intrinsic neuronal activity via expression of ESKir2.1 potassium channels decreases, whereas enhancing activity via expression of NaChBac sodium channels increases survival of new neurons. Neither of these modulations affects synaptic formation. Furthermore, even when neurons are induced to fire dramatically altered patterns of action potentials, increased levels of cell-intrinsic activity completely blocks cell death triggered by NMDA receptor deletion. These findings demonstrate that overall levels of cell-intrinsic activity govern survival of new neurons and precise firing patterns are not essential for neuronal integration into existing brain circuits.	[Lin, Chia-Wei; Sim, Shuyin; Ainsworth, Alice; Okada, Masayoshi; Kelsch, Wolfgang; Lois, Carlos] MIT, Dept Brain & Cognit Sci, Picower Inst Learning & Memory, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Northwell Health	Lois, C (corresponding author), MIT, Dept Brain & Cognit Sci, Picower Inst Learning & Memory, E25-618, Cambridge, MA 02139 USA.	los@mit.edu	Okada, Masayoshi/ABE-9020-2020	Okada, Masayoshi/0000-0001-8515-7143; Kelsch, Wolfgang/0000-0002-3470-8125; Ainsworth, Alice/0000-0002-8547-7734	NIDCD NIH HHS [R01 DC008870-03, R01 DC008870] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC008870] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Aimone JB, 2006, NAT NEUROSCI, V9, P723, DOI 10.1038/nn1707; Alonso M, 2006, J NEUROSCI, V26, P10508, DOI 10.1523/JNEUROSCI.2633-06.2006; Bean BP, 2007, NAT REV NEUROSCI, V8, P451, DOI 10.1038/nrn2148; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Burrone J, 2002, NATURE, V420, P414, DOI 10.1038/nature01242; Buss RR, 2006, ANNU REV NEUROSCI, V29, P1, DOI 10.1146/annurev.neuro.29.051605.112800; Cooper-Kuhn CM, 2004, J NEUROSCI RES, V77, P155, DOI 10.1002/jnr.20116; Dan Y, 2006, PHYSIOL REV, V86, P1033, DOI 10.1152/physrev.00030.2005; Dolmetsch RE, 2001, SCIENCE, V294, P333, DOI 10.1126/science.1063395; Fraser DD, 1996, J NEUROSCI, V16, P4113; Gould E, 1997, J NEUROSCI, V17, P2492; Hua JYY, 2004, NAT NEUROSCI, V7, P327, DOI 10.1038/nn1218; Isaacson JS, 2001, P NATL ACAD SCI USA, V98, P337, DOI 10.1073/pnas.021445798; Kaneko N, 2006, GENES CELLS, V11, P1145, DOI 10.1111/j.1365-2443.2006.01010.x; Kee N, 2007, NAT NEUROSCI, V10, P355, DOI 10.1038/nn1847; Kelsch W, 2007, PLOS BIOL, V5, P2501, DOI 10.1371/journal.pbio.0050300; Kelsch W, 2008, P NATL ACAD SCI USA, V105, P16803, DOI 10.1073/pnas.0807970105; Kelsch W, 2009, J NEUROSCI, V29, P11852, DOI 10.1523/JNEUROSCI.2406-09.2009; Kohara K, 2007, J NEUROSCI, V27, P7234, DOI 10.1523/JNEUROSCI.1943-07.2007; Lledo PM, 2006, NAT REV NEUROSCI, V7, P179, DOI 10.1038/nrn1867; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; Malberg JE, 2000, J NEUROSCI, V20, P9104, DOI 10.1523/jneurosci.20-24-09104.2000; Marder E, 2006, NAT REV NEUROSCI, V7, P563, DOI 10.1038/nrn1949; McCormick DA, 2001, NAT NEUROSCI, V4, P113, DOI 10.1038/83917; Mouret A, 2008, J NEUROSCI, V28, P11511, DOI 10.1523/JNEUROSCI.2954-08.2008; Petreanu L, 2002, J NEUROSCI, V22, P6106; Pressler RT, 2007, J NEUROSCI, V27, P10969, DOI 10.1523/JNEUROSCI.2961-07.2007; Ren DJ, 2001, SCIENCE, V294, P2372, DOI 10.1126/science.1065635; Saghatelyan A, 2005, NEURON, V46, P103, DOI 10.1016/j.neuron.2005.02.016; Schoppa NE, 1998, J NEUROSCI, V18, P6790; Tashiro A, 2006, NAT PROTOC, V1, P3049, DOI 10.1038/nprot.2006.473; Tashiro A, 2006, NATURE, V442, P929, DOI 10.1038/nature05028; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; Wilbrecht L, 2002, J NEUROSCI, V22, P825, DOI 10.1523/JNEUROSCI.22-03-00825.2002; Winner B, 2002, EUR J NEUROSCI, V16, P1681, DOI 10.1046/j.1460-9568.2002.02238.x; Yamaguchi M, 2005, P NATL ACAD SCI USA, V102, P9697, DOI 10.1073/pnas.0406082102; YANG J, 1995, NEURON, V14, P1047, DOI 10.1016/0896-6273(95)90343-7	38	96	96	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 14	2010	65	1					32	39		10.1016/j.neuron.2009.12.001	http://dx.doi.org/10.1016/j.neuron.2009.12.001			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	546DZ	20152111	Bronze, Green Accepted, Green Published			2022-12-24	WOS:000273791200006
J	Chng, ZZ; Teo, A; Pedersen, RA; Vallier, L				Chng, Zhenzhi; Teo, Adrian; Pedersen, Roger A.; Vallier, Ludovic			SIP1 Mediates Cell-Fate Decisions between Neuroectoderm and Mesendoderm in Human Pluripotent Stem Cells	CELL STEM CELL			English	Article							SMAD-INTERACTING PROTEIN-1; MOUSE EMBRYO; MAINTAINS PLURIPOTENCY; NEURAL DIFFERENTIATION; E-CADHERIN; EXPRESSION; XENOPUS; ENDODERM; EPIBLAST; XSIP1	Human embryonic stem cells (hESCs) rely on fibroblast growth factor and Activin-Nodal signaling to maintain their pluripotency. However, Activin-Nodal signaling is also known to induce mesendoderm differentiation. The mechanisms by which Activin-Nodal signaling can achieve these contradictory functions remain unknown. Here, we demonstrate that Smad-interacting protein 1 (SIP1) limits the mesendoderm-inducing effects of Activin-Nodal signaling without inhibiting the pluripotency-maintaining effects exerted by SMAD2/3. In turn, Activin-Nodal signaling cooperates with NANOG, OCT4, and SOX2 to control the expression of SIP1 in hESCs, thereby limiting the neuroectoderm-promoting effects of SIP1. Similar results were obtained with mouse epiblast stem cells, implying that these mechanisms are evolutionarily conserved and may operate in vivo during mammalian development. Overall, our results reveal the mechanisms by which Activin-Nodal signaling acts through SIP1 to regulate the cell-fate decision between neuroectoderm and mesendoderm in the progression from pluripotency to primary germ layer differentiation.	[Chng, Zhenzhi; Teo, Adrian; Pedersen, Roger A.; Vallier, Ludovic] Univ Cambridge, Lab Regenerat Med, Cambridge CB2 0SZ, England	University of Cambridge	Vallier, L (corresponding author), Univ Cambridge, Lab Regenerat Med, W Forvie Bldg,Robinson Way, Cambridge CB2 0SZ, England.	lv225@cam.ac.uk	vallier, ludovic/C-6368-2011; Teo, Adrian Kee Keong/A-4009-2013	Teo, Adrian Kee Keong/0000-0001-5901-7075; Vallier, Ludovic/0000-0002-3848-2602	Singapore Agency for Science, Technology and Research; MRC Programme and Centre Development; Cambridge Hospitals National Institute for Health Research Biomedical Research Center; MRC/Diabetes UK Career Development; MRC Senior Research fellowship; MRC [G0701448, G0800784, G0600275] Funding Source: UKRI; Medical Research Council [G0300723B, G0600275, G0800784B, G0800784, G0701448] Funding Source: researchfish	Singapore Agency for Science, Technology and Research(Agency for Science Technology & Research (A*STAR)); MRC Programme and Centre Development(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cambridge Hospitals National Institute for Health Research Biomedical Research Center; MRC/Diabetes UK Career Development(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)Diabetes UK); MRC Senior Research fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The authors thank Dr. Morag Park for the human SIP1 cDNA, Miss Stephanie Brown for technical advice on the ChIP experiments, Dr. Matthew Trotter for help with microarray, Prof. Danny Huylebroeck for helpful discussions, and members of the Pedersen lab for comments on the manuscript. This work was supported by the Singapore Agency for Science, Technology and Research (Z.C.), MRC Programme and Centre Development grants, and Cambridge Hospitals National Institute for Health Research Biomedical Research Center funding (R.A.P. and L.V.), and MRC/Diabetes UK Career Development fellowship and MRC Senior Research fellowship (L.V.).	Arnold SJ, 2009, NAT REV MOL CELL BIO, V10, P91, DOI 10.1038/nrm2618; Beattie GM, 2005, STEM CELLS, V23, P489, DOI 10.1634/stemcells.2004-0279; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Camus A, 2006, DEV BIOL, V295, P743, DOI 10.1016/j.ydbio.2006.03.047; Chambers I, 2004, CLONING STEM CELLS, V6, P386, DOI 10.1089/clo.2004.6.386; Comijn J, 2001, MOL CELL, V7, P1267, DOI 10.1016/S1097-2765(01)00260-X; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; Delalande JM, 2008, DEV DYNAM, V237, P1060, DOI 10.1002/dvdy.21485; Lerchner W, 2000, DEVELOPMENT, V127, P2729; Long JY, 2005, J BIOL CHEM, V280, P35477, DOI 10.1074/jbc.M504477200; Meno C, 1997, GENES CELLS, V2, P513, DOI 10.1046/j.1365-2443.1997.1400338.x; Mesnard D, 2006, DEVELOPMENT, V133, P2497, DOI 10.1242/dev.02413; Miyoshi T, 2006, DEV DYNAM, V235, P1941, DOI 10.1002/dvdy.20799; Moal FDL, 2007, HUM MUTAT, V28, P313, DOI 10.1002/humu.20452; Ninomiya H, 1999, DEV GROWTH DIFFER, V41, P391; Nitta KR, 2007, INT J DEV BIOL, V51, P321, DOI 10.1387/ijdb.062252kn; Nitta KR, 2004, DEV BIOL, V275, P258, DOI 10.1016/j.ydbio.2004.08.010; Nostro MC, 2008, CELL STEM CELL, V2, P60, DOI 10.1016/j.stem.2007.10.011; Papin C, 2002, MECH DEVELOP, V111, P37, DOI 10.1016/S0925-4773(01)00599-8; Postigo AA, 2003, EMBO J, V22, P2453, DOI 10.1093/emboj/cdg226; Pratt T, 2000, DEV BIOL, V228, P19, DOI 10.1006/dbio.2000.9935; Sheng GJ, 2003, CELL, V115, P603, DOI 10.1016/S0092-8674(03)00927-9; Smith JR, 2008, DEV BIOL, V313, P107, DOI 10.1016/j.ydbio.2007.10.003; Sumi T, 2008, DEVELOPMENT, V135, P2969, DOI 10.1242/dev.021121; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Vallier L, 2004, DEV BIOL, V275, P403, DOI 10.1016/j.ydbio.2004.08.031; Vallier L, 2004, STEM CELLS, V22, P2, DOI 10.1634/stemcells.22-1-2; Vallier L, 2005, J CELL SCI, V118, P4495, DOI 10.1242/jcs.02553; Vallier L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006082; Vallier L, 2009, DEVELOPMENT, V136, P1339, DOI 10.1242/dev.033951; Van de Putte T, 2003, AM J HUM GENET, V72, P465, DOI 10.1086/346092; van Grunsven LA, 2001, J BONE JOINT SURG AM, V83A, pS40; van Grunsven LA, 2000, MECH DEVELOP, V94, P189, DOI 10.1016/S0925-4773(00)00318-X; van Grunsven LA, 2007, DEV BIOL, V306, P34, DOI 10.1016/j.ydbio.2007.02.045; Verschueren K, 1999, J BIOL CHEM, V274, P20489, DOI 10.1074/jbc.274.29.20489; Xu RH, 2008, CELL STEM CELL, V3, P196, DOI 10.1016/j.stem.2008.07.001; Xu RH, 2006, METH MOLEC MED, V121, P189	38	97	100	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JAN 8	2010	6	1					59	70		10.1016/j.stem.2009.11.015	http://dx.doi.org/10.1016/j.stem.2009.11.015			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	549EW	20074535	Bronze			2022-12-24	WOS:000274029700012
J	Wurdak, H; Zhu, ST; Romero, A; Lorger, M; Watson, J; Chiang, CY; Zhang, J; Natu, VS; Lairson, LL; Walker, JR; Trussell, CM; Harsh, GR; Vogels, H; Felding-Habermann, B; Orth, AP; Miraglia, LJ; Rines, DR; Skirboll, SL; Schultz, PG				Wurdak, Heiko; Zhu, Shoutian; Romero, Angelica; Lorger, Mihaela; Watson, James; Chiang, Chih-yuan; Zhang, Jay; Natu, Vanita S.; Lairson, Luke L.; Walker, John R.; Trussell, Christopher M.; Harsh, Griffith R.; Vogels, Hannes; Felding-Habermann, Brunhilde; Orth, Anthony P.; Miraglia, Loren J.; Rines, Daniel R.; Skirboll, Stephen L.; Schultz, Peter G.			An RNAi Screen Identifies TRRAP as a Regulator of Brain Tumor-Initiating Cell Differentiation	CELL STEM CELL			English	Article							CANCER STEM-CELL; GLIOBLASTOMA-MULTIFORME; COFACTOR TRRAP; SELF-RENEWAL; C-MYC; EXPRESSION; LINES; ACETYLATION; DERIVATION; APOPTOSIS	Glioblastoma multiforme (GBM) is a highly aggressive form of brain cancer associated with a very poor prognosis. Recently, the initiation and growth of GBM has been linked to brain tumor-initiating cells (BTICs), which are poorly differentiated and share features with neural stem cells (NSCs). Here we describe a kinome-wide RNA interference screen to identify factors that control the tumorigenicity of BTICs. We identified several genes whose silencing induces differentiation of BTICs derived from multiple GBM patients. In particular, knockdown of the adaptor protein TRRAP significantly increased differentiation of cultured BTICs, sensitized the cells to apoptotic stimuli, and negatively affected cell cycle progression. TRRAP knockdown also significantly suppressed tumor formation upon intracranial BTIC implantation into mice. Together, these findings support a critical role for TRRAP in maintaining a tumorigenic, stem cell-like state.	[Wurdak, Heiko; Zhu, Shoutian; Lairson, Luke L.; Schultz, Peter G.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Wurdak, Heiko; Zhu, Shoutian; Lairson, Luke L.; Schultz, Peter G.] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; [Romero, Angelica; Watson, James; Chiang, Chih-yuan; Zhang, Jay; Walker, John R.; Trussell, Christopher M.; Orth, Anthony P.; Miraglia, Loren J.; Rines, Daniel R.; Schultz, Peter G.] Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA; [Lorger, Mihaela; Felding-Habermann, Brunhilde] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA; [Natu, Vanita S.; Harsh, Griffith R.; Skirboll, Stephen L.] Stanford Univ, Dept Neurosurg, Med Ctr, Stanford, CA 94305 USA; [Vogels, Hannes] Stanford Univ, Neuropathol Lab, Med Ctr, Dept Pathol, Stanford, CA 94305 USA; [Skirboll, Stephen L.] VA Palo Alto Hlth Care Syst, Sect Neurosurg, Palo Alto, CA 94304 USA	Scripps Research Institute; Scripps Research Institute; Novartis; Scripps Research Institute; Stanford University; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Schultz, PG (corresponding author), Scripps Res Inst, Skaggs Inst Chem Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	schultz@scripps.edu	zhu, shoutian/M-2108-2018	zhu, shoutian/0000-0001-6748-225X; Rines, Daniel/0000-0002-1830-2926; Vogel, Otto Hannes/0000-0002-0960-3508; Wurdak, Heiko/0000-0003-4385-4324; Lairson, Luke/0000-0001-6701-996X	EMBO; AACR	EMBO(European Molecular Biology Organization (EMBO)); AACR	We thank M. O'Neil, B.P. Tu, G. Welch, M. Ruiz, B. Chandler, C. Wright, J. To, and M. Medina for excellent technical assistance. We thank E. Remba and I. Taylor for excellent administrative assistance. We thank K.M. Smith, J. Alves, and V.A. Reddy for helpful comments on the manuscript. H.W. was funded by EMBO and AACR fellowships.	Al-Mayhani TMF, 2009, J NEUROSCI METH, V176, P192, DOI 10.1016/j.jneumeth.2008.07.022; Aza-Blanc P, 2003, MOL CELL, V12, P627, DOI 10.1016/S1097-2765(03)00348-4; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Bashyam MD, 2005, NEOPLASIA, V7, P556, DOI 10.1593/neo.04586; Blais A, 2007, CURR OPIN CELL BIOL, V19, P658, DOI 10.1016/j.ceb.2007.10.003; Bracken AP, 2004, TRENDS BIOCHEM SCI, V29, P409, DOI 10.1016/j.tibs.2004.06.006; Clement V, 2007, CURR BIOL, V17, P165, DOI 10.1016/j.cub.2006.11.033; Demuth T, 2007, MOL CANCER THER, V6, P1212, DOI 10.1158/1535-7163.MCT-06-0711; Enomoto A, 2008, ONCOGENE, V27, P1930, DOI 10.1038/sj.onc.1210828; GAGE FH, 1995, ANNU REV NEUROSCI, V18, P159, DOI 10.1146/annurev.neuro.18.1.159; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Gangemi RMR, 2009, STEM CELLS, V27, P40, DOI 10.1634/stemcells.2008-0493; Grossman SA, 2004, SEMIN ONCOL, V31, P635, DOI 10.1053/j.seminoncol.2004.07.005; Herceg Z, 2003, NUCLEIC ACIDS RES, V31, P7011, DOI 10.1093/nar/gkg902; Hochegger H, 2008, NAT REV MOL CELL BIO, V9, P910, DOI 10.1038/nrm2510; Kalaszczynska I, 2009, CELL, V138, P352, DOI 10.1016/j.cell.2009.04.062; Kucharczak J, 2001, ONCOGENE, V20, P7021, DOI 10.1038/sj.onc.1204882; Lee J, 2008, CANCER CELL, V13, P69, DOI 10.1016/j.ccr.2007.12.005; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Li GH, 2009, ONCOL REP, V21, P419, DOI 10.3892/or_00000239; Loukopoulos P, 2007, CANCER SCI, V98, P392, DOI 10.1111/j.1349-7006.2007.00395.x; Mangiola A, 2007, CLIN CANCER RES, V13, P6970, DOI 10.1158/1078-0432.CCR-07-1229; McKay R, 1997, SCIENCE, V276, P66, DOI 10.1126/science.276.5309.66; McMahon SB, 1998, CELL, V94, P363, DOI 10.1016/S0092-8674(00)81479-8; MISHIMA K, 1994, BIOCHEM BIOPH RES CO, V201, P363, DOI 10.1006/bbrc.1994.1710; Murr R, 2007, ONCOGENE, V26, P5358, DOI 10.1038/sj.onc.1210605; Murr R, 2006, NAT CELL BIOL, V8, P91, DOI 10.1038/ncb1343; Nakano I, 2006, PEDIATR RES, V59, p54R, DOI 10.1203/01.pdr.0000203568.63482.f9; Nightingale KP, 2007, J BIOL CHEM, V282, P4408, DOI 10.1074/jbc.M606773200; Nowak D, 2009, BLOOD, V113, P3655, DOI 10.1182/blood-2009-01-198911; Oishi H, 2006, J BIOL CHEM, V281, P20, DOI 10.1074/jbc.M510157200; Orford KW, 2008, NAT REV GENET, V9, P115, DOI 10.1038/nrg2269; Piccirillo SGM, 2006, NATURE, V444, P761, DOI 10.1038/nature05349; Pollard SM, 2009, CELL STEM CELL, V4, P568, DOI 10.1016/j.stem.2009.03.014; Purow BW, 2005, CANCER RES, V65, P2353, DOI 10.1158/0008-5472.CAN-04-1890; Robert F, 2006, MOL CELL BIOL, V26, P402, DOI 10.1128/MCB.26.2.402-412.2006; Roos WP, 2007, ONCOGENE, V26, P186, DOI 10.1038/sj.onc.1209785; Salhia B, 2008, AM J PATHOL, V173, P1828, DOI 10.2353/ajpath.2008.080043; Sanai N, 2005, NEW ENGL J MED, V353, P811, DOI 10.1056/NEJMra043666; Silber J, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-14; Singh SK, 2003, CANCER RES, V63, P5821; Walton NM, 2006, DEVELOPMENT, V133, P3671, DOI 10.1242/dev.02541; Wang JL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003769; XIAO HG, 1994, J NEUROSURG, V81, P734, DOI 10.3171/jns.1994.81.5.0734; Zheng HW, 2008, NATURE, V455, P1129, DOI 10.1038/nature07443; Zhu ST, 2009, CELL STEM CELL, V4, P416, DOI 10.1016/j.stem.2009.04.001	46	93	97	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JAN 8	2010	6	1					37	47		10.1016/j.stem.2009.11.002	http://dx.doi.org/10.1016/j.stem.2009.11.002			11	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	549EW	20085741	Bronze			2022-12-24	WOS:000274029700010
J	Belforte, JE; Zsiros, V; Sklar, ER; Jiang, ZH; Yu, G; Li, YQ; Quinlan, EM; Nakazawa, K				Belforte, Juan E.; Zsiros, Veronika; Sklar, Elyse R.; Jiang, Zhihong; Yu, Gu; Li, Yuqing; Quinlan, Elizabeth M.; Nakazawa, Kazu			Postnatal NMDA receptor ablation in corticolimbic interneurons confers schizophrenia-like phenotypes	NATURE NEUROSCIENCE			English	Article							SPATIAL WORKING-MEMORY; PREFRONTAL CORTEX; MICE LACKING; PREPULSE INHIBITION; SYNAPTIC PLASTICITY; BIPOLAR DISORDER; ANIMAL-MODELS; KETAMINE; PSYCHOSIS; PHENCYCLIDINE	Cortical GABAergic dysfunction may underlie the pathophysiology of psychiatric disorders, including schizophrenia. Here, we characterized a mouse strain in which the essential NR1 subunit of the NMDA receptor (NMDAR) was selectively eliminated in 40-50% of cortical and hippocampal interneurons in early postnatal development. Consistent with the NMDAR hypofunction theory of schizophrenia, distinct schizophrenia-related symptoms emerged after adolescence, including novelty-induced hyperlocomotion, mating and nest-building deficits, as well as anhedonia-like and anxiety-like behaviors. Many of these behaviors were exacerbated by social isolation stress. Social memory, spatial working memory and prepulse inhibition were also impaired. Reduced expression of glutamic acid decarboxylase 67 and parvalbumin was accompanied by disinhibition of cortical excitatory neurons and reduced neuronal synchrony. Postadolescent deletion of NR1 did not result in such abnormalities. These findings suggest that early postnatal inhibition of NMDAR activity in corticolimbic GABAergic interneurons contributes to the pathophysiology of schizophrenia-related disorders.	[Belforte, Juan E.; Zsiros, Veronika; Sklar, Elyse R.; Jiang, Zhihong; Nakazawa, Kazu] NIMH, Unit Genet Cognit & Behav, Mood & Anxiety Disorders Program, Intramural Res Program, Bethesda, MD 20892 USA; [Belforte, Juan E.] NIAAA, Intramural Res Program, NIH, US Dept HHS, Bethesda, MD USA; [Yu, Gu; Quinlan, Elizabeth M.] Univ Maryland, Dept Biol, Neurosci & Cognit Sci Program, College Pk, MD 20742 USA; [Li, Yuqing] Univ Alabama, Med Sch Birmingham, Dept Neurol, Ctr Neurodegenerat & Expt Therapeut, Birmingham, AL USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); University System of Maryland; University of Maryland College Park; University of Alabama System; University of Alabama Birmingham	Nakazawa, K (corresponding author), NIMH, Unit Genet Cognit & Behav, Mood & Anxiety Disorders Program, Intramural Res Program, Bethesda, MD 20892 USA.	nakazawk@mail.nih.gov	Belforte, Juan/Q-6633-2019; Li, Yuqing/AAR-9383-2021; Li, Yuqing/G-1596-2011; Nakazawa, Kazutoshi/J-6195-2015	Belforte, Juan/0000-0002-6300-5314; Li, Yuqing/0000-0003-1211-5529; Li, Yuqing/0000-0003-1211-5529; Nakazawa, Kazutoshi/0000-0001-5699-9093; Gu, Yu/0000-0001-7882-5422	US National Institute of Mental Health; US National Institute on Alcohol Abuse and Addiction; NATIONAL INSTITUTE OF MENTAL HEALTH [ZICMH002901, ZIAMH002895] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS065273] Funding Source: NIH RePORTER	US National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); US National Institute on Alcohol Abuse and Addiction; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We also acknowledge the CURE/Digestive diseases research center at the University of California Los Angeles and the US National Institute of Mental Health Chemical Synthesis and Drug Supply Program for antibodies and risperidone, respectively. This work was supported by the Intramural Research Program of the US National Institute of Mental Health and of the US National Institute on Alcohol Abuse and Addiction.	Agid O, 2000, BIOMED PHARMACOTHER, V54, P135, DOI 10.1016/S0753-3322(00)89046-0; Akbarian S, 2006, BRAIN RES REV, V52, P293, DOI 10.1016/j.brainresrev.2006.04.001; Behrens MM, 2007, SCIENCE, V318, P1645, DOI 10.1126/science.1148045; Benes FM, 2001, NEUROPSYCHOPHARMACOL, V25, P1, DOI 10.1016/S0893-133X(01)00225-1; Braff DL, 2001, PSYCHOPHARMACOLOGY, V156, P234, DOI 10.1007/s002130100810; BRAUTIGAN DL, 1990, NATURE, V344, P74, DOI 10.1038/344074a0; Breier A, 1997, AM J PSYCHIAT, V154, P805; Bubenikova-Valesova V, 2008, NEUROSCI BIOBEHAV R, V32, P1014, DOI 10.1016/j.neubiorev.2008.03.012; Cannon M, 1997, AM J PSYCHIAT, V154, P1544; Carter CJ, 2006, SCHIZOPHR RES, V86, P1, DOI 10.1016/j.schres.2006.05.023; Cobos I, 2005, NAT NEUROSCI, V8, P1059, DOI 10.1038/nn1499; Cochran SM, 2003, NEUROPSYCHOPHARMACOL, V28, P265, DOI 10.1038/sj.npp.1300031; Coyle JT, 1996, HARVARD REV PSYCHIAT, V3, P241, DOI 10.3109/10673229609017192; Dang MT, 2006, P NATL ACAD SCI USA, V103, P15254, DOI 10.1073/pnas.0601758103; DEUTSCH SI, 1989, CLIN NEUROPHARMACOL, V12, P1, DOI 10.1097/00002826-198902000-00001; Eyles DW, 2002, SCHIZOPHR RES, V57, P27, DOI 10.1016/S0920-9964(01)00299-7; Ferguson JN, 2000, NAT GENET, V25, P284, DOI 10.1038/77040; Gainetdinov RR, 2001, TRENDS NEUROSCI, V24, P527, DOI 10.1016/S0166-2236(00)01886-5; Gong SC, 2002, GENOME RES, V12, P1992, DOI 10.1101/gr.476202; Grunze HCR, 1996, J NEUROSCI, V16, P2034; Hagberg H, 2002, DEV NEUROSCI-BASEL, V24, P364, DOI 10.1159/000069040; HASEGAWA M, 1993, NEUROSCI LETT, V150, P53, DOI 10.1016/0304-3940(93)90106-U; Houthoofd SAMK, 2008, CLIN THER, V30, P1565, DOI 10.1016/j.clinthera.2008.09.014; Huang ZJ, 2009, J PHYSIOL-LONDON, V587, P1881, DOI 10.1113/jphysiol.2008.168211; Ikegaya Y, 2000, NEUROSCIENCE, V98, P647, DOI 10.1016/S0306-4522(00)00188-3; Jackson ME, 2004, P NATL ACAD SCI USA, V101, P8467, DOI 10.1073/pnas.0308455101; JAVITT D C, 1987, Hillside Journal of Clinical Psychiatry, V9, P12; Jinde S, 2009, EUR J NEUROSCI, V30, P1036, DOI 10.1111/j.1460-9568.2009.06896.x; Keilhoff G, 2004, NEUROSCIENCE, V126, P591, DOI 10.1016/j.neuroscience.2004.03.039; KRYSTAL JH, 1994, ARCH GEN PSYCHIAT, V51, P199, DOI 10.1001/archpsyc.1994.03950030035004; Labrie V, 2008, PSYCHOPHARMACOLOGY, V200, P217, DOI 10.1007/s00213-008-1196-6; LAHTI AC, 1995, NEUROPSYCHOPHARMACOL, V13, P9, DOI 10.1016/0893-133X(94)00131-I; Lewis DA, 2005, NAT REV NEUROSCI, V6, P312, DOI 10.1038/nrn1648; Li Q, 2002, J NEUROSCI, V22, P3070, DOI 10.1523/JNEUROSCI.22-08-03070.2002; Lim EP, 2007, PSYCHOPHARMACOLOGY, V191, P297, DOI 10.1007/s00213-006-0664-0; LODGE D, 1982, EUR J PHARMACOL, V77, P203, DOI 10.1016/0014-2999(82)90022-X; Martucci L, 2003, AM J MED GENET B, V119B, P24, DOI 10.1002/ajmg.b.20014; Moghaddam B, 1997, J NEUROSCI, V17, P2921; Morrow BA, 2007, PSYCHOPHARMACOLOGY, V192, P283, DOI 10.1007/s00213-007-0708-0; OLNEY JW, 1995, ARCH GEN PSYCHIAT, V52, P998; OLNEY JW, 1988, EXCITATORY AMINO ACI, P337; Paylor R, 1997, PSYCHOPHARMACOLOGY, V132, P169, DOI 10.1007/s002130050333; Piskulic D, 2007, PSYCHIAT RES, V150, P111, DOI 10.1016/j.psychres.2006.03.018; Reilly JL, 2006, ARCH GEN PSYCHIAT, V63, P1189, DOI 10.1001/archpsyc.63.11.1189; Rujescu D, 2006, BIOL PSYCHIAT, V59, P721, DOI 10.1016/j.biopsych.2005.08.029; Tsien JZ, 1996, CELL, V87, P1327, DOI 10.1016/S0092-8674(00)81827-9; Vollenweider FX, 1997, EUR NEUROPSYCHOPHARM, V7, P9, DOI 10.1016/S0924-977X(96)00039-9; WEINBERGER DR, 1987, ARCH GEN PSYCHIAT, V44, P660, DOI 10.1001/archpsyc.1987.01800190080012; Weisstaub NV, 2006, SCIENCE, V313, P536, DOI 10.1126/science.1123432; Whitfield-Gabrieli S, 2009, P NATL ACAD SCI USA, V106, P1279, DOI 10.1073/pnas.0809141106	50	571	580	2	102	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2010	13	1					76	U240		10.1038/nn.2447	http://dx.doi.org/10.1038/nn.2447			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	536PM	19915563	Green Accepted			2022-12-24	WOS:000273056300016
J	Truccolo, W; Hochberg, LR; Donoghue, JP				Truccolo, Wilson; Hochberg, Leigh R.; Donoghue, John P.			Collective dynamics in human and monkey sensorimotor cortex: predicting single neuron spikes	NATURE NEUROSCIENCE			English	Article							CORTICAL-NEURONS; MOTOR; ENSEMBLE; AREA; CELL	Coordinated spiking activity in neuronal ensembles, in local networks and across multiple cortical areas, is thought to provide the neural basis for cognition and adaptive behavior. Examining such collective dynamics at the level of single neuron spikes has remained, however, a considerable challenge. We found that the spiking history of small and randomly sampled ensembles (similar to 20-200 neurons) could predict subsequent single neuron spiking with substantial accuracy in the sensorimotor cortex of humans and nonhuman behaving primates. Furthermore, spiking was better predicted by the ensemble's history than by the ensemble's instantaneous state (Ising models), emphasizing the role of temporal dynamics leading to spiking. Notably, spiking could be predicted not only by local ensemble spiking histories, but also by spiking histories in different cortical areas. These strong collective dynamics may provide a basis for understanding cognition and adaptive behavior at the level of coordinated spiking in cortical networks.	[Truccolo, Wilson; Donoghue, John P.] Brown Univ, Dept Neurosci, Providence, RI 02912 USA; [Truccolo, Wilson; Hochberg, Leigh R.; Donoghue, John P.] Brown Univ, Brown Inst Brain Sci, Providence, RI 02912 USA; [Hochberg, Leigh R.] Brown Univ, Div Engn, Providence, RI 02912 USA; [Hochberg, Leigh R.; Donoghue, John P.] Dept Vet Affairs, Rehabil Res & Dev Serv, Providence, RI USA; [Truccolo, Wilson; Hochberg, Leigh R.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Neurol, Boston, MA USA; [Hochberg, Leigh R.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA; [Hochberg, Leigh R.] Harvard Univ, Sch Med, Spaulding Rehabil Hosp, Boston, MA USA	Brown University; Brown University; Brown University; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Spaulding Rehabilitation Hospital	Truccolo, W (corresponding author), Brown Univ, Dept Neurosci, Providence, RI 02912 USA.	wilson_truccolo@brown.edu	Hochberg, Leigh/R-6872-2019	Hochberg, Leigh/0000-0003-0261-2273	National Institute of Neurological Disorders and Stroke [5K01NS057389-02, NS-25074]; National Institute of Child Health and Human Development/National Center for Medical Rehabilitation Research [N01-HD53403]; Massachusetts General Hospital Deane Institute; Doris Duke Charitable Foundation; National Institute on Deafness and Other Communication Disorders [R01-DC-009899]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R03HD053403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS025074, K01NS057389, R37NS025074] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009899] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Child Health and Human Development/National Center for Medical Rehabilitation Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Massachusetts General Hospital Deane Institute; Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank M. R. Fellows, C. Vargas-Irwin and B. Philip for collecting the nonhuman primate data. We thank our clinical trial participants for their dedication to this research, G. Friehs for his role as surgical investigator for the pilot clinical trial, J. Mukand for his role as clinical investigator for the pilot clinical trial, and A. Caplan, M. Serruya, M. Saleh and other employees of Cyberkinetics Neurotechnology Systems for data collection, manufacturing and clinical trial management. This study was based on work supported in part by the Office of Research and Development, Rehabilitation R&D Service, Department of Veterans Affairs ( L. R. H. and J. P. D.). This work was supported by the National Institute of Neurological Disorders and Stroke (5K01NS057389-02 to W. T. and NS-25074 (Javits Award) to J. P. D.), the National Institute of Child Health and Human Development/National Center for Medical Rehabilitation Research (N01-HD53403, subcontract to L. R. H.), the Massachusetts General Hospital Deane Institute ( L. R. H.), the Doris Duke Charitable Foundation ( L. R. H) and the National Institute on Deafness and Other Communication Disorders (R01-DC-009899 to L. R. H.).	Amit DJ, 1989, MODELING BRAIN FUNCT, DOI 10.1017/CBO9780511623257; Arieli A, 1996, SCIENCE, V273, P1868, DOI 10.1126/science.273.5283.1868; BAMBER D, 1975, J MATH PSYCHOL, V12, P387, DOI 10.1016/0022-2496(75)90001-2; BESAG J, 1975, J ROY STAT SOC D-STA, V24, P179, DOI 10.2307/2987782; Braitenberg V, 1998, CORTEX STAT GEOMETRY; Cover TM, 1991, ELEMENTS INFORM THEO; Daley D., 2003, INTRO THEORY POINT P, V1; Dayan P., 2001, THEORETICAL NEUROSCI; Destexhe A, 2003, NAT REV NEUROSCI, V4, P739, DOI 10.1038/nrn1198; Elston GN, 2002, CEREB CORTEX, V12, P1071, DOI 10.1093/cercor/12.10.1071; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; GEMAN S, 1984, IEEE T PATTERN ANAL, V6, P721, DOI 10.1109/TPAMI.1984.4767596; Geman S, 1987, P INT C MATH, V1, P1496; GEWEKE J, 1982, J AM STAT ASSOC, V77, P304, DOI 10.2307/2287238; GIDAS B, 1988, STOCHASTIC DIFFERENT; Harris KD, 2003, NATURE, V424, P552, DOI 10.1038/nature01834; Hatsopoulos NG, 2007, J NEUROSCI, V27, P5105, DOI 10.1523/JNEUROSCI.3570-06.2007; Hochberg LR, 2006, NATURE, V442, P164, DOI 10.1038/nature04970; Hyvarinen A, 2006, NEURAL COMPUT, V18, P2283, DOI 10.1162/neco.2006.18.10.2283; JAYNES ET, 1982, P IEEE, V70, P939, DOI 10.1109/PROC.1982.12425; JONES EG, 1978, J COMP NEUROL, V181, P291, DOI 10.1002/cne.901810206; Kalaska JF, 1997, CURR OPIN NEUROBIOL, V7, P849, DOI 10.1016/S0959-4388(97)80146-8; Marre O, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.138101; Paninski L, 2004, J NEUROPHYSIOL, V91, P515, DOI 10.1152/jn.00587.2002; Paninski L, 2007, PROG BRAIN RES, V165, P493, DOI 10.1016/S0079-6123(06)65031-0; Pillow JW, 2008, NATURE, V454, P995, DOI 10.1038/nature07140; Schneidman E, 2006, NATURE, V440, P1007, DOI 10.1038/nature04701; Serruya MD, 2002, NATURE, V416, P141, DOI 10.1038/416141a; Shadmehr R, 2008, EXP BRAIN RES, V185, P359, DOI 10.1007/s00221-008-1280-5; Shimazu H, 2004, J NEUROSCI, V24, P1200, DOI 10.1523/JNEUROSCI.4731-03.2004; Shlens J, 2006, J NEUROSCI, V26, P8254, DOI 10.1523/JNEUROSCI.1282-06.2006; Tang A, 2008, J NEUROSCI, V28, P505, DOI 10.1523/JNEUROSCI.3359-07.2008; Truccolo W, 2005, J NEUROPHYSIOL, V93, P1074, DOI 10.1152/jn.00697.2004; TRUCCOLO W, ANAL PARALL IN PRESS; Truccolo W, 2008, J NEUROSCI, V28, P1163, DOI 10.1523/JNEUROSCI.4415-07.2008; Wessberg J, 2000, NATURE, V408, P361, DOI 10.1038/35042582; Yousry TA, 1997, BRAIN, V120, P141, DOI 10.1093/brain/120.1.141; Yu S, 2008, CEREB CORTEX, V18, P2891, DOI 10.1093/cercor/bhn047	39	149	150	1	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2010	13	1					105	U275		10.1038/nn.2455	http://dx.doi.org/10.1038/nn.2455			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	536PM	19966837	Green Accepted			2022-12-24	WOS:000273056300020
J	Cusumano, P; Klarsfeld, A; Chelot, E; Picot, M; Richier, B; Rouyer, F				Cusumano, Paola; Klarsfeld, Andre; Chelot, Elisabeth; Picot, Marie; Richier, Benjamin; Rouyer, Francois			PDF-modulated visual inputs and cryptochrome define diurnal behavior in Drosophila	NATURE NEUROSCIENCE			English	Article							CIRCADIAN CLOCK; LATERAL NEURONS; NERVOUS-SYSTEM; COMPOUND EYES; NEUROPEPTIDE; RHYTHMS; PERIOD; LIGHT; GENE; BRAIN	Morning and evening circadian oscillators control the bimodal activity of Drosophila in light-dark cycles. The lateral neurons evening oscillator (LN-EO) is important for promoting diurnal activity at dusk. We found that the LN-EO autonomously synchronized to light-dark cycles through either the cryptochrome (CRY) that it expressed or the visual system. In conditions in which CRY was not activated, flies depleted for pigment-dispersing factor (PDF) or its receptor lost the evening activity and displayed reversed PER oscillations in the LN-EO. Rescue experiments indicated that normal PER cycling and the presence of evening activity relied on PDF secretion from the large ventral lateral neurons and PDF receptor function in the LN-EO. The LN-EO thus integrates light inputs and PDF signaling to control Drosophila diurnal behavior, revealing a new clock-independent function for PDF.	[Cusumano, Paola; Klarsfeld, Andre; Chelot, Elisabeth; Picot, Marie; Richier, Benjamin; Rouyer, Francois] CNRS, Inst Neurobiol Alfred Fessard, UPR 2216, Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Rouyer, F (corresponding author), CNRS, Inst Neurobiol Alfred Fessard, UPR 2216, Gif Sur Yvette, France.	rouyer@inaf.cnrs-gif.fr	Rouyer, François/L-9043-2018	Rouyer, François/0000-0001-5641-397X; Cusumano, Paola/0000-0002-7627-3844; Klarsfeld, Andre/0000-0001-9293-4887; PICOT, Marie/0000-0002-5331-9723	Agence Nationale de la Recherche 'Neurosciences, neurologie et psychiatrie'; European Union 6<SUP>th</SUP> framework project 'EUCLOCK'; Ministere de l'Enseignement Superieur et de la Recherche and Fondation pour le Recherche Medicale; Ministere de l'Enseignement Superieur et de la Recherche and Association pour la Recherche sur le Cancer; Institut National de la Sante et des Etudes et Recherches Medicale	Agence Nationale de la Recherche 'Neurosciences, neurologie et psychiatrie'; European Union 6<SUP>th</SUP> framework project 'EUCLOCK'; Ministere de l'Enseignement Superieur et de la Recherche and Fondation pour le Recherche Medicale; Ministere de l'Enseignement Superieur et de la Recherche and Association pour la Recherche sur le Cancer; Institut National de la Sante et des Etudes et Recherches Medicale	We thank M. Boudinot for the FaasX software and ImageJ plugins, G. Levesque for helping with the behavioral setup, O. Lenoir and C. Lancelin for preliminary behavioral experiments and C. Vias for her help with dissections. We thank J. Champagnat for his strong support and M. Rosbash, Y. Shang and the members of the Rouyer laboratory for their comments on the manuscript. We are grateful to M. Ahmad, J. Hall, J. Kim, M. Rosbash, R. Stanewsky, P. Taghert and R. Ueda for providing material, stocks and reagents. This work was supported by Agence Nationale de la Recherche 'Neurosciences, neurologie et psychiatrie' and the European Union 6<SUP>th</SUP> framework project 'EUCLOCK'. P. C. was supported by EUCLOCK, M. P. by Ministere de l'Enseignement Superieur et de la Recherche and Fondation pour le Recherche Medicale, B. R. by Ministere de l'Enseignement Superieur et de la Recherche and Association pour la Recherche sur le Cancer, and F. R. by Institut National de la Sante et des Etudes et Recherches Medicale.	Aton SJ, 2005, NAT NEUROSCI, V8, P476, DOI 10.1038/nn1419; Benito J, 2008, J BIOL RHYTHM, V23, P296, DOI 10.1177/0748730408318588; Bergmann A, 1998, CELL, V95, P331, DOI 10.1016/S0092-8674(00)81765-1; Blanchardon E, 2001, EUR J NEUROSCI, V13, P871, DOI 10.1046/j.0953-816x.2000.01450.x; Dolezelova E, 2007, GENETICS, V177, P329, DOI 10.1534/genetics.107.076513; Doyle SE, 2008, P NATL ACAD SCI USA, V105, P13133, DOI 10.1073/pnas.0801728105; Dubruille R, 2008, MOL NEUROBIOL, V38, P129, DOI 10.1007/s12035-008-8035-y; Dunlap J.C., 2004, CHRONOBIOLOGY BIOL T; Emery P, 2000, NEURON, V26, P493, DOI 10.1016/S0896-6273(00)81181-2; Emery P, 2000, NATURE, V404, P456, DOI 10.1038/35006558; Emery P, 1998, CELL, V95, P669, DOI 10.1016/S0092-8674(00)81637-2; Fernandez MP, 2008, PLOS BIOL, V6, P518, DOI 10.1371/journal.pbio.0060069; Grima B, 2004, NATURE, V431, P869, DOI 10.1038/nature02935; HAMBLEN M, 1986, J NEUROGENET, V3, P249, DOI 10.3109/01677068609106855; Hanai S, 2009, NEUROREPORT, V20, P755, DOI 10.1097/WNR.0b013e32832a7c4e; Helfrich-Forster C, 2007, J COMP NEUROL, V500, P47, DOI 10.1002/cne.21146; Helfrich-Forster C, 2002, J NEUROSCI, V22, P9255; Helfrich-Forster C, 2001, NEURON, V30, P249, DOI 10.1016/S0896-6273(01)00277-X; HELFRICHFORSTER C, 1995, P NATL ACAD SCI USA, V92, P612, DOI 10.1073/pnas.92.2.612; Hyun S, 2005, NEURON, V48, P267, DOI 10.1016/j.neuron.2005.08.025; Kaneko M, 1997, J NEUROSCI, V17, P6745; Klarsfeld A, 2004, J NEUROSCI, V24, P1468, DOI 10.1523/JNEUROSCI.3661-03.2004; Lear BC, 2005, NEURON, V48, P221, DOI 10.1016/j.neuron.2005.09.008; Lin Y, 2004, J NEUROSCI, V24, P7951, DOI 10.1523/JNEUROSCI.2370-04.2004; Majercak J, 1999, NEURON, V24, P219, DOI 10.1016/S0896-6273(00)80834-X; Malpel S, 2002, DEVELOPMENT, V129, P1443; Mertens I, 2005, NEURON, V48, P213, DOI 10.1016/j.neuron.2005.09.009; Mrosovsky N, 2005, J COMP PHYSIOL A, V191, P1011, DOI 10.1007/s00359-005-0017-1; Park JH, 2000, P NATL ACAD SCI USA, V97, P3608, DOI 10.1073/pnas.070036197; Peng Y, 2003, PLOS BIOL, V1, P32, DOI 10.1371/journal.pbio.0000013; Picot M, 2007, PLOS BIOL, V5, P2513, DOI 10.1371/journal.pbio.0050315; Picot M, 2009, J NEUROSCI, V29, P8312, DOI 10.1523/JNEUROSCI.0279-08.2009; Renn SCP, 1999, CELL, V99, P791, DOI 10.1016/S0092-8674(00)81676-1; Rieger D, 2003, J BIOL RHYTHM, V18, P377, DOI 10.1177/0748730403256997; Shafer OT, 2008, NEURON, V58, P223, DOI 10.1016/j.neuron.2008.02.018; Shafer OT, 2006, J COMP NEUROL, V498, P180, DOI 10.1002/cne.21021; Shang YH, 2008, P NATL ACAD SCI USA, V105, P19587, DOI 10.1073/pnas.0809577105; Sheeba V, 2008, CURR BIOL, V18, P1537, DOI 10.1016/j.cub.2008.08.033; Sheeba V, 2008, J NEUROPHYSIOL, V99, P976, DOI 10.1152/jn.00930.2007; Stanewsky R, 1998, CELL, V95, P681, DOI 10.1016/S0092-8674(00)81638-4; Stoleru D, 2005, NATURE, V438, P238, DOI 10.1038/nature04192; Stoleru D, 2004, NATURE, V431, P862, DOI 10.1038/nature02926; Stoleru D, 2007, CELL, V129, P207, DOI 10.1016/j.cell.2007.02.038; Taghert PH, 2001, J NEUROSCI, V21, P6673, DOI 10.1523/JNEUROSCI.21-17-06673.2001; Tomioka K, 1998, J INSECT PHYSIOL, V44, P587, DOI 10.1016/S0022-1910(98)00046-8; Veleri S, 2007, J BIOL RHYTHM, V22, P29, DOI 10.1177/0748730406295754; Wu Y, 2008, J BIOL RHYTHM, V23, P117, DOI 10.1177/0748730407312984; Wulbeck C, 2008, J BIOL RHYTHM, V23, P409, DOI 10.1177/0748730408322699; Yoshii T, 2008, J COMP NEUROL, V508, P952, DOI 10.1002/cne.21702; Yoshii T, 2009, J NEUROSCI, V29, P2597, DOI 10.1523/JNEUROSCI.5439-08.2009	50	65	69	2	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2009	12	11					1431	1437		10.1038/nn.2429	http://dx.doi.org/10.1038/nn.2429			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	511UE	19820704				2022-12-24	WOS:000271194100016
J	King, T; Vera-Portocarrero, L; Gutierrez, T; Vanderah, TW; Dussor, G; Lai, J; Fields, HL; Porreca, F				King, Tamara; Vera-Portocarrero, Louis; Gutierrez, Tannia; Vanderah, Todd W.; Dussor, Gregory; Lai, Josephine; Fields, Howard L.; Porreca, Frank			Unmasking the tonic-aversive state in neuropathic pain	NATURE NEUROSCIENCE			English	Article							CLINICAL-TRIALS; MECHANISMS	Tonic pain has been difficult to demonstrate in animals. Because relief of pain is rewarding, analgesic agents that are not rewarding in the absence of pain should become rewarding only when there is ongoing pain. We used conditioned place preference to concomitantly determine the presence of tonic pain in rats and the efficacy of agents that relieve it. This provides a new approach for investigating tonic pain in animals and for evaluating the analgesic effects of drugs.	[King, Tamara; Vera-Portocarrero, Louis; Gutierrez, Tannia; Vanderah, Todd W.; Dussor, Gregory; Lai, Josephine; Porreca, Frank] Univ Arizona, Dept Pharmacol, Tucson, AZ 85721 USA; [Fields, Howard L.] Univ Calif San Francisco, Ernest Gallo Clin & Res Ctr, Emeryville, CA USA	University of Arizona; University of California System; University of California San Francisco; Ernest Gallo Clinic & Research Center	Porreca, F (corresponding author), Univ Arizona, Dept Pharmacol, Tucson, AZ 85721 USA.	frankp@u.arizona.edu	Fields, Howard/ABG-9073-2020		NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS066958] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS066958-02, R01 NS066958] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Backonja MM, 2004, J PAIN, V5, P491, DOI 10.1016/j.jpain.2004.09.001; Boulton AJM, 2005, CLIN DIABETES, V23, P9, DOI DOI 10.2337/DIACLIN.23.1.9; Burgess SE, 2002, J NEUROSCI, V22, P5129, DOI 10.1523/JNEUROSCI.22-12-05129.2002; Campbell JN, 2006, NEURON, V52, P77, DOI 10.1016/j.neuron.2006.09.021; Decosterd I, 2000, PAIN, V87, P149, DOI 10.1016/S0304-3959(00)00276-1; Eisenach JC, 2003, PAIN, V105, P65, DOI 10.1016/S0304-3959(03)00158-1; Fields H, 2004, NAT REV NEUROSCI, V5, P565, DOI 10.1038/nrn1431; Johansen JP, 2001, P NATL ACAD SCI USA, V98, P8077, DOI 10.1073/pnas.141218998; Martin TJ, 2007, ANESTHESIOLOGY, V106, P312, DOI 10.1097/00000542-200702000-00020; Niikura K, 2008, NEUROSCI LETT, V435, P257, DOI 10.1016/j.neulet.2008.02.059; Rice ASC, 2008, PAIN, V139, P243, DOI 10.1016/j.pain.2008.08.017; Rowbotham MC, 2005, NEUROLOGY, V65, pS66, DOI 10.1212/WNL.65.12_suppl_4.S66; Skinner B. F., 1938, BEHAV ORGAN EXP ANAL; Ungless MA, 2004, SCIENCE, V303, P2040, DOI 10.1126/science.1093360; Vierck CJ, 2008, PAIN, V135, P7, DOI 10.1016/j.pain.2007.12.008	15	382	390	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2009	12	11					1364	1366		10.1038/nn.2407	http://dx.doi.org/10.1038/nn.2407			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	511UE	19783992	Green Accepted			2022-12-24	WOS:000271194100006
J	Nishiyama, A; Xin, L; Sharov, AA; Thomas, M; Mowrer, G; Meyers, E; Piao, YL; Mehta, S; Yee, S; Nakatake, Y; Stagg, C; Sharova, L; Correa-Cerro, LS; Bassey, U; Hoang, H; Kim, E; Tapnio, R; Qian, Y; Dudekula, D; Zalzman, M; Li, MX; Falco, G; Yang, HT; Lee, SL; Monti, M; Stanghellini, I; Islam, MN; Nagaraja, R; Goldberg, I; Wang, WD; Longo, DL; Schlessinger, D; Ko, MSH				Nishiyama, Akira; Xin, Li; Sharov, Alexei A.; Thomas, Marshall; Mowrer, Gregory; Meyers, Emily; Piao, Yulan; Mehta, Samir; Yee, Sarah; Nakatake, Yuhki; Stagg, Carole; Sharova, Lioudmila; Correa-Cerro, Lina S.; Bassey, Uwem; Hoang, Hien; Kim, Eugene; Tapnio, Richard; Qian, Yong; Dudekula, Dawood; Zalzman, Michal; Li, Manxiang; Falco, Geppino; Yang, Hsih-Te; Lee, Sung-Lim; Monti, Manuela; Stanghellini, Ilaria; Islam, Md. Nurul; Nagaraja, Ramaiah; Goldberg, Ilya; Wang, Weidong; Longo, Dan L.; Schlessinger, David; Ko, Minoru S. H.			Uncovering Early Response of Gene Regulatory Networks in ESCs by Systematic Induction of Transcription Factors	CELL STEM CELL			English	Article							EMBRYONIC STEM-CELLS; GENOME-WIDE; DEVELOPMENTAL REGULATORS; SIGNALING PATHWAYS; SELF-RENEWAL; MOUSE; PLURIPOTENCY; EXPRESSION; CHROMATIN; NANOG	To examine transcription factor (TF) network(s), we created mouse ESC lines, in each of which 1 of 50 TFs tagged with a FLAG moiety is inserted into a ubiquitously controllable tetracycline-repressible locus. Of the 50 TFs, Cdx2 provoked the most extensive transcriptome perturbation in ESCs, followed by Esx1, Sox9, Tcf3, KIN, and Gata3. ChIP-Seq revealed that CDX2 binds to promoters of upregulated target genes. By contrast, genes downregulated by CDX2 did not show CDX2 binding but were enriched with binding sites for POU5F1, SOX2, and NANOG. Genes with binding sites for these core TFs were also downregulated by the induction of at least 15 other TFs, suggesting a common initial step for ESC differentiation mediated by interference with the binding of core TFs to their target genes. These ESC lines provide a fundamental resource to study biological networks in ESCs and mice.	[Nishiyama, Akira; Xin, Li; Sharov, Alexei A.; Thomas, Marshall; Mowrer, Gregory; Meyers, Emily; Piao, Yulan; Mehta, Samir; Yee, Sarah; Nakatake, Yuhki; Stagg, Carole; Sharova, Lioudmila; Correa-Cerro, Lina S.; Bassey, Uwem; Hoang, Hien; Kim, Eugene; Tapnio, Richard; Qian, Yong; Dudekula, Dawood; Zalzman, Michal; Li, Manxiang; Falco, Geppino; Yang, Hsih-Te; Lee, Sung-Lim; Monti, Manuela; Stanghellini, Ilaria; Islam, Md. Nurul; Nagaraja, Ramaiah; Goldberg, Ilya; Wang, Weidong; Longo, Dan L.; Schlessinger, David; Ko, Minoru S. H.] NIA, NIH, Baltimore, MD 21224 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Ko, MSH (corresponding author), NIA, NIH, Baltimore, MD 21224 USA.	kom@mail.nih.gov	Ko, Minoru S. H./B-7969-2009; Longo, Dan L./F-6022-2011; Zalzman, Michal/Z-2121-2019; Wang, Weidong/AAV-2446-2021; Nakatake, Yuhki/K-5405-2013; Monti, Manuela/Z-2232-2019; Goldberg, Ilya/H-5307-2011	Ko, Minoru S. H./0000-0002-3530-3015; Monti, Manuela/0000-0001-9651-7490; Goldberg, Ilya/0000-0001-8514-6110; Wang, Weidong/0000-0002-0658-7928; YANG, HSIH-TE/0000-0002-4851-1374; Zalzman, Michal/0000-0002-4689-2951; Dudekula, Dawood/0000-0002-4054-1827; falco, geppino/0000-0001-6193-7233	Intramural Research Program of the NIH, National Institute on Aging; NATIONAL INSTITUTE ON AGING [ZIAAG000702, ZIAAG000647, ZIAAG000646, ZIAAG000678, ZIAAG000650, ZIAAG000704, ZIAAG000700, ZIAAG000662, ZIAAG000701, ZIAAG000706, ZICAG000674, ZIAAG000656, ZIAAG000703] Funding Source: NIH RePORTER	Intramural Research Program of the NIH, National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Dr. Hitoshi Niwa for providing the Tet-inducible vector system and some cDNA clones and for discussion. This research was supported entirely by the Intramural Research Program of the NIH, National Institute on Aging.	Aiba K, 2009, DNA RES, V16, P73, DOI 10.1093/dnares/dsn035; Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Berger MF, 2008, CELL, V133, P1266, DOI 10.1016/j.cell.2008.05.024; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Carter MG, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-7-r61; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Cloonan N, 2008, NAT METHODS, V5, P613, DOI 10.1038/nmeth.1223; Collins FS, 2007, CELL, V128, P9, DOI 10.1016/j.cell.2006.12.018; Davidson EH, 2006, REG GEN GEN REG; Denslow SA, 2007, ONCOGENE, V26, P5433, DOI 10.1038/sj.onc.1210611; Diez del Corral R, 2001, NAT REV NEUROSCI, V2, P835; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Kaji K, 2006, NAT CELL BIOL, V8, P285, DOI 10.1038/ncb1372; Kanamori M, 2004, BIOCHEM BIOPH RES CO, V322, P787, DOI 10.1016/j.bbrc.2004.07.179; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Klaffky E, 2001, DEV BIOL, V239, P161, DOI 10.1006/dbio.2001.0404; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Liang J, 2008, NAT CELL BIOL, V10, P731, DOI 10.1038/ncb1736; Lim CY, 2008, CELL STEM CELL, V3, P543, DOI 10.1016/j.stem.2008.08.004; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Masui S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni043; Matoba R, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000026; Meshorer E, 2006, NAT REV MOL CELL BIO, V7, P540, DOI 10.1038/nrm1938; Messina DN, 2004, GENOME RES, V14, P2041, DOI 10.1101/gr.2584104; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; Nakatake Y, 2006, MOL CELL BIOL, V26, P7772, DOI 10.1128/MCB.00468-06; Natale DR, 2002, MECH DEVELOP, V119, pS21, DOI 10.1016/S0925-4773(03)00086-8; Naya FJ, 1999, CURR OPIN CELL BIOL, V11, P683, DOI 10.1016/S0955-0674(99)00036-8; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Niwa H, 2005, CELL, V123, P917, DOI 10.1016/j.cell.2005.08.040; Niwa H, 2007, DEVELOPMENT, V134, P635, DOI 10.1242/dev.02787; Pritsker M, 2006, P NATL ACAD SCI USA, V103, P6946, DOI 10.1073/pnas.0509861103; Roh TY, 2006, P NATL ACAD SCI USA, V103, P15782, DOI 10.1073/pnas.0607617103; SCHOLER HR, 1991, CELL, V66, P291, DOI 10.1016/0092-8674(91)90619-A; Sharov AA, 2005, BIOINFORMATICS, V21, P2548, DOI 10.1093/bioinformatics/bti343; SHAROV AA, 2009, DNA RES IN PRESS; Sharov AA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-269; Silva J, 2008, CELL, V132, P532, DOI 10.1016/j.cell.2008.02.006; Simmons DG, 2005, DEV BIOL, V284, P12, DOI 10.1016/j.ydbio.2005.05.010; Skarnes WC, 2004, NAT GENET, V36, P543, DOI 10.1038/ng0604-543; Solter D, 2006, NAT REV GENET, V7, P319, DOI 10.1038/nrg1827; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Strumpf D, 2005, DEVELOPMENT, V132, P2093, DOI 10.1242/dev.01801; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Walker E, 2007, CELL STEM CELL, V1, P71, DOI 10.1016/j.stem.2007.04.002; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Yang JC, 2008, P NATL ACAD SCI USA, V105, P19756, DOI 10.1073/pnas.0809321105; YUAN HB, 1995, GENE DEV, V9, P2635, DOI 10.1101/gad.9.21.2635; Zhou Q, 2007, P NATL ACAD SCI USA, V104, P16438, DOI 10.1073/pnas.0701014104	59	146	150	1	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	OCT 2	2009	5	4					420	433		10.1016/j.stem.2009.07.012	http://dx.doi.org/10.1016/j.stem.2009.07.012			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	514NP	19796622	Green Accepted, Bronze			2022-12-24	WOS:000271401900013
J	Luksys, G; Gerstner, W; Sandi, C				Luksys, Gediminas; Gerstner, Wulfram; Sandi, Carmen			Stress, genotype and norepinephrine in the prediction of mouse behavior using reinforcement learning	NATURE NEUROSCIENCE			English	Article							MEDIAL PREFRONTAL CORTEX; LOCUS-COERULEUS; INDIVIDUAL-DIFFERENCES; NUCLEUS-ACCUMBENS; INBRED STRAINS; EXPRESSION; REWARD; MODULATION; PLASTICITY; DOPAMINE	Individual behavioral performance during learning is known to be affected by modulatory factors, such as stress and motivation, and by genetic predispositions that influence sensitivity to these factors. Despite numerous studies, no integrative framework is available that could predict how a given animal would perform a certain learning task in a realistic situation. We found that a simple reinforcement learning model can predict mouse behavior in a hole-box conditioning task if model metaparameters are dynamically controlled on the basis of the mouse's genotype and phenotype, stress conditions, recent performance feedback and pharmacological manipulations of adrenergic alpha-2 receptors. We find that stress and motivation affect behavioral performance by altering the exploration-exploitation balance in a genotype-dependent manner. Our results also provide computational insights into how an inverted U-shape relation between stress/arousal/norepinephrine levels and behavioral performance could be explained through changes in task performance accuracy and future reward discounting.	[Luksys, Gediminas; Gerstner, Wulfram] Ecole Polytech Fed Lausanne, Brain Mind Inst, Lab Computat Neurosci, Lausanne, Switzerland; [Luksys, Gediminas; Sandi, Carmen] Ecole Polytech Fed Lausanne, Brain Mind Inst, Lab Behav Genet, Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Luksys, G (corresponding author), Ecole Polytech Fed Lausanne, Brain Mind Inst, Lab Computat Neurosci, Lausanne, Switzerland.	eurogedi@hotmail.com	Luksys, Gediminas/A-2169-2010	Sandi, Carmen/0000-0001-7713-8321	Swiss National Science Foundation; Ecole Polytechnique Federale de Lausanne; collaborative Swiss National Science Foundation Sinergia Project	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Ecole Polytechnique Federale de Lausanne; collaborative Swiss National Science Foundation Sinergia Project(Swiss National Science Foundation (SNSF))	We would like to thank C. Rossetti and E. Gantelet for their help with experiments and E. Vasilaki for her useful comments on the manuscript. This work was supported by a grant from the Swiss National Science Foundation to C. S. by funds from Ecole Polytechnique Federale de Lausanne to W. G. and by a collaborative Swiss National Science Foundation Sinergia Project to W. G. and C. S.	Amat J, 2005, NAT NEUROSCI, V8, P365, DOI 10.1038/nn1399; Aston-Jones G, 2000, PROG BRAIN RES, V126, P165; Aston-Jones G, 2005, ANNU REV NEUROSCI, V28, P403, DOI 10.1146/annurev.neuro.28.061604.135709; Bailey CH, 2000, NAT REV NEUROSCI, V1, P11, DOI 10.1038/35036191; Behrens TEJ, 2007, NAT NEUROSCI, V10, P1214, DOI 10.1038/nn1954; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Briand LA, 2007, PROG NEUROBIOL, V83, P69, DOI 10.1016/j.pneurobio.2007.06.007; Cabib S, 2002, BEHAV BRAIN RES, V130, P103, DOI 10.1016/S0166-4328(01)00422-3; CIARANELLO RD, 1972, LIFE SCI, V11, P565, DOI 10.1016/0024-3205(72)90191-9; Clement Yan, 2007, Neural Plasticity, V2007, P1, DOI 10.1155/2007/35457; Dalley JW, 2007, SCIENCE, V315, P1267, DOI 10.1126/science.1137073; David DJP, 2003, PSYCHOPHARMACOLOGY, V166, P373, DOI 10.1007/s00213-002-1335-4; Dayan P, 2002, NEURON, V36, P285, DOI 10.1016/S0896-6273(02)00963-7; Doya K, 2002, NEURAL NETWORKS, V15, P495, DOI 10.1016/S0893-6080(02)00044-8; Doya K, 2008, NAT NEUROSCI, V11, P410, DOI 10.1038/nn2077; Frank MJ, 2007, P NATL ACAD SCI USA, V104, P16311, DOI 10.1073/pnas.0706111104; Herrero AI, 2006, NEUROBIOL LEARN MEM, V86, P150, DOI 10.1016/j.nlm.2006.02.001; Holmes A, 2002, GENES BRAIN BEHAV, V1, P55, DOI 10.1046/j.1601-1848.2001.00005.x; Homayoun H, 2003, BEHAV PHARMACOL, V14, P41, DOI 10.1097/00008877-200302000-00004; Joels M, 2006, TRENDS COGN SCI, V10, P152, DOI 10.1016/j.tics.2006.02.002; Kabbaj M, 2000, J NEUROSCI, V20, P6983, DOI 10.1523/JNEUROSCI.20-18-06983.2000; Kim JJ, 1998, TRENDS NEUROSCI, V21, P505, DOI 10.1016/S0166-2236(98)01322-8; Kim JJ, 2002, NAT REV NEUROSCI, V3, P453, DOI 10.1038/nrn849; LUKSYS G, 2007, ADV NEURAL INF PROCE, V19, P937; MARQUARDT DW, 1963, J SOC IND APPL MATH, V11, P431, DOI 10.1137/0111030; Moscarello JM, 2007, BRAIN RES, V1169, P69, DOI 10.1016/j.brainres.2007.06.064; Pattij T, 2008, TRENDS PHARMACOL SCI, V29, P192, DOI 10.1016/j.tips.2008.01.002; Press W. H., 1992, ART SCI COMPUTING; Redish AD, 2004, SCIENCE, V306, P1944, DOI 10.1126/science.1102384; Samejima K, 2005, SCIENCE, V310, P1337, DOI 10.1126/science.1115270; Samini M, 2008, PHARMACOL BIOCHEM BE, V88, P403, DOI 10.1016/j.pbb.2007.09.013; Sandi C, 1997, EUR J NEUROSCI, V9, P637, DOI 10.1111/j.1460-9568.1997.tb01412.x; Sandi Carmen, 2007, Neural Plasticity, V2007, DOI 10.1055/2007/78970; Sara SJ, 2009, NAT REV NEUROSCI, V10, P211, DOI 10.1038/nrn2573; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schweighofer N, 2008, J NEUROSCI, V28, P4528, DOI 10.1523/JNEUROSCI.4982-07.2008; Sutton R.S., 2015, REINFORCEMENT LEARNI, V2nd ed.; Tanaka SC, 2004, NAT NEUROSCI, V7, P887, DOI 10.1038/nn1279; Wickens JR, 1996, NEUROSCIENCE, V70, P1, DOI 10.1016/0306-4522(95)00436-M; Yu AJ, 2005, NEURON, V46, P681, DOI 10.1016/j.neuron.2005.04.026	40	56	57	3	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2009	12	9					1180	+		10.1038/nn.2374	http://dx.doi.org/10.1038/nn.2374			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	487ZD	19684590	Green Submitted, Green Published			2022-12-24	WOS:000269317300021
J	Mameli, M; Halbout, B; Creton, C; Engblom, D; Parkitna, JR; Spanagel, R; Luscher, C				Mameli, Manuel; Halbout, Briac; Creton, Cyril; Engblom, David; Parkitna, Jan Rodriguez; Spanagel, Rainer; Luescher, Christian			Cocaine-evoked synaptic plasticity: persistence in the VTA triggers adaptations in the NAc	NATURE NEUROSCIENCE			English	Article							VENTRAL TEGMENTAL AREA; LONG-TERM POTENTIATION; NUCLEUS-ACCUMBENS; DOPAMINE NEURONS; BEHAVIORAL SENSITIZATION; GLUTAMATE SYSTEMS; NMDA-RECEPTORS; AMPA RECEPTORS; IN-VIVO; MIDBRAIN	Addictive drugs hijack mechanisms of learning and memory that normally underlie reinforcement of natural rewards and induce synaptic plasticity of glutamatergic transmission in the mesolimbic dopamine (DA) system. In the ventral tegmental area (VTA), a single exposure to cocaine efficiently triggers NMDA receptor-dependent synaptic plasticity in DA neurons, whereas plasticity in the nucleus accumbens (NAc) occurs only after repeated injections. Whether these two forms of plasticity are independent or hierarchically organized remains unknown. We combined ex vivo electrophysiology in acute brain slices with behavioral assays modeling drug relapse in mice and found that the duration of the cocaine-evoked synaptic plasticity in the VTA is gated by mGluR1. Overriding mGluR1 in vivo made the potentiation in the VTA persistent. This led to synaptic plasticity in the NAc, which contributes to cocaine-seeking behavior after protracted withdrawal. Impaired mGluR1 function in vulnerable individuals could represent a first step in the recruitment of the neuronal network that underlies drug addiction.	[Mameli, Manuel; Creton, Cyril; Luescher, Christian] Univ Geneva, Fac Med, Dept Basic Neurosci, Geneva, Switzerland; [Halbout, Briac; Spanagel, Rainer] Cent Inst Mental Hlth, Dept Psychopharmacol, D-6800 Mannheim, Germany; [Engblom, David; Parkitna, Jan Rodriguez] German Canc Res Ctr, Div Mol Biol Cell 1, D-6900 Heidelberg, Germany; [Luescher, Christian] Univ Hosp Geneva, Dept Clin Neurosci, Neurol Clin, Geneva, Switzerland; [Luescher, Christian] Geneva Neurosci Ctr, Geneva, Switzerland	University of Geneva; Central Institute of Mental Health; Helmholtz Association; German Cancer Research Center (DKFZ); University of Geneva	Luscher, C (corresponding author), Univ Geneva, Fac Med, Dept Basic Neurosci, Geneva, Switzerland.	christian.luscher@unige.ch	Halbout, Briac/I-4646-2019; Lüscher, Christian/A-2496-2011; Rodriguez, Jan/I-2910-2012	Lüscher, Christian/0000-0001-7917-4596; Rodriguez, Jan/0000-0003-0367-2331; Mameli, Manuel/0000-0002-0570-6964	Swiss National Science Foundation; Swiss initiative in system biology; Nationales Genomforschungsnetz; Deutsche Forschungsgemeinschaft	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss initiative in system biology; Nationales Genomforschungsnetz; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank members of the Luscher laboratory, as well as B. J. Everitt, M. Frerking, A. Luthi, M. Serafin, M. Carta and C. F. Valenzuela for helpful discussions and suggestions regarding the manuscript. R. Sprengel (Max Planck Institute Heidelberg) generated the NR12<SUP>loxP/loxP</SUP> mouse line and G. Schutz (Deutsches Krebsforschungszentrum Heidelberg) provided the NR1<SUP>DAT-CreERT2</SUP> mouse line. C. L. is supported by grants from the Swiss National Science Foundation and the Swiss initiative in system biology (SystemsX: neurochoice). R. S. is supported by Nationales Genomforschungsnetz and Deutsche Forschungsgemeinschaft.	Anderson SM, 2008, NAT NEUROSCI, V11, P344, DOI 10.1038/nn2054; Argilli E, 2008, J NEUROSCI, V28, P9092, DOI 10.1523/JNEUROSCI.1001-08.2008; Bellone C, 2006, NAT NEUROSCI, V9, P636, DOI 10.1038/nn1682; Borgland SL, 2004, J NEUROSCI, V24, P7482, DOI 10.1523/JNEUROSCI.1312-04.2004; Boudreau AC, 2005, J NEUROSCI, V25, P9144, DOI 10.1523/JNEUROSCI.2252-05.2005; Carlezon WA, 2002, TRENDS NEUROSCI, V25, P610, DOI 10.1016/S0166-2236(02)02289-0; Chen BT, 2008, NEURON, V59, P288, DOI 10.1016/j.neuron.2008.05.024; Churchill L, 1999, J NEUROCHEM, V72, P2397, DOI 10.1046/j.1471-4159.1999.0722397.x; Conrad KL, 2008, NATURE, V454, P118, DOI 10.1038/nature06995; Dong Y, 2004, P NATL ACAD SCI USA, V101, P14282, DOI 10.1073/pnas.0401553101; Engblom D, 2008, NEURON, V59, P497, DOI 10.1016/j.neuron.2008.07.010; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; Grimm JW, 2001, NATURE, V412, P141, DOI 10.1038/35084134; Haber SN, 2000, J NEUROSCI, V20, P2369; Harris GC, 2004, NEUROSCIENCE, V129, P841, DOI 10.1016/j.neuroscience.2004.09.018; Ikemoto S, 2007, BRAIN RES REV, V56, P27, DOI 10.1016/j.brainresrev.2007.05.004; Kalivas PW, 2004, CURR OPIN PHARMACOL, V4, P23, DOI 10.1016/j.coph.2003.11.002; Kauer JA, 2007, NAT REV NEUROSCI, V8, P844, DOI 10.1038/nrn2234; Kessels HW, 2009, NEURON, V61, P340, DOI 10.1016/j.neuron.2009.01.015; Kourrich S, 2007, J NEUROSCI, V27, P7921, DOI 10.1523/JNEUROSCI.1859-07.2007; Lammel S, 2008, NEURON, V57, P760, DOI 10.1016/j.neuron.2008.01.022; Luscher C, 2008, NAT NEUROSCI, V11, P737, DOI 10.1038/nn0708-737; Mameli M, 2007, SCIENCE, V317, P530, DOI 10.1126/science.1142365; Mao LM, 2005, J NEUROSCI, V25, P2741, DOI 10.1523/JNEUROSCI.4360-04.2005; Mead AN, 2005, PSYCHOPHARMACOLOGY, V179, P164, DOI 10.1007/s00213-004-2071-8; Moroni F, 1997, J PHARMACOL EXP THER, V281, P721; Ping AS, 2008, BRAIN RES, V1215, P173, DOI 10.1016/j.brainres.2008.03.088; Ronesi JA, 2008, J NEUROSCI, V28, P543, DOI 10.1523/JNEUROSCI.5019-07.2008; Saal D, 2003, NEURON, V37, P577, DOI 10.1016/S0896-6273(03)00021-7; Thomas MJ, 2008, BRIT J PHARMACOL, V154, P327, DOI 10.1038/bjp.2008.77; Thomas MJ, 2001, NAT NEUROSCI, V4, P1217, DOI 10.1038/nn757; Ungless MA, 2001, NATURE, V411, P583, DOI 10.1038/35079077; Vezina P, 2000, PSYCHOPHARMACOLOGY, V151, P184, DOI 10.1007/s002130000463; Zhao SL, 2004, EUR J NEUROSCI, V19, P1133, DOI 10.1111/j.1460-9568.2004.03206.x; Zweifel LS, 2008, NEURON, V59, P486, DOI 10.1016/j.neuron.2008.05.028	35	269	276	0	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2009	12	8					1036	U108		10.1038/nn.2367	http://dx.doi.org/10.1038/nn.2367			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	475WS	19597494				2022-12-24	WOS:000268396300018
